id|nct_id|result_group_id|ctgov_group_code|period|reason|count
5013858|NCT04542694|17215441|P2|Overall Study|Protocol Violation|0
5013859|NCT04542694|17215442|P1|Overall Study|Protocol Violation|1
5013860|NCT04542694|17215441|P2|Overall Study|Adverse Event|0
5013861|NCT04542694|17215442|P1|Overall Study|Adverse Event|1
5013862|NCT04542694|17215441|P2|Overall Study|The need for prohibited therapy|0
5013863|NCT04542694|17215442|P1|Overall Study|The need for prohibited therapy|2
5013864|NCT04534491|17215470|P1|Overall Study|Non-verifiable users|58
5013865|NCT04534491|17215470|P1|Overall Study|Non-users|70
5013866|NCT04534491|17215470|P1|Overall Study|Not completed end-of-study interview|24
5013867|NCT04532164|17215565|P1|Overall Study|Withdrawal by Subject|14
5013868|NCT04532164|17215565|P1|Overall Study|Found to be Ineligible|3
5013869|NCT04532164|17215565|P1|Overall Study|Lost to Follow-up|1
5013870|NCT04532164|17215565|P1|Overall Study|Protocol Violation|5
5013871|NCT04532164|17215565|P1|Overall Study|Adverse Event|1
5013872|NCT04531813|17215576|P1|Overall Study|Withdrawal by Subject|1
5013873|NCT04531813|17215576|P1|Overall Study|Protocol Violation|1
5013874|NCT04531540|17215580|P1|Overall Study|Found to be Ineligible|1
5013875|NCT04531540|17215580|P1|Overall Study|Withdrawal by Subject|4
5013876|NCT04531540|17215580|P1|Overall Study|Protocol Violation|3
5013877|NCT04531540|17215580|P1|Overall Study|Adverse Event|1
5013878|NCT04531527|17215587|P1|Overall Study|Found to be Ineligible|3
5013879|NCT04523831|17215594|P2|Overall Study|Adverse Event|0
5013880|NCT04523831|17215595|P1|Overall Study|Adverse Event|2
5013881|NCT04523831|17215594|P2|Overall Study|Death|3
5013882|NCT04523831|17215595|P1|Overall Study|Death|0
5013883|NCT04523831|17215594|P2|Overall Study|Lost to Follow-up|17
5013884|NCT04523831|17215595|P1|Overall Study|Lost to Follow-up|15
5013885|NCT04502979|17215609|P2|Overall Study|Withdrawal by Subject|1
5013886|NCT04502979|17215610|P1|Overall Study|Withdrawal by Subject|2
5013887|NCT04502979|17215609|P2|Overall Study|Lost to Follow-up|3
5013888|NCT04502979|17215610|P1|Overall Study|Lost to Follow-up|1
5013889|NCT04491994|17215639|P2|Overall Study|Lost to Follow-up|3
5013890|NCT04491994|17215640|P1|Overall Study|Lost to Follow-up|4
5013891|NCT04491994|17215639|P2|Overall Study|Protocol Violation|2
5013892|NCT04491994|17215640|P1|Overall Study|Protocol Violation|11
5013893|NCT04491994|17215639|P2|Overall Study|developed fever > 3 days|1
5013894|NCT04491994|17215640|P1|Overall Study|developed fever > 3 days|4
5013895|NCT04491994|17215639|P2|Overall Study|Withdrawal by Subject|5
5013896|NCT04491994|17215640|P1|Overall Study|Withdrawal by Subject|10
5013897|NCT04483011|17215676|P2|Washout (7 Days)|Withdrawal by Subject|1
5013898|NCT04483011|17215677|P1|Washout (7 Days)|Withdrawal by Subject|0
5013899|NCT04474405|17215711|P6|Overall Study|Other|0
5013900|NCT04474405|17215712|P5|Overall Study|Other|3
5013901|NCT04474405|17215713|P4|Overall Study|Other|0
5013902|NCT04474405|17215714|P3|Overall Study|Other|0
5013903|NCT04474405|17215715|P2|Overall Study|Other|0
5013904|NCT04474405|17215716|P1|Overall Study|Other|0
5013905|NCT04474405|17215711|P6|Overall Study|Withdrawal by Subject|0
5013906|NCT04474405|17215712|P5|Overall Study|Withdrawal by Subject|1
5013907|NCT04474405|17215713|P4|Overall Study|Withdrawal by Subject|0
5013908|NCT04474405|17215714|P3|Overall Study|Withdrawal by Subject|1
5013909|NCT04474405|17215715|P2|Overall Study|Withdrawal by Subject|0
5013910|NCT04474405|17215716|P1|Overall Study|Withdrawal by Subject|0
5013911|NCT04468347|17215737|P4|Overall Study|Protocol Violation|0
5013912|NCT04468347|17215738|P3|Overall Study|Protocol Violation|0
5013913|NCT04468347|17215739|P2|Overall Study|Protocol Violation|0
5013914|NCT04468347|17215740|P1|Overall Study|Protocol Violation|1
5013915|NCT04468347|17215737|P4|Overall Study|Physician Decision|0
5013916|NCT04468347|17215738|P3|Overall Study|Physician Decision|2
5013917|NCT04468347|17215739|P2|Overall Study|Physician Decision|0
5013918|NCT04468347|17215740|P1|Overall Study|Physician Decision|1
5013919|NCT04468347|17215737|P4|Overall Study|Lost to Follow-up|1
5013920|NCT04468347|17215738|P3|Overall Study|Lost to Follow-up|1
5013921|NCT04468347|17215739|P2|Overall Study|Lost to Follow-up|0
5013922|NCT04468347|17215740|P1|Overall Study|Lost to Follow-up|0
5013923|NCT04468347|17215737|P4|Overall Study|Withdrawal by Subject|3
5013924|NCT04468347|17215738|P3|Overall Study|Withdrawal by Subject|3
5013925|NCT04468347|17215739|P2|Overall Study|Withdrawal by Subject|1
5013926|NCT04468347|17215740|P1|Overall Study|Withdrawal by Subject|0
5013927|NCT04435808|17215817|P2|Overall Study|Study stopped by DSMB|1
5013928|NCT04435808|17215818|P1|Overall Study|Study stopped by DSMB|0
5013929|NCT04425863|17215827|P3|Overall Study|Death|1
5013930|NCT04425863|17215828|P2|Overall Study|Death|0
5013931|NCT04425863|17215829|P1|Overall Study|Death|0
5013932|NCT04422561|17215862|P2|Overall Study|Lost to Follow-up|11
5013933|NCT04422561|17215863|P1|Overall Study|Lost to Follow-up|25
5013934|NCT04406194|17215904|P2|Period 1|Withdrawal by Subject|1
5013935|NCT04406194|17215905|P1|Period 1|Withdrawal by Subject|0
5013936|NCT04400682|17215919|P2|Period 1|Withdrawal by Subject|4
5013937|NCT04400682|17215920|P1|Period 1|Withdrawal by Subject|1
5013938|NCT04399161|17215935|P3|Overall Study|Protocol Violation|0
5013939|NCT04399161|17215936|P2|Overall Study|Protocol Violation|2
5013940|NCT04399161|17215937|P1|Overall Study|Protocol Violation|1
5013941|NCT04399161|17215935|P3|Overall Study|Withdrawal by Subject|2
5013942|NCT04399161|17215936|P2|Overall Study|Withdrawal by Subject|0
5013943|NCT04399161|17215937|P1|Overall Study|Withdrawal by Subject|1
5013944|NCT04393493|17215958|P2|First 4 Days of Intervention|Early improvement|7
5013945|NCT04393493|17215959|P1|First 4 Days of Intervention|Early improvement|5
5013946|NCT04376060|17216032|P1|Overall Study|Physician Decision|1
5013947|NCT04359771|17216097|P2|Overall Study|Lack of Efficacy|2
5013948|NCT04359771|17216098|P1|Overall Study|Lack of Efficacy|2
5013949|NCT04355663|17216113|P3|Overall Study|Withdrawal by Subject|3
5013950|NCT04355663|17216114|P2|Overall Study|Withdrawal by Subject|8
5013951|NCT04355663|17216115|P1|Overall Study|Withdrawal by Subject|0
5013952|NCT04355663|17216113|P3|Overall Study|Adverse Event|1
5013953|NCT04355663|17216114|P2|Overall Study|Adverse Event|0
5013954|NCT04355663|17216115|P1|Overall Study|Adverse Event|0
5013955|NCT04355663|17216113|P3|Overall Study|Physician Decision|0
5013956|NCT04355663|17216114|P2|Overall Study|Physician Decision|7
5013957|NCT04355663|17216115|P1|Overall Study|Physician Decision|2
5013958|NCT04350788|17216158|P2|Overall Study|Protocol Violation|0
5013959|NCT04350788|17216159|P1|Overall Study|Protocol Violation|4
5013960|NCT04350788|17216158|P2|Overall Study|Withdrawal by Subject|4
5013961|NCT04350788|17216159|P1|Overall Study|Withdrawal by Subject|2
5013962|NCT04350788|17216158|P2|Overall Study|Lost to Follow-up|2
5013963|NCT04350788|17216159|P1|Overall Study|Lost to Follow-up|6
5013964|NCT04348851|17216215|P4|Post-Test 2|Stroke survivor death|1
5013965|NCT04348851|17216216|P3|Post-Test 2|Stroke survivor death|0
5013966|NCT04348851|17216217|P2|Post-Test 2|Stroke survivor death|1
5013967|NCT04348851|17216218|P1|Post-Test 2|Stroke survivor death|0
5013968|NCT04348851|17216215|P4|Post-Test 1|Lost to Follow-up|0
5013969|NCT04348851|17216216|P3|Post-Test 1|Lost to Follow-up|0
5013970|NCT04348851|17216217|P2|Post-Test 1|Lost to Follow-up|1
5013971|NCT04348851|17216218|P1|Post-Test 1|Lost to Follow-up|0
5013972|NCT04348851|17216215|P4|Post-Test 1|Withdrawal by Subject|0
5013973|NCT04348851|17216216|P3|Post-Test 1|Withdrawal by Subject|0
5013974|NCT04348851|17216217|P2|Post-Test 1|Withdrawal by Subject|1
5013975|NCT04348851|17216218|P1|Post-Test 1|Withdrawal by Subject|0
5013976|NCT04343261|17216325|P1|Overall Study|received inadequate amount of antibodies|7
5013977|NCT04343261|17216325|P1|Overall Study|Adverse Event|1
5013978|NCT04339296|17216366|P2|Overall Study|Discontinued intervention|3
5013979|NCT04339296|17216367|P1|Overall Study|Discontinued intervention|5
5013980|NCT04339296|17216366|P2|Overall Study|Lost to Follow-up|4
5013981|NCT04339296|17216367|P1|Overall Study|Lost to Follow-up|0
5013982|NCT04339296|17216366|P2|Overall Study|Withdrew after completion of baseline|1
5013983|NCT04339296|17216367|P1|Overall Study|Withdrew after completion of baseline|2
5013984|NCT04339296|17216366|P2|Overall Study|Refuse to participate after allocation|1
5013985|NCT04339296|17216367|P1|Overall Study|Refuse to participate after allocation|1
5013986|NCT04336475|17216377|P2|Overall Study|Lost to Follow-up|2
5013987|NCT04336475|17216378|P1|Overall Study|Lost to Follow-up|0
5013988|NCT04336475|17216377|P2|Overall Study|upper respiratory infection|0
5013989|NCT04336475|17216378|P1|Overall Study|upper respiratory infection|1
5013990|NCT04336475|17216377|P2|Overall Study|pain|0
5013991|NCT04336475|17216378|P1|Overall Study|pain|1
5013992|NCT04322526|17216430|P2|Washout (1 Week)|Lost to Follow-up|2
5013993|NCT04322526|17216431|P1|Washout (1 Week)|Lost to Follow-up|1
5013994|NCT04322526|17216430|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5013995|NCT04322526|17216431|P1|First Intervention (1 Day)|Withdrawal by Subject|1
5013996|NCT04308239|17216450|P2|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
5013997|NCT04308239|17216451|P1|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
5013998|NCT04308239|17216450|P2|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
5013999|NCT04308239|17216451|P1|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
5014000|NCT04308239|17216450|P2|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
5014001|NCT04308239|17216451|P1|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
5014002|NCT04308239|17216450|P2|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
5014003|NCT04308239|17216451|P1|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
5014004|NCT04287517|17216517|P2|Overall Study|Withdrawal by Subject|1
5014005|NCT04287517|17216518|P1|Overall Study|Withdrawal by Subject|1
5014006|NCT04280705|17216552|P2|Overall Study|Transferred to another hospital|1
5014007|NCT04280705|17216553|P1|Overall Study|Transferred to another hospital|1
5014008|NCT04280705|17216552|P2|Overall Study|Adverse Event|4
5014009|NCT04280705|17216553|P1|Overall Study|Adverse Event|0
5014010|NCT04280705|17216552|P2|Overall Study|Withdrawal by Subject|9
5014011|NCT04280705|17216553|P1|Overall Study|Withdrawal by Subject|7
5014012|NCT04280705|17216552|P2|Overall Study|Physician Decision|0
5014013|NCT04280705|17216553|P1|Overall Study|Physician Decision|1
5014014|NCT04280705|17216552|P2|Overall Study|Enrolled but not treated|10
5014015|NCT04280705|17216553|P1|Overall Study|Enrolled but not treated|4
5014016|NCT04272775|17216645|P2|Overall Study|Progressive Disease|1
5014017|NCT04272775|17216646|P1|Overall Study|Progressive Disease|3
5014018|NCT04272775|17216645|P2|Overall Study|Adverse Event|2
5014019|NCT04272775|17216646|P1|Overall Study|Adverse Event|1
5014020|NCT04272775|17216645|P2|Overall Study|Withdrawal by Subject|2
5014021|NCT04272775|17216646|P1|Overall Study|Withdrawal by Subject|1
5014022|NCT04272775|17216645|P2|Overall Study|Symptomatic Deterioration|1
5014023|NCT04272775|17216646|P1|Overall Study|Symptomatic Deterioration|1
5014024|NCT04272775|17216645|P2|Overall Study|Protocol Violation|1
5014025|NCT04272775|17216646|P1|Overall Study|Protocol Violation|0
5014026|NCT04272775|17216645|P2|Overall Study|Study Terminated by Sponsor|0
5014027|NCT04272775|17216646|P1|Overall Study|Study Terminated by Sponsor|1
5014028|NCT04223232|17216845|P1|Overall Study|Withdrawal by Subject|1
5014029|NCT04222699|17216874|P1|Overall Study|Lost to Follow-up|2
5014030|NCT04214600|17216909|P2|Overall Study|Lost to Follow-up|14
5014031|NCT04214600|17216910|P1|Overall Study|Lost to Follow-up|9
5014032|NCT04195893|17216986|P2|Second Intervention|Withdrawal by Subject|0
5014033|NCT04195893|17216987|P1|Second Intervention|Withdrawal by Subject|1
5014034|NCT04194151|17217046|P6|Overall Study|Monitorization problem|0
5014035|NCT04194151|17217047|P5|Overall Study|Monitorization problem|0
5014036|NCT04194151|17217048|P4|Overall Study|Monitorization problem|0
5014037|NCT04194151|17217049|P3|Overall Study|Monitorization problem|0
5014038|NCT04194151|17217050|P2|Overall Study|Monitorization problem|1
5014039|NCT04194151|17217051|P1|Overall Study|Monitorization problem|0
5014040|NCT04194151|17217046|P6|Overall Study|Physician Decision|1
5014041|NCT04194151|17217047|P5|Overall Study|Physician Decision|0
5014042|NCT04194151|17217048|P4|Overall Study|Physician Decision|1
5014043|NCT04194151|17217049|P3|Overall Study|Physician Decision|1
5014044|NCT04194151|17217050|P2|Overall Study|Physician Decision|1
5014045|NCT04194151|17217051|P1|Overall Study|Physician Decision|1
5014046|NCT04186806|17217091|P2|Period 1: 7 Days|Adverse Event|0
5014047|NCT04186806|17217092|P1|Period 1: 7 Days|Adverse Event|1
5014048|NCT04179838|17217248|P2|Second Intervention (1 Day)|Protocol Violation|1
5014049|NCT04179838|17217249|P1|Second Intervention (1 Day)|Protocol Violation|0
5014050|NCT04179838|17217248|P2|First Intervention (1 Day)|Withdrawal by Subject|3
5014051|NCT04179838|17217249|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5014052|NCT04178590|17217267|P1|Overall Study|Lost to Follow-up|1
5014053|NCT04178590|17217267|P1|Overall Study|Pregnancy|1
5014054|NCT04173741|17217377|P2|Overall Study|IVC measurement cannot be done|1
5014055|NCT04173741|17217378|P1|Overall Study|IVC measurement cannot be done|1
5014056|NCT04161079|17217442|P1|Clinical Investigation 2010-040|Adverse Event|1
5014057|NCT04149353|17217602|P1|Overall Study|Study terminated|1
5014058|NCT04142216|17217630|P2|Overall Study|Use of clove|1
5014059|NCT04142216|17217631|P1|Overall Study|Use of clove|0
5014060|NCT04142216|17217630|P2|Overall Study|Referral to another hemodialysis unit|2
5014061|NCT04142216|17217631|P1|Overall Study|Referral to another hemodialysis unit|3
5014062|NCT04142216|17217630|P2|Overall Study|Death|1
5014063|NCT04142216|17217631|P1|Overall Study|Death|3
5014064|NCT04142216|17217630|P2|Overall Study|Hospitalization|2
5014065|NCT04142216|17217631|P1|Overall Study|Hospitalization|0
5014066|NCT04140890|17217653|P2|Overall Study|Withdrawal by Subject|1
5014067|NCT04140890|17217654|P1|Overall Study|Withdrawal by Subject|0
5014068|NCT04138810|17217682|P2|Overall Study|Subject cancelled surgery|0
5014069|NCT04138810|17217683|P1|Overall Study|Subject cancelled surgery|1
5014070|NCT04138810|17217682|P2|Overall Study|Withdrawal by Subject|1
5014071|NCT04138810|17217683|P1|Overall Study|Withdrawal by Subject|0
5014072|NCT04128293|17217729|P4|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5014073|NCT04128293|17217730|P3|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5014074|NCT04128293|17217731|P2|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5014075|NCT04128293|17217732|P1|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5014076|NCT04123665|17217932|P2|Overall Study|Lost to Follow-up|0
5014077|NCT04123665|17217933|P1|Overall Study|Lost to Follow-up|1
5014078|NCT04123665|17217932|P2|Overall Study|Withdrawal by Subject|0
5014079|NCT04123665|17217933|P1|Overall Study|Withdrawal by Subject|7
5014080|NCT04106817|17218016|P3|Overall Study|Lost to Follow-up|0
5014081|NCT04106817|17218017|P2|Overall Study|Lost to Follow-up|0
5014082|NCT04106817|17218018|P1|Overall Study|Lost to Follow-up|1
5014083|NCT04098809|17218034|P2|Overall Study|Physician Decision|1
5014084|NCT04098809|17218035|P1|Overall Study|Physician Decision|2
5014085|NCT04098809|17218034|P2|Overall Study|Withdrawal by Subject|3
5014086|NCT04098809|17218035|P1|Overall Study|Withdrawal by Subject|1
5014087|NCT04095286|17218061|P6|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5014088|NCT04095286|17218062|P5|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
5014089|NCT04095286|17218063|P4|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5014090|NCT04095286|17218064|P3|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5014091|NCT04095286|17218065|P2|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5014092|NCT04095286|17218066|P1|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5014093|NCT04095286|17218061|P6|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014094|NCT04095286|17218062|P5|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014095|NCT04095286|17218063|P4|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014096|NCT04095286|17218064|P3|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
5014097|NCT04095286|17218065|P2|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014098|NCT04095286|17218066|P1|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014099|NCT04095286|17218061|P6|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5014100|NCT04095286|17218062|P5|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5014101|NCT04095286|17218063|P4|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5014102|NCT04095286|17218064|P3|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
5014103|NCT04095286|17218065|P2|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5014104|NCT04095286|17218066|P1|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5014105|NCT04095286|17218061|P6|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5014106|NCT04095286|17218062|P5|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5014107|NCT04095286|17218063|P4|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5014108|NCT04095286|17218064|P3|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5014109|NCT04095286|17218065|P2|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5014110|NCT04095286|17218066|P1|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
5014192|NCT04015232|17219878|P2|Overall Study|Withdrawal by Subject|4
5014111|NCT04095286|17218061|P6|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014112|NCT04095286|17218062|P5|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014113|NCT04095286|17218063|P4|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014114|NCT04095286|17218064|P3|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014115|NCT04095286|17218065|P2|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
5014116|NCT04095286|17218066|P1|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5014117|NCT04091659|17218109|P2|Overall Study|Lost to Follow-up|1
5014118|NCT04091659|17218110|P1|Overall Study|Lost to Follow-up|0
5014119|NCT04091659|17218109|P2|Overall Study|Protocol Violation|0
5014120|NCT04091659|17218110|P1|Overall Study|Protocol Violation|3
5014121|NCT04090164|17218120|P2|Overall Study|incomplete data on file|0
5014122|NCT04090164|17218121|P1|Overall Study|incomplete data on file|245
5014123|NCT04080297|17218208|P2|Overall Study|concurrent illness|0
5014124|NCT04080297|17218209|P1|Overall Study|concurrent illness|1
5014125|NCT04080297|17218208|P2|Overall Study|Adverse Event|3
5014126|NCT04080297|17218209|P1|Overall Study|Adverse Event|1
5014127|NCT04079790|17218231|P4|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5014128|NCT04079790|17218232|P3|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
5014129|NCT04079790|17218233|P2|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5014130|NCT04079790|17218234|P1|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5014131|NCT04079790|17218231|P4|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5014132|NCT04079790|17218232|P3|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
5014133|NCT04079790|17218233|P2|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5014134|NCT04079790|17218234|P1|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5014135|NCT04079790|17218231|P4|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5014136|NCT04079790|17218232|P3|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5014137|NCT04079790|17218233|P2|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5014138|NCT04079790|17218234|P1|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
5014139|NCT04079114|17218378|P1|Overall Study|Study prematuely terminated.|166
5014140|NCT04067401|17218463|P2|Overall Study|no data provided|0
5014141|NCT04067401|17218464|P1|Overall Study|no data provided|1
5014142|NCT04067401|17218463|P2|Overall Study|Withdrawal by Subject|0
5014143|NCT04067401|17218464|P1|Overall Study|Withdrawal by Subject|7
5014144|NCT04067141|17218484|P2|Second Intervention|Adverse Event|2
5014145|NCT04067141|17218485|P1|Second Intervention|Adverse Event|0
5014146|NCT04067141|17218484|P2|First Intervention|Withdrawal by Subject|1
5014147|NCT04067141|17218485|P1|First Intervention|Withdrawal by Subject|0
5014148|NCT04054011|17218568|P1|Overall Study|COVID|3
5014149|NCT04053465|17218576|P2|Overall Study|Withdrawal by Subject|4
5014150|NCT04053465|17218577|P1|Overall Study|Withdrawal by Subject|4
5014151|NCT04053023|17218606|P2|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
5014152|NCT04053023|17218607|P1|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
5014153|NCT04050722|17218799|P2|Overall Study|Withdrawal by Subject|0
5014154|NCT04050722|17218800|P1|Overall Study|Withdrawal by Subject|1
5014155|NCT04050618|17218818|P2|Second Intervention|Withdrawal by Subject|0
5014156|NCT04050618|17218819|P1|Second Intervention|Withdrawal by Subject|1
5014157|NCT04050618|17218818|P2|First Intervention|Withdrawal by Subject|0
5014158|NCT04050618|17218819|P1|First Intervention|Withdrawal by Subject|2
5014159|NCT04049578|17218987|P1|Overall Study|Physician Decision|1
5014160|NCT04048681|17218997|P5|Overall Study|family emergency|0
5014161|NCT04048681|17218998|P4|Overall Study|family emergency|1
5014162|NCT04048681|17218999|P3|Overall Study|family emergency|0
5014163|NCT04048681|17219000|P2|Overall Study|family emergency|0
5014164|NCT04048681|17219001|P1|Overall Study|family emergency|0
5014165|NCT04043416|17219317|P2|Washout|Change in health condition|1
5014166|NCT04043416|17219318|P1|Washout|Change in health condition|0
5014167|NCT04037748|17219434|P2|Treatment Period 2|Protocol Violation|0
5014168|NCT04037748|17219435|P1|Treatment Period 2|Protocol Violation|2
5014169|NCT04037748|17219434|P2|Treatment Period 2|Adverse Event|1
5014170|NCT04037748|17219435|P1|Treatment Period 2|Adverse Event|0
5014171|NCT04037748|17219434|P2|Treatment Period 1|Protocol Violation|5
5014172|NCT04037748|17219435|P1|Treatment Period 1|Protocol Violation|4
5014173|NCT04037748|17219434|P2|Treatment Period 1|Adverse Event|1
5014174|NCT04037748|17219435|P1|Treatment Period 1|Adverse Event|1
5014175|NCT04037748|17219434|P2|Treatment Period 1|Withdrawal by Subject|0
5014176|NCT04037748|17219435|P1|Treatment Period 1|Withdrawal by Subject|3
5014177|NCT04035577|17219453|P1|Overall Study|Withdrawal by Subject|1
5014178|NCT04035577|17219453|P1|Overall Study|Lost to Follow-up|1
5014179|NCT04035564|17219473|P2|Overall Study|Guardian declined consent|2
5014180|NCT04035564|17219474|P1|Overall Study|Guardian declined consent|1
5014181|NCT04035564|17219473|P2|Overall Study|No laboratory available|2
5014182|NCT04035564|17219474|P1|Overall Study|No laboratory available|2
5014183|NCT04035564|17219473|P2|Overall Study|Protocol Violation|2
5014184|NCT04035564|17219474|P1|Overall Study|Protocol Violation|1
5014185|NCT04032652|17219505|P2|Overall Study|The study was terminated and the PI has|1
5014186|NCT04032652|17219506|P1|Overall Study|The study was terminated and the PI has|1
5014187|NCT04017611|17219779|P1|Overall Study|Withdrawn prior to completion|1
5014188|NCT04015232|17219878|P2|Overall Study|Medical Grounds|3
5014189|NCT04015232|17219879|P1|Overall Study|Medical Grounds|3
5014190|NCT04015232|17219878|P2|Overall Study|Protocol Violation|0
5014191|NCT04015232|17219879|P1|Overall Study|Protocol Violation|1
5014193|NCT04015232|17219879|P1|Overall Study|Withdrawal by Subject|7
5014194|NCT04014062|17219951|P2|Period I: Dosing|Withdrawal by Subject|1
5014195|NCT04014062|17219952|P1|Period I: Dosing|Withdrawal by Subject|3
5014196|NCT04014062|17219951|P2|Period I: Dosing|Medical Grounds|5
5014197|NCT04014062|17219952|P1|Period I: Dosing|Medical Grounds|4
5014198|NCT04007107|17220035|P4|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5014199|NCT04007107|17220036|P3|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5014200|NCT04007107|17220037|P2|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
5014201|NCT04007107|17220038|P1|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5014202|NCT04006366|17220066|P1|Overall Study|Withdrawal by Subject|1
5014203|NCT04002960|17220087|P1|Overall Study|Withdrawn prior to Completion|2
5014204|NCT04002648|17220104|P2|Overall Study|Lost to Follow-up|0
5014205|NCT04002648|17220105|P1|Overall Study|Lost to Follow-up|2
5014206|NCT04000815|17220116|P3|Overall Study|Hypertension occured on follow up|2
5014207|NCT04000815|17220117|P2|Overall Study|Hypertension occured on follow up|0
5014208|NCT04000815|17220118|P1|Overall Study|Hypertension occured on follow up|0
5014209|NCT04000815|17220116|P3|Overall Study|Right ovarian cyst occured|0
5014210|NCT04000815|17220117|P2|Overall Study|Right ovarian cyst occured|0
5014211|NCT04000815|17220118|P1|Overall Study|Right ovarian cyst occured|1
5014212|NCT04000815|17220116|P3|Overall Study|Withdrawal by Subject|2
5014213|NCT04000815|17220117|P2|Overall Study|Withdrawal by Subject|3
5014214|NCT04000815|17220118|P1|Overall Study|Withdrawal by Subject|4
5014215|NCT04000815|17220116|P3|Overall Study|Lost to Follow-up|3
5014216|NCT04000815|17220117|P2|Overall Study|Lost to Follow-up|2
5014217|NCT04000815|17220118|P1|Overall Study|Lost to Follow-up|9
5014218|NCT03997825|17220138|P1|Overall Study|Refused participation|1
5014219|NCT03997825|17220138|P1|Overall Study|Withdrawal by Subject|3
5014220|NCT03997825|17220138|P1|Overall Study|Lost to Follow-up|10
5014221|NCT03997825|17220138|P1|Overall Study|Death|3
5014222|NCT03988907|17220284|P2|Overall Study|Unable to complete visit|1
5014223|NCT03988907|17220285|P1|Overall Study|Unable to complete visit|0
5014224|NCT03988088|17220341|P4|Open-Label Addendum|Lost to Follow-up|0
5014225|NCT03988088|17220342|P3|Open-Label Addendum|Lost to Follow-up|1
5014226|NCT03988088|17220343|P2|Open-Label Addendum|Lost to Follow-up|0
5014227|NCT03988088|17220344|P1|Open-Label Addendum|Lost to Follow-up|0
5014228|NCT03988088|17220341|P4|Single-Dose Pharmacokinetic Study|Adverse Event|0
5014229|NCT03988088|17220342|P3|Single-Dose Pharmacokinetic Study|Adverse Event|0
5014230|NCT03988088|17220343|P2|Single-Dose Pharmacokinetic Study|Adverse Event|1
5014231|NCT03988088|17220344|P1|Single-Dose Pharmacokinetic Study|Adverse Event|0
5014232|NCT03984825|17220414|P1|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
5014233|NCT03984825|17220414|P1|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
5014234|NCT03984825|17220414|P1|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
5014235|NCT03983317|17220528|P1|Overall Study|Physician Decision|5
5014236|NCT03982433|17220535|P1|Overall Study|Lost to Follow-up|1
5014237|NCT03977727|17220586|P2|Second Treatment|Lost to Follow-up|3
5014238|NCT03977727|17220587|P1|Second Treatment|Lost to Follow-up|0
5014239|NCT03976466|17220633|P2|Overall Study|Lost to Follow-up|3
5014240|NCT03976466|17220634|P1|Overall Study|Lost to Follow-up|1
5014241|NCT03972137|17220983|P1|Overall Study|Withdrawal by Subject|4
5014242|NCT03972137|17220983|P1|Overall Study|Lost to Follow-up|2
5014243|NCT03970395|17221007|P2|Overall Study|Lost to Follow-up|8
5014244|NCT03970395|17221008|P1|Overall Study|Lost to Follow-up|4
5014245|NCT03970395|17221007|P2|Overall Study|Withdrawal by Subject|4
5014246|NCT03970395|17221008|P1|Overall Study|Withdrawal by Subject|3
5014247|NCT03966365|17221026|P2|Overall Study|Protocol Violation|0
5014248|NCT03966365|17221027|P1|Overall Study|Protocol Violation|1
5014249|NCT03965403|17221162|P1|Overall Study|Subject not meeting eligibility criteria|1
5014250|NCT03965052|17221175|P2|Overall Study|Protocol Violation|0
5014251|NCT03965052|17221176|P1|Overall Study|Protocol Violation|1
5014252|NCT03962790|17221272|P2|Period 1|Withdrawal by Subject|0
5014253|NCT03962790|17221273|P1|Period 1|Withdrawal by Subject|1
5014254|NCT03962790|17221272|P2|Period 1|No Longer Meets Eligibility Criteria|0
5014255|NCT03962790|17221273|P1|Period 1|No Longer Meets Eligibility Criteria|1
5014256|NCT03962790|17221272|P2|Period 1|Failed to meet all eligibility criteria|1
5014257|NCT03962790|17221273|P1|Period 1|Failed to meet all eligibility criteria|1
5014258|NCT03962790|17221272|P2|Period 1|Adverse Event|1
5014259|NCT03962790|17221273|P1|Period 1|Adverse Event|0
5014260|NCT03961308|17221308|P2|Overall Study|Adverse Event|1
5014261|NCT03961308|17221309|P1|Overall Study|Adverse Event|0
5014262|NCT03961308|17221308|P2|Overall Study|Lost to Follow-up|1
5014263|NCT03961308|17221309|P1|Overall Study|Lost to Follow-up|0
5014264|NCT03961308|17221308|P2|Overall Study|Other|0
5014265|NCT03961308|17221309|P1|Overall Study|Other|1
5014266|NCT03961308|17221308|P2|Overall Study|Withdrawal by Subject|0
5014267|NCT03961308|17221309|P1|Overall Study|Withdrawal by Subject|1
5014268|NCT03953820|17221473|P3|Two-Sequence, Two-Way Crossover|Physician Decision|0
5014269|NCT03953820|17221474|P2|Two-Sequence, Two-Way Crossover|Physician Decision|0
5014270|NCT03953820|17221475|P1|Two-Sequence, Two-Way Crossover|Physician Decision|1
5014271|NCT03953820|17221473|P3|Two-Sequence, Two-Way Crossover|Adverse Event|0
5014272|NCT03953820|17221474|P2|Two-Sequence, Two-Way Crossover|Adverse Event|0
5014273|NCT03953820|17221475|P1|Two-Sequence, Two-Way Crossover|Adverse Event|1
5014274|NCT03950674|17221528|P2|Overall Study|Ongoing in Study|8
5014275|NCT03950674|17221529|P1|Overall Study|Ongoing in Study|22
5014276|NCT03950674|17221528|P2|Overall Study|Death|7
5014277|NCT03950674|17221529|P1|Overall Study|Death|3
5014278|NCT03948581|17221563|P2|Overall Study|Lost to Follow-up|1
5014279|NCT03948581|17221564|P1|Overall Study|Lost to Follow-up|0
5014280|NCT03946124|17221574|P1|Overall Study|Withdrawal by Subject|19
5014281|NCT03943095|17221580|P2|Overall Study|Withdrawal by Subject|0
5014282|NCT03943095|17221581|P1|Overall Study|Withdrawal by Subject|1
5014283|NCT03943095|17221580|P2|Overall Study|Incorrectly dispensed wrong box kit|1
5014284|NCT03943095|17221581|P1|Overall Study|Incorrectly dispensed wrong box kit|0
5014285|NCT03937479|17221630|P5|Overall Study|Physician Decision|1
5014286|NCT03937479|17221631|P4|Overall Study|Physician Decision|0
5014287|NCT03937479|17221632|P3|Overall Study|Physician Decision|1
5014288|NCT03937479|17221633|P2|Overall Study|Physician Decision|0
5014289|NCT03937479|17221634|P1|Overall Study|Physician Decision|0
5014290|NCT03937479|17221630|P5|Overall Study|Lost to Follow-up|0
5014291|NCT03937479|17221631|P4|Overall Study|Lost to Follow-up|1
5014292|NCT03937479|17221632|P3|Overall Study|Lost to Follow-up|0
5014293|NCT03937479|17221633|P2|Overall Study|Lost to Follow-up|1
5014294|NCT03937479|17221634|P1|Overall Study|Lost to Follow-up|0
5014295|NCT03937479|17221630|P5|Overall Study|Protocol Violation|2
5014296|NCT03937479|17221631|P4|Overall Study|Protocol Violation|3
5014297|NCT03937479|17221632|P3|Overall Study|Protocol Violation|4
5014298|NCT03937479|17221633|P2|Overall Study|Protocol Violation|6
5014299|NCT03937479|17221634|P1|Overall Study|Protocol Violation|5
5014300|NCT03937479|17221630|P5|Overall Study|Withdrawal by Subject|1
5014301|NCT03937479|17221631|P4|Overall Study|Withdrawal by Subject|2
5014302|NCT03937479|17221632|P3|Overall Study|Withdrawal by Subject|2
5014303|NCT03937479|17221633|P2|Overall Study|Withdrawal by Subject|5
5014304|NCT03937479|17221634|P1|Overall Study|Withdrawal by Subject|3
5014305|NCT03937479|17221630|P5|Overall Study|Adverse Event|1
5014306|NCT03937479|17221631|P4|Overall Study|Adverse Event|0
5014307|NCT03937479|17221632|P3|Overall Study|Adverse Event|0
5014308|NCT03937479|17221633|P2|Overall Study|Adverse Event|3
5014309|NCT03937479|17221634|P1|Overall Study|Adverse Event|2
5014310|NCT03936244|17221728|P2|Overall Study|Physician Decision|3
5014311|NCT03936244|17221729|P1|Overall Study|Physician Decision|7
5014312|NCT03936244|17221728|P2|Overall Study|Lost to Follow-up|1
5014313|NCT03936244|17221729|P1|Overall Study|Lost to Follow-up|5
5014314|NCT03933449|17222067|P2|Overall Study|Ongoing in Study|6
5014315|NCT03933449|17222068|P1|Overall Study|Ongoing in Study|20
5014316|NCT03933449|17222067|P2|Overall Study|Death|51
5014317|NCT03933449|17222068|P1|Overall Study|Death|36
5014318|NCT03933449|17222067|P2|Overall Study|Adverse Event|4
5014319|NCT03933449|17222068|P1|Overall Study|Adverse Event|6
5014320|NCT03927950|17222144|P1|Overall Study|Adverse Event|9
5014321|NCT03923933|17222177|P2|Overall Study|Withdrawal by Subject|1
5014322|NCT03923933|17222178|P1|Overall Study|Withdrawal by Subject|0
5014323|NCT03923933|17222177|P2|Overall Study|Lost to Follow-up|0
5014324|NCT03923933|17222178|P1|Overall Study|Lost to Follow-up|1
5014325|NCT03923530|17222196|P1|Overall Study|screen failure|3
5014326|NCT03923530|17222196|P1|Overall Study|Withdrawal by Subject|1
5014327|NCT03921723|17222206|P1|Period 3 (4 Days)|Withdrawal by Subject|1
5014328|NCT03921723|17222206|P1|Period 2 (4 Days)|Withdrawal by Subject|3
5014329|NCT03914950|17222274|P1|Overall Study|Physician Decision|54
5014330|NCT03914417|17222284|P1|Overall Study|Withdrawal by Subject|2
5014331|NCT03913377|17222291|P3|Period 1|No Longer Meets Eligibility Criteria|1
5014332|NCT03913377|17222292|P2|Period 1|No Longer Meets Eligibility Criteria|0
5014333|NCT03913377|17222293|P1|Period 1|No Longer Meets Eligibility Criteria|0
5014334|NCT03913377|17222291|P3|Period 1|Test Article no longer available|0
5014335|NCT03913377|17222292|P2|Period 1|Test Article no longer available|1
5014336|NCT03913377|17222293|P1|Period 1|Test Article no longer available|0
5014337|NCT03911960|17222310|P2|Overall Study|Lost to Follow-up|3
5014338|NCT03911960|17222311|P1|Overall Study|Lost to Follow-up|5
5014339|NCT03905642|17222510|P1|Overall Study|Completed study but not 24 of 28 days|2
5014340|NCT03905642|17222510|P1|Overall Study|Lack of Efficacy|1
5014341|NCT03905642|17222510|P1|Overall Study|Adverse Event|1
5014342|NCT03905642|17222510|P1|Overall Study|Pregnancy|1
5014343|NCT03905642|17222510|P1|Overall Study|Withdrawal by Subject|3
5014344|NCT03904420|17222521|P2|Overall Study|Study terminated|2
5014345|NCT03904420|17222522|P1|Overall Study|Study terminated|2
5014346|NCT03902613|17222528|P1|Overall Study|Physician Decision|1
5014347|NCT03902392|17222534|P2|Overall Study|Lost to Follow-up|7
5014348|NCT03902392|17222535|P1|Overall Study|Lost to Follow-up|7
5014349|NCT03899064|17222601|P1|Overall Study|Other|2
5014350|NCT03899064|17222601|P1|Overall Study|Withdrawal by Subject|2
5014351|NCT03899064|17222601|P1|Overall Study|Protocol Violation|2
5014352|NCT03899064|17222601|P1|Overall Study|Lost to Follow-up|1
5014353|NCT03897179|17222616|P1|Overall Study|Withdrawal by Subject|1
5014354|NCT03892564|17222842|P1|Overall Study|Withdrawal by Subject|2
5014355|NCT03891641|17222850|P2|Overall Study|Study Stoppage Due to COVID-19|2
5014356|NCT03891641|17222851|P1|Overall Study|Study Stoppage Due to COVID-19|2
5014357|NCT03888482|17222896|P2|Second Wear (8 -1/+2 Days)|Other|0
5014358|NCT03888482|17222897|P1|Second Wear (8 -1/+2 Days)|Other|1
5014359|NCT03888482|17222896|P2|Second Wear (8 -1/+2 Days)|Adverse Event|1
5014360|NCT03888482|17222897|P1|Second Wear (8 -1/+2 Days)|Adverse Event|0
5014361|NCT03888391|17222916|P1|Overall Study|Lost to Follow-up|15
5014362|NCT03885726|17222980|P1|Overall Study|Early discharge from hospital|3
5014363|NCT03885726|17222980|P1|Overall Study|Staffing issues/lost interest|1
5014364|NCT03883386|17223046|P2|First Assignment|Withdrawal by Subject|1
5014365|NCT03883386|17223047|P1|First Assignment|Withdrawal by Subject|1
5014366|NCT03883386|17223046|P2|First Assignment|Lost to Follow-up|0
5014367|NCT03883386|17223047|P1|First Assignment|Lost to Follow-up|1
5014368|NCT03882801|17223057|P2|Period 2|Non-compliance with study drug|1
5014369|NCT03882801|17223058|P1|Period 2|Non-compliance with study drug|0
5014370|NCT03882801|17223057|P2|Washout Period|Physician Decision|1
5014371|NCT03882801|17223058|P1|Washout Period|Physician Decision|0
5014372|NCT03882801|17223057|P2|Period 1|Never treated with study drug|0
5014373|NCT03882801|17223058|P1|Period 1|Never treated with study drug|1
5014374|NCT03882801|17223057|P2|Period 1|Non-compliance with study drug|1
5014375|NCT03882801|17223058|P1|Period 1|Non-compliance with study drug|1
5014376|NCT03882801|17223057|P2|Period 1|Adverse Event|1
5014377|NCT03882801|17223058|P1|Period 1|Adverse Event|0
5014378|NCT03882424|17223073|P3|Overall Study|schedule conflict|0
5014379|NCT03882424|17223074|P2|Overall Study|schedule conflict|0
5014380|NCT03882424|17223075|P1|Overall Study|schedule conflict|1
5014381|NCT03882424|17223073|P3|Overall Study|Lost to Follow-up|0
5014382|NCT03882424|17223074|P2|Overall Study|Lost to Follow-up|0
5014383|NCT03882424|17223075|P1|Overall Study|Lost to Follow-up|3
5014384|NCT03882047|17223098|P3|Overall Study|Did Not Meet Eligibility|1
5014385|NCT03882047|17223099|P2|Overall Study|Did Not Meet Eligibility|0
5014386|NCT03882047|17223100|P1|Overall Study|Did Not Meet Eligibility|0
5014387|NCT03882047|17223098|P3|Overall Study|Noncompliance With Protocol|0
5014388|NCT03882047|17223099|P2|Overall Study|Noncompliance With Protocol|0
5014389|NCT03882047|17223100|P1|Overall Study|Noncompliance With Protocol|2
5014390|NCT03882047|17223098|P3|Overall Study|Did Not Wish to Continue|1
5014391|NCT03882047|17223099|P2|Overall Study|Did Not Wish to Continue|4
5014392|NCT03882047|17223100|P1|Overall Study|Did Not Wish to Continue|1
5014393|NCT03882047|17223098|P3|Overall Study|Lost to Follow-up|0
5014394|NCT03882047|17223099|P2|Overall Study|Lost to Follow-up|1
5014395|NCT03882047|17223100|P1|Overall Study|Lost to Follow-up|0
5014396|NCT03882047|17223098|P3|Overall Study|Treatment Failure|12
5014397|NCT03882047|17223099|P2|Overall Study|Treatment Failure|3
5014398|NCT03882047|17223100|P1|Overall Study|Treatment Failure|3
5014399|NCT03882047|17223098|P3|Overall Study|Adverse Event|2
5014400|NCT03882047|17223099|P2|Overall Study|Adverse Event|2
5014401|NCT03882047|17223100|P1|Overall Study|Adverse Event|0
5014402|NCT03879772|17223156|P5|Overall Study|Did Not Meet Entry Requirements|0
5014403|NCT03879772|17223157|P4|Overall Study|Did Not Meet Entry Requirements|0
5014404|NCT03879772|17223158|P3|Overall Study|Did Not Meet Entry Requirements|1
5014405|NCT03879772|17223159|P2|Overall Study|Did Not Meet Entry Requirements|0
5014406|NCT03879772|17223160|P1|Overall Study|Did Not Meet Entry Requirements|1
5014407|NCT03879772|17223156|P5|Overall Study|Protocol Violation|2
5014408|NCT03879772|17223157|P4|Overall Study|Protocol Violation|1
5014409|NCT03879772|17223158|P3|Overall Study|Protocol Violation|3
5014410|NCT03879772|17223159|P2|Overall Study|Protocol Violation|0
5014411|NCT03879772|17223160|P1|Overall Study|Protocol Violation|0
5014412|NCT03879772|17223156|P5|Overall Study|Withdrawal by Subject|1
5014413|NCT03879772|17223157|P4|Overall Study|Withdrawal by Subject|1
5014414|NCT03879772|17223158|P3|Overall Study|Withdrawal by Subject|3
5014415|NCT03879772|17223159|P2|Overall Study|Withdrawal by Subject|1
5014416|NCT03879772|17223160|P1|Overall Study|Withdrawal by Subject|0
5014417|NCT03879772|17223156|P5|Overall Study|Lost to Follow-up|1
5014418|NCT03879772|17223157|P4|Overall Study|Lost to Follow-up|0
5014419|NCT03879772|17223158|P3|Overall Study|Lost to Follow-up|0
5014420|NCT03879772|17223159|P2|Overall Study|Lost to Follow-up|0
5014421|NCT03879772|17223160|P1|Overall Study|Lost to Follow-up|0
5014422|NCT03879772|17223156|P5|Overall Study|Treatment Failure|1
5014423|NCT03879772|17223157|P4|Overall Study|Treatment Failure|2
5014424|NCT03879772|17223158|P3|Overall Study|Treatment Failure|0
5014425|NCT03879772|17223159|P2|Overall Study|Treatment Failure|0
5014426|NCT03879772|17223160|P1|Overall Study|Treatment Failure|1
5014427|NCT03879772|17223156|P5|Overall Study|Adverse Event|3
5014428|NCT03879772|17223157|P4|Overall Study|Adverse Event|4
5014429|NCT03879772|17223158|P3|Overall Study|Adverse Event|3
5014430|NCT03879772|17223159|P2|Overall Study|Adverse Event|2
5014431|NCT03879772|17223160|P1|Overall Study|Adverse Event|2
5014432|NCT03878758|17223197|P1|Overall Study|Improper consent documentation|1
5014433|NCT03878758|17223197|P1|Overall Study|Protocol defined|2
5014434|NCT03878758|17223197|P1|Overall Study|Withdrawal by Subject|1
5014435|NCT03876743|17223238|P4|Overall Study|Lost to Follow-up|7
5014436|NCT03876743|17223239|P3|Overall Study|Lost to Follow-up|4
5014437|NCT03876743|17223240|P2|Overall Study|Lost to Follow-up|4
5014438|NCT03876743|17223241|P1|Overall Study|Lost to Follow-up|6
5014439|NCT03870997|17223336|P6|Overall Study|Did not complete mid-study/final survey|10531
5014440|NCT03870997|17223337|P5|Overall Study|Did not complete mid-study/final survey|10588
5014441|NCT03870997|17223338|P4|Overall Study|Did not complete mid-study/final survey|10947
5014442|NCT03870997|17223339|P3|Overall Study|Did not complete mid-study/final survey|10978
5014443|NCT03870997|17223340|P2|Overall Study|Did not complete mid-study/final survey|10431
5014444|NCT03870997|17223341|P1|Overall Study|Did not complete mid-study/final survey|10544
5014445|NCT03870555|17223408|P3|Period 3 (2 Days)|Adverse Event|0
5014446|NCT03870555|17223409|P2|Period 3 (2 Days)|Adverse Event|0
5014447|NCT03870555|17223410|P1|Period 3 (2 Days)|Adverse Event|1
5014448|NCT03868631|17223496|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
5014449|NCT03868631|17223497|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
5014450|NCT03868631|17223496|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
5014451|NCT03868631|17223497|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
5014452|NCT03868631|17223496|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
5014453|NCT03868631|17223497|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
5014454|NCT03868631|17223496|P2|Baseline to Week 6|Withdrawal by Subject|0
5014455|NCT03868631|17223497|P1|Baseline to Week 6|Withdrawal by Subject|3
5014456|NCT03868631|17223496|P2|Baseline to Week 6|Protocol Violation|1
5014457|NCT03868631|17223497|P1|Baseline to Week 6|Protocol Violation|1
5014458|NCT03868631|17223496|P2|Baseline to Week 6|Adverse Event|3
5014459|NCT03868631|17223497|P1|Baseline to Week 6|Adverse Event|0
5014460|NCT03864653|17223585|P1|Overall Study|Withdrawal by Subject|1
5014461|NCT03861559|17223625|P2|Overall Study|Did not meet eligibility requirements|0
5014462|NCT03861559|17223626|P1|Overall Study|Did not meet eligibility requirements|1
5014463|NCT03861559|17223625|P2|Overall Study|Noncompliance|1
5014464|NCT03861559|17223626|P1|Overall Study|Noncompliance|1
5014465|NCT03861559|17223625|P2|Overall Study|Treatment failure|2
5014466|NCT03861559|17223626|P1|Overall Study|Treatment failure|0
5014467|NCT03861559|17223625|P2|Overall Study|Adverse Event|2
5014468|NCT03861559|17223626|P1|Overall Study|Adverse Event|0
5014469|NCT03855228|17223809|P4|Overall Study|Did Not Meet Entry Requirements|1
5014470|NCT03855228|17223810|P3|Overall Study|Did Not Meet Entry Requirements|1
5014471|NCT03855228|17223811|P2|Overall Study|Did Not Meet Entry Requirements|2
5014472|NCT03855228|17223812|P1|Overall Study|Did Not Meet Entry Requirements|0
5014473|NCT03855228|17223809|P4|Overall Study|Protocol Violation|1
5014474|NCT03855228|17223810|P3|Overall Study|Protocol Violation|2
5014475|NCT03855228|17223811|P2|Overall Study|Protocol Violation|1
5014476|NCT03855228|17223812|P1|Overall Study|Protocol Violation|0
5014477|NCT03855228|17223809|P4|Overall Study|Lost to Follow-up|1
5014478|NCT03855228|17223810|P3|Overall Study|Lost to Follow-up|0
5014479|NCT03855228|17223811|P2|Overall Study|Lost to Follow-up|0
5014480|NCT03855228|17223812|P1|Overall Study|Lost to Follow-up|0
5014481|NCT03855228|17223809|P4|Overall Study|Treatment Failure|8
5014482|NCT03855228|17223810|P3|Overall Study|Treatment Failure|1
5014483|NCT03855228|17223811|P2|Overall Study|Treatment Failure|2
5014484|NCT03855228|17223812|P1|Overall Study|Treatment Failure|1
5014485|NCT03855228|17223809|P4|Overall Study|Adverse Event|8
5014486|NCT03855228|17223810|P3|Overall Study|Adverse Event|4
5014487|NCT03855228|17223811|P2|Overall Study|Adverse Event|4
5014488|NCT03855228|17223812|P1|Overall Study|Adverse Event|2
5014489|NCT03855189|17223861|P3|Overall Study|Did Not Return|0
5014490|NCT03855189|17223862|P2|Overall Study|Did Not Return|3
5014491|NCT03855189|17223863|P1|Overall Study|Did Not Return|4
5014492|NCT03855189|17223861|P3|Overall Study|Noncompliance with Protocol|0
5014493|NCT03855189|17223862|P2|Overall Study|Noncompliance with Protocol|1
5014494|NCT03855189|17223863|P1|Overall Study|Noncompliance with Protocol|0
5014495|NCT03855189|17223861|P3|Overall Study|Treatment Failure|2
5014496|NCT03855189|17223862|P2|Overall Study|Treatment Failure|1
5014497|NCT03855189|17223863|P1|Overall Study|Treatment Failure|1
5014498|NCT03855189|17223861|P3|Overall Study|Adverse Event|4
5014499|NCT03855189|17223862|P2|Overall Study|Adverse Event|2
5014500|NCT03855189|17223863|P1|Overall Study|Adverse Event|5
5014501|NCT03851016|17223981|P2|First Intervention (3 Weeks)|Withdrawal by Subject|2
5014502|NCT03851016|17223982|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5014503|NCT03850496|17223995|P3|Overall Study|Lost to Follow-up|4
5014504|NCT03850496|17223996|P2|Overall Study|Lost to Follow-up|1
5014505|NCT03850496|17223997|P1|Overall Study|Lost to Follow-up|0
5014506|NCT03850496|17223995|P3|Overall Study|Withdrawal by Subject|0
5014507|NCT03850496|17223996|P2|Overall Study|Withdrawal by Subject|0
5014508|NCT03850496|17223997|P1|Overall Study|Withdrawal by Subject|1
5014509|NCT03850444|17224019|P2|Overall Study|Ongoing in Study|59
5014510|NCT03850444|17224020|P1|Overall Study|Ongoing in Study|78
5014511|NCT03850444|17224019|P2|Overall Study|Withdrawal by Subject|1
5014512|NCT03850444|17224020|P1|Overall Study|Withdrawal by Subject|0
5014513|NCT03850444|17224019|P2|Overall Study|Lost to Follow-up|1
5014514|NCT03850444|17224020|P1|Overall Study|Lost to Follow-up|0
5014515|NCT03850444|17224019|P2|Overall Study|Death|64
5014516|NCT03850444|17224020|P1|Overall Study|Death|38
5014517|NCT03850444|17224019|P2|Overall Study|Adverse Event|9
5014518|NCT03850444|17224020|P1|Overall Study|Adverse Event|12
5014519|NCT03850093|17224049|P3|Overall Study|Withdrawal by Subject|2
5014520|NCT03850093|17224050|P2|Overall Study|Withdrawal by Subject|0
5014521|NCT03850093|17224051|P1|Overall Study|Withdrawal by Subject|1
5014522|NCT03849300|17224113|P4|Overall Study|scheduling/transportation conflict|2
5014523|NCT03849300|17224114|P3|Overall Study|scheduling/transportation conflict|3
5014524|NCT03849300|17224115|P2|Overall Study|scheduling/transportation conflict|4
5014525|NCT03849300|17224116|P1|Overall Study|scheduling/transportation conflict|4
5014526|NCT03849300|17224113|P4|Overall Study|move out to different area|4
5014527|NCT03849300|17224114|P3|Overall Study|move out to different area|1
5014528|NCT03849300|17224115|P2|Overall Study|move out to different area|3
5014529|NCT03849300|17224116|P1|Overall Study|move out to different area|1
5014530|NCT03848416|17224218|P3|Overall Study|Death|1
5014531|NCT03848416|17224219|P2|Overall Study|Death|0
5014532|NCT03848416|17224220|P1|Overall Study|Death|0
5014533|NCT03848416|17224218|P3|Overall Study|Withdrawal by Subject|0
5014534|NCT03848416|17224219|P2|Overall Study|Withdrawal by Subject|0
5014535|NCT03848416|17224220|P1|Overall Study|Withdrawal by Subject|1
5014536|NCT03848403|17224234|P3|Period 2 (Day 8)|Sponsor Decision|5
5014537|NCT03848403|17224235|P2|Period 2 (Day 8)|Sponsor Decision|6
5014538|NCT03848403|17224236|P1|Period 2 (Day 8)|Sponsor Decision|8
5014539|NCT03848403|17224234|P3|Period 2 (Day 8)|Physician Decision|0
5014540|NCT03848403|17224235|P2|Period 2 (Day 8)|Physician Decision|1
5014541|NCT03848403|17224236|P1|Period 2 (Day 8)|Physician Decision|0
5014542|NCT03848403|17224234|P3|Period 2 (Day 8)|Adverse Event|2
5014543|NCT03848403|17224235|P2|Period 2 (Day 8)|Adverse Event|2
5014544|NCT03848403|17224236|P1|Period 2 (Day 8)|Adverse Event|1
5014545|NCT03847987|17224321|P2|Overall Study|Adverse Event|0
5014546|NCT03847987|17224322|P1|Overall Study|Adverse Event|2
5014547|NCT03847987|17224321|P2|Overall Study|Lost to Follow-up|0
5014548|NCT03847987|17224322|P1|Overall Study|Lost to Follow-up|1
5014549|NCT03844945|17224358|P4|Overall Study|Lack of Efficacy|1
5014550|NCT03844945|17224359|P3|Overall Study|Lack of Efficacy|0
5014551|NCT03844945|17224360|P2|Overall Study|Lack of Efficacy|0
5014552|NCT03844945|17224361|P1|Overall Study|Lack of Efficacy|0
5014553|NCT03844945|17224358|P4|Overall Study|Withdrawal by Subject|0
5014554|NCT03844945|17224359|P3|Overall Study|Withdrawal by Subject|1
5014555|NCT03844945|17224360|P2|Overall Study|Withdrawal by Subject|0
5014556|NCT03844945|17224361|P1|Overall Study|Withdrawal by Subject|0
5014557|NCT03844945|17224358|P4|Overall Study|Adverse Event|0
5014558|NCT03844945|17224359|P3|Overall Study|Adverse Event|4
5014559|NCT03844945|17224360|P2|Overall Study|Adverse Event|1
5014560|NCT03844945|17224361|P1|Overall Study|Adverse Event|1
5014561|NCT03841331|17224378|P2|Overall Study|Lost to Follow-up|1
5014562|NCT03841331|17224379|P1|Overall Study|Lost to Follow-up|5
5014563|NCT03841331|17224378|P2|Overall Study|Withdrawal by Subject|9
5014564|NCT03841331|17224379|P1|Overall Study|Withdrawal by Subject|4
5014565|NCT03840135|17224420|P2|Overall Study|Withdrawal by Subject|0
5014566|NCT03840135|17224421|P1|Overall Study|Withdrawal by Subject|1
5014567|NCT03840135|17224420|P2|Overall Study|Protocol Violation|1
5014568|NCT03840135|17224421|P1|Overall Study|Protocol Violation|6
5014569|NCT03837028|17224451|P4|Overall Study|Withdrawal by Subject|7
5014570|NCT03837028|17224452|P3|Overall Study|Withdrawal by Subject|11
5014571|NCT03837028|17224453|P2|Overall Study|Withdrawal by Subject|11
5014572|NCT03837028|17224454|P1|Overall Study|Withdrawal by Subject|12
5014573|NCT03837028|17224451|P4|Overall Study|Lost to Follow-up|0
5014574|NCT03837028|17224452|P3|Overall Study|Lost to Follow-up|2
5014575|NCT03837028|17224453|P2|Overall Study|Lost to Follow-up|0
5014576|NCT03837028|17224454|P1|Overall Study|Lost to Follow-up|4
5014577|NCT03836729|17224507|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
5014578|NCT03836664|17224621|P2|Overall Study|Didn't complete forms and lost drug|3
5014579|NCT03836664|17224622|P1|Overall Study|Didn't complete forms and lost drug|3
5014580|NCT03835221|17224663|P1|Methafilcon A|Withdrawal by Subject|1
5014581|NCT03832387|17224745|P2|Overall Study|EXCLUSION CRITERIA|1
5014582|NCT03832387|17224746|P1|Overall Study|EXCLUSION CRITERIA|3
5014583|NCT03832387|17224745|P2|Overall Study|Protocol Violation|6
5014584|NCT03832387|17224746|P1|Overall Study|Protocol Violation|2
5014585|NCT03832322|17224776|P2|Overall Study|Failed cecal intubation in 2nd exam|1
5014586|NCT03832322|17224777|P1|Overall Study|Failed cecal intubation in 2nd exam|3
5014587|NCT03831282|17224813|P1|Overall Study|Could not place sensor|1
5014588|NCT03828617|17224853|P4|Overall Study|Withdrawal by Subject|0
5014589|NCT03828617|17224854|P3|Overall Study|Withdrawal by Subject|2
5014590|NCT03828617|17224855|P2|Overall Study|Withdrawal by Subject|0
5014591|NCT03828617|17224856|P1|Overall Study|Withdrawal by Subject|2
5014592|NCT03828617|17224853|P4|Overall Study|Protocol Violation|0
5014593|NCT03828617|17224854|P3|Overall Study|Protocol Violation|0
5014594|NCT03828617|17224855|P2|Overall Study|Protocol Violation|2
5014595|NCT03828617|17224856|P1|Overall Study|Protocol Violation|0
5014596|NCT03828617|17224853|P4|Overall Study|No longer met eligibility criteria|3
5014597|NCT03828617|17224854|P3|Overall Study|No longer met eligibility criteria|1
5014598|NCT03828617|17224855|P2|Overall Study|No longer met eligibility criteria|1
5014599|NCT03828617|17224856|P1|Overall Study|No longer met eligibility criteria|0
5014600|NCT03828617|17224853|P4|Overall Study|Lost to Follow-up|7
5014601|NCT03828617|17224854|P3|Overall Study|Lost to Follow-up|23
5014602|NCT03828617|17224855|P2|Overall Study|Lost to Follow-up|12
5014603|NCT03828617|17224856|P1|Overall Study|Lost to Follow-up|22
5014604|NCT03827473|17224893|P2|Overall Study|Withdrawal by Subject|0
5014605|NCT03827473|17224894|P1|Overall Study|Withdrawal by Subject|1
5014606|NCT03826914|17224910|P2|Overall Study|Withdrawal by Subject|1
5014607|NCT03826914|17224911|P1|Overall Study|Withdrawal by Subject|1
5014608|NCT03825042|17224934|P2|Overall Study|Withdrawal by Subject|0
5014609|NCT03825042|17224935|P1|Overall Study|Withdrawal by Subject|1
5014610|NCT03825042|17224934|P2|Overall Study|Adverse Event|0
5014611|NCT03825042|17224935|P1|Overall Study|Adverse Event|1
5014612|NCT03824912|17224948|P3|Overall Study|Participation in another study|0
5014613|NCT03824912|17224949|P2|Overall Study|Participation in another study|1
5014614|NCT03824912|17224950|P1|Overall Study|Participation in another study|0
5014615|NCT03824912|17224948|P3|Overall Study|Withdrawal by Subject|1
5014616|NCT03824912|17224949|P2|Overall Study|Withdrawal by Subject|2
5014617|NCT03824912|17224950|P1|Overall Study|Withdrawal by Subject|3
5014618|NCT03824912|17224948|P3|Overall Study|Protocol Violation|1
5014619|NCT03824912|17224949|P2|Overall Study|Protocol Violation|4
5014620|NCT03824912|17224950|P1|Overall Study|Protocol Violation|1
5014621|NCT03824912|17224948|P3|Overall Study|Non-Compliance with Study Drug|1
5014622|NCT03824912|17224949|P2|Overall Study|Non-Compliance with Study Drug|0
5014623|NCT03824912|17224950|P1|Overall Study|Non-Compliance with Study Drug|0
5014624|NCT03824912|17224948|P3|Overall Study|Negative Baseline Culture Result|57
5014625|NCT03824912|17224949|P2|Overall Study|Negative Baseline Culture Result|112
5014626|NCT03824912|17224950|P1|Overall Study|Negative Baseline Culture Result|118
5014627|NCT03824912|17224948|P3|Overall Study|Lost to Follow-up|8
5014628|NCT03824912|17224949|P2|Overall Study|Lost to Follow-up|15
5014629|NCT03824912|17224950|P1|Overall Study|Lost to Follow-up|18
5014630|NCT03824236|17224973|P3|Overall Study|Lost to Follow-up|1
5014631|NCT03824236|17224974|P2|Overall Study|Lost to Follow-up|0
5014632|NCT03824236|17224975|P1|Overall Study|Lost to Follow-up|0
5014633|NCT03822884|17225033|P6|Overall Study|Withdrawal by Subject|0
5014634|NCT03822884|17225034|P5|Overall Study|Withdrawal by Subject|1
5014635|NCT03822884|17225035|P4|Overall Study|Withdrawal by Subject|0
5014636|NCT03822884|17225036|P3|Overall Study|Withdrawal by Subject|0
5014637|NCT03822884|17225037|P2|Overall Study|Withdrawal by Subject|0
5014638|NCT03822884|17225038|P1|Overall Study|Withdrawal by Subject|0
5014639|NCT03822182|17225070|P3|Overall Study|Protocol Violation|1
5014640|NCT03822182|17225071|P2|Overall Study|Protocol Violation|1
5014641|NCT03822182|17225072|P1|Overall Study|Protocol Violation|0
5014642|NCT03817879|17225227|P2|Overall Study|Withdrawal by Subject|1
5014643|NCT03817879|17225228|P1|Overall Study|Withdrawal by Subject|0
5014644|NCT03817879|17225227|P2|Overall Study|Drop out|12
5014645|NCT03817879|17225228|P1|Overall Study|Drop out|5
5014646|NCT03816761|17225264|P6|Second Treatment Period (7 Days)|Unclassified|0
5014647|NCT03816761|17225265|P5|Second Treatment Period (7 Days)|Unclassified|0
5014648|NCT03816761|17225266|P4|Second Treatment Period (7 Days)|Unclassified|1
5014649|NCT03816761|17225267|P3|Second Treatment Period (7 Days)|Unclassified|0
5014650|NCT03816761|17225268|P2|Second Treatment Period (7 Days)|Unclassified|0
5014651|NCT03816761|17225269|P1|Second Treatment Period (7 Days)|Unclassified|0
5014652|NCT03816761|17225264|P6|First Treatment Period (7 Days)|Withdrawal by Subject|1
5014653|NCT03816761|17225265|P5|First Treatment Period (7 Days)|Withdrawal by Subject|0
5014654|NCT03816761|17225266|P4|First Treatment Period (7 Days)|Withdrawal by Subject|0
5014655|NCT03816761|17225267|P3|First Treatment Period (7 Days)|Withdrawal by Subject|0
5014656|NCT03816761|17225268|P2|First Treatment Period (7 Days)|Withdrawal by Subject|0
5014657|NCT03816761|17225269|P1|First Treatment Period (7 Days)|Withdrawal by Subject|0
5014658|NCT03812510|17225572|P1|Overall Study|Adverse Event|5
5014659|NCT03812510|17225572|P1|Overall Study|Did Not Start Study Medication|55
5014660|NCT03812510|17225572|P1|Overall Study|Study Terminated by Sponsor|9
5014661|NCT03812510|17225572|P1|Overall Study|Physician Decision|2
5014662|NCT03812510|17225572|P1|Overall Study|Withdrawal by Subject|42
5014663|NCT03812510|17225572|P1|Overall Study|Lost to Follow-up|39
5014664|NCT03811093|17225619|P2|Overall Study|Unable to measure body fat percentage|0
5014665|NCT03811093|17225620|P1|Overall Study|Unable to measure body fat percentage|2
5014666|NCT03811093|17225619|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
5014667|NCT03811093|17225620|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
5014668|NCT03810235|17225632|P2|Overall Study|Withdrawal by Subject|0
5014669|NCT03810235|17225633|P1|Overall Study|Withdrawal by Subject|2
5014670|NCT03810014|17225665|P4|Overall Study|Pregnancy|2
5014671|NCT03810014|17225666|P3|Overall Study|Pregnancy|0
5014672|NCT03810014|17225667|P2|Overall Study|Pregnancy|2
5014673|NCT03810014|17225668|P1|Overall Study|Pregnancy|2
5014674|NCT03809611|17225725|P2|Overall Study|Withdrawal by Subject|1
5014675|NCT03809611|17225726|P1|Overall Study|Withdrawal by Subject|1
5014676|NCT03809104|17225758|P1|Overall Study|Withdrawal by Subject|3
5014677|NCT03808688|17225769|P2|Overall Study|Medication Non-Compliance|1
5014678|NCT03808688|17225770|P1|Overall Study|Medication Non-Compliance|0
5014679|NCT03808688|17225769|P2|Overall Study|Visit Out of Window|1
5014680|NCT03808688|17225770|P1|Overall Study|Visit Out of Window|0
5014681|NCT03808688|17225769|P2|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
5014682|NCT03808688|17225770|P1|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
5014683|NCT03808688|17225769|P2|Overall Study|IOP Too High|1
5014684|NCT03808688|17225770|P1|Overall Study|IOP Too High|1
5014685|NCT03808688|17225769|P2|Overall Study|Intolerance to Conjunctival Hyperemia|0
5014686|NCT03808688|17225770|P1|Overall Study|Intolerance to Conjunctival Hyperemia|1
5014687|NCT03808688|17225769|P2|Overall Study|Withdrawal by Subject|0
5014688|NCT03808688|17225770|P1|Overall Study|Withdrawal by Subject|1
5014689|NCT03808688|17225769|P2|Overall Study|Lost to Follow-up|2
5014690|NCT03808688|17225770|P1|Overall Study|Lost to Follow-up|0
5014691|NCT03808688|17225769|P2|Overall Study|Lack of Efficacy|0
5014692|NCT03808688|17225770|P1|Overall Study|Lack of Efficacy|2
5014693|NCT03808688|17225769|P2|Overall Study|Adverse Event|17
5014694|NCT03808688|17225770|P1|Overall Study|Adverse Event|13
5014695|NCT03808298|17225815|P1|Overall Study|Positive Urine Drug Screen at Check-in|3
5014696|NCT03808298|17225815|P1|Overall Study|Withdrawal by Subject|1
5014697|NCT03808298|17225815|P1|Overall Study|Physician Decision|1
5014698|NCT03808298|17225815|P1|Overall Study|Adverse Event|3
5014699|NCT03807739|17225892|P4|Overall Study|Withdrawal by Subject|0
5014700|NCT03807739|17225893|P3|Overall Study|Withdrawal by Subject|0
5014701|NCT03807739|17225894|P2|Overall Study|Withdrawal by Subject|0
5014702|NCT03807739|17225895|P1|Overall Study|Withdrawal by Subject|1
5014703|NCT03807739|17225892|P4|Overall Study|Adverse Event|0
5014704|NCT03807739|17225893|P3|Overall Study|Adverse Event|0
5014705|NCT03807739|17225894|P2|Overall Study|Adverse Event|0
5014706|NCT03807739|17225895|P1|Overall Study|Adverse Event|1
5014707|NCT03807700|17225911|P2|Overall Study|Withdrawal by Subject|1
5014708|NCT03807700|17225912|P1|Overall Study|Withdrawal by Subject|2
5014709|NCT03805971|17225988|P1|Overall Study|Protocol Violation|2
5014710|NCT03805971|17225988|P1|Overall Study|Withdrawal by Subject|1
5014711|NCT03804918|17226010|P1|Overall Study|Participant did not use the app|1
5014712|NCT03804710|17226017|P2|Overall Study|Other|1
5014713|NCT03804710|17226018|P1|Overall Study|Other|0
5014714|NCT03804710|17226017|P2|Overall Study|Withdrawal by Subject|1
5014715|NCT03804710|17226018|P1|Overall Study|Withdrawal by Subject|2
5014716|NCT03804710|17226017|P2|Overall Study|Adverse Event|3
5014717|NCT03804710|17226018|P1|Overall Study|Adverse Event|0
5014718|NCT03802565|17226091|P5|Overall Study|Elevated Enzymes|2
5014719|NCT03802565|17226092|P4|Overall Study|Elevated Enzymes|0
5014720|NCT03802565|17226093|P3|Overall Study|Elevated Enzymes|0
5014721|NCT03802565|17226094|P2|Overall Study|Elevated Enzymes|0
5014722|NCT03802565|17226095|P1|Overall Study|Elevated Enzymes|0
5014723|NCT03802565|17226091|P5|Overall Study|Subjects Related to Each Other|1
5014724|NCT03802565|17226092|P4|Overall Study|Subjects Related to Each Other|2
5014725|NCT03802565|17226093|P3|Overall Study|Subjects Related to Each Other|0
5014726|NCT03802565|17226094|P2|Overall Study|Subjects Related to Each Other|0
5014727|NCT03802565|17226095|P1|Overall Study|Subjects Related to Each Other|1
5014728|NCT03802565|17226091|P5|Overall Study|Lost to Follow-up|0
5014729|NCT03802565|17226092|P4|Overall Study|Lost to Follow-up|0
5014730|NCT03802565|17226093|P3|Overall Study|Lost to Follow-up|1
5014731|NCT03802565|17226094|P2|Overall Study|Lost to Follow-up|0
5014732|NCT03802565|17226095|P1|Overall Study|Lost to Follow-up|0
5014733|NCT03802565|17226091|P5|Overall Study|Protocol Violation|1
5014734|NCT03802565|17226092|P4|Overall Study|Protocol Violation|5
5014735|NCT03802565|17226093|P3|Overall Study|Protocol Violation|4
5014736|NCT03802565|17226094|P2|Overall Study|Protocol Violation|1
5014737|NCT03802565|17226095|P1|Overall Study|Protocol Violation|2
5014738|NCT03802565|17226091|P5|Overall Study|Withdrawal by Subject|1
5014739|NCT03802565|17226092|P4|Overall Study|Withdrawal by Subject|0
5014740|NCT03802565|17226093|P3|Overall Study|Withdrawal by Subject|2
5014741|NCT03802565|17226094|P2|Overall Study|Withdrawal by Subject|2
5014742|NCT03802565|17226095|P1|Overall Study|Withdrawal by Subject|2
5014743|NCT03802565|17226091|P5|Overall Study|Adverse Event|1
5014744|NCT03802565|17226092|P4|Overall Study|Adverse Event|1
5014745|NCT03802565|17226093|P3|Overall Study|Adverse Event|2
5014746|NCT03802565|17226094|P2|Overall Study|Adverse Event|1
5014747|NCT03802565|17226095|P1|Overall Study|Adverse Event|0
5014748|NCT03801148|17226127|P4|Follow-Up (12 Days)|Lost to Follow-up|0
5014749|NCT03801148|17226128|P3|Follow-Up (12 Days)|Lost to Follow-up|1
5014750|NCT03801148|17226129|P2|Follow-Up (12 Days)|Lost to Follow-up|1
5014751|NCT03801148|17226130|P1|Follow-Up (12 Days)|Lost to Follow-up|0
5014752|NCT03801148|17226127|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5014753|NCT03801148|17226128|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5014754|NCT03801148|17226129|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5014755|NCT03801148|17226130|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5014756|NCT03801148|17226127|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
5014757|NCT03801148|17226128|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5014758|NCT03801148|17226129|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5014759|NCT03801148|17226130|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5014760|NCT03801148|17226127|P4|Period 1 (2 Days)|Adverse Event|0
5014761|NCT03801148|17226128|P3|Period 1 (2 Days)|Adverse Event|0
5014762|NCT03801148|17226129|P2|Period 1 (2 Days)|Adverse Event|1
5014763|NCT03801148|17226130|P1|Period 1 (2 Days)|Adverse Event|1
5014764|NCT03799211|17226229|P2|Overall Study|Withdrawal by Subject|0
5014765|NCT03799211|17226230|P1|Overall Study|Withdrawal by Subject|2
5014766|NCT03799211|17226229|P2|Overall Study|Lost to Follow-up|13
5014767|NCT03799211|17226230|P1|Overall Study|Lost to Follow-up|2
5014768|NCT03793556|17226364|P2|Overall Study|Lost to Follow-up|1
5014769|NCT03793556|17226365|P1|Overall Study|Lost to Follow-up|1
5014770|NCT03793556|17226364|P2|Overall Study|Withdrawal by Subject|1
5014771|NCT03793556|17226365|P1|Overall Study|Withdrawal by Subject|12
5014772|NCT03793010|17226409|P2|Overall Study|Did not meet eligibility criteria|0
5014773|NCT03793010|17226410|P1|Overall Study|Did not meet eligibility criteria|1
5014774|NCT03793010|17226409|P2|Overall Study|Withdrew to pursue other treatment|0
5014775|NCT03793010|17226410|P1|Overall Study|Withdrew to pursue other treatment|1
5014776|NCT03793010|17226409|P2|Overall Study|Patient couldn't sit still for injection|0
5014777|NCT03793010|17226410|P1|Overall Study|Patient couldn't sit still for injection|1
5014778|NCT03793010|17226409|P2|Overall Study|Lost to Follow-up|2
5014779|NCT03793010|17226410|P1|Overall Study|Lost to Follow-up|1
5014780|NCT03793010|17226409|P2|Overall Study|Withdrawn by Investigator or Sponsor|18
5014781|NCT03793010|17226410|P1|Overall Study|Withdrawn by Investigator or Sponsor|19
5014782|NCT03793010|17226409|P2|Overall Study|Withdrawal by Subject|7
5014783|NCT03793010|17226410|P1|Overall Study|Withdrawal by Subject|5
5014784|NCT03792672|17226420|P6|Treatment Period 4 (2 Days)|Other|0
5014785|NCT03792672|17226421|P5|Treatment Period 4 (2 Days)|Other|0
5014786|NCT03792672|17226422|P4|Treatment Period 4 (2 Days)|Other|0
5014787|NCT03792672|17226423|P3|Treatment Period 4 (2 Days)|Other|0
5014788|NCT03792672|17226424|P2|Treatment Period 4 (2 Days)|Other|0
5014789|NCT03792672|17226425|P1|Treatment Period 4 (2 Days)|Other|1
5014790|NCT03792672|17226420|P6|Washout Period 3 (10 Days)|Physician Decision|0
5014791|NCT03792672|17226421|P5|Washout Period 3 (10 Days)|Physician Decision|0
5014963|NCT03751280|17227555|P2|Overall Study|Adverse Event|1
5014792|NCT03792672|17226422|P4|Washout Period 3 (10 Days)|Physician Decision|0
5014793|NCT03792672|17226423|P3|Washout Period 3 (10 Days)|Physician Decision|1
5014794|NCT03792672|17226424|P2|Washout Period 3 (10 Days)|Physician Decision|0
5014795|NCT03792672|17226425|P1|Washout Period 3 (10 Days)|Physician Decision|0
5014796|NCT03792672|17226420|P6|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5014797|NCT03792672|17226421|P5|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5014798|NCT03792672|17226422|P4|Washout Period 3 (10 Days)|Withdrawal by Subject|2
5014799|NCT03792672|17226423|P3|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5014800|NCT03792672|17226424|P2|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5014801|NCT03792672|17226425|P1|Washout Period 3 (10 Days)|Withdrawal by Subject|1
5014802|NCT03790917|17226452|P1|Overall Study|Death|1
5014803|NCT03787212|17226582|P2|Period 1|Study Termination|2
5014804|NCT03787212|17226583|P1|Period 1|Study Termination|2
5014805|NCT03786718|17226603|P1|Overall Study|diagnosis changed from type 2 to type 1|1
5014806|NCT03786718|17226603|P1|Overall Study|Did not use the intervention|2
5014807|NCT03786718|17226603|P1|Overall Study|Withdrawal by Subject|1
5014808|NCT03786718|17226603|P1|Overall Study|Lost to Follow-up|3
5014809|NCT03785548|17226620|P2|Overall Study|no Postop queries|0
5014810|NCT03785548|17226621|P1|Overall Study|no Postop queries|1
5014811|NCT03785548|17226620|P2|Overall Study|age > 80|0
5014812|NCT03785548|17226621|P1|Overall Study|age > 80|1
5014813|NCT03783780|17226670|P1|Overall Study|Withdrawn prior to completion|1
5014814|NCT03782571|17226675|P4|Period 3|Adverse Event|0
5014815|NCT03782571|17226676|P3|Period 3|Adverse Event|0
5014816|NCT03782571|17226677|P2|Period 3|Adverse Event|0
5014817|NCT03782571|17226678|P1|Period 3|Adverse Event|1
5014818|NCT03782571|17226675|P4|Period 3|Subject Unable to Attend V5|0
5014819|NCT03782571|17226676|P3|Period 3|Subject Unable to Attend V5|0
5014820|NCT03782571|17226677|P2|Period 3|Subject Unable to Attend V5|0
5014821|NCT03782571|17226678|P1|Period 3|Subject Unable to Attend V5|1
5014822|NCT03782571|17226675|P4|Period 1|Withdrawal by Subject|0
5014823|NCT03782571|17226676|P3|Period 1|Withdrawal by Subject|0
5014824|NCT03782571|17226677|P2|Period 1|Withdrawal by Subject|0
5014825|NCT03782571|17226678|P1|Period 1|Withdrawal by Subject|1
5014826|NCT03781375|17226776|P2|Open-label Phase|Other|2
5014827|NCT03781375|17226777|P1|Open-label Phase|Other|2
5014828|NCT03781375|17226776|P2|Open-label Phase|Suboptimal Clinical Response|0
5014829|NCT03781375|17226777|P1|Open-label Phase|Suboptimal Clinical Response|1
5014830|NCT03781375|17226776|P2|Open-label Phase|Protocol Issues|1
5014831|NCT03781375|17226777|P1|Open-label Phase|Protocol Issues|0
5014832|NCT03781375|17226776|P2|Double-blind Phase|Other|3
5014833|NCT03781375|17226777|P1|Double-blind Phase|Other|1
5014834|NCT03781375|17226776|P2|Double-blind Phase|Lack of Response|2
5014835|NCT03781375|17226777|P1|Double-blind Phase|Lack of Response|6
5014836|NCT03781375|17226776|P2|Double-blind Phase|Adverse Event|1
5014837|NCT03781375|17226777|P1|Double-blind Phase|Adverse Event|0
5014838|NCT03780959|17226791|P3|Part 2|Response Status|6
5014839|NCT03780959|17226792|P2|Part 2|Response Status|18
5014840|NCT03780959|17226793|P1|Part 2|Response Status|0
5014841|NCT03780959|17226791|P3|Part 2|Withdrawal by Parent/Guardian|0
5014842|NCT03780959|17226792|P2|Part 2|Withdrawal by Parent/Guardian|1
5014843|NCT03780959|17226793|P1|Part 2|Withdrawal by Parent/Guardian|0
5014844|NCT03780959|17226791|P3|Part 1|Response Status|0
5014845|NCT03780959|17226792|P2|Part 1|Response Status|0
5014846|NCT03780959|17226793|P1|Part 1|Response Status|2
5014847|NCT03780959|17226791|P3|Part 1|Withdrawal by Parent/Guardian|0
5014848|NCT03780959|17226792|P2|Part 1|Withdrawal by Parent/Guardian|0
5014849|NCT03780959|17226793|P1|Part 1|Withdrawal by Parent/Guardian|1
5014850|NCT03780959|17226791|P3|Part 1|Withdrawal by Subject|0
5014851|NCT03780959|17226792|P2|Part 1|Withdrawal by Subject|0
5014852|NCT03780959|17226793|P1|Part 1|Withdrawal by Subject|1
5014853|NCT03780959|17226791|P3|Part 1|Adverse Event|0
5014854|NCT03780959|17226792|P2|Part 1|Adverse Event|0
5014855|NCT03780959|17226793|P1|Part 1|Adverse Event|1
5014856|NCT03780400|17226805|P1|Overall Study|Withdrawal by Subject|2
5014857|NCT03780400|17226805|P1|Overall Study|Lost to Follow-up|5
5014858|NCT03779503|17226868|P2|First Intervention|Withdrawal by Subject|0
5014859|NCT03779503|17226869|P1|First Intervention|Withdrawal by Subject|1
5014860|NCT03779503|17226868|P2|First Intervention|Adverse Event|1
5014861|NCT03779503|17226869|P1|First Intervention|Adverse Event|0
5014862|NCT03776175|17226908|P4|Follow-Up Period (35 Days)|Lost to Follow-up|2
5014863|NCT03776175|17226909|P3|Follow-Up Period (35 Days)|Lost to Follow-up|0
5014864|NCT03776175|17226910|P2|Follow-Up Period (35 Days)|Lost to Follow-up|0
5014865|NCT03776175|17226911|P1|Follow-Up Period (35 Days)|Lost to Follow-up|0
5014866|NCT03776175|17226908|P4|Treatment Period (42 Days)|Unable to attend study visits|0
5014867|NCT03776175|17226909|P3|Treatment Period (42 Days)|Unable to attend study visits|0
5014868|NCT03776175|17226910|P2|Treatment Period (42 Days)|Unable to attend study visits|2
5014869|NCT03776175|17226911|P1|Treatment Period (42 Days)|Unable to attend study visits|0
5014870|NCT03776175|17226908|P4|Treatment Period (42 Days)|Withdrawal by Subject|0
5014871|NCT03776175|17226909|P3|Treatment Period (42 Days)|Withdrawal by Subject|3
5014872|NCT03776175|17226910|P2|Treatment Period (42 Days)|Withdrawal by Subject|2
5014873|NCT03776175|17226911|P1|Treatment Period (42 Days)|Withdrawal by Subject|1
5014874|NCT03776175|17226908|P4|Treatment Period (42 Days)|Participants screened at other site|0
5014875|NCT03776175|17226909|P3|Treatment Period (42 Days)|Participants screened at other site|0
5014876|NCT03776175|17226910|P2|Treatment Period (42 Days)|Participants screened at other site|2
5014877|NCT03776175|17226911|P1|Treatment Period (42 Days)|Participants screened at other site|0
5014878|NCT03776175|17226908|P4|Treatment Period (42 Days)|Lost to Follow-up|2
5014879|NCT03776175|17226909|P3|Treatment Period (42 Days)|Lost to Follow-up|0
5014880|NCT03776175|17226910|P2|Treatment Period (42 Days)|Lost to Follow-up|0
5014881|NCT03776175|17226911|P1|Treatment Period (42 Days)|Lost to Follow-up|0
5014882|NCT03776175|17226908|P4|Treatment Period (42 Days)|Adverse Event|0
5014883|NCT03776175|17226909|P3|Treatment Period (42 Days)|Adverse Event|1
5014884|NCT03776175|17226910|P2|Treatment Period (42 Days)|Adverse Event|1
5014885|NCT03776175|17226911|P1|Treatment Period (42 Days)|Adverse Event|0
5014886|NCT03774576|17226958|P1|Period 2|Adverse Event|1
5014887|NCT03773133|17226971|P1|Overall Study|Screen Failure|8
5014888|NCT03772522|17226978|P2|Post-intervention Follow-up|Lost to Follow-up|0
5014889|NCT03772522|17226979|P1|Post-intervention Follow-up|Lost to Follow-up|1
5014890|NCT03772522|17226978|P2|Intervention|Withdrawal by Subject|0
5014891|NCT03772522|17226979|P1|Intervention|Withdrawal by Subject|1
5014892|NCT03772522|17226978|P2|Pre-intervention|Withdrawal by Subject|4
5014893|NCT03772522|17226979|P1|Pre-intervention|Withdrawal by Subject|3
5014894|NCT03772327|17227002|P2|Overall Study|Withdrawal by Subject|3
5014895|NCT03772327|17227003|P1|Overall Study|Withdrawal by Subject|2
5014896|NCT03772327|17227002|P2|Overall Study|Lost to Follow-up|4
5014897|NCT03772327|17227003|P1|Overall Study|Lost to Follow-up|3
5014898|NCT03767894|17227049|P1|Overall Study|Withdrawal by Subject|1
5014899|NCT03766646|17227071|P2|Overall Study|Protocol Violation|3
5014900|NCT03766646|17227072|P1|Overall Study|Protocol Violation|0
5014901|NCT03766646|17227071|P2|Overall Study|Withdrawal by Subject|0
5014902|NCT03766646|17227072|P1|Overall Study|Withdrawal by Subject|1
5014903|NCT03765164|17227152|P2|Pre-intervention|Withdrawal by Subject|6
5014904|NCT03765164|17227153|P1|Pre-intervention|Withdrawal by Subject|5
5014905|NCT03765138|17227163|P1|Overall Study|Lost to Follow-up|1
5014906|NCT03764813|17227173|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
5014907|NCT03764813|17227174|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
5014908|NCT03764813|17227175|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
5014909|NCT03764813|17227176|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
5014910|NCT03762668|17227297|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
5014911|NCT03762668|17227298|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
5014912|NCT03760510|17227340|P2|Overall Study|Not ventilated for 24 hours|97
5014913|NCT03760510|17227341|P1|Overall Study|Not ventilated for 24 hours|105
5014914|NCT03760250|17227353|P1|Overall Study|Physician Decision|1
5014915|NCT03760250|17227353|P1|Overall Study|Withdrawal by Subject|1
5014916|NCT03759600|17227358|P1|Overall Study|Progressive Disease|3
5014917|NCT03759600|17227358|P1|Overall Study|Adverse Event|1
5014918|NCT03759600|17227358|P1|Overall Study|Ongoing at Data Cut-off|16
5014919|NCT03759587|17227372|P1|Overall Study|Ongoing|19
5014920|NCT03759340|17227385|P1|Overall Study|Study Terminated by Sponsor|38
5014921|NCT03759340|17227385|P1|Overall Study|Withdrawal by Subject|15
5014922|NCT03759340|17227385|P1|Overall Study|Lost to Follow-up|1
5014923|NCT03759340|17227385|P1|Overall Study|Adverse Event|2
5014924|NCT03757988|17227405|P1|Overall Study|Withdrawal by Subject|1
5014925|NCT03757234|17227428|P5|Overall Study|Other|0
5014926|NCT03757234|17227429|P4|Overall Study|Other|0
5014927|NCT03757234|17227430|P3|Overall Study|Other|0
5014928|NCT03757234|17227431|P2|Overall Study|Other|1
5014929|NCT03757234|17227432|P1|Overall Study|Other|1
5014930|NCT03757234|17227428|P5|Overall Study|Withdrawal by Subject|2
5014931|NCT03757234|17227429|P4|Overall Study|Withdrawal by Subject|1
5014932|NCT03757234|17227430|P3|Overall Study|Withdrawal by Subject|0
5014933|NCT03757234|17227431|P2|Overall Study|Withdrawal by Subject|1
5014934|NCT03757234|17227432|P1|Overall Study|Withdrawal by Subject|1
5014935|NCT03757234|17227428|P5|Overall Study|Lost to Follow-up|1
5014936|NCT03757234|17227429|P4|Overall Study|Lost to Follow-up|0
5014937|NCT03757234|17227430|P3|Overall Study|Lost to Follow-up|0
5014938|NCT03757234|17227431|P2|Overall Study|Lost to Follow-up|0
5014939|NCT03757234|17227432|P1|Overall Study|Lost to Follow-up|1
5014940|NCT03757234|17227428|P5|Overall Study|Adverse Event|1
5014941|NCT03757234|17227429|P4|Overall Study|Adverse Event|0
5014942|NCT03757234|17227430|P3|Overall Study|Adverse Event|0
5014943|NCT03757234|17227431|P2|Overall Study|Adverse Event|0
5014944|NCT03757234|17227432|P1|Overall Study|Adverse Event|0
5014945|NCT03755882|17227499|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
5014946|NCT03755882|17227500|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
5014947|NCT03755882|17227499|P2|Period 1|Protocol Violation|0
5014948|NCT03755882|17227500|P1|Period 1|Protocol Violation|1
5014949|NCT03752528|17227528|P1|Part B|Study terminated by sponsor|3
5014950|NCT03752528|17227528|P1|Part B|Protocol Violation|1
5014951|NCT03752528|17227528|P1|Part A|Protocol Violation|1
5014952|NCT03752528|17227528|P1|Part A|Lost to Follow-up|1
5014953|NCT03752151|17227547|P1|Overall Study|Protocol Violation|1
5014954|NCT03752151|17227547|P1|Overall Study|Withdrawal by Subject|1
5014955|NCT03751280|17227555|P2|Overall Study|Withdrawal by Subject|2
5014956|NCT03751280|17227556|P1|Overall Study|Withdrawal by Subject|5
5014957|NCT03751280|17227555|P2|Overall Study|Protocol Violation|2
5014958|NCT03751280|17227556|P1|Overall Study|Protocol Violation|0
5014959|NCT03751280|17227555|P2|Overall Study|Physician Decision|2
5014960|NCT03751280|17227556|P1|Overall Study|Physician Decision|0
5014961|NCT03751280|17227555|P2|Overall Study|Lost to Follow-up|5
5014962|NCT03751280|17227556|P1|Overall Study|Lost to Follow-up|3
5014964|NCT03751280|17227556|P1|Overall Study|Adverse Event|0
5014965|NCT03751020|17227592|P3|Overall Study|Lost to Follow-up|10
5014966|NCT03751020|17227593|P2|Overall Study|Lost to Follow-up|4
5014967|NCT03751020|17227594|P1|Overall Study|Lost to Follow-up|7
5014968|NCT03751020|17227592|P3|Overall Study|Withdrawal by Subject|0
5014969|NCT03751020|17227593|P2|Overall Study|Withdrawal by Subject|0
5014970|NCT03751020|17227594|P1|Overall Study|Withdrawal by Subject|2
5014971|NCT03746405|17227748|P2|Overall Study|technical difficulties|2
5014972|NCT03746405|17227749|P1|Overall Study|technical difficulties|0
5014973|NCT03746405|17227748|P2|Overall Study|Withdrawal by Subject|0
5014974|NCT03746405|17227749|P1|Overall Study|Withdrawal by Subject|3
5014975|NCT03745937|17227759|P4|Overall Study|Not-specifed|1
5014976|NCT03745937|17227760|P3|Overall Study|Not-specifed|0
5014977|NCT03745937|17227761|P2|Overall Study|Not-specifed|1
5014978|NCT03745937|17227762|P1|Overall Study|Not-specifed|0
5014979|NCT03745937|17227759|P4|Overall Study|Withdrawal by Subject|1
5014980|NCT03745937|17227760|P3|Overall Study|Withdrawal by Subject|0
5014981|NCT03745937|17227761|P2|Overall Study|Withdrawal by Subject|0
5014982|NCT03745937|17227762|P1|Overall Study|Withdrawal by Subject|0
5014983|NCT03745222|17227876|P3|Overall Study|Withdrawal by Subject|0
5014984|NCT03745222|17227877|P2|Overall Study|Withdrawal by Subject|1
5014985|NCT03745222|17227878|P1|Overall Study|Withdrawal by Subject|0
5014986|NCT03742271|17227973|P1|Overall Study|Protocol Violation|1
5014987|NCT03742271|17227973|P1|Overall Study|Failed Insertion & removal|3
5014988|NCT03742271|17227973|P1|Overall Study|Lost to Follow-up|4
5014989|NCT03742271|17227973|P1|Overall Study|Withdrawal by Subject|3
5014990|NCT03742271|17227973|P1|Overall Study|Unsatisfactory Visual Response|1
5014991|NCT03741062|17228023|P2|Overall Study|Protocol Violation|0
5014992|NCT03741062|17228024|P1|Overall Study|Protocol Violation|1
5014993|NCT03739528|17228061|P2|Overall Study|Treatment discontinued + study completed|3
5014994|NCT03739528|17228062|P1|Overall Study|Treatment discontinued + study completed|1
5014995|NCT03739528|17228061|P2|Overall Study|Treatment and study discontinued|2
5014996|NCT03739528|17228062|P1|Overall Study|Treatment and study discontinued|6
5014997|NCT03739528|17228061|P2|Overall Study|Not treated|12
5014998|NCT03739528|17228062|P1|Overall Study|Not treated|8
5014999|NCT03739242|17228094|P2|Overall Study|Protocol Violation|1
5015000|NCT03739242|17228095|P1|Overall Study|Protocol Violation|0
5015001|NCT03739242|17228094|P2|Overall Study|Withdrawal by Subject|1
5015002|NCT03739242|17228095|P1|Overall Study|Withdrawal by Subject|1
5015003|NCT03738865|17228133|P2|Overall Study|Physician Decision|1
5015004|NCT03738865|17228134|P1|Overall Study|Physician Decision|0
5015005|NCT03738865|17228133|P2|Overall Study|Adverse Event|0
5015006|NCT03738865|17228134|P1|Overall Study|Adverse Event|2
5015007|NCT03738865|17228133|P2|Overall Study|Withdrawal by Subject|3
5015008|NCT03738865|17228134|P1|Overall Study|Withdrawal by Subject|3
5015009|NCT03738475|17228150|P2|Overall Study|Participant Non-Compliance|0
5015010|NCT03738475|17228151|P1|Overall Study|Participant Non-Compliance|1
5015011|NCT03736031|17228197|P2|Overall Study|Withdrawal by Subject|0
5015012|NCT03736031|17228198|P1|Overall Study|Withdrawal by Subject|9
5015013|NCT03736031|17228197|P2|Overall Study|Lost to Follow-up|2
5015014|NCT03736031|17228198|P1|Overall Study|Lost to Follow-up|21
5015015|NCT03736031|17228197|P2|Overall Study|Death|4
5015016|NCT03736031|17228198|P1|Overall Study|Death|2
5015017|NCT03733899|17228222|P6|Period 3|Withdrawal by Subject|0
5015018|NCT03733899|17228223|P5|Period 3|Withdrawal by Subject|0
5015019|NCT03733899|17228224|P4|Period 3|Withdrawal by Subject|0
5015020|NCT03733899|17228225|P3|Period 3|Withdrawal by Subject|0
5015021|NCT03733899|17228226|P2|Period 3|Withdrawal by Subject|0
5015022|NCT03733899|17228227|P1|Period 3|Withdrawal by Subject|1
5015023|NCT03733899|17228222|P6|Period 2|Unscuccessful Treatment|0
5015024|NCT03733899|17228223|P5|Period 2|Unscuccessful Treatment|0
5015025|NCT03733899|17228224|P4|Period 2|Unscuccessful Treatment|0
5015026|NCT03733899|17228225|P3|Period 2|Unscuccessful Treatment|0
5015027|NCT03733899|17228226|P2|Period 2|Unscuccessful Treatment|1
5015028|NCT03733899|17228227|P1|Period 2|Unscuccessful Treatment|0
5015029|NCT03733899|17228222|P6|Period 1|Protocol Violation|1
5015030|NCT03733899|17228223|P5|Period 1|Protocol Violation|0
5015031|NCT03733899|17228224|P4|Period 1|Protocol Violation|0
5015032|NCT03733899|17228225|P3|Period 1|Protocol Violation|0
5015033|NCT03733899|17228226|P2|Period 1|Protocol Violation|0
5015034|NCT03733899|17228227|P1|Period 1|Protocol Violation|0
5015035|NCT03733470|17228255|P2|Overall Study|PI Decision|1
5015036|NCT03733470|17228256|P1|Overall Study|PI Decision|1
5015037|NCT03733301|17228265|P3|Overall Study|Withdrawal by Subject|1
5015038|NCT03733301|17228266|P2|Overall Study|Withdrawal by Subject|5
5015039|NCT03733301|17228267|P1|Overall Study|Withdrawal by Subject|3
5015040|NCT03733301|17228265|P3|Overall Study|Adverse Event|3
5015041|NCT03733301|17228266|P2|Overall Study|Adverse Event|1
5015042|NCT03733301|17228267|P1|Overall Study|Adverse Event|0
5015043|NCT03733301|17228265|P3|Overall Study|Lack of Efficacy|0
5015044|NCT03733301|17228266|P2|Overall Study|Lack of Efficacy|3
5015045|NCT03733301|17228267|P1|Overall Study|Lack of Efficacy|2
5015046|NCT03733301|17228265|P3|Overall Study|Non-compliance|0
5015047|NCT03733301|17228266|P2|Overall Study|Non-compliance|0
5015048|NCT03733301|17228267|P1|Overall Study|Non-compliance|1
5015049|NCT03733301|17228265|P3|Overall Study|Screen Fail|0
5015050|NCT03733301|17228266|P2|Overall Study|Screen Fail|0
5015051|NCT03733301|17228267|P1|Overall Study|Screen Fail|1
5015052|NCT03730103|17228349|P2|Overall Study|Did not meet inclusion criteria|5
5015053|NCT03730103|17228350|P1|Overall Study|Did not meet inclusion criteria|0
5015054|NCT03728140|17228398|P2|Overall Study|Abnormal embryo transfer operation|7
5015055|NCT03728140|17228399|P1|Overall Study|Abnormal embryo transfer operation|10
5015056|NCT03726996|17228443|P1|Overall Study|Study early termination|2
5015057|NCT03726996|17228443|P1|Overall Study|Parent's decision|2
5015058|NCT03725982|17228453|P2|First Intervention|Physician Decision|1
5015059|NCT03725982|17228454|P1|First Intervention|Physician Decision|1
5015060|NCT03725982|17228453|P2|First Intervention|Withdrawal by Subject|1
5015061|NCT03725982|17228454|P1|First Intervention|Withdrawal by Subject|0
5015062|NCT03725085|17228487|P1|Overall Study|Lost to Follow-up|2
5015063|NCT03724981|17228495|P2|First Device|Protocol Violation|1
5015064|NCT03724981|17228496|P1|First Device|Protocol Violation|1
5015065|NCT03722784|17228642|P2|Overall Study|Protocol Violation|1
5015066|NCT03722784|17228643|P1|Overall Study|Protocol Violation|0
5015067|NCT03722784|17228642|P2|Overall Study|Physician Decision|1
5015068|NCT03722784|17228643|P1|Overall Study|Physician Decision|1
5015069|NCT03722784|17228642|P2|Overall Study|Withdrawal by Subject|0
5015070|NCT03722784|17228643|P1|Overall Study|Withdrawal by Subject|1
5015071|NCT03722446|17228687|P2|Overall Study|Protocol Violation|2
5015072|NCT03722446|17228688|P1|Overall Study|Protocol Violation|15
5015073|NCT03722264|17228704|P1|Overall Study|Physician Decision|3
5015074|NCT03722030|17228716|P2|Overall Study|Withdrawal by Subject|0
5015075|NCT03722030|17228717|P1|Overall Study|Withdrawal by Subject|1
5015076|NCT03720847|17228787|P2|Washout|Physician Decision|2
5015077|NCT03720847|17228788|P1|Washout|Physician Decision|1
5015078|NCT03718143|17228840|P3|Overall Study|Withdrawal of Informed Consent|1
5015079|NCT03718143|17228841|P2|Overall Study|Withdrawal of Informed Consent|2
5015080|NCT03718143|17228842|P1|Overall Study|Withdrawal of Informed Consent|1
5015081|NCT03718143|17228840|P3|Overall Study|Progression of Disease|0
5015082|NCT03718143|17228841|P2|Overall Study|Progression of Disease|0
5015083|NCT03718143|17228842|P1|Overall Study|Progression of Disease|1
5015084|NCT03718143|17228840|P3|Overall Study|Death|0
5015085|NCT03718143|17228841|P2|Overall Study|Death|0
5015086|NCT03718143|17228842|P1|Overall Study|Death|1
5015087|NCT03718000|17228858|P2|Overall Study|Pregnancy|1
5015088|NCT03718000|17228859|P1|Overall Study|Pregnancy|0
5015089|NCT03718000|17228858|P2|Overall Study|Relocation|4
5015090|NCT03718000|17228859|P1|Overall Study|Relocation|2
5015091|NCT03717064|17228881|P1|Period 2|Adverse Event|1
5015092|NCT03716050|17228913|P8|Overall Study|Protocol Violation|2
5015093|NCT03716050|17228914|P7|Overall Study|Protocol Violation|0
5015094|NCT03716050|17228915|P6|Overall Study|Protocol Violation|0
5015095|NCT03716050|17228916|P5|Overall Study|Protocol Violation|0
5015096|NCT03716050|17228917|P4|Overall Study|Protocol Violation|1
5015097|NCT03716050|17228918|P3|Overall Study|Protocol Violation|0
5015098|NCT03716050|17228919|P2|Overall Study|Protocol Violation|0
5015099|NCT03716050|17228920|P1|Overall Study|Protocol Violation|0
5015100|NCT03716050|17228913|P8|Overall Study|Physician Decision|0
5015101|NCT03716050|17228914|P7|Overall Study|Physician Decision|0
5015102|NCT03716050|17228915|P6|Overall Study|Physician Decision|0
5015103|NCT03716050|17228916|P5|Overall Study|Physician Decision|0
5015104|NCT03716050|17228917|P4|Overall Study|Physician Decision|1
5015105|NCT03716050|17228918|P3|Overall Study|Physician Decision|0
5015106|NCT03716050|17228919|P2|Overall Study|Physician Decision|0
5015107|NCT03716050|17228920|P1|Overall Study|Physician Decision|0
5015108|NCT03716050|17228913|P8|Overall Study|Lost to Follow-up|0
5015109|NCT03716050|17228914|P7|Overall Study|Lost to Follow-up|0
5015110|NCT03716050|17228915|P6|Overall Study|Lost to Follow-up|0
5015111|NCT03716050|17228916|P5|Overall Study|Lost to Follow-up|0
5015112|NCT03716050|17228917|P4|Overall Study|Lost to Follow-up|0
5015113|NCT03716050|17228918|P3|Overall Study|Lost to Follow-up|1
5015114|NCT03716050|17228919|P2|Overall Study|Lost to Follow-up|0
5015115|NCT03716050|17228920|P1|Overall Study|Lost to Follow-up|0
5015116|NCT03716024|17228974|P2|Overall Study|Missing Reason|1
5015117|NCT03716024|17228975|P1|Overall Study|Missing Reason|0
5015118|NCT03716024|17228974|P2|Overall Study|Withdrawal by Subject|1
5015119|NCT03716024|17228975|P1|Overall Study|Withdrawal by Subject|0
5015120|NCT03716024|17228974|P2|Overall Study|Lost to Follow-up|6
5015121|NCT03716024|17228975|P1|Overall Study|Lost to Follow-up|2
5015122|NCT03716024|17228974|P2|Overall Study|Treatment Failure|0
5015123|NCT03716024|17228975|P1|Overall Study|Treatment Failure|1
5015124|NCT03716024|17228974|P2|Overall Study|Adverse Event|2
5015125|NCT03716024|17228975|P1|Overall Study|Adverse Event|1
5015126|NCT03716024|17228974|P2|Overall Study|Randomized, not Treated|8
5015127|NCT03716024|17228975|P1|Overall Study|Randomized, not Treated|7
5015128|NCT03715530|17229009|P3|Overall Study|Lost to Follow-up|2
5015129|NCT03715530|17229010|P2|Overall Study|Lost to Follow-up|1
5015130|NCT03715530|17229011|P1|Overall Study|Lost to Follow-up|3
5015131|NCT03714672|17229071|P4|Overall Study|Lost to Follow-up|0
5015132|NCT03714672|17229072|P3|Overall Study|Lost to Follow-up|0
5015133|NCT03714672|17229073|P2|Overall Study|Lost to Follow-up|1
5015134|NCT03714672|17229074|P1|Overall Study|Lost to Follow-up|1
5015135|NCT03714672|17229071|P4|Overall Study|Other Reason|1
5015136|NCT03714672|17229072|P3|Overall Study|Other Reason|1
5015137|NCT03714672|17229073|P2|Overall Study|Other Reason|2
5015138|NCT03714672|17229074|P1|Overall Study|Other Reason|1
5015139|NCT03714672|17229071|P4|Overall Study|Physician Decision|0
5015140|NCT03714672|17229072|P3|Overall Study|Physician Decision|0
5015141|NCT03714672|17229073|P2|Overall Study|Physician Decision|1
5015142|NCT03714672|17229074|P1|Overall Study|Physician Decision|0
5015143|NCT03714672|17229071|P4|Overall Study|Adverse Event|0
5015144|NCT03714672|17229072|P3|Overall Study|Adverse Event|3
5015145|NCT03714672|17229073|P2|Overall Study|Adverse Event|0
5015146|NCT03714672|17229074|P1|Overall Study|Adverse Event|0
5015147|NCT03712917|17229128|P3|Overall Study|Lost to Follow-up|5
5015148|NCT03712917|17229129|P2|Overall Study|Lost to Follow-up|4
5015149|NCT03712917|17229130|P1|Overall Study|Lost to Follow-up|9
5015150|NCT03712917|17229128|P3|Overall Study|Adverse Event|3
5015151|NCT03712917|17229129|P2|Overall Study|Adverse Event|4
5015152|NCT03712917|17229130|P1|Overall Study|Adverse Event|0
5015153|NCT03712917|17229128|P3|Overall Study|Pregnancy|1
5015154|NCT03712917|17229129|P2|Overall Study|Pregnancy|0
5015155|NCT03712917|17229130|P1|Overall Study|Pregnancy|0
5015156|NCT03710083|17229158|P1|Overall Study|Unsuccessful Procedure|1
5015157|NCT03710083|17229158|P1|Overall Study|Withdrawal by Subject|2
5015158|NCT03709823|17229171|P6|Overall Study|Other, Not Specified|0
5015159|NCT03709823|17229172|P5|Overall Study|Other, Not Specified|0
5015160|NCT03709823|17229173|P4|Overall Study|Other, Not Specified|1
5015161|NCT03709823|17229174|P3|Overall Study|Other, Not Specified|0
5015162|NCT03709823|17229175|P2|Overall Study|Other, Not Specified|0
5015163|NCT03709823|17229176|P1|Overall Study|Other, Not Specified|0
5015164|NCT03709823|17229171|P6|Overall Study|Withdrawal by Subject|0
5015165|NCT03709823|17229172|P5|Overall Study|Withdrawal by Subject|0
5015166|NCT03709823|17229173|P4|Overall Study|Withdrawal by Subject|0
5015167|NCT03709823|17229174|P3|Overall Study|Withdrawal by Subject|0
5015168|NCT03709823|17229175|P2|Overall Study|Withdrawal by Subject|3
5015169|NCT03709823|17229176|P1|Overall Study|Withdrawal by Subject|1
5015170|NCT03709823|17229171|P6|Overall Study|Lost to Follow-up|0
5015171|NCT03709823|17229172|P5|Overall Study|Lost to Follow-up|1
5015172|NCT03709823|17229173|P4|Overall Study|Lost to Follow-up|1
5015173|NCT03709823|17229174|P3|Overall Study|Lost to Follow-up|2
5015174|NCT03709823|17229175|P2|Overall Study|Lost to Follow-up|2
5015175|NCT03709823|17229176|P1|Overall Study|Lost to Follow-up|2
5015176|NCT03709823|17229171|P6|Overall Study|Adverse Event|0
5015177|NCT03709823|17229172|P5|Overall Study|Adverse Event|0
5015178|NCT03709823|17229173|P4|Overall Study|Adverse Event|0
5015179|NCT03709823|17229174|P3|Overall Study|Adverse Event|1
5015180|NCT03709823|17229175|P2|Overall Study|Adverse Event|0
5015181|NCT03709823|17229176|P1|Overall Study|Adverse Event|0
5015182|NCT03709654|17229213|P2|Overall Study|Adverse Event|0
5015183|NCT03709654|17229214|P1|Overall Study|Adverse Event|1
5015184|NCT03709654|17229213|P2|Overall Study|Withdrawal by Subject|1
5015185|NCT03709654|17229214|P1|Overall Study|Withdrawal by Subject|1
5015186|NCT03709654|17229213|P2|Overall Study|Lost to Follow-up|1
5015187|NCT03709654|17229214|P1|Overall Study|Lost to Follow-up|1
5015188|NCT03709576|17229251|P1|Overall Study|progression prior to enrollment|1
5015189|NCT03708744|17229274|P4|Overall Study|Withdrawal by Subject|0
5015190|NCT03708744|17229275|P3|Overall Study|Withdrawal by Subject|1
5015191|NCT03708744|17229276|P2|Overall Study|Withdrawal by Subject|0
5015192|NCT03708744|17229277|P1|Overall Study|Withdrawal by Subject|0
5015193|NCT03707912|17229311|P2|Overall Study|Violation of inclusion criteria|0
5015194|NCT03707912|17229312|P1|Overall Study|Violation of inclusion criteria|1
5015195|NCT03707821|17229332|P2|Overall Study|Unsatisfactory Lens Fitting|0
5015196|NCT03707821|17229333|P1|Overall Study|Unsatisfactory Lens Fitting|1
5015197|NCT03707821|17229332|P2|Overall Study|Unsatisfactory Visual Response|0
5015198|NCT03707821|17229333|P1|Overall Study|Unsatisfactory Visual Response|1
5015199|NCT03707821|17229332|P2|Overall Study|Protocol Violation|1
5015200|NCT03707821|17229333|P1|Overall Study|Protocol Violation|0
5015201|NCT03707587|17229353|P2|Overall Study|Death|1
5015202|NCT03707587|17229354|P1|Overall Study|Death|0
5015203|NCT03707522|17229370|P4|Overall Study|Lost to Follow-up|36
5015204|NCT03707522|17229371|P3|Overall Study|Lost to Follow-up|41
5015205|NCT03707522|17229372|P2|Overall Study|Lost to Follow-up|27
5015206|NCT03707522|17229373|P1|Overall Study|Lost to Follow-up|24
5015207|NCT03704194|17229532|P2|Overall Study|Withdrawal by Subject|1
5015208|NCT03704194|17229533|P1|Overall Study|Withdrawal by Subject|0
5015209|NCT03703466|17229561|P3|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
5015210|NCT03703466|17229562|P2|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
5015211|NCT03703466|17229563|P1|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
5015212|NCT03703466|17229561|P3|Overall Study|Withdrawal by Subject|0
5015213|NCT03703466|17229562|P2|Overall Study|Withdrawal by Subject|3
5015214|NCT03703466|17229563|P1|Overall Study|Withdrawal by Subject|0
5015215|NCT03703466|17229561|P3|Overall Study|Protocol Violation|0
5015216|NCT03703466|17229562|P2|Overall Study|Protocol Violation|0
5015217|NCT03703466|17229563|P1|Overall Study|Protocol Violation|1
5015218|NCT03703466|17229561|P3|Overall Study|Death|0
5015219|NCT03703466|17229562|P2|Overall Study|Death|1
5015220|NCT03703466|17229563|P1|Overall Study|Death|2
5015221|NCT03700671|17229617|P2|Overall Study|Lack of Efficacy|2
5015222|NCT03700671|17229618|P1|Overall Study|Lack of Efficacy|1
5015223|NCT03700385|17229630|P1|Overall Study|Lost to Follow-up|1
5015224|NCT03698591|17229637|P2|Overall Study|Could not establish TMS dosage|1
5015225|NCT03698591|17229638|P1|Overall Study|Could not establish TMS dosage|0
5015226|NCT03698591|17229637|P2|Overall Study|Equipment Error|0
5015227|NCT03698591|17229638|P1|Overall Study|Equipment Error|1
5015228|NCT03698591|17229637|P2|Overall Study|Ineligible for financial compensation|0
5015229|NCT03698591|17229638|P1|Overall Study|Ineligible for financial compensation|1
5015230|NCT03698591|17229637|P2|Overall Study|Failed health screen|1
5015231|NCT03698591|17229638|P1|Overall Study|Failed health screen|0
5015232|NCT03698591|17229637|P2|Overall Study|Failed drug screen|1
5015233|NCT03698591|17229638|P1|Overall Study|Failed drug screen|1
5015234|NCT03698591|17229637|P2|Overall Study|Withdrawal by Subject|2
5015235|NCT03698591|17229638|P1|Overall Study|Withdrawal by Subject|2
5015236|NCT03698331|17229652|P2|Overall Study|Non-compliance with study drug|0
5015237|NCT03698331|17229653|P1|Overall Study|Non-compliance with study drug|1
5015238|NCT03698331|17229652|P2|Overall Study|Lost to Follow-up|2
5015239|NCT03698331|17229653|P1|Overall Study|Lost to Follow-up|0
5015240|NCT03698331|17229652|P2|Overall Study|Withdrawal by Subject|1
5015241|NCT03698331|17229653|P1|Overall Study|Withdrawal by Subject|1
5015242|NCT03698331|17229652|P2|Overall Study|Adverse Event|3
5015243|NCT03698331|17229653|P1|Overall Study|Adverse Event|2
5015244|NCT03698279|17229675|P6|Overall Study|Lost to Follow-up|0
5015245|NCT03698279|17229676|P5|Overall Study|Lost to Follow-up|0
5015246|NCT03698279|17229677|P4|Overall Study|Lost to Follow-up|5
5015247|NCT03698279|17229678|P3|Overall Study|Lost to Follow-up|4
5015248|NCT03698279|17229679|P2|Overall Study|Lost to Follow-up|1
5015249|NCT03698279|17229680|P1|Overall Study|Lost to Follow-up|3
5015250|NCT03698279|17229675|P6|Overall Study|Withdrawal by Subject|0
5015251|NCT03698279|17229676|P5|Overall Study|Withdrawal by Subject|0
5015252|NCT03698279|17229677|P4|Overall Study|Withdrawal by Subject|0
5015253|NCT03698279|17229678|P3|Overall Study|Withdrawal by Subject|1
5015254|NCT03698279|17229679|P2|Overall Study|Withdrawal by Subject|0
5015255|NCT03698279|17229680|P1|Overall Study|Withdrawal by Subject|0
5015256|NCT03698279|17229675|P6|Overall Study|Protocol deviation|0
5015257|NCT03698279|17229676|P5|Overall Study|Protocol deviation|0
5015258|NCT03698279|17229677|P4|Overall Study|Protocol deviation|0
5015259|NCT03698279|17229678|P3|Overall Study|Protocol deviation|1
5015260|NCT03698279|17229679|P2|Overall Study|Protocol deviation|0
5015261|NCT03698279|17229680|P1|Overall Study|Protocol deviation|1
5015262|NCT03698279|17229675|P6|Overall Study|Withdrawal by parent/guardian|0
5015263|NCT03698279|17229676|P5|Overall Study|Withdrawal by parent/guardian|0
5015264|NCT03698279|17229677|P4|Overall Study|Withdrawal by parent/guardian|1
5015265|NCT03698279|17229678|P3|Overall Study|Withdrawal by parent/guardian|1
5015266|NCT03698279|17229679|P2|Overall Study|Withdrawal by parent/guardian|1
5015267|NCT03698279|17229680|P1|Overall Study|Withdrawal by parent/guardian|1
5015268|NCT03697252|17229781|P2|Overall Study|Other|1
5015269|NCT03697252|17229782|P1|Overall Study|Other|0
5015270|NCT03697252|17229781|P2|Overall Study|Physician Decision|1
5015271|NCT03697252|17229782|P1|Overall Study|Physician Decision|1
5015272|NCT03697252|17229781|P2|Overall Study|Lost to Follow-up|1
5015273|NCT03697252|17229782|P1|Overall Study|Lost to Follow-up|0
5015274|NCT03697252|17229781|P2|Overall Study|Withdrawal by Subject|14
5015275|NCT03697252|17229782|P1|Overall Study|Withdrawal by Subject|14
5015276|NCT03697252|17229781|P2|Overall Study|Adverse Event|2
5015277|NCT03697252|17229782|P1|Overall Study|Adverse Event|3
5015278|NCT03695094|17229863|P2|Overall Study|Withdrawal by Subject|0
5015279|NCT03695094|17229864|P1|Overall Study|Withdrawal by Subject|1
5015280|NCT03695094|17229863|P2|Overall Study|Adverse Event|1
5015281|NCT03695094|17229864|P1|Overall Study|Adverse Event|1
5015282|NCT03694821|17229900|P3|Overall Study|Study terminated|4
5015283|NCT03694821|17229901|P2|Overall Study|Study terminated|8
5015284|NCT03694821|17229902|P1|Overall Study|Study terminated|4
5015285|NCT03693989|17229933|P2|Overall Study|Protocol Violation|4
5015286|NCT03693989|17229934|P1|Overall Study|Protocol Violation|3
5015287|NCT03693950|17229958|P2|Overall Study|Withdrawal by Subject|0
5015288|NCT03693950|17229959|P1|Overall Study|Withdrawal by Subject|1
5015289|NCT03693625|17229983|P2|Overall Study|Withdrawal by Subject|1
5015290|NCT03693625|17229984|P1|Overall Study|Withdrawal by Subject|1
5015291|NCT03693625|17229983|P2|Overall Study|Study Terminated By Sponsor|7
5015292|NCT03693625|17229984|P1|Overall Study|Study Terminated By Sponsor|20
5015293|NCT03693625|17229983|P2|Overall Study|Adverse Event|0
5015294|NCT03693625|17229984|P1|Overall Study|Adverse Event|2
5015295|NCT03691948|17229994|P2|Overall Study|Lost to Follow-up|3
5015296|NCT03691948|17229995|P1|Overall Study|Lost to Follow-up|1
5015297|NCT03691831|17230082|P2|Overall Study|Investigator Decision|2
5015298|NCT03691831|17230083|P1|Overall Study|Investigator Decision|2
5015299|NCT03691831|17230082|P2|Overall Study|Withdrawal by Subject|17
5015300|NCT03691831|17230083|P1|Overall Study|Withdrawal by Subject|9
5015301|NCT03691831|17230082|P2|Overall Study|Lost to Follow-up|12
5015302|NCT03691831|17230083|P1|Overall Study|Lost to Follow-up|16
5015303|NCT03689452|17230108|P2|Overall Study|Lost to Follow-up|1
5015304|NCT03689452|17230109|P1|Overall Study|Lost to Follow-up|1
5015305|NCT03688880|17230127|P2|Overall Study|Other|16
5015306|NCT03688880|17230128|P1|Overall Study|Other|10
5015307|NCT03688880|17230127|P2|Overall Study|Device deficiencies|2
5015308|NCT03688880|17230128|P1|Overall Study|Device deficiencies|0
5015309|NCT03688880|17230127|P2|Overall Study|Adverse Event|2
5015310|NCT03688880|17230128|P1|Overall Study|Adverse Event|0
5015311|NCT03688880|17230127|P2|Overall Study|Lost to Follow-up|7
5015312|NCT03688880|17230128|P1|Overall Study|Lost to Follow-up|4
5015313|NCT03688880|17230127|P2|Overall Study|Use of non-permitted concurrent therapy|2
5015314|NCT03688880|17230128|P1|Overall Study|Use of non-permitted concurrent therapy|0
5015315|NCT03688880|17230127|P2|Overall Study|Withdrawal by Subject|2
5015316|NCT03688880|17230128|P1|Overall Study|Withdrawal by Subject|0
5015317|NCT03688620|17230155|P3|Overall Study|Withdrawal by Subject|6
5015318|NCT03688620|17230156|P2|Overall Study|Withdrawal by Subject|0
5015319|NCT03688620|17230157|P1|Overall Study|Withdrawal by Subject|0
5015320|NCT03688620|17230155|P3|Overall Study|Lost to Follow-up|1
5015321|NCT03688620|17230156|P2|Overall Study|Lost to Follow-up|0
5015322|NCT03688620|17230157|P1|Overall Study|Lost to Follow-up|16
5015323|NCT03688620|17230155|P3|Overall Study|Unwilling to attend the scheduled visit|0
5015324|NCT03688620|17230156|P2|Overall Study|Unwilling to attend the scheduled visit|1
5015325|NCT03688620|17230157|P1|Overall Study|Unwilling to attend the scheduled visit|0
5015326|NCT03688620|17230155|P3|Overall Study|Other|1
5015327|NCT03688620|17230156|P2|Overall Study|Other|0
5015328|NCT03688620|17230157|P1|Overall Study|Other|0
5015329|NCT03687970|17230640|P2|Overall Study|visit scheduling conflicts|0
5015330|NCT03687970|17230641|P1|Overall Study|visit scheduling conflicts|2
5015331|NCT03687736|17230651|P1|Overall Study|Withdrawal by Subject|3
5015332|NCT03687736|17230651|P1|Overall Study|Lost to Follow-up|7
5015333|NCT03687372|17230797|P2|Overall Study|Investigator Decision|1
5015334|NCT03687372|17230798|P1|Overall Study|Investigator Decision|1
5015335|NCT03687372|17230797|P2|Overall Study|Withdrawal by Subject|17
5015336|NCT03687372|17230798|P1|Overall Study|Withdrawal by Subject|4
5015337|NCT03687372|17230797|P2|Overall Study|Lost to Follow-up|21
5015338|NCT03687372|17230798|P1|Overall Study|Lost to Follow-up|12
5015339|NCT03686176|17230815|P3|Overall Study|VR Malfunction|0
5015340|NCT03686176|17230816|P2|Overall Study|VR Malfunction|0
5015341|NCT03686176|17230817|P1|Overall Study|VR Malfunction|1
5015342|NCT03686176|17230815|P3|Overall Study|Procedure cancelled|0
5015343|NCT03686176|17230816|P2|Overall Study|Procedure cancelled|0
5015344|NCT03686176|17230817|P1|Overall Study|Procedure cancelled|1
5015345|NCT03686033|17230856|P6|Treatment Period 2 (1 Day)|Adverse Event|0
5015346|NCT03686033|17230857|P5|Treatment Period 2 (1 Day)|Adverse Event|1
5015347|NCT03686033|17230858|P4|Treatment Period 2 (1 Day)|Adverse Event|0
5015348|NCT03686033|17230859|P3|Treatment Period 2 (1 Day)|Adverse Event|0
5015349|NCT03686033|17230860|P2|Treatment Period 2 (1 Day)|Adverse Event|0
5015350|NCT03686033|17230861|P1|Treatment Period 2 (1 Day)|Adverse Event|0
5015351|NCT03685643|17230937|P2|Overall Study|Lost to Follow-up|22
5015352|NCT03685643|17230938|P1|Overall Study|Lost to Follow-up|14
5015353|NCT03684928|17230963|P2|Second Intervention|Soft Tissue Injury|0
5015354|NCT03684928|17230964|P1|Second Intervention|Soft Tissue Injury|1
5015355|NCT03684928|17230963|P2|First Intervention|Withdrawal by Subject|2
5015356|NCT03684928|17230964|P1|First Intervention|Withdrawal by Subject|0
5015357|NCT03684928|17230963|P2|First Intervention|Lost to Follow-up|1
5015358|NCT03684928|17230964|P1|First Intervention|Lost to Follow-up|0
5015359|NCT03684044|17230993|P2|Overall Study|Withdrawal by Subject|9
5015360|NCT03684044|17230994|P1|Overall Study|Withdrawal by Subject|11
5015361|NCT03684044|17230993|P2|Overall Study|Physician Decision|0
5015362|NCT03684044|17230994|P1|Overall Study|Physician Decision|1
5015363|NCT03684044|17230993|P2|Overall Study|Patient Not Available|2
5015364|NCT03684044|17230994|P1|Overall Study|Patient Not Available|0
5015365|NCT03684044|17230993|P2|Overall Study|Lost to Follow-up|2
5015366|NCT03684044|17230994|P1|Overall Study|Lost to Follow-up|3
5015367|NCT03684044|17230993|P2|Overall Study|Death|7
5015368|NCT03684044|17230994|P1|Overall Study|Death|4
5015369|NCT03684044|17230993|P2|Overall Study|Adverse Event|0
5015370|NCT03684044|17230994|P1|Overall Study|Adverse Event|3
5015371|NCT03683758|17231062|P2|Overall Study|Adverse Event|0
5015372|NCT03683758|17231063|P1|Overall Study|Adverse Event|1
5015373|NCT03683758|17231062|P2|Overall Study|Illness preventing participation|0
5015374|NCT03683758|17231063|P1|Overall Study|Illness preventing participation|1
5015375|NCT03683758|17231062|P2|Overall Study|Non-study commitment conflict|3
5015376|NCT03683758|17231063|P1|Overall Study|Non-study commitment conflict|1
5015377|NCT03681951|17231100|P8|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015378|NCT03681951|17231101|P7|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015379|NCT03681951|17231102|P6|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015380|NCT03681951|17231103|P5|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015381|NCT03681951|17231104|P4|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015382|NCT03681951|17231105|P3|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015383|NCT03681951|17231106|P2|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5015384|NCT03681951|17231107|P1|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
5015385|NCT03681951|17231100|P8|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015386|NCT03681951|17231101|P7|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015387|NCT03681951|17231102|P6|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015388|NCT03681951|17231103|P5|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015389|NCT03681951|17231104|P4|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015390|NCT03681951|17231105|P3|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015391|NCT03681951|17231106|P2|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5015392|NCT03681951|17231107|P1|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
5015393|NCT03681951|17231100|P8|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015394|NCT03681951|17231101|P7|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015395|NCT03681951|17231102|P6|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015396|NCT03681951|17231103|P5|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015397|NCT03681951|17231104|P4|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015398|NCT03681951|17231105|P3|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015399|NCT03681951|17231106|P2|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5015400|NCT03681951|17231107|P1|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
5015401|NCT03681119|17231300|P2|Overall Study|Sickness|0
5015402|NCT03681119|17231301|P1|Overall Study|Sickness|2
5015403|NCT03681119|17231300|P2|Overall Study|No specific reason|0
5015404|NCT03681119|17231301|P1|Overall Study|No specific reason|4
5015405|NCT03679741|17231372|P2|Period 2|Withdrawal by Subject|1
5015406|NCT03679741|17231373|P1|Period 2|Withdrawal by Subject|1
5015407|NCT03679741|17231372|P2|Period 2|Adverse Event|1
5015408|NCT03679741|17231373|P1|Period 2|Adverse Event|2
5015409|NCT03679741|17231372|P2|Period 1|Withdrawal by Subject|1
5015410|NCT03679741|17231373|P1|Period 1|Withdrawal by Subject|0
5015411|NCT03679741|17231372|P2|Period 1|Adverse Event|1
5015412|NCT03679741|17231373|P1|Period 1|Adverse Event|1
5015413|NCT03679741|17231372|P2|Period 1|Lost to Follow-up|1
5015414|NCT03679741|17231373|P1|Period 1|Lost to Follow-up|0
5015415|NCT03679741|17231372|P2|Period 1|No longer meet eligibility criteria|0
5015416|NCT03679741|17231373|P1|Period 1|No longer meet eligibility criteria|1
5015417|NCT03678870|17231416|P2|Overall Study|Lost to Follow-up|2
5015418|NCT03678870|17231417|P1|Overall Study|Lost to Follow-up|3
5015419|NCT03678870|17231416|P2|Overall Study|prescribed non- protocol medications|6
5015420|NCT03678870|17231417|P1|Overall Study|prescribed non- protocol medications|10
5015421|NCT03677401|17231437|P2|Overall Study|Reason Unspecified|0
5015422|NCT03677401|17231438|P1|Overall Study|Reason Unspecified|1
5015423|NCT03677401|17231437|P2|Overall Study|Sponsor decision|1
5015424|NCT03677401|17231438|P1|Overall Study|Sponsor decision|0
5015425|NCT03677401|17231437|P2|Overall Study|Withdrawal by Subject|2
5015426|NCT03677401|17231438|P1|Overall Study|Withdrawal by Subject|2
5015427|NCT03677401|17231437|P2|Overall Study|Lack of Efficacy|1
5015428|NCT03677401|17231438|P1|Overall Study|Lack of Efficacy|3
5015429|NCT03677401|17231437|P2|Overall Study|Adverse Event|14
5015430|NCT03677401|17231438|P1|Overall Study|Adverse Event|4
5015431|NCT03677375|17231462|P1|Overall Study|Physician Decision|1
5015432|NCT03677375|17231462|P1|Overall Study|Adverse Event|3
5015433|NCT03677375|17231462|P1|Overall Study|Incomplete procedure|8
5015434|NCT03675776|17231516|P3|Double Blind Treatment Period|Lack of Efficacy|0
5015435|NCT03675776|17231517|P2|Double Blind Treatment Period|Lack of Efficacy|0
5015436|NCT03675776|17231518|P1|Double Blind Treatment Period|Lack of Efficacy|1
5015437|NCT03675776|17231516|P3|Double Blind Treatment Period|Study Terminated by Sponsor|8
5015438|NCT03675776|17231517|P2|Double Blind Treatment Period|Study Terminated by Sponsor|6
5015439|NCT03675776|17231518|P1|Double Blind Treatment Period|Study Terminated by Sponsor|5
5015440|NCT03674177|17231584|P4|Overall Study|Lost to Follow-up|2
5015441|NCT03674177|17231585|P3|Overall Study|Lost to Follow-up|0
5015442|NCT03674177|17231586|P2|Overall Study|Lost to Follow-up|1
5015443|NCT03674177|17231587|P1|Overall Study|Lost to Follow-up|2
5015444|NCT03673670|17231651|P6|Treatment Period 3 (3 Days)|Adverse Event|0
5015445|NCT03673670|17231652|P5|Treatment Period 3 (3 Days)|Adverse Event|1
5015446|NCT03673670|17231653|P4|Treatment Period 3 (3 Days)|Adverse Event|0
5015447|NCT03673670|17231654|P3|Treatment Period 3 (3 Days)|Adverse Event|0
5015448|NCT03673670|17231655|P2|Treatment Period 3 (3 Days)|Adverse Event|0
5015449|NCT03673670|17231656|P1|Treatment Period 3 (3 Days)|Adverse Event|0
5015450|NCT03673670|17231651|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5015451|NCT03673670|17231652|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
5015452|NCT03673670|17231653|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5015453|NCT03673670|17231654|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5015454|NCT03673670|17231655|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5015455|NCT03673670|17231656|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5015456|NCT03673670|17231651|P6|Treatment Period 2 (3 Days)|Adverse Event|0
5015457|NCT03673670|17231652|P5|Treatment Period 2 (3 Days)|Adverse Event|1
5015458|NCT03673670|17231653|P4|Treatment Period 2 (3 Days)|Adverse Event|0
5015459|NCT03673670|17231654|P3|Treatment Period 2 (3 Days)|Adverse Event|1
5015460|NCT03673670|17231655|P2|Treatment Period 2 (3 Days)|Adverse Event|0
5015461|NCT03673670|17231656|P1|Treatment Period 2 (3 Days)|Adverse Event|0
5015462|NCT03673670|17231651|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
5015463|NCT03673670|17231652|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5015464|NCT03673670|17231653|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5015465|NCT03673670|17231654|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5015466|NCT03673670|17231655|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5015467|NCT03673670|17231656|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5015468|NCT03673670|17231651|P6|Treatment Period 1 (3 Days)|Adverse Event|1
5015469|NCT03673670|17231652|P5|Treatment Period 1 (3 Days)|Adverse Event|0
5015470|NCT03673670|17231653|P4|Treatment Period 1 (3 Days)|Adverse Event|0
5015471|NCT03673670|17231654|P3|Treatment Period 1 (3 Days)|Adverse Event|0
5015472|NCT03673670|17231655|P2|Treatment Period 1 (3 Days)|Adverse Event|0
5015473|NCT03673670|17231656|P1|Treatment Period 1 (3 Days)|Adverse Event|0
5015474|NCT03673670|17231651|P6|Treatment Period 1 (3 Days)|Physician Decision|0
5015475|NCT03673670|17231652|P5|Treatment Period 1 (3 Days)|Physician Decision|0
5015476|NCT03673670|17231653|P4|Treatment Period 1 (3 Days)|Physician Decision|0
5015477|NCT03673670|17231654|P3|Treatment Period 1 (3 Days)|Physician Decision|1
5015478|NCT03673670|17231655|P2|Treatment Period 1 (3 Days)|Physician Decision|0
5015479|NCT03673670|17231656|P1|Treatment Period 1 (3 Days)|Physician Decision|0
5015480|NCT03673670|17231651|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5015481|NCT03673670|17231652|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5015482|NCT03673670|17231653|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5015483|NCT03673670|17231654|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5015484|NCT03673670|17231655|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5015485|NCT03673670|17231656|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
5015486|NCT03670537|17231703|P1|Overall Study|Protocol Violation|1
5015487|NCT03669081|17231709|P2|Overall Study|Data could not be validated|1
5015488|NCT03669081|17231710|P1|Overall Study|Data could not be validated|1
5015489|NCT03668600|17231726|P1|Overall Study|Adverse Event|1
5015490|NCT03668600|17231726|P1|Overall Study|Lack of Efficacy|7
5015491|NCT03668600|17231726|P1|Overall Study|Withdrawal by Subject|56
5015492|NCT03668600|17231726|P1|Overall Study|Lost to Follow-up|7
5015493|NCT03668600|17231726|P1|Overall Study|Pregnancy|1
5015494|NCT03668600|17231726|P1|Overall Study|Protocol Violation|1
5015495|NCT03668600|17231726|P1|Overall Study|Study Terminated by the Sponsor|157
5015496|NCT03663582|17231777|P1|Overall Study|Physician Decision|1
5015497|NCT03663569|17231809|P1|Overall Study|Serious adverse event|1
5015498|NCT03663569|17231809|P1|Overall Study|Not meet inclusion / exclusion criterion|3
5015499|NCT03663569|17231809|P1|Overall Study|Not come to second visit|3
5015500|NCT03663569|17231809|P1|Overall Study|Adverse Event|4
5015501|NCT03663569|17231809|P1|Overall Study|Patient's request|11
5015502|NCT03663569|17231809|P1|Overall Study|Withdrawal of consent|5
5015503|NCT03663569|17231809|P1|Overall Study|Lost to Follow-up|18
5015504|NCT03663569|17231809|P1|Overall Study|Deceased patient|6
5015505|NCT03663569|17231809|P1|Overall Study|Never taken Spiolto® Respimat®|1
5015506|NCT03663569|17231809|P1|Overall Study|Discontinuation of study|11
5015507|NCT03663179|17231822|P2|Overall Study|Revealed exclusionary condition|0
5015508|NCT03663179|17231823|P1|Overall Study|Revealed exclusionary condition|1
5015509|NCT03663179|17231822|P2|Overall Study|Lost to Follow-up|1
5015510|NCT03663179|17231823|P1|Overall Study|Lost to Follow-up|1
5015511|NCT03663179|17231822|P2|Overall Study|Withdrawal by Subject|0
5015512|NCT03663179|17231823|P1|Overall Study|Withdrawal by Subject|2
5015513|NCT03662334|17231833|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
5015514|NCT03662334|17231834|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
5015515|NCT03658889|17231947|P2|Overall Study|Protocol Violation|0
5015516|NCT03658889|17231948|P1|Overall Study|Protocol Violation|2
5015517|NCT03658876|17231979|P2|Overall Study|Transplantation/other operation|5
5015518|NCT03658876|17231980|P1|Overall Study|Transplantation/other operation|1
5015519|NCT03658876|17231979|P2|Overall Study|Intercurrent illness|4
5015520|NCT03658876|17231980|P1|Overall Study|Intercurrent illness|6
5015521|NCT03658876|17231979|P2|Overall Study|Death|1
5015522|NCT03658876|17231980|P1|Overall Study|Death|0
5015523|NCT03658876|17231979|P2|Overall Study|Withdrawal by Subject|0
5015524|NCT03658876|17231980|P1|Overall Study|Withdrawal by Subject|2
5015525|NCT03658876|17231979|P2|Overall Study|Protocol Violation|2
5015526|NCT03658876|17231980|P1|Overall Study|Protocol Violation|3
5015527|NCT03658811|17231986|P1|Overall Study|Lost to Follow-up|3
5015528|NCT03657095|17232030|P2|Overall Study|Study Terminated by Sponsor|49
5015529|NCT03657095|17232031|P1|Overall Study|Study Terminated by Sponsor|58
5015530|NCT03657095|17232030|P2|Overall Study|Adverse Event|3
5015531|NCT03657095|17232031|P1|Overall Study|Adverse Event|0
5015532|NCT03657095|17232030|P2|Overall Study|Withdrawal by Subject|1
5015533|NCT03657095|17232031|P1|Overall Study|Withdrawal by Subject|1
5015534|NCT03655951|17232047|P2|Overall Study|Withdrawal by Subject|1
5015535|NCT03655951|17232048|P1|Overall Study|Withdrawal by Subject|0
5015536|NCT03655951|17232047|P2|Overall Study|Lost to Follow-up|20
5015537|NCT03655951|17232048|P1|Overall Study|Lost to Follow-up|39
5015538|NCT03655106|17232220|P2|Overall Study|Protocol Violation|0
5015539|NCT03655106|17232221|P1|Overall Study|Protocol Violation|3
5015540|NCT03655106|17232220|P2|Overall Study|Duplicate Enrollment|1
5015541|NCT03655106|17232221|P1|Overall Study|Duplicate Enrollment|1
5015542|NCT03655106|17232220|P2|Overall Study|Lost to Follow-up|1
5015543|NCT03655106|17232221|P1|Overall Study|Lost to Follow-up|2
5015544|NCT03655106|17232220|P2|Overall Study|Withdrawal by Subject|2
5015545|NCT03655106|17232221|P1|Overall Study|Withdrawal by Subject|3
5015546|NCT03654560|17232233|P2|Overall Study|Lost to Follow-up|0
5015547|NCT03654560|17232234|P1|Overall Study|Lost to Follow-up|1
5015548|NCT03654560|17232233|P2|Overall Study|Death|1
5015549|NCT03654560|17232234|P1|Overall Study|Death|3
5015550|NCT03653429|17232275|P2|Overall Study|Physician Decision|10
5015551|NCT03653429|17232276|P1|Overall Study|Physician Decision|4
5015552|NCT03653416|17232290|P2|Overall Study|Protocol Violation|1
5015553|NCT03653416|17232291|P1|Overall Study|Protocol Violation|6
5015554|NCT03650400|17232341|P2|Overall Study|Study terminated by sponsor|5
5015555|NCT03650400|17232342|P1|Overall Study|Study terminated by sponsor|0
5015556|NCT03649412|17232402|P2|Part B, Washout Period 5 (7 Days)|Adverse Event|1
5015557|NCT03649412|17232403|P1|Part B, Washout Period 5 (7 Days)|Adverse Event|0
5015558|NCT03649412|17232402|P2|Part B, Washout Period 1 (7 Days)|Adverse Event|1
5015559|NCT03649412|17232403|P1|Part B, Washout Period 1 (7 Days)|Adverse Event|0
5015560|NCT03649412|17232402|P2|Part A, Washout Period 5 (7 Days)|Adverse Event|0
5015561|NCT03649412|17232403|P1|Part A, Washout Period 5 (7 Days)|Adverse Event|1
5015562|NCT03649412|17232402|P2|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
5015563|NCT03649412|17232403|P1|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
5015564|NCT03649412|17232402|P2|Part A, Washout Period 4 (7 Days)|Adverse Event|0
5015565|NCT03649412|17232403|P1|Part A, Washout Period 4 (7 Days)|Adverse Event|1
5015566|NCT03649412|17232402|P2|Part A, Washout Period 1 (7 Days)|Physician Decision|0
5015567|NCT03649412|17232403|P1|Part A, Washout Period 1 (7 Days)|Physician Decision|1
5015568|NCT03648983|17232561|P1|Overall Study|Study was terminated due to PI departure|95
5015569|NCT03647709|17232571|P1|Overall Study|Withdrawal by Subject|3
5015570|NCT03647709|17232571|P1|Overall Study|Physician Decision|6
5015571|NCT03647709|17232571|P1|Overall Study|Lost to Follow-up|5
5015572|NCT03646656|17232604|P2|Overall Study|Withdrawal by Subject|0
5015573|NCT03646656|17232605|P1|Overall Study|Withdrawal by Subject|2
5015574|NCT03646656|17232604|P2|Overall Study|Lost to Follow-up|0
5015575|NCT03646656|17232605|P1|Overall Study|Lost to Follow-up|1
5015576|NCT03645421|17232639|P4|Overall Study|Study specific withdrawal criteria|0
5015577|NCT03645421|17232640|P3|Overall Study|Study specific withdrawal criteria|1
5015578|NCT03645421|17232641|P2|Overall Study|Study specific withdrawal criteria|0
5015579|NCT03645421|17232642|P1|Overall Study|Study specific withdrawal criteria|0
5015580|NCT03645421|17232639|P4|Overall Study|Withdrawal by patient|3
5015581|NCT03645421|17232640|P3|Overall Study|Withdrawal by patient|0
5015582|NCT03645421|17232641|P2|Overall Study|Withdrawal by patient|0
5015583|NCT03645421|17232642|P1|Overall Study|Withdrawal by patient|0
5015584|NCT03645421|17232639|P4|Overall Study|Adverse Event|1
5015585|NCT03645421|17232640|P3|Overall Study|Adverse Event|4
5015586|NCT03645421|17232641|P2|Overall Study|Adverse Event|0
5015587|NCT03645421|17232642|P1|Overall Study|Adverse Event|0
5015588|NCT03643575|17232751|P6|Washout: 7 Days|Non compliance check in|0
5015589|NCT03643575|17232752|P5|Washout: 7 Days|Non compliance check in|0
5015590|NCT03643575|17232753|P4|Washout: 7 Days|Non compliance check in|0
5015591|NCT03643575|17232754|P3|Washout: 7 Days|Non compliance check in|0
5015592|NCT03643575|17232755|P2|Washout: 7 Days|Non compliance check in|1
5015593|NCT03643575|17232756|P1|Washout: 7 Days|Non compliance check in|0
5015594|NCT03643575|17232751|P6|Washout: 7 Days|Adverse Event|0
5015595|NCT03643575|17232752|P5|Washout: 7 Days|Adverse Event|0
5015596|NCT03643575|17232753|P4|Washout: 7 Days|Adverse Event|0
5015597|NCT03643575|17232754|P3|Washout: 7 Days|Adverse Event|0
5015598|NCT03643575|17232755|P2|Washout: 7 Days|Adverse Event|0
5015599|NCT03643575|17232756|P1|Washout: 7 Days|Adverse Event|1
5015600|NCT03643575|17232751|P6|Washout: 7 Days|Withdrew consent due to illness|0
5015601|NCT03643575|17232752|P5|Washout: 7 Days|Withdrew consent due to illness|0
5015602|NCT03643575|17232753|P4|Washout: 7 Days|Withdrew consent due to illness|1
5015603|NCT03643575|17232754|P3|Washout: 7 Days|Withdrew consent due to illness|0
5015604|NCT03643575|17232755|P2|Washout: 7 Days|Withdrew consent due to illness|0
5015605|NCT03643575|17232756|P1|Washout: 7 Days|Withdrew consent due to illness|0
5015606|NCT03643432|17232814|P2|Overall Study|Lost to Follow-up|0
5015607|NCT03643432|17232815|P1|Overall Study|Lost to Follow-up|1
5015608|NCT03643159|17232839|P1|Overall Study|Withdrawal by Subject|1
5015609|NCT03643159|17232839|P1|Overall Study|Adverse Event|1
5015610|NCT03642873|17232846|P6|Third Intervention (1 Day)|Screen failure|0
5015611|NCT03642873|17232847|P5|Third Intervention (1 Day)|Screen failure|1
5015612|NCT03642873|17232848|P4|Third Intervention (1 Day)|Screen failure|0
5015613|NCT03642873|17232849|P3|Third Intervention (1 Day)|Screen failure|0
5015614|NCT03642873|17232850|P2|Third Intervention (1 Day)|Screen failure|0
5015615|NCT03642873|17232851|P1|Third Intervention (1 Day)|Screen failure|0
5015616|NCT03642262|17232902|P2|Period 1|Adverse Event|1
5015617|NCT03642262|17232903|P1|Period 1|Adverse Event|0
5015618|NCT03642262|17232902|P2|Period 1|Withdrawal by Subject|1
5015619|NCT03642262|17232903|P1|Period 1|Withdrawal by Subject|1
5015620|NCT03641508|17232924|P2|First Injection|Lost to Follow-up|0
5015621|NCT03641508|17232925|P1|First Injection|Lost to Follow-up|2
5015622|NCT03640559|17232952|P2|Overall Study|Withdrawal by Subject|0
5015623|NCT03640559|17232953|P1|Overall Study|Withdrawal by Subject|1
5015624|NCT03640559|17232952|P2|Overall Study|Physician Decision|1
5015625|NCT03640559|17232953|P1|Overall Study|Physician Decision|1
5015626|NCT03640507|17232962|P3|Overall Study|Withdrawal by Subject|1
5015627|NCT03640507|17232963|P2|Overall Study|Withdrawal by Subject|0
5015628|NCT03640507|17232964|P1|Overall Study|Withdrawal by Subject|0
5015629|NCT03640052|17232984|P5|Overall Study|Lost to Follow-up|0
5015630|NCT03640052|17232985|P4|Overall Study|Lost to Follow-up|0
5015631|NCT03640052|17232986|P3|Overall Study|Lost to Follow-up|0
5015632|NCT03640052|17232987|P2|Overall Study|Lost to Follow-up|1
5015633|NCT03640052|17232988|P1|Overall Study|Lost to Follow-up|0
5015634|NCT03639675|17233005|P1|Overall Study|Withdrawal by Subject|1
5015635|NCT03638635|17233027|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
5015636|NCT03638635|17233028|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
5015637|NCT03638635|17233027|P2|Initial Hospitalization|Withdrawal by study personnel|1
5015638|NCT03638635|17233028|P1|Initial Hospitalization|Withdrawal by study personnel|0
5015639|NCT03638635|17233027|P2|Initial Hospitalization|Study terminated prematurely|1
5015640|NCT03638635|17233028|P1|Initial Hospitalization|Study terminated prematurely|0
5015641|NCT03636893|17233117|P2|Overall Study|Adverse Event|1
5015642|NCT03636893|17233118|P1|Overall Study|Adverse Event|1
5015643|NCT03636893|17233117|P2|Overall Study|Early surgery (for acute bleeding)|0
5015644|NCT03636893|17233118|P1|Overall Study|Early surgery (for acute bleeding)|3
5015645|NCT03636893|17233117|P2|Overall Study|Refusal to surgery|3
5015646|NCT03636893|17233118|P1|Overall Study|Refusal to surgery|4
5015647|NCT03636893|17233117|P2|Overall Study|Withdrawal by Subject|2
5015648|NCT03636893|17233118|P1|Overall Study|Withdrawal by Subject|1
5015649|NCT03636893|17233117|P2|Overall Study|Protocol Violation|3
5015650|NCT03636893|17233118|P1|Overall Study|Protocol Violation|0
5015651|NCT03636893|17233117|P2|Overall Study|Death|1
5015652|NCT03636893|17233118|P1|Overall Study|Death|0
5015653|NCT03635957|17233135|P1|Pegloticase + IMM Period|Lack of Efficacy|3
5015654|NCT03635957|17233135|P1|Run-In Period|Lost to Follow-up|1
5015655|NCT03634579|17233146|P1|Overall Study|study termination|9
5015656|NCT03634085|17233244|P2|Overall Study|Withdrawal by Subject|2
5015657|NCT03634085|17233245|P1|Overall Study|Withdrawal by Subject|0
5015658|NCT03634085|17233244|P2|Overall Study|Adverse Event|0
5015659|NCT03634085|17233245|P1|Overall Study|Adverse Event|1
5015660|NCT03633825|17233260|P2|Follow up|Lost to Follow-up|450
5015661|NCT03633825|17233261|P1|Follow up|Lost to Follow-up|478
5015662|NCT03633825|17233260|P2|Enrollment|Post not classified as crisis|13757
5015663|NCT03633825|17233261|P1|Enrollment|Post not classified as crisis|13967
5015664|NCT03633825|17233260|P2|Enrollment|Did not post on network|5080
5015665|NCT03633825|17233261|P1|Enrollment|Did not post on network|5066
5015666|NCT03631732|17233446|P2|Overall Study|Lost to Follow-up|1
5015667|NCT03631732|17233447|P1|Overall Study|Lost to Follow-up|5
5015668|NCT03631732|17233446|P2|Overall Study|Withdrew consent|4
5015669|NCT03631732|17233447|P1|Overall Study|Withdrew consent|3
5015670|NCT03631732|17233446|P2|Overall Study|Investigator's Discretion|0
5015671|NCT03631732|17233447|P1|Overall Study|Investigator's Discretion|1
5015672|NCT03631732|17233446|P2|Overall Study|Lack of Efficacy|0
5015673|NCT03631732|17233447|P1|Overall Study|Lack of Efficacy|1
5015674|NCT03631732|17233446|P2|Overall Study|Death|0
5015675|NCT03631732|17233447|P1|Overall Study|Death|1
5015676|NCT03631732|17233446|P2|Overall Study|Adverse Event|0
5015677|NCT03631732|17233447|P1|Overall Study|Adverse Event|3
5015678|NCT03631732|17233446|P2|Overall Study|Still in Study|148
5015679|NCT03631732|17233447|P1|Overall Study|Still in Study|285
5015680|NCT03631732|17233446|P2|Overall Study|Randomized and Never Treated|0
5015681|NCT03631732|17233447|P1|Overall Study|Randomized and Never Treated|1
5015682|NCT03630016|17233533|P1|Overall Study|Poor Sensor Placement|1
5015683|NCT03629184|17233539|P2|Overall Study|Physician Decision|0
5015684|NCT03629184|17233540|P1|Overall Study|Physician Decision|1
5015685|NCT03629184|17233539|P2|Overall Study|Withdrawal by Subject|1
5015686|NCT03629184|17233540|P1|Overall Study|Withdrawal by Subject|2
5015687|NCT03629054|17233590|P2|Period 2 (4 Days)|Not treated|1
5015688|NCT03629054|17233591|P1|Period 2 (4 Days)|Not treated|0
5015689|NCT03629041|17233615|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5015690|NCT03629041|17233616|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5015691|NCT03629041|17233617|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
5015692|NCT03629041|17233618|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5015693|NCT03629028|17233646|P2|Overall Study|intolerance to examination|0
5015694|NCT03629028|17233647|P1|Overall Study|intolerance to examination|2
5015695|NCT03629028|17233646|P2|Overall Study|Pregnancy|2
5015696|NCT03629028|17233647|P1|Overall Study|Pregnancy|4
5015697|NCT03629028|17233646|P2|Overall Study|Lost to Follow-up|23
5015698|NCT03629028|17233647|P1|Overall Study|Lost to Follow-up|26
5015699|NCT03628599|17233678|P2|Overall Study|Adverse Event|1
5015700|NCT03628599|17233679|P1|Overall Study|Adverse Event|0
5015701|NCT03628417|17233709|P2|Overall Study|Death|1
5015702|NCT03628417|17233710|P1|Overall Study|Death|1
5015703|NCT03627832|17233722|P2|Overall Study|Withdrawal by Subject|1
5015704|NCT03627832|17233723|P1|Overall Study|Withdrawal by Subject|10
5015705|NCT03627494|17233757|P12|Part C Washout 1 (7 Days)|Adverse Event|1
5015706|NCT03627494|17233758|P11|Part C Washout 1 (7 Days)|Adverse Event|1
5015707|NCT03627494|17233759|P10|Part C Washout 1 (7 Days)|Adverse Event|0
5015708|NCT03627494|17233760|P9|Part C Washout 1 (7 Days)|Adverse Event|0
5015709|NCT03627494|17233761|P8|Part C Washout 1 (7 Days)|Adverse Event|0
5015710|NCT03627494|17233762|P7|Part C Washout 1 (7 Days)|Adverse Event|0
5015711|NCT03627494|17233763|P6|Part C Washout 1 (7 Days)|Adverse Event|0
5015712|NCT03627494|17233764|P5|Part C Washout 1 (7 Days)|Adverse Event|0
5015713|NCT03627494|17233765|P4|Part C Washout 1 (7 Days)|Adverse Event|0
5015714|NCT03627494|17233766|P3|Part C Washout 1 (7 Days)|Adverse Event|0
5015715|NCT03627494|17233767|P2|Part C Washout 1 (7 Days)|Adverse Event|0
5015716|NCT03627494|17233768|P1|Part C Washout 1 (7 Days)|Adverse Event|0
5015717|NCT03627494|17233757|P12|Part B (Maximum of 34 Days)|Adverse Event|0
5015718|NCT03627494|17233758|P11|Part B (Maximum of 34 Days)|Adverse Event|0
5015719|NCT03627494|17233759|P10|Part B (Maximum of 34 Days)|Adverse Event|0
5015720|NCT03627494|17233760|P9|Part B (Maximum of 34 Days)|Adverse Event|2
5015721|NCT03627494|17233761|P8|Part B (Maximum of 34 Days)|Adverse Event|0
5015722|NCT03627494|17233762|P7|Part B (Maximum of 34 Days)|Adverse Event|0
5015723|NCT03627494|17233763|P6|Part B (Maximum of 34 Days)|Adverse Event|0
5015724|NCT03627494|17233764|P5|Part B (Maximum of 34 Days)|Adverse Event|0
5015725|NCT03627494|17233765|P4|Part B (Maximum of 34 Days)|Adverse Event|0
5015726|NCT03627494|17233766|P3|Part B (Maximum of 34 Days)|Adverse Event|0
5015727|NCT03627494|17233767|P2|Part B (Maximum of 34 Days)|Adverse Event|0
5015728|NCT03627494|17233768|P1|Part B (Maximum of 34 Days)|Adverse Event|0
5015729|NCT03627494|17233757|P12|Part A Washout 2 (7 Days)|Adverse Event|0
5015730|NCT03627494|17233758|P11|Part A Washout 2 (7 Days)|Adverse Event|0
5015731|NCT03627494|17233759|P10|Part A Washout 2 (7 Days)|Adverse Event|0
5015732|NCT03627494|17233760|P9|Part A Washout 2 (7 Days)|Adverse Event|0
5015733|NCT03627494|17233761|P8|Part A Washout 2 (7 Days)|Adverse Event|0
5015734|NCT03627494|17233762|P7|Part A Washout 2 (7 Days)|Adverse Event|0
5015735|NCT03627494|17233763|P6|Part A Washout 2 (7 Days)|Adverse Event|0
5015736|NCT03627494|17233764|P5|Part A Washout 2 (7 Days)|Adverse Event|0
5015737|NCT03627494|17233765|P4|Part A Washout 2 (7 Days)|Adverse Event|0
5015738|NCT03627494|17233766|P3|Part A Washout 2 (7 Days)|Adverse Event|1
5015739|NCT03627494|17233767|P2|Part A Washout 2 (7 Days)|Adverse Event|0
5015740|NCT03627494|17233768|P1|Part A Washout 2 (7 Days)|Adverse Event|1
5015741|NCT03627195|17233982|P6|Overall Study|OTHER (LACK OF EFFICACY)|0
5015742|NCT03627195|17233983|P5|Overall Study|OTHER (LACK OF EFFICACY)|0
5015743|NCT03627195|17233984|P4|Overall Study|OTHER (LACK OF EFFICACY)|0
5015744|NCT03627195|17233985|P3|Overall Study|OTHER (LACK OF EFFICACY)|0
5015745|NCT03627195|17233986|P2|Overall Study|OTHER (LACK OF EFFICACY)|0
5015746|NCT03627195|17233987|P1|Overall Study|OTHER (LACK OF EFFICACY)|1
5015747|NCT03624946|17234058|P2|Overall Study|Lost to Follow-up|1
5015748|NCT03624946|17234059|P1|Overall Study|Lost to Follow-up|0
5015749|NCT03624504|17234079|P1|Overall Study|Unsuccessful Implant|1
5015750|NCT03622112|17234131|P7|Overall Study|Reason not specified|1
5015751|NCT03622112|17234132|P6|Overall Study|Reason not specified|2
5015752|NCT03622112|17234133|P5|Overall Study|Reason not specified|1
5015753|NCT03622112|17234134|P4|Overall Study|Reason not specified|1
5015754|NCT03622112|17234135|P3|Overall Study|Reason not specified|0
5015755|NCT03622112|17234136|P2|Overall Study|Reason not specified|1
5015756|NCT03622112|17234137|P1|Overall Study|Reason not specified|0
5015757|NCT03622112|17234131|P7|Overall Study|Adverse Event|2
5015758|NCT03622112|17234132|P6|Overall Study|Adverse Event|20
5015759|NCT03622112|17234133|P5|Overall Study|Adverse Event|4
5015760|NCT03622112|17234134|P4|Overall Study|Adverse Event|11
5015761|NCT03622112|17234135|P3|Overall Study|Adverse Event|4
5015762|NCT03622112|17234136|P2|Overall Study|Adverse Event|8
5015763|NCT03622112|17234137|P1|Overall Study|Adverse Event|6
5015764|NCT03622112|17234131|P7|Overall Study|Protocol Violation|0
5015765|NCT03622112|17234132|P6|Overall Study|Protocol Violation|0
5015766|NCT03622112|17234133|P5|Overall Study|Protocol Violation|0
5015767|NCT03622112|17234134|P4|Overall Study|Protocol Violation|1
5015768|NCT03622112|17234135|P3|Overall Study|Protocol Violation|1
5015769|NCT03622112|17234136|P2|Overall Study|Protocol Violation|0
5015770|NCT03622112|17234137|P1|Overall Study|Protocol Violation|2
5015771|NCT03622112|17234131|P7|Overall Study|Study-specific withdrawal criteria|4
5015772|NCT03622112|17234132|P6|Overall Study|Study-specific withdrawal criteria|18
5015773|NCT03622112|17234133|P5|Overall Study|Study-specific withdrawal criteria|4
5015774|NCT03622112|17234134|P4|Overall Study|Study-specific withdrawal criteria|6
5015775|NCT03622112|17234135|P3|Overall Study|Study-specific withdrawal criteria|7
5015776|NCT03622112|17234136|P2|Overall Study|Study-specific withdrawal criteria|8
5015777|NCT03622112|17234137|P1|Overall Study|Study-specific withdrawal criteria|10
5015778|NCT03622112|17234131|P7|Overall Study|Lost to Follow-up|0
5015779|NCT03622112|17234132|P6|Overall Study|Lost to Follow-up|0
5015780|NCT03622112|17234133|P5|Overall Study|Lost to Follow-up|0
5015781|NCT03622112|17234134|P4|Overall Study|Lost to Follow-up|0
5015782|NCT03622112|17234135|P3|Overall Study|Lost to Follow-up|0
5015783|NCT03622112|17234136|P2|Overall Study|Lost to Follow-up|1
5015784|NCT03622112|17234137|P1|Overall Study|Lost to Follow-up|1
5015785|NCT03622112|17234131|P7|Overall Study|Death|0
5015786|NCT03622112|17234132|P6|Overall Study|Death|0
5015787|NCT03622112|17234133|P5|Overall Study|Death|0
5015788|NCT03622112|17234134|P4|Overall Study|Death|1
5015789|NCT03622112|17234135|P3|Overall Study|Death|0
5015790|NCT03622112|17234136|P2|Overall Study|Death|0
5015791|NCT03622112|17234137|P1|Overall Study|Death|0
5015792|NCT03622112|17234131|P7|Overall Study|Withdrawal by Subject|2
5015793|NCT03622112|17234132|P6|Overall Study|Withdrawal by Subject|2
5015794|NCT03622112|17234133|P5|Overall Study|Withdrawal by Subject|1
5015795|NCT03622112|17234134|P4|Overall Study|Withdrawal by Subject|2
5015796|NCT03622112|17234135|P3|Overall Study|Withdrawal by Subject|4
5015797|NCT03622112|17234136|P2|Overall Study|Withdrawal by Subject|2
5015798|NCT03622112|17234137|P1|Overall Study|Withdrawal by Subject|6
5015799|NCT03620708|17234360|P3|Overall Study|Withdrawal by Subject|1
5015800|NCT03620708|17234361|P2|Overall Study|Withdrawal by Subject|0
5015801|NCT03620708|17234362|P1|Overall Study|Withdrawal by Subject|0
5015802|NCT03620708|17234360|P3|Overall Study|Lost to Follow-up|2
5015803|NCT03620708|17234361|P2|Overall Study|Lost to Follow-up|1
5015804|NCT03620708|17234362|P1|Overall Study|Lost to Follow-up|1
5015805|NCT03618628|17234443|P1|Overall Study|Lost to Follow-up|1
5015806|NCT03618628|17234443|P1|Overall Study|Death|1
5015807|NCT03617861|17234473|P4|Second Intervention (1 Day)|Adverse Event|0
5015808|NCT03617861|17234474|P3|Second Intervention (1 Day)|Adverse Event|1
5015809|NCT03617861|17234475|P2|Second Intervention (1 Day)|Adverse Event|0
5015810|NCT03617861|17234476|P1|Second Intervention (1 Day)|Adverse Event|0
5015811|NCT03617588|17234508|P2|Overall Study|Withdrawal by Subject|0
5015812|NCT03617588|17234509|P1|Overall Study|Withdrawal by Subject|1
5015813|NCT03616977|17234570|P2|Period 3|Adverse Event|1
5015814|NCT03616977|17234571|P1|Period 3|Adverse Event|1
5015815|NCT03616977|17234570|P2|Period 1|Physician Decision|1
5015816|NCT03616977|17234571|P1|Period 1|Physician Decision|0
5015817|NCT03616600|17234581|P2|Overall Study|Withdrawal by Subject|0
5015818|NCT03616600|17234582|P1|Overall Study|Withdrawal by Subject|1
5015819|NCT03616106|17234616|P2|Overall Study|Lost to Follow-up|0
5015820|NCT03616106|17234617|P1|Overall Study|Lost to Follow-up|7
5015821|NCT03616106|17234616|P2|Overall Study|Withdrawal by Subject|1
5015822|NCT03616106|17234617|P1|Overall Study|Withdrawal by Subject|1
5015823|NCT03616106|17234616|P2|Overall Study|Removed by PI|0
5015824|NCT03616106|17234617|P1|Overall Study|Removed by PI|6
5015825|NCT03615482|17234737|P2|Overall Study|Withdrawal by Subject|7
5015826|NCT03615482|17234738|P1|Overall Study|Withdrawal by Subject|7
5015827|NCT03615482|17234737|P2|Overall Study|Physician Decision|3
5015828|NCT03615482|17234738|P1|Overall Study|Physician Decision|2
5015829|NCT03615482|17234737|P2|Overall Study|Lost to Follow-up|7
5015830|NCT03615482|17234738|P1|Overall Study|Lost to Follow-up|7
5015831|NCT03615482|17234737|P2|Overall Study|Death|0
5015832|NCT03615482|17234738|P1|Overall Study|Death|1
5015833|NCT03614975|17234840|P2|Overall Study|Specimens not in lab batch shipment|1
5015834|NCT03614975|17234841|P1|Overall Study|Specimens not in lab batch shipment|1
5015835|NCT03614975|17234840|P2|Overall Study|Withdrawal by Subject|2
5015836|NCT03614975|17234841|P1|Overall Study|Withdrawal by Subject|2
5015837|NCT03614975|17234840|P2|Overall Study|Physician Decision|5
5015838|NCT03614975|17234841|P1|Overall Study|Physician Decision|7
5015839|NCT03614156|17234854|P4|Safety Follow-Up Period|Lost to Follow-up|1
5015840|NCT03614156|17234855|P3|Safety Follow-Up Period|Lost to Follow-up|0
5015841|NCT03614156|17234856|P2|Safety Follow-Up Period|Lost to Follow-up|0
5015842|NCT03614156|17234857|P1|Safety Follow-Up Period|Lost to Follow-up|1
5015843|NCT03614156|17234854|P4|Safety Follow-Up Period|Withdrawal by Subject|0
5015844|NCT03614156|17234855|P3|Safety Follow-Up Period|Withdrawal by Subject|1
5015845|NCT03614156|17234856|P2|Safety Follow-Up Period|Withdrawal by Subject|0
5015846|NCT03614156|17234857|P1|Safety Follow-Up Period|Withdrawal by Subject|0
5015847|NCT03614156|17234854|P4|Safety Follow-Up Period|Miscellaneous Reasons|0
5015848|NCT03614156|17234855|P3|Safety Follow-Up Period|Miscellaneous Reasons|0
5015849|NCT03614156|17234856|P2|Safety Follow-Up Period|Miscellaneous Reasons|0
5015850|NCT03614156|17234857|P1|Safety Follow-Up Period|Miscellaneous Reasons|2
5015851|NCT03614156|17234854|P4|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5015852|NCT03614156|17234855|P3|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5015853|NCT03614156|17234856|P2|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
5015854|NCT03614156|17234857|P1|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5015855|NCT03614156|17234854|P4|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
5015856|NCT03614156|17234855|P3|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
5015857|NCT03614156|17234856|P2|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
5015858|NCT03614156|17234857|P1|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
5015859|NCT03614156|17234854|P4|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5015860|NCT03614156|17234855|P3|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5015861|NCT03614156|17234856|P2|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5015862|NCT03614156|17234857|P1|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
5015863|NCT03614156|17234854|P4|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
5015864|NCT03614156|17234855|P3|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
5015865|NCT03614156|17234856|P2|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
5015866|NCT03614156|17234857|P1|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
5015867|NCT03614156|17234854|P4|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
5015868|NCT03614156|17234855|P3|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
5015869|NCT03614156|17234856|P2|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
5015870|NCT03614156|17234857|P1|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
5015871|NCT03614156|17234854|P4|Double-Blind Treatment Period (DBTP)|Adverse Event|1
5015872|NCT03614156|17234855|P3|Double-Blind Treatment Period (DBTP)|Adverse Event|0
5015873|NCT03614156|17234856|P2|Double-Blind Treatment Period (DBTP)|Adverse Event|2
5015874|NCT03614156|17234857|P1|Double-Blind Treatment Period (DBTP)|Adverse Event|0
5015875|NCT03614156|17234854|P4|Open-Label Treatment Period|Study terminated by sponsor|0
5015876|NCT03614156|17234855|P3|Open-Label Treatment Period|Study terminated by sponsor|0
5015877|NCT03614156|17234856|P2|Open-Label Treatment Period|Study terminated by sponsor|0
5015878|NCT03614156|17234857|P1|Open-Label Treatment Period|Study terminated by sponsor|74
5015879|NCT03614156|17234854|P4|Open-Label Treatment Period|Non-compliance with study drug|0
5015880|NCT03614156|17234855|P3|Open-Label Treatment Period|Non-compliance with study drug|0
5015881|NCT03614156|17234856|P2|Open-Label Treatment Period|Non-compliance with study drug|0
5015882|NCT03614156|17234857|P1|Open-Label Treatment Period|Non-compliance with study drug|1
5015883|NCT03614156|17234854|P4|Open-Label Treatment Period|Protocol Violation|0
5015884|NCT03614156|17234855|P3|Open-Label Treatment Period|Protocol Violation|0
5015885|NCT03614156|17234856|P2|Open-Label Treatment Period|Protocol Violation|0
5015886|NCT03614156|17234857|P1|Open-Label Treatment Period|Protocol Violation|2
5015887|NCT03614156|17234854|P4|Open-Label Treatment Period|Lost to Follow-up|0
5015888|NCT03614156|17234855|P3|Open-Label Treatment Period|Lost to Follow-up|0
5015889|NCT03614156|17234856|P2|Open-Label Treatment Period|Lost to Follow-up|0
5015890|NCT03614156|17234857|P1|Open-Label Treatment Period|Lost to Follow-up|10
5015891|NCT03614156|17234854|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5015892|NCT03614156|17234855|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5015893|NCT03614156|17234856|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5015894|NCT03614156|17234857|P1|Open-Label Treatment Period|Withdrawal by Subject|36
5015895|NCT03614156|17234854|P4|Open-Label Treatment Period|Lack of Efficacy|0
5015896|NCT03614156|17234855|P3|Open-Label Treatment Period|Lack of Efficacy|0
5015897|NCT03614156|17234856|P2|Open-Label Treatment Period|Lack of Efficacy|0
5015898|NCT03614156|17234857|P1|Open-Label Treatment Period|Lack of Efficacy|18
5015899|NCT03614156|17234854|P4|Open-Label Treatment Period|Adverse Event|0
5015900|NCT03614156|17234855|P3|Open-Label Treatment Period|Adverse Event|0
5015901|NCT03614156|17234856|P2|Open-Label Treatment Period|Adverse Event|0
5015902|NCT03614156|17234857|P1|Open-Label Treatment Period|Adverse Event|7
5015903|NCT03614156|17234854|P4|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5015904|NCT03614156|17234855|P3|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5015905|NCT03614156|17234856|P2|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5015906|NCT03614156|17234857|P1|Open-Label Treatment Period|Protocol-specified withdrawal met|6
5015907|NCT03614078|17234869|P3|Overall Study|Dizziness and Rash|0
5015908|NCT03614078|17234870|P2|Overall Study|Dizziness and Rash|1
5015909|NCT03614078|17234871|P1|Overall Study|Dizziness and Rash|0
5015910|NCT03614078|17234869|P3|Overall Study|Adverse Event|0
5015911|NCT03614078|17234870|P2|Overall Study|Adverse Event|2
5015912|NCT03614078|17234871|P1|Overall Study|Adverse Event|0
5015913|NCT03614078|17234869|P3|Overall Study|Exacerbation of Psoriasis|0
5015914|NCT03614078|17234870|P2|Overall Study|Exacerbation of Psoriasis|1
5015915|NCT03614078|17234871|P1|Overall Study|Exacerbation of Psoriasis|0
5015916|NCT03614078|17234869|P3|Overall Study|Patient Did Not Meet Eligibility|0
5015917|NCT03614078|17234870|P2|Overall Study|Patient Did Not Meet Eligibility|0
5015918|NCT03614078|17234871|P1|Overall Study|Patient Did Not Meet Eligibility|1
5015919|NCT03614078|17234869|P3|Overall Study|High Neutrophils|2
5015920|NCT03614078|17234870|P2|Overall Study|High Neutrophils|0
5015921|NCT03614078|17234871|P1|Overall Study|High Neutrophils|0
5015922|NCT03614078|17234869|P3|Overall Study|Participant Did Not Return for Visit|0
5015923|NCT03614078|17234870|P2|Overall Study|Participant Did Not Return for Visit|1
5015924|NCT03614078|17234871|P1|Overall Study|Participant Did Not Return for Visit|0
5015925|NCT03614078|17234869|P3|Overall Study|Withdrawal by Subject|3
5015926|NCT03614078|17234870|P2|Overall Study|Withdrawal by Subject|2
5015927|NCT03614078|17234871|P1|Overall Study|Withdrawal by Subject|2
5015928|NCT03613649|17234900|P12|Fourth Treatment|Physician Decision|0
5015929|NCT03613649|17234901|P11|Fourth Treatment|Physician Decision|0
5015930|NCT03613649|17234902|P10|Fourth Treatment|Physician Decision|0
5015931|NCT03613649|17234903|P9|Fourth Treatment|Physician Decision|0
5015932|NCT03613649|17234904|P8|Fourth Treatment|Physician Decision|0
5015933|NCT03613649|17234905|P7|Fourth Treatment|Physician Decision|1
5015934|NCT03613649|17234906|P6|Fourth Treatment|Physician Decision|0
5015935|NCT03613649|17234907|P5|Fourth Treatment|Physician Decision|0
5015936|NCT03613649|17234908|P4|Fourth Treatment|Physician Decision|0
5015937|NCT03613649|17234909|P3|Fourth Treatment|Physician Decision|0
5015938|NCT03613649|17234910|P2|Fourth Treatment|Physician Decision|0
5015939|NCT03613649|17234911|P1|Fourth Treatment|Physician Decision|0
5015940|NCT03613649|17234900|P12|Fourth Treatment|Protocol Violation|0
5015941|NCT03613649|17234901|P11|Fourth Treatment|Protocol Violation|0
5015942|NCT03613649|17234902|P10|Fourth Treatment|Protocol Violation|0
5015943|NCT03613649|17234903|P9|Fourth Treatment|Protocol Violation|0
5015944|NCT03613649|17234904|P8|Fourth Treatment|Protocol Violation|0
5015945|NCT03613649|17234905|P7|Fourth Treatment|Protocol Violation|0
5015946|NCT03613649|17234906|P6|Fourth Treatment|Protocol Violation|0
5015947|NCT03613649|17234907|P5|Fourth Treatment|Protocol Violation|1
5015948|NCT03613649|17234908|P4|Fourth Treatment|Protocol Violation|0
5015949|NCT03613649|17234909|P3|Fourth Treatment|Protocol Violation|0
5015950|NCT03613649|17234910|P2|Fourth Treatment|Protocol Violation|0
5015951|NCT03613649|17234911|P1|Fourth Treatment|Protocol Violation|1
5015952|NCT03613649|17234900|P12|Third Treatment|Protocol Violation|1
5015953|NCT03613649|17234901|P11|Third Treatment|Protocol Violation|0
5015954|NCT03613649|17234902|P10|Third Treatment|Protocol Violation|0
5015955|NCT03613649|17234903|P9|Third Treatment|Protocol Violation|0
5015956|NCT03613649|17234904|P8|Third Treatment|Protocol Violation|0
5015957|NCT03613649|17234905|P7|Third Treatment|Protocol Violation|1
5015958|NCT03613649|17234906|P6|Third Treatment|Protocol Violation|0
5015959|NCT03613649|17234907|P5|Third Treatment|Protocol Violation|0
5015960|NCT03613649|17234908|P4|Third Treatment|Protocol Violation|0
5015961|NCT03613649|17234909|P3|Third Treatment|Protocol Violation|0
5015962|NCT03613649|17234910|P2|Third Treatment|Protocol Violation|0
5015963|NCT03613649|17234911|P1|Third Treatment|Protocol Violation|0
5015964|NCT03613649|17234900|P12|Third Treatment|Lost to Follow-up|1
5015965|NCT03613649|17234901|P11|Third Treatment|Lost to Follow-up|0
5015966|NCT03613649|17234902|P10|Third Treatment|Lost to Follow-up|0
5015967|NCT03613649|17234903|P9|Third Treatment|Lost to Follow-up|0
5015968|NCT03613649|17234904|P8|Third Treatment|Lost to Follow-up|0
5015969|NCT03613649|17234905|P7|Third Treatment|Lost to Follow-up|0
5015970|NCT03613649|17234906|P6|Third Treatment|Lost to Follow-up|0
5015971|NCT03613649|17234907|P5|Third Treatment|Lost to Follow-up|1
5015972|NCT03613649|17234908|P4|Third Treatment|Lost to Follow-up|0
5015973|NCT03613649|17234909|P3|Third Treatment|Lost to Follow-up|0
5015974|NCT03613649|17234910|P2|Third Treatment|Lost to Follow-up|0
5015975|NCT03613649|17234911|P1|Third Treatment|Lost to Follow-up|0
5015976|NCT03613649|17234900|P12|Second Treatment|Withdrawal by Subject|0
5015977|NCT03613649|17234901|P11|Second Treatment|Withdrawal by Subject|0
5015978|NCT03613649|17234902|P10|Second Treatment|Withdrawal by Subject|0
5015979|NCT03613649|17234903|P9|Second Treatment|Withdrawal by Subject|0
5015980|NCT03613649|17234904|P8|Second Treatment|Withdrawal by Subject|0
5015981|NCT03613649|17234905|P7|Second Treatment|Withdrawal by Subject|0
5015982|NCT03613649|17234906|P6|Second Treatment|Withdrawal by Subject|0
5015983|NCT03613649|17234907|P5|Second Treatment|Withdrawal by Subject|1
5015984|NCT03613649|17234908|P4|Second Treatment|Withdrawal by Subject|0
5015985|NCT03613649|17234909|P3|Second Treatment|Withdrawal by Subject|0
5015986|NCT03613649|17234910|P2|Second Treatment|Withdrawal by Subject|0
5015987|NCT03613649|17234911|P1|Second Treatment|Withdrawal by Subject|0
5015988|NCT03613649|17234900|P12|Second Treatment|Lost to Follow-up|0
5015989|NCT03613649|17234901|P11|Second Treatment|Lost to Follow-up|0
5015990|NCT03613649|17234902|P10|Second Treatment|Lost to Follow-up|0
5015991|NCT03613649|17234903|P9|Second Treatment|Lost to Follow-up|0
5015992|NCT03613649|17234904|P8|Second Treatment|Lost to Follow-up|0
5015993|NCT03613649|17234905|P7|Second Treatment|Lost to Follow-up|0
5015994|NCT03613649|17234906|P6|Second Treatment|Lost to Follow-up|0
5015995|NCT03613649|17234907|P5|Second Treatment|Lost to Follow-up|0
5015996|NCT03613649|17234908|P4|Second Treatment|Lost to Follow-up|0
5015997|NCT03613649|17234909|P3|Second Treatment|Lost to Follow-up|1
5015998|NCT03613649|17234910|P2|Second Treatment|Lost to Follow-up|0
5015999|NCT03613649|17234911|P1|Second Treatment|Lost to Follow-up|0
5016000|NCT03613129|17235056|P5|Pre-treatment Assessment|Withdrawal by Subject|0
5016001|NCT03613129|17235057|P4|Pre-treatment Assessment|Withdrawal by Subject|0
5016002|NCT03613129|17235058|P3|Pre-treatment Assessment|Withdrawal by Subject|0
5016003|NCT03613129|17235059|P2|Pre-treatment Assessment|Withdrawal by Subject|0
5016004|NCT03613129|17235060|P1|Pre-treatment Assessment|Withdrawal by Subject|1
5016005|NCT03613129|17235056|P5|Pre-treatment Assessment|Protocol Violation|0
5016006|NCT03613129|17235057|P4|Pre-treatment Assessment|Protocol Violation|0
5016007|NCT03613129|17235058|P3|Pre-treatment Assessment|Protocol Violation|0
5016008|NCT03613129|17235059|P2|Pre-treatment Assessment|Protocol Violation|0
5016009|NCT03613129|17235060|P1|Pre-treatment Assessment|Protocol Violation|2
5016010|NCT03612856|17235085|P3|Pre-dose Period|Withdrawal by Subject|0
5016011|NCT03612856|17235086|P2|Pre-dose Period|Withdrawal by Subject|1
5016012|NCT03612856|17235087|P1|Pre-dose Period|Withdrawal by Subject|0
5016013|NCT03612856|17235085|P3|Pre-dose Period|Physician Decision|1
5016014|NCT03612856|17235086|P2|Pre-dose Period|Physician Decision|1
5016015|NCT03612856|17235087|P1|Pre-dose Period|Physician Decision|0
5016016|NCT03610269|17235287|P1|Overall Study|Screen fail|4
5016017|NCT03610269|17235287|P1|Overall Study|Unable to draw blood|1
5016018|NCT03610269|17235287|P1|Overall Study|Protocol Violation|1
5016019|NCT03610269|17235287|P1|Overall Study|Physician Decision|10
5016020|NCT03609619|17235293|P2|Overall Study|Lost to Follow-up|1
5016021|NCT03609619|17235294|P1|Overall Study|Lost to Follow-up|1
5016022|NCT03609619|17235293|P2|Overall Study|Withdrawal by Subject|3
5016023|NCT03609619|17235294|P1|Overall Study|Withdrawal by Subject|2
5016024|NCT03609619|17235293|P2|Overall Study|Protocol Violation|0
5016025|NCT03609619|17235294|P1|Overall Study|Protocol Violation|5
5016026|NCT03609619|17235293|P2|Overall Study|Lack of Efficacy|2
5016027|NCT03609619|17235294|P1|Overall Study|Lack of Efficacy|1
5016028|NCT03609619|17235293|P2|Overall Study|Adverse Event|0
5016029|NCT03609619|17235294|P1|Overall Study|Adverse Event|1
5016030|NCT03607682|17235375|P1|Overall Study|Disease progression|1
5016031|NCT03607682|17235375|P1|Overall Study|Withdrawal by Subject|1
5016032|NCT03607487|17235391|P4|Overall Study|Withdrawal by Subject|1
5016033|NCT03607487|17235392|P3|Overall Study|Withdrawal by Subject|0
5016034|NCT03607487|17235393|P2|Overall Study|Withdrawal by Subject|0
5016035|NCT03607487|17235394|P1|Overall Study|Withdrawal by Subject|2
5016036|NCT03606460|17235445|P2|Overall Study|Lost to Follow-up|8
5016037|NCT03606460|17235446|P1|Overall Study|Lost to Follow-up|1
5016038|NCT03605693|17235466|P2|Overall Study|Physician Decision|0
5016039|NCT03605693|17235467|P1|Overall Study|Physician Decision|1
5016040|NCT03605693|17235466|P2|Overall Study|Lost to Follow-up|0
5016041|NCT03605693|17235467|P1|Overall Study|Lost to Follow-up|4
5016042|NCT03605303|17235481|P2|Period 1|Study Terminated|1
5016043|NCT03605303|17235482|P1|Period 1|Study Terminated|2
5016044|NCT03604497|17235490|P1|Overall Study|Protocol Violation|52
5016045|NCT03604341|17235500|P2|Overall Study|Protocol Violation|1
5016046|NCT03604341|17235501|P1|Overall Study|Protocol Violation|0
5016047|NCT03604341|17235500|P2|Overall Study|Adverse Event|0
5016048|NCT03604341|17235501|P1|Overall Study|Adverse Event|1
5016049|NCT03604341|17235500|P2|Overall Study|Withdrawal by Subject|1
5016050|NCT03604341|17235501|P1|Overall Study|Withdrawal by Subject|1
5016051|NCT03603028|17235585|P1|Overall Study|Withdrawal by Subject|1
5016052|NCT03601715|17235593|P3|Second Intervention|Lost to Follow-up|0
5016053|NCT03601715|17235594|P2|Second Intervention|Lost to Follow-up|1
5016054|NCT03601715|17235595|P1|Second Intervention|Lost to Follow-up|1
5016055|NCT03599349|17235628|P1|Overall Study|Lost to Follow-up|1
5016056|NCT03599193|17235642|P2|Overall Study|Lost to Follow-up|1
5016057|NCT03599193|17235643|P1|Overall Study|Lost to Follow-up|0
5016058|NCT03599193|17235642|P2|Overall Study|Protocol Violation|0
5016059|NCT03599193|17235643|P1|Overall Study|Protocol Violation|1
5016060|NCT03599193|17235642|P2|Overall Study|Withdrawal by Subject|0
5016061|NCT03599193|17235643|P1|Overall Study|Withdrawal by Subject|1
5016062|NCT03599193|17235642|P2|Overall Study|Adverse Event|2
5016063|NCT03599193|17235643|P1|Overall Study|Adverse Event|0
5016064|NCT03598140|17235657|P2|Overall Study|enrolled but didn't start|0
5016065|NCT03598140|17235658|P1|Overall Study|enrolled but didn't start|1
5016066|NCT03597022|17235677|P3|Overall Study|Serious adverse event|0
5016067|NCT03597022|17235678|P2|Overall Study|Serious adverse event|1
5016068|NCT03597022|17235679|P1|Overall Study|Serious adverse event|1
5016069|NCT03597022|17235677|P3|Overall Study|Premature termination of the study|8
5016070|NCT03597022|17235678|P2|Overall Study|Premature termination of the study|7
5016071|NCT03597022|17235679|P1|Overall Study|Premature termination of the study|7
5016072|NCT03594227|17235715|P4|Overall Study|Programmatic Analysis Non-completer|1
5016073|NCT03594227|17235716|P3|Overall Study|Programmatic Analysis Non-completer|1
5016074|NCT03594227|17235717|P2|Overall Study|Programmatic Analysis Non-completer|0
5016075|NCT03594227|17235718|P1|Overall Study|Programmatic Analysis Non-completer|1
5016076|NCT03594227|17235715|P4|Overall Study|Sponsor Decision|1
5016077|NCT03594227|17235716|P3|Overall Study|Sponsor Decision|0
5016078|NCT03594227|17235717|P2|Overall Study|Sponsor Decision|0
5016079|NCT03594227|17235718|P1|Overall Study|Sponsor Decision|0
5016080|NCT03594227|17235715|P4|Overall Study|Pregnancy|0
5016081|NCT03594227|17235716|P3|Overall Study|Pregnancy|0
5016082|NCT03594227|17235717|P2|Overall Study|Pregnancy|1
5016083|NCT03594227|17235718|P1|Overall Study|Pregnancy|0
5016084|NCT03594227|17235715|P4|Overall Study|Withdrawal by Subject|1
5016085|NCT03594227|17235716|P3|Overall Study|Withdrawal by Subject|1
5016086|NCT03594227|17235717|P2|Overall Study|Withdrawal by Subject|1
5016087|NCT03594227|17235718|P1|Overall Study|Withdrawal by Subject|1
5016088|NCT03594227|17235715|P4|Overall Study|Lost to Follow-up|0
5016089|NCT03594227|17235716|P3|Overall Study|Lost to Follow-up|1
5016090|NCT03594227|17235717|P2|Overall Study|Lost to Follow-up|1
5016091|NCT03594227|17235718|P1|Overall Study|Lost to Follow-up|1
5016092|NCT03594227|17235715|P4|Overall Study|Adverse Event|2
5016093|NCT03594227|17235716|P3|Overall Study|Adverse Event|0
5016094|NCT03594227|17235717|P2|Overall Study|Adverse Event|1
5016095|NCT03594227|17235718|P1|Overall Study|Adverse Event|2
5016096|NCT03591406|17235899|P2|Overall Study|Withdrawal by Subject|5
5016097|NCT03591406|17235900|P1|Overall Study|Withdrawal by Subject|0
5016098|NCT03591406|17235899|P2|Overall Study|Protocol Violation|1
5016099|NCT03591406|17235900|P1|Overall Study|Protocol Violation|2
5016100|NCT03591406|17235899|P2|Overall Study|Adverse Event|3
5016101|NCT03591406|17235900|P1|Overall Study|Adverse Event|5
5016102|NCT03590743|17235946|P2|Overall Study|Withdrawal by Subject|1
5016103|NCT03590743|17235947|P1|Overall Study|Withdrawal by Subject|0
5016104|NCT03590613|17235959|P4|Period 2, 4 Days|Physician Decision|1
5016105|NCT03590613|17235960|P3|Period 2, 4 Days|Physician Decision|0
5016106|NCT03590613|17235961|P2|Period 2, 4 Days|Physician Decision|0
5016107|NCT03590613|17235962|P1|Period 2, 4 Days|Physician Decision|0
5016108|NCT03588741|17236091|P1|Overall Study|Withdrawal by Subject|1
5016109|NCT03588572|17236098|P2|Visitation 3|Withdrawal by Subject|0
5016110|NCT03588572|17236099|P1|Visitation 3|Withdrawal by Subject|1
5016111|NCT03588572|17236098|P2|Visitation 3|Physician Decision|1
5016112|NCT03588572|17236099|P1|Visitation 3|Physician Decision|1
5016113|NCT03588572|17236098|P2|Visitation 3|Lost to Follow-up|1
5016114|NCT03588572|17236099|P1|Visitation 3|Lost to Follow-up|1
5016115|NCT03588572|17236098|P2|Visitation 2|Withdrawal by Subject|0
5016116|NCT03588572|17236099|P1|Visitation 2|Withdrawal by Subject|1
5016117|NCT03588572|17236098|P2|Visitation 2|Lack of Efficacy|1
5016118|NCT03588572|17236099|P1|Visitation 2|Lack of Efficacy|0
5016119|NCT03588572|17236098|P2|Visitation 2|Lost to Follow-up|1
5016120|NCT03588572|17236099|P1|Visitation 2|Lost to Follow-up|1
5016121|NCT03588572|17236098|P2|Visitation 1|Lack of Efficacy|1
5016122|NCT03588572|17236099|P1|Visitation 1|Lack of Efficacy|1
5016123|NCT03587974|17236117|P2|Overall Study|Withdrawal by Subject|1
5016124|NCT03587974|17236118|P1|Overall Study|Withdrawal by Subject|2
5016125|NCT03587974|17236117|P2|Overall Study|caregiver demented, care recipient died|3
5016126|NCT03587974|17236118|P1|Overall Study|caregiver demented, care recipient died|3
5016127|NCT03586830|17236234|P4|Overall Study|Withdrawal by Subject|1
5016128|NCT03586830|17236235|P3|Overall Study|Withdrawal by Subject|3
5016129|NCT03586830|17236236|P2|Overall Study|Withdrawal by Subject|0
5016130|NCT03586830|17236237|P1|Overall Study|Withdrawal by Subject|1
5016131|NCT03586830|17236234|P4|Overall Study|Lost to Follow-up|1
5016132|NCT03586830|17236235|P3|Overall Study|Lost to Follow-up|2
5016133|NCT03586830|17236236|P2|Overall Study|Lost to Follow-up|2
5016134|NCT03586830|17236237|P1|Overall Study|Lost to Follow-up|0
5016135|NCT03586830|17236234|P4|Overall Study|Site terminated by Sponsor|3
5016136|NCT03586830|17236235|P3|Overall Study|Site terminated by Sponsor|3
5016137|NCT03586830|17236236|P2|Overall Study|Site terminated by Sponsor|4
5016138|NCT03586830|17236237|P1|Overall Study|Site terminated by Sponsor|1
5016139|NCT03586726|17236259|P1|Overall Study|Withdrawal by Subject|1
5016140|NCT03586648|17236276|P2|Period 2|Adverse Event|0
5016141|NCT03586648|17236277|P1|Period 2|Adverse Event|1
5016142|NCT03586648|17236276|P2|Period 1|Physician Decision|1
5016143|NCT03586648|17236277|P1|Period 1|Physician Decision|0
5016144|NCT03586648|17236276|P2|Period 1|Study related symptoms or complaints|1
5016145|NCT03586648|17236277|P1|Period 1|Study related symptoms or complaints|2
5016146|NCT03586648|17236276|P2|Period 1|Adverse Event|0
5016147|NCT03586648|17236277|P1|Period 1|Adverse Event|1
5016148|NCT03586648|17236276|P2|Period 1|Lost to Follow-up|1
5016149|NCT03586648|17236277|P1|Period 1|Lost to Follow-up|1
5016150|NCT03586648|17236276|P2|Period 1|Withdrawal by Subject|1
5016151|NCT03586648|17236277|P1|Period 1|Withdrawal by Subject|0
5016152|NCT03585959|17236290|P1|Overall Study|Unsuccessful Procedure|2
5016153|NCT03585959|17236290|P1|Overall Study|Physician Decision|1
5016154|NCT03585504|17236341|P2|Overall Study|Lost to Follow-up|29
5016155|NCT03585504|17236342|P1|Overall Study|Lost to Follow-up|26
5016156|NCT03585296|17236352|P1|Overall Study|Withdrawal by Subject|2
5016157|NCT03585296|17236352|P1|Overall Study|Lost to Follow-up|2
5016158|NCT03585296|17236352|P1|Overall Study|Adverse Event|1
5016159|NCT03583450|17236358|P2|Overall Study|hardware malfunction (battery depletion)|0
5016160|NCT03583450|17236359|P1|Overall Study|hardware malfunction (battery depletion)|1
5016161|NCT03583385|17236381|P2|Treatment Period 2|Adverse Event|0
5016162|NCT03583385|17236382|P1|Treatment Period 2|Adverse Event|1
5016163|NCT03583385|17236381|P2|Treatment Period 1|Withdrawal by Subject|1
5016164|NCT03583385|17236382|P1|Treatment Period 1|Withdrawal by Subject|1
5016165|NCT03582943|17236400|P2|Analyzed|Protocol Violation|1
5016166|NCT03582943|17236401|P1|Analyzed|Protocol Violation|4
5016167|NCT03582943|17236400|P2|Intervention and Follow up|Withdrawal by Subject|2
5016168|NCT03582943|17236401|P1|Intervention and Follow up|Withdrawal by Subject|4
5016169|NCT03582943|17236400|P2|Allocated to Groups|Withdrawal by Subject|1
5016170|NCT03582943|17236401|P1|Allocated to Groups|Withdrawal by Subject|1
5016171|NCT03582813|17236409|P2|Overall Study|Withdrawal by Subject|0
5016172|NCT03582813|17236410|P1|Overall Study|Withdrawal by Subject|1
5016173|NCT03582813|17236409|P2|Overall Study|Lost to Follow-up|21
5016174|NCT03582813|17236410|P1|Overall Study|Lost to Follow-up|18
5016175|NCT03582215|17236477|P8|Overall Study|Adverse Event|2
5016176|NCT03582215|17236478|P7|Overall Study|Adverse Event|2
5016177|NCT03582215|17236479|P6|Overall Study|Adverse Event|0
5016178|NCT03582215|17236480|P5|Overall Study|Adverse Event|0
5016179|NCT03582215|17236481|P4|Overall Study|Adverse Event|0
5016180|NCT03582215|17236482|P3|Overall Study|Adverse Event|0
5016181|NCT03582215|17236483|P2|Overall Study|Adverse Event|0
5016182|NCT03582215|17236484|P1|Overall Study|Adverse Event|1
5016183|NCT03581825|17236525|P2|Period 2|Unsatisfactory Vision to Test|1
5016184|NCT03581825|17236526|P1|Period 2|Unsatisfactory Vision to Test|0
5016185|NCT03581825|17236525|P2|Period 1|Lens Discomfort|0
5016186|NCT03581825|17236526|P1|Period 1|Lens Discomfort|1
5016187|NCT03580382|17236562|P2|Overall Study|Early Termination of Study|3
5016188|NCT03580382|17236563|P1|Overall Study|Early Termination of Study|0
5016189|NCT03579940|17236581|P11|Period 2|Withdrawal by Subject|0
5016190|NCT03579940|17236582|P10|Period 2|Withdrawal by Subject|0
5016191|NCT03579940|17236583|P9|Period 2|Withdrawal by Subject|0
5016192|NCT03579940|17236584|P8|Period 2|Withdrawal by Subject|0
5016193|NCT03579940|17236585|P7|Period 2|Withdrawal by Subject|0
5016194|NCT03579940|17236586|P6|Period 2|Withdrawal by Subject|0
5016195|NCT03579940|17236587|P5|Period 2|Withdrawal by Subject|0
5016196|NCT03579940|17236588|P4|Period 2|Withdrawal by Subject|0
5016197|NCT03579940|17236589|P3|Period 2|Withdrawal by Subject|1
5016198|NCT03579940|17236590|P2|Period 2|Withdrawal by Subject|0
5016199|NCT03579940|17236591|P1|Period 2|Withdrawal by Subject|0
5016200|NCT03579719|17236631|P1|Overall Study|Protocol deviation, pre-existent disease|1
5016201|NCT03578146|17236688|P6|Overall Study|Lost to Follow-up|1
5016202|NCT03578146|17236689|P5|Overall Study|Lost to Follow-up|0
5016203|NCT03578146|17236690|P4|Overall Study|Lost to Follow-up|0
5016204|NCT03578146|17236691|P3|Overall Study|Lost to Follow-up|1
5016205|NCT03578146|17236692|P2|Overall Study|Lost to Follow-up|1
5016206|NCT03578146|17236693|P1|Overall Study|Lost to Follow-up|0
5016207|NCT03578146|17236688|P6|Overall Study|Did Not Receive Treatment|2
5016208|NCT03578146|17236689|P5|Overall Study|Did Not Receive Treatment|0
5016209|NCT03578146|17236690|P4|Overall Study|Did Not Receive Treatment|0
5016210|NCT03578146|17236691|P3|Overall Study|Did Not Receive Treatment|0
5016211|NCT03578146|17236692|P2|Overall Study|Did Not Receive Treatment|0
5016212|NCT03578146|17236693|P1|Overall Study|Did Not Receive Treatment|1
5016213|NCT03575871|17236834|P3|Overall Study|Other than specified|0
5016214|NCT03575871|17236835|P2|Overall Study|Other than specified|2
5016215|NCT03575871|17236836|P1|Overall Study|Other than specified|2
5016216|NCT03575871|17236834|P3|Overall Study|Withdrawal by Subject|9
5016217|NCT03575871|17236835|P2|Overall Study|Withdrawal by Subject|1
5016218|NCT03575871|17236836|P1|Overall Study|Withdrawal by Subject|6
5016219|NCT03575871|17236834|P3|Overall Study|Protocol Deviation|1
5016220|NCT03575871|17236835|P2|Overall Study|Protocol Deviation|1
5016221|NCT03575871|17236836|P1|Overall Study|Protocol Deviation|1
5016222|NCT03575871|17236834|P3|Overall Study|Lost to Follow-up|1
5016223|NCT03575871|17236835|P2|Overall Study|Lost to Follow-up|1
5016224|NCT03575871|17236836|P1|Overall Study|Lost to Follow-up|1
5016225|NCT03575871|17236834|P3|Overall Study|Lack of Efficacy|7
5016226|NCT03575871|17236835|P2|Overall Study|Lack of Efficacy|4
5016227|NCT03575871|17236836|P1|Overall Study|Lack of Efficacy|5
5016228|NCT03575871|17236834|P3|Overall Study|Death|0
5016229|NCT03575871|17236835|P2|Overall Study|Death|0
5016230|NCT03575871|17236836|P1|Overall Study|Death|1
5016231|NCT03575871|17236834|P3|Overall Study|Adverse Event|8
5016232|NCT03575871|17236835|P2|Overall Study|Adverse Event|5
5016233|NCT03575871|17236836|P1|Overall Study|Adverse Event|5
5016234|NCT03575806|17236900|P2|Overall Study|Protocol Violation|2
5016235|NCT03575806|17236901|P1|Overall Study|Protocol Violation|0
5016236|NCT03575806|17236900|P2|Overall Study|Withdrawal by Subject|2
5016237|NCT03575806|17236901|P1|Overall Study|Withdrawal by Subject|0
5016238|NCT03575702|17236911|P2|Overall Study|Patient non compliance|0
5016239|NCT03575702|17236912|P1|Overall Study|Patient non compliance|4
5016240|NCT03575702|17236911|P2|Overall Study|Protocol Violation|1
5016241|NCT03575702|17236912|P1|Overall Study|Protocol Violation|0
5016242|NCT03575702|17236911|P2|Overall Study|Lost to Follow-up|2
5016243|NCT03575702|17236912|P1|Overall Study|Lost to Follow-up|1
5016244|NCT03575702|17236911|P2|Overall Study|Withdrawal by Subject|1
5016245|NCT03575702|17236912|P1|Overall Study|Withdrawal by Subject|1
5016246|NCT03573908|17236968|P5|Randomized Withdrawal Period|Other, Not Specified|0
5016247|NCT03573908|17236969|P4|Randomized Withdrawal Period|Other, Not Specified|2
5016248|NCT03573908|17236970|P3|Randomized Withdrawal Period|Other, Not Specified|4
5016249|NCT03573908|17236971|P2|Randomized Withdrawal Period|Other, Not Specified|0
5016250|NCT03573908|17236972|P1|Randomized Withdrawal Period|Other, Not Specified|0
5016251|NCT03573908|17236968|P5|Randomized Withdrawal Period|Lost to Follow-up|0
5016252|NCT03573908|17236969|P4|Randomized Withdrawal Period|Lost to Follow-up|0
5016253|NCT03573908|17236970|P3|Randomized Withdrawal Period|Lost to Follow-up|1
5016254|NCT03573908|17236971|P2|Randomized Withdrawal Period|Lost to Follow-up|0
5016255|NCT03573908|17236972|P1|Randomized Withdrawal Period|Lost to Follow-up|0
5016256|NCT03573908|17236968|P5|Randomized Withdrawal Period|Withdrawal by Subject|2
5016257|NCT03573908|17236969|P4|Randomized Withdrawal Period|Withdrawal by Subject|0
5016258|NCT03573908|17236970|P3|Randomized Withdrawal Period|Withdrawal by Subject|0
5016259|NCT03573908|17236971|P2|Randomized Withdrawal Period|Withdrawal by Subject|0
5016260|NCT03573908|17236972|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
5016261|NCT03573908|17236968|P5|Randomized Withdrawal Period|Adverse Event|0
5016262|NCT03573908|17236969|P4|Randomized Withdrawal Period|Adverse Event|0
5016263|NCT03573908|17236970|P3|Randomized Withdrawal Period|Adverse Event|3
5016264|NCT03573908|17236971|P2|Randomized Withdrawal Period|Adverse Event|0
5016265|NCT03573908|17236972|P1|Randomized Withdrawal Period|Adverse Event|0
5016266|NCT03573908|17236968|P5|Treatment Period|Other, Not Specified|0
5016267|NCT03573908|17236969|P4|Treatment Period|Other, Not Specified|0
5016268|NCT03573908|17236970|P3|Treatment Period|Other, Not Specified|0
5016269|NCT03573908|17236971|P2|Treatment Period|Other, Not Specified|6
5016270|NCT03573908|17236972|P1|Treatment Period|Other, Not Specified|4
5016271|NCT03573908|17236968|P5|Treatment Period|Pregnancy|0
5016272|NCT03573908|17236969|P4|Treatment Period|Pregnancy|0
5016273|NCT03573908|17236970|P3|Treatment Period|Pregnancy|0
5016274|NCT03573908|17236971|P2|Treatment Period|Pregnancy|0
5016275|NCT03573908|17236972|P1|Treatment Period|Pregnancy|1
5016276|NCT03573908|17236968|P5|Treatment Period|Lost to Follow-up|0
5016277|NCT03573908|17236969|P4|Treatment Period|Lost to Follow-up|0
5016278|NCT03573908|17236970|P3|Treatment Period|Lost to Follow-up|0
5016279|NCT03573908|17236971|P2|Treatment Period|Lost to Follow-up|6
5016280|NCT03573908|17236972|P1|Treatment Period|Lost to Follow-up|7
5016281|NCT03573908|17236968|P5|Treatment Period|Withdrawal by Subject|0
5016282|NCT03573908|17236969|P4|Treatment Period|Withdrawal by Subject|0
5016283|NCT03573908|17236970|P3|Treatment Period|Withdrawal by Subject|0
5016284|NCT03573908|17236971|P2|Treatment Period|Withdrawal by Subject|5
5016285|NCT03573908|17236972|P1|Treatment Period|Withdrawal by Subject|7
5016286|NCT03573908|17236968|P5|Treatment Period|Protocol Violation|0
5016287|NCT03573908|17236969|P4|Treatment Period|Protocol Violation|0
5016288|NCT03573908|17236970|P3|Treatment Period|Protocol Violation|0
5016289|NCT03573908|17236971|P2|Treatment Period|Protocol Violation|0
5016290|NCT03573908|17236972|P1|Treatment Period|Protocol Violation|1
5016291|NCT03573908|17236968|P5|Treatment Period|Adverse Event|0
5016292|NCT03573908|17236969|P4|Treatment Period|Adverse Event|0
5016293|NCT03573908|17236970|P3|Treatment Period|Adverse Event|0
5016294|NCT03573908|17236971|P2|Treatment Period|Adverse Event|9
5016295|NCT03573908|17236972|P1|Treatment Period|Adverse Event|4
5016296|NCT03573830|17236989|P2|Overall Study|Lost to Follow-up|0
5016297|NCT03573830|17236990|P1|Overall Study|Lost to Follow-up|4
5016298|NCT03573830|17236989|P2|Overall Study|Dropped without completing treatment|7
5016299|NCT03573830|17236990|P1|Overall Study|Dropped without completing treatment|0
5016300|NCT03573817|17237013|P2|Overall Study|Withdrawal by Subject|1
5016301|NCT03573817|17237014|P1|Overall Study|Withdrawal by Subject|1
5016302|NCT03573817|17237013|P2|Overall Study|Protocol Violation|1
5016303|NCT03573817|17237014|P1|Overall Study|Protocol Violation|0
5016304|NCT03573817|17237013|P2|Overall Study|Adverse Event|2
5016305|NCT03573817|17237014|P1|Overall Study|Adverse Event|0
5016306|NCT03573505|17237042|P2|Overall Study|Death|4
5016307|NCT03573505|17237043|P1|Overall Study|Death|0
5016308|NCT03573505|17237042|P2|Overall Study|Reason not specified|1
5016309|NCT03573505|17237043|P1|Overall Study|Reason not specified|0
5016310|NCT03573505|17237042|P2|Overall Study|Study terminated by sponsor|45
5016311|NCT03573505|17237043|P1|Overall Study|Study terminated by sponsor|50
5016312|NCT03573505|17237042|P2|Overall Study|Site Terminated by Sponsor|1
5016313|NCT03573505|17237043|P1|Overall Study|Site Terminated by Sponsor|1
5016314|NCT03573505|17237042|P2|Overall Study|Disease progression|1
5016315|NCT03573505|17237043|P1|Overall Study|Disease progression|0
5016316|NCT03573505|17237042|P2|Overall Study|Consent withdrawn|1
5016317|NCT03573505|17237043|P1|Overall Study|Consent withdrawn|0
5016318|NCT03573505|17237042|P2|Overall Study|Adverse Event|1
5016319|NCT03573505|17237043|P1|Overall Study|Adverse Event|1
5016320|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
5016321|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
5016322|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
5016323|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
5016324|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
5016325|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
5016326|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
5016327|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
5016328|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
5016329|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
5016330|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
5016331|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
5016332|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
5016333|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
5016334|NCT03573323|17237088|P2|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
5016335|NCT03573323|17237089|P1|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
5016336|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
5016337|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
5016338|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
5016339|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
5016340|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
5016341|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
5016342|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
5016343|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
5016344|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
5016345|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
5016346|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
5016347|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
5016348|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
5016349|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
5016350|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
5016351|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
5016352|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
5016353|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
5016354|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
5016355|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
5016356|NCT03573323|17237088|P2|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
5016357|NCT03573323|17237089|P1|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
5016358|NCT03572218|17237237|P2|Overall Study|No longer interested|2
5016359|NCT03572218|17237238|P1|Overall Study|No longer interested|1
5016360|NCT03572218|17237237|P2|Overall Study|No longer available for study visits|1
5016361|NCT03572218|17237238|P1|Overall Study|No longer available for study visits|2
5016362|NCT03572218|17237237|P2|Overall Study|Lost to Follow-up|2
5016363|NCT03572218|17237238|P1|Overall Study|Lost to Follow-up|3
5016364|NCT03571256|17237488|P3|Overall Study|Protocol Violation|1
5016365|NCT03571256|17237489|P2|Overall Study|Protocol Violation|1
5016366|NCT03571256|17237490|P1|Overall Study|Protocol Violation|0
5016367|NCT03571256|17237488|P3|Overall Study|Other than specified|1
5016368|NCT03571256|17237489|P2|Overall Study|Other than specified|1
5016369|NCT03571256|17237490|P1|Overall Study|Other than specified|0
5016370|NCT03571256|17237488|P3|Overall Study|Withdrawal by Subject|1
5016371|NCT03571256|17237489|P2|Overall Study|Withdrawal by Subject|1
5016372|NCT03571256|17237490|P1|Overall Study|Withdrawal by Subject|3
5016373|NCT03571256|17237488|P3|Overall Study|Adverse Event|1
5016374|NCT03571256|17237489|P2|Overall Study|Adverse Event|0
5016375|NCT03571256|17237490|P1|Overall Study|Adverse Event|3
5016376|NCT03570554|17237578|P4|Overall Study|Adverse Event|1
5016377|NCT03570554|17237579|P3|Overall Study|Adverse Event|0
5016378|NCT03570554|17237580|P2|Overall Study|Adverse Event|0
5016379|NCT03570554|17237581|P1|Overall Study|Adverse Event|0
5016380|NCT03570554|17237578|P4|Overall Study|Non-compliance with study drug|0
5016381|NCT03570554|17237579|P3|Overall Study|Non-compliance with study drug|1
5016382|NCT03570554|17237580|P2|Overall Study|Non-compliance with study drug|0
5016383|NCT03570554|17237581|P1|Overall Study|Non-compliance with study drug|0
5016384|NCT03569371|17237695|P1|Overall Study|Adverse Event|1
5016385|NCT03569371|17237695|P1|Overall Study|Lost to Follow-up|1
5016386|NCT03569371|17237695|P1|Overall Study|Lack of Efficacy|1
5016387|NCT03569202|17237716|P2|Part 3|Other|1
5016388|NCT03569202|17237717|P1|Part 3|Other|1
5016389|NCT03569202|17237716|P2|Part 3|Physician Decision|0
5016390|NCT03569202|17237717|P1|Part 3|Physician Decision|1
5016391|NCT03568942|17237766|P1|Overall Study|Lost to Follow-up|1
5016392|NCT03568942|17237766|P1|Overall Study|Family emergency|1
5016393|NCT03568500|17237804|P3|Overall Study|Participant Noncompliance|0
5016394|NCT03568500|17237805|P2|Overall Study|Participant Noncompliance|1
5016395|NCT03568500|17237806|P1|Overall Study|Participant Noncompliance|1
5016396|NCT03568500|17237804|P3|Overall Study|Technical Problems|0
5016397|NCT03568500|17237805|P2|Overall Study|Technical Problems|1
5016398|NCT03568500|17237806|P1|Overall Study|Technical Problems|2
5016399|NCT03568500|17237804|P3|Overall Study|Withdrawal by Subject|0
5016400|NCT03568500|17237805|P2|Overall Study|Withdrawal by Subject|2
5016401|NCT03568500|17237806|P1|Overall Study|Withdrawal by Subject|4
5016402|NCT03568500|17237804|P3|Overall Study|Physician Decision|0
5016403|NCT03568500|17237805|P2|Overall Study|Physician Decision|0
5016404|NCT03568500|17237806|P1|Overall Study|Physician Decision|1
5016405|NCT03568500|17237804|P3|Overall Study|Adverse Event|2
5016406|NCT03568500|17237805|P2|Overall Study|Adverse Event|1
5016407|NCT03568500|17237806|P1|Overall Study|Adverse Event|1
5016408|NCT03568500|17237804|P3|Overall Study|Lost to Follow-up|2
5016409|NCT03568500|17237805|P2|Overall Study|Lost to Follow-up|1
5016410|NCT03568500|17237806|P1|Overall Study|Lost to Follow-up|1
5016411|NCT03566979|17237833|P4|Overall Study|Adverse Event|0
5016412|NCT03566979|17237834|P3|Overall Study|Adverse Event|0
5016413|NCT03566979|17237835|P2|Overall Study|Adverse Event|0
5016414|NCT03566979|17237836|P1|Overall Study|Adverse Event|1
5016415|NCT03566979|17237833|P4|Overall Study|Lost to Follow-up|5
5016416|NCT03566979|17237834|P3|Overall Study|Lost to Follow-up|9
5016417|NCT03566979|17237835|P2|Overall Study|Lost to Follow-up|7
5016418|NCT03566979|17237836|P1|Overall Study|Lost to Follow-up|2
5016419|NCT03566979|17237833|P4|Overall Study|Withdrawal by Subject|1
5016420|NCT03566979|17237834|P3|Overall Study|Withdrawal by Subject|1
5016421|NCT03566979|17237835|P2|Overall Study|Withdrawal by Subject|0
5016422|NCT03566979|17237836|P1|Overall Study|Withdrawal by Subject|2
5016423|NCT03566810|17237852|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5016424|NCT03566810|17237853|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5016425|NCT03566810|17237854|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
5016426|NCT03566810|17237855|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5016427|NCT03566680|17237917|P1|Overall Study|Withdrawal by Subject|3
5016428|NCT03566680|17237917|P1|Overall Study|Lost to Follow-up|13
5016429|NCT03566680|17237917|P1|Overall Study|Pregnancy|1
5016430|NCT03565887|17237928|P2|Overall Study|Withdrawal by Subject|2
5016431|NCT03565887|17237929|P1|Overall Study|Withdrawal by Subject|0
5016432|NCT03565887|17237928|P2|Overall Study|Adverse Event|0
5016433|NCT03565887|17237929|P1|Overall Study|Adverse Event|1
5016434|NCT03565211|17238004|P1|Overall Study|Personal issues|1
5016435|NCT03565211|17238004|P1|Overall Study|Adverse Event|44
5016436|NCT03565211|17238004|P1|Overall Study|Lost to Follow-up|1
5016437|NCT03565211|17238004|P1|Overall Study|Withdrawal by Subject|2
5016438|NCT03563716|17238078|P2|Overall Study|Still on Study|50
5016439|NCT03563716|17238079|P1|Overall Study|Still on Study|45
5016440|NCT03563716|17238078|P2|Overall Study|Withdrawal by Subject|3
5016441|NCT03563716|17238079|P1|Overall Study|Withdrawal by Subject|3
5016442|NCT03563716|17238078|P2|Overall Study|Death|14
5016443|NCT03563716|17238079|P1|Overall Study|Death|20
5016444|NCT03562481|17238311|P2|First Intervention|Lost to Follow-up|0
5016445|NCT03562481|17238312|P1|First Intervention|Lost to Follow-up|1
5016446|NCT03562117|17238337|P3|Part 1, Up to 3 Days|Adverse Event|0
5016447|NCT03562117|17238338|P2|Part 1, Up to 3 Days|Adverse Event|0
5016448|NCT03562117|17238339|P1|Part 1, Up to 3 Days|Adverse Event|1
5016449|NCT03560986|17238427|P2|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
5016450|NCT03560986|17238428|P1|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
5016451|NCT03560986|17238427|P2|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
5016452|NCT03560986|17238428|P1|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
5016453|NCT03560986|17238427|P2|Treatment Period B/Follow-up Period 2|Adverse Event|0
5016454|NCT03560986|17238428|P1|Treatment Period B/Follow-up Period 2|Adverse Event|1
5016455|NCT03560986|17238427|P2|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
5016456|NCT03560986|17238428|P1|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
5016457|NCT03560986|17238427|P2|Treatment Period A/Follow-up Period 1|Protocol Violation|1
5016458|NCT03560986|17238428|P1|Treatment Period A/Follow-up Period 1|Protocol Violation|0
5016459|NCT03560986|17238427|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5016460|NCT03560986|17238428|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5016461|NCT03560986|17238427|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
5016462|NCT03560986|17238428|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
5016463|NCT03560739|17238454|P4|Overall Study|Adverse Event|0
5016464|NCT03560739|17238455|P3|Overall Study|Adverse Event|0
5016465|NCT03560739|17238456|P2|Overall Study|Adverse Event|1
5016466|NCT03560739|17238457|P1|Overall Study|Adverse Event|0
5016467|NCT03560518|17238486|P3|Double Blind Treatment Period|Adverse Event|1
5016468|NCT03560518|17238487|P2|Double Blind Treatment Period|Adverse Event|3
5016469|NCT03560518|17238488|P1|Double Blind Treatment Period|Adverse Event|0
5016470|NCT03560518|17238486|P3|Double Blind Treatment Period|Lack of Efficacy|1
5016471|NCT03560518|17238487|P2|Double Blind Treatment Period|Lack of Efficacy|1
5016472|NCT03560518|17238488|P1|Double Blind Treatment Period|Lack of Efficacy|2
5016473|NCT03560518|17238486|P3|Double Blind Treatment Period|Withdrawal by Subject|5
5016474|NCT03560518|17238487|P2|Double Blind Treatment Period|Withdrawal by Subject|6
5016475|NCT03560518|17238488|P1|Double Blind Treatment Period|Withdrawal by Subject|10
5016476|NCT03560518|17238486|P3|Double Blind Treatment Period|Lost to Follow-up|6
5016477|NCT03560518|17238487|P2|Double Blind Treatment Period|Lost to Follow-up|6
5016478|NCT03560518|17238488|P1|Double Blind Treatment Period|Lost to Follow-up|5
5016479|NCT03560518|17238486|P3|Double Blind Treatment Period|Pregnancy|0
5016480|NCT03560518|17238487|P2|Double Blind Treatment Period|Pregnancy|2
5016481|NCT03560518|17238488|P1|Double Blind Treatment Period|Pregnancy|0
5016482|NCT03560518|17238486|P3|Double Blind Treatment Period|Protocol Violation|0
5016483|NCT03560518|17238487|P2|Double Blind Treatment Period|Protocol Violation|2
5016484|NCT03560518|17238488|P1|Double Blind Treatment Period|Protocol Violation|1
5016485|NCT03560518|17238486|P3|Double Blind Treatment Period|Study Terminated by the Sponsor|10
5016486|NCT03560518|17238487|P2|Double Blind Treatment Period|Study Terminated by the Sponsor|9
5016487|NCT03560518|17238488|P1|Double Blind Treatment Period|Study Terminated by the Sponsor|6
5016488|NCT03560518|17238486|P3|Double Blind Treatment Period|Miscellaneous Reasons|0
5016489|NCT03560518|17238487|P2|Double Blind Treatment Period|Miscellaneous Reasons|0
5016490|NCT03560518|17238488|P1|Double Blind Treatment Period|Miscellaneous Reasons|1
5016491|NCT03560245|17238501|P2|Overall Study|Other|1
5016492|NCT03560245|17238502|P1|Overall Study|Other|0
5016493|NCT03560245|17238501|P2|Overall Study|Physician Decision|1
5016494|NCT03560245|17238502|P1|Overall Study|Physician Decision|0
5016495|NCT03560245|17238501|P2|Overall Study|Lost to Follow-up|1
5016496|NCT03560245|17238502|P1|Overall Study|Lost to Follow-up|0
5016497|NCT03560245|17238501|P2|Overall Study|Death|1
5016498|NCT03560245|17238502|P1|Overall Study|Death|0
5016499|NCT03560245|17238501|P2|Overall Study|Protocol Violation|0
5016500|NCT03560245|17238502|P1|Overall Study|Protocol Violation|1
5016501|NCT03560245|17238501|P2|Overall Study|Adverse Event|1
5016502|NCT03560245|17238502|P1|Overall Study|Adverse Event|1
5016503|NCT03560245|17238501|P2|Overall Study|Withdrawal by Subject|2
5016504|NCT03560245|17238502|P1|Overall Study|Withdrawal by Subject|3
5016505|NCT03559257|17238556|P2|Open-label Treatment Period|Physician Decision|1
5016506|NCT03559257|17238557|P1|Open-label Treatment Period|Physician Decision|0
5016507|NCT03559257|17238556|P2|Open-label Treatment Period|Lost to Follow-up|0
5016508|NCT03559257|17238557|P1|Open-label Treatment Period|Lost to Follow-up|1
5016509|NCT03559257|17238556|P2|Open-label Treatment Period|Protocol Violation|0
5016510|NCT03559257|17238557|P1|Open-label Treatment Period|Protocol Violation|2
5016511|NCT03559257|17238556|P2|Open-label Treatment Period|Withdrawal by Subject|0
5016512|NCT03559257|17238557|P1|Open-label Treatment Period|Withdrawal by Subject|3
5016513|NCT03559257|17238556|P2|Open-label Treatment Period|Lack of Efficacy|2
5016514|NCT03559257|17238557|P1|Open-label Treatment Period|Lack of Efficacy|3
5016515|NCT03559257|17238556|P2|Open-label Treatment Period|Adverse Event|4
5016516|NCT03559257|17238557|P1|Open-label Treatment Period|Adverse Event|1
5016517|NCT03559257|17238556|P2|Double Blind Treatment Period|Screen Failure|1
5016518|NCT03559257|17238557|P1|Double Blind Treatment Period|Screen Failure|0
5016519|NCT03559257|17238556|P2|Double Blind Treatment Period|Adverse Event|1
5016520|NCT03559257|17238557|P1|Double Blind Treatment Period|Adverse Event|0
5016521|NCT03559257|17238556|P2|Double Blind Treatment Period|Lack of Efficacy|1
5016522|NCT03559257|17238557|P1|Double Blind Treatment Period|Lack of Efficacy|1
5016523|NCT03559257|17238556|P2|Double Blind Treatment Period|Protocol Violation|4
5016524|NCT03559257|17238557|P1|Double Blind Treatment Period|Protocol Violation|1
5016525|NCT03559257|17238556|P2|Double Blind Treatment Period|Withdrawal by Subject|1
5016526|NCT03559257|17238557|P1|Double Blind Treatment Period|Withdrawal by Subject|2
5016527|NCT03559062|17238627|P3|Overall Study|Other|0
5016528|NCT03559062|17238628|P2|Overall Study|Other|1
5016529|NCT03559062|17238629|P1|Overall Study|Other|0
5016530|NCT03558997|17238644|P4|Overall Study|Lost to Follow-up|0
5016531|NCT03558997|17238645|P3|Overall Study|Lost to Follow-up|1
5016532|NCT03558997|17238646|P2|Overall Study|Lost to Follow-up|0
5016533|NCT03558997|17238647|P1|Overall Study|Lost to Follow-up|0
5016534|NCT03558997|17238644|P4|Overall Study|Withdrawal by Subject|1
5016535|NCT03558997|17238645|P3|Overall Study|Withdrawal by Subject|1
5016536|NCT03558997|17238646|P2|Overall Study|Withdrawal by Subject|0
5016537|NCT03558997|17238647|P1|Overall Study|Withdrawal by Subject|1
5016538|NCT03558997|17238644|P4|Overall Study|Physician Decision|0
5016539|NCT03558997|17238645|P3|Overall Study|Physician Decision|1
5016540|NCT03558997|17238646|P2|Overall Study|Physician Decision|0
5016541|NCT03558997|17238647|P1|Overall Study|Physician Decision|0
5016542|NCT03558997|17238644|P4|Overall Study|Adverse Event|1
5016543|NCT03558997|17238645|P3|Overall Study|Adverse Event|5
5016544|NCT03558997|17238646|P2|Overall Study|Adverse Event|2
5016545|NCT03558997|17238647|P1|Overall Study|Adverse Event|0
5016546|NCT03558672|17238679|P1|Overall Study|Study Early Termination|10
5016547|NCT03558555|17238691|P2|Overall Study|Lost to Follow-up|1
5016548|NCT03558555|17238692|P1|Overall Study|Lost to Follow-up|2
5016549|NCT03558516|17238710|P2|Overall Study|Protocol Violation|2
5016550|NCT03558516|17238711|P1|Overall Study|Protocol Violation|2
5016551|NCT03557931|17238751|P3|Overall Study|Miscellaneous|3
5016552|NCT03557931|17238752|P2|Overall Study|Miscellaneous|5
5016553|NCT03557931|17238753|P1|Overall Study|Miscellaneous|8
5016554|NCT03557931|17238751|P3|Overall Study|Withdrawal by Subject|7
5016555|NCT03557931|17238752|P2|Overall Study|Withdrawal by Subject|0
5016556|NCT03557931|17238753|P1|Overall Study|Withdrawal by Subject|14
5016557|NCT03557931|17238751|P3|Overall Study|Protocol Violation|1
5016558|NCT03557931|17238752|P2|Overall Study|Protocol Violation|4
5016559|NCT03557931|17238753|P1|Overall Study|Protocol Violation|1
5016560|NCT03557931|17238751|P3|Overall Study|Lost to Follow-up|1
5016561|NCT03557931|17238752|P2|Overall Study|Lost to Follow-up|4
5016562|NCT03557931|17238753|P1|Overall Study|Lost to Follow-up|4
5016563|NCT03557931|17238751|P3|Overall Study|Adverse Event|1
5016564|NCT03557931|17238752|P2|Overall Study|Adverse Event|6
5016565|NCT03557931|17238753|P1|Overall Study|Adverse Event|4
5016566|NCT03557801|17238784|P3|Overall Study|Lost to Follow-up|0
5016567|NCT03557801|17238785|P2|Overall Study|Lost to Follow-up|1
5016568|NCT03557801|17238786|P1|Overall Study|Lost to Follow-up|0
5016569|NCT03557801|17238784|P3|Overall Study|Withdrawal by Subject|3
5016570|NCT03557801|17238785|P2|Overall Study|Withdrawal by Subject|0
5016571|NCT03557801|17238786|P1|Overall Study|Withdrawal by Subject|1
5016572|NCT03557801|17238784|P3|Overall Study|Protocol Violation|0
5016573|NCT03557801|17238785|P2|Overall Study|Protocol Violation|0
5016574|NCT03557801|17238786|P1|Overall Study|Protocol Violation|1
5016575|NCT03557775|17238803|P3|Overall Study|Physician Decision|0
5016576|NCT03557775|17238804|P2|Overall Study|Physician Decision|1
5016577|NCT03557775|17238805|P1|Overall Study|Physician Decision|0
5016578|NCT03557775|17238803|P3|Overall Study|Withdrawal by Subject|4
5016579|NCT03557775|17238804|P2|Overall Study|Withdrawal by Subject|2
5016580|NCT03557775|17238805|P1|Overall Study|Withdrawal by Subject|1
5016581|NCT03555890|17238936|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5016582|NCT03555890|17238937|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5016583|NCT03555890|17238938|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5016584|NCT03555890|17238939|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5016585|NCT03555565|17239073|P1|Overall Study|Protocol Deviation|13
5016586|NCT03555565|17239073|P1|Overall Study|Case Report Forms Uncollected|2
5016587|NCT03555305|17239080|P2|Period 1|Adverse Event|1
5016588|NCT03555305|17239081|P1|Period 1|Adverse Event|0
5016589|NCT03555305|17239080|P2|Period 1|Physician Decision|1
5016590|NCT03555305|17239081|P1|Period 1|Physician Decision|0
5016591|NCT03554005|17239169|P6|Overall Study|Other|1
5016592|NCT03554005|17239170|P5|Overall Study|Other|0
5016593|NCT03554005|17239171|P4|Overall Study|Other|0
5016594|NCT03554005|17239172|P3|Overall Study|Other|0
5016595|NCT03554005|17239173|P2|Overall Study|Other|0
5016596|NCT03554005|17239174|P1|Overall Study|Other|0
5016597|NCT03554005|17239169|P6|Overall Study|Physician Decision|0
5016598|NCT03554005|17239170|P5|Overall Study|Physician Decision|1
5016599|NCT03554005|17239171|P4|Overall Study|Physician Decision|0
5016600|NCT03554005|17239172|P3|Overall Study|Physician Decision|0
5016601|NCT03554005|17239173|P2|Overall Study|Physician Decision|0
5016602|NCT03554005|17239174|P1|Overall Study|Physician Decision|0
5016603|NCT03554005|17239169|P6|Overall Study|Adverse Event|3
5016604|NCT03554005|17239170|P5|Overall Study|Adverse Event|0
5016605|NCT03554005|17239171|P4|Overall Study|Adverse Event|0
5016606|NCT03554005|17239172|P3|Overall Study|Adverse Event|0
5016607|NCT03554005|17239173|P2|Overall Study|Adverse Event|0
5016608|NCT03554005|17239174|P1|Overall Study|Adverse Event|0
5016609|NCT03554005|17239169|P6|Overall Study|Disease Progression|6
5016610|NCT03554005|17239170|P5|Overall Study|Disease Progression|5
5016611|NCT03554005|17239171|P4|Overall Study|Disease Progression|1
5016612|NCT03554005|17239172|P3|Overall Study|Disease Progression|1
5016613|NCT03554005|17239173|P2|Overall Study|Disease Progression|1
5016614|NCT03554005|17239174|P1|Overall Study|Disease Progression|1
5016615|NCT03554005|17239169|P6|Overall Study|Not in participant's best interest|1
5016616|NCT03554005|17239170|P5|Overall Study|Not in participant's best interest|0
5016617|NCT03554005|17239171|P4|Overall Study|Not in participant's best interest|0
5016618|NCT03554005|17239172|P3|Overall Study|Not in participant's best interest|0
5016619|NCT03554005|17239173|P2|Overall Study|Not in participant's best interest|0
5016620|NCT03554005|17239174|P1|Overall Study|Not in participant's best interest|0
5016621|NCT03553758|17239200|P1|Overall Study|Lost to Follow-up|1
5016622|NCT03552549|17239208|P2|Overall Study|Administrative|14
5016623|NCT03552549|17239209|P1|Overall Study|Administrative|0
5016624|NCT03552549|17239208|P2|Overall Study|Did not meet eligibility criteria|0
5016625|NCT03552549|17239209|P1|Overall Study|Did not meet eligibility criteria|1
5016626|NCT03552549|17239208|P2|Overall Study|Did not complete study treatment|3
5016627|NCT03552549|17239209|P1|Overall Study|Did not complete study treatment|2
5016628|NCT03552549|17239208|P2|Overall Study|Not in participant's best interest|1
5016629|NCT03552549|17239209|P1|Overall Study|Not in participant's best interest|2
5016630|NCT03552549|17239208|P2|Overall Study|Unknown (no reason provided)|2
5016631|NCT03552549|17239209|P1|Overall Study|Unknown (no reason provided)|4
5016632|NCT03552549|17239208|P2|Overall Study|Withdrawal by Subject|7
5016633|NCT03552549|17239209|P1|Overall Study|Withdrawal by Subject|7
5016634|NCT03552549|17239208|P2|Overall Study|Adverse event in first 12 months|8
5016635|NCT03552549|17239209|P1|Overall Study|Adverse event in first 12 months|12
5016636|NCT03552549|17239208|P2|Overall Study|Disease progression|17
5016637|NCT03552549|17239209|P1|Overall Study|Disease progression|25
5016638|NCT03552523|17239247|P2|Overall Study|Withdrawal by Subject|1
5016639|NCT03552523|17239248|P1|Overall Study|Withdrawal by Subject|1
5016640|NCT03551743|17239274|P4|Overall Study|Withdrawal by Subject|0
5016641|NCT03551743|17239275|P3|Overall Study|Withdrawal by Subject|0
5016642|NCT03551743|17239276|P2|Overall Study|Withdrawal by Subject|0
5016643|NCT03551743|17239277|P1|Overall Study|Withdrawal by Subject|1
5016644|NCT03551743|17239274|P4|Overall Study|Adverse Event|0
5016645|NCT03551743|17239275|P3|Overall Study|Adverse Event|0
5016646|NCT03551743|17239276|P2|Overall Study|Adverse Event|0
5016647|NCT03551743|17239277|P1|Overall Study|Adverse Event|1
5016648|NCT03551730|17239323|P4|Overall Study|Adverse Event|0
5016649|NCT03551730|17239324|P3|Overall Study|Adverse Event|0
5016650|NCT03551730|17239325|P2|Overall Study|Adverse Event|0
5016651|NCT03551730|17239326|P1|Overall Study|Adverse Event|1
5016652|NCT03550378|17239448|P2|Overall Study|Death|1
5016653|NCT03550378|17239449|P1|Overall Study|Death|0
5016654|NCT03549429|17239512|P2|Overall Study|Protocol Violation|3
5016655|NCT03549429|17239513|P1|Overall Study|Protocol Violation|5
5016656|NCT03549338|17239526|P3|Overall Study|Clinical Progression|0
5016657|NCT03549338|17239527|P2|Overall Study|Clinical Progression|1
5016658|NCT03549338|17239528|P1|Overall Study|Clinical Progression|0
5016659|NCT03549338|17239526|P3|Overall Study|Progressive Disease|0
5016660|NCT03549338|17239527|P2|Overall Study|Progressive Disease|0
5016661|NCT03549338|17239528|P1|Overall Study|Progressive Disease|1
5016662|NCT03549130|17239555|P2|Overall Study|Lost to Follow-up|1
5016663|NCT03549130|17239556|P1|Overall Study|Lost to Follow-up|0
5016664|NCT03549130|17239555|P2|Overall Study|Adverse Event|1
5016665|NCT03549130|17239556|P1|Overall Study|Adverse Event|0
5016666|NCT03549117|17239574|P2|Overall Study|Withdrawal by Subject|0
5016667|NCT03549117|17239575|P1|Overall Study|Withdrawal by Subject|1
5016668|NCT03548337|17239603|P2|Toddler Dose|Withdrawal by parent/guardian|1
5016669|NCT03548337|17239604|P1|Toddler Dose|Withdrawal by parent/guardian|1
5016670|NCT03548337|17239603|P2|Infant Series|Randomized but Not Vaccinated|0
5016671|NCT03548337|17239604|P1|Infant Series|Randomized but Not Vaccinated|1
5016672|NCT03548337|17239603|P2|Infant Series|Adverse Event|2
5016673|NCT03548337|17239604|P1|Infant Series|Adverse Event|0
5016674|NCT03548337|17239603|P2|Infant Series|Lost to Follow-up|1
5016675|NCT03548337|17239604|P1|Infant Series|Lost to Follow-up|2
5016676|NCT03548337|17239603|P2|Infant Series|No Longer Met Eligibility Criteria|0
5016677|NCT03548337|17239604|P1|Infant Series|No Longer Met Eligibility Criteria|1
5016678|NCT03548337|17239603|P2|Infant Series|Withdrawal by Parent/Guardian|8
5016679|NCT03548337|17239604|P1|Infant Series|Withdrawal by Parent/Guardian|8
5016680|NCT03547635|17239655|P3|Overall Study|Withdrawal by Subject|0
5016681|NCT03547635|17239656|P2|Overall Study|Withdrawal by Subject|0
5016682|NCT03547635|17239657|P1|Overall Study|Withdrawal by Subject|1
5016683|NCT03547635|17239655|P3|Overall Study|Errant Randomization before Treatment|0
5016684|NCT03547635|17239656|P2|Overall Study|Errant Randomization before Treatment|1
5016685|NCT03547635|17239657|P1|Overall Study|Errant Randomization before Treatment|0
5016686|NCT03547635|17239655|P3|Overall Study|Withdrawal by Sponsor|1
5016687|NCT03547635|17239656|P2|Overall Study|Withdrawal by Sponsor|0
5016688|NCT03547635|17239657|P1|Overall Study|Withdrawal by Sponsor|0
5016689|NCT03547635|17239655|P3|Overall Study|Withdrawal By PI|0
5016690|NCT03547635|17239656|P2|Overall Study|Withdrawal By PI|1
5016691|NCT03547635|17239657|P1|Overall Study|Withdrawal By PI|0
5016692|NCT03547635|17239655|P3|Overall Study|Withdrawal by Subject|0
5016693|NCT03547635|17239656|P2|Overall Study|Withdrawal by Subject|0
5016694|NCT03547635|17239657|P1|Overall Study|Withdrawal by Subject|1
5016695|NCT03547635|17239655|P3|Overall Study|Lost to Follow-up|4
5016696|NCT03547635|17239656|P2|Overall Study|Lost to Follow-up|3
5016697|NCT03547635|17239657|P1|Overall Study|Lost to Follow-up|1
5016698|NCT03547635|17239655|P3|Overall Study|Adverse Event|3
5016699|NCT03547635|17239656|P2|Overall Study|Adverse Event|2
5016700|NCT03547635|17239657|P1|Overall Study|Adverse Event|5
5016701|NCT03547531|17239667|P2|Overall Study|having family occasion|2
5016702|NCT03547531|17239668|P1|Overall Study|having family occasion|0
5016703|NCT03547531|17239667|P2|Overall Study|not coming in data collection : sick|2
5016704|NCT03547531|17239668|P1|Overall Study|not coming in data collection : sick|2
5016705|NCT03547154|17239682|P2|Overall Study|Continued treatment beyond 12 mo.|50
5016706|NCT03547154|17239683|P1|Overall Study|Continued treatment beyond 12 mo.|58
5016707|NCT03547154|17239682|P2|Overall Study|Not Selected|1
5016708|NCT03547154|17239683|P1|Overall Study|Not Selected|0
5016709|NCT03547154|17239682|P2|Overall Study|Withdrawal by Subject|6
5016710|NCT03547154|17239683|P1|Overall Study|Withdrawal by Subject|10
5016711|NCT03547154|17239682|P2|Overall Study|Insufficient Therapeutic Response|10
5016712|NCT03547154|17239683|P1|Overall Study|Insufficient Therapeutic Response|13
5016713|NCT03547154|17239682|P2|Overall Study|Physician Decision|3
5016714|NCT03547154|17239683|P1|Overall Study|Physician Decision|4
5016715|NCT03547154|17239682|P2|Overall Study|Protocol Violation|1
5016716|NCT03547154|17239683|P1|Overall Study|Protocol Violation|6
5016717|NCT03547154|17239682|P2|Overall Study|Adverse Event|31
5016718|NCT03547154|17239683|P1|Overall Study|Adverse Event|26
5016719|NCT03547154|17239682|P2|Overall Study|Disease Progression/Recurrence|14
5016720|NCT03547154|17239683|P1|Overall Study|Disease Progression/Recurrence|6
5016721|NCT03546842|17239695|P1|Overall Study|Withdrawal by Subject|2
5016722|NCT03546842|17239695|P1|Overall Study|Protocol Violation|1
5016723|NCT03546816|17239706|P2|Overall Study|Lost to Follow-up|2
5016724|NCT03546816|17239707|P1|Overall Study|Lost to Follow-up|3
5016725|NCT03546816|17239706|P2|Overall Study|Withdrawal by Subject|10
5016726|NCT03546816|17239707|P1|Overall Study|Withdrawal by Subject|8
5016727|NCT03546816|17239706|P2|Overall Study|Physician Decision|0
5016728|NCT03546816|17239707|P1|Overall Study|Physician Decision|2
5016729|NCT03546816|17239706|P2|Overall Study|Pregnancy|0
5016730|NCT03546816|17239707|P1|Overall Study|Pregnancy|1
5016731|NCT03546816|17239706|P2|Overall Study|Lack of Efficacy|4
5016732|NCT03546816|17239707|P1|Overall Study|Lack of Efficacy|2
5016733|NCT03546816|17239706|P2|Overall Study|Adverse Event|3
5016734|NCT03546816|17239707|P1|Overall Study|Adverse Event|5
5016735|NCT03546621|17239735|P4|Overall Study|Progressive disease|1
5016736|NCT03546621|17239736|P3|Overall Study|Progressive disease|0
5016737|NCT03546621|17239737|P2|Overall Study|Progressive disease|0
5016738|NCT03546621|17239738|P1|Overall Study|Progressive disease|0
5016739|NCT03546621|17239735|P4|Overall Study|Adverse Event|1
5016740|NCT03546621|17239736|P3|Overall Study|Adverse Event|0
5016741|NCT03546621|17239737|P2|Overall Study|Adverse Event|1
5016742|NCT03546621|17239738|P1|Overall Study|Adverse Event|0
5016743|NCT03546621|17239735|P4|Overall Study|Lost to Follow-up|0
5016744|NCT03546621|17239736|P3|Overall Study|Lost to Follow-up|0
5016745|NCT03546621|17239737|P2|Overall Study|Lost to Follow-up|1
5016746|NCT03546621|17239738|P1|Overall Study|Lost to Follow-up|0
5016747|NCT03546621|17239735|P4|Overall Study|Withdrawal by Subject|1
5016748|NCT03546621|17239736|P3|Overall Study|Withdrawal by Subject|2
5016749|NCT03546621|17239737|P2|Overall Study|Withdrawal by Subject|1
5016750|NCT03546621|17239738|P1|Overall Study|Withdrawal by Subject|0
5016751|NCT03545984|17239828|P2|Overall Study|CSF cases not present during rotation|9
5016752|NCT03545984|17239829|P1|Overall Study|CSF cases not present during rotation|11
5016753|NCT03543137|17239993|P2|Study Period 2: Up to Day 8|Adverse Event|1
5016754|NCT03543137|17239994|P1|Study Period 2: Up to Day 8|Adverse Event|0
5016755|NCT03543137|17239993|P2|Study Period 2: Up to Day 8|Protocol Violation|0
5016756|NCT03543137|17239994|P1|Study Period 2: Up to Day 8|Protocol Violation|1
5016757|NCT03543137|17239993|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
5016758|NCT03543137|17239994|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
5016759|NCT03541044|17240095|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
5016760|NCT03541044|17240096|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
5016761|NCT03541044|17240095|P2|Study Period 2: Up to Day 8|Protocol Violation|0
5016762|NCT03541044|17240096|P1|Study Period 2: Up to Day 8|Protocol Violation|1
5016763|NCT03540160|17240116|P1|Overall Study|Sponsor decision|191
5016764|NCT03540160|17240116|P1|Overall Study|Lost to Follow-up|18
5016765|NCT03540160|17240116|P1|Overall Study|Study Closure|10
5016766|NCT03540160|17240116|P1|Overall Study|COVID-19|2
5016767|NCT03540160|17240116|P1|Overall Study|Withdrawal by Subject|68
5016768|NCT03540160|17240116|P1|Overall Study|Adverse Event|20
5016769|NCT03540160|17240116|P1|Overall Study|Pregnancy|1
5016770|NCT03540160|17240116|P1|Overall Study|Lack of Efficacy|60
5016771|NCT03540160|17240116|P1|Overall Study|Physician Decision|8
5016772|NCT03540160|17240116|P1|Overall Study|Protocol Violation|1
5016773|NCT03540030|17240122|P2|Overall Study|never had surgery after signing consent|1
5016774|NCT03540030|17240123|P1|Overall Study|never had surgery after signing consent|9
5016775|NCT03540030|17240122|P2|Overall Study|screen fail|1
5016776|NCT03540030|17240123|P1|Overall Study|screen fail|7
5016777|NCT03540030|17240122|P2|Overall Study|Withdrawal by Subject|1
5016778|NCT03540030|17240123|P1|Overall Study|Withdrawal by Subject|2
5016779|NCT03539549|17240159|P1|Overall Study|Reason not Specified|1
5016780|NCT03539549|17240159|P1|Overall Study|Progressive Disease|1
5016781|NCT03539549|17240159|P1|Overall Study|Death|2
5016782|NCT03539549|17240159|P1|Overall Study|Lost to Follow-up|1
5016783|NCT03539549|17240159|P1|Overall Study|Adverse Event|12
5016784|NCT03539484|17240174|P7|Overall Study|Study Terminated by Sponsor|1
5016785|NCT03539484|17240175|P6|Overall Study|Study Terminated by Sponsor|2
5016786|NCT03539484|17240176|P5|Overall Study|Study Terminated by Sponsor|2
5016787|NCT03539484|17240177|P4|Overall Study|Study Terminated by Sponsor|1
5016788|NCT03539484|17240178|P3|Overall Study|Study Terminated by Sponsor|1
5016789|NCT03539484|17240179|P2|Overall Study|Study Terminated by Sponsor|0
5016790|NCT03539484|17240180|P1|Overall Study|Study Terminated by Sponsor|0
5016791|NCT03539484|17240174|P7|Overall Study|Withdrawal by Subject|1
5016792|NCT03539484|17240175|P6|Overall Study|Withdrawal by Subject|0
5016793|NCT03539484|17240176|P5|Overall Study|Withdrawal by Subject|2
5016794|NCT03539484|17240177|P4|Overall Study|Withdrawal by Subject|0
5016795|NCT03539484|17240178|P3|Overall Study|Withdrawal by Subject|0
5016796|NCT03539484|17240179|P2|Overall Study|Withdrawal by Subject|0
5016797|NCT03539484|17240180|P1|Overall Study|Withdrawal by Subject|0
5016798|NCT03539484|17240174|P7|Overall Study|Lost to Follow-up|0
5016799|NCT03539484|17240175|P6|Overall Study|Lost to Follow-up|0
5016800|NCT03539484|17240176|P5|Overall Study|Lost to Follow-up|1
5016801|NCT03539484|17240177|P4|Overall Study|Lost to Follow-up|0
5016802|NCT03539484|17240178|P3|Overall Study|Lost to Follow-up|0
5016803|NCT03539484|17240179|P2|Overall Study|Lost to Follow-up|1
5016804|NCT03539484|17240180|P1|Overall Study|Lost to Follow-up|0
5016805|NCT03539484|17240174|P7|Overall Study|Death|0
5016806|NCT03539484|17240175|P6|Overall Study|Death|3
5016807|NCT03539484|17240176|P5|Overall Study|Death|8
5016808|NCT03539484|17240177|P4|Overall Study|Death|2
5016809|NCT03539484|17240178|P3|Overall Study|Death|0
5016810|NCT03539484|17240179|P2|Overall Study|Death|0
5016811|NCT03539484|17240180|P1|Overall Study|Death|1
5016812|NCT03538743|17240334|P9|Overall Study|Withdrawal by Subject|0
5016813|NCT03538743|17240335|P8|Overall Study|Withdrawal by Subject|0
5016814|NCT03538743|17240336|P7|Overall Study|Withdrawal by Subject|0
5016815|NCT03538743|17240337|P6|Overall Study|Withdrawal by Subject|0
5016816|NCT03538743|17240338|P5|Overall Study|Withdrawal by Subject|0
5016817|NCT03538743|17240339|P4|Overall Study|Withdrawal by Subject|1
5016818|NCT03538743|17240340|P3|Overall Study|Withdrawal by Subject|0
5016819|NCT03538743|17240341|P2|Overall Study|Withdrawal by Subject|0
5016820|NCT03538743|17240342|P1|Overall Study|Withdrawal by Subject|0
5016821|NCT03538743|17240334|P9|Overall Study|Non-Treatment-Related Reasons|3
5016822|NCT03538743|17240335|P8|Overall Study|Non-Treatment-Related Reasons|0
5016823|NCT03538743|17240336|P7|Overall Study|Non-Treatment-Related Reasons|0
5016824|NCT03538743|17240337|P6|Overall Study|Non-Treatment-Related Reasons|0
5016825|NCT03538743|17240338|P5|Overall Study|Non-Treatment-Related Reasons|0
5016826|NCT03538743|17240339|P4|Overall Study|Non-Treatment-Related Reasons|0
5016827|NCT03538743|17240340|P3|Overall Study|Non-Treatment-Related Reasons|0
5016828|NCT03538743|17240341|P2|Overall Study|Non-Treatment-Related Reasons|0
5016829|NCT03538743|17240342|P1|Overall Study|Non-Treatment-Related Reasons|0
5016830|NCT03538743|17240334|P9|Overall Study|Adverse Event|0
5016831|NCT03538743|17240335|P8|Overall Study|Adverse Event|0
5016832|NCT03538743|17240336|P7|Overall Study|Adverse Event|0
5016833|NCT03538743|17240337|P6|Overall Study|Adverse Event|0
5016834|NCT03538743|17240338|P5|Overall Study|Adverse Event|0
5016835|NCT03538743|17240339|P4|Overall Study|Adverse Event|1
5016836|NCT03538743|17240340|P3|Overall Study|Adverse Event|1
5016837|NCT03538743|17240341|P2|Overall Study|Adverse Event|0
5016838|NCT03538743|17240342|P1|Overall Study|Adverse Event|0
5016839|NCT03536949|17240622|P2|Overall Study|Non-compliance|1
5016840|NCT03536949|17240623|P1|Overall Study|Non-compliance|2
5016841|NCT03536949|17240622|P2|Overall Study|Withdrawal by Subject|0
5016842|NCT03536949|17240623|P1|Overall Study|Withdrawal by Subject|6
5016843|NCT03536949|17240622|P2|Overall Study|Lost to Follow-up|1
5016844|NCT03536949|17240623|P1|Overall Study|Lost to Follow-up|2
5016845|NCT03536949|17240622|P2|Overall Study|Adverse Event|0
5016846|NCT03536949|17240623|P1|Overall Study|Adverse Event|4
5016847|NCT03536663|17240686|P1|Endexo|Protocol Violation|1
5016848|NCT03535974|17240704|P3|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
5016849|NCT03535974|17240705|P2|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
5016850|NCT03535974|17240706|P1|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
5016851|NCT03535974|17240704|P3|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
5016852|NCT03535974|17240705|P2|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
5016853|NCT03535974|17240706|P1|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
5016854|NCT03535844|17240716|P2|Overall Study|Withdrawal by Subject|1
5016855|NCT03535844|17240717|P1|Overall Study|Withdrawal by Subject|0
5016856|NCT03532048|17241005|P2|Overall Study|Withdrawal by Subject|0
5016857|NCT03532048|17241006|P1|Overall Study|Withdrawal by Subject|7
5016858|NCT03532048|17241005|P2|Overall Study|Lost to Follow-up|17
5016859|NCT03532048|17241006|P1|Overall Study|Lost to Follow-up|12
5016860|NCT03531905|17241023|P3|Overall Study|Could not speak with the participant|0
5016861|NCT03531905|17241024|P2|Overall Study|Could not speak with the participant|0
5016862|NCT03531905|17241025|P1|Overall Study|Could not speak with the participant|1
5016863|NCT03531905|17241023|P3|Overall Study|Participant was out of town|0
5016864|NCT03531905|17241024|P2|Overall Study|Participant was out of town|0
5016865|NCT03531905|17241025|P1|Overall Study|Participant was out of town|1
5016866|NCT03531905|17241023|P3|Overall Study|Lost to Follow-up|1
5016867|NCT03531905|17241024|P2|Overall Study|Lost to Follow-up|2
5016868|NCT03531905|17241025|P1|Overall Study|Lost to Follow-up|2
5016869|NCT03531905|17241023|P3|Overall Study|Withdrawal by Subject|2
5016870|NCT03531905|17241024|P2|Overall Study|Withdrawal by Subject|3
5016871|NCT03531905|17241025|P1|Overall Study|Withdrawal by Subject|3
5016872|NCT03530345|17241188|P2|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
5016873|NCT03530345|17241189|P1|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
5016874|NCT03530345|17241188|P2|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
5016875|NCT03530345|17241189|P1|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
5016876|NCT03530345|17241188|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
5016877|NCT03530345|17241189|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
5016878|NCT03530345|17241188|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
5016879|NCT03530345|17241189|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5016880|NCT03528369|17241237|P3|Overall Study|Adverse Event|0
5016881|NCT03528369|17241238|P2|Overall Study|Adverse Event|1
5016882|NCT03528369|17241239|P1|Overall Study|Adverse Event|0
5016883|NCT03528369|17241237|P3|Overall Study|Lost to Follow-up|0
5016884|NCT03528369|17241238|P2|Overall Study|Lost to Follow-up|0
5016885|NCT03528369|17241239|P1|Overall Study|Lost to Follow-up|1
5016886|NCT03528369|17241237|P3|Overall Study|Withdrawal by Subject|0
5016887|NCT03528369|17241238|P2|Overall Study|Withdrawal by Subject|0
5016888|NCT03528369|17241239|P1|Overall Study|Withdrawal by Subject|2
5016889|NCT03528174|17241268|P1|Overall Study|sensors dislodged|1
5016890|NCT03528174|17241268|P1|Overall Study|Adverse Event|1
5016891|NCT03527966|17241288|P2|Overall Study|Lost to Follow-up|0
5016892|NCT03527966|17241289|P1|Overall Study|Lost to Follow-up|3
5016893|NCT03527173|17241303|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
5016894|NCT03527173|17241304|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
5016895|NCT03527173|17241303|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
5016896|NCT03527173|17241304|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
5016897|NCT03527173|17241303|P2|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
5016898|NCT03527173|17241304|P1|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
5016899|NCT03527173|17241303|P2|Overall Study|Lost to Follow-up|2
5016900|NCT03527173|17241304|P1|Overall Study|Lost to Follow-up|4
5016901|NCT03525678|17241364|P3|Overall Study|Death|4
5016902|NCT03525678|17241365|P2|Overall Study|Death|31
5016903|NCT03525678|17241366|P1|Overall Study|Death|32
5016904|NCT03525678|17241364|P3|Overall Study|Lost to Follow-up|0
5016905|NCT03525678|17241365|P2|Overall Study|Lost to Follow-up|0
5016906|NCT03525678|17241366|P1|Overall Study|Lost to Follow-up|1
5016907|NCT03525678|17241364|P3|Overall Study|Physician Decision|0
5016908|NCT03525678|17241365|P2|Overall Study|Physician Decision|2
5016909|NCT03525678|17241366|P1|Overall Study|Physician Decision|1
5016910|NCT03525678|17241364|P3|Overall Study|Withdrawal by Subject|0
5016911|NCT03525678|17241365|P2|Overall Study|Withdrawal by Subject|1
5016912|NCT03525678|17241366|P1|Overall Study|Withdrawal by Subject|3
5016913|NCT03525678|17241364|P3|Overall Study|Ongoing at the time of interim analysis|21
5016914|NCT03525678|17241365|P2|Overall Study|Ongoing at the time of interim analysis|65
5016915|NCT03525678|17241366|P1|Overall Study|Ongoing at the time of interim analysis|60
5016916|NCT03525444|17241568|P2|Overall Study|Other|1
5016917|NCT03525444|17241569|P1|Overall Study|Other|0
5016918|NCT03525444|17241568|P2|Overall Study|Withdrawal of consent (not due to AE)|1
5016919|NCT03525444|17241569|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5016920|NCT03525444|17241568|P2|Overall Study|Adverse Event|1
5016921|NCT03525444|17241569|P1|Overall Study|Adverse Event|0
5016922|NCT03525119|17241601|P3|Overall Study|Randomized but not Vaccinated|2
5016923|NCT03525119|17241602|P2|Overall Study|Randomized but not Vaccinated|0
5016924|NCT03525119|17241603|P1|Overall Study|Randomized but not Vaccinated|1
5016925|NCT03525119|17241601|P3|Overall Study|Reason not Specified|2
5016926|NCT03525119|17241602|P2|Overall Study|Reason not Specified|1
5016927|NCT03525119|17241603|P1|Overall Study|Reason not Specified|2
5016928|NCT03525119|17241601|P3|Overall Study|Withdrawal by Subject|2
5016929|NCT03525119|17241602|P2|Overall Study|Withdrawal by Subject|4
5016930|NCT03525119|17241603|P1|Overall Study|Withdrawal by Subject|5
5016931|NCT03525119|17241601|P3|Overall Study|Lost to Follow-up|37
5016932|NCT03525119|17241602|P2|Overall Study|Lost to Follow-up|33
5016933|NCT03525119|17241603|P1|Overall Study|Lost to Follow-up|32
5016934|NCT03525119|17241601|P3|Overall Study|Adverse Event|0
5016935|NCT03525119|17241602|P2|Overall Study|Adverse Event|1
5016936|NCT03525119|17241603|P1|Overall Study|Adverse Event|0
5016937|NCT03524157|17241638|P3|Overall Study|cytology not readable|1
5016938|NCT03524157|17241639|P2|Overall Study|cytology not readable|0
5016939|NCT03524157|17241640|P1|Overall Study|cytology not readable|0
5016940|NCT03522675|17241694|P1|Overall Study|Non-reactive to histamine|1
5016941|NCT03522675|17241694|P1|Overall Study|Screen fail|1
5016942|NCT03522506|17241712|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
5016943|NCT03522506|17241713|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5016944|NCT03522506|17241714|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5016945|NCT03522506|17241715|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5016946|NCT03522506|17241712|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5016947|NCT03522506|17241713|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5016948|NCT03522506|17241714|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5016949|NCT03522506|17241715|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5016950|NCT03521817|17241793|P2|Overall Study|Protocol Violation|1
5016951|NCT03521817|17241794|P1|Overall Study|Protocol Violation|0
5016952|NCT03521791|17241802|P2|Overall Study|Protocol Violation|17
5016953|NCT03521791|17241803|P1|Overall Study|Protocol Violation|7
5016954|NCT03521141|17241830|P3|Overall Study|Death|1
5016955|NCT03521141|17241831|P2|Overall Study|Death|0
5016956|NCT03521141|17241832|P1|Overall Study|Death|1
5016957|NCT03520959|17241899|P2|Overall Study|Study terminated by Sponsor|1
5016958|NCT03520959|17241900|P1|Overall Study|Study terminated by Sponsor|0
5016959|NCT03519932|17241947|P2|First Intervention|Adverse Event|3
5016960|NCT03519932|17241948|P1|First Intervention|Adverse Event|1
5016961|NCT03519919|17241974|P1|Overall Study|Screen Failure|1
5016962|NCT03519919|17241974|P1|Overall Study|Lack of Efficacy|1
5016963|NCT03519919|17241974|P1|Overall Study|Withdrawal by Subject|1
5016964|NCT03519867|17242026|P10|Overall Study|Reason not provided|0
5016965|NCT03519867|17242027|P9|Overall Study|Reason not provided|1
5016966|NCT03519867|17242028|P8|Overall Study|Reason not provided|1
5016967|NCT03519867|17242029|P7|Overall Study|Reason not provided|0
5016968|NCT03519867|17242030|P6|Overall Study|Reason not provided|1
5016969|NCT03519867|17242031|P5|Overall Study|Reason not provided|0
5016970|NCT03519867|17242032|P4|Overall Study|Reason not provided|1
5016971|NCT03519867|17242033|P3|Overall Study|Reason not provided|1
5016972|NCT03519867|17242034|P2|Overall Study|Reason not provided|1
5016973|NCT03519867|17242035|P1|Overall Study|Reason not provided|1
5016974|NCT03519867|17242026|P10|Overall Study|Admin. of other reversal agent|0
5016975|NCT03519867|17242027|P9|Overall Study|Admin. of other reversal agent|0
5016976|NCT03519867|17242028|P8|Overall Study|Admin. of other reversal agent|0
5016977|NCT03519867|17242029|P7|Overall Study|Admin. of other reversal agent|0
5016978|NCT03519867|17242030|P6|Overall Study|Admin. of other reversal agent|1
5016979|NCT03519867|17242031|P5|Overall Study|Admin. of other reversal agent|0
5016980|NCT03519867|17242032|P4|Overall Study|Admin. of other reversal agent|0
5016981|NCT03519867|17242033|P3|Overall Study|Admin. of other reversal agent|0
5016982|NCT03519867|17242034|P2|Overall Study|Admin. of other reversal agent|1
5016983|NCT03519867|17242035|P1|Overall Study|Admin. of other reversal agent|1
5016984|NCT03519867|17242026|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
5016985|NCT03519867|17242027|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
5016986|NCT03519867|17242028|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
5016987|NCT03519867|17242029|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
5016988|NCT03519867|17242030|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
5016989|NCT03519867|17242031|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
5016990|NCT03519867|17242032|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
5016991|NCT03519867|17242033|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
5016992|NCT03519867|17242034|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
5016993|NCT03519867|17242035|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
5016994|NCT03519867|17242026|P10|Overall Study|Protocol Violation|0
5016995|NCT03519867|17242027|P9|Overall Study|Protocol Violation|0
5016996|NCT03519867|17242028|P8|Overall Study|Protocol Violation|0
5016997|NCT03519867|17242029|P7|Overall Study|Protocol Violation|0
5016998|NCT03519867|17242030|P6|Overall Study|Protocol Violation|1
5016999|NCT03519867|17242031|P5|Overall Study|Protocol Violation|0
5017000|NCT03519867|17242032|P4|Overall Study|Protocol Violation|0
5017001|NCT03519867|17242033|P3|Overall Study|Protocol Violation|0
5017002|NCT03519867|17242034|P2|Overall Study|Protocol Violation|0
5017003|NCT03519867|17242035|P1|Overall Study|Protocol Violation|0
5017004|NCT03519867|17242026|P10|Overall Study|Adverse Event|0
5017005|NCT03519867|17242027|P9|Overall Study|Adverse Event|0
5017006|NCT03519867|17242028|P8|Overall Study|Adverse Event|0
5017007|NCT03519867|17242029|P7|Overall Study|Adverse Event|0
5017008|NCT03519867|17242030|P6|Overall Study|Adverse Event|0
5017009|NCT03519867|17242031|P5|Overall Study|Adverse Event|0
5017010|NCT03519867|17242032|P4|Overall Study|Adverse Event|0
5017011|NCT03519867|17242033|P3|Overall Study|Adverse Event|0
5017012|NCT03519867|17242034|P2|Overall Study|Adverse Event|1
5017013|NCT03519867|17242035|P1|Overall Study|Adverse Event|1
5017014|NCT03519854|17242085|P18|Overall Study|Technical Error|0
5017015|NCT03519854|17242086|P17|Overall Study|Technical Error|0
5017016|NCT03519854|17242087|P16|Overall Study|Technical Error|0
5017017|NCT03519854|17242088|P15|Overall Study|Technical Error|0
5017018|NCT03519854|17242089|P14|Overall Study|Technical Error|0
5017019|NCT03519854|17242090|P13|Overall Study|Technical Error|0
5017020|NCT03519854|17242091|P12|Overall Study|Technical Error|0
5017021|NCT03519854|17242092|P11|Overall Study|Technical Error|0
5017022|NCT03519854|17242093|P10|Overall Study|Technical Error|0
5017023|NCT03519854|17242094|P9|Overall Study|Technical Error|0
5017024|NCT03519854|17242095|P8|Overall Study|Technical Error|0
5017025|NCT03519854|17242096|P7|Overall Study|Technical Error|0
5017026|NCT03519854|17242097|P6|Overall Study|Technical Error|0
5017027|NCT03519854|17242098|P5|Overall Study|Technical Error|0
5017028|NCT03519854|17242099|P4|Overall Study|Technical Error|0
5017029|NCT03519854|17242100|P3|Overall Study|Technical Error|1
5017030|NCT03519854|17242101|P2|Overall Study|Technical Error|0
5017031|NCT03519854|17242102|P1|Overall Study|Technical Error|0
5017032|NCT03519516|17242268|P2|Overall Study|Adverse Event|1
5017033|NCT03519516|17242269|P1|Overall Study|Adverse Event|0
5017034|NCT03519204|17242343|P2|Overall Study|Other Miscellaneous Reasons|0
5017035|NCT03519204|17242344|P1|Overall Study|Other Miscellaneous Reasons|1
5017036|NCT03519204|17242343|P2|Overall Study|Withdrawal by Subject|7
5017037|NCT03519204|17242344|P1|Overall Study|Withdrawal by Subject|9
5017038|NCT03519204|17242343|P2|Overall Study|Lost to Follow-up|8
5017039|NCT03519204|17242344|P1|Overall Study|Lost to Follow-up|3
5017040|NCT03519087|17242363|P5|Laboratory Testing|Protocol Violation|0
5017041|NCT03519087|17242364|P4|Laboratory Testing|Protocol Violation|1
5017042|NCT03519087|17242365|P3|Laboratory Testing|Protocol Violation|0
5017043|NCT03519087|17242366|P2|Laboratory Testing|Protocol Violation|0
5017044|NCT03519087|17242367|P1|Laboratory Testing|Protocol Violation|0
5017045|NCT03519087|17242363|P5|Laboratory Testing|Lost to Follow-up|6
5017046|NCT03519087|17242364|P4|Laboratory Testing|Lost to Follow-up|3
5017047|NCT03519087|17242365|P3|Laboratory Testing|Lost to Follow-up|2
5017048|NCT03519087|17242366|P2|Laboratory Testing|Lost to Follow-up|0
5017049|NCT03519087|17242367|P1|Laboratory Testing|Lost to Follow-up|0
5017050|NCT03519087|17242363|P5|Re-randomization for Treatment|Not appropriate|0
5017051|NCT03519087|17242364|P4|Re-randomization for Treatment|Not appropriate|0
5017052|NCT03519087|17242365|P3|Re-randomization for Treatment|Not appropriate|0
5017053|NCT03519087|17242366|P2|Re-randomization for Treatment|Not appropriate|3
5017054|NCT03519087|17242367|P1|Re-randomization for Treatment|Not appropriate|2
5017055|NCT03519087|17242363|P5|Re-randomization for Treatment|Withdrawal by Subject|0
5017056|NCT03519087|17242364|P4|Re-randomization for Treatment|Withdrawal by Subject|0
5017057|NCT03519087|17242365|P3|Re-randomization for Treatment|Withdrawal by Subject|0
5017058|NCT03519087|17242366|P2|Re-randomization for Treatment|Withdrawal by Subject|29
5017059|NCT03519087|17242367|P1|Re-randomization for Treatment|Withdrawal by Subject|25
5017060|NCT03519087|17242363|P5|Clinic Evaluation|Protocol Violation|0
5017061|NCT03519087|17242364|P4|Clinic Evaluation|Protocol Violation|0
5017062|NCT03519087|17242365|P3|Clinic Evaluation|Protocol Violation|0
5017063|NCT03519087|17242366|P2|Clinic Evaluation|Protocol Violation|0
5017064|NCT03519087|17242367|P1|Clinic Evaluation|Protocol Violation|1
5017065|NCT03519087|17242363|P5|Clinic Evaluation|Physician Decision|0
5017066|NCT03519087|17242364|P4|Clinic Evaluation|Physician Decision|0
5017067|NCT03519087|17242365|P3|Clinic Evaluation|Physician Decision|0
5017068|NCT03519087|17242366|P2|Clinic Evaluation|Physician Decision|18
5017069|NCT03519087|17242367|P1|Clinic Evaluation|Physician Decision|15
5017070|NCT03518840|17242403|P1|Overall Study|Lost to Follow-up|6
5017071|NCT03518125|17242416|P6|Overall Study|Missed Day 394 Visit|0
5017072|NCT03518125|17242417|P5|Overall Study|Missed Day 394 Visit|0
5017073|NCT03518125|17242418|P4|Overall Study|Missed Day 394 Visit|0
5017074|NCT03518125|17242419|P3|Overall Study|Missed Day 394 Visit|0
5017075|NCT03518125|17242420|P2|Overall Study|Missed Day 394 Visit|0
5017076|NCT03518125|17242421|P1|Overall Study|Missed Day 394 Visit|1
5017077|NCT03518125|17242416|P6|Overall Study|Withdrawal by Subject|3
5017078|NCT03518125|17242417|P5|Overall Study|Withdrawal by Subject|1
5017079|NCT03518125|17242418|P4|Overall Study|Withdrawal by Subject|1
5017080|NCT03518125|17242419|P3|Overall Study|Withdrawal by Subject|0
5017081|NCT03518125|17242420|P2|Overall Study|Withdrawal by Subject|1
5017082|NCT03518125|17242421|P1|Overall Study|Withdrawal by Subject|1
5017083|NCT03518125|17242416|P6|Overall Study|Physician Decision|0
5017084|NCT03518125|17242417|P5|Overall Study|Physician Decision|0
5017085|NCT03518125|17242418|P4|Overall Study|Physician Decision|0
5017086|NCT03518125|17242419|P3|Overall Study|Physician Decision|0
5017087|NCT03518125|17242420|P2|Overall Study|Physician Decision|1
5017088|NCT03518125|17242421|P1|Overall Study|Physician Decision|0
5017089|NCT03518125|17242416|P6|Overall Study|Lost to Follow-up|5
5017090|NCT03518125|17242417|P5|Overall Study|Lost to Follow-up|3
5017091|NCT03518125|17242418|P4|Overall Study|Lost to Follow-up|0
5017092|NCT03518125|17242419|P3|Overall Study|Lost to Follow-up|0
5017093|NCT03518125|17242420|P2|Overall Study|Lost to Follow-up|2
5017094|NCT03518125|17242421|P1|Overall Study|Lost to Follow-up|0
5017095|NCT03518008|17242519|P2|Period 2, Second Week of Wear|Family emergency|1
5017096|NCT03518008|17242520|P1|Period 2, Second Week of Wear|Family emergency|0
5017097|NCT03515941|17242545|P2|Overall Study|Adverse Event|0
5017098|NCT03515941|17242546|P1|Overall Study|Adverse Event|1
5017099|NCT03513588|17242614|P3|Overall Study|Death|1
5017100|NCT03513588|17242615|P2|Overall Study|Death|0
5017101|NCT03513588|17242616|P1|Overall Study|Death|0
5017102|NCT03513588|17242614|P3|Overall Study|Study dosing paused by sponsor|0
5017103|NCT03513588|17242615|P2|Overall Study|Study dosing paused by sponsor|1
5017104|NCT03513588|17242616|P1|Overall Study|Study dosing paused by sponsor|1
5017105|NCT03513588|17242614|P3|Overall Study|Lost to Follow-up|1
5017106|NCT03513588|17242615|P2|Overall Study|Lost to Follow-up|1
5017107|NCT03513588|17242616|P1|Overall Study|Lost to Follow-up|0
5017108|NCT03512028|17242691|P2|Overall Study|Protocol Violation|0
5017109|NCT03512028|17242692|P1|Overall Study|Protocol Violation|2
5017110|NCT03512028|17242691|P2|Overall Study|Withdrawal by Subject|0
5017111|NCT03512028|17242692|P1|Overall Study|Withdrawal by Subject|2
5017112|NCT03511105|17242713|P2|Overall Study|Withdrew consent|0
5017113|NCT03511105|17242714|P1|Overall Study|Withdrew consent|1
5017114|NCT03511105|17242713|P2|Overall Study|Adverse Event|0
5017115|NCT03511105|17242714|P1|Overall Study|Adverse Event|1
5017116|NCT03510273|17242768|P1|Overall Study|Moved away from study area|4
5017117|NCT03510273|17242768|P1|Overall Study|Care outside study, ineligible to cont.|3
5017118|NCT03510273|17242768|P1|Overall Study|Withdrawal by Subject|2
5017119|NCT03509948|17242791|P2|Overall Study|Protocol Violation|1
5017120|NCT03509948|17242792|P1|Overall Study|Protocol Violation|0
5017121|NCT03509675|17242860|P2|Second Intervention )7 Days)|Lost Rinse B|0
5017122|NCT03509675|17242861|P1|Second Intervention )7 Days)|Lost Rinse B|1
5017123|NCT03509675|17242860|P2|Second Intervention )7 Days)|Withdrawal by Subject|0
5017124|NCT03509675|17242861|P1|Second Intervention )7 Days)|Withdrawal by Subject|1
5017125|NCT03509675|17242860|P2|First Intervention (7 Days)|Lack of Efficacy|1
5017126|NCT03509675|17242861|P1|First Intervention (7 Days)|Lack of Efficacy|2
5017127|NCT03509675|17242860|P2|First Intervention (7 Days)|Lost to Follow-up|3
5017128|NCT03509675|17242861|P1|First Intervention (7 Days)|Lost to Follow-up|3
5017129|NCT03509350|17242869|P2|Overall Study|Withdrawal by Subject|2
5017130|NCT03509350|17242870|P1|Overall Study|Withdrawal by Subject|0
5017131|NCT03509207|17242876|P1|Overall Study|Death|2
5017132|NCT03508843|17242881|P1|Overall Study|technical difficulties|2
5017133|NCT03508843|17242881|P1|Overall Study|Withdrawal by Subject|1
5017134|NCT03508050|17242948|P2|Overall Study|Sustained desaturation|1
5017135|NCT03508050|17242949|P1|Overall Study|Sustained desaturation|0
5017136|NCT03508050|17242948|P2|Overall Study|Negative biopsy, surgery cancelled|1
5017137|NCT03508050|17242949|P1|Overall Study|Negative biopsy, surgery cancelled|3
5017138|NCT03508050|17242948|P2|Overall Study|Mucus plug|0
5017139|NCT03508050|17242949|P1|Overall Study|Mucus plug|1
5017140|NCT03508050|17242948|P2|Overall Study|Pleural adhesions|0
5017141|NCT03508050|17242949|P1|Overall Study|Pleural adhesions|1
5017142|NCT03506425|17243007|P3|Overall Study|Withdrawal by Subject|1
5017143|NCT03506425|17243008|P2|Overall Study|Withdrawal by Subject|0
5017144|NCT03506425|17243009|P1|Overall Study|Withdrawal by Subject|0
5017145|NCT03506425|17243007|P3|Overall Study|Death|0
5017146|NCT03506425|17243008|P2|Overall Study|Death|0
5017147|NCT03506425|17243009|P1|Overall Study|Death|1
5017148|NCT03506425|17243007|P3|Overall Study|Adverse Event|0
5017149|NCT03506425|17243008|P2|Overall Study|Adverse Event|3
5017150|NCT03506425|17243009|P1|Overall Study|Adverse Event|1
5017151|NCT03505593|17243044|P1|Overall Study|Obstruction by Endotracheal tube|1
5017152|NCT03505593|17243044|P1|Overall Study|Unable to pass through esophagus|1
5017153|NCT03505593|17243044|P1|Overall Study|Anatomical abnormality|1
5017154|NCT03505593|17243044|P1|Overall Study|Died before procedure|1
5017155|NCT03505593|17243044|P1|Overall Study|Withdrawal by Subject|1
5017156|NCT03504189|17243141|P1|Overall Study|Device Failure|2
5017157|NCT03504189|17243141|P1|Overall Study|Screening Failure|1
5017158|NCT03504189|17243141|P1|Overall Study|Withdrawal by Subject|1
5017159|NCT03503188|17243167|P2|Overall Study|Non eligible in the sub study|1
5017160|NCT03503188|17243168|P1|Overall Study|Non eligible in the sub study|0
5017161|NCT03502681|17243203|P2|Overall Study|Disease Progression|1
5017162|NCT03502681|17243204|P1|Overall Study|Disease Progression|2
5017163|NCT03502681|17243203|P2|Overall Study|Adverse Event|1
5017164|NCT03502681|17243204|P1|Overall Study|Adverse Event|1
5017165|NCT03502070|17243223|P1|Overall Study|Screen Failure|1
5017166|NCT03502070|17243223|P1|Overall Study|Withdrawal by Subject|1
5017167|NCT03501277|17243244|P4|Intervention Period 3 (4 Days)|Adverse Event|1
5017168|NCT03501277|17243245|P3|Intervention Period 3 (4 Days)|Adverse Event|0
5017169|NCT03501277|17243246|P2|Intervention Period 3 (4 Days)|Adverse Event|0
5017170|NCT03501277|17243247|P1|Intervention Period 3 (4 Days)|Adverse Event|0
5017171|NCT03501277|17243244|P4|Intervention Period 2 (4 Days)|Adverse Event|1
5017172|NCT03501277|17243245|P3|Intervention Period 2 (4 Days)|Adverse Event|0
5017173|NCT03501277|17243246|P2|Intervention Period 2 (4 Days)|Adverse Event|0
5017174|NCT03501277|17243247|P1|Intervention Period 2 (4 Days)|Adverse Event|0
5017175|NCT03501277|17243244|P4|Intervention Period 1 (4 Days)|Adverse Event|1
5017176|NCT03501277|17243245|P3|Intervention Period 1 (4 Days)|Adverse Event|0
5017177|NCT03501277|17243246|P2|Intervention Period 1 (4 Days)|Adverse Event|0
5017178|NCT03501277|17243247|P1|Intervention Period 1 (4 Days)|Adverse Event|0
5017179|NCT03501277|17243244|P4|Intervention Period 1 (4 Days)|Other|0
5017180|NCT03501277|17243245|P3|Intervention Period 1 (4 Days)|Other|1
5017181|NCT03501277|17243246|P2|Intervention Period 1 (4 Days)|Other|0
5017182|NCT03501277|17243247|P1|Intervention Period 1 (4 Days)|Other|0
5017183|NCT03500679|17243374|P2|Overall Study|Withdrawal by Subject|0
5017184|NCT03500679|17243375|P1|Overall Study|Withdrawal by Subject|3
5017185|NCT03500679|17243374|P2|Overall Study|Lost to Follow-up|3
5017186|NCT03500679|17243375|P1|Overall Study|Lost to Follow-up|6
5017187|NCT03500224|17243466|P1|Overall Study|Withdrawal by Subject|2
5017188|NCT03500211|17243505|P2|Overall Study|Withdrawal by Subject|1
5017189|NCT03500211|17243506|P1|Overall Study|Withdrawal by Subject|1
5017190|NCT03500198|17243522|P2|Overall Study|Lost to Follow-up|1
5017191|NCT03500198|17243523|P1|Overall Study|Lost to Follow-up|0
5017192|NCT03500159|17243539|P2|Overall Study|Study Terminated|1
5017193|NCT03500159|17243540|P1|Overall Study|Study Terminated|2
5017194|NCT03499067|17243546|P2|First Intervention|Withdrawal by Subject|6
5017195|NCT03499067|17243547|P1|First Intervention|Withdrawal by Subject|3
5017196|NCT03499067|17243546|P2|First Intervention|Physician Decision|1
5017197|NCT03499067|17243547|P1|First Intervention|Physician Decision|2
5017198|NCT03498560|17243587|P1|Overall Study|Death|1
5017199|NCT03498560|17243587|P1|Overall Study|Lost to Follow-up|4
5017200|NCT03498560|17243587|P1|Overall Study|Withdrawal by Subject|14
5017201|NCT03498560|17243587|P1|Overall Study|Found Ineligible|2
5017202|NCT03498287|17243604|P2|Overall Study|Adverse Event|1
5017203|NCT03498287|17243605|P1|Overall Study|Adverse Event|0
5017204|NCT03498287|17243604|P2|Overall Study|Protocol Violation|4
5017205|NCT03498287|17243605|P1|Overall Study|Protocol Violation|0
5017206|NCT03498287|17243604|P2|Overall Study|Withdrawal by Subject|0
5017207|NCT03498287|17243605|P1|Overall Study|Withdrawal by Subject|3
5017208|NCT03497130|17243699|P2|Overall Study|Lost to Follow-up|1
5017209|NCT03497130|17243700|P1|Overall Study|Lost to Follow-up|1
5017210|NCT03497039|17243712|P2|Overall Study|Protocol Violation|1
5017211|NCT03497039|17243713|P1|Overall Study|Protocol Violation|0
5017212|NCT03497039|17243712|P2|Overall Study|Withdrawal by Subject|0
5017213|NCT03497039|17243713|P1|Overall Study|Withdrawal by Subject|1
5017214|NCT03495102|17243850|P3|Overall Study|Participant was in Rehabilitation|0
5017215|NCT03495102|17243851|P2|Overall Study|Participant was in Rehabilitation|0
5017216|NCT03495102|17243852|P1|Overall Study|Participant was in Rehabilitation|1
5017217|NCT03495102|17243850|P3|Overall Study|Relocated to Another Country|0
5017218|NCT03495102|17243851|P2|Overall Study|Relocated to Another Country|1
5017219|NCT03495102|17243852|P1|Overall Study|Relocated to Another Country|0
5017220|NCT03495102|17243850|P3|Overall Study|Primary Care Physician Recommendation|0
5017221|NCT03495102|17243851|P2|Overall Study|Primary Care Physician Recommendation|1
5017222|NCT03495102|17243852|P1|Overall Study|Primary Care Physician Recommendation|0
5017223|NCT03495102|17243850|P3|Overall Study|Participant Duplicated at Another Site|1
5017224|NCT03495102|17243851|P2|Overall Study|Participant Duplicated at Another Site|0
5017225|NCT03495102|17243852|P1|Overall Study|Participant Duplicated at Another Site|0
5017226|NCT03495102|17243850|P3|Overall Study|Non-compliance|0
5017227|NCT03495102|17243851|P2|Overall Study|Non-compliance|0
5017228|NCT03495102|17243852|P1|Overall Study|Non-compliance|1
5017229|NCT03495102|17243850|P3|Overall Study|Site Closure|2
5017230|NCT03495102|17243851|P2|Overall Study|Site Closure|1
5017231|NCT03495102|17243852|P1|Overall Study|Site Closure|3
5017232|NCT03495102|17243850|P3|Overall Study|Protocol Violation|0
5017233|NCT03495102|17243851|P2|Overall Study|Protocol Violation|1
5017234|NCT03495102|17243852|P1|Overall Study|Protocol Violation|1
5017235|NCT03495102|17243850|P3|Overall Study|Withdrawal by Subject|18
5017236|NCT03495102|17243851|P2|Overall Study|Withdrawal by Subject|36
5017237|NCT03495102|17243852|P1|Overall Study|Withdrawal by Subject|25
5017238|NCT03495102|17243850|P3|Overall Study|Physician Decision|2
5017239|NCT03495102|17243851|P2|Overall Study|Physician Decision|0
5017240|NCT03495102|17243852|P1|Overall Study|Physician Decision|2
5017241|NCT03495102|17243850|P3|Overall Study|Lost to Follow-up|17
5017242|NCT03495102|17243851|P2|Overall Study|Lost to Follow-up|16
5017243|NCT03495102|17243852|P1|Overall Study|Lost to Follow-up|15
5017244|NCT03495102|17243850|P3|Overall Study|Death|4
5017245|NCT03495102|17243851|P2|Overall Study|Death|4
5017246|NCT03495102|17243852|P1|Overall Study|Death|3
5017247|NCT03495102|17243850|P3|Overall Study|Adverse Event|10
5017248|NCT03495102|17243851|P2|Overall Study|Adverse Event|7
5017249|NCT03495102|17243852|P1|Overall Study|Adverse Event|5
5017250|NCT03494985|17243882|P4|Overall Study|Other (Not specified)|0
5017251|NCT03494985|17243883|P3|Overall Study|Other (Not specified)|1
5017252|NCT03494985|17243884|P2|Overall Study|Other (Not specified)|1
5017253|NCT03494985|17243885|P1|Overall Study|Other (Not specified)|0
5017254|NCT03494985|17243882|P4|Overall Study|Other (Withdrawal of consent)|5
5017255|NCT03494985|17243883|P3|Overall Study|Other (Withdrawal of consent)|2
5017256|NCT03494985|17243884|P2|Overall Study|Other (Withdrawal of consent)|3
5017257|NCT03494985|17243885|P1|Overall Study|Other (Withdrawal of consent)|2
5017258|NCT03494985|17243882|P4|Overall Study|Adverse Event|0
5017259|NCT03494985|17243883|P3|Overall Study|Adverse Event|3
5017260|NCT03494985|17243884|P2|Overall Study|Adverse Event|2
5017261|NCT03494985|17243885|P1|Overall Study|Adverse Event|3
5017262|NCT03493854|17243921|P2|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
5017263|NCT03493854|17243922|P1|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
5017264|NCT03493854|17243921|P2|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
5017265|NCT03493854|17243922|P1|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
5017266|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
5017267|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
5017268|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
5017269|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
5017270|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
5017271|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
5017272|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
5017273|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
5017274|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
5017275|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
5017276|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
5017277|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
5017278|NCT03493854|17243921|P2|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
5017279|NCT03493854|17243922|P1|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
5017280|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
5017281|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
5017282|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
5017283|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
5017284|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
5017285|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
5017286|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
5017287|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
5017288|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
5017289|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
5017290|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
5017291|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
5017292|NCT03493854|17243921|P2|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
5017293|NCT03493854|17243922|P1|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
5017294|NCT03493698|17243968|P1|Treatment Period C|Withdrawal by Subject|1
5017295|NCT03493698|17243968|P1|Treatment Period C|Adverse Event|1
5017296|NCT03493542|17243993|P2|Overall Study|Withdrawal by Subject|6
5017297|NCT03493542|17243994|P1|Overall Study|Withdrawal by Subject|2
5017298|NCT03493542|17243993|P2|Overall Study|Withdrawal by parent or guardian|0
5017299|NCT03493542|17243994|P1|Overall Study|Withdrawal by parent or guardian|3
5017300|NCT03493542|17243993|P2|Overall Study|Ongoing|3
5017301|NCT03493542|17243994|P1|Overall Study|Ongoing|2
5017302|NCT03493386|17244018|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5017303|NCT03493386|17244019|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5017304|NCT03493386|17244020|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5017305|NCT03493386|17244021|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5017306|NCT03492554|17244141|P2|Overall Study|Protocol Violation|14
5017307|NCT03492554|17244142|P1|Overall Study|Protocol Violation|0
5017308|NCT03492398|17244163|P9|Overall Study|Withdrawal by Subject|0
5017309|NCT03492398|17244164|P8|Overall Study|Withdrawal by Subject|1
5017310|NCT03492398|17244165|P7|Overall Study|Withdrawal by Subject|0
5017311|NCT03492398|17244166|P6|Overall Study|Withdrawal by Subject|0
5017312|NCT03492398|17244167|P5|Overall Study|Withdrawal by Subject|0
5017313|NCT03492398|17244168|P4|Overall Study|Withdrawal by Subject|0
5017314|NCT03492398|17244169|P3|Overall Study|Withdrawal by Subject|0
5017315|NCT03492398|17244170|P2|Overall Study|Withdrawal by Subject|0
5017316|NCT03492398|17244171|P1|Overall Study|Withdrawal by Subject|0
5017317|NCT03492398|17244163|P9|Overall Study|Protocol Violation|0
5017318|NCT03492398|17244164|P8|Overall Study|Protocol Violation|0
5017319|NCT03492398|17244165|P7|Overall Study|Protocol Violation|1
5017320|NCT03492398|17244166|P6|Overall Study|Protocol Violation|0
5017321|NCT03492398|17244167|P5|Overall Study|Protocol Violation|0
5017322|NCT03492398|17244168|P4|Overall Study|Protocol Violation|0
5017323|NCT03492398|17244169|P3|Overall Study|Protocol Violation|0
5017324|NCT03492398|17244170|P2|Overall Study|Protocol Violation|0
5017325|NCT03492398|17244171|P1|Overall Study|Protocol Violation|0
5017326|NCT03491553|17244291|P6|Overall Study|Withdrew Consent|0
5017327|NCT03491553|17244292|P5|Overall Study|Withdrew Consent|0
5017328|NCT03491553|17244293|P4|Overall Study|Withdrew Consent|0
5017329|NCT03491553|17244294|P3|Overall Study|Withdrew Consent|0
5017330|NCT03491553|17244295|P2|Overall Study|Withdrew Consent|1
5017331|NCT03491553|17244296|P1|Overall Study|Withdrew Consent|1
5017332|NCT03491553|17244291|P6|Overall Study|Adverse Event|0
5017333|NCT03491553|17244292|P5|Overall Study|Adverse Event|0
5017334|NCT03491553|17244293|P4|Overall Study|Adverse Event|1
5017335|NCT03491553|17244294|P3|Overall Study|Adverse Event|0
5017336|NCT03491553|17244295|P2|Overall Study|Adverse Event|0
5017337|NCT03491553|17244296|P1|Overall Study|Adverse Event|0
5017338|NCT03491150|17244411|P2|Overall Study|Withdrawal by Subject|2
5017339|NCT03491150|17244412|P1|Overall Study|Withdrawal by Subject|1
5017340|NCT03491150|17244411|P2|Overall Study|Other|1
5017341|NCT03491150|17244412|P1|Overall Study|Other|0
5017342|NCT03491150|17244411|P2|Overall Study|Study Terminated by Sponsor|70
5017343|NCT03491150|17244412|P1|Overall Study|Study Terminated by Sponsor|74
5017344|NCT03491150|17244411|P2|Overall Study|Adverse Event|0
5017345|NCT03491150|17244412|P1|Overall Study|Adverse Event|1
5017346|NCT03490032|17244451|P3|Overall Study|family issue (child custody)|0
5017347|NCT03490032|17244452|P2|Overall Study|family issue (child custody)|0
5017348|NCT03490032|17244453|P1|Overall Study|family issue (child custody)|1
5017349|NCT03489863|17244493|P2|Overall Study|Withdrawal by Subject|1
5017350|NCT03489863|17244494|P1|Overall Study|Withdrawal by Subject|0
5017351|NCT03489720|17244502|P2|Overall Study|Withdrawal by Subject|0
5017352|NCT03489720|17244503|P1|Overall Study|Withdrawal by Subject|2
5017353|NCT03489551|17244528|P1|Overall Study|Withdrawal by Subject|2
5017354|NCT03489304|17244532|P1|Overall Study|Lost to Follow-up|4
5017355|NCT03488927|17244541|P3|Overall Study|Withdrawal by Subject|217
5017356|NCT03488927|17244542|P2|Overall Study|Withdrawal by Subject|118
5017357|NCT03488927|17244543|P1|Overall Study|Withdrawal by Subject|44
5017358|NCT03488108|17244556|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
5017359|NCT03488108|17244557|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
5017360|NCT03488108|17244556|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
5017361|NCT03488108|17244557|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
5017362|NCT03486392|17244826|P5|Overall Study|Death|1
5017363|NCT03486392|17244827|P4|Overall Study|Death|0
5017364|NCT03486392|17244828|P3|Overall Study|Death|0
5017365|NCT03486392|17244829|P2|Overall Study|Death|0
5017366|NCT03486392|17244830|P1|Overall Study|Death|0
5017367|NCT03486392|17244826|P5|Overall Study|Withdrawal by Subject|1
5017368|NCT03486392|17244827|P4|Overall Study|Withdrawal by Subject|4
5017369|NCT03486392|17244828|P3|Overall Study|Withdrawal by Subject|6
5017370|NCT03486392|17244829|P2|Overall Study|Withdrawal by Subject|0
5017371|NCT03486392|17244830|P1|Overall Study|Withdrawal by Subject|3
5017372|NCT03486392|17244826|P5|Overall Study|Lost to Follow-up|2
5017373|NCT03486392|17244827|P4|Overall Study|Lost to Follow-up|5
5017374|NCT03486392|17244828|P3|Overall Study|Lost to Follow-up|8
5017375|NCT03486392|17244829|P2|Overall Study|Lost to Follow-up|0
5017376|NCT03486392|17244830|P1|Overall Study|Lost to Follow-up|0
5017377|NCT03483623|17244879|P1|Overall Study|43 complete sets achieved|1
5017378|NCT03482882|17244928|P1|Overall Study|Not further specified|1
5017379|NCT03482882|17244928|P1|Overall Study|Protocol Violation|2
5017380|NCT03482882|17244928|P1|Overall Study|Lost to Follow-up|1
5017381|NCT03482882|17244928|P1|Overall Study|Adverse Event|3
5017382|NCT03482453|17244989|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017383|NCT03482453|17244990|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
5017384|NCT03482453|17244991|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017385|NCT03482453|17244992|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017386|NCT03482453|17244993|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017387|NCT03482453|17244994|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017388|NCT03482453|17244995|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017389|NCT03482453|17244996|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017390|NCT03482453|17244997|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017391|NCT03482453|17244998|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017392|NCT03482453|17244999|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017393|NCT03482453|17245000|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5017394|NCT03482011|17245119|P8|Follow-up Period (12 Weeks)|Lost to Follow-up|1
5017395|NCT03482011|17245120|P7|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017396|NCT03482011|17245121|P6|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017397|NCT03482011|17245122|P5|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017398|NCT03482011|17245123|P4|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017399|NCT03482011|17245124|P3|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017400|NCT03482011|17245125|P2|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017401|NCT03482011|17245126|P1|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5017402|NCT03482011|17245119|P8|Follow-up Period (12 Weeks)|Physician Decision|1
5017403|NCT03482011|17245120|P7|Follow-up Period (12 Weeks)|Physician Decision|0
5017404|NCT03482011|17245121|P6|Follow-up Period (12 Weeks)|Physician Decision|0
5017405|NCT03482011|17245122|P5|Follow-up Period (12 Weeks)|Physician Decision|0
5017406|NCT03482011|17245123|P4|Follow-up Period (12 Weeks)|Physician Decision|0
5017407|NCT03482011|17245124|P3|Follow-up Period (12 Weeks)|Physician Decision|0
5017408|NCT03482011|17245125|P2|Follow-up Period (12 Weeks)|Physician Decision|0
5017409|NCT03482011|17245126|P1|Follow-up Period (12 Weeks)|Physician Decision|0
5017410|NCT03482011|17245119|P8|Follow-up Period (12 Weeks)|Lack of Efficacy|6
5017411|NCT03482011|17245120|P7|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5017412|NCT03482011|17245121|P6|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5017413|NCT03482011|17245122|P5|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5017414|NCT03482011|17245123|P4|Follow-up Period (12 Weeks)|Lack of Efficacy|3
5017415|NCT03482011|17245124|P3|Follow-up Period (12 Weeks)|Lack of Efficacy|1
5017416|NCT03482011|17245125|P2|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5017417|NCT03482011|17245126|P1|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5017418|NCT03482011|17245119|P8|Follow-up Period (12 Weeks)|Adverse Event|4
5017419|NCT03482011|17245120|P7|Follow-up Period (12 Weeks)|Adverse Event|1
5017420|NCT03482011|17245121|P6|Follow-up Period (12 Weeks)|Adverse Event|0
5017421|NCT03482011|17245122|P5|Follow-up Period (12 Weeks)|Adverse Event|0
5017422|NCT03482011|17245123|P4|Follow-up Period (12 Weeks)|Adverse Event|0
5017423|NCT03482011|17245124|P3|Follow-up Period (12 Weeks)|Adverse Event|0
5017424|NCT03482011|17245125|P2|Follow-up Period (12 Weeks)|Adverse Event|0
5017425|NCT03482011|17245126|P1|Follow-up Period (12 Weeks)|Adverse Event|0
5017426|NCT03482011|17245119|P8|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
5017427|NCT03482011|17245120|P7|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
5017428|NCT03482011|17245121|P6|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
5017429|NCT03482011|17245122|P5|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5017430|NCT03482011|17245123|P4|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
5017431|NCT03482011|17245124|P3|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5017432|NCT03482011|17245125|P2|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5017433|NCT03482011|17245126|P1|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5017434|NCT03482011|17245119|P8|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5017435|NCT03482011|17245120|P7|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5017436|NCT03482011|17245121|P6|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
5017437|NCT03482011|17245122|P5|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5017438|NCT03482011|17245123|P4|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
5017439|NCT03482011|17245124|P3|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5017440|NCT03482011|17245125|P2|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5017441|NCT03482011|17245126|P1|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5017442|NCT03482011|17245119|P8|Maintenance Period (36 Weeks)|Physician Decision|1
5017443|NCT03482011|17245120|P7|Maintenance Period (36 Weeks)|Physician Decision|1
5017444|NCT03482011|17245121|P6|Maintenance Period (36 Weeks)|Physician Decision|1
5017445|NCT03482011|17245122|P5|Maintenance Period (36 Weeks)|Physician Decision|0
5017446|NCT03482011|17245123|P4|Maintenance Period (36 Weeks)|Physician Decision|1
5017447|NCT03482011|17245124|P3|Maintenance Period (36 Weeks)|Physician Decision|0
5017448|NCT03482011|17245125|P2|Maintenance Period (36 Weeks)|Physician Decision|0
5017449|NCT03482011|17245126|P1|Maintenance Period (36 Weeks)|Physician Decision|0
5017450|NCT03482011|17245119|P8|Maintenance Period (36 Weeks)|Lost to Follow-up|1
5017451|NCT03482011|17245120|P7|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5017452|NCT03482011|17245121|P6|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5017453|NCT03482011|17245122|P5|Maintenance Period (36 Weeks)|Lost to Follow-up|2
5017454|NCT03482011|17245123|P4|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5017455|NCT03482011|17245124|P3|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5017456|NCT03482011|17245125|P2|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5017457|NCT03482011|17245126|P1|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5017458|NCT03482011|17245119|P8|Maintenance Period (36 Weeks)|Lack of Efficacy|9
5017459|NCT03482011|17245120|P7|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5017460|NCT03482011|17245121|P6|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5017461|NCT03482011|17245122|P5|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5017462|NCT03482011|17245123|P4|Maintenance Period (36 Weeks)|Lack of Efficacy|2
5017463|NCT03482011|17245124|P3|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5017464|NCT03482011|17245125|P2|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5017465|NCT03482011|17245126|P1|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5017466|NCT03482011|17245119|P8|Maintenance Period (36 Weeks)|Adverse Event|4
5017467|NCT03482011|17245120|P7|Maintenance Period (36 Weeks)|Adverse Event|1
5017468|NCT03482011|17245121|P6|Maintenance Period (36 Weeks)|Adverse Event|1
5017469|NCT03482011|17245122|P5|Maintenance Period (36 Weeks)|Adverse Event|0
5017470|NCT03482011|17245123|P4|Maintenance Period (36 Weeks)|Adverse Event|0
5017471|NCT03482011|17245124|P3|Maintenance Period (36 Weeks)|Adverse Event|0
5017472|NCT03482011|17245125|P2|Maintenance Period (36 Weeks)|Adverse Event|0
5017473|NCT03482011|17245126|P1|Maintenance Period (36 Weeks)|Adverse Event|0
5017474|NCT03482011|17245119|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
5017475|NCT03482011|17245120|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
5017476|NCT03482011|17245121|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
5017477|NCT03482011|17245122|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
5017478|NCT03482011|17245123|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
5017479|NCT03482011|17245124|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
5017480|NCT03482011|17245125|P2|Induction Period (16 Weeks)|Withdrawal by Subject|5
5017481|NCT03482011|17245126|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
5017482|NCT03482011|17245119|P8|Induction Period (16 Weeks)|Screen Failure|0
5017483|NCT03482011|17245120|P7|Induction Period (16 Weeks)|Screen Failure|0
5017484|NCT03482011|17245121|P6|Induction Period (16 Weeks)|Screen Failure|0
5017485|NCT03482011|17245122|P5|Induction Period (16 Weeks)|Screen Failure|0
5017486|NCT03482011|17245123|P4|Induction Period (16 Weeks)|Screen Failure|0
5017487|NCT03482011|17245124|P3|Induction Period (16 Weeks)|Screen Failure|0
5017488|NCT03482011|17245125|P2|Induction Period (16 Weeks)|Screen Failure|1
5017489|NCT03482011|17245126|P1|Induction Period (16 Weeks)|Screen Failure|0
5017490|NCT03482011|17245119|P8|Induction Period (16 Weeks)|Lost to Follow-up|0
5017491|NCT03482011|17245120|P7|Induction Period (16 Weeks)|Lost to Follow-up|0
5017492|NCT03482011|17245121|P6|Induction Period (16 Weeks)|Lost to Follow-up|0
5017493|NCT03482011|17245122|P5|Induction Period (16 Weeks)|Lost to Follow-up|0
5017494|NCT03482011|17245123|P4|Induction Period (16 Weeks)|Lost to Follow-up|0
5017495|NCT03482011|17245124|P3|Induction Period (16 Weeks)|Lost to Follow-up|0
5017496|NCT03482011|17245125|P2|Induction Period (16 Weeks)|Lost to Follow-up|1
5017497|NCT03482011|17245126|P1|Induction Period (16 Weeks)|Lost to Follow-up|0
5017498|NCT03482011|17245119|P8|Induction Period (16 Weeks)|Lack of Efficacy|0
5017499|NCT03482011|17245120|P7|Induction Period (16 Weeks)|Lack of Efficacy|0
5017500|NCT03482011|17245121|P6|Induction Period (16 Weeks)|Lack of Efficacy|0
5017501|NCT03482011|17245122|P5|Induction Period (16 Weeks)|Lack of Efficacy|0
5017502|NCT03482011|17245123|P4|Induction Period (16 Weeks)|Lack of Efficacy|0
5017503|NCT03482011|17245124|P3|Induction Period (16 Weeks)|Lack of Efficacy|0
5017504|NCT03482011|17245125|P2|Induction Period (16 Weeks)|Lack of Efficacy|1
5017505|NCT03482011|17245126|P1|Induction Period (16 Weeks)|Lack of Efficacy|3
5017506|NCT03482011|17245119|P8|Induction Period (16 Weeks)|Adverse Event|0
5017507|NCT03482011|17245120|P7|Induction Period (16 Weeks)|Adverse Event|0
5017508|NCT03482011|17245121|P6|Induction Period (16 Weeks)|Adverse Event|0
5017509|NCT03482011|17245122|P5|Induction Period (16 Weeks)|Adverse Event|0
5017510|NCT03482011|17245123|P4|Induction Period (16 Weeks)|Adverse Event|0
5017511|NCT03482011|17245124|P3|Induction Period (16 Weeks)|Adverse Event|0
5017512|NCT03482011|17245125|P2|Induction Period (16 Weeks)|Adverse Event|3
5017513|NCT03482011|17245126|P1|Induction Period (16 Weeks)|Adverse Event|1
5017514|NCT03481309|17245189|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
5017515|NCT03481309|17245190|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
5017516|NCT03481309|17245191|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
5017517|NCT03481309|17245192|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
5017518|NCT03481309|17245193|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
5017519|NCT03481309|17245194|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
5017520|NCT03480841|17245236|P1|Overall Study|Lost to Follow-up|2
5017521|NCT03480802|17245247|P2|Overall Study|Relocated|1
5017522|NCT03480802|17245248|P1|Overall Study|Relocated|0
5017523|NCT03480802|17245247|P2|Overall Study|Withdrawal by Subject|1
5017524|NCT03480802|17245248|P1|Overall Study|Withdrawal by Subject|2
5017525|NCT03480802|17245247|P2|Overall Study|Lost to Follow-up|1
5017526|NCT03480802|17245248|P1|Overall Study|Lost to Follow-up|5
5017527|NCT03480750|17245280|P6|Overall Study|The interruption in Trientine shippment|1
5017528|NCT03480750|17245281|P5|Overall Study|The interruption in Trientine shippment|0
5017529|NCT03480750|17245282|P4|Overall Study|The interruption in Trientine shippment|0
5017530|NCT03480750|17245283|P3|Overall Study|The interruption in Trientine shippment|0
5017531|NCT03480750|17245284|P2|Overall Study|The interruption in Trientine shippment|0
5017532|NCT03480750|17245285|P1|Overall Study|The interruption in Trientine shippment|0
5017533|NCT03480750|17245280|P6|Overall Study|Withdrawal by Subject|0
5017534|NCT03480750|17245281|P5|Overall Study|Withdrawal by Subject|0
5017535|NCT03480750|17245282|P4|Overall Study|Withdrawal by Subject|0
5017536|NCT03480750|17245283|P3|Overall Study|Withdrawal by Subject|0
5017537|NCT03480750|17245284|P2|Overall Study|Withdrawal by Subject|1
5017538|NCT03480750|17245285|P1|Overall Study|Withdrawal by Subject|0
5017539|NCT03480425|17245309|P1|Overall Study|Force transducer technical failure|1
5017540|NCT03480152|17245315|P3|Phase I|Signed consent. Died before treatment.|0
5017541|NCT03480152|17245316|P2|Phase I|Signed consent. Died before treatment.|0
5017542|NCT03480152|17245317|P1|Phase I|Signed consent. Died before treatment.|1
5017543|NCT03480009|17245347|P4|Overall Study|Lost to Follow-up|0
5017544|NCT03480009|17245348|P3|Overall Study|Lost to Follow-up|4
5017545|NCT03480009|17245349|P2|Overall Study|Lost to Follow-up|5
5017546|NCT03480009|17245350|P1|Overall Study|Lost to Follow-up|4
5017547|NCT03479216|17245385|P2|Overall Study|Physician Decision|3
5017548|NCT03479216|17245386|P1|Overall Study|Physician Decision|2
5017549|NCT03479216|17245385|P2|Overall Study|Withdrawal by Subject|2
5017550|NCT03479216|17245386|P1|Overall Study|Withdrawal by Subject|3
5017551|NCT03478956|17245406|P2|Overall Study|Ongoing in the Study|11
5017552|NCT03478956|17245407|P1|Overall Study|Ongoing in the Study|11
5017553|NCT03478956|17245406|P2|Overall Study|Withdrawal by Subject|1
5017554|NCT03478956|17245407|P1|Overall Study|Withdrawal by Subject|0
5017555|NCT03478956|17245406|P2|Overall Study|Adverse Event|0
5017556|NCT03478956|17245407|P1|Overall Study|Adverse Event|1
5017557|NCT03478891|17245436|P3|Overall Study|Lost to Follow-up|1
5017558|NCT03478891|17245437|P2|Overall Study|Lost to Follow-up|0
5017559|NCT03478891|17245438|P1|Overall Study|Lost to Follow-up|1
5017560|NCT03478891|17245436|P3|Overall Study|Moved from area|1
5017561|NCT03478891|17245437|P2|Overall Study|Moved from area|0
5017562|NCT03478891|17245438|P1|Overall Study|Moved from area|0
5017563|NCT03478891|17245436|P3|Overall Study|Enrolled, but product never administered|1
5017564|NCT03478891|17245437|P2|Overall Study|Enrolled, but product never administered|0
5017565|NCT03478891|17245438|P1|Overall Study|Enrolled, but product never administered|0
5017566|NCT03478696|17245489|P2|Overall Study|Withdrawal by Subject|4
5017567|NCT03478696|17245490|P1|Overall Study|Withdrawal by Subject|9
5017568|NCT03478696|17245489|P2|Overall Study|Physician Decision|3
5017569|NCT03478696|17245490|P1|Overall Study|Physician Decision|6
5017570|NCT03478696|17245489|P2|Overall Study|Lost to Follow-up|0
5017571|NCT03478696|17245490|P1|Overall Study|Lost to Follow-up|1
5017572|NCT03478696|17245489|P2|Overall Study|Adverse Event|5
5017573|NCT03478696|17245490|P1|Overall Study|Adverse Event|1
5017574|NCT03478683|17245504|P2|Overall Study|Withdrawal by Subject|7
5017575|NCT03478683|17245505|P1|Overall Study|Withdrawal by Subject|7
5017576|NCT03478683|17245504|P2|Overall Study|Physician Decision|3
5017577|NCT03478683|17245505|P1|Overall Study|Physician Decision|1
5017578|NCT03478683|17245504|P2|Overall Study|Lost to Follow-up|5
5017579|NCT03478683|17245505|P1|Overall Study|Lost to Follow-up|0
5017580|NCT03478683|17245504|P2|Overall Study|Adverse Event|3
5017581|NCT03478683|17245505|P1|Overall Study|Adverse Event|5
5017582|NCT03478657|17245519|P2|Overall Study|Withdrawal by Subject|1
5017583|NCT03478657|17245520|P1|Overall Study|Withdrawal by Subject|0
5017584|NCT03478644|17245535|P2|Phase 2|Lost to Follow-up|0
5017585|NCT03478644|17245536|P1|Phase 2|Lost to Follow-up|1
5017586|NCT03478644|17245535|P2|Phase 2|Withdrawal by Subject|1
5017587|NCT03478644|17245536|P1|Phase 2|Withdrawal by Subject|2
5017588|NCT03478371|17245548|P1|Overall Study|Lost to Follow-up|4
5017589|NCT03478371|17245548|P1|Overall Study|non-compliance|1
5017590|NCT03477903|17245570|P1|Overall Study|Study Terminated by Sponsor|1
5017591|NCT03476239|17245646|P1|Overall Study|Did not receive study drug|1
5017592|NCT03476239|17245646|P1|Overall Study|Data Not Available|15
5017593|NCT03476239|17245646|P1|Overall Study|Lost to Follow-up|2
5017594|NCT03476239|17245646|P1|Overall Study|Death|39
5017595|NCT03476239|17245646|P1|Overall Study|Withdrawal by Subject|6
5017596|NCT03476239|17245646|P1|Overall Study|Continuing study|43
5017597|NCT03475875|17245696|P2|Period 2|Protocol Violation|1
5017598|NCT03475875|17245697|P1|Period 2|Protocol Violation|0
5017599|NCT03475875|17245696|P2|Period 2|Adverse Event|0
5017600|NCT03475875|17245697|P1|Period 2|Adverse Event|3
5017601|NCT03475875|17245696|P2|Period 1|Adverse Event|1
5017602|NCT03475875|17245697|P1|Period 1|Adverse Event|2
5017603|NCT03475875|17245696|P2|Period 1|Lost to Follow-up|0
5017604|NCT03475875|17245697|P1|Period 1|Lost to Follow-up|1
5017605|NCT03474081|17245735|P2|Overall Study|Investigator site closed|0
5017606|NCT03474081|17245736|P1|Overall Study|Investigator site closed|1
5017607|NCT03474081|17245735|P2|Overall Study|Withdrawal by Subject|7
5017608|NCT03474081|17245736|P1|Overall Study|Withdrawal by Subject|5
5017609|NCT03474081|17245735|P2|Overall Study|Physician Decision|2
5017610|NCT03474081|17245736|P1|Overall Study|Physician Decision|3
5017611|NCT03474081|17245735|P2|Overall Study|Lost to Follow-up|1
5017612|NCT03474081|17245736|P1|Overall Study|Lost to Follow-up|2
5017613|NCT03474081|17245735|P2|Overall Study|Adverse Event|3
5017614|NCT03474081|17245736|P1|Overall Study|Adverse Event|6
5017615|NCT03473808|17245777|P1|Overall Study|Withdrawal by Subject|1
5017616|NCT03473236|17245809|P10|Overall Study|Withdrawal by Subject|0
5017617|NCT03473236|17245810|P9|Overall Study|Withdrawal by Subject|1
5017618|NCT03473236|17245811|P8|Overall Study|Withdrawal by Subject|0
5017619|NCT03473236|17245812|P7|Overall Study|Withdrawal by Subject|0
5017620|NCT03473236|17245813|P6|Overall Study|Withdrawal by Subject|1
5017621|NCT03473236|17245814|P5|Overall Study|Withdrawal by Subject|0
5017622|NCT03473236|17245815|P4|Overall Study|Withdrawal by Subject|0
5017623|NCT03473236|17245816|P3|Overall Study|Withdrawal by Subject|0
5017624|NCT03473236|17245817|P2|Overall Study|Withdrawal by Subject|0
5017625|NCT03473236|17245818|P1|Overall Study|Withdrawal by Subject|0
5017626|NCT03473197|17245985|P1|Overall Study|Withdrawal by Subject|5
5017627|NCT03473197|17245985|P1|Overall Study|Lost to Follow-up|1
5017628|NCT03473197|17245985|P1|Overall Study|Adverse Event|4
5017629|NCT03472547|17245997|P1|Overall Study|Withdrawal by Subject|30
5017630|NCT03472534|17246001|P1|Overall Study|Adverse Event|2
5017631|NCT03472534|17246001|P1|Overall Study|Withdrawal by Subject|9
5017632|NCT03472014|17246014|P1|Overall Study|Lost to Follow-up|4
5017633|NCT03471871|17246036|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5017634|NCT03471871|17246037|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
5017635|NCT03471871|17246038|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5017636|NCT03471871|17246039|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5017637|NCT03471871|17246040|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5017638|NCT03471871|17246036|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
5017639|NCT03471871|17246037|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5017640|NCT03471871|17246038|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5017641|NCT03471871|17246039|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5017642|NCT03471871|17246040|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5017643|NCT03471871|17246036|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
5017644|NCT03471871|17246037|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5017645|NCT03471871|17246038|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5017646|NCT03471871|17246039|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5017647|NCT03471871|17246040|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5017648|NCT03471871|17246036|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
5017649|NCT03471871|17246037|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
5017650|NCT03471871|17246038|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5017651|NCT03471871|17246039|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5017652|NCT03471871|17246040|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5017653|NCT03471871|17246036|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5017654|NCT03471871|17246037|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5017655|NCT03471871|17246038|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
5017656|NCT03471871|17246039|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5017657|NCT03471871|17246040|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5017658|NCT03469349|17246154|P2|Overall Study|Adverse Event|4
5017659|NCT03469349|17246155|P1|Overall Study|Adverse Event|2
5017660|NCT03469349|17246154|P2|Overall Study|Lost to Follow-up|2
5017661|NCT03469349|17246155|P1|Overall Study|Lost to Follow-up|2
5017662|NCT03469349|17246154|P2|Overall Study|Progressive Disease|1
5017663|NCT03469349|17246155|P1|Overall Study|Progressive Disease|0
5017664|NCT03469349|17246154|P2|Overall Study|Withdrawal by Subject|3
5017665|NCT03469349|17246155|P1|Overall Study|Withdrawal by Subject|1
5017666|NCT03469336|17246171|P1|Overall Study|Adverse Event|1
5017667|NCT03469258|17246194|P1|Overall Study|Upon surgery, did not meet criteria|4
5017668|NCT03468855|17246223|P1|Overall Study|Inclusion/Exclusion Enrollment Violator|1
5017669|NCT03468855|17246223|P1|Overall Study|Withdrawal by Subject|3
5017670|NCT03468855|17246223|P1|Overall Study|Lost to Follow-up|5
5017671|NCT03468855|17246223|P1|Overall Study|Adverse Event|2
5017672|NCT03468543|17246277|P1|Overall Study|Protocol stopping rules met|3
5017673|NCT03467971|17246289|P2|Treatment Period 2|Withdrawal by Subject|1
5017674|NCT03467971|17246290|P1|Treatment Period 2|Withdrawal by Subject|0
5017675|NCT03467945|17246314|P4|Treatment Period 3|Withdrawal by Subject|1
5017676|NCT03467945|17246315|P3|Treatment Period 3|Withdrawal by Subject|2
5017677|NCT03467945|17246316|P2|Treatment Period 3|Withdrawal by Subject|0
5017678|NCT03467945|17246317|P1|Treatment Period 3|Withdrawal by Subject|1
5017679|NCT03467945|17246314|P4|Treatment Period 2|Withdrawal by Subject|0
5017680|NCT03467945|17246315|P3|Treatment Period 2|Withdrawal by Subject|0
5017681|NCT03467945|17246316|P2|Treatment Period 2|Withdrawal by Subject|1
5017682|NCT03467945|17246317|P1|Treatment Period 2|Withdrawal by Subject|0
5017683|NCT03467425|17246391|P2|Overall Study|Withdrawal by Subject|17
5017684|NCT03467425|17246392|P1|Overall Study|Withdrawal by Subject|15
5017685|NCT03467425|17246391|P2|Overall Study|Physician Decision|1
5017686|NCT03467425|17246392|P1|Overall Study|Physician Decision|2
5017687|NCT03467425|17246391|P2|Overall Study|Lost to Follow-up|25
5017688|NCT03467425|17246392|P1|Overall Study|Lost to Follow-up|18
5017689|NCT03467425|17246391|P2|Overall Study|Protocol Violation|1
5017690|NCT03467425|17246392|P1|Overall Study|Protocol Violation|0
5017691|NCT03467425|17246391|P2|Overall Study|Lack of Efficacy|1
5017692|NCT03467425|17246392|P1|Overall Study|Lack of Efficacy|3
5017693|NCT03467425|17246391|P2|Overall Study|Adverse Event|9
5017694|NCT03467425|17246392|P1|Overall Study|Adverse Event|9
5017695|NCT03466658|17246422|P1|Overall Study|Withdrawal by Subject|3
5017696|NCT03466086|17246428|P2|Period 1|Withdrawal by Subject|0
5017697|NCT03466086|17246429|P1|Period 1|Withdrawal by Subject|1
5017698|NCT03466086|17246428|P2|Period 1|Sponsor decision due to study timeline|0
5017699|NCT03466086|17246429|P1|Period 1|Sponsor decision due to study timeline|1
5017700|NCT03466073|17246443|P6|Overall Study|Death|1
5017701|NCT03466073|17246444|P5|Overall Study|Death|0
5017702|NCT03466073|17246445|P4|Overall Study|Death|0
5017703|NCT03466073|17246446|P3|Overall Study|Death|0
5017704|NCT03466073|17246447|P2|Overall Study|Death|0
5017705|NCT03466073|17246448|P1|Overall Study|Death|1
5017706|NCT03466060|17246481|P6|Period 2|Lens Handling Difficulties|0
5017707|NCT03466060|17246482|P5|Period 2|Lens Handling Difficulties|0
5017708|NCT03466060|17246483|P4|Period 2|Lens Handling Difficulties|0
5017709|NCT03466060|17246484|P3|Period 2|Lens Handling Difficulties|1
5017710|NCT03466060|17246485|P2|Period 2|Lens Handling Difficulties|0
5017711|NCT03466060|17246486|P1|Period 2|Lens Handling Difficulties|0
5017712|NCT03466060|17246481|P6|Period 1|Grade 2 Conjunctivitis|0
5017713|NCT03466060|17246482|P5|Period 1|Grade 2 Conjunctivitis|0
5017714|NCT03466060|17246483|P4|Period 1|Grade 2 Conjunctivitis|0
5017715|NCT03466060|17246484|P3|Period 1|Grade 2 Conjunctivitis|1
5017716|NCT03466060|17246485|P2|Period 1|Grade 2 Conjunctivitis|0
5017717|NCT03466060|17246486|P1|Period 1|Grade 2 Conjunctivitis|0
5017718|NCT03466060|17246481|P6|Period 1|Lost to Follow-up|0
5017719|NCT03466060|17246482|P5|Period 1|Lost to Follow-up|0
5017720|NCT03466060|17246483|P4|Period 1|Lost to Follow-up|1
5017721|NCT03466060|17246484|P3|Period 1|Lost to Follow-up|0
5017722|NCT03466060|17246485|P2|Period 1|Lost to Follow-up|0
5017723|NCT03466060|17246486|P1|Period 1|Lost to Follow-up|0
5017724|NCT03466060|17246481|P6|Period 1|Withdrawal by Subject|0
5017725|NCT03466060|17246482|P5|Period 1|Withdrawal by Subject|0
5017726|NCT03466060|17246483|P4|Period 1|Withdrawal by Subject|0
5017727|NCT03466060|17246484|P3|Period 1|Withdrawal by Subject|2
5017728|NCT03466060|17246485|P2|Period 1|Withdrawal by Subject|0
5017729|NCT03466060|17246486|P1|Period 1|Withdrawal by Subject|0
5017730|NCT03466060|17246481|P6|Period 1|Test Lens Damage|0
5017731|NCT03466060|17246482|P5|Period 1|Test Lens Damage|0
5017732|NCT03466060|17246483|P4|Period 1|Test Lens Damage|0
5017733|NCT03466060|17246484|P3|Period 1|Test Lens Damage|0
5017734|NCT03466060|17246485|P2|Period 1|Test Lens Damage|2
5017735|NCT03466060|17246486|P1|Period 1|Test Lens Damage|0
5017736|NCT03465904|17246528|P2|Overall Study|Ineligible for mITT analysis|47
5017737|NCT03465904|17246529|P1|Overall Study|Ineligible for mITT analysis|62
5017738|NCT03465904|17246528|P2|Overall Study|Protocol Violation|5
5017739|NCT03465904|17246529|P1|Overall Study|Protocol Violation|8
5017740|NCT03465904|17246528|P2|Overall Study|Lost to Follow-up|9
5017741|NCT03465904|17246529|P1|Overall Study|Lost to Follow-up|10
5017742|NCT03465904|17246528|P2|Overall Study|Withdrawal by Subject|5
5017743|NCT03465904|17246529|P1|Overall Study|Withdrawal by Subject|9
5017744|NCT03465878|17246549|P4|Period 1-Part B First Intervention Day 1|Physician Decision|1
5017745|NCT03465878|17246550|P3|Period 1-Part B First Intervention Day 1|Physician Decision|0
5017746|NCT03465878|17246551|P2|Period 1-Part B First Intervention Day 1|Physician Decision|0
5017747|NCT03465878|17246552|P1|Period 1-Part B First Intervention Day 1|Physician Decision|0
5017748|NCT03465878|17246549|P4|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
5017749|NCT03465878|17246550|P3|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5017750|NCT03465878|17246551|P2|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5017751|NCT03465878|17246552|P1|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5017752|NCT03465878|17246549|P4|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5017753|NCT03465878|17246550|P3|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5017754|NCT03465878|17246551|P2|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
5017755|NCT03465878|17246552|P1|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5017756|NCT03465709|17246599|P1|Overall Study|Withdrawal by Subject|3
5017757|NCT03465709|17246599|P1|Overall Study|Study/Site Terminated by Sponsor|14
5017758|NCT03465436|17246611|P4|Period 4|Protocol Violation|0
5017759|NCT03465436|17246612|P3|Period 4|Protocol Violation|1
5017760|NCT03465436|17246613|P2|Period 4|Protocol Violation|0
5017761|NCT03465436|17246614|P1|Period 4|Protocol Violation|0
5017762|NCT03465436|17246611|P4|Period 3|Protocol Violation|0
5017763|NCT03465436|17246612|P3|Period 3|Protocol Violation|0
5017764|NCT03465436|17246613|P2|Period 3|Protocol Violation|1
5017765|NCT03465436|17246614|P1|Period 3|Protocol Violation|1
5017766|NCT03465436|17246611|P4|Period 2|Protocol Violation|0
5017767|NCT03465436|17246612|P3|Period 2|Protocol Violation|0
5017768|NCT03465436|17246613|P2|Period 2|Protocol Violation|1
5017769|NCT03465436|17246614|P1|Period 2|Protocol Violation|0
5017770|NCT03465436|17246611|P4|Period 1|Protocol Violation|0
5017771|NCT03465436|17246612|P3|Period 1|Protocol Violation|1
5017772|NCT03465436|17246613|P2|Period 1|Protocol Violation|0
5017773|NCT03465436|17246614|P1|Period 1|Protocol Violation|0
5017774|NCT03464383|17246651|P3|Overall Study|Withdrawal by Subject|0
5017775|NCT03464383|17246652|P2|Overall Study|Withdrawal by Subject|1
5017776|NCT03464383|17246653|P1|Overall Study|Withdrawal by Subject|0
5017777|NCT03464383|17246651|P3|Overall Study|Lost to Follow-up|0
5017778|NCT03464383|17246652|P2|Overall Study|Lost to Follow-up|0
5017779|NCT03464383|17246653|P1|Overall Study|Lost to Follow-up|1
5017780|NCT03463031|17246710|P2|Overall Study|Use of prohibited medication by subject|0
5017781|NCT03463031|17246711|P1|Overall Study|Use of prohibited medication by subject|1
5017782|NCT03463031|17246710|P2|Overall Study|Adverse Event|1
5017783|NCT03463031|17246711|P1|Overall Study|Adverse Event|4
5017784|NCT03463031|17246710|P2|Overall Study|Lost to Follow-up|1
5017785|NCT03463031|17246711|P1|Overall Study|Lost to Follow-up|1
5017786|NCT03463031|17246710|P2|Overall Study|Investigator/Sponsor Decision|1
5017787|NCT03463031|17246711|P1|Overall Study|Investigator/Sponsor Decision|0
5017788|NCT03463031|17246710|P2|Overall Study|Withdrawal by Subject|2
5017789|NCT03463031|17246711|P1|Overall Study|Withdrawal by Subject|4
5017790|NCT03461757|17246761|P2|Overall Study|Other Reasons|4
5017791|NCT03461757|17246762|P1|Overall Study|Other Reasons|1
5017792|NCT03461757|17246761|P2|Overall Study|Withdrawal by Subject|7
5017793|NCT03461757|17246762|P1|Overall Study|Withdrawal by Subject|7
5017794|NCT03461757|17246761|P2|Overall Study|Protocol Violation|1
5017795|NCT03461757|17246762|P1|Overall Study|Protocol Violation|1
5017796|NCT03461757|17246761|P2|Overall Study|Pregnancy|0
5017797|NCT03461757|17246762|P1|Overall Study|Pregnancy|2
5017798|NCT03461757|17246761|P2|Overall Study|Non-compliance with study treatment|1
5017799|NCT03461757|17246762|P1|Overall Study|Non-compliance with study treatment|0
5017800|NCT03461757|17246761|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
5017801|NCT03461757|17246762|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
5017802|NCT03461757|17246761|P2|Overall Study|Lost to Follow-up|7
5017803|NCT03461757|17246762|P1|Overall Study|Lost to Follow-up|13
5017804|NCT03461757|17246761|P2|Overall Study|Adverse Event|0
5017805|NCT03461757|17246762|P1|Overall Study|Adverse Event|1
5017806|NCT03459196|17246931|P1|Overall Study|Subject didn't receive study catheter|2
5017807|NCT03458702|17246975|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
5017808|NCT03458702|17246976|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
5017809|NCT03458702|17246975|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
5017810|NCT03458702|17246976|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
5017811|NCT03457727|17247005|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
5017812|NCT03457727|17247006|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5017813|NCT03457727|17247007|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5017814|NCT03457727|17247008|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5017815|NCT03457636|17247205|P1|Overall Study|Lost to Follow-up|2
5017816|NCT03456960|17247218|P6|Period 2 (1 Day)|Adverse Event|0
5017817|NCT03456960|17247219|P5|Period 2 (1 Day)|Adverse Event|0
5017818|NCT03456960|17247220|P4|Period 2 (1 Day)|Adverse Event|1
5017819|NCT03456960|17247221|P3|Period 2 (1 Day)|Adverse Event|0
5017820|NCT03456960|17247222|P2|Period 2 (1 Day)|Adverse Event|0
5017821|NCT03456960|17247223|P1|Period 2 (1 Day)|Adverse Event|1
5017822|NCT03456960|17247218|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5017823|NCT03456960|17247219|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5017824|NCT03456960|17247220|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
5017825|NCT03456960|17247221|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
5017826|NCT03456960|17247222|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5017827|NCT03456960|17247223|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5017828|NCT03456856|17247315|P1|Overall Study|Withdrawal by Subject|1
5017829|NCT03456856|17247315|P1|Overall Study|Lost to Follow-up|2
5017830|NCT03456700|17247319|P1|Overall Study|Withdrawal by Subject|1
5017831|NCT03455543|17247351|P3|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
5017832|NCT03455543|17247352|P2|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
5017833|NCT03455543|17247353|P1|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
5017834|NCT03455543|17247351|P3|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
5017835|NCT03455543|17247352|P2|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
5017836|NCT03455543|17247353|P1|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
5017837|NCT03455543|17247351|P3|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
5017838|NCT03455543|17247352|P2|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
5017839|NCT03455543|17247353|P1|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
5017840|NCT03455543|17247351|P3|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
5017841|NCT03455543|17247352|P2|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
5017842|NCT03455543|17247353|P1|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
5017843|NCT03455543|17247351|P3|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
5017844|NCT03455543|17247352|P2|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
5017845|NCT03455543|17247353|P1|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
5017846|NCT03455543|17247351|P3|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
5017847|NCT03455543|17247352|P2|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
5017848|NCT03455543|17247353|P1|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
5017849|NCT03455543|17247351|P3|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
5017850|NCT03455543|17247352|P2|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
5017851|NCT03455543|17247353|P1|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
5017852|NCT03455543|17247351|P3|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
5017853|NCT03455543|17247352|P2|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
5017854|NCT03455543|17247353|P1|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
5017855|NCT03455543|17247351|P3|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
5017856|NCT03455543|17247352|P2|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
5017857|NCT03455543|17247353|P1|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
5017858|NCT03453151|17247542|P1|Overall Study|Physician Decision|3
5017859|NCT03453151|17247542|P1|Overall Study|Withdrawal by Subject|1
5017860|NCT03452943|17247779|P2|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
5017861|NCT03452943|17247780|P1|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
5017862|NCT03452943|17247779|P2|Maintenance Period (5 Weeks)|Adverse Event|0
5017863|NCT03452943|17247780|P1|Maintenance Period (5 Weeks)|Adverse Event|1
5017864|NCT03452943|17247779|P2|Titration Period (7 Weeks)|Lost to Follow-up|0
5017865|NCT03452943|17247780|P1|Titration Period (7 Weeks)|Lost to Follow-up|1
5017866|NCT03452943|17247779|P2|Titration Period (7 Weeks)|Withdrawal by Subject|2
5017867|NCT03452943|17247780|P1|Titration Period (7 Weeks)|Withdrawal by Subject|3
5017868|NCT03452943|17247779|P2|Titration Period (7 Weeks)|Protocol Violation|1
5017869|NCT03452943|17247780|P1|Titration Period (7 Weeks)|Protocol Violation|0
5017870|NCT03452943|17247779|P2|Titration Period (7 Weeks)|Adverse Event|1
5017871|NCT03452943|17247780|P1|Titration Period (7 Weeks)|Adverse Event|1
5017872|NCT03451721|17247832|P1|Overall Study|Death|1
5017873|NCT03450070|17247872|P1|Overall Study|Withdrawal by Subject|8
5017874|NCT03449979|17247880|P4|Overall Study|Technical difficulty|1
5017875|NCT03449979|17247881|P3|Overall Study|Technical difficulty|0
5017876|NCT03449979|17247882|P2|Overall Study|Technical difficulty|0
5017877|NCT03449979|17247883|P1|Overall Study|Technical difficulty|0
5017878|NCT03449758|17247893|P1|Overall Study|Other unspecified reason|3
5017879|NCT03449758|17247893|P1|Overall Study|Consent withdrawal|1
5017880|NCT03449758|17247893|P1|Overall Study|Adverse Event|9
5017881|NCT03449758|17247893|P1|Overall Study|Treatment inefficacy|5
5017882|NCT03449758|17247893|P1|Overall Study|Major protocol deviation|1
5017883|NCT03448536|17247967|P2|Overall Study|Physician Decision|0
5017884|NCT03448536|17247968|P1|Overall Study|Physician Decision|1
5017885|NCT03448536|17247967|P2|Overall Study|Other|0
5017886|NCT03448536|17247968|P1|Overall Study|Other|3
5017887|NCT03448536|17247967|P2|Overall Study|Inadequate pain reporter|0
5017888|NCT03448536|17247968|P1|Overall Study|Inadequate pain reporter|1
5017889|NCT03448536|17247967|P2|Overall Study|Lost to Follow-up|2
5017890|NCT03448536|17247968|P1|Overall Study|Lost to Follow-up|3
5017891|NCT03448536|17247967|P2|Overall Study|Withdrawal by Subject|2
5017892|NCT03448536|17247968|P1|Overall Study|Withdrawal by Subject|1
5017893|NCT03448536|17247967|P2|Overall Study|Pregnancy|0
5017894|NCT03448536|17247968|P1|Overall Study|Pregnancy|1
5017895|NCT03448536|17247967|P2|Overall Study|Protocol Violation|0
5017896|NCT03448536|17247968|P1|Overall Study|Protocol Violation|2
5017897|NCT03448419|17247994|P2|Overall Study|Withdrawn by Sponsor|1
5017898|NCT03448419|17247995|P1|Overall Study|Withdrawn by Sponsor|0
5017899|NCT03448419|17247994|P2|Overall Study|Patient did not attend all visits|2
5017900|NCT03448419|17247995|P1|Overall Study|Patient did not attend all visits|0
5017901|NCT03448419|17247994|P2|Overall Study|Not treated|1
5017902|NCT03448419|17247995|P1|Overall Study|Not treated|0
5017903|NCT03448419|17247994|P2|Overall Study|Withdrawal by Subject|1
5017904|NCT03448419|17247995|P1|Overall Study|Withdrawal by Subject|3
5017905|NCT03448419|17247994|P2|Overall Study|Lost to Follow-up|2
5017906|NCT03448419|17247995|P1|Overall Study|Lost to Follow-up|0
5017907|NCT03448419|17247994|P2|Overall Study|Adverse Event|9
5017908|NCT03448419|17247995|P1|Overall Study|Adverse Event|10
5017909|NCT03448224|17248021|P2|Overall Study|Provided same answer to every question|0
5017910|NCT03448224|17248022|P1|Overall Study|Provided same answer to every question|1
5017911|NCT03447821|17248039|P3|Overall Study|Lost to Follow-up|1
5017912|NCT03447821|17248040|P2|Overall Study|Lost to Follow-up|0
5017913|NCT03447821|17248041|P1|Overall Study|Lost to Follow-up|0
5017914|NCT03447821|17248039|P3|Overall Study|Withdrawal by Subject|0
5017915|NCT03447821|17248040|P2|Overall Study|Withdrawal by Subject|1
5017916|NCT03447821|17248041|P1|Overall Study|Withdrawal by Subject|1
5017917|NCT03447730|17248067|P3|Overall Study|Adverse Event|0
5017918|NCT03447730|17248068|P2|Overall Study|Adverse Event|2
5017919|NCT03447730|17248069|P1|Overall Study|Adverse Event|0
5018004|NCT03441789|17249068|P1|Overall Study|Protocol Violation|0
5017920|NCT03447353|17248096|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
5017921|NCT03447353|17248096|P1|Overall Study|Scheduling Conflicts|3
5017922|NCT03447353|17248096|P1|Overall Study|Lost to Follow-up|4
5017923|NCT03447353|17248096|P1|Overall Study|Failure at Screening Visit|2
5017924|NCT03447249|17248112|P2|Overall Study|Other|0
5017925|NCT03447249|17248113|P1|Overall Study|Other|3
5017926|NCT03447249|17248112|P2|Overall Study|Withdrawal of consent (not due to AE)|0
5017927|NCT03447249|17248113|P1|Overall Study|Withdrawal of consent (not due to AE)|1
5017928|NCT03447249|17248112|P2|Overall Study|Adverse Event|0
5017929|NCT03447249|17248113|P1|Overall Study|Adverse Event|1
5017930|NCT03446781|17248163|P2|Overall Study|Protocol Violation|3
5017931|NCT03446781|17248164|P1|Overall Study|Protocol Violation|0
5017932|NCT03446781|17248163|P2|Overall Study|Adverse Event|2
5017933|NCT03446781|17248164|P1|Overall Study|Adverse Event|8
5017934|NCT03446781|17248163|P2|Overall Study|Withdrawal by Subject|7
5017935|NCT03446781|17248164|P1|Overall Study|Withdrawal by Subject|9
5017936|NCT03446781|17248163|P2|Overall Study|Lost to Follow-up|5
5017937|NCT03446781|17248164|P1|Overall Study|Lost to Follow-up|11
5017938|NCT03446573|17248222|P2|Overall Study|Ongoing at the time of interim analysis|343
5017939|NCT03446573|17248223|P1|Overall Study|Ongoing at the time of interim analysis|342
5017940|NCT03446573|17248222|P2|Overall Study|Adverse Event|2
5017941|NCT03446573|17248223|P1|Overall Study|Adverse Event|13
5017942|NCT03446573|17248222|P2|Overall Study|Lack of Efficacy|3
5017943|NCT03446573|17248223|P1|Overall Study|Lack of Efficacy|0
5017944|NCT03446573|17248222|P2|Overall Study|Protocol Violation|2
5017945|NCT03446573|17248223|P1|Overall Study|Protocol Violation|3
5017946|NCT03446573|17248222|P2|Overall Study|Lost to Follow-up|5
5017947|NCT03446573|17248223|P1|Overall Study|Lost to Follow-up|3
5017948|NCT03446573|17248222|P2|Overall Study|Physician Decision|1
5017949|NCT03446573|17248223|P1|Overall Study|Physician Decision|1
5017950|NCT03446573|17248222|P2|Overall Study|Withdrawal by Subject|16
5017951|NCT03446573|17248223|P1|Overall Study|Withdrawal by Subject|7
5017952|NCT03444584|17248345|P2|Overall Study|Other|1
5017953|NCT03444584|17248346|P1|Overall Study|Other|0
5017954|NCT03444584|17248345|P2|Overall Study|Withdrawal by Subject|1
5017955|NCT03444584|17248346|P1|Overall Study|Withdrawal by Subject|0
5017956|NCT03443713|17248416|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
5017957|NCT03443713|17248417|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
5017958|NCT03443713|17248418|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
5017959|NCT03443427|17248449|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
5017960|NCT03443427|17248450|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
5017961|NCT03443427|17248449|P2|Overall Study|Adverse Event|3
5017962|NCT03443427|17248450|P1|Overall Study|Adverse Event|2
5017963|NCT03443414|17248487|P5|Overall Study|Reason not specified|1
5017964|NCT03443414|17248488|P4|Overall Study|Reason not specified|0
5017965|NCT03443414|17248489|P3|Overall Study|Reason not specified|0
5017966|NCT03443414|17248490|P2|Overall Study|Reason not specified|0
5017967|NCT03443414|17248491|P1|Overall Study|Reason not specified|2
5017968|NCT03443414|17248487|P5|Overall Study|Death|0
5017969|NCT03443414|17248488|P4|Overall Study|Death|1
5017970|NCT03443414|17248489|P3|Overall Study|Death|0
5017971|NCT03443414|17248490|P2|Overall Study|Death|1
5017972|NCT03443414|17248491|P1|Overall Study|Death|0
5017973|NCT03443414|17248487|P5|Overall Study|Withdrawal by Subject|1
5017974|NCT03443414|17248488|P4|Overall Study|Withdrawal by Subject|2
5017975|NCT03443414|17248489|P3|Overall Study|Withdrawal by Subject|2
5017976|NCT03443414|17248490|P2|Overall Study|Withdrawal by Subject|2
5017977|NCT03443414|17248491|P1|Overall Study|Withdrawal by Subject|3
5017978|NCT03443414|17248487|P5|Overall Study|Adverse Event|3
5017979|NCT03443414|17248488|P4|Overall Study|Adverse Event|2
5017980|NCT03443414|17248489|P3|Overall Study|Adverse Event|4
5017981|NCT03443414|17248490|P2|Overall Study|Adverse Event|0
5017982|NCT03443414|17248491|P1|Overall Study|Adverse Event|6
5017983|NCT03442829|17248602|P2|Overall Study|Illness unrelated to study|1
5017984|NCT03442829|17248603|P1|Overall Study|Illness unrelated to study|1
5017985|NCT03442829|17248602|P2|Overall Study|Scheduling clash|1
5017986|NCT03442829|17248603|P1|Overall Study|Scheduling clash|3
5017987|NCT03442595|17248662|P2|Overall Study|Lost to Follow-up|0
5017988|NCT03442595|17248663|P1|Overall Study|Lost to Follow-up|94
5017989|NCT03441984|17248695|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017990|NCT03441984|17248696|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017991|NCT03441984|17248697|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017992|NCT03441984|17248698|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017993|NCT03441984|17248699|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017994|NCT03441984|17248700|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017995|NCT03441984|17248701|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017996|NCT03441984|17248702|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017997|NCT03441984|17248703|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5017998|NCT03441984|17248704|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
5017999|NCT03441984|17248705|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5018000|NCT03441984|17248706|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5018001|NCT03441789|17249067|P2|Overall Study|Lost to Follow-up|1
5018002|NCT03441789|17249068|P1|Overall Study|Lost to Follow-up|0
5018003|NCT03441789|17249067|P2|Overall Study|Protocol Violation|1
5018005|NCT03441789|17249067|P2|Overall Study|Adverse Event|1
5018006|NCT03441789|17249068|P1|Overall Study|Adverse Event|0
5018007|NCT03441789|17249067|P2|Overall Study|Withdrawal by Subject|1
5018008|NCT03441789|17249068|P1|Overall Study|Withdrawal by Subject|1
5018009|NCT03440918|17249289|P2|Overall Study|Protocol Violation|16
5018010|NCT03440918|17249290|P1|Overall Study|Protocol Violation|0
5018011|NCT03439124|17249388|P2|Overall Study|Other reasons|0
5018012|NCT03439124|17249389|P1|Overall Study|Other reasons|1
5018013|NCT03439124|17249388|P2|Overall Study|Lost to Follow-up|0
5018014|NCT03439124|17249389|P1|Overall Study|Lost to Follow-up|1
5018015|NCT03439124|17249388|P2|Overall Study|Adverse Event|0
5018016|NCT03439124|17249389|P1|Overall Study|Adverse Event|2
5018017|NCT03439072|17249403|P2|Overall Study|Physician Decision|1
5018018|NCT03439072|17249404|P1|Overall Study|Physician Decision|0
5018019|NCT03439072|17249403|P2|Overall Study|Withdrawal by Subject|3
5018020|NCT03439072|17249404|P1|Overall Study|Withdrawal by Subject|2
5018021|NCT03438539|17249455|P6|Overall Study|Lost to Follow-up|8
5018022|NCT03438539|17249456|P5|Overall Study|Lost to Follow-up|3
5018023|NCT03438539|17249457|P4|Overall Study|Lost to Follow-up|9
5018024|NCT03438539|17249458|P3|Overall Study|Lost to Follow-up|10
5018025|NCT03438539|17249459|P2|Overall Study|Lost to Follow-up|4
5018026|NCT03438539|17249460|P1|Overall Study|Lost to Follow-up|8
5018027|NCT03438383|17249488|P2|Overall Study|Protocol Violation|3
5018028|NCT03438383|17249489|P1|Overall Study|Protocol Violation|9
5018029|NCT03437733|17249520|P2|Overall Study|Eligibility criteria not met|3
5018030|NCT03437733|17249521|P1|Overall Study|Eligibility criteria not met|0
5018031|NCT03437447|17249561|P3|Treatment Period 1|Withdrawal by Subject|1
5018032|NCT03437447|17249562|P2|Treatment Period 1|Withdrawal by Subject|0
5018033|NCT03437447|17249563|P1|Treatment Period 1|Withdrawal by Subject|0
5018034|NCT03436732|17249618|P2|Overall Study|Death|1
5018035|NCT03436732|17249619|P1|Overall Study|Death|0
5018036|NCT03436732|17249618|P2|Overall Study|Adverse Event|0
5018037|NCT03436732|17249619|P1|Overall Study|Adverse Event|2
5018038|NCT03436732|17249618|P2|Overall Study|Off study after cycle 1|0
5018039|NCT03436732|17249619|P1|Overall Study|Off study after cycle 1|1
5018040|NCT03436732|17249618|P2|Overall Study|Not treated-enrolled in different study|0
5018041|NCT03436732|17249619|P1|Overall Study|Not treated-enrolled in different study|1
5018042|NCT03436420|17249632|P1|Overall Study|Lack of Efficacy|3
5018043|NCT03435497|17249785|P2|Overall Study|Wrong survey administered|2
5018044|NCT03435497|17249786|P1|Overall Study|Wrong survey administered|0
5018045|NCT03435497|17249785|P2|Overall Study|Withdrawal by Subject|4
5018046|NCT03435497|17249786|P1|Overall Study|Withdrawal by Subject|0
5018047|NCT03435497|17249785|P2|Overall Study|Death|0
5018048|NCT03435497|17249786|P1|Overall Study|Death|1
5018049|NCT03435497|17249785|P2|Overall Study|Lost to Follow-up|0
5018050|NCT03435497|17249786|P1|Overall Study|Lost to Follow-up|1
5018051|NCT03434977|17249813|P2|Washout Period (at Least 6 Days)|Adverse Event|1
5018052|NCT03434977|17249814|P1|Washout Period (at Least 6 Days)|Adverse Event|0
5018053|NCT03434249|17249881|P2|Overall Study|Difficulties in completing daily diary|1
5018054|NCT03434249|17249882|P1|Overall Study|Difficulties in completing daily diary|2
5018055|NCT03434249|17249881|P2|Overall Study|Non-compliance of family|1
5018056|NCT03434249|17249882|P1|Overall Study|Non-compliance of family|2
5018057|NCT03434249|17249881|P2|Overall Study|Lost to Follow-up|1
5018058|NCT03434249|17249882|P1|Overall Study|Lost to Follow-up|0
5018059|NCT03434249|17249881|P2|Overall Study|Adverse Event|0
5018060|NCT03434249|17249882|P1|Overall Study|Adverse Event|1
5018061|NCT03434119|17249916|P2|Overall Study|Other than specified|5
5018062|NCT03434119|17249917|P1|Overall Study|Other than specified|7
5018063|NCT03434119|17249916|P2|Overall Study|Withdrawal by Subject|5
5018064|NCT03434119|17249917|P1|Overall Study|Withdrawal by Subject|7
5018065|NCT03434119|17249916|P2|Overall Study|Study Terminated by Sponsor|102
5018066|NCT03434119|17249917|P1|Overall Study|Study Terminated by Sponsor|91
5018067|NCT03434119|17249916|P2|Overall Study|Poor Compliance to Protocol|1
5018068|NCT03434119|17249917|P1|Overall Study|Poor Compliance to Protocol|0
5018069|NCT03434119|17249916|P2|Overall Study|Adverse Event|0
5018070|NCT03434119|17249917|P1|Overall Study|Adverse Event|1
5018071|NCT03434119|17249916|P2|Overall Study|Randomized but not treated|0
5018072|NCT03434119|17249917|P1|Overall Study|Randomized but not treated|1
5018073|NCT03433703|17249951|P1|Overall Study|Study terminated by Sponsor|2
5018074|NCT03433677|17249960|P2|Period 2|Withdrawal by Subject|1
5018075|NCT03433677|17249961|P1|Period 2|Withdrawal by Subject|1
5018076|NCT03433677|17249960|P2|Period 1|Protocol Violation|0
5018077|NCT03433677|17249961|P1|Period 1|Protocol Violation|1
5018078|NCT03432533|17249981|P2|Overall Study|Withdrawal by Subject|9
5018079|NCT03432533|17249982|P1|Overall Study|Withdrawal by Subject|14
5018080|NCT03432533|17249981|P2|Overall Study|Lost to Follow-up|2
5018081|NCT03432533|17249982|P1|Overall Study|Lost to Follow-up|1
5018082|NCT03432390|17249998|P2|Apnea Period|Protocol Violation|2
5018083|NCT03432390|17249999|P1|Apnea Period|Protocol Violation|2
5018084|NCT03431441|17250009|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
5018085|NCT03431441|17250009|P1|Overall Study|Adverse Event|2
5018086|NCT03431441|17250009|P1|Overall Study|Withdrawal by Subject|2
5018087|NCT03430856|17250045|P3|Overall Study|Voluntary withdrawal of consent|1
5018088|NCT03430856|17250046|P2|Overall Study|Voluntary withdrawal of consent|1
5018089|NCT03430856|17250047|P1|Overall Study|Voluntary withdrawal of consent|1
5018090|NCT03430856|17250045|P3|Overall Study|Rescue criteria|0
5018091|NCT03430856|17250046|P2|Overall Study|Rescue criteria|1
5018092|NCT03430856|17250047|P1|Overall Study|Rescue criteria|1
5018093|NCT03430856|17250045|P3|Overall Study|Adverse Event|0
5018094|NCT03430856|17250046|P2|Overall Study|Adverse Event|1
5018095|NCT03430856|17250047|P1|Overall Study|Adverse Event|0
5018096|NCT03430245|17250085|P1|Overall Study|Lost to Follow-up|1
5018097|NCT03430245|17250085|P1|Overall Study|Withdrawal by Subject|6
5018098|NCT03429556|17250132|P4|Overall Study|Lost to Follow-up|0
5018099|NCT03429556|17250133|P3|Overall Study|Lost to Follow-up|0
5018100|NCT03429556|17250134|P2|Overall Study|Lost to Follow-up|1
5018101|NCT03429556|17250135|P1|Overall Study|Lost to Follow-up|0
5018102|NCT03428997|17250186|P1|Overall Study|Lost to Follow-up|4
5018103|NCT03428997|17250186|P1|Overall Study|Withdrawal by Subject|3
5018104|NCT03428997|17250186|P1|Overall Study|Sponsor decision.|1
5018105|NCT03428750|17250194|P2|Overall Study|Administrative|1
5018106|NCT03428750|17250195|P1|Overall Study|Administrative|0
5018107|NCT03428750|17250194|P2|Overall Study|Protocol Violation|0
5018108|NCT03428750|17250195|P1|Overall Study|Protocol Violation|1
5018109|NCT03428750|17250194|P2|Overall Study|Adverse Event|1
5018110|NCT03428750|17250195|P1|Overall Study|Adverse Event|9
5018111|NCT03428750|17250194|P2|Overall Study|Lost to Follow-up|9
5018112|NCT03428750|17250195|P1|Overall Study|Lost to Follow-up|3
5018113|NCT03428750|17250194|P2|Overall Study|Withdrawal by Subject|10
5018114|NCT03428750|17250195|P1|Overall Study|Withdrawal by Subject|11
5018115|NCT03428152|17250244|P2|Overall Study|Lack of Efficacy|4
5018116|NCT03428152|17250245|P1|Overall Study|Lack of Efficacy|0
5018117|NCT03428152|17250244|P2|Overall Study|Protocol Violation|5
5018118|NCT03428152|17250245|P1|Overall Study|Protocol Violation|3
5018119|NCT03428152|17250244|P2|Overall Study|Physician Decision|2
5018120|NCT03428152|17250245|P1|Overall Study|Physician Decision|4
5018121|NCT03427892|17250266|P1|Overall Study|Lost to Follow-up|2
5018122|NCT03427073|17250290|P8|Overall Study|Physician Decision|1
5018123|NCT03427073|17250291|P7|Overall Study|Physician Decision|1
5018124|NCT03427073|17250292|P6|Overall Study|Physician Decision|0
5018125|NCT03427073|17250293|P5|Overall Study|Physician Decision|0
5018126|NCT03427073|17250294|P4|Overall Study|Physician Decision|0
5018127|NCT03427073|17250295|P3|Overall Study|Physician Decision|0
5018128|NCT03427073|17250296|P2|Overall Study|Physician Decision|0
5018129|NCT03427073|17250297|P1|Overall Study|Physician Decision|0
5018130|NCT03427073|17250290|P8|Overall Study|Disease Progression|3
5018131|NCT03427073|17250291|P7|Overall Study|Disease Progression|2
5018132|NCT03427073|17250292|P6|Overall Study|Disease Progression|4
5018133|NCT03427073|17250293|P5|Overall Study|Disease Progression|3
5018134|NCT03427073|17250294|P4|Overall Study|Disease Progression|3
5018135|NCT03427073|17250295|P3|Overall Study|Disease Progression|1
5018136|NCT03427073|17250296|P2|Overall Study|Disease Progression|1
5018137|NCT03427073|17250297|P1|Overall Study|Disease Progression|1
5018138|NCT03426787|17250347|P1|Overall Study|Unrelated to intervention death|1
5018139|NCT03426787|17250347|P1|Overall Study|Lost to Follow-up|7
5018140|NCT03426787|17250347|P1|Overall Study|Withdrawal by Subject|6
5018141|NCT03426631|17250357|P2|Overall Study|Lost to Follow-up|1
5018142|NCT03426631|17250358|P1|Overall Study|Lost to Follow-up|0
5018143|NCT03426436|17250370|P1|Overall Study|ECGs not saved|4
5018144|NCT03426436|17250370|P1|Overall Study|Consent issue|1
5018145|NCT03426436|17250370|P1|Overall Study|Withdrawal by Subject|2
5018146|NCT03426436|17250370|P1|Overall Study|Incorrect lead placement|12
5018147|NCT03426137|17250378|P3|Overall Study|Withdrawal by Subject|0
5018148|NCT03426137|17250379|P2|Overall Study|Withdrawal by Subject|0
5018149|NCT03426137|17250380|P1|Overall Study|Withdrawal by Subject|3
5018150|NCT03425396|17250393|P5|Overall Study|Other|1
5018151|NCT03425396|17250394|P4|Overall Study|Other|0
5018152|NCT03425396|17250395|P3|Overall Study|Other|1
5018153|NCT03425396|17250396|P2|Overall Study|Other|1
5018154|NCT03425396|17250397|P1|Overall Study|Other|0
5018155|NCT03425396|17250393|P5|Overall Study|Withdrawal by Subject|0
5018156|NCT03425396|17250394|P4|Overall Study|Withdrawal by Subject|1
5018157|NCT03425396|17250395|P3|Overall Study|Withdrawal by Subject|0
5018158|NCT03425396|17250396|P2|Overall Study|Withdrawal by Subject|1
5018159|NCT03425396|17250397|P1|Overall Study|Withdrawal by Subject|0
5018160|NCT03425396|17250393|P5|Overall Study|Lost to Follow-up|0
5018161|NCT03425396|17250394|P4|Overall Study|Lost to Follow-up|0
5018162|NCT03425396|17250395|P3|Overall Study|Lost to Follow-up|2
5018163|NCT03425396|17250396|P2|Overall Study|Lost to Follow-up|5
5018164|NCT03425396|17250397|P1|Overall Study|Lost to Follow-up|2
5018165|NCT03424265|17250496|P2|Overall Study|Withdrawal by Subject|2
5018166|NCT03424265|17250497|P1|Overall Study|Withdrawal by Subject|0
5018167|NCT03424265|17250496|P2|Overall Study|screening failure|0
5018168|NCT03424265|17250497|P1|Overall Study|screening failure|1
5018169|NCT03424044|17250503|P9|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018170|NCT03424044|17250504|P8|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018171|NCT03424044|17250505|P7|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018172|NCT03424044|17250506|P6|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018173|NCT03424044|17250507|P5|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018174|NCT03424044|17250508|P4|Third Intervention (76 Hours)|Withdrawal by Subject|1
5018175|NCT03424044|17250509|P3|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018176|NCT03424044|17250510|P2|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018177|NCT03424044|17250511|P1|Third Intervention (76 Hours)|Withdrawal by Subject|0
5018178|NCT03424044|17250503|P9|Third Intervention (76 Hours)|Adverse Event|0
5018179|NCT03424044|17250504|P8|Third Intervention (76 Hours)|Adverse Event|0
5018180|NCT03424044|17250505|P7|Third Intervention (76 Hours)|Adverse Event|1
5018181|NCT03424044|17250506|P6|Third Intervention (76 Hours)|Adverse Event|0
5018182|NCT03424044|17250507|P5|Third Intervention (76 Hours)|Adverse Event|0
5018183|NCT03424044|17250508|P4|Third Intervention (76 Hours)|Adverse Event|0
5018184|NCT03424044|17250509|P3|Third Intervention (76 Hours)|Adverse Event|0
5018185|NCT03424044|17250510|P2|Third Intervention (76 Hours)|Adverse Event|0
5018186|NCT03424044|17250511|P1|Third Intervention (76 Hours)|Adverse Event|1
5018187|NCT03424044|17250503|P9|First Intervention (76 Hours)|device issues|1
5018188|NCT03424044|17250504|P8|First Intervention (76 Hours)|device issues|1
5018189|NCT03424044|17250505|P7|First Intervention (76 Hours)|device issues|1
5018190|NCT03424044|17250506|P6|First Intervention (76 Hours)|device issues|0
5018191|NCT03424044|17250507|P5|First Intervention (76 Hours)|device issues|0
5018192|NCT03424044|17250508|P4|First Intervention (76 Hours)|device issues|0
5018193|NCT03424044|17250509|P3|First Intervention (76 Hours)|device issues|0
5018194|NCT03424044|17250510|P2|First Intervention (76 Hours)|device issues|0
5018195|NCT03424044|17250511|P1|First Intervention (76 Hours)|device issues|0
5018196|NCT03424044|17250503|P9|First Intervention (76 Hours)|Adverse Event|0
5018197|NCT03424044|17250504|P8|First Intervention (76 Hours)|Adverse Event|0
5018198|NCT03424044|17250505|P7|First Intervention (76 Hours)|Adverse Event|0
5018199|NCT03424044|17250506|P6|First Intervention (76 Hours)|Adverse Event|0
5018200|NCT03424044|17250507|P5|First Intervention (76 Hours)|Adverse Event|1
5018201|NCT03424044|17250508|P4|First Intervention (76 Hours)|Adverse Event|0
5018202|NCT03424044|17250509|P3|First Intervention (76 Hours)|Adverse Event|0
5018203|NCT03424044|17250510|P2|First Intervention (76 Hours)|Adverse Event|0
5018204|NCT03424044|17250511|P1|First Intervention (76 Hours)|Adverse Event|0
5018205|NCT03424044|17250503|P9|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018206|NCT03424044|17250504|P8|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018207|NCT03424044|17250505|P7|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018208|NCT03424044|17250506|P6|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018209|NCT03424044|17250507|P5|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018210|NCT03424044|17250508|P4|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018211|NCT03424044|17250509|P3|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
5018212|NCT03424044|17250510|P2|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018213|NCT03424044|17250511|P1|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5018214|NCT03423173|17250583|P4|Overall Study|Reason not Specified|1
5018215|NCT03423173|17250584|P3|Overall Study|Reason not Specified|3
5018216|NCT03423173|17250585|P2|Overall Study|Reason not Specified|5
5018217|NCT03423173|17250586|P1|Overall Study|Reason not Specified|2
5018218|NCT03423173|17250583|P4|Overall Study|Death|0
5018219|NCT03423173|17250584|P3|Overall Study|Death|0
5018220|NCT03423173|17250585|P2|Overall Study|Death|0
5018221|NCT03423173|17250586|P1|Overall Study|Death|1
5018222|NCT03423173|17250583|P4|Overall Study|Withdrawal of consent|5
5018223|NCT03423173|17250584|P3|Overall Study|Withdrawal of consent|4
5018224|NCT03423173|17250585|P2|Overall Study|Withdrawal of consent|10
5018225|NCT03423173|17250586|P1|Overall Study|Withdrawal of consent|4
5018226|NCT03423173|17250583|P4|Overall Study|Lost to Follow-up|22
5018227|NCT03423173|17250584|P3|Overall Study|Lost to Follow-up|17
5018228|NCT03423173|17250585|P2|Overall Study|Lost to Follow-up|19
5018229|NCT03423173|17250586|P1|Overall Study|Lost to Follow-up|10
5018230|NCT03423173|17250583|P4|Overall Study|Adverse Event|1
5018231|NCT03423173|17250584|P3|Overall Study|Adverse Event|1
5018232|NCT03423173|17250585|P2|Overall Study|Adverse Event|1
5018233|NCT03423173|17250586|P1|Overall Study|Adverse Event|1
5018234|NCT03423173|17250583|P4|Overall Study|Randomized but not vaccinated|1
5018235|NCT03423173|17250584|P3|Overall Study|Randomized but not vaccinated|2
5018236|NCT03423173|17250585|P2|Overall Study|Randomized but not vaccinated|0
5018237|NCT03423173|17250586|P1|Overall Study|Randomized but not vaccinated|1
5018238|NCT03421730|17250640|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018239|NCT03421730|17250641|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018240|NCT03421730|17250642|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018241|NCT03421730|17250643|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018242|NCT03421730|17250644|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018243|NCT03421730|17250645|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018244|NCT03421730|17250646|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018245|NCT03421730|17250647|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
5018246|NCT03421730|17250648|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018247|NCT03421730|17250649|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018248|NCT03421730|17250650|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018249|NCT03421730|17250651|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5018250|NCT03421730|17250640|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018251|NCT03421730|17250641|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018252|NCT03421730|17250642|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018253|NCT03421730|17250643|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018254|NCT03421730|17250644|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018255|NCT03421730|17250645|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018256|NCT03421730|17250646|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018257|NCT03421730|17250647|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018258|NCT03421730|17250648|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018259|NCT03421730|17250649|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018260|NCT03421730|17250650|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
5018261|NCT03421730|17250651|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5018262|NCT03421379|17250724|P2|Period 1|Did not receive treatment|2
5018263|NCT03421379|17250725|P1|Period 1|Did not receive treatment|1
5018264|NCT03421379|17250724|P2|Period 1|Physician Decision|1
5018265|NCT03421379|17250725|P1|Period 1|Physician Decision|1
5018266|NCT03421379|17250724|P2|Period 1|Withdrawal by Subject|1
5018267|NCT03421379|17250725|P1|Period 1|Withdrawal by Subject|0
5018268|NCT03420300|17250771|P1|Overall Study|Death|2
5018269|NCT03419962|17250780|P1|Overall Study|Missing completion data|31
5018270|NCT03419962|17250780|P1|Overall Study|Difficulty in inhaling the doses|1
5018271|NCT03419962|17250780|P1|Overall Study|Lost to Follow-up|3
5018272|NCT03419962|17250780|P1|Overall Study|Refusal of continuing with trial drug|1
5018273|NCT03419962|17250780|P1|Overall Study|Change to other medication|1
5018274|NCT03418571|17250860|P2|Overall Study|Consent withdrawn by legal guardian|0
5018275|NCT03418571|17250861|P1|Overall Study|Consent withdrawn by legal guardian|1
5018276|NCT03418376|17250873|P4|Overall Study|Exacerbation|0
5018277|NCT03418376|17250874|P3|Overall Study|Exacerbation|0
5018278|NCT03418376|17250875|P2|Overall Study|Exacerbation|1
5018279|NCT03418376|17250876|P1|Overall Study|Exacerbation|0
5018280|NCT03418376|17250873|P4|Overall Study|Personal reasons|1
5018281|NCT03418376|17250874|P3|Overall Study|Personal reasons|2
5018282|NCT03418376|17250875|P2|Overall Study|Personal reasons|2
5018283|NCT03418376|17250876|P1|Overall Study|Personal reasons|0
5018284|NCT03418376|17250873|P4|Overall Study|Musculoskeletal injury|0
5018285|NCT03418376|17250874|P3|Overall Study|Musculoskeletal injury|1
5018286|NCT03418376|17250875|P2|Overall Study|Musculoskeletal injury|2
5018287|NCT03418376|17250876|P1|Overall Study|Musculoskeletal injury|1
5018288|NCT03417830|17250934|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
5018289|NCT03417830|17250935|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
5018290|NCT03417505|17251069|P2|First Lens Type (30 Days)|Lost to Follow-up|1
5018291|NCT03417505|17251070|P1|First Lens Type (30 Days)|Lost to Follow-up|1
5018292|NCT03417219|17251101|P2|Overall Study|Lost to Follow-up|3
5018293|NCT03417219|17251102|P1|Overall Study|Lost to Follow-up|0
5018294|NCT03417141|17251112|P1|Overall Study|Protocol Violation|3
5018295|NCT03417141|17251112|P1|Overall Study|Withdrawal by Subject|1
5018296|NCT03417024|17251119|P1|Overall Study|Physician Decision|2
5018297|NCT03417024|17251119|P1|Overall Study|Study Termination prior to follow-up|11
5018298|NCT03416127|17251144|P3|Overall Study|Withdrawal by Subject|1
5018299|NCT03416127|17251145|P2|Overall Study|Withdrawal by Subject|1
5018300|NCT03416127|17251146|P1|Overall Study|Withdrawal by Subject|0
5018301|NCT03415178|17251290|P2|Single Arm Period (up to Week 16)|Adverse Event|1
5018302|NCT03415178|17251291|P1|Single Arm Period (up to Week 16)|Adverse Event|0
5018303|NCT03415178|17251290|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
5018304|NCT03415178|17251291|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
5018305|NCT03415022|17251345|P2|Overall Study|Lost to Follow-up|0
5018306|NCT03415022|17251346|P1|Overall Study|Lost to Follow-up|2
5018307|NCT03415022|17251345|P2|Overall Study|COVID-19 Suspension|3
5018308|NCT03415022|17251346|P1|Overall Study|COVID-19 Suspension|2
5018309|NCT03415022|17251345|P2|Overall Study|Withdrawal by Subject|2
5018310|NCT03415022|17251346|P1|Overall Study|Withdrawal by Subject|1
5018311|NCT03414359|17251356|P2|Overall Study|Protocol Violation|1
5018312|NCT03414359|17251357|P1|Overall Study|Protocol Violation|0
5018313|NCT03414359|17251356|P2|Overall Study|Lack of Efficacy|1
5018314|NCT03414359|17251357|P1|Overall Study|Lack of Efficacy|1
5018315|NCT03414047|17251369|P4|Overall Study|Withdrawal by Subject|2
5018316|NCT03414047|17251370|P3|Overall Study|Withdrawal by Subject|0
5018317|NCT03414047|17251371|P2|Overall Study|Withdrawal by Subject|0
5018318|NCT03414047|17251372|P1|Overall Study|Withdrawal by Subject|1
5018319|NCT03414047|17251369|P4|Overall Study|Adverse Event|1
5018320|NCT03414047|17251370|P3|Overall Study|Adverse Event|0
5018321|NCT03414047|17251371|P2|Overall Study|Adverse Event|0
5018322|NCT03414047|17251372|P1|Overall Study|Adverse Event|0
5018323|NCT03412929|17251432|P1|Overall Study|Protocol Violation|3
5018324|NCT03412734|17251443|P2|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
5018325|NCT03412734|17251444|P1|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
5018326|NCT03412734|17251443|P2|Overall Study|Incorrect labeling of samples|0
5018327|NCT03412734|17251444|P1|Overall Study|Incorrect labeling of samples|2
5018328|NCT03412019|17251452|P2|Overall Study|Withdrawal by Subject|1
5018329|NCT03412019|17251453|P1|Overall Study|Withdrawal by Subject|1
5018330|NCT03409796|17251470|P2|Overall Study|Other|1
5018331|NCT03409796|17251471|P1|Overall Study|Other|0
5018332|NCT03409796|17251470|P2|Overall Study|Adverse Event|0
5018333|NCT03409796|17251471|P1|Overall Study|Adverse Event|2
5018334|NCT03408639|17251539|P2|Overall Study|Physician Decision|6
5018335|NCT03408639|17251540|P1|Overall Study|Physician Decision|3
5018336|NCT03408639|17251539|P2|Overall Study|Withdrawal by Subject|7
5018337|NCT03408639|17251540|P1|Overall Study|Withdrawal by Subject|2
5018338|NCT03408639|17251539|P2|Overall Study|Lost to Follow-up|4
5018339|NCT03408639|17251540|P1|Overall Study|Lost to Follow-up|1
5018340|NCT03408639|17251539|P2|Overall Study|Death|5
5018341|NCT03408639|17251540|P1|Overall Study|Death|5
5018342|NCT03408483|17251570|P2|Overall Study|Lost to Follow-up|0
5018343|NCT03408483|17251571|P1|Overall Study|Lost to Follow-up|3
5018344|NCT03408483|17251570|P2|Overall Study|Physician Decision|3
5018345|NCT03408483|17251571|P1|Overall Study|Physician Decision|3
5018346|NCT03407430|17251749|P2|Washout|Protocol Violation|0
5018347|NCT03407430|17251750|P1|Washout|Protocol Violation|1
5018348|NCT03407170|17251782|P1|Overall Study|Adverse Event|1
5018349|NCT03407118|17251795|P2|Period 2|Withdrawal by Subject|0
5018350|NCT03407118|17251796|P1|Period 2|Withdrawal by Subject|1
5018351|NCT03406260|17251873|P6|Period 1|Adverse Event|0
5018352|NCT03406260|17251874|P5|Period 1|Adverse Event|1
5018353|NCT03406260|17251875|P4|Period 1|Adverse Event|0
5018354|NCT03406260|17251876|P3|Period 1|Adverse Event|0
5018355|NCT03406260|17251877|P2|Period 1|Adverse Event|0
5018356|NCT03406260|17251878|P1|Period 1|Adverse Event|0
5018357|NCT03405935|17251890|P1|Overall Study|Still on Study|83
5018358|NCT03405935|17251890|P1|Overall Study|Adverse Event|3
5018359|NCT03405818|17251901|P1|Overall Study|Lost to Follow-up|4
5018360|NCT03405818|17251901|P1|Overall Study|Withdrawal by Subject|4
5018361|NCT03404843|17251955|P2|Overall Study|Study difficulties unrelated to Tx|1
5018362|NCT03404843|17251956|P1|Overall Study|Study difficulties unrelated to Tx|4
5018363|NCT03404206|17251985|P3|Overall Study|Lost to Follow-up|0
5018364|NCT03404206|17251986|P2|Overall Study|Lost to Follow-up|1
5018365|NCT03404206|17251987|P1|Overall Study|Lost to Follow-up|3
5018366|NCT03404206|17251985|P3|Overall Study|Withdrawal by Subject|0
5018367|NCT03404206|17251986|P2|Overall Study|Withdrawal by Subject|1
5018368|NCT03404206|17251987|P1|Overall Study|Withdrawal by Subject|1
5018369|NCT03403413|17252115|P1|Overall Study|Lack of Efficacy|2
5018370|NCT03403400|17252133|P3|Overall Study|Benign Paroxysmal Positional Vertigo|1
5018371|NCT03403400|17252134|P2|Overall Study|Benign Paroxysmal Positional Vertigo|0
5018372|NCT03403400|17252135|P1|Overall Study|Benign Paroxysmal Positional Vertigo|0
5018373|NCT03403400|17252133|P3|Overall Study|Hospitalization|0
5018374|NCT03403400|17252134|P2|Overall Study|Hospitalization|0
5018375|NCT03403400|17252135|P1|Overall Study|Hospitalization|1
5018376|NCT03403400|17252133|P3|Overall Study|Lost to Follow-up|1
5018377|NCT03403400|17252134|P2|Overall Study|Lost to Follow-up|0
5018378|NCT03403400|17252135|P1|Overall Study|Lost to Follow-up|1
5018379|NCT03403374|17252167|P1|Overall Study|Lost to Follow-up|1
5018380|NCT03403036|17252174|P1|Overall Study|Lack of Efficacy|5
5018381|NCT03402893|17252201|P1|Overall Study|Withdrawal by Subject|1
5018382|NCT03402750|17252212|P2|Overall Study|Lost to Follow-up|1
5018383|NCT03402750|17252213|P1|Overall Study|Lost to Follow-up|2
5018384|NCT03400787|17252301|P2|Overall Study|Unblinded before 3-month follow-upa-|6
5018385|NCT03400787|17252302|P1|Overall Study|Unblinded before 3-month follow-upa-|0
5018386|NCT03400787|17252301|P2|Overall Study|Protocol Violation|2
5018387|NCT03400787|17252302|P1|Overall Study|Protocol Violation|0
5018388|NCT03400787|17252301|P2|Overall Study|Death|0
5018389|NCT03400787|17252302|P1|Overall Study|Death|1
5018390|NCT03400787|17252301|P2|Overall Study|Lost to Follow-up|0
5018391|NCT03400787|17252302|P1|Overall Study|Lost to Follow-up|1
5018392|NCT03398356|17252565|P3|After 6 Weeks of Treatment|Physician Decision|0
5018393|NCT03398356|17252566|P2|After 6 Weeks of Treatment|Physician Decision|2
5018394|NCT03398356|17252567|P1|After 6 Weeks of Treatment|Physician Decision|0
5018395|NCT03398356|17252565|P3|Before Treatment|Physician Decision|11
5018396|NCT03398356|17252566|P2|Before Treatment|Physician Decision|0
5018397|NCT03398356|17252567|P1|Before Treatment|Physician Decision|0
5018398|NCT03398356|17252565|P3|Before Treatment|Withdrawal by Subject|0
5018399|NCT03398356|17252566|P2|Before Treatment|Withdrawal by Subject|5
5018400|NCT03398356|17252567|P1|Before Treatment|Withdrawal by Subject|0
5018401|NCT03398356|17252565|P3|Before Treatment|drug intolerance|0
5018402|NCT03398356|17252566|P2|Before Treatment|drug intolerance|1
5018403|NCT03398356|17252567|P1|Before Treatment|drug intolerance|2
5018404|NCT03398356|17252565|P3|Before Treatment|Lost to Follow-up|0
5018405|NCT03398356|17252566|P2|Before Treatment|Lost to Follow-up|2
5018406|NCT03398356|17252567|P1|Before Treatment|Lost to Follow-up|1
5018407|NCT03397771|17252672|P2|Overall Study|Adverse Event|1
5018408|NCT03397771|17252673|P1|Overall Study|Adverse Event|2
5018409|NCT03397771|17252672|P2|Overall Study|Protocol Violation|2
5018410|NCT03397771|17252673|P1|Overall Study|Protocol Violation|2
5018411|NCT03397771|17252672|P2|Overall Study|Withdrawal by Subject|3
5018412|NCT03397771|17252673|P1|Overall Study|Withdrawal by Subject|1
5018413|NCT03397771|17252672|P2|Overall Study|2 erroneously randomized, never treated|1
5018414|NCT03397771|17252673|P1|Overall Study|2 erroneously randomized, never treated|3
5018415|NCT03396835|17252731|P1|Overall Study|Did not meet criteria for data analysis|1
5018416|NCT03396835|17252731|P1|Overall Study|Withdrawn prior to completion|1
5018417|NCT03394508|17252766|P2|Overall Study|Lost to Follow-up|0
5018418|NCT03394508|17252767|P1|Overall Study|Lost to Follow-up|1
5018419|NCT03394508|17252766|P2|Overall Study|Protocol Violation|3
5018420|NCT03394508|17252767|P1|Overall Study|Protocol Violation|0
5018421|NCT03394391|17252793|P2|Overall Study|Lost to Follow-up|2
5018422|NCT03394391|17252794|P1|Overall Study|Lost to Follow-up|1
5018423|NCT03393806|17252812|P2|Overall Study|Physician Decision|0
5018424|NCT03393806|17252813|P1|Overall Study|Physician Decision|1
5018425|NCT03392194|17252939|P2|Overall Study|Conflicts with personal schedule|0
5018426|NCT03392194|17252940|P1|Overall Study|Conflicts with personal schedule|1
5018427|NCT03392194|17252939|P2|Overall Study|Withdrawal by Subject|2
5018428|NCT03392194|17252940|P1|Overall Study|Withdrawal by Subject|1
5018429|NCT03390426|17252975|P2|Overall Study|Protocol Violation|1
5018430|NCT03390426|17252976|P1|Overall Study|Protocol Violation|0
5018431|NCT03390166|17252990|P2|Overall Study|Move to work oversea|1
5018432|NCT03390166|17252991|P1|Overall Study|Move to work oversea|0
5018433|NCT03390166|17252990|P2|Overall Study|To drug therapy course|1
5018434|NCT03390166|17252991|P1|Overall Study|To drug therapy course|0
5018435|NCT03390166|17252990|P2|Overall Study|To militarycamp for conscript|0
5018436|NCT03390166|17252991|P1|Overall Study|To militarycamp for conscript|1
5018437|NCT03390166|17252990|P2|Overall Study|Move from study area|2
5018438|NCT03390166|17252991|P1|Overall Study|Move from study area|3
5018439|NCT03390166|17252990|P2|Overall Study|Physician Decision|1
5018440|NCT03390166|17252991|P1|Overall Study|Physician Decision|2
5018441|NCT03390166|17252990|P2|Overall Study|Lost to Follow-up|4
5018442|NCT03390166|17252991|P1|Overall Study|Lost to Follow-up|6
5018443|NCT03390166|17252990|P2|Overall Study|Death|1
5018444|NCT03390166|17252991|P1|Overall Study|Death|0
5018445|NCT03389308|17253045|P1|Overall Study|Sponsor Request|2
5018446|NCT03389308|17253045|P1|Overall Study|Adverse Event|2
5018447|NCT03389308|17253045|P1|Overall Study|Lost to Follow-up|3
5018448|NCT03389308|17253045|P1|Overall Study|Withdrawal by Subject|5
5018449|NCT03387683|17253051|P2|Overall Study|Did not receive treatment|0
5018450|NCT03387683|17253052|P1|Overall Study|Did not receive treatment|1
5018451|NCT03387683|17253051|P2|Overall Study|In receipt of disallowed medication|0
5018452|NCT03387683|17253052|P1|Overall Study|In receipt of disallowed medication|1
5018453|NCT03387462|17253060|P1|Overall Study|Lost to Follow-up|1
5018454|NCT03387059|17253090|P2|Overall Study|Study termination|4
5018455|NCT03387059|17253091|P1|Overall Study|Study termination|5
5018456|NCT03387046|17253105|P2|Overall Study|Adverse Event|1
5018457|NCT03387046|17253106|P1|Overall Study|Adverse Event|1
5018458|NCT03386994|17253133|P1|Overall Study|Death|16
5018459|NCT03386994|17253133|P1|Overall Study|Withdrawal by Subject|3
5018460|NCT03386994|17253133|P1|Overall Study|Lost to Follow-up|4
5018461|NCT03386994|17253133|P1|Overall Study|Adverse Event|14
5018462|NCT03386994|17253133|P1|Overall Study|Lung transplant|1
5018463|NCT03386474|17253193|P2|Overall Study|Adverse Event|1
5018464|NCT03386474|17253194|P1|Overall Study|Adverse Event|0
5018465|NCT03386474|17253193|P2|Overall Study|Death|0
5018466|NCT03386474|17253194|P1|Overall Study|Death|1
5018467|NCT03386448|17253216|P2|Overall Study|Adverse Event|2
5018468|NCT03386448|17253217|P1|Overall Study|Adverse Event|0
5018469|NCT03386435|17253225|P2|Overall Study|Protocol Violation|7
5018470|NCT03386435|17253226|P1|Overall Study|Protocol Violation|5
5018471|NCT03384316|17253262|P2|Overall Study|Screen failure|1
5018472|NCT03384316|17253263|P1|Overall Study|Screen failure|0
5018473|NCT03383887|17253286|P2|Overall Study|Lost to Follow-up|1
5018474|NCT03383887|17253287|P1|Overall Study|Lost to Follow-up|0
5018475|NCT03383783|17253295|P1|Overall Study|Withdrawal by Subject|2
5018476|NCT03383614|17253373|P4|Overall Study|Withdrawal by Subject|0
5018477|NCT03383614|17253374|P3|Overall Study|Withdrawal by Subject|0
5018478|NCT03383614|17253375|P2|Overall Study|Withdrawal by Subject|1
5018479|NCT03383614|17253376|P1|Overall Study|Withdrawal by Subject|0
5018480|NCT03382912|17253644|P2|Overall Study|Withdrawal by Subject|5
5018481|NCT03382912|17253645|P1|Overall Study|Withdrawal by Subject|0
5018482|NCT03382912|17253644|P2|Overall Study|Sponsor Decision|6
5018483|NCT03382912|17253645|P1|Overall Study|Sponsor Decision|6
5018484|NCT03382912|17253644|P2|Overall Study|Physician Decision|1
5018485|NCT03382912|17253645|P1|Overall Study|Physician Decision|0
5018486|NCT03382834|17253661|P2|Overall Study|Withdrawal by Subject|1
5018487|NCT03382834|17253662|P1|Overall Study|Withdrawal by Subject|0
5018488|NCT03382834|17253661|P2|Overall Study|Lost to Follow-up|0
5018489|NCT03382834|17253662|P1|Overall Study|Lost to Follow-up|1
5018490|NCT03382262|17253686|P4|Overall Study|Withdrawal by Subject|1
5018491|NCT03382262|17253687|P3|Overall Study|Withdrawal by Subject|0
5018492|NCT03382262|17253688|P2|Overall Study|Withdrawal by Subject|0
5018493|NCT03382262|17253689|P1|Overall Study|Withdrawal by Subject|0
5018494|NCT03382262|17253686|P4|Overall Study|Physician Decision|0
5018495|NCT03382262|17253687|P3|Overall Study|Physician Decision|1
5018496|NCT03382262|17253688|P2|Overall Study|Physician Decision|0
5018497|NCT03382262|17253689|P1|Overall Study|Physician Decision|0
5018498|NCT03381248|17253747|P2|Overall Study|Protocol Violation|1
5018499|NCT03381248|17253748|P1|Overall Study|Protocol Violation|2
5018500|NCT03381248|17253747|P2|Overall Study|Adverse Event|0
5018501|NCT03381248|17253748|P1|Overall Study|Adverse Event|2
5018502|NCT03381248|17253747|P2|Overall Study|Lack of Efficacy|0
5018503|NCT03381248|17253748|P1|Overall Study|Lack of Efficacy|1
5018504|NCT03381248|17253747|P2|Overall Study|Lost to Follow-up|2
5018505|NCT03381248|17253748|P1|Overall Study|Lost to Follow-up|3
5018506|NCT03381248|17253747|P2|Overall Study|Withdrawal by Subject|3
5018507|NCT03381248|17253748|P1|Overall Study|Withdrawal by Subject|5
5018508|NCT03380429|17253855|P5|Overall Study|Adverse Event|0
5018509|NCT03380429|17253856|P4|Overall Study|Adverse Event|2
5018510|NCT03380429|17253857|P3|Overall Study|Adverse Event|1
5018511|NCT03380429|17253858|P2|Overall Study|Adverse Event|1
5018512|NCT03380429|17253859|P1|Overall Study|Adverse Event|1
5018513|NCT03380429|17253855|P5|Overall Study|Lack of Efficacy|1
5018514|NCT03380429|17253856|P4|Overall Study|Lack of Efficacy|2
5018515|NCT03380429|17253857|P3|Overall Study|Lack of Efficacy|0
5018516|NCT03380429|17253858|P2|Overall Study|Lack of Efficacy|0
5018517|NCT03380429|17253859|P1|Overall Study|Lack of Efficacy|0
5018518|NCT03380429|17253855|P5|Overall Study|Protocol Violation|1
5018519|NCT03380429|17253856|P4|Overall Study|Protocol Violation|0
5018520|NCT03380429|17253857|P3|Overall Study|Protocol Violation|1
5018521|NCT03380429|17253858|P2|Overall Study|Protocol Violation|0
5018522|NCT03380429|17253859|P1|Overall Study|Protocol Violation|1
5018523|NCT03380429|17253855|P5|Overall Study|Lost to Follow-up|1
5018524|NCT03380429|17253856|P4|Overall Study|Lost to Follow-up|3
5018525|NCT03380429|17253857|P3|Overall Study|Lost to Follow-up|4
5018526|NCT03380429|17253858|P2|Overall Study|Lost to Follow-up|2
5018527|NCT03380429|17253859|P1|Overall Study|Lost to Follow-up|0
5018528|NCT03380429|17253855|P5|Overall Study|Withdrawal by Subject|1
5018529|NCT03380429|17253856|P4|Overall Study|Withdrawal by Subject|2
5018530|NCT03380429|17253857|P3|Overall Study|Withdrawal by Subject|5
5018531|NCT03380429|17253858|P2|Overall Study|Withdrawal by Subject|3
5018532|NCT03380429|17253859|P1|Overall Study|Withdrawal by Subject|3
5018533|NCT03380429|17253855|P5|Overall Study|Physician Decision|1
5018534|NCT03380429|17253856|P4|Overall Study|Physician Decision|1
5018535|NCT03380429|17253857|P3|Overall Study|Physician Decision|0
5018536|NCT03380429|17253858|P2|Overall Study|Physician Decision|1
5018537|NCT03380429|17253859|P1|Overall Study|Physician Decision|0
5018538|NCT03380390|17253912|P1|Overall Study|Adverse Event|3
5018539|NCT03379506|17254008|P4|Overall Study|Ongoing in study|11
5018540|NCT03379506|17254009|P3|Overall Study|Ongoing in study|0
5018541|NCT03379506|17254010|P2|Overall Study|Ongoing in study|9
5018542|NCT03379506|17254011|P1|Overall Study|Ongoing in study|0
5018543|NCT03379376|17254061|P1|Overall Study|Death|1
5018544|NCT03379376|17254061|P1|Overall Study|Overwhelmed, didn't want to continue|1
5018545|NCT03379376|17254061|P1|Overall Study|Did not wish to complete follow up|1
5018546|NCT03379376|17254061|P1|Overall Study|Lost to Follow-up|2
5018547|NCT03379233|17254071|P2|Overall Study|Technical issues with Concept 2 inhalers|6
5018548|NCT03379233|17254072|P1|Overall Study|Technical issues with Concept 2 inhalers|1
5018549|NCT03376516|17254104|P1|Overall Study|Consent withdrawn|1
5018550|NCT03376516|17254104|P1|Overall Study|Not treated|1
5018551|NCT03374995|17254174|P2|Overall Study|Withdrawal by Subject|1
5018552|NCT03374995|17254175|P1|Overall Study|Withdrawal by Subject|0
5018553|NCT03374488|17254189|P2|Overall Study|On-going at clinical cut off date|28
5018554|NCT03374488|17254190|P1|Overall Study|On-going at clinical cut off date|30
5018555|NCT03374488|17254189|P2|Overall Study|Withdrawal by Subject|1
5018556|NCT03374488|17254190|P1|Overall Study|Withdrawal by Subject|1
5018557|NCT03374488|17254189|P2|Overall Study|Death|8
5018558|NCT03374488|17254190|P1|Overall Study|Death|10
5018559|NCT03374189|17254202|P2|Overall Study|Lost to Follow-up|0
5018560|NCT03374189|17254203|P1|Overall Study|Lost to Follow-up|1
5018561|NCT03372603|17254316|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
5018562|NCT03372603|17254317|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
5018563|NCT03372603|17254316|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
5018564|NCT03372603|17254317|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
5018565|NCT03372551|17254359|P2|First Intervention (1 Week)|Withdrawal by Subject|0
5018566|NCT03372551|17254360|P1|First Intervention (1 Week)|Withdrawal by Subject|1
5018567|NCT03372369|17254390|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
5018568|NCT03372369|17254391|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
5018569|NCT03372369|17254390|P2|Qualification Period|Inconsistent Eligibility Results|9
5018570|NCT03372369|17254391|P1|Qualification Period|Inconsistent Eligibility Results|10
5018571|NCT03372369|17254390|P2|Qualification Period|Withdrawal by Subject|13
5018572|NCT03372369|17254391|P1|Qualification Period|Withdrawal by Subject|16
5018573|NCT03372083|17254403|P1|Overall Study|Withdrawal by Subject|1
5018574|NCT03372083|17254403|P1|Overall Study|Physician Decision|1
5018575|NCT03372083|17254403|P1|Overall Study|Adverse Event|3
5018576|NCT03371459|17254435|P2|Washout|Lost to Follow-up|1
5018577|NCT03371459|17254436|P1|Washout|Lost to Follow-up|0
5018578|NCT03371381|17254444|P1|Overall Study|Other|4
5018579|NCT03371381|17254444|P1|Overall Study|Study terminated by sponsor|3
5018580|NCT03371381|17254444|P1|Overall Study|Death|5
5018581|NCT03370419|17254465|P1|Overall Study|Lost to Follow-up|16
5018582|NCT03370302|17254475|P6|Dose Expansion Phase|Progressive Disease|0
5018583|NCT03370302|17254476|P5|Dose Expansion Phase|Progressive Disease|0
5018584|NCT03370302|17254477|P4|Dose Expansion Phase|Progressive Disease|6
5018585|NCT03370302|17254478|P3|Dose Expansion Phase|Progressive Disease|0
5018586|NCT03370302|17254479|P2|Dose Expansion Phase|Progressive Disease|0
5018587|NCT03370302|17254480|P1|Dose Expansion Phase|Progressive Disease|0
5018588|NCT03370302|17254475|P6|Dose Escalation Phase|Progressive Disease|1
5018589|NCT03370302|17254476|P5|Dose Escalation Phase|Progressive Disease|3
5018590|NCT03370302|17254477|P4|Dose Escalation Phase|Progressive Disease|0
5018591|NCT03370302|17254478|P3|Dose Escalation Phase|Progressive Disease|2
5018592|NCT03370302|17254479|P2|Dose Escalation Phase|Progressive Disease|4
5018593|NCT03370302|17254480|P1|Dose Escalation Phase|Progressive Disease|2
5018594|NCT03370302|17254475|P6|Dose Escalation Phase|Adverse Event|0
5018595|NCT03370302|17254476|P5|Dose Escalation Phase|Adverse Event|0
5018596|NCT03370302|17254477|P4|Dose Escalation Phase|Adverse Event|0
5018597|NCT03370302|17254478|P3|Dose Escalation Phase|Adverse Event|2
5018598|NCT03370302|17254479|P2|Dose Escalation Phase|Adverse Event|0
5018599|NCT03370302|17254480|P1|Dose Escalation Phase|Adverse Event|1
5018600|NCT03370302|17254475|P6|Dose Escalation Phase|Withdrawal by Subject|2
5018601|NCT03370302|17254476|P5|Dose Escalation Phase|Withdrawal by Subject|0
5018602|NCT03370302|17254477|P4|Dose Escalation Phase|Withdrawal by Subject|0
5018603|NCT03370302|17254478|P3|Dose Escalation Phase|Withdrawal by Subject|2
5018604|NCT03370302|17254479|P2|Dose Escalation Phase|Withdrawal by Subject|1
5018605|NCT03370302|17254480|P1|Dose Escalation Phase|Withdrawal by Subject|0
5018606|NCT03370302|17254475|P6|Dose Escalation Phase|Other|0
5018607|NCT03370302|17254476|P5|Dose Escalation Phase|Other|0
5018608|NCT03370302|17254477|P4|Dose Escalation Phase|Other|0
5018609|NCT03370302|17254478|P3|Dose Escalation Phase|Other|1
5018610|NCT03370302|17254479|P2|Dose Escalation Phase|Other|1
5018611|NCT03370302|17254480|P1|Dose Escalation Phase|Other|0
5018612|NCT03370289|17254577|P1|Overall Study|Sample Size Sufficient|4
5018613|NCT03370289|17254577|P1|Overall Study|Screen Failure|1
5018614|NCT03369951|17254611|P1|Overall Study|Protocol Violation|1
5018615|NCT03369951|17254611|P1|Overall Study|Lost to Follow-up|1
5018616|NCT03369951|17254611|P1|Overall Study|Death|1
5018617|NCT03369951|17254611|P1|Overall Study|Withdrawal by Subject|3
5018618|NCT03369704|17254638|P2|Follow-up Epoch|Lost to Follow-up|0
5018619|NCT03369704|17254639|P1|Follow-up Epoch|Lost to Follow-up|1
5018620|NCT03369704|17254638|P2|Treatment Epoch|Adverse Event|0
5018621|NCT03369704|17254639|P1|Treatment Epoch|Adverse Event|2
5018622|NCT03369704|17254638|P2|Treatment Epoch|Lack of Efficacy|2
5018623|NCT03369704|17254639|P1|Treatment Epoch|Lack of Efficacy|0
5018624|NCT03369704|17254638|P2|Treatment Epoch|Lost to Follow-up|1
5018625|NCT03369704|17254639|P1|Treatment Epoch|Lost to Follow-up|0
5018626|NCT03369704|17254638|P2|Treatment Epoch|Protocol Violation|0
5018627|NCT03369704|17254639|P1|Treatment Epoch|Protocol Violation|1
5018628|NCT03369704|17254638|P2|Treatment Epoch|technical problems|0
5018629|NCT03369704|17254639|P1|Treatment Epoch|technical problems|1
5018630|NCT03369418|17254674|P2|Overall Study|Withdrawal by Subject|3
5018631|NCT03369418|17254675|P1|Overall Study|Withdrawal by Subject|3
5018632|NCT03368807|17254810|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
5018633|NCT03368807|17254810|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
5018634|NCT03368807|17254810|P1|Period 1 (Blinded CGM)|Protocol Violation|1
5018635|NCT03368807|17254810|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
5018636|NCT03368170|17254860|P2|Overall Study|Adverse Event|1
5018637|NCT03368170|17254861|P1|Overall Study|Adverse Event|2
5018638|NCT03365934|17254893|P1|Overall Study|Withdrawal by Subject|1
5018639|NCT03365934|17254893|P1|Overall Study|Adverse Event|1
5018640|NCT03365011|17255183|P2|Overall Study|Withdrawal by Subject|2
5018641|NCT03365011|17255184|P1|Overall Study|Withdrawal by Subject|1
5018642|NCT03364608|17255194|P1|Overall Study|Lost to Follow-up|2
5018643|NCT03364608|17255194|P1|Overall Study|Protocol Violation|2
5018644|NCT03364608|17255194|P1|Overall Study|Withdrawal by Subject|4
5018645|NCT03364335|17255221|P5|Overall Study|Lost to Follow-up|11
5018646|NCT03364335|17255222|P4|Overall Study|Lost to Follow-up|11
5018647|NCT03364335|17255223|P3|Overall Study|Lost to Follow-up|10
5018648|NCT03364335|17255224|P2|Overall Study|Lost to Follow-up|7
5018649|NCT03364335|17255225|P1|Overall Study|Lost to Follow-up|7
5018650|NCT03364335|17255221|P5|Overall Study|Adverse Event|0
5018651|NCT03364335|17255222|P4|Overall Study|Adverse Event|2
5018652|NCT03364335|17255223|P3|Overall Study|Adverse Event|1
5018653|NCT03364335|17255224|P2|Overall Study|Adverse Event|4
5018654|NCT03364335|17255225|P1|Overall Study|Adverse Event|3
5018655|NCT03364023|17255297|P1|Overall Study|Death|14
5018656|NCT03364023|17255297|P1|Overall Study|Lost to Follow-up|3
5018657|NCT03363906|17255304|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
5018658|NCT03363906|17255305|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
5018659|NCT03363906|17255304|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
5018660|NCT03363906|17255305|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
5018661|NCT03363906|17255304|P2|Period 2 (Test or Reference)|Adverse Event|0
5018662|NCT03363906|17255305|P1|Period 2 (Test or Reference)|Adverse Event|2
5018663|NCT03363906|17255304|P2|Period 1 (Reference or Test)|Adverse Event|2
5018664|NCT03363906|17255305|P1|Period 1 (Reference or Test)|Adverse Event|1
5018665|NCT03361865|17255375|P2|Overall Study|On-going at clinical cut off date|39
5018666|NCT03361865|17255376|P1|Overall Study|On-going at clinical cut off date|29
5018667|NCT03361865|17255375|P2|Overall Study|Physician Decision|0
5018668|NCT03361865|17255376|P1|Overall Study|Physician Decision|1
5018669|NCT03361865|17255375|P2|Overall Study|Death|10
5018670|NCT03361865|17255376|P1|Overall Study|Death|13
5018671|NCT03361605|17255386|P1|Overall Study|Analyzable data not available|3
5018672|NCT03361228|17255393|P2|Overall Study|Death|0
5018673|NCT03361228|17255394|P1|Overall Study|Death|3
5018674|NCT03361228|17255393|P2|Overall Study|Other|1
5018675|NCT03361228|17255394|P1|Overall Study|Other|1
5018676|NCT03361176|17255416|P2|Overall Study|Withdrawal by Subject|1
5018677|NCT03361176|17255417|P1|Overall Study|Withdrawal by Subject|0
5018678|NCT03361176|17255416|P2|Overall Study|Adverse Event|2
5018679|NCT03361176|17255417|P1|Overall Study|Adverse Event|0
5018680|NCT03361176|17255416|P2|Overall Study|Lost to Follow-up|2
5018681|NCT03361176|17255417|P1|Overall Study|Lost to Follow-up|1
5018682|NCT03360344|17255451|P3|Overall Study|Withdrawal by Subject|1
5018683|NCT03360344|17255452|P2|Overall Study|Withdrawal by Subject|1
5018684|NCT03360344|17255453|P1|Overall Study|Withdrawal by Subject|0
5018685|NCT03360071|17255516|P2|Overall Study|Lost to Follow-up|0
5018686|NCT03360071|17255517|P1|Overall Study|Lost to Follow-up|1
5018687|NCT03359850|17255531|P2|Extension Phase (Up to 18 Months)|Ongoing in the study|1
5018688|NCT03359850|17255532|P1|Extension Phase (Up to 18 Months)|Ongoing in the study|1
5018689|NCT03359850|17255531|P2|Extension Phase (Up to 18 Months)|Disease Progression|0
5018690|NCT03359850|17255532|P1|Extension Phase (Up to 18 Months)|Disease Progression|5
5018691|NCT03359850|17255531|P2|Extension Phase (Up to 18 Months)|Withdrawal by Subject|2
5018692|NCT03359850|17255532|P1|Extension Phase (Up to 18 Months)|Withdrawal by Subject|0
5018693|NCT03359850|17255531|P2|Extension Phase (Up to 18 Months)|Death|4
5018694|NCT03359850|17255532|P1|Extension Phase (Up to 18 Months)|Death|2
5018695|NCT03359850|17255531|P2|PK Phase (Up to Day 8)|Adverse Event|0
5018696|NCT03359850|17255532|P1|PK Phase (Up to Day 8)|Adverse Event|1
5018697|NCT03359850|17255531|P2|PK Phase (Up to Day 8)|Physician Decision|1
5018698|NCT03359850|17255532|P1|PK Phase (Up to Day 8)|Physician Decision|0
5018699|NCT03359473|17255615|P4|Overall Study|Protocol-defined stopping criteria|1
5018700|NCT03359473|17255616|P3|Overall Study|Protocol-defined stopping criteria|0
5018701|NCT03359473|17255617|P2|Overall Study|Protocol-defined stopping criteria|0
5018702|NCT03359473|17255618|P1|Overall Study|Protocol-defined stopping criteria|1
5018703|NCT03359473|17255615|P4|Overall Study|Withdrawal by Subject|0
5018704|NCT03359473|17255616|P3|Overall Study|Withdrawal by Subject|1
5018705|NCT03359473|17255617|P2|Overall Study|Withdrawal by Subject|2
5018706|NCT03359473|17255618|P1|Overall Study|Withdrawal by Subject|1
5018707|NCT03359473|17255615|P4|Overall Study|Physician Decision|1
5018708|NCT03359473|17255616|P3|Overall Study|Physician Decision|0
5018709|NCT03359473|17255617|P2|Overall Study|Physician Decision|1
5018710|NCT03359473|17255618|P1|Overall Study|Physician Decision|0
5018711|NCT03359473|17255615|P4|Overall Study|Lost to Follow-up|0
5018712|NCT03359473|17255616|P3|Overall Study|Lost to Follow-up|0
5018713|NCT03359473|17255617|P2|Overall Study|Lost to Follow-up|1
5018714|NCT03359473|17255618|P1|Overall Study|Lost to Follow-up|0
5018715|NCT03359473|17255615|P4|Overall Study|Adverse Event|3
5018716|NCT03359473|17255616|P3|Overall Study|Adverse Event|5
5018717|NCT03359473|17255617|P2|Overall Study|Adverse Event|2
5018718|NCT03359473|17255618|P1|Overall Study|Adverse Event|0
5018719|NCT03358472|17255831|P3|Overall Study|On-going at clinical cut off date|5
5018720|NCT03358472|17255832|P2|Overall Study|On-going at clinical cut off date|6
5018721|NCT03358472|17255833|P1|Overall Study|On-going at clinical cut off date|9
5018722|NCT03358472|17255831|P3|Overall Study|Withdrawal by Subject|1
5018723|NCT03358472|17255832|P2|Overall Study|Withdrawal by Subject|0
5018724|NCT03358472|17255833|P1|Overall Study|Withdrawal by Subject|0
5018725|NCT03358472|17255831|P3|Overall Study|Physician Decision|0
5018726|NCT03358472|17255832|P2|Overall Study|Physician Decision|1
5018727|NCT03358472|17255833|P1|Overall Study|Physician Decision|0
5018728|NCT03358472|17255831|P3|Overall Study|Death|10
5018729|NCT03358472|17255832|P2|Overall Study|Death|3
5018730|NCT03358472|17255833|P1|Overall Study|Death|6
5018731|NCT03358407|17255857|P10|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018732|NCT03358407|17255858|P9|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018733|NCT03358407|17255859|P8|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
5018734|NCT03358407|17255860|P7|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
5018735|NCT03358407|17255861|P6|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
5018736|NCT03358407|17255862|P5|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018737|NCT03358407|17255863|P4|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018738|NCT03358407|17255864|P3|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018739|NCT03358407|17255865|P2|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018740|NCT03358407|17255866|P1|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5018741|NCT03358407|17255857|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018742|NCT03358407|17255858|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018743|NCT03358407|17255859|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018744|NCT03358407|17255860|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
5018745|NCT03358407|17255861|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
5018746|NCT03358407|17255862|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018747|NCT03358407|17255863|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018748|NCT03358407|17255864|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018749|NCT03358407|17255865|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018750|NCT03358407|17255866|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5018751|NCT03358407|17255857|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018752|NCT03358407|17255858|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018753|NCT03358407|17255859|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
5018754|NCT03358407|17255860|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018755|NCT03358407|17255861|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
5018756|NCT03358407|17255862|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018757|NCT03358407|17255863|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018758|NCT03358407|17255864|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018759|NCT03358407|17255865|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018760|NCT03358407|17255866|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5018761|NCT03358407|17255857|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018762|NCT03358407|17255858|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018763|NCT03358407|17255859|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
5018764|NCT03358407|17255860|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018765|NCT03358407|17255861|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
5018766|NCT03358407|17255862|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018767|NCT03358407|17255863|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018768|NCT03358407|17255864|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018769|NCT03358407|17255865|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018770|NCT03358407|17255866|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5018771|NCT03358407|17255857|P10|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018772|NCT03358407|17255858|P9|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018773|NCT03358407|17255859|P8|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018774|NCT03358407|17255860|P7|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018775|NCT03358407|17255861|P6|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018776|NCT03358407|17255862|P5|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
5018777|NCT03358407|17255863|P4|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018778|NCT03358407|17255864|P3|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018779|NCT03358407|17255865|P2|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018780|NCT03358407|17255866|P1|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5018781|NCT03358407|17255857|P10|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018782|NCT03358407|17255858|P9|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018783|NCT03358407|17255859|P8|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018784|NCT03358407|17255860|P7|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018785|NCT03358407|17255861|P6|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018786|NCT03358407|17255862|P5|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018787|NCT03358407|17255863|P4|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018788|NCT03358407|17255864|P3|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
5018789|NCT03358407|17255865|P2|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018790|NCT03358407|17255866|P1|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5018791|NCT03358329|17256143|P1|Overall Study|Withdrawal by Subject|2
5018792|NCT03358329|17256143|P1|Overall Study|Lost to Follow-up|2
5018793|NCT03358238|17256174|P2|Overall Study|Withdrawal by Subject|1
5018794|NCT03358238|17256175|P1|Overall Study|Withdrawal by Subject|0
5018795|NCT03358147|17256195|P5|Overall Study|Lack of Efficacy|0
5018796|NCT03358147|17256196|P4|Overall Study|Lack of Efficacy|0
5018797|NCT03358147|17256197|P3|Overall Study|Lack of Efficacy|1
5018798|NCT03358147|17256198|P2|Overall Study|Lack of Efficacy|1
5018799|NCT03358147|17256199|P1|Overall Study|Lack of Efficacy|0
5018800|NCT03358147|17256195|P5|Overall Study|Administrative reasons|0
5018801|NCT03358147|17256196|P4|Overall Study|Administrative reasons|3
5018802|NCT03358147|17256197|P3|Overall Study|Administrative reasons|0
5018803|NCT03358147|17256198|P2|Overall Study|Administrative reasons|1
5018804|NCT03358147|17256199|P1|Overall Study|Administrative reasons|0
5018805|NCT03358147|17256195|P5|Overall Study|Physician Decision|1
5018806|NCT03358147|17256196|P4|Overall Study|Physician Decision|6
5018807|NCT03358147|17256197|P3|Overall Study|Physician Decision|1
5018808|NCT03358147|17256198|P2|Overall Study|Physician Decision|0
5018809|NCT03358147|17256199|P1|Overall Study|Physician Decision|1
5018810|NCT03358147|17256195|P5|Overall Study|Protocol specified criteria|1
5018811|NCT03358147|17256196|P4|Overall Study|Protocol specified criteria|3
5018812|NCT03358147|17256197|P3|Overall Study|Protocol specified criteria|0
5018813|NCT03358147|17256198|P2|Overall Study|Protocol specified criteria|3
5018814|NCT03358147|17256199|P1|Overall Study|Protocol specified criteria|2
5018815|NCT03358147|17256195|P5|Overall Study|Major Protocol Deviation|1
5018816|NCT03358147|17256196|P4|Overall Study|Major Protocol Deviation|3
5018817|NCT03358147|17256197|P3|Overall Study|Major Protocol Deviation|2
5018818|NCT03358147|17256198|P2|Overall Study|Major Protocol Deviation|3
5018819|NCT03358147|17256199|P1|Overall Study|Major Protocol Deviation|11
5018820|NCT03358147|17256195|P5|Overall Study|Lost to Follow-up|4
5018821|NCT03358147|17256196|P4|Overall Study|Lost to Follow-up|6
5018822|NCT03358147|17256197|P3|Overall Study|Lost to Follow-up|7
5018823|NCT03358147|17256198|P2|Overall Study|Lost to Follow-up|3
5018824|NCT03358147|17256199|P1|Overall Study|Lost to Follow-up|4
5018825|NCT03358147|17256195|P5|Overall Study|Adverse Event|2
5018826|NCT03358147|17256196|P4|Overall Study|Adverse Event|5
5018827|NCT03358147|17256197|P3|Overall Study|Adverse Event|7
5018828|NCT03358147|17256198|P2|Overall Study|Adverse Event|9
5018829|NCT03358147|17256199|P1|Overall Study|Adverse Event|3
5018830|NCT03358147|17256195|P5|Overall Study|Withdrawal by Subject|5
5018831|NCT03358147|17256196|P4|Overall Study|Withdrawal by Subject|10
5018832|NCT03358147|17256197|P3|Overall Study|Withdrawal by Subject|16
5018833|NCT03358147|17256198|P2|Overall Study|Withdrawal by Subject|19
5018834|NCT03358147|17256199|P1|Overall Study|Withdrawal by Subject|13
5018835|NCT03357952|17256238|P2|Overall Study|Sponsor Decision|0
5018836|NCT03357952|17256239|P1|Overall Study|Sponsor Decision|9
5018837|NCT03357952|17256238|P2|Overall Study|Withdrawal by Subject|1
5018838|NCT03357952|17256239|P1|Overall Study|Withdrawal by Subject|0
5018839|NCT03357731|17256246|P6|Overall Study|Lost to Follow-up|0
5018840|NCT03357731|17256247|P5|Overall Study|Lost to Follow-up|0
5018841|NCT03357731|17256248|P4|Overall Study|Lost to Follow-up|1
5018842|NCT03357731|17256249|P3|Overall Study|Lost to Follow-up|0
5018843|NCT03357731|17256250|P2|Overall Study|Lost to Follow-up|0
5018844|NCT03357731|17256251|P1|Overall Study|Lost to Follow-up|0
5018845|NCT03357731|17256246|P6|Overall Study|Hypotension|0
5018846|NCT03357731|17256247|P5|Overall Study|Hypotension|0
5018847|NCT03357731|17256248|P4|Overall Study|Hypotension|1
5018848|NCT03357731|17256249|P3|Overall Study|Hypotension|1
5018849|NCT03357731|17256250|P2|Overall Study|Hypotension|0
5018850|NCT03357731|17256251|P1|Overall Study|Hypotension|0
5018851|NCT03357731|17256246|P6|Overall Study|Adverse Event|1
5018852|NCT03357731|17256247|P5|Overall Study|Adverse Event|0
5018853|NCT03357731|17256248|P4|Overall Study|Adverse Event|0
5018854|NCT03357731|17256249|P3|Overall Study|Adverse Event|0
5018855|NCT03357731|17256250|P2|Overall Study|Adverse Event|0
5018856|NCT03357731|17256251|P1|Overall Study|Adverse Event|0
5018857|NCT03357731|17256246|P6|Overall Study|Acute bradycardia and hypotension|0
5018858|NCT03357731|17256247|P5|Overall Study|Acute bradycardia and hypotension|0
5018859|NCT03357731|17256248|P4|Overall Study|Acute bradycardia and hypotension|1
5018860|NCT03357731|17256249|P3|Overall Study|Acute bradycardia and hypotension|0
5018861|NCT03357731|17256250|P2|Overall Study|Acute bradycardia and hypotension|0
5018862|NCT03357731|17256251|P1|Overall Study|Acute bradycardia and hypotension|0
5018863|NCT03357731|17256246|P6|Overall Study|Withdrew consent due to personal reasons|0
5018864|NCT03357731|17256247|P5|Overall Study|Withdrew consent due to personal reasons|1
5018865|NCT03357731|17256248|P4|Overall Study|Withdrew consent due to personal reasons|0
5018866|NCT03357731|17256249|P3|Overall Study|Withdrew consent due to personal reasons|0
5018867|NCT03357731|17256250|P2|Overall Study|Withdrew consent due to personal reasons|0
5018868|NCT03357731|17256251|P1|Overall Study|Withdrew consent due to personal reasons|0
5018869|NCT03357471|17256279|P2|Overall Study|Lost to Follow-up|0
5018870|NCT03357471|17256280|P1|Overall Study|Lost to Follow-up|1
5018871|NCT03357471|17256279|P2|Overall Study|Adverse Event|0
5018872|NCT03357471|17256280|P1|Overall Study|Adverse Event|1
5018873|NCT03357341|17256306|P2|Overall Study|Death|1
5018874|NCT03357341|17256307|P1|Overall Study|Death|0
5018875|NCT03357341|17256306|P2|Overall Study|Lost to Follow-up|5
5018876|NCT03357341|17256307|P1|Overall Study|Lost to Follow-up|4
5018877|NCT03357341|17256306|P2|Overall Study|Withdrawal by Subject|6
5018878|NCT03357341|17256307|P1|Overall Study|Withdrawal by Subject|3
5018879|NCT03356977|17256347|P1|Overall Study|Withdrawal by parent/guardian|2
5018880|NCT03356977|17256347|P1|Overall Study|Lost to Follow-up|3
5018881|NCT03354663|17256395|P1|Completed 30-day Visit|Missed Visit|1
5018882|NCT03354663|17256395|P1|Completed 30-day Visit|Withdrawal by Subject|1
5018883|NCT03354663|17256395|P1|Enrollment to Catheter Insertion|Adverse Event|1
5018884|NCT03354663|17256395|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
5018885|NCT03354637|17256422|P3|Open Label Extension|Physician Decision|1
5018886|NCT03354637|17256423|P2|Open Label Extension|Physician Decision|0
5018887|NCT03354637|17256424|P1|Open Label Extension|Physician Decision|0
5018888|NCT03354637|17256422|P3|Open Label Extension|Lack of Efficacy|1
5018889|NCT03354637|17256423|P2|Open Label Extension|Lack of Efficacy|0
5018890|NCT03354637|17256424|P1|Open Label Extension|Lack of Efficacy|0
5018891|NCT03354637|17256422|P3|Open Label Extension|Subject Noncompliance|1
5018892|NCT03354637|17256423|P2|Open Label Extension|Subject Noncompliance|0
5018893|NCT03354637|17256424|P1|Open Label Extension|Subject Noncompliance|0
5018894|NCT03354637|17256422|P3|Open Label Extension|Study Terminated by Sponsor|17
5018895|NCT03354637|17256423|P2|Open Label Extension|Study Terminated by Sponsor|0
5018896|NCT03354637|17256424|P1|Open Label Extension|Study Terminated by Sponsor|0
5018897|NCT03354637|17256422|P3|Open Label Extension|Withdrawal by Subject|5
5018898|NCT03354637|17256423|P2|Open Label Extension|Withdrawal by Subject|0
5018899|NCT03354637|17256424|P1|Open Label Extension|Withdrawal by Subject|0
5018900|NCT03354637|17256422|P3|Open Label Extension|Lost to Follow-up|2
5018901|NCT03354637|17256423|P2|Open Label Extension|Lost to Follow-up|0
5018902|NCT03354637|17256424|P1|Open Label Extension|Lost to Follow-up|0
5018903|NCT03354637|17256422|P3|Open Label Extension|Adverse Event|1
5018904|NCT03354637|17256423|P2|Open Label Extension|Adverse Event|0
5018905|NCT03354637|17256424|P1|Open Label Extension|Adverse Event|0
5018906|NCT03354637|17256422|P3|Double-blind Period|Incomplete Efficacy Data Collection|0
5018907|NCT03354637|17256423|P2|Double-blind Period|Incomplete Efficacy Data Collection|1
5018908|NCT03354637|17256424|P1|Double-blind Period|Incomplete Efficacy Data Collection|1
5018909|NCT03354637|17256422|P3|Double-blind Period|Withdrawal by Subject|4
5018910|NCT03354637|17256423|P2|Double-blind Period|Withdrawal by Subject|6
5018911|NCT03354637|17256424|P1|Double-blind Period|Withdrawal by Subject|10
5018912|NCT03354637|17256422|P3|Double-blind Period|Lost to Follow-up|3
5018913|NCT03354637|17256423|P2|Double-blind Period|Lost to Follow-up|4
5018914|NCT03354637|17256424|P1|Double-blind Period|Lost to Follow-up|3
5018915|NCT03354637|17256422|P3|Double-blind Period|Adverse Event|0
5018916|NCT03354637|17256423|P2|Double-blind Period|Adverse Event|2
5018917|NCT03354637|17256424|P1|Double-blind Period|Adverse Event|1
5018918|NCT03354637|17256422|P3|Double-blind Period|Protocol Violation|0
5018919|NCT03354637|17256423|P2|Double-blind Period|Protocol Violation|0
5018920|NCT03354637|17256424|P1|Double-blind Period|Protocol Violation|2
5018921|NCT03353922|17256514|P6|Overall Study|Adverse Event|0
5018922|NCT03353922|17256515|P5|Overall Study|Adverse Event|0
5018923|NCT03353922|17256516|P4|Overall Study|Adverse Event|0
5018924|NCT03353922|17256517|P3|Overall Study|Adverse Event|0
5018925|NCT03353922|17256518|P2|Overall Study|Adverse Event|1
5018926|NCT03353922|17256519|P1|Overall Study|Adverse Event|0
5018927|NCT03353922|17256514|P6|Overall Study|Withdrawal by Subject|0
5018928|NCT03353922|17256515|P5|Overall Study|Withdrawal by Subject|0
5018929|NCT03353922|17256516|P4|Overall Study|Withdrawal by Subject|1
5018930|NCT03353922|17256517|P3|Overall Study|Withdrawal by Subject|1
5018931|NCT03353922|17256518|P2|Overall Study|Withdrawal by Subject|0
5018932|NCT03353922|17256519|P1|Overall Study|Withdrawal by Subject|1
5018933|NCT03352713|17256561|P1|Overall Study|Device incompatible/stolen|5
5018934|NCT03352713|17256561|P1|Overall Study|Completed 0 EMAs|8
5018935|NCT03352713|17256561|P1|Overall Study|Withdrawn by investigator|5
5018936|NCT03352713|17256561|P1|Overall Study|Lost to Follow-up|8
5018937|NCT03352453|17256582|P2|Overall Study|Adverse Event|9
5018938|NCT03352453|17256583|P1|Overall Study|Adverse Event|2
5018939|NCT03352453|17256582|P2|Overall Study|Lost to Follow-up|6
5018940|NCT03352453|17256583|P1|Overall Study|Lost to Follow-up|7
5018941|NCT03352453|17256582|P2|Overall Study|Protocol Deviation|0
5018942|NCT03352453|17256583|P1|Overall Study|Protocol Deviation|1
5018943|NCT03352453|17256582|P2|Overall Study|Study Terminated by Sponsor|1
5018944|NCT03352453|17256583|P1|Overall Study|Study Terminated by Sponsor|2
5018945|NCT03352453|17256582|P2|Overall Study|Withdrawal by Subject|14
5018946|NCT03352453|17256583|P1|Overall Study|Withdrawal by Subject|8
5018947|NCT03352453|17256582|P2|Overall Study|Lack of Efficacy|0
5018948|NCT03352453|17256583|P1|Overall Study|Lack of Efficacy|1
5018949|NCT03352453|17256582|P2|Overall Study|Miscellaneous Reasons|2
5018950|NCT03352453|17256583|P1|Overall Study|Miscellaneous Reasons|1
5018951|NCT03351738|17256605|P6|Overall Study|Withdrawal by Subject|0
5018952|NCT03351738|17256606|P5|Overall Study|Withdrawal by Subject|0
5018953|NCT03351738|17256607|P4|Overall Study|Withdrawal by Subject|1
5018954|NCT03351738|17256608|P3|Overall Study|Withdrawal by Subject|0
5018955|NCT03351738|17256609|P2|Overall Study|Withdrawal by Subject|1
5018956|NCT03351738|17256610|P1|Overall Study|Withdrawal by Subject|0
5018957|NCT03351335|17256762|P3|Overall Study|Failure to maintain inclusion/exclusion|4
5018958|NCT03351335|17256763|P2|Overall Study|Failure to maintain inclusion/exclusion|0
5018959|NCT03351335|17256764|P1|Overall Study|Failure to maintain inclusion/exclusion|0
5018960|NCT03351231|17256784|P1|Safety Follow-Up Period|Other reason|2
5018961|NCT03351231|17256784|P1|Safety Follow-Up Period|Participant withdrew consent|1
5018962|NCT03351231|17256784|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
5018963|NCT03351231|17256784|P1|Combination Therapy Period|Study drug toxicity|1
5018964|NCT03351231|17256784|P1|Combination Therapy Period|Disease progression|2
5018965|NCT03351231|17256784|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
5018966|NCT03350984|17256819|P2|Overall Study|Physician Decision|0
5018967|NCT03350984|17256820|P1|Overall Study|Physician Decision|1
5018968|NCT03350984|17256819|P2|Overall Study|Protocol Violation|2
5018969|NCT03350984|17256820|P1|Overall Study|Protocol Violation|1
5018970|NCT03350984|17256819|P2|Overall Study|Lost to Follow-up|6
5018971|NCT03350984|17256820|P1|Overall Study|Lost to Follow-up|5
5018972|NCT03350984|17256819|P2|Overall Study|Death|0
5018973|NCT03350984|17256820|P1|Overall Study|Death|1
5018974|NCT03350503|17256887|P1|Overall Study|Subject Wishes|2
5018975|NCT03350503|17256887|P1|Overall Study|Hospital Transfer or Removal|2
5018976|NCT03350503|17256887|P1|Overall Study|Adverse Event|1
5018977|NCT03350256|17256891|P1|Overall Study|Lack of Efficacy|2
5018978|NCT03350256|17256891|P1|Overall Study|Lost to Follow-up|1
5018979|NCT03350256|17256891|P1|Overall Study|Subject moving out of state|1
5018980|NCT03350256|17256891|P1|Overall Study|Withdrawal by Subject|3
5018981|NCT03350256|17256891|P1|Overall Study|Did not proceed to permanent implant|3
5018982|NCT03350256|17256891|P1|Overall Study|Trial failure|12
5018983|NCT03350256|17256891|P1|Overall Study|Adverse Event|2
5018984|NCT03350256|17256891|P1|Overall Study|Denial by insurance|1
5018985|NCT03350256|17256891|P1|Overall Study|Non compliance|2
5018986|NCT03350256|17256891|P1|Overall Study|Protocol Violation|3
5018987|NCT03350256|17256891|P1|Overall Study|Recommended for other therapies|2
5018988|NCT03350256|17256891|P1|Overall Study|Inclusion/exclusion violation|4
5018989|NCT03349515|17256965|P2|Overall Study|Physician Decision|1
5018990|NCT03349515|17256966|P1|Overall Study|Physician Decision|3
5018991|NCT03349515|17256965|P2|Overall Study|Lack of Efficacy|0
5018992|NCT03349515|17256966|P1|Overall Study|Lack of Efficacy|2
5018993|NCT03349437|17256972|P3|Screening|Withdrawn|0
5018994|NCT03349437|17256973|P2|Screening|Withdrawn|0
5018995|NCT03349437|17256974|P1|Screening|Withdrawn|1
5018996|NCT03349437|17256972|P3|Screening|Screen Fail|0
5018997|NCT03349437|17256973|P2|Screening|Screen Fail|0
5018998|NCT03349437|17256974|P1|Screening|Screen Fail|4
5018999|NCT03349333|17256981|P1|Overall Study|Patients in treatment less than 24 month|8
5019000|NCT03349333|17256981|P1|Overall Study|3-week lapse between pralatrexate doses|1
5019001|NCT03349333|17256981|P1|Overall Study|Physician Decision|2
5019002|NCT03349333|17256981|P1|Overall Study|Conditions interfere with participation|2
5019003|NCT03349333|17256981|P1|Overall Study|Withdrawal by Subject|5
5019004|NCT03349333|17256981|P1|Overall Study|Other|6
5019005|NCT03349333|17256981|P1|Overall Study|Adverse Event|11
5019006|NCT03349333|17256981|P1|Overall Study|Progression of Disease|36
5019007|NCT03349099|17257004|P2|Overall Study|Stone migrated from the kidney|0
5019008|NCT03349099|17257005|P1|Overall Study|Stone migrated from the kidney|1
5019009|NCT03349099|17257004|P2|Overall Study|Physician Decision|4
5019010|NCT03349099|17257005|P1|Overall Study|Physician Decision|3
5019011|NCT03349060|17257018|P3|Overall Study|Other|0
5019012|NCT03349060|17257019|P2|Overall Study|Other|1
5019013|NCT03349060|17257020|P1|Overall Study|Other|2
5019014|NCT03349060|17257018|P3|Overall Study|Withdrawal By Parent/Guardian|0
5019015|NCT03349060|17257019|P2|Overall Study|Withdrawal By Parent/Guardian|1
5019016|NCT03349060|17257020|P1|Overall Study|Withdrawal By Parent/Guardian|0
5019017|NCT03349060|17257018|P3|Overall Study|Medication error,no linked adverse event|1
5019018|NCT03349060|17257019|P2|Overall Study|Medication error,no linked adverse event|0
5019019|NCT03349060|17257020|P1|Overall Study|Medication error,no linked adverse event|0
5019020|NCT03349060|17257018|P3|Overall Study|Withdrawal by Subject|4
5019021|NCT03349060|17257019|P2|Overall Study|Withdrawal by Subject|3
5019022|NCT03349060|17257020|P1|Overall Study|Withdrawal by Subject|5
5019023|NCT03349060|17257018|P3|Overall Study|Protocol Violation|1
5019024|NCT03349060|17257019|P2|Overall Study|Protocol Violation|2
5019025|NCT03349060|17257020|P1|Overall Study|Protocol Violation|2
5019026|NCT03349060|17257018|P3|Overall Study|Lost to Follow-up|1
5019027|NCT03349060|17257019|P2|Overall Study|Lost to Follow-up|1
5019028|NCT03349060|17257020|P1|Overall Study|Lost to Follow-up|2
5019029|NCT03349060|17257018|P3|Overall Study|Lack of Efficacy|2
5019030|NCT03349060|17257019|P2|Overall Study|Lack of Efficacy|0
5019031|NCT03349060|17257020|P1|Overall Study|Lack of Efficacy|1
5019032|NCT03349060|17257018|P3|Overall Study|Adverse Event|7
5019033|NCT03349060|17257019|P2|Overall Study|Adverse Event|9
5019034|NCT03349060|17257020|P1|Overall Study|Adverse Event|9
5019035|NCT03349034|17257161|P2|Overall Study|Other|1
5019036|NCT03349034|17257162|P1|Overall Study|Other|0
5019037|NCT03349034|17257161|P2|Overall Study|soft tissue flap used|0
5019038|NCT03349034|17257162|P1|Overall Study|soft tissue flap used|1
5019039|NCT03349034|17257161|P2|Overall Study|intubated for >48 hrs following surgery|1
5019040|NCT03349034|17257162|P1|Overall Study|intubated for >48 hrs following surgery|1
5019041|NCT03349034|17257161|P2|Overall Study|catheters dislodged during transport|0
5019042|NCT03349034|17257162|P1|Overall Study|catheters dislodged during transport|2
5019043|NCT03348904|17257183|P3|Overall Study|Administrative reason by the sponsor|0
5019044|NCT03348904|17257184|P2|Overall Study|Administrative reason by the sponsor|1
5019045|NCT03348904|17257185|P1|Overall Study|Administrative reason by the sponsor|0
5019046|NCT03346759|17257261|P2|Second Menstrual Cycle|Lost to Follow-up|0
5019047|NCT03346759|17257262|P1|Second Menstrual Cycle|Lost to Follow-up|1
5019048|NCT03346759|17257261|P2|First Menstrual Cycle|Withdrawal by Subject|0
5019049|NCT03346759|17257262|P1|First Menstrual Cycle|Withdrawal by Subject|1
5019050|NCT03346759|17257261|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
5019051|NCT03346759|17257262|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
5019052|NCT03346070|17257307|P5|Overall Study|Screen Failure|1
5019053|NCT03346070|17257308|P4|Overall Study|Screen Failure|1
5019054|NCT03346070|17257309|P3|Overall Study|Screen Failure|0
5019055|NCT03346070|17257310|P2|Overall Study|Screen Failure|0
5019056|NCT03346070|17257311|P1|Overall Study|Screen Failure|0
5019057|NCT03346070|17257307|P5|Overall Study|Study medication not received as planned|2
5019058|NCT03346070|17257308|P4|Overall Study|Study medication not received as planned|3
5019059|NCT03346070|17257309|P3|Overall Study|Study medication not received as planned|2
5019060|NCT03346070|17257310|P2|Overall Study|Study medication not received as planned|3
5019061|NCT03346070|17257311|P1|Overall Study|Study medication not received as planned|2
5019062|NCT03346070|17257307|P5|Overall Study|Withdrawal by Subject|0
5019063|NCT03346070|17257308|P4|Overall Study|Withdrawal by Subject|1
5019064|NCT03346070|17257309|P3|Overall Study|Withdrawal by Subject|0
5019065|NCT03346070|17257310|P2|Overall Study|Withdrawal by Subject|0
5019066|NCT03346070|17257311|P1|Overall Study|Withdrawal by Subject|1
5019067|NCT03346070|17257307|P5|Overall Study|Physician Decision|1
5019068|NCT03346070|17257308|P4|Overall Study|Physician Decision|1
5019069|NCT03346070|17257309|P3|Overall Study|Physician Decision|0
5019070|NCT03346070|17257310|P2|Overall Study|Physician Decision|0
5019071|NCT03346070|17257311|P1|Overall Study|Physician Decision|0
5019072|NCT03346070|17257307|P5|Overall Study|Lost to Follow-up|0
5019073|NCT03346070|17257308|P4|Overall Study|Lost to Follow-up|0
5019074|NCT03346070|17257309|P3|Overall Study|Lost to Follow-up|2
5019075|NCT03346070|17257310|P2|Overall Study|Lost to Follow-up|1
5019076|NCT03346070|17257311|P1|Overall Study|Lost to Follow-up|0
5019077|NCT03346070|17257307|P5|Overall Study|Death|1
5019078|NCT03346070|17257308|P4|Overall Study|Death|0
5019079|NCT03346070|17257309|P3|Overall Study|Death|0
5019080|NCT03346070|17257310|P2|Overall Study|Death|0
5019081|NCT03346070|17257311|P1|Overall Study|Death|0
5019082|NCT03346057|17257399|P4|Overall Study|Withdrawal by Subject|0
5019083|NCT03346057|17257400|P3|Overall Study|Withdrawal by Subject|0
5019084|NCT03346057|17257401|P2|Overall Study|Withdrawal by Subject|0
5019085|NCT03346057|17257402|P1|Overall Study|Withdrawal by Subject|1
5019086|NCT03346057|17257399|P4|Overall Study|Randomization Mistake - Not Treated|0
5019087|NCT03346057|17257400|P3|Overall Study|Randomization Mistake - Not Treated|0
5019088|NCT03346057|17257401|P2|Overall Study|Randomization Mistake - Not Treated|1
5019089|NCT03346057|17257402|P1|Overall Study|Randomization Mistake - Not Treated|1
5019090|NCT03346057|17257399|P4|Overall Study|Physician Decision|2
5019091|NCT03346057|17257400|P3|Overall Study|Physician Decision|0
5019092|NCT03346057|17257401|P2|Overall Study|Physician Decision|2
5019093|NCT03346057|17257402|P1|Overall Study|Physician Decision|3
5019094|NCT03346057|17257399|P4|Overall Study|Renal Insufficiency - Not Treated|0
5019095|NCT03346057|17257400|P3|Overall Study|Renal Insufficiency - Not Treated|0
5019096|NCT03346057|17257401|P2|Overall Study|Renal Insufficiency - Not Treated|0
5019097|NCT03346057|17257402|P1|Overall Study|Renal Insufficiency - Not Treated|1
5019098|NCT03346057|17257399|P4|Overall Study|Ineligible For Study - Not Treated|0
5019099|NCT03346057|17257400|P3|Overall Study|Ineligible For Study - Not Treated|0
5019100|NCT03346057|17257401|P2|Overall Study|Ineligible For Study - Not Treated|1
5019101|NCT03346057|17257402|P1|Overall Study|Ineligible For Study - Not Treated|0
5019102|NCT03346057|17257399|P4|Overall Study|Lost to Follow-up|0
5019103|NCT03346057|17257400|P3|Overall Study|Lost to Follow-up|1
5019104|NCT03346057|17257401|P2|Overall Study|Lost to Follow-up|2
5019105|NCT03346057|17257402|P1|Overall Study|Lost to Follow-up|0
5019106|NCT03346057|17257399|P4|Overall Study|Death|0
5019107|NCT03346057|17257400|P3|Overall Study|Death|0
5019108|NCT03346057|17257401|P2|Overall Study|Death|2
5019109|NCT03346057|17257402|P1|Overall Study|Death|1
5019110|NCT03345979|17257434|P2|Overall Study|Physician Decision|2
5019111|NCT03345979|17257435|P1|Overall Study|Physician Decision|0
5019112|NCT03345979|17257434|P2|Overall Study|Protocol Violation|3
5019113|NCT03345979|17257435|P1|Overall Study|Protocol Violation|1
5019114|NCT03345979|17257434|P2|Overall Study|Lack of Efficacy|2
5019115|NCT03345979|17257435|P1|Overall Study|Lack of Efficacy|4
5019116|NCT03345979|17257434|P2|Overall Study|Lost to Follow-up|9
5019117|NCT03345979|17257435|P1|Overall Study|Lost to Follow-up|8
5019118|NCT03345979|17257434|P2|Overall Study|Adverse Event|11
5019119|NCT03345979|17257435|P1|Overall Study|Adverse Event|10
5019120|NCT03345979|17257434|P2|Overall Study|Withdrawal by Subject|31
5019121|NCT03345979|17257435|P1|Overall Study|Withdrawal by Subject|20
5019122|NCT03345914|17257456|P3|Overall Study|Ongoing|1
5019123|NCT03345914|17257457|P2|Overall Study|Ongoing|0
5019124|NCT03345914|17257458|P1|Overall Study|Ongoing|0
5019125|NCT03345914|17257456|P3|Overall Study|Other|1
5019126|NCT03345914|17257457|P2|Overall Study|Other|1
5019127|NCT03345914|17257458|P1|Overall Study|Other|1
5019128|NCT03345914|17257456|P3|Overall Study|Withdrawal by Subject|2
5019129|NCT03345914|17257457|P2|Overall Study|Withdrawal by Subject|1
5019130|NCT03345914|17257458|P1|Overall Study|Withdrawal by Subject|5
5019131|NCT03345914|17257456|P3|Overall Study|Physician Decision|1
5019132|NCT03345914|17257457|P2|Overall Study|Physician Decision|1
5019133|NCT03345914|17257458|P1|Overall Study|Physician Decision|0
5019134|NCT03345914|17257456|P3|Overall Study|Transition to OLE during follow-up|39
5019135|NCT03345914|17257457|P2|Overall Study|Transition to OLE during follow-up|33
5019136|NCT03345914|17257458|P1|Overall Study|Transition to OLE during follow-up|37
5019137|NCT03345914|17257456|P3|Overall Study|Transition to another study at week 16|78
5019138|NCT03345914|17257457|P2|Overall Study|Transition to another study at week 16|86
5019139|NCT03345914|17257458|P1|Overall Study|Transition to another study at week 16|80
5019140|NCT03345901|17257529|P1|Overall Study|The study was terminated|18
5019141|NCT03345472|17257534|P1|3 Months to 12 Months|Death|1
5019142|NCT03345472|17257534|P1|3 Months to 12 Months|Adverse Event|1
5019143|NCT03345472|17257534|P1|3 Months to 12 Months|Withdrawal by Subject|1
5019144|NCT03345472|17257534|P1|3 Months to 12 Months|Lost to Follow-up|2
5019145|NCT03345472|17257534|P1|3 Months to 12 Months|Physician Decision|3
5019146|NCT03345472|17257534|P1|Implant to 3 Months|Adverse Event|1
5019147|NCT03345472|17257534|P1|Implant to 3 Months|Physician Decision|1
5019148|NCT03345472|17257534|P1|Implant to 3 Months|Withdrawal by Subject|2
5019149|NCT03345407|17257548|P7|Overall Study|Adverse Event|16
5019150|NCT03345407|17257549|P6|Overall Study|Adverse Event|5
5019151|NCT03345407|17257550|P5|Overall Study|Adverse Event|6
5019152|NCT03345407|17257551|P4|Overall Study|Adverse Event|4
5019153|NCT03345407|17257552|P3|Overall Study|Adverse Event|5
5019154|NCT03345407|17257553|P2|Overall Study|Adverse Event|0
5019155|NCT03345407|17257554|P1|Overall Study|Adverse Event|4
5019156|NCT03345407|17257548|P7|Overall Study|Lack of Efficacy|3
5019157|NCT03345407|17257549|P6|Overall Study|Lack of Efficacy|0
5019158|NCT03345407|17257550|P5|Overall Study|Lack of Efficacy|1
5019159|NCT03345407|17257551|P4|Overall Study|Lack of Efficacy|1
5019160|NCT03345407|17257552|P3|Overall Study|Lack of Efficacy|1
5019161|NCT03345407|17257553|P2|Overall Study|Lack of Efficacy|1
5019162|NCT03345407|17257554|P1|Overall Study|Lack of Efficacy|1
5019163|NCT03345407|17257548|P7|Overall Study|Protocol Violation|3
5019164|NCT03345407|17257549|P6|Overall Study|Protocol Violation|0
5019165|NCT03345407|17257550|P5|Overall Study|Protocol Violation|1
5019166|NCT03345407|17257551|P4|Overall Study|Protocol Violation|0
5019167|NCT03345407|17257552|P3|Overall Study|Protocol Violation|0
5019168|NCT03345407|17257553|P2|Overall Study|Protocol Violation|0
5019169|NCT03345407|17257554|P1|Overall Study|Protocol Violation|2
5019170|NCT03345407|17257548|P7|Overall Study|Protocol-defined stopping criteria|1
5019171|NCT03345407|17257549|P6|Overall Study|Protocol-defined stopping criteria|1
5019172|NCT03345407|17257550|P5|Overall Study|Protocol-defined stopping criteria|2
5019173|NCT03345407|17257551|P4|Overall Study|Protocol-defined stopping criteria|0
5019174|NCT03345407|17257552|P3|Overall Study|Protocol-defined stopping criteria|0
5019175|NCT03345407|17257553|P2|Overall Study|Protocol-defined stopping criteria|0
5019176|NCT03345407|17257554|P1|Overall Study|Protocol-defined stopping criteria|9
5019177|NCT03345407|17257548|P7|Overall Study|Lost to Follow-up|3
5019178|NCT03345407|17257549|P6|Overall Study|Lost to Follow-up|2
5019179|NCT03345407|17257550|P5|Overall Study|Lost to Follow-up|1
5019180|NCT03345407|17257551|P4|Overall Study|Lost to Follow-up|0
5019181|NCT03345407|17257552|P3|Overall Study|Lost to Follow-up|1
5019182|NCT03345407|17257553|P2|Overall Study|Lost to Follow-up|0
5019183|NCT03345407|17257554|P1|Overall Study|Lost to Follow-up|2
5019184|NCT03345407|17257548|P7|Overall Study|Physician Decision|3
5019185|NCT03345407|17257549|P6|Overall Study|Physician Decision|2
5019186|NCT03345407|17257550|P5|Overall Study|Physician Decision|1
5019187|NCT03345407|17257551|P4|Overall Study|Physician Decision|0
5019188|NCT03345407|17257552|P3|Overall Study|Physician Decision|0
5019189|NCT03345407|17257553|P2|Overall Study|Physician Decision|1
5019190|NCT03345407|17257554|P1|Overall Study|Physician Decision|3
5019191|NCT03345407|17257548|P7|Overall Study|Withdrawal by Subject|16
5019192|NCT03345407|17257549|P6|Overall Study|Withdrawal by Subject|6
5019193|NCT03345407|17257550|P5|Overall Study|Withdrawal by Subject|3
5019194|NCT03345407|17257551|P4|Overall Study|Withdrawal by Subject|6
5019195|NCT03345407|17257552|P3|Overall Study|Withdrawal by Subject|5
5019196|NCT03345407|17257553|P2|Overall Study|Withdrawal by Subject|1
5019197|NCT03345407|17257554|P1|Overall Study|Withdrawal by Subject|11
5019198|NCT03344172|17257791|P2|Overall Study|Received <1 dose of treatment|0
5019199|NCT03344172|17257792|P1|Overall Study|Received <1 dose of treatment|1
5019200|NCT03343639|17257810|P2|Overall Study|Protocol Violation|1
5019201|NCT03343639|17257811|P1|Overall Study|Protocol Violation|0
5019202|NCT03343639|17257810|P2|Overall Study|Lost to Follow-up|5
5019203|NCT03343639|17257811|P1|Overall Study|Lost to Follow-up|4
5019204|NCT03343639|17257810|P2|Overall Study|Withdrawal by Subject|6
5019205|NCT03343639|17257811|P1|Overall Study|Withdrawal by Subject|10
5019206|NCT03343067|17257839|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
5019207|NCT03343067|17257840|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
5019208|NCT03343067|17257841|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
5019209|NCT03342898|17257969|P3|Overall Study|Reason not Specified|0
5019210|NCT03342898|17257970|P2|Overall Study|Reason not Specified|2
5019211|NCT03342898|17257971|P1|Overall Study|Reason not Specified|2
5019212|NCT03342898|17257969|P3|Overall Study|Death|1
5019213|NCT03342898|17257970|P2|Overall Study|Death|1
5019214|NCT03342898|17257971|P1|Overall Study|Death|0
5019215|NCT03342898|17257969|P3|Overall Study|Withdrawal of Consent|11
5019216|NCT03342898|17257970|P2|Overall Study|Withdrawal of Consent|9
5019217|NCT03342898|17257971|P1|Overall Study|Withdrawal of Consent|5
5019218|NCT03342898|17257969|P3|Overall Study|Lost to Follow-up|42
5019219|NCT03342898|17257970|P2|Overall Study|Lost to Follow-up|40
5019220|NCT03342898|17257971|P1|Overall Study|Lost to Follow-up|44
5019221|NCT03342898|17257969|P3|Overall Study|Adverse Event|0
5019222|NCT03342898|17257970|P2|Overall Study|Adverse Event|1
5019223|NCT03342898|17257971|P1|Overall Study|Adverse Event|3
5019224|NCT03342560|17258012|P1|Overall Study|Lost to Follow-up|2
5019225|NCT03342469|17258022|P4|Overall Study|Withdrawal by Subject|0
5019226|NCT03342469|17258023|P3|Overall Study|Withdrawal by Subject|0
5019227|NCT03342469|17258024|P2|Overall Study|Withdrawal by Subject|1
5019228|NCT03342469|17258025|P1|Overall Study|Withdrawal by Subject|0
5019229|NCT03341923|17258054|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
5019230|NCT03341923|17258055|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
5019231|NCT03341637|17258099|P2|Overall Study|Reason not Specified|1
5019232|NCT03341637|17258100|P1|Overall Study|Reason not Specified|1
5019233|NCT03341637|17258099|P2|Overall Study|Withdrawal by Subject|3
5019234|NCT03341637|17258100|P1|Overall Study|Withdrawal by Subject|3
5019235|NCT03341637|17258099|P2|Overall Study|Lost to Follow-up|0
5019236|NCT03341637|17258100|P1|Overall Study|Lost to Follow-up|1
5019237|NCT03341533|17258128|P2|Overall Study|Not eligible after randomization|1
5019238|NCT03341533|17258129|P1|Overall Study|Not eligible after randomization|2
5019239|NCT03341533|17258128|P2|Overall Study|Withdrawal by Subject|1
5019240|NCT03341533|17258129|P1|Overall Study|Withdrawal by Subject|1
5019241|NCT03341312|17258141|P4|Period 1|Withdrawal by Subject|0
5019242|NCT03341312|17258142|P3|Period 1|Withdrawal by Subject|0
5019243|NCT03341312|17258143|P2|Period 1|Withdrawal by Subject|1
5019244|NCT03341312|17258144|P1|Period 1|Withdrawal by Subject|0
5019245|NCT03341299|17258156|P4|Washout (A Minimum of 21 Hours)|Adverse Event|0
5019246|NCT03341299|17258157|P3|Washout (A Minimum of 21 Hours)|Adverse Event|1
5019247|NCT03341299|17258158|P2|Washout (A Minimum of 21 Hours)|Adverse Event|0
5019248|NCT03341299|17258159|P1|Washout (A Minimum of 21 Hours)|Adverse Event|0
5019249|NCT03340961|17258175|P4|Overall Study|Other|3
5019250|NCT03340961|17258176|P3|Overall Study|Other|1
5019251|NCT03340961|17258177|P2|Overall Study|Other|2
5019252|NCT03340961|17258178|P1|Overall Study|Other|0
5019253|NCT03340961|17258175|P4|Overall Study|Adverse Event|0
5019254|NCT03340961|17258176|P3|Overall Study|Adverse Event|0
5019255|NCT03340961|17258177|P2|Overall Study|Adverse Event|1
5019256|NCT03340961|17258178|P1|Overall Study|Adverse Event|1
5019257|NCT03340961|17258175|P4|Overall Study|Protocol Violation|0
5019258|NCT03340961|17258176|P3|Overall Study|Protocol Violation|1
5019259|NCT03340961|17258177|P2|Overall Study|Protocol Violation|0
5019260|NCT03340961|17258178|P1|Overall Study|Protocol Violation|1
5019261|NCT03340961|17258175|P4|Overall Study|Subject developed an exclusion criterion|0
5019262|NCT03340961|17258176|P3|Overall Study|Subject developed an exclusion criterion|0
5019263|NCT03340961|17258177|P2|Overall Study|Subject developed an exclusion criterion|1
5019264|NCT03340961|17258178|P1|Overall Study|Subject developed an exclusion criterion|0
5019265|NCT03340961|17258175|P4|Overall Study|rongful enrollment (I/E criteria not me|1
5019266|NCT03340961|17258176|P3|Overall Study|rongful enrollment (I/E criteria not me|0
5019267|NCT03340961|17258177|P2|Overall Study|rongful enrollment (I/E criteria not me|0
5019268|NCT03340961|17258178|P1|Overall Study|rongful enrollment (I/E criteria not me|0
5019269|NCT03340961|17258175|P4|Overall Study|Use of prohibited treatment|3
5019270|NCT03340961|17258176|P3|Overall Study|Use of prohibited treatment|2
5019271|NCT03340961|17258177|P2|Overall Study|Use of prohibited treatment|3
5019272|NCT03340961|17258178|P1|Overall Study|Use of prohibited treatment|0
5019273|NCT03340961|17258175|P4|Overall Study|Withdrawal by Subject|6
5019274|NCT03340961|17258176|P3|Overall Study|Withdrawal by Subject|3
5019275|NCT03340961|17258177|P2|Overall Study|Withdrawal by Subject|1
5019276|NCT03340961|17258178|P1|Overall Study|Withdrawal by Subject|3
5019277|NCT03340961|17258175|P4|Overall Study|Lost to Follow-up|1
5019278|NCT03340961|17258176|P3|Overall Study|Lost to Follow-up|0
5019279|NCT03340961|17258177|P2|Overall Study|Lost to Follow-up|1
5019280|NCT03340961|17258178|P1|Overall Study|Lost to Follow-up|0
5019281|NCT03340961|17258175|P4|Overall Study|Adverse Event|4
5019282|NCT03340961|17258176|P3|Overall Study|Adverse Event|2
5019283|NCT03340961|17258177|P2|Overall Study|Adverse Event|3
5019284|NCT03340961|17258178|P1|Overall Study|Adverse Event|1
5019285|NCT03339726|17258299|P3|Overall Study|Lost to Follow-up|0
5019286|NCT03339726|17258300|P2|Overall Study|Lost to Follow-up|1
5019287|NCT03339726|17258301|P1|Overall Study|Lost to Follow-up|0
5019288|NCT03339726|17258299|P3|Overall Study|Withdrawal by Subject|0
5019289|NCT03339726|17258300|P2|Overall Study|Withdrawal by Subject|0
5019290|NCT03339726|17258301|P1|Overall Study|Withdrawal by Subject|1
5019291|NCT03339583|17258359|P2|Follow-up (14 Days)|Physician Decision|3
5019292|NCT03339583|17258360|P1|Follow-up (14 Days)|Physician Decision|6
5019293|NCT03339583|17258359|P2|Second Intervention (14 Days)|Adverse Event|1
5019294|NCT03339583|17258360|P1|Second Intervention (14 Days)|Adverse Event|0
5019295|NCT03339583|17258359|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
5019296|NCT03339583|17258360|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
5019297|NCT03339583|17258359|P2|First Intervention (14 Days)|Adverse Event|0
5019298|NCT03339583|17258360|P1|First Intervention (14 Days)|Adverse Event|1
5019299|NCT03339453|17258398|P2|First Visit of Glucagon Treatment|Adverse Event|1
5019300|NCT03339453|17258399|P1|First Visit of Glucagon Treatment|Adverse Event|0
5019301|NCT03338816|17258463|P2|Open-Label Extension Period|Ongoing in Study|47
5019302|NCT03338816|17258464|P1|Open-Label Extension Period|Ongoing in Study|46
5019303|NCT03338816|17258463|P2|6-Month Double-blind Period|Adverse Event|1
5019304|NCT03338816|17258464|P1|6-Month Double-blind Period|Adverse Event|0
5019305|NCT03338673|17258501|P2|Overall Study|Lost to Follow-up|1
5019306|NCT03338673|17258502|P1|Overall Study|Lost to Follow-up|1
5019307|NCT03338400|17258537|P2|Overall Study|Lost to Follow-up|2
5019308|NCT03338400|17258538|P1|Overall Study|Lost to Follow-up|1
5019309|NCT03337490|17258574|P3|Overall Study|Lost to Follow-up|0
5019310|NCT03337490|17258575|P2|Overall Study|Lost to Follow-up|1
5019311|NCT03337490|17258576|P1|Overall Study|Lost to Follow-up|0
5019312|NCT03337490|17258574|P3|Overall Study|Physician Decision|0
5019313|NCT03337490|17258575|P2|Overall Study|Physician Decision|1
5019314|NCT03337490|17258576|P1|Overall Study|Physician Decision|0
5019315|NCT03337490|17258574|P3|Overall Study|Lack of Efficacy|35
5019316|NCT03337490|17258575|P2|Overall Study|Lack of Efficacy|12
5019317|NCT03337490|17258576|P1|Overall Study|Lack of Efficacy|10
5019318|NCT03337490|17258574|P3|Overall Study|Withdrawal by Subject|0
5019319|NCT03337490|17258575|P2|Overall Study|Withdrawal by Subject|0
5019320|NCT03337490|17258576|P1|Overall Study|Withdrawal by Subject|1
5019321|NCT03337477|17258589|P2|Overall Study|Lost to Follow-up|2
5019322|NCT03337477|17258590|P1|Overall Study|Lost to Follow-up|0
5019323|NCT03337477|17258589|P2|Overall Study|Death|1
5019324|NCT03337477|17258590|P1|Overall Study|Death|0
5019325|NCT03337477|17258589|P2|Overall Study|Withdrawal by Subject|1
5019326|NCT03337477|17258590|P1|Overall Study|Withdrawal by Subject|0
5019327|NCT03337477|17258589|P2|Overall Study|not categorized into the listed ones|9
5019328|NCT03337477|17258590|P1|Overall Study|not categorized into the listed ones|11
5019329|NCT03337308|17258614|P4|Overall Study|Protocol Violation|0
5019330|NCT03337308|17258615|P3|Overall Study|Protocol Violation|0
5019331|NCT03337308|17258616|P2|Overall Study|Protocol Violation|1
5019332|NCT03337308|17258617|P1|Overall Study|Protocol Violation|0
5019333|NCT03337308|17258614|P4|Overall Study|Withdrawal by Subject|1
5019334|NCT03337308|17258615|P3|Overall Study|Withdrawal by Subject|2
5019335|NCT03337308|17258616|P2|Overall Study|Withdrawal by Subject|1
5019336|NCT03337308|17258617|P1|Overall Study|Withdrawal by Subject|2
5019337|NCT03337308|17258614|P4|Overall Study|Lost to Follow-up|0
5019338|NCT03337308|17258615|P3|Overall Study|Lost to Follow-up|0
5019339|NCT03337308|17258616|P2|Overall Study|Lost to Follow-up|2
5019340|NCT03337308|17258617|P1|Overall Study|Lost to Follow-up|1
5019341|NCT03337308|17258614|P4|Overall Study|Adverse Event|1
5019342|NCT03337308|17258615|P3|Overall Study|Adverse Event|3
5019343|NCT03337308|17258616|P2|Overall Study|Adverse Event|3
5019344|NCT03337308|17258617|P1|Overall Study|Adverse Event|2
5019345|NCT03336502|17258684|P2|Overall Study|Adverse Event|5
5019346|NCT03336502|17258685|P1|Overall Study|Adverse Event|2
5019347|NCT03336502|17258684|P2|Overall Study|Death|2
5019348|NCT03336502|17258685|P1|Overall Study|Death|1
5019349|NCT03336502|17258684|P2|Overall Study|Prohibited Drugs|1
5019350|NCT03336502|17258685|P1|Overall Study|Prohibited Drugs|1
5019351|NCT03336502|17258684|P2|Overall Study|Physician Decision|1
5019352|NCT03336502|17258685|P1|Overall Study|Physician Decision|0
5019353|NCT03335566|17258721|P2|Overall Study|Other than specified above|2
5019354|NCT03335566|17258722|P1|Overall Study|Other than specified above|1
5019355|NCT03335566|17258721|P2|Overall Study|Protocol Violation|0
5019356|NCT03335566|17258722|P1|Overall Study|Protocol Violation|1
5019357|NCT03335566|17258721|P2|Overall Study|Technical Problems|0
5019358|NCT03335566|17258722|P1|Overall Study|Technical Problems|1
5019359|NCT03335566|17258721|P2|Overall Study|Lost to Follow-up|0
5019360|NCT03335566|17258722|P1|Overall Study|Lost to Follow-up|1
5019361|NCT03335566|17258721|P2|Overall Study|Adverse Event|1
5019362|NCT03335566|17258722|P1|Overall Study|Adverse Event|0
5019363|NCT03335150|17258804|P2|Overall Study|Adverse Event|1
5019364|NCT03335150|17258805|P1|Overall Study|Adverse Event|0
5019365|NCT03335150|17258804|P2|Overall Study|Withdrawal by Subject|4
5019366|NCT03335150|17258805|P1|Overall Study|Withdrawal by Subject|10
5019367|NCT03334747|17258876|P9|Follow-Up Phase|Subject/guardian decision|1
5019368|NCT03334747|17258877|P8|Follow-Up Phase|Subject/guardian decision|0
5019369|NCT03334747|17258878|P7|Follow-Up Phase|Subject/guardian decision|1
5019370|NCT03334747|17258879|P6|Follow-Up Phase|Subject/guardian decision|0
5019371|NCT03334747|17258880|P5|Follow-Up Phase|Subject/guardian decision|0
5019372|NCT03334747|17258881|P4|Follow-Up Phase|Subject/guardian decision|0
5019373|NCT03334747|17258882|P3|Follow-Up Phase|Subject/guardian decision|0
5019374|NCT03334747|17258883|P2|Follow-Up Phase|Subject/guardian decision|0
5019375|NCT03334747|17258884|P1|Follow-Up Phase|Subject/guardian decision|0
5019376|NCT03334747|17258876|P9|Treatment Phase|Subject/guardian decision|0
5019377|NCT03334747|17258877|P8|Treatment Phase|Subject/guardian decision|0
5019378|NCT03334747|17258878|P7|Treatment Phase|Subject/guardian decision|0
5019379|NCT03334747|17258879|P6|Treatment Phase|Subject/guardian decision|1
5019380|NCT03334747|17258880|P5|Treatment Phase|Subject/guardian decision|0
5019381|NCT03334747|17258881|P4|Treatment Phase|Subject/guardian decision|0
5019382|NCT03334747|17258882|P3|Treatment Phase|Subject/guardian decision|0
5019383|NCT03334747|17258883|P2|Treatment Phase|Subject/guardian decision|0
5019384|NCT03334747|17258884|P1|Treatment Phase|Subject/guardian decision|1
5019385|NCT03334747|17258876|P9|Treatment Phase|Technical problems|0
5019386|NCT03334747|17258877|P8|Treatment Phase|Technical problems|0
5019387|NCT03334747|17258878|P7|Treatment Phase|Technical problems|0
5019388|NCT03334747|17258879|P6|Treatment Phase|Technical problems|0
5019389|NCT03334747|17258880|P5|Treatment Phase|Technical problems|1
5019390|NCT03334747|17258881|P4|Treatment Phase|Technical problems|0
5019391|NCT03334747|17258882|P3|Treatment Phase|Technical problems|0
5019392|NCT03334747|17258883|P2|Treatment Phase|Technical problems|0
5019393|NCT03334747|17258884|P1|Treatment Phase|Technical problems|0
5019394|NCT03334721|17259074|P2|Overall Study|No longer met inclusion/exclusion criter|0
5019395|NCT03334721|17259075|P1|Overall Study|No longer met inclusion/exclusion criter|1
5019396|NCT03334721|17259074|P2|Overall Study|Withdrawal by Subject|0
5019397|NCT03334721|17259075|P1|Overall Study|Withdrawal by Subject|1
5019398|NCT03334448|17259081|P4|Washout|Protocol Violation|1
5019399|NCT03334448|17259082|P3|Washout|Protocol Violation|0
5019400|NCT03334448|17259083|P2|Washout|Protocol Violation|0
5019401|NCT03334448|17259084|P1|Washout|Protocol Violation|0
5019402|NCT03334448|17259081|P4|Washout|Personal Reason|0
5019403|NCT03334448|17259082|P3|Washout|Personal Reason|0
5019404|NCT03334448|17259083|P2|Washout|Personal Reason|1
5019405|NCT03334448|17259084|P1|Washout|Personal Reason|0
5019406|NCT03334422|17259096|P4|Overall Study|Pregnancy|0
5019407|NCT03334422|17259097|P3|Overall Study|Pregnancy|0
5019408|NCT03334422|17259098|P2|Overall Study|Pregnancy|1
5019409|NCT03334422|17259099|P1|Overall Study|Pregnancy|0
5019410|NCT03334422|17259096|P4|Overall Study|Inability to obtain laboratory samples|0
5019411|NCT03334422|17259097|P3|Overall Study|Inability to obtain laboratory samples|0
5019412|NCT03334422|17259098|P2|Overall Study|Inability to obtain laboratory samples|1
5019413|NCT03334422|17259099|P1|Overall Study|Inability to obtain laboratory samples|0
5019414|NCT03334422|17259096|P4|Overall Study|Lost to Follow-up|1
5019415|NCT03334422|17259097|P3|Overall Study|Lost to Follow-up|0
5019416|NCT03334422|17259098|P2|Overall Study|Lost to Follow-up|0
5019417|NCT03334422|17259099|P1|Overall Study|Lost to Follow-up|0
5019418|NCT03334422|17259096|P4|Overall Study|Withdrawal by Subject|0
5019419|NCT03334422|17259097|P3|Overall Study|Withdrawal by Subject|1
5019420|NCT03334422|17259098|P2|Overall Study|Withdrawal by Subject|3
5019421|NCT03334422|17259099|P1|Overall Study|Withdrawal by Subject|8
5019422|NCT03334422|17259096|P4|Overall Study|Lack of Efficacy|3
5019423|NCT03334422|17259097|P3|Overall Study|Lack of Efficacy|7
5019424|NCT03334422|17259098|P2|Overall Study|Lack of Efficacy|2
5019425|NCT03334422|17259099|P1|Overall Study|Lack of Efficacy|10
5019426|NCT03334422|17259096|P4|Overall Study|Adverse Event|2
5019427|NCT03334422|17259097|P3|Overall Study|Adverse Event|2
5019428|NCT03334422|17259098|P2|Overall Study|Adverse Event|3
5019429|NCT03334422|17259099|P1|Overall Study|Adverse Event|1
5019430|NCT03334396|17259206|P8|Overall Study|Started New Job|0
5019431|NCT03334396|17259207|P7|Overall Study|Started New Job|0
5019432|NCT03334396|17259208|P6|Overall Study|Started New Job|0
5019433|NCT03334396|17259209|P5|Overall Study|Started New Job|0
5019434|NCT03334396|17259210|P4|Overall Study|Started New Job|0
5019435|NCT03334396|17259211|P3|Overall Study|Started New Job|0
5019436|NCT03334396|17259212|P2|Overall Study|Started New Job|0
5019437|NCT03334396|17259213|P1|Overall Study|Started New Job|1
5019438|NCT03334396|17259206|P8|Overall Study|Ineligible|0
5019439|NCT03334396|17259207|P7|Overall Study|Ineligible|0
5019440|NCT03334396|17259208|P6|Overall Study|Ineligible|0
5019441|NCT03334396|17259209|P5|Overall Study|Ineligible|0
5019442|NCT03334396|17259210|P4|Overall Study|Ineligible|0
5019443|NCT03334396|17259211|P3|Overall Study|Ineligible|0
5019444|NCT03334396|17259212|P2|Overall Study|Ineligible|1
5019445|NCT03334396|17259213|P1|Overall Study|Ineligible|0
5019446|NCT03334396|17259206|P8|Overall Study|Pregnancy|0
5019447|NCT03334396|17259207|P7|Overall Study|Pregnancy|0
5019448|NCT03334396|17259208|P6|Overall Study|Pregnancy|0
5019449|NCT03334396|17259209|P5|Overall Study|Pregnancy|0
5019450|NCT03334396|17259210|P4|Overall Study|Pregnancy|0
5019451|NCT03334396|17259211|P3|Overall Study|Pregnancy|0
5019452|NCT03334396|17259212|P2|Overall Study|Pregnancy|1
5019453|NCT03334396|17259213|P1|Overall Study|Pregnancy|0
5019454|NCT03334396|17259206|P8|Overall Study|Withdrawal by Subject|0
5019455|NCT03334396|17259207|P7|Overall Study|Withdrawal by Subject|2
5019456|NCT03334396|17259208|P6|Overall Study|Withdrawal by Subject|1
5019457|NCT03334396|17259209|P5|Overall Study|Withdrawal by Subject|2
5019458|NCT03334396|17259210|P4|Overall Study|Withdrawal by Subject|2
5019459|NCT03334396|17259211|P3|Overall Study|Withdrawal by Subject|7
5019460|NCT03334396|17259212|P2|Overall Study|Withdrawal by Subject|5
5019461|NCT03334396|17259213|P1|Overall Study|Withdrawal by Subject|10
5019462|NCT03334396|17259206|P8|Overall Study|Physician Decision|0
5019463|NCT03334396|17259207|P7|Overall Study|Physician Decision|0
5019464|NCT03334396|17259208|P6|Overall Study|Physician Decision|0
5019465|NCT03334396|17259209|P5|Overall Study|Physician Decision|0
5019466|NCT03334396|17259210|P4|Overall Study|Physician Decision|0
5019467|NCT03334396|17259211|P3|Overall Study|Physician Decision|0
5019468|NCT03334396|17259212|P2|Overall Study|Physician Decision|0
5019469|NCT03334396|17259213|P1|Overall Study|Physician Decision|1
5019470|NCT03334396|17259206|P8|Overall Study|Lost to Follow-up|0
5019471|NCT03334396|17259207|P7|Overall Study|Lost to Follow-up|1
5019472|NCT03334396|17259208|P6|Overall Study|Lost to Follow-up|0
5019473|NCT03334396|17259209|P5|Overall Study|Lost to Follow-up|0
5019474|NCT03334396|17259210|P4|Overall Study|Lost to Follow-up|0
5019475|NCT03334396|17259211|P3|Overall Study|Lost to Follow-up|1
5019476|NCT03334396|17259212|P2|Overall Study|Lost to Follow-up|0
5019477|NCT03334396|17259213|P1|Overall Study|Lost to Follow-up|0
5019478|NCT03334396|17259206|P8|Overall Study|Lack of Efficacy|1
5019479|NCT03334396|17259207|P7|Overall Study|Lack of Efficacy|0
5019480|NCT03334396|17259208|P6|Overall Study|Lack of Efficacy|0
5019481|NCT03334396|17259209|P5|Overall Study|Lack of Efficacy|1
5019482|NCT03334396|17259210|P4|Overall Study|Lack of Efficacy|3
5019483|NCT03334396|17259211|P3|Overall Study|Lack of Efficacy|1
5019484|NCT03334396|17259212|P2|Overall Study|Lack of Efficacy|4
5019485|NCT03334396|17259213|P1|Overall Study|Lack of Efficacy|10
5019486|NCT03334396|17259206|P8|Overall Study|Adverse Event|0
5019487|NCT03334396|17259207|P7|Overall Study|Adverse Event|0
5019488|NCT03334396|17259208|P6|Overall Study|Adverse Event|0
5019489|NCT03334396|17259209|P5|Overall Study|Adverse Event|0
5019490|NCT03334396|17259210|P4|Overall Study|Adverse Event|0
5019491|NCT03334396|17259211|P3|Overall Study|Adverse Event|1
5019492|NCT03334396|17259212|P2|Overall Study|Adverse Event|0
5019493|NCT03334396|17259213|P1|Overall Study|Adverse Event|1
5019494|NCT03334214|17259318|P2|Overall Study|Other|0
5019495|NCT03334214|17259319|P1|Overall Study|Other|1
5019496|NCT03334214|17259318|P2|Overall Study|Withdrawal by Subject|1
5019497|NCT03334214|17259319|P1|Overall Study|Withdrawal by Subject|0
5019498|NCT03334214|17259318|P2|Overall Study|Adverse Event or Serious Adverse Event|1
5019499|NCT03334214|17259319|P1|Overall Study|Adverse Event or Serious Adverse Event|0
5019500|NCT03334175|17259345|P2|Overall Study|Lost to Follow-up|1
5019501|NCT03334175|17259346|P1|Overall Study|Lost to Follow-up|0
5019502|NCT03333876|17259368|P1|Mandibular Advancement|Product Damage|2
5019503|NCT03333876|17259368|P1|Mandibular Advancement|Adverse Event|2
5019504|NCT03333876|17259368|P1|Nasal Dilator|Bed Partner Lost to follow up|6
5019505|NCT03333876|17259368|P1|Screening Period|Screen Failure|4
5019506|NCT03332784|17259559|P20|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019507|NCT03332784|17259560|P19|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019508|NCT03332784|17259561|P18|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019509|NCT03332784|17259562|P17|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019510|NCT03332784|17259563|P16|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019511|NCT03332784|17259564|P15|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
5019512|NCT03332784|17259565|P14|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019513|NCT03332784|17259566|P13|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019514|NCT03332784|17259567|P12|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019515|NCT03332784|17259568|P11|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019516|NCT03332784|17259569|P10|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019517|NCT03332784|17259570|P9|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019518|NCT03332784|17259571|P8|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019519|NCT03332784|17259572|P7|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019520|NCT03332784|17259573|P6|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019521|NCT03332784|17259574|P5|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019522|NCT03332784|17259575|P4|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019523|NCT03332784|17259576|P3|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019524|NCT03332784|17259577|P2|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
5019525|NCT03332784|17259578|P1|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5019526|NCT03332160|17259836|P2|Overall Study|Non-adherence to treatment|2
5019527|NCT03332160|17259837|P1|Overall Study|Non-adherence to treatment|0
5019528|NCT03332160|17259836|P2|Overall Study|Developed Exclusion Criteria|1
5019529|NCT03332160|17259837|P1|Overall Study|Developed Exclusion Criteria|0
5019530|NCT03332160|17259836|P2|Overall Study|Adverse Event|1
5019531|NCT03332160|17259837|P1|Overall Study|Adverse Event|0
5019532|NCT03332160|17259836|P2|Overall Study|Withdrawal by Subject|1
5019533|NCT03332160|17259837|P1|Overall Study|Withdrawal by Subject|1
5019534|NCT03331315|17259921|P2|Overall Study|Physician Decision|14
5019535|NCT03331315|17259922|P1|Overall Study|Physician Decision|18
5019536|NCT03331042|17259959|P4|Overall Study|Lost to Follow-up|1
5019537|NCT03331042|17259960|P3|Overall Study|Lost to Follow-up|0
5019538|NCT03331042|17259961|P2|Overall Study|Lost to Follow-up|0
5019539|NCT03331042|17259962|P1|Overall Study|Lost to Follow-up|0
5019540|NCT03331042|17259959|P4|Overall Study|Physician Decision|0
5019541|NCT03331042|17259960|P3|Overall Study|Physician Decision|1
5019542|NCT03331042|17259961|P2|Overall Study|Physician Decision|0
5019543|NCT03331042|17259962|P1|Overall Study|Physician Decision|0
5019544|NCT03331042|17259959|P4|Overall Study|Protocol Violation|0
5019545|NCT03331042|17259960|P3|Overall Study|Protocol Violation|0
5019546|NCT03331042|17259961|P2|Overall Study|Protocol Violation|0
5019547|NCT03331042|17259962|P1|Overall Study|Protocol Violation|1
5019548|NCT03330236|17260072|P2|Overall Study|Surgery aborted/converted to open|52
5019549|NCT03330236|17260073|P1|Overall Study|Surgery aborted/converted to open|60
5019550|NCT03330236|17260072|P2|Overall Study|Volatile anesthetics used|8
5019551|NCT03330236|17260073|P1|Overall Study|Volatile anesthetics used|11
5019552|NCT03330236|17260072|P2|Overall Study|SedLine malfunction/blinding|14
5019553|NCT03330236|17260073|P1|Overall Study|SedLine malfunction/blinding|19
5019554|NCT03330236|17260072|P2|Overall Study|Protocol Violation|3
5019555|NCT03330236|17260073|P1|Overall Study|Protocol Violation|4
5019556|NCT03330236|17260072|P2|Overall Study|Physician Decision|0
5019557|NCT03330236|17260073|P1|Overall Study|Physician Decision|2
5019558|NCT03330236|17260072|P2|Overall Study|Lost to Follow-up|2
5019559|NCT03330236|17260073|P1|Overall Study|Lost to Follow-up|0
5019560|NCT03330236|17260072|P2|Overall Study|Withdrawal by Subject|4
5019561|NCT03330236|17260073|P1|Overall Study|Withdrawal by Subject|2
5019562|NCT03330236|17260072|P2|Overall Study|Death|1
5019563|NCT03330236|17260073|P1|Overall Study|Death|2
5019564|NCT03329989|17260107|P1|Overall Study|Protocol Violation|1
5019565|NCT03329989|17260107|P1|Overall Study|Adverse Event|5
5019566|NCT03329989|17260107|P1|Overall Study|Lost to Follow-up|8
5019567|NCT03329989|17260107|P1|Overall Study|Withdrawal by Subject|9
5019568|NCT03329885|17260125|P9|Overall Study|Sponsor discontinued the study early|0
5019569|NCT03329885|17260126|P8|Overall Study|Sponsor discontinued the study early|1
5019570|NCT03329885|17260127|P7|Overall Study|Sponsor discontinued the study early|1
5019571|NCT03329885|17260128|P6|Overall Study|Sponsor discontinued the study early|0
5019572|NCT03329885|17260129|P5|Overall Study|Sponsor discontinued the study early|0
5019573|NCT03329885|17260130|P4|Overall Study|Sponsor discontinued the study early|0
5019574|NCT03329885|17260131|P3|Overall Study|Sponsor discontinued the study early|0
5019575|NCT03329885|17260132|P2|Overall Study|Sponsor discontinued the study early|0
5019576|NCT03329885|17260133|P1|Overall Study|Sponsor discontinued the study early|0
5019577|NCT03329690|17260302|P5|Overall Study|Did not receive treatment|0
5019578|NCT03329690|17260303|P4|Overall Study|Did not receive treatment|1
5019579|NCT03329690|17260304|P3|Overall Study|Did not receive treatment|0
5019580|NCT03329690|17260305|P2|Overall Study|Did not receive treatment|0
5019581|NCT03329690|17260306|P1|Overall Study|Did not receive treatment|1
5019582|NCT03329690|17260302|P5|Overall Study|Physician Decision|1
5019583|NCT03329690|17260303|P4|Overall Study|Physician Decision|0
5019584|NCT03329690|17260304|P3|Overall Study|Physician Decision|0
5019585|NCT03329690|17260305|P2|Overall Study|Physician Decision|0
5019586|NCT03329690|17260306|P1|Overall Study|Physician Decision|1
5019587|NCT03329690|17260302|P5|Overall Study|Withdrawal by Subject|0
5019588|NCT03329690|17260303|P4|Overall Study|Withdrawal by Subject|1
5019589|NCT03329690|17260304|P3|Overall Study|Withdrawal by Subject|0
5019590|NCT03329690|17260305|P2|Overall Study|Withdrawal by Subject|3
5019591|NCT03329690|17260306|P1|Overall Study|Withdrawal by Subject|2
5019592|NCT03329690|17260302|P5|Overall Study|Death|0
5019593|NCT03329690|17260303|P4|Overall Study|Death|1
5019594|NCT03329690|17260304|P3|Overall Study|Death|0
5019595|NCT03329690|17260305|P2|Overall Study|Death|0
5019596|NCT03329690|17260306|P1|Overall Study|Death|2
5019597|NCT03329690|17260302|P5|Overall Study|Adverse Event|2
5019598|NCT03329690|17260303|P4|Overall Study|Adverse Event|1
5019599|NCT03329690|17260304|P3|Overall Study|Adverse Event|0
5019600|NCT03329690|17260305|P2|Overall Study|Adverse Event|4
5019601|NCT03329690|17260306|P1|Overall Study|Adverse Event|19
5019602|NCT03329690|17260302|P5|Overall Study|Clinical progression|0
5019603|NCT03329690|17260303|P4|Overall Study|Clinical progression|1
5019604|NCT03329690|17260304|P3|Overall Study|Clinical progression|1
5019605|NCT03329690|17260305|P2|Overall Study|Clinical progression|4
5019606|NCT03329690|17260306|P1|Overall Study|Clinical progression|6
5019607|NCT03329690|17260302|P5|Overall Study|Progressive disease per RECIST|19
5019608|NCT03329690|17260303|P4|Overall Study|Progressive disease per RECIST|16
5019609|NCT03329690|17260304|P3|Overall Study|Progressive disease per RECIST|5
5019610|NCT03329690|17260305|P2|Overall Study|Progressive disease per RECIST|42
5019611|NCT03329690|17260306|P1|Overall Study|Progressive disease per RECIST|67
5019612|NCT03329573|17260388|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5019613|NCT03329573|17260389|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5019614|NCT03329573|17260390|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
5019615|NCT03329573|17260391|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5019616|NCT03329573|17260388|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5019617|NCT03329573|17260389|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5019618|NCT03329573|17260390|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5019619|NCT03329573|17260391|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
5019620|NCT03329573|17260388|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
5019621|NCT03329573|17260389|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
5019622|NCT03329573|17260390|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
5019623|NCT03329573|17260391|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
5019624|NCT03329573|17260388|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5019625|NCT03329573|17260389|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5019626|NCT03329573|17260390|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
5019627|NCT03329573|17260391|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5019628|NCT03328897|17260475|P3|Follow-up Epoch|Patient/guardian decision|0
5019629|NCT03328897|17260476|P2|Follow-up Epoch|Patient/guardian decision|1
5019630|NCT03328897|17260477|P1|Follow-up Epoch|Patient/guardian decision|2
5019631|NCT03328897|17260475|P3|Follow-up Epoch|Pregnancy|0
5019632|NCT03328897|17260476|P2|Follow-up Epoch|Pregnancy|0
5019633|NCT03328897|17260477|P1|Follow-up Epoch|Pregnancy|1
5019634|NCT03328897|17260475|P3|Follow-up Epoch|Lost to Follow-up|0
5019635|NCT03328897|17260476|P2|Follow-up Epoch|Lost to Follow-up|1
5019636|NCT03328897|17260477|P1|Follow-up Epoch|Lost to Follow-up|0
5019637|NCT03328897|17260475|P3|Follow-up Epoch|Lack of Efficacy|1
5019638|NCT03328897|17260476|P2|Follow-up Epoch|Lack of Efficacy|1
5019639|NCT03328897|17260477|P1|Follow-up Epoch|Lack of Efficacy|1
5019640|NCT03328897|17260475|P3|Follow-up Epoch|Adverse Event|1
5019641|NCT03328897|17260476|P2|Follow-up Epoch|Adverse Event|0
5019642|NCT03328897|17260477|P1|Follow-up Epoch|Adverse Event|4
5019643|NCT03328897|17260475|P3|Randomized-treatment Epoch|Lack of Efficacy|0
5019644|NCT03328897|17260476|P2|Randomized-treatment Epoch|Lack of Efficacy|0
5019645|NCT03328897|17260477|P1|Randomized-treatment Epoch|Lack of Efficacy|1
5019646|NCT03328897|17260475|P3|Randomized-treatment Epoch|Patient/guardian decision|1
5019647|NCT03328897|17260476|P2|Randomized-treatment Epoch|Patient/guardian decision|3
5019648|NCT03328897|17260477|P1|Randomized-treatment Epoch|Patient/guardian decision|8
5019649|NCT03328897|17260475|P3|Randomized-treatment Epoch|Pregnancy|0
5019650|NCT03328897|17260476|P2|Randomized-treatment Epoch|Pregnancy|0
5019651|NCT03328897|17260477|P1|Randomized-treatment Epoch|Pregnancy|3
5019652|NCT03328897|17260475|P3|Randomized-treatment Epoch|Lost to Follow-up|0
5019653|NCT03328897|17260476|P2|Randomized-treatment Epoch|Lost to Follow-up|1
5019654|NCT03328897|17260477|P1|Randomized-treatment Epoch|Lost to Follow-up|0
5019655|NCT03328897|17260475|P3|Randomized-treatment Epoch|Adverse Event|1
5019656|NCT03328897|17260476|P2|Randomized-treatment Epoch|Adverse Event|1
5019657|NCT03328897|17260477|P1|Randomized-treatment Epoch|Adverse Event|4
5019658|NCT03328182|17260539|P1|Overall Study|No Product Evaluated|1
5019659|NCT03328182|17260539|P1|Overall Study|Protocol Violation|2
5019660|NCT03328182|17260539|P1|Overall Study|Withdrawal by Subject|1
5019661|NCT03327402|17260544|P1|Overall Study|Other (Visit Out-Of-Window)|1
5019662|NCT03327402|17260544|P1|Overall Study|Withdrawal by Subject|1
5019663|NCT03326869|17260858|P2|Overall Study|Study data has been lost to natural disa|1
5019664|NCT03326869|17260859|P1|Overall Study|Study data has been lost to natural disa|1
5019665|NCT03326518|17260875|P3|Overall Study|Lost to Follow-up|1
5019666|NCT03326518|17260876|P2|Overall Study|Lost to Follow-up|0
5019667|NCT03326518|17260877|P1|Overall Study|Lost to Follow-up|1
5019668|NCT03326518|17260875|P3|Overall Study|Withdrawal by Subject|0
5019669|NCT03326518|17260876|P2|Overall Study|Withdrawal by Subject|0
5019670|NCT03326518|17260877|P1|Overall Study|Withdrawal by Subject|1
5019671|NCT03326518|17260875|P3|Overall Study|Protocol Violation|0
5019672|NCT03326518|17260876|P2|Overall Study|Protocol Violation|0
5019673|NCT03326518|17260877|P1|Overall Study|Protocol Violation|1
5019674|NCT03326323|17260912|P1|Overall Study|Unable to receive ANH protocol|3
5019675|NCT03325894|17260919|P2|Overall Study|Other (Not received Treatment)|0
5019676|NCT03325894|17260920|P1|Overall Study|Other (Not received Treatment)|1
5019677|NCT03325894|17260919|P2|Overall Study|Study Terminated by Sponsor|43
5019678|NCT03325894|17260920|P1|Overall Study|Study Terminated by Sponsor|38
5019679|NCT03325894|17260919|P2|Overall Study|Lack of Efficacy|14
5019680|NCT03325894|17260920|P1|Overall Study|Lack of Efficacy|8
5019681|NCT03325894|17260919|P2|Overall Study|Lost to Follow-up|9
5019682|NCT03325894|17260920|P1|Overall Study|Lost to Follow-up|4
5019683|NCT03325894|17260919|P2|Overall Study|Withdrawal by Subject|6
5019684|NCT03325894|17260920|P1|Overall Study|Withdrawal by Subject|10
5019685|NCT03325894|17260919|P2|Overall Study|Protocol Violation|2
5019686|NCT03325894|17260920|P1|Overall Study|Protocol Violation|1
5019687|NCT03325894|17260919|P2|Overall Study|Adverse Event|3
5019688|NCT03325894|17260920|P1|Overall Study|Adverse Event|2
5019689|NCT03325881|17260988|P2|Overall Study|Not treated|0
5019690|NCT03325881|17260989|P1|Overall Study|Not treated|1
5019691|NCT03325881|17260988|P2|Overall Study|Lack of Efficacy|0
5019692|NCT03325881|17260989|P1|Overall Study|Lack of Efficacy|2
5019693|NCT03325881|17260988|P2|Overall Study|Withdrawal by Subject|2
5019694|NCT03325881|17260989|P1|Overall Study|Withdrawal by Subject|0
5019695|NCT03325881|17260988|P2|Overall Study|Protocol Violation|1
5019696|NCT03325881|17260989|P1|Overall Study|Protocol Violation|0
5019697|NCT03325673|17261017|P2|Overall Study|Adverse Event|0
5019698|NCT03325673|17261018|P1|Overall Study|Adverse Event|4
5019699|NCT03323736|17261050|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
5019700|NCT03323736|17261051|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
5019701|NCT03323736|17261052|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
5019702|NCT03323736|17261050|P3|Overall Study|Withdrawal Before Treatment|1
5019703|NCT03323736|17261051|P2|Overall Study|Withdrawal Before Treatment|1
5019704|NCT03323736|17261052|P1|Overall Study|Withdrawal Before Treatment|3
5019705|NCT03323736|17261050|P3|Overall Study|Screen Failure|1
5019706|NCT03323736|17261051|P2|Overall Study|Screen Failure|9
5019707|NCT03323736|17261052|P1|Overall Study|Screen Failure|14
5019708|NCT03323086|17261079|P2|Overall Study|Lost to Follow-up|2
5019709|NCT03323086|17261080|P1|Overall Study|Lost to Follow-up|3
5019710|NCT03322566|17261108|P3|Overall Study|On-going at clinical cut off date|36
5019711|NCT03322566|17261109|P2|Overall Study|On-going at clinical cut off date|74
5019712|NCT03322566|17261110|P1|Overall Study|On-going at clinical cut off date|68
5019713|NCT03322566|17261108|P3|Overall Study|Withdrawal by Subject|5
5019714|NCT03322566|17261109|P2|Overall Study|Withdrawal by Subject|1
5019715|NCT03322566|17261110|P1|Overall Study|Withdrawal by Subject|3
5019716|NCT03322566|17261108|P3|Overall Study|Physician Decision|1
5019717|NCT03322566|17261109|P2|Overall Study|Physician Decision|0
5019718|NCT03322566|17261110|P1|Overall Study|Physician Decision|0
5019719|NCT03322566|17261108|P3|Overall Study|Death|13
5019720|NCT03322566|17261109|P2|Overall Study|Death|12
5019721|NCT03322566|17261110|P1|Overall Study|Death|20
5019722|NCT03322540|17261129|P2|Overall Study|Participants Ongoing|59
5019723|NCT03322540|17261130|P1|Overall Study|Participants Ongoing|63
5019724|NCT03322540|17261129|P2|Overall Study|Withdrawal by Subject|1
5019725|NCT03322540|17261130|P1|Overall Study|Withdrawal by Subject|2
5019726|NCT03322540|17261129|P2|Overall Study|Physician Decision|1
5019727|NCT03322540|17261130|P1|Overall Study|Physician Decision|0
5019728|NCT03322540|17261129|P2|Overall Study|Lost to Follow-up|1
5019729|NCT03322540|17261130|P1|Overall Study|Lost to Follow-up|0
5019730|NCT03322540|17261129|P2|Overall Study|Death|15
5019731|NCT03322540|17261130|P1|Overall Study|Death|12
5019732|NCT03322514|17261138|P2|Overall Study|Withdrawal by Subject|1
5019733|NCT03322514|17261139|P1|Overall Study|Withdrawal by Subject|1
5019734|NCT03322462|17261149|P1|Overall Study|Other|1
5019735|NCT03322462|17261149|P1|Overall Study|Technical difficulties|2
5019736|NCT03322423|17261158|P2|Period 2|Subject not eligible for Pytergiumectomy|1
5019737|NCT03322423|17261159|P1|Period 2|Subject not eligible for Pytergiumectomy|0
5019738|NCT03322423|17261158|P2|Period 2|Protocol Violation|0
5019739|NCT03322423|17261159|P1|Period 2|Protocol Violation|1
5019740|NCT03322423|17261158|P2|Period 2|Dispensed incorrect lens in left eye|1
5019741|NCT03322423|17261159|P1|Period 2|Dispensed incorrect lens in left eye|0
5019742|NCT03322423|17261158|P2|Period 1|Unsatisfactory Lens Fitting|0
5019743|NCT03322423|17261159|P1|Period 1|Unsatisfactory Lens Fitting|1
5019744|NCT03322423|17261158|P2|Period 1|Incorrect Lens Dispensed|0
5019745|NCT03322423|17261159|P1|Period 1|Incorrect Lens Dispensed|1
5019746|NCT03322423|17261158|P2|Period 1|Withdrawal by Subject|1
5019747|NCT03322423|17261159|P1|Period 1|Withdrawal by Subject|0
5019748|NCT03322423|17261158|P2|Period 1|Subject no longer eligible|1
5019749|NCT03322423|17261159|P1|Period 1|Subject no longer eligible|0
5019750|NCT03322293|17261172|P3|Overall Study|Lost to Follow-up|1
5019751|NCT03322293|17261173|P2|Overall Study|Lost to Follow-up|0
5019752|NCT03322293|17261174|P1|Overall Study|Lost to Follow-up|0
5019753|NCT03321721|17261197|P3|Overall Study|Lost to Follow-up|11
5019754|NCT03321721|17261198|P2|Overall Study|Lost to Follow-up|8
5019755|NCT03321721|17261199|P1|Overall Study|Lost to Follow-up|4
5019756|NCT03321396|17261216|P1|Overall Study|Physician Decision|1
5019757|NCT03320941|17261254|P5|Overall Study|subject/guardian decision|0
5019758|NCT03320941|17261255|P4|Overall Study|subject/guardian decision|1
5019759|NCT03320941|17261256|P3|Overall Study|subject/guardian decision|0
5019760|NCT03320941|17261257|P2|Overall Study|subject/guardian decision|0
5019761|NCT03320941|17261258|P1|Overall Study|subject/guardian decision|0
5019762|NCT03320824|17261361|P2|Overall Study|could not complete final visit|1
5019763|NCT03320824|17261362|P1|Overall Study|could not complete final visit|0
5019764|NCT03320824|17261361|P2|Overall Study|moved out of state|1
5019765|NCT03320824|17261362|P1|Overall Study|moved out of state|0
5019766|NCT03320824|17261361|P2|Overall Study|Lost to Follow-up|1
5019767|NCT03320824|17261362|P1|Overall Study|Lost to Follow-up|10
5019768|NCT03320824|17261361|P2|Overall Study|Withdrawal by Subject|1
5019769|NCT03320824|17261362|P1|Overall Study|Withdrawal by Subject|8
5019770|NCT03320564|17261378|P1|Overall Study|Protocol Violation|1
5019771|NCT03320369|17261382|P1|Overall Study|Withdrawal by Subject|2
5019772|NCT03320369|17261382|P1|Overall Study|Adverse Event|1
5019773|NCT03319719|17261403|P1|Overall Study|Lost to Follow-up|1
5019774|NCT03319212|17261436|P2|Overall Study|Physician Decision|0
5019775|NCT03319212|17261437|P1|Overall Study|Physician Decision|1
5019776|NCT03319212|17261436|P2|Overall Study|Lost to Follow-up|1
5019777|NCT03319212|17261437|P1|Overall Study|Lost to Follow-up|0
5019778|NCT03319212|17261436|P2|Overall Study|Withdrawal by Subject|1
5019779|NCT03319212|17261437|P1|Overall Study|Withdrawal by Subject|0
5019780|NCT03319212|17261436|P2|Overall Study|Adverse Event|2
5019781|NCT03319212|17261437|P1|Overall Study|Adverse Event|2
5019782|NCT03319212|17261436|P2|Overall Study|Discontinued as moving out of local area|1
5019783|NCT03319212|17261437|P1|Overall Study|Discontinued as moving out of local area|0
5019784|NCT03318861|17261519|P5|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5019785|NCT03318861|17261520|P4|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5019786|NCT03318861|17261521|P3|Overall Study|Enrolled But Did Not Initiate KITE-585|0
5019787|NCT03318861|17261522|P2|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5019788|NCT03318861|17261523|P1|Overall Study|Enrolled But Did Not Initiate KITE-585|0
5019789|NCT03318861|17261519|P5|Overall Study|Still on Study|1
5019790|NCT03318861|17261520|P4|Overall Study|Still on Study|2
5019791|NCT03318861|17261521|P3|Overall Study|Still on Study|1
5019792|NCT03318861|17261522|P2|Overall Study|Still on Study|1
5019793|NCT03318861|17261523|P1|Overall Study|Still on Study|2
5019794|NCT03318861|17261519|P5|Overall Study|Death|1
5019795|NCT03318861|17261520|P4|Overall Study|Death|1
5019796|NCT03318861|17261521|P3|Overall Study|Death|2
5019797|NCT03318861|17261522|P2|Overall Study|Death|2
5019798|NCT03318861|17261523|P1|Overall Study|Death|1
5019799|NCT03318315|17261585|P3|Overall Study|Withdrawal by Subject|2
5019800|NCT03318315|17261586|P2|Overall Study|Withdrawal by Subject|0
5019801|NCT03318315|17261587|P1|Overall Study|Withdrawal by Subject|0
5019802|NCT03318315|17261585|P3|Overall Study|Protocol Violation|1
5019803|NCT03318315|17261586|P2|Overall Study|Protocol Violation|1
5019804|NCT03318315|17261587|P1|Overall Study|Protocol Violation|1
5019805|NCT03318315|17261585|P3|Overall Study|Lost to Follow-up|1
5019806|NCT03318315|17261586|P2|Overall Study|Lost to Follow-up|2
5019807|NCT03318315|17261587|P1|Overall Study|Lost to Follow-up|3
5019808|NCT03316911|17261701|P2|Overall Study|Lost to Follow-up|29
5019809|NCT03316911|17261702|P1|Overall Study|Lost to Follow-up|33
5019810|NCT03316131|17261747|P2|Treatment Period 2|Protocol deviation|0
5019811|NCT03316131|17261748|P1|Treatment Period 2|Protocol deviation|1
5019812|NCT03315689|17261814|P2|Open Label Extension = 52 Weeks|Lost to Follow-up|1
5019813|NCT03315689|17261815|P1|Open Label Extension = 52 Weeks|Lost to Follow-up|0
5019814|NCT03315689|17261814|P2|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
5019815|NCT03315689|17261815|P1|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
5019816|NCT03315689|17261814|P2|Double-blind Period = 28 Days|Withdrawal by Subject|0
5019817|NCT03315689|17261815|P1|Double-blind Period = 28 Days|Withdrawal by Subject|1
5019818|NCT03315286|17261909|P2|Overall Study|Protocol Violation|1
5019819|NCT03315286|17261910|P1|Overall Study|Protocol Violation|0
5019820|NCT03315286|17261909|P2|Overall Study|Withdrawal by Subject|0
5019821|NCT03315286|17261910|P1|Overall Study|Withdrawal by Subject|1
5019822|NCT03315286|17261909|P2|Overall Study|Lost to Follow-up|3
5019823|NCT03315286|17261910|P1|Overall Study|Lost to Follow-up|0
5019824|NCT03314857|17261951|P1|Overall Study|Physician Decision|1
5019825|NCT03314857|17261951|P1|Overall Study|Death|4
5019826|NCT03314662|17261985|P3|Overall Study|Death|0
5019827|NCT03314662|17261986|P2|Overall Study|Death|0
5019828|NCT03314662|17261987|P1|Overall Study|Death|2
5019829|NCT03314662|17261985|P3|Overall Study|Lost to Follow-up|4
5019830|NCT03314662|17261986|P2|Overall Study|Lost to Follow-up|4
5019831|NCT03314662|17261987|P1|Overall Study|Lost to Follow-up|5
5019832|NCT03314662|17261985|P3|Overall Study|Withdrawal by Subject|1
5019833|NCT03314662|17261986|P2|Overall Study|Withdrawal by Subject|1
5019834|NCT03314662|17261987|P1|Overall Study|Withdrawal by Subject|1
5019835|NCT03314519|17262032|P2|Overall Study|Protocol Violation|2
5019836|NCT03314519|17262033|P1|Overall Study|Protocol Violation|3
5019837|NCT03314233|17262043|P1|Overall Study|No longer eligible at time of delivery|1
5019838|NCT03313310|17262056|P2|Phase 3|Lost to Follow-up|1
5019839|NCT03313310|17262057|P1|Phase 3|Lost to Follow-up|0
5019840|NCT03313310|17262056|P2|Phase 2|Lost to Follow-up|0
5019841|NCT03313310|17262057|P1|Phase 2|Lost to Follow-up|4
5019842|NCT03313050|17262099|P4|Stage 2: 12 Months|Other|1
5019843|NCT03313050|17262100|P3|Stage 2: 12 Months|Other|0
5019844|NCT03313050|17262101|P2|Stage 2: 12 Months|Other|0
5019845|NCT03313050|17262102|P1|Stage 2: 12 Months|Other|0
5019846|NCT03313050|17262099|P4|Stage 2: 12 Months|Withdrawal by Subject|3
5019847|NCT03313050|17262100|P3|Stage 2: 12 Months|Withdrawal by Subject|0
5019848|NCT03313050|17262101|P2|Stage 2: 12 Months|Withdrawal by Subject|0
5019849|NCT03313050|17262102|P1|Stage 2: 12 Months|Withdrawal by Subject|0
5019850|NCT03313050|17262099|P4|Stage 2: 12 Months|Protocol deviation|7
5019851|NCT03313050|17262100|P3|Stage 2: 12 Months|Protocol deviation|7
5019852|NCT03313050|17262101|P2|Stage 2: 12 Months|Protocol deviation|0
5019853|NCT03313050|17262102|P1|Stage 2: 12 Months|Protocol deviation|0
5019854|NCT03313050|17262099|P4|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
5019855|NCT03313050|17262100|P3|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5019856|NCT03313050|17262101|P2|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5019857|NCT03313050|17262102|P1|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5019858|NCT03313050|17262099|P4|Stage 2: 12 Months|Lost to Follow-up|5
5019859|NCT03313050|17262100|P3|Stage 2: 12 Months|Lost to Follow-up|1
5019860|NCT03313050|17262101|P2|Stage 2: 12 Months|Lost to Follow-up|0
5019861|NCT03313050|17262102|P1|Stage 2: 12 Months|Lost to Follow-up|0
5019862|NCT03313050|17262099|P4|Stage 2: 12 Months|Death|0
5019863|NCT03313050|17262100|P3|Stage 2: 12 Months|Death|3
5019864|NCT03313050|17262101|P2|Stage 2: 12 Months|Death|0
5019865|NCT03313050|17262102|P1|Stage 2: 12 Months|Death|0
5019866|NCT03313050|17262099|P4|Stage 2: 12 Months|Adverse Event|1
5019867|NCT03313050|17262100|P3|Stage 2: 12 Months|Adverse Event|0
5019868|NCT03313050|17262101|P2|Stage 2: 12 Months|Adverse Event|0
5019869|NCT03313050|17262102|P1|Stage 2: 12 Months|Adverse Event|0
5019870|NCT03313037|17262142|P2|Overall Study|Randomized but not treated|0
5019871|NCT03313037|17262143|P1|Overall Study|Randomized but not treated|1
5019872|NCT03313037|17262142|P2|Overall Study|Lost to Follow-up|8
5019873|NCT03313037|17262143|P1|Overall Study|Lost to Follow-up|9
5019874|NCT03313037|17262142|P2|Overall Study|No longer meets eligibility criteria|7
5019875|NCT03313037|17262143|P1|Overall Study|No longer meets eligibility criteria|1
5019876|NCT03313037|17262142|P2|Overall Study|Withdrawal by Subject|3
5019877|NCT03313037|17262143|P1|Overall Study|Withdrawal by Subject|4
5019878|NCT03313037|17262142|P2|Overall Study|Other|1
5019879|NCT03313037|17262143|P1|Overall Study|Other|1
5019880|NCT03313037|17262142|P2|Overall Study|Protocol Violation|1
5019881|NCT03313037|17262143|P1|Overall Study|Protocol Violation|4
5019882|NCT03312933|17262165|P1|Overall Study|Withdrawal by Subject|3
5019883|NCT03312933|17262165|P1|Overall Study|Lost to Follow-up|36
5019884|NCT03312933|17262165|P1|Overall Study|Protocol Violation|15
5019885|NCT03312543|17262171|P2|Regression (Week 12 to Week 24)|Death|1
5019886|NCT03312543|17262172|P1|Regression (Week 12 to Week 24)|Death|0
5019887|NCT03312543|17262171|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
5019888|NCT03312543|17262172|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
5019889|NCT03312543|17262171|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
5019890|NCT03312543|17262172|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
5019891|NCT03312543|17262171|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
5019892|NCT03312543|17262172|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
5019893|NCT03312543|17262171|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
5019894|NCT03312543|17262172|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
5019895|NCT03312543|17262171|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
5019896|NCT03312543|17262172|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
5019897|NCT03312231|17262268|P5|Overall Study|Study Vaccination not Received|0
5019898|NCT03312231|17262269|P4|Overall Study|Study Vaccination not Received|0
5019899|NCT03312231|17262270|P3|Overall Study|Study Vaccination not Received|1
5019900|NCT03312231|17262271|P2|Overall Study|Study Vaccination not Received|1
5019901|NCT03312231|17262272|P1|Overall Study|Study Vaccination not Received|1
5019902|NCT03312231|17262268|P5|Overall Study|Death|0
5019903|NCT03312231|17262269|P4|Overall Study|Death|0
5019904|NCT03312231|17262270|P3|Overall Study|Death|1
5019905|NCT03312231|17262271|P2|Overall Study|Death|1
5019906|NCT03312231|17262272|P1|Overall Study|Death|0
5019907|NCT03312231|17262268|P5|Overall Study|Withdrawal by Subject|0
5019908|NCT03312231|17262269|P4|Overall Study|Withdrawal by Subject|0
5019909|NCT03312231|17262270|P3|Overall Study|Withdrawal by Subject|1
5019910|NCT03312231|17262271|P2|Overall Study|Withdrawal by Subject|3
5019911|NCT03312231|17262272|P1|Overall Study|Withdrawal by Subject|0
5019912|NCT03312231|17262268|P5|Overall Study|Lost to Follow-up|1
5019913|NCT03312231|17262269|P4|Overall Study|Lost to Follow-up|3
5019914|NCT03312231|17262270|P3|Overall Study|Lost to Follow-up|1
5019915|NCT03312231|17262271|P2|Overall Study|Lost to Follow-up|6
5019916|NCT03312231|17262272|P1|Overall Study|Lost to Follow-up|2
5019917|NCT03312114|17262474|P1|Overall Study|All the five enrolled dropped out of the|5
5019918|NCT03311841|17262484|P5|14-day Wash-out|Non-Compliance With Study Drug|0
5019919|NCT03311841|17262485|P4|14-day Wash-out|Non-Compliance With Study Drug|1
5019920|NCT03311841|17262486|P3|14-day Wash-out|Non-Compliance With Study Drug|0
5019921|NCT03311841|17262487|P2|14-day Wash-out|Non-Compliance With Study Drug|0
5019922|NCT03311841|17262488|P1|14-day Wash-out|Non-Compliance With Study Drug|0
5019923|NCT03311841|17262484|P5|14-day Wash-out|Adverse Event|0
5019924|NCT03311841|17262485|P4|14-day Wash-out|Adverse Event|0
5019925|NCT03311841|17262486|P3|14-day Wash-out|Adverse Event|0
5019926|NCT03311841|17262487|P2|14-day Wash-out|Adverse Event|1
5019927|NCT03311841|17262488|P1|14-day Wash-out|Adverse Event|0
5019928|NCT03311659|17262589|P1|Overall Study|Protocol Violation|1
5019929|NCT03311646|17262604|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
5019930|NCT03311646|17262604|P1|Overall Study|Lost to Follow-up|5
5019931|NCT03311646|17262604|P1|Overall Study|Withdrawal by Subject|5
5019932|NCT03311646|17262604|P1|Overall Study|Physician Decision|1
5019933|NCT03311373|17262611|P1|Overall Study|Withdrawal by Subject|3
5019934|NCT03311373|17262611|P1|Overall Study|Physician Decision|1
5019935|NCT03311373|17262611|P1|Overall Study|Lost to Follow-up|1
5019936|NCT03311373|17262611|P1|Overall Study|Protocol Discontinuation Criteria|3
5019937|NCT03311373|17262611|P1|Overall Study|Adverse Event|1
5019938|NCT03311230|17262669|P4|Overall Study|Unrelated injury|0
5019939|NCT03311230|17262670|P3|Overall Study|Unrelated injury|0
5019940|NCT03311230|17262671|P2|Overall Study|Unrelated injury|1
5019941|NCT03311230|17262672|P1|Overall Study|Unrelated injury|0
5019942|NCT03311230|17262669|P4|Overall Study|Withdrawal by Subject|7
5019943|NCT03311230|17262670|P3|Overall Study|Withdrawal by Subject|2
5019944|NCT03311230|17262671|P2|Overall Study|Withdrawal by Subject|4
5019945|NCT03311230|17262672|P1|Overall Study|Withdrawal by Subject|1
5019946|NCT03310775|17262696|P2|Overall Study|aggravation of depression|1
5019947|NCT03310775|17262697|P1|Overall Study|aggravation of depression|0
5019948|NCT03310775|17262696|P2|Overall Study|Lost to Follow-up|3
5019949|NCT03310775|17262697|P1|Overall Study|Lost to Follow-up|2
5019950|NCT03310723|17262715|P2|Overall Study|Protocol Violation|2
5019951|NCT03310723|17262716|P1|Overall Study|Protocol Violation|0
5019952|NCT03310723|17262715|P2|Overall Study|Withdrawal by Subject|1
5019953|NCT03310723|17262716|P1|Overall Study|Withdrawal by Subject|0
5019954|NCT03310580|17262727|P3|Overall Study|Adverse Event|0
5019955|NCT03310580|17262728|P2|Overall Study|Adverse Event|1
5019956|NCT03310580|17262729|P1|Overall Study|Adverse Event|0
5019957|NCT03310411|17262762|P4|Period 1|Adverse Event|1
5019958|NCT03310411|17262763|P3|Period 1|Adverse Event|0
5019959|NCT03310411|17262764|P2|Period 1|Adverse Event|0
5019960|NCT03310411|17262765|P1|Period 1|Adverse Event|0
5019961|NCT03310268|17262786|P3|Overall Study|(Not specified)|0
5019962|NCT03310268|17262787|P2|Overall Study|(Not specified)|5
5019963|NCT03310268|17262788|P1|Overall Study|(Not specified)|1
5019964|NCT03310021|17262819|P20|Overall Study|Lost to Follow-up|0
5019965|NCT03310021|17262820|P19|Overall Study|Lost to Follow-up|0
5019966|NCT03310021|17262821|P18|Overall Study|Lost to Follow-up|0
5019967|NCT03310021|17262822|P17|Overall Study|Lost to Follow-up|0
5019968|NCT03310021|17262823|P16|Overall Study|Lost to Follow-up|0
5019969|NCT03310021|17262824|P15|Overall Study|Lost to Follow-up|0
5019970|NCT03310021|17262825|P14|Overall Study|Lost to Follow-up|0
5019971|NCT03310021|17262826|P13|Overall Study|Lost to Follow-up|0
5019972|NCT03310021|17262827|P12|Overall Study|Lost to Follow-up|0
5019973|NCT03310021|17262828|P11|Overall Study|Lost to Follow-up|1
5019974|NCT03310021|17262829|P10|Overall Study|Lost to Follow-up|0
5019975|NCT03310021|17262830|P9|Overall Study|Lost to Follow-up|0
5019976|NCT03310021|17262831|P8|Overall Study|Lost to Follow-up|0
5019977|NCT03310021|17262832|P7|Overall Study|Lost to Follow-up|0
5019978|NCT03310021|17262833|P6|Overall Study|Lost to Follow-up|0
5019979|NCT03310021|17262834|P5|Overall Study|Lost to Follow-up|0
5019980|NCT03310021|17262835|P4|Overall Study|Lost to Follow-up|0
5019981|NCT03310021|17262836|P3|Overall Study|Lost to Follow-up|0
5019982|NCT03310021|17262837|P2|Overall Study|Lost to Follow-up|0
5019983|NCT03310021|17262838|P1|Overall Study|Lost to Follow-up|0
5019984|NCT03310021|17262819|P20|Overall Study|Withdrawal by Subject|0
5019985|NCT03310021|17262820|P19|Overall Study|Withdrawal by Subject|0
5019986|NCT03310021|17262821|P18|Overall Study|Withdrawal by Subject|0
5019987|NCT03310021|17262822|P17|Overall Study|Withdrawal by Subject|0
5019988|NCT03310021|17262823|P16|Overall Study|Withdrawal by Subject|0
5019989|NCT03310021|17262824|P15|Overall Study|Withdrawal by Subject|0
5019990|NCT03310021|17262825|P14|Overall Study|Withdrawal by Subject|0
5019991|NCT03310021|17262826|P13|Overall Study|Withdrawal by Subject|0
5019992|NCT03310021|17262827|P12|Overall Study|Withdrawal by Subject|0
5019993|NCT03310021|17262828|P11|Overall Study|Withdrawal by Subject|0
5019994|NCT03310021|17262829|P10|Overall Study|Withdrawal by Subject|0
5019995|NCT03310021|17262830|P9|Overall Study|Withdrawal by Subject|0
5019996|NCT03310021|17262831|P8|Overall Study|Withdrawal by Subject|0
5019997|NCT03310021|17262832|P7|Overall Study|Withdrawal by Subject|1
5019998|NCT03310021|17262833|P6|Overall Study|Withdrawal by Subject|0
5019999|NCT03310021|17262834|P5|Overall Study|Withdrawal by Subject|0
5020000|NCT03310021|17262835|P4|Overall Study|Withdrawal by Subject|0
5020001|NCT03310021|17262836|P3|Overall Study|Withdrawal by Subject|0
5020002|NCT03310021|17262837|P2|Overall Study|Withdrawal by Subject|0
5020003|NCT03310021|17262838|P1|Overall Study|Withdrawal by Subject|0
5020004|NCT03309943|17262982|P2|Overall Study|Inappropriate behavior towards staff|1
5020005|NCT03309943|17262983|P1|Overall Study|Inappropriate behavior towards staff|0
5020006|NCT03309943|17262982|P2|Overall Study|Withdrawal by Subject|1
5020007|NCT03309943|17262983|P1|Overall Study|Withdrawal by Subject|0
5020008|NCT03309696|17263046|P4|Overall Study|Analysis of TEP data could not be completed|0
5020009|NCT03309696|17263047|P3|Overall Study|Analysis of TEP data could not be completed|0
5020010|NCT03309696|17263048|P2|Overall Study|Analysis of TEP data could not be completed|5
5020011|NCT03309696|17263049|P1|Overall Study|Analysis of TEP data could not be completed|0
5020012|NCT03309202|17263068|P4|Overall Study|Lost to Follow-up|0
5020013|NCT03309202|17263069|P3|Overall Study|Lost to Follow-up|0
5020014|NCT03309202|17263070|P2|Overall Study|Lost to Follow-up|0
5020015|NCT03309202|17263071|P1|Overall Study|Lost to Follow-up|1
5020016|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
5020017|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
5020018|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
5020019|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
5020020|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
5020021|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
5020022|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
5020023|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
5020024|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
5020025|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
5020026|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
5020027|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
5020028|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
5020029|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
5020030|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
5020031|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Adverse Event|1
5020032|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Adverse Event|1
5020033|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Adverse Event|4
5020034|NCT03308968|17263165|P3|Open-Label Period (12 Weeks)|Other than specified|1
5020035|NCT03308968|17263166|P2|Open-Label Period (12 Weeks)|Other than specified|2
5020036|NCT03308968|17263167|P1|Open-Label Period (12 Weeks)|Other than specified|1
5020037|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Other than specified|2
5020038|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Other than specified|0
5020039|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Other than specified|1
5020040|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
5020041|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
5020042|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
5020043|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
5020044|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
5020045|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
5020046|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
5020047|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
5020048|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
5020049|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
5020050|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
5020051|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
5020052|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
5020053|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
5020054|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
5020055|NCT03308968|17263165|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
5020056|NCT03308968|17263166|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
5020057|NCT03308968|17263167|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
5020058|NCT03308825|17263245|P4|Overall Study|Protocol Violation|0
5020059|NCT03308825|17263246|P3|Overall Study|Protocol Violation|0
5020060|NCT03308825|17263247|P2|Overall Study|Protocol Violation|2
5020061|NCT03308825|17263248|P1|Overall Study|Protocol Violation|0
5020062|NCT03308825|17263245|P4|Overall Study|Lost to Follow-up|0
5020063|NCT03308825|17263246|P3|Overall Study|Lost to Follow-up|1
5020064|NCT03308825|17263247|P2|Overall Study|Lost to Follow-up|2
5020065|NCT03308825|17263248|P1|Overall Study|Lost to Follow-up|2
5020066|NCT03307252|17263336|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
5020067|NCT03307252|17263337|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020068|NCT03307252|17263338|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020069|NCT03307252|17263339|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020070|NCT03307252|17263340|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020071|NCT03307252|17263341|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020072|NCT03307252|17263342|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020073|NCT03307252|17263343|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020074|NCT03307252|17263344|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020075|NCT03307252|17263345|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020076|NCT03307252|17263346|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5020077|NCT03307252|17263336|P11|Part 2, Period 4|Other than listed|0
5020078|NCT03307252|17263337|P10|Part 2, Period 4|Other than listed|0
5020079|NCT03307252|17263338|P9|Part 2, Period 4|Other than listed|0
5020080|NCT03307252|17263339|P8|Part 2, Period 4|Other than listed|0
5020081|NCT03307252|17263340|P7|Part 2, Period 4|Other than listed|1
5020082|NCT03307252|17263341|P6|Part 2, Period 4|Other than listed|0
5020083|NCT03307252|17263342|P5|Part 2, Period 4|Other than listed|0
5020084|NCT03307252|17263343|P4|Part 2, Period 4|Other than listed|0
5020085|NCT03307252|17263344|P3|Part 2, Period 4|Other than listed|0
5020086|NCT03307252|17263345|P2|Part 2, Period 4|Other than listed|0
5020087|NCT03307252|17263346|P1|Part 2, Period 4|Other than listed|0
5020088|NCT03307252|17263336|P11|Part 2, Period 3|Other than listed|0
5020089|NCT03307252|17263337|P10|Part 2, Period 3|Other than listed|0
5020090|NCT03307252|17263338|P9|Part 2, Period 3|Other than listed|0
5020091|NCT03307252|17263339|P8|Part 2, Period 3|Other than listed|0
5020092|NCT03307252|17263340|P7|Part 2, Period 3|Other than listed|0
5020093|NCT03307252|17263341|P6|Part 2, Period 3|Other than listed|0
5020094|NCT03307252|17263342|P5|Part 2, Period 3|Other than listed|1
5020095|NCT03307252|17263343|P4|Part 2, Period 3|Other than listed|0
5020096|NCT03307252|17263344|P3|Part 2, Period 3|Other than listed|0
5020097|NCT03307252|17263345|P2|Part 2, Period 3|Other than listed|0
5020098|NCT03307252|17263346|P1|Part 2, Period 3|Other than listed|0
5020099|NCT03307252|17263336|P11|Part 2, Period 1|Treatment not received|0
5020100|NCT03307252|17263337|P10|Part 2, Period 1|Treatment not received|0
5020101|NCT03307252|17263338|P9|Part 2, Period 1|Treatment not received|0
5020102|NCT03307252|17263339|P8|Part 2, Period 1|Treatment not received|0
5020103|NCT03307252|17263340|P7|Part 2, Period 1|Treatment not received|0
5020104|NCT03307252|17263341|P6|Part 2, Period 1|Treatment not received|1
5020105|NCT03307252|17263342|P5|Part 2, Period 1|Treatment not received|0
5020106|NCT03307252|17263343|P4|Part 2, Period 1|Treatment not received|0
5020107|NCT03307252|17263344|P3|Part 2, Period 1|Treatment not received|0
5020108|NCT03307252|17263345|P2|Part 2, Period 1|Treatment not received|0
5020109|NCT03307252|17263346|P1|Part 2, Period 1|Treatment not received|0
5020110|NCT03307174|17263383|P2|Overall Study|Intrathecal catheter placement|1
5020111|NCT03307174|17263384|P1|Overall Study|Intrathecal catheter placement|0
5020112|NCT03307174|17263383|P2|Overall Study|Planned epidural removal|0
5020113|NCT03307174|17263384|P1|Overall Study|Planned epidural removal|1
5020114|NCT03307174|17263383|P2|Overall Study|Nonfunctional epidural|1
5020115|NCT03307174|17263384|P1|Overall Study|Nonfunctional epidural|1
5020116|NCT03307174|17263383|P2|Overall Study|Hypotension|0
5020117|NCT03307174|17263384|P1|Overall Study|Hypotension|6
5020118|NCT03307174|17263383|P2|Overall Study|Aborted Surgery|2
5020119|NCT03307174|17263384|P1|Overall Study|Aborted Surgery|1
5020120|NCT03307174|17263383|P2|Overall Study|Unplanned ICU Administrion|3
5020121|NCT03307174|17263384|P1|Overall Study|Unplanned ICU Administrion|5
5020122|NCT03306277|17263665|P1|Overall Study|Withdrawal by Subject|1
5020123|NCT03306277|17263665|P1|Overall Study|Adverse Event|1
5020124|NCT03306277|17263665|P1|Overall Study|Death|1
5020125|NCT03306043|17263676|P1|Overall Study|Withdrawal by Subject|2
5020126|NCT03306043|17263676|P1|Overall Study|Lost to Follow-up|1
5020127|NCT03306043|17263676|P1|Overall Study|Adverse Event|1
5020128|NCT03305770|17263702|P2|Overall Study|Subject moved|0
5020129|NCT03305770|17263703|P1|Overall Study|Subject moved|1
5020130|NCT03305770|17263702|P2|Overall Study|Physician Decision - prior to dispense|1
5020131|NCT03305770|17263703|P1|Overall Study|Physician Decision - prior to dispense|0
5020132|NCT03305731|17263711|P1|Overall Study|Protocol Violation|1
5020133|NCT03305575|17263722|P2|Overall Study|Physician Decision|0
5020134|NCT03305575|17263723|P1|Overall Study|Physician Decision|1
5020135|NCT03305419|17263743|P8|Part B (14 Days)|Physician Decision|0
5020136|NCT03305419|17263744|P7|Part B (14 Days)|Physician Decision|1
5020137|NCT03305419|17263745|P6|Part B (14 Days)|Physician Decision|8
5020138|NCT03305419|17263746|P5|Part B (14 Days)|Physician Decision|2
5020139|NCT03305419|17263747|P4|Part B (14 Days)|Physician Decision|0
5020140|NCT03305419|17263748|P3|Part B (14 Days)|Physician Decision|0
5020141|NCT03305419|17263749|P2|Part B (14 Days)|Physician Decision|0
5020142|NCT03305419|17263750|P1|Part B (14 Days)|Physician Decision|0
5020143|NCT03305419|17263743|P8|Part B (14 Days)|Adverse Event|0
5020144|NCT03305419|17263744|P7|Part B (14 Days)|Adverse Event|4
5020145|NCT03305419|17263745|P6|Part B (14 Days)|Adverse Event|2
5020146|NCT03305419|17263746|P5|Part B (14 Days)|Adverse Event|1
5020147|NCT03305419|17263747|P4|Part B (14 Days)|Adverse Event|0
5020148|NCT03305419|17263748|P3|Part B (14 Days)|Adverse Event|0
5020149|NCT03305419|17263749|P2|Part B (14 Days)|Adverse Event|0
5020150|NCT03305419|17263750|P1|Part B (14 Days)|Adverse Event|0
5020151|NCT03305419|17263743|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020152|NCT03305419|17263744|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020153|NCT03305419|17263745|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020154|NCT03305419|17263746|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020155|NCT03305419|17263747|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020156|NCT03305419|17263748|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020157|NCT03305419|17263749|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5020158|NCT03305419|17263750|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
5020159|NCT03305419|17263743|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020160|NCT03305419|17263744|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020161|NCT03305419|17263745|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020162|NCT03305419|17263746|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020163|NCT03305419|17263747|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020164|NCT03305419|17263748|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020165|NCT03305419|17263749|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5020166|NCT03305419|17263750|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
5020167|NCT03305419|17263743|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020168|NCT03305419|17263744|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020169|NCT03305419|17263745|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020170|NCT03305419|17263746|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020171|NCT03305419|17263747|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020172|NCT03305419|17263748|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020173|NCT03305419|17263749|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
5020174|NCT03305419|17263750|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5020175|NCT03305055|17263891|P2|Overall Study|Adverse Event|1
5020176|NCT03305055|17263892|P1|Overall Study|Adverse Event|1
5020177|NCT03305055|17263891|P2|Overall Study|Withdrawal by Subject|1
5020178|NCT03305055|17263892|P1|Overall Study|Withdrawal by Subject|0
5020179|NCT03304873|17263910|P2|Overall Study|Lost to Follow-up|8
5020180|NCT03304873|17263911|P1|Overall Study|Lost to Follow-up|1
5020181|NCT03303521|17264017|P2|Overall Study|Adverse Event|0
5020182|NCT03303521|17264018|P1|Overall Study|Adverse Event|1
5020183|NCT03303521|17264017|P2|Overall Study|Non-comliance to study protocol|1
5020184|NCT03303521|17264018|P1|Overall Study|Non-comliance to study protocol|0
5020185|NCT03303521|17264017|P2|Overall Study|Transferred to non-study dialysis center|0
5020186|NCT03303521|17264018|P1|Overall Study|Transferred to non-study dialysis center|1
5020187|NCT03303521|17264017|P2|Overall Study|Investigational product discontinuation|1
5020188|NCT03303521|17264018|P1|Overall Study|Investigational product discontinuation|0
5020189|NCT03303521|17264017|P2|Overall Study|Kidney transplantation|1
5020190|NCT03303521|17264018|P1|Overall Study|Kidney transplantation|0
5020191|NCT03303521|17264017|P2|Overall Study|Death|0
5020192|NCT03303521|17264018|P1|Overall Study|Death|1
5020193|NCT03303521|17264017|P2|Overall Study|Withdrawal by Subject|0
5020194|NCT03303521|17264018|P1|Overall Study|Withdrawal by Subject|2
5020195|NCT03303417|17264028|P2|Overall Study|Withdrawal by Subject|1
5020196|NCT03303417|17264029|P1|Overall Study|Withdrawal by Subject|1
5020197|NCT03302975|17264066|P1|Overall Study|Lost to Follow-up|4
5020198|NCT03302936|17264074|P2|Overall Study|Protocol Violation|4
5020199|NCT03302936|17264075|P1|Overall Study|Protocol Violation|3
5020200|NCT03302559|17264115|P1|Overall Study|Withdrew Consent|3
5020201|NCT03302559|17264115|P1|Overall Study|Lost to Follow-up|1
5020202|NCT03302559|17264115|P1|Overall Study|Adverse Event|2
5020203|NCT03302247|17264133|P1|Overall Study|Death|1
5020204|NCT03302247|17264133|P1|Overall Study|the study has closed prematurely|2
5020205|NCT03301844|17264140|P2|Overall Study|suspected colon cancer|1
5020206|NCT03301844|17264141|P1|Overall Study|suspected colon cancer|1
5020207|NCT03301740|17264168|P2|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
5020208|NCT03301740|17264169|P1|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
5020209|NCT03301740|17264168|P2|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
5020210|NCT03301740|17264169|P1|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
5020211|NCT03301714|17264212|P3|Overall Study|Did not receive allocated intervention|3
5020212|NCT03301714|17264213|P2|Overall Study|Did not receive allocated intervention|2
5020213|NCT03301714|17264214|P1|Overall Study|Did not receive allocated intervention|0
5020214|NCT03301714|17264212|P3|Overall Study|Lost to Follow-up|4
5020215|NCT03301714|17264213|P2|Overall Study|Lost to Follow-up|4
5020216|NCT03301714|17264214|P1|Overall Study|Lost to Follow-up|10
5020217|NCT03301649|17264231|P3|Overall Study|Other than specified|0
5020218|NCT03301649|17264232|P2|Overall Study|Other than specified|3
5020219|NCT03301649|17264233|P1|Overall Study|Other than specified|5
5020220|NCT03301649|17264231|P3|Overall Study|Withdrawal by Subject|0
5020221|NCT03301649|17264232|P2|Overall Study|Withdrawal by Subject|4
5020222|NCT03301649|17264233|P1|Overall Study|Withdrawal by Subject|10
5020223|NCT03301649|17264231|P3|Overall Study|Protocol Violation|1
5020224|NCT03301649|17264232|P2|Overall Study|Protocol Violation|1
5020225|NCT03301649|17264233|P1|Overall Study|Protocol Violation|0
5020226|NCT03301649|17264231|P3|Overall Study|Lost to Follow-up|3
5020227|NCT03301649|17264232|P2|Overall Study|Lost to Follow-up|11
5020228|NCT03301649|17264233|P1|Overall Study|Lost to Follow-up|11
5020229|NCT03301649|17264231|P3|Overall Study|Need alternate therapy due to live lice|81
5020230|NCT03301649|17264232|P2|Overall Study|Need alternate therapy due to live lice|25
5020231|NCT03301649|17264233|P1|Overall Study|Need alternate therapy due to live lice|17
5020232|NCT03301155|17264316|P2|Overall Study|Сompliance with exclusion criteria|7
5020233|NCT03301155|17264317|P1|Overall Study|Сompliance with exclusion criteria|8
5020234|NCT03300570|17264352|P2|Overall Study|Inadequate bowel prep|0
5020235|NCT03300570|17264353|P1|Overall Study|Inadequate bowel prep|1
5020236|NCT03300570|17264352|P2|Overall Study|Withdrawal by Subject|0
5020237|NCT03300570|17264353|P1|Overall Study|Withdrawal by Subject|1
5020238|NCT03300570|17264352|P2|Overall Study|Adverse Event|1
5020239|NCT03300570|17264353|P1|Overall Study|Adverse Event|0
5020240|NCT03300024|17264376|P2|Overall Study|Physician Decision|6
5020241|NCT03300024|17264377|P1|Overall Study|Physician Decision|4
5020242|NCT03299686|17264431|P2|Follow-up Epoch|Subject/Guardian Decision|1
5020243|NCT03299686|17264432|P1|Follow-up Epoch|Subject/Guardian Decision|0
5020244|NCT03299686|17264431|P2|Treatment Epoch|Adverse Event|4
5020245|NCT03299686|17264432|P1|Treatment Epoch|Adverse Event|8
5020246|NCT03299686|17264431|P2|Treatment Epoch|Physician Decision|0
5020247|NCT03299686|17264432|P1|Treatment Epoch|Physician Decision|1
5020248|NCT03299686|17264431|P2|Treatment Epoch|Subject/Guardian Decision|0
5020249|NCT03299686|17264432|P1|Treatment Epoch|Subject/Guardian Decision|2
5020250|NCT03299049|17264450|P2|Overall Study|Adverse Event|13
5020251|NCT03299049|17264451|P1|Overall Study|Adverse Event|12
5020252|NCT03299049|17264450|P2|Overall Study|Lack of Efficacy|3
5020253|NCT03299049|17264451|P1|Overall Study|Lack of Efficacy|9
5020254|NCT03299049|17264450|P2|Overall Study|Protocol Violation|1
5020255|NCT03299049|17264451|P1|Overall Study|Protocol Violation|1
5020256|NCT03299049|17264450|P2|Overall Study|Pregnancy|3
5020257|NCT03299049|17264451|P1|Overall Study|Pregnancy|1
5020258|NCT03299049|17264450|P2|Overall Study|Lost to Follow-up|0
5020259|NCT03299049|17264451|P1|Overall Study|Lost to Follow-up|2
5020260|NCT03299049|17264450|P2|Overall Study|Physician Decision|1
5020261|NCT03299049|17264451|P1|Overall Study|Physician Decision|5
5020262|NCT03299049|17264450|P2|Overall Study|Withdrawal by Subject|21
5020263|NCT03299049|17264451|P1|Overall Study|Withdrawal by Subject|6
5020264|NCT03299049|17264450|P2|Overall Study|On-going|481
5020265|NCT03299049|17264451|P1|Overall Study|On-going|486
5020266|NCT03298867|17264550|P2|Overall Study|Continued in the Follow-Up Period|1
5020267|NCT03298867|17264551|P1|Overall Study|Continued in the Follow-Up Period|0
5020268|NCT03298867|17264550|P2|Overall Study|Did not Continue in the Follow-Up Period|1
5020269|NCT03298867|17264551|P1|Overall Study|Did not Continue in the Follow-Up Period|2
5020270|NCT03298412|17264567|P1|Run-in Period|Decision by Sponsor|6
5020271|NCT03298412|17264567|P1|Run-in Period|Ineligibility Determined|1
5020272|NCT03298412|17264567|P1|Run-in Period|Disease Progression|1
5020273|NCT03298412|17264567|P1|Run-in Period|Other, Not Specified|1
5020274|NCT03297294|17264678|P5|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5020275|NCT03297294|17264679|P4|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
5020276|NCT03297294|17264680|P3|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5020277|NCT03297294|17264681|P2|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5020278|NCT03297294|17264682|P1|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5020279|NCT03297294|17264678|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
5020280|NCT03297294|17264679|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
5020281|NCT03297294|17264680|P3|Double-Blind Treatment Period (DB)|Physician Decision|0
5020282|NCT03297294|17264681|P2|Double-Blind Treatment Period (DB)|Physician Decision|1
5020283|NCT03297294|17264682|P1|Double-Blind Treatment Period (DB)|Physician Decision|1
5020284|NCT03297294|17264678|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
5020285|NCT03297294|17264679|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
5020286|NCT03297294|17264680|P3|Double-Blind Treatment Period (DB)|Adverse Event|0
5020287|NCT03297294|17264681|P2|Double-Blind Treatment Period (DB)|Adverse Event|1
5020288|NCT03297294|17264682|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
5020289|NCT03297294|17264678|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5020290|NCT03297294|17264679|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5020291|NCT03297294|17264680|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5020292|NCT03297294|17264681|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
5020293|NCT03297294|17264682|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
5020294|NCT03297294|17264678|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5020295|NCT03297294|17264679|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5020296|NCT03297294|17264680|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5020297|NCT03297294|17264681|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
5020298|NCT03297294|17264682|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
5020299|NCT03297021|17264724|P3|Overall Study|Missing Post-Op Data|1
5020300|NCT03297021|17264725|P2|Overall Study|Missing Post-Op Data|2
5020301|NCT03297021|17264726|P1|Overall Study|Missing Post-Op Data|1
5020302|NCT03297021|17264724|P3|Overall Study|Incomplete/illegible data sheet|3
5020303|NCT03297021|17264725|P2|Overall Study|Incomplete/illegible data sheet|2
5020304|NCT03297021|17264726|P1|Overall Study|Incomplete/illegible data sheet|4
5020305|NCT03296566|17264790|P2|Overall Study|Withdrawal by Subject|3
5020306|NCT03296566|17264791|P1|Overall Study|Withdrawal by Subject|0
5020307|NCT03296566|17264790|P2|Overall Study|Lost to Follow-up|46
5020308|NCT03296566|17264791|P1|Overall Study|Lost to Follow-up|19
5020309|NCT03295201|17264888|P2|Overall Study|Hospital admission|1
5020310|NCT03295201|17264889|P1|Overall Study|Hospital admission|0
5020311|NCT03295201|17264888|P2|Overall Study|Lost to Follow-up|1
5020312|NCT03295201|17264889|P1|Overall Study|Lost to Follow-up|1
5020313|NCT03294681|17264941|P1|Overall Study|Withdrawal by Subject|1
5020314|NCT03294538|17264979|P3|Overall Study|Outside of Visit Window|1
5020315|NCT03294538|17264980|P2|Overall Study|Outside of Visit Window|4
5020316|NCT03294538|17264981|P1|Overall Study|Outside of Visit Window|4
5020317|NCT03294538|17264979|P3|Overall Study|Lost to Follow-up|0
5020318|NCT03294538|17264980|P2|Overall Study|Lost to Follow-up|0
5020319|NCT03294538|17264981|P1|Overall Study|Lost to Follow-up|1
5020320|NCT03294538|17264979|P3|Overall Study|Adverse Event|1
5020321|NCT03294538|17264980|P2|Overall Study|Adverse Event|1
5020322|NCT03294538|17264981|P1|Overall Study|Adverse Event|0
5020323|NCT03293654|17264999|P3|Overall Study|Lost to Follow-up|0
5020324|NCT03293654|17265000|P2|Overall Study|Lost to Follow-up|1
5020325|NCT03293654|17265001|P1|Overall Study|Lost to Follow-up|0
5020326|NCT03293485|17265039|P1|Overall Study|Withdrawal by Subject|2
5020327|NCT03293485|17265039|P1|Overall Study|Screen Failure|2
5020328|NCT03293485|17265039|P1|Overall Study|Death|1
5020329|NCT03293394|17265050|P2|Follow-up (6 Months)|Adverse Event|2
5020330|NCT03293394|17265051|P1|Follow-up (6 Months)|Adverse Event|4
5020331|NCT03292640|17265113|P2|Overall Study|Lost to Follow-up|24
5020332|NCT03292640|17265114|P1|Overall Study|Lost to Follow-up|24
5020333|NCT03292640|17265113|P2|Overall Study|Adverse Event|2
5020334|NCT03292640|17265114|P1|Overall Study|Adverse Event|20
5020335|NCT03292640|17265113|P2|Overall Study|Withdrawal by Subject|16
5020336|NCT03292640|17265114|P1|Overall Study|Withdrawal by Subject|17
5020337|NCT03292016|17265157|P6|Second Washout|Adverse Event|0
5020338|NCT03292016|17265158|P5|Second Washout|Adverse Event|0
5020339|NCT03292016|17265159|P4|Second Washout|Adverse Event|0
5020340|NCT03292016|17265160|P3|Second Washout|Adverse Event|0
5020341|NCT03292016|17265161|P2|Second Washout|Adverse Event|1
5020342|NCT03292016|17265162|P1|Second Washout|Adverse Event|0
5020343|NCT03291288|17265204|P2|Pexidartinib Only|Ongoing|13
5020344|NCT03291288|17265205|P1|Pexidartinib Only|Ongoing|0
5020345|NCT03291288|17265204|P2|Pexidartinib Only|Other|2
5020346|NCT03291288|17265205|P1|Pexidartinib Only|Other|0
5020347|NCT03291288|17265204|P2|Pexidartinib Only|Patient request|1
5020348|NCT03291288|17265205|P1|Pexidartinib Only|Patient request|0
5020349|NCT03291288|17265204|P2|Pexidartinib Only|Disease progression|8
5020350|NCT03291288|17265205|P1|Pexidartinib Only|Disease progression|0
5020351|NCT03291288|17265204|P2|Pexidartinib Only|Adverse Event|1
5020352|NCT03291288|17265205|P1|Pexidartinib Only|Adverse Event|0
5020353|NCT03291288|17265204|P2|Drug-drug Interaction Phase|Did not receive treatment|0
5020354|NCT03291288|17265205|P1|Drug-drug Interaction Phase|Did not receive treatment|2
5020355|NCT03291288|17265204|P2|Drug-drug Interaction Phase|Disease progression|0
5020356|NCT03291288|17265205|P1|Drug-drug Interaction Phase|Disease progression|2
5020357|NCT03291288|17265204|P2|Drug-drug Interaction Phase|Adverse Event|0
5020358|NCT03291288|17265205|P1|Drug-drug Interaction Phase|Adverse Event|3
5020359|NCT03290300|17265279|P1|Overall Study|Lost to Follow-up|3
5020360|NCT03289676|17265312|P2|Overall Study|Lost to Follow-up|1
5020361|NCT03289676|17265313|P1|Overall Study|Lost to Follow-up|0
5020362|NCT03289676|17265312|P2|Overall Study|Protocol Violation|0
5020363|NCT03289676|17265313|P1|Overall Study|Protocol Violation|2
5020364|NCT03289676|17265312|P2|Overall Study|Withdrawal by Subject|0
5020365|NCT03289676|17265313|P1|Overall Study|Withdrawal by Subject|2
5020366|NCT03289533|17265323|P1|Overall Study|Terminated from study by sponsor|10
5020367|NCT03289533|17265323|P1|Overall Study|Death|12
5020368|NCT03289208|17265384|P3|Overall Study|Adverse Event|0
5020369|NCT03289208|17265385|P2|Overall Study|Adverse Event|0
5020370|NCT03289208|17265386|P1|Overall Study|Adverse Event|1
5020371|NCT03288779|17265403|P1|Overall Study|Withdrawal by Subject|3
5020372|NCT03287869|17265410|P2|Overall Study|Reason not Specified|3
5020373|NCT03287869|17265411|P1|Overall Study|Reason not Specified|6
5020374|NCT03287869|17265410|P2|Overall Study|Physician Decision|5
5020375|NCT03287869|17265411|P1|Overall Study|Physician Decision|5
5020376|NCT03287869|17265410|P2|Overall Study|Early Closure of the Site|1
5020377|NCT03287869|17265411|P1|Overall Study|Early Closure of the Site|0
5020378|NCT03287869|17265410|P2|Overall Study|Withdrawal by Subject|43
5020379|NCT03287869|17265411|P1|Overall Study|Withdrawal by Subject|36
5020380|NCT03287869|17265410|P2|Overall Study|Protocol Deviation|1
5020381|NCT03287869|17265411|P1|Overall Study|Protocol Deviation|2
5020382|NCT03287869|17265410|P2|Overall Study|Progressive Disease|0
5020383|NCT03287869|17265411|P1|Overall Study|Progressive Disease|1
5020384|NCT03287869|17265410|P2|Overall Study|Non-Compliance With Study Drug|9
5020385|NCT03287869|17265411|P1|Overall Study|Non-Compliance With Study Drug|5
5020386|NCT03287869|17265410|P2|Overall Study|Lost to Follow-up|19
5020387|NCT03287869|17265411|P1|Overall Study|Lost to Follow-up|13
5020388|NCT03287869|17265410|P2|Overall Study|Lack of Efficacy|0
5020389|NCT03287869|17265411|P1|Overall Study|Lack of Efficacy|1
5020390|NCT03287869|17265410|P2|Overall Study|Adverse Event|12
5020391|NCT03287869|17265411|P1|Overall Study|Adverse Event|14
5020392|NCT03287804|17265432|P1|Overall Study|Progressive disease|8
5020393|NCT03287804|17265432|P1|Overall Study|Physician Decision|2
5020394|NCT03287804|17265432|P1|Overall Study|Death|1
5020395|NCT03287791|17265448|P3|Overall Study|Did not meet inclusion criteria|0
5020396|NCT03287791|17265449|P2|Overall Study|Did not meet inclusion criteria|0
5020397|NCT03287791|17265450|P1|Overall Study|Did not meet inclusion criteria|1
5020398|NCT03287791|17265448|P3|Overall Study|Non-compliance|0
5020399|NCT03287791|17265449|P2|Overall Study|Non-compliance|1
5020400|NCT03287791|17265450|P1|Overall Study|Non-compliance|0
5020401|NCT03287791|17265448|P3|Overall Study|Too much time between 2 visits|0
5020402|NCT03287791|17265449|P2|Overall Study|Too much time between 2 visits|1
5020403|NCT03287791|17265450|P1|Overall Study|Too much time between 2 visits|0
5020404|NCT03287791|17265448|P3|Overall Study|Participant was enrolled at 2 sites|1
5020405|NCT03287791|17265449|P2|Overall Study|Participant was enrolled at 2 sites|0
5020406|NCT03287791|17265450|P1|Overall Study|Participant was enrolled at 2 sites|1
5020407|NCT03287791|17265448|P3|Overall Study|Protocol Violation|1
5020408|NCT03287791|17265449|P2|Overall Study|Protocol Violation|2
5020409|NCT03287791|17265450|P1|Overall Study|Protocol Violation|7
5020410|NCT03287791|17265448|P3|Overall Study|Lost to Follow-up|11
5020411|NCT03287791|17265449|P2|Overall Study|Lost to Follow-up|14
5020412|NCT03287791|17265450|P1|Overall Study|Lost to Follow-up|8
5020413|NCT03287791|17265448|P3|Overall Study|Missed more than 6 consecutive doses|2
5020414|NCT03287791|17265449|P2|Overall Study|Missed more than 6 consecutive doses|2
5020415|NCT03287791|17265450|P1|Overall Study|Missed more than 6 consecutive doses|3
5020416|NCT03287791|17265448|P3|Overall Study|Withdrawal by Subject|17
5020417|NCT03287791|17265449|P2|Overall Study|Withdrawal by Subject|12
5020418|NCT03287791|17265450|P1|Overall Study|Withdrawal by Subject|12
5020419|NCT03287791|17265448|P3|Overall Study|Adverse Event|3
5020420|NCT03287791|17265449|P2|Overall Study|Adverse Event|4
5020421|NCT03287791|17265450|P1|Overall Study|Adverse Event|0
5020422|NCT03287791|17265448|P3|Overall Study|Insufficient Therapeutic Response|1
5020423|NCT03287791|17265449|P2|Overall Study|Insufficient Therapeutic Response|0
5020424|NCT03287791|17265450|P1|Overall Study|Insufficient Therapeutic Response|0
5020425|NCT03287622|17265463|P2|Overall Study|surgery related|2
5020426|NCT03287622|17265464|P1|Overall Study|surgery related|0
5020427|NCT03287622|17265463|P2|Overall Study|prolonged Length of stay|0
5020428|NCT03287622|17265464|P1|Overall Study|prolonged Length of stay|2
5020429|NCT03287622|17265463|P2|Overall Study|No prescripion after surgery|31
5020430|NCT03287622|17265464|P1|Overall Study|No prescripion after surgery|28
5020431|NCT03287622|17265463|P2|Overall Study|Lost to Follow-up|15
5020432|NCT03287622|17265464|P1|Overall Study|Lost to Follow-up|27
5020433|NCT03287622|17265463|P2|Overall Study|Withdrawal by Subject|0
5020434|NCT03287622|17265464|P1|Overall Study|Withdrawal by Subject|1
5020435|NCT03287089|17265486|P2|Overall Study|Withdrawal by Subject|2
5020436|NCT03287089|17265487|P1|Overall Study|Withdrawal by Subject|0
5020437|NCT03287089|17265486|P2|Overall Study|Physician Decision|2
5020438|NCT03287089|17265487|P1|Overall Study|Physician Decision|0
5020439|NCT03287089|17265486|P2|Overall Study|Lost to Follow-up|2
5020440|NCT03287089|17265487|P1|Overall Study|Lost to Follow-up|0
5020441|NCT03286751|17265522|P6|Washout Period 5|Adverse Event|0
5020442|NCT03286751|17265523|P5|Washout Period 5|Adverse Event|1
5020443|NCT03286751|17265524|P4|Washout Period 5|Adverse Event|0
5020444|NCT03286751|17265525|P3|Washout Period 5|Adverse Event|0
5020445|NCT03286751|17265526|P2|Washout Period 5|Adverse Event|0
5020446|NCT03286751|17265527|P1|Washout Period 5|Adverse Event|0
5020447|NCT03286751|17265522|P6|Washout Period 2|Personal Reasons|0
5020448|NCT03286751|17265523|P5|Washout Period 2|Personal Reasons|0
5020449|NCT03286751|17265524|P4|Washout Period 2|Personal Reasons|0
5020450|NCT03286751|17265525|P3|Washout Period 2|Personal Reasons|0
5020451|NCT03286751|17265526|P2|Washout Period 2|Personal Reasons|1
5020452|NCT03286751|17265527|P1|Washout Period 2|Personal Reasons|0
5020453|NCT03286751|17265522|P6|Washout Period 1|Withdrawal by Subject|0
5020454|NCT03286751|17265523|P5|Washout Period 1|Withdrawal by Subject|1
5020455|NCT03286751|17265524|P4|Washout Period 1|Withdrawal by Subject|0
5020456|NCT03286751|17265525|P3|Washout Period 1|Withdrawal by Subject|0
5020457|NCT03286751|17265526|P2|Washout Period 1|Withdrawal by Subject|0
5020458|NCT03286751|17265527|P1|Washout Period 1|Withdrawal by Subject|0
5020459|NCT03286400|17265547|P1|Overall Study|Scheduling difficulty|4
5020460|NCT03286400|17265547|P1|Overall Study|Physician Decision|1
5020461|NCT03286400|17265547|P1|Overall Study|Lost to Follow-up|10
5020462|NCT03286400|17265547|P1|Overall Study|Death|10
5020463|NCT03286218|17265576|P12|Treatment Phase Period 4|Withdrawal by Subject|1
5020464|NCT03286218|17265577|P11|Treatment Phase Period 4|Withdrawal by Subject|0
5020465|NCT03286218|17265578|P10|Treatment Phase Period 4|Withdrawal by Subject|0
5020466|NCT03286218|17265579|P9|Treatment Phase Period 4|Withdrawal by Subject|0
5020467|NCT03286218|17265580|P8|Treatment Phase Period 4|Withdrawal by Subject|0
5020468|NCT03286218|17265581|P7|Treatment Phase Period 4|Withdrawal by Subject|0
5020469|NCT03286218|17265582|P6|Treatment Phase Period 4|Withdrawal by Subject|0
5020470|NCT03286218|17265583|P5|Treatment Phase Period 4|Withdrawal by Subject|0
5020471|NCT03286218|17265584|P4|Treatment Phase Period 4|Withdrawal by Subject|0
5020472|NCT03286218|17265585|P3|Treatment Phase Period 4|Withdrawal by Subject|0
5020473|NCT03286218|17265586|P2|Treatment Phase Period 4|Withdrawal by Subject|0
5020474|NCT03286218|17265587|P1|Treatment Phase Period 4|Withdrawal by Subject|0
5020475|NCT03286218|17265576|P12|Treatment Phase Period 1|Withdrawal by Subject|1
5020476|NCT03286218|17265577|P11|Treatment Phase Period 1|Withdrawal by Subject|0
5020477|NCT03286218|17265578|P10|Treatment Phase Period 1|Withdrawal by Subject|0
5020478|NCT03286218|17265579|P9|Treatment Phase Period 1|Withdrawal by Subject|0
5020479|NCT03286218|17265580|P8|Treatment Phase Period 1|Withdrawal by Subject|0
5020480|NCT03286218|17265581|P7|Treatment Phase Period 1|Withdrawal by Subject|0
5020481|NCT03286218|17265582|P6|Treatment Phase Period 1|Withdrawal by Subject|1
5020482|NCT03286218|17265583|P5|Treatment Phase Period 1|Withdrawal by Subject|0
5020483|NCT03286218|17265584|P4|Treatment Phase Period 1|Withdrawal by Subject|1
5020484|NCT03286218|17265585|P3|Treatment Phase Period 1|Withdrawal by Subject|1
5020485|NCT03286218|17265586|P2|Treatment Phase Period 1|Withdrawal by Subject|0
5020486|NCT03286218|17265587|P1|Treatment Phase Period 1|Withdrawal by Subject|0
5020487|NCT03286218|17265576|P12|Qualification Phase Period 2|Withdrawal by Subject|0
5020488|NCT03286218|17265577|P11|Qualification Phase Period 2|Withdrawal by Subject|0
5020489|NCT03286218|17265578|P10|Qualification Phase Period 2|Withdrawal by Subject|0
5020490|NCT03286218|17265579|P9|Qualification Phase Period 2|Withdrawal by Subject|0
5020491|NCT03286218|17265580|P8|Qualification Phase Period 2|Withdrawal by Subject|0
5020492|NCT03286218|17265581|P7|Qualification Phase Period 2|Withdrawal by Subject|0
5020493|NCT03286218|17265582|P6|Qualification Phase Period 2|Withdrawal by Subject|0
5020494|NCT03286218|17265583|P5|Qualification Phase Period 2|Withdrawal by Subject|0
5020495|NCT03286218|17265584|P4|Qualification Phase Period 2|Withdrawal by Subject|0
5020496|NCT03286218|17265585|P3|Qualification Phase Period 2|Withdrawal by Subject|0
5020497|NCT03286218|17265586|P2|Qualification Phase Period 2|Withdrawal by Subject|2
5020498|NCT03286218|17265587|P1|Qualification Phase Period 2|Withdrawal by Subject|1
5020499|NCT03286218|17265576|P12|Qualification Phase Period 2|Protocol Violation|0
5020500|NCT03286218|17265577|P11|Qualification Phase Period 2|Protocol Violation|0
5020501|NCT03286218|17265578|P10|Qualification Phase Period 2|Protocol Violation|0
5020502|NCT03286218|17265579|P9|Qualification Phase Period 2|Protocol Violation|0
5020503|NCT03286218|17265580|P8|Qualification Phase Period 2|Protocol Violation|0
5020504|NCT03286218|17265581|P7|Qualification Phase Period 2|Protocol Violation|0
5020505|NCT03286218|17265582|P6|Qualification Phase Period 2|Protocol Violation|0
5020506|NCT03286218|17265583|P5|Qualification Phase Period 2|Protocol Violation|0
5020507|NCT03286218|17265584|P4|Qualification Phase Period 2|Protocol Violation|0
5020508|NCT03286218|17265585|P3|Qualification Phase Period 2|Protocol Violation|0
5020509|NCT03286218|17265586|P2|Qualification Phase Period 2|Protocol Violation|0
5020510|NCT03286218|17265587|P1|Qualification Phase Period 2|Protocol Violation|2
5020511|NCT03286218|17265576|P12|Qualification Phase Period 2|Lost to Follow-up|0
5020512|NCT03286218|17265577|P11|Qualification Phase Period 2|Lost to Follow-up|0
5020513|NCT03286218|17265578|P10|Qualification Phase Period 2|Lost to Follow-up|0
5020514|NCT03286218|17265579|P9|Qualification Phase Period 2|Lost to Follow-up|0
5020515|NCT03286218|17265580|P8|Qualification Phase Period 2|Lost to Follow-up|0
5020516|NCT03286218|17265581|P7|Qualification Phase Period 2|Lost to Follow-up|0
5020517|NCT03286218|17265582|P6|Qualification Phase Period 2|Lost to Follow-up|0
5020518|NCT03286218|17265583|P5|Qualification Phase Period 2|Lost to Follow-up|0
5020519|NCT03286218|17265584|P4|Qualification Phase Period 2|Lost to Follow-up|0
5020520|NCT03286218|17265585|P3|Qualification Phase Period 2|Lost to Follow-up|0
5020521|NCT03286218|17265586|P2|Qualification Phase Period 2|Lost to Follow-up|1
5020522|NCT03286218|17265587|P1|Qualification Phase Period 2|Lost to Follow-up|0
5020523|NCT03286218|17265576|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020524|NCT03286218|17265577|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020525|NCT03286218|17265578|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020526|NCT03286218|17265579|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020527|NCT03286218|17265580|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020528|NCT03286218|17265581|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020529|NCT03286218|17265582|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020530|NCT03286218|17265583|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020531|NCT03286218|17265584|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020532|NCT03286218|17265585|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
5020533|NCT03286218|17265586|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
5020534|NCT03286218|17265587|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
5020535|NCT03286218|17265576|P12|Qualification Phase Period 2|Adverse Event|0
5020536|NCT03286218|17265577|P11|Qualification Phase Period 2|Adverse Event|0
5020537|NCT03286218|17265578|P10|Qualification Phase Period 2|Adverse Event|0
5020538|NCT03286218|17265579|P9|Qualification Phase Period 2|Adverse Event|0
5020539|NCT03286218|17265580|P8|Qualification Phase Period 2|Adverse Event|0
5020540|NCT03286218|17265581|P7|Qualification Phase Period 2|Adverse Event|0
5020541|NCT03286218|17265582|P6|Qualification Phase Period 2|Adverse Event|0
5020542|NCT03286218|17265583|P5|Qualification Phase Period 2|Adverse Event|0
5020543|NCT03286218|17265584|P4|Qualification Phase Period 2|Adverse Event|0
5020544|NCT03286218|17265585|P3|Qualification Phase Period 2|Adverse Event|0
5020545|NCT03286218|17265586|P2|Qualification Phase Period 2|Adverse Event|1
5020546|NCT03286218|17265587|P1|Qualification Phase Period 2|Adverse Event|0
5020547|NCT03286218|17265576|P12|Qualification Phase Period 1|Withdrawal by Subject|0
5020548|NCT03286218|17265577|P11|Qualification Phase Period 1|Withdrawal by Subject|0
5020549|NCT03286218|17265578|P10|Qualification Phase Period 1|Withdrawal by Subject|0
5020550|NCT03286218|17265579|P9|Qualification Phase Period 1|Withdrawal by Subject|0
5020551|NCT03286218|17265580|P8|Qualification Phase Period 1|Withdrawal by Subject|0
5020552|NCT03286218|17265581|P7|Qualification Phase Period 1|Withdrawal by Subject|0
5020553|NCT03286218|17265582|P6|Qualification Phase Period 1|Withdrawal by Subject|0
5020554|NCT03286218|17265583|P5|Qualification Phase Period 1|Withdrawal by Subject|0
5020555|NCT03286218|17265584|P4|Qualification Phase Period 1|Withdrawal by Subject|0
5020556|NCT03286218|17265585|P3|Qualification Phase Period 1|Withdrawal by Subject|0
5020557|NCT03286218|17265586|P2|Qualification Phase Period 1|Withdrawal by Subject|1
5020558|NCT03286218|17265587|P1|Qualification Phase Period 1|Withdrawal by Subject|0
5020559|NCT03286218|17265576|P12|Qualification Phase Period 1|Adverse Event|0
5020560|NCT03286218|17265577|P11|Qualification Phase Period 1|Adverse Event|0
5020561|NCT03286218|17265578|P10|Qualification Phase Period 1|Adverse Event|0
5020562|NCT03286218|17265579|P9|Qualification Phase Period 1|Adverse Event|0
5020563|NCT03286218|17265580|P8|Qualification Phase Period 1|Adverse Event|0
5020564|NCT03286218|17265581|P7|Qualification Phase Period 1|Adverse Event|0
5020565|NCT03286218|17265582|P6|Qualification Phase Period 1|Adverse Event|0
5020566|NCT03286218|17265583|P5|Qualification Phase Period 1|Adverse Event|0
5020567|NCT03286218|17265584|P4|Qualification Phase Period 1|Adverse Event|0
5020568|NCT03286218|17265585|P3|Qualification Phase Period 1|Adverse Event|0
5020569|NCT03286218|17265586|P2|Qualification Phase Period 1|Adverse Event|0
5020570|NCT03286218|17265587|P1|Qualification Phase Period 1|Adverse Event|1
5020571|NCT03285711|17265650|P4|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5020572|NCT03285711|17265651|P3|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5020573|NCT03285711|17265652|P2|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
5020574|NCT03285711|17265653|P1|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5020575|NCT03285711|17265650|P4|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5020576|NCT03285711|17265651|P3|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
5020577|NCT03285711|17265652|P2|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5020578|NCT03285711|17265653|P1|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5020579|NCT03285711|17265650|P4|Blinded Phase (Up to Week 16)|Protocol Violation|0
5020580|NCT03285711|17265651|P3|Blinded Phase (Up to Week 16)|Protocol Violation|0
5020581|NCT03285711|17265652|P2|Blinded Phase (Up to Week 16)|Protocol Violation|0
5020582|NCT03285711|17265653|P1|Blinded Phase (Up to Week 16)|Protocol Violation|1
5020583|NCT03285711|17265650|P4|Blinded Phase (Up to Week 16)|Adverse Event|0
5020584|NCT03285711|17265651|P3|Blinded Phase (Up to Week 16)|Adverse Event|0
5020585|NCT03285711|17265652|P2|Blinded Phase (Up to Week 16)|Adverse Event|1
5020586|NCT03285711|17265653|P1|Blinded Phase (Up to Week 16)|Adverse Event|2
5020587|NCT03285295|17265761|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5020588|NCT03285295|17265762|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5020589|NCT03285295|17265763|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5020590|NCT03285295|17265764|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5020591|NCT03285295|17265765|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
5020592|NCT03285295|17265761|P5|Alinity s Chagas|No Results Generated|0
5020593|NCT03285295|17265762|P4|Alinity s Chagas|No Results Generated|0
5020594|NCT03285295|17265763|P3|Alinity s Chagas|No Results Generated|0
5020595|NCT03285295|17265764|P2|Alinity s Chagas|No Results Generated|0
5020596|NCT03285295|17265765|P1|Alinity s Chagas|No Results Generated|105
5020597|NCT03285295|17265761|P5|Alinity s Chagas|No Results on Comparator Assay|0
5020598|NCT03285295|17265762|P4|Alinity s Chagas|No Results on Comparator Assay|0
5020599|NCT03285295|17265763|P3|Alinity s Chagas|No Results on Comparator Assay|0
5020600|NCT03285295|17265764|P2|Alinity s Chagas|No Results on Comparator Assay|0
5020601|NCT03285295|17265765|P1|Alinity s Chagas|No Results on Comparator Assay|38
5020602|NCT03285295|17265761|P5|Alinity s Chagas|Protocol Violation|0
5020603|NCT03285295|17265762|P4|Alinity s Chagas|Protocol Violation|0
5020604|NCT03285295|17265763|P3|Alinity s Chagas|Protocol Violation|0
5020605|NCT03285295|17265764|P2|Alinity s Chagas|Protocol Violation|0
5020606|NCT03285295|17265765|P1|Alinity s Chagas|Protocol Violation|76
5020607|NCT03285295|17265761|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5020608|NCT03285295|17265762|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5020609|NCT03285295|17265763|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5020610|NCT03285295|17265764|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5020611|NCT03285295|17265765|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
5020612|NCT03285295|17265761|P5|Alinity s Anti-HBc|No Results Generated|0
5020613|NCT03285295|17265762|P4|Alinity s Anti-HBc|No Results Generated|0
5020614|NCT03285295|17265763|P3|Alinity s Anti-HBc|No Results Generated|0
5020615|NCT03285295|17265764|P2|Alinity s Anti-HBc|No Results Generated|0
5020616|NCT03285295|17265765|P1|Alinity s Anti-HBc|No Results Generated|70
5020617|NCT03285295|17265761|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
5020618|NCT03285295|17265762|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
5020619|NCT03285295|17265763|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
5020620|NCT03285295|17265764|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
5020621|NCT03285295|17265765|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
5020622|NCT03285295|17265761|P5|Alinity s Anti-HBc|Protocol Violation|0
5020623|NCT03285295|17265762|P4|Alinity s Anti-HBc|Protocol Violation|0
5020624|NCT03285295|17265763|P3|Alinity s Anti-HBc|Protocol Violation|0
5020625|NCT03285295|17265764|P2|Alinity s Anti-HBc|Protocol Violation|0
5020626|NCT03285295|17265765|P1|Alinity s Anti-HBc|Protocol Violation|8
5020627|NCT03285295|17265761|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5020628|NCT03285295|17265762|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5020629|NCT03285295|17265763|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5020630|NCT03285295|17265764|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5020631|NCT03285295|17265765|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
5020632|NCT03285295|17265761|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5020633|NCT03285295|17265762|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5020634|NCT03285295|17265763|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5020635|NCT03285295|17265764|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5020636|NCT03285295|17265765|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
5020637|NCT03285295|17265761|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5020638|NCT03285295|17265762|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5020639|NCT03285295|17265763|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5020640|NCT03285295|17265764|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5020641|NCT03285295|17265765|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
5020642|NCT03285295|17265761|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5020643|NCT03285295|17265762|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5020644|NCT03285295|17265763|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5020645|NCT03285295|17265764|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5020646|NCT03285295|17265765|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
5020647|NCT03285295|17265761|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5020648|NCT03285295|17265762|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5020649|NCT03285295|17265763|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5020650|NCT03285295|17265764|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5020651|NCT03285295|17265765|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
5020652|NCT03285295|17265761|P5|Alinity s Anti-HCV|No Results Generated|0
5020653|NCT03285295|17265762|P4|Alinity s Anti-HCV|No Results Generated|0
5020654|NCT03285295|17265763|P3|Alinity s Anti-HCV|No Results Generated|0
5020655|NCT03285295|17265764|P2|Alinity s Anti-HCV|No Results Generated|0
5020656|NCT03285295|17265765|P1|Alinity s Anti-HCV|No Results Generated|71
5020657|NCT03285295|17265761|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
5020658|NCT03285295|17265762|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
5020659|NCT03285295|17265763|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
5020660|NCT03285295|17265764|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
5020661|NCT03285295|17265765|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
5020662|NCT03285295|17265761|P5|Alinity s Anti-HCV|Protocol Violation|0
5020663|NCT03285295|17265762|P4|Alinity s Anti-HCV|Protocol Violation|0
5020664|NCT03285295|17265763|P3|Alinity s Anti-HCV|Protocol Violation|0
5020665|NCT03285295|17265764|P2|Alinity s Anti-HCV|Protocol Violation|0
5020666|NCT03285295|17265765|P1|Alinity s Anti-HCV|Protocol Violation|12
5020667|NCT03285295|17265761|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5020668|NCT03285295|17265762|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5020669|NCT03285295|17265763|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5020670|NCT03285295|17265764|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5020671|NCT03285295|17265765|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
5020672|NCT03285295|17265761|P5|Alinity s HTLV I/II|No Results Generated|0
5020673|NCT03285295|17265762|P4|Alinity s HTLV I/II|No Results Generated|0
5020674|NCT03285295|17265763|P3|Alinity s HTLV I/II|No Results Generated|0
5020675|NCT03285295|17265764|P2|Alinity s HTLV I/II|No Results Generated|0
5020676|NCT03285295|17265765|P1|Alinity s HTLV I/II|No Results Generated|70
5020677|NCT03285295|17265761|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
5020678|NCT03285295|17265762|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
5020679|NCT03285295|17265763|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
5020680|NCT03285295|17265764|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
5020681|NCT03285295|17265765|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
5020682|NCT03285295|17265761|P5|Alinity s HTLV I/II|Protocol Violation|0
5020683|NCT03285295|17265762|P4|Alinity s HTLV I/II|Protocol Violation|0
5020684|NCT03285295|17265763|P3|Alinity s HTLV I/II|Protocol Violation|0
5020685|NCT03285295|17265764|P2|Alinity s HTLV I/II|Protocol Violation|0
5020686|NCT03285295|17265765|P1|Alinity s HTLV I/II|Protocol Violation|6
5020687|NCT03285295|17265761|P5|Alinity s HBsAg|No Results Generated|0
5020688|NCT03285295|17265762|P4|Alinity s HBsAg|No Results Generated|0
5020689|NCT03285295|17265763|P3|Alinity s HBsAg|No Results Generated|0
5020690|NCT03285295|17265764|P2|Alinity s HBsAg|No Results Generated|6
5020691|NCT03285295|17265765|P1|Alinity s HBsAg|No Results Generated|74
5020692|NCT03285295|17265761|P5|Alinity s HBsAg|No Result on Comparator Assay|0
5020693|NCT03285295|17265762|P4|Alinity s HBsAg|No Result on Comparator Assay|0
5020694|NCT03285295|17265763|P3|Alinity s HBsAg|No Result on Comparator Assay|0
5020695|NCT03285295|17265764|P2|Alinity s HBsAg|No Result on Comparator Assay|0
5020696|NCT03285295|17265765|P1|Alinity s HBsAg|No Result on Comparator Assay|17
5020697|NCT03285295|17265761|P5|Alinity s HBsAg|Protocol Violation|0
5020698|NCT03285295|17265762|P4|Alinity s HBsAg|Protocol Violation|0
5020699|NCT03285295|17265763|P3|Alinity s HBsAg|Protocol Violation|0
5020700|NCT03285295|17265764|P2|Alinity s HBsAg|Protocol Violation|0
5020701|NCT03285295|17265765|P1|Alinity s HBsAg|Protocol Violation|11
5020702|NCT03284229|17265799|P1|Overall Study|Lost to Follow-up|3
5020703|NCT03283709|17265833|P2|Overall Study|trial terminated|1
5020704|NCT03283709|17265834|P1|Overall Study|trial terminated|0
5020705|NCT03283696|17265866|P2|Overall Study|Withdrawal by Subject|0
5020706|NCT03283696|17265867|P1|Overall Study|Withdrawal by Subject|2
5020707|NCT03283696|17265866|P2|Overall Study|Physician Decision|6
5020708|NCT03283696|17265867|P1|Overall Study|Physician Decision|5
5020709|NCT03283319|17265912|P6|Overall Study|BARDA regulatory agency or IRB decision|0
5020710|NCT03283319|17265913|P5|Overall Study|BARDA regulatory agency or IRB decision|0
5020711|NCT03283319|17265914|P4|Overall Study|BARDA regulatory agency or IRB decision|1
5020712|NCT03283319|17265915|P3|Overall Study|BARDA regulatory agency or IRB decision|0
5020713|NCT03283319|17265916|P2|Overall Study|BARDA regulatory agency or IRB decision|0
5020714|NCT03283319|17265917|P1|Overall Study|BARDA regulatory agency or IRB decision|0
5020715|NCT03283319|17265912|P6|Overall Study|Withdrawal by Subject|1
5020716|NCT03283319|17265913|P5|Overall Study|Withdrawal by Subject|0
5020717|NCT03283319|17265914|P4|Overall Study|Withdrawal by Subject|1
5020718|NCT03283319|17265915|P3|Overall Study|Withdrawal by Subject|2
5020719|NCT03283319|17265916|P2|Overall Study|Withdrawal by Subject|2
5020720|NCT03283319|17265917|P1|Overall Study|Withdrawal by Subject|2
5020721|NCT03283319|17265912|P6|Overall Study|Lost to Follow-up|3
5020722|NCT03283319|17265913|P5|Overall Study|Lost to Follow-up|4
5020723|NCT03283319|17265914|P4|Overall Study|Lost to Follow-up|5
5020724|NCT03283319|17265915|P3|Overall Study|Lost to Follow-up|5
5020725|NCT03283319|17265916|P2|Overall Study|Lost to Follow-up|4
5020726|NCT03283319|17265917|P1|Overall Study|Lost to Follow-up|5
5020727|NCT03283098|17266059|P2|Overall Study|Withdrawal by Subject|1
5020728|NCT03283098|17266060|P1|Overall Study|Withdrawal by Subject|0
5020729|NCT03282240|17266180|P3|Overall Study|Withdrawal by Subject|1
5020730|NCT03282240|17266181|P2|Overall Study|Withdrawal by Subject|0
5020731|NCT03282240|17266182|P1|Overall Study|Withdrawal by Subject|1
5020732|NCT03282240|17266180|P3|Overall Study|Protocol Deviation|2
5020733|NCT03282240|17266181|P2|Overall Study|Protocol Deviation|1
5020734|NCT03282240|17266182|P1|Overall Study|Protocol Deviation|4
5020735|NCT03282240|17266180|P3|Overall Study|Lost to Follow-up|0
5020736|NCT03282240|17266181|P2|Overall Study|Lost to Follow-up|0
5020737|NCT03282240|17266182|P1|Overall Study|Lost to Follow-up|3
5020738|NCT03282240|17266180|P3|Overall Study|Adverse Event|0
5020739|NCT03282240|17266181|P2|Overall Study|Adverse Event|2
5020740|NCT03282240|17266182|P1|Overall Study|Adverse Event|2
5020741|NCT03282227|17266234|P1|Overall Study|Other|1
5020742|NCT03282227|17266234|P1|Overall Study|Pregnancy|2
5020743|NCT03282227|17266234|P1|Overall Study|Physician Decision|2
5020744|NCT03282227|17266234|P1|Overall Study|Sponsor decision|3
5020745|NCT03282227|17266234|P1|Overall Study|Lack of Efficacy|12
5020746|NCT03282227|17266234|P1|Overall Study|Withdrawal by Subject|20
5020747|NCT03282227|17266234|P1|Overall Study|Lost to Follow-up|21
5020748|NCT03282227|17266234|P1|Overall Study|Adverse Event|15
5020749|NCT03282227|17266234|P1|Overall Study|Non-compliance w/ protocol requirements|79
5020750|NCT03282227|17266234|P1|Overall Study|Exposure Goals Achieved|60
5020751|NCT03281668|17266268|P1|Overall Study|Lost to Follow-up|1
5020752|NCT03281668|17266268|P1|Overall Study|Withdrawal by Subject|4
5020753|NCT03281668|17266268|P1|Overall Study|scheduling conflict, family circumstance|2
5020754|NCT03281668|17266268|P1|Overall Study|Physician Decision|1
5020755|NCT03281577|17266296|P4|Overall Study|Withdrawal by Subject|0
5020756|NCT03281577|17266297|P3|Overall Study|Withdrawal by Subject|0
5020757|NCT03281577|17266298|P2|Overall Study|Withdrawal by Subject|0
5020758|NCT03281577|17266299|P1|Overall Study|Withdrawal by Subject|1
5020759|NCT03281577|17266296|P4|Overall Study|Adverse Event|1
5020760|NCT03281577|17266297|P3|Overall Study|Adverse Event|0
5020761|NCT03281577|17266298|P2|Overall Study|Adverse Event|0
5020762|NCT03281577|17266299|P1|Overall Study|Adverse Event|0
5020763|NCT03280615|17266354|P2|Overall Study|Withdrawal by Subject|2
5020764|NCT03280615|17266355|P1|Overall Study|Withdrawal by Subject|2
5020765|NCT03280615|17266354|P2|Overall Study|Adverse Event|1
5020766|NCT03280615|17266355|P1|Overall Study|Adverse Event|1
5020767|NCT03280615|17266354|P2|Overall Study|Lost to Follow-up|2
5020768|NCT03280615|17266355|P1|Overall Study|Lost to Follow-up|1
5020769|NCT03280550|17266367|P2|Overall Study|Physician Decision|1
5020770|NCT03280550|17266368|P1|Overall Study|Physician Decision|0
5020771|NCT03280550|17266367|P2|Overall Study|Withdrawal by Subject|2
5020772|NCT03280550|17266368|P1|Overall Study|Withdrawal by Subject|2
5020773|NCT03280537|17266420|P2|Overall Study|Withdrawal by Subject|4
5020774|NCT03280537|17266421|P1|Overall Study|Withdrawal by Subject|2
5020775|NCT03280381|17266473|P2|Overall Study|Physician Decision|2
5020776|NCT03280381|17266474|P1|Overall Study|Physician Decision|0
5020777|NCT03280108|17266484|P2|Overall Study|Lost to Follow-up|0
5020778|NCT03280108|17266485|P1|Overall Study|Lost to Follow-up|2
5020779|NCT03278106|17266567|P1|Overall Study|No protocol treatment|1
5020780|NCT03278028|17266983|P2|Overall Study|Pregnancy|1
5020781|NCT03278028|17266984|P1|Overall Study|Pregnancy|0
5020782|NCT03278028|17266983|P2|Overall Study|Withdrawal by Subject|1
5020783|NCT03278028|17266984|P1|Overall Study|Withdrawal by Subject|3
5020784|NCT03278028|17266983|P2|Overall Study|Lost to Follow-up|0
5020785|NCT03278028|17266984|P1|Overall Study|Lost to Follow-up|1
5020786|NCT03277846|17266992|P2|Overall Study|Inpatient stay too brief|11
5020787|NCT03277846|17266993|P1|Overall Study|Inpatient stay too brief|12
5020788|NCT03277105|17267050|P2|Overall Study|Ongoing|175
5020789|NCT03277105|17267051|P1|Overall Study|Ongoing|171
5020790|NCT03277105|17267050|P2|Overall Study|Other|3
5020791|NCT03277105|17267051|P1|Overall Study|Other|1
5020792|NCT03277105|17267050|P2|Overall Study|Withdrawal by Subject|9
5020793|NCT03277105|17267051|P1|Overall Study|Withdrawal by Subject|10
5020794|NCT03277105|17267050|P2|Overall Study|Lost to Follow-up|3
5020795|NCT03277105|17267051|P1|Overall Study|Lost to Follow-up|0
5020796|NCT03277105|17267050|P2|Overall Study|Death|73
5020797|NCT03277105|17267051|P1|Overall Study|Death|77
5020798|NCT03276078|17267101|P1|Overall Study|Adverse Event|1
5020799|NCT03276026|17267130|P2|Overall Study|Protocol Violation|0
5020800|NCT03276026|17267131|P1|Overall Study|Protocol Violation|1
5020801|NCT03274986|17267159|P2|Overall Study|Lost to Follow-up|1
5020802|NCT03274986|17267160|P1|Overall Study|Lost to Follow-up|0
5020803|NCT03274986|17267159|P2|Overall Study|Withdrawal by Subject|1
5020804|NCT03274986|17267160|P1|Overall Study|Withdrawal by Subject|0
5020805|NCT03274453|17267227|P4|Overall Study|Surgery Cancelled|0
5020806|NCT03274453|17267228|P3|Overall Study|Surgery Cancelled|0
5020807|NCT03274453|17267229|P2|Overall Study|Surgery Cancelled|1
5020808|NCT03274453|17267230|P1|Overall Study|Surgery Cancelled|0
5020809|NCT03274453|17267227|P4|Overall Study|Physician Decision|3
5020810|NCT03274453|17267228|P3|Overall Study|Physician Decision|0
5020811|NCT03274453|17267229|P2|Overall Study|Physician Decision|0
5020812|NCT03274453|17267230|P1|Overall Study|Physician Decision|2
5020813|NCT03274453|17267227|P4|Overall Study|Lost to Follow-up|1
5020814|NCT03274453|17267228|P3|Overall Study|Lost to Follow-up|4
5020815|NCT03274453|17267229|P2|Overall Study|Lost to Follow-up|5
5020816|NCT03274453|17267230|P1|Overall Study|Lost to Follow-up|2
5020817|NCT03274440|17267240|P6|Overall Study|Time commitment too great|0
5020818|NCT03274440|17267241|P5|Overall Study|Time commitment too great|0
5020819|NCT03274440|17267242|P4|Overall Study|Time commitment too great|1
5020820|NCT03274440|17267243|P3|Overall Study|Time commitment too great|0
5020821|NCT03274440|17267244|P2|Overall Study|Time commitment too great|0
5020822|NCT03274440|17267245|P1|Overall Study|Time commitment too great|1
5020823|NCT03274076|17267258|P4|24 Weeks Open Label|Withdrawal by Subject|1
5020824|NCT03274076|17267259|P3|24 Weeks Open Label|Withdrawal by Subject|0
5020825|NCT03274076|17267260|P2|24 Weeks Open Label|Withdrawal by Subject|0
5020826|NCT03274076|17267261|P1|24 Weeks Open Label|Withdrawal by Subject|0
5020827|NCT03274076|17267258|P4|24 Weeks Open Label|Adverse Event|0
5020828|NCT03274076|17267259|P3|24 Weeks Open Label|Adverse Event|2
5020829|NCT03274076|17267260|P2|24 Weeks Open Label|Adverse Event|0
5020830|NCT03274076|17267261|P1|24 Weeks Open Label|Adverse Event|0
5020831|NCT03274076|17267258|P4|24 Weeks Double Blind|Withdrawal by Subject|0
5020832|NCT03274076|17267259|P3|24 Weeks Double Blind|Withdrawal by Subject|0
5020833|NCT03274076|17267260|P2|24 Weeks Double Blind|Withdrawal by Subject|1
5020834|NCT03274076|17267261|P1|24 Weeks Double Blind|Withdrawal by Subject|0
5020835|NCT03273946|17267289|P1|Overall Study|Participant relative refused to use drug|1
5020836|NCT03273946|17267289|P1|Overall Study|Participant refused to use the drug|2
5020837|NCT03273946|17267289|P1|Overall Study|Unwillingness of the guardian|1
5020838|NCT03273946|17267289|P1|Overall Study|Withdrawal by Subject|5
5020839|NCT03273387|17267318|P2|Overall Study|Withdrawal by Subject|1
5020840|NCT03273387|17267319|P1|Overall Study|Withdrawal by Subject|1
5020841|NCT03273387|17267318|P2|Overall Study|Death|2
5020842|NCT03273387|17267319|P1|Overall Study|Death|2
5020843|NCT03273166|17267340|P1|Overall Study|Withdrawn prior to Completion|31
5020844|NCT03273153|17267347|P2|Overall Study|Other|1
5020845|NCT03273153|17267348|P1|Overall Study|Other|0
5020846|NCT03273153|17267347|P2|Overall Study|Symptomatic Deterioration|1
5020847|NCT03273153|17267348|P1|Overall Study|Symptomatic Deterioration|0
5020848|NCT03273153|17267347|P2|Overall Study|Withdrawal by Subject|13
5020849|NCT03273153|17267348|P1|Overall Study|Withdrawal by Subject|16
5020850|NCT03273153|17267347|P2|Overall Study|Protocol Violation|0
5020851|NCT03273153|17267348|P1|Overall Study|Protocol Violation|3
5020852|NCT03273153|17267347|P2|Overall Study|Lost to Follow-up|3
5020853|NCT03273153|17267348|P1|Overall Study|Lost to Follow-up|3
5020854|NCT03273153|17267347|P2|Overall Study|Death|45
5020855|NCT03273153|17267348|P1|Overall Study|Death|41
5020856|NCT03273153|17267347|P2|Overall Study|Remain on Study|159
5020857|NCT03273153|17267348|P1|Overall Study|Remain on Study|161
5020858|NCT03271021|17267411|P2|Overall Study|Miscellaneous|8
5020859|NCT03271021|17267412|P1|Overall Study|Miscellaneous|9
5020860|NCT03271021|17267411|P2|Overall Study|Abnormal Lab Results|0
5020861|NCT03271021|17267412|P1|Overall Study|Abnormal Lab Results|1
5020862|NCT03271021|17267411|P2|Overall Study|Protocol Violation|4
5020863|NCT03271021|17267412|P1|Overall Study|Protocol Violation|6
5020864|NCT03271021|17267411|P2|Overall Study|Lost to Follow-up|39
5020865|NCT03271021|17267412|P1|Overall Study|Lost to Follow-up|34
5020866|NCT03271021|17267411|P2|Overall Study|Withdrawal by Subject|53
5020867|NCT03271021|17267412|P1|Overall Study|Withdrawal by Subject|36
5020868|NCT03271021|17267411|P2|Overall Study|Adverse Event|2
5020869|NCT03271021|17267412|P1|Overall Study|Adverse Event|3
5020870|NCT03270657|17267430|P1|Overall Study|Withdrawal by Subject|1
5020871|NCT03270644|17267436|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
5020872|NCT03270644|17267436|P1|Day 1 Lasmiditan Reference|Physician Decision|1
5020873|NCT03270085|17267459|P2|Overall Study|Withdrawal by Subject|0
5020874|NCT03270085|17267460|P1|Overall Study|Withdrawal by Subject|1
5020875|NCT03269552|17267481|P1|Overall Study|Adverse Event|2
5020876|NCT03268941|17267492|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
5020877|NCT03268941|17267493|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
5020878|NCT03268941|17267494|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
5020879|NCT03268941|17267495|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
5020880|NCT03268941|17267496|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
5020881|NCT03268941|17267497|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
5020882|NCT03268941|17267498|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
5020883|NCT03268941|17267492|P7|Part 2: Days 17 to 25|Reason not specified|1
5020884|NCT03268941|17267493|P6|Part 2: Days 17 to 25|Reason not specified|0
5020885|NCT03268941|17267494|P5|Part 2: Days 17 to 25|Reason not specified|0
5020886|NCT03268941|17267495|P4|Part 2: Days 17 to 25|Reason not specified|0
5020887|NCT03268941|17267496|P3|Part 2: Days 17 to 25|Reason not specified|0
5020888|NCT03268941|17267497|P2|Part 2: Days 17 to 25|Reason not specified|0
5020889|NCT03268941|17267498|P1|Part 2: Days 17 to 25|Reason not specified|0
5020890|NCT03268941|17267492|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
5020891|NCT03268941|17267493|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
5020892|NCT03268941|17267494|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
5020893|NCT03268941|17267495|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
5020894|NCT03268941|17267496|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
5020895|NCT03268941|17267497|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
5020896|NCT03268941|17267498|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
5020897|NCT03268941|17267492|P7|Part 1 (Days 1 to 9)|Adverse Event|0
5020898|NCT03268941|17267493|P6|Part 1 (Days 1 to 9)|Adverse Event|0
5020899|NCT03268941|17267494|P5|Part 1 (Days 1 to 9)|Adverse Event|0
5020900|NCT03268941|17267495|P4|Part 1 (Days 1 to 9)|Adverse Event|1
5020901|NCT03268941|17267496|P3|Part 1 (Days 1 to 9)|Adverse Event|0
5020902|NCT03268941|17267497|P2|Part 1 (Days 1 to 9)|Adverse Event|0
5020903|NCT03268941|17267498|P1|Part 1 (Days 1 to 9)|Adverse Event|0
5020904|NCT03268941|17267492|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5020905|NCT03268941|17267493|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5020906|NCT03268941|17267494|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5020907|NCT03268941|17267495|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
5020908|NCT03268941|17267496|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5020909|NCT03268941|17267497|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5020910|NCT03268941|17267498|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5020911|NCT03268746|17267560|P1|Overall Study|Withdrawal by Subject|1
5020912|NCT03268590|17267582|P1|Overall Study|Previously unknown exclusion criteria|1
5020913|NCT03268005|17267617|P2|Overall Study|Withdrawal by Subject|11
5020914|NCT03268005|17267618|P1|Overall Study|Withdrawal by Subject|11
5020915|NCT03268005|17267617|P2|Overall Study|Lost to Follow-up|2
5020916|NCT03268005|17267618|P1|Overall Study|Lost to Follow-up|2
5020917|NCT03268005|17267617|P2|Overall Study|Death|1
5020918|NCT03268005|17267618|P1|Overall Study|Death|2
5020919|NCT03267940|17267732|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
5020920|NCT03267940|17267733|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
5020921|NCT03267940|17267734|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
5020922|NCT03267940|17267735|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
5020923|NCT03267940|17267736|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
5020924|NCT03267940|17267737|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
5020925|NCT03267940|17267732|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
5020926|NCT03267940|17267733|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
5020927|NCT03267940|17267734|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
5020928|NCT03267940|17267735|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
5020929|NCT03267940|17267736|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
5020930|NCT03267940|17267737|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
5020931|NCT03267940|17267732|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5020932|NCT03267940|17267733|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5020933|NCT03267940|17267734|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5020934|NCT03267940|17267735|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
5020935|NCT03267940|17267736|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
5020936|NCT03267940|17267737|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
5020937|NCT03267940|17267732|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5020938|NCT03267940|17267733|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
5020939|NCT03267940|17267734|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
5020940|NCT03267940|17267735|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
5020941|NCT03267940|17267736|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5020942|NCT03267940|17267737|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5020943|NCT03267940|17267732|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5020944|NCT03267940|17267733|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
5020945|NCT03267940|17267734|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
5020946|NCT03267940|17267735|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5020947|NCT03267940|17267736|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5020948|NCT03267940|17267737|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5020949|NCT03267940|17267732|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5020950|NCT03267940|17267733|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5020951|NCT03267940|17267734|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5020952|NCT03267940|17267735|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5020953|NCT03267940|17267736|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
5020954|NCT03267940|17267737|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
5020955|NCT03267940|17267732|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5020956|NCT03267940|17267733|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5020957|NCT03267940|17267734|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5020958|NCT03267940|17267735|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5020959|NCT03267940|17267736|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
5020960|NCT03267940|17267737|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5020961|NCT03267940|17267732|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5020962|NCT03267940|17267733|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5020963|NCT03267940|17267734|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5020964|NCT03267940|17267735|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5020965|NCT03267940|17267736|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
5020966|NCT03267940|17267737|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5020967|NCT03267940|17267732|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5020968|NCT03267940|17267733|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5020969|NCT03267940|17267734|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5020970|NCT03267940|17267735|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5020971|NCT03267940|17267736|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
5020972|NCT03267940|17267737|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
5020973|NCT03267576|17267839|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
5020974|NCT03267576|17267840|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
5020975|NCT03267576|17267839|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
5020976|NCT03267576|17267840|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
5020977|NCT03267511|17267878|P4|Overall Study|Lost to Follow-up|1
5020978|NCT03267511|17267879|P3|Overall Study|Lost to Follow-up|0
5020979|NCT03267511|17267880|P2|Overall Study|Lost to Follow-up|0
5020980|NCT03267511|17267881|P1|Overall Study|Lost to Follow-up|0
5020981|NCT03267264|17267897|P4|Overall Study|Withdrawal by Subject|4
5020982|NCT03267264|17267898|P3|Overall Study|Withdrawal by Subject|2
5020983|NCT03267264|17267899|P2|Overall Study|Withdrawal by Subject|0
5020984|NCT03267264|17267900|P1|Overall Study|Withdrawal by Subject|1
5020985|NCT03267212|17267917|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
5020986|NCT03267212|17267918|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
5020987|NCT03267212|17267917|P2|First Intervention|Withdrawal by Subject|1
5020988|NCT03267212|17267918|P1|First Intervention|Withdrawal by Subject|1
5020989|NCT03267212|17267917|P2|First Intervention|Lost to Follow-up|2
5020990|NCT03267212|17267918|P1|First Intervention|Lost to Follow-up|0
5020991|NCT03266588|17267933|P3|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
5020992|NCT03266588|17267934|P2|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
5020993|NCT03266588|17267935|P1|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
5020994|NCT03266588|17267933|P3|Long-term Treatment Period|Other Reasons|0
5020995|NCT03266588|17267934|P2|Long-term Treatment Period|Other Reasons|0
5020996|NCT03266588|17267935|P1|Long-term Treatment Period|Other Reasons|5
5020997|NCT03266588|17267933|P3|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
5020998|NCT03266588|17267934|P2|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
5020999|NCT03266588|17267935|P1|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
5021000|NCT03266588|17267933|P3|Long-term Treatment Period|Withdrawal by Subject|16
5021001|NCT03266588|17267934|P2|Long-term Treatment Period|Withdrawal by Subject|63
5021002|NCT03266588|17267935|P1|Long-term Treatment Period|Withdrawal by Subject|100
5021003|NCT03266588|17267933|P3|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
5021004|NCT03266588|17267934|P2|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
5021005|NCT03266588|17267935|P1|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
5021006|NCT03266588|17267933|P3|Long-term Treatment Period|Protocol Deviation|4
5021007|NCT03266588|17267934|P2|Long-term Treatment Period|Protocol Deviation|10
5021008|NCT03266588|17267935|P1|Long-term Treatment Period|Protocol Deviation|17
5021009|NCT03266588|17267933|P3|Long-term Treatment Period|Pregnancy|0
5021010|NCT03266588|17267934|P2|Long-term Treatment Period|Pregnancy|5
5021011|NCT03266588|17267935|P1|Long-term Treatment Period|Pregnancy|11
5021012|NCT03266588|17267933|P3|Long-term Treatment Period|Non-Compliance|7
5021013|NCT03266588|17267934|P2|Long-term Treatment Period|Non-Compliance|57
5021014|NCT03266588|17267935|P1|Long-term Treatment Period|Non-Compliance|126
5021015|NCT03266588|17267933|P3|Long-term Treatment Period|Lost to Follow-up|8
5021016|NCT03266588|17267934|P2|Long-term Treatment Period|Lost to Follow-up|37
5021017|NCT03266588|17267935|P1|Long-term Treatment Period|Lost to Follow-up|39
5021018|NCT03266588|17267933|P3|Long-term Treatment Period|Lack of Efficacy|5
5021019|NCT03266588|17267934|P2|Long-term Treatment Period|Lack of Efficacy|31
5021020|NCT03266588|17267935|P1|Long-term Treatment Period|Lack of Efficacy|41
5021021|NCT03266588|17267933|P3|Long-term Treatment Period|Adverse Event|8
5021022|NCT03266588|17267934|P2|Long-term Treatment Period|Adverse Event|17
5021023|NCT03266588|17267935|P1|Long-term Treatment Period|Adverse Event|33
5021024|NCT03266588|17267933|P3|Observational Period|Other Reasons|1
5021025|NCT03266588|17267934|P2|Observational Period|Other Reasons|0
5021026|NCT03266588|17267935|P1|Observational Period|Other Reasons|3
5021027|NCT03266588|17267933|P3|Observational Period|Protocol Deviation|0
5021028|NCT03266588|17267934|P2|Observational Period|Protocol Deviation|0
5021029|NCT03266588|17267935|P1|Observational Period|Protocol Deviation|1
5021030|NCT03266588|17267933|P3|Observational Period|Eligibility Failure- Baseline Lab Values|0
5021031|NCT03266588|17267934|P2|Observational Period|Eligibility Failure- Baseline Lab Values|1
5021032|NCT03266588|17267935|P1|Observational Period|Eligibility Failure- Baseline Lab Values|3
5021033|NCT03266588|17267933|P3|Observational Period|Lost to Follow-up|4
5021034|NCT03266588|17267934|P2|Observational Period|Lost to Follow-up|12
5021035|NCT03266588|17267935|P1|Observational Period|Lost to Follow-up|8
5021036|NCT03266588|17267933|P3|Observational Period|Non-compliance|10
5021037|NCT03266588|17267934|P2|Observational Period|Non-compliance|12
5021038|NCT03266588|17267935|P1|Observational Period|Non-compliance|18
5021039|NCT03266588|17267933|P3|Observational Period|Withdrawal by Subject|13
5021040|NCT03266588|17267934|P2|Observational Period|Withdrawal by Subject|22
5021041|NCT03266588|17267935|P1|Observational Period|Withdrawal by Subject|44
5021042|NCT03266588|17267933|P3|Observational Period|Screen Failure: Eligibility Criteria|140
5021043|NCT03266588|17267934|P2|Observational Period|Screen Failure: Eligibility Criteria|228
5021044|NCT03266588|17267935|P1|Observational Period|Screen Failure: Eligibility Criteria|439
5021045|NCT03266172|17267966|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
5021046|NCT03266172|17267967|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5021047|NCT03266172|17267968|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5021048|NCT03266172|17267966|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
5021049|NCT03266172|17267967|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5021050|NCT03266172|17267968|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5021051|NCT03266172|17267966|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
5021052|NCT03266172|17267967|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
5021053|NCT03266172|17267968|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
5021054|NCT03266172|17267966|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
5021055|NCT03266172|17267967|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
5021056|NCT03266172|17267968|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
5021057|NCT03266172|17267966|P3|Part A: Washout Period (7 Days)|Adverse Event|0
5021058|NCT03266172|17267967|P2|Part A: Washout Period (7 Days)|Adverse Event|0
5021059|NCT03266172|17267968|P1|Part A: Washout Period (7 Days)|Adverse Event|1
5021060|NCT03266172|17267966|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
5021061|NCT03266172|17267967|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
5021062|NCT03266172|17267968|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
5021063|NCT03266094|17268213|P1|Overall Study|Withdrawal by Subject|1
5021064|NCT03266094|17268213|P1|Overall Study|Lost to Follow-up|1
5021065|NCT03265938|17268231|P1|Overall Study|friable mass|6
5021066|NCT03265938|17268231|P1|Overall Study|Physician Decision|1
5021067|NCT03265938|17268231|P1|Overall Study|Withdrawal by Subject|1
5021068|NCT03265600|17268244|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
5021069|NCT03265600|17268245|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
5021070|NCT03265600|17268244|P2|Overall Study|Withdrawal by Subject|2
5021071|NCT03265600|17268245|P1|Overall Study|Withdrawal by Subject|4
5021072|NCT03265600|17268244|P2|Overall Study|Lost to Follow-up|5
5021073|NCT03265600|17268245|P1|Overall Study|Lost to Follow-up|17
5021074|NCT03265132|17268271|P2|Overall Study|Withdrawal by Subject|1
5021075|NCT03265132|17268272|P1|Overall Study|Withdrawal by Subject|0
5021076|NCT03265132|17268271|P2|Overall Study|Progressive disease|2
5021077|NCT03265132|17268272|P1|Overall Study|Progressive disease|0
5021078|NCT03265132|17268271|P2|Overall Study|Lack of Efficacy|2
5021079|NCT03265132|17268272|P1|Overall Study|Lack of Efficacy|0
5021080|NCT03265132|17268271|P2|Overall Study|Adverse Event|1
5021081|NCT03265132|17268272|P1|Overall Study|Adverse Event|0
5021082|NCT03265119|17268370|P2|Overall Study|Lack of Compliance|0
5021083|NCT03265119|17268371|P1|Overall Study|Lack of Compliance|1
5021084|NCT03265119|17268370|P2|Overall Study|Lost to Follow-up|0
5021085|NCT03265119|17268371|P1|Overall Study|Lost to Follow-up|1
5021086|NCT03265119|17268370|P2|Overall Study|Withdrawal by Subject|4
5021087|NCT03265119|17268371|P1|Overall Study|Withdrawal by Subject|2
5021088|NCT03265119|17268370|P2|Overall Study|Protocol Violation|2
5021089|NCT03265119|17268371|P1|Overall Study|Protocol Violation|1
5021090|NCT03265119|17268370|P2|Overall Study|Lack of Efficacy|0
5021091|NCT03265119|17268371|P1|Overall Study|Lack of Efficacy|3
5021092|NCT03265119|17268370|P2|Overall Study|Adverse Event|1
5021093|NCT03265119|17268371|P1|Overall Study|Adverse Event|2
5021094|NCT03264456|17268379|P1|Overall Study|Lost to Follow-up|1
5021095|NCT03264456|17268379|P1|Overall Study|Withdrawal by Subject|3
5021096|NCT03263806|17268414|P2|Overall Study|Study Termination|6
5021097|NCT03263806|17268415|P1|Overall Study|Study Termination|5
5021098|NCT03263806|17268414|P2|Overall Study|Withdrawal by Subject|1
5021099|NCT03263806|17268415|P1|Overall Study|Withdrawal by Subject|0
5021100|NCT03263806|17268414|P2|Overall Study|Elevated Troponin (failed screen)|0
5021101|NCT03263806|17268415|P1|Overall Study|Elevated Troponin (failed screen)|1
5021102|NCT03263702|17268429|P2|Overall Study|Withdrawal by Subject|2
5021103|NCT03263702|17268430|P1|Overall Study|Withdrawal by Subject|1
5021104|NCT03263702|17268429|P2|Overall Study|Lost to Follow-up|2
5021105|NCT03263702|17268430|P1|Overall Study|Lost to Follow-up|2
5021106|NCT03262233|17268460|P4|Overall Study|data collection artifact|0
5021107|NCT03262233|17268461|P3|Overall Study|data collection artifact|0
5021108|NCT03262233|17268462|P2|Overall Study|data collection artifact|1
5021109|NCT03262233|17268463|P1|Overall Study|data collection artifact|0
5021110|NCT03262233|17268460|P4|Overall Study|Protocol Violation|13
5021111|NCT03262233|17268461|P3|Overall Study|Protocol Violation|2
5021112|NCT03262233|17268462|P2|Overall Study|Protocol Violation|10
5021113|NCT03262233|17268463|P1|Overall Study|Protocol Violation|5
5021114|NCT03262233|17268460|P4|Overall Study|Declined due to shock|3
5021115|NCT03262233|17268461|P3|Overall Study|Declined due to shock|2
5021116|NCT03262233|17268462|P2|Overall Study|Declined due to shock|2
5021117|NCT03262233|17268463|P1|Overall Study|Declined due to shock|1
5021118|NCT03262233|17268460|P4|Overall Study|Withdrawal by Subject|13
5021119|NCT03262233|17268461|P3|Overall Study|Withdrawal by Subject|21
5021120|NCT03262233|17268462|P2|Overall Study|Withdrawal by Subject|8
5021121|NCT03262233|17268463|P1|Overall Study|Withdrawal by Subject|12
5021122|NCT03262012|17268489|P4|Overall Study|Protocol Discontinuation Criteria|0
5021123|NCT03262012|17268490|P3|Overall Study|Protocol Discontinuation Criteria|0
5021124|NCT03262012|17268491|P2|Overall Study|Protocol Discontinuation Criteria|1
5021125|NCT03262012|17268492|P1|Overall Study|Protocol Discontinuation Criteria|0
5021126|NCT03262012|17268489|P4|Overall Study|Lack of Efficacy|2
5021127|NCT03262012|17268490|P3|Overall Study|Lack of Efficacy|1
5021128|NCT03262012|17268491|P2|Overall Study|Lack of Efficacy|5
5021129|NCT03262012|17268492|P1|Overall Study|Lack of Efficacy|0
5021130|NCT03262012|17268489|P4|Overall Study|Physician Decision|0
5021131|NCT03262012|17268490|P3|Overall Study|Physician Decision|1
5021132|NCT03262012|17268491|P2|Overall Study|Physician Decision|5
5021133|NCT03262012|17268492|P1|Overall Study|Physician Decision|2
5021134|NCT03262012|17268489|P4|Overall Study|Adverse Event|6
5021135|NCT03262012|17268490|P3|Overall Study|Adverse Event|4
5021136|NCT03262012|17268491|P2|Overall Study|Adverse Event|12
5021137|NCT03262012|17268492|P1|Overall Study|Adverse Event|10
5021138|NCT03262012|17268489|P4|Overall Study|Withdrawal by Subject|7
5021139|NCT03262012|17268490|P3|Overall Study|Withdrawal by Subject|8
5021140|NCT03262012|17268491|P2|Overall Study|Withdrawal by Subject|13
5021141|NCT03262012|17268492|P1|Overall Study|Withdrawal by Subject|15
5021142|NCT03261531|17268515|P1|Overall Study|Withdrawal by Subject|4
5021143|NCT03261167|17268533|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
5021144|NCT03261167|17268534|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
5021145|NCT03261167|17268533|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
5021146|NCT03261167|17268534|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
5021147|NCT03261167|17268533|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
5021148|NCT03261167|17268534|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
5021149|NCT03261167|17268533|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
5021150|NCT03261167|17268534|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
5021151|NCT03261167|17268533|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
5021152|NCT03261167|17268534|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
5021153|NCT03260894|17268572|P2|Overall Study|On-going at clinical cut off date|31
5021154|NCT03260894|17268573|P1|Overall Study|On-going at clinical cut off date|36
5021155|NCT03260894|17268572|P2|Overall Study|Withdrawal by Subject|11
5021156|NCT03260894|17268573|P1|Overall Study|Withdrawal by Subject|4
5021157|NCT03260894|17268572|P2|Overall Study|Death|8
5021158|NCT03260894|17268573|P1|Overall Study|Death|6
5021159|NCT03260868|17268585|P2|Overall Study|Other than specified above|0
5021160|NCT03260868|17268586|P1|Overall Study|Other than specified above|1
5021161|NCT03260868|17268585|P2|Overall Study|Study Terminated By Sponsor|1
5021162|NCT03260868|17268586|P1|Overall Study|Study Terminated By Sponsor|2
5021163|NCT03260868|17268585|P2|Overall Study|Poor Compliance to Protocol|2
5021164|NCT03260868|17268586|P1|Overall Study|Poor Compliance to Protocol|0
5021165|NCT03260205|17268708|P5|Overall Study|Participant Who Did Not Received AnyDose|1
5021166|NCT03260205|17268709|P4|Overall Study|Participant Who Did Not Received AnyDose|3
5021167|NCT03260205|17268710|P3|Overall Study|Participant Who Did Not Received AnyDose|2
5021168|NCT03260205|17268711|P2|Overall Study|Participant Who Did Not Received AnyDose|1
5021169|NCT03260205|17268712|P1|Overall Study|Participant Who Did Not Received AnyDose|1
5021170|NCT03260205|17268708|P5|Overall Study|Other: Unspecified|1
5021171|NCT03260205|17268709|P4|Overall Study|Other: Unspecified|1
5021172|NCT03260205|17268710|P3|Overall Study|Other: Unspecified|3
5021173|NCT03260205|17268711|P2|Overall Study|Other: Unspecified|0
5021174|NCT03260205|17268712|P1|Overall Study|Other: Unspecified|0
5021175|NCT03260205|17268708|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
5021176|NCT03260205|17268709|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
5021177|NCT03260205|17268710|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
5021178|NCT03260205|17268711|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
5021179|NCT03260205|17268712|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
5021180|NCT03260205|17268708|P5|Overall Study|Protocol Violation|1
5021181|NCT03260205|17268709|P4|Overall Study|Protocol Violation|0
5021182|NCT03260205|17268710|P3|Overall Study|Protocol Violation|2
5021183|NCT03260205|17268711|P2|Overall Study|Protocol Violation|0
5021184|NCT03260205|17268712|P1|Overall Study|Protocol Violation|0
5021185|NCT03260205|17268708|P5|Overall Study|Lost to Follow-up|5
5021186|NCT03260205|17268709|P4|Overall Study|Lost to Follow-up|1
5021187|NCT03260205|17268710|P3|Overall Study|Lost to Follow-up|1
5021188|NCT03260205|17268711|P2|Overall Study|Lost to Follow-up|2
5021189|NCT03260205|17268712|P1|Overall Study|Lost to Follow-up|2
5021190|NCT03260205|17268708|P5|Overall Study|Adverse Event|4
5021191|NCT03260205|17268709|P4|Overall Study|Adverse Event|2
5021192|NCT03260205|17268710|P3|Overall Study|Adverse Event|2
5021193|NCT03260205|17268711|P2|Overall Study|Adverse Event|0
5021194|NCT03260205|17268712|P1|Overall Study|Adverse Event|2
5021195|NCT03259555|17268775|P2|Overall Study|Other|0
5021196|NCT03259555|17268776|P1|Overall Study|Other|1
5021197|NCT03259555|17268775|P2|Overall Study|Physician Decision|2
5021198|NCT03259555|17268776|P1|Overall Study|Physician Decision|1
5021199|NCT03259555|17268775|P2|Overall Study|Withdrawal by Subject|16
5021200|NCT03259555|17268776|P1|Overall Study|Withdrawal by Subject|19
5021201|NCT03259555|17268775|P2|Overall Study|Progressive Disease|2
5021202|NCT03259555|17268776|P1|Overall Study|Progressive Disease|0
5021203|NCT03259555|17268775|P2|Overall Study|Non-Compliance With Study Drug|0
5021204|NCT03259555|17268776|P1|Overall Study|Non-Compliance With Study Drug|1
5021205|NCT03259555|17268775|P2|Overall Study|Lost to Follow-up|2
5021206|NCT03259555|17268776|P1|Overall Study|Lost to Follow-up|0
5021207|NCT03259555|17268775|P2|Overall Study|Lack of Efficacy|4
5021208|NCT03259555|17268776|P1|Overall Study|Lack of Efficacy|6
5021209|NCT03259555|17268775|P2|Overall Study|Adverse Event|4
5021210|NCT03259555|17268776|P1|Overall Study|Adverse Event|6
5021211|NCT03259490|17268786|P2|Period 2|Protocol Violation|0
5021212|NCT03259490|17268787|P1|Period 2|Protocol Violation|1
5021213|NCT03259490|17268786|P2|Period 1|Withdrawal by Subject|1
5021214|NCT03259490|17268787|P1|Period 1|Withdrawal by Subject|0
5021215|NCT03259087|17268855|P5|Period 2 of Part 2|Adverse Event|1
5021216|NCT03259087|17268856|P4|Period 2 of Part 2|Adverse Event|0
5021217|NCT03259087|17268857|P3|Period 2 of Part 2|Adverse Event|0
5021218|NCT03259087|17268858|P2|Period 2 of Part 2|Adverse Event|0
5021219|NCT03259087|17268859|P1|Period 2 of Part 2|Adverse Event|0
5021220|NCT03259087|17268855|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
5021221|NCT03259087|17268856|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
5021222|NCT03259087|17268857|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
5021223|NCT03259087|17268858|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
5021224|NCT03259087|17268859|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
5021225|NCT03258814|17268987|P3|Overall Study|Early Termination|10
5021226|NCT03258814|17268988|P2|Overall Study|Early Termination|3
5021227|NCT03258814|17268989|P1|Overall Study|Early Termination|4
5021228|NCT03258762|17269044|P2|Overall Study|Lost to Follow-up|1
5021229|NCT03258762|17269045|P1|Overall Study|Lost to Follow-up|0
5021230|NCT03258710|17269105|P1|Overall Study|Physician Decision|1
5021231|NCT03258710|17269105|P1|Overall Study|Protocol-defined stopping criteria|1
5021232|NCT03258710|17269105|P1|Overall Study|Adverse Event|1
5021233|NCT03257995|17269199|P6|Overall Study|Protocol deviation|2
5021234|NCT03257995|17269200|P5|Overall Study|Protocol deviation|0
5021235|NCT03257995|17269201|P4|Overall Study|Protocol deviation|0
5021236|NCT03257995|17269202|P3|Overall Study|Protocol deviation|0
5021237|NCT03257995|17269203|P2|Overall Study|Protocol deviation|0
5021238|NCT03257995|17269204|P1|Overall Study|Protocol deviation|0
5021239|NCT03257995|17269199|P6|Overall Study|Adverse Event|0
5021240|NCT03257995|17269200|P5|Overall Study|Adverse Event|0
5021241|NCT03257995|17269201|P4|Overall Study|Adverse Event|0
5021242|NCT03257995|17269202|P3|Overall Study|Adverse Event|0
5021243|NCT03257995|17269203|P2|Overall Study|Adverse Event|1
5021244|NCT03257995|17269204|P1|Overall Study|Adverse Event|0
5021245|NCT03257865|17269254|P2|Overall Study|Lost to Follow-up|4
5021246|NCT03257865|17269255|P1|Overall Study|Lost to Follow-up|4
5021247|NCT03257865|17269254|P2|Overall Study|Other|1
5021248|NCT03257865|17269255|P1|Overall Study|Other|0
5021249|NCT03257865|17269254|P2|Overall Study|Physician Decision|1
5021250|NCT03257865|17269255|P1|Overall Study|Physician Decision|3
5021251|NCT03257865|17269254|P2|Overall Study|Withdrawal by Subject|17
5021252|NCT03257865|17269255|P1|Overall Study|Withdrawal by Subject|23
5021253|NCT03257865|17269254|P2|Overall Study|Non-compliance with Study Drug|2
5021254|NCT03257865|17269255|P1|Overall Study|Non-compliance with Study Drug|0
5021255|NCT03257865|17269254|P2|Overall Study|Lack of Efficacy|2
5021256|NCT03257865|17269255|P1|Overall Study|Lack of Efficacy|1
5021257|NCT03257865|17269254|P2|Overall Study|Adverse Event|8
5021258|NCT03257865|17269255|P1|Overall Study|Adverse Event|4
5021259|NCT03257813|17269265|P2|Overall Study|Protocol Violation|3
5021260|NCT03257813|17269266|P1|Overall Study|Protocol Violation|6
5021261|NCT03257657|17269288|P2|Overall Study|Noted not eligible right after enrolled|1
5021262|NCT03257657|17269289|P1|Overall Study|Noted not eligible right after enrolled|0
5021263|NCT03257657|17269288|P2|Overall Study|Withdrawn|1
5021264|NCT03257657|17269289|P1|Overall Study|Withdrawn|0
5021265|NCT03257657|17269288|P2|Overall Study|Lost to Follow-up|3
5021266|NCT03257657|17269289|P1|Overall Study|Lost to Follow-up|0
5021267|NCT03257631|17269320|P4|Overall Study|Still on Study|4
5021268|NCT03257631|17269321|P3|Overall Study|Still on Study|4
5021269|NCT03257631|17269322|P2|Overall Study|Still on Study|2
5021270|NCT03257631|17269323|P1|Overall Study|Still on Study|3
5021271|NCT03257631|17269320|P4|Overall Study|Lost to Follow-up|0
5021272|NCT03257631|17269321|P3|Overall Study|Lost to Follow-up|1
5021273|NCT03257631|17269322|P2|Overall Study|Lost to Follow-up|0
5021274|NCT03257631|17269323|P1|Overall Study|Lost to Follow-up|0
5021275|NCT03257631|17269320|P4|Overall Study|Withdrawal by Parent/Guardian|1
5021276|NCT03257631|17269321|P3|Overall Study|Withdrawal by Parent/Guardian|4
5021277|NCT03257631|17269322|P2|Overall Study|Withdrawal by Parent/Guardian|2
5021278|NCT03257631|17269323|P1|Overall Study|Withdrawal by Parent/Guardian|0
5021279|NCT03257631|17269320|P4|Overall Study|Progressive Disease|0
5021280|NCT03257631|17269321|P3|Overall Study|Progressive Disease|1
5021281|NCT03257631|17269322|P2|Overall Study|Progressive Disease|0
5021282|NCT03257631|17269323|P1|Overall Study|Progressive Disease|0
5021283|NCT03257631|17269320|P4|Overall Study|Death|5
5021284|NCT03257631|17269321|P3|Overall Study|Death|13
5021285|NCT03257631|17269322|P2|Overall Study|Death|5
5021286|NCT03257631|17269323|P1|Overall Study|Death|8
5021287|NCT03257358|17269359|P2|Overall Study|No longer requires treatment|1
5021288|NCT03257358|17269360|P1|Overall Study|No longer requires treatment|0
5021289|NCT03257358|17269359|P2|Overall Study|New therapy for study indication|0
5021290|NCT03257358|17269360|P1|Overall Study|New therapy for study indication|1
5021291|NCT03257358|17269359|P2|Overall Study|Withdrawal of informed consent|5
5021292|NCT03257358|17269360|P1|Overall Study|Withdrawal of informed consent|9
5021293|NCT03257358|17269359|P2|Overall Study|Withdrawal by Subject|3
5021294|NCT03257358|17269360|P1|Overall Study|Withdrawal by Subject|8
5021295|NCT03257358|17269359|P2|Overall Study|Technical problems|1
5021296|NCT03257358|17269360|P1|Overall Study|Technical problems|4
5021297|NCT03257358|17269359|P2|Overall Study|Protocol Violation|3
5021298|NCT03257358|17269360|P1|Overall Study|Protocol Violation|5
5021299|NCT03257358|17269359|P2|Overall Study|Physician Decision|2
5021300|NCT03257358|17269360|P1|Overall Study|Physician Decision|2
5021301|NCT03257358|17269359|P2|Overall Study|Non-compliance with fingolimod treatment|2
5021302|NCT03257358|17269360|P1|Overall Study|Non-compliance with fingolimod treatment|4
5021303|NCT03257358|17269359|P2|Overall Study|Lost to Follow-up|4
5021304|NCT03257358|17269360|P1|Overall Study|Lost to Follow-up|12
5021305|NCT03257358|17269359|P2|Overall Study|Lack of Efficacy|1
5021306|NCT03257358|17269360|P1|Overall Study|Lack of Efficacy|1
5021307|NCT03257358|17269359|P2|Overall Study|Adverse Event|12
5021308|NCT03257358|17269360|P1|Overall Study|Adverse Event|25
5021309|NCT03256851|17269488|P2|Overall Study|Withdrawal by Subject|0
5021310|NCT03256851|17269489|P1|Overall Study|Withdrawal by Subject|1
5021311|NCT03256695|17269501|P1|Overall Study|Other than specified|3
5021312|NCT03256695|17269501|P1|Overall Study|Protocol Violation|5
5021313|NCT03256695|17269501|P1|Overall Study|Lack of Efficacy|3
5021314|NCT03256695|17269501|P1|Overall Study|Lost to Follow-up|3
5021315|NCT03256695|17269501|P1|Overall Study|Non-compliance with study drug|1
5021316|NCT03256695|17269501|P1|Overall Study|Withdrawal by Subject|14
5021317|NCT03256695|17269501|P1|Overall Study|Death|2
5021318|NCT03256695|17269501|P1|Overall Study|Adverse Event|8
5021319|NCT03256552|17269509|P1|Overall Study|Withdrawal by Subject|2
5021320|NCT03256552|17269509|P1|Overall Study|Adverse Event|1
5021321|NCT03256552|17269509|P1|Overall Study|Physician Decision|1
5021322|NCT03256552|17269509|P1|Overall Study|Protocol Violation|1
5021323|NCT03256526|17269534|P3|Overall Study|Lost to Follow-up|2
5021324|NCT03256526|17269535|P2|Overall Study|Lost to Follow-up|0
5021325|NCT03256526|17269536|P1|Overall Study|Lost to Follow-up|1
5021326|NCT03256526|17269534|P3|Overall Study|Adverse Event|1
5021327|NCT03256526|17269535|P2|Overall Study|Adverse Event|0
5021328|NCT03256526|17269536|P1|Overall Study|Adverse Event|1
5021329|NCT03255824|17269621|P2|Overall Study|Under-sedation|1
5021330|NCT03255824|17269622|P1|Overall Study|Under-sedation|2
5021331|NCT03255733|17269650|P1|Overall Study|Lost to Follow-up|4
5021332|NCT03255655|17269657|P2|Overall Study|Lost to Follow-up|4
5021333|NCT03255655|17269658|P1|Overall Study|Lost to Follow-up|7
5021334|NCT03255382|17269668|P2|Overall Study|Other|0
5021335|NCT03255382|17269669|P1|Overall Study|Other|6
5021336|NCT03255382|17269668|P2|Overall Study|Withdrawal by Subject|0
5021337|NCT03255382|17269669|P1|Overall Study|Withdrawal by Subject|2
5021338|NCT03255382|17269668|P2|Overall Study|Lost to Follow-up|0
5021339|NCT03255382|17269669|P1|Overall Study|Lost to Follow-up|2
5021340|NCT03255382|17269668|P2|Overall Study|Adverse Event|0
5021341|NCT03255382|17269669|P1|Overall Study|Adverse Event|3
5021342|NCT03255291|17269843|P6|Overall Study|Baseline data collection issues|0
5021343|NCT03255291|17269844|P5|Overall Study|Baseline data collection issues|2
5021344|NCT03255291|17269845|P4|Overall Study|Baseline data collection issues|0
5021345|NCT03255291|17269846|P3|Overall Study|Baseline data collection issues|0
5021346|NCT03255291|17269847|P2|Overall Study|Baseline data collection issues|0
5021347|NCT03255291|17269848|P1|Overall Study|Baseline data collection issues|3
5021348|NCT03255291|17269843|P6|Overall Study|Determined to be ineligible|10
5021349|NCT03255291|17269844|P5|Overall Study|Determined to be ineligible|5
5021350|NCT03255291|17269845|P4|Overall Study|Determined to be ineligible|6
5021351|NCT03255291|17269846|P3|Overall Study|Determined to be ineligible|6
5021352|NCT03255291|17269847|P2|Overall Study|Determined to be ineligible|12
5021353|NCT03255291|17269848|P1|Overall Study|Determined to be ineligible|10
5021354|NCT03255187|17269881|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
5021355|NCT03255187|17269882|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
5021356|NCT03255187|17269881|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
5021357|NCT03255187|17269882|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
5021358|NCT03254602|17269941|P1|Overall Study|Lost to Follow-up|4
5021359|NCT03254459|17269949|P2|Overall Study|Miscellaneous|1
5021360|NCT03254459|17269950|P1|Overall Study|Miscellaneous|0
5021361|NCT03254459|17269949|P2|Overall Study|Lost to Follow-up|1
5021362|NCT03254459|17269950|P1|Overall Study|Lost to Follow-up|0
5021363|NCT03254459|17269949|P2|Overall Study|Withdrawal by Subject Consent|1
5021364|NCT03254459|17269950|P1|Overall Study|Withdrawal by Subject Consent|3
5021365|NCT03254459|17269949|P2|Overall Study|Adverse Event|20
5021366|NCT03254459|17269950|P1|Overall Study|Adverse Event|7
5021367|NCT03254134|17269975|P2|Overall Study|Not eligible patients|3630
5021368|NCT03254134|17269976|P1|Overall Study|Not eligible patients|599
5021369|NCT03252015|17270015|P4|Overall Study|Adverse Event|1
5021370|NCT03252015|17270016|P3|Overall Study|Adverse Event|0
5021371|NCT03252015|17270017|P2|Overall Study|Adverse Event|0
5021372|NCT03252015|17270018|P1|Overall Study|Adverse Event|1
5021373|NCT03252015|17270015|P4|Overall Study|Withdrawal by Subject|0
5021374|NCT03252015|17270016|P3|Overall Study|Withdrawal by Subject|1
5021375|NCT03252015|17270017|P2|Overall Study|Withdrawal by Subject|1
5021376|NCT03252015|17270018|P1|Overall Study|Withdrawal by Subject|0
5021377|NCT03251963|17270056|P2|Overall Study|bled prior to Xa level|2
5021378|NCT03251963|17270057|P1|Overall Study|bled prior to Xa level|1
5021379|NCT03251963|17270056|P2|Overall Study|no peak Xa level drawn|0
5021380|NCT03251963|17270057|P1|Overall Study|no peak Xa level drawn|2
5021381|NCT03251963|17270056|P2|Overall Study|inappropriate Xa level timing|3
5021382|NCT03251963|17270057|P1|Overall Study|inappropriate Xa level timing|6
5021383|NCT03251482|17270076|P5|Overall Study|Withdrawal by Subject|0
5021384|NCT03251482|17270077|P4|Overall Study|Withdrawal by Subject|0
5021385|NCT03251482|17270078|P3|Overall Study|Withdrawal by Subject|0
5021386|NCT03251482|17270079|P2|Overall Study|Withdrawal by Subject|1
5021387|NCT03251482|17270080|P1|Overall Study|Withdrawal by Subject|0
5021388|NCT03250182|17270237|P1|Overall Study|Withdrawal by Subject|1
5021389|NCT03249935|17270261|P1|Overall Study|Protocol Violation|5
5021390|NCT03249935|17270261|P1|Overall Study|Negative for chlamydia at enrollment|4
5021391|NCT03249935|17270261|P1|Overall Study|Discharged from facility early|36
5021392|NCT03249909|17270270|P3|Overall Study|Lost to Follow-up|0
5021393|NCT03249909|17270271|P2|Overall Study|Lost to Follow-up|1
5021394|NCT03249909|17270272|P1|Overall Study|Lost to Follow-up|0
5021395|NCT03249909|17270270|P3|Overall Study|Adverse Event|0
5021396|NCT03249909|17270271|P2|Overall Study|Adverse Event|0
5021397|NCT03249909|17270272|P1|Overall Study|Adverse Event|3
5021398|NCT03249909|17270270|P3|Overall Study|Withdrawal by Subject|0
5021399|NCT03249909|17270271|P2|Overall Study|Withdrawal by Subject|0
5021400|NCT03249909|17270272|P1|Overall Study|Withdrawal by Subject|3
5021401|NCT03249454|17270316|P11|Overall Study|Withdrawal by Subject|1
5021402|NCT03249454|17270317|P10|Overall Study|Withdrawal by Subject|1
5021403|NCT03249454|17270318|P9|Overall Study|Withdrawal by Subject|0
5021404|NCT03249454|17270319|P8|Overall Study|Withdrawal by Subject|0
5021405|NCT03249454|17270320|P7|Overall Study|Withdrawal by Subject|0
5021406|NCT03249454|17270321|P6|Overall Study|Withdrawal by Subject|0
5021407|NCT03249454|17270322|P5|Overall Study|Withdrawal by Subject|0
5021408|NCT03249454|17270323|P4|Overall Study|Withdrawal by Subject|0
5021409|NCT03249454|17270324|P3|Overall Study|Withdrawal by Subject|0
5021410|NCT03249454|17270325|P2|Overall Study|Withdrawal by Subject|0
5021411|NCT03249454|17270326|P1|Overall Study|Withdrawal by Subject|0
5021412|NCT03248882|17270414|P5|Overall Study|Withdrawal by Subject|2
5021413|NCT03248882|17270415|P4|Overall Study|Withdrawal by Subject|4
5021414|NCT03248882|17270416|P3|Overall Study|Withdrawal by Subject|3
5021415|NCT03248882|17270417|P2|Overall Study|Withdrawal by Subject|2
5021416|NCT03248882|17270418|P1|Overall Study|Withdrawal by Subject|2
5021417|NCT03248882|17270414|P5|Overall Study|Protocol Violation|1
5021418|NCT03248882|17270415|P4|Overall Study|Protocol Violation|0
5021419|NCT03248882|17270416|P3|Overall Study|Protocol Violation|2
5021420|NCT03248882|17270417|P2|Overall Study|Protocol Violation|0
5021421|NCT03248882|17270418|P1|Overall Study|Protocol Violation|2
5021422|NCT03248882|17270414|P5|Overall Study|Lost to Follow-up|1
5021423|NCT03248882|17270415|P4|Overall Study|Lost to Follow-up|0
5021424|NCT03248882|17270416|P3|Overall Study|Lost to Follow-up|0
5021425|NCT03248882|17270417|P2|Overall Study|Lost to Follow-up|0
5021426|NCT03248882|17270418|P1|Overall Study|Lost to Follow-up|0
5021427|NCT03248882|17270414|P5|Overall Study|Adverse Event|9
5021428|NCT03248882|17270415|P4|Overall Study|Adverse Event|6
5021429|NCT03248882|17270416|P3|Overall Study|Adverse Event|2
5021430|NCT03248882|17270417|P2|Overall Study|Adverse Event|3
5021431|NCT03248882|17270418|P1|Overall Study|Adverse Event|3
5021432|NCT03248492|17270460|P5|Overall Study|Other|0
5021433|NCT03248492|17270461|P4|Overall Study|Other|4
5021434|NCT03248492|17270462|P3|Overall Study|Other|0
5021435|NCT03248492|17270463|P2|Overall Study|Other|1
5021436|NCT03248492|17270464|P1|Overall Study|Other|0
5021437|NCT03248492|17270460|P5|Overall Study|Death|0
5021438|NCT03248492|17270461|P4|Overall Study|Death|6
5021439|NCT03248492|17270462|P3|Overall Study|Death|0
5021440|NCT03248492|17270463|P2|Overall Study|Death|0
5021441|NCT03248492|17270464|P1|Overall Study|Death|1
5021442|NCT03248492|17270460|P5|Overall Study|Physician Decision|0
5021443|NCT03248492|17270461|P4|Overall Study|Physician Decision|2
5021444|NCT03248492|17270462|P3|Overall Study|Physician Decision|1
5021445|NCT03248492|17270463|P2|Overall Study|Physician Decision|0
5021446|NCT03248492|17270464|P1|Overall Study|Physician Decision|1
5021447|NCT03248492|17270460|P5|Overall Study|Withdrawal by Subject|1
5021448|NCT03248492|17270461|P4|Overall Study|Withdrawal by Subject|3
5021449|NCT03248492|17270462|P3|Overall Study|Withdrawal by Subject|0
5021450|NCT03248492|17270463|P2|Overall Study|Withdrawal by Subject|3
5021451|NCT03248492|17270464|P1|Overall Study|Withdrawal by Subject|3
5021452|NCT03248492|17270460|P5|Overall Study|Adverse Event|1
5021453|NCT03248492|17270461|P4|Overall Study|Adverse Event|8
5021454|NCT03248492|17270462|P3|Overall Study|Adverse Event|8
5021455|NCT03248492|17270463|P2|Overall Study|Adverse Event|6
5021456|NCT03248492|17270464|P1|Overall Study|Adverse Event|6
5021457|NCT03248492|17270460|P5|Overall Study|Progressive disease per RECIST v1.1|0
5021458|NCT03248492|17270461|P4|Overall Study|Progressive disease per RECIST v1.1|22
5021459|NCT03248492|17270462|P3|Overall Study|Progressive disease per RECIST v1.1|9
5021460|NCT03248492|17270463|P2|Overall Study|Progressive disease per RECIST v1.1|12
5021461|NCT03248492|17270464|P1|Overall Study|Progressive disease per RECIST v1.1|16
5021462|NCT03248492|17270460|P5|Overall Study|Ongoing|2
5021463|NCT03248492|17270461|P4|Overall Study|Ongoing|85
5021464|NCT03248492|17270462|P3|Overall Study|Ongoing|3
5021465|NCT03248492|17270463|P2|Overall Study|Ongoing|26
5021466|NCT03248492|17270464|P1|Overall Study|Ongoing|23
5021467|NCT03247816|17270530|P1|Overall Study|Missing Feraccru stop date|3
5021468|NCT03247816|17270530|P1|Overall Study|Lost to Follow-up|10
5021469|NCT03247816|17270530|P1|Overall Study|Lack of Efficacy|1
5021470|NCT03247816|17270530|P1|Overall Study|Physician Decision|3
5021471|NCT03247816|17270530|P1|Overall Study|Adverse Event|12
5021472|NCT03247673|17270586|P3|Overall Study|Lost to Follow-up|1
5021473|NCT03247673|17270587|P2|Overall Study|Lost to Follow-up|0
5021474|NCT03247673|17270588|P1|Overall Study|Lost to Follow-up|0
5021475|NCT03247673|17270586|P3|Overall Study|Withdrawal by Subject|3
5021476|NCT03247673|17270587|P2|Overall Study|Withdrawal by Subject|0
5021477|NCT03247673|17270588|P1|Overall Study|Withdrawal by Subject|1
5021478|NCT03246724|17270612|P4|Overall Study|Re-consented to participate|1
5021479|NCT03246724|17270613|P3|Overall Study|Re-consented to participate|0
5021480|NCT03246724|17270614|P2|Overall Study|Re-consented to participate|0
5021481|NCT03246724|17270615|P1|Overall Study|Re-consented to participate|0
5021482|NCT03246724|17270612|P4|Overall Study|Unable to obtain medication timely|1
5021483|NCT03246724|17270613|P3|Overall Study|Unable to obtain medication timely|2
5021484|NCT03246724|17270614|P2|Overall Study|Unable to obtain medication timely|2
5021485|NCT03246724|17270615|P1|Overall Study|Unable to obtain medication timely|0
5021486|NCT03246724|17270612|P4|Overall Study|Transferred to other arm|0
5021487|NCT03246724|17270613|P3|Overall Study|Transferred to other arm|1
5021488|NCT03246724|17270614|P2|Overall Study|Transferred to other arm|0
5021489|NCT03246724|17270615|P1|Overall Study|Transferred to other arm|0
5021490|NCT03246724|17270612|P4|Overall Study|Study completed before surgical date|1
5021491|NCT03246724|17270613|P3|Overall Study|Study completed before surgical date|8
5021492|NCT03246724|17270614|P2|Overall Study|Study completed before surgical date|1
5021493|NCT03246724|17270615|P1|Overall Study|Study completed before surgical date|2
5021494|NCT03246724|17270612|P4|Overall Study|Ineligible on day of surgery|3
5021495|NCT03246724|17270613|P3|Overall Study|Ineligible on day of surgery|0
5021496|NCT03246724|17270614|P2|Overall Study|Ineligible on day of surgery|2
5021497|NCT03246724|17270615|P1|Overall Study|Ineligible on day of surgery|7
5021498|NCT03246724|17270612|P4|Overall Study|Withdrawal by Subject|2
5021499|NCT03246724|17270613|P3|Overall Study|Withdrawal by Subject|4
5021500|NCT03246724|17270614|P2|Overall Study|Withdrawal by Subject|2
5021501|NCT03246724|17270615|P1|Overall Study|Withdrawal by Subject|5
5021502|NCT03246672|17270641|P1|Overall Study|Lost to Follow-up|2
5021503|NCT03246152|17270647|P1|Overall Study|Protocol Violation|1
5021504|NCT03246152|17270647|P1|Overall Study|Lost to Follow-up|2
5021505|NCT03245619|17270679|P17|Part A (Up to Day 22)|Physician Decision|0
5021506|NCT03245619|17270680|P16|Part A (Up to Day 22)|Physician Decision|0
5021507|NCT03245619|17270681|P15|Part A (Up to Day 22)|Physician Decision|0
5021508|NCT03245619|17270682|P14|Part A (Up to Day 22)|Physician Decision|0
5021509|NCT03245619|17270683|P13|Part A (Up to Day 22)|Physician Decision|0
5021510|NCT03245619|17270684|P12|Part A (Up to Day 22)|Physician Decision|0
5021511|NCT03245619|17270685|P11|Part A (Up to Day 22)|Physician Decision|0
5021512|NCT03245619|17270686|P10|Part A (Up to Day 22)|Physician Decision|0
5021513|NCT03245619|17270687|P9|Part A (Up to Day 22)|Physician Decision|0
5021514|NCT03245619|17270688|P8|Part A (Up to Day 22)|Physician Decision|0
5021515|NCT03245619|17270689|P7|Part A (Up to Day 22)|Physician Decision|0
5021516|NCT03245619|17270690|P6|Part A (Up to Day 22)|Physician Decision|0
5021517|NCT03245619|17270691|P5|Part A (Up to Day 22)|Physician Decision|0
5021518|NCT03245619|17270692|P4|Part A (Up to Day 22)|Physician Decision|0
5021519|NCT03245619|17270693|P3|Part A (Up to Day 22)|Physician Decision|6
5021520|NCT03245619|17270694|P2|Part A (Up to Day 22)|Physician Decision|6
5021521|NCT03245619|17270695|P1|Part A (Up to Day 22)|Physician Decision|4
5021522|NCT03245398|17270969|P2|Overall Study|Travelled to another island|0
5021523|NCT03245398|17270970|P1|Overall Study|Travelled to another island|1
5021524|NCT03244800|17271000|P4|Overall Study|Withdrew treatment|1
5021525|NCT03244800|17271001|P3|Overall Study|Withdrew treatment|0
5021526|NCT03244800|17271002|P2|Overall Study|Withdrew treatment|0
5021527|NCT03244800|17271003|P1|Overall Study|Withdrew treatment|0
5021528|NCT03244800|17271000|P4|Overall Study|Adverse Event|1
5021529|NCT03244800|17271001|P3|Overall Study|Adverse Event|0
5021530|NCT03244800|17271002|P2|Overall Study|Adverse Event|1
5021531|NCT03244800|17271003|P1|Overall Study|Adverse Event|0
5021532|NCT03244618|17271063|P2|Overall Study|Withdrawal by Subject|2
5021533|NCT03244618|17271064|P1|Overall Study|Withdrawal by Subject|0
5021534|NCT03244618|17271063|P2|Overall Study|Protocol Violation|3
5021535|NCT03244618|17271064|P1|Overall Study|Protocol Violation|4
5021536|NCT03244618|17271063|P2|Overall Study|Lost to Follow-up|4
5021537|NCT03244618|17271064|P1|Overall Study|Lost to Follow-up|3
5021538|NCT03243630|17271099|P1|Overall Study|Physician Decision|1
5021539|NCT03243630|17271099|P1|Overall Study|Protocol Violation|1
5021540|NCT03243305|17271107|P1|Overall Study|Early terminations|267
5021541|NCT03243305|17271107|P1|Overall Study|Study Terminated by Sponsor|1
5021542|NCT03243305|17271107|P1|Overall Study|Study method no longer primary method|12
5021543|NCT03243305|17271107|P1|Overall Study|Protocol Violation|22
5021544|NCT03243305|17271107|P1|Overall Study|Physician Decision|22
5021545|NCT03243305|17271107|P1|Overall Study|No sexually active|26
5021546|NCT03243305|17271107|P1|Overall Study|Adverse Event|23
5021547|NCT03243305|17271107|P1|Overall Study|Non-Compliance with Study Drug|38
5021548|NCT03243305|17271107|P1|Overall Study|Pregnancy|104
5021549|NCT03243305|17271107|P1|Overall Study|Withdrawal by Subject|170
5021550|NCT03243305|17271107|P1|Overall Study|Lost to Follow-up|250
5021551|NCT03243084|17271114|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
5021552|NCT03243084|17271115|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
5021553|NCT03242863|17271131|P6|Study Week 1|Withdrawal by Subject|0
5021554|NCT03242863|17271132|P5|Study Week 1|Withdrawal by Subject|3
5021555|NCT03242863|17271133|P4|Study Week 1|Withdrawal by Subject|0
5021556|NCT03242863|17271134|P3|Study Week 1|Withdrawal by Subject|0
5021557|NCT03242863|17271135|P2|Study Week 1|Withdrawal by Subject|1
5021558|NCT03242863|17271136|P1|Study Week 1|Withdrawal by Subject|0
5021559|NCT03242434|17271159|P2|Overall Study|Death|2
5021560|NCT03242434|17271160|P1|Overall Study|Death|0
5021561|NCT03241927|17271172|P2|Overall Study|study terminated|0
5021562|NCT03241927|17271173|P1|Overall Study|study terminated|1
5021563|NCT03241368|17271219|P1|Overall Study|Protocol Violation|1
5021564|NCT03241368|17271219|P1|Overall Study|Withdrawal by Subject|6
5021565|NCT03241368|17271219|P1|Overall Study|Physician Decision|6
5021566|NCT03241368|17271219|P1|Overall Study|Lost to Follow-up|1
5021567|NCT03241368|17271219|P1|Overall Study|MRE Stricture or Patency Capsule Failure|25
5021568|NCT03241342|17271229|P3|Overall Study|not reported|19
5021569|NCT03241342|17271230|P2|Overall Study|not reported|22
5021570|NCT03241342|17271231|P1|Overall Study|not reported|16
5021571|NCT03241342|17271229|P3|Overall Study|sponsor decision|2
5021572|NCT03241342|17271230|P2|Overall Study|sponsor decision|1
5021573|NCT03241342|17271231|P1|Overall Study|sponsor decision|0
5021574|NCT03241342|17271229|P3|Overall Study|noncompliance with study drug|1
5021575|NCT03241342|17271230|P2|Overall Study|noncompliance with study drug|1
5021576|NCT03241342|17271231|P1|Overall Study|noncompliance with study drug|2
5021577|NCT03241342|17271229|P3|Overall Study|Lack of Efficacy|1
5021578|NCT03241342|17271230|P2|Overall Study|Lack of Efficacy|0
5021579|NCT03241342|17271231|P1|Overall Study|Lack of Efficacy|0
5021580|NCT03241342|17271229|P3|Overall Study|Adverse Event|4
5021581|NCT03241342|17271230|P2|Overall Study|Adverse Event|8
5021582|NCT03241342|17271231|P1|Overall Study|Adverse Event|5
5021583|NCT03240575|17271243|P4|Overall Study|Other|0
5021584|NCT03240575|17271244|P3|Overall Study|Other|0
5021585|NCT03240575|17271245|P2|Overall Study|Other|1
5021586|NCT03240575|17271246|P1|Overall Study|Other|0
5021587|NCT03240575|17271243|P4|Overall Study|Withdrawal by Subject|1
5021588|NCT03240575|17271244|P3|Overall Study|Withdrawal by Subject|0
5021589|NCT03240575|17271245|P2|Overall Study|Withdrawal by Subject|11
5021590|NCT03240575|17271246|P1|Overall Study|Withdrawal by Subject|2
5021591|NCT03240575|17271243|P4|Overall Study|Adverse Event|1
5021592|NCT03240575|17271244|P3|Overall Study|Adverse Event|0
5021593|NCT03240575|17271245|P2|Overall Study|Adverse Event|2
5021594|NCT03240575|17271246|P1|Overall Study|Adverse Event|0
5021595|NCT03239873|17271268|P2|Overall Study|Protocol Violation|0
5021596|NCT03239873|17271269|P1|Overall Study|Protocol Violation|1
5021597|NCT03239873|17271268|P2|Overall Study|Contraindication to study medication|0
5021598|NCT03239873|17271269|P1|Overall Study|Contraindication to study medication|1
5021599|NCT03239873|17271268|P2|Overall Study|Withdrawal by Subject|0
5021600|NCT03239873|17271269|P1|Overall Study|Withdrawal by Subject|2
5021601|NCT03239873|17271268|P2|Overall Study|Withdrawal by Parent/Guardian|11
5021602|NCT03239873|17271269|P1|Overall Study|Withdrawal by Parent/Guardian|12
5021603|NCT03239873|17271268|P2|Overall Study|Physician Decision|0
5021604|NCT03239873|17271269|P1|Overall Study|Physician Decision|1
5021605|NCT03239873|17271268|P2|Overall Study|Lost to Follow-up|16
5021606|NCT03239873|17271269|P1|Overall Study|Lost to Follow-up|15
5021607|NCT03239483|17271461|P2|Overall Study|Withdrawal by Subject|0
5021608|NCT03239483|17271462|P1|Overall Study|Withdrawal by Subject|1
5021609|NCT03239483|17271461|P2|Overall Study|Lost to Follow-up|0
5021610|NCT03239483|17271462|P1|Overall Study|Lost to Follow-up|1
5021611|NCT03238924|17271483|P2|Overall Study|Withdrawal by Subject|2
5021612|NCT03238924|17271484|P1|Overall Study|Withdrawal by Subject|2
5021613|NCT03238911|17271496|P2|Overall Study|Lost to Follow-up|1
5021614|NCT03238911|17271497|P1|Overall Study|Lost to Follow-up|2
5021615|NCT03238911|17271496|P2|Overall Study|Withdrawal by Subject|2
5021616|NCT03238911|17271497|P1|Overall Study|Withdrawal by Subject|1
5021617|NCT03238781|17271540|P3|Overall Study|Decision by sponsor|0
5021618|NCT03238781|17271541|P2|Overall Study|Decision by sponsor|1
5021619|NCT03238781|17271542|P1|Overall Study|Decision by sponsor|0
5021620|NCT03238781|17271540|P3|Overall Study|Withdrawal by Subject|16
5021621|NCT03238781|17271541|P2|Overall Study|Withdrawal by Subject|14
5021622|NCT03238781|17271542|P1|Overall Study|Withdrawal by Subject|23
5021623|NCT03238781|17271540|P3|Overall Study|Lost to Follow-up|2
5021624|NCT03238781|17271541|P2|Overall Study|Lost to Follow-up|1
5021625|NCT03238781|17271542|P1|Overall Study|Lost to Follow-up|2
5021626|NCT03238781|17271540|P3|Overall Study|Adverse Event|2
5021627|NCT03238781|17271541|P2|Overall Study|Adverse Event|1
5021628|NCT03238781|17271542|P1|Overall Study|Adverse Event|1
5021629|NCT03238352|17271592|P3|Overall Study|Withdrawal by Subject|0
5021630|NCT03238352|17271593|P2|Overall Study|Withdrawal by Subject|1
5021631|NCT03238352|17271594|P1|Overall Study|Withdrawal by Subject|0
5021632|NCT03238352|17271592|P3|Overall Study|Lost to Follow-up|1
5021633|NCT03238352|17271593|P2|Overall Study|Lost to Follow-up|2
5021634|NCT03238352|17271594|P1|Overall Study|Lost to Follow-up|0
5021635|NCT03238001|17271605|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
5021636|NCT03238001|17271605|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
5021637|NCT03238001|17271605|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
5021638|NCT03238001|17271605|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
5021639|NCT03238001|17271605|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
5021640|NCT03238001|17271605|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
5021641|NCT03238001|17271605|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
5021642|NCT03238001|17271605|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
5021643|NCT03237065|17271734|P2|Overall Study|Unable to obtain venous access|1
5021644|NCT03237065|17271735|P1|Overall Study|Unable to obtain venous access|0
5021645|NCT03237065|17271734|P2|Overall Study|Lost to Follow-up|0
5021646|NCT03237065|17271735|P1|Overall Study|Lost to Follow-up|1
5021647|NCT03237065|17271734|P2|Overall Study|Withdrawal by Subject|0
5021648|NCT03237065|17271735|P1|Overall Study|Withdrawal by Subject|3
5021649|NCT03237065|17271734|P2|Overall Study|Protocol Violation|1
5021650|NCT03237065|17271735|P1|Overall Study|Protocol Violation|0
5021651|NCT03237065|17271734|P2|Overall Study|Adverse Event|2
5021652|NCT03237065|17271735|P1|Overall Study|Adverse Event|0
5021653|NCT03237013|17271778|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
5021654|NCT03237013|17271779|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
5021655|NCT03237013|17271780|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
5021656|NCT03236311|17271829|P2|Overall Study|Adverse Event|1
5021657|NCT03236311|17271830|P1|Overall Study|Adverse Event|0
5021658|NCT03236311|17271829|P2|Overall Study|Study terminated by sponsor|2
5021659|NCT03236311|17271830|P1|Overall Study|Study terminated by sponsor|0
5021660|NCT03235726|17271874|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021661|NCT03235726|17271875|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021662|NCT03235726|17271876|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021663|NCT03235726|17271877|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021664|NCT03235726|17271878|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021665|NCT03235726|17271879|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
5021666|NCT03235726|17271880|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021667|NCT03235726|17271881|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021668|NCT03235726|17271882|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021669|NCT03235726|17271883|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5021670|NCT03235726|17271874|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021671|NCT03235726|17271875|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021672|NCT03235726|17271876|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021673|NCT03235726|17271877|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021674|NCT03235726|17271878|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021675|NCT03235726|17271879|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
5021676|NCT03235726|17271880|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021677|NCT03235726|17271881|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021678|NCT03235726|17271882|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021679|NCT03235726|17271883|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5021680|NCT03235349|17272042|P1|Overall Study|Other|1
5021681|NCT03235349|17272042|P1|Overall Study|Adverse Event|1
5021682|NCT03235284|17272052|P3|Overall Study|Adverse Event|1
5021683|NCT03235284|17272053|P2|Overall Study|Adverse Event|2
5021684|NCT03235284|17272054|P1|Overall Study|Adverse Event|1
5021685|NCT03235115|17272071|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
5021686|NCT03235115|17272072|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5021687|NCT03235115|17272073|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5021688|NCT03235115|17272074|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5021689|NCT03235115|17272075|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5021690|NCT03235115|17272076|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5021691|NCT03235089|17272096|P2|Overall Study|Physician Decision|2
5021692|NCT03235089|17272097|P1|Overall Study|Physician Decision|2
5021693|NCT03235089|17272096|P2|Overall Study|Lost to Follow-up|1
5021694|NCT03235089|17272097|P1|Overall Study|Lost to Follow-up|1
5021695|NCT03235050|17272138|P5|Overall Study|Other reasons|2
5021696|NCT03235050|17272139|P4|Overall Study|Other reasons|1
5021697|NCT03235050|17272140|P3|Overall Study|Other reasons|0
5021698|NCT03235050|17272141|P2|Overall Study|Other reasons|1
5021699|NCT03235050|17272142|P1|Overall Study|Other reasons|0
5021700|NCT03235050|17272138|P5|Overall Study|Withdrawal by Subject|7
5021701|NCT03235050|17272139|P4|Overall Study|Withdrawal by Subject|5
5021702|NCT03235050|17272140|P3|Overall Study|Withdrawal by Subject|2
5021703|NCT03235050|17272141|P2|Overall Study|Withdrawal by Subject|2
5021704|NCT03235050|17272142|P1|Overall Study|Withdrawal by Subject|3
5021705|NCT03235050|17272138|P5|Overall Study|Lost to Follow-up|0
5021706|NCT03235050|17272139|P4|Overall Study|Lost to Follow-up|2
5021707|NCT03235050|17272140|P3|Overall Study|Lost to Follow-up|1
5021708|NCT03235050|17272141|P2|Overall Study|Lost to Follow-up|2
5021709|NCT03235050|17272142|P1|Overall Study|Lost to Follow-up|1
5021710|NCT03235050|17272138|P5|Overall Study|Death|1
5021711|NCT03235050|17272139|P4|Overall Study|Death|2
5021712|NCT03235050|17272140|P3|Overall Study|Death|0
5021713|NCT03235050|17272141|P2|Overall Study|Death|0
5021714|NCT03235050|17272142|P1|Overall Study|Death|0
5021715|NCT03235050|17272138|P5|Overall Study|Adverse Event|1
5021716|NCT03235050|17272139|P4|Overall Study|Adverse Event|4
5021717|NCT03235050|17272140|P3|Overall Study|Adverse Event|1
5021718|NCT03235050|17272141|P2|Overall Study|Adverse Event|0
5021719|NCT03235050|17272142|P1|Overall Study|Adverse Event|0
5021720|NCT03234465|17272203|P2|Overall Study|Other|8
5021721|NCT03234465|17272204|P1|Overall Study|Other|14
5021722|NCT03234465|17272203|P2|Overall Study|Non-compliance|0
5021723|NCT03234465|17272204|P1|Overall Study|Non-compliance|2
5021724|NCT03234465|17272203|P2|Overall Study|Symptomatic deterioration|1
5021725|NCT03234465|17272204|P1|Overall Study|Symptomatic deterioration|0
5021726|NCT03234465|17272203|P2|Overall Study|Withdrawal by Subject|27
5021727|NCT03234465|17272204|P1|Overall Study|Withdrawal by Subject|12
5021728|NCT03234465|17272203|P2|Overall Study|Lost to Follow-up|1
5021729|NCT03234465|17272204|P1|Overall Study|Lost to Follow-up|1
5021730|NCT03234465|17272203|P2|Overall Study|Death|1
5021731|NCT03234465|17272204|P1|Overall Study|Death|0
5021732|NCT03234465|17272203|P2|Overall Study|Adverse Event|2
5021733|NCT03234465|17272204|P1|Overall Study|Adverse Event|4
5021734|NCT03234036|17272213|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
5021735|NCT03234036|17272214|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
5021736|NCT03234036|17272215|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
5021737|NCT03234036|17272216|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
5021738|NCT03233529|17272387|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
5021739|NCT03233529|17272387|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
5021740|NCT03233438|17272431|P2|Overall Study|No recording of dalbavancin|1
5021741|NCT03233438|17272432|P1|Overall Study|No recording of dalbavancin|0
5021742|NCT03233438|17272431|P2|Overall Study|Withdrawal by Subject|1
5021743|NCT03233438|17272432|P1|Overall Study|Withdrawal by Subject|2
5021744|NCT03233438|17272431|P2|Overall Study|Lost to Follow-up|9
5021745|NCT03233438|17272432|P1|Overall Study|Lost to Follow-up|4
5021746|NCT03233308|17272498|P1|Overall Study|Protocol Violation|1
5021747|NCT03233308|17272498|P1|Overall Study|Adverse Event|1
5021748|NCT03233230|17272514|P4|Overall Study|Lost to Follow-up|0
5021749|NCT03233230|17272515|P3|Overall Study|Lost to Follow-up|0
5021750|NCT03233230|17272516|P2|Overall Study|Lost to Follow-up|3
5021751|NCT03233230|17272517|P1|Overall Study|Lost to Follow-up|0
5021752|NCT03233230|17272514|P4|Overall Study|Withdrawal by Subject|1
5021753|NCT03233230|17272515|P3|Overall Study|Withdrawal by Subject|0
5021754|NCT03233230|17272516|P2|Overall Study|Withdrawal by Subject|2
5021755|NCT03233230|17272517|P1|Overall Study|Withdrawal by Subject|2
5021756|NCT03233230|17272514|P4|Overall Study|Other|3
5021757|NCT03233230|17272515|P3|Overall Study|Other|5
5021758|NCT03233230|17272516|P2|Overall Study|Other|5
5021759|NCT03233230|17272517|P1|Overall Study|Other|5
5021760|NCT03233230|17272514|P4|Overall Study|Lack of Efficacy|0
5021761|NCT03233230|17272515|P3|Overall Study|Lack of Efficacy|0
5021762|NCT03233230|17272516|P2|Overall Study|Lack of Efficacy|0
5021763|NCT03233230|17272517|P1|Overall Study|Lack of Efficacy|1
5021764|NCT03233230|17272514|P4|Overall Study|Protocol Violation|1
5021765|NCT03233230|17272515|P3|Overall Study|Protocol Violation|1
5021766|NCT03233230|17272516|P2|Overall Study|Protocol Violation|2
5021767|NCT03233230|17272517|P1|Overall Study|Protocol Violation|1
5021768|NCT03233230|17272514|P4|Overall Study|Adverse Event|3
5021769|NCT03233230|17272515|P3|Overall Study|Adverse Event|6
5021770|NCT03233230|17272516|P2|Overall Study|Adverse Event|3
5021771|NCT03233230|17272517|P1|Overall Study|Adverse Event|6
5021772|NCT03233009|17272709|P1|Overall Study|Lost to Follow-up|1
5021773|NCT03232983|17272752|P4|Period 4|Withdrawal by Subject|0
5021774|NCT03232983|17272753|P3|Period 4|Withdrawal by Subject|0
5021775|NCT03232983|17272754|P2|Period 4|Withdrawal by Subject|0
5021776|NCT03232983|17272755|P1|Period 4|Withdrawal by Subject|1
5021777|NCT03232983|17272752|P4|Washout Period 2|Withdrawal by Subject|1
5021778|NCT03232983|17272753|P3|Washout Period 2|Withdrawal by Subject|0
5021779|NCT03232983|17272754|P2|Washout Period 2|Withdrawal by Subject|0
5021780|NCT03232983|17272755|P1|Washout Period 2|Withdrawal by Subject|0
5021781|NCT03232983|17272752|P4|Washout Period 2|Physician Decision|0
5021782|NCT03232983|17272753|P3|Washout Period 2|Physician Decision|1
5021783|NCT03232983|17272754|P2|Washout Period 2|Physician Decision|0
5021784|NCT03232983|17272755|P1|Washout Period 2|Physician Decision|0
5021785|NCT03232983|17272752|P4|Period 1|Physician Decision|0
5021786|NCT03232983|17272753|P3|Period 1|Physician Decision|1
5021787|NCT03232983|17272754|P2|Period 1|Physician Decision|0
5021788|NCT03232983|17272755|P1|Period 1|Physician Decision|0
5021789|NCT03232567|17272799|P4|Overall Study|Withdrawal by Subject|0
5021790|NCT03232567|17272800|P3|Overall Study|Withdrawal by Subject|0
5021791|NCT03232567|17272801|P2|Overall Study|Withdrawal by Subject|1
5021792|NCT03232567|17272802|P1|Overall Study|Withdrawal by Subject|0
5021793|NCT03232333|17272824|P1|Overall Study|Withdrawal by Subject|2
5021794|NCT03232333|17272824|P1|Overall Study|Lost to Follow-up|4
5021795|NCT03232333|17272824|P1|Overall Study|Infection or Osteomyelitis|9
5021796|NCT03231943|17272841|P13|Part 2|Withdrawal by Subject|0
5021797|NCT03231943|17272842|P12|Part 2|Withdrawal by Subject|1
5021798|NCT03231943|17272843|P11|Part 2|Withdrawal by Subject|0
5021799|NCT03231943|17272844|P10|Part 2|Withdrawal by Subject|0
5021800|NCT03231943|17272845|P9|Part 2|Withdrawal by Subject|0
5021801|NCT03231943|17272846|P8|Part 2|Withdrawal by Subject|0
5021802|NCT03231943|17272847|P7|Part 2|Withdrawal by Subject|0
5021803|NCT03231943|17272848|P6|Part 2|Withdrawal by Subject|0
5021804|NCT03231943|17272849|P5|Part 2|Withdrawal by Subject|0
5021805|NCT03231943|17272850|P4|Part 2|Withdrawal by Subject|0
5021806|NCT03231943|17272851|P3|Part 2|Withdrawal by Subject|0
5021807|NCT03231943|17272852|P2|Part 2|Withdrawal by Subject|0
5021808|NCT03231943|17272853|P1|Part 2|Withdrawal by Subject|0
5021809|NCT03231943|17272841|P13|Part 2|Adverse Event|0
5021810|NCT03231943|17272842|P12|Part 2|Adverse Event|0
5021811|NCT03231943|17272843|P11|Part 2|Adverse Event|1
5021812|NCT03231943|17272844|P10|Part 2|Adverse Event|0
5021813|NCT03231943|17272845|P9|Part 2|Adverse Event|0
5021814|NCT03231943|17272846|P8|Part 2|Adverse Event|0
5021815|NCT03231943|17272847|P7|Part 2|Adverse Event|0
5021816|NCT03231943|17272848|P6|Part 2|Adverse Event|0
5021817|NCT03231943|17272849|P5|Part 2|Adverse Event|0
5021818|NCT03231943|17272850|P4|Part 2|Adverse Event|0
5021819|NCT03231943|17272851|P3|Part 2|Adverse Event|0
5021820|NCT03231943|17272852|P2|Part 2|Adverse Event|0
5021821|NCT03231943|17272853|P1|Part 2|Adverse Event|0
5021822|NCT03231943|17272841|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021823|NCT03231943|17272842|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021824|NCT03231943|17272843|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021825|NCT03231943|17272844|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021826|NCT03231943|17272845|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021827|NCT03231943|17272846|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021828|NCT03231943|17272847|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021829|NCT03231943|17272848|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021830|NCT03231943|17272849|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021831|NCT03231943|17272850|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021832|NCT03231943|17272851|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021833|NCT03231943|17272852|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5021834|NCT03231943|17272853|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
5021835|NCT03231943|17272841|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021836|NCT03231943|17272842|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021837|NCT03231943|17272843|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021838|NCT03231943|17272844|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021839|NCT03231943|17272845|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021840|NCT03231943|17272846|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021841|NCT03231943|17272847|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021842|NCT03231943|17272848|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021843|NCT03231943|17272849|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021844|NCT03231943|17272850|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021845|NCT03231943|17272851|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021846|NCT03231943|17272852|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
5021847|NCT03231943|17272853|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5021848|NCT03231943|17272841|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021849|NCT03231943|17272842|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021850|NCT03231943|17272843|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021851|NCT03231943|17272844|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021852|NCT03231943|17272845|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021853|NCT03231943|17272846|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021854|NCT03231943|17272847|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021855|NCT03231943|17272848|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021856|NCT03231943|17272849|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021857|NCT03231943|17272850|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021858|NCT03231943|17272851|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
5021859|NCT03231943|17272852|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
5021860|NCT03231943|17272853|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5021861|NCT03231800|17273316|P2|Overall Study|reason not provided|0
5021862|NCT03231800|17273317|P1|Overall Study|reason not provided|2
5021863|NCT03231800|17273316|P2|Overall Study|Protocol Violation|1
5021864|NCT03231800|17273317|P1|Overall Study|Protocol Violation|1
5021865|NCT03231800|17273316|P2|Overall Study|Lost to Follow-up|2
5021866|NCT03231800|17273317|P1|Overall Study|Lost to Follow-up|0
5021867|NCT03231709|17273333|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
5021868|NCT03231709|17273334|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
5021869|NCT03231709|17273333|P2|Treatment Period 1|Reason not Specified|1
5021870|NCT03231709|17273334|P1|Treatment Period 1|Reason not Specified|0
5021871|NCT03231371|17273352|P1|Overall Study|chose or were ineligible to have MRI|12
5021872|NCT03231371|17273352|P1|Overall Study|Withdrawal by Subject|1
5021873|NCT03231228|17273365|P2|Overall Study|Physician Decision|0
5021874|NCT03231228|17273366|P1|Overall Study|Physician Decision|1
5021875|NCT03231228|17273365|P2|Overall Study|Lost to Follow-up|0
5021876|NCT03231228|17273366|P1|Overall Study|Lost to Follow-up|2
5021877|NCT03230864|17273377|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5021878|NCT03230864|17273378|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
5021879|NCT03230864|17273379|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5021880|NCT03230864|17273380|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5021881|NCT03230864|17273377|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
5021882|NCT03230864|17273378|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
5021883|NCT03230864|17273379|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
5021884|NCT03230864|17273380|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
5021885|NCT03230864|17273377|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
5021886|NCT03230864|17273378|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
5021887|NCT03230864|17273379|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
5021888|NCT03230864|17273380|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
5021889|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5021890|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5021891|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5021892|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
5021893|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
5021894|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
5021895|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
5021896|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
5021897|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
5021898|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
5021899|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
5021900|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
5021901|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5021902|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5021903|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
5021904|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
5021905|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
5021906|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
5021907|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
5021908|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
5021909|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5021910|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5021911|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
5021912|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5021913|NCT03230864|17273377|P4|Prospective Confirmation (PC) Period|Adverse Event|0
5021914|NCT03230864|17273378|P3|Prospective Confirmation (PC) Period|Adverse Event|0
5021915|NCT03230864|17273379|P2|Prospective Confirmation (PC) Period|Adverse Event|0
5021916|NCT03230864|17273380|P1|Prospective Confirmation (PC) Period|Adverse Event|3
5021917|NCT03229486|17273398|P2|Overall Study|Protocol Violation|1
5021918|NCT03229486|17273399|P1|Overall Study|Protocol Violation|0
5021919|NCT03229109|17273440|P4|Overall Study|Withdrawal by Subject|1
5021920|NCT03229109|17273441|P3|Overall Study|Withdrawal by Subject|0
5021921|NCT03229109|17273442|P2|Overall Study|Withdrawal by Subject|0
5021922|NCT03229109|17273443|P1|Overall Study|Withdrawal by Subject|0
5021923|NCT03228433|17273459|P6|Overall Study|Positive alcohol test|0
5021924|NCT03228433|17273460|P5|Overall Study|Positive alcohol test|0
5021925|NCT03228433|17273461|P4|Overall Study|Positive alcohol test|1
5021926|NCT03228433|17273462|P3|Overall Study|Positive alcohol test|0
5021927|NCT03228433|17273463|P2|Overall Study|Positive alcohol test|0
5021928|NCT03228433|17273464|P1|Overall Study|Positive alcohol test|0
5021929|NCT03228433|17273459|P6|Overall Study|Lost to Follow-up|0
5021930|NCT03228433|17273460|P5|Overall Study|Lost to Follow-up|0
5021931|NCT03228433|17273461|P4|Overall Study|Lost to Follow-up|0
5021932|NCT03228433|17273462|P3|Overall Study|Lost to Follow-up|0
5021933|NCT03228433|17273463|P2|Overall Study|Lost to Follow-up|0
5021934|NCT03228433|17273464|P1|Overall Study|Lost to Follow-up|1
5021935|NCT03228212|17273539|P2|Period 2|Lost to Follow-up|0
5021936|NCT03228212|17273540|P1|Period 2|Lost to Follow-up|1
5021937|NCT03228212|17273539|P2|Period 1|no longer meets eligibility criteria|1
5021938|NCT03228212|17273540|P1|Period 1|no longer meets eligibility criteria|0
5021939|NCT03228212|17273539|P2|Period 1|Adverse Event|0
5021940|NCT03228212|17273540|P1|Period 1|Adverse Event|1
5021941|NCT03227861|17273556|P1|Extension Period (Week 48 to Week 96)|Other|2
5021942|NCT03227861|17273556|P1|Extension Period (Week 48 to Week 96)|Adverse Event|1
5021943|NCT03227861|17273556|P1|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
5021944|NCT03227861|17273556|P1|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
5021945|NCT03227861|17273556|P1|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
5021946|NCT03227861|17273556|P1|Main Study Period (Week 0 to Week 48)|Other|5
5021947|NCT03227861|17273556|P1|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
5021948|NCT03227861|17273556|P1|Main Study Period (Week 0 to Week 48)|Adverse Event|1
5021949|NCT03227861|17273556|P1|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
5021950|NCT03227861|17273556|P1|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
5021951|NCT03227692|17273588|P2|Overall Study|Adverse Event|2
5021952|NCT03227692|17273589|P1|Overall Study|Adverse Event|0
5021953|NCT03227692|17273588|P2|Overall Study|Lost to Follow-up|2
5021954|NCT03227692|17273589|P1|Overall Study|Lost to Follow-up|4
5021955|NCT03227692|17273588|P2|Overall Study|Protocol Violation|1
5021956|NCT03227692|17273589|P1|Overall Study|Protocol Violation|1
5021957|NCT03227445|17273617|P4|Period 2 (28 Days)|Withdrawal by Subject|1
5021958|NCT03227445|17273618|P3|Period 2 (28 Days)|Withdrawal by Subject|0
5021959|NCT03227445|17273619|P2|Period 2 (28 Days)|Withdrawal by Subject|1
5021960|NCT03227445|17273620|P1|Period 2 (28 Days)|Withdrawal by Subject|0
5021961|NCT03227445|17273617|P4|Period 2 (28 Days)|Protocol Violation|1
5021962|NCT03227445|17273618|P3|Period 2 (28 Days)|Protocol Violation|0
5021963|NCT03227445|17273619|P2|Period 2 (28 Days)|Protocol Violation|0
5021964|NCT03227445|17273620|P1|Period 2 (28 Days)|Protocol Violation|0
5021965|NCT03227445|17273617|P4|Period 2 (28 Days)|Adverse Event|1
5021966|NCT03227445|17273618|P3|Period 2 (28 Days)|Adverse Event|2
5021967|NCT03227445|17273619|P2|Period 2 (28 Days)|Adverse Event|0
5021968|NCT03227445|17273620|P1|Period 2 (28 Days)|Adverse Event|1
5021969|NCT03227445|17273617|P4|Period 1 (28 Days)|Withdrawal by Subject|1
5021970|NCT03227445|17273618|P3|Period 1 (28 Days)|Withdrawal by Subject|1
5021971|NCT03227445|17273619|P2|Period 1 (28 Days)|Withdrawal by Subject|0
5021972|NCT03227445|17273620|P1|Period 1 (28 Days)|Withdrawal by Subject|0
5021973|NCT03227445|17273617|P4|Period 1 (28 Days)|Protocol Violation|0
5021974|NCT03227445|17273618|P3|Period 1 (28 Days)|Protocol Violation|0
5021975|NCT03227445|17273619|P2|Period 1 (28 Days)|Protocol Violation|0
5021976|NCT03227445|17273620|P1|Period 1 (28 Days)|Protocol Violation|1
5021977|NCT03227445|17273617|P4|Period 1 (28 Days)|Adverse Event|1
5021978|NCT03227445|17273618|P3|Period 1 (28 Days)|Adverse Event|0
5021979|NCT03227445|17273619|P2|Period 1 (28 Days)|Adverse Event|2
5021980|NCT03227445|17273620|P1|Period 1 (28 Days)|Adverse Event|1
5021981|NCT03226769|17273646|P2|Overall Study|Withdrawal by Subject|1
5021982|NCT03226769|17273647|P1|Overall Study|Withdrawal by Subject|0
5021983|NCT03226392|17273661|P2|Overall Study|Subject/Guardian Decision|6
5021984|NCT03226392|17273662|P1|Overall Study|Subject/Guardian Decision|7
5021985|NCT03226392|17273661|P2|Overall Study|Technical Problems|2
5021986|NCT03226392|17273662|P1|Overall Study|Technical Problems|0
5021987|NCT03226392|17273661|P2|Overall Study|Adverse Event|0
5021988|NCT03226392|17273662|P1|Overall Study|Adverse Event|1
5021989|NCT03226392|17273661|P2|Overall Study|Lost to Follow-up|0
5021990|NCT03226392|17273662|P1|Overall Study|Lost to Follow-up|1
5021991|NCT03226392|17273661|P2|Overall Study|Physician Decision|0
5021992|NCT03226392|17273662|P1|Overall Study|Physician Decision|1
5021993|NCT03226392|17273661|P2|Overall Study|Protocol Deviation|0
5021994|NCT03226392|17273662|P1|Overall Study|Protocol Deviation|1
5021995|NCT03226353|17273703|P1|Overall Study|Screen Failure|5
5021996|NCT03226353|17273703|P1|Overall Study|Withdrawal by Subject|1
5021997|NCT03226275|17273727|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
5021998|NCT03226275|17273728|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5021999|NCT03226275|17273729|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5022000|NCT03226275|17273730|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5022001|NCT03226275|17273727|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5022002|NCT03226275|17273728|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
5022003|NCT03226275|17273729|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5022004|NCT03226275|17273730|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5022005|NCT03226249|17273776|P1|Survival Follow-up|Patients still in follow-up.|30
5022006|NCT03226249|17273776|P1|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
5022007|NCT03226249|17273776|P1|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
5022008|NCT03224598|17273846|P3|Overall Study|Other|0
5022009|NCT03224598|17273847|P2|Overall Study|Other|1
5022010|NCT03224598|17273848|P1|Overall Study|Other|0
5022011|NCT03224598|17273846|P3|Overall Study|Lost to Follow-up|0
5022012|NCT03224598|17273847|P2|Overall Study|Lost to Follow-up|2
5022013|NCT03224598|17273848|P1|Overall Study|Lost to Follow-up|0
5022014|NCT03224325|17273874|P7|Overall Study|Withdrawal by Subject|0
5022015|NCT03224325|17273875|P6|Overall Study|Withdrawal by Subject|0
5022016|NCT03224325|17273876|P5|Overall Study|Withdrawal by Subject|0
5022017|NCT03224325|17273877|P4|Overall Study|Withdrawal by Subject|1
5022018|NCT03224325|17273878|P3|Overall Study|Withdrawal by Subject|0
5022019|NCT03224325|17273879|P2|Overall Study|Withdrawal by Subject|0
5022020|NCT03224325|17273880|P1|Overall Study|Withdrawal by Subject|0
5022021|NCT03224325|17273874|P7|Overall Study|Adverse Event|1
5022022|NCT03224325|17273875|P6|Overall Study|Adverse Event|0
5022023|NCT03224325|17273876|P5|Overall Study|Adverse Event|0
5022024|NCT03224325|17273877|P4|Overall Study|Adverse Event|0
5022025|NCT03224325|17273878|P3|Overall Study|Adverse Event|0
5022026|NCT03224325|17273879|P2|Overall Study|Adverse Event|0
5022027|NCT03224325|17273880|P1|Overall Study|Adverse Event|1
5022028|NCT03224130|17273943|P2|Overall Study|consent issue|1
5022029|NCT03224130|17273944|P1|Overall Study|consent issue|0
5022030|NCT03223909|17273965|P3|Overall Study|Protocol Violation|16
5022031|NCT03223909|17273966|P2|Overall Study|Protocol Violation|45
5022032|NCT03223909|17273967|P1|Overall Study|Protocol Violation|48
5022033|NCT03223662|17273996|P1|Overall Study|Study closure|1
5022034|NCT03223662|17273996|P1|Overall Study|Physician Decision|1
5022035|NCT03222583|17274100|P2|Overall Study|Other|3
5022036|NCT03222583|17274101|P1|Overall Study|Other|1
5022037|NCT03222583|17274100|P2|Overall Study|Lost to Follow-up|0
5022038|NCT03222583|17274101|P1|Overall Study|Lost to Follow-up|1
5022039|NCT03222583|17274100|P2|Overall Study|Withdrawal by Subject|3
5022040|NCT03222583|17274101|P1|Overall Study|Withdrawal by Subject|3
5022041|NCT03222141|17274151|P1|Overall Study|Lost to Follow-up|3
5022042|NCT03222141|17274151|P1|Overall Study|Death|15
5022043|NCT03220737|17274229|P7|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5022044|NCT03220737|17274230|P6|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5022045|NCT03220737|17274231|P5|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5022046|NCT03220737|17274232|P4|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5022047|NCT03220737|17274233|P3|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5022048|NCT03220737|17274234|P2|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5022049|NCT03220737|17274235|P1|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
5022050|NCT03220737|17274229|P7|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5022051|NCT03220737|17274230|P6|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5022052|NCT03220737|17274231|P5|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5022053|NCT03220737|17274232|P4|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5022054|NCT03220737|17274233|P3|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5022055|NCT03220737|17274234|P2|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5022056|NCT03220737|17274235|P1|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
5022057|NCT03220737|17274229|P7|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5022058|NCT03220737|17274230|P6|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5022059|NCT03220737|17274231|P5|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5022060|NCT03220737|17274232|P4|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5022061|NCT03220737|17274233|P3|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5022062|NCT03220737|17274234|P2|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5022063|NCT03220737|17274235|P1|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
5022064|NCT03220737|17274229|P7|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5022065|NCT03220737|17274230|P6|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5022066|NCT03220737|17274231|P5|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
5022067|NCT03220737|17274232|P4|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5022068|NCT03220737|17274233|P3|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5022069|NCT03220737|17274234|P2|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5022070|NCT03220737|17274235|P1|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5022071|NCT03220737|17274229|P7|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5022072|NCT03220737|17274230|P6|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5022073|NCT03220737|17274231|P5|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5022074|NCT03220737|17274232|P4|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5022075|NCT03220737|17274233|P3|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
5022076|NCT03220737|17274234|P2|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5022077|NCT03220737|17274235|P1|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5022078|NCT03220737|17274229|P7|Main Study (Day 1 - 181)|Protocol Violation|1
5022079|NCT03220737|17274230|P6|Main Study (Day 1 - 181)|Protocol Violation|0
5022080|NCT03220737|17274231|P5|Main Study (Day 1 - 181)|Protocol Violation|3
5022081|NCT03220737|17274232|P4|Main Study (Day 1 - 181)|Protocol Violation|1
5022082|NCT03220737|17274233|P3|Main Study (Day 1 - 181)|Protocol Violation|1
5022083|NCT03220737|17274234|P2|Main Study (Day 1 - 181)|Protocol Violation|0
5022084|NCT03220737|17274235|P1|Main Study (Day 1 - 181)|Protocol Violation|0
5022085|NCT03220737|17274229|P7|Main Study (Day 1 - 181)|Lost to Follow-up|0
5022086|NCT03220737|17274230|P6|Main Study (Day 1 - 181)|Lost to Follow-up|1
5022087|NCT03220737|17274231|P5|Main Study (Day 1 - 181)|Lost to Follow-up|13
5022088|NCT03220737|17274232|P4|Main Study (Day 1 - 181)|Lost to Follow-up|1
5022089|NCT03220737|17274233|P3|Main Study (Day 1 - 181)|Lost to Follow-up|6
5022090|NCT03220737|17274234|P2|Main Study (Day 1 - 181)|Lost to Follow-up|1
5022091|NCT03220737|17274235|P1|Main Study (Day 1 - 181)|Lost to Follow-up|2
5022092|NCT03220737|17274229|P7|Main Study (Day 1 - 181)|Withdrawal by Subject|0
5022093|NCT03220737|17274230|P6|Main Study (Day 1 - 181)|Withdrawal by Subject|0
5022094|NCT03220737|17274231|P5|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5022095|NCT03220737|17274232|P4|Main Study (Day 1 - 181)|Withdrawal by Subject|1
5022096|NCT03220737|17274233|P3|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5022097|NCT03220737|17274234|P2|Main Study (Day 1 - 181)|Withdrawal by Subject|1
5022098|NCT03220737|17274235|P1|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5022099|NCT03219723|17274375|P1|Overall Study|Protocol Deviation|4
5022100|NCT03219723|17274375|P1|Overall Study|Case Report Forms Uncollected|6
5022101|NCT03219216|17274418|P2|Overall Study|Lost to Follow-up|1
5022102|NCT03219216|17274419|P1|Overall Study|Lost to Follow-up|0
5022103|NCT03218397|17274465|P2|Overall Study|Randomized during laboratory off hours|1
5022104|NCT03218397|17274466|P1|Overall Study|Randomized during laboratory off hours|2
5022105|NCT03218397|17274465|P2|Overall Study|No gram-negative bacilli (GNB)|2
5022106|NCT03218397|17274466|P1|Overall Study|No gram-negative bacilli (GNB)|0
5022107|NCT03218397|17274465|P2|Overall Study|Inaccessible hospital records|5
5022108|NCT03218397|17274466|P1|Overall Study|Inaccessible hospital records|2
5022109|NCT03218397|17274465|P2|Overall Study|Mixed culture|2
5022110|NCT03218397|17274466|P1|Overall Study|Mixed culture|2
5022111|NCT03218397|17274465|P2|Overall Study|Comfort care and mixed culture|1
5022112|NCT03218397|17274466|P1|Overall Study|Comfort care and mixed culture|0
5022113|NCT03218397|17274465|P2|Overall Study|Comfort care and positive blood culture|0
5022114|NCT03218397|17274466|P1|Overall Study|Comfort care and positive blood culture|1
5022115|NCT03218397|17274465|P2|Overall Study|Comfort care|5
5022116|NCT03218397|17274466|P1|Overall Study|Comfort care|8
5022117|NCT03218397|17274465|P2|Overall Study|Prior positive blood culture|13
5022118|NCT03218397|17274466|P1|Overall Study|Prior positive blood culture|8
5022119|NCT03217968|17274498|P1|Overall Study|Protocol Violation|6
5022120|NCT03217968|17274498|P1|Overall Study|Lost to Follow-up|1
5022121|NCT03217968|17274498|P1|Overall Study|Withdrawal by Subject|4
5022122|NCT03217175|17274507|P2|Overall Study|Physician Decision|1
5022123|NCT03217175|17274508|P1|Overall Study|Physician Decision|4
5022124|NCT03216850|17274603|P1|Overall Study|Pre-analytical error|6
5022125|NCT03216746|17274611|P4|Overall Study|Lost to Follow-up|6
5022126|NCT03216746|17274612|P3|Overall Study|Lost to Follow-up|5
5022127|NCT03216746|17274613|P2|Overall Study|Lost to Follow-up|8
5022128|NCT03216746|17274614|P1|Overall Study|Lost to Follow-up|6
5022129|NCT03216265|17274655|P3|Overall Study|Withdrawal by Subject|1
5022130|NCT03216265|17274656|P2|Overall Study|Withdrawal by Subject|0
5022131|NCT03216265|17274657|P1|Overall Study|Withdrawal by Subject|0
5022132|NCT03216265|17274655|P3|Overall Study|Lost to Follow-up|0
5022133|NCT03216265|17274656|P2|Overall Study|Lost to Follow-up|1
5022134|NCT03216265|17274657|P1|Overall Study|Lost to Follow-up|0
5022135|NCT03216265|17274655|P3|Overall Study|Adverse Event|2
5022136|NCT03216265|17274656|P2|Overall Study|Adverse Event|0
5022137|NCT03216265|17274657|P1|Overall Study|Adverse Event|2
5022138|NCT03215758|17274748|P2|Overall Study|Subject/Guardian Decision|3
5022139|NCT03215758|17274749|P1|Overall Study|Subject/Guardian Decision|3
5022140|NCT03215758|17274748|P2|Overall Study|Adverse Event|2
5022141|NCT03215758|17274749|P1|Overall Study|Adverse Event|1
5022142|NCT03215758|17274748|P2|Overall Study|Death|1
5022143|NCT03215758|17274749|P1|Overall Study|Death|0
5022144|NCT03215758|17274748|P2|Overall Study|Physician Decision|1
5022145|NCT03215758|17274749|P1|Overall Study|Physician Decision|0
5022146|NCT03215758|17274748|P2|Overall Study|Protocol deviation|1
5022147|NCT03215758|17274749|P1|Overall Study|Protocol deviation|0
5022148|NCT03215758|17274748|P2|Overall Study|Technical Problems|0
5022149|NCT03215758|17274749|P1|Overall Study|Technical Problems|1
5022150|NCT03215706|17274763|P2|Treatment Period|Ongoing in the treatment period|43
5022151|NCT03215706|17274764|P1|Treatment Period|Ongoing in the treatment period|105
5022152|NCT03215706|17274763|P2|Treatment Period|Other Reasons|5
5022153|NCT03215706|17274764|P1|Treatment Period|Other Reasons|4
5022154|NCT03215706|17274763|P2|Treatment Period|Lost to Follow-up|1
5022155|NCT03215706|17274764|P1|Treatment Period|Lost to Follow-up|0
5022156|NCT03215706|17274763|P2|Treatment Period|Participant withdrew consent|4
5022157|NCT03215706|17274764|P1|Treatment Period|Participant withdrew consent|3
5022158|NCT03215706|17274763|P2|Treatment Period|Request to D/C treatment|6
5022159|NCT03215706|17274764|P1|Treatment Period|Request to D/C treatment|1
5022160|NCT03215706|17274763|P2|Treatment Period|Adverse event unrelated to study drug|23
5022161|NCT03215706|17274764|P1|Treatment Period|Adverse event unrelated to study drug|24
5022162|NCT03215706|17274763|P2|Treatment Period|Death|1
5022163|NCT03215706|17274764|P1|Treatment Period|Death|2
5022164|NCT03215706|17274763|P2|Treatment Period|Study Drug Toxicity|21
5022165|NCT03215706|17274764|P1|Treatment Period|Study Drug Toxicity|53
5022166|NCT03215706|17274763|P2|Treatment Period|Disease Progression|142
5022167|NCT03215706|17274764|P1|Treatment Period|Disease Progression|150
5022168|NCT03215706|17274763|P2|Randomization|other reasons|2
5022169|NCT03215706|17274764|P1|Randomization|other reasons|0
5022170|NCT03215706|17274763|P2|Randomization|no longer meets study criteria|4
5022171|NCT03215706|17274764|P1|Randomization|no longer meets study criteria|1
5022172|NCT03215706|17274763|P2|Randomization|participant withdrew consent|3
5022173|NCT03215706|17274764|P1|Randomization|participant withdrew consent|1
5022174|NCT03215706|17274763|P2|Randomization|Adverse Event unrelated to study drug|0
5022175|NCT03215706|17274764|P1|Randomization|Adverse Event unrelated to study drug|1
5022176|NCT03214952|17274784|P1|Overall Study|Case Report Forms Uncollected|13
5022177|NCT03214952|17274784|P1|Overall Study|Protocol Deviation|45
5022178|NCT03214588|17274799|P3|Overall Study|Reason Not Specified|0
5022179|NCT03214588|17274800|P2|Overall Study|Reason Not Specified|1
5022180|NCT03214588|17274801|P1|Overall Study|Reason Not Specified|0
5022181|NCT03214588|17274799|P3|Overall Study|Adverse Event|2
5022182|NCT03214588|17274800|P2|Overall Study|Adverse Event|0
5022183|NCT03214588|17274801|P1|Overall Study|Adverse Event|1
5022184|NCT03214406|17274868|P2|Overall Study|Lost to Follow-up|2
5022185|NCT03214406|17274869|P1|Overall Study|Lost to Follow-up|0
5022186|NCT03214406|17274868|P2|Overall Study|Withdrawal by Subject|0
5022187|NCT03214406|17274869|P1|Overall Study|Withdrawal by Subject|1
5022188|NCT03214406|17274868|P2|Overall Study|did not meet enrollment criteria|13
5022189|NCT03214406|17274869|P1|Overall Study|did not meet enrollment criteria|9
5022190|NCT03214380|17274883|P6|Treatment Period|Treatment Interruption|0
5022191|NCT03214380|17274884|P5|Treatment Period|Treatment Interruption|0
5022192|NCT03214380|17274885|P4|Treatment Period|Treatment Interruption|0
5022193|NCT03214380|17274886|P3|Treatment Period|Treatment Interruption|1
5022194|NCT03214380|17274887|P2|Treatment Period|Treatment Interruption|0
5022195|NCT03214380|17274888|P1|Treatment Period|Treatment Interruption|0
5022196|NCT03214380|17274883|P6|Treatment Period|Participant schedule|0
5022197|NCT03214380|17274884|P5|Treatment Period|Participant schedule|0
5022198|NCT03214380|17274885|P4|Treatment Period|Participant schedule|0
5022199|NCT03214380|17274886|P3|Treatment Period|Participant schedule|1
5022200|NCT03214380|17274887|P2|Treatment Period|Participant schedule|0
5022201|NCT03214380|17274888|P1|Treatment Period|Participant schedule|0
5022202|NCT03214380|17274883|P6|Treatment Period|Lost to Follow-up|0
5022203|NCT03214380|17274884|P5|Treatment Period|Lost to Follow-up|0
5022204|NCT03214380|17274885|P4|Treatment Period|Lost to Follow-up|0
5022205|NCT03214380|17274886|P3|Treatment Period|Lost to Follow-up|3
5022206|NCT03214380|17274887|P2|Treatment Period|Lost to Follow-up|6
5022207|NCT03214380|17274888|P1|Treatment Period|Lost to Follow-up|0
5022208|NCT03214380|17274883|P6|Treatment Period|Death|0
5022209|NCT03214380|17274884|P5|Treatment Period|Death|0
5022210|NCT03214380|17274885|P4|Treatment Period|Death|0
5022211|NCT03214380|17274886|P3|Treatment Period|Death|2
5022212|NCT03214380|17274887|P2|Treatment Period|Death|1
5022213|NCT03214380|17274888|P1|Treatment Period|Death|0
5022214|NCT03214380|17274883|P6|Treatment Period|Withdrawal by Subject|11
5022215|NCT03214380|17274884|P5|Treatment Period|Withdrawal by Subject|7
5022216|NCT03214380|17274885|P4|Treatment Period|Withdrawal by Subject|0
5022217|NCT03214380|17274886|P3|Treatment Period|Withdrawal by Subject|8
5022218|NCT03214380|17274887|P2|Treatment Period|Withdrawal by Subject|10
5022219|NCT03214380|17274888|P1|Treatment Period|Withdrawal by Subject|0
5022220|NCT03214380|17274883|P6|Treatment Period|Non-Compliance with Study Drug|0
5022221|NCT03214380|17274884|P5|Treatment Period|Non-Compliance with Study Drug|1
5022222|NCT03214380|17274885|P4|Treatment Period|Non-Compliance with Study Drug|0
5022223|NCT03214380|17274886|P3|Treatment Period|Non-Compliance with Study Drug|0
5022224|NCT03214380|17274887|P2|Treatment Period|Non-Compliance with Study Drug|0
5022225|NCT03214380|17274888|P1|Treatment Period|Non-Compliance with Study Drug|0
5022226|NCT03214380|17274883|P6|Treatment Period|Adverse Event|0
5022227|NCT03214380|17274884|P5|Treatment Period|Adverse Event|1
5022228|NCT03214380|17274885|P4|Treatment Period|Adverse Event|0
5022229|NCT03214380|17274886|P3|Treatment Period|Adverse Event|1
5022230|NCT03214380|17274887|P2|Treatment Period|Adverse Event|1
5022231|NCT03214380|17274888|P1|Treatment Period|Adverse Event|0
5022232|NCT03214380|17274883|P6|Lead-in|Participant Schedule|0
5022233|NCT03214380|17274884|P5|Lead-in|Participant Schedule|0
5022234|NCT03214380|17274885|P4|Lead-in|Participant Schedule|0
5022235|NCT03214380|17274886|P3|Lead-in|Participant Schedule|0
5022236|NCT03214380|17274887|P2|Lead-in|Participant Schedule|0
5022237|NCT03214380|17274888|P1|Lead-in|Participant Schedule|2
5022238|NCT03214380|17274883|P6|Lead-in|Non Compliance|0
5022239|NCT03214380|17274884|P5|Lead-in|Non Compliance|0
5022240|NCT03214380|17274885|P4|Lead-in|Non Compliance|0
5022241|NCT03214380|17274886|P3|Lead-in|Non Compliance|0
5022242|NCT03214380|17274887|P2|Lead-in|Non Compliance|0
5022243|NCT03214380|17274888|P1|Lead-in|Non Compliance|1
5022244|NCT03214380|17274883|P6|Lead-in|Natural Disaster|0
5022245|NCT03214380|17274884|P5|Lead-in|Natural Disaster|0
5022246|NCT03214380|17274885|P4|Lead-in|Natural Disaster|0
5022247|NCT03214380|17274886|P3|Lead-in|Natural Disaster|0
5022248|NCT03214380|17274887|P2|Lead-in|Natural Disaster|0
5022249|NCT03214380|17274888|P1|Lead-in|Natural Disaster|9
5022250|NCT03214380|17274883|P6|Lead-in|Family Emergency|0
5022251|NCT03214380|17274884|P5|Lead-in|Family Emergency|0
5022252|NCT03214380|17274885|P4|Lead-in|Family Emergency|0
5022253|NCT03214380|17274886|P3|Lead-in|Family Emergency|0
5022254|NCT03214380|17274887|P2|Lead-in|Family Emergency|0
5022255|NCT03214380|17274888|P1|Lead-in|Family Emergency|1
5022256|NCT03214380|17274883|P6|Lead-in|Withdrawal by Subject|0
5022257|NCT03214380|17274884|P5|Lead-in|Withdrawal by Subject|0
5022258|NCT03214380|17274885|P4|Lead-in|Withdrawal by Subject|14
5022259|NCT03214380|17274886|P3|Lead-in|Withdrawal by Subject|0
5022260|NCT03214380|17274887|P2|Lead-in|Withdrawal by Subject|0
5022261|NCT03214380|17274888|P1|Lead-in|Withdrawal by Subject|41
5022262|NCT03214380|17274883|P6|Lead-in|Protocol Deviation|0
5022263|NCT03214380|17274884|P5|Lead-in|Protocol Deviation|0
5022264|NCT03214380|17274885|P4|Lead-in|Protocol Deviation|3
5022265|NCT03214380|17274886|P3|Lead-in|Protocol Deviation|0
5022266|NCT03214380|17274887|P2|Lead-in|Protocol Deviation|0
5022267|NCT03214380|17274888|P1|Lead-in|Protocol Deviation|7
5022268|NCT03214380|17274883|P6|Lead-in|Physician Decision|0
5022269|NCT03214380|17274884|P5|Lead-in|Physician Decision|0
5022270|NCT03214380|17274885|P4|Lead-in|Physician Decision|0
5022271|NCT03214380|17274886|P3|Lead-in|Physician Decision|0
5022272|NCT03214380|17274887|P2|Lead-in|Physician Decision|0
5022273|NCT03214380|17274888|P1|Lead-in|Physician Decision|6
5022274|NCT03214380|17274883|P6|Lead-in|Eligibility Criteria|0
5022275|NCT03214380|17274884|P5|Lead-in|Eligibility Criteria|0
5022276|NCT03214380|17274885|P4|Lead-in|Eligibility Criteria|0
5022277|NCT03214380|17274886|P3|Lead-in|Eligibility Criteria|0
5022278|NCT03214380|17274887|P2|Lead-in|Eligibility Criteria|0
5022279|NCT03214380|17274888|P1|Lead-in|Eligibility Criteria|3
5022280|NCT03214380|17274883|P6|Lead-in|Lost to Follow-up|0
5022281|NCT03214380|17274884|P5|Lead-in|Lost to Follow-up|0
5022282|NCT03214380|17274885|P4|Lead-in|Lost to Follow-up|1
5022283|NCT03214380|17274886|P3|Lead-in|Lost to Follow-up|0
5022284|NCT03214380|17274887|P2|Lead-in|Lost to Follow-up|0
5022285|NCT03214380|17274888|P1|Lead-in|Lost to Follow-up|4
5022286|NCT03214380|17274883|P6|Lead-in|Adverse Event|0
5022287|NCT03214380|17274884|P5|Lead-in|Adverse Event|0
5022288|NCT03214380|17274885|P4|Lead-in|Adverse Event|1
5022289|NCT03214380|17274886|P3|Lead-in|Adverse Event|0
5022290|NCT03214380|17274887|P2|Lead-in|Adverse Event|0
5022291|NCT03214380|17274888|P1|Lead-in|Adverse Event|3
5022292|NCT03214367|17274924|P8|Treatment Period|Withdrawal by Subject|1
5022293|NCT03214367|17274925|P7|Treatment Period|Withdrawal by Subject|1
5022294|NCT03214367|17274926|P6|Treatment Period|Withdrawal by Subject|1
5022295|NCT03214367|17274927|P5|Treatment Period|Withdrawal by Subject|0
5022296|NCT03214367|17274928|P4|Treatment Period|Withdrawal by Subject|14
5022297|NCT03214367|17274929|P3|Treatment Period|Withdrawal by Subject|23
5022298|NCT03214367|17274930|P2|Treatment Period|Withdrawal by Subject|20
5022299|NCT03214367|17274931|P1|Treatment Period|Withdrawal by Subject|0
5022300|NCT03214367|17274924|P8|Treatment Period|Protocol Violation|0
5022301|NCT03214367|17274925|P7|Treatment Period|Protocol Violation|0
5022302|NCT03214367|17274926|P6|Treatment Period|Protocol Violation|0
5022303|NCT03214367|17274927|P5|Treatment Period|Protocol Violation|0
5022304|NCT03214367|17274928|P4|Treatment Period|Protocol Violation|0
5022305|NCT03214367|17274929|P3|Treatment Period|Protocol Violation|0
5022306|NCT03214367|17274930|P2|Treatment Period|Protocol Violation|3
5022307|NCT03214367|17274931|P1|Treatment Period|Protocol Violation|0
5022308|NCT03214367|17274924|P8|Treatment Period|Physician Decision|0
5022309|NCT03214367|17274925|P7|Treatment Period|Physician Decision|0
5022310|NCT03214367|17274926|P6|Treatment Period|Physician Decision|0
5022311|NCT03214367|17274927|P5|Treatment Period|Physician Decision|0
5022312|NCT03214367|17274928|P4|Treatment Period|Physician Decision|0
5022313|NCT03214367|17274929|P3|Treatment Period|Physician Decision|2
5022314|NCT03214367|17274930|P2|Treatment Period|Physician Decision|1
5022315|NCT03214367|17274931|P1|Treatment Period|Physician Decision|0
5022316|NCT03214367|17274924|P8|Treatment Period|Sponsor Decision|0
5022317|NCT03214367|17274925|P7|Treatment Period|Sponsor Decision|0
5022318|NCT03214367|17274926|P6|Treatment Period|Sponsor Decision|0
5022319|NCT03214367|17274927|P5|Treatment Period|Sponsor Decision|0
5022320|NCT03214367|17274928|P4|Treatment Period|Sponsor Decision|0
5022321|NCT03214367|17274929|P3|Treatment Period|Sponsor Decision|0
5022322|NCT03214367|17274930|P2|Treatment Period|Sponsor Decision|3
5022323|NCT03214367|17274931|P1|Treatment Period|Sponsor Decision|0
5022324|NCT03214367|17274924|P8|Treatment Period|Lost to Follow-up|0
5022325|NCT03214367|17274925|P7|Treatment Period|Lost to Follow-up|1
5022326|NCT03214367|17274926|P6|Treatment Period|Lost to Follow-up|2
5022327|NCT03214367|17274927|P5|Treatment Period|Lost to Follow-up|0
5022328|NCT03214367|17274928|P4|Treatment Period|Lost to Follow-up|2
5022329|NCT03214367|17274929|P3|Treatment Period|Lost to Follow-up|3
5022330|NCT03214367|17274930|P2|Treatment Period|Lost to Follow-up|5
5022331|NCT03214367|17274931|P1|Treatment Period|Lost to Follow-up|0
5022332|NCT03214367|17274924|P8|Treatment Period|Death|0
5022333|NCT03214367|17274925|P7|Treatment Period|Death|0
5022334|NCT03214367|17274926|P6|Treatment Period|Death|0
5022335|NCT03214367|17274927|P5|Treatment Period|Death|0
5022336|NCT03214367|17274928|P4|Treatment Period|Death|1
5022337|NCT03214367|17274929|P3|Treatment Period|Death|1
5022338|NCT03214367|17274930|P2|Treatment Period|Death|1
5022339|NCT03214367|17274931|P1|Treatment Period|Death|0
5022340|NCT03214367|17274924|P8|Treatment Period|Adverse Event|0
5022341|NCT03214367|17274925|P7|Treatment Period|Adverse Event|0
5022342|NCT03214367|17274926|P6|Treatment Period|Adverse Event|0
5022343|NCT03214367|17274927|P5|Treatment Period|Adverse Event|0
5022344|NCT03214367|17274928|P4|Treatment Period|Adverse Event|2
5022345|NCT03214367|17274929|P3|Treatment Period|Adverse Event|4
5022346|NCT03214367|17274930|P2|Treatment Period|Adverse Event|1
5022347|NCT03214367|17274931|P1|Treatment Period|Adverse Event|0
5022348|NCT03214367|17274924|P8|Lead-in Period|Treatment Interruption|0
5022349|NCT03214367|17274925|P7|Lead-in Period|Treatment Interruption|0
5022350|NCT03214367|17274926|P6|Lead-in Period|Treatment Interruption|0
5022351|NCT03214367|17274927|P5|Lead-in Period|Treatment Interruption|0
5022352|NCT03214367|17274928|P4|Lead-in Period|Treatment Interruption|0
5022353|NCT03214367|17274929|P3|Lead-in Period|Treatment Interruption|0
5022354|NCT03214367|17274930|P2|Lead-in Period|Treatment Interruption|0
5022355|NCT03214367|17274931|P1|Lead-in Period|Treatment Interruption|1
5022356|NCT03214367|17274924|P8|Lead-in Period|Protocol Violation|0
5022357|NCT03214367|17274925|P7|Lead-in Period|Protocol Violation|0
5022358|NCT03214367|17274926|P6|Lead-in Period|Protocol Violation|0
5022359|NCT03214367|17274927|P5|Lead-in Period|Protocol Violation|0
5022360|NCT03214367|17274928|P4|Lead-in Period|Protocol Violation|0
5022361|NCT03214367|17274929|P3|Lead-in Period|Protocol Violation|0
5022362|NCT03214367|17274930|P2|Lead-in Period|Protocol Violation|0
5022363|NCT03214367|17274931|P1|Lead-in Period|Protocol Violation|5
5022364|NCT03214367|17274924|P8|Lead-in Period|Physician Decision|0
5022365|NCT03214367|17274925|P7|Lead-in Period|Physician Decision|0
5022366|NCT03214367|17274926|P6|Lead-in Period|Physician Decision|0
5022367|NCT03214367|17274927|P5|Lead-in Period|Physician Decision|0
5022368|NCT03214367|17274928|P4|Lead-in Period|Physician Decision|0
5022369|NCT03214367|17274929|P3|Lead-in Period|Physician Decision|0
5022370|NCT03214367|17274930|P2|Lead-in Period|Physician Decision|0
5022371|NCT03214367|17274931|P1|Lead-in Period|Physician Decision|12
5022372|NCT03214367|17274924|P8|Lead-in Period|Sponsor Decision|0
5022373|NCT03214367|17274925|P7|Lead-in Period|Sponsor Decision|0
5022374|NCT03214367|17274926|P6|Lead-in Period|Sponsor Decision|0
5022375|NCT03214367|17274927|P5|Lead-in Period|Sponsor Decision|0
5022376|NCT03214367|17274928|P4|Lead-in Period|Sponsor Decision|0
5022377|NCT03214367|17274929|P3|Lead-in Period|Sponsor Decision|0
5022378|NCT03214367|17274930|P2|Lead-in Period|Sponsor Decision|0
5022379|NCT03214367|17274931|P1|Lead-in Period|Sponsor Decision|11
5022380|NCT03214367|17274924|P8|Lead-in Period|Lost to Follow-up|0
5022381|NCT03214367|17274925|P7|Lead-in Period|Lost to Follow-up|0
5022382|NCT03214367|17274926|P6|Lead-in Period|Lost to Follow-up|0
5022383|NCT03214367|17274927|P5|Lead-in Period|Lost to Follow-up|0
5022384|NCT03214367|17274928|P4|Lead-in Period|Lost to Follow-up|0
5022385|NCT03214367|17274929|P3|Lead-in Period|Lost to Follow-up|0
5022386|NCT03214367|17274930|P2|Lead-in Period|Lost to Follow-up|0
5022387|NCT03214367|17274931|P1|Lead-in Period|Lost to Follow-up|12
5022388|NCT03214367|17274924|P8|Lead-in Period|Adverse Event|0
5022389|NCT03214367|17274925|P7|Lead-in Period|Adverse Event|0
5022390|NCT03214367|17274926|P6|Lead-in Period|Adverse Event|0
5022391|NCT03214367|17274927|P5|Lead-in Period|Adverse Event|0
5022392|NCT03214367|17274928|P4|Lead-in Period|Adverse Event|0
5022393|NCT03214367|17274929|P3|Lead-in Period|Adverse Event|0
5022394|NCT03214367|17274930|P2|Lead-in Period|Adverse Event|0
5022395|NCT03214367|17274931|P1|Lead-in Period|Adverse Event|3
5022396|NCT03214367|17274924|P8|Lead-in Period|Withdrawal by Subject|0
5022397|NCT03214367|17274925|P7|Lead-in Period|Withdrawal by Subject|0
5022398|NCT03214367|17274926|P6|Lead-in Period|Withdrawal by Subject|0
5022399|NCT03214367|17274927|P5|Lead-in Period|Withdrawal by Subject|2
5022400|NCT03214367|17274928|P4|Lead-in Period|Withdrawal by Subject|0
5022401|NCT03214367|17274929|P3|Lead-in Period|Withdrawal by Subject|0
5022402|NCT03214367|17274930|P2|Lead-in Period|Withdrawal by Subject|0
5022403|NCT03214367|17274931|P1|Lead-in Period|Withdrawal by Subject|50
5022404|NCT03214224|17274976|P1|Overall Study|Practice controls or therapists|6
5022405|NCT03214224|17274976|P1|Overall Study|Withdrawal by Subject|2
5022406|NCT03214224|17274976|P1|Overall Study|Protocol Violation|1
5022407|NCT03214094|17274985|P1|Overall Study|Protocol Deviation|46
5022408|NCT03214094|17274985|P1|Overall Study|Case Report Forms Uncollected|14
5022409|NCT03214081|17274993|P1|Overall Study|Protocol Deviation|54
5022410|NCT03214081|17274993|P1|Overall Study|Case Report Forms Uncollected|9
5022411|NCT03213626|17275008|P1|Overall Study|Progressive Disease|6
5022412|NCT03213626|17275008|P1|Overall Study|Adverse Event|1
5022413|NCT03213509|17275018|P2|Overall Study|Did not consent for verbal autopsy|5
5022414|NCT03213509|17275019|P1|Overall Study|Did not consent for verbal autopsy|4
5022415|NCT03213366|17275032|P2|Overall Study|Lost to Follow-up|4
5022416|NCT03213366|17275033|P1|Overall Study|Lost to Follow-up|9
5022417|NCT03212690|17275059|P1|Overall Study|Protocol Violation|1
5022418|NCT03212521|17275107|P1|Overall Study|Other|1
5022419|NCT03212521|17275107|P1|Overall Study|Withdrawal by Subject|1
5022420|NCT03212521|17275107|P1|Overall Study|Lost to Follow-up|4
5022421|NCT03212521|17275107|P1|Overall Study|Adverse Event|1
5022422|NCT03212365|17275116|P2|Overall Study|developed acute renal failure|1
5022423|NCT03212365|17275117|P1|Overall Study|developed acute renal failure|0
5022424|NCT03212365|17275116|P2|Overall Study|Withdrawal by Subject|1
5022425|NCT03212365|17275117|P1|Overall Study|Withdrawal by Subject|0
5022426|NCT03212365|17275116|P2|Overall Study|Required epidural placement|0
5022427|NCT03212365|17275117|P1|Overall Study|Required epidural placement|1
5022428|NCT03212365|17275116|P2|Overall Study|Medication distribution error|0
5022429|NCT03212365|17275117|P1|Overall Study|Medication distribution error|1
5022430|NCT03212365|17275116|P2|Overall Study|Unexpected return to OR|1
5022431|NCT03212365|17275117|P1|Overall Study|Unexpected return to OR|1
5022432|NCT03212365|17275116|P2|Overall Study|Initiated heparin infusion on floor|1
5022433|NCT03212365|17275117|P1|Overall Study|Initiated heparin infusion on floor|1
5022434|NCT03212365|17275116|P2|Overall Study|Refused study medication|0
5022435|NCT03212365|17275117|P1|Overall Study|Refused study medication|3
5022436|NCT03212365|17275116|P2|Overall Study|Bled requiring enoxaparin cessation|2
5022437|NCT03212365|17275117|P1|Overall Study|Bled requiring enoxaparin cessation|4
5022438|NCT03212365|17275116|P2|Overall Study|Discharged prior to Xa level|8
5022439|NCT03212365|17275117|P1|Overall Study|Discharged prior to Xa level|12
5022440|NCT03212326|17275129|P1|Overall Study|Physician Decision|4
5022441|NCT03212261|17275134|P1|Overall Study|Too busy/ No time|5
5022442|NCT03212261|17275134|P1|Overall Study|Family Emergency|1
5022443|NCT03212261|17275134|P1|Overall Study|Lost to Follow-up|7
5022444|NCT03212261|17275134|P1|Overall Study|Tech Trouble- No first study visit|1
5022445|NCT03212261|17275134|P1|Overall Study|Became ineligible d/t tech|2
5022446|NCT03212144|17275142|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
5022447|NCT03212144|17275143|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
5022448|NCT03212144|17275142|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
5022449|NCT03212144|17275143|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
5022450|NCT03211858|17275151|P2|Overall Study|Other than specified above|21
5022451|NCT03211858|17275152|P1|Overall Study|Other than specified above|22
5022452|NCT03211858|17275151|P2|Overall Study|Non-serious Hypoglycemia|0
5022453|NCT03211858|17275152|P1|Overall Study|Non-serious Hypoglycemia|1
5022454|NCT03211858|17275151|P2|Overall Study|Poor compliance to protocol|2
5022455|NCT03211858|17275152|P1|Overall Study|Poor compliance to protocol|6
5022456|NCT03211858|17275151|P2|Overall Study|Lack of Efficacy|4
5022457|NCT03211858|17275152|P1|Overall Study|Lack of Efficacy|0
5022458|NCT03211858|17275151|P2|Overall Study|Adverse Event|6
5022459|NCT03211858|17275152|P1|Overall Study|Adverse Event|8
5022460|NCT03211156|17275204|P2|Overall Study|Adverse Event|0
5022461|NCT03211156|17275205|P1|Overall Study|Adverse Event|1
5022462|NCT03211156|17275204|P2|Overall Study|Lost to Follow-up|1
5022463|NCT03211156|17275205|P1|Overall Study|Lost to Follow-up|1
5022464|NCT03211156|17275204|P2|Overall Study|Withdrawal by Subject|2
5022465|NCT03211156|17275205|P1|Overall Study|Withdrawal by Subject|0
5022466|NCT03210961|17275236|P15|Overall Study|Other|0
5022467|NCT03210961|17275237|P14|Overall Study|Other|2
5022468|NCT03210961|17275238|P13|Overall Study|Other|2
5022469|NCT03210961|17275239|P12|Overall Study|Other|0
5022470|NCT03210961|17275240|P11|Overall Study|Other|1
5022471|NCT03210961|17275241|P10|Overall Study|Other|0
5022472|NCT03210961|17275242|P9|Overall Study|Other|0
5022473|NCT03210961|17275243|P8|Overall Study|Other|0
5022474|NCT03210961|17275244|P7|Overall Study|Other|1
5022475|NCT03210961|17275245|P6|Overall Study|Other|0
5022476|NCT03210961|17275246|P5|Overall Study|Other|0
5022477|NCT03210961|17275247|P4|Overall Study|Other|1
5022478|NCT03210961|17275248|P3|Overall Study|Other|0
5022479|NCT03210961|17275249|P2|Overall Study|Other|0
5022480|NCT03210961|17275250|P1|Overall Study|Other|0
5022481|NCT03210961|17275236|P15|Overall Study|No Longer Meets Eligibility Criteria|0
5022482|NCT03210961|17275237|P14|Overall Study|No Longer Meets Eligibility Criteria|1
5022483|NCT03210961|17275238|P13|Overall Study|No Longer Meets Eligibility Criteria|0
5022484|NCT03210961|17275239|P12|Overall Study|No Longer Meets Eligibility Criteria|0
5022485|NCT03210961|17275240|P11|Overall Study|No Longer Meets Eligibility Criteria|0
5022486|NCT03210961|17275241|P10|Overall Study|No Longer Meets Eligibility Criteria|0
5022487|NCT03210961|17275242|P9|Overall Study|No Longer Meets Eligibility Criteria|0
5022488|NCT03210961|17275243|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5022489|NCT03210961|17275244|P7|Overall Study|No Longer Meets Eligibility Criteria|0
5022490|NCT03210961|17275245|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5022491|NCT03210961|17275246|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5022492|NCT03210961|17275247|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5022493|NCT03210961|17275248|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5022494|NCT03210961|17275249|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5022495|NCT03210961|17275250|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5022496|NCT03210961|17275236|P15|Overall Study|Withdrawal by Subject|1
5022497|NCT03210961|17275237|P14|Overall Study|Withdrawal by Subject|0
5022498|NCT03210961|17275238|P13|Overall Study|Withdrawal by Subject|0
5022499|NCT03210961|17275239|P12|Overall Study|Withdrawal by Subject|0
5022500|NCT03210961|17275240|P11|Overall Study|Withdrawal by Subject|0
5022501|NCT03210961|17275241|P10|Overall Study|Withdrawal by Subject|0
5022502|NCT03210961|17275242|P9|Overall Study|Withdrawal by Subject|0
5022503|NCT03210961|17275243|P8|Overall Study|Withdrawal by Subject|0
5022504|NCT03210961|17275244|P7|Overall Study|Withdrawal by Subject|0
5022505|NCT03210961|17275245|P6|Overall Study|Withdrawal by Subject|0
5022506|NCT03210961|17275246|P5|Overall Study|Withdrawal by Subject|0
5022507|NCT03210961|17275247|P4|Overall Study|Withdrawal by Subject|0
5022508|NCT03210961|17275248|P3|Overall Study|Withdrawal by Subject|0
5022509|NCT03210961|17275249|P2|Overall Study|Withdrawal by Subject|0
5022510|NCT03210961|17275250|P1|Overall Study|Withdrawal by Subject|0
5022511|NCT03210961|17275236|P15|Overall Study|Lost to Follow-up|1
5022512|NCT03210961|17275237|P14|Overall Study|Lost to Follow-up|0
5022513|NCT03210961|17275238|P13|Overall Study|Lost to Follow-up|0
5022514|NCT03210961|17275239|P12|Overall Study|Lost to Follow-up|0
5022515|NCT03210961|17275240|P11|Overall Study|Lost to Follow-up|0
5022516|NCT03210961|17275241|P10|Overall Study|Lost to Follow-up|0
5022517|NCT03210961|17275242|P9|Overall Study|Lost to Follow-up|0
5022518|NCT03210961|17275243|P8|Overall Study|Lost to Follow-up|0
5022519|NCT03210961|17275244|P7|Overall Study|Lost to Follow-up|0
5022520|NCT03210961|17275245|P6|Overall Study|Lost to Follow-up|0
5022521|NCT03210961|17275246|P5|Overall Study|Lost to Follow-up|0
5022522|NCT03210961|17275247|P4|Overall Study|Lost to Follow-up|0
5022523|NCT03210961|17275248|P3|Overall Study|Lost to Follow-up|0
5022524|NCT03210961|17275249|P2|Overall Study|Lost to Follow-up|0
5022525|NCT03210961|17275250|P1|Overall Study|Lost to Follow-up|0
5022526|NCT03210961|17275236|P15|Overall Study|Adverse Event|0
5022527|NCT03210961|17275237|P14|Overall Study|Adverse Event|1
5022528|NCT03210961|17275238|P13|Overall Study|Adverse Event|0
5022529|NCT03210961|17275239|P12|Overall Study|Adverse Event|0
5022530|NCT03210961|17275240|P11|Overall Study|Adverse Event|0
5022531|NCT03210961|17275241|P10|Overall Study|Adverse Event|0
5022532|NCT03210961|17275242|P9|Overall Study|Adverse Event|0
5022533|NCT03210961|17275243|P8|Overall Study|Adverse Event|0
5022534|NCT03210961|17275244|P7|Overall Study|Adverse Event|0
5022535|NCT03210961|17275245|P6|Overall Study|Adverse Event|0
5022536|NCT03210961|17275246|P5|Overall Study|Adverse Event|0
5022537|NCT03210961|17275247|P4|Overall Study|Adverse Event|0
5022538|NCT03210961|17275248|P3|Overall Study|Adverse Event|0
5022539|NCT03210961|17275249|P2|Overall Study|Adverse Event|0
5022540|NCT03210961|17275250|P1|Overall Study|Adverse Event|0
5022541|NCT03210519|17275609|P2|Overall Study|Adverse Event|0
5022542|NCT03210519|17275610|P1|Overall Study|Adverse Event|2
5022543|NCT03210220|17275666|P2|Overall Study|Physician Decision|0
5022544|NCT03210220|17275667|P1|Overall Study|Physician Decision|1
5022545|NCT03209973|17275690|P1|Overall Study|Death|1
5022546|NCT03209973|17275690|P1|Overall Study|Patient withdrew consent|3
5022547|NCT03209570|17275696|P2|Overall Study|Withdrawal by Subject|3
5022548|NCT03209570|17275697|P1|Overall Study|Withdrawal by Subject|0
5022549|NCT03209570|17275696|P2|Overall Study|Protocol Violation|0
5022550|NCT03209570|17275697|P1|Overall Study|Protocol Violation|1
5022551|NCT03209570|17275696|P2|Overall Study|Incomplete Data|10
5022552|NCT03209570|17275697|P1|Overall Study|Incomplete Data|8
5022553|NCT03209570|17275696|P2|Overall Study|Death|0
5022554|NCT03209570|17275697|P1|Overall Study|Death|1
5022555|NCT03209518|17275707|P1|Overall Study|Protocol Deviation|1
5022556|NCT03209518|17275707|P1|Overall Study|Case Report Forms Uncollected|1
5022557|NCT03209492|17275712|P1|Overall Study|Case Report Forms Uncollected|5
5022558|NCT03208933|17275717|P1|Overall Study|Protocol Violation|1
5022559|NCT03208933|17275717|P1|Overall Study|Physician Decision|3
5022560|NCT03208933|17275717|P1|Overall Study|Lost to Follow-up|2
5022561|NCT03208933|17275717|P1|Overall Study|Adverse Event|1
5022562|NCT03208933|17275717|P1|Overall Study|Withdrawal by Subject|3
5022563|NCT03208933|17275717|P1|Overall Study|Death|3
5022564|NCT03208088|17275764|P10|Period 4|Unsatisfactory Test Article|0
5022565|NCT03208088|17275765|P9|Period 4|Unsatisfactory Test Article|0
5022566|NCT03208088|17275766|P8|Period 4|Unsatisfactory Test Article|0
5022567|NCT03208088|17275767|P7|Period 4|Unsatisfactory Test Article|0
5022568|NCT03208088|17275768|P6|Period 4|Unsatisfactory Test Article|0
5022569|NCT03208088|17275769|P5|Period 4|Unsatisfactory Test Article|0
5022570|NCT03208088|17275770|P4|Period 4|Unsatisfactory Test Article|1
5022571|NCT03208088|17275771|P3|Period 4|Unsatisfactory Test Article|0
5022572|NCT03208088|17275772|P2|Period 4|Unsatisfactory Test Article|0
5022573|NCT03208088|17275773|P1|Period 4|Unsatisfactory Test Article|0
5022574|NCT03208088|17275764|P10|Period 3|Unsatisfactory Test Article|0
5022575|NCT03208088|17275765|P9|Period 3|Unsatisfactory Test Article|0
5022576|NCT03208088|17275766|P8|Period 3|Unsatisfactory Test Article|0
5022577|NCT03208088|17275767|P7|Period 3|Unsatisfactory Test Article|0
5022578|NCT03208088|17275768|P6|Period 3|Unsatisfactory Test Article|0
5022579|NCT03208088|17275769|P5|Period 3|Unsatisfactory Test Article|0
5022580|NCT03208088|17275770|P4|Period 3|Unsatisfactory Test Article|1
5022581|NCT03208088|17275771|P3|Period 3|Unsatisfactory Test Article|0
5022582|NCT03208088|17275772|P2|Period 3|Unsatisfactory Test Article|0
5022583|NCT03208088|17275773|P1|Period 3|Unsatisfactory Test Article|0
5022584|NCT03208088|17275764|P10|Period 2|Withdrawal by Subject|0
5022585|NCT03208088|17275765|P9|Period 2|Withdrawal by Subject|1
5022586|NCT03208088|17275766|P8|Period 2|Withdrawal by Subject|0
5022587|NCT03208088|17275767|P7|Period 2|Withdrawal by Subject|0
5022588|NCT03208088|17275768|P6|Period 2|Withdrawal by Subject|0
5022589|NCT03208088|17275769|P5|Period 2|Withdrawal by Subject|0
5022590|NCT03208088|17275770|P4|Period 2|Withdrawal by Subject|0
5022591|NCT03208088|17275771|P3|Period 2|Withdrawal by Subject|0
5022592|NCT03208088|17275772|P2|Period 2|Withdrawal by Subject|0
5022593|NCT03208088|17275773|P1|Period 2|Withdrawal by Subject|0
5022594|NCT03207763|17275803|P2|Overall Study|Lost to Follow-up|0
5022595|NCT03207763|17275804|P1|Overall Study|Lost to Follow-up|1
5022596|NCT03207750|17275830|P2|Overall Study|OTHER, NOT SPECIFIED|4
5022597|NCT03207750|17275831|P1|Overall Study|OTHER, NOT SPECIFIED|5
5022598|NCT03207750|17275830|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
5022599|NCT03207750|17275831|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
5022600|NCT03207750|17275830|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
5022601|NCT03207750|17275831|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
5022602|NCT03207750|17275830|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
5022603|NCT03207750|17275831|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
5022604|NCT03207750|17275830|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
5022605|NCT03207750|17275831|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
5022606|NCT03207750|17275830|P2|Overall Study|Protocol Violation|1
5022607|NCT03207750|17275831|P1|Overall Study|Protocol Violation|0
5022608|NCT03207750|17275830|P2|Overall Study|Lost to Follow-up|29
5022609|NCT03207750|17275831|P1|Overall Study|Lost to Follow-up|21
5022610|NCT03207750|17275830|P2|Overall Study|Adverse Event|2
5022611|NCT03207750|17275831|P1|Overall Study|Adverse Event|3
5022612|NCT03207243|17275911|P2|Overall Study|Protocol Violation|3
5022613|NCT03207243|17275912|P1|Overall Study|Protocol Violation|0
5022614|NCT03207243|17275911|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
5022615|NCT03207243|17275912|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
5022616|NCT03207243|17275911|P2|Overall Study|Lost to Follow-up|1
5022617|NCT03207243|17275912|P1|Overall Study|Lost to Follow-up|0
5022618|NCT03207243|17275911|P2|Overall Study|Physician Decision|1
5022619|NCT03207243|17275912|P1|Overall Study|Physician Decision|1
5022620|NCT03207243|17275911|P2|Overall Study|Withdrawal by Subject|4
5022621|NCT03207243|17275912|P1|Overall Study|Withdrawal by Subject|2
5022622|NCT03207243|17275911|P2|Overall Study|Loss of Asthma Control|31
5022623|NCT03207243|17275912|P1|Overall Study|Loss of Asthma Control|47
5022624|NCT03207243|17275911|P2|Overall Study|Adverse Event|2
5022625|NCT03207243|17275912|P1|Overall Study|Adverse Event|2
5022626|NCT03206970|17276023|P1|Overall Study|Lost to Follow-up|3
5022627|NCT03206970|17276023|P1|Overall Study|Withdrawal by Subject|9
5022628|NCT03206970|17276023|P1|Overall Study|Death|14
5022629|NCT03206918|17276027|P1|Overall Study|Withdrawal by Subject|2
5022630|NCT03206918|17276027|P1|Overall Study|Death|4
5022631|NCT03206788|17276033|P2|Overall Study|Physician Decision|1
5022632|NCT03206788|17276034|P1|Overall Study|Physician Decision|0
5022633|NCT03206788|17276033|P2|Overall Study|Adverse Event|1
5022634|NCT03206788|17276034|P1|Overall Study|Adverse Event|0
5022635|NCT03206788|17276033|P2|Overall Study|Withdrawal by Subject|1
5022636|NCT03206788|17276034|P1|Overall Study|Withdrawal by Subject|0
5022637|NCT03206216|17276072|P2|Overall Study|Withdrawal by Subject|1
5022638|NCT03206216|17276073|P1|Overall Study|Withdrawal by Subject|0
5022639|NCT03205488|17276084|P3|Overall Study|Protocol Violation|1
5022640|NCT03205488|17276085|P2|Overall Study|Protocol Violation|0
5022641|NCT03205488|17276086|P1|Overall Study|Protocol Violation|0
5022642|NCT03205488|17276084|P3|Overall Study|Adverse Event|4
5022643|NCT03205488|17276085|P2|Overall Study|Adverse Event|2
5022644|NCT03205488|17276086|P1|Overall Study|Adverse Event|1
5022645|NCT03205371|17276112|P12|Overall Study|Adverse Event|0
5022646|NCT03205371|17276113|P11|Overall Study|Adverse Event|0
5022647|NCT03205371|17276114|P10|Overall Study|Adverse Event|0
5022648|NCT03205371|17276115|P9|Overall Study|Adverse Event|0
5022649|NCT03205371|17276116|P8|Overall Study|Adverse Event|1
5022650|NCT03205371|17276117|P7|Overall Study|Adverse Event|0
5022651|NCT03205371|17276118|P6|Overall Study|Adverse Event|0
5022652|NCT03205371|17276119|P5|Overall Study|Adverse Event|0
5022653|NCT03205371|17276120|P4|Overall Study|Adverse Event|0
5022654|NCT03205371|17276121|P3|Overall Study|Adverse Event|0
5022655|NCT03205371|17276122|P2|Overall Study|Adverse Event|0
5022656|NCT03205371|17276123|P1|Overall Study|Adverse Event|0
5022657|NCT03205371|17276112|P12|Overall Study|Protocol Violation|0
5022658|NCT03205371|17276113|P11|Overall Study|Protocol Violation|0
5022659|NCT03205371|17276114|P10|Overall Study|Protocol Violation|0
5022660|NCT03205371|17276115|P9|Overall Study|Protocol Violation|0
5022661|NCT03205371|17276116|P8|Overall Study|Protocol Violation|0
5022662|NCT03205371|17276117|P7|Overall Study|Protocol Violation|1
5022663|NCT03205371|17276118|P6|Overall Study|Protocol Violation|0
5022664|NCT03205371|17276119|P5|Overall Study|Protocol Violation|0
5022665|NCT03205371|17276120|P4|Overall Study|Protocol Violation|0
5022666|NCT03205371|17276121|P3|Overall Study|Protocol Violation|0
5022667|NCT03205371|17276122|P2|Overall Study|Protocol Violation|0
5022668|NCT03205371|17276123|P1|Overall Study|Protocol Violation|0
5022669|NCT03205371|17276112|P12|Overall Study|Lost to Follow-up|0
5022670|NCT03205371|17276113|P11|Overall Study|Lost to Follow-up|0
5022671|NCT03205371|17276114|P10|Overall Study|Lost to Follow-up|0
5022672|NCT03205371|17276115|P9|Overall Study|Lost to Follow-up|3
5022673|NCT03205371|17276116|P8|Overall Study|Lost to Follow-up|2
5022674|NCT03205371|17276117|P7|Overall Study|Lost to Follow-up|5
5022675|NCT03205371|17276118|P6|Overall Study|Lost to Follow-up|0
5022676|NCT03205371|17276119|P5|Overall Study|Lost to Follow-up|0
5022677|NCT03205371|17276120|P4|Overall Study|Lost to Follow-up|0
5022678|NCT03205371|17276121|P3|Overall Study|Lost to Follow-up|0
5022679|NCT03205371|17276122|P2|Overall Study|Lost to Follow-up|0
5022680|NCT03205371|17276123|P1|Overall Study|Lost to Follow-up|0
5022681|NCT03205371|17276112|P12|Overall Study|Withdrawal by Subject|1
5022682|NCT03205371|17276113|P11|Overall Study|Withdrawal by Subject|0
5022683|NCT03205371|17276114|P10|Overall Study|Withdrawal by Subject|0
5022684|NCT03205371|17276115|P9|Overall Study|Withdrawal by Subject|2
5022685|NCT03205371|17276116|P8|Overall Study|Withdrawal by Subject|0
5022686|NCT03205371|17276117|P7|Overall Study|Withdrawal by Subject|4
5022687|NCT03205371|17276118|P6|Overall Study|Withdrawal by Subject|0
5022688|NCT03205371|17276119|P5|Overall Study|Withdrawal by Subject|0
5022689|NCT03205371|17276120|P4|Overall Study|Withdrawal by Subject|0
5022690|NCT03205371|17276121|P3|Overall Study|Withdrawal by Subject|0
5022691|NCT03205371|17276122|P2|Overall Study|Withdrawal by Subject|1
5022692|NCT03205371|17276123|P1|Overall Study|Withdrawal by Subject|4
5022693|NCT03205163|17276212|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
5022694|NCT03205163|17276213|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
5022695|NCT03204539|17276309|P2|Overall Study|Loss of funding|1
5022696|NCT03204539|17276310|P1|Overall Study|Loss of funding|0
5022697|NCT03203291|17276448|P1|Overall Study|Withdrawal by Subject|1
5022698|NCT03201900|17276496|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
5022699|NCT03201900|17276496|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
5022700|NCT03201900|17276496|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
5022701|NCT03201900|17276496|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
5022702|NCT03201900|17276496|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
5022703|NCT03201900|17276496|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
5022704|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
5022705|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
5022706|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
5022707|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
5022708|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
5022709|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
5022710|NCT03201900|17276496|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
5022711|NCT03200912|17276518|P3|Overall Study|Non-compliance with study drug|0
5022712|NCT03200912|17276519|P2|Overall Study|Non-compliance with study drug|1
5022713|NCT03200912|17276520|P1|Overall Study|Non-compliance with study drug|0
5022714|NCT03200912|17276518|P3|Overall Study|Withdrawal by Subject|4
5022715|NCT03200912|17276519|P2|Overall Study|Withdrawal by Subject|2
5022716|NCT03200912|17276520|P1|Overall Study|Withdrawal by Subject|1
5022717|NCT03200912|17276518|P3|Overall Study|Adverse Event|0
5022718|NCT03200912|17276519|P2|Overall Study|Adverse Event|0
5022719|NCT03200912|17276520|P1|Overall Study|Adverse Event|3
5022720|NCT03200860|17276530|P2|Overall Study|Withdrawal by Subject|0
5022721|NCT03200860|17276531|P1|Overall Study|Withdrawal by Subject|1
5022722|NCT03199911|17276574|P2|Overall Study|Did not proceed with surgery|1
5022723|NCT03199911|17276575|P1|Overall Study|Did not proceed with surgery|2
5022724|NCT03199911|17276574|P2|Overall Study|Lost to Follow-up|5
5022725|NCT03199911|17276575|P1|Overall Study|Lost to Follow-up|5
5022726|NCT03198767|17276626|P7|Overall Study|Protocol Violation|0
5022727|NCT03198767|17276627|P6|Overall Study|Protocol Violation|0
5022728|NCT03198767|17276628|P5|Overall Study|Protocol Violation|0
5022729|NCT03198767|17276629|P4|Overall Study|Protocol Violation|6
5022730|NCT03198767|17276630|P3|Overall Study|Protocol Violation|0
5022731|NCT03198767|17276631|P2|Overall Study|Protocol Violation|0
5022732|NCT03198767|17276632|P1|Overall Study|Protocol Violation|0
5022733|NCT03198754|17276673|P2|Overall Study|Ineligible|1
5022734|NCT03198754|17276674|P1|Overall Study|Ineligible|2
5022735|NCT03198754|17276673|P2|Overall Study|Lost to Follow-up|3
5022736|NCT03198754|17276674|P1|Overall Study|Lost to Follow-up|4
5022737|NCT03198754|17276673|P2|Overall Study|Withdrawal by Subject|4
5022738|NCT03198754|17276674|P1|Overall Study|Withdrawal by Subject|5
5022739|NCT03198520|17276712|P1|Overall Study|Study Ended|1
5022740|NCT03198520|17276712|P1|Overall Study|Withdrawal by Subject|1
5022741|NCT03198520|17276712|P1|Overall Study|Protocol Violation|2
5022742|NCT03198520|17276712|P1|Overall Study|Physician Decision|2
5022743|NCT03198507|17276735|P2|Overall Study|Withdrawal by Subject|0
5022744|NCT03198507|17276736|P1|Overall Study|Withdrawal by Subject|1
5022745|NCT03197883|17276862|P2|Overall Study|Other (Not Specified)|5
5022746|NCT03197883|17276863|P1|Overall Study|Other (Not Specified)|0
5022747|NCT03197883|17276862|P2|Overall Study|Protocol Violation|0
5022748|NCT03197883|17276863|P1|Overall Study|Protocol Violation|1
5022749|NCT03197883|17276862|P2|Overall Study|Lost to Follow-up|0
5022750|NCT03197883|17276863|P1|Overall Study|Lost to Follow-up|1
5022751|NCT03197883|17276862|P2|Overall Study|Adverse Event|1
5022752|NCT03197883|17276863|P1|Overall Study|Adverse Event|1
5022753|NCT03197558|17276893|P1|Overall Study|Tubes not placed|1
5022754|NCT03197376|17276901|P4|Immune Persistence Phase|Not vaccine related|1
5022755|NCT03197376|17276902|P3|Immune Persistence Phase|Not vaccine related|1
5022756|NCT03197376|17276903|P2|Immune Persistence Phase|Not vaccine related|0
5022757|NCT03197376|17276904|P1|Immune Persistence Phase|Not vaccine related|1
5022758|NCT03197376|17276901|P4|Immune Persistence Phase|Withdrawal by subject's parents|3
5022759|NCT03197376|17276902|P3|Immune Persistence Phase|Withdrawal by subject's parents|2
5022760|NCT03197376|17276903|P2|Immune Persistence Phase|Withdrawal by subject's parents|4
5022761|NCT03197376|17276904|P1|Immune Persistence Phase|Withdrawal by subject's parents|4
5022762|NCT03197376|17276901|P4|Immune Persistence Phase|Lost to Follow-up|1
5022763|NCT03197376|17276902|P3|Immune Persistence Phase|Lost to Follow-up|2
5022764|NCT03197376|17276903|P2|Immune Persistence Phase|Lost to Follow-up|0
5022765|NCT03197376|17276904|P1|Immune Persistence Phase|Lost to Follow-up|0
5022766|NCT03197376|17276901|P4|Primary and Booster Phase|Not vaccine related|6
5022767|NCT03197376|17276902|P3|Primary and Booster Phase|Not vaccine related|0
5022768|NCT03197376|17276903|P2|Primary and Booster Phase|Not vaccine related|2
5022769|NCT03197376|17276904|P1|Primary and Booster Phase|Not vaccine related|1
5022770|NCT03197376|17276901|P4|Primary and Booster Phase|Ineligibility criteria|2
5022771|NCT03197376|17276902|P3|Primary and Booster Phase|Ineligibility criteria|4
5022772|NCT03197376|17276903|P2|Primary and Booster Phase|Ineligibility criteria|1
5022773|NCT03197376|17276904|P1|Primary and Booster Phase|Ineligibility criteria|1
5022774|NCT03197376|17276901|P4|Primary and Booster Phase|Withdrawal by subject's parents|11
5022775|NCT03197376|17276902|P3|Primary and Booster Phase|Withdrawal by subject's parents|14
5022776|NCT03197376|17276903|P2|Primary and Booster Phase|Withdrawal by subject's parents|10
5022777|NCT03197376|17276904|P1|Primary and Booster Phase|Withdrawal by subject's parents|11
5022778|NCT03197376|17276901|P4|Primary and Booster Phase|Physician Decision|3
5022779|NCT03197376|17276902|P3|Primary and Booster Phase|Physician Decision|1
5022780|NCT03197376|17276903|P2|Primary and Booster Phase|Physician Decision|0
5022781|NCT03197376|17276904|P1|Primary and Booster Phase|Physician Decision|1
5022782|NCT03197376|17276901|P4|Primary and Booster Phase|Lost to Follow-up|0
5022783|NCT03197376|17276902|P3|Primary and Booster Phase|Lost to Follow-up|1
5022784|NCT03197376|17276903|P2|Primary and Booster Phase|Lost to Follow-up|0
5022785|NCT03197376|17276904|P1|Primary and Booster Phase|Lost to Follow-up|0
5022786|NCT03197376|17276901|P4|Primary and Booster Phase|Death|2
5022787|NCT03197376|17276902|P3|Primary and Booster Phase|Death|0
5022788|NCT03197376|17276903|P2|Primary and Booster Phase|Death|0
5022789|NCT03197376|17276904|P1|Primary and Booster Phase|Death|1
5022790|NCT03197376|17276901|P4|Primary and Booster Phase|Adverse Event|1
5022791|NCT03197376|17276902|P3|Primary and Booster Phase|Adverse Event|0
5022792|NCT03197376|17276903|P2|Primary and Booster Phase|Adverse Event|0
5022793|NCT03197376|17276904|P1|Primary and Booster Phase|Adverse Event|0
5022794|NCT03196635|17276978|P1|Overall Study|Withdrawal by Subject|1
5022795|NCT03196505|17276998|P2|Overall Study|Physician Decision|26
5022796|NCT03196505|17276999|P1|Overall Study|Physician Decision|26
5022797|NCT03196349|17277010|P3|Overall Study|Study Terminated early|11
5022798|NCT03196349|17277011|P2|Overall Study|Study Terminated early|9
5022799|NCT03196349|17277012|P1|Overall Study|Study Terminated early|15
5022800|NCT03196349|17277010|P3|Overall Study|No data entered|0
5022801|NCT03196349|17277011|P2|Overall Study|No data entered|4
5022802|NCT03196349|17277012|P1|Overall Study|No data entered|2
5022803|NCT03196349|17277010|P3|Overall Study|Did not receive study drug|2
5022804|NCT03196349|17277011|P2|Overall Study|Did not receive study drug|1
5022805|NCT03196349|17277012|P1|Overall Study|Did not receive study drug|0
5022806|NCT03196193|17277049|P2|Overall Study|Computed Tomography (CT) data missing|0
5022807|NCT03196193|17277050|P1|Overall Study|Computed Tomography (CT) data missing|2
5022808|NCT03196193|17277049|P2|Overall Study|Adverse Event|0
5022809|NCT03196193|17277050|P1|Overall Study|Adverse Event|1
5022810|NCT03194490|17277148|P2|Overall Study|participant developed specific neck pain|0
5022811|NCT03194490|17277149|P1|Overall Study|participant developed specific neck pain|1
5022812|NCT03194490|17277148|P2|Overall Study|Lost to Follow-up|3
5022813|NCT03194490|17277149|P1|Overall Study|Lost to Follow-up|1
5022814|NCT03194464|17277191|P1|Overall Study|data not usable|2
5022815|NCT03194217|17277282|P4|Overall Study|Other|0
5022816|NCT03194217|17277283|P3|Overall Study|Other|1
5022817|NCT03194217|17277284|P2|Overall Study|Other|1
5022818|NCT03194217|17277285|P1|Overall Study|Other|0
5022819|NCT03194217|17277282|P4|Overall Study|Failure to meet randomisation criteria|1
5022820|NCT03194217|17277283|P3|Overall Study|Failure to meet randomisation criteria|0
5022821|NCT03194217|17277284|P2|Overall Study|Failure to meet randomisation criteria|0
5022822|NCT03194217|17277285|P1|Overall Study|Failure to meet randomisation criteria|0
5022823|NCT03194217|17277282|P4|Overall Study|Adverse Event|3
5022824|NCT03194217|17277283|P3|Overall Study|Adverse Event|3
5022825|NCT03194217|17277284|P2|Overall Study|Adverse Event|2
5022826|NCT03194217|17277285|P1|Overall Study|Adverse Event|0
5022827|NCT03193047|17277326|P2|Overall Study|Participant Left State|0
5022828|NCT03193047|17277327|P1|Overall Study|Participant Left State|1
5022829|NCT03193047|17277326|P2|Overall Study|Physician Decision|0
5022830|NCT03193047|17277327|P1|Overall Study|Physician Decision|1
5022831|NCT03193021|17277347|P2|Overall Study|Lost to Follow-up|1
5022832|NCT03193021|17277348|P1|Overall Study|Lost to Follow-up|1
5022833|NCT03192904|17277373|P2|Overall Study|Lost to Follow-up|1
5022834|NCT03192904|17277374|P1|Overall Study|Lost to Follow-up|0
5022835|NCT03192904|17277373|P2|Overall Study|Physician Decision|1
5022836|NCT03192904|17277374|P1|Overall Study|Physician Decision|3
5022837|NCT03192488|17277430|P6|Third Intervention (d1)|Adverse Event|0
5022838|NCT03192488|17277431|P5|Third Intervention (d1)|Adverse Event|1
5022839|NCT03192488|17277432|P4|Third Intervention (d1)|Adverse Event|0
5022840|NCT03192488|17277433|P3|Third Intervention (d1)|Adverse Event|0
5022841|NCT03192488|17277434|P2|Third Intervention (d1)|Adverse Event|0
5022842|NCT03192488|17277435|P1|Third Intervention (d1)|Adverse Event|0
5022843|NCT03192488|17277430|P6|First Washout (>6d)|Withdrawal by Subject|1
5022844|NCT03192488|17277431|P5|First Washout (>6d)|Withdrawal by Subject|0
5022845|NCT03192488|17277432|P4|First Washout (>6d)|Withdrawal by Subject|0
5022846|NCT03192488|17277433|P3|First Washout (>6d)|Withdrawal by Subject|1
5022847|NCT03192488|17277434|P2|First Washout (>6d)|Withdrawal by Subject|0
5022848|NCT03192488|17277435|P1|First Washout (>6d)|Withdrawal by Subject|0
5022849|NCT03192475|17277451|P2|Overall Study|Lost to Follow-up|8
5022850|NCT03192475|17277452|P1|Overall Study|Lost to Follow-up|13
5022851|NCT03192475|17277451|P2|Overall Study|Death|1
5022852|NCT03192475|17277452|P1|Overall Study|Death|0
5022853|NCT03192306|17277488|P2|Overall Study|Protocol Violation|1
5022854|NCT03192306|17277489|P1|Overall Study|Protocol Violation|1
5022855|NCT03192306|17277488|P2|Overall Study|Lost to Follow-up|0
5022856|NCT03192306|17277489|P1|Overall Study|Lost to Follow-up|1
5022857|NCT03192306|17277488|P2|Overall Study|Withdrawal by Subject|1
5022858|NCT03192306|17277489|P1|Overall Study|Withdrawal by Subject|1
5022859|NCT03192306|17277488|P2|Overall Study|Did not treat cold sore during study|143
5022860|NCT03192306|17277489|P1|Overall Study|Did not treat cold sore during study|149
5022861|NCT03192137|17277509|P2|Overall Study|Other - Various Administrative Reasons|3
5022862|NCT03192137|17277510|P1|Overall Study|Other - Various Administrative Reasons|8
5022863|NCT03192137|17277509|P2|Overall Study|Surgery Cancelled|1
5022864|NCT03192137|17277510|P1|Overall Study|Surgery Cancelled|4
5022865|NCT03192137|17277509|P2|Overall Study|Protocol Violation|3
5022866|NCT03192137|17277510|P1|Overall Study|Protocol Violation|4
5022867|NCT03192137|17277509|P2|Overall Study|Withdrawal by Subject|3
5022868|NCT03192137|17277510|P1|Overall Study|Withdrawal by Subject|3
5022869|NCT03192137|17277509|P2|Overall Study|Lack of Efficacy|37
5022870|NCT03192137|17277510|P1|Overall Study|Lack of Efficacy|20
5022871|NCT03192137|17277509|P2|Overall Study|Physician Decision|0
5022872|NCT03192137|17277510|P1|Overall Study|Physician Decision|1
5022873|NCT03192137|17277509|P2|Overall Study|Adverse Event|11
5022874|NCT03192137|17277510|P1|Overall Study|Adverse Event|10
5022875|NCT03191552|17277521|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
5022876|NCT03191552|17277522|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
5022877|NCT03191552|17277523|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
5022878|NCT03191552|17277521|P3|Overall Study|Lost to Follow-up|0
5022879|NCT03191552|17277522|P2|Overall Study|Lost to Follow-up|0
5022880|NCT03191552|17277523|P1|Overall Study|Lost to Follow-up|1
5022881|NCT03191396|17277576|P2|Overall Study|Withdrawal by Subject|2
5022882|NCT03191396|17277577|P1|Overall Study|Withdrawal by Subject|3
5022883|NCT03191396|17277576|P2|Overall Study|Lost to Follow-up|3
5022884|NCT03191396|17277577|P1|Overall Study|Lost to Follow-up|0
5022885|NCT03190369|17277674|P2|Overall Study|Randomized but not treated|2
5022886|NCT03190369|17277675|P1|Overall Study|Randomized but not treated|0
5022887|NCT03190369|17277674|P2|Overall Study|Withdraw before treatment|5
5022888|NCT03190369|17277675|P1|Overall Study|Withdraw before treatment|1
5022889|NCT03190369|17277674|P2|Overall Study|Poor compliance to protocol|1
5022890|NCT03190369|17277675|P1|Overall Study|Poor compliance to protocol|0
5022891|NCT03189745|17277736|P2|Overall Study|Conflict in work schedule of participant|1
5022892|NCT03189745|17277737|P1|Overall Study|Conflict in work schedule of participant|1
5022893|NCT03188536|17277796|P1|Overall Study|Not participated/met inclusion criteria|1
5022894|NCT03188536|17277796|P1|Overall Study|No relapse/refractoriness(last 6 months)|5
5022895|NCT03188120|17277863|P1|Overall Study|No visit after the first visit|13
5022896|NCT03188120|17277863|P1|Overall Study|Other than specified|3
5022897|NCT03188120|17277863|P1|Overall Study|Lost to Follow-up|7
5022898|NCT03188120|17277863|P1|Overall Study|Improved|12
5022899|NCT03188120|17277863|P1|Overall Study|Insufficient Effectiveness|8
5022900|NCT03188120|17277863|P1|Overall Study|Adverse Event|4
5022901|NCT03187756|17277868|P1|Overall Study|Termination of study|4
5022902|NCT03187301|17277886|P7|Pre-Intervention|Withdrawal by Subject|0
5022903|NCT03187301|17277887|P6|Pre-Intervention|Withdrawal by Subject|0
5022904|NCT03187301|17277888|P5|Pre-Intervention|Withdrawal by Subject|0
5022905|NCT03187301|17277889|P4|Pre-Intervention|Withdrawal by Subject|0
5022906|NCT03187301|17277890|P3|Pre-Intervention|Withdrawal by Subject|0
5022907|NCT03187301|17277891|P2|Pre-Intervention|Withdrawal by Subject|0
5022908|NCT03187301|17277892|P1|Pre-Intervention|Withdrawal by Subject|1
5022909|NCT03187301|17277886|P7|Titration Period|Exclusion Criteria Met|1
5022910|NCT03187301|17277887|P6|Titration Period|Exclusion Criteria Met|0
5022911|NCT03187301|17277888|P5|Titration Period|Exclusion Criteria Met|0
5022912|NCT03187301|17277889|P4|Titration Period|Exclusion Criteria Met|0
5022913|NCT03187301|17277890|P3|Titration Period|Exclusion Criteria Met|0
5022914|NCT03187301|17277891|P2|Titration Period|Exclusion Criteria Met|0
5022915|NCT03187301|17277892|P1|Titration Period|Exclusion Criteria Met|0
5022916|NCT03187301|17277886|P7|Titration Period|Withdrawal by Subject|1
5022917|NCT03187301|17277887|P6|Titration Period|Withdrawal by Subject|0
5022918|NCT03187301|17277888|P5|Titration Period|Withdrawal by Subject|0
5022919|NCT03187301|17277889|P4|Titration Period|Withdrawal by Subject|0
5022920|NCT03187301|17277890|P3|Titration Period|Withdrawal by Subject|0
5022921|NCT03187301|17277891|P2|Titration Period|Withdrawal by Subject|0
5022922|NCT03187301|17277892|P1|Titration Period|Withdrawal by Subject|0
5022923|NCT03187301|17277886|P7|Titration Period|Adverse Event|5
5022924|NCT03187301|17277887|P6|Titration Period|Adverse Event|0
5022925|NCT03187301|17277888|P5|Titration Period|Adverse Event|0
5022926|NCT03187301|17277889|P4|Titration Period|Adverse Event|0
5022927|NCT03187301|17277890|P3|Titration Period|Adverse Event|0
5022928|NCT03187301|17277891|P2|Titration Period|Adverse Event|0
5022929|NCT03187301|17277892|P1|Titration Period|Adverse Event|0
5022930|NCT03187197|17277944|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
5022931|NCT03187197|17277945|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
5022932|NCT03187197|17277946|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
5022933|NCT03187197|17277944|P3|Overall Study|Status missing|3
5022934|NCT03187197|17277945|P2|Overall Study|Status missing|33
5022935|NCT03187197|17277946|P1|Overall Study|Status missing|2
5022936|NCT03187197|17277944|P3|Overall Study|Missing|3
5022937|NCT03187197|17277945|P2|Overall Study|Missing|32
5022938|NCT03187197|17277946|P1|Overall Study|Missing|1
5022939|NCT03187197|17277944|P3|Overall Study|Reason not listed|1
5022940|NCT03187197|17277945|P2|Overall Study|Reason not listed|54
5022941|NCT03187197|17277946|P1|Overall Study|Reason not listed|2
5022942|NCT03187197|17277944|P3|Overall Study|Administrative problem|0
5022943|NCT03187197|17277945|P2|Overall Study|Administrative problem|1
5022944|NCT03187197|17277946|P1|Overall Study|Administrative problem|1
5022945|NCT03187197|17277944|P3|Overall Study|Death|0
5022946|NCT03187197|17277945|P2|Overall Study|Death|11
5022947|NCT03187197|17277946|P1|Overall Study|Death|0
5022948|NCT03187197|17277944|P3|Overall Study|Adverse Event|0
5022949|NCT03187197|17277945|P2|Overall Study|Adverse Event|29
5022950|NCT03187197|17277946|P1|Overall Study|Adverse Event|6
5022951|NCT03187197|17277944|P3|Overall Study|Lost to Follow-up|7
5022952|NCT03187197|17277945|P2|Overall Study|Lost to Follow-up|60
5022953|NCT03187197|17277946|P1|Overall Study|Lost to Follow-up|1
5022954|NCT03187197|17277944|P3|Overall Study|Withdrawal by Subject|4
5022955|NCT03187197|17277945|P2|Overall Study|Withdrawal by Subject|63
5022956|NCT03187197|17277946|P1|Overall Study|Withdrawal by Subject|8
5022957|NCT03187197|17277944|P3|Overall Study|Stopped Pradaxa®/VKA|4
5022958|NCT03187197|17277945|P2|Overall Study|Stopped Pradaxa®/VKA|65
5022959|NCT03187197|17277946|P1|Overall Study|Stopped Pradaxa®/VKA|11
5022960|NCT03186781|17277984|P6|Overall Study|Withdrawal by Subject|0
5022961|NCT03186781|17277985|P5|Overall Study|Withdrawal by Subject|1
5022962|NCT03186781|17277986|P4|Overall Study|Withdrawal by Subject|0
5022963|NCT03186781|17277987|P3|Overall Study|Withdrawal by Subject|0
5022964|NCT03186781|17277988|P2|Overall Study|Withdrawal by Subject|0
5022965|NCT03186781|17277989|P1|Overall Study|Withdrawal by Subject|0
5022966|NCT03186781|17277984|P6|Overall Study|Moved from Area|0
5022967|NCT03186781|17277985|P5|Overall Study|Moved from Area|1
5022968|NCT03186781|17277986|P4|Overall Study|Moved from Area|0
5022969|NCT03186781|17277987|P3|Overall Study|Moved from Area|0
5022970|NCT03186781|17277988|P2|Overall Study|Moved from Area|0
5022971|NCT03186781|17277989|P1|Overall Study|Moved from Area|0
5022972|NCT03186781|17277984|P6|Overall Study|Lost to Follow-up|0
5022973|NCT03186781|17277985|P5|Overall Study|Lost to Follow-up|1
5022974|NCT03186781|17277986|P4|Overall Study|Lost to Follow-up|0
5022975|NCT03186781|17277987|P3|Overall Study|Lost to Follow-up|1
5022976|NCT03186781|17277988|P2|Overall Study|Lost to Follow-up|0
5022977|NCT03186781|17277989|P1|Overall Study|Lost to Follow-up|0
5022978|NCT03185481|17278086|P1|Overall Study|Study Terminated by Sponsor|4
5022979|NCT03185481|17278086|P1|Overall Study|Adverse Event|1
5022980|NCT03184987|17278157|P3|Overall Study|Adverse Event|1
5022981|NCT03184987|17278158|P2|Overall Study|Adverse Event|0
5022982|NCT03184987|17278159|P1|Overall Study|Adverse Event|1
5022983|NCT03184987|17278157|P3|Overall Study|Physician Decision|1
5022984|NCT03184987|17278158|P2|Overall Study|Physician Decision|0
5022985|NCT03184987|17278159|P1|Overall Study|Physician Decision|0
5022986|NCT03184987|17278157|P3|Overall Study|Withdrawal by Subject|2
5022987|NCT03184987|17278158|P2|Overall Study|Withdrawal by Subject|1
5022988|NCT03184987|17278159|P1|Overall Study|Withdrawal by Subject|0
5022989|NCT03184701|17278224|P1|Overall Study|Lost to Follow-up|5
5022990|NCT03184701|17278224|P1|Overall Study|Withdrawal by Subject|6
5022991|NCT03184701|17278224|P1|Overall Study|Physician Decision|3
5022992|NCT03184701|17278224|P1|Overall Study|Death|3
5022993|NCT03184519|17278228|P1|Overall Study|Physician Decision|21
5022994|NCT03184519|17278228|P1|Overall Study|Lost to Follow-up|6
5022995|NCT03184441|17278232|P1|Overall Study|Withdrawal by Subject|1
5022996|NCT03184077|17278258|P2|Overall Study|Lost to Follow-up|21
5022997|NCT03184077|17278259|P1|Overall Study|Lost to Follow-up|21
5022998|NCT03183518|17278278|P1|Overall Study|Other (Withdrawal of consent)|1
5022999|NCT03183518|17278278|P1|Overall Study|Other (Not specified)|2
5023000|NCT03183063|17278312|P3|Overall Study|Physician Decision|4
5023001|NCT03183063|17278313|P2|Overall Study|Physician Decision|4
5023002|NCT03183063|17278314|P1|Overall Study|Physician Decision|3
5023003|NCT03183063|17278312|P3|Overall Study|Withdrawal by Subject|0
5023004|NCT03183063|17278313|P2|Overall Study|Withdrawal by Subject|0
5023005|NCT03183063|17278314|P1|Overall Study|Withdrawal by Subject|2
5023006|NCT03182738|17278369|P2|Overall Study|Withdrawal by Subject|1
5023007|NCT03182738|17278370|P1|Overall Study|Withdrawal by Subject|0
5023008|NCT03182738|17278369|P2|Overall Study|Pregnancy|1
5023009|NCT03182738|17278370|P1|Overall Study|Pregnancy|0
5023010|NCT03182738|17278369|P2|Overall Study|Lost to Follow-up|3
5023011|NCT03182738|17278370|P1|Overall Study|Lost to Follow-up|9
5023012|NCT03181594|17278419|P1|Overall Study|Physician Decision|1
5023013|NCT03181594|17278419|P1|Overall Study|Lost to Follow-up|1
5023014|NCT03181503|17278427|P2|Overall Study|Lost to Follow-up|1
5023015|NCT03181503|17278428|P1|Overall Study|Lost to Follow-up|1
5023016|NCT03181503|17278427|P2|Overall Study|Withdrawal by Subject|0
5023017|NCT03181503|17278428|P1|Overall Study|Withdrawal by Subject|3
5023018|NCT03181503|17278427|P2|Overall Study|Protocol Violation|0
5023019|NCT03181503|17278428|P1|Overall Study|Protocol Violation|1
5023020|NCT03181503|17278427|P2|Overall Study|Adverse Event|2
5023021|NCT03181503|17278428|P1|Overall Study|Adverse Event|2
5023022|NCT03181451|17278467|P3|Overall Study|Withdrawal by Subject|0
5023023|NCT03181451|17278468|P2|Overall Study|Withdrawal by Subject|1
5023024|NCT03181451|17278469|P1|Overall Study|Withdrawal by Subject|0
5023025|NCT03181451|17278467|P3|Overall Study|Adverse Event|0
5023026|NCT03181451|17278468|P2|Overall Study|Adverse Event|1
5023027|NCT03181451|17278469|P1|Overall Study|Adverse Event|0
5023028|NCT03180801|17278656|P3|Overall Study|Lost to Follow-up|3
5023029|NCT03180801|17278657|P2|Overall Study|Lost to Follow-up|2
5023030|NCT03180801|17278658|P1|Overall Study|Lost to Follow-up|0
5023031|NCT03180801|17278656|P3|Overall Study|Withdrawal by Subject|1
5023032|NCT03180801|17278657|P2|Overall Study|Withdrawal by Subject|2
5023033|NCT03180801|17278658|P1|Overall Study|Withdrawal by Subject|2
5023034|NCT03180801|17278656|P3|Overall Study|Adverse Event|2
5023035|NCT03180801|17278657|P2|Overall Study|Adverse Event|0
5023036|NCT03180801|17278658|P1|Overall Study|Adverse Event|1
5023037|NCT03180801|17278656|P3|Overall Study|Inoculation Target Reached|3
5023038|NCT03180801|17278657|P2|Overall Study|Inoculation Target Reached|1
5023039|NCT03180801|17278658|P1|Overall Study|Inoculation Target Reached|1
5023040|NCT03180801|17278656|P3|Overall Study|Non-compliance|0
5023041|NCT03180801|17278657|P2|Overall Study|Non-compliance|4
5023042|NCT03180801|17278658|P1|Overall Study|Non-compliance|1
5023043|NCT03180801|17278656|P3|Overall Study|Physician Decision|1
5023044|NCT03180801|17278657|P2|Overall Study|Physician Decision|3
5023045|NCT03180801|17278658|P1|Overall Study|Physician Decision|3
5023046|NCT03180645|17278702|P3|Overall Study|Adverse Event|2
5023047|NCT03180645|17278703|P2|Overall Study|Adverse Event|1
5023048|NCT03180645|17278704|P1|Overall Study|Adverse Event|0
5023049|NCT03180619|17278746|P3|Overall Study|Investigator's discretion|1
5023050|NCT03180619|17278747|P2|Overall Study|Investigator's discretion|0
5023051|NCT03180619|17278748|P1|Overall Study|Investigator's discretion|1
5023052|NCT03180619|17278746|P3|Overall Study|Adverse Event|1
5023053|NCT03180619|17278747|P2|Overall Study|Adverse Event|0
5023054|NCT03180619|17278748|P1|Overall Study|Adverse Event|2
5023055|NCT03180619|17278746|P3|Overall Study|Still on Study|25
5023056|NCT03180619|17278747|P2|Overall Study|Still on Study|14
5023057|NCT03180619|17278748|P1|Overall Study|Still on Study|64
5023058|NCT03180619|17278746|P3|Overall Study|Death|0
5023059|NCT03180619|17278747|P2|Overall Study|Death|1
5023060|NCT03180619|17278748|P1|Overall Study|Death|1
5023061|NCT03180619|17278746|P3|Overall Study|Withdrew Consent|1
5023062|NCT03180619|17278747|P2|Overall Study|Withdrew Consent|0
5023063|NCT03180619|17278748|P1|Overall Study|Withdrew Consent|5
5023064|NCT03180138|17278951|P3|Overall Study|Found to be >24 mon after randomization|3
5023065|NCT03180138|17278952|P2|Overall Study|Found to be >24 mon after randomization|0
5023066|NCT03180138|17278953|P1|Overall Study|Found to be >24 mon after randomization|3
5023067|NCT03180138|17278951|P3|Overall Study|No prior immunization records|6
5023068|NCT03180138|17278952|P2|Overall Study|No prior immunization records|0
5023069|NCT03180138|17278953|P1|Overall Study|No prior immunization records|17
5023070|NCT03180138|17278951|P3|Overall Study|Mobile-phone could not be verified|15
5023071|NCT03180138|17278952|P2|Overall Study|Mobile-phone could not be verified|13
5023072|NCT03180138|17278953|P1|Overall Study|Mobile-phone could not be verified|2
5023073|NCT03179891|17278964|P2|First Intervention|Protocol Violation|1
5023074|NCT03179891|17278965|P1|First Intervention|Protocol Violation|0
5023075|NCT03179891|17278964|P2|First Intervention|Unspecified reason|0
5023076|NCT03179891|17278965|P1|First Intervention|Unspecified reason|1
5023077|NCT03179891|17278964|P2|First Intervention|Withdrawal by Subject|1
5023078|NCT03179891|17278965|P1|First Intervention|Withdrawal by Subject|1
5023079|NCT03178942|17279044|P2|Overall Study|Lost to Follow-up|2
5023080|NCT03178942|17279045|P1|Overall Study|Lost to Follow-up|1
5023081|NCT03178942|17279044|P2|Overall Study|Withdrawal by Subject|0
5023082|NCT03178942|17279045|P1|Overall Study|Withdrawal by Subject|2
5023083|NCT03178851|17279060|P3|Overall Study|Lost to Follow-up|0
5023084|NCT03178851|17279061|P2|Overall Study|Lost to Follow-up|1
5023085|NCT03178851|17279062|P1|Overall Study|Lost to Follow-up|2
5023086|NCT03178851|17279060|P3|Overall Study|Withdrawal by Subject|0
5023087|NCT03178851|17279061|P2|Overall Study|Withdrawal by Subject|0
5023088|NCT03178851|17279062|P1|Overall Study|Withdrawal by Subject|8
5023089|NCT03178851|17279060|P3|Overall Study|Death|10
5023090|NCT03178851|17279061|P2|Overall Study|Death|1
5023091|NCT03178851|17279062|P1|Overall Study|Death|35
5023092|NCT03178851|17279060|P3|Overall Study|Continuing on Study|42
5023093|NCT03178851|17279061|P2|Overall Study|Continuing on Study|9
5023094|NCT03178851|17279062|P1|Overall Study|Continuing on Study|47
5023095|NCT03178266|17279109|P2|Overall Study|Withdrawal by Subject|2
5023096|NCT03178266|17279110|P1|Overall Study|Withdrawal by Subject|0
5023097|NCT03178266|17279109|P2|Overall Study|Disont. Early|1
5023098|NCT03178266|17279110|P1|Overall Study|Disont. Early|0
5023099|NCT03178266|17279109|P2|Overall Study|Death|1
5023100|NCT03178266|17279110|P1|Overall Study|Death|0
5023101|NCT03178045|17279120|P2|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
5023102|NCT03178045|17279121|P1|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
5023103|NCT03178045|17279120|P2|Overall Study|Surgery Cancelled/Relocated|30
5023104|NCT03178045|17279121|P1|Overall Study|Surgery Cancelled/Relocated|34
5023105|NCT03178045|17279120|P2|Overall Study|Withdrawal by Subject|7
5023106|NCT03178045|17279121|P1|Overall Study|Withdrawal by Subject|5
5023107|NCT03176407|17279462|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
5023108|NCT03176407|17279462|P1|Overall Study|human failure|1
5023109|NCT03176407|17279462|P1|Overall Study|Protocol Violation|1
5023110|NCT03176238|17279472|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
5023111|NCT03176238|17279473|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
5023112|NCT03176238|17279472|P2|Overall Study|Changes in the patient's condition|1
5023113|NCT03176238|17279473|P1|Overall Study|Changes in the patient's condition|2
5023114|NCT03176238|17279472|P2|Overall Study|Protocol Violation|0
5023115|NCT03176238|17279473|P1|Overall Study|Protocol Violation|1
5023116|NCT03176238|17279472|P2|Overall Study|Patient is switched to commercial drug|1
5023117|NCT03176238|17279473|P1|Overall Study|Patient is switched to commercial drug|16
5023118|NCT03176238|17279472|P2|Overall Study|Tx duration completed per EAP|1
5023119|NCT03176238|17279473|P1|Overall Study|Tx duration completed per EAP|0
5023120|NCT03176238|17279472|P2|Overall Study|Disease Progression|22
5023121|NCT03176238|17279473|P1|Overall Study|Disease Progression|133
5023122|NCT03176238|17279472|P2|Overall Study|Death|0
5023123|NCT03176238|17279473|P1|Overall Study|Death|3
5023124|NCT03176238|17279472|P2|Overall Study|Administrative problems|0
5023125|NCT03176238|17279473|P1|Overall Study|Administrative problems|1
5023126|NCT03176238|17279472|P2|Overall Study|Lost to Follow-up|0
5023127|NCT03176238|17279473|P1|Overall Study|Lost to Follow-up|3
5023128|NCT03176238|17279472|P2|Overall Study|Consent withdrawal|2
5023129|NCT03176238|17279473|P1|Overall Study|Consent withdrawal|14
5023130|NCT03176238|17279472|P2|Overall Study|Inter-current illness|1
5023131|NCT03176238|17279473|P1|Overall Study|Inter-current illness|0
5023132|NCT03176238|17279472|P2|Overall Study|Abnormal lab value(s)|0
5023133|NCT03176238|17279473|P1|Overall Study|Abnormal lab value(s)|2
5023134|NCT03176238|17279472|P2|Overall Study|Unacceptable AEs|8
5023135|NCT03176238|17279473|P1|Overall Study|Unacceptable AEs|15
5023136|NCT03175562|17279492|P1|Overall Study|Other (Not Specified)|5
5023137|NCT03175562|17279492|P1|Overall Study|Withdrawal by Subject|7
5023138|NCT03175562|17279492|P1|Overall Study|Lost to Follow-up|3
5023139|NCT03175562|17279492|P1|Overall Study|Adverse Event|1
5023140|NCT03175172|17279517|P1|Overall Study|Study Terminated by Sponsor|3
5023141|NCT03175172|17279517|P1|Overall Study|Lost to Follow-up|1
5023142|NCT03175172|17279517|P1|Overall Study|Withdrawal by Subject|3
5023143|NCT03175172|17279517|P1|Overall Study|Death|3
5023144|NCT03175120|17279527|P2|Overall Study|Other|3
5023145|NCT03175120|17279528|P1|Overall Study|Other|2
5023146|NCT03175120|17279527|P2|Overall Study|Withdrawal by Subject|5
5023147|NCT03175120|17279528|P1|Overall Study|Withdrawal by Subject|2
5023148|NCT03175120|17279527|P2|Overall Study|Lost to Follow-up|0
5023149|NCT03175120|17279528|P1|Overall Study|Lost to Follow-up|1
5023150|NCT03175120|17279527|P2|Overall Study|Protocol Violation|2
5023151|NCT03175120|17279528|P1|Overall Study|Protocol Violation|5
5023152|NCT03175120|17279527|P2|Overall Study|Adverse Event|2
5023153|NCT03175120|17279528|P1|Overall Study|Adverse Event|2
5023154|NCT03172702|17279712|P1|Overall Study|Other|2
5023155|NCT03172702|17279712|P1|Overall Study|Withdrawal by Subject|5
5023156|NCT03172702|17279712|P1|Overall Study|Study-specific Withdrawal Criteria|10
5023157|NCT03172702|17279712|P1|Overall Study|Death|2
5023158|NCT03172702|17279712|P1|Overall Study|Adverse Event|9
5023159|NCT03172494|17279740|P3|Overall Study|Non-compliance towards treatment|0
5023160|NCT03172494|17279741|P2|Overall Study|Non-compliance towards treatment|0
5023161|NCT03172494|17279742|P1|Overall Study|Non-compliance towards treatment|2
5023162|NCT03172494|17279740|P3|Overall Study|Severe hypoglycaemic episode|1
5023163|NCT03172494|17279741|P2|Overall Study|Severe hypoglycaemic episode|0
5023164|NCT03172494|17279742|P1|Overall Study|Severe hypoglycaemic episode|0
5023165|NCT03172494|17279740|P3|Overall Study|Withdrawal by Subject|8
5023166|NCT03172494|17279741|P2|Overall Study|Withdrawal by Subject|8
5023167|NCT03172494|17279742|P1|Overall Study|Withdrawal by Subject|10
5023168|NCT03172494|17279740|P3|Overall Study|Pregnancy|0
5023169|NCT03172494|17279741|P2|Overall Study|Pregnancy|1
5023170|NCT03172494|17279742|P1|Overall Study|Pregnancy|0
5023171|NCT03172494|17279740|P3|Overall Study|Lack of Efficacy|4
5023172|NCT03172494|17279741|P2|Overall Study|Lack of Efficacy|0
5023173|NCT03172494|17279742|P1|Overall Study|Lack of Efficacy|0
5023174|NCT03172494|17279740|P3|Overall Study|Protocol Violation|1
5023175|NCT03172494|17279741|P2|Overall Study|Protocol Violation|2
5023176|NCT03172494|17279742|P1|Overall Study|Protocol Violation|3
5023177|NCT03172494|17279740|P3|Overall Study|Adverse Event|15
5023178|NCT03172494|17279741|P2|Overall Study|Adverse Event|1
5023179|NCT03172494|17279742|P1|Overall Study|Adverse Event|5
5023180|NCT03172481|17279925|P2|Double-blind|Withdrawal by Subject|0
5023181|NCT03172481|17279926|P1|Double-blind|Withdrawal by Subject|1
5023182|NCT03172364|17279934|P2|Overall Study|Protocol Violation|0
5023183|NCT03172364|17279935|P1|Overall Study|Protocol Violation|1
5023184|NCT03172364|17279934|P2|Overall Study|Adverse Event|1
5023185|NCT03172364|17279935|P1|Overall Study|Adverse Event|1
5023186|NCT03172130|17279953|P2|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
5023187|NCT03172130|17279954|P1|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
5023188|NCT03171415|17279979|P5|Overall Study|Lost to Follow-up|2
5023189|NCT03171415|17279980|P4|Overall Study|Lost to Follow-up|0
5023190|NCT03171415|17279981|P3|Overall Study|Lost to Follow-up|0
5023191|NCT03171415|17279982|P2|Overall Study|Lost to Follow-up|0
5023192|NCT03171415|17279983|P1|Overall Study|Lost to Follow-up|0
5023193|NCT03170609|17280056|P7|Overall Study|Other|0
5023194|NCT03170609|17280057|P6|Overall Study|Other|1
5023195|NCT03170609|17280058|P5|Overall Study|Other|0
5023196|NCT03170609|17280059|P4|Overall Study|Other|0
5023197|NCT03170609|17280060|P3|Overall Study|Other|0
5023198|NCT03170609|17280061|P2|Overall Study|Other|0
5023199|NCT03170609|17280062|P1|Overall Study|Other|1
5023200|NCT03170609|17280056|P7|Overall Study|Lost to Follow-up|0
5023201|NCT03170609|17280057|P6|Overall Study|Lost to Follow-up|1
5023202|NCT03170609|17280058|P5|Overall Study|Lost to Follow-up|1
5023203|NCT03170609|17280059|P4|Overall Study|Lost to Follow-up|2
5023204|NCT03170609|17280060|P3|Overall Study|Lost to Follow-up|5
5023205|NCT03170609|17280061|P2|Overall Study|Lost to Follow-up|0
5023206|NCT03170609|17280062|P1|Overall Study|Lost to Follow-up|1
5023207|NCT03170609|17280056|P7|Overall Study|Withdrawal by Subject|1
5023208|NCT03170609|17280057|P6|Overall Study|Withdrawal by Subject|0
5023209|NCT03170609|17280058|P5|Overall Study|Withdrawal by Subject|0
5023210|NCT03170609|17280059|P4|Overall Study|Withdrawal by Subject|0
5023211|NCT03170609|17280060|P3|Overall Study|Withdrawal by Subject|0
5023212|NCT03170609|17280061|P2|Overall Study|Withdrawal by Subject|2
5023213|NCT03170609|17280062|P1|Overall Study|Withdrawal by Subject|1
5023214|NCT03170609|17280056|P7|Overall Study|Death|0
5023215|NCT03170609|17280057|P6|Overall Study|Death|0
5023216|NCT03170609|17280058|P5|Overall Study|Death|0
5023217|NCT03170609|17280059|P4|Overall Study|Death|0
5023218|NCT03170609|17280060|P3|Overall Study|Death|1
5023219|NCT03170609|17280061|P2|Overall Study|Death|0
5023220|NCT03170609|17280062|P1|Overall Study|Death|0
5023221|NCT03170544|17280132|P12|Part 1|Not treated|0
5023222|NCT03170544|17280133|P11|Part 1|Not treated|0
5023223|NCT03170544|17280134|P10|Part 1|Not treated|0
5023224|NCT03170544|17280135|P9|Part 1|Not treated|0
5023225|NCT03170544|17280136|P8|Part 1|Not treated|0
5023226|NCT03170544|17280137|P7|Part 1|Not treated|0
5023227|NCT03170544|17280138|P6|Part 1|Not treated|0
5023228|NCT03170544|17280139|P5|Part 1|Not treated|0
5023229|NCT03170544|17280140|P4|Part 1|Not treated|1
5023230|NCT03170544|17280141|P3|Part 1|Not treated|0
5023231|NCT03170544|17280142|P2|Part 1|Not treated|0
5023232|NCT03170544|17280143|P1|Part 1|Not treated|0
5023233|NCT03170544|17280132|P12|Part 1|Lost to Follow-up|0
5023234|NCT03170544|17280133|P11|Part 1|Lost to Follow-up|0
5023235|NCT03170544|17280134|P10|Part 1|Lost to Follow-up|0
5023236|NCT03170544|17280135|P9|Part 1|Lost to Follow-up|0
5023237|NCT03170544|17280136|P8|Part 1|Lost to Follow-up|0
5023238|NCT03170544|17280137|P7|Part 1|Lost to Follow-up|0
5023239|NCT03170544|17280138|P6|Part 1|Lost to Follow-up|0
5023240|NCT03170544|17280139|P5|Part 1|Lost to Follow-up|0
5023241|NCT03170544|17280140|P4|Part 1|Lost to Follow-up|0
5023242|NCT03170544|17280141|P3|Part 1|Lost to Follow-up|0
5023243|NCT03170544|17280142|P2|Part 1|Lost to Follow-up|0
5023244|NCT03170544|17280143|P1|Part 1|Lost to Follow-up|1
5023245|NCT03170232|17280307|P2|Overall Study|Withdrawal by Subject|1
5023246|NCT03170232|17280308|P1|Overall Study|Withdrawal by Subject|0
5023247|NCT03170232|17280307|P2|Overall Study|Lost to Follow-up|0
5023248|NCT03170232|17280308|P1|Overall Study|Lost to Follow-up|1
5023249|NCT03170232|17280307|P2|Overall Study|Study closed/terminated|23
5023250|NCT03170232|17280308|P1|Overall Study|Study closed/terminated|26
5023251|NCT03170232|17280307|P2|Overall Study|Lack of Efficacy|1
5023252|NCT03170232|17280308|P1|Overall Study|Lack of Efficacy|0
5023253|NCT03170232|17280307|P2|Overall Study|Protocol Violation|1
5023254|NCT03170232|17280308|P1|Overall Study|Protocol Violation|0
5023255|NCT03170232|17280307|P2|Overall Study|Adverse Event|1
5023256|NCT03170232|17280308|P1|Overall Study|Adverse Event|0
5023257|NCT03170193|17280386|P7|Overall Study|Lost to Follow-up|0
5023258|NCT03170193|17280387|P6|Overall Study|Lost to Follow-up|0
5023259|NCT03170193|17280388|P5|Overall Study|Lost to Follow-up|0
5023260|NCT03170193|17280389|P4|Overall Study|Lost to Follow-up|0
5023261|NCT03170193|17280390|P3|Overall Study|Lost to Follow-up|0
5023262|NCT03170193|17280391|P2|Overall Study|Lost to Follow-up|1
5023263|NCT03170193|17280392|P1|Overall Study|Lost to Follow-up|1
5023264|NCT03170193|17280386|P7|Overall Study|Withdrawal by Subject|0
5023265|NCT03170193|17280387|P6|Overall Study|Withdrawal by Subject|0
5023266|NCT03170193|17280388|P5|Overall Study|Withdrawal by Subject|0
5023267|NCT03170193|17280389|P4|Overall Study|Withdrawal by Subject|1
5023268|NCT03170193|17280390|P3|Overall Study|Withdrawal by Subject|0
5023269|NCT03170193|17280391|P2|Overall Study|Withdrawal by Subject|0
5023270|NCT03170193|17280392|P1|Overall Study|Withdrawal by Subject|0
5023271|NCT03170154|17280461|P1|Overall Study|Withdrawal by Subject|2
5023272|NCT03170154|17280461|P1|Overall Study|Death|2
5023273|NCT03170154|17280461|P1|Overall Study|Lost to Follow-up|4
5023274|NCT03169530|17280485|P2|Overall Study|Study ended by NIH|17
5023275|NCT03169530|17280486|P1|Overall Study|Study ended by NIH|15
5023276|NCT03169244|17280506|P2|Overall Study|Physician Decision|0
5023277|NCT03169244|17280507|P1|Overall Study|Physician Decision|1
5023278|NCT03169244|17280506|P2|Overall Study|Withdrawal by Subject|2
5023279|NCT03169244|17280507|P1|Overall Study|Withdrawal by Subject|2
5023280|NCT03169244|17280506|P2|Overall Study|Adverse Event|0
5023281|NCT03169244|17280507|P1|Overall Study|Adverse Event|1
5023282|NCT03169244|17280506|P2|Overall Study|Lost to Follow-up|2
5023283|NCT03169244|17280507|P1|Overall Study|Lost to Follow-up|1
5023284|NCT03169153|17280517|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
5023285|NCT03169153|17280518|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
5023286|NCT03169153|17280517|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
5023287|NCT03169153|17280518|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
5023288|NCT03169153|17280517|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
5023289|NCT03169153|17280518|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
5023290|NCT03169153|17280517|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5023291|NCT03169153|17280518|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5023292|NCT03168919|17280529|P1|Overall Study|Withdrawal by Subject|2
5023293|NCT03168906|17280539|P2|Overall Study|Lack of Efficacy|6
5023294|NCT03168906|17280540|P1|Overall Study|Lack of Efficacy|6
5023295|NCT03168425|17280586|P2|Overall Study|unable to confirm post op opioids|3
5023296|NCT03168425|17280587|P1|Overall Study|unable to confirm post op opioids|2
5023297|NCT03168425|17280586|P2|Overall Study|Lost to Follow-up|8
5023298|NCT03168425|17280587|P1|Overall Study|Lost to Follow-up|5
5023299|NCT03167151|17280664|P3|Overall Study|No evidence of tumour at surgery|1
5023300|NCT03167151|17280665|P2|Overall Study|No evidence of tumour at surgery|1
5023301|NCT03167151|17280666|P1|Overall Study|No evidence of tumour at surgery|0
5023302|NCT03167151|17280664|P3|Overall Study|Withdrawal by Subject|0
5023303|NCT03167151|17280665|P2|Overall Study|Withdrawal by Subject|0
5023304|NCT03167151|17280666|P1|Overall Study|Withdrawal by Subject|1
5023305|NCT03166735|17280679|P5|Overall Study|Lost to Follow-up|1
5023306|NCT03166735|17280680|P4|Overall Study|Lost to Follow-up|0
5023307|NCT03166735|17280681|P3|Overall Study|Lost to Follow-up|1
5023308|NCT03166735|17280682|P2|Overall Study|Lost to Follow-up|2
5023309|NCT03166735|17280683|P1|Overall Study|Lost to Follow-up|0
5023310|NCT03166735|17280679|P5|Overall Study|Withdrawal by Subject|2
5023311|NCT03166735|17280680|P4|Overall Study|Withdrawal by Subject|1
5023312|NCT03166735|17280681|P3|Overall Study|Withdrawal by Subject|1
5023313|NCT03166735|17280682|P2|Overall Study|Withdrawal by Subject|0
5023314|NCT03166735|17280683|P1|Overall Study|Withdrawal by Subject|0
5023315|NCT03166735|17280679|P5|Overall Study|follow-up not completed as planned|1
5023316|NCT03166735|17280680|P4|Overall Study|follow-up not completed as planned|0
5023317|NCT03166735|17280681|P3|Overall Study|follow-up not completed as planned|1
5023318|NCT03166735|17280682|P2|Overall Study|follow-up not completed as planned|1
5023319|NCT03166735|17280683|P1|Overall Study|follow-up not completed as planned|0
5023320|NCT03166735|17280679|P5|Overall Study|Not Treated|0
5023321|NCT03166735|17280680|P4|Overall Study|Not Treated|0
5023322|NCT03166735|17280681|P3|Overall Study|Not Treated|0
5023323|NCT03166735|17280682|P2|Overall Study|Not Treated|0
5023324|NCT03166735|17280683|P1|Overall Study|Not Treated|1
5023325|NCT03166618|17280733|P2|Overall Study|Study was Terminated|1
5023326|NCT03166618|17280734|P1|Overall Study|Study was Terminated|0
5023327|NCT03166215|17280746|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
5023328|NCT03166215|17280747|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
5023329|NCT03166215|17280748|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
5023330|NCT03166215|17280746|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
5023331|NCT03166215|17280747|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
5023332|NCT03166215|17280748|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
5023333|NCT03166124|17280788|P4|Wash-out Period|Adverse Event|0
5023334|NCT03166124|17280789|P3|Wash-out Period|Adverse Event|1
5023335|NCT03166124|17280790|P2|Wash-out Period|Adverse Event|1
5023336|NCT03166124|17280791|P1|Wash-out Period|Adverse Event|0
5023337|NCT03166124|17280788|P4|Wash-out Period|Withdrawal by Subject|1
5023338|NCT03166124|17280789|P3|Wash-out Period|Withdrawal by Subject|0
5023339|NCT03166124|17280790|P2|Wash-out Period|Withdrawal by Subject|1
5023340|NCT03166124|17280791|P1|Wash-out Period|Withdrawal by Subject|0
5023341|NCT03166124|17280788|P4|Treatment Period 1|Adverse Event|0
5023342|NCT03166124|17280789|P3|Treatment Period 1|Adverse Event|1
5023343|NCT03166124|17280790|P2|Treatment Period 1|Adverse Event|0
5023344|NCT03166124|17280791|P1|Treatment Period 1|Adverse Event|0
5023345|NCT03165955|17280836|P1|Treatment|Progressive disease|3
5023346|NCT03165955|17280836|P1|Treatment|Adverse Event|1
5023347|NCT03165955|17280836|P1|Treatment|Death|1
5023348|NCT03165955|17280836|P1|Treatment|Withdrawal by Subject|3
5023349|NCT03165110|17280973|P1|Overall Study|Anroid phone software incompatibility|1
5023350|NCT03165045|17280995|P1|Visit 2|Available total CCQ score at vist 2 only|44
5023351|NCT03165045|17280995|P1|Visit 2|No available total CCQ score at all|29
5023352|NCT03165045|17280995|P1|Visit 2|Available CCQ score at visit 1 only|109
5023353|NCT03165045|17280995|P1|Visit 1|No visit 1|10
5023354|NCT03165045|17280995|P1|Visit 1|No treatment documented|10
5023355|NCT03165045|17280995|P1|Visit 1|No registration after visit 1|9
5023356|NCT03162796|17281100|P3|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
5023357|NCT03162796|17281101|P2|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
5023358|NCT03162796|17281102|P1|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
5023359|NCT03162796|17281100|P3|Active Treatment Period: Week 24 - 52|Adverse Event|0
5023360|NCT03162796|17281101|P2|Active Treatment Period: Week 24 - 52|Adverse Event|2
5023361|NCT03162796|17281102|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
5023362|NCT03162796|17281100|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
5023363|NCT03162796|17281101|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
5023364|NCT03162796|17281102|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
5023365|NCT03162796|17281100|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
5023366|NCT03162796|17281101|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
5023367|NCT03162796|17281102|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
5023368|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
5023369|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
5023370|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
5023371|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
5023372|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
5023373|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
5023374|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
5023375|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
5023376|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
5023377|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
5023378|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
5023379|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
5023380|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Death|0
5023381|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Death|0
5023382|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Death|1
5023383|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
5023384|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
5023385|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
5023386|NCT03162796|17281100|P3|Placebo Controlled Period: Week 0 - 24|Other|1
5023387|NCT03162796|17281101|P2|Placebo Controlled Period: Week 0 - 24|Other|1
5023388|NCT03162796|17281102|P1|Placebo Controlled Period: Week 0 - 24|Other|0
5023389|NCT03162614|17281412|P6|Overall Study|Missed vaccination, exclusion criteria|0
5023390|NCT03162614|17281413|P5|Overall Study|Missed vaccination, exclusion criteria|3
5023391|NCT03162614|17281414|P4|Overall Study|Missed vaccination, exclusion criteria|4
5023392|NCT03162614|17281415|P3|Overall Study|Missed vaccination, exclusion criteria|2
5023393|NCT03162614|17281416|P2|Overall Study|Missed vaccination, exclusion criteria|2
5023394|NCT03162614|17281417|P1|Overall Study|Missed vaccination, exclusion criteria|2
5023395|NCT03162614|17281412|P6|Overall Study|Withdrawal by Subject|0
5023396|NCT03162614|17281413|P5|Overall Study|Withdrawal by Subject|0
5023397|NCT03162614|17281414|P4|Overall Study|Withdrawal by Subject|1
5023398|NCT03162614|17281415|P3|Overall Study|Withdrawal by Subject|1
5023399|NCT03162614|17281416|P2|Overall Study|Withdrawal by Subject|1
5023400|NCT03162614|17281417|P1|Overall Study|Withdrawal by Subject|2
5023401|NCT03162614|17281412|P6|Overall Study|Protocol Violation|0
5023402|NCT03162614|17281413|P5|Overall Study|Protocol Violation|0
5023403|NCT03162614|17281414|P4|Overall Study|Protocol Violation|1
5023404|NCT03162614|17281415|P3|Overall Study|Protocol Violation|0
5023405|NCT03162614|17281416|P2|Overall Study|Protocol Violation|1
5023406|NCT03162614|17281417|P1|Overall Study|Protocol Violation|0
5023407|NCT03162614|17281412|P6|Overall Study|Lost to Follow-up|0
5023408|NCT03162614|17281413|P5|Overall Study|Lost to Follow-up|2
5023409|NCT03162614|17281414|P4|Overall Study|Lost to Follow-up|1
5023410|NCT03162614|17281415|P3|Overall Study|Lost to Follow-up|1
5023411|NCT03162614|17281416|P2|Overall Study|Lost to Follow-up|1
5023412|NCT03162614|17281417|P1|Overall Study|Lost to Follow-up|2
5023413|NCT03162328|17281536|P3|Study Period|Withdrawal by Subject|1
5023414|NCT03162328|17281537|P2|Study Period|Withdrawal by Subject|0
5023415|NCT03162328|17281538|P1|Study Period|Withdrawal by Subject|0
5023416|NCT03162328|17281536|P3|Screening Period|Withdrawal by Subject|0
5023417|NCT03162328|17281537|P2|Screening Period|Withdrawal by Subject|0
5023418|NCT03162328|17281538|P1|Screening Period|Withdrawal by Subject|1
5023419|NCT03162328|17281536|P3|Screening Period|Did not meet inclusion/exclusion|0
5023420|NCT03162328|17281537|P2|Screening Period|Did not meet inclusion/exclusion|0
5023421|NCT03162328|17281538|P1|Screening Period|Did not meet inclusion/exclusion|21
5023422|NCT03162055|17281567|P2|Overall Study|Other|15
5023423|NCT03162055|17281568|P1|Overall Study|Other|8
5023424|NCT03162055|17281567|P2|Overall Study|Incorrect randomization|3
5023425|NCT03162055|17281568|P1|Overall Study|Incorrect randomization|4
5023426|NCT03162055|17281567|P2|Overall Study|Did not receive treatment|0
5023427|NCT03162055|17281568|P1|Overall Study|Did not receive treatment|2
5023428|NCT03162055|17281567|P2|Overall Study|Withdrawal by Subject|2
5023429|NCT03162055|17281568|P1|Overall Study|Withdrawal by Subject|17
5023430|NCT03162055|17281567|P2|Overall Study|Study-specific withdrawal criteria|14
5023431|NCT03162055|17281568|P1|Overall Study|Study-specific withdrawal criteria|22
5023432|NCT03162055|17281567|P2|Overall Study|Lost to Follow-up|1
5023433|NCT03162055|17281568|P1|Overall Study|Lost to Follow-up|0
5023434|NCT03162055|17281567|P2|Overall Study|Death|3
5023435|NCT03162055|17281568|P1|Overall Study|Death|3
5023436|NCT03162055|17281567|P2|Overall Study|Adverse Event|5
5023437|NCT03162055|17281568|P1|Overall Study|Adverse Event|6
5023438|NCT03161405|17281660|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
5023439|NCT03160898|17281680|P4|Overall Study|Other|2
5023440|NCT03160898|17281681|P3|Overall Study|Other|2
5023441|NCT03160898|17281682|P2|Overall Study|Other|0
5023442|NCT03160898|17281683|P1|Overall Study|Other|2
5023443|NCT03160898|17281680|P4|Overall Study|Withdrawal by Subject|1
5023444|NCT03160898|17281681|P3|Overall Study|Withdrawal by Subject|2
5023445|NCT03160898|17281682|P2|Overall Study|Withdrawal by Subject|3
5023446|NCT03160898|17281683|P1|Overall Study|Withdrawal by Subject|1
5023447|NCT03160898|17281680|P4|Overall Study|Sponsor Discretion|0
5023448|NCT03160898|17281681|P3|Overall Study|Sponsor Discretion|0
5023449|NCT03160898|17281682|P2|Overall Study|Sponsor Discretion|0
5023450|NCT03160898|17281683|P1|Overall Study|Sponsor Discretion|2
5023451|NCT03160898|17281680|P4|Overall Study|Protocol Violation|0
5023452|NCT03160898|17281681|P3|Overall Study|Protocol Violation|2
5023453|NCT03160898|17281682|P2|Overall Study|Protocol Violation|0
5023454|NCT03160898|17281683|P1|Overall Study|Protocol Violation|1
5023455|NCT03160898|17281680|P4|Overall Study|Progressive Disease|1
5023456|NCT03160898|17281681|P3|Overall Study|Progressive Disease|2
5023457|NCT03160898|17281682|P2|Overall Study|Progressive Disease|1
5023458|NCT03160898|17281683|P1|Overall Study|Progressive Disease|4
5023459|NCT03160898|17281680|P4|Overall Study|Physician Decision|1
5023460|NCT03160898|17281681|P3|Overall Study|Physician Decision|0
5023461|NCT03160898|17281682|P2|Overall Study|Physician Decision|0
5023462|NCT03160898|17281683|P1|Overall Study|Physician Decision|1
5023463|NCT03160898|17281680|P4|Overall Study|Lost to Follow-up|2
5023464|NCT03160898|17281681|P3|Overall Study|Lost to Follow-up|1
5023465|NCT03160898|17281682|P2|Overall Study|Lost to Follow-up|1
5023466|NCT03160898|17281683|P1|Overall Study|Lost to Follow-up|1
5023467|NCT03160898|17281680|P4|Overall Study|Difficulty Traveling to Clinic Visits|1
5023468|NCT03160898|17281681|P3|Overall Study|Difficulty Traveling to Clinic Visits|0
5023469|NCT03160898|17281682|P2|Overall Study|Difficulty Traveling to Clinic Visits|0
5023470|NCT03160898|17281683|P1|Overall Study|Difficulty Traveling to Clinic Visits|3
5023471|NCT03160898|17281680|P4|Overall Study|Death|1
5023472|NCT03160898|17281681|P3|Overall Study|Death|0
5023473|NCT03160898|17281682|P2|Overall Study|Death|0
5023474|NCT03160898|17281683|P1|Overall Study|Death|1
5023475|NCT03160898|17281680|P4|Overall Study|Adverse Event|10
5023476|NCT03160898|17281681|P3|Overall Study|Adverse Event|7
5023477|NCT03160898|17281682|P2|Overall Study|Adverse Event|8
5023478|NCT03160898|17281683|P1|Overall Study|Adverse Event|4
5023479|NCT03160885|17281706|P7|Maintenance Treatment Period|Completed Week 50|0
5023480|NCT03160885|17281707|P6|Maintenance Treatment Period|Completed Week 50|0
5023481|NCT03160885|17281708|P5|Maintenance Treatment Period|Completed Week 50|0
5023482|NCT03160885|17281709|P4|Maintenance Treatment Period|Completed Week 50|0
5023483|NCT03160885|17281710|P3|Maintenance Treatment Period|Completed Week 50|1
5023484|NCT03160885|17281711|P2|Maintenance Treatment Period|Completed Week 50|0
5023485|NCT03160885|17281712|P1|Maintenance Treatment Period|Completed Week 50|0
5023486|NCT03160885|17281706|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
5023487|NCT03160885|17281707|P6|Maintenance Treatment Period|Transfer to open-label treatment|8
5023488|NCT03160885|17281708|P5|Maintenance Treatment Period|Transfer to open-label treatment|26
5023489|NCT03160885|17281709|P4|Maintenance Treatment Period|Transfer to open-label treatment|26
5023490|NCT03160885|17281710|P3|Maintenance Treatment Period|Transfer to open-label treatment|29
5023491|NCT03160885|17281711|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
5023492|NCT03160885|17281712|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
5023493|NCT03160885|17281706|P7|Maintenance Treatment Period|Discontinued IMP|0
5023494|NCT03160885|17281707|P6|Maintenance Treatment Period|Discontinued IMP|7
5023495|NCT03160885|17281708|P5|Maintenance Treatment Period|Discontinued IMP|5
5023496|NCT03160885|17281709|P4|Maintenance Treatment Period|Discontinued IMP|13
5023497|NCT03160885|17281710|P3|Maintenance Treatment Period|Discontinued IMP|9
5023498|NCT03160885|17281711|P2|Maintenance Treatment Period|Discontinued IMP|0
5023499|NCT03160885|17281712|P1|Maintenance Treatment Period|Discontinued IMP|0
5023500|NCT03160885|17281706|P7|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5023501|NCT03160885|17281707|P6|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5023502|NCT03160885|17281708|P5|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5023503|NCT03160885|17281709|P4|Maintenance Treatment Period|Not dosed - transfer to open-label|1
5023504|NCT03160885|17281710|P3|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5023505|NCT03160885|17281711|P2|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5023506|NCT03160885|17281712|P1|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5023507|NCT03160885|17281706|P7|Open-label Treatment|Completed Week 50|4
5023508|NCT03160885|17281707|P6|Open-label Treatment|Completed Week 50|0
5023509|NCT03160885|17281708|P5|Open-label Treatment|Completed Week 50|0
5023510|NCT03160885|17281709|P4|Open-label Treatment|Completed Week 50|0
5023511|NCT03160885|17281710|P3|Open-label Treatment|Completed Week 50|0
5023512|NCT03160885|17281711|P2|Open-label Treatment|Completed Week 50|0
5023513|NCT03160885|17281712|P1|Open-label Treatment|Completed Week 50|0
5023514|NCT03160885|17281706|P7|Open-label Treatment|Discontinued IMP|131
5023515|NCT03160885|17281707|P6|Open-label Treatment|Discontinued IMP|0
5023516|NCT03160885|17281708|P5|Open-label Treatment|Discontinued IMP|0
5023517|NCT03160885|17281709|P4|Open-label Treatment|Discontinued IMP|0
5023518|NCT03160885|17281710|P3|Open-label Treatment|Discontinued IMP|0
5023519|NCT03160885|17281711|P2|Open-label Treatment|Discontinued IMP|0
5023520|NCT03160885|17281712|P1|Open-label Treatment|Discontinued IMP|0
5023521|NCT03160885|17281706|P7|Open-label Treatment|Not dosed|2
5023522|NCT03160885|17281707|P6|Open-label Treatment|Not dosed|0
5023523|NCT03160885|17281708|P5|Open-label Treatment|Not dosed|0
5023524|NCT03160885|17281709|P4|Open-label Treatment|Not dosed|0
5023525|NCT03160885|17281710|P3|Open-label Treatment|Not dosed|0
5023526|NCT03160885|17281711|P2|Open-label Treatment|Not dosed|0
5023527|NCT03160885|17281712|P1|Open-label Treatment|Not dosed|0
5023528|NCT03160885|17281706|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
5023529|NCT03160885|17281707|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
5023530|NCT03160885|17281708|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
5023531|NCT03160885|17281709|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
5023532|NCT03160885|17281710|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
5023533|NCT03160885|17281711|P2|Initial Treatment Period|Discontinued IMP before Week 16|22
5023534|NCT03160885|17281712|P1|Initial Treatment Period|Discontinued IMP before Week 16|33
5023535|NCT03160885|17281706|P7|Initial Treatment Period|Not dosed|0
5023536|NCT03160885|17281707|P6|Initial Treatment Period|Not dosed|0
5023537|NCT03160885|17281708|P5|Initial Treatment Period|Not dosed|0
5023538|NCT03160885|17281709|P4|Initial Treatment Period|Not dosed|0
5023539|NCT03160885|17281710|P3|Initial Treatment Period|Not dosed|0
5023540|NCT03160885|17281711|P2|Initial Treatment Period|Not dosed|0
5023541|NCT03160885|17281712|P1|Initial Treatment Period|Not dosed|2
5023542|NCT03160716|17281758|P1|Overall Study|Lost to Follow-up|1
5023543|NCT03160703|17281769|P4|Overall Study|Withdrawal by Subject|1
5023544|NCT03160703|17281770|P3|Overall Study|Withdrawal by Subject|0
5023545|NCT03160703|17281771|P2|Overall Study|Withdrawal by Subject|0
5023546|NCT03160703|17281772|P1|Overall Study|Withdrawal by Subject|0
5023547|NCT03159611|17281850|P2|Overall Study|Inability to perform procedures|0
5023548|NCT03159611|17281851|P1|Overall Study|Inability to perform procedures|1
5023549|NCT03159611|17281850|P2|Overall Study|Non-compliance with protocol requirement|2
5023550|NCT03159611|17281851|P1|Overall Study|Non-compliance with protocol requirement|3
5023551|NCT03159611|17281850|P2|Overall Study|Withdrawal by Subject|1
5023552|NCT03159611|17281851|P1|Overall Study|Withdrawal by Subject|1
5023553|NCT03159611|17281850|P2|Overall Study|Adverse Event|0
5023554|NCT03159611|17281851|P1|Overall Study|Adverse Event|1
5023555|NCT03159611|17281850|P2|Overall Study|Protocol Violation|4
5023556|NCT03159611|17281851|P1|Overall Study|Protocol Violation|7
5023557|NCT03159611|17281850|P2|Overall Study|Did Not Meet Exclusion Criteria|3
5023558|NCT03159611|17281851|P1|Overall Study|Did Not Meet Exclusion Criteria|1
5023559|NCT03159611|17281850|P2|Overall Study|Did Not Meet Inclusion Criteria|5
5023560|NCT03159611|17281851|P1|Overall Study|Did Not Meet Inclusion Criteria|9
5023561|NCT03159468|17281871|P6|Overall Study|Withdrawal by Subject|0
5023562|NCT03159468|17281872|P5|Overall Study|Withdrawal by Subject|0
5023563|NCT03159468|17281873|P4|Overall Study|Withdrawal by Subject|0
5023564|NCT03159468|17281874|P3|Overall Study|Withdrawal by Subject|3
5023565|NCT03159468|17281875|P2|Overall Study|Withdrawal by Subject|0
5023566|NCT03159468|17281876|P1|Overall Study|Withdrawal by Subject|0
5023567|NCT03158688|17281925|P2|Overall Study|Lost to Follow-up|3
5023568|NCT03158688|17281926|P1|Overall Study|Lost to Follow-up|0
5023569|NCT03158688|17281925|P2|Overall Study|Decision by sponsor|3
5023570|NCT03158688|17281926|P1|Overall Study|Decision by sponsor|2
5023571|NCT03158688|17281925|P2|Overall Study|Withdrawal by Subject|14
5023572|NCT03158688|17281926|P1|Overall Study|Withdrawal by Subject|9
5023573|NCT03158688|17281925|P2|Overall Study|Death|59
5023574|NCT03158688|17281926|P1|Overall Study|Death|36
5023575|NCT03158688|17281925|P2|Overall Study|Continuing in study|233
5023576|NCT03158688|17281926|P1|Overall Study|Continuing in study|107
5023577|NCT03158311|17281959|P3|Overall Study|Randomized in error|1
5023578|NCT03158311|17281960|P2|Overall Study|Randomized in error|0
5023579|NCT03158311|17281961|P1|Overall Study|Randomized in error|0
5023580|NCT03158311|17281959|P3|Overall Study|Pregnancy|0
5023581|NCT03158311|17281960|P2|Overall Study|Pregnancy|2
5023582|NCT03158311|17281961|P1|Overall Study|Pregnancy|0
5023583|NCT03158311|17281959|P3|Overall Study|Sponsor decision|0
5023584|NCT03158311|17281960|P2|Overall Study|Sponsor decision|0
5023585|NCT03158311|17281961|P1|Overall Study|Sponsor decision|1
5023586|NCT03158311|17281959|P3|Overall Study|Lost to Follow-up|1
5023587|NCT03158311|17281960|P2|Overall Study|Lost to Follow-up|1
5023588|NCT03158311|17281961|P1|Overall Study|Lost to Follow-up|1
5023589|NCT03158311|17281959|P3|Overall Study|Physician Decision|7
5023590|NCT03158311|17281960|P2|Overall Study|Physician Decision|3
5023591|NCT03158311|17281961|P1|Overall Study|Physician Decision|2
5023592|NCT03158311|17281959|P3|Overall Study|Techinical Problems|5
5023593|NCT03158311|17281960|P2|Overall Study|Techinical Problems|1
5023594|NCT03158311|17281961|P1|Overall Study|Techinical Problems|3
5023595|NCT03158311|17281959|P3|Overall Study|Adverse Event|3
5023596|NCT03158311|17281960|P2|Overall Study|Adverse Event|3
5023597|NCT03158311|17281961|P1|Overall Study|Adverse Event|5
5023598|NCT03158311|17281959|P3|Overall Study|Subject/Guardian Decision|11
5023599|NCT03158311|17281960|P2|Overall Study|Subject/Guardian Decision|6
5023600|NCT03158311|17281961|P1|Overall Study|Subject/Guardian Decision|10
5023601|NCT03158285|17281993|P3|Active Treatment Period: Week 24 - 52|Other|0
5023602|NCT03158285|17281994|P2|Active Treatment Period: Week 24 - 52|Other|1
5023603|NCT03158285|17281995|P1|Active Treatment Period: Week 24 - 52|Other|1
5023604|NCT03158285|17281993|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
5023605|NCT03158285|17281994|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
5023606|NCT03158285|17281995|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
5023607|NCT03158285|17281993|P3|Active Treatment Period: Week 24 - 52|Pregnancy|1
5023608|NCT03158285|17281994|P2|Active Treatment Period: Week 24 - 52|Pregnancy|0
5023609|NCT03158285|17281995|P1|Active Treatment Period: Week 24 - 52|Pregnancy|0
5023610|NCT03158285|17281993|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
5023611|NCT03158285|17281994|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
5023612|NCT03158285|17281995|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
5023613|NCT03158285|17281993|P3|Active Treatment Period: Week 24 - 52|Adverse Event|1
5023614|NCT03158285|17281994|P2|Active Treatment Period: Week 24 - 52|Adverse Event|0
5023615|NCT03158285|17281995|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
5023616|NCT03158285|17281993|P3|Placebo-controlled Period: Week 0 - 24|Other|0
5023617|NCT03158285|17281994|P2|Placebo-controlled Period: Week 0 - 24|Other|1
5023618|NCT03158285|17281995|P1|Placebo-controlled Period: Week 0 - 24|Other|1
5023619|NCT03158285|17281993|P3|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
5023620|NCT03158285|17281994|P2|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
5023621|NCT03158285|17281995|P1|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
5023622|NCT03158285|17281993|P3|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
5023623|NCT03158285|17281994|P2|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
5023624|NCT03158285|17281995|P1|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
5023625|NCT03158285|17281993|P3|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
5023626|NCT03158285|17281994|P2|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
5023627|NCT03158285|17281995|P1|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
5023628|NCT03158285|17281993|P3|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
5023629|NCT03158285|17281994|P2|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
5023630|NCT03158285|17281995|P1|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
5023631|NCT03158220|17282209|P2|Overall Study|Physician Decision|0
5023632|NCT03158220|17282210|P1|Overall Study|Physician Decision|1
5023633|NCT03158220|17282209|P2|Overall Study|Lost to Follow-up|5
5023634|NCT03158220|17282210|P1|Overall Study|Lost to Follow-up|8
5023635|NCT03158220|17282209|P2|Overall Study|Status unknown|1
5023636|NCT03158220|17282210|P1|Overall Study|Status unknown|0
5023637|NCT03158220|17282209|P2|Overall Study|Withdrawal by Subject|9
5023638|NCT03158220|17282210|P1|Overall Study|Withdrawal by Subject|8
5023639|NCT03158220|17282209|P2|Overall Study|Screen Failure|1
5023640|NCT03158220|17282210|P1|Overall Study|Screen Failure|0
5023641|NCT03158012|17282247|P2|Overall Study|Withdrawal by Subject|1
5023642|NCT03158012|17282248|P1|Overall Study|Withdrawal by Subject|0
5023643|NCT03157583|17282254|P1|Overall Study|Other (did not meet study criteria)|1
5023644|NCT03157531|17282272|P1|Overall Study|Lost to Follow-up|4
5023645|NCT03157531|17282272|P1|Overall Study|Death|2
5023646|NCT03156543|17282293|P2|Overall Study|Withdrawal by Subject|0
5023647|NCT03156543|17282294|P1|Overall Study|Withdrawal by Subject|1
5023648|NCT03155269|17282304|P2|Overall Study|Lost to Follow-up|2
5023649|NCT03155269|17282305|P1|Overall Study|Lost to Follow-up|1
5023650|NCT03155269|17282304|P2|Overall Study|Withdrawal by Subject|5
5023651|NCT03155269|17282305|P1|Overall Study|Withdrawal by Subject|4
5023652|NCT03155178|17282351|P4|Overall Study|Did not meet treatment day baseline|7
5023653|NCT03155178|17282352|P3|Overall Study|Did not meet treatment day baseline|7
5023654|NCT03155178|17282353|P2|Overall Study|Did not meet treatment day baseline|7
5023655|NCT03155178|17282354|P1|Overall Study|Did not meet treatment day baseline|7
5023656|NCT03154086|17282398|P15|Part B (Up to 25 Days)|Adverse Event|0
5023657|NCT03154086|17282399|P14|Part B (Up to 25 Days)|Adverse Event|0
5023658|NCT03154086|17282400|P13|Part B (Up to 25 Days)|Adverse Event|0
5023659|NCT03154086|17282401|P12|Part B (Up to 25 Days)|Adverse Event|0
5023660|NCT03154086|17282402|P11|Part B (Up to 25 Days)|Adverse Event|1
5023661|NCT03154086|17282403|P10|Part B (Up to 25 Days)|Adverse Event|0
5023662|NCT03154086|17282404|P9|Part B (Up to 25 Days)|Adverse Event|0
5023663|NCT03154086|17282405|P8|Part B (Up to 25 Days)|Adverse Event|0
5023664|NCT03154086|17282406|P7|Part B (Up to 25 Days)|Adverse Event|0
5023665|NCT03154086|17282407|P6|Part B (Up to 25 Days)|Adverse Event|0
5023666|NCT03154086|17282408|P5|Part B (Up to 25 Days)|Adverse Event|0
5023667|NCT03154086|17282409|P4|Part B (Up to 25 Days)|Adverse Event|0
5023668|NCT03154086|17282410|P3|Part B (Up to 25 Days)|Adverse Event|0
5023669|NCT03154086|17282411|P2|Part B (Up to 25 Days)|Adverse Event|0
5023670|NCT03154086|17282412|P1|Part B (Up to 25 Days)|Adverse Event|0
5023671|NCT03154086|17282398|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023672|NCT03154086|17282399|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023673|NCT03154086|17282400|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023674|NCT03154086|17282401|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023675|NCT03154086|17282402|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023676|NCT03154086|17282403|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023677|NCT03154086|17282404|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023678|NCT03154086|17282405|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
5023679|NCT03154086|17282406|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023680|NCT03154086|17282407|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023681|NCT03154086|17282408|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023682|NCT03154086|17282409|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023683|NCT03154086|17282410|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023684|NCT03154086|17282411|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023685|NCT03154086|17282412|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5023686|NCT03154086|17282398|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023687|NCT03154086|17282399|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023688|NCT03154086|17282400|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023689|NCT03154086|17282401|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023690|NCT03154086|17282402|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023691|NCT03154086|17282403|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023692|NCT03154086|17282404|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
5023693|NCT03154086|17282405|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023694|NCT03154086|17282406|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023695|NCT03154086|17282407|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023696|NCT03154086|17282408|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023697|NCT03154086|17282409|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023698|NCT03154086|17282410|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023699|NCT03154086|17282411|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023700|NCT03154086|17282412|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5023701|NCT03154086|17282398|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023702|NCT03154086|17282399|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023703|NCT03154086|17282400|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023704|NCT03154086|17282401|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023705|NCT03154086|17282402|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023706|NCT03154086|17282403|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023707|NCT03154086|17282404|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023708|NCT03154086|17282405|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023709|NCT03154086|17282406|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023710|NCT03154086|17282407|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023711|NCT03154086|17282408|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023712|NCT03154086|17282409|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023713|NCT03154086|17282410|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023714|NCT03154086|17282411|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5023715|NCT03154086|17282412|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
5023716|NCT03154086|17282398|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023717|NCT03154086|17282399|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023718|NCT03154086|17282400|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023719|NCT03154086|17282401|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023720|NCT03154086|17282402|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023721|NCT03154086|17282403|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023722|NCT03154086|17282404|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023723|NCT03154086|17282405|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023724|NCT03154086|17282406|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023725|NCT03154086|17282407|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023726|NCT03154086|17282408|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023727|NCT03154086|17282409|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023728|NCT03154086|17282410|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
5023729|NCT03154086|17282411|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023730|NCT03154086|17282412|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5023731|NCT03154086|17282398|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023732|NCT03154086|17282399|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023733|NCT03154086|17282400|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023734|NCT03154086|17282401|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023735|NCT03154086|17282402|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023736|NCT03154086|17282403|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023737|NCT03154086|17282404|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023738|NCT03154086|17282405|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023739|NCT03154086|17282406|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023740|NCT03154086|17282407|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023741|NCT03154086|17282408|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023742|NCT03154086|17282409|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023743|NCT03154086|17282410|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023744|NCT03154086|17282411|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
5023745|NCT03154086|17282412|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5023746|NCT03154086|17282398|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023747|NCT03154086|17282399|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023748|NCT03154086|17282400|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023749|NCT03154086|17282401|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023750|NCT03154086|17282402|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023751|NCT03154086|17282403|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023752|NCT03154086|17282404|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023753|NCT03154086|17282405|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023754|NCT03154086|17282406|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023755|NCT03154086|17282407|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023756|NCT03154086|17282408|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023757|NCT03154086|17282409|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
5023758|NCT03154086|17282410|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023759|NCT03154086|17282411|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023760|NCT03154086|17282412|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5023761|NCT03154047|17282812|P1|Overall Study|Withdrawal by Subject|3
5023762|NCT03154047|17282812|P1|Overall Study|Study terminated by sponsor|76
5023763|NCT03154047|17282812|P1|Overall Study|Death|1
5023764|NCT03152552|17282859|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
5023765|NCT03152552|17282860|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
5023766|NCT03152552|17282861|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
5023767|NCT03152552|17282862|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
5023768|NCT03152552|17282863|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
5023769|NCT03152552|17282859|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5023770|NCT03152552|17282860|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
5023771|NCT03152552|17282861|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5023772|NCT03152552|17282862|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5023773|NCT03152552|17282863|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5023774|NCT03152552|17282859|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
5023775|NCT03152552|17282860|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
5023776|NCT03152552|17282861|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
5023777|NCT03152552|17282862|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
5023778|NCT03152552|17282863|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
5023779|NCT03152552|17282859|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5023780|NCT03152552|17282860|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5023781|NCT03152552|17282861|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5023782|NCT03152552|17282862|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5023783|NCT03152552|17282863|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5023784|NCT03152552|17282859|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
5023785|NCT03152552|17282860|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
5023786|NCT03152552|17282861|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
5023787|NCT03152552|17282862|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
5023788|NCT03152552|17282863|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
5023789|NCT03152552|17282859|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5023790|NCT03152552|17282860|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5023791|NCT03152552|17282861|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5023792|NCT03152552|17282862|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
5023793|NCT03152552|17282863|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5023794|NCT03152552|17282859|P5|Treatment Period 1 (12 Weeks)|Death|1
5023795|NCT03152552|17282860|P4|Treatment Period 1 (12 Weeks)|Death|0
5023796|NCT03152552|17282861|P3|Treatment Period 1 (12 Weeks)|Death|0
5023797|NCT03152552|17282862|P2|Treatment Period 1 (12 Weeks)|Death|1
5023798|NCT03152552|17282863|P1|Treatment Period 1 (12 Weeks)|Death|0
5023799|NCT03152526|17282996|P2|Overall Study|Withdrawal by Subject|1
5023800|NCT03152526|17282997|P1|Overall Study|Withdrawal by Subject|0
5023801|NCT03152110|17283017|P1|Overall Study|Withdrawal by Subject|3
5023802|NCT03152019|17283032|P2|Overall Study|Adverse Event|1
5023803|NCT03152019|17283033|P1|Overall Study|Adverse Event|0
5023804|NCT03151551|17283041|P2|Post-Treatment Follow-Up Period|Physician Decision|1
5023805|NCT03151551|17283042|P1|Post-Treatment Follow-Up Period|Physician Decision|0
5023806|NCT03151551|17283041|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
5023807|NCT03151551|17283042|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
5023808|NCT03151551|17283041|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5023809|NCT03151551|17283042|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5023810|NCT03151551|17283041|P2|Post-Treatment Follow-Up Period|Adverse Event|3
5023811|NCT03151551|17283042|P1|Post-Treatment Follow-Up Period|Adverse Event|1
5023812|NCT03151551|17283041|P2|Open-Label Treatment Period|Protocol Deviation|2
5023813|NCT03151551|17283042|P1|Open-Label Treatment Period|Protocol Deviation|1
5023814|NCT03151551|17283041|P2|Open-Label Treatment Period|Physician Decision|0
5023815|NCT03151551|17283042|P1|Open-Label Treatment Period|Physician Decision|3
5023816|NCT03151551|17283041|P2|Open-Label Treatment Period|Lack of Efficacy|1
5023817|NCT03151551|17283042|P1|Open-Label Treatment Period|Lack of Efficacy|1
5023818|NCT03151551|17283041|P2|Open-Label Treatment Period|Withdrawal by Subject|18
5023819|NCT03151551|17283042|P1|Open-Label Treatment Period|Withdrawal by Subject|12
5023820|NCT03151551|17283041|P2|Open-Label Treatment Period|Lost to Follow-up|1
5023821|NCT03151551|17283042|P1|Open-Label Treatment Period|Lost to Follow-up|1
5023822|NCT03151551|17283041|P2|Open-Label Treatment Period|Adverse Event|2
5023823|NCT03151551|17283042|P1|Open-Label Treatment Period|Adverse Event|0
5023824|NCT03151226|17283131|P1|Overall Study|not wear device correctly|1
5023825|NCT03151226|17283131|P1|Overall Study|Withdrawal by Subject|2
5023826|NCT03151148|17283137|P2|Overall Study|Withdrawal by Subject|0
5023827|NCT03151148|17283138|P1|Overall Study|Withdrawal by Subject|1
5023828|NCT03151148|17283137|P2|Overall Study|Lost to Follow-up|0
5023829|NCT03151148|17283138|P1|Overall Study|Lost to Follow-up|1
5023830|NCT03150719|17283192|P2|Overall Study|Other|0
5023831|NCT03150719|17283193|P1|Overall Study|Other|1
5023832|NCT03150719|17283192|P2|Overall Study|Death|1
5023833|NCT03150719|17283193|P1|Overall Study|Death|0
5023834|NCT03150719|17283192|P2|Overall Study|Adverse Event|1
5023835|NCT03150719|17283193|P1|Overall Study|Adverse Event|0
5023836|NCT03150485|17283209|P6|Overall Study|Unsatisfactory Lens Fitting|0
5023837|NCT03150485|17283210|P5|Overall Study|Unsatisfactory Lens Fitting|0
5023838|NCT03150485|17283211|P4|Overall Study|Unsatisfactory Lens Fitting|0
5023839|NCT03150485|17283212|P3|Overall Study|Unsatisfactory Lens Fitting|0
5023840|NCT03150485|17283213|P2|Overall Study|Unsatisfactory Lens Fitting|1
5023841|NCT03150485|17283214|P1|Overall Study|Unsatisfactory Lens Fitting|0
5023842|NCT03150082|17283391|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
5023843|NCT03150082|17283392|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
5023844|NCT03149848|17283498|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
5023845|NCT03149848|17283498|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
5023846|NCT03149055|17283551|P1|Overall Study|Not treated|4
5023847|NCT03149042|17283556|P1|Overall Study|Invasive FFR Measurement cancelled|1
5023848|NCT03149042|17283556|P1|Overall Study|Poor CT Image Quality|1
5023849|NCT03149042|17283556|P1|Overall Study|Invasive FFR not performed|21
5023850|NCT03148756|17283570|P2|Overall Study|Study Terminated|1
5023851|NCT03148756|17283571|P1|Overall Study|Study Terminated|0
5023852|NCT03148691|17283604|P3|Overall Study|Withdrawal by Subject|0
5023853|NCT03148691|17283605|P2|Overall Study|Withdrawal by Subject|0
5023854|NCT03148691|17283606|P1|Overall Study|Withdrawal by Subject|1
5023855|NCT03148691|17283604|P3|Overall Study|Other|0
5023856|NCT03148691|17283605|P2|Overall Study|Other|0
5023857|NCT03148691|17283606|P1|Overall Study|Other|1
5023858|NCT03148691|17283604|P3|Overall Study|Lost to Follow-up|1
5023859|NCT03148691|17283605|P2|Overall Study|Lost to Follow-up|0
5023860|NCT03148691|17283606|P1|Overall Study|Lost to Follow-up|0
5023861|NCT03148691|17283604|P3|Overall Study|Protocol Violation|7
5023862|NCT03148691|17283605|P2|Overall Study|Protocol Violation|2
5023863|NCT03148691|17283606|P1|Overall Study|Protocol Violation|1
5023864|NCT03148067|17283669|P1|Overall Study|Death|1
5023865|NCT03148067|17283669|P1|Overall Study|Lost to Follow-up|3
5023866|NCT03147248|17283680|P6|Overall Study|Prolonged Dosing Interval|1
5023867|NCT03147248|17283681|P5|Overall Study|Prolonged Dosing Interval|1
5023868|NCT03147248|17283682|P4|Overall Study|Prolonged Dosing Interval|0
5023869|NCT03147248|17283683|P3|Overall Study|Prolonged Dosing Interval|0
5023870|NCT03147248|17283684|P2|Overall Study|Prolonged Dosing Interval|0
5023871|NCT03147248|17283685|P1|Overall Study|Prolonged Dosing Interval|0
5023872|NCT03147248|17283680|P6|Overall Study|Physician Decision|4
5023873|NCT03147248|17283681|P5|Overall Study|Physician Decision|2
5023874|NCT03147248|17283682|P4|Overall Study|Physician Decision|0
5023875|NCT03147248|17283683|P3|Overall Study|Physician Decision|0
5023876|NCT03147248|17283684|P2|Overall Study|Physician Decision|0
5023877|NCT03147248|17283685|P1|Overall Study|Physician Decision|0
5023878|NCT03147248|17283680|P6|Overall Study|Death|4
5023879|NCT03147248|17283681|P5|Overall Study|Death|0
5023880|NCT03147248|17283682|P4|Overall Study|Death|0
5023881|NCT03147248|17283683|P3|Overall Study|Death|0
5023882|NCT03147248|17283684|P2|Overall Study|Death|0
5023883|NCT03147248|17283685|P1|Overall Study|Death|0
5023884|NCT03147248|17283680|P6|Overall Study|Pregnancy|0
5023885|NCT03147248|17283681|P5|Overall Study|Pregnancy|1
5023886|NCT03147248|17283682|P4|Overall Study|Pregnancy|0
5023887|NCT03147248|17283683|P3|Overall Study|Pregnancy|0
5023888|NCT03147248|17283684|P2|Overall Study|Pregnancy|0
5023889|NCT03147248|17283685|P1|Overall Study|Pregnancy|0
5023890|NCT03147248|17283680|P6|Overall Study|Lost to Follow-up|0
5023891|NCT03147248|17283681|P5|Overall Study|Lost to Follow-up|2
5023892|NCT03147248|17283682|P4|Overall Study|Lost to Follow-up|0
5023893|NCT03147248|17283683|P3|Overall Study|Lost to Follow-up|0
5023894|NCT03147248|17283684|P2|Overall Study|Lost to Follow-up|0
5023895|NCT03147248|17283685|P1|Overall Study|Lost to Follow-up|0
5023896|NCT03147248|17283680|P6|Overall Study|Protocol Violation|0
5023897|NCT03147248|17283681|P5|Overall Study|Protocol Violation|2
5023898|NCT03147248|17283682|P4|Overall Study|Protocol Violation|0
5023899|NCT03147248|17283683|P3|Overall Study|Protocol Violation|0
5023900|NCT03147248|17283684|P2|Overall Study|Protocol Violation|0
5023901|NCT03147248|17283685|P1|Overall Study|Protocol Violation|0
5023902|NCT03147248|17283680|P6|Overall Study|Withdrawal by Subject|9
5023903|NCT03147248|17283681|P5|Overall Study|Withdrawal by Subject|12
5023904|NCT03147248|17283682|P4|Overall Study|Withdrawal by Subject|0
5023905|NCT03147248|17283683|P3|Overall Study|Withdrawal by Subject|0
5023906|NCT03147248|17283684|P2|Overall Study|Withdrawal by Subject|0
5023907|NCT03147248|17283685|P1|Overall Study|Withdrawal by Subject|0
5023908|NCT03147248|17283680|P6|Overall Study|Disease progression|2
5023909|NCT03147248|17283681|P5|Overall Study|Disease progression|0
5023910|NCT03147248|17283682|P4|Overall Study|Disease progression|0
5023911|NCT03147248|17283683|P3|Overall Study|Disease progression|0
5023912|NCT03147248|17283684|P2|Overall Study|Disease progression|0
5023913|NCT03147248|17283685|P1|Overall Study|Disease progression|1
5023914|NCT03147248|17283680|P6|Overall Study|Adverse Event|11
5023915|NCT03147248|17283681|P5|Overall Study|Adverse Event|6
5023916|NCT03147248|17283682|P4|Overall Study|Adverse Event|2
5023917|NCT03147248|17283683|P3|Overall Study|Adverse Event|2
5023918|NCT03147248|17283684|P2|Overall Study|Adverse Event|2
5023919|NCT03147248|17283685|P1|Overall Study|Adverse Event|0
5023920|NCT03146741|17283707|P1|Overall Study|Awaiting txp|2
5023921|NCT03146741|17283707|P1|Overall Study|Physician Decision|2
5023922|NCT03146741|17283707|P1|Overall Study|Listeted for MOT|2
5023923|NCT03146741|17283707|P1|Overall Study|Txp with non-HCV+ heart|4
5023924|NCT03146403|17283727|P2|Overall Study|Lost to Follow-up|0
5023925|NCT03146403|17283728|P1|Overall Study|Lost to Follow-up|2
5023926|NCT03146403|17283727|P2|Overall Study|Withdrawal by Subject|3
5023927|NCT03146403|17283728|P1|Overall Study|Withdrawal by Subject|0
5023928|NCT03145207|17283764|P1|Overall Study|baseline blood pressure high|1
5023929|NCT03145207|17283764|P1|Overall Study|volunteer started taking allergy shots|1
5023930|NCT03144180|17283809|P2|Overall Study|Scrub tech removed tube cap|1
5023931|NCT03144180|17283810|P1|Overall Study|Scrub tech removed tube cap|0
5023932|NCT03144180|17283809|P2|Overall Study|Provider forgot to use the Q-cup|1
5023933|NCT03144180|17283810|P1|Overall Study|Provider forgot to use the Q-cup|0
5023934|NCT03144180|17283809|P2|Overall Study|Provider forgot to fill out forms|3
5023935|NCT03144180|17283810|P1|Overall Study|Provider forgot to fill out forms|1
5023936|NCT03144180|17283809|P2|Overall Study|STAT Delivery|1
5023937|NCT03144180|17283810|P1|Overall Study|STAT Delivery|1
5023938|NCT03143855|17283822|P2|Overall Study|Participant experienced withdrawal|1
5023939|NCT03143855|17283823|P1|Overall Study|Participant experienced withdrawal|0
5023940|NCT03143855|17283822|P2|Overall Study|Protocol Violation|0
5023941|NCT03143855|17283823|P1|Overall Study|Protocol Violation|1
5023942|NCT03143855|17283822|P2|Overall Study|Withdrawal by Subject|3
5023943|NCT03143855|17283823|P1|Overall Study|Withdrawal by Subject|4
5023944|NCT03143166|17283854|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
5023945|NCT03143101|17283873|P3|Overall Study|Lost to Follow-up|0
5023946|NCT03143101|17283874|P2|Overall Study|Lost to Follow-up|2
5023947|NCT03143101|17283875|P1|Overall Study|Lost to Follow-up|2
5023948|NCT03143101|17283873|P3|Overall Study|Withdrawal by Subject|0
5023949|NCT03143101|17283874|P2|Overall Study|Withdrawal by Subject|1
5023950|NCT03143101|17283875|P1|Overall Study|Withdrawal by Subject|0
5023951|NCT03142932|17283930|P2|Overall Study|Lost to Follow-up|11
5023952|NCT03142932|17283931|P1|Overall Study|Lost to Follow-up|2
5023953|NCT03142750|17283947|P2|Overall Study|Lost to Follow-up|1
5023954|NCT03142750|17283948|P1|Overall Study|Lost to Follow-up|4
5023955|NCT03141788|17283982|P1|Overall Study|Withdrawal by Subject|4
5023956|NCT03141788|17283982|P1|Overall Study|Protocol Violation|3
5023957|NCT03141788|17283982|P1|Overall Study|Lost to Follow-up|1
5023958|NCT03141307|17284063|P2|Follow-Up|Lost to Follow-up|54
5023959|NCT03141307|17284064|P1|Follow-Up|Lost to Follow-up|97
5023960|NCT03141307|17284063|P2|In-Hospital|Protocol Violation|0
5023961|NCT03141307|17284064|P1|In-Hospital|Protocol Violation|4
5023962|NCT03141307|17284063|P2|In-Hospital|Withdrawal by Subject|2
5023963|NCT03141307|17284064|P1|In-Hospital|Withdrawal by Subject|0
5023964|NCT03141151|17284082|P2|Overall Study|Withdrawal by Subject|2
5023965|NCT03141151|17284083|P1|Overall Study|Withdrawal by Subject|3
5023966|NCT03141151|17284082|P2|Overall Study|Lost to Follow-up|2
5023967|NCT03141151|17284083|P1|Overall Study|Lost to Follow-up|3
5023968|NCT03141086|17284101|P2|Overall Study|Adverse Event|2
5023969|NCT03141086|17284102|P1|Overall Study|Adverse Event|0
5023970|NCT03141086|17284101|P2|Overall Study|Protocol Violation|1
5023971|NCT03141086|17284102|P1|Overall Study|Protocol Violation|0
5023972|NCT03141086|17284101|P2|Overall Study|Withdrawal by Subject|1
5023973|NCT03141086|17284102|P1|Overall Study|Withdrawal by Subject|0
5023974|NCT03141086|17284101|P2|Overall Study|Study Terminated By Sponsor|1
5023975|NCT03141086|17284102|P1|Overall Study|Study Terminated By Sponsor|1
5023976|NCT03139604|17284142|P2|Overall Study|Continuing on Study|136
5023977|NCT03139604|17284143|P1|Overall Study|Continuing on Study|134
5023978|NCT03139604|17284142|P2|Overall Study|Death|64
5023979|NCT03139604|17284143|P1|Overall Study|Death|60
5023980|NCT03139604|17284142|P2|Overall Study|Lost to Follow-up|1
5023981|NCT03139604|17284143|P1|Overall Study|Lost to Follow-up|1
5023982|NCT03139604|17284142|P2|Overall Study|Physician Decision|2
5023983|NCT03139604|17284143|P1|Overall Study|Physician Decision|1
5023984|NCT03139604|17284142|P2|Overall Study|Withdrawal by Subject|15
5023985|NCT03139604|17284143|P1|Overall Study|Withdrawal by Subject|16
5023986|NCT03139604|17284142|P2|Overall Study|Other|2
5023987|NCT03139604|17284143|P1|Overall Study|Other|7
5023988|NCT03139552|17284192|P1|Overall Study|unable to attend tasting due to schedule|3
5023989|NCT03139448|17284235|P2|Overall Study|Physician Decision|2
5023990|NCT03139448|17284236|P1|Overall Study|Physician Decision|0
5023991|NCT03139448|17284235|P2|Overall Study|Screen fail|3
5023992|NCT03139448|17284236|P1|Overall Study|Screen fail|1
5023993|NCT03139448|17284235|P2|Overall Study|Withdrawal by Subject|6
5023994|NCT03139448|17284236|P1|Overall Study|Withdrawal by Subject|3
5023995|NCT03139448|17284235|P2|Overall Study|Location of procedure changed|8
5023996|NCT03139448|17284236|P1|Overall Study|Location of procedure changed|2
5023997|NCT03139448|17284235|P2|Overall Study|Lack of Efficacy|7
5023998|NCT03139448|17284236|P1|Overall Study|Lack of Efficacy|6
5023999|NCT03139279|17284260|P2|Overall Study|Withdrawal by Subject|2
5024000|NCT03139279|17284261|P1|Overall Study|Withdrawal by Subject|0
5024001|NCT03139279|17284260|P2|Overall Study|Protocol Violation|4
5024002|NCT03139279|17284261|P1|Overall Study|Protocol Violation|5
5024003|NCT03139279|17284260|P2|Overall Study|Physician Decision|0
5024004|NCT03139279|17284261|P1|Overall Study|Physician Decision|2
5024005|NCT03139240|17284279|P4|Overall Study|Lost to Follow-up|0
5024006|NCT03139240|17284280|P3|Overall Study|Lost to Follow-up|1
5024007|NCT03139240|17284281|P2|Overall Study|Lost to Follow-up|1
5024008|NCT03139240|17284282|P1|Overall Study|Lost to Follow-up|0
5024009|NCT03138967|17284294|P2|Overall Study|Physician Decision|3
5024010|NCT03138967|17284295|P1|Overall Study|Physician Decision|1
5024011|NCT03138967|17284294|P2|Overall Study|Death|1
5024012|NCT03138967|17284295|P1|Overall Study|Death|0
5024013|NCT03137784|17284419|P6|Overall Study|Non-compliance with study treatment|0
5024014|NCT03137784|17284420|P5|Overall Study|Non-compliance with study treatment|1
5024015|NCT03137784|17284421|P4|Overall Study|Non-compliance with study treatment|0
5024016|NCT03137784|17284422|P3|Overall Study|Non-compliance with study treatment|0
5024017|NCT03137784|17284423|P2|Overall Study|Non-compliance with study treatment|0
5024018|NCT03137784|17284424|P1|Overall Study|Non-compliance with study treatment|0
5024019|NCT03137784|17284419|P6|Overall Study|Subject/guardian decision|0
5024020|NCT03137784|17284420|P5|Overall Study|Subject/guardian decision|0
5024021|NCT03137784|17284421|P4|Overall Study|Subject/guardian decision|0
5024022|NCT03137784|17284422|P3|Overall Study|Subject/guardian decision|0
5024023|NCT03137784|17284423|P2|Overall Study|Subject/guardian decision|0
5024024|NCT03137784|17284424|P1|Overall Study|Subject/guardian decision|1
5024025|NCT03137784|17284419|P6|Overall Study|Adverse Event|0
5024026|NCT03137784|17284420|P5|Overall Study|Adverse Event|0
5024027|NCT03137784|17284421|P4|Overall Study|Adverse Event|0
5024028|NCT03137784|17284422|P3|Overall Study|Adverse Event|0
5024029|NCT03137784|17284423|P2|Overall Study|Adverse Event|1
5024030|NCT03137784|17284424|P1|Overall Study|Adverse Event|1
5024031|NCT03137173|17284476|P2|Overall Study|Other reasons|2
5024032|NCT03137173|17284477|P1|Overall Study|Other reasons|3
5024033|NCT03137173|17284476|P2|Overall Study|Lost to Follow-up|18
5024034|NCT03137173|17284477|P1|Overall Study|Lost to Follow-up|13
5024035|NCT03137173|17284476|P2|Overall Study|Physician Decision|0
5024036|NCT03137173|17284477|P1|Overall Study|Physician Decision|1
5024037|NCT03137173|17284476|P2|Overall Study|Death|3
5024038|NCT03137173|17284477|P1|Overall Study|Death|1
5024039|NCT03137173|17284476|P2|Overall Study|Withdrawal by Subject|13
5024040|NCT03137173|17284477|P1|Overall Study|Withdrawal by Subject|8
5024041|NCT03137069|17284493|P6|Overall Study|Data Entry Error|0
5024042|NCT03137069|17284494|P5|Overall Study|Data Entry Error|0
5024043|NCT03137069|17284495|P4|Overall Study|Data Entry Error|1
5024044|NCT03137069|17284496|P3|Overall Study|Data Entry Error|0
5024045|NCT03137069|17284497|P2|Overall Study|Data Entry Error|0
5024046|NCT03137069|17284498|P1|Overall Study|Data Entry Error|0
5024047|NCT03137069|17284493|P6|Overall Study|Study Terminated by Sponsor|0
5024048|NCT03137069|17284494|P5|Overall Study|Study Terminated by Sponsor|1
5024049|NCT03137069|17284495|P4|Overall Study|Study Terminated by Sponsor|0
5024050|NCT03137069|17284496|P3|Overall Study|Study Terminated by Sponsor|0
5024051|NCT03137069|17284497|P2|Overall Study|Study Terminated by Sponsor|0
5024052|NCT03137069|17284498|P1|Overall Study|Study Terminated by Sponsor|0
5024053|NCT03137069|17284493|P6|Overall Study|Physician Decision|0
5024054|NCT03137069|17284494|P5|Overall Study|Physician Decision|0
5024055|NCT03137069|17284495|P4|Overall Study|Physician Decision|1
5024056|NCT03137069|17284496|P3|Overall Study|Physician Decision|0
5024057|NCT03137069|17284497|P2|Overall Study|Physician Decision|0
5024058|NCT03137069|17284498|P1|Overall Study|Physician Decision|0
5024059|NCT03137069|17284493|P6|Overall Study|Protocol Violation|1
5024060|NCT03137069|17284494|P5|Overall Study|Protocol Violation|1
5024061|NCT03137069|17284495|P4|Overall Study|Protocol Violation|1
5024062|NCT03137069|17284496|P3|Overall Study|Protocol Violation|0
5024063|NCT03137069|17284497|P2|Overall Study|Protocol Violation|1
5024064|NCT03137069|17284498|P1|Overall Study|Protocol Violation|0
5024065|NCT03137069|17284493|P6|Overall Study|Adverse Event|1
5024066|NCT03137069|17284494|P5|Overall Study|Adverse Event|0
5024067|NCT03137069|17284495|P4|Overall Study|Adverse Event|1
5024068|NCT03137069|17284496|P3|Overall Study|Adverse Event|1
5024069|NCT03137069|17284497|P2|Overall Study|Adverse Event|3
5024070|NCT03137069|17284498|P1|Overall Study|Adverse Event|0
5024071|NCT03137069|17284493|P6|Overall Study|Withdrawal by Subject|0
5024072|NCT03137069|17284494|P5|Overall Study|Withdrawal by Subject|0
5024073|NCT03137069|17284495|P4|Overall Study|Withdrawal by Subject|2
5024074|NCT03137069|17284496|P3|Overall Study|Withdrawal by Subject|2
5024075|NCT03137069|17284497|P2|Overall Study|Withdrawal by Subject|2
5024076|NCT03137069|17284498|P1|Overall Study|Withdrawal by Subject|1
5024077|NCT03136861|17284541|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5024078|NCT03136861|17284542|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5024079|NCT03136861|17284543|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5024080|NCT03136861|17284544|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5024081|NCT03136861|17284545|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
5024082|NCT03136861|17284546|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5024083|NCT03136861|17284547|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5024084|NCT03136861|17284541|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5024085|NCT03136861|17284542|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5024086|NCT03136861|17284543|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5024087|NCT03136861|17284544|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5024088|NCT03136861|17284545|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
5024089|NCT03136861|17284546|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5024090|NCT03136861|17284547|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5024091|NCT03136861|17284541|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
5024092|NCT03136861|17284542|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5024093|NCT03136861|17284543|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
5024094|NCT03136861|17284544|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
5024095|NCT03136861|17284545|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5024096|NCT03136861|17284546|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5024097|NCT03136861|17284547|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5024098|NCT03136861|17284541|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5024099|NCT03136861|17284542|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5024100|NCT03136861|17284543|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5024101|NCT03136861|17284544|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5024102|NCT03136861|17284545|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5024103|NCT03136861|17284546|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
5024104|NCT03136861|17284547|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
5024105|NCT03136861|17284541|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5024106|NCT03136861|17284542|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5024107|NCT03136861|17284543|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5024108|NCT03136861|17284544|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5024109|NCT03136861|17284545|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5024110|NCT03136861|17284546|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
5024111|NCT03136861|17284547|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5024112|NCT03136861|17284541|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5024113|NCT03136861|17284542|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5024114|NCT03136861|17284543|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5024115|NCT03136861|17284544|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5024116|NCT03136861|17284545|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5024117|NCT03136861|17284546|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
5024118|NCT03136861|17284547|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
5024119|NCT03136861|17284541|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5024120|NCT03136861|17284542|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5024121|NCT03136861|17284543|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5024122|NCT03136861|17284544|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5024123|NCT03136861|17284545|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5024124|NCT03136861|17284546|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
5024125|NCT03136861|17284547|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
5024126|NCT03136861|17284541|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5024127|NCT03136861|17284542|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5024128|NCT03136861|17284543|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5024129|NCT03136861|17284544|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5024130|NCT03136861|17284545|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5024131|NCT03136861|17284546|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
5024132|NCT03136861|17284547|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
5024133|NCT03136484|17284562|P2|Overall Study|Death|0
5024134|NCT03136484|17284563|P1|Overall Study|Death|1
5024135|NCT03136484|17284562|P2|Overall Study|Lost to Follow-up|8
5024136|NCT03136484|17284563|P1|Overall Study|Lost to Follow-up|7
5024137|NCT03136484|17284562|P2|Overall Study|Withdrawal by Subject|14
5024138|NCT03136484|17284563|P1|Overall Study|Withdrawal by Subject|19
5024139|NCT03136380|17284691|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5024140|NCT03136380|17284692|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5024141|NCT03136380|17284693|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5024142|NCT03136380|17284694|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
5024143|NCT03136380|17284695|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5024144|NCT03136198|17284876|P2|Overall Study|Withdrawal by Subject|1
5024145|NCT03136198|17284877|P1|Overall Study|Withdrawal by Subject|0
5024146|NCT03136107|17284883|P1|Overall Study|Other (Not specified)|1
5024147|NCT03136068|17284893|P2|Overall Study|Protocol Violation|0
5024148|NCT03136068|17284894|P1|Overall Study|Protocol Violation|1
5024149|NCT03136068|17284893|P2|Overall Study|Lost to Follow-up|1
5024150|NCT03136068|17284894|P1|Overall Study|Lost to Follow-up|1
5024151|NCT03135899|17284916|P8|Overall Study|Withdrawal by Subject|0
5024152|NCT03135899|17284917|P7|Overall Study|Withdrawal by Subject|0
5024153|NCT03135899|17284918|P6|Overall Study|Withdrawal by Subject|2
5024154|NCT03135899|17284919|P5|Overall Study|Withdrawal by Subject|0
5024155|NCT03135899|17284920|P4|Overall Study|Withdrawal by Subject|0
5024156|NCT03135899|17284921|P3|Overall Study|Withdrawal by Subject|0
5024157|NCT03135899|17284922|P2|Overall Study|Withdrawal by Subject|0
5024158|NCT03135899|17284923|P1|Overall Study|Withdrawal by Subject|0
5024159|NCT03135899|17284916|P8|Overall Study|Failed spirometry,unable to repeat visit|0
5024160|NCT03135899|17284917|P7|Overall Study|Failed spirometry,unable to repeat visit|1
5024161|NCT03135899|17284918|P6|Overall Study|Failed spirometry,unable to repeat visit|0
5024162|NCT03135899|17284919|P5|Overall Study|Failed spirometry,unable to repeat visit|0
5024163|NCT03135899|17284920|P4|Overall Study|Failed spirometry,unable to repeat visit|0
5024164|NCT03135899|17284921|P3|Overall Study|Failed spirometry,unable to repeat visit|0
5024165|NCT03135899|17284922|P2|Overall Study|Failed spirometry,unable to repeat visit|0
5024166|NCT03135899|17284923|P1|Overall Study|Failed spirometry,unable to repeat visit|0
5024167|NCT03135548|17284956|P3|Overall Study|Other than listed|2
5024168|NCT03135548|17284957|P2|Overall Study|Other than listed|2
5024169|NCT03135548|17284958|P1|Overall Study|Other than listed|0
5024170|NCT03135548|17284956|P3|Overall Study|Withdrawal by Subject|1
5024171|NCT03135548|17284957|P2|Overall Study|Withdrawal by Subject|2
5024172|NCT03135548|17284958|P1|Overall Study|Withdrawal by Subject|2
5024173|NCT03135548|17284956|P3|Overall Study|Lost to Follow-up|0
5024174|NCT03135548|17284957|P2|Overall Study|Lost to Follow-up|0
5024175|NCT03135548|17284958|P1|Overall Study|Lost to Follow-up|3
5024176|NCT03135431|17284988|P2|Overall Study|Study Surgeon not available|0
5024177|NCT03135431|17284989|P1|Overall Study|Study Surgeon not available|2
5024178|NCT03135028|17285010|P1|Overall Study|Withdrew Consent|1
5024179|NCT03135028|17285010|P1|Overall Study|Study Terminated by Sponsor|2
5024180|NCT03135028|17285010|P1|Overall Study|Death|6
5024181|NCT03134911|17285156|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
5024182|NCT03134911|17285156|P1|Overall Study|Screen failure|31
5024183|NCT03134599|17285218|P6|Week 3|Lost to Follow-up|1
5024184|NCT03134599|17285219|P5|Week 3|Lost to Follow-up|0
5024185|NCT03134599|17285220|P4|Week 3|Lost to Follow-up|1
5024186|NCT03134599|17285221|P3|Week 3|Lost to Follow-up|0
5024187|NCT03134599|17285222|P2|Week 3|Lost to Follow-up|0
5024188|NCT03134599|17285223|P1|Week 3|Lost to Follow-up|0
5024189|NCT03134599|17285218|P6|Week 2|Lost to Follow-up|0
5024190|NCT03134599|17285219|P5|Week 2|Lost to Follow-up|1
5024191|NCT03134599|17285220|P4|Week 2|Lost to Follow-up|1
5024192|NCT03134599|17285221|P3|Week 2|Lost to Follow-up|0
5024193|NCT03134599|17285222|P2|Week 2|Lost to Follow-up|0
5024194|NCT03134599|17285223|P1|Week 2|Lost to Follow-up|1
5024195|NCT03134599|17285218|P6|Week 1|Lost to Follow-up|0
5024196|NCT03134599|17285219|P5|Week 1|Lost to Follow-up|1
5024197|NCT03134599|17285220|P4|Week 1|Lost to Follow-up|0
5024198|NCT03134599|17285221|P3|Week 1|Lost to Follow-up|0
5024199|NCT03134599|17285222|P2|Week 1|Lost to Follow-up|0
5024200|NCT03134599|17285223|P1|Week 1|Lost to Follow-up|0
5024201|NCT03134222|17285263|P5|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5024202|NCT03134222|17285264|P4|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5024203|NCT03134222|17285265|P3|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5024204|NCT03134222|17285266|P2|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
5024205|NCT03134222|17285267|P1|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5024206|NCT03134222|17285263|P5|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5024207|NCT03134222|17285264|P4|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
5024208|NCT03134222|17285265|P3|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5024209|NCT03134222|17285266|P2|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5024210|NCT03134222|17285267|P1|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5024211|NCT03134222|17285263|P5|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5024212|NCT03134222|17285264|P4|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5024213|NCT03134222|17285265|P3|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5024214|NCT03134222|17285266|P2|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5024215|NCT03134222|17285267|P1|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
5024216|NCT03134222|17285263|P5|Treatment Period (Week 12 to 48)|Withdrew Consent|1
5024217|NCT03134222|17285264|P4|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5024218|NCT03134222|17285265|P3|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5024219|NCT03134222|17285266|P2|Treatment Period (Week 12 to 48)|Withdrew Consent|2
5024220|NCT03134222|17285267|P1|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5024221|NCT03134222|17285263|P5|Treatment Period (Up to Week 12)|Randomized but not treated|0
5024222|NCT03134222|17285264|P4|Treatment Period (Up to Week 12)|Randomized but not treated|0
5024223|NCT03134222|17285265|P3|Treatment Period (Up to Week 12)|Randomized but not treated|1
5024224|NCT03134222|17285266|P2|Treatment Period (Up to Week 12)|Randomized but not treated|1
5024225|NCT03134222|17285267|P1|Treatment Period (Up to Week 12)|Randomized but not treated|0
5024226|NCT03134222|17285263|P5|Treatment Period (Up to Week 12)|Withdrew Consent|0
5024227|NCT03134222|17285264|P4|Treatment Period (Up to Week 12)|Withdrew Consent|0
5024228|NCT03134222|17285265|P3|Treatment Period (Up to Week 12)|Withdrew Consent|0
5024229|NCT03134222|17285266|P2|Treatment Period (Up to Week 12)|Withdrew Consent|1
5024230|NCT03134222|17285267|P1|Treatment Period (Up to Week 12)|Withdrew Consent|0
5024231|NCT03134222|17285263|P5|Treatment Period (Up to Week 12)|Lost to Follow-up|0
5024232|NCT03134222|17285264|P4|Treatment Period (Up to Week 12)|Lost to Follow-up|0
5024233|NCT03134222|17285265|P3|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5024234|NCT03134222|17285266|P2|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5024235|NCT03134222|17285267|P1|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5024236|NCT03134222|17285263|P5|Treatment Period (Up to Week 12)|Adverse Event|0
5024237|NCT03134222|17285264|P4|Treatment Period (Up to Week 12)|Adverse Event|0
5024238|NCT03134222|17285265|P3|Treatment Period (Up to Week 12)|Adverse Event|0
5024239|NCT03134222|17285266|P2|Treatment Period (Up to Week 12)|Adverse Event|1
5024240|NCT03134222|17285267|P1|Treatment Period (Up to Week 12)|Adverse Event|4
5024241|NCT03134183|17285289|P2|Overall Study|Withdrawal by Subject|1
5024242|NCT03134183|17285290|P1|Overall Study|Withdrawal by Subject|1
5024243|NCT03133767|17285341|P2|Overall Study|Protocol Violation|1
5024244|NCT03133767|17285342|P1|Overall Study|Protocol Violation|0
5024245|NCT03133767|17285341|P2|Overall Study|Lost to Follow-up|24
5024246|NCT03133767|17285342|P1|Overall Study|Lost to Follow-up|38
5024247|NCT03133481|17285358|P2|Overall Study|FC Catheter fell out post operative day1|4
5024248|NCT03133481|17285359|P1|Overall Study|FC Catheter fell out post operative day1|0
5024249|NCT03132753|17285389|P2|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
5024250|NCT03132753|17285390|P1|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
5024251|NCT03132753|17285389|P2|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
5024252|NCT03132753|17285390|P1|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
5024253|NCT03132220|17285535|P2|Overall Study|Withdrawal by Subject|4
5024254|NCT03132220|17285536|P1|Overall Study|Withdrawal by Subject|1
5024255|NCT03132220|17285535|P2|Overall Study|Lost to Follow-up|8
5024256|NCT03132220|17285536|P1|Overall Study|Lost to Follow-up|17
5024257|NCT03131999|17285564|P2|Overall Study|Withdrawal by Subject|1
5024258|NCT03131999|17285565|P1|Overall Study|Withdrawal by Subject|0
5024259|NCT03131895|17285577|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5024260|NCT03131895|17285578|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5024261|NCT03131895|17285579|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5024262|NCT03131895|17285580|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
5024263|NCT03131895|17285577|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5024264|NCT03131895|17285578|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5024265|NCT03131895|17285579|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
5024266|NCT03131895|17285580|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5024267|NCT03131895|17285577|P4|Washout Period (at Least 5 Days)|Other|0
5024268|NCT03131895|17285578|P3|Washout Period (at Least 5 Days)|Other|2
5024269|NCT03131895|17285579|P2|Washout Period (at Least 5 Days)|Other|0
5024270|NCT03131895|17285580|P1|Washout Period (at Least 5 Days)|Other|0
5024271|NCT03131895|17285577|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5024272|NCT03131895|17285578|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5024273|NCT03131895|17285579|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
5024274|NCT03131895|17285580|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5024275|NCT03131895|17285577|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
5024276|NCT03131895|17285578|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
5024277|NCT03131895|17285579|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
5024278|NCT03131895|17285580|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5024279|NCT03131895|17285577|P4|Washout Period (at Least 5 Days)|Adverse Event|1
5024280|NCT03131895|17285578|P3|Washout Period (at Least 5 Days)|Adverse Event|0
5024281|NCT03131895|17285579|P2|Washout Period (at Least 5 Days)|Adverse Event|0
5024282|NCT03131895|17285580|P1|Washout Period (at Least 5 Days)|Adverse Event|1
5024283|NCT03131713|17285600|P2|Overall Study|Lost to Follow-up|0
5024284|NCT03131713|17285601|P1|Overall Study|Lost to Follow-up|5
5024285|NCT03131687|17285625|P6|Overall Study|Inadvertent Enrollment|0
5024286|NCT03131687|17285626|P5|Overall Study|Inadvertent Enrollment|0
5024287|NCT03131687|17285627|P4|Overall Study|Inadvertent Enrollment|1
5024288|NCT03131687|17285628|P3|Overall Study|Inadvertent Enrollment|0
5024289|NCT03131687|17285629|P2|Overall Study|Inadvertent Enrollment|0
5024290|NCT03131687|17285630|P1|Overall Study|Inadvertent Enrollment|0
5024291|NCT03131687|17285625|P6|Overall Study|Principle Investigator Decision|0
5024292|NCT03131687|17285626|P5|Overall Study|Principle Investigator Decision|0
5024293|NCT03131687|17285627|P4|Overall Study|Principle Investigator Decision|0
5024294|NCT03131687|17285628|P3|Overall Study|Principle Investigator Decision|0
5024295|NCT03131687|17285629|P2|Overall Study|Principle Investigator Decision|1
5024296|NCT03131687|17285630|P1|Overall Study|Principle Investigator Decision|0
5024297|NCT03131687|17285625|P6|Overall Study|Participant Started New Diabetic Drug|0
5024298|NCT03131687|17285626|P5|Overall Study|Participant Started New Diabetic Drug|0
5024299|NCT03131687|17285627|P4|Overall Study|Participant Started New Diabetic Drug|0
5024300|NCT03131687|17285628|P3|Overall Study|Participant Started New Diabetic Drug|0
5024301|NCT03131687|17285629|P2|Overall Study|Participant Started New Diabetic Drug|0
5024302|NCT03131687|17285630|P1|Overall Study|Participant Started New Diabetic Drug|1
5024303|NCT03131687|17285625|P6|Overall Study|Lost to Follow-up|2
5024304|NCT03131687|17285626|P5|Overall Study|Lost to Follow-up|4
5024305|NCT03131687|17285627|P4|Overall Study|Lost to Follow-up|1
5024306|NCT03131687|17285628|P3|Overall Study|Lost to Follow-up|0
5024307|NCT03131687|17285629|P2|Overall Study|Lost to Follow-up|4
5024308|NCT03131687|17285630|P1|Overall Study|Lost to Follow-up|1
5024309|NCT03131687|17285625|P6|Overall Study|Withdrawal by Subject|1
5024310|NCT03131687|17285626|P5|Overall Study|Withdrawal by Subject|2
5024311|NCT03131687|17285627|P4|Overall Study|Withdrawal by Subject|1
5024312|NCT03131687|17285628|P3|Overall Study|Withdrawal by Subject|3
5024313|NCT03131687|17285629|P2|Overall Study|Withdrawal by Subject|3
5024314|NCT03131687|17285630|P1|Overall Study|Withdrawal by Subject|3
5024315|NCT03131687|17285625|P6|Overall Study|Death|0
5024316|NCT03131687|17285626|P5|Overall Study|Death|0
5024317|NCT03131687|17285627|P4|Overall Study|Death|0
5024318|NCT03131687|17285628|P3|Overall Study|Death|0
5024319|NCT03131687|17285629|P2|Overall Study|Death|0
5024320|NCT03131687|17285630|P1|Overall Study|Death|1
5024321|NCT03131687|17285625|P6|Overall Study|Adverse Event|2
5024322|NCT03131687|17285626|P5|Overall Study|Adverse Event|2
5024323|NCT03131687|17285627|P4|Overall Study|Adverse Event|1
5024324|NCT03131687|17285628|P3|Overall Study|Adverse Event|0
5024325|NCT03131687|17285629|P2|Overall Study|Adverse Event|1
5024326|NCT03131687|17285630|P1|Overall Study|Adverse Event|0
5024327|NCT03131648|17285740|P8|Open-label (Short Term Extension)|Discontinued IMP|3
5024328|NCT03131648|17285741|P7|Open-label (Short Term Extension)|Discontinued IMP|0
5024329|NCT03131648|17285742|P6|Open-label (Short Term Extension)|Discontinued IMP|0
5024330|NCT03131648|17285743|P5|Open-label (Short Term Extension)|Discontinued IMP|0
5024331|NCT03131648|17285744|P4|Open-label (Short Term Extension)|Discontinued IMP|0
5024332|NCT03131648|17285745|P3|Open-label (Short Term Extension)|Discontinued IMP|0
5024333|NCT03131648|17285746|P2|Open-label (Short Term Extension)|Discontinued IMP|0
5024334|NCT03131648|17285747|P1|Open-label (Short Term Extension)|Discontinued IMP|0
5024335|NCT03131648|17285740|P8|Maintenance Treatment Period|Completed Week 50|0
5024336|NCT03131648|17285741|P7|Maintenance Treatment Period|Completed Week 50|0
5024337|NCT03131648|17285742|P6|Maintenance Treatment Period|Completed Week 50|0
5024338|NCT03131648|17285743|P5|Maintenance Treatment Period|Completed Week 50|1
5024339|NCT03131648|17285744|P4|Maintenance Treatment Period|Completed Week 50|0
5024340|NCT03131648|17285745|P3|Maintenance Treatment Period|Completed Week 50|0
5024341|NCT03131648|17285746|P2|Maintenance Treatment Period|Completed Week 50|0
5024342|NCT03131648|17285747|P1|Maintenance Treatment Period|Completed Week 50|0
5024343|NCT03131648|17285740|P8|Maintenance Treatment Period|Transfer to open-label treatment|0
5024344|NCT03131648|17285741|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
5024345|NCT03131648|17285742|P6|Maintenance Treatment Period|Transfer to open-label treatment|10
5024346|NCT03131648|17285743|P5|Maintenance Treatment Period|Transfer to open-label treatment|9
5024347|NCT03131648|17285744|P4|Maintenance Treatment Period|Transfer to open-label treatment|18
5024348|NCT03131648|17285745|P3|Maintenance Treatment Period|Transfer to open-label treatment|21
5024349|NCT03131648|17285746|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
5024350|NCT03131648|17285747|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
5024351|NCT03131648|17285740|P8|Maintenance Treatment Period|Discontinued IMP|0
5024352|NCT03131648|17285741|P7|Maintenance Treatment Period|Discontinued IMP|0
5024353|NCT03131648|17285742|P6|Maintenance Treatment Period|Discontinued IMP|4
5024354|NCT03131648|17285743|P5|Maintenance Treatment Period|Discontinued IMP|4
5024355|NCT03131648|17285744|P4|Maintenance Treatment Period|Discontinued IMP|5
5024356|NCT03131648|17285745|P3|Maintenance Treatment Period|Discontinued IMP|3
5024357|NCT03131648|17285746|P2|Maintenance Treatment Period|Discontinued IMP|0
5024358|NCT03131648|17285747|P1|Maintenance Treatment Period|Discontinued IMP|0
5024359|NCT03131648|17285740|P8|Maintenance Treatment Period|Not dosed|0
5024360|NCT03131648|17285741|P7|Maintenance Treatment Period|Not dosed|0
5024361|NCT03131648|17285742|P6|Maintenance Treatment Period|Not dosed|0
5024362|NCT03131648|17285743|P5|Maintenance Treatment Period|Not dosed|1
5024363|NCT03131648|17285744|P4|Maintenance Treatment Period|Not dosed|2
5024364|NCT03131648|17285745|P3|Maintenance Treatment Period|Not dosed|3
5024365|NCT03131648|17285746|P2|Maintenance Treatment Period|Not dosed|0
5024366|NCT03131648|17285747|P1|Maintenance Treatment Period|Not dosed|0
5024367|NCT03131648|17285740|P8|Open-label Treatment|Completed Week 50|0
5024368|NCT03131648|17285741|P7|Open-label Treatment|Completed Week 50|6
5024369|NCT03131648|17285742|P6|Open-label Treatment|Completed Week 50|0
5024370|NCT03131648|17285743|P5|Open-label Treatment|Completed Week 50|0
5024371|NCT03131648|17285744|P4|Open-label Treatment|Completed Week 50|0
5024372|NCT03131648|17285745|P3|Open-label Treatment|Completed Week 50|0
5024373|NCT03131648|17285746|P2|Open-label Treatment|Completed Week 50|0
5024374|NCT03131648|17285747|P1|Open-label Treatment|Completed Week 50|0
5024375|NCT03131648|17285740|P8|Open-label Treatment|Discontinued IMP|0
5024376|NCT03131648|17285741|P7|Open-label Treatment|Discontinued IMP|112
5024377|NCT03131648|17285742|P6|Open-label Treatment|Discontinued IMP|0
5024378|NCT03131648|17285743|P5|Open-label Treatment|Discontinued IMP|0
5024379|NCT03131648|17285744|P4|Open-label Treatment|Discontinued IMP|0
5024380|NCT03131648|17285745|P3|Open-label Treatment|Discontinued IMP|0
5024381|NCT03131648|17285746|P2|Open-label Treatment|Discontinued IMP|0
5024382|NCT03131648|17285747|P1|Open-label Treatment|Discontinued IMP|0
5024383|NCT03131648|17285740|P8|Initial Treatment Period|Discontinued IMP before Week 16|0
5024384|NCT03131648|17285741|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
5024385|NCT03131648|17285742|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
5024386|NCT03131648|17285743|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
5024387|NCT03131648|17285744|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
5024388|NCT03131648|17285745|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
5024389|NCT03131648|17285746|P2|Initial Treatment Period|Discontinued IMP before Week 16|18
5024390|NCT03131648|17285747|P1|Initial Treatment Period|Discontinued IMP before Week 16|51
5024391|NCT03131648|17285740|P8|Initial Treatment Period|Not dosed|0
5024392|NCT03131648|17285741|P7|Initial Treatment Period|Not dosed|0
5024393|NCT03131648|17285742|P6|Initial Treatment Period|Not dosed|0
5024394|NCT03131648|17285743|P5|Initial Treatment Period|Not dosed|0
5024395|NCT03131648|17285744|P4|Initial Treatment Period|Not dosed|0
5024396|NCT03131648|17285745|P3|Initial Treatment Period|Not dosed|0
5024397|NCT03131648|17285746|P2|Initial Treatment Period|Not dosed|2
5024398|NCT03131648|17285747|P1|Initial Treatment Period|Not dosed|2
5024399|NCT03131596|17285795|P2|Overall Study|Lost to Follow-up|0
5024400|NCT03131596|17285796|P1|Overall Study|Lost to Follow-up|3
5024401|NCT03131596|17285795|P2|Overall Study|Protocol Violation|3
5024402|NCT03131596|17285796|P1|Overall Study|Protocol Violation|3
5024403|NCT03131479|17285813|P5|Overall Study|Subject/Guardian Decision|0
5024404|NCT03131479|17285814|P4|Overall Study|Subject/Guardian Decision|1
5024405|NCT03131479|17285815|P3|Overall Study|Subject/Guardian Decision|0
5024406|NCT03131479|17285816|P2|Overall Study|Subject/Guardian Decision|0
5024407|NCT03131479|17285817|P1|Overall Study|Subject/Guardian Decision|0
5024408|NCT03131479|17285813|P5|Overall Study|Adverse Event|0
5024409|NCT03131479|17285814|P4|Overall Study|Adverse Event|1
5024410|NCT03131479|17285815|P3|Overall Study|Adverse Event|1
5024411|NCT03131479|17285816|P2|Overall Study|Adverse Event|0
5024412|NCT03131479|17285817|P1|Overall Study|Adverse Event|0
5024413|NCT03131219|17285876|P2|Initial Evaluation Period|Deemed ineligible post treatment|0
5024414|NCT03131219|17285877|P1|Initial Evaluation Period|Deemed ineligible post treatment|2
5024415|NCT03131219|17285876|P2|Initial Evaluation Period|Protocol Violation|0
5024416|NCT03131219|17285877|P1|Initial Evaluation Period|Protocol Violation|1
5024417|NCT03131219|17285876|P2|Initial Evaluation Period|Adverse Event|0
5024418|NCT03131219|17285877|P1|Initial Evaluation Period|Adverse Event|1
5024419|NCT03131167|17285937|P13|Overall Study|Other (Unspecified)|0
5024420|NCT03131167|17285938|P12|Overall Study|Other (Unspecified)|0
5024421|NCT03131167|17285939|P11|Overall Study|Other (Unspecified)|0
5024422|NCT03131167|17285940|P10|Overall Study|Other (Unspecified)|0
5024423|NCT03131167|17285941|P9|Overall Study|Other (Unspecified)|0
5024424|NCT03131167|17285942|P8|Overall Study|Other (Unspecified)|0
5024425|NCT03131167|17285943|P7|Overall Study|Other (Unspecified)|0
5024426|NCT03131167|17285944|P6|Overall Study|Other (Unspecified)|1
5024427|NCT03131167|17285945|P5|Overall Study|Other (Unspecified)|0
5024428|NCT03131167|17285946|P4|Overall Study|Other (Unspecified)|0
5024429|NCT03131167|17285947|P3|Overall Study|Other (Unspecified)|0
5024430|NCT03131167|17285948|P2|Overall Study|Other (Unspecified)|0
5024431|NCT03131167|17285949|P1|Overall Study|Other (Unspecified)|0
5024432|NCT03130257|17286009|P3|Overall Study|Withdrawal by Subject|2
5024433|NCT03130257|17286010|P2|Overall Study|Withdrawal by Subject|0
5024434|NCT03130257|17286011|P1|Overall Study|Withdrawal by Subject|1
5024435|NCT03128931|17286065|P1|Overall Study|Equipment Issues|3
5024436|NCT03128931|17286065|P1|Overall Study|Physician Decision|1
5024437|NCT03128892|17286069|P1|Overall Study|Physician Decision|1
5024438|NCT03128892|17286069|P1|Overall Study|Withdrawal by Subject|2
5024439|NCT03128723|17286075|P1|Overall Study|Withdrawal by Subject|2
5024440|NCT03128411|17286090|P1|Long Term Follow-up Phase|Ongoing|18
5024441|NCT03128411|17286090|P1|Long Term Follow-up Phase|Death|1
5024442|NCT03128411|17286090|P1|Treatment Phase|Ongoing|41
5024443|NCT03128411|17286090|P1|Treatment Phase|Physician Decision|1
5024444|NCT03128411|17286090|P1|Treatment Phase|Adverse Event|18
5024445|NCT03128307|17286133|P1|Overall Study|Withdrawal by Subject|5
5024446|NCT03128307|17286133|P1|Overall Study|Lost to Follow-up|29
5024447|NCT03128099|17286141|P3|Overall Study|Did not complete all the assessments|1
5024448|NCT03128099|17286142|P2|Overall Study|Did not complete all the assessments|0
5024449|NCT03128099|17286143|P1|Overall Study|Did not complete all the assessments|0
5024450|NCT03128099|17286141|P3|Overall Study|Became homeless and lost contact|0
5024451|NCT03128099|17286142|P2|Overall Study|Became homeless and lost contact|0
5024452|NCT03128099|17286143|P1|Overall Study|Became homeless and lost contact|1
5024453|NCT03128099|17286141|P3|Overall Study|Participant got a full time job.|0
5024454|NCT03128099|17286142|P2|Overall Study|Participant got a full time job.|0
5024455|NCT03128099|17286143|P1|Overall Study|Participant got a full time job.|1
5024456|NCT03128099|17286141|P3|Overall Study|High dose task was too long|0
5024457|NCT03128099|17286142|P2|Overall Study|High dose task was too long|4
5024458|NCT03128099|17286143|P1|Overall Study|High dose task was too long|0
5024459|NCT03127644|17286193|P3|Overall Study|Study-specific withdrawal criteria|2
5024460|NCT03127644|17286194|P2|Overall Study|Study-specific withdrawal criteria|0
5024461|NCT03127644|17286195|P1|Overall Study|Study-specific withdrawal criteria|0
5024462|NCT03127384|17286227|P1|Overall Study|Subject request|2
5024463|NCT03127384|17286227|P1|Overall Study|Lost to Follow-up|4
5024464|NCT03126539|17286263|P5|Overall Study|Lost to Follow-up|0
5024465|NCT03126539|17286264|P4|Overall Study|Lost to Follow-up|0
5024466|NCT03126539|17286265|P3|Overall Study|Lost to Follow-up|1
5024467|NCT03126539|17286266|P2|Overall Study|Lost to Follow-up|1
5024468|NCT03126539|17286267|P1|Overall Study|Lost to Follow-up|1
5024469|NCT03126344|17286296|P3|Overall Study|Lost to Follow-up|5
5024470|NCT03126344|17286297|P2|Overall Study|Lost to Follow-up|0
5024471|NCT03126344|17286298|P1|Overall Study|Lost to Follow-up|0
5024472|NCT03125941|17286314|P2|Overall Study|did not receive intervention|2
5024473|NCT03125941|17286315|P1|Overall Study|did not receive intervention|1
5024474|NCT03125915|17286351|P4|6 Month Follow-up|Lost to Follow-up|3
5024475|NCT03125915|17286352|P3|6 Month Follow-up|Lost to Follow-up|6
5024476|NCT03125915|17286353|P2|6 Month Follow-up|Lost to Follow-up|3
5024477|NCT03125915|17286354|P1|6 Month Follow-up|Lost to Follow-up|7
5024478|NCT03125915|17286351|P4|3 Month Follow-up|Lost to Follow-up|2
5024479|NCT03125915|17286352|P3|3 Month Follow-up|Lost to Follow-up|4
5024480|NCT03125915|17286353|P2|3 Month Follow-up|Lost to Follow-up|4
5024481|NCT03125915|17286354|P1|3 Month Follow-up|Lost to Follow-up|6
5024482|NCT03125915|17286351|P4|1 Month Follow up|Lost to Follow-up|3
5024483|NCT03125915|17286352|P3|1 Month Follow up|Lost to Follow-up|2
5024484|NCT03125915|17286353|P2|1 Month Follow up|Lost to Follow-up|3
5024485|NCT03125915|17286354|P1|1 Month Follow up|Lost to Follow-up|3
5024486|NCT03125395|17286372|P1|Overall Study|Commercial drug is available|5
5024487|NCT03125395|17286372|P1|Overall Study|Physician Decision|2
5024488|NCT03125395|17286372|P1|Overall Study|Withdrawal of consent (not due to AE)|1
5024489|NCT03125395|17286372|P1|Overall Study|Adverse Event|2
5024490|NCT03125200|17286398|P7|Overall Study|Consent Withdrawn by Subject|1
5024491|NCT03125200|17286399|P6|Overall Study|Consent Withdrawn by Subject|0
5024492|NCT03125200|17286400|P5|Overall Study|Consent Withdrawn by Subject|1
5024493|NCT03125200|17286401|P4|Overall Study|Consent Withdrawn by Subject|0
5024494|NCT03125200|17286402|P3|Overall Study|Consent Withdrawn by Subject|0
5024495|NCT03125200|17286403|P2|Overall Study|Consent Withdrawn by Subject|1
5024496|NCT03125200|17286404|P1|Overall Study|Consent Withdrawn by Subject|0
5024497|NCT03125200|17286398|P7|Overall Study|Toxicity|0
5024498|NCT03125200|17286399|P6|Overall Study|Toxicity|0
5024499|NCT03125200|17286400|P5|Overall Study|Toxicity|0
5024500|NCT03125200|17286401|P4|Overall Study|Toxicity|1
5024501|NCT03125200|17286402|P3|Overall Study|Toxicity|0
5024502|NCT03125200|17286403|P2|Overall Study|Toxicity|0
5024503|NCT03125200|17286404|P1|Overall Study|Toxicity|0
5024504|NCT03125200|17286398|P7|Overall Study|Lack of Efficacy|0
5024505|NCT03125200|17286399|P6|Overall Study|Lack of Efficacy|0
5024506|NCT03125200|17286400|P5|Overall Study|Lack of Efficacy|0
5024507|NCT03125200|17286401|P4|Overall Study|Lack of Efficacy|1
5024508|NCT03125200|17286402|P3|Overall Study|Lack of Efficacy|0
5024509|NCT03125200|17286403|P2|Overall Study|Lack of Efficacy|0
5024510|NCT03125200|17286404|P1|Overall Study|Lack of Efficacy|0
5024511|NCT03125200|17286398|P7|Overall Study|Progressive Disease|1
5024512|NCT03125200|17286399|P6|Overall Study|Progressive Disease|0
5024513|NCT03125200|17286400|P5|Overall Study|Progressive Disease|2
5024514|NCT03125200|17286401|P4|Overall Study|Progressive Disease|1
5024515|NCT03125200|17286402|P3|Overall Study|Progressive Disease|2
5024516|NCT03125200|17286403|P2|Overall Study|Progressive Disease|1
5024517|NCT03125200|17286404|P1|Overall Study|Progressive Disease|2
5024518|NCT03125200|17286398|P7|Overall Study|Clinical Progression|0
5024519|NCT03125200|17286399|P6|Overall Study|Clinical Progression|1
5024520|NCT03125200|17286400|P5|Overall Study|Clinical Progression|0
5024521|NCT03125200|17286401|P4|Overall Study|Clinical Progression|1
5024522|NCT03125200|17286402|P3|Overall Study|Clinical Progression|0
5024523|NCT03125200|17286403|P2|Overall Study|Clinical Progression|0
5024524|NCT03125200|17286404|P1|Overall Study|Clinical Progression|0
5024525|NCT03125200|17286398|P7|Overall Study|Study Termination|1
5024526|NCT03125200|17286399|P6|Overall Study|Study Termination|2
5024527|NCT03125200|17286400|P5|Overall Study|Study Termination|1
5024528|NCT03125200|17286401|P4|Overall Study|Study Termination|1
5024529|NCT03125200|17286402|P3|Overall Study|Study Termination|0
5024530|NCT03125200|17286403|P2|Overall Study|Study Termination|0
5024531|NCT03125200|17286404|P1|Overall Study|Study Termination|0
5024532|NCT03124784|17286644|P1|Overall Study|Computer/Equip Malfunction|1
5024533|NCT03124784|17286644|P1|Overall Study|Adverse Event|1
5024534|NCT03124563|17286666|P2|Overall Study|Withdrawal by Subject|1
5024535|NCT03124563|17286667|P1|Overall Study|Withdrawal by Subject|1
5024536|NCT03124563|17286666|P2|Overall Study|Lost to Follow-up|1
5024537|NCT03124563|17286667|P1|Overall Study|Lost to Follow-up|1
5024538|NCT03124537|17286692|P2|Overall Study|App Crash, Incomplete Data|8
5024539|NCT03124537|17286693|P1|Overall Study|App Crash, Incomplete Data|7
5024540|NCT03124537|17286692|P2|Overall Study|Lost to Follow-up|5
5024541|NCT03124537|17286693|P1|Overall Study|Lost to Follow-up|3
5024542|NCT03124407|17286717|P4|Overall Study|Adverse Event|0
5024543|NCT03124407|17286718|P3|Overall Study|Adverse Event|1
5024544|NCT03124407|17286719|P2|Overall Study|Adverse Event|0
5024545|NCT03124407|17286720|P1|Overall Study|Adverse Event|0
5024546|NCT03124407|17286717|P4|Overall Study|Lost to Follow-up|0
5024547|NCT03124407|17286718|P3|Overall Study|Lost to Follow-up|0
5024548|NCT03124407|17286719|P2|Overall Study|Lost to Follow-up|0
5024549|NCT03124407|17286720|P1|Overall Study|Lost to Follow-up|1
5024550|NCT03124381|17286740|P2|Overall Study|Non-Compliance with Study Treatment|0
5024551|NCT03124381|17286741|P1|Overall Study|Non-Compliance with Study Treatment|1
5024552|NCT03124381|17286740|P2|Overall Study|Adverse Event|1
5024553|NCT03124381|17286741|P1|Overall Study|Adverse Event|1
5024554|NCT03124381|17286740|P2|Overall Study|Protocol Violation|1
5024555|NCT03124381|17286741|P1|Overall Study|Protocol Violation|0
5024556|NCT03124381|17286740|P2|Overall Study|Withdrawal by Subject|3
5024557|NCT03124381|17286741|P1|Overall Study|Withdrawal by Subject|6
5024558|NCT03124381|17286740|P2|Overall Study|Lost to Follow-up|1
5024559|NCT03124381|17286741|P1|Overall Study|Lost to Follow-up|1
5024560|NCT03124199|17286848|P1|Overall Study|Lost to Follow-up|4
5024561|NCT03124108|17286857|P3|Overall Study|Adverse Event|0
5024562|NCT03124108|17286858|P2|Overall Study|Adverse Event|1
5024563|NCT03124108|17286859|P1|Overall Study|Adverse Event|0
5024564|NCT03123861|17287005|P2|Overall Study|Withdrawal by Subject|2
5024565|NCT03123861|17287006|P1|Overall Study|Withdrawal by Subject|2
5024566|NCT03123861|17287005|P2|Overall Study|Protocol Violation|1
5024567|NCT03123861|17287006|P1|Overall Study|Protocol Violation|1
5024568|NCT03123471|17287042|P2|Apremilast Extension Phase|Withdrawal by Subject|7
5024569|NCT03123471|17287043|P1|Apremilast Extension Phase|Withdrawal by Subject|3
5024570|NCT03123471|17287042|P2|Apremilast Extension Phase|Lack of Efficacy|8
5024571|NCT03123471|17287043|P1|Apremilast Extension Phase|Lack of Efficacy|2
5024572|NCT03123471|17287042|P2|Apremilast Extension Phase|Adverse Event|5
5024573|NCT03123471|17287043|P1|Apremilast Extension Phase|Adverse Event|1
5024574|NCT03123471|17287042|P2|Apremilast Extension Phase|Lost to Follow-up|5
5024575|NCT03123471|17287043|P1|Apremilast Extension Phase|Lost to Follow-up|2
5024576|NCT03123471|17287042|P2|Placebo-controlled Phase|Miscellaneous|1
5024577|NCT03123471|17287043|P1|Placebo-controlled Phase|Miscellaneous|0
5024578|NCT03123471|17287042|P2|Placebo-controlled Phase|Protocol Deviation|1
5024579|NCT03123471|17287043|P1|Placebo-controlled Phase|Protocol Deviation|2
5024580|NCT03123471|17287042|P2|Placebo-controlled Phase|Lost to Follow-up|3
5024581|NCT03123471|17287043|P1|Placebo-controlled Phase|Lost to Follow-up|1
5024582|NCT03123471|17287042|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
5024583|NCT03123471|17287043|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
5024584|NCT03123471|17287042|P2|Placebo-controlled Phase|Withdrawal by Subject|16
5024585|NCT03123471|17287043|P1|Placebo-controlled Phase|Withdrawal by Subject|6
5024586|NCT03123471|17287042|P2|Placebo-controlled Phase|Lack of Efficacy|4
5024587|NCT03123471|17287043|P1|Placebo-controlled Phase|Lack of Efficacy|3
5024588|NCT03123471|17287042|P2|Placebo-controlled Phase|Adverse Event|8
5024589|NCT03123471|17287043|P1|Placebo-controlled Phase|Adverse Event|3
5024590|NCT03123393|17287070|P2|Overall Study|Reason not Specified|13
5024591|NCT03123393|17287071|P1|Overall Study|Reason not Specified|13
5024592|NCT03123393|17287070|P2|Overall Study|Withdrawal by Subject|1
5024593|NCT03123393|17287071|P1|Overall Study|Withdrawal by Subject|2
5024594|NCT03123393|17287070|P2|Overall Study|Study Terminated by Sponsor|9
5024595|NCT03123393|17287071|P1|Overall Study|Study Terminated by Sponsor|6
5024596|NCT03123354|17287099|P1|Overall Study|Physician Decision|6
5024597|NCT03122886|17287124|P2|Overall Study|Withdrawal by Subject|2
5024598|NCT03122886|17287125|P1|Overall Study|Withdrawal by Subject|1
5024599|NCT03122548|17287147|P1|Overall Study|Study Terminated by Sponsor|2
5024600|NCT03122548|17287147|P1|Overall Study|Progression - subject went into hospice|1
5024601|NCT03122548|17287147|P1|Overall Study|Death|2
5024602|NCT03122457|17287155|P1|Overall Study|Withdrawal by Subject|6
5024603|NCT03122184|17287162|P2|Overall Study|Terminated due to cognitive problem|0
5024604|NCT03122184|17287163|P1|Overall Study|Terminated due to cognitive problem|1
5024605|NCT03122184|17287162|P2|Overall Study|Withdrawal by Subject|0
5024606|NCT03122184|17287163|P1|Overall Study|Withdrawal by Subject|3
5024607|NCT03122184|17287162|P2|Overall Study|Lost to Follow-up|6
5024608|NCT03122184|17287163|P1|Overall Study|Lost to Follow-up|4
5024609|NCT03122171|17287200|P1|Overall Study|Withdrawal by Subject|1
5024610|NCT03122145|17287209|P2|Overall Study|Concurrent respiratory disease|0
5024611|NCT03122145|17287210|P1|Overall Study|Concurrent respiratory disease|3
5024612|NCT03121950|17287220|P2|Overall Study|Withdrawal by Subject|2
5024613|NCT03121950|17287221|P1|Overall Study|Withdrawal by Subject|11
5024614|NCT03120676|17287322|P1|Overall Study|Not treated|1
5024615|NCT03120520|17287330|P4|Overall Study|Other|0
5024616|NCT03120520|17287331|P3|Overall Study|Other|0
5024617|NCT03120520|17287332|P2|Overall Study|Other|1
5024618|NCT03120520|17287333|P1|Overall Study|Other|0
5024619|NCT03120520|17287330|P4|Overall Study|Withdrawal by Subject|2
5024620|NCT03120520|17287331|P3|Overall Study|Withdrawal by Subject|3
5024621|NCT03120520|17287332|P2|Overall Study|Withdrawal by Subject|2
5024622|NCT03120520|17287333|P1|Overall Study|Withdrawal by Subject|3
5024623|NCT03120520|17287330|P4|Overall Study|Lost to Follow-up|1
5024624|NCT03120520|17287331|P3|Overall Study|Lost to Follow-up|1
5024625|NCT03120520|17287332|P2|Overall Study|Lost to Follow-up|1
5024626|NCT03120520|17287333|P1|Overall Study|Lost to Follow-up|1
5024627|NCT03120351|17287357|P2|Overall Study|Physician Decision|1
5024628|NCT03120351|17287358|P1|Overall Study|Physician Decision|1
5024629|NCT03120013|17287364|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
5024630|NCT03120013|17287365|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
5024631|NCT03119688|17287407|P1|Overall Study|Adverse Event|4
5024632|NCT03119662|17287440|P2|Overall Study|Withdrawal by Subject|1
5024633|NCT03119662|17287441|P1|Overall Study|Withdrawal by Subject|0
5024634|NCT03119610|17287511|P2|Overall Study|Lost to Follow-up|1
5024635|NCT03119610|17287512|P1|Overall Study|Lost to Follow-up|0
5024636|NCT03119610|17287511|P2|Overall Study|Adverse Event|0
5024637|NCT03119610|17287512|P1|Overall Study|Adverse Event|1
5024638|NCT03118947|17287590|P1|Overall Study|Lost to Follow-up|2
5024639|NCT03118947|17287590|P1|Overall Study|Change in patient's living situation|4
5024640|NCT03118947|17287590|P1|Overall Study|Withdrawal by caregiver|3
5024641|NCT03118947|17287590|P1|Overall Study|Withdrawal by Subject|3
5024642|NCT03118947|17287590|P1|Overall Study|Protocol Violation|2
5024643|NCT03118947|17287590|P1|Overall Study|Non-compliance with study drug|1
5024644|NCT03118947|17287590|P1|Overall Study|Lack of Efficacy|4
5024645|NCT03118947|17287590|P1|Overall Study|Death|3
5024646|NCT03118947|17287590|P1|Overall Study|Adverse Event|7
5024647|NCT03118934|17287597|P6|Overall Study|Discontinued prior to exposure|0
5024648|NCT03118934|17287598|P5|Overall Study|Discontinued prior to exposure|2
5024649|NCT03118934|17287599|P4|Overall Study|Discontinued prior to exposure|1
5024650|NCT03118934|17287600|P3|Overall Study|Discontinued prior to exposure|1
5024651|NCT03118934|17287601|P2|Overall Study|Discontinued prior to exposure|1
5024652|NCT03118934|17287602|P1|Overall Study|Discontinued prior to exposure|0
5024653|NCT03118934|17287597|P6|Overall Study|Physician Decision|1
5024654|NCT03118934|17287598|P5|Overall Study|Physician Decision|0
5024655|NCT03118934|17287599|P4|Overall Study|Physician Decision|0
5024656|NCT03118934|17287600|P3|Overall Study|Physician Decision|0
5024657|NCT03118934|17287601|P2|Overall Study|Physician Decision|0
5024658|NCT03118934|17287602|P1|Overall Study|Physician Decision|0
5024659|NCT03118934|17287597|P6|Overall Study|Adverse Event|1
5024660|NCT03118934|17287598|P5|Overall Study|Adverse Event|0
5024661|NCT03118934|17287599|P4|Overall Study|Adverse Event|0
5024662|NCT03118934|17287600|P3|Overall Study|Adverse Event|0
5024663|NCT03118934|17287601|P2|Overall Study|Adverse Event|0
5024664|NCT03118934|17287602|P1|Overall Study|Adverse Event|0
5024665|NCT03118765|17287626|P5|Overall Study|Sponsor Decision|1
5024666|NCT03118765|17287627|P4|Overall Study|Sponsor Decision|0
5024667|NCT03118765|17287628|P3|Overall Study|Sponsor Decision|1
5024668|NCT03118765|17287629|P2|Overall Study|Sponsor Decision|0
5024669|NCT03118765|17287630|P1|Overall Study|Sponsor Decision|1
5024670|NCT03118765|17287626|P5|Overall Study|Lost to Follow-up|0
5024671|NCT03118765|17287627|P4|Overall Study|Lost to Follow-up|0
5024672|NCT03118765|17287628|P3|Overall Study|Lost to Follow-up|1
5024673|NCT03118765|17287629|P2|Overall Study|Lost to Follow-up|0
5024674|NCT03118765|17287630|P1|Overall Study|Lost to Follow-up|1
5024675|NCT03118765|17287626|P5|Overall Study|COPD Exacerbation|0
5024676|NCT03118765|17287627|P4|Overall Study|COPD Exacerbation|1
5024677|NCT03118765|17287628|P3|Overall Study|COPD Exacerbation|0
5024678|NCT03118765|17287629|P2|Overall Study|COPD Exacerbation|0
5024679|NCT03118765|17287630|P1|Overall Study|COPD Exacerbation|1
5024680|NCT03118765|17287626|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5024681|NCT03118765|17287627|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5024682|NCT03118765|17287628|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
5024683|NCT03118765|17287629|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
5024684|NCT03118765|17287630|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5024685|NCT03118765|17287626|P5|Overall Study|Non compliance with Study Procedures|0
5024686|NCT03118765|17287627|P4|Overall Study|Non compliance with Study Procedures|1
5024687|NCT03118765|17287628|P3|Overall Study|Non compliance with Study Procedures|0
5024688|NCT03118765|17287629|P2|Overall Study|Non compliance with Study Procedures|0
5024689|NCT03118765|17287630|P1|Overall Study|Non compliance with Study Procedures|0
5024690|NCT03118765|17287626|P5|Overall Study|Adverse Event|1
5024691|NCT03118765|17287627|P4|Overall Study|Adverse Event|1
5024692|NCT03118765|17287628|P3|Overall Study|Adverse Event|1
5024693|NCT03118765|17287629|P2|Overall Study|Adverse Event|1
5024694|NCT03118765|17287630|P1|Overall Study|Adverse Event|1
5024695|NCT03118765|17287626|P5|Overall Study|Withdrawal by Subject|0
5024696|NCT03118765|17287627|P4|Overall Study|Withdrawal by Subject|0
5024697|NCT03118765|17287628|P3|Overall Study|Withdrawal by Subject|1
5024698|NCT03118765|17287629|P2|Overall Study|Withdrawal by Subject|0
5024699|NCT03118765|17287630|P1|Overall Study|Withdrawal by Subject|0
5024700|NCT03118739|17287726|P2|Overall Study|Lost to Follow-up|0
5024701|NCT03118739|17287727|P1|Overall Study|Lost to Follow-up|2
5024702|NCT03118739|17287726|P2|Overall Study|Withdrawal by Subject|3
5024703|NCT03118739|17287727|P1|Overall Study|Withdrawal by Subject|5
5024704|NCT03118739|17287726|P2|Overall Study|Physician Decision|1
5024705|NCT03118739|17287727|P1|Overall Study|Physician Decision|0
5024706|NCT03118297|17287840|P2|Overall Study|Lost to Follow-up|2
5024707|NCT03118297|17287841|P1|Overall Study|Lost to Follow-up|0
5024708|NCT03116828|17287985|P2|Overall Study|OTHER|3
5024709|NCT03116828|17287986|P1|Overall Study|OTHER|3
5024710|NCT03116828|17287985|P2|Overall Study|Withdrawal by Subject|8
5024711|NCT03116828|17287986|P1|Overall Study|Withdrawal by Subject|4
5024712|NCT03116828|17287985|P2|Overall Study|Adverse Event|10
5024713|NCT03116828|17287986|P1|Overall Study|Adverse Event|1
5024714|NCT03116698|17287996|P4|Overall Study|Death|0
5024715|NCT03116698|17287997|P3|Overall Study|Death|2
5024716|NCT03116698|17287998|P2|Overall Study|Death|0
5024717|NCT03116698|17287999|P1|Overall Study|Death|0
5024718|NCT03116698|17287996|P4|Overall Study|Protocol Violation|0
5024719|NCT03116698|17287997|P3|Overall Study|Protocol Violation|0
5024720|NCT03116698|17287998|P2|Overall Study|Protocol Violation|0
5024721|NCT03116698|17287999|P1|Overall Study|Protocol Violation|1
5024722|NCT03116698|17287996|P4|Overall Study|Physician Decision|0
5024723|NCT03116698|17287997|P3|Overall Study|Physician Decision|0
5024724|NCT03116698|17287998|P2|Overall Study|Physician Decision|1
5024725|NCT03116698|17287999|P1|Overall Study|Physician Decision|1
5024726|NCT03116698|17287996|P4|Overall Study|Lost to Follow-up|0
5024727|NCT03116698|17287997|P3|Overall Study|Lost to Follow-up|0
5024728|NCT03116698|17287998|P2|Overall Study|Lost to Follow-up|0
5024729|NCT03116698|17287999|P1|Overall Study|Lost to Follow-up|2
5024730|NCT03116698|17287996|P4|Overall Study|Withdrawal by Subject|2
5024731|NCT03116698|17287997|P3|Overall Study|Withdrawal by Subject|5
5024732|NCT03116698|17287998|P2|Overall Study|Withdrawal by Subject|4
5024733|NCT03116698|17287999|P1|Overall Study|Withdrawal by Subject|1
5024734|NCT03116698|17287996|P4|Overall Study|Adverse Event|0
5024735|NCT03116698|17287997|P3|Overall Study|Adverse Event|1
5024736|NCT03116698|17287998|P2|Overall Study|Adverse Event|1
5024737|NCT03116698|17287999|P1|Overall Study|Adverse Event|1
5024738|NCT03115476|17288061|P3|LP0084-1369|Trial terminated by Sponsor|160
5024739|NCT03115476|17288062|P2|LP0084-1369|Trial terminated by Sponsor|210
5024740|NCT03115476|17288063|P1|LP0084-1369|Trial terminated by Sponsor|190
5024741|NCT03115476|17288061|P3|LP0084-1369|Death|2
5024742|NCT03115476|17288062|P2|LP0084-1369|Death|0
5024743|NCT03115476|17288063|P1|LP0084-1369|Death|1
5024744|NCT03114969|17288112|P9|Overall Study|Adverse Event|2
5024745|NCT03114969|17288113|P8|Overall Study|Adverse Event|0
5024746|NCT03114969|17288114|P7|Overall Study|Adverse Event|1
5024747|NCT03114969|17288115|P6|Overall Study|Adverse Event|1
5024748|NCT03114969|17288116|P5|Overall Study|Adverse Event|0
5024749|NCT03114969|17288117|P4|Overall Study|Adverse Event|0
5024750|NCT03114969|17288118|P3|Overall Study|Adverse Event|1
5024751|NCT03114969|17288119|P2|Overall Study|Adverse Event|0
5024752|NCT03114969|17288120|P1|Overall Study|Adverse Event|0
5024753|NCT03114969|17288112|P9|Overall Study|Lost to Follow-up|0
5024754|NCT03114969|17288113|P8|Overall Study|Lost to Follow-up|0
5024755|NCT03114969|17288114|P7|Overall Study|Lost to Follow-up|0
5024756|NCT03114969|17288115|P6|Overall Study|Lost to Follow-up|0
5024757|NCT03114969|17288116|P5|Overall Study|Lost to Follow-up|0
5024758|NCT03114969|17288117|P4|Overall Study|Lost to Follow-up|2
5024759|NCT03114969|17288118|P3|Overall Study|Lost to Follow-up|3
5024760|NCT03114969|17288119|P2|Overall Study|Lost to Follow-up|0
5024761|NCT03114969|17288120|P1|Overall Study|Lost to Follow-up|0
5024762|NCT03114657|17288217|P2|Overall Study|Withdrawal by Subject|22
5024763|NCT03114657|17288218|P1|Overall Study|Withdrawal by Subject|28
5024764|NCT03114657|17288217|P2|Overall Study|Symptomatic Deterioration|1
5024765|NCT03114657|17288218|P1|Overall Study|Symptomatic Deterioration|0
5024766|NCT03114657|17288217|P2|Overall Study|Study Terminated By Sponsor|374
5024767|NCT03114657|17288218|P1|Overall Study|Study Terminated By Sponsor|355
5024768|NCT03114657|17288217|P2|Overall Study|Physician Decision|2
5024769|NCT03114657|17288218|P1|Overall Study|Physician Decision|2
5024770|NCT03114657|17288217|P2|Overall Study|Multiple Reasons|2
5024771|NCT03114657|17288218|P1|Overall Study|Multiple Reasons|1
5024772|NCT03114657|17288217|P2|Overall Study|Death|0
5024773|NCT03114657|17288218|P1|Overall Study|Death|4
5024774|NCT03114657|17288217|P2|Overall Study|Adverse Event|6
5024775|NCT03114657|17288218|P1|Overall Study|Adverse Event|9
5024776|NCT03114488|17288263|P2|Time Period 2|Withdrawal by Subject|3
5024777|NCT03114488|17288264|P1|Time Period 2|Withdrawal by Subject|1
5024778|NCT03113916|17288276|P2|Overall Study|Lost to Follow-up|2
5024779|NCT03113916|17288277|P1|Overall Study|Lost to Follow-up|1
5024780|NCT03113916|17288276|P2|Overall Study|Pregnancy|3
5024781|NCT03113916|17288277|P1|Overall Study|Pregnancy|1
5024782|NCT03113916|17288276|P2|Overall Study|Withdrawal by Subject|7
5024783|NCT03113916|17288277|P1|Overall Study|Withdrawal by Subject|9
5024784|NCT03111108|17288374|P2|Overall Study|Withdrawal by Subject|0
5024785|NCT03111108|17288375|P1|Overall Study|Withdrawal by Subject|1
5024786|NCT03111108|17288374|P2|Overall Study|Death|1
5024787|NCT03111108|17288375|P1|Overall Study|Death|0
5024788|NCT03110900|17288393|P2|Overall Study|Sponsor withdrew|1
5024789|NCT03110900|17288394|P1|Overall Study|Sponsor withdrew|1
5024790|NCT03110380|17288461|P2|Overall Study|Lost to Follow-up|1
5024791|NCT03110380|17288462|P1|Overall Study|Lost to Follow-up|4
5024792|NCT03110380|17288461|P2|Overall Study|Withdrew Consent|16
5024793|NCT03110380|17288462|P1|Overall Study|Withdrew Consent|9
5024794|NCT03110380|17288461|P2|Overall Study|Protocol Violation|1
5024795|NCT03110380|17288462|P1|Overall Study|Protocol Violation|0
5024796|NCT03110380|17288461|P2|Overall Study|Non-Compliance with Study Drug|1
5024797|NCT03110380|17288462|P1|Overall Study|Non-Compliance with Study Drug|1
5024798|NCT03110380|17288461|P2|Overall Study|Investigator's Discretion|2
5024799|NCT03110380|17288462|P1|Overall Study|Investigator's Discretion|1
5024800|NCT03110380|17288461|P2|Overall Study|Death|1
5024801|NCT03110380|17288462|P1|Overall Study|Death|2
5024802|NCT03110380|17288461|P2|Overall Study|Adverse Event|3
5024803|NCT03110380|17288462|P1|Overall Study|Adverse Event|3
5024804|NCT03110380|17288461|P2|Overall Study|Still in Study|256
5024805|NCT03110380|17288462|P1|Overall Study|Still in Study|264
5024806|NCT03110380|17288461|P2|Overall Study|Randomized and Never Treated|2
5024807|NCT03110380|17288462|P1|Overall Study|Randomized and Never Treated|0
5024808|NCT03110185|17288474|P2|Overall Study|Patient Refusal|1
5024809|NCT03110185|17288475|P1|Overall Study|Patient Refusal|0
5024810|NCT03110185|17288474|P2|Overall Study|MRI Incompatible|0
5024811|NCT03110185|17288475|P1|Overall Study|MRI Incompatible|2
5024812|NCT03110185|17288474|P2|Overall Study|Protocol Violation|4
5024813|NCT03110185|17288475|P1|Overall Study|Protocol Violation|1
5024814|NCT03110185|17288474|P2|Overall Study|Conflict with care|12
5024815|NCT03110185|17288475|P1|Overall Study|Conflict with care|5
5024816|NCT03110185|17288474|P2|Overall Study|Time Constraints|6
5024817|NCT03110185|17288475|P1|Overall Study|Time Constraints|0
5024818|NCT03110185|17288474|P2|Overall Study|Withdrawal by Subject|7
5024819|NCT03110185|17288475|P1|Overall Study|Withdrawal by Subject|2
5024820|NCT03110185|17288474|P2|Overall Study|Death|1
5024821|NCT03110185|17288475|P1|Overall Study|Death|0
5024822|NCT03110159|17288485|P1|Overall Study|Study termination|1
5024823|NCT03110029|17288496|P2|Overall Study|Withdrawal by Subject|1
5024824|NCT03110029|17288497|P1|Overall Study|Withdrawal by Subject|1
5024825|NCT03109184|17288571|P2|Overall Study|Withdrawal by Subject|1
5024826|NCT03109184|17288572|P1|Overall Study|Withdrawal by Subject|1
5024827|NCT03109184|17288571|P2|Overall Study|Lost to Follow-up|6
5024828|NCT03109184|17288572|P1|Overall Study|Lost to Follow-up|6
5024829|NCT03108521|17288693|P2|Overall Study|Adverse Event|0
5024830|NCT03108521|17288694|P1|Overall Study|Adverse Event|3
5024831|NCT03108521|17288693|P2|Overall Study|Physician Decision|0
5024832|NCT03108521|17288694|P1|Overall Study|Physician Decision|4
5024833|NCT03108521|17288693|P2|Overall Study|Lack of Efficacy|0
5024834|NCT03108521|17288694|P1|Overall Study|Lack of Efficacy|2
5024835|NCT03108521|17288693|P2|Overall Study|Lost to Follow-up|0
5024836|NCT03108521|17288694|P1|Overall Study|Lost to Follow-up|3
5024837|NCT03108157|17288746|P2|Overall Study|Protocol Violation|4
5024838|NCT03108157|17288747|P1|Overall Study|Protocol Violation|15
5024839|NCT03108027|17288757|P6|Period 3|Adverse Event|0
5024840|NCT03108027|17288758|P5|Period 3|Adverse Event|0
5024841|NCT03108027|17288759|P4|Period 3|Adverse Event|0
5024842|NCT03108027|17288760|P3|Period 3|Adverse Event|0
5024843|NCT03108027|17288761|P2|Period 3|Adverse Event|1
5024844|NCT03108027|17288762|P1|Period 3|Adverse Event|0
5024845|NCT03108027|17288757|P6|Period 1|Subject/Guardian Decision|0
5024846|NCT03108027|17288758|P5|Period 1|Subject/Guardian Decision|0
5024847|NCT03108027|17288759|P4|Period 1|Subject/Guardian Decision|2
5024848|NCT03108027|17288760|P3|Period 1|Subject/Guardian Decision|0
5024849|NCT03108027|17288761|P2|Period 1|Subject/Guardian Decision|0
5024850|NCT03108027|17288762|P1|Period 1|Subject/Guardian Decision|0
5024851|NCT03107715|17288789|P2|Overall Study|infant stillborn|1
5024852|NCT03107715|17288790|P1|Overall Study|infant stillborn|0
5024853|NCT03107715|17288789|P2|Overall Study|did not deliver at the home hospital|6
5024854|NCT03107715|17288790|P1|Overall Study|did not deliver at the home hospital|4
5024855|NCT03107611|17288805|P3|Overall Study|Worsening signs/symptoms|2
5024856|NCT03107611|17288806|P2|Overall Study|Worsening signs/symptoms|1
5024857|NCT03107611|17288807|P1|Overall Study|Worsening signs/symptoms|2
5024858|NCT03107611|17288805|P3|Overall Study|Withdrawal by Subject|1
5024859|NCT03107611|17288806|P2|Overall Study|Withdrawal by Subject|0
5024860|NCT03107611|17288807|P1|Overall Study|Withdrawal by Subject|1
5024861|NCT03107611|17288805|P3|Overall Study|Protocol Violation|1
5024862|NCT03107611|17288806|P2|Overall Study|Protocol Violation|0
5024863|NCT03107611|17288807|P1|Overall Study|Protocol Violation|0
5024864|NCT03107611|17288805|P3|Overall Study|Lost to Follow-up|3
5024865|NCT03107611|17288806|P2|Overall Study|Lost to Follow-up|3
5024866|NCT03107611|17288807|P1|Overall Study|Lost to Follow-up|3
5024867|NCT03107611|17288805|P3|Overall Study|Adverse Event|2
5024868|NCT03107611|17288806|P2|Overall Study|Adverse Event|0
5024869|NCT03107611|17288807|P1|Overall Study|Adverse Event|1
5024870|NCT03107377|17288826|P2|Overall Study|Other reason not specified|15
5024871|NCT03107377|17288827|P1|Overall Study|Other reason not specified|16
5024872|NCT03107377|17288826|P2|Overall Study|Lost to Follow-up|34
5024873|NCT03107377|17288827|P1|Overall Study|Lost to Follow-up|37
5024874|NCT03107377|17288826|P2|Overall Study|Withdrawal by Subject|22
5024875|NCT03107377|17288827|P1|Overall Study|Withdrawal by Subject|16
5024876|NCT03107377|17288826|P2|Overall Study|Pregnancy|7
5024877|NCT03107377|17288827|P1|Overall Study|Pregnancy|7
5024878|NCT03107377|17288826|P2|Overall Study|Physician Decision|6
5024879|NCT03107377|17288827|P1|Overall Study|Physician Decision|3
5024880|NCT03107377|17288826|P2|Overall Study|Protocol Violation|12
5024881|NCT03107377|17288827|P1|Overall Study|Protocol Violation|9
5024882|NCT03107377|17288826|P2|Overall Study|Adverse Event|3
5024883|NCT03107377|17288827|P1|Overall Study|Adverse Event|3
5024884|NCT03107052|17288852|P3|Overall Study|Study terminated due to futility|23
5024885|NCT03107052|17288853|P2|Overall Study|Study terminated due to futility|31
5024886|NCT03107052|17288854|P1|Overall Study|Study terminated due to futility|67
5024887|NCT03107052|17288852|P3|Overall Study|Other than specified|0
5024888|NCT03107052|17288853|P2|Overall Study|Other than specified|2
5024889|NCT03107052|17288854|P1|Overall Study|Other than specified|4
5024890|NCT03107052|17288852|P3|Overall Study|Lack of Efficacy|4
5024891|NCT03107052|17288853|P2|Overall Study|Lack of Efficacy|7
5024892|NCT03107052|17288854|P1|Overall Study|Lack of Efficacy|23
5024893|NCT03107052|17288852|P3|Overall Study|Lost to Follow-up|1
5024894|NCT03107052|17288853|P2|Overall Study|Lost to Follow-up|0
5024895|NCT03107052|17288854|P1|Overall Study|Lost to Follow-up|4
5024896|NCT03107052|17288852|P3|Overall Study|Protocol Violation|3
5024897|NCT03107052|17288853|P2|Overall Study|Protocol Violation|0
5024898|NCT03107052|17288854|P1|Overall Study|Protocol Violation|6
5024899|NCT03107052|17288852|P3|Overall Study|Withdrawal by Subject|8
5024900|NCT03107052|17288853|P2|Overall Study|Withdrawal by Subject|5
5024901|NCT03107052|17288854|P1|Overall Study|Withdrawal by Subject|9
5024902|NCT03107052|17288852|P3|Overall Study|Adverse Event|2
5024903|NCT03107052|17288853|P2|Overall Study|Adverse Event|1
5024904|NCT03107052|17288854|P1|Overall Study|Adverse Event|6
5024905|NCT03107026|17288898|P3|Overall Study|Physician Decision|0
5024906|NCT03107026|17288899|P2|Overall Study|Physician Decision|1
5024907|NCT03107026|17288900|P1|Overall Study|Physician Decision|0
5024908|NCT03107026|17288898|P3|Overall Study|non-compliance with study drug|3
5024909|NCT03107026|17288899|P2|Overall Study|non-compliance with study drug|2
5024910|NCT03107026|17288900|P1|Overall Study|non-compliance with study drug|2
5024911|NCT03107026|17288898|P3|Overall Study|non compliance with study visits|0
5024912|NCT03107026|17288899|P2|Overall Study|non compliance with study visits|2
5024913|NCT03107026|17288900|P1|Overall Study|non compliance with study visits|1
5024914|NCT03107026|17288898|P3|Overall Study|Withdrawal by Subject|17
5024915|NCT03107026|17288899|P2|Overall Study|Withdrawal by Subject|5
5024916|NCT03107026|17288900|P1|Overall Study|Withdrawal by Subject|13
5024917|NCT03107026|17288898|P3|Overall Study|Pregnancy|0
5024918|NCT03107026|17288899|P2|Overall Study|Pregnancy|0
5024919|NCT03107026|17288900|P1|Overall Study|Pregnancy|1
5024920|NCT03107026|17288898|P3|Overall Study|Protocol Violation|0
5024921|NCT03107026|17288899|P2|Overall Study|Protocol Violation|2
5024922|NCT03107026|17288900|P1|Overall Study|Protocol Violation|1
5024923|NCT03107026|17288898|P3|Overall Study|Lost to Follow-up|13
5024924|NCT03107026|17288899|P2|Overall Study|Lost to Follow-up|12
5024925|NCT03107026|17288900|P1|Overall Study|Lost to Follow-up|12
5024926|NCT03107026|17288898|P3|Overall Study|Adverse Event|23
5024927|NCT03107026|17288899|P2|Overall Study|Adverse Event|14
5024928|NCT03107026|17288900|P1|Overall Study|Adverse Event|2
5024929|NCT03106753|17288967|P2|Overall Study|Withdrawal by Subject|1
5024930|NCT03106753|17288968|P1|Overall Study|Withdrawal by Subject|0
5024931|NCT03106077|17289034|P2|Overall Study|Screen Failure|0
5024932|NCT03106077|17289035|P1|Overall Study|Screen Failure|94
5024933|NCT03105362|17289079|P1|Overall Study|Lost to Follow-up|1
5024934|NCT03105362|17289079|P1|Overall Study|Withdrawal by Subject|1
5024935|NCT03105297|17289086|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
5024936|NCT03105297|17289086|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
5024937|NCT03105297|17289086|P1|Baseline Phase (Day 1)|Other|21
5024938|NCT03104816|17289130|P3|Overall Study|Protocol Violation|2
5024939|NCT03104816|17289131|P2|Overall Study|Protocol Violation|0
5024940|NCT03104816|17289132|P1|Overall Study|Protocol Violation|2
5024941|NCT03104816|17289130|P3|Overall Study|Lack of Efficacy|0
5024942|NCT03104816|17289131|P2|Overall Study|Lack of Efficacy|2
5024943|NCT03104816|17289132|P1|Overall Study|Lack of Efficacy|0
5024944|NCT03103919|17289240|P2|Overall Study|Adverse Event|2
5024945|NCT03103919|17289241|P1|Overall Study|Adverse Event|2
5024946|NCT03103906|17289277|P2|Overall Study|Other|0
5024947|NCT03103906|17289278|P1|Overall Study|Other|2
5024948|NCT03103906|17289277|P2|Overall Study|Adverse Event|3
5024949|NCT03103906|17289278|P1|Overall Study|Adverse Event|2
5024950|NCT03103763|17289301|P3|Overall Study|Withdrawal by Subject|2
5024951|NCT03103763|17289302|P2|Overall Study|Withdrawal by Subject|3
5024952|NCT03103763|17289303|P1|Overall Study|Withdrawal by Subject|0
5024953|NCT03103763|17289301|P3|Overall Study|Death|5
5024954|NCT03103763|17289302|P2|Overall Study|Death|5
5024955|NCT03103763|17289303|P1|Overall Study|Death|15
5024956|NCT03103503|17289332|P1|Overall Study|Study Closure|757
5024957|NCT03103503|17289332|P1|Overall Study|Lost to Follow-up|3
5024958|NCT03103503|17289332|P1|Overall Study|Plexa Lead or Pulse Generator Extraction|10
5024959|NCT03103503|17289332|P1|Overall Study|Withdrawal by Subject|10
5024960|NCT03103503|17289332|P1|Overall Study|Physician Decision|57
5024961|NCT03103503|17289332|P1|Overall Study|Death|64
5024962|NCT03103100|17289345|P3|Overall Study|Physician Decision|2
5024963|NCT03103100|17289346|P2|Overall Study|Physician Decision|0
5024964|NCT03103100|17289347|P1|Overall Study|Physician Decision|1
5024965|NCT03103100|17289345|P3|Overall Study|Adverse Event|0
5024966|NCT03103100|17289346|P2|Overall Study|Adverse Event|0
5024967|NCT03103100|17289347|P1|Overall Study|Adverse Event|1
5024968|NCT03102918|17289371|P2|Overall Study|Protocol Violation|0
5024969|NCT03102918|17289372|P1|Overall Study|Protocol Violation|1
5024970|NCT03102762|17289398|P2|Overall Study|Lost to Follow-up|0
5024971|NCT03102762|17289399|P1|Overall Study|Lost to Follow-up|1
5024972|NCT03102710|17289443|P3|Overall Study|Subject unable to attend final session|0
5024973|NCT03102710|17289444|P2|Overall Study|Subject unable to attend final session|1
5024974|NCT03102710|17289445|P1|Overall Study|Subject unable to attend final session|0
5024975|NCT03102710|17289443|P3|Overall Study|Nausea during MRI scan|0
5024976|NCT03102710|17289444|P2|Overall Study|Nausea during MRI scan|1
5024977|NCT03102710|17289445|P1|Overall Study|Nausea during MRI scan|0
5024978|NCT03102710|17289443|P3|Overall Study|Technical issues during final MRI scan|0
5024979|NCT03102710|17289444|P2|Overall Study|Technical issues during final MRI scan|1
5024980|NCT03102710|17289445|P1|Overall Study|Technical issues during final MRI scan|0
5024981|NCT03102710|17289443|P3|Overall Study|Dental metal affected MRI scan quality|0
5024982|NCT03102710|17289444|P2|Overall Study|Dental metal affected MRI scan quality|0
5024983|NCT03102710|17289445|P1|Overall Study|Dental metal affected MRI scan quality|1
5024984|NCT03102034|17289470|P2|Overall Study|Withdrawal by Subject|0
5024985|NCT03102034|17289471|P1|Overall Study|Withdrawal by Subject|1
5024986|NCT03101592|17289500|P3|Overall Study|participant files could not be located|118
5024987|NCT03101592|17289501|P2|Overall Study|participant files could not be located|170
5024988|NCT03101592|17289502|P1|Overall Study|participant files could not be located|111
5024989|NCT03101462|17289521|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
5024990|NCT03101462|17289522|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
5024991|NCT03101371|17289538|P2|Overall Study|Did not meet eligibility criteria|1
5024992|NCT03101371|17289539|P1|Overall Study|Did not meet eligibility criteria|2
5024993|NCT03101371|17289538|P2|Overall Study|Lost to Follow-up|4
5024994|NCT03101371|17289539|P1|Overall Study|Lost to Follow-up|1
5024995|NCT03101371|17289538|P2|Overall Study|Physician Decision|1
5024996|NCT03101371|17289539|P1|Overall Study|Physician Decision|0
5024997|NCT03101293|17289559|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
5024998|NCT03101293|17289560|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
5024999|NCT03101267|17289575|P3|Primary Study Period|Miscellaneous|0
5025000|NCT03101267|17289576|P2|Primary Study Period|Miscellaneous|0
5025001|NCT03101267|17289577|P1|Primary Study Period|Miscellaneous|2
5025002|NCT03101267|17289575|P3|Primary Study Period|Withdrawal by Subject|3
5025003|NCT03101267|17289576|P2|Primary Study Period|Withdrawal by Subject|2
5025004|NCT03101267|17289577|P1|Primary Study Period|Withdrawal by Subject|1
5025005|NCT03101150|17289632|P2|Overall Study|Miscarriage|6
5025006|NCT03101150|17289633|P1|Overall Study|Miscarriage|3
5025007|NCT03101150|17289632|P2|Overall Study|Lost to Follow-up|4
5025008|NCT03101150|17289633|P1|Overall Study|Lost to Follow-up|2
5025009|NCT03101020|17289668|P2|Overall Study|Withdrawal by Subject|2
5025010|NCT03101020|17289669|P1|Overall Study|Withdrawal by Subject|0
5025011|NCT03101020|17289668|P2|Overall Study|Ran over by a car|1
5025012|NCT03101020|17289669|P1|Overall Study|Ran over by a car|0
5025013|NCT03101020|17289668|P2|Overall Study|Lack of time to participate|0
5025014|NCT03101020|17289669|P1|Overall Study|Lack of time to participate|1
5025015|NCT03100942|17289704|P7|Placebo Arm Re-Randomized|Withdrew Consent|1
5025016|NCT03100942|17289705|P6|Placebo Arm Re-Randomized|Withdrew Consent|0
5025017|NCT03100942|17289706|P5|Placebo Arm Re-Randomized|Withdrew Consent|0
5025018|NCT03100942|17289707|P4|Placebo Arm Re-Randomized|Withdrew Consent|0
5025019|NCT03100942|17289708|P3|Placebo Arm Re-Randomized|Withdrew Consent|0
5025020|NCT03100942|17289709|P2|Placebo Arm Re-Randomized|Withdrew Consent|0
5025021|NCT03100942|17289710|P1|Placebo Arm Re-Randomized|Withdrew Consent|0
5025022|NCT03100942|17289704|P7|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5025023|NCT03100942|17289705|P6|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5025024|NCT03100942|17289706|P5|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5025025|NCT03100942|17289707|P4|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
5025026|NCT03100942|17289708|P3|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5025027|NCT03100942|17289709|P2|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5025028|NCT03100942|17289710|P1|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
5025029|NCT03100942|17289704|P7|Randomized Treatment Period|Lost to Follow-up|0
5025030|NCT03100942|17289705|P6|Randomized Treatment Period|Lost to Follow-up|0
5025031|NCT03100942|17289706|P5|Randomized Treatment Period|Lost to Follow-up|0
5025032|NCT03100942|17289707|P4|Randomized Treatment Period|Lost to Follow-up|0
5025033|NCT03100942|17289708|P3|Randomized Treatment Period|Lost to Follow-up|1
5025034|NCT03100942|17289709|P2|Randomized Treatment Period|Lost to Follow-up|0
5025035|NCT03100942|17289710|P1|Randomized Treatment Period|Lost to Follow-up|0
5025036|NCT03100942|17289704|P7|Randomized Treatment Period|Protocol Violation|0
5025037|NCT03100942|17289705|P6|Randomized Treatment Period|Protocol Violation|0
5025038|NCT03100942|17289706|P5|Randomized Treatment Period|Protocol Violation|0
5025039|NCT03100942|17289707|P4|Randomized Treatment Period|Protocol Violation|1
5025040|NCT03100942|17289708|P3|Randomized Treatment Period|Protocol Violation|1
5025041|NCT03100942|17289709|P2|Randomized Treatment Period|Protocol Violation|1
5025042|NCT03100942|17289710|P1|Randomized Treatment Period|Protocol Violation|0
5025043|NCT03100942|17289704|P7|Randomized Treatment Period|Investigator's Discretion|0
5025044|NCT03100942|17289705|P6|Randomized Treatment Period|Investigator's Discretion|0
5025045|NCT03100942|17289706|P5|Randomized Treatment Period|Investigator's Discretion|0
5025046|NCT03100942|17289707|P4|Randomized Treatment Period|Investigator's Discretion|0
5025047|NCT03100942|17289708|P3|Randomized Treatment Period|Investigator's Discretion|0
5025048|NCT03100942|17289709|P2|Randomized Treatment Period|Investigator's Discretion|1
5025049|NCT03100942|17289710|P1|Randomized Treatment Period|Investigator's Discretion|2
5025050|NCT03100942|17289704|P7|Randomized Treatment Period|Adverse Event|0
5025051|NCT03100942|17289705|P6|Randomized Treatment Period|Adverse Event|0
5025052|NCT03100942|17289706|P5|Randomized Treatment Period|Adverse Event|0
5025053|NCT03100942|17289707|P4|Randomized Treatment Period|Adverse Event|0
5025054|NCT03100942|17289708|P3|Randomized Treatment Period|Adverse Event|1
5025055|NCT03100942|17289709|P2|Randomized Treatment Period|Adverse Event|2
5025056|NCT03100942|17289710|P1|Randomized Treatment Period|Adverse Event|5
5025057|NCT03100942|17289704|P7|Randomized Treatment Period|Withdrew Consent|0
5025058|NCT03100942|17289705|P6|Randomized Treatment Period|Withdrew Consent|0
5025059|NCT03100942|17289706|P5|Randomized Treatment Period|Withdrew Consent|0
5025060|NCT03100942|17289707|P4|Randomized Treatment Period|Withdrew Consent|3
5025061|NCT03100942|17289708|P3|Randomized Treatment Period|Withdrew Consent|3
5025062|NCT03100942|17289709|P2|Randomized Treatment Period|Withdrew Consent|5
5025063|NCT03100942|17289710|P1|Randomized Treatment Period|Withdrew Consent|4
5025064|NCT03100838|17289748|P4|Overall Study|Lost to Follow-up|0
5025065|NCT03100838|17289749|P3|Overall Study|Lost to Follow-up|1
5025066|NCT03100838|17289750|P2|Overall Study|Lost to Follow-up|0
5025067|NCT03100838|17289751|P1|Overall Study|Lost to Follow-up|0
5025068|NCT03100838|17289748|P4|Overall Study|Pregnancy|0
5025069|NCT03100838|17289749|P3|Overall Study|Pregnancy|0
5025070|NCT03100838|17289750|P2|Overall Study|Pregnancy|1
5025071|NCT03100838|17289751|P1|Overall Study|Pregnancy|0
5025072|NCT03100838|17289748|P4|Overall Study|Physician Decision|1
5025073|NCT03100838|17289749|P3|Overall Study|Physician Decision|1
5025074|NCT03100838|17289750|P2|Overall Study|Physician Decision|1
5025075|NCT03100838|17289751|P1|Overall Study|Physician Decision|1
5025076|NCT03100838|17289748|P4|Overall Study|Adverse Event|0
5025077|NCT03100838|17289749|P3|Overall Study|Adverse Event|0
5025078|NCT03100838|17289750|P2|Overall Study|Adverse Event|0
5025079|NCT03100838|17289751|P1|Overall Study|Adverse Event|1
5025080|NCT03100825|17289777|P1|Overall Study|Physician Decision|1
5025081|NCT03100825|17289777|P1|Overall Study|Participant/Guardian Decision|7
5025082|NCT03100344|17289804|P4|Overall Study|Lost to Follow-up|1
5025083|NCT03100344|17289805|P3|Overall Study|Lost to Follow-up|1
5025084|NCT03100344|17289806|P2|Overall Study|Lost to Follow-up|1
5025085|NCT03100344|17289807|P1|Overall Study|Lost to Follow-up|1
5025086|NCT03100344|17289804|P4|Overall Study|Withdrawal by Subject|8
5025087|NCT03100344|17289805|P3|Overall Study|Withdrawal by Subject|4
5025088|NCT03100344|17289806|P2|Overall Study|Withdrawal by Subject|7
5025089|NCT03100344|17289807|P1|Overall Study|Withdrawal by Subject|10
5025090|NCT03100344|17289804|P4|Overall Study|Protocol Violation|0
5025091|NCT03100344|17289805|P3|Overall Study|Protocol Violation|0
5025092|NCT03100344|17289806|P2|Overall Study|Protocol Violation|0
5025093|NCT03100344|17289807|P1|Overall Study|Protocol Violation|1
5025094|NCT03100344|17289804|P4|Overall Study|Lack of Efficacy|0
5025095|NCT03100344|17289805|P3|Overall Study|Lack of Efficacy|0
5025096|NCT03100344|17289806|P2|Overall Study|Lack of Efficacy|0
5025097|NCT03100344|17289807|P1|Overall Study|Lack of Efficacy|2
5025098|NCT03100344|17289804|P4|Overall Study|Adverse Event|3
5025099|NCT03100344|17289805|P3|Overall Study|Adverse Event|2
5025100|NCT03100344|17289806|P2|Overall Study|Adverse Event|3
5025101|NCT03100344|17289807|P1|Overall Study|Adverse Event|0
5025102|NCT03100058|17289910|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025103|NCT03100058|17289911|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025104|NCT03100058|17289912|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025105|NCT03100058|17289913|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
5025106|NCT03100058|17289914|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025107|NCT03100058|17289915|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025108|NCT03100058|17289916|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025109|NCT03100058|17289917|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025110|NCT03100058|17289918|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025111|NCT03100058|17289919|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025112|NCT03100058|17289920|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025113|NCT03100058|17289921|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025114|NCT03100058|17289922|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5025115|NCT03100058|17289910|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
5025116|NCT03100058|17289911|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025117|NCT03100058|17289912|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025118|NCT03100058|17289913|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025119|NCT03100058|17289914|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025120|NCT03100058|17289915|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025121|NCT03100058|17289916|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025122|NCT03100058|17289917|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025123|NCT03100058|17289918|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025124|NCT03100058|17289919|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025125|NCT03100058|17289920|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025126|NCT03100058|17289921|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025127|NCT03100058|17289922|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5025128|NCT03100058|17289910|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025129|NCT03100058|17289911|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025130|NCT03100058|17289912|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
5025131|NCT03100058|17289913|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025132|NCT03100058|17289914|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025133|NCT03100058|17289915|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025134|NCT03100058|17289916|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025135|NCT03100058|17289917|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025136|NCT03100058|17289918|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025137|NCT03100058|17289919|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025138|NCT03100058|17289920|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025139|NCT03100058|17289921|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025140|NCT03100058|17289922|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5025141|NCT03100058|17289910|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
5025142|NCT03100058|17289911|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025143|NCT03100058|17289912|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
5025144|NCT03100058|17289913|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
5025145|NCT03100058|17289914|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025146|NCT03100058|17289915|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025147|NCT03100058|17289916|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025148|NCT03100058|17289917|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025149|NCT03100058|17289918|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025150|NCT03100058|17289919|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025151|NCT03100058|17289920|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025152|NCT03100058|17289921|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025153|NCT03100058|17289922|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5025154|NCT03100058|17289910|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025155|NCT03100058|17289911|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
5025156|NCT03100058|17289912|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
5025157|NCT03100058|17289913|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025158|NCT03100058|17289914|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025159|NCT03100058|17289915|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025160|NCT03100058|17289916|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025161|NCT03100058|17289917|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025162|NCT03100058|17289918|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025163|NCT03100058|17289919|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025164|NCT03100058|17289920|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025165|NCT03100058|17289921|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025166|NCT03100058|17289922|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5025167|NCT03100058|17289910|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
5025168|NCT03100058|17289911|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
5025169|NCT03100058|17289912|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
5025170|NCT03100058|17289913|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025171|NCT03100058|17289914|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025172|NCT03100058|17289915|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025173|NCT03100058|17289916|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025174|NCT03100058|17289917|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025175|NCT03100058|17289918|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025176|NCT03100058|17289919|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025177|NCT03100058|17289920|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025178|NCT03100058|17289921|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025179|NCT03100058|17289922|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5025180|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025181|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025182|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025183|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025184|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025185|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025186|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
5025187|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025188|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025189|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025190|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025191|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025192|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5025193|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025194|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025195|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025196|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025197|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025198|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025199|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025200|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025201|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025202|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025203|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025204|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5025205|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
5025206|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
5025207|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
5025208|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
5025209|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
5025210|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
5025211|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
5025212|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
5025213|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
5025214|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
5025215|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
5025216|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
5025217|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
5025218|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
5025219|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025220|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025221|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025222|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025223|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025224|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025225|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
5025226|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025227|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025228|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
5025229|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025230|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025231|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5025232|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025233|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025234|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025235|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025236|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025237|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
5025238|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025239|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025240|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025241|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
5025242|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025243|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025244|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5025245|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025246|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025247|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025248|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025249|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5025250|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025251|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5025252|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025253|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025254|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025255|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5025256|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5025257|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5025258|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025259|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025260|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025261|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025262|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025263|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025264|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5025265|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5025266|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025267|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025268|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5025269|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5025270|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5025271|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5025272|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5025273|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5025274|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5025275|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
5025276|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5025277|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5025278|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5025279|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5025280|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5025281|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
5025282|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5025283|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
5025284|NCT03100058|17289910|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025285|NCT03100058|17289911|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025286|NCT03100058|17289912|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025287|NCT03100058|17289913|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025288|NCT03100058|17289914|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
5025289|NCT03100058|17289915|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
5025290|NCT03100058|17289916|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
5025291|NCT03100058|17289917|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025292|NCT03100058|17289918|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
5025293|NCT03100058|17289919|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
5025294|NCT03100058|17289920|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
5025295|NCT03100058|17289921|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025296|NCT03100058|17289922|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5025297|NCT03099694|17290129|P2|Overall Study|Lost to Follow-up|5
5025298|NCT03099694|17290130|P1|Overall Study|Lost to Follow-up|9
5025299|NCT03099694|17290129|P2|Overall Study|Withdrawal by Subject|13
5025300|NCT03099694|17290130|P1|Overall Study|Withdrawal by Subject|11
5025301|NCT03099538|17290169|P1|Overall Study|Lack of Efficacy|3
5025302|NCT03099187|17290194|P2|Overall Study|Non-compliance with Protocol procedure|2
5025303|NCT03099187|17290195|P1|Overall Study|Non-compliance with Protocol procedure|1
5025304|NCT03099187|17290194|P2|Overall Study|Randomization error|2
5025305|NCT03099187|17290195|P1|Overall Study|Randomization error|0
5025306|NCT03099187|17290194|P2|Overall Study|Symptomatic deterioration|1
5025307|NCT03099187|17290195|P1|Overall Study|Symptomatic deterioration|0
5025308|NCT03099187|17290194|P2|Overall Study|Disease progression|1
5025309|NCT03099187|17290195|P1|Overall Study|Disease progression|0
5025310|NCT03099187|17290194|P2|Overall Study|Non-compliance with study drug|1
5025311|NCT03099187|17290195|P1|Overall Study|Non-compliance with study drug|0
5025312|NCT03099187|17290194|P2|Overall Study|Lung transplantation|3
5025313|NCT03099187|17290195|P1|Overall Study|Lung transplantation|1
5025314|NCT03099187|17290194|P2|Overall Study|Withdrawal by Subject|6
5025315|NCT03099187|17290195|P1|Overall Study|Withdrawal by Subject|11
5025316|NCT03099187|17290194|P2|Overall Study|Physician Decision|2
5025317|NCT03099187|17290195|P1|Overall Study|Physician Decision|2
5025318|NCT03099187|17290194|P2|Overall Study|Lack of Efficacy|0
5025319|NCT03099187|17290195|P1|Overall Study|Lack of Efficacy|1
5025320|NCT03099187|17290194|P2|Overall Study|Death|7
5025321|NCT03099187|17290195|P1|Overall Study|Death|4
5025322|NCT03099187|17290194|P2|Overall Study|Adverse Event|9
5025323|NCT03099187|17290195|P1|Overall Study|Adverse Event|23
5025324|NCT03099161|17290244|P3|Overall Study|Progressive Disease|1
5025325|NCT03099161|17290245|P2|Overall Study|Progressive Disease|4
5025326|NCT03099161|17290246|P1|Overall Study|Progressive Disease|1
5025327|NCT03099161|17290244|P3|Overall Study|Physician Decision|0
5025328|NCT03099161|17290245|P2|Overall Study|Physician Decision|0
5025329|NCT03099161|17290246|P1|Overall Study|Physician Decision|2
5025330|NCT03099161|17290244|P3|Overall Study|Adverse Event|2
5025331|NCT03099161|17290245|P2|Overall Study|Adverse Event|0
5025332|NCT03099161|17290246|P1|Overall Study|Adverse Event|0
5025333|NCT03099096|17290263|P1|Overall Study|Physician Decision|1
5025334|NCT03099096|17290263|P1|Overall Study|Adverse Event|1
5025335|NCT03098979|17290276|P6|Overall Study|Protocol Violation|1
5025336|NCT03098979|17290277|P5|Overall Study|Protocol Violation|0
5025337|NCT03098979|17290278|P4|Overall Study|Protocol Violation|0
5025338|NCT03098979|17290279|P3|Overall Study|Protocol Violation|0
5025339|NCT03098979|17290280|P2|Overall Study|Protocol Violation|0
5025340|NCT03098979|17290281|P1|Overall Study|Protocol Violation|0
5025341|NCT03098979|17290276|P6|Overall Study|Non-compliance|1
5025342|NCT03098979|17290277|P5|Overall Study|Non-compliance|0
5025343|NCT03098979|17290278|P4|Overall Study|Non-compliance|0
5025344|NCT03098979|17290279|P3|Overall Study|Non-compliance|0
5025345|NCT03098979|17290280|P2|Overall Study|Non-compliance|0
5025346|NCT03098979|17290281|P1|Overall Study|Non-compliance|0
5025347|NCT03098979|17290276|P6|Overall Study|Physician Decision|0
5025348|NCT03098979|17290277|P5|Overall Study|Physician Decision|0
5025349|NCT03098979|17290278|P4|Overall Study|Physician Decision|0
5025350|NCT03098979|17290279|P3|Overall Study|Physician Decision|0
5025351|NCT03098979|17290280|P2|Overall Study|Physician Decision|1
5025352|NCT03098979|17290281|P1|Overall Study|Physician Decision|2
5025353|NCT03098979|17290276|P6|Overall Study|Death|0
5025354|NCT03098979|17290277|P5|Overall Study|Death|1
5025355|NCT03098979|17290278|P4|Overall Study|Death|0
5025356|NCT03098979|17290279|P3|Overall Study|Death|2
5025357|NCT03098979|17290280|P2|Overall Study|Death|0
5025358|NCT03098979|17290281|P1|Overall Study|Death|1
5025359|NCT03098979|17290276|P6|Overall Study|Withdrawal by Subject|1
5025360|NCT03098979|17290277|P5|Overall Study|Withdrawal by Subject|2
5025361|NCT03098979|17290278|P4|Overall Study|Withdrawal by Subject|1
5025362|NCT03098979|17290279|P3|Overall Study|Withdrawal by Subject|1
5025363|NCT03098979|17290280|P2|Overall Study|Withdrawal by Subject|1
5025364|NCT03098979|17290281|P1|Overall Study|Withdrawal by Subject|2
5025365|NCT03098979|17290276|P6|Overall Study|Adverse Event|1
5025366|NCT03098979|17290277|P5|Overall Study|Adverse Event|6
5025367|NCT03098979|17290278|P4|Overall Study|Adverse Event|4
5025368|NCT03098979|17290279|P3|Overall Study|Adverse Event|1
5025369|NCT03098979|17290280|P2|Overall Study|Adverse Event|0
5025370|NCT03098979|17290281|P1|Overall Study|Adverse Event|1
5025371|NCT03097861|17290423|P3|Overall Study|Reason not provided|1
5025372|NCT03097861|17290424|P2|Overall Study|Reason not provided|1
5025373|NCT03097861|17290425|P1|Overall Study|Reason not provided|3
5025374|NCT03097861|17290423|P3|Overall Study|Withdrawal by Subject|3
5025375|NCT03097861|17290424|P2|Overall Study|Withdrawal by Subject|5
5025376|NCT03097861|17290425|P1|Overall Study|Withdrawal by Subject|1
5025377|NCT03097861|17290423|P3|Overall Study|Lost to Follow-up|1
5025378|NCT03097861|17290424|P2|Overall Study|Lost to Follow-up|7
5025379|NCT03097861|17290425|P1|Overall Study|Lost to Follow-up|0
5025380|NCT03097861|17290423|P3|Overall Study|Investigator Decision|0
5025381|NCT03097861|17290424|P2|Overall Study|Investigator Decision|1
5025382|NCT03097861|17290425|P1|Overall Study|Investigator Decision|0
5025383|NCT03097861|17290423|P3|Overall Study|Adverse Event|4
5025384|NCT03097861|17290424|P2|Overall Study|Adverse Event|8
5025385|NCT03097861|17290425|P1|Overall Study|Adverse Event|3
5025386|NCT03097614|17290442|P1|Overall Study|Adverse Event|3
5025387|NCT03097289|17290544|P1|Overall Study|Collected platelet product unusable|3
5025388|NCT03097289|17290544|P1|Overall Study|Equipment failure|2
5025389|NCT03097289|17290544|P1|Overall Study|Adverse Event|1
5025390|NCT03097133|17290553|P2|Overall Study|Adverse Event|0
5025391|NCT03097133|17290554|P1|Overall Study|Adverse Event|1
5025392|NCT03097133|17290553|P2|Overall Study|Other|2
5025393|NCT03097133|17290554|P1|Overall Study|Other|3
5025394|NCT03097133|17290553|P2|Overall Study|Discontinued DB, not entered FU Phase|25
5025395|NCT03097133|17290554|P1|Overall Study|Discontinued DB, not entered FU Phase|21
5025396|NCT03097133|17290553|P2|Overall Study|Withdrawal by Subject|5
5025397|NCT03097133|17290554|P1|Overall Study|Withdrawal by Subject|2
5025398|NCT03097133|17290553|P2|Overall Study|Lost to Follow-up|2
5025399|NCT03097133|17290554|P1|Overall Study|Lost to Follow-up|3
5025400|NCT03097029|17290604|P1|Overall Study|Withdrawal by Subject|1
5025401|NCT03096483|17290648|P1|Overall Study|Withdrawal by site|1
5025402|NCT03096314|17290677|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
5025403|NCT03096314|17290678|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
5025404|NCT03095651|17290740|P8|Overall Study|Withdrawal by Subject|0
5025405|NCT03095651|17290741|P7|Overall Study|Withdrawal by Subject|0
5025406|NCT03095651|17290742|P6|Overall Study|Withdrawal by Subject|1
5025407|NCT03095651|17290743|P5|Overall Study|Withdrawal by Subject|0
5025408|NCT03095651|17290744|P4|Overall Study|Withdrawal by Subject|0
5025409|NCT03095651|17290745|P3|Overall Study|Withdrawal by Subject|0
5025410|NCT03095651|17290746|P2|Overall Study|Withdrawal by Subject|0
5025411|NCT03095651|17290747|P1|Overall Study|Withdrawal by Subject|0
5025412|NCT03095651|17290740|P8|Overall Study|Lost to Follow-up|0
5025413|NCT03095651|17290741|P7|Overall Study|Lost to Follow-up|0
5025414|NCT03095651|17290742|P6|Overall Study|Lost to Follow-up|0
5025415|NCT03095651|17290743|P5|Overall Study|Lost to Follow-up|0
5025416|NCT03095651|17290744|P4|Overall Study|Lost to Follow-up|1
5025417|NCT03095651|17290745|P3|Overall Study|Lost to Follow-up|0
5025418|NCT03095651|17290746|P2|Overall Study|Lost to Follow-up|1
5025419|NCT03095651|17290747|P1|Overall Study|Lost to Follow-up|1
5025420|NCT03095599|17291026|P2|Overall Study|Withdrawal prior to vaccination|0
5025421|NCT03095599|17291027|P1|Overall Study|Withdrawal prior to vaccination|1
5025422|NCT03095599|17291026|P2|Overall Study|Lost to Follow-up|0
5025423|NCT03095599|17291027|P1|Overall Study|Lost to Follow-up|1
5025424|NCT03095599|17291026|P2|Overall Study|Withdrawal by Subject|0
5025425|NCT03095599|17291027|P1|Overall Study|Withdrawal by Subject|1
5025426|NCT03095521|17291063|P2|Overall Study|Lost to Follow-up|1
5025427|NCT03095521|17291064|P1|Overall Study|Lost to Follow-up|0
5025428|NCT03095521|17291063|P2|Overall Study|Withdrawal by Subject|1
5025429|NCT03095521|17291064|P1|Overall Study|Withdrawal by Subject|0
5025430|NCT03095508|17291082|P2|Overall Study|Adverse Event|1
5025431|NCT03095508|17291083|P1|Overall Study|Adverse Event|0
5025432|NCT03095027|17291131|P2|Period 2, Second Week of Wear|Adverse Event|0
5025433|NCT03095027|17291132|P1|Period 2, Second Week of Wear|Adverse Event|1
5025434|NCT03094195|17291168|P8|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5025435|NCT03094195|17291169|P7|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5025436|NCT03094195|17291170|P6|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5025437|NCT03094195|17291171|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5025438|NCT03094195|17291172|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5025439|NCT03094195|17291173|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
5025440|NCT03094195|17291174|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
5025441|NCT03094195|17291175|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5025442|NCT03094195|17291168|P8|Double-Blind Treatment Period (DB)|Physician Decision|0
5025443|NCT03094195|17291169|P7|Double-Blind Treatment Period (DB)|Physician Decision|0
5025444|NCT03094195|17291170|P6|Double-Blind Treatment Period (DB)|Physician Decision|0
5025445|NCT03094195|17291171|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
5025446|NCT03094195|17291172|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
5025447|NCT03094195|17291173|P3|Double-Blind Treatment Period (DB)|Physician Decision|1
5025448|NCT03094195|17291174|P2|Double-Blind Treatment Period (DB)|Physician Decision|0
5025449|NCT03094195|17291175|P1|Double-Blind Treatment Period (DB)|Physician Decision|0
5025450|NCT03094195|17291168|P8|Double-Blind Treatment Period (DB)|Adverse Event|0
5025451|NCT03094195|17291169|P7|Double-Blind Treatment Period (DB)|Adverse Event|0
5025452|NCT03094195|17291170|P6|Double-Blind Treatment Period (DB)|Adverse Event|0
5025453|NCT03094195|17291171|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
5025454|NCT03094195|17291172|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
5025455|NCT03094195|17291173|P3|Double-Blind Treatment Period (DB)|Adverse Event|1
5025456|NCT03094195|17291174|P2|Double-Blind Treatment Period (DB)|Adverse Event|2
5025457|NCT03094195|17291175|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
5025458|NCT03094195|17291168|P8|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5025459|NCT03094195|17291169|P7|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5025460|NCT03094195|17291170|P6|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5025461|NCT03094195|17291171|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5025462|NCT03094195|17291172|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5025463|NCT03094195|17291173|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
5025464|NCT03094195|17291174|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
5025465|NCT03094195|17291175|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
5025466|NCT03093415|17291224|P3|Enrollment to SVR12 Results|Lost to Follow-up|3
5025467|NCT03093415|17291225|P2|Enrollment to SVR12 Results|Lost to Follow-up|8
5025468|NCT03093415|17291226|P1|Enrollment to SVR12 Results|Lost to Follow-up|1
5025547|NCT03092791|17291371|P6|Overall Study|Withdrawal of Consent|12
5025469|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
5025470|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
5025471|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
5025472|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
5025473|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
5025474|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
5025475|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
5025476|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
5025477|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
5025478|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
5025479|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
5025480|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
5025481|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
5025482|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
5025483|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
5025484|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
5025485|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
5025486|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
5025487|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
5025488|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
5025489|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
5025490|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
5025491|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
5025492|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
5025493|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
5025494|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
5025495|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
5025496|NCT03093415|17291224|P3|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
5025497|NCT03093415|17291225|P2|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
5025498|NCT03093415|17291226|P1|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
5025499|NCT03093350|17291249|P1|Overall Study|Signed consent, never began treartment|1
5025500|NCT03093350|17291249|P1|Overall Study|Death|1
5025501|NCT03093324|17291257|P2|Overall Study|Withdrawal by Subject|2
5025502|NCT03093324|17291258|P1|Overall Study|Withdrawal by Subject|2
5025503|NCT03093324|17291257|P2|Overall Study|Protocol Deviation|2
5025504|NCT03093324|17291258|P1|Overall Study|Protocol Deviation|2
5025505|NCT03093324|17291257|P2|Overall Study|Lost to Follow-up|0
5025506|NCT03093324|17291258|P1|Overall Study|Lost to Follow-up|1
5025507|NCT03093324|17291257|P2|Overall Study|Adverse Event|15
5025508|NCT03093324|17291258|P1|Overall Study|Adverse Event|4
5025509|NCT03093181|17291305|P3|Overall Study|Other (Protocol violation)|1
5025510|NCT03093181|17291306|P2|Overall Study|Other (Protocol violation)|0
5025511|NCT03093181|17291307|P1|Overall Study|Other (Protocol violation)|0
5025512|NCT03093181|17291305|P3|Overall Study|Adverse Event|0
5025513|NCT03093181|17291306|P2|Overall Study|Adverse Event|1
5025514|NCT03093181|17291307|P1|Overall Study|Adverse Event|0
5025515|NCT03093181|17291305|P3|Overall Study|Other (Not specified)|0
5025516|NCT03093181|17291306|P2|Overall Study|Other (Not specified)|0
5025517|NCT03093181|17291307|P1|Overall Study|Other (Not specified)|1
5025518|NCT03093181|17291305|P3|Overall Study|Withdrawal by Subject|2
5025519|NCT03093181|17291306|P2|Overall Study|Withdrawal by Subject|1
5025520|NCT03093181|17291307|P1|Overall Study|Withdrawal by Subject|2
5025521|NCT03092791|17291369|P8|Overall Study|Reason Not Specified|0
5025522|NCT03092791|17291370|P7|Overall Study|Reason Not Specified|0
5025523|NCT03092791|17291371|P6|Overall Study|Reason Not Specified|1
5025524|NCT03092791|17291372|P5|Overall Study|Reason Not Specified|1
5025525|NCT03092791|17291373|P4|Overall Study|Reason Not Specified|0
5025526|NCT03092791|17291374|P3|Overall Study|Reason Not Specified|0
5025527|NCT03092791|17291375|P2|Overall Study|Reason Not Specified|0
5025528|NCT03092791|17291376|P1|Overall Study|Reason Not Specified|0
5025529|NCT03092791|17291369|P8|Overall Study|Death|1
5025530|NCT03092791|17291370|P7|Overall Study|Death|0
5025531|NCT03092791|17291371|P6|Overall Study|Death|1
5025532|NCT03092791|17291372|P5|Overall Study|Death|0
5025533|NCT03092791|17291373|P4|Overall Study|Death|0
5025534|NCT03092791|17291374|P3|Overall Study|Death|0
5025535|NCT03092791|17291375|P2|Overall Study|Death|0
5025536|NCT03092791|17291376|P1|Overall Study|Death|0
5025537|NCT03092791|17291369|P8|Overall Study|Study Termination|55
5025538|NCT03092791|17291370|P7|Overall Study|Study Termination|53
5025539|NCT03092791|17291371|P6|Overall Study|Study Termination|46
5025540|NCT03092791|17291372|P5|Overall Study|Study Termination|55
5025541|NCT03092791|17291373|P4|Overall Study|Study Termination|0
5025542|NCT03092791|17291374|P3|Overall Study|Study Termination|0
5025543|NCT03092791|17291375|P2|Overall Study|Study Termination|0
5025544|NCT03092791|17291376|P1|Overall Study|Study Termination|0
5025545|NCT03092791|17291369|P8|Overall Study|Withdrawal of Consent|4
5025546|NCT03092791|17291370|P7|Overall Study|Withdrawal of Consent|6
5025548|NCT03092791|17291372|P5|Overall Study|Withdrawal of Consent|4
5025549|NCT03092791|17291373|P4|Overall Study|Withdrawal of Consent|0
5025550|NCT03092791|17291374|P3|Overall Study|Withdrawal of Consent|0
5025551|NCT03092791|17291375|P2|Overall Study|Withdrawal of Consent|0
5025552|NCT03092791|17291376|P1|Overall Study|Withdrawal of Consent|0
5025553|NCT03092791|17291369|P8|Overall Study|Lost to Follow-up|0
5025554|NCT03092791|17291370|P7|Overall Study|Lost to Follow-up|1
5025555|NCT03092791|17291371|P6|Overall Study|Lost to Follow-up|0
5025556|NCT03092791|17291372|P5|Overall Study|Lost to Follow-up|0
5025557|NCT03092791|17291373|P4|Overall Study|Lost to Follow-up|0
5025558|NCT03092791|17291374|P3|Overall Study|Lost to Follow-up|0
5025559|NCT03092791|17291375|P2|Overall Study|Lost to Follow-up|0
5025560|NCT03092791|17291376|P1|Overall Study|Lost to Follow-up|0
5025561|NCT03092752|17291491|P1|Overall Study|<6 month history|245900
5025562|NCT03092752|17291491|P1|Overall Study|Average hospital visit interval >92 days|10779
5025563|NCT03092752|17291491|P1|Overall Study|Having no claim of study drugs|29282
5025564|NCT03092752|17291491|P1|Overall Study|At least one claim with T2DM|61299
5025565|NCT03092752|17291491|P1|Overall Study|Aged <40 years|14209
5025566|NCT03092726|17291556|P2|Overall Study|Withdrawal by Subject|3
5025567|NCT03092726|17291557|P1|Overall Study|Withdrawal by Subject|5
5025568|NCT03092726|17291556|P2|Overall Study|Lost to Follow-up|0
5025569|NCT03092726|17291557|P1|Overall Study|Lost to Follow-up|1
5025570|NCT03092726|17291556|P2|Overall Study|Lack of Efficacy|1
5025571|NCT03092726|17291557|P1|Overall Study|Lack of Efficacy|0
5025572|NCT03092726|17291556|P2|Overall Study|Adverse Event|10
5025573|NCT03092726|17291557|P1|Overall Study|Adverse Event|3
5025574|NCT03092479|17291583|P2|Overall Study|Withdrawal by Subject|0
5025575|NCT03092479|17291584|P1|Overall Study|Withdrawal by Subject|4
5025576|NCT03092479|17291583|P2|Overall Study|Lost to Follow-up|2
5025577|NCT03092479|17291584|P1|Overall Study|Lost to Follow-up|3
5025578|NCT03092375|17291606|P4|Overall Study|Lack of Efficacy|0
5025579|NCT03092375|17291607|P3|Overall Study|Lack of Efficacy|1
5025580|NCT03092375|17291608|P2|Overall Study|Lack of Efficacy|1
5025581|NCT03092375|17291609|P1|Overall Study|Lack of Efficacy|0
5025582|NCT03092219|17291637|P2|Overall Study|Protocol Violation|4
5025583|NCT03092219|17291638|P1|Overall Study|Protocol Violation|7
5025584|NCT03091920|17291682|P3|Overall Study|Adverse Event|0
5025585|NCT03091920|17291683|P2|Overall Study|Adverse Event|1
5025586|NCT03091920|17291684|P1|Overall Study|Adverse Event|0
5025587|NCT03091777|17291831|P3|Overall Study|Abnormal Laboratory Value|12
5025588|NCT03091777|17291832|P2|Overall Study|Abnormal Laboratory Value|11
5025589|NCT03091777|17291833|P1|Overall Study|Abnormal Laboratory Value|7
5025590|NCT03091777|17291831|P3|Overall Study|Physician Decision|1
5025591|NCT03091777|17291832|P2|Overall Study|Physician Decision|0
5025592|NCT03091777|17291833|P1|Overall Study|Physician Decision|1
5025593|NCT03091777|17291831|P3|Overall Study|Noncompliance with study drug|1
5025594|NCT03091777|17291832|P2|Overall Study|Noncompliance with study drug|3
5025595|NCT03091777|17291833|P1|Overall Study|Noncompliance with study drug|2
5025596|NCT03091777|17291831|P3|Overall Study|Lack of Efficacy|5
5025597|NCT03091777|17291832|P2|Overall Study|Lack of Efficacy|0
5025598|NCT03091777|17291833|P1|Overall Study|Lack of Efficacy|0
5025599|NCT03091777|17291831|P3|Overall Study|Lost to Follow-up|7
5025600|NCT03091777|17291832|P2|Overall Study|Lost to Follow-up|14
5025601|NCT03091777|17291833|P1|Overall Study|Lost to Follow-up|12
5025602|NCT03091777|17291831|P3|Overall Study|Protocol Violation|1
5025603|NCT03091777|17291832|P2|Overall Study|Protocol Violation|1
5025604|NCT03091777|17291833|P1|Overall Study|Protocol Violation|2
5025605|NCT03091777|17291831|P3|Overall Study|Withdrawal by Subject|6
5025606|NCT03091777|17291832|P2|Overall Study|Withdrawal by Subject|2
5025607|NCT03091777|17291833|P1|Overall Study|Withdrawal by Subject|4
5025608|NCT03091777|17291831|P3|Overall Study|Adverse Event|4
5025609|NCT03091777|17291832|P2|Overall Study|Adverse Event|1
5025610|NCT03091777|17291833|P1|Overall Study|Adverse Event|2
5025611|NCT03091777|17291831|P3|Overall Study|Pregnancy|0
5025612|NCT03091777|17291832|P2|Overall Study|Pregnancy|1
5025613|NCT03091777|17291833|P1|Overall Study|Pregnancy|2
5025614|NCT03091439|17291875|P2|Overall Study|Study Terminated by the Sponsor|0
5025615|NCT03091439|17291876|P1|Overall Study|Study Terminated by the Sponsor|1
5025616|NCT03091400|17291900|P2|Washout - 2 Weeks|Withdrawal by Subject|0
5025617|NCT03091400|17291901|P1|Washout - 2 Weeks|Withdrawal by Subject|1
5025618|NCT03091348|17291923|P2|Overall Study|Lost to Follow-up|1
5025619|NCT03091348|17291924|P1|Overall Study|Lost to Follow-up|2
5025620|NCT03091192|17291950|P2|Overall Study|Lost to Follow-up|0
5025621|NCT03091192|17291951|P1|Overall Study|Lost to Follow-up|1
5025622|NCT03091192|17291950|P2|Overall Study|Withdrawal by Subject|0
5025623|NCT03091192|17291951|P1|Overall Study|Withdrawal by Subject|2
5025624|NCT03091192|17291950|P2|Overall Study|Death|13
5025625|NCT03091192|17291951|P1|Overall Study|Death|9
5025626|NCT03091192|17291950|P2|Overall Study|Study terminated by sponsor|14
5025627|NCT03091192|17291951|P1|Overall Study|Study terminated by sponsor|21
5025628|NCT03090100|17292019|P2|Overall Study|Other|2
5025629|NCT03090100|17292020|P1|Overall Study|Other|2
5025630|NCT03090100|17292019|P2|Overall Study|Non-compliance|0
5025631|NCT03090100|17292020|P1|Overall Study|Non-compliance|2
5025632|NCT03090100|17292019|P2|Overall Study|Protocol Violation|6
5025633|NCT03090100|17292020|P1|Overall Study|Protocol Violation|2
5025634|NCT03090100|17292019|P2|Overall Study|Withdrawal by Subject|19
5025635|NCT03090100|17292020|P1|Overall Study|Withdrawal by Subject|7
5025636|NCT03090100|17292019|P2|Overall Study|Lost to Follow-up|2
5025637|NCT03090100|17292020|P1|Overall Study|Lost to Follow-up|2
5025638|NCT03090100|17292019|P2|Overall Study|Lack of Efficacy|7
5025639|NCT03090100|17292020|P1|Overall Study|Lack of Efficacy|2
5025640|NCT03090100|17292019|P2|Overall Study|Pregnancy|1
5025641|NCT03090100|17292020|P1|Overall Study|Pregnancy|1
5025642|NCT03090100|17292019|P2|Overall Study|Adverse Event|11
5025643|NCT03090100|17292020|P1|Overall Study|Adverse Event|9
5025644|NCT03089944|17292060|P1|Overall Study|Other|1
5025645|NCT03089944|17292060|P1|Overall Study|Adverse Event|1
5025646|NCT03089944|17292060|P1|Overall Study|Withdrew Consent|2
5025647|NCT03089944|17292060|P1|Overall Study|Lost to Follow-up|8
5025648|NCT03089853|17292107|P2|Overall Study|Lost to Follow-up|1
5025649|NCT03089853|17292108|P1|Overall Study|Lost to Follow-up|2
5025650|NCT03089580|17292130|P1|Overall Study|Lost to Follow-up|2
5025651|NCT03089216|17292141|P4|Overall Study|Adverse Event|1
5025652|NCT03089216|17292142|P3|Overall Study|Adverse Event|0
5025653|NCT03089216|17292143|P2|Overall Study|Adverse Event|0
5025654|NCT03089216|17292144|P1|Overall Study|Adverse Event|0
5025655|NCT03088917|17292158|P1|Overall Study|Moved outside study region|50
5025656|NCT03088917|17292158|P1|Overall Study|Severe comorbidity/short life expectancy|5
5025657|NCT03088917|17292158|P1|Overall Study|Contact not established|13
5025658|NCT03088917|17292158|P1|Overall Study|Refuse re-evaluation|13
5025659|NCT03088917|17292158|P1|Overall Study|In care/cured elsewhere|15
5025660|NCT03087643|17292228|P2|Overall Study|Death|2
5025661|NCT03087643|17292229|P1|Overall Study|Death|2
5025662|NCT03087643|17292228|P2|Overall Study|Withdrawal by Subject|4
5025663|NCT03087643|17292229|P1|Overall Study|Withdrawal by Subject|2
5025664|NCT03087513|17292256|P1|Second Intervention After 3 hr Washout|Equipment malfunction|2
5025665|NCT03086551|17292303|P2|Washout|Withdrawal by Subject|1
5025666|NCT03086551|17292304|P1|Washout|Withdrawal by Subject|2
5025667|NCT03086551|17292303|P2|Washout|Lost to Follow-up|2
5025668|NCT03086551|17292304|P1|Washout|Lost to Follow-up|1
5025669|NCT03086551|17292303|P2|First Intervention|Lost to Follow-up|1
5025670|NCT03086551|17292304|P1|First Intervention|Lost to Follow-up|0
5025671|NCT03086551|17292303|P2|First Intervention|Failure to meet inclusion criterion|0
5025672|NCT03086551|17292304|P1|First Intervention|Failure to meet inclusion criterion|1
5025673|NCT03086447|17292320|P2|Overall Study|Lens Discomfort|1
5025674|NCT03086447|17292321|P1|Overall Study|Lens Discomfort|2
5025675|NCT03086447|17292320|P2|Overall Study|Adverse Event|0
5025676|NCT03086447|17292321|P1|Overall Study|Adverse Event|3
5025677|NCT03086447|17292320|P2|Overall Study|Lost to Follow-up|1
5025678|NCT03086447|17292321|P1|Overall Study|Lost to Follow-up|0
5025679|NCT03086447|17292320|P2|Overall Study|Protocol Violation|4
5025680|NCT03086447|17292321|P1|Overall Study|Protocol Violation|2
5025681|NCT03086447|17292320|P2|Overall Study|Test Article No Longer Available|0
5025682|NCT03086447|17292321|P1|Overall Study|Test Article No Longer Available|1
5025683|NCT03086447|17292320|P2|Overall Study|Unsatisfactory Lens Fitting|1
5025684|NCT03086447|17292321|P1|Overall Study|Unsatisfactory Lens Fitting|0
5025685|NCT03086447|17292320|P2|Overall Study|Lens Damage|6
5025686|NCT03086447|17292321|P1|Overall Study|Lens Damage|1
5025687|NCT03086447|17292320|P2|Overall Study|Product quality complaint|1
5025688|NCT03086447|17292321|P1|Overall Study|Product quality complaint|0
5025689|NCT03086447|17292320|P2|Overall Study|Lost Lens|5
5025690|NCT03086447|17292321|P1|Overall Study|Lost Lens|2
5025691|NCT03086447|17292320|P2|Overall Study|No Longer Meets Eligibility Criteria|1
5025692|NCT03086447|17292321|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5025693|NCT03086343|17292379|P2|Overall Study|Missing|1
5025694|NCT03086343|17292380|P1|Overall Study|Missing|0
5025695|NCT03086343|17292379|P2|Overall Study|Other, not specified|4
5025696|NCT03086343|17292380|P1|Overall Study|Other, not specified|8
5025697|NCT03086343|17292379|P2|Overall Study|Lack of Efficacy|6
5025698|NCT03086343|17292380|P1|Overall Study|Lack of Efficacy|4
5025699|NCT03086343|17292379|P2|Overall Study|Lost to Follow-up|1
5025700|NCT03086343|17292380|P1|Overall Study|Lost to Follow-up|3
5025701|NCT03086343|17292379|P2|Overall Study|Withdrawal by Subject|6
5025702|NCT03086343|17292380|P1|Overall Study|Withdrawal by Subject|10
5025703|NCT03086343|17292379|P2|Overall Study|Adverse Event|7
5025704|NCT03086343|17292380|P1|Overall Study|Adverse Event|7
5025705|NCT03086330|17292392|P2|Overall Study|Lost to Follow-up|2
5025706|NCT03086330|17292393|P1|Overall Study|Lost to Follow-up|1
5025707|NCT03086330|17292392|P2|Overall Study|Withdrawal by Subject|2
5025708|NCT03086330|17292393|P1|Overall Study|Withdrawal by Subject|3
5025709|NCT03086135|17292590|P1|Overall Study|Lost to Follow-up|2
5025710|NCT03086135|17292590|P1|Overall Study|Adverse Event|1
5025711|NCT03086018|17292617|P1|Final Testing for End of Trial|Withdrawal by Subject|1
5025712|NCT03086018|17292617|P1|Final Testing for End of Trial|Adverse Event|1
5025713|NCT03085914|17292632|P7|Overall Study|Ongoing in Trial|3
5025714|NCT03085914|17292633|P6|Overall Study|Ongoing in Trial|3
5025715|NCT03085914|17292634|P5|Overall Study|Ongoing in Trial|4
5025716|NCT03085914|17292635|P4|Overall Study|Ongoing in Trial|3
5025717|NCT03085914|17292636|P3|Overall Study|Ongoing in Trial|5
5025718|NCT03085914|17292637|P2|Overall Study|Ongoing in Trial|0
5025719|NCT03085914|17292638|P1|Overall Study|Ongoing in Trial|1
5025720|NCT03085914|17292632|P7|Overall Study|Other Unspecified|4
5025721|NCT03085914|17292633|P6|Overall Study|Other Unspecified|2
5025722|NCT03085914|17292634|P5|Overall Study|Other Unspecified|2
5025723|NCT03085914|17292635|P4|Overall Study|Other Unspecified|3
5025724|NCT03085914|17292636|P3|Overall Study|Other Unspecified|1
5025725|NCT03085914|17292637|P2|Overall Study|Other Unspecified|2
5025726|NCT03085914|17292638|P1|Overall Study|Other Unspecified|2
5025727|NCT03085914|17292632|P7|Overall Study|Withdrawal by Subject|1
5025728|NCT03085914|17292633|P6|Overall Study|Withdrawal by Subject|0
5025729|NCT03085914|17292634|P5|Overall Study|Withdrawal by Subject|2
5025730|NCT03085914|17292635|P4|Overall Study|Withdrawal by Subject|2
5025731|NCT03085914|17292636|P3|Overall Study|Withdrawal by Subject|0
5025732|NCT03085914|17292637|P2|Overall Study|Withdrawal by Subject|1
5025733|NCT03085914|17292638|P1|Overall Study|Withdrawal by Subject|1
5025734|NCT03085914|17292632|P7|Overall Study|Lost to Follow-up|1
5025735|NCT03085914|17292633|P6|Overall Study|Lost to Follow-up|1
5025736|NCT03085914|17292634|P5|Overall Study|Lost to Follow-up|0
5025737|NCT03085914|17292635|P4|Overall Study|Lost to Follow-up|0
5025738|NCT03085914|17292636|P3|Overall Study|Lost to Follow-up|1
5025739|NCT03085914|17292637|P2|Overall Study|Lost to Follow-up|0
5025740|NCT03085914|17292638|P1|Overall Study|Lost to Follow-up|1
5025741|NCT03085914|17292632|P7|Overall Study|Death|2
5025742|NCT03085914|17292633|P6|Overall Study|Death|2
5025743|NCT03085914|17292634|P5|Overall Study|Death|5
5025744|NCT03085914|17292635|P4|Overall Study|Death|1
5025745|NCT03085914|17292636|P3|Overall Study|Death|4
5025746|NCT03085914|17292637|P2|Overall Study|Death|6
5025747|NCT03085914|17292638|P1|Overall Study|Death|4
5025748|NCT03085238|17292720|P1|Overall Study|Death|2
5025749|NCT03085238|17292720|P1|Overall Study|Adverse Event|2
5025750|NCT03085017|17292747|P2|Overall Study|Death|3
5025751|NCT03085017|17292748|P1|Overall Study|Death|0
5025752|NCT03084315|17292774|P2|Overall Study|Withdrawal by Subject|2
5025753|NCT03084315|17292775|P1|Overall Study|Withdrawal by Subject|2
5025754|NCT03084315|17292774|P2|Overall Study|Lost to Follow-up|7
5025755|NCT03084315|17292775|P1|Overall Study|Lost to Follow-up|8
5025756|NCT03083990|17292785|P2|Overall Study|Adverse Event|0
5025757|NCT03083990|17292786|P1|Overall Study|Adverse Event|1
5025758|NCT03083639|17292868|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
5025759|NCT03083639|17292869|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
5025760|NCT03083639|17292868|P2|Washout Period (at Least 6 Days)|Pregnancy|1
5025761|NCT03083639|17292869|P1|Washout Period (at Least 6 Days)|Pregnancy|0
5025762|NCT03083483|17292882|P3|Overall Study|technological issues|1
5025763|NCT03083483|17292883|P2|Overall Study|technological issues|0
5025764|NCT03083483|17292884|P1|Overall Study|technological issues|1
5025765|NCT03083483|17292882|P3|Overall Study|Lost to Follow-up|1
5025766|NCT03083483|17292883|P2|Overall Study|Lost to Follow-up|1
5025767|NCT03083483|17292884|P1|Overall Study|Lost to Follow-up|2
5025768|NCT03083483|17292882|P3|Overall Study|Adverse Event|1
5025769|NCT03083483|17292883|P2|Overall Study|Adverse Event|1
5025770|NCT03083483|17292884|P1|Overall Study|Adverse Event|1
5025771|NCT03083470|17292903|P5|Overall Study|Withdrawal by Subject|1
5025772|NCT03083470|17292904|P4|Overall Study|Withdrawal by Subject|0
5025773|NCT03083470|17292905|P3|Overall Study|Withdrawal by Subject|0
5025774|NCT03083470|17292906|P2|Overall Study|Withdrawal by Subject|0
5025775|NCT03083470|17292907|P1|Overall Study|Withdrawal by Subject|0
5025776|NCT03083470|17292903|P5|Overall Study|Lost to Follow-up|1
5025777|NCT03083470|17292904|P4|Overall Study|Lost to Follow-up|0
5025778|NCT03083470|17292905|P3|Overall Study|Lost to Follow-up|0
5025779|NCT03083470|17292906|P2|Overall Study|Lost to Follow-up|0
5025780|NCT03083470|17292907|P1|Overall Study|Lost to Follow-up|0
5025781|NCT03082599|17292955|P2|Overall Study|Lost to Follow-up|0
5025782|NCT03082599|17292956|P1|Overall Study|Lost to Follow-up|1
5025783|NCT03080961|17293022|P1|Overall Study|Withdrawal by Subject|3
5025784|NCT03080493|17293033|P2|Overall Study|Randomization error (parity group)|1
5025785|NCT03080493|17293034|P1|Overall Study|Randomization error (parity group)|0
5025786|NCT03080493|17293033|P2|Overall Study|Adverse Event|1
5025787|NCT03080493|17293034|P1|Overall Study|Adverse Event|0
5025788|NCT03080493|17293033|P2|Overall Study|Did not provide NRS pain results|0
5025789|NCT03080493|17293034|P1|Overall Study|Did not provide NRS pain results|1
5025790|NCT03080454|17293050|P1|Anodal FU (7 Days)|Lost to Follow-up|4
5025791|NCT03080454|17293050|P1|Anodal Doublestim (5 Days)|Adverse Event|1
5025792|NCT03080454|17293050|P1|Baseline|Adverse Event|2
5025793|NCT03078816|17293117|P1|Overall Study|Withdrawal by Subject|1
5025794|NCT03078582|17293167|P2|Overall Study|Adverse Event|8
5025795|NCT03078582|17293168|P1|Overall Study|Adverse Event|0
5025796|NCT03078556|17293188|P4|Washout Period 1 (7 Days)|Physician Decision|0
5025797|NCT03078556|17293189|P3|Washout Period 1 (7 Days)|Physician Decision|0
5025798|NCT03078556|17293190|P2|Washout Period 1 (7 Days)|Physician Decision|1
5025799|NCT03078556|17293191|P1|Washout Period 1 (7 Days)|Physician Decision|0
5025800|NCT03078556|17293188|P4|Washout Period 1 (7 Days)|Adverse Event|1
5025801|NCT03078556|17293189|P3|Washout Period 1 (7 Days)|Adverse Event|0
5025802|NCT03078556|17293190|P2|Washout Period 1 (7 Days)|Adverse Event|1
5025803|NCT03078556|17293191|P1|Washout Period 1 (7 Days)|Adverse Event|0
5025804|NCT03078556|17293188|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
5025805|NCT03078556|17293189|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
5025806|NCT03078556|17293190|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
5025807|NCT03078556|17293191|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
5025808|NCT03078556|17293188|P4|Treatment Period 1 (4 Days)|Adverse Event|0
5025809|NCT03078556|17293189|P3|Treatment Period 1 (4 Days)|Adverse Event|0
5025810|NCT03078556|17293190|P2|Treatment Period 1 (4 Days)|Adverse Event|1
5025811|NCT03078556|17293191|P1|Treatment Period 1 (4 Days)|Adverse Event|0
5025812|NCT03078478|17293335|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
5025813|NCT03078478|17293336|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
5025814|NCT03078478|17293335|P2|Maintencance Period 2 (36 Weeks)|Death|6
5025815|NCT03078478|17293336|P1|Maintencance Period 2 (36 Weeks)|Death|4
5025816|NCT03078478|17293335|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
5025817|NCT03078478|17293336|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
5025818|NCT03078478|17293335|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
5025819|NCT03078478|17293336|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
5025820|NCT03078478|17293335|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
5025821|NCT03078478|17293336|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
5025822|NCT03078478|17293335|P2|Maintenance Period 1 (36 Weeks)|Death|3
5025823|NCT03078478|17293336|P1|Maintenance Period 1 (36 Weeks)|Death|3
5025824|NCT03078478|17293335|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
5025825|NCT03078478|17293336|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
5025826|NCT03078478|17293335|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
5025827|NCT03078478|17293336|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
5025828|NCT03077919|17293422|P2|Overall Study|Lost to Follow-up|1
5025829|NCT03077919|17293423|P1|Overall Study|Lost to Follow-up|4
5025830|NCT03077724|17293483|P2|Overall Study|Withdrawal by Subject|1
5025831|NCT03077724|17293484|P1|Overall Study|Withdrawal by Subject|3
5025832|NCT03077724|17293483|P2|Overall Study|Lost to Follow-up|1
5025833|NCT03077724|17293484|P1|Overall Study|Lost to Follow-up|5
5025834|NCT03077711|17293496|P2|Overall Study|noncompliant taking medication|0
5025835|NCT03077711|17293497|P1|Overall Study|noncompliant taking medication|2
5025836|NCT03077711|17293496|P2|Overall Study|Lost to Follow-up|2
5025837|NCT03077711|17293497|P1|Overall Study|Lost to Follow-up|2
5025838|NCT03077659|17293516|P3|Overall Study|Withdrawal by Subject|1
5025839|NCT03077659|17293517|P2|Overall Study|Withdrawal by Subject|0
5025840|NCT03077659|17293518|P1|Overall Study|Withdrawal by Subject|0
5025841|NCT03077607|17293549|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
5025842|NCT03077607|17293550|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
5025843|NCT03077607|17293549|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
5025844|NCT03077607|17293550|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
5025845|NCT03077607|17293549|P2|Period 1 (15 Days)|Death|0
5025846|NCT03077607|17293550|P1|Period 1 (15 Days)|Death|1
5025847|NCT03077607|17293549|P2|Period 1 (15 Days)|Adverse Event|0
5025848|NCT03077607|17293550|P1|Period 1 (15 Days)|Adverse Event|1
5025849|NCT03077438|17293618|P2|Overall Study|Lost to Follow-up|3
5025850|NCT03077438|17293619|P1|Overall Study|Lost to Follow-up|6
5025851|NCT03077438|17293618|P2|Overall Study|Withdrawal by Subject|6
5025852|NCT03077438|17293619|P1|Overall Study|Withdrawal by Subject|3
5025853|NCT03077438|17293618|P2|Overall Study|Protocol Violation|5
5025854|NCT03077438|17293619|P1|Overall Study|Protocol Violation|3
5025855|NCT03076996|17293660|P1|Overall Study|Literacy precluded participation|1
5025856|NCT03076996|17293660|P1|Overall Study|Lost to Follow-up|3
5025857|NCT03076996|17293660|P1|Overall Study|Withdrawal by Subject|2
5025858|NCT03076970|17293686|P6|Period 3|Failure to meet I/E criteria|0
5025859|NCT03076970|17293687|P5|Period 3|Failure to meet I/E criteria|1
5025860|NCT03076970|17293688|P4|Period 3|Failure to meet I/E criteria|0
5025861|NCT03076970|17293689|P3|Period 3|Failure to meet I/E criteria|0
5025862|NCT03076970|17293690|P2|Period 3|Failure to meet I/E criteria|0
5025863|NCT03076970|17293691|P1|Period 3|Failure to meet I/E criteria|0
5025864|NCT03076970|17293686|P6|Period 3|Withdrawal by Subject|1
5025865|NCT03076970|17293687|P5|Period 3|Withdrawal by Subject|0
5025866|NCT03076970|17293688|P4|Period 3|Withdrawal by Subject|0
5025867|NCT03076970|17293689|P3|Period 3|Withdrawal by Subject|0
5025868|NCT03076970|17293690|P2|Period 3|Withdrawal by Subject|0
5025869|NCT03076970|17293691|P1|Period 3|Withdrawal by Subject|0
5025870|NCT03076970|17293686|P6|Washout Period 2|Adverse Event|0
5025871|NCT03076970|17293687|P5|Washout Period 2|Adverse Event|1
5025872|NCT03076970|17293688|P4|Washout Period 2|Adverse Event|0
5025873|NCT03076970|17293689|P3|Washout Period 2|Adverse Event|0
5025874|NCT03076970|17293690|P2|Washout Period 2|Adverse Event|0
5025875|NCT03076970|17293691|P1|Washout Period 2|Adverse Event|0
5025876|NCT03076515|17293743|P2|Overall Study|DMC decision based on interim analysis|29
5025877|NCT03076515|17293744|P1|Overall Study|DMC decision based on interim analysis|25
5025878|NCT03076190|17293763|P2|Overall Study|Excluded from Analysis (zero duration ev|7
5025879|NCT03076190|17293764|P1|Overall Study|Excluded from Analysis (zero duration ev|9
5025880|NCT03076190|17293763|P2|Overall Study|Lost to Follow-up|34
5025881|NCT03076190|17293764|P1|Overall Study|Lost to Follow-up|9
5025882|NCT03075904|17293777|P1|Overall Study|Need for Medication not Permitted|1
5025883|NCT03075904|17293777|P1|Overall Study|Physician Decision|3
5025884|NCT03075891|17293787|P2|Overall Study|Drug abuse relapse issue|1
5025885|NCT03075891|17293788|P1|Overall Study|Drug abuse relapse issue|0
5025886|NCT03075891|17293787|P2|Overall Study|Patient requiring study withdrawal|1
5025887|NCT03075891|17293788|P1|Overall Study|Patient requiring study withdrawal|0
5025888|NCT03075891|17293787|P2|Overall Study|Other visits not performed (no time)|0
5025889|NCT03075891|17293788|P1|Overall Study|Other visits not performed (no time)|1
5025890|NCT03075891|17293787|P2|Overall Study|Pregnancy|1
5025891|NCT03075891|17293788|P1|Overall Study|Pregnancy|3
5025892|NCT03075891|17293787|P2|Overall Study|Lost to Follow-up|0
5025893|NCT03075891|17293788|P1|Overall Study|Lost to Follow-up|1
5025894|NCT03075891|17293787|P2|Overall Study|Withdrawal by Subject|6
5025895|NCT03075891|17293788|P1|Overall Study|Withdrawal by Subject|3
5025896|NCT03075891|17293787|P2|Overall Study|Adverse Event|4
5025897|NCT03075891|17293788|P1|Overall Study|Adverse Event|1
5025898|NCT03075878|17293794|P1|Overall Study|Physician Decision|1
5025899|NCT03075839|17293802|P1|Overall Study|Lost to Follow-up|4
5025900|NCT03075644|17293810|P2|Overall Study|Withdrawal by Subject|1
5025901|NCT03075644|17293811|P1|Overall Study|Withdrawal by Subject|1
5025902|NCT03075527|17293881|P1|Overall Study|Ongoing treatment|2
5025903|NCT03075410|17293905|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025904|NCT03075410|17293906|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025905|NCT03075410|17293907|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025906|NCT03075410|17293908|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025907|NCT03075410|17293909|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025908|NCT03075410|17293910|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025909|NCT03075410|17293911|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025910|NCT03075410|17293912|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5025911|NCT03075410|17293913|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
5025912|NCT03075410|17293905|P9|Part A-Period 2 (14 Days)|Personal reasons|0
5025913|NCT03075410|17293906|P8|Part A-Period 2 (14 Days)|Personal reasons|0
5025914|NCT03075410|17293907|P7|Part A-Period 2 (14 Days)|Personal reasons|0
5025915|NCT03075410|17293908|P6|Part A-Period 2 (14 Days)|Personal reasons|0
5025916|NCT03075410|17293909|P5|Part A-Period 2 (14 Days)|Personal reasons|0
5025917|NCT03075410|17293910|P4|Part A-Period 2 (14 Days)|Personal reasons|0
5025918|NCT03075410|17293911|P3|Part A-Period 2 (14 Days)|Personal reasons|1
5025919|NCT03075410|17293912|P2|Part A-Period 2 (14 Days)|Personal reasons|0
5025920|NCT03075410|17293913|P1|Part A-Period 2 (14 Days)|Personal reasons|1
5025921|NCT03075163|17294079|P2|Overall Study|not eligible for treatment limb|138
5025922|NCT03075163|17294080|P1|Overall Study|not eligible for treatment limb|138
5025923|NCT03074500|17294127|P3|Overall Study|Adverse Event|1
5025924|NCT03074500|17294128|P2|Overall Study|Adverse Event|0
5025925|NCT03074500|17294129|P1|Overall Study|Adverse Event|0
5025926|NCT03074500|17294127|P3|Overall Study|Lack of Efficacy|0
5025927|NCT03074500|17294128|P2|Overall Study|Lack of Efficacy|1
5025928|NCT03074500|17294129|P1|Overall Study|Lack of Efficacy|0
5025929|NCT03074500|17294127|P3|Overall Study|Lost to Follow-up|0
5025930|NCT03074500|17294128|P2|Overall Study|Lost to Follow-up|0
5025931|NCT03074500|17294129|P1|Overall Study|Lost to Follow-up|1
5025932|NCT03074331|17294166|P1|Overall Study|Withdrew Consent|1
5025933|NCT03074331|17294166|P1|Overall Study|Lost to Follow-up|5
5025934|NCT03074331|17294166|P1|Overall Study|Enrolled but Not Treated|1
5025935|NCT03074162|17294178|P6|Period 3|Withdrawal by Subject|0
5025936|NCT03074162|17294179|P5|Period 3|Withdrawal by Subject|1
5025937|NCT03074162|17294180|P4|Period 3|Withdrawal by Subject|0
5025938|NCT03074162|17294181|P3|Period 3|Withdrawal by Subject|0
5025939|NCT03074162|17294182|P2|Period 3|Withdrawal by Subject|0
5025940|NCT03074162|17294183|P1|Period 3|Withdrawal by Subject|1
5025941|NCT03074162|17294178|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
5025942|NCT03074162|17294179|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
5025943|NCT03074162|17294180|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
5025944|NCT03074162|17294181|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
5025945|NCT03074162|17294182|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
5025946|NCT03074162|17294183|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
5025947|NCT03074162|17294178|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
5025948|NCT03074162|17294179|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
5025949|NCT03074162|17294180|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
5025950|NCT03074162|17294181|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
5025951|NCT03074162|17294182|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
5025952|NCT03074162|17294183|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
5025953|NCT03073798|17294245|P1|Overall Study|Withdrawal by Subject|1
5025954|NCT03073798|17294245|P1|Overall Study|Adverse Event|1
5025955|NCT03073213|17294283|P3|Multiple Dose Period|Protocol Violation|1
5025956|NCT03073213|17294284|P2|Multiple Dose Period|Protocol Violation|0
5025957|NCT03073213|17294285|P1|Multiple Dose Period|Protocol Violation|0
5025958|NCT03073200|17294300|P3|Overall Study|Lack of Efficacy|0
5025959|NCT03073200|17294301|P2|Overall Study|Lack of Efficacy|0
5025960|NCT03073200|17294302|P1|Overall Study|Lack of Efficacy|1
5025961|NCT03073200|17294300|P3|Overall Study|Protocol Violation|0
5025962|NCT03073200|17294301|P2|Overall Study|Protocol Violation|0
5025963|NCT03073200|17294302|P1|Overall Study|Protocol Violation|2
5025964|NCT03073200|17294300|P3|Overall Study|Site closed by sponsor|1
5025965|NCT03073200|17294301|P2|Overall Study|Site closed by sponsor|0
5025966|NCT03073200|17294302|P1|Overall Study|Site closed by sponsor|0
5025967|NCT03073200|17294300|P3|Overall Study|Withdrawal by parent/guardian|1
5025968|NCT03073200|17294301|P2|Overall Study|Withdrawal by parent/guardian|1
5025969|NCT03073200|17294302|P1|Overall Study|Withdrawal by parent/guardian|0
5025970|NCT03073200|17294300|P3|Overall Study|Continuing treatment (Ongoing)|28
5025971|NCT03073200|17294301|P2|Overall Study|Continuing treatment (Ongoing)|106
5025972|NCT03073200|17294302|P1|Overall Study|Continuing treatment (Ongoing)|48
5025973|NCT03073200|17294300|P3|Overall Study|Withdrawal by Subject|0
5025974|NCT03073200|17294301|P2|Overall Study|Withdrawal by Subject|3
5025975|NCT03073200|17294302|P1|Overall Study|Withdrawal by Subject|3
5025976|NCT03073200|17294300|P3|Overall Study|Participant had Crohns disease|0
5025977|NCT03073200|17294301|P2|Overall Study|Participant had Crohns disease|1
5025978|NCT03073200|17294302|P1|Overall Study|Participant had Crohns disease|0
5025979|NCT03073200|17294300|P3|Overall Study|Lost to Follow-up|0
5025980|NCT03073200|17294301|P2|Overall Study|Lost to Follow-up|2
5025981|NCT03073200|17294302|P1|Overall Study|Lost to Follow-up|1
5025982|NCT03073200|17294300|P3|Overall Study|Adverse Event|0
5025983|NCT03073200|17294301|P2|Overall Study|Adverse Event|2
5025984|NCT03073200|17294302|P1|Overall Study|Adverse Event|0
5025985|NCT03073109|17294364|P2|Overall Study|Lost to Follow-up|1
5025986|NCT03073109|17294365|P1|Overall Study|Lost to Follow-up|8
5025987|NCT03073109|17294364|P2|Overall Study|Other|0
5025988|NCT03073109|17294365|P1|Overall Study|Other|2
5025989|NCT03073109|17294364|P2|Overall Study|Adverse Event|1
5025990|NCT03073109|17294365|P1|Overall Study|Adverse Event|0
5025991|NCT03072875|17294393|P1|Overall Study|Lost to Follow-up|1
5025992|NCT03072719|17294409|P2|Overall Study|Adverse Event|1
5025993|NCT03072719|17294410|P1|Overall Study|Adverse Event|1
5025994|NCT03071276|17294435|P1|Overall Study|Lack of Efficacy|14
5025995|NCT03071276|17294435|P1|Overall Study|Adverse Event|1
5025996|NCT03071263|17294443|P2|Overall Study|Participant moved to another city|1
5025997|NCT03071263|17294444|P1|Overall Study|Participant moved to another city|0
5025998|NCT03071263|17294443|P2|Overall Study|Physician Decision|0
5025999|NCT03071263|17294444|P1|Overall Study|Physician Decision|1
5026000|NCT03071263|17294443|P2|Overall Study|Withdrawal by Subject|3
5026001|NCT03071263|17294444|P1|Overall Study|Withdrawal by Subject|1
5026002|NCT03071263|17294443|P2|Overall Study|Adverse Event|3
5026003|NCT03071263|17294444|P1|Overall Study|Adverse Event|1
5026004|NCT03070964|17294468|P1|Overall Study|Adverse Event|1
5026005|NCT03070964|17294468|P1|Overall Study|Withdrawal by Subject|1
5026006|NCT03070964|17294468|P1|Overall Study|Physician Decision|1
5026007|NCT03070964|17294468|P1|Overall Study|Never treated|1
5026008|NCT03070964|17294468|P1|Overall Study|Treatment-unrelated adverse event|2
5026009|NCT03070964|17294468|P1|Overall Study|Progressive disease|8
5026010|NCT03070782|17294479|P6|Overall Study|Investigator Judgement|0
5026011|NCT03070782|17294480|P5|Overall Study|Investigator Judgement|0
5026012|NCT03070782|17294481|P4|Overall Study|Investigator Judgement|1
5026013|NCT03070782|17294482|P3|Overall Study|Investigator Judgement|0
5026014|NCT03070782|17294483|P2|Overall Study|Investigator Judgement|0
5026015|NCT03070782|17294484|P1|Overall Study|Investigator Judgement|0
5026016|NCT03070782|17294479|P6|Overall Study|Pregnancy|0
5026017|NCT03070782|17294480|P5|Overall Study|Pregnancy|0
5026018|NCT03070782|17294481|P4|Overall Study|Pregnancy|1
5026019|NCT03070782|17294482|P3|Overall Study|Pregnancy|0
5026020|NCT03070782|17294483|P2|Overall Study|Pregnancy|0
5026021|NCT03070782|17294484|P1|Overall Study|Pregnancy|0
5026022|NCT03070782|17294479|P6|Overall Study|Ineligibility|1
5026023|NCT03070782|17294480|P5|Overall Study|Ineligibility|0
5026024|NCT03070782|17294481|P4|Overall Study|Ineligibility|1
5026025|NCT03070782|17294482|P3|Overall Study|Ineligibility|0
5026026|NCT03070782|17294483|P2|Overall Study|Ineligibility|0
5026027|NCT03070782|17294484|P1|Overall Study|Ineligibility|0
5026028|NCT03070782|17294479|P6|Overall Study|Reason Not Specified|1
5026029|NCT03070782|17294480|P5|Overall Study|Reason Not Specified|2
5026030|NCT03070782|17294481|P4|Overall Study|Reason Not Specified|1
5026031|NCT03070782|17294482|P3|Overall Study|Reason Not Specified|0
5026032|NCT03070782|17294483|P2|Overall Study|Reason Not Specified|0
5026033|NCT03070782|17294484|P1|Overall Study|Reason Not Specified|2
5026034|NCT03070782|17294479|P6|Overall Study|Withdrawal by Subject|3
5026035|NCT03070782|17294480|P5|Overall Study|Withdrawal by Subject|4
5026036|NCT03070782|17294481|P4|Overall Study|Withdrawal by Subject|0
5026037|NCT03070782|17294482|P3|Overall Study|Withdrawal by Subject|1
5026038|NCT03070782|17294483|P2|Overall Study|Withdrawal by Subject|1
5026039|NCT03070782|17294484|P1|Overall Study|Withdrawal by Subject|2
5026040|NCT03070782|17294479|P6|Overall Study|Adverse Event|2
5026041|NCT03070782|17294480|P5|Overall Study|Adverse Event|6
5026042|NCT03070782|17294481|P4|Overall Study|Adverse Event|1
5026043|NCT03070782|17294482|P3|Overall Study|Adverse Event|3
5026044|NCT03070782|17294483|P2|Overall Study|Adverse Event|0
5026045|NCT03070782|17294484|P1|Overall Study|Adverse Event|3
5026046|NCT03070483|17294724|P1|Overall Study|Lost to Follow-up|2
5026047|NCT03070431|17294771|P1|Overall Study|Lost to Follow-up|2
5026048|NCT03070431|17294771|P1|Overall Study|Withdrawal by Subject|2
5026049|NCT03070171|17294793|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
5026050|NCT03070171|17294794|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
5026051|NCT03070171|17294793|P2|Treatment Period 2 + Washout|Other Adverse Event|1
5026052|NCT03070171|17294794|P1|Treatment Period 2 + Washout|Other Adverse Event|0
5026053|NCT03070002|17294810|P1|Follow up for 2 Years|Death|1
5026054|NCT03069989|17294818|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
5026055|NCT03069989|17294819|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
5026056|NCT03069482|17294926|P2|Overall Study|Physician Decision|0
5026057|NCT03069482|17294927|P1|Overall Study|Physician Decision|1
5026058|NCT03069482|17294926|P2|Overall Study|Lost to Follow-up|1
5026059|NCT03069482|17294927|P1|Overall Study|Lost to Follow-up|0
5026060|NCT03069365|17295037|P1|Overall Study|Adverse Event|1
5026061|NCT03069352|17295045|P2|Overall Study|Ongoing|40
5026062|NCT03069352|17295046|P1|Overall Study|Ongoing|12
5026063|NCT03069313|17295088|P1|Overall Study|Adverse Event|5
5026064|NCT03068767|17295126|P2|Overall Study|Protocol Violation|0
5026065|NCT03068767|17295127|P1|Overall Study|Protocol Violation|3
5026066|NCT03068767|17295126|P2|Overall Study|Lost to Follow-up|3
5026067|NCT03068767|17295127|P1|Overall Study|Lost to Follow-up|7
5026068|NCT03068754|17295137|P4|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
5026069|NCT03068754|17295138|P3|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
5026070|NCT03068754|17295139|P2|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
5026071|NCT03068754|17295140|P1|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
5026072|NCT03068754|17295137|P4|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5026073|NCT03068754|17295138|P3|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
5026074|NCT03068754|17295139|P2|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5026075|NCT03068754|17295140|P1|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5026076|NCT03068754|17295137|P4|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5026077|NCT03068754|17295138|P3|Open Label Extension Period (OLE)|Withdrawal by Subject|5
5026078|NCT03068754|17295139|P2|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5026079|NCT03068754|17295140|P1|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5026080|NCT03068754|17295137|P4|Open Label Extension Period (OLE)|Disease progression|1
5026081|NCT03068754|17295138|P3|Open Label Extension Period (OLE)|Disease progression|3
5026082|NCT03068754|17295139|P2|Open Label Extension Period (OLE)|Disease progression|0
5026083|NCT03068754|17295140|P1|Open Label Extension Period (OLE)|Disease progression|0
5026084|NCT03068754|17295137|P4|Open Label Extension Period (OLE)|Death|1
5026085|NCT03068754|17295138|P3|Open Label Extension Period (OLE)|Death|0
5026086|NCT03068754|17295139|P2|Open Label Extension Period (OLE)|Death|0
5026087|NCT03068754|17295140|P1|Open Label Extension Period (OLE)|Death|0
5026088|NCT03068754|17295137|P4|Open Label Extension Period (OLE)|Adverse Event|1
5026089|NCT03068754|17295138|P3|Open Label Extension Period (OLE)|Adverse Event|0
5026090|NCT03068754|17295139|P2|Open Label Extension Period (OLE)|Adverse Event|0
5026091|NCT03068754|17295140|P1|Open Label Extension Period (OLE)|Adverse Event|0
5026092|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
5026093|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
5026094|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
5026095|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
5026096|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5026097|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5026098|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
5026099|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5026100|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5026101|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5026102|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5026103|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Discontinued by Physician|1
5026104|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
5026105|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
5026106|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
5026107|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
5026108|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5026109|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5026110|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5026111|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Lost to Follow-up|1
5026112|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Disease progression|0
5026113|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Disease progression|0
5026114|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Disease progression|2
5026115|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Disease progression|1
5026116|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Death|0
5026117|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Death|0
5026118|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Death|2
5026119|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Death|2
5026120|NCT03068754|17295137|P4|Randomized Treatment Period (RTP)|Adverse Event|0
5026121|NCT03068754|17295138|P3|Randomized Treatment Period (RTP)|Adverse Event|0
5026122|NCT03068754|17295139|P2|Randomized Treatment Period (RTP)|Adverse Event|3
5026123|NCT03068754|17295140|P1|Randomized Treatment Period (RTP)|Adverse Event|1
5026124|NCT03067987|17295189|P2|Overall Study|Withdrawal by Subject|1
5026125|NCT03067987|17295190|P1|Overall Study|Withdrawal by Subject|2
5026126|NCT03067987|17295189|P2|Overall Study|Protocol Violation|2
5026127|NCT03067987|17295190|P1|Overall Study|Protocol Violation|1
5026128|NCT03067987|17295189|P2|Overall Study|Lost to Follow-up|10
5026129|NCT03067987|17295190|P1|Overall Study|Lost to Follow-up|7
5026130|NCT03066999|17295216|P2|Overall Study|abnormal urethraBladder neck contracture|2
5026131|NCT03066999|17295217|P1|Overall Study|abnormal urethraBladder neck contracture|0
5026132|NCT03066622|17295237|P2|Overall Study|Withdrawal by Subject|1
5026133|NCT03066622|17295238|P1|Overall Study|Withdrawal by Subject|2
5026134|NCT03066622|17295237|P2|Overall Study|Lost to Follow-up|25
5026135|NCT03066622|17295238|P1|Overall Study|Lost to Follow-up|24
5026136|NCT03066609|17295251|P4|OVERALL STUDY|discontinued follow up|0
5026137|NCT03066609|17295252|P3|OVERALL STUDY|discontinued follow up|0
5026138|NCT03066609|17295253|P2|OVERALL STUDY|discontinued follow up|2
5026139|NCT03066609|17295254|P1|OVERALL STUDY|discontinued follow up|0
5026140|NCT03066609|17295251|P4|OVERALL STUDY|Lack of Efficacy|1
5026141|NCT03066609|17295252|P3|OVERALL STUDY|Lack of Efficacy|1
5026142|NCT03066609|17295253|P2|OVERALL STUDY|Lack of Efficacy|1
5026143|NCT03066609|17295254|P1|OVERALL STUDY|Lack of Efficacy|2
5026144|NCT03066609|17295251|P4|OVERALL STUDY|Pregnancy|0
5026145|NCT03066609|17295252|P3|OVERALL STUDY|Pregnancy|1
5026146|NCT03066609|17295253|P2|OVERALL STUDY|Pregnancy|0
5026147|NCT03066609|17295254|P1|OVERALL STUDY|Pregnancy|1
5026148|NCT03066609|17295251|P4|OVERALL STUDY|Lost to Follow-up|1
5026149|NCT03066609|17295252|P3|OVERALL STUDY|Lost to Follow-up|1
5026150|NCT03066609|17295253|P2|OVERALL STUDY|Lost to Follow-up|1
5026151|NCT03066609|17295254|P1|OVERALL STUDY|Lost to Follow-up|1
5026152|NCT03066609|17295251|P4|OVERALL STUDY|Withdrawal by Subject|2
5026153|NCT03066609|17295252|P3|OVERALL STUDY|Withdrawal by Subject|1
5026154|NCT03066609|17295253|P2|OVERALL STUDY|Withdrawal by Subject|2
5026155|NCT03066609|17295254|P1|OVERALL STUDY|Withdrawal by Subject|4
5026156|NCT03066609|17295251|P4|OVERALL STUDY|Adverse Event|1
5026157|NCT03066609|17295252|P3|OVERALL STUDY|Adverse Event|0
5026158|NCT03066609|17295253|P2|OVERALL STUDY|Adverse Event|2
5026159|NCT03066609|17295254|P1|OVERALL STUDY|Adverse Event|2
5026160|NCT03066609|17295251|P4|MAINTENANCE|Lack of Efficacy|1
5026161|NCT03066609|17295252|P3|MAINTENANCE|Lack of Efficacy|0
5026162|NCT03066609|17295253|P2|MAINTENANCE|Lack of Efficacy|1
5026163|NCT03066609|17295254|P1|MAINTENANCE|Lack of Efficacy|2
5026164|NCT03066609|17295251|P4|MAINTENANCE|Pregnancy|0
5026165|NCT03066609|17295252|P3|MAINTENANCE|Pregnancy|0
5026166|NCT03066609|17295253|P2|MAINTENANCE|Pregnancy|0
5026167|NCT03066609|17295254|P1|MAINTENANCE|Pregnancy|1
5026168|NCT03066609|17295251|P4|MAINTENANCE|Lost to Follow-up|0
5026169|NCT03066609|17295252|P3|MAINTENANCE|Lost to Follow-up|1
5026170|NCT03066609|17295253|P2|MAINTENANCE|Lost to Follow-up|1
5026171|NCT03066609|17295254|P1|MAINTENANCE|Lost to Follow-up|0
5026172|NCT03066609|17295251|P4|MAINTENANCE|Withdrawal by Subject|1
5026173|NCT03066609|17295252|P3|MAINTENANCE|Withdrawal by Subject|1
5026174|NCT03066609|17295253|P2|MAINTENANCE|Withdrawal by Subject|2
5026175|NCT03066609|17295254|P1|MAINTENANCE|Withdrawal by Subject|4
5026176|NCT03066609|17295251|P4|MAINTENANCE|Adverse Event|1
5026177|NCT03066609|17295252|P3|MAINTENANCE|Adverse Event|0
5026178|NCT03066609|17295253|P2|MAINTENANCE|Adverse Event|0
5026179|NCT03066609|17295254|P1|MAINTENANCE|Adverse Event|0
5026180|NCT03066609|17295251|P4|INDUCTION|Adverse Event|0
5026181|NCT03066609|17295252|P3|INDUCTION|Adverse Event|0
5026182|NCT03066609|17295253|P2|INDUCTION|Adverse Event|2
5026183|NCT03066609|17295254|P1|INDUCTION|Adverse Event|2
5026184|NCT03066609|17295251|P4|INDUCTION|Lack of Efficacy|0
5026185|NCT03066609|17295252|P3|INDUCTION|Lack of Efficacy|1
5026186|NCT03066609|17295253|P2|INDUCTION|Lack of Efficacy|0
5026187|NCT03066609|17295254|P1|INDUCTION|Lack of Efficacy|0
5026188|NCT03066609|17295251|P4|INDUCTION|Pregnancy|0
5026189|NCT03066609|17295252|P3|INDUCTION|Pregnancy|1
5026190|NCT03066609|17295253|P2|INDUCTION|Pregnancy|0
5026191|NCT03066609|17295254|P1|INDUCTION|Pregnancy|0
5026192|NCT03066193|17295284|P1|Overall Study|Withdrawal by Subject|1
5026193|NCT03065933|17295297|P1|Overall Study|study terminated|5
5026194|NCT03065530|17295305|P4|Overall Study|Protocol Violation|1
5026195|NCT03065530|17295306|P3|Overall Study|Protocol Violation|1
5026196|NCT03065530|17295307|P2|Overall Study|Protocol Violation|0
5026197|NCT03065530|17295308|P1|Overall Study|Protocol Violation|1
5026198|NCT03065530|17295305|P4|Overall Study|Lack of Efficacy|1
5026199|NCT03065530|17295306|P3|Overall Study|Lack of Efficacy|0
5026200|NCT03065530|17295307|P2|Overall Study|Lack of Efficacy|1
5026201|NCT03065530|17295308|P1|Overall Study|Lack of Efficacy|1
5026202|NCT03065023|17295416|P5|Overall Study|Withdrawal by Subject|0
5026203|NCT03065023|17295417|P4|Overall Study|Withdrawal by Subject|1
5026204|NCT03065023|17295418|P3|Overall Study|Withdrawal by Subject|0
5026205|NCT03065023|17295419|P2|Overall Study|Withdrawal by Subject|0
5026206|NCT03065023|17295420|P1|Overall Study|Withdrawal by Subject|0
5026207|NCT03065023|17295416|P5|Overall Study|Participant Decision|0
5026208|NCT03065023|17295417|P4|Overall Study|Participant Decision|1
5026209|NCT03065023|17295418|P3|Overall Study|Participant Decision|0
5026210|NCT03065023|17295419|P2|Overall Study|Participant Decision|0
5026211|NCT03065023|17295420|P1|Overall Study|Participant Decision|0
5026212|NCT03065023|17295416|P5|Overall Study|Lost to Follow-up|0
5026213|NCT03065023|17295417|P4|Overall Study|Lost to Follow-up|0
5026214|NCT03065023|17295418|P3|Overall Study|Lost to Follow-up|0
5026215|NCT03065023|17295419|P2|Overall Study|Lost to Follow-up|1
5026216|NCT03065023|17295420|P1|Overall Study|Lost to Follow-up|0
5026217|NCT03065023|17295416|P5|Overall Study|Death|0
5026218|NCT03065023|17295417|P4|Overall Study|Death|1
5026219|NCT03065023|17295418|P3|Overall Study|Death|1
5026220|NCT03065023|17295419|P2|Overall Study|Death|0
5026221|NCT03065023|17295420|P1|Overall Study|Death|2
5026222|NCT03065023|17295416|P5|Overall Study|Progressive Disease|0
5026223|NCT03065023|17295417|P4|Overall Study|Progressive Disease|0
5026224|NCT03065023|17295418|P3|Overall Study|Progressive Disease|0
5026225|NCT03065023|17295419|P2|Overall Study|Progressive Disease|1
5026226|NCT03065023|17295420|P1|Overall Study|Progressive Disease|0
5026227|NCT03064841|17295486|P1|Overall Study|Screen failure|2
5026228|NCT03064841|17295486|P1|Overall Study|No glycated haemoglobinA1c measurement|11
5026229|NCT03064841|17295486|P1|Overall Study|Inclusion/exclusion criteria violation|4
5026230|NCT03064451|17295501|P1|Overall Study|Withdrew consent: 3-month FU visit|1
5026231|NCT03064451|17295501|P1|Overall Study|Exited prior to procedure|8
5026232|NCT03064451|17295501|P1|Overall Study|Mapping Failure|4
5026233|NCT03064451|17295501|P1|Overall Study|Lost to Follow-up|1
5026234|NCT03064126|17295519|P4|Overall Study|Protocol Violation|0
5026235|NCT03064126|17295520|P3|Overall Study|Protocol Violation|1
5026236|NCT03064126|17295521|P2|Overall Study|Protocol Violation|1
5026237|NCT03064126|17295522|P1|Overall Study|Protocol Violation|11
5026238|NCT03064126|17295519|P4|Overall Study|Subject moved|0
5026239|NCT03064126|17295520|P3|Overall Study|Subject moved|0
5026240|NCT03064126|17295521|P2|Overall Study|Subject moved|0
5026241|NCT03064126|17295522|P1|Overall Study|Subject moved|1
5026242|NCT03064126|17295519|P4|Overall Study|Withdrawal by Subject|0
5026243|NCT03064126|17295520|P3|Overall Study|Withdrawal by Subject|0
5026244|NCT03064126|17295521|P2|Overall Study|Withdrawal by Subject|4
5026245|NCT03064126|17295522|P1|Overall Study|Withdrawal by Subject|7
5026246|NCT03064126|17295519|P4|Overall Study|Investigator Discretion|0
5026247|NCT03064126|17295520|P3|Overall Study|Investigator Discretion|0
5026248|NCT03064126|17295521|P2|Overall Study|Investigator Discretion|0
5026249|NCT03064126|17295522|P1|Overall Study|Investigator Discretion|1
5026250|NCT03064126|17295519|P4|Overall Study|Death|1
5026251|NCT03064126|17295520|P3|Overall Study|Death|2
5026252|NCT03064126|17295521|P2|Overall Study|Death|2
5026253|NCT03064126|17295522|P1|Overall Study|Death|6
5026254|NCT03063086|17295655|P6|Overall Study|Physician Decision|0
5026255|NCT03063086|17295656|P5|Overall Study|Physician Decision|0
5026256|NCT03063086|17295657|P4|Overall Study|Physician Decision|1
5026257|NCT03063086|17295658|P3|Overall Study|Physician Decision|0
5026258|NCT03063086|17295659|P2|Overall Study|Physician Decision|0
5026259|NCT03063086|17295660|P1|Overall Study|Physician Decision|0
5026260|NCT03063086|17295655|P6|Overall Study|Non-compliance with study treatment|1
5026261|NCT03063086|17295656|P5|Overall Study|Non-compliance with study treatment|0
5026262|NCT03063086|17295657|P4|Overall Study|Non-compliance with study treatment|1
5026263|NCT03063086|17295658|P3|Overall Study|Non-compliance with study treatment|0
5026264|NCT03063086|17295659|P2|Overall Study|Non-compliance with study treatment|0
5026265|NCT03063086|17295660|P1|Overall Study|Non-compliance with study treatment|0
5026266|NCT03063086|17295655|P6|Overall Study|subject/guardian decision|0
5026267|NCT03063086|17295656|P5|Overall Study|subject/guardian decision|0
5026268|NCT03063086|17295657|P4|Overall Study|subject/guardian decision|0
5026269|NCT03063086|17295658|P3|Overall Study|subject/guardian decision|0
5026270|NCT03063086|17295659|P2|Overall Study|subject/guardian decision|0
5026271|NCT03063086|17295660|P1|Overall Study|subject/guardian decision|1
5026272|NCT03063086|17295655|P6|Overall Study|Adverse Event|0
5026273|NCT03063086|17295656|P5|Overall Study|Adverse Event|0
5026274|NCT03063086|17295657|P4|Overall Study|Adverse Event|1
5026275|NCT03063086|17295658|P3|Overall Study|Adverse Event|1
5026276|NCT03063086|17295659|P2|Overall Study|Adverse Event|1
5026277|NCT03063086|17295660|P1|Overall Study|Adverse Event|1
5026278|NCT03063086|17295655|P6|Overall Study|technical problems|0
5026279|NCT03063086|17295656|P5|Overall Study|technical problems|0
5026280|NCT03063086|17295657|P4|Overall Study|technical problems|0
5026281|NCT03063086|17295658|P3|Overall Study|technical problems|0
5026282|NCT03063086|17295659|P2|Overall Study|technical problems|0
5026283|NCT03063086|17295660|P1|Overall Study|technical problems|1
5026284|NCT03062891|17295706|P2|Overall Study|Lost to Follow-up|38
5026285|NCT03062891|17295707|P1|Overall Study|Lost to Follow-up|50
5026286|NCT03062891|17295706|P2|Overall Study|Withdrawal by Subject|0
5026287|NCT03062891|17295707|P1|Overall Study|Withdrawal by Subject|2
5026288|NCT03061331|17295817|P2|Washout Period (8 Weeks)|Adverse Event|1
5026289|NCT03061331|17295818|P1|Washout Period (8 Weeks)|Adverse Event|2
5026290|NCT03061214|17295848|P3|Overall Study|Death|0
5026291|NCT03061214|17295849|P2|Overall Study|Death|1
5026292|NCT03061214|17295850|P1|Overall Study|Death|1
5026293|NCT03061214|17295848|P3|Overall Study|Lost to Follow-up|1
5026294|NCT03061214|17295849|P2|Overall Study|Lost to Follow-up|1
5026295|NCT03061214|17295850|P1|Overall Study|Lost to Follow-up|3
5026296|NCT03061214|17295848|P3|Overall Study|Withdrawal by Subject|9
5026297|NCT03061214|17295849|P2|Overall Study|Withdrawal by Subject|26
5026298|NCT03061214|17295850|P1|Overall Study|Withdrawal by Subject|21
5026299|NCT03061188|17296076|P4|On Follow-up for 3 Years|Still in follow-up|3
5026300|NCT03061188|17296077|P3|On Follow-up for 3 Years|Still in follow-up|0
5026301|NCT03061188|17296078|P2|On Follow-up for 3 Years|Still in follow-up|0
5026302|NCT03061188|17296079|P1|On Follow-up for 3 Years|Still in follow-up|0
5026303|NCT03061188|17296076|P4|On Follow-up for 3 Years|Death|2
5026304|NCT03061188|17296077|P3|On Follow-up for 3 Years|Death|5
5026305|NCT03061188|17296078|P2|On Follow-up for 3 Years|Death|3
5026306|NCT03061188|17296079|P1|On Follow-up for 3 Years|Death|0
5026307|NCT03061188|17296076|P4|Went on to Cycle 2 and Beyond|Adverse Event|1
5026308|NCT03061188|17296077|P3|Went on to Cycle 2 and Beyond|Adverse Event|1
5026309|NCT03061188|17296078|P2|Went on to Cycle 2 and Beyond|Adverse Event|0
5026310|NCT03061188|17296079|P1|Went on to Cycle 2 and Beyond|Adverse Event|0
5026311|NCT03061175|17296101|P2|Followup 2 at 6 Months|Lost to Follow-up|7
5026312|NCT03061175|17296102|P1|Followup 2 at 6 Months|Lost to Follow-up|4
5026313|NCT03061175|17296101|P2|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
5026314|NCT03061175|17296102|P1|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
5026315|NCT03061175|17296101|P2|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
5026316|NCT03061175|17296102|P1|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
5026317|NCT03061175|17296101|P2|Baseline|Participant was deemed ineligible|0
5026318|NCT03061175|17296102|P1|Baseline|Participant was deemed ineligible|1
5026319|NCT03060551|17296133|P1|Overall Study|Adverse Event|1
5026320|NCT03060551|17296133|P1|Overall Study|Withdrawal by Subject|1
5026321|NCT03060512|17296154|P2|Overall Study|Non-compliance with study medication|2
5026322|NCT03060512|17296155|P1|Overall Study|Non-compliance with study medication|1
5026323|NCT03060512|17296154|P2|Overall Study|Withdrawal by Subject|0
5026324|NCT03060512|17296155|P1|Overall Study|Withdrawal by Subject|1
5026325|NCT03060512|17296154|P2|Overall Study|Lost to Follow-up|1
5026326|NCT03060512|17296155|P1|Overall Study|Lost to Follow-up|1
5026327|NCT03060512|17296154|P2|Overall Study|Adverse Event|6
5026328|NCT03060512|17296155|P1|Overall Study|Adverse Event|4
5026329|NCT03058991|17296192|P3|Overall Study|Withdrawal by Subject|0
5026330|NCT03058991|17296193|P2|Overall Study|Withdrawal by Subject|0
5026331|NCT03058991|17296194|P1|Overall Study|Withdrawal by Subject|1
5026332|NCT03058991|17296192|P3|Overall Study|Lost to Follow-up|12
5026333|NCT03058991|17296193|P2|Overall Study|Lost to Follow-up|12
5026334|NCT03058991|17296194|P1|Overall Study|Lost to Follow-up|17
5026335|NCT03058705|17296220|P1|Overall Study|Physician Decision|2
5026336|NCT03058705|17296220|P1|Overall Study|Withdrawal by Subject|2
5026337|NCT03058692|17296226|P2|Overall Study|Withdrawal by Subject|1
5026338|NCT03058692|17296227|P1|Overall Study|Withdrawal by Subject|1
5026339|NCT03058692|17296226|P2|Overall Study|Lost to Follow-up|1
5026340|NCT03058692|17296227|P1|Overall Study|Lost to Follow-up|2
5026341|NCT03056573|17296388|P2|Overall Study|Lost to Follow-up|1
5026342|NCT03056573|17296389|P1|Overall Study|Lost to Follow-up|1
5026343|NCT03056573|17296388|P2|Overall Study|Withdrawal by Subject|0
5026344|NCT03056573|17296389|P1|Overall Study|Withdrawal by Subject|2
5026345|NCT03056573|17296388|P2|Overall Study|Death|4
5026346|NCT03056573|17296389|P1|Overall Study|Death|2
5026347|NCT03056352|17296449|P1|Overall Study|Lost to Follow-up|1
5026348|NCT03056300|17296455|P1|Overall Study|Surgical reason per study protocol|3
5026349|NCT03056040|17296472|P2|Primary Evaluation Period|Pregnancy|1
5026350|NCT03056040|17296473|P1|Primary Evaluation Period|Pregnancy|0
5026351|NCT03056040|17296472|P2|Primary Evaluation Period|Lack of Efficacy|1
5026352|NCT03056040|17296473|P1|Primary Evaluation Period|Lack of Efficacy|0
5026353|NCT03056040|17296472|P2|Primary Evaluation Period|Withdrawal by Subject|1
5026354|NCT03056040|17296473|P1|Primary Evaluation Period|Withdrawal by Subject|1
5026355|NCT03055988|17296487|P2|Period 2|Other than listed|1
5026356|NCT03055988|17296488|P1|Period 2|Other than listed|1
5026357|NCT03055988|17296487|P2|Period 2|Adverse Event|1
5026358|NCT03055988|17296488|P1|Period 2|Adverse Event|0
5026359|NCT03055988|17296487|P2|Period 1|Withdrawal by Subject|4
5026360|NCT03055988|17296488|P1|Period 1|Withdrawal by Subject|0
5026361|NCT03055988|17296487|P2|Period 1|Lost to Follow-up|0
5026362|NCT03055988|17296488|P1|Period 1|Lost to Follow-up|1
5026363|NCT03055988|17296487|P2|Period 1|Adverse Event|1
5026364|NCT03055988|17296488|P1|Period 1|Adverse Event|0
5026365|NCT03055858|17296510|P1|Overall Study|Adverse Event|1
5026366|NCT03055858|17296510|P1|Overall Study|Death|5
5026367|NCT03055832|17296518|P2|Week 2|Withdrawal by Subject|0
5026368|NCT03055832|17296519|P1|Week 2|Withdrawal by Subject|1
5026369|NCT03055806|17296579|P4|Overall Study|Partner not willing to try intercourse|0
5026370|NCT03055806|17296580|P3|Overall Study|Partner not willing to try intercourse|0
5026371|NCT03055806|17296581|P2|Overall Study|Partner not willing to try intercourse|0
5026372|NCT03055806|17296582|P1|Overall Study|Partner not willing to try intercourse|1
5026373|NCT03055806|17296579|P4|Overall Study|Withdrawal of consent to continue study|6
5026374|NCT03055806|17296580|P3|Overall Study|Withdrawal of consent to continue study|4
5026375|NCT03055806|17296581|P2|Overall Study|Withdrawal of consent to continue study|3
5026376|NCT03055806|17296582|P1|Overall Study|Withdrawal of consent to continue study|2
5026377|NCT03055806|17296579|P4|Overall Study|Withdrawal of consent to continue drug|0
5026378|NCT03055806|17296580|P3|Overall Study|Withdrawal of consent to continue drug|2
5026379|NCT03055806|17296581|P2|Overall Study|Withdrawal of consent to continue drug|1
5026380|NCT03055806|17296582|P1|Overall Study|Withdrawal of consent to continue drug|1
5026381|NCT03055806|17296579|P4|Overall Study|Protocol Violation|0
5026382|NCT03055806|17296580|P3|Overall Study|Protocol Violation|0
5026383|NCT03055806|17296581|P2|Overall Study|Protocol Violation|0
5026384|NCT03055806|17296582|P1|Overall Study|Protocol Violation|1
5026385|NCT03055806|17296579|P4|Overall Study|Physician Decision|1
5026386|NCT03055806|17296580|P3|Overall Study|Physician Decision|0
5026387|NCT03055806|17296581|P2|Overall Study|Physician Decision|0
5026388|NCT03055806|17296582|P1|Overall Study|Physician Decision|1
5026389|NCT03055806|17296579|P4|Overall Study|Lost to Follow-up|7
5026390|NCT03055806|17296580|P3|Overall Study|Lost to Follow-up|6
5026391|NCT03055806|17296581|P2|Overall Study|Lost to Follow-up|3
5026392|NCT03055806|17296582|P1|Overall Study|Lost to Follow-up|0
5026393|NCT03055806|17296579|P4|Overall Study|Adverse Event|1
5026394|NCT03055806|17296580|P3|Overall Study|Adverse Event|1
5026395|NCT03055806|17296581|P2|Overall Study|Adverse Event|0
5026396|NCT03055806|17296582|P1|Overall Study|Adverse Event|0
5026397|NCT03055624|17296631|P1|Overall Study|Study closed|9
5026398|NCT03055494|17296642|P2|Overall Study|Non-compliance with study treatment|0
5026399|NCT03055494|17296643|P1|Overall Study|Non-compliance with study treatment|1
5026400|NCT03055494|17296642|P2|Overall Study|Adverse Event|1
5026401|NCT03055494|17296643|P1|Overall Study|Adverse Event|0
5026402|NCT03055494|17296642|P2|Overall Study|Withdrawal by Subject|0
5026403|NCT03055494|17296643|P1|Overall Study|Withdrawal by Subject|1
5026404|NCT03055494|17296642|P2|Overall Study|Physician Decision|0
5026405|NCT03055494|17296643|P1|Overall Study|Physician Decision|2
5026406|NCT03055494|17296642|P2|Overall Study|Lost to Follow-up|0
5026407|NCT03055494|17296643|P1|Overall Study|Lost to Follow-up|6
5026408|NCT03055338|17296674|P3|Overall Study|Withdrawal by Subject|7
5026409|NCT03055338|17296675|P2|Overall Study|Withdrawal by Subject|8
5026410|NCT03055338|17296676|P1|Overall Study|Withdrawal by Subject|9
5026411|NCT03055338|17296674|P3|Overall Study|Physician Decision|2
5026412|NCT03055338|17296675|P2|Overall Study|Physician Decision|0
5026413|NCT03055338|17296676|P1|Overall Study|Physician Decision|0
5026414|NCT03055338|17296674|P3|Overall Study|No Post-treatment Protocol Contact|0
5026415|NCT03055338|17296675|P2|Overall Study|No Post-treatment Protocol Contact|1
5026416|NCT03055338|17296676|P1|Overall Study|No Post-treatment Protocol Contact|0
5026417|NCT03055338|17296674|P3|Overall Study|Lost to Follow-up|3
5026418|NCT03055338|17296675|P2|Overall Study|Lost to Follow-up|2
5026419|NCT03055338|17296676|P1|Overall Study|Lost to Follow-up|9
5026420|NCT03055260|17296695|P2|Overall Study|Withdrawal by Subject|0
5026421|NCT03055260|17296696|P1|Overall Study|Withdrawal by Subject|1
5026422|NCT03055221|17296704|P1|Overall Study|Study terminated by Sponsor|3
5026423|NCT03055221|17296704|P1|Overall Study|Physician Decision|1
5026424|NCT03055221|17296704|P1|Overall Study|Death|6
5026425|NCT03055221|17296704|P1|Overall Study|Withdrawal by Subject|4
5026426|NCT03055221|17296704|P1|Overall Study|Adverse Event|2
5026427|NCT03055195|17296711|P2|Overall Study|Physician Decision|0
5026428|NCT03055195|17296712|P1|Overall Study|Physician Decision|1
5026429|NCT03055195|17296711|P2|Overall Study|Protocol Violation|1
5026430|NCT03055195|17296712|P1|Overall Study|Protocol Violation|2
5026431|NCT03055195|17296711|P2|Overall Study|Study Terminated by Sponsor|6
5026432|NCT03055195|17296712|P1|Overall Study|Study Terminated by Sponsor|2
5026433|NCT03055195|17296711|P2|Overall Study|Withdrawal by Subject|7
5026434|NCT03055195|17296712|P1|Overall Study|Withdrawal by Subject|6
5026435|NCT03055195|17296711|P2|Overall Study|Lack of Efficacy|0
5026436|NCT03055195|17296712|P1|Overall Study|Lack of Efficacy|1
5026437|NCT03054428|17297084|P3|Overall Study|Lost to Follow-up|1
5026438|NCT03054428|17297085|P2|Overall Study|Lost to Follow-up|0
5026439|NCT03054428|17297086|P1|Overall Study|Lost to Follow-up|0
5026440|NCT03054428|17297084|P3|Overall Study|Withdrawal by Subject|3
5026441|NCT03054428|17297085|P2|Overall Study|Withdrawal by Subject|2
5026442|NCT03054428|17297086|P1|Overall Study|Withdrawal by Subject|3
5026443|NCT03054428|17297084|P3|Overall Study|Transitioned to OLE study|73
5026444|NCT03054428|17297085|P2|Overall Study|Transitioned to OLE study|76
5026445|NCT03054428|17297086|P1|Overall Study|Transitioned to OLE study|76
5026446|NCT03054428|17297084|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
5026447|NCT03054428|17297085|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
5026448|NCT03054428|17297086|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
5026449|NCT03054428|17297084|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
5026450|NCT03054428|17297085|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
5026451|NCT03054428|17297086|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
5026452|NCT03054428|17297084|P3|Overall Study|Lack of Efficacy|0
5026453|NCT03054428|17297085|P2|Overall Study|Lack of Efficacy|1
5026454|NCT03054428|17297086|P1|Overall Study|Lack of Efficacy|3
5026455|NCT03054428|17297084|P3|Overall Study|Physician Decision|1
5026456|NCT03054428|17297085|P2|Overall Study|Physician Decision|1
5026457|NCT03054428|17297086|P1|Overall Study|Physician Decision|0
5026458|NCT03054064|17297182|P1|Overall Study|Change in Status|1
5026459|NCT03054064|17297182|P1|Overall Study|High Blood Pressure|1
5026460|NCT03054064|17297182|P1|Overall Study|Bladder Issue|1
5026461|NCT03054064|17297182|P1|Overall Study|Investigator Decision|2
5026462|NCT03054064|17297182|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
5026463|NCT03053518|17297227|P1|Overall Study|Ineligible|5
5026464|NCT03053518|17297227|P1|Overall Study|Lost to Follow-up|2
5026465|NCT03053518|17297227|P1|Overall Study|Withdrawal by Subject|3
5026466|NCT03053492|17297233|P2|Overall Study|Withdrawal by Subject|5
5026467|NCT03053492|17297234|P1|Overall Study|Withdrawal by Subject|7
5026468|NCT03053492|17297233|P2|Overall Study|Adverse Event|1
5026469|NCT03053492|17297234|P1|Overall Study|Adverse Event|1
5026470|NCT03053427|17297248|P2|Overall Study|Miscellaneous|1
5026471|NCT03053427|17297249|P1|Overall Study|Miscellaneous|0
5026472|NCT03053427|17297248|P2|Overall Study|Withdrawal by Subject|2
5026473|NCT03053427|17297249|P1|Overall Study|Withdrawal by Subject|3
5026474|NCT03053427|17297248|P2|Overall Study|Protocol Deviation|3
5026475|NCT03053427|17297249|P1|Overall Study|Protocol Deviation|3
5026476|NCT03053427|17297248|P2|Overall Study|Worsening of the target disease|1
5026477|NCT03053427|17297249|P1|Overall Study|Worsening of the target disease|0
5026478|NCT03053427|17297248|P2|Overall Study|Lost to Follow-up|2
5026479|NCT03053427|17297249|P1|Overall Study|Lost to Follow-up|2
5026480|NCT03053427|17297248|P2|Overall Study|Lack of Efficacy|3
5026481|NCT03053427|17297249|P1|Overall Study|Lack of Efficacy|1
5026482|NCT03053427|17297248|P2|Overall Study|Adverse Event|4
5026483|NCT03053427|17297249|P1|Overall Study|Adverse Event|4
5026484|NCT03053180|17297271|P1|Overall Study|Failure to Return|1
5026485|NCT03053063|17297283|P4|Open-Label Phase|Investigator's discretion|2
5026486|NCT03053063|17297284|P3|Open-Label Phase|Investigator's discretion|0
5026487|NCT03053063|17297285|P2|Open-Label Phase|Investigator's discretion|0
5026488|NCT03053063|17297286|P1|Open-Label Phase|Investigator's discretion|0
5026489|NCT03053063|17297283|P4|Open-Label Phase|Death|2
5026490|NCT03053063|17297284|P3|Open-Label Phase|Death|0
5026491|NCT03053063|17297285|P2|Open-Label Phase|Death|0
5026492|NCT03053063|17297286|P1|Open-Label Phase|Death|0
5026493|NCT03053063|17297283|P4|Open-Label Phase|Study Terminated by Sponsor|19
5026494|NCT03053063|17297284|P3|Open-Label Phase|Study Terminated by Sponsor|0
5026495|NCT03053063|17297285|P2|Open-Label Phase|Study Terminated by Sponsor|0
5026496|NCT03053063|17297286|P1|Open-Label Phase|Study Terminated by Sponsor|0
5026497|NCT03053063|17297283|P4|Randomized Phase|Entered the Open-Label Phase|0
5026498|NCT03053063|17297284|P3|Randomized Phase|Entered the Open-Label Phase|3
5026499|NCT03053063|17297285|P2|Randomized Phase|Entered the Open-Label Phase|11
5026500|NCT03053063|17297286|P1|Randomized Phase|Entered the Open-Label Phase|9
5026501|NCT03053063|17297283|P4|Randomized Phase|Randomized but Never Treated|0
5026502|NCT03053063|17297284|P3|Randomized Phase|Randomized but Never Treated|2
5026503|NCT03053063|17297285|P2|Randomized Phase|Randomized but Never Treated|3
5026504|NCT03053063|17297286|P1|Randomized Phase|Randomized but Never Treated|1
5026505|NCT03053063|17297283|P4|Randomized Phase|Adverse Event|0
5026506|NCT03053063|17297284|P3|Randomized Phase|Adverse Event|0
5026507|NCT03053063|17297285|P2|Randomized Phase|Adverse Event|1
5026508|NCT03053063|17297286|P1|Randomized Phase|Adverse Event|0
5026509|NCT03053063|17297283|P4|Randomized Phase|Lost to Follow-up|0
5026510|NCT03053063|17297284|P3|Randomized Phase|Lost to Follow-up|1
5026511|NCT03053063|17297285|P2|Randomized Phase|Lost to Follow-up|5
5026512|NCT03053063|17297286|P1|Randomized Phase|Lost to Follow-up|3
5026513|NCT03053063|17297283|P4|Randomized Phase|Investigator's Discretion|0
5026514|NCT03053063|17297284|P3|Randomized Phase|Investigator's Discretion|2
5026515|NCT03053063|17297285|P2|Randomized Phase|Investigator's Discretion|6
5026516|NCT03053063|17297286|P1|Randomized Phase|Investigator's Discretion|8
5026517|NCT03053063|17297283|P4|Randomized Phase|Withdrew consent|0
5026518|NCT03053063|17297284|P3|Randomized Phase|Withdrew consent|5
5026519|NCT03053063|17297285|P2|Randomized Phase|Withdrew consent|11
5026520|NCT03053063|17297286|P1|Randomized Phase|Withdrew consent|8
5026521|NCT03053063|17297283|P4|Randomized Phase|Study Terminated by Sponsor|0
5026522|NCT03053063|17297284|P3|Randomized Phase|Study Terminated by Sponsor|161
5026523|NCT03053063|17297285|P2|Randomized Phase|Study Terminated by Sponsor|317
5026524|NCT03053063|17297286|P1|Randomized Phase|Study Terminated by Sponsor|326
5026525|NCT03053050|17297316|P4|Open-label Phase|Investigator's Discretion|4
5026526|NCT03053050|17297317|P3|Open-label Phase|Investigator's Discretion|0
5026527|NCT03053050|17297318|P2|Open-label Phase|Investigator's Discretion|0
5026528|NCT03053050|17297319|P1|Open-label Phase|Investigator's Discretion|0
5026529|NCT03053050|17297316|P4|Open-label Phase|Withdrew Consent|6
5026530|NCT03053050|17297317|P3|Open-label Phase|Withdrew Consent|0
5026531|NCT03053050|17297318|P2|Open-label Phase|Withdrew Consent|0
5026532|NCT03053050|17297319|P1|Open-label Phase|Withdrew Consent|0
5026533|NCT03053050|17297316|P4|Open-label Phase|Study Terminated by Sponsor|89
5026534|NCT03053050|17297317|P3|Open-label Phase|Study Terminated by Sponsor|0
5026535|NCT03053050|17297318|P2|Open-label Phase|Study Terminated by Sponsor|0
5026536|NCT03053050|17297319|P1|Open-label Phase|Study Terminated by Sponsor|0
5026537|NCT03053050|17297316|P4|Randomized Phase|Entered the Open-Label Phase|0
5026538|NCT03053050|17297317|P3|Randomized Phase|Entered the Open-Label Phase|18
5026539|NCT03053050|17297318|P2|Randomized Phase|Entered the Open-Label Phase|45
5026540|NCT03053050|17297319|P1|Randomized Phase|Entered the Open-Label Phase|36
5026541|NCT03053050|17297316|P4|Randomized Phase|Randomized but Never Treated|0
5026542|NCT03053050|17297317|P3|Randomized Phase|Randomized but Never Treated|2
5026543|NCT03053050|17297318|P2|Randomized Phase|Randomized but Never Treated|2
5026544|NCT03053050|17297319|P1|Randomized Phase|Randomized but Never Treated|2
5026545|NCT03053050|17297316|P4|Randomized Phase|Adverse Event|0
5026546|NCT03053050|17297317|P3|Randomized Phase|Adverse Event|0
5026547|NCT03053050|17297318|P2|Randomized Phase|Adverse Event|1
5026548|NCT03053050|17297319|P1|Randomized Phase|Adverse Event|0
5026549|NCT03053050|17297316|P4|Randomized Phase|Lost to Follow-up|0
5026550|NCT03053050|17297317|P3|Randomized Phase|Lost to Follow-up|1
5026551|NCT03053050|17297318|P2|Randomized Phase|Lost to Follow-up|1
5026552|NCT03053050|17297319|P1|Randomized Phase|Lost to Follow-up|5
5026553|NCT03053050|17297316|P4|Randomized Phase|Investigator's Discretion|0
5026554|NCT03053050|17297317|P3|Randomized Phase|Investigator's Discretion|3
5026555|NCT03053050|17297318|P2|Randomized Phase|Investigator's Discretion|6
5026556|NCT03053050|17297319|P1|Randomized Phase|Investigator's Discretion|6
5026557|NCT03053050|17297316|P4|Randomized Phase|Withdrew Consent|0
5026558|NCT03053050|17297317|P3|Randomized Phase|Withdrew Consent|9
5026559|NCT03053050|17297318|P2|Randomized Phase|Withdrew Consent|8
5026560|NCT03053050|17297319|P1|Randomized Phase|Withdrew Consent|16
5026561|NCT03053050|17297316|P4|Randomized Phase|Study Terminated by Sponsor|0
5026562|NCT03053050|17297317|P3|Randomized Phase|Study Terminated by Sponsor|128
5026563|NCT03053050|17297318|P2|Randomized Phase|Study Terminated by Sponsor|260
5026564|NCT03053050|17297319|P1|Randomized Phase|Study Terminated by Sponsor|259
5026565|NCT03052764|17297363|P2|Double-Blind Treatment Period|Reason not Specified|1
5026566|NCT03052764|17297364|P1|Double-Blind Treatment Period|Reason not Specified|2
5026567|NCT03052764|17297363|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5026568|NCT03052764|17297364|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
5026569|NCT03052764|17297363|P2|Double-Blind Treatment Period|Protocol Violation|1
5026570|NCT03052764|17297364|P1|Double-Blind Treatment Period|Protocol Violation|2
5026571|NCT03052764|17297363|P2|Double-Blind Treatment Period|Lack of Efficacy|0
5026572|NCT03052764|17297364|P1|Double-Blind Treatment Period|Lack of Efficacy|1
5026573|NCT03052764|17297363|P2|Double-Blind Treatment Period|Adverse Event|0
5026574|NCT03052764|17297364|P1|Double-Blind Treatment Period|Adverse Event|2
5026575|NCT03052725|17297384|P2|Overall Study|Study terminated by sponsor|144
5026576|NCT03052725|17297385|P1|Overall Study|Study terminated by sponsor|143
5026577|NCT03052725|17297384|P2|Overall Study|Site closure|1
5026578|NCT03052725|17297385|P1|Overall Study|Site closure|0
5026579|NCT03052725|17297384|P2|Overall Study|Pregnancy|1
5026580|NCT03052725|17297385|P1|Overall Study|Pregnancy|0
5026581|NCT03052725|17297384|P2|Overall Study|Withdrawal by Subject|4
5026582|NCT03052725|17297385|P1|Overall Study|Withdrawal by Subject|3
5026583|NCT03052725|17297384|P2|Overall Study|Adverse Event|0
5026584|NCT03052725|17297385|P1|Overall Study|Adverse Event|2
5026585|NCT03052517|17297432|P3|Overall Study|Technical Problems|0
5026586|NCT03052517|17297433|P2|Overall Study|Technical Problems|1
5026587|NCT03052517|17297434|P1|Overall Study|Technical Problems|0
5026588|NCT03052517|17297432|P3|Overall Study|Non-Compliance With Study Treatment|0
5026589|NCT03052517|17297433|P2|Overall Study|Non-Compliance With Study Treatment|2
5026590|NCT03052517|17297434|P1|Overall Study|Non-Compliance With Study Treatment|0
5026591|NCT03052517|17297432|P3|Overall Study|Pregnancy|1
5026592|NCT03052517|17297433|P2|Overall Study|Pregnancy|0
5026593|NCT03052517|17297434|P1|Overall Study|Pregnancy|1
5026594|NCT03052517|17297432|P3|Overall Study|Lost to Follow-up|0
5026595|NCT03052517|17297433|P2|Overall Study|Lost to Follow-up|4
5026596|NCT03052517|17297434|P1|Overall Study|Lost to Follow-up|2
5026597|NCT03052517|17297432|P3|Overall Study|Death|1
5026598|NCT03052517|17297433|P2|Overall Study|Death|0
5026599|NCT03052517|17297434|P1|Overall Study|Death|3
5026600|NCT03052517|17297432|P3|Overall Study|Physician Decision|1
5026601|NCT03052517|17297433|P2|Overall Study|Physician Decision|5
5026602|NCT03052517|17297434|P1|Overall Study|Physician Decision|4
5026603|NCT03052517|17297432|P3|Overall Study|Adverse Event|0
5026604|NCT03052517|17297433|P2|Overall Study|Adverse Event|5
5026605|NCT03052517|17297434|P1|Overall Study|Adverse Event|6
5026606|NCT03052517|17297432|P3|Overall Study|Lack of Efficacy|7
5026607|NCT03052517|17297433|P2|Overall Study|Lack of Efficacy|14
5026608|NCT03052517|17297434|P1|Overall Study|Lack of Efficacy|23
5026609|NCT03052517|17297432|P3|Overall Study|Subject/Guardian Decision|22
5026610|NCT03052517|17297433|P2|Overall Study|Subject/Guardian Decision|45
5026611|NCT03052517|17297434|P1|Overall Study|Subject/Guardian Decision|50
5026612|NCT03052517|17297432|P3|Overall Study|Study Terminated By Sponsor|296
5026613|NCT03052517|17297433|P2|Overall Study|Study Terminated By Sponsor|938
5026614|NCT03052517|17297434|P1|Overall Study|Study Terminated By Sponsor|928
5026615|NCT03052426|17297478|P3|Overall Study|Lost to Follow-up|1
5026616|NCT03052426|17297479|P2|Overall Study|Lost to Follow-up|0
5026617|NCT03052426|17297480|P1|Overall Study|Lost to Follow-up|2
5026618|NCT03052426|17297478|P3|Overall Study|Withdrawal by Subject|0
5026619|NCT03052426|17297479|P2|Overall Study|Withdrawal by Subject|1
5026620|NCT03052426|17297480|P1|Overall Study|Withdrawal by Subject|0
5026621|NCT03052322|17297495|P2|Overall Study|Adverse Event|13
5026622|NCT03052322|17297496|P1|Overall Study|Adverse Event|6
5026623|NCT03052322|17297495|P2|Overall Study|Lost to Follow-up|4
5026624|NCT03052322|17297496|P1|Overall Study|Lost to Follow-up|2
5026625|NCT03052322|17297495|P2|Overall Study|Protocol Violation|0
5026626|NCT03052322|17297496|P1|Overall Study|Protocol Violation|1
5026627|NCT03052322|17297495|P2|Overall Study|Lack of Efficacy|2
5026628|NCT03052322|17297496|P1|Overall Study|Lack of Efficacy|1
5026629|NCT03052322|17297495|P2|Overall Study|Death|2
5026630|NCT03052322|17297496|P1|Overall Study|Death|0
5026631|NCT03052322|17297495|P2|Overall Study|Withdrawal by Subject|9
5026632|NCT03052322|17297496|P1|Overall Study|Withdrawal by Subject|10
5026633|NCT03052322|17297495|P2|Overall Study|Other un-specified|2
5026634|NCT03052322|17297496|P1|Overall Study|Other un-specified|1
5026635|NCT03051607|17297579|P1|Overall Study|Adverse Event|66
5026636|NCT03051217|17297589|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5026637|NCT03051217|17297590|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
5026638|NCT03051217|17297591|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5026639|NCT03051217|17297592|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5026640|NCT03051217|17297593|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5026641|NCT03051217|17297594|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5026642|NCT03051217|17297595|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5026643|NCT03051217|17297589|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5026644|NCT03051217|17297590|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5026645|NCT03051217|17297591|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
5026646|NCT03051217|17297592|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5026647|NCT03051217|17297593|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5026648|NCT03051217|17297594|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5026649|NCT03051217|17297595|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5026650|NCT03051217|17297589|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5026651|NCT03051217|17297590|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5026652|NCT03051217|17297591|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5026653|NCT03051217|17297592|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
5026654|NCT03051217|17297593|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5026655|NCT03051217|17297594|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5026656|NCT03051217|17297595|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5026657|NCT03051217|17297589|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5026658|NCT03051217|17297590|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5026659|NCT03051217|17297591|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5026660|NCT03051217|17297592|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
5026661|NCT03051217|17297593|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5026662|NCT03051217|17297594|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5026663|NCT03051217|17297595|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5026664|NCT03051217|17297589|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5026665|NCT03051217|17297590|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5026666|NCT03051217|17297591|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
5026667|NCT03051217|17297592|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5026668|NCT03051217|17297593|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5026669|NCT03051217|17297594|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5026670|NCT03051217|17297595|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5026671|NCT03051217|17297589|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5026672|NCT03051217|17297590|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5026673|NCT03051217|17297591|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5026674|NCT03051217|17297592|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5026675|NCT03051217|17297593|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5026676|NCT03051217|17297594|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5026677|NCT03051217|17297595|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5026678|NCT03051217|17297589|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5026679|NCT03051217|17297590|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5026680|NCT03051217|17297591|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5026681|NCT03051217|17297592|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5026682|NCT03051217|17297593|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5026683|NCT03051217|17297594|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
5026684|NCT03051217|17297595|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5026685|NCT03051217|17297589|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5026686|NCT03051217|17297590|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5026687|NCT03051217|17297591|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5026688|NCT03051217|17297592|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5026689|NCT03051217|17297593|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5026690|NCT03051217|17297594|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
5026691|NCT03051217|17297595|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
5026692|NCT03051165|17297624|P1|Overall Study|Early termination of study|12
5026693|NCT03051165|17297624|P1|Overall Study|Withdrawal by Subject|1
5026694|NCT03051100|17297638|P2|Overall Study|Withdrawal by Subject|0
5026695|NCT03051100|17297639|P1|Overall Study|Withdrawal by Subject|1
5026696|NCT03050398|17297889|P1|Overall Study|Study terminated by sponsor|8
5026697|NCT03050372|17297894|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
5026698|NCT03050372|17297895|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
5026699|NCT03050372|17297894|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
5026700|NCT03050372|17297895|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
5026701|NCT03050359|17297918|P2|Overall Study|Reason Not Specified|0
5026702|NCT03050359|17297919|P1|Overall Study|Reason Not Specified|1
5026703|NCT03050359|17297918|P2|Overall Study|Pregnancy|0
5026704|NCT03050359|17297919|P1|Overall Study|Pregnancy|1
5026705|NCT03050359|17297918|P2|Overall Study|Voluntary Withdrawal|6
5026706|NCT03050359|17297919|P1|Overall Study|Voluntary Withdrawal|4
5026707|NCT03050359|17297918|P2|Overall Study|Lost to Follow-up|1
5026708|NCT03050359|17297919|P1|Overall Study|Lost to Follow-up|2
5026709|NCT03050359|17297918|P2|Overall Study|Significant Protocol Deviation|3
5026710|NCT03050359|17297919|P1|Overall Study|Significant Protocol Deviation|2
5026711|NCT03050359|17297918|P2|Overall Study|Pretreatment Event/Adverse Event|10
5026712|NCT03050359|17297919|P1|Overall Study|Pretreatment Event/Adverse Event|5
5026713|NCT03050359|17297918|P2|Overall Study|Randomized But Not Treated|0
5026714|NCT03050359|17297919|P1|Overall Study|Randomized But Not Treated|2
5026715|NCT03049852|17298015|P3|Overall Study|Lost to Follow-up|0
5026716|NCT03049852|17298016|P2|Overall Study|Lost to Follow-up|1
5026717|NCT03049852|17298017|P1|Overall Study|Lost to Follow-up|0
5026718|NCT03049748|17298029|P2|Overall Study|Moved out of state (relocation)|1
5026719|NCT03049748|17298030|P1|Overall Study|Moved out of state (relocation)|0
5026720|NCT03049748|17298029|P2|Overall Study|Protocol Violation|2
5026721|NCT03049748|17298030|P1|Overall Study|Protocol Violation|0
5026722|NCT03049748|17298029|P2|Overall Study|Withdrawal by Subject|3
5026723|NCT03049748|17298030|P1|Overall Study|Withdrawal by Subject|0
5026724|NCT03049748|17298029|P2|Overall Study|Death|0
5026725|NCT03049748|17298030|P1|Overall Study|Death|3
5026726|NCT03049748|17298029|P2|Overall Study|Lost to Follow-up|0
5026727|NCT03049748|17298030|P1|Overall Study|Lost to Follow-up|1
5026728|NCT03049488|17298071|P6|Overall Study|Withdrawal by Subject|0
5026729|NCT03049488|17298072|P5|Overall Study|Withdrawal by Subject|1
5026730|NCT03049488|17298073|P4|Overall Study|Withdrawal by Subject|1
5026731|NCT03049488|17298074|P3|Overall Study|Withdrawal by Subject|0
5026732|NCT03049488|17298075|P2|Overall Study|Withdrawal by Subject|0
5026733|NCT03049488|17298076|P1|Overall Study|Withdrawal by Subject|0
5026734|NCT03049488|17298071|P6|Overall Study|Physician Decision|0
5026735|NCT03049488|17298072|P5|Overall Study|Physician Decision|0
5026736|NCT03049488|17298073|P4|Overall Study|Physician Decision|0
5026737|NCT03049488|17298074|P3|Overall Study|Physician Decision|0
5026738|NCT03049488|17298075|P2|Overall Study|Physician Decision|1
5026739|NCT03049488|17298076|P1|Overall Study|Physician Decision|0
5026740|NCT03049488|17298071|P6|Overall Study|Moved from Area|0
5026741|NCT03049488|17298072|P5|Overall Study|Moved from Area|1
5026742|NCT03049488|17298073|P4|Overall Study|Moved from Area|1
5026743|NCT03049488|17298074|P3|Overall Study|Moved from Area|0
5026744|NCT03049488|17298075|P2|Overall Study|Moved from Area|0
5026745|NCT03049488|17298076|P1|Overall Study|Moved from Area|1
5026746|NCT03049488|17298071|P6|Overall Study|Lost to Follow-up|0
5026747|NCT03049488|17298072|P5|Overall Study|Lost to Follow-up|0
5026748|NCT03049488|17298073|P4|Overall Study|Lost to Follow-up|0
5026749|NCT03049488|17298074|P3|Overall Study|Lost to Follow-up|0
5026750|NCT03049488|17298075|P2|Overall Study|Lost to Follow-up|1
5026751|NCT03049488|17298076|P1|Overall Study|Lost to Follow-up|1
5026752|NCT03049280|17298159|P1|Overall Study|Physician Decision|1
5026753|NCT03048747|17298165|P1|Overall Study|Physician Decision|1
5026754|NCT03048747|17298165|P1|Overall Study|Participant Met Withdrawal Criteria|2
5026755|NCT03048747|17298165|P1|Overall Study|Adverse Event|2
5026756|NCT03048500|17298170|P1|Follow up for 3 Years|Death|12
5026757|NCT03048500|17298170|P1|Follow up for 3 Years|Currently in Follow-up|4
5026758|NCT03048500|17298170|P1|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
5026759|NCT03048500|17298170|P1|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
5026760|NCT03048500|17298170|P1|Reached 1st Response/Continued Treatment|Death|1
5026761|NCT03048500|17298170|P1|Reached 1st Response/Continued Treatment|Progressive Disease|4
5026762|NCT03048500|17298170|P1|2 Cycles of Treatment|Withdrawal by Subject|1
5026763|NCT03048058|17298193|P2|Overall Study|Withdrawal by Subject|4
5026764|NCT03048058|17298194|P1|Overall Study|Withdrawal by Subject|0
5026765|NCT03048058|17298193|P2|Overall Study|Lost to Follow-up|0
5026766|NCT03048058|17298194|P1|Overall Study|Lost to Follow-up|4
5026767|NCT03047720|17298220|P2|First Intervention (6weeks)|Participant data entry insufficient|0
5026768|NCT03047720|17298221|P1|First Intervention (6weeks)|Participant data entry insufficient|7
5026769|NCT03047551|17298235|P2|Overall Study|Ineligible|1
5026770|NCT03047551|17298236|P1|Overall Study|Ineligible|0
5026771|NCT03047551|17298235|P2|Overall Study|Probe malfunction|1
5026772|NCT03047551|17298236|P1|Overall Study|Probe malfunction|0
5026773|NCT03047551|17298235|P2|Overall Study|Withdrawal by Subject|1
5026774|NCT03047551|17298236|P1|Overall Study|Withdrawal by Subject|0
5026775|NCT03047551|17298235|P2|Overall Study|Physician Decision|0
5026776|NCT03047551|17298236|P1|Overall Study|Physician Decision|1
5026777|NCT03047551|17298235|P2|Overall Study|Did not receive TAS|0
5026778|NCT03047551|17298236|P1|Overall Study|Did not receive TAS|1
5026779|NCT03046446|17298313|P1|Overall Study|Non OA related knee surgery|1
5026780|NCT03046446|17298313|P1|Overall Study|Disease Progression (see caveats)|25
5026781|NCT03046446|17298313|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
5026782|NCT03046446|17298313|P1|Overall Study|Withdrawal by Subject|14
5026783|NCT03046446|17298313|P1|Overall Study|Lost to Follow-up|3
5026784|NCT03046446|17298313|P1|Overall Study|Adverse Event|6
5026785|NCT03046446|17298313|P1|Overall Study|Lack of Efficacy|7
5026786|NCT03045887|17298376|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026787|NCT03045887|17298377|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026788|NCT03045887|17298378|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026789|NCT03045887|17298379|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026790|NCT03045887|17298380|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026791|NCT03045887|17298381|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026792|NCT03045887|17298382|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
5026793|NCT03045887|17298383|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026794|NCT03045887|17298384|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026795|NCT03045887|17298385|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5026796|NCT03045887|17298376|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026797|NCT03045887|17298377|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026798|NCT03045887|17298378|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026799|NCT03045887|17298379|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026800|NCT03045887|17298380|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026801|NCT03045887|17298381|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026802|NCT03045887|17298382|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
5026803|NCT03045887|17298383|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
5026804|NCT03045887|17298384|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026805|NCT03045887|17298385|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5026806|NCT03045887|17298376|P10|Part A, Period 2 (1 Day)|Adverse Event|0
5026807|NCT03045887|17298377|P9|Part A, Period 2 (1 Day)|Adverse Event|0
5026808|NCT03045887|17298378|P8|Part A, Period 2 (1 Day)|Adverse Event|0
5026809|NCT03045887|17298379|P7|Part A, Period 2 (1 Day)|Adverse Event|0
5026810|NCT03045887|17298380|P6|Part A, Period 2 (1 Day)|Adverse Event|0
5026811|NCT03045887|17298381|P5|Part A, Period 2 (1 Day)|Adverse Event|0
5026812|NCT03045887|17298382|P4|Part A, Period 2 (1 Day)|Adverse Event|0
5026813|NCT03045887|17298383|P3|Part A, Period 2 (1 Day)|Adverse Event|0
5026814|NCT03045887|17298384|P2|Part A, Period 2 (1 Day)|Adverse Event|0
5026815|NCT03045887|17298385|P1|Part A, Period 2 (1 Day)|Adverse Event|1
5026816|NCT03045887|17298376|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026817|NCT03045887|17298377|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026818|NCT03045887|17298378|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026819|NCT03045887|17298379|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026820|NCT03045887|17298380|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026821|NCT03045887|17298381|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026822|NCT03045887|17298382|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
5026823|NCT03045887|17298383|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026824|NCT03045887|17298384|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026825|NCT03045887|17298385|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5026826|NCT03045887|17298376|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026827|NCT03045887|17298377|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026828|NCT03045887|17298378|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026829|NCT03045887|17298379|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026830|NCT03045887|17298380|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026831|NCT03045887|17298381|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026832|NCT03045887|17298382|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026833|NCT03045887|17298383|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026834|NCT03045887|17298384|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5026835|NCT03045887|17298385|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
5026836|NCT03045302|17298667|P1|Overall Study|Pre-treatment adverse event|1
5026837|NCT03045081|17298673|P2|Overall Study|Withdrawal by Subject|11
5026838|NCT03045081|17298674|P1|Overall Study|Withdrawal by Subject|6
5026839|NCT03044886|17298693|P3|Overall Study|Lost to Follow-up|12
5026840|NCT03044886|17298694|P2|Overall Study|Lost to Follow-up|10
5026841|NCT03044886|17298695|P1|Overall Study|Lost to Follow-up|15
5026842|NCT03044730|17298736|P1|On Follow-up for 2 Years|Death|17
5026843|NCT03044730|17298736|P1|On Follow-up for 2 Years|Lost to Follow-up|1
5026844|NCT03044730|17298736|P1|On Follow-up for 2 Years|Still in follow-up|7
5026845|NCT03044730|17298736|P1|Cycles 4 and Beyond|Adverse Event|1
5026846|NCT03044730|17298736|P1|Cycles 4 and Beyond|Progressive Disease|9
5026847|NCT03044730|17298736|P1|3 Cycles of Pembro + Capecitab|Adverse Event|1
5026848|NCT03044730|17298736|P1|3 Cycles of Pembro + Capecitab|Death|1
5026849|NCT03044730|17298736|P1|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
5026850|NCT03044730|17298736|P1|3 Cycles of Pembro + Capecitab|Progressive Disease|1
5026851|NCT03044574|17298756|P2|Overall Study|Lost to Follow-up|45
5026852|NCT03044574|17298757|P1|Overall Study|Lost to Follow-up|37
5026853|NCT03044431|17298783|P1|Overall Study|Lost to Follow-up|59
5026854|NCT03044353|17298796|P3|Overall Study|Adverse Event|0
5026855|NCT03044353|17298797|P2|Overall Study|Adverse Event|1
5026856|NCT03044353|17298798|P1|Overall Study|Adverse Event|0
5026857|NCT03044197|17298881|P2|Overall Study|Withdrawal by Subject|1
5026858|NCT03044197|17298882|P1|Overall Study|Withdrawal by Subject|3
5026859|NCT03044106|17298892|P2|Washout (1 Week)|Withdrawal by Subject|2
5026860|NCT03044106|17298893|P1|Washout (1 Week)|Withdrawal by Subject|0
5026861|NCT03043651|17298965|P1|Overall Study|Study Terminated by Sponsor|39
5026862|NCT03043651|17298965|P1|Overall Study|Withdrawal by Subject|4
5026863|NCT03043651|17298965|P1|Overall Study|Adverse Event|2
5026864|NCT03043651|17298965|P1|Overall Study|Progressive Disease|2
5026865|NCT03043651|17298965|P1|Overall Study|Death|1
5026866|NCT03043560|17298977|P2|Overall Study|Lost to Follow-up|1
5026867|NCT03043560|17298978|P1|Overall Study|Lost to Follow-up|0
5026868|NCT03043560|17298977|P2|Overall Study|Discontinued Intervention|2
5026869|NCT03043560|17298978|P1|Overall Study|Discontinued Intervention|1
5026870|NCT03043365|17299019|P2|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
5026871|NCT03043365|17299020|P1|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
5026872|NCT03043365|17299019|P2|Weeks 0 to Week 8|Lost to Follow-up|0
5026873|NCT03043365|17299020|P1|Weeks 0 to Week 8|Lost to Follow-up|2
5026874|NCT03043365|17299019|P2|Weeks 0 to Week 8|Adverse Event|3
5026875|NCT03043365|17299020|P1|Weeks 0 to Week 8|Adverse Event|1
5026876|NCT03042910|17299074|P1|Overall Study|Enrolled but not treated|1
5026877|NCT03042910|17299074|P1|Overall Study|Withdrawal by Subject|3
5026878|NCT03042910|17299074|P1|Overall Study|Disease Progression|2
5026879|NCT03042910|17299074|P1|Overall Study|Adverse Event|1
5026880|NCT03042559|17299118|P2|Overall Study|drop out|1
5026881|NCT03042559|17299119|P1|Overall Study|drop out|1
5026882|NCT03041792|17299254|P2|Overall Study|Randomized but not treated|1
5026883|NCT03041792|17299255|P1|Overall Study|Randomized but not treated|0
5026884|NCT03041792|17299254|P2|Overall Study|Death in the family|2
5026885|NCT03041792|17299255|P1|Overall Study|Death in the family|0
5026886|NCT03041792|17299254|P2|Overall Study|Adverse Event|0
5026887|NCT03041792|17299255|P1|Overall Study|Adverse Event|4
5026888|NCT03041181|17299328|P2|Overall Study|Disease Progression|2
5026889|NCT03041181|17299329|P1|Overall Study|Disease Progression|1
5026890|NCT03041090|17299345|P2|Overall Study|technical error|3
5026891|NCT03041090|17299346|P1|Overall Study|technical error|0
5026892|NCT03040713|17299356|P1|Overall Study|Positive amyloid scan|3
5026893|NCT03040687|17299364|P3|Overall Study|Withdrawal by Subject|0
5026894|NCT03040687|17299365|P2|Overall Study|Withdrawal by Subject|0
5026895|NCT03040687|17299366|P1|Overall Study|Withdrawal by Subject|1
5026896|NCT03040336|17299435|P2|Overall Study|Withdrawal by Subject|3
5026897|NCT03040336|17299436|P1|Overall Study|Withdrawal by Subject|2
5026898|NCT03040336|17299435|P2|Overall Study|Death|0
5026899|NCT03040336|17299436|P1|Overall Study|Death|1
5026900|NCT03039738|17299549|P2|Overall Study|Incomplete data sets|0
5026901|NCT03039738|17299550|P1|Overall Study|Incomplete data sets|54
5026902|NCT03039699|17299572|P2|Overall Study|Bacterial infection|28
5026903|NCT03039699|17299573|P1|Overall Study|Bacterial infection|12
5026904|NCT03039699|17299572|P2|Overall Study|Lack of data to assess study endpoint|3
5026905|NCT03039699|17299573|P1|Overall Study|Lack of data to assess study endpoint|5
5026906|NCT03039699|17299572|P2|Overall Study|Incorrect inclusion|4
5026907|NCT03039699|17299573|P1|Overall Study|Incorrect inclusion|5
5026908|NCT03039621|17299595|P2|Overall Study|Violation of non-inclusion criteria|2
5026909|NCT03039621|17299596|P1|Overall Study|Violation of non-inclusion criteria|1
5026910|NCT03039621|17299595|P2|Overall Study|Necessity to use drugs forbidden by pro|7
5026911|NCT03039621|17299596|P1|Overall Study|Necessity to use drugs forbidden by pro|4
5026912|NCT03039621|17299595|P2|Overall Study|Non-compliance with protocol requirement|5
5026913|NCT03039621|17299596|P1|Overall Study|Non-compliance with protocol requirement|4
5026914|NCT03039621|17299595|P2|Overall Study|Violation of inclusion criteria|2
5026915|NCT03039621|17299596|P1|Overall Study|Violation of inclusion criteria|3
5026916|NCT03039569|17299620|P2|Overall Study|Lost to Follow-up|4
5026917|NCT03039569|17299621|P1|Overall Study|Lost to Follow-up|5
5026918|NCT03039283|17299666|P1|Overall Study|Protocol Violation|2
5026919|NCT03039192|17299677|P2|Overall Study|Other|2
5026920|NCT03039192|17299678|P1|Overall Study|Other|3
5026921|NCT03039192|17299677|P2|Overall Study|Discontinued from treatment phase|12
5026922|NCT03039192|17299678|P1|Overall Study|Discontinued from treatment phase|19
5026923|NCT03039192|17299677|P2|Overall Study|Withdrawal by Subject|9
5026924|NCT03039192|17299678|P1|Overall Study|Withdrawal by Subject|6
5026925|NCT03039192|17299677|P2|Overall Study|Adverse event, non-fatal|2
5026926|NCT03039192|17299678|P1|Overall Study|Adverse event, non-fatal|0
5026927|NCT03039192|17299677|P2|Overall Study|Adverse event, serious fatal|1
5026928|NCT03039192|17299678|P1|Overall Study|Adverse event, serious fatal|0
5026929|NCT03039192|17299677|P2|Overall Study|Lost to Follow-up|4
5026930|NCT03039192|17299678|P1|Overall Study|Lost to Follow-up|4
5026931|NCT03038126|17299880|P2|Overall Study|Too Ill to Participate|2
5026932|NCT03038126|17299881|P1|Overall Study|Too Ill to Participate|1
5026933|NCT03038126|17299880|P2|Overall Study|Long Term Hospitalization|0
5026934|NCT03038126|17299881|P1|Overall Study|Long Term Hospitalization|2
5026935|NCT03038126|17299880|P2|Overall Study|Lost to Follow-up|1
5026936|NCT03038126|17299881|P1|Overall Study|Lost to Follow-up|0
5026937|NCT03038126|17299880|P2|Overall Study|Withdrawal by Subject|0
5026938|NCT03038126|17299881|P1|Overall Study|Withdrawal by Subject|5
5026939|NCT03038126|17299880|P2|Overall Study|Death|1
5026940|NCT03038126|17299881|P1|Overall Study|Death|1
5026941|NCT03037619|17299923|P2|Overall Study|Lost to Follow-up|1
5026942|NCT03037619|17299924|P1|Overall Study|Lost to Follow-up|0
5026943|NCT03037580|17299938|P2|Overall Study|Death|1
5026944|NCT03037580|17299939|P1|Overall Study|Death|0
5026945|NCT03037580|17299938|P2|Overall Study|Study Terminated by Sponsor|15
5026946|NCT03037580|17299939|P1|Overall Study|Study Terminated by Sponsor|12
5026947|NCT03037580|17299938|P2|Overall Study|Adverse Event|0
5026948|NCT03037580|17299939|P1|Overall Study|Adverse Event|1
5026949|NCT03037580|17299938|P2|Overall Study|Withdrawal by Subject|0
5026950|NCT03037580|17299939|P1|Overall Study|Withdrawal by Subject|3
5026951|NCT03037489|17299964|P2|Overall Study|Withdrawal by Subject|0
5026952|NCT03037489|17299965|P1|Overall Study|Withdrawal by Subject|3
5026953|NCT03037489|17299964|P2|Overall Study|Adverse Event|0
5026954|NCT03037489|17299965|P1|Overall Study|Adverse Event|4
5026955|NCT03037307|17299971|P6|Period 1|Did Not Meet Study Criteria|0
5026956|NCT03037307|17299972|P5|Period 1|Did Not Meet Study Criteria|0
5026957|NCT03037307|17299973|P4|Period 1|Did Not Meet Study Criteria|1
5026958|NCT03037307|17299974|P3|Period 1|Did Not Meet Study Criteria|0
5026959|NCT03037307|17299975|P2|Period 1|Did Not Meet Study Criteria|0
5026960|NCT03037307|17299976|P1|Period 1|Did Not Meet Study Criteria|0
5026961|NCT03036852|17300015|P1|Overall Study|Lost to Follow-up|1
5026962|NCT03036852|17300015|P1|Overall Study|Adverse Event|1
5026963|NCT03036852|17300015|P1|Overall Study|Lack of Efficacy|2
5026964|NCT03036852|17300015|P1|Overall Study|Death|2
5026965|NCT03036839|17300072|P3|Overall Study|Withdrew Consent|1
5026966|NCT03036839|17300073|P2|Overall Study|Withdrew Consent|0
5026967|NCT03036839|17300074|P1|Overall Study|Withdrew Consent|0
5026968|NCT03036839|17300072|P3|Overall Study|Death|3
5026969|NCT03036839|17300073|P2|Overall Study|Death|0
5026970|NCT03036839|17300074|P1|Overall Study|Death|3
5026971|NCT03036839|17300072|P3|Overall Study|Adverse Event|1
5026972|NCT03036839|17300073|P2|Overall Study|Adverse Event|0
5026973|NCT03036839|17300074|P1|Overall Study|Adverse Event|0
5026974|NCT03036124|17300300|P2|Overall Study|Withdrawal by Subject|4
5026975|NCT03036124|17300301|P1|Overall Study|Withdrawal by Subject|5
5026976|NCT03036124|17300300|P2|Overall Study|Lost to Follow-up|2
5026977|NCT03036124|17300301|P1|Overall Study|Lost to Follow-up|0
5026978|NCT03036072|17300319|P2|Overall Study|Physician Decision|1
5026979|NCT03036072|17300320|P1|Overall Study|Physician Decision|0
5026980|NCT03036072|17300319|P2|Overall Study|Withdrawal by Subject|1
5026981|NCT03036072|17300320|P1|Overall Study|Withdrawal by Subject|0
5026982|NCT03036072|17300319|P2|Overall Study|Death|1
5026983|NCT03036072|17300320|P1|Overall Study|Death|0
5026984|NCT03035942|17300340|P3|Overall Study|Adverse Event|5
5026985|NCT03035942|17300341|P2|Overall Study|Adverse Event|4
5026986|NCT03035942|17300342|P1|Overall Study|Adverse Event|8
5026987|NCT03035916|17300371|P3|Overall Study|Puncture failed|0
5026988|NCT03035916|17300372|P2|Overall Study|Puncture failed|2
5026989|NCT03035916|17300373|P1|Overall Study|Puncture failed|0
5026990|NCT03035864|17300422|P2|Follow-up Period|Other|2
5026991|NCT03035864|17300423|P1|Follow-up Period|Other|3
5026992|NCT03035864|17300422|P2|Follow-up Period|Physician Decision|0
5026993|NCT03035864|17300423|P1|Follow-up Period|Physician Decision|1
5026994|NCT03035864|17300422|P2|Follow-up Period|Lost to Follow-up|2
5026995|NCT03035864|17300423|P1|Follow-up Period|Lost to Follow-up|6
5026996|NCT03035864|17300422|P2|Follow-up Period|Adverse Event|0
5026997|NCT03035864|17300423|P1|Follow-up Period|Adverse Event|1
5026998|NCT03035864|17300422|P2|Treatment Period|Other|1
5026999|NCT03035864|17300423|P1|Treatment Period|Other|3
5027000|NCT03035864|17300422|P2|Treatment Period|Adverse Event|0
5027001|NCT03035864|17300423|P1|Treatment Period|Adverse Event|1
5027002|NCT03034967|17300503|P6|Overall Study|Adverse Event, Serious Fatal|1
5027003|NCT03034967|17300504|P5|Overall Study|Adverse Event, Serious Fatal|1
5027004|NCT03034967|17300505|P4|Overall Study|Adverse Event, Serious Fatal|2
5027005|NCT03034967|17300506|P3|Overall Study|Adverse Event, Serious Fatal|1
5027006|NCT03034967|17300507|P2|Overall Study|Adverse Event, Serious Fatal|1
5027007|NCT03034967|17300508|P1|Overall Study|Adverse Event, Serious Fatal|0
5027008|NCT03034967|17300503|P6|Overall Study|Adverse Event, non-fatal|8
5027009|NCT03034967|17300504|P5|Overall Study|Adverse Event, non-fatal|2
5027010|NCT03034967|17300505|P4|Overall Study|Adverse Event, non-fatal|0
5027011|NCT03034967|17300506|P3|Overall Study|Adverse Event, non-fatal|2
5027012|NCT03034967|17300507|P2|Overall Study|Adverse Event, non-fatal|1
5027013|NCT03034967|17300508|P1|Overall Study|Adverse Event, non-fatal|3
5027014|NCT03034967|17300503|P6|Overall Study|Lack of Efficacy|0
5027015|NCT03034967|17300504|P5|Overall Study|Lack of Efficacy|1
5027016|NCT03034967|17300505|P4|Overall Study|Lack of Efficacy|1
5027017|NCT03034967|17300506|P3|Overall Study|Lack of Efficacy|2
5027018|NCT03034967|17300507|P2|Overall Study|Lack of Efficacy|1
5027019|NCT03034967|17300508|P1|Overall Study|Lack of Efficacy|0
5027020|NCT03034967|17300503|P6|Overall Study|Protocol Violation|2
5027021|NCT03034967|17300504|P5|Overall Study|Protocol Violation|0
5027022|NCT03034967|17300505|P4|Overall Study|Protocol Violation|0
5027023|NCT03034967|17300506|P3|Overall Study|Protocol Violation|0
5027024|NCT03034967|17300507|P2|Overall Study|Protocol Violation|0
5027025|NCT03034967|17300508|P1|Overall Study|Protocol Violation|1
5027026|NCT03034967|17300503|P6|Overall Study|Liver function test abnormality|0
5027027|NCT03034967|17300504|P5|Overall Study|Liver function test abnormality|0
5027028|NCT03034967|17300505|P4|Overall Study|Liver function test abnormality|0
5027029|NCT03034967|17300506|P3|Overall Study|Liver function test abnormality|1
5027030|NCT03034967|17300507|P2|Overall Study|Liver function test abnormality|0
5027031|NCT03034967|17300508|P1|Overall Study|Liver function test abnormality|0
5027032|NCT03034967|17300503|P6|Overall Study|Lost to Follow-up|2
5027033|NCT03034967|17300504|P5|Overall Study|Lost to Follow-up|0
5027034|NCT03034967|17300505|P4|Overall Study|Lost to Follow-up|1
5027035|NCT03034967|17300506|P3|Overall Study|Lost to Follow-up|0
5027036|NCT03034967|17300507|P2|Overall Study|Lost to Follow-up|0
5027037|NCT03034967|17300508|P1|Overall Study|Lost to Follow-up|0
5027038|NCT03034967|17300503|P6|Overall Study|Physician Decision|0
5027039|NCT03034967|17300504|P5|Overall Study|Physician Decision|1
5027040|NCT03034967|17300505|P4|Overall Study|Physician Decision|1
5027041|NCT03034967|17300506|P3|Overall Study|Physician Decision|1
5027042|NCT03034967|17300507|P2|Overall Study|Physician Decision|0
5027043|NCT03034967|17300508|P1|Overall Study|Physician Decision|1
5027044|NCT03034967|17300503|P6|Overall Study|Withdrawal by Subject|2
5027045|NCT03034967|17300504|P5|Overall Study|Withdrawal by Subject|9
5027046|NCT03034967|17300505|P4|Overall Study|Withdrawal by Subject|6
5027047|NCT03034967|17300506|P3|Overall Study|Withdrawal by Subject|6
5027048|NCT03034967|17300507|P2|Overall Study|Withdrawal by Subject|2
5027049|NCT03034967|17300508|P1|Overall Study|Withdrawal by Subject|9
5027050|NCT03034954|17300706|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
5027051|NCT03034954|17300707|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
5027052|NCT03034915|17300774|P3|Overall Study|Physician Decision|2
5027053|NCT03034915|17300775|P2|Overall Study|Physician Decision|5
5027054|NCT03034915|17300776|P1|Overall Study|Physician Decision|1
5027055|NCT03034915|17300774|P3|Overall Study|Protocol-defined withdrawal criteria met|29
5027056|NCT03034915|17300775|P2|Overall Study|Protocol-defined withdrawal criteria met|26
5027057|NCT03034915|17300776|P1|Overall Study|Protocol-defined withdrawal criteria met|19
5027058|NCT03034915|17300774|P3|Overall Study|Site closed|4
5027059|NCT03034915|17300775|P2|Overall Study|Site closed|2
5027060|NCT03034915|17300776|P1|Overall Study|Site closed|2
5027061|NCT03034915|17300774|P3|Overall Study|Lack of Efficacy|18
5027062|NCT03034915|17300775|P2|Overall Study|Lack of Efficacy|16
5027063|NCT03034915|17300776|P1|Overall Study|Lack of Efficacy|8
5027064|NCT03034915|17300774|P3|Overall Study|Protocol Deviation|7
5027065|NCT03034915|17300775|P2|Overall Study|Protocol Deviation|14
5027066|NCT03034915|17300776|P1|Overall Study|Protocol Deviation|2
5027067|NCT03034915|17300774|P3|Overall Study|Withdrawal by Subject|41
5027068|NCT03034915|17300775|P2|Overall Study|Withdrawal by Subject|46
5027069|NCT03034915|17300776|P1|Overall Study|Withdrawal by Subject|29
5027070|NCT03034915|17300774|P3|Overall Study|Lost to Follow-up|3
5027071|NCT03034915|17300775|P2|Overall Study|Lost to Follow-up|13
5027072|NCT03034915|17300776|P1|Overall Study|Lost to Follow-up|5
5027073|NCT03034915|17300774|P3|Overall Study|Adverse Event|22
5027074|NCT03034915|17300775|P2|Overall Study|Adverse Event|32
5027075|NCT03034915|17300776|P1|Overall Study|Adverse Event|29
5027076|NCT03034772|17300816|P2|Overall Study|Withdrawal by Subject|1
5027077|NCT03034772|17300817|P1|Overall Study|Withdrawal by Subject|0
5027078|NCT03034772|17300816|P2|Overall Study|Adverse Event|1
5027079|NCT03034772|17300817|P1|Overall Study|Adverse Event|0
5027080|NCT03034577|17300833|P2|Overall Study|Lost to Follow-up|26
5027081|NCT03034577|17300834|P1|Overall Study|Lost to Follow-up|25
5027082|NCT03034577|17300833|P2|Overall Study|Withdrawal by Subject|9
5027083|NCT03034577|17300834|P1|Overall Study|Withdrawal by Subject|6
5027084|NCT03034057|17300850|P1|Overall Study|Medication error without associated AE|1
5027085|NCT03034057|17300850|P1|Overall Study|Adverse Event|22
5027086|NCT03034057|17300850|P1|Overall Study|Lost to Follow-up|19
5027087|NCT03034057|17300850|P1|Overall Study|Not defined|2
5027088|NCT03034057|17300850|P1|Overall Study|Protocol Violation|1
5027089|NCT03034057|17300850|P1|Overall Study|Withdrawal by Subject|10
5027090|NCT03034044|17300856|P1|Overall Study|Enrolled, but not received Xyntha|1
5027091|NCT03033745|17300879|P3|Overall Study|Withdrawal by Subject|0
5027092|NCT03033745|17300880|P2|Overall Study|Withdrawal by Subject|1
5027093|NCT03033745|17300881|P1|Overall Study|Withdrawal by Subject|0
5027094|NCT03033745|17300879|P3|Overall Study|Adverse Event|1
5027095|NCT03033745|17300880|P2|Overall Study|Adverse Event|0
5027096|NCT03033745|17300881|P1|Overall Study|Adverse Event|1
5027097|NCT03033745|17300879|P3|Overall Study|Protocol Violation|1
5027098|NCT03033745|17300880|P2|Overall Study|Protocol Violation|0
5027099|NCT03033745|17300881|P1|Overall Study|Protocol Violation|0
5027100|NCT03032523|17300964|P2|Overall Study|Physician Decision|0
5027101|NCT03032523|17300965|P1|Overall Study|Physician Decision|1
5027102|NCT03032523|17300964|P2|Overall Study|Withdrawal by Subject|2
5027103|NCT03032523|17300965|P1|Overall Study|Withdrawal by Subject|2
5027104|NCT03032510|17300977|P2|Overall Study|Physician Decision|0
5027105|NCT03032510|17300978|P1|Overall Study|Physician Decision|2
5027106|NCT03032510|17300977|P2|Overall Study|Subject noncompliance|2
5027107|NCT03032510|17300978|P1|Overall Study|Subject noncompliance|4
5027108|NCT03032510|17300977|P2|Overall Study|Withdrawal by Subject|7
5027109|NCT03032510|17300978|P1|Overall Study|Withdrawal by Subject|8
5027110|NCT03032510|17300977|P2|Overall Study|Lost to Follow-up|7
5027111|NCT03032510|17300978|P1|Overall Study|Lost to Follow-up|8
5027112|NCT03032510|17300977|P2|Overall Study|Adverse Event|2
5027113|NCT03032510|17300978|P1|Overall Study|Adverse Event|5
5027114|NCT03032380|17300999|P2|Overall Study|Other - Miscellaneous|1
5027115|NCT03032380|17301000|P1|Overall Study|Other - Miscellaneous|0
5027116|NCT03032380|17300999|P2|Overall Study|Death|34
5027117|NCT03032380|17301000|P1|Overall Study|Death|39
5027118|NCT03032380|17300999|P2|Overall Study|Recovery|1
5027119|NCT03032380|17301000|P1|Overall Study|Recovery|0
5027120|NCT03032380|17300999|P2|Overall Study|Withdrawal by Subject|3
5027121|NCT03032380|17301000|P1|Overall Study|Withdrawal by Subject|2
5027122|NCT03032380|17300999|P2|Overall Study|Lack of Efficacy|0
5027123|NCT03032380|17301000|P1|Overall Study|Lack of Efficacy|1
5027124|NCT03032380|17300999|P2|Overall Study|Adverse Event|1
5027125|NCT03032380|17301000|P1|Overall Study|Adverse Event|0
5027126|NCT03031899|17301047|P1|Overall Study|lesion disappeared after stopping habit|1
5027127|NCT03031899|17301047|P1|Overall Study|Protocol Violation|1
5027128|NCT03031678|17301064|P1|Overall Study|Study closed prior to completion|1
5027129|NCT03031496|17301073|P2|Period 1|Withdrawal by Subject|2
5027130|NCT03031496|17301074|P1|Period 1|Withdrawal by Subject|0
5027131|NCT03031496|17301073|P2|Period 1|Adverse Event|0
5027132|NCT03031496|17301074|P1|Period 1|Adverse Event|2
5027133|NCT03031431|17301110|P1|Overall Study|Infant removed by maternal request|1
5027134|NCT03030599|17301181|P3|Open-label Extension|Other Reason|0
5027135|NCT03030599|17301182|P2|Open-label Extension|Other Reason|0
5027136|NCT03030599|17301183|P1|Open-label Extension|Other Reason|1
5027137|NCT03030599|17301181|P3|Open-label Extension|Lack of Efficacy|0
5027138|NCT03030599|17301182|P2|Open-label Extension|Lack of Efficacy|0
5027139|NCT03030599|17301183|P1|Open-label Extension|Lack of Efficacy|1
5027140|NCT03030599|17301181|P3|Open-label Extension|Lost to Follow-up|0
5027141|NCT03030599|17301182|P2|Open-label Extension|Lost to Follow-up|0
5027142|NCT03030599|17301183|P1|Open-label Extension|Lost to Follow-up|2
5027143|NCT03030599|17301181|P3|Open-label Extension|Adverse Event|0
5027144|NCT03030599|17301182|P2|Open-label Extension|Adverse Event|0
5027145|NCT03030599|17301183|P1|Open-label Extension|Adverse Event|3
5027146|NCT03030599|17301181|P3|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
5027147|NCT03030599|17301182|P2|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
5027148|NCT03030599|17301183|P1|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
5027149|NCT03030599|17301181|P3|Double Blind Randomized Withdrawal|Randomized in error|2
5027150|NCT03030599|17301182|P2|Double Blind Randomized Withdrawal|Randomized in error|0
5027151|NCT03030599|17301183|P1|Double Blind Randomized Withdrawal|Randomized in error|0
5027152|NCT03030599|17301181|P3|Double Blind Randomized Withdrawal|Adverse Event|3
5027153|NCT03030599|17301182|P2|Double Blind Randomized Withdrawal|Adverse Event|0
5027154|NCT03030599|17301183|P1|Double Blind Randomized Withdrawal|Adverse Event|0
5027155|NCT03030599|17301181|P3|Double Blind Randomized Withdrawal|Lack of Efficacy|2
5027156|NCT03030599|17301182|P2|Double Blind Randomized Withdrawal|Lack of Efficacy|0
5027157|NCT03030599|17301183|P1|Double Blind Randomized Withdrawal|Lack of Efficacy|0
5027158|NCT03030599|17301181|P3|Stable Dose|Lost to Follow-up|0
5027159|NCT03030599|17301182|P2|Stable Dose|Lost to Follow-up|0
5027160|NCT03030599|17301183|P1|Stable Dose|Lost to Follow-up|1
5027161|NCT03030599|17301181|P3|Stable Dose|Adverse Event|0
5027162|NCT03030599|17301182|P2|Stable Dose|Adverse Event|0
5027163|NCT03030599|17301183|P1|Stable Dose|Adverse Event|1
5027164|NCT03030599|17301181|P3|Stable Dose|Protocol deviation|0
5027165|NCT03030599|17301182|P2|Stable Dose|Protocol deviation|0
5027166|NCT03030599|17301183|P1|Stable Dose|Protocol deviation|3
5027167|NCT03030599|17301181|P3|Open Label Treatment and Titration|Lost to Follow-up|0
5027168|NCT03030599|17301182|P2|Open Label Treatment and Titration|Lost to Follow-up|0
5027169|NCT03030599|17301183|P1|Open Label Treatment and Titration|Lost to Follow-up|3
5027170|NCT03030599|17301181|P3|Open Label Treatment and Titration|Sponsor decision|0
5027171|NCT03030599|17301182|P2|Open Label Treatment and Titration|Sponsor decision|0
5027172|NCT03030599|17301183|P1|Open Label Treatment and Titration|Sponsor decision|2
5027173|NCT03030599|17301181|P3|Open Label Treatment and Titration|Withdrawal by Subject|0
5027174|NCT03030599|17301182|P2|Open Label Treatment and Titration|Withdrawal by Subject|0
5027175|NCT03030599|17301183|P1|Open Label Treatment and Titration|Withdrawal by Subject|6
5027176|NCT03030599|17301181|P3|Open Label Treatment and Titration|Adverse Event|0
5027177|NCT03030599|17301182|P2|Open Label Treatment and Titration|Adverse Event|0
5027178|NCT03030599|17301183|P1|Open Label Treatment and Titration|Adverse Event|18
5027179|NCT03030599|17301181|P3|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
5027180|NCT03030599|17301182|P2|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
5027181|NCT03030599|17301183|P1|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
5027182|NCT03030599|17301181|P3|Open Label Treatment and Titration|Lack of Efficacy|0
5027183|NCT03030599|17301182|P2|Open Label Treatment and Titration|Lack of Efficacy|0
5027184|NCT03030599|17301183|P1|Open Label Treatment and Titration|Lack of Efficacy|1
5027185|NCT03030599|17301181|P3|Open Label Treatment and Titration|Physician Decision|0
5027186|NCT03030599|17301182|P2|Open Label Treatment and Titration|Physician Decision|0
5027187|NCT03030599|17301183|P1|Open Label Treatment and Titration|Physician Decision|3
5027188|NCT03030599|17301181|P3|Open Label Treatment and Titration|Other|0
5027189|NCT03030599|17301182|P2|Open Label Treatment and Titration|Other|0
5027190|NCT03030599|17301183|P1|Open Label Treatment and Titration|Other|1
5027191|NCT03030599|17301181|P3|Open Label Treatment and Titration|Protocol deviation|0
5027192|NCT03030599|17301182|P2|Open Label Treatment and Titration|Protocol deviation|0
5027193|NCT03030599|17301183|P1|Open Label Treatment and Titration|Protocol deviation|8
5027194|NCT03029832|17301216|P2|Overall Study|Study Terminated By Sponsor|1
5027195|NCT03029832|17301217|P1|Overall Study|Study Terminated By Sponsor|1
5027196|NCT03029832|17301216|P2|Overall Study|Death due to Disease Progression|0
5027197|NCT03029832|17301217|P1|Overall Study|Death due to Disease Progression|1
5027198|NCT03029832|17301216|P2|Overall Study|Safety Follow-Up Completed|0
5027199|NCT03029832|17301217|P1|Overall Study|Safety Follow-Up Completed|2
5027200|NCT03029819|17301247|P2|Overall Study|Removed due to disruptive behavior|1
5027201|NCT03029819|17301248|P1|Overall Study|Removed due to disruptive behavior|0
5027202|NCT03029819|17301247|P2|Overall Study|Lost to Follow-up|5
5027203|NCT03029819|17301248|P1|Overall Study|Lost to Follow-up|3
5027204|NCT03029780|17301262|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5027205|NCT03029780|17301263|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
5027206|NCT03029780|17301262|P2|Overall Study|Study Drug Toxicity|5
5027207|NCT03029780|17301263|P1|Overall Study|Study Drug Toxicity|5
5027208|NCT03029780|17301262|P2|Overall Study|Disease Progression|3
5027209|NCT03029780|17301263|P1|Overall Study|Disease Progression|1
5027210|NCT03029650|17301286|P2|Washout (1 Week)|Physician Decision|1
5027211|NCT03029650|17301287|P1|Washout (1 Week)|Physician Decision|0
5027212|NCT03029650|17301286|P2|Washout (1 Week)|Withdrawal by Subject|1
5027213|NCT03029650|17301287|P1|Washout (1 Week)|Withdrawal by Subject|1
5027214|NCT03029624|17301302|P1|Overall Study|MRI need|2
5027215|NCT03029624|17301302|P1|Overall Study|Lack of Efficacy|1
5027216|NCT03029624|17301302|P1|Overall Study|Withdrawal by Subject|1
5027217|NCT03029624|17301302|P1|Overall Study|Adverse Event|1
5027218|NCT03029234|17301309|P1|Overall Study|Death|61
5027219|NCT03029234|17301309|P1|Overall Study|Withdrawal by Subject|5
5027220|NCT03029234|17301309|P1|Overall Study|Sponsor Decision|1
5027221|NCT03028870|17301432|P4|Overall Study|Administrative|4
5027222|NCT03028870|17301433|P3|Overall Study|Administrative|12
5027223|NCT03028870|17301434|P2|Overall Study|Administrative|5
5027224|NCT03028870|17301435|P1|Overall Study|Administrative|5
5027225|NCT03028870|17301432|P4|Overall Study|Lack of Efficacy|0
5027226|NCT03028870|17301433|P3|Overall Study|Lack of Efficacy|0
5027227|NCT03028870|17301434|P2|Overall Study|Lack of Efficacy|0
5027228|NCT03028870|17301435|P1|Overall Study|Lack of Efficacy|3
5027229|NCT03028870|17301432|P4|Overall Study|Lost to Follow-up|0
5027230|NCT03028870|17301433|P3|Overall Study|Lost to Follow-up|0
5027231|NCT03028870|17301434|P2|Overall Study|Lost to Follow-up|0
5027232|NCT03028870|17301435|P1|Overall Study|Lost to Follow-up|1
5027233|NCT03028870|17301432|P4|Overall Study|Withdrawal by Subject|2
5027234|NCT03028870|17301433|P3|Overall Study|Withdrawal by Subject|1
5027235|NCT03028870|17301434|P2|Overall Study|Withdrawal by Subject|1
5027236|NCT03028870|17301435|P1|Overall Study|Withdrawal by Subject|1
5027237|NCT03028870|17301432|P4|Overall Study|Adverse Event|3
5027238|NCT03028870|17301433|P3|Overall Study|Adverse Event|3
5027239|NCT03028870|17301434|P2|Overall Study|Adverse Event|4
5027240|NCT03028870|17301435|P1|Overall Study|Adverse Event|7
5027241|NCT03028142|17301640|P6|Overall Study|Withdrawal by Subject|0
5027242|NCT03028142|17301641|P5|Overall Study|Withdrawal by Subject|1
5027243|NCT03028142|17301642|P4|Overall Study|Withdrawal by Subject|0
5027244|NCT03028142|17301643|P3|Overall Study|Withdrawal by Subject|0
5027245|NCT03028142|17301644|P2|Overall Study|Withdrawal by Subject|0
5027246|NCT03028142|17301645|P1|Overall Study|Withdrawal by Subject|0
5027247|NCT03028142|17301640|P6|Overall Study|Adverse Event|1
5027248|NCT03028142|17301641|P5|Overall Study|Adverse Event|0
5027249|NCT03028142|17301642|P4|Overall Study|Adverse Event|0
5027250|NCT03028142|17301643|P3|Overall Study|Adverse Event|0
5027251|NCT03028142|17301644|P2|Overall Study|Adverse Event|1
5027252|NCT03028142|17301645|P1|Overall Study|Adverse Event|1
5027253|NCT03028129|17301664|P2|Overall Study|Withdrawal by Subject|45
5027254|NCT03028129|17301665|P1|Overall Study|Withdrawal by Subject|62
5027255|NCT03028129|17301664|P2|Overall Study|Protocol Violation|1
5027256|NCT03028129|17301665|P1|Overall Study|Protocol Violation|1
5027257|NCT03028129|17301664|P2|Overall Study|Physician Decision|1
5027258|NCT03028129|17301665|P1|Overall Study|Physician Decision|0
5027259|NCT03028129|17301664|P2|Overall Study|Lost to Follow-up|38
5027260|NCT03028129|17301665|P1|Overall Study|Lost to Follow-up|50
5027261|NCT03028129|17301664|P2|Overall Study|Adverse Event|2
5027262|NCT03028129|17301665|P1|Overall Study|Adverse Event|13
5027263|NCT03028012|17301685|P3|Overall Study|Lost to Follow-up|3
5027264|NCT03028012|17301686|P2|Overall Study|Lost to Follow-up|3
5027265|NCT03028012|17301687|P1|Overall Study|Lost to Follow-up|2
5027266|NCT03026530|17301780|P2|Overall Study|Protocol Violation|5
5027267|NCT03026530|17301781|P1|Overall Study|Protocol Violation|2
5027268|NCT03026530|17301780|P2|Overall Study|Lost to Follow-up|24
5027269|NCT03026530|17301781|P1|Overall Study|Lost to Follow-up|19
5027270|NCT03026283|17301789|P8|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5027271|NCT03026283|17301790|P7|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5027272|NCT03026283|17301791|P6|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
5027273|NCT03026283|17301792|P5|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
5027274|NCT03026283|17301793|P4|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5027275|NCT03026283|17301794|P3|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5027276|NCT03026283|17301795|P2|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5027277|NCT03026283|17301796|P1|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5027278|NCT03026283|17301789|P8|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027279|NCT03026283|17301790|P7|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027280|NCT03026283|17301791|P6|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027281|NCT03026283|17301792|P5|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027282|NCT03026283|17301793|P4|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
5027283|NCT03026283|17301794|P3|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027284|NCT03026283|17301795|P2|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027285|NCT03026283|17301796|P1|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5027286|NCT03026283|17301789|P8|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5027287|NCT03026283|17301790|P7|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5027288|NCT03026283|17301791|P6|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
5027289|NCT03026283|17301792|P5|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5027290|NCT03026283|17301793|P4|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
5027291|NCT03026283|17301794|P3|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5027292|NCT03026283|17301795|P2|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5027293|NCT03026283|17301796|P1|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5027294|NCT03026283|17301789|P8|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5027295|NCT03026283|17301790|P7|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5027296|NCT03026283|17301791|P6|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
5027297|NCT03026283|17301792|P5|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
5027298|NCT03026283|17301793|P4|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
5027299|NCT03026283|17301794|P3|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5027300|NCT03026283|17301795|P2|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5027301|NCT03026283|17301796|P1|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5027302|NCT03026283|17301789|P8|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5027303|NCT03026283|17301790|P7|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5027304|NCT03026283|17301791|P6|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5027305|NCT03026283|17301792|P5|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
5027306|NCT03026283|17301793|P4|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
5027307|NCT03026283|17301794|P3|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5027308|NCT03026283|17301795|P2|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5027309|NCT03026283|17301796|P1|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5027310|NCT03026283|17301789|P8|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027311|NCT03026283|17301790|P7|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027312|NCT03026283|17301791|P6|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027313|NCT03026283|17301792|P5|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027314|NCT03026283|17301793|P4|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027399|NCT03023423|17302069|P1|Overall Study|Ongoing|2
5027315|NCT03026283|17301794|P3|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
5027316|NCT03026283|17301795|P2|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027317|NCT03026283|17301796|P1|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5027318|NCT03026283|17301789|P8|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027319|NCT03026283|17301790|P7|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027320|NCT03026283|17301791|P6|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027321|NCT03026283|17301792|P5|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027322|NCT03026283|17301793|P4|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027323|NCT03026283|17301794|P3|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027324|NCT03026283|17301795|P2|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
5027325|NCT03026283|17301796|P1|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5027326|NCT03026283|17301789|P8|CCTA Diagnosis|Withdrawal by Subject|0
5027327|NCT03026283|17301790|P7|CCTA Diagnosis|Withdrawal by Subject|0
5027328|NCT03026283|17301791|P6|CCTA Diagnosis|Withdrawal by Subject|0
5027329|NCT03026283|17301792|P5|CCTA Diagnosis|Withdrawal by Subject|0
5027330|NCT03026283|17301793|P4|CCTA Diagnosis|Withdrawal by Subject|0
5027331|NCT03026283|17301794|P3|CCTA Diagnosis|Withdrawal by Subject|0
5027332|NCT03026283|17301795|P2|CCTA Diagnosis|Withdrawal by Subject|0
5027333|NCT03026283|17301796|P1|CCTA Diagnosis|Withdrawal by Subject|5
5027334|NCT03026283|17301789|P8|CCTA Diagnosis|CCTA not performed as planned|0
5027335|NCT03026283|17301790|P7|CCTA Diagnosis|CCTA not performed as planned|0
5027336|NCT03026283|17301791|P6|CCTA Diagnosis|CCTA not performed as planned|0
5027337|NCT03026283|17301792|P5|CCTA Diagnosis|CCTA not performed as planned|0
5027338|NCT03026283|17301793|P4|CCTA Diagnosis|CCTA not performed as planned|0
5027339|NCT03026283|17301794|P3|CCTA Diagnosis|CCTA not performed as planned|0
5027340|NCT03026283|17301795|P2|CCTA Diagnosis|CCTA not performed as planned|0
5027341|NCT03026283|17301796|P1|CCTA Diagnosis|CCTA not performed as planned|9
5027342|NCT03026257|17301817|P6|Overall Study|Withdrawal by Subject|0
5027343|NCT03026257|17301818|P5|Overall Study|Withdrawal by Subject|0
5027344|NCT03026257|17301819|P4|Overall Study|Withdrawal by Subject|0
5027345|NCT03026257|17301820|P3|Overall Study|Withdrawal by Subject|0
5027346|NCT03026257|17301821|P2|Overall Study|Withdrawal by Subject|1
5027347|NCT03026257|17301822|P1|Overall Study|Withdrawal by Subject|1
5027348|NCT03026257|17301817|P6|Overall Study|Protocol Violation|0
5027349|NCT03026257|17301818|P5|Overall Study|Protocol Violation|1
5027350|NCT03026257|17301819|P4|Overall Study|Protocol Violation|1
5027351|NCT03026257|17301820|P3|Overall Study|Protocol Violation|0
5027352|NCT03026257|17301821|P2|Overall Study|Protocol Violation|0
5027353|NCT03026257|17301822|P1|Overall Study|Protocol Violation|1
5027354|NCT03026257|17301817|P6|Overall Study|Lost to Follow-up|0
5027355|NCT03026257|17301818|P5|Overall Study|Lost to Follow-up|0
5027356|NCT03026257|17301819|P4|Overall Study|Lost to Follow-up|0
5027357|NCT03026257|17301820|P3|Overall Study|Lost to Follow-up|0
5027358|NCT03026257|17301821|P2|Overall Study|Lost to Follow-up|0
5027359|NCT03026257|17301822|P1|Overall Study|Lost to Follow-up|1
5027360|NCT03026257|17301817|P6|Overall Study|Adverse Event|0
5027361|NCT03026257|17301818|P5|Overall Study|Adverse Event|0
5027362|NCT03026257|17301819|P4|Overall Study|Adverse Event|0
5027363|NCT03026257|17301820|P3|Overall Study|Adverse Event|0
5027364|NCT03026257|17301821|P2|Overall Study|Adverse Event|0
5027365|NCT03026257|17301822|P1|Overall Study|Adverse Event|3
5027366|NCT03026166|17301838|P2|Overall Study|Other|0
5027367|NCT03026166|17301839|P1|Overall Study|Other|1
5027368|NCT03026166|17301838|P2|Overall Study|Study Terminated by Sponsor|3
5027369|NCT03026166|17301839|P1|Overall Study|Study Terminated by Sponsor|3
5027370|NCT03026166|17301838|P2|Overall Study|Lost to Follow-up|0
5027371|NCT03026166|17301839|P1|Overall Study|Lost to Follow-up|1
5027372|NCT03026166|17301838|P2|Overall Study|Withdrawal by Subject|2
5027373|NCT03026166|17301839|P1|Overall Study|Withdrawal by Subject|1
5027374|NCT03026166|17301838|P2|Overall Study|Physician Decision|0
5027375|NCT03026166|17301839|P1|Overall Study|Physician Decision|2
5027376|NCT03026166|17301838|P2|Overall Study|Death|7
5027377|NCT03026166|17301839|P1|Overall Study|Death|22
5027378|NCT03026088|17301855|P1|Overall Study|Study termination|20
5027379|NCT03026075|17301879|P1|Overall Study|Physician Decision|1
5027380|NCT03025217|17301892|P1|Overall Study|Not eligible, poor English|2
5027381|NCT03025217|17301892|P1|Overall Study|Lost to Follow-up|1
5027382|NCT03025217|17301892|P1|Overall Study|Pregnancy|1
5027383|NCT03024970|17301897|P2|Second Intervention|Lost to Follow-up|0
5027384|NCT03024970|17301898|P1|Second Intervention|Lost to Follow-up|1
5027385|NCT03024970|17301897|P2|First Intervention|Adverse Event|0
5027386|NCT03024970|17301898|P1|First Intervention|Adverse Event|1
5027387|NCT03024606|17301976|P2|Overall Study|Withdrawal by Subject|10
5027388|NCT03024606|17301977|P1|Overall Study|Withdrawal by Subject|9
5027389|NCT03023878|17302005|P1|Long Term Follow-Up Period|Death|2
5027390|NCT03023878|17302005|P1|Treatment Period|Adverse Event|1
5027391|NCT03023878|17302005|P1|Treatment Period|Withdrawal by Subject|1
5027392|NCT03023878|17302005|P1|Treatment Period|Disease Progression|1
5027393|NCT03023878|17302005|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
5027394|NCT03023878|17302005|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
5027395|NCT03023878|17302005|P1|Pre-Study Run-In Period|Death|1
5027396|NCT03023878|17302005|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
5027397|NCT03023423|17302067|P3|Overall Study|Ongoing|24
5027398|NCT03023423|17302068|P2|Overall Study|Ongoing|32
5027400|NCT03023423|17302067|P3|Overall Study|Other|2
5027401|NCT03023423|17302068|P2|Overall Study|Other|2
5027402|NCT03023423|17302069|P1|Overall Study|Other|0
5027403|NCT03023423|17302067|P3|Overall Study|Death|20
5027404|NCT03023423|17302068|P2|Overall Study|Death|12
5027405|NCT03023423|17302069|P1|Overall Study|Death|5
5027406|NCT03023137|17302106|P2|Overall Study|Lost the baby in a car accident|0
5027407|NCT03023137|17302107|P1|Overall Study|Lost the baby in a car accident|1
5027408|NCT03023137|17302106|P2|Overall Study|Protocol Violation|4
5027409|NCT03023137|17302107|P1|Overall Study|Protocol Violation|0
5027410|NCT03023137|17302106|P2|Overall Study|Lost to Follow-up|1
5027411|NCT03023137|17302107|P1|Overall Study|Lost to Follow-up|1
5027412|NCT03023137|17302106|P2|Overall Study|Multiple pregnancy|4
5027413|NCT03023137|17302107|P1|Overall Study|Multiple pregnancy|2
5027414|NCT03022981|17302136|P3|Overall Study|Withdrew Assent By Parent/Guardian|1
5027415|NCT03022981|17302137|P2|Overall Study|Withdrew Assent By Parent/Guardian|0
5027416|NCT03022981|17302138|P1|Overall Study|Withdrew Assent By Parent/Guardian|0
5027417|NCT03022981|17302136|P3|Overall Study|Non-Compliance With Study Drug|2
5027418|NCT03022981|17302137|P2|Overall Study|Non-Compliance With Study Drug|0
5027419|NCT03022981|17302138|P1|Overall Study|Non-Compliance With Study Drug|0
5027420|NCT03022981|17302136|P3|Overall Study|Lost to Follow-up|1
5027421|NCT03022981|17302137|P2|Overall Study|Lost to Follow-up|2
5027422|NCT03022981|17302138|P1|Overall Study|Lost to Follow-up|6
5027423|NCT03022981|17302136|P3|Overall Study|Investigator's Discretion|2
5027424|NCT03022981|17302137|P2|Overall Study|Investigator's Discretion|1
5027425|NCT03022981|17302138|P1|Overall Study|Investigator's Discretion|0
5027426|NCT03022981|17302136|P3|Overall Study|Adverse Event|0
5027427|NCT03022981|17302137|P2|Overall Study|Adverse Event|1
5027428|NCT03022981|17302138|P1|Overall Study|Adverse Event|0
5027429|NCT03022799|17302237|P13|Overall Study|Adverse Event|0
5027430|NCT03022799|17302238|P12|Overall Study|Adverse Event|0
5027431|NCT03022799|17302239|P11|Overall Study|Adverse Event|1
5027432|NCT03022799|17302240|P10|Overall Study|Adverse Event|1
5027433|NCT03022799|17302241|P9|Overall Study|Adverse Event|0
5027434|NCT03022799|17302242|P8|Overall Study|Adverse Event|0
5027435|NCT03022799|17302243|P7|Overall Study|Adverse Event|0
5027436|NCT03022799|17302244|P6|Overall Study|Adverse Event|0
5027437|NCT03022799|17302245|P5|Overall Study|Adverse Event|0
5027438|NCT03022799|17302246|P4|Overall Study|Adverse Event|0
5027439|NCT03022799|17302247|P3|Overall Study|Adverse Event|0
5027440|NCT03022799|17302248|P2|Overall Study|Adverse Event|0
5027441|NCT03022799|17302249|P1|Overall Study|Adverse Event|0
5027442|NCT03022630|17302446|P2|Overall Study|Withdrawal by Subject|5
5027443|NCT03022630|17302447|P1|Overall Study|Withdrawal by Subject|0
5027444|NCT03022630|17302446|P2|Overall Study|Death|7
5027445|NCT03022630|17302447|P1|Overall Study|Death|9
5027446|NCT03022422|17302564|P6|Overall Study|3 subjects consented but not vaccinated|0
5027447|NCT03022422|17302565|P5|Overall Study|3 subjects consented but not vaccinated|0
5027448|NCT03022422|17302566|P4|Overall Study|3 subjects consented but not vaccinated|0
5027449|NCT03022422|17302567|P3|Overall Study|3 subjects consented but not vaccinated|3
5027450|NCT03022422|17302568|P2|Overall Study|3 subjects consented but not vaccinated|0
5027451|NCT03022422|17302569|P1|Overall Study|3 subjects consented but not vaccinated|0
5027452|NCT03022370|17302624|P2|Overall Study|Lost to Follow-up|109
5027453|NCT03022370|17302625|P1|Overall Study|Lost to Follow-up|174
5027454|NCT03022370|17302624|P2|Overall Study|Death|12
5027455|NCT03022370|17302625|P1|Overall Study|Death|6
5027456|NCT03022084|17302701|P2|Overall Study|Lost to Follow-up|3
5027457|NCT03022084|17302702|P1|Overall Study|Lost to Follow-up|2
5027458|NCT03022045|17302710|P2|Overall Study|Withdrawal by Subject|1
5027459|NCT03022045|17302711|P1|Overall Study|Withdrawal by Subject|1
5027460|NCT03022045|17302710|P2|Overall Study|Adverse Event|1
5027461|NCT03022045|17302711|P1|Overall Study|Adverse Event|0
5027462|NCT03021668|17302740|P2|Overall Study|Physician Decision|1
5027463|NCT03021668|17302741|P1|Overall Study|Physician Decision|0
5027464|NCT03021642|17302753|P2|Washout Period (21 Days)|Adverse Event|1
5027465|NCT03021642|17302754|P1|Washout Period (21 Days)|Adverse Event|1
5027466|NCT03021564|17302794|P2|Overall Study|Lost to Follow-up|2
5027467|NCT03021564|17302795|P1|Overall Study|Lost to Follow-up|0
5027468|NCT03021564|17302794|P2|Overall Study|Death|466
5027469|NCT03021564|17302795|P1|Overall Study|Death|84
5027470|NCT03021304|17302839|P1|Overall Study|Lack of Efficacy|1
5027471|NCT03021265|17302844|P1|Overall Study|No visit since the first visit|4
5027472|NCT03021265|17302844|P1|Overall Study|No reason given|2
5027473|NCT03021265|17302844|P1|Overall Study|Lost to Follow-up|67
5027474|NCT03021265|17302844|P1|Overall Study|Improved|17
5027475|NCT03021265|17302844|P1|Overall Study|Lack of Efficacy|3
5027476|NCT03021265|17302844|P1|Overall Study|Adverse Event|29
5027477|NCT03021187|17302854|P4|Overall Study|Lost to Follow-up|4
5027478|NCT03021187|17302855|P3|Overall Study|Lost to Follow-up|1
5027479|NCT03021187|17302856|P2|Overall Study|Lost to Follow-up|3
5027480|NCT03021187|17302857|P1|Overall Study|Lost to Follow-up|10
5027481|NCT03021187|17302854|P4|Overall Study|Withdrawal by Subject|5
5027482|NCT03021187|17302855|P3|Overall Study|Withdrawal by Subject|2
5027483|NCT03021187|17302856|P2|Overall Study|Withdrawal by Subject|6
5027484|NCT03021187|17302857|P1|Overall Study|Withdrawal by Subject|0
5027485|NCT03021187|17302854|P4|Overall Study|Death|0
5027486|NCT03021187|17302855|P3|Overall Study|Death|3
5027487|NCT03021187|17302856|P2|Overall Study|Death|0
5027488|NCT03021187|17302857|P1|Overall Study|Death|0
5027570|NCT03018938|17303659|P1|Overall Study|Lost to Follow-up|21
5027489|NCT03021018|17303013|P3|Overall Study|Fall with subsequent nasal fracture|0
5027490|NCT03021018|17303014|P2|Overall Study|Fall with subsequent nasal fracture|0
5027491|NCT03021018|17303015|P1|Overall Study|Fall with subsequent nasal fracture|1
5027492|NCT03021018|17303013|P3|Overall Study|Adverse Event|0
5027493|NCT03021018|17303014|P2|Overall Study|Adverse Event|0
5027494|NCT03021018|17303015|P1|Overall Study|Adverse Event|1
5027495|NCT03021005|17303046|P2|Overall Study|Lost to Follow-up|26
5027496|NCT03021005|17303047|P1|Overall Study|Lost to Follow-up|39
5027497|NCT03020745|17303061|P10|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027498|NCT03020745|17303062|P9|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
5027499|NCT03020745|17303063|P8|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027500|NCT03020745|17303064|P7|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027501|NCT03020745|17303065|P6|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027502|NCT03020745|17303066|P5|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027503|NCT03020745|17303067|P4|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027504|NCT03020745|17303068|P3|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027505|NCT03020745|17303069|P2|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027506|NCT03020745|17303070|P1|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5027507|NCT03020745|17303061|P10|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027508|NCT03020745|17303062|P9|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
5027509|NCT03020745|17303063|P8|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027510|NCT03020745|17303064|P7|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027511|NCT03020745|17303065|P6|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
5027512|NCT03020745|17303066|P5|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027513|NCT03020745|17303067|P4|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027514|NCT03020745|17303068|P3|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027515|NCT03020745|17303069|P2|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027516|NCT03020745|17303070|P1|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5027517|NCT03020745|17303061|P10|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027518|NCT03020745|17303062|P9|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027519|NCT03020745|17303063|P8|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
5027520|NCT03020745|17303064|P7|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027521|NCT03020745|17303065|P6|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027522|NCT03020745|17303066|P5|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027523|NCT03020745|17303067|P4|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027524|NCT03020745|17303068|P3|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027525|NCT03020745|17303069|P2|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027526|NCT03020745|17303070|P1|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5027527|NCT03020745|17303061|P10|Part 2 (Up to 169 Days)|Adverse Event|0
5027528|NCT03020745|17303062|P9|Part 2 (Up to 169 Days)|Adverse Event|1
5027529|NCT03020745|17303063|P8|Part 2 (Up to 169 Days)|Adverse Event|0
5027530|NCT03020745|17303064|P7|Part 2 (Up to 169 Days)|Adverse Event|0
5027531|NCT03020745|17303065|P6|Part 2 (Up to 169 Days)|Adverse Event|0
5027532|NCT03020745|17303066|P5|Part 2 (Up to 169 Days)|Adverse Event|0
5027533|NCT03020745|17303067|P4|Part 2 (Up to 169 Days)|Adverse Event|0
5027534|NCT03020745|17303068|P3|Part 2 (Up to 169 Days)|Adverse Event|0
5027535|NCT03020745|17303069|P2|Part 2 (Up to 169 Days)|Adverse Event|0
5027536|NCT03020745|17303070|P1|Part 2 (Up to 169 Days)|Adverse Event|0
5027537|NCT03020576|17303431|P2|Overall Study|Withdrawal by Subject|2
5027538|NCT03020576|17303432|P1|Overall Study|Withdrawal by Subject|1
5027539|NCT03020160|17303506|P2|Overall Study|Continuing to receive emicizumab|41
5027540|NCT03020160|17303507|P1|Overall Study|Continuing to receive emicizumab|7
5027541|NCT03020069|17303566|P2|Overall Study|Lost to Follow-up|1
5027542|NCT03020069|17303567|P1|Overall Study|Lost to Follow-up|0
5027543|NCT03019627|17303613|P2|Overall Study|Other|2
5027544|NCT03019627|17303614|P1|Overall Study|Other|2
5027545|NCT03019627|17303613|P2|Overall Study|not compliance|2
5027546|NCT03019627|17303614|P1|Overall Study|not compliance|2
5027547|NCT03019627|17303613|P2|Overall Study|Lost to Follow-up|1
5027548|NCT03019627|17303614|P1|Overall Study|Lost to Follow-up|2
5027549|NCT03019627|17303613|P2|Overall Study|Unrelated to adverse event|3
5027550|NCT03019627|17303614|P1|Overall Study|Unrelated to adverse event|1
5027551|NCT03019627|17303613|P2|Overall Study|Adverse Event|0
5027552|NCT03019627|17303614|P1|Overall Study|Adverse Event|8
5027553|NCT03019549|17303630|P1|Period 2|Withdrawal by Subject|1
5027554|NCT03019549|17303630|P1|Period 2|Physician Decision|2
5027555|NCT03019549|17303630|P1|Period 2|Adverse Event|2
5027556|NCT03019549|17303630|P1|Washout|DId not meet genotype criteria|11
5027557|NCT03019458|17303643|P2|Overall Study|Death|1
5027558|NCT03019458|17303644|P1|Overall Study|Death|0
5027559|NCT03018938|17303658|P2|Overall Study|Not recorded|2
5027560|NCT03018938|17303659|P1|Overall Study|Not recorded|0
5027561|NCT03018938|17303658|P2|Overall Study|Screen failure-After randomization|2
5027562|NCT03018938|17303659|P1|Overall Study|Screen failure-After randomization|4
5027563|NCT03018938|17303658|P2|Overall Study|Sponsor Decision|1
5027564|NCT03018938|17303659|P1|Overall Study|Sponsor Decision|0
5027565|NCT03018938|17303658|P2|Overall Study|Physician Decision|2
5027566|NCT03018938|17303659|P1|Overall Study|Physician Decision|3
5027567|NCT03018938|17303658|P2|Overall Study|Withdrawal by Subject|45
5027568|NCT03018938|17303659|P1|Overall Study|Withdrawal by Subject|38
5027569|NCT03018938|17303658|P2|Overall Study|Lost to Follow-up|32
5027571|NCT03018938|17303658|P2|Overall Study|Death|1
5027572|NCT03018938|17303659|P1|Overall Study|Death|0
5027573|NCT03018691|17303698|P3|Overall Study|Withdrawal by parent/guardian|1
5027574|NCT03018691|17303699|P2|Overall Study|Withdrawal by parent/guardian|0
5027575|NCT03018691|17303700|P1|Overall Study|Withdrawal by parent/guardian|1
5027576|NCT03018691|17303698|P3|Overall Study|Withdrawal by Subject|1
5027577|NCT03018691|17303699|P2|Overall Study|Withdrawal by Subject|0
5027578|NCT03018691|17303700|P1|Overall Study|Withdrawal by Subject|0
5027579|NCT03018691|17303698|P3|Overall Study|Lack of Efficacy|1
5027580|NCT03018691|17303699|P2|Overall Study|Lack of Efficacy|0
5027581|NCT03018691|17303700|P1|Overall Study|Lack of Efficacy|0
5027582|NCT03018691|17303698|P3|Overall Study|Adverse Event|4
5027583|NCT03018691|17303699|P2|Overall Study|Adverse Event|1
5027584|NCT03018691|17303700|P1|Overall Study|Adverse Event|1
5027585|NCT03018340|17303736|P2|Overall Study|Not further specified|1
5027586|NCT03018340|17303737|P1|Overall Study|Not further specified|0
5027587|NCT03018340|17303736|P2|Overall Study|Protocol Violation|7
5027588|NCT03018340|17303737|P1|Overall Study|Protocol Violation|3
5027589|NCT03018340|17303736|P2|Overall Study|Lost to Follow-up|7
5027590|NCT03018340|17303737|P1|Overall Study|Lost to Follow-up|1
5027591|NCT03018340|17303736|P2|Overall Study|Non-compliance with study drug/procedure|4
5027592|NCT03018340|17303737|P1|Overall Study|Non-compliance with study drug/procedure|3
5027593|NCT03018340|17303736|P2|Overall Study|Lack of Efficacy|1
5027594|NCT03018340|17303737|P1|Overall Study|Lack of Efficacy|0
5027595|NCT03018340|17303736|P2|Overall Study|Withdrawal by Subject|8
5027596|NCT03018340|17303737|P1|Overall Study|Withdrawal by Subject|0
5027597|NCT03018340|17303736|P2|Overall Study|Adverse Event|2
5027598|NCT03018340|17303737|P1|Overall Study|Adverse Event|1
5027599|NCT03018106|17303796|P2|Overall Study|Lost to Follow-up|1
5027600|NCT03018106|17303797|P1|Overall Study|Lost to Follow-up|0
5027601|NCT03018028|17303810|P5|Overall Study|Withdrawal by Subject|0
5027602|NCT03018028|17303811|P4|Overall Study|Withdrawal by Subject|2
5027603|NCT03018028|17303812|P3|Overall Study|Withdrawal by Subject|1
5027604|NCT03018028|17303813|P2|Overall Study|Withdrawal by Subject|0
5027605|NCT03018028|17303814|P1|Overall Study|Withdrawal by Subject|3
5027606|NCT03017846|17304064|P1|Overall Study|Adverse Event|2
5027607|NCT03017846|17304064|P1|Overall Study|Lost to Follow-up|3
5027608|NCT03017612|17304072|P1|Overall Study|Adverse Event|2
5027609|NCT03017235|17304117|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
5027610|NCT03017235|17304118|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
5027611|NCT03017235|17304117|P2|Overall Study|Protocol Violation|1
5027612|NCT03017235|17304118|P1|Overall Study|Protocol Violation|2
5027613|NCT03017235|17304117|P2|Overall Study|Adverse Event|1
5027614|NCT03017235|17304118|P1|Overall Study|Adverse Event|0
5027615|NCT03017235|17304117|P2|Overall Study|Lost to Follow-up|7
5027616|NCT03017235|17304118|P1|Overall Study|Lost to Follow-up|2
5027617|NCT03017235|17304117|P2|Overall Study|Withdrawal by Subject|3
5027618|NCT03017235|17304118|P1|Overall Study|Withdrawal by Subject|4
5027619|NCT03016325|17304184|P5|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5027620|NCT03016325|17304185|P4|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5027621|NCT03016325|17304186|P3|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5027622|NCT03016325|17304187|P2|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
5027623|NCT03016325|17304188|P1|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5027624|NCT03016325|17304184|P5|182-Day Follow-Up Period|Vital status collected via EMR|0
5027625|NCT03016325|17304185|P4|182-Day Follow-Up Period|Vital status collected via EMR|1
5027626|NCT03016325|17304186|P3|182-Day Follow-Up Period|Vital status collected via EMR|0
5027627|NCT03016325|17304187|P2|182-Day Follow-Up Period|Vital status collected via EMR|0
5027628|NCT03016325|17304188|P1|182-Day Follow-Up Period|Vital status collected via EMR|0
5027629|NCT03016325|17304184|P5|182-Day Follow-Up Period|Alive, per civil unit|1
5027630|NCT03016325|17304185|P4|182-Day Follow-Up Period|Alive, per civil unit|0
5027631|NCT03016325|17304186|P3|182-Day Follow-Up Period|Alive, per civil unit|0
5027632|NCT03016325|17304187|P2|182-Day Follow-Up Period|Alive, per civil unit|0
5027633|NCT03016325|17304188|P1|182-Day Follow-Up Period|Alive, per civil unit|0
5027634|NCT03016325|17304184|P5|182-Day Follow-Up Period|Alive, per Family doctor|1
5027635|NCT03016325|17304185|P4|182-Day Follow-Up Period|Alive, per Family doctor|0
5027636|NCT03016325|17304186|P3|182-Day Follow-Up Period|Alive, per Family doctor|0
5027637|NCT03016325|17304187|P2|182-Day Follow-Up Period|Alive, per Family doctor|0
5027638|NCT03016325|17304188|P1|182-Day Follow-Up Period|Alive, per Family doctor|0
5027639|NCT03016325|17304184|P5|182-Day Follow-Up Period|Participant withdrew consent|1
5027640|NCT03016325|17304185|P4|182-Day Follow-Up Period|Participant withdrew consent|0
5027641|NCT03016325|17304186|P3|182-Day Follow-Up Period|Participant withdrew consent|0
5027642|NCT03016325|17304187|P2|182-Day Follow-Up Period|Participant withdrew consent|0
5027643|NCT03016325|17304188|P1|182-Day Follow-Up Period|Participant withdrew consent|0
5027644|NCT03016325|17304184|P5|182-Day Follow-Up Period|Alive, per national insurance system|0
5027645|NCT03016325|17304185|P4|182-Day Follow-Up Period|Alive, per national insurance system|0
5027646|NCT03016325|17304186|P3|182-Day Follow-Up Period|Alive, per national insurance system|0
5027647|NCT03016325|17304187|P2|182-Day Follow-Up Period|Alive, per national insurance system|0
5027648|NCT03016325|17304188|P1|182-Day Follow-Up Period|Alive, per national insurance system|1
5027649|NCT03016325|17304184|P5|182-Day Follow-Up Period|Death|9
5027650|NCT03016325|17304185|P4|182-Day Follow-Up Period|Death|12
5027651|NCT03016325|17304186|P3|182-Day Follow-Up Period|Death|11
5027652|NCT03016325|17304187|P2|182-Day Follow-Up Period|Death|3
5027653|NCT03016325|17304188|P1|182-Day Follow-Up Period|Death|3
5027654|NCT03016325|17304184|P5|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5027655|NCT03016325|17304185|P4|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5027656|NCT03016325|17304186|P3|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5027657|NCT03016325|17304187|P2|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
5027658|NCT03016325|17304188|P1|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5027659|NCT03016325|17304184|P5|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5027660|NCT03016325|17304185|P4|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5027661|NCT03016325|17304186|P3|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
5027662|NCT03016325|17304187|P2|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5027663|NCT03016325|17304188|P1|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5027664|NCT03016325|17304184|P5|32-Day Follow-Up Period|Participant withdrew consent|2
5027665|NCT03016325|17304185|P4|32-Day Follow-Up Period|Participant withdrew consent|0
5027666|NCT03016325|17304186|P3|32-Day Follow-Up Period|Participant withdrew consent|0
5027667|NCT03016325|17304187|P2|32-Day Follow-Up Period|Participant withdrew consent|0
5027668|NCT03016325|17304188|P1|32-Day Follow-Up Period|Participant withdrew consent|0
5027669|NCT03016325|17304184|P5|32-Day Follow-Up Period|Participant refused to visit|2
5027670|NCT03016325|17304185|P4|32-Day Follow-Up Period|Participant refused to visit|0
5027671|NCT03016325|17304186|P3|32-Day Follow-Up Period|Participant refused to visit|2
5027672|NCT03016325|17304187|P2|32-Day Follow-Up Period|Participant refused to visit|1
5027673|NCT03016325|17304188|P1|32-Day Follow-Up Period|Participant refused to visit|0
5027674|NCT03016325|17304184|P5|32-Day Follow-Up Period|Poor/non-compliance|1
5027675|NCT03016325|17304185|P4|32-Day Follow-Up Period|Poor/non-compliance|1
5027676|NCT03016325|17304186|P3|32-Day Follow-Up Period|Poor/non-compliance|0
5027677|NCT03016325|17304187|P2|32-Day Follow-Up Period|Poor/non-compliance|0
5027678|NCT03016325|17304188|P1|32-Day Follow-Up Period|Poor/non-compliance|1
5027679|NCT03016325|17304184|P5|32-Day Follow-Up Period|Lost to Follow-up|0
5027680|NCT03016325|17304185|P4|32-Day Follow-Up Period|Lost to Follow-up|1
5027681|NCT03016325|17304186|P3|32-Day Follow-Up Period|Lost to Follow-up|1
5027682|NCT03016325|17304187|P2|32-Day Follow-Up Period|Lost to Follow-up|0
5027683|NCT03016325|17304188|P1|32-Day Follow-Up Period|Lost to Follow-up|1
5027684|NCT03016325|17304184|P5|32-Day Follow-Up Period|Death|3
5027685|NCT03016325|17304185|P4|32-Day Follow-Up Period|Death|6
5027686|NCT03016325|17304186|P3|32-Day Follow-Up Period|Death|5
5027687|NCT03016325|17304187|P2|32-Day Follow-Up Period|Death|0
5027688|NCT03016325|17304188|P1|32-Day Follow-Up Period|Death|2
5027689|NCT03016325|17304184|P5|Treatment Period|Participant refuses assessments|0
5027690|NCT03016325|17304185|P4|Treatment Period|Participant refuses assessments|0
5027691|NCT03016325|17304186|P3|Treatment Period|Participant refuses assessments|1
5027692|NCT03016325|17304187|P2|Treatment Period|Participant refuses assessments|0
5027693|NCT03016325|17304188|P1|Treatment Period|Participant refuses assessments|0
5027694|NCT03016325|17304184|P5|Treatment Period|Death|2
5027695|NCT03016325|17304185|P4|Treatment Period|Death|0
5027696|NCT03016325|17304186|P3|Treatment Period|Death|0
5027697|NCT03016325|17304187|P2|Treatment Period|Death|0
5027698|NCT03016325|17304188|P1|Treatment Period|Death|0
5027699|NCT03016325|17304184|P5|Treatment Period|Participant withdrew consent|0
5027700|NCT03016325|17304185|P4|Treatment Period|Participant withdrew consent|0
5027701|NCT03016325|17304186|P3|Treatment Period|Participant withdrew consent|0
5027702|NCT03016325|17304187|P2|Treatment Period|Participant withdrew consent|1
5027703|NCT03016325|17304188|P1|Treatment Period|Participant withdrew consent|0
5027704|NCT03016078|17304330|P1|Overall Study|Protocol Violation|1
5027705|NCT03016078|17304330|P1|Overall Study|Protocol Violation|1
5027706|NCT03015220|17304349|P4|Overall Study|Lost to Follow-up|0
5027707|NCT03015220|17304350|P3|Overall Study|Lost to Follow-up|1
5027708|NCT03015220|17304351|P2|Overall Study|Lost to Follow-up|0
5027709|NCT03015220|17304352|P1|Overall Study|Lost to Follow-up|0
5027710|NCT03015220|17304349|P4|Overall Study|Withdrawal by Subject|2
5027711|NCT03015220|17304350|P3|Overall Study|Withdrawal by Subject|2
5027712|NCT03015220|17304351|P2|Overall Study|Withdrawal by Subject|2
5027713|NCT03015220|17304352|P1|Overall Study|Withdrawal by Subject|3
5027714|NCT03015181|17304497|P7|Overall Study|Physician Decision|1
5027715|NCT03015181|17304498|P6|Overall Study|Physician Decision|0
5027716|NCT03015181|17304499|P5|Overall Study|Physician Decision|0
5027717|NCT03015181|17304500|P4|Overall Study|Physician Decision|0
5027718|NCT03015181|17304501|P3|Overall Study|Physician Decision|0
5027719|NCT03015181|17304502|P2|Overall Study|Physician Decision|0
5027720|NCT03015181|17304503|P1|Overall Study|Physician Decision|0
5027721|NCT03015181|17304497|P7|Overall Study|Withdrawal by Subject|0
5027722|NCT03015181|17304498|P6|Overall Study|Withdrawal by Subject|1
5027723|NCT03015181|17304499|P5|Overall Study|Withdrawal by Subject|0
5027724|NCT03015181|17304500|P4|Overall Study|Withdrawal by Subject|0
5027725|NCT03015181|17304501|P3|Overall Study|Withdrawal by Subject|0
5027726|NCT03015181|17304502|P2|Overall Study|Withdrawal by Subject|0
5027727|NCT03015181|17304503|P1|Overall Study|Withdrawal by Subject|0
5027728|NCT03015181|17304497|P7|Overall Study|Enrolled, but product never administered|0
5027729|NCT03015181|17304498|P6|Overall Study|Enrolled, but product never administered|0
5027730|NCT03015181|17304499|P5|Overall Study|Enrolled, but product never administered|0
5027731|NCT03015181|17304500|P4|Overall Study|Enrolled, but product never administered|0
5027732|NCT03015181|17304501|P3|Overall Study|Enrolled, but product never administered|0
5027733|NCT03015181|17304502|P2|Overall Study|Enrolled, but product never administered|0
5027734|NCT03015181|17304503|P1|Overall Study|Enrolled, but product never administered|1
5027735|NCT03014674|17304649|P3|Overall Study|Withdrawal by Subject|0
5027736|NCT03014674|17304650|P2|Overall Study|Withdrawal by Subject|0
5027737|NCT03014674|17304651|P1|Overall Study|Withdrawal by Subject|1
5027738|NCT03014479|17304726|P2|Overall Study|Unacceptable Inability of Site Visit|1
5027739|NCT03014479|17304727|P1|Overall Study|Unacceptable Inability of Site Visit|0
5027740|NCT03014479|17304726|P2|Overall Study|Voluntary Withdrawal|2
5027741|NCT03014479|17304727|P1|Overall Study|Voluntary Withdrawal|0
5027742|NCT03014479|17304726|P2|Overall Study|Adverse Event|1
5027743|NCT03014479|17304727|P1|Overall Study|Adverse Event|0
5027744|NCT03014453|17304773|P1|Overall Study|Refused to take part in|37
5027745|NCT03014453|17304773|P1|Overall Study|Excluded|19
5027746|NCT03014453|17304773|P1|Overall Study|Discontinued GER|3
5027747|NCT03014453|17304773|P1|Overall Study|Lost to Follow-up|12
5027748|NCT03014206|17304777|P1|Overall Study|Registration Violation|12
5027749|NCT03014180|17304781|P1|Overall Study|Protocol Violation|2
5027750|NCT03014011|17304790|P2|Washout|Withdrawal by Subject|0
5027751|NCT03014011|17304791|P1|Washout|Withdrawal by Subject|1
5027752|NCT03014011|17304790|P2|First Intervention|Withdrawal by Subject|0
5027753|NCT03014011|17304791|P1|First Intervention|Withdrawal by Subject|1
5027754|NCT03013985|17304799|P2|Overall Study|Withdrawal by Subject|17
5027755|NCT03013985|17304800|P1|Overall Study|Withdrawal by Subject|14
5027756|NCT03013985|17304799|P2|Overall Study|Protocol Violation|2
5027757|NCT03013985|17304800|P1|Overall Study|Protocol Violation|2
5027758|NCT03012841|17304832|P2|Overall Study|Insurance change|1
5027759|NCT03012841|17304833|P1|Overall Study|Insurance change|0
5027760|NCT03012841|17304832|P2|Overall Study|Study reached n=165 treated subject cap|5
5027761|NCT03012841|17304833|P1|Overall Study|Study reached n=165 treated subject cap|0
5027762|NCT03012841|17304832|P2|Overall Study|No ablation performed|2
5027763|NCT03012841|17304833|P1|Overall Study|No ablation performed|0
5027764|NCT03012841|17304832|P2|Overall Study|Physician Decision|2
5027765|NCT03012841|17304833|P1|Overall Study|Physician Decision|0
5027766|NCT03012841|17304832|P2|Overall Study|Seasonal winter travel|0
5027767|NCT03012841|17304833|P1|Overall Study|Seasonal winter travel|1
5027768|NCT03012841|17304832|P2|Overall Study|Subject relocation|0
5027769|NCT03012841|17304833|P1|Overall Study|Subject relocation|1
5027770|NCT03012841|17304832|P2|Overall Study|Unable to complete 12 month visit|0
5027771|NCT03012841|17304833|P1|Overall Study|Unable to complete 12 month visit|6
5027772|NCT03012841|17304832|P2|Overall Study|Withdrawal by Subject|0
5027773|NCT03012841|17304833|P1|Overall Study|Withdrawal by Subject|6
5027774|NCT03012841|17304832|P2|Overall Study|Lost to Follow-up|1
5027775|NCT03012841|17304833|P1|Overall Study|Lost to Follow-up|6
5027776|NCT03012841|17304832|P2|Overall Study|Protocol Violation|10
5027777|NCT03012841|17304833|P1|Overall Study|Protocol Violation|0
5027778|NCT03012828|17304847|P6|Overall Study|Delay to last visit would delay DBL|1
5027779|NCT03012828|17304848|P5|Overall Study|Delay to last visit would delay DBL|0
5027780|NCT03012828|17304849|P4|Overall Study|Delay to last visit would delay DBL|0
5027781|NCT03012828|17304850|P3|Overall Study|Delay to last visit would delay DBL|0
5027782|NCT03012828|17304851|P2|Overall Study|Delay to last visit would delay DBL|0
5027783|NCT03012828|17304852|P1|Overall Study|Delay to last visit would delay DBL|0
5027784|NCT03012828|17304847|P6|Overall Study|Non-compliance with protocol|0
5027785|NCT03012828|17304848|P5|Overall Study|Non-compliance with protocol|1
5027786|NCT03012828|17304849|P4|Overall Study|Non-compliance with protocol|0
5027787|NCT03012828|17304850|P3|Overall Study|Non-compliance with protocol|0
5027788|NCT03012828|17304851|P2|Overall Study|Non-compliance with protocol|0
5027789|NCT03012828|17304852|P1|Overall Study|Non-compliance with protocol|0
5027790|NCT03012828|17304847|P6|Overall Study|Withdrawal by Subject|1
5027791|NCT03012828|17304848|P5|Overall Study|Withdrawal by Subject|0
5027792|NCT03012828|17304849|P4|Overall Study|Withdrawal by Subject|0
5027793|NCT03012828|17304850|P3|Overall Study|Withdrawal by Subject|1
5027794|NCT03012828|17304851|P2|Overall Study|Withdrawal by Subject|0
5027795|NCT03012828|17304852|P1|Overall Study|Withdrawal by Subject|0
5027796|NCT03012828|17304847|P6|Overall Study|Lost to Follow-up|0
5027797|NCT03012828|17304848|P5|Overall Study|Lost to Follow-up|1
5027798|NCT03012828|17304849|P4|Overall Study|Lost to Follow-up|0
5027799|NCT03012828|17304850|P3|Overall Study|Lost to Follow-up|1
5027800|NCT03012828|17304851|P2|Overall Study|Lost to Follow-up|0
5027801|NCT03012828|17304852|P1|Overall Study|Lost to Follow-up|1
5027802|NCT03012334|17304895|P10|Period 4|Adverse Event|0
5027803|NCT03012334|17304896|P9|Period 4|Adverse Event|1
5027804|NCT03012334|17304897|P8|Period 4|Adverse Event|0
5027805|NCT03012334|17304898|P7|Period 4|Adverse Event|0
5027806|NCT03012334|17304899|P6|Period 4|Adverse Event|0
5027807|NCT03012334|17304900|P5|Period 4|Adverse Event|0
5027808|NCT03012334|17304901|P4|Period 4|Adverse Event|0
5027809|NCT03012334|17304902|P3|Period 4|Adverse Event|0
5027810|NCT03012334|17304903|P2|Period 4|Adverse Event|0
5027811|NCT03012334|17304904|P1|Period 4|Adverse Event|0
5027812|NCT03012334|17304895|P10|Period 4|Non-Compliance|0
5027813|NCT03012334|17304896|P9|Period 4|Non-Compliance|0
5027814|NCT03012334|17304897|P8|Period 4|Non-Compliance|0
5027815|NCT03012334|17304898|P7|Period 4|Non-Compliance|1
5027816|NCT03012334|17304899|P6|Period 4|Non-Compliance|0
5027817|NCT03012334|17304900|P5|Period 4|Non-Compliance|0
5027818|NCT03012334|17304901|P4|Period 4|Non-Compliance|0
5027819|NCT03012334|17304902|P3|Period 4|Non-Compliance|0
5027820|NCT03012334|17304903|P2|Period 4|Non-Compliance|0
5027821|NCT03012334|17304904|P1|Period 4|Non-Compliance|0
5027822|NCT03012334|17304895|P10|Period 2|Protocol Violation|0
5027823|NCT03012334|17304896|P9|Period 2|Protocol Violation|0
5027824|NCT03012334|17304897|P8|Period 2|Protocol Violation|1
5027825|NCT03012334|17304898|P7|Period 2|Protocol Violation|0
5027826|NCT03012334|17304899|P6|Period 2|Protocol Violation|0
5027827|NCT03012334|17304900|P5|Period 2|Protocol Violation|0
5027828|NCT03012334|17304901|P4|Period 2|Protocol Violation|0
5027829|NCT03012334|17304902|P3|Period 2|Protocol Violation|1
5027830|NCT03012334|17304903|P2|Period 2|Protocol Violation|0
5027831|NCT03012334|17304904|P1|Period 2|Protocol Violation|0
5027832|NCT03012334|17304895|P10|Period 2|Withdrawal by Subject|0
5027833|NCT03012334|17304896|P9|Period 2|Withdrawal by Subject|0
5027834|NCT03012334|17304897|P8|Period 2|Withdrawal by Subject|0
5027835|NCT03012334|17304898|P7|Period 2|Withdrawal by Subject|0
5027836|NCT03012334|17304899|P6|Period 2|Withdrawal by Subject|0
5027837|NCT03012334|17304900|P5|Period 2|Withdrawal by Subject|0
5027838|NCT03012334|17304901|P4|Period 2|Withdrawal by Subject|0
5027839|NCT03012334|17304902|P3|Period 2|Withdrawal by Subject|0
5027840|NCT03012334|17304903|P2|Period 2|Withdrawal by Subject|1
5027841|NCT03012334|17304904|P1|Period 2|Withdrawal by Subject|0
5027842|NCT03012334|17304895|P10|Period 1|Withdrawal by Subject|1
5027843|NCT03012334|17304896|P9|Period 1|Withdrawal by Subject|0
5027844|NCT03012334|17304897|P8|Period 1|Withdrawal by Subject|0
5027845|NCT03012334|17304898|P7|Period 1|Withdrawal by Subject|0
5027846|NCT03012334|17304899|P6|Period 1|Withdrawal by Subject|0
5027847|NCT03012334|17304900|P5|Period 1|Withdrawal by Subject|0
5027848|NCT03012334|17304901|P4|Period 1|Withdrawal by Subject|0
5027849|NCT03012334|17304902|P3|Period 1|Withdrawal by Subject|0
5027850|NCT03012334|17304903|P2|Period 1|Withdrawal by Subject|0
5027851|NCT03012334|17304904|P1|Period 1|Withdrawal by Subject|0
5027852|NCT03012061|17304974|P3|Overall Study|Adverse Event|0
5027853|NCT03012061|17304975|P2|Overall Study|Adverse Event|0
5027854|NCT03012061|17304976|P1|Overall Study|Adverse Event|2
5027855|NCT03012061|17304974|P3|Overall Study|Lack of Efficacy|0
5027856|NCT03012061|17304975|P2|Overall Study|Lack of Efficacy|1
5027857|NCT03012061|17304976|P1|Overall Study|Lack of Efficacy|0
5027858|NCT03012061|17304974|P3|Overall Study|Protocol Violation|2
5027859|NCT03012061|17304975|P2|Overall Study|Protocol Violation|0
5027860|NCT03012061|17304976|P1|Overall Study|Protocol Violation|0
5027861|NCT03012061|17304974|P3|Overall Study|Met Protocol Withdrawal Criterion|1
5027862|NCT03012061|17304975|P2|Overall Study|Met Protocol Withdrawal Criterion|0
5027863|NCT03012061|17304976|P1|Overall Study|Met Protocol Withdrawal Criterion|0
5027864|NCT03012061|17304974|P3|Overall Study|Study closed/ Terminated|1
5027865|NCT03012061|17304975|P2|Overall Study|Study closed/ Terminated|0
5027866|NCT03012061|17304976|P1|Overall Study|Study closed/ Terminated|0
5027867|NCT03012061|17304974|P3|Overall Study|Lost to Follow-up|0
5027868|NCT03012061|17304975|P2|Overall Study|Lost to Follow-up|1
5027869|NCT03012061|17304976|P1|Overall Study|Lost to Follow-up|2
5027870|NCT03012061|17304974|P3|Overall Study|Investigator Site Closed|0
5027871|NCT03012061|17304975|P2|Overall Study|Investigator Site Closed|2
5027872|NCT03012061|17304976|P1|Overall Study|Investigator Site Closed|1
5027873|NCT03012061|17304974|P3|Overall Study|Withdrawal by Subject|4
5027874|NCT03012061|17304975|P2|Overall Study|Withdrawal by Subject|5
5027875|NCT03012061|17304976|P1|Overall Study|Withdrawal by Subject|1
5027876|NCT03011840|17305001|P2|Overall Study|Not received PIL in post PIL phase|21
5027877|NCT03011840|17305002|P1|Overall Study|Not received PIL in post PIL phase|0
5027878|NCT03011099|17305012|P2|Overall Study|Withdrawal by Subject|2
5027879|NCT03011099|17305013|P1|Overall Study|Withdrawal by Subject|0
5027880|NCT03011034|17305039|P2|Overall Study|Adverse Event|0
5027881|NCT03011034|17305040|P1|Overall Study|Adverse Event|1
5027882|NCT03010501|17305102|P6|Study Week 3|Withdrawal by Subject|0
5027883|NCT03010501|17305103|P5|Study Week 3|Withdrawal by Subject|0
5027884|NCT03010501|17305104|P4|Study Week 3|Withdrawal by Subject|1
5027885|NCT03010501|17305105|P3|Study Week 3|Withdrawal by Subject|0
5027886|NCT03010501|17305106|P2|Study Week 3|Withdrawal by Subject|0
5027887|NCT03010501|17305107|P1|Study Week 3|Withdrawal by Subject|0
5027888|NCT03010501|17305102|P6|Study Week 1|Withdrawal by Subject|0
5027889|NCT03010501|17305103|P5|Study Week 1|Withdrawal by Subject|0
5027890|NCT03010501|17305104|P4|Study Week 1|Withdrawal by Subject|2
5027891|NCT03010501|17305105|P3|Study Week 1|Withdrawal by Subject|0
5027892|NCT03010501|17305106|P2|Study Week 1|Withdrawal by Subject|1
5027893|NCT03010501|17305107|P1|Study Week 1|Withdrawal by Subject|2
5027894|NCT03010423|17305121|P1|Overall Study|Study termination|8
5027895|NCT03010254|17305134|P2|Overall Study|Other|3
5027896|NCT03010254|17305135|P1|Overall Study|Other|2
5027897|NCT03010254|17305134|P2|Overall Study|Withdrawal by Subject|1
5027898|NCT03010254|17305135|P1|Overall Study|Withdrawal by Subject|1
5027899|NCT03010254|17305134|P2|Overall Study|Lost to Follow-up|0
5027900|NCT03010254|17305135|P1|Overall Study|Lost to Follow-up|4
5027901|NCT03010254|17305134|P2|Overall Study|Adverse Event|1
5027902|NCT03010254|17305135|P1|Overall Study|Adverse Event|0
5027903|NCT03007966|17305277|P2|Overall Study|Did not meeting inclusion/exclusion|0
5027904|NCT03007966|17305278|P1|Overall Study|Did not meeting inclusion/exclusion|1
5027905|NCT03006562|17305341|P2|Overall Study|Lost to Follow-up|1
5027906|NCT03006562|17305342|P1|Overall Study|Lost to Follow-up|0
5027907|NCT03006458|17305433|P2|First Intervention|Unsatisfied Vision|3
5027908|NCT03006458|17305434|P1|First Intervention|Unsatisfied Vision|0
5027909|NCT03006341|17305476|P4|Overall Study|Not linked in the EMR|10685
5027910|NCT03006341|17305477|P3|Overall Study|Not linked in the EMR|30993
5027911|NCT03006341|17305478|P2|Overall Study|Not linked in the EMR|67505
5027912|NCT03006341|17305479|P1|Overall Study|Not linked in the EMR|25069
5027913|NCT03005288|17305523|P2|Overall Study|Physician Decision|1
5027914|NCT03005288|17305524|P1|Overall Study|Physician Decision|0
5027915|NCT03005288|17305523|P2|Overall Study|Protocol deviation|1
5027916|NCT03005288|17305524|P1|Overall Study|Protocol deviation|0
5027917|NCT03005288|17305523|P2|Overall Study|Adverse Event|0
5027918|NCT03005288|17305524|P1|Overall Study|Adverse Event|5
5027919|NCT03005288|17305523|P2|Overall Study|Lost to Follow-up|1
5027920|NCT03005288|17305524|P1|Overall Study|Lost to Follow-up|0
5027921|NCT03005288|17305523|P2|Overall Study|Withdrawal by Subject|5
5027922|NCT03005288|17305524|P1|Overall Study|Withdrawal by Subject|7
5027923|NCT03005067|17305556|P2|Overall Study|Protocol Violation|1
5027924|NCT03005067|17305557|P1|Overall Study|Protocol Violation|0
5027925|NCT03005067|17305556|P2|Overall Study|Other (reason not specified)|1
5027926|NCT03005067|17305557|P1|Overall Study|Other (reason not specified)|3
5027927|NCT03005067|17305556|P2|Overall Study|Adverse Event|3
5027928|NCT03005067|17305557|P1|Overall Study|Adverse Event|4
5027929|NCT03005067|17305556|P2|Overall Study|Withdrawal by Subject|2
5027930|NCT03005067|17305557|P1|Overall Study|Withdrawal by Subject|3
5027931|NCT03004924|17305585|P3|Overall Study|HSV1 Positive|0
5027932|NCT03004924|17305586|P2|Overall Study|HSV1 Positive|0
5027933|NCT03004924|17305587|P1|Overall Study|HSV1 Positive|1
5027934|NCT03004924|17305585|P3|Overall Study|Missed Study Visit|2
5027935|NCT03004924|17305586|P2|Overall Study|Missed Study Visit|0
5027936|NCT03004924|17305587|P1|Overall Study|Missed Study Visit|0
5027937|NCT03004924|17305585|P3|Overall Study|Terminated by Sponsor|1
5027938|NCT03004924|17305586|P2|Overall Study|Terminated by Sponsor|0
5027939|NCT03004924|17305587|P1|Overall Study|Terminated by Sponsor|0
5027940|NCT03004924|17305585|P3|Overall Study|Pregnancy|0
5027941|NCT03004924|17305586|P2|Overall Study|Pregnancy|1
5027942|NCT03004924|17305587|P1|Overall Study|Pregnancy|0
5027943|NCT03004924|17305585|P3|Overall Study|Screen Failure|0
5027944|NCT03004924|17305586|P2|Overall Study|Screen Failure|0
5027945|NCT03004924|17305587|P1|Overall Study|Screen Failure|1
5027946|NCT03004924|17305585|P3|Overall Study|Withdrawal by parent/guardian|2
5027947|NCT03004924|17305586|P2|Overall Study|Withdrawal by parent/guardian|0
5027948|NCT03004924|17305587|P1|Overall Study|Withdrawal by parent/guardian|1
5027949|NCT03004924|17305585|P3|Overall Study|Physician Decision|1
5027950|NCT03004924|17305586|P2|Overall Study|Physician Decision|0
5027951|NCT03004924|17305587|P1|Overall Study|Physician Decision|1
5027952|NCT03004924|17305585|P3|Overall Study|Lack of Efficacy|2
5027953|NCT03004924|17305586|P2|Overall Study|Lack of Efficacy|4
5027954|NCT03004924|17305587|P1|Overall Study|Lack of Efficacy|2
5027955|NCT03004924|17305585|P3|Overall Study|Lost to Follow-up|4
5027956|NCT03004924|17305586|P2|Overall Study|Lost to Follow-up|1
5027957|NCT03004924|17305587|P1|Overall Study|Lost to Follow-up|6
5027958|NCT03004924|17305585|P3|Overall Study|Withdrawal by Subject|5
5027959|NCT03004924|17305586|P2|Overall Study|Withdrawal by Subject|3
5027960|NCT03004924|17305587|P1|Overall Study|Withdrawal by Subject|5
5027961|NCT03004924|17305585|P3|Overall Study|Protocol Violation|1
5027962|NCT03004924|17305586|P2|Overall Study|Protocol Violation|0
5027963|NCT03004924|17305587|P1|Overall Study|Protocol Violation|4
5027964|NCT03004924|17305585|P3|Overall Study|Adverse Event|10
5027965|NCT03004924|17305586|P2|Overall Study|Adverse Event|5
5027966|NCT03004924|17305587|P1|Overall Study|Adverse Event|6
5027967|NCT03004469|17305831|P3|Overall Study|Other unspecified reason|1
5027968|NCT03004469|17305832|P2|Overall Study|Other unspecified reason|4
5027969|NCT03004469|17305833|P1|Overall Study|Other unspecified reason|0
5027970|NCT03004469|17305831|P3|Overall Study|Withdrawal by Subject|10
5027971|NCT03004469|17305832|P2|Overall Study|Withdrawal by Subject|27
5027972|NCT03004469|17305833|P1|Overall Study|Withdrawal by Subject|29
5027973|NCT03004469|17305831|P3|Overall Study|Protocol Violation|1
5027974|NCT03004469|17305832|P2|Overall Study|Protocol Violation|0
5027975|NCT03004469|17305833|P1|Overall Study|Protocol Violation|0
5027976|NCT03004469|17305831|P3|Overall Study|Non-Compliance with Study Drug|0
5027977|NCT03004469|17305832|P2|Overall Study|Non-Compliance with Study Drug|0
5027978|NCT03004469|17305833|P1|Overall Study|Non-Compliance with Study Drug|2
5027979|NCT03004469|17305831|P3|Overall Study|Lost to Follow-up|6
5027980|NCT03004469|17305832|P2|Overall Study|Lost to Follow-up|14
5027981|NCT03004469|17305833|P1|Overall Study|Lost to Follow-up|23
5027982|NCT03004469|17305831|P3|Overall Study|Lack of Efficacy|1
5027983|NCT03004469|17305832|P2|Overall Study|Lack of Efficacy|0
5027984|NCT03004469|17305833|P1|Overall Study|Lack of Efficacy|1
5027985|NCT03004469|17305831|P3|Overall Study|Adverse Event|6
5027986|NCT03004469|17305832|P2|Overall Study|Adverse Event|4
5027987|NCT03004469|17305833|P1|Overall Study|Adverse Event|6
5027988|NCT03003520|17305876|P2|Follow-up|Withdrawal by Subject|0
5027989|NCT03003520|17305877|P1|Follow-up|Withdrawal by Subject|1
5027990|NCT03003520|17305876|P2|Follow-up|Ongoing|2
5027991|NCT03003520|17305877|P1|Follow-up|Ongoing|12
5027992|NCT03003520|17305876|P2|Follow-up|Death|1
5027993|NCT03003520|17305877|P1|Follow-up|Death|1
5027994|NCT03003520|17305876|P2|Consolidation|Withdrawal by Subject|0
5027995|NCT03003520|17305877|P1|Consolidation|Withdrawal by Subject|1
5027996|NCT03003520|17305876|P2|Consolidation|Progressive disease|1
5027997|NCT03003520|17305877|P1|Consolidation|Progressive disease|3
5027998|NCT03003520|17305876|P2|Consolidation|Adverse Event|0
5027999|NCT03003520|17305877|P1|Consolidation|Adverse Event|2
5028000|NCT03003520|17305876|P2|Consolidation|Ongoing|0
5028001|NCT03003520|17305877|P1|Consolidation|Ongoing|18
5028002|NCT03003520|17305876|P2|Induction|Progressive disease|0
5028003|NCT03003520|17305877|P1|Induction|Progressive disease|1
5028004|NCT03003520|17305876|P2|Induction|Withdrawal by Subject|0
5028005|NCT03003520|17305877|P1|Induction|Withdrawal by Subject|3
5028006|NCT03003520|17305876|P2|Induction|Physician Decision|0
5028007|NCT03003520|17305877|P1|Induction|Physician Decision|2
5028008|NCT03003520|17305876|P2|Induction|Palliative care|0
5028009|NCT03003520|17305877|P1|Induction|Palliative care|1
5028010|NCT03003520|17305876|P2|Induction|Death|0
5028011|NCT03003520|17305877|P1|Induction|Death|1
5028012|NCT03003520|17305876|P2|Induction|Adverse Event|0
5028013|NCT03003520|17305877|P1|Induction|Adverse Event|4
5028014|NCT03003520|17305876|P2|Induction|Ongoing|0
5028015|NCT03003520|17305877|P1|Induction|Ongoing|1
5028016|NCT03003494|17305895|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
5028017|NCT03003390|17305906|P2|Overall Study|Parent refused intervention|0
5028018|NCT03003390|17305907|P1|Overall Study|Parent refused intervention|2
5028019|NCT03003390|17305906|P2|Overall Study|Physician Decision|0
5028020|NCT03003390|17305907|P1|Overall Study|Physician Decision|2
5028021|NCT03003000|17305935|P3|Overall Study|Other than listed|1
5028022|NCT03003000|17305936|P2|Overall Study|Other than listed|1
5028023|NCT03003000|17305937|P1|Overall Study|Other than listed|1
5028024|NCT03003000|17305935|P3|Overall Study|Refused to continue medication|0
5028025|NCT03003000|17305936|P2|Overall Study|Refused to continue medication|0
5028026|NCT03003000|17305937|P1|Overall Study|Refused to continue medication|2
5028027|NCT03003000|17305935|P3|Overall Study|Non-compliant with protocol|1
5028028|NCT03003000|17305936|P2|Overall Study|Non-compliant with protocol|1
5028029|NCT03003000|17305937|P1|Overall Study|Non-compliant with protocol|0
5028030|NCT03003000|17305935|P3|Overall Study|Lack of Efficacy|0
5028031|NCT03003000|17305936|P2|Overall Study|Lack of Efficacy|0
5028032|NCT03003000|17305937|P1|Overall Study|Lack of Efficacy|1
5028033|NCT03003000|17305935|P3|Overall Study|Adverse Event|3
5028034|NCT03003000|17305936|P2|Overall Study|Adverse Event|2
5028035|NCT03003000|17305937|P1|Overall Study|Adverse Event|1
5028036|NCT03002818|17306039|P1|Overall Study|Decision of the investigator|1
5028037|NCT03002623|17306065|P2|Overall Study|Physician Decision|1
5028038|NCT03002623|17306066|P1|Overall Study|Physician Decision|1
5028039|NCT03002623|17306065|P2|Overall Study|Lost to Follow-up|0
5028040|NCT03002623|17306066|P1|Overall Study|Lost to Follow-up|1
5028041|NCT03002610|17306083|P3|Overall Study|Withdrawal by Subject|13
5028042|NCT03002610|17306084|P2|Overall Study|Withdrawal by Subject|25
5028043|NCT03002610|17306085|P1|Overall Study|Withdrawal by Subject|6
5028044|NCT03002311|17306109|P2|Overall Study|Physician Decision|1
5028045|NCT03002311|17306110|P1|Overall Study|Physician Decision|3
5028046|NCT03002311|17306109|P2|Overall Study|Referral provider called to schedule app|3
5028047|NCT03002311|17306110|P1|Overall Study|Referral provider called to schedule app|3
5028048|NCT03002311|17306109|P2|Overall Study|Lost to Follow-up|26
5028049|NCT03002311|17306110|P1|Overall Study|Lost to Follow-up|13
5028050|NCT03002194|17306118|P1|Overall Study|Withdrawal by Subject|2
5028051|NCT03002194|17306118|P1|Overall Study|Lack of Efficacy|1
5028052|NCT03002194|17306118|P1|Overall Study|Adverse Event|1
5028053|NCT03002194|17306118|P1|Overall Study|Lost to Follow-up|6
5028054|NCT03002077|17306124|P1|Overall Study|Protocol Violation|21
5028055|NCT03002077|17306124|P1|Overall Study|Pregnancy|4
5028056|NCT03002077|17306124|P1|Overall Study|Lost to Follow-up|21
5028057|NCT03002077|17306124|P1|Overall Study|Withdrawal by Subject|72
5028058|NCT03002077|17306124|P1|Overall Study|Lack of Efficacy|20
5028059|NCT03002077|17306124|P1|Overall Study|Adverse Event|23
5028060|NCT03002077|17306124|P1|Overall Study|Miscellaneous Reasons|10
5028061|NCT03002077|17306124|P1|Overall Study|Site Terminated by Sponsor|5
5028062|NCT03002077|17306124|P1|Overall Study|Study Terminated by Sponsor|257
5028063|NCT03002077|17306124|P1|Overall Study|Non-compliance w/Background ADT|1
5028064|NCT03002077|17306124|P1|Overall Study|Non-compliance with Study Drug|4
5028065|NCT03002038|17306132|P2|Overall Study|Immigration to another region|2
5028066|NCT03002038|17306133|P1|Overall Study|Immigration to another region|0
5028067|NCT03002038|17306132|P2|Overall Study|Withdrawal by Subject|4
5028068|NCT03002038|17306133|P1|Overall Study|Withdrawal by Subject|8
5028069|NCT03002038|17306132|P2|Overall Study|Adverse Event|1
5028070|NCT03002038|17306133|P1|Overall Study|Adverse Event|3
5028071|NCT03001557|17306189|P5|Overall Study|Randomized but not treated|0
5028072|NCT03001557|17306190|P4|Overall Study|Randomized but not treated|0
5028073|NCT03001557|17306191|P3|Overall Study|Randomized but not treated|1
5028074|NCT03001557|17306192|P2|Overall Study|Randomized but not treated|0
5028075|NCT03001557|17306193|P1|Overall Study|Randomized but not treated|0
5028076|NCT03001219|17306492|P2|Extension Period Analysis|Withdrawal by Subject|5
5028077|NCT03001219|17306493|P1|Extension Period Analysis|Withdrawal by Subject|4
5028078|NCT03001219|17306492|P2|Extension Period Analysis|Protocol Deviation|1
5028079|NCT03001219|17306493|P1|Extension Period Analysis|Protocol Deviation|0
5028080|NCT03001219|17306492|P2|Extension Period Analysis|Adverse Event|1
5028081|NCT03001219|17306493|P1|Extension Period Analysis|Adverse Event|1
5028082|NCT03001219|17306492|P2|Extension Period Analysis|Physician Decision|1
5028083|NCT03001219|17306493|P1|Extension Period Analysis|Physician Decision|0
5028084|NCT03001219|17306492|P2|Extension Period Analysis|Participant Non-Compliance|1
5028085|NCT03001219|17306493|P1|Extension Period Analysis|Participant Non-Compliance|0
5028086|NCT03001219|17306492|P2|Extension Period Analysis|Study Termination by Sponsor|36
5028087|NCT03001219|17306493|P1|Extension Period Analysis|Study Termination by Sponsor|0
5028088|NCT03001219|17306492|P2|Proof of Concept|Physician Decision|0
5028089|NCT03001219|17306493|P1|Proof of Concept|Physician Decision|1
5028090|NCT03001219|17306492|P2|Proof of Concept|Adverse Event|1
5028091|NCT03001219|17306493|P1|Proof of Concept|Adverse Event|1
5028092|NCT03001219|17306492|P2|Proof of Concept|Protocol Deviation|1
5028093|NCT03001219|17306493|P1|Proof of Concept|Protocol Deviation|0
5028094|NCT03001219|17306492|P2|Proof of Concept|Withdrawal by Subject|4
5028095|NCT03001219|17306493|P1|Proof of Concept|Withdrawal by Subject|0
5028096|NCT03001219|17306492|P2|Proof of Concept|Study Termination by Sponsor|1
5028097|NCT03001219|17306493|P1|Proof of Concept|Study Termination by Sponsor|0
5028098|NCT03001076|17306554|P2|Overall Study|Lost to Follow-up|2
5028099|NCT03001076|17306555|P1|Overall Study|Lost to Follow-up|0
5028100|NCT03001076|17306554|P2|Overall Study|Sponsor decision|0
5028101|NCT03001076|17306555|P1|Overall Study|Sponsor decision|1
5028102|NCT03001076|17306554|P2|Overall Study|Adverse Event|3
5028103|NCT03001076|17306555|P1|Overall Study|Adverse Event|3
5028104|NCT03001076|17306554|P2|Overall Study|Other|0
5028105|NCT03001076|17306555|P1|Overall Study|Other|1
5028106|NCT03001076|17306554|P2|Overall Study|Withdrawal by patient|0
5028107|NCT03001076|17306555|P1|Overall Study|Withdrawal by patient|2
5028108|NCT03001011|17306589|P2|Overall Study|Other than specified above|8
5028109|NCT03001011|17306590|P1|Overall Study|Other than specified above|3
5028110|NCT03001011|17306589|P2|Overall Study|Chronic kidney disease lead to dialysis|10
5028111|NCT03001011|17306590|P1|Overall Study|Chronic kidney disease lead to dialysis|15
5028112|NCT03001011|17306589|P2|Overall Study|Adverse Event|3
5028113|NCT03001011|17306590|P1|Overall Study|Adverse Event|9
5028114|NCT03000686|17306624|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
5028115|NCT03000686|17306625|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
5028116|NCT03000686|17306626|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
5028117|NCT03000686|17306627|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
5028118|NCT03000569|17306706|P2|Overall Study|Withdrawal by Subject|0
5028119|NCT03000569|17306707|P1|Overall Study|Withdrawal by Subject|1
5028120|NCT03000452|17306839|P1|Follow-Up Period|Withdrawal by Subject|3
5028121|NCT03000452|17306839|P1|Follow-Up Period|Death|3
5028122|NCT03000452|17306839|P1|Follow-Up Period|Study Terminated by Sponsor|1
5028123|NCT03000452|17306839|P1|Treatment Period|Miscellaneous|2
5028124|NCT03000452|17306839|P1|Treatment Period|Physician Decision|1
5028125|NCT03000452|17306839|P1|Treatment Period|Progressive Disease (PD)|14
5028126|NCT03000452|17306839|P1|Treatment Period|Death|1
5028127|NCT03000075|17306896|P7|Part B|Adverse Event|0
5028128|NCT03000075|17306897|P6|Part B|Adverse Event|0
5028129|NCT03000075|17306898|P5|Part B|Adverse Event|1
5028130|NCT03000075|17306899|P4|Part B|Adverse Event|0
5028131|NCT03000075|17306900|P3|Part B|Adverse Event|0
5028132|NCT03000075|17306901|P2|Part B|Adverse Event|0
5028133|NCT03000075|17306902|P1|Part B|Adverse Event|0
5028134|NCT03000075|17306896|P7|Part B|Not dosed due to AE|1
5028135|NCT03000075|17306897|P6|Part B|Not dosed due to AE|2
5028136|NCT03000075|17306898|P5|Part B|Not dosed due to AE|0
5028137|NCT03000075|17306899|P4|Part B|Not dosed due to AE|0
5028138|NCT03000075|17306900|P3|Part B|Not dosed due to AE|0
5028139|NCT03000075|17306901|P2|Part B|Not dosed due to AE|0
5028140|NCT03000075|17306902|P1|Part B|Not dosed due to AE|0
5028141|NCT03000075|17306896|P7|Part A|Adverse Event|0
5028142|NCT03000075|17306897|P6|Part A|Adverse Event|0
5028143|NCT03000075|17306898|P5|Part A|Adverse Event|0
5028144|NCT03000075|17306899|P4|Part A|Adverse Event|0
5028145|NCT03000075|17306900|P3|Part A|Adverse Event|0
5028146|NCT03000075|17306901|P2|Part A|Adverse Event|0
5028147|NCT03000075|17306902|P1|Part A|Adverse Event|4
5028148|NCT02999672|17306955|P2|Overall Study|Adverse Event|0
5028149|NCT02999672|17306956|P1|Overall Study|Adverse Event|4
5028150|NCT02999672|17306955|P2|Overall Study|Progressive Disease|5
5028151|NCT02999672|17306956|P1|Overall Study|Progressive Disease|9
5028152|NCT02999672|17306955|P2|Overall Study|Study Terminated by Sponsor|1
5028153|NCT02999672|17306956|P1|Overall Study|Study Terminated by Sponsor|0
5028154|NCT02999672|17306955|P2|Overall Study|Death|1
5028155|NCT02999672|17306956|P1|Overall Study|Death|0
5028156|NCT02999633|17306972|P1|Overall Study|Progressive disease|12
5028157|NCT02999633|17306972|P1|Overall Study|Adverse Event|2
5028158|NCT02999178|17306982|P2|Overall Study|Other reason not defined above|13
5028159|NCT02999178|17306983|P1|Overall Study|Other reason not defined above|7
5028160|NCT02999178|17306982|P2|Overall Study|Withdrawal by Subject|21
5028161|NCT02999178|17306983|P1|Overall Study|Withdrawal by Subject|21
5028162|NCT02999178|17306982|P2|Overall Study|Lost to Follow-up|2
5028163|NCT02999178|17306983|P1|Overall Study|Lost to Follow-up|0
5028164|NCT02999178|17306982|P2|Overall Study|Protocol Violation|2
5028165|NCT02999178|17306983|P1|Overall Study|Protocol Violation|1
5028166|NCT02999178|17306982|P2|Overall Study|Adverse Event|62
5028167|NCT02999178|17306983|P1|Overall Study|Adverse Event|85
5028168|NCT02999100|17307033|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5028169|NCT02999100|17307034|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5028170|NCT02999100|17307035|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5028171|NCT02999100|17307036|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
5028172|NCT02999100|17307037|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5028173|NCT02999100|17307038|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5028174|NCT02999100|17307033|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
5028175|NCT02999100|17307034|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5028176|NCT02999100|17307035|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5028177|NCT02999100|17307036|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5028178|NCT02999100|17307037|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5028179|NCT02999100|17307038|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5028180|NCT02999100|17307033|P6|Part 1 (up to 15 Days)|Adverse Event|0
5028181|NCT02999100|17307034|P5|Part 1 (up to 15 Days)|Adverse Event|0
5028182|NCT02999100|17307035|P4|Part 1 (up to 15 Days)|Adverse Event|0
5028183|NCT02999100|17307036|P3|Part 1 (up to 15 Days)|Adverse Event|0
5028184|NCT02999100|17307037|P2|Part 1 (up to 15 Days)|Adverse Event|1
5028185|NCT02999100|17307038|P1|Part 1 (up to 15 Days)|Adverse Event|0
5028186|NCT02998996|17307206|P6|Overall Study|Family reasons|0
5028187|NCT02998996|17307207|P5|Overall Study|Family reasons|1
5028188|NCT02998996|17307208|P4|Overall Study|Family reasons|0
5028189|NCT02998996|17307209|P3|Overall Study|Family reasons|0
5028190|NCT02998996|17307210|P2|Overall Study|Family reasons|0
5028191|NCT02998996|17307211|P1|Overall Study|Family reasons|0
5028192|NCT02998996|17307206|P6|Overall Study|Pregnancy|0
5028193|NCT02998996|17307207|P5|Overall Study|Pregnancy|0
5028194|NCT02998996|17307208|P4|Overall Study|Pregnancy|0
5028195|NCT02998996|17307209|P3|Overall Study|Pregnancy|0
5028196|NCT02998996|17307210|P2|Overall Study|Pregnancy|1
5028197|NCT02998996|17307211|P1|Overall Study|Pregnancy|0
5028198|NCT02998996|17307206|P6|Overall Study|Lost to Follow-up|0
5028199|NCT02998996|17307207|P5|Overall Study|Lost to Follow-up|0
5028200|NCT02998996|17307208|P4|Overall Study|Lost to Follow-up|0
5028201|NCT02998996|17307209|P3|Overall Study|Lost to Follow-up|1
5028202|NCT02998996|17307210|P2|Overall Study|Lost to Follow-up|0
5028203|NCT02998996|17307211|P1|Overall Study|Lost to Follow-up|0
5028204|NCT02998671|17307245|P5|Period 2|Lost to Follow-up|0
5028205|NCT02998671|17307246|P4|Period 2|Lost to Follow-up|1
5028206|NCT02998671|17307247|P3|Period 2|Lost to Follow-up|0
5028207|NCT02998671|17307248|P2|Period 2|Lost to Follow-up|0
5028208|NCT02998671|17307249|P1|Period 2|Lost to Follow-up|0
5028209|NCT02998671|17307245|P5|Period 2|Withdrawal by Subject|0
5028210|NCT02998671|17307246|P4|Period 2|Withdrawal by Subject|0
5028211|NCT02998671|17307247|P3|Period 2|Withdrawal by Subject|0
5028212|NCT02998671|17307248|P2|Period 2|Withdrawal by Subject|1
5028213|NCT02998671|17307249|P1|Period 2|Withdrawal by Subject|0
5028214|NCT02998671|17307245|P5|Period 2|Study Terminated By Sponsor|0
5028215|NCT02998671|17307246|P4|Period 2|Study Terminated By Sponsor|3
5028216|NCT02998671|17307247|P3|Period 2|Study Terminated By Sponsor|1
5028217|NCT02998671|17307248|P2|Period 2|Study Terminated By Sponsor|5
5028218|NCT02998671|17307249|P1|Period 2|Study Terminated By Sponsor|3
5028219|NCT02998671|17307245|P5|Period 2|Adverse Event|0
5028220|NCT02998671|17307246|P4|Period 2|Adverse Event|0
5028221|NCT02998671|17307247|P3|Period 2|Adverse Event|0
5028222|NCT02998671|17307248|P2|Period 2|Adverse Event|1
5028223|NCT02998671|17307249|P1|Period 2|Adverse Event|0
5028224|NCT02998671|17307245|P5|Period 1|Adverse Event|1
5028225|NCT02998671|17307246|P4|Period 1|Adverse Event|0
5028226|NCT02998671|17307247|P3|Period 1|Adverse Event|0
5028227|NCT02998671|17307248|P2|Period 1|Adverse Event|0
5028228|NCT02998671|17307249|P1|Period 1|Adverse Event|0
5028229|NCT02998671|17307245|P5|Period 1|Pregnancy|0
5028230|NCT02998671|17307246|P4|Period 1|Pregnancy|0
5028231|NCT02998671|17307247|P3|Period 1|Pregnancy|0
5028232|NCT02998671|17307248|P2|Period 1|Pregnancy|0
5028233|NCT02998671|17307249|P1|Period 1|Pregnancy|1
5028234|NCT02998671|17307245|P5|Period 1|Withdrawal by Subject|2
5028235|NCT02998671|17307246|P4|Period 1|Withdrawal by Subject|0
5028236|NCT02998671|17307247|P3|Period 1|Withdrawal by Subject|0
5028237|NCT02998671|17307248|P2|Period 1|Withdrawal by Subject|2
5028238|NCT02998671|17307249|P1|Period 1|Withdrawal by Subject|1
5028239|NCT02998671|17307245|P5|Period 1|Study Terminated By Sponsor|1
5028240|NCT02998671|17307246|P4|Period 1|Study Terminated By Sponsor|0
5028241|NCT02998671|17307247|P3|Period 1|Study Terminated By Sponsor|0
5028242|NCT02998671|17307248|P2|Period 1|Study Terminated By Sponsor|1
5028243|NCT02998671|17307249|P1|Period 1|Study Terminated By Sponsor|2
5028244|NCT02998554|17307294|P2|Overall Study|Lack of Efficacy|1
5028245|NCT02998554|17307295|P1|Overall Study|Lack of Efficacy|0
5028246|NCT02998554|17307294|P2|Overall Study|Lost to Follow-up|1
5028247|NCT02998554|17307295|P1|Overall Study|Lost to Follow-up|0
5028248|NCT02998554|17307294|P2|Overall Study|Withdrawal by Subject|6
5028249|NCT02998554|17307295|P1|Overall Study|Withdrawal by Subject|2
5028250|NCT02998554|17307294|P2|Overall Study|Protocol deviation|0
5028251|NCT02998554|17307295|P1|Overall Study|Protocol deviation|1
5028252|NCT02998554|17307294|P2|Overall Study|Adverse Event|3
5028253|NCT02998554|17307295|P1|Overall Study|Adverse Event|8
5028254|NCT02998541|17307326|P3|Overall Study|Withdrawal by Parent/Guardian|1
5028255|NCT02998541|17307327|P2|Overall Study|Withdrawal by Parent/Guardian|0
5028256|NCT02998541|17307328|P1|Overall Study|Withdrawal by Parent/Guardian|0
5028257|NCT02998541|17307326|P3|Overall Study|Physician Decision|3
5028258|NCT02998541|17307327|P2|Overall Study|Physician Decision|0
5028259|NCT02998541|17307328|P1|Overall Study|Physician Decision|0
5028260|NCT02998541|17307326|P3|Overall Study|Lost to Follow-up|1
5028261|NCT02998541|17307327|P2|Overall Study|Lost to Follow-up|3
5028262|NCT02998541|17307328|P1|Overall Study|Lost to Follow-up|0
5028263|NCT02998541|17307326|P3|Overall Study|Withdrawal by Subject|0
5028264|NCT02998541|17307327|P2|Overall Study|Withdrawal by Subject|1
5028265|NCT02998541|17307328|P1|Overall Study|Withdrawal by Subject|3
5028266|NCT02998541|17307326|P3|Overall Study|Protocol Violation|0
5028267|NCT02998541|17307327|P2|Overall Study|Protocol Violation|0
5028268|NCT02998541|17307328|P1|Overall Study|Protocol Violation|1
5028269|NCT02998541|17307326|P3|Overall Study|Adverse Event|1
5028270|NCT02998541|17307327|P2|Overall Study|Adverse Event|5
5028271|NCT02998541|17307328|P1|Overall Study|Adverse Event|4
5028272|NCT02998476|17307383|P2|Overall Study|Death|2
5028273|NCT02998476|17307384|P1|Overall Study|Death|32
5028274|NCT02998476|17307383|P2|Overall Study|Withdrawal by Subject|2
5028275|NCT02998476|17307384|P1|Overall Study|Withdrawal by Subject|1
5028276|NCT02998476|17307383|P2|Overall Study|Disease Progression|0
5028277|NCT02998476|17307384|P1|Overall Study|Disease Progression|1
5028278|NCT02998476|17307383|P2|Overall Study|Ongoing in study|1
5028279|NCT02998476|17307384|P1|Overall Study|Ongoing in study|21
5028280|NCT02998021|17307394|P2|Overall Study|unsafe home|1
5028281|NCT02998021|17307395|P1|Overall Study|unsafe home|0
5028282|NCT02998021|17307394|P2|Overall Study|Withdrawal by Subject|1
5028283|NCT02998021|17307395|P1|Overall Study|Withdrawal by Subject|3
5028284|NCT02997163|17307470|P4|Overall Study|Adverse Event|1
5028285|NCT02997163|17307471|P3|Overall Study|Adverse Event|0
5028286|NCT02997163|17307472|P2|Overall Study|Adverse Event|0
5028287|NCT02997163|17307473|P1|Overall Study|Adverse Event|1
5028288|NCT02996968|17307605|P2|Overall Study|Withdrawal by Subject|0
5028289|NCT02996968|17307606|P1|Overall Study|Withdrawal by Subject|1
5028290|NCT02996682|17307614|P2|Overall Study|Death|3
5028291|NCT02996682|17307615|P1|Overall Study|Death|0
5028292|NCT02996500|17307694|P6|Overall Study|Withdrawal by Subject|0
5028293|NCT02996500|17307695|P5|Overall Study|Withdrawal by Subject|2
5028294|NCT02996500|17307696|P4|Overall Study|Withdrawal by Subject|0
5028295|NCT02996500|17307697|P3|Overall Study|Withdrawal by Subject|3
5028296|NCT02996500|17307698|P2|Overall Study|Withdrawal by Subject|0
5028297|NCT02996500|17307699|P1|Overall Study|Withdrawal by Subject|3
5028298|NCT02996500|17307694|P6|Overall Study|Protocol Violation|0
5028299|NCT02996500|17307695|P5|Overall Study|Protocol Violation|0
5028300|NCT02996500|17307696|P4|Overall Study|Protocol Violation|1
5028301|NCT02996500|17307697|P3|Overall Study|Protocol Violation|0
5028302|NCT02996500|17307698|P2|Overall Study|Protocol Violation|0
5028303|NCT02996500|17307699|P1|Overall Study|Protocol Violation|0
5028304|NCT02996500|17307694|P6|Overall Study|Other|0
5028305|NCT02996500|17307695|P5|Overall Study|Other|0
5028306|NCT02996500|17307696|P4|Overall Study|Other|0
5028307|NCT02996500|17307697|P3|Overall Study|Other|2
5028308|NCT02996500|17307698|P2|Overall Study|Other|0
5028309|NCT02996500|17307699|P1|Overall Study|Other|2
5028310|NCT02996500|17307694|P6|Overall Study|Progressive Disease|0
5028311|NCT02996500|17307695|P5|Overall Study|Progressive Disease|0
5028312|NCT02996500|17307696|P4|Overall Study|Progressive Disease|0
5028313|NCT02996500|17307697|P3|Overall Study|Progressive Disease|0
5028314|NCT02996500|17307698|P2|Overall Study|Progressive Disease|0
5028315|NCT02996500|17307699|P1|Overall Study|Progressive Disease|1
5028316|NCT02996500|17307694|P6|Overall Study|Non-Compliance With Study Drug|1
5028317|NCT02996500|17307695|P5|Overall Study|Non-Compliance With Study Drug|0
5028318|NCT02996500|17307696|P4|Overall Study|Non-Compliance With Study Drug|0
5028319|NCT02996500|17307697|P3|Overall Study|Non-Compliance With Study Drug|0
5028320|NCT02996500|17307698|P2|Overall Study|Non-Compliance With Study Drug|0
5028321|NCT02996500|17307699|P1|Overall Study|Non-Compliance With Study Drug|0
5028322|NCT02996500|17307694|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5028323|NCT02996500|17307695|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5028324|NCT02996500|17307696|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5028325|NCT02996500|17307697|P3|Overall Study|No Longer Meets Eligibility Criteria|1
5028326|NCT02996500|17307698|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5028327|NCT02996500|17307699|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5028328|NCT02996500|17307694|P6|Overall Study|Lost to Follow-up|1
5028329|NCT02996500|17307695|P5|Overall Study|Lost to Follow-up|0
5028330|NCT02996500|17307696|P4|Overall Study|Lost to Follow-up|0
5028331|NCT02996500|17307697|P3|Overall Study|Lost to Follow-up|0
5028332|NCT02996500|17307698|P2|Overall Study|Lost to Follow-up|0
5028333|NCT02996500|17307699|P1|Overall Study|Lost to Follow-up|1
5028334|NCT02996500|17307694|P6|Overall Study|Lack of Efficacy|0
5028335|NCT02996500|17307695|P5|Overall Study|Lack of Efficacy|2
5028336|NCT02996500|17307696|P4|Overall Study|Lack of Efficacy|0
5028337|NCT02996500|17307697|P3|Overall Study|Lack of Efficacy|0
5028338|NCT02996500|17307698|P2|Overall Study|Lack of Efficacy|0
5028339|NCT02996500|17307699|P1|Overall Study|Lack of Efficacy|0
5028340|NCT02996500|17307694|P6|Overall Study|Adverse Event|2
5028341|NCT02996500|17307695|P5|Overall Study|Adverse Event|1
5028342|NCT02996500|17307696|P4|Overall Study|Adverse Event|3
5028343|NCT02996500|17307697|P3|Overall Study|Adverse Event|4
5028344|NCT02996500|17307698|P2|Overall Study|Adverse Event|1
5028345|NCT02996500|17307699|P1|Overall Study|Adverse Event|1
5028346|NCT02996474|17307882|P1|Overall Study|Physician Decision|5
5028347|NCT02996448|17307886|P1|Overall Study|Study terminated due to adverse effects|3
5028348|NCT02996097|17307892|P2|Overall Study|Lost to Follow-up|11
5028349|NCT02996097|17307893|P1|Overall Study|Lost to Follow-up|11
5028350|NCT02995980|17307900|P1|Overall Study|Lost to Follow-up|14
5028351|NCT02994108|17307977|P2|Phase 2 Assessment|Withdrawal by Subject|0
5028352|NCT02994108|17307978|P1|Phase 2 Assessment|Withdrawal by Subject|1
5028353|NCT02994108|17307977|P2|Phase 2 Assessment|Lost to Follow-up|7
5028354|NCT02994108|17307978|P1|Phase 2 Assessment|Lost to Follow-up|8
5028355|NCT02994108|17307977|P2|Phase 1 Assessment|Lost to Follow-up|3
5028356|NCT02994108|17307978|P1|Phase 1 Assessment|Lost to Follow-up|5
5028357|NCT02994108|17307977|P2|Intervention Messages|Withdrawal by Subject|0
5028358|NCT02994108|17307978|P1|Intervention Messages|Withdrawal by Subject|2
5028359|NCT02994056|17308010|P1|Overall Study|Withdrew Consent|1
5028360|NCT02994056|17308010|P1|Overall Study|Death|8
5028361|NCT02993926|17308044|P3|Enantone Treatment Phase|Reason Not Specified|0
5028362|NCT02993926|17308045|P2|Enantone Treatment Phase|Reason Not Specified|0
5028363|NCT02993926|17308046|P1|Enantone Treatment Phase|Reason Not Specified|4
5028364|NCT02993926|17308044|P3|Enantone Treatment Phase|Investigator Judgment|0
5028365|NCT02993926|17308045|P2|Enantone Treatment Phase|Investigator Judgment|0
5028366|NCT02993926|17308046|P1|Enantone Treatment Phase|Investigator Judgment|1
5028367|NCT02993926|17308044|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
5028368|NCT02993926|17308045|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
5028369|NCT02993926|17308046|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
5028370|NCT02993926|17308044|P3|Enantone Treatment Phase|Adverse Event|0
5028371|NCT02993926|17308045|P2|Enantone Treatment Phase|Adverse Event|0
5028372|NCT02993926|17308046|P1|Enantone Treatment Phase|Adverse Event|1
5028373|NCT02993783|17308078|P2|Overall Study|Reason not Specified|9
5028374|NCT02993783|17308079|P1|Overall Study|Reason not Specified|6
5028375|NCT02993757|17308111|P2|Overall Study|Voluntary withdraw not due adverse event|8
5028376|NCT02993757|17308112|P1|Overall Study|Voluntary withdraw not due adverse event|8
5028377|NCT02993757|17308111|P2|Overall Study|Lost to Follow-up|0
5028378|NCT02993757|17308112|P1|Overall Study|Lost to Follow-up|1
5028379|NCT02993757|17308111|P2|Overall Study|Non compliance with the protocol|170
5028380|NCT02993757|17308112|P1|Overall Study|Non compliance with the protocol|155
5028381|NCT02993471|17308144|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
5028382|NCT02993471|17308144|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
5028383|NCT02993250|17308206|P2|Overall Study|Lost to Follow-up|1
5028384|NCT02993250|17308207|P1|Overall Study|Lost to Follow-up|0
5028385|NCT02992691|17308227|P1|Overall Study|Withdrawal by Subject|1
5028386|NCT02992691|17308227|P1|Overall Study|Adverse Event|2
5028387|NCT02992418|17308246|P2|Overall Study|Lost to Follow-up|22
5028388|NCT02992418|17308247|P1|Overall Study|Lost to Follow-up|27
5028389|NCT02992418|17308246|P2|Overall Study|Non-compliance with the protocol|308
5028390|NCT02992418|17308247|P1|Overall Study|Non-compliance with the protocol|308
5028391|NCT02992418|17308246|P2|Overall Study|Withdrawal by Subject|12
5028392|NCT02992418|17308247|P1|Overall Study|Withdrawal by Subject|11
5028393|NCT02992288|17308287|P6|Overall Study|Withdrawal by Subject|4
5028394|NCT02992288|17308288|P5|Overall Study|Withdrawal by Subject|3
5028395|NCT02992288|17308289|P4|Overall Study|Withdrawal by Subject|5
5028396|NCT02992288|17308290|P3|Overall Study|Withdrawal by Subject|1
5028397|NCT02992288|17308291|P2|Overall Study|Withdrawal by Subject|2
5028398|NCT02992288|17308292|P1|Overall Study|Withdrawal by Subject|4
5028399|NCT02992288|17308287|P6|Overall Study|Protocol Violation|1
5028400|NCT02992288|17308288|P5|Overall Study|Protocol Violation|0
5028401|NCT02992288|17308289|P4|Overall Study|Protocol Violation|0
5028402|NCT02992288|17308290|P3|Overall Study|Protocol Violation|0
5028403|NCT02992288|17308291|P2|Overall Study|Protocol Violation|0
5028404|NCT02992288|17308292|P1|Overall Study|Protocol Violation|0
5028405|NCT02992288|17308287|P6|Overall Study|Lost to Follow-up|0
5028406|NCT02992288|17308288|P5|Overall Study|Lost to Follow-up|0
5028407|NCT02992288|17308289|P4|Overall Study|Lost to Follow-up|1
5028408|NCT02992288|17308290|P3|Overall Study|Lost to Follow-up|0
5028409|NCT02992288|17308291|P2|Overall Study|Lost to Follow-up|0
5028410|NCT02992288|17308292|P1|Overall Study|Lost to Follow-up|0
5028411|NCT02992288|17308287|P6|Overall Study|Death|0
5028412|NCT02992288|17308288|P5|Overall Study|Death|2
5028413|NCT02992288|17308289|P4|Overall Study|Death|1
5028414|NCT02992288|17308290|P3|Overall Study|Death|2
5028415|NCT02992288|17308291|P2|Overall Study|Death|0
5028416|NCT02992288|17308292|P1|Overall Study|Death|2
5028417|NCT02992288|17308287|P6|Overall Study|Physician Decision|1
5028418|NCT02992288|17308288|P5|Overall Study|Physician Decision|0
5028419|NCT02992288|17308289|P4|Overall Study|Physician Decision|0
5028420|NCT02992288|17308290|P3|Overall Study|Physician Decision|1
5028421|NCT02992288|17308291|P2|Overall Study|Physician Decision|0
5028422|NCT02992288|17308292|P1|Overall Study|Physician Decision|3
5028423|NCT02992288|17308287|P6|Overall Study|Non-compliance with study drug|0
5028424|NCT02992288|17308288|P5|Overall Study|Non-compliance with study drug|1
5028425|NCT02992288|17308289|P4|Overall Study|Non-compliance with study drug|0
5028426|NCT02992288|17308290|P3|Overall Study|Non-compliance with study drug|1
5028427|NCT02992288|17308291|P2|Overall Study|Non-compliance with study drug|1
5028428|NCT02992288|17308292|P1|Overall Study|Non-compliance with study drug|0
5028429|NCT02992288|17308287|P6|Overall Study|Adverse Event|7
5028430|NCT02992288|17308288|P5|Overall Study|Adverse Event|2
5028431|NCT02992288|17308289|P4|Overall Study|Adverse Event|2
5028432|NCT02992288|17308290|P3|Overall Study|Adverse Event|2
5028433|NCT02992288|17308291|P2|Overall Study|Adverse Event|2
5028434|NCT02992288|17308292|P1|Overall Study|Adverse Event|8
5028435|NCT02992132|17308377|P3|Overall Study|Physician Decision|1
5028436|NCT02992132|17308378|P2|Overall Study|Physician Decision|0
5028437|NCT02992132|17308379|P1|Overall Study|Physician Decision|0
5028438|NCT02992132|17308377|P3|Overall Study|Withdrawal by Subject|1
5028439|NCT02992132|17308378|P2|Overall Study|Withdrawal by Subject|2
5028440|NCT02992132|17308379|P1|Overall Study|Withdrawal by Subject|0
5028441|NCT02992132|17308377|P3|Overall Study|Caregiver withdrew consent|2
5028442|NCT02992132|17308378|P2|Overall Study|Caregiver withdrew consent|3
5028443|NCT02992132|17308379|P1|Overall Study|Caregiver withdrew consent|2
5028444|NCT02992132|17308377|P3|Overall Study|Protocol Violation|0
5028445|NCT02992132|17308378|P2|Overall Study|Protocol Violation|2
5028446|NCT02992132|17308379|P1|Overall Study|Protocol Violation|2
5028447|NCT02992132|17308377|P3|Overall Study|Progressive disease|0
5028448|NCT02992132|17308378|P2|Overall Study|Progressive disease|0
5028449|NCT02992132|17308379|P1|Overall Study|Progressive disease|1
5028450|NCT02992132|17308377|P3|Overall Study|Non-compliance with study drug|0
5028451|NCT02992132|17308378|P2|Overall Study|Non-compliance with study drug|0
5028452|NCT02992132|17308379|P1|Overall Study|Non-compliance with study drug|2
5028453|NCT02992132|17308377|P3|Overall Study|Lack of Efficacy|0
5028454|NCT02992132|17308378|P2|Overall Study|Lack of Efficacy|0
5028455|NCT02992132|17308379|P1|Overall Study|Lack of Efficacy|2
5028456|NCT02992132|17308377|P3|Overall Study|Adverse Event|3
5028457|NCT02992132|17308378|P2|Overall Study|Adverse Event|1
5028458|NCT02992132|17308379|P1|Overall Study|Adverse Event|4
5028459|NCT02991859|17308492|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028460|NCT02991859|17308493|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028461|NCT02991859|17308494|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028462|NCT02991859|17308495|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028463|NCT02991859|17308496|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028464|NCT02991859|17308497|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028465|NCT02991859|17308498|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028466|NCT02991859|17308499|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028467|NCT02991859|17308500|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
5028468|NCT02991859|17308501|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028469|NCT02991859|17308502|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028470|NCT02991859|17308503|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028471|NCT02991859|17308504|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028472|NCT02991859|17308505|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028473|NCT02991859|17308506|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028474|NCT02991859|17308507|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028475|NCT02991859|17308508|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5028476|NCT02991859|17308492|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
5028477|NCT02991859|17308493|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
5028478|NCT02991859|17308494|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
5028479|NCT02991859|17308495|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
5028480|NCT02991859|17308496|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
5028481|NCT02991859|17308497|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
5028482|NCT02991859|17308498|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
5028483|NCT02991859|17308499|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
5028484|NCT02991859|17308500|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
5028485|NCT02991859|17308501|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
5028486|NCT02991859|17308502|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
5028487|NCT02991859|17308503|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
5028488|NCT02991859|17308504|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
5028489|NCT02991859|17308505|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
5028490|NCT02991859|17308506|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
5028491|NCT02991859|17308507|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
5028492|NCT02991859|17308508|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
5028493|NCT02991859|17308492|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028494|NCT02991859|17308493|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028495|NCT02991859|17308494|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028496|NCT02991859|17308495|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028497|NCT02991859|17308496|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028498|NCT02991859|17308497|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028499|NCT02991859|17308498|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028500|NCT02991859|17308499|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028501|NCT02991859|17308500|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028502|NCT02991859|17308501|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028503|NCT02991859|17308502|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028504|NCT02991859|17308503|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
5028505|NCT02991859|17308504|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028506|NCT02991859|17308505|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028507|NCT02991859|17308506|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028508|NCT02991859|17308507|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028509|NCT02991859|17308508|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
5028510|NCT02991859|17308492|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028511|NCT02991859|17308493|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028512|NCT02991859|17308494|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028513|NCT02991859|17308495|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
5028514|NCT02991859|17308496|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
5028515|NCT02991859|17308497|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028516|NCT02991859|17308498|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028517|NCT02991859|17308499|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028518|NCT02991859|17308500|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028519|NCT02991859|17308501|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028520|NCT02991859|17308502|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028521|NCT02991859|17308503|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028522|NCT02991859|17308504|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028523|NCT02991859|17308505|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028524|NCT02991859|17308506|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028525|NCT02991859|17308507|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028526|NCT02991859|17308508|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5028527|NCT02991859|17308492|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028528|NCT02991859|17308493|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028529|NCT02991859|17308494|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028530|NCT02991859|17308495|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028531|NCT02991859|17308496|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028532|NCT02991859|17308497|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028533|NCT02991859|17308498|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028534|NCT02991859|17308499|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028535|NCT02991859|17308500|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028536|NCT02991859|17308501|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028537|NCT02991859|17308502|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028538|NCT02991859|17308503|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028539|NCT02991859|17308504|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
5028540|NCT02991859|17308505|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028541|NCT02991859|17308506|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028542|NCT02991859|17308507|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
5028543|NCT02991859|17308508|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5028544|NCT02991430|17308803|P3|Post-treatment Observation Period|Study Termination|5
5028545|NCT02991430|17308804|P2|Post-treatment Observation Period|Study Termination|6
5028546|NCT02991430|17308805|P1|Post-treatment Observation Period|Study Termination|3
5028547|NCT02991430|17308803|P3|Treatment Period 2|Lost to Follow-up|1
5028548|NCT02991430|17308804|P2|Treatment Period 2|Lost to Follow-up|0
5028549|NCT02991430|17308805|P1|Treatment Period 2|Lost to Follow-up|0
5028550|NCT02991430|17308803|P3|Treatment Period 2|Study Termination|3
5028551|NCT02991430|17308804|P2|Treatment Period 2|Study Termination|3
5028552|NCT02991430|17308805|P1|Treatment Period 2|Study Termination|6
5028553|NCT02991430|17308803|P3|Treatment Period 1|Withdrawal by Subject|0
5028554|NCT02991430|17308804|P2|Treatment Period 1|Withdrawal by Subject|4
5028555|NCT02991430|17308805|P1|Treatment Period 1|Withdrawal by Subject|0
5028556|NCT02991430|17308803|P3|Treatment Period 1|Adverse Event|2
5028557|NCT02991430|17308804|P2|Treatment Period 1|Adverse Event|0
5028558|NCT02991430|17308805|P1|Treatment Period 1|Adverse Event|1
5028559|NCT02991118|17308842|P2|Overall Study|Lost to Follow-up|9
5028560|NCT02991118|17308843|P1|Overall Study|Lost to Follow-up|1
5028561|NCT02991118|17308842|P2|Overall Study|Could not attend study visits|1
5028562|NCT02991118|17308843|P1|Overall Study|Could not attend study visits|0
5028563|NCT02991118|17308842|P2|Overall Study|Withdrawal by Subject|7
5028564|NCT02991118|17308843|P1|Overall Study|Withdrawal by Subject|1
5028565|NCT02991118|17308842|P2|Overall Study|Adverse Event|2
5028566|NCT02991118|17308843|P1|Overall Study|Adverse Event|2
5028567|NCT02991118|17308842|P2|Overall Study|Moved out of the country|1
5028568|NCT02991118|17308843|P1|Overall Study|Moved out of the country|0
5028569|NCT02991118|17308842|P2|Overall Study|Physician Decision|1
5028570|NCT02991118|17308843|P1|Overall Study|Physician Decision|0
5028571|NCT02991118|17308842|P2|Overall Study|Protocol Violation|3
5028572|NCT02991118|17308843|P1|Overall Study|Protocol Violation|0
5028573|NCT02991118|17308842|P2|Overall Study|Death|8
5028574|NCT02991118|17308843|P1|Overall Study|Death|3
5028575|NCT02991040|17308887|P1|Overall Study|Lost to Follow-up|2
5028576|NCT02991040|17308887|P1|Overall Study|Withdrawal by Subject|2
5028577|NCT02990910|17308902|P2|Overall Study|Lack of Efficacy|10
5028578|NCT02990910|17308903|P1|Overall Study|Lack of Efficacy|6
5028579|NCT02990338|17308913|P2|Overall Study|Randomized but not treated|2
5028580|NCT02990338|17308914|P1|Overall Study|Randomized but not treated|4
5028581|NCT02990338|17308913|P2|Overall Study|Other|4
5028582|NCT02990338|17308914|P1|Overall Study|Other|1
5028583|NCT02990338|17308913|P2|Overall Study|Withdrawal by Subject|5
5028584|NCT02990338|17308914|P1|Overall Study|Withdrawal by Subject|6
5028585|NCT02990338|17308913|P2|Overall Study|Poor compliance to protocol|1
5028586|NCT02990338|17308914|P1|Overall Study|Poor compliance to protocol|0
5028587|NCT02990338|17308913|P2|Overall Study|Progressive disease|66
5028588|NCT02990338|17308914|P1|Overall Study|Progressive disease|88
5028589|NCT02990338|17308913|P2|Overall Study|Adverse Event|11
5028590|NCT02990338|17308914|P1|Overall Study|Adverse Event|19
5028681|NCT02987543|17309392|P1|Overall Study|Screen failure|0
5028591|NCT02990000|17308962|P2|Overall Study|Failed to provide data beyond baseline|34
5028592|NCT02990000|17308963|P1|Overall Study|Failed to provide data beyond baseline|36
5028593|NCT02989805|17308983|P2|Overall Study|invalid consent|4
5028594|NCT02989805|17308984|P1|Overall Study|invalid consent|6
5028595|NCT02989649|17309085|P1|Overall Study|Reason Not Specified|13
5028596|NCT02989649|17309085|P1|Overall Study|Lost For Observation During Study|3
5028597|NCT02989649|17309085|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
5028598|NCT02989649|17309085|P1|Overall Study|Patient/Investigator's Decision to Stop|403
5028599|NCT02989610|17309097|P1|Overall Study|Withdrawal/Other reasons|39
5028600|NCT02989389|17309127|P10|Period 1|Physician Decision|0
5028601|NCT02989389|17309128|P9|Period 1|Physician Decision|1
5028602|NCT02989389|17309129|P8|Period 1|Physician Decision|0
5028603|NCT02989389|17309130|P7|Period 1|Physician Decision|0
5028604|NCT02989389|17309131|P6|Period 1|Physician Decision|0
5028605|NCT02989389|17309132|P5|Period 1|Physician Decision|0
5028606|NCT02989389|17309133|P4|Period 1|Physician Decision|0
5028607|NCT02989389|17309134|P3|Period 1|Physician Decision|0
5028608|NCT02989389|17309135|P2|Period 1|Physician Decision|0
5028609|NCT02989389|17309136|P1|Period 1|Physician Decision|0
5028610|NCT02989389|17309127|P10|Period 1|Lost to Follow-up|0
5028611|NCT02989389|17309128|P9|Period 1|Lost to Follow-up|0
5028612|NCT02989389|17309129|P8|Period 1|Lost to Follow-up|0
5028613|NCT02989389|17309130|P7|Period 1|Lost to Follow-up|0
5028614|NCT02989389|17309131|P6|Period 1|Lost to Follow-up|0
5028615|NCT02989389|17309132|P5|Period 1|Lost to Follow-up|0
5028616|NCT02989389|17309133|P4|Period 1|Lost to Follow-up|0
5028617|NCT02989389|17309134|P3|Period 1|Lost to Follow-up|0
5028618|NCT02989389|17309135|P2|Period 1|Lost to Follow-up|1
5028619|NCT02989389|17309136|P1|Period 1|Lost to Follow-up|0
5028620|NCT02989168|17309202|P2|Overall Study|Sponsor stopped study.|0
5028621|NCT02989168|17309203|P1|Overall Study|Sponsor stopped study.|1
5028622|NCT02989168|17309202|P2|Overall Study|Adverse Event|2
5028623|NCT02989168|17309203|P1|Overall Study|Adverse Event|1
5028624|NCT02989168|17309202|P2|Overall Study|Physician Decision|1
5028625|NCT02989168|17309203|P1|Overall Study|Physician Decision|0
5028626|NCT02989168|17309202|P2|Overall Study|Withdrawal by Subject|0
5028627|NCT02989168|17309203|P1|Overall Study|Withdrawal by Subject|2
5028628|NCT02988622|17309242|P1|Overall Study|Lost to Follow-up|17
5028629|NCT02988219|17309277|P2|Overall Study|Withdrawal by Subject|2
5028630|NCT02988219|17309278|P1|Overall Study|Withdrawal by Subject|0
5028631|NCT02988219|17309277|P2|Overall Study|Lack of Efficacy|1
5028632|NCT02988219|17309278|P1|Overall Study|Lack of Efficacy|1
5028633|NCT02988115|17309297|P2|Overall Study|Lost to Follow-up|0
5028634|NCT02988115|17309298|P1|Overall Study|Lost to Follow-up|1
5028635|NCT02988115|17309297|P2|Overall Study|Withdrawn by Mistake|0
5028636|NCT02988115|17309298|P1|Overall Study|Withdrawn by Mistake|1
5028637|NCT02988115|17309297|P2|Overall Study|Withdrawal by Subject|1
5028638|NCT02988115|17309298|P1|Overall Study|Withdrawal by Subject|1
5028639|NCT02988115|17309297|P2|Overall Study|Sponsor Decision|2
5028640|NCT02988115|17309298|P1|Overall Study|Sponsor Decision|5
5028641|NCT02988115|17309297|P2|Overall Study|Adverse Event|1
5028642|NCT02988115|17309298|P1|Overall Study|Adverse Event|6
5028643|NCT02987972|17309324|P3|Overall Study|Withdrawal by Subject|21
5028644|NCT02987972|17309325|P2|Overall Study|Withdrawal by Subject|17
5028645|NCT02987972|17309326|P1|Overall Study|Withdrawal by Subject|22
5028646|NCT02987972|17309324|P3|Overall Study|Protocol Violation|5
5028647|NCT02987972|17309325|P2|Overall Study|Protocol Violation|1
5028648|NCT02987972|17309326|P1|Overall Study|Protocol Violation|2
5028649|NCT02987972|17309324|P3|Overall Study|Physician Decision|0
5028650|NCT02987972|17309325|P2|Overall Study|Physician Decision|6
5028651|NCT02987972|17309326|P1|Overall Study|Physician Decision|1
5028652|NCT02987972|17309324|P3|Overall Study|Lost to Follow-up|4
5028653|NCT02987972|17309325|P2|Overall Study|Lost to Follow-up|8
5028654|NCT02987972|17309326|P1|Overall Study|Lost to Follow-up|7
5028655|NCT02987972|17309324|P3|Overall Study|Lack of Efficacy|12
5028656|NCT02987972|17309325|P2|Overall Study|Lack of Efficacy|12
5028657|NCT02987972|17309326|P1|Overall Study|Lack of Efficacy|9
5028658|NCT02987972|17309324|P3|Overall Study|Death|0
5028659|NCT02987972|17309325|P2|Overall Study|Death|0
5028660|NCT02987972|17309326|P1|Overall Study|Death|1
5028661|NCT02987972|17309324|P3|Overall Study|Adverse Event|0
5028662|NCT02987972|17309325|P2|Overall Study|Adverse Event|1
5028663|NCT02987972|17309326|P1|Overall Study|Adverse Event|1
5028664|NCT02987660|17309364|P2|Overall Study|Study terminated by sponsor|10
5028665|NCT02987660|17309365|P1|Overall Study|Study terminated by sponsor|10
5028666|NCT02987543|17309389|P4|Overall Study|Investigator's decision|0
5028667|NCT02987543|17309390|P3|Overall Study|Investigator's decision|0
5028668|NCT02987543|17309391|P2|Overall Study|Investigator's decision|1
5028669|NCT02987543|17309392|P1|Overall Study|Investigator's decision|0
5028670|NCT02987543|17309389|P4|Overall Study|Disease Progression|1
5028671|NCT02987543|17309390|P3|Overall Study|Disease Progression|0
5028672|NCT02987543|17309391|P2|Overall Study|Disease Progression|0
5028673|NCT02987543|17309392|P1|Overall Study|Disease Progression|0
5028674|NCT02987543|17309389|P4|Overall Study|Withdrawal by Subject|7
5028675|NCT02987543|17309390|P3|Overall Study|Withdrawal by Subject|6
5028676|NCT02987543|17309391|P2|Overall Study|Withdrawal by Subject|6
5028677|NCT02987543|17309392|P1|Overall Study|Withdrawal by Subject|17
5028678|NCT02987543|17309389|P4|Overall Study|Screen failure|1
5028679|NCT02987543|17309390|P3|Overall Study|Screen failure|0
5028680|NCT02987543|17309391|P2|Overall Study|Screen failure|0
5028682|NCT02987543|17309389|P4|Overall Study|Death|21
5028683|NCT02987543|17309390|P3|Overall Study|Death|42
5028684|NCT02987543|17309391|P2|Overall Study|Death|36
5028685|NCT02987543|17309392|P1|Overall Study|Death|53
5028686|NCT02987543|17309389|P4|Overall Study|Ongoing study at data cut off|18
5028687|NCT02987543|17309390|P3|Overall Study|Ongoing study at data cut off|46
5028688|NCT02987543|17309391|P2|Overall Study|Ongoing study at data cut off|40
5028689|NCT02987543|17309392|P1|Overall Study|Ongoing study at data cut off|92
5028690|NCT02987205|17309422|P1|Overall Study|Withdrawal by Subject|3
5028691|NCT02987205|17309422|P1|Overall Study|Adverse Event|1
5028692|NCT02986854|17309456|P3|Overall Study|Lost to Follow-up|2
5028693|NCT02986854|17309457|P2|Overall Study|Lost to Follow-up|11
5028694|NCT02986854|17309458|P1|Overall Study|Lost to Follow-up|3
5028695|NCT02986854|17309456|P3|Overall Study|Withdrawal by Subject|1
5028696|NCT02986854|17309457|P2|Overall Study|Withdrawal by Subject|1
5028697|NCT02986854|17309458|P1|Overall Study|Withdrawal by Subject|0
5028698|NCT02986373|17309542|P1|Overall Study|Other|24
5028699|NCT02986373|17309542|P1|Overall Study|Withdrawal by Subject|10
5028700|NCT02986373|17309542|P1|Overall Study|Lost to Follow-up|1
5028701|NCT02986373|17309542|P1|Overall Study|Adverse Event|4
5028702|NCT02986139|17309584|P2|Overall Study|Lost to Follow-up|1
5028703|NCT02986139|17309585|P1|Overall Study|Lost to Follow-up|0
5028704|NCT02986139|17309584|P2|Overall Study|Withdrawal by Subject|1
5028705|NCT02986139|17309585|P1|Overall Study|Withdrawal by Subject|0
5028706|NCT02986139|17309584|P2|Overall Study|Sponsor Decision|2
5028707|NCT02986139|17309585|P1|Overall Study|Sponsor Decision|1
5028708|NCT02985996|17309602|P5|Overall Study|Protocol Violation|0
5028709|NCT02985996|17309603|P4|Overall Study|Protocol Violation|0
5028710|NCT02985996|17309604|P3|Overall Study|Protocol Violation|0
5028711|NCT02985996|17309605|P2|Overall Study|Protocol Violation|1
5028712|NCT02985996|17309606|P1|Overall Study|Protocol Violation|0
5028713|NCT02985996|17309602|P5|Overall Study|Withdrawal by Subject|0
5028714|NCT02985996|17309603|P4|Overall Study|Withdrawal by Subject|0
5028715|NCT02985996|17309604|P3|Overall Study|Withdrawal by Subject|1
5028716|NCT02985996|17309605|P2|Overall Study|Withdrawal by Subject|0
5028717|NCT02985996|17309606|P1|Overall Study|Withdrawal by Subject|0
5028718|NCT02985684|17309740|P1|6-Month Closure Success Evaluation|Device Removal|3
5028719|NCT02985684|17309740|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
5028720|NCT02985684|17309740|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
5028721|NCT02985398|17309751|P1|Overall Study|Study Burden|9
5028722|NCT02985398|17309751|P1|Overall Study|Withdrawal by Subject|8
5028723|NCT02985398|17309751|P1|Overall Study|Lost to Follow-up|4
5028724|NCT02985398|17309751|P1|Overall Study|Adverse Event|1
5028725|NCT02984995|17309769|P2|Overall Study|Adverse Event|0
5028726|NCT02984995|17309770|P1|Overall Study|Adverse Event|1
5028727|NCT02984995|17309769|P2|Overall Study|Progressive disease|1
5028728|NCT02984995|17309770|P1|Overall Study|Progressive disease|11
5028729|NCT02984995|17309769|P2|Overall Study|Required stem cell transplant|2
5028730|NCT02984995|17309770|P1|Overall Study|Required stem cell transplant|13
5028731|NCT02984982|17309817|P2|Overall Study|Randomized but not treated|1
5028732|NCT02984982|17309818|P1|Overall Study|Randomized but not treated|0
5028733|NCT02984982|17309817|P2|Overall Study|Withdrawal by Subject|0
5028734|NCT02984982|17309818|P1|Overall Study|Withdrawal by Subject|2
5028735|NCT02984982|17309817|P2|Overall Study|Poor Compliance to Protocol|4
5028736|NCT02984982|17309818|P1|Overall Study|Poor Compliance to Protocol|4
5028737|NCT02984982|17309817|P2|Overall Study|Adverse Event|5
5028738|NCT02984982|17309818|P1|Overall Study|Adverse Event|2
5028739|NCT02984943|17309870|P1|Overall Study|Physician Decision|1
5028740|NCT02984943|17309870|P1|Overall Study|Withdrawal by Subject|3
5028741|NCT02984267|17309984|P2|Overall Study|Withdrawal by Subject|1
5028742|NCT02984267|17309985|P1|Overall Study|Withdrawal by Subject|0
5028743|NCT02984267|17309984|P2|Overall Study|Protocol Violation|0
5028744|NCT02984267|17309985|P1|Overall Study|Protocol Violation|1
5028745|NCT02983617|17310030|P2|Overall Study|Still on Study|28
5028746|NCT02983617|17310031|P1|Overall Study|Still on Study|6
5028747|NCT02983617|17310030|P2|Overall Study|Death|1
5028748|NCT02983617|17310031|P1|Overall Study|Death|0
5028749|NCT02983617|17310030|P2|Overall Study|Adverse Event|1
5028750|NCT02983617|17310031|P1|Overall Study|Adverse Event|0
5028751|NCT02983604|17310049|P4|Overall Study|Enrolled but not Treated|0
5028752|NCT02983604|17310050|P3|Overall Study|Enrolled but not Treated|1
5028753|NCT02983604|17310051|P2|Overall Study|Enrolled but not Treated|0
5028754|NCT02983604|17310052|P1|Overall Study|Enrolled but not Treated|0
5028755|NCT02983305|17310101|P2|Overall Study|incomplete data|0
5028756|NCT02983305|17310102|P1|Overall Study|incomplete data|2
5028757|NCT02983227|17310112|P2|Overall Study|Withdrawal by Subject|8
5028758|NCT02983227|17310113|P1|Overall Study|Withdrawal by Subject|19
5028759|NCT02983227|17310112|P2|Overall Study|Physician Decision|1
5028760|NCT02983227|17310113|P1|Overall Study|Physician Decision|3
5028761|NCT02983227|17310112|P2|Overall Study|Multiple Reasons|1
5028762|NCT02983227|17310113|P1|Overall Study|Multiple Reasons|2
5028763|NCT02983227|17310112|P2|Overall Study|Lost to Follow-up|0
5028764|NCT02983227|17310113|P1|Overall Study|Lost to Follow-up|3
5028765|NCT02983227|17310112|P2|Overall Study|Lack of Efficacy|1
5028766|NCT02983227|17310113|P1|Overall Study|Lack of Efficacy|8
5028767|NCT02983227|17310112|P2|Overall Study|Death|0
5028768|NCT02983227|17310113|P1|Overall Study|Death|3
5028769|NCT02983227|17310112|P2|Overall Study|Adverse Event|3
5028770|NCT02983227|17310113|P1|Overall Study|Adverse Event|21
5028771|NCT02982863|17310193|P5|Overall Study|Not eligible patients|492
5028772|NCT02982863|17310194|P4|Overall Study|Not eligible patients|1400
5028773|NCT02982863|17310195|P3|Overall Study|Not eligible patients|1852
5028774|NCT02982863|17310196|P2|Overall Study|Not eligible patients|4261
5028775|NCT02982863|17310197|P1|Overall Study|Not eligible patients|809
5028776|NCT02982720|17310254|P1|Overall Study|Death|1
5028777|NCT02982720|17310254|P1|Overall Study|Adverse Event|3
5028778|NCT02982239|17310264|P2|Overall Study|Lost to Follow-up|2
5028779|NCT02982239|17310265|P1|Overall Study|Lost to Follow-up|3
5028780|NCT02982187|17310281|P8|Overall Study|Withdrawal by Subject|0
5028781|NCT02982187|17310282|P7|Overall Study|Withdrawal by Subject|1
5028782|NCT02982187|17310283|P6|Overall Study|Withdrawal by Subject|0
5028783|NCT02982187|17310284|P5|Overall Study|Withdrawal by Subject|0
5028784|NCT02982187|17310285|P4|Overall Study|Withdrawal by Subject|0
5028785|NCT02982187|17310286|P3|Overall Study|Withdrawal by Subject|0
5028786|NCT02982187|17310287|P2|Overall Study|Withdrawal by Subject|0
5028787|NCT02982187|17310288|P1|Overall Study|Withdrawal by Subject|0
5028788|NCT02982018|17310338|P2|Overall Study|Withdrawal by Subject|1
5028789|NCT02982018|17310339|P1|Overall Study|Withdrawal by Subject|0
5028790|NCT02982018|17310338|P2|Overall Study|Lens Discomfort|0
5028791|NCT02982018|17310339|P1|Overall Study|Lens Discomfort|2
5028792|NCT02982018|17310338|P2|Overall Study|Adverse Event|1
5028793|NCT02982018|17310339|P1|Overall Study|Adverse Event|1
5028794|NCT02982018|17310338|P2|Overall Study|Protocol Violation|1
5028795|NCT02982018|17310339|P1|Overall Study|Protocol Violation|1
5028796|NCT02982018|17310338|P2|Overall Study|Incorrect Lens Dispensed|0
5028797|NCT02982018|17310339|P1|Overall Study|Incorrect Lens Dispensed|1
5028798|NCT02981524|17310353|P1|Overall Study|Withdrawal by Subject|1
5028799|NCT02981524|17310353|P1|Overall Study|Treatment Related Toxicity|1
5028800|NCT02981524|17310353|P1|Overall Study|Death (unrelated)|1
5028801|NCT02981524|17310353|P1|Overall Study|Progressive Disease|14
5028802|NCT02981342|17310365|P4|Overall Study|Lost to Follow-up|0
5028803|NCT02981342|17310366|P3|Overall Study|Lost to Follow-up|0
5028804|NCT02981342|17310367|P2|Overall Study|Lost to Follow-up|1
5028805|NCT02981342|17310368|P1|Overall Study|Lost to Follow-up|0
5028806|NCT02981342|17310365|P4|Overall Study|Randomized, Never Treated|7
5028807|NCT02981342|17310366|P3|Overall Study|Randomized, Never Treated|0
5028808|NCT02981342|17310367|P2|Overall Study|Randomized, Never Treated|1
5028809|NCT02981342|17310368|P1|Overall Study|Randomized, Never Treated|0
5028810|NCT02981342|17310365|P4|Overall Study|Study closed by sponsor|1
5028811|NCT02981342|17310366|P3|Overall Study|Study closed by sponsor|1
5028812|NCT02981342|17310367|P2|Overall Study|Study closed by sponsor|0
5028813|NCT02981342|17310368|P1|Overall Study|Study closed by sponsor|0
5028814|NCT02981342|17310365|P4|Overall Study|Withdrawal by Subject|1
5028815|NCT02981342|17310366|P3|Overall Study|Withdrawal by Subject|3
5028816|NCT02981342|17310367|P2|Overall Study|Withdrawal by Subject|0
5028817|NCT02981342|17310368|P1|Overall Study|Withdrawal by Subject|0
5028818|NCT02981342|17310365|P4|Overall Study|Death|4
5028819|NCT02981342|17310366|P3|Overall Study|Death|9
5028820|NCT02981342|17310367|P2|Overall Study|Death|9
5028821|NCT02981342|17310368|P1|Overall Study|Death|0
5028822|NCT02981342|17310365|P4|Overall Study|Adverse Event|1
5028823|NCT02981342|17310366|P3|Overall Study|Adverse Event|0
5028824|NCT02981342|17310367|P2|Overall Study|Adverse Event|0
5028825|NCT02981342|17310368|P1|Overall Study|Adverse Event|0
5028826|NCT02980783|17310426|P1|Overall Study|Lost to Follow-up|1
5028827|NCT02980601|17310439|P2|Overall Study|Failed to sign consent|0
5028828|NCT02980601|17310440|P1|Overall Study|Failed to sign consent|2
5028829|NCT02980601|17310439|P2|Overall Study|Graft loss|0
5028830|NCT02980601|17310440|P1|Overall Study|Graft loss|1
5028831|NCT02980601|17310439|P2|Overall Study|Death|1
5028832|NCT02980601|17310440|P1|Overall Study|Death|0
5028833|NCT02980601|17310439|P2|Overall Study|Lost to Follow-up|2
5028834|NCT02980601|17310440|P1|Overall Study|Lost to Follow-up|2
5028835|NCT02980523|17310533|P5|Overall Study|Did not receive intervention|0
5028836|NCT02980523|17310534|P4|Overall Study|Did not receive intervention|1
5028837|NCT02980523|17310535|P3|Overall Study|Did not receive intervention|0
5028838|NCT02980523|17310536|P2|Overall Study|Did not receive intervention|0
5028839|NCT02980523|17310537|P1|Overall Study|Did not receive intervention|0
5028840|NCT02980523|17310533|P5|Overall Study|Lack of Efficacy|8
5028841|NCT02980523|17310534|P4|Overall Study|Lack of Efficacy|5
5028842|NCT02980523|17310535|P3|Overall Study|Lack of Efficacy|4
5028843|NCT02980523|17310536|P2|Overall Study|Lack of Efficacy|4
5028844|NCT02980523|17310537|P1|Overall Study|Lack of Efficacy|1
5028845|NCT02980523|17310533|P5|Overall Study|Excluded from analysis|1
5028846|NCT02980523|17310534|P4|Overall Study|Excluded from analysis|1
5028847|NCT02980523|17310535|P3|Overall Study|Excluded from analysis|1
5028848|NCT02980523|17310536|P2|Overall Study|Excluded from analysis|3
5028849|NCT02980523|17310537|P1|Overall Study|Excluded from analysis|1
5028850|NCT02980523|17310533|P5|Overall Study|Lost to Follow-up|1
5028851|NCT02980523|17310534|P4|Overall Study|Lost to Follow-up|2
5028852|NCT02980523|17310535|P3|Overall Study|Lost to Follow-up|1
5028853|NCT02980523|17310536|P2|Overall Study|Lost to Follow-up|4
5028854|NCT02980523|17310537|P1|Overall Study|Lost to Follow-up|1
5028855|NCT02980224|17310581|P2|Overall Study|Withdrawal by Subject|2
5028856|NCT02980224|17310582|P1|Overall Study|Withdrawal by Subject|0
5028857|NCT02980224|17310581|P2|Overall Study|Adverse Event|1
5028858|NCT02980224|17310582|P1|Overall Study|Adverse Event|4
5028859|NCT02980133|17310600|P4|Overall Study|Withdrawal by Subject|0
5028860|NCT02980133|17310601|P3|Overall Study|Withdrawal by Subject|1
5028861|NCT02980133|17310602|P2|Overall Study|Withdrawal by Subject|0
5028862|NCT02980133|17310603|P1|Overall Study|Withdrawal by Subject|0
5028863|NCT02980133|17310600|P4|Overall Study|Withdrawal by parent/guardian|1
5028864|NCT02980133|17310601|P3|Overall Study|Withdrawal by parent/guardian|3
5028865|NCT02980133|17310602|P2|Overall Study|Withdrawal by parent/guardian|3
5028866|NCT02980133|17310603|P1|Overall Study|Withdrawal by parent/guardian|6
5028867|NCT02980133|17310600|P4|Overall Study|Protocol Violation|0
5028868|NCT02980133|17310601|P3|Overall Study|Protocol Violation|0
5028869|NCT02980133|17310602|P2|Overall Study|Protocol Violation|1
5028870|NCT02980133|17310603|P1|Overall Study|Protocol Violation|0
5028871|NCT02980133|17310600|P4|Overall Study|Lost to Follow-up|3
5028872|NCT02980133|17310601|P3|Overall Study|Lost to Follow-up|1
5028873|NCT02980133|17310602|P2|Overall Study|Lost to Follow-up|0
5028874|NCT02980133|17310603|P1|Overall Study|Lost to Follow-up|0
5028875|NCT02980133|17310600|P4|Overall Study|Other than specified|2
5028876|NCT02980133|17310601|P3|Overall Study|Other than specified|2
5028877|NCT02980133|17310602|P2|Overall Study|Other than specified|1
5028878|NCT02980133|17310603|P1|Overall Study|Other than specified|1
5028879|NCT02980107|17310641|P2|Overall Study|Withdrawal by Subject|62
5028880|NCT02980107|17310642|P1|Overall Study|Withdrawal by Subject|51
5028881|NCT02980042|17310656|P2|Overall Study|Insurance issues/treatment plan changes|0
5028882|NCT02980042|17310657|P1|Overall Study|Insurance issues/treatment plan changes|2
5028883|NCT02980042|17310656|P2|Overall Study|Lost to Follow-up|0
5028884|NCT02980042|17310657|P1|Overall Study|Lost to Follow-up|5
5028885|NCT02979639|17310689|P1|Overall Study|Adverse Event|2
5028886|NCT02979639|17310689|P1|Overall Study|Withdrawal by Subject|3
5028887|NCT02979639|17310689|P1|Overall Study|Lost to Follow-up|8
5028888|NCT02979639|17310689|P1|Overall Study|Withdrawal based on medical judgement|1
5028889|NCT02979613|17310721|P2|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
5028890|NCT02979613|17310722|P1|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
5028891|NCT02979613|17310721|P2|Open-Label Extension (OLE) Phase|Death|1
5028892|NCT02979613|17310722|P1|Open-Label Extension (OLE) Phase|Death|0
5028893|NCT02979613|17310721|P2|Open-Label Extension (OLE) Phase|Adverse Event|0
5028894|NCT02979613|17310722|P1|Open-Label Extension (OLE) Phase|Adverse Event|1
5028895|NCT02979613|17310721|P2|Open-Label Extension (OLE) Phase|Withdrew Consent|4
5028896|NCT02979613|17310722|P1|Open-Label Extension (OLE) Phase|Withdrew Consent|2
5028897|NCT02979613|17310721|P2|Double-Blind Phase|Randomized but Never Treated|0
5028898|NCT02979613|17310722|P1|Double-Blind Phase|Randomized but Never Treated|2
5028899|NCT02979613|17310721|P2|Double-Blind Phase|Protocol Violation|1
5028900|NCT02979613|17310722|P1|Double-Blind Phase|Protocol Violation|1
5028901|NCT02979613|17310721|P2|Double-Blind Phase|Lost to Follow-up|1
5028902|NCT02979613|17310722|P1|Double-Blind Phase|Lost to Follow-up|1
5028903|NCT02979613|17310721|P2|Double-Blind Phase|Adverse Event|0
5028904|NCT02979613|17310722|P1|Double-Blind Phase|Adverse Event|2
5028905|NCT02979613|17310721|P2|Double-Blind Phase|Pregnancy|2
5028906|NCT02979613|17310722|P1|Double-Blind Phase|Pregnancy|2
5028907|NCT02979613|17310721|P2|Double-Blind Phase|Withdrew Consent|4
5028908|NCT02979613|17310722|P1|Double-Blind Phase|Withdrew Consent|2
5028909|NCT02979535|17310782|P2|Overall Study|Lost to Follow-up|1
5028910|NCT02979535|17310783|P1|Overall Study|Lost to Follow-up|6
5028911|NCT02979535|17310782|P2|Overall Study|Consent withdrawn by participant|18
5028912|NCT02979535|17310783|P1|Overall Study|Consent withdrawn by participant|11
5028913|NCT02979535|17310782|P2|Overall Study|Non compliance with the protocol|82
5028914|NCT02979535|17310783|P1|Overall Study|Non compliance with the protocol|78
5028915|NCT02979431|17310846|P4|Overall Study|Subject left country after Day14|0
5028916|NCT02979431|17310847|P3|Overall Study|Subject left country after Day14|0
5028917|NCT02979431|17310848|P2|Overall Study|Subject left country after Day14|0
5028918|NCT02979431|17310849|P1|Overall Study|Subject left country after Day14|1
5028919|NCT02979431|17310846|P4|Overall Study|Adverse Event|0
5028920|NCT02979431|17310847|P3|Overall Study|Adverse Event|1
5028921|NCT02979431|17310848|P2|Overall Study|Adverse Event|0
5028922|NCT02979431|17310849|P1|Overall Study|Adverse Event|0
5028923|NCT02979431|17310846|P4|Overall Study|Randomized but received no study drug|0
5028924|NCT02979431|17310847|P3|Overall Study|Randomized but received no study drug|0
5028925|NCT02979431|17310848|P2|Overall Study|Randomized but received no study drug|1
5028926|NCT02979431|17310849|P1|Overall Study|Randomized but received no study drug|1
5028927|NCT02979431|17310846|P4|Overall Study|Parent/guardian withdrew consent|1
5028928|NCT02979431|17310847|P3|Overall Study|Parent/guardian withdrew consent|1
5028929|NCT02979431|17310848|P2|Overall Study|Parent/guardian withdrew consent|1
5028930|NCT02979431|17310849|P1|Overall Study|Parent/guardian withdrew consent|2
5028931|NCT02979249|17310927|P1|Overall Study|Withdrawal by Subject|4
5028932|NCT02979249|17310927|P1|Overall Study|Lost to Follow-up|2
5028933|NCT02979197|17310935|P3|Overall Study|Subject unable to commit to study dates|0
5028934|NCT02979197|17310936|P2|Overall Study|Subject unable to commit to study dates|1
5028935|NCT02979197|17310937|P1|Overall Study|Subject unable to commit to study dates|0
5028936|NCT02979197|17310935|P3|Overall Study|Protocol Violation|0
5028937|NCT02979197|17310936|P2|Overall Study|Protocol Violation|1
5028938|NCT02979197|17310937|P1|Overall Study|Protocol Violation|0
5028939|NCT02979197|17310935|P3|Overall Study|Adverse Event|0
5028940|NCT02979197|17310936|P2|Overall Study|Adverse Event|2
5028941|NCT02979197|17310937|P1|Overall Study|Adverse Event|4
5028942|NCT02978833|17310980|P2|Overall Study|Study terminated|1
5028943|NCT02978833|17310981|P1|Overall Study|Study terminated|1
5028944|NCT02978417|17311010|P2|Overall Study|Lost to Follow-up|2
5028945|NCT02978417|17311011|P1|Overall Study|Lost to Follow-up|2
5028946|NCT02977572|17311066|P2|Overall Study|Exclusion criterion|2
5028947|NCT02977572|17311067|P1|Overall Study|Exclusion criterion|2
5028948|NCT02977507|17311089|P2|Overall Study|Lost to Follow-up|0
5028949|NCT02977507|17311090|P1|Overall Study|Lost to Follow-up|1
5028950|NCT02977507|17311089|P2|Overall Study|Protocol Deviation|0
5028951|NCT02977507|17311090|P1|Overall Study|Protocol Deviation|1
5028952|NCT02976519|17311120|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
5028953|NCT02976519|17311121|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5028954|NCT02976519|17311122|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5028955|NCT02976519|17311123|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5028956|NCT02976519|17311124|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5028957|NCT02976519|17311125|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5028958|NCT02976519|17311126|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5028959|NCT02976519|17311120|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
5028960|NCT02976519|17311121|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5028961|NCT02976519|17311122|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5028962|NCT02976519|17311123|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5028963|NCT02976519|17311124|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5028964|NCT02976519|17311125|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5028965|NCT02976519|17311126|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5028966|NCT02976519|17311120|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
5028967|NCT02976519|17311121|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
5028968|NCT02976519|17311122|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
5028969|NCT02976519|17311123|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
5028970|NCT02976519|17311124|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
5028971|NCT02976519|17311125|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
5028972|NCT02976519|17311126|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
5028973|NCT02976519|17311120|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5028974|NCT02976519|17311121|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5028975|NCT02976519|17311122|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5028976|NCT02976519|17311123|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
5028977|NCT02976519|17311124|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5028978|NCT02976519|17311125|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5028979|NCT02976519|17311126|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5028980|NCT02976519|17311120|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5028981|NCT02976519|17311121|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5028982|NCT02976519|17311122|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5028983|NCT02976519|17311123|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5028984|NCT02976519|17311124|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5028985|NCT02976519|17311125|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
5028986|NCT02976519|17311126|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5028987|NCT02976103|17311157|P2|Overall Study|Lost to Follow-up|8
5028988|NCT02976103|17311158|P1|Overall Study|Lost to Follow-up|12
5028989|NCT02976103|17311157|P2|Overall Study|Withdrawal by Subject|0
5028990|NCT02976103|17311158|P1|Overall Study|Withdrawal by Subject|1
5028991|NCT02975973|17311213|P4|Overall Study|Adverse Event|0
5028992|NCT02975973|17311214|P3|Overall Study|Adverse Event|1
5028993|NCT02975973|17311215|P2|Overall Study|Adverse Event|1
5028994|NCT02975973|17311216|P1|Overall Study|Adverse Event|1
5028995|NCT02975700|17311279|P1|Overall Study|Failed screening criteria|2
5028996|NCT02975700|17311279|P1|Overall Study|Progressive disease|3
5028997|NCT02975700|17311279|P1|Overall Study|Adverse Event|1
5028998|NCT02975206|17311313|P3|Overall Study|Other (e.g., lost to follow up)|6
5028999|NCT02975206|17311314|P2|Overall Study|Other (e.g., lost to follow up)|6
5029000|NCT02975206|17311315|P1|Overall Study|Other (e.g., lost to follow up)|13
5029001|NCT02975206|17311313|P3|Overall Study|Withdrawal by Subject|11
5029002|NCT02975206|17311314|P2|Overall Study|Withdrawal by Subject|11
5029003|NCT02975206|17311315|P1|Overall Study|Withdrawal by Subject|14
5029004|NCT02974868|17311332|P4|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
5029005|NCT02974868|17311333|P3|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
5029006|NCT02974868|17311334|P2|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
5029007|NCT02974868|17311335|P1|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
5029008|NCT02974868|17311332|P4|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
5029009|NCT02974868|17311333|P3|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
5029010|NCT02974868|17311334|P2|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
5029011|NCT02974868|17311335|P1|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
5029012|NCT02974868|17311332|P4|Initial 24-Week Treatment Period (TP)|others|8
5029013|NCT02974868|17311333|P3|Initial 24-Week Treatment Period (TP)|others|1
5029014|NCT02974868|17311334|P2|Initial 24-Week Treatment Period (TP)|others|8
5029015|NCT02974868|17311335|P1|Initial 24-Week Treatment Period (TP)|others|3
5029016|NCT02974868|17311332|P4|Initial 24-Week Treatment Period (TP)|Adverse Event|4
5029017|NCT02974868|17311333|P3|Initial 24-Week Treatment Period (TP)|Adverse Event|2
5029018|NCT02974868|17311334|P2|Initial 24-Week Treatment Period (TP)|Adverse Event|1
5029019|NCT02974868|17311335|P1|Initial 24-Week Treatment Period (TP)|Adverse Event|1
5029020|NCT02974855|17311457|P4|Overall Study|Adverse Event|1
5029021|NCT02974855|17311458|P3|Overall Study|Adverse Event|0
5029022|NCT02974855|17311459|P2|Overall Study|Adverse Event|1
5029023|NCT02974855|17311460|P1|Overall Study|Adverse Event|0
5029024|NCT02974842|17311646|P1|Overall Study|Screen failures|4
5029025|NCT02974842|17311646|P1|Overall Study|Withdrawal by Subject|4
5029026|NCT02974634|17311665|P2|Overall Study|Death|11
5029027|NCT02974634|17311666|P1|Overall Study|Death|8
5029028|NCT02974634|17311665|P2|Overall Study|intervention technology related issues|0
5029029|NCT02974634|17311666|P1|Overall Study|intervention technology related issues|5
5029030|NCT02974634|17311665|P2|Overall Study|Noncompliance|7
5029031|NCT02974634|17311666|P1|Overall Study|Noncompliance|3
5029032|NCT02974634|17311665|P2|Overall Study|Advanced disease|3
5029033|NCT02974634|17311666|P1|Overall Study|Advanced disease|12
5029034|NCT02974543|17311676|P2|Overall Study|Withdrawal by Subject|0
5029035|NCT02974543|17311677|P1|Overall Study|Withdrawal by Subject|1
5029036|NCT02974153|17311711|P3|Overall Study|Other|7
5029037|NCT02974153|17311712|P2|Overall Study|Other|8
5029038|NCT02974153|17311713|P1|Overall Study|Other|14
5029039|NCT02974153|17311711|P3|Overall Study|Study Burden|3
5029040|NCT02974153|17311712|P2|Overall Study|Study Burden|7
5029041|NCT02974153|17311713|P1|Overall Study|Study Burden|8
5029042|NCT02974153|17311711|P3|Overall Study|Withdrawal by Subject|11
5029043|NCT02974153|17311712|P2|Overall Study|Withdrawal by Subject|16
5029044|NCT02974153|17311713|P1|Overall Study|Withdrawal by Subject|9
5029045|NCT02974153|17311711|P3|Overall Study|Physician Decision|1
5029046|NCT02974153|17311712|P2|Overall Study|Physician Decision|2
5029047|NCT02974153|17311713|P1|Overall Study|Physician Decision|0
5029048|NCT02974153|17311711|P3|Overall Study|Lost to Follow-up|17
5029049|NCT02974153|17311712|P2|Overall Study|Lost to Follow-up|10
5029050|NCT02974153|17311713|P1|Overall Study|Lost to Follow-up|9
5029051|NCT02974153|17311711|P3|Overall Study|Lack of Efficacy|10
5029052|NCT02974153|17311712|P2|Overall Study|Lack of Efficacy|5
5029053|NCT02974153|17311713|P1|Overall Study|Lack of Efficacy|6
5029054|NCT02974153|17311711|P3|Overall Study|Adverse Event|1
5029055|NCT02974153|17311712|P2|Overall Study|Adverse Event|0
5029056|NCT02974153|17311713|P1|Overall Study|Adverse Event|6
5029057|NCT02974140|17311799|P1|Overall Study|Study Terminated by Sponsor|36
5029058|NCT02974140|17311799|P1|Overall Study|Lost to Follow-up|1
5029059|NCT02974140|17311799|P1|Overall Study|Adverse Event|2
5029060|NCT02974114|17311815|P3|Overall Study|Other (Not specified)|2
5029061|NCT02974114|17311816|P2|Overall Study|Other (Not specified)|1
5029062|NCT02974114|17311817|P1|Overall Study|Other (Not specified)|0
5029063|NCT02974088|17311860|P2|Overall Study|Adverse Event|1
5029064|NCT02974088|17311861|P1|Overall Study|Adverse Event|0
5029065|NCT02974088|17311860|P2|Overall Study|Lost to Follow-up|2
5029066|NCT02974088|17311861|P1|Overall Study|Lost to Follow-up|0
5029067|NCT02973802|17311867|P1|Overall Study|Withdrawal by Subject|1
5029068|NCT02973802|17311867|P1|Overall Study|Lost to Follow-up|1
5029069|NCT02973477|17311894|P2|Second Intervention|Lost to Follow-up|0
5029070|NCT02973477|17311895|P1|Second Intervention|Lost to Follow-up|1
5029071|NCT02973477|17311894|P2|Washout|Withdrawal by Subject|0
5029072|NCT02973477|17311895|P1|Washout|Withdrawal by Subject|1
5029073|NCT02973477|17311894|P2|First Intervention|Lost to Follow-up|2
5029074|NCT02973477|17311895|P1|First Intervention|Lost to Follow-up|0
5029075|NCT02973100|17311912|P4|Overall Study|Failed to attend Safety followup period|0
5029076|NCT02973100|17311913|P3|Overall Study|Failed to attend Safety followup period|1
5029077|NCT02973100|17311914|P2|Overall Study|Failed to attend Safety followup period|0
5029078|NCT02973100|17311915|P1|Overall Study|Failed to attend Safety followup period|0
5029079|NCT02973100|17311912|P4|Overall Study|Notification of change in address|1
5029080|NCT02973100|17311913|P3|Overall Study|Notification of change in address|0
5029081|NCT02973100|17311914|P2|Overall Study|Notification of change in address|0
5029082|NCT02973100|17311915|P1|Overall Study|Notification of change in address|0
5029083|NCT02973100|17311912|P4|Overall Study|Withdrawal by Subject|4
5029084|NCT02973100|17311913|P3|Overall Study|Withdrawal by Subject|1
5029085|NCT02973100|17311914|P2|Overall Study|Withdrawal by Subject|5
5029086|NCT02973100|17311915|P1|Overall Study|Withdrawal by Subject|3
5029087|NCT02973100|17311912|P4|Overall Study|Lost to Follow-up|0
5029088|NCT02973100|17311913|P3|Overall Study|Lost to Follow-up|1
5029089|NCT02973100|17311914|P2|Overall Study|Lost to Follow-up|1
5029090|NCT02973100|17311915|P1|Overall Study|Lost to Follow-up|3
5029091|NCT02973100|17311912|P4|Overall Study|Adverse Event|2
5029092|NCT02973100|17311913|P3|Overall Study|Adverse Event|1
5029093|NCT02973100|17311914|P2|Overall Study|Adverse Event|2
5029094|NCT02973100|17311915|P1|Overall Study|Adverse Event|1
5029095|NCT02973048|17311953|P2|Overall Study|Withdrawal by Subject|3
5029096|NCT02973048|17311954|P1|Overall Study|Withdrawal by Subject|0
5029097|NCT02973048|17311953|P2|Overall Study|Epidural catheter insertion failure|0
5029098|NCT02973048|17311954|P1|Overall Study|Epidural catheter insertion failure|1
5029099|NCT02972658|17312006|P4|Overall Study|Sponsor Decision|119
5029100|NCT02972658|17312007|P3|Overall Study|Sponsor Decision|72
5029101|NCT02972658|17312008|P2|Overall Study|Sponsor Decision|127
5029102|NCT02972658|17312009|P1|Overall Study|Sponsor Decision|70
5029103|NCT02972658|17312006|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
5029104|NCT02972658|17312007|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
5029105|NCT02972658|17312008|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
5029106|NCT02972658|17312009|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
5029107|NCT02972658|17312006|P4|Overall Study|Withdrawal by Subject|6
5029108|NCT02972658|17312007|P3|Overall Study|Withdrawal by Subject|1
5029109|NCT02972658|17312008|P2|Overall Study|Withdrawal by Subject|4
5029110|NCT02972658|17312009|P1|Overall Study|Withdrawal by Subject|4
5029111|NCT02972658|17312006|P4|Overall Study|Progressive Disease|1
5029112|NCT02972658|17312007|P3|Overall Study|Progressive Disease|0
5029113|NCT02972658|17312008|P2|Overall Study|Progressive Disease|1
5029114|NCT02972658|17312009|P1|Overall Study|Progressive Disease|0
5029115|NCT02972658|17312006|P4|Overall Study|Lost to Follow-up|2
5029116|NCT02972658|17312007|P3|Overall Study|Lost to Follow-up|1
5029117|NCT02972658|17312008|P2|Overall Study|Lost to Follow-up|1
5029118|NCT02972658|17312009|P1|Overall Study|Lost to Follow-up|0
5029119|NCT02972658|17312006|P4|Overall Study|Death|1
5029120|NCT02972658|17312007|P3|Overall Study|Death|0
5029121|NCT02972658|17312008|P2|Overall Study|Death|0
5029122|NCT02972658|17312009|P1|Overall Study|Death|0
5029123|NCT02972658|17312006|P4|Overall Study|Other-determined by Investigator|0
5029124|NCT02972658|17312007|P3|Overall Study|Other-determined by Investigator|0
5029125|NCT02972658|17312008|P2|Overall Study|Other-determined by Investigator|1
5029126|NCT02972658|17312009|P1|Overall Study|Other-determined by Investigator|1
5029127|NCT02972658|17312006|P4|Overall Study|Adverse Event|2
5029128|NCT02972658|17312007|P3|Overall Study|Adverse Event|0
5029129|NCT02972658|17312008|P2|Overall Study|Adverse Event|3
5029130|NCT02972658|17312009|P1|Overall Study|Adverse Event|0
5029131|NCT02972632|17312039|P1|Overall Study|Voluntary Withdrawal|10
5029132|NCT02972632|17312039|P1|Overall Study|Lost to Follow-up|4
5029133|NCT02972632|17312039|P1|Overall Study|Pretreatment Event/Adverse Event|3
5029134|NCT02972515|17312069|P1|Overall Study|Lost to Follow-up|78
5029135|NCT02972502|17312078|P2|Overall Study|Withdrawal by Subject|1
5029136|NCT02972502|17312079|P1|Overall Study|Withdrawal by Subject|1
5029137|NCT02972502|17312078|P2|Overall Study|Lost to Follow-up|1
5029138|NCT02972502|17312079|P1|Overall Study|Lost to Follow-up|3
5029139|NCT02972359|17312089|P1|Overall Study|Missing|1
5029140|NCT02972359|17312089|P1|Overall Study|Other reasons|5
5029141|NCT02972359|17312089|P1|Overall Study|Lost to Follow-up|26
5029142|NCT02972359|17312089|P1|Overall Study|Protocol Violation|1
5029143|NCT02972359|17312089|P1|Overall Study|Withdrawal by Subject|30
5029144|NCT02972359|17312089|P1|Overall Study|Death|1
5029145|NCT02972359|17312089|P1|Overall Study|Adverse Event|4
5029146|NCT02972359|17312089|P1|Overall Study|Lack of Efficacy|1
5029147|NCT02972359|17312089|P1|Overall Study|Incl. criteria not met/Exclusion met|2
5029148|NCT02972242|17312102|P2|Overall Study|Withdrawal by Subject|0
5029149|NCT02972242|17312103|P1|Overall Study|Withdrawal by Subject|1
5029150|NCT02971670|17312160|P4|Overall Study|Withdrawal by Subject|2
5029151|NCT02971670|17312161|P3|Overall Study|Withdrawal by Subject|1
5029152|NCT02971670|17312162|P2|Overall Study|Withdrawal by Subject|1
5029153|NCT02971670|17312163|P1|Overall Study|Withdrawal by Subject|4
5029154|NCT02971605|17312202|P1|Overall Study|Withdrawal by Subject|1
5029155|NCT02971202|17312316|P3|Overall Study|screen fail after consent|1
5029156|NCT02971202|17312317|P2|Overall Study|screen fail after consent|0
5029157|NCT02971202|17312318|P1|Overall Study|screen fail after consent|1
5029158|NCT02971202|17312316|P3|Overall Study|Pregnancy|0
5029159|NCT02971202|17312317|P2|Overall Study|Pregnancy|0
5029160|NCT02971202|17312318|P1|Overall Study|Pregnancy|1
5029161|NCT02971163|17312334|P2|Overall Study|Lost to Follow-up|2
5029162|NCT02971163|17312335|P1|Overall Study|Lost to Follow-up|4
5029163|NCT02971007|17312358|P3|Overall Study|Patient discontinued study drug|0
5029164|NCT02971007|17312359|P2|Overall Study|Patient discontinued study drug|1
5029165|NCT02971007|17312360|P1|Overall Study|Patient discontinued study drug|0
5029166|NCT02971007|17312358|P3|Overall Study|Patient had yeast at Day 5 visit|0
5029167|NCT02971007|17312359|P2|Overall Study|Patient had yeast at Day 5 visit|0
5029168|NCT02971007|17312360|P1|Overall Study|Patient had yeast at Day 5 visit|1
5029169|NCT02971007|17312358|P3|Overall Study|Withdrawal by Subject|0
5029170|NCT02971007|17312359|P2|Overall Study|Withdrawal by Subject|1
5029171|NCT02971007|17312360|P1|Overall Study|Withdrawal by Subject|0
5029172|NCT02971007|17312358|P3|Overall Study|Lost to Follow-up|1
5029173|NCT02971007|17312359|P2|Overall Study|Lost to Follow-up|1
5029174|NCT02971007|17312360|P1|Overall Study|Lost to Follow-up|0
5029175|NCT02971007|17312358|P3|Overall Study|Adverse Event|0
5029176|NCT02971007|17312359|P2|Overall Study|Adverse Event|0
5029177|NCT02971007|17312360|P1|Overall Study|Adverse Event|1
5029178|NCT02970669|17312392|P2|Open-label Period|Physician Decision|0
5029179|NCT02970669|17312393|P1|Open-label Period|Physician Decision|1
5029180|NCT02970669|17312392|P2|Open-label Period|Adverse Event|0
5029181|NCT02970669|17312393|P1|Open-label Period|Adverse Event|1
5029182|NCT02970669|17312392|P2|Open-label Period|Withdrawal by Subject|2
5029183|NCT02970669|17312393|P1|Open-label Period|Withdrawal by Subject|2
5029184|NCT02970669|17312392|P2|Double-blind Period|Withdrawal by Subject|2
5029185|NCT02970669|17312393|P1|Double-blind Period|Withdrawal by Subject|2
5029186|NCT02970669|17312392|P2|Double-blind Period|Physician Decision|2
5029187|NCT02970669|17312393|P1|Double-blind Period|Physician Decision|0
5029188|NCT02970669|17312392|P2|Double-blind Period|Study terminated by sponsor|2
5029189|NCT02970669|17312393|P1|Double-blind Period|Study terminated by sponsor|1
5029190|NCT02970669|17312392|P2|Double-blind Period|Death|0
5029191|NCT02970669|17312393|P1|Double-blind Period|Death|1
5029192|NCT02970669|17312392|P2|Double-blind Period|Adverse Event|0
5029193|NCT02970669|17312393|P1|Double-blind Period|Adverse Event|4
5029194|NCT02970292|17312444|P2|Overall Study|Other|0
5029195|NCT02970292|17312445|P1|Overall Study|Other|1
5029196|NCT02970292|17312444|P2|Overall Study|Protocol Violation|0
5029197|NCT02970292|17312445|P1|Overall Study|Protocol Violation|2
5029198|NCT02970292|17312444|P2|Overall Study|Lost to Follow-up|0
5029199|NCT02970292|17312445|P1|Overall Study|Lost to Follow-up|1
5029200|NCT02970292|17312444|P2|Overall Study|Lack of Efficacy|0
5029201|NCT02970292|17312445|P1|Overall Study|Lack of Efficacy|1
5029202|NCT02970292|17312444|P2|Overall Study|Adverse Event|0
5029203|NCT02970292|17312445|P1|Overall Study|Adverse Event|5
5029204|NCT02970292|17312444|P2|Overall Study|Noncompliance with study drug|2
5029205|NCT02970292|17312445|P1|Overall Study|Noncompliance with study drug|2
5029206|NCT02970292|17312444|P2|Overall Study|Withdrawal by Subject|5
5029207|NCT02970292|17312445|P1|Overall Study|Withdrawal by Subject|11
5029208|NCT02970292|17312444|P2|Overall Study|Physician Decision|1
5029209|NCT02970292|17312445|P1|Overall Study|Physician Decision|1
5029210|NCT02969863|17312511|P6|Overall Study|Physician Decision|0
5029211|NCT02969863|17312512|P5|Overall Study|Physician Decision|0
5029212|NCT02969863|17312513|P4|Overall Study|Physician Decision|0
5029213|NCT02969863|17312514|P3|Overall Study|Physician Decision|0
5029214|NCT02969863|17312515|P2|Overall Study|Physician Decision|0
5029215|NCT02969863|17312516|P1|Overall Study|Physician Decision|1
5029216|NCT02969655|17312532|P2|Overall Study|Adverse Event|8
5029217|NCT02969655|17312533|P1|Overall Study|Adverse Event|10
5029218|NCT02969655|17312532|P2|Overall Study|Protocol-specified withdrawal criteria|2
5029219|NCT02969655|17312533|P1|Overall Study|Protocol-specified withdrawal criteria|4
5029220|NCT02969655|17312532|P2|Overall Study|Physician Decision|3
5029221|NCT02969655|17312533|P1|Overall Study|Physician Decision|4
5029222|NCT02969655|17312532|P2|Overall Study|Withdrawal by Subject|2
5029223|NCT02969655|17312533|P1|Overall Study|Withdrawal by Subject|3
5029224|NCT02969590|17312568|P3|Screening Period|Hormones not suppressed post Lupron|0
5029225|NCT02969590|17312569|P2|Screening Period|Hormones not suppressed post Lupron|0
5029226|NCT02969590|17312570|P1|Screening Period|Hormones not suppressed post Lupron|1
5029227|NCT02969525|17312593|P12|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029228|NCT02969525|17312594|P11|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
5029229|NCT02969525|17312595|P10|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029230|NCT02969525|17312596|P9|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029231|NCT02969525|17312597|P8|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029232|NCT02969525|17312598|P7|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029233|NCT02969525|17312599|P6|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029234|NCT02969525|17312600|P5|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029235|NCT02969525|17312601|P4|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029236|NCT02969525|17312602|P3|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029237|NCT02969525|17312603|P2|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029238|NCT02969525|17312604|P1|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5029239|NCT02969525|17312593|P12|Dose-Blind Period|Non-cooperating patient|1
5029240|NCT02969525|17312594|P11|Dose-Blind Period|Non-cooperating patient|0
5029241|NCT02969525|17312595|P10|Dose-Blind Period|Non-cooperating patient|0
5029242|NCT02969525|17312596|P9|Dose-Blind Period|Non-cooperating patient|0
5029243|NCT02969525|17312597|P8|Dose-Blind Period|Non-cooperating patient|0
5029244|NCT02969525|17312598|P7|Dose-Blind Period|Non-cooperating patient|0
5029245|NCT02969525|17312599|P6|Dose-Blind Period|Non-cooperating patient|0
5029246|NCT02969525|17312600|P5|Dose-Blind Period|Non-cooperating patient|0
5029247|NCT02969525|17312601|P4|Dose-Blind Period|Non-cooperating patient|0
5029248|NCT02969525|17312602|P3|Dose-Blind Period|Non-cooperating patient|0
5029249|NCT02969525|17312603|P2|Dose-Blind Period|Non-cooperating patient|0
5029250|NCT02969525|17312604|P1|Dose-Blind Period|Non-cooperating patient|0
5029251|NCT02969525|17312593|P12|Dose-Blind Period|Withdrawal by Subject|0
5029252|NCT02969525|17312594|P11|Dose-Blind Period|Withdrawal by Subject|0
5029253|NCT02969525|17312595|P10|Dose-Blind Period|Withdrawal by Subject|2
5029254|NCT02969525|17312596|P9|Dose-Blind Period|Withdrawal by Subject|1
5029255|NCT02969525|17312597|P8|Dose-Blind Period|Withdrawal by Subject|0
5029256|NCT02969525|17312598|P7|Dose-Blind Period|Withdrawal by Subject|2
5029257|NCT02969525|17312599|P6|Dose-Blind Period|Withdrawal by Subject|0
5029258|NCT02969525|17312600|P5|Dose-Blind Period|Withdrawal by Subject|0
5029259|NCT02969525|17312601|P4|Dose-Blind Period|Withdrawal by Subject|0
5029260|NCT02969525|17312602|P3|Dose-Blind Period|Withdrawal by Subject|0
5029261|NCT02969525|17312603|P2|Dose-Blind Period|Withdrawal by Subject|0
5029262|NCT02969525|17312604|P1|Dose-Blind Period|Withdrawal by Subject|0
5029263|NCT02969525|17312593|P12|Dose-Blind Period|Adverse Event|1
5029264|NCT02969525|17312594|P11|Dose-Blind Period|Adverse Event|1
5029265|NCT02969525|17312595|P10|Dose-Blind Period|Adverse Event|1
5029266|NCT02969525|17312596|P9|Dose-Blind Period|Adverse Event|0
5029267|NCT02969525|17312597|P8|Dose-Blind Period|Adverse Event|0
5029268|NCT02969525|17312598|P7|Dose-Blind Period|Adverse Event|0
5029269|NCT02969525|17312599|P6|Dose-Blind Period|Adverse Event|0
5029270|NCT02969525|17312600|P5|Dose-Blind Period|Adverse Event|0
5029271|NCT02969525|17312601|P4|Dose-Blind Period|Adverse Event|0
5029272|NCT02969525|17312602|P3|Dose-Blind Period|Adverse Event|0
5029273|NCT02969525|17312603|P2|Dose-Blind Period|Adverse Event|0
5029274|NCT02969525|17312604|P1|Dose-Blind Period|Adverse Event|0
5029275|NCT02969525|17312593|P12|Double-Blind Period|Study medication discontinued prior Wk12|0
5029276|NCT02969525|17312594|P11|Double-Blind Period|Study medication discontinued prior Wk12|0
5029365|NCT02969018|17312885|P2|Overall Study|Non-Compliance With Study Drug|0
5029277|NCT02969525|17312595|P10|Double-Blind Period|Study medication discontinued prior Wk12|0
5029278|NCT02969525|17312596|P9|Double-Blind Period|Study medication discontinued prior Wk12|0
5029279|NCT02969525|17312597|P8|Double-Blind Period|Study medication discontinued prior Wk12|0
5029280|NCT02969525|17312598|P7|Double-Blind Period|Study medication discontinued prior Wk12|0
5029281|NCT02969525|17312599|P6|Double-Blind Period|Study medication discontinued prior Wk12|0
5029282|NCT02969525|17312600|P5|Double-Blind Period|Study medication discontinued prior Wk12|0
5029283|NCT02969525|17312601|P4|Double-Blind Period|Study medication discontinued prior Wk12|2
5029284|NCT02969525|17312602|P3|Double-Blind Period|Study medication discontinued prior Wk12|0
5029285|NCT02969525|17312603|P2|Double-Blind Period|Study medication discontinued prior Wk12|0
5029286|NCT02969525|17312604|P1|Double-Blind Period|Study medication discontinued prior Wk12|2
5029287|NCT02969525|17312593|P12|Double-Blind Period|LOW EGFR|0
5029288|NCT02969525|17312594|P11|Double-Blind Period|LOW EGFR|0
5029289|NCT02969525|17312595|P10|Double-Blind Period|LOW EGFR|0
5029290|NCT02969525|17312596|P9|Double-Blind Period|LOW EGFR|0
5029291|NCT02969525|17312597|P8|Double-Blind Period|LOW EGFR|0
5029292|NCT02969525|17312598|P7|Double-Blind Period|LOW EGFR|0
5029293|NCT02969525|17312599|P6|Double-Blind Period|LOW EGFR|0
5029294|NCT02969525|17312600|P5|Double-Blind Period|LOW EGFR|0
5029295|NCT02969525|17312601|P4|Double-Blind Period|LOW EGFR|1
5029296|NCT02969525|17312602|P3|Double-Blind Period|LOW EGFR|0
5029297|NCT02969525|17312603|P2|Double-Blind Period|LOW EGFR|0
5029298|NCT02969525|17312604|P1|Double-Blind Period|LOW EGFR|0
5029299|NCT02969525|17312593|P12|Double-Blind Period|Adverse Event|0
5029300|NCT02969525|17312594|P11|Double-Blind Period|Adverse Event|0
5029301|NCT02969525|17312595|P10|Double-Blind Period|Adverse Event|0
5029302|NCT02969525|17312596|P9|Double-Blind Period|Adverse Event|0
5029303|NCT02969525|17312597|P8|Double-Blind Period|Adverse Event|0
5029304|NCT02969525|17312598|P7|Double-Blind Period|Adverse Event|0
5029305|NCT02969525|17312599|P6|Double-Blind Period|Adverse Event|0
5029306|NCT02969525|17312600|P5|Double-Blind Period|Adverse Event|0
5029307|NCT02969525|17312601|P4|Double-Blind Period|Adverse Event|1
5029308|NCT02969525|17312602|P3|Double-Blind Period|Adverse Event|1
5029309|NCT02969525|17312603|P2|Double-Blind Period|Adverse Event|0
5029310|NCT02969525|17312604|P1|Double-Blind Period|Adverse Event|0
5029311|NCT02969408|17312755|P1|Overall Study|Other than specified|1
5029312|NCT02969408|17312755|P1|Overall Study|Protocol Violation|1
5029313|NCT02969408|17312755|P1|Overall Study|Lost to Follow-up|4
5029314|NCT02969408|17312755|P1|Overall Study|Withdrawal by Subject|8
5029315|NCT02969408|17312755|P1|Overall Study|Adverse Event|2
5029316|NCT02969356|17312763|P1|Overall Study|Personal reasons|5
5029317|NCT02969356|17312763|P1|Overall Study|Did not need to be reinjected|6
5029318|NCT02969356|17312763|P1|Overall Study|Lost to Follow-up|3
5029319|NCT02969356|17312763|P1|Overall Study|Consent withdrawn|2
5029320|NCT02969356|17312763|P1|Overall Study|Adverse Event|7
5029321|NCT02969187|17312806|P2|Overall Study|Physician Decision|13
5029322|NCT02969187|17312807|P1|Overall Study|Physician Decision|12
5029323|NCT02969044|17312819|P2|Overall Study|Adverse Event|0
5029324|NCT02969044|17312820|P1|Overall Study|Adverse Event|3
5029325|NCT02969044|17312819|P2|Overall Study|Withdrawal by Subject|6
5029326|NCT02969044|17312820|P1|Overall Study|Withdrawal by Subject|2
5029327|NCT02969018|17312879|P8|Overall Study|Withdrawal by Subject|3
5029328|NCT02969018|17312880|P7|Overall Study|Withdrawal by Subject|4
5029329|NCT02969018|17312881|P6|Overall Study|Withdrawal by Subject|4
5029330|NCT02969018|17312882|P5|Overall Study|Withdrawal by Subject|0
5029331|NCT02969018|17312883|P4|Overall Study|Withdrawal by Subject|1
5029332|NCT02969018|17312884|P3|Overall Study|Withdrawal by Subject|2
5029333|NCT02969018|17312885|P2|Overall Study|Withdrawal by Subject|1
5029334|NCT02969018|17312886|P1|Overall Study|Withdrawal by Subject|0
5029335|NCT02969018|17312879|P8|Overall Study|Protocol Violation|0
5029336|NCT02969018|17312880|P7|Overall Study|Protocol Violation|0
5029337|NCT02969018|17312881|P6|Overall Study|Protocol Violation|0
5029338|NCT02969018|17312882|P5|Overall Study|Protocol Violation|0
5029339|NCT02969018|17312883|P4|Overall Study|Protocol Violation|1
5029340|NCT02969018|17312884|P3|Overall Study|Protocol Violation|1
5029341|NCT02969018|17312885|P2|Overall Study|Protocol Violation|0
5029342|NCT02969018|17312886|P1|Overall Study|Protocol Violation|0
5029343|NCT02969018|17312879|P8|Overall Study|Pregnancy|0
5029344|NCT02969018|17312880|P7|Overall Study|Pregnancy|0
5029345|NCT02969018|17312881|P6|Overall Study|Pregnancy|1
5029346|NCT02969018|17312882|P5|Overall Study|Pregnancy|0
5029347|NCT02969018|17312883|P4|Overall Study|Pregnancy|0
5029348|NCT02969018|17312884|P3|Overall Study|Pregnancy|0
5029349|NCT02969018|17312885|P2|Overall Study|Pregnancy|0
5029350|NCT02969018|17312886|P1|Overall Study|Pregnancy|0
5029351|NCT02969018|17312879|P8|Overall Study|Other|2
5029352|NCT02969018|17312880|P7|Overall Study|Other|0
5029353|NCT02969018|17312881|P6|Overall Study|Other|0
5029354|NCT02969018|17312882|P5|Overall Study|Other|0
5029355|NCT02969018|17312883|P4|Overall Study|Other|1
5029356|NCT02969018|17312884|P3|Overall Study|Other|0
5029357|NCT02969018|17312885|P2|Overall Study|Other|0
5029358|NCT02969018|17312886|P1|Overall Study|Other|0
5029359|NCT02969018|17312879|P8|Overall Study|Non-Compliance With Study Drug|0
5029360|NCT02969018|17312880|P7|Overall Study|Non-Compliance With Study Drug|0
5029361|NCT02969018|17312881|P6|Overall Study|Non-Compliance With Study Drug|0
5029362|NCT02969018|17312882|P5|Overall Study|Non-Compliance With Study Drug|0
5029363|NCT02969018|17312883|P4|Overall Study|Non-Compliance With Study Drug|0
5029364|NCT02969018|17312884|P3|Overall Study|Non-Compliance With Study Drug|0
5029366|NCT02969018|17312886|P1|Overall Study|Non-Compliance With Study Drug|1
5029367|NCT02969018|17312879|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5029368|NCT02969018|17312880|P7|Overall Study|No Longer Meets Eligibility Criteria|1
5029369|NCT02969018|17312881|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5029370|NCT02969018|17312882|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5029371|NCT02969018|17312883|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5029372|NCT02969018|17312884|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5029373|NCT02969018|17312885|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5029374|NCT02969018|17312886|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5029375|NCT02969018|17312879|P8|Overall Study|Lost to Follow-up|1
5029376|NCT02969018|17312880|P7|Overall Study|Lost to Follow-up|0
5029377|NCT02969018|17312881|P6|Overall Study|Lost to Follow-up|1
5029378|NCT02969018|17312882|P5|Overall Study|Lost to Follow-up|1
5029379|NCT02969018|17312883|P4|Overall Study|Lost to Follow-up|0
5029380|NCT02969018|17312884|P3|Overall Study|Lost to Follow-up|2
5029381|NCT02969018|17312885|P2|Overall Study|Lost to Follow-up|2
5029382|NCT02969018|17312886|P1|Overall Study|Lost to Follow-up|1
5029383|NCT02969018|17312879|P8|Overall Study|Lack of Efficacy|1
5029384|NCT02969018|17312880|P7|Overall Study|Lack of Efficacy|1
5029385|NCT02969018|17312881|P6|Overall Study|Lack of Efficacy|1
5029386|NCT02969018|17312882|P5|Overall Study|Lack of Efficacy|1
5029387|NCT02969018|17312883|P4|Overall Study|Lack of Efficacy|0
5029388|NCT02969018|17312884|P3|Overall Study|Lack of Efficacy|0
5029389|NCT02969018|17312885|P2|Overall Study|Lack of Efficacy|1
5029390|NCT02969018|17312886|P1|Overall Study|Lack of Efficacy|0
5029391|NCT02969018|17312879|P8|Overall Study|Adverse Event|0
5029392|NCT02969018|17312880|P7|Overall Study|Adverse Event|2
5029393|NCT02969018|17312881|P6|Overall Study|Adverse Event|1
5029394|NCT02969018|17312882|P5|Overall Study|Adverse Event|0
5029395|NCT02969018|17312883|P4|Overall Study|Adverse Event|2
5029396|NCT02969018|17312884|P3|Overall Study|Adverse Event|1
5029397|NCT02969018|17312885|P2|Overall Study|Adverse Event|4
5029398|NCT02969018|17312886|P1|Overall Study|Adverse Event|2
5029399|NCT02968979|17313026|P1|Overall Study|Withdrawal by Subject|1
5029400|NCT02968979|17313026|P1|Overall Study|Protocol Violation|7
5029401|NCT02968576|17313151|P2|Overall Study|Pregnancy|1
5029402|NCT02968576|17313152|P1|Overall Study|Pregnancy|0
5029403|NCT02968563|17313159|P2|Overall Study|Still on Study|17
5029404|NCT02968563|17313160|P1|Overall Study|Still on Study|0
5029405|NCT02968563|17313159|P2|Overall Study|Death|1
5029406|NCT02968563|17313160|P1|Overall Study|Death|1
5029407|NCT02968563|17313159|P2|Overall Study|Adverse Event|5
5029408|NCT02968563|17313160|P1|Overall Study|Adverse Event|0
5029409|NCT02968173|17313238|P1|Overall Study|Withdrawal by Subject|1
5029410|NCT02967679|17313275|P1|Overall Study|Adverse Event|1
5029411|NCT02967562|17313296|P2|Overall Study|High leak precluding analysis|1
5029412|NCT02967562|17313297|P1|Overall Study|High leak precluding analysis|1
5029413|NCT02967562|17313296|P2|Overall Study|Consent not obtained|0
5029414|NCT02967562|17313297|P1|Overall Study|Consent not obtained|1
5029415|NCT02967055|17313523|P1|Overall Study|Stopped due to drug cost|1
5029416|NCT02967055|17313523|P1|Overall Study|Stopped due to side effects|3
5029417|NCT02967055|17313523|P1|Overall Study|Lost to Follow-up|2
5029418|NCT02967055|17313523|P1|Overall Study|Screen fail|3
5029419|NCT02967055|17313523|P1|Overall Study|Excluded|40
5029420|NCT02966795|17313544|P2|Overall Study|Patient Left the Country|1
5029421|NCT02966795|17313545|P1|Overall Study|Patient Left the Country|0
5029422|NCT02966509|17313556|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
5029423|NCT02966509|17313557|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
5029424|NCT02966509|17313556|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
5029425|NCT02966509|17313557|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
5029426|NCT02966509|17313556|P2|6 Month Satisfaction Survey|Refused to Answer|11
5029427|NCT02966509|17313557|P1|6 Month Satisfaction Survey|Refused to Answer|8
5029428|NCT02966509|17313556|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
5029429|NCT02966509|17313557|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
5029430|NCT02966509|17313556|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
5029431|NCT02966509|17313557|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
5029432|NCT02966509|17313556|P2|6 Month Satisfaction Survey|Death|33
5029433|NCT02966509|17313557|P1|6 Month Satisfaction Survey|Death|36
5029434|NCT02966509|17313556|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
5029435|NCT02966509|17313557|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
5029436|NCT02966509|17313556|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5029437|NCT02966509|17313557|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5029438|NCT02966509|17313556|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
5029439|NCT02966509|17313557|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
5029440|NCT02966509|17313556|P2|6 Month Satisfaction Decision Survey|Death|25
5029441|NCT02966509|17313557|P1|6 Month Satisfaction Decision Survey|Death|22
5029442|NCT02966509|17313556|P2|Baseline Satisfaction Survey|Refused to Answer|2
5029443|NCT02966509|17313557|P1|Baseline Satisfaction Survey|Refused to Answer|1
5029444|NCT02966509|17313556|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
5029445|NCT02966509|17313557|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
5029446|NCT02966509|17313556|P2|Baseline Satisfaction Survey|Death|1
5029447|NCT02966509|17313557|P1|Baseline Satisfaction Survey|Death|0
5029448|NCT02966509|17313556|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
5029449|NCT02966509|17313557|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
5029450|NCT02966353|17313581|P1|Overall Study|Protocol deviation|2
5029451|NCT02966353|17313581|P1|Overall Study|Progressive disease|2
5029452|NCT02966353|17313581|P1|Overall Study|Physician Decision|3
5029453|NCT02966353|17313581|P1|Overall Study|Death|4
5029454|NCT02966353|17313581|P1|Overall Study|Adverse Event|4
5029455|NCT02966353|17313581|P1|Overall Study|Withdrawal by Subject|7
5029456|NCT02966340|17313590|P2|Overall Study|startle non-responder|1
5029457|NCT02966340|17313591|P1|Overall Study|startle non-responder|1
5029458|NCT02966340|17313590|P2|Overall Study|data acquisition error|0
5029459|NCT02966340|17313591|P1|Overall Study|data acquisition error|1
5029460|NCT02966340|17313590|P2|Overall Study|Withdrawal by Subject|0
5029461|NCT02966340|17313591|P1|Overall Study|Withdrawal by Subject|1
5029462|NCT02966340|17313590|P2|Overall Study|Lost to Follow-up|1
5029463|NCT02966340|17313591|P1|Overall Study|Lost to Follow-up|0
5029464|NCT02966340|17313590|P2|Overall Study|Adverse Event|1
5029465|NCT02966340|17313591|P1|Overall Study|Adverse Event|0
5029466|NCT02966223|17313634|P1|Overall Study|Lost to Follow-up|1
5029467|NCT02966223|17313634|P1|Overall Study|Withdrawal by Subject|11
5029468|NCT02966223|17313634|P1|Overall Study|Physician Decision|3
5029469|NCT02966015|17313642|P2|Inclusion Visit|did not answer questionnaire|3
5029470|NCT02966015|17313643|P1|Inclusion Visit|did not answer questionnaire|8
5029471|NCT02966002|17313649|P1|Overall Study|Lost to Follow-up|1
5029472|NCT02966002|17313649|P1|Overall Study|Adverse Event|1
5029473|NCT02966002|17313649|P1|Overall Study|Withdrawal by Subject|2
5029474|NCT02965846|17313664|P3|Overall Study|Participants not randomized|33
5029475|NCT02965846|17313665|P2|Overall Study|Participants not randomized|0
5029476|NCT02965846|17313666|P1|Overall Study|Participants not randomized|0
5029477|NCT02965846|17313664|P3|Overall Study|Study Terminated By Sponsor|0
5029478|NCT02965846|17313665|P2|Overall Study|Study Terminated By Sponsor|4
5029479|NCT02965846|17313666|P1|Overall Study|Study Terminated By Sponsor|4
5029480|NCT02965846|17313664|P3|Overall Study|Withdrawal by Subject|0
5029481|NCT02965846|17313665|P2|Overall Study|Withdrawal by Subject|1
5029482|NCT02965846|17313666|P1|Overall Study|Withdrawal by Subject|0
5029483|NCT02965846|17313664|P3|Overall Study|Lost to Follow-up|0
5029484|NCT02965846|17313665|P2|Overall Study|Lost to Follow-up|0
5029485|NCT02965846|17313666|P1|Overall Study|Lost to Follow-up|1
5029486|NCT02965833|17313674|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
5029487|NCT02965833|17313675|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
5029488|NCT02965833|17313674|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5029489|NCT02965833|17313675|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5029490|NCT02965833|17313674|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
5029491|NCT02965833|17313675|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
5029492|NCT02965833|17313674|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5029493|NCT02965833|17313675|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5029494|NCT02965833|17313674|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5029495|NCT02965833|17313675|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5029496|NCT02965820|17313681|P2|Period 2, Second 30 Days|Adverse Event|1
5029497|NCT02965820|17313682|P1|Period 2, Second 30 Days|Adverse Event|1
5029498|NCT02965599|17313721|P2|Overall Study|Protocol-defined stop criteria reached|0
5029499|NCT02965599|17313722|P1|Overall Study|Protocol-defined stop criteria reached|1
5029500|NCT02965456|17313801|P2|Overall Study|Participant ran out of study drug|1
5029501|NCT02965456|17313802|P1|Overall Study|Participant ran out of study drug|0
5029502|NCT02965456|17313801|P2|Overall Study|Protocol Violation|1
5029503|NCT02965456|17313802|P1|Overall Study|Protocol Violation|0
5029504|NCT02965456|17313801|P2|Overall Study|Pregnancy|0
5029505|NCT02965456|17313802|P1|Overall Study|Pregnancy|1
5029506|NCT02965456|17313801|P2|Overall Study|Physician Decision|1
5029507|NCT02965456|17313802|P1|Overall Study|Physician Decision|0
5029508|NCT02965456|17313801|P2|Overall Study|Lack of Efficacy|0
5029509|NCT02965456|17313802|P1|Overall Study|Lack of Efficacy|1
5029510|NCT02965456|17313801|P2|Overall Study|Worsening Condition|2
5029511|NCT02965456|17313802|P1|Overall Study|Worsening Condition|0
5029512|NCT02965456|17313801|P2|Overall Study|Noncompliance with Study Drug|1
5029513|NCT02965456|17313802|P1|Overall Study|Noncompliance with Study Drug|1
5029514|NCT02965456|17313801|P2|Overall Study|Adverse Event|0
5029515|NCT02965456|17313802|P1|Overall Study|Adverse Event|3
5029516|NCT02965456|17313801|P2|Overall Study|Withdrawal by Parent or Guardian|6
5029517|NCT02965456|17313802|P1|Overall Study|Withdrawal by Parent or Guardian|3
5029518|NCT02965456|17313801|P2|Overall Study|Subject Request|13
5029519|NCT02965456|17313802|P1|Overall Study|Subject Request|22
5029520|NCT02965456|17313801|P2|Overall Study|Lost to Follow-up|18
5029521|NCT02965456|17313802|P1|Overall Study|Lost to Follow-up|40
5029522|NCT02964338|17313893|P3|Overall Study|Did not meet criteria|0
5029523|NCT02964338|17313894|P2|Overall Study|Did not meet criteria|0
5029524|NCT02964338|17313895|P1|Overall Study|Did not meet criteria|1
5029525|NCT02964338|17313893|P3|Overall Study|Non-compliant with e-diary|0
5029526|NCT02964338|17313894|P2|Overall Study|Non-compliant with e-diary|1
5029527|NCT02964338|17313895|P1|Overall Study|Non-compliant with e-diary|0
5029528|NCT02964338|17313893|P3|Overall Study|Adverse Event|1
5029529|NCT02964338|17313894|P2|Overall Study|Adverse Event|1
5029530|NCT02964338|17313895|P1|Overall Study|Adverse Event|2
5029531|NCT02964338|17313893|P3|Overall Study|Withdrawal by Subject|1
5029532|NCT02964338|17313894|P2|Overall Study|Withdrawal by Subject|3
5029533|NCT02964338|17313895|P1|Overall Study|Withdrawal by Subject|1
5029534|NCT02964338|17313893|P3|Overall Study|Protocol Violation|0
5029535|NCT02964338|17313894|P2|Overall Study|Protocol Violation|1
5029536|NCT02964338|17313895|P1|Overall Study|Protocol Violation|0
5029537|NCT02964338|17313893|P3|Overall Study|Lost to Follow-up|3
5029538|NCT02964338|17313894|P2|Overall Study|Lost to Follow-up|0
5029539|NCT02964338|17313895|P1|Overall Study|Lost to Follow-up|1
5029540|NCT02964338|17313893|P3|Overall Study|Lack of Efficacy|0
5029541|NCT02964338|17313894|P2|Overall Study|Lack of Efficacy|3
5029542|NCT02964338|17313895|P1|Overall Study|Lack of Efficacy|0
5029543|NCT02964338|17313893|P3|Overall Study|Sponsor terminated study for futility|14
5029544|NCT02964338|17313894|P2|Overall Study|Sponsor terminated study for futility|15
5029545|NCT02964338|17313895|P1|Overall Study|Sponsor terminated study for futility|12
5029546|NCT02964312|17313939|P1|Overall Study|Death|1
5029547|NCT02964312|17313939|P1|Overall Study|Did not consent to long-term FU|14
5029548|NCT02964312|17313939|P1|Overall Study|Lack of Efficacy|10
5029549|NCT02964312|17313939|P1|Overall Study|Withdrawal by Subject|11
5029550|NCT02964312|17313939|P1|Overall Study|Lost to Follow-up|28
5029551|NCT02964247|17313950|P2|Overall Study|Withdrawal by Subject|2
5029552|NCT02964247|17313951|P1|Overall Study|Withdrawal by Subject|1
5029553|NCT02964247|17313950|P2|Overall Study|Lost to Follow-up|0
5029554|NCT02964247|17313951|P1|Overall Study|Lost to Follow-up|2
5029555|NCT02964234|17314009|P2|Overall Study|Lost to Follow-up|13
5029556|NCT02964234|17314010|P1|Overall Study|Lost to Follow-up|22
5029557|NCT02963935|17314039|P2|Overall Study|Unclassified|22
5029558|NCT02963935|17314040|P1|Overall Study|Unclassified|13
5029559|NCT02963935|17314039|P2|Overall Study|Lost to Follow-up|6
5029560|NCT02963935|17314040|P1|Overall Study|Lost to Follow-up|1
5029561|NCT02963935|17314039|P2|Overall Study|Lack of Efficacy|2
5029562|NCT02963935|17314040|P1|Overall Study|Lack of Efficacy|0
5029563|NCT02963935|17314039|P2|Overall Study|Protocol Violation|1
5029564|NCT02963935|17314040|P1|Overall Study|Protocol Violation|2
5029565|NCT02963935|17314039|P2|Overall Study|Adverse Event|6
5029566|NCT02963935|17314040|P1|Overall Study|Adverse Event|12
5029567|NCT02963922|17314148|P2|Overall Study|Other|14
5029568|NCT02963922|17314149|P1|Overall Study|Other|8
5029569|NCT02963922|17314148|P2|Overall Study|Lost to Follow-up|3
5029570|NCT02963922|17314149|P1|Overall Study|Lost to Follow-up|2
5029571|NCT02963922|17314148|P2|Overall Study|Lack of Efficacy|1
5029572|NCT02963922|17314149|P1|Overall Study|Lack of Efficacy|1
5029573|NCT02963922|17314148|P2|Overall Study|Protocol deviation|6
5029574|NCT02963922|17314149|P1|Overall Study|Protocol deviation|6
5029575|NCT02963922|17314148|P2|Overall Study|Adverse Event|6
5029576|NCT02963922|17314149|P1|Overall Study|Adverse Event|15
5029577|NCT02963701|17314247|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
5029578|NCT02963701|17314248|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
5029579|NCT02963506|17314308|P13|Dose-Blind Period|Meeting exclusion criteria 9|1
5029580|NCT02963506|17314309|P12|Dose-Blind Period|Meeting exclusion criteria 9|0
5029581|NCT02963506|17314310|P11|Dose-Blind Period|Meeting exclusion criteria 9|0
5029582|NCT02963506|17314311|P10|Dose-Blind Period|Meeting exclusion criteria 9|0
5029583|NCT02963506|17314312|P9|Dose-Blind Period|Meeting exclusion criteria 9|0
5029584|NCT02963506|17314313|P8|Dose-Blind Period|Meeting exclusion criteria 9|0
5029585|NCT02963506|17314314|P7|Dose-Blind Period|Meeting exclusion criteria 9|0
5029586|NCT02963506|17314315|P6|Dose-Blind Period|Meeting exclusion criteria 9|0
5029587|NCT02963506|17314316|P5|Dose-Blind Period|Meeting exclusion criteria 9|0
5029588|NCT02963506|17314317|P4|Dose-Blind Period|Meeting exclusion criteria 9|0
5029589|NCT02963506|17314318|P3|Dose-Blind Period|Meeting exclusion criteria 9|0
5029590|NCT02963506|17314319|P2|Dose-Blind Period|Meeting exclusion criteria 9|0
5029591|NCT02963506|17314320|P1|Dose-Blind Period|Meeting exclusion criteria 9|0
5029592|NCT02963506|17314308|P13|Dose-Blind Period|Sponsor decision|0
5029593|NCT02963506|17314309|P12|Dose-Blind Period|Sponsor decision|0
5029594|NCT02963506|17314310|P11|Dose-Blind Period|Sponsor decision|0
5029595|NCT02963506|17314311|P10|Dose-Blind Period|Sponsor decision|0
5029596|NCT02963506|17314312|P9|Dose-Blind Period|Sponsor decision|0
5029597|NCT02963506|17314313|P8|Dose-Blind Period|Sponsor decision|0
5029598|NCT02963506|17314314|P7|Dose-Blind Period|Sponsor decision|0
5029599|NCT02963506|17314315|P6|Dose-Blind Period|Sponsor decision|1
5029600|NCT02963506|17314316|P5|Dose-Blind Period|Sponsor decision|0
5029601|NCT02963506|17314317|P4|Dose-Blind Period|Sponsor decision|0
5029602|NCT02963506|17314318|P3|Dose-Blind Period|Sponsor decision|0
5029603|NCT02963506|17314319|P2|Dose-Blind Period|Sponsor decision|0
5029604|NCT02963506|17314320|P1|Dose-Blind Period|Sponsor decision|0
5029605|NCT02963506|17314308|P13|Dose-Blind Period|Withdrawal by Subject|0
5029606|NCT02963506|17314309|P12|Dose-Blind Period|Withdrawal by Subject|0
5029607|NCT02963506|17314310|P11|Dose-Blind Period|Withdrawal by Subject|0
5029608|NCT02963506|17314311|P10|Dose-Blind Period|Withdrawal by Subject|1
5029609|NCT02963506|17314312|P9|Dose-Blind Period|Withdrawal by Subject|0
5029610|NCT02963506|17314313|P8|Dose-Blind Period|Withdrawal by Subject|2
5029611|NCT02963506|17314314|P7|Dose-Blind Period|Withdrawal by Subject|2
5029612|NCT02963506|17314315|P6|Dose-Blind Period|Withdrawal by Subject|1
5029613|NCT02963506|17314316|P5|Dose-Blind Period|Withdrawal by Subject|0
5029614|NCT02963506|17314317|P4|Dose-Blind Period|Withdrawal by Subject|0
5029615|NCT02963506|17314318|P3|Dose-Blind Period|Withdrawal by Subject|0
5029616|NCT02963506|17314319|P2|Dose-Blind Period|Withdrawal by Subject|0
5029617|NCT02963506|17314320|P1|Dose-Blind Period|Withdrawal by Subject|0
5029618|NCT02963506|17314308|P13|Dose-Blind Period|Lost to Follow-up|0
5029619|NCT02963506|17314309|P12|Dose-Blind Period|Lost to Follow-up|1
5029620|NCT02963506|17314310|P11|Dose-Blind Period|Lost to Follow-up|0
5029621|NCT02963506|17314311|P10|Dose-Blind Period|Lost to Follow-up|0
5029622|NCT02963506|17314312|P9|Dose-Blind Period|Lost to Follow-up|1
5029623|NCT02963506|17314313|P8|Dose-Blind Period|Lost to Follow-up|0
5029624|NCT02963506|17314314|P7|Dose-Blind Period|Lost to Follow-up|0
5029625|NCT02963506|17314315|P6|Dose-Blind Period|Lost to Follow-up|1
5029626|NCT02963506|17314316|P5|Dose-Blind Period|Lost to Follow-up|0
5029627|NCT02963506|17314317|P4|Dose-Blind Period|Lost to Follow-up|0
5029628|NCT02963506|17314318|P3|Dose-Blind Period|Lost to Follow-up|0
5029629|NCT02963506|17314319|P2|Dose-Blind Period|Lost to Follow-up|0
5029630|NCT02963506|17314320|P1|Dose-Blind Period|Lost to Follow-up|0
5029631|NCT02963506|17314308|P13|Dose-Blind Period|Lack of Efficacy|0
5029632|NCT02963506|17314309|P12|Dose-Blind Period|Lack of Efficacy|0
5029633|NCT02963506|17314310|P11|Dose-Blind Period|Lack of Efficacy|0
5029634|NCT02963506|17314311|P10|Dose-Blind Period|Lack of Efficacy|1
5029635|NCT02963506|17314312|P9|Dose-Blind Period|Lack of Efficacy|0
5029636|NCT02963506|17314313|P8|Dose-Blind Period|Lack of Efficacy|1
5029637|NCT02963506|17314314|P7|Dose-Blind Period|Lack of Efficacy|0
5029638|NCT02963506|17314315|P6|Dose-Blind Period|Lack of Efficacy|0
5029639|NCT02963506|17314316|P5|Dose-Blind Period|Lack of Efficacy|0
5029640|NCT02963506|17314317|P4|Dose-Blind Period|Lack of Efficacy|0
5029641|NCT02963506|17314318|P3|Dose-Blind Period|Lack of Efficacy|0
5029642|NCT02963506|17314319|P2|Dose-Blind Period|Lack of Efficacy|0
5029643|NCT02963506|17314320|P1|Dose-Blind Period|Lack of Efficacy|0
5029644|NCT02963506|17314308|P13|Dose-Blind Period|Adverse Event|6
5029645|NCT02963506|17314309|P12|Dose-Blind Period|Adverse Event|1
5029646|NCT02963506|17314310|P11|Dose-Blind Period|Adverse Event|1
5029647|NCT02963506|17314311|P10|Dose-Blind Period|Adverse Event|2
5029648|NCT02963506|17314312|P9|Dose-Blind Period|Adverse Event|2
5029649|NCT02963506|17314313|P8|Dose-Blind Period|Adverse Event|2
5029650|NCT02963506|17314314|P7|Dose-Blind Period|Adverse Event|3
5029651|NCT02963506|17314315|P6|Dose-Blind Period|Adverse Event|1
5029652|NCT02963506|17314316|P5|Dose-Blind Period|Adverse Event|0
5029653|NCT02963506|17314317|P4|Dose-Blind Period|Adverse Event|0
5029654|NCT02963506|17314318|P3|Dose-Blind Period|Adverse Event|0
5029655|NCT02963506|17314319|P2|Dose-Blind Period|Adverse Event|0
5029656|NCT02963506|17314320|P1|Dose-Blind Period|Adverse Event|0
5029657|NCT02963506|17314308|P13|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029658|NCT02963506|17314309|P12|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029659|NCT02963506|17314310|P11|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029660|NCT02963506|17314311|P10|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029661|NCT02963506|17314312|P9|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029662|NCT02963506|17314313|P8|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029663|NCT02963506|17314314|P7|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029664|NCT02963506|17314315|P6|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029665|NCT02963506|17314316|P5|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029666|NCT02963506|17314317|P4|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029667|NCT02963506|17314318|P3|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029668|NCT02963506|17314319|P2|Double-Blind Period|Adverse event, non fatal after Wk12|1
5029669|NCT02963506|17314320|P1|Double-Blind Period|Adverse event, non fatal after Wk12|0
5029670|NCT02963506|17314308|P13|Double-Blind Period|No compliance|0
5029671|NCT02963506|17314309|P12|Double-Blind Period|No compliance|0
5029672|NCT02963506|17314310|P11|Double-Blind Period|No compliance|0
5029673|NCT02963506|17314311|P10|Double-Blind Period|No compliance|0
5029674|NCT02963506|17314312|P9|Double-Blind Period|No compliance|0
5029675|NCT02963506|17314313|P8|Double-Blind Period|No compliance|0
5029676|NCT02963506|17314314|P7|Double-Blind Period|No compliance|0
5029677|NCT02963506|17314315|P6|Double-Blind Period|No compliance|0
5029678|NCT02963506|17314316|P5|Double-Blind Period|No compliance|0
5029679|NCT02963506|17314317|P4|Double-Blind Period|No compliance|0
5029680|NCT02963506|17314318|P3|Double-Blind Period|No compliance|0
5029681|NCT02963506|17314319|P2|Double-Blind Period|No compliance|1
5029682|NCT02963506|17314320|P1|Double-Blind Period|No compliance|0
5029683|NCT02963506|17314308|P13|Double-Blind Period|Withdrawal by Subject|0
5029684|NCT02963506|17314309|P12|Double-Blind Period|Withdrawal by Subject|0
5029685|NCT02963506|17314310|P11|Double-Blind Period|Withdrawal by Subject|0
5029686|NCT02963506|17314311|P10|Double-Blind Period|Withdrawal by Subject|0
5029687|NCT02963506|17314312|P9|Double-Blind Period|Withdrawal by Subject|0
5029688|NCT02963506|17314313|P8|Double-Blind Period|Withdrawal by Subject|0
5029689|NCT02963506|17314314|P7|Double-Blind Period|Withdrawal by Subject|0
5029690|NCT02963506|17314315|P6|Double-Blind Period|Withdrawal by Subject|0
5029691|NCT02963506|17314316|P5|Double-Blind Period|Withdrawal by Subject|0
5029692|NCT02963506|17314317|P4|Double-Blind Period|Withdrawal by Subject|1
5029693|NCT02963506|17314318|P3|Double-Blind Period|Withdrawal by Subject|1
5029694|NCT02963506|17314319|P2|Double-Blind Period|Withdrawal by Subject|0
5029695|NCT02963506|17314320|P1|Double-Blind Period|Withdrawal by Subject|0
5029696|NCT02963506|17314308|P13|Double-Blind Period|Lost to Follow-up|0
5029697|NCT02963506|17314309|P12|Double-Blind Period|Lost to Follow-up|0
5029698|NCT02963506|17314310|P11|Double-Blind Period|Lost to Follow-up|0
5029699|NCT02963506|17314311|P10|Double-Blind Period|Lost to Follow-up|0
5029700|NCT02963506|17314312|P9|Double-Blind Period|Lost to Follow-up|0
5029701|NCT02963506|17314313|P8|Double-Blind Period|Lost to Follow-up|0
5029702|NCT02963506|17314314|P7|Double-Blind Period|Lost to Follow-up|0
5029703|NCT02963506|17314315|P6|Double-Blind Period|Lost to Follow-up|0
5029704|NCT02963506|17314316|P5|Double-Blind Period|Lost to Follow-up|0
5029705|NCT02963506|17314317|P4|Double-Blind Period|Lost to Follow-up|0
5029706|NCT02963506|17314318|P3|Double-Blind Period|Lost to Follow-up|0
5029707|NCT02963506|17314319|P2|Double-Blind Period|Lost to Follow-up|1
5029708|NCT02963506|17314320|P1|Double-Blind Period|Lost to Follow-up|0
5029709|NCT02963506|17314308|P13|Double-Blind Period|Death|0
5029710|NCT02963506|17314309|P12|Double-Blind Period|Death|0
5029711|NCT02963506|17314310|P11|Double-Blind Period|Death|0
5029712|NCT02963506|17314311|P10|Double-Blind Period|Death|0
5029713|NCT02963506|17314312|P9|Double-Blind Period|Death|0
5029714|NCT02963506|17314313|P8|Double-Blind Period|Death|0
5029715|NCT02963506|17314314|P7|Double-Blind Period|Death|0
5029716|NCT02963506|17314315|P6|Double-Blind Period|Death|0
5029717|NCT02963506|17314316|P5|Double-Blind Period|Death|0
5029718|NCT02963506|17314317|P4|Double-Blind Period|Death|1
5029719|NCT02963506|17314318|P3|Double-Blind Period|Death|0
5029720|NCT02963506|17314319|P2|Double-Blind Period|Death|0
5029721|NCT02963506|17314320|P1|Double-Blind Period|Death|0
5029722|NCT02963506|17314308|P13|Double-Blind Period|Adverse Event|0
5029723|NCT02963506|17314309|P12|Double-Blind Period|Adverse Event|0
5029724|NCT02963506|17314310|P11|Double-Blind Period|Adverse Event|0
5029725|NCT02963506|17314311|P10|Double-Blind Period|Adverse Event|0
5029726|NCT02963506|17314312|P9|Double-Blind Period|Adverse Event|0
5029727|NCT02963506|17314313|P8|Double-Blind Period|Adverse Event|0
5029728|NCT02963506|17314314|P7|Double-Blind Period|Adverse Event|0
5029729|NCT02963506|17314315|P6|Double-Blind Period|Adverse Event|0
5029730|NCT02963506|17314316|P5|Double-Blind Period|Adverse Event|0
5029731|NCT02963506|17314317|P4|Double-Blind Period|Adverse Event|0
5029732|NCT02963506|17314318|P3|Double-Blind Period|Adverse Event|1
5029733|NCT02963506|17314319|P2|Double-Blind Period|Adverse Event|0
5029734|NCT02963506|17314320|P1|Double-Blind Period|Adverse Event|0
5029735|NCT02963311|17314372|P1|Overall Study|Screen Failure|4
5029736|NCT02963311|17314372|P1|Overall Study|Withdrawal by Subject|1
5029737|NCT02962960|17314399|P3|Overall Study|Protocol Violation|0
5029738|NCT02962960|17314400|P2|Overall Study|Protocol Violation|0
5029739|NCT02962960|17314401|P1|Overall Study|Protocol Violation|1
5029740|NCT02962960|17314399|P3|Overall Study|Adverse Event|0
5029741|NCT02962960|17314400|P2|Overall Study|Adverse Event|1
5029742|NCT02962960|17314401|P1|Overall Study|Adverse Event|1
5029743|NCT02962960|17314399|P3|Overall Study|Withdrawal by Subject|0
5029744|NCT02962960|17314400|P2|Overall Study|Withdrawal by Subject|1
5029745|NCT02962960|17314401|P1|Overall Study|Withdrawal by Subject|1
5029746|NCT02962908|17314485|P4|Overall Study|Physician Decision|0
5029747|NCT02962908|17314486|P3|Overall Study|Physician Decision|0
5029748|NCT02962908|17314487|P2|Overall Study|Physician Decision|1
5029749|NCT02962908|17314488|P1|Overall Study|Physician Decision|0
5029750|NCT02962908|17314485|P4|Overall Study|Protocol Violation|0
5029751|NCT02962908|17314486|P3|Overall Study|Protocol Violation|0
5029752|NCT02962908|17314487|P2|Overall Study|Protocol Violation|1
5029753|NCT02962908|17314488|P1|Overall Study|Protocol Violation|0
5029754|NCT02962908|17314485|P4|Overall Study|Withdrawal by Subject|2
5029755|NCT02962908|17314486|P3|Overall Study|Withdrawal by Subject|0
5029756|NCT02962908|17314487|P2|Overall Study|Withdrawal by Subject|3
5029757|NCT02962908|17314488|P1|Overall Study|Withdrawal by Subject|0
5029758|NCT02962908|17314485|P4|Overall Study|Lost to Follow-up|1
5029759|NCT02962908|17314486|P3|Overall Study|Lost to Follow-up|0
5029760|NCT02962908|17314487|P2|Overall Study|Lost to Follow-up|3
5029761|NCT02962908|17314488|P1|Overall Study|Lost to Follow-up|0
5029762|NCT02962882|17314552|P1|Overall Study|Transfer from ICU|32
5029763|NCT02962882|17314552|P1|Overall Study|Withdrawal by Subject|2
5029764|NCT02962882|17314552|P1|Overall Study|Adverse Event|2
5029765|NCT02962648|17314588|P1|Overall Study|Subject had problems with transportation|2
5029766|NCT02962648|17314588|P1|Overall Study|Physician Decision|1
5029767|NCT02962648|17314588|P1|Overall Study|Lost to Follow-up|3
5029768|NCT02962648|17314588|P1|Overall Study|Withdrawal by Subject|3
5029769|NCT02962284|17314626|P2|Overall Study|Withdrawal by Subject|0
5029770|NCT02962284|17314627|P1|Overall Study|Withdrawal by Subject|1
5029771|NCT02962284|17314626|P2|Overall Study|Progressive disease|3
5029772|NCT02962284|17314627|P1|Overall Study|Progressive disease|2
5029773|NCT02962284|17314626|P2|Overall Study|Death|0
5029774|NCT02962284|17314627|P1|Overall Study|Death|2
5029775|NCT02961920|17314658|P2|Overall Study|did not achive stydy protocol schedule|1
5029776|NCT02961920|17314659|P1|Overall Study|did not achive stydy protocol schedule|1
5029777|NCT02961790|17314687|P4|Overall Study|without post baseline data|1
5029778|NCT02961790|17314688|P3|Overall Study|without post baseline data|4
5029779|NCT02961790|17314689|P2|Overall Study|without post baseline data|6
5029780|NCT02961790|17314690|P1|Overall Study|without post baseline data|7
5029781|NCT02961790|17314687|P4|Overall Study|without baseline data|0
5029782|NCT02961790|17314688|P3|Overall Study|without baseline data|1
5029783|NCT02961790|17314689|P2|Overall Study|without baseline data|0
5029784|NCT02961790|17314690|P1|Overall Study|without baseline data|4
5029785|NCT02961790|17314687|P4|Overall Study|Canceled|4
5029786|NCT02961790|17314688|P3|Overall Study|Canceled|1
5029787|NCT02961790|17314689|P2|Overall Study|Canceled|5
5029788|NCT02961790|17314690|P1|Overall Study|Canceled|4
5029789|NCT02961764|17314713|P2|Overall Study|Withdrawal by Subject|0
5029790|NCT02961764|17314714|P1|Overall Study|Withdrawal by Subject|2
5029791|NCT02961764|17314713|P2|Overall Study|Lost to Follow-up|24
5029792|NCT02961764|17314714|P1|Overall Study|Lost to Follow-up|35
5029793|NCT02961764|17314713|P2|Overall Study|Death|0
5029794|NCT02961764|17314714|P1|Overall Study|Death|2
5029795|NCT02961764|17314713|P2|Overall Study|Protocol Violation|1
5029796|NCT02961764|17314714|P1|Overall Study|Protocol Violation|0
5029797|NCT02961751|17314788|P1|Overall Study|Protocol Violation|1
5029798|NCT02961751|17314788|P1|Overall Study|Not Eligible at Enrollment|1
5029799|NCT02961751|17314788|P1|Overall Study|Physician Decision|2
5029800|NCT02961751|17314788|P1|Overall Study|Lost to Follow-up|11
5029801|NCT02961244|17314801|P2|Overall Study|İnadequate data|2
5029802|NCT02961244|17314802|P1|Overall Study|İnadequate data|0
5029803|NCT02961244|17314801|P2|Overall Study|Lost to Follow-up|2
5029804|NCT02961244|17314802|P1|Overall Study|Lost to Follow-up|0
5029805|NCT02961244|17314801|P2|Overall Study|Surgery plan change after study approval|2
5029806|NCT02961244|17314802|P1|Overall Study|Surgery plan change after study approval|0
5029807|NCT02961244|17314801|P2|Overall Study|Withdrawal by Subject|2
5029808|NCT02961244|17314802|P1|Overall Study|Withdrawal by Subject|1
5029809|NCT02961244|17314801|P2|Overall Study|Protocol Violation|1
5029810|NCT02961244|17314802|P1|Overall Study|Protocol Violation|0
5029811|NCT02960893|17314855|P2|Extension Phase (48-week)|Sponsors Decision|0
5029812|NCT02960893|17314856|P1|Extension Phase (48-week)|Sponsors Decision|1
5029813|NCT02960893|17314855|P2|Extension Phase (48-week)|Lost to Follow-up|1
5029814|NCT02960893|17314856|P1|Extension Phase (48-week)|Lost to Follow-up|1
5029815|NCT02960893|17314855|P2|Extension Phase (48-week)|Other Reason|1
5029816|NCT02960893|17314856|P1|Extension Phase (48-week)|Other Reason|2
5029817|NCT02960893|17314855|P2|Extension Phase (48-week)|Withdrawal by Subject|8
5029818|NCT02960893|17314856|P1|Extension Phase (48-week)|Withdrawal by Subject|8
5029819|NCT02960893|17314855|P2|Extension Phase (48-week)|Adverse Event|3
5029820|NCT02960893|17314856|P1|Extension Phase (48-week)|Adverse Event|2
5029821|NCT02960893|17314855|P2|Randomization Phase (8-week)|Reason Not Specified|1
5029822|NCT02960893|17314856|P1|Randomization Phase (8-week)|Reason Not Specified|0
5029823|NCT02960893|17314855|P2|Randomization Phase (8-week)|Withdrawal by Subject|1
5029824|NCT02960893|17314856|P1|Randomization Phase (8-week)|Withdrawal by Subject|2
5029825|NCT02960893|17314855|P2|Randomization Phase (8-week)|Adverse Event|0
5029826|NCT02960893|17314856|P1|Randomization Phase (8-week)|Adverse Event|5
5029827|NCT02960854|17314874|P2|Overall Study|Death|6
5029828|NCT02960854|17314875|P1|Overall Study|Death|4
5029829|NCT02960854|17314874|P2|Overall Study|Subject Withdrew Consent|1
5029830|NCT02960854|17314875|P1|Overall Study|Subject Withdrew Consent|0
5029831|NCT02960854|17314874|P2|Overall Study|Subject No Longer Meets Study Criteria|0
5029832|NCT02960854|17314875|P1|Overall Study|Subject No Longer Meets Study Criteria|1
5029833|NCT02960854|17314874|P2|Overall Study|Not Disclosed|2
5029834|NCT02960854|17314875|P1|Overall Study|Not Disclosed|2
5029835|NCT02960217|17314914|P2|Open-Label Extension Phase|Other, Not Specified|1
5029836|NCT02960217|17314915|P1|Open-Label Extension Phase|Other, Not Specified|0
5029837|NCT02960217|17314914|P2|Open-Label Extension Phase|Lack of Efficacy|1
5029838|NCT02960217|17314915|P1|Open-Label Extension Phase|Lack of Efficacy|1
5029839|NCT02960217|17314914|P2|Open-Label Extension Phase|Sponsor Decision|11
5029840|NCT02960217|17314915|P1|Open-Label Extension Phase|Sponsor Decision|18
5029841|NCT02960217|17314914|P2|Open-Label Extension Phase|Adverse Event|0
5029842|NCT02960217|17314915|P1|Open-Label Extension Phase|Adverse Event|1
5029843|NCT02960217|17314914|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
5029844|NCT02960217|17314915|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
5029845|NCT02960217|17314914|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
5029846|NCT02960217|17314915|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
5029847|NCT02960217|17314914|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
5029848|NCT02960217|17314915|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
5029849|NCT02960217|17314914|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
5029850|NCT02960217|17314915|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
5029851|NCT02960217|17314914|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
5029852|NCT02960217|17314915|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
5029853|NCT02959983|17314994|P2|Overall Study|Withdrawal by Subject|12
5029854|NCT02959983|17314995|P1|Overall Study|Withdrawal by Subject|7
5029855|NCT02959983|17314994|P2|Overall Study|Adverse Event|1
5029856|NCT02959983|17314995|P1|Overall Study|Adverse Event|5
5029857|NCT02959983|17314994|P2|Overall Study|Physician Decision|0
5029858|NCT02959983|17314995|P1|Overall Study|Physician Decision|1
5029859|NCT02959983|17314994|P2|Overall Study|Other|1
5029860|NCT02959983|17314995|P1|Overall Study|Other|1
5029861|NCT02959983|17314994|P2|Overall Study|Lost to Follow-up|9
5029862|NCT02959983|17314995|P1|Overall Study|Lost to Follow-up|12
5029863|NCT02959983|17314994|P2|Overall Study|Lack of Efficacy|1
5029864|NCT02959983|17314995|P1|Overall Study|Lack of Efficacy|0
5029865|NCT02959983|17314994|P2|Overall Study|Protocol Violation|1
5029866|NCT02959983|17314995|P1|Overall Study|Protocol Violation|0
5029867|NCT02959970|17315009|P2|Overall Study|Lost to Follow-up|5
5029868|NCT02959970|17315010|P1|Overall Study|Lost to Follow-up|1
5029869|NCT02959970|17315009|P2|Overall Study|Withdrawal by Subject|2
5029870|NCT02959970|17315010|P1|Overall Study|Withdrawal by Subject|0
5029871|NCT02959970|17315009|P2|Overall Study|Adverse Event|0
5029872|NCT02959970|17315010|P1|Overall Study|Adverse Event|1
5029873|NCT02959892|17315044|P2|Overall Study|Study termination|1
5029874|NCT02959892|17315045|P1|Overall Study|Study termination|0
5029875|NCT02959892|17315044|P2|Overall Study|PET tracer synthesis failure|0
5029876|NCT02959892|17315045|P1|Overall Study|PET tracer synthesis failure|1
5029877|NCT02959866|17315053|P1|Overall Study|Withdrawal by Subject|1
5029878|NCT02959814|17315142|P1|Overall Study|Excluded by FFR core-lab|24
5029879|NCT02959814|17315142|P1|Overall Study|In-procedure QFR not computed|6
5029880|NCT02959814|17315142|P1|Overall Study|FFR not measured|2
5029881|NCT02959814|17315142|P1|Overall Study|Protocol Violation|7
5029882|NCT02959814|17315142|P1|Overall Study|Excluded based on anatomical criteria|2
5029883|NCT02959814|17315142|P1|Overall Study|Excluded based on diagnostic angiography|16
5029884|NCT02959437|17315165|P4|Overall Study|Participants Ongoing in Study|0
5029885|NCT02959437|17315166|P3|Overall Study|Participants Ongoing in Study|0
5029886|NCT02959437|17315167|P2|Overall Study|Participants Ongoing in Study|0
5029887|NCT02959437|17315168|P1|Overall Study|Participants Ongoing in Study|7
5029888|NCT02959437|17315165|P4|Overall Study|Other Unspecified|0
5029889|NCT02959437|17315166|P3|Overall Study|Other Unspecified|0
5029890|NCT02959437|17315167|P2|Overall Study|Other Unspecified|0
5029891|NCT02959437|17315168|P1|Overall Study|Other Unspecified|2
5029892|NCT02959437|17315165|P4|Overall Study|Study Terminated by Sponsor|0
5029893|NCT02959437|17315166|P3|Overall Study|Study Terminated by Sponsor|0
5029894|NCT02959437|17315167|P2|Overall Study|Study Terminated by Sponsor|0
5029895|NCT02959437|17315168|P1|Overall Study|Study Terminated by Sponsor|2
5029896|NCT02959437|17315165|P4|Overall Study|Progressive Disease|0
5029897|NCT02959437|17315166|P3|Overall Study|Progressive Disease|0
5029898|NCT02959437|17315167|P2|Overall Study|Progressive Disease|1
5029899|NCT02959437|17315168|P1|Overall Study|Progressive Disease|8
5029900|NCT02959437|17315165|P4|Overall Study|Withdrawal by Subject|0
5029901|NCT02959437|17315166|P3|Overall Study|Withdrawal by Subject|0
5029902|NCT02959437|17315167|P2|Overall Study|Withdrawal by Subject|3
5029903|NCT02959437|17315168|P1|Overall Study|Withdrawal by Subject|10
5029904|NCT02959437|17315165|P4|Overall Study|Lost to Follow-up|0
5029905|NCT02959437|17315166|P3|Overall Study|Lost to Follow-up|0
5029906|NCT02959437|17315167|P2|Overall Study|Lost to Follow-up|1
5029907|NCT02959437|17315168|P1|Overall Study|Lost to Follow-up|2
5029908|NCT02959437|17315165|P4|Overall Study|Death|0
5029909|NCT02959437|17315166|P3|Overall Study|Death|0
5029910|NCT02959437|17315167|P2|Overall Study|Death|3
5029911|NCT02959437|17315168|P1|Overall Study|Death|31
5029912|NCT02959190|17315201|P4|Post Treatment Follow Up|Withdrawal by Subject|0
5029913|NCT02959190|17315202|P3|Post Treatment Follow Up|Withdrawal by Subject|1
5029914|NCT02959190|17315203|P2|Post Treatment Follow Up|Withdrawal by Subject|0
5029915|NCT02959190|17315204|P1|Post Treatment Follow Up|Withdrawal by Subject|2
5029916|NCT02959190|17315201|P4|Post Treatment Follow Up|Adverse Event|0
5029917|NCT02959190|17315202|P3|Post Treatment Follow Up|Adverse Event|0
5029918|NCT02959190|17315203|P2|Post Treatment Follow Up|Adverse Event|1
5029919|NCT02959190|17315204|P1|Post Treatment Follow Up|Adverse Event|1
5029920|NCT02959190|17315201|P4|Open Label|Protocol Violation|2
5029921|NCT02959190|17315202|P3|Open Label|Protocol Violation|0
5029922|NCT02959190|17315203|P2|Open Label|Protocol Violation|0
5029923|NCT02959190|17315204|P1|Open Label|Protocol Violation|0
5029924|NCT02959190|17315201|P4|Open Label|Physician Decision|0
5029925|NCT02959190|17315202|P3|Open Label|Physician Decision|1
5029926|NCT02959190|17315203|P2|Open Label|Physician Decision|0
5029927|NCT02959190|17315204|P1|Open Label|Physician Decision|0
5029928|NCT02959190|17315201|P4|Open Label|Withdrawal by Subject|0
5029929|NCT02959190|17315202|P3|Open Label|Withdrawal by Subject|0
5029930|NCT02959190|17315203|P2|Open Label|Withdrawal by Subject|8
5029931|NCT02959190|17315204|P1|Open Label|Withdrawal by Subject|2
5029932|NCT02959190|17315201|P4|Open Label|Pregnancy|0
5029933|NCT02959190|17315202|P3|Open Label|Pregnancy|0
5029934|NCT02959190|17315203|P2|Open Label|Pregnancy|1
5029935|NCT02959190|17315204|P1|Open Label|Pregnancy|0
5029936|NCT02959190|17315201|P4|Open Label|Adverse Event|4
5029937|NCT02959190|17315202|P3|Open Label|Adverse Event|3
5029938|NCT02959190|17315203|P2|Open Label|Adverse Event|7
5029939|NCT02959190|17315204|P1|Open Label|Adverse Event|5
5029940|NCT02959177|17315297|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
5029941|NCT02959177|17315298|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
5029942|NCT02959177|17315299|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
5029943|NCT02959177|17315297|P3|Follow-up Post Treatment Phase|Adverse Event|0
5029944|NCT02959177|17315298|P2|Follow-up Post Treatment Phase|Adverse Event|1
5029945|NCT02959177|17315299|P1|Follow-up Post Treatment Phase|Adverse Event|0
5029946|NCT02959177|17315297|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
5029947|NCT02959177|17315298|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
5029948|NCT02959177|17315299|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
5029949|NCT02959177|17315297|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
5029950|NCT02959177|17315298|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
5029951|NCT02959177|17315299|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
5029952|NCT02959177|17315297|P3|Double-Blind Treatment Phase|Protocol Violation|0
5029953|NCT02959177|17315298|P2|Double-Blind Treatment Phase|Protocol Violation|1
5029954|NCT02959177|17315299|P1|Double-Blind Treatment Phase|Protocol Violation|0
5029955|NCT02959177|17315297|P3|Double-Blind Treatment Phase|Physician Decision|0
5029956|NCT02959177|17315298|P2|Double-Blind Treatment Phase|Physician Decision|0
5029957|NCT02959177|17315299|P1|Double-Blind Treatment Phase|Physician Decision|1
5029958|NCT02959177|17315297|P3|Double-Blind Treatment Phase|Adverse Event|0
5029959|NCT02959177|17315298|P2|Double-Blind Treatment Phase|Adverse Event|2
5029960|NCT02959177|17315299|P1|Double-Blind Treatment Phase|Adverse Event|5
5029961|NCT02959138|17315354|P3|Overall Study|Enrolled but Never Treated|0
5029962|NCT02959138|17315355|P2|Overall Study|Enrolled but Never Treated|1
5029963|NCT02959138|17315356|P1|Overall Study|Enrolled but Never Treated|0
5029964|NCT02958553|17315497|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
5029965|NCT02958553|17315497|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
5029966|NCT02958267|17315531|P2|Follow-up Visits|Additional treatment pursued|1
5029967|NCT02958267|17315532|P1|Follow-up Visits|Additional treatment pursued|2
5029968|NCT02958267|17315531|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
5029969|NCT02958267|17315532|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
5029970|NCT02958267|17315531|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
5029971|NCT02958267|17315532|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
5029972|NCT02957942|17315544|P2|Overall Study|Practicing experiment protocol|6
5029973|NCT02957942|17315545|P1|Overall Study|Practicing experiment protocol|0
5029974|NCT02957942|17315544|P2|Overall Study|Withdrawal by Subject|1
5029975|NCT02957942|17315545|P1|Overall Study|Withdrawal by Subject|0
5029976|NCT02957747|17315561|P2|Overall Study|Lost to Follow-up|5
5029977|NCT02957747|17315562|P1|Overall Study|Lost to Follow-up|10
5029978|NCT02957747|17315561|P2|Overall Study|Withdrawal by Subject|3
5029979|NCT02957747|17315562|P1|Overall Study|Withdrawal by Subject|0
5029980|NCT02957331|17315590|P2|Overall Study|Protocol Violation|0
5029981|NCT02957331|17315591|P1|Overall Study|Protocol Violation|1
5029982|NCT02956967|17315610|P1|Overall Study|Termination of Nivestim administration|29
5029983|NCT02956967|17315610|P1|Overall Study|Missing|1
5029984|NCT02956967|17315610|P1|Overall Study|Lost to Follow-up|5
5029985|NCT02956967|17315610|P1|Overall Study|Reason non-related to neutropenia|10
5029986|NCT02956967|17315610|P1|Overall Study|Adverse Event|3
5029987|NCT02956837|17315637|P4|Overall Study|Lost to Follow-up|0
5029988|NCT02956837|17315638|P3|Overall Study|Lost to Follow-up|2
5029989|NCT02956837|17315639|P2|Overall Study|Lost to Follow-up|1
5029990|NCT02956837|17315640|P1|Overall Study|Lost to Follow-up|0
5029991|NCT02956837|17315637|P4|Overall Study|Withdrawal by Subject|3
5029992|NCT02956837|17315638|P3|Overall Study|Withdrawal by Subject|0
5029993|NCT02956837|17315639|P2|Overall Study|Withdrawal by Subject|1
5029994|NCT02956837|17315640|P1|Overall Study|Withdrawal by Subject|0
5029995|NCT02956837|17315637|P4|Overall Study|Serious Adverse Events|0
5029996|NCT02956837|17315638|P3|Overall Study|Serious Adverse Events|0
5029997|NCT02956837|17315639|P2|Overall Study|Serious Adverse Events|1
5029998|NCT02956837|17315640|P1|Overall Study|Serious Adverse Events|0
5029999|NCT02956629|17315775|P6|Overall Study|Withdrawal by Subject|0
5030000|NCT02956629|17315776|P5|Overall Study|Withdrawal by Subject|0
5030001|NCT02956629|17315777|P4|Overall Study|Withdrawal by Subject|0
5030002|NCT02956629|17315778|P3|Overall Study|Withdrawal by Subject|0
5030003|NCT02956629|17315779|P2|Overall Study|Withdrawal by Subject|1
5030004|NCT02956629|17315780|P1|Overall Study|Withdrawal by Subject|3
5030005|NCT02956629|17315775|P6|Overall Study|Lost to Follow-up|1
5030006|NCT02956629|17315776|P5|Overall Study|Lost to Follow-up|0
5030007|NCT02956629|17315777|P4|Overall Study|Lost to Follow-up|1
5030008|NCT02956629|17315778|P3|Overall Study|Lost to Follow-up|3
5030009|NCT02956629|17315779|P2|Overall Study|Lost to Follow-up|5
5030010|NCT02956629|17315780|P1|Overall Study|Lost to Follow-up|2
5030011|NCT02956629|17315775|P6|Overall Study|Adverse Event|0
5030012|NCT02956629|17315776|P5|Overall Study|Adverse Event|0
5030013|NCT02956629|17315777|P4|Overall Study|Adverse Event|0
5030014|NCT02956629|17315778|P3|Overall Study|Adverse Event|1
5030015|NCT02956629|17315779|P2|Overall Study|Adverse Event|0
5030016|NCT02956629|17315780|P1|Overall Study|Adverse Event|0
5030017|NCT02956460|17315859|P2|Lens 1|Lost to Follow-up|0
5030018|NCT02956460|17315860|P1|Lens 1|Lost to Follow-up|1
5030019|NCT02956278|17315889|P3|Overall Study|Withdrawal by Subject|0
5030020|NCT02956278|17315890|P2|Overall Study|Withdrawal by Subject|2
5030021|NCT02956278|17315891|P1|Overall Study|Withdrawal by Subject|6
5030022|NCT02956057|17315975|P6|Overall Study|Lost to Follow-up|0
5030023|NCT02956057|17315976|P5|Overall Study|Lost to Follow-up|1
5030024|NCT02956057|17315977|P4|Overall Study|Lost to Follow-up|1
5030025|NCT02956057|17315978|P3|Overall Study|Lost to Follow-up|1
5030026|NCT02956057|17315979|P2|Overall Study|Lost to Follow-up|2
5030027|NCT02956057|17315980|P1|Overall Study|Lost to Follow-up|0
5030028|NCT02956057|17315975|P6|Overall Study|Discontinued intervention|17
5030029|NCT02956057|17315976|P5|Overall Study|Discontinued intervention|4
5030030|NCT02956057|17315977|P4|Overall Study|Discontinued intervention|14
5030031|NCT02956057|17315978|P3|Overall Study|Discontinued intervention|7
5030032|NCT02956057|17315979|P2|Overall Study|Discontinued intervention|10
5030033|NCT02956057|17315980|P1|Overall Study|Discontinued intervention|14
5030034|NCT02956005|17316000|P1|Overall Study|Physician Decision|12
5030035|NCT02956005|17316000|P1|Overall Study|Withdrawal by Subject|3
5030036|NCT02956005|17316000|P1|Overall Study|Not eligible|1
5030037|NCT02955797|17316009|P4|Overall Study|Lost to Follow-up|0
5030038|NCT02955797|17316010|P3|Overall Study|Lost to Follow-up|0
5030039|NCT02955797|17316011|P2|Overall Study|Lost to Follow-up|1
5030040|NCT02955797|17316012|P1|Overall Study|Lost to Follow-up|0
5030041|NCT02955797|17316009|P4|Overall Study|Withdrawal by Subject|1
5030042|NCT02955797|17316010|P3|Overall Study|Withdrawal by Subject|0
5030043|NCT02955797|17316011|P2|Overall Study|Withdrawal by Subject|2
5030044|NCT02955797|17316012|P1|Overall Study|Withdrawal by Subject|2
5030045|NCT02955797|17316009|P4|Overall Study|Protocol Violation|1
5030046|NCT02955797|17316010|P3|Overall Study|Protocol Violation|0
5030047|NCT02955797|17316011|P2|Overall Study|Protocol Violation|0
5030048|NCT02955797|17316012|P1|Overall Study|Protocol Violation|1
5030049|NCT02955212|17316030|P2|Overall Study|Other|2
5030050|NCT02955212|17316031|P1|Overall Study|Other|3
5030051|NCT02955212|17316030|P2|Overall Study|Lost to Follow-up|0
5030052|NCT02955212|17316031|P1|Overall Study|Lost to Follow-up|1
5030053|NCT02955212|17316030|P2|Overall Study|Withdrawal by Subject|3
5030054|NCT02955212|17316031|P1|Overall Study|Withdrawal by Subject|8
5030055|NCT02955212|17316030|P2|Overall Study|Adverse Event|7
5030056|NCT02955212|17316031|P1|Overall Study|Adverse Event|4
5030057|NCT02955186|17316057|P2|Overall Study|Protocol Violation|0
5030058|NCT02955186|17316058|P1|Overall Study|Protocol Violation|1
5030059|NCT02955186|17316057|P2|Overall Study|Withdrawal by Subject|2
5030060|NCT02955186|17316058|P1|Overall Study|Withdrawal by Subject|6
5030061|NCT02954952|17316080|P3|Overall Study|No data collected|0
5030062|NCT02954952|17316081|P2|Overall Study|No data collected|1
5030063|NCT02954952|17316082|P1|Overall Study|No data collected|0
5030064|NCT02954952|17316080|P3|Overall Study|Withdrawal by Subject|0
5030065|NCT02954952|17316081|P2|Overall Study|Withdrawal by Subject|0
5030066|NCT02954952|17316082|P1|Overall Study|Withdrawal by Subject|1
5030067|NCT02954887|17316090|P1|Overall Study|Other|1
5030068|NCT02954887|17316090|P1|Overall Study|Lack of Efficacy|3
5030069|NCT02954887|17316090|P1|Overall Study|Withdrawal by Subject|3
5030070|NCT02954848|17316119|P2|Overall Study|Withdrawal by Participant|1
5030071|NCT02954848|17316120|P1|Overall Study|Withdrawal by Participant|0
5030072|NCT02954848|17316119|P2|Overall Study|Adverse Event|3
5030073|NCT02954848|17316120|P1|Overall Study|Adverse Event|2
5030074|NCT02954848|17316119|P2|Overall Study|Randomized but Not Treated|1
5030075|NCT02954848|17316120|P1|Overall Study|Randomized but Not Treated|0
5030076|NCT02954653|17316180|P9|Overall Study|Treatment failure and consent withdrawal|0
5030077|NCT02954653|17316181|P8|Overall Study|Treatment failure and consent withdrawal|0
5030078|NCT02954653|17316182|P7|Overall Study|Treatment failure and consent withdrawal|0
5030079|NCT02954653|17316183|P6|Overall Study|Treatment failure and consent withdrawal|0
5030080|NCT02954653|17316184|P5|Overall Study|Treatment failure and consent withdrawal|0
5030081|NCT02954653|17316185|P4|Overall Study|Treatment failure and consent withdrawal|0
5030082|NCT02954653|17316186|P3|Overall Study|Treatment failure and consent withdrawal|0
5030083|NCT02954653|17316187|P2|Overall Study|Treatment failure and consent withdrawal|1
5030084|NCT02954653|17316188|P1|Overall Study|Treatment failure and consent withdrawal|0
5030085|NCT02954653|17316180|P9|Overall Study|Started another anti-cancer therapy|0
5030086|NCT02954653|17316181|P8|Overall Study|Started another anti-cancer therapy|0
5030087|NCT02954653|17316182|P7|Overall Study|Started another anti-cancer therapy|0
5030088|NCT02954653|17316183|P6|Overall Study|Started another anti-cancer therapy|0
5030089|NCT02954653|17316184|P5|Overall Study|Started another anti-cancer therapy|0
5030090|NCT02954653|17316185|P4|Overall Study|Started another anti-cancer therapy|0
5030091|NCT02954653|17316186|P3|Overall Study|Started another anti-cancer therapy|0
5030092|NCT02954653|17316187|P2|Overall Study|Started another anti-cancer therapy|1
5030093|NCT02954653|17316188|P1|Overall Study|Started another anti-cancer therapy|0
5030094|NCT02954653|17316180|P9|Overall Study|Randomized but did not receive treatment|0
5030095|NCT02954653|17316181|P8|Overall Study|Randomized but did not receive treatment|0
5030096|NCT02954653|17316182|P7|Overall Study|Randomized but did not receive treatment|0
5030097|NCT02954653|17316183|P6|Overall Study|Randomized but did not receive treatment|0
5030098|NCT02954653|17316184|P5|Overall Study|Randomized but did not receive treatment|0
5030099|NCT02954653|17316185|P4|Overall Study|Randomized but did not receive treatment|0
5030100|NCT02954653|17316186|P3|Overall Study|Randomized but did not receive treatment|0
5030101|NCT02954653|17316187|P2|Overall Study|Randomized but did not receive treatment|0
5030102|NCT02954653|17316188|P1|Overall Study|Randomized but did not receive treatment|1
5030103|NCT02954653|17316180|P9|Overall Study|Death|0
5030104|NCT02954653|17316181|P8|Overall Study|Death|0
5030105|NCT02954653|17316182|P7|Overall Study|Death|0
5030106|NCT02954653|17316183|P6|Overall Study|Death|0
5030107|NCT02954653|17316184|P5|Overall Study|Death|0
5030108|NCT02954653|17316185|P4|Overall Study|Death|0
5030109|NCT02954653|17316186|P3|Overall Study|Death|0
5030110|NCT02954653|17316187|P2|Overall Study|Death|1
5030111|NCT02954653|17316188|P1|Overall Study|Death|3
5030112|NCT02954601|17316307|P4|First Intervention (Five Days)|Withdrawal by Subject|0
5030113|NCT02954601|17316308|P3|First Intervention (Five Days)|Withdrawal by Subject|1
5030114|NCT02954601|17316309|P2|First Intervention (Five Days)|Withdrawal by Subject|0
5030115|NCT02954601|17316310|P1|First Intervention (Five Days)|Withdrawal by Subject|0
5030116|NCT02954575|17316332|P1|Overall Study|Adverse Event|1
5030117|NCT02954575|17316332|P1|Overall Study|Withdrawal by Subject|2
5030118|NCT02954354|17316352|P3|Overall Study|Miscellaneous|1
5030119|NCT02954354|17316353|P2|Overall Study|Miscellaneous|2
5030120|NCT02954354|17316354|P1|Overall Study|Miscellaneous|2
5030121|NCT02954354|17316352|P3|Overall Study|Lost to Follow-up|0
5030122|NCT02954354|17316353|P2|Overall Study|Lost to Follow-up|5
5030123|NCT02954354|17316354|P1|Overall Study|Lost to Follow-up|12
5030124|NCT02954354|17316352|P3|Overall Study|Withdrawal by Subject|11
5030125|NCT02954354|17316353|P2|Overall Study|Withdrawal by Subject|9
5030126|NCT02954354|17316354|P1|Overall Study|Withdrawal by Subject|17
5030127|NCT02954354|17316352|P3|Overall Study|Lack of Efficacy|0
5030128|NCT02954354|17316353|P2|Overall Study|Lack of Efficacy|2
5030129|NCT02954354|17316354|P1|Overall Study|Lack of Efficacy|0
5030130|NCT02954354|17316352|P3|Overall Study|Failure to Meet Eligibility Criteria|0
5030131|NCT02954354|17316353|P2|Overall Study|Failure to Meet Eligibility Criteria|0
5030132|NCT02954354|17316354|P1|Overall Study|Failure to Meet Eligibility Criteria|1
5030133|NCT02954354|17316352|P3|Overall Study|Adverse Event|4
5030134|NCT02954354|17316353|P2|Overall Study|Adverse Event|2
5030135|NCT02954354|17316354|P1|Overall Study|Adverse Event|2
5030136|NCT02954159|17316455|P2|Overall Study|Withdrawal by Subject|1
5030137|NCT02954159|17316456|P1|Overall Study|Withdrawal by Subject|0
5030138|NCT02954159|17316455|P2|Overall Study|Study ended prematurely due to low enrol|0
5030139|NCT02954159|17316456|P1|Overall Study|Study ended prematurely due to low enrol|1
5030140|NCT02953938|17316470|P2|Overall Study|Withdrawal by Subject|1
5030141|NCT02953938|17316471|P1|Overall Study|Withdrawal by Subject|1
5030142|NCT02953938|17316470|P2|Overall Study|Adverse Event|1
5030143|NCT02953938|17316471|P1|Overall Study|Adverse Event|0
5030144|NCT02953821|17316502|P2|Overall Study|Refused follow-up visit|1
5030145|NCT02953821|17316503|P1|Overall Study|Refused follow-up visit|2
5030146|NCT02953821|17316502|P2|Overall Study|No improvement|1
5030147|NCT02953821|17316503|P1|Overall Study|No improvement|0
5030148|NCT02953821|17316502|P2|Overall Study|Out of state for indeterminate time|1
5030149|NCT02953821|17316503|P1|Overall Study|Out of state for indeterminate time|0
5030150|NCT02953821|17316502|P2|Overall Study|Lack of Efficacy|0
5030151|NCT02953821|17316503|P1|Overall Study|Lack of Efficacy|1
5030152|NCT02953821|17316502|P2|Overall Study|Change of address|1
5030153|NCT02953821|17316503|P1|Overall Study|Change of address|0
5030154|NCT02953821|17316502|P2|Overall Study|Withdrawal by Subject|3
5030155|NCT02953821|17316503|P1|Overall Study|Withdrawal by Subject|3
5030156|NCT02953821|17316502|P2|Overall Study|Physician Decision|1
5030157|NCT02953821|17316503|P1|Overall Study|Physician Decision|1
5030158|NCT02953821|17316502|P2|Overall Study|Lost to Follow-up|0
5030159|NCT02953821|17316503|P1|Overall Study|Lost to Follow-up|2
5030160|NCT02953821|17316502|P2|Overall Study|Progressive Disease|1
5030161|NCT02953821|17316503|P1|Overall Study|Progressive Disease|5
5030162|NCT02953821|17316502|P2|Overall Study|Death|0
5030163|NCT02953821|17316503|P1|Overall Study|Death|1
5030164|NCT02953821|17316502|P2|Overall Study|Adverse Event|4
5030165|NCT02953821|17316503|P1|Overall Study|Adverse Event|0
5030166|NCT02953678|17316521|P1|Overall Study|Reason unspecified|2
5030167|NCT02953678|17316521|P1|Overall Study|Withdrawal by Subject|3
5030168|NCT02953678|17316521|P1|Overall Study|Relapse of Underlying Malignancy|2
5030169|NCT02953678|17316521|P1|Overall Study|Progressive Disease of GVHD|6
5030170|NCT02953678|17316521|P1|Overall Study|Physician Decision|20
5030171|NCT02953678|17316521|P1|Overall Study|Death|7
5030172|NCT02953678|17316521|P1|Overall Study|Adverse Event|20
5030173|NCT02953314|17316569|P2|Overall Study|Withdrawal of consent (not due to AE)|2
5030174|NCT02953314|17316570|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5030175|NCT02953314|17316569|P2|Overall Study|Adverse Event|1
5030176|NCT02953314|17316570|P1|Overall Study|Adverse Event|0
5030177|NCT02952898|17316596|P3|Overall Study|Non-compliance with study drug|2
5030178|NCT02952898|17316597|P2|Overall Study|Non-compliance with study drug|1
5030179|NCT02952898|17316598|P1|Overall Study|Non-compliance with study drug|1
5030180|NCT02952898|17316596|P3|Overall Study|Lost to Follow-up|2
5030181|NCT02952898|17316597|P2|Overall Study|Lost to Follow-up|2
5030182|NCT02952898|17316598|P1|Overall Study|Lost to Follow-up|3
5030183|NCT02952898|17316596|P3|Overall Study|Adverse Event|3
5030184|NCT02952898|17316597|P2|Overall Study|Adverse Event|8
5030185|NCT02952898|17316598|P1|Overall Study|Adverse Event|8
5030186|NCT02952898|17316596|P3|Overall Study|Withdrawal by Subject|8
5030187|NCT02952898|17316597|P2|Overall Study|Withdrawal by Subject|8
5030188|NCT02952898|17316598|P1|Overall Study|Withdrawal by Subject|10
5030189|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Not treated|1
5030190|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Not treated|0
5030191|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Not treated|0
5030192|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Other than specified|2
5030193|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Other than specified|6
5030194|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Other than specified|0
5030195|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
5030196|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
5030197|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
5030198|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
5030199|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
5030200|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
5030201|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Subject choice|7
5030202|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Subject choice|10
5030203|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Subject choice|0
5030204|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
5030205|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
5030206|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
5030207|NCT02952820|17316722|P3|Active Treatment Period (6 Months)|Adverse Event|5
5030208|NCT02952820|17316723|P2|Active Treatment Period (6 Months)|Adverse Event|6
5030209|NCT02952820|17316724|P1|Active Treatment Period (6 Months)|Adverse Event|0
5030210|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
5030211|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
5030212|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
5030213|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
5030214|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
5030215|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
5030216|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
5030217|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
5030218|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
5030219|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
5030220|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
5030221|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
5030222|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
5030223|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
5030224|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
5030225|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
5030226|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
5030227|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
5030228|NCT02952820|17316722|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
5030229|NCT02952820|17316723|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
5030230|NCT02952820|17316724|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
5030231|NCT02952313|17316784|P1|Long-term Follow-up|Death|1
5030232|NCT02952313|17316784|P1|Long-term Follow-up|Physician Decision|1
5030233|NCT02952313|17316784|P1|Long-term Follow-up|Withdrawal by Subject|5
5030234|NCT02952313|17316784|P1|Long-term Follow-up|Lack of Efficacy|6
5030235|NCT02952313|17316784|P1|Long-term Follow-up|Did not reconsent for long-term FU|7
5030236|NCT02952313|17316784|P1|Long-term Follow-up|Lost to Follow-up|12
5030237|NCT02952313|17316784|P1|Primary Endpoint|Missed visit|1
5030238|NCT02952313|17316784|P1|Primary Endpoint|Lack of Efficacy|1
5030239|NCT02952313|17316784|P1|Primary Endpoint|Withdrawal by Subject|1
5030240|NCT02952313|17316784|P1|Primary Endpoint|Lost to Follow-up|4
5030241|NCT02952261|17316795|P2|Overall Study|Protocol Violation|0
5030242|NCT02952261|17316796|P1|Overall Study|Protocol Violation|1
5030243|NCT02952261|17316795|P2|Overall Study|Withdrawal by Subject|5
5030244|NCT02952261|17316796|P1|Overall Study|Withdrawal by Subject|4
5030245|NCT02951988|17316811|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
5030246|NCT02951988|17316812|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
5030247|NCT02951988|17316813|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
5030248|NCT02951988|17316814|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
5030249|NCT02951988|17316811|P4|Double-Blind Treatment Period|Adverse Event|6
5030250|NCT02951988|17316812|P3|Double-Blind Treatment Period|Adverse Event|3
5030251|NCT02951988|17316813|P2|Double-Blind Treatment Period|Adverse Event|8
5030252|NCT02951988|17316814|P1|Double-Blind Treatment Period|Adverse Event|0
5030253|NCT02951988|17316811|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
5030254|NCT02951988|17316812|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
5030255|NCT02951988|17316813|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
5030256|NCT02951988|17316814|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5030257|NCT02951988|17316811|P4|Double-Blind Treatment Period|Lost to Follow-up|3
5030258|NCT02951988|17316812|P3|Double-Blind Treatment Period|Lost to Follow-up|12
5030259|NCT02951988|17316813|P2|Double-Blind Treatment Period|Lost to Follow-up|4
5030260|NCT02951988|17316814|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5030261|NCT02951988|17316811|P4|Double-Blind Treatment Period|Pregnancy|0
5030262|NCT02951988|17316812|P3|Double-Blind Treatment Period|Pregnancy|1
5030263|NCT02951988|17316813|P2|Double-Blind Treatment Period|Pregnancy|1
5030264|NCT02951988|17316814|P1|Double-Blind Treatment Period|Pregnancy|0
5030265|NCT02951988|17316811|P4|Double-Blind Treatment Period|Protocol Violation|8
5030266|NCT02951988|17316812|P3|Double-Blind Treatment Period|Protocol Violation|4
5030267|NCT02951988|17316813|P2|Double-Blind Treatment Period|Protocol Violation|4
5030268|NCT02951988|17316814|P1|Double-Blind Treatment Period|Protocol Violation|0
5030269|NCT02951988|17316811|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
5030270|NCT02951988|17316812|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
5030271|NCT02951988|17316813|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
5030272|NCT02951988|17316814|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
5030273|NCT02951988|17316811|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
5030274|NCT02951988|17316812|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
5030275|NCT02951988|17316813|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
5030276|NCT02951988|17316814|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
5030277|NCT02951988|17316811|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
5030278|NCT02951988|17316812|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
5030279|NCT02951988|17316813|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
5030280|NCT02951988|17316814|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
5030281|NCT02951988|17316811|P4|Open-Label Treatment Period|Adverse Event|0
5030282|NCT02951988|17316812|P3|Open-Label Treatment Period|Adverse Event|0
5030283|NCT02951988|17316813|P2|Open-Label Treatment Period|Adverse Event|0
5030284|NCT02951988|17316814|P1|Open-Label Treatment Period|Adverse Event|45
5030285|NCT02951988|17316811|P4|Open-Label Treatment Period|Lack of Efficacy|0
5030286|NCT02951988|17316812|P3|Open-Label Treatment Period|Lack of Efficacy|0
5030287|NCT02951988|17316813|P2|Open-Label Treatment Period|Lack of Efficacy|0
5030288|NCT02951988|17316814|P1|Open-Label Treatment Period|Lack of Efficacy|49
5030289|NCT02951988|17316811|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5030290|NCT02951988|17316812|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5030291|NCT02951988|17316813|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5030292|NCT02951988|17316814|P1|Open-Label Treatment Period|Withdrawal by Subject|78
5030293|NCT02951988|17316811|P4|Open-Label Treatment Period|Lost to Follow-up|0
5030294|NCT02951988|17316812|P3|Open-Label Treatment Period|Lost to Follow-up|0
5030295|NCT02951988|17316813|P2|Open-Label Treatment Period|Lost to Follow-up|0
5030296|NCT02951988|17316814|P1|Open-Label Treatment Period|Lost to Follow-up|28
5030297|NCT02951988|17316811|P4|Open-Label Treatment Period|Pregnancy|0
5030298|NCT02951988|17316812|P3|Open-Label Treatment Period|Pregnancy|0
5030299|NCT02951988|17316813|P2|Open-Label Treatment Period|Pregnancy|0
5030300|NCT02951988|17316814|P1|Open-Label Treatment Period|Pregnancy|2
5030301|NCT02951988|17316811|P4|Open-Label Treatment Period|Protocol Violation|0
5030302|NCT02951988|17316812|P3|Open-Label Treatment Period|Protocol Violation|0
5030303|NCT02951988|17316813|P2|Open-Label Treatment Period|Protocol Violation|0
5030304|NCT02951988|17316814|P1|Open-Label Treatment Period|Protocol Violation|22
5030305|NCT02951988|17316811|P4|Open-Label Treatment Period|Non-compliance with study drug|0
5030306|NCT02951988|17316812|P3|Open-Label Treatment Period|Non-compliance with study drug|0
5030307|NCT02951988|17316813|P2|Open-Label Treatment Period|Non-compliance with study drug|0
5030308|NCT02951988|17316814|P1|Open-Label Treatment Period|Non-compliance with study drug|5
5030309|NCT02951988|17316811|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
5030310|NCT02951988|17316812|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
5030311|NCT02951988|17316813|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
5030312|NCT02951988|17316814|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
5030313|NCT02951988|17316811|P4|Open-Label Treatment Period|Study terminated by sponsor|0
5030314|NCT02951988|17316812|P3|Open-Label Treatment Period|Study terminated by sponsor|0
5030315|NCT02951988|17316813|P2|Open-Label Treatment Period|Study terminated by sponsor|0
5030316|NCT02951988|17316814|P1|Open-Label Treatment Period|Study terminated by sponsor|9
5030317|NCT02951988|17316811|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
5030318|NCT02951988|17316812|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
5030319|NCT02951988|17316813|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
5030320|NCT02951988|17316814|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
5030321|NCT02951819|17316847|P2|Overall Study|Ongoing|11
5030322|NCT02951819|17316848|P1|Overall Study|Ongoing|83
5030323|NCT02951819|17316847|P2|Overall Study|Other|0
5030324|NCT02951819|17316848|P1|Overall Study|Other|1
5030325|NCT02951819|17316847|P2|Overall Study|Progressive Disease|0
5030326|NCT02951819|17316848|P1|Overall Study|Progressive Disease|1
5030327|NCT02951819|17316847|P2|Overall Study|Withdrawal by Subject|0
5030328|NCT02951819|17316848|P1|Overall Study|Withdrawal by Subject|1
5030329|NCT02951819|17316847|P2|Overall Study|Death|3
5030330|NCT02951819|17316848|P1|Overall Study|Death|1
5030331|NCT02951780|17316879|P9|Period 2|Scheduling Conflicts|0
5030332|NCT02951780|17316880|P8|Period 2|Scheduling Conflicts|1
5030333|NCT02951780|17316881|P7|Period 2|Scheduling Conflicts|0
5030334|NCT02951780|17316882|P6|Period 2|Scheduling Conflicts|0
5030335|NCT02951780|17316883|P5|Period 2|Scheduling Conflicts|0
5030336|NCT02951780|17316884|P4|Period 2|Scheduling Conflicts|0
5030337|NCT02951780|17316885|P3|Period 2|Scheduling Conflicts|0
5030338|NCT02951780|17316886|P2|Period 2|Scheduling Conflicts|0
5030339|NCT02951780|17316887|P1|Period 2|Scheduling Conflicts|0
5030340|NCT02951780|17316879|P9|Period 1|Scheduling Conflicts|0
5030341|NCT02951780|17316880|P8|Period 1|Scheduling Conflicts|1
5030342|NCT02951780|17316881|P7|Period 1|Scheduling Conflicts|0
5030343|NCT02951780|17316882|P6|Period 1|Scheduling Conflicts|0
5030344|NCT02951780|17316883|P5|Period 1|Scheduling Conflicts|0
5030345|NCT02951780|17316884|P4|Period 1|Scheduling Conflicts|0
5030346|NCT02951780|17316885|P3|Period 1|Scheduling Conflicts|0
5030347|NCT02951780|17316886|P2|Period 1|Scheduling Conflicts|0
5030348|NCT02951780|17316887|P1|Period 1|Scheduling Conflicts|0
5030349|NCT02951780|17316879|P9|Period 1|Adverse Event|0
5030350|NCT02951780|17316880|P8|Period 1|Adverse Event|0
5030351|NCT02951780|17316881|P7|Period 1|Adverse Event|0
5030352|NCT02951780|17316882|P6|Period 1|Adverse Event|0
5030353|NCT02951780|17316883|P5|Period 1|Adverse Event|0
5030354|NCT02951780|17316884|P4|Period 1|Adverse Event|1
5030355|NCT02951780|17316885|P3|Period 1|Adverse Event|0
5030356|NCT02951780|17316886|P2|Period 1|Adverse Event|0
5030357|NCT02951780|17316887|P1|Period 1|Adverse Event|0
5030358|NCT02951767|17316952|P1|Overall Study|Lost to Follow-up|1
5030359|NCT02951767|17316952|P1|Overall Study|Death|59
5030360|NCT02951767|17316952|P1|Overall Study|Withdrawal by Subject|5
5030361|NCT02951767|17316952|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
5030362|NCT02951533|17316984|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
5030363|NCT02951533|17316985|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
5030364|NCT02951533|17316986|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
5030365|NCT02951533|17316984|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
5030366|NCT02951533|17316985|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
5030367|NCT02951533|17316986|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
5030449|NCT02950545|17317600|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
5030368|NCT02951533|17316984|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
5030369|NCT02951533|17316985|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
5030370|NCT02951533|17316986|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
5030371|NCT02951533|17316984|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
5030372|NCT02951533|17316985|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
5030373|NCT02951533|17316986|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
5030374|NCT02951533|17316984|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
5030375|NCT02951533|17316985|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
5030376|NCT02951533|17316986|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
5030377|NCT02951533|17316984|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
5030378|NCT02951533|17316985|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
5030379|NCT02951533|17316986|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
5030380|NCT02951533|17316984|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
5030381|NCT02951533|17316985|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
5030382|NCT02951533|17316986|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
5030383|NCT02951533|17316984|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
5030384|NCT02951533|17316985|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
5030385|NCT02951533|17316986|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
5030386|NCT02951533|17316984|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
5030387|NCT02951533|17316985|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
5030388|NCT02951533|17316986|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
5030389|NCT02951533|17316984|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
5030390|NCT02951533|17316985|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
5030391|NCT02951533|17316986|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
5030392|NCT02951533|17316984|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
5030393|NCT02951533|17316985|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
5030394|NCT02951533|17316986|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
5030395|NCT02951429|17317108|P2|Overall Study|Participant ongoing in the study|17
5030396|NCT02951429|17317109|P1|Overall Study|Participant ongoing in the study|23
5030397|NCT02951429|17317108|P2|Overall Study|Withdrawal by Subject|11
5030398|NCT02951429|17317109|P1|Overall Study|Withdrawal by Subject|7
5030399|NCT02951429|17317108|P2|Overall Study|Progressive Disease|1
5030400|NCT02951429|17317109|P1|Overall Study|Progressive Disease|1
5030401|NCT02951429|17317108|P2|Overall Study|Other|3
5030402|NCT02951429|17317109|P1|Overall Study|Other|1
5030403|NCT02951429|17317108|P2|Overall Study|Lung Transplantation|6
5030404|NCT02951429|17317109|P1|Overall Study|Lung Transplantation|9
5030405|NCT02951429|17317108|P2|Overall Study|Lost to Follow-up|1
5030406|NCT02951429|17317109|P1|Overall Study|Lost to Follow-up|0
5030407|NCT02951429|17317108|P2|Overall Study|Lack of Efficacy|1
5030408|NCT02951429|17317109|P1|Overall Study|Lack of Efficacy|0
5030409|NCT02951429|17317108|P2|Overall Study|Death|36
5030410|NCT02951429|17317109|P1|Overall Study|Death|28
5030411|NCT02951429|17317108|P2|Overall Study|Adverse Event|7
5030412|NCT02951429|17317109|P1|Overall Study|Adverse Event|3
5030413|NCT02951052|17317384|P2|Overall Study|Ongoing|0
5030414|NCT02951052|17317385|P1|Overall Study|Ongoing|1
5030415|NCT02951052|17317384|P2|Overall Study|Lack of Efficacy|4
5030416|NCT02951052|17317385|P1|Overall Study|Lack of Efficacy|3
5030417|NCT02951052|17317384|P2|Overall Study|Protocol Violation|3
5030418|NCT02951052|17317385|P1|Overall Study|Protocol Violation|5
5030419|NCT02951052|17317384|P2|Overall Study|Protocol-specified withdrawal criterion|0
5030420|NCT02951052|17317385|P1|Overall Study|Protocol-specified withdrawal criterion|1
5030421|NCT02951052|17317384|P2|Overall Study|Lost to Follow-up|1
5030422|NCT02951052|17317385|P1|Overall Study|Lost to Follow-up|1
5030423|NCT02951052|17317384|P2|Overall Study|Physician Decision|0
5030424|NCT02951052|17317385|P1|Overall Study|Physician Decision|2
5030425|NCT02951052|17317384|P2|Overall Study|Withdrawal by Subject|5
5030426|NCT02951052|17317385|P1|Overall Study|Withdrawal by Subject|1
5030427|NCT02951052|17317384|P2|Overall Study|Adverse Event|5
5030428|NCT02951052|17317385|P1|Overall Study|Adverse Event|13
5030429|NCT02950831|17317553|P1|Overall Study|stimulation trail failure|5
5030430|NCT02950831|17317553|P1|Overall Study|Withdrawal by Subject|3
5030431|NCT02950831|17317553|P1|Overall Study|Lost to Follow-up|1
5030432|NCT02950545|17317595|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
5030433|NCT02950545|17317596|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
5030434|NCT02950545|17317597|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
5030435|NCT02950545|17317598|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
5030436|NCT02950545|17317599|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
5030437|NCT02950545|17317600|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
5030438|NCT02950545|17317595|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5030439|NCT02950545|17317596|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5030440|NCT02950545|17317597|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5030441|NCT02950545|17317598|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5030442|NCT02950545|17317599|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5030443|NCT02950545|17317600|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
5030444|NCT02950545|17317595|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
5030445|NCT02950545|17317596|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
5030446|NCT02950545|17317597|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
5030447|NCT02950545|17317598|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
5030448|NCT02950545|17317599|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
5030450|NCT02950545|17317595|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5030451|NCT02950545|17317596|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5030452|NCT02950545|17317597|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5030453|NCT02950545|17317598|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5030454|NCT02950545|17317599|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5030455|NCT02950545|17317600|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5030456|NCT02950545|17317595|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
5030457|NCT02950545|17317596|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
5030458|NCT02950545|17317597|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
5030459|NCT02950545|17317598|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
5030460|NCT02950545|17317599|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
5030461|NCT02950545|17317600|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
5030462|NCT02950480|17317609|P2|Overall Study|Withdrawal by Subject|0
5030463|NCT02950480|17317610|P1|Overall Study|Withdrawal by Subject|1
5030464|NCT02949947|17317643|P2|Overall Study|Insurance change|0
5030465|NCT02949947|17317644|P1|Overall Study|Insurance change|1
5030466|NCT02949947|17317643|P2|Overall Study|Non Compliance|1
5030467|NCT02949947|17317644|P1|Overall Study|Non Compliance|0
5030468|NCT02949908|17317677|P1|Overall Study|Study termination|2
5030469|NCT02949271|17317741|P2|Overall Study|Outside the window for cervical dilation|3
5030470|NCT02949271|17317742|P1|Overall Study|Outside the window for cervical dilation|2
5030471|NCT02949271|17317741|P2|Overall Study|Delivered prior to intervention|9
5030472|NCT02949271|17317742|P1|Overall Study|Delivered prior to intervention|7
5030473|NCT02949271|17317741|P2|Overall Study|Withdrawal by Subject|0
5030474|NCT02949271|17317742|P1|Overall Study|Withdrawal by Subject|1
5030475|NCT02949271|17317741|P2|Overall Study|Protocol Violation|3
5030476|NCT02949271|17317742|P1|Overall Study|Protocol Violation|6
5030477|NCT02949271|17317741|P2|Overall Study|Physician Decision|5
5030478|NCT02949271|17317742|P1|Overall Study|Physician Decision|5
5030479|NCT02949271|17317741|P2|Overall Study|Lost to Follow-up|6
5030480|NCT02949271|17317742|P1|Overall Study|Lost to Follow-up|3
5030481|NCT02949271|17317741|P2|Overall Study|Lack of Efficacy|4
5030482|NCT02949271|17317742|P1|Overall Study|Lack of Efficacy|5
5030483|NCT02949219|17317768|P1|Overall Study|Withdrawal by Subject|1
5030484|NCT02949128|17317782|P1|Extension Period|Withdrawal by Subject|1
5030485|NCT02949128|17317782|P1|Extension Period|Physician Decision|1
5030486|NCT02949128|17317782|P1|Initial Evaluation Period|Protocol Violation|1
5030487|NCT02949128|17317782|P1|Initial Evaluation Period|Physician Decision|1
5030488|NCT02949128|17317782|P1|Initial Evaluation Period|Death|2
5030489|NCT02949128|17317782|P1|Initial Evaluation Period|Adverse Event|3
5030490|NCT02949128|17317782|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
5030491|NCT02949011|17317799|P3|Overall Study|Miscellaneous|6
5030492|NCT02949011|17317800|P2|Overall Study|Miscellaneous|4
5030493|NCT02949011|17317801|P1|Overall Study|Miscellaneous|2
5030494|NCT02949011|17317799|P3|Overall Study|Death|1
5030495|NCT02949011|17317800|P2|Overall Study|Death|0
5030496|NCT02949011|17317801|P1|Overall Study|Death|0
5030497|NCT02949011|17317799|P3|Overall Study|Lost to Follow-up|5
5030498|NCT02949011|17317800|P2|Overall Study|Lost to Follow-up|5
5030499|NCT02949011|17317801|P1|Overall Study|Lost to Follow-up|7
5030500|NCT02949011|17317799|P3|Overall Study|Withdrawal by Subject|21
5030501|NCT02949011|17317800|P2|Overall Study|Withdrawal by Subject|13
5030502|NCT02949011|17317801|P1|Overall Study|Withdrawal by Subject|13
5030503|NCT02949011|17317799|P3|Overall Study|Lack of Efficacy|0
5030504|NCT02949011|17317800|P2|Overall Study|Lack of Efficacy|2
5030505|NCT02949011|17317801|P1|Overall Study|Lack of Efficacy|0
5030506|NCT02949011|17317799|P3|Overall Study|Protocol Deviation|3
5030507|NCT02949011|17317800|P2|Overall Study|Protocol Deviation|3
5030508|NCT02949011|17317801|P1|Overall Study|Protocol Deviation|5
5030509|NCT02949011|17317799|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
5030510|NCT02949011|17317800|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
5030511|NCT02949011|17317801|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5030512|NCT02949011|17317799|P3|Overall Study|Adverse Event|3
5030513|NCT02949011|17317800|P2|Overall Study|Adverse Event|7
5030514|NCT02949011|17317801|P1|Overall Study|Adverse Event|6
5030515|NCT02948634|17317871|P2|Overall Study|Lack of efficacy and study suspended|2
5030516|NCT02948634|17317872|P1|Overall Study|Lack of efficacy and study suspended|10
5030517|NCT02948582|17317882|P6|Washout Period 4|Adverse Event|0
5030518|NCT02948582|17317883|P5|Washout Period 4|Adverse Event|0
5030519|NCT02948582|17317884|P4|Washout Period 4|Adverse Event|0
5030520|NCT02948582|17317885|P3|Washout Period 4|Adverse Event|1
5030521|NCT02948582|17317886|P2|Washout Period 4|Adverse Event|0
5030522|NCT02948582|17317887|P1|Washout Period 4|Adverse Event|1
5030523|NCT02948582|17317882|P6|Washout Period 2|personal reasons|0
5030524|NCT02948582|17317883|P5|Washout Period 2|personal reasons|0
5030525|NCT02948582|17317884|P4|Washout Period 2|personal reasons|1
5030526|NCT02948582|17317885|P3|Washout Period 2|personal reasons|0
5030527|NCT02948582|17317886|P2|Washout Period 2|personal reasons|0
5030528|NCT02948582|17317887|P1|Washout Period 2|personal reasons|0
5030529|NCT02948582|17317882|P6|Washout Period 2|Adverse Event|0
5030530|NCT02948582|17317883|P5|Washout Period 2|Adverse Event|0
5030531|NCT02948582|17317884|P4|Washout Period 2|Adverse Event|0
5030532|NCT02948582|17317885|P3|Washout Period 2|Adverse Event|0
5030533|NCT02948582|17317886|P2|Washout Period 2|Adverse Event|1
5030534|NCT02948582|17317887|P1|Washout Period 2|Adverse Event|0
5030535|NCT02948582|17317882|P6|Washout Period 1|Protocol Violation|1
5030536|NCT02948582|17317883|P5|Washout Period 1|Protocol Violation|0
5030537|NCT02948582|17317884|P4|Washout Period 1|Protocol Violation|0
5030538|NCT02948582|17317885|P3|Washout Period 1|Protocol Violation|0
5030539|NCT02948582|17317886|P2|Washout Period 1|Protocol Violation|0
5030540|NCT02948582|17317887|P1|Washout Period 1|Protocol Violation|0
5030541|NCT02948582|17317882|P6|Washout Period 1|Adverse Event|0
5030542|NCT02948582|17317883|P5|Washout Period 1|Adverse Event|0
5030543|NCT02948582|17317884|P4|Washout Period 1|Adverse Event|0
5030544|NCT02948582|17317885|P3|Washout Period 1|Adverse Event|0
5030545|NCT02948582|17317886|P2|Washout Period 1|Adverse Event|2
5030546|NCT02948582|17317887|P1|Washout Period 1|Adverse Event|0
5030547|NCT02947100|17318009|P1|Overall Study|did not meet inclusion criteria|1
5030548|NCT02947100|17318009|P1|Overall Study|study terminated early|3
5030549|NCT02947022|17318017|P1|Overall Study|Study Stopped|1
5030550|NCT02946580|17318038|P2|Overall Study|Did not undergo posterior spinal fusion|1
5030551|NCT02946580|17318039|P1|Overall Study|Did not undergo posterior spinal fusion|0
5030552|NCT02946580|17318038|P2|Overall Study|Adverse Event|2
5030553|NCT02946580|17318039|P1|Overall Study|Adverse Event|0
5030554|NCT02946580|17318038|P2|Overall Study|Withdrawal by Subject|2
5030555|NCT02946580|17318039|P1|Overall Study|Withdrawal by Subject|1
5030556|NCT02946515|17318057|P2|Overall Study|Lost to Follow-up|1
5030557|NCT02946515|17318058|P1|Overall Study|Lost to Follow-up|2
5030558|NCT02946463|17318071|P2|Primary Evaluation Period|Withdrawal by Subject|1
5030559|NCT02946463|17318072|P1|Primary Evaluation Period|Withdrawal by Subject|0
5030560|NCT02946463|17318071|P2|Primary Evaluation Period|Physician Decision|1
5030561|NCT02946463|17318072|P1|Primary Evaluation Period|Physician Decision|0
5030562|NCT02946385|17318094|P6|Overall Study|Lost to Follow-up|1
5030563|NCT02946385|17318095|P5|Overall Study|Lost to Follow-up|2
5030564|NCT02946385|17318096|P4|Overall Study|Lost to Follow-up|0
5030565|NCT02946385|17318097|P3|Overall Study|Lost to Follow-up|3
5030566|NCT02946385|17318098|P2|Overall Study|Lost to Follow-up|0
5030567|NCT02946385|17318099|P1|Overall Study|Lost to Follow-up|0
5030568|NCT02945657|17318202|P1|Overall Study|Withdrawal by Parent/Guardian|3
5030569|NCT02945657|17318202|P1|Overall Study|Adverse Event|1
5030570|NCT02945410|17318225|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
5030571|NCT02945410|17318226|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
5030572|NCT02945410|17318227|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
5030573|NCT02945410|17318228|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
5030574|NCT02945410|17318229|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
5030575|NCT02945410|17318230|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
5030576|NCT02945410|17318225|P6|Intervention 1 (5 Days)|Adverse Event|1
5030577|NCT02945410|17318226|P5|Intervention 1 (5 Days)|Adverse Event|0
5030578|NCT02945410|17318227|P4|Intervention 1 (5 Days)|Adverse Event|0
5030579|NCT02945410|17318228|P3|Intervention 1 (5 Days)|Adverse Event|0
5030580|NCT02945410|17318229|P2|Intervention 1 (5 Days)|Adverse Event|0
5030581|NCT02945410|17318230|P1|Intervention 1 (5 Days)|Adverse Event|1
5030582|NCT02945410|17318225|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
5030583|NCT02945410|17318226|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
5030584|NCT02945410|17318227|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
5030585|NCT02945410|17318228|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
5030586|NCT02945410|17318229|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
5030587|NCT02945410|17318230|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
5030588|NCT02945254|17318261|P2|Overall Study|Withdrawal by Subject|0
5030589|NCT02945254|17318262|P1|Overall Study|Withdrawal by Subject|1
5030590|NCT02945254|17318261|P2|Overall Study|Lost to Follow-up|0
5030591|NCT02945254|17318262|P1|Overall Study|Lost to Follow-up|1
5030592|NCT02945046|17318278|P3|Overall Study|Other than specified|7
5030593|NCT02945046|17318279|P2|Overall Study|Other than specified|4
5030594|NCT02945046|17318280|P1|Overall Study|Other than specified|5
5030595|NCT02945046|17318278|P3|Overall Study|Lack of Efficacy|1
5030596|NCT02945046|17318279|P2|Overall Study|Lack of Efficacy|2
5030597|NCT02945046|17318280|P1|Overall Study|Lack of Efficacy|1
5030598|NCT02945046|17318278|P3|Overall Study|Lost to Follow-up|0
5030599|NCT02945046|17318279|P2|Overall Study|Lost to Follow-up|1
5030600|NCT02945046|17318280|P1|Overall Study|Lost to Follow-up|1
5030601|NCT02945046|17318278|P3|Overall Study|Protocol Violation|2
5030602|NCT02945046|17318279|P2|Overall Study|Protocol Violation|3
5030603|NCT02945046|17318280|P1|Overall Study|Protocol Violation|2
5030604|NCT02945046|17318278|P3|Overall Study|Withdrawal by Subject|3
5030605|NCT02945046|17318279|P2|Overall Study|Withdrawal by Subject|3
5030606|NCT02945046|17318280|P1|Overall Study|Withdrawal by Subject|3
5030607|NCT02945046|17318278|P3|Overall Study|Adverse Event|2
5030608|NCT02945046|17318279|P2|Overall Study|Adverse Event|0
5030609|NCT02945046|17318280|P1|Overall Study|Adverse Event|1
5030610|NCT02944968|17318333|P1|Overall Study|Subject didn't meet eligibility criteria|2
5030611|NCT02944968|17318333|P1|Overall Study|Subject excluded before study procedure|1
5030612|NCT02944656|17318340|P2|Overall Study|Lost to Follow-up|10
5030613|NCT02944656|17318341|P1|Overall Study|Lost to Follow-up|7
5030614|NCT02944656|17318340|P2|Overall Study|No longer eligible|0
5030615|NCT02944656|17318341|P1|Overall Study|No longer eligible|3
5030616|NCT02944513|17318377|P2|Overall Study|Withdrawal by Subject|1
5030617|NCT02944513|17318378|P1|Overall Study|Withdrawal by Subject|4
5030618|NCT02944448|17318403|P2|Overall Study|Abnormal laboratory values|0
5030619|NCT02944448|17318404|P1|Overall Study|Abnormal laboratory values|1
5030620|NCT02944448|17318403|P2|Overall Study|Noncompliant with dosing|0
5030621|NCT02944448|17318404|P1|Overall Study|Noncompliant with dosing|1
5030622|NCT02944448|17318403|P2|Overall Study|Sponsor did not supply drug in time|1
5030623|NCT02944448|17318404|P1|Overall Study|Sponsor did not supply drug in time|0
5030624|NCT02944448|17318403|P2|Overall Study|Withdrawal by Subject|4
5030625|NCT02944448|17318404|P1|Overall Study|Withdrawal by Subject|14
5030626|NCT02944448|17318403|P2|Overall Study|Protocol Violation|7
5030627|NCT02944448|17318404|P1|Overall Study|Protocol Violation|25
5030628|NCT02944448|17318403|P2|Overall Study|Lost to Follow-up|1
5030629|NCT02944448|17318404|P1|Overall Study|Lost to Follow-up|3
5030630|NCT02944448|17318403|P2|Overall Study|Lack of Efficacy|5
5030631|NCT02944448|17318404|P1|Overall Study|Lack of Efficacy|8
5030632|NCT02944448|17318403|P2|Overall Study|Adverse Event|6
5030633|NCT02944448|17318404|P1|Overall Study|Adverse Event|37
5030634|NCT02944383|17318431|P3|Overall Study|Withdrawal by Subject|0
5030635|NCT02944383|17318432|P2|Overall Study|Withdrawal by Subject|0
5030636|NCT02944383|17318433|P1|Overall Study|Withdrawal by Subject|1
5030637|NCT02944383|17318431|P3|Overall Study|Lost to Follow-up|1
5030638|NCT02944383|17318432|P2|Overall Study|Lost to Follow-up|0
5030639|NCT02944383|17318433|P1|Overall Study|Lost to Follow-up|0
5030640|NCT02943668|17318594|P1|Overall Study|Disease Progression|1
5030641|NCT02943577|17318605|P2|Overall Study|Pregnancy|0
5030642|NCT02943577|17318606|P1|Overall Study|Pregnancy|1
5030643|NCT02943577|17318605|P2|Overall Study|Withdrawal by Subject|1
5030644|NCT02943577|17318606|P1|Overall Study|Withdrawal by Subject|1
5030645|NCT02943577|17318605|P2|Overall Study|Lost to Follow-up|1
5030646|NCT02943577|17318606|P1|Overall Study|Lost to Follow-up|0
5030647|NCT02943577|17318605|P2|Overall Study|Adverse Event|2
5030648|NCT02943577|17318606|P1|Overall Study|Adverse Event|3
5030649|NCT02943577|17318605|P2|Overall Study|Protocol Violation|1
5030650|NCT02943577|17318606|P1|Overall Study|Protocol Violation|0
5030651|NCT02943564|17318621|P3|Overall Study|Lack of Efficacy|0
5030652|NCT02943564|17318622|P2|Overall Study|Lack of Efficacy|1
5030653|NCT02943564|17318623|P1|Overall Study|Lack of Efficacy|0
5030654|NCT02943564|17318621|P3|Overall Study|Adverse Event|1
5030655|NCT02943564|17318622|P2|Overall Study|Adverse Event|2
5030656|NCT02943564|17318623|P1|Overall Study|Adverse Event|1
5030657|NCT02943564|17318621|P3|Overall Study|Withdrawal by Subject|2
5030658|NCT02943564|17318622|P2|Overall Study|Withdrawal by Subject|5
5030659|NCT02943564|17318623|P1|Overall Study|Withdrawal by Subject|6
5030660|NCT02943564|17318621|P3|Overall Study|Lost to Follow-up|0
5030661|NCT02943564|17318622|P2|Overall Study|Lost to Follow-up|0
5030662|NCT02943564|17318623|P1|Overall Study|Lost to Follow-up|1
5030663|NCT02943564|17318621|P3|Overall Study|Protocol Violation|2
5030664|NCT02943564|17318622|P2|Overall Study|Protocol Violation|2
5030665|NCT02943564|17318623|P1|Overall Study|Protocol Violation|2
5030666|NCT02943564|17318621|P3|Overall Study|Pregnancy|1
5030667|NCT02943564|17318622|P2|Overall Study|Pregnancy|1
5030668|NCT02943564|17318623|P1|Overall Study|Pregnancy|0
5030669|NCT02943564|17318621|P3|Overall Study|Non-compliance with study drug|0
5030670|NCT02943564|17318622|P2|Overall Study|Non-compliance with study drug|1
5030671|NCT02943564|17318623|P1|Overall Study|Non-compliance with study drug|0
5030672|NCT02943564|17318621|P3|Overall Study|Site terminated by sponsor|0
5030673|NCT02943564|17318622|P2|Overall Study|Site terminated by sponsor|1
5030674|NCT02943564|17318623|P1|Overall Study|Site terminated by sponsor|0
5030675|NCT02943564|17318621|P3|Overall Study|Miscellaneous Reasons|3
5030676|NCT02943564|17318622|P2|Overall Study|Miscellaneous Reasons|0
5030677|NCT02943564|17318623|P1|Overall Study|Miscellaneous Reasons|0
5030678|NCT02943460|17318646|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
5030679|NCT02943460|17318647|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
5030680|NCT02943460|17318648|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
5030681|NCT02943460|17318646|P3|Open Label Extension (OLE)|Investigator's Discretion|0
5030682|NCT02943460|17318647|P2|Open Label Extension (OLE)|Investigator's Discretion|1
5030683|NCT02943460|17318648|P1|Open Label Extension (OLE)|Investigator's Discretion|0
5030684|NCT02943460|17318646|P3|Open Label Extension (OLE)|Withdrew Consent|0
5030685|NCT02943460|17318647|P2|Open Label Extension (OLE)|Withdrew Consent|1
5030686|NCT02943460|17318648|P1|Open Label Extension (OLE)|Withdrew Consent|1
5030687|NCT02943460|17318646|P3|Open Label Extension (OLE)|Adverse Event|1
5030688|NCT02943460|17318647|P2|Open Label Extension (OLE)|Adverse Event|2
5030689|NCT02943460|17318648|P1|Open Label Extension (OLE)|Adverse Event|0
5030690|NCT02943460|17318646|P3|Blinded Study|Withdrew Consent|0
5030691|NCT02943460|17318647|P2|Blinded Study|Withdrew Consent|1
5030692|NCT02943460|17318648|P1|Blinded Study|Withdrew Consent|0
5030693|NCT02943460|17318646|P3|Blinded Study|Adverse Event|0
5030694|NCT02943460|17318647|P2|Blinded Study|Adverse Event|0
5030695|NCT02943460|17318648|P1|Blinded Study|Adverse Event|3
5030696|NCT02943447|17318666|P3|Open-Label Extension Phase|Lost to Follow-up|0
5030697|NCT02943447|17318667|P2|Open-Label Extension Phase|Lost to Follow-up|1
5030698|NCT02943447|17318668|P1|Open-Label Extension Phase|Lost to Follow-up|0
5030699|NCT02943447|17318666|P3|Open-Label Extension Phase|Withdrew consent|1
5030700|NCT02943447|17318667|P2|Open-Label Extension Phase|Withdrew consent|1
5030701|NCT02943447|17318668|P1|Open-Label Extension Phase|Withdrew consent|1
5030702|NCT02943447|17318666|P3|Open-Label Extension Phase|Lack of Efficacy|0
5030703|NCT02943447|17318667|P2|Open-Label Extension Phase|Lack of Efficacy|4
5030704|NCT02943447|17318668|P1|Open-Label Extension Phase|Lack of Efficacy|3
5030705|NCT02943447|17318666|P3|Open-Label Extension Phase|Adverse Event|3
5030706|NCT02943447|17318667|P2|Open-Label Extension Phase|Adverse Event|7
5030707|NCT02943447|17318668|P1|Open-Label Extension Phase|Adverse Event|4
5030708|NCT02943447|17318666|P3|Open-Label Extension Phase|Study terminated by sponsor|6
5030709|NCT02943447|17318667|P2|Open-Label Extension Phase|Study terminated by sponsor|12
5030710|NCT02943447|17318668|P1|Open-Label Extension Phase|Study terminated by sponsor|10
5030711|NCT02943447|17318666|P3|Blinded Study Phase|Investigator's discretion|0
5030712|NCT02943447|17318667|P2|Blinded Study Phase|Investigator's discretion|0
5030713|NCT02943447|17318668|P1|Blinded Study Phase|Investigator's discretion|1
5030714|NCT02943447|17318666|P3|Blinded Study Phase|Adverse Event|0
5030715|NCT02943447|17318667|P2|Blinded Study Phase|Adverse Event|0
5030716|NCT02943447|17318668|P1|Blinded Study Phase|Adverse Event|3
5030717|NCT02943447|17318666|P3|Blinded Study Phase|Withdrew Consent|1
5030718|NCT02943447|17318667|P2|Blinded Study Phase|Withdrew Consent|2
5030719|NCT02943447|17318668|P1|Blinded Study Phase|Withdrew Consent|1
5030720|NCT02943096|17318737|P2|Overall Study|Lack of Efficacy|1
5030721|NCT02943096|17318738|P1|Overall Study|Lack of Efficacy|0
5030722|NCT02942771|17318757|P5|Overall Study|Withdrawal by Subject|2
5030723|NCT02942771|17318758|P4|Overall Study|Withdrawal by Subject|0
5030724|NCT02942771|17318759|P3|Overall Study|Withdrawal by Subject|0
5030725|NCT02942771|17318760|P2|Overall Study|Withdrawal by Subject|0
5030726|NCT02942771|17318761|P1|Overall Study|Withdrawal by Subject|1
5030727|NCT02942771|17318757|P5|Overall Study|Lost to Follow-up|0
5030728|NCT02942771|17318758|P4|Overall Study|Lost to Follow-up|0
5030729|NCT02942771|17318759|P3|Overall Study|Lost to Follow-up|0
5030730|NCT02942771|17318760|P2|Overall Study|Lost to Follow-up|0
5030731|NCT02942771|17318761|P1|Overall Study|Lost to Follow-up|1
5030732|NCT02942771|17318757|P5|Overall Study|Adverse Event|2
5030733|NCT02942771|17318758|P4|Overall Study|Adverse Event|0
5030734|NCT02942771|17318759|P3|Overall Study|Adverse Event|0
5030735|NCT02942771|17318760|P2|Overall Study|Adverse Event|0
5030736|NCT02942771|17318761|P1|Overall Study|Adverse Event|1
5030737|NCT02942576|17318814|P2|Overall Study|Other|8
5030738|NCT02942576|17318815|P1|Overall Study|Other|10
5030739|NCT02942576|17318814|P2|Overall Study|Physician Decision|4
5030740|NCT02942576|17318815|P1|Overall Study|Physician Decision|1
5030741|NCT02942576|17318814|P2|Overall Study|Withdrawal by Subject|5
5030742|NCT02942576|17318815|P1|Overall Study|Withdrawal by Subject|7
5030743|NCT02942576|17318814|P2|Overall Study|Adverse Event|6
5030744|NCT02942576|17318815|P1|Overall Study|Adverse Event|28
5030745|NCT02942485|17318829|P2|Overall Study|Lost to Follow-up|0
5030746|NCT02942485|17318830|P1|Overall Study|Lost to Follow-up|1
5030747|NCT02942017|17318874|P2|Overall Study|Randomized but not dosed|3
5030748|NCT02942017|17318875|P1|Overall Study|Randomized but not dosed|1
5030749|NCT02942017|17318874|P2|Overall Study|Lost to Follow-up|1
5030750|NCT02942017|17318875|P1|Overall Study|Lost to Follow-up|1
5030751|NCT02942017|17318874|P2|Overall Study|Withdrawal by Subject|1
5030752|NCT02942017|17318875|P1|Overall Study|Withdrawal by Subject|0
5030753|NCT02942017|17318874|P2|Overall Study|Adverse Event|1
5030754|NCT02942017|17318875|P1|Overall Study|Adverse Event|0
5030755|NCT02942004|17318906|P3|Overall Study|Randomized but not dosed|4
5030756|NCT02942004|17318907|P2|Overall Study|Randomized but not dosed|9
5030757|NCT02942004|17318908|P1|Overall Study|Randomized but not dosed|3
5030758|NCT02942004|17318906|P3|Overall Study|Lost to Follow-up|2
5030759|NCT02942004|17318907|P2|Overall Study|Lost to Follow-up|1
5030760|NCT02942004|17318908|P1|Overall Study|Lost to Follow-up|1
5030761|NCT02942004|17318906|P3|Overall Study|Withdrawal by Subject|3
5030762|NCT02942004|17318907|P2|Overall Study|Withdrawal by Subject|2
5030763|NCT02942004|17318908|P1|Overall Study|Withdrawal by Subject|0
5030764|NCT02940886|17319022|P2|Overall Study|Enrolment error|1
5030765|NCT02940886|17319023|P1|Overall Study|Enrolment error|0
5030766|NCT02940886|17319022|P2|Overall Study|No treatment|2
5030767|NCT02940886|17319023|P1|Overall Study|No treatment|7
5030768|NCT02940886|17319022|P2|Overall Study|Sponsor decision|1
5030769|NCT02940886|17319023|P1|Overall Study|Sponsor decision|0
5030770|NCT02940886|17319022|P2|Overall Study|Physician Decision|4
5030771|NCT02940886|17319023|P1|Overall Study|Physician Decision|9
5030772|NCT02940886|17319022|P2|Overall Study|Lost to Follow-up|21
5030773|NCT02940886|17319023|P1|Overall Study|Lost to Follow-up|49
5030774|NCT02940886|17319022|P2|Overall Study|Lack of Efficacy|0
5030775|NCT02940886|17319023|P1|Overall Study|Lack of Efficacy|1
5030776|NCT02940886|17319022|P2|Overall Study|Death|0
5030777|NCT02940886|17319023|P1|Overall Study|Death|1
5030778|NCT02940886|17319022|P2|Overall Study|Withdrawal by Subject|20
5030779|NCT02940886|17319023|P1|Overall Study|Withdrawal by Subject|28
5030780|NCT02940886|17319022|P2|Overall Study|Protocol Violation|2
5030781|NCT02940886|17319023|P1|Overall Study|Protocol Violation|0
5030782|NCT02940886|17319022|P2|Overall Study|Adverse Event|3
5030783|NCT02940886|17319023|P1|Overall Study|Adverse Event|7
5030784|NCT02940860|17319069|P2|Overall Study|Not treated|2
5030785|NCT02940860|17319070|P1|Overall Study|Not treated|2
5030786|NCT02940860|17319069|P2|Overall Study|Moved, poor venous access, transport|4
5030787|NCT02940860|17319070|P1|Overall Study|Moved, poor venous access, transport|6
5030788|NCT02940860|17319069|P2|Overall Study|Death|2
5030789|NCT02940860|17319070|P1|Overall Study|Death|3
5030790|NCT02940860|17319069|P2|Overall Study|Protocol Violation|2
5030791|NCT02940860|17319070|P1|Overall Study|Protocol Violation|0
5030792|NCT02940860|17319069|P2|Overall Study|Sponsor Decision|1
5030793|NCT02940860|17319070|P1|Overall Study|Sponsor Decision|0
5030794|NCT02940860|17319069|P2|Overall Study|Physician Decision|3
5030795|NCT02940860|17319070|P1|Overall Study|Physician Decision|5
5030796|NCT02940860|17319069|P2|Overall Study|Lost to Follow-up|7
5030797|NCT02940860|17319070|P1|Overall Study|Lost to Follow-up|13
5030798|NCT02940860|17319069|P2|Overall Study|Withdrawal by Subject|9
5030799|NCT02940860|17319070|P1|Overall Study|Withdrawal by Subject|19
5030800|NCT02940860|17319069|P2|Overall Study|Serious AE|3
5030801|NCT02940860|17319070|P1|Overall Study|Serious AE|7
5030802|NCT02940860|17319069|P2|Overall Study|Non-serious AE|2
5030803|NCT02940860|17319070|P1|Overall Study|Non-serious AE|1
5030804|NCT02940691|17319114|P1|Overall Study|Incarceration|1
5030805|NCT02940691|17319114|P1|Overall Study|Lost to Follow-up|5
5030806|NCT02940626|17319123|P2|Overall Study|Prohibited Concomitant Medication|1
5030807|NCT02940626|17319124|P1|Overall Study|Prohibited Concomitant Medication|0
5030808|NCT02940626|17319123|P2|Overall Study|Transfer to Hospice Care|0
5030809|NCT02940626|17319124|P1|Overall Study|Transfer to Hospice Care|1
5030810|NCT02940626|17319123|P2|Overall Study|Withdrawal by Subject|0
5030811|NCT02940626|17319124|P1|Overall Study|Withdrawal by Subject|1
5030812|NCT02940626|17319123|P2|Overall Study|Lost to Follow-up|2
5030813|NCT02940626|17319124|P1|Overall Study|Lost to Follow-up|5
5030814|NCT02940626|17319123|P2|Overall Study|Death|32
5030815|NCT02940626|17319124|P1|Overall Study|Death|40
5030816|NCT02940574|17319146|P2|1-year Follow-up|Lost to Follow-up|4
5030817|NCT02940574|17319147|P1|1-year Follow-up|Lost to Follow-up|3
5030818|NCT02940574|17319146|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
5030819|NCT02940574|17319147|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
5030820|NCT02940522|17319185|P2|Overall Study|Withdrawal by Subject|0
5030821|NCT02940522|17319186|P1|Overall Study|Withdrawal by Subject|1
5030822|NCT02940522|17319185|P2|Overall Study|Lost to Follow-up|2
5030823|NCT02940522|17319186|P1|Overall Study|Lost to Follow-up|1
5030824|NCT02939950|17319277|P2|Overall Study|Ineligible at Baseline|8
5030825|NCT02939950|17319278|P1|Overall Study|Ineligible at Baseline|2
5030826|NCT02939950|17319277|P2|Overall Study|Randomized, not dispensed|0
5030827|NCT02939950|17319278|P1|Overall Study|Randomized, not dispensed|1
5030828|NCT02939950|17319277|P2|Overall Study|Adverse Event|3
5030829|NCT02939950|17319278|P1|Overall Study|Adverse Event|7
5030830|NCT02939950|17319277|P2|Overall Study|Withdrawal by Subject|28
5030831|NCT02939950|17319278|P1|Overall Study|Withdrawal by Subject|12
5030832|NCT02939950|17319277|P2|Overall Study|Pregnancy|7
5030833|NCT02939950|17319278|P1|Overall Study|Pregnancy|6
5030834|NCT02939950|17319277|P2|Overall Study|Physician Decision|0
5030835|NCT02939950|17319278|P1|Overall Study|Physician Decision|2
5030836|NCT02939950|17319277|P2|Overall Study|Protocol Violation|3
5030837|NCT02939950|17319278|P1|Overall Study|Protocol Violation|6
5030838|NCT02939950|17319277|P2|Overall Study|Unacceptable lens movement|0
5030839|NCT02939950|17319278|P1|Overall Study|Unacceptable lens movement|2
5030840|NCT02939950|17319277|P2|Overall Study|Study related symptoms|8
5030841|NCT02939950|17319278|P1|Overall Study|Study related symptoms|8
5030842|NCT02939950|17319277|P2|Overall Study|Participant Relocated|3
5030843|NCT02939950|17319278|P1|Overall Study|Participant Relocated|5
5030844|NCT02939950|17319277|P2|Overall Study|Military orders|0
5030845|NCT02939950|17319278|P1|Overall Study|Military orders|1
5030846|NCT02939950|17319277|P2|Overall Study|Unacceptable distance lens visual acuity|1
5030847|NCT02939950|17319278|P1|Overall Study|Unacceptable distance lens visual acuity|1
5030848|NCT02939950|17319277|P2|Overall Study|Lack of motivation|2
5030849|NCT02939950|17319278|P1|Overall Study|Lack of motivation|0
5030850|NCT02939950|17319277|P2|Overall Study|Chalazion upper lid|1
5030851|NCT02939950|17319278|P1|Overall Study|Chalazion upper lid|0
5030852|NCT02939950|17319277|P2|Overall Study|Positive slit lamp findings|1
5030853|NCT02939950|17319278|P1|Overall Study|Positive slit lamp findings|0
5030854|NCT02939950|17319277|P2|Overall Study|Lost to Follow-up|16
5030855|NCT02939950|17319278|P1|Overall Study|Lost to Follow-up|13
5030856|NCT02939937|17319288|P2|Overall Study|Lost to Follow-up|3
5030857|NCT02939937|17319289|P1|Overall Study|Lost to Follow-up|1
5030858|NCT02939937|17319288|P2|Overall Study|Adverse Event|0
5030859|NCT02939937|17319289|P1|Overall Study|Adverse Event|5
5030860|NCT02939716|17319303|P6|Overall Study|scanner failure|1
5030861|NCT02939716|17319304|P5|Overall Study|scanner failure|1
5030862|NCT02939716|17319305|P4|Overall Study|scanner failure|1
5030863|NCT02939716|17319306|P3|Overall Study|scanner failure|0
5030864|NCT02939716|17319307|P2|Overall Study|scanner failure|0
5030865|NCT02939716|17319308|P1|Overall Study|scanner failure|0
5030866|NCT02939599|17319333|P2|Overall Study|Study Terminated By Sponsor|2
5030867|NCT02939599|17319334|P1|Overall Study|Study Terminated By Sponsor|2
5030868|NCT02939599|17319333|P2|Overall Study|Adverse Event|0
5030869|NCT02939599|17319334|P1|Overall Study|Adverse Event|1
5030870|NCT02939560|17319348|P1|Overall Study|Protocol Violation|1
5030871|NCT02939560|17319348|P1|Overall Study|Withdrawal by Subject|2
5030872|NCT02939131|17319406|P2|Overall Study|not willing to adhere to protocol|0
5030873|NCT02939131|17319407|P1|Overall Study|not willing to adhere to protocol|2
5030874|NCT02939131|17319406|P2|Overall Study|Other|1
5030875|NCT02939131|17319407|P1|Overall Study|Other|0
5030876|NCT02939131|17319406|P2|Overall Study|severe debilitation|0
5030877|NCT02939131|17319407|P1|Overall Study|severe debilitation|1
5030878|NCT02939131|17319406|P2|Overall Study|Lost to Follow-up|4
5030879|NCT02939131|17319407|P1|Overall Study|Lost to Follow-up|2
5030880|NCT02939131|17319406|P2|Overall Study|Unable to get to clinic|4
5030881|NCT02939131|17319407|P1|Overall Study|Unable to get to clinic|6
5030882|NCT02939079|17319425|P2|Overall Study|relapse during the study|1
5030883|NCT02939079|17319426|P1|Overall Study|relapse during the study|1
5030884|NCT02939079|17319425|P2|Overall Study|Withdrawal by Subject|1
5030885|NCT02939079|17319426|P1|Overall Study|Withdrawal by Subject|0
5030886|NCT02939079|17319425|P2|Overall Study|Protocol Violation|0
5030887|NCT02939079|17319426|P1|Overall Study|Protocol Violation|1
5030888|NCT02939079|17319425|P2|Overall Study|Lost to Follow-up|2
5030889|NCT02939079|17319426|P1|Overall Study|Lost to Follow-up|0
5030890|NCT02939079|17319425|P2|Overall Study|Adverse Event|1
5030891|NCT02939079|17319426|P1|Overall Study|Adverse Event|2
5030892|NCT02939014|17319456|P2|Overall Study|In Overall Survival Follow-up|4
5030893|NCT02939014|17319457|P1|Overall Study|In Overall Survival Follow-up|22
5030894|NCT02939014|17319456|P2|Overall Study|In Progression-Free Survival Follow-up|2
5030895|NCT02939014|17319457|P1|Overall Study|In Progression-Free Survival Follow-up|5
5030896|NCT02939014|17319456|P2|Overall Study|Death|3
5030897|NCT02939014|17319457|P1|Overall Study|Death|3
5030898|NCT02938585|17319501|P4|Overall Study|Withdrawal by Subject|5
5030899|NCT02938585|17319502|P3|Overall Study|Withdrawal by Subject|0
5030900|NCT02938585|17319503|P2|Overall Study|Withdrawal by Subject|0
5030901|NCT02938585|17319504|P1|Overall Study|Withdrawal by Subject|0
5030902|NCT02938585|17319501|P4|Overall Study|Withdrawal by parent or guardian|0
5030903|NCT02938585|17319502|P3|Overall Study|Withdrawal by parent or guardian|0
5030904|NCT02938585|17319503|P2|Overall Study|Withdrawal by parent or guardian|1
5030905|NCT02938585|17319504|P1|Overall Study|Withdrawal by parent or guardian|0
5030906|NCT02938520|17319668|P2|Overall Study|Adverse Event|4
5030907|NCT02938520|17319669|P1|Overall Study|Adverse Event|9
5030908|NCT02938520|17319668|P2|Overall Study|Lack of Efficacy|3
5030909|NCT02938520|17319669|P1|Overall Study|Lack of Efficacy|5
5030910|NCT02938520|17319668|P2|Overall Study|Protocol Violation|1
5030911|NCT02938520|17319669|P1|Overall Study|Protocol Violation|0
5030912|NCT02938520|17319668|P2|Overall Study|Withdrawal by Subject|7
5030913|NCT02938520|17319669|P1|Overall Study|Withdrawal by Subject|7
5030914|NCT02938520|17319668|P2|Overall Study|Lost to Follow-up|2
5030915|NCT02938520|17319669|P1|Overall Study|Lost to Follow-up|2
5030916|NCT02938520|17319668|P2|Overall Study|Physician Decision|5
5030917|NCT02938520|17319669|P1|Overall Study|Physician Decision|2
5030918|NCT02938520|17319668|P2|Overall Study|On-going at the time of analysis|261
5030919|NCT02938520|17319669|P1|Overall Study|On-going at the time of analysis|258
5030920|NCT02937870|17319891|P1|Overall Study|Protocol Deviation|2
5030921|NCT02937870|17319891|P1|Overall Study|Adverse Event|1
5030922|NCT02937740|17319922|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
5030923|NCT02937740|17319923|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
5030924|NCT02937740|17319922|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
5030925|NCT02937740|17319923|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
5030926|NCT02937740|17319922|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
5030927|NCT02937740|17319923|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
5030928|NCT02937740|17319922|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
5030929|NCT02937740|17319923|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
5030930|NCT02937740|17319922|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
5030931|NCT02937740|17319923|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
5030932|NCT02937740|17319922|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
5030933|NCT02937740|17319923|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
5030934|NCT02937701|17319939|P5|Week 22 to Week 50|Other|1
5030935|NCT02937701|17319940|P4|Week 22 to Week 50|Other|0
5030936|NCT02937701|17319941|P3|Week 22 to Week 50|Other|0
5030937|NCT02937701|17319942|P2|Week 22 to Week 50|Other|0
5030938|NCT02937701|17319943|P1|Week 22 to Week 50|Other|0
5030939|NCT02937701|17319939|P5|Week 22 to Week 50|Physician Decision|1
5030940|NCT02937701|17319940|P4|Week 22 to Week 50|Physician Decision|0
5030941|NCT02937701|17319941|P3|Week 22 to Week 50|Physician Decision|2
5030942|NCT02937701|17319942|P2|Week 22 to Week 50|Physician Decision|0
5030943|NCT02937701|17319943|P1|Week 22 to Week 50|Physician Decision|0
5030944|NCT02937701|17319939|P5|Week 22 to Week 50|Lost to Follow-up|1
5030945|NCT02937701|17319940|P4|Week 22 to Week 50|Lost to Follow-up|0
5030946|NCT02937701|17319941|P3|Week 22 to Week 50|Lost to Follow-up|2
5030947|NCT02937701|17319942|P2|Week 22 to Week 50|Lost to Follow-up|0
5030948|NCT02937701|17319943|P1|Week 22 to Week 50|Lost to Follow-up|0
5030949|NCT02937701|17319939|P5|Week 22 to Week 50|Withdrawal by Subject|1
5030950|NCT02937701|17319940|P4|Week 22 to Week 50|Withdrawal by Subject|2
5030951|NCT02937701|17319941|P3|Week 22 to Week 50|Withdrawal by Subject|8
5030952|NCT02937701|17319942|P2|Week 22 to Week 50|Withdrawal by Subject|0
5030953|NCT02937701|17319943|P1|Week 22 to Week 50|Withdrawal by Subject|0
5030954|NCT02937701|17319939|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
5030955|NCT02937701|17319940|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
5030956|NCT02937701|17319941|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
5030957|NCT02937701|17319942|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5030958|NCT02937701|17319943|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5030959|NCT02937701|17319939|P5|Week 22 to Week 50|Adverse Event|3
5030960|NCT02937701|17319940|P4|Week 22 to Week 50|Adverse Event|3
5030961|NCT02937701|17319941|P3|Week 22 to Week 50|Adverse Event|10
5030962|NCT02937701|17319942|P2|Week 22 to Week 50|Adverse Event|0
5030963|NCT02937701|17319943|P1|Week 22 to Week 50|Adverse Event|0
5030964|NCT02937701|17319939|P5|Day 1 to Week 22|Other|0
5030965|NCT02937701|17319940|P4|Day 1 to Week 22|Other|0
5030966|NCT02937701|17319941|P3|Day 1 to Week 22|Other|0
5030967|NCT02937701|17319942|P2|Day 1 to Week 22|Other|0
5030968|NCT02937701|17319943|P1|Day 1 to Week 22|Other|1
5030969|NCT02937701|17319939|P5|Day 1 to Week 22|Physician Decision|0
5030970|NCT02937701|17319940|P4|Day 1 to Week 22|Physician Decision|0
5030971|NCT02937701|17319941|P3|Day 1 to Week 22|Physician Decision|0
5030972|NCT02937701|17319942|P2|Day 1 to Week 22|Physician Decision|0
5030973|NCT02937701|17319943|P1|Day 1 to Week 22|Physician Decision|2
5030974|NCT02937701|17319939|P5|Day 1 to Week 22|Lost to Follow-up|0
5030975|NCT02937701|17319940|P4|Day 1 to Week 22|Lost to Follow-up|0
5030976|NCT02937701|17319941|P3|Day 1 to Week 22|Lost to Follow-up|0
5030977|NCT02937701|17319942|P2|Day 1 to Week 22|Lost to Follow-up|1
5030978|NCT02937701|17319943|P1|Day 1 to Week 22|Lost to Follow-up|1
5030979|NCT02937701|17319939|P5|Day 1 to Week 22|Protocol Violation|0
5030980|NCT02937701|17319940|P4|Day 1 to Week 22|Protocol Violation|0
5030981|NCT02937701|17319941|P3|Day 1 to Week 22|Protocol Violation|0
5030982|NCT02937701|17319942|P2|Day 1 to Week 22|Protocol Violation|1
5030983|NCT02937701|17319943|P1|Day 1 to Week 22|Protocol Violation|1
5030984|NCT02937701|17319939|P5|Day 1 to Week 22|Death|0
5030985|NCT02937701|17319940|P4|Day 1 to Week 22|Death|0
5030986|NCT02937701|17319941|P3|Day 1 to Week 22|Death|0
5030987|NCT02937701|17319942|P2|Day 1 to Week 22|Death|1
5030988|NCT02937701|17319943|P1|Day 1 to Week 22|Death|1
5030989|NCT02937701|17319939|P5|Day 1 to Week 22|Withdrawal by Subject|0
5030990|NCT02937701|17319940|P4|Day 1 to Week 22|Withdrawal by Subject|0
5030991|NCT02937701|17319941|P3|Day 1 to Week 22|Withdrawal by Subject|0
5030992|NCT02937701|17319942|P2|Day 1 to Week 22|Withdrawal by Subject|6
5030993|NCT02937701|17319943|P1|Day 1 to Week 22|Withdrawal by Subject|6
5030994|NCT02937701|17319939|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5030995|NCT02937701|17319940|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5030996|NCT02937701|17319941|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5030997|NCT02937701|17319942|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
5030998|NCT02937701|17319943|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
5030999|NCT02937701|17319939|P5|Day 1 to Week 22|Protocol Specified Criteria|0
5031000|NCT02937701|17319940|P4|Day 1 to Week 22|Protocol Specified Criteria|0
5031001|NCT02937701|17319941|P3|Day 1 to Week 22|Protocol Specified Criteria|0
5031002|NCT02937701|17319942|P2|Day 1 to Week 22|Protocol Specified Criteria|7
5031003|NCT02937701|17319943|P1|Day 1 to Week 22|Protocol Specified Criteria|7
5031004|NCT02937701|17319939|P5|Day 1 to Week 22|Adverse Event|0
5031005|NCT02937701|17319940|P4|Day 1 to Week 22|Adverse Event|0
5031006|NCT02937701|17319941|P3|Day 1 to Week 22|Adverse Event|0
5031007|NCT02937701|17319942|P2|Day 1 to Week 22|Adverse Event|14
5031008|NCT02937701|17319943|P1|Day 1 to Week 22|Adverse Event|11
5031009|NCT02937636|17319974|P2|Overall Study|Other (Not specified)|2
5031010|NCT02937636|17319975|P1|Overall Study|Other (Not specified)|3
5031011|NCT02937584|17320002|P2|Washout|Adverse Event|1
5031012|NCT02937584|17320003|P1|Washout|Adverse Event|0
5031013|NCT02937584|17320002|P2|Period 1|Adverse Event|2
5031014|NCT02937584|17320003|P1|Period 1|Adverse Event|1
5031015|NCT02936869|17320066|P2|Overall Study|Protocol Violation|0
5031016|NCT02936869|17320067|P1|Overall Study|Protocol Violation|1
5031017|NCT02936869|17320066|P2|Overall Study|Legal Case|1
5031018|NCT02936869|17320067|P1|Overall Study|Legal Case|0
5031019|NCT02936869|17320066|P2|Overall Study|Death|1
5031020|NCT02936869|17320067|P1|Overall Study|Death|0
5031021|NCT02936869|17320066|P2|Overall Study|Lost to Follow-up|3
5031022|NCT02936869|17320067|P1|Overall Study|Lost to Follow-up|1
5031023|NCT02936037|17320100|P2|Open Label Extension|Withdrawal by Subject|4
5031024|NCT02936037|17320101|P1|Open Label Extension|Withdrawal by Subject|0
5031025|NCT02936037|17320100|P2|Open Label Extension|Other|3
5031026|NCT02936037|17320101|P1|Open Label Extension|Other|0
5031027|NCT02936037|17320100|P2|Open Label Extension|Adverse Event|3
5031028|NCT02936037|17320101|P1|Open Label Extension|Adverse Event|0
5031029|NCT02936037|17320100|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5031030|NCT02936037|17320101|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5031031|NCT02936037|17320100|P2|Double-Blind Treatment Period|Withdrawal by Subject|28
5031032|NCT02936037|17320101|P1|Double-Blind Treatment Period|Withdrawal by Subject|31
5031033|NCT02936037|17320100|P2|Double-Blind Treatment Period|Adverse Event|11
5031034|NCT02936037|17320101|P1|Double-Blind Treatment Period|Adverse Event|11
5031035|NCT02936037|17320100|P2|Double-Blind Treatment Period|Death|1
5031036|NCT02936037|17320101|P1|Double-Blind Treatment Period|Death|0
5031037|NCT02936037|17320100|P2|Double-Blind Treatment Period|Lack of Efficacy|12
5031038|NCT02936037|17320101|P1|Double-Blind Treatment Period|Lack of Efficacy|4
5031039|NCT02936037|17320100|P2|Double-Blind Treatment Period|Suicidal risk, etc.|8
5031040|NCT02936037|17320101|P1|Double-Blind Treatment Period|Suicidal risk, etc.|2
5031041|NCT02936037|17320100|P2|Double-Blind Treatment Period|Protocol Violation|4
5031042|NCT02936037|17320101|P1|Double-Blind Treatment Period|Protocol Violation|1
5031043|NCT02935894|17320107|P1|Overall Study|Subject dismissed|1
5031044|NCT02935842|17320122|P4|Testing and Therapy Period 3|Withdrawal by Subject|0
5031045|NCT02935842|17320123|P3|Testing and Therapy Period 3|Withdrawal by Subject|3
5031046|NCT02935842|17320124|P2|Testing and Therapy Period 3|Withdrawal by Subject|0
5031047|NCT02935842|17320125|P1|Testing and Therapy Period 3|Withdrawal by Subject|0
5031048|NCT02935842|17320122|P4|Testing and Therapy Period 3|Lost to Follow-up|1
5031049|NCT02935842|17320123|P3|Testing and Therapy Period 3|Lost to Follow-up|0
5031050|NCT02935842|17320124|P2|Testing and Therapy Period 3|Lost to Follow-up|0
5031051|NCT02935842|17320125|P1|Testing and Therapy Period 3|Lost to Follow-up|0
5031052|NCT02935842|17320122|P4|Testing and Therapy Period 3|Accident prior to treatment|0
5031053|NCT02935842|17320123|P3|Testing and Therapy Period 3|Accident prior to treatment|0
5031054|NCT02935842|17320124|P2|Testing and Therapy Period 3|Accident prior to treatment|2
5031055|NCT02935842|17320125|P1|Testing and Therapy Period 3|Accident prior to treatment|2
5031056|NCT02935842|17320122|P4|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
5031057|NCT02935842|17320123|P3|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
5031058|NCT02935842|17320124|P2|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
5031059|NCT02935842|17320125|P1|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
5031060|NCT02935842|17320122|P4|Testing and Therapy Period 2|Withdrawal by Subject|0
5031061|NCT02935842|17320123|P3|Testing and Therapy Period 2|Withdrawal by Subject|0
5031062|NCT02935842|17320124|P2|Testing and Therapy Period 2|Withdrawal by Subject|0
5031063|NCT02935842|17320125|P1|Testing and Therapy Period 2|Withdrawal by Subject|2
5031064|NCT02935673|17320194|P3|Overall Study|Withdrawal by Subject|0
5031065|NCT02935673|17320195|P2|Overall Study|Withdrawal by Subject|2
5031066|NCT02935673|17320196|P1|Overall Study|Withdrawal by Subject|1
5031067|NCT02935673|17320194|P3|Overall Study|Adverse Event|0
5031068|NCT02935673|17320195|P2|Overall Study|Adverse Event|1
5031069|NCT02935673|17320196|P1|Overall Study|Adverse Event|0
5031070|NCT02935192|17320341|P2|Overall Study|Withdrawal by Subject|4
5031071|NCT02935192|17320342|P1|Overall Study|Withdrawal by Subject|8
5031072|NCT02934178|17320459|P2|Received Vaccination 3|Withdrawal by Subject|0
5031073|NCT02934178|17320460|P1|Received Vaccination 3|Withdrawal by Subject|1
5031074|NCT02934178|17320459|P2|Received Vaccination 2|Death|1
5031075|NCT02934178|17320460|P1|Received Vaccination 2|Death|0
5031076|NCT02933528|17320600|P1|Overall Study|Lost to Follow-up|2
5031077|NCT02933060|17320628|P2|Overall Study|Withdrawal by Subject|1
5031078|NCT02933060|17320629|P1|Overall Study|Withdrawal by Subject|0
5031079|NCT02932943|17320670|P2|Overall Study|Withdrawal by Subject|3
5031080|NCT02932943|17320671|P1|Overall Study|Withdrawal by Subject|3
5031081|NCT02932943|17320670|P2|Overall Study|Adverse Event|2
5031082|NCT02932943|17320671|P1|Overall Study|Adverse Event|2
5031083|NCT02932943|17320670|P2|Overall Study|Lost to Follow-up|2
5031084|NCT02932943|17320671|P1|Overall Study|Lost to Follow-up|0
5031085|NCT02932904|17320687|P4|Overall Study|Randomized But Not Treated|2
5031086|NCT02932904|17320688|P3|Overall Study|Randomized But Not Treated|0
5031087|NCT02932904|17320689|P2|Overall Study|Randomized But Not Treated|1
5031088|NCT02932904|17320690|P1|Overall Study|Randomized But Not Treated|1
5031089|NCT02932904|17320687|P4|Overall Study|Pretreatment Event/Adverse Event|3
5031090|NCT02932904|17320688|P3|Overall Study|Pretreatment Event/Adverse Event|1
5031091|NCT02932904|17320689|P2|Overall Study|Pretreatment Event/Adverse Event|5
5031092|NCT02932904|17320690|P1|Overall Study|Pretreatment Event/Adverse Event|3
5031093|NCT02932904|17320687|P4|Overall Study|Significant Protocol Deviation|1
5031094|NCT02932904|17320688|P3|Overall Study|Significant Protocol Deviation|6
5031095|NCT02932904|17320689|P2|Overall Study|Significant Protocol Deviation|3
5031096|NCT02932904|17320690|P1|Overall Study|Significant Protocol Deviation|2
5031097|NCT02932904|17320687|P4|Overall Study|Lost to Follow-up|0
5031098|NCT02932904|17320688|P3|Overall Study|Lost to Follow-up|6
5031099|NCT02932904|17320689|P2|Overall Study|Lost to Follow-up|3
5031100|NCT02932904|17320690|P1|Overall Study|Lost to Follow-up|5
5031101|NCT02932904|17320687|P4|Overall Study|Voluntary Withdrawal|2
5031102|NCT02932904|17320688|P3|Overall Study|Voluntary Withdrawal|4
5031103|NCT02932904|17320689|P2|Overall Study|Voluntary Withdrawal|1
5031104|NCT02932904|17320690|P1|Overall Study|Voluntary Withdrawal|2
5031105|NCT02932904|17320687|P4|Overall Study|Study Termination|0
5031106|NCT02932904|17320688|P3|Overall Study|Study Termination|0
5031107|NCT02932904|17320689|P2|Overall Study|Study Termination|1
5031108|NCT02932904|17320690|P1|Overall Study|Study Termination|0
5031109|NCT02932904|17320687|P4|Overall Study|Pregnancy|0
5031110|NCT02932904|17320688|P3|Overall Study|Pregnancy|1
5031111|NCT02932904|17320689|P2|Overall Study|Pregnancy|1
5031112|NCT02932904|17320690|P1|Overall Study|Pregnancy|0
5031113|NCT02932904|17320687|P4|Overall Study|Noncompliance with Study Drug|4
5031114|NCT02932904|17320688|P3|Overall Study|Noncompliance with Study Drug|3
5031115|NCT02932904|17320689|P2|Overall Study|Noncompliance with Study Drug|3
5031116|NCT02932904|17320690|P1|Overall Study|Noncompliance with Study Drug|2
5031117|NCT02932904|17320687|P4|Overall Study|Reason not Specified|2
5031118|NCT02932904|17320688|P3|Overall Study|Reason not Specified|2
5031119|NCT02932904|17320689|P2|Overall Study|Reason not Specified|0
5031120|NCT02932904|17320690|P1|Overall Study|Reason not Specified|1
5031121|NCT02932891|17320725|P1|Overall Study|HPA Suppress|2
5031122|NCT02932891|17320725|P1|Overall Study|Lost to Follow-up|2
5031123|NCT02932878|17320731|P2|Overall Study|Due to Lab Results|1
5031124|NCT02932878|17320732|P1|Overall Study|Due to Lab Results|2
5031125|NCT02932462|17320753|P2|Overall Study|Progressive Disease|0
5031126|NCT02932462|17320754|P1|Overall Study|Progressive Disease|1
5031127|NCT02932462|17320753|P2|Overall Study|Non-Compliance With Study Drug|1
5031128|NCT02932462|17320754|P1|Overall Study|Non-Compliance With Study Drug|0
5031129|NCT02932462|17320753|P2|Overall Study|Withdrawal by Subject|4
5031130|NCT02932462|17320754|P1|Overall Study|Withdrawal by Subject|1
5031131|NCT02932462|17320753|P2|Overall Study|Protocol Violation|5
5031132|NCT02932462|17320754|P1|Overall Study|Protocol Violation|0
5031133|NCT02932462|17320753|P2|Overall Study|Lost to Follow-up|1
5031134|NCT02932462|17320754|P1|Overall Study|Lost to Follow-up|4
5031135|NCT02932462|17320753|P2|Overall Study|Adverse Event|2
5031136|NCT02932462|17320754|P1|Overall Study|Adverse Event|1
5031137|NCT02932306|17320766|P2|Overall Study|Withdrew due to burning,itching,stinging|0
5031138|NCT02932306|17320767|P1|Overall Study|Withdrew due to burning,itching,stinging|1
5031139|NCT02932306|17320766|P2|Overall Study|Worsening condition|0
5031140|NCT02932306|17320767|P1|Overall Study|Worsening condition|2
5031141|NCT02932306|17320766|P2|Overall Study|Lack of Efficacy|2
5031142|NCT02932306|17320767|P1|Overall Study|Lack of Efficacy|0
5031143|NCT02932306|17320766|P2|Overall Study|Withdrawal by Parent or Guardian|8
5031144|NCT02932306|17320767|P1|Overall Study|Withdrawal by Parent or Guardian|6
5031145|NCT02932306|17320766|P2|Overall Study|Lost to Follow-up|40
5031146|NCT02932306|17320767|P1|Overall Study|Lost to Follow-up|36
5031147|NCT02932306|17320766|P2|Overall Study|Noncompliance with Study Drug|1
5031148|NCT02932306|17320767|P1|Overall Study|Noncompliance with Study Drug|1
5031149|NCT02932306|17320766|P2|Overall Study|Protocol Violation|1
5031150|NCT02932306|17320767|P1|Overall Study|Protocol Violation|1
5031151|NCT02932306|17320766|P2|Overall Study|Pregnancy|0
5031152|NCT02932306|17320767|P1|Overall Study|Pregnancy|2
5031153|NCT02932306|17320766|P2|Overall Study|Adverse Event|0
5031154|NCT02932306|17320767|P1|Overall Study|Adverse Event|3
5031155|NCT02932306|17320766|P2|Overall Study|Withdrawal by Subject|25
5031156|NCT02932306|17320767|P1|Overall Study|Withdrawal by Subject|16
5031157|NCT02932267|17320781|P1|Overall Study|Pregnancy|1
5031158|NCT02932267|17320781|P1|Overall Study|Lost to Follow-up|4
5031159|NCT02932267|17320781|P1|Overall Study|Withdrawal by Subject|3
5031160|NCT02932228|17320787|P2|Overall Study|not eligible upon chart review|5
5031161|NCT02932228|17320788|P1|Overall Study|not eligible upon chart review|2
5031162|NCT02932228|17320787|P2|Overall Study|Death|23
5031163|NCT02932228|17320788|P1|Overall Study|Death|8
5031164|NCT02931838|17320813|P6|Overall Study|Adverse Event|1
5031165|NCT02931838|17320814|P5|Overall Study|Adverse Event|3
5031166|NCT02931838|17320815|P4|Overall Study|Adverse Event|1
5031167|NCT02931838|17320816|P3|Overall Study|Adverse Event|2
5031168|NCT02931838|17320817|P2|Overall Study|Adverse Event|1
5031169|NCT02931838|17320818|P1|Overall Study|Adverse Event|2
5031170|NCT02931838|17320813|P6|Overall Study|Withdrawal by Subject|0
5031171|NCT02931838|17320814|P5|Overall Study|Withdrawal by Subject|0
5031172|NCT02931838|17320815|P4|Overall Study|Withdrawal by Subject|1
5031173|NCT02931838|17320816|P3|Overall Study|Withdrawal by Subject|0
5031174|NCT02931838|17320817|P2|Overall Study|Withdrawal by Subject|2
5031175|NCT02931838|17320818|P1|Overall Study|Withdrawal by Subject|1
5031176|NCT02931838|17320813|P6|Overall Study|Subject request to discontinue treatment|0
5031177|NCT02931838|17320814|P5|Overall Study|Subject request to discontinue treatment|1
5031178|NCT02931838|17320815|P4|Overall Study|Subject request to discontinue treatment|0
5031179|NCT02931838|17320816|P3|Overall Study|Subject request to discontinue treatment|3
5031180|NCT02931838|17320817|P2|Overall Study|Subject request to discontinue treatment|3
5031181|NCT02931838|17320818|P1|Overall Study|Subject request to discontinue treatment|4
5031182|NCT02931838|17320813|P6|Overall Study|Lost to Follow-up|0
5031183|NCT02931838|17320814|P5|Overall Study|Lost to Follow-up|2
5031184|NCT02931838|17320815|P4|Overall Study|Lost to Follow-up|1
5031185|NCT02931838|17320816|P3|Overall Study|Lost to Follow-up|1
5031186|NCT02931838|17320817|P2|Overall Study|Lost to Follow-up|0
5031187|NCT02931838|17320818|P1|Overall Study|Lost to Follow-up|1
5031188|NCT02931838|17320813|P6|Overall Study|Lack of Efficacy|1
5031189|NCT02931838|17320814|P5|Overall Study|Lack of Efficacy|0
5031190|NCT02931838|17320815|P4|Overall Study|Lack of Efficacy|0
5031191|NCT02931838|17320816|P3|Overall Study|Lack of Efficacy|0
5031192|NCT02931838|17320817|P2|Overall Study|Lack of Efficacy|4
5031193|NCT02931838|17320818|P1|Overall Study|Lack of Efficacy|5
5031194|NCT02931838|17320813|P6|Overall Study|Poor/non-compliance|0
5031195|NCT02931838|17320814|P5|Overall Study|Poor/non-compliance|0
5031196|NCT02931838|17320815|P4|Overall Study|Poor/non-compliance|0
5031197|NCT02931838|17320816|P3|Overall Study|Poor/non-compliance|1
5031198|NCT02931838|17320817|P2|Overall Study|Poor/non-compliance|0
5031199|NCT02931838|17320818|P1|Overall Study|Poor/non-compliance|0
5031200|NCT02931838|17320813|P6|Overall Study|Reason not provided by investigator|0
5031201|NCT02931838|17320814|P5|Overall Study|Reason not provided by investigator|0
5031202|NCT02931838|17320815|P4|Overall Study|Reason not provided by investigator|0
5031203|NCT02931838|17320816|P3|Overall Study|Reason not provided by investigator|1
5031204|NCT02931838|17320817|P2|Overall Study|Reason not provided by investigator|0
5031205|NCT02931838|17320818|P1|Overall Study|Reason not provided by investigator|1
5031206|NCT02931396|17320869|P2|Overall Study|Withdrawal by Subject|0
5031207|NCT02931396|17320870|P1|Overall Study|Withdrawal by Subject|2
5031208|NCT02931396|17320869|P2|Overall Study|Lost to Follow-up|0
5031209|NCT02931396|17320870|P1|Overall Study|Lost to Follow-up|3
5031210|NCT02930837|17320907|P1|Overall Study|Withdrawal by Subject|1
5031211|NCT02930837|17320907|P1|Overall Study|Lost to Follow-up|5
5031212|NCT02930837|17320907|P1|Overall Study|Adverse Event|6
5031213|NCT02930226|17321203|P6|Overall Study|Technical Problems: Leak in plasma bag|0
5031214|NCT02930226|17321204|P5|Overall Study|Technical Problems: Leak in plasma bag|1
5031215|NCT02930226|17321205|P4|Overall Study|Technical Problems: Leak in plasma bag|0
5031216|NCT02930226|17321206|P3|Overall Study|Technical Problems: Leak in plasma bag|0
5031217|NCT02930226|17321207|P2|Overall Study|Technical Problems: Leak in plasma bag|0
5031218|NCT02930226|17321208|P1|Overall Study|Technical Problems: Leak in plasma bag|0
5031219|NCT02930005|17321262|P2|Overall Study|Lost to Follow-up|5
5031220|NCT02930005|17321263|P1|Overall Study|Lost to Follow-up|1
5031221|NCT02929498|17321303|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
5031222|NCT02929498|17321304|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
5031223|NCT02929498|17321305|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
5031224|NCT02929498|17321303|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
5031225|NCT02929498|17321304|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
5031226|NCT02929498|17321305|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
5031227|NCT02929407|17321399|P1|Overall Study|Adverse Event|1
5031228|NCT02928770|17321414|P1|Overall Study|Withdrawal by Subject|2
5031229|NCT02928224|17321454|P4|Overall Study|not listed|0
5031230|NCT02928224|17321455|P3|Overall Study|not listed|1
5031231|NCT02928224|17321456|P2|Overall Study|not listed|3
5031232|NCT02928224|17321457|P1|Overall Study|not listed|0
5031233|NCT02928224|17321454|P4|Overall Study|Physician Decision|2
5031234|NCT02928224|17321455|P3|Overall Study|Physician Decision|4
5031235|NCT02928224|17321456|P2|Overall Study|Physician Decision|2
5031236|NCT02928224|17321457|P1|Overall Study|Physician Decision|0
5031237|NCT02928224|17321454|P4|Overall Study|Patient Decision to Discontinue Drug|4
5031238|NCT02928224|17321455|P3|Overall Study|Patient Decision to Discontinue Drug|2
5031239|NCT02928224|17321456|P2|Overall Study|Patient Decision to Discontinue Drug|2
5031240|NCT02928224|17321457|P1|Overall Study|Patient Decision to Discontinue Drug|0
5031241|NCT02928224|17321454|P4|Overall Study|Dose Interruptions>28|4
5031242|NCT02928224|17321455|P3|Overall Study|Dose Interruptions>28|2
5031243|NCT02928224|17321456|P2|Overall Study|Dose Interruptions>28|2
5031244|NCT02928224|17321457|P1|Overall Study|Dose Interruptions>28|1
5031245|NCT02928224|17321454|P4|Overall Study|Withdrawal by Subject|9
5031246|NCT02928224|17321455|P3|Overall Study|Withdrawal by Subject|3
5031247|NCT02928224|17321456|P2|Overall Study|Withdrawal by Subject|4
5031248|NCT02928224|17321457|P1|Overall Study|Withdrawal by Subject|1
5031249|NCT02928224|17321454|P4|Overall Study|Death|11
5031250|NCT02928224|17321455|P3|Overall Study|Death|5
5031251|NCT02928224|17321456|P2|Overall Study|Death|7
5031252|NCT02928224|17321457|P1|Overall Study|Death|1
5031253|NCT02928224|17321454|P4|Overall Study|Changes in Patient's Condition|13
5031254|NCT02928224|17321455|P3|Overall Study|Changes in Patient's Condition|9
5031255|NCT02928224|17321456|P2|Overall Study|Changes in Patient's Condition|9
5031256|NCT02928224|17321457|P1|Overall Study|Changes in Patient's Condition|3
5031257|NCT02928224|17321454|P4|Overall Study|Adverse Event|10
5031258|NCT02928224|17321455|P3|Overall Study|Adverse Event|11
5031259|NCT02928224|17321456|P2|Overall Study|Adverse Event|11
5031260|NCT02928224|17321457|P1|Overall Study|Adverse Event|2
5031261|NCT02928224|17321454|P4|Overall Study|Progressive Disease|103
5031262|NCT02928224|17321455|P3|Overall Study|Progressive Disease|101
5031263|NCT02928224|17321456|P2|Overall Study|Progressive Disease|104
5031264|NCT02928224|17321457|P1|Overall Study|Progressive Disease|23
5031265|NCT02928224|17321454|P4|Overall Study|Treatment Ongoing|37
5031266|NCT02928224|17321455|P3|Overall Study|Treatment Ongoing|78
5031267|NCT02928224|17321456|P2|Overall Study|Treatment Ongoing|78
5031268|NCT02928224|17321457|P1|Overall Study|Treatment Ongoing|6
5031269|NCT02928224|17321454|P4|Overall Study|Randomized, Not Treated|28
5031270|NCT02928224|17321455|P3|Overall Study|Randomized, Not Treated|4
5031271|NCT02928224|17321456|P2|Overall Study|Randomized, Not Treated|2
5031272|NCT02928224|17321457|P1|Overall Study|Randomized, Not Treated|0
5031273|NCT02928029|17321561|P2|Overall Study|AE not related to clinical progression|1
5031274|NCT02928029|17321562|P1|Overall Study|AE not related to clinical progression|1
5031275|NCT02928029|17321561|P2|Overall Study|Clinical progression|2
5031276|NCT02928029|17321562|P1|Overall Study|Clinical progression|1
5031277|NCT02928029|17321561|P2|Overall Study|Radiological progression|0
5031278|NCT02928029|17321562|P1|Overall Study|Radiological progression|1
5031279|NCT02928029|17321561|P2|Overall Study|Withdrawal by Subject|1
5031280|NCT02928029|17321562|P1|Overall Study|Withdrawal by Subject|0
5031281|NCT02927938|17321576|P4|Overall Study|Early Study Termination|3
5031282|NCT02927938|17321577|P3|Overall Study|Early Study Termination|4
5031283|NCT02927938|17321578|P2|Overall Study|Early Study Termination|5
5031284|NCT02927938|17321579|P1|Overall Study|Early Study Termination|1
5031285|NCT02927938|17321576|P4|Overall Study|Death|4
5031286|NCT02927938|17321577|P3|Overall Study|Death|0
5031287|NCT02927938|17321578|P2|Overall Study|Death|1
5031288|NCT02927938|17321579|P1|Overall Study|Death|0
5031289|NCT02927795|17321587|P1|Overall Study|Not Treated|4
5031290|NCT02927795|17321587|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
5031291|NCT02927431|17321643|P3|Overall Study|Withdrawal by Subject|1
5031292|NCT02927431|17321644|P2|Overall Study|Withdrawal by Subject|0
5031293|NCT02927431|17321645|P1|Overall Study|Withdrawal by Subject|0
5031294|NCT02927366|17321723|P2|Overall Study|Patient schedule|0
5031295|NCT02927366|17321724|P1|Overall Study|Patient schedule|1
5031296|NCT02927366|17321723|P2|Overall Study|Adverse Event|0
5031297|NCT02927366|17321724|P1|Overall Study|Adverse Event|1
5031298|NCT02927171|17321779|P2|Overall Study|Lost to Follow-up|1
5031299|NCT02927171|17321780|P1|Overall Study|Lost to Follow-up|0
5031300|NCT02926833|17321794|P4|Overall Study|Adverse Event|0
5031301|NCT02926833|17321795|P3|Overall Study|Adverse Event|1
5031302|NCT02926833|17321796|P2|Overall Study|Adverse Event|0
5031303|NCT02926833|17321797|P1|Overall Study|Adverse Event|0
5031304|NCT02926833|17321794|P4|Overall Study|Still on study|14
5031305|NCT02926833|17321795|P3|Overall Study|Still on study|5
5031306|NCT02926833|17321796|P2|Overall Study|Still on study|3
5031307|NCT02926833|17321797|P1|Overall Study|Still on study|2
5031308|NCT02926833|17321794|P4|Overall Study|Death|7
5031309|NCT02926833|17321795|P3|Overall Study|Death|1
5031310|NCT02926833|17321796|P2|Overall Study|Death|1
5031311|NCT02926833|17321797|P1|Overall Study|Death|1
5031312|NCT02926833|17321794|P4|Overall Study|Full Consent Withdrawal|2
5031313|NCT02926833|17321795|P3|Overall Study|Full Consent Withdrawal|0
5031314|NCT02926833|17321796|P2|Overall Study|Full Consent Withdrawal|0
5031315|NCT02926833|17321797|P1|Overall Study|Full Consent Withdrawal|0
5031316|NCT02926638|17321853|P2|Overall Study|Not protocol specified|0
5031317|NCT02926638|17321854|P1|Overall Study|Not protocol specified|1
5031318|NCT02926638|17321853|P2|Overall Study|Ineligible|0
5031319|NCT02926638|17321854|P1|Overall Study|Ineligible|1
5031320|NCT02926638|17321853|P2|Overall Study|Progression|5
5031321|NCT02926638|17321854|P1|Overall Study|Progression|2
5031322|NCT02926573|17321868|P2|Overall Study|Delirium|1
5031323|NCT02926573|17321869|P1|Overall Study|Delirium|0
5031324|NCT02926573|17321868|P2|Overall Study|Return to operating room|2
5031325|NCT02926573|17321869|P1|Overall Study|Return to operating room|0
5031326|NCT02926573|17321868|P2|Overall Study|Withdrawal by Subject|2
5031327|NCT02926573|17321869|P1|Overall Study|Withdrawal by Subject|0
5031328|NCT02926573|17321868|P2|Overall Study|Change to outpatient status|1
5031329|NCT02926573|17321869|P1|Overall Study|Change to outpatient status|5
5031330|NCT02926573|17321868|P2|Overall Study|Change in surgery plan|1
5031331|NCT02926573|17321869|P1|Overall Study|Change in surgery plan|3
5031332|NCT02926573|17321868|P2|Overall Study|Remain intubated|2
5031333|NCT02926573|17321869|P1|Overall Study|Remain intubated|2
5031334|NCT02926573|17321868|P2|Overall Study|Nausea|0
5031335|NCT02926573|17321869|P1|Overall Study|Nausea|1
5031336|NCT02926209|17321887|P2|Study Cohort|Poor Bowel Preparation|0
5031337|NCT02926209|17321888|P1|Study Cohort|Poor Bowel Preparation|1
5031338|NCT02925923|17321901|P2|Overall Study|blood samples hemolyzed|2
5031339|NCT02925923|17321902|P1|Overall Study|blood samples hemolyzed|0
5031340|NCT02925741|17321959|P2|Overall Study|Withdrawal by Subject|0
5031341|NCT02925741|17321960|P1|Overall Study|Withdrawal by Subject|11
5031342|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Adverse Event|1
5031343|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Adverse Event|0
5031344|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Adverse Event|0
5031345|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Adverse Event|0
5031346|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Non-Compliance|2
5031347|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
5031348|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
5031349|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5031350|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Pregnancy|2
5031351|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Pregnancy|1
5031352|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Pregnancy|0
5031353|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Pregnancy|1
5031354|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
5031355|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
5031356|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
5031357|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
5031358|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Other|6
5031359|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Other|3
5031360|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Other|4
5031361|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Other|1
5031362|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|10
5031363|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|9
5031364|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5031365|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5031366|NCT02925494|17321993|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
5031367|NCT02925494|17321994|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5031368|NCT02925494|17321995|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5031369|NCT02925494|17321996|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5031370|NCT02925403|17322024|P2|Overall Study|Lost to Follow-up|1
5031371|NCT02925403|17322025|P1|Overall Study|Lost to Follow-up|0
5031372|NCT02925312|17322039|P2|Overall Study|Adverse Event|0
5031373|NCT02925312|17322040|P1|Overall Study|Adverse Event|2
5031374|NCT02925312|17322039|P2|Overall Study|Lost to Follow-up|0
5031375|NCT02925312|17322040|P1|Overall Study|Lost to Follow-up|25
5031376|NCT02925117|17322056|P12|Period 2 (Weeks 16 - 88)|Other|0
5031377|NCT02925117|17322057|P11|Period 2 (Weeks 16 - 88)|Other|3
5031378|NCT02925117|17322058|P10|Period 2 (Weeks 16 - 88)|Other|4
5031379|NCT02925117|17322059|P9|Period 2 (Weeks 16 - 88)|Other|3
5031380|NCT02925117|17322060|P8|Period 2 (Weeks 16 - 88)|Other|1
5031381|NCT02925117|17322061|P7|Period 2 (Weeks 16 - 88)|Other|1
5031382|NCT02925117|17322062|P6|Period 2 (Weeks 16 - 88)|Other|1
5031383|NCT02925117|17322063|P5|Period 2 (Weeks 16 - 88)|Other|1
5031384|NCT02925117|17322064|P4|Period 2 (Weeks 16 - 88)|Other|0
5031385|NCT02925117|17322065|P3|Period 2 (Weeks 16 - 88)|Other|0
5031386|NCT02925117|17322066|P2|Period 2 (Weeks 16 - 88)|Other|0
5031387|NCT02925117|17322067|P1|Period 2 (Weeks 16 - 88)|Other|0
5031388|NCT02925117|17322056|P12|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5031389|NCT02925117|17322057|P11|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5031390|NCT02925117|17322058|P10|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5031391|NCT02925117|17322059|P9|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5031392|NCT02925117|17322060|P8|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5031393|NCT02925117|17322061|P7|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5031394|NCT02925117|17322062|P6|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
5031395|NCT02925117|17322063|P5|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5031396|NCT02925117|17322064|P4|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5031397|NCT02925117|17322065|P3|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5031398|NCT02925117|17322066|P2|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5031399|NCT02925117|17322067|P1|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5031400|NCT02925117|17322056|P12|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5031401|NCT02925117|17322057|P11|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5031402|NCT02925117|17322058|P10|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5031403|NCT02925117|17322059|P9|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5031404|NCT02925117|17322060|P8|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
5031405|NCT02925117|17322061|P7|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
5031406|NCT02925117|17322062|P6|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
5031407|NCT02925117|17322063|P5|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5031408|NCT02925117|17322064|P4|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5031409|NCT02925117|17322065|P3|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5031410|NCT02925117|17322066|P2|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5031411|NCT02925117|17322067|P1|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5031412|NCT02925117|17322056|P12|Period 2 (Weeks 16 - 88)|Adverse Event|2
5031413|NCT02925117|17322057|P11|Period 2 (Weeks 16 - 88)|Adverse Event|3
5031414|NCT02925117|17322058|P10|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031415|NCT02925117|17322059|P9|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031416|NCT02925117|17322060|P8|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031417|NCT02925117|17322061|P7|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031418|NCT02925117|17322062|P6|Period 2 (Weeks 16 - 88)|Adverse Event|1
5031419|NCT02925117|17322063|P5|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031420|NCT02925117|17322064|P4|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031421|NCT02925117|17322065|P3|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031422|NCT02925117|17322066|P2|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031423|NCT02925117|17322067|P1|Period 2 (Weeks 16 - 88)|Adverse Event|0
5031424|NCT02925117|17322056|P12|Period 1 (Weeks 0 - 16)|Other|0
5031425|NCT02925117|17322057|P11|Period 1 (Weeks 0 - 16)|Other|0
5031426|NCT02925117|17322058|P10|Period 1 (Weeks 0 - 16)|Other|0
5031427|NCT02925117|17322059|P9|Period 1 (Weeks 0 - 16)|Other|0
5031428|NCT02925117|17322060|P8|Period 1 (Weeks 0 - 16)|Other|0
5031429|NCT02925117|17322061|P7|Period 1 (Weeks 0 - 16)|Other|0
5031430|NCT02925117|17322062|P6|Period 1 (Weeks 0 - 16)|Other|0
5031431|NCT02925117|17322063|P5|Period 1 (Weeks 0 - 16)|Other|0
5031432|NCT02925117|17322064|P4|Period 1 (Weeks 0 - 16)|Other|1
5031433|NCT02925117|17322065|P3|Period 1 (Weeks 0 - 16)|Other|1
5031434|NCT02925117|17322066|P2|Period 1 (Weeks 0 - 16)|Other|4
5031435|NCT02925117|17322067|P1|Period 1 (Weeks 0 - 16)|Other|5
5031436|NCT02925117|17322056|P12|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031437|NCT02925117|17322057|P11|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031438|NCT02925117|17322058|P10|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031439|NCT02925117|17322059|P9|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031440|NCT02925117|17322060|P8|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031441|NCT02925117|17322061|P7|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031442|NCT02925117|17322062|P6|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031443|NCT02925117|17322063|P5|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031444|NCT02925117|17322064|P4|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031445|NCT02925117|17322065|P3|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5031446|NCT02925117|17322066|P2|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
5031447|NCT02925117|17322067|P1|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
5031448|NCT02925117|17322056|P12|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031449|NCT02925117|17322057|P11|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031450|NCT02925117|17322058|P10|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031451|NCT02925117|17322059|P9|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031452|NCT02925117|17322060|P8|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031453|NCT02925117|17322061|P7|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031454|NCT02925117|17322062|P6|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031455|NCT02925117|17322063|P5|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031456|NCT02925117|17322064|P4|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5031457|NCT02925117|17322065|P3|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
5031458|NCT02925117|17322066|P2|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
5031459|NCT02925117|17322067|P1|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
5031460|NCT02925117|17322056|P12|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031461|NCT02925117|17322057|P11|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031462|NCT02925117|17322058|P10|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031463|NCT02925117|17322059|P9|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031464|NCT02925117|17322060|P8|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031465|NCT02925117|17322061|P7|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031466|NCT02925117|17322062|P6|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031467|NCT02925117|17322063|P5|Period 1 (Weeks 0 - 16)|Adverse Event|0
5031468|NCT02925117|17322064|P4|Period 1 (Weeks 0 - 16)|Adverse Event|2
5031469|NCT02925117|17322065|P3|Period 1 (Weeks 0 - 16)|Adverse Event|1
5031470|NCT02925117|17322066|P2|Period 1 (Weeks 0 - 16)|Adverse Event|3
5031471|NCT02925117|17322067|P1|Period 1 (Weeks 0 - 16)|Adverse Event|1
5031472|NCT02924883|17322178|P2|Overall Study|Ongoing in Study|115
5031473|NCT02924883|17322179|P1|Overall Study|Ongoing in Study|56
5031474|NCT02924883|17322178|P2|Overall Study|Death|13
5031475|NCT02924883|17322179|P1|Overall Study|Death|8
5031476|NCT02924883|17322178|P2|Overall Study|Protocol Violation|1
5031477|NCT02924883|17322179|P1|Overall Study|Protocol Violation|0
5031478|NCT02924883|17322178|P2|Overall Study|Withdrawal by Subject|4
5031479|NCT02924883|17322179|P1|Overall Study|Withdrawal by Subject|5
5031480|NCT02924688|17322204|P6|Overall Study|Withdrawal by Subject|14
5031481|NCT02924688|17322205|P5|Overall Study|Withdrawal by Subject|13
5031482|NCT02924688|17322206|P4|Overall Study|Withdrawal by Subject|12
5031483|NCT02924688|17322207|P3|Overall Study|Withdrawal by Subject|9
5031484|NCT02924688|17322208|P2|Overall Study|Withdrawal by Subject|13
5031485|NCT02924688|17322209|P1|Overall Study|Withdrawal by Subject|14
5031486|NCT02924688|17322204|P6|Overall Study|Physician Decision|1
5031487|NCT02924688|17322205|P5|Overall Study|Physician Decision|1
5031488|NCT02924688|17322206|P4|Overall Study|Physician Decision|1
5031489|NCT02924688|17322207|P3|Overall Study|Physician Decision|0
5031490|NCT02924688|17322208|P2|Overall Study|Physician Decision|1
5031491|NCT02924688|17322209|P1|Overall Study|Physician Decision|2
5031492|NCT02924688|17322204|P6|Overall Study|Lost to Follow-up|4
5031493|NCT02924688|17322205|P5|Overall Study|Lost to Follow-up|2
5031494|NCT02924688|17322206|P4|Overall Study|Lost to Follow-up|4
5031495|NCT02924688|17322207|P3|Overall Study|Lost to Follow-up|2
5031496|NCT02924688|17322208|P2|Overall Study|Lost to Follow-up|4
5031497|NCT02924688|17322209|P1|Overall Study|Lost to Follow-up|2
5031498|NCT02924688|17322204|P6|Overall Study|Protocol defined withdrawal criteria met|0
5031499|NCT02924688|17322205|P5|Overall Study|Protocol defined withdrawal criteria met|1
5031500|NCT02924688|17322206|P4|Overall Study|Protocol defined withdrawal criteria met|1
5031501|NCT02924688|17322207|P3|Overall Study|Protocol defined withdrawal criteria met|1
5031502|NCT02924688|17322208|P2|Overall Study|Protocol defined withdrawal criteria met|0
5031503|NCT02924688|17322209|P1|Overall Study|Protocol defined withdrawal criteria met|1
5031504|NCT02924688|17322204|P6|Overall Study|Protocol Violation|2
5031505|NCT02924688|17322205|P5|Overall Study|Protocol Violation|2
5031506|NCT02924688|17322206|P4|Overall Study|Protocol Violation|6
5031507|NCT02924688|17322207|P3|Overall Study|Protocol Violation|5
5031508|NCT02924688|17322208|P2|Overall Study|Protocol Violation|7
5031509|NCT02924688|17322209|P1|Overall Study|Protocol Violation|3
5031510|NCT02924688|17322204|P6|Overall Study|Lack of Efficacy|1
5031511|NCT02924688|17322205|P5|Overall Study|Lack of Efficacy|1
5031512|NCT02924688|17322206|P4|Overall Study|Lack of Efficacy|2
5031513|NCT02924688|17322207|P3|Overall Study|Lack of Efficacy|4
5031514|NCT02924688|17322208|P2|Overall Study|Lack of Efficacy|3
5031515|NCT02924688|17322209|P1|Overall Study|Lack of Efficacy|2
5031516|NCT02924688|17322204|P6|Overall Study|Adverse Event|2
5031517|NCT02924688|17322205|P5|Overall Study|Adverse Event|3
5031518|NCT02924688|17322206|P4|Overall Study|Adverse Event|2
5031519|NCT02924688|17322207|P3|Overall Study|Adverse Event|2
5031520|NCT02924688|17322208|P2|Overall Study|Adverse Event|3
5031521|NCT02924688|17322209|P1|Overall Study|Adverse Event|9
5031522|NCT02924428|17322279|P2|Overall Study|Pregnancy|1
5031523|NCT02924428|17322280|P1|Overall Study|Pregnancy|0
5031524|NCT02924428|17322279|P2|Overall Study|Lost to Follow-up|4
5031525|NCT02924428|17322280|P1|Overall Study|Lost to Follow-up|2
5031526|NCT02924428|17322279|P2|Overall Study|Physician Decision|0
5031527|NCT02924428|17322280|P1|Overall Study|Physician Decision|1
5031528|NCT02924428|17322279|P2|Overall Study|Adverse Event|0
5031529|NCT02924428|17322280|P1|Overall Study|Adverse Event|1
5031530|NCT02924051|17322315|P2|Overall Study|Withdrawal by Subject|9
5031531|NCT02924051|17322316|P1|Overall Study|Withdrawal by Subject|1
5031532|NCT02923921|17322328|P2|Overall Study|Unknown, Not Collected|6
5031533|NCT02923921|17322329|P1|Overall Study|Unknown, Not Collected|7
5031534|NCT02923921|17322328|P2|Overall Study|Withdrawal by Subject|13
5031535|NCT02923921|17322329|P1|Overall Study|Withdrawal by Subject|6
5031536|NCT02923921|17322328|P2|Overall Study|Lost to Follow-up|0
5031537|NCT02923921|17322329|P1|Overall Study|Lost to Follow-up|1
5031538|NCT02923921|17322328|P2|Overall Study|Sponsor Decision|38
5031539|NCT02923921|17322329|P1|Overall Study|Sponsor Decision|39
5031540|NCT02923830|17322362|P2|Overall Study|Physician Decision|15
5031541|NCT02923830|17322363|P1|Overall Study|Physician Decision|13
5031542|NCT02923427|17322383|P2|Overall Study|can not replace LMA|0
5031543|NCT02923427|17322384|P1|Overall Study|can not replace LMA|1
5031544|NCT02923427|17322383|P2|Overall Study|destaturation|0
5031545|NCT02923427|17322384|P1|Overall Study|destaturation|1
5031546|NCT02923427|17322383|P2|Overall Study|convert to laparatomy|2
5031547|NCT02923427|17322384|P1|Overall Study|convert to laparatomy|2
5031548|NCT02923349|17322411|P7|Overall Study|Death|0
5031549|NCT02923349|17322412|P6|Overall Study|Death|3
5031550|NCT02923349|17322413|P5|Overall Study|Death|2
5031551|NCT02923349|17322414|P4|Overall Study|Death|4
5031552|NCT02923349|17322415|P3|Overall Study|Death|2
5031553|NCT02923349|17322416|P2|Overall Study|Death|0
5031554|NCT02923349|17322417|P1|Overall Study|Death|1
5031555|NCT02923349|17322411|P7|Overall Study|Lost to Follow-up|0
5031556|NCT02923349|17322412|P6|Overall Study|Lost to Follow-up|1
5031557|NCT02923349|17322413|P5|Overall Study|Lost to Follow-up|1
5031558|NCT02923349|17322414|P4|Overall Study|Lost to Follow-up|0
5031559|NCT02923349|17322415|P3|Overall Study|Lost to Follow-up|3
5031560|NCT02923349|17322416|P2|Overall Study|Lost to Follow-up|0
5031561|NCT02923349|17322417|P1|Overall Study|Lost to Follow-up|0
5031562|NCT02923349|17322411|P7|Overall Study|Physician Decision|2
5031563|NCT02923349|17322412|P6|Overall Study|Physician Decision|0
5031564|NCT02923349|17322413|P5|Overall Study|Physician Decision|1
5031565|NCT02923349|17322414|P4|Overall Study|Physician Decision|1
5031566|NCT02923349|17322415|P3|Overall Study|Physician Decision|0
5031567|NCT02923349|17322416|P2|Overall Study|Physician Decision|0
5031568|NCT02923349|17322417|P1|Overall Study|Physician Decision|0
5031569|NCT02923349|17322411|P7|Overall Study|Withdrawal by Subject|0
5031570|NCT02923349|17322412|P6|Overall Study|Withdrawal by Subject|3
5031571|NCT02923349|17322413|P5|Overall Study|Withdrawal by Subject|12
5031572|NCT02923349|17322414|P4|Overall Study|Withdrawal by Subject|10
5031573|NCT02923349|17322415|P3|Overall Study|Withdrawal by Subject|8
5031574|NCT02923349|17322416|P2|Overall Study|Withdrawal by Subject|2
5031575|NCT02923349|17322417|P1|Overall Study|Withdrawal by Subject|2
5031576|NCT02923349|17322411|P7|Overall Study|Other|1
5031577|NCT02923349|17322412|P6|Overall Study|Other|0
5031578|NCT02923349|17322413|P5|Overall Study|Other|3
5031579|NCT02923349|17322414|P4|Overall Study|Other|1
5031580|NCT02923349|17322415|P3|Overall Study|Other|4
5031581|NCT02923349|17322416|P2|Overall Study|Other|2
5031582|NCT02923349|17322417|P1|Overall Study|Other|1
5031583|NCT02923245|17322502|P2|Overall Study|ultrasound order was cancelled|1
5031584|NCT02923245|17322503|P1|Overall Study|ultrasound order was cancelled|2
5031585|NCT02923115|17322526|P6|Overall Study|Randomized, but not dosed|0
5031586|NCT02923115|17322527|P5|Overall Study|Randomized, but not dosed|5
5031587|NCT02923115|17322528|P4|Overall Study|Randomized, but not dosed|1
5031588|NCT02923115|17322529|P3|Overall Study|Randomized, but not dosed|3
5031589|NCT02923115|17322530|P2|Overall Study|Randomized, but not dosed|0
5031590|NCT02923115|17322531|P1|Overall Study|Randomized, but not dosed|0
5031591|NCT02923115|17322526|P6|Overall Study|Withdrawal by Subject|0
5031592|NCT02923115|17322527|P5|Overall Study|Withdrawal by Subject|0
5031593|NCT02923115|17322528|P4|Overall Study|Withdrawal by Subject|0
5031594|NCT02923115|17322529|P3|Overall Study|Withdrawal by Subject|0
5031595|NCT02923115|17322530|P2|Overall Study|Withdrawal by Subject|1
5031596|NCT02923115|17322531|P1|Overall Study|Withdrawal by Subject|0
5031597|NCT02923115|17322526|P6|Overall Study|Lost to Follow-up|0
5031598|NCT02923115|17322527|P5|Overall Study|Lost to Follow-up|0
5031599|NCT02923115|17322528|P4|Overall Study|Lost to Follow-up|1
5031600|NCT02923115|17322529|P3|Overall Study|Lost to Follow-up|0
5031601|NCT02923115|17322530|P2|Overall Study|Lost to Follow-up|0
5031602|NCT02923115|17322531|P1|Overall Study|Lost to Follow-up|0
5031603|NCT02922153|17322648|P2|Overall Study|Physician Decision|1
5031604|NCT02922153|17322649|P1|Overall Study|Physician Decision|1
5031605|NCT02922153|17322648|P2|Overall Study|Lost to Follow-up|0
5031606|NCT02922153|17322649|P1|Overall Study|Lost to Follow-up|1
5031607|NCT02922153|17322648|P2|Overall Study|Death|1
5031608|NCT02922153|17322649|P1|Overall Study|Death|8
5031609|NCT02921750|17322708|P2|Overall Study|Serious Adverse Event|2
5031610|NCT02921750|17322709|P1|Overall Study|Serious Adverse Event|1
5031611|NCT02921750|17322708|P2|Overall Study|Wound healed|3
5031612|NCT02921750|17322709|P1|Overall Study|Wound healed|3
5031613|NCT02921750|17322708|P2|Overall Study|Lost to Follow-up|3
5031614|NCT02921750|17322709|P1|Overall Study|Lost to Follow-up|3
5031615|NCT02921750|17322708|P2|Overall Study|Withdrawal by Subject|1
5031616|NCT02921750|17322709|P1|Overall Study|Withdrawal by Subject|1
5031617|NCT02921750|17322708|P2|Overall Study|Adverse Event|2
5031618|NCT02921750|17322709|P1|Overall Study|Adverse Event|1
5031619|NCT02921425|17322740|P1|Overall Study|Protocol Violation|9
5031620|NCT02921087|17322812|P2|Overall Study|Withdrawal by Subject|1
5031621|NCT02921087|17322813|P1|Overall Study|Withdrawal by Subject|0
5031622|NCT02920983|17322842|P6|Dispense 3|Unacceptable Lens Fit|0
5031623|NCT02920983|17322843|P5|Dispense 3|Unacceptable Lens Fit|1
5031624|NCT02920983|17322844|P4|Dispense 3|Unacceptable Lens Fit|0
5031625|NCT02920983|17322845|P3|Dispense 3|Unacceptable Lens Fit|0
5031626|NCT02920983|17322846|P2|Dispense 3|Unacceptable Lens Fit|1
5031627|NCT02920983|17322847|P1|Dispense 3|Unacceptable Lens Fit|1
5031628|NCT02920983|17322842|P6|Dispense 2|Unscceptable lens fit|0
5031629|NCT02920983|17322843|P5|Dispense 2|Unscceptable lens fit|1
5031630|NCT02920983|17322844|P4|Dispense 2|Unscceptable lens fit|0
5031631|NCT02920983|17322845|P3|Dispense 2|Unscceptable lens fit|0
5031632|NCT02920983|17322846|P2|Dispense 2|Unscceptable lens fit|0
5031633|NCT02920983|17322847|P1|Dispense 2|Unscceptable lens fit|1
5031634|NCT02920983|17322842|P6|Dispense 1|Unacceptable Lens Fit|0
5031635|NCT02920983|17322843|P5|Dispense 1|Unacceptable Lens Fit|1
5031636|NCT02920983|17322844|P4|Dispense 1|Unacceptable Lens Fit|0
5031637|NCT02920983|17322845|P3|Dispense 1|Unacceptable Lens Fit|0
5031638|NCT02920983|17322846|P2|Dispense 1|Unacceptable Lens Fit|0
5031639|NCT02920983|17322847|P1|Dispense 1|Unacceptable Lens Fit|0
5031640|NCT02920970|17322876|P2|Second Intervention|Poor Lens Fit|0
5031641|NCT02920970|17322877|P1|Second Intervention|Poor Lens Fit|1
5031642|NCT02920970|17322876|P2|First Intervention|Adverse Event|1
5031643|NCT02920970|17322877|P1|First Intervention|Adverse Event|0
5031644|NCT02920970|17322876|P2|First Intervention|Protocol Violation|1
5031645|NCT02920970|17322877|P1|First Intervention|Protocol Violation|0
5031646|NCT02920957|17322903|P2|Second Intervention: 1 Month|Lost to Follow-up|1
5031647|NCT02920957|17322904|P1|Second Intervention: 1 Month|Lost to Follow-up|0
5031648|NCT02920957|17322903|P2|First Intervention : 1 Month|Adverse Event|0
5031649|NCT02920957|17322904|P1|First Intervention : 1 Month|Adverse Event|1
5031650|NCT02920957|17322903|P2|First Intervention : 1 Month|Lost to Follow-up|0
5031651|NCT02920957|17322904|P1|First Intervention : 1 Month|Lost to Follow-up|1
5031652|NCT02920957|17322903|P2|First Intervention : 1 Month|Withdrawal by Subject|0
5031653|NCT02920957|17322904|P1|First Intervention : 1 Month|Withdrawal by Subject|2
5031654|NCT02920450|17322993|P4|Overall Study|Withdrawal by Subject|0
5031655|NCT02920450|17322994|P3|Overall Study|Withdrawal by Subject|0
5031656|NCT02920450|17322995|P2|Overall Study|Withdrawal by Subject|0
5031657|NCT02920450|17322996|P1|Overall Study|Withdrawal by Subject|1
5031658|NCT02920450|17322993|P4|Overall Study|Death|0
5031659|NCT02920450|17322994|P3|Overall Study|Death|0
5031660|NCT02920450|17322995|P2|Overall Study|Death|0
5031661|NCT02920450|17322996|P1|Overall Study|Death|1
5031662|NCT02920242|17323007|P3|Overall Study|Did not meet inc./exc. criteria|0
5031663|NCT02920242|17323008|P2|Overall Study|Did not meet inc./exc. criteria|0
5031664|NCT02920242|17323009|P1|Overall Study|Did not meet inc./exc. criteria|1
5031665|NCT02920242|17323007|P3|Overall Study|Withdrawal by Subject|1
5031666|NCT02920242|17323008|P2|Overall Study|Withdrawal by Subject|0
5031667|NCT02920242|17323009|P1|Overall Study|Withdrawal by Subject|1
5031668|NCT02920177|17323037|P2|Overall Study|Lost to Follow-up|1
5031669|NCT02920177|17323038|P1|Overall Study|Lost to Follow-up|0
5031670|NCT02920177|17323037|P2|Overall Study|Physician Decision|0
5031671|NCT02920177|17323038|P1|Overall Study|Physician Decision|1
5031672|NCT02920177|17323037|P2|Overall Study|Withdrawal by Subject|1
5031673|NCT02920177|17323038|P1|Overall Study|Withdrawal by Subject|1
5031674|NCT02919995|17323058|P6|Overall Study|Adverse Event|1
5031675|NCT02919995|17323059|P5|Overall Study|Adverse Event|0
5031676|NCT02919995|17323060|P4|Overall Study|Adverse Event|0
5031677|NCT02919995|17323061|P3|Overall Study|Adverse Event|0
5031678|NCT02919995|17323062|P2|Overall Study|Adverse Event|0
5031679|NCT02919995|17323063|P1|Overall Study|Adverse Event|0
5031680|NCT02919761|17323126|P3|Part 2: Double-blind|Discontinued exclusion 16|2
5031681|NCT02919761|17323127|P2|Part 2: Double-blind|Discontinued exclusion 16|0
5031682|NCT02919761|17323128|P1|Part 2: Double-blind|Discontinued exclusion 16|0
5031683|NCT02919761|17323126|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
5031684|NCT02919761|17323127|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
5031685|NCT02919761|17323128|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
5031686|NCT02919761|17323126|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
5031687|NCT02919761|17323127|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
5031688|NCT02919761|17323128|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
5031689|NCT02919761|17323126|P3|Part 2: Double-blind|Worsening of disease activity|10
5031690|NCT02919761|17323127|P2|Part 2: Double-blind|Worsening of disease activity|4
5031691|NCT02919761|17323128|P1|Part 2: Double-blind|Worsening of disease activity|0
5031692|NCT02919761|17323126|P3|Part 2: Double-blind|Met withdrawal criteria|2
5031693|NCT02919761|17323127|P2|Part 2: Double-blind|Met withdrawal criteria|1
5031694|NCT02919761|17323128|P1|Part 2: Double-blind|Met withdrawal criteria|0
5031695|NCT02919761|17323126|P3|Part 2: Double-blind|Lost to Follow-up|3
5031696|NCT02919761|17323127|P2|Part 2: Double-blind|Lost to Follow-up|0
5031697|NCT02919761|17323128|P1|Part 2: Double-blind|Lost to Follow-up|0
5031698|NCT02919761|17323126|P3|Part 2: Double-blind|Adverse Event|0
5031699|NCT02919761|17323127|P2|Part 2: Double-blind|Adverse Event|1
5031700|NCT02919761|17323128|P1|Part 2: Double-blind|Adverse Event|0
5031701|NCT02919761|17323126|P3|Part 2: Double-blind|Withdrawal by Subject|2
5031702|NCT02919761|17323127|P2|Part 2: Double-blind|Withdrawal by Subject|0
5031703|NCT02919761|17323128|P1|Part 2: Double-blind|Withdrawal by Subject|0
5031704|NCT02919761|17323126|P3|Part 1: Open Label|Termination by Sponsor|0
5031705|NCT02919761|17323127|P2|Part 1: Open Label|Termination by Sponsor|0
5031706|NCT02919761|17323128|P1|Part 1: Open Label|Termination by Sponsor|1
5031707|NCT02919761|17323126|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
5031708|NCT02919761|17323127|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
5031709|NCT02919761|17323128|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
5031710|NCT02919761|17323126|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
5031711|NCT02919761|17323127|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
5031712|NCT02919761|17323128|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
5031713|NCT02919761|17323126|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
5031714|NCT02919761|17323127|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
5031715|NCT02919761|17323128|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
5031716|NCT02919761|17323126|P3|Part 1: Open Label|Met withdrawal criteria|0
5031717|NCT02919761|17323127|P2|Part 1: Open Label|Met withdrawal criteria|0
5031718|NCT02919761|17323128|P1|Part 1: Open Label|Met withdrawal criteria|5
5031719|NCT02919761|17323126|P3|Part 1: Open Label|Lost to Follow-up|0
5031720|NCT02919761|17323127|P2|Part 1: Open Label|Lost to Follow-up|0
5031721|NCT02919761|17323128|P1|Part 1: Open Label|Lost to Follow-up|1
5031722|NCT02919761|17323126|P3|Part 1: Open Label|Adverse Event|0
5031723|NCT02919761|17323127|P2|Part 1: Open Label|Adverse Event|0
5031724|NCT02919761|17323128|P1|Part 1: Open Label|Adverse Event|1
5031725|NCT02919761|17323126|P3|Part 1: Open Label|Withdrawal by Subject|0
5031726|NCT02919761|17323127|P2|Part 1: Open Label|Withdrawal by Subject|0
5031727|NCT02919761|17323128|P1|Part 1: Open Label|Withdrawal by Subject|12
5031728|NCT02919696|17323156|P2|Overall Study|Never Treated|1
5031729|NCT02919696|17323157|P1|Overall Study|Never Treated|0
5031730|NCT02919696|17323156|P2|Overall Study|Sponsor Decision|1
5031731|NCT02919696|17323157|P1|Overall Study|Sponsor Decision|1
5031732|NCT02919696|17323156|P2|Overall Study|Withdrawal by Subject|1
5031733|NCT02919696|17323157|P1|Overall Study|Withdrawal by Subject|2
5031734|NCT02919696|17323156|P2|Overall Study|Adverse Event|2
5031735|NCT02919696|17323157|P1|Overall Study|Adverse Event|1
5031736|NCT02919683|17323179|P2|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
5031737|NCT02919683|17323180|P1|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
5031738|NCT02919683|17323179|P2|Post-Surgery Follow-Up|Death|2
5031739|NCT02919683|17323180|P1|Post-Surgery Follow-Up|Death|2
5031740|NCT02919618|17323193|P1|Overall Study|Death|1
5031741|NCT02919267|17323223|P4|Overall Study|Protocol Violation|4
5031742|NCT02919267|17323224|P3|Overall Study|Protocol Violation|3
5031743|NCT02919267|17323225|P2|Overall Study|Protocol Violation|3
5031744|NCT02919267|17323226|P1|Overall Study|Protocol Violation|0
5031745|NCT02918552|17323366|P2|Overall Study|Lost to Follow-up|1
5031746|NCT02918552|17323367|P1|Overall Study|Lost to Follow-up|0
5031747|NCT02918552|17323366|P2|Overall Study|Withdrawal by Subject|1
5031748|NCT02918552|17323367|P1|Overall Study|Withdrawal by Subject|0
5031749|NCT02918552|17323366|P2|Overall Study|Failed Pharmacokinetics|0
5031750|NCT02918552|17323367|P1|Overall Study|Failed Pharmacokinetics|1
5031751|NCT02918318|17323443|P5|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
5031752|NCT02918318|17323444|P4|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5031753|NCT02918318|17323445|P3|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5031754|NCT02918318|17323446|P2|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5031755|NCT02918318|17323447|P1|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5031756|NCT02918318|17323443|P5|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
5031757|NCT02918318|17323444|P4|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5031758|NCT02918318|17323445|P3|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5031759|NCT02918318|17323446|P2|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5031760|NCT02918318|17323447|P1|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5031761|NCT02918318|17323443|P5|Posttreatment Phase: Up to 24 Weeks|Other|0
5031762|NCT02918318|17323444|P4|Posttreatment Phase: Up to 24 Weeks|Other|1
5031763|NCT02918318|17323445|P3|Posttreatment Phase: Up to 24 Weeks|Other|1
5031764|NCT02918318|17323446|P2|Posttreatment Phase: Up to 24 Weeks|Other|3
5031765|NCT02918318|17323447|P1|Posttreatment Phase: Up to 24 Weeks|Other|0
5031766|NCT02918318|17323443|P5|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5031767|NCT02918318|17323444|P4|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
5031768|NCT02918318|17323445|P3|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5031769|NCT02918318|17323446|P2|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5031770|NCT02918318|17323447|P1|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
5031771|NCT02918318|17323443|P5|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
5031772|NCT02918318|17323444|P4|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5031773|NCT02918318|17323445|P3|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5031774|NCT02918318|17323446|P2|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
5031775|NCT02918318|17323447|P1|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5031776|NCT02918318|17323443|P5|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5031777|NCT02918318|17323444|P4|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
5031778|NCT02918318|17323445|P3|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5031779|NCT02918318|17323446|P2|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5031780|NCT02918318|17323447|P1|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5031781|NCT02918318|17323443|P5|Double-blind Induction Phase: 4 Weeks|Other|0
5031782|NCT02918318|17323444|P4|Double-blind Induction Phase: 4 Weeks|Other|1
5031783|NCT02918318|17323445|P3|Double-blind Induction Phase: 4 Weeks|Other|0
5031784|NCT02918318|17323446|P2|Double-blind Induction Phase: 4 Weeks|Other|2
5031785|NCT02918318|17323447|P1|Double-blind Induction Phase: 4 Weeks|Other|0
5031786|NCT02918318|17323443|P5|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5031787|NCT02918318|17323444|P4|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
5031788|NCT02918318|17323445|P3|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5031789|NCT02918318|17323446|P2|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5031790|NCT02918318|17323447|P1|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5031791|NCT02918318|17323443|P5|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5031792|NCT02918318|17323444|P4|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5031793|NCT02918318|17323445|P3|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5031794|NCT02918318|17323446|P2|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
5031795|NCT02918318|17323447|P1|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
5031796|NCT02918318|17323443|P5|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5031797|NCT02918318|17323444|P4|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
5031798|NCT02918318|17323445|P3|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5031799|NCT02918318|17323446|P2|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5031800|NCT02918318|17323447|P1|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5031801|NCT02918318|17323443|P5|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5031802|NCT02918318|17323444|P4|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
5031803|NCT02918318|17323445|P3|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5031804|NCT02918318|17323446|P2|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5031805|NCT02918318|17323447|P1|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5031806|NCT02918318|17323443|P5|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
5031807|NCT02918318|17323444|P4|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
5031808|NCT02918318|17323445|P3|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
5031809|NCT02918318|17323446|P2|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
5031810|NCT02918318|17323447|P1|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
5031811|NCT02918279|17323508|P2|Overall Study|Other|1
5031812|NCT02918279|17323509|P1|Overall Study|Other|3
5031813|NCT02918279|17323508|P2|Overall Study|Withdrawal by parent/guardian|1
5031814|NCT02918279|17323509|P1|Overall Study|Withdrawal by parent/guardian|2
5031815|NCT02918279|17323508|P2|Overall Study|Withdrawal by Subject|15
5031816|NCT02918279|17323509|P1|Overall Study|Withdrawal by Subject|5
5031817|NCT02918279|17323508|P2|Overall Study|Lost to Follow-up|6
5031818|NCT02918279|17323509|P1|Overall Study|Lost to Follow-up|3
5031819|NCT02918266|17323645|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031820|NCT02918266|17323646|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031821|NCT02918266|17323647|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
5031822|NCT02918266|17323648|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031823|NCT02918266|17323649|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
5031824|NCT02918266|17323650|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031825|NCT02918266|17323651|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031826|NCT02918266|17323652|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031827|NCT02918266|17323653|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031828|NCT02918266|17323654|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5031829|NCT02918266|17323655|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
5031830|NCT02918071|17323760|P1|Overall Study|Lost to Follow-up|1
5031831|NCT02918071|17323760|P1|Overall Study|Withdrawal by Subject|2
5031832|NCT02917941|17323770|P1|Survival Follow-up Period|Withdrawal by Subject|4
5031833|NCT02917941|17323770|P1|Survival Follow-up Period|Lost to Follow-up|1
5031834|NCT02917941|17323770|P1|Treatment Period|Reason not Specified|2
5031835|NCT02917941|17323770|P1|Treatment Period|Progressive Disease|11
5031836|NCT02917941|17323770|P1|Treatment Period|Adverse Event|11
5031837|NCT02917265|17323823|P2|Overall Study|Withdrawal by Subject|0
5031838|NCT02917265|17323824|P1|Overall Study|Withdrawal by Subject|1
5031839|NCT02917265|17323823|P2|Overall Study|Physician Decision|0
5031840|NCT02917265|17323824|P1|Overall Study|Physician Decision|1
5031841|NCT02916927|17323840|P2|Overall Study|Withdrawal before first time point|0
5031842|NCT02916927|17323841|P1|Overall Study|Withdrawal before first time point|1
5031843|NCT02916927|17323840|P2|Overall Study|At radiology for 45 & 60 min time points|1
5031844|NCT02916927|17323841|P1|Overall Study|At radiology for 45 & 60 min time points|0
5031845|NCT02916927|17323840|P2|Overall Study|Discharged prior to study drug receipt|2
5031846|NCT02916927|17323841|P1|Overall Study|Discharged prior to study drug receipt|0
5031847|NCT02916433|17323900|P2|Overall Study|Physician Decision|0
5031848|NCT02916433|17323901|P1|Overall Study|Physician Decision|1
5031849|NCT02916433|17323900|P2|Overall Study|Withdrawal by Subject|0
5031850|NCT02916433|17323901|P1|Overall Study|Withdrawal by Subject|1
5031851|NCT02915978|17323924|P3|Overall Study|Adverse Event|0
5031852|NCT02915978|17323925|P2|Overall Study|Adverse Event|1
5031853|NCT02915978|17323926|P1|Overall Study|Adverse Event|2
5031854|NCT02915874|17323978|P2|Overall Study|Started New Anxiety Medication|1
5031855|NCT02915874|17323979|P1|Overall Study|Started New Anxiety Medication|0
5031856|NCT02915874|17323978|P2|Overall Study|Withdrawal by Subject|1
5031857|NCT02915874|17323979|P1|Overall Study|Withdrawal by Subject|1
5031858|NCT02915874|17323978|P2|Overall Study|Lost to Follow-up|4
5031859|NCT02915874|17323979|P1|Overall Study|Lost to Follow-up|5
5031860|NCT02915835|17323999|P2|Overall Study|Withdrawal by Subject|1
5031861|NCT02915835|17324000|P1|Overall Study|Withdrawal by Subject|0
5031862|NCT02915835|17323999|P2|Overall Study|Physician Decision|0
5031863|NCT02915835|17324000|P1|Overall Study|Physician Decision|1
5031864|NCT02915783|17324124|P1|Overall Study|Ongoing: In Survival Follow Up|8
5031865|NCT02915783|17324124|P1|Overall Study|Ongoing: Receiving Treatment|6
5031866|NCT02915302|17324206|P2|Overall Study|Other|0
5031867|NCT02915302|17324207|P1|Overall Study|Other|1
5031868|NCT02915302|17324206|P2|Overall Study|Withdrawal by Subject|29
5031869|NCT02915302|17324207|P1|Overall Study|Withdrawal by Subject|22
5031870|NCT02915302|17324206|P2|Overall Study|Lost to Follow-up|22
5031871|NCT02915302|17324207|P1|Overall Study|Lost to Follow-up|19
5031872|NCT02915302|17324206|P2|Overall Study|Protocol Violation|27
5031873|NCT02915302|17324207|P1|Overall Study|Protocol Violation|20
5031874|NCT02915302|17324206|P2|Overall Study|Adverse Event|0
5031875|NCT02915302|17324207|P1|Overall Study|Adverse Event|3
5031876|NCT02915159|17324219|P2|Overall Study|Lack of Efficacy|3
5031877|NCT02915159|17324220|P1|Overall Study|Lack of Efficacy|0
5031878|NCT02915159|17324219|P2|Overall Study|Adverse Event|2
5031879|NCT02915159|17324220|P1|Overall Study|Adverse Event|2
5031880|NCT02915159|17324219|P2|Overall Study|Request to discontinue treatment|2
5031881|NCT02915159|17324220|P1|Overall Study|Request to discontinue treatment|1
5031882|NCT02915159|17324219|P2|Overall Study|Participant withdrew consent|1
5031883|NCT02915159|17324220|P1|Overall Study|Participant withdrew consent|5
5031884|NCT02915159|17324219|P2|Overall Study|poor/non-compliance|0
5031885|NCT02915159|17324220|P1|Overall Study|poor/non-compliance|1
5031886|NCT02915159|17324219|P2|Overall Study|Participant no longer meets criteria|0
5031887|NCT02915159|17324220|P1|Overall Study|Participant no longer meets criteria|2
5031888|NCT02915016|17324359|P8|Overall Study|Participant unable to adhere|1
5031889|NCT02915016|17324360|P7|Overall Study|Participant unable to adhere|0
5031890|NCT02915016|17324361|P6|Overall Study|Participant unable to adhere|0
5031891|NCT02915016|17324362|P5|Overall Study|Participant unable to adhere|0
5031892|NCT02915016|17324363|P4|Overall Study|Participant unable to adhere|0
5031893|NCT02915016|17324364|P3|Overall Study|Participant unable to adhere|0
5031894|NCT02915016|17324365|P2|Overall Study|Participant unable to adhere|0
5031895|NCT02915016|17324366|P1|Overall Study|Participant unable to adhere|0
5031896|NCT02915016|17324359|P8|Overall Study|HIV infection|0
5031897|NCT02915016|17324360|P7|Overall Study|HIV infection|0
5031898|NCT02915016|17324361|P6|Overall Study|HIV infection|0
5031899|NCT02915016|17324362|P5|Overall Study|HIV infection|1
5031900|NCT02915016|17324363|P4|Overall Study|HIV infection|0
5031901|NCT02915016|17324364|P3|Overall Study|HIV infection|1
5031902|NCT02915016|17324365|P2|Overall Study|HIV infection|1
5031903|NCT02915016|17324366|P1|Overall Study|HIV infection|1
5031904|NCT02915016|17324359|P8|Overall Study|Elected not to continue|0
5031905|NCT02915016|17324360|P7|Overall Study|Elected not to continue|1
5031906|NCT02915016|17324361|P6|Overall Study|Elected not to continue|0
5031907|NCT02915016|17324362|P5|Overall Study|Elected not to continue|0
5031908|NCT02915016|17324363|P4|Overall Study|Elected not to continue|1
5031909|NCT02915016|17324364|P3|Overall Study|Elected not to continue|0
5031910|NCT02915016|17324365|P2|Overall Study|Elected not to continue|0
5031911|NCT02915016|17324366|P1|Overall Study|Elected not to continue|0
5031912|NCT02915016|17324359|P8|Overall Study|Withdrawal by Subject|1
5031913|NCT02915016|17324360|P7|Overall Study|Withdrawal by Subject|1
5031914|NCT02915016|17324361|P6|Overall Study|Withdrawal by Subject|3
5031915|NCT02915016|17324362|P5|Overall Study|Withdrawal by Subject|1
5031916|NCT02915016|17324363|P4|Overall Study|Withdrawal by Subject|0
5031917|NCT02915016|17324364|P3|Overall Study|Withdrawal by Subject|1
5031918|NCT02915016|17324365|P2|Overall Study|Withdrawal by Subject|0
5031919|NCT02915016|17324366|P1|Overall Study|Withdrawal by Subject|2
5031920|NCT02915016|17324359|P8|Overall Study|Physician Decision|0
5031921|NCT02915016|17324360|P7|Overall Study|Physician Decision|2
5031922|NCT02915016|17324361|P6|Overall Study|Physician Decision|1
5031923|NCT02915016|17324362|P5|Overall Study|Physician Decision|0
5031924|NCT02915016|17324363|P4|Overall Study|Physician Decision|0
5031925|NCT02915016|17324364|P3|Overall Study|Physician Decision|1
5031926|NCT02915016|17324365|P2|Overall Study|Physician Decision|0
5031927|NCT02915016|17324366|P1|Overall Study|Physician Decision|0
5031928|NCT02915016|17324359|P8|Overall Study|Lost to Follow-up|2
5031929|NCT02915016|17324360|P7|Overall Study|Lost to Follow-up|8
5031930|NCT02915016|17324361|P6|Overall Study|Lost to Follow-up|2
5031931|NCT02915016|17324362|P5|Overall Study|Lost to Follow-up|5
5031932|NCT02915016|17324363|P4|Overall Study|Lost to Follow-up|3
5031933|NCT02915016|17324364|P3|Overall Study|Lost to Follow-up|5
5031934|NCT02915016|17324365|P2|Overall Study|Lost to Follow-up|2
5031935|NCT02915016|17324366|P1|Overall Study|Lost to Follow-up|4
5031936|NCT02914548|17324579|P3|Overall Study|>40% of body surface area|1
5031937|NCT02914548|17324580|P2|Overall Study|>40% of body surface area|1
5031938|NCT02914548|17324581|P1|Overall Study|>40% of body surface area|0
5031939|NCT02914548|17324579|P3|Overall Study|Withdrawal by Subject|4
5031940|NCT02914548|17324580|P2|Overall Study|Withdrawal by Subject|4
5031941|NCT02914548|17324581|P1|Overall Study|Withdrawal by Subject|3
5031942|NCT02914548|17324579|P3|Overall Study|Protocol Violation|0
5031943|NCT02914548|17324580|P2|Overall Study|Protocol Violation|0
5031944|NCT02914548|17324581|P1|Overall Study|Protocol Violation|1
5031945|NCT02914548|17324579|P3|Overall Study|Physician Decision|0
5031946|NCT02914548|17324580|P2|Overall Study|Physician Decision|2
5031947|NCT02914548|17324581|P1|Overall Study|Physician Decision|2
5031948|NCT02914548|17324579|P3|Overall Study|Adverse Event|15
5031949|NCT02914548|17324580|P2|Overall Study|Adverse Event|7
5031950|NCT02914548|17324581|P1|Overall Study|Adverse Event|15
5031951|NCT02914457|17324612|P1|Overall Study|Protocol Violation|1
5031952|NCT02914457|17324612|P1|Overall Study|ECG acquisition error due to sweating|1
5031953|NCT02914457|17324612|P1|Overall Study|Electrical instability of patient|1
5031954|NCT02914457|17324612|P1|Overall Study|No veins available for lead placement|1
5031955|NCT02914457|17324612|P1|Overall Study|Physician Decision|1
5031956|NCT02914457|17324612|P1|Overall Study|Withdrawal by Subject|1
5031957|NCT02914275|17324622|P2|Overall Study|Excluded due to invalid informed consent|0
5031958|NCT02914275|17324623|P1|Overall Study|Excluded due to invalid informed consent|3
5031959|NCT02914275|17324622|P2|Overall Study|Other|1
5031960|NCT02914275|17324623|P1|Overall Study|Other|4
5031961|NCT02914275|17324622|P2|Overall Study|Physician Decision|1
5031962|NCT02914275|17324623|P1|Overall Study|Physician Decision|3
5031963|NCT02914275|17324622|P2|Overall Study|Protocol Violation|1
5031964|NCT02914275|17324623|P1|Overall Study|Protocol Violation|1
5031965|NCT02914275|17324622|P2|Overall Study|Withdrawal by Subject|10
5031966|NCT02914275|17324623|P1|Overall Study|Withdrawal by Subject|26
5031967|NCT02914275|17324622|P2|Overall Study|Lost to Follow-up|29
5031968|NCT02914275|17324623|P1|Overall Study|Lost to Follow-up|84
5031969|NCT02914236|17324655|P1|Overall Study|Lost to Follow-up|1
5031970|NCT02914184|17324701|P4|Overall Study|Migrated/moved from the study area|1
5031971|NCT02914184|17324702|P3|Overall Study|Migrated/moved from the study area|2
5031972|NCT02914184|17324703|P2|Overall Study|Migrated/moved from the study area|1
5031973|NCT02914184|17324704|P1|Overall Study|Migrated/moved from the study area|2
5031974|NCT02914184|17324701|P4|Overall Study|Other|0
5031975|NCT02914184|17324702|P3|Overall Study|Other|0
5031976|NCT02914184|17324703|P2|Overall Study|Other|0
5031977|NCT02914184|17324704|P1|Overall Study|Other|1
5031978|NCT02914184|17324701|P4|Overall Study|Withdrawal by Subject|3
5031979|NCT02914184|17324702|P3|Overall Study|Withdrawal by Subject|7
5031980|NCT02914184|17324703|P2|Overall Study|Withdrawal by Subject|2
5031981|NCT02914184|17324704|P1|Overall Study|Withdrawal by Subject|4
5031982|NCT02914184|17324701|P4|Overall Study|Lost to Follow-up|7
5031983|NCT02914184|17324702|P3|Overall Study|Lost to Follow-up|8
5031984|NCT02914184|17324703|P2|Overall Study|Lost to Follow-up|10
5031985|NCT02914184|17324704|P1|Overall Study|Lost to Follow-up|7
5031986|NCT02913326|17324761|P2|Overall Study|Adverse Event|0
5031987|NCT02913326|17324762|P1|Overall Study|Adverse Event|1
5031988|NCT02913326|17324761|P2|Overall Study|Lost to Follow-up|1
5031989|NCT02913326|17324762|P1|Overall Study|Lost to Follow-up|0
5031990|NCT02913326|17324761|P2|Overall Study|Reason not listed|1
5031991|NCT02913326|17324762|P1|Overall Study|Reason not listed|0
5031992|NCT02913105|17324798|P3|Overall Study|Withdrawal by Subject|1
5031993|NCT02913105|17324799|P2|Overall Study|Withdrawal by Subject|3
5031994|NCT02913105|17324800|P1|Overall Study|Withdrawal by Subject|0
5031995|NCT02913105|17324798|P3|Overall Study|Physician Decision|0
5031996|NCT02913105|17324799|P2|Overall Study|Physician Decision|1
5031997|NCT02913105|17324800|P1|Overall Study|Physician Decision|1
5031998|NCT02913105|17324798|P3|Overall Study|Reason Not Specified|1
5031999|NCT02913105|17324799|P2|Overall Study|Reason Not Specified|1
5032000|NCT02913105|17324800|P1|Overall Study|Reason Not Specified|3
5032001|NCT02913105|17324798|P3|Overall Study|Non-Compliance With Study Drug|1
5032002|NCT02913105|17324799|P2|Overall Study|Non-Compliance With Study Drug|0
5032003|NCT02913105|17324800|P1|Overall Study|Non-Compliance With Study Drug|0
5032004|NCT02913105|17324798|P3|Overall Study|Adverse Event|4
5032005|NCT02913105|17324799|P2|Overall Study|Adverse Event|0
5032006|NCT02913105|17324800|P1|Overall Study|Adverse Event|11
5032007|NCT02912650|17324853|P4|Overall Study|Adverse Event|0
5032008|NCT02912650|17324854|P3|Overall Study|Adverse Event|1
5032009|NCT02912650|17324855|P2|Overall Study|Adverse Event|0
5032010|NCT02912650|17324856|P1|Overall Study|Adverse Event|0
5032011|NCT02912650|17324853|P4|Overall Study|Withdrawal by Subject|5
5032012|NCT02912650|17324854|P3|Overall Study|Withdrawal by Subject|1
5032013|NCT02912650|17324855|P2|Overall Study|Withdrawal by Subject|0
5032014|NCT02912650|17324856|P1|Overall Study|Withdrawal by Subject|1
5032015|NCT02912468|17324940|P2|Overall Study|Randomized and not treated|1
5032016|NCT02912468|17324941|P1|Overall Study|Randomized and not treated|0
5032017|NCT02912468|17324940|P2|Overall Study|Withdrawal by Subject|2
5032018|NCT02912468|17324941|P1|Overall Study|Withdrawal by Subject|6
5032019|NCT02912468|17324940|P2|Overall Study|Adverse Event|2
5032020|NCT02912468|17324941|P1|Overall Study|Adverse Event|3
5032021|NCT02912455|17325020|P2|Overall Study|Lost to Follow-up|1
5032022|NCT02912455|17325021|P1|Overall Study|Lost to Follow-up|2
5032023|NCT02912455|17325020|P2|Overall Study|Lack of Efficacy|1
5032024|NCT02912455|17325021|P1|Overall Study|Lack of Efficacy|0
5032025|NCT02912455|17325020|P2|Overall Study|Withdrawal by Subject|1
5032026|NCT02912455|17325021|P1|Overall Study|Withdrawal by Subject|0
5032027|NCT02911948|17325116|P2|Overall Study|Unclassified|3
5032028|NCT02911948|17325117|P1|Overall Study|Unclassified|0
5032029|NCT02911948|17325116|P2|Overall Study|Lack of Efficacy|1
5032030|NCT02911948|17325117|P1|Overall Study|Lack of Efficacy|0
5032031|NCT02911948|17325116|P2|Overall Study|Withdrawal by Subject|2
5032032|NCT02911948|17325117|P1|Overall Study|Withdrawal by Subject|0
5032033|NCT02911948|17325116|P2|Overall Study|Protocol Violation|1
5032034|NCT02911948|17325117|P1|Overall Study|Protocol Violation|0
5032035|NCT02911688|17325379|P2|Washout|Withdrawal by Subject|1
5032036|NCT02911688|17325380|P1|Washout|Withdrawal by Subject|0
5032037|NCT02911688|17325379|P2|Washout|Lost to Follow-up|1
5032038|NCT02911688|17325380|P1|Washout|Lost to Follow-up|1
5032039|NCT02911519|17325404|P2|Overall Study|Death|2
5032040|NCT02911519|17325405|P1|Overall Study|Death|0
5032041|NCT02911519|17325404|P2|Overall Study|Lost to Follow-up|2
5032042|NCT02911519|17325405|P1|Overall Study|Lost to Follow-up|2
5032043|NCT02910739|17325437|P4|Overall Study|Adverse Event|0
5032044|NCT02910739|17325438|P3|Overall Study|Adverse Event|0
5032045|NCT02910739|17325439|P2|Overall Study|Adverse Event|0
5032046|NCT02910739|17325440|P1|Overall Study|Adverse Event|1
5032047|NCT02910713|17325466|P1|Overall Study|Investigator Discretion|1
5032048|NCT02910713|17325466|P1|Overall Study|Enrollment cap|7
5032049|NCT02910713|17325466|P1|Overall Study|Received Neither Application|18
5032050|NCT02910713|17325466|P1|Overall Study|Received One Application|10
5032051|NCT02910713|17325466|P1|Overall Study|Subject Choice|4
5032052|NCT02910713|17325466|P1|Overall Study|Protocol Violation|2
5032053|NCT02910167|17325482|P1|Overall Study|Lost to Follow-up|18
5032054|NCT02910167|17325482|P1|Overall Study|Adverse Event|1
5032055|NCT02910089|17325507|P2|Overall Study|Lost insurance eligibility|16
5032056|NCT02910089|17325508|P1|Overall Study|Lost insurance eligibility|22
5032057|NCT02910011|17325520|P1|Overall Study|Physician Decision|2
5032058|NCT02909907|17325629|P2|Overall Study|Withdrawal by Subject|1
5032059|NCT02909907|17325630|P1|Overall Study|Withdrawal by Subject|0
5032060|NCT02909504|17325671|P1|Overall Study|Lost to Follow-up|1
5032061|NCT02909504|17325671|P1|Overall Study|Subject moved|1
5032062|NCT02909504|17325671|P1|Overall Study|Pregnancy|1
5032063|NCT02909504|17325671|P1|Overall Study|Withdrawal by Subject|4
5032064|NCT02909504|17325671|P1|Overall Study|Lack of Efficacy|3
5032065|NCT02909504|17325671|P1|Overall Study|Adverse Event|2
5032066|NCT02909153|17325708|P5|Overall Study|Withdrawal by Subject|0
5032067|NCT02909153|17325709|P4|Overall Study|Withdrawal by Subject|0
5032068|NCT02909153|17325710|P3|Overall Study|Withdrawal by Subject|0
5032069|NCT02909153|17325711|P2|Overall Study|Withdrawal by Subject|1
5032070|NCT02909153|17325712|P1|Overall Study|Withdrawal by Subject|0
5032071|NCT02909101|17325802|P2|Overall Study|Lost to Follow-up|1
5032072|NCT02909101|17325803|P1|Overall Study|Lost to Follow-up|1
5032073|NCT02908880|17325821|P1|Overall Study|Death|5
5032074|NCT02908880|17325821|P1|Overall Study|Withdrawal by Subject|17
5032075|NCT02908880|17325821|P1|Overall Study|Explantation of the device|1
5032076|NCT02908880|17325821|P1|Overall Study|Lost to Follow-up|4
5032077|NCT02908672|17325831|P2|Overall Study|Discontinued the study during run-in|0
5032078|NCT02908672|17325832|P1|Overall Study|Discontinued the study during run-in|3
5032079|NCT02908672|17325831|P2|Overall Study|Study is ongoing|141
5032080|NCT02908672|17325832|P1|Overall Study|Study is ongoing|124
5032081|NCT02908672|17325831|P2|Overall Study|Withdrawal by Subject|18
5032082|NCT02908672|17325832|P1|Overall Study|Withdrawal by Subject|13
5032083|NCT02908672|17325831|P2|Overall Study|Protocol Violation|1
5032084|NCT02908672|17325832|P1|Overall Study|Protocol Violation|1
5032085|NCT02908672|17325831|P2|Overall Study|Other|0
5032086|NCT02908672|17325832|P1|Overall Study|Other|2
5032087|NCT02908672|17325831|P2|Overall Study|Lost to Follow-up|3
5032088|NCT02908672|17325832|P1|Overall Study|Lost to Follow-up|3
5032089|NCT02908672|17325831|P2|Overall Study|Death|93
5032090|NCT02908672|17325832|P1|Overall Study|Death|112
5032091|NCT02908529|17325905|P2|Overall Study|Lost to Follow-up|2
5032092|NCT02908529|17325906|P1|Overall Study|Lost to Follow-up|0
5032093|NCT02908516|17325916|P2|Overall Study|Study Terminated|3
5032094|NCT02908516|17325917|P1|Overall Study|Study Terminated|3
5032095|NCT02908464|17325933|P2|Overall Study|Found ineligible after randomization|2
5032096|NCT02908464|17325934|P1|Overall Study|Found ineligible after randomization|0
5032097|NCT02908464|17325933|P2|Overall Study|Withdrawal by Subject|1
5032098|NCT02908464|17325934|P1|Overall Study|Withdrawal by Subject|2
5032099|NCT02908347|17325955|P2|Overall Study|Lost to Follow-up|0
5032100|NCT02908347|17325956|P1|Overall Study|Lost to Follow-up|1
5032101|NCT02908347|17325955|P2|Overall Study|Adverse Event|1
5032102|NCT02908347|17325956|P1|Overall Study|Adverse Event|0
5032103|NCT02908100|17326052|P3|Overall Study|Randomised in Error|0
5032104|NCT02908100|17326053|P2|Overall Study|Randomised in Error|0
5032105|NCT02908100|17326054|P1|Overall Study|Randomised in Error|1
5032106|NCT02908100|17326052|P3|Overall Study|Withdrawal by Subject|5
5032107|NCT02908100|17326053|P2|Overall Study|Withdrawal by Subject|7
5032108|NCT02908100|17326054|P1|Overall Study|Withdrawal by Subject|8
5032109|NCT02908100|17326052|P3|Overall Study|Pregnancy|0
5032110|NCT02908100|17326053|P2|Overall Study|Pregnancy|2
5032111|NCT02908100|17326054|P1|Overall Study|Pregnancy|1
5032112|NCT02908100|17326052|P3|Overall Study|Physician Decision|0
5032113|NCT02908100|17326053|P2|Overall Study|Physician Decision|1
5032114|NCT02908100|17326054|P1|Overall Study|Physician Decision|0
5032115|NCT02908100|17326052|P3|Overall Study|Non-Compliance With Contraceptive Method|0
5032116|NCT02908100|17326053|P2|Overall Study|Non-Compliance With Contraceptive Method|0
5032117|NCT02908100|17326054|P1|Overall Study|Non-Compliance With Contraceptive Method|1
5032118|NCT02908100|17326052|P3|Overall Study|Non-Compliance With Study Drug|2
5032119|NCT02908100|17326053|P2|Overall Study|Non-Compliance With Study Drug|1
5032120|NCT02908100|17326054|P1|Overall Study|Non-Compliance With Study Drug|1
5032121|NCT02908100|17326052|P3|Overall Study|Lost to Follow-up|2
5032122|NCT02908100|17326053|P2|Overall Study|Lost to Follow-up|1
5032123|NCT02908100|17326054|P1|Overall Study|Lost to Follow-up|0
5032124|NCT02908100|17326052|P3|Overall Study|Lack of Efficacy|3
5032125|NCT02908100|17326053|P2|Overall Study|Lack of Efficacy|3
5032126|NCT02908100|17326054|P1|Overall Study|Lack of Efficacy|2
5032127|NCT02908100|17326052|P3|Overall Study|Death|0
5032128|NCT02908100|17326053|P2|Overall Study|Death|0
5032129|NCT02908100|17326054|P1|Overall Study|Death|2
5032130|NCT02908100|17326052|P3|Overall Study|Adverse Event|9
5032131|NCT02908100|17326053|P2|Overall Study|Adverse Event|6
5032132|NCT02908100|17326054|P1|Overall Study|Adverse Event|7
5032133|NCT02907892|17326090|P2|Overall Study|Lost to Follow-up|40
5032134|NCT02907892|17326091|P1|Overall Study|Lost to Follow-up|27
5032135|NCT02907619|17326111|P3|Overall Study|Other|0
5032136|NCT02907619|17326112|P2|Overall Study|Other|1
5032137|NCT02907619|17326113|P1|Overall Study|Other|0
5032138|NCT02907619|17326111|P3|Overall Study|Withdrawal by Subject|0
5032139|NCT02907619|17326112|P2|Overall Study|Withdrawal by Subject|1
5032140|NCT02907619|17326113|P1|Overall Study|Withdrawal by Subject|1
5032141|NCT02907619|17326111|P3|Overall Study|Death|1
5032142|NCT02907619|17326112|P2|Overall Study|Death|0
5032143|NCT02907619|17326113|P1|Overall Study|Death|0
5032144|NCT02907619|17326111|P3|Overall Study|Study terminated by sponsor|19
5032145|NCT02907619|17326112|P2|Overall Study|Study terminated by sponsor|18
5032146|NCT02907619|17326113|P1|Overall Study|Study terminated by sponsor|18
5032147|NCT02907463|17326329|P1|Overall Study|Missing Exit Form|1
5032148|NCT02907463|17326329|P1|Overall Study|Device Explanted|1
5032149|NCT02907463|17326329|P1|Overall Study|Not Implanted with Study Device|2
5032150|NCT02907463|17326329|P1|Overall Study|MIS Approach was not used|2
5032151|NCT02907463|17326329|P1|Overall Study|Withdrawal by Subject|4
5032152|NCT02907463|17326329|P1|Overall Study|Death|10
5032153|NCT02907463|17326329|P1|Overall Study|Lost to Follow-up|17
5032154|NCT02907216|17326411|P2|Overall Study|Withdrawal by Subject|0
5032155|NCT02907216|17326412|P1|Overall Study|Withdrawal by Subject|1
5032156|NCT02907216|17326411|P2|Overall Study|No benefit to be obtained by continuing|1
5032157|NCT02907216|17326412|P1|Overall Study|No benefit to be obtained by continuing|0
5032158|NCT02906930|17326464|P4|Overall Study|Other|2
5032159|NCT02906930|17326465|P3|Overall Study|Other|1
5032160|NCT02906930|17326466|P2|Overall Study|Other|2
5032161|NCT02906930|17326467|P1|Overall Study|Other|1
5032162|NCT02906930|17326464|P4|Overall Study|Death|0
5032163|NCT02906930|17326465|P3|Overall Study|Death|1
5032164|NCT02906930|17326466|P2|Overall Study|Death|0
5032165|NCT02906930|17326467|P1|Overall Study|Death|0
5032166|NCT02906930|17326464|P4|Overall Study|Lost to Follow-up|2
5032167|NCT02906930|17326465|P3|Overall Study|Lost to Follow-up|5
5032168|NCT02906930|17326466|P2|Overall Study|Lost to Follow-up|7
5032169|NCT02906930|17326467|P1|Overall Study|Lost to Follow-up|5
5032170|NCT02906930|17326464|P4|Overall Study|Withdrawal by Subject|4
5032171|NCT02906930|17326465|P3|Overall Study|Withdrawal by Subject|5
5032172|NCT02906930|17326466|P2|Overall Study|Withdrawal by Subject|5
5032173|NCT02906930|17326467|P1|Overall Study|Withdrawal by Subject|0
5032174|NCT02906917|17326660|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
5032175|NCT02906917|17326661|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
5032176|NCT02906917|17326660|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
5032177|NCT02906917|17326661|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
5032178|NCT02906917|17326660|P2|Intensification Period (Week 26-38)|Adverse Event|2
5032179|NCT02906917|17326661|P1|Intensification Period (Week 26-38)|Adverse Event|0
5032180|NCT02906917|17326660|P2|Intensification Period (Week 26-38)|Unclassified|2
5032181|NCT02906917|17326661|P1|Intensification Period (Week 26-38)|Unclassified|3
5032182|NCT02906917|17326660|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
5032183|NCT02906917|17326661|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
5032184|NCT02906917|17326660|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
5032185|NCT02906917|17326661|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
5032186|NCT02906917|17326660|P2|Initiation Period (Week 0-26)|Adverse Event|0
5032187|NCT02906917|17326661|P1|Initiation Period (Week 0-26)|Adverse Event|1
5032188|NCT02906917|17326660|P2|Initiation Period (Week 0-26)|Unclassified|3
5032189|NCT02906917|17326661|P1|Initiation Period (Week 0-26)|Unclassified|1
5032190|NCT02906709|17326722|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
5032191|NCT02906709|17326723|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
5032192|NCT02906709|17326722|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
5032193|NCT02906709|17326723|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
5032194|NCT02906709|17326722|P2|Phase A (Week 0 to Week 16)|Death|1
5032195|NCT02906709|17326723|P1|Phase A (Week 0 to Week 16)|Death|0
5032196|NCT02906709|17326722|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
5032197|NCT02906709|17326723|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
5032198|NCT02906670|17326777|P10|Cohort 5P, QW|Radiological Progression|0
5032199|NCT02906670|17326778|P9|Cohort 5P, QW|Radiological Progression|0
5032200|NCT02906670|17326779|P8|Cohort 5P, QW|Radiological Progression|0
5032201|NCT02906670|17326780|P7|Cohort 5P, QW|Radiological Progression|0
5032202|NCT02906670|17326781|P6|Cohort 5P, QW|Radiological Progression|0
5032203|NCT02906670|17326782|P5|Cohort 5P, QW|Radiological Progression|3
5032204|NCT02906670|17326783|P4|Cohort 5P, QW|Radiological Progression|0
5032205|NCT02906670|17326784|P3|Cohort 5P, QW|Radiological Progression|0
5032206|NCT02906670|17326785|P2|Cohort 5P, QW|Radiological Progression|0
5032207|NCT02906670|17326786|P1|Cohort 5P, QW|Radiological Progression|0
5032208|NCT02906670|17326777|P10|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
5032209|NCT02906670|17326778|P9|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032210|NCT02906670|17326779|P8|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032211|NCT02906670|17326780|P7|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032212|NCT02906670|17326781|P6|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032213|NCT02906670|17326782|P5|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032214|NCT02906670|17326783|P4|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032215|NCT02906670|17326784|P3|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032216|NCT02906670|17326785|P2|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032217|NCT02906670|17326786|P1|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5032218|NCT02906670|17326777|P10|Cohort 7P, Q2W|Physician Decision|1
5032219|NCT02906670|17326778|P9|Cohort 7P, Q2W|Physician Decision|0
5032220|NCT02906670|17326779|P8|Cohort 7P, Q2W|Physician Decision|0
5032221|NCT02906670|17326780|P7|Cohort 7P, Q2W|Physician Decision|0
5032222|NCT02906670|17326781|P6|Cohort 7P, Q2W|Physician Decision|0
5032223|NCT02906670|17326782|P5|Cohort 7P, Q2W|Physician Decision|0
5032224|NCT02906670|17326783|P4|Cohort 7P, Q2W|Physician Decision|0
5032225|NCT02906670|17326784|P3|Cohort 7P, Q2W|Physician Decision|0
5032226|NCT02906670|17326785|P2|Cohort 7P, Q2W|Physician Decision|0
5032227|NCT02906670|17326786|P1|Cohort 7P, Q2W|Physician Decision|0
5032228|NCT02906670|17326777|P10|Cohort 7P, Q2W|Adverse Event|1
5032229|NCT02906670|17326778|P9|Cohort 7P, Q2W|Adverse Event|0
5032230|NCT02906670|17326779|P8|Cohort 7P, Q2W|Adverse Event|0
5032231|NCT02906670|17326780|P7|Cohort 7P, Q2W|Adverse Event|0
5032232|NCT02906670|17326781|P6|Cohort 7P, Q2W|Adverse Event|0
5032233|NCT02906670|17326782|P5|Cohort 7P, Q2W|Adverse Event|0
5032234|NCT02906670|17326783|P4|Cohort 7P, Q2W|Adverse Event|0
5032235|NCT02906670|17326784|P3|Cohort 7P, Q2W|Adverse Event|0
5032236|NCT02906670|17326785|P2|Cohort 7P, Q2W|Adverse Event|0
5032237|NCT02906670|17326786|P1|Cohort 7P, Q2W|Adverse Event|0
5032238|NCT02906670|17326777|P10|Cohort 4P, QW|Radiological Progression|0
5032239|NCT02906670|17326778|P9|Cohort 4P, QW|Radiological Progression|0
5032240|NCT02906670|17326779|P8|Cohort 4P, QW|Radiological Progression|0
5032241|NCT02906670|17326780|P7|Cohort 4P, QW|Radiological Progression|0
5032242|NCT02906670|17326781|P6|Cohort 4P, QW|Radiological Progression|0
5032243|NCT02906670|17326782|P5|Cohort 4P, QW|Radiological Progression|0
5032244|NCT02906670|17326783|P4|Cohort 4P, QW|Radiological Progression|3
5032245|NCT02906670|17326784|P3|Cohort 4P, QW|Radiological Progression|0
5032246|NCT02906670|17326785|P2|Cohort 4P, QW|Radiological Progression|0
5032247|NCT02906670|17326786|P1|Cohort 4P, QW|Radiological Progression|0
5032248|NCT02906670|17326777|P10|Cohort 6P, Q2W|Clinical Progression|0
5032249|NCT02906670|17326778|P9|Cohort 6P, Q2W|Clinical Progression|3
5032250|NCT02906670|17326779|P8|Cohort 6P, Q2W|Clinical Progression|0
5032251|NCT02906670|17326780|P7|Cohort 6P, Q2W|Clinical Progression|0
5032252|NCT02906670|17326781|P6|Cohort 6P, Q2W|Clinical Progression|0
5032253|NCT02906670|17326782|P5|Cohort 6P, Q2W|Clinical Progression|0
5032254|NCT02906670|17326783|P4|Cohort 6P, Q2W|Clinical Progression|0
5032255|NCT02906670|17326784|P3|Cohort 6P, Q2W|Clinical Progression|0
5032256|NCT02906670|17326785|P2|Cohort 6P, Q2W|Clinical Progression|0
5032257|NCT02906670|17326786|P1|Cohort 6P, Q2W|Clinical Progression|0
5032258|NCT02906670|17326777|P10|Cohort 6P, Q2W|Radiological Progression|0
5032259|NCT02906670|17326778|P9|Cohort 6P, Q2W|Radiological Progression|1
5032260|NCT02906670|17326779|P8|Cohort 6P, Q2W|Radiological Progression|0
5032261|NCT02906670|17326780|P7|Cohort 6P, Q2W|Radiological Progression|0
5032262|NCT02906670|17326781|P6|Cohort 6P, Q2W|Radiological Progression|0
5032263|NCT02906670|17326782|P5|Cohort 6P, Q2W|Radiological Progression|0
5032264|NCT02906670|17326783|P4|Cohort 6P, Q2W|Radiological Progression|0
5032265|NCT02906670|17326784|P3|Cohort 6P, Q2W|Radiological Progression|0
5032266|NCT02906670|17326785|P2|Cohort 6P, Q2W|Radiological Progression|0
5032267|NCT02906670|17326786|P1|Cohort 6P, Q2W|Radiological Progression|0
5032268|NCT02906670|17326777|P10|Cohort 5P, Q2W|Adverse Event|0
5032269|NCT02906670|17326778|P9|Cohort 5P, Q2W|Adverse Event|0
5032270|NCT02906670|17326779|P8|Cohort 5P, Q2W|Adverse Event|1
5032271|NCT02906670|17326780|P7|Cohort 5P, Q2W|Adverse Event|0
5032272|NCT02906670|17326781|P6|Cohort 5P, Q2W|Adverse Event|0
5032273|NCT02906670|17326782|P5|Cohort 5P, Q2W|Adverse Event|0
5032274|NCT02906670|17326783|P4|Cohort 5P, Q2W|Adverse Event|0
5032275|NCT02906670|17326784|P3|Cohort 5P, Q2W|Adverse Event|0
5032276|NCT02906670|17326785|P2|Cohort 5P, Q2W|Adverse Event|0
5032277|NCT02906670|17326786|P1|Cohort 5P, Q2W|Adverse Event|0
5032278|NCT02906670|17326777|P10|Cohort 5P, Q2W|Radiological Progression|0
5032279|NCT02906670|17326778|P9|Cohort 5P, Q2W|Radiological Progression|0
5032280|NCT02906670|17326779|P8|Cohort 5P, Q2W|Radiological Progression|2
5032281|NCT02906670|17326780|P7|Cohort 5P, Q2W|Radiological Progression|0
5032282|NCT02906670|17326781|P6|Cohort 5P, Q2W|Radiological Progression|0
5032283|NCT02906670|17326782|P5|Cohort 5P, Q2W|Radiological Progression|0
5032284|NCT02906670|17326783|P4|Cohort 5P, Q2W|Radiological Progression|0
5032285|NCT02906670|17326784|P3|Cohort 5P, Q2W|Radiological Progression|0
5032286|NCT02906670|17326785|P2|Cohort 5P, Q2W|Radiological Progression|0
5032287|NCT02906670|17326786|P1|Cohort 5P, Q2W|Radiological Progression|0
5032288|NCT02906670|17326777|P10|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032289|NCT02906670|17326778|P9|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032290|NCT02906670|17326779|P8|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032291|NCT02906670|17326780|P7|Cohort 5, Q2W|Lack of Clinical Benefit|1
5032292|NCT02906670|17326781|P6|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032293|NCT02906670|17326782|P5|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032294|NCT02906670|17326783|P4|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032295|NCT02906670|17326784|P3|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032296|NCT02906670|17326785|P2|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032297|NCT02906670|17326786|P1|Cohort 5, Q2W|Lack of Clinical Benefit|0
5032298|NCT02906670|17326777|P10|Cohort 5, Q2W|Adverse Event|0
5032299|NCT02906670|17326778|P9|Cohort 5, Q2W|Adverse Event|0
5032300|NCT02906670|17326779|P8|Cohort 5, Q2W|Adverse Event|0
5032301|NCT02906670|17326780|P7|Cohort 5, Q2W|Adverse Event|1
5032302|NCT02906670|17326781|P6|Cohort 5, Q2W|Adverse Event|0
5032303|NCT02906670|17326782|P5|Cohort 5, Q2W|Adverse Event|0
5032304|NCT02906670|17326783|P4|Cohort 5, Q2W|Adverse Event|0
5032305|NCT02906670|17326784|P3|Cohort 5, Q2W|Adverse Event|0
5032306|NCT02906670|17326785|P2|Cohort 5, Q2W|Adverse Event|0
5032307|NCT02906670|17326786|P1|Cohort 5, Q2W|Adverse Event|0
5032308|NCT02906670|17326777|P10|Cohort 5, Q2W|Clinical Progression|0
5032309|NCT02906670|17326778|P9|Cohort 5, Q2W|Clinical Progression|0
5032310|NCT02906670|17326779|P8|Cohort 5, Q2W|Clinical Progression|0
5032311|NCT02906670|17326780|P7|Cohort 5, Q2W|Clinical Progression|1
5032312|NCT02906670|17326781|P6|Cohort 5, Q2W|Clinical Progression|0
5032313|NCT02906670|17326782|P5|Cohort 5, Q2W|Clinical Progression|0
5032314|NCT02906670|17326783|P4|Cohort 5, Q2W|Clinical Progression|0
5032315|NCT02906670|17326784|P3|Cohort 5, Q2W|Clinical Progression|0
5032316|NCT02906670|17326785|P2|Cohort 5, Q2W|Clinical Progression|0
5032317|NCT02906670|17326786|P1|Cohort 5, Q2W|Clinical Progression|0
5032318|NCT02906670|17326777|P10|Cohort 5, Q2W|Radiological Progression|0
5032319|NCT02906670|17326778|P9|Cohort 5, Q2W|Radiological Progression|0
5032320|NCT02906670|17326779|P8|Cohort 5, Q2W|Radiological Progression|0
5032321|NCT02906670|17326780|P7|Cohort 5, Q2W|Radiological Progression|4
5032322|NCT02906670|17326781|P6|Cohort 5, Q2W|Radiological Progression|0
5032323|NCT02906670|17326782|P5|Cohort 5, Q2W|Radiological Progression|0
5032324|NCT02906670|17326783|P4|Cohort 5, Q2W|Radiological Progression|0
5032325|NCT02906670|17326784|P3|Cohort 5, Q2W|Radiological Progression|0
5032326|NCT02906670|17326785|P2|Cohort 5, Q2W|Radiological Progression|0
5032327|NCT02906670|17326786|P1|Cohort 5, Q2W|Radiological Progression|0
5032328|NCT02906670|17326777|P10|Cohort 4, Q2W|Clinical Progression|0
5032329|NCT02906670|17326778|P9|Cohort 4, Q2W|Clinical Progression|0
5032330|NCT02906670|17326779|P8|Cohort 4, Q2W|Clinical Progression|0
5032331|NCT02906670|17326780|P7|Cohort 4, Q2W|Clinical Progression|0
5032332|NCT02906670|17326781|P6|Cohort 4, Q2W|Clinical Progression|2
5032333|NCT02906670|17326782|P5|Cohort 4, Q2W|Clinical Progression|0
5032334|NCT02906670|17326783|P4|Cohort 4, Q2W|Clinical Progression|0
5032335|NCT02906670|17326784|P3|Cohort 4, Q2W|Clinical Progression|0
5032336|NCT02906670|17326785|P2|Cohort 4, Q2W|Clinical Progression|0
5032337|NCT02906670|17326786|P1|Cohort 4, Q2W|Clinical Progression|0
5032338|NCT02906670|17326777|P10|Cohort 4, Q2W|Radiological Progression|0
5032339|NCT02906670|17326778|P9|Cohort 4, Q2W|Radiological Progression|0
5032340|NCT02906670|17326779|P8|Cohort 4, Q2W|Radiological Progression|0
5032341|NCT02906670|17326780|P7|Cohort 4, Q2W|Radiological Progression|0
5032342|NCT02906670|17326781|P6|Cohort 4, Q2W|Radiological Progression|1
5032343|NCT02906670|17326782|P5|Cohort 4, Q2W|Radiological Progression|0
5032344|NCT02906670|17326783|P4|Cohort 4, Q2W|Radiological Progression|0
5032345|NCT02906670|17326784|P3|Cohort 4, Q2W|Radiological Progression|0
5032346|NCT02906670|17326785|P2|Cohort 4, Q2W|Radiological Progression|0
5032347|NCT02906670|17326786|P1|Cohort 4, Q2W|Radiological Progression|0
5032348|NCT02906670|17326777|P10|Cohort 3, QW|Lack of Clinical Benefit|0
5032349|NCT02906670|17326778|P9|Cohort 3, QW|Lack of Clinical Benefit|0
5032350|NCT02906670|17326779|P8|Cohort 3, QW|Lack of Clinical Benefit|0
5032351|NCT02906670|17326780|P7|Cohort 3, QW|Lack of Clinical Benefit|0
5032352|NCT02906670|17326781|P6|Cohort 3, QW|Lack of Clinical Benefit|0
5032353|NCT02906670|17326782|P5|Cohort 3, QW|Lack of Clinical Benefit|0
5032354|NCT02906670|17326783|P4|Cohort 3, QW|Lack of Clinical Benefit|0
5032355|NCT02906670|17326784|P3|Cohort 3, QW|Lack of Clinical Benefit|2
5032356|NCT02906670|17326785|P2|Cohort 3, QW|Lack of Clinical Benefit|0
5032357|NCT02906670|17326786|P1|Cohort 3, QW|Lack of Clinical Benefit|0
5032358|NCT02906670|17326777|P10|Cohort 3, QW|Radiological Progression|0
5032359|NCT02906670|17326778|P9|Cohort 3, QW|Radiological Progression|0
5032360|NCT02906670|17326779|P8|Cohort 3, QW|Radiological Progression|0
5032361|NCT02906670|17326780|P7|Cohort 3, QW|Radiological Progression|0
5032362|NCT02906670|17326781|P6|Cohort 3, QW|Radiological Progression|0
5032363|NCT02906670|17326782|P5|Cohort 3, QW|Radiological Progression|0
5032364|NCT02906670|17326783|P4|Cohort 3, QW|Radiological Progression|0
5032365|NCT02906670|17326784|P3|Cohort 3, QW|Radiological Progression|2
5032366|NCT02906670|17326785|P2|Cohort 3, QW|Radiological Progression|0
5032367|NCT02906670|17326786|P1|Cohort 3, QW|Radiological Progression|0
5032368|NCT02906670|17326777|P10|Cohort 2, QW|Radiological Progression|0
5032369|NCT02906670|17326778|P9|Cohort 2, QW|Radiological Progression|0
5032370|NCT02906670|17326779|P8|Cohort 2, QW|Radiological Progression|0
5032371|NCT02906670|17326780|P7|Cohort 2, QW|Radiological Progression|0
5032372|NCT02906670|17326781|P6|Cohort 2, QW|Radiological Progression|0
5032373|NCT02906670|17326782|P5|Cohort 2, QW|Radiological Progression|0
5032374|NCT02906670|17326783|P4|Cohort 2, QW|Radiological Progression|0
5032375|NCT02906670|17326784|P3|Cohort 2, QW|Radiological Progression|0
5032376|NCT02906670|17326785|P2|Cohort 2, QW|Radiological Progression|1
5032377|NCT02906670|17326786|P1|Cohort 2, QW|Radiological Progression|0
5032378|NCT02906670|17326777|P10|Cohort 1, QW|Radiological Progression|0
5032379|NCT02906670|17326778|P9|Cohort 1, QW|Radiological Progression|0
5032380|NCT02906670|17326779|P8|Cohort 1, QW|Radiological Progression|0
5032381|NCT02906670|17326780|P7|Cohort 1, QW|Radiological Progression|0
5032382|NCT02906670|17326781|P6|Cohort 1, QW|Radiological Progression|0
5032383|NCT02906670|17326782|P5|Cohort 1, QW|Radiological Progression|0
5032384|NCT02906670|17326783|P4|Cohort 1, QW|Radiological Progression|0
5032385|NCT02906670|17326784|P3|Cohort 1, QW|Radiological Progression|0
5032386|NCT02906670|17326785|P2|Cohort 1, QW|Radiological Progression|0
5032387|NCT02906670|17326786|P1|Cohort 1, QW|Radiological Progression|1
5032388|NCT02906644|17326903|P2|Weeks 3 to 14|Lost to Follow-up|4
5032389|NCT02906644|17326904|P1|Weeks 3 to 14|Lost to Follow-up|3
5032390|NCT02906644|17326903|P2|Weeks 3 to 14|Withdrawal by Subject|7
5032391|NCT02906644|17326904|P1|Weeks 3 to 14|Withdrawal by Subject|13
5032392|NCT02906644|17326903|P2|First 2 Weeks|Physician Decision|1
5032393|NCT02906644|17326904|P1|First 2 Weeks|Physician Decision|1
5032394|NCT02906644|17326903|P2|First 2 Weeks|Withdrawal by Subject|2
5032395|NCT02906644|17326904|P1|First 2 Weeks|Withdrawal by Subject|0
5032396|NCT02906579|17326920|P1|Overall Study|Physician Decision|1
5032397|NCT02906579|17326920|P1|Overall Study|Adverse Event|1
5032398|NCT02906358|17327124|P2|Overall Study|Lost to Follow-up|15
5032399|NCT02906358|17327125|P1|Overall Study|Lost to Follow-up|12
5032400|NCT02906358|17327124|P2|Overall Study|Withdrawal by Subject|7
5032401|NCT02906358|17327125|P1|Overall Study|Withdrawal by Subject|10
5032402|NCT02905825|17327159|P1|Overall Study|Device Malfunction|1
5032403|NCT02905825|17327159|P1|Overall Study|Protocol Violation|11
5032404|NCT02905331|17327167|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
5032405|NCT02905331|17327168|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
5032406|NCT02905331|17327169|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
5032407|NCT02905331|17327167|P3|Active Treatment and Follow up (wk16-40)|Other|0
5032489|NCT02905006|17327243|P2|Overall Study|Protocol Violation|0
5032408|NCT02905331|17327168|P2|Active Treatment and Follow up (wk16-40)|Other|6
5032409|NCT02905331|17327169|P1|Active Treatment and Follow up (wk16-40)|Other|0
5032410|NCT02905331|17327167|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
5032411|NCT02905331|17327168|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
5032412|NCT02905331|17327169|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
5032413|NCT02905331|17327167|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
5032414|NCT02905331|17327168|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
5032415|NCT02905331|17327169|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
5032416|NCT02905331|17327167|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
5032417|NCT02905331|17327168|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
5032418|NCT02905331|17327169|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
5032419|NCT02905266|17327197|P2|Maintenance Phase Part 2|Not Reported|17
5032420|NCT02905266|17327198|P1|Maintenance Phase Part 2|Not Reported|10
5032421|NCT02905266|17327197|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|1
5032422|NCT02905266|17327198|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
5032423|NCT02905266|17327197|P2|Maintenance Phase Part 2|Study Drug Toxicity|2
5032424|NCT02905266|17327198|P1|Maintenance Phase Part 2|Study Drug Toxicity|1
5032425|NCT02905266|17327197|P2|Maintenance Phase Part 2|Disease Progression|2
5032426|NCT02905266|17327198|P1|Maintenance Phase Part 2|Disease Progression|8
5032427|NCT02905266|17327197|P2|Treatment Period Part 1|Maximum Clinical Benefit|1
5032428|NCT02905266|17327198|P1|Treatment Period Part 1|Maximum Clinical Benefit|0
5032429|NCT02905266|17327197|P2|Treatment Period Part 1|Study Drug Toxicity|15
5032430|NCT02905266|17327198|P1|Treatment Period Part 1|Study Drug Toxicity|22
5032431|NCT02905266|17327197|P2|Treatment Period Part 1|Disease Progression|7
5032432|NCT02905266|17327198|P1|Treatment Period Part 1|Disease Progression|6
5032433|NCT02905266|17327197|P2|Treatment Period Part 1|Subject Withdrew Consent|0
5032434|NCT02905266|17327198|P1|Treatment Period Part 1|Subject Withdrew Consent|1
5032435|NCT02905149|17327220|P2|Overall Study|Lost to Follow-up|0
5032436|NCT02905149|17327221|P1|Overall Study|Lost to Follow-up|2
5032437|NCT02905006|17327239|P6|Overall Study|Patient randomized by mistake|1
5032438|NCT02905006|17327240|P5|Overall Study|Patient randomized by mistake|0
5032439|NCT02905006|17327241|P4|Overall Study|Patient randomized by mistake|0
5032440|NCT02905006|17327242|P3|Overall Study|Patient randomized by mistake|0
5032441|NCT02905006|17327243|P2|Overall Study|Patient randomized by mistake|0
5032442|NCT02905006|17327244|P1|Overall Study|Patient randomized by mistake|0
5032443|NCT02905006|17327239|P6|Overall Study|Patient moved abroad|0
5032444|NCT02905006|17327240|P5|Overall Study|Patient moved abroad|0
5032445|NCT02905006|17327241|P4|Overall Study|Patient moved abroad|1
5032446|NCT02905006|17327242|P3|Overall Study|Patient moved abroad|0
5032447|NCT02905006|17327243|P2|Overall Study|Patient moved abroad|0
5032448|NCT02905006|17327244|P1|Overall Study|Patient moved abroad|0
5032449|NCT02905006|17327239|P6|Overall Study|Subject positive for Hep B|0
5032450|NCT02905006|17327240|P5|Overall Study|Subject positive for Hep B|0
5032451|NCT02905006|17327241|P4|Overall Study|Subject positive for Hep B|0
5032452|NCT02905006|17327242|P3|Overall Study|Subject positive for Hep B|1
5032453|NCT02905006|17327243|P2|Overall Study|Subject positive for Hep B|0
5032454|NCT02905006|17327244|P1|Overall Study|Subject positive for Hep B|0
5032455|NCT02905006|17327239|P6|Overall Study|Positive for Tuberculosis|0
5032456|NCT02905006|17327240|P5|Overall Study|Positive for Tuberculosis|0
5032457|NCT02905006|17327241|P4|Overall Study|Positive for Tuberculosis|0
5032458|NCT02905006|17327242|P3|Overall Study|Positive for Tuberculosis|0
5032459|NCT02905006|17327243|P2|Overall Study|Positive for Tuberculosis|1
5032460|NCT02905006|17327244|P1|Overall Study|Positive for Tuberculosis|0
5032461|NCT02905006|17327239|P6|Overall Study|Lab withdrawal criterion met|1
5032462|NCT02905006|17327240|P5|Overall Study|Lab withdrawal criterion met|2
5032463|NCT02905006|17327241|P4|Overall Study|Lab withdrawal criterion met|2
5032464|NCT02905006|17327242|P3|Overall Study|Lab withdrawal criterion met|2
5032465|NCT02905006|17327243|P2|Overall Study|Lab withdrawal criterion met|1
5032466|NCT02905006|17327244|P1|Overall Study|Lab withdrawal criterion met|0
5032467|NCT02905006|17327239|P6|Overall Study|Screening exclusion criteria met|0
5032468|NCT02905006|17327240|P5|Overall Study|Screening exclusion criteria met|0
5032469|NCT02905006|17327241|P4|Overall Study|Screening exclusion criteria met|0
5032470|NCT02905006|17327242|P3|Overall Study|Screening exclusion criteria met|0
5032471|NCT02905006|17327243|P2|Overall Study|Screening exclusion criteria met|0
5032472|NCT02905006|17327244|P1|Overall Study|Screening exclusion criteria met|1
5032473|NCT02905006|17327239|P6|Overall Study|Withdrawal by Subject|1
5032474|NCT02905006|17327240|P5|Overall Study|Withdrawal by Subject|0
5032475|NCT02905006|17327241|P4|Overall Study|Withdrawal by Subject|1
5032476|NCT02905006|17327242|P3|Overall Study|Withdrawal by Subject|1
5032477|NCT02905006|17327243|P2|Overall Study|Withdrawal by Subject|0
5032478|NCT02905006|17327244|P1|Overall Study|Withdrawal by Subject|0
5032479|NCT02905006|17327239|P6|Overall Study|Lost to Follow-up|0
5032480|NCT02905006|17327240|P5|Overall Study|Lost to Follow-up|1
5032481|NCT02905006|17327241|P4|Overall Study|Lost to Follow-up|1
5032482|NCT02905006|17327242|P3|Overall Study|Lost to Follow-up|0
5032483|NCT02905006|17327243|P2|Overall Study|Lost to Follow-up|0
5032484|NCT02905006|17327244|P1|Overall Study|Lost to Follow-up|0
5032485|NCT02905006|17327239|P6|Overall Study|Protocol Violation|0
5032486|NCT02905006|17327240|P5|Overall Study|Protocol Violation|0
5032487|NCT02905006|17327241|P4|Overall Study|Protocol Violation|0
5032488|NCT02905006|17327242|P3|Overall Study|Protocol Violation|0
5032490|NCT02905006|17327244|P1|Overall Study|Protocol Violation|2
5032491|NCT02905006|17327239|P6|Overall Study|Lack of Efficacy|0
5032492|NCT02905006|17327240|P5|Overall Study|Lack of Efficacy|0
5032493|NCT02905006|17327241|P4|Overall Study|Lack of Efficacy|0
5032494|NCT02905006|17327242|P3|Overall Study|Lack of Efficacy|0
5032495|NCT02905006|17327243|P2|Overall Study|Lack of Efficacy|0
5032496|NCT02905006|17327244|P1|Overall Study|Lack of Efficacy|1
5032497|NCT02905006|17327239|P6|Overall Study|Adverse Event|1
5032498|NCT02905006|17327240|P5|Overall Study|Adverse Event|0
5032499|NCT02905006|17327241|P4|Overall Study|Adverse Event|1
5032500|NCT02905006|17327242|P3|Overall Study|Adverse Event|1
5032501|NCT02905006|17327243|P2|Overall Study|Adverse Event|1
5032502|NCT02905006|17327244|P1|Overall Study|Adverse Event|1
5032503|NCT02904902|17327471|P1|Overall Study|Withdrawal by Subject|1
5032504|NCT02904265|17327484|P2|Overall Study|Physician Decision|2
5032505|NCT02904265|17327485|P1|Overall Study|Physician Decision|1
5032506|NCT02904096|17327493|P2|Overall Study|Sponsor instructed|0
5032507|NCT02904096|17327494|P1|Overall Study|Sponsor instructed|1
5032508|NCT02904096|17327493|P2|Overall Study|Non-compliant|1
5032509|NCT02904096|17327494|P1|Overall Study|Non-compliant|3
5032510|NCT02904096|17327493|P2|Overall Study|Lost to Follow-up|17
5032511|NCT02904096|17327494|P1|Overall Study|Lost to Follow-up|10
5032512|NCT02904096|17327493|P2|Overall Study|Withdrawal by Subject|3
5032513|NCT02904096|17327494|P1|Overall Study|Withdrawal by Subject|4
5032514|NCT02904096|17327493|P2|Overall Study|Adverse Event|0
5032515|NCT02904096|17327494|P1|Overall Study|Adverse Event|1
5032516|NCT02903966|17327520|P2|Part B (Day 44 to 112)|Withdrawal by Subject|1
5032517|NCT02903966|17327521|P1|Part B (Day 44 to 112)|Withdrawal by Subject|0
5032518|NCT02903966|17327520|P2|Part B (Day 44 to 112)|Lack of Efficacy|1
5032519|NCT02903966|17327521|P1|Part B (Day 44 to 112)|Lack of Efficacy|0
5032520|NCT02903966|17327520|P2|Part A (Day 1 to 43)|Adverse Event|0
5032521|NCT02903966|17327521|P1|Part A (Day 1 to 43)|Adverse Event|1
5032522|NCT02903420|17327603|P1|Overall Study|Death|3
5032523|NCT02903238|17327655|P1|Overall Study|Lost to Follow-up|4
5032524|NCT02903030|17327681|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
5032525|NCT02903030|17327682|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5032526|NCT02902965|17327700|P1|Overall Study|Withdrawal by Subject|10
5032527|NCT02902809|17327718|P1|Overall Study|Discontinuation of asthma program|28
5032528|NCT02901054|17327799|P1|Overall Study|Withdrawal by Subject|3
5032529|NCT02901054|17327799|P1|Overall Study|Physician Decision|1
5032530|NCT02900378|17327814|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
5032531|NCT02900378|17327815|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
5032532|NCT02900378|17327814|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
5032533|NCT02900378|17327815|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
5032534|NCT02900378|17327814|P2|Randomization (Visit 2)|Protocol Deviation|7
5032535|NCT02900378|17327815|P1|Randomization (Visit 2)|Protocol Deviation|1
5032536|NCT02900378|17327814|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
5032537|NCT02900378|17327815|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
5032538|NCT02900378|17327814|P2|Randomization (Visit 2)|Lost to Follow-up|0
5032539|NCT02900378|17327815|P1|Randomization (Visit 2)|Lost to Follow-up|1
5032540|NCT02900378|17327814|P2|Randomization (Visit 2)|Death|4
5032541|NCT02900378|17327815|P1|Randomization (Visit 2)|Death|1
5032542|NCT02900378|17327814|P2|Randomization (Visit 2)|Adverse Event|11
5032543|NCT02900378|17327815|P1|Randomization (Visit 2)|Adverse Event|14
5032544|NCT02900170|17327859|P1|Overall Study|Lost to Follow-up|8
5032545|NCT02900092|17327863|P1|Overall Study|Adverse Event|1
5032546|NCT02899988|17327871|P11|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
5032547|NCT02899988|17327872|P10|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5032548|NCT02899988|17327873|P9|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
5032549|NCT02899988|17327874|P8|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
5032550|NCT02899988|17327875|P7|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
5032551|NCT02899988|17327876|P6|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5032552|NCT02899988|17327877|P5|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
5032553|NCT02899988|17327878|P4|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5032554|NCT02899988|17327879|P3|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5032555|NCT02899988|17327880|P2|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5032556|NCT02899988|17327881|P1|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5032557|NCT02899988|17327871|P11|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032558|NCT02899988|17327872|P10|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032559|NCT02899988|17327873|P9|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032560|NCT02899988|17327874|P8|Maintenance Period (88 Weeks)|Lost to Follow-up|1
5032561|NCT02899988|17327875|P7|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032562|NCT02899988|17327876|P6|Maintenance Period (88 Weeks)|Lost to Follow-up|1
5032563|NCT02899988|17327877|P5|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032564|NCT02899988|17327878|P4|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032565|NCT02899988|17327879|P3|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032566|NCT02899988|17327880|P2|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032567|NCT02899988|17327881|P1|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5032568|NCT02899988|17327871|P11|Maintenance Period (88 Weeks)|Adverse Event|1
5032569|NCT02899988|17327872|P10|Maintenance Period (88 Weeks)|Adverse Event|2
5032570|NCT02899988|17327873|P9|Maintenance Period (88 Weeks)|Adverse Event|2
5032571|NCT02899988|17327874|P8|Maintenance Period (88 Weeks)|Adverse Event|2
5032572|NCT02899988|17327875|P7|Maintenance Period (88 Weeks)|Adverse Event|1
5032573|NCT02899988|17327876|P6|Maintenance Period (88 Weeks)|Adverse Event|2
5032574|NCT02899988|17327877|P5|Maintenance Period (88 Weeks)|Adverse Event|1
5032575|NCT02899988|17327878|P4|Maintenance Period (88 Weeks)|Adverse Event|0
5032576|NCT02899988|17327879|P3|Maintenance Period (88 Weeks)|Adverse Event|0
5032577|NCT02899988|17327880|P2|Maintenance Period (88 Weeks)|Adverse Event|0
5032578|NCT02899988|17327881|P1|Maintenance Period (88 Weeks)|Adverse Event|0
5032579|NCT02899988|17327871|P11|Induction Period (16 Weeks)|Physician Decision|0
5032580|NCT02899988|17327872|P10|Induction Period (16 Weeks)|Physician Decision|0
5032581|NCT02899988|17327873|P9|Induction Period (16 Weeks)|Physician Decision|0
5032582|NCT02899988|17327874|P8|Induction Period (16 Weeks)|Physician Decision|0
5032583|NCT02899988|17327875|P7|Induction Period (16 Weeks)|Physician Decision|0
5032584|NCT02899988|17327876|P6|Induction Period (16 Weeks)|Physician Decision|0
5032585|NCT02899988|17327877|P5|Induction Period (16 Weeks)|Physician Decision|0
5032586|NCT02899988|17327878|P4|Induction Period (16 Weeks)|Physician Decision|0
5032587|NCT02899988|17327879|P3|Induction Period (16 Weeks)|Physician Decision|0
5032588|NCT02899988|17327880|P2|Induction Period (16 Weeks)|Physician Decision|1
5032589|NCT02899988|17327881|P1|Induction Period (16 Weeks)|Physician Decision|0
5032590|NCT02899988|17327871|P11|Induction Period (16 Weeks)|Adverse Event|0
5032591|NCT02899988|17327872|P10|Induction Period (16 Weeks)|Adverse Event|0
5032592|NCT02899988|17327873|P9|Induction Period (16 Weeks)|Adverse Event|0
5032593|NCT02899988|17327874|P8|Induction Period (16 Weeks)|Adverse Event|0
5032594|NCT02899988|17327875|P7|Induction Period (16 Weeks)|Adverse Event|0
5032595|NCT02899988|17327876|P6|Induction Period (16 Weeks)|Adverse Event|0
5032596|NCT02899988|17327877|P5|Induction Period (16 Weeks)|Adverse Event|0
5032597|NCT02899988|17327878|P4|Induction Period (16 Weeks)|Adverse Event|2
5032598|NCT02899988|17327879|P3|Induction Period (16 Weeks)|Adverse Event|0
5032599|NCT02899988|17327880|P2|Induction Period (16 Weeks)|Adverse Event|0
5032600|NCT02899988|17327881|P1|Induction Period (16 Weeks)|Adverse Event|0
5032601|NCT02899988|17327871|P11|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032602|NCT02899988|17327872|P10|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032603|NCT02899988|17327873|P9|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032604|NCT02899988|17327874|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032605|NCT02899988|17327875|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032606|NCT02899988|17327876|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032607|NCT02899988|17327877|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032608|NCT02899988|17327878|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032609|NCT02899988|17327879|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
5032610|NCT02899988|17327880|P2|Induction Period (16 Weeks)|Withdrawal by Subject|1
5032611|NCT02899988|17327881|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
5032612|NCT02899962|17327940|P3|Maintenance Phase|Withdrawal by Subject|36
5032613|NCT02899962|17327941|P2|Maintenance Phase|Withdrawal by Subject|30
5032614|NCT02899962|17327942|P1|Maintenance Phase|Withdrawal by Subject|0
5032615|NCT02899962|17327940|P3|Maintenance Phase|Not clear/almost clear after rescue med|70
5032616|NCT02899962|17327941|P2|Maintenance Phase|Not clear/almost clear after rescue med|65
5032617|NCT02899962|17327942|P1|Maintenance Phase|Not clear/almost clear after rescue med|0
5032618|NCT02899962|17327940|P3|Maintenance Phase|Not achieve treatment success after Wk 4|2
5032619|NCT02899962|17327941|P2|Maintenance Phase|Not achieve treatment success after Wk 4|3
5032620|NCT02899962|17327942|P1|Maintenance Phase|Not achieve treatment success after Wk 4|0
5032621|NCT02899962|17327940|P3|Maintenance Phase|Other reasons|13
5032622|NCT02899962|17327941|P2|Maintenance Phase|Other reasons|9
5032623|NCT02899962|17327942|P1|Maintenance Phase|Other reasons|0
5032624|NCT02899962|17327940|P3|Maintenance Phase|Lost to Follow-up|14
5032625|NCT02899962|17327941|P2|Maintenance Phase|Lost to Follow-up|12
5032626|NCT02899962|17327942|P1|Maintenance Phase|Lost to Follow-up|0
5032627|NCT02899962|17327940|P3|Maintenance Phase|Lack of Efficacy|16
5032628|NCT02899962|17327941|P2|Maintenance Phase|Lack of Efficacy|20
5032629|NCT02899962|17327942|P1|Maintenance Phase|Lack of Efficacy|0
5032630|NCT02899962|17327940|P3|Maintenance Phase|Death|1
5032631|NCT02899962|17327941|P2|Maintenance Phase|Death|0
5032632|NCT02899962|17327942|P1|Maintenance Phase|Death|0
5032633|NCT02899962|17327940|P3|Maintenance Phase|Adverse Event|1
5032634|NCT02899962|17327941|P2|Maintenance Phase|Adverse Event|2
5032635|NCT02899962|17327942|P1|Maintenance Phase|Adverse Event|0
5032636|NCT02899962|17327940|P3|Open-label Phase|Withdrawal by Subject|0
5032637|NCT02899962|17327941|P2|Open-label Phase|Withdrawal by Subject|0
5032638|NCT02899962|17327942|P1|Open-label Phase|Withdrawal by Subject|7
5032639|NCT02899962|17327940|P3|Open-label Phase|Other reasons|0
5032640|NCT02899962|17327941|P2|Open-label Phase|Other reasons|0
5032641|NCT02899962|17327942|P1|Open-label Phase|Other reasons|9
5032642|NCT02899962|17327940|P3|Open-label Phase|Lost to Follow-up|0
5032643|NCT02899962|17327941|P2|Open-label Phase|Lost to Follow-up|0
5032644|NCT02899962|17327942|P1|Open-label Phase|Lost to Follow-up|9
5032645|NCT02899962|17327940|P3|Open-label Phase|Adverse Event|0
5032646|NCT02899962|17327941|P2|Open-label Phase|Adverse Event|0
5032647|NCT02899962|17327942|P1|Open-label Phase|Adverse Event|2
5032648|NCT02899377|17327992|P2|Overall Study|Adverse Event|0
5032649|NCT02899377|17327993|P1|Overall Study|Adverse Event|1
5032650|NCT02899338|17328026|P2|Overall Study|Withdrawal by Subject|0
5032651|NCT02899338|17328027|P1|Overall Study|Withdrawal by Subject|2
5032652|NCT02899338|17328026|P2|Overall Study|Adverse Event|2
5032653|NCT02899338|17328027|P1|Overall Study|Adverse Event|1
5032654|NCT02899156|17328041|P2|Overall Study|Physician Decision|1
5032655|NCT02899156|17328042|P1|Overall Study|Physician Decision|0
5032656|NCT02899156|17328041|P2|Overall Study|Death|0
5032657|NCT02899156|17328042|P1|Overall Study|Death|1
5032658|NCT02898662|17328084|P2|Overall Study|Other|1
5032659|NCT02898662|17328085|P1|Overall Study|Other|0
5032660|NCT02898662|17328084|P2|Overall Study|Subject decision|0
5032661|NCT02898662|17328085|P1|Overall Study|Subject decision|1
5032662|NCT02898662|17328084|P2|Overall Study|Randomized in error|1
5032663|NCT02898662|17328085|P1|Overall Study|Randomized in error|0
5032664|NCT02898662|17328084|P2|Overall Study|Technical issue|1
5032665|NCT02898662|17328085|P1|Overall Study|Technical issue|0
5032666|NCT02898662|17328084|P2|Overall Study|Withdrawal by Subject|1
5032667|NCT02898662|17328085|P1|Overall Study|Withdrawal by Subject|4
5032668|NCT02898662|17328084|P2|Overall Study|Loss of asthma control|24
5032669|NCT02898662|17328085|P1|Overall Study|Loss of asthma control|23
5032670|NCT02898662|17328084|P2|Overall Study|Adverse Event|0
5032671|NCT02898662|17328085|P1|Overall Study|Adverse Event|1
5032672|NCT02898597|17328109|P2|Overall Study|Death|1
5032673|NCT02898597|17328110|P1|Overall Study|Death|0
5032674|NCT02898597|17328109|P2|Overall Study|Lost to Follow-up|9
5032675|NCT02898597|17328110|P1|Overall Study|Lost to Follow-up|0
5032676|NCT02898597|17328109|P2|Overall Study|Protocol Violation|2
5032677|NCT02898597|17328110|P1|Overall Study|Protocol Violation|4
5032678|NCT02898454|17328119|P3|Overall Study|Did Not Met Eligibility Criteria|0
5032679|NCT02898454|17328120|P2|Overall Study|Did Not Met Eligibility Criteria|0
5032680|NCT02898454|17328121|P1|Overall Study|Did Not Met Eligibility Criteria|1
5032681|NCT02898454|17328119|P3|Overall Study|Lost to Follow-up|0
5032682|NCT02898454|17328120|P2|Overall Study|Lost to Follow-up|0
5032683|NCT02898454|17328121|P1|Overall Study|Lost to Follow-up|1
5032684|NCT02898454|17328119|P3|Overall Study|Withdrawal by Subject|3
5032685|NCT02898454|17328120|P2|Overall Study|Withdrawal by Subject|3
5032686|NCT02898454|17328121|P1|Overall Study|Withdrawal by Subject|6
5032687|NCT02898454|17328119|P3|Overall Study|Lack of Efficacy|0
5032688|NCT02898454|17328120|P2|Overall Study|Lack of Efficacy|1
5032689|NCT02898454|17328121|P1|Overall Study|Lack of Efficacy|4
5032690|NCT02898454|17328119|P3|Overall Study|Protocol Violation|1
5032691|NCT02898454|17328120|P2|Overall Study|Protocol Violation|0
5032692|NCT02898454|17328121|P1|Overall Study|Protocol Violation|1
5032693|NCT02898454|17328119|P3|Overall Study|Adverse Event|2
5032694|NCT02898454|17328120|P2|Overall Study|Adverse Event|1
5032695|NCT02898454|17328121|P1|Overall Study|Adverse Event|4
5032696|NCT02898116|17328234|P1|Overall Study|Progressive disease|1
5032697|NCT02898116|17328234|P1|Overall Study|Adverse Event|1
5032698|NCT02897349|17328242|P2|Overall Study|Other than listed above|1
5032699|NCT02897349|17328243|P1|Overall Study|Other than listed above|0
5032700|NCT02897349|17328242|P2|Overall Study|Adverse Event|3
5032701|NCT02897349|17328243|P1|Overall Study|Adverse Event|3
5032702|NCT02897349|17328242|P2|Overall Study|Lost to Follow-up|2
5032703|NCT02897349|17328243|P1|Overall Study|Lost to Follow-up|2
5032704|NCT02897115|17328285|P2|Overall Study|Early termination of study by sponsor|8
5032705|NCT02897115|17328286|P1|Overall Study|Early termination of study by sponsor|11
5032706|NCT02896855|17328363|P2|Overall Study|Withdrawal by Subject|1
5032707|NCT02896855|17328364|P1|Overall Study|Withdrawal by Subject|1
5032708|NCT02896855|17328363|P2|Overall Study|Lost to Follow-up|0
5032709|NCT02896855|17328364|P1|Overall Study|Lost to Follow-up|5
5032710|NCT02896855|17328363|P2|Overall Study|Death|12
5032711|NCT02896855|17328364|P1|Overall Study|Death|13
5032712|NCT02896855|17328363|P2|Overall Study|In Follow-Up|49
5032713|NCT02896855|17328364|P1|Overall Study|In Follow-Up|61
5032714|NCT02896855|17328363|P2|Overall Study|On Study Treatment|60
5032715|NCT02896855|17328364|P1|Overall Study|On Study Treatment|41
5032716|NCT02896569|17328447|P2|Overall Study|Withdrawal by Subject|0
5032717|NCT02896569|17328448|P1|Overall Study|Withdrawal by Subject|1
5032718|NCT02896569|17328447|P2|Overall Study|Adverse Event|1
5032719|NCT02896569|17328448|P1|Overall Study|Adverse Event|0
5032720|NCT02896569|17328447|P2|Overall Study|Physician Decision|3
5032721|NCT02896569|17328448|P1|Overall Study|Physician Decision|1
5032722|NCT02896569|17328447|P2|Overall Study|Lost to Follow-up|1
5032723|NCT02896569|17328448|P1|Overall Study|Lost to Follow-up|2
5032724|NCT02896400|17328482|P16|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
5032725|NCT02896400|17328483|P15|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5032726|NCT02896400|17328484|P14|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5032727|NCT02896400|17328485|P13|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5032728|NCT02896400|17328486|P12|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
5032729|NCT02896400|17328487|P11|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
5032730|NCT02896400|17328488|P10|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5032731|NCT02896400|17328489|P9|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
5032732|NCT02896400|17328490|P8|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
5032733|NCT02896400|17328491|P7|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5032734|NCT02896400|17328492|P6|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5032735|NCT02896400|17328493|P5|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
5032736|NCT02896400|17328494|P4|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
5032737|NCT02896400|17328495|P3|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
5032738|NCT02896400|17328496|P2|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5032739|NCT02896400|17328497|P1|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
5032740|NCT02896400|17328482|P16|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032741|NCT02896400|17328483|P15|Biochemical Verification at 3 Months|Lost to Follow-up|3
5032742|NCT02896400|17328484|P14|Biochemical Verification at 3 Months|Lost to Follow-up|0
5032743|NCT02896400|17328485|P13|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032744|NCT02896400|17328486|P12|Biochemical Verification at 3 Months|Lost to Follow-up|0
5032745|NCT02896400|17328487|P11|Biochemical Verification at 3 Months|Lost to Follow-up|0
5032746|NCT02896400|17328488|P10|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032747|NCT02896400|17328489|P9|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032748|NCT02896400|17328490|P8|Biochemical Verification at 3 Months|Lost to Follow-up|2
5032749|NCT02896400|17328491|P7|Biochemical Verification at 3 Months|Lost to Follow-up|3
5032750|NCT02896400|17328492|P6|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032751|NCT02896400|17328493|P5|Biochemical Verification at 3 Months|Lost to Follow-up|0
5032752|NCT02896400|17328494|P4|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032753|NCT02896400|17328495|P3|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032754|NCT02896400|17328496|P2|Biochemical Verification at 3 Months|Lost to Follow-up|0
5032755|NCT02896400|17328497|P1|Biochemical Verification at 3 Months|Lost to Follow-up|1
5032756|NCT02896400|17328482|P16|3 Month Follow-up|Death|1
5032757|NCT02896400|17328483|P15|3 Month Follow-up|Death|1
5032758|NCT02896400|17328484|P14|3 Month Follow-up|Death|1
5032759|NCT02896400|17328485|P13|3 Month Follow-up|Death|0
5032760|NCT02896400|17328486|P12|3 Month Follow-up|Death|0
5032761|NCT02896400|17328487|P11|3 Month Follow-up|Death|0
5032762|NCT02896400|17328488|P10|3 Month Follow-up|Death|0
5032763|NCT02896400|17328489|P9|3 Month Follow-up|Death|0
5032764|NCT02896400|17328490|P8|3 Month Follow-up|Death|0
5032765|NCT02896400|17328491|P7|3 Month Follow-up|Death|0
5032766|NCT02896400|17328492|P6|3 Month Follow-up|Death|0
5032767|NCT02896400|17328493|P5|3 Month Follow-up|Death|0
5032768|NCT02896400|17328494|P4|3 Month Follow-up|Death|0
5032769|NCT02896400|17328495|P3|3 Month Follow-up|Death|0
5032770|NCT02896400|17328496|P2|3 Month Follow-up|Death|0
5032771|NCT02896400|17328497|P1|3 Month Follow-up|Death|0
5032772|NCT02896400|17328482|P16|3 Month Follow-up|Lost to Follow-up|2
5032773|NCT02896400|17328483|P15|3 Month Follow-up|Lost to Follow-up|3
5032774|NCT02896400|17328484|P14|3 Month Follow-up|Lost to Follow-up|5
5032775|NCT02896400|17328485|P13|3 Month Follow-up|Lost to Follow-up|3
5032776|NCT02896400|17328486|P12|3 Month Follow-up|Lost to Follow-up|6
5032777|NCT02896400|17328487|P11|3 Month Follow-up|Lost to Follow-up|6
5032778|NCT02896400|17328488|P10|3 Month Follow-up|Lost to Follow-up|5
5032779|NCT02896400|17328489|P9|3 Month Follow-up|Lost to Follow-up|6
5032780|NCT02896400|17328490|P8|3 Month Follow-up|Lost to Follow-up|3
5032781|NCT02896400|17328491|P7|3 Month Follow-up|Lost to Follow-up|4
5032782|NCT02896400|17328492|P6|3 Month Follow-up|Lost to Follow-up|6
5032783|NCT02896400|17328493|P5|3 Month Follow-up|Lost to Follow-up|12
5032784|NCT02896400|17328494|P4|3 Month Follow-up|Lost to Follow-up|11
5032785|NCT02896400|17328495|P3|3 Month Follow-up|Lost to Follow-up|6
5032786|NCT02896400|17328496|P2|3 Month Follow-up|Lost to Follow-up|3
5032787|NCT02896400|17328497|P1|3 Month Follow-up|Lost to Follow-up|6
5032788|NCT02896400|17328482|P16|1 Month Follow-up|Death|1
5032789|NCT02896400|17328483|P15|1 Month Follow-up|Death|0
5032790|NCT02896400|17328484|P14|1 Month Follow-up|Death|0
5032791|NCT02896400|17328485|P13|1 Month Follow-up|Death|0
5032792|NCT02896400|17328486|P12|1 Month Follow-up|Death|0
5032793|NCT02896400|17328487|P11|1 Month Follow-up|Death|0
5032794|NCT02896400|17328488|P10|1 Month Follow-up|Death|0
5032795|NCT02896400|17328489|P9|1 Month Follow-up|Death|0
5032796|NCT02896400|17328490|P8|1 Month Follow-up|Death|0
5032797|NCT02896400|17328491|P7|1 Month Follow-up|Death|0
5032798|NCT02896400|17328492|P6|1 Month Follow-up|Death|0
5032799|NCT02896400|17328493|P5|1 Month Follow-up|Death|0
5032800|NCT02896400|17328494|P4|1 Month Follow-up|Death|0
5032801|NCT02896400|17328495|P3|1 Month Follow-up|Death|0
5032802|NCT02896400|17328496|P2|1 Month Follow-up|Death|0
5032803|NCT02896400|17328497|P1|1 Month Follow-up|Death|0
5032804|NCT02896400|17328482|P16|1 Month Follow-up|Lost to Follow-up|2
5032805|NCT02896400|17328483|P15|1 Month Follow-up|Lost to Follow-up|1
5032806|NCT02896400|17328484|P14|1 Month Follow-up|Lost to Follow-up|4
5032807|NCT02896400|17328485|P13|1 Month Follow-up|Lost to Follow-up|3
5032808|NCT02896400|17328486|P12|1 Month Follow-up|Lost to Follow-up|5
5032809|NCT02896400|17328487|P11|1 Month Follow-up|Lost to Follow-up|5
5032810|NCT02896400|17328488|P10|1 Month Follow-up|Lost to Follow-up|7
5032811|NCT02896400|17328489|P9|1 Month Follow-up|Lost to Follow-up|4
5032812|NCT02896400|17328490|P8|1 Month Follow-up|Lost to Follow-up|6
5032813|NCT02896400|17328491|P7|1 Month Follow-up|Lost to Follow-up|5
5032814|NCT02896400|17328492|P6|1 Month Follow-up|Lost to Follow-up|6
5032815|NCT02896400|17328493|P5|1 Month Follow-up|Lost to Follow-up|9
5032816|NCT02896400|17328494|P4|1 Month Follow-up|Lost to Follow-up|8
5032817|NCT02896400|17328495|P3|1 Month Follow-up|Lost to Follow-up|5
5032818|NCT02896400|17328496|P2|1 Month Follow-up|Lost to Follow-up|7
5032819|NCT02896400|17328497|P1|1 Month Follow-up|Lost to Follow-up|7
5032985|NCT02887183|17329665|P1|Overall Study|Withdrawal by Subject|35
5032820|NCT02896361|17328523|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
5032821|NCT02896361|17328524|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
5032822|NCT02896361|17328525|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
5032823|NCT02896361|17328523|P3|Third Intervention (2 Weeks)|Protocol Violation|0
5032824|NCT02896361|17328524|P2|Third Intervention (2 Weeks)|Protocol Violation|0
5032825|NCT02896361|17328525|P1|Third Intervention (2 Weeks)|Protocol Violation|1
5032826|NCT02896296|17328543|P1|Overall Study|Relocation|1
5032827|NCT02896296|17328543|P1|Overall Study|Incarceration|1
5032828|NCT02896296|17328543|P1|Overall Study|Site closing|7
5032829|NCT02896296|17328543|P1|Overall Study|Withdrawal by Subject|10
5032830|NCT02896296|17328543|P1|Overall Study|Physician Decision|2
5032831|NCT02896296|17328543|P1|Overall Study|Pregnancy|1
5032832|NCT02896296|17328543|P1|Overall Study|Lost to Follow-up|19
5032833|NCT02896296|17328543|P1|Overall Study|Adverse Event|1
5032834|NCT02895347|17328551|P2|Overall Study|Withdrawal by Subject|1
5032835|NCT02895347|17328552|P1|Overall Study|Withdrawal by Subject|3
5032836|NCT02895295|17328564|P3|Overall Study|Survey Non-response|92
5032837|NCT02895295|17328565|P2|Overall Study|Survey Non-response|94
5032838|NCT02895295|17328566|P1|Overall Study|Survey Non-response|71
5032839|NCT02894840|17328600|P4|Overall Study|Lost to Follow-up|0
5032840|NCT02894840|17328601|P3|Overall Study|Lost to Follow-up|3
5032841|NCT02894840|17328602|P2|Overall Study|Lost to Follow-up|0
5032842|NCT02894840|17328603|P1|Overall Study|Lost to Follow-up|1
5032843|NCT02892734|17328875|P1|Follow up for 2 Years|Study closed early|1
5032844|NCT02892734|17328875|P1|Follow up for 2 Years|Death|2
5032845|NCT02892734|17328875|P1|Treatment on Study|Progressive Disease|2
5032846|NCT02892513|17328885|P2|Overall Study|Withdrawal by Subject|1
5032847|NCT02892513|17328886|P1|Overall Study|Withdrawal by Subject|0
5032848|NCT02892448|17328906|P3|Overall Study|Screening failure|1
5032849|NCT02892448|17328907|P2|Overall Study|Screening failure|2
5032850|NCT02892448|17328908|P1|Overall Study|Screening failure|2
5032851|NCT02892422|17328928|P1|Overall Study|Investigator decision|1
5032852|NCT02892422|17328928|P1|Overall Study|patient decision|7
5032853|NCT02892422|17328928|P1|Overall Study|patient legally incapable|1
5032854|NCT02892422|17328928|P1|Overall Study|non-compliance|10
5032855|NCT02892422|17328928|P1|Overall Study|moving elsewhere|4
5032856|NCT02892422|17328928|P1|Overall Study|exclusion criteria met|3
5032857|NCT02892422|17328928|P1|Overall Study|withdrawal of consent|13
5032858|NCT02892422|17328928|P1|Overall Study|sponsor information 16159A results|21
5032859|NCT02892422|17328928|P1|Overall Study|Lost to Follow-up|5
5032860|NCT02892422|17328928|P1|Overall Study|Withdrawal by Subject|56
5032861|NCT02892422|17328928|P1|Overall Study|Protocol Violation|4
5032862|NCT02892422|17328928|P1|Overall Study|Non-compliance with study drug|11
5032863|NCT02892422|17328928|P1|Overall Study|Lack of Efficacy|32
5032864|NCT02892422|17328928|P1|Overall Study|Adverse Event|38
5032865|NCT02892422|17328928|P1|Overall Study|Enrolled not treated|4
5032866|NCT02892409|17328934|P2|Overall Study|Withdrawal by Subject|1
5032867|NCT02892409|17328935|P1|Overall Study|Withdrawal by Subject|2
5032868|NCT02892409|17328934|P2|Overall Study|Adverse Event|0
5032869|NCT02892409|17328935|P1|Overall Study|Adverse Event|1
5032870|NCT02892344|17328957|P2|Overall Study|Technical problems|1
5032871|NCT02892344|17328958|P1|Overall Study|Technical problems|0
5032872|NCT02892344|17328957|P2|Overall Study|Subject/guardian decision|4
5032873|NCT02892344|17328958|P1|Overall Study|Subject/guardian decision|0
5032874|NCT02892344|17328957|P2|Overall Study|Physician Decision|2
5032875|NCT02892344|17328958|P1|Overall Study|Physician Decision|0
5032876|NCT02892344|17328957|P2|Overall Study|Non-compliance with study treatment|1
5032877|NCT02892344|17328958|P1|Overall Study|Non-compliance with study treatment|0
5032878|NCT02892344|17328957|P2|Overall Study|Lost to Follow-up|1
5032879|NCT02892344|17328958|P1|Overall Study|Lost to Follow-up|0
5032880|NCT02892344|17328957|P2|Overall Study|Adverse Event|8
5032881|NCT02892344|17328958|P1|Overall Study|Adverse Event|1
5032882|NCT02892344|17328957|P2|Overall Study|Protocol deviation|4
5032883|NCT02892344|17328958|P1|Overall Study|Protocol deviation|3
5032884|NCT02892019|17329007|P2|Overall Study|Adverse Event|1
5032885|NCT02892019|17329008|P1|Overall Study|Adverse Event|1
5032886|NCT02892019|17329007|P2|Overall Study|Withdrawal by Subject|1
5032887|NCT02892019|17329008|P1|Overall Study|Withdrawal by Subject|0
5032888|NCT02892019|17329007|P2|Overall Study|randomized but not treated|1
5032889|NCT02892019|17329008|P1|Overall Study|randomized but not treated|0
5032890|NCT02891200|17329048|P2|Overall Study|Withdrawal by Subject|4
5032891|NCT02891200|17329049|P1|Overall Study|Withdrawal by Subject|1
5032892|NCT02891200|17329048|P2|Overall Study|Death|9
5032893|NCT02891200|17329049|P1|Overall Study|Death|10
5032894|NCT02891200|17329048|P2|Overall Study|Lost to Follow-up|36
5032895|NCT02891200|17329049|P1|Overall Study|Lost to Follow-up|31
5032896|NCT02891174|17329077|P2|Second Intervention (24 Hours)|Protocol Violation|1
5032897|NCT02891174|17329078|P1|Second Intervention (24 Hours)|Protocol Violation|0
5032898|NCT02891174|17329077|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
5032899|NCT02891174|17329078|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
5032900|NCT02891174|17329077|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
5032901|NCT02891174|17329078|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
5032902|NCT02891174|17329077|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
5032903|NCT02891174|17329078|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
5032904|NCT02891174|17329077|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
5032905|NCT02891174|17329078|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
5032906|NCT02891174|17329077|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
5032907|NCT02891174|17329078|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
5032908|NCT02891174|17329077|P2|First Intervention (24 Hours)|Declined any study medication|5
5032909|NCT02891174|17329078|P1|First Intervention (24 Hours)|Declined any study medication|1
5032910|NCT02891070|17329092|P2|Overall Study|Death|0
5032911|NCT02891070|17329093|P1|Overall Study|Death|3
5032912|NCT02891070|17329092|P2|Overall Study|Withdrawal by Subject|2
5032913|NCT02891070|17329093|P1|Overall Study|Withdrawal by Subject|1
5032914|NCT02891070|17329092|P2|Overall Study|Protocol Violation|1
5032915|NCT02891070|17329093|P1|Overall Study|Protocol Violation|0
5032916|NCT02891070|17329092|P2|Overall Study|Other|0
5032917|NCT02891070|17329093|P1|Overall Study|Other|1
5032918|NCT02891070|17329092|P2|Overall Study|Lost to Follow-up|4
5032919|NCT02891070|17329093|P1|Overall Study|Lost to Follow-up|4
5032920|NCT02891070|17329092|P2|Overall Study|Physician Decision|1
5032921|NCT02891070|17329093|P1|Overall Study|Physician Decision|0
5032922|NCT02891070|17329092|P2|Overall Study|Adverse Event|0
5032923|NCT02891070|17329093|P1|Overall Study|Adverse Event|1
5032924|NCT02890992|17329119|P8|130 Weeks Open-Label Extension Period|Other than specified|0
5032925|NCT02890992|17329120|P7|130 Weeks Open-Label Extension Period|Other than specified|0
5032926|NCT02890992|17329121|P6|130 Weeks Open-Label Extension Period|Other than specified|0
5032927|NCT02890992|17329122|P5|130 Weeks Open-Label Extension Period|Other than specified|0
5032928|NCT02890992|17329123|P4|130 Weeks Open-Label Extension Period|Other than specified|0
5032929|NCT02890992|17329124|P3|130 Weeks Open-Label Extension Period|Other than specified|0
5032930|NCT02890992|17329125|P2|130 Weeks Open-Label Extension Period|Other than specified|2
5032931|NCT02890992|17329126|P1|130 Weeks Open-Label Extension Period|Other than specified|0
5032932|NCT02890992|17329119|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
5032933|NCT02890992|17329120|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
5032934|NCT02890992|17329121|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
5032935|NCT02890992|17329122|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
5032936|NCT02890992|17329123|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
5032937|NCT02890992|17329124|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
5032938|NCT02890992|17329125|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
5032939|NCT02890992|17329126|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
5032940|NCT02890992|17329119|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
5032941|NCT02890992|17329120|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
5032942|NCT02890992|17329121|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
5032943|NCT02890992|17329122|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
5032944|NCT02890992|17329123|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
5032945|NCT02890992|17329124|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
5032946|NCT02890992|17329125|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
5032947|NCT02890992|17329126|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
5032948|NCT02890355|17329323|P2|Overall Study|Not protocol specified|4
5032949|NCT02890355|17329324|P1|Overall Study|Not protocol specified|3
5032950|NCT02890355|17329323|P2|Overall Study|Progression/relapse|39
5032951|NCT02890355|17329324|P1|Overall Study|Progression/relapse|46
5032952|NCT02890355|17329323|P2|Overall Study|Refusal unrelated to adverse event|10
5032953|NCT02890355|17329324|P1|Overall Study|Refusal unrelated to adverse event|5
5032954|NCT02890355|17329323|P2|Overall Study|Adverse Event|5
5032955|NCT02890355|17329324|P1|Overall Study|Adverse Event|5
5032956|NCT02889900|17329344|P1|Overall Study|Not treated|2
5032957|NCT02889900|17329344|P1|Overall Study|Withdrawal by Subject|7
5032958|NCT02889900|17329344|P1|Overall Study|Other|5
5032959|NCT02889900|17329344|P1|Overall Study|Condition under investigation worsened|32
5032960|NCT02889900|17329344|P1|Overall Study|Adverse Event|11
5032961|NCT02889861|17329356|P1|Overall Study|Ongoing in Survival Follow-up|2
5032962|NCT02888756|17329389|P3|Analytical Treatment Interruption|Physician Decision|5
5032963|NCT02888756|17329390|P2|Analytical Treatment Interruption|Physician Decision|6
5032964|NCT02888756|17329391|P1|Analytical Treatment Interruption|Physician Decision|10
5032965|NCT02888171|17329531|P2|Overall Study|Adverse Event|1
5032966|NCT02888171|17329532|P1|Overall Study|Adverse Event|0
5032967|NCT02888171|17329531|P2|Overall Study|Withdrawal by Subject|2
5032968|NCT02888171|17329532|P1|Overall Study|Withdrawal by Subject|3
5032969|NCT02888171|17329531|P2|Overall Study|Lost to Follow-up|1
5032970|NCT02888171|17329532|P1|Overall Study|Lost to Follow-up|2
5032971|NCT02888080|17329561|P2|Overall Study|Adverse Event|1
5032972|NCT02888080|17329562|P1|Overall Study|Adverse Event|0
5032973|NCT02888080|17329561|P2|Overall Study|Lack of Efficacy|1
5032974|NCT02888080|17329562|P1|Overall Study|Lack of Efficacy|0
5032975|NCT02888080|17329561|P2|Overall Study|New Therapy for study indication|0
5032976|NCT02888080|17329562|P1|Overall Study|New Therapy for study indication|1
5032977|NCT02888080|17329561|P2|Overall Study|Subject / Guardian decision|3
5032978|NCT02888080|17329562|P1|Overall Study|Subject / Guardian decision|1
5032979|NCT02887989|17329588|P2|Overall Study|Death|0
5032980|NCT02887989|17329589|P1|Overall Study|Death|1
5032981|NCT02887989|17329588|P2|Overall Study|Withdrawal by Subject|11
5032982|NCT02887989|17329589|P1|Overall Study|Withdrawal by Subject|8
5032983|NCT02887521|17329601|P2|Overall Study|Withdrawal by Subject|3
5032984|NCT02887521|17329602|P1|Overall Study|Withdrawal by Subject|0
5032986|NCT02887183|17329665|P1|Overall Study|Physician Decision|10
5032987|NCT02887183|17329665|P1|Overall Study|Lost to Follow-up|13
5032988|NCT02887183|17329665|P1|Overall Study|Technical Problems|2
5032989|NCT02887183|17329665|P1|Overall Study|Protocol Violation|6
5032990|NCT02887183|17329665|P1|Overall Study|Pregnancy|1
5032991|NCT02887183|17329665|P1|Overall Study|Death|30
5032992|NCT02887183|17329665|P1|Overall Study|Adverse Event|44
5032993|NCT02886715|17329692|P3|Overall Study|missing|2
5032994|NCT02886715|17329693|P2|Overall Study|missing|2
5032995|NCT02886715|17329694|P1|Overall Study|missing|7
5032996|NCT02886715|17329692|P3|Overall Study|Withdrawal by Subject|5
5032997|NCT02886715|17329693|P2|Overall Study|Withdrawal by Subject|18
5032998|NCT02886715|17329694|P1|Overall Study|Withdrawal by Subject|20
5032999|NCT02886715|17329692|P3|Overall Study|Protocol Violation|1
5033000|NCT02886715|17329693|P2|Overall Study|Protocol Violation|2
5033001|NCT02886715|17329694|P1|Overall Study|Protocol Violation|3
5033002|NCT02886715|17329692|P3|Overall Study|Pregnancy|1
5033003|NCT02886715|17329693|P2|Overall Study|Pregnancy|1
5033004|NCT02886715|17329694|P1|Overall Study|Pregnancy|1
5033005|NCT02886715|17329692|P3|Overall Study|Lost to Follow-up|10
5033006|NCT02886715|17329693|P2|Overall Study|Lost to Follow-up|26
5033007|NCT02886715|17329694|P1|Overall Study|Lost to Follow-up|29
5033008|NCT02886715|17329692|P3|Overall Study|Lack of Efficacy|1
5033009|NCT02886715|17329693|P2|Overall Study|Lack of Efficacy|2
5033010|NCT02886715|17329694|P1|Overall Study|Lack of Efficacy|0
5033011|NCT02886715|17329692|P3|Overall Study|Adverse Event|0
5033012|NCT02886715|17329693|P2|Overall Study|Adverse Event|2
5033013|NCT02886715|17329694|P1|Overall Study|Adverse Event|4
5033014|NCT02886715|17329692|P3|Overall Study|Non-Compliance With Study Drug|0
5033015|NCT02886715|17329693|P2|Overall Study|Non-Compliance With Study Drug|2
5033016|NCT02886715|17329694|P1|Overall Study|Non-Compliance With Study Drug|0
5033017|NCT02886702|17329711|P3|Overall Study|Administrative Reasons|1
5033018|NCT02886702|17329712|P2|Overall Study|Administrative Reasons|0
5033019|NCT02886702|17329713|P1|Overall Study|Administrative Reasons|0
5033020|NCT02886702|17329711|P3|Overall Study|Adverse Event|3
5033021|NCT02886702|17329712|P2|Overall Study|Adverse Event|9
5033022|NCT02886702|17329713|P1|Overall Study|Adverse Event|4
5033023|NCT02886702|17329711|P3|Overall Study|Lack of Efficacy|5
5033024|NCT02886702|17329712|P2|Overall Study|Lack of Efficacy|4
5033025|NCT02886702|17329713|P1|Overall Study|Lack of Efficacy|3
5033026|NCT02886702|17329711|P3|Overall Study|Lost to Follow-up|8
5033027|NCT02886702|17329712|P2|Overall Study|Lost to Follow-up|13
5033028|NCT02886702|17329713|P1|Overall Study|Lost to Follow-up|11
5033029|NCT02886702|17329711|P3|Overall Study|Non-Compliance With Study Drug|4
5033030|NCT02886702|17329712|P2|Overall Study|Non-Compliance With Study Drug|1
5033031|NCT02886702|17329713|P1|Overall Study|Non-Compliance With Study Drug|0
5033032|NCT02886702|17329711|P3|Overall Study|Protocol Violation|1
5033033|NCT02886702|17329712|P2|Overall Study|Protocol Violation|2
5033034|NCT02886702|17329713|P1|Overall Study|Protocol Violation|2
5033035|NCT02886702|17329711|P3|Overall Study|Significant Worsening of Condition|0
5033036|NCT02886702|17329712|P2|Overall Study|Significant Worsening of Condition|1
5033037|NCT02886702|17329713|P1|Overall Study|Significant Worsening of Condition|0
5033038|NCT02886702|17329711|P3|Overall Study|Withdrawal by Subject|22
5033039|NCT02886702|17329712|P2|Overall Study|Withdrawal by Subject|18
5033040|NCT02886702|17329713|P1|Overall Study|Withdrawal by Subject|24
5033041|NCT02886702|17329711|P3|Overall Study|Other|9
5033042|NCT02886702|17329712|P2|Overall Study|Other|3
5033043|NCT02886702|17329713|P1|Overall Study|Other|4
5033044|NCT02886624|17329727|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
5033045|NCT02886624|17329727|P1|12-week Post Treatment Follow-up|Death|1
5033046|NCT02886338|17329736|P1|Overall Study|Withdrawal by Subject|1
5033047|NCT02885181|17329925|P4|Overall Study|Withdrawal by Subject|1
5033048|NCT02885181|17329926|P3|Overall Study|Withdrawal by Subject|0
5033049|NCT02885181|17329927|P2|Overall Study|Withdrawal by Subject|0
5033050|NCT02885181|17329928|P1|Overall Study|Withdrawal by Subject|0
5033051|NCT02885181|17329925|P4|Overall Study|Adverse Event|1
5033052|NCT02885181|17329926|P3|Overall Study|Adverse Event|0
5033053|NCT02885181|17329927|P2|Overall Study|Adverse Event|0
5033054|NCT02885181|17329928|P1|Overall Study|Adverse Event|0
5033055|NCT02885181|17329925|P4|Overall Study|Investigator's Discretion|1
5033056|NCT02885181|17329926|P3|Overall Study|Investigator's Discretion|0
5033057|NCT02885181|17329927|P2|Overall Study|Investigator's Discretion|1
5033058|NCT02885181|17329928|P1|Overall Study|Investigator's Discretion|0
5033059|NCT02884089|17330040|P4|Follow-up Visit|Withdrawal by Subject|1
5033060|NCT02884089|17330041|P3|Follow-up Visit|Withdrawal by Subject|0
5033061|NCT02884089|17330042|P2|Follow-up Visit|Withdrawal by Subject|0
5033062|NCT02884089|17330043|P1|Follow-up Visit|Withdrawal by Subject|1
5033063|NCT02884089|17330040|P4|Period 4|Lost to Follow-up|0
5033064|NCT02884089|17330041|P3|Period 4|Lost to Follow-up|0
5033065|NCT02884089|17330042|P2|Period 4|Lost to Follow-up|0
5033066|NCT02884089|17330043|P1|Period 4|Lost to Follow-up|1
5033067|NCT02884089|17330040|P4|Period 4|Withdrawal by Subject|0
5033068|NCT02884089|17330041|P3|Period 4|Withdrawal by Subject|0
5033069|NCT02884089|17330042|P2|Period 4|Withdrawal by Subject|1
5033070|NCT02884089|17330043|P1|Period 4|Withdrawal by Subject|0
5033071|NCT02884089|17330040|P4|Washout Period 3|Lost to Follow-up|1
5033072|NCT02884089|17330041|P3|Washout Period 3|Lost to Follow-up|0
5033073|NCT02884089|17330042|P2|Washout Period 3|Lost to Follow-up|0
5033074|NCT02884089|17330043|P1|Washout Period 3|Lost to Follow-up|0
5033075|NCT02884089|17330040|P4|Washout Period 3|Withdrawal by Subject|0
5033076|NCT02884089|17330041|P3|Washout Period 3|Withdrawal by Subject|1
5033077|NCT02884089|17330042|P2|Washout Period 3|Withdrawal by Subject|0
5033078|NCT02884089|17330043|P1|Washout Period 3|Withdrawal by Subject|0
5033079|NCT02884089|17330040|P4|Period 3|Withdrawal by Subject|0
5033080|NCT02884089|17330041|P3|Period 3|Withdrawal by Subject|1
5033081|NCT02884089|17330042|P2|Period 3|Withdrawal by Subject|0
5033082|NCT02884089|17330043|P1|Period 3|Withdrawal by Subject|0
5033083|NCT02884089|17330040|P4|Period 2|Adverse Event|0
5033084|NCT02884089|17330041|P3|Period 2|Adverse Event|0
5033085|NCT02884089|17330042|P2|Period 2|Adverse Event|0
5033086|NCT02884089|17330043|P1|Period 2|Adverse Event|1
5033087|NCT02884089|17330040|P4|Washout Period 1|Withdrawal by Subject|0
5033088|NCT02884089|17330041|P3|Washout Period 1|Withdrawal by Subject|0
5033089|NCT02884089|17330042|P2|Washout Period 1|Withdrawal by Subject|1
5033090|NCT02884089|17330043|P1|Washout Period 1|Withdrawal by Subject|0
5033091|NCT02884089|17330040|P4|Washout Period 1|Lost to Follow-up|1
5033092|NCT02884089|17330041|P3|Washout Period 1|Lost to Follow-up|0
5033093|NCT02884089|17330042|P2|Washout Period 1|Lost to Follow-up|1
5033094|NCT02884089|17330043|P1|Washout Period 1|Lost to Follow-up|0
5033095|NCT02884089|17330040|P4|Period 1|Dosing error|0
5033096|NCT02884089|17330041|P3|Period 1|Dosing error|0
5033097|NCT02884089|17330042|P2|Period 1|Dosing error|2
5033098|NCT02884089|17330043|P1|Period 1|Dosing error|2
5033099|NCT02883452|17330063|P6|Overall Study|Other|1
5033100|NCT02883452|17330064|P5|Overall Study|Other|0
5033101|NCT02883452|17330065|P4|Overall Study|Other|0
5033102|NCT02883452|17330066|P3|Overall Study|Other|0
5033103|NCT02883452|17330067|P2|Overall Study|Other|0
5033104|NCT02883452|17330068|P1|Overall Study|Other|0
5033105|NCT02883452|17330063|P6|Overall Study|Death|0
5033106|NCT02883452|17330064|P5|Overall Study|Death|0
5033107|NCT02883452|17330065|P4|Overall Study|Death|0
5033108|NCT02883452|17330066|P3|Overall Study|Death|1
5033109|NCT02883452|17330067|P2|Overall Study|Death|0
5033110|NCT02883452|17330068|P1|Overall Study|Death|1
5033111|NCT02883452|17330063|P6|Overall Study|Physician Decision|1
5033112|NCT02883452|17330064|P5|Overall Study|Physician Decision|4
5033113|NCT02883452|17330065|P4|Overall Study|Physician Decision|0
5033114|NCT02883452|17330066|P3|Overall Study|Physician Decision|0
5033115|NCT02883452|17330067|P2|Overall Study|Physician Decision|0
5033116|NCT02883452|17330068|P1|Overall Study|Physician Decision|0
5033117|NCT02883452|17330063|P6|Overall Study|Adverse Event|3
5033118|NCT02883452|17330064|P5|Overall Study|Adverse Event|1
5033119|NCT02883452|17330065|P4|Overall Study|Adverse Event|1
5033120|NCT02883452|17330066|P3|Overall Study|Adverse Event|1
5033121|NCT02883452|17330067|P2|Overall Study|Adverse Event|1
5033122|NCT02883452|17330068|P1|Overall Study|Adverse Event|2
5033123|NCT02883452|17330063|P6|Overall Study|Disease progression|5
5033124|NCT02883452|17330064|P5|Overall Study|Disease progression|4
5033125|NCT02883452|17330065|P4|Overall Study|Disease progression|1
5033126|NCT02883452|17330066|P3|Overall Study|Disease progression|0
5033127|NCT02883452|17330067|P2|Overall Study|Disease progression|0
5033128|NCT02883452|17330068|P1|Overall Study|Disease progression|1
5033129|NCT02883452|17330063|P6|Overall Study|Withdrawal by Subject|5
5033130|NCT02883452|17330064|P5|Overall Study|Withdrawal by Subject|2
5033131|NCT02883452|17330065|P4|Overall Study|Withdrawal by Subject|0
5033132|NCT02883452|17330066|P3|Overall Study|Withdrawal by Subject|3
5033133|NCT02883452|17330067|P2|Overall Study|Withdrawal by Subject|1
5033134|NCT02883452|17330068|P1|Overall Study|Withdrawal by Subject|1
5033135|NCT02883244|17330096|P2|Overall Study|Lost to Follow-up|1
5033136|NCT02883244|17330097|P1|Overall Study|Lost to Follow-up|0
5033137|NCT02882854|17330115|P2|Overall Study|Physician Decision|1
5033138|NCT02882854|17330116|P1|Overall Study|Physician Decision|0
5033139|NCT02882854|17330115|P2|Overall Study|Lost to Follow-up|2
5033140|NCT02882854|17330116|P1|Overall Study|Lost to Follow-up|1
5033141|NCT02882152|17330159|P2|Overall Study|Lost to Follow-up|0
5033142|NCT02882152|17330160|P1|Overall Study|Lost to Follow-up|1
5033143|NCT02881957|17330170|P2|Overall Study|Protocol Violation|0
5033144|NCT02881957|17330171|P1|Overall Study|Protocol Violation|1
5033145|NCT02881957|17330170|P2|Overall Study|Withdrawal by Subject|1
5033146|NCT02881957|17330171|P1|Overall Study|Withdrawal by Subject|2
5033147|NCT02881957|17330170|P2|Overall Study|Discharged within 48 hours|1
5033148|NCT02881957|17330171|P1|Overall Study|Discharged within 48 hours|0
5033149|NCT02881957|17330170|P2|Overall Study|Concurrent trial enrollment|1
5033150|NCT02881957|17330171|P1|Overall Study|Concurrent trial enrollment|0
5033151|NCT02881957|17330170|P2|Overall Study|Comfort care|1
5033152|NCT02881957|17330171|P1|Overall Study|Comfort care|0
5033153|NCT02881567|17330257|P1|Overall Study|Reason not Specified|3
5033154|NCT02881567|17330257|P1|Overall Study|Study terminated by sponsor|9
5033155|NCT02881567|17330257|P1|Overall Study|Investigator decision|1
5033156|NCT02881567|17330257|P1|Overall Study|Consent withdrawn|1
5033157|NCT02881567|17330257|P1|Overall Study|Lost to Follow-up|3
5033158|NCT02881567|17330257|P1|Overall Study|Adverse Event|1
5033159|NCT02881047|17330273|P1|Overall Study|Withdrawal by Subject|1
5033160|NCT02881047|17330273|P1|Overall Study|Adverse Event|1
5033161|NCT02880865|17330325|P2|Overall Study|Physician Decision|1
5033162|NCT02880865|17330326|P1|Overall Study|Physician Decision|0
5033163|NCT02880865|17330325|P2|Overall Study|Withdrawal by Subject|2
5033164|NCT02880865|17330326|P1|Overall Study|Withdrawal by Subject|0
5033165|NCT02880865|17330325|P2|Overall Study|Adverse Event|0
5033166|NCT02880865|17330326|P1|Overall Study|Adverse Event|1
5033167|NCT02880761|17330409|P2|Overall Study|Lost to Follow-up|4
5033168|NCT02880761|17330410|P1|Overall Study|Lost to Follow-up|3
5033169|NCT02880761|17330409|P2|Overall Study|Protocol Violation|3
5033170|NCT02880761|17330410|P1|Overall Study|Protocol Violation|4
5033171|NCT02880761|17330409|P2|Overall Study|Withdrawal by Subject|6
5033172|NCT02880761|17330410|P1|Overall Study|Withdrawal by Subject|3
5033173|NCT02880761|17330409|P2|Overall Study|Death|8
5033174|NCT02880761|17330410|P1|Overall Study|Death|6
5033175|NCT02878590|17330638|P1|Overall Study|Withdrawal by Subject|2
5033176|NCT02878330|17330676|P2|Overall Study|Other|7
5033177|NCT02878330|17330677|P1|Overall Study|Other|4
5033178|NCT02878330|17330676|P2|Overall Study|Withdrawal by Subject|21
5033179|NCT02878330|17330677|P1|Overall Study|Withdrawal by Subject|11
5033180|NCT02878330|17330676|P2|Overall Study|Lost to Follow-up|26
5033181|NCT02878330|17330677|P1|Overall Study|Lost to Follow-up|11
5033182|NCT02878330|17330676|P2|Overall Study|Death|2
5033183|NCT02878330|17330677|P1|Overall Study|Death|3
5033184|NCT02878213|17330693|P1|Overall Study|Adverse Event|1
5033185|NCT02878213|17330693|P1|Overall Study|Withdrawal by Subject|2
5033186|NCT02877927|17330700|P2|Overall Study|Missed EOT/PTE Visit|6
5033187|NCT02877927|17330701|P1|Overall Study|Missed EOT/PTE Visit|5
5033188|NCT02877927|17330700|P2|Overall Study|Physician Decision|1
5033189|NCT02877927|17330701|P1|Overall Study|Physician Decision|0
5033190|NCT02877927|17330700|P2|Overall Study|Withdrawal by Subject|12
5033191|NCT02877927|17330701|P1|Overall Study|Withdrawal by Subject|11
5033192|NCT02877927|17330700|P2|Overall Study|Lost to Follow-up|38
5033193|NCT02877927|17330701|P1|Overall Study|Lost to Follow-up|37
5033194|NCT02877927|17330700|P2|Overall Study|Adverse Event|0
5033195|NCT02877927|17330701|P1|Overall Study|Adverse Event|1
5033196|NCT02877680|17330732|P2|Overall Study|Lost to Follow-up|1
5033197|NCT02877680|17330733|P1|Overall Study|Lost to Follow-up|1
5033198|NCT02877082|17330791|P1|Overall Study|Trial was closed early|5
5033199|NCT02877004|17330802|P3|Overall Study|Pregnancy|1
5033200|NCT02877004|17330803|P2|Overall Study|Pregnancy|0
5033201|NCT02877004|17330804|P1|Overall Study|Pregnancy|0
5033202|NCT02876601|17330888|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5033203|NCT02876601|17330889|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
5033204|NCT02876601|17330890|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5033205|NCT02876601|17330891|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5033206|NCT02875977|17330989|P2|Overall Study|Lost to Follow-up|29
5033207|NCT02875977|17330990|P1|Overall Study|Lost to Follow-up|42
5033208|NCT02875834|17331008|P4|Randomized Treatment Phase|(Not collected)|9
5033209|NCT02875834|17331009|P3|Randomized Treatment Phase|(Not collected)|10
5033210|NCT02875834|17331010|P2|Randomized Treatment Phase|(Not collected)|9
5033211|NCT02875834|17331011|P1|Randomized Treatment Phase|(Not collected)|0
5033212|NCT02875834|17331008|P4|Randomized Treatment Phase|Protocol Violation|0
5033213|NCT02875834|17331009|P3|Randomized Treatment Phase|Protocol Violation|0
5033214|NCT02875834|17331010|P2|Randomized Treatment Phase|Protocol Violation|2
5033215|NCT02875834|17331011|P1|Randomized Treatment Phase|Protocol Violation|0
5033216|NCT02875834|17331008|P4|Randomized Treatment Phase|Withdrawal by Subject|0
5033217|NCT02875834|17331009|P3|Randomized Treatment Phase|Withdrawal by Subject|1
5033218|NCT02875834|17331010|P2|Randomized Treatment Phase|Withdrawal by Subject|3
5033219|NCT02875834|17331011|P1|Randomized Treatment Phase|Withdrawal by Subject|0
5033220|NCT02875834|17331008|P4|Open-label Phase|(Not collected)|0
5033221|NCT02875834|17331009|P3|Open-label Phase|(Not collected)|0
5033222|NCT02875834|17331010|P2|Open-label Phase|(Not collected)|0
5033223|NCT02875834|17331011|P1|Open-label Phase|(Not collected)|4
5033224|NCT02875834|17331008|P4|Open-label Phase|Withdrawal by Subject|0
5033225|NCT02875834|17331009|P3|Open-label Phase|Withdrawal by Subject|0
5033226|NCT02875834|17331010|P2|Open-label Phase|Withdrawal by Subject|0
5033227|NCT02875834|17331011|P1|Open-label Phase|Withdrawal by Subject|3
5033228|NCT02875613|17331069|P1|Overall Study|Withdrawal by Subject|1
5033229|NCT02875366|17331075|P2|Overall Study|Noncompliance|1
5033230|NCT02875366|17331076|P1|Overall Study|Noncompliance|0
5033231|NCT02875366|17331075|P2|Overall Study|Adverse Event|2
5033232|NCT02875366|17331076|P1|Overall Study|Adverse Event|0
5033233|NCT02875340|17331128|P1|Overall Study|Adverse Event|1
5033234|NCT02875340|17331128|P1|Overall Study|Physician Decision|3
5033235|NCT02875340|17331128|P1|Overall Study|Withdrawal by Subject|2
5033236|NCT02875340|17331128|P1|Overall Study|Death|2
5033237|NCT02875067|17331150|P1|Overall Study|Withdrawal by Termination of Study|5
5033238|NCT02875067|17331150|P1|Overall Study|Withdrawal by Subject|1
5033239|NCT02875028|17331165|P2|Washout Period|Withdrawal by Subject|1
5033240|NCT02875028|17331166|P1|Washout Period|Withdrawal by Subject|0
5033241|NCT02874924|17331197|P3|Overall Study|Withdrawal by Subject|0
5033242|NCT02874924|17331198|P2|Overall Study|Withdrawal by Subject|0
5033243|NCT02874924|17331199|P1|Overall Study|Withdrawal by Subject|1
5033244|NCT02874924|17331197|P3|Overall Study|Adverse Event|0
5033245|NCT02874924|17331198|P2|Overall Study|Adverse Event|0
5033246|NCT02874924|17331199|P1|Overall Study|Adverse Event|2
5033247|NCT02874794|17331232|P2|Overall Study|Death|1
5033248|NCT02874794|17331233|P1|Overall Study|Death|2
5033249|NCT02874794|17331232|P2|Overall Study|Withdrawal by Subject|8
5033250|NCT02874794|17331233|P1|Overall Study|Withdrawal by Subject|2
5033251|NCT02874794|17331232|P2|Overall Study|Physician Decision|2
5033252|NCT02874794|17331233|P1|Overall Study|Physician Decision|3
5033253|NCT02874742|17331265|P3|Overall Study|Ongoing|15
5033254|NCT02874742|17331266|P2|Overall Study|Ongoing|98
5033255|NCT02874742|17331267|P1|Overall Study|Ongoing|87
5033256|NCT02874742|17331265|P3|Overall Study|Other|0
5033257|NCT02874742|17331266|P2|Overall Study|Other|1
5033258|NCT02874742|17331267|P1|Overall Study|Other|3
5033259|NCT02874742|17331265|P3|Overall Study|Withdrawal by Subject|0
5033260|NCT02874742|17331266|P2|Overall Study|Withdrawal by Subject|4
5033261|NCT02874742|17331267|P1|Overall Study|Withdrawal by Subject|8
5033262|NCT02874742|17331265|P3|Overall Study|Lost to Follow-up|0
5033263|NCT02874742|17331266|P2|Overall Study|Lost to Follow-up|0
5033264|NCT02874742|17331267|P1|Overall Study|Lost to Follow-up|2
5033265|NCT02874742|17331265|P3|Overall Study|Death|1
5033266|NCT02874742|17331266|P2|Overall Study|Death|1
5033267|NCT02874742|17331267|P1|Overall Study|Death|3
5033268|NCT02874534|17331321|P2|Overall Study|Ongoing in study|1
5033269|NCT02874534|17331322|P1|Overall Study|Ongoing in study|1
5033270|NCT02874534|17331321|P2|Overall Study|Lost to Follow-up|2
5033271|NCT02874534|17331322|P1|Overall Study|Lost to Follow-up|2
5033272|NCT02874534|17331321|P2|Overall Study|Withdrawal by Subject|8
5033273|NCT02874534|17331322|P1|Overall Study|Withdrawal by Subject|5
5033274|NCT02873754|17331344|P1|Overall Study|Couldn't complete study procedures|1
5033275|NCT02873754|17331344|P1|Overall Study|Lost to Follow-up|5
5033276|NCT02873702|17331361|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
5033277|NCT02873702|17331362|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
5033278|NCT02873702|17331363|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
5033279|NCT02873702|17331364|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
5033280|NCT02873702|17331361|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
5033281|NCT02873702|17331362|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
5033282|NCT02873702|17331363|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
5033283|NCT02873702|17331364|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
5033284|NCT02873702|17331361|P4|Maintenance Period (up to Month 6)|Adverse Event|0
5033285|NCT02873702|17331362|P3|Maintenance Period (up to Month 6)|Adverse Event|1
5033286|NCT02873702|17331363|P2|Maintenance Period (up to Month 6)|Adverse Event|0
5033287|NCT02873702|17331364|P1|Maintenance Period (up to Month 6)|Adverse Event|0
5033288|NCT02873702|17331361|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
5033289|NCT02873702|17331362|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
5033290|NCT02873702|17331363|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
5033291|NCT02873702|17331364|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
5033292|NCT02873702|17331361|P4|Healing Period (up to Week 8)|Adverse Event|0
5033293|NCT02873702|17331362|P3|Healing Period (up to Week 8)|Adverse Event|0
5033294|NCT02873702|17331363|P2|Healing Period (up to Week 8)|Adverse Event|0
5033295|NCT02873702|17331364|P1|Healing Period (up to Week 8)|Adverse Event|1
5033296|NCT02873689|17331376|P2|Overall Study|Randomized but not Treated|1
5033297|NCT02873689|17331377|P1|Overall Study|Randomized but not Treated|1
5033298|NCT02873689|17331376|P2|Overall Study|Adverse Event|2
5033299|NCT02873689|17331377|P1|Overall Study|Adverse Event|2
5033300|NCT02873689|17331376|P2|Overall Study|Protocol Violation|0
5033301|NCT02873689|17331377|P1|Overall Study|Protocol Violation|1
5033302|NCT02873689|17331376|P2|Overall Study|Withdrawal by Subject|2
5033303|NCT02873689|17331377|P1|Overall Study|Withdrawal by Subject|2
5033304|NCT02873689|17331376|P2|Overall Study|Lack of Efficacy|0
5033305|NCT02873689|17331377|P1|Overall Study|Lack of Efficacy|1
5033306|NCT02873429|17331418|P2|16 Weeks|Lost to Follow-up|0
5033307|NCT02873429|17331419|P1|16 Weeks|Lost to Follow-up|3
5033308|NCT02873429|17331418|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
5033309|NCT02873429|17331419|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
5033310|NCT02873429|17331418|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
5033311|NCT02873429|17331419|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
5033312|NCT02873377|17331431|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
5033313|NCT02873377|17331432|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
5033314|NCT02873377|17331431|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
5033315|NCT02873377|17331432|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
5033316|NCT02873221|17331690|P3|Safety Follow-up Period|Withdrawal of Consent|8
5033317|NCT02873221|17331691|P2|Safety Follow-up Period|Withdrawal of Consent|10
5033318|NCT02873221|17331692|P1|Safety Follow-up Period|Withdrawal of Consent|4
5033319|NCT02873221|17331690|P3|Safety Follow-up Period|Lost to Follow-up|5
5033320|NCT02873221|17331691|P2|Safety Follow-up Period|Lost to Follow-up|5
5033321|NCT02873221|17331692|P1|Safety Follow-up Period|Lost to Follow-up|3
5033322|NCT02873221|17331690|P3|Safety Follow-up Period|Protocol Violation|1
5033323|NCT02873221|17331691|P2|Safety Follow-up Period|Protocol Violation|0
5033324|NCT02873221|17331692|P1|Safety Follow-up Period|Protocol Violation|0
5033325|NCT02873221|17331690|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
5033326|NCT02873221|17331691|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
5033327|NCT02873221|17331692|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
5033328|NCT02873221|17331690|P3|Treatment Period|Lost to Follow-up|26
5033329|NCT02873221|17331691|P2|Treatment Period|Lost to Follow-up|30
5033330|NCT02873221|17331692|P1|Treatment Period|Lost to Follow-up|26
5033331|NCT02873221|17331690|P3|Treatment Period|Adverse Event|11
5033332|NCT02873221|17331691|P2|Treatment Period|Adverse Event|9
5033333|NCT02873221|17331692|P1|Treatment Period|Adverse Event|4
5033334|NCT02873221|17331690|P3|Treatment Period|Lack of Efficacy|12
5033335|NCT02873221|17331691|P2|Treatment Period|Lack of Efficacy|17
5033336|NCT02873221|17331692|P1|Treatment Period|Lack of Efficacy|0
5033337|NCT02873221|17331690|P3|Treatment Period|Withdrawal of Consent|41
5033338|NCT02873221|17331691|P2|Treatment Period|Withdrawal of Consent|51
5033339|NCT02873221|17331692|P1|Treatment Period|Withdrawal of Consent|52
5033340|NCT02873221|17331690|P3|Treatment Period|Lack of Qualifying Event|1
5033341|NCT02873221|17331691|P2|Treatment Period|Lack of Qualifying Event|3
5033342|NCT02873221|17331692|P1|Treatment Period|Lack of Qualifying Event|0
5033343|NCT02873221|17331690|P3|Treatment Period|Pregnancy|3
5033344|NCT02873221|17331691|P2|Treatment Period|Pregnancy|6
5033345|NCT02873221|17331692|P1|Treatment Period|Pregnancy|4
5033346|NCT02873221|17331690|P3|Treatment Period|Protocol Violation|8
5033347|NCT02873221|17331691|P2|Treatment Period|Protocol Violation|5
5033348|NCT02873221|17331692|P1|Treatment Period|Protocol Violation|2
5033349|NCT02873221|17331690|P3|Treatment Period|Non-Compliance with Study Drug|2
5033350|NCT02873221|17331691|P2|Treatment Period|Non-Compliance with Study Drug|3
5033351|NCT02873221|17331692|P1|Treatment Period|Non-Compliance with Study Drug|0
5033352|NCT02873221|17331690|P3|Treatment Period|Other Miscellaneous Reasons|1
5033353|NCT02873221|17331691|P2|Treatment Period|Other Miscellaneous Reasons|2
5033354|NCT02873221|17331692|P1|Treatment Period|Other Miscellaneous Reasons|0
5033355|NCT02873195|17331714|P2|Overall Study|Ineligible|0
5033356|NCT02873195|17331715|P1|Overall Study|Ineligible|5
5033357|NCT02872935|17331744|P2|Overall Study|Other|1
5033358|NCT02872935|17331745|P1|Overall Study|Other|0
5033359|NCT02872311|17331773|P5|Overall Study|Protocol Violation|0
5033360|NCT02872311|17331774|P4|Overall Study|Protocol Violation|0
5033361|NCT02872311|17331775|P3|Overall Study|Protocol Violation|1
5033362|NCT02872311|17331776|P2|Overall Study|Protocol Violation|2
5033363|NCT02872311|17331777|P1|Overall Study|Protocol Violation|0
5033364|NCT02872311|17331773|P5|Overall Study|Lost to Follow-up|0
5033365|NCT02872311|17331774|P4|Overall Study|Lost to Follow-up|0
5033366|NCT02872311|17331775|P3|Overall Study|Lost to Follow-up|0
5033367|NCT02872311|17331776|P2|Overall Study|Lost to Follow-up|0
5033368|NCT02872311|17331777|P1|Overall Study|Lost to Follow-up|2
5033369|NCT02872311|17331773|P5|Overall Study|Death|0
5033370|NCT02872311|17331774|P4|Overall Study|Death|0
5033371|NCT02872311|17331775|P3|Overall Study|Death|0
5033372|NCT02872311|17331776|P2|Overall Study|Death|0
5033373|NCT02872311|17331777|P1|Overall Study|Death|2
5033374|NCT02872285|17331838|P2|Overall Study|Discontinued due to back surgery|0
5033375|NCT02872285|17331839|P1|Overall Study|Discontinued due to back surgery|1
5033376|NCT02872285|17331838|P2|Overall Study|Lost to Follow-up|2
5033377|NCT02872285|17331839|P1|Overall Study|Lost to Follow-up|2
5033378|NCT02872285|17331838|P2|Overall Study|Withdrawal by Subject|0
5033379|NCT02872285|17331839|P1|Overall Study|Withdrawal by Subject|2
5033380|NCT02872012|17331885|P5|Overall Study|Withdrawal by Subject|0
5033381|NCT02872012|17331886|P4|Overall Study|Withdrawal by Subject|0
5033382|NCT02872012|17331887|P3|Overall Study|Withdrawal by Subject|0
5033383|NCT02872012|17331888|P2|Overall Study|Withdrawal by Subject|0
5033384|NCT02872012|17331889|P1|Overall Study|Withdrawal by Subject|1
5033385|NCT02871739|17331907|P4|Overall Study|Lost to Follow-up|2
5033386|NCT02871739|17331908|P3|Overall Study|Lost to Follow-up|0
5033387|NCT02871739|17331909|P2|Overall Study|Lost to Follow-up|2
5033388|NCT02871739|17331910|P1|Overall Study|Lost to Follow-up|3
5033389|NCT02871635|17331922|P2|Overall Study|Secondary lack of efficacy|1
5033390|NCT02871635|17331923|P1|Overall Study|Secondary lack of efficacy|2
5033391|NCT02871635|17331922|P2|Overall Study|Adverse Event|4
5033392|NCT02871635|17331923|P1|Overall Study|Adverse Event|4
5033393|NCT02871635|17331922|P2|Overall Study|Withdrawal by Subject|4
5033394|NCT02871635|17331923|P1|Overall Study|Withdrawal by Subject|3
5033395|NCT02871635|17331922|P2|Overall Study|Physician Decision|1
5033396|NCT02871635|17331923|P1|Overall Study|Physician Decision|1
5033397|NCT02871635|17331922|P2|Overall Study|Pregnancy|2
5033398|NCT02871635|17331923|P1|Overall Study|Pregnancy|0
5033399|NCT02871635|17331922|P2|Overall Study|Lost to Follow-up|2
5033400|NCT02871635|17331923|P1|Overall Study|Lost to Follow-up|1
5033401|NCT02871635|17331922|P2|Overall Study|Protocol Violation|1
5033402|NCT02871635|17331923|P1|Overall Study|Protocol Violation|3
5033403|NCT02871635|17331922|P2|Overall Study|Primary lack of efficacy|4
5033404|NCT02871635|17331923|P1|Overall Study|Primary lack of efficacy|4
5033405|NCT02871375|17332013|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
5033406|NCT02871375|17332014|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
5033407|NCT02870933|17332060|P2|Overall Study|Withdrawal by Subject|1
5033408|NCT02870933|17332061|P1|Overall Study|Withdrawal by Subject|0
5033409|NCT02870933|17332060|P2|Overall Study|Death|1
5033410|NCT02870933|17332061|P1|Overall Study|Death|2
5033411|NCT02869893|17332134|P1|Overall Study|participant fear of MRI scanner|2
5033412|NCT02869893|17332134|P1|Overall Study|participant aversion to IV|5
5033413|NCT02869438|17332164|P2|Overall Study|Withdrawal by Subject|2
5033414|NCT02869438|17332165|P1|Overall Study|Withdrawal by Subject|1
5033415|NCT02869438|17332164|P2|Overall Study|Adverse Event|0
5033416|NCT02869438|17332165|P1|Overall Study|Adverse Event|1
5033417|NCT02869438|17332164|P2|Overall Study|Lost to Follow-up|0
5033418|NCT02869438|17332165|P1|Overall Study|Lost to Follow-up|1
5033419|NCT02868892|17332213|P1|Overall Study|Investigator left site and no follow-up|6
5033420|NCT02868554|17332222|P3|Overall Study|Lost to Follow-up|1
5033421|NCT02868554|17332223|P2|Overall Study|Lost to Follow-up|0
5033422|NCT02868554|17332224|P1|Overall Study|Lost to Follow-up|3
5033423|NCT02868281|17332249|P2|Overall Study|Long journey/moving away|1
5033424|NCT02868281|17332250|P1|Overall Study|Long journey/moving away|1
5033425|NCT02868281|17332249|P2|Overall Study|Inclusion/exclusion criteria violation|2
5033426|NCT02868281|17332250|P1|Overall Study|Inclusion/exclusion criteria violation|3
5033427|NCT02868281|17332249|P2|Overall Study|Had protocol-defined asthma exacerbation|8
5033428|NCT02868281|17332250|P1|Overall Study|Had protocol-defined asthma exacerbation|8
5033429|NCT02868281|17332249|P2|Overall Study|Physician Decision|0
5033430|NCT02868281|17332250|P1|Overall Study|Physician Decision|2
5033431|NCT02868281|17332249|P2|Overall Study|Withdrawal by Subject|15
5033432|NCT02868281|17332250|P1|Overall Study|Withdrawal by Subject|11
5033433|NCT02868281|17332249|P2|Overall Study|Lost to Follow-up|6
5033434|NCT02868281|17332250|P1|Overall Study|Lost to Follow-up|3
5033435|NCT02868281|17332249|P2|Overall Study|Protocol Violation|10
5033436|NCT02868281|17332250|P1|Overall Study|Protocol Violation|13
5033437|NCT02868281|17332249|P2|Overall Study|Adverse Event|2
5033438|NCT02868281|17332250|P1|Overall Study|Adverse Event|2
5033439|NCT02868216|17332284|P2|Overall Study|Withdrawal by Subject|5
5033440|NCT02868216|17332285|P1|Overall Study|Withdrawal by Subject|7
5033441|NCT02868216|17332284|P2|Overall Study|coronary artery bypass|0
5033442|NCT02868216|17332285|P1|Overall Study|coronary artery bypass|1
5033443|NCT02868216|17332284|P2|Overall Study|Death|1
5033444|NCT02868216|17332285|P1|Overall Study|Death|0
5033445|NCT02867995|17332293|P2|Overall Study|Lost to Follow-up|2
5033446|NCT02867995|17332294|P1|Overall Study|Lost to Follow-up|0
5033447|NCT02867995|17332293|P2|Overall Study|Withdrawal by Subject|1
5033448|NCT02867995|17332294|P1|Overall Study|Withdrawal by Subject|0
5033449|NCT02867709|17332313|P3|Safety Follow-up Period|Protocol Violation|1
5033450|NCT02867709|17332314|P2|Safety Follow-up Period|Protocol Violation|1
5033451|NCT02867709|17332315|P1|Safety Follow-up Period|Protocol Violation|0
5033452|NCT02867709|17332313|P3|Safety Follow-up Period|Pregnancy|0
5033453|NCT02867709|17332314|P2|Safety Follow-up Period|Pregnancy|1
5033454|NCT02867709|17332315|P1|Safety Follow-up Period|Pregnancy|0
5033455|NCT02867709|17332313|P3|Safety Follow-up Period|Lost to Follow-up|7
5033456|NCT02867709|17332314|P2|Safety Follow-up Period|Lost to Follow-up|5
5033457|NCT02867709|17332315|P1|Safety Follow-up Period|Lost to Follow-up|10
5033458|NCT02867709|17332313|P3|Safety Follow-up Period|Withdrawal of Consent|6
5033459|NCT02867709|17332314|P2|Safety Follow-up Period|Withdrawal of Consent|8
5033460|NCT02867709|17332315|P1|Safety Follow-up Period|Withdrawal of Consent|1
5033461|NCT02867709|17332313|P3|Treatment Period|Protocol Violation|3
5033462|NCT02867709|17332314|P2|Treatment Period|Protocol Violation|2
5033463|NCT02867709|17332315|P1|Treatment Period|Protocol Violation|3
5033464|NCT02867709|17332313|P3|Treatment Period|Lack of Qualifying Event|42
5033465|NCT02867709|17332314|P2|Treatment Period|Lack of Qualifying Event|55
5033466|NCT02867709|17332315|P1|Treatment Period|Lack of Qualifying Event|42
5033467|NCT02867709|17332313|P3|Treatment Period|Lost to Follow-up|20
5033468|NCT02867709|17332314|P2|Treatment Period|Lost to Follow-up|20
5033469|NCT02867709|17332315|P1|Treatment Period|Lost to Follow-up|17
5033470|NCT02867709|17332313|P3|Treatment Period|Withdrawal of Consent|8
5033471|NCT02867709|17332314|P2|Treatment Period|Withdrawal of Consent|9
5033472|NCT02867709|17332315|P1|Treatment Period|Withdrawal of Consent|7
5033473|NCT02867709|17332313|P3|Treatment Period|Adverse Event|2
5033474|NCT02867709|17332314|P2|Treatment Period|Adverse Event|1
5033475|NCT02867709|17332315|P1|Treatment Period|Adverse Event|1
5033476|NCT02866942|17332422|P1|Overall Study|Invalid consent|1
5033477|NCT02866695|17332427|P1|Overall Study|Lost to Follow-up|1
5033478|NCT02866695|17332427|P1|Overall Study|Adverse Event|1
5033479|NCT02866175|17332444|P2|Overall Study|Did not receive treatment|15
5033480|NCT02866175|17332445|P1|Overall Study|Did not receive treatment|5
5033481|NCT02866175|17332444|P2|Overall Study|Physician Decision|15
5033482|NCT02866175|17332445|P1|Overall Study|Physician Decision|3
5033483|NCT02866175|17332444|P2|Overall Study|Lack of Efficacy|1
5033484|NCT02866175|17332445|P1|Overall Study|Lack of Efficacy|0
5033485|NCT02866175|17332444|P2|Overall Study|Lost to Follow-up|0
5033486|NCT02866175|17332445|P1|Overall Study|Lost to Follow-up|2
5033487|NCT02866175|17332444|P2|Overall Study|Progressive disease|1
5033488|NCT02866175|17332445|P1|Overall Study|Progressive disease|1
5033489|NCT02866175|17332444|P2|Overall Study|Other|14
5033490|NCT02866175|17332445|P1|Overall Study|Other|7
5033491|NCT02866175|17332444|P2|Overall Study|Death|23
5033492|NCT02866175|17332445|P1|Overall Study|Death|30
5033493|NCT02866175|17332444|P2|Overall Study|Withdrawal by Subject|52
5033494|NCT02866175|17332445|P1|Overall Study|Withdrawal by Subject|31
5033495|NCT02866175|17332444|P2|Overall Study|Adverse Event|54
5033496|NCT02866175|17332445|P1|Overall Study|Adverse Event|56
5033497|NCT02865915|17332465|P2|Overall Study|Dosing group discontinued|5
5033498|NCT02865915|17332466|P1|Overall Study|Dosing group discontinued|0
5033499|NCT02865915|17332465|P2|Overall Study|Study terminated by sponsor|18
5033500|NCT02865915|17332466|P1|Overall Study|Study terminated by sponsor|23
5033501|NCT02865915|17332465|P2|Overall Study|Protocol Violation|1
5033502|NCT02865915|17332466|P1|Overall Study|Protocol Violation|0
5033503|NCT02865915|17332465|P2|Overall Study|Lost to Follow-up|1
5033504|NCT02865915|17332466|P1|Overall Study|Lost to Follow-up|0
5033505|NCT02865915|17332465|P2|Overall Study|Adverse Event|4
5033506|NCT02865915|17332466|P1|Overall Study|Adverse Event|0
5033507|NCT02865915|17332465|P2|Overall Study|Withdrawal by Subject|1
5033508|NCT02865915|17332466|P1|Overall Study|Withdrawal by Subject|1
5033509|NCT02865915|17332465|P2|Overall Study|Pregnancy|0
5033510|NCT02865915|17332466|P1|Overall Study|Pregnancy|1
5033511|NCT02865499|17332509|P1|Baseline|Withdrawal by Subject|1
5033512|NCT02865499|17332509|P1|Baseline|Adverse Event|1
5033513|NCT02865395|17332516|P3|Overall Study|Physician Decision|7
5033514|NCT02865395|17332517|P2|Overall Study|Physician Decision|10
5033515|NCT02865395|17332518|P1|Overall Study|Physician Decision|6
5033516|NCT02865083|17332544|P2|Overall Study|Early Termination|1
5033517|NCT02865083|17332545|P1|Overall Study|Early Termination|3
5033518|NCT02864394|17332606|P2|Overall Study|Ongoing In Study|53
5033519|NCT02864394|17332607|P1|Overall Study|Ongoing In Study|77
5033520|NCT02864394|17332606|P2|Overall Study|Withdrawal by Subject|9
5033521|NCT02864394|17332607|P1|Overall Study|Withdrawal by Subject|1
5033522|NCT02864394|17332606|P2|Overall Study|Death|150
5033523|NCT02864394|17332607|P1|Overall Study|Death|135
5033524|NCT02864381|17332633|P2|Overall Study|Protocol Violation|1
5033525|NCT02864381|17332634|P1|Overall Study|Protocol Violation|0
5033526|NCT02864381|17332633|P2|Overall Study|Investigator's Discretion|0
5033527|NCT02864381|17332634|P1|Overall Study|Investigator's Discretion|1
5033528|NCT02864381|17332633|P2|Overall Study|Lost to Follow-up|1
5033529|NCT02864381|17332634|P1|Overall Study|Lost to Follow-up|1
5033530|NCT02864381|17332633|P2|Overall Study|Reason Unknown|3
5033531|NCT02864381|17332634|P1|Overall Study|Reason Unknown|7
5033532|NCT02864381|17332633|P2|Overall Study|Withdrew Consent|6
5033533|NCT02864381|17332634|P1|Overall Study|Withdrew Consent|5
5033534|NCT02864381|17332633|P2|Overall Study|Death|61
5033535|NCT02864381|17332634|P1|Overall Study|Death|58
5033536|NCT02864342|17332652|P2|Overall Study|Adverse Event|0
5033537|NCT02864342|17332653|P1|Overall Study|Adverse Event|1
5033538|NCT02864342|17332652|P2|Overall Study|Lost Device|0
5033539|NCT02864342|17332653|P1|Overall Study|Lost Device|1
5033540|NCT02864342|17332652|P2|Overall Study|Lost to Follow-up|5
5033541|NCT02864342|17332653|P1|Overall Study|Lost to Follow-up|1
5033542|NCT02864342|17332652|P2|Overall Study|Did Not Start Treatment with Symbicort|1
5033543|NCT02864342|17332653|P1|Overall Study|Did Not Start Treatment with Symbicort|0
5033544|NCT02864342|17332652|P2|Overall Study|Death|1
5033545|NCT02864342|17332653|P1|Overall Study|Death|0
5033546|NCT02864342|17332652|P2|Overall Study|Device Technology Issue|7
5033547|NCT02864342|17332653|P1|Overall Study|Device Technology Issue|6
5033548|NCT02864342|17332652|P2|Overall Study|Withdrawal by Subject|2
5033549|NCT02864342|17332653|P1|Overall Study|Withdrawal by Subject|4
5033550|NCT02864342|17332652|P2|Overall Study|Eligibility Criteria Deviation|3
5033551|NCT02864342|17332653|P1|Overall Study|Eligibility Criteria Deviation|2
5033552|NCT02864316|17332670|P2|Overall Study|Adverse Event|1
5033553|NCT02864316|17332671|P1|Overall Study|Adverse Event|0
5033554|NCT02864316|17332670|P2|Overall Study|Progressive Disease|1
5033555|NCT02864316|17332671|P1|Overall Study|Progressive Disease|2
5033556|NCT02863575|17332709|P3|Overall Study|Adverse Event|0
5033557|NCT02863575|17332710|P2|Overall Study|Adverse Event|1
5033558|NCT02863575|17332711|P1|Overall Study|Adverse Event|0
5033559|NCT02863575|17332709|P3|Overall Study|Withdrawal by Subject|1
5033560|NCT02863575|17332710|P2|Overall Study|Withdrawal by Subject|1
5033561|NCT02863575|17332711|P1|Overall Study|Withdrawal by Subject|0
5033562|NCT02863575|17332709|P3|Overall Study|Participants Unable To Swallow Capsule|0
5033563|NCT02863575|17332710|P2|Overall Study|Participants Unable To Swallow Capsule|0
5033564|NCT02863575|17332711|P1|Overall Study|Participants Unable To Swallow Capsule|1
5033565|NCT02863419|17332763|P3|Overall Study|Died|1
5033566|NCT02863419|17332764|P2|Overall Study|Died|4
5033567|NCT02863419|17332765|P1|Overall Study|Died|3
5033568|NCT02863419|17332763|P3|Overall Study|Withdrawal by Subject|3
5033569|NCT02863419|17332764|P2|Overall Study|Withdrawal by Subject|5
5033570|NCT02863419|17332765|P1|Overall Study|Withdrawal by Subject|5
5033571|NCT02863419|17332763|P3|Overall Study|Lost to Follow-up|4
5033572|NCT02863419|17332764|P2|Overall Study|Lost to Follow-up|1
5033573|NCT02863419|17332765|P1|Overall Study|Lost to Follow-up|0
5033574|NCT02863328|17332882|P2|Overall Study|Died|1
5033575|NCT02863328|17332883|P1|Overall Study|Died|0
5033576|NCT02863328|17332882|P2|Overall Study|Withdrawal by Subject|12
5033577|NCT02863328|17332883|P1|Overall Study|Withdrawal by Subject|7
5033578|NCT02863328|17332882|P2|Overall Study|Lost to Follow-up|10
5033579|NCT02863328|17332883|P1|Overall Study|Lost to Follow-up|4
5033580|NCT02862730|17333038|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5033581|NCT02862730|17333039|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5033582|NCT02862730|17333040|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5033583|NCT02862730|17333041|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
5033584|NCT02862730|17333042|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5033585|NCT02862730|17333043|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5033586|NCT02862730|17333044|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5033587|NCT02862730|17333038|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5033588|NCT02862730|17333039|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5033589|NCT02862730|17333040|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
5033590|NCT02862730|17333041|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5033591|NCT02862730|17333042|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
5033592|NCT02862730|17333043|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5033593|NCT02862730|17333044|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5033594|NCT02862730|17333038|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
5033595|NCT02862730|17333039|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
5033596|NCT02862730|17333040|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
5033597|NCT02862730|17333041|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
5033598|NCT02862730|17333042|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
5033599|NCT02862730|17333043|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
5033600|NCT02862730|17333044|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
5033601|NCT02862730|17333038|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5033602|NCT02862730|17333039|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5033603|NCT02862730|17333040|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5033604|NCT02862730|17333041|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5033605|NCT02862730|17333042|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
5033606|NCT02862730|17333043|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5033607|NCT02862730|17333044|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5033608|NCT02862600|17333099|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
5033609|NCT02862600|17333099|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
5033610|NCT02862600|17333099|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
5033611|NCT02862600|17333099|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
5033612|NCT02862574|17333109|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
5033613|NCT02862574|17333110|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
5033614|NCT02862574|17333111|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
5033615|NCT02862574|17333109|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
5033616|NCT02862574|17333110|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
5033617|NCT02862574|17333111|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
5033618|NCT02862574|17333109|P3|Double-Blind Treatment Period|Adverse Event|0
5033619|NCT02862574|17333110|P2|Double-Blind Treatment Period|Adverse Event|1
5033620|NCT02862574|17333111|P1|Double-Blind Treatment Period|Adverse Event|0
5033621|NCT02862548|17333131|P2|Open-Label Extension Phase|Still on Study|24
5033622|NCT02862548|17333132|P1|Open-Label Extension Phase|Still on Study|26
5033623|NCT02862548|17333131|P2|Open-Label Phase|Death|1
5033624|NCT02862548|17333132|P1|Open-Label Phase|Death|0
5033625|NCT02862106|17333162|P2|Overall Study|Subjects moved to other city|0
5033626|NCT02862106|17333163|P1|Overall Study|Subjects moved to other city|1
5033627|NCT02862106|17333162|P2|Overall Study|Withdrawal by Subject|0
5033628|NCT02862106|17333163|P1|Overall Study|Withdrawal by Subject|2
5033629|NCT02862106|17333162|P2|Overall Study|Lost to Follow-up|5
5033630|NCT02862106|17333163|P1|Overall Study|Lost to Follow-up|15
5033631|NCT02862106|17333162|P2|Overall Study|Protocol Violation|1
5033632|NCT02862106|17333163|P1|Overall Study|Protocol Violation|16
5033633|NCT02862106|17333162|P2|Overall Study|Adverse Event|0
5033634|NCT02862106|17333163|P1|Overall Study|Adverse Event|4
5033635|NCT02861807|17333248|P2|Overall Study|Withdrawal by Subject|8
5033636|NCT02861807|17333249|P1|Overall Study|Withdrawal by Subject|5
5033637|NCT02861807|17333248|P2|Overall Study|Lost to Follow-up|6
5033638|NCT02861807|17333249|P1|Overall Study|Lost to Follow-up|7
5033639|NCT02861664|17333265|P2|Overall Study|Withdrawal of Consent|1
5033640|NCT02861664|17333266|P1|Overall Study|Withdrawal of Consent|0
5033641|NCT02861534|17333278|P2|Overall Study|Withdrawal by Subject|18
5033642|NCT02861534|17333279|P1|Overall Study|Withdrawal by Subject|15
5033643|NCT02861534|17333278|P2|Overall Study|Site Terminated by Sponsor|3
5033644|NCT02861534|17333279|P1|Overall Study|Site Terminated by Sponsor|4
5033645|NCT02861534|17333278|P2|Overall Study|Lost to Follow-up|14
5033646|NCT02861534|17333279|P1|Overall Study|Lost to Follow-up|14
5033647|NCT02861534|17333278|P2|Overall Study|Death|552
5033648|NCT02861534|17333279|P1|Overall Study|Death|541
5033649|NCT02860169|17333367|P1|Part C|Other (Screening failure)|1
5033650|NCT02860169|17333367|P1|Part B|Withdrawal by Subject|1
5033651|NCT02860169|17333367|P1|Part B|Other (Screening failure)|10
5033652|NCT02860169|17333367|P1|Part A|Other (did not completed consent)|1
5033653|NCT02860169|17333367|P1|Part A|Other (Survey not completed)|3
5033654|NCT02860169|17333367|P1|Part A|Other (Screening failure)|6
5033655|NCT02860169|17333367|P1|Part A|Withdrawal by Subject|1
5033656|NCT02859454|17333396|P1|Overall Study|PI discretion/off study prior to trtmt|1
5033657|NCT02859246|17333452|P1|Overall Study|Withdrawal by Subject|1
5033658|NCT02859246|17333452|P1|Overall Study|Adverse Event|1
5033659|NCT02859246|17333452|P1|Overall Study|Screen fails|3
5033660|NCT02858726|17333461|P4|Overall Study|Noncompliance|0
5033661|NCT02858726|17333462|P3|Overall Study|Noncompliance|0
5033662|NCT02858726|17333463|P2|Overall Study|Noncompliance|1
5033663|NCT02858726|17333464|P1|Overall Study|Noncompliance|0
5033664|NCT02858726|17333461|P4|Overall Study|Withdrawal by Subject|0
5033665|NCT02858726|17333462|P3|Overall Study|Withdrawal by Subject|1
5033666|NCT02858726|17333463|P2|Overall Study|Withdrawal by Subject|2
5033667|NCT02858726|17333464|P1|Overall Study|Withdrawal by Subject|1
5033668|NCT02858726|17333461|P4|Overall Study|Study Terminated by Sponsor|1
5033669|NCT02858726|17333462|P3|Overall Study|Study Terminated by Sponsor|0
5033670|NCT02858726|17333463|P2|Overall Study|Study Terminated by Sponsor|0
5033671|NCT02858726|17333464|P1|Overall Study|Study Terminated by Sponsor|0
5033672|NCT02858726|17333461|P4|Overall Study|Protocol Violation|1
5033673|NCT02858726|17333462|P3|Overall Study|Protocol Violation|0
5033674|NCT02858726|17333463|P2|Overall Study|Protocol Violation|0
5033675|NCT02858726|17333464|P1|Overall Study|Protocol Violation|0
5033676|NCT02858726|17333461|P4|Overall Study|Physician Decision|0
5033677|NCT02858726|17333462|P3|Overall Study|Physician Decision|1
5033678|NCT02858726|17333463|P2|Overall Study|Physician Decision|0
5033679|NCT02858726|17333464|P1|Overall Study|Physician Decision|0
5033680|NCT02858726|17333461|P4|Overall Study|Adverse Event|1
5033681|NCT02858726|17333462|P3|Overall Study|Adverse Event|9
5033682|NCT02858726|17333463|P2|Overall Study|Adverse Event|4
5033683|NCT02858726|17333464|P1|Overall Study|Adverse Event|4
5033684|NCT02858492|17333495|P4|Overall Study|Protocol defined stopping criteria|1
5033685|NCT02858492|17333496|P3|Overall Study|Protocol defined stopping criteria|0
5033686|NCT02858492|17333497|P2|Overall Study|Protocol defined stopping criteria|0
5033687|NCT02858492|17333498|P1|Overall Study|Protocol defined stopping criteria|0
5033688|NCT02858492|17333495|P4|Overall Study|Lack of Efficacy|1
5033689|NCT02858492|17333496|P3|Overall Study|Lack of Efficacy|0
5033690|NCT02858492|17333497|P2|Overall Study|Lack of Efficacy|0
5033691|NCT02858492|17333498|P1|Overall Study|Lack of Efficacy|0
5033692|NCT02858492|17333495|P4|Overall Study|Adverse Event|3
5033693|NCT02858492|17333496|P3|Overall Study|Adverse Event|0
5033694|NCT02858492|17333497|P2|Overall Study|Adverse Event|0
5033695|NCT02858492|17333498|P1|Overall Study|Adverse Event|0
5033696|NCT02858492|17333495|P4|Overall Study|Withdrawal by Subject|1
5033697|NCT02858492|17333496|P3|Overall Study|Withdrawal by Subject|0
5033698|NCT02858492|17333497|P2|Overall Study|Withdrawal by Subject|1
5033699|NCT02858492|17333498|P1|Overall Study|Withdrawal by Subject|0
5033700|NCT02858440|17333674|P1|Overall Study|Migrated/moved from study area|4
5033701|NCT02858440|17333674|P1|Overall Study|Consent withdrawal|3
5033702|NCT02858440|17333674|P1|Overall Study|Protocol Violation|2
5033703|NCT02858440|17333674|P1|Overall Study|Lost to Follow-up|3
5033704|NCT02858401|17333707|P7|Overall Study|Lost to Follow-up|0
5033705|NCT02858401|17333708|P6|Overall Study|Lost to Follow-up|0
5033706|NCT02858401|17333709|P5|Overall Study|Lost to Follow-up|0
5033707|NCT02858401|17333710|P4|Overall Study|Lost to Follow-up|0
5033708|NCT02858401|17333711|P3|Overall Study|Lost to Follow-up|0
5033709|NCT02858401|17333712|P2|Overall Study|Lost to Follow-up|1
5033710|NCT02858401|17333713|P1|Overall Study|Lost to Follow-up|0
5033711|NCT02858401|17333707|P7|Overall Study|Withdrew Consent|0
5033712|NCT02858401|17333708|P6|Overall Study|Withdrew Consent|1
5033713|NCT02858401|17333709|P5|Overall Study|Withdrew Consent|0
5033714|NCT02858401|17333710|P4|Overall Study|Withdrew Consent|0
5033715|NCT02858401|17333711|P3|Overall Study|Withdrew Consent|0
5033716|NCT02858401|17333712|P2|Overall Study|Withdrew Consent|0
5033717|NCT02858401|17333713|P1|Overall Study|Withdrew Consent|0
5033718|NCT02858362|17334124|P3|Overall Study|Lost to Follow-up|0
5033719|NCT02858362|17334125|P2|Overall Study|Lost to Follow-up|0
5033720|NCT02858362|17334126|P1|Overall Study|Lost to Follow-up|1
5033721|NCT02858362|17334124|P3|Overall Study|Early Study Termination|3
5033722|NCT02858362|17334125|P2|Overall Study|Early Study Termination|0
5033723|NCT02858362|17334126|P1|Overall Study|Early Study Termination|0
5033724|NCT02858362|17334124|P3|Overall Study|Withdrawal by Subject|0
5033725|NCT02858362|17334125|P2|Overall Study|Withdrawal by Subject|0
5033726|NCT02858362|17334126|P1|Overall Study|Withdrawal by Subject|1
5033727|NCT02858362|17334124|P3|Overall Study|Protocol Violation|0
5033728|NCT02858362|17334125|P2|Overall Study|Protocol Violation|1
5033729|NCT02858362|17334126|P1|Overall Study|Protocol Violation|0
5033730|NCT02858180|17334167|P2|Overall Study|Lost to Follow-up|2
5033731|NCT02858180|17334168|P1|Overall Study|Lost to Follow-up|0
5033732|NCT02857816|17334189|P1|Overall Study|Lost to Follow-up|1
5033733|NCT02857816|17334189|P1|Overall Study|Withdrawal by Subject|4
5033734|NCT02857816|17334189|P1|Overall Study|Screen Failure|33
5033735|NCT02857426|17334197|P2|Follow-up|other reason|0
5033736|NCT02857426|17334198|P1|Follow-up|other reason|1
5033737|NCT02857426|17334197|P2|Follow-up|Participant withdrew consent|4
5033738|NCT02857426|17334198|P1|Follow-up|Participant withdrew consent|3
5033739|NCT02857426|17334197|P2|Follow-up|Death|2
5033740|NCT02857426|17334198|P1|Follow-up|Death|6
5033741|NCT02857426|17334197|P2|Treatment|Maximum clinical benefit|0
5033742|NCT02857426|17334198|P1|Treatment|Maximum clinical benefit|1
5033743|NCT02857426|17334197|P2|Treatment|Participant withdrew consent|1
5033744|NCT02857426|17334198|P1|Treatment|Participant withdrew consent|1
5033745|NCT02857426|17334197|P2|Treatment|Adverse event unrelated to study drug|2
5033746|NCT02857426|17334198|P1|Treatment|Adverse event unrelated to study drug|6
5033747|NCT02857426|17334197|P2|Treatment|Death|0
5033748|NCT02857426|17334198|P1|Treatment|Death|1
5033749|NCT02857426|17334197|P2|Treatment|Study drug toxicity|1
5033750|NCT02857426|17334198|P1|Treatment|Study drug toxicity|4
5033751|NCT02857426|17334197|P2|Treatment|Disease progression|13
5033752|NCT02857426|17334198|P1|Treatment|Disease progression|33
5033753|NCT02857283|17334214|P2|First Exposure|Withdrawal by Subject|0
5033754|NCT02857283|17334215|P1|First Exposure|Withdrawal by Subject|1
5033755|NCT02856880|17334249|P1|Overall Study|Withdrawal of consent|1
5033756|NCT02856555|17334293|P3|Overall Study|Randomized but Never Treated|0
5033757|NCT02856555|17334294|P2|Overall Study|Randomized but Never Treated|1
5033758|NCT02856555|17334295|P1|Overall Study|Randomized but Never Treated|0
5033759|NCT02856555|17334293|P3|Overall Study|Withdrawal by Subject|0
5033760|NCT02856555|17334294|P2|Overall Study|Withdrawal by Subject|0
5033761|NCT02856555|17334295|P1|Overall Study|Withdrawal by Subject|3
5033762|NCT02856555|17334293|P3|Overall Study|Lost to Follow-up|0
5033763|NCT02856555|17334294|P2|Overall Study|Lost to Follow-up|3
5033764|NCT02856555|17334295|P1|Overall Study|Lost to Follow-up|1
5033765|NCT02856555|17334293|P3|Overall Study|Adverse Event|0
5033766|NCT02856555|17334294|P2|Overall Study|Adverse Event|0
5033767|NCT02856555|17334295|P1|Overall Study|Adverse Event|1
5033768|NCT02856282|17334303|P1|Overall Study|Withdrawal by Subject|1
5033769|NCT02855541|17334335|P1|Overall Study|Withdrawal by Subject|2
5033770|NCT02855541|17334335|P1|Overall Study|Change in health status|2
5033771|NCT02855450|17334348|P2|Overall Study|Lost to Follow-up|0
5033772|NCT02855450|17334349|P1|Overall Study|Lost to Follow-up|4
5033773|NCT02855450|17334348|P2|Overall Study|Adverse Event|0
5033774|NCT02855450|17334349|P1|Overall Study|Adverse Event|1
5033775|NCT02855411|17334366|P1|Overall Study|Does not meet entrance criteria|14
5033776|NCT02855411|17334366|P1|Overall Study|Study terminated by sponsor|21
5033777|NCT02855359|17334388|P4|Overall Study|Study Termination by Sponsor|0
5033778|NCT02855359|17334389|P3|Overall Study|Study Termination by Sponsor|0
5033779|NCT02855359|17334390|P2|Overall Study|Study Termination by Sponsor|11
5033780|NCT02855359|17334391|P1|Overall Study|Study Termination by Sponsor|9
5033781|NCT02855359|17334388|P4|Overall Study|Death|0
5033782|NCT02855359|17334389|P3|Overall Study|Death|0
5033783|NCT02855359|17334390|P2|Overall Study|Death|2
5033784|NCT02855359|17334391|P1|Overall Study|Death|2
5033785|NCT02854800|17334437|P3|Overall Study|Withdrawal by Subject|3
5033786|NCT02854800|17334438|P2|Overall Study|Withdrawal by Subject|2
5033787|NCT02854800|17334439|P1|Overall Study|Withdrawal by Subject|4
5033788|NCT02854800|17334437|P3|Overall Study|Protocol Violation|3
5033789|NCT02854800|17334438|P2|Overall Study|Protocol Violation|11
5033790|NCT02854800|17334439|P1|Overall Study|Protocol Violation|16
5033791|NCT02854631|17334479|P2|Overall Study|Lost to Follow-up|2
5033792|NCT02854631|17334480|P1|Overall Study|Lost to Follow-up|4
5033793|NCT02854631|17334479|P2|Overall Study|Subjects Randomized but Never Treated|0
5033794|NCT02854631|17334480|P1|Overall Study|Subjects Randomized but Never Treated|2
5033795|NCT02854631|17334479|P2|Overall Study|Protocol Violation|1
5033796|NCT02854631|17334480|P1|Overall Study|Protocol Violation|0
5033797|NCT02854631|17334479|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
5033798|NCT02854631|17334480|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
5033799|NCT02854631|17334479|P2|Overall Study|Death|8
5033800|NCT02854631|17334480|P1|Overall Study|Death|12
5033801|NCT02854631|17334479|P2|Overall Study|Investigator's Discretion|0
5033802|NCT02854631|17334480|P1|Overall Study|Investigator's Discretion|2
5033803|NCT02854631|17334479|P2|Overall Study|Withdrew Consent|2
5033804|NCT02854631|17334480|P1|Overall Study|Withdrew Consent|3
5033805|NCT02854631|17334479|P2|Overall Study|Adverse Event|2
5033806|NCT02854631|17334480|P1|Overall Study|Adverse Event|1
5033807|NCT02854605|17334541|P3|Overall Study|Protocol Violation|1
5033808|NCT02854605|17334542|P2|Overall Study|Protocol Violation|0
5033809|NCT02854605|17334543|P1|Overall Study|Protocol Violation|0
5033810|NCT02854605|17334541|P3|Overall Study|Investigator's Discretion|0
5033811|NCT02854605|17334542|P2|Overall Study|Investigator's Discretion|0
5033812|NCT02854605|17334543|P1|Overall Study|Investigator's Discretion|1
5033813|NCT02854605|17334541|P3|Overall Study|Withdrew Consent|1
5033814|NCT02854605|17334542|P2|Overall Study|Withdrew Consent|0
5033815|NCT02854605|17334543|P1|Overall Study|Withdrew Consent|1
5033816|NCT02854605|17334541|P3|Overall Study|Lost to Follow-up|0
5033817|NCT02854605|17334542|P2|Overall Study|Lost to Follow-up|2
5033818|NCT02854605|17334543|P1|Overall Study|Lost to Follow-up|0
5033819|NCT02854605|17334541|P3|Overall Study|Adverse Event|2
5033820|NCT02854605|17334542|P2|Overall Study|Adverse Event|5
5033821|NCT02854605|17334543|P1|Overall Study|Adverse Event|1
5033822|NCT02854527|17334573|P10|Overall Study|Lost to Follow-up|0
5033823|NCT02854527|17334574|P9|Overall Study|Lost to Follow-up|0
5033824|NCT02854527|17334575|P8|Overall Study|Lost to Follow-up|0
5033825|NCT02854527|17334576|P7|Overall Study|Lost to Follow-up|0
5033826|NCT02854527|17334577|P6|Overall Study|Lost to Follow-up|0
5033827|NCT02854527|17334578|P5|Overall Study|Lost to Follow-up|0
5033828|NCT02854527|17334579|P4|Overall Study|Lost to Follow-up|1
5033829|NCT02854527|17334580|P3|Overall Study|Lost to Follow-up|0
5033830|NCT02854527|17334581|P2|Overall Study|Lost to Follow-up|0
5033831|NCT02854527|17334582|P1|Overall Study|Lost to Follow-up|0
5033832|NCT02854527|17334573|P10|Overall Study|Adverse Event|0
5033833|NCT02854527|17334574|P9|Overall Study|Adverse Event|0
5033834|NCT02854527|17334575|P8|Overall Study|Adverse Event|0
5033835|NCT02854527|17334576|P7|Overall Study|Adverse Event|0
5033836|NCT02854527|17334577|P6|Overall Study|Adverse Event|0
5033837|NCT02854527|17334578|P5|Overall Study|Adverse Event|1
5033838|NCT02854527|17334579|P4|Overall Study|Adverse Event|0
5033839|NCT02854527|17334580|P3|Overall Study|Adverse Event|0
5033840|NCT02854527|17334581|P2|Overall Study|Adverse Event|0
5033841|NCT02854527|17334582|P1|Overall Study|Adverse Event|0
5033842|NCT02853929|17334640|P2|Overall Study|Subjects enrolled but not vaccinated|4
5033843|NCT02853929|17334641|P1|Overall Study|Subjects enrolled but not vaccinated|7
5033844|NCT02853929|17334640|P2|Overall Study|Withdrawal by Subject|0
5033845|NCT02853929|17334641|P1|Overall Study|Withdrawal by Subject|1
5033846|NCT02853929|17334640|P2|Overall Study|Lost to Follow-up|0
5033847|NCT02853929|17334641|P1|Overall Study|Lost to Follow-up|3
5033848|NCT02853435|17334682|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5033849|NCT02853435|17334683|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
5033850|NCT02853435|17334684|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5033851|NCT02853435|17334685|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5033852|NCT02853435|17334686|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5033853|NCT02853435|17334687|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5033854|NCT02853331|17334997|P2|Overall Study|Ongoing in study|325
5033855|NCT02853331|17334998|P1|Overall Study|Ongoing in study|368
5033856|NCT02853331|17334997|P2|Overall Study|Withdrawal by Subject|9
5033857|NCT02853331|17334998|P1|Overall Study|Withdrawal by Subject|5
5033858|NCT02853331|17334997|P2|Overall Study|Death|95
5033859|NCT02853331|17334998|P1|Overall Study|Death|59
5033860|NCT02853318|17335030|P1|Overall Study|Withdrawal by Subject|1
5033861|NCT02853123|17335038|P2|Washout Period|Adverse Event|0
5033862|NCT02853123|17335039|P1|Washout Period|Adverse Event|1
5033863|NCT02853123|17335038|P2|Washout Period|Worsening of COPD|3
5033864|NCT02853123|17335039|P1|Washout Period|Worsening of COPD|0
5033865|NCT02853123|17335038|P2|Treatment Period 1|Adverse Event|3
5033866|NCT02853123|17335039|P1|Treatment Period 1|Adverse Event|0
5033867|NCT02853032|17335062|P2|Overall Study|Requested to withdraw from all treatment|2
5033868|NCT02853032|17335063|P1|Overall Study|Requested to withdraw from all treatment|2
5033869|NCT02853032|17335062|P2|Overall Study|Withdrawal by Subject|1
5033870|NCT02853032|17335063|P1|Overall Study|Withdrawal by Subject|3
5033871|NCT02853032|17335062|P2|Overall Study|Adverse Event|0
5033872|NCT02853032|17335063|P1|Overall Study|Adverse Event|4
5033873|NCT02852434|17335139|P2|Overall Study|Unsuccessful Dilator Procedure|0
5033874|NCT02852434|17335140|P1|Overall Study|Unsuccessful Dilator Procedure|2
5033875|NCT02852434|17335139|P2|Overall Study|Withdrawal by Subject|1
5033876|NCT02852434|17335140|P1|Overall Study|Withdrawal by Subject|0
5033877|NCT02852265|17335156|P2|3-month Follow-up|Lost to Follow-up|1
5033878|NCT02852265|17335157|P1|3-month Follow-up|Lost to Follow-up|1
5033879|NCT02851069|17335190|P1|Overall Study|Other|3
5033880|NCT02851069|17335190|P1|Overall Study|Failure to Return|3
5033881|NCT02850978|17335212|P1|Overall Study|Reason not listed|88
5033882|NCT02850978|17335212|P1|Overall Study|Lost to Follow-up|121
5033883|NCT02850978|17335212|P1|Overall Study|Improvement in condition|34
5033884|NCT02850978|17335212|P1|Overall Study|Lack of Efficacy|40
5033885|NCT02850978|17335212|P1|Overall Study|Adverse Event|81
5033886|NCT02850978|17335212|P1|Overall Study|No visit since the first visit|35
5033887|NCT02850978|17335212|P1|Overall Study|Uncollectable CRF|27
5033888|NCT02850965|17335219|P2|Overall Study|Randomized but not treated|1
5033889|NCT02850965|17335220|P1|Overall Study|Randomized but not treated|0
5033890|NCT02850965|17335219|P2|Overall Study|Physician Decision|1
5033891|NCT02850965|17335220|P1|Overall Study|Physician Decision|0
5033892|NCT02850965|17335219|P2|Overall Study|Withdrawal by Subject|4
5033893|NCT02850965|17335220|P1|Overall Study|Withdrawal by Subject|3
5033894|NCT02850965|17335219|P2|Overall Study|Adverse Event|2
5033895|NCT02850965|17335220|P1|Overall Study|Adverse Event|3
5033896|NCT02850965|17335219|P2|Overall Study|Lack of Efficacy|8
5033897|NCT02850965|17335220|P1|Overall Study|Lack of Efficacy|4
5033898|NCT02850965|17335219|P2|Overall Study|Lost to Follow-up|3
5033899|NCT02850965|17335220|P1|Overall Study|Lost to Follow-up|5
5033900|NCT02850965|17335219|P2|Overall Study|Protocol Violation|2
5033901|NCT02850965|17335220|P1|Overall Study|Protocol Violation|0
5033902|NCT02850965|17335219|P2|Overall Study|Other than listed|4
5033903|NCT02850965|17335220|P1|Overall Study|Other than listed|3
5033904|NCT02850276|17335236|P1|Overall Study|Lost to Follow-up|2
5033905|NCT02850276|17335236|P1|Overall Study|Physician Decision|2
5033906|NCT02850276|17335236|P1|Overall Study|Withdrawal by Subject|14
5033907|NCT02850276|17335236|P1|Overall Study|screen failure|43
5033908|NCT02849990|17335263|P1|Overall Study|Withdrawal by Subject|1
5033909|NCT02849990|17335263|P1|Overall Study|Adverse Event|1
5033910|NCT02849704|17335288|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
5033911|NCT02849704|17335289|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
5033912|NCT02849704|17335288|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
5033913|NCT02849704|17335289|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
5033914|NCT02849704|17335288|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
5033915|NCT02849704|17335289|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
5033916|NCT02849678|17335304|P2|Overall Study|Protocol Violation|6
5033917|NCT02849678|17335305|P1|Overall Study|Protocol Violation|3
5033918|NCT02849626|17335325|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
5033919|NCT02849626|17335326|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
5033920|NCT02849626|17335325|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
5033921|NCT02849626|17335326|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
5033922|NCT02849626|17335325|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
5033923|NCT02849626|17335326|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
5033924|NCT02849626|17335325|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
5033925|NCT02849626|17335326|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
5033926|NCT02849626|17335325|P2|Core Phase (up to 23 Weeks)|Non-specified|0
5033927|NCT02849626|17335326|P1|Core Phase (up to 23 Weeks)|Non-specified|3
5033928|NCT02849626|17335325|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
5033929|NCT02849626|17335326|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
5033930|NCT02849626|17335325|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
5033931|NCT02849626|17335326|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
5033932|NCT02849626|17335325|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
5033933|NCT02849626|17335326|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
5033934|NCT02849509|17335389|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
5033935|NCT02849509|17335390|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
5033936|NCT02849509|17335391|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
5033937|NCT02849509|17335389|P3|Overall Study|Other, reason not specified|25
5033938|NCT02849509|17335390|P2|Overall Study|Other, reason not specified|29
5033939|NCT02849509|17335391|P1|Overall Study|Other, reason not specified|14
5033940|NCT02849509|17335389|P3|Overall Study|Lost to Follow-up|36
5033941|NCT02849509|17335390|P2|Overall Study|Lost to Follow-up|67
5033942|NCT02849509|17335391|P1|Overall Study|Lost to Follow-up|27
5033943|NCT02849509|17335389|P3|Overall Study|Withdrawal by Subject|12
5033944|NCT02849509|17335390|P2|Overall Study|Withdrawal by Subject|17
5033945|NCT02849509|17335391|P1|Overall Study|Withdrawal by Subject|6
5033946|NCT02849509|17335389|P3|Overall Study|Other adverse event|8
5033947|NCT02849509|17335390|P2|Overall Study|Other adverse event|41
5033948|NCT02849509|17335391|P1|Overall Study|Other adverse event|36
5033949|NCT02849509|17335389|P3|Overall Study|Worsening of other pre-existing disease|2
5033950|NCT02849509|17335390|P2|Overall Study|Worsening of other pre-existing disease|1
5033951|NCT02849509|17335391|P1|Overall Study|Worsening of other pre-existing disease|0
5033952|NCT02849509|17335389|P3|Overall Study|Worsening of disease under study|1
5033953|NCT02849509|17335390|P2|Overall Study|Worsening of disease under study|1
5033954|NCT02849509|17335391|P1|Overall Study|Worsening of disease under study|1
5033955|NCT02849080|17335598|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5033956|NCT02849080|17335599|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5033957|NCT02849080|17335600|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5033958|NCT02849080|17335601|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
5033959|NCT02849080|17335598|P4|Extension Phase: 53 - 104 Weeks|Other|0
5033960|NCT02849080|17335599|P3|Extension Phase: 53 - 104 Weeks|Other|1
5033961|NCT02849080|17335600|P2|Extension Phase: 53 - 104 Weeks|Other|0
5033962|NCT02849080|17335601|P1|Extension Phase: 53 - 104 Weeks|Other|0
5033963|NCT02849080|17335598|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5033964|NCT02849080|17335599|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5033965|NCT02849080|17335600|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5033966|NCT02849080|17335601|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
5033967|NCT02849080|17335598|P4|Main Phase: 0 - 52 Weeks|Death|0
5033968|NCT02849080|17335599|P3|Main Phase: 0 - 52 Weeks|Death|0
5033969|NCT02849080|17335600|P2|Main Phase: 0 - 52 Weeks|Death|2
5033970|NCT02849080|17335601|P1|Main Phase: 0 - 52 Weeks|Death|0
5033971|NCT02849080|17335598|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
5033972|NCT02849080|17335599|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
5033973|NCT02849080|17335600|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
5033974|NCT02849080|17335601|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
5033975|NCT02849080|17335598|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
5033976|NCT02849080|17335599|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
5033977|NCT02849080|17335600|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
5033978|NCT02849080|17335601|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
5033979|NCT02848729|17335728|P2|Overall Study|Emesis|11
5033980|NCT02848729|17335729|P1|Overall Study|Emesis|15
5033981|NCT02848729|17335728|P2|Overall Study|Withdrawal by Subject|0
5033982|NCT02848729|17335729|P1|Overall Study|Withdrawal by Subject|1
5033983|NCT02848664|17335746|P1|Overall Study|no assistance for device training|1
5033984|NCT02848664|17335746|P1|Overall Study|Adverse Event|1
5033985|NCT02848664|17335746|P1|Overall Study|Withdrawal by Subject|2
5033986|NCT02848651|17335754|P1|Overall Study|Withdrawal by Subject|14
5033987|NCT02848651|17335754|P1|Overall Study|Physician Decision|4
5033988|NCT02848651|17335754|P1|Overall Study|Symptomatic Deterioration|1
5033989|NCT02848651|17335754|P1|Overall Study|Non-Compliance|1
5033990|NCT02848651|17335754|P1|Overall Study|Lost to Follow-up|1
5033991|NCT02848651|17335754|P1|Overall Study|Death|85
5033992|NCT02848599|17335783|P2|Overall Study|Protocol Violation|9
5033993|NCT02848599|17335784|P1|Overall Study|Protocol Violation|7
5033994|NCT02848326|17335806|P6|Safety Follow-up Period|Lost to Follow-up|3
5033995|NCT02848326|17335807|P5|Safety Follow-up Period|Lost to Follow-up|1
5033996|NCT02848326|17335808|P4|Safety Follow-up Period|Lost to Follow-up|0
5033997|NCT02848326|17335809|P3|Safety Follow-up Period|Lost to Follow-up|2
5033998|NCT02848326|17335810|P2|Safety Follow-up Period|Lost to Follow-up|0
5033999|NCT02848326|17335811|P1|Safety Follow-up Period|Lost to Follow-up|4
5034000|NCT02848326|17335806|P6|Safety Follow-up Period|Withdrawal of Consent|2
5034001|NCT02848326|17335807|P5|Safety Follow-up Period|Withdrawal of Consent|0
5034002|NCT02848326|17335808|P4|Safety Follow-up Period|Withdrawal of Consent|0
5034003|NCT02848326|17335809|P3|Safety Follow-up Period|Withdrawal of Consent|1
5034004|NCT02848326|17335810|P2|Safety Follow-up Period|Withdrawal of Consent|1
5034005|NCT02848326|17335811|P1|Safety Follow-up Period|Withdrawal of Consent|0
5034006|NCT02848326|17335806|P6|Treatment Period|Non-compliance with Study Drug|0
5034007|NCT02848326|17335807|P5|Treatment Period|Non-compliance with Study Drug|0
5034008|NCT02848326|17335808|P4|Treatment Period|Non-compliance with Study Drug|1
5034009|NCT02848326|17335809|P3|Treatment Period|Non-compliance with Study Drug|0
5034010|NCT02848326|17335810|P2|Treatment Period|Non-compliance with Study Drug|0
5034011|NCT02848326|17335811|P1|Treatment Period|Non-compliance with Study Drug|4
5034012|NCT02848326|17335806|P6|Treatment Period|Protocol Violation|3
5034013|NCT02848326|17335807|P5|Treatment Period|Protocol Violation|3
5034014|NCT02848326|17335808|P4|Treatment Period|Protocol Violation|2
5034015|NCT02848326|17335809|P3|Treatment Period|Protocol Violation|4
5034016|NCT02848326|17335810|P2|Treatment Period|Protocol Violation|3
5034017|NCT02848326|17335811|P1|Treatment Period|Protocol Violation|4
5034018|NCT02848326|17335806|P6|Treatment Period|Pregnancy|1
5034019|NCT02848326|17335807|P5|Treatment Period|Pregnancy|0
5034020|NCT02848326|17335808|P4|Treatment Period|Pregnancy|1
5034021|NCT02848326|17335809|P3|Treatment Period|Pregnancy|1
5034022|NCT02848326|17335810|P2|Treatment Period|Pregnancy|0
5034023|NCT02848326|17335811|P1|Treatment Period|Pregnancy|0
5034024|NCT02848326|17335806|P6|Treatment Period|Lost to Follow-up|3
5034025|NCT02848326|17335807|P5|Treatment Period|Lost to Follow-up|2
5034026|NCT02848326|17335808|P4|Treatment Period|Lost to Follow-up|7
5034027|NCT02848326|17335809|P3|Treatment Period|Lost to Follow-up|11
5034028|NCT02848326|17335810|P2|Treatment Period|Lost to Follow-up|1
5034029|NCT02848326|17335811|P1|Treatment Period|Lost to Follow-up|5
5034030|NCT02848326|17335806|P6|Treatment Period|Withdrawal of Consent|6
5034031|NCT02848326|17335807|P5|Treatment Period|Withdrawal of Consent|9
5034032|NCT02848326|17335808|P4|Treatment Period|Withdrawal of Consent|6
5034033|NCT02848326|17335809|P3|Treatment Period|Withdrawal of Consent|9
5034034|NCT02848326|17335810|P2|Treatment Period|Withdrawal of Consent|6
5034035|NCT02848326|17335811|P1|Treatment Period|Withdrawal of Consent|20
5034036|NCT02848326|17335806|P6|Treatment Period|Adverse Event|7
5034037|NCT02848326|17335807|P5|Treatment Period|Adverse Event|5
5034038|NCT02848326|17335808|P4|Treatment Period|Adverse Event|6
5034039|NCT02848326|17335809|P3|Treatment Period|Adverse Event|11
5034040|NCT02848326|17335810|P2|Treatment Period|Adverse Event|4
5034041|NCT02848326|17335811|P1|Treatment Period|Adverse Event|5
5034042|NCT02848313|17335845|P2|Overall Study|Lost to follow up|0
5034043|NCT02848313|17335846|P1|Overall Study|Lost to follow up|1
5034044|NCT02848313|17335845|P2|Overall Study|Withdrawal by Subject|1
5034045|NCT02848313|17335846|P1|Overall Study|Withdrawal by Subject|1
5034046|NCT02848313|17335845|P2|Overall Study|Lack of Efficacy|1
5034047|NCT02848313|17335846|P1|Overall Study|Lack of Efficacy|0
5034048|NCT02848313|17335845|P2|Overall Study|Adverse Event|2
5034049|NCT02848313|17335846|P1|Overall Study|Adverse Event|1
5034050|NCT02847858|17335893|P2|Overall Study|Lost to Follow-up|269
5034051|NCT02847858|17335894|P1|Overall Study|Lost to Follow-up|401
5034052|NCT02847650|17335920|P2|Overall Study|Withdrawal by Subject|1
5034053|NCT02847650|17335921|P1|Overall Study|Withdrawal by Subject|1
5034054|NCT02847650|17335920|P2|Overall Study|Protocol Violation|1
5034055|NCT02847650|17335921|P1|Overall Study|Protocol Violation|0
5034056|NCT02847650|17335920|P2|Overall Study|Lost to Follow-up|0
5034057|NCT02847650|17335921|P1|Overall Study|Lost to Follow-up|1
5034058|NCT02847650|17335920|P2|Overall Study|Adverse Event|4
5034059|NCT02847650|17335921|P1|Overall Study|Adverse Event|2
5034060|NCT02847637|17335945|P4|Overall Study|First emicizumab dose delayed|0
5034061|NCT02847637|17335946|P3|Overall Study|First emicizumab dose delayed|0
5034062|NCT02847637|17335947|P2|Overall Study|First emicizumab dose delayed|0
5034063|NCT02847637|17335948|P1|Overall Study|First emicizumab dose delayed|1
5034064|NCT02847637|17335945|P4|Overall Study|Ongoing treatment with emicizumab|63
5034065|NCT02847637|17335946|P3|Overall Study|Ongoing treatment with emicizumab|34
5034066|NCT02847637|17335947|P2|Overall Study|Ongoing treatment with emicizumab|35
5034067|NCT02847637|17335948|P1|Overall Study|Ongoing treatment with emicizumab|16
5034068|NCT02847637|17335945|P4|Overall Study|Withdrew from treatment due to AE|0
5034069|NCT02847637|17335946|P3|Overall Study|Withdrew from treatment due to AE|1
5034070|NCT02847637|17335947|P2|Overall Study|Withdrew from treatment due to AE|0
5034071|NCT02847637|17335948|P1|Overall Study|Withdrew from treatment due to AE|0
5034072|NCT02847494|17336062|P2|Overall Study|Lost to Follow-up|5
5034073|NCT02847494|17336063|P1|Overall Study|Lost to Follow-up|8
5034074|NCT02847260|17336073|P1|Overall Study|Physician Decision|1
5034075|NCT02847260|17336073|P1|Overall Study|Clinical Deterioration|1
5034076|NCT02847260|17336073|P1|Overall Study|Withdrawal by Subject|2
5034077|NCT02847260|17336073|P1|Overall Study|Adverse Event|3
5034078|NCT02847182|17336087|P2|Overall Study|Withdrawal by Subject|1
5034079|NCT02847182|17336088|P1|Overall Study|Withdrawal by Subject|0
5034080|NCT02846779|17336212|P3|Overall Study|Less than 31 days of follow-up|52
5034081|NCT02846779|17336213|P2|Overall Study|Less than 31 days of follow-up|45
5034082|NCT02846779|17336214|P1|Overall Study|Less than 31 days of follow-up|56
5034083|NCT02846779|17336212|P3|Overall Study|Lost Enrollment|86
5034084|NCT02846779|17336213|P2|Overall Study|Lost Enrollment|82
5034085|NCT02846779|17336214|P1|Overall Study|Lost Enrollment|83
5034086|NCT02846558|17336270|P4|Overall Study|Lost to Follow-up|0
5034087|NCT02846558|17336271|P3|Overall Study|Lost to Follow-up|0
5034088|NCT02846558|17336272|P2|Overall Study|Lost to Follow-up|0
5034089|NCT02846558|17336273|P1|Overall Study|Lost to Follow-up|2
5034090|NCT02846558|17336270|P4|Overall Study|Withdrawal by Subject|2
5034091|NCT02846558|17336271|P3|Overall Study|Withdrawal by Subject|2
5034092|NCT02846558|17336272|P2|Overall Study|Withdrawal by Subject|4
5034093|NCT02846558|17336273|P1|Overall Study|Withdrawal by Subject|5
5034094|NCT02846558|17336270|P4|Overall Study|Adverse Event|0
5034095|NCT02846558|17336271|P3|Overall Study|Adverse Event|0
5034096|NCT02846558|17336272|P2|Overall Study|Adverse Event|0
5034097|NCT02846558|17336273|P1|Overall Study|Adverse Event|1
5034098|NCT02846324|17336313|P4|Overall Study|Withdrawal by Subject|0
5034099|NCT02846324|17336314|P3|Overall Study|Withdrawal by Subject|4
5034100|NCT02846324|17336315|P2|Overall Study|Withdrawal by Subject|0
5034101|NCT02846324|17336316|P1|Overall Study|Withdrawal by Subject|1
5034102|NCT02846324|17336313|P4|Overall Study|Other|0
5034103|NCT02846324|17336314|P3|Overall Study|Other|0
5034104|NCT02846324|17336315|P2|Overall Study|Other|0
5034105|NCT02846324|17336316|P1|Overall Study|Other|1
5034106|NCT02845375|17336433|P3|Overall Study|upper airway obstruction|1
5034107|NCT02845375|17336434|P2|Overall Study|upper airway obstruction|2
5034108|NCT02845375|17336435|P1|Overall Study|upper airway obstruction|1
5034109|NCT02845336|17336448|P2|Overall Study|Inability to get medication|0
5034110|NCT02845336|17336449|P1|Overall Study|Inability to get medication|2
5034111|NCT02845336|17336448|P2|Overall Study|Lost to Follow-up|1
5034112|NCT02845336|17336449|P1|Overall Study|Lost to Follow-up|3
5034113|NCT02844946|17336491|P2|Overall Study|Lost to Follow-up|0
5034114|NCT02844946|17336492|P1|Overall Study|Lost to Follow-up|7
5034115|NCT02844920|17336510|P1|Overall Study|Lost to Follow-up|2
5034116|NCT02844543|17336528|P1|Overall Study|Did not meet eligibility criteria|1
5034117|NCT02844543|17336528|P1|Overall Study|Withdrawal by Subject|4
5034118|NCT02843659|17336538|P3|Overall Study|Adverse Event|0
5034119|NCT02843659|17336539|P2|Overall Study|Adverse Event|1
5034120|NCT02843659|17336540|P1|Overall Study|Adverse Event|0
5034121|NCT02843659|17336538|P3|Overall Study|Administrative Reason by Sponsor|4
5034122|NCT02843659|17336539|P2|Overall Study|Administrative Reason by Sponsor|5
5034123|NCT02843659|17336540|P1|Overall Study|Administrative Reason by Sponsor|4
5034124|NCT02843659|17336538|P3|Overall Study|Subject Withdrew Consent|1
5034125|NCT02843659|17336539|P2|Overall Study|Subject Withdrew Consent|0
5034126|NCT02843659|17336540|P1|Overall Study|Subject Withdrew Consent|0
5034127|NCT02843178|17336609|P4|Overall Study|Withdrawal by Subject|1
5034128|NCT02843178|17336610|P3|Overall Study|Withdrawal by Subject|1
5034129|NCT02843178|17336611|P2|Overall Study|Withdrawal by Subject|0
5034130|NCT02843178|17336612|P1|Overall Study|Withdrawal by Subject|0
5034131|NCT02843178|17336609|P4|Overall Study|Lost to Follow-up|3
5034132|NCT02843178|17336610|P3|Overall Study|Lost to Follow-up|6
5034133|NCT02843178|17336611|P2|Overall Study|Lost to Follow-up|8
5034134|NCT02843178|17336612|P1|Overall Study|Lost to Follow-up|8
5034135|NCT02842866|17336652|P2|Overall Study|Withdrawal by Subject|0
5034136|NCT02842866|17336653|P1|Overall Study|Withdrawal by Subject|1
5034137|NCT02842866|17336652|P2|Overall Study|Lost to Follow-up|0
5034138|NCT02842866|17336653|P1|Overall Study|Lost to Follow-up|2
5034139|NCT02842866|17336652|P2|Overall Study|Protocol Violation|2
5034140|NCT02842866|17336653|P1|Overall Study|Protocol Violation|4
5034141|NCT02842866|17336652|P2|Overall Study|Serious Adverse Event|1
5034142|NCT02842866|17336653|P1|Overall Study|Serious Adverse Event|0
5034143|NCT02842853|17336665|P4|Overall Study|Lost to Follow-up|11
5034144|NCT02842853|17336666|P3|Overall Study|Lost to Follow-up|10
5034145|NCT02842853|17336667|P2|Overall Study|Lost to Follow-up|13
5034146|NCT02842853|17336668|P1|Overall Study|Lost to Follow-up|9
5034147|NCT02842853|17336665|P4|Overall Study|Withdrawal by Subject|8
5034148|NCT02842853|17336666|P3|Overall Study|Withdrawal by Subject|9
5034149|NCT02842853|17336667|P2|Overall Study|Withdrawal by Subject|13
5034150|NCT02842853|17336668|P1|Overall Study|Withdrawal by Subject|11
5034151|NCT02842853|17336665|P4|Overall Study|Subject met exclusion criteria|0
5034152|NCT02842853|17336666|P3|Overall Study|Subject met exclusion criteria|0
5034153|NCT02842853|17336667|P2|Overall Study|Subject met exclusion criteria|1
5034154|NCT02842853|17336668|P1|Overall Study|Subject met exclusion criteria|0
5034155|NCT02842853|17336665|P4|Overall Study|Non-compliance with the protocol|5
5034156|NCT02842853|17336666|P3|Overall Study|Non-compliance with the protocol|2
5034157|NCT02842853|17336667|P2|Overall Study|Non-compliance with the protocol|7
5034158|NCT02842853|17336668|P1|Overall Study|Non-compliance with the protocol|3
5034159|NCT02842736|17336688|P1|Overall Study|Diary or safety evaluation not available|1
5034160|NCT02842736|17336688|P1|Overall Study|Intervention for menstrual bleeding|4
5034161|NCT02842736|17336688|P1|Overall Study|Lost to Follow-up|7
5034162|NCT02842151|17336718|P1|Overall Study|Subject moved too far away|1
5034163|NCT02842151|17336718|P1|Overall Study|Adverse Event|1
5034164|NCT02842086|17336726|P2|Overall Study|HIV-1 Infection|6
5034165|NCT02842086|17336727|P1|Overall Study|HIV-1 Infection|5
5034166|NCT02842086|17336726|P2|Overall Study|Lost to Follow-up|236
5034167|NCT02842086|17336727|P1|Overall Study|Lost to Follow-up|274
5034168|NCT02842086|17336726|P2|Overall Study|Withdrew Consent|194
5034169|NCT02842086|17336727|P1|Overall Study|Withdrew Consent|205
5034170|NCT02842086|17336726|P2|Overall Study|Protocol Violation|4
5034171|NCT02842086|17336727|P1|Overall Study|Protocol Violation|8
5034172|NCT02842086|17336726|P2|Overall Study|Non-Compliance with Study Drug|8
5034173|NCT02842086|17336727|P1|Overall Study|Non-Compliance with Study Drug|9
5034174|NCT02842086|17336726|P2|Overall Study|Investigator's Discretion|13
5034175|NCT02842086|17336727|P1|Overall Study|Investigator's Discretion|9
5034176|NCT02842086|17336726|P2|Overall Study|Death|3
5034177|NCT02842086|17336727|P1|Overall Study|Death|3
5034178|NCT02842086|17336726|P2|Overall Study|Adverse Event|20
5034179|NCT02842086|17336727|P1|Overall Study|Adverse Event|18
5034180|NCT02842086|17336726|P2|Overall Study|Still in Double-Blind Phase|3
5034181|NCT02842086|17336727|P1|Overall Study|Still in Double-Blind Phase|7
5034182|NCT02842086|17336726|P2|Overall Study|Randomized but Never Treated|6
5034183|NCT02842086|17336727|P1|Overall Study|Randomized but Never Treated|6
5034184|NCT02842073|17336763|P1|Overall Study|Withdrawal by Subject|1
5034185|NCT02841787|17336789|P3|Overall Study|Withdrawal by Subject|0
5034186|NCT02841787|17336790|P2|Overall Study|Withdrawal by Subject|4
5034187|NCT02841787|17336791|P1|Overall Study|Withdrawal by Subject|1
5034188|NCT02841787|17336789|P3|Overall Study|Symptoms dropped below threshold|0
5034189|NCT02841787|17336790|P2|Overall Study|Symptoms dropped below threshold|0
5034190|NCT02841787|17336791|P1|Overall Study|Symptoms dropped below threshold|1
5034191|NCT02841787|17336789|P3|Overall Study|Lost to Follow-up|0
5034192|NCT02841787|17336790|P2|Overall Study|Lost to Follow-up|0
5034193|NCT02841787|17336791|P1|Overall Study|Lost to Follow-up|1
5034194|NCT02841709|17336805|P5|5th Intervention|Adverse Event|2
5034195|NCT02841709|17336806|P4|5th Intervention|Adverse Event|0
5034196|NCT02841709|17336807|P3|5th Intervention|Adverse Event|0
5034197|NCT02841709|17336808|P2|5th Intervention|Adverse Event|0
5034198|NCT02841709|17336809|P1|5th Intervention|Adverse Event|2
5034199|NCT02840721|17336939|P1|Follow-Up|Withdrawal of Consent|2
5034200|NCT02840721|17336939|P1|Follow-Up|Withdrawal by Subject|4
5034201|NCT02840721|17336939|P1|Follow-Up|Lack of Efficacy|1
5034202|NCT02840721|17336939|P1|Treatment Period|Adverse Event|1
5034203|NCT02840461|17336961|P3|Overall Study|Worsening of Symptom & Kit Error|2
5034204|NCT02840461|17336962|P2|Overall Study|Worsening of Symptom & Kit Error|0
5034205|NCT02840461|17336963|P1|Overall Study|Worsening of Symptom & Kit Error|0
5034206|NCT02840461|17336961|P3|Overall Study|Withdrawal by Subject|2
5034207|NCT02840461|17336962|P2|Overall Study|Withdrawal by Subject|6
5034208|NCT02840461|17336963|P1|Overall Study|Withdrawal by Subject|10
5034209|NCT02840461|17336961|P3|Overall Study|Protocol Violation|1
5034210|NCT02840461|17336962|P2|Overall Study|Protocol Violation|3
5034211|NCT02840461|17336963|P1|Overall Study|Protocol Violation|2
5034212|NCT02840461|17336961|P3|Overall Study|Non-Comliance with Dosing Requirements|0
5034213|NCT02840461|17336962|P2|Overall Study|Non-Comliance with Dosing Requirements|1
5034214|NCT02840461|17336963|P1|Overall Study|Non-Comliance with Dosing Requirements|0
5034215|NCT02840461|17336961|P3|Overall Study|Lost to Follow-up|6
5034216|NCT02840461|17336962|P2|Overall Study|Lost to Follow-up|7
5034217|NCT02840461|17336963|P1|Overall Study|Lost to Follow-up|10
5034218|NCT02840461|17336961|P3|Overall Study|Adverse Event|3
5034219|NCT02840461|17336962|P2|Overall Study|Adverse Event|5
5034220|NCT02840461|17336963|P1|Overall Study|Adverse Event|1
5034221|NCT02840253|17336974|P1|Overall Study|Unsuccessful block|4
5034222|NCT02839876|17337059|P2|Overall Study|Protocol Violation|11
5034223|NCT02839876|17337060|P1|Overall Study|Protocol Violation|10
5034224|NCT02839798|17337122|P1|Overall Study|Withdrawal by Subject|2
5034225|NCT02839746|17337168|P1|Overall Study|Not met selection criteria|12
5034226|NCT02839681|17337182|P1|Overall Study|Death|2
5034227|NCT02839330|17337195|P4|Overall Study|Other reason, not specified|6
5034228|NCT02839330|17337196|P3|Overall Study|Other reason, not specified|3
5034229|NCT02839330|17337197|P2|Overall Study|Other reason, not specified|3
5034230|NCT02839330|17337198|P1|Overall Study|Other reason, not specified|4
5034231|NCT02839330|17337195|P4|Overall Study|Protocol Violation|3
5034232|NCT02839330|17337196|P3|Overall Study|Protocol Violation|2
5034233|NCT02839330|17337197|P2|Overall Study|Protocol Violation|2
5034234|NCT02839330|17337198|P1|Overall Study|Protocol Violation|1
5034235|NCT02839330|17337195|P4|Overall Study|Administrative Reason|1
5034236|NCT02839330|17337196|P3|Overall Study|Administrative Reason|0
5034237|NCT02839330|17337197|P2|Overall Study|Administrative Reason|0
5034238|NCT02839330|17337198|P1|Overall Study|Administrative Reason|0
5034239|NCT02839330|17337195|P4|Overall Study|Lost to Follow-up|25
5034240|NCT02839330|17337196|P3|Overall Study|Lost to Follow-up|29
5034241|NCT02839330|17337197|P2|Overall Study|Lost to Follow-up|27
5034242|NCT02839330|17337198|P1|Overall Study|Lost to Follow-up|22
5034243|NCT02839330|17337195|P4|Overall Study|Withdrawal by Subject|13
5034244|NCT02839330|17337196|P3|Overall Study|Withdrawal by Subject|11
5034245|NCT02839330|17337197|P2|Overall Study|Withdrawal by Subject|19
5034246|NCT02839330|17337198|P1|Overall Study|Withdrawal by Subject|27
5034247|NCT02839330|17337195|P4|Overall Study|Death|1
5034248|NCT02839330|17337196|P3|Overall Study|Death|1
5034249|NCT02839330|17337197|P2|Overall Study|Death|6
5034250|NCT02839330|17337198|P1|Overall Study|Death|4
5034251|NCT02839330|17337195|P4|Overall Study|Adverse Event|2
5034252|NCT02839330|17337196|P3|Overall Study|Adverse Event|2
5034253|NCT02839330|17337197|P2|Overall Study|Adverse Event|1
5034254|NCT02839330|17337198|P1|Overall Study|Adverse Event|0
5034255|NCT02839200|17337233|P6|Overall Study|Randomized in error|0
5034256|NCT02839200|17337234|P5|Overall Study|Randomized in error|0
5034257|NCT02839200|17337235|P4|Overall Study|Randomized in error|0
5034258|NCT02839200|17337236|P3|Overall Study|Randomized in error|0
5034259|NCT02839200|17337237|P2|Overall Study|Randomized in error|1
5034260|NCT02839200|17337238|P1|Overall Study|Randomized in error|0
5034261|NCT02839200|17337233|P6|Overall Study|Adverse Event|0
5034262|NCT02839200|17337234|P5|Overall Study|Adverse Event|1
5034263|NCT02839200|17337235|P4|Overall Study|Adverse Event|0
5034264|NCT02839200|17337236|P3|Overall Study|Adverse Event|0
5034265|NCT02839200|17337237|P2|Overall Study|Adverse Event|0
5034266|NCT02839200|17337238|P1|Overall Study|Adverse Event|0
5034267|NCT02839200|17337233|P6|Overall Study|Lost to Follow-up|0
5034268|NCT02839200|17337234|P5|Overall Study|Lost to Follow-up|1
5034269|NCT02839200|17337235|P4|Overall Study|Lost to Follow-up|0
5034270|NCT02839200|17337236|P3|Overall Study|Lost to Follow-up|0
5034271|NCT02839200|17337237|P2|Overall Study|Lost to Follow-up|0
5034272|NCT02839200|17337238|P1|Overall Study|Lost to Follow-up|2
5034273|NCT02839200|17337233|P6|Overall Study|Withdrawal by Subject|1
5034274|NCT02839200|17337234|P5|Overall Study|Withdrawal by Subject|0
5034275|NCT02839200|17337235|P4|Overall Study|Withdrawal by Subject|0
5034276|NCT02839200|17337236|P3|Overall Study|Withdrawal by Subject|1
5034277|NCT02839200|17337237|P2|Overall Study|Withdrawal by Subject|0
5034278|NCT02839200|17337238|P1|Overall Study|Withdrawal by Subject|2
5034279|NCT02838901|17337272|P2|Overall Study|Lost to Follow-up|1
5034280|NCT02838901|17337273|P1|Overall Study|Lost to Follow-up|1
5034281|NCT02838901|17337272|P2|Overall Study|Withdrawal by Subject|1
5034282|NCT02838901|17337273|P1|Overall Study|Withdrawal by Subject|1
5034283|NCT02838420|17337303|P2|Overall Study|Death|13
5034284|NCT02838420|17337304|P1|Overall Study|Death|8
5034285|NCT02838420|17337303|P2|Overall Study|Withdrawal by Subject|4
5034286|NCT02838420|17337304|P1|Overall Study|Withdrawal by Subject|3
5034287|NCT02838420|17337303|P2|Overall Study|Lost to Follow-up|0
5034288|NCT02838420|17337304|P1|Overall Study|Lost to Follow-up|1
5034289|NCT02838420|17337303|P2|Overall Study|Ongoing in Study|45
5034290|NCT02838420|17337304|P1|Overall Study|Ongoing in Study|113
5034291|NCT02838134|17337367|P2|Overall Study|logistic problems|1
5034292|NCT02838134|17337368|P1|Overall Study|logistic problems|1
5034293|NCT02838134|17337367|P2|Overall Study|Lost to Follow-up|2
5034294|NCT02838134|17337368|P1|Overall Study|Lost to Follow-up|1
5034295|NCT02838017|17337400|P2|Overall Study|Lost to Follow-up|11
5034296|NCT02838017|17337401|P1|Overall Study|Lost to Follow-up|14
5034297|NCT02837952|17337419|P2|Overall Study|Medication Error|0
5034298|NCT02837952|17337420|P1|Overall Study|Medication Error|1
5034299|NCT02837952|17337419|P2|Overall Study|Withdrawal by Subject|5
5034300|NCT02837952|17337420|P1|Overall Study|Withdrawal by Subject|4
5034301|NCT02837952|17337419|P2|Overall Study|Adverse Event|1
5034302|NCT02837952|17337420|P1|Overall Study|Adverse Event|0
5034303|NCT02837029|17337473|P3|2 Year Follow-up|Still in follow-up|0
5034304|NCT02837029|17337474|P2|2 Year Follow-up|Still in follow-up|1
5034305|NCT02837029|17337475|P1|2 Year Follow-up|Still in follow-up|0
5034306|NCT02837029|17337473|P3|2 Year Follow-up|Death|0
5034307|NCT02837029|17337474|P2|2 Year Follow-up|Death|6
5034308|NCT02837029|17337475|P1|2 Year Follow-up|Death|6
5034309|NCT02837029|17337473|P3|Cycle 2 and Beyond|Adverse Event|0
5034310|NCT02837029|17337474|P2|Cycle 2 and Beyond|Adverse Event|0
5034311|NCT02837029|17337475|P1|Cycle 2 and Beyond|Adverse Event|1
5034312|NCT02837029|17337473|P3|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
5034313|NCT02837029|17337474|P2|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
5034314|NCT02837029|17337475|P1|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
5034315|NCT02837029|17337473|P3|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
5034316|NCT02837029|17337474|P2|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
5034317|NCT02837029|17337475|P1|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
5034318|NCT02837029|17337473|P3|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
5034319|NCT02837029|17337474|P2|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
5034320|NCT02837029|17337475|P1|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
5034321|NCT02837029|17337473|P3|Screening|Failed to meet screening requirements.|0
5034322|NCT02837029|17337474|P2|Screening|Failed to meet screening requirements.|3
5034323|NCT02837029|17337475|P1|Screening|Failed to meet screening requirements.|7
5034324|NCT02836652|17337484|P2|Overall Study|Not on treatment regimen post-op day 15|3
5034325|NCT02836652|17337485|P1|Overall Study|Not on treatment regimen post-op day 15|3
5034326|NCT02836652|17337484|P2|Overall Study|Withdrawn|9
5034327|NCT02836652|17337485|P1|Overall Study|Withdrawn|9
5034328|NCT02836652|17337484|P2|Overall Study|Transplant/Explant|4
5034329|NCT02836652|17337485|P1|Overall Study|Transplant/Explant|3
5034330|NCT02836652|17337484|P2|Overall Study|Death|3
5034331|NCT02836652|17337485|P1|Overall Study|Death|3
5034332|NCT02836613|17337499|P2|Overall Study|Withdrawal by Subject|2
5034333|NCT02836613|17337500|P1|Overall Study|Withdrawal by Subject|0
5034334|NCT02836613|17337499|P2|Overall Study|Lost to Follow-up|1
5034335|NCT02836613|17337500|P1|Overall Study|Lost to Follow-up|0
5034336|NCT02836613|17337499|P2|Overall Study|Accidental drowning|0
5034337|NCT02836613|17337500|P1|Overall Study|Accidental drowning|1
5034338|NCT02836496|17337514|P2|Overall Study|Withdrawal by Subject|1
5034339|NCT02836496|17337515|P1|Overall Study|Withdrawal by Subject|0
5034340|NCT02836496|17337514|P2|Overall Study|Adverse Event|1
5034341|NCT02836496|17337515|P1|Overall Study|Adverse Event|2
5034342|NCT02836249|17337531|P2|Overall Study|Still on Study|55
5034343|NCT02836249|17337532|P1|Overall Study|Still on Study|121
5034344|NCT02836249|17337531|P2|Overall Study|Lost to Follow-up|1
5034345|NCT02836249|17337532|P1|Overall Study|Lost to Follow-up|0
5034346|NCT02836249|17337531|P2|Overall Study|Withdrew Consent|1
5034347|NCT02836249|17337532|P1|Overall Study|Withdrew Consent|0
5034348|NCT02836249|17337531|P2|Overall Study|Pregnancy|0
5034349|NCT02836249|17337532|P1|Overall Study|Pregnancy|2
5034350|NCT02836249|17337531|P2|Overall Study|Randomized but Never Treated|1
5034351|NCT02836249|17337532|P1|Overall Study|Randomized but Never Treated|0
5034352|NCT02836236|17337550|P2|Overall Study|Still on Study|49
5034353|NCT02836236|17337551|P1|Overall Study|Still on Study|101
5034354|NCT02836236|17337550|P2|Overall Study|Investigator's Discretion|0
5034355|NCT02836236|17337551|P1|Overall Study|Investigator's Discretion|1
5034356|NCT02836236|17337550|P2|Overall Study|Adverse Event|1
5034357|NCT02836236|17337551|P1|Overall Study|Adverse Event|0
5034358|NCT02836236|17337550|P2|Overall Study|Withdrew Consent|0
5034359|NCT02836236|17337551|P1|Overall Study|Withdrew Consent|2
5034360|NCT02836236|17337550|P2|Overall Study|Randomized but Never Treated|0
5034361|NCT02836236|17337551|P1|Overall Study|Randomized but Never Treated|1
5034362|NCT02835820|17337567|P2|Overall Study|Baseline Screen Failure|3
5034363|NCT02835820|17337568|P1|Overall Study|Baseline Screen Failure|0
5034364|NCT02835690|17337615|P3|Overall Study|Not Treated|0
5034365|NCT02835690|17337616|P2|Overall Study|Not Treated|2
5034366|NCT02835690|17337617|P1|Overall Study|Not Treated|0
5034367|NCT02835690|17337615|P3|Overall Study|Ongoing in Study (Follow-up)|9
5034368|NCT02835690|17337616|P2|Overall Study|Ongoing in Study (Follow-up)|7
5034369|NCT02835690|17337617|P1|Overall Study|Ongoing in Study (Follow-up)|10
5034370|NCT02835690|17337615|P3|Overall Study|Death|6
5034371|NCT02835690|17337616|P2|Overall Study|Death|6
5034372|NCT02835690|17337617|P1|Overall Study|Death|4
5034373|NCT02835495|17337680|P2|Overall Study|Declined in-person follow-up visit|2
5034374|NCT02835495|17337681|P1|Overall Study|Declined in-person follow-up visit|4
5034375|NCT02835495|17337680|P2|Overall Study|Cancer diagnosis prior intervention|0
5034376|NCT02835495|17337681|P1|Overall Study|Cancer diagnosis prior intervention|1
5034377|NCT02835339|17337707|P2|Overall Study|Did not receive allocated intervention|16
5034378|NCT02835339|17337708|P1|Overall Study|Did not receive allocated intervention|13
5034379|NCT02835092|17337730|P3|Overall Study|Lost to Follow-up|0
5034380|NCT02835092|17337731|P2|Overall Study|Lost to Follow-up|2
5034381|NCT02835092|17337732|P1|Overall Study|Lost to Follow-up|0
5034382|NCT02835092|17337730|P3|Overall Study|Withdrawal by Subject|3
5034383|NCT02835092|17337731|P2|Overall Study|Withdrawal by Subject|6
5034384|NCT02835092|17337732|P1|Overall Study|Withdrawal by Subject|3
5034385|NCT02834819|17337742|P2|Overall Study|Did not complete 7 day follow up call.|0
5034386|NCT02834819|17337743|P1|Overall Study|Did not complete 7 day follow up call.|5
5034387|NCT02834247|17337802|P4|Dose Expansion Phase|Withdrawal by Subject|1
5034388|NCT02834247|17337803|P3|Dose Expansion Phase|Withdrawal by Subject|0
5034389|NCT02834247|17337804|P2|Dose Expansion Phase|Withdrawal by Subject|0
5034390|NCT02834247|17337805|P1|Dose Expansion Phase|Withdrawal by Subject|0
5034391|NCT02834247|17337802|P4|Dose Expansion Phase|Lost to Follow-up|1
5034392|NCT02834247|17337803|P3|Dose Expansion Phase|Lost to Follow-up|0
5034393|NCT02834247|17337804|P2|Dose Expansion Phase|Lost to Follow-up|0
5034394|NCT02834247|17337805|P1|Dose Expansion Phase|Lost to Follow-up|0
5034395|NCT02834247|17337802|P4|Dose Expansion Phase|Death|8
5034396|NCT02834247|17337803|P3|Dose Expansion Phase|Death|0
5034397|NCT02834247|17337804|P2|Dose Expansion Phase|Death|0
5034398|NCT02834247|17337805|P1|Dose Expansion Phase|Death|0
5034399|NCT02834247|17337802|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
5034400|NCT02834247|17337803|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
5034401|NCT02834247|17337804|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
5034402|NCT02834247|17337805|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
5034403|NCT02834247|17337802|P4|Dose Escalation Phase|Withdrawal by Subject|0
5034404|NCT02834247|17337803|P3|Dose Escalation Phase|Withdrawal by Subject|0
5034405|NCT02834247|17337804|P2|Dose Escalation Phase|Withdrawal by Subject|2
5034406|NCT02834247|17337805|P1|Dose Escalation Phase|Withdrawal by Subject|2
5034407|NCT02834247|17337802|P4|Dose Escalation Phase|Lost to Follow-up|0
5034408|NCT02834247|17337803|P3|Dose Escalation Phase|Lost to Follow-up|0
5034409|NCT02834247|17337804|P2|Dose Escalation Phase|Lost to Follow-up|1
5034410|NCT02834247|17337805|P1|Dose Escalation Phase|Lost to Follow-up|0
5034411|NCT02834247|17337802|P4|Dose Escalation Phase|Death|0
5034412|NCT02834247|17337803|P3|Dose Escalation Phase|Death|5
5034413|NCT02834247|17337804|P2|Dose Escalation Phase|Death|6
5034414|NCT02834247|17337805|P1|Dose Escalation Phase|Death|5
5034415|NCT02834247|17337802|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
5034416|NCT02834247|17337803|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
5034417|NCT02834247|17337804|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
5034418|NCT02834247|17337805|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
5034419|NCT02833974|17337834|P2|Overall Study|Adverse Event|3
5034420|NCT02833974|17337835|P1|Overall Study|Adverse Event|0
5034421|NCT02833974|17337834|P2|Overall Study|Lost to Follow-up|0
5034422|NCT02833974|17337835|P1|Overall Study|Lost to Follow-up|1
5034423|NCT02833948|17337861|P2|Overall Study|scans could not be evaluated|2
5034424|NCT02833948|17337862|P1|Overall Study|scans could not be evaluated|5
5034425|NCT02833948|17337861|P2|Overall Study|were not scanned|13
5034426|NCT02833948|17337862|P1|Overall Study|were not scanned|8
5034427|NCT02833948|17337861|P2|Overall Study|Death|3
5034428|NCT02833948|17337862|P1|Overall Study|Death|2
5034429|NCT02833844|17337921|P2|Overall Study|Protocol Violation|4
5034430|NCT02833844|17337922|P1|Overall Study|Protocol Violation|0
5034431|NCT02833844|17337921|P2|Overall Study|Withdrawal by Subject|3
5034432|NCT02833844|17337922|P1|Overall Study|Withdrawal by Subject|2
5034433|NCT02833350|17337964|P7|Overall Study|Withdrawal by Subject|2
5034434|NCT02833350|17337965|P6|Overall Study|Withdrawal by Subject|0
5034435|NCT02833350|17337966|P5|Overall Study|Withdrawal by Subject|2
5034436|NCT02833350|17337967|P4|Overall Study|Withdrawal by Subject|0
5034437|NCT02833350|17337968|P3|Overall Study|Withdrawal by Subject|2
5034438|NCT02833350|17337969|P2|Overall Study|Withdrawal by Subject|3
5034439|NCT02833350|17337970|P1|Overall Study|Withdrawal by Subject|3
5034440|NCT02833350|17337964|P7|Overall Study|Lost to Follow-up|1
5034441|NCT02833350|17337965|P6|Overall Study|Lost to Follow-up|0
5034442|NCT02833350|17337966|P5|Overall Study|Lost to Follow-up|0
5034443|NCT02833350|17337967|P4|Overall Study|Lost to Follow-up|0
5034444|NCT02833350|17337968|P3|Overall Study|Lost to Follow-up|0
5034445|NCT02833350|17337969|P2|Overall Study|Lost to Follow-up|1
5034446|NCT02833350|17337970|P1|Overall Study|Lost to Follow-up|0
5034447|NCT02833350|17337964|P7|Overall Study|Lack of Efficacy|1
5034448|NCT02833350|17337965|P6|Overall Study|Lack of Efficacy|1
5034449|NCT02833350|17337966|P5|Overall Study|Lack of Efficacy|0
5034450|NCT02833350|17337967|P4|Overall Study|Lack of Efficacy|4
5034451|NCT02833350|17337968|P3|Overall Study|Lack of Efficacy|1
5034452|NCT02833350|17337969|P2|Overall Study|Lack of Efficacy|2
5034453|NCT02833350|17337970|P1|Overall Study|Lack of Efficacy|0
5034454|NCT02833350|17337964|P7|Overall Study|Death|0
5034455|NCT02833350|17337965|P6|Overall Study|Death|0
5034456|NCT02833350|17337966|P5|Overall Study|Death|0
5034457|NCT02833350|17337967|P4|Overall Study|Death|0
5034458|NCT02833350|17337968|P3|Overall Study|Death|1
5034459|NCT02833350|17337969|P2|Overall Study|Death|0
5034460|NCT02833350|17337970|P1|Overall Study|Death|0
5034461|NCT02833350|17337964|P7|Overall Study|Adverse Event|1
5034462|NCT02833350|17337965|P6|Overall Study|Adverse Event|0
5034463|NCT02833350|17337966|P5|Overall Study|Adverse Event|1
5034464|NCT02833350|17337967|P4|Overall Study|Adverse Event|4
5034465|NCT02833350|17337968|P3|Overall Study|Adverse Event|4
5034466|NCT02833350|17337969|P2|Overall Study|Adverse Event|3
5034467|NCT02833350|17337970|P1|Overall Study|Adverse Event|0
5034468|NCT02833077|17338177|P2|Overall Study|Protocol Deviation|1
5034469|NCT02833077|17338178|P1|Overall Study|Protocol Deviation|0
5034470|NCT02833077|17338177|P2|Overall Study|Personal Reasons|4
5034471|NCT02833077|17338178|P1|Overall Study|Personal Reasons|6
5034472|NCT02833077|17338177|P2|Overall Study|Lost to Follow-up|1
5034473|NCT02833077|17338178|P1|Overall Study|Lost to Follow-up|10
5034474|NCT02833077|17338177|P2|Overall Study|Adverse Event|2
5034475|NCT02833077|17338178|P1|Overall Study|Adverse Event|1
5034476|NCT02832375|17338201|P2|Overall Study|Withdrawal of Consent|0
5034477|NCT02832375|17338202|P1|Overall Study|Withdrawal of Consent|1
5034478|NCT02832375|17338201|P2|Overall Study|Lost to Follow-up|0
5034479|NCT02832375|17338202|P1|Overall Study|Lost to Follow-up|1
5034480|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
5034481|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
5034482|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
5034483|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
5034484|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
5034485|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
5034486|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
5034487|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
5034488|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
5034489|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Other|5
5034490|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Other|2
5034491|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Other|0
5034492|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
5034493|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
5034494|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
5034495|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
5034496|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
5034497|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
5034498|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
5034499|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
5034500|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
5034501|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Death|2
5034502|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Death|0
5034503|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Death|0
5034504|NCT02831855|17338250|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
5034505|NCT02831855|17338251|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
5034506|NCT02831855|17338252|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
5034507|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Other|0
5034508|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Other|0
5034509|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Other|4
5034510|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
5034511|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
5034512|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
5034513|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
5034514|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
5034515|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
5034516|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
5034517|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
5034518|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
5034519|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
5034520|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
5034521|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
5034522|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
5034523|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
5034524|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
5034525|NCT02831855|17338250|P3|Open Label Phase (24 Weeks)|Adverse Event|0
5034526|NCT02831855|17338251|P2|Open Label Phase (24 Weeks)|Adverse Event|0
5034527|NCT02831855|17338252|P1|Open Label Phase (24 Weeks)|Adverse Event|39
5034528|NCT02831764|17338313|P2|Overall Study|Ongoing at the time of the analysis|335
5034529|NCT02831764|17338314|P1|Overall Study|Ongoing at the time of the analysis|330
5034530|NCT02831764|17338313|P2|Overall Study|Protocol Violation|2
5034531|NCT02831764|17338314|P1|Overall Study|Protocol Violation|5
5034532|NCT02831764|17338313|P2|Overall Study|Lack of Efficacy|2
5034533|NCT02831764|17338314|P1|Overall Study|Lack of Efficacy|2
5034534|NCT02831764|17338313|P2|Overall Study|Adverse Event|5
5034535|NCT02831764|17338314|P1|Overall Study|Adverse Event|8
5034536|NCT02831764|17338313|P2|Overall Study|Lost to Follow-up|5
5034537|NCT02831764|17338314|P1|Overall Study|Lost to Follow-up|6
5034538|NCT02831764|17338313|P2|Overall Study|Physician Decision|2
5034539|NCT02831764|17338314|P1|Overall Study|Physician Decision|2
5034540|NCT02831764|17338313|P2|Overall Study|Withdrawal by Subject|6
5034541|NCT02831764|17338314|P1|Overall Study|Withdrawal by Subject|7
5034542|NCT02831764|17338313|P2|Overall Study|Protocol specific withdrawal criteria|2
5034543|NCT02831764|17338314|P1|Overall Study|Protocol specific withdrawal criteria|0
5034544|NCT02831673|17338378|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
5034545|NCT02831673|17338379|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
5034546|NCT02831673|17338378|P2|Overall Study|Withdrawal by Subject|4
5034547|NCT02831673|17338379|P1|Overall Study|Withdrawal by Subject|6
5034548|NCT02831673|17338378|P2|Overall Study|Physician Decision|3
5034549|NCT02831673|17338379|P1|Overall Study|Physician Decision|6
5034550|NCT02831673|17338378|P2|Overall Study|Lost to Follow-up|6
5034551|NCT02831673|17338379|P1|Overall Study|Lost to Follow-up|9
5034552|NCT02831673|17338378|P2|Overall Study|Protocol Withdrawal Criterion Met|6
5034553|NCT02831673|17338379|P1|Overall Study|Protocol Withdrawal Criterion Met|1
5034554|NCT02831673|17338378|P2|Overall Study|Protocol Violation|4
5034555|NCT02831673|17338379|P1|Overall Study|Protocol Violation|5
5034556|NCT02831673|17338378|P2|Overall Study|Lack of Efficacy|1
5034557|NCT02831673|17338379|P1|Overall Study|Lack of Efficacy|3
5034558|NCT02831673|17338378|P2|Overall Study|Adverse Event|4
5034559|NCT02831673|17338379|P1|Overall Study|Adverse Event|6
5034560|NCT02831387|17338452|P2|Overall Study|Discontinued due to stock recovery|1
5034561|NCT02831387|17338453|P1|Overall Study|Discontinued due to stock recovery|0
5034562|NCT02831387|17338452|P2|Overall Study|Withdrawal by Subject|1
5034563|NCT02831387|17338453|P1|Overall Study|Withdrawal by Subject|1
5034564|NCT02830893|17338473|P2|Overall Study|Discharged to SNF, no transportation.|1
5034565|NCT02830893|17338474|P1|Overall Study|Discharged to SNF, no transportation.|0
5034566|NCT02830893|17338473|P2|Overall Study|Lost to Follow-up|2
5034567|NCT02830893|17338474|P1|Overall Study|Lost to Follow-up|0
5034568|NCT02830893|17338473|P2|Overall Study|Relocation to out of the country|0
5034569|NCT02830893|17338474|P1|Overall Study|Relocation to out of the country|1
5034570|NCT02830880|17338486|P1|Overall Study|Physician Decision|1
5034571|NCT02830880|17338486|P1|Overall Study|Death|1
5034572|NCT02830880|17338486|P1|Overall Study|Adverse reaction to chemotherapy|1
5034573|NCT02830087|17338505|P6|Overall Study|No study staff to follow-up patients|3
5034574|NCT02830087|17338506|P5|Overall Study|No study staff to follow-up patients|3
5034575|NCT02830087|17338507|P4|Overall Study|No study staff to follow-up patients|3
5034576|NCT02830087|17338508|P3|Overall Study|No study staff to follow-up patients|4
5034577|NCT02830087|17338509|P2|Overall Study|No study staff to follow-up patients|4
5034578|NCT02830087|17338510|P1|Overall Study|No study staff to follow-up patients|4
5034579|NCT02829996|17338577|P5|Overall Study|Withdrawal by Subject|0
5034580|NCT02829996|17338578|P4|Overall Study|Withdrawal by Subject|0
5034581|NCT02829996|17338579|P3|Overall Study|Withdrawal by Subject|0
5034582|NCT02829996|17338580|P2|Overall Study|Withdrawal by Subject|0
5034583|NCT02829996|17338581|P1|Overall Study|Withdrawal by Subject|1
5034584|NCT02829944|17338606|P2|Overall Study|Staff unavailable|1
5034585|NCT02829944|17338607|P1|Overall Study|Staff unavailable|0
5034586|NCT02829944|17338606|P2|Overall Study|Catheter broke|1
5034587|NCT02829944|17338607|P1|Overall Study|Catheter broke|0
5034588|NCT02829944|17338606|P2|Overall Study|Catheter Displacement|0
5034589|NCT02829944|17338607|P1|Overall Study|Catheter Displacement|1
5034590|NCT02829944|17338606|P2|Overall Study|Withdrawal by Subject|1
5034591|NCT02829944|17338607|P1|Overall Study|Withdrawal by Subject|2
5034592|NCT02829944|17338606|P2|Overall Study|Inadequate Neuraxial Block|1
5034593|NCT02829944|17338607|P1|Overall Study|Inadequate Neuraxial Block|1
5034594|NCT02829944|17338606|P2|Overall Study|Screen Failure|2
5034595|NCT02829944|17338607|P1|Overall Study|Screen Failure|2
5034596|NCT02829944|17338606|P2|Overall Study|Physician Decision|1
5034597|NCT02829944|17338607|P1|Overall Study|Physician Decision|0
5034598|NCT02829918|17338657|P1|Overall Study|Progression|1
5034599|NCT02829918|17338657|P1|Overall Study|Adverse Event|1
5034600|NCT02829918|17338657|P1|Overall Study|Withdrawal by Subject|4
5034601|NCT02829918|17338657|P1|Overall Study|Death|2
5034602|NCT02829775|17338662|P1|Overall Study|Disease remission|1
5034603|NCT02829775|17338662|P1|Overall Study|Withdrawal by Subject|3
5034604|NCT02829775|17338662|P1|Overall Study|Death|1
5034605|NCT02829138|17338744|P2|Overall Study|Withdrawal by Subject|0
5034606|NCT02829138|17338745|P1|Overall Study|Withdrawal by Subject|1
5034607|NCT02828982|17338768|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5034608|NCT02828982|17338769|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5034609|NCT02828644|17338791|P2|Overall Study|Lost to Follow-up|22
5034610|NCT02828644|17338792|P1|Overall Study|Lost to Follow-up|23
5034611|NCT02828436|17338799|P2|Period 2|Lost to Follow-up|0
5034612|NCT02828436|17338800|P1|Period 2|Lost to Follow-up|1
5034613|NCT02828436|17338799|P2|Period 2|Did Not Meet Inclusion Criteria|0
5034614|NCT02828436|17338800|P1|Period 2|Did Not Meet Inclusion Criteria|3
5034615|NCT02828436|17338799|P2|Period 2|Withdrawal by Subject|0
5034616|NCT02828436|17338800|P1|Period 2|Withdrawal by Subject|4
5034617|NCT02828436|17338799|P2|Period 1|Lost to Follow-up|1
5034618|NCT02828436|17338800|P1|Period 1|Lost to Follow-up|0
5034619|NCT02828436|17338799|P2|Period 1|Did Not Meet Inclusion Criteria|3
5034620|NCT02828436|17338800|P1|Period 1|Did Not Meet Inclusion Criteria|0
5034621|NCT02828241|17338808|P2|Overall Study|Protocol Violation|0
5034622|NCT02828241|17338809|P1|Overall Study|Protocol Violation|1
5034623|NCT02828241|17338808|P2|Overall Study|Adverse Event|2
5034624|NCT02828241|17338809|P1|Overall Study|Adverse Event|7
5034625|NCT02828124|17338836|P4|Overall Study|Subject Withdrew Consent|1
5034626|NCT02828124|17338837|P3|Overall Study|Subject Withdrew Consent|0
5034627|NCT02828124|17338838|P2|Overall Study|Subject Withdrew Consent|0
5034628|NCT02828124|17338839|P1|Overall Study|Subject Withdrew Consent|0
5034629|NCT02828124|17338836|P4|Overall Study|AE Unrelated to Study Drug|1
5034630|NCT02828124|17338837|P3|Overall Study|AE Unrelated to Study Drug|0
5034631|NCT02828124|17338838|P2|Overall Study|AE Unrelated to Study Drug|0
5034632|NCT02828124|17338839|P1|Overall Study|AE Unrelated to Study Drug|0
5034633|NCT02828124|17338836|P4|Overall Study|Disease Progression|4
5034634|NCT02828124|17338837|P3|Overall Study|Disease Progression|1
5034635|NCT02828124|17338838|P2|Overall Study|Disease Progression|2
5034636|NCT02828124|17338839|P1|Overall Study|Disease Progression|1
5034637|NCT02828111|17338954|P5|Overall Study|Lost to Follow-up|1
5034638|NCT02828111|17338955|P4|Overall Study|Lost to Follow-up|1
5034639|NCT02828111|17338956|P3|Overall Study|Lost to Follow-up|0
5034640|NCT02828111|17338957|P2|Overall Study|Lost to Follow-up|0
5034641|NCT02828111|17338958|P1|Overall Study|Lost to Follow-up|0
5034642|NCT02828111|17338954|P5|Overall Study|Withdrawal by Subject|0
5034643|NCT02828111|17338955|P4|Overall Study|Withdrawal by Subject|0
5034644|NCT02828111|17338956|P3|Overall Study|Withdrawal by Subject|2
5034645|NCT02828111|17338957|P2|Overall Study|Withdrawal by Subject|0
5034646|NCT02828111|17338958|P1|Overall Study|Withdrawal by Subject|0
5034647|NCT02828020|17339019|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
5034648|NCT02828020|17339020|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
5034649|NCT02828020|17339021|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
5034650|NCT02828020|17339019|P3|Safety Follow-up Period|Protocol Violation|1
5034651|NCT02828020|17339020|P2|Safety Follow-up Period|Protocol Violation|2
5034652|NCT02828020|17339021|P1|Safety Follow-up Period|Protocol Violation|0
5034653|NCT02828020|17339019|P3|Safety Follow-up Period|Lost to Follow-up|11
5034654|NCT02828020|17339020|P2|Safety Follow-up Period|Lost to Follow-up|8
5034655|NCT02828020|17339021|P1|Safety Follow-up Period|Lost to Follow-up|9
5034656|NCT02828020|17339019|P3|Safety Follow-up Period|Withdrawal of Consent|7
5034657|NCT02828020|17339020|P2|Safety Follow-up Period|Withdrawal of Consent|8
5034658|NCT02828020|17339021|P1|Safety Follow-up Period|Withdrawal of Consent|10
5034659|NCT02828020|17339019|P3|Treatment Period|Other Miscellaneous Reasons|0
5034660|NCT02828020|17339020|P2|Treatment Period|Other Miscellaneous Reasons|1
5034661|NCT02828020|17339021|P1|Treatment Period|Other Miscellaneous Reasons|0
5034662|NCT02828020|17339019|P3|Treatment Period|Protocol Violation|7
5034663|NCT02828020|17339020|P2|Treatment Period|Protocol Violation|4
5034664|NCT02828020|17339021|P1|Treatment Period|Protocol Violation|2
5034665|NCT02828020|17339019|P3|Treatment Period|Pregnancy|0
5034666|NCT02828020|17339020|P2|Treatment Period|Pregnancy|2
5034667|NCT02828020|17339021|P1|Treatment Period|Pregnancy|0
5034668|NCT02828020|17339019|P3|Treatment Period|Lack of Qualifying Event|43
5034669|NCT02828020|17339020|P2|Treatment Period|Lack of Qualifying Event|53
5034670|NCT02828020|17339021|P1|Treatment Period|Lack of Qualifying Event|44
5034671|NCT02828020|17339019|P3|Treatment Period|Lost to Follow-up|18
5034672|NCT02828020|17339020|P2|Treatment Period|Lost to Follow-up|24
5034673|NCT02828020|17339021|P1|Treatment Period|Lost to Follow-up|21
5034674|NCT02828020|17339019|P3|Treatment Period|Withdrawal of Consent|9
5034675|NCT02828020|17339020|P2|Treatment Period|Withdrawal of Consent|14
5034676|NCT02828020|17339021|P1|Treatment Period|Withdrawal of Consent|10
5034677|NCT02828020|17339019|P3|Treatment Period|Adverse Event|1
5034678|NCT02828020|17339020|P2|Treatment Period|Adverse Event|1
5034679|NCT02828020|17339021|P1|Treatment Period|Adverse Event|3
5034680|NCT02827708|17339052|P2|Overall Study|Death|2
5034681|NCT02827708|17339053|P1|Overall Study|Death|1
5034682|NCT02827708|17339052|P2|Overall Study|Withdrawal by Subject|2
5034683|NCT02827708|17339053|P1|Overall Study|Withdrawal by Subject|1
5034684|NCT02827708|17339052|P2|Overall Study|Lost to Follow-up|1
5034685|NCT02827708|17339053|P1|Overall Study|Lost to Follow-up|3
5034686|NCT02827500|17339132|P2|Overall Study|Other|1
5034687|NCT02827500|17339133|P1|Overall Study|Other|5
5034688|NCT02827500|17339132|P2|Overall Study|Missing primary endpoint data|1
5034689|NCT02827500|17339133|P1|Overall Study|Missing primary endpoint data|3
5034690|NCT02827500|17339132|P2|Overall Study|Withdrawal by Subject|1
5034691|NCT02827500|17339133|P1|Overall Study|Withdrawal by Subject|3
5034692|NCT02827500|17339132|P2|Overall Study|Lost to Follow-up|1
5034693|NCT02827500|17339133|P1|Overall Study|Lost to Follow-up|1
5034694|NCT02827500|17339132|P2|Overall Study|Death|3
5034695|NCT02827500|17339133|P1|Overall Study|Death|7
5034696|NCT02826798|17339154|P5|Overall Study|Withdrawal by Subject|0
5034697|NCT02826798|17339155|P4|Overall Study|Withdrawal by Subject|1
5034698|NCT02826798|17339156|P3|Overall Study|Withdrawal by Subject|0
5034699|NCT02826798|17339157|P2|Overall Study|Withdrawal by Subject|1
5034700|NCT02826798|17339158|P1|Overall Study|Withdrawal by Subject|0
5034701|NCT02826603|17339220|P2|Overall Study|New therapy for study indication|1
5034702|NCT02826603|17339221|P1|Overall Study|New therapy for study indication|0
5034703|NCT02826603|17339220|P2|Overall Study|Death|0
5034704|NCT02826603|17339221|P1|Overall Study|Death|2
5034705|NCT02826603|17339220|P2|Overall Study|Withdrawal by Subject|19
5034706|NCT02826603|17339221|P1|Overall Study|Withdrawal by Subject|20
5034707|NCT02826603|17339220|P2|Overall Study|Protocol Violation|3
5034708|NCT02826603|17339221|P1|Overall Study|Protocol Violation|3
5034709|NCT02826603|17339220|P2|Overall Study|Pregnancy|2
5034710|NCT02826603|17339221|P1|Overall Study|Pregnancy|1
5034711|NCT02826603|17339220|P2|Overall Study|Physician Decision|7
5034712|NCT02826603|17339221|P1|Overall Study|Physician Decision|1
5034713|NCT02826603|17339220|P2|Overall Study|Noncompliance with treatment|2
5034714|NCT02826603|17339221|P1|Overall Study|Noncompliance with treatment|0
5034715|NCT02826603|17339220|P2|Overall Study|Lost to Follow-up|12
5034716|NCT02826603|17339221|P1|Overall Study|Lost to Follow-up|13
5034717|NCT02826603|17339220|P2|Overall Study|Lack of Efficacy|9
5034718|NCT02826603|17339221|P1|Overall Study|Lack of Efficacy|4
5034719|NCT02826603|17339220|P2|Overall Study|Adverse Event|9
5034720|NCT02826603|17339221|P1|Overall Study|Adverse Event|17
5034721|NCT02826421|17339261|P4|Overall Study|Reason not given|0
5034722|NCT02826421|17339262|P3|Overall Study|Reason not given|1
5034723|NCT02826421|17339263|P2|Overall Study|Reason not given|0
5034724|NCT02826421|17339264|P1|Overall Study|Reason not given|1
5034725|NCT02826421|17339261|P4|Overall Study|Withdrawal by Subject|1
5034726|NCT02826421|17339262|P3|Overall Study|Withdrawal by Subject|1
5034727|NCT02826421|17339263|P2|Overall Study|Withdrawal by Subject|3
5034728|NCT02826421|17339264|P1|Overall Study|Withdrawal by Subject|1
5034729|NCT02826421|17339261|P4|Overall Study|Adverse Event|1
5034730|NCT02826421|17339262|P3|Overall Study|Adverse Event|0
5034731|NCT02826421|17339263|P2|Overall Study|Adverse Event|0
5034732|NCT02826421|17339264|P1|Overall Study|Adverse Event|1
5034733|NCT02825992|17339276|P1|Overall Study|Procedure terminated|2
5034734|NCT02825992|17339276|P1|Overall Study|Lost to Follow-up|2
5034735|NCT02825992|17339276|P1|Overall Study|Withdrawal by Subject|4
5034736|NCT02825550|17339297|P1|Overall Study|Physician Decision|1
5034737|NCT02825251|17339305|P2|Overall Study|Unclassified|0
5034738|NCT02825251|17339306|P1|Overall Study|Unclassified|2
5034739|NCT02825251|17339305|P2|Overall Study|Withdrawal by Subject|4
5034740|NCT02825251|17339306|P1|Overall Study|Withdrawal by Subject|1
5034741|NCT02825251|17339305|P2|Overall Study|Lost to Follow-up|1
5034742|NCT02825251|17339306|P1|Overall Study|Lost to Follow-up|0
5034743|NCT02825251|17339305|P2|Overall Study|Adverse Event|1
5034744|NCT02825251|17339306|P1|Overall Study|Adverse Event|0
5034745|NCT02825043|17339492|P1|Overall Study|Lost to Follow-up|4
5034746|NCT02824562|17339514|P2|Overall Study|Death|1
5034747|NCT02824562|17339515|P1|Overall Study|Death|0
5034748|NCT02824562|17339514|P2|Overall Study|Lost to Follow-up|4
5034749|NCT02824562|17339515|P1|Overall Study|Lost to Follow-up|3
5034750|NCT02824432|17339524|P2|Overall Study|Major Protocol Deviation|0
5034751|NCT02824432|17339525|P1|Overall Study|Major Protocol Deviation|1
5034752|NCT02824224|17339601|P2|Overall Study|Did not show up for allocation visit|0
5034753|NCT02824224|17339602|P1|Overall Study|Did not show up for allocation visit|2
5034754|NCT02824224|17339601|P2|Overall Study|Discontinued, IUS expulsion|1
5034755|NCT02824224|17339602|P1|Overall Study|Discontinued, IUS expulsion|0
5034756|NCT02824198|17339622|P2|Overall Study|Withdrawal by Subject|0
5034757|NCT02824198|17339623|P1|Overall Study|Withdrawal by Subject|5
5034758|NCT02824198|17339622|P2|Overall Study|Lost to Follow-up|2
5034759|NCT02824198|17339623|P1|Overall Study|Lost to Follow-up|5
5034760|NCT02824198|17339622|P2|Overall Study|Non-compliance with the protocol|1
5034761|NCT02824198|17339623|P1|Overall Study|Non-compliance with the protocol|5
5034762|NCT02823964|17339653|P1|Overall Study|Withdrawal by Subject|1
5034763|NCT02823964|17339653|P1|Overall Study|Lack of Efficacy|1
5034764|NCT02823964|17339653|P1|Overall Study|Physician Decision|1
5034765|NCT02823964|17339653|P1|Overall Study|Adverse Event|2
5034766|NCT02823470|17339667|P2|Overall Study|Study terminated by sponsor|15
5034767|NCT02823470|17339668|P1|Overall Study|Study terminated by sponsor|8
5034768|NCT02823470|17339667|P2|Overall Study|Adverse Event|0
5034769|NCT02823470|17339668|P1|Overall Study|Adverse Event|1
5034770|NCT02822794|17339736|P2|Overall Study|Withdrew Consent|0
5034771|NCT02822794|17339737|P1|Overall Study|Withdrew Consent|1
5034772|NCT02822235|17339838|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
5034773|NCT02822235|17339839|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
5034774|NCT02822235|17339838|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
5034775|NCT02822235|17339839|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
5034776|NCT02822235|17339838|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
5034777|NCT02822235|17339839|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
5034778|NCT02822235|17339838|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
5034779|NCT02822235|17339839|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
5034780|NCT02822235|17339838|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
5034781|NCT02822235|17339839|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
5034782|NCT02822235|17339838|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
5034783|NCT02822235|17339839|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
5034784|NCT02822222|17339894|P2|Overall Study|Protocol requirement SBP<110 mmHg|0
5034785|NCT02822222|17339895|P1|Overall Study|Protocol requirement SBP<110 mmHg|1
5034786|NCT02821962|17339945|P2|Overall Study|Lost to Follow-up|0
5034787|NCT02821962|17339946|P1|Overall Study|Lost to Follow-up|2
5034788|NCT02821910|17339990|P6|Overall Study|Other than specified|0
5034789|NCT02821910|17339991|P5|Overall Study|Other than specified|0
5034790|NCT02821910|17339992|P4|Overall Study|Other than specified|0
5034791|NCT02821910|17339993|P3|Overall Study|Other than specified|1
5034792|NCT02821910|17339994|P2|Overall Study|Other than specified|0
5034793|NCT02821910|17339995|P1|Overall Study|Other than specified|1
5034794|NCT02821910|17339990|P6|Overall Study|Withdrawal by Subject|1
5034795|NCT02821910|17339991|P5|Overall Study|Withdrawal by Subject|0
5034796|NCT02821910|17339992|P4|Overall Study|Withdrawal by Subject|0
5034797|NCT02821910|17339993|P3|Overall Study|Withdrawal by Subject|1
5034798|NCT02821910|17339994|P2|Overall Study|Withdrawal by Subject|0
5034799|NCT02821910|17339995|P1|Overall Study|Withdrawal by Subject|0
5034800|NCT02821819|17340057|P1|Overall Study|Protocol Violation|1
5034801|NCT02821715|17340062|P6|Overall Study|Protocol Violation|0
5034802|NCT02821715|17340063|P5|Overall Study|Protocol Violation|0
5034803|NCT02821715|17340064|P4|Overall Study|Protocol Violation|0
5034804|NCT02821715|17340065|P3|Overall Study|Protocol Violation|0
5034805|NCT02821715|17340066|P2|Overall Study|Protocol Violation|0
5034806|NCT02821715|17340067|P1|Overall Study|Protocol Violation|1
5034807|NCT02821000|17340154|P1|Overall Study|Ongoing in Study|58
5034808|NCT02821000|17340154|P1|Overall Study|Withdrawal by Subject|1
5034809|NCT02821000|17340154|P1|Overall Study|Death|44
5034810|NCT02820844|17340192|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
5034811|NCT02820844|17340193|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034812|NCT02820844|17340194|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034813|NCT02820844|17340195|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034814|NCT02820844|17340196|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034815|NCT02820844|17340197|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034816|NCT02820844|17340192|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5034817|NCT02820844|17340193|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
5034818|NCT02820844|17340194|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5034819|NCT02820844|17340195|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5034820|NCT02820844|17340196|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5034821|NCT02820844|17340197|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5034822|NCT02820844|17340192|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034823|NCT02820844|17340193|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034824|NCT02820844|17340194|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
5034825|NCT02820844|17340195|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
5034826|NCT02820844|17340196|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034827|NCT02820844|17340197|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5034828|NCT02820844|17340192|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5034829|NCT02820844|17340193|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5034830|NCT02820844|17340194|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5034831|NCT02820844|17340195|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
5034832|NCT02820844|17340196|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5034833|NCT02820844|17340197|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5034834|NCT02820844|17340192|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5034835|NCT02820844|17340193|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5034836|NCT02820844|17340194|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
5034837|NCT02820844|17340195|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
5034838|NCT02820844|17340196|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5034839|NCT02820844|17340197|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5034840|NCT02820844|17340192|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5034841|NCT02820844|17340193|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5034842|NCT02820844|17340194|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5034843|NCT02820844|17340195|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5034844|NCT02820844|17340196|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5034845|NCT02820844|17340197|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
5034846|NCT02820844|17340192|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5034847|NCT02820844|17340193|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5034848|NCT02820844|17340194|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5034849|NCT02820844|17340195|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5034850|NCT02820844|17340196|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
5034851|NCT02820844|17340197|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
5034852|NCT02820844|17340192|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5034853|NCT02820844|17340193|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5034854|NCT02820844|17340194|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5034855|NCT02820844|17340195|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5034856|NCT02820844|17340196|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
5034857|NCT02820844|17340197|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5034858|NCT02820844|17340192|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5034859|NCT02820844|17340193|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5034860|NCT02820844|17340194|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5034861|NCT02820844|17340195|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5034862|NCT02820844|17340196|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
5034863|NCT02820844|17340197|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
5034864|NCT02820844|17340192|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5034865|NCT02820844|17340193|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5034866|NCT02820844|17340194|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5034867|NCT02820844|17340195|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5034868|NCT02820844|17340196|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
5034869|NCT02820844|17340197|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
5034870|NCT02820597|17340411|P1|Overall Study|Lost to Follow-up|12
5034871|NCT02820038|17340462|P4|Overall Study|Withdrawal by Subject|13
5034872|NCT02820038|17340463|P3|Overall Study|Withdrawal by Subject|3
5034873|NCT02820038|17340464|P2|Overall Study|Withdrawal by Subject|14
5034874|NCT02820038|17340465|P1|Overall Study|Withdrawal by Subject|3
5034875|NCT02820038|17340462|P4|Overall Study|Lost to Follow-up|9
5034876|NCT02820038|17340463|P3|Overall Study|Lost to Follow-up|2
5034877|NCT02820038|17340464|P2|Overall Study|Lost to Follow-up|11
5034878|NCT02820038|17340465|P1|Overall Study|Lost to Follow-up|7
5034879|NCT02819804|17340592|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
5034880|NCT02819726|17340599|P4|Part B (All Participants)|Protocol non-compliance|0
5034881|NCT02819726|17340600|P3|Part B (All Participants)|Protocol non-compliance|1
5034882|NCT02819726|17340601|P2|Part B (All Participants)|Protocol non-compliance|0
5034883|NCT02819726|17340602|P1|Part B (All Participants)|Protocol non-compliance|0
5034884|NCT02819726|17340599|P4|Part B (All Participants)|Withdrawal by Subject|0
5034885|NCT02819726|17340600|P3|Part B (All Participants)|Withdrawal by Subject|1
5034886|NCT02819726|17340601|P2|Part B (All Participants)|Withdrawal by Subject|1
5034887|NCT02819726|17340602|P1|Part B (All Participants)|Withdrawal by Subject|2
5034888|NCT02819726|17340599|P4|Part B (All Participants)|Lost to Follow-up|2
5034889|NCT02819726|17340600|P3|Part B (All Participants)|Lost to Follow-up|2
5034890|NCT02819726|17340601|P2|Part B (All Participants)|Lost to Follow-up|1
5034891|NCT02819726|17340602|P1|Part B (All Participants)|Lost to Follow-up|1
5034892|NCT02819726|17340599|P4|Part A (All Participants)|Protocol non-compliance|0
5034893|NCT02819726|17340600|P3|Part A (All Participants)|Protocol non-compliance|5
5034894|NCT02819726|17340601|P2|Part A (All Participants)|Protocol non-compliance|4
5034895|NCT02819726|17340602|P1|Part A (All Participants)|Protocol non-compliance|3
5034896|NCT02819726|17340599|P4|Part A (All Participants)|Withdrawal by Subject|0
5034897|NCT02819726|17340600|P3|Part A (All Participants)|Withdrawal by Subject|6
5034898|NCT02819726|17340601|P2|Part A (All Participants)|Withdrawal by Subject|5
5034899|NCT02819726|17340602|P1|Part A (All Participants)|Withdrawal by Subject|3
5034900|NCT02819726|17340599|P4|Part A (All Participants)|Lost to Follow-up|0
5034901|NCT02819726|17340600|P3|Part A (All Participants)|Lost to Follow-up|0
5034902|NCT02819726|17340601|P2|Part A (All Participants)|Lost to Follow-up|1
5034903|NCT02819726|17340602|P1|Part A (All Participants)|Lost to Follow-up|0
5034904|NCT02819310|17340729|P1|Overall Study|Protocol Violation|30
5034905|NCT02819310|17340729|P1|Overall Study|Physician Decision|8
5034906|NCT02819310|17340729|P1|Overall Study|Lack of Efficacy|5
5034907|NCT02819310|17340729|P1|Overall Study|Adverse Event|13
5034908|NCT02819310|17340729|P1|Overall Study|Lost to Follow-up|16
5034909|NCT02819310|17340729|P1|Overall Study|Withdrawal by Subject|37
5034910|NCT02819297|17340735|P2|Overall Study|Protocol Violation|2
5034911|NCT02819297|17340736|P1|Overall Study|Protocol Violation|1
5034912|NCT02819297|17340735|P2|Overall Study|Lack of Efficacy|8
5034913|NCT02819297|17340736|P1|Overall Study|Lack of Efficacy|5
5034914|NCT02819297|17340735|P2|Overall Study|Physician Decision|5
5034915|NCT02819297|17340736|P1|Overall Study|Physician Decision|5
5034916|NCT02819297|17340735|P2|Overall Study|Adverse Event|10
5034917|NCT02819297|17340736|P1|Overall Study|Adverse Event|12
5034918|NCT02819297|17340735|P2|Overall Study|Lost to Follow-up|14
5034919|NCT02819297|17340736|P1|Overall Study|Lost to Follow-up|12
5034920|NCT02819297|17340735|P2|Overall Study|Withdrawal by Subject|13
5034921|NCT02819297|17340736|P1|Overall Study|Withdrawal by Subject|25
5034922|NCT02818998|17340775|P3|Overall Study|Physician Decision|0
5034923|NCT02818998|17340776|P2|Overall Study|Physician Decision|0
5034924|NCT02818998|17340777|P1|Overall Study|Physician Decision|1
5034925|NCT02818998|17340775|P3|Overall Study|Withdrawal by Subject|6
5034926|NCT02818998|17340776|P2|Overall Study|Withdrawal by Subject|6
5034927|NCT02818998|17340777|P1|Overall Study|Withdrawal by Subject|7
5034928|NCT02818998|17340775|P3|Overall Study|Death|8
5034929|NCT02818998|17340776|P2|Overall Study|Death|6
5034930|NCT02818998|17340777|P1|Overall Study|Death|3
5034931|NCT02818998|17340775|P3|Overall Study|Withdrawal by sponsor|1
5034932|NCT02818998|17340776|P2|Overall Study|Withdrawal by sponsor|1
5034933|NCT02818998|17340777|P1|Overall Study|Withdrawal by sponsor|0
5034934|NCT02818998|17340775|P3|Overall Study|Lost to Follow-up|2
5034935|NCT02818998|17340776|P2|Overall Study|Lost to Follow-up|1
5034936|NCT02818998|17340777|P1|Overall Study|Lost to Follow-up|4
5034937|NCT02818998|17340775|P3|Overall Study|Adverse Event|1
5034938|NCT02818998|17340776|P2|Overall Study|Adverse Event|2
5034939|NCT02818998|17340777|P1|Overall Study|Adverse Event|3
5034940|NCT02818920|17340810|P1|Overall Study|Refused Further Treatment|1
5034941|NCT02818920|17340810|P1|Overall Study|Developed Other Disease|1
5034942|NCT02818920|17340810|P1|Overall Study|Adverse Event|3
5034943|NCT02818920|17340810|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
5034944|NCT02818920|17340810|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
5034945|NCT02818920|17340810|P1|Overall Study|Unresectable|4
5034946|NCT02818777|17340814|P1|Overall Study|Adverse Event|3
5034947|NCT02818036|17340881|P2|Overall Study|Withdrawal by Subject|0
5034948|NCT02818036|17340882|P1|Overall Study|Withdrawal by Subject|1
5034949|NCT02818036|17340881|P2|Overall Study|head did not fit in fMRI scanner headres|0
5034950|NCT02818036|17340882|P1|Overall Study|head did not fit in fMRI scanner headres|1
5034951|NCT02817841|17340890|P1|Overall Study|Protocol Violation|94
5034952|NCT02817841|17340890|P1|Overall Study|Other reasons|53
5034953|NCT02817841|17340890|P1|Overall Study|Pregnancy wish|17
5034954|NCT02817841|17340890|P1|Overall Study|Pregnancy|32
5034955|NCT02817841|17340890|P1|Overall Study|Adverse event related to bleeding|51
5034956|NCT02817841|17340890|P1|Overall Study|Adverse event not related to bleeding|131
5034957|NCT02817841|17340890|P1|Overall Study|Withdrawal by Subject|183
5034958|NCT02817841|17340890|P1|Overall Study|Lost to Follow-up|287
5034959|NCT02817828|17340917|P1|Overall Study|Other|26
5034960|NCT02817828|17340917|P1|Overall Study|Withdrawal by Subject|78
5034961|NCT02817828|17340917|P1|Overall Study|Pregnancy wish|15
5034962|NCT02817828|17340917|P1|Overall Study|Pregnancy|7
5034963|NCT02817828|17340917|P1|Overall Study|Protocol Violation|11
5034964|NCT02817828|17340917|P1|Overall Study|Adverse event related to bleeding|53
5034965|NCT02817828|17340917|P1|Overall Study|Adverse event not related to bleeding|104
5034966|NCT02817828|17340917|P1|Overall Study|Lost to Follow-up|41
5034967|NCT02817594|17340952|P1|Overall Study|Did Not Receive Treatment|1
5034968|NCT02817594|17340952|P1|Overall Study|Other|1
5034969|NCT02817594|17340952|P1|Overall Study|Withdrawal by Subject|1
5034970|NCT02817555|17340973|P2|Overall Study|changed to Peritoneal Dialysis|1
5034971|NCT02817555|17340974|P1|Overall Study|changed to Peritoneal Dialysis|0
5034972|NCT02817555|17340973|P2|Overall Study|transplant|1
5034973|NCT02817555|17340974|P1|Overall Study|transplant|1
5034974|NCT02817555|17340973|P2|Overall Study|moved away|0
5034975|NCT02817555|17340974|P1|Overall Study|moved away|1
5034976|NCT02817555|17340973|P2|Overall Study|Death|3
5034977|NCT02817555|17340974|P1|Overall Study|Death|1
5034978|NCT02817516|17340994|P4|Overall Study|Other|0
5034979|NCT02817516|17340995|P3|Overall Study|Other|1
5034980|NCT02817516|17340996|P2|Overall Study|Other|0
5034981|NCT02817516|17340997|P1|Overall Study|Other|0
5034982|NCT02817087|17341034|P2|Overall Study|Withdrawal by Subject|0
5034983|NCT02817087|17341035|P1|Overall Study|Withdrawal by Subject|2
5034984|NCT02816398|17341106|P1|Overall Study|Lost to Follow-up|1
5034985|NCT02816398|17341106|P1|Overall Study|Lack of Efficacy|8
5034986|NCT02816398|17341106|P1|Overall Study|Death|5
5034987|NCT02816138|17341164|P1|Overall Study|Adverse Event|1
5034988|NCT02815735|17341210|P2|Second Intervention (4 Weeks)|Protocol Violation|0
5034989|NCT02815735|17341211|P1|Second Intervention (4 Weeks)|Protocol Violation|1
5034990|NCT02815735|17341210|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
5034991|NCT02815735|17341211|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
5034992|NCT02815735|17341210|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
5034993|NCT02815735|17341211|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
5034994|NCT02815735|17341210|P2|First Intervention (4 Weeks)|Discomfort|0
5034995|NCT02815735|17341211|P1|First Intervention (4 Weeks)|Discomfort|1
5034996|NCT02815670|17341265|P1|Overall Study|Prematurely discontinued of the trial|1
5034997|NCT02815397|17341297|P1|Overall Study|Physician Decision|2
5034998|NCT02815293|17341307|P3|Overall Study|Adverse Event|0
5034999|NCT02815293|17341308|P2|Overall Study|Adverse Event|1
5035000|NCT02815293|17341309|P1|Overall Study|Adverse Event|0
5035001|NCT02815293|17341307|P3|Overall Study|Participants not randomized|18
5035002|NCT02815293|17341308|P2|Overall Study|Participants not randomized|0
5035003|NCT02815293|17341309|P1|Overall Study|Participants not randomized|0
5035004|NCT02815293|17341307|P3|Overall Study|Study termination by sponsor|0
5035005|NCT02815293|17341308|P2|Overall Study|Study termination by sponsor|7
5035006|NCT02815293|17341309|P1|Overall Study|Study termination by sponsor|10
5035007|NCT02815280|17341319|P2|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
5035008|NCT02815280|17341320|P1|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
5035009|NCT02815280|17341319|P2|Open-Label Phase|Administrative|12
5035010|NCT02815280|17341320|P1|Open-Label Phase|Administrative|26
5035011|NCT02815280|17341319|P2|Open-Label Phase|Protocol Violation|0
5035012|NCT02815280|17341320|P1|Open-Label Phase|Protocol Violation|3
5035013|NCT02815280|17341319|P2|Open-Label Phase|Withdrawal by Subject|18
5035014|NCT02815280|17341320|P1|Open-Label Phase|Withdrawal by Subject|33
5035015|NCT02815280|17341319|P2|Open-Label Phase|Lost to Follow-up|9
5035016|NCT02815280|17341320|P1|Open-Label Phase|Lost to Follow-up|18
5035017|NCT02815280|17341319|P2|Open-Label Phase|Adverse Event|3
5035018|NCT02815280|17341320|P1|Open-Label Phase|Adverse Event|2
5035019|NCT02815280|17341319|P2|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
5035020|NCT02815280|17341320|P1|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
5035021|NCT02815280|17341319|P2|Double-Blind Phase|Protocol Violation|2
5035022|NCT02815280|17341320|P1|Double-Blind Phase|Protocol Violation|2
5035023|NCT02815280|17341319|P2|Double-Blind Phase|Withdrawal by Subject|11
5035024|NCT02815280|17341320|P1|Double-Blind Phase|Withdrawal by Subject|20
5035025|NCT02815280|17341319|P2|Double-Blind Phase|Lost to Follow-up|9
5035026|NCT02815280|17341320|P1|Double-Blind Phase|Lost to Follow-up|10
5035027|NCT02815280|17341319|P2|Double-Blind Phase|Adverse Event|1
5035028|NCT02815280|17341320|P1|Double-Blind Phase|Adverse Event|1
5035029|NCT02815267|17341340|P2|Open-Label Phase|Other|5
5035030|NCT02815267|17341341|P1|Open-Label Phase|Other|2
5035031|NCT02815267|17341340|P2|Open-Label Phase|Administrative|12
5035032|NCT02815267|17341341|P1|Open-Label Phase|Administrative|21
5035033|NCT02815267|17341340|P2|Open-Label Phase|Protocol Violation|1
5035034|NCT02815267|17341341|P1|Open-Label Phase|Protocol Violation|0
5035035|NCT02815267|17341340|P2|Open-Label Phase|Withdrawal by Subject|13
5035036|NCT02815267|17341341|P1|Open-Label Phase|Withdrawal by Subject|24
5035037|NCT02815267|17341340|P2|Open-Label Phase|Lost to Follow-up|9
5035038|NCT02815267|17341341|P1|Open-Label Phase|Lost to Follow-up|23
5035039|NCT02815267|17341340|P2|Open-Label Phase|Adverse Event|1
5035040|NCT02815267|17341341|P1|Open-Label Phase|Adverse Event|1
5035041|NCT02815267|17341340|P2|Double-Blind Phase|Received a disallowed medication|1
5035042|NCT02815267|17341341|P1|Double-Blind Phase|Received a disallowed medication|1
5035043|NCT02815267|17341340|P2|Double-Blind Phase|Site withdrawal|6
5035044|NCT02815267|17341341|P1|Double-Blind Phase|Site withdrawal|1
5035045|NCT02815267|17341340|P2|Double-Blind Phase|Protocol Violation|2
5035046|NCT02815267|17341341|P1|Double-Blind Phase|Protocol Violation|3
5035047|NCT02815267|17341340|P2|Double-Blind Phase|Withdrawal by Subject|10
5035048|NCT02815267|17341341|P1|Double-Blind Phase|Withdrawal by Subject|11
5035049|NCT02815267|17341340|P2|Double-Blind Phase|Lost to Follow-up|9
5035050|NCT02815267|17341341|P1|Double-Blind Phase|Lost to Follow-up|17
5035051|NCT02815267|17341340|P2|Double-Blind Phase|Adverse Event|3
5035052|NCT02815267|17341341|P1|Double-Blind Phase|Adverse Event|0
5035053|NCT02814643|17341481|P2|Overall Study|Withdrawal by Subject|2
5035054|NCT02814643|17341482|P1|Overall Study|Withdrawal by Subject|1
5035055|NCT02814643|17341481|P2|Overall Study|Lost to Follow-up|1
5035056|NCT02814643|17341482|P1|Overall Study|Lost to Follow-up|0
5035057|NCT02814565|17341506|P2|Overall Study|Subject decision, caused by AE Influenza|1
5035058|NCT02814565|17341507|P1|Overall Study|Subject decision, caused by AE Influenza|1
5035059|NCT02814565|17341506|P2|Overall Study|Lack of Efficacy|1
5035060|NCT02814565|17341507|P1|Overall Study|Lack of Efficacy|0
5035061|NCT02814175|17341577|P6|Part 2|Lack of Efficacy|3
5035062|NCT02814175|17341578|P5|Part 2|Lack of Efficacy|0
5035063|NCT02814175|17341579|P4|Part 2|Lack of Efficacy|0
5035064|NCT02814175|17341580|P3|Part 2|Lack of Efficacy|0
5035065|NCT02814175|17341581|P2|Part 2|Lack of Efficacy|0
5035066|NCT02814175|17341582|P1|Part 2|Lack of Efficacy|0
5035067|NCT02814175|17341577|P6|Part 2|Lost to Follow-up|0
5035068|NCT02814175|17341578|P5|Part 2|Lost to Follow-up|0
5035069|NCT02814175|17341579|P4|Part 2|Lost to Follow-up|1
5035070|NCT02814175|17341580|P3|Part 2|Lost to Follow-up|0
5035071|NCT02814175|17341581|P2|Part 2|Lost to Follow-up|0
5035072|NCT02814175|17341582|P1|Part 2|Lost to Follow-up|0
5035073|NCT02814175|17341577|P6|Part 2|Withdrawal Consent|1
5035074|NCT02814175|17341578|P5|Part 2|Withdrawal Consent|1
5035075|NCT02814175|17341579|P4|Part 2|Withdrawal Consent|2
5035076|NCT02814175|17341580|P3|Part 2|Withdrawal Consent|0
5035077|NCT02814175|17341581|P2|Part 2|Withdrawal Consent|0
5035078|NCT02814175|17341582|P1|Part 2|Withdrawal Consent|0
5035079|NCT02814175|17341577|P6|Part 2|Adverse Event|2
5035080|NCT02814175|17341578|P5|Part 2|Adverse Event|1
5035081|NCT02814175|17341579|P4|Part 2|Adverse Event|1
5035082|NCT02814175|17341580|P3|Part 2|Adverse Event|0
5035083|NCT02814175|17341581|P2|Part 2|Adverse Event|0
5035084|NCT02814175|17341582|P1|Part 2|Adverse Event|0
5035085|NCT02814175|17341577|P6|Part 1|Lack of Efficacy|0
5035086|NCT02814175|17341578|P5|Part 1|Lack of Efficacy|0
5035087|NCT02814175|17341579|P4|Part 1|Lack of Efficacy|0
5035088|NCT02814175|17341580|P3|Part 1|Lack of Efficacy|0
5035089|NCT02814175|17341581|P2|Part 1|Lack of Efficacy|2
5035090|NCT02814175|17341582|P1|Part 1|Lack of Efficacy|1
5035091|NCT02814175|17341577|P6|Part 1|Lost to Follow-up|0
5035092|NCT02814175|17341578|P5|Part 1|Lost to Follow-up|0
5035093|NCT02814175|17341579|P4|Part 1|Lost to Follow-up|0
5035094|NCT02814175|17341580|P3|Part 1|Lost to Follow-up|0
5035095|NCT02814175|17341581|P2|Part 1|Lost to Follow-up|0
5035096|NCT02814175|17341582|P1|Part 1|Lost to Follow-up|1
5035097|NCT02814175|17341577|P6|Part 1|Withdrawal Consent|0
5035098|NCT02814175|17341578|P5|Part 1|Withdrawal Consent|0
5035099|NCT02814175|17341579|P4|Part 1|Withdrawal Consent|0
5035100|NCT02814175|17341580|P3|Part 1|Withdrawal Consent|0
5035101|NCT02814175|17341581|P2|Part 1|Withdrawal Consent|1
5035102|NCT02814175|17341582|P1|Part 1|Withdrawal Consent|8
5035103|NCT02814175|17341577|P6|Part 1|Adverse Event|0
5035104|NCT02814175|17341578|P5|Part 1|Adverse Event|0
5035105|NCT02814175|17341579|P4|Part 1|Adverse Event|0
5035106|NCT02814175|17341580|P3|Part 1|Adverse Event|0
5035107|NCT02814175|17341581|P2|Part 1|Adverse Event|3
5035108|NCT02814175|17341582|P1|Part 1|Adverse Event|2
5035109|NCT02813694|17341620|P2|Overall Study|Patient hospitalized|0
5035110|NCT02813694|17341621|P1|Overall Study|Patient hospitalized|1
5035111|NCT02813694|17341620|P2|Overall Study|Randomized- did not receive study drug|0
5035112|NCT02813694|17341621|P1|Overall Study|Randomized- did not receive study drug|2
5035113|NCT02813694|17341620|P2|Overall Study|Death|3
5035114|NCT02813694|17341621|P1|Overall Study|Death|3
5035115|NCT02813694|17341620|P2|Overall Study|Lost to Follow-up|1
5035116|NCT02813694|17341621|P1|Overall Study|Lost to Follow-up|1
5035117|NCT02813694|17341620|P2|Overall Study|Withdrawal by Subject|9
5035118|NCT02813694|17341621|P1|Overall Study|Withdrawal by Subject|10
5035119|NCT02813694|17341620|P2|Overall Study|Physician Decision|1
5035120|NCT02813694|17341621|P1|Overall Study|Physician Decision|0
5035121|NCT02813681|17341634|P3|Overall Study|Lost to Follow-up|0
5035122|NCT02813681|17341635|P2|Overall Study|Lost to Follow-up|1
5035123|NCT02813681|17341636|P1|Overall Study|Lost to Follow-up|0
5035124|NCT02813681|17341634|P3|Overall Study|Physician Decision|0
5035125|NCT02813681|17341635|P2|Overall Study|Physician Decision|5
5035126|NCT02813681|17341636|P1|Overall Study|Physician Decision|5
5035127|NCT02813577|17341657|P1|Overall Study|Study terminated|4
5035128|NCT02812186|17341734|P2|Period 1|nonevaluable data sets|6
5035129|NCT02812186|17341735|P1|Period 1|nonevaluable data sets|6
5035130|NCT02812186|17341734|P2|Period 1|Post randomization screen failure|9
5035131|NCT02812186|17341735|P1|Period 1|Post randomization screen failure|5
5035132|NCT02811640|17341779|P1|Overall Study|Technology malfunction|2
5035133|NCT02811159|17341814|P1|Treatment Course 1|Lost to Follow-up|1
5035134|NCT02810457|17341853|P2|Overall Study|Physician Decision|1
5035135|NCT02810457|17341854|P1|Overall Study|Physician Decision|0
5035136|NCT02810457|17341853|P2|Overall Study|Miscalculated PD|0
5035137|NCT02810457|17341854|P1|Overall Study|Miscalculated PD|1
5035138|NCT02810457|17341853|P2|Overall Study|Patient ineligibility|0
5035139|NCT02810457|17341854|P1|Overall Study|Patient ineligibility|3
5035140|NCT02810457|17341853|P2|Overall Study|Investigator decision|2
5035141|NCT02810457|17341854|P1|Overall Study|Investigator decision|3
5035142|NCT02810457|17341853|P2|Overall Study|Clinical progression|16
5035143|NCT02810457|17341854|P1|Overall Study|Clinical progression|15
5035144|NCT02810457|17341853|P2|Overall Study|Ongoing at data cutoff and discontinued|2
5035145|NCT02810457|17341854|P1|Overall Study|Ongoing at data cutoff and discontinued|3
5035146|NCT02810457|17341853|P2|Overall Study|Death|28
5035147|NCT02810457|17341854|P1|Overall Study|Death|39
5035148|NCT02810457|17341853|P2|Overall Study|Patient lost to follow-up|2
5035149|NCT02810457|17341854|P1|Overall Study|Patient lost to follow-up|2
5035150|NCT02810457|17341853|P2|Overall Study|Patient decision|35
5035151|NCT02810457|17341854|P1|Overall Study|Patient decision|31
5035152|NCT02810457|17341853|P2|Overall Study|Adverse Event|43
5035153|NCT02810457|17341854|P1|Overall Study|Adverse Event|37
5035154|NCT02810457|17341853|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
5035155|NCT02810457|17341854|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
5035156|NCT02810457|17341853|P2|Overall Study|Randomised but no treatment received|1
5035157|NCT02810457|17341854|P1|Overall Study|Randomised but no treatment received|2
5035158|NCT02809976|17341883|P1|Overall Study|Withdrawal by Subject|1
5035159|NCT02809976|17341883|P1|Overall Study|Lost to Follow-up|1
5035160|NCT02809833|17341921|P1|Overall Study|Missing Information|52
5035161|NCT02809833|17341921|P1|Overall Study|Other|5
5035162|NCT02809833|17341921|P1|Overall Study|Adverse Event (AE)|24
5035163|NCT02809833|17341921|P1|Overall Study|Lost to Follow-up|35
5035164|NCT02809833|17341921|P1|Overall Study|Withdrawal by Subject|34
5035165|NCT02809833|17341921|P1|Overall Study|Noncompliance|1
5035166|NCT02809833|17341921|P1|Overall Study|Remission/Treatment No Longer Needed|3
5035167|NCT02809833|17341921|P1|Overall Study|Lack of Efficacy|89
5035168|NCT02809833|17341921|P1|Overall Study|Intolerance|54
5035169|NCT02809833|17341921|P1|Overall Study|Death|3
5035170|NCT02809118|17342042|P3|Overall Study|Withdrawal by Subject|1
5035171|NCT02809118|17342043|P2|Overall Study|Withdrawal by Subject|1
5035172|NCT02809118|17342044|P1|Overall Study|Withdrawal by Subject|0
5035173|NCT02809053|17342057|P2|Overall Study|Disease Progression|1
5035174|NCT02809053|17342058|P1|Overall Study|Disease Progression|2
5035175|NCT02809053|17342057|P2|Overall Study|Withdrawal by Subject|3
5035176|NCT02809053|17342058|P1|Overall Study|Withdrawal by Subject|2
5035177|NCT02809053|17342057|P2|Overall Study|Lost to Follow-up|1
5035178|NCT02809053|17342058|P1|Overall Study|Lost to Follow-up|3
5035179|NCT02809053|17342057|P2|Overall Study|Death|1
5035180|NCT02809053|17342058|P1|Overall Study|Death|0
5035181|NCT02808975|17342104|P2|Overall Study|Other, not specified|1
5035182|NCT02808975|17342105|P1|Overall Study|Other, not specified|5
5035183|NCT02808975|17342104|P2|Overall Study|Planned HS surgery performed prior Wk 13|0
5035184|NCT02808975|17342105|P1|Overall Study|Planned HS surgery performed prior Wk 13|1
5035185|NCT02808975|17342104|P2|Overall Study|Lost to Follow-up|6
5035186|NCT02808975|17342105|P1|Overall Study|Lost to Follow-up|4
5035187|NCT02808975|17342104|P2|Overall Study|Withdrew consent|8
5035188|NCT02808975|17342105|P1|Overall Study|Withdrew consent|9
5035189|NCT02808975|17342104|P2|Overall Study|Adverse Event|4
5035190|NCT02808975|17342105|P1|Overall Study|Adverse Event|3
5035191|NCT02808338|17342132|P1|Overnight In-lab Polysomonography|Reason not given|1
5035192|NCT02808338|17342132|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
5035193|NCT02808338|17342132|P1|Screening|Screen Failure|10
5035194|NCT02808312|17342147|P4|Overall Study|Enrolled but Never Treated|1
5035195|NCT02808312|17342148|P3|Overall Study|Enrolled but Never Treated|0
5035196|NCT02808312|17342149|P2|Overall Study|Enrolled but Never Treated|0
5035197|NCT02808312|17342150|P1|Overall Study|Enrolled but Never Treated|0
5035198|NCT02807948|17342307|P2|Overall Study|Physician Decision|0
5035199|NCT02807948|17342308|P1|Overall Study|Physician Decision|1
5035200|NCT02807623|17342316|P3|Overall Study|incomplete blood draw|1
5035201|NCT02807623|17342317|P2|Overall Study|incomplete blood draw|2
5035202|NCT02807623|17342318|P1|Overall Study|incomplete blood draw|0
5035203|NCT02807623|17342316|P3|Overall Study|Drug intolerance|0
5035204|NCT02807623|17342317|P2|Overall Study|Drug intolerance|1
5035205|NCT02807623|17342318|P1|Overall Study|Drug intolerance|0
5035206|NCT02807623|17342316|P3|Overall Study|Lost to Follow-up|22
5035207|NCT02807623|17342317|P2|Overall Study|Lost to Follow-up|18
5035208|NCT02807623|17342318|P1|Overall Study|Lost to Follow-up|23
5035209|NCT02807402|17342345|P1|Overall Study|Other|2
5035210|NCT02807402|17342345|P1|Overall Study|Death|3
5035211|NCT02807402|17342345|P1|Overall Study|Failure to Return|1
5035212|NCT02807376|17342383|P2|Overall Study|Lost to Follow-up|1
5035213|NCT02807376|17342384|P1|Overall Study|Lost to Follow-up|0
5035214|NCT02807376|17342383|P2|Overall Study|Intra-operative exclusion criteria|0
5035215|NCT02807376|17342384|P1|Overall Study|Intra-operative exclusion criteria|3
5035216|NCT02807259|17342394|P2|Endline (3 Months)|migration, refusal, not available|87
5035217|NCT02807259|17342395|P1|Endline (3 Months)|migration, refusal, not available|35
5035218|NCT02807259|17342394|P2|Midline (3 Months)|migration, refusal, not available|34
5035219|NCT02807259|17342395|P1|Midline (3 Months)|migration, refusal, not available|30
5035220|NCT02807259|17342394|P2|Baseline (3 Months)|migration, refusal, not available|112
5035221|NCT02807259|17342395|P1|Baseline (3 Months)|migration, refusal, not available|77
5035222|NCT02806986|17342413|P1|Treatment Stage 2|Withdrawal by Subject|2
5035223|NCT02806986|17342413|P1|Treatment Stage 2|Adverse Event|3
5035224|NCT02806986|17342413|P1|Treatment Stage 1|Adverse Event|1
5035225|NCT02806973|17342433|P4|Period 3|Adverse Event|0
5035226|NCT02806973|17342434|P3|Period 3|Adverse Event|1
5035227|NCT02806973|17342435|P2|Period 3|Adverse Event|0
5035228|NCT02806973|17342436|P1|Period 3|Adverse Event|0
5035229|NCT02806973|17342433|P4|Period 3|Withdrawal by Subject|3
5035230|NCT02806973|17342434|P3|Period 3|Withdrawal by Subject|0
5035231|NCT02806973|17342435|P2|Period 3|Withdrawal by Subject|0
5035232|NCT02806973|17342436|P1|Period 3|Withdrawal by Subject|0
5035233|NCT02806973|17342433|P4|Period 1|Adverse Event|1
5035234|NCT02806973|17342434|P3|Period 1|Adverse Event|0
5035235|NCT02806973|17342435|P2|Period 1|Adverse Event|0
5035236|NCT02806973|17342436|P1|Period 1|Adverse Event|0
5035237|NCT02806973|17342433|P4|Period 1|Withdrawal by Subject|1
5035238|NCT02806973|17342434|P3|Period 1|Withdrawal by Subject|1
5035239|NCT02806973|17342435|P2|Period 1|Withdrawal by Subject|2
5035240|NCT02806973|17342436|P1|Period 1|Withdrawal by Subject|0
5035241|NCT02806960|17342470|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
5035242|NCT02806960|17342471|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
5035243|NCT02806960|17342472|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
5035244|NCT02806960|17342473|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
5035245|NCT02806947|17342509|P2|Overall Study|Withdrawal by Subject|1
5035246|NCT02806947|17342510|P1|Overall Study|Withdrawal by Subject|5
5035247|NCT02806726|17342592|P1|Overall Study|Lost to Follow-up|1
5035248|NCT02806713|17342601|P2|Overall Study|cancelled surgery|2
5035249|NCT02806713|17342602|P1|Overall Study|cancelled surgery|1
5035250|NCT02806713|17342601|P2|Overall Study|Urethral injury during procedure|0
5035251|NCT02806713|17342602|P1|Overall Study|Urethral injury during procedure|1
5035252|NCT02806505|17342621|P2|Overall Study|Insufficient therapeutic response|4
5035253|NCT02806505|17342622|P1|Overall Study|Insufficient therapeutic response|2
5035254|NCT02806505|17342621|P2|Overall Study|Failure to return|1
5035255|NCT02806505|17342622|P1|Overall Study|Failure to return|0
5035256|NCT02806505|17342621|P2|Overall Study|Did not cooperate/refused treatment|3
5035257|NCT02806505|17342622|P1|Overall Study|Did not cooperate/refused treatment|3
5035258|NCT02806505|17342621|P2|Overall Study|Death|0
5035259|NCT02806505|17342622|P1|Overall Study|Death|4
5035260|NCT02806505|17342621|P2|Overall Study|Adverse event/intercurrent illness|3
5035261|NCT02806505|17342622|P1|Overall Study|Adverse event/intercurrent illness|1
5035262|NCT02806414|17342632|P1|Overall Study|Lost to Follow-up|2
5035263|NCT02806232|17342646|P9|Overall Study|Withdrawal by Subject|0
5035264|NCT02806232|17342647|P8|Overall Study|Withdrawal by Subject|0
5035265|NCT02806232|17342648|P7|Overall Study|Withdrawal by Subject|0
5035266|NCT02806232|17342649|P6|Overall Study|Withdrawal by Subject|1
5035267|NCT02806232|17342650|P5|Overall Study|Withdrawal by Subject|2
5035268|NCT02806232|17342651|P4|Overall Study|Withdrawal by Subject|0
5035269|NCT02806232|17342652|P3|Overall Study|Withdrawal by Subject|0
5035270|NCT02806232|17342653|P2|Overall Study|Withdrawal by Subject|2
5035271|NCT02806232|17342654|P1|Overall Study|Withdrawal by Subject|0
5035272|NCT02806232|17342646|P9|Overall Study|Lost to Follow-up|0
5035273|NCT02806232|17342647|P8|Overall Study|Lost to Follow-up|0
5035274|NCT02806232|17342648|P7|Overall Study|Lost to Follow-up|0
5035275|NCT02806232|17342649|P6|Overall Study|Lost to Follow-up|1
5035276|NCT02806232|17342650|P5|Overall Study|Lost to Follow-up|0
5035277|NCT02806232|17342651|P4|Overall Study|Lost to Follow-up|0
5035278|NCT02806232|17342652|P3|Overall Study|Lost to Follow-up|1
5035279|NCT02806232|17342653|P2|Overall Study|Lost to Follow-up|2
5035280|NCT02806232|17342654|P1|Overall Study|Lost to Follow-up|1
5035281|NCT02806024|17342694|P2|Overall Study|DVT during antepartum admission|1
5035282|NCT02806024|17342695|P1|Overall Study|DVT during antepartum admission|0
5035283|NCT02806024|17342694|P2|Overall Study|Night Delivery|1
5035284|NCT02806024|17342695|P1|Overall Study|Night Delivery|1
5035285|NCT02805907|17342705|P2|Overall Study|Lost to Follow-up|3
5035286|NCT02805907|17342706|P1|Overall Study|Lost to Follow-up|3
5035287|NCT02805790|17342720|P2|Second Intervention (4 Weeks)|Physician Decision|1
5035288|NCT02805790|17342721|P1|Second Intervention (4 Weeks)|Physician Decision|0
5035289|NCT02804750|17342756|P2|Period 4|Adverse Event|5
5035290|NCT02804750|17342757|P1|Period 4|Adverse Event|0
5035291|NCT02804750|17342756|P2|Period 3|Adverse Event|2
5035292|NCT02804750|17342757|P1|Period 3|Adverse Event|0
5035293|NCT02804750|17342756|P2|Period 2|Adverse Event|0
5035294|NCT02804750|17342757|P1|Period 2|Adverse Event|1
5035295|NCT02804750|17342756|P2|Period 1|Withdrawal by Subject|1
5035296|NCT02804750|17342757|P1|Period 1|Withdrawal by Subject|0
5035297|NCT02804750|17342756|P2|Period 1|Adverse Event|2
5035298|NCT02804750|17342757|P1|Period 1|Adverse Event|0
5035299|NCT02804399|17342784|P2|Period 2|Adverse Event|1
5035300|NCT02804399|17342785|P1|Period 2|Adverse Event|0
5035301|NCT02803580|17342857|P1|Overall Study|Inclusion in clinical trial|1
5035302|NCT02803580|17342857|P1|Overall Study|Withdrawal by Subject|3
5035303|NCT02803580|17342857|P1|Overall Study|Lost to Follow-up|19
5035304|NCT02803580|17342857|P1|Overall Study|Death|13
5035305|NCT02803138|17342896|P1|Overall Study|Other, not specified|28
5035306|NCT02803138|17342896|P1|Overall Study|Death|1
5035307|NCT02803138|17342896|P1|Overall Study|Withdrawn consent|1
5035308|NCT02803138|17342896|P1|Overall Study|Insufficient virological response|2
5035309|NCT02803138|17342896|P1|Overall Study|Failure to return|38
5035310|NCT02802878|17342912|P2|Overall Study|Protocol Violation|0
5035311|NCT02802878|17342913|P1|Overall Study|Protocol Violation|1
5035312|NCT02802878|17342912|P2|Overall Study|Withdrawal by Subject|3
5035313|NCT02802878|17342913|P1|Overall Study|Withdrawal by Subject|3
5035314|NCT02802865|17342929|P2|Overall Study|Ineliegible due to tuberculosis|1
5035315|NCT02802865|17342930|P1|Overall Study|Ineliegible due to tuberculosis|0
5035316|NCT02802865|17342929|P2|Overall Study|Pregnancy|1
5035317|NCT02802865|17342930|P1|Overall Study|Pregnancy|1
5035318|NCT02802592|17342952|P1|Overall Study|Study terminated due to loss of funding|4
5035319|NCT02802345|17343129|P2|Overall Study|Other than listed|5
5035320|NCT02802345|17343130|P1|Overall Study|Other than listed|1
5035321|NCT02802345|17343129|P2|Overall Study|Protocol Violation|1
5035322|NCT02802345|17343130|P1|Overall Study|Protocol Violation|0
5035323|NCT02802345|17343129|P2|Overall Study|Withdrawal by Subject|3
5035324|NCT02802345|17343130|P1|Overall Study|Withdrawal by Subject|3
5035325|NCT02802345|17343129|P2|Overall Study|Adverse Event|20
5035326|NCT02802345|17343130|P1|Overall Study|Adverse Event|28
5035327|NCT02802345|17343129|P2|Overall Study|Not Treated|1
5035328|NCT02802345|17343130|P1|Overall Study|Not Treated|0
5035329|NCT02802319|17343146|P2|Overall Study|Lost to Follow-up|4
5035330|NCT02802319|17343147|P1|Overall Study|Lost to Follow-up|0
5035331|NCT02802319|17343146|P2|Overall Study|Physician Decision|1
5035332|NCT02802319|17343147|P1|Overall Study|Physician Decision|2
5035333|NCT02801877|17343310|P4|Overall Study|Never Started Treatment|0
5035334|NCT02801877|17343311|P3|Overall Study|Never Started Treatment|4
5035335|NCT02801877|17343312|P2|Overall Study|Never Started Treatment|0
5035336|NCT02801877|17343313|P1|Overall Study|Never Started Treatment|2
5035337|NCT02801877|17343310|P4|Overall Study|Lost to Follow-up|0
5035338|NCT02801877|17343311|P3|Overall Study|Lost to Follow-up|2
5035339|NCT02801877|17343312|P2|Overall Study|Lost to Follow-up|1
5035340|NCT02801877|17343313|P1|Overall Study|Lost to Follow-up|1
5035341|NCT02801669|17343333|P2|Overall Study|Other|6
5035342|NCT02801669|17343334|P1|Overall Study|Other|4
5035343|NCT02801669|17343333|P2|Overall Study|Withdrawal by Subject|77
5035344|NCT02801669|17343334|P1|Overall Study|Withdrawal by Subject|81
5035345|NCT02801669|17343333|P2|Overall Study|Death|69
5035346|NCT02801669|17343334|P1|Overall Study|Death|66
5035347|NCT02801617|17343361|P2|Overall Study|Protocol Violation|6
5035348|NCT02801617|17343362|P1|Overall Study|Protocol Violation|2
5035349|NCT02801578|17343380|P1|Overall Study|Adverse Event|2
5035350|NCT02801396|17343384|P6|Period 1|Withdrawal by Subject|0
5035351|NCT02801396|17343385|P5|Period 1|Withdrawal by Subject|1
5035352|NCT02801396|17343386|P4|Period 1|Withdrawal by Subject|0
5035353|NCT02801396|17343387|P3|Period 1|Withdrawal by Subject|0
5035354|NCT02801396|17343388|P2|Period 1|Withdrawal by Subject|0
5035355|NCT02801396|17343389|P1|Period 1|Withdrawal by Subject|0
5035356|NCT02800928|17343434|P2|Overall Study|Protocol Violation|1
5035357|NCT02800928|17343435|P1|Overall Study|Protocol Violation|1
5035358|NCT02800928|17343434|P2|Overall Study|Withdrawal by Subject|1
5035359|NCT02800928|17343435|P1|Overall Study|Withdrawal by Subject|1
5035360|NCT02800642|17343443|P1|Overall Study|Lost to Follow-up|1
5035361|NCT02800642|17343443|P1|Overall Study|Withdrawal by Subject|3
5035362|NCT02800642|17343443|P1|Overall Study|Adverse Event|6
5035363|NCT02800642|17343443|P1|Overall Study|Physician Decision|2
5035364|NCT02800642|17343443|P1|Overall Study|Other|10
5035365|NCT02800642|17343443|P1|Overall Study|Death|3
5035366|NCT02799784|17343474|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
5035367|NCT02799784|17343475|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
5035368|NCT02799784|17343474|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
5035369|NCT02799784|17343475|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
5035370|NCT02799784|17343474|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
5035371|NCT02799784|17343475|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
5035372|NCT02799784|17343474|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
5035373|NCT02799784|17343475|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
5035374|NCT02799784|17343474|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
5035375|NCT02799784|17343475|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
5035376|NCT02799784|17343474|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
5035377|NCT02799784|17343475|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
5035378|NCT02799472|17343483|P2|Overall Study|Lost to Follow-up|1
5035379|NCT02799472|17343484|P1|Overall Study|Lost to Follow-up|0
5035380|NCT02799472|17343483|P2|Overall Study|Lack of Efficacy|0
5035381|NCT02799472|17343484|P1|Overall Study|Lack of Efficacy|2
5035382|NCT02799472|17343483|P2|Overall Study|Withdrawal by Subject|4
5035383|NCT02799472|17343484|P1|Overall Study|Withdrawal by Subject|2
5035384|NCT02799381|17343544|P2|Overall Study|Participant did not take any study drug|0
5035385|NCT02799381|17343545|P1|Overall Study|Participant did not take any study drug|1
5035386|NCT02799381|17343544|P2|Overall Study|Adverse Event|1
5035387|NCT02799381|17343545|P1|Overall Study|Adverse Event|0
5035388|NCT02799381|17343544|P2|Overall Study|Withdrew consent|2
5035389|NCT02799381|17343545|P1|Overall Study|Withdrew consent|3
5035390|NCT02799082|17343565|P2|Overall Study|Protocol Violation|1
5035391|NCT02799082|17343566|P1|Overall Study|Protocol Violation|0
5035392|NCT02799082|17343565|P2|Overall Study|Refused second PDT or withdraw consent|3
5035393|NCT02799082|17343566|P1|Overall Study|Refused second PDT or withdraw consent|4
5035394|NCT02799069|17343603|P3|Overall Study|Protocol Violation|2
5035395|NCT02799069|17343604|P2|Overall Study|Protocol Violation|0
5035396|NCT02799069|17343605|P1|Overall Study|Protocol Violation|1
5035397|NCT02799069|17343603|P3|Overall Study|Withdrawal by Subject|3
5035398|NCT02799069|17343604|P2|Overall Study|Withdrawal by Subject|4
5035399|NCT02799069|17343605|P1|Overall Study|Withdrawal by Subject|4
5035400|NCT02799069|17343603|P3|Overall Study|Lost to Follow-up|0
5035401|NCT02799069|17343604|P2|Overall Study|Lost to Follow-up|1
5035402|NCT02799069|17343605|P1|Overall Study|Lost to Follow-up|1
5035403|NCT02799069|17343603|P3|Overall Study|Lack of Efficacy|0
5035404|NCT02799069|17343604|P2|Overall Study|Lack of Efficacy|0
5035405|NCT02799069|17343605|P1|Overall Study|Lack of Efficacy|2
5035406|NCT02799069|17343603|P3|Overall Study|Adverse Event|2
5035407|NCT02799069|17343604|P2|Overall Study|Adverse Event|2
5035408|NCT02799069|17343605|P1|Overall Study|Adverse Event|0
5035409|NCT02798861|17343943|P1|Overall Study|Withdrawal by Subject|1
5035410|NCT02798861|17343943|P1|Overall Study|Lost to Follow-up|22
5035411|NCT02798835|17343951|P3|Overall Study|Protocol Violation|3
5035412|NCT02798835|17343952|P2|Overall Study|Protocol Violation|0
5035413|NCT02798835|17343953|P1|Overall Study|Protocol Violation|0
5035414|NCT02798315|17344019|P1|Overall Study|Failure to return|1
5035415|NCT02797678|17344053|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
5035416|NCT02797678|17344054|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
5035417|NCT02797678|17344055|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
5035418|NCT02797678|17344056|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
5035419|NCT02797678|17344053|P4|First Intervention (5 Nights)|study/device use non-compliance|0
5035420|NCT02797678|17344054|P3|First Intervention (5 Nights)|study/device use non-compliance|0
5035421|NCT02797678|17344055|P2|First Intervention (5 Nights)|study/device use non-compliance|1
5035422|NCT02797678|17344056|P1|First Intervention (5 Nights)|study/device use non-compliance|0
5035423|NCT02797678|17344053|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5035424|NCT02797678|17344054|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5035425|NCT02797678|17344055|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5035426|NCT02797678|17344056|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
5035427|NCT02797522|17344091|P11|Overall Study|Study Terminated by Sponsor|1
5035428|NCT02797522|17344092|P10|Overall Study|Study Terminated by Sponsor|4
5035429|NCT02797522|17344093|P9|Overall Study|Study Terminated by Sponsor|2
5035430|NCT02797522|17344094|P8|Overall Study|Study Terminated by Sponsor|4
5035431|NCT02797522|17344095|P7|Overall Study|Study Terminated by Sponsor|0
5035432|NCT02797522|17344096|P6|Overall Study|Study Terminated by Sponsor|0
5035433|NCT02797522|17344097|P5|Overall Study|Study Terminated by Sponsor|0
5035434|NCT02797522|17344098|P4|Overall Study|Study Terminated by Sponsor|0
5035435|NCT02797522|17344099|P3|Overall Study|Study Terminated by Sponsor|0
5035436|NCT02797522|17344100|P2|Overall Study|Study Terminated by Sponsor|0
5035437|NCT02797522|17344101|P1|Overall Study|Study Terminated by Sponsor|0
5035438|NCT02797132|17344207|P1|Part B (24 Weeks)|Adverse Event|3
5035439|NCT02797132|17344207|P1|Part A (15 Days)|Adverse Event|1
5035440|NCT02797080|17344259|P1|Overall Study|Withdrawal by Subject|1
5035441|NCT02797080|17344259|P1|Overall Study|Lost to Follow-up|1
5035442|NCT02796963|17344301|P4|Overall Study|Lost to Follow-up|72
5035443|NCT02796963|17344302|P3|Overall Study|Lost to Follow-up|69
5035444|NCT02796963|17344303|P2|Overall Study|Lost to Follow-up|76
5035445|NCT02796963|17344304|P1|Overall Study|Lost to Follow-up|89
5035446|NCT02796677|17344374|P4|Overall Study|Reason not mentioned|5
5035447|NCT02796677|17344375|P3|Overall Study|Reason not mentioned|0
5035448|NCT02796677|17344376|P2|Overall Study|Reason not mentioned|3
5035449|NCT02796677|17344377|P1|Overall Study|Reason not mentioned|2
5035450|NCT02796677|17344374|P4|Overall Study|Progressive disease|18
5035451|NCT02796677|17344375|P3|Overall Study|Progressive disease|13
5035452|NCT02796677|17344376|P2|Overall Study|Progressive disease|15
5035453|NCT02796677|17344377|P1|Overall Study|Progressive disease|6
5035454|NCT02796677|17344374|P4|Overall Study|Withdrawal by Subject|7
5035455|NCT02796677|17344375|P3|Overall Study|Withdrawal by Subject|6
5035456|NCT02796677|17344376|P2|Overall Study|Withdrawal by Subject|14
5035457|NCT02796677|17344377|P1|Overall Study|Withdrawal by Subject|4
5035458|NCT02796677|17344374|P4|Overall Study|Lack of Efficacy|20
5035459|NCT02796677|17344375|P3|Overall Study|Lack of Efficacy|14
5035460|NCT02796677|17344376|P2|Overall Study|Lack of Efficacy|9
5035461|NCT02796677|17344377|P1|Overall Study|Lack of Efficacy|7
5035462|NCT02796677|17344374|P4|Overall Study|Lost to Follow-up|2
5035463|NCT02796677|17344375|P3|Overall Study|Lost to Follow-up|2
5035464|NCT02796677|17344376|P2|Overall Study|Lost to Follow-up|5
5035465|NCT02796677|17344377|P1|Overall Study|Lost to Follow-up|1
5035466|NCT02796677|17344374|P4|Overall Study|Protocol Violation|8
5035467|NCT02796677|17344375|P3|Overall Study|Protocol Violation|4
5035468|NCT02796677|17344376|P2|Overall Study|Protocol Violation|5
5035469|NCT02796677|17344377|P1|Overall Study|Protocol Violation|7
5035470|NCT02796677|17344374|P4|Overall Study|Adverse Event|14
5035471|NCT02796677|17344375|P3|Overall Study|Adverse Event|14
5035472|NCT02796677|17344376|P2|Overall Study|Adverse Event|22
5035473|NCT02796677|17344377|P1|Overall Study|Adverse Event|11
5035474|NCT02796651|17344401|P1|Overall Study|Other|10
5035475|NCT02796651|17344401|P1|Overall Study|Lack of Efficacy|1
5035476|NCT02796651|17344401|P1|Overall Study|Protocol Violation|4
5035477|NCT02796651|17344401|P1|Overall Study|Withdrawal by Subject|4
5035478|NCT02796651|17344401|P1|Overall Study|Lost to Follow-up|1
5035479|NCT02796651|17344401|P1|Overall Study|Adverse Event|6
5035480|NCT02795832|17344497|P6|Overall Study|Adverse Event|3
5035481|NCT02795832|17344498|P5|Overall Study|Adverse Event|0
5035482|NCT02795832|17344499|P4|Overall Study|Adverse Event|0
5035483|NCT02795832|17344500|P3|Overall Study|Adverse Event|0
5035484|NCT02795832|17344501|P2|Overall Study|Adverse Event|0
5035485|NCT02795832|17344502|P1|Overall Study|Adverse Event|0
5035486|NCT02795767|17344580|P3|Overall Study|Lack of Efficacy|1
5035487|NCT02795767|17344581|P2|Overall Study|Lack of Efficacy|0
5035488|NCT02795767|17344582|P1|Overall Study|Lack of Efficacy|0
5035489|NCT02795767|17344580|P3|Overall Study|Ongoing Study Treatment|9
5035490|NCT02795767|17344581|P2|Overall Study|Ongoing Study Treatment|10
5035491|NCT02795767|17344582|P1|Overall Study|Ongoing Study Treatment|66
5035492|NCT02795767|17344580|P3|Overall Study|Received Commercial Emicizumab|0
5035493|NCT02795767|17344581|P2|Overall Study|Received Commercial Emicizumab|0
5035494|NCT02795767|17344582|P1|Overall Study|Received Commercial Emicizumab|2
5035495|NCT02794974|17344703|P2|Overall Study|Physician Decision|1
5035496|NCT02794974|17344704|P1|Overall Study|Physician Decision|0
5035497|NCT02794870|17344720|P2|Overall Study|Withdrawal by Subject|0
5035498|NCT02794870|17344721|P1|Overall Study|Withdrawal by Subject|2
5035499|NCT02794480|17344818|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5035500|NCT02794480|17344819|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5035501|NCT02794480|17344820|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5035502|NCT02794480|17344821|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5035503|NCT02794480|17344818|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5035504|NCT02794480|17344819|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5035505|NCT02794480|17344820|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
5035506|NCT02794480|17344821|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5035507|NCT02794480|17344818|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
5035508|NCT02794480|17344819|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5035509|NCT02794480|17344820|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5035510|NCT02794480|17344821|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5035511|NCT02794480|17344818|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5035512|NCT02794480|17344819|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
5035513|NCT02794480|17344820|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5035514|NCT02794480|17344821|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5035515|NCT02794480|17344818|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5035516|NCT02794480|17344819|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
5035517|NCT02794480|17344820|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5035518|NCT02794480|17344821|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5035519|NCT02794246|17344864|P1|Overall Study|Physician Decision|4
5035520|NCT02794246|17344864|P1|Overall Study|Withdrawal by Subject|2
5035521|NCT02794103|17344876|P1|Overall Study|Loss to follow up due to high sedation|3
5035522|NCT02793947|17344887|P2|Overall Study|Physician Decision|5
5035523|NCT02793947|17344888|P1|Overall Study|Physician Decision|1
5035524|NCT02793947|17344887|P2|Overall Study|Death|0
5035525|NCT02793947|17344888|P1|Overall Study|Death|1
5035526|NCT02793232|17344943|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035527|NCT02793232|17344944|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035528|NCT02793232|17344945|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
5035529|NCT02793232|17344946|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035530|NCT02793232|17344947|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
5035531|NCT02793232|17344948|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035532|NCT02793232|17344949|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035533|NCT02793232|17344950|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035534|NCT02793232|17344951|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5035535|NCT02793128|17345204|P1|Overall Study|Patient elected nephroureterectomy|1
5035536|NCT02793128|17345204|P1|Overall Study|Comorbid conditions and noncompliance|1
5035537|NCT02793128|17345204|P1|Overall Study|Physician Decision|1
5035538|NCT02793128|17345204|P1|Overall Study|Withdrawal by Subject|2
5035539|NCT02793128|17345204|P1|Overall Study|Death|4
5035540|NCT02792829|17345226|P8|Treatment Period 2|Use of proscribed medications|1
5035541|NCT02792829|17345227|P7|Treatment Period 2|Use of proscribed medications|0
5035542|NCT02792829|17345228|P6|Treatment Period 2|Use of proscribed medications|0
5035543|NCT02792829|17345229|P5|Treatment Period 2|Use of proscribed medications|0
5035544|NCT02792829|17345230|P4|Treatment Period 2|Use of proscribed medications|0
5035545|NCT02792829|17345231|P3|Treatment Period 2|Use of proscribed medications|0
5035546|NCT02792829|17345232|P2|Treatment Period 2|Use of proscribed medications|0
5035547|NCT02792829|17345233|P1|Treatment Period 2|Use of proscribed medications|0
5035548|NCT02792829|17345226|P8|Treatment Period 2|Adverse Event|1
5035549|NCT02792829|17345227|P7|Treatment Period 2|Adverse Event|1
5035550|NCT02792829|17345228|P6|Treatment Period 2|Adverse Event|0
5035551|NCT02792829|17345229|P5|Treatment Period 2|Adverse Event|1
5035552|NCT02792829|17345230|P4|Treatment Period 2|Adverse Event|0
5035553|NCT02792829|17345231|P3|Treatment Period 2|Adverse Event|0
5035554|NCT02792829|17345232|P2|Treatment Period 2|Adverse Event|0
5035555|NCT02792829|17345233|P1|Treatment Period 2|Adverse Event|0
5035556|NCT02792829|17345226|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
5035557|NCT02792829|17345227|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
5035558|NCT02792829|17345228|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
5035559|NCT02792829|17345229|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
5035560|NCT02792829|17345230|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
5035561|NCT02792829|17345231|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
5035562|NCT02792829|17345232|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
5035563|NCT02792829|17345233|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
5035564|NCT02792777|17345341|P2|Overall Study|Participant interviewed twice|0
5035565|NCT02792777|17345342|P1|Overall Study|Participant interviewed twice|1
5035566|NCT02792777|17345341|P2|Overall Study|Later determined to be ineligible|0
5035567|NCT02792777|17345342|P1|Overall Study|Later determined to be ineligible|2
5035568|NCT02792777|17345341|P2|Overall Study|Recording malfunction|0
5035569|NCT02792777|17345342|P1|Overall Study|Recording malfunction|2
5035570|NCT02792777|17345341|P2|Overall Study|Withdrawal by Subject|0
5035571|NCT02792777|17345342|P1|Overall Study|Withdrawal by Subject|2
5035572|NCT02792699|17345358|P3|Overall Study|Other|0
5035573|NCT02792699|17345359|P2|Overall Study|Other|0
5035574|NCT02792699|17345360|P1|Overall Study|Other|1
5035575|NCT02792699|17345358|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
5035576|NCT02792699|17345359|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
5035577|NCT02792699|17345360|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
5035578|NCT02792699|17345358|P3|Overall Study|Physician Decision|0
5035579|NCT02792699|17345359|P2|Overall Study|Physician Decision|0
5035580|NCT02792699|17345360|P1|Overall Study|Physician Decision|2
5035581|NCT02792699|17345358|P3|Overall Study|Lost to Follow-up|2
5035582|NCT02792699|17345359|P2|Overall Study|Lost to Follow-up|1
5035583|NCT02792699|17345360|P1|Overall Study|Lost to Follow-up|0
5035584|NCT02792699|17345358|P3|Overall Study|Withdrawal by Subject|3
5035585|NCT02792699|17345359|P2|Overall Study|Withdrawal by Subject|4
5035586|NCT02792699|17345360|P1|Overall Study|Withdrawal by Subject|4
5035587|NCT02792699|17345358|P3|Overall Study|Adverse Event|4
5035588|NCT02792699|17345359|P2|Overall Study|Adverse Event|2
5035589|NCT02792699|17345360|P1|Overall Study|Adverse Event|1
5035590|NCT02792517|17345441|P1|Overall Study|Lost to Follow-up|3
5035591|NCT02792517|17345441|P1|Overall Study|Decision by Sponsor|7
5035592|NCT02792517|17345441|P1|Overall Study|Withdrawal by Subject|10
5035593|NCT02792231|17345457|P2|Overall Study|Ongoing at interim data cutoff|1
5035594|NCT02792231|17345458|P1|Overall Study|Ongoing at interim data cutoff|1
5035595|NCT02792231|17345457|P2|Overall Study|Technical problems|1
5035596|NCT02792231|17345458|P1|Overall Study|Technical problems|0
5035597|NCT02792231|17345457|P2|Overall Study|Protocol deviation|0
5035598|NCT02792231|17345458|P1|Overall Study|Protocol deviation|2
5035599|NCT02792231|17345457|P2|Overall Study|Non-compliance with study treatment|1
5035600|NCT02792231|17345458|P1|Overall Study|Non-compliance with study treatment|2
5035601|NCT02792231|17345457|P2|Overall Study|Pregnancy|3
5035602|NCT02792231|17345458|P1|Overall Study|Pregnancy|1
5035603|NCT02792231|17345457|P2|Overall Study|Lost to Follow-up|5
5035604|NCT02792231|17345458|P1|Overall Study|Lost to Follow-up|9
5035605|NCT02792231|17345457|P2|Overall Study|Lack of Efficacy|9
5035606|NCT02792231|17345458|P1|Overall Study|Lack of Efficacy|7
5035607|NCT02792231|17345457|P2|Overall Study|Physician Decision|11
5035608|NCT02792231|17345458|P1|Overall Study|Physician Decision|14
5035609|NCT02792231|17345457|P2|Overall Study|Adverse Event|13
5035610|NCT02792231|17345458|P1|Overall Study|Adverse Event|16
5035611|NCT02792231|17345457|P2|Overall Study|Patient/guardian decision|41
5035612|NCT02792231|17345458|P1|Overall Study|Patient/guardian decision|32
5035613|NCT02792218|17345480|P2|Overall Study|Ongoing at interim cutoff|5
5035614|NCT02792218|17345481|P1|Overall Study|Ongoing at interim cutoff|1
5035615|NCT02792218|17345480|P2|Overall Study|Pregnancy|0
5035616|NCT02792218|17345481|P1|Overall Study|Pregnancy|1
5035617|NCT02792218|17345480|P2|Overall Study|Non-compliance with study treatment|1
5035618|NCT02792218|17345481|P1|Overall Study|Non-compliance with study treatment|0
5035619|NCT02792218|17345480|P2|Overall Study|New therapy for study indication|1
5035620|NCT02792218|17345481|P1|Overall Study|New therapy for study indication|0
5035621|NCT02792218|17345480|P2|Overall Study|Protocol deviation|2
5035622|NCT02792218|17345481|P1|Overall Study|Protocol deviation|3
5035623|NCT02792218|17345480|P2|Overall Study|Physician Decision|4
5035624|NCT02792218|17345481|P1|Overall Study|Physician Decision|3
5035625|NCT02792218|17345480|P2|Overall Study|Lack of Efficacy|12
5035626|NCT02792218|17345481|P1|Overall Study|Lack of Efficacy|1
5035627|NCT02792218|17345480|P2|Overall Study|Lost to Follow-up|5
5035628|NCT02792218|17345481|P1|Overall Study|Lost to Follow-up|10
5035629|NCT02792218|17345480|P2|Overall Study|Adverse Event|14
5035630|NCT02792218|17345481|P1|Overall Study|Adverse Event|14
5035631|NCT02792218|17345480|P2|Overall Study|Patient/guardian decision|42
5035632|NCT02792218|17345481|P1|Overall Study|Patient/guardian decision|16
5035633|NCT02792062|17345507|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5035634|NCT02792062|17345508|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5035635|NCT02792062|17345509|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5035636|NCT02792062|17345510|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5035637|NCT02792062|17345511|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5035638|NCT02792062|17345512|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
5035639|NCT02791763|17345581|P3|Overall Study|Adverse Event|7
5035640|NCT02791763|17345582|P2|Overall Study|Adverse Event|13
5035641|NCT02791763|17345583|P1|Overall Study|Adverse Event|12
5035642|NCT02791763|17345581|P3|Overall Study|Met hemoglobin stopping criteria|0
5035643|NCT02791763|17345582|P2|Overall Study|Met hemoglobin stopping criteria|0
5035644|NCT02791763|17345583|P1|Overall Study|Met hemoglobin stopping criteria|1
5035645|NCT02791763|17345581|P3|Overall Study|Participant had renal transplant|0
5035646|NCT02791763|17345582|P2|Overall Study|Participant had renal transplant|0
5035647|NCT02791763|17345583|P1|Overall Study|Participant had renal transplant|3
5035648|NCT02791763|17345581|P3|Overall Study|Cancer event|0
5035649|NCT02791763|17345582|P2|Overall Study|Cancer event|3
5035650|NCT02791763|17345583|P1|Overall Study|Cancer event|1
5035651|NCT02791763|17345581|P3|Overall Study|Needs maintenance/changes in dialysis|5
5035652|NCT02791763|17345582|P2|Overall Study|Needs maintenance/changes in dialysis|19
5035653|NCT02791763|17345583|P1|Overall Study|Needs maintenance/changes in dialysis|16
5035654|NCT02791763|17345581|P3|Overall Study|Physician Decision|0
5035655|NCT02791763|17345582|P2|Overall Study|Physician Decision|1
5035656|NCT02791763|17345583|P1|Overall Study|Physician Decision|0
5035657|NCT02791763|17345581|P3|Overall Study|Withdrawal by Subject|0
5035658|NCT02791763|17345582|P2|Overall Study|Withdrawal by Subject|1
5035659|NCT02791763|17345583|P1|Overall Study|Withdrawal by Subject|5
5035660|NCT02791763|17345581|P3|Overall Study|Protocol Violation|1
5035661|NCT02791763|17345582|P2|Overall Study|Protocol Violation|0
5035662|NCT02791763|17345583|P1|Overall Study|Protocol Violation|0
5035663|NCT02791659|17345702|P2|Overall Study|Protocol Violation|1
5035664|NCT02791659|17345703|P1|Overall Study|Protocol Violation|0
5035665|NCT02791516|17345711|P2|Overall Study|Withdrawal by Subject|1
5035666|NCT02791516|17345712|P1|Overall Study|Withdrawal by Subject|1
5035667|NCT02791490|17345724|P2|Overall Study|Withdrawal by Subject|6
5035668|NCT02791490|17345725|P1|Overall Study|Withdrawal by Subject|2
5035669|NCT02791490|17345724|P2|Overall Study|Lost to Follow-up|2
5035670|NCT02791490|17345725|P1|Overall Study|Lost to Follow-up|1
5035671|NCT02791438|17345745|P2|Treatment Period|Withdrawal by Parent/Guardian|0
5035672|NCT02791438|17345746|P1|Treatment Period|Withdrawal by Parent/Guardian|2
5035673|NCT02791438|17345745|P2|Treatment Period|Withdrawal by Subject|1
5035674|NCT02791438|17345746|P1|Treatment Period|Withdrawal by Subject|0
5035675|NCT02791438|17345745|P2|Treatment Period|Adverse Event|0
5035676|NCT02791438|17345746|P1|Treatment Period|Adverse Event|1
5035677|NCT02791269|17345787|P2|Overall Study|Lost to Follow-up|1
5035678|NCT02791269|17345788|P1|Overall Study|Lost to Follow-up|0
5035679|NCT02790606|17345866|P1|Overall Study|Withdrawal by Subject|1
5035680|NCT02790606|17345866|P1|Overall Study|Physician Decision|3
5035681|NCT02790606|17345866|P1|Overall Study|Lost to Follow-up|4
5035682|NCT02790606|17345866|P1|Overall Study|Death|27
5035683|NCT02790073|17345898|P1|Overall Study|Withdrawal by Subject|1
5035684|NCT02790073|17345898|P1|Overall Study|Withdrawal from HD|1
5035685|NCT02790073|17345898|P1|Overall Study|Death|1
5035686|NCT02789176|17345921|P4|Overall Study|Lost to Follow-up|1
5035687|NCT02789176|17345922|P3|Overall Study|Lost to Follow-up|6
5035688|NCT02789176|17345923|P2|Overall Study|Lost to Follow-up|2
5035689|NCT02789176|17345924|P1|Overall Study|Lost to Follow-up|8
5035690|NCT02789176|17345921|P4|Overall Study|Withdrawal by Subject|0
5035691|NCT02789176|17345922|P3|Overall Study|Withdrawal by Subject|1
5035692|NCT02789176|17345923|P2|Overall Study|Withdrawal by Subject|0
5035693|NCT02789176|17345924|P1|Overall Study|Withdrawal by Subject|0
5035694|NCT02789176|17345921|P4|Overall Study|Death|0
5035695|NCT02789176|17345922|P3|Overall Study|Death|3
5035696|NCT02789176|17345923|P2|Overall Study|Death|0
5035697|NCT02789176|17345924|P1|Overall Study|Death|0
5035698|NCT02788747|17345949|P3|Overall Study|Adverse Event|0
5035699|NCT02788747|17345950|P2|Overall Study|Adverse Event|0
5035700|NCT02788747|17345951|P1|Overall Study|Adverse Event|1
5035701|NCT02788656|17346021|P2|Overall Study|Withdrawal by Subject|0
5035702|NCT02788656|17346022|P1|Overall Study|Withdrawal by Subject|1
5035703|NCT02788513|17346047|P5|Overall Study|Decision by the study team|1
5035704|NCT02788513|17346048|P4|Overall Study|Decision by the study team|0
5035705|NCT02788513|17346049|P3|Overall Study|Decision by the study team|0
5035706|NCT02788513|17346050|P2|Overall Study|Decision by the study team|0
5035707|NCT02788513|17346051|P1|Overall Study|Decision by the study team|0
5035708|NCT02788513|17346047|P5|Overall Study|Subject decided to stop taking treatment|0
5035709|NCT02788513|17346048|P4|Overall Study|Subject decided to stop taking treatment|0
5035710|NCT02788513|17346049|P3|Overall Study|Subject decided to stop taking treatment|1
5035711|NCT02788513|17346050|P2|Overall Study|Subject decided to stop taking treatment|0
5035712|NCT02788513|17346051|P1|Overall Study|Subject decided to stop taking treatment|0
5035713|NCT02788513|17346047|P5|Overall Study|Protocol Violation|0
5035714|NCT02788513|17346048|P4|Overall Study|Protocol Violation|1
5035715|NCT02788513|17346049|P3|Overall Study|Protocol Violation|1
5035716|NCT02788513|17346050|P2|Overall Study|Protocol Violation|0
5035717|NCT02788513|17346051|P1|Overall Study|Protocol Violation|0
5035718|NCT02788513|17346047|P5|Overall Study|Adverse Event|2
5035719|NCT02788513|17346048|P4|Overall Study|Adverse Event|2
5035720|NCT02788513|17346049|P3|Overall Study|Adverse Event|4
5035721|NCT02788513|17346050|P2|Overall Study|Adverse Event|8
5035722|NCT02788513|17346051|P1|Overall Study|Adverse Event|5
5035723|NCT02788513|17346047|P5|Overall Study|Lost to Follow-up|1
5035724|NCT02788513|17346048|P4|Overall Study|Lost to Follow-up|0
5035725|NCT02788513|17346049|P3|Overall Study|Lost to Follow-up|0
5035726|NCT02788513|17346050|P2|Overall Study|Lost to Follow-up|0
5035727|NCT02788513|17346051|P1|Overall Study|Lost to Follow-up|1
5035728|NCT02788513|17346047|P5|Overall Study|Withdrawal by Subject|1
5035729|NCT02788513|17346048|P4|Overall Study|Withdrawal by Subject|3
5035730|NCT02788513|17346049|P3|Overall Study|Withdrawal by Subject|2
5035731|NCT02788513|17346050|P2|Overall Study|Withdrawal by Subject|0
5035732|NCT02788513|17346051|P1|Overall Study|Withdrawal by Subject|3
5035733|NCT02788474|17346075|P2|Open Label Treatment Period|Non-compliance|0
5035734|NCT02788474|17346076|P1|Open Label Treatment Period|Non-compliance|1
5035735|NCT02788474|17346075|P2|Open Label Treatment Period|Patient's refusal|3
5035736|NCT02788474|17346076|P1|Open Label Treatment Period|Patient's refusal|1
5035737|NCT02788474|17346075|P2|Open Label Treatment Period|Other than reason specified|0
5035738|NCT02788474|17346076|P1|Open Label Treatment Period|Other than reason specified|1
5035739|NCT02788474|17346075|P2|Open Label Treatment Period|Adverse Event|9
5035740|NCT02788474|17346076|P1|Open Label Treatment Period|Adverse Event|29
5035741|NCT02788474|17346075|P2|Double Blind Treatment Period|Adverse Event|4
5035742|NCT02788474|17346076|P1|Double Blind Treatment Period|Adverse Event|6
5035743|NCT02788474|17346075|P2|Double Blind Treatment Period|Patient's refusal|0
5035744|NCT02788474|17346076|P1|Double Blind Treatment Period|Patient's refusal|3
5035745|NCT02788474|17346075|P2|Double Blind Treatment Period|Not treated|0
5035746|NCT02788474|17346076|P1|Double Blind Treatment Period|Not treated|1
5035747|NCT02788357|17346091|P2|Overall Study|Lost to Follow-up|0
5035748|NCT02788357|17346092|P1|Overall Study|Lost to Follow-up|3
5035749|NCT02788279|17346107|P3|Overall Study|Sponsor decision|11
5035750|NCT02788279|17346108|P2|Overall Study|Sponsor decision|29
5035751|NCT02788279|17346109|P1|Overall Study|Sponsor decision|18
5035752|NCT02788279|17346107|P3|Overall Study|Lost to Follow-up|2
5035753|NCT02788279|17346108|P2|Overall Study|Lost to Follow-up|3
5035754|NCT02788279|17346109|P1|Overall Study|Lost to Follow-up|0
5035755|NCT02788279|17346107|P3|Overall Study|Withdrawal by Subject|5
5035756|NCT02788279|17346108|P2|Overall Study|Withdrawal by Subject|15
5035757|NCT02788279|17346109|P1|Overall Study|Withdrawal by Subject|10
5035758|NCT02788279|17346107|P3|Overall Study|Death|72
5035759|NCT02788279|17346108|P2|Overall Study|Death|136
5035760|NCT02788279|17346109|P1|Overall Study|Death|62
5035761|NCT02788201|17346146|P6|Overall Study|Withdrawal by Subject|1
5035762|NCT02788201|17346147|P5|Overall Study|Withdrawal by Subject|0
5035763|NCT02788201|17346148|P4|Overall Study|Withdrawal by Subject|0
5035764|NCT02788201|17346149|P3|Overall Study|Withdrawal by Subject|0
5035765|NCT02788201|17346150|P2|Overall Study|Withdrawal by Subject|0
5035766|NCT02788201|17346151|P1|Overall Study|Withdrawal by Subject|0
5035767|NCT02788201|17346146|P6|Overall Study|Ineligible|1
5035768|NCT02788201|17346147|P5|Overall Study|Ineligible|0
5035769|NCT02788201|17346148|P4|Overall Study|Ineligible|0
5035770|NCT02788201|17346149|P3|Overall Study|Ineligible|0
5035771|NCT02788201|17346150|P2|Overall Study|Ineligible|0
5035772|NCT02788201|17346151|P1|Overall Study|Ineligible|0
5035773|NCT02788201|17346146|P6|Overall Study|Death|1
5035774|NCT02788201|17346147|P5|Overall Study|Death|0
5035775|NCT02788201|17346148|P4|Overall Study|Death|1
5035776|NCT02788201|17346149|P3|Overall Study|Death|1
5035777|NCT02788201|17346150|P2|Overall Study|Death|1
5035778|NCT02788201|17346151|P1|Overall Study|Death|1
5035779|NCT02788175|17346204|P1|Overall Study|Ineligible prior to study agent|6
5035780|NCT02788175|17346204|P1|Overall Study|Withdrawal by Subject|4
5035781|NCT02788175|17346204|P1|Overall Study|Protocol Violation|3
5035782|NCT02787863|17346226|P8|Overall Study|Withdrawal by Subject|0
5035783|NCT02787863|17346227|P7|Overall Study|Withdrawal by Subject|0
5035784|NCT02787863|17346228|P6|Overall Study|Withdrawal by Subject|0
5035785|NCT02787863|17346229|P5|Overall Study|Withdrawal by Subject|0
5035786|NCT02787863|17346230|P4|Overall Study|Withdrawal by Subject|0
5035787|NCT02787863|17346231|P3|Overall Study|Withdrawal by Subject|1
5035788|NCT02787863|17346232|P2|Overall Study|Withdrawal by Subject|1
5035789|NCT02787863|17346233|P1|Overall Study|Withdrawal by Subject|0
5035790|NCT02787863|17346226|P8|Overall Study|Death|0
5035791|NCT02787863|17346227|P7|Overall Study|Death|0
5035792|NCT02787863|17346228|P6|Overall Study|Death|0
5035793|NCT02787863|17346229|P5|Overall Study|Death|0
5035794|NCT02787863|17346230|P4|Overall Study|Death|0
5035795|NCT02787863|17346231|P3|Overall Study|Death|1
5035796|NCT02787863|17346232|P2|Overall Study|Death|0
5035797|NCT02787863|17346233|P1|Overall Study|Death|1
5035798|NCT02787551|17346331|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
5035799|NCT02787551|17346332|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
5035800|NCT02787551|17346331|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
5035801|NCT02787551|17346332|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
5035802|NCT02787551|17346331|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
5035803|NCT02787551|17346332|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
5035804|NCT02787551|17346331|P2|Core Period: 26 Weeks|Other than specified|1
5035805|NCT02787551|17346332|P1|Core Period: 26 Weeks|Other than specified|3
5035806|NCT02787551|17346331|P2|Core Period: 26 Weeks|Randomized but not treated|1
5035807|NCT02787551|17346332|P1|Core Period: 26 Weeks|Randomized but not treated|2
5035808|NCT02787551|17346331|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
5035809|NCT02787551|17346332|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
5035810|NCT02787551|17346331|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
5035811|NCT02787551|17346332|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
5035812|NCT02787551|17346331|P2|Core Period: 26 Weeks|Lack of Efficacy|0
5035813|NCT02787551|17346332|P1|Core Period: 26 Weeks|Lack of Efficacy|1
5035814|NCT02787551|17346331|P2|Core Period: 26 Weeks|Adverse Event|0
5035815|NCT02787551|17346332|P1|Core Period: 26 Weeks|Adverse Event|10
5035816|NCT02787304|17346368|P4|Overall Study|Study terminated by sponsor|32
5035817|NCT02787304|17346369|P3|Overall Study|Study terminated by sponsor|31
5035818|NCT02787304|17346370|P2|Overall Study|Study terminated by sponsor|31
5035819|NCT02787304|17346371|P1|Overall Study|Study terminated by sponsor|25
5035820|NCT02787304|17346368|P4|Overall Study|Physician Decision|0
5035821|NCT02787304|17346369|P3|Overall Study|Physician Decision|1
5035822|NCT02787304|17346370|P2|Overall Study|Physician Decision|0
5035823|NCT02787304|17346371|P1|Overall Study|Physician Decision|0
5035824|NCT02787304|17346368|P4|Overall Study|Noncompliance with study drug|0
5035825|NCT02787304|17346369|P3|Overall Study|Noncompliance with study drug|1
5035826|NCT02787304|17346370|P2|Overall Study|Noncompliance with study drug|0
5035827|NCT02787304|17346371|P1|Overall Study|Noncompliance with study drug|0
5035828|NCT02787304|17346368|P4|Overall Study|Lost to Follow-up|1
5035829|NCT02787304|17346369|P3|Overall Study|Lost to Follow-up|0
5035830|NCT02787304|17346370|P2|Overall Study|Lost to Follow-up|0
5035831|NCT02787304|17346371|P1|Overall Study|Lost to Follow-up|1
5035832|NCT02787304|17346368|P4|Overall Study|Withdrawal by Subject|0
5035833|NCT02787304|17346369|P3|Overall Study|Withdrawal by Subject|0
5035834|NCT02787304|17346370|P2|Overall Study|Withdrawal by Subject|4
5035835|NCT02787304|17346371|P1|Overall Study|Withdrawal by Subject|1
5035836|NCT02787304|17346368|P4|Overall Study|Adverse Event|1
5035837|NCT02787304|17346369|P3|Overall Study|Adverse Event|8
5035838|NCT02787304|17346370|P2|Overall Study|Adverse Event|3
5035839|NCT02787304|17346371|P1|Overall Study|Adverse Event|9
5035840|NCT02787083|17346425|P2|Overall Study|Withdrawal by Subject|2
5035841|NCT02787083|17346426|P1|Overall Study|Withdrawal by Subject|2
5035842|NCT02787083|17346425|P2|Overall Study|Adverse Event|0
5035843|NCT02787083|17346426|P1|Overall Study|Adverse Event|1
5035844|NCT02786953|17346451|P2|Overall Study|Physician Decision|1
5035845|NCT02786953|17346452|P1|Overall Study|Physician Decision|0
5035846|NCT02786953|17346451|P2|Overall Study|Withdrawal by Subject|0
5035847|NCT02786953|17346452|P1|Overall Study|Withdrawal by Subject|3
5035848|NCT02786927|17346474|P1|Overall Study|Protocol Violation|4
5035849|NCT02786927|17346474|P1|Overall Study|Adverse Event|1
5035850|NCT02786901|17346484|P3|Overall Study|Randomized in error|1
5035851|NCT02786901|17346485|P2|Overall Study|Randomized in error|0
5035852|NCT02786901|17346486|P1|Overall Study|Randomized in error|2
5035853|NCT02786901|17346484|P3|Overall Study|Disallowed medication|0
5035854|NCT02786901|17346485|P2|Overall Study|Disallowed medication|1
5035855|NCT02786901|17346486|P1|Overall Study|Disallowed medication|1
5035856|NCT02786901|17346484|P3|Overall Study|Subject Request/Lost to Follow up|5
5035857|NCT02786901|17346485|P2|Overall Study|Subject Request/Lost to Follow up|5
5035858|NCT02786901|17346486|P1|Overall Study|Subject Request/Lost to Follow up|1
5035859|NCT02786901|17346484|P3|Overall Study|Rescue Therapy Use|33
5035860|NCT02786901|17346485|P2|Overall Study|Rescue Therapy Use|49
5035861|NCT02786901|17346486|P1|Overall Study|Rescue Therapy Use|71
5035862|NCT02786901|17346484|P3|Overall Study|Physician Decision|0
5035863|NCT02786901|17346485|P2|Overall Study|Physician Decision|0
5035864|NCT02786901|17346486|P1|Overall Study|Physician Decision|1
5035865|NCT02786901|17346484|P3|Overall Study|Adverse Event|2
5035866|NCT02786901|17346485|P2|Overall Study|Adverse Event|1
5035867|NCT02786901|17346486|P1|Overall Study|Adverse Event|1
5035868|NCT02786537|17346541|P6|As Treated|Advised to stop tx after loss of meds|0
5035869|NCT02786537|17346542|P5|As Treated|Advised to stop tx after loss of meds|0
5035870|NCT02786537|17346543|P4|As Treated|Advised to stop tx after loss of meds|0
5035871|NCT02786537|17346544|P3|As Treated|Advised to stop tx after loss of meds|0
5035872|NCT02786537|17346545|P2|As Treated|Advised to stop tx after loss of meds|1
5035873|NCT02786537|17346546|P1|As Treated|Advised to stop tx after loss of meds|0
5035874|NCT02786537|17346541|P6|As Treated|Drugs stolen from patient|0
5035875|NCT02786537|17346542|P5|As Treated|Drugs stolen from patient|0
5035876|NCT02786537|17346543|P4|As Treated|Drugs stolen from patient|0
5035877|NCT02786537|17346544|P3|As Treated|Drugs stolen from patient|0
5035878|NCT02786537|17346545|P2|As Treated|Drugs stolen from patient|1
5035879|NCT02786537|17346546|P1|As Treated|Drugs stolen from patient|0
5035880|NCT02786537|17346541|P6|As Treated|Opiate dependency relapse|0
5035881|NCT02786537|17346542|P5|As Treated|Opiate dependency relapse|0
5035882|NCT02786537|17346543|P4|As Treated|Opiate dependency relapse|0
5035883|NCT02786537|17346544|P3|As Treated|Opiate dependency relapse|0
5035884|NCT02786537|17346545|P2|As Treated|Opiate dependency relapse|1
5035885|NCT02786537|17346546|P1|As Treated|Opiate dependency relapse|0
5035886|NCT02786537|17346541|P6|As Treated|Incarceration|0
5035887|NCT02786537|17346542|P5|As Treated|Incarceration|0
5035888|NCT02786537|17346543|P4|As Treated|Incarceration|0
5035889|NCT02786537|17346544|P3|As Treated|Incarceration|0
5035890|NCT02786537|17346545|P2|As Treated|Incarceration|1
5035891|NCT02786537|17346546|P1|As Treated|Incarceration|0
5035892|NCT02786537|17346541|P6|As Treated|Withdrawal by Subject|0
5035893|NCT02786537|17346542|P5|As Treated|Withdrawal by Subject|1
5035894|NCT02786537|17346543|P4|As Treated|Withdrawal by Subject|0
5035895|NCT02786537|17346544|P3|As Treated|Withdrawal by Subject|0
5035896|NCT02786537|17346545|P2|As Treated|Withdrawal by Subject|2
5035897|NCT02786537|17346546|P1|As Treated|Withdrawal by Subject|1
5035898|NCT02786537|17346541|P6|As Treated|Lost insurance|0
5035899|NCT02786537|17346542|P5|As Treated|Lost insurance|0
5035900|NCT02786537|17346543|P4|As Treated|Lost insurance|1
5035901|NCT02786537|17346544|P3|As Treated|Lost insurance|0
5035902|NCT02786537|17346545|P2|As Treated|Lost insurance|0
5035903|NCT02786537|17346546|P1|As Treated|Lost insurance|0
5035904|NCT02786537|17346541|P6|As Treated|Non-compliance with study drug|1
5035905|NCT02786537|17346542|P5|As Treated|Non-compliance with study drug|0
5035906|NCT02786537|17346543|P4|As Treated|Non-compliance with study drug|1
5035907|NCT02786537|17346544|P3|As Treated|Non-compliance with study drug|0
5035908|NCT02786537|17346545|P2|As Treated|Non-compliance with study drug|11
5035909|NCT02786537|17346546|P1|As Treated|Non-compliance with study drug|1
5035910|NCT02786537|17346541|P6|As Treated|Lost to Follow-up|4
5035911|NCT02786537|17346542|P5|As Treated|Lost to Follow-up|4
5035912|NCT02786537|17346543|P4|As Treated|Lost to Follow-up|25
5035913|NCT02786537|17346544|P3|As Treated|Lost to Follow-up|0
5035914|NCT02786537|17346545|P2|As Treated|Lost to Follow-up|32
5035915|NCT02786537|17346546|P1|As Treated|Lost to Follow-up|4
5035916|NCT02786537|17346541|P6|As Treated|Lack of Efficacy|0
5035917|NCT02786537|17346542|P5|As Treated|Lack of Efficacy|0
5035918|NCT02786537|17346543|P4|As Treated|Lack of Efficacy|1
5035919|NCT02786537|17346544|P3|As Treated|Lack of Efficacy|0
5035920|NCT02786537|17346545|P2|As Treated|Lack of Efficacy|0
5035921|NCT02786537|17346546|P1|As Treated|Lack of Efficacy|0
5035922|NCT02786537|17346541|P6|As Treated|Death|0
5035923|NCT02786537|17346542|P5|As Treated|Death|1
5035924|NCT02786537|17346543|P4|As Treated|Death|3
5035925|NCT02786537|17346544|P3|As Treated|Death|0
5035926|NCT02786537|17346545|P2|As Treated|Death|2
5035927|NCT02786537|17346546|P1|As Treated|Death|0
5035928|NCT02786537|17346541|P6|As Treated|Adverse Event|2
5035929|NCT02786537|17346542|P5|As Treated|Adverse Event|6
5035930|NCT02786537|17346543|P4|As Treated|Adverse Event|4
5035931|NCT02786537|17346544|P3|As Treated|Adverse Event|0
5035932|NCT02786537|17346545|P2|As Treated|Adverse Event|11
5035933|NCT02786537|17346546|P1|As Treated|Adverse Event|0
5035934|NCT02786537|17346541|P6|As Randomized|Subject lost insurance|0
5035935|NCT02786537|17346542|P5|As Randomized|Subject lost insurance|0
5035936|NCT02786537|17346543|P4|As Randomized|Subject lost insurance|1
5035937|NCT02786537|17346544|P3|As Randomized|Subject lost insurance|0
5035938|NCT02786537|17346545|P2|As Randomized|Subject lost insurance|0
5035939|NCT02786537|17346546|P1|As Randomized|Subject lost insurance|0
5035940|NCT02786537|17346541|P6|As Randomized|Advised to stop after lapse in dosing|0
5035941|NCT02786537|17346542|P5|As Randomized|Advised to stop after lapse in dosing|0
5035942|NCT02786537|17346543|P4|As Randomized|Advised to stop after lapse in dosing|0
5035943|NCT02786537|17346544|P3|As Randomized|Advised to stop after lapse in dosing|0
5035944|NCT02786537|17346545|P2|As Randomized|Advised to stop after lapse in dosing|1
5035945|NCT02786537|17346546|P1|As Randomized|Advised to stop after lapse in dosing|0
5035946|NCT02786537|17346541|P6|As Randomized|HCV drugs stolen from pt|0
5035947|NCT02786537|17346542|P5|As Randomized|HCV drugs stolen from pt|0
5035948|NCT02786537|17346543|P4|As Randomized|HCV drugs stolen from pt|0
5035949|NCT02786537|17346544|P3|As Randomized|HCV drugs stolen from pt|0
5035950|NCT02786537|17346545|P2|As Randomized|HCV drugs stolen from pt|1
5035951|NCT02786537|17346546|P1|As Randomized|HCV drugs stolen from pt|0
5035952|NCT02786537|17346541|P6|As Randomized|Opiate Dependency Relapse|0
5035953|NCT02786537|17346542|P5|As Randomized|Opiate Dependency Relapse|0
5035954|NCT02786537|17346543|P4|As Randomized|Opiate Dependency Relapse|0
5035955|NCT02786537|17346544|P3|As Randomized|Opiate Dependency Relapse|0
5035956|NCT02786537|17346545|P2|As Randomized|Opiate Dependency Relapse|1
5035957|NCT02786537|17346546|P1|As Randomized|Opiate Dependency Relapse|0
5035958|NCT02786537|17346541|P6|As Randomized|Incarceration|0
5035959|NCT02786537|17346542|P5|As Randomized|Incarceration|0
5035960|NCT02786537|17346543|P4|As Randomized|Incarceration|0
5035961|NCT02786537|17346544|P3|As Randomized|Incarceration|0
5035962|NCT02786537|17346545|P2|As Randomized|Incarceration|1
5035963|NCT02786537|17346546|P1|As Randomized|Incarceration|0
5035964|NCT02786537|17346541|P6|As Randomized|Lost to treatment follow-up|4
5035965|NCT02786537|17346542|P5|As Randomized|Lost to treatment follow-up|4
5035966|NCT02786537|17346543|P4|As Randomized|Lost to treatment follow-up|24
5035967|NCT02786537|17346544|P3|As Randomized|Lost to treatment follow-up|0
5035968|NCT02786537|17346545|P2|As Randomized|Lost to treatment follow-up|32
5035969|NCT02786537|17346546|P1|As Randomized|Lost to treatment follow-up|4
5035970|NCT02786537|17346541|P6|As Randomized|Non-compliance with study drug|1
5035971|NCT02786537|17346542|P5|As Randomized|Non-compliance with study drug|0
5035972|NCT02786537|17346543|P4|As Randomized|Non-compliance with study drug|1
5035973|NCT02786537|17346544|P3|As Randomized|Non-compliance with study drug|0
5035974|NCT02786537|17346545|P2|As Randomized|Non-compliance with study drug|11
5035975|NCT02786537|17346546|P1|As Randomized|Non-compliance with study drug|1
5035976|NCT02786537|17346541|P6|As Randomized|Death|0
5035977|NCT02786537|17346542|P5|As Randomized|Death|1
5035978|NCT02786537|17346543|P4|As Randomized|Death|3
5035979|NCT02786537|17346544|P3|As Randomized|Death|0
5035980|NCT02786537|17346545|P2|As Randomized|Death|2
5035981|NCT02786537|17346546|P1|As Randomized|Death|0
5035982|NCT02786537|17346541|P6|As Randomized|Withdrawal by Subject|0
5035983|NCT02786537|17346542|P5|As Randomized|Withdrawal by Subject|1
5035984|NCT02786537|17346543|P4|As Randomized|Withdrawal by Subject|1
5035985|NCT02786537|17346544|P3|As Randomized|Withdrawal by Subject|0
5035986|NCT02786537|17346545|P2|As Randomized|Withdrawal by Subject|2
5035987|NCT02786537|17346546|P1|As Randomized|Withdrawal by Subject|1
5035988|NCT02786537|17346541|P6|As Randomized|Lack of Efficacy|0
5035989|NCT02786537|17346542|P5|As Randomized|Lack of Efficacy|0
5035990|NCT02786537|17346543|P4|As Randomized|Lack of Efficacy|1
5035991|NCT02786537|17346544|P3|As Randomized|Lack of Efficacy|0
5035992|NCT02786537|17346545|P2|As Randomized|Lack of Efficacy|0
5035993|NCT02786537|17346546|P1|As Randomized|Lack of Efficacy|0
5035994|NCT02786537|17346541|P6|As Randomized|Adverse Event|2
5035995|NCT02786537|17346542|P5|As Randomized|Adverse Event|6
5035996|NCT02786537|17346543|P4|As Randomized|Adverse Event|4
5035997|NCT02786537|17346544|P3|As Randomized|Adverse Event|0
5035998|NCT02786537|17346545|P2|As Randomized|Adverse Event|11
5035999|NCT02786537|17346546|P1|As Randomized|Adverse Event|0
5036000|NCT02786004|17346603|P2|Overall Study|Withdrawal by Subject|1
5036001|NCT02786004|17346604|P1|Overall Study|Withdrawal by Subject|0
5036002|NCT02785913|17346612|P1|Overall Study|Not protocol specified|1
5036003|NCT02785913|17346612|P1|Overall Study|Progression|18
5036004|NCT02785913|17346612|P1|Overall Study|Death|2
5036005|NCT02785913|17346612|P1|Overall Study|Adverse Event|5
5036006|NCT02785900|17346623|P2|Overall Study|Physician Decision|2
5036007|NCT02785900|17346624|P1|Overall Study|Physician Decision|3
5036008|NCT02785900|17346623|P2|Overall Study|Withdrawal by Subject|8
5036009|NCT02785900|17346624|P1|Overall Study|Withdrawal by Subject|4
5036010|NCT02785900|17346623|P2|Overall Study|Death|32
5036011|NCT02785900|17346624|P1|Overall Study|Death|46
5036012|NCT02785900|17346623|P2|Overall Study|Study Termination by Sponsor|81
5036013|NCT02785900|17346624|P1|Overall Study|Study Termination by Sponsor|64
5036014|NCT02785770|17346648|P4|Intervention Period 3 (1 Day)|Adverse Event|1
5036015|NCT02785770|17346649|P3|Intervention Period 3 (1 Day)|Adverse Event|0
5036016|NCT02785770|17346650|P2|Intervention Period 3 (1 Day)|Adverse Event|0
5036017|NCT02785770|17346651|P1|Intervention Period 3 (1 Day)|Adverse Event|0
5036018|NCT02785770|17346648|P4|Intervention Period 2 (1 Day)|Family related obligations|0
5036019|NCT02785770|17346649|P3|Intervention Period 2 (1 Day)|Family related obligations|1
5036020|NCT02785770|17346650|P2|Intervention Period 2 (1 Day)|Family related obligations|0
5036021|NCT02785770|17346651|P1|Intervention Period 2 (1 Day)|Family related obligations|0
5036022|NCT02785770|17346648|P4|Intervention Period 2 (1 Day)|Adverse Event|0
5036023|NCT02785770|17346649|P3|Intervention Period 2 (1 Day)|Adverse Event|0
5036024|NCT02785770|17346650|P2|Intervention Period 2 (1 Day)|Adverse Event|1
5036025|NCT02785770|17346651|P1|Intervention Period 2 (1 Day)|Adverse Event|0
5036026|NCT02785588|17346718|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
5036027|NCT02785588|17346718|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
5036028|NCT02785458|17346734|P2|3 Months|Completed Evaluation at 1 Month|89
5036029|NCT02785458|17346735|P1|3 Months|Completed Evaluation at 1 Month|100
5036030|NCT02785458|17346734|P2|3 Months|Lost to Follow-up|21
5036031|NCT02785458|17346735|P1|3 Months|Lost to Follow-up|25
5036032|NCT02785458|17346734|P2|3 Months|Withdrawal by Subject|1
5036033|NCT02785458|17346735|P1|3 Months|Withdrawal by Subject|3
5036034|NCT02785458|17346734|P2|1 Month|Partial Interview|4
5036035|NCT02785458|17346735|P1|1 Month|Partial Interview|0
5036036|NCT02785458|17346734|P2|1 Month|Completed Evaluation by Baseline|39
5036037|NCT02785458|17346735|P1|1 Month|Completed Evaluation by Baseline|42
5036038|NCT02785458|17346734|P2|1 Month|Deemed Ineligible|0
5036039|NCT02785458|17346735|P1|1 Month|Deemed Ineligible|1
5036040|NCT02785458|17346734|P2|1 Month|Lost to Follow-up|31
5036041|NCT02785458|17346735|P1|1 Month|Lost to Follow-up|38
5036042|NCT02785458|17346734|P2|1 Month|Withdrawal by Subject|1
5036043|NCT02785458|17346735|P1|1 Month|Withdrawal by Subject|2
5036044|NCT02784834|17346922|P1|Overall Study|Lack of Efficacy|1
5036045|NCT02784704|17346928|P2|Overall Study|Subject Non Compliance|0
5036046|NCT02784704|17346929|P1|Overall Study|Subject Non Compliance|2
5036047|NCT02784704|17346928|P2|Overall Study|Withdrawal by Subject|3
5036048|NCT02784704|17346929|P1|Overall Study|Withdrawal by Subject|1
5036049|NCT02784704|17346928|P2|Overall Study|Lost to Follow-up|4
5036050|NCT02784704|17346929|P1|Overall Study|Lost to Follow-up|6
5036051|NCT02784704|17346928|P2|Overall Study|Adverse Event|2
5036052|NCT02784704|17346929|P1|Overall Study|Adverse Event|4
5036053|NCT02784106|17347050|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
5036054|NCT02784106|17347051|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
5036055|NCT02784106|17347052|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
5036056|NCT02784106|17347053|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
5036057|NCT02784106|17347050|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
5036058|NCT02784106|17347051|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
5036059|NCT02784106|17347052|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
5036060|NCT02784106|17347053|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
5036061|NCT02784106|17347050|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5036062|NCT02784106|17347051|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5036063|NCT02784106|17347052|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5036064|NCT02784106|17347053|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
5036065|NCT02784106|17347050|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
5036066|NCT02784106|17347051|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
5036067|NCT02784106|17347052|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
5036068|NCT02784106|17347053|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
5036069|NCT02784106|17347050|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5036070|NCT02784106|17347051|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5036071|NCT02784106|17347052|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
5036072|NCT02784106|17347053|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
5036073|NCT02784106|17347050|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
5036074|NCT02784106|17347051|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
5036075|NCT02784106|17347052|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
5036076|NCT02784106|17347053|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
5036077|NCT02783768|17347154|P2|Overall Study|Lost to Follow-up|0
5036078|NCT02783768|17347155|P1|Overall Study|Lost to Follow-up|1
5036079|NCT02783729|17347177|P4|Overall Study|Lost to Follow-up|0
5036080|NCT02783729|17347178|P3|Overall Study|Lost to Follow-up|1
5036081|NCT02783729|17347179|P2|Overall Study|Lost to Follow-up|1
5036082|NCT02783729|17347180|P1|Overall Study|Lost to Follow-up|2
5036083|NCT02783729|17347177|P4|Overall Study|Participant's choice|1
5036084|NCT02783729|17347178|P3|Overall Study|Participant's choice|2
5036085|NCT02783729|17347179|P2|Overall Study|Participant's choice|1
5036086|NCT02783729|17347180|P1|Overall Study|Participant's choice|2
5036087|NCT02783729|17347177|P4|Overall Study|Withdrawal by Subject|2
5036088|NCT02783729|17347178|P3|Overall Study|Withdrawal by Subject|1
5036089|NCT02783729|17347179|P2|Overall Study|Withdrawal by Subject|3
5036090|NCT02783729|17347180|P1|Overall Study|Withdrawal by Subject|2
5036091|NCT02783729|17347177|P4|Overall Study|Other|3
5036092|NCT02783729|17347178|P3|Overall Study|Other|2
5036093|NCT02783729|17347179|P2|Overall Study|Other|6
5036094|NCT02783729|17347180|P1|Overall Study|Other|1
5036095|NCT02783729|17347177|P4|Overall Study|Adverse Event|3
5036096|NCT02783729|17347178|P3|Overall Study|Adverse Event|2
5036097|NCT02783729|17347179|P2|Overall Study|Adverse Event|6
5036098|NCT02783729|17347180|P1|Overall Study|Adverse Event|2
5036099|NCT02783729|17347177|P4|Overall Study|Lack of Efficacy|0
5036100|NCT02783729|17347178|P3|Overall Study|Lack of Efficacy|0
5036101|NCT02783729|17347179|P2|Overall Study|Lack of Efficacy|0
5036102|NCT02783729|17347180|P1|Overall Study|Lack of Efficacy|1
5036103|NCT02783599|17347246|P1|Overall Study|Death|1
5036104|NCT02783599|17347246|P1|Overall Study|Physician Decision|2
5036105|NCT02783599|17347246|P1|Overall Study|Adverse Event|4
5036106|NCT02783599|17347246|P1|Overall Study|Surgical Resection|10
5036107|NCT02783599|17347246|P1|Overall Study|Progressive disease|23
5036108|NCT02783573|17347262|P3|Delayed-Start Period|Sponsor Decision|12
5036109|NCT02783573|17347263|P2|Delayed-Start Period|Sponsor Decision|17
5036110|NCT02783573|17347264|P1|Delayed-Start Period|Sponsor Decision|0
5036111|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
5036112|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
5036113|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
5036114|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
5036115|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
5036116|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
5036117|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
5036118|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
5036119|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
5036120|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
5036121|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
5036122|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
5036123|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Physician Decision|3
5036124|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Physician Decision|1
5036125|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Physician Decision|3
5036126|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
5036127|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
5036128|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
5036129|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
5036130|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
5036131|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
5036132|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
5036133|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
5036134|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
5036135|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
5036136|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
5036137|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
5036138|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Death|3
5036139|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Death|2
5036140|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Death|4
5036141|NCT02783573|17347262|P3|Placebo-Controlled Treatment Period|Adverse Event|13
5036142|NCT02783573|17347263|P2|Placebo-Controlled Treatment Period|Adverse Event|17
5036143|NCT02783573|17347264|P1|Placebo-Controlled Treatment Period|Adverse Event|13
5036144|NCT02783170|17347329|P2|Overall Study|Randomized but not Vaccinated|0
5036145|NCT02783170|17347330|P1|Overall Study|Randomized but not Vaccinated|1
5036146|NCT02783066|17347371|P1|Overall Study|Withdrawal by Subject|13
5036147|NCT02782923|17347402|P1|Overall Study|Lost to Follow-up|15
5036148|NCT02782676|17347408|P2|Overall Study|Lost to Follow-up|1
5036149|NCT02782676|17347409|P1|Overall Study|Lost to Follow-up|0
5036150|NCT02782377|17347437|P1|Overall Study|Physician Decision|5
5036151|NCT02782325|17347452|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
5036152|NCT02782325|17347453|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
5036153|NCT02782325|17347454|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
5036154|NCT02782325|17347452|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
5036155|NCT02782325|17347453|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
5036156|NCT02782325|17347454|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
5036157|NCT02782169|17347482|P2|Overall Study|Lost to Follow-up|2
5036158|NCT02782169|17347483|P1|Overall Study|Lost to Follow-up|1
5036159|NCT02781844|17347501|P8|Treatment Period 1|Adverse Event|0
5036160|NCT02781844|17347502|P7|Treatment Period 1|Adverse Event|0
5036161|NCT02781844|17347503|P6|Treatment Period 1|Adverse Event|1
5036162|NCT02781844|17347504|P5|Treatment Period 1|Adverse Event|0
5036163|NCT02781844|17347505|P4|Treatment Period 1|Adverse Event|0
5036164|NCT02781844|17347506|P3|Treatment Period 1|Adverse Event|0
5036165|NCT02781844|17347507|P2|Treatment Period 1|Adverse Event|0
5036166|NCT02781844|17347508|P1|Treatment Period 1|Adverse Event|0
5036167|NCT02781818|17347641|P3|Overall Study|Lost to Follow-up|1
5036168|NCT02781818|17347642|P2|Overall Study|Lost to Follow-up|2
5036169|NCT02781818|17347643|P1|Overall Study|Lost to Follow-up|4
5036170|NCT02781558|17347709|P2|Overall Study|Adverse Event|0
5036171|NCT02781558|17347710|P1|Overall Study|Adverse Event|1
5036172|NCT02781558|17347709|P2|Overall Study|Lost to Follow-up|2
5036173|NCT02781558|17347710|P1|Overall Study|Lost to Follow-up|2
5036174|NCT02781324|17347797|P2|Overall Study|Physician Decision|2
5036175|NCT02781324|17347798|P1|Overall Study|Physician Decision|1
5036176|NCT02781324|17347797|P2|Overall Study|Withdrawal by Subject|0
5036177|NCT02781324|17347798|P1|Overall Study|Withdrawal by Subject|1
5036178|NCT02781311|17347827|P3|Overall Study|Non-Compliance with Study Drug|0
5036179|NCT02781311|17347828|P2|Overall Study|Non-Compliance with Study Drug|0
5036180|NCT02781311|17347829|P1|Overall Study|Non-Compliance with Study Drug|2
5036181|NCT02781311|17347827|P3|Overall Study|Lost to Follow-up|1
5036182|NCT02781311|17347828|P2|Overall Study|Lost to Follow-up|8
5036183|NCT02781311|17347829|P1|Overall Study|Lost to Follow-up|11
5036184|NCT02781311|17347827|P3|Overall Study|Withdrawal of Consent|2
5036185|NCT02781311|17347828|P2|Overall Study|Withdrawal of Consent|12
5036186|NCT02781311|17347829|P1|Overall Study|Withdrawal of Consent|11
5036187|NCT02781311|17347827|P3|Overall Study|Adverse Event|1
5036188|NCT02781311|17347828|P2|Overall Study|Adverse Event|6
5036189|NCT02781311|17347829|P1|Overall Study|Adverse Event|2
5036190|NCT02780856|17347856|P1|Overall Study|Lost to Follow-up|1
5036191|NCT02780700|17347875|P1|Overall Study|Progressive disease|1
5036192|NCT02780687|17347885|P2|Overall Study|progressive disease|6
5036193|NCT02780687|17347886|P1|Overall Study|progressive disease|29
5036194|NCT02780687|17347885|P2|Overall Study|Switched to commercial program (in CTP)|0
5036195|NCT02780687|17347886|P1|Overall Study|Switched to commercial program (in CTP)|2
5036196|NCT02780687|17347885|P2|Overall Study|Withdrawal by Subject|1
5036197|NCT02780687|17347886|P1|Overall Study|Withdrawal by Subject|2
5036198|NCT02780687|17347885|P2|Overall Study|Adverse Event|1
5036199|NCT02780687|17347886|P1|Overall Study|Adverse Event|1
5036200|NCT02780388|17347958|P5|Overall Study|Withdrawal by Subject|0
5036201|NCT02780388|17347959|P4|Overall Study|Withdrawal by Subject|0
5036202|NCT02780388|17347960|P3|Overall Study|Withdrawal by Subject|0
5036203|NCT02780388|17347961|P2|Overall Study|Withdrawal by Subject|1
5036204|NCT02780388|17347962|P1|Overall Study|Withdrawal by Subject|1
5036205|NCT02780388|17347958|P5|Overall Study|Lost to Follow-up|0
5036206|NCT02780388|17347959|P4|Overall Study|Lost to Follow-up|0
5036207|NCT02780388|17347960|P3|Overall Study|Lost to Follow-up|0
5036208|NCT02780388|17347961|P2|Overall Study|Lost to Follow-up|1
5036209|NCT02780388|17347962|P1|Overall Study|Lost to Follow-up|0
5036210|NCT02780167|17348028|P5|Overall Study|Other|2
5036211|NCT02780167|17348029|P4|Overall Study|Other|1
5036212|NCT02780167|17348030|P3|Overall Study|Other|3
5036213|NCT02780167|17348031|P2|Overall Study|Other|0
5036214|NCT02780167|17348032|P1|Overall Study|Other|0
5036215|NCT02780167|17348028|P5|Overall Study|Withdrawal by Subject|4
5036216|NCT02780167|17348029|P4|Overall Study|Withdrawal by Subject|3
5036217|NCT02780167|17348030|P3|Overall Study|Withdrawal by Subject|4
5036218|NCT02780167|17348031|P2|Overall Study|Withdrawal by Subject|4
5036219|NCT02780167|17348032|P1|Overall Study|Withdrawal by Subject|6
5036220|NCT02780167|17348028|P5|Overall Study|Protocol Violation|2
5036221|NCT02780167|17348029|P4|Overall Study|Protocol Violation|1
5036222|NCT02780167|17348030|P3|Overall Study|Protocol Violation|1
5036223|NCT02780167|17348031|P2|Overall Study|Protocol Violation|5
5036224|NCT02780167|17348032|P1|Overall Study|Protocol Violation|5
5036225|NCT02780167|17348028|P5|Overall Study|No longer meets eligibility criteria|1
5036226|NCT02780167|17348029|P4|Overall Study|No longer meets eligibility criteria|1
5036227|NCT02780167|17348030|P3|Overall Study|No longer meets eligibility criteria|0
5036228|NCT02780167|17348031|P2|Overall Study|No longer meets eligibility criteria|0
5036229|NCT02780167|17348032|P1|Overall Study|No longer meets eligibility criteria|0
5036230|NCT02780167|17348028|P5|Overall Study|Does not meet entrance criteria|0
5036231|NCT02780167|17348029|P4|Overall Study|Does not meet entrance criteria|0
5036232|NCT02780167|17348030|P3|Overall Study|Does not meet entrance criteria|1
5036233|NCT02780167|17348031|P2|Overall Study|Does not meet entrance criteria|0
5036234|NCT02780167|17348032|P1|Overall Study|Does not meet entrance criteria|0
5036235|NCT02780167|17348028|P5|Overall Study|Lost to Follow-up|0
5036236|NCT02780167|17348029|P4|Overall Study|Lost to Follow-up|0
5036237|NCT02780167|17348030|P3|Overall Study|Lost to Follow-up|1
5036238|NCT02780167|17348031|P2|Overall Study|Lost to Follow-up|0
5036239|NCT02780167|17348032|P1|Overall Study|Lost to Follow-up|2
5036240|NCT02780167|17348028|P5|Overall Study|Lack of Efficacy|0
5036241|NCT02780167|17348029|P4|Overall Study|Lack of Efficacy|1
5036242|NCT02780167|17348030|P3|Overall Study|Lack of Efficacy|6
5036243|NCT02780167|17348031|P2|Overall Study|Lack of Efficacy|5
5036244|NCT02780167|17348032|P1|Overall Study|Lack of Efficacy|6
5036245|NCT02780167|17348028|P5|Overall Study|Adverse Event|8
5036246|NCT02780167|17348029|P4|Overall Study|Adverse Event|12
5036247|NCT02780167|17348030|P3|Overall Study|Adverse Event|8
5036248|NCT02780167|17348031|P2|Overall Study|Adverse Event|8
5036249|NCT02780167|17348032|P1|Overall Study|Adverse Event|9
5036250|NCT02779075|17348217|P2|Overall Study|IV lost during 2nd study|0
5036251|NCT02779075|17348218|P1|Overall Study|IV lost during 2nd study|1
5036252|NCT02779075|17348217|P2|Overall Study|Withdrawal by Subject|3
5036253|NCT02779075|17348218|P1|Overall Study|Withdrawal by Subject|1
5036254|NCT02778867|17348281|P4|Phase 2|Adverse Event|1
5036255|NCT02778867|17348282|P3|Phase 2|Adverse Event|0
5036256|NCT02778867|17348283|P2|Phase 2|Adverse Event|0
5036257|NCT02778867|17348284|P1|Phase 2|Adverse Event|0
5036258|NCT02778867|17348281|P4|Phase 2|Physician Decision|1
5036259|NCT02778867|17348282|P3|Phase 2|Physician Decision|0
5036260|NCT02778867|17348283|P2|Phase 2|Physician Decision|0
5036261|NCT02778867|17348284|P1|Phase 2|Physician Decision|0
5036262|NCT02778867|17348281|P4|Phase 2|Withdrawal by Subject|0
5036263|NCT02778867|17348282|P3|Phase 2|Withdrawal by Subject|1
5036264|NCT02778867|17348283|P2|Phase 2|Withdrawal by Subject|0
5036265|NCT02778867|17348284|P1|Phase 2|Withdrawal by Subject|0
5036266|NCT02778867|17348281|P4|Phase 1|Withdrawal by Subject|0
5036267|NCT02778867|17348282|P3|Phase 1|Withdrawal by Subject|0
5036268|NCT02778867|17348283|P2|Phase 1|Withdrawal by Subject|3
5036269|NCT02778867|17348284|P1|Phase 1|Withdrawal by Subject|2
5036270|NCT02778555|17348305|P3|Overall Study|Withdrawal by Subject|107
5036271|NCT02778555|17348306|P2|Overall Study|Withdrawal by Subject|32
5036272|NCT02778555|17348307|P1|Overall Study|Withdrawal by Subject|55
5036273|NCT02778204|17348319|P4|Overall Study|Eligibility Violation|1
5036274|NCT02778204|17348320|P3|Overall Study|Eligibility Violation|0
5036275|NCT02778204|17348321|P2|Overall Study|Eligibility Violation|0
5036276|NCT02778204|17348322|P1|Overall Study|Eligibility Violation|0
5036277|NCT02778204|17348319|P4|Overall Study|Protocol Violation|0
5036278|NCT02778204|17348320|P3|Overall Study|Protocol Violation|1
5036279|NCT02778204|17348321|P2|Overall Study|Protocol Violation|0
5036280|NCT02778204|17348322|P1|Overall Study|Protocol Violation|0
5036281|NCT02778204|17348319|P4|Overall Study|Lost to Follow-up|1
5036282|NCT02778204|17348320|P3|Overall Study|Lost to Follow-up|2
5036283|NCT02778204|17348321|P2|Overall Study|Lost to Follow-up|0
5036284|NCT02778204|17348322|P1|Overall Study|Lost to Follow-up|1
5036285|NCT02778204|17348319|P4|Overall Study|Withdrawal by Subject|2
5036286|NCT02778204|17348320|P3|Overall Study|Withdrawal by Subject|1
5036287|NCT02778204|17348321|P2|Overall Study|Withdrawal by Subject|0
5036288|NCT02778204|17348322|P1|Overall Study|Withdrawal by Subject|0
5036289|NCT02778204|17348319|P4|Overall Study|Adverse Event|0
5036290|NCT02778204|17348320|P3|Overall Study|Adverse Event|0
5036291|NCT02778204|17348321|P2|Overall Study|Adverse Event|0
5036292|NCT02778204|17348322|P1|Overall Study|Adverse Event|1
5036293|NCT02778100|17348414|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
5036294|NCT02778100|17348415|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
5036295|NCT02778074|17348446|P2|Overall Study|Lost to Follow-up|10
5036296|NCT02778074|17348447|P1|Overall Study|Lost to Follow-up|7
5036297|NCT02777918|17348479|P2|Overall Study|Withdrawal by Subject|1
5036298|NCT02777918|17348480|P1|Overall Study|Withdrawal by Subject|1
5036299|NCT02777918|17348479|P2|Overall Study|Too busy / stressed|1
5036300|NCT02777918|17348480|P1|Overall Study|Too busy / stressed|1
5036301|NCT02777918|17348479|P2|Overall Study|Medical reasons|2
5036302|NCT02777918|17348480|P1|Overall Study|Medical reasons|1
5036303|NCT02777827|17348498|P6|Washout Between Periods 3 and 4|Protocol Violation|0
5036304|NCT02777827|17348499|P5|Washout Between Periods 3 and 4|Protocol Violation|0
5036305|NCT02777827|17348500|P4|Washout Between Periods 3 and 4|Protocol Violation|0
5036306|NCT02777827|17348501|P3|Washout Between Periods 3 and 4|Protocol Violation|1
5036307|NCT02777827|17348502|P2|Washout Between Periods 3 and 4|Protocol Violation|0
5036308|NCT02777827|17348503|P1|Washout Between Periods 3 and 4|Protocol Violation|0
5036309|NCT02777242|17348706|P1|Overall Study|Withdrawal by Subject|1
5036310|NCT02777242|17348706|P1|Overall Study|Sponsor's request|1
5036311|NCT02777242|17348706|P1|Overall Study|Multiple|1
5036312|NCT02777242|17348706|P1|Overall Study|Lost to Follow-up|1
5036313|NCT02777242|17348706|P1|Overall Study|Other|2
5036314|NCT02777125|17348712|P2|Overall Study|Protocol Violation|12
5036315|NCT02777125|17348713|P1|Overall Study|Protocol Violation|8
5036316|NCT02777125|17348712|P2|Overall Study|Assent form violation|23
5036317|NCT02777125|17348713|P1|Overall Study|Assent form violation|21
5036318|NCT02777125|17348712|P2|Overall Study|Consent form violation|12
5036319|NCT02777125|17348713|P1|Overall Study|Consent form violation|14
5036320|NCT02777086|17348729|P2|Overall Study|Lost to Follow-up|99
5036321|NCT02777086|17348730|P1|Overall Study|Lost to Follow-up|96
5036322|NCT02776683|17348773|P2|Post-switch Period|Other than listed|15
5036323|NCT02776683|17348774|P1|Post-switch Period|Other than listed|0
5036324|NCT02776683|17348773|P2|Post-switch Period|Progressive disease|20
5036325|NCT02776683|17348774|P1|Post-switch Period|Progressive disease|0
5036326|NCT02776683|17348773|P2|Post-switch Period|Physician Decision|3
5036327|NCT02776683|17348774|P1|Post-switch Period|Physician Decision|0
5036328|NCT02776683|17348773|P2|Post-switch Period|Withdrawal by Subject|2
5036329|NCT02776683|17348774|P1|Post-switch Period|Withdrawal by Subject|0
5036330|NCT02776683|17348773|P2|Post-switch Period|Adverse Event|3
5036331|NCT02776683|17348774|P1|Post-switch Period|Adverse Event|0
5036332|NCT02776683|17348773|P2|Pre-switch Period|Other than listed|0
5036333|NCT02776683|17348774|P1|Pre-switch Period|Other than listed|3
5036334|NCT02776683|17348773|P2|Pre-switch Period|Progressive disease|0
5036335|NCT02776683|17348774|P1|Pre-switch Period|Progressive disease|39
5036336|NCT02776683|17348773|P2|Pre-switch Period|Physician Decision|0
5036337|NCT02776683|17348774|P1|Pre-switch Period|Physician Decision|7
5036338|NCT02776683|17348773|P2|Pre-switch Period|Withdrawal by Subject|0
5036339|NCT02776683|17348774|P1|Pre-switch Period|Withdrawal by Subject|9
5036340|NCT02776683|17348773|P2|Pre-switch Period|Adverse Event|0
5036341|NCT02776683|17348774|P1|Pre-switch Period|Adverse Event|21
5036342|NCT02776683|17348773|P2|Pre-switch Period|Protocol Violation|0
5036343|NCT02776683|17348774|P1|Pre-switch Period|Protocol Violation|1
5036344|NCT02776670|17348785|P2|Overall Study|Other - Reason not given|1
5036345|NCT02776670|17348786|P1|Overall Study|Other - Reason not given|0
5036346|NCT02776670|17348785|P2|Overall Study|Withdrawal by Subject|1
5036347|NCT02776670|17348786|P1|Overall Study|Withdrawal by Subject|0
5036348|NCT02776670|17348785|P2|Overall Study|Protocol Violation|2
5036349|NCT02776670|17348786|P1|Overall Study|Protocol Violation|0
5036350|NCT02776670|17348785|P2|Overall Study|Adverse Event|2
5036351|NCT02776670|17348786|P1|Overall Study|Adverse Event|0
5036352|NCT02776553|17348843|P2|Overall Study|Protocol Violation|1
5036353|NCT02776553|17348844|P1|Overall Study|Protocol Violation|0
5036354|NCT02776553|17348843|P2|Overall Study|had other surgery|0
5036355|NCT02776553|17348844|P1|Overall Study|had other surgery|1
5036356|NCT02776553|17348843|P2|Overall Study|got liver transplant|2
5036357|NCT02776553|17348844|P1|Overall Study|got liver transplant|1
5036358|NCT02776553|17348843|P2|Overall Study|Lost to Follow-up|0
5036359|NCT02776553|17348844|P1|Overall Study|Lost to Follow-up|1
5036360|NCT02776033|17348857|P3|Overall Study|Adverse Event|0
5036361|NCT02776033|17348858|P2|Overall Study|Adverse Event|2
5036362|NCT02776033|17348859|P1|Overall Study|Adverse Event|1
5036363|NCT02776033|17348857|P3|Overall Study|Lost to Follow-up|0
5036364|NCT02776033|17348858|P2|Overall Study|Lost to Follow-up|0
5036365|NCT02776033|17348859|P1|Overall Study|Lost to Follow-up|1
5036366|NCT02776033|17348857|P3|Overall Study|Physician Decision|0
5036367|NCT02776033|17348858|P2|Overall Study|Physician Decision|0
5036368|NCT02776033|17348859|P1|Overall Study|Physician Decision|2
5036369|NCT02776033|17348857|P3|Overall Study|Withdrawal by Subject|2
5036370|NCT02776033|17348858|P2|Overall Study|Withdrawal by Subject|0
5036371|NCT02776033|17348859|P1|Overall Study|Withdrawal by Subject|0
5036372|NCT02775916|17348924|P2|Overall Study|Subject/Guardian Decision|0
5036373|NCT02775916|17348925|P1|Overall Study|Subject/Guardian Decision|2
5036374|NCT02775916|17348924|P2|Overall Study|Adverse Event|0
5036375|NCT02775916|17348925|P1|Overall Study|Adverse Event|1
5036376|NCT02775903|17348947|P4|Overall Study|Other-Miscellaneous|5
5036377|NCT02775903|17348948|P3|Overall Study|Other-Miscellaneous|4
5036378|NCT02775903|17348949|P2|Overall Study|Other-Miscellaneous|3
5036379|NCT02775903|17348950|P1|Overall Study|Other-Miscellaneous|4
5036380|NCT02775903|17348947|P4|Overall Study|Lost to Follow-up|1
5036381|NCT02775903|17348948|P3|Overall Study|Lost to Follow-up|1
5036382|NCT02775903|17348949|P2|Overall Study|Lost to Follow-up|0
5036383|NCT02775903|17348950|P1|Overall Study|Lost to Follow-up|0
5036384|NCT02775903|17348947|P4|Overall Study|Adverse Event|1
5036385|NCT02775903|17348948|P3|Overall Study|Adverse Event|1
5036386|NCT02775903|17348949|P2|Overall Study|Adverse Event|0
5036387|NCT02775903|17348950|P1|Overall Study|Adverse Event|0
5036388|NCT02775903|17348947|P4|Overall Study|Withdrawal by Subject|4
5036389|NCT02775903|17348948|P3|Overall Study|Withdrawal by Subject|5
5036390|NCT02775903|17348949|P2|Overall Study|Withdrawal by Subject|5
5036391|NCT02775903|17348950|P1|Overall Study|Withdrawal by Subject|5
5036392|NCT02775903|17348947|P4|Overall Study|Death|35
5036393|NCT02775903|17348948|P3|Overall Study|Death|38
5036394|NCT02775903|17348949|P2|Overall Study|Death|18
5036395|NCT02775903|17348950|P1|Overall Study|Death|19
5036396|NCT02775903|17348947|P4|Overall Study|Ongoing|19
5036397|NCT02775903|17348948|P3|Overall Study|Ongoing|15
5036398|NCT02775903|17348949|P2|Overall Study|Ongoing|15
5036399|NCT02775903|17348950|P1|Overall Study|Ongoing|14
5036400|NCT02775864|17349002|P4|Overall Study|Medicaid eligibility discontinued|890
5036401|NCT02775864|17349003|P3|Overall Study|Medicaid eligibility discontinued|720
5036402|NCT02775864|17349004|P2|Overall Study|Medicaid eligibility discontinued|2019
5036403|NCT02775864|17349005|P1|Overall Study|Medicaid eligibility discontinued|1478
5036404|NCT02775864|17349002|P4|Overall Study|Data ended end of 2010|1194
5036405|NCT02775864|17349003|P3|Overall Study|Data ended end of 2010|1140
5036406|NCT02775864|17349004|P2|Overall Study|Data ended end of 2010|2880
5036407|NCT02775864|17349005|P1|Overall Study|Data ended end of 2010|1764
5036408|NCT02775435|17349038|P2|Overall Study|Not Treated|1
5036409|NCT02775435|17349039|P1|Overall Study|Not Treated|0
5036410|NCT02775435|17349038|P2|Overall Study|Ongoing in Study|72
5036411|NCT02775435|17349039|P1|Overall Study|Ongoing in Study|121
5036412|NCT02775435|17349038|P2|Overall Study|Clinical Progression|26
5036413|NCT02775435|17349039|P1|Overall Study|Clinical Progression|13
5036414|NCT02775435|17349038|P2|Overall Study|Progressive Disease|140
5036415|NCT02775435|17349039|P1|Overall Study|Progressive Disease|86
5036416|NCT02775435|17349038|P2|Overall Study|Withdrawal by Subject|9
5036417|NCT02775435|17349039|P1|Overall Study|Withdrawal by Subject|5
5036418|NCT02775435|17349038|P2|Overall Study|Physician Decision|6
5036419|NCT02775435|17349039|P1|Overall Study|Physician Decision|5
5036420|NCT02775435|17349038|P2|Overall Study|Lost to Follow-up|2
5036421|NCT02775435|17349039|P1|Overall Study|Lost to Follow-up|0
5036422|NCT02775435|17349038|P2|Overall Study|Adverse Event|25
5036423|NCT02775435|17349039|P1|Overall Study|Adverse Event|48
5036424|NCT02775344|17349057|P2|Overall Study|No ovarian cyst identified|2
5036425|NCT02775344|17349058|P1|Overall Study|No ovarian cyst identified|3
5036426|NCT02774681|17349191|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
5036427|NCT02774681|17349191|P1|Follow-Up for 3 Years|Death|11
5036428|NCT02774681|17349191|P1|Treatment on Study|Progressive Disease|7
5036429|NCT02774278|17349255|P1|Overall Study|Protocol Violation|2
5036430|NCT02774278|17349255|P1|Overall Study|Withdrawal by Subject|3
5036431|NCT02774278|17349255|P1|Overall Study|Administrative reasons|6
5036432|NCT02774278|17349255|P1|Overall Study|Refused treatment/did not cooperate|9
5036433|NCT02774278|17349255|P1|Overall Study|Adverse event/intercurrent illness|16
5036434|NCT02774278|17349255|P1|Overall Study|Death|29
5036435|NCT02774278|17349255|P1|Overall Study|Lack of Efficacy|199
5036436|NCT02773537|17349430|P3|Overall Study|Lost to Follow-up|4
5036437|NCT02773537|17349431|P2|Overall Study|Lost to Follow-up|1
5036438|NCT02773537|17349432|P1|Overall Study|Lost to Follow-up|0
5036439|NCT02773446|17349467|P6|First Admission|Lost to Follow-up|0
5036440|NCT02773446|17349468|P5|First Admission|Lost to Follow-up|0
5036441|NCT02773446|17349469|P4|First Admission|Lost to Follow-up|0
5036442|NCT02773446|17349470|P3|First Admission|Lost to Follow-up|0
5036443|NCT02773446|17349471|P2|First Admission|Lost to Follow-up|0
5036444|NCT02773446|17349472|P1|First Admission|Lost to Follow-up|1
5036445|NCT02773446|17349467|P6|First Admission|Withdrawal by Subject|0
5036446|NCT02773446|17349468|P5|First Admission|Withdrawal by Subject|0
5036447|NCT02773446|17349469|P4|First Admission|Withdrawal by Subject|1
5036448|NCT02773446|17349470|P3|First Admission|Withdrawal by Subject|0
5036449|NCT02773446|17349471|P2|First Admission|Withdrawal by Subject|0
5036450|NCT02773446|17349472|P1|First Admission|Withdrawal by Subject|0
5036451|NCT02773368|17349513|P2|Overall Study|Missing|1
5036452|NCT02773368|17349514|P1|Overall Study|Missing|0
5036453|NCT02773368|17349513|P2|Overall Study|Unclassified|1
5036454|NCT02773368|17349514|P1|Overall Study|Unclassified|1
5036455|NCT02773368|17349513|P2|Overall Study|Withdrawal by Subject|1
5036456|NCT02773368|17349514|P1|Overall Study|Withdrawal by Subject|5
5036457|NCT02773368|17349513|P2|Overall Study|Lost to Follow-up|1
5036458|NCT02773368|17349514|P1|Overall Study|Lost to Follow-up|4
5036459|NCT02772809|17349584|P1|Overall Study|not completed some tasks|6
5036460|NCT02772757|17349596|P3|Overall Study|Physician Decision|3
5036461|NCT02772757|17349597|P2|Overall Study|Physician Decision|3
5036462|NCT02772757|17349598|P1|Overall Study|Physician Decision|0
5036463|NCT02772757|17349596|P3|Overall Study|Protocol Violation|1
5036464|NCT02772757|17349597|P2|Overall Study|Protocol Violation|0
5036465|NCT02772757|17349598|P1|Overall Study|Protocol Violation|0
5036466|NCT02772757|17349596|P3|Overall Study|Withdrawal by Subject|1
5036467|NCT02772757|17349597|P2|Overall Study|Withdrawal by Subject|0
5036468|NCT02772757|17349598|P1|Overall Study|Withdrawal by Subject|1
5036469|NCT02771522|17349681|P1|Overall Study|No white spot lesions|3
5036470|NCT02771522|17349681|P1|Overall Study|Withdrawal by Subject|2
5036471|NCT02771522|17349681|P1|Overall Study|Lost to Follow-up|3
5036472|NCT02771366|17349692|P2|Period 2 (Crossover)|Withdrawal by Subject|0
5036473|NCT02771366|17349693|P1|Period 2 (Crossover)|Withdrawal by Subject|2
5036474|NCT02771366|17349692|P2|Period 1|Withdrawal by Subject|2
5036475|NCT02771366|17349693|P1|Period 1|Withdrawal by Subject|0
5036476|NCT02771275|17349719|P1|Overall Study|On Study|11
5036477|NCT02771275|17349719|P1|Overall Study|Reoperation|2
5036478|NCT02771145|17349727|P1|Overall Study|Lost to Follow-up|1
5036479|NCT02771145|17349727|P1|Overall Study|Adverse Event|3
5036480|NCT02770612|17349861|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
5036481|NCT02770547|17349867|P2|Overall Study|Adverse Event|1
5036482|NCT02770547|17349868|P1|Overall Study|Adverse Event|0
5036483|NCT02770547|17349867|P2|Overall Study|Patient non-compliant|0
5036484|NCT02770547|17349868|P1|Overall Study|Patient non-compliant|1
5036485|NCT02770248|17349941|P2|Overall Study|Randomized in error, prior to treatment|1
5036486|NCT02770248|17349942|P1|Overall Study|Randomized in error, prior to treatment|0
5036487|NCT02770248|17349941|P2|Overall Study|Adverse Event|1
5036488|NCT02770248|17349942|P1|Overall Study|Adverse Event|0
5036489|NCT02769858|17349960|P1|Overall Study|Withdrawal by Subject|2
5036490|NCT02769624|17349971|P2|Overall Study|Lost to Follow-up|1
5036491|NCT02769624|17349972|P1|Overall Study|Lost to Follow-up|0
5036492|NCT02769312|17350001|P2|Follow-up|Lost to Follow-up|1
5036493|NCT02769312|17350002|P1|Follow-up|Lost to Follow-up|1
5036494|NCT02769312|17350001|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
5036495|NCT02769312|17350002|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
5036496|NCT02769312|17350001|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
5036497|NCT02769312|17350002|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
5036498|NCT02769312|17350001|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
5036499|NCT02769312|17350002|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
5036500|NCT02769312|17350001|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
5036501|NCT02769312|17350002|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
5036502|NCT02769247|17350019|P4|Overall Study|Physician Decision|0
5036503|NCT02769247|17350020|P3|Overall Study|Physician Decision|0
5036504|NCT02769247|17350021|P2|Overall Study|Physician Decision|0
5036505|NCT02769247|17350022|P1|Overall Study|Physician Decision|1
5036506|NCT02769247|17350019|P4|Overall Study|Protocol Violation|0
5036507|NCT02769247|17350020|P3|Overall Study|Protocol Violation|1
5036508|NCT02769247|17350021|P2|Overall Study|Protocol Violation|0
5036509|NCT02769247|17350022|P1|Overall Study|Protocol Violation|0
5036510|NCT02769247|17350019|P4|Overall Study|Withdrawal by Subject|1
5036511|NCT02769247|17350020|P3|Overall Study|Withdrawal by Subject|0
5036512|NCT02769247|17350021|P2|Overall Study|Withdrawal by Subject|0
5036513|NCT02769247|17350022|P1|Overall Study|Withdrawal by Subject|1
5036514|NCT02769065|17350090|P30|Overall Study|Pre-treatment Event/Adverse Event|0
5036515|NCT02769065|17350091|P29|Overall Study|Pre-treatment Event/Adverse Event|0
5036516|NCT02769065|17350092|P28|Overall Study|Pre-treatment Event/Adverse Event|0
5036517|NCT02769065|17350093|P27|Overall Study|Pre-treatment Event/Adverse Event|0
5036518|NCT02769065|17350094|P26|Overall Study|Pre-treatment Event/Adverse Event|0
5036519|NCT02769065|17350095|P25|Overall Study|Pre-treatment Event/Adverse Event|0
5036520|NCT02769065|17350096|P24|Overall Study|Pre-treatment Event/Adverse Event|0
5036521|NCT02769065|17350097|P23|Overall Study|Pre-treatment Event/Adverse Event|0
5036522|NCT02769065|17350098|P22|Overall Study|Pre-treatment Event/Adverse Event|0
5036523|NCT02769065|17350099|P21|Overall Study|Pre-treatment Event/Adverse Event|0
5036524|NCT02769065|17350100|P20|Overall Study|Pre-treatment Event/Adverse Event|0
5036525|NCT02769065|17350101|P19|Overall Study|Pre-treatment Event/Adverse Event|0
5036526|NCT02769065|17350102|P18|Overall Study|Pre-treatment Event/Adverse Event|0
5036527|NCT02769065|17350103|P17|Overall Study|Pre-treatment Event/Adverse Event|0
5036528|NCT02769065|17350104|P16|Overall Study|Pre-treatment Event/Adverse Event|0
5036529|NCT02769065|17350105|P15|Overall Study|Pre-treatment Event/Adverse Event|0
5036530|NCT02769065|17350106|P14|Overall Study|Pre-treatment Event/Adverse Event|0
5036531|NCT02769065|17350107|P13|Overall Study|Pre-treatment Event/Adverse Event|0
5036532|NCT02769065|17350108|P12|Overall Study|Pre-treatment Event/Adverse Event|0
5036533|NCT02769065|17350109|P11|Overall Study|Pre-treatment Event/Adverse Event|1
5036534|NCT02769065|17350110|P10|Overall Study|Pre-treatment Event/Adverse Event|0
5036535|NCT02769065|17350111|P9|Overall Study|Pre-treatment Event/Adverse Event|0
5036536|NCT02769065|17350112|P8|Overall Study|Pre-treatment Event/Adverse Event|0
5036537|NCT02769065|17350113|P7|Overall Study|Pre-treatment Event/Adverse Event|0
5036538|NCT02769065|17350114|P6|Overall Study|Pre-treatment Event/Adverse Event|0
5036539|NCT02769065|17350115|P5|Overall Study|Pre-treatment Event/Adverse Event|0
5036540|NCT02769065|17350116|P4|Overall Study|Pre-treatment Event/Adverse Event|0
5036541|NCT02769065|17350117|P3|Overall Study|Pre-treatment Event/Adverse Event|0
5036542|NCT02769065|17350118|P2|Overall Study|Pre-treatment Event/Adverse Event|0
5036543|NCT02769065|17350119|P1|Overall Study|Pre-treatment Event/Adverse Event|0
5036544|NCT02769065|17350090|P30|Overall Study|Reason Not Specified|0
5036545|NCT02769065|17350091|P29|Overall Study|Reason Not Specified|0
5036546|NCT02769065|17350092|P28|Overall Study|Reason Not Specified|0
5036547|NCT02769065|17350093|P27|Overall Study|Reason Not Specified|0
5036548|NCT02769065|17350094|P26|Overall Study|Reason Not Specified|0
5036549|NCT02769065|17350095|P25|Overall Study|Reason Not Specified|0
5036550|NCT02769065|17350096|P24|Overall Study|Reason Not Specified|0
5036551|NCT02769065|17350097|P23|Overall Study|Reason Not Specified|0
5036552|NCT02769065|17350098|P22|Overall Study|Reason Not Specified|0
5036553|NCT02769065|17350099|P21|Overall Study|Reason Not Specified|0
5036554|NCT02769065|17350100|P20|Overall Study|Reason Not Specified|0
5036555|NCT02769065|17350101|P19|Overall Study|Reason Not Specified|0
5036556|NCT02769065|17350102|P18|Overall Study|Reason Not Specified|0
5036557|NCT02769065|17350103|P17|Overall Study|Reason Not Specified|0
5036558|NCT02769065|17350104|P16|Overall Study|Reason Not Specified|0
5036559|NCT02769065|17350105|P15|Overall Study|Reason Not Specified|0
5036560|NCT02769065|17350106|P14|Overall Study|Reason Not Specified|0
5036561|NCT02769065|17350107|P13|Overall Study|Reason Not Specified|0
5036562|NCT02769065|17350108|P12|Overall Study|Reason Not Specified|0
5036563|NCT02769065|17350109|P11|Overall Study|Reason Not Specified|0
5036564|NCT02769065|17350110|P10|Overall Study|Reason Not Specified|0
5036565|NCT02769065|17350111|P9|Overall Study|Reason Not Specified|0
5036566|NCT02769065|17350112|P8|Overall Study|Reason Not Specified|0
5036567|NCT02769065|17350113|P7|Overall Study|Reason Not Specified|1
5036568|NCT02769065|17350114|P6|Overall Study|Reason Not Specified|0
5036569|NCT02769065|17350115|P5|Overall Study|Reason Not Specified|0
5036570|NCT02769065|17350116|P4|Overall Study|Reason Not Specified|0
5036571|NCT02769065|17350117|P3|Overall Study|Reason Not Specified|0
5036572|NCT02769065|17350118|P2|Overall Study|Reason Not Specified|0
5036573|NCT02769065|17350119|P1|Overall Study|Reason Not Specified|0
5036574|NCT02769065|17350090|P30|Overall Study|Voluntary Withdrawal|0
5036575|NCT02769065|17350091|P29|Overall Study|Voluntary Withdrawal|0
5036576|NCT02769065|17350092|P28|Overall Study|Voluntary Withdrawal|0
5036577|NCT02769065|17350093|P27|Overall Study|Voluntary Withdrawal|0
5036578|NCT02769065|17350094|P26|Overall Study|Voluntary Withdrawal|0
5036579|NCT02769065|17350095|P25|Overall Study|Voluntary Withdrawal|0
5036580|NCT02769065|17350096|P24|Overall Study|Voluntary Withdrawal|0
5036581|NCT02769065|17350097|P23|Overall Study|Voluntary Withdrawal|0
5036582|NCT02769065|17350098|P22|Overall Study|Voluntary Withdrawal|0
5036583|NCT02769065|17350099|P21|Overall Study|Voluntary Withdrawal|0
5036584|NCT02769065|17350100|P20|Overall Study|Voluntary Withdrawal|0
5036585|NCT02769065|17350101|P19|Overall Study|Voluntary Withdrawal|0
5036586|NCT02769065|17350102|P18|Overall Study|Voluntary Withdrawal|0
5036587|NCT02769065|17350103|P17|Overall Study|Voluntary Withdrawal|0
5036588|NCT02769065|17350104|P16|Overall Study|Voluntary Withdrawal|0
5036589|NCT02769065|17350105|P15|Overall Study|Voluntary Withdrawal|0
5036590|NCT02769065|17350106|P14|Overall Study|Voluntary Withdrawal|0
5036591|NCT02769065|17350107|P13|Overall Study|Voluntary Withdrawal|0
5036592|NCT02769065|17350108|P12|Overall Study|Voluntary Withdrawal|0
5036593|NCT02769065|17350109|P11|Overall Study|Voluntary Withdrawal|0
5036594|NCT02769065|17350110|P10|Overall Study|Voluntary Withdrawal|0
5036595|NCT02769065|17350111|P9|Overall Study|Voluntary Withdrawal|0
5036596|NCT02769065|17350112|P8|Overall Study|Voluntary Withdrawal|0
5036597|NCT02769065|17350113|P7|Overall Study|Voluntary Withdrawal|0
5036598|NCT02769065|17350114|P6|Overall Study|Voluntary Withdrawal|0
5036599|NCT02769065|17350115|P5|Overall Study|Voluntary Withdrawal|0
5036600|NCT02769065|17350116|P4|Overall Study|Voluntary Withdrawal|0
5036601|NCT02769065|17350117|P3|Overall Study|Voluntary Withdrawal|0
5036602|NCT02769065|17350118|P2|Overall Study|Voluntary Withdrawal|0
5036603|NCT02769065|17350119|P1|Overall Study|Voluntary Withdrawal|1
5036604|NCT02768870|17350529|P1|Overall Study|On Study|19
5036605|NCT02768870|17350529|P1|Overall Study|Reoperation|4
5036606|NCT02768870|17350529|P1|Overall Study|Death|1
5036607|NCT02768870|17350529|P1|Overall Study|Not Implanted with Device|2
5036608|NCT02768298|17350573|P2|Overall Study|Withdrawal of informed consent|1
5036609|NCT02768298|17350574|P1|Overall Study|Withdrawal of informed consent|0
5036610|NCT02768298|17350573|P2|Overall Study|Subject/guardian decision|0
5036611|NCT02768298|17350574|P1|Overall Study|Subject/guardian decision|1
5036612|NCT02768298|17350573|P2|Overall Study|Non-compliance with study treatment|1
5036613|NCT02768298|17350574|P1|Overall Study|Non-compliance with study treatment|0
5036614|NCT02768298|17350573|P2|Overall Study|Death|1
5036615|NCT02768298|17350574|P1|Overall Study|Death|2
5036616|NCT02768298|17350573|P2|Overall Study|Adverse Event|4
5036617|NCT02768298|17350574|P1|Overall Study|Adverse Event|1
5036618|NCT02768194|17350588|P6|Period 3|Other (Reason not specified)|0
5036619|NCT02768194|17350589|P5|Period 3|Other (Reason not specified)|0
5036620|NCT02768194|17350590|P4|Period 3|Other (Reason not specified)|0
5036621|NCT02768194|17350591|P3|Period 3|Other (Reason not specified)|0
5036622|NCT02768194|17350592|P2|Period 3|Other (Reason not specified)|1
5036623|NCT02768194|17350593|P1|Period 3|Other (Reason not specified)|0
5036624|NCT02768194|17350588|P6|Period 2|Other (Reason not specified)|0
5036625|NCT02768194|17350589|P5|Period 2|Other (Reason not specified)|0
5036626|NCT02768194|17350590|P4|Period 2|Other (Reason not specified)|0
5036627|NCT02768194|17350591|P3|Period 2|Other (Reason not specified)|0
5036628|NCT02768194|17350592|P2|Period 2|Other (Reason not specified)|0
5036629|NCT02768194|17350593|P1|Period 2|Other (Reason not specified)|1
5036630|NCT02768194|17350588|P6|Period 1|Adverse Event|0
5036631|NCT02768194|17350589|P5|Period 1|Adverse Event|0
5036632|NCT02768194|17350590|P4|Period 1|Adverse Event|1
5036633|NCT02768194|17350591|P3|Period 1|Adverse Event|0
5036634|NCT02768194|17350592|P2|Period 1|Adverse Event|0
5036635|NCT02768194|17350593|P1|Period 1|Adverse Event|0
5036636|NCT02768103|17350615|P1|Overall Study|1 participant did not fit in the fMRI|1
5036637|NCT02767765|17350676|P1|Overall Study|Withdrawal by Subject|1
5036638|NCT02767765|17350676|P1|Overall Study|Non-Compliance|1
5036639|NCT02767765|17350676|P1|Overall Study|Investigator decision|1
5036640|NCT02767765|17350676|P1|Overall Study|Lost to Follow-up|2
5036641|NCT02767765|17350676|P1|Overall Study|Insufficient response|1
5036642|NCT02767765|17350676|P1|Overall Study|Death|1
5036643|NCT02767765|17350676|P1|Overall Study|Adverse Event|4
5036644|NCT02766777|17350802|P1|Overall Study|Withdrawal by Subject|4
5036645|NCT02766777|17350802|P1|Overall Study|Protocol Violation|1
5036646|NCT02766777|17350802|P1|Overall Study|Non-Compliance With Study Drug|1
5036647|NCT02766777|17350802|P1|Overall Study|Lost to Follow-up|16
5036648|NCT02766777|17350802|P1|Overall Study|Adverse Event|12
5036649|NCT02766608|17350827|P5|Overall Study|Administrative Reasons|0
5036650|NCT02766608|17350828|P4|Overall Study|Administrative Reasons|0
5036651|NCT02766608|17350829|P3|Overall Study|Administrative Reasons|1
5036652|NCT02766608|17350830|P2|Overall Study|Administrative Reasons|1
5036653|NCT02766608|17350831|P1|Overall Study|Administrative Reasons|3
5036654|NCT02766608|17350827|P5|Overall Study|Protocol Violation|1
5036655|NCT02766608|17350828|P4|Overall Study|Protocol Violation|0
5036656|NCT02766608|17350829|P3|Overall Study|Protocol Violation|4
5036657|NCT02766608|17350830|P2|Overall Study|Protocol Violation|4
5036658|NCT02766608|17350831|P1|Overall Study|Protocol Violation|0
5036659|NCT02766608|17350827|P5|Overall Study|Protocol disc criteria|0
5036660|NCT02766608|17350828|P4|Overall Study|Protocol disc criteria|0
5036661|NCT02766608|17350829|P3|Overall Study|Protocol disc criteria|4
5036662|NCT02766608|17350830|P2|Overall Study|Protocol disc criteria|3
5036663|NCT02766608|17350831|P1|Overall Study|Protocol disc criteria|3
5036664|NCT02766608|17350827|P5|Overall Study|Physician Decision|2
5036665|NCT02766608|17350828|P4|Overall Study|Physician Decision|1
5036666|NCT02766608|17350829|P3|Overall Study|Physician Decision|3
5036667|NCT02766608|17350830|P2|Overall Study|Physician Decision|2
5036668|NCT02766608|17350831|P1|Overall Study|Physician Decision|3
5036669|NCT02766608|17350827|P5|Overall Study|Lost to Follow-up|2
5036670|NCT02766608|17350828|P4|Overall Study|Lost to Follow-up|2
5036671|NCT02766608|17350829|P3|Overall Study|Lost to Follow-up|5
5036672|NCT02766608|17350830|P2|Overall Study|Lost to Follow-up|3
5036673|NCT02766608|17350831|P1|Overall Study|Lost to Follow-up|6
5036674|NCT02766608|17350827|P5|Overall Study|Lack of Efficacy|2
5036675|NCT02766608|17350828|P4|Overall Study|Lack of Efficacy|8
5036676|NCT02766608|17350829|P3|Overall Study|Lack of Efficacy|32
5036677|NCT02766608|17350830|P2|Overall Study|Lack of Efficacy|15
5036678|NCT02766608|17350831|P1|Overall Study|Lack of Efficacy|16
5036679|NCT02766608|17350827|P5|Overall Study|Withdrawal by Subject|10
5036680|NCT02766608|17350828|P4|Overall Study|Withdrawal by Subject|13
5036681|NCT02766608|17350829|P3|Overall Study|Withdrawal by Subject|24
5036682|NCT02766608|17350830|P2|Overall Study|Withdrawal by Subject|20
5036683|NCT02766608|17350831|P1|Overall Study|Withdrawal by Subject|21
5036684|NCT02766608|17350827|P5|Overall Study|Adverse Event|12
5036685|NCT02766608|17350828|P4|Overall Study|Adverse Event|13
5036686|NCT02766608|17350829|P3|Overall Study|Adverse Event|17
5036687|NCT02766608|17350830|P2|Overall Study|Adverse Event|22
5036688|NCT02766608|17350831|P1|Overall Study|Adverse Event|27
5036689|NCT02766400|17350923|P2|Overall Study|Withdrawal by Subject|0
5036690|NCT02766400|17350924|P1|Overall Study|Withdrawal by Subject|1
5036691|NCT02766400|17350923|P2|Overall Study|Death|2
5036692|NCT02766400|17350924|P1|Overall Study|Death|1
5036693|NCT02766283|17350939|P1|Overall Study|Lost to Follow-up|27
5036694|NCT02766088|17350972|P1|Overall Study|Death|1
5036695|NCT02766088|17350972|P1|Overall Study|Other|1
5036696|NCT02766088|17350972|P1|Overall Study|Lost to Follow-up|5
5036697|NCT02766088|17350972|P1|Overall Study|Migrated/moved from the study area|1
5036698|NCT02766088|17350972|P1|Overall Study|Sponsor study termination|498
5036699|NCT02766023|17350987|P2|Overall Study|Not Eligible at Enrollment|1
5036700|NCT02766023|17350988|P1|Overall Study|Not Eligible at Enrollment|0
5036701|NCT02766023|17350987|P2|Overall Study|Physician Decision|0
5036702|NCT02766023|17350988|P1|Overall Study|Physician Decision|1
5036703|NCT02766023|17350987|P2|Overall Study|Withdrawal by Subject|5
5036704|NCT02766023|17350988|P1|Overall Study|Withdrawal by Subject|4
5036705|NCT02766023|17350987|P2|Overall Study|Adverse Event|0
5036706|NCT02766023|17350988|P1|Overall Study|Adverse Event|1
5036707|NCT02766023|17350987|P2|Overall Study|Pregnancy|0
5036708|NCT02766023|17350988|P1|Overall Study|Pregnancy|1
5036709|NCT02766023|17350987|P2|Overall Study|Lost to Follow-up|11
5036710|NCT02766023|17350988|P1|Overall Study|Lost to Follow-up|23
5036711|NCT02765490|17351038|P2|Overall Study|Death|1
5036712|NCT02765490|17351039|P1|Overall Study|Death|0
5036713|NCT02765490|17351038|P2|Overall Study|Other|1
5036714|NCT02765490|17351039|P1|Overall Study|Other|0
5036715|NCT02765490|17351038|P2|Overall Study|Lost to Follow-up|1
5036716|NCT02765490|17351039|P1|Overall Study|Lost to Follow-up|1
5036717|NCT02765100|17351072|P2|Overall Study|Lost to Follow-up|1
5036718|NCT02765100|17351073|P1|Overall Study|Lost to Follow-up|0
5036719|NCT02765100|17351072|P2|Overall Study|subject found ineligible after baseline|1
5036720|NCT02765100|17351073|P1|Overall Study|subject found ineligible after baseline|1
5036721|NCT02764775|17351094|P1|Overall Study|Withdrawal by Subject|3
5036722|NCT02764775|17351094|P1|Overall Study|Lost to Follow-up|2
5036723|NCT02764775|17351094|P1|Overall Study|Death|1
5036724|NCT02764697|17351098|P1|Overall Study|Lack of Efficacy|3
5036725|NCT02764229|17351103|P1|Overall Study|Study Stopped by Sponsor|69
5036726|NCT02764229|17351103|P1|Overall Study|Lack of Efficacy|1
5036727|NCT02764229|17351103|P1|Overall Study|Lost to Follow-up|3
5036728|NCT02764229|17351103|P1|Overall Study|Physician Decision|5
5036729|NCT02764229|17351103|P1|Overall Study|Adverse Event|9
5036730|NCT02764229|17351103|P1|Overall Study|Withdrawal by Subject|15
5036731|NCT02764190|17351109|P2|Overall Study|Lost to Follow-up|13
5036732|NCT02764190|17351110|P1|Overall Study|Lost to Follow-up|17
5036733|NCT02764151|17351164|P4|Overall Study|Other|2
5036734|NCT02764151|17351165|P3|Overall Study|Other|0
5036735|NCT02764151|17351166|P2|Overall Study|Other|0
5036736|NCT02764151|17351167|P1|Overall Study|Other|0
5036737|NCT02764151|17351164|P4|Overall Study|Subject refused further follow-up|1
5036738|NCT02764151|17351165|P3|Overall Study|Subject refused further follow-up|0
5036739|NCT02764151|17351166|P2|Overall Study|Subject refused further follow-up|0
5036740|NCT02764151|17351167|P1|Overall Study|Subject refused further follow-up|0
5036741|NCT02763644|17351306|P2|Overall Study|Adverse Event|1
5036742|NCT02763644|17351307|P1|Overall Study|Adverse Event|1
5036743|NCT02763644|17351306|P2|Overall Study|Death|1
5036744|NCT02763644|17351307|P1|Overall Study|Death|1
5036745|NCT02763644|17351306|P2|Overall Study|Patient/guardian decision|0
5036746|NCT02763644|17351307|P1|Overall Study|Patient/guardian decision|1
5036747|NCT02763579|17351327|P2|Overall Study|On-going in study|60
5036748|NCT02763579|17351328|P1|Overall Study|On-going in study|77
5036749|NCT02763579|17351327|P2|Overall Study|Physician Decision|0
5036750|NCT02763579|17351328|P1|Overall Study|Physician Decision|2
5036751|NCT02763579|17351327|P2|Overall Study|Withdrawal by Subject|9
5036752|NCT02763579|17351328|P1|Overall Study|Withdrawal by Subject|18
5036753|NCT02763579|17351327|P2|Overall Study|Lost to Follow-up|1
5036754|NCT02763579|17351328|P1|Overall Study|Lost to Follow-up|3
5036755|NCT02763579|17351327|P2|Overall Study|Death|132
5036756|NCT02763579|17351328|P1|Overall Study|Death|101
5036757|NCT02763566|17351340|P4|Overall Study|Withdrawal by Subject|0
5036758|NCT02763566|17351341|P3|Overall Study|Withdrawal by Subject|0
5036759|NCT02763566|17351342|P2|Overall Study|Withdrawal by Subject|1
5036760|NCT02763566|17351343|P1|Overall Study|Withdrawal by Subject|3
5036761|NCT02763566|17351340|P4|Overall Study|On study treatment at study conclusion|13
5036762|NCT02763566|17351341|P3|Overall Study|On study treatment at study conclusion|54
5036763|NCT02763566|17351342|P2|Overall Study|On study treatment at study conclusion|34
5036764|NCT02763566|17351343|P1|Overall Study|On study treatment at study conclusion|114
5036765|NCT02763566|17351340|P4|Overall Study|Lost to Follow-up|1
5036766|NCT02763566|17351341|P3|Overall Study|Lost to Follow-up|0
5036767|NCT02763566|17351342|P2|Overall Study|Lost to Follow-up|4
5036768|NCT02763566|17351343|P1|Overall Study|Lost to Follow-up|1
5036769|NCT02763254|17351371|P1|Overall Study|Adverse Event|1
5036770|NCT02763215|17351376|P1|Overall Study|Lost to Follow-up|1
5036771|NCT02763215|17351376|P1|Overall Study|Death|1
5036772|NCT02763215|17351376|P1|Overall Study|Visit outside visit-window|1
5036773|NCT02763215|17351376|P1|Overall Study|Missed visit|1
5036774|NCT02763215|17351376|P1|Overall Study|Participants withdrew from study|3
5036775|NCT02763189|17351399|P2|Overall Study|Device failure|2
5036776|NCT02763189|17351400|P1|Overall Study|Device failure|0
5036777|NCT02763046|17351418|P3|Overall Study|Subject/guardian decision|4
5036778|NCT02763046|17351419|P2|Overall Study|Subject/guardian decision|0
5036779|NCT02763046|17351420|P1|Overall Study|Subject/guardian decision|2
5036780|NCT02763046|17351418|P3|Overall Study|Physician Decision|1
5036781|NCT02763046|17351419|P2|Overall Study|Physician Decision|0
5036782|NCT02763046|17351420|P1|Overall Study|Physician Decision|1
5036783|NCT02763046|17351418|P3|Overall Study|Lack of Efficacy|3
5036784|NCT02763046|17351419|P2|Overall Study|Lack of Efficacy|1
5036785|NCT02763046|17351420|P1|Overall Study|Lack of Efficacy|1
5036786|NCT02763046|17351418|P3|Overall Study|Adverse Event|0
5036787|NCT02763046|17351419|P2|Overall Study|Adverse Event|4
5036788|NCT02763046|17351420|P1|Overall Study|Adverse Event|5
5036789|NCT02762578|17351536|P2|Overall Study|Unclassified|0
5036790|NCT02762578|17351537|P1|Overall Study|Unclassified|6
5036791|NCT02762578|17351536|P2|Overall Study|Withdrawal by Subject|2
5036792|NCT02762578|17351537|P1|Overall Study|Withdrawal by Subject|4
5036793|NCT02762578|17351536|P2|Overall Study|Protocol Violation|2
5036794|NCT02762578|17351537|P1|Overall Study|Protocol Violation|4
5036795|NCT02762578|17351536|P2|Overall Study|Adverse Event|6
5036796|NCT02762578|17351537|P1|Overall Study|Adverse Event|1
5036797|NCT02762500|17351639|P2|Overall Study|Adverse Event|2
5036798|NCT02762500|17351640|P1|Overall Study|Adverse Event|0
5036799|NCT02762500|17351639|P2|Overall Study|Withdrawal by Subject|1
5036800|NCT02762500|17351640|P1|Overall Study|Withdrawal by Subject|1
5036801|NCT02762500|17351639|P2|Overall Study|Lack of Efficacy|0
5036802|NCT02762500|17351640|P1|Overall Study|Lack of Efficacy|1
5036803|NCT02762370|17351660|P2|Overall Study|Protocol Violation|0
5036804|NCT02762370|17351661|P1|Overall Study|Protocol Violation|1
5036805|NCT02762084|17351701|P3|Overall Study|Adverse Event|1
5036806|NCT02762084|17351702|P2|Overall Study|Adverse Event|0
5036807|NCT02762084|17351703|P1|Overall Study|Adverse Event|0
5036808|NCT02762084|17351701|P3|Overall Study|Withdrawal by Subject|0
5036809|NCT02762084|17351702|P2|Overall Study|Withdrawal by Subject|0
5036810|NCT02762084|17351703|P1|Overall Study|Withdrawal by Subject|1
5036811|NCT02761980|17351764|P4|Overall Study|Other|0
5036812|NCT02761980|17351765|P3|Overall Study|Other|1
5036813|NCT02761980|17351766|P2|Overall Study|Other|0
5036814|NCT02761980|17351767|P1|Overall Study|Other|0
5036815|NCT02761980|17351764|P4|Overall Study|Withdrawal by Subject|0
5036816|NCT02761980|17351765|P3|Overall Study|Withdrawal by Subject|0
5036817|NCT02761980|17351766|P2|Overall Study|Withdrawal by Subject|1
5036818|NCT02761980|17351767|P1|Overall Study|Withdrawal by Subject|0
5036819|NCT02761980|17351764|P4|Overall Study|Adverse Event|6
5036820|NCT02761980|17351765|P3|Overall Study|Adverse Event|5
5036821|NCT02761980|17351766|P2|Overall Study|Adverse Event|6
5036822|NCT02761980|17351767|P1|Overall Study|Adverse Event|4
5036823|NCT02761733|17351814|P4|Overall Study|Cognitive Impairment|0
5036824|NCT02761733|17351815|P3|Overall Study|Cognitive Impairment|1
5036825|NCT02761733|17351816|P2|Overall Study|Cognitive Impairment|0
5036826|NCT02761733|17351817|P1|Overall Study|Cognitive Impairment|5
5036827|NCT02761733|17351814|P4|Overall Study|Discharged from Study Site|11
5036828|NCT02761733|17351815|P3|Overall Study|Discharged from Study Site|25
5036829|NCT02761733|17351816|P2|Overall Study|Discharged from Study Site|9
5036830|NCT02761733|17351817|P1|Overall Study|Discharged from Study Site|10
5036831|NCT02761733|17351814|P4|Overall Study|Withdrawal by Subject|0
5036832|NCT02761733|17351815|P3|Overall Study|Withdrawal by Subject|0
5036833|NCT02761733|17351816|P2|Overall Study|Withdrawal by Subject|0
5036834|NCT02761733|17351817|P1|Overall Study|Withdrawal by Subject|2
5036835|NCT02761733|17351814|P4|Overall Study|Physician Decision|0
5036836|NCT02761733|17351815|P3|Overall Study|Physician Decision|0
5036837|NCT02761733|17351816|P2|Overall Study|Physician Decision|0
5036838|NCT02761733|17351817|P1|Overall Study|Physician Decision|4
5036839|NCT02761733|17351814|P4|Overall Study|Lost to Follow-up|3
5036840|NCT02761733|17351815|P3|Overall Study|Lost to Follow-up|0
5036841|NCT02761733|17351816|P2|Overall Study|Lost to Follow-up|7
5036842|NCT02761733|17351817|P1|Overall Study|Lost to Follow-up|6
5036843|NCT02761733|17351814|P4|Overall Study|Death|1
5036844|NCT02761733|17351815|P3|Overall Study|Death|1
5036845|NCT02761733|17351816|P2|Overall Study|Death|5
5036846|NCT02761733|17351817|P1|Overall Study|Death|3
5036847|NCT02761642|17351847|P1|Overall Study|Reason Unspecified|21
5036848|NCT02761642|17351847|P1|Overall Study|Physician Decision|1
5036849|NCT02761642|17351847|P1|Overall Study|Lack of Efficacy|20
5036850|NCT02761642|17351847|P1|Overall Study|Death|3
5036851|NCT02761642|17351847|P1|Overall Study|Non-compliant|7
5036852|NCT02761642|17351847|P1|Overall Study|Withdrawal by Subject|2
5036853|NCT02761642|17351847|P1|Overall Study|Adverse Event|13
5036854|NCT02761642|17351847|P1|Overall Study|Did not Receive Study Treatment|3
5036855|NCT02761629|17351860|P2|Overall Study|Randomized But Not Treated|4
5036856|NCT02761629|17351861|P1|Overall Study|Randomized But Not Treated|8
5036857|NCT02761629|17351860|P2|Overall Study|Lost to Follow-up|1
5036858|NCT02761629|17351861|P1|Overall Study|Lost to Follow-up|4
5036859|NCT02761629|17351860|P2|Overall Study|Other|2
5036860|NCT02761629|17351861|P1|Overall Study|Other|0
5036861|NCT02761629|17351860|P2|Overall Study|Withdrawal by Subject|3
5036862|NCT02761629|17351861|P1|Overall Study|Withdrawal by Subject|0
5036863|NCT02761629|17351860|P2|Overall Study|Protocol Violation|2
5036864|NCT02761629|17351861|P1|Overall Study|Protocol Violation|2
5036865|NCT02761629|17351860|P2|Overall Study|Did not Cooperate/Refused Treatment|4
5036866|NCT02761629|17351861|P1|Overall Study|Did not Cooperate/Refused Treatment|2
5036867|NCT02761629|17351860|P2|Overall Study|Failure to Return|4
5036868|NCT02761629|17351861|P1|Overall Study|Failure to Return|2
5036869|NCT02761629|17351860|P2|Overall Study|Insufficient Therapeutic Response|7
5036870|NCT02761629|17351861|P1|Overall Study|Insufficient Therapeutic Response|2
5036871|NCT02761629|17351860|P2|Overall Study|Adverse Event/Intercurrent Illness|5
5036872|NCT02761629|17351861|P1|Overall Study|Adverse Event/Intercurrent Illness|7
5036873|NCT02760927|17351908|P1|Overall Study|Tube Slippage from Device|1
5036874|NCT02760810|17351925|P1|Overall Study|Protocol Violation|1
5036875|NCT02760654|17351933|P2|Overall Study|Withdrawal by Subject|3
5036876|NCT02760654|17351934|P1|Overall Study|Withdrawal by Subject|4
5036877|NCT02760654|17351933|P2|Overall Study|Lost to Follow-up|3
5036878|NCT02760654|17351934|P1|Overall Study|Lost to Follow-up|3
5036879|NCT02760602|17351960|P2|Overall Study|Terminated by sponsor|13
5036880|NCT02760602|17351961|P1|Overall Study|Terminated by sponsor|12
5036881|NCT02760602|17351960|P2|Overall Study|Withdrawal by Subject|0
5036882|NCT02760602|17351961|P1|Overall Study|Withdrawal by Subject|1
5036883|NCT02760368|17352002|P3|Overall Study|Withdrawal by Sponsor|1
5036884|NCT02760368|17352003|P2|Overall Study|Withdrawal by Sponsor|0
5036885|NCT02760368|17352004|P1|Overall Study|Withdrawal by Sponsor|0
5036886|NCT02760368|17352002|P3|Overall Study|Death|0
5036887|NCT02760368|17352003|P2|Overall Study|Death|0
5036888|NCT02760368|17352004|P1|Overall Study|Death|1
5036889|NCT02760368|17352002|P3|Overall Study|Screen Failure|1
5036890|NCT02760368|17352003|P2|Overall Study|Screen Failure|0
5036891|NCT02760368|17352004|P1|Overall Study|Screen Failure|0
5036892|NCT02760368|17352002|P3|Overall Study|Withdrawal by Subject|9
5036893|NCT02760368|17352003|P2|Overall Study|Withdrawal by Subject|8
5036894|NCT02760368|17352004|P1|Overall Study|Withdrawal by Subject|12
5036895|NCT02760069|17352186|P3|Overall Study|Withdrawal by Subject|1
5036896|NCT02760069|17352187|P2|Overall Study|Withdrawal by Subject|1
5036897|NCT02760069|17352188|P1|Overall Study|Withdrawal by Subject|0
5036898|NCT02759939|17352214|P4|Overall Study|Lost to Follow-up|650
5036899|NCT02759939|17352215|P3|Overall Study|Lost to Follow-up|783
5036900|NCT02759939|17352216|P2|Overall Study|Lost to Follow-up|791
5036901|NCT02759939|17352217|P1|Overall Study|Lost to Follow-up|735
5036902|NCT02759939|17352214|P4|Overall Study|Ineligible for T2 and T3|391
5036903|NCT02759939|17352215|P3|Overall Study|Ineligible for T2 and T3|366
5036904|NCT02759939|17352216|P2|Overall Study|Ineligible for T2 and T3|179
5036905|NCT02759939|17352217|P1|Overall Study|Ineligible for T2 and T3|310
5036906|NCT02759939|17352214|P4|Overall Study|Missing data on first outcome assessed|2
5036907|NCT02759939|17352215|P3|Overall Study|Missing data on first outcome assessed|5
5036908|NCT02759939|17352216|P2|Overall Study|Missing data on first outcome assessed|2
5036909|NCT02759939|17352217|P1|Overall Study|Missing data on first outcome assessed|11
5036910|NCT02759692|17352227|P2|Period 2|Test article no longer available|1
5036911|NCT02759692|17352228|P1|Period 2|Test article no longer available|0
5036912|NCT02759692|17352227|P2|Period 2|Lost to Follow-up|0
5036913|NCT02759692|17352228|P1|Period 2|Lost to Follow-up|1
5036914|NCT02759692|17352227|P2|Period 1|Miss-Randomized|1
5036915|NCT02759692|17352228|P1|Period 1|Miss-Randomized|1
5036916|NCT02759692|17352227|P2|Period 1|No longer meets eligibility criteria.|0
5036917|NCT02759692|17352228|P1|Period 1|No longer meets eligibility criteria.|1
5036918|NCT02759692|17352227|P2|Period 1|Test article no longer available|1
5036919|NCT02759692|17352228|P1|Period 1|Test article no longer available|1
5036920|NCT02759562|17352246|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
5036921|NCT02759562|17352247|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
5036922|NCT02759562|17352246|P2|Open-Label Treatment Period|Withdrew Consent|0
5036923|NCT02759562|17352247|P1|Open-Label Treatment Period|Withdrew Consent|1
5036924|NCT02759471|17352260|P1|Overall Study|discomfort|2
5036925|NCT02759315|17352316|P5|Overall Study|Study terminated prior to completion|1
5036926|NCT02759315|17352317|P4|Overall Study|Study terminated prior to completion|0
5036927|NCT02759315|17352318|P3|Overall Study|Study terminated prior to completion|5
5036928|NCT02759315|17352319|P2|Overall Study|Study terminated prior to completion|0
5036929|NCT02759315|17352320|P1|Overall Study|Study terminated prior to completion|2
5036930|NCT02759315|17352316|P5|Overall Study|Protocol Violation|0
5036931|NCT02759315|17352317|P4|Overall Study|Protocol Violation|0
5036932|NCT02759315|17352318|P3|Overall Study|Protocol Violation|0
5036933|NCT02759315|17352319|P2|Overall Study|Protocol Violation|1
5036934|NCT02759315|17352320|P1|Overall Study|Protocol Violation|0
5036935|NCT02759315|17352316|P5|Overall Study|Lost to Follow-up|0
5036936|NCT02759315|17352317|P4|Overall Study|Lost to Follow-up|0
5036937|NCT02759315|17352318|P3|Overall Study|Lost to Follow-up|4
5036938|NCT02759315|17352319|P2|Overall Study|Lost to Follow-up|0
5036939|NCT02759315|17352320|P1|Overall Study|Lost to Follow-up|2
5036940|NCT02759315|17352316|P5|Overall Study|Death|0
5036941|NCT02759315|17352317|P4|Overall Study|Death|0
5036942|NCT02759315|17352318|P3|Overall Study|Death|1
5036943|NCT02759315|17352319|P2|Overall Study|Death|0
5036944|NCT02759315|17352320|P1|Overall Study|Death|0
5036945|NCT02759315|17352316|P5|Overall Study|Adverse Event|0
5036946|NCT02759315|17352317|P4|Overall Study|Adverse Event|1
5036947|NCT02759315|17352318|P3|Overall Study|Adverse Event|0
5036948|NCT02759315|17352319|P2|Overall Study|Adverse Event|0
5036949|NCT02759315|17352320|P1|Overall Study|Adverse Event|0
5036950|NCT02759016|17352366|P2|Overall Study|Other not defined above|1
5036951|NCT02759016|17352367|P1|Overall Study|Other not defined above|2
5036952|NCT02759016|17352366|P2|Overall Study|SD, PR-MRDpos or PR-L|2
5036953|NCT02759016|17352367|P1|Overall Study|SD, PR-MRDpos or PR-L|0
5036954|NCT02759016|17352366|P2|Overall Study|Progressive disease|0
5036955|NCT02759016|17352367|P1|Overall Study|Progressive disease|1
5036956|NCT02759016|17352366|P2|Overall Study|Not treated with BI 836826|0
5036957|NCT02759016|17352367|P1|Overall Study|Not treated with BI 836826|1
5036958|NCT02758613|17352396|P4|Treatment|Withdrawal by Subject|0
5036959|NCT02758613|17352397|P3|Treatment|Withdrawal by Subject|1
5036960|NCT02758613|17352398|P2|Treatment|Withdrawal by Subject|0
5036961|NCT02758613|17352399|P1|Treatment|Withdrawal by Subject|1
5036962|NCT02758613|17352396|P4|Treatment|Physician and Sponsor Decision|0
5036963|NCT02758613|17352397|P3|Treatment|Physician and Sponsor Decision|0
5036964|NCT02758613|17352398|P2|Treatment|Physician and Sponsor Decision|0
5036965|NCT02758613|17352399|P1|Treatment|Physician and Sponsor Decision|1
5036966|NCT02758301|17352417|P2|Overall Study|Protocol Violation|1
5036967|NCT02758301|17352418|P1|Overall Study|Protocol Violation|0
5036968|NCT02758301|17352417|P2|Overall Study|Lost to Follow-up|0
5036969|NCT02758301|17352418|P1|Overall Study|Lost to Follow-up|7
5036970|NCT02758301|17352417|P2|Overall Study|Withdrawal by Subject|6
5036971|NCT02758301|17352418|P1|Overall Study|Withdrawal by Subject|5
5036972|NCT02758301|17352417|P2|Overall Study|Physician Decision|1
5036973|NCT02758301|17352418|P1|Overall Study|Physician Decision|10
5036974|NCT02758301|17352417|P2|Overall Study|Death|0
5036975|NCT02758301|17352418|P1|Overall Study|Death|12
5036976|NCT02758171|17352437|P2|Wash-out|Other reason|0
5036977|NCT02758171|17352438|P1|Wash-out|Other reason|1
5036978|NCT02758171|17352437|P2|Wash-out|Withdrawal by Subject|0
5036979|NCT02758171|17352438|P1|Wash-out|Withdrawal by Subject|1
5036980|NCT02757963|17352492|P1|Overall Study|Withdrawal by Subject|34
5036981|NCT02757963|17352492|P1|Overall Study|Physician Decision|1
5036982|NCT02757963|17352492|P1|Overall Study|Lost to Follow-up|5
5036983|NCT02757963|17352492|P1|Overall Study|Reached Stopping Criteria|1054
5036984|NCT02757963|17352492|P1|Overall Study|Adverse Event|3
5036985|NCT02757768|17352532|P2|Overall Study|Miscellaneous|2
5036986|NCT02757768|17352533|P1|Overall Study|Miscellaneous|4
5036987|NCT02757768|17352532|P2|Overall Study|Withdrawal by Subject|9
5036988|NCT02757768|17352533|P1|Overall Study|Withdrawal by Subject|16
5036989|NCT02757768|17352532|P2|Overall Study|Protocol Deviation|9
5036990|NCT02757768|17352533|P1|Overall Study|Protocol Deviation|2
5036991|NCT02757768|17352532|P2|Overall Study|Lost to Follow-up|0
5036992|NCT02757768|17352533|P1|Overall Study|Lost to Follow-up|1
5036993|NCT02757768|17352532|P2|Overall Study|Lack of Efficacy|1
5036994|NCT02757768|17352533|P1|Overall Study|Lack of Efficacy|2
5036995|NCT02757768|17352532|P2|Overall Study|Adverse Event|3
5036996|NCT02757768|17352533|P1|Overall Study|Adverse Event|5
5036997|NCT02757768|17352532|P2|Overall Study|Randomized Never Received Study Drug|4
5036998|NCT02757768|17352533|P1|Overall Study|Randomized Never Received Study Drug|3
5036999|NCT02757625|17352583|P4|Overall Study|Adverse Event|0
5037000|NCT02757625|17352584|P3|Overall Study|Adverse Event|1
5037001|NCT02757625|17352585|P2|Overall Study|Adverse Event|0
5037002|NCT02757625|17352586|P1|Overall Study|Adverse Event|0
5037003|NCT02757625|17352583|P4|Overall Study|Investigator's discretion|0
5037004|NCT02757625|17352584|P3|Overall Study|Investigator's discretion|1
5037005|NCT02757625|17352585|P2|Overall Study|Investigator's discretion|0
5037006|NCT02757625|17352586|P1|Overall Study|Investigator's discretion|0
5037007|NCT02757521|17352745|P2|Overall Study|Adverse Event|0
5037008|NCT02757521|17352746|P1|Overall Study|Adverse Event|1
5037009|NCT02757430|17352752|P1|Overall Study|No procedure performed|2
5037010|NCT02757430|17352752|P1|Overall Study|No informed consent|1
5037011|NCT02757430|17352752|P1|Overall Study|Inclusion/Exclusion criteria not met|3
5037012|NCT02757430|17352752|P1|Overall Study|Physician Decision|6
5037013|NCT02757352|17352771|P10|Follow-Up Period|Withdrawal by Subject|2
5037014|NCT02757352|17352772|P9|Follow-Up Period|Withdrawal by Subject|6
5037015|NCT02757352|17352773|P8|Follow-Up Period|Withdrawal by Subject|1
5037016|NCT02757352|17352774|P7|Follow-Up Period|Withdrawal by Subject|0
5037017|NCT02757352|17352775|P6|Follow-Up Period|Withdrawal by Subject|0
5037018|NCT02757352|17352776|P5|Follow-Up Period|Withdrawal by Subject|0
5037019|NCT02757352|17352777|P4|Follow-Up Period|Withdrawal by Subject|0
5037020|NCT02757352|17352778|P3|Follow-Up Period|Withdrawal by Subject|0
5037021|NCT02757352|17352779|P2|Follow-Up Period|Withdrawal by Subject|0
5037022|NCT02757352|17352780|P1|Follow-Up Period|Withdrawal by Subject|0
5037023|NCT02757352|17352771|P10|Follow-Up Period|Lack of Efficacy|1
5037024|NCT02757352|17352772|P9|Follow-Up Period|Lack of Efficacy|1
5037025|NCT02757352|17352773|P8|Follow-Up Period|Lack of Efficacy|0
5037026|NCT02757352|17352774|P7|Follow-Up Period|Lack of Efficacy|0
5037027|NCT02757352|17352775|P6|Follow-Up Period|Lack of Efficacy|0
5037028|NCT02757352|17352776|P5|Follow-Up Period|Lack of Efficacy|0
5037029|NCT02757352|17352777|P4|Follow-Up Period|Lack of Efficacy|0
5037030|NCT02757352|17352778|P3|Follow-Up Period|Lack of Efficacy|0
5037031|NCT02757352|17352779|P2|Follow-Up Period|Lack of Efficacy|0
5037032|NCT02757352|17352780|P1|Follow-Up Period|Lack of Efficacy|0
5037033|NCT02757352|17352771|P10|Follow-Up Period|Lost to Follow-up|0
5037034|NCT02757352|17352772|P9|Follow-Up Period|Lost to Follow-up|1
5037035|NCT02757352|17352773|P8|Follow-Up Period|Lost to Follow-up|0
5037036|NCT02757352|17352774|P7|Follow-Up Period|Lost to Follow-up|0
5037037|NCT02757352|17352775|P6|Follow-Up Period|Lost to Follow-up|0
5037038|NCT02757352|17352776|P5|Follow-Up Period|Lost to Follow-up|0
5037039|NCT02757352|17352777|P4|Follow-Up Period|Lost to Follow-up|0
5037040|NCT02757352|17352778|P3|Follow-Up Period|Lost to Follow-up|0
5037041|NCT02757352|17352779|P2|Follow-Up Period|Lost to Follow-up|0
5037042|NCT02757352|17352780|P1|Follow-Up Period|Lost to Follow-up|0
5037043|NCT02757352|17352771|P10|Follow-Up Period|Adverse Event|0
5037044|NCT02757352|17352772|P9|Follow-Up Period|Adverse Event|2
5037045|NCT02757352|17352773|P8|Follow-Up Period|Adverse Event|0
5037046|NCT02757352|17352774|P7|Follow-Up Period|Adverse Event|1
5037047|NCT02757352|17352775|P6|Follow-Up Period|Adverse Event|0
5037048|NCT02757352|17352776|P5|Follow-Up Period|Adverse Event|0
5037049|NCT02757352|17352777|P4|Follow-Up Period|Adverse Event|0
5037050|NCT02757352|17352778|P3|Follow-Up Period|Adverse Event|0
5037051|NCT02757352|17352779|P2|Follow-Up Period|Adverse Event|0
5037052|NCT02757352|17352780|P1|Follow-Up Period|Adverse Event|0
5037053|NCT02757352|17352771|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037054|NCT02757352|17352772|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037055|NCT02757352|17352773|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037056|NCT02757352|17352774|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037057|NCT02757352|17352775|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
5037058|NCT02757352|17352776|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
5037059|NCT02757352|17352777|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
5037060|NCT02757352|17352778|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037061|NCT02757352|17352779|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037062|NCT02757352|17352780|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037063|NCT02757352|17352771|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037064|NCT02757352|17352772|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037065|NCT02757352|17352773|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037066|NCT02757352|17352774|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037067|NCT02757352|17352775|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
5037068|NCT02757352|17352776|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037069|NCT02757352|17352777|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037070|NCT02757352|17352778|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037071|NCT02757352|17352779|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037072|NCT02757352|17352780|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5037073|NCT02757352|17352771|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037074|NCT02757352|17352772|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037075|NCT02757352|17352773|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037076|NCT02757352|17352774|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037077|NCT02757352|17352775|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037078|NCT02757352|17352776|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
5037079|NCT02757352|17352777|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037080|NCT02757352|17352778|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037081|NCT02757352|17352779|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037082|NCT02757352|17352780|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5037083|NCT02757352|17352771|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037084|NCT02757352|17352772|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037085|NCT02757352|17352773|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037086|NCT02757352|17352774|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037087|NCT02757352|17352775|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
5037088|NCT02757352|17352776|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
5037089|NCT02757352|17352777|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
5037090|NCT02757352|17352778|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037091|NCT02757352|17352779|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037092|NCT02757352|17352780|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5037093|NCT02757352|17352771|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037094|NCT02757352|17352772|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037095|NCT02757352|17352773|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037096|NCT02757352|17352774|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037250|NCT02755649|17353310|P3|Overall Study|Transitioned into OLE study|100
5037097|NCT02757352|17352775|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
5037098|NCT02757352|17352776|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037099|NCT02757352|17352777|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
5037100|NCT02757352|17352778|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037101|NCT02757352|17352779|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037102|NCT02757352|17352780|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5037103|NCT02757352|17352771|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037104|NCT02757352|17352772|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037105|NCT02757352|17352773|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037106|NCT02757352|17352774|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037107|NCT02757352|17352775|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037108|NCT02757352|17352776|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037109|NCT02757352|17352777|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5037110|NCT02757352|17352778|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
5037111|NCT02757352|17352779|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
5037112|NCT02757352|17352780|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
5037113|NCT02757352|17352771|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037114|NCT02757352|17352772|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037115|NCT02757352|17352773|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037116|NCT02757352|17352774|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037117|NCT02757352|17352775|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037118|NCT02757352|17352776|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037119|NCT02757352|17352777|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5037120|NCT02757352|17352778|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
5037121|NCT02757352|17352779|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
5037122|NCT02757352|17352780|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
5037123|NCT02757352|17352771|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037124|NCT02757352|17352772|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037125|NCT02757352|17352773|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037126|NCT02757352|17352774|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037127|NCT02757352|17352775|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037128|NCT02757352|17352776|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037129|NCT02757352|17352777|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037130|NCT02757352|17352778|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037131|NCT02757352|17352779|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
5037132|NCT02757352|17352780|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5037133|NCT02757352|17352771|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037134|NCT02757352|17352772|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037135|NCT02757352|17352773|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037136|NCT02757352|17352774|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037137|NCT02757352|17352775|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037138|NCT02757352|17352776|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037139|NCT02757352|17352777|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037140|NCT02757352|17352778|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037141|NCT02757352|17352779|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
5037142|NCT02757352|17352780|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5037143|NCT02757352|17352771|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037144|NCT02757352|17352772|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037145|NCT02757352|17352773|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037146|NCT02757352|17352774|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037147|NCT02757352|17352775|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037148|NCT02757352|17352776|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037149|NCT02757352|17352777|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5037150|NCT02757352|17352778|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
5037151|NCT02757352|17352779|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
5037152|NCT02757352|17352780|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
5037153|NCT02757352|17352771|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037154|NCT02757352|17352772|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037155|NCT02757352|17352773|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037156|NCT02757352|17352774|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037157|NCT02757352|17352775|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037158|NCT02757352|17352776|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037159|NCT02757352|17352777|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037160|NCT02757352|17352778|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
5037161|NCT02757352|17352779|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037162|NCT02757352|17352780|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5037163|NCT02757352|17352771|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037164|NCT02757352|17352772|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037165|NCT02757352|17352773|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037166|NCT02757352|17352774|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037167|NCT02757352|17352775|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037168|NCT02757352|17352776|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037169|NCT02757352|17352777|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037170|NCT02757352|17352778|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
5037171|NCT02757352|17352779|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5037172|NCT02757352|17352780|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
5037173|NCT02756832|17353003|P1|Overall Study|Protocol Deviation|10
5037174|NCT02756832|17353003|P1|Overall Study|Reason not Specified|9
5037175|NCT02756832|17353003|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
5037176|NCT02756832|17353003|P1|Overall Study|Insufficient Efficacy|2
5037177|NCT02756832|17353003|P1|Overall Study|Patient's Unwillingness|12
5037178|NCT02756832|17353003|P1|Overall Study|Lost for Observation|13
5037179|NCT02756832|17353003|P1|Overall Study|Lost for Observation after Baseline|6
5037180|NCT02756819|17353017|P1|Overall Study|Reason not Specified|9
5037181|NCT02756819|17353017|P1|Overall Study|Adverse Event|2
5037182|NCT02756819|17353017|P1|Overall Study|Insufficient efficacy|2
5037183|NCT02756819|17353017|P1|Overall Study|Patient's unwillingness|16
5037184|NCT02756819|17353017|P1|Overall Study|Lost for observation|23
5037185|NCT02756650|17353116|P1|Overall Study|Adverse Event|1
5037186|NCT02756650|17353116|P1|Overall Study|Physician Decision|1
5037187|NCT02756637|17353139|P2|Overall Study|Did not complete curative therapy|0
5037188|NCT02756637|17353140|P1|Overall Study|Did not complete curative therapy|33
5037189|NCT02756637|17353139|P2|Overall Study|No available NLR value|44
5037190|NCT02756637|17353140|P1|Overall Study|No available NLR value|44
5037191|NCT02756637|17353139|P2|Overall Study|Not eligible for initial SWOG study|10
5037192|NCT02756637|17353140|P1|Overall Study|Not eligible for initial SWOG study|10
5037193|NCT02756611|17353161|P1|Overall Study|Active on Study|205
5037194|NCT02756611|17353161|P1|Overall Study|Missing|2
5037195|NCT02756611|17353161|P1|Overall Study|Other|7
5037196|NCT02756611|17353161|P1|Overall Study|Lost to Follow-up|2
5037197|NCT02756611|17353161|P1|Overall Study|Withdrawal by Subject|1
5037198|NCT02756611|17353161|P1|Overall Study|Death|39
5037199|NCT02756338|17353183|P1|Overall Study|Device Replaced with Pacemaker|4
5037200|NCT02756338|17353183|P1|Overall Study|Withdrawn by Investigator|1
5037201|NCT02756182|17353192|P1|Overall Study|StudyTechnical Difficulties|4
5037202|NCT02756078|17353207|P2|Period 2|Withdrawal by Subject|1
5037203|NCT02756078|17353208|P1|Period 2|Withdrawal by Subject|3
5037204|NCT02756078|17353207|P2|Period 2|Unsatisfactory Lens Fitting|1
5037205|NCT02756078|17353208|P1|Period 2|Unsatisfactory Lens Fitting|0
5037206|NCT02756078|17353207|P2|Period 2|Adverse Event|5
5037207|NCT02756078|17353208|P1|Period 2|Adverse Event|3
5037208|NCT02756078|17353207|P2|Period 1|Lens Discomfort|2
5037209|NCT02756078|17353208|P1|Period 1|Lens Discomfort|2
5037210|NCT02756078|17353207|P2|Period 1|Withdrawal by Subject|6
5037211|NCT02756078|17353208|P1|Period 1|Withdrawal by Subject|6
5037212|NCT02756078|17353207|P2|Period 1|Adverse Event|10
5037213|NCT02756078|17353208|P1|Period 1|Adverse Event|1
5037214|NCT02756078|17353207|P2|Period 1|Protocol Violation|1
5037215|NCT02756078|17353208|P1|Period 1|Protocol Violation|0
5037216|NCT02756078|17353207|P2|Period 1|Lost to Follow-up|2
5037217|NCT02756078|17353208|P1|Period 1|Lost to Follow-up|0
5037218|NCT02756078|17353207|P2|Period 1|Unsatisfactory Lens Fitting|1
5037219|NCT02756078|17353208|P1|Period 1|Unsatisfactory Lens Fitting|0
5037220|NCT02756013|17353226|P1|Overall Study|Hypersensitivity|1
5037221|NCT02756013|17353226|P1|Overall Study|Adverse Event|1
5037222|NCT02755831|17353238|P2|Overall Study|Lost to Follow-up|3
5037223|NCT02755831|17353239|P1|Overall Study|Lost to Follow-up|3
5037224|NCT02755818|17353255|P4|Overall Study|withdrawal by PI|1
5037225|NCT02755818|17353256|P3|Overall Study|withdrawal by PI|1
5037226|NCT02755818|17353257|P2|Overall Study|withdrawal by PI|0
5037227|NCT02755818|17353258|P1|Overall Study|withdrawal by PI|0
5037228|NCT02755818|17353255|P4|Overall Study|Withdrawal by Subject|2
5037229|NCT02755818|17353256|P3|Overall Study|Withdrawal by Subject|0
5037230|NCT02755818|17353257|P2|Overall Study|Withdrawal by Subject|0
5037231|NCT02755818|17353258|P1|Overall Study|Withdrawal by Subject|0
5037232|NCT02755805|17353294|P2|Overall Study|Withdrawal by Subject|2
5037233|NCT02755805|17353295|P1|Overall Study|Withdrawal by Subject|0
5037234|NCT02755805|17353294|P2|Overall Study|Refused assessments|0
5037235|NCT02755805|17353295|P1|Overall Study|Refused assessments|1
5037236|NCT02755805|17353294|P2|Overall Study|Lost to Follow-up|2
5037237|NCT02755805|17353295|P1|Overall Study|Lost to Follow-up|1
5037238|NCT02755649|17353310|P3|Overall Study|Undecided|0
5037239|NCT02755649|17353311|P2|Overall Study|Undecided|0
5037240|NCT02755649|17353312|P1|Overall Study|Undecided|1
5037241|NCT02755649|17353310|P3|Overall Study|Withdrawal by Subject|0
5037242|NCT02755649|17353311|P2|Overall Study|Withdrawal by Subject|1
5037243|NCT02755649|17353312|P1|Overall Study|Withdrawal by Subject|0
5037244|NCT02755649|17353310|P3|Overall Study|Physician Decision|2
5037245|NCT02755649|17353311|P2|Overall Study|Physician Decision|0
5037246|NCT02755649|17353312|P1|Overall Study|Physician Decision|0
5037247|NCT02755649|17353310|P3|Overall Study|Did Not Complete Follow-up Visits|0
5037248|NCT02755649|17353311|P2|Overall Study|Did Not Complete Follow-up Visits|0
5037249|NCT02755649|17353312|P1|Overall Study|Did Not Complete Follow-up Visits|1
5037251|NCT02755649|17353311|P2|Overall Study|Transitioned into OLE study|98
5037252|NCT02755649|17353312|P1|Overall Study|Transitioned into OLE study|99
5037253|NCT02755116|17353387|P2|Overall Study|surgery converted to open, pt admitted|1
5037254|NCT02755116|17353388|P1|Overall Study|surgery converted to open, pt admitted|3
5037255|NCT02755090|17353404|P2|Overall Study|equipment malfunction|0
5037256|NCT02755090|17353405|P1|Overall Study|equipment malfunction|1
5037257|NCT02754492|17353457|P4|Overall Study|Venous access issues not resulting in AE|4
5037258|NCT02754492|17353458|P3|Overall Study|Venous access issues not resulting in AE|0
5037259|NCT02754492|17353459|P2|Overall Study|Venous access issues not resulting in AE|0
5037260|NCT02754492|17353460|P1|Overall Study|Venous access issues not resulting in AE|0
5037261|NCT02754492|17353457|P4|Overall Study|Adverse Event|13
5037262|NCT02754492|17353458|P3|Overall Study|Adverse Event|0
5037263|NCT02754492|17353459|P2|Overall Study|Adverse Event|0
5037264|NCT02754492|17353460|P1|Overall Study|Adverse Event|0
5037265|NCT02754492|17353457|P4|Overall Study|Equipment malfuntion|5
5037266|NCT02754492|17353458|P3|Overall Study|Equipment malfuntion|2
5037267|NCT02754492|17353459|P2|Overall Study|Equipment malfuntion|0
5037268|NCT02754492|17353460|P1|Overall Study|Equipment malfuntion|0
5037269|NCT02754492|17353457|P4|Overall Study|Withdrawal by Subject|0
5037270|NCT02754492|17353458|P3|Overall Study|Withdrawal by Subject|0
5037271|NCT02754492|17353459|P2|Overall Study|Withdrawal by Subject|0
5037272|NCT02754492|17353460|P1|Overall Study|Withdrawal by Subject|2
5037273|NCT02754492|17353457|P4|Overall Study|Protocol Violation|1
5037274|NCT02754492|17353458|P3|Overall Study|Protocol Violation|0
5037275|NCT02754492|17353459|P2|Overall Study|Protocol Violation|2
5037276|NCT02754492|17353460|P1|Overall Study|Protocol Violation|2
5037277|NCT02754440|17353476|P4|Overall Study|Subject issues not resulting in AE|12
5037278|NCT02754440|17353477|P3|Overall Study|Subject issues not resulting in AE|0
5037279|NCT02754440|17353478|P2|Overall Study|Subject issues not resulting in AE|0
5037280|NCT02754440|17353479|P1|Overall Study|Subject issues not resulting in AE|0
5037281|NCT02754440|17353476|P4|Overall Study|Equipment failure|7
5037282|NCT02754440|17353477|P3|Overall Study|Equipment failure|5
5037283|NCT02754440|17353478|P2|Overall Study|Equipment failure|5
5037284|NCT02754440|17353479|P1|Overall Study|Equipment failure|0
5037285|NCT02754440|17353476|P4|Overall Study|Withdrawal by Subject|1
5037286|NCT02754440|17353477|P3|Overall Study|Withdrawal by Subject|0
5037287|NCT02754440|17353478|P2|Overall Study|Withdrawal by Subject|0
5037288|NCT02754440|17353479|P1|Overall Study|Withdrawal by Subject|0
5037289|NCT02754440|17353476|P4|Overall Study|Adverse Event|9
5037290|NCT02754440|17353477|P3|Overall Study|Adverse Event|0
5037291|NCT02754440|17353478|P2|Overall Study|Adverse Event|1
5037292|NCT02754440|17353479|P1|Overall Study|Adverse Event|3
5037293|NCT02754440|17353476|P4|Overall Study|Protocol Violation|6
5037294|NCT02754440|17353477|P3|Overall Study|Protocol Violation|2
5037295|NCT02754440|17353478|P2|Overall Study|Protocol Violation|2
5037296|NCT02754440|17353479|P1|Overall Study|Protocol Violation|3
5037297|NCT02753946|17353531|P2|Overall Study|Physician Decision|2
5037298|NCT02753946|17353532|P1|Overall Study|Physician Decision|0
5037299|NCT02753946|17353531|P2|Overall Study|Lack of Efficacy|0
5037300|NCT02753946|17353532|P1|Overall Study|Lack of Efficacy|1
5037301|NCT02753946|17353531|P2|Overall Study|Withdrawal by Subject|1
5037302|NCT02753946|17353532|P1|Overall Study|Withdrawal by Subject|6
5037303|NCT02753946|17353531|P2|Overall Study|Adverse Event|6
5037304|NCT02753946|17353532|P1|Overall Study|Adverse Event|7
5037305|NCT02753595|17353633|P2|Overall Study|Sponsor termination|2
5037306|NCT02753595|17353634|P1|Overall Study|Sponsor termination|2
5037307|NCT02753075|17353678|P3|Overall Study|Physician Decision|0
5037308|NCT02753075|17353679|P2|Overall Study|Physician Decision|1
5037309|NCT02753075|17353680|P1|Overall Study|Physician Decision|3
5037310|NCT02753075|17353678|P3|Overall Study|Withdrawal of Consent|3
5037311|NCT02753075|17353679|P2|Overall Study|Withdrawal of Consent|1
5037312|NCT02753075|17353680|P1|Overall Study|Withdrawal of Consent|1
5037313|NCT02753075|17353678|P3|Overall Study|Lost to Follow-up|0
5037314|NCT02753075|17353679|P2|Overall Study|Lost to Follow-up|0
5037315|NCT02753075|17353680|P1|Overall Study|Lost to Follow-up|2
5037316|NCT02753075|17353678|P3|Overall Study|Adverse Event|0
5037317|NCT02753075|17353679|P2|Overall Study|Adverse Event|1
5037318|NCT02753075|17353680|P1|Overall Study|Adverse Event|2
5037319|NCT02752958|17353705|P1|Overall Study|Other (Reason not specified)|2
5037320|NCT02752958|17353705|P1|Overall Study|Withdrawal by Subject|2
5037321|NCT02752958|17353705|P1|Overall Study|Protocol Violation|1
5037322|NCT02752958|17353705|P1|Overall Study|Lost to Follow-up|1
5037323|NCT02752958|17353705|P1|Overall Study|Adverse Event|3
5037324|NCT02752906|17353776|P2|Overall Study|Lost to Follow-up|2
5037325|NCT02752906|17353777|P1|Overall Study|Lost to Follow-up|3
5037326|NCT02752906|17353776|P2|Overall Study|Withdrawal by Subject|2
5037327|NCT02752906|17353777|P1|Overall Study|Withdrawal by Subject|2
5037328|NCT02752906|17353776|P2|Overall Study|Protocol Violation|1
5037329|NCT02752906|17353777|P1|Overall Study|Protocol Violation|2
5037330|NCT02752802|17353802|P2|Overall Study|Contrast Volume Not Collected|0
5037331|NCT02752802|17353803|P1|Overall Study|Contrast Volume Not Collected|1
5037332|NCT02752776|17353815|P3|Overall Study|Withdrawal by Subject|2
5037333|NCT02752776|17353816|P2|Overall Study|Withdrawal by Subject|4
5037334|NCT02752776|17353817|P1|Overall Study|Withdrawal by Subject|3
5037335|NCT02752776|17353815|P3|Overall Study|Death|1
5037336|NCT02752776|17353816|P2|Overall Study|Death|0
5037337|NCT02752776|17353817|P1|Overall Study|Death|0
5037338|NCT02752776|17353815|P3|Overall Study|Subject/guardian decision|4
5037339|NCT02752776|17353816|P2|Overall Study|Subject/guardian decision|6
5037340|NCT02752776|17353817|P1|Overall Study|Subject/guardian decision|8
5037341|NCT02752776|17353815|P3|Overall Study|Protocol Violation|6
5037342|NCT02752776|17353816|P2|Overall Study|Protocol Violation|13
5037343|NCT02752776|17353817|P1|Overall Study|Protocol Violation|10
5037344|NCT02752776|17353815|P3|Overall Study|Pregnancy|3
5037345|NCT02752776|17353816|P2|Overall Study|Pregnancy|6
5037346|NCT02752776|17353817|P1|Overall Study|Pregnancy|1
5037347|NCT02752776|17353815|P3|Overall Study|Physician Decision|2
5037348|NCT02752776|17353816|P2|Overall Study|Physician Decision|6
5037349|NCT02752776|17353817|P1|Overall Study|Physician Decision|2
5037350|NCT02752776|17353815|P3|Overall Study|Non-compliance with study treatment|1
5037351|NCT02752776|17353816|P2|Overall Study|Non-compliance with study treatment|0
5037352|NCT02752776|17353817|P1|Overall Study|Non-compliance with study treatment|0
5037353|NCT02752776|17353815|P3|Overall Study|Lost to Follow-up|4
5037354|NCT02752776|17353816|P2|Overall Study|Lost to Follow-up|12
5037355|NCT02752776|17353817|P1|Overall Study|Lost to Follow-up|11
5037356|NCT02752776|17353815|P3|Overall Study|Lack of Efficacy|14
5037357|NCT02752776|17353816|P2|Overall Study|Lack of Efficacy|6
5037358|NCT02752776|17353817|P1|Overall Study|Lack of Efficacy|2
5037359|NCT02752776|17353815|P3|Overall Study|Adverse Event|11
5037360|NCT02752776|17353816|P2|Overall Study|Adverse Event|23
5037361|NCT02752776|17353817|P1|Overall Study|Adverse Event|15
5037362|NCT02752633|17353863|P1|Overall Study|Withdrawal by Subject|1
5037363|NCT02752087|17353901|P2|Washout|Physician Decision|0
5037364|NCT02752087|17353902|P1|Washout|Physician Decision|1
5037365|NCT02752074|17353912|P2|Overall Study|Withdrawal by Subject|10
5037366|NCT02752074|17353913|P1|Overall Study|Withdrawal by Subject|9
5037367|NCT02752074|17353912|P2|Overall Study|Death|129
5037368|NCT02752074|17353913|P1|Overall Study|Death|146
5037369|NCT02752074|17353912|P2|Overall Study|Lost to Follow-up|4
5037370|NCT02752074|17353913|P1|Overall Study|Lost to Follow-up|1
5037371|NCT02752048|17353938|P3|Overall Study|Withdrawal by Subject|3
5037372|NCT02752048|17353939|P2|Overall Study|Withdrawal by Subject|0
5037373|NCT02752048|17353940|P1|Overall Study|Withdrawal by Subject|0
5037374|NCT02751983|17353959|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
5037375|NCT02751983|17353960|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
5037376|NCT02751983|17353959|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
5037377|NCT02751983|17353960|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
5037378|NCT02751983|17353959|P2|Post-Treatment Assessment|Lost to Follow-up|0
5037379|NCT02751983|17353960|P1|Post-Treatment Assessment|Lost to Follow-up|5
5037380|NCT02751983|17353959|P2|Treatment|Discharged prior to beginning ACT|0
5037381|NCT02751983|17353960|P1|Treatment|Discharged prior to beginning ACT|2
5037382|NCT02751983|17353959|P2|Treatment|Stopped ACT, but Remained in study|0
5037383|NCT02751983|17353960|P1|Treatment|Stopped ACT, but Remained in study|2
5037384|NCT02751931|17353981|P2|Overall Study|Other: Miscelleneous|8
5037385|NCT02751931|17353982|P1|Overall Study|Other: Miscelleneous|10
5037386|NCT02751931|17353981|P2|Overall Study|Adverse Event|0
5037387|NCT02751931|17353982|P1|Overall Study|Adverse Event|3
5037388|NCT02751450|17354072|P2|Overall Study|Adverse Event|0
5037389|NCT02751450|17354073|P1|Overall Study|Adverse Event|1
5037390|NCT02751424|17354094|P9|Part 2|Adverse Event|0
5037391|NCT02751424|17354095|P8|Part 2|Adverse Event|5
5037392|NCT02751424|17354096|P7|Part 2|Adverse Event|0
5037393|NCT02751424|17354097|P6|Part 2|Adverse Event|0
5037394|NCT02751424|17354098|P5|Part 2|Adverse Event|0
5037395|NCT02751424|17354099|P4|Part 2|Adverse Event|0
5037396|NCT02751424|17354100|P3|Part 2|Adverse Event|0
5037397|NCT02751424|17354101|P2|Part 2|Adverse Event|0
5037398|NCT02751424|17354102|P1|Part 2|Adverse Event|0
5037399|NCT02751320|17354258|P1|Overall Study|Withdrawal by Subject|1
5037400|NCT02751320|17354258|P1|Overall Study|Adverse Event|2
5037401|NCT02750943|17354296|P2|Overall Study|Withdrawal by Subject|7
5037402|NCT02750943|17354297|P1|Overall Study|Withdrawal by Subject|5
5037403|NCT02750943|17354296|P2|Overall Study|Lost to Follow-up|2
5037404|NCT02750943|17354297|P1|Overall Study|Lost to Follow-up|1
5037405|NCT02750930|17354311|P1|Overall Study|Study closed/terminated|8
5037406|NCT02750813|17354323|P2|Period 1, First 14 Days of Wear|Reason not given|1
5037407|NCT02750813|17354324|P1|Period 1, First 14 Days of Wear|Reason not given|0
5037408|NCT02750813|17354323|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
5037409|NCT02750813|17354324|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
5037410|NCT02750800|17354339|P1|Overall Study|Other, not specified|3
5037411|NCT02750800|17354339|P1|Overall Study|Patient request|12
5037412|NCT02750800|17354339|P1|Overall Study|Investigator decision|53
5037413|NCT02750800|17354339|P1|Overall Study|Lost to Follow-up|12
5037414|NCT02750800|17354339|P1|Overall Study|Adverse Event|18
5037415|NCT02750761|17354444|P6|Overall Study|Lost to Follow-up|0
5037416|NCT02750761|17354445|P5|Overall Study|Lost to Follow-up|0
5037417|NCT02750761|17354446|P4|Overall Study|Lost to Follow-up|0
5037418|NCT02750761|17354447|P3|Overall Study|Lost to Follow-up|1
5037419|NCT02750761|17354448|P2|Overall Study|Lost to Follow-up|0
5037420|NCT02750761|17354449|P1|Overall Study|Lost to Follow-up|0
5037421|NCT02750709|17354545|P6|Treatment Period 1|Adverse Event|1
5037422|NCT02750709|17354546|P5|Treatment Period 1|Adverse Event|0
5037423|NCT02750709|17354547|P4|Treatment Period 1|Adverse Event|0
5037424|NCT02750709|17354548|P3|Treatment Period 1|Adverse Event|0
5037425|NCT02750709|17354549|P2|Treatment Period 1|Adverse Event|0
5037426|NCT02750709|17354550|P1|Treatment Period 1|Adverse Event|0
5037427|NCT02750618|17354576|P1|Overall Study|Withdrawal by Subject|1
5037428|NCT02750592|17354592|P1|Overall Study|Lack of Efficacy|2
5037429|NCT02750592|17354592|P1|Overall Study|Adverse Event|3
5037430|NCT02750501|17354611|P1|Overall Study|Non-compliant use of PERT|1
5037431|NCT02750501|17354611|P1|Overall Study|G-tube came out|1
5037432|NCT02750501|17354611|P1|Overall Study|Protocol Violation|1
5037433|NCT02750501|17354611|P1|Overall Study|Physician Decision|1
5037434|NCT02750501|17354611|P1|Overall Study|Adverse Event|4
5037435|NCT02750410|17354625|P2|Open-Label Extension Period|Withdrawal by Subject|2
5037436|NCT02750410|17354626|P1|Open-Label Extension Period|Withdrawal by Subject|1
5037437|NCT02750410|17354625|P2|Open-Label Extension Period|Protocol Violation|1
5037438|NCT02750410|17354626|P1|Open-Label Extension Period|Protocol Violation|0
5037439|NCT02750410|17354625|P2|Open-Label Extension Period|Adverse Event|3
5037440|NCT02750410|17354626|P1|Open-Label Extension Period|Adverse Event|5
5037441|NCT02750410|17354625|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5037442|NCT02750410|17354626|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5037443|NCT02750410|17354625|P2|Double-Blind Treatment Period|Adverse Event|2
5037444|NCT02750410|17354626|P1|Double-Blind Treatment Period|Adverse Event|2
5037445|NCT02750345|17354644|P6|Intervention 1|Adverse Event|0
5037446|NCT02750345|17354645|P5|Intervention 1|Adverse Event|1
5037447|NCT02750345|17354646|P4|Intervention 1|Adverse Event|0
5037448|NCT02750345|17354647|P3|Intervention 1|Adverse Event|0
5037449|NCT02750345|17354648|P2|Intervention 1|Adverse Event|0
5037450|NCT02750345|17354649|P1|Intervention 1|Adverse Event|0
5037451|NCT02750332|17354675|P2|Treatment Period 1|Withdrawal by Subject|1
5037452|NCT02750332|17354676|P1|Treatment Period 1|Withdrawal by Subject|0
5037453|NCT02750306|17354696|P2|Overall Study|Protocol Violation|0
5037454|NCT02750306|17354697|P1|Overall Study|Protocol Violation|1
5037455|NCT02750306|17354696|P2|Overall Study|Withdrawal by Subject|2
5037456|NCT02750306|17354697|P1|Overall Study|Withdrawal by Subject|5
5037457|NCT02749799|17354756|P1|Overall Study|Withdrawal by Subject|1
5037458|NCT02749799|17354756|P1|Overall Study|Protocol Violation|1
5037459|NCT02749799|17354756|P1|Overall Study|Lost to Follow-up|4
5037460|NCT02749799|17354756|P1|Overall Study|Adverse Event|2
5037461|NCT02749370|17354762|P1|Overall Study|Lost to Follow-up|3
5037462|NCT02749370|17354762|P1|Overall Study|Withdrawal by Subject|11
5037463|NCT02748863|17354812|P5|Treatment Period 2|Pregnancy|1
5037464|NCT02748863|17354813|P4|Treatment Period 2|Pregnancy|0
5037465|NCT02748863|17354814|P3|Treatment Period 2|Pregnancy|0
5037466|NCT02748863|17354815|P2|Treatment Period 2|Pregnancy|0
5037467|NCT02748863|17354816|P1|Treatment Period 2|Pregnancy|0
5037468|NCT02748863|17354812|P5|Treatment Period 2|Lack of Efficacy|0
5037469|NCT02748863|17354813|P4|Treatment Period 2|Lack of Efficacy|0
5037470|NCT02748863|17354814|P3|Treatment Period 2|Lack of Efficacy|0
5037471|NCT02748863|17354815|P2|Treatment Period 2|Lack of Efficacy|1
5037472|NCT02748863|17354816|P1|Treatment Period 2|Lack of Efficacy|0
5037473|NCT02748863|17354812|P5|Treatment Period 2|Adverse Event|0
5037474|NCT02748863|17354813|P4|Treatment Period 2|Adverse Event|2
5037475|NCT02748863|17354814|P3|Treatment Period 2|Adverse Event|0
5037476|NCT02748863|17354815|P2|Treatment Period 2|Adverse Event|2
5037477|NCT02748863|17354816|P1|Treatment Period 2|Adverse Event|3
5037478|NCT02748863|17354812|P5|Treatment Period 2|Lost to Follow-up|0
5037479|NCT02748863|17354813|P4|Treatment Period 2|Lost to Follow-up|0
5037480|NCT02748863|17354814|P3|Treatment Period 2|Lost to Follow-up|0
5037481|NCT02748863|17354815|P2|Treatment Period 2|Lost to Follow-up|0
5037482|NCT02748863|17354816|P1|Treatment Period 2|Lost to Follow-up|2
5037483|NCT02748863|17354812|P5|Treatment Period 1|Withdrawal by Subject|0
5037484|NCT02748863|17354813|P4|Treatment Period 1|Withdrawal by Subject|0
5037485|NCT02748863|17354814|P3|Treatment Period 1|Withdrawal by Subject|1
5037486|NCT02748863|17354815|P2|Treatment Period 1|Withdrawal by Subject|1
5037487|NCT02748863|17354816|P1|Treatment Period 1|Withdrawal by Subject|0
5037488|NCT02748863|17354812|P5|Treatment Period 1|Lack of Efficacy|0
5037489|NCT02748863|17354813|P4|Treatment Period 1|Lack of Efficacy|0
5037490|NCT02748863|17354814|P3|Treatment Period 1|Lack of Efficacy|1
5037491|NCT02748863|17354815|P2|Treatment Period 1|Lack of Efficacy|0
5037492|NCT02748863|17354816|P1|Treatment Period 1|Lack of Efficacy|0
5037493|NCT02748863|17354812|P5|Treatment Period 1|Adverse Event|0
5037494|NCT02748863|17354813|P4|Treatment Period 1|Adverse Event|0
5037495|NCT02748863|17354814|P3|Treatment Period 1|Adverse Event|0
5037496|NCT02748863|17354815|P2|Treatment Period 1|Adverse Event|1
5037497|NCT02748863|17354816|P1|Treatment Period 1|Adverse Event|0
5037498|NCT02748512|17354900|P2|Overall Study|Lost to Follow-up|1
5037499|NCT02748512|17354901|P1|Overall Study|Lost to Follow-up|1
5037500|NCT02748356|17354909|P1|Overall Study|Withdrawal by Subject|1
5037501|NCT02748317|17354914|P1|Overall Study|Death|1
5037502|NCT02748317|17354914|P1|Overall Study|Lost to Follow-up|8
5037503|NCT02748317|17354914|P1|Overall Study|Withdrawal by Subject|14
5037504|NCT02748213|17354921|P2|Overall Study|Other|29
5037505|NCT02748213|17354922|P1|Overall Study|Other|30
5037506|NCT02748213|17354921|P2|Overall Study|Failure to Return|0
5037507|NCT02748213|17354922|P1|Overall Study|Failure to Return|1
5037508|NCT02748213|17354921|P2|Overall Study|Refused Treatment*|6
5037509|NCT02748213|17354922|P1|Overall Study|Refused Treatment*|6
5037510|NCT02748213|17354921|P2|Overall Study|Protocol Violation|4
5037511|NCT02748213|17354922|P1|Overall Study|Protocol Violation|6
5037512|NCT02748213|17354921|P2|Overall Study|Violation of Selection Criteria|0
5037513|NCT02748213|17354922|P1|Overall Study|Violation of Selection Criteria|2
5037514|NCT02748213|17354921|P2|Overall Study|Insufficient Therapeutic Response|57
5037515|NCT02748213|17354922|P1|Overall Study|Insufficient Therapeutic Response|56
5037516|NCT02748213|17354921|P2|Overall Study|Death|3
5037517|NCT02748213|17354922|P1|Overall Study|Death|5
5037518|NCT02748213|17354921|P2|Overall Study|Adverse Event or Intercurrent Illness|11
5037519|NCT02748213|17354922|P1|Overall Study|Adverse Event or Intercurrent Illness|5
5037520|NCT02748213|17354921|P2|Overall Study|Abnormal Laboratory Test|0
5037521|NCT02748213|17354922|P1|Overall Study|Abnormal Laboratory Test|1
5037522|NCT02748213|17354921|P2|Overall Study|Withdrawal Prior to Treatment|2
5037523|NCT02748213|17354922|P1|Overall Study|Withdrawal Prior to Treatment|1
5037524|NCT02748057|17354951|P2|Overall Study|Withdrawal by Subject|0
5037525|NCT02748057|17354952|P1|Overall Study|Withdrawal by Subject|1
5037526|NCT02748057|17354951|P2|Overall Study|Participant Moved|0
5037527|NCT02748057|17354952|P1|Overall Study|Participant Moved|1
5037528|NCT02748057|17354951|P2|Overall Study|Protocol Violation|1
5037529|NCT02748057|17354952|P1|Overall Study|Protocol Violation|2
5037530|NCT02748057|17354951|P2|Overall Study|Physician Decision|1
5037531|NCT02748057|17354952|P1|Overall Study|Physician Decision|0
5037532|NCT02748057|17354951|P2|Overall Study|Adverse Event|0
5037533|NCT02748057|17354952|P1|Overall Study|Adverse Event|1
5037534|NCT02747108|17355030|P2|Overall Study|Protocol Violation|0
5037535|NCT02747108|17355031|P1|Overall Study|Protocol Violation|2
5037536|NCT02747108|17355030|P2|Overall Study|Withdrawal by Subject|0
5037537|NCT02747108|17355031|P1|Overall Study|Withdrawal by Subject|1
5037538|NCT02747108|17355030|P2|Overall Study|Death|2
5037539|NCT02747108|17355031|P1|Overall Study|Death|2
5037540|NCT02747043|17355073|P2|Overall Study|Disease progression|0
5037541|NCT02747043|17355074|P1|Overall Study|Disease progression|4
5037542|NCT02747043|17355073|P2|Overall Study|Protocol Violation|1
5037543|NCT02747043|17355074|P1|Overall Study|Protocol Violation|0
5037544|NCT02747043|17355073|P2|Overall Study|Physician Decision|1
5037545|NCT02747043|17355074|P1|Overall Study|Physician Decision|1
5037546|NCT02747043|17355073|P2|Overall Study|Withdrawal by Subject|1
5037547|NCT02747043|17355074|P1|Overall Study|Withdrawal by Subject|1
5037548|NCT02747043|17355073|P2|Overall Study|Adverse Event|1
5037549|NCT02747043|17355074|P1|Overall Study|Adverse Event|3
5037550|NCT02747043|17355073|P2|Overall Study|Other|1
5037551|NCT02747043|17355074|P1|Overall Study|Other|1
5037552|NCT02747004|17355103|P3|Overall Study|on study treatment/follow-up|41
5037553|NCT02747004|17355104|P2|Overall Study|on study treatment/follow-up|42
5037554|NCT02747004|17355105|P1|Overall Study|on study treatment/follow-up|48
5037555|NCT02747004|17355103|P3|Overall Study|Lost to Follow-up|2
5037556|NCT02747004|17355104|P2|Overall Study|Lost to Follow-up|2
5037557|NCT02747004|17355105|P1|Overall Study|Lost to Follow-up|1
5037558|NCT02747004|17355103|P3|Overall Study|Withdrawal by Subject|4
5037559|NCT02747004|17355104|P2|Overall Study|Withdrawal by Subject|5
5037560|NCT02747004|17355105|P1|Overall Study|Withdrawal by Subject|8
5037561|NCT02746705|17355164|P2|Overall Study|outlier scores deemed not valid|1
5037562|NCT02746705|17355165|P1|Overall Study|outlier scores deemed not valid|0
5037563|NCT02746705|17355164|P2|Overall Study|Lost to Follow-up|0
5037564|NCT02746705|17355165|P1|Overall Study|Lost to Follow-up|1
5037565|NCT02746705|17355164|P2|Overall Study|Physician Decision|1
5037566|NCT02746705|17355165|P1|Overall Study|Physician Decision|1
5037567|NCT02746679|17355179|P2|Overall Study|Lost to Follow-up|6
5037568|NCT02746679|17355180|P1|Overall Study|Lost to Follow-up|4
5037569|NCT02746627|17355213|P3|Overall Study|Withdrawal by Subject|1
5037570|NCT02746627|17355214|P2|Overall Study|Withdrawal by Subject|1
5037571|NCT02746627|17355215|P1|Overall Study|Withdrawal by Subject|1
5037572|NCT02746575|17355238|P1|Overall Study|Unknown history of CVA|1
5037573|NCT02746575|17355238|P1|Overall Study|PI unavailable|1
5037574|NCT02746575|17355238|P1|Overall Study|typ of surgery|1
5037575|NCT02746575|17355238|P1|Overall Study|type of surgery|1
5037576|NCT02746575|17355238|P1|Overall Study|put on beta-blocker|3
5037577|NCT02746575|17355238|P1|Overall Study|Study paused|8
5037578|NCT02746575|17355238|P1|Overall Study|Bradycardia/hypotension|9
5037579|NCT02746575|17355238|P1|Overall Study|Withdrawal by Subject|3
5037580|NCT02746575|17355238|P1|Overall Study|Received epidural|10
5037581|NCT02746575|17355238|P1|Overall Study|Surgery cancelled or time chaned|13
5037582|NCT02745535|17355301|P1|Overall Study|Lost to Follow-up|2
5037583|NCT02745535|17355301|P1|Overall Study|Adverse Event|3
5037584|NCT02745535|17355301|P1|Overall Study|Death|1
5037585|NCT02745392|17355313|P4|Overall Study|Lost to Follow-up|0
5037586|NCT02745392|17355314|P3|Overall Study|Lost to Follow-up|0
5037587|NCT02745392|17355315|P2|Overall Study|Lost to Follow-up|1
5037588|NCT02745392|17355316|P1|Overall Study|Lost to Follow-up|0
5037589|NCT02745145|17355342|P3|Overall Study|Study Termination|7
5037590|NCT02745145|17355343|P2|Overall Study|Study Termination|3
5037591|NCT02745145|17355344|P1|Overall Study|Study Termination|8
5037592|NCT02745145|17355342|P3|Overall Study|Withdrew consent|1
5037593|NCT02745145|17355343|P2|Overall Study|Withdrew consent|1
5037594|NCT02745145|17355344|P1|Overall Study|Withdrew consent|1
5037595|NCT02745145|17355342|P3|Overall Study|Progressive disease|1
5037596|NCT02745145|17355343|P2|Overall Study|Progressive disease|0
5037597|NCT02745145|17355344|P1|Overall Study|Progressive disease|0
5037598|NCT02745145|17355342|P3|Overall Study|Death|0
5037599|NCT02745145|17355343|P2|Overall Study|Death|1
5037600|NCT02745145|17355344|P1|Overall Study|Death|0
5037601|NCT02745145|17355342|P3|Overall Study|Adverse Event|0
5037602|NCT02745145|17355343|P2|Overall Study|Adverse Event|0
5037603|NCT02745145|17355344|P1|Overall Study|Adverse Event|1
5037604|NCT02745119|17355383|P4|Overall Study|Reason Not Specified|1
5037605|NCT02745119|17355384|P3|Overall Study|Reason Not Specified|0
5037606|NCT02745119|17355385|P2|Overall Study|Reason Not Specified|2
5037607|NCT02745119|17355386|P1|Overall Study|Reason Not Specified|0
5037608|NCT02745119|17355383|P4|Overall Study|Physician Decision|2
5037609|NCT02745119|17355384|P3|Overall Study|Physician Decision|2
5037610|NCT02745119|17355385|P2|Overall Study|Physician Decision|2
5037611|NCT02745119|17355386|P1|Overall Study|Physician Decision|0
5037612|NCT02745119|17355383|P4|Overall Study|Study Terminated by Sponsor|251
5037613|NCT02745119|17355384|P3|Overall Study|Study Terminated by Sponsor|135
5037614|NCT02745119|17355385|P2|Overall Study|Study Terminated by Sponsor|252
5037615|NCT02745119|17355386|P1|Overall Study|Study Terminated by Sponsor|134
5037616|NCT02745119|17355383|P4|Overall Study|Withdrawal by Subject|14
5037617|NCT02745119|17355384|P3|Overall Study|Withdrawal by Subject|8
5037618|NCT02745119|17355385|P2|Overall Study|Withdrawal by Subject|15
5037619|NCT02745119|17355386|P1|Overall Study|Withdrawal by Subject|7
5037620|NCT02745119|17355383|P4|Overall Study|Protocol Deviation|1
5037621|NCT02745119|17355384|P3|Overall Study|Protocol Deviation|0
5037622|NCT02745119|17355385|P2|Overall Study|Protocol Deviation|0
5037623|NCT02745119|17355386|P1|Overall Study|Protocol Deviation|0
5037624|NCT02745119|17355383|P4|Overall Study|Lost to Follow-up|1
5037625|NCT02745119|17355384|P3|Overall Study|Lost to Follow-up|0
5037626|NCT02745119|17355385|P2|Overall Study|Lost to Follow-up|0
5037627|NCT02745119|17355386|P1|Overall Study|Lost to Follow-up|0
5037628|NCT02745119|17355383|P4|Overall Study|Death|4
5037629|NCT02745119|17355384|P3|Overall Study|Death|0
5037630|NCT02745119|17355385|P2|Overall Study|Death|3
5037631|NCT02745119|17355386|P1|Overall Study|Death|3
5037632|NCT02745119|17355383|P4|Overall Study|Adverse Event|3
5037633|NCT02745119|17355384|P3|Overall Study|Adverse Event|1
5037634|NCT02745119|17355385|P2|Overall Study|Adverse Event|0
5037635|NCT02745119|17355386|P1|Overall Study|Adverse Event|1
5037636|NCT02744898|17355408|P1|Overall Study|Toxicity|1
5037637|NCT02744898|17355408|P1|Overall Study|Physician Decision|1
5037638|NCT02744898|17355408|P1|Overall Study|Progressive Disease|2
5037639|NCT02744755|17355422|P2|Study Period 2|Lack of Efficacy|2
5037640|NCT02744755|17355423|P1|Study Period 2|Lack of Efficacy|3
5037641|NCT02744755|17355422|P2|Study Period 2|Withdrawal by Subject|2
5037642|NCT02744755|17355423|P1|Study Period 2|Withdrawal by Subject|2
5037643|NCT02744755|17355422|P2|Study Period 2|Lost to Follow-up|2
5037644|NCT02744755|17355423|P1|Study Period 2|Lost to Follow-up|0
5037645|NCT02744755|17355422|P2|Study Period 2|not defined|2
5037646|NCT02744755|17355423|P1|Study Period 2|not defined|3
5037647|NCT02744755|17355422|P2|Study Period 2|Protocol Violation|0
5037648|NCT02744755|17355423|P1|Study Period 2|Protocol Violation|1
5037649|NCT02744755|17355422|P2|Study Period 2|Adverse Event|0
5037650|NCT02744755|17355423|P1|Study Period 2|Adverse Event|5
5037651|NCT02744755|17355422|P2|Study Period 1|Withdrawal by Subject|4
5037652|NCT02744755|17355423|P1|Study Period 1|Withdrawal by Subject|8
5037653|NCT02744755|17355422|P2|Study Period 1|Lack of Efficacy|0
5037654|NCT02744755|17355423|P1|Study Period 1|Lack of Efficacy|1
5037655|NCT02744755|17355422|P2|Study Period 1|Lost to Follow-up|1
5037656|NCT02744755|17355423|P1|Study Period 1|Lost to Follow-up|1
5037657|NCT02744755|17355422|P2|Study Period 1|Adverse Event|1
5037658|NCT02744755|17355423|P1|Study Period 1|Adverse Event|1
5037659|NCT02744755|17355422|P2|Study Period 1|Pregnancy|0
5037660|NCT02744755|17355423|P1|Study Period 1|Pregnancy|1
5037661|NCT02744755|17355422|P2|Study Period 1|not defined|1
5037662|NCT02744755|17355423|P1|Study Period 1|not defined|0
5037663|NCT02744755|17355422|P2|Study Period 1|Protocol Violation|1
5037664|NCT02744755|17355423|P1|Study Period 1|Protocol Violation|2
5037665|NCT02744391|17355483|P1|Overall Study|Withdrawal by Subject|3
5037666|NCT02744391|17355483|P1|Overall Study|Physician Decision|2
5037667|NCT02744391|17355483|P1|Overall Study|Lost to Follow-up|9
5037668|NCT02744066|17355524|P2|Overall Study|Discharged from NICU prior to completion|4
5037669|NCT02744066|17355525|P1|Overall Study|Discharged from NICU prior to completion|0
5037670|NCT02744066|17355524|P2|Overall Study|Withdrawal by parent|1
5037671|NCT02744066|17355525|P1|Overall Study|Withdrawal by parent|0
5037672|NCT02743962|17355535|P2|Overall Study|Atrophic vaginitis diagnosed|0
5037673|NCT02743962|17355536|P1|Overall Study|Atrophic vaginitis diagnosed|1
5037674|NCT02743949|17355558|P3|Overall Study|Voluntary Withdrawal|0
5037675|NCT02743949|17355559|P2|Overall Study|Voluntary Withdrawal|1
5037676|NCT02743949|17355560|P1|Overall Study|Voluntary Withdrawal|2
5037677|NCT02743949|17355558|P3|Overall Study|Significant Protocol Deviation|1
5037678|NCT02743949|17355559|P2|Overall Study|Significant Protocol Deviation|0
5037679|NCT02743949|17355560|P1|Overall Study|Significant Protocol Deviation|2
5037680|NCT02743949|17355558|P3|Overall Study|Adverse Event|2
5037681|NCT02743949|17355559|P2|Overall Study|Adverse Event|0
5037682|NCT02743949|17355560|P1|Overall Study|Adverse Event|0
5037683|NCT02743780|17355587|P5|Part 3 (7 Days)|Adverse Event|0
5037684|NCT02743780|17355588|P4|Part 3 (7 Days)|Adverse Event|0
5037685|NCT02743780|17355589|P3|Part 3 (7 Days)|Adverse Event|1
5037686|NCT02743780|17355590|P2|Part 3 (7 Days)|Adverse Event|0
5037687|NCT02743780|17355591|P1|Part 3 (7 Days)|Adverse Event|0
5037688|NCT02743520|17355645|P1|Overall Study|Withdrawal by Subject|1
5037689|NCT02743221|17355718|P2|Overall Study|Patient not eligible, not treated|1
5037690|NCT02743221|17355719|P1|Overall Study|Patient not eligible, not treated|0
5037691|NCT02743221|17355718|P2|Overall Study|Physician Decision|5
5037692|NCT02743221|17355719|P1|Overall Study|Physician Decision|2
5037693|NCT02743221|17355718|P2|Overall Study|non medical reason|2
5037694|NCT02743221|17355719|P1|Overall Study|non medical reason|8
5037695|NCT02743221|17355718|P2|Overall Study|Adverse Event|14
5037696|NCT02743221|17355719|P1|Overall Study|Adverse Event|17
5037697|NCT02743221|17355718|P2|Overall Study|Progressive disease|38
5037698|NCT02743221|17355719|P1|Overall Study|Progressive disease|29
5037699|NCT02743117|17355735|P2|Overall Study|Other|0
5037700|NCT02743117|17355736|P1|Overall Study|Other|1
5037701|NCT02743117|17355735|P2|Overall Study|Lost to Follow-up|1
5037702|NCT02743117|17355736|P1|Overall Study|Lost to Follow-up|0
5037703|NCT02742818|17355769|P2|Overall Study|Protocol Violation|1
5037704|NCT02742818|17355770|P1|Overall Study|Protocol Violation|0
5037705|NCT02742818|17355769|P2|Overall Study|Adverse Event|1
5037706|NCT02742818|17355770|P1|Overall Study|Adverse Event|0
5037707|NCT02742766|17355803|P19|Part 2 (Up to 22 Days)|Physician Decision|0
5037708|NCT02742766|17355804|P18|Part 2 (Up to 22 Days)|Physician Decision|0
5037709|NCT02742766|17355805|P17|Part 2 (Up to 22 Days)|Physician Decision|0
5037710|NCT02742766|17355806|P16|Part 2 (Up to 22 Days)|Physician Decision|1
5037711|NCT02742766|17355807|P15|Part 2 (Up to 22 Days)|Physician Decision|0
5037712|NCT02742766|17355808|P14|Part 2 (Up to 22 Days)|Physician Decision|5
5037713|NCT02742766|17355809|P13|Part 2 (Up to 22 Days)|Physician Decision|2
5037714|NCT02742766|17355810|P12|Part 2 (Up to 22 Days)|Physician Decision|0
5037715|NCT02742766|17355811|P11|Part 2 (Up to 22 Days)|Physician Decision|0
5037716|NCT02742766|17355812|P10|Part 2 (Up to 22 Days)|Physician Decision|0
5037717|NCT02742766|17355813|P9|Part 2 (Up to 22 Days)|Physician Decision|0
5037718|NCT02742766|17355814|P8|Part 2 (Up to 22 Days)|Physician Decision|0
5037719|NCT02742766|17355815|P7|Part 2 (Up to 22 Days)|Physician Decision|0
5037720|NCT02742766|17355816|P6|Part 2 (Up to 22 Days)|Physician Decision|0
5037721|NCT02742766|17355817|P5|Part 2 (Up to 22 Days)|Physician Decision|0
5037722|NCT02742766|17355818|P4|Part 2 (Up to 22 Days)|Physician Decision|0
5037723|NCT02742766|17355819|P3|Part 2 (Up to 22 Days)|Physician Decision|0
5037724|NCT02742766|17355820|P2|Part 2 (Up to 22 Days)|Physician Decision|0
5037725|NCT02742766|17355821|P1|Part 2 (Up to 22 Days)|Physician Decision|0
5037726|NCT02742766|17355803|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037727|NCT02742766|17355804|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037728|NCT02742766|17355805|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037729|NCT02742766|17355806|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037730|NCT02742766|17355807|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037731|NCT02742766|17355808|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
5037732|NCT02742766|17355809|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037733|NCT02742766|17355810|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037734|NCT02742766|17355811|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037735|NCT02742766|17355812|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037736|NCT02742766|17355813|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037737|NCT02742766|17355814|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037738|NCT02742766|17355815|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037739|NCT02742766|17355816|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037740|NCT02742766|17355817|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037741|NCT02742766|17355818|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037742|NCT02742766|17355819|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037743|NCT02742766|17355820|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037744|NCT02742766|17355821|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5037745|NCT02742649|17356081|P5|Open-Label Period|Lost to Follow-up|1
5037746|NCT02742649|17356082|P4|Open-Label Period|Lost to Follow-up|0
5037747|NCT02742649|17356083|P3|Open-Label Period|Lost to Follow-up|0
5037748|NCT02742649|17356084|P2|Open-Label Period|Lost to Follow-up|0
5037749|NCT02742649|17356085|P1|Open-Label Period|Lost to Follow-up|0
5037750|NCT02742649|17356081|P5|Double-Blind Treatment Period|Adverse Event|0
5037751|NCT02742649|17356082|P4|Double-Blind Treatment Period|Adverse Event|0
5037752|NCT02742649|17356083|P3|Double-Blind Treatment Period|Adverse Event|0
5037753|NCT02742649|17356084|P2|Double-Blind Treatment Period|Adverse Event|1
5037754|NCT02742649|17356085|P1|Double-Blind Treatment Period|Adverse Event|0
5037755|NCT02742649|17356081|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5037756|NCT02742649|17356082|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5037757|NCT02742649|17356083|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5037758|NCT02742649|17356084|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5037759|NCT02742649|17356085|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
5037760|NCT02742519|17356124|P3|Part 2 Open Label Period (32 Weeks)|Other|1
5037761|NCT02742519|17356125|P2|Part 2 Open Label Period (32 Weeks)|Other|0
5037762|NCT02742519|17356126|P1|Part 2 Open Label Period (32 Weeks)|Other|0
5037763|NCT02742519|17356124|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
5037764|NCT02742519|17356125|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
5037765|NCT02742519|17356126|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
5037766|NCT02742519|17356124|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
5037767|NCT02742519|17356125|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
5037768|NCT02742519|17356126|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
5037769|NCT02742441|17356146|P2|Overall Study|Adverse Event|2
5037770|NCT02742441|17356147|P1|Overall Study|Adverse Event|0
5037771|NCT02742441|17356146|P2|Overall Study|Withdrawal by Subject|2
5037772|NCT02742441|17356147|P1|Overall Study|Withdrawal by Subject|2
5037773|NCT02742441|17356146|P2|Overall Study|Lost to Follow-up|4
5037774|NCT02742441|17356147|P1|Overall Study|Lost to Follow-up|4
5037775|NCT02742103|17356194|P2|Overall Study|Withdrawal by Subject|2
5037776|NCT02742103|17356195|P1|Overall Study|Withdrawal by Subject|5
5037777|NCT02742103|17356194|P2|Overall Study|Moved to another town|1
5037778|NCT02742103|17356195|P1|Overall Study|Moved to another town|0
5037779|NCT02742103|17356194|P2|Overall Study|Adverse Event|0
5037780|NCT02742103|17356195|P1|Overall Study|Adverse Event|1
5037781|NCT02742103|17356194|P2|Overall Study|Death|2
5037782|NCT02742103|17356195|P1|Overall Study|Death|2
5037783|NCT02742103|17356194|P2|Overall Study|Protocol Violation|0
5037784|NCT02742103|17356195|P1|Overall Study|Protocol Violation|1
5037785|NCT02741713|17356241|P2|Overall Study|Surgery type changed intra-operatively|1
5037786|NCT02741713|17356242|P1|Overall Study|Surgery type changed intra-operatively|2
5037787|NCT02741635|17356282|P1|Overall Study|Withdrawal by Subject|1
5037788|NCT02741596|17356290|P2|Overall Study|Subject withdrawn-to commercial product|63
5037789|NCT02741596|17356291|P1|Overall Study|Subject withdrawn-to commercial product|54
5037790|NCT02741596|17356290|P2|Overall Study|Subject withdrawn-Other|4
5037791|NCT02741596|17356291|P1|Overall Study|Subject withdrawn-Other|17
5037792|NCT02741596|17356290|P2|Overall Study|Other (Unspecified)|3
5037793|NCT02741596|17356291|P1|Overall Study|Other (Unspecified)|0
5037794|NCT02741596|17356290|P2|Overall Study|Pregnancy|1
5037795|NCT02741596|17356291|P1|Overall Study|Pregnancy|3
5037796|NCT02741596|17356290|P2|Overall Study|Physician Decision|1
5037797|NCT02741596|17356291|P1|Overall Study|Physician Decision|2
5037798|NCT02741596|17356290|P2|Overall Study|Lost to Follow-up|1
5037799|NCT02741596|17356291|P1|Overall Study|Lost to Follow-up|1
5037800|NCT02741596|17356290|P2|Overall Study|Adverse Event|5
5037801|NCT02741596|17356291|P1|Overall Study|Adverse Event|1
5037802|NCT02741518|17356309|P2|Overall Study|Withdrawal by Subject|1
5037803|NCT02741518|17356310|P1|Overall Study|Withdrawal by Subject|1
5037804|NCT02741310|17356320|P2|Overall Study|Sponsor Decision|2
5037805|NCT02741310|17356321|P1|Overall Study|Sponsor Decision|2
5037806|NCT02741271|17356366|P2|Overall Study|Withdrawal by Parent/Guardian|2
5037807|NCT02741271|17356367|P1|Overall Study|Withdrawal by Parent/Guardian|0
5037808|NCT02741271|17356366|P2|Overall Study|Lost to Follow-up|0
5037809|NCT02741271|17356367|P1|Overall Study|Lost to Follow-up|2
5037810|NCT02741245|17356400|P5|Overall Study|Withdrawal by Subject|0
5037811|NCT02741245|17356401|P4|Overall Study|Withdrawal by Subject|1
5037812|NCT02741245|17356402|P3|Overall Study|Withdrawal by Subject|0
5037813|NCT02741245|17356403|P2|Overall Study|Withdrawal by Subject|0
5037814|NCT02741245|17356404|P1|Overall Study|Withdrawal by Subject|0
5037815|NCT02741245|17356400|P5|Overall Study|Protocol Violation|0
5037816|NCT02741245|17356401|P4|Overall Study|Protocol Violation|1
5037817|NCT02741245|17356402|P3|Overall Study|Protocol Violation|0
5037818|NCT02741245|17356403|P2|Overall Study|Protocol Violation|1
5037819|NCT02741245|17356404|P1|Overall Study|Protocol Violation|0
5037820|NCT02741245|17356400|P5|Overall Study|Adverse Event|2
5037821|NCT02741245|17356401|P4|Overall Study|Adverse Event|2
5037822|NCT02741245|17356402|P3|Overall Study|Adverse Event|0
5037823|NCT02741245|17356403|P2|Overall Study|Adverse Event|0
5037824|NCT02741245|17356404|P1|Overall Study|Adverse Event|0
5037825|NCT02741076|17356510|P4|Overall Study|No additional information available|1
5037826|NCT02741076|17356511|P3|Overall Study|No additional information available|1
5037827|NCT02741076|17356512|P2|Overall Study|No additional information available|0
5037828|NCT02741076|17356513|P1|Overall Study|No additional information available|0
5037829|NCT02741076|17356510|P4|Overall Study|Sponsor Request|1
5037830|NCT02741076|17356511|P3|Overall Study|Sponsor Request|0
5037831|NCT02741076|17356512|P2|Overall Study|Sponsor Request|3
5037832|NCT02741076|17356513|P1|Overall Study|Sponsor Request|2
5037833|NCT02741076|17356510|P4|Overall Study|Withdrawal by Subject|0
5037834|NCT02741076|17356511|P3|Overall Study|Withdrawal by Subject|0
5037835|NCT02741076|17356512|P2|Overall Study|Withdrawal by Subject|1
5037836|NCT02741076|17356513|P1|Overall Study|Withdrawal by Subject|0
5037837|NCT02741076|17356510|P4|Overall Study|Lack of Efficacy|0
5037838|NCT02741076|17356511|P3|Overall Study|Lack of Efficacy|0
5037839|NCT02741076|17356512|P2|Overall Study|Lack of Efficacy|0
5037840|NCT02741076|17356513|P1|Overall Study|Lack of Efficacy|1
5037841|NCT02741076|17356510|P4|Overall Study|Adverse Event|0
5037842|NCT02741076|17356511|P3|Overall Study|Adverse Event|1
5037843|NCT02741076|17356512|P2|Overall Study|Adverse Event|1
5037844|NCT02741076|17356513|P1|Overall Study|Adverse Event|0
5037845|NCT02740049|17356638|P1|Overall Study|Isolated cells did not grow sufficiently|1
5037846|NCT02739997|17356644|P1|Overall Study|Withdrawal by Subject|1
5037847|NCT02739997|17356644|P1|Overall Study|Death|1
5037848|NCT02739984|17356658|P2|Overall Study|Lost to Follow-up|0
5037849|NCT02739984|17356659|P1|Overall Study|Lost to Follow-up|3
5037850|NCT02739984|17356658|P2|Overall Study|Death|1
5037851|NCT02739984|17356659|P1|Overall Study|Death|0
5037852|NCT02739984|17356658|P2|Overall Study|Withdrawal by Subject|1
5037853|NCT02739984|17356659|P1|Overall Study|Withdrawal by Subject|1
5037854|NCT02739984|17356658|P2|Overall Study|Sponsor Decision|0
5037855|NCT02739984|17356659|P1|Overall Study|Sponsor Decision|1
5037856|NCT02739828|17356707|P1|Overall Study|Lost to Follow-up|4
5037857|NCT02739828|17356707|P1|Overall Study|Adverse Event|1
5037858|NCT02739594|17356767|P2|Overall Study|Other|2
5037859|NCT02739594|17356768|P1|Overall Study|Other|6
5037860|NCT02739594|17356767|P2|Overall Study|Elevated Serum Creatinine|1
5037861|NCT02739594|17356768|P1|Overall Study|Elevated Serum Creatinine|0
5037862|NCT02739594|17356767|P2|Overall Study|Lost to Follow-up|1
5037863|NCT02739594|17356768|P1|Overall Study|Lost to Follow-up|0
5037864|NCT02739594|17356767|P2|Overall Study|Withdrawal by Subject|1
5037865|NCT02739594|17356768|P1|Overall Study|Withdrawal by Subject|1
5037866|NCT02739594|17356767|P2|Overall Study|Administrative Reasons|3
5037867|NCT02739594|17356768|P1|Overall Study|Administrative Reasons|1
5037868|NCT02739594|17356767|P2|Overall Study|Renal Insufficiency|6
5037869|NCT02739594|17356768|P1|Overall Study|Renal Insufficiency|4
5037870|NCT02739594|17356767|P2|Overall Study|Death|2
5037871|NCT02739594|17356768|P1|Overall Study|Death|4
5037872|NCT02739594|17356767|P2|Overall Study|Protocol Violation|6
5037873|NCT02739594|17356768|P1|Overall Study|Protocol Violation|5
5037874|NCT02739594|17356767|P2|Overall Study|Violation of Eligibility Criteria|2
5037875|NCT02739594|17356768|P1|Overall Study|Violation of Eligibility Criteria|1
5037876|NCT02739594|17356767|P2|Overall Study|Undesired Event|4
5037877|NCT02739594|17356768|P1|Overall Study|Undesired Event|3
5037878|NCT02739360|17356798|P1|Overall Study|Study terminated by Sponsor|2
5037879|NCT02739360|17356798|P1|Overall Study|Adverse Event|1
5037880|NCT02739321|17356804|P2|Overall Study|Withdrawal by Subject|2
5037881|NCT02739321|17356805|P1|Overall Study|Withdrawal by Subject|1
5037882|NCT02739321|17356804|P2|Overall Study|Lost to Follow-up|1
5037883|NCT02739321|17356805|P1|Overall Study|Lost to Follow-up|1
5037884|NCT02739321|17356804|P2|Overall Study|Lack of Efficacy|1
5037885|NCT02739321|17356805|P1|Overall Study|Lack of Efficacy|1
5037886|NCT02739269|17356851|P2|Overall Study|Withdrawal by Subject|2
5037887|NCT02739269|17356852|P1|Overall Study|Withdrawal by Subject|0
5037888|NCT02739269|17356851|P2|Overall Study|Cycle cancellation|2
5037889|NCT02739269|17356852|P1|Overall Study|Cycle cancellation|2
5037890|NCT02739269|17356851|P2|Overall Study|Protocol Violation|0
5037891|NCT02739269|17356852|P1|Overall Study|Protocol Violation|5
5037892|NCT02738879|17356879|P2|Overall Study|Withdrawal by Subject|7
5037893|NCT02738879|17356880|P1|Overall Study|Withdrawal by Subject|5
5037894|NCT02738879|17356879|P2|Overall Study|Site Discontinued Study Participation|0
5037895|NCT02738879|17356880|P1|Overall Study|Site Discontinued Study Participation|1
5037896|NCT02738879|17356879|P2|Overall Study|Screen Failure|2
5037897|NCT02738879|17356880|P1|Overall Study|Screen Failure|1
5037898|NCT02738879|17356879|P2|Overall Study|Pregnancy|1
5037899|NCT02738879|17356880|P1|Overall Study|Pregnancy|0
5037900|NCT02738879|17356879|P2|Overall Study|Physician Decision|4
5037901|NCT02738879|17356880|P1|Overall Study|Physician Decision|3
5037902|NCT02738879|17356879|P2|Overall Study|Protocol Violation|3
5037903|NCT02738879|17356880|P1|Overall Study|Protocol Violation|1
5037904|NCT02738879|17356879|P2|Overall Study|Lost to Follow-up|5
5037905|NCT02738879|17356880|P1|Overall Study|Lost to Follow-up|1
5037906|NCT02738879|17356879|P2|Overall Study|Death|2
5037907|NCT02738879|17356880|P1|Overall Study|Death|0
5037908|NCT02738879|17356879|P2|Overall Study|Adverse Event|1
5037909|NCT02738879|17356880|P1|Overall Study|Adverse Event|1
5037910|NCT02738801|17356932|P2|Overall Study|Withdrawal by Subject|1
5037911|NCT02738801|17356933|P1|Overall Study|Withdrawal by Subject|0
5037912|NCT02738801|17356932|P2|Overall Study|Adverse Event|1
5037913|NCT02738801|17356933|P1|Overall Study|Adverse Event|1
5037914|NCT02738580|17356949|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
5037915|NCT02738580|17356950|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
5037916|NCT02738580|17356949|P2|Overall Study|Withdrawal by Subject|1
5037917|NCT02738580|17356950|P1|Overall Study|Withdrawal by Subject|0
5037918|NCT02738580|17356949|P2|Overall Study|Lack of Efficacy|2
5037919|NCT02738580|17356950|P1|Overall Study|Lack of Efficacy|3
5037920|NCT02738580|17356949|P2|Overall Study|Adverse Event|0
5037921|NCT02738580|17356950|P1|Overall Study|Adverse Event|1
5037922|NCT02738333|17356961|P3|Overall Study|Lost to Follow-up|0
5037923|NCT02738333|17356962|P2|Overall Study|Lost to Follow-up|0
5037924|NCT02738333|17356963|P1|Overall Study|Lost to Follow-up|1
5037925|NCT02738333|17356961|P3|Overall Study|Death|0
5037926|NCT02738333|17356962|P2|Overall Study|Death|0
5037927|NCT02738333|17356963|P1|Overall Study|Death|1
5037928|NCT02738203|17357052|P2|Overall Study|Protocol Violation|1
5037929|NCT02738203|17357053|P1|Overall Study|Protocol Violation|0
5037930|NCT02738203|17357052|P2|Overall Study|Failed IUD Insertion|2
5037931|NCT02738203|17357053|P1|Overall Study|Failed IUD Insertion|2
5037932|NCT02738151|17357069|P2|Overall Study|Other than specified above|21
5037933|NCT02738151|17357070|P1|Overall Study|Other than specified above|11
5037934|NCT02738151|17357069|P2|Overall Study|Poor Compliance to Protocol|3
5037935|NCT02738151|17357070|P1|Overall Study|Poor Compliance to Protocol|4
5037936|NCT02738151|17357069|P2|Overall Study|Hypoglycemia|1
5037937|NCT02738151|17357070|P1|Overall Study|Hypoglycemia|0
5037938|NCT02738151|17357069|P2|Overall Study|Adverse Event|5
5037939|NCT02738151|17357070|P1|Overall Study|Adverse Event|4
5037940|NCT02738151|17357069|P2|Overall Study|Randomized but not treated|1
5037941|NCT02738151|17357070|P1|Overall Study|Randomized but not treated|4
5037942|NCT02738138|17357114|P2|Overall Study|Other - not further specified|0
5037943|NCT02738138|17357115|P1|Overall Study|Other - not further specified|1
5037944|NCT02738138|17357114|P2|Overall Study|Lost to Follow-up|0
5037945|NCT02738138|17357115|P1|Overall Study|Lost to Follow-up|2
5037946|NCT02738138|17357114|P2|Overall Study|Adverse Event|1
5037947|NCT02738138|17357115|P1|Overall Study|Adverse Event|0
5037948|NCT02738008|17357152|P3|Overall Study|Adverse Event|2
5037949|NCT02738008|17357153|P2|Overall Study|Adverse Event|1
5037950|NCT02738008|17357154|P1|Overall Study|Adverse Event|0
5037951|NCT02738008|17357152|P3|Overall Study|Study Terminated by Sponsor|3
5037952|NCT02738008|17357153|P2|Overall Study|Study Terminated by Sponsor|5
5037953|NCT02738008|17357154|P1|Overall Study|Study Terminated by Sponsor|1
5037954|NCT02737852|17357192|P1|Overall Study|Withdrawal by Subject|2
5037955|NCT02737722|17357201|P4|Overall Study|Physician Decision|0
5037956|NCT02737722|17357202|P3|Overall Study|Physician Decision|1
5037957|NCT02737722|17357203|P2|Overall Study|Physician Decision|0
5037958|NCT02737722|17357204|P1|Overall Study|Physician Decision|0
5037959|NCT02737618|17357255|P1|Overall Study|Withdrawal by Subject|9
5037960|NCT02737592|17357260|P1|Overall Study|Withdrawal by Subject|1
5037961|NCT02737358|17357281|P2|Overall Study|Lost to Follow-up|3
5037962|NCT02737358|17357282|P1|Overall Study|Lost to Follow-up|2
5037963|NCT02737358|17357281|P2|Overall Study|Withdrawal by Subject|12
5037964|NCT02737358|17357282|P1|Overall Study|Withdrawal by Subject|7
5037965|NCT02736890|17357389|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
5037966|NCT02736890|17357390|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
5037967|NCT02736890|17357389|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
5037968|NCT02736890|17357390|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
5037969|NCT02736825|17357412|P2|Overall Study|Early Termination|1
5037970|NCT02736825|17357413|P1|Overall Study|Early Termination|0
5037971|NCT02736825|17357412|P2|Overall Study|Lost to Follow-up|11
5037972|NCT02736825|17357413|P1|Overall Study|Lost to Follow-up|10
5037973|NCT02736721|17357453|P1|Overall Study|Other|5
5037974|NCT02736721|17357453|P1|Overall Study|Lost to Follow-up|3
5037975|NCT02736721|17357453|P1|Overall Study|Adverse Event|8
5037976|NCT02736578|17357464|P2|Overall Study|Adverse Event|0
5037977|NCT02736578|17357465|P1|Overall Study|Adverse Event|1
5037978|NCT02736188|17357483|P1|Overall Study|Other|6
5037979|NCT02736188|17357483|P1|Overall Study|Withdrawal by Subject|1
5037980|NCT02736188|17357483|P1|Overall Study|Adverse Event|1
5037981|NCT02736188|17357483|P1|Overall Study|Discontinuation of Study by Sponsor|134
5037982|NCT02735980|17357521|P3|Overall Study|Withdrawal by Subject|0
5037983|NCT02735980|17357522|P2|Overall Study|Withdrawal by Subject|2
5037984|NCT02735980|17357523|P1|Overall Study|Withdrawal by Subject|1
5037985|NCT02735980|17357521|P3|Overall Study|Screen failure|0
5037986|NCT02735980|17357522|P2|Overall Study|Screen failure|0
5037987|NCT02735980|17357523|P1|Overall Study|Screen failure|1
5037988|NCT02735980|17357521|P3|Overall Study|Physician Decision|0
5037989|NCT02735980|17357522|P2|Overall Study|Physician Decision|1
5037990|NCT02735980|17357523|P1|Overall Study|Physician Decision|3
5037991|NCT02735980|17357521|P3|Overall Study|Death|0
5037992|NCT02735980|17357522|P2|Overall Study|Death|4
5037993|NCT02735980|17357523|P1|Overall Study|Death|5
5037994|NCT02735980|17357521|P3|Overall Study|Adverse Event|1
5037995|NCT02735980|17357522|P2|Overall Study|Adverse Event|4
5037996|NCT02735980|17357523|P1|Overall Study|Adverse Event|0
5037997|NCT02735915|17357552|P1|Overall Study|Withdrawal by Subject|1
5037998|NCT02735915|17357552|P1|Overall Study|Withdrawal following SAE|2
5037999|NCT02735915|17357552|P1|Overall Study|Not vaccinated but subject ID assigned|8
5038000|NCT02735577|17357584|P1|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
5038001|NCT02735577|17357584|P1|Disulfiram Treatment|Lost to Follow-up|1
5038002|NCT02735421|17357601|P1|Overall Study|Pregnancy|1
5038003|NCT02735421|17357601|P1|Overall Study|Inadequate compliance to treatment|1
5038004|NCT02735421|17357601|P1|Overall Study|Lost to Follow-up|3
5038005|NCT02735421|17357601|P1|Overall Study|Withdrawal by Subject|6
5038006|NCT02735421|17357601|P1|Overall Study|Adverse Event|2
5038007|NCT02735200|17357631|P2|Overall Study|Withdrawal by Subject|0
5038008|NCT02735200|17357632|P1|Overall Study|Withdrawal by Subject|8
5038009|NCT02735200|17357631|P2|Overall Study|Lost to Follow-up|5
5038010|NCT02735200|17357632|P1|Overall Study|Lost to Follow-up|0
5038011|NCT02735096|17357675|P1|Overall Study|No symptoms in clinic/personal leave|1
5038012|NCT02735044|17357684|P2|Overall Study|Other, not specified above|11
5038013|NCT02735044|17357685|P1|Overall Study|Other, not specified above|5
5038014|NCT02735044|17357684|P2|Overall Study|Randomized and not treated|2
5038015|NCT02735044|17357685|P1|Overall Study|Randomized and not treated|0
5038016|NCT02735044|17357684|P2|Overall Study|Poor compliance to protocol|7
5038017|NCT02735044|17357685|P1|Overall Study|Poor compliance to protocol|7
5038018|NCT02735044|17357684|P2|Overall Study|Lack of Efficacy|0
5038019|NCT02735044|17357685|P1|Overall Study|Lack of Efficacy|1
5038020|NCT02735044|17357684|P2|Overall Study|Adverse Event|3
5038021|NCT02735044|17357685|P1|Overall Study|Adverse Event|3
5038022|NCT02734810|17357753|P2|Overall Study|Lack of Efficacy|0
5038023|NCT02734810|17357754|P1|Overall Study|Lack of Efficacy|1
5038024|NCT02734810|17357753|P2|Overall Study|Adverse Event|0
5038025|NCT02734810|17357754|P1|Overall Study|Adverse Event|1
5038026|NCT02734693|17357763|P3|Overall Study|Withdrawal by Subject|0
5038027|NCT02734693|17357764|P2|Overall Study|Withdrawal by Subject|0
5038028|NCT02734693|17357765|P1|Overall Study|Withdrawal by Subject|1
5038029|NCT02734693|17357763|P3|Overall Study|Protocol Violation|0
5038030|NCT02734693|17357764|P2|Overall Study|Protocol Violation|0
5038031|NCT02734693|17357765|P1|Overall Study|Protocol Violation|1
5038032|NCT02734693|17357763|P3|Overall Study|Lost to Follow-up|0
5038033|NCT02734693|17357764|P2|Overall Study|Lost to Follow-up|0
5038034|NCT02734693|17357765|P1|Overall Study|Lost to Follow-up|2
5038035|NCT02734693|17357763|P3|Overall Study|Lack of Efficacy|0
5038036|NCT02734693|17357764|P2|Overall Study|Lack of Efficacy|0
5038037|NCT02734693|17357765|P1|Overall Study|Lack of Efficacy|1
5038038|NCT02734693|17357763|P3|Overall Study|Adverse Event|3
5038039|NCT02734693|17357764|P2|Overall Study|Adverse Event|3
5038040|NCT02734693|17357765|P1|Overall Study|Adverse Event|1
5038041|NCT02734433|17357806|P2|Overall Study|Withdrawal by Subject|2
5038042|NCT02734433|17357807|P1|Overall Study|Withdrawal by Subject|1
5038043|NCT02734433|17357806|P2|Overall Study|Clinical progression|1
5038044|NCT02734433|17357807|P1|Overall Study|Clinical progression|0
5038045|NCT02734433|17357806|P2|Overall Study|Disease progression|5
5038046|NCT02734433|17357807|P1|Overall Study|Disease progression|1
5038047|NCT02734212|17357883|P2|Overall Study|Lost to Follow-up|10
5038048|NCT02734212|17357884|P1|Overall Study|Lost to Follow-up|5
5038049|NCT02733991|17357905|P2|Overall Study|Withdrawal by Subject|5
5038050|NCT02733991|17357906|P1|Overall Study|Withdrawal by Subject|0
5038051|NCT02733991|17357905|P2|Overall Study|Adverse Event|0
5038052|NCT02733991|17357906|P1|Overall Study|Adverse Event|1
5038053|NCT02733367|17357946|P1|Overall Study|Withdrawal by Subject|6
5038054|NCT02733042|17357972|P19|Follow-up Period|Withdrawal by Subject|0
5038055|NCT02733042|17357973|P18|Follow-up Period|Withdrawal by Subject|0
5038056|NCT02733042|17357974|P17|Follow-up Period|Withdrawal by Subject|0
5038057|NCT02733042|17357975|P16|Follow-up Period|Withdrawal by Subject|1
5038058|NCT02733042|17357976|P15|Follow-up Period|Withdrawal by Subject|0
5038059|NCT02733042|17357977|P14|Follow-up Period|Withdrawal by Subject|0
5038060|NCT02733042|17357978|P13|Follow-up Period|Withdrawal by Subject|0
5038061|NCT02733042|17357979|P12|Follow-up Period|Withdrawal by Subject|0
5038062|NCT02733042|17357980|P11|Follow-up Period|Withdrawal by Subject|1
5038063|NCT02733042|17357981|P10|Follow-up Period|Withdrawal by Subject|0
5038064|NCT02733042|17357982|P9|Follow-up Period|Withdrawal by Subject|1
5038065|NCT02733042|17357983|P8|Follow-up Period|Withdrawal by Subject|0
5038066|NCT02733042|17357984|P7|Follow-up Period|Withdrawal by Subject|0
5038067|NCT02733042|17357985|P6|Follow-up Period|Withdrawal by Subject|0
5038068|NCT02733042|17357986|P5|Follow-up Period|Withdrawal by Subject|0
5038069|NCT02733042|17357987|P4|Follow-up Period|Withdrawal by Subject|0
5038070|NCT02733042|17357988|P3|Follow-up Period|Withdrawal by Subject|0
5038071|NCT02733042|17357989|P2|Follow-up Period|Withdrawal by Subject|0
5038072|NCT02733042|17357990|P1|Follow-up Period|Withdrawal by Subject|0
5038073|NCT02733042|17357972|P19|Follow-up Period|Other|0
5038074|NCT02733042|17357973|P18|Follow-up Period|Other|0
5038075|NCT02733042|17357974|P17|Follow-up Period|Other|0
5038076|NCT02733042|17357975|P16|Follow-up Period|Other|0
5038077|NCT02733042|17357976|P15|Follow-up Period|Other|0
5038078|NCT02733042|17357977|P14|Follow-up Period|Other|0
5038079|NCT02733042|17357978|P13|Follow-up Period|Other|0
5038080|NCT02733042|17357979|P12|Follow-up Period|Other|0
5038081|NCT02733042|17357980|P11|Follow-up Period|Other|0
5038082|NCT02733042|17357981|P10|Follow-up Period|Other|0
5038083|NCT02733042|17357982|P9|Follow-up Period|Other|0
5038084|NCT02733042|17357983|P8|Follow-up Period|Other|0
5038085|NCT02733042|17357984|P7|Follow-up Period|Other|0
5038086|NCT02733042|17357985|P6|Follow-up Period|Other|0
5038087|NCT02733042|17357986|P5|Follow-up Period|Other|0
5038088|NCT02733042|17357987|P4|Follow-up Period|Other|1
5038089|NCT02733042|17357988|P3|Follow-up Period|Other|0
5038090|NCT02733042|17357989|P2|Follow-up Period|Other|0
5038091|NCT02733042|17357990|P1|Follow-up Period|Other|0
5038092|NCT02733042|17357972|P19|Follow-up Period|Death|2
5038093|NCT02733042|17357973|P18|Follow-up Period|Death|1
5038094|NCT02733042|17357974|P17|Follow-up Period|Death|0
5038095|NCT02733042|17357975|P16|Follow-up Period|Death|4
5038096|NCT02733042|17357976|P15|Follow-up Period|Death|1
5038097|NCT02733042|17357977|P14|Follow-up Period|Death|1
5038098|NCT02733042|17357978|P13|Follow-up Period|Death|8
5038099|NCT02733042|17357979|P12|Follow-up Period|Death|0
5038100|NCT02733042|17357980|P11|Follow-up Period|Death|0
5038101|NCT02733042|17357981|P10|Follow-up Period|Death|0
5038102|NCT02733042|17357982|P9|Follow-up Period|Death|3
5038103|NCT02733042|17357983|P8|Follow-up Period|Death|3
5038104|NCT02733042|17357984|P7|Follow-up Period|Death|0
5038105|NCT02733042|17357985|P6|Follow-up Period|Death|2
5038106|NCT02733042|17357986|P5|Follow-up Period|Death|1
5038107|NCT02733042|17357987|P4|Follow-up Period|Death|0
5038108|NCT02733042|17357988|P3|Follow-up Period|Death|2
5038109|NCT02733042|17357989|P2|Follow-up Period|Death|1
5038110|NCT02733042|17357990|P1|Follow-up Period|Death|1
5038111|NCT02733042|17357972|P19|Follow-up Period|Ongoing on Follow-up|0
5038112|NCT02733042|17357973|P18|Follow-up Period|Ongoing on Follow-up|1
5038113|NCT02733042|17357974|P17|Follow-up Period|Ongoing on Follow-up|0
5038114|NCT02733042|17357975|P16|Follow-up Period|Ongoing on Follow-up|0
5038115|NCT02733042|17357976|P15|Follow-up Period|Ongoing on Follow-up|0
5038116|NCT02733042|17357977|P14|Follow-up Period|Ongoing on Follow-up|3
5038117|NCT02733042|17357978|P13|Follow-up Period|Ongoing on Follow-up|1
5038118|NCT02733042|17357979|P12|Follow-up Period|Ongoing on Follow-up|9
5038119|NCT02733042|17357980|P11|Follow-up Period|Ongoing on Follow-up|4
5038120|NCT02733042|17357981|P10|Follow-up Period|Ongoing on Follow-up|2
5038121|NCT02733042|17357982|P9|Follow-up Period|Ongoing on Follow-up|0
5038122|NCT02733042|17357983|P8|Follow-up Period|Ongoing on Follow-up|1
5038123|NCT02733042|17357984|P7|Follow-up Period|Ongoing on Follow-up|0
5038124|NCT02733042|17357985|P6|Follow-up Period|Ongoing on Follow-up|0
5038125|NCT02733042|17357986|P5|Follow-up Period|Ongoing on Follow-up|0
5038126|NCT02733042|17357987|P4|Follow-up Period|Ongoing on Follow-up|2
5038127|NCT02733042|17357988|P3|Follow-up Period|Ongoing on Follow-up|4
5038128|NCT02733042|17357989|P2|Follow-up Period|Ongoing on Follow-up|2
5038129|NCT02733042|17357990|P1|Follow-up Period|Ongoing on Follow-up|2
5038130|NCT02733042|17357972|P19|Treatment Period|Death|0
5038131|NCT02733042|17357973|P18|Treatment Period|Death|0
5038132|NCT02733042|17357974|P17|Treatment Period|Death|0
5038133|NCT02733042|17357975|P16|Treatment Period|Death|2
5038134|NCT02733042|17357976|P15|Treatment Period|Death|1
5038135|NCT02733042|17357977|P14|Treatment Period|Death|0
5038136|NCT02733042|17357978|P13|Treatment Period|Death|0
5038137|NCT02733042|17357979|P12|Treatment Period|Death|0
5038138|NCT02733042|17357980|P11|Treatment Period|Death|1
5038139|NCT02733042|17357981|P10|Treatment Period|Death|0
5038140|NCT02733042|17357982|P9|Treatment Period|Death|1
5038141|NCT02733042|17357983|P8|Treatment Period|Death|0
5038142|NCT02733042|17357984|P7|Treatment Period|Death|1
5038143|NCT02733042|17357985|P6|Treatment Period|Death|0
5038144|NCT02733042|17357986|P5|Treatment Period|Death|0
5038145|NCT02733042|17357987|P4|Treatment Period|Death|0
5038146|NCT02733042|17357988|P3|Treatment Period|Death|0
5038147|NCT02733042|17357989|P2|Treatment Period|Death|0
5038148|NCT02733042|17357990|P1|Treatment Period|Death|0
5038149|NCT02733042|17357972|P19|Treatment Period|Ongoing on Assigned Treatment|1
5038150|NCT02733042|17357973|P18|Treatment Period|Ongoing on Assigned Treatment|0
5038151|NCT02733042|17357974|P17|Treatment Period|Ongoing on Assigned Treatment|0
5038152|NCT02733042|17357975|P16|Treatment Period|Ongoing on Assigned Treatment|0
5038153|NCT02733042|17357976|P15|Treatment Period|Ongoing on Assigned Treatment|0
5038154|NCT02733042|17357977|P14|Treatment Period|Ongoing on Assigned Treatment|0
5038155|NCT02733042|17357978|P13|Treatment Period|Ongoing on Assigned Treatment|0
5038156|NCT02733042|17357979|P12|Treatment Period|Ongoing on Assigned Treatment|0
5038157|NCT02733042|17357980|P11|Treatment Period|Ongoing on Assigned Treatment|4
5038158|NCT02733042|17357981|P10|Treatment Period|Ongoing on Assigned Treatment|8
5038159|NCT02733042|17357982|P9|Treatment Period|Ongoing on Assigned Treatment|0
5038160|NCT02733042|17357983|P8|Treatment Period|Ongoing on Assigned Treatment|0
5038161|NCT02733042|17357984|P7|Treatment Period|Ongoing on Assigned Treatment|0
5038162|NCT02733042|17357985|P6|Treatment Period|Ongoing on Assigned Treatment|0
5038163|NCT02733042|17357986|P5|Treatment Period|Ongoing on Assigned Treatment|3
5038164|NCT02733042|17357987|P4|Treatment Period|Ongoing on Assigned Treatment|0
5038165|NCT02733042|17357988|P3|Treatment Period|Ongoing on Assigned Treatment|0
5038166|NCT02733042|17357989|P2|Treatment Period|Ongoing on Assigned Treatment|0
5038167|NCT02733042|17357990|P1|Treatment Period|Ongoing on Assigned Treatment|0
5038168|NCT02733042|17357972|P19|Treatment Period|Other|0
5038169|NCT02733042|17357973|P18|Treatment Period|Other|1
5038170|NCT02733042|17357974|P17|Treatment Period|Other|0
5038171|NCT02733042|17357975|P16|Treatment Period|Other|1
5038172|NCT02733042|17357976|P15|Treatment Period|Other|0
5038173|NCT02733042|17357977|P14|Treatment Period|Other|0
5038174|NCT02733042|17357978|P13|Treatment Period|Other|0
5038175|NCT02733042|17357979|P12|Treatment Period|Other|0
5038176|NCT02733042|17357980|P11|Treatment Period|Other|1
5038177|NCT02733042|17357981|P10|Treatment Period|Other|1
5038178|NCT02733042|17357982|P9|Treatment Period|Other|0
5038179|NCT02733042|17357983|P8|Treatment Period|Other|0
5038180|NCT02733042|17357984|P7|Treatment Period|Other|0
5038181|NCT02733042|17357985|P6|Treatment Period|Other|0
5038182|NCT02733042|17357986|P5|Treatment Period|Other|0
5038183|NCT02733042|17357987|P4|Treatment Period|Other|0
5038184|NCT02733042|17357988|P3|Treatment Period|Other|1
5038185|NCT02733042|17357989|P2|Treatment Period|Other|0
5038186|NCT02733042|17357990|P1|Treatment Period|Other|0
5038187|NCT02733042|17357972|P19|Treatment Period|Withdrawal by Subject|0
5038188|NCT02733042|17357973|P18|Treatment Period|Withdrawal by Subject|0
5038189|NCT02733042|17357974|P17|Treatment Period|Withdrawal by Subject|0
5038190|NCT02733042|17357975|P16|Treatment Period|Withdrawal by Subject|0
5038191|NCT02733042|17357976|P15|Treatment Period|Withdrawal by Subject|0
5038192|NCT02733042|17357977|P14|Treatment Period|Withdrawal by Subject|1
5038193|NCT02733042|17357978|P13|Treatment Period|Withdrawal by Subject|1
5038194|NCT02733042|17357979|P12|Treatment Period|Withdrawal by Subject|2
5038195|NCT02733042|17357980|P11|Treatment Period|Withdrawal by Subject|0
5038196|NCT02733042|17357981|P10|Treatment Period|Withdrawal by Subject|1
5038197|NCT02733042|17357982|P9|Treatment Period|Withdrawal by Subject|1
5038198|NCT02733042|17357983|P8|Treatment Period|Withdrawal by Subject|0
5038199|NCT02733042|17357984|P7|Treatment Period|Withdrawal by Subject|0
5038200|NCT02733042|17357985|P6|Treatment Period|Withdrawal by Subject|0
5038201|NCT02733042|17357986|P5|Treatment Period|Withdrawal by Subject|0
5038202|NCT02733042|17357987|P4|Treatment Period|Withdrawal by Subject|1
5038203|NCT02733042|17357988|P3|Treatment Period|Withdrawal by Subject|2
5038204|NCT02733042|17357989|P2|Treatment Period|Withdrawal by Subject|1
5038205|NCT02733042|17357990|P1|Treatment Period|Withdrawal by Subject|0
5038206|NCT02733042|17357972|P19|Treatment Period|Progressive Disease|4
5038207|NCT02733042|17357973|P18|Treatment Period|Progressive Disease|3
5038208|NCT02733042|17357974|P17|Treatment Period|Progressive Disease|2
5038209|NCT02733042|17357975|P16|Treatment Period|Progressive Disease|7
5038210|NCT02733042|17357976|P15|Treatment Period|Progressive Disease|4
5038211|NCT02733042|17357977|P14|Treatment Period|Progressive Disease|1
5038212|NCT02733042|17357978|P13|Treatment Period|Progressive Disease|8
5038213|NCT02733042|17357979|P12|Treatment Period|Progressive Disease|2
5038214|NCT02733042|17357980|P11|Treatment Period|Progressive Disease|2
5038215|NCT02733042|17357981|P10|Treatment Period|Progressive Disease|0
5038216|NCT02733042|17357982|P9|Treatment Period|Progressive Disease|3
5038217|NCT02733042|17357983|P8|Treatment Period|Progressive Disease|3
5038218|NCT02733042|17357984|P7|Treatment Period|Progressive Disease|0
5038219|NCT02733042|17357985|P6|Treatment Period|Progressive Disease|3
5038220|NCT02733042|17357986|P5|Treatment Period|Progressive Disease|1
5038221|NCT02733042|17357987|P4|Treatment Period|Progressive Disease|1
5038222|NCT02733042|17357988|P3|Treatment Period|Progressive Disease|3
5038223|NCT02733042|17357989|P2|Treatment Period|Progressive Disease|1
5038224|NCT02733042|17357990|P1|Treatment Period|Progressive Disease|2
5038225|NCT02733042|17357972|P19|Treatment Period|Adverse Event|0
5038226|NCT02733042|17357973|P18|Treatment Period|Adverse Event|1
5038227|NCT02733042|17357974|P17|Treatment Period|Adverse Event|0
5038228|NCT02733042|17357975|P16|Treatment Period|Adverse Event|0
5038229|NCT02733042|17357976|P15|Treatment Period|Adverse Event|0
5038230|NCT02733042|17357977|P14|Treatment Period|Adverse Event|2
5038231|NCT02733042|17357978|P13|Treatment Period|Adverse Event|0
5038232|NCT02733042|17357979|P12|Treatment Period|Adverse Event|2
5038233|NCT02733042|17357980|P11|Treatment Period|Adverse Event|2
5038234|NCT02733042|17357981|P10|Treatment Period|Adverse Event|0
5038235|NCT02733042|17357982|P9|Treatment Period|Adverse Event|0
5038236|NCT02733042|17357983|P8|Treatment Period|Adverse Event|0
5038237|NCT02733042|17357984|P7|Treatment Period|Adverse Event|0
5038238|NCT02733042|17357985|P6|Treatment Period|Adverse Event|0
5038239|NCT02733042|17357986|P5|Treatment Period|Adverse Event|0
5038240|NCT02733042|17357987|P4|Treatment Period|Adverse Event|1
5038241|NCT02733042|17357988|P3|Treatment Period|Adverse Event|1
5038242|NCT02733042|17357989|P2|Treatment Period|Adverse Event|0
5038243|NCT02733042|17357990|P1|Treatment Period|Adverse Event|1
5038244|NCT02732951|17358195|P2|Overall Study|Protocol Violation|1
5038245|NCT02732951|17358196|P1|Overall Study|Protocol Violation|0
5038246|NCT02732951|17358195|P2|Overall Study|Adverse Event|4
5038247|NCT02732951|17358196|P1|Overall Study|Adverse Event|4
5038248|NCT02732951|17358195|P2|Overall Study|Lost to Follow-up|1
5038249|NCT02732951|17358196|P1|Overall Study|Lost to Follow-up|0
5038250|NCT02732951|17358195|P2|Overall Study|Other than listed|0
5038251|NCT02732951|17358196|P1|Overall Study|Other than listed|1
5038252|NCT02732938|17358206|P3|Overall Study|Study terminated by sponsor|0
5038253|NCT02732938|17358207|P2|Overall Study|Study terminated by sponsor|6
5038254|NCT02732938|17358208|P1|Overall Study|Study terminated by sponsor|3
5038255|NCT02732938|17358206|P3|Overall Study|Refused further follow-up|0
5038256|NCT02732938|17358207|P2|Overall Study|Refused further follow-up|0
5038257|NCT02732938|17358208|P1|Overall Study|Refused further follow-up|1
5038258|NCT02732938|17358206|P3|Overall Study|Randomized but did not receive treatment|0
5038259|NCT02732938|17358207|P2|Overall Study|Randomized but did not receive treatment|1
5038260|NCT02732938|17358208|P1|Overall Study|Randomized but did not receive treatment|0
5038261|NCT02732938|17358206|P3|Overall Study|Death|0
5038262|NCT02732938|17358207|P2|Overall Study|Death|11
5038263|NCT02732938|17358208|P1|Overall Study|Death|0
5038264|NCT02732912|17358254|P2|Overall Study|No outcome; discharged or refused|9
5038265|NCT02732912|17358255|P1|Overall Study|No outcome; discharged or refused|6
5038266|NCT02732912|17358254|P2|Overall Study|Incomplete completion of questionnaire|3
5038267|NCT02732912|17358255|P1|Overall Study|Incomplete completion of questionnaire|2
5038268|NCT02732912|17358254|P2|Overall Study|Discharged before night|6
5038269|NCT02732912|17358255|P1|Overall Study|Discharged before night|2
5038270|NCT02732639|17358280|P1|Overall Study|Lost to Follow-up|1
5038271|NCT02732561|17358306|P2|Overall Study|Withdrawal by Subject|0
5038272|NCT02732561|17358307|P1|Overall Study|Withdrawal by Subject|1
5038273|NCT02732561|17358306|P2|Overall Study|Lost to Follow-up|1
5038274|NCT02732561|17358307|P1|Overall Study|Lost to Follow-up|1
5038275|NCT02732327|17358333|P2|Overall Study|Protocol Violation|1
5038276|NCT02732327|17358334|P1|Overall Study|Protocol Violation|0
5038277|NCT02732210|17358342|P2|Overall Study|Missing|8
5038278|NCT02732210|17358343|P1|Overall Study|Missing|0
5038279|NCT02732210|17358342|P2|Overall Study|Other|103
5038280|NCT02732210|17358343|P1|Overall Study|Other|35
5038281|NCT02732210|17358342|P2|Overall Study|Death|15
5038282|NCT02732210|17358343|P1|Overall Study|Death|4
5038283|NCT02732210|17358342|P2|Overall Study|Lost to Follow-up|57
5038284|NCT02732210|17358343|P1|Overall Study|Lost to Follow-up|5
5038285|NCT02732210|17358342|P2|Overall Study|Withdrawal by Subject|87
5038286|NCT02732210|17358343|P1|Overall Study|Withdrawal by Subject|28
5038287|NCT02732210|17358342|P2|Overall Study|Study Ended|13
5038288|NCT02732210|17358343|P1|Overall Study|Study Ended|13
5038289|NCT02732210|17358342|P2|Overall Study|Site Closed|11
5038290|NCT02732210|17358343|P1|Overall Study|Site Closed|0
5038291|NCT02731755|17358522|P2|First Intervention|Withdrawal by Subject|2
5038292|NCT02731755|17358523|P1|First Intervention|Withdrawal by Subject|0
5038293|NCT02731742|17358547|P4|Overall Study|Study Terminated by Sponsor|1
5038294|NCT02731742|17358548|P3|Overall Study|Study Terminated by Sponsor|1
5038295|NCT02731742|17358549|P2|Overall Study|Study Terminated by Sponsor|1
5038296|NCT02731742|17358550|P1|Overall Study|Study Terminated by Sponsor|2
5038297|NCT02731742|17358547|P4|Overall Study|Physician Decision|1
5038298|NCT02731742|17358548|P3|Overall Study|Physician Decision|0
5038299|NCT02731742|17358549|P2|Overall Study|Physician Decision|0
5038300|NCT02731742|17358550|P1|Overall Study|Physician Decision|0
5038301|NCT02731742|17358547|P4|Overall Study|Death|0
5038302|NCT02731742|17358548|P3|Overall Study|Death|5
5038303|NCT02731742|17358549|P2|Overall Study|Death|2
5038304|NCT02731742|17358550|P1|Overall Study|Death|1
5038305|NCT02731690|17358568|P1|Overall Study|Discontinuation of Study by Sponsor|26
5038306|NCT02731690|17358568|P1|Overall Study|Withdrawal by Subject|3
5038307|NCT02731690|17358568|P1|Overall Study|Adverse Event|1
5038308|NCT02731638|17358588|P2|Overall Study|Lost to Follow-up|9
5038309|NCT02731638|17358589|P1|Overall Study|Lost to Follow-up|6
5038310|NCT02731157|17358832|P1|First Rejuvenated RCE|Withdrawal by Subject|1
5038311|NCT02731131|17358850|P2|Overall Study|Refused Therapy|1
5038312|NCT02731131|17358851|P1|Overall Study|Refused Therapy|0
5038313|NCT02731131|17358850|P2|Overall Study|Psychiatric Disorder|1
5038314|NCT02731131|17358851|P1|Overall Study|Psychiatric Disorder|0
5038315|NCT02730871|17358901|P2|Overall Study|Adverse Event|0
5038316|NCT02730871|17358902|P1|Overall Study|Adverse Event|6
5038317|NCT02730819|17358916|P1|Overall Study|Lost to Follow-up|9
5038318|NCT02730728|17358925|P3|Overall Study|Lack of Efficacy|1
5038319|NCT02730728|17358926|P2|Overall Study|Lack of Efficacy|1
5038320|NCT02730728|17358927|P1|Overall Study|Lack of Efficacy|0
5038321|NCT02730728|17358925|P3|Overall Study|Withdrawal by Subject|0
5038322|NCT02730728|17358926|P2|Overall Study|Withdrawal by Subject|1
5038323|NCT02730728|17358927|P1|Overall Study|Withdrawal by Subject|0
5038324|NCT02730598|17358956|P2|Overall Study|Unrelated Injury affecting outcomes.|0
5038325|NCT02730598|17358957|P1|Overall Study|Unrelated Injury affecting outcomes.|1
5038326|NCT02730598|17358956|P2|Overall Study|Protocol Violation|1
5038327|NCT02730598|17358957|P1|Overall Study|Protocol Violation|0
5038328|NCT02730598|17358956|P2|Overall Study|Withdrawal by Subject|3
5038329|NCT02730598|17358957|P1|Overall Study|Withdrawal by Subject|3
5038330|NCT02730455|17358980|P3|Overall Study|Other|0
5038331|NCT02730455|17358981|P2|Overall Study|Other|2
5038332|NCT02730455|17358982|P1|Overall Study|Other|2
5038333|NCT02730455|17358980|P3|Overall Study|Other|2
5038334|NCT02730455|17358981|P2|Overall Study|Other|1
5038335|NCT02730455|17358982|P1|Overall Study|Other|1
5038336|NCT02730455|17358980|P3|Overall Study|Lost to Follow-up|4
5038337|NCT02730455|17358981|P2|Overall Study|Lost to Follow-up|1
5038338|NCT02730455|17358982|P1|Overall Study|Lost to Follow-up|3
5038339|NCT02730455|17358980|P3|Overall Study|Consent withdrawn|1
5038340|NCT02730455|17358981|P2|Overall Study|Consent withdrawn|4
5038341|NCT02730455|17358982|P1|Overall Study|Consent withdrawn|2
5038342|NCT02730455|17358980|P3|Overall Study|Death|4
5038343|NCT02730455|17358981|P2|Overall Study|Death|6
5038344|NCT02730455|17358982|P1|Overall Study|Death|5
5038345|NCT02730377|17359032|P2|Overall Study|Lost to Follow-up|21
5038346|NCT02730377|17359033|P1|Overall Study|Lost to Follow-up|25
5038347|NCT02730377|17359032|P2|Overall Study|Withdrawal by Subject|42
5038348|NCT02730377|17359033|P1|Overall Study|Withdrawal by Subject|45
5038349|NCT02730377|17359032|P2|Overall Study|Pregnancy|1
5038350|NCT02730377|17359033|P1|Overall Study|Pregnancy|0
5038351|NCT02730377|17359032|P2|Overall Study|Lack of Efficacy|13
5038352|NCT02730377|17359033|P1|Overall Study|Lack of Efficacy|4
5038353|NCT02730377|17359032|P2|Overall Study|Protocol Violation|30
5038354|NCT02730377|17359033|P1|Overall Study|Protocol Violation|23
5038355|NCT02730377|17359032|P2|Overall Study|Adverse Event|41
5038356|NCT02730377|17359033|P1|Overall Study|Adverse Event|79
5038357|NCT02730377|17359032|P2|Overall Study|Inadequate glycaemic control|473
5038358|NCT02730377|17359033|P1|Overall Study|Inadequate glycaemic control|368
5038359|NCT02730377|17359032|P2|Overall Study|Death|8
5038360|NCT02730377|17359033|P1|Overall Study|Death|1
5038361|NCT02730377|17359032|P2|Overall Study|Other|4
5038362|NCT02730377|17359033|P1|Overall Study|Other|5
5038363|NCT02730351|17359083|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
5038364|NCT02730351|17359084|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
5038365|NCT02730351|17359083|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
5038366|NCT02730351|17359084|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
5038367|NCT02730351|17359083|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
5038368|NCT02730351|17359084|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
5038369|NCT02730351|17359083|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
5038370|NCT02730351|17359084|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
5038371|NCT02730351|17359083|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
5038372|NCT02730351|17359084|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
5038373|NCT02730208|17359118|P2|Overall Study|Withdrawal of consent (not due to AE)|1
5038374|NCT02730208|17359119|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5038375|NCT02730195|17359127|P1|Overall Study|Withdrawal by Subject|1
5038376|NCT02730169|17359137|P4|Overall Study|Other|1
5038377|NCT02730169|17359138|P3|Overall Study|Other|1
5038378|NCT02730169|17359139|P2|Overall Study|Other|0
5038379|NCT02730169|17359140|P1|Overall Study|Other|0
5038380|NCT02730169|17359137|P4|Overall Study|Lost to Follow-up|6
5038381|NCT02730169|17359138|P3|Overall Study|Lost to Follow-up|5
5038382|NCT02730169|17359139|P2|Overall Study|Lost to Follow-up|6
5038383|NCT02730169|17359140|P1|Overall Study|Lost to Follow-up|5
5038384|NCT02730169|17359137|P4|Overall Study|Withdrawal by Subject|8
5038385|NCT02730169|17359138|P3|Overall Study|Withdrawal by Subject|6
5038386|NCT02730169|17359139|P2|Overall Study|Withdrawal by Subject|11
5038387|NCT02730169|17359140|P1|Overall Study|Withdrawal by Subject|6
5038388|NCT02730169|17359137|P4|Overall Study|Adverse Event of Special Interest|0
5038389|NCT02730169|17359138|P3|Overall Study|Adverse Event of Special Interest|2
5038390|NCT02730169|17359139|P2|Overall Study|Adverse Event of Special Interest|1
5038391|NCT02730169|17359140|P1|Overall Study|Adverse Event of Special Interest|0
5038392|NCT02730169|17359137|P4|Overall Study|Adverse Event|0
5038393|NCT02730169|17359138|P3|Overall Study|Adverse Event|3
5038394|NCT02730169|17359139|P2|Overall Study|Adverse Event|3
5038395|NCT02730169|17359140|P1|Overall Study|Adverse Event|2
5038396|NCT02730169|17359137|P4|Overall Study|Protocol Violation|1
5038397|NCT02730169|17359138|P3|Overall Study|Protocol Violation|0
5038398|NCT02730169|17359139|P2|Overall Study|Protocol Violation|0
5038399|NCT02730169|17359140|P1|Overall Study|Protocol Violation|1
5038400|NCT02729909|17359208|P2|Overall Study|Voluntary Withdrawal|0
5038401|NCT02729909|17359209|P1|Overall Study|Voluntary Withdrawal|1
5038402|NCT02729909|17359208|P2|Overall Study|Significant Protocol Deviation|2
5038403|NCT02729909|17359209|P1|Overall Study|Significant Protocol Deviation|0
5038404|NCT02729909|17359208|P2|Overall Study|Lack of Efficacy|2
5038405|NCT02729909|17359209|P1|Overall Study|Lack of Efficacy|0
5038406|NCT02729909|17359208|P2|Overall Study|Lost to Follow-up|1
5038407|NCT02729909|17359209|P1|Overall Study|Lost to Follow-up|0
5038408|NCT02729896|17359228|P3|Overall Study|Progressive Disease|1
5038409|NCT02729896|17359229|P2|Overall Study|Progressive Disease|0
5038410|NCT02729896|17359230|P1|Overall Study|Progressive Disease|0
5038411|NCT02729896|17359228|P3|Overall Study|Physician Decision|5
5038412|NCT02729896|17359229|P2|Overall Study|Physician Decision|0
5038413|NCT02729896|17359230|P1|Overall Study|Physician Decision|0
5038414|NCT02729896|17359228|P3|Overall Study|Death|10
5038415|NCT02729896|17359229|P2|Overall Study|Death|2
5038416|NCT02729896|17359230|P1|Overall Study|Death|0
5038417|NCT02729831|17359251|P4|6 Month Follow-up|Death|1
5038418|NCT02729831|17359252|P3|6 Month Follow-up|Death|0
5038419|NCT02729831|17359253|P2|6 Month Follow-up|Death|3
5038420|NCT02729831|17359254|P1|6 Month Follow-up|Death|1
5038421|NCT02729831|17359251|P4|6 Month Follow-up|Lost to Follow-up|42
5038422|NCT02729831|17359252|P3|6 Month Follow-up|Lost to Follow-up|48
5038423|NCT02729831|17359253|P2|6 Month Follow-up|Lost to Follow-up|51
5038424|NCT02729831|17359254|P1|6 Month Follow-up|Lost to Follow-up|54
5038425|NCT02729831|17359251|P4|1 Week Post-visit|Lost to Follow-up|36
5038426|NCT02729831|17359252|P3|1 Week Post-visit|Lost to Follow-up|38
5038427|NCT02729831|17359253|P2|1 Week Post-visit|Lost to Follow-up|40
5038428|NCT02729831|17359254|P1|1 Week Post-visit|Lost to Follow-up|43
5038429|NCT02729831|17359251|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
5038430|NCT02729831|17359252|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
5038431|NCT02729831|17359253|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
5038432|NCT02729831|17359254|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
5038433|NCT02729753|17359282|P2|Overall Study|Device Malfunction. No units in stock.|1
5038434|NCT02729753|17359283|P1|Overall Study|Device Malfunction. No units in stock.|0
5038435|NCT02729545|17359297|P2|Overall Study|Withdrawal by Subject|3
5038436|NCT02729545|17359298|P1|Overall Study|Withdrawal by Subject|2
5038437|NCT02729545|17359297|P2|Overall Study|Lost to Follow-up|1
5038438|NCT02729545|17359298|P1|Overall Study|Lost to Follow-up|0
5038439|NCT02729545|17359297|P2|Overall Study|Pregnancy|1
5038440|NCT02729545|17359298|P1|Overall Study|Pregnancy|1
5038441|NCT02729194|17359320|P1|Overall Study|Withdrawal by Subject|3
5038442|NCT02729051|17359332|P2|Overall Study|Withdrawal by Subject|17
5038443|NCT02729051|17359333|P1|Overall Study|Withdrawal by Subject|6
5038444|NCT02729051|17359332|P2|Overall Study|Physician Decision|1
5038445|NCT02729051|17359333|P1|Overall Study|Physician Decision|1
5038446|NCT02729051|17359332|P2|Overall Study|Lost to Follow-up|2
5038447|NCT02729051|17359333|P1|Overall Study|Lost to Follow-up|1
5038448|NCT02729051|17359332|P2|Overall Study|Lack of Efficacy|1
5038449|NCT02729051|17359333|P1|Overall Study|Lack of Efficacy|1
5038450|NCT02729051|17359332|P2|Overall Study|Adverse Event|11
5038451|NCT02729051|17359333|P1|Overall Study|Adverse Event|21
5038452|NCT02729025|17359477|P2|Overall Study|Sponsor Decision|1
5038453|NCT02729025|17359478|P1|Overall Study|Sponsor Decision|0
5038454|NCT02728895|17359492|P2|Overall Study|Withdrawal by Subject|3
5038455|NCT02728895|17359493|P1|Overall Study|Withdrawal by Subject|0
5038456|NCT02728895|17359492|P2|Overall Study|Other|2
5038457|NCT02728895|17359493|P1|Overall Study|Other|1
5038458|NCT02728830|17359513|P1|Overall Study|Language Barrier|1
5038459|NCT02728830|17359513|P1|Overall Study|Contraindicated Illness|1
5038460|NCT02728830|17359513|P1|Overall Study|Exclusionary Lab Values|1
5038461|NCT02728830|17359513|P1|Overall Study|Lost to Follow-up|1
5038462|NCT02728830|17359513|P1|Overall Study|Withdrawal by Subject|2
5038463|NCT02728830|17359513|P1|Overall Study|Physician Decision|3
5038464|NCT02728830|17359513|P1|Overall Study|Exclusionary Pathology|6
5038465|NCT02728830|17359513|P1|Overall Study|Exclusionary Surgery|9
5038466|NCT02728206|17359528|P1|Overall Study|Death|1
5038467|NCT02728089|17359536|P1|Overall Study|Withdrawal by Subject|1
5038468|NCT02728089|17359536|P1|Overall Study|Physician Decision|2
5038469|NCT02727777|17359624|P3|Overall Study|Progressive disease|0
5038470|NCT02727777|17359625|P2|Overall Study|Progressive disease|0
5038471|NCT02727777|17359626|P1|Overall Study|Progressive disease|2
5038472|NCT02727777|17359624|P3|Overall Study|Screen Failure|0
5038473|NCT02727777|17359625|P2|Overall Study|Screen Failure|0
5038474|NCT02727777|17359626|P1|Overall Study|Screen Failure|2
5038475|NCT02727660|17359647|P3|Overall Study|Administrative Reasons|4
5038476|NCT02727660|17359648|P2|Overall Study|Administrative Reasons|3
5038477|NCT02727660|17359649|P1|Overall Study|Administrative Reasons|2
5038478|NCT02727660|17359647|P3|Overall Study|Protocol Specified Disc. Criteria|2
5038479|NCT02727660|17359648|P2|Overall Study|Protocol Specified Disc. Criteria|5
5038480|NCT02727660|17359649|P1|Overall Study|Protocol Specified Disc. Criteria|5
5038481|NCT02727660|17359647|P3|Overall Study|Protocol Violation|5
5038482|NCT02727660|17359648|P2|Overall Study|Protocol Violation|5
5038483|NCT02727660|17359649|P1|Overall Study|Protocol Violation|7
5038484|NCT02727660|17359647|P3|Overall Study|Lost to Follow-up|8
5038485|NCT02727660|17359648|P2|Overall Study|Lost to Follow-up|9
5038486|NCT02727660|17359649|P1|Overall Study|Lost to Follow-up|5
5038487|NCT02727660|17359647|P3|Overall Study|Physician Decision|14
5038488|NCT02727660|17359648|P2|Overall Study|Physician Decision|8
5038489|NCT02727660|17359649|P1|Overall Study|Physician Decision|3
5038490|NCT02727660|17359647|P3|Overall Study|Withdrawal by Subject|30
5038491|NCT02727660|17359648|P2|Overall Study|Withdrawal by Subject|25
5038492|NCT02727660|17359649|P1|Overall Study|Withdrawal by Subject|26
5038493|NCT02727660|17359647|P3|Overall Study|Adverse Event|32
5038494|NCT02727660|17359648|P2|Overall Study|Adverse Event|21
5038495|NCT02727660|17359649|P1|Overall Study|Adverse Event|28
5038496|NCT02727660|17359647|P3|Overall Study|Lack of Efficacy|70
5038497|NCT02727660|17359648|P2|Overall Study|Lack of Efficacy|40
5038498|NCT02727660|17359649|P1|Overall Study|Lack of Efficacy|40
5038499|NCT02727322|17359668|P2|Overall Study|Protocol Violation|0
5038500|NCT02727322|17359669|P1|Overall Study|Protocol Violation|1
5038501|NCT02727322|17359668|P2|Overall Study|Withdrawal by Subject|1
5038502|NCT02727322|17359669|P1|Overall Study|Withdrawal by Subject|1
5038503|NCT02726945|17359695|P3|Overall Study|Elected to have total knee replacement|0
5038504|NCT02726945|17359696|P2|Overall Study|Elected to have total knee replacement|1
5038505|NCT02726945|17359697|P1|Overall Study|Elected to have total knee replacement|0
5038506|NCT02726945|17359695|P3|Overall Study|Withdrawal by Subject|1
5038507|NCT02726945|17359696|P2|Overall Study|Withdrawal by Subject|0
5038508|NCT02726945|17359697|P1|Overall Study|Withdrawal by Subject|0
5038509|NCT02726399|17359831|P1|Overall Study|Progression of disease|4
5038510|NCT02726399|17359831|P1|Overall Study|Adverse Event|2
5038511|NCT02726399|17359831|P1|Overall Study|Participant Non-Compliance|1
5038512|NCT02726113|17359848|P2|Genomic Analysis|Insurance non-coverage for surgery|1
5038513|NCT02726113|17359849|P1|Genomic Analysis|Insurance non-coverage for surgery|1
5038514|NCT02726113|17359848|P2|Genomic Analysis|Withdrawal by Subject|1
5038515|NCT02726113|17359849|P1|Genomic Analysis|Withdrawal by Subject|2
5038516|NCT02726113|17359848|P2|Genomic Analysis|Protocol Violation|0
5038517|NCT02726113|17359849|P1|Genomic Analysis|Protocol Violation|1
5038518|NCT02726113|17359848|P2|Total Enrollment|Insurance non-coverage for surgery|1
5038519|NCT02726113|17359849|P1|Total Enrollment|Insurance non-coverage for surgery|1
5038520|NCT02726113|17359848|P2|Total Enrollment|Withdrawal by Subject|1
5038521|NCT02726113|17359849|P1|Total Enrollment|Withdrawal by Subject|2
5038522|NCT02726113|17359848|P2|Total Enrollment|Protocol Violation|0
5038523|NCT02726113|17359849|P1|Total Enrollment|Protocol Violation|1
5038524|NCT02726113|17359848|P2|Total Enrollment|Physician Decision|1
5038525|NCT02726113|17359849|P1|Total Enrollment|Physician Decision|0
5038526|NCT02726074|17359856|P1|Overall Study|Others|3
5038527|NCT02726074|17359856|P1|Overall Study|Lost to Follow-up|2
5038528|NCT02726074|17359856|P1|Overall Study|Protocol Violation|3
5038529|NCT02726074|17359856|P1|Overall Study|Adverse Event|14
5038530|NCT02726074|17359856|P1|Overall Study|Withdrawal by Subject|4
5038531|NCT02726022|17359868|P1|Overall Study|Treatment Failure and Poor Compliance|1
5038532|NCT02726022|17359868|P1|Overall Study|Poor Compliance|13
5038533|NCT02726022|17359868|P1|Overall Study|Treatment Failure|8
5038534|NCT02726022|17359868|P1|Overall Study|Adverse Event|14
5038535|NCT02725866|17359877|P1|Overall Study|Other, not specified|4
5038536|NCT02725866|17359877|P1|Overall Study|Insufficient virological response|1
5038537|NCT02725866|17359877|P1|Overall Study|Withdrew consent|3
5038538|NCT02725866|17359877|P1|Overall Study|Failure to return|6
5038539|NCT02725788|17359901|P2|Overall Study|Protocol Violation|1
5038540|NCT02725788|17359902|P1|Overall Study|Protocol Violation|0
5038541|NCT02725788|17359901|P2|Overall Study|Lost to Follow-up|1
5038542|NCT02725788|17359902|P1|Overall Study|Lost to Follow-up|1
5038543|NCT02725710|17359910|P2|Overall Study|Lost to Follow-up|0
5038544|NCT02725710|17359911|P1|Overall Study|Lost to Follow-up|1
5038545|NCT02725671|17359939|P1|Overall Study|Lost to Follow-up|1
5038546|NCT02725515|17359954|P2|Overall Study|Lack of Response|1
5038547|NCT02725515|17359955|P1|Overall Study|Lack of Response|0
5038548|NCT02725515|17359954|P2|Overall Study|Completed Study Under Original Protocol|1
5038549|NCT02725515|17359955|P1|Overall Study|Completed Study Under Original Protocol|0
5038550|NCT02725515|17359954|P2|Overall Study|No Documented Disease Improvement|1
5038551|NCT02725515|17359955|P1|Overall Study|No Documented Disease Improvement|0
5038552|NCT02725515|17359954|P2|Overall Study|Adverse Event|2
5038553|NCT02725515|17359955|P1|Overall Study|Adverse Event|7
5038554|NCT02725515|17359954|P2|Overall Study|Lost to Follow-up|1
5038555|NCT02725515|17359955|P1|Overall Study|Lost to Follow-up|1
5038556|NCT02725515|17359954|P2|Overall Study|Non-Compliance With Study Drug|3
5038557|NCT02725515|17359955|P1|Overall Study|Non-Compliance With Study Drug|0
5038558|NCT02725515|17359954|P2|Overall Study|Withdrawal by Subject|1
5038559|NCT02725515|17359955|P1|Overall Study|Withdrawal by Subject|2
5038560|NCT02725515|17359954|P2|Overall Study|Loss of Improvement per Protocol|25
5038561|NCT02725515|17359955|P1|Overall Study|Loss of Improvement per Protocol|14
5038562|NCT02725515|17359954|P2|Overall Study|Refused infusion (no study treatment)|0
5038563|NCT02725515|17359955|P1|Overall Study|Refused infusion (no study treatment)|1
5038564|NCT02725476|17359967|P2|Overall Study|Adverse Event|1
5038565|NCT02725476|17359968|P1|Overall Study|Adverse Event|1
5038566|NCT02725476|17359967|P2|Overall Study|Physician Decision|0
5038567|NCT02725476|17359968|P1|Overall Study|Physician Decision|2
5038568|NCT02725411|17359979|P3|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
5038569|NCT02725411|17359980|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
5038570|NCT02725411|17359981|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5038571|NCT02725411|17359979|P3|Follow-up Period (24 Weeks)|Other|2
5038572|NCT02725411|17359980|P2|Follow-up Period (24 Weeks)|Other|4
5038573|NCT02725411|17359981|P1|Follow-up Period (24 Weeks)|Other|1
5038574|NCT02725411|17359979|P3|Follow-up Period (24 Weeks)|Lost to Follow-up|0
5038575|NCT02725411|17359980|P2|Follow-up Period (24 Weeks)|Lost to Follow-up|1
5038576|NCT02725411|17359981|P1|Follow-up Period (24 Weeks)|Lost to Follow-up|1
5038577|NCT02725411|17359979|P3|Follow-up Period (24 Weeks)|Lack of Efficacy|0
5038578|NCT02725411|17359980|P2|Follow-up Period (24 Weeks)|Lack of Efficacy|2
5038579|NCT02725411|17359981|P1|Follow-up Period (24 Weeks)|Lack of Efficacy|0
5038580|NCT02725411|17359979|P3|Follow-up Period (24 Weeks)|Adverse Event|0
5038581|NCT02725411|17359980|P2|Follow-up Period (24 Weeks)|Adverse Event|1
5038582|NCT02725411|17359981|P1|Follow-up Period (24 Weeks)|Adverse Event|1
5038583|NCT02725411|17359979|P3|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
5038584|NCT02725411|17359980|P2|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
5038585|NCT02725411|17359981|P1|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
5038586|NCT02725411|17359979|P3|Treatment Period (56 Weeks)|Withdrawal by Subject|4
5038587|NCT02725411|17359980|P2|Treatment Period (56 Weeks)|Withdrawal by Subject|1
5038588|NCT02725411|17359981|P1|Treatment Period (56 Weeks)|Withdrawal by Subject|0
5038589|NCT02725411|17359979|P3|Treatment Period (56 Weeks)|Other|5
5038590|NCT02725411|17359980|P2|Treatment Period (56 Weeks)|Other|4
5038591|NCT02725411|17359981|P1|Treatment Period (56 Weeks)|Other|1
5038592|NCT02725411|17359979|P3|Treatment Period (56 Weeks)|Lost to Follow-up|0
5038593|NCT02725411|17359980|P2|Treatment Period (56 Weeks)|Lost to Follow-up|1
5038594|NCT02725411|17359981|P1|Treatment Period (56 Weeks)|Lost to Follow-up|0
5038595|NCT02725411|17359979|P3|Treatment Period (56 Weeks)|Lack of Efficacy|1
5038596|NCT02725411|17359980|P2|Treatment Period (56 Weeks)|Lack of Efficacy|4
5038597|NCT02725411|17359981|P1|Treatment Period (56 Weeks)|Lack of Efficacy|1
5038598|NCT02725411|17359979|P3|Treatment Period (56 Weeks)|Adverse Event|4
5038599|NCT02725411|17359980|P2|Treatment Period (56 Weeks)|Adverse Event|5
5038600|NCT02725411|17359981|P1|Treatment Period (56 Weeks)|Adverse Event|3
5038601|NCT02725268|17360197|P4|Overall Study|Ongoing|0
5038602|NCT02725268|17360198|P3|Overall Study|Ongoing|0
5038603|NCT02725268|17360199|P2|Overall Study|Ongoing|3
5038604|NCT02725268|17360200|P1|Overall Study|Ongoing|3
5038605|NCT02725268|17360197|P4|Overall Study|Reason not Specified|0
5038606|NCT02725268|17360198|P3|Overall Study|Reason not Specified|0
5038607|NCT02725268|17360199|P2|Overall Study|Reason not Specified|1
5038608|NCT02725268|17360200|P1|Overall Study|Reason not Specified|1
5038609|NCT02725268|17360197|P4|Overall Study|Withdrawal by Subject|1
5038610|NCT02725268|17360198|P3|Overall Study|Withdrawal by Subject|8
5038611|NCT02725268|17360199|P2|Overall Study|Withdrawal by Subject|4
5038612|NCT02725268|17360200|P1|Overall Study|Withdrawal by Subject|8
5038613|NCT02725268|17360197|P4|Overall Study|Lost to Follow-up|0
5038614|NCT02725268|17360198|P3|Overall Study|Lost to Follow-up|0
5038615|NCT02725268|17360199|P2|Overall Study|Lost to Follow-up|3
5038616|NCT02725268|17360200|P1|Overall Study|Lost to Follow-up|2
5038617|NCT02725268|17360197|P4|Overall Study|Death|16
5038618|NCT02725268|17360198|P3|Overall Study|Death|29
5038619|NCT02725268|17360199|P2|Overall Study|Death|48
5038620|NCT02725268|17360200|P1|Overall Study|Death|45
5038621|NCT02725008|17360236|P2|Overall Study|Admitted to hospital|1
5038622|NCT02725008|17360237|P1|Overall Study|Admitted to hospital|0
5038623|NCT02725008|17360236|P2|Overall Study|Withdrawal by Subject|2
5038624|NCT02725008|17360237|P1|Overall Study|Withdrawal by Subject|2
5038625|NCT02725008|17360236|P2|Overall Study|Lost to Follow-up|9
5038626|NCT02725008|17360237|P1|Overall Study|Lost to Follow-up|7
5038627|NCT02724839|17360248|P3|Overall Study|Physician Decision|3
5038628|NCT02724839|17360249|P2|Overall Study|Physician Decision|0
5038629|NCT02724839|17360250|P1|Overall Study|Physician Decision|0
5038630|NCT02724839|17360248|P3|Overall Study|Lost to Follow-up|2
5038631|NCT02724839|17360249|P2|Overall Study|Lost to Follow-up|3
5038632|NCT02724839|17360250|P1|Overall Study|Lost to Follow-up|0
5038633|NCT02724839|17360248|P3|Overall Study|Withdrawal by Subject|0
5038634|NCT02724839|17360249|P2|Overall Study|Withdrawal by Subject|1
5038635|NCT02724839|17360250|P1|Overall Study|Withdrawal by Subject|1
5038636|NCT02724644|17360327|P2|Overall Study|Administrative|0
5038637|NCT02724644|17360328|P1|Overall Study|Administrative|1
5038638|NCT02724644|17360327|P2|Overall Study|Withdrawal by Subject|1
5038639|NCT02724644|17360328|P1|Overall Study|Withdrawal by Subject|7
5038640|NCT02724644|17360327|P2|Overall Study|Lost to Follow-up|2
5038641|NCT02724644|17360328|P1|Overall Study|Lost to Follow-up|6
5038642|NCT02724644|17360327|P2|Overall Study|Adverse Event|1
5038643|NCT02724644|17360328|P1|Overall Study|Adverse Event|7
5038644|NCT02724111|17360362|P2|Overall Study|Protocol Violation|5
5038645|NCT02724111|17360363|P1|Overall Study|Protocol Violation|2
5038646|NCT02723786|17360396|P1|Overall Study|Lost to Follow-up|1
5038647|NCT02723630|17360424|P6|Intervention Period 3|consumption of restricted item|0
5038648|NCT02723630|17360425|P5|Intervention Period 3|consumption of restricted item|0
5038649|NCT02723630|17360426|P4|Intervention Period 3|consumption of restricted item|0
5038650|NCT02723630|17360427|P3|Intervention Period 3|consumption of restricted item|0
5038651|NCT02723630|17360428|P2|Intervention Period 3|consumption of restricted item|1
5038652|NCT02723630|17360429|P1|Intervention Period 3|consumption of restricted item|0
5038653|NCT02723630|17360424|P6|Intervention Period 1|Adverse Event|0
5038654|NCT02723630|17360425|P5|Intervention Period 1|Adverse Event|0
5038655|NCT02723630|17360426|P4|Intervention Period 1|Adverse Event|0
5038656|NCT02723630|17360427|P3|Intervention Period 1|Adverse Event|0
5038657|NCT02723630|17360428|P2|Intervention Period 1|Adverse Event|0
5038658|NCT02723630|17360429|P1|Intervention Period 1|Adverse Event|1
5038659|NCT02723591|17360460|P2|Overall Study|Miscellaneous|6
5038660|NCT02723591|17360461|P1|Overall Study|Miscellaneous|5
5038661|NCT02723591|17360460|P2|Overall Study|Randomized but Never Received StudyDrug|12
5038662|NCT02723591|17360461|P1|Overall Study|Randomized but Never Received StudyDrug|12
5038663|NCT02723591|17360460|P2|Overall Study|Withdrawal by Subject|8
5038664|NCT02723591|17360461|P1|Overall Study|Withdrawal by Subject|4
5038665|NCT02723591|17360460|P2|Overall Study|Protocol Violation|23
5038666|NCT02723591|17360461|P1|Overall Study|Protocol Violation|20
5038667|NCT02723591|17360460|P2|Overall Study|Lost to Follow-up|7
5038668|NCT02723591|17360461|P1|Overall Study|Lost to Follow-up|1
5038669|NCT02723591|17360460|P2|Overall Study|Lack of Efficacy|3
5038670|NCT02723591|17360461|P1|Overall Study|Lack of Efficacy|4
5038671|NCT02723591|17360460|P2|Overall Study|Death|2
5038672|NCT02723591|17360461|P1|Overall Study|Death|2
5038673|NCT02723591|17360460|P2|Overall Study|Adverse Event|40
5038674|NCT02723591|17360461|P1|Overall Study|Adverse Event|48
5038675|NCT02723344|17360589|P2|Overall Study|Lost to Follow-up|4
5038676|NCT02723344|17360590|P1|Overall Study|Lost to Follow-up|0
5038677|NCT02723201|17360613|P3|Second Intervention Period|Adverse Event|0
5038678|NCT02723201|17360614|P2|Second Intervention Period|Adverse Event|0
5038679|NCT02723201|17360615|P1|Second Intervention Period|Adverse Event|1
5038680|NCT02723201|17360613|P3|Second Intervention Period|Protocol Violation|0
5038681|NCT02723201|17360614|P2|Second Intervention Period|Protocol Violation|0
5038682|NCT02723201|17360615|P1|Second Intervention Period|Protocol Violation|1
5038683|NCT02723188|17360674|P3|Overall Study|Withdrawal by Subject|0
5038684|NCT02723188|17360675|P2|Overall Study|Withdrawal by Subject|0
5038685|NCT02723188|17360676|P1|Overall Study|Withdrawal by Subject|1
5038686|NCT02723175|17360689|P2|Overall Study|Lost to 3 Month Follow Up|1
5038687|NCT02723175|17360690|P1|Overall Study|Lost to 3 Month Follow Up|1
5038688|NCT02723175|17360689|P2|Overall Study|Lost to 1 Month Follow Up|2
5038689|NCT02723175|17360690|P1|Overall Study|Lost to 1 Month Follow Up|3
5038690|NCT02723084|17360732|P2|Overall Study|Lost to Follow-up|0
5038691|NCT02723084|17360733|P1|Overall Study|Lost to Follow-up|3
5038692|NCT02723084|17360732|P2|Overall Study|Withdrawal by Subject|1
5038693|NCT02723084|17360733|P1|Overall Study|Withdrawal by Subject|1
5038694|NCT02722967|17360747|P3|Overall Study|Non-adherence of the patch to the skin|2
5038695|NCT02722967|17360748|P2|Overall Study|Non-adherence of the patch to the skin|0
5038696|NCT02722967|17360749|P1|Overall Study|Non-adherence of the patch to the skin|0
5038697|NCT02722967|17360747|P3|Overall Study|Physician Decision|0
5038698|NCT02722967|17360748|P2|Overall Study|Physician Decision|0
5038699|NCT02722967|17360749|P1|Overall Study|Physician Decision|1
5038700|NCT02722967|17360747|P3|Overall Study|Withdrawal by Subject|1
5038701|NCT02722967|17360748|P2|Overall Study|Withdrawal by Subject|0
5038702|NCT02722967|17360749|P1|Overall Study|Withdrawal by Subject|1
5038703|NCT02722967|17360747|P3|Overall Study|Non-compliance with patch wearing|1
5038704|NCT02722967|17360748|P2|Overall Study|Non-compliance with patch wearing|1
5038705|NCT02722967|17360749|P1|Overall Study|Non-compliance with patch wearing|2
5038706|NCT02722967|17360747|P3|Overall Study|Lost to Follow-up|0
5038707|NCT02722967|17360748|P2|Overall Study|Lost to Follow-up|1
5038708|NCT02722967|17360749|P1|Overall Study|Lost to Follow-up|0
5038709|NCT02722967|17360747|P3|Overall Study|Adverse Event|0
5038710|NCT02722967|17360748|P2|Overall Study|Adverse Event|0
5038711|NCT02722967|17360749|P1|Overall Study|Adverse Event|1
5038712|NCT02722928|17360759|P2|Overall Study|Required Intraoperative MRI|7
5038713|NCT02722928|17360760|P1|Overall Study|Required Intraoperative MRI|5
5038714|NCT02722928|17360759|P2|Overall Study|Standard CT was not as required per prot|13
5038715|NCT02722928|17360760|P1|Overall Study|Standard CT was not as required per prot|5
5038716|NCT02722304|17360890|P5|Overall Study|Other|1
5038717|NCT02722304|17360891|P4|Overall Study|Other|1
5038718|NCT02722304|17360892|P3|Overall Study|Other|0
5038719|NCT02722304|17360893|P2|Overall Study|Other|0
5038720|NCT02722304|17360894|P1|Overall Study|Other|0
5038721|NCT02722304|17360890|P5|Overall Study|Study Terminated by Sponsor|1
5038722|NCT02722304|17360891|P4|Overall Study|Study Terminated by Sponsor|1
5038723|NCT02722304|17360892|P3|Overall Study|Study Terminated by Sponsor|2
5038724|NCT02722304|17360893|P2|Overall Study|Study Terminated by Sponsor|0
5038725|NCT02722304|17360894|P1|Overall Study|Study Terminated by Sponsor|1
5038726|NCT02722278|17360946|P2|Overall Study|Site closure not study related|1
5038727|NCT02722278|17360947|P1|Overall Study|Site closure not study related|0
5038728|NCT02722278|17360946|P2|Overall Study|Subject declined after tx assignment|1
5038729|NCT02722278|17360947|P1|Overall Study|Subject declined after tx assignment|0
5038730|NCT02722278|17360946|P2|Overall Study|High PSA pre-study/ not eligible|1
5038731|NCT02722278|17360947|P1|Overall Study|High PSA pre-study/ not eligible|0
5038732|NCT02722278|17360946|P2|Overall Study|Protocol Violation|0
5038733|NCT02722278|17360947|P1|Overall Study|Protocol Violation|1
5038734|NCT02722278|17360946|P2|Overall Study|Lost to Follow-up|0
5038735|NCT02722278|17360947|P1|Overall Study|Lost to Follow-up|2
5038736|NCT02722278|17360946|P2|Overall Study|Adverse Event|1
5038737|NCT02722278|17360947|P1|Overall Study|Adverse Event|4
5038738|NCT02722278|17360946|P2|Overall Study|Withdrawal by Subject|3
5038739|NCT02722278|17360947|P1|Overall Study|Withdrawal by Subject|5
5038740|NCT02722148|17360971|P1|Overall Study|Non compliant with treatment regimen|3
5038741|NCT02722148|17360971|P1|Overall Study|Lost to Follow-up|2
5038742|NCT02722044|17360978|P1|Overall Study|Did Not Meet Criteria at Week 14|1
5038743|NCT02722044|17360978|P1|Overall Study|Withdrawal by Subject|1
5038744|NCT02722044|17360978|P1|Overall Study|Physician Decision|1
5038745|NCT02722044|17360978|P1|Overall Study|Adverse Event|2
5038746|NCT02721966|17361008|P5|Overall Study|Did not continue to period 2|5
5038747|NCT02721966|17361009|P4|Overall Study|Did not continue to period 2|0
5038748|NCT02721966|17361010|P3|Overall Study|Did not continue to period 2|0
5038749|NCT02721966|17361011|P2|Overall Study|Did not continue to period 2|12
5038750|NCT02721966|17361012|P1|Overall Study|Did not continue to period 2|5
5038751|NCT02721966|17361008|P5|Overall Study|Pregnancy|0
5038752|NCT02721966|17361009|P4|Overall Study|Pregnancy|0
5038753|NCT02721966|17361010|P3|Overall Study|Pregnancy|0
5038754|NCT02721966|17361011|P2|Overall Study|Pregnancy|0
5038755|NCT02721966|17361012|P1|Overall Study|Pregnancy|1
5038756|NCT02721966|17361008|P5|Overall Study|Physician Decision|0
5038757|NCT02721966|17361009|P4|Overall Study|Physician Decision|0
5038758|NCT02721966|17361010|P3|Overall Study|Physician Decision|0
5038759|NCT02721966|17361011|P2|Overall Study|Physician Decision|1
5038760|NCT02721966|17361012|P1|Overall Study|Physician Decision|1
5038761|NCT02721966|17361008|P5|Overall Study|Lost to Follow-up|0
5038762|NCT02721966|17361009|P4|Overall Study|Lost to Follow-up|0
5038763|NCT02721966|17361010|P3|Overall Study|Lost to Follow-up|3
5038764|NCT02721966|17361011|P2|Overall Study|Lost to Follow-up|0
5038765|NCT02721966|17361012|P1|Overall Study|Lost to Follow-up|0
5038766|NCT02721966|17361008|P5|Overall Study|Lack of Efficacy|0
5038767|NCT02721966|17361009|P4|Overall Study|Lack of Efficacy|0
5038768|NCT02721966|17361010|P3|Overall Study|Lack of Efficacy|0
5038769|NCT02721966|17361011|P2|Overall Study|Lack of Efficacy|4
5038770|NCT02721966|17361012|P1|Overall Study|Lack of Efficacy|7
5038771|NCT02721966|17361008|P5|Overall Study|Death|0
5038772|NCT02721966|17361009|P4|Overall Study|Death|0
5038773|NCT02721966|17361010|P3|Overall Study|Death|0
5038774|NCT02721966|17361011|P2|Overall Study|Death|0
5038775|NCT02721966|17361012|P1|Overall Study|Death|1
5038776|NCT02721966|17361008|P5|Overall Study|Adverse Event|0
5038777|NCT02721966|17361009|P4|Overall Study|Adverse Event|0
5038778|NCT02721966|17361010|P3|Overall Study|Adverse Event|3
5038779|NCT02721966|17361011|P2|Overall Study|Adverse Event|4
5038780|NCT02721966|17361012|P1|Overall Study|Adverse Event|4
5038781|NCT02721966|17361008|P5|Overall Study|Withdrawal by Subject|0
5038782|NCT02721966|17361009|P4|Overall Study|Withdrawal by Subject|7
5038783|NCT02721966|17361010|P3|Overall Study|Withdrawal by Subject|3
5038784|NCT02721966|17361011|P2|Overall Study|Withdrawal by Subject|2
5038785|NCT02721966|17361012|P1|Overall Study|Withdrawal by Subject|9
5038786|NCT02721966|17361008|P5|Overall Study|Protocol Violation|0
5038787|NCT02721966|17361009|P4|Overall Study|Protocol Violation|0
5038788|NCT02721966|17361010|P3|Overall Study|Protocol Violation|0
5038789|NCT02721966|17361011|P2|Overall Study|Protocol Violation|0
5038790|NCT02721966|17361012|P1|Overall Study|Protocol Violation|1
5038791|NCT02721875|17361052|P2|Overall Study|Progressive disease/relapse|0
5038792|NCT02721875|17361053|P1|Overall Study|Progressive disease/relapse|1
5038793|NCT02721147|17361104|P3|Overall Study|Lost to Follow-up|0
5038794|NCT02721147|17361105|P2|Overall Study|Lost to Follow-up|0
5038795|NCT02721147|17361106|P1|Overall Study|Lost to Follow-up|2
5038796|NCT02720757|17361150|P1|Overall Study|General exclusion|3
5038797|NCT02720757|17361150|P1|Overall Study|Missing|3
5038798|NCT02720757|17361150|P1|Overall Study|Patients wish to withdraw|2
5038799|NCT02720757|17361150|P1|Overall Study|Informed consent withdrawal|1
5038800|NCT02720757|17361150|P1|Overall Study|Loss of contact|4
5038801|NCT02720757|17361150|P1|Overall Study|Other reason|5
5038802|NCT02720536|17361164|P1|Overall Study|PR- unwilling to comply with procedures|1
5038803|NCT02720536|17361164|P1|Overall Study|PR - abnormal lab value(s)|1
5038804|NCT02720536|17361164|P1|Overall Study|PR - adverse event|1
5038805|NCT02720536|17361164|P1|Overall Study|PR - death|1
5038806|NCT02720536|17361164|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
5038807|NCT02720536|17361164|P1|Overall Study|PR - pregnancy|2
5038808|NCT02720536|17361164|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
5038809|NCT02720523|17361199|P7|Period 2: Long-term Extension Period|Other|3
5038810|NCT02720523|17361200|P6|Period 2: Long-term Extension Period|Other|0
5038811|NCT02720523|17361201|P5|Period 2: Long-term Extension Period|Other|2
5038812|NCT02720523|17361202|P4|Period 2: Long-term Extension Period|Other|0
5038813|NCT02720523|17361203|P3|Period 2: Long-term Extension Period|Other|0
5038814|NCT02720523|17361204|P2|Period 2: Long-term Extension Period|Other|0
5038815|NCT02720523|17361205|P1|Period 2: Long-term Extension Period|Other|0
5038816|NCT02720523|17361199|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
5038817|NCT02720523|17361200|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
5038818|NCT02720523|17361201|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
5038819|NCT02720523|17361202|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5038820|NCT02720523|17361203|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5038821|NCT02720523|17361204|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5038822|NCT02720523|17361205|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5038823|NCT02720523|17361199|P7|Period 2: Long-term Extension Period|Adverse Event|11
5038824|NCT02720523|17361200|P6|Period 2: Long-term Extension Period|Adverse Event|7
5038825|NCT02720523|17361201|P5|Period 2: Long-term Extension Period|Adverse Event|4
5038826|NCT02720523|17361202|P4|Period 2: Long-term Extension Period|Adverse Event|0
5038827|NCT02720523|17361203|P3|Period 2: Long-term Extension Period|Adverse Event|0
5038828|NCT02720523|17361204|P2|Period 2: Long-term Extension Period|Adverse Event|0
5038829|NCT02720523|17361205|P1|Period 2: Long-term Extension Period|Adverse Event|0
5038830|NCT02720523|17361199|P7|Period 2: Long-term Extension Period|Ongoing|45
5038831|NCT02720523|17361200|P6|Period 2: Long-term Extension Period|Ongoing|54
5038832|NCT02720523|17361201|P5|Period 2: Long-term Extension Period|Ongoing|57
5038833|NCT02720523|17361202|P4|Period 2: Long-term Extension Period|Ongoing|0
5038834|NCT02720523|17361203|P3|Period 2: Long-term Extension Period|Ongoing|0
5038835|NCT02720523|17361204|P2|Period 2: Long-term Extension Period|Ongoing|0
5038836|NCT02720523|17361205|P1|Period 2: Long-term Extension Period|Ongoing|0
5038837|NCT02720523|17361199|P7|Period 1: Placebo-controlled Period|Other|0
5038838|NCT02720523|17361200|P6|Period 1: Placebo-controlled Period|Other|0
5038839|NCT02720523|17361201|P5|Period 1: Placebo-controlled Period|Other|0
5038840|NCT02720523|17361202|P4|Period 1: Placebo-controlled Period|Other|1
5038841|NCT02720523|17361203|P3|Period 1: Placebo-controlled Period|Other|1
5038842|NCT02720523|17361204|P2|Period 1: Placebo-controlled Period|Other|0
5038843|NCT02720523|17361205|P1|Period 1: Placebo-controlled Period|Other|0
5038844|NCT02720523|17361199|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5038845|NCT02720523|17361200|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5038846|NCT02720523|17361201|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5038847|NCT02720523|17361202|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5038848|NCT02720523|17361203|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5038849|NCT02720523|17361204|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5038850|NCT02720523|17361205|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
5038851|NCT02720523|17361199|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5038852|NCT02720523|17361200|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5038853|NCT02720523|17361201|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5038854|NCT02720523|17361202|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5038855|NCT02720523|17361203|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5038856|NCT02720523|17361204|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5038857|NCT02720523|17361205|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
5038858|NCT02720523|17361199|P7|Period 1: Placebo-controlled Period|Adverse Event|0
5038859|NCT02720523|17361200|P6|Period 1: Placebo-controlled Period|Adverse Event|0
5038860|NCT02720523|17361201|P5|Period 1: Placebo-controlled Period|Adverse Event|0
5038861|NCT02720523|17361202|P4|Period 1: Placebo-controlled Period|Adverse Event|5
5038862|NCT02720523|17361203|P3|Period 1: Placebo-controlled Period|Adverse Event|1
5038863|NCT02720523|17361204|P2|Period 1: Placebo-controlled Period|Adverse Event|0
5038864|NCT02720523|17361205|P1|Period 1: Placebo-controlled Period|Adverse Event|0
5038865|NCT02720510|17361264|P2|Overall Study|Physician Decision|2
5038866|NCT02720510|17361265|P1|Overall Study|Physician Decision|1
5038867|NCT02720510|17361264|P2|Overall Study|Adverse Event|1
5038868|NCT02720510|17361265|P1|Overall Study|Adverse Event|0
5038869|NCT02720510|17361264|P2|Overall Study|Study Terminated by the sponsor|0
5038870|NCT02720510|17361265|P1|Overall Study|Study Terminated by the sponsor|2
5038871|NCT02720484|17361283|P1|Follow Up for 2 Years|Lost to Follow-up|2
5038872|NCT02720484|17361283|P1|Follow Up for 2 Years|Death|3
5038873|NCT02720484|17361283|P1|Follow Up for 2 Years|Withdrawal by Subject|1
5038874|NCT02720484|17361283|P1|Treatment on Study|Progressive Disease|4
5038875|NCT02720484|17361283|P1|Treatment on Study|Withdrawal by Subject|1
5038876|NCT02720484|17361283|P1|Treatment on Study|Adverse Event|1
5038877|NCT02720198|17361315|P2|Overall Study|Withdrawal by Subject|1
5038878|NCT02720198|17361316|P1|Overall Study|Withdrawal by Subject|0
5038879|NCT02720081|17361351|P2|Overall Study|Protocol Violation|1
5038880|NCT02720081|17361352|P1|Overall Study|Protocol Violation|4
5038881|NCT02720081|17361351|P2|Overall Study|Adverse Event|3
5038882|NCT02720081|17361352|P1|Overall Study|Adverse Event|0
5038883|NCT02720042|17361408|P1|Overall Study|unable due to non-study-related illness|3
5038884|NCT02720042|17361408|P1|Overall Study|Phasix Mesh explanted|1
5038885|NCT02720042|17361408|P1|Overall Study|Physician Decision|3
5038886|NCT02720042|17361408|P1|Overall Study|Withdrawal by Subject|1
5038887|NCT02720042|17361408|P1|Overall Study|Lost to Follow-up|4
5038888|NCT02720042|17361408|P1|Overall Study|Death|3
5038889|NCT02719743|17361449|P5|Overall Study|Lost to Follow-up|0
5038890|NCT02719743|17361450|P4|Overall Study|Lost to Follow-up|0
5038891|NCT02719743|17361451|P3|Overall Study|Lost to Follow-up|0
5038892|NCT02719743|17361452|P2|Overall Study|Lost to Follow-up|1
5038893|NCT02719743|17361453|P1|Overall Study|Lost to Follow-up|1
5038894|NCT02719743|17361449|P5|Overall Study|Migrated/moved from study area|2
5038895|NCT02719743|17361450|P4|Overall Study|Migrated/moved from study area|0
5038896|NCT02719743|17361451|P3|Overall Study|Migrated/moved from study area|0
5038897|NCT02719743|17361452|P2|Overall Study|Migrated/moved from study area|0
5038898|NCT02719743|17361453|P1|Overall Study|Migrated/moved from study area|0
5038899|NCT02719743|17361449|P5|Overall Study|Consent withdrawal|0
5038900|NCT02719743|17361450|P4|Overall Study|Consent withdrawal|1
5038901|NCT02719743|17361451|P3|Overall Study|Consent withdrawal|0
5038902|NCT02719743|17361452|P2|Overall Study|Consent withdrawal|2
5038903|NCT02719743|17361453|P1|Overall Study|Consent withdrawal|0
5038904|NCT02719522|17361594|P1|Overall Study|Lost to Follow-up|5
5038905|NCT02719522|17361594|P1|Overall Study|Death|2
5038906|NCT02719522|17361594|P1|Overall Study|Implant Failure|4
5038907|NCT02719353|17361636|P2|First Intervention|Physician Decision|1
5038908|NCT02719353|17361637|P1|First Intervention|Physician Decision|0
5038909|NCT02719171|17361676|P5|Overall Study|Other|0
5038910|NCT02719171|17361677|P4|Overall Study|Other|1
5038911|NCT02719171|17361678|P3|Overall Study|Other|0
5038912|NCT02719171|17361679|P2|Overall Study|Other|0
5038913|NCT02719171|17361680|P1|Overall Study|Other|0
5038914|NCT02719171|17361676|P5|Overall Study|Subject Withdrawal|0
5038915|NCT02719171|17361677|P4|Overall Study|Subject Withdrawal|1
5038916|NCT02719171|17361678|P3|Overall Study|Subject Withdrawal|2
5038917|NCT02719171|17361679|P2|Overall Study|Subject Withdrawal|2
5038918|NCT02719171|17361680|P1|Overall Study|Subject Withdrawal|0
5038919|NCT02719171|17361676|P5|Overall Study|Lost to Follow-up|0
5038920|NCT02719171|17361677|P4|Overall Study|Lost to Follow-up|0
5038921|NCT02719171|17361678|P3|Overall Study|Lost to Follow-up|1
5038922|NCT02719171|17361679|P2|Overall Study|Lost to Follow-up|0
5038923|NCT02719171|17361680|P1|Overall Study|Lost to Follow-up|0
5038924|NCT02719171|17361676|P5|Overall Study|Adverse Event|2
5038925|NCT02719171|17361677|P4|Overall Study|Adverse Event|0
5038926|NCT02719171|17361678|P3|Overall Study|Adverse Event|0
5038927|NCT02719171|17361679|P2|Overall Study|Adverse Event|2
5038928|NCT02719171|17361680|P1|Overall Study|Adverse Event|1
5038929|NCT02719028|17361797|P4|Overall Study|Protocol Violation|1
5038930|NCT02719028|17361798|P3|Overall Study|Protocol Violation|0
5038931|NCT02719028|17361799|P2|Overall Study|Protocol Violation|0
5038932|NCT02719028|17361800|P1|Overall Study|Protocol Violation|0
5038933|NCT02719028|17361797|P4|Overall Study|Use of prohibited medication|0
5038934|NCT02719028|17361798|P3|Overall Study|Use of prohibited medication|1
5038935|NCT02719028|17361799|P2|Overall Study|Use of prohibited medication|0
5038936|NCT02719028|17361800|P1|Overall Study|Use of prohibited medication|0
5038937|NCT02719028|17361797|P4|Overall Study|Physician Decision|1
5038938|NCT02719028|17361798|P3|Overall Study|Physician Decision|1
5038939|NCT02719028|17361799|P2|Overall Study|Physician Decision|1
5038940|NCT02719028|17361800|P1|Overall Study|Physician Decision|0
5038941|NCT02719028|17361797|P4|Overall Study|Adverse Event|8
5038942|NCT02719028|17361798|P3|Overall Study|Adverse Event|4
5038943|NCT02719028|17361799|P2|Overall Study|Adverse Event|1
5038944|NCT02719028|17361800|P1|Overall Study|Adverse Event|2
5038945|NCT02718898|17361833|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
5038946|NCT02718898|17361834|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
5038947|NCT02718898|17361835|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
5038948|NCT02718898|17361836|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
5038949|NCT02718898|17361837|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
5038950|NCT02718898|17361838|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
5038951|NCT02718898|17361839|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
5038952|NCT02718898|17361833|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
5038953|NCT02718898|17361834|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
5038954|NCT02718898|17361835|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
5038955|NCT02718898|17361836|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
5038956|NCT02718898|17361837|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
5038957|NCT02718898|17361838|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
5038958|NCT02718898|17361839|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
5038959|NCT02718898|17361833|P7|Post Treatment Follow-up Period|Adverse Event|1
5038960|NCT02718898|17361834|P6|Post Treatment Follow-up Period|Adverse Event|1
5038961|NCT02718898|17361835|P5|Post Treatment Follow-up Period|Adverse Event|0
5038962|NCT02718898|17361836|P4|Post Treatment Follow-up Period|Adverse Event|0
5038963|NCT02718898|17361837|P3|Post Treatment Follow-up Period|Adverse Event|0
5038964|NCT02718898|17361838|P2|Post Treatment Follow-up Period|Adverse Event|0
5038965|NCT02718898|17361839|P1|Post Treatment Follow-up Period|Adverse Event|0
5038966|NCT02718898|17361833|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5038967|NCT02718898|17361834|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5038968|NCT02718898|17361835|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5038969|NCT02718898|17361836|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
5038970|NCT02718898|17361837|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5038971|NCT02718898|17361838|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5038972|NCT02718898|17361839|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5038973|NCT02718898|17361833|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5038974|NCT02718898|17361834|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5038975|NCT02718898|17361835|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5038976|NCT02718898|17361836|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
5038977|NCT02718898|17361837|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5038978|NCT02718898|17361838|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5038979|NCT02718898|17361839|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5038980|NCT02718898|17361833|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5038981|NCT02718898|17361834|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5038982|NCT02718898|17361835|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5038983|NCT02718898|17361836|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
5038984|NCT02718898|17361837|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
5038985|NCT02718898|17361838|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5038986|NCT02718898|17361839|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5038987|NCT02718898|17361833|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5038988|NCT02718898|17361834|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5038989|NCT02718898|17361835|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5038990|NCT02718898|17361836|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
5038991|NCT02718898|17361837|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
5038992|NCT02718898|17361838|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5038993|NCT02718898|17361839|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5038994|NCT02718898|17361833|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5038995|NCT02718898|17361834|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5038996|NCT02718898|17361835|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5038997|NCT02718898|17361836|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
5038998|NCT02718898|17361837|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5038999|NCT02718898|17361838|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5039000|NCT02718898|17361839|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5039001|NCT02718898|17361833|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
5039002|NCT02718898|17361834|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
5039003|NCT02718898|17361835|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
5039004|NCT02718898|17361836|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
5039005|NCT02718898|17361837|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
5039006|NCT02718898|17361838|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
5039007|NCT02718898|17361839|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
5039008|NCT02718898|17361833|P7|Blinded Treatment Period|Lost to Follow-up|0
5039009|NCT02718898|17361834|P6|Blinded Treatment Period|Lost to Follow-up|0
5039010|NCT02718898|17361835|P5|Blinded Treatment Period|Lost to Follow-up|0
5039011|NCT02718898|17361836|P4|Blinded Treatment Period|Lost to Follow-up|0
5039012|NCT02718898|17361837|P3|Blinded Treatment Period|Lost to Follow-up|0
5039013|NCT02718898|17361838|P2|Blinded Treatment Period|Lost to Follow-up|0
5039014|NCT02718898|17361839|P1|Blinded Treatment Period|Lost to Follow-up|2
5039015|NCT02718898|17361833|P7|Blinded Treatment Period|Lack of Efficacy|0
5039016|NCT02718898|17361834|P6|Blinded Treatment Period|Lack of Efficacy|0
5039017|NCT02718898|17361835|P5|Blinded Treatment Period|Lack of Efficacy|0
5039018|NCT02718898|17361836|P4|Blinded Treatment Period|Lack of Efficacy|0
5039019|NCT02718898|17361837|P3|Blinded Treatment Period|Lack of Efficacy|0
5039020|NCT02718898|17361838|P2|Blinded Treatment Period|Lack of Efficacy|0
5039021|NCT02718898|17361839|P1|Blinded Treatment Period|Lack of Efficacy|1
5039022|NCT02718898|17361833|P7|Blinded Treatment Period|Physician Decision|0
5039023|NCT02718898|17361834|P6|Blinded Treatment Period|Physician Decision|0
5039024|NCT02718898|17361835|P5|Blinded Treatment Period|Physician Decision|0
5039025|NCT02718898|17361836|P4|Blinded Treatment Period|Physician Decision|0
5039026|NCT02718898|17361837|P3|Blinded Treatment Period|Physician Decision|0
5039027|NCT02718898|17361838|P2|Blinded Treatment Period|Physician Decision|0
5039028|NCT02718898|17361839|P1|Blinded Treatment Period|Physician Decision|1
5039029|NCT02718898|17361833|P7|Blinded Treatment Period|Adverse Event|0
5039030|NCT02718898|17361834|P6|Blinded Treatment Period|Adverse Event|0
5039031|NCT02718898|17361835|P5|Blinded Treatment Period|Adverse Event|0
5039032|NCT02718898|17361836|P4|Blinded Treatment Period|Adverse Event|0
5039033|NCT02718898|17361837|P3|Blinded Treatment Period|Adverse Event|0
5039034|NCT02718898|17361838|P2|Blinded Treatment Period|Adverse Event|1
5039035|NCT02718898|17361839|P1|Blinded Treatment Period|Adverse Event|5
5039036|NCT02718625|17361874|P2|Overall Study|Termination of Study by Sponsor|1
5039037|NCT02718625|17361875|P1|Overall Study|Termination of Study by Sponsor|0
5039038|NCT02718625|17361874|P2|Overall Study|Adverse Event|1
5039039|NCT02718625|17361875|P1|Overall Study|Adverse Event|0
5039040|NCT02718417|17361894|P3|Long-term Follow-up Phase|Other|0
5039041|NCT02718417|17361895|P2|Long-term Follow-up Phase|Other|2
5039042|NCT02718417|17361896|P1|Long-term Follow-up Phase|Other|0
5039043|NCT02718417|17361894|P3|Long-term Follow-up Phase|Withdrawal by Subject|9
5039044|NCT02718417|17361895|P2|Long-term Follow-up Phase|Withdrawal by Subject|9
5039045|NCT02718417|17361896|P1|Long-term Follow-up Phase|Withdrawal by Subject|6
5039046|NCT02718417|17361894|P3|Long-term Follow-up Phase|Study terminated by sponsor|112
5039047|NCT02718417|17361895|P2|Long-term Follow-up Phase|Study terminated by sponsor|80
5039048|NCT02718417|17361896|P1|Long-term Follow-up Phase|Study terminated by sponsor|105
5039049|NCT02718417|17361894|P3|Long-term Follow-up Phase|Lost to Follow-up|3
5039050|NCT02718417|17361895|P2|Long-term Follow-up Phase|Lost to Follow-up|4
5039051|NCT02718417|17361896|P1|Long-term Follow-up Phase|Lost to Follow-up|8
5039052|NCT02718417|17361894|P3|Long-term Follow-up Phase|Death leading to discontinuation|11
5039053|NCT02718417|17361895|P2|Long-term Follow-up Phase|Death leading to discontinuation|17
5039054|NCT02718417|17361896|P1|Long-term Follow-up Phase|Death leading to discontinuation|20
5039055|NCT02718417|17361894|P3|Follow-up Phase|Death leading to discontinuation|3
5039056|NCT02718417|17361895|P2|Follow-up Phase|Death leading to discontinuation|7
5039057|NCT02718417|17361896|P1|Follow-up Phase|Death leading to discontinuation|7
5039058|NCT02718417|17361894|P3|Follow-up Phase|Lost to Follow-up|0
5039059|NCT02718417|17361895|P2|Follow-up Phase|Lost to Follow-up|3
5039060|NCT02718417|17361896|P1|Follow-up Phase|Lost to Follow-up|2
5039061|NCT02718417|17361894|P3|Follow-up Phase|Study terminated by sponsor|6
5039062|NCT02718417|17361895|P2|Follow-up Phase|Study terminated by sponsor|138
5039063|NCT02718417|17361896|P1|Follow-up Phase|Study terminated by sponsor|100
5039064|NCT02718417|17361894|P3|Follow-up Phase|Withdrawal by Subject|5
5039065|NCT02718417|17361895|P2|Follow-up Phase|Withdrawal by Subject|17
5039066|NCT02718417|17361896|P1|Follow-up Phase|Withdrawal by Subject|19
5039067|NCT02718417|17361894|P3|Follow-up Phase|Other|4
5039068|NCT02718417|17361895|P2|Follow-up Phase|Other|6
5039069|NCT02718417|17361896|P1|Follow-up Phase|Other|4
5039070|NCT02718417|17361894|P3|Follow-up Phase|Adverse Event|1
5039071|NCT02718417|17361895|P2|Follow-up Phase|Adverse Event|1
5039072|NCT02718417|17361896|P1|Follow-up Phase|Adverse Event|3
5039073|NCT02718417|17361894|P3|Observation Phase (OP)|Other|7
5039074|NCT02718417|17361895|P2|Observation Phase (OP)|Other|0
5039075|NCT02718417|17361896|P1|Observation Phase (OP)|Other|0
5039076|NCT02718417|17361894|P3|Observation Phase (OP)|Global deterioration of health status|1
5039077|NCT02718417|17361895|P2|Observation Phase (OP)|Global deterioration of health status|0
5039078|NCT02718417|17361896|P1|Observation Phase (OP)|Global deterioration of health status|0
5039079|NCT02718417|17361894|P3|Observation Phase (OP)|Withdrawal by Subject|34
5039080|NCT02718417|17361895|P2|Observation Phase (OP)|Withdrawal by Subject|0
5039081|NCT02718417|17361896|P1|Observation Phase (OP)|Withdrawal by Subject|0
5039082|NCT02718417|17361894|P3|Observation Phase (OP)|Study terminated by sponsor|135
5039083|NCT02718417|17361895|P2|Observation Phase (OP)|Study terminated by sponsor|0
5039084|NCT02718417|17361896|P1|Observation Phase (OP)|Study terminated by sponsor|0
5039085|NCT02718417|17361894|P3|Observation Phase (OP)|Progressive disease|92
5039086|NCT02718417|17361895|P2|Observation Phase (OP)|Progressive disease|0
5039087|NCT02718417|17361896|P1|Observation Phase (OP)|Progressive disease|0
5039088|NCT02718417|17361894|P3|Observation Phase (OP)|Physician Decision|9
5039089|NCT02718417|17361895|P2|Observation Phase (OP)|Physician Decision|0
5039090|NCT02718417|17361896|P1|Observation Phase (OP)|Physician Decision|0
5039091|NCT02718417|17361894|P3|Observation Phase (OP)|Lost to Follow-up|1
5039092|NCT02718417|17361895|P2|Observation Phase (OP)|Lost to Follow-up|0
5039093|NCT02718417|17361896|P1|Observation Phase (OP)|Lost to Follow-up|0
5039094|NCT02718417|17361894|P3|Observation Phase (OP)|Death leading to discontinuation|2
5039095|NCT02718417|17361895|P2|Observation Phase (OP)|Death leading to discontinuation|0
5039096|NCT02718417|17361896|P1|Observation Phase (OP)|Death leading to discontinuation|0
5039097|NCT02718417|17361894|P3|Observation Phase (OP)|Adverse Event|1
5039098|NCT02718417|17361895|P2|Observation Phase (OP)|Adverse Event|0
5039099|NCT02718417|17361896|P1|Observation Phase (OP)|Adverse Event|0
5039100|NCT02718417|17361894|P3|Maintenance Phase (MP)|Study terminated by sponsor|0
5039101|NCT02718417|17361895|P2|Maintenance Phase (MP)|Study terminated by sponsor|140
5039102|NCT02718417|17361896|P1|Maintenance Phase (MP)|Study terminated by sponsor|114
5039103|NCT02718417|17361894|P3|Maintenance Phase (MP)|Withdrawal by Subject|0
5039104|NCT02718417|17361895|P2|Maintenance Phase (MP)|Withdrawal by Subject|20
5039105|NCT02718417|17361896|P1|Maintenance Phase (MP)|Withdrawal by Subject|17
5039106|NCT02718417|17361894|P3|Maintenance Phase (MP)|Other|0
5039107|NCT02718417|17361895|P2|Maintenance Phase (MP)|Other|1
5039108|NCT02718417|17361896|P1|Maintenance Phase (MP)|Other|2
5039109|NCT02718417|17361894|P3|Maintenance Phase (MP)|Progressive disease|0
5039110|NCT02718417|17361895|P2|Maintenance Phase (MP)|Progressive disease|88
5039111|NCT02718417|17361896|P1|Maintenance Phase (MP)|Progressive disease|100
5039112|NCT02718417|17361894|P3|Maintenance Phase (MP)|Physician's decision|0
5039113|NCT02718417|17361895|P2|Maintenance Phase (MP)|Physician's decision|7
5039114|NCT02718417|17361896|P1|Maintenance Phase (MP)|Physician's decision|6
5039115|NCT02718417|17361894|P3|Maintenance Phase (MP)|No longer met eligibility criteria|0
5039116|NCT02718417|17361895|P2|Maintenance Phase (MP)|No longer met eligibility criteria|1
5039117|NCT02718417|17361896|P1|Maintenance Phase (MP)|No longer met eligibility criteria|0
5039118|NCT02718417|17361894|P3|Maintenance Phase (MP)|Global deterioration of health status|0
5039119|NCT02718417|17361895|P2|Maintenance Phase (MP)|Global deterioration of health status|3
5039120|NCT02718417|17361896|P1|Maintenance Phase (MP)|Global deterioration of health status|5
5039121|NCT02718417|17361894|P3|Maintenance Phase (MP)|Death leading to discontinuation|0
5039122|NCT02718417|17361895|P2|Maintenance Phase (MP)|Death leading to discontinuation|1
5039123|NCT02718417|17361896|P1|Maintenance Phase (MP)|Death leading to discontinuation|1
5039124|NCT02718417|17361894|P3|Maintenance Phase (MP)|Adverse Event|0
5039125|NCT02718417|17361895|P2|Maintenance Phase (MP)|Adverse Event|26
5039126|NCT02718417|17361896|P1|Maintenance Phase (MP)|Adverse Event|21
5039127|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Other|1
5039128|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Other|0
5039129|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Other|2
5039130|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Withdrawal by Subject|15
5039131|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Withdrawal by Subject|8
5039132|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Withdrawal by Subject|13
5039133|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Progressive disease|10
5039134|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Progressive disease|7
5039135|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Progressive disease|11
5039136|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Physician's decision|4
5039137|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Physician's decision|0
5039138|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Physician's decision|5
5039436|NCT02714218|17362876|P1|Overall Study|Complete Response|1
5039139|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
5039140|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
5039141|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
5039142|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Global deterioration of health status|1
5039143|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Global deterioration of health status|2
5039144|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Global deterioration of health status|3
5039145|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Death leading to discontinuation|1
5039146|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Death leading to discontinuation|4
5039147|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Death leading to discontinuation|5
5039148|NCT02718417|17361894|P3|Chemotherapy Phase (CP)|Adverse Event|13
5039149|NCT02718417|17361895|P2|Chemotherapy Phase (CP)|Adverse Event|14
5039150|NCT02718417|17361896|P1|Chemotherapy Phase (CP)|Adverse Event|9
5039151|NCT02718326|17362002|P3|Overall Study|Pregnancy|0
5039152|NCT02718326|17362003|P2|Overall Study|Pregnancy|0
5039153|NCT02718326|17362004|P1|Overall Study|Pregnancy|1
5039154|NCT02718326|17362002|P3|Overall Study|Protocol Deviation|0
5039155|NCT02718326|17362003|P2|Overall Study|Protocol Deviation|0
5039156|NCT02718326|17362004|P1|Overall Study|Protocol Deviation|1
5039157|NCT02718326|17362002|P3|Overall Study|Lost to Follow-up|14
5039158|NCT02718326|17362003|P2|Overall Study|Lost to Follow-up|5
5039159|NCT02718326|17362004|P1|Overall Study|Lost to Follow-up|18
5039160|NCT02718326|17362002|P3|Overall Study|Withdrawal by Subject|6
5039161|NCT02718326|17362003|P2|Overall Study|Withdrawal by Subject|9
5039162|NCT02718326|17362004|P1|Overall Study|Withdrawal by Subject|4
5039163|NCT02718326|17362002|P3|Overall Study|Death|2
5039164|NCT02718326|17362003|P2|Overall Study|Death|1
5039165|NCT02718326|17362004|P1|Overall Study|Death|8
5039166|NCT02718326|17362002|P3|Overall Study|Adverse Event|0
5039167|NCT02718326|17362003|P2|Overall Study|Adverse Event|9
5039168|NCT02718326|17362004|P1|Overall Study|Adverse Event|4
5039169|NCT02717754|17362125|P6|Overall Study|Incorrect Infusion Duration|20
5039170|NCT02717754|17362126|P5|Overall Study|Incorrect Infusion Duration|20
5039171|NCT02717754|17362127|P4|Overall Study|Incorrect Infusion Duration|10
5039172|NCT02717754|17362128|P3|Overall Study|Incorrect Infusion Duration|0
5039173|NCT02717754|17362129|P2|Overall Study|Incorrect Infusion Duration|0
5039174|NCT02717754|17362130|P1|Overall Study|Incorrect Infusion Duration|0
5039175|NCT02717494|17362161|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
5039176|NCT02717494|17362162|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
5039177|NCT02717494|17362163|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
5039178|NCT02717494|17362161|P3|First Intervention (Step 1)|Death|1
5039179|NCT02717494|17362162|P2|First Intervention (Step 1)|Death|0
5039180|NCT02717494|17362163|P1|First Intervention (Step 1)|Death|0
5039181|NCT02717494|17362161|P3|First Intervention (Step 1)|Withdrawal by Subject|1
5039182|NCT02717494|17362162|P2|First Intervention (Step 1)|Withdrawal by Subject|0
5039183|NCT02717494|17362163|P1|First Intervention (Step 1)|Withdrawal by Subject|2
5039184|NCT02717494|17362161|P3|First Intervention (Step 1)|Lost to Follow-up|3
5039185|NCT02717494|17362162|P2|First Intervention (Step 1)|Lost to Follow-up|7
5039186|NCT02717494|17362163|P1|First Intervention (Step 1)|Lost to Follow-up|4
5039187|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
5039188|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
5039189|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5039190|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5039191|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5039192|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5039193|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5039194|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
5039195|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5039196|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5039197|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
5039198|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5039199|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5039200|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5039201|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5039202|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Change of residence|1
5039203|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Change of residence|1
5039204|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Change of residence|0
5039205|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Change of residence|0
5039206|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Change of residence|0
5039207|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
5039208|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
5039209|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
5039210|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
5039211|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
5039212|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
5039213|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
5039214|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
5039215|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
5039216|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
5039217|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Patient decision|2
5039218|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Patient decision|2
5039219|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Patient decision|0
5039220|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Patient decision|0
5039221|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Patient decision|0
5039222|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5039223|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5039224|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
5039225|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5039226|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5039227|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
5039228|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
5039229|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5039230|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5039231|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5039232|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
5039233|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
5039234|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
5039235|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
5039236|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
5039237|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
5039238|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
5039239|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
5039240|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
5039241|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
5039242|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
5039243|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
5039244|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
5039245|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
5039246|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
5039247|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
5039248|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
5039249|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
5039250|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
5039251|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
5039252|NCT02717195|17362225|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
5039253|NCT02717195|17362226|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
5039254|NCT02717195|17362227|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
5039255|NCT02717195|17362228|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
5039256|NCT02717195|17362229|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
5039257|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5039258|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5039259|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5039260|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5039261|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
5039262|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5039263|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5039264|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5039265|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5039266|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
5039267|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
5039268|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
5039269|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
5039270|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
5039271|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
5039272|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
5039273|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
5039274|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
5039275|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
5039276|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
5039277|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5039278|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5039279|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5039280|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
5039281|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5039282|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5039283|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5039284|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5039285|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5039286|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
5039287|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5039288|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5039289|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5039290|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
5039291|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5039292|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Investigator decision|0
5039293|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Investigator decision|0
5039294|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Investigator decision|0
5039295|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Investigator decision|1
5039296|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Investigator decision|2
5039297|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5039298|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5039299|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5039300|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
5039301|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5039302|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
5039303|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
5039304|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
5039305|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
5039306|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
5039307|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5039308|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5039309|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5039310|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5039311|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
5039312|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Patient decision|0
5039313|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Patient decision|0
5039314|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Patient decision|0
5039315|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Patient decision|2
5039316|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Patient decision|5
5039317|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Technical error|0
5039318|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Technical error|0
5039319|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Technical error|0
5039320|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Technical error|0
5039321|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Technical error|1
5039322|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5039323|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5039324|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5039325|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5039326|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
5039327|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5039328|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5039329|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5039330|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
5039331|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
5039332|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5039333|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5039334|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5039335|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
5039336|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
5039337|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5039338|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5039339|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5039340|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
5039341|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
5039342|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5039343|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5039344|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5039345|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
5039346|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
5039347|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
5039348|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
5039349|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
5039350|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
5039351|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
5039352|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5039353|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5039354|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5039355|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
5039356|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
5039357|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5039358|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5039359|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5039360|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
5039361|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
5039362|NCT02717195|17362225|P5|Prospective Confirmation (PC) Period|Adverse Event|0
5039363|NCT02717195|17362226|P4|Prospective Confirmation (PC) Period|Adverse Event|0
5039364|NCT02717195|17362227|P3|Prospective Confirmation (PC) Period|Adverse Event|0
5039365|NCT02717195|17362228|P2|Prospective Confirmation (PC) Period|Adverse Event|7
5039366|NCT02717195|17362229|P1|Prospective Confirmation (PC) Period|Adverse Event|19
5039367|NCT02717130|17362260|P1|Overall Study|Study Closure|4
5039368|NCT02717130|17362260|P1|Overall Study|Physician Decision|1
5039369|NCT02717130|17362260|P1|Overall Study|Adverse Event|1
5039370|NCT02717130|17362260|P1|Overall Study|Withdrawal by Subject|1
5039371|NCT02716987|17362270|P6|Overall Study|Withdrawal by Subject|1
5039372|NCT02716987|17362271|P5|Overall Study|Withdrawal by Subject|1
5039373|NCT02716987|17362272|P4|Overall Study|Withdrawal by Subject|0
5039374|NCT02716987|17362273|P3|Overall Study|Withdrawal by Subject|0
5039375|NCT02716987|17362274|P2|Overall Study|Withdrawal by Subject|0
5039376|NCT02716987|17362275|P1|Overall Study|Withdrawal by Subject|0
5039377|NCT02716987|17362270|P6|Overall Study|Ligand synthesis failure|0
5039378|NCT02716987|17362271|P5|Overall Study|Ligand synthesis failure|0
5039379|NCT02716987|17362272|P4|Overall Study|Ligand synthesis failure|0
5039380|NCT02716987|17362273|P3|Overall Study|Ligand synthesis failure|1
5039381|NCT02716987|17362274|P2|Overall Study|Ligand synthesis failure|0
5039382|NCT02716987|17362275|P1|Overall Study|Ligand synthesis failure|0
5039383|NCT02716896|17362341|P2|Overall Study|Physician Decision|1
5039384|NCT02716896|17362342|P1|Overall Study|Physician Decision|0
5039385|NCT02716805|17362393|P4|Overall Study|Progressive disease|0
5039386|NCT02716805|17362394|P3|Overall Study|Progressive disease|0
5039387|NCT02716805|17362395|P2|Overall Study|Progressive disease|0
5039388|NCT02716805|17362396|P1|Overall Study|Progressive disease|2
5039389|NCT02716779|17362404|P3|Combination Therapy|Adverse Event|1
5039390|NCT02716779|17362405|P2|Combination Therapy|Adverse Event|2
5039391|NCT02716779|17362406|P1|Combination Therapy|Adverse Event|0
5039392|NCT02716779|17362404|P3|Monotherapy|Adverse Event|1
5039393|NCT02716779|17362405|P2|Monotherapy|Adverse Event|1
5039394|NCT02716779|17362406|P1|Monotherapy|Adverse Event|0
5039395|NCT02716584|17362506|P2|Overall Study|Lost to Follow-up|5
5039396|NCT02716584|17362507|P1|Overall Study|Lost to Follow-up|8
5039397|NCT02716298|17362563|P2|First Intervention (1 Month)|Lens discomfort|1
5039398|NCT02716298|17362564|P1|First Intervention (1 Month)|Lens discomfort|1
5039399|NCT02716194|17362582|P3|Period 1 - ADVATE|Withdrawal by Subject|0
5039400|NCT02716194|17362583|P2|Period 1 - ADVATE|Withdrawal by Subject|1
5039401|NCT02716194|17362584|P1|Period 1 - ADVATE|Withdrawal by Subject|1
5039402|NCT02715804|17362664|P2|Overall Study|Other than specified|3
5039403|NCT02715804|17362665|P1|Overall Study|Other than specified|2
5039404|NCT02715804|17362664|P2|Overall Study|Withdrawal by Subject|4
5039405|NCT02715804|17362665|P1|Overall Study|Withdrawal by Subject|5
5039406|NCT02715804|17362664|P2|Overall Study|Death|106
5039407|NCT02715804|17362665|P1|Overall Study|Death|222
5039408|NCT02715765|17362688|P3|Overall Study|Study Termination|0
5039409|NCT02715765|17362689|P2|Overall Study|Study Termination|0
5039410|NCT02715765|17362690|P1|Overall Study|Study Termination|3
5039411|NCT02715726|17362703|P2|Overall Study|Randomized but not treated|2
5039412|NCT02715726|17362704|P1|Overall Study|Randomized but not treated|1
5039413|NCT02715726|17362703|P2|Overall Study|Other than specified above|15
5039414|NCT02715726|17362704|P1|Overall Study|Other than specified above|11
5039415|NCT02715726|17362703|P2|Overall Study|Participant moved|3
5039416|NCT02715726|17362704|P1|Overall Study|Participant moved|1
5039417|NCT02715726|17362703|P2|Overall Study|Death|1
5039418|NCT02715726|17362704|P1|Overall Study|Death|2
5039419|NCT02715726|17362703|P2|Overall Study|Protocol Violation|0
5039420|NCT02715726|17362704|P1|Overall Study|Protocol Violation|1
5039421|NCT02715726|17362703|P2|Overall Study|Adverse Event|6
5039422|NCT02715726|17362704|P1|Overall Study|Adverse Event|2
5039423|NCT02714868|17362784|P2|Overall Study|PI withdraw did not meet inclusion|0
5039424|NCT02714868|17362785|P1|Overall Study|PI withdraw did not meet inclusion|1
5039425|NCT02714868|17362784|P2|Overall Study|PI withdrawal safety risk self/others|0
5039426|NCT02714868|17362785|P1|Overall Study|PI withdrawal safety risk self/others|1
5039427|NCT02714868|17362784|P2|Overall Study|Withdrawal by Subject|0
5039428|NCT02714868|17362785|P1|Overall Study|Withdrawal by Subject|3
5039429|NCT02714426|17362812|P2|Overall Study|Withdrawal by Subject|2
5039430|NCT02714426|17362813|P1|Overall Study|Withdrawal by Subject|2
5039431|NCT02714218|17362874|P3|Overall Study|Stop treatment, but will do follow up|0
5039432|NCT02714218|17362875|P2|Overall Study|Stop treatment, but will do follow up|1
5039433|NCT02714218|17362876|P1|Overall Study|Stop treatment, but will do follow up|0
5039434|NCT02714218|17362874|P3|Overall Study|Complete Response|0
5039435|NCT02714218|17362875|P2|Overall Study|Complete Response|0
5039437|NCT02714218|17362874|P3|Overall Study|Dose Delayed > 6 weeks|0
5039438|NCT02714218|17362875|P2|Overall Study|Dose Delayed > 6 weeks|0
5039439|NCT02714218|17362876|P1|Overall Study|Dose Delayed > 6 weeks|1
5039440|NCT02714218|17362874|P3|Overall Study|Completed|0
5039441|NCT02714218|17362875|P2|Overall Study|Completed|0
5039442|NCT02714218|17362876|P1|Overall Study|Completed|2
5039443|NCT02714218|17362874|P3|Overall Study|Not Reported|0
5039444|NCT02714218|17362875|P2|Overall Study|Not Reported|5
5039445|NCT02714218|17362876|P1|Overall Study|Not Reported|9
5039446|NCT02714218|17362874|P3|Overall Study|Medical Decision|0
5039447|NCT02714218|17362875|P2|Overall Study|Medical Decision|1
5039448|NCT02714218|17362876|P1|Overall Study|Medical Decision|0
5039449|NCT02714218|17362874|P3|Overall Study|Maximum Clinical Benefit|0
5039450|NCT02714218|17362875|P2|Overall Study|Maximum Clinical Benefit|2
5039451|NCT02714218|17362876|P1|Overall Study|Maximum Clinical Benefit|2
5039452|NCT02714218|17362874|P3|Overall Study|Participant Withdrew Consent|0
5039453|NCT02714218|17362875|P2|Overall Study|Participant Withdrew Consent|3
5039454|NCT02714218|17362876|P1|Overall Study|Participant Withdrew Consent|2
5039455|NCT02714218|17362874|P3|Overall Study|Request to Discontinue Treatment|1
5039456|NCT02714218|17362875|P2|Overall Study|Request to Discontinue Treatment|5
5039457|NCT02714218|17362876|P1|Overall Study|Request to Discontinue Treatment|1
5039458|NCT02714218|17362874|P3|Overall Study|Study Drug Toxicity|4
5039459|NCT02714218|17362875|P2|Overall Study|Study Drug Toxicity|69
5039460|NCT02714218|17362876|P1|Overall Study|Study Drug Toxicity|46
5039461|NCT02714218|17362874|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
5039462|NCT02714218|17362875|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
5039463|NCT02714218|17362876|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
5039464|NCT02714218|17362874|P3|Overall Study|Disease Progression|14
5039465|NCT02714218|17362875|P2|Overall Study|Disease Progression|51
5039466|NCT02714218|17362876|P1|Overall Study|Disease Progression|56
5039467|NCT02714062|17362926|P3|Overall Study|Protocol Violation|0
5039468|NCT02714062|17362927|P2|Overall Study|Protocol Violation|1
5039469|NCT02714062|17362928|P1|Overall Study|Protocol Violation|0
5039470|NCT02714062|17362926|P3|Overall Study|Withdrawal by Subject|1
5039471|NCT02714062|17362927|P2|Overall Study|Withdrawal by Subject|0
5039472|NCT02714062|17362928|P1|Overall Study|Withdrawal by Subject|1
5039473|NCT02714062|17362926|P3|Overall Study|Adverse Event|2
5039474|NCT02714062|17362927|P2|Overall Study|Adverse Event|0
5039475|NCT02714062|17362928|P1|Overall Study|Adverse Event|0
5039476|NCT02713867|17362974|P2|Treatment Period|Disease Progression|78
5039477|NCT02713867|17362975|P1|Treatment Period|Disease Progression|79
5039478|NCT02713867|17362974|P2|Treatment Period|Study Drug Toxicity|20
5039479|NCT02713867|17362975|P1|Treatment Period|Study Drug Toxicity|16
5039480|NCT02713867|17362974|P2|Treatment Period|Death|3
5039481|NCT02713867|17362975|P1|Treatment Period|Death|7
5039482|NCT02713867|17362974|P2|Treatment Period|AE unrelated to Study Drug|9
5039483|NCT02713867|17362975|P1|Treatment Period|AE unrelated to Study Drug|8
5039484|NCT02713867|17362974|P2|Treatment Period|Requested to Discontinue|7
5039485|NCT02713867|17362975|P1|Treatment Period|Requested to Discontinue|8
5039486|NCT02713867|17362974|P2|Treatment Period|Withdrew consent|6
5039487|NCT02713867|17362975|P1|Treatment Period|Withdrew consent|1
5039488|NCT02713867|17362974|P2|Treatment Period|Maximum Clinical Benefit|4
5039489|NCT02713867|17362975|P1|Treatment Period|Maximum Clinical Benefit|3
5039490|NCT02713867|17362974|P2|Treatment Period|Poor/Non Compliance|0
5039491|NCT02713867|17362975|P1|Treatment Period|Poor/Non Compliance|1
5039492|NCT02713867|17362974|P2|Treatment Period|No longer meets study criteria|1
5039493|NCT02713867|17362975|P1|Treatment Period|No longer meets study criteria|2
5039494|NCT02713867|17362974|P2|Treatment Period|Administrative reason by sponsor|4
5039495|NCT02713867|17362975|P1|Treatment Period|Administrative reason by sponsor|9
5039496|NCT02713867|17362974|P2|Treatment Period|Other Reasons|18
5039497|NCT02713867|17362975|P1|Treatment Period|Other Reasons|12
5039498|NCT02713867|17362974|P2|Treatment Period|Not Reported|0
5039499|NCT02713867|17362975|P1|Treatment Period|Not Reported|1
5039500|NCT02713867|17362974|P2|Randomization|Participant Withdrew consent|2
5039501|NCT02713867|17362975|P1|Randomization|Participant Withdrew consent|0
5039502|NCT02713867|17362974|P2|Randomization|Other Reason|1
5039503|NCT02713867|17362975|P1|Randomization|Other Reason|2
5039504|NCT02713828|17363013|P2|Overall Study|study terminated but patient allowed to|0
5039505|NCT02713828|17363014|P1|Overall Study|study terminated but patient allowed to|2
5039506|NCT02713828|17363013|P2|Overall Study|Withdrawal by Subject|0
5039507|NCT02713828|17363014|P1|Overall Study|Withdrawal by Subject|1
5039508|NCT02713828|17363013|P2|Overall Study|Death|0
5039509|NCT02713828|17363014|P1|Overall Study|Death|2
5039510|NCT02713789|17363026|P3|Overall Study|Lost to Follow-up|1
5039511|NCT02713789|17363027|P2|Overall Study|Lost to Follow-up|1
5039512|NCT02713789|17363028|P1|Overall Study|Lost to Follow-up|0
5039513|NCT02713594|17363091|P2|Overall Study|Lost to Follow-up|374
5039514|NCT02713594|17363092|P1|Overall Study|Lost to Follow-up|358
5039515|NCT02713594|17363091|P2|Overall Study|Withdrawal by Subject|22
5039516|NCT02713594|17363092|P1|Overall Study|Withdrawal by Subject|32
5039517|NCT02713542|17363104|P2|Overall Study|Withdrawal by Subject|1
5039518|NCT02713542|17363105|P1|Overall Study|Withdrawal by Subject|4
5039519|NCT02713542|17363104|P2|Overall Study|Use of prohibited medication|5
5039520|NCT02713542|17363105|P1|Overall Study|Use of prohibited medication|14
5039521|NCT02713529|17363118|P7|Overall Study|Death|3
5039522|NCT02713529|17363119|P6|Overall Study|Death|13
5039523|NCT02713529|17363120|P5|Overall Study|Death|3
5039524|NCT02713529|17363121|P4|Overall Study|Death|27
5039525|NCT02713529|17363122|P3|Overall Study|Death|26
5039526|NCT02713529|17363123|P2|Overall Study|Death|3
5039527|NCT02713529|17363124|P1|Overall Study|Death|3
5039528|NCT02713529|17363118|P7|Overall Study|Lost to Follow-up|0
5039529|NCT02713529|17363119|P6|Overall Study|Lost to Follow-up|0
5039530|NCT02713529|17363120|P5|Overall Study|Lost to Follow-up|0
5039531|NCT02713529|17363121|P4|Overall Study|Lost to Follow-up|0
5039532|NCT02713529|17363122|P3|Overall Study|Lost to Follow-up|1
5039533|NCT02713529|17363123|P2|Overall Study|Lost to Follow-up|0
5039534|NCT02713529|17363124|P1|Overall Study|Lost to Follow-up|1
5039535|NCT02713529|17363118|P7|Overall Study|Withdrawal by Subject|1
5039536|NCT02713529|17363119|P6|Overall Study|Withdrawal by Subject|1
5039537|NCT02713529|17363120|P5|Overall Study|Withdrawal by Subject|0
5039538|NCT02713529|17363121|P4|Overall Study|Withdrawal by Subject|2
5039539|NCT02713529|17363122|P3|Overall Study|Withdrawal by Subject|4
5039540|NCT02713529|17363123|P2|Overall Study|Withdrawal by Subject|1
5039541|NCT02713529|17363124|P1|Overall Study|Withdrawal by Subject|3
5039542|NCT02713243|17363217|P2|Overall Study|Protocol deviation|1
5039543|NCT02713243|17363218|P1|Overall Study|Protocol deviation|0
5039544|NCT02713243|17363217|P2|Overall Study|Administrative problems|1
5039545|NCT02713243|17363218|P1|Overall Study|Administrative problems|0
5039546|NCT02713243|17363217|P2|Overall Study|Abnormal laboratory value(s)#|0
5039547|NCT02713243|17363218|P1|Overall Study|Abnormal laboratory value(s)#|1
5039548|NCT02713204|17363236|P8|From Week 12 up to Week 36|Participant Re-located|0
5039549|NCT02713204|17363237|P7|From Week 12 up to Week 36|Participant Re-located|0
5039550|NCT02713204|17363238|P6|From Week 12 up to Week 36|Participant Re-located|0
5039551|NCT02713204|17363239|P5|From Week 12 up to Week 36|Participant Re-located|1
5039552|NCT02713204|17363240|P4|From Week 12 up to Week 36|Participant Re-located|0
5039553|NCT02713204|17363241|P3|From Week 12 up to Week 36|Participant Re-located|0
5039554|NCT02713204|17363242|P2|From Week 12 up to Week 36|Participant Re-located|0
5039555|NCT02713204|17363243|P1|From Week 12 up to Week 36|Participant Re-located|0
5039556|NCT02713204|17363236|P8|From Week 12 up to Week 36|Lost to Follow-up|0
5039557|NCT02713204|17363237|P7|From Week 12 up to Week 36|Lost to Follow-up|0
5039558|NCT02713204|17363238|P6|From Week 12 up to Week 36|Lost to Follow-up|0
5039559|NCT02713204|17363239|P5|From Week 12 up to Week 36|Lost to Follow-up|0
5039560|NCT02713204|17363240|P4|From Week 12 up to Week 36|Lost to Follow-up|2
5039561|NCT02713204|17363241|P3|From Week 12 up to Week 36|Lost to Follow-up|0
5039562|NCT02713204|17363242|P2|From Week 12 up to Week 36|Lost to Follow-up|0
5039563|NCT02713204|17363243|P1|From Week 12 up to Week 36|Lost to Follow-up|0
5039564|NCT02713204|17363236|P8|From Week 12 up to Week 36|Death|3
5039565|NCT02713204|17363237|P7|From Week 12 up to Week 36|Death|0
5039566|NCT02713204|17363238|P6|From Week 12 up to Week 36|Death|1
5039567|NCT02713204|17363239|P5|From Week 12 up to Week 36|Death|0
5039568|NCT02713204|17363240|P4|From Week 12 up to Week 36|Death|1
5039569|NCT02713204|17363241|P3|From Week 12 up to Week 36|Death|0
5039570|NCT02713204|17363242|P2|From Week 12 up to Week 36|Death|0
5039571|NCT02713204|17363243|P1|From Week 12 up to Week 36|Death|0
5039572|NCT02713204|17363236|P8|From Week 12 up to Week 36|Adverse Event|1
5039573|NCT02713204|17363237|P7|From Week 12 up to Week 36|Adverse Event|2
5039574|NCT02713204|17363238|P6|From Week 12 up to Week 36|Adverse Event|0
5039575|NCT02713204|17363239|P5|From Week 12 up to Week 36|Adverse Event|1
5039576|NCT02713204|17363240|P4|From Week 12 up to Week 36|Adverse Event|1
5039577|NCT02713204|17363241|P3|From Week 12 up to Week 36|Adverse Event|0
5039578|NCT02713204|17363242|P2|From Week 12 up to Week 36|Adverse Event|0
5039579|NCT02713204|17363243|P1|From Week 12 up to Week 36|Adverse Event|1
5039580|NCT02713204|17363236|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039581|NCT02713204|17363237|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039582|NCT02713204|17363238|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039583|NCT02713204|17363239|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039584|NCT02713204|17363240|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039585|NCT02713204|17363241|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039586|NCT02713204|17363242|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
5039587|NCT02713204|17363243|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039588|NCT02713204|17363236|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039589|NCT02713204|17363237|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039590|NCT02713204|17363238|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039591|NCT02713204|17363239|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039592|NCT02713204|17363240|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039593|NCT02713204|17363241|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
5039594|NCT02713204|17363242|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039595|NCT02713204|17363243|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039596|NCT02713204|17363236|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
5039597|NCT02713204|17363237|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
5039598|NCT02713204|17363238|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
5039599|NCT02713204|17363239|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
5039600|NCT02713204|17363240|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
5039601|NCT02713204|17363241|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
5039602|NCT02713204|17363242|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
5039603|NCT02713204|17363243|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
5039604|NCT02712996|17363302|P2|Second Intervention (Study Days 43-84)|Adverse Event|1
5039605|NCT02712996|17363303|P1|Second Intervention (Study Days 43-84)|Adverse Event|0
5039606|NCT02712983|17363362|P9|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5039607|NCT02712983|17363363|P8|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
5039608|NCT02712983|17363364|P7|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
5039609|NCT02712983|17363365|P6|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
5039610|NCT02712983|17363366|P5|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
5039611|NCT02712983|17363367|P4|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5039612|NCT02712983|17363368|P3|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5039613|NCT02712983|17363369|P2|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5039614|NCT02712983|17363370|P1|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5039615|NCT02712983|17363362|P9|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039616|NCT02712983|17363363|P8|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039617|NCT02712983|17363364|P7|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039618|NCT02712983|17363365|P6|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039619|NCT02712983|17363366|P5|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039620|NCT02712983|17363367|P4|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
5039621|NCT02712983|17363368|P3|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039622|NCT02712983|17363369|P2|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039623|NCT02712983|17363370|P1|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5039624|NCT02712983|17363362|P9|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5039625|NCT02712983|17363363|P8|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5039626|NCT02712983|17363364|P7|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5039627|NCT02712983|17363365|P6|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5039628|NCT02712983|17363366|P5|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5039629|NCT02712983|17363367|P4|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5039630|NCT02712983|17363368|P3|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5039631|NCT02712983|17363369|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5039632|NCT02712983|17363370|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5039633|NCT02712983|17363362|P9|Treatment Phase|Subject Decision|0
5039634|NCT02712983|17363363|P8|Treatment Phase|Subject Decision|2
5039635|NCT02712983|17363364|P7|Treatment Phase|Subject Decision|1
5039636|NCT02712983|17363365|P6|Treatment Phase|Subject Decision|0
5039637|NCT02712983|17363366|P5|Treatment Phase|Subject Decision|1
5039638|NCT02712983|17363367|P4|Treatment Phase|Subject Decision|2
5039639|NCT02712983|17363368|P3|Treatment Phase|Subject Decision|0
5039640|NCT02712983|17363369|P2|Treatment Phase|Subject Decision|0
5039641|NCT02712983|17363370|P1|Treatment Phase|Subject Decision|2
5039642|NCT02712983|17363362|P9|Treatment Phase|Physician Decision|1
5039643|NCT02712983|17363363|P8|Treatment Phase|Physician Decision|1
5039644|NCT02712983|17363364|P7|Treatment Phase|Physician Decision|0
5039645|NCT02712983|17363365|P6|Treatment Phase|Physician Decision|0
5039646|NCT02712983|17363366|P5|Treatment Phase|Physician Decision|0
5039647|NCT02712983|17363367|P4|Treatment Phase|Physician Decision|0
5039648|NCT02712983|17363368|P3|Treatment Phase|Physician Decision|0
5039649|NCT02712983|17363369|P2|Treatment Phase|Physician Decision|0
5039650|NCT02712983|17363370|P1|Treatment Phase|Physician Decision|0
5039651|NCT02712983|17363362|P9|Treatment Phase|Technical Problems|0
5039652|NCT02712983|17363363|P8|Treatment Phase|Technical Problems|0
5039653|NCT02712983|17363364|P7|Treatment Phase|Technical Problems|1
5039654|NCT02712983|17363365|P6|Treatment Phase|Technical Problems|0
5039655|NCT02712983|17363366|P5|Treatment Phase|Technical Problems|0
5039656|NCT02712983|17363367|P4|Treatment Phase|Technical Problems|0
5039657|NCT02712983|17363368|P3|Treatment Phase|Technical Problems|0
5039658|NCT02712983|17363369|P2|Treatment Phase|Technical Problems|0
5039659|NCT02712983|17363370|P1|Treatment Phase|Technical Problems|0
5039660|NCT02712983|17363362|P9|Treatment Phase|Protocol Deviation|0
5039661|NCT02712983|17363363|P8|Treatment Phase|Protocol Deviation|0
5039662|NCT02712983|17363364|P7|Treatment Phase|Protocol Deviation|1
5039663|NCT02712983|17363365|P6|Treatment Phase|Protocol Deviation|0
5039664|NCT02712983|17363366|P5|Treatment Phase|Protocol Deviation|0
5039665|NCT02712983|17363367|P4|Treatment Phase|Protocol Deviation|2
5039666|NCT02712983|17363368|P3|Treatment Phase|Protocol Deviation|0
5039667|NCT02712983|17363369|P2|Treatment Phase|Protocol Deviation|0
5039668|NCT02712983|17363370|P1|Treatment Phase|Protocol Deviation|0
5039669|NCT02712983|17363362|P9|Treatment Phase|Adverse Event|1
5039670|NCT02712983|17363363|P8|Treatment Phase|Adverse Event|6
5039671|NCT02712983|17363364|P7|Treatment Phase|Adverse Event|6
5039672|NCT02712983|17363365|P6|Treatment Phase|Adverse Event|0
5039673|NCT02712983|17363366|P5|Treatment Phase|Adverse Event|3
5039674|NCT02712983|17363367|P4|Treatment Phase|Adverse Event|4
5039675|NCT02712983|17363368|P3|Treatment Phase|Adverse Event|1
5039676|NCT02712983|17363369|P2|Treatment Phase|Adverse Event|1
5039677|NCT02712983|17363370|P1|Treatment Phase|Adverse Event|3
5039678|NCT02712788|17363602|P2|Overall Study|Protocol Violation|0
5039679|NCT02712788|17363603|P1|Overall Study|Protocol Violation|1
5039680|NCT02712788|17363602|P2|Overall Study|Physician Decision|0
5039681|NCT02712788|17363603|P1|Overall Study|Physician Decision|1
5039682|NCT02712554|17363613|P2|Part B: Treatment Phase|Other|1
5039683|NCT02712554|17363614|P1|Part B: Treatment Phase|Other|0
5039684|NCT02712554|17363613|P2|Part B: Treatment Phase|Withdrawal by Subject|1
5039685|NCT02712554|17363614|P1|Part B: Treatment Phase|Withdrawal by Subject|0
5039686|NCT02712554|17363613|P2|Part B: Treatment Phase|Adverse Event|1
5039687|NCT02712554|17363614|P1|Part B: Treatment Phase|Adverse Event|0
5039688|NCT02712554|17363613|P2|Part B: Qualification Phase|Adverse Event|1
5039689|NCT02712554|17363614|P1|Part B: Qualification Phase|Adverse Event|0
5039690|NCT02712554|17363613|P2|Part B: Qualification Phase|Withdrawal by Subject|3
5039691|NCT02712554|17363614|P1|Part B: Qualification Phase|Withdrawal by Subject|0
5039692|NCT02712554|17363613|P2|Part B: Qualification Phase|Sponsor Decision|4
5039693|NCT02712554|17363614|P1|Part B: Qualification Phase|Sponsor Decision|0
5039694|NCT02712554|17363613|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
5039695|NCT02712554|17363614|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
5039696|NCT02712333|17363759|P2|First Period|Withdrawal by Subject|2
5039697|NCT02712333|17363760|P1|First Period|Withdrawal by Subject|3
5039698|NCT02712320|17363778|P1|Overall Study|Treating with the prohibited medications|2
5039699|NCT02712320|17363778|P1|Overall Study|Transferred to another facility|1
5039700|NCT02712320|17363778|P1|Overall Study|Withdrawal by Subject|1
5039701|NCT02712320|17363778|P1|Overall Study|Lost to Follow-up|1
5039702|NCT02712008|17363821|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
5039703|NCT02712008|17363822|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
5039704|NCT02712008|17363823|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
5039705|NCT02712008|17363824|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
5039706|NCT02712008|17363825|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
5039707|NCT02712008|17363826|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
5039708|NCT02712008|17363827|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
5039709|NCT02712008|17363828|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
5039710|NCT02712008|17363821|P8|From Week 12 up to Week 36|Physician Decision|0
5039711|NCT02712008|17363822|P7|From Week 12 up to Week 36|Physician Decision|0
5039712|NCT02712008|17363823|P6|From Week 12 up to Week 36|Physician Decision|0
5039713|NCT02712008|17363824|P5|From Week 12 up to Week 36|Physician Decision|1
5039714|NCT02712008|17363825|P4|From Week 12 up to Week 36|Physician Decision|1
5039715|NCT02712008|17363826|P3|From Week 12 up to Week 36|Physician Decision|0
5039716|NCT02712008|17363827|P2|From Week 12 up to Week 36|Physician Decision|0
5039717|NCT02712008|17363828|P1|From Week 12 up to Week 36|Physician Decision|0
5039718|NCT02712008|17363821|P8|From Week 12 up to Week 36|Lost to Follow-up|0
5039719|NCT02712008|17363822|P7|From Week 12 up to Week 36|Lost to Follow-up|1
5039720|NCT02712008|17363823|P6|From Week 12 up to Week 36|Lost to Follow-up|0
5039721|NCT02712008|17363824|P5|From Week 12 up to Week 36|Lost to Follow-up|0
5039722|NCT02712008|17363825|P4|From Week 12 up to Week 36|Lost to Follow-up|1
5039723|NCT02712008|17363826|P3|From Week 12 up to Week 36|Lost to Follow-up|0
5039724|NCT02712008|17363827|P2|From Week 12 up to Week 36|Lost to Follow-up|0
5039725|NCT02712008|17363828|P1|From Week 12 up to Week 36|Lost to Follow-up|0
5039726|NCT02712008|17363821|P8|From Week 12 up to Week 36|Death|0
5039727|NCT02712008|17363822|P7|From Week 12 up to Week 36|Death|1
5039728|NCT02712008|17363823|P6|From Week 12 up to Week 36|Death|0
5039729|NCT02712008|17363824|P5|From Week 12 up to Week 36|Death|0
5039730|NCT02712008|17363825|P4|From Week 12 up to Week 36|Death|0
5039731|NCT02712008|17363826|P3|From Week 12 up to Week 36|Death|0
5039732|NCT02712008|17363827|P2|From Week 12 up to Week 36|Death|0
5039733|NCT02712008|17363828|P1|From Week 12 up to Week 36|Death|1
5039734|NCT02712008|17363821|P8|From Week 12 up to Week 36|Adverse Event|2
5039735|NCT02712008|17363822|P7|From Week 12 up to Week 36|Adverse Event|0
5039736|NCT02712008|17363823|P6|From Week 12 up to Week 36|Adverse Event|0
5039737|NCT02712008|17363824|P5|From Week 12 up to Week 36|Adverse Event|1
5039738|NCT02712008|17363825|P4|From Week 12 up to Week 36|Adverse Event|0
5039739|NCT02712008|17363826|P3|From Week 12 up to Week 36|Adverse Event|0
5039740|NCT02712008|17363827|P2|From Week 12 up to Week 36|Adverse Event|0
5039741|NCT02712008|17363828|P1|From Week 12 up to Week 36|Adverse Event|0
5039742|NCT02712008|17363821|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039743|NCT02712008|17363822|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039744|NCT02712008|17363823|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039745|NCT02712008|17363824|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039746|NCT02712008|17363825|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039747|NCT02712008|17363826|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039748|NCT02712008|17363827|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
5039749|NCT02712008|17363828|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
5039750|NCT02712008|17363821|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039751|NCT02712008|17363822|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039752|NCT02712008|17363823|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039753|NCT02712008|17363824|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039754|NCT02712008|17363825|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039755|NCT02712008|17363826|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
5039756|NCT02712008|17363827|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039757|NCT02712008|17363828|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
5039758|NCT02712008|17363821|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039759|NCT02712008|17363822|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039760|NCT02712008|17363823|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039761|NCT02712008|17363824|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039762|NCT02712008|17363825|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039763|NCT02712008|17363826|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
5039764|NCT02712008|17363827|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5039765|NCT02712008|17363828|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
5039766|NCT02712008|17363821|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039767|NCT02712008|17363822|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039768|NCT02712008|17363823|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039769|NCT02712008|17363824|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039770|NCT02712008|17363825|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039771|NCT02712008|17363826|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
5039772|NCT02712008|17363827|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
5039773|NCT02712008|17363828|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5039774|NCT02712008|17363821|P8|Baseline (Day 1) up to Week 12|Death|0
5039775|NCT02712008|17363822|P7|Baseline (Day 1) up to Week 12|Death|0
5039776|NCT02712008|17363823|P6|Baseline (Day 1) up to Week 12|Death|0
5039777|NCT02712008|17363824|P5|Baseline (Day 1) up to Week 12|Death|0
5039778|NCT02712008|17363825|P4|Baseline (Day 1) up to Week 12|Death|0
5039779|NCT02712008|17363826|P3|Baseline (Day 1) up to Week 12|Death|0
5039780|NCT02712008|17363827|P2|Baseline (Day 1) up to Week 12|Death|0
5039781|NCT02712008|17363828|P1|Baseline (Day 1) up to Week 12|Death|3
5039782|NCT02711995|17363860|P1|Washout (90 Days)|Conflicting medication|1
5039783|NCT02711800|17363899|P1|Overall Study|Withdrawal by Subject|1
5039784|NCT02711800|17363899|P1|Overall Study|Lost to Follow-up|1
5039785|NCT02711345|17363918|P10|Overall Study|Death|0
5039786|NCT02711345|17363919|P9|Overall Study|Death|0
5039787|NCT02711345|17363920|P8|Overall Study|Death|1
5039788|NCT02711345|17363921|P7|Overall Study|Death|0
5039789|NCT02711345|17363922|P6|Overall Study|Death|0
5039790|NCT02711345|17363923|P5|Overall Study|Death|0
5039791|NCT02711345|17363924|P4|Overall Study|Death|0
5039792|NCT02711345|17363925|P3|Overall Study|Death|0
5039793|NCT02711345|17363926|P2|Overall Study|Death|0
5039794|NCT02711345|17363927|P1|Overall Study|Death|1
5039795|NCT02711345|17363918|P10|Overall Study|Subject/guardian decision|4
5039796|NCT02711345|17363919|P9|Overall Study|Subject/guardian decision|0
5039797|NCT02711345|17363920|P8|Overall Study|Subject/guardian decision|1
5039798|NCT02711345|17363921|P7|Overall Study|Subject/guardian decision|3
5039799|NCT02711345|17363922|P6|Overall Study|Subject/guardian decision|2
5039800|NCT02711345|17363923|P5|Overall Study|Subject/guardian decision|0
5039801|NCT02711345|17363924|P4|Overall Study|Subject/guardian decision|0
5039802|NCT02711345|17363925|P3|Overall Study|Subject/guardian decision|0
5039803|NCT02711345|17363926|P2|Overall Study|Subject/guardian decision|0
5039804|NCT02711345|17363927|P1|Overall Study|Subject/guardian decision|0
5039805|NCT02711345|17363918|P10|Overall Study|Progressive disease|6
5039806|NCT02711345|17363919|P9|Overall Study|Progressive disease|5
5039807|NCT02711345|17363920|P8|Overall Study|Progressive disease|4
5039808|NCT02711345|17363921|P7|Overall Study|Progressive disease|8
5039809|NCT02711345|17363922|P6|Overall Study|Progressive disease|2
5039810|NCT02711345|17363923|P5|Overall Study|Progressive disease|7
5039811|NCT02711345|17363924|P4|Overall Study|Progressive disease|3
5039812|NCT02711345|17363925|P3|Overall Study|Progressive disease|5
5039813|NCT02711345|17363926|P2|Overall Study|Progressive disease|3
5039814|NCT02711345|17363927|P1|Overall Study|Progressive disease|1
5039815|NCT02711345|17363918|P10|Overall Study|Physician Decision|0
5039816|NCT02711345|17363919|P9|Overall Study|Physician Decision|1
5039817|NCT02711345|17363920|P8|Overall Study|Physician Decision|0
5039818|NCT02711345|17363921|P7|Overall Study|Physician Decision|0
5039819|NCT02711345|17363922|P6|Overall Study|Physician Decision|0
5039820|NCT02711345|17363923|P5|Overall Study|Physician Decision|0
5039821|NCT02711345|17363924|P4|Overall Study|Physician Decision|0
5039822|NCT02711345|17363925|P3|Overall Study|Physician Decision|1
5039823|NCT02711345|17363926|P2|Overall Study|Physician Decision|0
5039824|NCT02711345|17363927|P1|Overall Study|Physician Decision|0
5039825|NCT02711345|17363918|P10|Overall Study|Adverse Event|2
5039826|NCT02711345|17363919|P9|Overall Study|Adverse Event|0
5039827|NCT02711345|17363920|P8|Overall Study|Adverse Event|0
5039828|NCT02711345|17363921|P7|Overall Study|Adverse Event|1
5039829|NCT02711345|17363922|P6|Overall Study|Adverse Event|2
5039830|NCT02711345|17363923|P5|Overall Study|Adverse Event|1
5039831|NCT02711345|17363924|P4|Overall Study|Adverse Event|1
5039832|NCT02711345|17363925|P3|Overall Study|Adverse Event|0
5039833|NCT02711345|17363926|P2|Overall Study|Adverse Event|0
5039834|NCT02711345|17363927|P1|Overall Study|Adverse Event|0
5039835|NCT02711306|17364113|P2|Overall Study|Withdrawal by Subject|2
5039836|NCT02711306|17364114|P1|Overall Study|Withdrawal by Subject|2
5039837|NCT02710422|17364307|P2|Overall Study|Termination of study|9
5039838|NCT02710422|17364308|P1|Overall Study|Termination of study|9
5039839|NCT02710292|17364324|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
5039840|NCT02710292|17364325|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
5039841|NCT02710292|17364324|P2|Period 1, First 10 Days of Wear|Adverse Event|1
5039842|NCT02710292|17364325|P1|Period 1, First 10 Days of Wear|Adverse Event|0
5039843|NCT02710214|17364334|P2|Overall Study|Death|1
5039844|NCT02710214|17364335|P1|Overall Study|Death|0
5039845|NCT02710214|17364334|P2|Overall Study|Lack of Efficacy|1
5039846|NCT02710214|17364335|P1|Overall Study|Lack of Efficacy|0
5039847|NCT02710214|17364334|P2|Overall Study|Lost to Follow-up|0
5039848|NCT02710214|17364335|P1|Overall Study|Lost to Follow-up|1
5039849|NCT02710136|17364369|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
5039850|NCT02710136|17364370|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
5039851|NCT02710071|17364395|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
5039852|NCT02710071|17364396|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|1
5039853|NCT02710071|17364395|P2|First Intervention (6 Weeks).|Withdrawal by Subject|4
5039854|NCT02710071|17364396|P1|First Intervention (6 Weeks).|Withdrawal by Subject|3
5039855|NCT02710045|17364406|P3|Overall Study|Poor Attendance|0
5039856|NCT02710045|17364407|P2|Overall Study|Poor Attendance|1
5039857|NCT02710045|17364408|P1|Overall Study|Poor Attendance|0
5039858|NCT02710045|17364406|P3|Overall Study|Physician Decision|1
5039859|NCT02710045|17364407|P2|Overall Study|Physician Decision|0
5039860|NCT02710045|17364408|P1|Overall Study|Physician Decision|0
5039861|NCT02710045|17364406|P3|Overall Study|Lost to Follow-up|7
5039862|NCT02710045|17364407|P2|Overall Study|Lost to Follow-up|6
5039863|NCT02710045|17364408|P1|Overall Study|Lost to Follow-up|3
5039864|NCT02710045|17364406|P3|Overall Study|Protocol Violation|3
5039865|NCT02710045|17364407|P2|Overall Study|Protocol Violation|2
5039866|NCT02710045|17364408|P1|Overall Study|Protocol Violation|1
5039867|NCT02710045|17364406|P3|Overall Study|Withdrawal by Subject|2
5039868|NCT02710045|17364407|P2|Overall Study|Withdrawal by Subject|6
5039869|NCT02710045|17364408|P1|Overall Study|Withdrawal by Subject|6
5039870|NCT02710045|17364406|P3|Overall Study|Death|0
5039871|NCT02710045|17364407|P2|Overall Study|Death|2
5039872|NCT02710045|17364408|P1|Overall Study|Death|1
5039873|NCT02709889|17364442|P4|Overall Study|Other, Not Specified|6
5039874|NCT02709889|17364443|P3|Overall Study|Other, Not Specified|1
5039875|NCT02709889|17364444|P2|Overall Study|Other, Not Specified|1
5039876|NCT02709889|17364445|P1|Overall Study|Other, Not Specified|0
5039877|NCT02709889|17364442|P4|Overall Study|Study Terminated by Sponsor|17
5039878|NCT02709889|17364443|P3|Overall Study|Study Terminated by Sponsor|2
5039879|NCT02709889|17364444|P2|Overall Study|Study Terminated by Sponsor|6
5039880|NCT02709889|17364445|P1|Overall Study|Study Terminated by Sponsor|4
5039881|NCT02709889|17364442|P4|Overall Study|Lost to Follow-up|4
5039882|NCT02709889|17364443|P3|Overall Study|Lost to Follow-up|0
5039883|NCT02709889|17364444|P2|Overall Study|Lost to Follow-up|0
5039884|NCT02709889|17364445|P1|Overall Study|Lost to Follow-up|2
5039885|NCT02709889|17364442|P4|Overall Study|Physician Decision|5
5039886|NCT02709889|17364443|P3|Overall Study|Physician Decision|3
5039887|NCT02709889|17364444|P2|Overall Study|Physician Decision|2
5039888|NCT02709889|17364445|P1|Overall Study|Physician Decision|1
5039889|NCT02709889|17364442|P4|Overall Study|Death|44
5039890|NCT02709889|17364443|P3|Overall Study|Death|4
5039891|NCT02709889|17364444|P2|Overall Study|Death|38
5039892|NCT02709889|17364445|P1|Overall Study|Death|25
5039893|NCT02709889|17364442|P4|Overall Study|Withdrawal by Subject|12
5039894|NCT02709889|17364443|P3|Overall Study|Withdrawal by Subject|2
5039895|NCT02709889|17364444|P2|Overall Study|Withdrawal by Subject|10
5039896|NCT02709889|17364445|P1|Overall Study|Withdrawal by Subject|11
5039897|NCT02709785|17364526|P3|Overall Study|Withdrawal by Subject|1
5039898|NCT02709785|17364527|P2|Overall Study|Withdrawal by Subject|2
5039899|NCT02709785|17364528|P1|Overall Study|Withdrawal by Subject|1
5039900|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
5039901|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
5039902|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
5039903|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
5039904|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
5039905|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5039906|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5039907|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|enrolled not treated|1
5039908|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5039909|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5039910|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
5039911|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5039912|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5039913|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5039914|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
5039915|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Adverse Event|2
5039916|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Adverse Event|5
5039917|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Adverse Event|8
5039918|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Adverse Event|4
5039919|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Adverse Event|0
5039920|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
5039921|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
5039922|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
5039923|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
5039924|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
5039925|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
5039926|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
5039927|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
5039928|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
5039929|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
5039930|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Other|7
5039931|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Other|6
5039932|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Other|5
5039933|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Other|6
5039934|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Other|0
5039935|NCT02709746|17364553|P5|Phase B (Double-blind Treatment Period)|Protocol Violation|2
5039936|NCT02709746|17364554|P4|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5039937|NCT02709746|17364555|P3|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5039938|NCT02709746|17364556|P2|Phase B (Double-blind Treatment Period)|Protocol Violation|1
5039939|NCT02709746|17364557|P1|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5039940|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5039941|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5039942|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5039943|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5039944|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
5039945|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5039946|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5039947|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5039948|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5039949|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
5039950|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5039951|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5039952|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5039953|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5039954|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
5039955|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5039956|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5039957|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5039958|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5039959|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
5039960|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Adverse Event|0
5039961|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Adverse Event|0
5039962|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Adverse Event|0
5039963|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Adverse Event|0
5039964|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Adverse Event|2
5039965|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5039966|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5039967|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5039968|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5039969|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
5039970|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5039971|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5039972|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5039973|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5039974|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
5039975|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Not sepcified|0
5039976|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Not sepcified|0
5039977|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Not sepcified|0
5039978|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Not sepcified|0
5039979|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Not sepcified|14
5039980|NCT02709746|17364553|P5|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5039981|NCT02709746|17364554|P4|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5039982|NCT02709746|17364555|P3|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5039983|NCT02709746|17364556|P2|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5039984|NCT02709746|17364557|P1|Phase A (Single-blind Treatment Period)|Protocol Violation|4
5039985|NCT02709577|17364679|P4|Overall Study|Withdrawal by Subject|0
5039986|NCT02709577|17364680|P3|Overall Study|Withdrawal by Subject|2
5039987|NCT02709577|17364681|P2|Overall Study|Withdrawal by Subject|3
5039988|NCT02709577|17364682|P1|Overall Study|Withdrawal by Subject|2
5039989|NCT02709577|17364679|P4|Overall Study|procedural complication|0
5039990|NCT02709577|17364680|P3|Overall Study|procedural complication|0
5039991|NCT02709577|17364681|P2|Overall Study|procedural complication|1
5039992|NCT02709577|17364682|P1|Overall Study|procedural complication|0
5039993|NCT02709577|17364679|P4|Overall Study|non-accommodating anatomy|0
5039994|NCT02709577|17364680|P3|Overall Study|non-accommodating anatomy|0
5039995|NCT02709577|17364681|P2|Overall Study|non-accommodating anatomy|1
5039996|NCT02709577|17364682|P1|Overall Study|non-accommodating anatomy|0
5039997|NCT02709538|17364697|P3|Overall Study|Other|5
5039998|NCT02709538|17364698|P2|Overall Study|Other|7
5039999|NCT02709538|17364699|P1|Overall Study|Other|16
5040000|NCT02709538|17364697|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
5040001|NCT02709538|17364698|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
5040002|NCT02709538|17364699|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
5040003|NCT02709538|17364697|P3|Overall Study|Protocol deviation|4
5040004|NCT02709538|17364698|P2|Overall Study|Protocol deviation|4
5040005|NCT02709538|17364699|P1|Overall Study|Protocol deviation|10
5040006|NCT02709538|17364697|P3|Overall Study|Non-compliance with study drug|0
5040007|NCT02709538|17364698|P2|Overall Study|Non-compliance with study drug|0
5040008|NCT02709538|17364699|P1|Overall Study|Non-compliance with study drug|2
5040009|NCT02709538|17364697|P3|Overall Study|Non-compliance with study procedures|0
5040010|NCT02709538|17364698|P2|Overall Study|Non-compliance with study procedures|0
5040011|NCT02709538|17364699|P1|Overall Study|Non-compliance with study procedures|5
5040012|NCT02709538|17364697|P3|Overall Study|Withdrawal by Subject|4
5040013|NCT02709538|17364698|P2|Overall Study|Withdrawal by Subject|7
5040014|NCT02709538|17364699|P1|Overall Study|Withdrawal by Subject|40
5040015|NCT02709538|17364697|P3|Overall Study|Physician Decision|0
5040016|NCT02709538|17364698|P2|Overall Study|Physician Decision|0
5040017|NCT02709538|17364699|P1|Overall Study|Physician Decision|1
5040018|NCT02709538|17364697|P3|Overall Study|Lost to Follow-up|4
5040019|NCT02709538|17364698|P2|Overall Study|Lost to Follow-up|8
5040020|NCT02709538|17364699|P1|Overall Study|Lost to Follow-up|24
5040021|NCT02709538|17364697|P3|Overall Study|Lack of Efficacy|0
5040022|NCT02709538|17364698|P2|Overall Study|Lack of Efficacy|0
5040023|NCT02709538|17364699|P1|Overall Study|Lack of Efficacy|1
5040024|NCT02709538|17364697|P3|Overall Study|Adverse Event|3
5040025|NCT02709538|17364698|P2|Overall Study|Adverse Event|2
5040026|NCT02709538|17364699|P1|Overall Study|Adverse Event|13
5040027|NCT02709486|17364710|P3|Overall Study|Withdrawal by Subject|32
5040028|NCT02709486|17364711|P2|Overall Study|Withdrawal by Subject|22
5040029|NCT02709486|17364712|P1|Overall Study|Withdrawal by Subject|32
5040030|NCT02709486|17364710|P3|Overall Study|Other|3
5040031|NCT02709486|17364711|P2|Overall Study|Other|2
5040032|NCT02709486|17364712|P1|Overall Study|Other|0
5040033|NCT02709486|17364710|P3|Overall Study|Lost to Follow-up|2
5040034|NCT02709486|17364711|P2|Overall Study|Lost to Follow-up|2
5040035|NCT02709486|17364712|P1|Overall Study|Lost to Follow-up|3
5040036|NCT02709486|17364710|P3|Overall Study|Insufficient clinical response|3
5040037|NCT02709486|17364711|P2|Overall Study|Insufficient clinical response|3
5040038|NCT02709486|17364712|P1|Overall Study|Insufficient clinical response|7
5040039|NCT02709486|17364710|P3|Overall Study|Death|2
5040040|NCT02709486|17364711|P2|Overall Study|Death|0
5040041|NCT02709486|17364712|P1|Overall Study|Death|0
5040042|NCT02709486|17364710|P3|Overall Study|Adverse Event|3
5040043|NCT02709486|17364711|P2|Overall Study|Adverse Event|5
5040044|NCT02709486|17364712|P1|Overall Study|Adverse Event|2
5040045|NCT02709369|17364903|P1|Overall Study|Did not received intervention|2
5040046|NCT02709369|17364903|P1|Overall Study|Withdrawal by Subject|10
5040047|NCT02709369|17364903|P1|Overall Study|Lost to Follow-up|15
5040048|NCT02709330|17364937|P2|Overall Study|Withdrawal by Subject|0
5040049|NCT02709330|17364938|P1|Overall Study|Withdrawal by Subject|4
5040050|NCT02709330|17364937|P2|Overall Study|Physician Decision|0
5040051|NCT02709330|17364938|P1|Overall Study|Physician Decision|2
5040052|NCT02709330|17364937|P2|Overall Study|Lost to Follow-up|0
5040053|NCT02709330|17364938|P1|Overall Study|Lost to Follow-up|2
5040054|NCT02709330|17364937|P2|Overall Study|Death|0
5040055|NCT02709330|17364938|P1|Overall Study|Death|5
5040056|NCT02709096|17364952|P2|Overall Study|non-compliance|1
5040057|NCT02709096|17364953|P1|Overall Study|non-compliance|1
5040058|NCT02709083|17364959|P1|Overall Study|Original PI left institution|7
5040059|NCT02709005|17364972|P2|Overall Study|Withdrawal by Subject|0
5040060|NCT02709005|17364973|P1|Overall Study|Withdrawal by Subject|3
5040061|NCT02709005|17364972|P2|Overall Study|Lost to Follow-up|1
5040062|NCT02709005|17364973|P1|Overall Study|Lost to Follow-up|1
5040063|NCT02708966|17365003|P2|Overall Study|Lost to Follow-up|2
5040064|NCT02708966|17365004|P1|Overall Study|Lost to Follow-up|2
5040065|NCT02708524|17365087|P4|Overall Study|Subject lost study lens|0
5040066|NCT02708524|17365088|P3|Overall Study|Subject lost study lens|0
5040067|NCT02708524|17365089|P2|Overall Study|Subject lost study lens|0
5040068|NCT02708524|17365090|P1|Overall Study|Subject lost study lens|1
5040069|NCT02708524|17365087|P4|Overall Study|Did not wear lens at final visit|0
5040070|NCT02708524|17365088|P3|Overall Study|Did not wear lens at final visit|0
5040071|NCT02708524|17365089|P2|Overall Study|Did not wear lens at final visit|1
5040072|NCT02708524|17365090|P1|Overall Study|Did not wear lens at final visit|0
5040073|NCT02708524|17365087|P4|Overall Study|Dispensed incorrect study lens|0
5040074|NCT02708524|17365088|P3|Overall Study|Dispensed incorrect study lens|1
5040075|NCT02708524|17365089|P2|Overall Study|Dispensed incorrect study lens|1
5040076|NCT02708524|17365090|P1|Overall Study|Dispensed incorrect study lens|0
5040077|NCT02708524|17365087|P4|Overall Study|Withdrawal by Subject|0
5040078|NCT02708524|17365088|P3|Overall Study|Withdrawal by Subject|0
5040079|NCT02708524|17365089|P2|Overall Study|Withdrawal by Subject|1
5040080|NCT02708524|17365090|P1|Overall Study|Withdrawal by Subject|1
5040081|NCT02708524|17365087|P4|Overall Study|Protocol Violation|0
5040082|NCT02708524|17365088|P3|Overall Study|Protocol Violation|0
5040083|NCT02708524|17365089|P2|Overall Study|Protocol Violation|1
5040084|NCT02708524|17365090|P1|Overall Study|Protocol Violation|0
5040085|NCT02708524|17365087|P4|Overall Study|Lost to Follow-up|0
5040086|NCT02708524|17365088|P3|Overall Study|Lost to Follow-up|1
5040087|NCT02708524|17365089|P2|Overall Study|Lost to Follow-up|1
5040088|NCT02708524|17365090|P1|Overall Study|Lost to Follow-up|1
5040089|NCT02708524|17365087|P4|Overall Study|Lens Discomfort|0
5040090|NCT02708524|17365088|P3|Overall Study|Lens Discomfort|1
5040091|NCT02708524|17365089|P2|Overall Study|Lens Discomfort|0
5040092|NCT02708524|17365090|P1|Overall Study|Lens Discomfort|1
5040093|NCT02708524|17365087|P4|Overall Study|Adverse Event|0
5040094|NCT02708524|17365088|P3|Overall Study|Adverse Event|0
5040095|NCT02708524|17365089|P2|Overall Study|Adverse Event|1
5040096|NCT02708524|17365090|P1|Overall Study|Adverse Event|0
5040097|NCT02708498|17365144|P8|Overall Study|Unknown reason, missing data|0
5040098|NCT02708498|17365145|P7|Overall Study|Unknown reason, missing data|0
5040099|NCT02708498|17365146|P6|Overall Study|Unknown reason, missing data|132
5040100|NCT02708498|17365147|P5|Overall Study|Unknown reason, missing data|195
5040101|NCT02708498|17365148|P4|Overall Study|Unknown reason, missing data|51
5040102|NCT02708498|17365149|P3|Overall Study|Unknown reason, missing data|62
5040103|NCT02708498|17365150|P2|Overall Study|Unknown reason, missing data|0
5040104|NCT02708498|17365151|P1|Overall Study|Unknown reason, missing data|0
5040105|NCT02708498|17365144|P8|Overall Study|Death|0
5040106|NCT02708498|17365145|P7|Overall Study|Death|0
5040107|NCT02708498|17365146|P6|Overall Study|Death|0
5040108|NCT02708498|17365147|P5|Overall Study|Death|1
5040109|NCT02708498|17365148|P4|Overall Study|Death|0
5040110|NCT02708498|17365149|P3|Overall Study|Death|0
5040111|NCT02708498|17365150|P2|Overall Study|Death|19
5040112|NCT02708498|17365151|P1|Overall Study|Death|20
5040113|NCT02708485|17365179|P2|Overall Study|Withdrawal by Subject|2
5040114|NCT02708485|17365180|P1|Overall Study|Withdrawal by Subject|3
5040115|NCT02708355|17365200|P3|Overall Study|Adverse Event|0
5040116|NCT02708355|17365201|P2|Overall Study|Adverse Event|0
5040117|NCT02708355|17365202|P1|Overall Study|Adverse Event|1
5040118|NCT02708277|17365224|P2|Overall Study|Lost to Follow-up|4
5040119|NCT02708277|17365225|P1|Overall Study|Lost to Follow-up|7
5040120|NCT02708121|17365277|P2|Overall Study|Withdrawal by Subject|4
5040121|NCT02708121|17365278|P1|Overall Study|Withdrawal by Subject|0
5040122|NCT02708121|17365277|P2|Overall Study|Withdrawn by Study Team|1
5040123|NCT02708121|17365278|P1|Overall Study|Withdrawn by Study Team|1
5040124|NCT02708095|17365290|P3|Overall Study|Withdrawal by Subject|4
5040125|NCT02708095|17365291|P2|Overall Study|Withdrawal by Subject|3
5040126|NCT02708095|17365292|P1|Overall Study|Withdrawal by Subject|5
5040127|NCT02708095|17365290|P3|Overall Study|Protocol Violation|1
5040128|NCT02708095|17365291|P2|Overall Study|Protocol Violation|0
5040129|NCT02708095|17365292|P1|Overall Study|Protocol Violation|0
5040130|NCT02708095|17365290|P3|Overall Study|Physician Decision|2
5040131|NCT02708095|17365291|P2|Overall Study|Physician Decision|3
5040132|NCT02708095|17365292|P1|Overall Study|Physician Decision|2
5040133|NCT02708095|17365290|P3|Overall Study|Lost to Follow-up|0
5040134|NCT02708095|17365291|P2|Overall Study|Lost to Follow-up|0
5040135|NCT02708095|17365292|P1|Overall Study|Lost to Follow-up|2
5040136|NCT02708095|17365290|P3|Overall Study|Lack of Efficacy|0
5040137|NCT02708095|17365291|P2|Overall Study|Lack of Efficacy|3
5040138|NCT02708095|17365292|P1|Overall Study|Lack of Efficacy|9
5040139|NCT02708095|17365290|P3|Overall Study|Adverse Event|11
5040140|NCT02708095|17365291|P2|Overall Study|Adverse Event|10
5040141|NCT02708095|17365292|P1|Overall Study|Adverse Event|4
5040142|NCT02707991|17365315|P2|Overall Study|Became ineligible|1
5040143|NCT02707991|17365316|P1|Overall Study|Became ineligible|0
5040144|NCT02707991|17365315|P2|Overall Study|Protocol Violation|0
5040145|NCT02707991|17365316|P1|Overall Study|Protocol Violation|1
5040146|NCT02707965|17365333|P16|Overall Study|Protocol deviation|0
5040147|NCT02707965|17365334|P15|Overall Study|Protocol deviation|0
5040148|NCT02707965|17365335|P14|Overall Study|Protocol deviation|0
5040149|NCT02707965|17365336|P13|Overall Study|Protocol deviation|0
5040150|NCT02707965|17365337|P12|Overall Study|Protocol deviation|0
5040151|NCT02707965|17365338|P11|Overall Study|Protocol deviation|0
5040152|NCT02707965|17365339|P10|Overall Study|Protocol deviation|0
5040153|NCT02707965|17365340|P9|Overall Study|Protocol deviation|0
5040154|NCT02707965|17365341|P8|Overall Study|Protocol deviation|1
5040155|NCT02707965|17365342|P7|Overall Study|Protocol deviation|0
5040156|NCT02707965|17365343|P6|Overall Study|Protocol deviation|0
5040157|NCT02707965|17365344|P5|Overall Study|Protocol deviation|0
5040158|NCT02707965|17365345|P4|Overall Study|Protocol deviation|0
5040159|NCT02707965|17365346|P3|Overall Study|Protocol deviation|0
5040160|NCT02707965|17365347|P2|Overall Study|Protocol deviation|1
5040161|NCT02707965|17365348|P1|Overall Study|Protocol deviation|1
5040162|NCT02707965|17365333|P16|Overall Study|PI decisions|0
5040163|NCT02707965|17365334|P15|Overall Study|PI decisions|2
5040164|NCT02707965|17365335|P14|Overall Study|PI decisions|0
5040165|NCT02707965|17365336|P13|Overall Study|PI decisions|0
5040166|NCT02707965|17365337|P12|Overall Study|PI decisions|0
5040167|NCT02707965|17365338|P11|Overall Study|PI decisions|0
5040168|NCT02707965|17365339|P10|Overall Study|PI decisions|0
5040169|NCT02707965|17365340|P9|Overall Study|PI decisions|0
5040170|NCT02707965|17365341|P8|Overall Study|PI decisions|0
5040171|NCT02707965|17365342|P7|Overall Study|PI decisions|0
5040172|NCT02707965|17365343|P6|Overall Study|PI decisions|0
5040173|NCT02707965|17365344|P5|Overall Study|PI decisions|0
5040174|NCT02707965|17365345|P4|Overall Study|PI decisions|0
5040175|NCT02707965|17365346|P3|Overall Study|PI decisions|0
5040176|NCT02707965|17365347|P2|Overall Study|PI decisions|0
5040177|NCT02707965|17365348|P1|Overall Study|PI decisions|0
5040178|NCT02707965|17365333|P16|Overall Study|Withdrawal by Subject|0
5040179|NCT02707965|17365334|P15|Overall Study|Withdrawal by Subject|0
5040180|NCT02707965|17365335|P14|Overall Study|Withdrawal by Subject|0
5040181|NCT02707965|17365336|P13|Overall Study|Withdrawal by Subject|0
5040182|NCT02707965|17365337|P12|Overall Study|Withdrawal by Subject|0
5040183|NCT02707965|17365338|P11|Overall Study|Withdrawal by Subject|0
5040184|NCT02707965|17365339|P10|Overall Study|Withdrawal by Subject|0
5040185|NCT02707965|17365340|P9|Overall Study|Withdrawal by Subject|0
5040186|NCT02707965|17365341|P8|Overall Study|Withdrawal by Subject|2
5040187|NCT02707965|17365342|P7|Overall Study|Withdrawal by Subject|0
5040188|NCT02707965|17365343|P6|Overall Study|Withdrawal by Subject|0
5040189|NCT02707965|17365344|P5|Overall Study|Withdrawal by Subject|0
5040190|NCT02707965|17365345|P4|Overall Study|Withdrawal by Subject|0
5040191|NCT02707965|17365346|P3|Overall Study|Withdrawal by Subject|1
5040192|NCT02707965|17365347|P2|Overall Study|Withdrawal by Subject|0
5040193|NCT02707965|17365348|P1|Overall Study|Withdrawal by Subject|0
5040194|NCT02707952|17365400|P4|Overall Study|Withdrawal by Subject|0
5040195|NCT02707952|17365401|P3|Overall Study|Withdrawal by Subject|2
5040196|NCT02707952|17365402|P2|Overall Study|Withdrawal by Subject|1
5040197|NCT02707952|17365403|P1|Overall Study|Withdrawal by Subject|0
5040198|NCT02707952|17365400|P4|Overall Study|Lost to Follow-up|0
5040199|NCT02707952|17365401|P3|Overall Study|Lost to Follow-up|0
5040200|NCT02707952|17365402|P2|Overall Study|Lost to Follow-up|0
5040201|NCT02707952|17365403|P1|Overall Study|Lost to Follow-up|1
5040202|NCT02707952|17365400|P4|Overall Study|Adverse Event|0
5040203|NCT02707952|17365401|P3|Overall Study|Adverse Event|0
5040204|NCT02707952|17365402|P2|Overall Study|Adverse Event|0
5040205|NCT02707952|17365403|P1|Overall Study|Adverse Event|1
5040206|NCT02707640|17365424|P2|Overall Study|Sponsor Discretion|0
5040207|NCT02707640|17365425|P1|Overall Study|Sponsor Discretion|1
5040208|NCT02707640|17365424|P2|Overall Study|Participant's Personal Decision|2
5040209|NCT02707640|17365425|P1|Overall Study|Participant's Personal Decision|1
5040210|NCT02707640|17365424|P2|Overall Study|Withdrawal by Subject|1
5040211|NCT02707640|17365425|P1|Overall Study|Withdrawal by Subject|0
5040212|NCT02707640|17365424|P2|Overall Study|Physician Decision|0
5040213|NCT02707640|17365425|P1|Overall Study|Physician Decision|2
5040214|NCT02707640|17365424|P2|Overall Study|Death|2
5040215|NCT02707640|17365425|P1|Overall Study|Death|1
5040216|NCT02707640|17365424|P2|Overall Study|Adverse Event|2
5040217|NCT02707640|17365425|P1|Overall Study|Adverse Event|4
5040218|NCT02707601|17365445|P2|Overall Study|Participants Randomized but Not Treated|0
5040219|NCT02707601|17365446|P1|Overall Study|Participants Randomized but Not Treated|2
5040220|NCT02707601|17365445|P2|Overall Study|Lost to Follow-up|1
5040221|NCT02707601|17365446|P1|Overall Study|Lost to Follow-up|1
5040222|NCT02707601|17365445|P2|Overall Study|Withdrew Consent|1
5040223|NCT02707601|17365446|P1|Overall Study|Withdrew Consent|0
5040224|NCT02707601|17365445|P2|Overall Study|Investigator's Discretion|0
5040225|NCT02707601|17365446|P1|Overall Study|Investigator's Discretion|1
5040226|NCT02707601|17365445|P2|Overall Study|Lack of Efficacy|1
5040227|NCT02707601|17365446|P1|Overall Study|Lack of Efficacy|0
5040228|NCT02707601|17365445|P2|Overall Study|Death|1
5040229|NCT02707601|17365446|P1|Overall Study|Death|0
5040230|NCT02706951|17365535|P3|Overall Study|Other|0
5040231|NCT02706951|17365536|P2|Overall Study|Other|1
5040232|NCT02706951|17365537|P1|Overall Study|Other|2
5040233|NCT02706951|17365535|P3|Overall Study|Lost to Follow-up|1
5040234|NCT02706951|17365536|P2|Overall Study|Lost to Follow-up|4
5040235|NCT02706951|17365537|P1|Overall Study|Lost to Follow-up|0
5040236|NCT02706951|17365535|P3|Overall Study|Withdrawal by Subject|6
5040237|NCT02706951|17365536|P2|Overall Study|Withdrawal by Subject|6
5040238|NCT02706951|17365537|P1|Overall Study|Withdrawal by Subject|11
5040239|NCT02706951|17365535|P3|Overall Study|Adverse Event|3
5040240|NCT02706951|17365536|P2|Overall Study|Adverse Event|5
5040241|NCT02706951|17365537|P1|Overall Study|Adverse Event|1
5040242|NCT02706938|17365571|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
5040243|NCT02706938|17365572|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
5040244|NCT02706938|17365571|P2|Second Period, 6 Weeks|Adverse Event|7
5040245|NCT02706938|17365572|P1|Second Period, 6 Weeks|Adverse Event|0
5040246|NCT02706938|17365571|P2|First Period, 6 Weeks|Withdrawal by Subject|0
5040247|NCT02706938|17365572|P1|First Period, 6 Weeks|Withdrawal by Subject|1
5040248|NCT02706938|17365571|P2|First Period, 6 Weeks|Lost to Follow-up|2
5040249|NCT02706938|17365572|P1|First Period, 6 Weeks|Lost to Follow-up|2
5040250|NCT02706938|17365571|P2|First Period, 6 Weeks|Adverse Event|0
5040251|NCT02706938|17365572|P1|First Period, 6 Weeks|Adverse Event|8
5040252|NCT02706899|17365636|P2|Overall Study|Study Termination by Sponsor|6
5040253|NCT02706899|17365637|P1|Overall Study|Study Termination by Sponsor|4
5040254|NCT02706899|17365636|P2|Overall Study|Death|0
5040255|NCT02706899|17365637|P1|Overall Study|Death|8
5040256|NCT02706899|17365636|P2|Overall Study|Withdrawal by Subject|0
5040257|NCT02706899|17365637|P1|Overall Study|Withdrawal by Subject|1
5040258|NCT02706886|17365668|P9|Part A: SAD Period|Withdrawal by Subject|0
5040259|NCT02706886|17365669|P8|Part A: SAD Period|Withdrawal by Subject|0
5040260|NCT02706886|17365670|P7|Part A: SAD Period|Withdrawal by Subject|0
5040261|NCT02706886|17365671|P6|Part A: SAD Period|Withdrawal by Subject|0
5040262|NCT02706886|17365672|P5|Part A: SAD Period|Withdrawal by Subject|0
5040263|NCT02706886|17365673|P4|Part A: SAD Period|Withdrawal by Subject|2
5040264|NCT02706886|17365674|P3|Part A: SAD Period|Withdrawal by Subject|0
5040265|NCT02706886|17365675|P2|Part A: SAD Period|Withdrawal by Subject|0
5040266|NCT02706886|17365676|P1|Part A: SAD Period|Withdrawal by Subject|0
5040267|NCT02706873|17365793|P4|Overall Study|Ongoing|1
5040268|NCT02706873|17365794|P3|Overall Study|Ongoing|0
5040269|NCT02706873|17365795|P2|Overall Study|Ongoing|0
5040270|NCT02706873|17365796|P1|Overall Study|Ongoing|0
5040271|NCT02706873|17365793|P4|Overall Study|Not Dosed|1
5040272|NCT02706873|17365794|P3|Overall Study|Not Dosed|0
5040273|NCT02706873|17365795|P2|Overall Study|Not Dosed|0
5040274|NCT02706873|17365796|P1|Overall Study|Not Dosed|1
5040275|NCT02706873|17365793|P4|Overall Study|Other|3
5040276|NCT02706873|17365794|P3|Overall Study|Other|2
5040277|NCT02706873|17365795|P2|Overall Study|Other|1
5040278|NCT02706873|17365796|P1|Overall Study|Other|5
5040279|NCT02706873|17365793|P4|Overall Study|Lack of Efficacy|3
5040280|NCT02706873|17365794|P3|Overall Study|Lack of Efficacy|0
5040281|NCT02706873|17365795|P2|Overall Study|Lack of Efficacy|0
5040282|NCT02706873|17365796|P1|Overall Study|Lack of Efficacy|10
5040283|NCT02706873|17365793|P4|Overall Study|Lost to Follow-up|2
5040284|NCT02706873|17365794|P3|Overall Study|Lost to Follow-up|4
5040285|NCT02706873|17365795|P2|Overall Study|Lost to Follow-up|0
5040286|NCT02706873|17365796|P1|Overall Study|Lost to Follow-up|3
5040287|NCT02706873|17365793|P4|Overall Study|Withdrawal by Subject|11
5040288|NCT02706873|17365794|P3|Overall Study|Withdrawal by Subject|8
5040289|NCT02706873|17365795|P2|Overall Study|Withdrawal by Subject|0
5040290|NCT02706873|17365796|P1|Overall Study|Withdrawal by Subject|15
5040291|NCT02706873|17365793|P4|Overall Study|Adverse Event|12
5040292|NCT02706873|17365794|P3|Overall Study|Adverse Event|13
5040293|NCT02706873|17365795|P2|Overall Study|Adverse Event|3
5040294|NCT02706873|17365796|P1|Overall Study|Adverse Event|13
5040295|NCT02706847|17365896|P4|Week 12 to Week 24|Other|4
5040296|NCT02706847|17365897|P3|Week 12 to Week 24|Other|1
5040297|NCT02706847|17365898|P2|Week 12 to Week 24|Other|0
5040298|NCT02706847|17365899|P1|Week 12 to Week 24|Other|1
5040299|NCT02706847|17365896|P4|Week 12 to Week 24|Lost to Follow-up|1
5040300|NCT02706847|17365897|P3|Week 12 to Week 24|Lost to Follow-up|0
5040301|NCT02706847|17365898|P2|Week 12 to Week 24|Lost to Follow-up|0
5040302|NCT02706847|17365899|P1|Week 12 to Week 24|Lost to Follow-up|0
5040303|NCT02706847|17365896|P4|Week 12 to Week 24|Withdrawal by Subject|4
5040304|NCT02706847|17365897|P3|Week 12 to Week 24|Withdrawal by Subject|1
5040305|NCT02706847|17365898|P2|Week 12 to Week 24|Withdrawal by Subject|0
5040306|NCT02706847|17365899|P1|Week 12 to Week 24|Withdrawal by Subject|1
5040307|NCT02706847|17365896|P4|Week 12 to Week 24|Adverse Event|5
5040308|NCT02706847|17365897|P3|Week 12 to Week 24|Adverse Event|2
5040309|NCT02706847|17365898|P2|Week 12 to Week 24|Adverse Event|2
5040310|NCT02706847|17365899|P1|Week 12 to Week 24|Adverse Event|1
5040311|NCT02706847|17365896|P4|Day 1 to Week 12|Randomized in Error|0
5040312|NCT02706847|17365897|P3|Day 1 to Week 12|Randomized in Error|1
5040313|NCT02706847|17365898|P2|Day 1 to Week 12|Randomized in Error|0
5040314|NCT02706847|17365899|P1|Day 1 to Week 12|Randomized in Error|0
5040315|NCT02706847|17365896|P4|Day 1 to Week 12|Other|2
5040316|NCT02706847|17365897|P3|Day 1 to Week 12|Other|2
5040317|NCT02706847|17365898|P2|Day 1 to Week 12|Other|4
5040318|NCT02706847|17365899|P1|Day 1 to Week 12|Other|4
5040319|NCT02706847|17365896|P4|Day 1 to Week 12|Lost to Follow-up|0
5040320|NCT02706847|17365897|P3|Day 1 to Week 12|Lost to Follow-up|0
5040321|NCT02706847|17365898|P2|Day 1 to Week 12|Lost to Follow-up|1
5040322|NCT02706847|17365899|P1|Day 1 to Week 12|Lost to Follow-up|2
5040323|NCT02706847|17365896|P4|Day 1 to Week 12|Withdrawal by Subject|2
5040324|NCT02706847|17365897|P3|Day 1 to Week 12|Withdrawal by Subject|4
5040325|NCT02706847|17365898|P2|Day 1 to Week 12|Withdrawal by Subject|1
5040326|NCT02706847|17365899|P1|Day 1 to Week 12|Withdrawal by Subject|2
5040327|NCT02706847|17365896|P4|Day 1 to Week 12|Adverse Event|12
5040328|NCT02706847|17365897|P3|Day 1 to Week 12|Adverse Event|1
5040329|NCT02706847|17365898|P2|Day 1 to Week 12|Adverse Event|2
5040330|NCT02706847|17365899|P1|Day 1 to Week 12|Adverse Event|2
5040331|NCT02706834|17365941|P11|Overall Study|Other Reason Not Specified|0
5040332|NCT02706834|17365942|P10|Overall Study|Other Reason Not Specified|0
5040333|NCT02706834|17365943|P9|Overall Study|Other Reason Not Specified|0
5040334|NCT02706834|17365944|P8|Overall Study|Other Reason Not Specified|0
5040335|NCT02706834|17365945|P7|Overall Study|Other Reason Not Specified|0
5040336|NCT02706834|17365946|P6|Overall Study|Other Reason Not Specified|0
5040337|NCT02706834|17365947|P5|Overall Study|Other Reason Not Specified|1
5040338|NCT02706834|17365948|P4|Overall Study|Other Reason Not Specified|0
5040339|NCT02706834|17365949|P3|Overall Study|Other Reason Not Specified|0
5040340|NCT02706834|17365950|P2|Overall Study|Other Reason Not Specified|0
5040341|NCT02706834|17365951|P1|Overall Study|Other Reason Not Specified|1
5040342|NCT02706834|17365941|P11|Overall Study|Voluntary Withdrawal|0
5040343|NCT02706834|17365942|P10|Overall Study|Voluntary Withdrawal|1
5040344|NCT02706834|17365943|P9|Overall Study|Voluntary Withdrawal|0
5040345|NCT02706834|17365944|P8|Overall Study|Voluntary Withdrawal|0
5040346|NCT02706834|17365945|P7|Overall Study|Voluntary Withdrawal|0
5040347|NCT02706834|17365946|P6|Overall Study|Voluntary Withdrawal|0
5040348|NCT02706834|17365947|P5|Overall Study|Voluntary Withdrawal|0
5040349|NCT02706834|17365948|P4|Overall Study|Voluntary Withdrawal|0
5040350|NCT02706834|17365949|P3|Overall Study|Voluntary Withdrawal|0
5040351|NCT02706834|17365950|P2|Overall Study|Voluntary Withdrawal|0
5040352|NCT02706834|17365951|P1|Overall Study|Voluntary Withdrawal|1
5040353|NCT02706834|17365941|P11|Overall Study|Lost to Follow-up|0
5040354|NCT02706834|17365942|P10|Overall Study|Lost to Follow-up|0
5040355|NCT02706834|17365943|P9|Overall Study|Lost to Follow-up|0
5040356|NCT02706834|17365944|P8|Overall Study|Lost to Follow-up|0
5040357|NCT02706834|17365945|P7|Overall Study|Lost to Follow-up|0
5040358|NCT02706834|17365946|P6|Overall Study|Lost to Follow-up|0
5040359|NCT02706834|17365947|P5|Overall Study|Lost to Follow-up|0
5040360|NCT02706834|17365948|P4|Overall Study|Lost to Follow-up|0
5040361|NCT02706834|17365949|P3|Overall Study|Lost to Follow-up|1
5040362|NCT02706834|17365950|P2|Overall Study|Lost to Follow-up|0
5040363|NCT02706834|17365951|P1|Overall Study|Lost to Follow-up|0
5040364|NCT02706834|17365941|P11|Overall Study|Pretreatment Event/Adverse Event|1
5040365|NCT02706834|17365942|P10|Overall Study|Pretreatment Event/Adverse Event|0
5040366|NCT02706834|17365943|P9|Overall Study|Pretreatment Event/Adverse Event|0
5040367|NCT02706834|17365944|P8|Overall Study|Pretreatment Event/Adverse Event|0
5040368|NCT02706834|17365945|P7|Overall Study|Pretreatment Event/Adverse Event|0
5040369|NCT02706834|17365946|P6|Overall Study|Pretreatment Event/Adverse Event|0
5040370|NCT02706834|17365947|P5|Overall Study|Pretreatment Event/Adverse Event|0
5040371|NCT02706834|17365948|P4|Overall Study|Pretreatment Event/Adverse Event|0
5040372|NCT02706834|17365949|P3|Overall Study|Pretreatment Event/Adverse Event|0
5040373|NCT02706834|17365950|P2|Overall Study|Pretreatment Event/Adverse Event|1
5040374|NCT02706834|17365951|P1|Overall Study|Pretreatment Event/Adverse Event|0
5040375|NCT02706717|17366095|P2|Overall Study|Death|1
5040376|NCT02706717|17366096|P1|Overall Study|Death|0
5040377|NCT02706717|17366095|P2|Overall Study|Physician Decision|1
5040378|NCT02706717|17366096|P1|Overall Study|Physician Decision|0
5040379|NCT02706717|17366095|P2|Overall Study|Lost to Follow-up|1
5040380|NCT02706717|17366096|P1|Overall Study|Lost to Follow-up|0
5040381|NCT02706717|17366095|P2|Overall Study|Withdrawal by Subject|8
5040382|NCT02706717|17366096|P1|Overall Study|Withdrawal by Subject|1
5040383|NCT02706691|17366160|P1|Overall Study|Adverse Event|1
5040384|NCT02706483|17366167|P1|Overall Study|Subject moved|1
5040385|NCT02706483|17366167|P1|Overall Study|Site closure|4
5040386|NCT02706483|17366167|P1|Overall Study|Non-compliance with visits|6
5040387|NCT02706483|17366167|P1|Overall Study|Withdrawal by Subject|136
5040388|NCT02706483|17366167|P1|Overall Study|Protocol Violation|18
5040389|NCT02706483|17366167|P1|Overall Study|Pregnancy|6
5040390|NCT02706483|17366167|P1|Overall Study|Physician Decision|6
5040391|NCT02706483|17366167|P1|Overall Study|Non-compliance with study drug|15
5040392|NCT02706483|17366167|P1|Overall Study|Lost to Follow-up|101
5040393|NCT02706483|17366167|P1|Overall Study|Lack of Efficacy|39
5040394|NCT02706483|17366167|P1|Overall Study|Death|1
5040395|NCT02706483|17366167|P1|Overall Study|Adverse Event|97
5040396|NCT02706327|17366174|P3|Overall Study|Lost to Follow-up|2
5040397|NCT02706327|17366175|P2|Overall Study|Lost to Follow-up|1
5040398|NCT02706327|17366176|P1|Overall Study|Lost to Follow-up|1
5040399|NCT02705716|17366228|P2|Overall Study|Withdrawal of Consent|1
5040400|NCT02705716|17366229|P1|Overall Study|Withdrawal of Consent|1
5040401|NCT02705716|17366228|P2|Overall Study|Protocol Violation|0
5040402|NCT02705716|17366229|P1|Overall Study|Protocol Violation|3
5040403|NCT02705716|17366228|P2|Overall Study|Adverse Event|1
5040404|NCT02705716|17366229|P1|Overall Study|Adverse Event|0
5040405|NCT02705625|17366242|P3|Overall Study|Overdosing|1
5040406|NCT02705625|17366243|P2|Overall Study|Overdosing|0
5040407|NCT02705625|17366244|P1|Overall Study|Overdosing|0
5040408|NCT02705625|17366242|P3|Overall Study|Non-compliance|1
5040409|NCT02705625|17366243|P2|Overall Study|Non-compliance|1
5040410|NCT02705625|17366244|P1|Overall Study|Non-compliance|0
5040411|NCT02705625|17366242|P3|Overall Study|Lost to Follow-up|1
5040412|NCT02705625|17366243|P2|Overall Study|Lost to Follow-up|0
5040413|NCT02705625|17366244|P1|Overall Study|Lost to Follow-up|0
5040414|NCT02705625|17366242|P3|Overall Study|Withdrawal by Subject|5
5040415|NCT02705625|17366243|P2|Overall Study|Withdrawal by Subject|4
5040416|NCT02705625|17366244|P1|Overall Study|Withdrawal by Subject|1
5040417|NCT02705625|17366242|P3|Overall Study|Death|1
5040418|NCT02705625|17366243|P2|Overall Study|Death|0
5040419|NCT02705625|17366244|P1|Overall Study|Death|0
5040420|NCT02705625|17366242|P3|Overall Study|Adverse Event|2
5040421|NCT02705625|17366243|P2|Overall Study|Adverse Event|5
5040422|NCT02705625|17366244|P1|Overall Study|Adverse Event|6
5040423|NCT02705625|17366242|P3|Overall Study|Protocol Violation|0
5040424|NCT02705625|17366243|P2|Overall Study|Protocol Violation|0
5040425|NCT02705625|17366244|P1|Overall Study|Protocol Violation|1
5040426|NCT02705586|17366273|P1|Overall Study|Vacation/Planned Absence|1
5040427|NCT02705586|17366273|P1|Overall Study|Transportation Difficulties|5
5040428|NCT02705586|17366273|P1|Overall Study|Health Issues|2
5040429|NCT02705105|17366311|P2|Follow-Up|Discontinued per Amendment 3|2
5040430|NCT02705105|17366312|P1|Follow-Up|Discontinued per Amendment 3|0
5040431|NCT02705105|17366311|P2|Follow-Up|Study Terminated|26
5040432|NCT02705105|17366312|P1|Follow-Up|Study Terminated|0
5040433|NCT02705105|17366311|P2|Follow-Up|Withdrawal by Subject|14
5040434|NCT02705105|17366312|P1|Follow-Up|Withdrawal by Subject|1
5040435|NCT02705105|17366311|P2|Follow-Up|Death|68
5040436|NCT02705105|17366312|P1|Follow-Up|Death|3
5040437|NCT02705105|17366311|P2|Treatment|Ongoing w/ Treatment at time of data cut|2
5040438|NCT02705105|17366312|P1|Treatment|Ongoing w/ Treatment at time of data cut|0
5040439|NCT02705105|17366311|P2|Treatment|Physician Decision|3
5040440|NCT02705105|17366312|P1|Treatment|Physician Decision|0
5040441|NCT02705105|17366311|P2|Treatment|Clinical Disease Progression|32
5040442|NCT02705105|17366312|P1|Treatment|Clinical Disease Progression|0
5040443|NCT02705105|17366311|P2|Treatment|Adverse Event|17
5040444|NCT02705105|17366312|P1|Treatment|Adverse Event|0
5040445|NCT02705105|17366311|P2|Treatment|Withdrawal by Subject|5
5040446|NCT02705105|17366312|P1|Treatment|Withdrawal by Subject|3
5040447|NCT02705105|17366311|P2|Treatment|Objective Disease Progression|50
5040448|NCT02705105|17366312|P1|Treatment|Objective Disease Progression|1
5040449|NCT02704689|17366375|P1|Overall Study|Study device not implanted|2
5040450|NCT02704689|17366375|P1|Overall Study|Physician Decision|1
5040451|NCT02704143|17366392|P1|Overall Study|disease progression|10
5040452|NCT02704091|17366417|P2|Overall Study|Other|8
5040453|NCT02704091|17366418|P1|Overall Study|Other|2
5040454|NCT02704091|17366417|P2|Overall Study|Lost to Follow-up|5
5040455|NCT02704091|17366418|P1|Overall Study|Lost to Follow-up|13
5040456|NCT02704091|17366417|P2|Overall Study|Consent withdrawn|4
5040457|NCT02704091|17366418|P1|Overall Study|Consent withdrawn|4
5040458|NCT02704091|17366417|P2|Overall Study|Protocol Violation|3
5040459|NCT02704091|17366418|P1|Overall Study|Protocol Violation|5
5040460|NCT02704091|17366417|P2|Overall Study|Adverse Event|3
5040461|NCT02704091|17366418|P1|Overall Study|Adverse Event|4
5040462|NCT02703636|17366478|P1|Overall Study|Withdrawal by Subject|1
5040463|NCT02703636|17366478|P1|Overall Study|Study stopped by sponsor|1
5040464|NCT02703636|17366478|P1|Overall Study|Adverse Event|14
5040465|NCT02703532|17366493|P4|Overall Study|Lost to Follow-up|0
5040466|NCT02703532|17366494|P3|Overall Study|Lost to Follow-up|2
5040467|NCT02703532|17366495|P2|Overall Study|Lost to Follow-up|0
5040468|NCT02703532|17366496|P1|Overall Study|Lost to Follow-up|2
5040469|NCT02703532|17366493|P4|Overall Study|Withdrawal by Subject|1
5040470|NCT02703532|17366494|P3|Overall Study|Withdrawal by Subject|0
5040471|NCT02703532|17366495|P2|Overall Study|Withdrawal by Subject|1
5040472|NCT02703532|17366496|P1|Overall Study|Withdrawal by Subject|0
5040473|NCT02703454|17366558|P2|Overall Study|Study discontinuation|8
5040474|NCT02703454|17366559|P1|Overall Study|Study discontinuation|5
5040475|NCT02703454|17366558|P2|Overall Study|Lost to Follow-up|2
5040476|NCT02703454|17366559|P1|Overall Study|Lost to Follow-up|1
5040477|NCT02703454|17366558|P2|Overall Study|Withdrawal by Subject|3
5040478|NCT02703454|17366559|P1|Overall Study|Withdrawal by Subject|4
5040479|NCT02703454|17366558|P2|Overall Study|Not treated|3
5040480|NCT02703454|17366559|P1|Overall Study|Not treated|1
5040481|NCT02703337|17366594|P8|Period One (Part A)|Withdrawal by Subject|0
5040482|NCT02703337|17366595|P7|Period One (Part A)|Withdrawal by Subject|0
5040483|NCT02703337|17366596|P6|Period One (Part A)|Withdrawal by Subject|0
5040484|NCT02703337|17366597|P5|Period One (Part A)|Withdrawal by Subject|1
5040485|NCT02703337|17366598|P4|Period One (Part A)|Withdrawal by Subject|0
5040486|NCT02703337|17366599|P3|Period One (Part A)|Withdrawal by Subject|0
5040487|NCT02703337|17366600|P2|Period One (Part A)|Withdrawal by Subject|0
5040488|NCT02703337|17366601|P1|Period One (Part A)|Withdrawal by Subject|0
5040489|NCT02703324|17366621|P6|Period Two|Withdrawal by Subject|0
5040490|NCT02703324|17366622|P5|Period Two|Withdrawal by Subject|0
5040491|NCT02703324|17366623|P4|Period Two|Withdrawal by Subject|0
5040492|NCT02703324|17366624|P3|Period Two|Withdrawal by Subject|1
5040493|NCT02703324|17366625|P2|Period Two|Withdrawal by Subject|0
5040494|NCT02703324|17366626|P1|Period Two|Withdrawal by Subject|0
5040495|NCT02703311|17366635|P1|Overall Study|Withdrawal by Subject|3
5040496|NCT02703311|17366635|P1|Overall Study|Death|5
5040497|NCT02703259|17366653|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
5040498|NCT02703259|17366654|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
5040499|NCT02703259|17366653|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
5040500|NCT02703259|17366654|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
5040501|NCT02703259|17366653|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
5040502|NCT02703259|17366654|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
5040503|NCT02702609|17366702|P2|Overall Study|Physician Decision|0
5040504|NCT02702609|17366703|P1|Overall Study|Physician Decision|1
5040505|NCT02702609|17366702|P2|Overall Study|Lost to Follow-up|4
5040506|NCT02702609|17366703|P1|Overall Study|Lost to Follow-up|8
5040507|NCT02702401|17366721|P2|Overall Study|Ongoing in study|34
5040508|NCT02702401|17366722|P1|Overall Study|Ongoing in study|94
5040509|NCT02702401|17366721|P2|Overall Study|Withdrawal by Subject|0
5040510|NCT02702401|17366722|P1|Overall Study|Withdrawal by Subject|4
5040511|NCT02702401|17366721|P2|Overall Study|Death|101
5040512|NCT02702401|17366722|P1|Overall Study|Death|180
5040513|NCT02702193|17366744|P2|12 Month Follow up|Lost to Follow-up|18
5040514|NCT02702193|17366745|P1|12 Month Follow up|Lost to Follow-up|16
5040515|NCT02702193|17366744|P2|12 Month Follow up|Withdrawal by Subject|0
5040516|NCT02702193|17366745|P1|12 Month Follow up|Withdrawal by Subject|1
5040517|NCT02702193|17366744|P2|8 Month Follow up|Lost to Follow-up|18
5040518|NCT02702193|17366745|P1|8 Month Follow up|Lost to Follow-up|14
5040519|NCT02702193|17366744|P2|8 Month Follow up|Withdrawal by Subject|0
5040520|NCT02702193|17366745|P1|8 Month Follow up|Withdrawal by Subject|1
5040521|NCT02702193|17366744|P2|4 Month Follow up|Lost to Follow-up|18
5040522|NCT02702193|17366745|P1|4 Month Follow up|Lost to Follow-up|17
5040523|NCT02702193|17366744|P2|4 Month Follow up|Withdrawal by Subject|0
5040524|NCT02702193|17366745|P1|4 Month Follow up|Withdrawal by Subject|1
5040525|NCT02702193|17366744|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
5040526|NCT02702193|17366745|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
5040527|NCT02702011|17366773|P4|Overall Study|Withdrawal by Subject|0
5040528|NCT02702011|17366774|P3|Overall Study|Withdrawal by Subject|0
5040529|NCT02702011|17366775|P2|Overall Study|Withdrawal by Subject|1
5040530|NCT02702011|17366776|P1|Overall Study|Withdrawal by Subject|0
5040531|NCT02701985|17366788|P2|Overall Study|Adverse Event|5
5040532|NCT02701985|17366789|P1|Overall Study|Adverse Event|0
5040533|NCT02701985|17366788|P2|Overall Study|Death|0
5040534|NCT02701985|17366789|P1|Overall Study|Death|1
5040535|NCT02701985|17366788|P2|Overall Study|Lost to Follow-up|0
5040536|NCT02701985|17366789|P1|Overall Study|Lost to Follow-up|1
5040537|NCT02701985|17366788|P2|Overall Study|Withdrawal by Subject|1
5040538|NCT02701985|17366789|P1|Overall Study|Withdrawal by Subject|1
5040539|NCT02701764|17366832|P2|Overall Study|Lost to Follow-up|1
5040540|NCT02701764|17366833|P1|Overall Study|Lost to Follow-up|0
5040541|NCT02701634|17366892|P2|Overall Study|Randomized but not treated|0
5040542|NCT02701634|17366893|P1|Overall Study|Randomized but not treated|1
5040543|NCT02701634|17366892|P2|Overall Study|Withdrew Consent|7
5040544|NCT02701634|17366893|P1|Overall Study|Withdrew Consent|6
5040545|NCT02701634|17366892|P2|Overall Study|Study terminated by Sponsor|17
5040546|NCT02701634|17366893|P1|Overall Study|Study terminated by Sponsor|15
5040547|NCT02701634|17366892|P2|Overall Study|Investigator's Discretion|4
5040548|NCT02701634|17366893|P1|Overall Study|Investigator's Discretion|7
5040549|NCT02701634|17366892|P2|Overall Study|Death|0
5040550|NCT02701634|17366893|P1|Overall Study|Death|1
5040551|NCT02701634|17366892|P2|Overall Study|Adverse Event|3
5040552|NCT02701634|17366893|P1|Overall Study|Adverse Event|2
5040553|NCT02701361|17366963|P3|Overall Study|incarceration|1
5040554|NCT02701361|17366964|P2|Overall Study|incarceration|0
5040555|NCT02701361|17366965|P1|Overall Study|incarceration|0
5040556|NCT02701361|17366963|P3|Overall Study|timed out in rehab center|0
5040557|NCT02701361|17366964|P2|Overall Study|timed out in rehab center|1
5040558|NCT02701361|17366965|P1|Overall Study|timed out in rehab center|0
5040559|NCT02701361|17366963|P3|Overall Study|Withdrawal by Subject|0
5040560|NCT02701361|17366964|P2|Overall Study|Withdrawal by Subject|0
5040561|NCT02701361|17366965|P1|Overall Study|Withdrawal by Subject|4
5040562|NCT02701361|17366963|P3|Overall Study|Lost to Follow-up|1
5040563|NCT02701361|17366964|P2|Overall Study|Lost to Follow-up|2
5040564|NCT02701361|17366965|P1|Overall Study|Lost to Follow-up|5
5040565|NCT02701296|17367006|P2|Overall Study|Incomplete Data|2
5040566|NCT02701296|17367007|P1|Overall Study|Incomplete Data|0
5040567|NCT02700997|17367259|P1|Overall Study|No CT measurement - pelvic calcification|1
5040568|NCT02700997|17367259|P1|Overall Study|Did not undergo CT imaging|1
5040569|NCT02700984|17367265|P2|Overall Study|Reason not specified|2
5040570|NCT02700984|17367266|P1|Overall Study|Reason not specified|3
5040571|NCT02700984|17367265|P2|Overall Study|Withdrawal by Subject|9
5040572|NCT02700984|17367266|P1|Overall Study|Withdrawal by Subject|8
5040573|NCT02700984|17367265|P2|Overall Study|Physician Decision|1
5040574|NCT02700984|17367266|P1|Overall Study|Physician Decision|0
5040575|NCT02700984|17367265|P2|Overall Study|Lost to Follow-up|1
5040576|NCT02700984|17367266|P1|Overall Study|Lost to Follow-up|2
5040577|NCT02700984|17367265|P2|Overall Study|Death|1
5040578|NCT02700984|17367266|P1|Overall Study|Death|2
5040579|NCT02700919|17367318|P3|Overall Study|Other|1
5040580|NCT02700919|17367319|P2|Overall Study|Other|1
5040581|NCT02700919|17367320|P1|Overall Study|Other|2
5040582|NCT02700919|17367318|P3|Overall Study|Lost to Follow-up|0
5040583|NCT02700919|17367319|P2|Overall Study|Lost to Follow-up|0
5040584|NCT02700919|17367320|P1|Overall Study|Lost to Follow-up|2
5040585|NCT02700919|17367318|P3|Overall Study|Withdrawal by Subject|2
5040586|NCT02700919|17367319|P2|Overall Study|Withdrawal by Subject|8
5040587|NCT02700919|17367320|P1|Overall Study|Withdrawal by Subject|5
5040588|NCT02700919|17367318|P3|Overall Study|Adverse Event|1
5040589|NCT02700919|17367319|P2|Overall Study|Adverse Event|3
5040590|NCT02700919|17367320|P1|Overall Study|Adverse Event|1
5040591|NCT02700919|17367318|P3|Overall Study|Protocol Violation|0
5040592|NCT02700919|17367319|P2|Overall Study|Protocol Violation|0
5040593|NCT02700919|17367320|P1|Overall Study|Protocol Violation|1
5040594|NCT02700919|17367318|P3|Overall Study|Physician Decision|0
5040595|NCT02700919|17367319|P2|Overall Study|Physician Decision|0
5040596|NCT02700919|17367320|P1|Overall Study|Physician Decision|1
5040597|NCT02700815|17367382|P4|Overall Study|Withdrawal by Subject|0
5040598|NCT02700815|17367383|P3|Overall Study|Withdrawal by Subject|1
5040599|NCT02700815|17367384|P2|Overall Study|Withdrawal by Subject|0
5040600|NCT02700815|17367385|P1|Overall Study|Withdrawal by Subject|0
5040601|NCT02700815|17367382|P4|Overall Study|Refusal to continue medication|1
5040602|NCT02700815|17367383|P3|Overall Study|Refusal to continue medication|0
5040603|NCT02700815|17367384|P2|Overall Study|Refusal to continue medication|1
5040604|NCT02700815|17367385|P1|Overall Study|Refusal to continue medication|0
5040605|NCT02700815|17367382|P4|Overall Study|Lost to Follow-up|1
5040606|NCT02700815|17367383|P3|Overall Study|Lost to Follow-up|0
5040607|NCT02700815|17367384|P2|Overall Study|Lost to Follow-up|0
5040608|NCT02700815|17367385|P1|Overall Study|Lost to Follow-up|1
5040609|NCT02700815|17367382|P4|Overall Study|Lack of Efficacy|2
5040610|NCT02700815|17367383|P3|Overall Study|Lack of Efficacy|1
5040611|NCT02700815|17367384|P2|Overall Study|Lack of Efficacy|0
5040612|NCT02700815|17367385|P1|Overall Study|Lack of Efficacy|0
5040613|NCT02700815|17367382|P4|Overall Study|Adverse Event|3
5040614|NCT02700815|17367383|P3|Overall Study|Adverse Event|2
5040615|NCT02700815|17367384|P2|Overall Study|Adverse Event|6
5040616|NCT02700815|17367385|P1|Overall Study|Adverse Event|0
5040617|NCT02700412|17367423|P1|Overall Study|Withdrawal by Subject|2
5040618|NCT02700412|17367423|P1|Overall Study|Protocol Violation|5
5040619|NCT02700412|17367423|P1|Overall Study|Lack of Efficacy|19
5040620|NCT02700412|17367423|P1|Overall Study|Death|1
5040621|NCT02700412|17367423|P1|Overall Study|Adverse Event|6
5040622|NCT02699996|17367474|P2|Overall Study|Withdrawal by Subject|2
5040623|NCT02699996|17367475|P1|Overall Study|Withdrawal by Subject|5
5040624|NCT02699983|17367493|P2|Overall Study|Withdrawal by Subject|0
5040625|NCT02699983|17367494|P1|Overall Study|Withdrawal by Subject|1
5040626|NCT02699892|17367559|P1|Overall Study|Other|36
5040627|NCT02699866|17367564|P1|Overall Study|Adverse Event|3
5040628|NCT02699866|17367564|P1|Overall Study|Physician Decision|2
5040629|NCT02699866|17367564|P1|Overall Study|Withdrawal by Subject|3
5040630|NCT02699684|17367572|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
5040631|NCT02699684|17367573|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
5040632|NCT02699593|17367590|P2|Period 2|Torn Contact Lens|0
5040633|NCT02699593|17367591|P1|Period 2|Torn Contact Lens|1
5040634|NCT02699593|17367590|P2|Period 2|Lost Contact Lens|1
5040635|NCT02699593|17367591|P1|Period 2|Lost Contact Lens|0
5040636|NCT02699593|17367590|P2|Period 2|Adverse Event|1
5040637|NCT02699593|17367591|P1|Period 2|Adverse Event|1
5040638|NCT02699593|17367590|P2|Period 1|Adverse Event|1
5040639|NCT02699593|17367591|P1|Period 1|Adverse Event|1
5040640|NCT02699593|17367590|P2|Period 1|Withdrawal by Subject|1
5040641|NCT02699593|17367591|P1|Period 1|Withdrawal by Subject|0
5040642|NCT02699593|17367590|P2|Period 1|Protocol Violation|1
5040643|NCT02699593|17367591|P1|Period 1|Protocol Violation|0
5040644|NCT02699593|17367590|P2|Period 1|Torn Contact Len|3
5040645|NCT02699593|17367591|P1|Period 1|Torn Contact Len|4
5040646|NCT02699593|17367590|P2|Period 1|Unsatisfactory Visual Response|1
5040647|NCT02699593|17367591|P1|Period 1|Unsatisfactory Visual Response|0
5040648|NCT02699450|17367602|P3|Overall Study|Adverse Event|0
5040649|NCT02699450|17367603|P2|Overall Study|Adverse Event|0
5040650|NCT02699450|17367604|P1|Overall Study|Adverse Event|1
5040651|NCT02699450|17367602|P3|Overall Study|Withdrawal by Subject|2
5040652|NCT02699450|17367603|P2|Overall Study|Withdrawal by Subject|1
5040653|NCT02699450|17367604|P1|Overall Study|Withdrawal by Subject|3
5040654|NCT02699450|17367602|P3|Overall Study|Physician Decision|0
5040655|NCT02699450|17367603|P2|Overall Study|Physician Decision|0
5040656|NCT02699450|17367604|P1|Overall Study|Physician Decision|2
5040657|NCT02699450|17367602|P3|Overall Study|Lost to Follow-up|5
5040658|NCT02699450|17367603|P2|Overall Study|Lost to Follow-up|0
5040659|NCT02699450|17367604|P1|Overall Study|Lost to Follow-up|3
5040660|NCT02699450|17367602|P3|Overall Study|Protocol Violation|5
5040661|NCT02699450|17367603|P2|Overall Study|Protocol Violation|3
5040662|NCT02699450|17367604|P1|Overall Study|Protocol Violation|4
5040663|NCT02699450|17367602|P3|Overall Study|Met Criteria for Study Exit|1
5040664|NCT02699450|17367603|P2|Overall Study|Met Criteria for Study Exit|0
5040665|NCT02699450|17367604|P1|Overall Study|Met Criteria for Study Exit|0
5040666|NCT02699450|17367602|P3|Overall Study|Death|2
5040667|NCT02699450|17367603|P2|Overall Study|Death|1
5040668|NCT02699450|17367604|P1|Overall Study|Death|2
5040669|NCT02699099|17367742|P3|Overall Study|Withdrawal by Subject|2
5040670|NCT02699099|17367743|P2|Overall Study|Withdrawal by Subject|1
5040671|NCT02699099|17367744|P1|Overall Study|Withdrawal by Subject|6
5040672|NCT02699099|17367742|P3|Overall Study|Lost to Follow-up|0
5040673|NCT02699099|17367743|P2|Overall Study|Lost to Follow-up|1
5040674|NCT02699099|17367744|P1|Overall Study|Lost to Follow-up|0
5040675|NCT02699099|17367742|P3|Overall Study|Adverse Event|1
5040676|NCT02699099|17367743|P2|Overall Study|Adverse Event|0
5040677|NCT02699099|17367744|P1|Overall Study|Adverse Event|1
5040678|NCT02698865|17367820|P2|Overall Study|Lost to Follow-up|2
5040679|NCT02698865|17367821|P1|Overall Study|Lost to Follow-up|4
5040680|NCT02698865|17367820|P2|Overall Study|Physician Decision|4
5040681|NCT02698865|17367821|P1|Overall Study|Physician Decision|0
5040682|NCT02698865|17367820|P2|Overall Study|Withdrawal by Subject|16
5040683|NCT02698865|17367821|P1|Overall Study|Withdrawal by Subject|20
5040684|NCT02698865|17367820|P2|Overall Study|Other|11
5040685|NCT02698865|17367821|P1|Overall Study|Other|11
5040686|NCT02698475|17367859|P1|Overall Study|Protocol Violation|1
5040687|NCT02698475|17367859|P1|Overall Study|Withdrawal by Subject|3
5040688|NCT02698475|17367859|P1|Overall Study|Lack of Efficacy|1
5040689|NCT02698436|17367876|P2|Overall Study|Non-compliance with study regimen|0
5040690|NCT02698436|17367877|P1|Overall Study|Non-compliance with study regimen|1
5040691|NCT02698436|17367876|P2|Overall Study|Lost to Follow-up|4
5040692|NCT02698436|17367877|P1|Overall Study|Lost to Follow-up|2
5040693|NCT02698436|17367876|P2|Overall Study|Withdrawal by Subject|3
5040694|NCT02698436|17367877|P1|Overall Study|Withdrawal by Subject|3
5040695|NCT02698436|17367876|P2|Overall Study|Adverse Event|0
5040696|NCT02698436|17367877|P1|Overall Study|Adverse Event|1
5040697|NCT02698423|17367917|P2|Overall Study|Lost to Follow-up|24
5040698|NCT02698423|17367918|P1|Overall Study|Lost to Follow-up|19
5040699|NCT02698410|17367926|P1|Overall Study|Other|1
5040700|NCT02698410|17367926|P1|Overall Study|Withdrawal by Subject|1
5040701|NCT02698410|17367926|P1|Overall Study|Adverse Event|2
5040702|NCT02698371|17367945|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
5040703|NCT02698371|17367945|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
5040704|NCT02698371|17367945|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
5040705|NCT02698371|17367945|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
5040706|NCT02698371|17367945|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
5040707|NCT02698371|17367945|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
5040708|NCT02698371|17367945|P1|All Participants Flow|Lost to Follow-up|3
5040709|NCT02698241|17368067|P1|Overall Study|Death|2
5040710|NCT02698241|17368067|P1|Overall Study|geographic and licensing issue|1
5040711|NCT02698241|17368067|P1|Overall Study|Subject on inodrip not safe to continue|6
5040712|NCT02698241|17368067|P1|Overall Study|Lost to Follow-up|3
5040713|NCT02698241|17368067|P1|Overall Study|Subject underwent system modification|2
5040714|NCT02698241|17368067|P1|Overall Study|Physician Decision|2
5040715|NCT02698241|17368067|P1|Overall Study|Withdrawal by Subject|7
5040716|NCT02698241|17368067|P1|Overall Study|Screening not met|7
5040717|NCT02698241|17368067|P1|Overall Study|Inclusion/exclusion criteria not met|4
5040718|NCT02698189|17368074|P2|Overall Study|Still ongoing in the study|1
5040719|NCT02698189|17368075|P1|Overall Study|Still ongoing in the study|0
5040720|NCT02698189|17368074|P2|Overall Study|Progressive disease|5
5040721|NCT02698189|17368075|P1|Overall Study|Progressive disease|3
5040722|NCT02698176|17368105|P4|Overall Study|Clinical progression|0
5040723|NCT02698176|17368106|P3|Overall Study|Clinical progression|0
5040724|NCT02698176|17368107|P2|Overall Study|Clinical progression|0
5040725|NCT02698176|17368108|P1|Overall Study|Clinical progression|3
5040726|NCT02698176|17368105|P4|Overall Study|Adverse Event|0
5040727|NCT02698176|17368106|P3|Overall Study|Adverse Event|0
5040728|NCT02698176|17368107|P2|Overall Study|Adverse Event|0
5040729|NCT02698176|17368108|P1|Overall Study|Adverse Event|2
5040730|NCT02698176|17368105|P4|Overall Study|Progressive disease|0
5040731|NCT02698176|17368106|P3|Overall Study|Progressive disease|1
5040732|NCT02698176|17368107|P2|Overall Study|Progressive disease|3
5040733|NCT02698176|17368108|P1|Overall Study|Progressive disease|4
5040734|NCT02697773|17368165|P3|Overall Study|Randomized but not treated|0
5040735|NCT02697773|17368166|P2|Overall Study|Randomized but not treated|1
5040736|NCT02697773|17368167|P1|Overall Study|Randomized but not treated|1
5040737|NCT02697773|17368165|P3|Overall Study|Withdrawal by Subject|13
5040738|NCT02697773|17368166|P2|Overall Study|Withdrawal by Subject|13
5040739|NCT02697773|17368167|P1|Overall Study|Withdrawal by Subject|10
5040740|NCT02697773|17368165|P3|Overall Study|Protocol Violation|0
5040741|NCT02697773|17368166|P2|Overall Study|Protocol Violation|1
5040742|NCT02697773|17368167|P1|Overall Study|Protocol Violation|1
5040743|NCT02697773|17368165|P3|Overall Study|Other|10
5040744|NCT02697773|17368166|P2|Overall Study|Other|11
5040745|NCT02697773|17368167|P1|Overall Study|Other|15
5040746|NCT02697773|17368165|P3|Overall Study|Lost to Follow-up|7
5040747|NCT02697773|17368166|P2|Overall Study|Lost to Follow-up|5
5040748|NCT02697773|17368167|P1|Overall Study|Lost to Follow-up|5
5040749|NCT02697773|17368165|P3|Overall Study|Lack of Efficacy|6
5040750|NCT02697773|17368166|P2|Overall Study|Lack of Efficacy|6
5040751|NCT02697773|17368167|P1|Overall Study|Lack of Efficacy|4
5040752|NCT02697773|17368165|P3|Overall Study|Death|2
5040753|NCT02697773|17368166|P2|Overall Study|Death|0
5040754|NCT02697773|17368167|P1|Overall Study|Death|0
5040755|NCT02697773|17368165|P3|Overall Study|Adverse Event|2
5040756|NCT02697773|17368166|P2|Overall Study|Adverse Event|1
5040757|NCT02697773|17368167|P1|Overall Study|Adverse Event|2
5040758|NCT02697435|17368348|P2|Overall Study|Physician Decision|4
5040759|NCT02697435|17368349|P1|Overall Study|Physician Decision|0
5040760|NCT02697435|17368348|P2|Overall Study|Withdrawal by Subject|0
5040761|NCT02697435|17368349|P1|Overall Study|Withdrawal by Subject|1
5040762|NCT02696850|17368457|P2|Overall Study|Lost to Follow-up|5
5040763|NCT02696850|17368458|P1|Overall Study|Lost to Follow-up|8
5040764|NCT02696850|17368457|P2|Overall Study|Withdrawal by Subject|3
5040765|NCT02696850|17368458|P1|Overall Study|Withdrawal by Subject|3
5040766|NCT02696798|17368471|P3|Post-treatment Follow-up Period|No progressive improvement|0
5040767|NCT02696798|17368472|P2|Post-treatment Follow-up Period|No progressive improvement|1
5040768|NCT02696798|17368473|P1|Post-treatment Follow-up Period|No progressive improvement|0
5040769|NCT02696798|17368471|P3|Post-treatment Follow-up Period|Physician Decision|0
5040770|NCT02696798|17368472|P2|Post-treatment Follow-up Period|Physician Decision|2
5040771|NCT02696798|17368473|P1|Post-treatment Follow-up Period|Physician Decision|0
5040772|NCT02696798|17368471|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
5040773|NCT02696798|17368472|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
5040774|NCT02696798|17368473|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
5040775|NCT02696798|17368471|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
5040776|NCT02696798|17368472|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
5040777|NCT02696798|17368473|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
5040778|NCT02696798|17368471|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
5040779|NCT02696798|17368472|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
5040780|NCT02696798|17368473|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
5040781|NCT02696798|17368471|P3|Post-treatment Follow-up Period|Adverse Event|6
5040782|NCT02696798|17368472|P2|Post-treatment Follow-up Period|Adverse Event|12
5040783|NCT02696798|17368473|P1|Post-treatment Follow-up Period|Adverse Event|2
5040784|NCT02696798|17368471|P3|Extended Treatment Period|Withdrawal by Subject|3
5040785|NCT02696798|17368472|P2|Extended Treatment Period|Withdrawal by Subject|2
5040786|NCT02696798|17368473|P1|Extended Treatment Period|Withdrawal by Subject|3
5040787|NCT02696798|17368471|P3|Extended Treatment Period|Physician Decision|0
5040788|NCT02696798|17368472|P2|Extended Treatment Period|Physician Decision|1
5040789|NCT02696798|17368473|P1|Extended Treatment Period|Physician Decision|0
5040790|NCT02696798|17368471|P3|Extended Treatment Period|Lost to Follow-up|0
5040791|NCT02696798|17368472|P2|Extended Treatment Period|Lost to Follow-up|0
5040792|NCT02696798|17368473|P1|Extended Treatment Period|Lost to Follow-up|1
5040793|NCT02696798|17368471|P3|Extended Treatment Period|Lack of Efficacy|2
5040794|NCT02696798|17368472|P2|Extended Treatment Period|Lack of Efficacy|2
5040795|NCT02696798|17368473|P1|Extended Treatment Period|Lack of Efficacy|7
5040796|NCT02696798|17368471|P3|Extended Treatment Period|Adverse Event|5
5040797|NCT02696798|17368472|P2|Extended Treatment Period|Adverse Event|4
5040798|NCT02696798|17368473|P1|Extended Treatment Period|Adverse Event|1
5040799|NCT02696798|17368471|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
5040800|NCT02696798|17368472|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
5040801|NCT02696798|17368473|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
5040802|NCT02696798|17368471|P3|Blinded Treatment Dosing Period|Physician Decision|0
5040803|NCT02696798|17368472|P2|Blinded Treatment Dosing Period|Physician Decision|1
5040804|NCT02696798|17368473|P1|Blinded Treatment Dosing Period|Physician Decision|0
5040805|NCT02696798|17368471|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
5040806|NCT02696798|17368472|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
5040807|NCT02696798|17368473|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
5040808|NCT02696798|17368471|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
5040809|NCT02696798|17368472|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
5040810|NCT02696798|17368473|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
5040811|NCT02696798|17368471|P3|Blinded Treatment Dosing Period|Death|1
5040812|NCT02696798|17368472|P2|Blinded Treatment Dosing Period|Death|0
5040813|NCT02696798|17368473|P1|Blinded Treatment Dosing Period|Death|0
5040814|NCT02696798|17368471|P3|Blinded Treatment Dosing Period|Adverse Event|2
5040815|NCT02696798|17368472|P2|Blinded Treatment Dosing Period|Adverse Event|9
5040816|NCT02696798|17368473|P1|Blinded Treatment Dosing Period|Adverse Event|2
5040817|NCT02696785|17368570|P4|Follow-up Period|Withdrawal by Subject|4
5040818|NCT02696785|17368571|P3|Follow-up Period|Withdrawal by Subject|5
5040819|NCT02696785|17368572|P2|Follow-up Period|Withdrawal by Subject|0
5040820|NCT02696785|17368573|P1|Follow-up Period|Withdrawal by Subject|1
5040821|NCT02696785|17368570|P4|Follow-up Period|Lack of Efficacy|1
5040822|NCT02696785|17368571|P3|Follow-up Period|Lack of Efficacy|0
5040823|NCT02696785|17368572|P2|Follow-up Period|Lack of Efficacy|0
5040824|NCT02696785|17368573|P1|Follow-up Period|Lack of Efficacy|0
5040825|NCT02696785|17368570|P4|Follow-up Period|Lost to Follow-up|1
5040826|NCT02696785|17368571|P3|Follow-up Period|Lost to Follow-up|0
5040827|NCT02696785|17368572|P2|Follow-up Period|Lost to Follow-up|0
5040828|NCT02696785|17368573|P1|Follow-up Period|Lost to Follow-up|0
5040829|NCT02696785|17368570|P4|Follow-up Period|Adverse Event|2
5040830|NCT02696785|17368571|P3|Follow-up Period|Adverse Event|8
5040831|NCT02696785|17368572|P2|Follow-up Period|Adverse Event|0
5040832|NCT02696785|17368573|P1|Follow-up Period|Adverse Event|0
5040833|NCT02696785|17368570|P4|Extended Treatment Period|Withdrawal by Subject|5
5040834|NCT02696785|17368571|P3|Extended Treatment Period|Withdrawal by Subject|3
5040835|NCT02696785|17368572|P2|Extended Treatment Period|Withdrawal by Subject|2
5040836|NCT02696785|17368573|P1|Extended Treatment Period|Withdrawal by Subject|1
5040837|NCT02696785|17368570|P4|Extended Treatment Period|Lack of Efficacy|0
5040838|NCT02696785|17368571|P3|Extended Treatment Period|Lack of Efficacy|0
5040839|NCT02696785|17368572|P2|Extended Treatment Period|Lack of Efficacy|1
5040840|NCT02696785|17368573|P1|Extended Treatment Period|Lack of Efficacy|0
5040841|NCT02696785|17368570|P4|Extended Treatment Period|Adverse Event|1
5040842|NCT02696785|17368571|P3|Extended Treatment Period|Adverse Event|2
5040843|NCT02696785|17368572|P2|Extended Treatment Period|Adverse Event|3
5040844|NCT02696785|17368573|P1|Extended Treatment Period|Adverse Event|2
5040845|NCT02696785|17368570|P4|Washout Period|Lack of Efficacy|0
5040846|NCT02696785|17368571|P3|Washout Period|Lack of Efficacy|0
5040847|NCT02696785|17368572|P2|Washout Period|Lack of Efficacy|1
5040848|NCT02696785|17368573|P1|Washout Period|Lack of Efficacy|0
5040849|NCT02696785|17368570|P4|Washout Period|Withdrawal by Subject|0
5040850|NCT02696785|17368571|P3|Washout Period|Withdrawal by Subject|0
5040851|NCT02696785|17368572|P2|Washout Period|Withdrawal by Subject|1
5040852|NCT02696785|17368573|P1|Washout Period|Withdrawal by Subject|0
5040853|NCT02696785|17368570|P4|Blinded Treatment Period|Screen Failure|0
5040854|NCT02696785|17368571|P3|Blinded Treatment Period|Screen Failure|0
5040855|NCT02696785|17368572|P2|Blinded Treatment Period|Screen Failure|0
5040856|NCT02696785|17368573|P1|Blinded Treatment Period|Screen Failure|1
5040857|NCT02696785|17368570|P4|Blinded Treatment Period|Lack of Efficacy|1
5040858|NCT02696785|17368571|P3|Blinded Treatment Period|Lack of Efficacy|0
5040859|NCT02696785|17368572|P2|Blinded Treatment Period|Lack of Efficacy|0
5040860|NCT02696785|17368573|P1|Blinded Treatment Period|Lack of Efficacy|0
5040861|NCT02696785|17368570|P4|Blinded Treatment Period|Withdrawal by Subject|2
5040862|NCT02696785|17368571|P3|Blinded Treatment Period|Withdrawal by Subject|1
5040863|NCT02696785|17368572|P2|Blinded Treatment Period|Withdrawal by Subject|1
5040864|NCT02696785|17368573|P1|Blinded Treatment Period|Withdrawal by Subject|0
5040865|NCT02696785|17368570|P4|Blinded Treatment Period|Adverse Event|0
5040866|NCT02696785|17368571|P3|Blinded Treatment Period|Adverse Event|3
5040867|NCT02696785|17368572|P2|Blinded Treatment Period|Adverse Event|1
5040868|NCT02696785|17368573|P1|Blinded Treatment Period|Adverse Event|0
5040869|NCT02696434|17368693|P2|Overall Study|Physician Decision|1
5040870|NCT02696434|17368694|P1|Overall Study|Physician Decision|0
5040871|NCT02696434|17368693|P2|Overall Study|Withdrawal by Subject|12
5040872|NCT02696434|17368694|P1|Overall Study|Withdrawal by Subject|14
5040873|NCT02696434|17368693|P2|Overall Study|Lost to Follow-up|4
5040874|NCT02696434|17368694|P1|Overall Study|Lost to Follow-up|5
5040875|NCT02696434|17368693|P2|Overall Study|Adverse Event|1
5040876|NCT02696434|17368694|P1|Overall Study|Adverse Event|3
5040877|NCT02696317|17368712|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
5040878|NCT02696317|17368713|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
5040879|NCT02696317|17368712|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
5040880|NCT02696317|17368713|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
5040881|NCT02696226|17368757|P4|Overall Study|Study terminated - lack of enrollment|0
5040882|NCT02696226|17368758|P3|Overall Study|Study terminated - lack of enrollment|2
5040883|NCT02696226|17368759|P2|Overall Study|Study terminated - lack of enrollment|0
5040884|NCT02696226|17368760|P1|Overall Study|Study terminated - lack of enrollment|1
5040885|NCT02696031|17368791|P3|Week 52|Withdrawal by Subject|9
5040886|NCT02696031|17368792|P2|Week 52|Withdrawal by Subject|3
5040887|NCT02696031|17368793|P1|Week 52|Withdrawal by Subject|12
5040888|NCT02696031|17368791|P3|Week 52|Protocol Violation|0
5040889|NCT02696031|17368792|P2|Week 52|Protocol Violation|0
5040890|NCT02696031|17368793|P1|Week 52|Protocol Violation|1
5040891|NCT02696031|17368791|P3|Week 52|Pregnancy|0
5040892|NCT02696031|17368792|P2|Week 52|Pregnancy|2
5040893|NCT02696031|17368793|P1|Week 52|Pregnancy|0
5040894|NCT02696031|17368791|P3|Week 52|Physician Decision|2
5040895|NCT02696031|17368792|P2|Week 52|Physician Decision|1
5040896|NCT02696031|17368793|P1|Week 52|Physician Decision|1
5040897|NCT02696031|17368791|P3|Week 52|Lost to Follow-up|1
5040898|NCT02696031|17368792|P2|Week 52|Lost to Follow-up|1
5040899|NCT02696031|17368793|P1|Week 52|Lost to Follow-up|1
5040900|NCT02696031|17368791|P3|Week 52|Lack of Efficacy|11
5040901|NCT02696031|17368792|P2|Week 52|Lack of Efficacy|7
5040902|NCT02696031|17368793|P1|Week 52|Lack of Efficacy|10
5040903|NCT02696031|17368791|P3|Week 52|Adverse Event|3
5040904|NCT02696031|17368792|P2|Week 52|Adverse Event|5
5040905|NCT02696031|17368793|P1|Week 52|Adverse Event|4
5040906|NCT02696031|17368791|P3|Week 24|Withdrawal by Subject|5
5040907|NCT02696031|17368792|P2|Week 24|Withdrawal by Subject|1
5040908|NCT02696031|17368793|P1|Week 24|Withdrawal by Subject|4
5040909|NCT02696031|17368791|P3|Week 24|Protocol Violation|0
5040910|NCT02696031|17368792|P2|Week 24|Protocol Violation|0
5040911|NCT02696031|17368793|P1|Week 24|Protocol Violation|1
5040912|NCT02696031|17368791|P3|Week 24|Physician Decision|1
5040913|NCT02696031|17368792|P2|Week 24|Physician Decision|0
5040914|NCT02696031|17368793|P1|Week 24|Physician Decision|1
5040915|NCT02696031|17368791|P3|Week 24|Lost to Follow-up|1
5040916|NCT02696031|17368792|P2|Week 24|Lost to Follow-up|1
5040917|NCT02696031|17368793|P1|Week 24|Lost to Follow-up|0
5040918|NCT02696031|17368791|P3|Week 24|Lack of Efficacy|2
5040919|NCT02696031|17368792|P2|Week 24|Lack of Efficacy|1
5040920|NCT02696031|17368793|P1|Week 24|Lack of Efficacy|2
5040921|NCT02696031|17368791|P3|Week 24|Adverse Event|2
5040922|NCT02696031|17368792|P2|Week 24|Adverse Event|4
5040923|NCT02696031|17368793|P1|Week 24|Adverse Event|2
5040924|NCT02695719|17368807|P2|Overall Study|Voluntary Withdrawal|0
5040925|NCT02695719|17368808|P1|Overall Study|Voluntary Withdrawal|1
5040926|NCT02695719|17368807|P2|Overall Study|Significant Protocol Deviation|1
5040927|NCT02695719|17368808|P1|Overall Study|Significant Protocol Deviation|0
5040928|NCT02695719|17368807|P2|Overall Study|Pretreatment Event/Adverse Event|9
5040929|NCT02695719|17368808|P1|Overall Study|Pretreatment Event/Adverse Event|2
5040930|NCT02695628|17368826|P1|Overall Study|Withdrawal by Subject|1
5040931|NCT02695537|17368832|P1|Overall Study|Protocol Violation|3
5040932|NCT02695537|17368832|P1|Overall Study|Withdrawal by Subject|4
5040933|NCT02695537|17368832|P1|Overall Study|Lack of Efficacy|28
5040934|NCT02695537|17368832|P1|Overall Study|Adverse Event|3
5040935|NCT02695524|17368842|P2|Overall Study|Death|1
5040936|NCT02695524|17368843|P1|Overall Study|Death|0
5040937|NCT02695524|17368842|P2|Overall Study|Lost to Follow-up|2
5040938|NCT02695524|17368843|P1|Overall Study|Lost to Follow-up|3
5040939|NCT02695420|17368872|P4|Overall Study|Death|0
5040940|NCT02695420|17368873|P3|Overall Study|Death|0
5040941|NCT02695420|17368874|P2|Overall Study|Death|1
5040942|NCT02695420|17368875|P1|Overall Study|Death|0
5040943|NCT02695329|17368897|P2|Overall Study|Poor X-ray quality for measurement|5
5040944|NCT02695329|17368898|P1|Overall Study|Poor X-ray quality for measurement|4
5040945|NCT02695329|17368897|P2|Overall Study|Adverse Event|0
5040946|NCT02695329|17368898|P1|Overall Study|Adverse Event|1
5040947|NCT02694978|17368918|P2|Overall Study|Other-Withdrew prior to dosing|8
5040948|NCT02694978|17368919|P1|Overall Study|Other-Withdrew prior to dosing|9
5040949|NCT02694978|17368918|P2|Overall Study|Other-Personal reasons|3
5040950|NCT02694978|17368919|P1|Overall Study|Other-Personal reasons|3
5040951|NCT02694978|17368918|P2|Overall Study|Other-Protocol noncompliant|1
5040952|NCT02694978|17368919|P1|Overall Study|Other-Protocol noncompliant|2
5040953|NCT02694978|17368918|P2|Overall Study|Other-Unable to be reached|1
5040954|NCT02694978|17368919|P1|Overall Study|Other-Unable to be reached|0
5040955|NCT02694978|17368918|P2|Overall Study|Other-Investigator's decision|0
5040956|NCT02694978|17368919|P1|Overall Study|Other-Investigator's decision|1
5040957|NCT02694978|17368918|P2|Overall Study|Other-Decision of Participant|1
5040958|NCT02694978|17368919|P1|Overall Study|Other-Decision of Participant|6
5040959|NCT02694978|17368918|P2|Overall Study|Death|1
5040960|NCT02694978|17368919|P1|Overall Study|Death|4
5040961|NCT02694978|17368918|P2|Overall Study|Lost to Follow-up|17
5040962|NCT02694978|17368919|P1|Overall Study|Lost to Follow-up|14
5040963|NCT02694978|17368918|P2|Overall Study|Withdrawal by Subject|19
5040964|NCT02694978|17368919|P1|Overall Study|Withdrawal by Subject|22
5040965|NCT02694978|17368918|P2|Overall Study|Adverse Event|9
5040966|NCT02694978|17368919|P1|Overall Study|Adverse Event|10
5040967|NCT02694757|17368940|P1|Overall Study|Lack of Efficacy|3
5040968|NCT02694744|17368946|P2|Overall Study|Taking potassium supplement: exclusion 6|1
5040969|NCT02694744|17368947|P1|Overall Study|Taking potassium supplement: exclusion 6|0
5040970|NCT02694744|17368946|P2|Overall Study|Lost to Follow-up|0
5040971|NCT02694744|17368947|P1|Overall Study|Lost to Follow-up|1
5040972|NCT02694744|17368946|P2|Overall Study|Physician Decision|2
5040973|NCT02694744|17368947|P1|Overall Study|Physician Decision|1
5040974|NCT02694744|17368946|P2|Overall Study|Withdrawal by Subject|1
5040975|NCT02694744|17368947|P1|Overall Study|Withdrawal by Subject|2
5040976|NCT02694744|17368946|P2|Overall Study|Adverse Event|1
5040977|NCT02694744|17368947|P1|Overall Study|Adverse Event|2
5040978|NCT02694718|17368955|P1|Overall Study|Withdrawal by Subject|1
5040979|NCT02694718|17368955|P1|Overall Study|Death|1
5040980|NCT02694562|17368973|P1|Overall Study|Physician Decision|1
5040981|NCT02694562|17368973|P1|Overall Study|Screen Failure|2
5040982|NCT02694562|17368973|P1|Overall Study|Lost to Follow-up|3
5040983|NCT02694562|17368973|P1|Overall Study|Protocol Violation|4
5040984|NCT02694562|17368973|P1|Overall Study|Death|8
5040985|NCT02694549|17368982|P1|Overall Study|screen failures|2
5040986|NCT02694536|17368988|P1|Overall Study|Other|22
5040987|NCT02694536|17368988|P1|Overall Study|Death|8
5040988|NCT02694536|17368988|P1|Overall Study|Withdrawal by Subject|8
5040989|NCT02694536|17368988|P1|Overall Study|Study Drug-Related Adverse Event|1
5040990|NCT02694536|17368988|P1|Overall Study|Lost to Follow-up|1
5040991|NCT02694536|17368988|P1|Overall Study|Progressive Disease|40
5040992|NCT02694523|17368999|P7|Part B|Other|1
5040993|NCT02694523|17369000|P6|Part B|Other|0
5040994|NCT02694523|17369001|P5|Part B|Other|0
5040995|NCT02694523|17369002|P4|Part B|Other|0
5040996|NCT02694523|17369003|P3|Part B|Other|1
5040997|NCT02694523|17369004|P2|Part B|Other|0
5040998|NCT02694523|17369005|P1|Part B|Other|0
5040999|NCT02694523|17368999|P7|Part B|Withdrawal by Subject|0
5041000|NCT02694523|17369000|P6|Part B|Withdrawal by Subject|3
5041001|NCT02694523|17369001|P5|Part B|Withdrawal by Subject|1
5041002|NCT02694523|17369002|P4|Part B|Withdrawal by Subject|0
5041003|NCT02694523|17369003|P3|Part B|Withdrawal by Subject|9
5041004|NCT02694523|17369004|P2|Part B|Withdrawal by Subject|0
5041005|NCT02694523|17369005|P1|Part B|Withdrawal by Subject|0
5041006|NCT02694523|17368999|P7|Part B|Lost to Follow-up|1
5041007|NCT02694523|17369000|P6|Part B|Lost to Follow-up|0
5041008|NCT02694523|17369001|P5|Part B|Lost to Follow-up|2
5041009|NCT02694523|17369002|P4|Part B|Lost to Follow-up|3
5041010|NCT02694523|17369003|P3|Part B|Lost to Follow-up|2
5041011|NCT02694523|17369004|P2|Part B|Lost to Follow-up|0
5041012|NCT02694523|17369005|P1|Part B|Lost to Follow-up|0
5041013|NCT02694523|17368999|P7|Part B|Protocol Violation|0
5041014|NCT02694523|17369000|P6|Part B|Protocol Violation|0
5041015|NCT02694523|17369001|P5|Part B|Protocol Violation|0
5041016|NCT02694523|17369002|P4|Part B|Protocol Violation|0
5041017|NCT02694523|17369003|P3|Part B|Protocol Violation|1
5041018|NCT02694523|17369004|P2|Part B|Protocol Violation|0
5041019|NCT02694523|17369005|P1|Part B|Protocol Violation|0
5041020|NCT02694523|17368999|P7|Part B|Adverse Event|0
5041021|NCT02694523|17369000|P6|Part B|Adverse Event|2
5041022|NCT02694523|17369001|P5|Part B|Adverse Event|1
5041023|NCT02694523|17369002|P4|Part B|Adverse Event|1
5041024|NCT02694523|17369003|P3|Part B|Adverse Event|7
5041025|NCT02694523|17369004|P2|Part B|Adverse Event|0
5041026|NCT02694523|17369005|P1|Part B|Adverse Event|0
5041027|NCT02694523|17368999|P7|Part A|Other|0
5041028|NCT02694523|17369000|P6|Part A|Other|0
5041029|NCT02694523|17369001|P5|Part A|Other|0
5041030|NCT02694523|17369002|P4|Part A|Other|0
5041031|NCT02694523|17369003|P3|Part A|Other|0
5041032|NCT02694523|17369004|P2|Part A|Other|1
5041033|NCT02694523|17369005|P1|Part A|Other|1
5041034|NCT02694523|17368999|P7|Part A|Withdrawal by Subject|0
5041035|NCT02694523|17369000|P6|Part A|Withdrawal by Subject|0
5041036|NCT02694523|17369001|P5|Part A|Withdrawal by Subject|0
5041037|NCT02694523|17369002|P4|Part A|Withdrawal by Subject|0
5041038|NCT02694523|17369003|P3|Part A|Withdrawal by Subject|0
5041039|NCT02694523|17369004|P2|Part A|Withdrawal by Subject|1
5041040|NCT02694523|17369005|P1|Part A|Withdrawal by Subject|3
5041041|NCT02694523|17368999|P7|Part A|Lost to Follow-up|0
5041042|NCT02694523|17369000|P6|Part A|Lost to Follow-up|0
5041043|NCT02694523|17369001|P5|Part A|Lost to Follow-up|0
5041044|NCT02694523|17369002|P4|Part A|Lost to Follow-up|0
5041045|NCT02694523|17369003|P3|Part A|Lost to Follow-up|0
5041046|NCT02694523|17369004|P2|Part A|Lost to Follow-up|2
5041047|NCT02694523|17369005|P1|Part A|Lost to Follow-up|1
5041048|NCT02694523|17368999|P7|Part A|Protocol Violation|0
5041049|NCT02694523|17369000|P6|Part A|Protocol Violation|0
5041050|NCT02694523|17369001|P5|Part A|Protocol Violation|0
5041051|NCT02694523|17369002|P4|Part A|Protocol Violation|0
5041052|NCT02694523|17369003|P3|Part A|Protocol Violation|0
5041053|NCT02694523|17369004|P2|Part A|Protocol Violation|0
5041054|NCT02694523|17369005|P1|Part A|Protocol Violation|1
5041055|NCT02694523|17368999|P7|Part A|Adverse Event|0
5041056|NCT02694523|17369000|P6|Part A|Adverse Event|0
5041057|NCT02694523|17369001|P5|Part A|Adverse Event|0
5041058|NCT02694523|17369002|P4|Part A|Adverse Event|0
5041059|NCT02694523|17369003|P3|Part A|Adverse Event|0
5041060|NCT02694523|17369004|P2|Part A|Adverse Event|3
5041061|NCT02694523|17369005|P1|Part A|Adverse Event|7
5041062|NCT02694328|17369035|P2|Overall Study|Abnormal Laboratory Value|3
5041063|NCT02694328|17369036|P1|Overall Study|Abnormal Laboratory Value|0
5041064|NCT02694328|17369035|P2|Overall Study|Protocol Violation|5
5041065|NCT02694328|17369036|P1|Overall Study|Protocol Violation|6
5041066|NCT02694328|17369035|P2|Overall Study|Pregnancy|1
5041067|NCT02694328|17369036|P1|Overall Study|Pregnancy|1
5041068|NCT02694328|17369035|P2|Overall Study|Lack of Efficacy|2
5041069|NCT02694328|17369036|P1|Overall Study|Lack of Efficacy|1
5041070|NCT02694328|17369035|P2|Overall Study|Incarceration|1
5041071|NCT02694328|17369036|P1|Overall Study|Incarceration|1
5041072|NCT02694328|17369035|P2|Overall Study|Noncompliant with study drug|8
5041073|NCT02694328|17369036|P1|Overall Study|Noncompliant with study drug|11
5041074|NCT02694328|17369035|P2|Overall Study|Lost to Follow-up|22
5041075|NCT02694328|17369036|P1|Overall Study|Lost to Follow-up|26
5041076|NCT02694328|17369035|P2|Overall Study|Withdrawal by Subject|23
5041077|NCT02694328|17369036|P1|Overall Study|Withdrawal by Subject|27
5041078|NCT02694328|17369035|P2|Overall Study|Adverse Event|33
5041079|NCT02694328|17369036|P1|Overall Study|Adverse Event|27
5041080|NCT02693834|17369058|P2|Week 2 Practice|Adverse Event|1
5041081|NCT02693834|17369059|P1|Week 2 Practice|Adverse Event|0
5041082|NCT02693834|17369058|P2|Baseline Measurement|Adverse Event|0
5041083|NCT02693834|17369059|P1|Baseline Measurement|Adverse Event|1
5041084|NCT02693834|17369058|P2|Baseline Measurement|Withdrawal by Subject|0
5041085|NCT02693834|17369059|P1|Baseline Measurement|Withdrawal by Subject|1
5041086|NCT02693743|17369069|P2|Overall Study|Physician Decision|0
5041087|NCT02693743|17369070|P1|Overall Study|Physician Decision|1
5041088|NCT02693691|17369101|P1|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
5041089|NCT02693691|17369101|P1|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
5041090|NCT02693691|17369101|P1|Extended Follow-Up (Until Last pt 12M)|Death|12
5041091|NCT02693691|17369101|P1|Primary Endpoint Analysis (First 12M)|Adverse Event|1
5041092|NCT02693691|17369101|P1|Primary Endpoint Analysis (First 12M)|Physician Decision|7
5041093|NCT02693691|17369101|P1|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
5041094|NCT02693691|17369101|P1|Primary Endpoint Analysis (First 12M)|Death|30
5041095|NCT02693418|17369113|P5|Overall Study|Menses during study period|0
5041096|NCT02693418|17369114|P4|Overall Study|Menses during study period|0
5041097|NCT02693418|17369115|P3|Overall Study|Menses during study period|2
5041098|NCT02693418|17369116|P2|Overall Study|Menses during study period|0
5041099|NCT02693418|17369117|P1|Overall Study|Menses during study period|0
5041100|NCT02693418|17369113|P5|Overall Study|Lost to Follow-up|0
5041101|NCT02693418|17369114|P4|Overall Study|Lost to Follow-up|0
5041102|NCT02693418|17369115|P3|Overall Study|Lost to Follow-up|0
5041103|NCT02693418|17369116|P2|Overall Study|Lost to Follow-up|2
5041104|NCT02693418|17369117|P1|Overall Study|Lost to Follow-up|1
5041105|NCT02693171|17369134|P1|Overall Study|Discontinuation of Study by Sponsor|8
5041106|NCT02693171|17369134|P1|Overall Study|Adverse Event|1
5041107|NCT02693106|17369166|P1|Overall Study|No time|3
5041108|NCT02693002|17369178|P2|Overall Study|Withdrawal by Subject|0
5041109|NCT02693002|17369179|P1|Overall Study|Withdrawal by Subject|1
5041110|NCT02692716|17369202|P2|Overall Study|Withdrawal by Subject|1
5041111|NCT02692716|17369203|P1|Overall Study|Withdrawal by Subject|3
5041112|NCT02692716|17369202|P2|Overall Study|Lost to Follow-up|5
5041113|NCT02692716|17369203|P1|Overall Study|Lost to Follow-up|2
5041114|NCT02692703|17369243|P1|Overall Study|Other|1
5041115|NCT02692703|17369243|P1|Overall Study|Lost to Follow-up|1
5041116|NCT02692560|17369251|P2|Overall Study|Withdrawal by Subject|6
5041117|NCT02692560|17369252|P1|Overall Study|Withdrawal by Subject|0
5041118|NCT02692482|17369292|P2|Overall Study|Withdrawal by Subject|2
5041119|NCT02692482|17369293|P1|Overall Study|Withdrawal by Subject|1
5041120|NCT02692482|17369292|P2|Overall Study|Death|2
5041121|NCT02692482|17369293|P1|Overall Study|Death|2
5041122|NCT02692417|17369307|P2|Overall Study|Adverse Event|0
5041123|NCT02692417|17369308|P1|Overall Study|Adverse Event|1
5041124|NCT02692417|17369307|P2|Overall Study|Withdrawal by Subject|1
5041125|NCT02692417|17369308|P1|Overall Study|Withdrawal by Subject|5
5041126|NCT02692235|17369320|P2|Overall Study|Adverse Event|2
5041127|NCT02692235|17369321|P1|Overall Study|Adverse Event|1
5041128|NCT02692235|17369320|P2|Overall Study|Withdrawal by Subject|1
5041129|NCT02692235|17369321|P1|Overall Study|Withdrawal by Subject|2
5041130|NCT02691936|17369337|P2|Overall Study|Withdrawal by Subject|5
5041131|NCT02691936|17369338|P1|Overall Study|Withdrawal by Subject|2
5041132|NCT02691741|17369360|P2|Overall Study|Withdrawal by Subject|4
5041133|NCT02691741|17369361|P1|Overall Study|Withdrawal by Subject|0
5041134|NCT02691741|17369360|P2|Overall Study|Physician Decision|1
5041135|NCT02691741|17369361|P1|Overall Study|Physician Decision|0
5041136|NCT02691741|17369360|P2|Overall Study|Lost to Follow-up|0
5041137|NCT02691741|17369361|P1|Overall Study|Lost to Follow-up|1
5041138|NCT02691741|17369360|P2|Overall Study|Adverse Event|2
5041139|NCT02691741|17369361|P1|Overall Study|Adverse Event|0
5041140|NCT02691702|17369401|P11|Overall Study|Protocol Violation|0
5041141|NCT02691702|17369402|P10|Overall Study|Protocol Violation|2
5041142|NCT02691702|17369403|P9|Overall Study|Protocol Violation|0
5041143|NCT02691702|17369404|P8|Overall Study|Protocol Violation|0
5041144|NCT02691702|17369405|P7|Overall Study|Protocol Violation|0
5041145|NCT02691702|17369406|P6|Overall Study|Protocol Violation|0
5041146|NCT02691702|17369407|P5|Overall Study|Protocol Violation|0
5041147|NCT02691702|17369408|P4|Overall Study|Protocol Violation|0
5041148|NCT02691702|17369409|P3|Overall Study|Protocol Violation|0
5041149|NCT02691702|17369410|P2|Overall Study|Protocol Violation|0
5041150|NCT02691702|17369411|P1|Overall Study|Protocol Violation|0
5041151|NCT02691702|17369401|P11|Overall Study|Other|0
5041152|NCT02691702|17369402|P10|Overall Study|Other|0
5041153|NCT02691702|17369403|P9|Overall Study|Other|1
5041154|NCT02691702|17369404|P8|Overall Study|Other|0
5041155|NCT02691702|17369405|P7|Overall Study|Other|1
5041156|NCT02691702|17369406|P6|Overall Study|Other|0
5041157|NCT02691702|17369407|P5|Overall Study|Other|0
5041158|NCT02691702|17369408|P4|Overall Study|Other|0
5041159|NCT02691702|17369409|P3|Overall Study|Other|0
5041160|NCT02691702|17369410|P2|Overall Study|Other|0
5041161|NCT02691702|17369411|P1|Overall Study|Other|0
5041162|NCT02691702|17369401|P11|Overall Study|Withdrawal by Subject|0
5041163|NCT02691702|17369402|P10|Overall Study|Withdrawal by Subject|0
5041164|NCT02691702|17369403|P9|Overall Study|Withdrawal by Subject|0
5041165|NCT02691702|17369404|P8|Overall Study|Withdrawal by Subject|0
5041166|NCT02691702|17369405|P7|Overall Study|Withdrawal by Subject|2
5041167|NCT02691702|17369406|P6|Overall Study|Withdrawal by Subject|1
5041168|NCT02691702|17369407|P5|Overall Study|Withdrawal by Subject|0
5041169|NCT02691702|17369408|P4|Overall Study|Withdrawal by Subject|0
5041170|NCT02691702|17369409|P3|Overall Study|Withdrawal by Subject|0
5041171|NCT02691702|17369410|P2|Overall Study|Withdrawal by Subject|1
5041172|NCT02691702|17369411|P1|Overall Study|Withdrawal by Subject|1
5041173|NCT02691702|17369401|P11|Overall Study|Lost to Follow-up|1
5041174|NCT02691702|17369402|P10|Overall Study|Lost to Follow-up|0
5041175|NCT02691702|17369403|P9|Overall Study|Lost to Follow-up|0
5041176|NCT02691702|17369404|P8|Overall Study|Lost to Follow-up|0
5041177|NCT02691702|17369405|P7|Overall Study|Lost to Follow-up|0
5041178|NCT02691702|17369406|P6|Overall Study|Lost to Follow-up|2
5041179|NCT02691702|17369407|P5|Overall Study|Lost to Follow-up|0
5041180|NCT02691702|17369408|P4|Overall Study|Lost to Follow-up|0
5041181|NCT02691702|17369409|P3|Overall Study|Lost to Follow-up|1
5041182|NCT02691702|17369410|P2|Overall Study|Lost to Follow-up|0
5041183|NCT02691702|17369411|P1|Overall Study|Lost to Follow-up|0
5041184|NCT02691702|17369401|P11|Overall Study|Adverse Event|1
5041185|NCT02691702|17369402|P10|Overall Study|Adverse Event|0
5041186|NCT02691702|17369403|P9|Overall Study|Adverse Event|1
5041187|NCT02691702|17369404|P8|Overall Study|Adverse Event|0
5041188|NCT02691702|17369405|P7|Overall Study|Adverse Event|0
5041189|NCT02691702|17369406|P6|Overall Study|Adverse Event|0
5041190|NCT02691702|17369407|P5|Overall Study|Adverse Event|0
5041191|NCT02691702|17369408|P4|Overall Study|Adverse Event|0
5041192|NCT02691702|17369409|P3|Overall Study|Adverse Event|0
5041193|NCT02691702|17369410|P2|Overall Study|Adverse Event|0
5041194|NCT02691702|17369411|P1|Overall Study|Adverse Event|1
5041195|NCT02691572|17369697|P2|Overall Study|Protocol Violation|1
5041196|NCT02691572|17369698|P1|Overall Study|Protocol Violation|0
5041197|NCT02691572|17369697|P2|Overall Study|Withdrawal by Subject|0
5041198|NCT02691572|17369698|P1|Overall Study|Withdrawal by Subject|1
5041199|NCT02691507|17369706|P2|Overall Study|Missed Visit 3|1
5041200|NCT02691507|17369707|P1|Overall Study|Missed Visit 3|0
5041201|NCT02691494|17369840|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
5041202|NCT02691494|17369841|P2|Post-Treatment Follow-Up Period|Non-Compliance|1
5041203|NCT02691494|17369842|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5041204|NCT02691494|17369840|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
5041205|NCT02691494|17369841|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
5041206|NCT02691494|17369842|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
5041207|NCT02691494|17369840|P3|Post-Treatment Follow-Up Period|Other|1
5041208|NCT02691494|17369841|P2|Post-Treatment Follow-Up Period|Other|1
5041209|NCT02691494|17369842|P1|Post-Treatment Follow-Up Period|Other|2
5041210|NCT02691494|17369840|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5041211|NCT02691494|17369841|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5041212|NCT02691494|17369842|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5041213|NCT02691494|17369840|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5041214|NCT02691494|17369841|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5041215|NCT02691494|17369842|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
5041216|NCT02691468|17369870|P2|Overall Study|Failure to advance FOB|0
5041217|NCT02691468|17369871|P1|Overall Study|Failure to advance FOB|2
5041218|NCT02691468|17369870|P2|Overall Study|Lost to Follow-up|1
5041219|NCT02691468|17369871|P1|Overall Study|Lost to Follow-up|2
5041220|NCT02691468|17369870|P2|Overall Study|Bronchial blocker use|1
5041221|NCT02691468|17369871|P1|Overall Study|Bronchial blocker use|2
5041222|NCT02691013|17369932|P2|Overall Study|Withdrawal by Subject|0
5041223|NCT02691013|17369933|P1|Overall Study|Withdrawal by Subject|3
5041224|NCT02690974|17369947|P1|Overall Study|Protocol Deviation|1
5041225|NCT02690974|17369947|P1|Overall Study|Protocol-defined stopping criteria|1
5041226|NCT02690974|17369947|P1|Overall Study|Non-compliance with study treatment|1
5041227|NCT02690974|17369947|P1|Overall Study|Physician Decision|2
5041228|NCT02690974|17369947|P1|Overall Study|Withdrawal of Informed Consent|3
5041229|NCT02690974|17369947|P1|Overall Study|Lost to Follow-up|3
5041230|NCT02690974|17369947|P1|Overall Study|Subject/guardian decision|4
5041231|NCT02690974|17369947|P1|Overall Study|Death|9
5041232|NCT02690974|17369947|P1|Overall Study|Adverse Event|16
5041233|NCT02690727|17369988|P2|Overall Study|Adverse Event|2
5041234|NCT02690727|17369989|P1|Overall Study|Adverse Event|2
5041235|NCT02690701|17370001|P2|Treatment Period 2|Protocol Violation|1
5041236|NCT02690701|17370002|P1|Treatment Period 2|Protocol Violation|0
5041237|NCT02690701|17370001|P2|Treatment Period 2|Withdrawal by Subject|2
5041238|NCT02690701|17370002|P1|Treatment Period 2|Withdrawal by Subject|0
5041239|NCT02690701|17370001|P2|Treatment Period 2|Lost to Follow-up|2
5041240|NCT02690701|17370002|P1|Treatment Period 2|Lost to Follow-up|0
5041241|NCT02690701|17370001|P2|Treatment Period 2|Lack of Efficacy|0
5041242|NCT02690701|17370002|P1|Treatment Period 2|Lack of Efficacy|1
5041243|NCT02690701|17370001|P2|Treatment Period 2|Adverse Event|0
5041244|NCT02690701|17370002|P1|Treatment Period 2|Adverse Event|2
5041245|NCT02690701|17370001|P2|Treatment Period 1|Withdrawal by Subject|1
5041246|NCT02690701|17370002|P1|Treatment Period 1|Withdrawal by Subject|0
5041247|NCT02690701|17370001|P2|Treatment Period 1|Adverse Event|2
5041248|NCT02690701|17370002|P1|Treatment Period 1|Adverse Event|2
5041249|NCT02690207|17370067|P1|Overall Study|Other reasons for withdrawal|23
5041250|NCT02690207|17370067|P1|Overall Study|Suspected HZ Episode|1
5041251|NCT02690207|17370067|P1|Overall Study|Migrated/moved from study area|5
5041252|NCT02690207|17370067|P1|Overall Study|Non-serious Adverse Event|18
5041253|NCT02690207|17370067|P1|Overall Study|Serious adverse event|110
5041254|NCT02690207|17370067|P1|Overall Study|Protocol Violation|2
5041255|NCT02690207|17370067|P1|Overall Study|Withdrawal by Subject|46
5041256|NCT02690207|17370067|P1|Overall Study|Lost to Follow-up|48
5041257|NCT02690194|17370077|P3|Overall Study|Withdrawal by Subject|0
5041258|NCT02690194|17370078|P2|Overall Study|Withdrawal by Subject|4
5041259|NCT02690194|17370079|P1|Overall Study|Withdrawal by Subject|1
5041260|NCT02689804|17370286|P2|Overall Study|Withdrawal by Subject|0
5041261|NCT02689804|17370287|P1|Overall Study|Withdrawal by Subject|2
5041262|NCT02689492|17370313|P1|Overall Study|Other than listed|1
5041263|NCT02689492|17370313|P1|Overall Study|Withdrawal/ Physician's Decision|1
5041264|NCT02689492|17370313|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
5041265|NCT02689492|17370313|P1|Overall Study|Physician Decision|2
5041266|NCT02689492|17370313|P1|Overall Study|Death|9
5041267|NCT02689492|17370313|P1|Overall Study|Withdrawal by Subject|11
5041268|NCT02689492|17370313|P1|Overall Study|Lost to Follow-up|61
5041269|NCT02689219|17370329|P2|Overall Study|Disease Progression|6
5041270|NCT02689219|17370330|P1|Overall Study|Disease Progression|10
5041271|NCT02689219|17370329|P2|Overall Study|Death|1
5041272|NCT02689219|17370330|P1|Overall Study|Death|1
5041273|NCT02689206|17370347|P5|Overall Study|Withdrawal by Subject|0
5041274|NCT02689206|17370348|P4|Overall Study|Withdrawal by Subject|0
5041275|NCT02689206|17370349|P3|Overall Study|Withdrawal by Subject|1
5041276|NCT02689206|17370350|P2|Overall Study|Withdrawal by Subject|0
5041277|NCT02689206|17370351|P1|Overall Study|Withdrawal by Subject|1
5041278|NCT02689206|17370347|P5|Overall Study|Physician Decision|0
5041279|NCT02689206|17370348|P4|Overall Study|Physician Decision|0
5041280|NCT02689206|17370349|P3|Overall Study|Physician Decision|0
5041281|NCT02689206|17370350|P2|Overall Study|Physician Decision|0
5041282|NCT02689206|17370351|P1|Overall Study|Physician Decision|1
5041283|NCT02689206|17370347|P5|Overall Study|Other: Reached stopping criteria|4
5041284|NCT02689206|17370348|P4|Overall Study|Other: Reached stopping criteria|3
5041285|NCT02689206|17370349|P3|Overall Study|Other: Reached stopping criteria|2
5041286|NCT02689206|17370350|P2|Overall Study|Other: Reached stopping criteria|1
5041287|NCT02689206|17370351|P1|Overall Study|Other: Reached stopping criteria|0
5041288|NCT02689206|17370347|P5|Overall Study|Protocol Violation|2
5041289|NCT02689206|17370348|P4|Overall Study|Protocol Violation|1
5041290|NCT02689206|17370349|P3|Overall Study|Protocol Violation|0
5041291|NCT02689206|17370350|P2|Overall Study|Protocol Violation|0
5041292|NCT02689206|17370351|P1|Overall Study|Protocol Violation|1
5041293|NCT02689206|17370347|P5|Overall Study|Adverse Event|2
5041294|NCT02689206|17370348|P4|Overall Study|Adverse Event|0
5041295|NCT02689206|17370349|P3|Overall Study|Adverse Event|1
5041296|NCT02689206|17370350|P2|Overall Study|Adverse Event|0
5041297|NCT02689206|17370351|P1|Overall Study|Adverse Event|0
5041298|NCT02688933|17370564|P2|Overall Study|Lost to Follow-up|5
5041299|NCT02688933|17370565|P1|Overall Study|Lost to Follow-up|1
5041300|NCT02688933|17370564|P2|Overall Study|Other than Specified|25
5041301|NCT02688933|17370565|P1|Overall Study|Other than Specified|14
5041302|NCT02688933|17370564|P2|Overall Study|Hypoglycemia|0
5041303|NCT02688933|17370565|P1|Overall Study|Hypoglycemia|2
5041304|NCT02688933|17370564|P2|Overall Study|Poor compliance to protocol|4
5041305|NCT02688933|17370565|P1|Overall Study|Poor compliance to protocol|7
5041306|NCT02688933|17370564|P2|Overall Study|Lack of Efficacy|2
5041307|NCT02688933|17370565|P1|Overall Study|Lack of Efficacy|2
5041308|NCT02688933|17370564|P2|Overall Study|Adverse Event|1
5041309|NCT02688933|17370565|P1|Overall Study|Adverse Event|3
5041310|NCT02688764|17370625|P2|Overall Study|Withdrawal by parent|0
5041311|NCT02688764|17370626|P1|Overall Study|Withdrawal by parent|3
5041312|NCT02688764|17370625|P2|Overall Study|Subject taken off dialysis|0
5041313|NCT02688764|17370626|P1|Overall Study|Subject taken off dialysis|1
5041314|NCT02688764|17370625|P2|Overall Study|Subject moving out|0
5041315|NCT02688764|17370626|P1|Overall Study|Subject moving out|2
5041316|NCT02688764|17370625|P2|Overall Study|Study drug taste/Withd. parent|0
5041317|NCT02688764|17370626|P1|Overall Study|Study drug taste/Withd. parent|1
5041318|NCT02688764|17370625|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
5041319|NCT02688764|17370626|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
5041320|NCT02688764|17370625|P2|Overall Study|Phosphorus level outside safe range|1
5041321|NCT02688764|17370626|P1|Overall Study|Phosphorus level outside safe range|0
5041322|NCT02688764|17370625|P2|Overall Study|Non-compl./Withd. subject|2
5041323|NCT02688764|17370626|P1|Overall Study|Non-compl./Withd. subject|0
5041324|NCT02688764|17370625|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
5041325|NCT02688764|17370626|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
5041326|NCT02688764|17370625|P2|Overall Study|Non-compl./Physician decision|0
5041327|NCT02688764|17370626|P1|Overall Study|Non-compl./Physician decision|2
5041328|NCT02688764|17370625|P2|Overall Study|Non-compliance with study drug|0
5041329|NCT02688764|17370626|P1|Overall Study|Non-compliance with study drug|4
5041330|NCT02688764|17370625|P2|Overall Study|Lack of efficacy/Physician decision|1
5041331|NCT02688764|17370626|P1|Overall Study|Lack of efficacy/Physician decision|0
5041332|NCT02688764|17370625|P2|Overall Study|Lack of Efficacy|2
5041333|NCT02688764|17370626|P1|Overall Study|Lack of Efficacy|3
5041334|NCT02688764|17370625|P2|Overall Study|Kidney transplant|4
5041335|NCT02688764|17370626|P1|Overall Study|Kidney transplant|10
5041336|NCT02688764|17370625|P2|Overall Study|AE/Withd. subject|0
5041337|NCT02688764|17370626|P1|Overall Study|AE/Withd. subject|1
5041338|NCT02688764|17370625|P2|Overall Study|AE/Withd. parent/Withd. subject|1
5041339|NCT02688764|17370626|P1|Overall Study|AE/Withd. parent/Withd. subject|1
5041340|NCT02688764|17370625|P2|Overall Study|AE/Withd. parent|0
5041341|NCT02688764|17370626|P1|Overall Study|AE/Withd. parent|3
5041342|NCT02688764|17370625|P2|Overall Study|AE/Physician decision|0
5041343|NCT02688764|17370626|P1|Overall Study|AE/Physician decision|1
5041344|NCT02688764|17370625|P2|Overall Study|AE/Other|1
5041345|NCT02688764|17370626|P1|Overall Study|AE/Other|0
5041346|NCT02688764|17370625|P2|Overall Study|AE/Non-compl./Withd. parent|1
5041347|NCT02688764|17370626|P1|Overall Study|AE/Non-compl./Withd. parent|0
5041348|NCT02688764|17370625|P2|Overall Study|AE/Non-compl.|0
5041349|NCT02688764|17370626|P1|Overall Study|AE/Non-compl.|1
5041350|NCT02688764|17370625|P2|Overall Study|AE/Lack of efficacy|0
5041351|NCT02688764|17370626|P1|Overall Study|AE/Lack of efficacy|1
5041352|NCT02688764|17370625|P2|Overall Study|AE/Kidney transplant|0
5041353|NCT02688764|17370626|P1|Overall Study|AE/Kidney transplant|1
5041354|NCT02688764|17370625|P2|Overall Study|Adverse Event|3
5041355|NCT02688764|17370626|P1|Overall Study|Adverse Event|3
5041356|NCT02688387|17370693|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041357|NCT02688387|17370694|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041358|NCT02688387|17370695|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
5041359|NCT02688387|17370696|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041360|NCT02688387|17370697|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041361|NCT02688387|17370698|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041362|NCT02688387|17370699|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041363|NCT02688387|17370700|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041364|NCT02688387|17370701|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041365|NCT02688387|17370702|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041366|NCT02688387|17370703|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041367|NCT02688387|17370704|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041368|NCT02688387|17370705|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041369|NCT02688387|17370706|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041370|NCT02688387|17370707|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041371|NCT02688387|17370708|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041372|NCT02688387|17370709|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041373|NCT02688387|17370710|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041374|NCT02688387|17370711|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041375|NCT02688387|17370712|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041376|NCT02688387|17370713|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041377|NCT02688387|17370714|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5041378|NCT02688387|17370693|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041379|NCT02688387|17370694|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
5041380|NCT02688387|17370695|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041381|NCT02688387|17370696|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
5041382|NCT02688387|17370697|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041383|NCT02688387|17370698|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041384|NCT02688387|17370699|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041385|NCT02688387|17370700|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041386|NCT02688387|17370701|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041387|NCT02688387|17370702|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041388|NCT02688387|17370703|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041389|NCT02688387|17370704|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041390|NCT02688387|17370705|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041391|NCT02688387|17370706|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041392|NCT02688387|17370707|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041393|NCT02688387|17370708|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041394|NCT02688387|17370709|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041395|NCT02688387|17370710|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041396|NCT02688387|17370711|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041397|NCT02688387|17370712|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041398|NCT02688387|17370713|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041399|NCT02688387|17370714|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5041400|NCT02688387|17370693|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041401|NCT02688387|17370694|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
5041402|NCT02688387|17370695|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041403|NCT02688387|17370696|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041404|NCT02688387|17370697|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041405|NCT02688387|17370698|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041406|NCT02688387|17370699|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041407|NCT02688387|17370700|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041408|NCT02688387|17370701|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041409|NCT02688387|17370702|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041410|NCT02688387|17370703|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041411|NCT02688387|17370704|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041412|NCT02688387|17370705|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041413|NCT02688387|17370706|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041414|NCT02688387|17370707|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041415|NCT02688387|17370708|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041416|NCT02688387|17370709|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041417|NCT02688387|17370710|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041418|NCT02688387|17370711|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041419|NCT02688387|17370712|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041420|NCT02688387|17370713|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041421|NCT02688387|17370714|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5041422|NCT02688387|17370693|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041423|NCT02688387|17370694|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041424|NCT02688387|17370695|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041425|NCT02688387|17370696|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041426|NCT02688387|17370697|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041427|NCT02688387|17370698|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041428|NCT02688387|17370699|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041429|NCT02688387|17370700|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
5041430|NCT02688387|17370701|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041431|NCT02688387|17370702|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041432|NCT02688387|17370703|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041433|NCT02688387|17370704|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041434|NCT02688387|17370705|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041435|NCT02688387|17370706|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041436|NCT02688387|17370707|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041437|NCT02688387|17370708|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041438|NCT02688387|17370709|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041439|NCT02688387|17370710|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041440|NCT02688387|17370711|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041441|NCT02688387|17370712|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041442|NCT02688387|17370713|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041443|NCT02688387|17370714|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041444|NCT02688387|17370693|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041445|NCT02688387|17370694|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041446|NCT02688387|17370695|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041447|NCT02688387|17370696|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041448|NCT02688387|17370697|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041449|NCT02688387|17370698|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041450|NCT02688387|17370699|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041451|NCT02688387|17370700|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041452|NCT02688387|17370701|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041453|NCT02688387|17370702|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041454|NCT02688387|17370703|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041455|NCT02688387|17370704|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
5041456|NCT02688387|17370705|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041457|NCT02688387|17370706|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041458|NCT02688387|17370707|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041459|NCT02688387|17370708|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041460|NCT02688387|17370709|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041461|NCT02688387|17370710|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041462|NCT02688387|17370711|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041463|NCT02688387|17370712|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041464|NCT02688387|17370713|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041465|NCT02688387|17370714|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5041466|NCT02688387|17370693|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041467|NCT02688387|17370694|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041468|NCT02688387|17370695|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041469|NCT02688387|17370696|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041470|NCT02688387|17370697|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041471|NCT02688387|17370698|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041472|NCT02688387|17370699|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041473|NCT02688387|17370700|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041474|NCT02688387|17370701|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041475|NCT02688387|17370702|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041476|NCT02688387|17370703|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041477|NCT02688387|17370704|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041478|NCT02688387|17370705|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041479|NCT02688387|17370706|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041480|NCT02688387|17370707|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041481|NCT02688387|17370708|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041482|NCT02688387|17370709|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041483|NCT02688387|17370710|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041484|NCT02688387|17370711|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041485|NCT02688387|17370712|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041486|NCT02688387|17370713|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5041487|NCT02688387|17370714|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
5041488|NCT02688387|17370693|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041489|NCT02688387|17370694|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041490|NCT02688387|17370695|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041491|NCT02688387|17370696|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041492|NCT02688387|17370697|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041493|NCT02688387|17370698|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041494|NCT02688387|17370699|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041495|NCT02688387|17370700|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041496|NCT02688387|17370701|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041497|NCT02688387|17370702|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041498|NCT02688387|17370703|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041499|NCT02688387|17370704|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041500|NCT02688387|17370705|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041501|NCT02688387|17370706|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041502|NCT02688387|17370707|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041503|NCT02688387|17370708|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041504|NCT02688387|17370709|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041505|NCT02688387|17370710|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
5041506|NCT02688387|17370711|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041507|NCT02688387|17370712|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
5041508|NCT02688387|17370713|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041509|NCT02688387|17370714|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5041510|NCT02688387|17370693|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041511|NCT02688387|17370694|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041512|NCT02688387|17370695|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041513|NCT02688387|17370696|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041514|NCT02688387|17370697|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041515|NCT02688387|17370698|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041516|NCT02688387|17370699|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041517|NCT02688387|17370700|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041518|NCT02688387|17370701|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041519|NCT02688387|17370702|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041520|NCT02688387|17370703|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041521|NCT02688387|17370704|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041522|NCT02688387|17370705|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041523|NCT02688387|17370706|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041524|NCT02688387|17370707|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041525|NCT02688387|17370708|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041526|NCT02688387|17370709|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041527|NCT02688387|17370710|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041528|NCT02688387|17370711|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041529|NCT02688387|17370712|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041530|NCT02688387|17370713|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
5041531|NCT02688387|17370714|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5041532|NCT02688387|17370693|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041533|NCT02688387|17370694|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041534|NCT02688387|17370695|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041535|NCT02688387|17370696|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041536|NCT02688387|17370697|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041537|NCT02688387|17370698|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041538|NCT02688387|17370699|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041539|NCT02688387|17370700|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041540|NCT02688387|17370701|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041541|NCT02688387|17370702|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041715|NCT02684370|17371905|P5|Part A|Subject Withdrawal|0
5041542|NCT02688387|17370703|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041543|NCT02688387|17370704|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041544|NCT02688387|17370705|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041545|NCT02688387|17370706|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041546|NCT02688387|17370707|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041547|NCT02688387|17370708|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041548|NCT02688387|17370709|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041549|NCT02688387|17370710|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041550|NCT02688387|17370711|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
5041551|NCT02688387|17370712|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041552|NCT02688387|17370713|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041553|NCT02688387|17370714|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5041554|NCT02688387|17370693|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041555|NCT02688387|17370694|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041556|NCT02688387|17370695|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041557|NCT02688387|17370696|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041558|NCT02688387|17370697|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041559|NCT02688387|17370698|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041560|NCT02688387|17370699|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041561|NCT02688387|17370700|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041562|NCT02688387|17370701|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041563|NCT02688387|17370702|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041564|NCT02688387|17370703|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041565|NCT02688387|17370704|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041566|NCT02688387|17370705|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041567|NCT02688387|17370706|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041568|NCT02688387|17370707|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041569|NCT02688387|17370708|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041570|NCT02688387|17370709|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041571|NCT02688387|17370710|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041572|NCT02688387|17370711|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041573|NCT02688387|17370712|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
5041574|NCT02688387|17370713|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041575|NCT02688387|17370714|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5041576|NCT02688192|17370982|P2|Overall Study|Physician Decision|0
5041577|NCT02688192|17370983|P1|Overall Study|Physician Decision|1
5041578|NCT02688192|17370982|P2|Overall Study|Lost to Follow-up|5
5041579|NCT02688192|17370983|P1|Overall Study|Lost to Follow-up|11
5041580|NCT02688153|17371002|P2|Overall Study|Conversion to Commercial Valve|0
5041581|NCT02688153|17371003|P1|Overall Study|Conversion to Commercial Valve|3
5041582|NCT02688153|17371002|P2|Overall Study|Valve Explant|0
5041583|NCT02688153|17371003|P1|Overall Study|Valve Explant|1
5041584|NCT02688153|17371002|P2|Overall Study|Withdrawal by Subject|2
5041585|NCT02688153|17371003|P1|Overall Study|Withdrawal by Subject|4
5041586|NCT02688153|17371002|P2|Overall Study|Death|5
5041587|NCT02688153|17371003|P1|Overall Study|Death|7
5041588|NCT02687919|17371063|P2|Overall Study|Protocol Violation|0
5041589|NCT02687919|17371064|P1|Overall Study|Protocol Violation|2
5041590|NCT02687919|17371063|P2|Overall Study|Withdrawal by Subject|6
5041591|NCT02687919|17371064|P1|Overall Study|Withdrawal by Subject|6
5041592|NCT02687815|17371094|P2|Overall Study|Withdrawal by Subject|4
5041593|NCT02687815|17371095|P1|Overall Study|Withdrawal by Subject|2
5041594|NCT02687815|17371094|P2|Overall Study|Lost to Follow-up|4
5041595|NCT02687815|17371095|P1|Overall Study|Lost to Follow-up|2
5041596|NCT02687542|17371112|P5|Overall Study|Withdrawal by Subject|4
5041597|NCT02687542|17371113|P4|Overall Study|Withdrawal by Subject|2
5041598|NCT02687542|17371114|P3|Overall Study|Withdrawal by Subject|1
5041599|NCT02687542|17371115|P2|Overall Study|Withdrawal by Subject|1
5041600|NCT02687542|17371116|P1|Overall Study|Withdrawal by Subject|0
5041601|NCT02687542|17371112|P5|Overall Study|Adverse Event|9
5041602|NCT02687542|17371113|P4|Overall Study|Adverse Event|2
5041603|NCT02687542|17371114|P3|Overall Study|Adverse Event|3
5041604|NCT02687542|17371115|P2|Overall Study|Adverse Event|1
5041605|NCT02687542|17371116|P1|Overall Study|Adverse Event|3
5041606|NCT02687542|17371112|P5|Overall Study|Other|5
5041607|NCT02687542|17371113|P4|Overall Study|Other|6
5041608|NCT02687542|17371114|P3|Overall Study|Other|10
5041609|NCT02687542|17371115|P2|Overall Study|Other|9
5041610|NCT02687542|17371116|P1|Overall Study|Other|5
5041611|NCT02687542|17371112|P5|Overall Study|Protocol Violation|0
5041612|NCT02687542|17371113|P4|Overall Study|Protocol Violation|0
5041613|NCT02687542|17371114|P3|Overall Study|Protocol Violation|0
5041614|NCT02687542|17371115|P2|Overall Study|Protocol Violation|1
5041615|NCT02687542|17371116|P1|Overall Study|Protocol Violation|0
5041616|NCT02687542|17371112|P5|Overall Study|Lost to Follow-up|1
5041617|NCT02687542|17371113|P4|Overall Study|Lost to Follow-up|0
5041618|NCT02687542|17371114|P3|Overall Study|Lost to Follow-up|0
5041619|NCT02687542|17371115|P2|Overall Study|Lost to Follow-up|0
5041620|NCT02687542|17371116|P1|Overall Study|Lost to Follow-up|0
5041621|NCT02687542|17371112|P5|Overall Study|Medication error without associated AEs|1
5041622|NCT02687542|17371113|P4|Overall Study|Medication error without associated AEs|0
5041623|NCT02687542|17371114|P3|Overall Study|Medication error without associated AEs|0
5041624|NCT02687542|17371115|P2|Overall Study|Medication error without associated AEs|0
5041625|NCT02687542|17371116|P1|Overall Study|Medication error without associated AEs|0
5041626|NCT02687191|17371245|P6|Overall Study|Withdrawal by Subject|0
5041627|NCT02687191|17371246|P5|Overall Study|Withdrawal by Subject|0
5041628|NCT02687191|17371247|P4|Overall Study|Withdrawal by Subject|1
5041629|NCT02687191|17371248|P3|Overall Study|Withdrawal by Subject|0
5041630|NCT02687191|17371249|P2|Overall Study|Withdrawal by Subject|0
5041631|NCT02687191|17371250|P1|Overall Study|Withdrawal by Subject|0
5041632|NCT02687191|17371245|P6|Overall Study|Death|1
5041633|NCT02687191|17371246|P5|Overall Study|Death|1
5041634|NCT02687191|17371247|P4|Overall Study|Death|0
5041635|NCT02687191|17371248|P3|Overall Study|Death|1
5041636|NCT02687191|17371249|P2|Overall Study|Death|1
5041637|NCT02687191|17371250|P1|Overall Study|Death|0
5041638|NCT02686164|17371414|P1|Overall Study|Clinical progression|1
5041639|NCT02686164|17371414|P1|Overall Study|Withdrawal of consent|1
5041640|NCT02686164|17371414|P1|Overall Study|Adverse Event|1
5041641|NCT02686034|17371451|P2|Open Label Period 3|Lost to Follow-up|1
5041642|NCT02686034|17371452|P1|Open Label Period 3|Lost to Follow-up|0
5041643|NCT02686034|17371451|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
5041644|NCT02686034|17371452|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
5041645|NCT02686034|17371451|P2|Randomized Controlled Period 2|Adverse Event|2
5041646|NCT02686034|17371452|P1|Randomized Controlled Period 2|Adverse Event|0
5041647|NCT02686034|17371451|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
5041648|NCT02686034|17371452|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
5041649|NCT02686034|17371451|P2|Randomized Controlled Period 2|Lost to Follow-up|2
5041650|NCT02686034|17371452|P1|Randomized Controlled Period 2|Lost to Follow-up|1
5041651|NCT02686034|17371451|P2|Run-In Period 1|Lost to Follow-up|4
5041652|NCT02686034|17371452|P1|Run-In Period 1|Lost to Follow-up|4
5041653|NCT02686034|17371451|P2|Run-In Period 1|Withdrawal by Subject|3
5041654|NCT02686034|17371452|P1|Run-In Period 1|Withdrawal by Subject|4
5041655|NCT02686034|17371451|P2|Run-In Period 1|Eligibility|10
5041656|NCT02686034|17371452|P1|Run-In Period 1|Eligibility|12
5041657|NCT02685826|17371502|P3|Overall Study|Full Clinical Hold by FDA|20
5041658|NCT02685826|17371503|P2|Overall Study|Full Clinical Hold by FDA|9
5041659|NCT02685826|17371504|P1|Overall Study|Full Clinical Hold by FDA|19
5041660|NCT02685826|17371502|P3|Overall Study|Withdrawal by Subject|0
5041661|NCT02685826|17371503|P2|Overall Study|Withdrawal by Subject|0
5041662|NCT02685826|17371504|P1|Overall Study|Withdrawal by Subject|2
5041663|NCT02685826|17371502|P3|Overall Study|Progressive Disease|0
5041664|NCT02685826|17371503|P2|Overall Study|Progressive Disease|1
5041665|NCT02685826|17371504|P1|Overall Study|Progressive Disease|2
5041666|NCT02685826|17371502|P3|Overall Study|Adverse Event|1
5041667|NCT02685826|17371503|P2|Overall Study|Adverse Event|0
5041668|NCT02685826|17371504|P1|Overall Study|Adverse Event|2
5041669|NCT02685488|17371598|P2|Overall Study|Withdrawal by Subject|1
5041670|NCT02685488|17371599|P1|Overall Study|Withdrawal by Subject|0
5041671|NCT02685202|17371652|P1|Overall Study|Lost to Follow-up|9
5041672|NCT02685072|17371660|P2|1-Month Follow-Up|Withdrawal by Subject|0
5041673|NCT02685072|17371661|P1|1-Month Follow-Up|Withdrawal by Subject|1
5041674|NCT02685072|17371660|P2|Treatment Period|Withdrawal by Subject|3
5041675|NCT02685072|17371661|P1|Treatment Period|Withdrawal by Subject|1
5041676|NCT02685072|17371660|P2|Treatment Period|Lost to Follow-up|6
5041677|NCT02685072|17371661|P1|Treatment Period|Lost to Follow-up|12
5041678|NCT02685033|17371705|P2|Overall Study|Adverse Event|0
5041679|NCT02685033|17371706|P1|Overall Study|Adverse Event|1
5041680|NCT02685033|17371705|P2|Overall Study|Lost to Follow-up|1
5041681|NCT02685033|17371706|P1|Overall Study|Lost to Follow-up|2
5041682|NCT02685033|17371705|P2|Overall Study|Withdrawal of Consent|1
5041683|NCT02685033|17371706|P1|Overall Study|Withdrawal of Consent|0
5041684|NCT02684981|17371742|P3|Overall Study|Other|17
5041685|NCT02684981|17371743|P2|Overall Study|Other|49
5041686|NCT02684981|17371744|P1|Overall Study|Other|83
5041687|NCT02684981|17371742|P3|Overall Study|Permanently discontinued the treatment|110
5041688|NCT02684981|17371743|P2|Overall Study|Permanently discontinued the treatment|161
5041689|NCT02684981|17371744|P1|Overall Study|Permanently discontinued the treatment|157
5041690|NCT02684370|17371904|P6|Part B|Subject Withdrawal|2
5041691|NCT02684370|17371905|P5|Part B|Subject Withdrawal|1
5041692|NCT02684370|17371906|P4|Part B|Subject Withdrawal|1
5041693|NCT02684370|17371907|P3|Part B|Subject Withdrawal|0
5041694|NCT02684370|17371908|P2|Part B|Subject Withdrawal|0
5041695|NCT02684370|17371909|P1|Part B|Subject Withdrawal|0
5041696|NCT02684370|17371904|P6|Part B|Lost to Follow-up|5
5041697|NCT02684370|17371905|P5|Part B|Lost to Follow-up|2
5041698|NCT02684370|17371906|P4|Part B|Lost to Follow-up|1
5041699|NCT02684370|17371907|P3|Part B|Lost to Follow-up|0
5041700|NCT02684370|17371908|P2|Part B|Lost to Follow-up|0
5041701|NCT02684370|17371909|P1|Part B|Lost to Follow-up|0
5041702|NCT02684370|17371904|P6|Part B|Adverse Event|1
5041703|NCT02684370|17371905|P5|Part B|Adverse Event|2
5041704|NCT02684370|17371906|P4|Part B|Adverse Event|0
5041705|NCT02684370|17371907|P3|Part B|Adverse Event|0
5041706|NCT02684370|17371908|P2|Part B|Adverse Event|0
5041707|NCT02684370|17371909|P1|Part B|Adverse Event|0
5041708|NCT02684370|17371904|P6|Part A|Other|0
5041709|NCT02684370|17371905|P5|Part A|Other|0
5041710|NCT02684370|17371906|P4|Part A|Other|0
5041711|NCT02684370|17371907|P3|Part A|Other|1
5041712|NCT02684370|17371908|P2|Part A|Other|0
5041713|NCT02684370|17371909|P1|Part A|Other|0
5041714|NCT02684370|17371904|P6|Part A|Subject Withdrawal|0
5041716|NCT02684370|17371906|P4|Part A|Subject Withdrawal|0
5041717|NCT02684370|17371907|P3|Part A|Subject Withdrawal|3
5041718|NCT02684370|17371908|P2|Part A|Subject Withdrawal|0
5041719|NCT02684370|17371909|P1|Part A|Subject Withdrawal|1
5041720|NCT02684370|17371904|P6|Part A|Lost to Follow-up|0
5041721|NCT02684370|17371905|P5|Part A|Lost to Follow-up|0
5041722|NCT02684370|17371906|P4|Part A|Lost to Follow-up|0
5041723|NCT02684370|17371907|P3|Part A|Lost to Follow-up|0
5041724|NCT02684370|17371908|P2|Part A|Lost to Follow-up|1
5041725|NCT02684370|17371909|P1|Part A|Lost to Follow-up|1
5041726|NCT02684370|17371904|P6|Part A|Adverse Event|0
5041727|NCT02684370|17371905|P5|Part A|Adverse Event|0
5041728|NCT02684370|17371906|P4|Part A|Adverse Event|0
5041729|NCT02684370|17371907|P3|Part A|Adverse Event|1
5041730|NCT02684370|17371908|P2|Part A|Adverse Event|0
5041731|NCT02684370|17371909|P1|Part A|Adverse Event|2
5041732|NCT02684357|17371954|P6|Part B|Other|1
5041733|NCT02684357|17371955|P5|Part B|Other|0
5041734|NCT02684357|17371956|P4|Part B|Other|1
5041735|NCT02684357|17371957|P3|Part B|Other|0
5041736|NCT02684357|17371958|P2|Part B|Other|0
5041737|NCT02684357|17371959|P1|Part B|Other|0
5041738|NCT02684357|17371954|P6|Part B|Withdrawal by Subject|4
5041739|NCT02684357|17371955|P5|Part B|Withdrawal by Subject|2
5041740|NCT02684357|17371956|P4|Part B|Withdrawal by Subject|0
5041741|NCT02684357|17371957|P3|Part B|Withdrawal by Subject|0
5041742|NCT02684357|17371958|P2|Part B|Withdrawal by Subject|0
5041743|NCT02684357|17371959|P1|Part B|Withdrawal by Subject|0
5041744|NCT02684357|17371954|P6|Part B|Lost to Follow-up|7
5041745|NCT02684357|17371955|P5|Part B|Lost to Follow-up|1
5041746|NCT02684357|17371956|P4|Part B|Lost to Follow-up|1
5041747|NCT02684357|17371957|P3|Part B|Lost to Follow-up|0
5041748|NCT02684357|17371958|P2|Part B|Lost to Follow-up|0
5041749|NCT02684357|17371959|P1|Part B|Lost to Follow-up|0
5041750|NCT02684357|17371954|P6|Part B|Adverse Event (Other)|1
5041751|NCT02684357|17371955|P5|Part B|Adverse Event (Other)|1
5041752|NCT02684357|17371956|P4|Part B|Adverse Event (Other)|1
5041753|NCT02684357|17371957|P3|Part B|Adverse Event (Other)|0
5041754|NCT02684357|17371958|P2|Part B|Adverse Event (Other)|0
5041755|NCT02684357|17371959|P1|Part B|Adverse Event (Other)|0
5041756|NCT02684357|17371954|P6|Part A|Other|0
5041757|NCT02684357|17371955|P5|Part A|Other|0
5041758|NCT02684357|17371956|P4|Part A|Other|0
5041759|NCT02684357|17371957|P3|Part A|Other|0
5041760|NCT02684357|17371958|P2|Part A|Other|1
5041761|NCT02684357|17371959|P1|Part A|Other|0
5041762|NCT02684357|17371954|P6|Part A|Withdrawal by Subject|0
5041763|NCT02684357|17371955|P5|Part A|Withdrawal by Subject|0
5041764|NCT02684357|17371956|P4|Part A|Withdrawal by Subject|0
5041765|NCT02684357|17371957|P3|Part A|Withdrawal by Subject|0
5041766|NCT02684357|17371958|P2|Part A|Withdrawal by Subject|0
5041767|NCT02684357|17371959|P1|Part A|Withdrawal by Subject|3
5041768|NCT02684357|17371954|P6|Part A|Lost to Follow-up|0
5041769|NCT02684357|17371955|P5|Part A|Lost to Follow-up|0
5041770|NCT02684357|17371956|P4|Part A|Lost to Follow-up|0
5041771|NCT02684357|17371957|P3|Part A|Lost to Follow-up|2
5041772|NCT02684357|17371958|P2|Part A|Lost to Follow-up|2
5041773|NCT02684357|17371959|P1|Part A|Lost to Follow-up|0
5041774|NCT02684357|17371954|P6|Part A|Adverse Event (Worsening of Disease)|0
5041775|NCT02684357|17371955|P5|Part A|Adverse Event (Worsening of Disease)|0
5041776|NCT02684357|17371956|P4|Part A|Adverse Event (Worsening of Disease)|0
5041777|NCT02684357|17371957|P3|Part A|Adverse Event (Worsening of Disease)|0
5041778|NCT02684357|17371958|P2|Part A|Adverse Event (Worsening of Disease)|0
5041779|NCT02684357|17371959|P1|Part A|Adverse Event (Worsening of Disease)|1
5041780|NCT02684344|17372009|P2|Overall Study|Withdrawal by Subject|1
5041781|NCT02684344|17372010|P1|Overall Study|Withdrawal by Subject|0
5041782|NCT02684279|17372016|P1|Overall Study|Physician Decision|1
5041783|NCT02684279|17372016|P1|Overall Study|Site closures|7
5041784|NCT02684279|17372016|P1|Overall Study|family emergency|1
5041785|NCT02684279|17372016|P1|Overall Study|subject to have surgery|1
5041786|NCT02684279|17372016|P1|Overall Study|non compliance with study visits|2
5041787|NCT02684279|17372016|P1|Overall Study|non-compliance with study drug|9
5041788|NCT02684279|17372016|P1|Overall Study|Withdrawal by Subject|92
5041789|NCT02684279|17372016|P1|Overall Study|Pregnancy|8
5041790|NCT02684279|17372016|P1|Overall Study|Protocol Violation|6
5041791|NCT02684279|17372016|P1|Overall Study|Lost to Follow-up|61
5041792|NCT02684279|17372016|P1|Overall Study|Lack of Efficacy|4
5041793|NCT02684279|17372016|P1|Overall Study|Adverse Event|87
5041794|NCT02684097|17372068|P2|Overall Study|Lack of Efficacy|6
5041795|NCT02684097|17372069|P1|Overall Study|Lack of Efficacy|13
5041796|NCT02683889|17372115|P1|Overall Study|Withdrawal by Subject|1
5041797|NCT02683876|17372123|P2|Overall Study|samples damaged during shipping|0
5041798|NCT02683876|17372124|P1|Overall Study|samples damaged during shipping|2
5041799|NCT02683785|17372134|P2|Overall Study|Adverse Event|2
5041800|NCT02683785|17372135|P1|Overall Study|Adverse Event|0
5041801|NCT02683785|17372134|P2|Overall Study|Lost to Follow-up|1
5041802|NCT02683785|17372135|P1|Overall Study|Lost to Follow-up|0
5041803|NCT02683785|17372134|P2|Overall Study|Withdrawal by Subject|1
5041804|NCT02683785|17372135|P1|Overall Study|Withdrawal by Subject|1
5041805|NCT02683746|17372192|P2|Overall Study|Physician Decision|1
5041806|NCT02683746|17372193|P1|Overall Study|Physician Decision|2
5041807|NCT02683746|17372192|P2|Overall Study|Withdrawal by Subject|5
5041808|NCT02683746|17372193|P1|Overall Study|Withdrawal by Subject|6
5041809|NCT02683746|17372192|P2|Overall Study|Lost to Follow-up|6
5041810|NCT02683746|17372193|P1|Overall Study|Lost to Follow-up|5
5041811|NCT02683746|17372192|P2|Overall Study|Adverse Event|2
5041812|NCT02683746|17372193|P1|Overall Study|Adverse Event|3
5041813|NCT02683668|17372236|P3|Period 2|Withdrawal by Subject|0
5041814|NCT02683668|17372237|P2|Period 2|Withdrawal by Subject|1
5041815|NCT02683668|17372238|P1|Period 2|Withdrawal by Subject|0
5041816|NCT02683109|17372345|P2|Overall Study|Adverse Event|0
5041817|NCT02683109|17372346|P1|Overall Study|Adverse Event|1
5041818|NCT02682823|17372367|P5|Overall Study|Adverse Event|0
5041819|NCT02682823|17372368|P4|Overall Study|Adverse Event|1
5041820|NCT02682823|17372369|P3|Overall Study|Adverse Event|0
5041821|NCT02682823|17372370|P2|Overall Study|Adverse Event|0
5041822|NCT02682823|17372371|P1|Overall Study|Adverse Event|0
5041823|NCT02682823|17372367|P5|Overall Study|Protocol Deviation|0
5041824|NCT02682823|17372368|P4|Overall Study|Protocol Deviation|0
5041825|NCT02682823|17372369|P3|Overall Study|Protocol Deviation|0
5041826|NCT02682823|17372370|P2|Overall Study|Protocol Deviation|1
5041827|NCT02682823|17372371|P1|Overall Study|Protocol Deviation|0
5041828|NCT02682823|17372367|P5|Overall Study|Withdrawal by Subject|1
5041829|NCT02682823|17372368|P4|Overall Study|Withdrawal by Subject|0
5041830|NCT02682823|17372369|P3|Overall Study|Withdrawal by Subject|1
5041831|NCT02682823|17372370|P2|Overall Study|Withdrawal by Subject|0
5041832|NCT02682823|17372371|P1|Overall Study|Withdrawal by Subject|0
5041833|NCT02682602|17372407|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
5041834|NCT02682602|17372408|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
5041835|NCT02682602|17372407|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
5041836|NCT02682602|17372408|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
5041837|NCT02682264|17372541|P2|Overall Study|Stopped test article application|1
5041838|NCT02682264|17372542|P1|Overall Study|Stopped test article application|0
5041839|NCT02682264|17372541|P2|Overall Study|Moved abroad and unable to continue|3
5041840|NCT02682264|17372542|P1|Overall Study|Moved abroad and unable to continue|0
5041841|NCT02682264|17372541|P2|Overall Study|Technical Problems|1
5041842|NCT02682264|17372542|P1|Overall Study|Technical Problems|0
5041843|NCT02682264|17372541|P2|Overall Study|Progressive Disease|0
5041844|NCT02682264|17372542|P1|Overall Study|Progressive Disease|1
5041845|NCT02682264|17372541|P2|Overall Study|Recovery|2
5041846|NCT02682264|17372542|P1|Overall Study|Recovery|1
5041847|NCT02682264|17372541|P2|Overall Study|Pregnancy|2
5041848|NCT02682264|17372542|P1|Overall Study|Pregnancy|1
5041849|NCT02682264|17372541|P2|Overall Study|Noncompliance with study drug|4
5041850|NCT02682264|17372542|P1|Overall Study|Noncompliance with study drug|1
5041851|NCT02682264|17372541|P2|Overall Study|Adverse Event|0
5041852|NCT02682264|17372542|P1|Overall Study|Adverse Event|9
5041853|NCT02682264|17372541|P2|Overall Study|Withdrawal by Parent|7
5041854|NCT02682264|17372542|P1|Overall Study|Withdrawal by Parent|6
5041855|NCT02682264|17372541|P2|Overall Study|Lack of Efficacy|16
5041856|NCT02682264|17372542|P1|Overall Study|Lack of Efficacy|14
5041857|NCT02682264|17372541|P2|Overall Study|Lost to Follow-up|41
5041858|NCT02682264|17372542|P1|Overall Study|Lost to Follow-up|49
5041859|NCT02682264|17372541|P2|Overall Study|Withdrawal by Subject|45
5041860|NCT02682264|17372542|P1|Overall Study|Withdrawal by Subject|56
5041861|NCT02681510|17372612|P1|Overall Study|Lost to Follow-up|9
5041862|NCT02681510|17372612|P1|Overall Study|Withdrawal by Subject|1
5041863|NCT02681094|17372642|P3|2 - Enrolled Participants Set|No treatment given|1
5041864|NCT02681094|17372643|P2|2 - Enrolled Participants Set|No treatment given|1
5041865|NCT02681094|17372644|P1|2 - Enrolled Participants Set|No treatment given|0
5041866|NCT02681094|17372642|P3|2 - Enrolled Participants Set|Other|7
5041867|NCT02681094|17372643|P2|2 - Enrolled Participants Set|Other|6
5041868|NCT02681094|17372644|P1|2 - Enrolled Participants Set|Other|6
5041869|NCT02681094|17372642|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
5041870|NCT02681094|17372643|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
5041871|NCT02681094|17372644|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
5041872|NCT02681094|17372642|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
5041873|NCT02681094|17372643|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
5041874|NCT02681094|17372644|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
5041875|NCT02681094|17372642|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
5041876|NCT02681094|17372643|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
5041877|NCT02681094|17372644|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
5041878|NCT02681094|17372642|P3|2 - Enrolled Participants Set|Adverse Event|1
5041879|NCT02681094|17372643|P2|2 - Enrolled Participants Set|Adverse Event|4
5041880|NCT02681094|17372644|P1|2 - Enrolled Participants Set|Adverse Event|10
5041881|NCT02681094|17372642|P3|2 - Enrolled Participants Set|Participant decision|9
5041882|NCT02681094|17372643|P2|2 - Enrolled Participants Set|Participant decision|10
5041883|NCT02681094|17372644|P1|2 - Enrolled Participants Set|Participant decision|7
5041884|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|No treatment given|1
5041885|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|No treatment given|1
5041886|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|No treatment given|0
5041887|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|Other|7
5041888|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|Other|6
5041889|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|Other|6
5041890|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
5041891|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
5041892|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
5041893|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
5041894|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
5041895|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
5041896|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
5041897|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
5041898|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
5041899|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
5041900|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
5041901|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
5041902|NCT02681094|17372642|P3|1 -Modified Enrolled Participants Set|Participant decision|9
5041903|NCT02681094|17372643|P2|1 -Modified Enrolled Participants Set|Participant decision|10
5041904|NCT02681094|17372644|P1|1 -Modified Enrolled Participants Set|Participant decision|7
5041905|NCT02680847|17372663|P3|Overall Study|Adverse Event|1
5041906|NCT02680847|17372664|P2|Overall Study|Adverse Event|0
5041907|NCT02680847|17372665|P1|Overall Study|Adverse Event|0
5041908|NCT02680847|17372663|P3|Overall Study|Lack of Efficacy|2
5041909|NCT02680847|17372664|P2|Overall Study|Lack of Efficacy|0
5041910|NCT02680847|17372665|P1|Overall Study|Lack of Efficacy|0
5041911|NCT02680847|17372663|P3|Overall Study|Unwilling to participate in study|0
5041912|NCT02680847|17372664|P2|Overall Study|Unwilling to participate in study|1
5041913|NCT02680847|17372665|P1|Overall Study|Unwilling to participate in study|1
5041914|NCT02680847|17372663|P3|Overall Study|No longer met eligibility criteria|0
5041915|NCT02680847|17372664|P2|Overall Study|No longer met eligibility criteria|2
5041916|NCT02680847|17372665|P1|Overall Study|No longer met eligibility criteria|2
5041917|NCT02680847|17372663|P3|Overall Study|Other|0
5041918|NCT02680847|17372664|P2|Overall Study|Other|0
5041919|NCT02680847|17372665|P1|Overall Study|Other|2
5041920|NCT02680834|17372702|P2|Overall Study|Lost to Follow-up|1
5041921|NCT02680834|17372703|P1|Overall Study|Lost to Follow-up|0
5041922|NCT02680834|17372702|P2|Overall Study|Withdrawal by Subject|0
5041923|NCT02680834|17372703|P1|Overall Study|Withdrawal by Subject|6
5041924|NCT02680834|17372702|P2|Overall Study|Physician Decision|2
5041925|NCT02680834|17372703|P1|Overall Study|Physician Decision|5
5041926|NCT02680756|17372715|P2|Overall Study|None of above or not recorded|2
5041927|NCT02680756|17372716|P1|Overall Study|None of above or not recorded|3
5041928|NCT02680756|17372715|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
5041929|NCT02680756|17372716|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
5041930|NCT02680756|17372715|P2|Overall Study|Protocol Violation|0
5041931|NCT02680756|17372716|P1|Overall Study|Protocol Violation|1
5041932|NCT02680756|17372715|P2|Overall Study|Death|0
5041933|NCT02680756|17372716|P1|Overall Study|Death|1
5041934|NCT02680756|17372715|P2|Overall Study|Blood transfusion for any reason|1
5041935|NCT02680756|17372716|P1|Overall Study|Blood transfusion for any reason|0
5041936|NCT02680756|17372715|P2|Overall Study|Hb ≤7.5 g/dL|2
5041937|NCT02680756|17372716|P1|Overall Study|Hb ≤7.5 g/dL|0
5041938|NCT02680756|17372715|P2|Overall Study|Physician Decision|1
5041939|NCT02680756|17372716|P1|Overall Study|Physician Decision|4
5041940|NCT02680756|17372715|P2|Overall Study|Withdrawal by Subject|5
5041941|NCT02680756|17372716|P1|Overall Study|Withdrawal by Subject|5
5041942|NCT02680756|17372715|P2|Overall Study|Lost to Follow-up|6
5041943|NCT02680756|17372716|P1|Overall Study|Lost to Follow-up|7
5041944|NCT02680756|17372715|P2|Overall Study|Adverse Event|2
5041945|NCT02680756|17372716|P1|Overall Study|Adverse Event|10
5041946|NCT02680665|17372764|P1|Overall Study|No visit after the first prescription|5
5041947|NCT02680639|17372770|P3|Screening Period|Screen Failure|0
5041948|NCT02680639|17372771|P2|Screening Period|Screen Failure|0
5041949|NCT02680639|17372772|P1|Screening Period|Screen Failure|7
5041950|NCT02680041|17372854|P1|Overall Study|Lost to Follow-up|2
5041951|NCT02680041|17372854|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
5041952|NCT02680002|17372869|P6|Overall Study|Adverse Event|2
5041953|NCT02680002|17372870|P5|Overall Study|Adverse Event|1
5041954|NCT02680002|17372871|P4|Overall Study|Adverse Event|0
5041955|NCT02680002|17372872|P3|Overall Study|Adverse Event|0
5041956|NCT02680002|17372873|P2|Overall Study|Adverse Event|0
5041957|NCT02680002|17372874|P1|Overall Study|Adverse Event|0
5041958|NCT02680002|17372869|P6|Overall Study|Other|0
5041959|NCT02680002|17372870|P5|Overall Study|Other|1
5041960|NCT02680002|17372871|P4|Overall Study|Other|0
5041961|NCT02680002|17372872|P3|Overall Study|Other|0
5041962|NCT02680002|17372873|P2|Overall Study|Other|1
5041963|NCT02680002|17372874|P1|Overall Study|Other|0
5041964|NCT02680002|17372869|P6|Overall Study|Missed Visit 8 (Day 201)|0
5041965|NCT02680002|17372870|P5|Overall Study|Missed Visit 8 (Day 201)|5
5041966|NCT02680002|17372871|P4|Overall Study|Missed Visit 8 (Day 201)|1
5041967|NCT02680002|17372872|P3|Overall Study|Missed Visit 8 (Day 201)|3
5041968|NCT02680002|17372873|P2|Overall Study|Missed Visit 8 (Day 201)|1
5041969|NCT02680002|17372874|P1|Overall Study|Missed Visit 8 (Day 201)|2
5041970|NCT02680002|17372869|P6|Overall Study|Withdrawal by Subject|2
5041971|NCT02680002|17372870|P5|Overall Study|Withdrawal by Subject|2
5041972|NCT02680002|17372871|P4|Overall Study|Withdrawal by Subject|0
5041973|NCT02680002|17372872|P3|Overall Study|Withdrawal by Subject|1
5041974|NCT02680002|17372873|P2|Overall Study|Withdrawal by Subject|0
5041975|NCT02680002|17372874|P1|Overall Study|Withdrawal by Subject|0
5041976|NCT02680002|17372869|P6|Overall Study|Protocol Violation|2
5041977|NCT02680002|17372870|P5|Overall Study|Protocol Violation|1
5041978|NCT02680002|17372871|P4|Overall Study|Protocol Violation|0
5041979|NCT02680002|17372872|P3|Overall Study|Protocol Violation|1
5041980|NCT02680002|17372873|P2|Overall Study|Protocol Violation|0
5041981|NCT02680002|17372874|P1|Overall Study|Protocol Violation|1
5041982|NCT02680002|17372869|P6|Overall Study|Physician Decision|1
5041983|NCT02680002|17372870|P5|Overall Study|Physician Decision|1
5041984|NCT02680002|17372871|P4|Overall Study|Physician Decision|1
5041985|NCT02680002|17372872|P3|Overall Study|Physician Decision|1
5041986|NCT02680002|17372873|P2|Overall Study|Physician Decision|1
5041987|NCT02680002|17372874|P1|Overall Study|Physician Decision|5
5041988|NCT02680002|17372869|P6|Overall Study|Lost to Follow-up|2
5041989|NCT02680002|17372870|P5|Overall Study|Lost to Follow-up|0
5041990|NCT02680002|17372871|P4|Overall Study|Lost to Follow-up|2
5041991|NCT02680002|17372872|P3|Overall Study|Lost to Follow-up|4
5041992|NCT02680002|17372873|P2|Overall Study|Lost to Follow-up|1
5041993|NCT02680002|17372874|P1|Overall Study|Lost to Follow-up|5
5041994|NCT02679755|17373017|P2|Overall Study|Adverse events not related to study drug|2
5041995|NCT02679755|17373018|P1|Overall Study|Adverse events not related to study drug|1
5041996|NCT02679755|17373017|P2|Overall Study|Adverse Event|4
5041997|NCT02679755|17373018|P1|Overall Study|Adverse Event|1
5041998|NCT02679755|17373017|P2|Overall Study|Withdrawal by participant|3
5041999|NCT02679755|17373018|P1|Overall Study|Withdrawal by participant|6
5042000|NCT02679755|17373017|P2|Overall Study|Not defined|2
5042001|NCT02679755|17373018|P1|Overall Study|Not defined|0
5042002|NCT02679755|17373017|P2|Overall Study|Objective progression or relapse|83
5042003|NCT02679755|17373018|P1|Overall Study|Objective progression or relapse|24
5042004|NCT02679755|17373017|P2|Overall Study|Lost to Follow-up|0
5042005|NCT02679755|17373018|P1|Overall Study|Lost to Follow-up|1
5042006|NCT02679755|17373017|P2|Overall Study|Global deterioration of health status|8
5042007|NCT02679755|17373018|P1|Overall Study|Global deterioration of health status|1
5042008|NCT02679755|17373017|P2|Overall Study|Death|3
5042009|NCT02679755|17373018|P1|Overall Study|Death|0
5042010|NCT02679729|17373060|P9|Overall Study|Participant decision|0
5042011|NCT02679729|17373061|P8|Overall Study|Participant decision|0
5042012|NCT02679729|17373062|P7|Overall Study|Participant decision|1
5042013|NCT02679729|17373063|P6|Overall Study|Participant decision|0
5042014|NCT02679729|17373064|P5|Overall Study|Participant decision|0
5042015|NCT02679729|17373065|P4|Overall Study|Participant decision|0
5042016|NCT02679729|17373066|P3|Overall Study|Participant decision|0
5042017|NCT02679729|17373067|P2|Overall Study|Participant decision|1
5042018|NCT02679729|17373068|P1|Overall Study|Participant decision|0
5042019|NCT02679729|17373060|P9|Overall Study|Lost to Follow-up|0
5042020|NCT02679729|17373061|P8|Overall Study|Lost to Follow-up|0
5042021|NCT02679729|17373062|P7|Overall Study|Lost to Follow-up|0
5042022|NCT02679729|17373063|P6|Overall Study|Lost to Follow-up|0
5042023|NCT02679729|17373064|P5|Overall Study|Lost to Follow-up|1
5042024|NCT02679729|17373065|P4|Overall Study|Lost to Follow-up|0
5042025|NCT02679729|17373066|P3|Overall Study|Lost to Follow-up|0
5042026|NCT02679729|17373067|P2|Overall Study|Lost to Follow-up|1
5042027|NCT02679729|17373068|P1|Overall Study|Lost to Follow-up|0
5042028|NCT02679573|17373180|P2|Overall Study|Lost to Follow-up|3
5042029|NCT02679573|17373181|P1|Overall Study|Lost to Follow-up|0
5042030|NCT02679573|17373180|P2|Overall Study|Physician Decision|4
5042031|NCT02679573|17373181|P1|Overall Study|Physician Decision|2
5042032|NCT02679573|17373180|P2|Overall Study|Death|0
5042033|NCT02679573|17373181|P1|Overall Study|Death|2
5042034|NCT02679573|17373180|P2|Overall Study|Withdrawal by Subject|9
5042035|NCT02679573|17373181|P1|Overall Study|Withdrawal by Subject|2
5042036|NCT02679573|17373180|P2|Overall Study|Could not complete required study visits|2
5042037|NCT02679573|17373181|P1|Overall Study|Could not complete required study visits|6
5042038|NCT02679573|17373180|P2|Overall Study|Lack of Efficacy|15
5042039|NCT02679573|17373181|P1|Overall Study|Lack of Efficacy|12
5042040|NCT02679573|17373180|P2|Overall Study|Adverse Event|6
5042041|NCT02679573|17373181|P1|Overall Study|Adverse Event|13
5042042|NCT02679287|17373205|P2|Period 3|Work/Scheduling Conflict|1
5042043|NCT02679287|17373206|P1|Period 3|Work/Scheduling Conflict|0
5042044|NCT02679287|17373205|P2|Period 2|Disliked Mobile System|0
5042045|NCT02679287|17373206|P1|Period 2|Disliked Mobile System|2
5042046|NCT02679287|17373205|P2|Period 2|Work/Scheduling Conflict|0
5042047|NCT02679287|17373206|P1|Period 2|Work/Scheduling Conflict|1
5042048|NCT02679287|17373205|P2|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
5042049|NCT02679287|17373206|P1|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
5042050|NCT02679287|17373205|P2|Period 1: Randomization-Study Session 1|Disliked mobile system|1
5042051|NCT02679287|17373206|P1|Period 1: Randomization-Study Session 1|Disliked mobile system|0
5042052|NCT02679287|17373205|P2|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
5042053|NCT02679287|17373206|P1|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
5042054|NCT02679287|17373205|P2|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
5042055|NCT02679287|17373206|P1|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
5042056|NCT02679274|17373236|P2|Overall Study|Withdrawal by Subject|0
5042057|NCT02679274|17373237|P1|Overall Study|Withdrawal by Subject|1
5042058|NCT02679235|17373267|P1|Overall Study|Adverse Event|1
5042059|NCT02679235|17373267|P1|Overall Study|Withdrawal by Subject|3
5042060|NCT02679222|17373274|P1|Overall Study|No time for project|1
5042061|NCT02678923|17373304|P2|Overall Study|Did Not Return for Study Visits|0
5042062|NCT02678923|17373305|P1|Overall Study|Did Not Return for Study Visits|1
5042063|NCT02678923|17373304|P2|Overall Study|Lost to Follow-up|0
5042064|NCT02678923|17373305|P1|Overall Study|Lost to Follow-up|1
5042065|NCT02678923|17373304|P2|Overall Study|Withdrawal by Subject|2
5042066|NCT02678923|17373305|P1|Overall Study|Withdrawal by Subject|3
5042067|NCT02678923|17373304|P2|Overall Study|Protocol Deviation (Not Dosed)|3
5042068|NCT02678923|17373305|P1|Overall Study|Protocol Deviation (Not Dosed)|1
5042069|NCT02678676|17373321|P2|Overall Study|Unconfirmed for lost to follow-up|67
5042070|NCT02678676|17373322|P1|Overall Study|Unconfirmed for lost to follow-up|85
5042071|NCT02678676|17373321|P2|Overall Study|Lost to Follow-up|151
5042072|NCT02678676|17373322|P1|Overall Study|Lost to Follow-up|171
5042073|NCT02678676|17373321|P2|Overall Study|Withdrawal by Subject|5
5042074|NCT02678676|17373322|P1|Overall Study|Withdrawal by Subject|13
5042075|NCT02678676|17373321|P2|Overall Study|Death|649
5042076|NCT02678676|17373322|P1|Overall Study|Death|619
5042077|NCT02678416|17373353|P1|Part 2|Withdrawal by Subject|1
5042078|NCT02678416|17373353|P1|Part 2|Adverse Event|2
5042079|NCT02678416|17373353|P1|Part 1|Withdrawal by Subject|1
5042080|NCT02678390|17373373|P2|AE (1 Day)|Withdrawal by Subject|1
5042081|NCT02678390|17373374|P1|AE (1 Day)|Withdrawal by Subject|0
5042082|NCT02678286|17373390|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
5042083|NCT02678286|17373391|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
5042084|NCT02678286|17373390|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
5042085|NCT02678286|17373391|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
5042086|NCT02678286|17373390|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
5042087|NCT02678286|17373391|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
5042088|NCT02678286|17373390|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
5042089|NCT02678286|17373391|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
5042090|NCT02678286|17373390|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
5042091|NCT02678286|17373391|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
5042092|NCT02678000|17373443|P5|PART 2|Withdrawal by Subject|0
5042093|NCT02678000|17373444|P4|PART 2|Withdrawal by Subject|0
5042094|NCT02678000|17373445|P3|PART 2|Withdrawal by Subject|1
5042095|NCT02678000|17373446|P2|PART 2|Withdrawal by Subject|0
5042096|NCT02678000|17373447|P1|PART 2|Withdrawal by Subject|0
5042097|NCT02678000|17373443|P5|PART 2|Adverse Event|0
5042098|NCT02678000|17373444|P4|PART 2|Adverse Event|1
5042099|NCT02678000|17373445|P3|PART 2|Adverse Event|2
5042100|NCT02678000|17373446|P2|PART 2|Adverse Event|0
5042101|NCT02678000|17373447|P1|PART 2|Adverse Event|0
5042102|NCT02677896|17373485|P2|Overall Study|Did not receive study drug|2
5042103|NCT02677896|17373486|P1|Overall Study|Did not receive study drug|2
5042104|NCT02677896|17373485|P2|Overall Study|Miscellaneous|11
5042105|NCT02677896|17373486|P1|Overall Study|Miscellaneous|6
5042106|NCT02677896|17373485|P2|Overall Study|Withdrawal by patient:|30
5042107|NCT02677896|17373486|P1|Overall Study|Withdrawal by patient:|25
5042108|NCT02677896|17373485|P2|Overall Study|Protocol deviation|1
5042109|NCT02677896|17373486|P1|Overall Study|Protocol deviation|2
5042110|NCT02677896|17373485|P2|Overall Study|Progressive disease:|171
5042111|NCT02677896|17373486|P1|Overall Study|Progressive disease:|65
5042112|NCT02677896|17373485|P2|Overall Study|Lost to Follow-up|1
5042113|NCT02677896|17373486|P1|Overall Study|Lost to Follow-up|0
5042114|NCT02677896|17373485|P2|Overall Study|Death|7
5042115|NCT02677896|17373486|P1|Overall Study|Death|9
5042116|NCT02677896|17373485|P2|Overall Study|Adverse Event|21
5042117|NCT02677896|17373486|P1|Overall Study|Adverse Event|28
5042118|NCT02677844|17373514|P7|Period 3|Withdrawal by Subject|0
5042119|NCT02677844|17373515|P6|Period 3|Withdrawal by Subject|0
5042120|NCT02677844|17373516|P5|Period 3|Withdrawal by Subject|0
5042121|NCT02677844|17373517|P4|Period 3|Withdrawal by Subject|1
5042122|NCT02677844|17373518|P3|Period 3|Withdrawal by Subject|0
5042123|NCT02677844|17373519|P2|Period 3|Withdrawal by Subject|0
5042124|NCT02677844|17373520|P1|Period 3|Withdrawal by Subject|0
5042125|NCT02677220|17373658|P1|Overall Study|Adverse Event|1
5042126|NCT02677116|17373673|P9|Overall Study|Withdrawal by Subject|0
5042127|NCT02677116|17373674|P8|Overall Study|Withdrawal by Subject|0
5042128|NCT02677116|17373675|P7|Overall Study|Withdrawal by Subject|0
5042129|NCT02677116|17373676|P6|Overall Study|Withdrawal by Subject|0
5042130|NCT02677116|17373677|P5|Overall Study|Withdrawal by Subject|0
5042131|NCT02677116|17373678|P4|Overall Study|Withdrawal by Subject|0
5042132|NCT02677116|17373679|P3|Overall Study|Withdrawal by Subject|0
5042133|NCT02677116|17373680|P2|Overall Study|Withdrawal by Subject|0
5042134|NCT02677116|17373681|P1|Overall Study|Withdrawal by Subject|1
5042135|NCT02677116|17373673|P9|Overall Study|Withdrawal by parent or guardian|0
5042136|NCT02677116|17373674|P8|Overall Study|Withdrawal by parent or guardian|1
5042137|NCT02677116|17373675|P7|Overall Study|Withdrawal by parent or guardian|2
5042138|NCT02677116|17373676|P6|Overall Study|Withdrawal by parent or guardian|0
5042139|NCT02677116|17373677|P5|Overall Study|Withdrawal by parent or guardian|0
5042140|NCT02677116|17373678|P4|Overall Study|Withdrawal by parent or guardian|1
5042141|NCT02677116|17373679|P3|Overall Study|Withdrawal by parent or guardian|0
5042142|NCT02677116|17373680|P2|Overall Study|Withdrawal by parent or guardian|1
5042143|NCT02677116|17373681|P1|Overall Study|Withdrawal by parent or guardian|2
5042144|NCT02677116|17373673|P9|Overall Study|Physician Decision|2
5042145|NCT02677116|17373674|P8|Overall Study|Physician Decision|1
5042146|NCT02677116|17373675|P7|Overall Study|Physician Decision|1
5042147|NCT02677116|17373676|P6|Overall Study|Physician Decision|3
5042148|NCT02677116|17373677|P5|Overall Study|Physician Decision|1
5042149|NCT02677116|17373678|P4|Overall Study|Physician Decision|2
5042150|NCT02677116|17373679|P3|Overall Study|Physician Decision|3
5042151|NCT02677116|17373680|P2|Overall Study|Physician Decision|2
5042152|NCT02677116|17373681|P1|Overall Study|Physician Decision|0
5042153|NCT02677116|17373673|P9|Overall Study|Adverse Event|0
5042154|NCT02677116|17373674|P8|Overall Study|Adverse Event|0
5042155|NCT02677116|17373675|P7|Overall Study|Adverse Event|1
5042156|NCT02677116|17373676|P6|Overall Study|Adverse Event|1
5042157|NCT02677116|17373677|P5|Overall Study|Adverse Event|0
5042158|NCT02677116|17373678|P4|Overall Study|Adverse Event|0
5042159|NCT02677116|17373679|P3|Overall Study|Adverse Event|0
5042160|NCT02677116|17373680|P2|Overall Study|Adverse Event|1
5042161|NCT02677116|17373681|P1|Overall Study|Adverse Event|0
5042162|NCT02676895|17373754|P3|Overall Study|Withdrawal by Subject|1
5042163|NCT02676895|17373755|P2|Overall Study|Withdrawal by Subject|0
5042164|NCT02676895|17373756|P1|Overall Study|Withdrawal by Subject|0
5042165|NCT02676895|17373754|P3|Overall Study|Lost to Follow-up|1
5042166|NCT02676895|17373755|P2|Overall Study|Lost to Follow-up|0
5042167|NCT02676895|17373756|P1|Overall Study|Lost to Follow-up|0
5042168|NCT02676895|17373754|P3|Overall Study|Adverse Event|1
5042169|NCT02676895|17373755|P2|Overall Study|Adverse Event|3
5042170|NCT02676895|17373756|P1|Overall Study|Adverse Event|0
5042171|NCT02676895|17373754|P3|Overall Study|Protocol Violation|0
5042172|NCT02676895|17373755|P2|Overall Study|Protocol Violation|0
5042173|NCT02676895|17373756|P1|Overall Study|Protocol Violation|1
5042174|NCT02676895|17373754|P3|Overall Study|Administrative reason|0
5042175|NCT02676895|17373755|P2|Overall Study|Administrative reason|0
5042176|NCT02676895|17373756|P1|Overall Study|Administrative reason|1
5042177|NCT02676882|17373799|P2|Overall Study|Withdrawal by Subject|2
5042178|NCT02676882|17373800|P1|Overall Study|Withdrawal by Subject|1
5042179|NCT02676882|17373799|P2|Overall Study|Lost to Follow-up|0
5042180|NCT02676882|17373800|P1|Overall Study|Lost to Follow-up|1
5042181|NCT02676882|17373799|P2|Overall Study|Adverse Event|0
5042182|NCT02676882|17373800|P1|Overall Study|Adverse Event|1
5042183|NCT02676466|17373819|P8|Overall Study|Withdrawal by Subject|1
5042184|NCT02676466|17373820|P7|Overall Study|Withdrawal by Subject|1
5042185|NCT02676466|17373821|P6|Overall Study|Withdrawal by Subject|1
5042186|NCT02676466|17373822|P5|Overall Study|Withdrawal by Subject|3
5042187|NCT02676466|17373823|P4|Overall Study|Withdrawal by Subject|0
5042188|NCT02676466|17373824|P3|Overall Study|Withdrawal by Subject|1
5042189|NCT02676466|17373825|P2|Overall Study|Withdrawal by Subject|3
5042190|NCT02676466|17373826|P1|Overall Study|Withdrawal by Subject|4
5042191|NCT02676466|17373819|P8|Overall Study|Death|0
5042192|NCT02676466|17373820|P7|Overall Study|Death|0
5042193|NCT02676466|17373821|P6|Overall Study|Death|0
5042194|NCT02676466|17373822|P5|Overall Study|Death|0
5042195|NCT02676466|17373823|P4|Overall Study|Death|0
5042196|NCT02676466|17373824|P3|Overall Study|Death|1
5042197|NCT02676466|17373825|P2|Overall Study|Death|2
5042198|NCT02676466|17373826|P1|Overall Study|Death|0
5042199|NCT02675998|17373909|P4|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
5042200|NCT02675998|17373910|P3|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5042201|NCT02675998|17373911|P2|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5042202|NCT02675998|17373912|P1|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5042203|NCT02675998|17373909|P4|4-Week Randomized Withdrawal Period|Physician Decision|0
5042204|NCT02675998|17373910|P3|4-Week Randomized Withdrawal Period|Physician Decision|0
5042205|NCT02675998|17373911|P2|4-Week Randomized Withdrawal Period|Physician Decision|0
5042206|NCT02675998|17373912|P1|4-Week Randomized Withdrawal Period|Physician Decision|1
5042207|NCT02675998|17373909|P4|4-Week Randomized Withdrawal Period|Protocol Violation|1
5042208|NCT02675998|17373910|P3|4-Week Randomized Withdrawal Period|Protocol Violation|0
5042209|NCT02675998|17373911|P2|4-Week Randomized Withdrawal Period|Protocol Violation|0
5042210|NCT02675998|17373912|P1|4-Week Randomized Withdrawal Period|Protocol Violation|0
5042211|NCT02675998|17373909|P4|4-Week Randomized Withdrawal Period|Adverse Event|3
5042212|NCT02675998|17373910|P3|4-Week Randomized Withdrawal Period|Adverse Event|1
5042213|NCT02675998|17373911|P2|4-Week Randomized Withdrawal Period|Adverse Event|0
5042214|NCT02675998|17373912|P1|4-Week Randomized Withdrawal Period|Adverse Event|0
5042215|NCT02675998|17373909|P4|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
5042216|NCT02675998|17373910|P3|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
5042217|NCT02675998|17373911|P2|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
5042218|NCT02675998|17373912|P1|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
5042219|NCT02675998|17373909|P4|8-Week Treatment Period|Other|0
5042220|NCT02675998|17373910|P3|8-Week Treatment Period|Other|2
5042221|NCT02675998|17373911|P2|8-Week Treatment Period|Other|1
5042222|NCT02675998|17373912|P1|8-Week Treatment Period|Other|3
5042223|NCT02675998|17373909|P4|8-Week Treatment Period|Protocol Violation|0
5042224|NCT02675998|17373910|P3|8-Week Treatment Period|Protocol Violation|1
5042225|NCT02675998|17373911|P2|8-Week Treatment Period|Protocol Violation|1
5042226|NCT02675998|17373912|P1|8-Week Treatment Period|Protocol Violation|1
5042227|NCT02675998|17373909|P4|8-Week Treatment Period|GI side Effects|0
5042228|NCT02675998|17373910|P3|8-Week Treatment Period|GI side Effects|2
5042229|NCT02675998|17373911|P2|8-Week Treatment Period|GI side Effects|4
5042230|NCT02675998|17373912|P1|8-Week Treatment Period|GI side Effects|1
5042231|NCT02675998|17373909|P4|8-Week Treatment Period|Physician Decision|0
5042232|NCT02675998|17373910|P3|8-Week Treatment Period|Physician Decision|2
5042233|NCT02675998|17373911|P2|8-Week Treatment Period|Physician Decision|0
5042234|NCT02675998|17373912|P1|8-Week Treatment Period|Physician Decision|1
5042235|NCT02675998|17373909|P4|8-Week Treatment Period|Lack of Efficacy|0
5042236|NCT02675998|17373910|P3|8-Week Treatment Period|Lack of Efficacy|3
5042237|NCT02675998|17373911|P2|8-Week Treatment Period|Lack of Efficacy|5
5042238|NCT02675998|17373912|P1|8-Week Treatment Period|Lack of Efficacy|2
5042239|NCT02675998|17373909|P4|8-Week Treatment Period|Withdrawal by Subject|0
5042240|NCT02675998|17373910|P3|8-Week Treatment Period|Withdrawal by Subject|3
5042241|NCT02675998|17373911|P2|8-Week Treatment Period|Withdrawal by Subject|3
5042242|NCT02675998|17373912|P1|8-Week Treatment Period|Withdrawal by Subject|3
5042243|NCT02675998|17373909|P4|8-Week Treatment Period|Adverse Event|0
5042244|NCT02675998|17373910|P3|8-Week Treatment Period|Adverse Event|6
5042245|NCT02675998|17373911|P2|8-Week Treatment Period|Adverse Event|5
5042246|NCT02675998|17373912|P1|8-Week Treatment Period|Adverse Event|6
5042247|NCT02675907|17373928|P2|Study Overall|Lost to Follow-up|2
5042248|NCT02675907|17373929|P1|Study Overall|Lost to Follow-up|0
5042249|NCT02675907|17373928|P2|Study Overall|Withdrawal by Subject|2
5042250|NCT02675907|17373929|P1|Study Overall|Withdrawal by Subject|2
5042251|NCT02675907|17373928|P2|Study Overall|Lack of Efficacy|0
5042252|NCT02675907|17373929|P1|Study Overall|Lack of Efficacy|1
5042253|NCT02675907|17373928|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
5042254|NCT02675907|17373929|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
5042255|NCT02675907|17373928|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
5042256|NCT02675907|17373929|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
5042257|NCT02675751|17373974|P1|Overall Study|Lost to Follow-up|16
5042258|NCT02675634|17373978|P6|Test Period 2|Adverse Event|1
5042259|NCT02675634|17373979|P5|Test Period 2|Adverse Event|0
5042260|NCT02675634|17373980|P4|Test Period 2|Adverse Event|0
5042261|NCT02675634|17373981|P3|Test Period 2|Adverse Event|0
5042262|NCT02675634|17373982|P2|Test Period 2|Adverse Event|0
5042263|NCT02675634|17373983|P1|Test Period 2|Adverse Event|0
5042264|NCT02675634|17373978|P6|Test Period 2|Lack of Efficacy|0
5042265|NCT02675634|17373979|P5|Test Period 2|Lack of Efficacy|0
5042266|NCT02675634|17373980|P4|Test Period 2|Lack of Efficacy|0
5042267|NCT02675634|17373981|P3|Test Period 2|Lack of Efficacy|0
5042268|NCT02675634|17373982|P2|Test Period 2|Lack of Efficacy|0
5042269|NCT02675634|17373983|P1|Test Period 2|Lack of Efficacy|1
5042270|NCT02675634|17373978|P6|Test Period 1|Device deficiency that did not lead to A|0
5042271|NCT02675634|17373979|P5|Test Period 1|Device deficiency that did not lead to A|0
5042272|NCT02675634|17373980|P4|Test Period 1|Device deficiency that did not lead to A|0
5042273|NCT02675634|17373981|P3|Test Period 1|Device deficiency that did not lead to A|1
5042274|NCT02675634|17373982|P2|Test Period 1|Device deficiency that did not lead to A|0
5042275|NCT02675634|17373983|P1|Test Period 1|Device deficiency that did not lead to A|0
5042276|NCT02675634|17373978|P6|Test Period 1|Adverse Event|0
5042277|NCT02675634|17373979|P5|Test Period 1|Adverse Event|0
5042278|NCT02675634|17373980|P4|Test Period 1|Adverse Event|1
5042279|NCT02675634|17373981|P3|Test Period 1|Adverse Event|0
5042280|NCT02675634|17373982|P2|Test Period 1|Adverse Event|1
5042281|NCT02675634|17373983|P1|Test Period 1|Adverse Event|0
5042282|NCT02675517|17374000|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
5042283|NCT02675517|17374000|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
5042284|NCT02675426|17374012|P3|Overall Study|Other|2
5042285|NCT02675426|17374013|P2|Overall Study|Other|1
5042286|NCT02675426|17374014|P1|Overall Study|Other|3
5042287|NCT02675426|17374012|P3|Overall Study|Lost to Follow-up|2
5042288|NCT02675426|17374013|P2|Overall Study|Lost to Follow-up|0
5042289|NCT02675426|17374014|P1|Overall Study|Lost to Follow-up|1
5042290|NCT02675426|17374012|P3|Overall Study|Withdrawal by Subject|5
5042291|NCT02675426|17374013|P2|Overall Study|Withdrawal by Subject|5
5042292|NCT02675426|17374014|P1|Overall Study|Withdrawal by Subject|3
5042293|NCT02675426|17374012|P3|Overall Study|Adverse Event|9
5042294|NCT02675426|17374013|P2|Overall Study|Adverse Event|2
5042295|NCT02675426|17374014|P1|Overall Study|Adverse Event|6
5042296|NCT02675231|17374058|P3|Overall Study|On study treatment/follow up|23
5042297|NCT02675231|17374059|P2|Overall Study|On study treatment/follow up|31
5042298|NCT02675231|17374060|P1|Overall Study|On study treatment/follow up|23
5042299|NCT02675231|17374058|P3|Overall Study|Lost to Follow-up|2
5042300|NCT02675231|17374059|P2|Overall Study|Lost to Follow-up|2
5042301|NCT02675231|17374060|P1|Overall Study|Lost to Follow-up|2
5042302|NCT02675231|17374058|P3|Overall Study|Withdrawal by Subject|1
5042303|NCT02675231|17374059|P2|Overall Study|Withdrawal by Subject|3
5042304|NCT02675231|17374060|P1|Overall Study|Withdrawal by Subject|1
5042305|NCT02675075|17374096|P2|Overall Study|Lost to Follow-up|0
5042306|NCT02675075|17374097|P1|Overall Study|Lost to Follow-up|3
5042307|NCT02674854|17374109|P3|Overall Study|Subject missed V6.2|0
5042308|NCT02674854|17374110|P2|Overall Study|Subject missed V6.2|0
5042309|NCT02674854|17374111|P1|Overall Study|Subject missed V6.2|1
5042310|NCT02674854|17374109|P3|Overall Study|Death|0
5042311|NCT02674854|17374110|P2|Overall Study|Death|1
5042312|NCT02674854|17374111|P1|Overall Study|Death|0
5042313|NCT02674854|17374109|P3|Overall Study|Protocol Violation|2
5042314|NCT02674854|17374110|P2|Overall Study|Protocol Violation|1
5042315|NCT02674854|17374111|P1|Overall Study|Protocol Violation|1
5042316|NCT02674854|17374109|P3|Overall Study|Disallowed Concurrent Medication|0
5042317|NCT02674854|17374110|P2|Overall Study|Disallowed Concurrent Medication|2
5042318|NCT02674854|17374111|P1|Overall Study|Disallowed Concurrent Medication|2
5042319|NCT02674854|17374109|P3|Overall Study|Lack of Efficacy|0
5042320|NCT02674854|17374110|P2|Overall Study|Lack of Efficacy|3
5042321|NCT02674854|17374111|P1|Overall Study|Lack of Efficacy|0
5042322|NCT02674854|17374109|P3|Overall Study|Lost to Follow-up|2
5042323|NCT02674854|17374110|P2|Overall Study|Lost to Follow-up|0
5042324|NCT02674854|17374111|P1|Overall Study|Lost to Follow-up|1
5042325|NCT02674854|17374109|P3|Overall Study|No-compliant subject|1
5042326|NCT02674854|17374110|P2|Overall Study|No-compliant subject|0
5042327|NCT02674854|17374111|P1|Overall Study|No-compliant subject|1
5042328|NCT02674854|17374109|P3|Overall Study|Withdrawal by Subject|4
5042329|NCT02674854|17374110|P2|Overall Study|Withdrawal by Subject|5
5042330|NCT02674854|17374111|P1|Overall Study|Withdrawal by Subject|1
5042331|NCT02674854|17374109|P3|Overall Study|Adverse Event|5
5042332|NCT02674854|17374110|P2|Overall Study|Adverse Event|15
5042333|NCT02674854|17374111|P1|Overall Study|Adverse Event|17
5042334|NCT02674685|17374119|P1|Overall Study|Protocol Violation|4
5042335|NCT02674633|17374160|P2|Overall Study|Withdrawal by Parent/Guardian|2
5042336|NCT02674633|17374161|P1|Overall Study|Withdrawal by Parent/Guardian|1
5042337|NCT02674633|17374160|P2|Overall Study|Physician Decision|0
5042338|NCT02674633|17374161|P1|Overall Study|Physician Decision|1
5042339|NCT02674633|17374160|P2|Overall Study|Lost to Follow-up|2
5042340|NCT02674633|17374161|P1|Overall Study|Lost to Follow-up|3
5042341|NCT02674568|17374181|P1|Overall Study|Other, Not Specified|20
5042342|NCT02674568|17374181|P1|Overall Study|Lost to Follow-up|9
5042343|NCT02674568|17374181|P1|Overall Study|Physician Decision|2
5042344|NCT02674568|17374181|P1|Overall Study|Death|303
5042345|NCT02674568|17374181|P1|Overall Study|Withdrawal by Subject|5
5042346|NCT02674477|17374206|P2|Overall Study|Protocol Violation|2
5042347|NCT02674477|17374207|P1|Overall Study|Protocol Violation|8
5042348|NCT02674386|17374231|P3|Overall Study|Enrolled but not evaluated|0
5042349|NCT02674386|17374232|P2|Overall Study|Enrolled but not evaluated|4
5042350|NCT02674386|17374233|P1|Overall Study|Enrolled but not evaluated|0
5042351|NCT02674386|17374231|P3|Overall Study|Other|0
5042352|NCT02674386|17374232|P2|Overall Study|Other|1
5042353|NCT02674386|17374233|P1|Overall Study|Other|0
5042354|NCT02674386|17374231|P3|Overall Study|Withdrawal by Subject|0
5042355|NCT02674386|17374232|P2|Overall Study|Withdrawal by Subject|4
5042356|NCT02674386|17374233|P1|Overall Study|Withdrawal by Subject|0
5042357|NCT02674386|17374231|P3|Overall Study|Lost to Follow-up|1
5042358|NCT02674386|17374232|P2|Overall Study|Lost to Follow-up|1
5042359|NCT02674386|17374233|P1|Overall Study|Lost to Follow-up|0
5042360|NCT02674334|17374288|P2|Overall Study|NIRS not recording|0
5042361|NCT02674334|17374289|P1|Overall Study|NIRS not recording|1
5042362|NCT02674334|17374288|P2|Overall Study|participant difficulty breathing|0
5042363|NCT02674334|17374289|P1|Overall Study|participant difficulty breathing|1
5042364|NCT02674334|17374288|P2|Overall Study|Lost to Follow-up|3
5042365|NCT02674334|17374289|P1|Overall Study|Lost to Follow-up|5
5042366|NCT02674204|17374299|P2|Overall Study|Adverse Event|0
5042367|NCT02674204|17374300|P1|Overall Study|Adverse Event|1
5042368|NCT02674061|17374336|P2|Overall Study|Ongoing in Study|20
5042369|NCT02674061|17374337|P1|Overall Study|Ongoing in Study|71
5042370|NCT02674061|17374336|P2|Overall Study|Withdrawal by Subject|2
5042371|NCT02674061|17374337|P1|Overall Study|Withdrawal by Subject|9
5042372|NCT02674061|17374336|P2|Overall Study|Lost to Follow-up|0
5042373|NCT02674061|17374337|P1|Overall Study|Lost to Follow-up|1
5042374|NCT02674061|17374336|P2|Overall Study|Death|69
5042375|NCT02674061|17374337|P1|Overall Study|Death|204
5042376|NCT02673684|17374561|P2|Overall Study|Study not completed d/t loss of funding|8
5042377|NCT02673684|17374562|P1|Overall Study|Study not completed d/t loss of funding|9
5042378|NCT02673619|17374578|P4|Overall Study|Lack of Efficacy|0
5042379|NCT02673619|17374579|P3|Overall Study|Lack of Efficacy|1
5042380|NCT02673619|17374580|P2|Overall Study|Lack of Efficacy|0
5042381|NCT02673619|17374581|P1|Overall Study|Lack of Efficacy|0
5042382|NCT02673619|17374578|P4|Overall Study|Adverse Event|0
5042383|NCT02673619|17374579|P3|Overall Study|Adverse Event|1
5042384|NCT02673619|17374580|P2|Overall Study|Adverse Event|0
5042385|NCT02673619|17374581|P1|Overall Study|Adverse Event|0
5042386|NCT02673619|17374578|P4|Overall Study|Withdrawal by Subject|0
5042387|NCT02673619|17374579|P3|Overall Study|Withdrawal by Subject|1
5042388|NCT02673619|17374580|P2|Overall Study|Withdrawal by Subject|1
5042389|NCT02673619|17374581|P1|Overall Study|Withdrawal by Subject|1
5042390|NCT02673619|17374578|P4|Overall Study|Lost to Follow-up|0
5042391|NCT02673619|17374579|P3|Overall Study|Lost to Follow-up|0
5042392|NCT02673619|17374580|P2|Overall Study|Lost to Follow-up|0
5042393|NCT02673619|17374581|P1|Overall Study|Lost to Follow-up|1
5042394|NCT02673515|17374692|P2|Overall Study|Lack of motivation|1
5042395|NCT02673515|17374693|P1|Overall Study|Lack of motivation|2
5042396|NCT02673489|17374709|P2|Follow Up Period|Unable to return for follow-up|1
5042397|NCT02673489|17374710|P1|Follow Up Period|Unable to return for follow-up|0
5042398|NCT02673489|17374709|P2|Follow Up Period|Unable to return for week 24 follow-up|1
5042399|NCT02673489|17374710|P1|Follow Up Period|Unable to return for week 24 follow-up|0
5042400|NCT02673489|17374709|P2|Treatment Period|Adverse Event|1
5042401|NCT02673489|17374710|P1|Treatment Period|Adverse Event|0
5042402|NCT02673489|17374709|P2|Treatment Period|Participant was incarcerated|1
5042403|NCT02673489|17374710|P1|Treatment Period|Participant was incarcerated|0
5042404|NCT02673489|17374709|P2|Treatment Period|Participant moved to another province|0
5042405|NCT02673489|17374710|P1|Treatment Period|Participant moved to another province|1
5042406|NCT02673489|17374709|P2|Treatment Period|Participant request to discontinue|1
5042407|NCT02673489|17374710|P1|Treatment Period|Participant request to discontinue|1
5042408|NCT02673489|17374709|P2|Treatment Period|Lost to Follow-up|0
5042409|NCT02673489|17374710|P1|Treatment Period|Lost to Follow-up|3
5042410|NCT02672852|17374775|P7|Part B|Other|2
5042411|NCT02672852|17374776|P6|Part B|Other|1
5042412|NCT02672852|17374777|P5|Part B|Other|4
5042413|NCT02672852|17374778|P4|Part B|Other|0
5042414|NCT02672852|17374779|P3|Part B|Other|0
5042415|NCT02672852|17374780|P2|Part B|Other|0
5042416|NCT02672852|17374781|P1|Part B|Other|0
5042417|NCT02672852|17374775|P7|Part B|Withdrawal by Subject|7
5042418|NCT02672852|17374776|P6|Part B|Withdrawal by Subject|0
5042419|NCT02672852|17374777|P5|Part B|Withdrawal by Subject|5
5042420|NCT02672852|17374778|P4|Part B|Withdrawal by Subject|0
5042421|NCT02672852|17374779|P3|Part B|Withdrawal by Subject|0
5042422|NCT02672852|17374780|P2|Part B|Withdrawal by Subject|0
5042423|NCT02672852|17374781|P1|Part B|Withdrawal by Subject|0
5042424|NCT02672852|17374775|P7|Part B|Lost to Follow-up|1
5042425|NCT02672852|17374776|P6|Part B|Lost to Follow-up|4
5042426|NCT02672852|17374777|P5|Part B|Lost to Follow-up|3
5042427|NCT02672852|17374778|P4|Part B|Lost to Follow-up|0
5042428|NCT02672852|17374779|P3|Part B|Lost to Follow-up|0
5042429|NCT02672852|17374780|P2|Part B|Lost to Follow-up|0
5042430|NCT02672852|17374781|P1|Part B|Lost to Follow-up|0
5042431|NCT02672852|17374775|P7|Part B|Other adverse event|1
5042432|NCT02672852|17374776|P6|Part B|Other adverse event|5
5042433|NCT02672852|17374777|P5|Part B|Other adverse event|3
5042434|NCT02672852|17374778|P4|Part B|Other adverse event|0
5042435|NCT02672852|17374779|P3|Part B|Other adverse event|0
5042436|NCT02672852|17374780|P2|Part B|Other adverse event|0
5042437|NCT02672852|17374781|P1|Part B|Other adverse event|0
5042438|NCT02672852|17374775|P7|Part B|Worsening pre-existing condition|0
5042439|NCT02672852|17374776|P6|Part B|Worsening pre-existing condition|1
5042440|NCT02672852|17374777|P5|Part B|Worsening pre-existing condition|0
5042441|NCT02672852|17374778|P4|Part B|Worsening pre-existing condition|0
5042442|NCT02672852|17374779|P3|Part B|Worsening pre-existing condition|0
5042443|NCT02672852|17374780|P2|Part B|Worsening pre-existing condition|0
5042444|NCT02672852|17374781|P1|Part B|Worsening pre-existing condition|0
5042445|NCT02672852|17374775|P7|Part B|Disease worsening|1
5042446|NCT02672852|17374776|P6|Part B|Disease worsening|0
5042447|NCT02672852|17374777|P5|Part B|Disease worsening|1
5042448|NCT02672852|17374778|P4|Part B|Disease worsening|0
5042449|NCT02672852|17374779|P3|Part B|Disease worsening|0
5042450|NCT02672852|17374780|P2|Part B|Disease worsening|0
5042451|NCT02672852|17374781|P1|Part B|Disease worsening|0
5042452|NCT02672852|17374775|P7|Part A2|Not entered in Part B|0
5042453|NCT02672852|17374776|P6|Part A2|Not entered in Part B|0
5042454|NCT02672852|17374777|P5|Part A2|Not entered in Part B|0
5042455|NCT02672852|17374778|P4|Part A2|Not entered in Part B|4
5042456|NCT02672852|17374779|P3|Part A2|Not entered in Part B|0
5042457|NCT02672852|17374780|P2|Part A2|Not entered in Part B|0
5042458|NCT02672852|17374781|P1|Part A2|Not entered in Part B|0
5042459|NCT02672852|17374775|P7|Part A2|Other|0
5042460|NCT02672852|17374776|P6|Part A2|Other|0
5042461|NCT02672852|17374777|P5|Part A2|Other|0
5042462|NCT02672852|17374778|P4|Part A2|Other|0
5042463|NCT02672852|17374779|P3|Part A2|Other|3
5042464|NCT02672852|17374780|P2|Part A2|Other|0
5042465|NCT02672852|17374781|P1|Part A2|Other|0
5042466|NCT02672852|17374775|P7|Part A2|Withdrawal by Subject|0
5042467|NCT02672852|17374776|P6|Part A2|Withdrawal by Subject|0
5042468|NCT02672852|17374777|P5|Part A2|Withdrawal by Subject|0
5042469|NCT02672852|17374778|P4|Part A2|Withdrawal by Subject|0
5042470|NCT02672852|17374779|P3|Part A2|Withdrawal by Subject|1
5042471|NCT02672852|17374780|P2|Part A2|Withdrawal by Subject|0
5042472|NCT02672852|17374781|P1|Part A2|Withdrawal by Subject|0
5042473|NCT02672852|17374775|P7|Part A2|Lost to Follow-up|0
5042474|NCT02672852|17374776|P6|Part A2|Lost to Follow-up|0
5042475|NCT02672852|17374777|P5|Part A2|Lost to Follow-up|0
5042476|NCT02672852|17374778|P4|Part A2|Lost to Follow-up|0
5042477|NCT02672852|17374779|P3|Part A2|Lost to Follow-up|2
5042478|NCT02672852|17374780|P2|Part A2|Lost to Follow-up|0
5042479|NCT02672852|17374781|P1|Part A2|Lost to Follow-up|0
5042480|NCT02672852|17374775|P7|Part A2|Adverse Event|0
5042481|NCT02672852|17374776|P6|Part A2|Adverse Event|0
5042482|NCT02672852|17374777|P5|Part A2|Adverse Event|0
5042483|NCT02672852|17374778|P4|Part A2|Adverse Event|0
5042484|NCT02672852|17374779|P3|Part A2|Adverse Event|3
5042485|NCT02672852|17374780|P2|Part A2|Adverse Event|0
5042486|NCT02672852|17374781|P1|Part A2|Adverse Event|0
5042487|NCT02672852|17374775|P7|Part A2|Disease worsening|0
5042488|NCT02672852|17374776|P6|Part A2|Disease worsening|0
5042489|NCT02672852|17374777|P5|Part A2|Disease worsening|0
5042490|NCT02672852|17374778|P4|Part A2|Disease worsening|0
5042491|NCT02672852|17374779|P3|Part A2|Disease worsening|1
5042492|NCT02672852|17374780|P2|Part A2|Disease worsening|0
5042493|NCT02672852|17374781|P1|Part A2|Disease worsening|0
5042494|NCT02672852|17374775|P7|Part A1|Withdrawal by Subject|0
5042495|NCT02672852|17374776|P6|Part A1|Withdrawal by Subject|0
5042496|NCT02672852|17374777|P5|Part A1|Withdrawal by Subject|0
5042497|NCT02672852|17374778|P4|Part A1|Withdrawal by Subject|0
5042498|NCT02672852|17374779|P3|Part A1|Withdrawal by Subject|0
5042499|NCT02672852|17374780|P2|Part A1|Withdrawal by Subject|1
5042500|NCT02672852|17374781|P1|Part A1|Withdrawal by Subject|1
5042501|NCT02672852|17374775|P7|Part A1|Lost to Follow-up|0
5042502|NCT02672852|17374776|P6|Part A1|Lost to Follow-up|0
5042503|NCT02672852|17374777|P5|Part A1|Lost to Follow-up|0
5042504|NCT02672852|17374778|P4|Part A1|Lost to Follow-up|0
5042505|NCT02672852|17374779|P3|Part A1|Lost to Follow-up|0
5042506|NCT02672852|17374780|P2|Part A1|Lost to Follow-up|2
5042507|NCT02672852|17374781|P1|Part A1|Lost to Follow-up|1
5042508|NCT02672852|17374775|P7|Part A1|Adverse Event|0
5042509|NCT02672852|17374776|P6|Part A1|Adverse Event|0
5042510|NCT02672852|17374777|P5|Part A1|Adverse Event|0
5042511|NCT02672852|17374778|P4|Part A1|Adverse Event|0
5042512|NCT02672852|17374779|P3|Part A1|Adverse Event|0
5042513|NCT02672852|17374780|P2|Part A1|Adverse Event|1
5042514|NCT02672852|17374781|P1|Part A1|Adverse Event|0
5042515|NCT02672852|17374775|P7|Part A1|Disease Worsening|0
5042516|NCT02672852|17374776|P6|Part A1|Disease Worsening|0
5042517|NCT02672852|17374777|P5|Part A1|Disease Worsening|0
5042518|NCT02672852|17374778|P4|Part A1|Disease Worsening|0
5042519|NCT02672852|17374779|P3|Part A1|Disease Worsening|0
5042520|NCT02672852|17374780|P2|Part A1|Disease Worsening|0
5042521|NCT02672852|17374781|P1|Part A1|Disease Worsening|1
5042522|NCT02672553|17374812|P2|Overall Study|Intraoperative screen failure|0
5042523|NCT02672553|17374813|P1|Overall Study|Intraoperative screen failure|2
5042524|NCT02672553|17374812|P2|Overall Study|Withdrawal by Subject|3
5042525|NCT02672553|17374813|P1|Overall Study|Withdrawal by Subject|3
5042526|NCT02672553|17374812|P2|Overall Study|Conversion to Commercial Valve|0
5042527|NCT02672553|17374813|P1|Overall Study|Conversion to Commercial Valve|3
5042528|NCT02672553|17374812|P2|Overall Study|Valve Explant|0
5042529|NCT02672553|17374813|P1|Overall Study|Valve Explant|1
5042530|NCT02672553|17374812|P2|Overall Study|Death|5
5042531|NCT02672553|17374813|P1|Overall Study|Death|3
5042532|NCT02672423|17374885|P10|Period 3|Physician Decision|0
5042533|NCT02672423|17374886|P9|Period 3|Physician Decision|0
5042534|NCT02672423|17374887|P8|Period 3|Physician Decision|0
5042535|NCT02672423|17374888|P7|Period 3|Physician Decision|0
5042536|NCT02672423|17374889|P6|Period 3|Physician Decision|1
5042537|NCT02672423|17374890|P5|Period 3|Physician Decision|0
5042538|NCT02672423|17374891|P4|Period 3|Physician Decision|0
5042539|NCT02672423|17374892|P3|Period 3|Physician Decision|0
5042540|NCT02672423|17374893|P2|Period 3|Physician Decision|0
5042541|NCT02672423|17374894|P1|Period 3|Physician Decision|0
5042542|NCT02672423|17374885|P10|Period 3|Withdrawal by Subject|0
5042543|NCT02672423|17374886|P9|Period 3|Withdrawal by Subject|0
5042544|NCT02672423|17374887|P8|Period 3|Withdrawal by Subject|1
5042545|NCT02672423|17374888|P7|Period 3|Withdrawal by Subject|0
5042546|NCT02672423|17374889|P6|Period 3|Withdrawal by Subject|0
5042547|NCT02672423|17374890|P5|Period 3|Withdrawal by Subject|0
5042548|NCT02672423|17374891|P4|Period 3|Withdrawal by Subject|0
5042549|NCT02672423|17374892|P3|Period 3|Withdrawal by Subject|0
5042550|NCT02672423|17374893|P2|Period 3|Withdrawal by Subject|0
5042551|NCT02672423|17374894|P1|Period 3|Withdrawal by Subject|0
5042552|NCT02672423|17374885|P10|Period 2|Withdrawal by Subject|0
5042553|NCT02672423|17374886|P9|Period 2|Withdrawal by Subject|0
5042554|NCT02672423|17374887|P8|Period 2|Withdrawal by Subject|0
5042555|NCT02672423|17374888|P7|Period 2|Withdrawal by Subject|0
5042556|NCT02672423|17374889|P6|Period 2|Withdrawal by Subject|0
5042557|NCT02672423|17374890|P5|Period 2|Withdrawal by Subject|0
5042558|NCT02672423|17374891|P4|Period 2|Withdrawal by Subject|0
5042559|NCT02672423|17374892|P3|Period 2|Withdrawal by Subject|1
5042560|NCT02672423|17374893|P2|Period 2|Withdrawal by Subject|0
5042561|NCT02672423|17374894|P1|Period 2|Withdrawal by Subject|0
5042562|NCT02672423|17374885|P10|Period 1|Adverse Event|0
5042563|NCT02672423|17374886|P9|Period 1|Adverse Event|0
5042564|NCT02672423|17374887|P8|Period 1|Adverse Event|0
5042565|NCT02672423|17374888|P7|Period 1|Adverse Event|0
5042566|NCT02672423|17374889|P6|Period 1|Adverse Event|0
5042567|NCT02672423|17374890|P5|Period 1|Adverse Event|1
5042568|NCT02672423|17374891|P4|Period 1|Adverse Event|0
5042569|NCT02672423|17374892|P3|Period 1|Adverse Event|0
5042570|NCT02672423|17374893|P2|Period 1|Adverse Event|0
5042571|NCT02672423|17374894|P1|Period 1|Adverse Event|0
5042572|NCT02671760|17374989|P3|Overall Study|Lost to Follow-up|0
5042573|NCT02671760|17374990|P2|Overall Study|Lost to Follow-up|1
5042574|NCT02671760|17374991|P1|Overall Study|Lost to Follow-up|0
5042575|NCT02671500|17375017|P1|Overall Study|Lost to Follow-up|2
5042576|NCT02671500|17375017|P1|Overall Study|Lack of Efficacy|12
5042577|NCT02671461|17375032|P3|Follow-up|Administrative Reason by Sponsor|0
5042578|NCT02671461|17375033|P2|Follow-up|Administrative Reason by Sponsor|1
5042579|NCT02671461|17375034|P1|Follow-up|Administrative Reason by Sponsor|0
5042580|NCT02671461|17375032|P3|Follow-up|Lost to Follow-up|1
5042581|NCT02671461|17375033|P2|Follow-up|Lost to Follow-up|0
5042582|NCT02671461|17375034|P1|Follow-up|Lost to Follow-up|0
5042583|NCT02671461|17375032|P3|Follow-up|Withdrawal by Subject|0
5042584|NCT02671461|17375033|P2|Follow-up|Withdrawal by Subject|0
5042585|NCT02671461|17375034|P1|Follow-up|Withdrawal by Subject|1
5042586|NCT02671461|17375032|P3|Treatment|Randomized, not treated|0
5042587|NCT02671461|17375033|P2|Treatment|Randomized, not treated|0
5042588|NCT02671461|17375034|P1|Treatment|Randomized, not treated|1
5042589|NCT02671461|17375032|P3|Treatment|Administrative Reason by Sponsor|4
5042590|NCT02671461|17375033|P2|Treatment|Administrative Reason by Sponsor|3
5042591|NCT02671461|17375034|P1|Treatment|Administrative Reason by Sponsor|1
5042592|NCT02671461|17375032|P3|Treatment|Adverse Event|1
5042593|NCT02671461|17375033|P2|Treatment|Adverse Event|0
5042594|NCT02671461|17375034|P1|Treatment|Adverse Event|0
5042595|NCT02671422|17375057|P1|Overall Study|Other not defined above|3
5042596|NCT02671422|17375057|P1|Overall Study|Not treated with Vargatef®|3
5042597|NCT02671422|17375057|P1|Overall Study|Adverse Event unrelated to Vargatef®|8
5042598|NCT02671422|17375057|P1|Overall Study|Sponsor decision|5
5042599|NCT02671422|17375057|P1|Overall Study|Worsening of Disease|4
5042600|NCT02671422|17375057|P1|Overall Study|Progressive Disease|156
5042601|NCT02671422|17375057|P1|Overall Study|Withdrawal by Subject|7
5042602|NCT02671422|17375057|P1|Overall Study|Lost to Follow-up|4
5042603|NCT02671422|17375057|P1|Overall Study|Lack of Efficacy|1
5042604|NCT02671422|17375057|P1|Overall Study|Adverse Event|68
5042605|NCT02671422|17375057|P1|Overall Study|Lost to Follow-up|1
5042606|NCT02671266|17375063|P2|Overall Study|Withdrawal by Subject|1
5042607|NCT02671266|17375064|P1|Overall Study|Withdrawal by Subject|1
5042608|NCT02670928|17375095|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
5042609|NCT02670928|17375096|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
5042610|NCT02670928|17375095|P2|Overall Study|Lost to Follow-up|0
5042611|NCT02670928|17375096|P1|Overall Study|Lost to Follow-up|1
5042612|NCT02670928|17375095|P2|Overall Study|Withdrawal by Subject|0
5042613|NCT02670928|17375096|P1|Overall Study|Withdrawal by Subject|4
5042614|NCT02670928|17375095|P2|Overall Study|Adverse Event|1
5042615|NCT02670928|17375096|P1|Overall Study|Adverse Event|3
5042616|NCT02670915|17375123|P3|Overall Study|Unclassified|0
5042617|NCT02670915|17375124|P2|Overall Study|Unclassified|3
5042618|NCT02670915|17375125|P1|Overall Study|Unclassified|0
5042619|NCT02670915|17375123|P3|Overall Study|Withdrawal by parent/guardian|1
5042620|NCT02670915|17375124|P2|Overall Study|Withdrawal by parent/guardian|4
5042621|NCT02670915|17375125|P1|Overall Study|Withdrawal by parent/guardian|4
5042622|NCT02670915|17375123|P3|Overall Study|Withdrawal by Subject|4
5042623|NCT02670915|17375124|P2|Overall Study|Withdrawal by Subject|1
5042624|NCT02670915|17375125|P1|Overall Study|Withdrawal by Subject|0
5042625|NCT02670551|17375409|P3|Overall Study|Did Not Receive Treatment|0
5042626|NCT02670551|17375410|P2|Overall Study|Did Not Receive Treatment|3
5042627|NCT02670551|17375411|P1|Overall Study|Did Not Receive Treatment|5
5042628|NCT02670551|17375409|P3|Overall Study|Other Miscellaneous Reasons|3
5042629|NCT02670551|17375410|P2|Overall Study|Other Miscellaneous Reasons|3
5042630|NCT02670551|17375411|P1|Overall Study|Other Miscellaneous Reasons|2
5042631|NCT02670551|17375409|P3|Overall Study|Noncompliance with study drug|2
5042632|NCT02670551|17375410|P2|Overall Study|Noncompliance with study drug|3
5042633|NCT02670551|17375411|P1|Overall Study|Noncompliance with study drug|3
5042634|NCT02670551|17375409|P3|Overall Study|Protocol Violation|0
5042635|NCT02670551|17375410|P2|Overall Study|Protocol Violation|0
5042636|NCT02670551|17375411|P1|Overall Study|Protocol Violation|1
5042637|NCT02670551|17375409|P3|Overall Study|Lost to Follow-up|6
5042638|NCT02670551|17375410|P2|Overall Study|Lost to Follow-up|7
5042639|NCT02670551|17375411|P1|Overall Study|Lost to Follow-up|5
5042640|NCT02670551|17375409|P3|Overall Study|Withdrawal of Consent|8
5042641|NCT02670551|17375410|P2|Overall Study|Withdrawal of Consent|3
5042642|NCT02670551|17375411|P1|Overall Study|Withdrawal of Consent|6
5042643|NCT02670551|17375409|P3|Overall Study|Lack of Efficacy|3
5042644|NCT02670551|17375410|P2|Overall Study|Lack of Efficacy|0
5042645|NCT02670551|17375411|P1|Overall Study|Lack of Efficacy|2
5042646|NCT02670551|17375409|P3|Overall Study|Adverse Event|9
5042647|NCT02670551|17375410|P2|Overall Study|Adverse Event|7
5042648|NCT02670551|17375411|P1|Overall Study|Adverse Event|4
5042649|NCT02670538|17375425|P3|Overall Study|Other Miscellaneous Reasons|2
5042650|NCT02670538|17375426|P2|Overall Study|Other Miscellaneous Reasons|1
5042651|NCT02670538|17375427|P1|Overall Study|Other Miscellaneous Reasons|0
5042652|NCT02670538|17375425|P3|Overall Study|Noncompliance with Study Drug|2
5042653|NCT02670538|17375426|P2|Overall Study|Noncompliance with Study Drug|3
5042654|NCT02670538|17375427|P1|Overall Study|Noncompliance with Study Drug|1
5042655|NCT02670538|17375425|P3|Overall Study|Protocol Violation|1
5042656|NCT02670538|17375426|P2|Overall Study|Protocol Violation|4
5042657|NCT02670538|17375427|P1|Overall Study|Protocol Violation|3
5042658|NCT02670538|17375425|P3|Overall Study|Lack of Efficacy|2
5042659|NCT02670538|17375426|P2|Overall Study|Lack of Efficacy|1
5042660|NCT02670538|17375427|P1|Overall Study|Lack of Efficacy|7
5042661|NCT02670538|17375425|P3|Overall Study|Adverse Event|11
5042662|NCT02670538|17375426|P2|Overall Study|Adverse Event|5
5042663|NCT02670538|17375427|P1|Overall Study|Adverse Event|5
5042664|NCT02670538|17375425|P3|Overall Study|Lost to Follow-up|7
5042665|NCT02670538|17375426|P2|Overall Study|Lost to Follow-up|12
5042666|NCT02670538|17375427|P1|Overall Study|Lost to Follow-up|8
5042667|NCT02670538|17375425|P3|Overall Study|Withdrawal of Consent|5
5042668|NCT02670538|17375426|P2|Overall Study|Withdrawal of Consent|6
5042669|NCT02670538|17375427|P1|Overall Study|Withdrawal of Consent|8
5042670|NCT02670473|17375438|P1|Overall Study|Withdrawal by Subject|1
5042671|NCT02670330|17375497|P2|Overall Study|Lost to Follow-up|2
5042672|NCT02670330|17375498|P1|Overall Study|Lost to Follow-up|3
5042673|NCT02670330|17375497|P2|Overall Study|Withdrawal by Subject|29
5042674|NCT02670330|17375498|P1|Overall Study|Withdrawal by Subject|34
5042675|NCT02670330|17375497|P2|Overall Study|Adverse Event|3
5042676|NCT02670330|17375498|P1|Overall Study|Adverse Event|1
5042677|NCT02670330|17375497|P2|Overall Study|Study Terminated By Sponsor|43
5042678|NCT02670330|17375498|P1|Overall Study|Study Terminated By Sponsor|36
5042679|NCT02670330|17375497|P2|Overall Study|Protocol Deviation|0
5042680|NCT02670330|17375498|P1|Overall Study|Protocol Deviation|1
5042681|NCT02670083|17375510|P2|Overall Study|Non-Compliance With Study Drug|0
5042682|NCT02670083|17375511|P1|Overall Study|Non-Compliance With Study Drug|1
5042683|NCT02670083|17375510|P2|Overall Study|Withdrawal by Subject|31
5042684|NCT02670083|17375511|P1|Overall Study|Withdrawal by Subject|32
5042685|NCT02670083|17375510|P2|Overall Study|Symptomatic Deterioration|2
5042686|NCT02670083|17375511|P1|Overall Study|Symptomatic Deterioration|0
5042687|NCT02670083|17375510|P2|Overall Study|Study Terminated By Sponsor|254
5042688|NCT02670083|17375511|P1|Overall Study|Study Terminated By Sponsor|257
5042689|NCT02670083|17375510|P2|Overall Study|Physician Decision|2
5042690|NCT02670083|17375511|P1|Overall Study|Physician Decision|0
5042691|NCT02670083|17375510|P2|Overall Study|Multiple Reasons|9
5042692|NCT02670083|17375511|P1|Overall Study|Multiple Reasons|9
5042693|NCT02670083|17375510|P2|Overall Study|Lost to Follow-up|2
5042694|NCT02670083|17375511|P1|Overall Study|Lost to Follow-up|2
5042695|NCT02670083|17375510|P2|Overall Study|Death|6
5042696|NCT02670083|17375511|P1|Overall Study|Death|4
5042697|NCT02670083|17375510|P2|Overall Study|Adverse Event|13
5042698|NCT02670083|17375511|P1|Overall Study|Adverse Event|16
5042699|NCT02669940|17375556|P2|Overall Study|Insufficient follow-up data|0
5042700|NCT02669940|17375557|P1|Overall Study|Insufficient follow-up data|1
5042701|NCT02669940|17375556|P2|Overall Study|Failure to return|3
5042702|NCT02669940|17375557|P1|Overall Study|Failure to return|0
5042703|NCT02669862|17375659|P3|Overall Study|Protocol Violation|1
5042704|NCT02669862|17375660|P2|Overall Study|Protocol Violation|0
5042705|NCT02669862|17375661|P1|Overall Study|Protocol Violation|0
5042706|NCT02669862|17375659|P3|Overall Study|moved|0
5042707|NCT02669862|17375660|P2|Overall Study|moved|1
5042708|NCT02669862|17375661|P1|Overall Study|moved|0
5042709|NCT02669862|17375659|P3|Overall Study|Withdrawal by Subject|3
5042710|NCT02669862|17375660|P2|Overall Study|Withdrawal by Subject|2
5042711|NCT02669862|17375661|P1|Overall Study|Withdrawal by Subject|2
5042712|NCT02669862|17375659|P3|Overall Study|Lost to Follow-up|1
5042713|NCT02669862|17375660|P2|Overall Study|Lost to Follow-up|2
5042714|NCT02669862|17375661|P1|Overall Study|Lost to Follow-up|0
5042715|NCT02669849|17375677|P3|Overall Study|Other|2
5042716|NCT02669849|17375678|P2|Overall Study|Other|0
5042717|NCT02669849|17375679|P1|Overall Study|Other|0
5042718|NCT02669849|17375677|P3|Overall Study|Study terminated by sponsor|14
5042719|NCT02669849|17375678|P2|Overall Study|Study terminated by sponsor|1
5042720|NCT02669849|17375679|P1|Overall Study|Study terminated by sponsor|16
5042721|NCT02669849|17375677|P3|Overall Study|Death|2
5042722|NCT02669849|17375678|P2|Overall Study|Death|1
5042723|NCT02669849|17375679|P1|Overall Study|Death|1
5042724|NCT02669849|17375677|P3|Overall Study|Lost to Follow-up|3
5042725|NCT02669849|17375678|P2|Overall Study|Lost to Follow-up|0
5042726|NCT02669849|17375679|P1|Overall Study|Lost to Follow-up|1
5042727|NCT02669849|17375677|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
5042728|NCT02669849|17375678|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
5042729|NCT02669849|17375679|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
5042730|NCT02669758|17375722|P1|Overall Study|Protocol Violation|1
5042731|NCT02669758|17375722|P1|Overall Study|Study noncompliance|1
5042732|NCT02669758|17375722|P1|Overall Study|Pregnancy|1
5042733|NCT02669758|17375722|P1|Overall Study|Lack of Efficacy|5
5042734|NCT02669758|17375722|P1|Overall Study|Non-Compliance with Study Drug|8
5042735|NCT02669758|17375722|P1|Overall Study|Adverse Event|16
5042736|NCT02669758|17375722|P1|Overall Study|Lost to Follow-up|19
5042737|NCT02669758|17375722|P1|Overall Study|Withdrawal by Subject|43
5042738|NCT02669667|17375733|P7|Overall Study|Lost to Follow-up|0
5042739|NCT02669667|17375734|P6|Overall Study|Lost to Follow-up|1
5042740|NCT02669667|17375735|P5|Overall Study|Lost to Follow-up|0
5042741|NCT02669667|17375736|P4|Overall Study|Lost to Follow-up|0
5042742|NCT02669667|17375737|P3|Overall Study|Lost to Follow-up|0
5042743|NCT02669667|17375738|P2|Overall Study|Lost to Follow-up|0
5042744|NCT02669667|17375739|P1|Overall Study|Lost to Follow-up|0
5042745|NCT02669433|17375842|P3|Overall Study|Death|1
5042746|NCT02669433|17375843|P2|Overall Study|Death|1
5042747|NCT02669433|17375844|P1|Overall Study|Death|0
5042748|NCT02669433|17375842|P3|Overall Study|Withdrawal by Caregiver|2
5042749|NCT02669433|17375843|P2|Overall Study|Withdrawal by Caregiver|0
5042750|NCT02669433|17375844|P1|Overall Study|Withdrawal by Caregiver|1
5042751|NCT02669433|17375842|P3|Overall Study|Withdrawal by Subject|0
5042752|NCT02669433|17375843|P2|Overall Study|Withdrawal by Subject|1
5042753|NCT02669433|17375844|P1|Overall Study|Withdrawal by Subject|5
5042754|NCT02669433|17375842|P3|Overall Study|Sponsor Termination|1
5042755|NCT02669433|17375843|P2|Overall Study|Sponsor Termination|0
5042756|NCT02669433|17375844|P1|Overall Study|Sponsor Termination|1
5042757|NCT02669433|17375842|P3|Overall Study|Adverse Event|10
5042758|NCT02669433|17375843|P2|Overall Study|Adverse Event|7
5042759|NCT02669433|17375844|P1|Overall Study|Adverse Event|6
5042760|NCT02669433|17375842|P3|Overall Study|Physician Decision|0
5042761|NCT02669433|17375843|P2|Overall Study|Physician Decision|1
5042762|NCT02669433|17375844|P1|Overall Study|Physician Decision|1
5042763|NCT02669433|17375842|P3|Overall Study|Disease Progression|0
5042764|NCT02669433|17375843|P2|Overall Study|Disease Progression|0
5042765|NCT02669433|17375844|P1|Overall Study|Disease Progression|1
5042766|NCT02669433|17375842|P3|Overall Study|Protocol Violation|1
5042767|NCT02669433|17375843|P2|Overall Study|Protocol Violation|4
5042768|NCT02669433|17375844|P1|Overall Study|Protocol Violation|0
5042769|NCT02669407|17375858|P1|Overall Study|Physician Decision|3
5042770|NCT02669264|17375887|P7|Overall Study|Miscellaneous|2
5042771|NCT02669264|17375888|P6|Overall Study|Miscellaneous|0
5042772|NCT02669264|17375889|P5|Overall Study|Miscellaneous|0
5042773|NCT02669264|17375890|P4|Overall Study|Miscellaneous|0
5042774|NCT02669264|17375891|P3|Overall Study|Miscellaneous|0
5042775|NCT02669264|17375892|P2|Overall Study|Miscellaneous|0
5042776|NCT02669264|17375893|P1|Overall Study|Miscellaneous|0
5042777|NCT02669264|17375887|P7|Overall Study|Lost to Follow-up|0
5042778|NCT02669264|17375888|P6|Overall Study|Lost to Follow-up|0
5042779|NCT02669264|17375889|P5|Overall Study|Lost to Follow-up|1
5042780|NCT02669264|17375890|P4|Overall Study|Lost to Follow-up|0
5042781|NCT02669264|17375891|P3|Overall Study|Lost to Follow-up|0
5042782|NCT02669264|17375892|P2|Overall Study|Lost to Follow-up|0
5042783|NCT02669264|17375893|P1|Overall Study|Lost to Follow-up|0
5042784|NCT02669264|17375887|P7|Overall Study|Withdrawal by Subject|0
5042785|NCT02669264|17375888|P6|Overall Study|Withdrawal by Subject|0
5042786|NCT02669264|17375889|P5|Overall Study|Withdrawal by Subject|1
5042787|NCT02669264|17375890|P4|Overall Study|Withdrawal by Subject|0
5042788|NCT02669264|17375891|P3|Overall Study|Withdrawal by Subject|0
5042789|NCT02669264|17375892|P2|Overall Study|Withdrawal by Subject|1
5042790|NCT02669264|17375893|P1|Overall Study|Withdrawal by Subject|0
5042791|NCT02669264|17375887|P7|Overall Study|Death|3
5042792|NCT02669264|17375888|P6|Overall Study|Death|6
5042793|NCT02669264|17375889|P5|Overall Study|Death|3
5042794|NCT02669264|17375890|P4|Overall Study|Death|3
5042795|NCT02669264|17375891|P3|Overall Study|Death|3
5042796|NCT02669264|17375892|P2|Overall Study|Death|5
5042797|NCT02669264|17375893|P1|Overall Study|Death|5
5042798|NCT02669095|17376039|P2|Overall Study|Visit 5 assessments not completed|1
5042799|NCT02669095|17376040|P1|Overall Study|Visit 5 assessments not completed|0
5042800|NCT02669095|17376039|P2|Overall Study|Torn Lens|1
5042801|NCT02669095|17376040|P1|Overall Study|Torn Lens|0
5042802|NCT02669095|17376039|P2|Overall Study|Unsatisfactory Lens Fitting|1
5042803|NCT02669095|17376040|P1|Overall Study|Unsatisfactory Lens Fitting|0
5042804|NCT02669095|17376039|P2|Overall Study|Adverse Event|0
5042805|NCT02669095|17376040|P1|Overall Study|Adverse Event|1
5042806|NCT02669082|17376048|P1|Overall Study|Adverse Event|1
5042807|NCT02669043|17376060|P1|Overall Study|Didn't meet I/E criteria|4
5042808|NCT02669017|17376073|P9|Overall Study|Miscellaneous|2
5042809|NCT02669017|17376074|P8|Overall Study|Miscellaneous|13
5042810|NCT02669017|17376075|P7|Overall Study|Miscellaneous|1
5042811|NCT02669017|17376076|P6|Overall Study|Miscellaneous|1
5042812|NCT02669017|17376077|P5|Overall Study|Miscellaneous|2
5042813|NCT02669017|17376078|P4|Overall Study|Miscellaneous|0
5042814|NCT02669017|17376079|P3|Overall Study|Miscellaneous|0
5042815|NCT02669017|17376080|P2|Overall Study|Miscellaneous|0
5042816|NCT02669017|17376081|P1|Overall Study|Miscellaneous|0
5042817|NCT02669017|17376073|P9|Overall Study|Lost to Follow-up|1
5042818|NCT02669017|17376074|P8|Overall Study|Lost to Follow-up|0
5042819|NCT02669017|17376075|P7|Overall Study|Lost to Follow-up|0
5042820|NCT02669017|17376076|P6|Overall Study|Lost to Follow-up|0
5042821|NCT02669017|17376077|P5|Overall Study|Lost to Follow-up|0
5042822|NCT02669017|17376078|P4|Overall Study|Lost to Follow-up|0
5042823|NCT02669017|17376079|P3|Overall Study|Lost to Follow-up|0
5042824|NCT02669017|17376080|P2|Overall Study|Lost to Follow-up|0
5042825|NCT02669017|17376081|P1|Overall Study|Lost to Follow-up|0
5042826|NCT02669017|17376073|P9|Overall Study|Withdrawal by Subject|2
5042827|NCT02669017|17376074|P8|Overall Study|Withdrawal by Subject|2
5042828|NCT02669017|17376075|P7|Overall Study|Withdrawal by Subject|0
5042829|NCT02669017|17376076|P6|Overall Study|Withdrawal by Subject|0
5042830|NCT02669017|17376077|P5|Overall Study|Withdrawal by Subject|2
5042831|NCT02669017|17376078|P4|Overall Study|Withdrawal by Subject|1
5042832|NCT02669017|17376079|P3|Overall Study|Withdrawal by Subject|0
5042833|NCT02669017|17376080|P2|Overall Study|Withdrawal by Subject|0
5042834|NCT02669017|17376081|P1|Overall Study|Withdrawal by Subject|0
5042835|NCT02669017|17376073|P9|Overall Study|Death|20
5042836|NCT02669017|17376074|P8|Overall Study|Death|47
5042837|NCT02669017|17376075|P7|Overall Study|Death|10
5042838|NCT02669017|17376076|P6|Overall Study|Death|18
5042839|NCT02669017|17376077|P5|Overall Study|Death|8
5042840|NCT02669017|17376078|P4|Overall Study|Death|3
5042841|NCT02669017|17376079|P3|Overall Study|Death|2
5042842|NCT02669017|17376080|P2|Overall Study|Death|2
5042843|NCT02669017|17376081|P1|Overall Study|Death|1
5042844|NCT02668822|17376226|P2|Overall Study|Study Terminated by Sponsor|9
5042845|NCT02668822|17376227|P1|Overall Study|Study Terminated by Sponsor|7
5042846|NCT02668822|17376226|P2|Overall Study|Protocol Violation|0
5042847|NCT02668822|17376227|P1|Overall Study|Protocol Violation|2
5042848|NCT02668783|17376249|P2|Overall Study|Withdrawal by Subject|0
5042849|NCT02668783|17376250|P1|Overall Study|Withdrawal by Subject|1
5042850|NCT02668783|17376249|P2|Overall Study|Subject moved|0
5042851|NCT02668783|17376250|P1|Overall Study|Subject moved|1
5042852|NCT02668783|17376249|P2|Overall Study|Study terminated by sponsor|10
5042853|NCT02668783|17376250|P1|Overall Study|Study terminated by sponsor|9
5042854|NCT02668783|17376249|P2|Overall Study|Protocol Violation|1
5042855|NCT02668783|17376250|P1|Overall Study|Protocol Violation|2
5042856|NCT02668783|17376249|P2|Overall Study|Pregnancy|1
5042857|NCT02668783|17376250|P1|Overall Study|Pregnancy|0
5042858|NCT02668640|17376270|P1|Overall Study|Other, not specified|1
5042859|NCT02668640|17376270|P1|Overall Study|Lost to Follow-up|13
5042860|NCT02668302|17376322|P2|Overall Study|Withdrawal by Subject|0
5042861|NCT02668302|17376323|P1|Overall Study|Withdrawal by Subject|1
5042862|NCT02667912|17376362|P2|Overall Study|Withdrawal by Subject|0
5042863|NCT02667912|17376363|P1|Overall Study|Withdrawal by Subject|1
5042864|NCT02667912|17376362|P2|Overall Study|Withdrawal by Subject|2
5042865|NCT02667912|17376363|P1|Overall Study|Withdrawal by Subject|1
5042866|NCT02667912|17376362|P2|Overall Study|Death|1
5042867|NCT02667912|17376363|P1|Overall Study|Death|3
5042868|NCT02667626|17376463|P2|Overall Study|Withdrawal by Subject|1
5042869|NCT02667626|17376464|P1|Overall Study|Withdrawal by Subject|0
5042870|NCT02667457|17376480|P2|Overall Study|Other Reason|2
5042871|NCT02667457|17376481|P1|Overall Study|Other Reason|0
5042872|NCT02667457|17376480|P2|Overall Study|Withdrawal by Subject|0
5042873|NCT02667457|17376481|P1|Overall Study|Withdrawal by Subject|1
5042874|NCT02667288|17376505|P1|Overall Study|Withdrawal by Subject|5
5042875|NCT02667288|17376505|P1|Overall Study|Lost to Follow-up|3
5042876|NCT02667288|17376505|P1|Overall Study|Protocol Violation|5
5042877|NCT02667275|17376512|P2|Overall Study|Discontinued early without completing|1
5042878|NCT02667275|17376513|P1|Overall Study|Discontinued early without completing|0
5042879|NCT02667275|17376512|P2|Overall Study|Withdrawal by Subject|5
5042880|NCT02667275|17376513|P1|Overall Study|Withdrawal by Subject|0
5042881|NCT02667275|17376512|P2|Overall Study|Lost to Follow-up|2
5042882|NCT02667275|17376513|P1|Overall Study|Lost to Follow-up|0
5042883|NCT02667275|17376512|P2|Overall Study|Protocol Violation|7
5042884|NCT02667275|17376513|P1|Overall Study|Protocol Violation|11
5042885|NCT02667236|17376523|P2|Overall Study|Withdrawal by Subject|0
5042886|NCT02667236|17376524|P1|Overall Study|Withdrawal by Subject|2
5042887|NCT02667236|17376523|P2|Overall Study|Adverse Event|1
5042888|NCT02667236|17376524|P1|Overall Study|Adverse Event|1
5042889|NCT02666664|17376646|P2|Overall Study|Lost to Follow-up|2
5042890|NCT02666664|17376647|P1|Overall Study|Lost to Follow-up|1
5042891|NCT02666664|17376646|P2|Overall Study|Sponsor decision|1
5042892|NCT02666664|17376647|P1|Overall Study|Sponsor decision|0
5042893|NCT02666664|17376646|P2|Overall Study|Withdrawal by participant|40
5042894|NCT02666664|17376647|P1|Overall Study|Withdrawal by participant|23
5042895|NCT02666664|17376646|P2|Overall Study|Adverse Event|37
5042896|NCT02666664|17376647|P1|Overall Study|Adverse Event|12
5042897|NCT02666664|17376646|P2|Overall Study|Other|1
5042898|NCT02666664|17376647|P1|Overall Study|Other|0
5042899|NCT02666664|17376646|P2|Overall Study|Protocol Violation|2
5042900|NCT02666664|17376647|P1|Overall Study|Protocol Violation|0
5042901|NCT02666664|17376646|P2|Overall Study|Physician Decision|1
5042902|NCT02666664|17376647|P1|Overall Study|Physician Decision|0
5042903|NCT02666430|17376730|P2|Period 3|Lost to Follow-up|0
5042904|NCT02666430|17376731|P1|Period 3|Lost to Follow-up|1
5042905|NCT02666430|17376730|P2|Period 2|Withdrawal by Subject|4
5042906|NCT02666430|17376731|P1|Period 2|Withdrawal by Subject|1
5042907|NCT02666430|17376730|P2|Period 1|Adverse Event|1
5042908|NCT02666430|17376731|P1|Period 1|Adverse Event|0
5042909|NCT02666430|17376730|P2|Period 1|Lost to Follow-up|0
5042910|NCT02666430|17376731|P1|Period 1|Lost to Follow-up|1
5042911|NCT02666222|17376866|P1|Overall Study|Death|2
5042912|NCT02665689|17376902|P2|Overall Study|Lost to Follow-up|1
5042913|NCT02665689|17376903|P1|Overall Study|Lost to Follow-up|0
5042914|NCT02665689|17376902|P2|Overall Study|Trial termination|1
5042915|NCT02665689|17376903|P1|Overall Study|Trial termination|1
5042916|NCT02665689|17376902|P2|Overall Study|Adverse Event|0
5042917|NCT02665689|17376903|P1|Overall Study|Adverse Event|1
5042918|NCT02665455|17376938|P1|Overall Study|Protocol Violation|1
5042919|NCT02665455|17376938|P1|Overall Study|Adverse Event|1
5042920|NCT02665455|17376938|P1|Overall Study|Lost to Follow-up|1
5042921|NCT02665455|17376938|P1|Overall Study|Withdrawal by Subject|6
5042922|NCT02665286|17376982|P3|Overall Study|Lost to Follow-up|1
5042923|NCT02665286|17376983|P2|Overall Study|Lost to Follow-up|2
5042924|NCT02665286|17376984|P1|Overall Study|Lost to Follow-up|3
5042925|NCT02664415|17377135|P2|Overall Study|Adverse Event|0
5042926|NCT02664415|17377136|P1|Overall Study|Adverse Event|1
5042927|NCT02664272|17377182|P1|Overall Study|Fluoroscopic images not made available|2
5042928|NCT02663817|17377203|P1|Overall Study|Screen failure|2
5042929|NCT02663687|17377223|P5|Overall Study|Other|0
5042930|NCT02663687|17377224|P4|Overall Study|Other|0
5042931|NCT02663687|17377225|P3|Overall Study|Other|1
5042932|NCT02663687|17377226|P2|Overall Study|Other|0
5042933|NCT02663687|17377227|P1|Overall Study|Other|1
5042934|NCT02663687|17377223|P5|Overall Study|Adverse Event|0
5042935|NCT02663687|17377224|P4|Overall Study|Adverse Event|0
5042936|NCT02663687|17377225|P3|Overall Study|Adverse Event|0
5042937|NCT02663687|17377226|P2|Overall Study|Adverse Event|0
5042938|NCT02663687|17377227|P1|Overall Study|Adverse Event|1
5042939|NCT02663674|17377281|P2|Overall Study|Other Event (Health Related)|1
5042940|NCT02663674|17377282|P1|Overall Study|Other Event (Health Related)|0
5042941|NCT02663674|17377281|P2|Overall Study|Physician Decision|1
5042942|NCT02663674|17377282|P1|Overall Study|Physician Decision|1
5042943|NCT02663674|17377281|P2|Overall Study|Withdrawal by Subject|4
5042944|NCT02663674|17377282|P1|Overall Study|Withdrawal by Subject|1
5042945|NCT02663674|17377281|P2|Overall Study|Lost to Follow-up|4
5042946|NCT02663674|17377282|P1|Overall Study|Lost to Follow-up|5
5042947|NCT02663453|17377546|P2|Overall Study|Withdrawal by Subject|0
5042948|NCT02663453|17377547|P1|Overall Study|Withdrawal by Subject|1
5042949|NCT02663453|17377546|P2|Overall Study|Death|4
5042950|NCT02663453|17377547|P1|Overall Study|Death|4
5042951|NCT02663128|17377592|P6|Period 2|Physician Decision|0
5042952|NCT02663128|17377593|P5|Period 2|Physician Decision|1
5042953|NCT02663128|17377594|P4|Period 2|Physician Decision|0
5042954|NCT02663128|17377595|P3|Period 2|Physician Decision|0
5042955|NCT02663128|17377596|P2|Period 2|Physician Decision|0
5042956|NCT02663128|17377597|P1|Period 2|Physician Decision|0
5042957|NCT02662764|17377611|P1|Overall Study|Patient discharged prior to 24 hrs|5
5042958|NCT02662764|17377611|P1|Overall Study|Patient changed treatment|1
5042959|NCT02662764|17377611|P1|Overall Study|Device failure|4
5042960|NCT02662764|17377611|P1|Overall Study|Withdrawal by Subject|5
5042961|NCT02662764|17377611|P1|Overall Study|Protocol Violation|1
5042962|NCT02662764|17377611|P1|Overall Study|Lack of Efficacy|8
5042963|NCT02662764|17377611|P1|Overall Study|Adverse Event|6
5042964|NCT02662569|17377679|P4|Overall Study|Lost to Follow-up|0
5042965|NCT02662569|17377680|P3|Overall Study|Lost to Follow-up|0
5042966|NCT02662569|17377681|P2|Overall Study|Lost to Follow-up|0
5042967|NCT02662569|17377682|P1|Overall Study|Lost to Follow-up|1
5042968|NCT02662569|17377679|P4|Overall Study|Withdrawal by Subject|4
5042969|NCT02662569|17377680|P3|Overall Study|Withdrawal by Subject|6
5042970|NCT02662569|17377681|P2|Overall Study|Withdrawal by Subject|1
5042971|NCT02662569|17377682|P1|Overall Study|Withdrawal by Subject|6
5042972|NCT02662556|17377780|P1|Overall Study|Lack of Efficacy|4
5042973|NCT02662556|17377780|P1|Overall Study|Adverse Event|4
5042974|NCT02661815|17377849|P4|Overall Study|Withdrawal by Subject|0
5042975|NCT02661815|17377850|P3|Overall Study|Withdrawal by Subject|0
5042976|NCT02661815|17377851|P2|Overall Study|Withdrawal by Subject|0
5042977|NCT02661815|17377852|P1|Overall Study|Withdrawal by Subject|1
5042978|NCT02661594|17377874|P4|Overall Study|Protocol Violation|0
5042979|NCT02661594|17377875|P3|Overall Study|Protocol Violation|1
5042980|NCT02661594|17377876|P2|Overall Study|Protocol Violation|0
5042981|NCT02661594|17377877|P1|Overall Study|Protocol Violation|1
5042982|NCT02661490|17377892|P5|Overall Study|Reason not Specified|1
5042983|NCT02661490|17377893|P4|Overall Study|Reason not Specified|0
5042984|NCT02661490|17377894|P3|Overall Study|Reason not Specified|0
5042985|NCT02661490|17377895|P2|Overall Study|Reason not Specified|0
5042986|NCT02661490|17377896|P1|Overall Study|Reason not Specified|0
5042987|NCT02661490|17377892|P5|Overall Study|Death|0
5042988|NCT02661490|17377893|P4|Overall Study|Death|1
5042989|NCT02661490|17377894|P3|Overall Study|Death|0
5042990|NCT02661490|17377895|P2|Overall Study|Death|1
5042991|NCT02661490|17377896|P1|Overall Study|Death|1
5042992|NCT02661490|17377892|P5|Overall Study|Withdrawal by Subject|0
5042993|NCT02661490|17377893|P4|Overall Study|Withdrawal by Subject|0
5042994|NCT02661490|17377894|P3|Overall Study|Withdrawal by Subject|2
5042995|NCT02661490|17377895|P2|Overall Study|Withdrawal by Subject|0
5042996|NCT02661490|17377896|P1|Overall Study|Withdrawal by Subject|2
5042997|NCT02661490|17377892|P5|Overall Study|Lost to Follow-up|2
5042998|NCT02661490|17377893|P4|Overall Study|Lost to Follow-up|0
5042999|NCT02661490|17377894|P3|Overall Study|Lost to Follow-up|0
5043000|NCT02661490|17377895|P2|Overall Study|Lost to Follow-up|1
5043001|NCT02661490|17377896|P1|Overall Study|Lost to Follow-up|0
5043002|NCT02661178|17378064|P15|Part 1|Protocol Violation|0
5043003|NCT02661178|17378065|P14|Part 1|Protocol Violation|0
5043004|NCT02661178|17378066|P13|Part 1|Protocol Violation|0
5043005|NCT02661178|17378067|P12|Part 1|Protocol Violation|0
5043006|NCT02661178|17378068|P11|Part 1|Protocol Violation|0
5043007|NCT02661178|17378069|P10|Part 1|Protocol Violation|0
5043008|NCT02661178|17378070|P9|Part 1|Protocol Violation|0
5043009|NCT02661178|17378071|P8|Part 1|Protocol Violation|0
5043010|NCT02661178|17378072|P7|Part 1|Protocol Violation|0
5043011|NCT02661178|17378073|P6|Part 1|Protocol Violation|0
5043012|NCT02661178|17378074|P5|Part 1|Protocol Violation|0
5043013|NCT02661178|17378075|P4|Part 1|Protocol Violation|0
5043014|NCT02661178|17378076|P3|Part 1|Protocol Violation|0
5043015|NCT02661178|17378077|P2|Part 1|Protocol Violation|0
5043016|NCT02661178|17378078|P1|Part 1|Protocol Violation|1
5043017|NCT02661061|17378436|P2|Overall Study|Withdrawal by Subject|1
5043018|NCT02661061|17378437|P1|Overall Study|Withdrawal by Subject|1
5043019|NCT02661061|17378436|P2|Overall Study|Lack of Efficacy|1
5043020|NCT02661061|17378437|P1|Overall Study|Lack of Efficacy|1
5043021|NCT02660983|17378447|P2|Open Label Extension Phase (24 Weeks)|Other|1
5043022|NCT02660983|17378448|P1|Open Label Extension Phase (24 Weeks)|Other|0
5043023|NCT02660983|17378447|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
5043024|NCT02660983|17378448|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
5043025|NCT02660983|17378447|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
5043026|NCT02660983|17378448|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
5043027|NCT02660983|17378447|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
5043028|NCT02660983|17378448|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
5043029|NCT02660983|17378447|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
5043030|NCT02660983|17378448|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
5043031|NCT02660983|17378447|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
5043032|NCT02660983|17378448|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
5043033|NCT02660983|17378447|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
5043034|NCT02660983|17378448|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
5043035|NCT02660827|17378499|P1|2-6 Years Old Age Group|Withdrawal by Subject|1
5043036|NCT02660580|17378533|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
5043037|NCT02660580|17378534|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
5043038|NCT02660580|17378535|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5043039|NCT02660580|17378536|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5043040|NCT02660580|17378537|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5043041|NCT02660580|17378533|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
5043042|NCT02660580|17378534|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
5043043|NCT02660580|17378535|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
5043044|NCT02660580|17378536|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
5043045|NCT02660580|17378537|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
5043046|NCT02660580|17378533|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
5043047|NCT02660580|17378534|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
5043048|NCT02660580|17378535|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
5043049|NCT02660580|17378536|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
5043050|NCT02660580|17378537|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
5043051|NCT02660580|17378533|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
5043052|NCT02660580|17378534|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
5043053|NCT02660580|17378535|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
5043054|NCT02660580|17378536|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
5043055|NCT02660580|17378537|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
5043056|NCT02660580|17378533|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
5043057|NCT02660580|17378534|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5043058|NCT02660580|17378535|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
5043059|NCT02660580|17378536|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5043060|NCT02660580|17378537|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5043061|NCT02660580|17378533|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
5043062|NCT02660580|17378534|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5043063|NCT02660580|17378535|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
5043064|NCT02660580|17378536|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5043065|NCT02660580|17378537|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5043066|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5043067|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5043068|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5043069|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
5043070|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
5043071|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5043072|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5043073|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5043074|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
5043075|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
5043076|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5043077|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5043078|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5043079|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
5043080|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
5043081|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5043082|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5043083|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5043084|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
5043085|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5043086|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5043087|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5043088|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5043089|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5043090|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
5043091|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5043092|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5043093|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5043094|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
5043095|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
5043096|NCT02660580|17378533|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5043097|NCT02660580|17378534|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5043098|NCT02660580|17378535|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5043099|NCT02660580|17378536|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
5043100|NCT02660580|17378537|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
5043101|NCT02660242|17378652|P1|Glucagon Injection|Lost to Follow-up|1
5043102|NCT02660242|17378652|P1|Glucose Tabs|Lost to Follow-up|1
5043103|NCT02660229|17378708|P2|Overall Study|Withdrawal by Subject|1
5043104|NCT02660229|17378709|P1|Overall Study|Withdrawal by Subject|0
5043105|NCT02660229|17378708|P2|Overall Study|Adverse Event|0
5043106|NCT02660229|17378709|P1|Overall Study|Adverse Event|2
5043107|NCT02659631|17378750|P10|Overall Study|Death (treatment phase)|0
5043108|NCT02659631|17378751|P9|Overall Study|Death (treatment phase)|0
5043109|NCT02659631|17378752|P8|Overall Study|Death (treatment phase)|0
5043110|NCT02659631|17378753|P7|Overall Study|Death (treatment phase)|1
5043111|NCT02659631|17378754|P6|Overall Study|Death (treatment phase)|0
5043112|NCT02659631|17378755|P5|Overall Study|Death (treatment phase)|1
5043113|NCT02659631|17378756|P4|Overall Study|Death (treatment phase)|0
5043114|NCT02659631|17378757|P3|Overall Study|Death (treatment phase)|0
5043115|NCT02659631|17378758|P2|Overall Study|Death (treatment phase)|0
5043116|NCT02659631|17378759|P1|Overall Study|Death (treatment phase)|0
5043117|NCT02659631|17378750|P10|Overall Study|Death (follow-up phase)|0
5043118|NCT02659631|17378751|P9|Overall Study|Death (follow-up phase)|1
5043119|NCT02659631|17378752|P8|Overall Study|Death (follow-up phase)|3
5043120|NCT02659631|17378753|P7|Overall Study|Death (follow-up phase)|0
5043121|NCT02659631|17378754|P6|Overall Study|Death (follow-up phase)|2
5043122|NCT02659631|17378755|P5|Overall Study|Death (follow-up phase)|3
5043123|NCT02659631|17378756|P4|Overall Study|Death (follow-up phase)|1
5043124|NCT02659631|17378757|P3|Overall Study|Death (follow-up phase)|1
5043125|NCT02659631|17378758|P2|Overall Study|Death (follow-up phase)|2
5043126|NCT02659631|17378759|P1|Overall Study|Death (follow-up phase)|1
5043127|NCT02659631|17378750|P10|Overall Study|Participant refused further follow-up|0
5043128|NCT02659631|17378751|P9|Overall Study|Participant refused further follow-up|1
5043129|NCT02659631|17378752|P8|Overall Study|Participant refused further follow-up|0
5043130|NCT02659631|17378753|P7|Overall Study|Participant refused further follow-up|0
5043131|NCT02659631|17378754|P6|Overall Study|Participant refused further follow-up|0
5043132|NCT02659631|17378755|P5|Overall Study|Participant refused further follow-up|0
5043133|NCT02659631|17378756|P4|Overall Study|Participant refused further follow-up|1
5043134|NCT02659631|17378757|P3|Overall Study|Participant refused further follow-up|0
5043135|NCT02659631|17378758|P2|Overall Study|Participant refused further follow-up|0
5043136|NCT02659631|17378759|P1|Overall Study|Participant refused further follow-up|0
5043137|NCT02659631|17378750|P10|Overall Study|Withdrawal prior to treatment|0
5043138|NCT02659631|17378751|P9|Overall Study|Withdrawal prior to treatment|0
5043139|NCT02659631|17378752|P8|Overall Study|Withdrawal prior to treatment|0
5043140|NCT02659631|17378753|P7|Overall Study|Withdrawal prior to treatment|0
5043141|NCT02659631|17378754|P6|Overall Study|Withdrawal prior to treatment|0
5043142|NCT02659631|17378755|P5|Overall Study|Withdrawal prior to treatment|1
5043143|NCT02659631|17378756|P4|Overall Study|Withdrawal prior to treatment|0
5043144|NCT02659631|17378757|P3|Overall Study|Withdrawal prior to treatment|0
5043145|NCT02659631|17378758|P2|Overall Study|Withdrawal prior to treatment|0
5043146|NCT02659631|17378759|P1|Overall Study|Withdrawal prior to treatment|0
5043147|NCT02659631|17378750|P10|Overall Study|Lost to Follow-up|0
5043148|NCT02659631|17378751|P9|Overall Study|Lost to Follow-up|0
5043149|NCT02659631|17378752|P8|Overall Study|Lost to Follow-up|0
5043150|NCT02659631|17378753|P7|Overall Study|Lost to Follow-up|0
5043151|NCT02659631|17378754|P6|Overall Study|Lost to Follow-up|1
5043152|NCT02659631|17378755|P5|Overall Study|Lost to Follow-up|0
5043153|NCT02659631|17378756|P4|Overall Study|Lost to Follow-up|0
5043154|NCT02659631|17378757|P3|Overall Study|Lost to Follow-up|2
5043155|NCT02659631|17378758|P2|Overall Study|Lost to Follow-up|0
5043156|NCT02659631|17378759|P1|Overall Study|Lost to Follow-up|0
5043157|NCT02659540|17378893|P2|Overall Study|Progressive disease|6
5043158|NCT02659540|17378894|P1|Overall Study|Progressive disease|2
5043159|NCT02659540|17378893|P2|Overall Study|Death|0
5043160|NCT02659540|17378894|P1|Overall Study|Death|1
5043161|NCT02659540|17378893|P2|Overall Study|Adverse Event|2
5043162|NCT02659540|17378894|P1|Overall Study|Adverse Event|3
5043163|NCT02659098|17378925|P1|Overall Study|Withdrawal by Subject|7
5043164|NCT02658487|17378983|P1|Overall Study|Refractory AML|1
5043165|NCT02658487|17378983|P1|Overall Study|Treatment Failure, circulating blasts|1
5043166|NCT02658487|17378983|P1|Overall Study|Adverse Event|1
5043167|NCT02658487|17378983|P1|Overall Study|Alternative therapy|1
5043168|NCT02658487|17378983|P1|Overall Study|Disease progression|10
5043169|NCT02658487|17378983|P1|Overall Study|Death|2
5043170|NCT02658149|17379054|P2|Overall Study|Physician Decision|0
5043171|NCT02658149|17379055|P1|Overall Study|Physician Decision|1
5043172|NCT02658084|17379071|P2|Overall Study|Study Termination|0
5043173|NCT02658084|17379072|P1|Overall Study|Study Termination|1
5043174|NCT02658084|17379071|P2|Overall Study|Withdrawal by Subject|0
5043175|NCT02658084|17379072|P1|Overall Study|Withdrawal by Subject|1
5043176|NCT02658019|17379081|P1|Overall Study|Adverse Event|1
5043177|NCT02657889|17379134|P4|Overall Study|Ongoing in Study|19
5043178|NCT02657889|17379135|P3|Overall Study|Ongoing in Study|24
5043179|NCT02657889|17379136|P2|Overall Study|Ongoing in Study|5
5043180|NCT02657889|17379137|P1|Overall Study|Ongoing in Study|0
5043181|NCT02657889|17379134|P4|Overall Study|Withdrawal by Subject|0
5043182|NCT02657889|17379135|P3|Overall Study|Withdrawal by Subject|8
5043183|NCT02657889|17379136|P2|Overall Study|Withdrawal by Subject|0
5043184|NCT02657889|17379137|P1|Overall Study|Withdrawal by Subject|0
5043185|NCT02657889|17379134|P4|Overall Study|Lost to Follow-up|2
5043186|NCT02657889|17379135|P3|Overall Study|Lost to Follow-up|1
5043187|NCT02657889|17379136|P2|Overall Study|Lost to Follow-up|0
5043188|NCT02657889|17379137|P1|Overall Study|Lost to Follow-up|2
5043189|NCT02657889|17379134|P4|Overall Study|Death|34
5043190|NCT02657889|17379135|P3|Overall Study|Death|20
5043191|NCT02657889|17379136|P2|Overall Study|Death|2
5043192|NCT02657889|17379137|P1|Overall Study|Death|5
5043193|NCT02657434|17379178|P2|Overall Study|Protocol Violation|0
5043194|NCT02657434|17379179|P1|Overall Study|Protocol Violation|1
5043195|NCT02657434|17379178|P2|Overall Study|Withdrawal by Subject|16
5043196|NCT02657434|17379179|P1|Overall Study|Withdrawal by Subject|27
5043197|NCT02657434|17379178|P2|Overall Study|Randomization by Error|0
5043198|NCT02657434|17379179|P1|Overall Study|Randomization by Error|2
5043199|NCT02657434|17379178|P2|Overall Study|Lost to Follow-up|2
5043200|NCT02657434|17379179|P1|Overall Study|Lost to Follow-up|2
5043201|NCT02657434|17379178|P2|Overall Study|Death|183
5043202|NCT02657434|17379179|P1|Overall Study|Death|177
5043203|NCT02657434|17379178|P2|Overall Study|On-Going in Study|91
5043204|NCT02657434|17379179|P1|Overall Study|On-Going in Study|77
5043205|NCT02657408|17379209|P2|Overall Study|Adverse Event|7
5043206|NCT02657408|17379210|P1|Overall Study|Adverse Event|3
5043207|NCT02657369|17379234|P1|Overall Study|Study terminated by sponsor|7
5043208|NCT02657369|17379234|P1|Overall Study|Death|27
5043209|NCT02657031|17379265|P2|Overall Study|Adverse Event|2
5043210|NCT02657031|17379266|P1|Overall Study|Adverse Event|1
5043211|NCT02656693|17379298|P3|Overall Study|Bariatric surgery|2
5043212|NCT02656693|17379299|P2|Overall Study|Bariatric surgery|1
5043213|NCT02656693|17379300|P1|Overall Study|Bariatric surgery|0
5043214|NCT02656693|17379298|P3|Overall Study|Pregnancy|1
5043215|NCT02656693|17379299|P2|Overall Study|Pregnancy|1
5043216|NCT02656693|17379300|P1|Overall Study|Pregnancy|1
5043217|NCT02656329|17379425|P2|Overall Study|Other than specified above|6
5043218|NCT02656329|17379426|P1|Overall Study|Other than specified above|5
5043219|NCT02656329|17379425|P2|Overall Study|Study termination by Sponsor|142
5043220|NCT02656329|17379426|P1|Overall Study|Study termination by Sponsor|150
5043221|NCT02656329|17379425|P2|Overall Study|Withdrawal by Subject|6
5043222|NCT02656329|17379426|P1|Overall Study|Withdrawal by Subject|7
5043223|NCT02656329|17379425|P2|Overall Study|Lost to Follow-up|3
5043224|NCT02656329|17379426|P1|Overall Study|Lost to Follow-up|2
5043225|NCT02656290|17379449|P1|Overall Study|Subjects Remain On Study|26
5043226|NCT02656173|17379459|P2|Overall Study|Miscellaneous|0
5043227|NCT02656173|17379460|P1|Overall Study|Miscellaneous|2
5043228|NCT02656173|17379459|P2|Overall Study|Protocol Violation|1
5043229|NCT02656173|17379460|P1|Overall Study|Protocol Violation|0
5043230|NCT02656173|17379459|P2|Overall Study|Withdrawal by Subject|3
5043231|NCT02656173|17379460|P1|Overall Study|Withdrawal by Subject|1
5043232|NCT02656173|17379459|P2|Overall Study|Adverse Event|5
5043233|NCT02656173|17379460|P1|Overall Study|Adverse Event|7
5043234|NCT02656173|17379459|P2|Overall Study|Deviation from the Eligible Criteria|2
5043235|NCT02656173|17379460|P1|Overall Study|Deviation from the Eligible Criteria|3
5043236|NCT02655887|17379532|P1|Overall Study|Missed 12-month follow-up visit|4
5043237|NCT02655887|17379532|P1|Overall Study|Withdrawal by Subject|3
5043238|NCT02655887|17379532|P1|Overall Study|Death|4
5043239|NCT02655887|17379532|P1|Overall Study|Lost to Follow-up|3
5043240|NCT02655679|17379551|P5|Overall Study|Other Miscellaneous Reasons|0
5043241|NCT02655679|17379552|P4|Overall Study|Other Miscellaneous Reasons|0
5043242|NCT02655679|17379553|P3|Overall Study|Other Miscellaneous Reasons|0
5043243|NCT02655679|17379554|P2|Overall Study|Other Miscellaneous Reasons|0
5043244|NCT02655679|17379555|P1|Overall Study|Other Miscellaneous Reasons|1
5043245|NCT02655679|17379551|P5|Overall Study|Lost to Follow-up|0
5043246|NCT02655679|17379552|P4|Overall Study|Lost to Follow-up|1
5043247|NCT02655679|17379553|P3|Overall Study|Lost to Follow-up|1
5043248|NCT02655679|17379554|P2|Overall Study|Lost to Follow-up|1
5043249|NCT02655679|17379555|P1|Overall Study|Lost to Follow-up|0
5043250|NCT02655679|17379551|P5|Overall Study|Inability to Comply with the Protocol|0
5043251|NCT02655679|17379552|P4|Overall Study|Inability to Comply with the Protocol|0
5043252|NCT02655679|17379553|P3|Overall Study|Inability to Comply with the Protocol|0
5043253|NCT02655679|17379554|P2|Overall Study|Inability to Comply with the Protocol|0
5043254|NCT02655679|17379555|P1|Overall Study|Inability to Comply with the Protocol|1
5043255|NCT02655679|17379551|P5|Overall Study|Withdrawal by Subject|1
5043256|NCT02655679|17379552|P4|Overall Study|Withdrawal by Subject|3
5043257|NCT02655679|17379553|P3|Overall Study|Withdrawal by Subject|0
5043258|NCT02655679|17379554|P2|Overall Study|Withdrawal by Subject|1
5043259|NCT02655679|17379555|P1|Overall Study|Withdrawal by Subject|1
5043260|NCT02655679|17379551|P5|Overall Study|Adverse Event|0
5043261|NCT02655679|17379552|P4|Overall Study|Adverse Event|0
5043262|NCT02655679|17379553|P3|Overall Study|Adverse Event|0
5043263|NCT02655679|17379554|P2|Overall Study|Adverse Event|1
5043264|NCT02655679|17379555|P1|Overall Study|Adverse Event|0
5043265|NCT02655666|17379627|P1|Overall Study|Sponsor stopped this clinical research.|12
5043266|NCT02655419|17379681|P2|Overall Study|Other|1
5043267|NCT02655419|17379682|P1|Overall Study|Other|0
5043268|NCT02655419|17379681|P2|Overall Study|Withdrawal by Subject|1
5043269|NCT02655419|17379682|P1|Overall Study|Withdrawal by Subject|4
5043270|NCT02655419|17379681|P2|Overall Study|Enrolled but not treated|5
5043271|NCT02655419|17379682|P1|Overall Study|Enrolled but not treated|1
5043272|NCT02655237|17379802|P2|Overall Study|Randomized but Not Treated|0
5043273|NCT02655237|17379803|P1|Overall Study|Randomized but Not Treated|1
5043274|NCT02655237|17379802|P2|Overall Study|Reduction of Hemoglobin Concentration|0
5043275|NCT02655237|17379803|P1|Overall Study|Reduction of Hemoglobin Concentration|1
5043276|NCT02655237|17379802|P2|Overall Study|Recovery Leading to Surgery|1
5043277|NCT02655237|17379803|P1|Overall Study|Recovery Leading to Surgery|2
5043278|NCT02655237|17379802|P2|Overall Study|Lack of Efficacy|1
5043279|NCT02655237|17379803|P1|Overall Study|Lack of Efficacy|0
5043280|NCT02655237|17379802|P2|Overall Study|Withdrawal by Participant|2
5043281|NCT02655237|17379803|P1|Overall Study|Withdrawal by Participant|1
5043282|NCT02655237|17379802|P2|Overall Study|Protocol Deviation|0
5043283|NCT02655237|17379803|P1|Overall Study|Protocol Deviation|2
5043284|NCT02655237|17379802|P2|Overall Study|Adverse Event|7
5043285|NCT02655237|17379803|P1|Overall Study|Adverse Event|10
5043286|NCT02655224|17379843|P2|Overall Study|Adverse Event|1
5043287|NCT02655224|17379844|P1|Overall Study|Adverse Event|1
5043288|NCT02655016|17379876|P2|Overall Study|Withdrawal by Subject|36
5043289|NCT02655016|17379877|P1|Overall Study|Withdrawal by Subject|18
5043290|NCT02655016|17379876|P2|Overall Study|Lost to Follow-up|1
5043291|NCT02655016|17379877|P1|Overall Study|Lost to Follow-up|1
5043292|NCT02655016|17379876|P2|Overall Study|Death|48
5043293|NCT02655016|17379877|P1|Overall Study|Death|30
5043294|NCT02655016|17379876|P2|Overall Study|Site closed|1
5043295|NCT02655016|17379877|P1|Overall Study|Site closed|0
5043296|NCT02655016|17379876|P2|Overall Study|Disease progression|4
5043297|NCT02655016|17379877|P1|Overall Study|Disease progression|6
5043298|NCT02654977|17379909|P1|Overall Study|Lack of Efficacy|3
5043299|NCT02654977|17379909|P1|Overall Study|Withdrawal by Subject|1
5043300|NCT02654977|17379909|P1|Overall Study|Adverse Event|1
5043301|NCT02654977|17379909|P1|Overall Study|Lost to Follow-up|1
5043302|NCT02654977|17379909|P1|Overall Study|Death|1
5043303|NCT02654717|17379943|P2|Overall Study|Non-permitted medication|0
5043304|NCT02654717|17379944|P1|Overall Study|Non-permitted medication|3
5043305|NCT02654717|17379943|P2|Overall Study|Withdrawal by Subject|1
5043306|NCT02654717|17379944|P1|Overall Study|Withdrawal by Subject|0
5043307|NCT02654717|17379943|P2|Overall Study|Protocol Violation|2
5043308|NCT02654717|17379944|P1|Overall Study|Protocol Violation|1
5043309|NCT02654717|17379943|P2|Overall Study|Adverse Event|2
5043310|NCT02654717|17379944|P1|Overall Study|Adverse Event|2
5043311|NCT02654145|17379995|P1|Overall Study|Withdrawal by Subject|5
5043312|NCT02654145|17379995|P1|Overall Study|Protocol Violation|1
5043313|NCT02654145|17379995|P1|Overall Study|Lack of Efficacy|1
5043314|NCT02654132|17380004|P2|Overall Study|Never treated|2
5043315|NCT02654132|17380005|P1|Overall Study|Never treated|0
5043316|NCT02654132|17380004|P2|Overall Study|Clinical Progression (not protocol)|1
5043317|NCT02654132|17380005|P1|Overall Study|Clinical Progression (not protocol)|0
5043318|NCT02654132|17380004|P2|Overall Study|Inadequate response to therapy|0
5043319|NCT02654132|17380005|P1|Overall Study|Inadequate response to therapy|1
5043320|NCT02654132|17380004|P2|Overall Study|Subject Withdrew Consent|1
5043321|NCT02654132|17380005|P1|Overall Study|Subject Withdrew Consent|2
5043322|NCT02654132|17380004|P2|Overall Study|Not Reported|1
5043323|NCT02654132|17380005|P1|Overall Study|Not Reported|0
5043324|NCT02654132|17380004|P2|Overall Study|Subj Request to Discontinue Treatment|0
5043325|NCT02654132|17380005|P1|Overall Study|Subj Request to Discontinue Treatment|1
5043326|NCT02654132|17380004|P2|Overall Study|Maximum Clinical Benefit|2
5043327|NCT02654132|17380005|P1|Overall Study|Maximum Clinical Benefit|0
5043328|NCT02654132|17380004|P2|Overall Study|Study Drug Toxicity|2
5043329|NCT02654132|17380005|P1|Overall Study|Study Drug Toxicity|1
5043330|NCT02654132|17380004|P2|Overall Study|Switched to another tx|1
5043331|NCT02654132|17380005|P1|Overall Study|Switched to another tx|0
5043332|NCT02654132|17380004|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
5043333|NCT02654132|17380005|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
5043334|NCT02654132|17380004|P2|Overall Study|Disease Progression|31
5043335|NCT02654132|17380005|P1|Overall Study|Disease Progression|26
5043336|NCT02654054|17380016|P3|Post-Treatment Follow-Up Period|Non-Compliance|4
5043337|NCT02654054|17380017|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
5043338|NCT02654054|17380018|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5043339|NCT02654054|17380016|P3|Post-Treatment Follow-Up Period|Other|4
5043340|NCT02654054|17380017|P2|Post-Treatment Follow-Up Period|Other|0
5043341|NCT02654054|17380018|P1|Post-Treatment Follow-Up Period|Other|1
5043342|NCT02654054|17380016|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5043343|NCT02654054|17380017|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5043344|NCT02654054|17380018|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5043345|NCT02654054|17380016|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5043346|NCT02654054|17380017|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5043347|NCT02654054|17380018|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5043348|NCT02654054|17380016|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
5043349|NCT02654054|17380017|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
5043350|NCT02654054|17380018|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5043351|NCT02654002|17380053|P9|Overall Study|Withdrew Consent|0
5043352|NCT02654002|17380054|P8|Overall Study|Withdrew Consent|1
5043353|NCT02654002|17380055|P7|Overall Study|Withdrew Consent|0
5043354|NCT02654002|17380056|P6|Overall Study|Withdrew Consent|1
5043355|NCT02654002|17380057|P5|Overall Study|Withdrew Consent|0
5043356|NCT02654002|17380058|P4|Overall Study|Withdrew Consent|0
5043357|NCT02654002|17380059|P3|Overall Study|Withdrew Consent|0
5043358|NCT02654002|17380060|P2|Overall Study|Withdrew Consent|0
5043359|NCT02654002|17380061|P1|Overall Study|Withdrew Consent|0
5043360|NCT02654002|17380053|P9|Overall Study|Adverse Event|0
5043361|NCT02654002|17380054|P8|Overall Study|Adverse Event|0
5043362|NCT02654002|17380055|P7|Overall Study|Adverse Event|1
5043363|NCT02654002|17380056|P6|Overall Study|Adverse Event|0
5043364|NCT02654002|17380057|P5|Overall Study|Adverse Event|0
5043365|NCT02654002|17380058|P4|Overall Study|Adverse Event|0
5043366|NCT02654002|17380059|P3|Overall Study|Adverse Event|0
5043367|NCT02654002|17380060|P2|Overall Study|Adverse Event|0
5043368|NCT02654002|17380061|P1|Overall Study|Adverse Event|0
5043369|NCT02653625|17380235|P1|Overall Study|Suspected Drug Induced Liver Injury|1
5043370|NCT02653625|17380235|P1|Overall Study|Protocol Violation|1
5043371|NCT02653625|17380235|P1|Overall Study|Non-compliance with Study Drug|1
5043372|NCT02653625|17380235|P1|Overall Study|Adverse Event|1
5043373|NCT02653495|17380259|P2|Overall Study|Screening Failure|0
5043374|NCT02653495|17380260|P1|Overall Study|Screening Failure|10
5043375|NCT02653495|17380259|P2|Overall Study|Lost to Follow-up|0
5043376|NCT02653495|17380260|P1|Overall Study|Lost to Follow-up|2
5043377|NCT02653326|17380312|P2|Overall Study|Lost to Follow-up|7
5043378|NCT02653326|17380313|P1|Overall Study|Lost to Follow-up|10
5043379|NCT02653170|17380351|P3|Overall Study|Lost to Follow-up|10
5043380|NCT02653170|17380352|P2|Overall Study|Lost to Follow-up|4
5043381|NCT02653170|17380353|P1|Overall Study|Lost to Follow-up|12
5043382|NCT02653170|17380351|P3|Overall Study|withdrawn by study team|5
5043383|NCT02653170|17380352|P2|Overall Study|withdrawn by study team|4
5043384|NCT02653170|17380353|P1|Overall Study|withdrawn by study team|2
5043385|NCT02653170|17380351|P3|Overall Study|Withdrawal by Subject|3
5043386|NCT02653170|17380352|P2|Overall Study|Withdrawal by Subject|8
5043387|NCT02653170|17380353|P1|Overall Study|Withdrawal by Subject|3
5043388|NCT02652949|17380395|P1|12-Month Follow-up Secondary Endpoint|Death|4
5043389|NCT02652949|17380395|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
5043390|NCT02652949|17380395|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
5043391|NCT02652949|17380395|P1|6-Month Follow-up Secondary Endpoint|Death|5
5043392|NCT02652949|17380395|P1|30-Day Follow-up for Secondary Endpoint|Death|1
5043393|NCT02652949|17380395|P1|30-Day Follow-up for Primary Endpoint|Death|1
5043394|NCT02652767|17380430|P1|Overall Study|Withdrawal by Subject|1
5043395|NCT02652767|17380430|P1|Overall Study|Lost to Follow-up|1
5043396|NCT02652767|17380430|P1|Overall Study|Death|2
5043397|NCT02652624|17380458|P2|Extension Phase|Withdrew Consent|1
5043398|NCT02652624|17380459|P1|Extension Phase|Withdrew Consent|0
5043399|NCT02652624|17380458|P2|Extension Phase|Adverse Event|1
5043400|NCT02652624|17380459|P1|Extension Phase|Adverse Event|0
5043401|NCT02652624|17380458|P2|Extension Phase|Pregnancy|1
5043402|NCT02652624|17380459|P1|Extension Phase|Pregnancy|1
5043403|NCT02652624|17380458|P2|Extension Phase|Lost to Follow-up|1
5043404|NCT02652624|17380459|P1|Extension Phase|Lost to Follow-up|3
5043405|NCT02652624|17380458|P2|Randomized Phase|Lost to Follow-up|1
5043406|NCT02652624|17380459|P1|Randomized Phase|Lost to Follow-up|0
5043407|NCT02652624|17380458|P2|Randomized Phase|Death|1
5043408|NCT02652624|17380459|P1|Randomized Phase|Death|0
5043409|NCT02652624|17380458|P2|Randomized Phase|Investigator's Discretion|2
5043410|NCT02652624|17380459|P1|Randomized Phase|Investigator's Discretion|0
5043411|NCT02652624|17380458|P2|Randomized Phase|Pregnancy|1
5043412|NCT02652624|17380459|P1|Randomized Phase|Pregnancy|3
5043413|NCT02652260|17380547|P2|Overall Study|Withdrawal by Subject|1
5043414|NCT02652260|17380548|P1|Overall Study|Withdrawal by Subject|0
5043415|NCT02652260|17380547|P2|Overall Study|Pregnancy|1
5043416|NCT02652260|17380548|P1|Overall Study|Pregnancy|0
5043417|NCT02652156|17380607|P3|Overall Study|Physician Decision|0
5043418|NCT02652156|17380608|P2|Overall Study|Physician Decision|0
5043419|NCT02652156|17380609|P1|Overall Study|Physician Decision|1
5043420|NCT02651922|17380635|P1|Overall Study|due to exclusion criteria|2
5043421|NCT02651688|17380655|P3|Overall Study|Withdrawal by Subject|2
5043422|NCT02651688|17380656|P2|Overall Study|Withdrawal by Subject|0
5043423|NCT02651688|17380657|P1|Overall Study|Withdrawal by Subject|1
5043424|NCT02651688|17380655|P3|Overall Study|Lost to Follow-up|0
5043425|NCT02651688|17380656|P2|Overall Study|Lost to Follow-up|3
5043426|NCT02651688|17380657|P1|Overall Study|Lost to Follow-up|1
5043427|NCT02651688|17380655|P3|Overall Study|Principal Investigator (PI) decision|0
5043428|NCT02651688|17380656|P2|Overall Study|Principal Investigator (PI) decision|2
5043429|NCT02651688|17380657|P1|Overall Study|Principal Investigator (PI) decision|0
5043430|NCT02651688|17380655|P3|Overall Study|Non-compliance|1
5043431|NCT02651688|17380656|P2|Overall Study|Non-compliance|0
5043432|NCT02651688|17380657|P1|Overall Study|Non-compliance|0
5043433|NCT02651467|17380740|P3|Overall Study|Other (Not specified)|2
5043434|NCT02651467|17380741|P2|Overall Study|Other (Not specified)|0
5043435|NCT02651467|17380742|P1|Overall Study|Other (Not specified)|1
5043436|NCT02651467|17380740|P3|Overall Study|Withdrawal by Subject|2
5043437|NCT02651467|17380741|P2|Overall Study|Withdrawal by Subject|0
5043438|NCT02651467|17380742|P1|Overall Study|Withdrawal by Subject|0
5043439|NCT02651220|17380821|P3|Overall Study|Withdrawal by Parent/Guardian|1
5043440|NCT02651220|17380822|P2|Overall Study|Withdrawal by Parent/Guardian|1
5043441|NCT02651220|17380823|P1|Overall Study|Withdrawal by Parent/Guardian|0
5043442|NCT02651220|17380821|P3|Overall Study|Miscellaneous|2
5043443|NCT02651220|17380822|P2|Overall Study|Miscellaneous|1
5043444|NCT02651220|17380823|P1|Overall Study|Miscellaneous|4
5043445|NCT02651220|17380821|P3|Overall Study|Withdrawal by Subject|8
5043446|NCT02651220|17380822|P2|Overall Study|Withdrawal by Subject|6
5043447|NCT02651220|17380823|P1|Overall Study|Withdrawal by Subject|5
5043448|NCT02651220|17380821|P3|Overall Study|Protocol Violation|1
5043449|NCT02651220|17380822|P2|Overall Study|Protocol Violation|0
5043450|NCT02651220|17380823|P1|Overall Study|Protocol Violation|0
5043451|NCT02651220|17380821|P3|Overall Study|Pregnancy|1
5043452|NCT02651220|17380822|P2|Overall Study|Pregnancy|0
5043453|NCT02651220|17380823|P1|Overall Study|Pregnancy|1
5043454|NCT02651220|17380821|P3|Overall Study|Non-Compliance with Study Drug|1
5043455|NCT02651220|17380822|P2|Overall Study|Non-Compliance with Study Drug|0
5043456|NCT02651220|17380823|P1|Overall Study|Non-Compliance with Study Drug|4
5043457|NCT02651220|17380821|P3|Overall Study|Lost to Follow-up|14
5043458|NCT02651220|17380822|P2|Overall Study|Lost to Follow-up|14
5043459|NCT02651220|17380823|P1|Overall Study|Lost to Follow-up|8
5043460|NCT02651220|17380821|P3|Overall Study|Adverse Event|1
5043461|NCT02651220|17380822|P2|Overall Study|Adverse Event|5
5043462|NCT02651220|17380823|P1|Overall Study|Adverse Event|1
5043463|NCT02651194|17380837|P1|Overall Study|Other|2
5043464|NCT02651194|17380837|P1|Overall Study|Lost to Follow-up|3
5043465|NCT02651155|17380845|P2|Overall Study|Voluntary Withdrawal|0
5043466|NCT02651155|17380846|P1|Overall Study|Voluntary Withdrawal|5
5043467|NCT02651155|17380845|P2|Overall Study|Pretreatment Event/Adverse Event|2
5043468|NCT02651155|17380846|P1|Overall Study|Pretreatment Event/Adverse Event|1
5043469|NCT02650921|17380871|P1|Overall Study|Due to Medical Condition|1
5043470|NCT02650921|17380871|P1|Overall Study|Adverse Event|1
5043471|NCT02650921|17380871|P1|Overall Study|Lost to Follow-up|2
5043472|NCT02650921|17380871|P1|Overall Study|Withdrawal by Subject|4
5043473|NCT02650895|17380925|P6|Overall Study|Withdrawal by Subject|0
5043474|NCT02650895|17380926|P5|Overall Study|Withdrawal by Subject|0
5043475|NCT02650895|17380927|P4|Overall Study|Withdrawal by Subject|0
5043476|NCT02650895|17380928|P3|Overall Study|Withdrawal by Subject|0
5043477|NCT02650895|17380929|P2|Overall Study|Withdrawal by Subject|1
5043478|NCT02650895|17380930|P1|Overall Study|Withdrawal by Subject|0
5043479|NCT02650466|17380977|P1|Overall Study|Lost to Follow-up|1
5043480|NCT02650466|17380977|P1|Overall Study|Withdrawal by Subject|5
5043481|NCT02650466|17380977|P1|Overall Study|Physician Decision|1
5043482|NCT02650128|17381107|P1|Overall Study|Death|2
5043483|NCT02649946|17381116|P2|Overall Study|Missed 6-month follow-up visit|4
5043484|NCT02649946|17381117|P1|Overall Study|Missed 6-month follow-up visit|0
5043485|NCT02649946|17381116|P2|Overall Study|Erroneously enrolled|0
5043486|NCT02649946|17381117|P1|Overall Study|Erroneously enrolled|1
5043487|NCT02649946|17381116|P2|Overall Study|Lost to Follow-up|1
5043488|NCT02649946|17381117|P1|Overall Study|Lost to Follow-up|2
5043489|NCT02649946|17381116|P2|Overall Study|Physician Decision|0
5043490|NCT02649946|17381117|P1|Overall Study|Physician Decision|1
5043491|NCT02649946|17381116|P2|Overall Study|Death|9
5043492|NCT02649946|17381117|P1|Overall Study|Death|7
5043493|NCT02649946|17381116|P2|Overall Study|Withdrawal by Subject|1
5043494|NCT02649946|17381117|P1|Overall Study|Withdrawal by Subject|1
5043495|NCT02649894|17381146|P2|Overall Study|Other, not specified|0
5043496|NCT02649894|17381147|P1|Overall Study|Other, not specified|6
5043497|NCT02649894|17381146|P2|Overall Study|Death|7
5043498|NCT02649894|17381147|P1|Overall Study|Death|30
5043499|NCT02649894|17381146|P2|Overall Study|Lost to Follow-up|1
5043500|NCT02649894|17381147|P1|Overall Study|Lost to Follow-up|2
5043501|NCT02649894|17381146|P2|Overall Study|Withdrawal by Subject|2
5043502|NCT02649894|17381147|P1|Overall Study|Withdrawal by Subject|5
5043503|NCT02649894|17381146|P2|Overall Study|Physician Decision|1
5043504|NCT02649894|17381147|P1|Overall Study|Physician Decision|0
5043505|NCT02649894|17381146|P2|Overall Study|Adverse Event|0
5043506|NCT02649894|17381147|P1|Overall Study|Adverse Event|1
5043507|NCT02649634|17381175|P2|Overall Study|Lost to Follow-up|1
5043508|NCT02649634|17381176|P1|Overall Study|Lost to Follow-up|0
5043509|NCT02649634|17381175|P2|Overall Study|Withdrawal by Subject|5
5043510|NCT02649634|17381176|P1|Overall Study|Withdrawal by Subject|3
5043511|NCT02649218|17381293|P1|Overall Study|Withdrawal by Subject|2
5043512|NCT02649218|17381293|P1|Overall Study|Physician Decision|1
5043513|NCT02649218|17381293|P1|Overall Study|Protocol Violation|3
5043514|NCT02649218|17381293|P1|Overall Study|Pregnancy|3
5043515|NCT02649218|17381293|P1|Overall Study|Lack of Efficacy|8
5043516|NCT02649218|17381293|P1|Overall Study|Adverse Event|8
5043517|NCT02648698|17381368|P2|Overall Study|Protocol Violation|5
5043518|NCT02648698|17381369|P1|Overall Study|Protocol Violation|1
5043519|NCT02648438|17381426|P3|Overall Study|Withdrawal by Subject|0
5043520|NCT02648438|17381427|P2|Overall Study|Withdrawal by Subject|1
5043521|NCT02648438|17381428|P1|Overall Study|Withdrawal by Subject|1
5043522|NCT02648438|17381426|P3|Overall Study|Protocol Violation|0
5043523|NCT02648438|17381427|P2|Overall Study|Protocol Violation|0
5043524|NCT02648438|17381428|P1|Overall Study|Protocol Violation|2
5043525|NCT02648438|17381426|P3|Overall Study|Eligibility criteria not fulfilled|0
5043526|NCT02648438|17381427|P2|Overall Study|Eligibility criteria not fulfilled|2
5043527|NCT02648438|17381428|P1|Overall Study|Eligibility criteria not fulfilled|0
5043528|NCT02648217|17381474|P2|Overall Study|Unclassified|0
5043529|NCT02648217|17381475|P1|Overall Study|Unclassified|5
5043530|NCT02648217|17381474|P2|Overall Study|Withdrawal by Subject|3
5043531|NCT02648217|17381475|P1|Overall Study|Withdrawal by Subject|4
5043532|NCT02648217|17381474|P2|Overall Study|Lost to Follow-up|1
5043533|NCT02648217|17381475|P1|Overall Study|Lost to Follow-up|1
5043534|NCT02648217|17381474|P2|Overall Study|Adverse Event|1
5043535|NCT02648217|17381475|P1|Overall Study|Adverse Event|0
5043536|NCT02648204|17381497|P4|Overall Study|Adverse Event|0
5043537|NCT02648204|17381498|P3|Overall Study|Adverse Event|1
5043538|NCT02648204|17381499|P2|Overall Study|Adverse Event|0
5043539|NCT02648204|17381500|P1|Overall Study|Adverse Event|0
5043540|NCT02648204|17381497|P4|Overall Study|Death|2
5043541|NCT02648204|17381498|P3|Overall Study|Death|2
5043542|NCT02648204|17381499|P2|Overall Study|Death|1
5043543|NCT02648204|17381500|P1|Overall Study|Death|1
5043544|NCT02648204|17381497|P4|Overall Study|Missing follow-up information|2
5043545|NCT02648204|17381498|P3|Overall Study|Missing follow-up information|4
5043546|NCT02648204|17381499|P2|Overall Study|Missing follow-up information|4
5043547|NCT02648204|17381500|P1|Overall Study|Missing follow-up information|4
5043548|NCT02648204|17381497|P4|Overall Study|Lost to Follow-up|6
5043549|NCT02648204|17381498|P3|Overall Study|Lost to Follow-up|4
5043550|NCT02648204|17381499|P2|Overall Study|Lost to Follow-up|8
5043551|NCT02648204|17381500|P1|Overall Study|Lost to Follow-up|5
5043552|NCT02648204|17381497|P4|Overall Study|Withdrawal by Subject|6
5043553|NCT02648204|17381498|P3|Overall Study|Withdrawal by Subject|2
5043554|NCT02648204|17381499|P2|Overall Study|Withdrawal by Subject|8
5043555|NCT02648204|17381500|P1|Overall Study|Withdrawal by Subject|12
5043556|NCT02647944|17381638|P2|Overall Study|Adverse Event|0
5043557|NCT02647944|17381639|P1|Overall Study|Adverse Event|2
5043558|NCT02647944|17381638|P2|Overall Study|Withdrawal by Subject|3
5043559|NCT02647944|17381639|P1|Overall Study|Withdrawal by Subject|0
5043560|NCT02647905|17381663|P1|Overall Study|Withdrawal by Subject|2
5043561|NCT02647905|17381663|P1|Overall Study|Lost to Follow-up|1
5043562|NCT02647866|17381673|P5|Overall Study|Subject moved to different country|0
5043563|NCT02647866|17381674|P4|Overall Study|Subject moved to different country|0
5043564|NCT02647866|17381675|P3|Overall Study|Subject moved to different country|0
5043565|NCT02647866|17381676|P2|Overall Study|Subject moved to different country|0
5043566|NCT02647866|17381677|P1|Overall Study|Subject moved to different country|1
5043567|NCT02647866|17381673|P5|Overall Study|Death|0
5043568|NCT02647866|17381674|P4|Overall Study|Death|0
5043569|NCT02647866|17381675|P3|Overall Study|Death|0
5043570|NCT02647866|17381676|P2|Overall Study|Death|1
5043571|NCT02647866|17381677|P1|Overall Study|Death|0
5043572|NCT02647866|17381673|P5|Overall Study|Physician Decision|2
5043573|NCT02647866|17381674|P4|Overall Study|Physician Decision|0
5043574|NCT02647866|17381675|P3|Overall Study|Physician Decision|1
5043575|NCT02647866|17381676|P2|Overall Study|Physician Decision|1
5043576|NCT02647866|17381677|P1|Overall Study|Physician Decision|0
5043577|NCT02647866|17381673|P5|Overall Study|Withdrawal by Subject|4
5043578|NCT02647866|17381674|P4|Overall Study|Withdrawal by Subject|4
5043579|NCT02647866|17381675|P3|Overall Study|Withdrawal by Subject|2
5043580|NCT02647866|17381676|P2|Overall Study|Withdrawal by Subject|1
5043581|NCT02647866|17381677|P1|Overall Study|Withdrawal by Subject|1
5043582|NCT02647866|17381673|P5|Overall Study|Disease Worsening|1
5043583|NCT02647866|17381674|P4|Overall Study|Disease Worsening|0
5043584|NCT02647866|17381675|P3|Overall Study|Disease Worsening|0
5043585|NCT02647866|17381676|P2|Overall Study|Disease Worsening|1
5043586|NCT02647866|17381677|P1|Overall Study|Disease Worsening|3
5043587|NCT02647866|17381673|P5|Overall Study|Adverse Event|1
5043588|NCT02647866|17381674|P4|Overall Study|Adverse Event|2
5043589|NCT02647866|17381675|P3|Overall Study|Adverse Event|2
5043590|NCT02647866|17381676|P2|Overall Study|Adverse Event|0
5043591|NCT02647866|17381677|P1|Overall Study|Adverse Event|0
5043592|NCT02647788|17381754|P2|Overall Study|Felt nauseous with assigned medication|1
5043593|NCT02647788|17381755|P1|Overall Study|Felt nauseous with assigned medication|1
5043594|NCT02647788|17381754|P2|Overall Study|Felt itchy with assigned medication|0
5043595|NCT02647788|17381755|P1|Overall Study|Felt itchy with assigned medication|1
5043596|NCT02647788|17381754|P2|Overall Study|Withdrawal by Subject|0
5043597|NCT02647788|17381755|P1|Overall Study|Withdrawal by Subject|1
5043598|NCT02647788|17381754|P2|Overall Study|Did not want opiate|1
5043599|NCT02647788|17381755|P1|Overall Study|Did not want opiate|0
5043600|NCT02647788|17381754|P2|Overall Study|Lost to Follow-up|11
5043601|NCT02647788|17381755|P1|Overall Study|Lost to Follow-up|13
5043602|NCT02647658|17381767|P2|Overall Study|Consent refusal|24
5043603|NCT02647658|17381768|P1|Overall Study|Consent refusal|15
5043604|NCT02647645|17381796|P2|Overall Study|Lost to Follow-up|1
5043605|NCT02647645|17381797|P1|Overall Study|Lost to Follow-up|2
5043606|NCT02647320|17381819|P5|Overall Study|Disposition Missing Due to Fire at Site|4
5043607|NCT02647320|17381820|P4|Overall Study|Disposition Missing Due to Fire at Site|3
5043608|NCT02647320|17381821|P3|Overall Study|Disposition Missing Due to Fire at Site|4
5043609|NCT02647320|17381822|P2|Overall Study|Disposition Missing Due to Fire at Site|3
5043610|NCT02647320|17381823|P1|Overall Study|Disposition Missing Due to Fire at Site|2
5043611|NCT02647320|17381819|P5|Overall Study|Lack of Efficacy|0
5043612|NCT02647320|17381820|P4|Overall Study|Lack of Efficacy|1
5043613|NCT02647320|17381821|P3|Overall Study|Lack of Efficacy|0
5043614|NCT02647320|17381822|P2|Overall Study|Lack of Efficacy|0
5043615|NCT02647320|17381823|P1|Overall Study|Lack of Efficacy|0
5043616|NCT02647320|17381819|P5|Overall Study|Develop anemia|0
5043617|NCT02647320|17381820|P4|Overall Study|Develop anemia|0
5043618|NCT02647320|17381821|P3|Overall Study|Develop anemia|0
5043619|NCT02647320|17381822|P2|Overall Study|Develop anemia|0
5043620|NCT02647320|17381823|P1|Overall Study|Develop anemia|1
5043621|NCT02647320|17381819|P5|Overall Study|Lost to Follow-up|0
5043622|NCT02647320|17381820|P4|Overall Study|Lost to Follow-up|0
5043623|NCT02647320|17381821|P3|Overall Study|Lost to Follow-up|0
5043624|NCT02647320|17381822|P2|Overall Study|Lost to Follow-up|1
5043625|NCT02647320|17381823|P1|Overall Study|Lost to Follow-up|1
5043626|NCT02647320|17381819|P5|Overall Study|Reason not provided|2
5043627|NCT02647320|17381820|P4|Overall Study|Reason not provided|0
5043628|NCT02647320|17381821|P3|Overall Study|Reason not provided|1
5043629|NCT02647320|17381822|P2|Overall Study|Reason not provided|0
5043630|NCT02647320|17381823|P1|Overall Study|Reason not provided|0
5043631|NCT02647320|17381819|P5|Overall Study|Study terminated by sponsor|2
5043632|NCT02647320|17381820|P4|Overall Study|Study terminated by sponsor|1
5043633|NCT02647320|17381821|P3|Overall Study|Study terminated by sponsor|1
5043634|NCT02647320|17381822|P2|Overall Study|Study terminated by sponsor|1
5043635|NCT02647320|17381823|P1|Overall Study|Study terminated by sponsor|1
5043636|NCT02647320|17381819|P5|Overall Study|Persistent hyperglycemia|1
5043637|NCT02647320|17381820|P4|Overall Study|Persistent hyperglycemia|1
5043638|NCT02647320|17381821|P3|Overall Study|Persistent hyperglycemia|1
5043639|NCT02647320|17381822|P2|Overall Study|Persistent hyperglycemia|1
5043640|NCT02647320|17381823|P1|Overall Study|Persistent hyperglycemia|0
5043641|NCT02647320|17381819|P5|Overall Study|Withdrawal by Subject|7
5043642|NCT02647320|17381820|P4|Overall Study|Withdrawal by Subject|2
5043643|NCT02647320|17381821|P3|Overall Study|Withdrawal by Subject|2
5043644|NCT02647320|17381822|P2|Overall Study|Withdrawal by Subject|4
5043645|NCT02647320|17381823|P1|Overall Study|Withdrawal by Subject|7
5043646|NCT02647320|17381819|P5|Overall Study|Protocol Violation|0
5043647|NCT02647320|17381820|P4|Overall Study|Protocol Violation|0
5043648|NCT02647320|17381821|P3|Overall Study|Protocol Violation|3
5043649|NCT02647320|17381822|P2|Overall Study|Protocol Violation|0
5043650|NCT02647320|17381823|P1|Overall Study|Protocol Violation|0
5043651|NCT02647320|17381819|P5|Overall Study|Adverse Event|1
5043652|NCT02647320|17381820|P4|Overall Study|Adverse Event|2
5043653|NCT02647320|17381821|P3|Overall Study|Adverse Event|3
5043654|NCT02647320|17381822|P2|Overall Study|Adverse Event|1
5043655|NCT02647320|17381823|P1|Overall Study|Adverse Event|0
5043656|NCT02647281|17381914|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
5043657|NCT02647281|17381915|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043658|NCT02647281|17381916|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043659|NCT02647281|17381917|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043660|NCT02647281|17381918|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043661|NCT02647281|17381919|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043662|NCT02647281|17381920|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043663|NCT02647281|17381921|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043664|NCT02647281|17381922|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5043665|NCT02646891|17382110|P10|Overall Study|Death|0
5043666|NCT02646891|17382111|P9|Overall Study|Death|1
5043667|NCT02646891|17382112|P8|Overall Study|Death|1
5043668|NCT02646891|17382113|P7|Overall Study|Death|1
5043669|NCT02646891|17382114|P6|Overall Study|Death|0
5043670|NCT02646891|17382115|P5|Overall Study|Death|0
5043671|NCT02646891|17382116|P4|Overall Study|Death|0
5043672|NCT02646891|17382117|P3|Overall Study|Death|0
5043673|NCT02646891|17382118|P2|Overall Study|Death|0
5043674|NCT02646891|17382119|P1|Overall Study|Death|0
5043675|NCT02646891|17382110|P10|Overall Study|Withdrawal by Subject|3
5043676|NCT02646891|17382111|P9|Overall Study|Withdrawal by Subject|7
5043677|NCT02646891|17382112|P8|Overall Study|Withdrawal by Subject|9
5043678|NCT02646891|17382113|P7|Overall Study|Withdrawal by Subject|5
5043679|NCT02646891|17382114|P6|Overall Study|Withdrawal by Subject|0
5043680|NCT02646891|17382115|P5|Overall Study|Withdrawal by Subject|0
5043681|NCT02646891|17382116|P4|Overall Study|Withdrawal by Subject|0
5043682|NCT02646891|17382117|P3|Overall Study|Withdrawal by Subject|1
5043683|NCT02646891|17382118|P2|Overall Study|Withdrawal by Subject|0
5043684|NCT02646891|17382119|P1|Overall Study|Withdrawal by Subject|2
5043685|NCT02646891|17382110|P10|Overall Study|Protocol Violation|0
5043686|NCT02646891|17382111|P9|Overall Study|Protocol Violation|0
5043687|NCT02646891|17382112|P8|Overall Study|Protocol Violation|1
5043688|NCT02646891|17382113|P7|Overall Study|Protocol Violation|1
5043689|NCT02646891|17382114|P6|Overall Study|Protocol Violation|0
5043690|NCT02646891|17382115|P5|Overall Study|Protocol Violation|0
5043691|NCT02646891|17382116|P4|Overall Study|Protocol Violation|0
5043692|NCT02646891|17382117|P3|Overall Study|Protocol Violation|0
5043693|NCT02646891|17382118|P2|Overall Study|Protocol Violation|0
5043694|NCT02646891|17382119|P1|Overall Study|Protocol Violation|0
5043695|NCT02646891|17382110|P10|Overall Study|Lost to Follow-up|2
5043696|NCT02646891|17382111|P9|Overall Study|Lost to Follow-up|2
5043697|NCT02646891|17382112|P8|Overall Study|Lost to Follow-up|2
5043698|NCT02646891|17382113|P7|Overall Study|Lost to Follow-up|2
5043699|NCT02646891|17382114|P6|Overall Study|Lost to Follow-up|0
5043700|NCT02646891|17382115|P5|Overall Study|Lost to Follow-up|0
5043701|NCT02646891|17382116|P4|Overall Study|Lost to Follow-up|0
5043702|NCT02646891|17382117|P3|Overall Study|Lost to Follow-up|0
5043703|NCT02646891|17382118|P2|Overall Study|Lost to Follow-up|0
5043704|NCT02646891|17382119|P1|Overall Study|Lost to Follow-up|0
5043705|NCT02646891|17382110|P10|Overall Study|Adverse Event|0
5043706|NCT02646891|17382111|P9|Overall Study|Adverse Event|0
5043707|NCT02646891|17382112|P8|Overall Study|Adverse Event|0
5043708|NCT02646891|17382113|P7|Overall Study|Adverse Event|0
5043709|NCT02646891|17382114|P6|Overall Study|Adverse Event|0
5043710|NCT02646891|17382115|P5|Overall Study|Adverse Event|0
5043711|NCT02646891|17382116|P4|Overall Study|Adverse Event|0
5043712|NCT02646891|17382117|P3|Overall Study|Adverse Event|0
5043713|NCT02646891|17382118|P2|Overall Study|Adverse Event|1
5043714|NCT02646891|17382119|P1|Overall Study|Adverse Event|0
5043715|NCT02646566|17382293|P3|Overall Study|Treatment failure|0
5043716|NCT02646566|17382294|P2|Overall Study|Treatment failure|0
5043717|NCT02646566|17382295|P1|Overall Study|Treatment failure|1
5043718|NCT02646566|17382293|P3|Overall Study|Lost to Follow-up|5
5043719|NCT02646566|17382294|P2|Overall Study|Lost to Follow-up|4
5043720|NCT02646566|17382295|P1|Overall Study|Lost to Follow-up|5
5043721|NCT02646332|17382346|P2|Overall Study|Lost to Follow-up|3
5043722|NCT02646332|17382347|P1|Overall Study|Lost to Follow-up|0
5043723|NCT02646124|17382355|P2|Overall Study|Lost to Follow-up|2
5043724|NCT02646124|17382356|P1|Overall Study|Lost to Follow-up|0
5043725|NCT02645409|17382392|P2|Overall Study|Physician Decision|0
5043726|NCT02645409|17382393|P1|Overall Study|Physician Decision|1
5043727|NCT02645409|17382392|P2|Overall Study|Withdrawal by Subject|0
5043728|NCT02645409|17382393|P1|Overall Study|Withdrawal by Subject|3
5043729|NCT02644668|17382580|P3|Overall Study|Withdrawal by Subject|1
5043730|NCT02644668|17382581|P2|Overall Study|Withdrawal by Subject|0
5043731|NCT02644668|17382582|P1|Overall Study|Withdrawal by Subject|0
5043732|NCT02644668|17382580|P3|Overall Study|Protocol Violation|1
5043733|NCT02644668|17382581|P2|Overall Study|Protocol Violation|0
5043734|NCT02644668|17382582|P1|Overall Study|Protocol Violation|0
5043735|NCT02644668|17382580|P3|Overall Study|Adverse Event|1
5043736|NCT02644668|17382581|P2|Overall Study|Adverse Event|0
5043737|NCT02644668|17382582|P1|Overall Study|Adverse Event|2
5043738|NCT02644356|17382621|P1|Overall Study|Withdrawal by Subject|2
5043739|NCT02644343|17382631|P1|Overall Study|Withdrawal by Subject|1
5043740|NCT02644122|17382708|P1|Overall Study|Withdrawal by Subject|1
5043741|NCT02644109|17382718|P2|Overall Study|Adverse Event|4
5043742|NCT02644109|17382719|P1|Overall Study|Adverse Event|0
5043743|NCT02644096|17382727|P2|Overall Study|Withdrawal by Subject|25
5043744|NCT02644096|17382728|P1|Overall Study|Withdrawal by Subject|28
5043745|NCT02643693|17382780|P6|Overall Study|Protocol Adherence Issues|1
5043746|NCT02643693|17382781|P5|Overall Study|Protocol Adherence Issues|0
5043747|NCT02643693|17382782|P4|Overall Study|Protocol Adherence Issues|0
5043748|NCT02643693|17382783|P3|Overall Study|Protocol Adherence Issues|1
5043749|NCT02643693|17382784|P2|Overall Study|Protocol Adherence Issues|0
5043750|NCT02643693|17382785|P1|Overall Study|Protocol Adherence Issues|2
5043751|NCT02643693|17382780|P6|Overall Study|Withdrawal by Subject|0
5043752|NCT02643693|17382781|P5|Overall Study|Withdrawal by Subject|0
5043753|NCT02643693|17382782|P4|Overall Study|Withdrawal by Subject|0
5043754|NCT02643693|17382783|P3|Overall Study|Withdrawal by Subject|0
5043755|NCT02643693|17382784|P2|Overall Study|Withdrawal by Subject|1
5043756|NCT02643693|17382785|P1|Overall Study|Withdrawal by Subject|0
5043757|NCT02643693|17382780|P6|Overall Study|Physician Decision|0
5043758|NCT02643693|17382781|P5|Overall Study|Physician Decision|0
5043759|NCT02643693|17382782|P4|Overall Study|Physician Decision|0
5043760|NCT02643693|17382783|P3|Overall Study|Physician Decision|0
5043761|NCT02643693|17382784|P2|Overall Study|Physician Decision|1
5043762|NCT02643693|17382785|P1|Overall Study|Physician Decision|0
5043763|NCT02643628|17382798|P2|Overall Study|Relocated out of state|1
5043764|NCT02643628|17382799|P1|Overall Study|Relocated out of state|0
5043765|NCT02643628|17382798|P2|Overall Study|Withdrawal by Subject|1
5043766|NCT02643628|17382799|P1|Overall Study|Withdrawal by Subject|0
5043767|NCT02643628|17382798|P2|Overall Study|Lost to Follow-up|4
5043768|NCT02643628|17382799|P1|Overall Study|Lost to Follow-up|1
5043769|NCT02643472|17382830|P2|Overall Study|Lost to Follow-up|26
5043770|NCT02643472|17382831|P1|Overall Study|Lost to Follow-up|22
5043771|NCT02643472|17382830|P2|Overall Study|Protocol Violation|1
5043772|NCT02643472|17382831|P1|Overall Study|Protocol Violation|0
5043773|NCT02643472|17382830|P2|Overall Study|Withdrawal by Subject|2
5043774|NCT02643472|17382831|P1|Overall Study|Withdrawal by Subject|3
5043775|NCT02643472|17382830|P2|Overall Study|Death|5
5043776|NCT02643472|17382831|P1|Overall Study|Death|2
5043777|NCT02643394|17382857|P2|Overall Study|Protocol Violation|5
5043778|NCT02643394|17382858|P1|Overall Study|Protocol Violation|4
5043779|NCT02643355|17382868|P2|Overall Study|Protocol Violation|2
5043780|NCT02643355|17382869|P1|Overall Study|Protocol Violation|0
5043781|NCT02643355|17382868|P2|Overall Study|Withdrawal by Subject|3
5043782|NCT02643355|17382869|P1|Overall Study|Withdrawal by Subject|1
5043783|NCT02643251|17382883|P2|Overall Study|PI Decision to terminate patient|0
5043784|NCT02643251|17382884|P1|Overall Study|PI Decision to terminate patient|1
5043785|NCT02643251|17382883|P2|Overall Study|Protocol Violation|0
5043786|NCT02643251|17382884|P1|Overall Study|Protocol Violation|1
5043787|NCT02643251|17382883|P2|Overall Study|Lost to Follow-up|1
5043788|NCT02643251|17382884|P1|Overall Study|Lost to Follow-up|4
5043789|NCT02643251|17382883|P2|Overall Study|Withdrawal by Subject|0
5043790|NCT02643251|17382884|P1|Overall Study|Withdrawal by Subject|2
5043791|NCT02643251|17382883|P2|Overall Study|Adverse Event|1
5043792|NCT02643251|17382884|P1|Overall Study|Adverse Event|3
5043793|NCT02643082|17382916|P2|Period 1|Adverse Event|0
5043794|NCT02643082|17382917|P1|Period 1|Adverse Event|1
5043795|NCT02642965|17382975|P1|Overall Study|Physician Decision|9
5043796|NCT02642965|17382975|P1|Overall Study|Lack of Efficacy|4
5043797|NCT02642679|17383019|P1|Overall Study|Physician Decision|1
5043798|NCT02642679|17383019|P1|Overall Study|Physician Decision|1
5043799|NCT02642679|17383019|P1|Overall Study|Withdrawal by Subject|1
5043800|NCT02642653|17383027|P2|Overall Study|Adverse Event|0
5043801|NCT02642653|17383028|P1|Overall Study|Adverse Event|2
5043802|NCT02642614|17383069|P4|Overall Study|Withdrawal by Subject|0
5043803|NCT02642614|17383070|P3|Overall Study|Withdrawal by Subject|0
5043804|NCT02642614|17383071|P2|Overall Study|Withdrawal by Subject|1
5043805|NCT02642614|17383072|P1|Overall Study|Withdrawal by Subject|1
5043806|NCT02642614|17383069|P4|Overall Study|Lost to Follow-up|0
5043807|NCT02642614|17383070|P3|Overall Study|Lost to Follow-up|0
5043808|NCT02642614|17383071|P2|Overall Study|Lost to Follow-up|0
5043809|NCT02642614|17383072|P1|Overall Study|Lost to Follow-up|1
5043810|NCT02642614|17383069|P4|Overall Study|Adverse Event|2
5043811|NCT02642614|17383070|P3|Overall Study|Adverse Event|2
5043812|NCT02642614|17383071|P2|Overall Study|Adverse Event|1
5043813|NCT02642614|17383072|P1|Overall Study|Adverse Event|1
5043814|NCT02642432|17383139|P1|Overall Study|Other|3
5043815|NCT02642432|17383139|P1|Overall Study|Lost to Follow-up|2
5043816|NCT02642432|17383139|P1|Overall Study|Withdrew Consent|1
5043817|NCT02642432|17383139|P1|Overall Study|Adverse Event|2
5043818|NCT02642159|17383185|P2|Overall Study|Other than specified above|3
5043819|NCT02642159|17383186|P1|Overall Study|Other than specified above|10
5043820|NCT02642159|17383185|P2|Overall Study|Poor compliance to study protocol|0
5043821|NCT02642159|17383186|P1|Overall Study|Poor compliance to study protocol|1
5043822|NCT02642159|17383185|P2|Overall Study|Withdrawal by Subject|1
5043823|NCT02642159|17383186|P1|Overall Study|Withdrawal by Subject|9
5043824|NCT02642159|17383185|P2|Overall Study|Adverse Event|4
5043825|NCT02642159|17383186|P1|Overall Study|Adverse Event|10
5043826|NCT02642159|17383185|P2|Overall Study|Randomized but not treated|0
5043827|NCT02642159|17383186|P1|Overall Study|Randomized but not treated|1
5043828|NCT02641730|17383310|P5|Observational Period (Week 60 - Week 84)|Other|1
5043829|NCT02641730|17383311|P4|Observational Period (Week 60 - Week 84)|Other|0
5043830|NCT02641730|17383312|P3|Observational Period (Week 60 - Week 84)|Other|0
5043831|NCT02641730|17383313|P2|Observational Period (Week 60 - Week 84)|Other|0
5043832|NCT02641730|17383314|P1|Observational Period (Week 60 - Week 84)|Other|0
5043833|NCT02641730|17383310|P5|After Controlled Period (Week 16 - 52)|Other|1
5043834|NCT02641730|17383311|P4|After Controlled Period (Week 16 - 52)|Other|0
5043835|NCT02641730|17383312|P3|After Controlled Period (Week 16 - 52)|Other|1
5043836|NCT02641730|17383313|P2|After Controlled Period (Week 16 - 52)|Other|1
5043837|NCT02641730|17383314|P1|After Controlled Period (Week 16 - 52)|Other|0
5043838|NCT02641730|17383310|P5|After Controlled Period (Week 16 - 52)|Pregnancy|1
5043839|NCT02641730|17383311|P4|After Controlled Period (Week 16 - 52)|Pregnancy|1
5043840|NCT02641730|17383312|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
5043841|NCT02641730|17383313|P2|After Controlled Period (Week 16 - 52)|Pregnancy|0
5043842|NCT02641730|17383314|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
5043843|NCT02641730|17383310|P5|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5043844|NCT02641730|17383311|P4|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
5043845|NCT02641730|17383312|P3|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5043846|NCT02641730|17383313|P2|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
5043847|NCT02641730|17383314|P1|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5043848|NCT02641730|17383310|P5|After Controlled Period (Week 16 - 52)|Adverse Event|4
5043849|NCT02641730|17383311|P4|After Controlled Period (Week 16 - 52)|Adverse Event|5
5043850|NCT02641730|17383312|P3|After Controlled Period (Week 16 - 52)|Adverse Event|1
5043851|NCT02641730|17383313|P2|After Controlled Period (Week 16 - 52)|Adverse Event|1
5043852|NCT02641730|17383314|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
5043853|NCT02641730|17383310|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
5043854|NCT02641730|17383311|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
5043855|NCT02641730|17383312|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
5043856|NCT02641730|17383313|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
5043857|NCT02641730|17383314|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
5043858|NCT02641587|17383418|P2|Ambulatory Period|Withdrawal by Subject|0
5043859|NCT02641587|17383419|P1|Ambulatory Period|Withdrawal by Subject|1
5043860|NCT02641587|17383418|P2|Confinement Period|Withdrawal by Subject|1
5043861|NCT02641587|17383419|P1|Confinement Period|Withdrawal by Subject|2
5043862|NCT02641587|17383418|P2|Confinement Period|Adverse Event|0
5043863|NCT02641587|17383419|P1|Confinement Period|Adverse Event|1
5043864|NCT02641392|17383540|P3|Overall Study|Death|1
5043865|NCT02641392|17383541|P2|Overall Study|Death|0
5043866|NCT02641392|17383542|P1|Overall Study|Death|0
5043867|NCT02641392|17383540|P3|Overall Study|Miscellaneous|3
5043868|NCT02641392|17383541|P2|Overall Study|Miscellaneous|0
5043869|NCT02641392|17383542|P1|Overall Study|Miscellaneous|0
5043870|NCT02641392|17383540|P3|Overall Study|Lack of Efficacy|101
5043871|NCT02641392|17383541|P2|Overall Study|Lack of Efficacy|0
5043872|NCT02641392|17383542|P1|Overall Study|Lack of Efficacy|0
5043873|NCT02641392|17383540|P3|Overall Study|Study Terminated by Sponsor|144
5043874|NCT02641392|17383541|P2|Overall Study|Study Terminated by Sponsor|12
5043875|NCT02641392|17383542|P1|Overall Study|Study Terminated by Sponsor|4
5043876|NCT02641392|17383540|P3|Overall Study|Adverse Event|25
5043877|NCT02641392|17383541|P2|Overall Study|Adverse Event|1
5043878|NCT02641392|17383542|P1|Overall Study|Adverse Event|0
5043879|NCT02641392|17383540|P3|Overall Study|Withdrawal by Subject|17
5043880|NCT02641392|17383541|P2|Overall Study|Withdrawal by Subject|0
5043881|NCT02641392|17383542|P1|Overall Study|Withdrawal by Subject|0
5043882|NCT02641392|17383540|P3|Overall Study|Lost to Follow-up|2
5043883|NCT02641392|17383541|P2|Overall Study|Lost to Follow-up|0
5043884|NCT02641392|17383542|P1|Overall Study|Lost to Follow-up|0
5043885|NCT02641379|17383561|P11|Overall Study|PCR positive|0
5043886|NCT02641379|17383562|P10|Overall Study|PCR positive|0
5043887|NCT02641379|17383563|P9|Overall Study|PCR positive|0
5043888|NCT02641379|17383564|P8|Overall Study|PCR positive|0
5043889|NCT02641379|17383565|P7|Overall Study|PCR positive|1
5043890|NCT02641379|17383566|P6|Overall Study|PCR positive|0
5043891|NCT02641379|17383567|P5|Overall Study|PCR positive|0
5043892|NCT02641379|17383568|P4|Overall Study|PCR positive|0
5043893|NCT02641379|17383569|P3|Overall Study|PCR positive|0
5043894|NCT02641379|17383570|P2|Overall Study|PCR positive|0
5043895|NCT02641379|17383571|P1|Overall Study|PCR positive|0
5043896|NCT02641379|17383561|P11|Overall Study|Missing PCR result at Week 8|0
5043897|NCT02641379|17383562|P10|Overall Study|Missing PCR result at Week 8|1
5043898|NCT02641379|17383563|P9|Overall Study|Missing PCR result at Week 8|0
5043899|NCT02641379|17383564|P8|Overall Study|Missing PCR result at Week 8|0
5043900|NCT02641379|17383565|P7|Overall Study|Missing PCR result at Week 8|0
5043901|NCT02641379|17383566|P6|Overall Study|Missing PCR result at Week 8|0
5043902|NCT02641379|17383567|P5|Overall Study|Missing PCR result at Week 8|0
5043903|NCT02641379|17383568|P4|Overall Study|Missing PCR result at Week 8|0
5043904|NCT02641379|17383569|P3|Overall Study|Missing PCR result at Week 8|0
5043905|NCT02641379|17383570|P2|Overall Study|Missing PCR result at Week 8|0
5043906|NCT02641379|17383571|P1|Overall Study|Missing PCR result at Week 8|0
5043907|NCT02641379|17383561|P11|Overall Study|Participant treated after Week 24|0
5043908|NCT02641379|17383562|P10|Overall Study|Participant treated after Week 24|0
5043909|NCT02641379|17383563|P9|Overall Study|Participant treated after Week 24|1
5043910|NCT02641379|17383564|P8|Overall Study|Participant treated after Week 24|0
5043911|NCT02641379|17383565|P7|Overall Study|Participant treated after Week 24|0
5043912|NCT02641379|17383566|P6|Overall Study|Participant treated after Week 24|0
5043913|NCT02641379|17383567|P5|Overall Study|Participant treated after Week 24|0
5043914|NCT02641379|17383568|P4|Overall Study|Participant treated after Week 24|0
5043915|NCT02641379|17383569|P3|Overall Study|Participant treated after Week 24|0
5043916|NCT02641379|17383570|P2|Overall Study|Participant treated after Week 24|0
5043917|NCT02641379|17383571|P1|Overall Study|Participant treated after Week 24|0
5043918|NCT02641379|17383561|P11|Overall Study|Participant's PCR high|0
5043919|NCT02641379|17383562|P10|Overall Study|Participant's PCR high|0
5043920|NCT02641379|17383563|P9|Overall Study|Participant's PCR high|0
5043921|NCT02641379|17383564|P8|Overall Study|Participant's PCR high|1
5043922|NCT02641379|17383565|P7|Overall Study|Participant's PCR high|0
5043923|NCT02641379|17383566|P6|Overall Study|Participant's PCR high|0
5043924|NCT02641379|17383567|P5|Overall Study|Participant's PCR high|0
5043925|NCT02641379|17383568|P4|Overall Study|Participant's PCR high|0
5043926|NCT02641379|17383569|P3|Overall Study|Participant's PCR high|0
5043927|NCT02641379|17383570|P2|Overall Study|Participant's PCR high|0
5043928|NCT02641379|17383571|P1|Overall Study|Participant's PCR high|0
5043929|NCT02641379|17383561|P11|Overall Study|Negative PCR result|0
5043930|NCT02641379|17383562|P10|Overall Study|Negative PCR result|1
5043931|NCT02641379|17383563|P9|Overall Study|Negative PCR result|0
5043932|NCT02641379|17383564|P8|Overall Study|Negative PCR result|0
5043933|NCT02641379|17383565|P7|Overall Study|Negative PCR result|0
5043934|NCT02641379|17383566|P6|Overall Study|Negative PCR result|0
5043935|NCT02641379|17383567|P5|Overall Study|Negative PCR result|0
5043936|NCT02641379|17383568|P4|Overall Study|Negative PCR result|0
5043937|NCT02641379|17383569|P3|Overall Study|Negative PCR result|0
5043938|NCT02641379|17383570|P2|Overall Study|Negative PCR result|0
5043939|NCT02641379|17383571|P1|Overall Study|Negative PCR result|0
5043940|NCT02641379|17383561|P11|Overall Study|No 2 Log drop at Week 12|1
5043941|NCT02641379|17383562|P10|Overall Study|No 2 Log drop at Week 12|0
5043942|NCT02641379|17383563|P9|Overall Study|No 2 Log drop at Week 12|0
5043943|NCT02641379|17383564|P8|Overall Study|No 2 Log drop at Week 12|0
5043944|NCT02641379|17383565|P7|Overall Study|No 2 Log drop at Week 12|0
5043945|NCT02641379|17383566|P6|Overall Study|No 2 Log drop at Week 12|0
5043946|NCT02641379|17383567|P5|Overall Study|No 2 Log drop at Week 12|0
5043947|NCT02641379|17383568|P4|Overall Study|No 2 Log drop at Week 12|0
5043948|NCT02641379|17383569|P3|Overall Study|No 2 Log drop at Week 12|0
5043949|NCT02641379|17383570|P2|Overall Study|No 2 Log drop at Week 12|0
5043950|NCT02641379|17383571|P1|Overall Study|No 2 Log drop at Week 12|0
5043951|NCT02641379|17383561|P11|Overall Study|Non-response Week 12|0
5043952|NCT02641379|17383562|P10|Overall Study|Non-response Week 12|0
5043953|NCT02641379|17383563|P9|Overall Study|Non-response Week 12|0
5043954|NCT02641379|17383564|P8|Overall Study|Non-response Week 12|1
5043955|NCT02641379|17383565|P7|Overall Study|Non-response Week 12|0
5043956|NCT02641379|17383566|P6|Overall Study|Non-response Week 12|0
5043957|NCT02641379|17383567|P5|Overall Study|Non-response Week 12|0
5043958|NCT02641379|17383568|P4|Overall Study|Non-response Week 12|0
5043959|NCT02641379|17383569|P3|Overall Study|Non-response Week 12|0
5043960|NCT02641379|17383570|P2|Overall Study|Non-response Week 12|0
5043961|NCT02641379|17383571|P1|Overall Study|Non-response Week 12|0
5043962|NCT02641379|17383561|P11|Overall Study|Participant showed weight reduction|0
5043963|NCT02641379|17383562|P10|Overall Study|Participant showed weight reduction|0
5043964|NCT02641379|17383563|P9|Overall Study|Participant showed weight reduction|0
5043965|NCT02641379|17383564|P8|Overall Study|Participant showed weight reduction|1
5043966|NCT02641379|17383565|P7|Overall Study|Participant showed weight reduction|0
5043967|NCT02641379|17383566|P6|Overall Study|Participant showed weight reduction|0
5043968|NCT02641379|17383567|P5|Overall Study|Participant showed weight reduction|0
5043969|NCT02641379|17383568|P4|Overall Study|Participant showed weight reduction|0
5043970|NCT02641379|17383569|P3|Overall Study|Participant showed weight reduction|0
5043971|NCT02641379|17383570|P2|Overall Study|Participant showed weight reduction|0
5043972|NCT02641379|17383571|P1|Overall Study|Participant showed weight reduction|0
5043973|NCT02641379|17383561|P11|Overall Study|Source data not found|0
5043974|NCT02641379|17383562|P10|Overall Study|Source data not found|0
5043975|NCT02641379|17383563|P9|Overall Study|Source data not found|0
5043976|NCT02641379|17383564|P8|Overall Study|Source data not found|0
5043977|NCT02641379|17383565|P7|Overall Study|Source data not found|0
5043978|NCT02641379|17383566|P6|Overall Study|Source data not found|1
5043979|NCT02641379|17383567|P5|Overall Study|Source data not found|0
5043980|NCT02641379|17383568|P4|Overall Study|Source data not found|0
5043981|NCT02641379|17383569|P3|Overall Study|Source data not found|0
5043982|NCT02641379|17383570|P2|Overall Study|Source data not found|0
5043983|NCT02641379|17383571|P1|Overall Study|Source data not found|0
5043984|NCT02641379|17383561|P11|Overall Study|Lost to Follow-up|0
5043985|NCT02641379|17383562|P10|Overall Study|Lost to Follow-up|0
5043986|NCT02641379|17383563|P9|Overall Study|Lost to Follow-up|1
5043987|NCT02641379|17383564|P8|Overall Study|Lost to Follow-up|0
5043988|NCT02641379|17383565|P7|Overall Study|Lost to Follow-up|0
5043989|NCT02641379|17383566|P6|Overall Study|Lost to Follow-up|0
5043990|NCT02641379|17383567|P5|Overall Study|Lost to Follow-up|0
5043991|NCT02641379|17383568|P4|Overall Study|Lost to Follow-up|0
5043992|NCT02641379|17383569|P3|Overall Study|Lost to Follow-up|0
5043993|NCT02641379|17383570|P2|Overall Study|Lost to Follow-up|0
5043994|NCT02641379|17383571|P1|Overall Study|Lost to Follow-up|0
5043995|NCT02641379|17383561|P11|Overall Study|Participation in sili rescue study|0
5043996|NCT02641379|17383562|P10|Overall Study|Participation in sili rescue study|0
5043997|NCT02641379|17383563|P9|Overall Study|Participation in sili rescue study|0
5043998|NCT02641379|17383564|P8|Overall Study|Participation in sili rescue study|0
5043999|NCT02641379|17383565|P7|Overall Study|Participation in sili rescue study|0
5044000|NCT02641379|17383566|P6|Overall Study|Participation in sili rescue study|1
5044001|NCT02641379|17383567|P5|Overall Study|Participation in sili rescue study|0
5044002|NCT02641379|17383568|P4|Overall Study|Participation in sili rescue study|0
5044003|NCT02641379|17383569|P3|Overall Study|Participation in sili rescue study|0
5044004|NCT02641379|17383570|P2|Overall Study|Participation in sili rescue study|0
5044005|NCT02641379|17383571|P1|Overall Study|Participation in sili rescue study|0
5044006|NCT02641379|17383561|P11|Overall Study|Protocol Violation|0
5044007|NCT02641379|17383562|P10|Overall Study|Protocol Violation|0
5044008|NCT02641379|17383563|P9|Overall Study|Protocol Violation|1
5044009|NCT02641379|17383564|P8|Overall Study|Protocol Violation|0
5044010|NCT02641379|17383565|P7|Overall Study|Protocol Violation|0
5044011|NCT02641379|17383566|P6|Overall Study|Protocol Violation|0
5044012|NCT02641379|17383567|P5|Overall Study|Protocol Violation|2
5044013|NCT02641379|17383568|P4|Overall Study|Protocol Violation|0
5044014|NCT02641379|17383569|P3|Overall Study|Protocol Violation|0
5044015|NCT02641379|17383570|P2|Overall Study|Protocol Violation|0
5044016|NCT02641379|17383571|P1|Overall Study|Protocol Violation|0
5044017|NCT02641379|17383561|P11|Overall Study|Blood could not be drawn|0
5044018|NCT02641379|17383562|P10|Overall Study|Blood could not be drawn|0
5044019|NCT02641379|17383563|P9|Overall Study|Blood could not be drawn|0
5044020|NCT02641379|17383564|P8|Overall Study|Blood could not be drawn|0
5044021|NCT02641379|17383565|P7|Overall Study|Blood could not be drawn|0
5044022|NCT02641379|17383566|P6|Overall Study|Blood could not be drawn|0
5044023|NCT02641379|17383567|P5|Overall Study|Blood could not be drawn|1
5044024|NCT02641379|17383568|P4|Overall Study|Blood could not be drawn|0
5044025|NCT02641379|17383569|P3|Overall Study|Blood could not be drawn|0
5044026|NCT02641379|17383570|P2|Overall Study|Blood could not be drawn|0
5044027|NCT02641379|17383571|P1|Overall Study|Blood could not be drawn|0
5044028|NCT02641379|17383561|P11|Overall Study|Baseline viral load unavailable|0
5044029|NCT02641379|17383562|P10|Overall Study|Baseline viral load unavailable|0
5044030|NCT02641379|17383563|P9|Overall Study|Baseline viral load unavailable|0
5044031|NCT02641379|17383564|P8|Overall Study|Baseline viral load unavailable|0
5044032|NCT02641379|17383565|P7|Overall Study|Baseline viral load unavailable|0
5044033|NCT02641379|17383566|P6|Overall Study|Baseline viral load unavailable|0
5044034|NCT02641379|17383567|P5|Overall Study|Baseline viral load unavailable|0
5044035|NCT02641379|17383568|P4|Overall Study|Baseline viral load unavailable|1
5044036|NCT02641379|17383569|P3|Overall Study|Baseline viral load unavailable|0
5044037|NCT02641379|17383570|P2|Overall Study|Baseline viral load unavailable|0
5044038|NCT02641379|17383571|P1|Overall Study|Baseline viral load unavailable|0
5044039|NCT02641379|17383561|P11|Overall Study|Inclusion criteria not fulfilled|0
5044040|NCT02641379|17383562|P10|Overall Study|Inclusion criteria not fulfilled|0
5044041|NCT02641379|17383563|P9|Overall Study|Inclusion criteria not fulfilled|0
5044042|NCT02641379|17383564|P8|Overall Study|Inclusion criteria not fulfilled|0
5044043|NCT02641379|17383565|P7|Overall Study|Inclusion criteria not fulfilled|0
5044044|NCT02641379|17383566|P6|Overall Study|Inclusion criteria not fulfilled|0
5044045|NCT02641379|17383567|P5|Overall Study|Inclusion criteria not fulfilled|0
5044046|NCT02641379|17383568|P4|Overall Study|Inclusion criteria not fulfilled|1
5044047|NCT02641379|17383569|P3|Overall Study|Inclusion criteria not fulfilled|0
5044048|NCT02641379|17383570|P2|Overall Study|Inclusion criteria not fulfilled|0
5044049|NCT02641379|17383571|P1|Overall Study|Inclusion criteria not fulfilled|0
5044050|NCT02641379|17383561|P11|Overall Study|PCR sample for Week 4 not drawn|0
5044051|NCT02641379|17383562|P10|Overall Study|PCR sample for Week 4 not drawn|0
5044052|NCT02641379|17383563|P9|Overall Study|PCR sample for Week 4 not drawn|0
5044053|NCT02641379|17383564|P8|Overall Study|PCR sample for Week 4 not drawn|0
5044054|NCT02641379|17383565|P7|Overall Study|PCR sample for Week 4 not drawn|0
5044055|NCT02641379|17383566|P6|Overall Study|PCR sample for Week 4 not drawn|0
5044056|NCT02641379|17383567|P5|Overall Study|PCR sample for Week 4 not drawn|0
5044057|NCT02641379|17383568|P4|Overall Study|PCR sample for Week 4 not drawn|1
5044058|NCT02641379|17383569|P3|Overall Study|PCR sample for Week 4 not drawn|0
5044059|NCT02641379|17383570|P2|Overall Study|PCR sample for Week 4 not drawn|0
5044060|NCT02641379|17383571|P1|Overall Study|PCR sample for Week 4 not drawn|0
5044061|NCT02641379|17383561|P11|Overall Study|PCR positive at Week 28|0
5044062|NCT02641379|17383562|P10|Overall Study|PCR positive at Week 28|0
5044063|NCT02641379|17383563|P9|Overall Study|PCR positive at Week 28|0
5044064|NCT02641379|17383564|P8|Overall Study|PCR positive at Week 28|0
5044065|NCT02641379|17383565|P7|Overall Study|PCR positive at Week 28|0
5044066|NCT02641379|17383566|P6|Overall Study|PCR positive at Week 28|0
5044067|NCT02641379|17383567|P5|Overall Study|PCR positive at Week 28|0
5044068|NCT02641379|17383568|P4|Overall Study|PCR positive at Week 28|0
5044069|NCT02641379|17383569|P3|Overall Study|PCR positive at Week 28|1
5044070|NCT02641379|17383570|P2|Overall Study|PCR positive at Week 28|0
5044071|NCT02641379|17383571|P1|Overall Study|PCR positive at Week 28|0
5044072|NCT02641379|17383561|P11|Overall Study|No PCR at baseline|0
5044073|NCT02641379|17383562|P10|Overall Study|No PCR at baseline|0
5044074|NCT02641379|17383563|P9|Overall Study|No PCR at baseline|0
5044075|NCT02641379|17383564|P8|Overall Study|No PCR at baseline|0
5044076|NCT02641379|17383565|P7|Overall Study|No PCR at baseline|0
5044077|NCT02641379|17383566|P6|Overall Study|No PCR at baseline|0
5044078|NCT02641379|17383567|P5|Overall Study|No PCR at baseline|0
5044079|NCT02641379|17383568|P4|Overall Study|No PCR at baseline|0
5044080|NCT02641379|17383569|P3|Overall Study|No PCR at baseline|1
5044081|NCT02641379|17383570|P2|Overall Study|No PCR at baseline|0
5044082|NCT02641379|17383571|P1|Overall Study|No PCR at baseline|0
5044083|NCT02641379|17383561|P11|Overall Study|PCR not performed at Week 12|0
5044084|NCT02641379|17383562|P10|Overall Study|PCR not performed at Week 12|0
5044085|NCT02641379|17383563|P9|Overall Study|PCR not performed at Week 12|0
5044086|NCT02641379|17383564|P8|Overall Study|PCR not performed at Week 12|0
5044087|NCT02641379|17383565|P7|Overall Study|PCR not performed at Week 12|0
5044088|NCT02641379|17383566|P6|Overall Study|PCR not performed at Week 12|0
5044089|NCT02641379|17383567|P5|Overall Study|PCR not performed at Week 12|0
5044090|NCT02641379|17383568|P4|Overall Study|PCR not performed at Week 12|0
5044091|NCT02641379|17383569|P3|Overall Study|PCR not performed at Week 12|1
5044092|NCT02641379|17383570|P2|Overall Study|PCR not performed at Week 12|0
5044093|NCT02641379|17383571|P1|Overall Study|PCR not performed at Week 12|0
5044094|NCT02641379|17383561|P11|Overall Study|PCR positive at Week 48|0
5044095|NCT02641379|17383562|P10|Overall Study|PCR positive at Week 48|0
5044096|NCT02641379|17383563|P9|Overall Study|PCR positive at Week 48|0
5044097|NCT02641379|17383564|P8|Overall Study|PCR positive at Week 48|0
5044098|NCT02641379|17383565|P7|Overall Study|PCR positive at Week 48|0
5044099|NCT02641379|17383566|P6|Overall Study|PCR positive at Week 48|0
5044100|NCT02641379|17383567|P5|Overall Study|PCR positive at Week 48|0
5044101|NCT02641379|17383568|P4|Overall Study|PCR positive at Week 48|0
5044102|NCT02641379|17383569|P3|Overall Study|PCR positive at Week 48|0
5044103|NCT02641379|17383570|P2|Overall Study|PCR positive at Week 48|1
5044104|NCT02641379|17383571|P1|Overall Study|PCR positive at Week 48|0
5044105|NCT02641379|17383561|P11|Overall Study|PCR positive at Week 68|0
5044106|NCT02641379|17383562|P10|Overall Study|PCR positive at Week 68|0
5044107|NCT02641379|17383563|P9|Overall Study|PCR positive at Week 68|0
5044108|NCT02641379|17383564|P8|Overall Study|PCR positive at Week 68|0
5044109|NCT02641379|17383565|P7|Overall Study|PCR positive at Week 68|0
5044110|NCT02641379|17383566|P6|Overall Study|PCR positive at Week 68|0
5044111|NCT02641379|17383567|P5|Overall Study|PCR positive at Week 68|0
5044112|NCT02641379|17383568|P4|Overall Study|PCR positive at Week 68|0
5044113|NCT02641379|17383569|P3|Overall Study|PCR positive at Week 68|0
5044114|NCT02641379|17383570|P2|Overall Study|PCR positive at Week 68|1
5044115|NCT02641379|17383571|P1|Overall Study|PCR positive at Week 68|0
5044116|NCT02641379|17383561|P11|Overall Study|Financial problems|0
5044117|NCT02641379|17383562|P10|Overall Study|Financial problems|0
5044118|NCT02641379|17383563|P9|Overall Study|Financial problems|0
5044119|NCT02641379|17383564|P8|Overall Study|Financial problems|0
5044120|NCT02641379|17383565|P7|Overall Study|Financial problems|0
5044121|NCT02641379|17383566|P6|Overall Study|Financial problems|0
5044122|NCT02641379|17383567|P5|Overall Study|Financial problems|0
5044123|NCT02641379|17383568|P4|Overall Study|Financial problems|0
5044124|NCT02641379|17383569|P3|Overall Study|Financial problems|0
5044125|NCT02641379|17383570|P2|Overall Study|Financial problems|1
5044126|NCT02641379|17383571|P1|Overall Study|Financial problems|0
5044127|NCT02641379|17383561|P11|Overall Study|Therapy stopped due to misunderstanding|0
5044128|NCT02641379|17383562|P10|Overall Study|Therapy stopped due to misunderstanding|0
5044129|NCT02641379|17383563|P9|Overall Study|Therapy stopped due to misunderstanding|0
5044130|NCT02641379|17383564|P8|Overall Study|Therapy stopped due to misunderstanding|0
5044131|NCT02641379|17383565|P7|Overall Study|Therapy stopped due to misunderstanding|0
5044132|NCT02641379|17383566|P6|Overall Study|Therapy stopped due to misunderstanding|0
5044133|NCT02641379|17383567|P5|Overall Study|Therapy stopped due to misunderstanding|0
5044134|NCT02641379|17383568|P4|Overall Study|Therapy stopped due to misunderstanding|0
5044135|NCT02641379|17383569|P3|Overall Study|Therapy stopped due to misunderstanding|0
5044136|NCT02641379|17383570|P2|Overall Study|Therapy stopped due to misunderstanding|0
5044137|NCT02641379|17383571|P1|Overall Study|Therapy stopped due to misunderstanding|1
5044138|NCT02641379|17383561|P11|Overall Study|Participant stopped study/treatment|0
5044139|NCT02641379|17383562|P10|Overall Study|Participant stopped study/treatment|0
5044140|NCT02641379|17383563|P9|Overall Study|Participant stopped study/treatment|1
5044141|NCT02641379|17383564|P8|Overall Study|Participant stopped study/treatment|0
5044142|NCT02641379|17383565|P7|Overall Study|Participant stopped study/treatment|2
5044143|NCT02641379|17383566|P6|Overall Study|Participant stopped study/treatment|1
5044144|NCT02641379|17383567|P5|Overall Study|Participant stopped study/treatment|0
5044145|NCT02641379|17383568|P4|Overall Study|Participant stopped study/treatment|0
5044146|NCT02641379|17383569|P3|Overall Study|Participant stopped study/treatment|1
5044147|NCT02641379|17383570|P2|Overall Study|Participant stopped study/treatment|3
5044148|NCT02641379|17383571|P1|Overall Study|Participant stopped study/treatment|1
5044149|NCT02641379|17383561|P11|Overall Study|Participant showed relapse|0
5044150|NCT02641379|17383562|P10|Overall Study|Participant showed relapse|0
5044151|NCT02641379|17383563|P9|Overall Study|Participant showed relapse|0
5044152|NCT02641379|17383564|P8|Overall Study|Participant showed relapse|0
5044153|NCT02641379|17383565|P7|Overall Study|Participant showed relapse|1
5044154|NCT02641379|17383566|P6|Overall Study|Participant showed relapse|0
5044155|NCT02641379|17383567|P5|Overall Study|Participant showed relapse|0
5044156|NCT02641379|17383568|P4|Overall Study|Participant showed relapse|0
5044157|NCT02641379|17383569|P3|Overall Study|Participant showed relapse|0
5044158|NCT02641379|17383570|P2|Overall Study|Participant showed relapse|0
5044159|NCT02641379|17383571|P1|Overall Study|Participant showed relapse|1
5044160|NCT02641379|17383561|P11|Overall Study|PCR positive at follow up 2|0
5044161|NCT02641379|17383562|P10|Overall Study|PCR positive at follow up 2|0
5044162|NCT02641379|17383563|P9|Overall Study|PCR positive at follow up 2|0
5044163|NCT02641379|17383564|P8|Overall Study|PCR positive at follow up 2|0
5044164|NCT02641379|17383565|P7|Overall Study|PCR positive at follow up 2|0
5044165|NCT02641379|17383566|P6|Overall Study|PCR positive at follow up 2|0
5044166|NCT02641379|17383567|P5|Overall Study|PCR positive at follow up 2|0
5044167|NCT02641379|17383568|P4|Overall Study|PCR positive at follow up 2|0
5044168|NCT02641379|17383569|P3|Overall Study|PCR positive at follow up 2|0
5044169|NCT02641379|17383570|P2|Overall Study|PCR positive at follow up 2|0
5044170|NCT02641379|17383571|P1|Overall Study|PCR positive at follow up 2|1
5044171|NCT02641379|17383561|P11|Overall Study|PCR positive at Week 24|0
5044172|NCT02641379|17383562|P10|Overall Study|PCR positive at Week 24|1
5044173|NCT02641379|17383563|P9|Overall Study|PCR positive at Week 24|0
5044174|NCT02641379|17383564|P8|Overall Study|PCR positive at Week 24|8
5044175|NCT02641379|17383565|P7|Overall Study|PCR positive at Week 24|3
5044176|NCT02641379|17383566|P6|Overall Study|PCR positive at Week 24|6
5044177|NCT02641379|17383567|P5|Overall Study|PCR positive at Week 24|0
5044178|NCT02641379|17383568|P4|Overall Study|PCR positive at Week 24|0
5044179|NCT02641379|17383569|P3|Overall Study|PCR positive at Week 24|62
5044180|NCT02641379|17383570|P2|Overall Study|PCR positive at Week 24|21
5044181|NCT02641379|17383571|P1|Overall Study|PCR positive at Week 24|15
5044182|NCT02641379|17383561|P11|Overall Study|Participant cannot be reached|1
5044183|NCT02641379|17383562|P10|Overall Study|Participant cannot be reached|2
5044184|NCT02641379|17383563|P9|Overall Study|Participant cannot be reached|0
5044185|NCT02641379|17383564|P8|Overall Study|Participant cannot be reached|1
5044186|NCT02641379|17383565|P7|Overall Study|Participant cannot be reached|0
5044187|NCT02641379|17383566|P6|Overall Study|Participant cannot be reached|1
5044188|NCT02641379|17383567|P5|Overall Study|Participant cannot be reached|2
5044189|NCT02641379|17383568|P4|Overall Study|Participant cannot be reached|8
5044190|NCT02641379|17383569|P3|Overall Study|Participant cannot be reached|0
5044191|NCT02641379|17383570|P2|Overall Study|Participant cannot be reached|4
5044192|NCT02641379|17383571|P1|Overall Study|Participant cannot be reached|4
5044193|NCT02641379|17383561|P11|Overall Study|Participant's compliance|1
5044194|NCT02641379|17383562|P10|Overall Study|Participant's compliance|1
5044195|NCT02641379|17383563|P9|Overall Study|Participant's compliance|1
5044196|NCT02641379|17383564|P8|Overall Study|Participant's compliance|0
5044197|NCT02641379|17383565|P7|Overall Study|Participant's compliance|0
5044198|NCT02641379|17383566|P6|Overall Study|Participant's compliance|2
5044199|NCT02641379|17383567|P5|Overall Study|Participant's compliance|0
5044200|NCT02641379|17383568|P4|Overall Study|Participant's compliance|1
5044201|NCT02641379|17383569|P3|Overall Study|Participant's compliance|0
5044202|NCT02641379|17383570|P2|Overall Study|Participant's compliance|1
5044203|NCT02641379|17383571|P1|Overall Study|Participant's compliance|0
5044204|NCT02641379|17383561|P11|Overall Study|Participant unable to attend study visit|0
5044205|NCT02641379|17383562|P10|Overall Study|Participant unable to attend study visit|2
5044206|NCT02641379|17383563|P9|Overall Study|Participant unable to attend study visit|0
5044207|NCT02641379|17383564|P8|Overall Study|Participant unable to attend study visit|1
5044208|NCT02641379|17383565|P7|Overall Study|Participant unable to attend study visit|1
5044209|NCT02641379|17383566|P6|Overall Study|Participant unable to attend study visit|1
5044210|NCT02641379|17383567|P5|Overall Study|Participant unable to attend study visit|5
5044211|NCT02641379|17383568|P4|Overall Study|Participant unable to attend study visit|2
5044212|NCT02641379|17383569|P3|Overall Study|Participant unable to attend study visit|1
5044213|NCT02641379|17383570|P2|Overall Study|Participant unable to attend study visit|10
5044214|NCT02641379|17383571|P1|Overall Study|Participant unable to attend study visit|4
5044215|NCT02641379|17383561|P11|Overall Study|Lack of Efficacy|0
5044216|NCT02641379|17383562|P10|Overall Study|Lack of Efficacy|0
5044217|NCT02641379|17383563|P9|Overall Study|Lack of Efficacy|0
5044218|NCT02641379|17383564|P8|Overall Study|Lack of Efficacy|5
5044219|NCT02641379|17383565|P7|Overall Study|Lack of Efficacy|0
5044220|NCT02641379|17383566|P6|Overall Study|Lack of Efficacy|2
5044221|NCT02641379|17383567|P5|Overall Study|Lack of Efficacy|0
5044222|NCT02641379|17383568|P4|Overall Study|Lack of Efficacy|0
5044223|NCT02641379|17383569|P3|Overall Study|Lack of Efficacy|2
5044224|NCT02641379|17383570|P2|Overall Study|Lack of Efficacy|0
5044225|NCT02641379|17383571|P1|Overall Study|Lack of Efficacy|0
5044226|NCT02641379|17383561|P11|Overall Study|Adverse Event|5
5044227|NCT02641379|17383562|P10|Overall Study|Adverse Event|1
5044228|NCT02641379|17383563|P9|Overall Study|Adverse Event|1
5044229|NCT02641379|17383564|P8|Overall Study|Adverse Event|0
5044230|NCT02641379|17383565|P7|Overall Study|Adverse Event|5
5044231|NCT02641379|17383566|P6|Overall Study|Adverse Event|1
5044232|NCT02641379|17383567|P5|Overall Study|Adverse Event|5
5044233|NCT02641379|17383568|P4|Overall Study|Adverse Event|2
5044234|NCT02641379|17383569|P3|Overall Study|Adverse Event|2
5044235|NCT02641379|17383570|P2|Overall Study|Adverse Event|8
5044236|NCT02641379|17383571|P1|Overall Study|Adverse Event|7
5044237|NCT02641379|17383561|P11|Overall Study|Withdrawal of informed consent|0
5044238|NCT02641379|17383562|P10|Overall Study|Withdrawal of informed consent|0
5044239|NCT02641379|17383563|P9|Overall Study|Withdrawal of informed consent|0
5044240|NCT02641379|17383564|P8|Overall Study|Withdrawal of informed consent|1
5044241|NCT02641379|17383565|P7|Overall Study|Withdrawal of informed consent|0
5044242|NCT02641379|17383566|P6|Overall Study|Withdrawal of informed consent|0
5044243|NCT02641379|17383567|P5|Overall Study|Withdrawal of informed consent|0
5044244|NCT02641379|17383568|P4|Overall Study|Withdrawal of informed consent|0
5044245|NCT02641379|17383569|P3|Overall Study|Withdrawal of informed consent|0
5044246|NCT02641379|17383570|P2|Overall Study|Withdrawal of informed consent|1
5044247|NCT02641379|17383571|P1|Overall Study|Withdrawal of informed consent|0
5044248|NCT02641379|17383561|P11|Overall Study|Exclusion criterion during screening|0
5044249|NCT02641379|17383562|P10|Overall Study|Exclusion criterion during screening|0
5044250|NCT02641379|17383563|P9|Overall Study|Exclusion criterion during screening|0
5044251|NCT02641379|17383564|P8|Overall Study|Exclusion criterion during screening|0
5044252|NCT02641379|17383565|P7|Overall Study|Exclusion criterion during screening|0
5044253|NCT02641379|17383566|P6|Overall Study|Exclusion criterion during screening|0
5044254|NCT02641379|17383567|P5|Overall Study|Exclusion criterion during screening|2
5044255|NCT02641379|17383568|P4|Overall Study|Exclusion criterion during screening|1
5044256|NCT02641379|17383569|P3|Overall Study|Exclusion criterion during screening|0
5044257|NCT02641379|17383570|P2|Overall Study|Exclusion criterion during screening|0
5044258|NCT02641379|17383571|P1|Overall Study|Exclusion criterion during screening|1
5044259|NCT02641080|17383647|P2|Overall Study|Lost to Follow-up|3
5044260|NCT02641080|17383648|P1|Overall Study|Lost to Follow-up|0
5044261|NCT02641080|17383647|P2|Overall Study|Rehab Center denied use of pumps|3
5044262|NCT02641080|17383648|P1|Overall Study|Rehab Center denied use of pumps|0
5044263|NCT02641080|17383647|P2|Overall Study|Withdrawal by Subject|1
5044264|NCT02641080|17383648|P1|Overall Study|Withdrawal by Subject|0
5044265|NCT02641080|17383647|P2|Overall Study|Physician Decision|0
5044266|NCT02641080|17383648|P1|Overall Study|Physician Decision|2
5044267|NCT02640755|17383704|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
5044268|NCT02640755|17383705|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
5044269|NCT02640755|17383704|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
5044270|NCT02640755|17383705|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
5044271|NCT02640755|17383704|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
5044272|NCT02640755|17383705|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
5044273|NCT02640677|17383759|P1|Overall Study|Withdrawal by Subject|1
5044274|NCT02640677|17383759|P1|Overall Study|Lost to Follow-up|1
5044275|NCT02640625|17383766|P1|Overall Study|Adverse Event|1
5044276|NCT02640612|17383775|P3|Overall Study|Lack of Efficacy|0
5044277|NCT02640612|17383776|P2|Overall Study|Lack of Efficacy|1
5044278|NCT02640612|17383777|P1|Overall Study|Lack of Efficacy|1
5044279|NCT02640612|17383775|P3|Overall Study|Protocol Violation|0
5044280|NCT02640612|17383776|P2|Overall Study|Protocol Violation|2
5044281|NCT02640612|17383777|P1|Overall Study|Protocol Violation|0
5044282|NCT02640612|17383775|P3|Overall Study|Lost to Follow-up|1
5044283|NCT02640612|17383776|P2|Overall Study|Lost to Follow-up|1
5044284|NCT02640612|17383777|P1|Overall Study|Lost to Follow-up|4
5044285|NCT02640612|17383775|P3|Overall Study|Withdrawal by Subject|3
5044286|NCT02640612|17383776|P2|Overall Study|Withdrawal by Subject|3
5044287|NCT02640612|17383777|P1|Overall Study|Withdrawal by Subject|10
5044288|NCT02640612|17383775|P3|Overall Study|Death|0
5044289|NCT02640612|17383776|P2|Overall Study|Death|0
5044290|NCT02640612|17383777|P1|Overall Study|Death|1
5044291|NCT02640612|17383775|P3|Overall Study|Adverse Event|2
5044292|NCT02640612|17383776|P2|Overall Study|Adverse Event|7
5044293|NCT02640612|17383777|P1|Overall Study|Adverse Event|6
5044294|NCT02640547|17383801|P1|Overall Study|Miscellaneous|3
5044295|NCT02640547|17383801|P1|Overall Study|Death|6
5044296|NCT02640547|17383801|P1|Overall Study|Withdrawal by Subject|1
5044297|NCT02640547|17383801|P1|Overall Study|Failure to Return|1
5044298|NCT02640482|17383878|P2|Overall Study|Lost to Follow-up|0
5044299|NCT02640482|17383879|P1|Overall Study|Lost to Follow-up|3
5044300|NCT02640404|17383891|P2|Overall Study|Withdrawal by Subject|0
5044301|NCT02640404|17383892|P1|Overall Study|Withdrawal by Subject|1
5044302|NCT02640404|17383891|P2|Overall Study|Protocol Violation|0
5044303|NCT02640404|17383892|P1|Overall Study|Protocol Violation|1
5044304|NCT02640235|17383902|P2|Overall Study|Other|2
5044305|NCT02640235|17383903|P1|Overall Study|Other|1
5044306|NCT02640235|17383902|P2|Overall Study|Death|3
5044307|NCT02640235|17383903|P1|Overall Study|Death|2
5044308|NCT02640235|17383902|P2|Overall Study|Lost to Follow-up|3
5044309|NCT02640235|17383903|P1|Overall Study|Lost to Follow-up|4
5044310|NCT02640235|17383902|P2|Overall Study|Withdrawal by Subject|6
5044311|NCT02640235|17383903|P1|Overall Study|Withdrawal by Subject|7
5044312|NCT02640157|17383926|P3|Overall Study|Randomized in error; did not receive Tx|0
5044313|NCT02640157|17383927|P2|Overall Study|Randomized in error; did not receive Tx|1
5044314|NCT02640157|17383928|P1|Overall Study|Randomized in error; did not receive Tx|0
5044315|NCT02640157|17383926|P3|Overall Study|Lost to Follow-up|7
5044316|NCT02640157|17383927|P2|Overall Study|Lost to Follow-up|2
5044317|NCT02640157|17383928|P1|Overall Study|Lost to Follow-up|9
5044318|NCT02640157|17383926|P3|Overall Study|Withdrew consent|2
5044319|NCT02640157|17383927|P2|Overall Study|Withdrew consent|0
5044320|NCT02640157|17383928|P1|Overall Study|Withdrew consent|2
5044321|NCT02640157|17383926|P3|Overall Study|Adverse Event|1
5044322|NCT02640157|17383927|P2|Overall Study|Adverse Event|2
5044323|NCT02640157|17383928|P1|Overall Study|Adverse Event|2
5044324|NCT02640053|17383947|P2|Overall Study|Chemo regimen changed after 1st Rx|1
5044325|NCT02640053|17383948|P1|Overall Study|Chemo regimen changed after 1st Rx|0
5044326|NCT02640053|17383947|P2|Overall Study|Alternative Therapy|1
5044327|NCT02640053|17383948|P1|Overall Study|Alternative Therapy|1
5044328|NCT02640053|17383947|P2|Overall Study|Adverse Event|1
5044329|NCT02640053|17383948|P1|Overall Study|Adverse Event|1
5044330|NCT02640053|17383947|P2|Overall Study|Withdrawal by Subject|1
5044331|NCT02640053|17383948|P1|Overall Study|Withdrawal by Subject|2
5044332|NCT02639559|17384055|P2|Overall Study|Issues with vascular acess|0
5044333|NCT02639559|17384056|P1|Overall Study|Issues with vascular acess|1
5044334|NCT02639559|17384055|P2|Overall Study|Mobilization failure|3
5044335|NCT02639559|17384056|P1|Overall Study|Mobilization failure|0
5044336|NCT02639390|17384136|P2|Overall Study|Subject unable to comply with treatment schedule.|2
5044337|NCT02639390|17384137|P1|Overall Study|Subject unable to comply with treatment schedule.|0
5044338|NCT02639338|17384511|P2|Overall Study|Randomized but Not Treated|1
5044339|NCT02639338|17384512|P1|Overall Study|Randomized but Not Treated|0
5044340|NCT02639338|17384511|P2|Overall Study|Death|0
5044341|NCT02639338|17384512|P1|Overall Study|Death|1
5044342|NCT02639338|17384511|P2|Overall Study|Withdrew Consent|2
5044343|NCT02639338|17384512|P1|Overall Study|Withdrew Consent|1
5044344|NCT02639338|17384511|P2|Overall Study|Lost to Follow-up|2
5044345|NCT02639338|17384512|P1|Overall Study|Lost to Follow-up|2
5044346|NCT02639247|17384557|P2|Overall Study|Protocol Violation|0
5044347|NCT02639247|17384558|P1|Overall Study|Protocol Violation|1
5044348|NCT02639247|17384557|P2|Overall Study|Withdrew Consent|1
5044349|NCT02639247|17384558|P1|Overall Study|Withdrew Consent|0
5044350|NCT02639247|17384557|P2|Overall Study|Death|0
5044351|NCT02639247|17384558|P1|Overall Study|Death|2
5044352|NCT02639247|17384557|P2|Overall Study|Lost to Follow-up|1
5044353|NCT02639247|17384558|P1|Overall Study|Lost to Follow-up|2
5044354|NCT02639182|17384576|P2|Overall Study|Participants Still on Study|24
5044355|NCT02639182|17384577|P1|Overall Study|Participants Still on Study|25
5044356|NCT02639182|17384576|P2|Overall Study|Withdrew consent|0
5044357|NCT02639182|17384577|P1|Overall Study|Withdrew consent|6
5044358|NCT02639182|17384576|P2|Overall Study|Lost to Follow-up|1
5044359|NCT02639182|17384577|P1|Overall Study|Lost to Follow-up|1
5044360|NCT02639182|17384576|P2|Overall Study|Death|41
5044361|NCT02639182|17384577|P1|Overall Study|Death|35
5044362|NCT02639052|17384610|P1|Overall Study|Lost to Follow-up|1
5044363|NCT02638948|17384647|P4|Overall Study|Other than specified above|1
5044364|NCT02638948|17384648|P3|Overall Study|Other than specified above|1
5044365|NCT02638948|17384649|P2|Overall Study|Other than specified above|1
5044366|NCT02638948|17384650|P1|Overall Study|Other than specified above|4
5044367|NCT02638948|17384647|P4|Overall Study|Participant no longer met study criteria|0
5044368|NCT02638948|17384648|P3|Overall Study|Participant no longer met study criteria|0
5044369|NCT02638948|17384649|P2|Overall Study|Participant no longer met study criteria|1
5044370|NCT02638948|17384650|P1|Overall Study|Participant no longer met study criteria|0
5044371|NCT02638948|17384647|P4|Overall Study|Poor/Non-Compliance|0
5044372|NCT02638948|17384648|P3|Overall Study|Poor/Non-Compliance|1
5044373|NCT02638948|17384649|P2|Overall Study|Poor/Non-Compliance|2
5044374|NCT02638948|17384650|P1|Overall Study|Poor/Non-Compliance|0
5044375|NCT02638948|17384647|P4|Overall Study|Lost to Follow-up|1
5044376|NCT02638948|17384648|P3|Overall Study|Lost to Follow-up|1
5044377|NCT02638948|17384649|P2|Overall Study|Lost to Follow-up|0
5044378|NCT02638948|17384650|P1|Overall Study|Lost to Follow-up|0
5044379|NCT02638948|17384647|P4|Overall Study|Lack of Efficacy|0
5044380|NCT02638948|17384648|P3|Overall Study|Lack of Efficacy|0
5044381|NCT02638948|17384649|P2|Overall Study|Lack of Efficacy|1
5044382|NCT02638948|17384650|P1|Overall Study|Lack of Efficacy|1
5044383|NCT02638948|17384647|P4|Overall Study|Adverse Event|1
5044384|NCT02638948|17384648|P3|Overall Study|Adverse Event|1
5044385|NCT02638948|17384649|P2|Overall Study|Adverse Event|0
5044386|NCT02638948|17384650|P1|Overall Study|Adverse Event|0
5044387|NCT02638948|17384647|P4|Overall Study|Administrative Reason by Sponsor|4
5044388|NCT02638948|17384648|P3|Overall Study|Administrative Reason by Sponsor|0
5044389|NCT02638948|17384649|P2|Overall Study|Administrative Reason by Sponsor|1
5044390|NCT02638948|17384650|P1|Overall Study|Administrative Reason by Sponsor|0
5044391|NCT02638948|17384647|P4|Overall Study|Withdrawal by Subject|1
5044392|NCT02638948|17384648|P3|Overall Study|Withdrawal by Subject|3
5044393|NCT02638948|17384649|P2|Overall Study|Withdrawal by Subject|5
5044394|NCT02638948|17384650|P1|Overall Study|Withdrawal by Subject|4
5044395|NCT02638623|17384737|P2|Overall Study|Not given intervention|0
5044396|NCT02638623|17384738|P1|Overall Study|Not given intervention|2
5044397|NCT02638623|17384737|P2|Overall Study|Surgery timing|6
5044398|NCT02638623|17384738|P1|Overall Study|Surgery timing|5
5044399|NCT02638493|17384768|P3|Overall Study|Inability to provide semen samples|0
5044400|NCT02638493|17384769|P2|Overall Study|Inability to provide semen samples|0
5044401|NCT02638493|17384770|P1|Overall Study|Inability to provide semen samples|2
5044402|NCT02638337|17384801|P2|Overall Study|Other - Miscellaneous|3
5044403|NCT02638337|17384802|P1|Overall Study|Other - Miscellaneous|4
5044404|NCT02638337|17384801|P2|Overall Study|Lost to Follow-up|7
5044405|NCT02638337|17384802|P1|Overall Study|Lost to Follow-up|7
5044406|NCT02638337|17384801|P2|Overall Study|Withdrawal by Subject|16
5044407|NCT02638337|17384802|P1|Overall Study|Withdrawal by Subject|13
5044408|NCT02638337|17384801|P2|Overall Study|Protocol Violation|0
5044409|NCT02638337|17384802|P1|Overall Study|Protocol Violation|3
5044410|NCT02638337|17384801|P2|Overall Study|Adverse Event|10
5044411|NCT02638337|17384802|P1|Overall Study|Adverse Event|6
5044412|NCT02638259|17384886|P2|Treatment Period 2|Withdrawal by Subject|7
5044413|NCT02638259|17384887|P1|Treatment Period 2|Withdrawal by Subject|1
5044414|NCT02638259|17384886|P2|Treatment Period 2|Adverse Event|4
5044415|NCT02638259|17384887|P1|Treatment Period 2|Adverse Event|5
5044416|NCT02638259|17384886|P2|Treatment Period 1|Withdrawn per sponsor decision|2
5044417|NCT02638259|17384887|P1|Treatment Period 1|Withdrawn per sponsor decision|0
5044418|NCT02638259|17384886|P2|Treatment Period 1|Withdrawal by Subject|6
5044419|NCT02638259|17384887|P1|Treatment Period 1|Withdrawal by Subject|4
5044420|NCT02638259|17384886|P2|Treatment Period 1|Protocol Violation|3
5044421|NCT02638259|17384887|P1|Treatment Period 1|Protocol Violation|0
5044422|NCT02638259|17384886|P2|Treatment Period 1|Lack of Efficacy|1
5044423|NCT02638259|17384887|P1|Treatment Period 1|Lack of Efficacy|0
5044424|NCT02638259|17384886|P2|Treatment Period 1|Death|1
5044425|NCT02638259|17384887|P1|Treatment Period 1|Death|0
5044426|NCT02638259|17384886|P2|Treatment Period 1|Adverse Event|5
5044427|NCT02638259|17384887|P1|Treatment Period 1|Adverse Event|1
5044428|NCT02638129|17384979|P2|Overall Study|Study terminated|30
5044429|NCT02638129|17384980|P1|Overall Study|Study terminated|28
5044430|NCT02638103|17384996|P4|Overall Study|Other than specified|4
5044431|NCT02638103|17384997|P3|Overall Study|Other than specified|2
5044432|NCT02638103|17384998|P2|Overall Study|Other than specified|4
5044433|NCT02638103|17384999|P1|Overall Study|Other than specified|5
5044434|NCT02638103|17384996|P4|Overall Study|Lack of Efficacy|22
5044435|NCT02638103|17384997|P3|Overall Study|Lack of Efficacy|12
5044436|NCT02638103|17384998|P2|Overall Study|Lack of Efficacy|10
5044437|NCT02638103|17384999|P1|Overall Study|Lack of Efficacy|14
5044438|NCT02638103|17384996|P4|Overall Study|Lost to Follow-up|37
5044439|NCT02638103|17384997|P3|Overall Study|Lost to Follow-up|20
5044440|NCT02638103|17384998|P2|Overall Study|Lost to Follow-up|33
5044441|NCT02638103|17384999|P1|Overall Study|Lost to Follow-up|26
5044442|NCT02638103|17384996|P4|Overall Study|Non-compliance to Study Procedures|1
5044443|NCT02638103|17384997|P3|Overall Study|Non-compliance to Study Procedures|1
5044444|NCT02638103|17384998|P2|Overall Study|Non-compliance to Study Procedures|1
5044445|NCT02638103|17384999|P1|Overall Study|Non-compliance to Study Procedures|2
5044446|NCT02638103|17384996|P4|Overall Study|Pregnancy|1
5044447|NCT02638103|17384997|P3|Overall Study|Pregnancy|0
5044448|NCT02638103|17384998|P2|Overall Study|Pregnancy|3
5044449|NCT02638103|17384999|P1|Overall Study|Pregnancy|2
5044450|NCT02638103|17384996|P4|Overall Study|Protocol Violation|4
5044451|NCT02638103|17384997|P3|Overall Study|Protocol Violation|1
5044452|NCT02638103|17384998|P2|Overall Study|Protocol Violation|2
5044453|NCT02638103|17384999|P1|Overall Study|Protocol Violation|1
5044454|NCT02638103|17384996|P4|Overall Study|Withdrawal by Subject|61
5044455|NCT02638103|17384997|P3|Overall Study|Withdrawal by Subject|30
5044456|NCT02638103|17384998|P2|Overall Study|Withdrawal by Subject|53
5044457|NCT02638103|17384999|P1|Overall Study|Withdrawal by Subject|43
5044458|NCT02638103|17384996|P4|Overall Study|Adverse Event|12
5044459|NCT02638103|17384997|P3|Overall Study|Adverse Event|19
5044460|NCT02638103|17384998|P2|Overall Study|Adverse Event|12
5044461|NCT02638103|17384999|P1|Overall Study|Adverse Event|13
5044462|NCT02638012|17385086|P1|Overall Study|Lost to Follow-up|1
5044463|NCT02637856|17385131|P2|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
5044464|NCT02637856|17385132|P1|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
5044465|NCT02637856|17385131|P2|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
5044466|NCT02637856|17385132|P1|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
5044467|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Site Closing|0
5044468|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Site Closing|6
5044469|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
5044470|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
5044471|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Incarceration|0
5044472|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Incarceration|1
5044473|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Failed Drug Test|0
5044474|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Failed Drug Test|1
5044475|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
5044476|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
5044477|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Protocol Deviation|0
5044478|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Protocol Deviation|2
5044479|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
5044480|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
5044481|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Pregnancy|0
5044482|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Pregnancy|7
5044483|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Physician Decision|0
5044484|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Physician Decision|2
5044485|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Lost to Follow-up|0
5044486|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Lost to Follow-up|5
5044487|NCT02637856|17385131|P2|Main Study (Baseline to Week 100)|Adverse Event|0
5044488|NCT02637856|17385132|P1|Main Study (Baseline to Week 100)|Adverse Event|9
5044489|NCT02637557|17385262|P4|Overall Study|Withdrawal by Subject|2
5044490|NCT02637557|17385263|P3|Overall Study|Withdrawal by Subject|4
5044491|NCT02637557|17385264|P2|Overall Study|Withdrawal by Subject|3
5044492|NCT02637557|17385265|P1|Overall Study|Withdrawal by Subject|1
5044493|NCT02637557|17385262|P4|Overall Study|Protocol Violation|1
5044494|NCT02637557|17385263|P3|Overall Study|Protocol Violation|2
5044495|NCT02637557|17385264|P2|Overall Study|Protocol Violation|0
5044496|NCT02637557|17385265|P1|Overall Study|Protocol Violation|2
5044497|NCT02637557|17385262|P4|Overall Study|Physician Decision|0
5044498|NCT02637557|17385263|P3|Overall Study|Physician Decision|0
5044499|NCT02637557|17385264|P2|Overall Study|Physician Decision|0
5044500|NCT02637557|17385265|P1|Overall Study|Physician Decision|1
5044501|NCT02637557|17385262|P4|Overall Study|Lost to Follow-up|1
5044502|NCT02637557|17385263|P3|Overall Study|Lost to Follow-up|0
5044503|NCT02637557|17385264|P2|Overall Study|Lost to Follow-up|1
5044504|NCT02637557|17385265|P1|Overall Study|Lost to Follow-up|1
5044505|NCT02637557|17385262|P4|Overall Study|Adverse Event|3
5044506|NCT02637557|17385263|P3|Overall Study|Adverse Event|3
5044507|NCT02637557|17385264|P2|Overall Study|Adverse Event|1
5044508|NCT02637557|17385265|P1|Overall Study|Adverse Event|3
5044509|NCT02637323|17385357|P2|Overall Study|Protocol Violation|1
5044510|NCT02637323|17385358|P1|Overall Study|Protocol Violation|0
5044511|NCT02637323|17385357|P2|Overall Study|Lost to Follow-up|0
5044512|NCT02637323|17385358|P1|Overall Study|Lost to Follow-up|2
5044513|NCT02637141|17385369|P3|Overall Study|Withdrawal by Subject|1
5044514|NCT02637141|17385370|P2|Overall Study|Withdrawal by Subject|1
5044515|NCT02637141|17385371|P1|Overall Study|Withdrawal by Subject|1
5044516|NCT02637141|17385369|P3|Overall Study|Adverse Event|0
5044517|NCT02637141|17385370|P2|Overall Study|Adverse Event|1
5044518|NCT02637141|17385371|P1|Overall Study|Adverse Event|1
5044519|NCT02637063|17385406|P3|Overall Study|Withdrawal by Subject|3
5044520|NCT02637063|17385407|P2|Overall Study|Withdrawal by Subject|2
5044521|NCT02637063|17385408|P1|Overall Study|Withdrawal by Subject|2
5044522|NCT02637063|17385406|P3|Overall Study|Lost to Follow-up|3
5044523|NCT02637063|17385407|P2|Overall Study|Lost to Follow-up|2
5044524|NCT02637063|17385408|P1|Overall Study|Lost to Follow-up|3
5044525|NCT02637037|17385436|P2|Overall Study|Adverse Event|0
5044526|NCT02637037|17385437|P1|Overall Study|Adverse Event|1
5044527|NCT02637037|17385436|P2|Overall Study|Withdrawal by Subject|1
5044528|NCT02637037|17385437|P1|Overall Study|Withdrawal by Subject|2
5044529|NCT02637037|17385436|P2|Overall Study|Positive drug screen at admission|0
5044530|NCT02637037|17385437|P1|Overall Study|Positive drug screen at admission|1
5044531|NCT02636907|17385503|P1|Extension Phase|Lack of Efficacy|1
5044532|NCT02636907|17385503|P1|Extension Phase|Lost to Follow-up|2
5044533|NCT02636907|17385503|P1|Extension Phase|Physician Decision|1
5044534|NCT02636907|17385503|P1|Extension Phase|Withdrawal by Subject|4
5044535|NCT02636907|17385503|P1|Extension Phase|Adverse Event|2
5044536|NCT02636907|17385503|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
5044537|NCT02636907|17385503|P1|Autoinjector Assessment Period|Adverse Event|2
5044538|NCT02636608|17385520|P1|Overall Study|Did Not Receive Treatment|1
5044539|NCT02636608|17385520|P1|Overall Study|Other|2
5044540|NCT02636608|17385520|P1|Overall Study|Death|3
5044541|NCT02636608|17385520|P1|Overall Study|Insufficient Virological Response|1
5044542|NCT02636608|17385520|P1|Overall Study|Failure to Return|4
5044543|NCT02636595|17385548|P1|Overall Study|Other|1
5044544|NCT02636595|17385548|P1|Overall Study|Lost to Follow-up|1
5044545|NCT02636361|17385554|P5|Period 4|Physician Decision|0
5044546|NCT02636361|17385555|P4|Period 4|Physician Decision|1
5044547|NCT02636361|17385556|P3|Period 4|Physician Decision|0
5044548|NCT02636361|17385557|P2|Period 4|Physician Decision|0
5044549|NCT02636361|17385558|P1|Period 4|Physician Decision|0
5044550|NCT02636283|17385577|P2|Overall Study|Trial Terminated Prematurely|3
5044551|NCT02636283|17385578|P1|Overall Study|Trial Terminated Prematurely|0
5044552|NCT02636283|17385577|P2|Overall Study|Adverse Event|0
5044553|NCT02636283|17385578|P1|Overall Study|Adverse Event|2
5044554|NCT02635984|17385606|P2|Overall Study|Study Arm Closed|0
5044555|NCT02635984|17385607|P1|Overall Study|Study Arm Closed|1
5044556|NCT02635984|17385606|P2|Overall Study|Lost to Follow-up|4
5044557|NCT02635984|17385607|P1|Overall Study|Lost to Follow-up|2
5044558|NCT02635646|17385639|P2|Overall Study|Pregnancy|1
5044559|NCT02635646|17385640|P1|Overall Study|Pregnancy|1
5044560|NCT02635646|17385639|P2|Overall Study|Lost to Follow-up|25
5044561|NCT02635646|17385640|P1|Overall Study|Lost to Follow-up|24
5044562|NCT02635347|17385676|P2|Overall Study|Failed screening|7
5044563|NCT02635347|17385677|P1|Overall Study|Failed screening|20
5044564|NCT02635204|17385708|P2|Overall Study|Lost to Follow-up|1
5044565|NCT02635204|17385709|P1|Overall Study|Lost to Follow-up|1
5044566|NCT02635204|17385708|P2|Overall Study|Adverse Event|0
5044567|NCT02635204|17385709|P1|Overall Study|Adverse Event|1
5044568|NCT02634983|17385719|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
5044569|NCT02634983|17385720|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
5044570|NCT02634801|17385779|P3|Follow-up Period|Adverse Event|0
5044571|NCT02634801|17385780|P2|Follow-up Period|Adverse Event|5
5044572|NCT02634801|17385781|P1|Follow-up Period|Adverse Event|1
5044573|NCT02634801|17385779|P3|Follow-up Period|Withdrawal by Subject|5
5044574|NCT02634801|17385780|P2|Follow-up Period|Withdrawal by Subject|2
5044575|NCT02634801|17385781|P1|Follow-up Period|Withdrawal by Subject|1
5044576|NCT02634801|17385779|P3|Follow-up Period|Physician Decision|1
5044577|NCT02634801|17385780|P2|Follow-up Period|Physician Decision|0
5044578|NCT02634801|17385781|P1|Follow-up Period|Physician Decision|0
5044579|NCT02634801|17385779|P3|Follow-up Period|Lost to Follow-up|2
5044580|NCT02634801|17385780|P2|Follow-up Period|Lost to Follow-up|1
5044581|NCT02634801|17385781|P1|Follow-up Period|Lost to Follow-up|3
5044582|NCT02634801|17385779|P3|Extension Period (Weeks 24 to 36)|Missing|0
5044583|NCT02634801|17385780|P2|Extension Period (Weeks 24 to 36)|Missing|0
5044584|NCT02634801|17385781|P1|Extension Period (Weeks 24 to 36)|Missing|1
5044585|NCT02634801|17385779|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5044586|NCT02634801|17385780|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5044587|NCT02634801|17385781|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5044588|NCT02634801|17385779|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
5044589|NCT02634801|17385780|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
5044590|NCT02634801|17385781|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
5044591|NCT02634801|17385779|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
5044592|NCT02634801|17385780|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
5044593|NCT02634801|17385781|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
5044594|NCT02634801|17385779|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
5044595|NCT02634801|17385780|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
5044596|NCT02634801|17385781|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
5044597|NCT02634801|17385779|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
5044598|NCT02634801|17385780|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
5044599|NCT02634801|17385781|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
5044600|NCT02634801|17385779|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
5044601|NCT02634801|17385780|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
5044602|NCT02634801|17385781|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
5044603|NCT02634801|17385779|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
5044604|NCT02634801|17385780|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
5044605|NCT02634801|17385781|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
5044606|NCT02634801|17385779|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
5044607|NCT02634801|17385780|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
5044608|NCT02634801|17385781|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
5044609|NCT02634788|17385881|P4|Overall Study|Withdrawal by Subject|0
5044610|NCT02634788|17385882|P3|Overall Study|Withdrawal by Subject|1
5044611|NCT02634788|17385883|P2|Overall Study|Withdrawal by Subject|1
5044612|NCT02634788|17385884|P1|Overall Study|Withdrawal by Subject|0
5044613|NCT02634788|17385881|P4|Overall Study|Lost to Follow-up|0
5044614|NCT02634788|17385882|P3|Overall Study|Lost to Follow-up|0
5044615|NCT02634788|17385883|P2|Overall Study|Lost to Follow-up|1
5044616|NCT02634788|17385884|P1|Overall Study|Lost to Follow-up|0
5044617|NCT02634788|17385881|P4|Overall Study|Lack of Efficacy|4
5044618|NCT02634788|17385882|P3|Overall Study|Lack of Efficacy|1
5044619|NCT02634788|17385883|P2|Overall Study|Lack of Efficacy|0
5044620|NCT02634788|17385884|P1|Overall Study|Lack of Efficacy|4
5044621|NCT02634788|17385881|P4|Overall Study|Adverse Event|1
5044622|NCT02634788|17385882|P3|Overall Study|Adverse Event|3
5044623|NCT02634788|17385883|P2|Overall Study|Adverse Event|8
5044624|NCT02634788|17385884|P1|Overall Study|Adverse Event|0
5044625|NCT02634606|17385950|P1|Overall Study|unable to obtain the drug at start|13
5044626|NCT02634580|17385962|P4|Open-label Extension Period|Withdrawal by Subject|1
5044627|NCT02634580|17385963|P3|Open-label Extension Period|Withdrawal by Subject|0
5044628|NCT02634580|17385964|P2|Open-label Extension Period|Withdrawal by Subject|1
5044629|NCT02634580|17385965|P1|Open-label Extension Period|Withdrawal by Subject|0
5044630|NCT02634580|17385962|P4|Double-blind Treatment Period|Subject Request|1
5044631|NCT02634580|17385963|P3|Double-blind Treatment Period|Subject Request|1
5044632|NCT02634580|17385964|P2|Double-blind Treatment Period|Subject Request|0
5044633|NCT02634580|17385965|P1|Double-blind Treatment Period|Subject Request|1
5044634|NCT02634346|17386023|P3|Overall Study|Protocol Violation|0
5044635|NCT02634346|17386024|P2|Overall Study|Protocol Violation|1
5044636|NCT02634346|17386025|P1|Overall Study|Protocol Violation|0
5044637|NCT02634346|17386023|P3|Overall Study|Lost to Follow-up|0
5044638|NCT02634346|17386024|P2|Overall Study|Lost to Follow-up|0
5044639|NCT02634346|17386025|P1|Overall Study|Lost to Follow-up|1
5044640|NCT02634346|17386023|P3|Overall Study|Lack of Efficacy|8
5044641|NCT02634346|17386024|P2|Overall Study|Lack of Efficacy|2
5044642|NCT02634346|17386025|P1|Overall Study|Lack of Efficacy|1
5044643|NCT02634346|17386023|P3|Overall Study|Adverse Event|7
5044644|NCT02634346|17386024|P2|Overall Study|Adverse Event|2
5044645|NCT02634346|17386025|P1|Overall Study|Adverse Event|2
5044646|NCT02634346|17386023|P3|Overall Study|Withdrawal by Subject|8
5044647|NCT02634346|17386024|P2|Overall Study|Withdrawal by Subject|9
5044648|NCT02634346|17386025|P1|Overall Study|Withdrawal by Subject|8
5044649|NCT02634320|17386039|P1|Overall Study|Lack of Efficacy|2
5044650|NCT02634320|17386039|P1|Overall Study|Withdrawal by Subject|5
5044651|NCT02634320|17386039|P1|Overall Study|Protocol Violation|1
5044652|NCT02634320|17386039|P1|Overall Study|Out of window for study visits|1
5044653|NCT02634320|17386039|P1|Overall Study|Moved out of area|2
5044654|NCT02634320|17386039|P1|Overall Study|Lost to Follow-up|3
5044655|NCT02634320|17386039|P1|Overall Study|Adverse Event|2
5044656|NCT02634151|17386075|P2|Overall Study|Other|1
5044657|NCT02634151|17386076|P1|Overall Study|Other|0
5044658|NCT02634151|17386075|P2|Overall Study|Non-Compliance|1
5044659|NCT02634151|17386076|P1|Overall Study|Non-Compliance|0
5044660|NCT02634151|17386075|P2|Overall Study|Withdrawal by Subject|0
5044661|NCT02634151|17386076|P1|Overall Study|Withdrawal by Subject|1
5044662|NCT02633800|17386278|P2|Overall Study|Patient Request|1
5044663|NCT02633800|17386279|P1|Overall Study|Patient Request|1
5044664|NCT02633800|17386278|P2|Overall Study|Withdrawal by Subject|3
5044665|NCT02633800|17386279|P1|Overall Study|Withdrawal by Subject|0
5044666|NCT02633800|17386278|P2|Overall Study|Adverse event, non-fatal|2
5044667|NCT02633800|17386279|P1|Overall Study|Adverse event, non-fatal|7
5044668|NCT02633800|17386278|P2|Overall Study|Study terminated by sponsor|5
5044669|NCT02633800|17386279|P1|Overall Study|Study terminated by sponsor|6
5044670|NCT02633800|17386278|P2|Overall Study|Clinical progression|6
5044671|NCT02633800|17386279|P1|Overall Study|Clinical progression|3
5044672|NCT02633800|17386278|P2|Overall Study|Radiologic(al) progression|23
5044673|NCT02633800|17386279|P1|Overall Study|Radiologic(al) progression|23
5044674|NCT02633800|17386278|P2|Overall Study|Reason not provided|0
5044675|NCT02633800|17386279|P1|Overall Study|Reason not provided|1
5044676|NCT02633800|17386278|P2|Overall Study|Death|3
5044677|NCT02633800|17386279|P1|Overall Study|Death|3
5044678|NCT02633787|17386289|P1|Overall Study|Withdrawal by Subject|1
5044679|NCT02633501|17386310|P6|Overall Study|Lost to Follow-up|0
5044680|NCT02633501|17386311|P5|Overall Study|Lost to Follow-up|2
5044681|NCT02633501|17386312|P4|Overall Study|Lost to Follow-up|1
5044682|NCT02633501|17386313|P3|Overall Study|Lost to Follow-up|0
5044683|NCT02633501|17386314|P2|Overall Study|Lost to Follow-up|0
5044684|NCT02633501|17386315|P1|Overall Study|Lost to Follow-up|0
5044685|NCT02633501|17386310|P6|Overall Study|Various other reasons|11
5044686|NCT02633501|17386311|P5|Overall Study|Various other reasons|7
5044687|NCT02633501|17386312|P4|Overall Study|Various other reasons|1
5044688|NCT02633501|17386313|P3|Overall Study|Various other reasons|4
5044689|NCT02633501|17386314|P2|Overall Study|Various other reasons|2
5044690|NCT02633501|17386315|P1|Overall Study|Various other reasons|0
5044691|NCT02633501|17386310|P6|Overall Study|Withdrawal by Subject|3
5044692|NCT02633501|17386311|P5|Overall Study|Withdrawal by Subject|1
5044693|NCT02633501|17386312|P4|Overall Study|Withdrawal by Subject|2
5044694|NCT02633501|17386313|P3|Overall Study|Withdrawal by Subject|2
5044695|NCT02633501|17386314|P2|Overall Study|Withdrawal by Subject|1
5044696|NCT02633501|17386315|P1|Overall Study|Withdrawal by Subject|2
5044697|NCT02633501|17386310|P6|Overall Study|Adverse Event|1
5044698|NCT02633501|17386311|P5|Overall Study|Adverse Event|1
5044699|NCT02633501|17386312|P4|Overall Study|Adverse Event|0
5044700|NCT02633501|17386313|P3|Overall Study|Adverse Event|1
5044701|NCT02633501|17386314|P2|Overall Study|Adverse Event|0
5044702|NCT02633501|17386315|P1|Overall Study|Adverse Event|0
5044703|NCT02633215|17386377|P2|Overall Study|Lost to Follow-up|3
5044704|NCT02633215|17386378|P1|Overall Study|Lost to Follow-up|2
5044705|NCT02633020|17386390|P2|Overall Study|Adverse Event|0
5044706|NCT02633020|17386391|P1|Overall Study|Adverse Event|1
5044707|NCT02632838|17386415|P2|Overall Study|Lost to Follow-up|2
5044708|NCT02632838|17386416|P1|Overall Study|Lost to Follow-up|0
5044709|NCT02632838|17386415|P2|Overall Study|Withdrawal by Subject|0
5044710|NCT02632838|17386416|P1|Overall Study|Withdrawal by Subject|3
5044711|NCT02632786|17386453|P2|Overall Study|Withdrawal by Subject|0
5044712|NCT02632786|17386454|P1|Overall Study|Withdrawal by Subject|1
5044713|NCT02632786|17386453|P2|Overall Study|Physician Decision|4
5044714|NCT02632786|17386454|P1|Overall Study|Physician Decision|5
5044715|NCT02632786|17386453|P2|Overall Study|Death|2
5044716|NCT02632786|17386454|P1|Overall Study|Death|3
5044717|NCT02632786|17386453|P2|Overall Study|Adverse Event|1
5044718|NCT02632786|17386454|P1|Overall Study|Adverse Event|2
5044719|NCT02632747|17386474|P2|Wash-out Period|Adverse Event|0
5044720|NCT02632747|17386475|P1|Wash-out Period|Adverse Event|1
5044721|NCT02632110|17386675|P10|Overall Study|Withdrawal by Subject|1
5044722|NCT02632110|17386676|P9|Overall Study|Withdrawal by Subject|1
5044723|NCT02632110|17386677|P8|Overall Study|Withdrawal by Subject|3
5044724|NCT02632110|17386678|P7|Overall Study|Withdrawal by Subject|3
5044725|NCT02632110|17386679|P6|Overall Study|Withdrawal by Subject|1
5044726|NCT02632110|17386680|P5|Overall Study|Withdrawal by Subject|1
5044727|NCT02632110|17386681|P4|Overall Study|Withdrawal by Subject|0
5044728|NCT02632110|17386682|P3|Overall Study|Withdrawal by Subject|0
5044729|NCT02632110|17386683|P2|Overall Study|Withdrawal by Subject|1
5044730|NCT02632110|17386684|P1|Overall Study|Withdrawal by Subject|1
5044731|NCT02631876|17387174|P2|Overall Study|Other than specified|4
5044732|NCT02631876|17387175|P1|Overall Study|Other than specified|4
5044733|NCT02631876|17387174|P2|Overall Study|Withdrawal by Subject|9
5044734|NCT02631876|17387175|P1|Overall Study|Withdrawal by Subject|16
5044735|NCT02631876|17387174|P2|Overall Study|Lost to Follow-up|0
5044736|NCT02631876|17387175|P1|Overall Study|Lost to Follow-up|2
5044737|NCT02631876|17387174|P2|Overall Study|Investigator's discretion|0
5044738|NCT02631876|17387175|P1|Overall Study|Investigator's discretion|1
5044739|NCT02631876|17387174|P2|Overall Study|Death|50
5044740|NCT02631876|17387175|P1|Overall Study|Death|96
5044741|NCT02631746|17387251|P1|Overall Study|Lack of Efficacy|3
5044742|NCT02631577|17387270|P2|Overall Study|Withdrawal by Subject|1
5044743|NCT02631577|17387271|P1|Overall Study|Withdrawal by Subject|0
5044744|NCT02631577|17387270|P2|Overall Study|Death|3
5044745|NCT02631577|17387271|P1|Overall Study|Death|1
5044746|NCT02631551|17387289|P4|Overall Study|Other, specific reasons not collected|2
5044747|NCT02631551|17387290|P3|Overall Study|Other, specific reasons not collected|2
5044748|NCT02631551|17387291|P2|Overall Study|Other, specific reasons not collected|7
5044749|NCT02631551|17387292|P1|Overall Study|Other, specific reasons not collected|5
5044750|NCT02631551|17387289|P4|Overall Study|Non-compliance with study drug|0
5044751|NCT02631551|17387290|P3|Overall Study|Non-compliance with study drug|0
5044752|NCT02631551|17387291|P2|Overall Study|Non-compliance with study drug|0
5044753|NCT02631551|17387292|P1|Overall Study|Non-compliance with study drug|1
5044754|NCT02631551|17387289|P4|Overall Study|Non-compliance with study procedures|1
5044755|NCT02631551|17387290|P3|Overall Study|Non-compliance with study procedures|1
5044756|NCT02631551|17387291|P2|Overall Study|Non-compliance with study procedures|0
5044757|NCT02631551|17387292|P1|Overall Study|Non-compliance with study procedures|0
5044758|NCT02631551|17387289|P4|Overall Study|Protocol deviation|0
5044759|NCT02631551|17387290|P3|Overall Study|Protocol deviation|3
5044760|NCT02631551|17387291|P2|Overall Study|Protocol deviation|6
5044761|NCT02631551|17387292|P1|Overall Study|Protocol deviation|3
5044762|NCT02631551|17387289|P4|Overall Study|Withdrawal by Subject|5
5044763|NCT02631551|17387290|P3|Overall Study|Withdrawal by Subject|0
5044764|NCT02631551|17387291|P2|Overall Study|Withdrawal by Subject|2
5044765|NCT02631551|17387292|P1|Overall Study|Withdrawal by Subject|2
5044766|NCT02631551|17387289|P4|Overall Study|Lost to Follow-up|3
5044767|NCT02631551|17387290|P3|Overall Study|Lost to Follow-up|0
5044768|NCT02631551|17387291|P2|Overall Study|Lost to Follow-up|2
5044769|NCT02631551|17387292|P1|Overall Study|Lost to Follow-up|1
5044770|NCT02631551|17387289|P4|Overall Study|Lack of Efficacy|0
5044771|NCT02631551|17387290|P3|Overall Study|Lack of Efficacy|1
5044772|NCT02631551|17387291|P2|Overall Study|Lack of Efficacy|0
5044773|NCT02631551|17387292|P1|Overall Study|Lack of Efficacy|0
5044774|NCT02631551|17387289|P4|Overall Study|Adverse Event|0
5044775|NCT02631551|17387290|P3|Overall Study|Adverse Event|4
5044776|NCT02631551|17387291|P2|Overall Study|Adverse Event|2
5044777|NCT02631551|17387292|P1|Overall Study|Adverse Event|1
5044778|NCT02631070|17387313|P2|Overall Study|Miscellaneous|10
5044779|NCT02631070|17387314|P1|Overall Study|Miscellaneous|4
5044780|NCT02631070|17387313|P2|Overall Study|Progressive Disease|2
5044781|NCT02631070|17387314|P1|Overall Study|Progressive Disease|6
5044782|NCT02631070|17387313|P2|Overall Study|Protocol Violation|0
5044783|NCT02631070|17387314|P1|Overall Study|Protocol Violation|2
5044784|NCT02631070|17387313|P2|Overall Study|Withdrawal by Subject|10
5044785|NCT02631070|17387314|P1|Overall Study|Withdrawal by Subject|17
5044786|NCT02631070|17387313|P2|Overall Study|Lack of Efficacy|50
5044787|NCT02631070|17387314|P1|Overall Study|Lack of Efficacy|68
5044788|NCT02631070|17387313|P2|Overall Study|Adverse Event|4
5044789|NCT02631070|17387314|P1|Overall Study|Adverse Event|15
5044790|NCT02630966|17387408|P2|Overall Study|Lack of Efficacy|2
5044791|NCT02630966|17387409|P1|Overall Study|Lack of Efficacy|0
5044792|NCT02630966|17387408|P2|Overall Study|Voluntary Withdrawal|1
5044793|NCT02630966|17387409|P1|Overall Study|Voluntary Withdrawal|1
5044794|NCT02630966|17387408|P2|Overall Study|Significant Protocol Deviation|2
5044795|NCT02630966|17387409|P1|Overall Study|Significant Protocol Deviation|0
5044796|NCT02630966|17387408|P2|Overall Study|Adverse Event|3
5044797|NCT02630966|17387409|P1|Overall Study|Adverse Event|1
5044798|NCT02630706|17387437|P3|Overall Study|Withdrawal by Subject|7
5044799|NCT02630706|17387438|P2|Overall Study|Withdrawal by Subject|5
5044800|NCT02630706|17387439|P1|Overall Study|Withdrawal by Subject|4
5044801|NCT02630706|17387437|P3|Overall Study|Pregnancy|0
5044802|NCT02630706|17387438|P2|Overall Study|Pregnancy|1
5044803|NCT02630706|17387439|P1|Overall Study|Pregnancy|0
5044804|NCT02630706|17387437|P3|Overall Study|Physician Decision|0
5044805|NCT02630706|17387438|P2|Overall Study|Physician Decision|1
5044806|NCT02630706|17387439|P1|Overall Study|Physician Decision|1
5044807|NCT02630706|17387437|P3|Overall Study|Lost to Follow-up|2
5044808|NCT02630706|17387438|P2|Overall Study|Lost to Follow-up|1
5044809|NCT02630706|17387439|P1|Overall Study|Lost to Follow-up|0
5044810|NCT02630706|17387437|P3|Overall Study|Adverse Event|1
5044811|NCT02630706|17387438|P2|Overall Study|Adverse Event|1
5044812|NCT02630706|17387439|P1|Overall Study|Adverse Event|2
5044813|NCT02630693|17387548|P2|Overall Study|No receive treatment|1
5044814|NCT02630693|17387549|P1|Overall Study|No receive treatment|0
5044815|NCT02630563|17387561|P1|Overall Study|Administrative|1
5044816|NCT02630472|17387572|P2|Overall Study|Physician Decision|0
5044817|NCT02630472|17387573|P1|Overall Study|Physician Decision|10
5044818|NCT02630459|17387591|P8|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044819|NCT02630459|17387592|P7|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044820|NCT02630459|17387593|P6|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044821|NCT02630459|17387594|P5|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
5044822|NCT02630459|17387595|P4|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044823|NCT02630459|17387596|P3|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044824|NCT02630459|17387597|P2|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044825|NCT02630459|17387598|P1|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5044826|NCT02630459|17387591|P8|Open-Label Treatment Phase (OLTP)|Subject Request|0
5044827|NCT02630459|17387592|P7|Open-Label Treatment Phase (OLTP)|Subject Request|0
5044828|NCT02630459|17387593|P6|Open-Label Treatment Phase (OLTP)|Subject Request|3
5044829|NCT02630459|17387594|P5|Open-Label Treatment Phase (OLTP)|Subject Request|24
5044830|NCT02630459|17387595|P4|Open-Label Treatment Phase (OLTP)|Subject Request|0
5044831|NCT02630459|17387596|P3|Open-Label Treatment Phase (OLTP)|Subject Request|0
5044832|NCT02630459|17387597|P2|Open-Label Treatment Phase (OLTP)|Subject Request|0
5044833|NCT02630459|17387598|P1|Open-Label Treatment Phase (OLTP)|Subject Request|0
5044834|NCT02630459|17387591|P8|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5044835|NCT02630459|17387592|P7|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5044836|NCT02630459|17387593|P6|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
5044837|NCT02630459|17387594|P5|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
5044838|NCT02630459|17387595|P4|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5044839|NCT02630459|17387596|P3|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5044840|NCT02630459|17387597|P2|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5044841|NCT02630459|17387598|P1|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5044842|NCT02630459|17387591|P8|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044843|NCT02630459|17387592|P7|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044844|NCT02630459|17387593|P6|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044845|NCT02630459|17387594|P5|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044846|NCT02630459|17387595|P4|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044847|NCT02630459|17387596|P3|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044848|NCT02630459|17387597|P2|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5044849|NCT02630459|17387598|P1|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
5044850|NCT02630459|17387591|P8|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5044851|NCT02630459|17387592|P7|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5044852|NCT02630459|17387593|P6|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5044853|NCT02630459|17387594|P5|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5044854|NCT02630459|17387595|P4|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
5044855|NCT02630459|17387596|P3|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
5044856|NCT02630459|17387597|P2|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
5044857|NCT02630459|17387598|P1|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
5044858|NCT02630459|17387591|P8|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044859|NCT02630459|17387592|P7|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044860|NCT02630459|17387593|P6|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044861|NCT02630459|17387594|P5|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044862|NCT02630459|17387595|P4|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044863|NCT02630459|17387596|P3|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
5044864|NCT02630459|17387597|P2|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044865|NCT02630459|17387598|P1|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5044866|NCT02630459|17387591|P8|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5044867|NCT02630459|17387592|P7|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5044868|NCT02630459|17387593|P6|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5044869|NCT02630459|17387594|P5|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5044870|NCT02630459|17387595|P4|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
5044871|NCT02630459|17387596|P3|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5044872|NCT02630459|17387597|P2|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
5044873|NCT02630459|17387598|P1|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5044874|NCT02630251|17387657|P4|Overall Study|Physician Decision|0
5044875|NCT02630251|17387658|P3|Overall Study|Physician Decision|1
5044876|NCT02630251|17387659|P2|Overall Study|Physician Decision|0
5044877|NCT02630251|17387660|P1|Overall Study|Physician Decision|0
5044878|NCT02630186|17387774|P1|Overall Study|Withdrawal by Subject|1
5044879|NCT02629965|17387790|P2|Period 2|Adverse Event|0
5044880|NCT02629965|17387791|P1|Period 2|Adverse Event|1
5044881|NCT02629965|17387790|P2|Period 1|Other than listed above|2
5044882|NCT02629965|17387791|P1|Period 1|Other than listed above|1
5044883|NCT02629965|17387790|P2|Period 1|Unexpected worsening of disease|0
5044884|NCT02629965|17387791|P1|Period 1|Unexpected worsening of disease|2
5044885|NCT02629965|17387790|P2|Period 1|Adverse Event|0
5044886|NCT02629965|17387791|P1|Period 1|Adverse Event|1
5044887|NCT02629861|17387830|P3|Overall Study|Pregnancy|0
5044888|NCT02629861|17387831|P2|Overall Study|Pregnancy|1
5044889|NCT02629861|17387832|P1|Overall Study|Pregnancy|2
5044890|NCT02629861|17387830|P3|Overall Study|Other|0
5044891|NCT02629861|17387831|P2|Overall Study|Other|1
5044892|NCT02629861|17387832|P1|Overall Study|Other|1
5044893|NCT02629861|17387830|P3|Overall Study|Lost to Follow-up|4
5044894|NCT02629861|17387831|P2|Overall Study|Lost to Follow-up|9
5044895|NCT02629861|17387832|P1|Overall Study|Lost to Follow-up|12
5044896|NCT02629861|17387830|P3|Overall Study|Protocol Violation|7
5044897|NCT02629861|17387831|P2|Overall Study|Protocol Violation|3
5044898|NCT02629861|17387832|P1|Overall Study|Protocol Violation|2
5044899|NCT02629861|17387830|P3|Overall Study|Withdrawal by Subject|13
5044900|NCT02629861|17387831|P2|Overall Study|Withdrawal by Subject|8
5044901|NCT02629861|17387832|P1|Overall Study|Withdrawal by Subject|5
5044902|NCT02629861|17387830|P3|Overall Study|Adverse Event|4
5044903|NCT02629861|17387831|P2|Overall Study|Adverse Event|5
5044904|NCT02629861|17387832|P1|Overall Study|Adverse Event|7
5044905|NCT02629822|17387879|P1|Extension Study|Extension Period is Ongoing|6
5044906|NCT02629822|17387879|P1|Base Study|Non-Compliance With Study Drug|1
5044907|NCT02629822|17387879|P1|Base Study|Lost to Follow-up|2
5044908|NCT02629159|17387921|P3|Overall Study|Other|8
5044909|NCT02629159|17387922|P2|Overall Study|Other|4
5044910|NCT02629159|17387923|P1|Overall Study|Other|6
5044911|NCT02629159|17387921|P3|Overall Study|Lack of Efficacy|1
5044912|NCT02629159|17387922|P2|Overall Study|Lack of Efficacy|0
5044913|NCT02629159|17387923|P1|Overall Study|Lack of Efficacy|4
5044914|NCT02629159|17387921|P3|Overall Study|Lost to Follow-up|5
5044915|NCT02629159|17387922|P2|Overall Study|Lost to Follow-up|4
5044916|NCT02629159|17387923|P1|Overall Study|Lost to Follow-up|7
5044917|NCT02629159|17387921|P3|Overall Study|Withdrawal by Subject|15
5044918|NCT02629159|17387922|P2|Overall Study|Withdrawal by Subject|11
5044919|NCT02629159|17387923|P1|Overall Study|Withdrawal by Subject|22
5044920|NCT02629159|17387921|P3|Overall Study|Adverse Event|22
5044921|NCT02629159|17387922|P2|Overall Study|Adverse Event|20
5044922|NCT02629159|17387923|P1|Overall Study|Adverse Event|17
5044923|NCT02629133|17387975|P2|Overall Study|Withdrawal by Subject|1
5044924|NCT02629133|17387976|P1|Overall Study|Withdrawal by Subject|1
5044925|NCT02629133|17387975|P2|Overall Study|Lost to Follow-up|1
5044926|NCT02629133|17387976|P1|Overall Study|Lost to Follow-up|3
5044927|NCT02628938|17388019|P3|Overall Study|Failure to comply with the instructions|3
5044928|NCT02628938|17388020|P2|Overall Study|Failure to comply with the instructions|0
5044929|NCT02628938|17388021|P1|Overall Study|Failure to comply with the instructions|3
5044930|NCT02628938|17388019|P3|Overall Study|Did not attend the follow up recall|1
5044931|NCT02628938|17388020|P2|Overall Study|Did not attend the follow up recall|2
5044932|NCT02628938|17388021|P1|Overall Study|Did not attend the follow up recall|2
5044933|NCT02628873|17388037|P2|Second Test (1 Hour)|Physician Decision|0
5044934|NCT02628873|17388038|P1|Second Test (1 Hour)|Physician Decision|1
5044935|NCT02628873|17388037|P2|Break (1 Hour)|Withdrawal by Subject|1
5044936|NCT02628873|17388038|P1|Break (1 Hour)|Withdrawal by Subject|0
5044937|NCT02628769|17388048|P2|Second Intervention|Physician Decision|1
5044938|NCT02628769|17388049|P1|Second Intervention|Physician Decision|0
5044939|NCT02628769|17388048|P2|Second Intervention|Adverse Event|0
5044940|NCT02628769|17388049|P1|Second Intervention|Adverse Event|2
5044941|NCT02628769|17388048|P2|First Intervention|Withdrawal by Subject|1
5044942|NCT02628769|17388049|P1|First Intervention|Withdrawal by Subject|0
5044943|NCT02628769|17388048|P2|First Intervention|Adverse Event|0
5044944|NCT02628769|17388049|P1|First Intervention|Adverse Event|1
5044945|NCT02628743|17388087|P1|Overall Study|Physician Decision|2
5044946|NCT02628743|17388087|P1|Overall Study|Study Terminated by Sponsor|76
5044947|NCT02628743|17388087|P1|Overall Study|Withdrawal by Subject|50
5044948|NCT02628743|17388087|P1|Overall Study|Other|3
5044949|NCT02628600|17388113|P2|Overall Study|Other not specified|0
5044950|NCT02628600|17388114|P1|Overall Study|Other not specified|1
5044951|NCT02628600|17388113|P2|Overall Study|Physician Decision|2
5044952|NCT02628600|17388114|P1|Overall Study|Physician Decision|2
5044953|NCT02628600|17388113|P2|Overall Study|Lost to Follow-up|0
5044954|NCT02628600|17388114|P1|Overall Study|Lost to Follow-up|1
5044955|NCT02628600|17388113|P2|Overall Study|Withdrawal by Subject|8
5044956|NCT02628600|17388114|P1|Overall Study|Withdrawal by Subject|13
5044957|NCT02628600|17388113|P2|Overall Study|Lack of Efficacy|0
5044958|NCT02628600|17388114|P1|Overall Study|Lack of Efficacy|2
5044959|NCT02628600|17388113|P2|Overall Study|Protocol Violation|1
5044960|NCT02628600|17388114|P1|Overall Study|Protocol Violation|0
5044961|NCT02628600|17388113|P2|Overall Study|Adverse Event|20
5044962|NCT02628600|17388114|P1|Overall Study|Adverse Event|3
5044963|NCT02628600|17388113|P2|Overall Study|Death|1
5044964|NCT02628600|17388114|P1|Overall Study|Death|2
5044965|NCT02628418|17388128|P2|Overall Study|Lost to Follow-up|2
5044966|NCT02628418|17388129|P1|Overall Study|Lost to Follow-up|1
5044967|NCT02628028|17388239|P8|Long-term Extension (LTE) Period|Other|3
5044968|NCT02628028|17388240|P7|Long-term Extension (LTE) Period|Other|4
5044969|NCT02628028|17388241|P6|Long-term Extension (LTE) Period|Other|3
5044970|NCT02628028|17388242|P5|Long-term Extension (LTE) Period|Other|0
5044971|NCT02628028|17388243|P4|Long-term Extension (LTE) Period|Other|0
5044972|NCT02628028|17388244|P3|Long-term Extension (LTE) Period|Other|0
5044973|NCT02628028|17388245|P2|Long-term Extension (LTE) Period|Other|0
5044974|NCT02628028|17388246|P1|Long-term Extension (LTE) Period|Other|0
5044975|NCT02628028|17388239|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
5044976|NCT02628028|17388240|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
5044977|NCT02628028|17388241|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
5044978|NCT02628028|17388242|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5044979|NCT02628028|17388243|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5044980|NCT02628028|17388244|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5044981|NCT02628028|17388245|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5044982|NCT02628028|17388246|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5044983|NCT02628028|17388239|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
5044984|NCT02628028|17388240|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
5044985|NCT02628028|17388241|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
5044986|NCT02628028|17388242|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5044987|NCT02628028|17388243|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5044988|NCT02628028|17388244|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5044989|NCT02628028|17388245|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5044990|NCT02628028|17388246|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5044991|NCT02628028|17388239|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
5044992|NCT02628028|17388240|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
5044993|NCT02628028|17388241|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
5044994|NCT02628028|17388242|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
5044995|NCT02628028|17388243|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
5044996|NCT02628028|17388244|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
5044997|NCT02628028|17388245|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
5044998|NCT02628028|17388246|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
5044999|NCT02628028|17388239|P8|Long-term Extension (LTE) Period|Adverse Event|3
5045000|NCT02628028|17388240|P7|Long-term Extension (LTE) Period|Adverse Event|0
5045001|NCT02628028|17388241|P6|Long-term Extension (LTE) Period|Adverse Event|1
5045002|NCT02628028|17388242|P5|Long-term Extension (LTE) Period|Adverse Event|0
5045003|NCT02628028|17388243|P4|Long-term Extension (LTE) Period|Adverse Event|0
5045004|NCT02628028|17388244|P3|Long-term Extension (LTE) Period|Adverse Event|0
5045005|NCT02628028|17388245|P2|Long-term Extension (LTE) Period|Adverse Event|0
5045006|NCT02628028|17388246|P1|Long-term Extension (LTE) Period|Adverse Event|0
5045007|NCT02628028|17388239|P8|Dosing Period|Other|4
5045008|NCT02628028|17388240|P7|Dosing Period|Other|2
5045009|NCT02628028|17388241|P6|Dosing Period|Other|1
5045010|NCT02628028|17388242|P5|Dosing Period|Other|2
5045011|NCT02628028|17388243|P4|Dosing Period|Other|0
5045012|NCT02628028|17388244|P3|Dosing Period|Other|0
5045013|NCT02628028|17388245|P2|Dosing Period|Other|0
5045014|NCT02628028|17388246|P1|Dosing Period|Other|0
5045015|NCT02628028|17388239|P8|Dosing Period|Lost to Follow-up|0
5045016|NCT02628028|17388240|P7|Dosing Period|Lost to Follow-up|1
5045017|NCT02628028|17388241|P6|Dosing Period|Lost to Follow-up|0
5045018|NCT02628028|17388242|P5|Dosing Period|Lost to Follow-up|0
5045019|NCT02628028|17388243|P4|Dosing Period|Lost to Follow-up|0
5045020|NCT02628028|17388244|P3|Dosing Period|Lost to Follow-up|0
5045021|NCT02628028|17388245|P2|Dosing Period|Lost to Follow-up|0
5045022|NCT02628028|17388246|P1|Dosing Period|Lost to Follow-up|0
5045023|NCT02628028|17388239|P8|Dosing Period|Site Terminated by Sponsor|0
5045024|NCT02628028|17388240|P7|Dosing Period|Site Terminated by Sponsor|1
5045025|NCT02628028|17388241|P6|Dosing Period|Site Terminated by Sponsor|1
5045026|NCT02628028|17388242|P5|Dosing Period|Site Terminated by Sponsor|0
5045027|NCT02628028|17388243|P4|Dosing Period|Site Terminated by Sponsor|0
5045028|NCT02628028|17388244|P3|Dosing Period|Site Terminated by Sponsor|0
5045029|NCT02628028|17388245|P2|Dosing Period|Site Terminated by Sponsor|0
5045030|NCT02628028|17388246|P1|Dosing Period|Site Terminated by Sponsor|0
5045031|NCT02628028|17388239|P8|Dosing Period|Physician Decision|0
5045032|NCT02628028|17388240|P7|Dosing Period|Physician Decision|0
5045033|NCT02628028|17388241|P6|Dosing Period|Physician Decision|1
5045034|NCT02628028|17388242|P5|Dosing Period|Physician Decision|0
5045035|NCT02628028|17388243|P4|Dosing Period|Physician Decision|0
5045036|NCT02628028|17388244|P3|Dosing Period|Physician Decision|0
5045037|NCT02628028|17388245|P2|Dosing Period|Physician Decision|0
5045038|NCT02628028|17388246|P1|Dosing Period|Physician Decision|0
5045039|NCT02628028|17388239|P8|Dosing Period|Study Terminated by Sponsor|7
5045040|NCT02628028|17388240|P7|Dosing Period|Study Terminated by Sponsor|7
5045041|NCT02628028|17388241|P6|Dosing Period|Study Terminated by Sponsor|6
5045042|NCT02628028|17388242|P5|Dosing Period|Study Terminated by Sponsor|7
5045043|NCT02628028|17388243|P4|Dosing Period|Study Terminated by Sponsor|0
5045044|NCT02628028|17388244|P3|Dosing Period|Study Terminated by Sponsor|0
5045045|NCT02628028|17388245|P2|Dosing Period|Study Terminated by Sponsor|0
5045046|NCT02628028|17388246|P1|Dosing Period|Study Terminated by Sponsor|0
5045047|NCT02628028|17388239|P8|Dosing Period|Lack of Efficacy|0
5045048|NCT02628028|17388240|P7|Dosing Period|Lack of Efficacy|1
5045049|NCT02628028|17388241|P6|Dosing Period|Lack of Efficacy|0
5045050|NCT02628028|17388242|P5|Dosing Period|Lack of Efficacy|3
5045051|NCT02628028|17388243|P4|Dosing Period|Lack of Efficacy|0
5045052|NCT02628028|17388244|P3|Dosing Period|Lack of Efficacy|0
5045053|NCT02628028|17388245|P2|Dosing Period|Lack of Efficacy|0
5045054|NCT02628028|17388246|P1|Dosing Period|Lack of Efficacy|0
5045055|NCT02628028|17388239|P8|Dosing Period|Death|1
5045056|NCT02628028|17388240|P7|Dosing Period|Death|0
5045057|NCT02628028|17388241|P6|Dosing Period|Death|0
5045058|NCT02628028|17388242|P5|Dosing Period|Death|0
5045059|NCT02628028|17388243|P4|Dosing Period|Death|0
5045060|NCT02628028|17388244|P3|Dosing Period|Death|0
5045061|NCT02628028|17388245|P2|Dosing Period|Death|0
5045062|NCT02628028|17388246|P1|Dosing Period|Death|0
5045063|NCT02628028|17388239|P8|Dosing Period|Adverse Event|2
5045064|NCT02628028|17388240|P7|Dosing Period|Adverse Event|3
5045065|NCT02628028|17388241|P6|Dosing Period|Adverse Event|1
5045066|NCT02628028|17388242|P5|Dosing Period|Adverse Event|2
5045067|NCT02628028|17388243|P4|Dosing Period|Adverse Event|0
5045068|NCT02628028|17388244|P3|Dosing Period|Adverse Event|0
5045069|NCT02628028|17388245|P2|Dosing Period|Adverse Event|0
5045070|NCT02628028|17388246|P1|Dosing Period|Adverse Event|0
5045071|NCT02628028|17388239|P8|Dosing Period|Withdrawal by Subject|1
5045072|NCT02628028|17388240|P7|Dosing Period|Withdrawal by Subject|1
5045073|NCT02628028|17388241|P6|Dosing Period|Withdrawal by Subject|4
5045074|NCT02628028|17388242|P5|Dosing Period|Withdrawal by Subject|2
5045075|NCT02628028|17388243|P4|Dosing Period|Withdrawal by Subject|0
5045076|NCT02628028|17388244|P3|Dosing Period|Withdrawal by Subject|1
5045077|NCT02628028|17388245|P2|Dosing Period|Withdrawal by Subject|0
5045078|NCT02628028|17388246|P1|Dosing Period|Withdrawal by Subject|0
5045079|NCT02627144|17388331|P1|Overall Study|Other|17
5045080|NCT02627144|17388331|P1|Overall Study|Enrolled, not treated|6
5045081|NCT02627144|17388331|P1|Overall Study|Lost to Follow-up|8
5045082|NCT02627144|17388331|P1|Overall Study|Administrative reasons|65
5045083|NCT02627144|17388331|P1|Overall Study|Refusal of treatment / poor cooperation|38
5045084|NCT02627144|17388331|P1|Overall Study|Death from other cause|8
5045085|NCT02627144|17388331|P1|Overall Study|Death from cancer|20
5045086|NCT02627144|17388331|P1|Overall Study|Cancer progression|171
5045087|NCT02627144|17388331|P1|Overall Study|Serious adverse event|32
5045088|NCT02626819|17388372|P2|Overall Study|Diagnosed w/ catastrophic illness|1
5045089|NCT02626819|17388373|P1|Overall Study|Diagnosed w/ catastrophic illness|0
5045090|NCT02626819|17388372|P2|Overall Study|Withdrawal by Subject|0
5045091|NCT02626819|17388373|P1|Overall Study|Withdrawal by Subject|1
5045092|NCT02626819|17388372|P2|Overall Study|Lost to Follow-up|2
5045093|NCT02626819|17388373|P1|Overall Study|Lost to Follow-up|3
5045094|NCT02626780|17388393|P1|Overall Study|Withdrawal by Subject|3
5045095|NCT02626520|17388426|P2|Overall Study|Study terminated|1
5045096|NCT02626520|17388427|P1|Overall Study|Study terminated|0
5045097|NCT02626520|17388426|P2|Overall Study|Did not start protocol therapy|2
5045098|NCT02626520|17388427|P1|Overall Study|Did not start protocol therapy|0
5045099|NCT02626520|17388426|P2|Overall Study|Lack of Efficacy|2
5045100|NCT02626520|17388427|P1|Overall Study|Lack of Efficacy|0
5045101|NCT02626520|17388426|P2|Overall Study|Adverse Event|4
5045102|NCT02626520|17388427|P1|Overall Study|Adverse Event|0
5045103|NCT02626520|17388426|P2|Overall Study|Physician Decision|1
5045104|NCT02626520|17388427|P1|Overall Study|Physician Decision|1
5045105|NCT02626182|17388439|P2|Overall Study|Adverse Event|0
5045106|NCT02626182|17388440|P1|Overall Study|Adverse Event|2
5045107|NCT02626026|17388456|P6|Overall Study|Randomized but Never Treated|0
5045108|NCT02626026|17388457|P5|Overall Study|Randomized but Never Treated|1
5045109|NCT02626026|17388458|P4|Overall Study|Randomized but Never Treated|0
5045110|NCT02626026|17388459|P3|Overall Study|Randomized but Never Treated|0
5045111|NCT02626026|17388460|P2|Overall Study|Randomized but Never Treated|0
5045112|NCT02626026|17388461|P1|Overall Study|Randomized but Never Treated|0
5045113|NCT02626000|17388539|P1|Overall Study|Death|23
5045114|NCT02626000|17388539|P1|Overall Study|Continuing Study|13
5045115|NCT02625974|17388553|P2|Overall Study|Protocol Violation|1
5045116|NCT02625974|17388554|P1|Overall Study|Protocol Violation|0
5045117|NCT02625974|17388553|P2|Overall Study|non-compliance with study drug|2
5045118|NCT02625974|17388554|P1|Overall Study|non-compliance with study drug|0
5045119|NCT02625974|17388553|P2|Overall Study|positive parasitemia|0
5045120|NCT02625974|17388554|P1|Overall Study|positive parasitemia|1
5045121|NCT02625974|17388553|P2|Overall Study|Withdrawal by Subject|1
5045122|NCT02625974|17388554|P1|Overall Study|Withdrawal by Subject|3
5045123|NCT02625974|17388553|P2|Overall Study|Adverse Event|2
5045124|NCT02625974|17388554|P1|Overall Study|Adverse Event|12
5045125|NCT02625922|17388664|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
5045126|NCT02625922|17388665|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
5045127|NCT02625922|17388664|P2|Overall Study|Non-availability of IMP|1
5045128|NCT02625922|17388665|P1|Overall Study|Non-availability of IMP|1
5045129|NCT02625623|17388684|P2|Overall Study|Participants randomized but not treated|1
5045130|NCT02625623|17388685|P1|Overall Study|Participants randomized but not treated|9
5045131|NCT02625324|17388748|P1|12-Month Follow-up Secondary Endpoint|Death|4
5045132|NCT02625324|17388748|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
5045133|NCT02625324|17388748|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
5045134|NCT02625324|17388748|P1|6-Month Follow-up Subject Accountability|Death|5
5045135|NCT02625324|17388748|P1|30-Day Follow-up for Secondary Endpoint|Death|1
5045136|NCT02625324|17388748|P1|30-Day Follow-up for Primary Endpoint|Death|1
5045137|NCT02625259|17388773|P5|First Intervention (Day 1)|Withdrawal by Subject|0
5045138|NCT02625259|17388774|P4|First Intervention (Day 1)|Withdrawal by Subject|1
5045139|NCT02625259|17388775|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5045140|NCT02625259|17388776|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5045141|NCT02625259|17388777|P1|First Intervention (Day 1)|Withdrawal by Subject|0
5045142|NCT02625259|17388773|P5|First Intervention (Day 1)|Adverse Event|0
5045143|NCT02625259|17388774|P4|First Intervention (Day 1)|Adverse Event|0
5045144|NCT02625259|17388775|P3|First Intervention (Day 1)|Adverse Event|0
5045145|NCT02625259|17388776|P2|First Intervention (Day 1)|Adverse Event|1
5045146|NCT02625259|17388777|P1|First Intervention (Day 1)|Adverse Event|2
5045147|NCT02625259|17388773|P5|First Intervention (Day 1)|Other|0
5045148|NCT02625259|17388774|P4|First Intervention (Day 1)|Other|0
5045149|NCT02625259|17388775|P3|First Intervention (Day 1)|Other|1
5045150|NCT02625259|17388776|P2|First Intervention (Day 1)|Other|0
5045151|NCT02625259|17388777|P1|First Intervention (Day 1)|Other|0
5045152|NCT02625233|17388814|P2|Overall Study|Adverse Event|0
5045153|NCT02625233|17388815|P1|Overall Study|Adverse Event|2
5045154|NCT02625220|17388823|P1|Overall Study|Study discontinued at site|2
5045155|NCT02625220|17388823|P1|Overall Study|Protocol Violation|1
5045156|NCT02625220|17388823|P1|Overall Study|Lost to Follow-up|2
5045157|NCT02625220|17388823|P1|Overall Study|Adverse Event|2
5045158|NCT02624986|17388951|P8|Overall Study|Withdrawal by Subject|1
5045159|NCT02624986|17388952|P7|Overall Study|Withdrawal by Subject|0
5045160|NCT02624986|17388953|P6|Overall Study|Withdrawal by Subject|0
5045161|NCT02624986|17388954|P5|Overall Study|Withdrawal by Subject|0
5045162|NCT02624986|17388955|P4|Overall Study|Withdrawal by Subject|0
5045163|NCT02624986|17388956|P3|Overall Study|Withdrawal by Subject|0
5045164|NCT02624986|17388957|P2|Overall Study|Withdrawal by Subject|0
5045165|NCT02624986|17388958|P1|Overall Study|Withdrawal by Subject|0
5045166|NCT02624986|17388951|P8|Overall Study|Protocol Violation|0
5045167|NCT02624986|17388952|P7|Overall Study|Protocol Violation|0
5045168|NCT02624986|17388953|P6|Overall Study|Protocol Violation|0
5045169|NCT02624986|17388954|P5|Overall Study|Protocol Violation|0
5045170|NCT02624986|17388955|P4|Overall Study|Protocol Violation|0
5045171|NCT02624986|17388956|P3|Overall Study|Protocol Violation|0
5045172|NCT02624986|17388957|P2|Overall Study|Protocol Violation|0
5045173|NCT02624986|17388958|P1|Overall Study|Protocol Violation|1
5045174|NCT02624986|17388951|P8|Overall Study|Progressive Disease|0
5045175|NCT02624986|17388952|P7|Overall Study|Progressive Disease|0
5045176|NCT02624986|17388953|P6|Overall Study|Progressive Disease|0
5045177|NCT02624986|17388954|P5|Overall Study|Progressive Disease|0
5045178|NCT02624986|17388955|P4|Overall Study|Progressive Disease|0
5045179|NCT02624986|17388956|P3|Overall Study|Progressive Disease|0
5045180|NCT02624986|17388957|P2|Overall Study|Progressive Disease|1
5045181|NCT02624986|17388958|P1|Overall Study|Progressive Disease|0
5045182|NCT02624986|17388951|P8|Overall Study|Study Terminated by Sponsor|3
5045183|NCT02624986|17388952|P7|Overall Study|Study Terminated by Sponsor|4
5045184|NCT02624986|17388953|P6|Overall Study|Study Terminated by Sponsor|2
5045185|NCT02624986|17388954|P5|Overall Study|Study Terminated by Sponsor|2
5045186|NCT02624986|17388955|P4|Overall Study|Study Terminated by Sponsor|1
5045187|NCT02624986|17388956|P3|Overall Study|Study Terminated by Sponsor|0
5045188|NCT02624986|17388957|P2|Overall Study|Study Terminated by Sponsor|1
5045189|NCT02624986|17388958|P1|Overall Study|Study Terminated by Sponsor|1
5045190|NCT02624986|17388951|P8|Overall Study|Death|1
5045191|NCT02624986|17388952|P7|Overall Study|Death|0
5045192|NCT02624986|17388953|P6|Overall Study|Death|0
5045193|NCT02624986|17388954|P5|Overall Study|Death|2
5045194|NCT02624986|17388955|P4|Overall Study|Death|2
5045195|NCT02624986|17388956|P3|Overall Study|Death|2
5045196|NCT02624986|17388957|P2|Overall Study|Death|1
5045197|NCT02624986|17388958|P1|Overall Study|Death|0
5045198|NCT02624791|17389148|P6|Overall Study|Withdrawal by Subject|0
5045199|NCT02624791|17389149|P5|Overall Study|Withdrawal by Subject|0
5045200|NCT02624791|17389150|P4|Overall Study|Withdrawal by Subject|0
5045201|NCT02624791|17389151|P3|Overall Study|Withdrawal by Subject|0
5045202|NCT02624791|17389152|P2|Overall Study|Withdrawal by Subject|0
5045203|NCT02624791|17389153|P1|Overall Study|Withdrawal by Subject|2
5045204|NCT02624713|17389160|P2|Overall Study|Lost to Follow-up|0
5045205|NCT02624713|17389161|P1|Overall Study|Lost to Follow-up|14
5045206|NCT02624687|17389185|P2|Overall Study|medical leave from work|1
5045207|NCT02624687|17389186|P1|Overall Study|medical leave from work|0
5045208|NCT02624687|17389185|P2|Overall Study|Withdrawal by Subject|1
5045209|NCT02624687|17389186|P1|Overall Study|Withdrawal by Subject|1
5045210|NCT02624492|17389217|P3|Overall Study|Progressive disease|3
5045211|NCT02624492|17389218|P2|Overall Study|Progressive disease|2
5045212|NCT02624492|17389219|P1|Overall Study|Progressive disease|0
5045213|NCT02624492|17389217|P3|Overall Study|Adverse Event|2
5045214|NCT02624492|17389218|P2|Overall Study|Adverse Event|2
5045215|NCT02624492|17389219|P1|Overall Study|Adverse Event|2
5045216|NCT02624284|17389254|P3|Overall Study|Adverse Event|1
5045217|NCT02624284|17389255|P2|Overall Study|Adverse Event|0
5045218|NCT02624284|17389256|P1|Overall Study|Adverse Event|0
5045219|NCT02624284|17389254|P3|Overall Study|Revealed exclusionary condition|0
5045220|NCT02624284|17389255|P2|Overall Study|Revealed exclusionary condition|2
5045221|NCT02624284|17389256|P1|Overall Study|Revealed exclusionary condition|2
5045222|NCT02624284|17389254|P3|Overall Study|Protocol Violation|7
5045223|NCT02624284|17389255|P2|Overall Study|Protocol Violation|10
5045224|NCT02624284|17389256|P1|Overall Study|Protocol Violation|9
5045225|NCT02624284|17389254|P3|Overall Study|Withdrawal by Subject|3
5045226|NCT02624284|17389255|P2|Overall Study|Withdrawal by Subject|6
5045227|NCT02624284|17389256|P1|Overall Study|Withdrawal by Subject|3
5045228|NCT02624050|17389275|P2|Overall Study|Protocol Violation|0
5045229|NCT02624050|17389276|P1|Overall Study|Protocol Violation|2
5045230|NCT02624050|17389275|P2|Overall Study|Physician Decision|0
5045231|NCT02624050|17389276|P1|Overall Study|Physician Decision|4
5045232|NCT02623959|17389304|P2|Overall Study|Progression|1
5045233|NCT02623959|17389305|P1|Overall Study|Progression|0
5045234|NCT02623829|17389338|P2|Overall Study|Lost to Follow-up|1
5045235|NCT02623829|17389339|P1|Overall Study|Lost to Follow-up|1
5045236|NCT02623725|17389398|P2|Overall Study|Withdrawal by Subject|1
5045237|NCT02623725|17389399|P1|Overall Study|Withdrawal by Subject|7
5045238|NCT02623725|17389398|P2|Overall Study|Serious adverse event|2
5045239|NCT02623725|17389399|P1|Overall Study|Serious adverse event|0
5045240|NCT02623725|17389398|P2|Overall Study|Non compliance with protocol|3
5045241|NCT02623725|17389399|P1|Overall Study|Non compliance with protocol|9
5045242|NCT02623361|17389433|P2|Overall Study|Withdrawal by Subject|1
5045243|NCT02623361|17389434|P1|Overall Study|Withdrawal by Subject|0
5045244|NCT02623361|17389433|P2|Overall Study|Protocol Violation|1
5045245|NCT02623361|17389434|P1|Overall Study|Protocol Violation|0
5045246|NCT02623335|17389473|P2|Overall Study|Protocol Violation|1
5045247|NCT02623335|17389474|P1|Overall Study|Protocol Violation|2
5045248|NCT02623335|17389473|P2|Overall Study|Withdrawal by Subject|5
5045249|NCT02623335|17389474|P1|Overall Study|Withdrawal by Subject|2
5045250|NCT02623335|17389473|P2|Overall Study|Lost to Follow-up|23
5045251|NCT02623335|17389474|P1|Overall Study|Lost to Follow-up|15
5045252|NCT02623335|17389473|P2|Overall Study|Death|7
5045253|NCT02623335|17389474|P1|Overall Study|Death|8
5045254|NCT02623322|17389501|P3|Overall Study|Lost to Follow-up|0
5045255|NCT02623322|17389502|P2|Overall Study|Lost to Follow-up|1
5045256|NCT02623322|17389503|P1|Overall Study|Lost to Follow-up|2
5045257|NCT02623218|17389541|P5|Overall Study|Lost to Follow-up|0
5045258|NCT02623218|17389542|P4|Overall Study|Lost to Follow-up|0
5045259|NCT02623218|17389543|P3|Overall Study|Lost to Follow-up|0
5045260|NCT02623218|17389544|P2|Overall Study|Lost to Follow-up|1
5045261|NCT02623218|17389545|P1|Overall Study|Lost to Follow-up|0
5045262|NCT02622828|17389567|P1|Overall Study|participant withdrew|3
5045263|NCT02622724|17389574|P2|Overall Study|Early termination of study|43
5045264|NCT02622724|17389575|P1|Overall Study|Early termination of study|38
5045265|NCT02622724|17389574|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
5045266|NCT02622724|17389575|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
5045267|NCT02622724|17389574|P2|Overall Study|Death|53
5045268|NCT02622724|17389575|P1|Overall Study|Death|51
5045269|NCT02622568|17389653|P2|Overall Study|Lost to Follow-up|5
5045270|NCT02622568|17389654|P1|Overall Study|Lost to Follow-up|5
5045271|NCT02622321|17389664|P4|Overall Study|Withdrawal by Subject|0
5045272|NCT02622321|17389665|P3|Overall Study|Withdrawal by Subject|0
5045273|NCT02622321|17389666|P2|Overall Study|Withdrawal by Subject|0
5045274|NCT02622321|17389667|P1|Overall Study|Withdrawal by Subject|1
5045275|NCT02622321|17389664|P4|Overall Study|Ongoing treatment with emicizumab|7
5045276|NCT02622321|17389665|P3|Overall Study|Ongoing treatment with emicizumab|49
5045277|NCT02622321|17389666|P2|Overall Study|Ongoing treatment with emicizumab|13
5045278|NCT02622321|17389667|P1|Overall Study|Ongoing treatment with emicizumab|31
5045279|NCT02622321|17389664|P4|Overall Study|Ongoing in safety follow-up|0
5045280|NCT02622321|17389665|P3|Overall Study|Ongoing in safety follow-up|0
5045281|NCT02622321|17389666|P2|Overall Study|Ongoing in safety follow-up|0
5045282|NCT02622321|17389667|P1|Overall Study|Ongoing in safety follow-up|3
5045283|NCT02622321|17389664|P4|Overall Study|Ongoing treatment with no emicizumab|0
5045284|NCT02622321|17389665|P3|Overall Study|Ongoing treatment with no emicizumab|0
5045285|NCT02622321|17389666|P2|Overall Study|Ongoing treatment with no emicizumab|5
5045286|NCT02622321|17389667|P1|Overall Study|Ongoing treatment with no emicizumab|0
5045287|NCT02622113|17389738|P2|Overall Study|Stopping Criteria|3
5045288|NCT02622113|17389739|P1|Overall Study|Stopping Criteria|1
5045289|NCT02622113|17389738|P2|Overall Study|Withdrawal by Subject|2
5045290|NCT02622113|17389739|P1|Overall Study|Withdrawal by Subject|0
5045291|NCT02622113|17389738|P2|Overall Study|Physician Decision|1
5045292|NCT02622113|17389739|P1|Overall Study|Physician Decision|0
5045293|NCT02622113|17389738|P2|Overall Study|Adverse Event|4
5045294|NCT02622113|17389739|P1|Overall Study|Adverse Event|4
5045295|NCT02622074|17389757|P6|Overall Study|Withdrawal by Subject|0
5045296|NCT02622074|17389758|P5|Overall Study|Withdrawal by Subject|0
5045297|NCT02622074|17389759|P4|Overall Study|Withdrawal by Subject|0
5045298|NCT02622074|17389760|P3|Overall Study|Withdrawal by Subject|0
5045299|NCT02622074|17389761|P2|Overall Study|Withdrawal by Subject|1
5045300|NCT02622074|17389762|P1|Overall Study|Withdrawal by Subject|0
5045301|NCT02622074|17389757|P6|Overall Study|Death|0
5045302|NCT02622074|17389758|P5|Overall Study|Death|1
5045303|NCT02622074|17389759|P4|Overall Study|Death|1
5045304|NCT02622074|17389760|P3|Overall Study|Death|0
5045305|NCT02622074|17389761|P2|Overall Study|Death|0
5045306|NCT02622074|17389762|P1|Overall Study|Death|4
5045307|NCT02621931|17389866|P3|Overall Study|Other|3
5045308|NCT02621931|17389867|P2|Overall Study|Other|1
5045309|NCT02621931|17389868|P1|Overall Study|Other|1
5045310|NCT02621931|17389866|P3|Overall Study|Lack of Efficacy|1
5045311|NCT02621931|17389867|P2|Overall Study|Lack of Efficacy|0
5045312|NCT02621931|17389868|P1|Overall Study|Lack of Efficacy|0
5045313|NCT02621931|17389866|P3|Overall Study|Lost to Follow-up|10
5045314|NCT02621931|17389867|P2|Overall Study|Lost to Follow-up|7
5045315|NCT02621931|17389868|P1|Overall Study|Lost to Follow-up|8
5045316|NCT02621931|17389866|P3|Overall Study|Noncompliance to study procedures|2
5045317|NCT02621931|17389867|P2|Overall Study|Noncompliance to study procedures|1
5045318|NCT02621931|17389868|P1|Overall Study|Noncompliance to study procedures|0
5045319|NCT02621931|17389866|P3|Overall Study|Pregnancy|0
5045320|NCT02621931|17389867|P2|Overall Study|Pregnancy|0
5045321|NCT02621931|17389868|P1|Overall Study|Pregnancy|2
5045322|NCT02621931|17389866|P3|Overall Study|Protocol Violation|2
5045323|NCT02621931|17389867|P2|Overall Study|Protocol Violation|2
5045324|NCT02621931|17389868|P1|Overall Study|Protocol Violation|2
5045325|NCT02621931|17389866|P3|Overall Study|Withdrawal by Subject|11
5045326|NCT02621931|17389867|P2|Overall Study|Withdrawal by Subject|10
5045327|NCT02621931|17389868|P1|Overall Study|Withdrawal by Subject|12
5045328|NCT02621931|17389866|P3|Overall Study|Adverse Event|7
5045329|NCT02621931|17389867|P2|Overall Study|Adverse Event|5
5045330|NCT02621931|17389868|P1|Overall Study|Adverse Event|8
5045331|NCT02621931|17389866|P3|Overall Study|Death|0
5045332|NCT02621931|17389867|P2|Overall Study|Death|1
5045333|NCT02621931|17389868|P1|Overall Study|Death|0
5045334|NCT02621606|17389950|P3|Overall Study|Withdrawal by Subject|0
5045335|NCT02621606|17389951|P2|Overall Study|Withdrawal by Subject|1
5045336|NCT02621606|17389952|P1|Overall Study|Withdrawal by Subject|0
5045337|NCT02621424|17389980|P2|Overall Study|Withdrawal by Subject|2
5045338|NCT02621424|17389981|P1|Overall Study|Withdrawal by Subject|1
5045339|NCT02621073|17389989|P2|Overall Study|Physician Decision|2
5045340|NCT02621073|17389990|P1|Overall Study|Physician Decision|3
5045341|NCT02621073|17389989|P2|Overall Study|Lost to Follow-up|1
5045342|NCT02621073|17389990|P1|Overall Study|Lost to Follow-up|0
5045343|NCT02621047|17390052|P3|Overall Study|Adverse Event|1
5045344|NCT02621047|17390053|P2|Overall Study|Adverse Event|0
5045345|NCT02621047|17390054|P1|Overall Study|Adverse Event|0
5045346|NCT02621034|17390170|P3|Overall Study|Lost to Follow-up|5
5045347|NCT02621034|17390171|P2|Overall Study|Lost to Follow-up|2
5045348|NCT02621034|17390172|P1|Overall Study|Lost to Follow-up|3
5045349|NCT02620787|17390206|P2|Overall Study|Eligibility Criteria Not Met|0
5045350|NCT02620787|17390207|P1|Overall Study|Eligibility Criteria Not Met|1
5045351|NCT02620787|17390206|P2|Overall Study|Adverse Event|0
5045352|NCT02620787|17390207|P1|Overall Study|Adverse Event|1
5045353|NCT02620384|17390249|P2|Overall Study|Drug shortage prevented 2nd dose|1
5045354|NCT02620384|17390250|P1|Overall Study|Drug shortage prevented 2nd dose|0
5045355|NCT02620384|17390249|P2|Overall Study|Discharged prior to 2nd dose|5
5045356|NCT02620384|17390250|P1|Overall Study|Discharged prior to 2nd dose|2
5045357|NCT02620384|17390249|P2|Overall Study|Adverse Event|1
5045358|NCT02620384|17390250|P1|Overall Study|Adverse Event|2
5045359|NCT02620020|17390282|P4|Overall Study|Death|0
5045360|NCT02620020|17390283|P3|Overall Study|Death|0
5045361|NCT02620020|17390284|P2|Overall Study|Death|1
5045362|NCT02620020|17390285|P1|Overall Study|Death|0
5045363|NCT02620020|17390282|P4|Overall Study|Withdrawal by Subject|12
5045364|NCT02620020|17390283|P3|Overall Study|Withdrawal by Subject|17
5045365|NCT02620020|17390284|P2|Overall Study|Withdrawal by Subject|16
5045366|NCT02620020|17390285|P1|Overall Study|Withdrawal by Subject|20
5045367|NCT02620020|17390282|P4|Overall Study|Protocol Violation|1
5045368|NCT02620020|17390283|P3|Overall Study|Protocol Violation|1
5045369|NCT02620020|17390284|P2|Overall Study|Protocol Violation|2
5045370|NCT02620020|17390285|P1|Overall Study|Protocol Violation|5
5045371|NCT02620020|17390282|P4|Overall Study|Physician Decision|4
5045372|NCT02620020|17390283|P3|Overall Study|Physician Decision|3
5045373|NCT02620020|17390284|P2|Overall Study|Physician Decision|4
5045374|NCT02620020|17390285|P1|Overall Study|Physician Decision|7
5045375|NCT02620020|17390282|P4|Overall Study|Lost to Follow-up|4
5045376|NCT02620020|17390283|P3|Overall Study|Lost to Follow-up|1
5045377|NCT02620020|17390284|P2|Overall Study|Lost to Follow-up|8
5045378|NCT02620020|17390285|P1|Overall Study|Lost to Follow-up|4
5045379|NCT02620020|17390282|P4|Overall Study|Adverse Event|5
5045380|NCT02620020|17390283|P3|Overall Study|Adverse Event|3
5045381|NCT02620020|17390284|P2|Overall Study|Adverse Event|4
5045382|NCT02620020|17390285|P1|Overall Study|Adverse Event|8
5045383|NCT02619812|17390311|P4|Overall Study|Withdrawal by Subject|2
5045384|NCT02619812|17390312|P3|Overall Study|Withdrawal by Subject|1
5045385|NCT02619812|17390313|P2|Overall Study|Withdrawal by Subject|0
5045386|NCT02619812|17390314|P1|Overall Study|Withdrawal by Subject|0
5045387|NCT02619617|17390347|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
5045388|NCT02619617|17390348|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
5045389|NCT02619617|17390347|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
5045390|NCT02619617|17390348|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
5045391|NCT02619175|17390444|P2|Overall Study|foot pain|0
5045392|NCT02619175|17390445|P1|Overall Study|foot pain|1
5045393|NCT02619175|17390444|P2|Overall Study|Withdrawal by Subject|0
5045394|NCT02619175|17390445|P1|Overall Study|Withdrawal by Subject|1
5045395|NCT02618928|17390459|P1|Overall Study|Treatment Never Started|7
5045396|NCT02618928|17390459|P1|Overall Study|Missing|6
5045397|NCT02618928|17390459|P1|Overall Study|Other|11
5045398|NCT02618928|17390459|P1|Overall Study|Death|3
5045399|NCT02618928|17390459|P1|Overall Study|Withdrawal by Subject|2
5045400|NCT02618928|17390459|P1|Overall Study|Insufficient Virological Response|1
5045401|NCT02618928|17390459|P1|Overall Study|Failure to Return|28
5045402|NCT02618759|17390554|P2|Overall Study|Other Reasons|4
5045403|NCT02618759|17390555|P1|Overall Study|Other Reasons|1
5045404|NCT02618759|17390554|P2|Overall Study|Withdrawal by Subject|0
5045405|NCT02618759|17390555|P1|Overall Study|Withdrawal by Subject|1
5045406|NCT02618759|17390554|P2|Overall Study|Lost to Follow-up|1
5045407|NCT02618759|17390555|P1|Overall Study|Lost to Follow-up|0
5045408|NCT02617628|17390743|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
5045409|NCT02617628|17390744|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
5045410|NCT02616900|17390752|P1|Overall Study|Incomplete data|6
5045411|NCT02616900|17390752|P1|Overall Study|Withdrawal by Subject|3
5045412|NCT02616900|17390752|P1|Overall Study|Protocol Violation|5
5045413|NCT02616900|17390752|P1|Overall Study|Lost to Follow-up|2
5045414|NCT02616900|17390752|P1|Overall Study|Lack of Efficacy|7
5045415|NCT02616783|17390760|P2|Overall Study|Withdrew Consent|1
5045416|NCT02616783|17390761|P1|Overall Study|Withdrew Consent|1
5045417|NCT02616783|17390760|P2|Overall Study|Protocol Violation|1
5045418|NCT02616783|17390761|P1|Overall Study|Protocol Violation|1
5045419|NCT02616783|17390760|P2|Overall Study|Non-Compliance with Study Drug|0
5045420|NCT02616783|17390761|P1|Overall Study|Non-Compliance with Study Drug|1
5045421|NCT02616783|17390760|P2|Overall Study|Death|0
5045422|NCT02616783|17390761|P1|Overall Study|Death|1
5045423|NCT02616783|17390760|P2|Overall Study|Adverse Event|0
5045424|NCT02616783|17390761|P1|Overall Study|Adverse Event|1
5045425|NCT02616783|17390760|P2|Overall Study|Randomized but Not Treated|0
5045426|NCT02616783|17390761|P1|Overall Study|Randomized but Not Treated|1
5045427|NCT02616614|17390784|P3|Overall Study|Other|1
5045428|NCT02616614|17390785|P2|Overall Study|Other|2
5045429|NCT02616614|17390786|P1|Overall Study|Other|1
5045430|NCT02616614|17390784|P3|Overall Study|Pregnancy|1
5045431|NCT02616614|17390785|P2|Overall Study|Pregnancy|0
5045432|NCT02616614|17390786|P1|Overall Study|Pregnancy|2
5045433|NCT02616614|17390784|P3|Overall Study|Lost to Follow-up|13
5045434|NCT02616614|17390785|P2|Overall Study|Lost to Follow-up|28
5045435|NCT02616614|17390786|P1|Overall Study|Lost to Follow-up|31
5045436|NCT02616614|17390784|P3|Overall Study|More than 3 applications missed|1
5045437|NCT02616614|17390785|P2|Overall Study|More than 3 applications missed|8
5045438|NCT02616614|17390786|P1|Overall Study|More than 3 applications missed|6
5045439|NCT02616614|17390784|P3|Overall Study|Prohibited Medication|5
5045440|NCT02616614|17390785|P2|Overall Study|Prohibited Medication|9
5045441|NCT02616614|17390786|P1|Overall Study|Prohibited Medication|12
5045442|NCT02616614|17390784|P3|Overall Study|Protocol Violation|1
5045443|NCT02616614|17390785|P2|Overall Study|Protocol Violation|3
5045444|NCT02616614|17390786|P1|Overall Study|Protocol Violation|0
5045445|NCT02616614|17390784|P3|Overall Study|Adverse Event|1
5045446|NCT02616614|17390785|P2|Overall Study|Adverse Event|4
5045447|NCT02616614|17390786|P1|Overall Study|Adverse Event|1
5045448|NCT02616614|17390784|P3|Overall Study|Physician Decision|0
5045449|NCT02616614|17390785|P2|Overall Study|Physician Decision|1
5045450|NCT02616614|17390786|P1|Overall Study|Physician Decision|2
5045451|NCT02616614|17390784|P3|Overall Study|Withdrawal by Subject|6
5045452|NCT02616614|17390785|P2|Overall Study|Withdrawal by Subject|5
5045453|NCT02616614|17390786|P1|Overall Study|Withdrawal by Subject|10
5045454|NCT02616601|17390803|P3|Overall Study|Non-Compliance with Test Article|1
5045455|NCT02616601|17390804|P2|Overall Study|Non-Compliance with Test Article|0
5045456|NCT02616601|17390805|P1|Overall Study|Non-Compliance with Test Article|1
5045457|NCT02616601|17390803|P3|Overall Study|Lost to Follow-up|1
5045458|NCT02616601|17390804|P2|Overall Study|Lost to Follow-up|0
5045459|NCT02616601|17390805|P1|Overall Study|Lost to Follow-up|1
5045460|NCT02616601|17390803|P3|Overall Study|Death|0
5045461|NCT02616601|17390804|P2|Overall Study|Death|0
5045462|NCT02616601|17390805|P1|Overall Study|Death|1
5045463|NCT02616601|17390803|P3|Overall Study|Adverse Event|2
5045464|NCT02616601|17390804|P2|Overall Study|Adverse Event|0
5045465|NCT02616601|17390805|P1|Overall Study|Adverse Event|2
5045466|NCT02616601|17390803|P3|Overall Study|Withdrawal by Subject|3
5045467|NCT02616601|17390804|P2|Overall Study|Withdrawal by Subject|4
5045468|NCT02616601|17390805|P1|Overall Study|Withdrawal by Subject|4
5045469|NCT02616380|17390832|P1|Overall Study|Other|2
5045470|NCT02616380|17390832|P1|Overall Study|Lost to Follow-up|1
5045471|NCT02616146|17390856|P2|Overall Study|Physician Decision|1
5045472|NCT02616146|17390857|P1|Overall Study|Physician Decision|2
5045473|NCT02616146|17390856|P2|Overall Study|Withdrawal by Subject|24
5045474|NCT02616146|17390857|P1|Overall Study|Withdrawal by Subject|30
5045475|NCT02616146|17390856|P2|Overall Study|Participant moved|3
5045476|NCT02616146|17390857|P1|Overall Study|Participant moved|4
5045477|NCT02616146|17390856|P2|Overall Study|Study terminated by sponsor|432
5045478|NCT02616146|17390857|P1|Overall Study|Study terminated by sponsor|1372
5045479|NCT02616146|17390856|P2|Overall Study|Protocol Violation|3
5045480|NCT02616146|17390857|P1|Overall Study|Protocol Violation|6
5045481|NCT02616146|17390856|P2|Overall Study|Pregnancy wish|0
5045482|NCT02616146|17390857|P1|Overall Study|Pregnancy wish|3
5045483|NCT02616146|17390856|P2|Overall Study|Pregnancy|2
5045484|NCT02616146|17390857|P1|Overall Study|Pregnancy|2
5045485|NCT02616146|17390856|P2|Overall Study|Non-compliance with study drug|2
5045486|NCT02616146|17390857|P1|Overall Study|Non-compliance with study drug|4
5045487|NCT02616146|17390856|P2|Overall Study|Non-compliance with study protocol|0
5045488|NCT02616146|17390857|P1|Overall Study|Non-compliance with study protocol|2
5045489|NCT02616146|17390856|P2|Overall Study|Lost to Follow-up|13
5045490|NCT02616146|17390857|P1|Overall Study|Lost to Follow-up|23
5045491|NCT02616146|17390856|P2|Overall Study|Adverse Event|24
5045492|NCT02616146|17390857|P1|Overall Study|Adverse Event|64
5045493|NCT02616029|17390873|P2|Overall Study|Enrolled and Never Treated|1
5045494|NCT02616029|17390874|P1|Overall Study|Enrolled and Never Treated|1
5045495|NCT02616029|17390873|P2|Overall Study|Withdrew Consent|0
5045496|NCT02616029|17390874|P1|Overall Study|Withdrew Consent|1
5045497|NCT02616029|17390873|P2|Overall Study|Protocol Violation|0
5045498|NCT02616029|17390874|P1|Overall Study|Protocol Violation|1
5045499|NCT02616029|17390873|P2|Overall Study|Death|1
5045500|NCT02616029|17390874|P1|Overall Study|Death|0
5045501|NCT02616029|17390873|P2|Overall Study|Adverse Event|0
5045502|NCT02616029|17390874|P1|Overall Study|Adverse Event|1
5045503|NCT02615990|17390945|P2|Overall Study|study terminated|1
5045504|NCT02615990|17390946|P1|Overall Study|study terminated|1
5045505|NCT02615509|17391043|P1|Overall Study|Withdrawal by Subject|8
5045506|NCT02615509|17391043|P1|Overall Study|Death|4
5045507|NCT02615509|17391043|P1|Overall Study|Lost to Follow-up|134
5045508|NCT02615470|17391053|P2|Overall Study|Lost to Follow-up|32
5045509|NCT02615470|17391054|P1|Overall Study|Lost to Follow-up|21
5045510|NCT02615249|17391064|P1|Overall Study|Withdrawal by Subject|1
5045511|NCT02615145|17391105|P4|Overall Study|Other, Not Specified|0
5045512|NCT02615145|17391106|P3|Overall Study|Other, Not Specified|0
5045513|NCT02615145|17391107|P2|Overall Study|Other, Not Specified|2
5045514|NCT02615145|17391108|P1|Overall Study|Other, Not Specified|5
5045515|NCT02615145|17391105|P4|Overall Study|Death|0
5045516|NCT02615145|17391106|P3|Overall Study|Death|0
5045517|NCT02615145|17391107|P2|Overall Study|Death|3
5045518|NCT02615145|17391108|P1|Overall Study|Death|2
5045519|NCT02615145|17391105|P4|Overall Study|Failure to Return|0
5045520|NCT02615145|17391106|P3|Overall Study|Failure to Return|7
5045521|NCT02615145|17391107|P2|Overall Study|Failure to Return|10
5045522|NCT02615145|17391108|P1|Overall Study|Failure to Return|20
5045523|NCT02615145|17391105|P4|Overall Study|Did Not Start Treatment|1
5045524|NCT02615145|17391106|P3|Overall Study|Did Not Start Treatment|1
5045525|NCT02615145|17391107|P2|Overall Study|Did Not Start Treatment|0
5045526|NCT02615145|17391108|P1|Overall Study|Did Not Start Treatment|0
5045527|NCT02614898|17391195|P2|Overall Study|Missing|1
5045528|NCT02614898|17391196|P1|Overall Study|Missing|0
5045529|NCT02614898|17391195|P2|Overall Study|Other-Additional Information Unavailable|11
5045530|NCT02614898|17391196|P1|Overall Study|Other-Additional Information Unavailable|0
5045531|NCT02614898|17391195|P2|Overall Study|Withdrawal by Parent/Guardian|1
5045532|NCT02614898|17391196|P1|Overall Study|Withdrawal by Parent/Guardian|1
5045533|NCT02614898|17391195|P2|Overall Study|Withdrawal by Subject|2
5045534|NCT02614898|17391196|P1|Overall Study|Withdrawal by Subject|0
5045535|NCT02614898|17391195|P2|Overall Study|Study Terminated by Sponsor|0
5045536|NCT02614898|17391196|P1|Overall Study|Study Terminated by Sponsor|3
5045537|NCT02614898|17391195|P2|Overall Study|Physician Decision|8
5045538|NCT02614898|17391196|P1|Overall Study|Physician Decision|1
5045539|NCT02614898|17391195|P2|Overall Study|Lost to Follow-up|2
5045540|NCT02614898|17391196|P1|Overall Study|Lost to Follow-up|0
5045541|NCT02614898|17391195|P2|Overall Study|Participated until study termination|26
5045542|NCT02614898|17391196|P1|Overall Study|Participated until study termination|10
5045543|NCT02614794|17391208|P2|Overall Study|Physician Decision|1
5045544|NCT02614794|17391209|P1|Overall Study|Physician Decision|0
5045545|NCT02614794|17391208|P2|Overall Study|Lost to Follow-up|0
5045546|NCT02614794|17391209|P1|Overall Study|Lost to Follow-up|2
5045547|NCT02614794|17391208|P2|Overall Study|Withdrawal by Subject|5
5045548|NCT02614794|17391209|P1|Overall Study|Withdrawal by Subject|16
5045549|NCT02614794|17391208|P2|Overall Study|Death|84
5045550|NCT02614794|17391209|P1|Overall Study|Death|126
5045551|NCT02614794|17391208|P2|Overall Study|In long term follow up|85
5045552|NCT02614794|17391209|P1|Overall Study|In long term follow up|148
5045553|NCT02614794|17391208|P2|Overall Study|On treatment|27
5045554|NCT02614794|17391209|P1|Overall Study|On treatment|118
5045555|NCT02614729|17391243|P2|Overall Study|Withdrawal by Subject|0
5045556|NCT02614729|17391244|P1|Overall Study|Withdrawal by Subject|1
5045557|NCT02614703|17391264|P2|Overall Study|Withdrawal by Subject|1
5045558|NCT02614703|17391265|P1|Overall Study|Withdrawal by Subject|7
5045559|NCT02614560|17391309|P2|Overall Study|Death|2
5045560|NCT02614560|17391310|P1|Overall Study|Death|6
5045561|NCT02614287|17391358|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
5045562|NCT02614287|17391359|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
5045563|NCT02614287|17391358|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
5045564|NCT02614287|17391359|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
5045565|NCT02614287|17391358|P2|Post Treatment Follow-up Phase|Adverse Event|0
5045566|NCT02614287|17391359|P1|Post Treatment Follow-up Phase|Adverse Event|1
5045567|NCT02614287|17391358|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
5045568|NCT02614287|17391359|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
5045569|NCT02614287|17391358|P2|Open Label (OL) Treatment Phase|Physician Decision|0
5045570|NCT02614287|17391359|P1|Open Label (OL) Treatment Phase|Physician Decision|1
5045571|NCT02614287|17391358|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
5045572|NCT02614287|17391359|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
5045573|NCT02614287|17391358|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
5045574|NCT02614287|17391359|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
5045575|NCT02614287|17391358|P2|Open Label (OL) Treatment Phase|Adverse Event|6
5045576|NCT02614287|17391359|P1|Open Label (OL) Treatment Phase|Adverse Event|7
5045577|NCT02614261|17391405|P3|Overall Study|Withdrawal by Subject|7
5045578|NCT02614261|17391406|P2|Overall Study|Withdrawal by Subject|4
5045579|NCT02614261|17391407|P1|Overall Study|Withdrawal by Subject|19
5045580|NCT02614261|17391405|P3|Overall Study|Protocol Violation|0
5045581|NCT02614261|17391406|P2|Overall Study|Protocol Violation|1
5045582|NCT02614261|17391407|P1|Overall Study|Protocol Violation|6
5045583|NCT02614261|17391405|P3|Overall Study|Pregnancy|0
5045584|NCT02614261|17391406|P2|Overall Study|Pregnancy|2
5045585|NCT02614261|17391407|P1|Overall Study|Pregnancy|2
5045586|NCT02614261|17391405|P3|Overall Study|Physician Decision|1
5045587|NCT02614261|17391406|P2|Overall Study|Physician Decision|1
5045588|NCT02614261|17391407|P1|Overall Study|Physician Decision|2
5045589|NCT02614261|17391405|P3|Overall Study|Lost to Follow-up|1
5045590|NCT02614261|17391406|P2|Overall Study|Lost to Follow-up|4
5045591|NCT02614261|17391407|P1|Overall Study|Lost to Follow-up|10
5045592|NCT02614261|17391405|P3|Overall Study|Lack of Efficacy|0
5045593|NCT02614261|17391406|P2|Overall Study|Lack of Efficacy|0
5045594|NCT02614261|17391407|P1|Overall Study|Lack of Efficacy|4
5045595|NCT02614261|17391405|P3|Overall Study|Adverse Event|2
5045596|NCT02614261|17391406|P2|Overall Study|Adverse Event|3
5045597|NCT02614261|17391407|P1|Overall Study|Adverse Event|6
5045598|NCT02614196|17391473|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5045599|NCT02614196|17391474|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5045600|NCT02614196|17391475|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5045601|NCT02614196|17391476|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
5045602|NCT02614196|17391477|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5045603|NCT02614196|17391478|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
5045604|NCT02614196|17391473|P6|Post Treatment Follow-up Phase|Protocol Violation|0
5045605|NCT02614196|17391474|P5|Post Treatment Follow-up Phase|Protocol Violation|1
5045606|NCT02614196|17391475|P4|Post Treatment Follow-up Phase|Protocol Violation|0
5045607|NCT02614196|17391476|P3|Post Treatment Follow-up Phase|Protocol Violation|0
5045608|NCT02614196|17391477|P2|Post Treatment Follow-up Phase|Protocol Violation|1
5045609|NCT02614196|17391478|P1|Post Treatment Follow-up Phase|Protocol Violation|0
5045610|NCT02614196|17391473|P6|Post Treatment Follow-up Phase|Pregnancy|0
5045611|NCT02614196|17391474|P5|Post Treatment Follow-up Phase|Pregnancy|0
5045612|NCT02614196|17391475|P4|Post Treatment Follow-up Phase|Pregnancy|0
5045613|NCT02614196|17391476|P3|Post Treatment Follow-up Phase|Pregnancy|0
5045614|NCT02614196|17391477|P2|Post Treatment Follow-up Phase|Pregnancy|0
5045615|NCT02614196|17391478|P1|Post Treatment Follow-up Phase|Pregnancy|2
5045616|NCT02614196|17391473|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
5045617|NCT02614196|17391474|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
5045618|NCT02614196|17391475|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
5045619|NCT02614196|17391476|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
5045620|NCT02614196|17391477|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
5045621|NCT02614196|17391478|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
5045622|NCT02614196|17391473|P6|Double Blind Treatment Phase|Did not receive study drug|0
5045623|NCT02614196|17391474|P5|Double Blind Treatment Phase|Did not receive study drug|0
5045624|NCT02614196|17391475|P4|Double Blind Treatment Phase|Did not receive study drug|0
5045625|NCT02614196|17391476|P3|Double Blind Treatment Phase|Did not receive study drug|3
5045626|NCT02614196|17391477|P2|Double Blind Treatment Phase|Did not receive study drug|2
5045627|NCT02614196|17391478|P1|Double Blind Treatment Phase|Did not receive study drug|2
5045628|NCT02614196|17391473|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
5045629|NCT02614196|17391474|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
5045630|NCT02614196|17391475|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
5045631|NCT02614196|17391476|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
5045632|NCT02614196|17391477|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
5045633|NCT02614196|17391478|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
5045634|NCT02614196|17391473|P6|Double Blind Treatment Phase|Terminated by sponsor|0
5045635|NCT02614196|17391474|P5|Double Blind Treatment Phase|Terminated by sponsor|0
5045636|NCT02614196|17391475|P4|Double Blind Treatment Phase|Terminated by sponsor|0
5045637|NCT02614196|17391476|P3|Double Blind Treatment Phase|Terminated by sponsor|0
5045638|NCT02614196|17391477|P2|Double Blind Treatment Phase|Terminated by sponsor|0
5045639|NCT02614196|17391478|P1|Double Blind Treatment Phase|Terminated by sponsor|1
5045640|NCT02614196|17391473|P6|Double Blind Treatment Phase|Protocol Violation|0
5045641|NCT02614196|17391474|P5|Double Blind Treatment Phase|Protocol Violation|1
5045642|NCT02614196|17391475|P4|Double Blind Treatment Phase|Protocol Violation|0
5045643|NCT02614196|17391476|P3|Double Blind Treatment Phase|Protocol Violation|1
5045644|NCT02614196|17391477|P2|Double Blind Treatment Phase|Protocol Violation|2
5045645|NCT02614196|17391478|P1|Double Blind Treatment Phase|Protocol Violation|5
5045646|NCT02614196|17391473|P6|Double Blind Treatment Phase|Pregnancy|0
5045647|NCT02614196|17391474|P5|Double Blind Treatment Phase|Pregnancy|0
5045648|NCT02614196|17391475|P4|Double Blind Treatment Phase|Pregnancy|0
5045649|NCT02614196|17391476|P3|Double Blind Treatment Phase|Pregnancy|0
5045650|NCT02614196|17391477|P2|Double Blind Treatment Phase|Pregnancy|2
5045651|NCT02614196|17391478|P1|Double Blind Treatment Phase|Pregnancy|1
5045652|NCT02614196|17391473|P6|Double Blind Treatment Phase|Physician Decision|0
5045653|NCT02614196|17391474|P5|Double Blind Treatment Phase|Physician Decision|0
5045654|NCT02614196|17391475|P4|Double Blind Treatment Phase|Physician Decision|0
5045655|NCT02614196|17391476|P3|Double Blind Treatment Phase|Physician Decision|2
5045656|NCT02614196|17391477|P2|Double Blind Treatment Phase|Physician Decision|0
5045657|NCT02614196|17391478|P1|Double Blind Treatment Phase|Physician Decision|4
5045658|NCT02614196|17391473|P6|Double Blind Treatment Phase|Lost to Follow-up|0
5045659|NCT02614196|17391474|P5|Double Blind Treatment Phase|Lost to Follow-up|0
5045660|NCT02614196|17391475|P4|Double Blind Treatment Phase|Lost to Follow-up|0
5045661|NCT02614196|17391476|P3|Double Blind Treatment Phase|Lost to Follow-up|1
5045662|NCT02614196|17391477|P2|Double Blind Treatment Phase|Lost to Follow-up|7
5045663|NCT02614196|17391478|P1|Double Blind Treatment Phase|Lost to Follow-up|10
5045664|NCT02614196|17391473|P6|Double Blind Treatment Phase|Lack of Efficacy|0
5045665|NCT02614196|17391474|P5|Double Blind Treatment Phase|Lack of Efficacy|0
5045666|NCT02614196|17391475|P4|Double Blind Treatment Phase|Lack of Efficacy|0
5045667|NCT02614196|17391476|P3|Double Blind Treatment Phase|Lack of Efficacy|1
5045668|NCT02614196|17391477|P2|Double Blind Treatment Phase|Lack of Efficacy|1
5045669|NCT02614196|17391478|P1|Double Blind Treatment Phase|Lack of Efficacy|6
5045670|NCT02614196|17391473|P6|Double Blind Treatment Phase|Adverse Event|0
5045671|NCT02614196|17391474|P5|Double Blind Treatment Phase|Adverse Event|0
5045672|NCT02614196|17391475|P4|Double Blind Treatment Phase|Adverse Event|0
5045673|NCT02614196|17391476|P3|Double Blind Treatment Phase|Adverse Event|9
5045674|NCT02614196|17391477|P2|Double Blind Treatment Phase|Adverse Event|5
5045675|NCT02614196|17391478|P1|Double Blind Treatment Phase|Adverse Event|8
5045676|NCT02614183|17391524|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
5045677|NCT02614183|17391525|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
5045678|NCT02614183|17391526|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
5045679|NCT02614183|17391524|P3|Post Treatment Follow-up Phase|Protocol Violation|0
5045680|NCT02614183|17391525|P2|Post Treatment Follow-up Phase|Protocol Violation|0
5045681|NCT02614183|17391526|P1|Post Treatment Follow-up Phase|Protocol Violation|1
5045682|NCT02614183|17391524|P3|Post Treatment Follow-up Phase|Physician Decision|2
5045683|NCT02614183|17391525|P2|Post Treatment Follow-up Phase|Physician Decision|1
5045684|NCT02614183|17391526|P1|Post Treatment Follow-up Phase|Physician Decision|5
5045685|NCT02614183|17391524|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
5045686|NCT02614183|17391525|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
5045687|NCT02614183|17391526|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
5045688|NCT02614183|17391524|P3|Double Blind Treatment Phase|Did not receive study drug|2
5045689|NCT02614183|17391525|P2|Double Blind Treatment Phase|Did not receive study drug|1
5045690|NCT02614183|17391526|P1|Double Blind Treatment Phase|Did not receive study drug|1
5045691|NCT02614183|17391524|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
5045692|NCT02614183|17391525|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
5045693|NCT02614183|17391526|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
5045694|NCT02614183|17391524|P3|Double Blind Treatment Phase|Protocol Violation|2
5045695|NCT02614183|17391525|P2|Double Blind Treatment Phase|Protocol Violation|2
5045696|NCT02614183|17391526|P1|Double Blind Treatment Phase|Protocol Violation|2
5045697|NCT02614183|17391524|P3|Double Blind Treatment Phase|Pregnancy|3
5045698|NCT02614183|17391525|P2|Double Blind Treatment Phase|Pregnancy|1
5045699|NCT02614183|17391526|P1|Double Blind Treatment Phase|Pregnancy|2
5045700|NCT02614183|17391524|P3|Double Blind Treatment Phase|Physician Decision|2
5045701|NCT02614183|17391525|P2|Double Blind Treatment Phase|Physician Decision|3
5045702|NCT02614183|17391526|P1|Double Blind Treatment Phase|Physician Decision|7
5045703|NCT02614183|17391524|P3|Double Blind Treatment Phase|Lost to Follow-up|5
5045704|NCT02614183|17391525|P2|Double Blind Treatment Phase|Lost to Follow-up|9
5045705|NCT02614183|17391526|P1|Double Blind Treatment Phase|Lost to Follow-up|18
5045706|NCT02614183|17391524|P3|Double Blind Treatment Phase|Lack of Efficacy|2
5045707|NCT02614183|17391525|P2|Double Blind Treatment Phase|Lack of Efficacy|1
5045708|NCT02614183|17391526|P1|Double Blind Treatment Phase|Lack of Efficacy|10
5045709|NCT02614183|17391524|P3|Double Blind Treatment Phase|Adverse Event|7
5045710|NCT02614183|17391525|P2|Double Blind Treatment Phase|Adverse Event|9
5045711|NCT02614183|17391526|P1|Double Blind Treatment Phase|Adverse Event|10
5045712|NCT02614131|17391570|P7|Overall Study|Adverse Event|1
5045713|NCT02614131|17391571|P6|Overall Study|Adverse Event|0
5045714|NCT02614131|17391572|P5|Overall Study|Adverse Event|0
5045715|NCT02614131|17391573|P4|Overall Study|Adverse Event|0
5045716|NCT02614131|17391574|P3|Overall Study|Adverse Event|0
5045717|NCT02614131|17391575|P2|Overall Study|Adverse Event|0
5045718|NCT02614131|17391576|P1|Overall Study|Adverse Event|0
5045719|NCT02614131|17391570|P7|Overall Study|Withdrawal by Subject|0
5045720|NCT02614131|17391571|P6|Overall Study|Withdrawal by Subject|0
5045721|NCT02614131|17391572|P5|Overall Study|Withdrawal by Subject|0
5045722|NCT02614131|17391573|P4|Overall Study|Withdrawal by Subject|0
5045723|NCT02614131|17391574|P3|Overall Study|Withdrawal by Subject|0
5045724|NCT02614131|17391575|P2|Overall Study|Withdrawal by Subject|0
5045725|NCT02614131|17391576|P1|Overall Study|Withdrawal by Subject|1
5045726|NCT02614079|17391607|P1|Overall Study|Withdrawal by Subject|1
5045727|NCT02613910|17391611|P1|Overall Study|Termination of study|1
5045728|NCT02613871|17391697|P1|Overall Study|Withdrew Consent|1
5045729|NCT02613871|17391697|P1|Overall Study|Death|2
5045730|NCT02613572|17391719|P3|Phase II: Double-Blind Rand Plac Control|Death|0
5045731|NCT02613572|17391720|P2|Phase II: Double-Blind Rand Plac Control|Death|1
5045732|NCT02613572|17391721|P1|Phase II: Double-Blind Rand Plac Control|Death|0
5045733|NCT02613572|17391719|P3|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
5045734|NCT02613572|17391720|P2|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
5045735|NCT02613572|17391721|P1|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
5045736|NCT02613507|17391743|P2|Overall Study|Randomized but not Treated|10
5045737|NCT02613507|17391744|P1|Overall Study|Randomized but not Treated|1
5045738|NCT02613507|17391743|P2|Overall Study|Subject no Longer Meets Study Criteria|0
5045739|NCT02613507|17391744|P1|Overall Study|Subject no Longer Meets Study Criteria|1
5045740|NCT02613507|17391743|P2|Overall Study|Brain Radiotherapy Activity Limited|0
5045741|NCT02613507|17391744|P1|Overall Study|Brain Radiotherapy Activity Limited|1
5045742|NCT02613507|17391743|P2|Overall Study|Maximum Clinical Benefit|10
5045743|NCT02613507|17391744|P1|Overall Study|Maximum Clinical Benefit|4
5045744|NCT02613507|17391743|P2|Overall Study|Lost to Follow-up|0
5045745|NCT02613507|17391744|P1|Overall Study|Lost to Follow-up|1
5045746|NCT02613507|17391743|P2|Overall Study|Participant Withdrew Consent|2
5045747|NCT02613507|17391744|P1|Overall Study|Participant Withdrew Consent|0
5045748|NCT02613507|17391743|P2|Overall Study|Request to Discontinue Study Treatment|17
5045749|NCT02613507|17391744|P1|Overall Study|Request to Discontinue Study Treatment|8
5045750|NCT02613507|17391743|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
5045751|NCT02613507|17391744|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
5045752|NCT02613507|17391743|P2|Overall Study|Death|0
5045753|NCT02613507|17391744|P1|Overall Study|Death|3
5045754|NCT02613507|17391743|P2|Overall Study|Study Drug Toxicity|14
5045755|NCT02613507|17391744|P1|Overall Study|Study Drug Toxicity|15
5045756|NCT02613507|17391743|P2|Overall Study|Disease Progression|109
5045757|NCT02613507|17391744|P1|Overall Study|Disease Progression|237
5045758|NCT02613481|17391760|P1|Overall Study|Withdrawal by Subject|2
5045759|NCT02613481|17391760|P1|Overall Study|Lost to Follow-up|7
5045760|NCT02613403|17391771|P5|Overall Study|Withdrawal by Subject|0
5045761|NCT02613403|17391772|P4|Overall Study|Withdrawal by Subject|0
5045762|NCT02613403|17391773|P3|Overall Study|Withdrawal by Subject|0
5045763|NCT02613403|17391774|P2|Overall Study|Withdrawal by Subject|0
5045764|NCT02613403|17391775|P1|Overall Study|Withdrawal by Subject|2
5045765|NCT02613403|17391771|P5|Overall Study|Lost to Follow-up|0
5045766|NCT02613403|17391772|P4|Overall Study|Lost to Follow-up|0
5045767|NCT02613403|17391773|P3|Overall Study|Lost to Follow-up|0
5045768|NCT02613403|17391774|P2|Overall Study|Lost to Follow-up|1
5045769|NCT02613403|17391775|P1|Overall Study|Lost to Follow-up|0
5045770|NCT02613221|17391827|P1|Overall Study|Enrolled but Not Treated|1
5045771|NCT02613221|17391827|P1|Overall Study|Delayed Treatment|1
5045772|NCT02613221|17391827|P1|Overall Study|Voluntary Discontinuation|1
5045773|NCT02613221|17391827|P1|Overall Study|Adverse Event|2
5045774|NCT02613221|17391827|P1|Overall Study|Lack of efficacy (exacerbation)|50
5045775|NCT02613208|17391839|P1|Overall Study|Death|37
5045776|NCT02613208|17391839|P1|Overall Study|Lost to Follow-up|5
5045777|NCT02613208|17391839|P1|Overall Study|Physician Decision|2
5045778|NCT02613208|17391839|P1|Overall Study|Change of address|2
5045779|NCT02613208|17391839|P1|Overall Study|Withdrawal by Subject|1
5045780|NCT02613182|17391853|P1|Overall Study|Withdrawal by Subject|6
5045781|NCT02613182|17391853|P1|Overall Study|Study Terminated by Sponsor|21
5045782|NCT02613182|17391853|P1|Overall Study|Physician Decision|1
5045783|NCT02613182|17391853|P1|Overall Study|Death|6
5045784|NCT02612909|17391875|P5|Phase 3|Withdrawal by Subject|0
5045785|NCT02612909|17391876|P4|Phase 3|Withdrawal by Subject|1
5045786|NCT02612909|17391877|P3|Phase 3|Withdrawal by Subject|0
5045787|NCT02612909|17391878|P2|Phase 3|Withdrawal by Subject|0
5045788|NCT02612909|17391879|P1|Phase 3|Withdrawal by Subject|0
5045789|NCT02612909|17391875|P5|Phase 2|Pregnancy|0
5045790|NCT02612909|17391876|P4|Phase 2|Pregnancy|0
5045791|NCT02612909|17391877|P3|Phase 2|Pregnancy|1
5045792|NCT02612909|17391878|P2|Phase 2|Pregnancy|0
5045793|NCT02612909|17391879|P1|Phase 2|Pregnancy|0
5045794|NCT02612909|17391875|P5|Phase 2|Withdrawal by Subject|0
5045795|NCT02612909|17391876|P4|Phase 2|Withdrawal by Subject|0
5045796|NCT02612909|17391877|P3|Phase 2|Withdrawal by Subject|0
5045797|NCT02612909|17391878|P2|Phase 2|Withdrawal by Subject|5
5045798|NCT02612909|17391879|P1|Phase 2|Withdrawal by Subject|2
5045799|NCT02612779|17391962|P2|Overall Study|Subsequent therapy|0
5045800|NCT02612779|17391963|P1|Overall Study|Subsequent therapy|3
5045801|NCT02612779|17391962|P2|Overall Study|Principal Investigator decision|0
5045802|NCT02612779|17391963|P1|Overall Study|Principal Investigator decision|2
5045803|NCT02612779|17391962|P2|Overall Study|Maximum clinical benefit|1
5045804|NCT02612779|17391963|P1|Overall Study|Maximum clinical benefit|10
5045805|NCT02612779|17391962|P2|Overall Study|Lost to Follow-up|0
5045806|NCT02612779|17391963|P1|Overall Study|Lost to Follow-up|1
5045807|NCT02612779|17391962|P2|Overall Study|Participant withdrew consent|0
5045808|NCT02612779|17391963|P1|Overall Study|Participant withdrew consent|4
5045809|NCT02612779|17391962|P2|Overall Study|Adverse event unrelated to study drug|0
5045810|NCT02612779|17391963|P1|Overall Study|Adverse event unrelated to study drug|5
5045811|NCT02612779|17391962|P2|Overall Study|Death|0
5045812|NCT02612779|17391963|P1|Overall Study|Death|1
5045813|NCT02612779|17391962|P2|Overall Study|Study drug toxicity|0
5045814|NCT02612779|17391963|P1|Overall Study|Study drug toxicity|9
5045815|NCT02612779|17391962|P2|Overall Study|Disease progression|2
5045816|NCT02612779|17391963|P1|Overall Study|Disease progression|29
5045817|NCT02612779|17391962|P2|Overall Study|No longer meet study criteria|1
5045818|NCT02612779|17391963|P1|Overall Study|No longer meet study criteria|0
5045819|NCT02612779|17391962|P2|Overall Study|Administrative reason by sponsor|1
5045820|NCT02612779|17391963|P1|Overall Study|Administrative reason by sponsor|0
5045821|NCT02612727|17391975|P2|Overall Study|Direct hyperbilirubinemia|2
5045822|NCT02612727|17391976|P1|Overall Study|Direct hyperbilirubinemia|0
5045823|NCT02612727|17391975|P2|Overall Study|Needed treatment incompatible with PT|1
5045824|NCT02612727|17391976|P1|Overall Study|Needed treatment incompatible with PT|1
5045825|NCT02612727|17391975|P2|Overall Study|Parent request|1
5045826|NCT02612727|17391976|P1|Overall Study|Parent request|4
5045827|NCT02612623|17392035|P4|Overall Study|Adverse Event|0
5045828|NCT02612623|17392036|P3|Overall Study|Adverse Event|1
5045829|NCT02612623|17392037|P2|Overall Study|Adverse Event|0
5045830|NCT02612623|17392038|P1|Overall Study|Adverse Event|1
5045831|NCT02612623|17392035|P4|Overall Study|Withdrawal by Subject|0
5045832|NCT02612623|17392036|P3|Overall Study|Withdrawal by Subject|0
5045833|NCT02612623|17392037|P2|Overall Study|Withdrawal by Subject|1
5045834|NCT02612623|17392038|P1|Overall Study|Withdrawal by Subject|0
5045835|NCT02612610|17392052|P4|Overall Study|Cough Improvement|0
5045836|NCT02612610|17392053|P3|Overall Study|Cough Improvement|1
5045837|NCT02612610|17392054|P2|Overall Study|Cough Improvement|0
5045838|NCT02612610|17392055|P1|Overall Study|Cough Improvement|0
5045839|NCT02612610|17392052|P4|Overall Study|Noncompliance|0
5045840|NCT02612610|17392053|P3|Overall Study|Noncompliance|0
5045841|NCT02612610|17392054|P2|Overall Study|Noncompliance|0
5045842|NCT02612610|17392055|P1|Overall Study|Noncompliance|1
5045843|NCT02612610|17392052|P4|Overall Study|Physician Decision|0
5045844|NCT02612610|17392053|P3|Overall Study|Physician Decision|0
5045845|NCT02612610|17392054|P2|Overall Study|Physician Decision|1
5045846|NCT02612610|17392055|P1|Overall Study|Physician Decision|0
5045847|NCT02612610|17392052|P4|Overall Study|Lack of Efficacy|1
5045848|NCT02612610|17392053|P3|Overall Study|Lack of Efficacy|0
5045849|NCT02612610|17392054|P2|Overall Study|Lack of Efficacy|2
5045850|NCT02612610|17392055|P1|Overall Study|Lack of Efficacy|1
5045851|NCT02612610|17392052|P4|Overall Study|Protocol Violation|0
5045852|NCT02612610|17392053|P3|Overall Study|Protocol Violation|1
5045853|NCT02612610|17392054|P2|Overall Study|Protocol Violation|1
5045854|NCT02612610|17392055|P1|Overall Study|Protocol Violation|0
5045855|NCT02612610|17392052|P4|Overall Study|Lost to Follow-up|0
5045856|NCT02612610|17392053|P3|Overall Study|Lost to Follow-up|0
5045857|NCT02612610|17392054|P2|Overall Study|Lost to Follow-up|1
5045858|NCT02612610|17392055|P1|Overall Study|Lost to Follow-up|0
5045859|NCT02612610|17392052|P4|Overall Study|Adverse Event|10
5045860|NCT02612610|17392053|P3|Overall Study|Adverse Event|3
5045861|NCT02612610|17392054|P2|Overall Study|Adverse Event|2
5045862|NCT02612610|17392055|P1|Overall Study|Adverse Event|2
5045863|NCT02612610|17392052|P4|Overall Study|Withdrawal by Subject|2
5045864|NCT02612610|17392053|P3|Overall Study|Withdrawal by Subject|0
5045865|NCT02612610|17392054|P2|Overall Study|Withdrawal by Subject|1
5045866|NCT02612610|17392055|P1|Overall Study|Withdrawal by Subject|1
5045867|NCT02612428|17392299|P2|VTL-308E|Lost to Follow-up|0
5045868|NCT02612428|17392300|P1|VTL-308E|Lost to Follow-up|2
5045869|NCT02612428|17392299|P2|VTL-308E|Death|7
5045870|NCT02612428|17392300|P1|VTL-308E|Death|9
5045871|NCT02612428|17392299|P2|VTL-308|Withdrawal by Subject|1
5045872|NCT02612428|17392300|P1|VTL-308|Withdrawal by Subject|0
5045873|NCT02612428|17392299|P2|VTL-308|Death|16
5045874|NCT02612428|17392300|P1|VTL-308|Death|14
5045875|NCT02612285|17392310|P1|Overall Study|Withdrawal by Subject|1
5045876|NCT02612155|17392316|P2|Overall Study|Lost to Follow-up|2
5045877|NCT02612155|17392317|P1|Overall Study|Lost to Follow-up|2
5045878|NCT02612155|17392316|P2|Overall Study|Death|1
5045879|NCT02612155|17392317|P1|Overall Study|Death|1
5045880|NCT02612077|17392337|P1|Overall Study|Unknown reason|2
5045881|NCT02612077|17392337|P1|Overall Study|Disease Progression|3
5045882|NCT02612077|17392337|P1|Overall Study|Enrollment in a Clinical Trial|1
5045883|NCT02612077|17392337|P1|Overall Study|Moved or Changed Medical Team|23
5045884|NCT02612077|17392337|P1|Overall Study|Death|377
5045885|NCT02612077|17392337|P1|Overall Study|Lost to Follow-up|20
5045886|NCT02612077|17392337|P1|Overall Study|Protocol Violation|28
5045887|NCT02612077|17392337|P1|Overall Study|Withdrawal by Subject|9
5045888|NCT02612077|17392337|P1|Overall Study|Adverse Event|3
5045889|NCT02612064|17392349|P2|Overall Study|Other|2
5045890|NCT02612064|17392350|P1|Overall Study|Other|0
5045891|NCT02612064|17392349|P2|Overall Study|Withdrawal by Subject|1
5045892|NCT02612064|17392350|P1|Overall Study|Withdrawal by Subject|1
5045893|NCT02611830|17392364|P4|Maintenance Phase|Reason not specified|0
5045894|NCT02611830|17392365|P3|Maintenance Phase|Reason not specified|4
5045895|NCT02611830|17392366|P2|Maintenance Phase|Reason not specified|1
5045896|NCT02611830|17392367|P1|Maintenance Phase|Reason not specified|0
5045897|NCT02611830|17392364|P4|Maintenance Phase|Pregnancy|0
5045898|NCT02611830|17392365|P3|Maintenance Phase|Pregnancy|1
5045899|NCT02611830|17392366|P2|Maintenance Phase|Pregnancy|0
5045900|NCT02611830|17392367|P1|Maintenance Phase|Pregnancy|0
5045901|NCT02611830|17392364|P4|Maintenance Phase|Voluntary Withdrawal|5
5045902|NCT02611830|17392365|P3|Maintenance Phase|Voluntary Withdrawal|2
5045903|NCT02611830|17392366|P2|Maintenance Phase|Voluntary Withdrawal|1
5045904|NCT02611830|17392367|P1|Maintenance Phase|Voluntary Withdrawal|0
5045905|NCT02611830|17392364|P4|Maintenance Phase|Lost to Follow-up|1
5045906|NCT02611830|17392365|P3|Maintenance Phase|Lost to Follow-up|0
5045907|NCT02611830|17392366|P2|Maintenance Phase|Lost to Follow-up|0
5045908|NCT02611830|17392367|P1|Maintenance Phase|Lost to Follow-up|0
5045909|NCT02611830|17392364|P4|Maintenance Phase|Significant Protocol Deviation|1
5045910|NCT02611830|17392365|P3|Maintenance Phase|Significant Protocol Deviation|1
5045911|NCT02611830|17392366|P2|Maintenance Phase|Significant Protocol Deviation|0
5045912|NCT02611830|17392367|P1|Maintenance Phase|Significant Protocol Deviation|0
5045913|NCT02611830|17392364|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
5045914|NCT02611830|17392365|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
5045915|NCT02611830|17392366|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
5045916|NCT02611830|17392367|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
5045917|NCT02611830|17392364|P4|Maintenance Phase|Lack of Efficacy|6
5045918|NCT02611830|17392365|P3|Maintenance Phase|Lack of Efficacy|18
5045919|NCT02611830|17392366|P2|Maintenance Phase|Lack of Efficacy|29
5045920|NCT02611830|17392367|P1|Maintenance Phase|Lack of Efficacy|0
5045921|NCT02611830|17392364|P4|OL Induction Phase|Reason not specified|0
5045922|NCT02611830|17392365|P3|OL Induction Phase|Reason not specified|0
5045923|NCT02611830|17392366|P2|OL Induction Phase|Reason not specified|0
5045924|NCT02611830|17392367|P1|OL Induction Phase|Reason not specified|3
5045925|NCT02611830|17392364|P4|OL Induction Phase|Lack of Efficacy|0
5045926|NCT02611830|17392365|P3|OL Induction Phase|Lack of Efficacy|0
5045927|NCT02611830|17392366|P2|OL Induction Phase|Lack of Efficacy|0
5045928|NCT02611830|17392367|P1|OL Induction Phase|Lack of Efficacy|9
5045929|NCT02611830|17392364|P4|OL Induction Phase|Voluntary Withdrawal|0
5045930|NCT02611830|17392365|P3|OL Induction Phase|Voluntary Withdrawal|0
5045931|NCT02611830|17392366|P2|OL Induction Phase|Voluntary Withdrawal|0
5045932|NCT02611830|17392367|P1|OL Induction Phase|Voluntary Withdrawal|5
5045933|NCT02611830|17392364|P4|OL Induction Phase|Significant Protocol Deviation|0
5045934|NCT02611830|17392365|P3|OL Induction Phase|Significant Protocol Deviation|0
5045935|NCT02611830|17392366|P2|OL Induction Phase|Significant Protocol Deviation|0
5045936|NCT02611830|17392367|P1|OL Induction Phase|Significant Protocol Deviation|4
5045937|NCT02611830|17392364|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
5045938|NCT02611830|17392365|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
5045939|NCT02611830|17392366|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
5045940|NCT02611830|17392367|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
5045941|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Lost to Follow-up|1
5045942|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Lost to Follow-up|0
5045943|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Lost to Follow-up|0
5045944|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Withdrawal by Subject|14
5045945|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Withdrawal by Subject|5
5045946|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Withdrawal by Subject|0
5045947|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Pregnancy|1
5045948|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Pregnancy|0
5045949|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Pregnancy|0
5045950|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Lack of Efficacy|78
5045951|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Lack of Efficacy|43
5045952|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Lack of Efficacy|0
5045953|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Reason not Specified|2
5045954|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Reason not Specified|1
5045955|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Reason not Specified|0
5045956|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Randomized but not Treated|0
5045957|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Randomized but not Treated|1
5045958|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Randomized but not Treated|0
5045959|NCT02611817|17392391|P3|Double-blind Maintenance Phase|Adverse Event|11
5045960|NCT02611817|17392392|P2|Double-blind Maintenance Phase|Adverse Event|12
5045961|NCT02611817|17392393|P1|Double-blind Maintenance Phase|Adverse Event|0
5045962|NCT02611817|17392391|P3|Open-label Induction Phase|Adverse Event|0
5045963|NCT02611817|17392392|P2|Open-label Induction Phase|Adverse Event|0
5045964|NCT02611817|17392393|P1|Open-label Induction Phase|Adverse Event|16
5045965|NCT02611817|17392391|P3|Open-label Induction Phase|Protocol Violation|0
5045966|NCT02611817|17392392|P2|Open-label Induction Phase|Protocol Violation|0
5045967|NCT02611817|17392393|P1|Open-label Induction Phase|Protocol Violation|5
5045968|NCT02611817|17392391|P3|Open-label Induction Phase|Lost to Follow-up|0
5045969|NCT02611817|17392392|P2|Open-label Induction Phase|Lost to Follow-up|0
5045970|NCT02611817|17392393|P1|Open-label Induction Phase|Lost to Follow-up|2
5045971|NCT02611817|17392391|P3|Open-label Induction Phase|Withdrawal by Subject|0
5045972|NCT02611817|17392392|P2|Open-label Induction Phase|Withdrawal by Subject|0
5045973|NCT02611817|17392393|P1|Open-label Induction Phase|Withdrawal by Subject|9
5045974|NCT02611817|17392391|P3|Open-label Induction Phase|Pregnancy|0
5045975|NCT02611817|17392392|P2|Open-label Induction Phase|Pregnancy|0
5045976|NCT02611817|17392393|P1|Open-label Induction Phase|Pregnancy|1
5045977|NCT02611817|17392391|P3|Open-label Induction Phase|Lack of Efficacy|0
5045978|NCT02611817|17392392|P2|Open-label Induction Phase|Lack of Efficacy|0
5045979|NCT02611817|17392393|P1|Open-label Induction Phase|Lack of Efficacy|8
5045980|NCT02611817|17392391|P3|Open-label Induction Phase|Reason not Specified|0
5045981|NCT02611817|17392392|P2|Open-label Induction Phase|Reason not Specified|0
5045982|NCT02611817|17392393|P1|Open-label Induction Phase|Reason not Specified|9
5045983|NCT02611752|17392417|P2|Overall Study|Adverse Event|1
5045984|NCT02611752|17392418|P1|Overall Study|Adverse Event|0
5045985|NCT02611479|17392450|P1|Data Cleaning|No baseline function or pain metrics|2
5045986|NCT02611479|17392450|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
5045987|NCT02611479|17392450|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
5045988|NCT02611479|17392450|P1|Baseline Enrollment|Exited study|13
5045989|NCT02610842|17392582|P1|Overall Study|Lost to Follow-up|5
5045990|NCT02610816|17392591|P4|Phase 2|Pregnancy|1
5045991|NCT02610816|17392592|P3|Phase 2|Pregnancy|0
5045992|NCT02610816|17392593|P2|Phase 2|Pregnancy|0
5045993|NCT02610816|17392594|P1|Phase 2|Pregnancy|0
5045994|NCT02610816|17392591|P4|Phase 2|Physician Decision|2
5045995|NCT02610816|17392592|P3|Phase 2|Physician Decision|0
5045996|NCT02610816|17392593|P2|Phase 2|Physician Decision|0
5045997|NCT02610816|17392594|P1|Phase 2|Physician Decision|0
5045998|NCT02610816|17392591|P4|Phase 2|Lost to Follow-up|0
5045999|NCT02610816|17392592|P3|Phase 2|Lost to Follow-up|2
5046000|NCT02610816|17392593|P2|Phase 2|Lost to Follow-up|0
5046001|NCT02610816|17392594|P1|Phase 2|Lost to Follow-up|0
5046002|NCT02610816|17392591|P4|Phase 2|Withdrawal by Subject|3
5046003|NCT02610816|17392592|P3|Phase 2|Withdrawal by Subject|9
5046004|NCT02610816|17392593|P2|Phase 2|Withdrawal by Subject|0
5046005|NCT02610816|17392594|P1|Phase 2|Withdrawal by Subject|0
5046006|NCT02610816|17392591|P4|Phase 1|Physician Decision|0
5046007|NCT02610816|17392592|P3|Phase 1|Physician Decision|0
5046008|NCT02610816|17392593|P2|Phase 1|Physician Decision|1
5046009|NCT02610816|17392594|P1|Phase 1|Physician Decision|0
5046010|NCT02610816|17392591|P4|Phase 1|Lost to Follow-up|0
5046011|NCT02610816|17392592|P3|Phase 1|Lost to Follow-up|0
5046012|NCT02610816|17392593|P2|Phase 1|Lost to Follow-up|1
5046013|NCT02610816|17392594|P1|Phase 1|Lost to Follow-up|2
5046014|NCT02610816|17392591|P4|Phase 1|Withdrawal by Subject|0
5046015|NCT02610816|17392592|P3|Phase 1|Withdrawal by Subject|0
5046016|NCT02610816|17392593|P2|Phase 1|Withdrawal by Subject|6
5046017|NCT02610816|17392594|P1|Phase 1|Withdrawal by Subject|2
5046018|NCT02610777|17392617|P2|Overall Study|Ongoing on Treatment|7
5046019|NCT02610777|17392618|P1|Overall Study|Ongoing on Treatment|6
5046020|NCT02610777|17392617|P2|Overall Study|Other|1
5046021|NCT02610777|17392618|P1|Overall Study|Other|0
5046022|NCT02610777|17392617|P2|Overall Study|Withdrawal by Subject|2
5046023|NCT02610777|17392618|P1|Overall Study|Withdrawal by Subject|1
5046024|NCT02610777|17392617|P2|Overall Study|Ongoing in Follow-up|12
5046025|NCT02610777|17392618|P1|Overall Study|Ongoing in Follow-up|14
5046026|NCT02610725|17392624|P1|Overall Study|self-reported contraindication|9
5046027|NCT02610725|17392624|P1|Overall Study|Lost to Follow-up|197
5046028|NCT02610231|17392639|P1|Overall Study|Other|3
5046029|NCT02610231|17392639|P1|Overall Study|Non Compliance|2
5046030|NCT02610231|17392639|P1|Overall Study|Physician Decision|1
5046031|NCT02610231|17392639|P1|Overall Study|Surgery|2
5046032|NCT02610231|17392639|P1|Overall Study|Death|5
5046033|NCT02610231|17392639|P1|Overall Study|Adverse Event|20
5046034|NCT02610231|17392639|P1|Overall Study|Withdrawal by Subject|27
5046035|NCT02610192|17392646|P1|Overall Study|Physician Decision|1
5046036|NCT02610192|17392646|P1|Overall Study|Received other treatment|8
5046037|NCT02610140|17392661|P2|Long-term Follow-up|Ongoing but not completed|17
5046038|NCT02610140|17392662|P1|Long-term Follow-up|Ongoing but not completed|30
5046039|NCT02610140|17392661|P2|Long-term Follow-up|Lost to Follow-up|2
5046040|NCT02610140|17392662|P1|Long-term Follow-up|Lost to Follow-up|1
5046041|NCT02610140|17392661|P2|Long-term Follow-up|Withdrawal by Subject|3
5046042|NCT02610140|17392662|P1|Long-term Follow-up|Withdrawal by Subject|6
5046043|NCT02610140|17392661|P2|Long-term Follow-up|Death|44
5046044|NCT02610140|17392662|P1|Long-term Follow-up|Death|86
5046045|NCT02610140|17392661|P2|Active Follow-up|Ongoing but not completed|1
5046046|NCT02610140|17392662|P1|Active Follow-up|Ongoing but not completed|4
5046047|NCT02610140|17392661|P2|Active Follow-up|Deterioration of general conditions|0
5046048|NCT02610140|17392662|P1|Active Follow-up|Deterioration of general conditions|1
5046049|NCT02610140|17392661|P2|Active Follow-up|Progressive disease - clinical|2
5046050|NCT02610140|17392662|P1|Active Follow-up|Progressive disease - clinical|1
5046051|NCT02610140|17392661|P2|Active Follow-up|Withdrawal by Subject|0
5046052|NCT02610140|17392662|P1|Active Follow-up|Withdrawal by Subject|4
5046053|NCT02610140|17392661|P2|Active Follow-up|Death|1
5046054|NCT02610140|17392662|P1|Active Follow-up|Death|8
5046055|NCT02610140|17392661|P2|Active Follow-up|Progressive disease - radiological|22
5046056|NCT02610140|17392662|P1|Active Follow-up|Progressive disease - radiological|30
5046057|NCT02610140|17392661|P2|Safety Follow-up|Withdrawal by Subject|12
5046058|NCT02610140|17392662|P1|Safety Follow-up|Withdrawal by Subject|12
5046059|NCT02610140|17392661|P2|Safety Follow-up|Deterioration of general conditions|5
5046060|NCT02610140|17392662|P1|Safety Follow-up|Deterioration of general conditions|15
5046061|NCT02610140|17392661|P2|Safety Follow-up|Death|2
5046062|NCT02610140|17392662|P1|Safety Follow-up|Death|12
5046063|NCT02610140|17392661|P2|Safety Follow-up|No follow-up|3
5046064|NCT02610140|17392662|P1|Safety Follow-up|No follow-up|5
5046065|NCT02610140|17392661|P2|Safety Follow-up|Lost to Follow-up|0
5046066|NCT02610140|17392662|P1|Safety Follow-up|Lost to Follow-up|1
5046067|NCT02610140|17392661|P2|Safety Follow-up|Other|2
5046068|NCT02610140|17392662|P1|Safety Follow-up|Other|0
5046069|NCT02610140|17392661|P2|Randomization and Treatment Period|Not treated|10
5046070|NCT02610140|17392662|P1|Randomization and Treatment Period|Not treated|3
5046071|NCT02610140|17392661|P2|Randomization and Treatment Period|Ongoing but not completed|2
5046072|NCT02610140|17392662|P1|Randomization and Treatment Period|Ongoing but not completed|9
5046073|NCT02610140|17392661|P2|Randomization and Treatment Period|Progressive disease - clinical|5
5046074|NCT02610140|17392662|P1|Randomization and Treatment Period|Progressive disease - clinical|12
5046075|NCT02610140|17392661|P2|Randomization and Treatment Period|Adverse Event|13
5046076|NCT02610140|17392662|P1|Randomization and Treatment Period|Adverse Event|44
5046077|NCT02610140|17392661|P2|Randomization and Treatment Period|Withdrawal by Subject|12
5046078|NCT02610140|17392662|P1|Randomization and Treatment Period|Withdrawal by Subject|12
5046079|NCT02610140|17392661|P2|Randomization and Treatment Period|Death|1
5046080|NCT02610140|17392662|P1|Randomization and Treatment Period|Death|7
5046081|NCT02610140|17392661|P2|Randomization and Treatment Period|Lack of Efficacy|0
5046082|NCT02610140|17392662|P1|Randomization and Treatment Period|Lack of Efficacy|1
5046083|NCT02610140|17392661|P2|Randomization and Treatment Period|Physician Decision|1
5046084|NCT02610140|17392662|P1|Randomization and Treatment Period|Physician Decision|0
5046085|NCT02610140|17392661|P2|Randomization and Treatment Period|Protocol Violation|0
5046086|NCT02610140|17392662|P1|Randomization and Treatment Period|Protocol Violation|1
5046087|NCT02610140|17392661|P2|Randomization and Treatment Period|Progressive disease - radiological|23
5046088|NCT02610140|17392662|P1|Randomization and Treatment Period|Progressive disease - radiological|54
5046089|NCT02610140|17392661|P2|Randomization and Treatment Period|Radiological progression|15
5046090|NCT02610140|17392662|P1|Randomization and Treatment Period|Radiological progression|23
5046091|NCT02609984|17392694|P2|Overall Study|Disease Progression|0
5046092|NCT02609984|17392695|P1|Overall Study|Disease Progression|2
5046093|NCT02609984|17392694|P2|Overall Study|Withdrawal by Subject|1
5046094|NCT02609984|17392695|P1|Overall Study|Withdrawal by Subject|0
5046095|NCT02609984|17392694|P2|Overall Study|Lost to Follow-up|2
5046096|NCT02609984|17392695|P1|Overall Study|Lost to Follow-up|1
5046097|NCT02609984|17392694|P2|Overall Study|Participation Discontinued by Sponsor|10
5046098|NCT02609984|17392695|P1|Overall Study|Participation Discontinued by Sponsor|12
5046099|NCT02609984|17392694|P2|Overall Study|Death|26
5046100|NCT02609984|17392695|P1|Overall Study|Death|29
5046101|NCT02609672|17392737|P2|Overall Study|Lost to Follow-up|1
5046102|NCT02609672|17392738|P1|Overall Study|Lost to Follow-up|3
5046103|NCT02609659|17392772|P1|Overall Study|Other|1
5046104|NCT02609659|17392772|P1|Overall Study|Lost to Follow-up|6
5046105|NCT02609659|17392772|P1|Overall Study|Adverse Event|1
5046106|NCT02609633|17392782|P2|Overall Study|Reason not Specified|1
5046107|NCT02609633|17392783|P1|Overall Study|Reason not Specified|2
5046108|NCT02609633|17392782|P2|Overall Study|Non-Compliant with Study Procedures|0
5046109|NCT02609633|17392783|P1|Overall Study|Non-Compliant with Study Procedures|2
5046110|NCT02609633|17392782|P2|Overall Study|Protocol Deviation|0
5046111|NCT02609633|17392783|P1|Overall Study|Protocol Deviation|1
5046112|NCT02609633|17392782|P2|Overall Study|Consent Withdrawn|1
5046113|NCT02609633|17392783|P1|Overall Study|Consent Withdrawn|0
5046114|NCT02609607|17392810|P2|Overall Study|Lost to Follow-up|1
5046115|NCT02609607|17392811|P1|Overall Study|Lost to Follow-up|0
5046116|NCT02609399|17392835|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
5046117|NCT02609399|17392836|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
5046118|NCT02609399|17392835|P2|Influenza Season 2016-2017|Lost to Follow-up|5
5046119|NCT02609399|17392836|P1|Influenza Season 2016-2017|Lost to Follow-up|8
5046120|NCT02609399|17392835|P2|Influenza Season 2015-2016|Lost to Follow-up|2
5046121|NCT02609399|17392836|P1|Influenza Season 2015-2016|Lost to Follow-up|3
5046122|NCT02609178|17392866|P6|First Crown|Withdrawal by Subject|0
5046123|NCT02609178|17392867|P5|First Crown|Withdrawal by Subject|0
5046124|NCT02609178|17392868|P4|First Crown|Withdrawal by Subject|1
5046125|NCT02609178|17392869|P3|First Crown|Withdrawal by Subject|1
5046126|NCT02609178|17392870|P2|First Crown|Withdrawal by Subject|0
5046127|NCT02609178|17392871|P1|First Crown|Withdrawal by Subject|0
5046128|NCT02608892|17392933|P2|Overall Study|Lost to Follow-up|0
5046129|NCT02608892|17392934|P1|Overall Study|Lost to Follow-up|1
5046130|NCT02608879|17392946|P3|Overall Study|Did not meet continuation criteria|3
5046131|NCT02608879|17392947|P2|Overall Study|Did not meet continuation criteria|0
5046132|NCT02608879|17392948|P1|Overall Study|Did not meet continuation criteria|0
5046133|NCT02608879|17392946|P3|Overall Study|Lost to Follow-up|0
5046134|NCT02608879|17392947|P2|Overall Study|Lost to Follow-up|0
5046135|NCT02608879|17392948|P1|Overall Study|Lost to Follow-up|1
5046136|NCT02608684|17392967|P1|Overall Study|Withdrawal by Subject|1
5046137|NCT02608684|17392967|P1|Overall Study|Physician Decision|2
5046138|NCT02608476|17393002|P2|Overall Study|Progressive disease|0
5046139|NCT02608476|17393003|P1|Overall Study|Progressive disease|1
5046140|NCT02608476|17393002|P2|Overall Study|Pregnancy|1
5046141|NCT02608476|17393003|P1|Overall Study|Pregnancy|0
5046142|NCT02608476|17393002|P2|Overall Study|Physician Decision|0
5046143|NCT02608476|17393003|P1|Overall Study|Physician Decision|1
5046144|NCT02608476|17393002|P2|Overall Study|Other|1
5046145|NCT02608476|17393003|P1|Overall Study|Other|0
5046146|NCT02608476|17393002|P2|Overall Study|Lack of Efficacy|1
5046147|NCT02608476|17393003|P1|Overall Study|Lack of Efficacy|3
5046148|NCT02608476|17393002|P2|Overall Study|Noncompliance with treatment|5
5046149|NCT02608476|17393003|P1|Overall Study|Noncompliance with treatment|1
5046150|NCT02608476|17393002|P2|Overall Study|Withdrawal by Parent/Guardian|4
5046151|NCT02608476|17393003|P1|Overall Study|Withdrawal by Parent/Guardian|5
5046152|NCT02608476|17393002|P2|Overall Study|Adverse Event|8
5046153|NCT02608476|17393003|P1|Overall Study|Adverse Event|2
5046154|NCT02608476|17393002|P2|Overall Study|Lost to Follow-up|24
5046155|NCT02608476|17393003|P1|Overall Study|Lost to Follow-up|24
5046156|NCT02608476|17393002|P2|Overall Study|Withdrawal by Subject|37
5046157|NCT02608476|17393003|P1|Overall Study|Withdrawal by Subject|30
5046158|NCT02608450|17393033|P2|Overall Study|Multiple reasons|2
5046159|NCT02608450|17393034|P1|Overall Study|Multiple reasons|0
5046160|NCT02608450|17393033|P2|Overall Study|Progressive disease|0
5046161|NCT02608450|17393034|P1|Overall Study|Progressive disease|1
5046162|NCT02608450|17393033|P2|Overall Study|Pregnancy|1
5046163|NCT02608450|17393034|P1|Overall Study|Pregnancy|0
5046164|NCT02608450|17393033|P2|Overall Study|Physician Decision|1
5046165|NCT02608450|17393034|P1|Overall Study|Physician Decision|0
5046166|NCT02608450|17393033|P2|Overall Study|Noncompliance with study drug|2
5046167|NCT02608450|17393034|P1|Overall Study|Noncompliance with study drug|0
5046168|NCT02608450|17393033|P2|Overall Study|Lack of Efficacy|3
5046169|NCT02608450|17393034|P1|Overall Study|Lack of Efficacy|0
5046170|NCT02608450|17393033|P2|Overall Study|Withdrawal by parent|3
5046171|NCT02608450|17393034|P1|Overall Study|Withdrawal by parent|2
5046172|NCT02608450|17393033|P2|Overall Study|Adverse Event|6
5046173|NCT02608450|17393034|P1|Overall Study|Adverse Event|3
5046174|NCT02608450|17393033|P2|Overall Study|Withdrawal by Subject|15
5046175|NCT02608450|17393034|P1|Overall Study|Withdrawal by Subject|21
5046176|NCT02608450|17393033|P2|Overall Study|Lost to Follow-up|32
5046177|NCT02608450|17393034|P1|Overall Study|Lost to Follow-up|39
5046178|NCT02608099|17393096|P2|Overall Study|Ablation procedure not initiated|2
5046179|NCT02608099|17393097|P1|Overall Study|Ablation procedure not initiated|3
5046180|NCT02607956|17393135|P2|Overall Study|Lost to Follow-up|15
5046181|NCT02607956|17393136|P1|Overall Study|Lost to Follow-up|18
5046182|NCT02607956|17393135|P2|Overall Study|Withdrew Consent|16
5046183|NCT02607956|17393136|P1|Overall Study|Withdrew Consent|16
5046184|NCT02607956|17393135|P2|Overall Study|Protocol Violation|1
5046185|NCT02607956|17393136|P1|Overall Study|Protocol Violation|3
5046186|NCT02607956|17393135|P2|Overall Study|Non-Compliance with Study Drug|3
5046187|NCT02607956|17393136|P1|Overall Study|Non-Compliance with Study Drug|0
5046188|NCT02607956|17393135|P2|Overall Study|Investigator's Discretion|2
5046189|NCT02607956|17393136|P1|Overall Study|Investigator's Discretion|7
5046190|NCT02607956|17393135|P2|Overall Study|Death|4
5046191|NCT02607956|17393136|P1|Overall Study|Death|4
5046192|NCT02607956|17393135|P2|Overall Study|Adverse Event|3
5046193|NCT02607956|17393136|P1|Overall Study|Adverse Event|4
5046194|NCT02607956|17393135|P2|Overall Study|Still on Study|281
5046195|NCT02607956|17393136|P1|Overall Study|Still on Study|268
5046196|NCT02607956|17393135|P2|Overall Study|Randomized and Never Treated|5
5046197|NCT02607956|17393136|P1|Overall Study|Randomized and Never Treated|7
5046198|NCT02607930|17393166|P2|Overall Study|Lost to Follow-up|16
5046199|NCT02607930|17393167|P1|Overall Study|Lost to Follow-up|24
5046200|NCT02607930|17393166|P2|Overall Study|Withdrew Consent|15
5046201|NCT02607930|17393167|P1|Overall Study|Withdrew Consent|14
5046202|NCT02607930|17393166|P2|Overall Study|Protocol Violation|3
5046203|NCT02607930|17393167|P1|Overall Study|Protocol Violation|2
5046204|NCT02607930|17393166|P2|Overall Study|Non-Compliance with Study Drug|5
5046205|NCT02607930|17393167|P1|Overall Study|Non-Compliance with Study Drug|3
5046206|NCT02607930|17393166|P2|Overall Study|Investigator's Discretion|2
5046207|NCT02607930|17393167|P1|Overall Study|Investigator's Discretion|6
5046208|NCT02607930|17393166|P2|Overall Study|Death|1
5046209|NCT02607930|17393167|P1|Overall Study|Death|2
5046210|NCT02607930|17393166|P2|Overall Study|Adverse Event|4
5046211|NCT02607930|17393167|P1|Overall Study|Adverse Event|0
5046212|NCT02607930|17393166|P2|Overall Study|Still in Study|269
5046213|NCT02607930|17393167|P1|Overall Study|Still in Study|263
5046214|NCT02607930|17393166|P2|Overall Study|Randomized and Never Treated|0
5046215|NCT02607930|17393167|P1|Overall Study|Randomized and Never Treated|2
5046216|NCT02607865|17393211|P4|Overall Study|Unclassified|0
5046217|NCT02607865|17393212|P3|Overall Study|Unclassified|2
5046218|NCT02607865|17393213|P2|Overall Study|Unclassified|1
5046219|NCT02607865|17393214|P1|Overall Study|Unclassified|1
5046220|NCT02607865|17393211|P4|Overall Study|Death|3
5046221|NCT02607865|17393212|P3|Overall Study|Death|1
5046222|NCT02607865|17393213|P2|Overall Study|Death|4
5046223|NCT02607865|17393214|P1|Overall Study|Death|5
5046224|NCT02607865|17393211|P4|Overall Study|Withdrawal by Subject|8
5046225|NCT02607865|17393212|P3|Overall Study|Withdrawal by Subject|17
5046226|NCT02607865|17393213|P2|Overall Study|Withdrawal by Subject|18
5046227|NCT02607865|17393214|P1|Overall Study|Withdrawal by Subject|18
5046228|NCT02607865|17393211|P4|Overall Study|Lost to Follow-up|5
5046229|NCT02607865|17393212|P3|Overall Study|Lost to Follow-up|7
5046230|NCT02607865|17393213|P2|Overall Study|Lost to Follow-up|7
5046231|NCT02607865|17393214|P1|Overall Study|Lost to Follow-up|9
5046232|NCT02607800|17393388|P2|Overall Study|Randomized/Enrolled but Not Treated|1
5046233|NCT02607800|17393389|P1|Overall Study|Randomized/Enrolled but Not Treated|1
5046234|NCT02607800|17393388|P2|Overall Study|Withdrew Consent|0
5046235|NCT02607800|17393389|P1|Overall Study|Withdrew Consent|2
5046236|NCT02607800|17393388|P2|Overall Study|Lost to Follow-up|10
5046237|NCT02607800|17393389|P1|Overall Study|Lost to Follow-up|7
5046238|NCT02607735|17393407|P3|Deferred Treatment Substudy|Withdrew Consent|1
5046239|NCT02607735|17393408|P2|Deferred Treatment Substudy|Withdrew Consent|0
5046240|NCT02607735|17393409|P1|Deferred Treatment Substudy|Withdrew Consent|0
5046241|NCT02607735|17393407|P3|Deferred Treatment Substudy|Lost to Follow-up|4
5046242|NCT02607735|17393408|P2|Deferred Treatment Substudy|Lost to Follow-up|0
5046243|NCT02607735|17393409|P1|Deferred Treatment Substudy|Lost to Follow-up|0
5046244|NCT02607735|17393407|P3|Primary Study|Withdrew Consent|0
5046245|NCT02607735|17393408|P2|Primary Study|Withdrew Consent|0
5046246|NCT02607735|17393409|P1|Primary Study|Withdrew Consent|2
5046247|NCT02607735|17393407|P3|Primary Study|Lost to Follow-up|0
5046248|NCT02607735|17393408|P2|Primary Study|Lost to Follow-up|0
5046249|NCT02607735|17393409|P1|Primary Study|Lost to Follow-up|4
5046250|NCT02607735|17393407|P3|Primary Study|Randomized but Never Treated|0
5046251|NCT02607735|17393408|P2|Primary Study|Randomized but Never Treated|0
5046252|NCT02607735|17393409|P1|Primary Study|Randomized but Never Treated|1
5046253|NCT02607306|17393443|P3|Overall Study|Protocol Violation|1
5046254|NCT02607306|17393444|P2|Overall Study|Protocol Violation|2
5046255|NCT02607306|17393445|P1|Overall Study|Protocol Violation|4
5046256|NCT02607306|17393443|P3|Overall Study|Lack of Efficacy|1
5046257|NCT02607306|17393444|P2|Overall Study|Lack of Efficacy|1
5046258|NCT02607306|17393445|P1|Overall Study|Lack of Efficacy|0
5046259|NCT02607306|17393443|P3|Overall Study|Withdrawal by Subject|2
5046260|NCT02607306|17393444|P2|Overall Study|Withdrawal by Subject|10
5046261|NCT02607306|17393445|P1|Overall Study|Withdrawal by Subject|8
5046262|NCT02607306|17393443|P3|Overall Study|Unclassified|0
5046263|NCT02607306|17393444|P2|Overall Study|Unclassified|4
5046264|NCT02607306|17393445|P1|Overall Study|Unclassified|1
5046265|NCT02607306|17393443|P3|Overall Study|Adverse Event|6
5046266|NCT02607306|17393444|P2|Overall Study|Adverse Event|6
5046267|NCT02607306|17393445|P1|Overall Study|Adverse Event|8
5046268|NCT02607280|17393567|P2|Overall Study|Decrease in CrCl <15|1
5046269|NCT02607280|17393568|P1|Overall Study|Decrease in CrCl <15|0
5046270|NCT02607280|17393567|P2|Overall Study|Adverse Event|0
5046271|NCT02607280|17393568|P1|Overall Study|Adverse Event|4
5046272|NCT02606877|17393620|P2|Overall Study|Other than listed above|0
5046273|NCT02606877|17393621|P1|Overall Study|Other than listed above|1
5046274|NCT02606877|17393620|P2|Overall Study|Non-compliance with protocol|1
5046275|NCT02606877|17393621|P1|Overall Study|Non-compliance with protocol|0
5046276|NCT02606877|17393620|P2|Overall Study|Adverse Event|0
5046277|NCT02606877|17393621|P1|Overall Study|Adverse Event|3
5046278|NCT02606643|17393660|P2|Overall Study|did not meet inclusion criteria|3
5046279|NCT02606643|17393661|P1|Overall Study|did not meet inclusion criteria|1
5046280|NCT02606279|17393719|P2|Overall Study|Lost to Follow-up|1
5046281|NCT02606279|17393720|P1|Overall Study|Lost to Follow-up|0
5046282|NCT02606253|17393735|P3|Overall Study|Physician Decision|0
5046283|NCT02606253|17393736|P2|Overall Study|Physician Decision|1
5046284|NCT02606253|17393737|P1|Overall Study|Physician Decision|1
5046285|NCT02606253|17393735|P3|Overall Study|Protocol Violation|0
5046286|NCT02606253|17393736|P2|Overall Study|Protocol Violation|1
5046287|NCT02606253|17393737|P1|Overall Study|Protocol Violation|2
5046288|NCT02606253|17393735|P3|Overall Study|Adverse Event|0
5046289|NCT02606253|17393736|P2|Overall Study|Adverse Event|0
5046290|NCT02606253|17393737|P1|Overall Study|Adverse Event|2
5046291|NCT02605954|17393839|P2|Overall Study|Randomized but not treated|1
5046292|NCT02605954|17393840|P1|Overall Study|Randomized but not treated|0
5046293|NCT02605954|17393839|P2|Overall Study|Lost to Follow-up|0
5046294|NCT02605954|17393840|P1|Overall Study|Lost to Follow-up|3
5046295|NCT02605954|17393839|P2|Overall Study|Withdrew Consent|2
5046296|NCT02605954|17393840|P1|Overall Study|Withdrew Consent|2
5046297|NCT02605954|17393839|P2|Overall Study|Non-Compliance with Study Drug|0
5046298|NCT02605954|17393840|P1|Overall Study|Non-Compliance with Study Drug|1
5046299|NCT02605954|17393839|P2|Overall Study|Investigator's Discretion|0
5046300|NCT02605954|17393840|P1|Overall Study|Investigator's Discretion|1
5046301|NCT02605954|17393839|P2|Overall Study|Adverse Event|1
5046302|NCT02605954|17393840|P1|Overall Study|Adverse Event|5
5046303|NCT02605928|17393857|P1|Overall Study|Lack of Efficacy|5
5046304|NCT02605928|17393857|P1|Overall Study|Model tuning phase|28
5046305|NCT02605837|17393900|P2|Overall Study|Physician Decision|1
5046306|NCT02605837|17393901|P1|Overall Study|Physician Decision|0
5046307|NCT02605837|17393900|P2|Overall Study|Withdrawal by Subject|8
5046308|NCT02605837|17393901|P1|Overall Study|Withdrawal by Subject|8
5046309|NCT02605837|17393900|P2|Overall Study|Non-Compliance with Study Drug|1
5046310|NCT02605837|17393901|P1|Overall Study|Non-Compliance with Study Drug|0
5046311|NCT02605837|17393900|P2|Overall Study|Adverse Event|1
5046312|NCT02605837|17393901|P1|Overall Study|Adverse Event|3
5046313|NCT02605824|17393940|P2|Overall Study|Physician Decision|0
5046314|NCT02605824|17393941|P1|Overall Study|Physician Decision|1
5046315|NCT02605642|17393951|P2|Overall Study|Lack of response|11
5046316|NCT02605642|17393952|P1|Overall Study|Lack of response|24
5046317|NCT02605642|17393951|P2|Overall Study|Withdrawal by Subject|2
5046318|NCT02605642|17393952|P1|Overall Study|Withdrawal by Subject|23
5046319|NCT02605642|17393951|P2|Overall Study|Adverse Event|2
5046320|NCT02605642|17393952|P1|Overall Study|Adverse Event|14
5046321|NCT02605642|17393951|P2|Overall Study|Lost to Follow-up|1
5046322|NCT02605642|17393952|P1|Overall Study|Lost to Follow-up|12
5046323|NCT02605642|17393951|P2|Overall Study|Physician Decision|0
5046324|NCT02605642|17393952|P1|Overall Study|Physician Decision|10
5046325|NCT02605642|17393951|P2|Overall Study|Participant non-compliance|4
5046326|NCT02605642|17393952|P1|Overall Study|Participant non-compliance|2
5046327|NCT02605642|17393951|P2|Overall Study|Other|1
5046328|NCT02605642|17393952|P1|Overall Study|Other|11
5046329|NCT02605447|17393994|P1|Overall Study|Not disclosed|1
5046330|NCT02605447|17393994|P1|Overall Study|Withdrawal by Subject|10
5046331|NCT02605447|17393994|P1|Overall Study|Lost to Follow-up|24
5046332|NCT02605447|17393994|P1|Overall Study|Physician Decision|1
5046333|NCT02605447|17393994|P1|Overall Study|Death|66
5046334|NCT02605174|17394105|P7|Overall Study|Randomization Failure|30
5046335|NCT02605174|17394106|P6|Overall Study|Randomization Failure|11
5046336|NCT02605174|17394107|P5|Overall Study|Randomization Failure|16
5046337|NCT02605174|17394108|P4|Overall Study|Randomization Failure|7
5046338|NCT02605174|17394109|P3|Overall Study|Randomization Failure|20
5046339|NCT02605174|17394110|P2|Overall Study|Randomization Failure|6
5046340|NCT02605174|17394111|P1|Overall Study|Randomization Failure|22
5046341|NCT02605174|17394105|P7|Overall Study|Physician Decision|3
5046342|NCT02605174|17394106|P6|Overall Study|Physician Decision|0
5046343|NCT02605174|17394107|P5|Overall Study|Physician Decision|0
5046344|NCT02605174|17394108|P4|Overall Study|Physician Decision|0
5046345|NCT02605174|17394109|P3|Overall Study|Physician Decision|0
5046346|NCT02605174|17394110|P2|Overall Study|Physician Decision|0
5046347|NCT02605174|17394111|P1|Overall Study|Physician Decision|2
5046348|NCT02605174|17394105|P7|Overall Study|Withdrawal by Subject|15
5046349|NCT02605174|17394106|P6|Overall Study|Withdrawal by Subject|4
5046350|NCT02605174|17394107|P5|Overall Study|Withdrawal by Subject|6
5046351|NCT02605174|17394108|P4|Overall Study|Withdrawal by Subject|11
5046352|NCT02605174|17394109|P3|Overall Study|Withdrawal by Subject|14
5046353|NCT02605174|17394110|P2|Overall Study|Withdrawal by Subject|6
5046354|NCT02605174|17394111|P1|Overall Study|Withdrawal by Subject|9
5046355|NCT02605174|17394105|P7|Overall Study|Pregnancy|0
5046356|NCT02605174|17394106|P6|Overall Study|Pregnancy|0
5046357|NCT02605174|17394107|P5|Overall Study|Pregnancy|0
5046358|NCT02605174|17394108|P4|Overall Study|Pregnancy|2
5046359|NCT02605174|17394109|P3|Overall Study|Pregnancy|0
5046360|NCT02605174|17394110|P2|Overall Study|Pregnancy|0
5046361|NCT02605174|17394111|P1|Overall Study|Pregnancy|1
5046362|NCT02605174|17394105|P7|Overall Study|Protocol Violation|12
5046363|NCT02605174|17394106|P6|Overall Study|Protocol Violation|7
5046364|NCT02605174|17394107|P5|Overall Study|Protocol Violation|7
5046365|NCT02605174|17394108|P4|Overall Study|Protocol Violation|6
5046366|NCT02605174|17394109|P3|Overall Study|Protocol Violation|14
5046367|NCT02605174|17394110|P2|Overall Study|Protocol Violation|4
5046368|NCT02605174|17394111|P1|Overall Study|Protocol Violation|10
5046369|NCT02605174|17394105|P7|Overall Study|Lost to Follow-up|29
5046370|NCT02605174|17394106|P6|Overall Study|Lost to Follow-up|10
5046371|NCT02605174|17394107|P5|Overall Study|Lost to Follow-up|20
5046372|NCT02605174|17394108|P4|Overall Study|Lost to Follow-up|10
5046373|NCT02605174|17394109|P3|Overall Study|Lost to Follow-up|27
5046374|NCT02605174|17394110|P2|Overall Study|Lost to Follow-up|7
5046375|NCT02605174|17394111|P1|Overall Study|Lost to Follow-up|20
5046376|NCT02605174|17394105|P7|Overall Study|Adverse Event|0
5046377|NCT02605174|17394106|P6|Overall Study|Adverse Event|0
5046378|NCT02605174|17394107|P5|Overall Study|Adverse Event|4
5046379|NCT02605174|17394108|P4|Overall Study|Adverse Event|0
5046380|NCT02605174|17394109|P3|Overall Study|Adverse Event|1
5046381|NCT02605174|17394110|P2|Overall Study|Adverse Event|0
5046382|NCT02605174|17394111|P1|Overall Study|Adverse Event|0
5046383|NCT02605122|17394173|P2|Overall Study|Lost to Follow-up|1
5046384|NCT02605122|17394174|P1|Overall Study|Lost to Follow-up|1
5046385|NCT02605122|17394173|P2|Overall Study|Withdrawal by Subject|1
5046386|NCT02605122|17394174|P1|Overall Study|Withdrawal by Subject|4
5046387|NCT02604589|17394197|P3|Overall Study|catheter dislodgement|1
5046388|NCT02604589|17394198|P2|Overall Study|catheter dislodgement|0
5046389|NCT02604589|17394199|P1|Overall Study|catheter dislodgement|0
5046390|NCT02604550|17394227|P2|Overall Study|Incomplete data using paper journal|19
5046391|NCT02604550|17394228|P1|Overall Study|Incomplete data using paper journal|18
5046392|NCT02604550|17394227|P2|Overall Study|Withdrawal by Subject|1
5046393|NCT02604550|17394228|P1|Overall Study|Withdrawal by Subject|0
5046394|NCT02604550|17394227|P2|Overall Study|Lost to Follow-up|6
5046395|NCT02604550|17394228|P1|Overall Study|Lost to Follow-up|7
5046396|NCT02604433|17394254|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
5046397|NCT02604433|17394255|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
5046398|NCT02604433|17394254|P2|Double-blind Treatment Period|Study is ongoing|74
5046399|NCT02604433|17394255|P1|Double-blind Treatment Period|Study is ongoing|156
5046400|NCT02604433|17394254|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
5046401|NCT02604433|17394255|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
5046402|NCT02604433|17394254|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
5046403|NCT02604433|17394255|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
5046404|NCT02604433|17394254|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
5046405|NCT02604433|17394255|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
5046406|NCT02604433|17394254|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
5046407|NCT02604433|17394255|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
5046408|NCT02604433|17394254|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
5046409|NCT02604433|17394255|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
5046410|NCT02604433|17394254|P2|Double-blind Treatment Period|Death|1
5046411|NCT02604433|17394255|P1|Double-blind Treatment Period|Death|1
5046412|NCT02604433|17394254|P2|Double-blind Treatment Period|Personal reasons or moved|1
5046413|NCT02604433|17394255|P1|Double-blind Treatment Period|Personal reasons or moved|2
5046414|NCT02604433|17394254|P2|Double-blind Treatment Period|Adverse Event|0
5046415|NCT02604433|17394255|P1|Double-blind Treatment Period|Adverse Event|4
5046416|NCT02604433|17394254|P2|Double-blind Treatment Period|Withdrawal by Subject|6
5046417|NCT02604433|17394255|P1|Double-blind Treatment Period|Withdrawal by Subject|13
5046418|NCT02604407|17394324|P3|Overall Study|Other|4
5046419|NCT02604407|17394325|P2|Overall Study|Other|1
5046420|NCT02604407|17394326|P1|Overall Study|Other|3
5046421|NCT02604407|17394324|P3|Overall Study|Lack of Efficacy|0
5046422|NCT02604407|17394325|P2|Overall Study|Lack of Efficacy|0
5046423|NCT02604407|17394326|P1|Overall Study|Lack of Efficacy|1
5046424|NCT02604407|17394324|P3|Overall Study|Lost to Follow-up|2
5046425|NCT02604407|17394325|P2|Overall Study|Lost to Follow-up|1
5046426|NCT02604407|17394326|P1|Overall Study|Lost to Follow-up|2
5046427|NCT02604407|17394324|P3|Overall Study|Withdrawal by Subject|5
5046428|NCT02604407|17394325|P2|Overall Study|Withdrawal by Subject|3
5046429|NCT02604407|17394326|P1|Overall Study|Withdrawal by Subject|3
5046430|NCT02604407|17394324|P3|Overall Study|Protocol Violation|0
5046431|NCT02604407|17394325|P2|Overall Study|Protocol Violation|0
5046432|NCT02604407|17394326|P1|Overall Study|Protocol Violation|2
5046433|NCT02604407|17394324|P3|Overall Study|Adverse Event|5
5046434|NCT02604407|17394325|P2|Overall Study|Adverse Event|7
5046435|NCT02604407|17394326|P1|Overall Study|Adverse Event|0
5046436|NCT02604342|17394339|P2|Overall Study|Physician Decision|0
5046437|NCT02604342|17394340|P1|Overall Study|Physician Decision|2
5046438|NCT02604342|17394339|P2|Overall Study|Lost to Follow-up|1
5046439|NCT02604342|17394340|P1|Overall Study|Lost to Follow-up|1
5046440|NCT02604342|17394339|P2|Overall Study|Study Termination by Sponsor|0
5046441|NCT02604342|17394340|P1|Overall Study|Study Termination by Sponsor|1
5046442|NCT02604342|17394339|P2|Overall Study|Other|0
5046443|NCT02604342|17394340|P1|Overall Study|Other|1
5046444|NCT02604342|17394339|P2|Overall Study|Withdrawal by Subject|6
5046445|NCT02604342|17394340|P1|Overall Study|Withdrawal by Subject|5
5046446|NCT02604342|17394339|P2|Overall Study|Progression of disease|0
5046447|NCT02604342|17394340|P1|Overall Study|Progression of disease|1
5046448|NCT02604342|17394339|P2|Overall Study|Death|16
5046449|NCT02604342|17394340|P1|Overall Study|Death|32
5046450|NCT02604264|17394392|P2|Intervention|Didn't use CVC for at least 21 days|242
5046451|NCT02604264|17394393|P1|Intervention|Didn't use CVC for at least 21 days|200
5046452|NCT02604212|17394403|P4|Overall Study|Withdrawal by Subject|0
5046453|NCT02604212|17394404|P3|Overall Study|Withdrawal by Subject|1
5046454|NCT02604212|17394405|P2|Overall Study|Withdrawal by Subject|0
5046455|NCT02604212|17394406|P1|Overall Study|Withdrawal by Subject|0
5046456|NCT02604212|17394403|P4|Overall Study|Study Terminated by Sponsor|3
5046457|NCT02604212|17394404|P3|Overall Study|Study Terminated by Sponsor|3
5046458|NCT02604212|17394405|P2|Overall Study|Study Terminated by Sponsor|1
5046459|NCT02604212|17394406|P1|Overall Study|Study Terminated by Sponsor|2
5046460|NCT02604199|17394474|P4|Overall Study|Withdrawal by Subject|0
5046461|NCT02604199|17394475|P3|Overall Study|Withdrawal by Subject|0
5046462|NCT02604199|17394476|P2|Overall Study|Withdrawal by Subject|1
5046463|NCT02604199|17394477|P1|Overall Study|Withdrawal by Subject|0
5046464|NCT02604199|17394474|P4|Overall Study|Study terminated by sponsor|2
5046465|NCT02604199|17394475|P3|Overall Study|Study terminated by sponsor|0
5046466|NCT02604199|17394476|P2|Overall Study|Study terminated by sponsor|2
5046467|NCT02604199|17394477|P1|Overall Study|Study terminated by sponsor|0
5046468|NCT02604199|17394474|P4|Overall Study|Pregnancy|1
5046469|NCT02604199|17394475|P3|Overall Study|Pregnancy|0
5046470|NCT02604199|17394476|P2|Overall Study|Pregnancy|0
5046471|NCT02604199|17394477|P1|Overall Study|Pregnancy|0
5046472|NCT02604160|17394546|P2|Overall Study|Physician Decision|1
5046473|NCT02604160|17394547|P1|Overall Study|Physician Decision|0
5046474|NCT02604160|17394546|P2|Overall Study|Protocol Violation|1
5046475|NCT02604160|17394547|P1|Overall Study|Protocol Violation|0
5046476|NCT02604017|17394561|P2|Overall Study|Other|0
5046477|NCT02604017|17394562|P1|Overall Study|Other|1
5046478|NCT02604017|17394561|P2|Overall Study|Lost to Follow-up|6
5046479|NCT02604017|17394562|P1|Overall Study|Lost to Follow-up|5
5046480|NCT02604017|17394561|P2|Overall Study|Withdrew Consent|2
5046481|NCT02604017|17394562|P1|Overall Study|Withdrew Consent|0
5046482|NCT02603952|17394591|P4|Overall Study|Received oseltamivir by error|1
5046483|NCT02603952|17394592|P3|Overall Study|Received oseltamivir by error|0
5046484|NCT02603952|17394593|P2|Overall Study|Received oseltamivir by error|0
5046485|NCT02603952|17394594|P1|Overall Study|Received oseltamivir by error|0
5046486|NCT02603952|17394591|P4|Overall Study|Withdrawal by Subject|0
5046487|NCT02603952|17394592|P3|Overall Study|Withdrawal by Subject|0
5046488|NCT02603952|17394593|P2|Overall Study|Withdrawal by Subject|0
5046489|NCT02603952|17394594|P1|Overall Study|Withdrawal by Subject|1
5046490|NCT02603887|17394642|P1|Overall Study|Disease progression|1
5046491|NCT02603887|17394642|P1|Overall Study|Adverse Event|4
5046492|NCT02603887|17394642|P1|Overall Study|FDA Guidance|1
5046493|NCT02603809|17394655|P6|Overall Study|Lack of Efficacy|1
5046494|NCT02603809|17394656|P5|Overall Study|Lack of Efficacy|0
5046495|NCT02603809|17394657|P4|Overall Study|Lack of Efficacy|0
5046496|NCT02603809|17394658|P3|Overall Study|Lack of Efficacy|0
5046497|NCT02603809|17394659|P2|Overall Study|Lack of Efficacy|1
5046498|NCT02603809|17394660|P1|Overall Study|Lack of Efficacy|0
5046499|NCT02603809|17394655|P6|Overall Study|Adverse Event|1
5046500|NCT02603809|17394656|P5|Overall Study|Adverse Event|1
5046501|NCT02603809|17394657|P4|Overall Study|Adverse Event|2
5046502|NCT02603809|17394658|P3|Overall Study|Adverse Event|2
5046503|NCT02603809|17394659|P2|Overall Study|Adverse Event|0
5046504|NCT02603809|17394660|P1|Overall Study|Adverse Event|3
5046505|NCT02603809|17394655|P6|Overall Study|Physician Decision|1
5046506|NCT02603809|17394656|P5|Overall Study|Physician Decision|2
5046507|NCT02603809|17394657|P4|Overall Study|Physician Decision|1
5046508|NCT02603809|17394658|P3|Overall Study|Physician Decision|0
5046509|NCT02603809|17394659|P2|Overall Study|Physician Decision|0
5046510|NCT02603809|17394660|P1|Overall Study|Physician Decision|0
5046511|NCT02603809|17394655|P6|Overall Study|Pre-specified discontinuation criteria|1
5046512|NCT02603809|17394656|P5|Overall Study|Pre-specified discontinuation criteria|3
5046513|NCT02603809|17394657|P4|Overall Study|Pre-specified discontinuation criteria|2
5046514|NCT02603809|17394658|P3|Overall Study|Pre-specified discontinuation criteria|2
5046515|NCT02603809|17394659|P2|Overall Study|Pre-specified discontinuation criteria|3
5046516|NCT02603809|17394660|P1|Overall Study|Pre-specified discontinuation criteria|3
5046517|NCT02603809|17394655|P6|Overall Study|Lost to Follow-up|2
5046518|NCT02603809|17394656|P5|Overall Study|Lost to Follow-up|2
5046519|NCT02603809|17394657|P4|Overall Study|Lost to Follow-up|4
5046520|NCT02603809|17394658|P3|Overall Study|Lost to Follow-up|1
5046521|NCT02603809|17394659|P2|Overall Study|Lost to Follow-up|3
5046522|NCT02603809|17394660|P1|Overall Study|Lost to Follow-up|2
5046523|NCT02603809|17394655|P6|Overall Study|Withdrawal by Subject|4
5046524|NCT02603809|17394656|P5|Overall Study|Withdrawal by Subject|3
5046525|NCT02603809|17394657|P4|Overall Study|Withdrawal by Subject|3
5046526|NCT02603809|17394658|P3|Overall Study|Withdrawal by Subject|2
5046527|NCT02603809|17394659|P2|Overall Study|Withdrawal by Subject|1
5046528|NCT02603809|17394660|P1|Overall Study|Withdrawal by Subject|4
5046529|NCT02603419|17394726|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
5046530|NCT02603419|17394727|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5046531|NCT02603419|17394728|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5046532|NCT02603419|17394729|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5046533|NCT02603419|17394730|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5046534|NCT02603419|17394731|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5046535|NCT02603419|17394726|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
5046536|NCT02603419|17394727|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5046537|NCT02603419|17394728|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5046538|NCT02603419|17394729|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5046539|NCT02603419|17394730|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5046540|NCT02603419|17394731|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5046541|NCT02603419|17394726|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
5046542|NCT02603419|17394727|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5046543|NCT02603419|17394728|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5046544|NCT02603419|17394729|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5046545|NCT02603419|17394730|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5046546|NCT02603419|17394731|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5046547|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5046548|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5046549|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
5046550|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5046551|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5046552|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5046553|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
5046554|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5046555|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
5046556|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5046557|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5046558|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
5046559|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5046560|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5046561|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5046562|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5046563|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
5046564|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5046565|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5046566|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
5046567|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5046568|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5046569|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5046570|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5046571|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5046572|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
5046573|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5046574|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
5046575|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5046576|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
5046577|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
5046578|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
5046579|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
5046580|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
5046581|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
5046582|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
5046583|NCT02603419|17394726|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5046584|NCT02603419|17394727|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5046585|NCT02603419|17394728|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5046586|NCT02603419|17394729|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5046587|NCT02603419|17394730|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
5046588|NCT02603419|17394731|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5046589|NCT02603393|17394918|P2|Overall Study|Sponsor decision|0
5046590|NCT02603393|17394919|P1|Overall Study|Sponsor decision|1
5046591|NCT02603393|17394918|P2|Overall Study|Non-compliance with study treatment|0
5046592|NCT02603393|17394919|P1|Overall Study|Non-compliance with study treatment|1
5046593|NCT02603393|17394918|P2|Overall Study|Lost to Follow-up|2
5046594|NCT02603393|17394919|P1|Overall Study|Lost to Follow-up|1
5046595|NCT02603393|17394918|P2|Overall Study|Protocol deviation|3
5046596|NCT02603393|17394919|P1|Overall Study|Protocol deviation|2
5046597|NCT02603393|17394918|P2|Overall Study|Physician Decision|3
5046598|NCT02603393|17394919|P1|Overall Study|Physician Decision|3
5046599|NCT02603393|17394918|P2|Overall Study|Death|4
5046600|NCT02603393|17394919|P1|Overall Study|Death|3
5046601|NCT02603393|17394918|P2|Overall Study|Lack of Efficacy|2
5046602|NCT02603393|17394919|P1|Overall Study|Lack of Efficacy|7
5046603|NCT02603393|17394918|P2|Overall Study|Technical problems|7
5046604|NCT02603393|17394919|P1|Overall Study|Technical problems|4
5046605|NCT02603393|17394918|P2|Overall Study|Adverse Event|15
5046606|NCT02603393|17394919|P1|Overall Study|Adverse Event|17
5046607|NCT02603393|17394918|P2|Overall Study|Patient/guardian decision|18
5046608|NCT02603393|17394919|P1|Overall Study|Patient/guardian decision|32
5046609|NCT02603172|17394958|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
5046610|NCT02603172|17394959|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
5046611|NCT02603172|17394960|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
5046612|NCT02603172|17394961|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
5046613|NCT02603172|17394962|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
5046614|NCT02603172|17394963|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
5046615|NCT02603172|17394964|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
5046616|NCT02603172|17394965|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
5046617|NCT02603120|17395093|P2|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
5046618|NCT02603120|17395094|P1|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
5046619|NCT02603120|17395093|P2|OL Extension B/F/TAF Treatment Phase|Death|1
5046620|NCT02603120|17395094|P1|OL Extension B/F/TAF Treatment Phase|Death|0
5046621|NCT02603120|17395093|P2|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
5046622|NCT02603120|17395094|P1|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
5046623|NCT02603120|17395093|P2|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
5046624|NCT02603120|17395094|P1|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
5046625|NCT02603120|17395093|P2|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
5046626|NCT02603120|17395094|P1|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
5046627|NCT02603120|17395093|P2|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
5046628|NCT02603120|17395094|P1|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
5046629|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Did not receive study drug|2
5046630|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Did not receive study drug|2
5046631|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Non-compliance with study drug|0
5046632|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Non-compliance with study drug|1
5046633|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Pregnancy|1
5046634|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Pregnancy|1
5046635|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Investigator's discretion|0
5046636|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Investigator's discretion|2
5046637|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Death|0
5046638|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Death|2
5046639|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
5046640|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Lost to Follow-up|4
5046641|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Adverse Event|3
5046642|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Adverse Event|3
5046643|NCT02603120|17395093|P2|Double-Blind Treatment Phase|Withdrew consent|8
5046644|NCT02603120|17395094|P1|Double-Blind Treatment Phase|Withdrew consent|4
5046645|NCT02603107|17395116|P2|Optional Extension Phase|Still in Study|213
5046646|NCT02603107|17395117|P1|Optional Extension Phase|Still in Study|241
5046647|NCT02603107|17395116|P2|Randomized Phase|Lost to Follow-up|3
5046648|NCT02603107|17395117|P1|Randomized Phase|Lost to Follow-up|0
5046649|NCT02603107|17395116|P2|Randomized Phase|Withdrew Consent|14
5046650|NCT02603107|17395117|P1|Randomized Phase|Withdrew Consent|8
5046651|NCT02603107|17395116|P2|Randomized Phase|Protocol Violation|0
5046652|NCT02603107|17395117|P1|Randomized Phase|Protocol Violation|1
5046653|NCT02603107|17395116|P2|Randomized Phase|Non-Compliance with Study Drug|1
5046654|NCT02603107|17395117|P1|Randomized Phase|Non-Compliance with Study Drug|1
5046655|NCT02603107|17395116|P2|Randomized Phase|Investigator's Discretion|1
5046656|NCT02603107|17395117|P1|Randomized Phase|Investigator's Discretion|0
5046657|NCT02603107|17395116|P2|Randomized Phase|Death|1
5046658|NCT02603107|17395117|P1|Randomized Phase|Death|1
5046659|NCT02603107|17395116|P2|Randomized Phase|Adverse Event|0
5046660|NCT02603107|17395117|P1|Randomized Phase|Adverse Event|2
5046661|NCT02603107|17395116|P2|Randomized Phase|Still in Study|27
5046662|NCT02603107|17395117|P1|Randomized Phase|Still in Study|32
5046663|NCT02603107|17395116|P2|Randomized Phase|Randomized and Never Treated|1
5046664|NCT02603107|17395117|P1|Randomized Phase|Randomized and Never Treated|0
5046665|NCT02602080|17395180|P3|Overall Study|Protocol Violation|3
5046666|NCT02602080|17395181|P2|Overall Study|Protocol Violation|1
5046667|NCT02602080|17395182|P1|Overall Study|Protocol Violation|6
5046668|NCT02601820|17395225|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
5046669|NCT02601820|17395225|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
5046670|NCT02601820|17395225|P1|Late On-Treatment (T3)|missing T3 Record|49
5046671|NCT02601820|17395225|P1|Early On-Treatment (T2)|Missing T2 Record|51
5046672|NCT02601625|17395254|P4|Overall Study|Lost to Follow-up|1
5046673|NCT02601625|17395255|P3|Overall Study|Lost to Follow-up|1
5046674|NCT02601625|17395256|P2|Overall Study|Lost to Follow-up|0
5046675|NCT02601625|17395257|P1|Overall Study|Lost to Follow-up|0
5046676|NCT02601573|17395310|P5|Overall Study|Withdrawal by Subject|0
5046677|NCT02601573|17395311|P4|Overall Study|Withdrawal by Subject|1
5046678|NCT02601573|17395312|P3|Overall Study|Withdrawal by Subject|0
5046679|NCT02601573|17395313|P2|Overall Study|Withdrawal by Subject|1
5046680|NCT02601573|17395314|P1|Overall Study|Withdrawal by Subject|0
5046681|NCT02601573|17395310|P5|Overall Study|Lost to Follow-up|2
5046682|NCT02601573|17395311|P4|Overall Study|Lost to Follow-up|0
5046683|NCT02601573|17395312|P3|Overall Study|Lost to Follow-up|1
5046684|NCT02601573|17395313|P2|Overall Study|Lost to Follow-up|3
5046685|NCT02601573|17395314|P1|Overall Study|Lost to Follow-up|0
5046686|NCT02601560|17395349|P8|Overall Study|Other|0
5046687|NCT02601560|17395350|P7|Overall Study|Other|1
5046688|NCT02601560|17395351|P6|Overall Study|Other|0
5046689|NCT02601560|17395352|P5|Overall Study|Other|0
5046690|NCT02601560|17395353|P4|Overall Study|Other|0
5046691|NCT02601560|17395354|P3|Overall Study|Other|0
5046692|NCT02601560|17395355|P2|Overall Study|Other|0
5046693|NCT02601560|17395356|P1|Overall Study|Other|0
5046694|NCT02601469|17395540|P2|Overall Study|Enrolled in Error|0
5046695|NCT02601469|17395541|P1|Overall Study|Enrolled in Error|1
5046696|NCT02601313|17395550|P3|Overall Study|Enrolled, did not initiate AC|0
5046697|NCT02601313|17395551|P2|Overall Study|Enrolled, did not initiate AC|0
5046698|NCT02601313|17395552|P1|Overall Study|Enrolled, did not initiate AC|4
5046699|NCT02601313|17395550|P3|Overall Study|Still on study|10
5046700|NCT02601313|17395551|P2|Overall Study|Still on study|52
5046701|NCT02601313|17395552|P1|Overall Study|Still on study|0
5046702|NCT02601313|17395550|P3|Overall Study|Enrolled, did not initiate KTE-X19|1
5046703|NCT02601313|17395551|P2|Overall Study|Enrolled, did not initiate KTE-X19|1
5046704|NCT02601313|17395552|P1|Overall Study|Enrolled, did not initiate KTE-X19|0
5046705|NCT02601313|17395550|P3|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
5046706|NCT02601313|17395551|P2|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
5046707|NCT02601313|17395552|P1|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
5046708|NCT02601313|17395550|P3|Overall Study|Death|4
5046709|NCT02601313|17395551|P2|Overall Study|Death|16
5046710|NCT02601313|17395552|P1|Overall Study|Death|2
5046711|NCT02601300|17395571|P1|Extension Phase|Lack of Efficacy|10
5046712|NCT02601300|17395571|P1|Extension Phase|Adverse Event|4
5046713|NCT02601300|17395571|P1|Extension Phase|Withdrawal by Subject|3
5046714|NCT02601300|17395571|P1|Induction Phase|Protocol Violation|1
5046715|NCT02601300|17395571|P1|Induction Phase|Lack of Efficacy|2
5046716|NCT02601209|17395591|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5046717|NCT02601209|17395592|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5046718|NCT02601209|17395593|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
5046719|NCT02601209|17395594|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
5046720|NCT02601209|17395595|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
5046721|NCT02601209|17395596|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5046722|NCT02601209|17395597|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5046723|NCT02601209|17395598|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5046724|NCT02601209|17395599|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5046725|NCT02601209|17395591|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5046726|NCT02601209|17395592|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5046727|NCT02601209|17395593|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5046728|NCT02601209|17395594|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5046729|NCT02601209|17395595|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5046730|NCT02601209|17395596|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5046731|NCT02601209|17395597|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5046732|NCT02601209|17395598|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5046733|NCT02601209|17395599|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5046734|NCT02600923|17395646|P1|Overall Study|Not treated|1
5046735|NCT02600923|17395646|P1|Overall Study|Study terminated by Sponsor|53
5046736|NCT02600923|17395646|P1|Overall Study|Objective progression or relapse|50
5046737|NCT02600923|17395646|P1|Overall Study|Withdrawal by Subject|5
5046738|NCT02600923|17395646|P1|Overall Study|Lost to Follow-up|1
5046739|NCT02600923|17395646|P1|Overall Study|Insufficient clinical response|6
5046740|NCT02600923|17395646|P1|Overall Study|Global deterioration of health status|2
5046741|NCT02600923|17395646|P1|Overall Study|Adverse Event|3
5046742|NCT02600923|17395646|P1|Overall Study|Death|10
5046743|NCT02600871|17395656|P2|Overall Study|Lost to Follow-up|10
5046744|NCT02600871|17395657|P1|Overall Study|Lost to Follow-up|13
5046745|NCT02600845|17395667|P1|Overall Study|Consent Withdrawal|5
5046746|NCT02600845|17395667|P1|Overall Study|Non-compliance with Study Procedures|10
5046747|NCT02600845|17395667|P1|Overall Study|Reason Not Specified|3
5046748|NCT02600819|17395682|P2|GEN Phase|Lost to Follow-up|0
5046749|NCT02600819|17395683|P1|GEN Phase|Lost to Follow-up|2
5046750|NCT02600819|17395682|P2|GEN Phase|Withdrew Consent|0
5046751|NCT02600819|17395683|P1|GEN Phase|Withdrew Consent|5
5046752|NCT02600819|17395682|P2|GEN Phase|Non-Compliance with Study Drug|0
5046753|NCT02600819|17395683|P1|GEN Phase|Non-Compliance with Study Drug|1
5046754|NCT02600819|17395682|P2|GEN Phase|Investigator's Discretion|0
5046755|NCT02600819|17395683|P1|GEN Phase|Investigator's Discretion|4
5046756|NCT02600819|17395682|P2|GEN Phase|Death|0
5046757|NCT02600819|17395683|P1|GEN Phase|Death|2
5046758|NCT02600819|17395682|P2|GEN Phase|Adverse Event|0
5046759|NCT02600819|17395683|P1|GEN Phase|Adverse Event|2
5046760|NCT02600559|17395763|P1|Overall Study|Lost to Follow-up|20
5046761|NCT02600559|17395763|P1|Overall Study|Withdrawal by Subject|3
5046762|NCT02600351|17395804|P4|Overall Study|Randomized but Not Treated|3
5046763|NCT02600351|17395805|P3|Overall Study|Randomized but Not Treated|1
5046764|NCT02600351|17395806|P2|Overall Study|Randomized but Not Treated|0
5046765|NCT02600351|17395807|P1|Overall Study|Randomized but Not Treated|1
5046766|NCT02600351|17395804|P4|Overall Study|Lost to Follow-up|0
5046767|NCT02600351|17395805|P3|Overall Study|Lost to Follow-up|0
5046768|NCT02600351|17395806|P2|Overall Study|Lost to Follow-up|0
5046769|NCT02600351|17395807|P1|Overall Study|Lost to Follow-up|1
5046770|NCT02600351|17395804|P4|Overall Study|Lack of Efficacy|2
5046771|NCT02600351|17395805|P3|Overall Study|Lack of Efficacy|5
5046772|NCT02600351|17395806|P2|Overall Study|Lack of Efficacy|0
5046773|NCT02600351|17395807|P1|Overall Study|Lack of Efficacy|3
5046774|NCT02599961|17395842|P1|Overall Study|Other, Not Specified|3
5046775|NCT02599961|17395842|P1|Overall Study|Discontinuation of Study by Sponsor|9
5046776|NCT02599961|17395842|P1|Overall Study|Subject Non-Compliance|2
5046777|NCT02599961|17395842|P1|Overall Study|Withdrawal by Subject|1
5046778|NCT02599129|17395916|P2|Overall Study|Withdrawal by Subject|1
5046779|NCT02599129|17395917|P1|Overall Study|Withdrawal by Subject|2
5046780|NCT02599129|17395916|P2|Overall Study|Lost to Follow-up|0
5046781|NCT02599129|17395917|P1|Overall Study|Lost to Follow-up|1
5046782|NCT02599129|17395916|P2|Overall Study|Lack of Efficacy|2
5046783|NCT02599129|17395917|P1|Overall Study|Lack of Efficacy|2
5046784|NCT02598934|17395933|P2|Overall Study|Protocol Violation|2
5046785|NCT02598934|17395934|P1|Overall Study|Protocol Violation|1
5046786|NCT02598934|17395933|P2|Overall Study|Administrative|1
5046787|NCT02598934|17395934|P1|Overall Study|Administrative|2
5046788|NCT02598934|17395933|P2|Overall Study|Withdrawal by Subject|3
5046789|NCT02598934|17395934|P1|Overall Study|Withdrawal by Subject|2
5046790|NCT02598934|17395933|P2|Overall Study|Failure to Return|3
5046791|NCT02598934|17395934|P1|Overall Study|Failure to Return|3
5046792|NCT02598934|17395933|P2|Overall Study|Adverse Event|13
5046793|NCT02598934|17395934|P1|Overall Study|Adverse Event|11
5046794|NCT02598622|17395946|P2|Overall Study|Physician Decision|0
5046795|NCT02598622|17395947|P1|Overall Study|Physician Decision|3
5046796|NCT02598622|17395946|P2|Overall Study|Withdrawal by Subject|0
5046797|NCT02598622|17395947|P1|Overall Study|Withdrawal by Subject|3
5046798|NCT02598297|17395976|P2|Overall Study|Followed for survival|0
5046799|NCT02598297|17395977|P1|Overall Study|Followed for survival|1
5046800|NCT02598297|17395976|P2|Overall Study|Subject/guardian decision|0
5046801|NCT02598297|17395977|P1|Overall Study|Subject/guardian decision|1
5046802|NCT02598297|17395976|P2|Overall Study|Physician Decision|0
5046803|NCT02598297|17395977|P1|Overall Study|Physician Decision|1
5046804|NCT02598297|17395976|P2|Overall Study|Adverse Event|1
5046805|NCT02598297|17395977|P1|Overall Study|Adverse Event|1
5046806|NCT02598297|17395976|P2|Overall Study|Study terminated by Sponsor|23
5046807|NCT02598297|17395977|P1|Overall Study|Study terminated by Sponsor|21
5046808|NCT02598193|17396003|P1|Overall Study|Does not want to take Nintedanib|1
5046809|NCT02598193|17396003|P1|Overall Study|Listed in active lung transplant list|1
5046810|NCT02598193|17396003|P1|Overall Study|Withdrawal by Subject|1
5046811|NCT02598193|17396003|P1|Overall Study|Adverse Event|13
5046812|NCT02598128|17396011|P4|Period A: Days -7 to -1|Adverse Event|0
5046813|NCT02598128|17396012|P3|Period A: Days -7 to -1|Adverse Event|0
5046814|NCT02598128|17396013|P2|Period A: Days -7 to -1|Adverse Event|0
5046815|NCT02598128|17396014|P1|Period A: Days -7 to -1|Adverse Event|1
5046816|NCT02598076|17396057|P2|Overall Study|Lost to Follow-up|3
5046817|NCT02598076|17396058|P1|Overall Study|Lost to Follow-up|2
5046818|NCT02597946|17396072|P1|Overall Study|Other than above|1
5046819|NCT02597946|17396072|P1|Overall Study|Progressive disease|16
5046820|NCT02597946|17396072|P1|Overall Study|Withdrawal by Subject|1
5046821|NCT02597933|17396083|P2|Overall Study|Other than stated above|14
5046822|NCT02597933|17396084|P1|Overall Study|Other than stated above|7
5046823|NCT02597933|17396083|P2|Overall Study|Not treated|2
5046824|NCT02597933|17396084|P1|Overall Study|Not treated|2
5046825|NCT02597933|17396083|P2|Overall Study|Adverse Event|28
5046826|NCT02597933|17396084|P1|Overall Study|Adverse Event|20
5046827|NCT02597933|17396083|P2|Overall Study|Protocol Violation|2
5046828|NCT02597933|17396084|P1|Overall Study|Protocol Violation|2
5046829|NCT02597933|17396083|P2|Overall Study|Withdrawal by Subject|5
5046830|NCT02597933|17396084|P1|Overall Study|Withdrawal by Subject|7
5046831|NCT02597920|17396115|P3|Overall Study|Other|0
5046832|NCT02597920|17396116|P2|Overall Study|Other|0
5046833|NCT02597920|17396117|P1|Overall Study|Other|1
5046834|NCT02597920|17396115|P3|Overall Study|Other than specified|5
5046835|NCT02597920|17396116|P2|Overall Study|Other than specified|31
5046836|NCT02597920|17396117|P1|Overall Study|Other than specified|10
5046837|NCT02597920|17396115|P3|Overall Study|Refuse to continue in the study|1
5046838|NCT02597920|17396116|P2|Overall Study|Refuse to continue in the study|13
5046839|NCT02597920|17396117|P1|Overall Study|Refuse to continue in the study|3
5046840|NCT02597920|17396115|P3|Overall Study|Lost to Follow-up|0
5046841|NCT02597920|17396116|P2|Overall Study|Lost to Follow-up|9
5046842|NCT02597920|17396117|P1|Overall Study|Lost to Follow-up|7
5046843|NCT02597920|17396115|P3|Overall Study|Other adverse event|0
5046844|NCT02597920|17396116|P2|Overall Study|Other adverse event|30
5046845|NCT02597920|17396117|P1|Overall Study|Other adverse event|20
5046846|NCT02597920|17396115|P3|Overall Study|Worsening of other pre-existing disease|0
5046847|NCT02597920|17396116|P2|Overall Study|Worsening of other pre-existing disease|1
5046848|NCT02597920|17396117|P1|Overall Study|Worsening of other pre-existing disease|0
5046849|NCT02597855|17396151|P2|Overall Study|Lost to Follow-up|1
5046850|NCT02597855|17396152|P1|Overall Study|Lost to Follow-up|2
5046851|NCT02597452|17396255|P1|Overall Study|testing incomplete|30
5046852|NCT02597062|17396367|P1|Overall Study|Ineligible|1
5046853|NCT02597049|17396376|P3|Overall Study|Noncompliant with Study Visits|0
5046854|NCT02597049|17396377|P2|Overall Study|Noncompliant with Study Visits|0
5046855|NCT02597049|17396378|P1|Overall Study|Noncompliant with Study Visits|1
5046856|NCT02597049|17396376|P3|Overall Study|Death|0
5046857|NCT02597049|17396377|P2|Overall Study|Death|0
5046858|NCT02597049|17396378|P1|Overall Study|Death|2
5046859|NCT02597049|17396376|P3|Overall Study|Adverse Event|0
5046860|NCT02597049|17396377|P2|Overall Study|Adverse Event|0
5046861|NCT02597049|17396378|P1|Overall Study|Adverse Event|2
5046862|NCT02597049|17396376|P3|Overall Study|Withdrawal by Subject|1
5046863|NCT02597049|17396377|P2|Overall Study|Withdrawal by Subject|2
5046864|NCT02597049|17396378|P1|Overall Study|Withdrawal by Subject|2
5046865|NCT02597049|17396376|P3|Overall Study|Lost to Follow-up|2
5046866|NCT02597049|17396377|P2|Overall Study|Lost to Follow-up|3
5046867|NCT02597049|17396378|P1|Overall Study|Lost to Follow-up|0
5046868|NCT02596971|17396419|P3|Overall Study|Death|0
5046869|NCT02596971|17396420|P2|Overall Study|Death|0
5046870|NCT02596971|17396421|P1|Overall Study|Death|2
5046871|NCT02596971|17396419|P3|Overall Study|In Follow-up|15
5046872|NCT02596971|17396420|P2|Overall Study|In Follow-up|0
5046873|NCT02596971|17396421|P1|Overall Study|In Follow-up|4
5046874|NCT02596971|17396419|P3|Overall Study|Ongoing|24
5046875|NCT02596971|17396420|P2|Overall Study|Ongoing|6
5046876|NCT02596971|17396421|P1|Overall Study|Ongoing|36
5046877|NCT02596971|17396419|P3|Overall Study|Withdrawal by Subject|2
5046878|NCT02596971|17396420|P2|Overall Study|Withdrawal by Subject|0
5046879|NCT02596971|17396421|P1|Overall Study|Withdrawal by Subject|0
5046880|NCT02596971|17396419|P3|Overall Study|Physician Decision|1
5046881|NCT02596971|17396420|P2|Overall Study|Physician Decision|0
5046882|NCT02596971|17396421|P1|Overall Study|Physician Decision|0
5046883|NCT02596971|17396419|P3|Overall Study|Disease Progression|0
5046884|NCT02596971|17396420|P2|Overall Study|Disease Progression|1
5046885|NCT02596971|17396421|P1|Overall Study|Disease Progression|0
5046886|NCT02596958|17396450|P1|Overall Study|Excluded Due to Second Line Treatment|9
5046887|NCT02596958|17396450|P1|Overall Study|Missing|32
5046888|NCT02596958|17396450|P1|Overall Study|Lost to Follow-up|33
5046889|NCT02596958|17396450|P1|Overall Study|Administrative Reasons/Other|231
5046890|NCT02596958|17396450|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
5046891|NCT02596958|17396450|P1|Overall Study|Death From Other Cause|33
5046892|NCT02596958|17396450|P1|Overall Study|Death From Cancer|112
5046893|NCT02596958|17396450|P1|Overall Study|Cancer Progression|441
5046894|NCT02596958|17396450|P1|Overall Study|Serious Adverse Drug Reactions|44
5046895|NCT02596945|17396462|P1|Overall Study|Missing|1
5046896|NCT02596945|17396462|P1|Overall Study|Withdrawal by Subject|1
5046897|NCT02596945|17396462|P1|Overall Study|Other Erythropoietin stimulating agent|4
5046898|NCT02596945|17396462|P1|Overall Study|Change to hemodialysis|15
5046899|NCT02596945|17396462|P1|Overall Study|Other|32
5046900|NCT02596945|17396462|P1|Overall Study|No documentation of study drug dosing|3
5046901|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
5046902|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
5046903|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
5046904|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
5046905|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
5046906|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5046907|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5046908|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5046909|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Death|0
5046910|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Death|1
5046911|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Death|0
5046912|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Death|0
5046913|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
5046914|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
5046915|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
5046916|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
5046917|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5046918|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5046919|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5046920|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
5046921|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
5046922|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
5046923|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
5046924|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
5046925|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
5046926|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
5046927|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
5046928|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
5046929|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
5046930|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
5046931|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
5046932|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
5046933|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
5046934|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5046935|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5046936|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5046937|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
5046938|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
5046939|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
5046940|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
5046941|NCT02596893|17396472|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
5046942|NCT02596893|17396473|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
5046943|NCT02596893|17396474|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
5046944|NCT02596893|17396475|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
5046945|NCT02596854|17396534|P1|Overall Study|Withdrawn|8
5046946|NCT02596711|17396556|P3|Overall Study|Lost to Follow-up|3
5046947|NCT02596711|17396557|P2|Overall Study|Lost to Follow-up|2
5046948|NCT02596711|17396558|P1|Overall Study|Lost to Follow-up|1
5046949|NCT02596620|17396574|P2|Overall Study|Lost to Follow-up|1
5046950|NCT02596620|17396575|P1|Overall Study|Lost to Follow-up|1
5046951|NCT02596230|17396613|P5|Objective 2, One Year|Other|0
5046952|NCT02596230|17396614|P4|Objective 2, One Year|Other|0
5046953|NCT02596230|17396615|P3|Objective 2, One Year|Other|2
5046954|NCT02596230|17396616|P2|Objective 2, One Year|Other|3
5046955|NCT02596230|17396617|P1|Objective 2, One Year|Other|0
5046956|NCT02596230|17396613|P5|Objective 2, One Year|Death|30
5046957|NCT02596230|17396614|P4|Objective 2, One Year|Death|21
5046958|NCT02596230|17396615|P3|Objective 2, One Year|Death|41
5046959|NCT02596230|17396616|P2|Objective 2, One Year|Death|12
5046960|NCT02596230|17396617|P1|Objective 2, One Year|Death|0
5046961|NCT02596230|17396613|P5|Objective 2, One Year|Adverse drug reaction|0
5046962|NCT02596230|17396614|P4|Objective 2, One Year|Adverse drug reaction|0
5046963|NCT02596230|17396615|P3|Objective 2, One Year|Adverse drug reaction|0
5046964|NCT02596230|17396616|P2|Objective 2, One Year|Adverse drug reaction|1
5046965|NCT02596230|17396617|P1|Objective 2, One Year|Adverse drug reaction|0
5046966|NCT02596230|17396613|P5|Objective 2, One Year|Withdrawal by Subject|2
5046967|NCT02596230|17396614|P4|Objective 2, One Year|Withdrawal by Subject|5
5046968|NCT02596230|17396615|P3|Objective 2, One Year|Withdrawal by Subject|14
5046969|NCT02596230|17396616|P2|Objective 2, One Year|Withdrawal by Subject|11
5046970|NCT02596230|17396617|P1|Objective 2, One Year|Withdrawal by Subject|0
5046971|NCT02596230|17396613|P5|Objective 2, One Year|Lost to Follow-up|46
5046972|NCT02596230|17396614|P4|Objective 2, One Year|Lost to Follow-up|32
5046973|NCT02596230|17396615|P3|Objective 2, One Year|Lost to Follow-up|41
5046974|NCT02596230|17396616|P2|Objective 2, One Year|Lost to Follow-up|41
5046975|NCT02596230|17396617|P1|Objective 2, One Year|Lost to Follow-up|0
5046976|NCT02596230|17396613|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
5046977|NCT02596230|17396614|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
5046978|NCT02596230|17396615|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
5046979|NCT02596230|17396616|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
5046980|NCT02596230|17396617|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
5046981|NCT02596035|17396641|P3|Overall Study|Other Reasons|0
5046982|NCT02596035|17396642|P2|Overall Study|Other Reasons|4
5046983|NCT02596035|17396643|P1|Overall Study|Other Reasons|3
5046984|NCT02596035|17396641|P3|Overall Study|Poor/Non-Compliance|0
5046985|NCT02596035|17396642|P2|Overall Study|Poor/Non-Compliance|1
5046986|NCT02596035|17396643|P1|Overall Study|Poor/Non-Compliance|0
5046987|NCT02596035|17396641|P3|Overall Study|Withdrawal by Subject|0
5046988|NCT02596035|17396642|P2|Overall Study|Withdrawal by Subject|2
5046989|NCT02596035|17396643|P1|Overall Study|Withdrawal by Subject|4
5046990|NCT02596035|17396641|P3|Overall Study|Adverse Event|0
5046991|NCT02596035|17396642|P2|Overall Study|Adverse Event|2
5046992|NCT02596035|17396643|P1|Overall Study|Adverse Event|6
5046993|NCT02596035|17396641|P3|Overall Study|Study Drug Toxicity|0
5046994|NCT02596035|17396642|P2|Overall Study|Study Drug Toxicity|3
5046995|NCT02596035|17396643|P1|Overall Study|Study Drug Toxicity|11
5046996|NCT02596035|17396641|P3|Overall Study|Disease Progression|1
5046997|NCT02596035|17396642|P2|Overall Study|Disease Progression|32
5046998|NCT02596035|17396643|P1|Overall Study|Disease Progression|62
5046999|NCT02596009|17396679|P6|Overall Study|Administrative problems|0
5047000|NCT02596009|17396680|P5|Overall Study|Administrative problems|0
5047001|NCT02596009|17396681|P4|Overall Study|Administrative problems|0
5047002|NCT02596009|17396682|P3|Overall Study|Administrative problems|0
5047003|NCT02596009|17396683|P2|Overall Study|Administrative problems|1
5047004|NCT02596009|17396684|P1|Overall Study|Administrative problems|0
5047005|NCT02595970|17396701|P1|Overall Study|Lack of Efficacy|7
5047006|NCT02595970|17396701|P1|Overall Study|Adverse Event|5
5047007|NCT02595970|17396701|P1|Overall Study|Protocol Violation|4
5047008|NCT02595970|17396701|P1|Overall Study|Physician Decision|2
5047009|NCT02595970|17396701|P1|Overall Study|Withdrawal by Subject|2
5047010|NCT02595723|17396718|P3|First Washout (21 Days)|Lost to Follow-up|0
5047011|NCT02595723|17396719|P2|First Washout (21 Days)|Lost to Follow-up|0
5047012|NCT02595723|17396720|P1|First Washout (21 Days)|Lost to Follow-up|1
5047013|NCT02595723|17396718|P3|First Washout (21 Days)|Withdrawal by Subject|0
5047014|NCT02595723|17396719|P2|First Washout (21 Days)|Withdrawal by Subject|0
5047015|NCT02595723|17396720|P1|First Washout (21 Days)|Withdrawal by Subject|1
5047016|NCT02595502|17396773|P2|Period 3|Received Incorrect Treatment at period 3|1
5047017|NCT02595502|17396774|P1|Period 3|Received Incorrect Treatment at period 3|0
5047018|NCT02595502|17396773|P2|Period 3|Lost to Follow-up|0
5047019|NCT02595502|17396774|P1|Period 3|Lost to Follow-up|1
5047020|NCT02595502|17396773|P2|Period 3|Protocol Violation|1
5047021|NCT02595502|17396774|P1|Period 3|Protocol Violation|0
5047022|NCT02595502|17396773|P2|Period 2|Received incorrect lens at Period 1|1
5047023|NCT02595502|17396774|P1|Period 2|Received incorrect lens at Period 1|0
5047024|NCT02595502|17396773|P2|Period 2|Adverse Event|1
5047025|NCT02595502|17396774|P1|Period 2|Adverse Event|1
5047026|NCT02595502|17396773|P2|Period 1|Lost to Follow-up|1
5047027|NCT02595502|17396774|P1|Period 1|Lost to Follow-up|0
5047028|NCT02595502|17396773|P2|Period 1|Withdrawal by Subject|0
5047029|NCT02595502|17396774|P1|Period 1|Withdrawal by Subject|1
5047030|NCT02595502|17396773|P2|Period 1|Adverse Event|1
5047031|NCT02595502|17396774|P1|Period 1|Adverse Event|0
5047032|NCT02595450|17396780|P1|Overall Study|Enrolled, but not treated|8
5047033|NCT02595450|17396780|P1|Overall Study|Unspecified (only completed 1 cycle)|73
5047034|NCT02595437|17396786|P1|Triferic Via IV|Withdrawal by Subject|1
5047035|NCT02595372|17396804|P1|Overall Study|Disease Progression|1
5047036|NCT02595372|17396804|P1|Overall Study|Physician Decision|2
5047037|NCT02595372|17396804|P1|Overall Study|Adverse Event|6
5047038|NCT02595073|17396815|P2|Overall Study|Protocol Violation|0
5047039|NCT02595073|17396816|P1|Overall Study|Protocol Violation|2
5047040|NCT02595073|17396815|P2|Overall Study|Progressive Disease|1
5047041|NCT02595073|17396816|P1|Overall Study|Progressive Disease|0
5047042|NCT02595008|17396826|P2|Overall Study|Enrolled In Error|0
5047043|NCT02595008|17396827|P1|Overall Study|Enrolled In Error|1
5047044|NCT02594163|17396865|P2|Follow-up Period|Physician Decision|1
5047045|NCT02594163|17396866|P1|Follow-up Period|Physician Decision|0
5047046|NCT02594163|17396865|P2|Follow-up Period|Progressive Disease|0
5047047|NCT02594163|17396866|P1|Follow-up Period|Progressive Disease|2
5047048|NCT02594163|17396865|P2|Follow-up Period|Adverse Event|1
5047049|NCT02594163|17396866|P1|Follow-up Period|Adverse Event|0
5047050|NCT02594163|17396865|P2|Follow-up Period|Death|5
5047051|NCT02594163|17396866|P1|Follow-up Period|Death|2
5047052|NCT02594163|17396865|P2|Follow-up Period|Lost to Follow-up|0
5047053|NCT02594163|17396866|P1|Follow-up Period|Lost to Follow-up|1
5047054|NCT02594163|17396865|P2|Follow-up Period|Study Termination by Sponsor|4
5047055|NCT02594163|17396866|P1|Follow-up Period|Study Termination by Sponsor|6
5047056|NCT02594163|17396865|P2|Follow-up Period|Withdrawal by Subject|1
5047057|NCT02594163|17396866|P1|Follow-up Period|Withdrawal by Subject|0
5047058|NCT02594163|17396865|P2|Treatment Period|Other, Non-AE|0
5047059|NCT02594163|17396866|P1|Treatment Period|Other, Non-AE|1
5047060|NCT02594163|17396865|P2|Treatment Period|Study termination by sponsor|1
5047061|NCT02594163|17396866|P1|Treatment Period|Study termination by sponsor|2
5047062|NCT02594163|17396865|P2|Treatment Period|Physician Decision|3
5047063|NCT02594163|17396866|P1|Treatment Period|Physician Decision|1
5047064|NCT02594163|17396865|P2|Treatment Period|Adverse Event|5
5047065|NCT02594163|17396866|P1|Treatment Period|Adverse Event|1
5047066|NCT02594163|17396865|P2|Treatment Period|Progressive disease|3
5047067|NCT02594163|17396866|P1|Treatment Period|Progressive disease|2
5047068|NCT02594098|17396897|P2|Overall Study|Other|1
5047069|NCT02594098|17396898|P1|Overall Study|Other|0
5047070|NCT02594098|17396897|P2|Overall Study|Seek alternative treatment|1
5047071|NCT02594098|17396898|P1|Overall Study|Seek alternative treatment|2
5047072|NCT02594098|17396897|P2|Overall Study|Terminated participation|2
5047073|NCT02594098|17396898|P1|Overall Study|Terminated participation|6
5047074|NCT02594098|17396897|P2|Overall Study|Withdrawal by Subject|3
5047075|NCT02594098|17396898|P1|Overall Study|Withdrawal by Subject|1
5047076|NCT02594098|17396897|P2|Overall Study|Lack of Efficacy|6
5047077|NCT02594098|17396898|P1|Overall Study|Lack of Efficacy|17
5047078|NCT02593864|17396967|P1|Overall Study|Lost to Follow-up|3
5047079|NCT02593864|17396967|P1|Overall Study|Withdrawal by Subject|3
5047080|NCT02593825|17396974|P2|Intervention|Lost to Follow-up|12
5047081|NCT02593825|17396975|P1|Intervention|Lost to Follow-up|10
5047082|NCT02593773|17396987|P1|Overall Study|Death|1
5047083|NCT02593773|17396987|P1|Overall Study|Study Terminated by Sponsor|31
5047084|NCT02593773|17396987|P1|Overall Study|Voluntary Withdrawal|3
5047085|NCT02593305|17397019|P3|Post 1|Comparison only group. No intervention.|10
5047086|NCT02593305|17397020|P2|Post 1|Comparison only group. No intervention.|0
5047087|NCT02593305|17397021|P1|Post 1|Comparison only group. No intervention.|0
5047088|NCT02593149|17397036|P2|Intervention|Didn't use CVC for at least 21 day|115
5047089|NCT02593149|17397037|P1|Intervention|Didn't use CVC for at least 21 day|116
5047090|NCT02593149|17397036|P2|Run-In|Didn't use CVC for at least 21 days|38
5047091|NCT02593149|17397037|P1|Run-In|Didn't use CVC for at least 21 days|36
5047092|NCT02593097|17397045|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
5047093|NCT02593097|17397046|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
5047094|NCT02593097|17397045|P2|Second Intervention (12 Weeks)|Lack of Efficacy|0
5047095|NCT02593097|17397046|P1|Second Intervention (12 Weeks)|Lack of Efficacy|1
5047096|NCT02593097|17397045|P2|Second Intervention (12 Weeks)|Lost to Follow-up|1
5047097|NCT02593097|17397046|P1|Second Intervention (12 Weeks)|Lost to Follow-up|1
5047098|NCT02593097|17397045|P2|First Intervention (12 Weeks)|Withdrawal by Subject|2
5047099|NCT02593097|17397046|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5047100|NCT02593097|17397045|P2|First Intervention (12 Weeks)|Lost to Follow-up|2
5047101|NCT02593097|17397046|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
5047102|NCT02592876|17397067|P2|Overall Study|Death|9
5047103|NCT02592876|17397068|P1|Overall Study|Death|6
5047104|NCT02592876|17397067|P2|Overall Study|Lost to Follow-up|1
5047105|NCT02592876|17397068|P1|Overall Study|Lost to Follow-up|0
5047106|NCT02592876|17397067|P2|Overall Study|Study Termination by Sponsor|27
5047107|NCT02592876|17397068|P1|Overall Study|Study Termination by Sponsor|32
5047108|NCT02592876|17397067|P2|Overall Study|Withdrawal by Subject|3
5047109|NCT02592876|17397068|P1|Overall Study|Withdrawal by Subject|3
5047110|NCT02592447|17397139|P2|Overall Study|Withdrawal by Subject|1
5047111|NCT02592447|17397140|P1|Overall Study|Withdrawal by Subject|0
5047112|NCT02592447|17397139|P2|Overall Study|Ineligible after randomization|0
5047113|NCT02592447|17397140|P1|Overall Study|Ineligible after randomization|1
5047114|NCT02592447|17397139|P2|Overall Study|Lost to Follow-up|0
5047115|NCT02592447|17397140|P1|Overall Study|Lost to Follow-up|1
5047116|NCT02592434|17397148|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
5047117|NCT02592434|17397149|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
5047118|NCT02592434|17397150|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
5047119|NCT02592434|17397148|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
5047120|NCT02592434|17397149|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
5047121|NCT02592434|17397150|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
5047122|NCT02592434|17397148|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
5047123|NCT02592434|17397149|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
5047124|NCT02592434|17397150|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
5047125|NCT02592434|17397148|P3|Double Blind Phase (26 Weeks)|Other|0
5047126|NCT02592434|17397149|P2|Double Blind Phase (26 Weeks)|Other|1
5047127|NCT02592434|17397150|P1|Double Blind Phase (26 Weeks)|Other|0
5047128|NCT02592434|17397148|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
5047129|NCT02592434|17397149|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
5047130|NCT02592434|17397150|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
5047131|NCT02592434|17397148|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
5047132|NCT02592434|17397149|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
5047133|NCT02592434|17397150|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
5047134|NCT02592434|17397148|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
5047135|NCT02592434|17397149|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
5047136|NCT02592434|17397150|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
5047137|NCT02592434|17397148|P3|Open-Label Phase (18 Weeks)|Other|0
5047138|NCT02592434|17397149|P2|Open-Label Phase (18 Weeks)|Other|0
5047139|NCT02592434|17397150|P1|Open-Label Phase (18 Weeks)|Other|3
5047140|NCT02592434|17397148|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
5047141|NCT02592434|17397149|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
5047142|NCT02592434|17397150|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
5047143|NCT02592434|17397148|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
5047144|NCT02592434|17397149|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
5047145|NCT02592434|17397150|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
5047146|NCT02592018|17397281|P1|Overall Study|Lost to Follow-up|1
5047147|NCT02592018|17397281|P1|Overall Study|Adverse Event|1
5047148|NCT02591290|17397328|P1|Overall Study|Withdrawal by Subject|2
5047149|NCT02591238|17397338|P4|Overall Study|personal circumstances|0
5047150|NCT02591238|17397339|P3|Overall Study|personal circumstances|0
5047151|NCT02591238|17397340|P2|Overall Study|personal circumstances|1
5047152|NCT02591238|17397341|P1|Overall Study|personal circumstances|0
5047153|NCT02591238|17397338|P4|Overall Study|personal circumstances|1
5047154|NCT02591238|17397339|P3|Overall Study|personal circumstances|0
5047155|NCT02591238|17397340|P2|Overall Study|personal circumstances|0
5047156|NCT02591238|17397341|P1|Overall Study|personal circumstances|0
5047157|NCT02591238|17397338|P4|Overall Study|influenza|1
5047158|NCT02591238|17397339|P3|Overall Study|influenza|0
5047159|NCT02591238|17397340|P2|Overall Study|influenza|0
5047160|NCT02591238|17397341|P1|Overall Study|influenza|0
5047161|NCT02591238|17397338|P4|Overall Study|Withdrawal by Subject|1
5047162|NCT02591238|17397339|P3|Overall Study|Withdrawal by Subject|0
5047163|NCT02591238|17397340|P2|Overall Study|Withdrawal by Subject|0
5047164|NCT02591238|17397341|P1|Overall Study|Withdrawal by Subject|0
5047165|NCT02591238|17397338|P4|Overall Study|Pregnancy|0
5047166|NCT02591238|17397339|P3|Overall Study|Pregnancy|0
5047167|NCT02591238|17397340|P2|Overall Study|Pregnancy|0
5047168|NCT02591238|17397341|P1|Overall Study|Pregnancy|1
5047169|NCT02590939|17397377|P2|Overall Study|Failed the nociceptive test|1
5047170|NCT02590939|17397378|P1|Overall Study|Failed the nociceptive test|2
5047171|NCT02590939|17397377|P2|Overall Study|Withdrawal by Subject|1
5047172|NCT02590939|17397378|P1|Overall Study|Withdrawal by Subject|3
5047173|NCT02590588|17397398|P1|Overall Study|Adverse Event|1
5047174|NCT02590562|17397406|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
5047175|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047176|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
5047177|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047178|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047179|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047180|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047181|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047182|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047183|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5047184|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047185|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
5047186|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047187|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047188|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047189|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047190|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047191|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047192|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5047193|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
5047194|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047195|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047196|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047197|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047198|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047199|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047200|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047201|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5047202|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
5047203|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047204|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047205|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047206|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047207|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047208|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047209|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047210|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5047211|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
5047212|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
5047213|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047214|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047215|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047216|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047217|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047218|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047219|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5047220|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047221|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
5047222|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047223|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047224|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047225|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047226|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047227|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047228|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5047229|NCT02590432|17397465|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
5047230|NCT02590432|17397466|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
5047231|NCT02590432|17397467|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047232|NCT02590432|17397468|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047233|NCT02590432|17397469|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047234|NCT02590432|17397470|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047235|NCT02590432|17397471|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047236|NCT02590432|17397472|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047237|NCT02590432|17397473|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
5047238|NCT02590432|17397465|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047239|NCT02590432|17397466|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047240|NCT02590432|17397467|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047241|NCT02590432|17397468|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
5047242|NCT02590432|17397469|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047243|NCT02590432|17397470|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047244|NCT02590432|17397471|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047245|NCT02590432|17397472|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047246|NCT02590432|17397473|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
5047247|NCT02590432|17397465|P9|Double-blind Treatment Period|Lost to Follow-up|0
5047248|NCT02590432|17397466|P8|Double-blind Treatment Period|Lost to Follow-up|0
5047249|NCT02590432|17397467|P7|Double-blind Treatment Period|Lost to Follow-up|0
5047250|NCT02590432|17397468|P6|Double-blind Treatment Period|Lost to Follow-up|2
5047251|NCT02590432|17397469|P5|Double-blind Treatment Period|Lost to Follow-up|0
5047252|NCT02590432|17397470|P4|Double-blind Treatment Period|Lost to Follow-up|0
5047253|NCT02590432|17397471|P3|Double-blind Treatment Period|Lost to Follow-up|1
5047254|NCT02590432|17397472|P2|Double-blind Treatment Period|Lost to Follow-up|0
5047255|NCT02590432|17397473|P1|Double-blind Treatment Period|Lost to Follow-up|0
5047256|NCT02590432|17397465|P9|Double-blind Treatment Period|Withdrawal of Consent|0
5047257|NCT02590432|17397466|P8|Double-blind Treatment Period|Withdrawal of Consent|0
5047258|NCT02590432|17397467|P7|Double-blind Treatment Period|Withdrawal of Consent|1
5047259|NCT02590432|17397468|P6|Double-blind Treatment Period|Withdrawal of Consent|1
5047260|NCT02590432|17397469|P5|Double-blind Treatment Period|Withdrawal of Consent|3
5047261|NCT02590432|17397470|P4|Double-blind Treatment Period|Withdrawal of Consent|3
5047262|NCT02590432|17397471|P3|Double-blind Treatment Period|Withdrawal of Consent|1
5047263|NCT02590432|17397472|P2|Double-blind Treatment Period|Withdrawal of Consent|0
5047264|NCT02590432|17397473|P1|Double-blind Treatment Period|Withdrawal of Consent|0
5047265|NCT02590432|17397465|P9|Double-blind Treatment Period|Lack of Efficacy|0
5047266|NCT02590432|17397466|P8|Double-blind Treatment Period|Lack of Efficacy|0
5047267|NCT02590432|17397467|P7|Double-blind Treatment Period|Lack of Efficacy|0
5047268|NCT02590432|17397468|P6|Double-blind Treatment Period|Lack of Efficacy|0
5047269|NCT02590432|17397469|P5|Double-blind Treatment Period|Lack of Efficacy|0
5047270|NCT02590432|17397470|P4|Double-blind Treatment Period|Lack of Efficacy|0
5047271|NCT02590432|17397471|P3|Double-blind Treatment Period|Lack of Efficacy|1
5047272|NCT02590432|17397472|P2|Double-blind Treatment Period|Lack of Efficacy|0
5047273|NCT02590432|17397473|P1|Double-blind Treatment Period|Lack of Efficacy|0
5047274|NCT02590432|17397465|P9|Double-blind Treatment Period|Adverse Event|0
5047275|NCT02590432|17397466|P8|Double-blind Treatment Period|Adverse Event|0
5047276|NCT02590432|17397467|P7|Double-blind Treatment Period|Adverse Event|20
5047277|NCT02590432|17397468|P6|Double-blind Treatment Period|Adverse Event|22
5047278|NCT02590432|17397469|P5|Double-blind Treatment Period|Adverse Event|6
5047279|NCT02590432|17397470|P4|Double-blind Treatment Period|Adverse Event|12
5047280|NCT02590432|17397471|P3|Double-blind Treatment Period|Adverse Event|14
5047281|NCT02590432|17397472|P2|Double-blind Treatment Period|Adverse Event|0
5047282|NCT02590432|17397473|P1|Double-blind Treatment Period|Adverse Event|0
5047283|NCT02590432|17397465|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047284|NCT02590432|17397466|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047285|NCT02590432|17397467|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047286|NCT02590432|17397468|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047287|NCT02590432|17397469|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047288|NCT02590432|17397470|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047289|NCT02590432|17397471|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
5047290|NCT02590432|17397472|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
5047291|NCT02590432|17397473|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
5047292|NCT02590432|17397465|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
5047293|NCT02590432|17397466|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
5047294|NCT02590432|17397467|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
5047295|NCT02590432|17397468|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
5047296|NCT02590432|17397469|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
5047297|NCT02590432|17397470|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
5047298|NCT02590432|17397471|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
5047299|NCT02590432|17397472|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
5047300|NCT02590432|17397473|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
5047301|NCT02590432|17397465|P9|Open-label Treatment Period|Protocol Violation|0
5047302|NCT02590432|17397466|P8|Open-label Treatment Period|Protocol Violation|0
5047303|NCT02590432|17397467|P7|Open-label Treatment Period|Protocol Violation|0
5047304|NCT02590432|17397468|P6|Open-label Treatment Period|Protocol Violation|0
5047305|NCT02590432|17397469|P5|Open-label Treatment Period|Protocol Violation|0
5047306|NCT02590432|17397470|P4|Open-label Treatment Period|Protocol Violation|0
5047307|NCT02590432|17397471|P3|Open-label Treatment Period|Protocol Violation|0
5047308|NCT02590432|17397472|P2|Open-label Treatment Period|Protocol Violation|4
5047309|NCT02590432|17397473|P1|Open-label Treatment Period|Protocol Violation|10
5047310|NCT02590432|17397465|P9|Open-label Treatment Period|Lost to Follow-up|0
5047311|NCT02590432|17397466|P8|Open-label Treatment Period|Lost to Follow-up|0
5047312|NCT02590432|17397467|P7|Open-label Treatment Period|Lost to Follow-up|0
5047313|NCT02590432|17397468|P6|Open-label Treatment Period|Lost to Follow-up|0
5047314|NCT02590432|17397469|P5|Open-label Treatment Period|Lost to Follow-up|0
5047315|NCT02590432|17397470|P4|Open-label Treatment Period|Lost to Follow-up|0
5047316|NCT02590432|17397471|P3|Open-label Treatment Period|Lost to Follow-up|0
5047317|NCT02590432|17397472|P2|Open-label Treatment Period|Lost to Follow-up|29
5047318|NCT02590432|17397473|P1|Open-label Treatment Period|Lost to Follow-up|51
5047319|NCT02590432|17397465|P9|Open-label Treatment Period|Withdrawal of Consent|0
5047320|NCT02590432|17397466|P8|Open-label Treatment Period|Withdrawal of Consent|0
5047477|NCT02589665|17397598|P1|Maintenance Period|Physician Decision|0
5047321|NCT02590432|17397467|P7|Open-label Treatment Period|Withdrawal of Consent|0
5047322|NCT02590432|17397468|P6|Open-label Treatment Period|Withdrawal of Consent|0
5047323|NCT02590432|17397469|P5|Open-label Treatment Period|Withdrawal of Consent|0
5047324|NCT02590432|17397470|P4|Open-label Treatment Period|Withdrawal of Consent|0
5047325|NCT02590432|17397471|P3|Open-label Treatment Period|Withdrawal of Consent|0
5047326|NCT02590432|17397472|P2|Open-label Treatment Period|Withdrawal of Consent|28
5047327|NCT02590432|17397473|P1|Open-label Treatment Period|Withdrawal of Consent|43
5047328|NCT02590432|17397465|P9|Open-label Treatment Period|Lack of Efficacy|0
5047329|NCT02590432|17397466|P8|Open-label Treatment Period|Lack of Efficacy|0
5047330|NCT02590432|17397467|P7|Open-label Treatment Period|Lack of Efficacy|0
5047331|NCT02590432|17397468|P6|Open-label Treatment Period|Lack of Efficacy|0
5047332|NCT02590432|17397469|P5|Open-label Treatment Period|Lack of Efficacy|0
5047333|NCT02590432|17397470|P4|Open-label Treatment Period|Lack of Efficacy|0
5047334|NCT02590432|17397471|P3|Open-label Treatment Period|Lack of Efficacy|0
5047335|NCT02590432|17397472|P2|Open-label Treatment Period|Lack of Efficacy|5
5047336|NCT02590432|17397473|P1|Open-label Treatment Period|Lack of Efficacy|14
5047337|NCT02590432|17397465|P9|Open-label Treatment Period|Adverse Event|0
5047338|NCT02590432|17397466|P8|Open-label Treatment Period|Adverse Event|0
5047339|NCT02590432|17397467|P7|Open-label Treatment Period|Adverse Event|0
5047340|NCT02590432|17397468|P6|Open-label Treatment Period|Adverse Event|0
5047341|NCT02590432|17397469|P5|Open-label Treatment Period|Adverse Event|0
5047342|NCT02590432|17397470|P4|Open-label Treatment Period|Adverse Event|0
5047343|NCT02590432|17397471|P3|Open-label Treatment Period|Adverse Event|0
5047344|NCT02590432|17397472|P2|Open-label Treatment Period|Adverse Event|79
5047345|NCT02590432|17397473|P1|Open-label Treatment Period|Adverse Event|97
5047346|NCT02590406|17397509|P2|Overall Study|Saturometer malfunction|1
5047347|NCT02590406|17397510|P1|Overall Study|Saturometer malfunction|0
5047348|NCT02590406|17397509|P2|Overall Study|Adverse Event|0
5047349|NCT02590406|17397510|P1|Overall Study|Adverse Event|1
5047350|NCT02590354|17397524|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
5047351|NCT02590354|17397524|P1|Phase 1|Lost to Follow-up|1
5047352|NCT02590354|17397524|P1|Phase 1|Subject does not want to participate|20
5047353|NCT02590354|17397524|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
5047354|NCT02590354|17397524|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
5047355|NCT02590354|17397524|P1|Phase 1|Active hepatitis B or C infection|1
5047356|NCT02590003|17397551|P2|Overall Study|Death|2
5047357|NCT02590003|17397552|P1|Overall Study|Death|1
5047358|NCT02589665|17397589|P10|Maintenance Extension Period|Non-responder|1
5047359|NCT02589665|17397590|P9|Maintenance Extension Period|Non-responder|0
5047360|NCT02589665|17397591|P8|Maintenance Extension Period|Non-responder|0
5047361|NCT02589665|17397592|P7|Maintenance Extension Period|Non-responder|0
5047362|NCT02589665|17397593|P6|Maintenance Extension Period|Non-responder|0
5047363|NCT02589665|17397594|P5|Maintenance Extension Period|Non-responder|0
5047364|NCT02589665|17397595|P4|Maintenance Extension Period|Non-responder|0
5047365|NCT02589665|17397596|P3|Maintenance Extension Period|Non-responder|0
5047366|NCT02589665|17397597|P2|Maintenance Extension Period|Non-responder|0
5047367|NCT02589665|17397598|P1|Maintenance Extension Period|Non-responder|0
5047368|NCT02589665|17397589|P10|Maintenance Extension Period|Adverse Event|2
5047369|NCT02589665|17397590|P9|Maintenance Extension Period|Adverse Event|0
5047370|NCT02589665|17397591|P8|Maintenance Extension Period|Adverse Event|0
5047371|NCT02589665|17397592|P7|Maintenance Extension Period|Adverse Event|0
5047372|NCT02589665|17397593|P6|Maintenance Extension Period|Adverse Event|0
5047373|NCT02589665|17397594|P5|Maintenance Extension Period|Adverse Event|0
5047374|NCT02589665|17397595|P4|Maintenance Extension Period|Adverse Event|0
5047375|NCT02589665|17397596|P3|Maintenance Extension Period|Adverse Event|0
5047376|NCT02589665|17397597|P2|Maintenance Extension Period|Adverse Event|0
5047377|NCT02589665|17397598|P1|Maintenance Extension Period|Adverse Event|0
5047378|NCT02589665|17397589|P10|Maintenance Extension Period|Lack of Efficacy|4
5047379|NCT02589665|17397590|P9|Maintenance Extension Period|Lack of Efficacy|0
5047380|NCT02589665|17397591|P8|Maintenance Extension Period|Lack of Efficacy|0
5047381|NCT02589665|17397592|P7|Maintenance Extension Period|Lack of Efficacy|0
5047382|NCT02589665|17397593|P6|Maintenance Extension Period|Lack of Efficacy|0
5047383|NCT02589665|17397594|P5|Maintenance Extension Period|Lack of Efficacy|0
5047384|NCT02589665|17397595|P4|Maintenance Extension Period|Lack of Efficacy|0
5047385|NCT02589665|17397596|P3|Maintenance Extension Period|Lack of Efficacy|0
5047386|NCT02589665|17397597|P2|Maintenance Extension Period|Lack of Efficacy|0
5047387|NCT02589665|17397598|P1|Maintenance Extension Period|Lack of Efficacy|0
5047388|NCT02589665|17397589|P10|Maintenance Extension Period|Withdrawal by Subject|4
5047389|NCT02589665|17397590|P9|Maintenance Extension Period|Withdrawal by Subject|0
5047390|NCT02589665|17397591|P8|Maintenance Extension Period|Withdrawal by Subject|0
5047391|NCT02589665|17397592|P7|Maintenance Extension Period|Withdrawal by Subject|0
5047392|NCT02589665|17397593|P6|Maintenance Extension Period|Withdrawal by Subject|0
5047393|NCT02589665|17397594|P5|Maintenance Extension Period|Withdrawal by Subject|0
5047394|NCT02589665|17397595|P4|Maintenance Extension Period|Withdrawal by Subject|0
5047395|NCT02589665|17397596|P3|Maintenance Extension Period|Withdrawal by Subject|0
5047396|NCT02589665|17397597|P2|Maintenance Extension Period|Withdrawal by Subject|0
5047397|NCT02589665|17397598|P1|Maintenance Extension Period|Withdrawal by Subject|0
5047398|NCT02589665|17397589|P10|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
5047399|NCT02589665|17397590|P9|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047400|NCT02589665|17397591|P8|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047401|NCT02589665|17397592|P7|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047402|NCT02589665|17397593|P6|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047403|NCT02589665|17397594|P5|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047404|NCT02589665|17397595|P4|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047405|NCT02589665|17397596|P3|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047406|NCT02589665|17397597|P2|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047407|NCT02589665|17397598|P1|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5047408|NCT02589665|17397589|P10|Induction Extension Period|Reason Not Collected|0
5047409|NCT02589665|17397590|P9|Induction Extension Period|Reason Not Collected|1
5047410|NCT02589665|17397591|P8|Induction Extension Period|Reason Not Collected|0
5047411|NCT02589665|17397592|P7|Induction Extension Period|Reason Not Collected|0
5047412|NCT02589665|17397593|P6|Induction Extension Period|Reason Not Collected|0
5047413|NCT02589665|17397594|P5|Induction Extension Period|Reason Not Collected|0
5047414|NCT02589665|17397595|P4|Induction Extension Period|Reason Not Collected|0
5047415|NCT02589665|17397596|P3|Induction Extension Period|Reason Not Collected|0
5047416|NCT02589665|17397597|P2|Induction Extension Period|Reason Not Collected|0
5047417|NCT02589665|17397598|P1|Induction Extension Period|Reason Not Collected|0
5047418|NCT02589665|17397589|P10|Induction Extension Period|Physician Decision|0
5047419|NCT02589665|17397590|P9|Induction Extension Period|Physician Decision|1
5047420|NCT02589665|17397591|P8|Induction Extension Period|Physician Decision|0
5047421|NCT02589665|17397592|P7|Induction Extension Period|Physician Decision|0
5047422|NCT02589665|17397593|P6|Induction Extension Period|Physician Decision|0
5047423|NCT02589665|17397594|P5|Induction Extension Period|Physician Decision|0
5047424|NCT02589665|17397595|P4|Induction Extension Period|Physician Decision|0
5047425|NCT02589665|17397596|P3|Induction Extension Period|Physician Decision|0
5047426|NCT02589665|17397597|P2|Induction Extension Period|Physician Decision|0
5047427|NCT02589665|17397598|P1|Induction Extension Period|Physician Decision|0
5047428|NCT02589665|17397589|P10|Induction Extension Period|Withdrawal by Subject|0
5047429|NCT02589665|17397590|P9|Induction Extension Period|Withdrawal by Subject|3
5047430|NCT02589665|17397591|P8|Induction Extension Period|Withdrawal by Subject|2
5047431|NCT02589665|17397592|P7|Induction Extension Period|Withdrawal by Subject|0
5047432|NCT02589665|17397593|P6|Induction Extension Period|Withdrawal by Subject|0
5047433|NCT02589665|17397594|P5|Induction Extension Period|Withdrawal by Subject|0
5047434|NCT02589665|17397595|P4|Induction Extension Period|Withdrawal by Subject|0
5047435|NCT02589665|17397596|P3|Induction Extension Period|Withdrawal by Subject|0
5047436|NCT02589665|17397597|P2|Induction Extension Period|Withdrawal by Subject|0
5047437|NCT02589665|17397598|P1|Induction Extension Period|Withdrawal by Subject|0
5047438|NCT02589665|17397589|P10|Induction Extension Period|Lack of Efficacy|0
5047439|NCT02589665|17397590|P9|Induction Extension Period|Lack of Efficacy|3
5047440|NCT02589665|17397591|P8|Induction Extension Period|Lack of Efficacy|0
5047441|NCT02589665|17397592|P7|Induction Extension Period|Lack of Efficacy|0
5047442|NCT02589665|17397593|P6|Induction Extension Period|Lack of Efficacy|0
5047443|NCT02589665|17397594|P5|Induction Extension Period|Lack of Efficacy|0
5047444|NCT02589665|17397595|P4|Induction Extension Period|Lack of Efficacy|0
5047445|NCT02589665|17397596|P3|Induction Extension Period|Lack of Efficacy|0
5047446|NCT02589665|17397597|P2|Induction Extension Period|Lack of Efficacy|0
5047447|NCT02589665|17397598|P1|Induction Extension Period|Lack of Efficacy|0
5047448|NCT02589665|17397589|P10|Induction Extension Period|Adverse Event|0
5047449|NCT02589665|17397590|P9|Induction Extension Period|Adverse Event|4
5047450|NCT02589665|17397591|P8|Induction Extension Period|Adverse Event|0
5047451|NCT02589665|17397592|P7|Induction Extension Period|Adverse Event|0
5047452|NCT02589665|17397593|P6|Induction Extension Period|Adverse Event|0
5047453|NCT02589665|17397594|P5|Induction Extension Period|Adverse Event|0
5047454|NCT02589665|17397595|P4|Induction Extension Period|Adverse Event|0
5047455|NCT02589665|17397596|P3|Induction Extension Period|Adverse Event|0
5047456|NCT02589665|17397597|P2|Induction Extension Period|Adverse Event|0
5047457|NCT02589665|17397598|P1|Induction Extension Period|Adverse Event|0
5047458|NCT02589665|17397589|P10|Maintenance Period|Reason Not Collected|0
5047459|NCT02589665|17397590|P9|Maintenance Period|Reason Not Collected|0
5047460|NCT02589665|17397591|P8|Maintenance Period|Reason Not Collected|0
5047461|NCT02589665|17397592|P7|Maintenance Period|Reason Not Collected|1
5047462|NCT02589665|17397593|P6|Maintenance Period|Reason Not Collected|1
5047463|NCT02589665|17397594|P5|Maintenance Period|Reason Not Collected|0
5047464|NCT02589665|17397595|P4|Maintenance Period|Reason Not Collected|0
5047465|NCT02589665|17397596|P3|Maintenance Period|Reason Not Collected|0
5047466|NCT02589665|17397597|P2|Maintenance Period|Reason Not Collected|0
5047467|NCT02589665|17397598|P1|Maintenance Period|Reason Not Collected|0
5047468|NCT02589665|17397589|P10|Maintenance Period|Physician Decision|0
5047469|NCT02589665|17397590|P9|Maintenance Period|Physician Decision|0
5047470|NCT02589665|17397591|P8|Maintenance Period|Physician Decision|0
5047471|NCT02589665|17397592|P7|Maintenance Period|Physician Decision|0
5047472|NCT02589665|17397593|P6|Maintenance Period|Physician Decision|1
5047473|NCT02589665|17397594|P5|Maintenance Period|Physician Decision|0
5047474|NCT02589665|17397595|P4|Maintenance Period|Physician Decision|0
5047475|NCT02589665|17397596|P3|Maintenance Period|Physician Decision|0
5047476|NCT02589665|17397597|P2|Maintenance Period|Physician Decision|0
5047478|NCT02589665|17397589|P10|Maintenance Period|Lost to Follow-up|0
5047479|NCT02589665|17397590|P9|Maintenance Period|Lost to Follow-up|0
5047480|NCT02589665|17397591|P8|Maintenance Period|Lost to Follow-up|0
5047481|NCT02589665|17397592|P7|Maintenance Period|Lost to Follow-up|0
5047482|NCT02589665|17397593|P6|Maintenance Period|Lost to Follow-up|1
5047483|NCT02589665|17397594|P5|Maintenance Period|Lost to Follow-up|0
5047484|NCT02589665|17397595|P4|Maintenance Period|Lost to Follow-up|0
5047485|NCT02589665|17397596|P3|Maintenance Period|Lost to Follow-up|0
5047486|NCT02589665|17397597|P2|Maintenance Period|Lost to Follow-up|0
5047487|NCT02589665|17397598|P1|Maintenance Period|Lost to Follow-up|0
5047488|NCT02589665|17397589|P10|Maintenance Period|Adverse Event|0
5047489|NCT02589665|17397590|P9|Maintenance Period|Adverse Event|0
5047490|NCT02589665|17397591|P8|Maintenance Period|Adverse Event|0
5047491|NCT02589665|17397592|P7|Maintenance Period|Adverse Event|2
5047492|NCT02589665|17397593|P6|Maintenance Period|Adverse Event|0
5047493|NCT02589665|17397594|P5|Maintenance Period|Adverse Event|0
5047494|NCT02589665|17397595|P4|Maintenance Period|Adverse Event|0
5047495|NCT02589665|17397596|P3|Maintenance Period|Adverse Event|0
5047496|NCT02589665|17397597|P2|Maintenance Period|Adverse Event|0
5047497|NCT02589665|17397598|P1|Maintenance Period|Adverse Event|0
5047498|NCT02589665|17397589|P10|Maintenance Period|Lack of Efficacy|0
5047499|NCT02589665|17397590|P9|Maintenance Period|Lack of Efficacy|0
5047500|NCT02589665|17397591|P8|Maintenance Period|Lack of Efficacy|0
5047501|NCT02589665|17397592|P7|Maintenance Period|Lack of Efficacy|0
5047502|NCT02589665|17397593|P6|Maintenance Period|Lack of Efficacy|1
5047503|NCT02589665|17397594|P5|Maintenance Period|Lack of Efficacy|2
5047504|NCT02589665|17397595|P4|Maintenance Period|Lack of Efficacy|0
5047505|NCT02589665|17397596|P3|Maintenance Period|Lack of Efficacy|0
5047506|NCT02589665|17397597|P2|Maintenance Period|Lack of Efficacy|0
5047507|NCT02589665|17397598|P1|Maintenance Period|Lack of Efficacy|0
5047508|NCT02589665|17397589|P10|Maintenance Period|Withdrawal by Subject|0
5047509|NCT02589665|17397590|P9|Maintenance Period|Withdrawal by Subject|0
5047510|NCT02589665|17397591|P8|Maintenance Period|Withdrawal by Subject|0
5047511|NCT02589665|17397592|P7|Maintenance Period|Withdrawal by Subject|4
5047512|NCT02589665|17397593|P6|Maintenance Period|Withdrawal by Subject|2
5047513|NCT02589665|17397594|P5|Maintenance Period|Withdrawal by Subject|4
5047514|NCT02589665|17397595|P4|Maintenance Period|Withdrawal by Subject|0
5047515|NCT02589665|17397596|P3|Maintenance Period|Withdrawal by Subject|0
5047516|NCT02589665|17397597|P2|Maintenance Period|Withdrawal by Subject|0
5047517|NCT02589665|17397598|P1|Maintenance Period|Withdrawal by Subject|0
5047518|NCT02589665|17397589|P10|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047519|NCT02589665|17397590|P9|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047520|NCT02589665|17397591|P8|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047521|NCT02589665|17397592|P7|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
5047522|NCT02589665|17397593|P6|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
5047523|NCT02589665|17397594|P5|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
5047524|NCT02589665|17397595|P4|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047525|NCT02589665|17397596|P3|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047526|NCT02589665|17397597|P2|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047527|NCT02589665|17397598|P1|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5047528|NCT02589665|17397589|P10|Induction Period|Protocol Violation|0
5047529|NCT02589665|17397590|P9|Induction Period|Protocol Violation|0
5047530|NCT02589665|17397591|P8|Induction Period|Protocol Violation|0
5047531|NCT02589665|17397592|P7|Induction Period|Protocol Violation|0
5047532|NCT02589665|17397593|P6|Induction Period|Protocol Violation|0
5047533|NCT02589665|17397594|P5|Induction Period|Protocol Violation|0
5047534|NCT02589665|17397595|P4|Induction Period|Protocol Violation|0
5047535|NCT02589665|17397596|P3|Induction Period|Protocol Violation|0
5047536|NCT02589665|17397597|P2|Induction Period|Protocol Violation|1
5047537|NCT02589665|17397598|P1|Induction Period|Protocol Violation|0
5047538|NCT02589665|17397589|P10|Induction Period|Withdrawal by Subject|0
5047539|NCT02589665|17397590|P9|Induction Period|Withdrawal by Subject|0
5047540|NCT02589665|17397591|P8|Induction Period|Withdrawal by Subject|0
5047541|NCT02589665|17397592|P7|Induction Period|Withdrawal by Subject|0
5047542|NCT02589665|17397593|P6|Induction Period|Withdrawal by Subject|0
5047543|NCT02589665|17397594|P5|Induction Period|Withdrawal by Subject|0
5047544|NCT02589665|17397595|P4|Induction Period|Withdrawal by Subject|1
5047545|NCT02589665|17397596|P3|Induction Period|Withdrawal by Subject|0
5047546|NCT02589665|17397597|P2|Induction Period|Withdrawal by Subject|1
5047547|NCT02589665|17397598|P1|Induction Period|Withdrawal by Subject|0
5047548|NCT02589665|17397589|P10|Induction Period|Adverse Event|0
5047549|NCT02589665|17397590|P9|Induction Period|Adverse Event|0
5047550|NCT02589665|17397591|P8|Induction Period|Adverse Event|0
5047551|NCT02589665|17397592|P7|Induction Period|Adverse Event|0
5047552|NCT02589665|17397593|P6|Induction Period|Adverse Event|0
5047553|NCT02589665|17397594|P5|Induction Period|Adverse Event|0
5047554|NCT02589665|17397595|P4|Induction Period|Adverse Event|2
5047555|NCT02589665|17397596|P3|Induction Period|Adverse Event|2
5047556|NCT02589665|17397597|P2|Induction Period|Adverse Event|0
5047557|NCT02589665|17397598|P1|Induction Period|Adverse Event|3
5047558|NCT02589665|17397589|P10|Induction Period|Did not receive drug|0
5047559|NCT02589665|17397590|P9|Induction Period|Did not receive drug|0
5047560|NCT02589665|17397591|P8|Induction Period|Did not receive drug|0
5047561|NCT02589665|17397592|P7|Induction Period|Did not receive drug|0
5047562|NCT02589665|17397593|P6|Induction Period|Did not receive drug|0
5047563|NCT02589665|17397594|P5|Induction Period|Did not receive drug|0
5047564|NCT02589665|17397595|P4|Induction Period|Did not receive drug|1
5047565|NCT02589665|17397596|P3|Induction Period|Did not receive drug|0
5047566|NCT02589665|17397597|P2|Induction Period|Did not receive drug|0
5047567|NCT02589665|17397598|P1|Induction Period|Did not receive drug|0
5047568|NCT02589639|17397663|P3|Overall Study|Not Treated|0
5047569|NCT02589639|17397664|P2|Overall Study|Not Treated|3
5047570|NCT02589639|17397665|P1|Overall Study|Not Treated|0
5047571|NCT02589639|17397663|P3|Overall Study|Other reason than specified above|1
5047572|NCT02589639|17397664|P2|Overall Study|Other reason than specified above|2
5047573|NCT02589639|17397665|P1|Overall Study|Other reason than specified above|1
5047574|NCT02589639|17397663|P3|Overall Study|Adverse Event|3
5047575|NCT02589639|17397664|P2|Overall Study|Adverse Event|5
5047576|NCT02589639|17397665|P1|Overall Study|Adverse Event|4
5047577|NCT02589639|17397663|P3|Overall Study|Patient withdrawal, not due to AE|0
5047578|NCT02589639|17397664|P2|Overall Study|Patient withdrawal, not due to AE|0
5047579|NCT02589639|17397665|P1|Overall Study|Patient withdrawal, not due to AE|3
5047580|NCT02589639|17397663|P3|Overall Study|Protocol Violation|0
5047581|NCT02589639|17397664|P2|Overall Study|Protocol Violation|0
5047582|NCT02589639|17397665|P1|Overall Study|Protocol Violation|1
5047583|NCT02589639|17397663|P3|Overall Study|Lost to Follow-up|0
5047584|NCT02589639|17397664|P2|Overall Study|Lost to Follow-up|0
5047585|NCT02589639|17397665|P1|Overall Study|Lost to Follow-up|1
5047586|NCT02589626|17397678|P2|Overall Study|Adverse Event|1
5047587|NCT02589626|17397679|P1|Overall Study|Adverse Event|1
5047588|NCT02589626|17397678|P2|Overall Study|Withdrawal by Subject|1
5047589|NCT02589626|17397679|P1|Overall Study|Withdrawal by Subject|1
5047590|NCT02589626|17397678|P2|Overall Study|Other than the reason specified|0
5047591|NCT02589626|17397679|P1|Overall Study|Other than the reason specified|1
5047592|NCT02589405|17397687|P1|Overall Study|Withdrawal by Subject|1
5047593|NCT02589405|17397687|P1|Overall Study|Adverse Event|3
5047594|NCT02588339|17397825|P1|Overall Study|GVHD Progression prior to treatment|2
5047595|NCT02588339|17397825|P1|Overall Study|Withdrawal by Subject|1
5047596|NCT02588261|17397837|P2|Overall Study|Lost to Follow-up|0
5047597|NCT02588261|17397838|P1|Overall Study|Lost to Follow-up|1
5047598|NCT02588261|17397837|P2|Overall Study|Adverse Event|24
5047599|NCT02588261|17397838|P1|Overall Study|Adverse Event|29
5047600|NCT02588261|17397837|P2|Overall Study|Progressive Disease|82
5047601|NCT02588261|17397838|P1|Overall Study|Progressive Disease|61
5047602|NCT02588261|17397837|P2|Overall Study|Miscellaneous|4
5047603|NCT02588261|17397838|P1|Overall Study|Miscellaneous|5
5047604|NCT02588261|17397837|P2|Overall Study|Noncompliance with Study Drug|1
5047605|NCT02588261|17397838|P1|Overall Study|Noncompliance with Study Drug|0
5047606|NCT02588261|17397837|P2|Overall Study|Withdrawal by Subject|8
5047607|NCT02588261|17397838|P1|Overall Study|Withdrawal by Subject|12
5047608|NCT02588261|17397837|P2|Overall Study|Death|2
5047609|NCT02588261|17397838|P1|Overall Study|Death|1
5047610|NCT02588261|17397837|P2|Overall Study|Protocol Deviation|0
5047611|NCT02588261|17397838|P1|Overall Study|Protocol Deviation|1
5047612|NCT02588261|17397837|P2|Overall Study|Study Terminated by Sponsor|142
5047613|NCT02588261|17397838|P1|Overall Study|Study Terminated by Sponsor|157
5047614|NCT02588092|17397874|P10|Overall Study|Sponsor Decision|1
5047615|NCT02588092|17397875|P9|Overall Study|Sponsor Decision|1
5047616|NCT02588092|17397876|P8|Overall Study|Sponsor Decision|0
5047617|NCT02588092|17397877|P7|Overall Study|Sponsor Decision|0
5047618|NCT02588092|17397878|P6|Overall Study|Sponsor Decision|0
5047619|NCT02588092|17397879|P5|Overall Study|Sponsor Decision|0
5047620|NCT02588092|17397880|P4|Overall Study|Sponsor Decision|0
5047621|NCT02588092|17397881|P3|Overall Study|Sponsor Decision|0
5047622|NCT02588092|17397882|P2|Overall Study|Sponsor Decision|0
5047623|NCT02588092|17397883|P1|Overall Study|Sponsor Decision|0
5047624|NCT02588092|17397874|P10|Overall Study|Started Another Treatment|0
5047625|NCT02588092|17397875|P9|Overall Study|Started Another Treatment|0
5047626|NCT02588092|17397876|P8|Overall Study|Started Another Treatment|1
5047627|NCT02588092|17397877|P7|Overall Study|Started Another Treatment|0
5047628|NCT02588092|17397878|P6|Overall Study|Started Another Treatment|0
5047629|NCT02588092|17397879|P5|Overall Study|Started Another Treatment|1
5047630|NCT02588092|17397880|P4|Overall Study|Started Another Treatment|0
5047631|NCT02588092|17397881|P3|Overall Study|Started Another Treatment|0
5047632|NCT02588092|17397882|P2|Overall Study|Started Another Treatment|0
5047633|NCT02588092|17397883|P1|Overall Study|Started Another Treatment|0
5047634|NCT02588092|17397874|P10|Overall Study|Withdrawal by Subject|0
5047635|NCT02588092|17397875|P9|Overall Study|Withdrawal by Subject|0
5047636|NCT02588092|17397876|P8|Overall Study|Withdrawal by Subject|2
5047637|NCT02588092|17397877|P7|Overall Study|Withdrawal by Subject|1
5047638|NCT02588092|17397878|P6|Overall Study|Withdrawal by Subject|1
5047639|NCT02588092|17397879|P5|Overall Study|Withdrawal by Subject|0
5047640|NCT02588092|17397880|P4|Overall Study|Withdrawal by Subject|0
5047641|NCT02588092|17397881|P3|Overall Study|Withdrawal by Subject|0
5047642|NCT02588092|17397882|P2|Overall Study|Withdrawal by Subject|0
5047643|NCT02588092|17397883|P1|Overall Study|Withdrawal by Subject|0
5047644|NCT02588092|17397874|P10|Overall Study|Death|2
5047645|NCT02588092|17397875|P9|Overall Study|Death|5
5047646|NCT02588092|17397876|P8|Overall Study|Death|1
5047647|NCT02588092|17397877|P7|Overall Study|Death|2
5047648|NCT02588092|17397878|P6|Overall Study|Death|2
5047649|NCT02588092|17397879|P5|Overall Study|Death|2
5047650|NCT02588092|17397880|P4|Overall Study|Death|3
5047651|NCT02588092|17397881|P3|Overall Study|Death|3
5047652|NCT02588092|17397882|P2|Overall Study|Death|3
5047653|NCT02588092|17397883|P1|Overall Study|Death|4
5047654|NCT02587819|17398077|P1|Overall Study|Lost to Follow-up|1
5047655|NCT02587819|17398077|P1|Overall Study|Adverse Event|1
5047656|NCT02587520|17398113|P18|Overall Study|Lost to Follow-up|0
5047657|NCT02587520|17398114|P17|Overall Study|Lost to Follow-up|0
5047658|NCT02587520|17398115|P16|Overall Study|Lost to Follow-up|0
5047659|NCT02587520|17398116|P15|Overall Study|Lost to Follow-up|0
5047660|NCT02587520|17398117|P14|Overall Study|Lost to Follow-up|0
5047661|NCT02587520|17398118|P13|Overall Study|Lost to Follow-up|0
5047662|NCT02587520|17398119|P12|Overall Study|Lost to Follow-up|1
5047663|NCT02587520|17398120|P11|Overall Study|Lost to Follow-up|2
5047664|NCT02587520|17398121|P10|Overall Study|Lost to Follow-up|2
5047665|NCT02587520|17398122|P9|Overall Study|Lost to Follow-up|0
5047666|NCT02587520|17398123|P8|Overall Study|Lost to Follow-up|1
5047667|NCT02587520|17398124|P7|Overall Study|Lost to Follow-up|1
5047668|NCT02587520|17398125|P6|Overall Study|Lost to Follow-up|1
5047669|NCT02587520|17398126|P5|Overall Study|Lost to Follow-up|0
5047670|NCT02587520|17398127|P4|Overall Study|Lost to Follow-up|2
5047671|NCT02587520|17398128|P3|Overall Study|Lost to Follow-up|0
5047672|NCT02587520|17398129|P2|Overall Study|Lost to Follow-up|2
5047673|NCT02587520|17398130|P1|Overall Study|Lost to Follow-up|0
5047674|NCT02587520|17398113|P18|Overall Study|Withdrawal by Subject|0
5047675|NCT02587520|17398114|P17|Overall Study|Withdrawal by Subject|0
5047676|NCT02587520|17398115|P16|Overall Study|Withdrawal by Subject|0
5047677|NCT02587520|17398116|P15|Overall Study|Withdrawal by Subject|0
5047678|NCT02587520|17398117|P14|Overall Study|Withdrawal by Subject|1
5047679|NCT02587520|17398118|P13|Overall Study|Withdrawal by Subject|0
5047680|NCT02587520|17398119|P12|Overall Study|Withdrawal by Subject|0
5047681|NCT02587520|17398120|P11|Overall Study|Withdrawal by Subject|0
5047682|NCT02587520|17398121|P10|Overall Study|Withdrawal by Subject|0
5047683|NCT02587520|17398122|P9|Overall Study|Withdrawal by Subject|0
5047684|NCT02587520|17398123|P8|Overall Study|Withdrawal by Subject|0
5047685|NCT02587520|17398124|P7|Overall Study|Withdrawal by Subject|1
5047686|NCT02587520|17398125|P6|Overall Study|Withdrawal by Subject|1
5047687|NCT02587520|17398126|P5|Overall Study|Withdrawal by Subject|0
5047688|NCT02587520|17398127|P4|Overall Study|Withdrawal by Subject|1
5047689|NCT02587520|17398128|P3|Overall Study|Withdrawal by Subject|1
5047690|NCT02587520|17398129|P2|Overall Study|Withdrawal by Subject|0
5047691|NCT02587520|17398130|P1|Overall Study|Withdrawal by Subject|0
5047692|NCT02587520|17398113|P18|Overall Study|Adverse Event|0
5047693|NCT02587520|17398114|P17|Overall Study|Adverse Event|0
5047694|NCT02587520|17398115|P16|Overall Study|Adverse Event|0
5047695|NCT02587520|17398116|P15|Overall Study|Adverse Event|0
5047696|NCT02587520|17398117|P14|Overall Study|Adverse Event|0
5047697|NCT02587520|17398118|P13|Overall Study|Adverse Event|0
5047698|NCT02587520|17398119|P12|Overall Study|Adverse Event|1
5047699|NCT02587520|17398120|P11|Overall Study|Adverse Event|0
5047700|NCT02587520|17398121|P10|Overall Study|Adverse Event|0
5047701|NCT02587520|17398122|P9|Overall Study|Adverse Event|0
5047702|NCT02587520|17398123|P8|Overall Study|Adverse Event|0
5047703|NCT02587520|17398124|P7|Overall Study|Adverse Event|0
5047704|NCT02587520|17398125|P6|Overall Study|Adverse Event|0
5047705|NCT02587520|17398126|P5|Overall Study|Adverse Event|0
5047706|NCT02587520|17398127|P4|Overall Study|Adverse Event|0
5047707|NCT02587520|17398128|P3|Overall Study|Adverse Event|0
5047708|NCT02587520|17398129|P2|Overall Study|Adverse Event|0
5047709|NCT02587520|17398130|P1|Overall Study|Adverse Event|0
5047710|NCT02587520|17398113|P18|Overall Study|Protocol Violation|0
5047711|NCT02587520|17398114|P17|Overall Study|Protocol Violation|0
5047712|NCT02587520|17398115|P16|Overall Study|Protocol Violation|0
5047713|NCT02587520|17398116|P15|Overall Study|Protocol Violation|0
5047714|NCT02587520|17398117|P14|Overall Study|Protocol Violation|0
5047715|NCT02587520|17398118|P13|Overall Study|Protocol Violation|0
5047716|NCT02587520|17398119|P12|Overall Study|Protocol Violation|2
5047717|NCT02587520|17398120|P11|Overall Study|Protocol Violation|1
5047718|NCT02587520|17398121|P10|Overall Study|Protocol Violation|3
5047719|NCT02587520|17398122|P9|Overall Study|Protocol Violation|3
5047720|NCT02587520|17398123|P8|Overall Study|Protocol Violation|1
5047721|NCT02587520|17398124|P7|Overall Study|Protocol Violation|1
5047722|NCT02587520|17398125|P6|Overall Study|Protocol Violation|1
5047723|NCT02587520|17398126|P5|Overall Study|Protocol Violation|0
5047724|NCT02587520|17398127|P4|Overall Study|Protocol Violation|2
5047725|NCT02587520|17398128|P3|Overall Study|Protocol Violation|0
5047726|NCT02587520|17398129|P2|Overall Study|Protocol Violation|0
5047727|NCT02587520|17398130|P1|Overall Study|Protocol Violation|2
5047728|NCT02587234|17398170|P2|Overall Study|Lost to Follow-up|2
5047729|NCT02587234|17398171|P1|Overall Study|Lost to Follow-up|0
5047730|NCT02587234|17398170|P2|Overall Study|Withdrawal by Subject|1
5047731|NCT02587234|17398171|P1|Overall Study|Withdrawal by Subject|1
5047732|NCT02587221|17398183|P2|Overall Study|Other Reason or Unspecified|1
5047733|NCT02587221|17398184|P1|Overall Study|Other Reason or Unspecified|2
5047734|NCT02587221|17398183|P2|Overall Study|Protocol Violation|5
5047735|NCT02587221|17398184|P1|Overall Study|Protocol Violation|6
5047736|NCT02587221|17398183|P2|Overall Study|Lost to Follow-up|19
5047737|NCT02587221|17398184|P1|Overall Study|Lost to Follow-up|21
5047738|NCT02587221|17398183|P2|Overall Study|Withdrawal by Subject|61
5047739|NCT02587221|17398184|P1|Overall Study|Withdrawal by Subject|66
5047740|NCT02587221|17398183|P2|Overall Study|Death|34
5047741|NCT02587221|17398184|P1|Overall Study|Death|33
5047742|NCT02587221|17398183|P2|Overall Study|Adverse Event|3
5047743|NCT02587221|17398184|P1|Overall Study|Adverse Event|3
5047744|NCT02587143|17398230|P2|Overall Study|Adverse Event|0
5047745|NCT02587143|17398231|P1|Overall Study|Adverse Event|1
5047746|NCT02587065|17398248|P1|Overall Study|Reason not Specified|3
5047747|NCT02587065|17398248|P1|Overall Study|Discontinuation of Study Medication|2
5047748|NCT02587065|17398248|P1|Overall Study|Non-adherence to the Protocol|3
5047749|NCT02587065|17398248|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
5047750|NCT02587065|17398248|P1|Overall Study|Adverse Event|14
5047751|NCT02586805|17398313|P4|Overall Study|Physician Decision|0
5047752|NCT02586805|17398314|P3|Overall Study|Physician Decision|0
5047753|NCT02586805|17398315|P2|Overall Study|Physician Decision|0
5047754|NCT02586805|17398316|P1|Overall Study|Physician Decision|1
5047755|NCT02586805|17398313|P4|Overall Study|Lost to Follow-up|0
5047756|NCT02586805|17398314|P3|Overall Study|Lost to Follow-up|1
5047757|NCT02586805|17398315|P2|Overall Study|Lost to Follow-up|0
5047758|NCT02586805|17398316|P1|Overall Study|Lost to Follow-up|0
5047759|NCT02586805|17398313|P4|Overall Study|Adverse Event|0
5047760|NCT02586805|17398314|P3|Overall Study|Adverse Event|1
5047761|NCT02586805|17398315|P2|Overall Study|Adverse Event|0
5047762|NCT02586805|17398316|P1|Overall Study|Adverse Event|2
5047763|NCT02586805|17398313|P4|Overall Study|Withdrawal by Subject|2
5047764|NCT02586805|17398314|P3|Overall Study|Withdrawal by Subject|1
5047765|NCT02586805|17398315|P2|Overall Study|Withdrawal by Subject|1
5047766|NCT02586805|17398316|P1|Overall Study|Withdrawal by Subject|3
5047767|NCT02586506|17398344|P1|Overall Study|Other Reason|2
5047768|NCT02586506|17398344|P1|Overall Study|Lost to Follow-up|1
5047769|NCT02586506|17398344|P1|Overall Study|Protocol Violation|6
5047770|NCT02586493|17398350|P1|Overall Study|Withdrawal by Subject|1
5047771|NCT02586493|17398350|P1|Overall Study|Lost to Follow-up|1
5047772|NCT02586493|17398350|P1|Overall Study|Protocol Violation|6
5047773|NCT02586493|17398350|P1|Overall Study|Adverse Event|4
5047774|NCT02586415|17398358|P2|Overall Study|Lost to Follow-up|2
5047775|NCT02586415|17398359|P1|Overall Study|Lost to Follow-up|1
5047776|NCT02586415|17398358|P2|Overall Study|Death|23
5047777|NCT02586415|17398359|P1|Overall Study|Death|13
5047778|NCT02586233|17398376|P7|Overall Study|Death|0
5047779|NCT02586233|17398377|P6|Overall Study|Death|0
5047780|NCT02586233|17398378|P5|Overall Study|Death|2
5047781|NCT02586233|17398379|P4|Overall Study|Death|0
5047782|NCT02586233|17398380|P3|Overall Study|Death|0
5047783|NCT02586233|17398381|P2|Overall Study|Death|1
5047784|NCT02586233|17398382|P1|Overall Study|Death|0
5047785|NCT02586233|17398376|P7|Overall Study|Randomized but did not receive treatment|2
5047786|NCT02586233|17398377|P6|Overall Study|Randomized but did not receive treatment|2
5047787|NCT02586233|17398378|P5|Overall Study|Randomized but did not receive treatment|0
5047788|NCT02586233|17398379|P4|Overall Study|Randomized but did not receive treatment|0
5047789|NCT02586233|17398380|P3|Overall Study|Randomized but did not receive treatment|0
5047790|NCT02586233|17398381|P2|Overall Study|Randomized but did not receive treatment|1
5047791|NCT02586233|17398382|P1|Overall Study|Randomized but did not receive treatment|0
5047792|NCT02586077|17398441|P1|Overall Study|Lost to Follow-up|3
5047793|NCT02586077|17398441|P1|Overall Study|Physician Decision|4
5047794|NCT02586077|17398441|P1|Overall Study|Withdrawal by Subject|1
5047795|NCT02586025|17398451|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
5047796|NCT02586025|17398452|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
5047797|NCT02586025|17398451|P2|Adjuvant Treatment|Recurrent Disease|4
5047798|NCT02586025|17398452|P1|Adjuvant Treatment|Recurrent Disease|1
5047799|NCT02586025|17398451|P2|Adjuvant Treatment|Physician Decision|1
5047800|NCT02586025|17398452|P1|Adjuvant Treatment|Physician Decision|0
5047801|NCT02586025|17398451|P2|Adjuvant Treatment|Withdrawal by Subject|3
5047802|NCT02586025|17398452|P1|Adjuvant Treatment|Withdrawal by Subject|5
5047803|NCT02586025|17398451|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
5047804|NCT02586025|17398452|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
5047805|NCT02586025|17398451|P2|Neoadjuvant Treatment|Progressive Disease|3
5047806|NCT02586025|17398452|P1|Neoadjuvant Treatment|Progressive Disease|2
5047807|NCT02586025|17398451|P2|Neoadjuvant Treatment|Physician Decision|1
5047808|NCT02586025|17398452|P1|Neoadjuvant Treatment|Physician Decision|2
5047809|NCT02586025|17398451|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
5047810|NCT02586025|17398452|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
5047811|NCT02586025|17398451|P2|Neoadjuvant Treatment|Adverse Event|0
5047812|NCT02586025|17398452|P1|Neoadjuvant Treatment|Adverse Event|1
5047813|NCT02586025|17398451|P2|Neoadjuvant Treatment|Death|0
5047814|NCT02586025|17398452|P1|Neoadjuvant Treatment|Death|1
5047815|NCT02586025|17398451|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
5047816|NCT02586025|17398452|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
5047817|NCT02586012|17398488|P6|Overall Study|study terminated|0
5047818|NCT02586012|17398489|P5|Overall Study|study terminated|1
5047819|NCT02586012|17398490|P4|Overall Study|study terminated|1
5047820|NCT02586012|17398491|P3|Overall Study|study terminated|1
5047821|NCT02586012|17398492|P2|Overall Study|study terminated|2
5047822|NCT02586012|17398493|P1|Overall Study|study terminated|0
5047823|NCT02586012|17398488|P6|Overall Study|Protocol Violation|1
5047824|NCT02586012|17398489|P5|Overall Study|Protocol Violation|0
5047825|NCT02586012|17398490|P4|Overall Study|Protocol Violation|0
5047826|NCT02586012|17398491|P3|Overall Study|Protocol Violation|0
5047827|NCT02586012|17398492|P2|Overall Study|Protocol Violation|0
5047828|NCT02586012|17398493|P1|Overall Study|Protocol Violation|0
5047829|NCT02586012|17398488|P6|Overall Study|Withdrawal by Subject|2
5047830|NCT02586012|17398489|P5|Overall Study|Withdrawal by Subject|0
5047831|NCT02586012|17398490|P4|Overall Study|Withdrawal by Subject|1
5047832|NCT02586012|17398491|P3|Overall Study|Withdrawal by Subject|0
5047833|NCT02586012|17398492|P2|Overall Study|Withdrawal by Subject|1
5047834|NCT02586012|17398493|P1|Overall Study|Withdrawal by Subject|1
5047835|NCT02585999|17398504|P1|Overall Study|Protocol Violation|1
5047836|NCT02585999|17398504|P1|Overall Study|Lost to Follow-up|1
5047837|NCT02585960|17398512|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
5047838|NCT02585960|17398513|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
5047839|NCT02585960|17398514|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
5047840|NCT02585960|17398512|P3|Prophylactic Treatment Period|Major protocol deviation|0
5047841|NCT02585960|17398513|P2|Prophylactic Treatment Period|Major protocol deviation|4
5047842|NCT02585960|17398514|P1|Prophylactic Treatment Period|Major protocol deviation|0
5047843|NCT02585960|17398512|P3|PK/Safety Assessment Period|Screen Failure|1
5047844|NCT02585960|17398513|P2|PK/Safety Assessment Period|Screen Failure|0
5047845|NCT02585960|17398514|P1|PK/Safety Assessment Period|Screen Failure|0
5047846|NCT02585960|17398512|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
5047847|NCT02585960|17398513|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
5047848|NCT02585960|17398514|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
5047849|NCT02585960|17398512|P3|PK/Safety Assessment Period|Other|0
5047850|NCT02585960|17398513|P2|PK/Safety Assessment Period|Other|4
5047851|NCT02585960|17398514|P1|PK/Safety Assessment Period|Other|4
5047852|NCT02585960|17398512|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
5047853|NCT02585960|17398513|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
5047854|NCT02585960|17398514|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
5047855|NCT02585960|17398512|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
5047856|NCT02585960|17398513|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
5047857|NCT02585960|17398514|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
5047858|NCT02585960|17398512|P3|PK/Safety Assessment Period|Physician Decision|0
5047859|NCT02585960|17398513|P2|PK/Safety Assessment Period|Physician Decision|1
5047860|NCT02585960|17398514|P1|PK/Safety Assessment Period|Physician Decision|0
5047861|NCT02585934|17398584|P2|Overall Study|Another Reason|5
5047862|NCT02585934|17398585|P1|Overall Study|Another Reason|10
5047863|NCT02585934|17398584|P2|Overall Study|Sponsor Termination|2
5047864|NCT02585934|17398585|P1|Overall Study|Sponsor Termination|1
5047865|NCT02585934|17398584|P2|Overall Study|Caregiver Withdrew Consent|7
5047866|NCT02585934|17398585|P1|Overall Study|Caregiver Withdrew Consent|7
5047867|NCT02585934|17398584|P2|Overall Study|Death|0
5047868|NCT02585934|17398585|P1|Overall Study|Death|2
5047869|NCT02585934|17398584|P2|Overall Study|Lack of Efficacy|1
5047870|NCT02585934|17398585|P1|Overall Study|Lack of Efficacy|2
5047871|NCT02585934|17398584|P2|Overall Study|Withdrawal by Subject|21
5047872|NCT02585934|17398585|P1|Overall Study|Withdrawal by Subject|7
5047873|NCT02585934|17398584|P2|Overall Study|Physician Decision|2
5047874|NCT02585934|17398585|P1|Overall Study|Physician Decision|3
5047875|NCT02585934|17398584|P2|Overall Study|Adverse Event|22
5047876|NCT02585934|17398585|P1|Overall Study|Adverse Event|21
5047877|NCT02585934|17398584|P2|Overall Study|Protocol Violation|11
5047878|NCT02585934|17398585|P1|Overall Study|Protocol Violation|14
5047879|NCT02585934|17398584|P2|Overall Study|Lost to Follow-up|2
5047880|NCT02585934|17398585|P1|Overall Study|Lost to Follow-up|2
5047881|NCT02585830|17398641|P1|Overall Study|Withdrawal by Subject|3
5047882|NCT02585778|17398650|P2|Overall Study|Other than specified above|2
5047883|NCT02585778|17398651|P1|Overall Study|Other than specified above|6
5047884|NCT02585778|17398650|P2|Overall Study|Randomized but not treated|2
5047885|NCT02585778|17398651|P1|Overall Study|Randomized but not treated|1
5047886|NCT02585778|17398650|P2|Overall Study|Death|1
5047887|NCT02585778|17398651|P1|Overall Study|Death|0
5047888|NCT02585778|17398650|P2|Overall Study|Poor compliance to study protocol|2
5047889|NCT02585778|17398651|P1|Overall Study|Poor compliance to study protocol|0
5047890|NCT02585778|17398650|P2|Overall Study|Participant did not wish to continue|4
5047891|NCT02585778|17398651|P1|Overall Study|Participant did not wish to continue|9
5047892|NCT02585778|17398650|P2|Overall Study|Adverse Event|4
5047893|NCT02585778|17398651|P1|Overall Study|Adverse Event|17
5047894|NCT02585713|17398767|P2|Overall Study|Other|1
5047895|NCT02585713|17398768|P1|Overall Study|Other|3
5047896|NCT02585713|17398767|P2|Overall Study|Withdrew prior to treatment|7
5047897|NCT02585713|17398768|P1|Overall Study|Withdrew prior to treatment|2
5047898|NCT02584959|17398831|P3|Period 2|Withdrawn from study|2
5047899|NCT02584959|17398832|P2|Period 2|Withdrawn from study|1
5047900|NCT02584959|17398833|P1|Period 2|Withdrawn from study|6
5047901|NCT02584959|17398831|P3|Period 1|Withdrawn from study|0
5047902|NCT02584959|17398832|P2|Period 1|Withdrawn from study|4
5047903|NCT02584959|17398833|P1|Period 1|Withdrawn from study|3
5047904|NCT02584855|17398961|P6|Post Treatment Follow-up Period|Protocol Violation|0
5047905|NCT02584855|17398962|P5|Post Treatment Follow-up Period|Protocol Violation|1
5047906|NCT02584855|17398963|P4|Post Treatment Follow-up Period|Protocol Violation|0
5047907|NCT02584855|17398964|P3|Post Treatment Follow-up Period|Protocol Violation|0
5047908|NCT02584855|17398965|P2|Post Treatment Follow-up Period|Protocol Violation|0
5047909|NCT02584855|17398966|P1|Post Treatment Follow-up Period|Protocol Violation|0
5047910|NCT02584855|17398961|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
5047911|NCT02584855|17398962|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
5047912|NCT02584855|17398963|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
5047913|NCT02584855|17398964|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
5047914|NCT02584855|17398965|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
5047915|NCT02584855|17398966|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
5047916|NCT02584855|17398961|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5047917|NCT02584855|17398962|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5047918|NCT02584855|17398963|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5047919|NCT02584855|17398964|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5047920|NCT02584855|17398965|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
5047921|NCT02584855|17398966|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5047922|NCT02584855|17398961|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
5047923|NCT02584855|17398962|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
5047924|NCT02584855|17398963|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
5047925|NCT02584855|17398964|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
5047926|NCT02584855|17398965|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
5047927|NCT02584855|17398966|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
5047928|NCT02584855|17398961|P6|Double-Blind Withdrawal Period|Adverse Event|0
5047929|NCT02584855|17398962|P5|Double-Blind Withdrawal Period|Adverse Event|0
5047930|NCT02584855|17398963|P4|Double-Blind Withdrawal Period|Adverse Event|1
5047931|NCT02584855|17398964|P3|Double-Blind Withdrawal Period|Adverse Event|0
5047932|NCT02584855|17398965|P2|Double-Blind Withdrawal Period|Adverse Event|4
5047933|NCT02584855|17398966|P1|Double-Blind Withdrawal Period|Adverse Event|0
5047934|NCT02584855|17398961|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5047935|NCT02584855|17398962|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5047936|NCT02584855|17398963|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5047937|NCT02584855|17398964|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
5047938|NCT02584855|17398965|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5047939|NCT02584855|17398966|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5047940|NCT02584855|17398961|P6|Open-Label Treatment Period|Sponsor Decision|0
5047941|NCT02584855|17398962|P5|Open-Label Treatment Period|Sponsor Decision|0
5047942|NCT02584855|17398963|P4|Open-Label Treatment Period|Sponsor Decision|0
5047943|NCT02584855|17398964|P3|Open-Label Treatment Period|Sponsor Decision|0
5047944|NCT02584855|17398965|P2|Open-Label Treatment Period|Sponsor Decision|0
5047945|NCT02584855|17398966|P1|Open-Label Treatment Period|Sponsor Decision|1
5047946|NCT02584855|17398961|P6|Open-Label Treatment Period|No PI Available|0
5047947|NCT02584855|17398962|P5|Open-Label Treatment Period|No PI Available|0
5047948|NCT02584855|17398963|P4|Open-Label Treatment Period|No PI Available|0
5047949|NCT02584855|17398964|P3|Open-Label Treatment Period|No PI Available|0
5047950|NCT02584855|17398965|P2|Open-Label Treatment Period|No PI Available|0
5047951|NCT02584855|17398966|P1|Open-Label Treatment Period|No PI Available|2
5047952|NCT02584855|17398961|P6|Open-Label Treatment Period|Protocol Violation|0
5047953|NCT02584855|17398962|P5|Open-Label Treatment Period|Protocol Violation|0
5047954|NCT02584855|17398963|P4|Open-Label Treatment Period|Protocol Violation|0
5047955|NCT02584855|17398964|P3|Open-Label Treatment Period|Protocol Violation|0
5047956|NCT02584855|17398965|P2|Open-Label Treatment Period|Protocol Violation|0
5047957|NCT02584855|17398966|P1|Open-Label Treatment Period|Protocol Violation|1
5047958|NCT02584855|17398961|P6|Open-Label Treatment Period|Lost to Follow-up|0
5047959|NCT02584855|17398962|P5|Open-Label Treatment Period|Lost to Follow-up|0
5047960|NCT02584855|17398963|P4|Open-Label Treatment Period|Lost to Follow-up|0
5047961|NCT02584855|17398964|P3|Open-Label Treatment Period|Lost to Follow-up|0
5047962|NCT02584855|17398965|P2|Open-Label Treatment Period|Lost to Follow-up|0
5047963|NCT02584855|17398966|P1|Open-Label Treatment Period|Lost to Follow-up|1
5047964|NCT02584855|17398961|P6|Open-Label Treatment Period|Death|0
5047965|NCT02584855|17398962|P5|Open-Label Treatment Period|Death|0
5047966|NCT02584855|17398963|P4|Open-Label Treatment Period|Death|0
5047967|NCT02584855|17398964|P3|Open-Label Treatment Period|Death|0
5047968|NCT02584855|17398965|P2|Open-Label Treatment Period|Death|0
5047969|NCT02584855|17398966|P1|Open-Label Treatment Period|Death|2
5047970|NCT02584855|17398961|P6|Open-Label Treatment Period|Adverse Event|0
5047971|NCT02584855|17398962|P5|Open-Label Treatment Period|Adverse Event|0
5047972|NCT02584855|17398963|P4|Open-Label Treatment Period|Adverse Event|0
5047973|NCT02584855|17398964|P3|Open-Label Treatment Period|Adverse Event|0
5047974|NCT02584855|17398965|P2|Open-Label Treatment Period|Adverse Event|0
5047975|NCT02584855|17398966|P1|Open-Label Treatment Period|Adverse Event|14
5047976|NCT02584855|17398961|P6|Open-Label Treatment Period|Withdrawal by Subject|0
5047977|NCT02584855|17398962|P5|Open-Label Treatment Period|Withdrawal by Subject|0
5047978|NCT02584855|17398963|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5047979|NCT02584855|17398964|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5047980|NCT02584855|17398965|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5047981|NCT02584855|17398966|P1|Open-Label Treatment Period|Withdrawal by Subject|21
5047982|NCT02584855|17398961|P6|Open-Label Treatment Period|Lack of Efficacy|0
5047983|NCT02584855|17398962|P5|Open-Label Treatment Period|Lack of Efficacy|0
5047984|NCT02584855|17398963|P4|Open-Label Treatment Period|Lack of Efficacy|0
5047985|NCT02584855|17398964|P3|Open-Label Treatment Period|Lack of Efficacy|0
5047986|NCT02584855|17398965|P2|Open-Label Treatment Period|Lack of Efficacy|0
5047987|NCT02584855|17398966|P1|Open-Label Treatment Period|Lack of Efficacy|61
5047988|NCT02584660|17399098|P2|Overall Study|Other|1
5047989|NCT02584660|17399099|P1|Overall Study|Other|0
5047990|NCT02584660|17399098|P2|Overall Study|Withdrawal by Subject|2
5047991|NCT02584660|17399099|P1|Overall Study|Withdrawal by Subject|0
5047992|NCT02584660|17399098|P2|Overall Study|Protocol Violation|1
5047993|NCT02584660|17399099|P1|Overall Study|Protocol Violation|0
5047994|NCT02584660|17399098|P2|Overall Study|Lost to Follow-up|4
5047995|NCT02584660|17399099|P1|Overall Study|Lost to Follow-up|3
5047996|NCT02584660|17399098|P2|Overall Study|Adverse Event|0
5047997|NCT02584660|17399099|P1|Overall Study|Adverse Event|4
5047998|NCT02584504|17399118|P3|Open-label Treatment|Entered but not treated|1
5047999|NCT02584504|17399119|P2|Open-label Treatment|Entered but not treated|1
5048000|NCT02584504|17399120|P1|Open-label Treatment|Entered but not treated|0
5048001|NCT02584504|17399118|P3|Open-label Treatment|Physician Decision|0
5048002|NCT02584504|17399119|P2|Open-label Treatment|Physician Decision|1
5048003|NCT02584504|17399120|P1|Open-label Treatment|Physician Decision|0
5048004|NCT02584504|17399118|P3|Open-label Treatment|Adverse Event|3
5048005|NCT02584504|17399119|P2|Open-label Treatment|Adverse Event|2
5048006|NCT02584504|17399120|P1|Open-label Treatment|Adverse Event|2
5048007|NCT02584504|17399118|P3|Open-label Treatment|Participant withdrew consent|4
5048008|NCT02584504|17399119|P2|Open-label Treatment|Participant withdrew consent|0
5048009|NCT02584504|17399120|P1|Open-label Treatment|Participant withdrew consent|0
5048010|NCT02584504|17399118|P3|Double-blind Treatment|Family Matter|0
5048011|NCT02584504|17399119|P2|Double-blind Treatment|Family Matter|1
5048012|NCT02584504|17399120|P1|Double-blind Treatment|Family Matter|0
5048013|NCT02584504|17399118|P3|Double-blind Treatment|Adverse Event|0
5048014|NCT02584504|17399119|P2|Double-blind Treatment|Adverse Event|1
5048015|NCT02584504|17399120|P1|Double-blind Treatment|Adverse Event|0
5048016|NCT02584504|17399118|P3|Double-blind Treatment|Participant withdrew consent|1
5048017|NCT02584504|17399119|P2|Double-blind Treatment|Participant withdrew consent|0
5048018|NCT02584504|17399120|P1|Double-blind Treatment|Participant withdrew consent|0
5048019|NCT02584452|17399176|P2|Overall Study|Lost to Follow-up|1
5048020|NCT02584452|17399177|P1|Overall Study|Lost to Follow-up|1
5048021|NCT02584452|17399176|P2|Overall Study|Physician Decision|1
5048022|NCT02584452|17399177|P1|Overall Study|Physician Decision|1
5048023|NCT02584257|17399205|P9|Period 2|Adverse Event|0
5048024|NCT02584257|17399206|P8|Period 2|Adverse Event|0
5048025|NCT02584257|17399207|P7|Period 2|Adverse Event|0
5048026|NCT02584257|17399208|P6|Period 2|Adverse Event|0
5048027|NCT02584257|17399209|P5|Period 2|Adverse Event|0
5048028|NCT02584257|17399210|P4|Period 2|Adverse Event|0
5048029|NCT02584257|17399211|P3|Period 2|Adverse Event|0
5048030|NCT02584257|17399212|P2|Period 2|Adverse Event|1
5048031|NCT02584257|17399213|P1|Period 2|Adverse Event|0
5048032|NCT02584257|17399205|P9|Period 2|Physician Decision|0
5048033|NCT02584257|17399206|P8|Period 2|Physician Decision|0
5048034|NCT02584257|17399207|P7|Period 2|Physician Decision|0
5048035|NCT02584257|17399208|P6|Period 2|Physician Decision|0
5048036|NCT02584257|17399209|P5|Period 2|Physician Decision|0
5048037|NCT02584257|17399210|P4|Period 2|Physician Decision|0
5048038|NCT02584257|17399211|P3|Period 2|Physician Decision|0
5048039|NCT02584257|17399212|P2|Period 2|Physician Decision|0
5048040|NCT02584257|17399213|P1|Period 2|Physician Decision|1
5048041|NCT02584257|17399205|P9|Period 1|Withdrawal by Subject|0
5048042|NCT02584257|17399206|P8|Period 1|Withdrawal by Subject|0
5048043|NCT02584257|17399207|P7|Period 1|Withdrawal by Subject|1
5048044|NCT02584257|17399208|P6|Period 1|Withdrawal by Subject|0
5048045|NCT02584257|17399209|P5|Period 1|Withdrawal by Subject|0
5048046|NCT02584257|17399210|P4|Period 1|Withdrawal by Subject|0
5048047|NCT02584257|17399211|P3|Period 1|Withdrawal by Subject|0
5048048|NCT02584257|17399212|P2|Period 1|Withdrawal by Subject|0
5048049|NCT02584257|17399213|P1|Period 1|Withdrawal by Subject|0
5048050|NCT02583477|17399234|P2|Overall Study|Study terminated|2
5048051|NCT02583477|17399235|P1|Overall Study|Study terminated|2
5048052|NCT02583477|17399234|P2|Overall Study|Death|16
5048053|NCT02583477|17399235|P1|Overall Study|Death|1
5048054|NCT02583477|17399234|P2|Overall Study|Adverse Event|2
5048055|NCT02583477|17399235|P1|Overall Study|Adverse Event|0
5048056|NCT02583425|17399255|P1|Treatment Period|Adverse Event|1
5048057|NCT02583425|17399255|P1|Baseline|Did not meet continued criteria|5
5048058|NCT02583425|17399255|P1|Screening|Did not meet entry criteria|12
5048059|NCT02583399|17399260|P1|Overall Study|Wanted to use a restricted medication|3
5048060|NCT02583399|17399260|P1|Overall Study|Able to be discharged|3
5048061|NCT02583269|17399272|P5|Overall Study|Patient hospitalized prior to start|0
5048062|NCT02583269|17399273|P4|Overall Study|Patient hospitalized prior to start|0
5048063|NCT02583269|17399274|P3|Overall Study|Patient hospitalized prior to start|0
5048064|NCT02583269|17399275|P2|Overall Study|Patient hospitalized prior to start|0
5048065|NCT02583269|17399276|P1|Overall Study|Patient hospitalized prior to start|1
5048066|NCT02583256|17399305|P4|Overall Study|Administrative/Other|2
5048067|NCT02583256|17399306|P3|Overall Study|Administrative/Other|1
5048068|NCT02583256|17399307|P2|Overall Study|Administrative/Other|0
5048069|NCT02583256|17399308|P1|Overall Study|Administrative/Other|2
5048070|NCT02583256|17399305|P4|Overall Study|Lost to Follow-up|1
5048071|NCT02583256|17399306|P3|Overall Study|Lost to Follow-up|0
5048072|NCT02583256|17399307|P2|Overall Study|Lost to Follow-up|1
5048073|NCT02583256|17399308|P1|Overall Study|Lost to Follow-up|1
5048074|NCT02583256|17399305|P4|Overall Study|Withdrawal by Subject|0
5048075|NCT02583256|17399306|P3|Overall Study|Withdrawal by Subject|1
5048076|NCT02583256|17399307|P2|Overall Study|Withdrawal by Subject|1
5048077|NCT02583256|17399308|P1|Overall Study|Withdrawal by Subject|0
5048078|NCT02583048|17399405|P3|Overall Study|Failed to meet eligibility criterion|1
5048079|NCT02583048|17399406|P2|Overall Study|Failed to meet eligibility criterion|0
5048080|NCT02583048|17399407|P1|Overall Study|Failed to meet eligibility criterion|0
5048081|NCT02583048|17399405|P3|Overall Study|Withdrawal by Subject|0
5048082|NCT02583048|17399406|P2|Overall Study|Withdrawal by Subject|1
5048083|NCT02583048|17399407|P1|Overall Study|Withdrawal by Subject|0
5048084|NCT02582983|17399442|P1|Overall Study|Adverse Event|1
5048085|NCT02582983|17399442|P1|Overall Study|Withdrawal by Subject|2
5048086|NCT02582983|17399442|P1|Overall Study|Death|3
5048087|NCT02582814|17399505|P2|Overall Study|Adverse Event|4
5048088|NCT02582814|17399506|P1|Overall Study|Adverse Event|4
5048089|NCT02582814|17399505|P2|Overall Study|Withdrawal by Subject|3
5048090|NCT02582814|17399506|P1|Overall Study|Withdrawal by Subject|4
5048091|NCT02582814|17399505|P2|Overall Study|Study-specific withdrawal criteria|0
5048092|NCT02582814|17399506|P1|Overall Study|Study-specific withdrawal criteria|1
5048093|NCT02582749|17399546|P2|Overall Study|Withdrawal by Subject|1
5048094|NCT02582749|17399547|P1|Overall Study|Withdrawal by Subject|0
5048095|NCT02582749|17399546|P2|Overall Study|Study terminated by funder|10
5048096|NCT02582749|17399547|P1|Overall Study|Study terminated by funder|5
5048097|NCT02582684|17399577|P1|Overall Study|Found to be ineligible after enrollment|2
5048098|NCT02582684|17399577|P1|Overall Study|Subject withdrew consent|1
5048099|NCT02582684|17399577|P1|Overall Study|Subject not able to get to clinic|10
5048100|NCT02582684|17399577|P1|Overall Study|Unable to contact subject/parent|4
5048101|NCT02582671|17399596|P1|Overall Study|Other, not specified|1
5048102|NCT02582671|17399596|P1|Overall Study|Failure to return|1
5048103|NCT02582658|17399608|P1|Overall Study|Not further specified|11
5048104|NCT02582658|17399608|P1|Overall Study|Death|1
5048105|NCT02582658|17399608|P1|Overall Study|Withdrawn Consent|1
5048106|NCT02582658|17399608|P1|Overall Study|Insufficient Virological Response|2
5048107|NCT02582658|17399608|P1|Overall Study|Failure to Return|10
5048108|NCT02582632|17399626|P1|Overall Study|Other|1
5048109|NCT02582515|17399641|P2|Overall Study|Withdrawal by Subject|1
5048110|NCT02582515|17399642|P1|Overall Study|Withdrawal by Subject|0
5048111|NCT02582255|17399650|P2|Overall Study|Protocol Violation|3
5048112|NCT02582255|17399651|P1|Overall Study|Protocol Violation|0
5048113|NCT02582242|17399664|P2|Overall Study|Unclassified|1
5048114|NCT02582242|17399665|P1|Overall Study|Unclassified|2
5048115|NCT02582242|17399664|P2|Overall Study|Withdrawal by Subject|11
5048116|NCT02582242|17399665|P1|Overall Study|Withdrawal by Subject|11
5048117|NCT02582242|17399664|P2|Overall Study|Lost to Follow-up|1
5048118|NCT02582242|17399665|P1|Overall Study|Lost to Follow-up|0
5048119|NCT02582242|17399664|P2|Overall Study|Protocol Violation|1
5048120|NCT02582242|17399665|P1|Overall Study|Protocol Violation|3
5048121|NCT02582242|17399664|P2|Overall Study|Adverse Event|3
5048122|NCT02582242|17399665|P1|Overall Study|Adverse Event|4
5048123|NCT02581995|17399729|P1|Overall Study|Death|4
5048124|NCT02581995|17399729|P1|Overall Study|Physician Decision|1
5048125|NCT02581995|17399729|P1|Overall Study|Withdrawal by participant|12
5048126|NCT02581995|17399729|P1|Overall Study|Lost to Follow-up|5
5048127|NCT02581995|17399729|P1|Overall Study|Adverse Event|6
5048128|NCT02581995|17399729|P1|Overall Study|Unspecified other|3
5048129|NCT02581930|17399743|P1|Overall Study|patient declined further treatment|1
5048130|NCT02581930|17399743|P1|Overall Study|Withdrawal by Subject|1
5048131|NCT02581891|17399751|P2|Overall Study|Discontinued during followup|0
5048132|NCT02581891|17399752|P1|Overall Study|Discontinued during followup|1
5048133|NCT02581891|17399751|P2|Overall Study|Other Reasons|1
5048134|NCT02581891|17399752|P1|Overall Study|Other Reasons|3
5048135|NCT02581891|17399751|P2|Overall Study|Withdrawal by Subject|5
5048136|NCT02581891|17399752|P1|Overall Study|Withdrawal by Subject|4
5048137|NCT02581891|17399751|P2|Overall Study|Physician Decision|1
5048138|NCT02581891|17399752|P1|Overall Study|Physician Decision|0
5048139|NCT02581891|17399751|P2|Overall Study|Lost to Follow-up|2
5048140|NCT02581891|17399752|P1|Overall Study|Lost to Follow-up|1
5048141|NCT02581891|17399751|P2|Overall Study|Death|4
5048142|NCT02581891|17399752|P1|Overall Study|Death|3
5048143|NCT02581891|17399751|P2|Overall Study|Adverse Event|6
5048144|NCT02581891|17399752|P1|Overall Study|Adverse Event|4
5048145|NCT02581488|17399815|P2|Overall Study|Protocol Violation|4
5048146|NCT02581488|17399816|P1|Overall Study|Protocol Violation|0
5048147|NCT02581488|17399815|P2|Overall Study|Non-Compliance|0
5048148|NCT02581488|17399816|P1|Overall Study|Non-Compliance|1
5048149|NCT02581488|17399815|P2|Overall Study|Withdrawal by Subject|0
5048150|NCT02581488|17399816|P1|Overall Study|Withdrawal by Subject|1
5048151|NCT02581488|17399815|P2|Overall Study|Lost to Follow-up|0
5048152|NCT02581488|17399816|P1|Overall Study|Lost to Follow-up|1
5048153|NCT02581488|17399815|P2|Overall Study|Adverse Event|7
5048154|NCT02581488|17399816|P1|Overall Study|Adverse Event|6
5048155|NCT02581410|17399847|P2|End of Study Phase|Other-transfer of subject not completed|1
5048156|NCT02581410|17399848|P1|End of Study Phase|Other-transfer of subject not completed|0
5048157|NCT02581410|17399847|P2|End of Study Phase|Lost to Follow-up|2
5048158|NCT02581410|17399848|P1|End of Study Phase|Lost to Follow-up|0
5048159|NCT02581410|17399847|P2|End of Study Phase|Migrated/moved from study area|3
5048160|NCT02581410|17399848|P1|End of Study Phase|Migrated/moved from study area|0
5048161|NCT02581410|17399847|P2|End of Study Phase|Withdrawal by Subject|2
5048162|NCT02581410|17399848|P1|End of Study Phase|Withdrawal by Subject|1
5048163|NCT02581410|17399847|P2|End of Study Phase|Adverse Event|3
5048164|NCT02581410|17399848|P1|End of Study Phase|Adverse Event|4
5048165|NCT02581410|17399847|P2|Vaccination Phase|Migrated/moved from study area|1
5048166|NCT02581410|17399848|P1|Vaccination Phase|Migrated/moved from study area|0
5048167|NCT02581410|17399847|P2|Vaccination Phase|Withdrawal by Subject|1
5048168|NCT02581410|17399848|P1|Vaccination Phase|Withdrawal by Subject|0
5048169|NCT02581410|17399847|P2|Vaccination Phase|Adverse Event|1
5048170|NCT02581410|17399848|P1|Vaccination Phase|Adverse Event|2
5048171|NCT02581345|17399878|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
5048172|NCT02581345|17399879|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
5048173|NCT02581345|17399880|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
5048174|NCT02581345|17399881|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
5048175|NCT02581345|17399878|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
5048176|NCT02581345|17399879|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
5048177|NCT02581345|17399880|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
5048178|NCT02581345|17399881|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
5048179|NCT02581345|17399878|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
5048180|NCT02581345|17399879|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
5048181|NCT02581345|17399880|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
5048182|NCT02581345|17399881|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
5048183|NCT02581345|17399878|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
5048184|NCT02581345|17399879|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
5048185|NCT02581345|17399880|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
5048186|NCT02581345|17399881|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
5048187|NCT02581345|17399878|P4|Part 2: Week 17 to Week 47|Physician Decision|1
5048188|NCT02581345|17399879|P3|Part 2: Week 17 to Week 47|Physician Decision|2
5048189|NCT02581345|17399880|P2|Part 2: Week 17 to Week 47|Physician Decision|0
5048190|NCT02581345|17399881|P1|Part 2: Week 17 to Week 47|Physician Decision|3
5048191|NCT02581345|17399878|P4|Part 2: Week 17 to Week 47|Adverse Event|2
5048192|NCT02581345|17399879|P3|Part 2: Week 17 to Week 47|Adverse Event|2
5048193|NCT02581345|17399880|P2|Part 2: Week 17 to Week 47|Adverse Event|0
5048194|NCT02581345|17399881|P1|Part 2: Week 17 to Week 47|Adverse Event|5
5048195|NCT02581345|17399878|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
5048196|NCT02581345|17399879|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
5048197|NCT02581345|17399880|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
5048198|NCT02581345|17399881|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
5048199|NCT02581345|17399878|P4|Part 1: up to Week 16|Unspecified Reason|0
5048200|NCT02581345|17399879|P3|Part 1: up to Week 16|Unspecified Reason|0
5048201|NCT02581345|17399880|P2|Part 1: up to Week 16|Unspecified Reason|3
5048202|NCT02581345|17399881|P1|Part 1: up to Week 16|Unspecified Reason|3
5048203|NCT02581345|17399878|P4|Part 1: up to Week 16|Lost to Follow-up|0
5048204|NCT02581345|17399879|P3|Part 1: up to Week 16|Lost to Follow-up|0
5048205|NCT02581345|17399880|P2|Part 1: up to Week 16|Lost to Follow-up|0
5048206|NCT02581345|17399881|P1|Part 1: up to Week 16|Lost to Follow-up|2
5048207|NCT02581345|17399878|P4|Part 1: up to Week 16|Withdrawal by Subject|0
5048208|NCT02581345|17399879|P3|Part 1: up to Week 16|Withdrawal by Subject|0
5048209|NCT02581345|17399880|P2|Part 1: up to Week 16|Withdrawal by Subject|7
5048210|NCT02581345|17399881|P1|Part 1: up to Week 16|Withdrawal by Subject|4
5048211|NCT02581345|17399878|P4|Part 1: up to Week 16|Physician Decision|0
5048212|NCT02581345|17399879|P3|Part 1: up to Week 16|Physician Decision|0
5048213|NCT02581345|17399880|P2|Part 1: up to Week 16|Physician Decision|4
5048214|NCT02581345|17399881|P1|Part 1: up to Week 16|Physician Decision|2
5048215|NCT02581345|17399878|P4|Part 1: up to Week 16|Adverse Event|0
5048216|NCT02581345|17399879|P3|Part 1: up to Week 16|Adverse Event|0
5048217|NCT02581345|17399880|P2|Part 1: up to Week 16|Adverse Event|8
5048218|NCT02581345|17399881|P1|Part 1: up to Week 16|Adverse Event|3
5048219|NCT02581202|17399983|P1|Overall Study|Pregnancy|3
5048220|NCT02581202|17399983|P1|Overall Study|Lost to Follow-up|5
5048221|NCT02581202|17399983|P1|Overall Study|Withdrawal by Subject|4
5048222|NCT02581202|17399983|P1|Overall Study|Lack of Efficacy|2
5048223|NCT02581189|17400022|P1|Overall Study|Other, not specified|7
5048224|NCT02581189|17400022|P1|Overall Study|Insufficient virological response|2
5048225|NCT02581189|17400022|P1|Overall Study|Death|3
5048226|NCT02581189|17400022|P1|Overall Study|Withdrew consent|5
5048227|NCT02581189|17400022|P1|Overall Study|Failure to return|36
5048228|NCT02581163|17400036|P1|Overall Study|Other, not specified|9
5048229|NCT02581163|17400036|P1|Overall Study|Death|1
5048230|NCT02581163|17400036|P1|Overall Study|Withdrew consent|1
5048231|NCT02581163|17400036|P1|Overall Study|Insufficient virological response|3
5048232|NCT02581163|17400036|P1|Overall Study|Failure to return|15
5048233|NCT02580877|17400070|P2|Overall Study|Adverse Event|1
5048234|NCT02580877|17400071|P1|Overall Study|Adverse Event|0
5048235|NCT02580877|17400070|P2|Overall Study|Withdrawal by Subject|3
5048236|NCT02580877|17400071|P1|Overall Study|Withdrawal by Subject|1
5048237|NCT02580591|17400105|P4|Overall Study|Other than specified|2
5048238|NCT02580591|17400106|P3|Overall Study|Other than specified|5
5048239|NCT02580591|17400107|P2|Overall Study|Other than specified|2
5048240|NCT02580591|17400108|P1|Overall Study|Other than specified|3
5048241|NCT02580591|17400105|P4|Overall Study|Not treated|0
5048242|NCT02580591|17400106|P3|Overall Study|Not treated|0
5048243|NCT02580591|17400107|P2|Overall Study|Not treated|1
5048244|NCT02580591|17400108|P1|Overall Study|Not treated|1
5048245|NCT02580591|17400105|P4|Overall Study|Withdrawal by Subject|3
5048246|NCT02580591|17400106|P3|Overall Study|Withdrawal by Subject|2
5048247|NCT02580591|17400107|P2|Overall Study|Withdrawal by Subject|1
5048248|NCT02580591|17400108|P1|Overall Study|Withdrawal by Subject|6
5048249|NCT02580591|17400105|P4|Overall Study|Lost to Follow-up|1
5048250|NCT02580591|17400106|P3|Overall Study|Lost to Follow-up|3
5048251|NCT02580591|17400107|P2|Overall Study|Lost to Follow-up|3
5048252|NCT02580591|17400108|P1|Overall Study|Lost to Follow-up|5
5048253|NCT02580591|17400105|P4|Overall Study|Protocol Violation|1
5048254|NCT02580591|17400106|P3|Overall Study|Protocol Violation|1
5048255|NCT02580591|17400107|P2|Overall Study|Protocol Violation|2
5048256|NCT02580591|17400108|P1|Overall Study|Protocol Violation|3
5048257|NCT02580591|17400105|P4|Overall Study|Adverse Event|5
5048258|NCT02580591|17400106|P3|Overall Study|Adverse Event|2
5048259|NCT02580591|17400107|P2|Overall Study|Adverse Event|1
5048260|NCT02580591|17400108|P1|Overall Study|Adverse Event|0
5048261|NCT02580357|17400141|P3|Overall Study|Protocol Violation|0
5048262|NCT02580357|17400142|P2|Overall Study|Protocol Violation|0
5048263|NCT02580357|17400143|P1|Overall Study|Protocol Violation|1
5048264|NCT02580357|17400141|P3|Overall Study|Lost to Follow-up|0
5048265|NCT02580357|17400142|P2|Overall Study|Lost to Follow-up|0
5048266|NCT02580357|17400143|P1|Overall Study|Lost to Follow-up|2
5048267|NCT02580240|17400160|P2|Overall Study|Physician Decision|0
5048268|NCT02580240|17400161|P1|Overall Study|Physician Decision|2
5048269|NCT02580058|17400199|P3|Overall Study|Withdrawal by Subject|36
5048270|NCT02580058|17400200|P2|Overall Study|Withdrawal by Subject|26
5048271|NCT02580058|17400201|P1|Overall Study|Withdrawal by Subject|24
5048272|NCT02580058|17400199|P3|Overall Study|Ongoing|46
5048273|NCT02580058|17400200|P2|Overall Study|Ongoing|55
5048274|NCT02580058|17400201|P1|Overall Study|Ongoing|51
5048275|NCT02580058|17400199|P3|Overall Study|Lost to Follow-up|4
5048276|NCT02580058|17400200|P2|Overall Study|Lost to Follow-up|5
5048277|NCT02580058|17400201|P1|Overall Study|Lost to Follow-up|4
5048278|NCT02579928|17400268|P2|Overall Study|Withdrawal by Subject|0
5048279|NCT02579928|17400269|P1|Overall Study|Withdrawal by Subject|1
5048280|NCT02579863|17400309|P2|Overall Study|Withdrawal by Subject|19
5048281|NCT02579863|17400310|P1|Overall Study|Withdrawal by Subject|17
5048282|NCT02579863|17400309|P2|Overall Study|Study Terminated at Selected Sites|3
5048283|NCT02579863|17400310|P1|Overall Study|Study Terminated at Selected Sites|3
5048284|NCT02579863|17400309|P2|Overall Study|Screen Failure|2
5048285|NCT02579863|17400310|P1|Overall Study|Screen Failure|1
5048286|NCT02579863|17400309|P2|Overall Study|Physician Decision|2
5048287|NCT02579863|17400310|P1|Overall Study|Physician Decision|0
5048288|NCT02579863|17400309|P2|Overall Study|Lost to Follow-up|1
5048289|NCT02579863|17400310|P1|Overall Study|Lost to Follow-up|2
5048290|NCT02579863|17400309|P2|Overall Study|Death|3
5048291|NCT02579863|17400310|P1|Overall Study|Death|11
5048292|NCT02579863|17400309|P2|Overall Study|Adverse Event|12
5048293|NCT02579863|17400310|P1|Overall Study|Adverse Event|17
5048294|NCT02579863|17400309|P2|Overall Study|Ongoing in Trial|112
5048295|NCT02579863|17400310|P1|Overall Study|Ongoing in Trial|105
5048296|NCT02579772|17400337|P2|Overall Study|flu-like illness, orthopedic trauma|1
5048297|NCT02579772|17400338|P1|Overall Study|flu-like illness, orthopedic trauma|1
5048298|NCT02579772|17400337|P2|Overall Study|Usage of additional antioxidants|0
5048299|NCT02579772|17400338|P1|Overall Study|Usage of additional antioxidants|1
5048300|NCT02579772|17400337|P2|Overall Study|Withdrawal by Subject|1
5048301|NCT02579772|17400338|P1|Overall Study|Withdrawal by Subject|0
5048302|NCT02579759|17400359|P3|Overall Study|Lost to Follow-up|2
5048303|NCT02579759|17400360|P2|Overall Study|Lost to Follow-up|2
5048304|NCT02579759|17400361|P1|Overall Study|Lost to Follow-up|2
5048305|NCT02579759|17400359|P3|Overall Study|Withdrawal by Subject|5
5048306|NCT02579759|17400360|P2|Overall Study|Withdrawal by Subject|3
5048307|NCT02579759|17400361|P1|Overall Study|Withdrawal by Subject|3
5048308|NCT02579759|17400359|P3|Overall Study|Adverse Event|1
5048309|NCT02579759|17400360|P2|Overall Study|Adverse Event|3
5048310|NCT02579759|17400361|P1|Overall Study|Adverse Event|4
5048311|NCT02579759|17400359|P3|Overall Study|Inclusion/exclusion criteria|1
5048312|NCT02579759|17400360|P2|Overall Study|Inclusion/exclusion criteria|0
5048313|NCT02579759|17400361|P1|Overall Study|Inclusion/exclusion criteria|0
5048314|NCT02579759|17400359|P3|Overall Study|Pregnancy|0
5048315|NCT02579759|17400360|P2|Overall Study|Pregnancy|1
5048316|NCT02579759|17400361|P1|Overall Study|Pregnancy|0
5048317|NCT02579759|17400359|P3|Overall Study|Non compliance|0
5048318|NCT02579759|17400360|P2|Overall Study|Non compliance|1
5048319|NCT02579759|17400361|P1|Overall Study|Non compliance|0
5048320|NCT02579759|17400359|P3|Overall Study|Sponsor stopped Dose 2|0
5048321|NCT02579759|17400360|P2|Overall Study|Sponsor stopped Dose 2|41
5048322|NCT02579759|17400361|P1|Overall Study|Sponsor stopped Dose 2|0
5048323|NCT02579759|17400359|P3|Overall Study|BfArM hold|12
5048324|NCT02579759|17400360|P2|Overall Study|BfArM hold|12
5048325|NCT02579759|17400361|P1|Overall Study|BfArM hold|13
5048326|NCT02579759|17400359|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
5048327|NCT02579759|17400360|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
5048328|NCT02579759|17400361|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
5048329|NCT02579759|17400359|P3|Overall Study|Protocol Violation|0
5048330|NCT02579759|17400360|P2|Overall Study|Protocol Violation|0
5048331|NCT02579759|17400361|P1|Overall Study|Protocol Violation|2
5048332|NCT02579629|17400408|P3|Overall Study|Screen Failure|2
5048333|NCT02579629|17400409|P2|Overall Study|Screen Failure|0
5048334|NCT02579629|17400410|P1|Overall Study|Screen Failure|2
5048335|NCT02579629|17400408|P3|Overall Study|Withdrawal by Subject|0
5048336|NCT02579629|17400409|P2|Overall Study|Withdrawal by Subject|1
5048337|NCT02579629|17400410|P1|Overall Study|Withdrawal by Subject|0
5048338|NCT02579603|17400459|P2|Overall Study|Other than stated|0
5048339|NCT02579603|17400460|P1|Overall Study|Other than stated|1
5048340|NCT02579603|17400459|P2|Overall Study|Adverse Event|2
5048341|NCT02579603|17400460|P1|Overall Study|Adverse Event|2
5048342|NCT02579603|17400459|P2|Overall Study|Not treated|0
5048343|NCT02579603|17400460|P1|Overall Study|Not treated|1
5048344|NCT02579382|17400490|P4|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5048345|NCT02579382|17400491|P3|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5048346|NCT02579382|17400492|P2|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
5048347|NCT02579382|17400493|P1|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5048348|NCT02579382|17400490|P4|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5048349|NCT02579382|17400491|P3|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5048350|NCT02579382|17400492|P2|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
5048351|NCT02579382|17400493|P1|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5048352|NCT02579382|17400490|P4|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5048353|NCT02579382|17400491|P3|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5048354|NCT02579382|17400492|P2|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
5048355|NCT02579382|17400493|P1|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5048356|NCT02579382|17400490|P4|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5048357|NCT02579382|17400491|P3|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5048358|NCT02579382|17400492|P2|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5048359|NCT02579382|17400493|P1|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
5048360|NCT02579382|17400490|P4|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
5048361|NCT02579382|17400491|P3|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
5048362|NCT02579382|17400492|P2|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
5048363|NCT02579382|17400493|P1|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
5048364|NCT02579382|17400490|P4|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
5048365|NCT02579382|17400491|P3|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
5048366|NCT02579382|17400492|P2|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
5048367|NCT02579382|17400493|P1|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
5048368|NCT02579382|17400490|P4|Main Study Phase|Lack of Efficacy|1
5048369|NCT02579382|17400491|P3|Main Study Phase|Lack of Efficacy|0
5048370|NCT02579382|17400492|P2|Main Study Phase|Lack of Efficacy|0
5048371|NCT02579382|17400493|P1|Main Study Phase|Lack of Efficacy|0
5048372|NCT02579382|17400490|P4|Main Study Phase|Withdrew Consent|2
5048373|NCT02579382|17400491|P3|Main Study Phase|Withdrew Consent|0
5048374|NCT02579382|17400492|P2|Main Study Phase|Withdrew Consent|0
5048375|NCT02579382|17400493|P1|Main Study Phase|Withdrew Consent|0
5048376|NCT02579382|17400490|P4|Main Study Phase|Lost to Follow-up|0
5048377|NCT02579382|17400491|P3|Main Study Phase|Lost to Follow-up|2
5048378|NCT02579382|17400492|P2|Main Study Phase|Lost to Follow-up|0
5048379|NCT02579382|17400493|P1|Main Study Phase|Lost to Follow-up|0
5048380|NCT02578992|17400615|P2|Overall Study|equipment not available or malfunction|3
5048381|NCT02578992|17400616|P1|Overall Study|equipment not available or malfunction|3
5048382|NCT02578940|17400628|P1|Overall Study|Lost to Follow-up|1
5048383|NCT02578940|17400628|P1|Overall Study|Screening failure|5
5048384|NCT02578862|17400637|P2|Overall Study|Unplanned unilateral procedure|1
5048385|NCT02578862|17400638|P1|Overall Study|Unplanned unilateral procedure|0
5048386|NCT02578862|17400637|P2|Overall Study|Withdrawal by Subject|1
5048387|NCT02578862|17400638|P1|Overall Study|Withdrawal by Subject|0
5048388|NCT02578706|17400676|P3|Overall Study|Physician Decision|0
5048389|NCT02578706|17400677|P2|Overall Study|Physician Decision|1
5048390|NCT02578706|17400678|P1|Overall Study|Physician Decision|0
5048391|NCT02578706|17400676|P3|Overall Study|Lost to Follow-up|0
5048392|NCT02578706|17400677|P2|Overall Study|Lost to Follow-up|4
5048393|NCT02578706|17400678|P1|Overall Study|Lost to Follow-up|0
5048394|NCT02578706|17400676|P3|Overall Study|Withdrawal by Subject|0
5048395|NCT02578706|17400677|P2|Overall Study|Withdrawal by Subject|0
5048396|NCT02578706|17400678|P1|Overall Study|Withdrawal by Subject|1
5048397|NCT02578680|17400757|P2|Overall Study|Ongoing in Study|96
5048398|NCT02578680|17400758|P1|Overall Study|Ongoing in Study|276
5048399|NCT02578680|17400757|P2|Overall Study|Withdrawal by Subject|5
5048400|NCT02578680|17400758|P1|Overall Study|Withdrawal by Subject|8
5048401|NCT02578680|17400757|P2|Overall Study|Withdrawal by Parent/Guardian|0
5048402|NCT02578680|17400758|P1|Overall Study|Withdrawal by Parent/Guardian|1
5048403|NCT02578680|17400757|P2|Overall Study|Protocol Violation|1
5048404|NCT02578680|17400758|P1|Overall Study|Protocol Violation|1
5048405|NCT02578680|17400757|P2|Overall Study|Death|104
5048406|NCT02578680|17400758|P1|Overall Study|Death|124
5048407|NCT02578316|17400774|P1|Extension Phase|Progression of disease|6
5048408|NCT02578186|17400807|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
5048409|NCT02578186|17400808|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
5048410|NCT02578186|17400807|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
5048411|NCT02578186|17400808|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
5048412|NCT02577887|17400897|P1|Overall Study|Withdrawal by Subject|80
5048413|NCT02577887|17400897|P1|Overall Study|Protocol Violation|125
5048414|NCT02577887|17400897|P1|Overall Study|Death|93
5048415|NCT02577718|17400923|P1|Overall Study|Withdrawal by Subject|2
5048416|NCT02577718|17400923|P1|Overall Study|Death|6
5048417|NCT02577354|17400965|P2|Overall Study|Adverse Event|5
5048418|NCT02577354|17400966|P1|Overall Study|Adverse Event|4
5048419|NCT02577354|17400965|P2|Overall Study|Missed Visit|3
5048420|NCT02577354|17400966|P1|Overall Study|Missed Visit|4
5048421|NCT02577354|17400965|P2|Overall Study|Lost to Follow-up|1
5048422|NCT02577354|17400966|P1|Overall Study|Lost to Follow-up|3
5048423|NCT02577354|17400965|P2|Overall Study|Lack of Efficacy|4
5048424|NCT02577354|17400966|P1|Overall Study|Lack of Efficacy|4
5048425|NCT02577315|17401026|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5048426|NCT02577315|17401027|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5048427|NCT02577146|17401043|P1|Overall Study|Screen Failure|17
5048428|NCT02577146|17401043|P1|Overall Study|Physician Decision|3
5048429|NCT02577146|17401043|P1|Overall Study|Lost to Follow-up|8
5048430|NCT02577107|17401050|P2|Overall Study|Protocol deviation|1
5048431|NCT02577107|17401051|P1|Overall Study|Protocol deviation|0
5048432|NCT02577029|17401118|P8|Overall Study|Sponsor Termination of the Study|12
5048433|NCT02577029|17401119|P7|Overall Study|Sponsor Termination of the Study|12
5048434|NCT02577029|17401120|P6|Overall Study|Sponsor Termination of the Study|12
5048435|NCT02577029|17401121|P5|Overall Study|Sponsor Termination of the Study|10
5048436|NCT02577029|17401122|P4|Overall Study|Sponsor Termination of the Study|12
5048437|NCT02577029|17401123|P3|Overall Study|Sponsor Termination of the Study|5
5048438|NCT02577029|17401124|P2|Overall Study|Sponsor Termination of the Study|2
5048439|NCT02577029|17401125|P1|Overall Study|Sponsor Termination of the Study|9
5048440|NCT02577029|17401118|P8|Overall Study|Withdrawal by Subject|0
5048441|NCT02577029|17401119|P7|Overall Study|Withdrawal by Subject|0
5048442|NCT02577029|17401120|P6|Overall Study|Withdrawal by Subject|1
5048443|NCT02577029|17401121|P5|Overall Study|Withdrawal by Subject|0
5048444|NCT02577029|17401122|P4|Overall Study|Withdrawal by Subject|0
5048445|NCT02577029|17401123|P3|Overall Study|Withdrawal by Subject|0
5048446|NCT02577029|17401124|P2|Overall Study|Withdrawal by Subject|0
5048447|NCT02577029|17401125|P1|Overall Study|Withdrawal by Subject|0
5048448|NCT02577029|17401118|P8|Overall Study|Adverse Event|0
5048449|NCT02577029|17401119|P7|Overall Study|Adverse Event|0
5048450|NCT02577029|17401120|P6|Overall Study|Adverse Event|0
5048451|NCT02577029|17401121|P5|Overall Study|Adverse Event|1
5048452|NCT02577029|17401122|P4|Overall Study|Adverse Event|0
5048453|NCT02577029|17401123|P3|Overall Study|Adverse Event|2
5048454|NCT02577029|17401124|P2|Overall Study|Adverse Event|0
5048455|NCT02577029|17401125|P1|Overall Study|Adverse Event|1
5048456|NCT02577016|17401233|P2|Overall Study|Physician Decision|1
5048457|NCT02577016|17401234|P1|Overall Study|Physician Decision|0
5048458|NCT02577016|17401233|P2|Overall Study|Adverse Event|1
5048459|NCT02577016|17401234|P1|Overall Study|Adverse Event|2
5048460|NCT02577003|17401252|P2|Overall Study|Withdrawal by Subject|1
5048461|NCT02577003|17401253|P1|Overall Study|Withdrawal by Subject|0
5048462|NCT02577003|17401252|P2|Overall Study|Adverse Event|4
5048463|NCT02577003|17401253|P1|Overall Study|Adverse Event|2
5048464|NCT02576990|17401273|P2|Overall Study|Clinical Progression|4
5048465|NCT02576990|17401274|P1|Overall Study|Clinical Progression|13
5048466|NCT02576990|17401273|P2|Overall Study|Did not receive study treatment|1
5048467|NCT02576990|17401274|P1|Overall Study|Did not receive study treatment|3
5048468|NCT02576990|17401273|P2|Overall Study|Withdrawal by Subject|2
5048469|NCT02576990|17401274|P1|Overall Study|Withdrawal by Subject|0
5048470|NCT02576990|17401273|P2|Overall Study|Complete Response|0
5048471|NCT02576990|17401274|P1|Overall Study|Complete Response|1
5048472|NCT02576990|17401273|P2|Overall Study|Adverse Event|4
5048473|NCT02576990|17401274|P1|Overall Study|Adverse Event|6
5048474|NCT02576990|17401273|P2|Overall Study|Progressive Disease|12
5048475|NCT02576990|17401274|P1|Overall Study|Progressive Disease|17
5048476|NCT02576990|17401273|P2|Overall Study|Physician Decision|1
5048477|NCT02576990|17401274|P1|Overall Study|Physician Decision|3
5048478|NCT02576977|17401302|P2|Overall Study|Ongoing in trial|77
5048479|NCT02576977|17401303|P1|Overall Study|Ongoing in trial|53
5048480|NCT02576977|17401302|P2|Overall Study|Withdrawal by Subject|9
5048481|NCT02576977|17401303|P1|Overall Study|Withdrawal by Subject|9
5048482|NCT02576977|17401302|P2|Overall Study|Study Terminated at Selected Sites|2
5048483|NCT02576977|17401303|P1|Overall Study|Study Terminated at Selected Sites|3
5048484|NCT02576977|17401302|P2|Overall Study|Screen failure|0
5048485|NCT02576977|17401303|P1|Overall Study|Screen failure|1
5048486|NCT02576977|17401302|P2|Overall Study|Death|35
5048487|NCT02576977|17401303|P1|Overall Study|Death|47
5048488|NCT02576977|17401302|P2|Overall Study|Adverse Event|2
5048489|NCT02576977|17401303|P1|Overall Study|Adverse Event|13
5048490|NCT02576951|17401325|P4|Overall Study|Protocol Violation|1
5048491|NCT02576951|17401326|P3|Overall Study|Protocol Violation|0
5048492|NCT02576951|17401327|P2|Overall Study|Protocol Violation|0
5048493|NCT02576951|17401328|P1|Overall Study|Protocol Violation|0
5048494|NCT02576951|17401325|P4|Overall Study|Withdrawal by Subject|2
5048495|NCT02576951|17401326|P3|Overall Study|Withdrawal by Subject|0
5048496|NCT02576951|17401327|P2|Overall Study|Withdrawal by Subject|0
5048497|NCT02576951|17401328|P1|Overall Study|Withdrawal by Subject|1
5048498|NCT02576951|17401325|P4|Overall Study|Lost to Follow-up|2
5048499|NCT02576951|17401326|P3|Overall Study|Lost to Follow-up|2
5048500|NCT02576951|17401327|P2|Overall Study|Lost to Follow-up|0
5048501|NCT02576951|17401328|P1|Overall Study|Lost to Follow-up|0
5048502|NCT02576938|17401352|P3|Overall Study|Met Exclusion Criteria|0
5048503|NCT02576938|17401353|P2|Overall Study|Met Exclusion Criteria|1
5048504|NCT02576938|17401354|P1|Overall Study|Met Exclusion Criteria|0
5048505|NCT02576938|17401352|P3|Overall Study|Physician Decision|0
5048506|NCT02576938|17401353|P2|Overall Study|Physician Decision|1
5048507|NCT02576938|17401354|P1|Overall Study|Physician Decision|0
5048508|NCT02576938|17401352|P3|Overall Study|Lost to Follow-up|1
5048509|NCT02576938|17401353|P2|Overall Study|Lost to Follow-up|0
5048510|NCT02576938|17401354|P1|Overall Study|Lost to Follow-up|2
5048511|NCT02576938|17401352|P3|Overall Study|Lack of Efficacy|0
5048512|NCT02576938|17401353|P2|Overall Study|Lack of Efficacy|4
5048513|NCT02576938|17401354|P1|Overall Study|Lack of Efficacy|9
5048514|NCT02576938|17401352|P3|Overall Study|Withdrawal by Subject|4
5048515|NCT02576938|17401353|P2|Overall Study|Withdrawal by Subject|2
5048516|NCT02576938|17401354|P1|Overall Study|Withdrawal by Subject|3
5048517|NCT02576938|17401352|P3|Overall Study|Protocol Violation|1
5048518|NCT02576938|17401353|P2|Overall Study|Protocol Violation|1
5048519|NCT02576938|17401354|P1|Overall Study|Protocol Violation|1
5048520|NCT02576938|17401352|P3|Overall Study|Adverse Event|6
5048521|NCT02576938|17401353|P2|Overall Study|Adverse Event|3
5048522|NCT02576938|17401354|P1|Overall Study|Adverse Event|5
5048523|NCT02576678|17401400|P3|Overall Study|Miscellaneous|0
5048524|NCT02576678|17401401|P2|Overall Study|Miscellaneous|0
5048525|NCT02576678|17401402|P1|Overall Study|Miscellaneous|2
5048526|NCT02576678|17401400|P3|Overall Study|Lost to Follow-up|1
5048527|NCT02576678|17401401|P2|Overall Study|Lost to Follow-up|0
5048528|NCT02576678|17401402|P1|Overall Study|Lost to Follow-up|0
5048529|NCT02576678|17401400|P3|Overall Study|Withdrawal by Subject|2
5048530|NCT02576678|17401401|P2|Overall Study|Withdrawal by Subject|1
5048531|NCT02576678|17401402|P1|Overall Study|Withdrawal by Subject|3
5048532|NCT02576678|17401400|P3|Overall Study|Adverse Event|2
5048533|NCT02576678|17401401|P2|Overall Study|Adverse Event|0
5048534|NCT02576678|17401402|P1|Overall Study|Adverse Event|0
5048535|NCT02576652|17401434|P1|Overall Study|Withdrawal by Subject|2
5048536|NCT02576639|17401446|P5|Overall Study|Physician Decision|1
5048537|NCT02576639|17401447|P4|Overall Study|Physician Decision|0
5048538|NCT02576639|17401448|P3|Overall Study|Physician Decision|0
5048539|NCT02576639|17401449|P2|Overall Study|Physician Decision|0
5048540|NCT02576639|17401450|P1|Overall Study|Physician Decision|0
5048541|NCT02576639|17401446|P5|Overall Study|Adverse Event|2
5048542|NCT02576639|17401447|P4|Overall Study|Adverse Event|1
5048543|NCT02576639|17401448|P3|Overall Study|Adverse Event|1
5048544|NCT02576639|17401449|P2|Overall Study|Adverse Event|0
5048545|NCT02576639|17401450|P1|Overall Study|Adverse Event|1
5048546|NCT02576639|17401446|P5|Overall Study|Withdrawal by Subject|1
5048547|NCT02576639|17401447|P4|Overall Study|Withdrawal by Subject|0
5048548|NCT02576639|17401448|P3|Overall Study|Withdrawal by Subject|1
5048549|NCT02576639|17401449|P2|Overall Study|Withdrawal by Subject|2
5048550|NCT02576639|17401450|P1|Overall Study|Withdrawal by Subject|1
5048551|NCT02576587|17401509|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
5048552|NCT02576587|17401510|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
5048553|NCT02576587|17401509|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
5048554|NCT02576587|17401510|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
5048555|NCT02576587|17401509|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
5048556|NCT02576587|17401510|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
5048557|NCT02576587|17401509|P2|Baseline|Equipment failure|1
5048558|NCT02576587|17401510|P1|Baseline|Equipment failure|0
5048559|NCT02576535|17401528|P1|Overall Study|Withdrawal by Subject|2
5048560|NCT02576509|17401539|P2|Follow-up Period|Other reason|2
5048561|NCT02576509|17401540|P1|Follow-up Period|Other reason|1
5048562|NCT02576509|17401539|P2|Follow-up Period|Lost to Follow-up|1
5048563|NCT02576509|17401540|P1|Follow-up Period|Lost to Follow-up|0
5048564|NCT02576509|17401539|P2|Follow-up Period|Participant withdrew consent|14
5048565|NCT02576509|17401540|P1|Follow-up Period|Participant withdrew consent|7
5048566|NCT02576509|17401539|P2|Follow-up Period|Death|35
5048567|NCT02576509|17401540|P1|Follow-up Period|Death|41
5048568|NCT02576509|17401539|P2|Treatment Period|Other reason|7
5048569|NCT02576509|17401540|P1|Treatment Period|Other reason|2
5048570|NCT02576509|17401539|P2|Treatment Period|Participant no longer meets criteria|0
5048571|NCT02576509|17401540|P1|Treatment Period|Participant no longer meets criteria|1
5048572|NCT02576509|17401539|P2|Treatment Period|Poor/non-compliance|1
5048573|NCT02576509|17401540|P1|Treatment Period|Poor/non-compliance|0
5048574|NCT02576509|17401539|P2|Treatment Period|Maximum clinical benefit|0
5048575|NCT02576509|17401540|P1|Treatment Period|Maximum clinical benefit|1
5048576|NCT02576509|17401539|P2|Treatment Period|Lost to Follow-up|1
5048577|NCT02576509|17401540|P1|Treatment Period|Lost to Follow-up|0
5048578|NCT02576509|17401539|P2|Treatment Period|Participant withdrew consent|7
5048579|NCT02576509|17401540|P1|Treatment Period|Participant withdrew consent|2
5048580|NCT02576509|17401539|P2|Treatment Period|Participant request to stop treatment|17
5048581|NCT02576509|17401540|P1|Treatment Period|Participant request to stop treatment|8
5048582|NCT02576509|17401539|P2|Treatment Period|Adverse event unrelated to study drug|40
5048583|NCT02576509|17401540|P1|Treatment Period|Adverse event unrelated to study drug|37
5048584|NCT02576509|17401539|P2|Treatment Period|Death|1
5048585|NCT02576509|17401540|P1|Treatment Period|Death|1
5048586|NCT02576509|17401539|P2|Treatment Period|Study drug toxicity|41
5048587|NCT02576509|17401540|P1|Treatment Period|Study drug toxicity|32
5048588|NCT02576509|17401539|P2|Treatment Period|Disease progression|240
5048589|NCT02576509|17401540|P1|Treatment Period|Disease progression|245
5048590|NCT02576509|17401539|P2|Pre-Treatment Period|Participant no longer meets criteria|2
5048591|NCT02576509|17401540|P1|Pre-Treatment Period|Participant no longer meets criteria|3
5048592|NCT02576509|17401539|P2|Pre-Treatment Period|Participant withdrew consent|5
5048593|NCT02576509|17401540|P1|Pre-Treatment Period|Participant withdrew consent|1
5048594|NCT02576509|17401539|P2|Pre-Treatment Period|Participant request to stop therapy|2
5048595|NCT02576509|17401540|P1|Pre-Treatment Period|Participant request to stop therapy|0
5048596|NCT02576145|17401569|P2|Overall Study|Tetanus Titers Decreased|1
5048597|NCT02576145|17401570|P1|Overall Study|Tetanus Titers Decreased|0
5048598|NCT02576145|17401569|P2|Overall Study|Acute rejection|0
5048599|NCT02576145|17401570|P1|Overall Study|Acute rejection|1
5048600|NCT02576145|17401569|P2|Overall Study|Withdrawal by Subject|0
5048601|NCT02576145|17401570|P1|Overall Study|Withdrawal by Subject|1
5048602|NCT02576145|17401569|P2|Overall Study|Adverse Event|0
5048603|NCT02576145|17401570|P1|Overall Study|Adverse Event|1
5048604|NCT02576067|17401608|P2|Overall Study|Physician Decision|0
5048605|NCT02576067|17401609|P1|Overall Study|Physician Decision|4
5048606|NCT02576067|17401608|P2|Overall Study|screen failure/ re-enrolled|25
5048607|NCT02576067|17401609|P1|Overall Study|screen failure/ re-enrolled|0
5048608|NCT02576067|17401608|P2|Overall Study|not randomized, failed run-in|0
5048609|NCT02576067|17401609|P1|Overall Study|not randomized, failed run-in|7
5048610|NCT02576067|17401608|P2|Overall Study|study closure of main CIRT trial)|8
5048611|NCT02576067|17401609|P1|Overall Study|study closure of main CIRT trial)|0
5048612|NCT02576067|17401608|P2|Overall Study|Withdrawal by Subject|2
5048613|NCT02576067|17401609|P1|Overall Study|Withdrawal by Subject|11
5048614|NCT02576067|17401608|P2|Overall Study|Lost to Follow-up|0
5048615|NCT02576067|17401609|P1|Overall Study|Lost to Follow-up|11
5048616|NCT02576067|17401608|P2|Overall Study|Lack of Efficacy|0
5048617|NCT02576067|17401609|P1|Overall Study|Lack of Efficacy|1
5048618|NCT02576067|17401608|P2|Overall Study|Death|1
5048619|NCT02576067|17401609|P1|Overall Study|Death|0
5048620|NCT02576054|17401619|P1|Overall Study|Withdrawal by Subject|1
5048621|NCT02575950|17401640|P4|Overall Study|Lost to Follow-up|3
5048622|NCT02575950|17401641|P3|Overall Study|Lost to Follow-up|0
5048623|NCT02575950|17401642|P2|Overall Study|Lost to Follow-up|1
5048624|NCT02575950|17401643|P1|Overall Study|Lost to Follow-up|0
5048625|NCT02575950|17401640|P4|Overall Study|Withdrawal by Subject|2
5048626|NCT02575950|17401641|P3|Overall Study|Withdrawal by Subject|0
5048627|NCT02575950|17401642|P2|Overall Study|Withdrawal by Subject|0
5048628|NCT02575950|17401643|P1|Overall Study|Withdrawal by Subject|0
5048629|NCT02575911|17401672|P1|Overall Study|Lost to Follow-up|1
5048630|NCT02575833|17401692|P2|Overall Study|Lost to Follow-up|0
5048631|NCT02575833|17401693|P1|Overall Study|Lost to Follow-up|1
5048632|NCT02575833|17401692|P2|Overall Study|Withdrawal by Subject|1
5048633|NCT02575833|17401693|P1|Overall Study|Withdrawal by Subject|0
5048634|NCT02575807|17401708|P5|Overall Study|Withdrawal by Subject|2
5048635|NCT02575807|17401709|P4|Overall Study|Withdrawal by Subject|1
5048636|NCT02575807|17401710|P3|Overall Study|Withdrawal by Subject|1
5048637|NCT02575807|17401711|P2|Overall Study|Withdrawal by Subject|0
5048638|NCT02575807|17401712|P1|Overall Study|Withdrawal by Subject|0
5048639|NCT02575807|17401708|P5|Overall Study|Subject ineligible - medical implant|0
5048640|NCT02575807|17401709|P4|Overall Study|Subject ineligible - medical implant|1
5048641|NCT02575807|17401710|P3|Overall Study|Subject ineligible - medical implant|0
5048642|NCT02575807|17401711|P2|Overall Study|Subject ineligible - medical implant|0
5048643|NCT02575807|17401712|P1|Overall Study|Subject ineligible - medical implant|0
5048644|NCT02575807|17401708|P5|Overall Study|Terminated due to physician decision|0
5048645|NCT02575807|17401709|P4|Overall Study|Terminated due to physician decision|0
5048646|NCT02575807|17401710|P3|Overall Study|Terminated due to physician decision|1
5048647|NCT02575807|17401711|P2|Overall Study|Terminated due to physician decision|0
5048648|NCT02575807|17401712|P1|Overall Study|Terminated due to physician decision|0
5048649|NCT02575807|17401708|P5|Overall Study|Terminated due to FDA clinical hold|0
5048650|NCT02575807|17401709|P4|Overall Study|Terminated due to FDA clinical hold|0
5048651|NCT02575807|17401710|P3|Overall Study|Terminated due to FDA clinical hold|0
5048652|NCT02575807|17401711|P2|Overall Study|Terminated due to FDA clinical hold|0
5048653|NCT02575807|17401712|P1|Overall Study|Terminated due to FDA clinical hold|1
5048654|NCT02575807|17401708|P5|Overall Study|Study terminated by Sponsor|1
5048655|NCT02575807|17401709|P4|Overall Study|Study terminated by Sponsor|0
5048656|NCT02575807|17401710|P3|Overall Study|Study terminated by Sponsor|7
5048657|NCT02575807|17401711|P2|Overall Study|Study terminated by Sponsor|1
5048658|NCT02575807|17401712|P1|Overall Study|Study terminated by Sponsor|0
5048659|NCT02575807|17401708|P5|Overall Study|Death|1
5048660|NCT02575807|17401709|P4|Overall Study|Death|0
5048661|NCT02575807|17401710|P3|Overall Study|Death|7
5048662|NCT02575807|17401711|P2|Overall Study|Death|3
5048663|NCT02575807|17401712|P1|Overall Study|Death|8
5048664|NCT02575365|17401752|P1|Overall Study|Lost to Follow-up|4
5048665|NCT02575079|17401772|P2|Overall Study|Withdrawal by Subject|0
5048666|NCT02575079|17401773|P1|Overall Study|Withdrawal by Subject|3
5048667|NCT02575079|17401772|P2|Overall Study|Death|0
5048668|NCT02575079|17401773|P1|Overall Study|Death|3
5048669|NCT02574845|17401798|P6|Overall Study|Adverse Event|1
5048670|NCT02574845|17401799|P5|Overall Study|Adverse Event|0
5048671|NCT02574845|17401800|P4|Overall Study|Adverse Event|0
5048672|NCT02574845|17401801|P3|Overall Study|Adverse Event|0
5048673|NCT02574845|17401802|P2|Overall Study|Adverse Event|1
5048674|NCT02574845|17401803|P1|Overall Study|Adverse Event|0
5048675|NCT02574845|17401798|P6|Overall Study|Consent withdrawn further participation|0
5048676|NCT02574845|17401799|P5|Overall Study|Consent withdrawn further participation|1
5048677|NCT02574845|17401800|P4|Overall Study|Consent withdrawn further participation|0
5048678|NCT02574845|17401801|P3|Overall Study|Consent withdrawn further participation|0
5048679|NCT02574845|17401802|P2|Overall Study|Consent withdrawn further participation|0
5048680|NCT02574845|17401803|P1|Overall Study|Consent withdrawn further participation|0
5048681|NCT02574637|17401838|P10|Open-label (OL) Period|Study Terminated By Sponsor|0
5048682|NCT02574637|17401839|P9|Open-label (OL) Period|Study Terminated By Sponsor|1
5048683|NCT02574637|17401840|P8|Open-label (OL) Period|Study Terminated By Sponsor|1
5048684|NCT02574637|17401841|P7|Open-label (OL) Period|Study Terminated By Sponsor|2
5048685|NCT02574637|17401842|P6|Open-label (OL) Period|Study Terminated By Sponsor|1
5048686|NCT02574637|17401843|P5|Open-label (OL) Period|Study Terminated By Sponsor|0
5048687|NCT02574637|17401844|P4|Open-label (OL) Period|Study Terminated By Sponsor|0
5048688|NCT02574637|17401845|P3|Open-label (OL) Period|Study Terminated By Sponsor|0
5048689|NCT02574637|17401846|P2|Open-label (OL) Period|Study Terminated By Sponsor|0
5048690|NCT02574637|17401847|P1|Open-label (OL) Period|Study Terminated By Sponsor|0
5048691|NCT02574637|17401838|P10|Open-label (OL) Period|Withdrawal by Subject|1
5048692|NCT02574637|17401839|P9|Open-label (OL) Period|Withdrawal by Subject|0
5048693|NCT02574637|17401840|P8|Open-label (OL) Period|Withdrawal by Subject|0
5048694|NCT02574637|17401841|P7|Open-label (OL) Period|Withdrawal by Subject|0
5048695|NCT02574637|17401842|P6|Open-label (OL) Period|Withdrawal by Subject|1
5048696|NCT02574637|17401843|P5|Open-label (OL) Period|Withdrawal by Subject|0
5048697|NCT02574637|17401844|P4|Open-label (OL) Period|Withdrawal by Subject|0
5048698|NCT02574637|17401845|P3|Open-label (OL) Period|Withdrawal by Subject|0
5048699|NCT02574637|17401846|P2|Open-label (OL) Period|Withdrawal by Subject|0
5048700|NCT02574637|17401847|P1|Open-label (OL) Period|Withdrawal by Subject|0
5048701|NCT02574637|17401838|P10|Open-label (OL) Period|Adverse Event|0
5048702|NCT02574637|17401839|P9|Open-label (OL) Period|Adverse Event|1
5048703|NCT02574637|17401840|P8|Open-label (OL) Period|Adverse Event|0
5048704|NCT02574637|17401841|P7|Open-label (OL) Period|Adverse Event|0
5048705|NCT02574637|17401842|P6|Open-label (OL) Period|Adverse Event|0
5048706|NCT02574637|17401843|P5|Open-label (OL) Period|Adverse Event|0
5048707|NCT02574637|17401844|P4|Open-label (OL) Period|Adverse Event|0
5048708|NCT02574637|17401845|P3|Open-label (OL) Period|Adverse Event|0
5048709|NCT02574637|17401846|P2|Open-label (OL) Period|Adverse Event|0
5048710|NCT02574637|17401847|P1|Open-label (OL) Period|Adverse Event|0
5048711|NCT02574637|17401838|P10|Double-blind Period|Reason Not Specified|0
5048712|NCT02574637|17401839|P9|Double-blind Period|Reason Not Specified|0
5048713|NCT02574637|17401840|P8|Double-blind Period|Reason Not Specified|0
5048714|NCT02574637|17401841|P7|Double-blind Period|Reason Not Specified|0
5048715|NCT02574637|17401842|P6|Double-blind Period|Reason Not Specified|0
5048716|NCT02574637|17401843|P5|Double-blind Period|Reason Not Specified|0
5048717|NCT02574637|17401844|P4|Double-blind Period|Reason Not Specified|1
5048718|NCT02574637|17401845|P3|Double-blind Period|Reason Not Specified|0
5048719|NCT02574637|17401846|P2|Double-blind Period|Reason Not Specified|0
5048720|NCT02574637|17401847|P1|Double-blind Period|Reason Not Specified|0
5048721|NCT02574637|17401838|P10|Double-blind Period|Study Terminated By Sponsor|0
5048722|NCT02574637|17401839|P9|Double-blind Period|Study Terminated By Sponsor|0
5048723|NCT02574637|17401840|P8|Double-blind Period|Study Terminated By Sponsor|0
5048724|NCT02574637|17401841|P7|Double-blind Period|Study Terminated By Sponsor|0
5048725|NCT02574637|17401842|P6|Double-blind Period|Study Terminated By Sponsor|0
5048726|NCT02574637|17401843|P5|Double-blind Period|Study Terminated By Sponsor|2
5048727|NCT02574637|17401844|P4|Double-blind Period|Study Terminated By Sponsor|2
5048728|NCT02574637|17401845|P3|Double-blind Period|Study Terminated By Sponsor|5
5048729|NCT02574637|17401846|P2|Double-blind Period|Study Terminated By Sponsor|1
5048730|NCT02574637|17401847|P1|Double-blind Period|Study Terminated By Sponsor|1
5048731|NCT02574637|17401838|P10|Double-blind Period|Non-Compliance With Study Drug|0
5048732|NCT02574637|17401839|P9|Double-blind Period|Non-Compliance With Study Drug|0
5048733|NCT02574637|17401840|P8|Double-blind Period|Non-Compliance With Study Drug|0
5048734|NCT02574637|17401841|P7|Double-blind Period|Non-Compliance With Study Drug|0
5048735|NCT02574637|17401842|P6|Double-blind Period|Non-Compliance With Study Drug|0
5048736|NCT02574637|17401843|P5|Double-blind Period|Non-Compliance With Study Drug|0
5048737|NCT02574637|17401844|P4|Double-blind Period|Non-Compliance With Study Drug|1
5048738|NCT02574637|17401845|P3|Double-blind Period|Non-Compliance With Study Drug|0
5048739|NCT02574637|17401846|P2|Double-blind Period|Non-Compliance With Study Drug|0
5048740|NCT02574637|17401847|P1|Double-blind Period|Non-Compliance With Study Drug|0
5048741|NCT02574637|17401838|P10|Double-blind Period|Protocol Deviation|0
5048742|NCT02574637|17401839|P9|Double-blind Period|Protocol Deviation|0
5048743|NCT02574637|17401840|P8|Double-blind Period|Protocol Deviation|0
5048744|NCT02574637|17401841|P7|Double-blind Period|Protocol Deviation|0
5048745|NCT02574637|17401842|P6|Double-blind Period|Protocol Deviation|0
5048746|NCT02574637|17401843|P5|Double-blind Period|Protocol Deviation|0
5048747|NCT02574637|17401844|P4|Double-blind Period|Protocol Deviation|0
5048748|NCT02574637|17401845|P3|Double-blind Period|Protocol Deviation|0
5048749|NCT02574637|17401846|P2|Double-blind Period|Protocol Deviation|0
5048750|NCT02574637|17401847|P1|Double-blind Period|Protocol Deviation|1
5048751|NCT02574637|17401838|P10|Double-blind Period|Lack of Efficacy|0
5048752|NCT02574637|17401839|P9|Double-blind Period|Lack of Efficacy|0
5048753|NCT02574637|17401840|P8|Double-blind Period|Lack of Efficacy|0
5048754|NCT02574637|17401841|P7|Double-blind Period|Lack of Efficacy|0
5048755|NCT02574637|17401842|P6|Double-blind Period|Lack of Efficacy|0
5048756|NCT02574637|17401843|P5|Double-blind Period|Lack of Efficacy|0
5048757|NCT02574637|17401844|P4|Double-blind Period|Lack of Efficacy|0
5048758|NCT02574637|17401845|P3|Double-blind Period|Lack of Efficacy|2
5048759|NCT02574637|17401846|P2|Double-blind Period|Lack of Efficacy|0
5048760|NCT02574637|17401847|P1|Double-blind Period|Lack of Efficacy|0
5048761|NCT02574637|17401838|P10|Double-blind Period|Adverse Event|0
5048762|NCT02574637|17401839|P9|Double-blind Period|Adverse Event|0
5048763|NCT02574637|17401840|P8|Double-blind Period|Adverse Event|0
5048764|NCT02574637|17401841|P7|Double-blind Period|Adverse Event|0
5048765|NCT02574637|17401842|P6|Double-blind Period|Adverse Event|0
5048766|NCT02574637|17401843|P5|Double-blind Period|Adverse Event|0
5048767|NCT02574637|17401844|P4|Double-blind Period|Adverse Event|0
5048768|NCT02574637|17401845|P3|Double-blind Period|Adverse Event|0
5048769|NCT02574637|17401846|P2|Double-blind Period|Adverse Event|0
5048770|NCT02574637|17401847|P1|Double-blind Period|Adverse Event|1
5048771|NCT02574481|17401947|P4|Overall Study|Death|0
5048772|NCT02574481|17401948|P3|Overall Study|Death|0
5048773|NCT02574481|17401949|P2|Overall Study|Death|6
5048774|NCT02574481|17401950|P1|Overall Study|Death|6
5048775|NCT02574481|17401947|P4|Overall Study|Other|0
5048776|NCT02574481|17401948|P3|Overall Study|Other|0
5048777|NCT02574481|17401949|P2|Overall Study|Other|0
5048778|NCT02574481|17401950|P1|Overall Study|Other|1
5048779|NCT02574481|17401947|P4|Overall Study|Visit Missed|0
5048780|NCT02574481|17401948|P3|Overall Study|Visit Missed|2
5048781|NCT02574481|17401949|P2|Overall Study|Visit Missed|4
5048782|NCT02574481|17401950|P1|Overall Study|Visit Missed|12
5048783|NCT02574481|17401947|P4|Overall Study|Adverse Event|0
5048784|NCT02574481|17401948|P3|Overall Study|Adverse Event|0
5048785|NCT02574481|17401949|P2|Overall Study|Adverse Event|0
5048786|NCT02574481|17401950|P1|Overall Study|Adverse Event|2
5048787|NCT02574481|17401947|P4|Overall Study|Withdrawal by Subject|0
5048788|NCT02574481|17401948|P3|Overall Study|Withdrawal by Subject|1
5048789|NCT02574481|17401949|P2|Overall Study|Withdrawal by Subject|4
5048790|NCT02574481|17401950|P1|Overall Study|Withdrawal by Subject|6
5048791|NCT02574312|17401990|P2|3 Months Follow-up|Withdrawal by Subject|0
5048792|NCT02574312|17401991|P1|3 Months Follow-up|Withdrawal by Subject|1
5048793|NCT02574260|17402007|P1|Overall Study|Disease Progression|1
5048794|NCT02574247|17402016|P3|Overall Study|Did not meet inclusion criteria|5
5048795|NCT02574247|17402017|P2|Overall Study|Did not meet inclusion criteria|3
5048796|NCT02574247|17402018|P1|Overall Study|Did not meet inclusion criteria|4
5048797|NCT02574247|17402016|P3|Overall Study|Withdrawal by Subject|0
5048798|NCT02574247|17402017|P2|Overall Study|Withdrawal by Subject|0
5048799|NCT02574247|17402018|P1|Overall Study|Withdrawal by Subject|1
5048800|NCT02573948|17402030|P1|Longitudinal Cohort|Incarcerated|25
5048801|NCT02573948|17402030|P1|Longitudinal Cohort|Lost to Follow-up|22
5048802|NCT02573948|17402030|P1|Longitudinal Cohort|Death|9
5048803|NCT02573870|17402040|P2|Overall Study|Other: Fail to Meet Visit|2
5048804|NCT02573870|17402041|P1|Overall Study|Other: Fail to Meet Visit|0
5048805|NCT02573870|17402040|P2|Overall Study|Lost to Follow-up|1
5048806|NCT02573870|17402041|P1|Overall Study|Lost to Follow-up|0
5048807|NCT02573870|17402040|P2|Overall Study|Other: Reached defined stopping criteria|1
5048808|NCT02573870|17402041|P1|Overall Study|Other: Reached defined stopping criteria|0
5048809|NCT02573870|17402040|P2|Overall Study|Lack of Efficacy|1
5048810|NCT02573870|17402041|P1|Overall Study|Lack of Efficacy|0
5048811|NCT02573870|17402040|P2|Overall Study|Adverse Event|2
5048812|NCT02573870|17402041|P1|Overall Study|Adverse Event|0
5048813|NCT02573467|17402089|P4|Post-treatment Follow up Epoch|Technical problems|0
5048814|NCT02573467|17402090|P3|Post-treatment Follow up Epoch|Technical problems|1
5048815|NCT02573467|17402091|P2|Post-treatment Follow up Epoch|Technical problems|0
5048816|NCT02573467|17402092|P1|Post-treatment Follow up Epoch|Technical problems|0
5048817|NCT02573467|17402089|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
5048818|NCT02573467|17402090|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
5048819|NCT02573467|17402091|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
5048820|NCT02573467|17402092|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
5048821|NCT02573467|17402089|P4|Post-treatment Follow up Epoch|Death|1
5048822|NCT02573467|17402090|P3|Post-treatment Follow up Epoch|Death|0
5048823|NCT02573467|17402091|P2|Post-treatment Follow up Epoch|Death|1
5048824|NCT02573467|17402092|P1|Post-treatment Follow up Epoch|Death|1
5048825|NCT02573467|17402089|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
5048826|NCT02573467|17402090|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
5048827|NCT02573467|17402091|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
5048828|NCT02573467|17402092|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
5048829|NCT02573467|17402089|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
5048830|NCT02573467|17402090|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
5048831|NCT02573467|17402091|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
5048832|NCT02573467|17402092|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
5048833|NCT02573467|17402089|P4|Double-blind Treatment Epoch|Adverse Event|0
5048834|NCT02573467|17402090|P3|Double-blind Treatment Epoch|Adverse Event|1
5048835|NCT02573467|17402091|P2|Double-blind Treatment Epoch|Adverse Event|0
5048836|NCT02573467|17402092|P1|Double-blind Treatment Epoch|Adverse Event|1
5048837|NCT02573467|17402089|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
5048838|NCT02573467|17402090|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
5048839|NCT02573467|17402091|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
5048840|NCT02573467|17402092|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
5048841|NCT02573311|17402156|P2|Disposition for Part 2|Other than specified above|3
5048842|NCT02573311|17402157|P1|Disposition for Part 2|Other than specified above|13
5048843|NCT02573311|17402156|P2|Disposition for Part 2|Investigator decision|1
5048844|NCT02573311|17402157|P1|Disposition for Part 2|Investigator decision|0
5048845|NCT02573311|17402156|P2|Disposition for Part 2|Withdrawal by Subject|3
5048846|NCT02573311|17402157|P1|Disposition for Part 2|Withdrawal by Subject|60
5048847|NCT02573311|17402156|P2|Disposition for Part 2|Lost to Follow-up|7
5048848|NCT02573311|17402157|P1|Disposition for Part 2|Lost to Follow-up|76
5048849|NCT02573311|17402156|P2|Disposition for Part 2|Adverse Event|5
5048850|NCT02573311|17402157|P1|Disposition for Part 2|Adverse Event|36
5048851|NCT02573311|17402156|P2|Disposition for Part 2|Physician Decision|7
5048852|NCT02573311|17402157|P1|Disposition for Part 2|Physician Decision|25
5048853|NCT02573311|17402156|P2|Disposition for Part 1|Withdrawal by Subject|3
5048854|NCT02573311|17402157|P1|Disposition for Part 1|Withdrawal by Subject|7
5048855|NCT02573155|17402226|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
5048856|NCT02573155|17402227|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
5048857|NCT02573155|17402226|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
5048858|NCT02573155|17402227|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
5048859|NCT02573155|17402226|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
5048860|NCT02573155|17402227|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
5048861|NCT02573155|17402226|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
5048862|NCT02573155|17402227|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
5048863|NCT02573155|17402226|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
5048864|NCT02573155|17402227|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
5048865|NCT02573155|17402226|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
5048866|NCT02573155|17402227|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
5048867|NCT02573155|17402226|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
5048868|NCT02573155|17402227|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
5048869|NCT02573155|17402226|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
5048870|NCT02573155|17402227|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
5048871|NCT02573012|17402375|P2|Overall Study|Physician Decision|2
5048872|NCT02573012|17402376|P1|Overall Study|Physician Decision|1
5048873|NCT02573012|17402375|P2|Overall Study|Study Ended per Protocol|0
5048874|NCT02573012|17402376|P1|Overall Study|Study Ended per Protocol|1
5048875|NCT02573012|17402375|P2|Overall Study|Withdrawal by Subject|2
5048876|NCT02573012|17402376|P1|Overall Study|Withdrawal by Subject|2
5048877|NCT02573012|17402375|P2|Overall Study|Non-compliance|2
5048878|NCT02573012|17402376|P1|Overall Study|Non-compliance|1
5048879|NCT02573012|17402375|P2|Overall Study|Lack of Efficacy|4
5048880|NCT02573012|17402376|P1|Overall Study|Lack of Efficacy|5
5048881|NCT02573012|17402375|P2|Overall Study|Adverse Event|5
5048882|NCT02573012|17402376|P1|Overall Study|Adverse Event|5
5048883|NCT02572817|17402428|P2|Overall Study|Lost to Follow-up|3
5048884|NCT02572817|17402429|P1|Overall Study|Lost to Follow-up|3
5048885|NCT02572817|17402428|P2|Overall Study|Death|3
5048886|NCT02572817|17402429|P1|Overall Study|Death|6
5048887|NCT02572401|17402537|P4|Overall Study|Death|1
5048888|NCT02572401|17402538|P3|Overall Study|Death|0
5048889|NCT02572401|17402539|P2|Overall Study|Death|0
5048890|NCT02572401|17402540|P1|Overall Study|Death|0
5048891|NCT02572401|17402537|P4|Overall Study|Lost to Follow-up|9
5048892|NCT02572401|17402538|P3|Overall Study|Lost to Follow-up|9
5048893|NCT02572401|17402539|P2|Overall Study|Lost to Follow-up|8
5048894|NCT02572401|17402540|P1|Overall Study|Lost to Follow-up|5
5048895|NCT02572388|17402570|P4|Overall Study|Withdrawal by Subject|2
5048896|NCT02572388|17402571|P3|Overall Study|Withdrawal by Subject|2
5048897|NCT02572388|17402572|P2|Overall Study|Withdrawal by Subject|1
5048898|NCT02572388|17402573|P1|Overall Study|Withdrawal by Subject|1
5048899|NCT02572167|17402598|P3|Overall Study|Did not meet inclusion criteria|1
5048900|NCT02572167|17402599|P2|Overall Study|Did not meet inclusion criteria|0
5048901|NCT02572167|17402600|P1|Overall Study|Did not meet inclusion criteria|0
5048902|NCT02572167|17402598|P3|Overall Study|Death|1
5048903|NCT02572167|17402599|P2|Overall Study|Death|3
5048904|NCT02572167|17402600|P1|Overall Study|Death|0
5048905|NCT02572167|17402598|P3|Overall Study|Lost to Follow-up|1
5048906|NCT02572167|17402599|P2|Overall Study|Lost to Follow-up|2
5048907|NCT02572167|17402600|P1|Overall Study|Lost to Follow-up|0
5048908|NCT02572167|17402598|P3|Overall Study|Withdrawal by Subject|1
5048909|NCT02572167|17402599|P2|Overall Study|Withdrawal by Subject|3
5048910|NCT02572167|17402600|P1|Overall Study|Withdrawal by Subject|0
5048911|NCT02572167|17402598|P3|Overall Study|In follow up|27
5048912|NCT02572167|17402599|P2|Overall Study|In follow up|48
5048913|NCT02572167|17402600|P1|Overall Study|In follow up|6
5048914|NCT02572076|17402614|P1|Overall Study|Protocol Violation|1
5048915|NCT02571972|17402618|P1|Overall Study|Withdrawal by Subject|2
5048916|NCT02571972|17402618|P1|Overall Study|Protocol Violation|2
5048917|NCT02571777|17402630|P5|Overall Study|Pregnancy|0
5048918|NCT02571777|17402631|P4|Overall Study|Pregnancy|2
5048919|NCT02571777|17402632|P3|Overall Study|Pregnancy|0
5048920|NCT02571777|17402633|P2|Overall Study|Pregnancy|0
5048921|NCT02571777|17402634|P1|Overall Study|Pregnancy|0
5048922|NCT02571777|17402630|P5|Overall Study|Physician Decision|4
5048923|NCT02571777|17402631|P4|Overall Study|Physician Decision|2
5048924|NCT02571777|17402632|P3|Overall Study|Physician Decision|5
5048925|NCT02571777|17402633|P2|Overall Study|Physician Decision|7
5048926|NCT02571777|17402634|P1|Overall Study|Physician Decision|1
5048927|NCT02571777|17402630|P5|Overall Study|Lost to Follow-up|1
5048928|NCT02571777|17402631|P4|Overall Study|Lost to Follow-up|0
5048929|NCT02571777|17402632|P3|Overall Study|Lost to Follow-up|2
5048930|NCT02571777|17402633|P2|Overall Study|Lost to Follow-up|1
5048931|NCT02571777|17402634|P1|Overall Study|Lost to Follow-up|1
5048932|NCT02571777|17402630|P5|Overall Study|Death|0
5048933|NCT02571777|17402631|P4|Overall Study|Death|0
5048934|NCT02571777|17402632|P3|Overall Study|Death|4
5048935|NCT02571777|17402633|P2|Overall Study|Death|1
5048936|NCT02571777|17402634|P1|Overall Study|Death|1
5048937|NCT02571777|17402630|P5|Overall Study|Protocol Deviation|4
5048938|NCT02571777|17402631|P4|Overall Study|Protocol Deviation|8
5048939|NCT02571777|17402632|P3|Overall Study|Protocol Deviation|4
5048940|NCT02571777|17402633|P2|Overall Study|Protocol Deviation|3
5048941|NCT02571777|17402634|P1|Overall Study|Protocol Deviation|2
5048942|NCT02571777|17402630|P5|Overall Study|Subject/guardian decision|27
5048943|NCT02571777|17402631|P4|Overall Study|Subject/guardian decision|25
5048944|NCT02571777|17402632|P3|Overall Study|Subject/guardian decision|26
5048945|NCT02571777|17402633|P2|Overall Study|Subject/guardian decision|26
5048946|NCT02571777|17402634|P1|Overall Study|Subject/guardian decision|34
5048947|NCT02571452|17402771|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
5048948|NCT02571452|17402772|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
5048949|NCT02571452|17402771|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
5048950|NCT02571452|17402772|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
5048951|NCT02571452|17402771|P2|Overall Study Treatment|Protocol Violation|1
5048952|NCT02571452|17402772|P1|Overall Study Treatment|Protocol Violation|0
5048953|NCT02571244|17402813|P2|Overall Study|Unable to reach out post discharge|0
5048954|NCT02571244|17402814|P1|Overall Study|Unable to reach out post discharge|3
5048955|NCT02571244|17402813|P2|Overall Study|Lost to Follow-up|1
5048956|NCT02571244|17402814|P1|Overall Study|Lost to Follow-up|0
5048957|NCT02571075|17402872|P2|Overall Study|Lost to Follow-up|24
5048958|NCT02571075|17402873|P1|Overall Study|Lost to Follow-up|20
5048959|NCT02571049|17402887|P2|Randomization|Adverse Event|1
5048960|NCT02571049|17402888|P1|Randomization|Adverse Event|0
5048961|NCT02571049|17402887|P2|Randomization|No migraine attack|1
5048962|NCT02571049|17402888|P1|Randomization|No migraine attack|0
5048963|NCT02571049|17402887|P2|Screening|Did not meet entry criteria|2
5048964|NCT02571049|17402888|P1|Screening|Did not meet entry criteria|2
5048965|NCT02570750|17402896|P2|Overall Study|Adverse Event|1
5048966|NCT02570750|17402897|P1|Overall Study|Adverse Event|2
5048967|NCT02570750|17402896|P2|Overall Study|Lost to Follow-up|2
5048968|NCT02570750|17402897|P1|Overall Study|Lost to Follow-up|2
5048969|NCT02570750|17402896|P2|Overall Study|Withdrawal by Subject|0
5048970|NCT02570750|17402897|P1|Overall Study|Withdrawal by Subject|5
5048971|NCT02570750|17402896|P2|Overall Study|Protocol deviation|2
5048972|NCT02570750|17402897|P1|Overall Study|Protocol deviation|4
5048973|NCT02570750|17402896|P2|Overall Study|Inclusion/exclusion criteria deviation|0
5048974|NCT02570750|17402897|P1|Overall Study|Inclusion/exclusion criteria deviation|1
5048975|NCT02570711|17402915|P2|Overall Study|Early Termination of Study by Sponsor|2
5048976|NCT02570711|17402916|P1|Overall Study|Early Termination of Study by Sponsor|0
5048977|NCT02570711|17402915|P2|Overall Study|Death|0
5048978|NCT02570711|17402916|P1|Overall Study|Death|1
5048979|NCT02570165|17403004|P7|Overall Study|Withdrawal Request by GSK|0
5048980|NCT02570165|17403005|P6|Overall Study|Withdrawal Request by GSK|0
5048981|NCT02570165|17403006|P5|Overall Study|Withdrawal Request by GSK|0
5048982|NCT02570165|17403007|P4|Overall Study|Withdrawal Request by GSK|0
5048983|NCT02570165|17403008|P3|Overall Study|Withdrawal Request by GSK|2
5048984|NCT02570165|17403009|P2|Overall Study|Withdrawal Request by GSK|0
5048985|NCT02570165|17403010|P1|Overall Study|Withdrawal Request by GSK|0
5048986|NCT02570165|17403004|P7|Overall Study|Par. did not Meet Continuation Criteria|0
5048987|NCT02570165|17403005|P6|Overall Study|Par. did not Meet Continuation Criteria|1
5048988|NCT02570165|17403006|P5|Overall Study|Par. did not Meet Continuation Criteria|0
5048989|NCT02570165|17403007|P4|Overall Study|Par. did not Meet Continuation Criteria|0
5048990|NCT02570165|17403008|P3|Overall Study|Par. did not Meet Continuation Criteria|0
5048991|NCT02570165|17403009|P2|Overall Study|Par. did not Meet Continuation Criteria|0
5048992|NCT02570165|17403010|P1|Overall Study|Par. did not Meet Continuation Criteria|0
5048993|NCT02570165|17403004|P7|Overall Study|Withdrawal by Subject|0
5048994|NCT02570165|17403005|P6|Overall Study|Withdrawal by Subject|0
5048995|NCT02570165|17403006|P5|Overall Study|Withdrawal by Subject|1
5048996|NCT02570165|17403007|P4|Overall Study|Withdrawal by Subject|2
5048997|NCT02570165|17403008|P3|Overall Study|Withdrawal by Subject|0
5048998|NCT02570165|17403009|P2|Overall Study|Withdrawal by Subject|0
5048999|NCT02570165|17403010|P1|Overall Study|Withdrawal by Subject|0
5049000|NCT02570165|17403004|P7|Overall Study|Physician Decision|0
5049001|NCT02570165|17403005|P6|Overall Study|Physician Decision|0
5049002|NCT02570165|17403006|P5|Overall Study|Physician Decision|0
5049003|NCT02570165|17403007|P4|Overall Study|Physician Decision|0
5049004|NCT02570165|17403008|P3|Overall Study|Physician Decision|0
5049005|NCT02570165|17403009|P2|Overall Study|Physician Decision|1
5049006|NCT02570165|17403010|P1|Overall Study|Physician Decision|0
5049007|NCT02570165|17403004|P7|Overall Study|Lost to Follow-up|0
5049008|NCT02570165|17403005|P6|Overall Study|Lost to Follow-up|0
5049009|NCT02570165|17403006|P5|Overall Study|Lost to Follow-up|0
5049010|NCT02570165|17403007|P4|Overall Study|Lost to Follow-up|1
5049011|NCT02570165|17403008|P3|Overall Study|Lost to Follow-up|1
5049012|NCT02570165|17403009|P2|Overall Study|Lost to Follow-up|0
5049013|NCT02570165|17403010|P1|Overall Study|Lost to Follow-up|0
5049014|NCT02570165|17403004|P7|Overall Study|Par. Reached Stopping Criteria|0
5049015|NCT02570165|17403005|P6|Overall Study|Par. Reached Stopping Criteria|1
5049016|NCT02570165|17403006|P5|Overall Study|Par. Reached Stopping Criteria|1
5049017|NCT02570165|17403007|P4|Overall Study|Par. Reached Stopping Criteria|2
5049018|NCT02570165|17403008|P3|Overall Study|Par. Reached Stopping Criteria|0
5049019|NCT02570165|17403009|P2|Overall Study|Par. Reached Stopping Criteria|1
5049020|NCT02570165|17403010|P1|Overall Study|Par. Reached Stopping Criteria|1
5049021|NCT02570165|17403004|P7|Overall Study|Lack of Efficacy|0
5049022|NCT02570165|17403005|P6|Overall Study|Lack of Efficacy|0
5049023|NCT02570165|17403006|P5|Overall Study|Lack of Efficacy|4
5049024|NCT02570165|17403007|P4|Overall Study|Lack of Efficacy|0
5049025|NCT02570165|17403008|P3|Overall Study|Lack of Efficacy|0
5049026|NCT02570165|17403009|P2|Overall Study|Lack of Efficacy|1
5049027|NCT02570165|17403010|P1|Overall Study|Lack of Efficacy|0
5049028|NCT02570165|17403004|P7|Overall Study|Adverse Event|0
5049029|NCT02570165|17403005|P6|Overall Study|Adverse Event|0
5049030|NCT02570165|17403006|P5|Overall Study|Adverse Event|0
5049031|NCT02570165|17403007|P4|Overall Study|Adverse Event|0
5049032|NCT02570165|17403008|P3|Overall Study|Adverse Event|2
5049033|NCT02570165|17403009|P2|Overall Study|Adverse Event|0
5049034|NCT02570165|17403010|P1|Overall Study|Adverse Event|1
5049035|NCT02570152|17403033|P1|Overall Study|Migrated/moved from study area|13
5049036|NCT02570152|17403033|P1|Overall Study|Protocol Violation|2
5049037|NCT02570126|17403064|P2|Overall Study|Withdrawal by Subject|7
5049038|NCT02570126|17403065|P1|Overall Study|Withdrawal by Subject|3
5049039|NCT02570126|17403064|P2|Overall Study|Protocol Violation|1
5049040|NCT02570126|17403065|P1|Overall Study|Protocol Violation|0
5049041|NCT02570126|17403064|P2|Overall Study|Violation Of Procedures GSK|1
5049042|NCT02570126|17403065|P1|Overall Study|Violation Of Procedures GSK|0
5049043|NCT02570126|17403064|P2|Overall Study|Unable To Arrange Visit 3|0
5049044|NCT02570126|17403065|P1|Overall Study|Unable To Arrange Visit 3|1
5049045|NCT02570126|17403064|P2|Overall Study|Lost to Follow-up|0
5049046|NCT02570126|17403065|P1|Overall Study|Lost to Follow-up|2
5049047|NCT02570074|17403091|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
5049048|NCT02570074|17403092|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
5049049|NCT02569996|17403161|P1|Overall Study|Unknown reason|1
5049050|NCT02569996|17403161|P1|Overall Study|Complete remission|7
5049051|NCT02569996|17403161|P1|Overall Study|Lost to Follow-up|5
5049052|NCT02569996|17403161|P1|Overall Study|Withdrawal by Subject|5
5049053|NCT02569996|17403161|P1|Overall Study|Non-compliance|9
5049054|NCT02569996|17403161|P1|Overall Study|New anti-lymphoma treatment|1
5049055|NCT02569996|17403161|P1|Overall Study|Progression of the disease|18
5049056|NCT02569996|17403161|P1|Overall Study|Physician Decision|3
5049057|NCT02569996|17403161|P1|Overall Study|Adverse Event|6
5049058|NCT02569957|17403173|P2|Overall Study|Withdrawal by Subject|1
5049059|NCT02569957|17403174|P1|Overall Study|Withdrawal by Subject|0
5049060|NCT02569853|17403206|P2|Overall Study|Physician Decision|1
5049061|NCT02569853|17403207|P1|Overall Study|Physician Decision|1
5049062|NCT02569853|17403206|P2|Overall Study|Did not experience migraine attack|7
5049063|NCT02569853|17403207|P1|Overall Study|Did not experience migraine attack|10
5049064|NCT02569853|17403206|P2|Overall Study|Protocol Violation|1
5049065|NCT02569853|17403207|P1|Overall Study|Protocol Violation|1
5049066|NCT02569853|17403206|P2|Overall Study|Lost to Follow-up|3
5049067|NCT02569853|17403207|P1|Overall Study|Lost to Follow-up|3
5049068|NCT02569853|17403206|P2|Overall Study|Withdrawal by Subject|2
5049069|NCT02569853|17403207|P1|Overall Study|Withdrawal by Subject|3
5049070|NCT02569853|17403206|P2|Overall Study|Adverse Event|0
5049071|NCT02569853|17403207|P1|Overall Study|Adverse Event|2
5049072|NCT02569710|17403225|P10|Overall Study|Withdrawal by Subject|0
5049073|NCT02569710|17403226|P9|Overall Study|Withdrawal by Subject|0
5049074|NCT02569710|17403227|P8|Overall Study|Withdrawal by Subject|0
5049075|NCT02569710|17403228|P7|Overall Study|Withdrawal by Subject|0
5049076|NCT02569710|17403229|P6|Overall Study|Withdrawal by Subject|1
5049077|NCT02569710|17403230|P5|Overall Study|Withdrawal by Subject|0
5049078|NCT02569710|17403231|P4|Overall Study|Withdrawal by Subject|0
5049079|NCT02569710|17403232|P3|Overall Study|Withdrawal by Subject|0
5049080|NCT02569710|17403233|P2|Overall Study|Withdrawal by Subject|0
5049081|NCT02569710|17403234|P1|Overall Study|Withdrawal by Subject|0
5049082|NCT02569710|17403225|P10|Overall Study|Virologic failure|0
5049083|NCT02569710|17403226|P9|Overall Study|Virologic failure|0
5049084|NCT02569710|17403227|P8|Overall Study|Virologic failure|0
5049085|NCT02569710|17403228|P7|Overall Study|Virologic failure|1
5049086|NCT02569710|17403229|P6|Overall Study|Virologic failure|0
5049087|NCT02569710|17403230|P5|Overall Study|Virologic failure|1
5049088|NCT02569710|17403231|P4|Overall Study|Virologic failure|0
5049089|NCT02569710|17403232|P3|Overall Study|Virologic failure|0
5049090|NCT02569710|17403233|P2|Overall Study|Virologic failure|0
5049091|NCT02569710|17403234|P1|Overall Study|Virologic failure|0
5049092|NCT02569710|17403225|P10|Overall Study|Lost to Follow-up|0
5049093|NCT02569710|17403226|P9|Overall Study|Lost to Follow-up|1
5049094|NCT02569710|17403227|P8|Overall Study|Lost to Follow-up|0
5049095|NCT02569710|17403228|P7|Overall Study|Lost to Follow-up|1
5049096|NCT02569710|17403229|P6|Overall Study|Lost to Follow-up|0
5049097|NCT02569710|17403230|P5|Overall Study|Lost to Follow-up|0
5049098|NCT02569710|17403231|P4|Overall Study|Lost to Follow-up|0
5049099|NCT02569710|17403232|P3|Overall Study|Lost to Follow-up|0
5049100|NCT02569710|17403233|P2|Overall Study|Lost to Follow-up|0
5049101|NCT02569710|17403234|P1|Overall Study|Lost to Follow-up|0
5049102|NCT02569710|17403225|P10|Overall Study|Adverse Event|0
5049103|NCT02569710|17403226|P9|Overall Study|Adverse Event|0
5049104|NCT02569710|17403227|P8|Overall Study|Adverse Event|0
5049105|NCT02569710|17403228|P7|Overall Study|Adverse Event|0
5049106|NCT02569710|17403229|P6|Overall Study|Adverse Event|0
5049107|NCT02569710|17403230|P5|Overall Study|Adverse Event|0
5049108|NCT02569710|17403231|P4|Overall Study|Adverse Event|0
5049109|NCT02569710|17403232|P3|Overall Study|Adverse Event|0
5049110|NCT02569710|17403233|P2|Overall Study|Adverse Event|0
5049111|NCT02569710|17403234|P1|Overall Study|Adverse Event|1
5049112|NCT02569437|17403574|P2|Overall Study|Lost to Follow-up|14
5049113|NCT02569437|17403575|P1|Overall Study|Lost to Follow-up|12
5049114|NCT02569398|17403605|P3|Overall Study|Other|13
5049115|NCT02569398|17403606|P2|Overall Study|Other|14
5049116|NCT02569398|17403607|P1|Overall Study|Other|12
5049117|NCT02569398|17403605|P3|Overall Study|Study terminated by sponsor|134
5049118|NCT02569398|17403606|P2|Overall Study|Study terminated by sponsor|131
5049119|NCT02569398|17403607|P1|Overall Study|Study terminated by sponsor|130
5049120|NCT02569398|17403605|P3|Overall Study|Withdrawal by Subject|30
5049121|NCT02569398|17403606|P2|Overall Study|Withdrawal by Subject|43
5049122|NCT02569398|17403607|P1|Overall Study|Withdrawal by Subject|43
5049123|NCT02569398|17403605|P3|Overall Study|Adverse Event|6
5049124|NCT02569398|17403606|P2|Overall Study|Adverse Event|1
5049125|NCT02569398|17403607|P1|Overall Study|Adverse Event|0
5049126|NCT02568683|17403682|P2|Overall Study|Study Terminated By Sponsor|2
5049127|NCT02568683|17403683|P1|Overall Study|Study Terminated By Sponsor|5
5049128|NCT02568683|17403682|P2|Overall Study|Withdrew Consent|0
5049129|NCT02568683|17403683|P1|Overall Study|Withdrew Consent|1
5049130|NCT02568683|17403682|P2|Overall Study|Death|2
5049131|NCT02568683|17403683|P1|Overall Study|Death|0
5049132|NCT02568475|17403712|P2|Overall Study|Transferred to another facility|0
5049133|NCT02568475|17403713|P1|Overall Study|Transferred to another facility|1
5049134|NCT02568475|17403712|P2|Overall Study|Short-term: Discharge location unknown|0
5049135|NCT02568475|17403713|P1|Overall Study|Short-term: Discharge location unknown|4
5049136|NCT02568475|17403712|P2|Overall Study|Discharged home|4
5049137|NCT02568475|17403713|P1|Overall Study|Discharged home|4
5049138|NCT02568475|17403712|P2|Overall Study|Withdrawal by Subject|0
5049139|NCT02568475|17403713|P1|Overall Study|Withdrawal by Subject|2
5049140|NCT02568475|17403712|P2|Overall Study|Lost to Follow-up|39
5049141|NCT02568475|17403713|P1|Overall Study|Lost to Follow-up|40
5049142|NCT02568397|17403727|P2|Period 2|Physician Decision|1
5049143|NCT02568397|17403728|P1|Period 2|Physician Decision|0
5049144|NCT02568397|17403727|P2|Period 2|Withdrawal by Subject|1
5049145|NCT02568397|17403728|P1|Period 2|Withdrawal by Subject|0
5049146|NCT02568384|17403752|P1|Overall Study|Mobile devices incompatible with App|2
5049147|NCT02568254|17403766|P6|Period 3|Unstatisfactory Lens fitting|0
5049148|NCT02568254|17403767|P5|Period 3|Unstatisfactory Lens fitting|1
5049149|NCT02568254|17403768|P4|Period 3|Unstatisfactory Lens fitting|0
5049150|NCT02568254|17403769|P3|Period 3|Unstatisfactory Lens fitting|0
5049151|NCT02568254|17403770|P2|Period 3|Unstatisfactory Lens fitting|0
5049152|NCT02568254|17403771|P1|Period 3|Unstatisfactory Lens fitting|0
5049153|NCT02568254|17403766|P6|Period 2|Adverse Event|0
5049154|NCT02568254|17403767|P5|Period 2|Adverse Event|0
5049155|NCT02568254|17403768|P4|Period 2|Adverse Event|0
5049156|NCT02568254|17403769|P3|Period 2|Adverse Event|1
5049157|NCT02568254|17403770|P2|Period 2|Adverse Event|0
5049158|NCT02568254|17403771|P1|Period 2|Adverse Event|0
5049159|NCT02568046|17403781|P2|Overall Study|Other Events|1
5049160|NCT02568046|17403782|P1|Overall Study|Other Events|0
5049161|NCT02568046|17403781|P2|Overall Study|Withdrawal by Subject|1
5049162|NCT02568046|17403782|P1|Overall Study|Withdrawal by Subject|2
5049163|NCT02568046|17403781|P2|Overall Study|Progressive Disease|0
5049164|NCT02568046|17403782|P1|Overall Study|Progressive Disease|1
5049165|NCT02568046|17403781|P2|Overall Study|Death|0
5049166|NCT02568046|17403782|P1|Overall Study|Death|2
5049167|NCT02568046|17403781|P2|Overall Study|Adverse Event|1
5049168|NCT02568046|17403782|P1|Overall Study|Adverse Event|0
5049169|NCT02567708|17403845|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
5049170|NCT02567708|17403846|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
5049171|NCT02567708|17403845|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
5049172|NCT02567708|17403846|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
5049173|NCT02567708|17403845|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
5049174|NCT02567708|17403846|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
5049175|NCT02567708|17403845|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
5049176|NCT02567708|17403846|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
5049177|NCT02567656|17403891|P6|Overall Study|Premature discontinuation due to PD|0
5049178|NCT02567656|17403892|P5|Overall Study|Premature discontinuation due to PD|0
5049179|NCT02567656|17403893|P4|Overall Study|Premature discontinuation due to PD|0
5049180|NCT02567656|17403894|P3|Overall Study|Premature discontinuation due to PD|2
5049181|NCT02567656|17403895|P2|Overall Study|Premature discontinuation due to PD|1
5049182|NCT02567656|17403896|P1|Overall Study|Premature discontinuation due to PD|1
5049183|NCT02567552|17403928|P2|Overall Study|Adverse Event|1
5049184|NCT02567552|17403929|P1|Overall Study|Adverse Event|0
5049185|NCT02567188|17403959|P1|Overall Study|Protocol Violation|5
5049186|NCT02567188|17403959|P1|Overall Study|Started Hemodialysis|2
5049187|NCT02567188|17403959|P1|Overall Study|Moved and Changed Clinic|1
5049188|NCT02567188|17403959|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
5049189|NCT02567188|17403959|P1|Overall Study|Withdrawal by Subject|1
5049190|NCT02567188|17403959|P1|Overall Study|Adverse Event|1
5049191|NCT02567188|17403959|P1|Overall Study|Lost to Follow-up|5
5049192|NCT02567188|17403959|P1|Overall Study|Terminated Mircera Treatment|9
5049193|NCT02567188|17403959|P1|Overall Study|Death|10
5049194|NCT02566889|17403990|P2|Overall Study|Other|2
5049195|NCT02566889|17403991|P1|Overall Study|Other|6
5049196|NCT02566889|17403990|P2|Overall Study|Adverse Event|2
5049197|NCT02566889|17403991|P1|Overall Study|Adverse Event|4
5049198|NCT02566889|17403990|P2|Overall Study|Withdrawal by Subject|1
5049199|NCT02566889|17403991|P1|Overall Study|Withdrawal by Subject|3
5049200|NCT02566785|17404009|P2|Overall Study|Worsening condition|1
5049201|NCT02566785|17404010|P1|Overall Study|Worsening condition|1
5049202|NCT02566785|17404009|P2|Overall Study|Lost to Follow-up|2
5049203|NCT02566785|17404010|P1|Overall Study|Lost to Follow-up|0
5049204|NCT02566759|17404037|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
5049205|NCT02566759|17404038|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049206|NCT02566759|17404039|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049207|NCT02566759|17404040|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049208|NCT02566759|17404041|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049209|NCT02566759|17404042|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049210|NCT02566759|17404043|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049211|NCT02566759|17404044|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049212|NCT02566759|17404045|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049213|NCT02566759|17404046|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049214|NCT02566759|17404047|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049215|NCT02566759|17404048|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049216|NCT02566759|17404049|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049217|NCT02566759|17404050|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049218|NCT02566759|17404051|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049219|NCT02566759|17404052|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049220|NCT02566759|17404053|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5049221|NCT02566759|17404037|P17|All Parts|Other|0
5049222|NCT02566759|17404038|P16|All Parts|Other|0
5049223|NCT02566759|17404039|P15|All Parts|Other|0
5049224|NCT02566759|17404040|P14|All Parts|Other|2
5049225|NCT02566759|17404041|P13|All Parts|Other|0
5049226|NCT02566759|17404042|P12|All Parts|Other|0
5049227|NCT02566759|17404043|P11|All Parts|Other|0
5049228|NCT02566759|17404044|P10|All Parts|Other|0
5049229|NCT02566759|17404045|P9|All Parts|Other|0
5049230|NCT02566759|17404046|P8|All Parts|Other|0
5049231|NCT02566759|17404047|P7|All Parts|Other|0
5049232|NCT02566759|17404048|P6|All Parts|Other|0
5049233|NCT02566759|17404049|P5|All Parts|Other|0
5049234|NCT02566759|17404050|P4|All Parts|Other|0
5049235|NCT02566759|17404051|P3|All Parts|Other|0
5049236|NCT02566759|17404052|P2|All Parts|Other|0
5049237|NCT02566759|17404053|P1|All Parts|Other|0
5049238|NCT02566759|17404037|P17|All Parts|Adverse Event|0
5049239|NCT02566759|17404038|P16|All Parts|Adverse Event|0
5049240|NCT02566759|17404039|P15|All Parts|Adverse Event|0
5049241|NCT02566759|17404040|P14|All Parts|Adverse Event|3
5049242|NCT02566759|17404041|P13|All Parts|Adverse Event|1
5049243|NCT02566759|17404042|P12|All Parts|Adverse Event|0
5049244|NCT02566759|17404043|P11|All Parts|Adverse Event|0
5049245|NCT02566759|17404044|P10|All Parts|Adverse Event|0
5049246|NCT02566759|17404045|P9|All Parts|Adverse Event|0
5049247|NCT02566759|17404046|P8|All Parts|Adverse Event|0
5049248|NCT02566759|17404047|P7|All Parts|Adverse Event|0
5049249|NCT02566759|17404048|P6|All Parts|Adverse Event|0
5049250|NCT02566759|17404049|P5|All Parts|Adverse Event|0
5049251|NCT02566759|17404050|P4|All Parts|Adverse Event|0
5049252|NCT02566759|17404051|P3|All Parts|Adverse Event|0
5049253|NCT02566759|17404052|P2|All Parts|Adverse Event|0
5049254|NCT02566759|17404053|P1|All Parts|Adverse Event|0
5049255|NCT02566759|17404037|P17|All Parts|Withdrawal by Subject|0
5049256|NCT02566759|17404038|P16|All Parts|Withdrawal by Subject|0
5049257|NCT02566759|17404039|P15|All Parts|Withdrawal by Subject|0
5049258|NCT02566759|17404040|P14|All Parts|Withdrawal by Subject|0
5049259|NCT02566759|17404041|P13|All Parts|Withdrawal by Subject|0
5049260|NCT02566759|17404042|P12|All Parts|Withdrawal by Subject|0
5049261|NCT02566759|17404043|P11|All Parts|Withdrawal by Subject|0
5049262|NCT02566759|17404044|P10|All Parts|Withdrawal by Subject|0
5049263|NCT02566759|17404045|P9|All Parts|Withdrawal by Subject|0
5049264|NCT02566759|17404046|P8|All Parts|Withdrawal by Subject|0
5049265|NCT02566759|17404047|P7|All Parts|Withdrawal by Subject|0
5049266|NCT02566759|17404048|P6|All Parts|Withdrawal by Subject|0
5049267|NCT02566759|17404049|P5|All Parts|Withdrawal by Subject|0
5049268|NCT02566759|17404050|P4|All Parts|Withdrawal by Subject|0
5049269|NCT02566759|17404051|P3|All Parts|Withdrawal by Subject|0
5049270|NCT02566759|17404052|P2|All Parts|Withdrawal by Subject|1
5049271|NCT02566759|17404053|P1|All Parts|Withdrawal by Subject|0
5049272|NCT02566577|17404215|P2|Overall Study|Physical limitation|0
5049273|NCT02566577|17404216|P1|Overall Study|Physical limitation|1
5049274|NCT02566577|17404215|P2|Overall Study|Equipment failure|1
5049275|NCT02566577|17404216|P1|Overall Study|Equipment failure|1
5049276|NCT02566577|17404215|P2|Overall Study|Withdrawal by Subject|1
5049277|NCT02566577|17404216|P1|Overall Study|Withdrawal by Subject|1
5049278|NCT02566109|17404296|P1|Overall Study|Withdrawal by Subject|1
5049279|NCT02566031|17404360|P2|Overall Study|Lost to Follow-up|1
5049280|NCT02566031|17404361|P1|Overall Study|Lost to Follow-up|1
5049281|NCT02566031|17404360|P2|Overall Study|Adverse Event|1
5049282|NCT02566031|17404361|P1|Overall Study|Adverse Event|3
5049283|NCT02566031|17404360|P2|Overall Study|Protocol deviation|3
5049284|NCT02566031|17404361|P1|Overall Study|Protocol deviation|2
5049285|NCT02566031|17404360|P2|Overall Study|Patient/guardian decision|7
5049286|NCT02566031|17404361|P1|Overall Study|Patient/guardian decision|14
5049287|NCT02566005|17404378|P2|Overall Study|labor after randomization|4
5049288|NCT02566005|17404379|P1|Overall Study|labor after randomization|0
5049289|NCT02566005|17404378|P2|Overall Study|did not receive foley|1
5049290|NCT02566005|17404379|P1|Overall Study|did not receive foley|0
5049291|NCT02566005|17404378|P2|Overall Study|received foley|0
5049292|NCT02566005|17404379|P1|Overall Study|received foley|8
5049293|NCT02566005|17404378|P2|Overall Study|vaginal bleeding|1
5049294|NCT02566005|17404379|P1|Overall Study|vaginal bleeding|0
5049295|NCT02565914|17404407|P1|Overall Study|Enrolled, but did not receive study drug|2
5049296|NCT02565914|17404407|P1|Overall Study|Other|18
5049297|NCT02565914|17404407|P1|Overall Study|Commercial drug available|5
5049298|NCT02565914|17404407|P1|Overall Study|Parent study termination by sponsor|1
5049299|NCT02565914|17404407|P1|Overall Study|Physician Decision|6
5049300|NCT02565914|17404407|P1|Overall Study|Other noncompliance|6
5049301|NCT02565914|17404407|P1|Overall Study|Death (not treatment emergent)|1
5049302|NCT02565914|17404407|P1|Overall Study|Lost to Follow-up|12
5049303|NCT02565914|17404407|P1|Overall Study|Withdrawal of consent (not due to AE)|25
5049304|NCT02565914|17404407|P1|Overall Study|Adverse Event|17
5049305|NCT02565810|17404441|P1|Overall Study|Withdrawal by Subject|1
5049306|NCT02565784|17404450|P1|Second Treatment|Withdrawal by Subject|2
5049307|NCT02565784|17404450|P1|First Treatment|Withdrawal by Subject|1
5049308|NCT02565784|17404450|P1|First Treatment|Adverse Event|1
5049309|NCT02565706|17404462|P4|Overall Study|Lost to Follow-up|74
5049310|NCT02565706|17404463|P3|Overall Study|Lost to Follow-up|82
5049311|NCT02565706|17404464|P2|Overall Study|Lost to Follow-up|75
5049312|NCT02565706|17404465|P1|Overall Study|Lost to Follow-up|72
5049313|NCT02565706|17404462|P4|Overall Study|Withdrawal by Subject|11
5049314|NCT02565706|17404463|P3|Overall Study|Withdrawal by Subject|7
5049315|NCT02565706|17404464|P2|Overall Study|Withdrawal by Subject|7
5049316|NCT02565706|17404465|P1|Overall Study|Withdrawal by Subject|5
5049317|NCT02565615|17404571|P5|Overall Study|Untreated|567
5049318|NCT02565615|17404572|P4|Overall Study|Untreated|0
5049319|NCT02565615|17404573|P3|Overall Study|Untreated|0
5049320|NCT02565615|17404574|P2|Overall Study|Untreated|0
5049321|NCT02565615|17404575|P1|Overall Study|Untreated|0
5049322|NCT02565615|17404571|P5|Overall Study|Adverse Event|9
5049323|NCT02565615|17404572|P4|Overall Study|Adverse Event|0
5049324|NCT02565615|17404573|P3|Overall Study|Adverse Event|0
5049325|NCT02565615|17404574|P2|Overall Study|Adverse Event|1
5049326|NCT02565615|17404575|P1|Overall Study|Adverse Event|1
5049327|NCT02565615|17404571|P5|Overall Study|Reason not defined|62
5049328|NCT02565615|17404572|P4|Overall Study|Reason not defined|1
5049329|NCT02565615|17404573|P3|Overall Study|Reason not defined|0
5049330|NCT02565615|17404574|P2|Overall Study|Reason not defined|2
5049331|NCT02565615|17404575|P1|Overall Study|Reason not defined|0
5049332|NCT02565615|17404571|P5|Overall Study|Not meeting eligibility criteria|25
5049333|NCT02565615|17404572|P4|Overall Study|Not meeting eligibility criteria|0
5049334|NCT02565615|17404573|P3|Overall Study|Not meeting eligibility criteria|0
5049335|NCT02565615|17404574|P2|Overall Study|Not meeting eligibility criteria|7
5049336|NCT02565615|17404575|P1|Overall Study|Not meeting eligibility criteria|0
5049337|NCT02565615|17404571|P5|Overall Study|Lost to Follow-up|765
5049338|NCT02565615|17404572|P4|Overall Study|Lost to Follow-up|1
5049339|NCT02565615|17404573|P3|Overall Study|Lost to Follow-up|0
5049340|NCT02565615|17404574|P2|Overall Study|Lost to Follow-up|4
5049341|NCT02565615|17404575|P1|Overall Study|Lost to Follow-up|0
5049342|NCT02565615|17404571|P5|Overall Study|Not willing to participate in study|169
5049343|NCT02565615|17404572|P4|Overall Study|Not willing to participate in study|1
5049344|NCT02565615|17404573|P3|Overall Study|Not willing to participate in study|0
5049345|NCT02565615|17404574|P2|Overall Study|Not willing to participate in study|21
5049346|NCT02565615|17404575|P1|Overall Study|Not willing to participate in study|2
5049347|NCT02565615|17404571|P5|Overall Study|Death|4
5049348|NCT02565615|17404572|P4|Overall Study|Death|0
5049349|NCT02565615|17404573|P3|Overall Study|Death|0
5049350|NCT02565615|17404574|P2|Overall Study|Death|1
5049351|NCT02565615|17404575|P1|Overall Study|Death|0
5049352|NCT02565576|17404689|P2|Overall Study|Adverse Event|0
5049353|NCT02565576|17404690|P1|Overall Study|Adverse Event|1
5049354|NCT02565576|17404689|P2|Overall Study|Death|2
5049355|NCT02565576|17404690|P1|Overall Study|Death|0
5049356|NCT02565576|17404689|P2|Overall Study|Lost to Follow-up|0
5049357|NCT02565576|17404690|P1|Overall Study|Lost to Follow-up|1
5049358|NCT02565576|17404689|P2|Overall Study|subject / guardian decision|3
5049359|NCT02565576|17404690|P1|Overall Study|subject / guardian decision|1
5049360|NCT02565576|17404689|P2|Overall Study|abnormal lab value|0
5049361|NCT02565576|17404690|P1|Overall Study|abnormal lab value|2
5049362|NCT02565381|17404733|P3|Overall Study|Lost to Follow-up|1
5049363|NCT02565381|17404734|P2|Overall Study|Lost to Follow-up|0
5049364|NCT02565381|17404735|P1|Overall Study|Lost to Follow-up|1
5049365|NCT02565186|17404775|P2|Overall Study|Did Not Receive Study Drug|86
5049366|NCT02565186|17404776|P1|Overall Study|Did Not Receive Study Drug|55
5049367|NCT02565186|17404775|P2|Overall Study|Missing|0
5049368|NCT02565186|17404776|P1|Overall Study|Missing|1
5049369|NCT02565186|17404775|P2|Overall Study|Sponsor Request|9
5049370|NCT02565186|17404776|P1|Overall Study|Sponsor Request|5
5049371|NCT02565186|17404775|P2|Overall Study|Physician Decision|16
5049372|NCT02565186|17404776|P1|Overall Study|Physician Decision|18
5049373|NCT02565186|17404775|P2|Overall Study|Withdrawal by Subject|214
5049374|NCT02565186|17404776|P1|Overall Study|Withdrawal by Subject|229
5049375|NCT02565186|17404775|P2|Overall Study|Non-Compliance|55
5049376|NCT02565186|17404776|P1|Overall Study|Non-Compliance|57
5049377|NCT02565186|17404775|P2|Overall Study|Lost to Follow-up|93
5049378|NCT02565186|17404776|P1|Overall Study|Lost to Follow-up|102
5049379|NCT02565186|17404775|P2|Overall Study|Adverse Event|148
5049380|NCT02565186|17404776|P1|Overall Study|Adverse Event|113
5049381|NCT02565147|17404790|P2|Overall Study|Death|1
5049382|NCT02565147|17404791|P1|Overall Study|Death|1
5049383|NCT02565147|17404790|P2|Overall Study|Lost to Follow-up|1
5049384|NCT02565147|17404791|P1|Overall Study|Lost to Follow-up|0
5049385|NCT02565147|17404790|P2|Overall Study|Withdrawal by Subject|1
5049386|NCT02565147|17404791|P1|Overall Study|Withdrawal by Subject|5
5049387|NCT02565108|17404815|P2|Overall Study|Withdrew Consent|0
5049388|NCT02565108|17404816|P1|Overall Study|Withdrew Consent|1
5049389|NCT02565108|17404815|P2|Overall Study|Adverse Event|0
5049390|NCT02565108|17404816|P1|Overall Study|Adverse Event|1
5049391|NCT02564952|17404832|P1|Overall Study|Participant Met Withdrawal Criteria|1
5049392|NCT02564952|17404832|P1|Overall Study|Low Efficacy|1
5049393|NCT02564952|17404832|P1|Overall Study|Withdrawal by Subject|1
5049394|NCT02564952|17404832|P1|Overall Study|Participant Withdrawn by Investigator|1
5049395|NCT02564952|17404832|P1|Overall Study|Lost to Follow-up|1
5049396|NCT02564952|17404832|P1|Overall Study|Adverse Event|6
5049397|NCT02564887|17404877|P2|Overall Study|Lost to Follow-up|0
5049398|NCT02564887|17404878|P1|Overall Study|Lost to Follow-up|6
5049399|NCT02564718|17404896|P2|Overall Study|Withdrew from treatment|1
5049400|NCT02564718|17404897|P1|Overall Study|Withdrew from treatment|0
5049401|NCT02564263|17404985|P2|Overall Study|Ongoing in Study|25
5049402|NCT02564263|17404986|P1|Overall Study|Ongoing in Study|42
5049403|NCT02564263|17404985|P2|Overall Study|Withdrawal by Subject|18
5049404|NCT02564263|17404986|P1|Overall Study|Withdrawal by Subject|5
5049405|NCT02564263|17404985|P2|Overall Study|Death|242
5049406|NCT02564263|17404986|P1|Overall Study|Death|236
5049407|NCT02564263|17404985|P2|Overall Study|Adverse Event|29
5049408|NCT02564263|17404986|P1|Overall Study|Adverse Event|31
5049409|NCT02564211|17405008|P1|Overall Study|Adverse Event|4
5049410|NCT02564120|17405019|P1|Overall Study|Other medical condition|24
5049411|NCT02564120|17405019|P1|Overall Study|Withdrawal by Subject|204
5049412|NCT02564120|17405019|P1|Overall Study|Death|58
5049413|NCT02564120|17405019|P1|Overall Study|Did not return release forms|160
5049414|NCT02564055|17405067|P6|Overall Study|Withdrawal by Subject|10
5049415|NCT02564055|17405068|P5|Overall Study|Withdrawal by Subject|10
5049416|NCT02564055|17405069|P4|Overall Study|Withdrawal by Subject|3
5049417|NCT02564055|17405070|P3|Overall Study|Withdrawal by Subject|3
5049418|NCT02564055|17405071|P2|Overall Study|Withdrawal by Subject|4
5049419|NCT02564055|17405072|P1|Overall Study|Withdrawal by Subject|4
5049420|NCT02564055|17405067|P6|Overall Study|Physician Decision|0
5049421|NCT02564055|17405068|P5|Overall Study|Physician Decision|0
5049422|NCT02564055|17405069|P4|Overall Study|Physician Decision|0
5049423|NCT02564055|17405070|P3|Overall Study|Physician Decision|1
5049424|NCT02564055|17405071|P2|Overall Study|Physician Decision|0
5049425|NCT02564055|17405072|P1|Overall Study|Physician Decision|0
5049426|NCT02564055|17405067|P6|Overall Study|Lost to Follow-up|0
5049427|NCT02564055|17405068|P5|Overall Study|Lost to Follow-up|1
5049428|NCT02564055|17405069|P4|Overall Study|Lost to Follow-up|2
5049429|NCT02564055|17405070|P3|Overall Study|Lost to Follow-up|4
5049430|NCT02564055|17405071|P2|Overall Study|Lost to Follow-up|1
5049431|NCT02564055|17405072|P1|Overall Study|Lost to Follow-up|0
5049432|NCT02564055|17405067|P6|Overall Study|Reached stopping criteria|1
5049433|NCT02564055|17405068|P5|Overall Study|Reached stopping criteria|0
5049434|NCT02564055|17405069|P4|Overall Study|Reached stopping criteria|0
5049435|NCT02564055|17405070|P3|Overall Study|Reached stopping criteria|0
5049436|NCT02564055|17405071|P2|Overall Study|Reached stopping criteria|0
5049437|NCT02564055|17405072|P1|Overall Study|Reached stopping criteria|0
5049438|NCT02564055|17405067|P6|Overall Study|Protocol Violation|0
5049439|NCT02564055|17405068|P5|Overall Study|Protocol Violation|0
5049440|NCT02564055|17405069|P4|Overall Study|Protocol Violation|0
5049441|NCT02564055|17405070|P3|Overall Study|Protocol Violation|0
5049442|NCT02564055|17405071|P2|Overall Study|Protocol Violation|0
5049443|NCT02564055|17405072|P1|Overall Study|Protocol Violation|1
5049444|NCT02564055|17405067|P6|Overall Study|Adverse Event|1
5049445|NCT02564055|17405068|P5|Overall Study|Adverse Event|4
5049446|NCT02564055|17405069|P4|Overall Study|Adverse Event|1
5049447|NCT02564055|17405070|P3|Overall Study|Adverse Event|4
5049448|NCT02564055|17405071|P2|Overall Study|Adverse Event|0
5049449|NCT02564055|17405072|P1|Overall Study|Adverse Event|1
5049450|NCT02564042|17405326|P6|Overall Study|Withdrawal by Subject|12
5049451|NCT02564042|17405327|P5|Overall Study|Withdrawal by Subject|10
5049452|NCT02564042|17405328|P4|Overall Study|Withdrawal by Subject|2
5049453|NCT02564042|17405329|P3|Overall Study|Withdrawal by Subject|2
5049454|NCT02564042|17405330|P2|Overall Study|Withdrawal by Subject|3
5049455|NCT02564042|17405331|P1|Overall Study|Withdrawal by Subject|5
5049456|NCT02564042|17405326|P6|Overall Study|Physician Decision|0
5049457|NCT02564042|17405327|P5|Overall Study|Physician Decision|0
5049458|NCT02564042|17405328|P4|Overall Study|Physician Decision|1
5049459|NCT02564042|17405329|P3|Overall Study|Physician Decision|0
5049460|NCT02564042|17405330|P2|Overall Study|Physician Decision|0
5049461|NCT02564042|17405331|P1|Overall Study|Physician Decision|1
5049462|NCT02564042|17405326|P6|Overall Study|Lost to Follow-up|1
5049463|NCT02564042|17405327|P5|Overall Study|Lost to Follow-up|1
5049464|NCT02564042|17405328|P4|Overall Study|Lost to Follow-up|0
5049465|NCT02564042|17405329|P3|Overall Study|Lost to Follow-up|1
5049466|NCT02564042|17405330|P2|Overall Study|Lost to Follow-up|1
5049467|NCT02564042|17405331|P1|Overall Study|Lost to Follow-up|1
5049468|NCT02564042|17405326|P6|Overall Study|Adverse Event|1
5049469|NCT02564042|17405327|P5|Overall Study|Adverse Event|0
5049470|NCT02564042|17405328|P4|Overall Study|Adverse Event|0
5049471|NCT02564042|17405329|P3|Overall Study|Adverse Event|3
5049472|NCT02564042|17405330|P2|Overall Study|Adverse Event|4
5049473|NCT02564042|17405331|P1|Overall Study|Adverse Event|4
5049474|NCT02563899|17405626|P4|Overall Study|Withdrawal by Subject|0
5049475|NCT02563899|17405627|P3|Overall Study|Withdrawal by Subject|1
5049476|NCT02563899|17405628|P2|Overall Study|Withdrawal by Subject|0
5049477|NCT02563899|17405629|P1|Overall Study|Withdrawal by Subject|0
5049478|NCT02563899|17405626|P4|Overall Study|Protocol Violation|0
5049479|NCT02563899|17405627|P3|Overall Study|Protocol Violation|0
5049480|NCT02563899|17405628|P2|Overall Study|Protocol Violation|0
5049481|NCT02563899|17405629|P1|Overall Study|Protocol Violation|1
5049482|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5049483|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
5049484|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5049485|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5049486|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5049487|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5049488|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
5049489|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5049490|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5049491|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5049492|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5049493|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5049494|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
5049495|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5049496|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5049497|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5049498|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5049499|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5049500|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
5049501|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5049502|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5049503|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5049504|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5049505|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5049506|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
5049507|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
5049508|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5049509|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5049510|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5049511|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5049512|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5049513|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
5049514|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5049515|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5049516|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5049517|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5049518|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
5049519|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
5049520|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5049521|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5049522|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5049523|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5049524|NCT02563548|17405705|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
5049525|NCT02563548|17405706|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
5049526|NCT02563548|17405707|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5049527|NCT02563548|17405708|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5049528|NCT02563548|17405709|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5049529|NCT02563548|17405710|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5049530|NCT02563548|17405705|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5049531|NCT02563548|17405706|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5049532|NCT02563548|17405707|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
5049533|NCT02563548|17405708|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
5049534|NCT02563548|17405709|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5049535|NCT02563548|17405710|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5049536|NCT02563548|17405705|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5049537|NCT02563548|17405706|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5049538|NCT02563548|17405707|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5049539|NCT02563548|17405708|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
5049540|NCT02563548|17405709|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5049541|NCT02563548|17405710|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5049542|NCT02563548|17405705|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5049543|NCT02563548|17405706|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5049544|NCT02563548|17405707|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5049545|NCT02563548|17405708|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
5049546|NCT02563548|17405709|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
5049547|NCT02563548|17405710|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
5049548|NCT02563548|17405705|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5049549|NCT02563548|17405706|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5049550|NCT02563548|17405707|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
5049551|NCT02563548|17405708|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5049552|NCT02563548|17405709|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5049553|NCT02563548|17405710|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
5049554|NCT02563106|17405819|P2|Overall Study|Other reason - not specified|1
5049555|NCT02563106|17405820|P1|Overall Study|Other reason - not specified|2
5049556|NCT02563106|17405819|P2|Overall Study|Physician Decision|1
5049557|NCT02563106|17405820|P1|Overall Study|Physician Decision|3
5049558|NCT02563106|17405819|P2|Overall Study|Lost to Follow-up|2
5049559|NCT02563106|17405820|P1|Overall Study|Lost to Follow-up|3
5049560|NCT02563106|17405819|P2|Overall Study|Use of non-permitted concurrent therapy|2
5049561|NCT02563106|17405820|P1|Overall Study|Use of non-permitted concurrent therapy|1
5049562|NCT02563106|17405819|P2|Overall Study|Protocol Violation|0
5049563|NCT02563106|17405820|P1|Overall Study|Protocol Violation|1
5049564|NCT02563106|17405819|P2|Overall Study|Adverse Event|15
5049565|NCT02563106|17405820|P1|Overall Study|Adverse Event|17
5049566|NCT02563106|17405819|P2|Overall Study|Withdrawal by Subject|8
5049567|NCT02563106|17405820|P1|Overall Study|Withdrawal by Subject|7
5049568|NCT02563028|17405859|P1|Overall Study|Unable to elicit VEP post induction|1
5049569|NCT02563028|17405859|P1|Overall Study|Lack of equipment|1
5049570|NCT02562482|17405948|P2|Overall Study|Illness/Injury unrelated to product|1
5049571|NCT02562482|17405949|P1|Overall Study|Illness/Injury unrelated to product|0
5049572|NCT02562482|17405948|P2|Overall Study|Physician Decision|3
5049573|NCT02562482|17405949|P1|Overall Study|Physician Decision|1
5049574|NCT02562482|17405948|P2|Overall Study|Withdrawal by Subject|3
5049575|NCT02562482|17405949|P1|Overall Study|Withdrawal by Subject|5
5049576|NCT02562482|17405948|P2|Overall Study|Moved from area|3
5049577|NCT02562482|17405949|P1|Overall Study|Moved from area|2
5049578|NCT02562482|17405948|P2|Overall Study|Lost to Follow-up|6
5049579|NCT02562482|17405949|P1|Overall Study|Lost to Follow-up|9
5049580|NCT02562482|17405948|P2|Overall Study|Enrolled, but did not receive product|0
5049581|NCT02562482|17405949|P1|Overall Study|Enrolled, but did not receive product|4
5049582|NCT02561832|17405984|P2|Overall Study|Disease progression|3
5049583|NCT02561832|17405985|P1|Overall Study|Disease progression|3
5049584|NCT02561832|17405984|P2|Overall Study|Adverse Event|0
5049585|NCT02561832|17405985|P1|Overall Study|Adverse Event|3
5049586|NCT02561832|17405984|P2|Overall Study|Withdrawal by Subject|1
5049587|NCT02561832|17405985|P1|Overall Study|Withdrawal by Subject|1
5049588|NCT02561806|17405993|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
5049589|NCT02561806|17405994|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
5049590|NCT02561806|17405993|P2|Post-Treatment Follow-up|Lost to Follow-up|1
5049591|NCT02561806|17405994|P1|Post-Treatment Follow-up|Lost to Follow-up|1
5049592|NCT02561806|17405993|P2|Maintenance Period|Site staff became unblinded|1
5049593|NCT02561806|17405994|P1|Maintenance Period|Site staff became unblinded|0
5049594|NCT02561806|17405993|P2|Maintenance Period|Withdrawal by Subject|3
5049595|NCT02561806|17405994|P1|Maintenance Period|Withdrawal by Subject|5
5049596|NCT02561806|17405993|P2|Maintenance Period|Protocol Violation|0
5049597|NCT02561806|17405994|P1|Maintenance Period|Protocol Violation|1
5049598|NCT02561806|17405993|P2|Maintenance Period|Lost to Follow-up|2
5049599|NCT02561806|17405994|P1|Maintenance Period|Lost to Follow-up|2
5049600|NCT02561806|17405993|P2|Maintenance Period|Lack of Efficacy|1
5049601|NCT02561806|17405994|P1|Maintenance Period|Lack of Efficacy|3
5049602|NCT02561806|17405993|P2|Maintenance Period|Adverse Event|1
5049603|NCT02561806|17405994|P1|Maintenance Period|Adverse Event|2
5049604|NCT02561806|17405993|P2|Induction Period|Randomized but not treated|1
5049605|NCT02561806|17405994|P1|Induction Period|Randomized but not treated|0
5049606|NCT02561806|17405993|P2|Induction Period|Site staff became unblinded|0
5049607|NCT02561806|17405994|P1|Induction Period|Site staff became unblinded|1
5049608|NCT02561806|17405993|P2|Induction Period|Withdrawal by Subject|2
5049609|NCT02561806|17405994|P1|Induction Period|Withdrawal by Subject|0
5049610|NCT02561806|17405993|P2|Induction Period|Lack of Efficacy|0
5049611|NCT02561806|17405994|P1|Induction Period|Lack of Efficacy|1
5049612|NCT02561806|17405993|P2|Induction Period|Adverse Event|2
5049613|NCT02561806|17405994|P1|Induction Period|Adverse Event|0
5049614|NCT02561572|17406098|P2|Overall Study|Protocol Violation|1
5049615|NCT02561572|17406099|P1|Overall Study|Protocol Violation|0
5049616|NCT02561572|17406098|P2|Overall Study|Inadequate time before surgery|1
5049617|NCT02561572|17406099|P1|Overall Study|Inadequate time before surgery|2
5049618|NCT02561195|17406198|P6|Overall Study|Randomized but not treated|0
5049619|NCT02561195|17406199|P5|Overall Study|Randomized but not treated|0
5049620|NCT02561195|17406200|P4|Overall Study|Randomized but not treated|0
5049621|NCT02561195|17406201|P3|Overall Study|Randomized but not treated|0
5049622|NCT02561195|17406202|P2|Overall Study|Randomized but not treated|0
5049623|NCT02561195|17406203|P1|Overall Study|Randomized but not treated|1
5049624|NCT02561195|17406198|P6|Overall Study|Withdrawal by Subject|0
5049625|NCT02561195|17406199|P5|Overall Study|Withdrawal by Subject|6
5049626|NCT02561195|17406200|P4|Overall Study|Withdrawal by Subject|2
5049627|NCT02561195|17406201|P3|Overall Study|Withdrawal by Subject|4
5049628|NCT02561195|17406202|P2|Overall Study|Withdrawal by Subject|4
5049629|NCT02561195|17406203|P1|Overall Study|Withdrawal by Subject|3
5049630|NCT02561195|17406198|P6|Overall Study|Death|0
5049631|NCT02561195|17406199|P5|Overall Study|Death|0
5049632|NCT02561195|17406200|P4|Overall Study|Death|2
5049633|NCT02561195|17406201|P3|Overall Study|Death|0
5049634|NCT02561195|17406202|P2|Overall Study|Death|1
5049635|NCT02561195|17406203|P1|Overall Study|Death|2
5049636|NCT02561195|17406198|P6|Overall Study|Protocol Violation|2
5049637|NCT02561195|17406199|P5|Overall Study|Protocol Violation|5
5049638|NCT02561195|17406200|P4|Overall Study|Protocol Violation|2
5049639|NCT02561195|17406201|P3|Overall Study|Protocol Violation|1
5049640|NCT02561195|17406202|P2|Overall Study|Protocol Violation|0
5049641|NCT02561195|17406203|P1|Overall Study|Protocol Violation|1
5049642|NCT02561195|17406198|P6|Overall Study|Other|1
5049643|NCT02561195|17406199|P5|Overall Study|Other|5
5049644|NCT02561195|17406200|P4|Overall Study|Other|7
5049645|NCT02561195|17406201|P3|Overall Study|Other|1
5049646|NCT02561195|17406202|P2|Overall Study|Other|3
5049647|NCT02561195|17406203|P1|Overall Study|Other|7
5049648|NCT02561195|17406198|P6|Overall Study|No longer willing to participate|3
5049649|NCT02561195|17406199|P5|Overall Study|No longer willing to participate|1
5049650|NCT02561195|17406200|P4|Overall Study|No longer willing to participate|4
5049651|NCT02561195|17406201|P3|Overall Study|No longer willing to participate|0
5049652|NCT02561195|17406202|P2|Overall Study|No longer willing to participate|4
5049653|NCT02561195|17406203|P1|Overall Study|No longer willing to participate|2
5049654|NCT02561195|17406198|P6|Overall Study|No longer meets eligibility criteria|1
5049655|NCT02561195|17406199|P5|Overall Study|No longer meets eligibility criteria|4
5049656|NCT02561195|17406200|P4|Overall Study|No longer meets eligibility criteria|4
5049657|NCT02561195|17406201|P3|Overall Study|No longer meets eligibility criteria|0
5049658|NCT02561195|17406202|P2|Overall Study|No longer meets eligibility criteria|1
5049659|NCT02561195|17406203|P1|Overall Study|No longer meets eligibility criteria|0
5049660|NCT02561195|17406198|P6|Overall Study|Lost to Follow-up|3
5049661|NCT02561195|17406199|P5|Overall Study|Lost to Follow-up|3
5049662|NCT02561195|17406200|P4|Overall Study|Lost to Follow-up|2
5049663|NCT02561195|17406201|P3|Overall Study|Lost to Follow-up|0
5049664|NCT02561195|17406202|P2|Overall Study|Lost to Follow-up|4
5049665|NCT02561195|17406203|P1|Overall Study|Lost to Follow-up|3
5049666|NCT02561195|17406198|P6|Overall Study|Adverse Event|0
5049667|NCT02561195|17406199|P5|Overall Study|Adverse Event|4
5049668|NCT02561195|17406200|P4|Overall Study|Adverse Event|3
5049669|NCT02561195|17406201|P3|Overall Study|Adverse Event|0
5049670|NCT02561195|17406202|P2|Overall Study|Adverse Event|5
5049671|NCT02561195|17406203|P1|Overall Study|Adverse Event|4
5049672|NCT02561156|17406364|P13|Part 2|Adverse Event|0
5049673|NCT02561156|17406365|P12|Part 2|Adverse Event|1
5049674|NCT02561156|17406366|P11|Part 2|Adverse Event|0
5049675|NCT02561156|17406367|P10|Part 2|Adverse Event|0
5049676|NCT02561156|17406368|P9|Part 2|Adverse Event|0
5049677|NCT02561156|17406369|P8|Part 2|Adverse Event|0
5049678|NCT02561156|17406370|P7|Part 2|Adverse Event|0
5049679|NCT02561156|17406371|P6|Part 2|Adverse Event|0
5049680|NCT02561156|17406372|P5|Part 2|Adverse Event|0
5049681|NCT02561156|17406373|P4|Part 2|Adverse Event|0
5049682|NCT02561156|17406374|P3|Part 2|Adverse Event|0
5049683|NCT02561156|17406375|P2|Part 2|Adverse Event|0
5049684|NCT02561156|17406376|P1|Part 2|Adverse Event|0
5049685|NCT02561078|17406573|P2|Overall Study|Withdrawal by Subject|10
5049686|NCT02561078|17406574|P1|Overall Study|Withdrawal by Subject|13
5049687|NCT02561078|17406573|P2|Overall Study|Physician Decision|3
5049688|NCT02561078|17406574|P1|Overall Study|Physician Decision|2
5049689|NCT02561078|17406573|P2|Overall Study|Non-Compliance with Study Drug|3
5049690|NCT02561078|17406574|P1|Overall Study|Non-Compliance with Study Drug|6
5049691|NCT02561078|17406573|P2|Overall Study|Lost to Follow-up|6
5049692|NCT02561078|17406574|P1|Overall Study|Lost to Follow-up|2
5049693|NCT02561078|17406573|P2|Overall Study|Death|1
5049694|NCT02561078|17406574|P1|Overall Study|Death|2
5049695|NCT02561078|17406573|P2|Overall Study|Adverse Event|2
5049696|NCT02561078|17406574|P1|Overall Study|Adverse Event|5
5049697|NCT02560558|17406699|P2|Overall Study|Withdrawal by Subject|0
5049698|NCT02560558|17406700|P1|Overall Study|Withdrawal by Subject|3
5049699|NCT02560558|17406699|P2|Overall Study|Protocol Violation|0
5049700|NCT02560558|17406700|P1|Overall Study|Protocol Violation|3
5049701|NCT02560558|17406699|P2|Overall Study|Lost to Follow-up|4
5049702|NCT02560558|17406700|P1|Overall Study|Lost to Follow-up|0
5049703|NCT02560558|17406699|P2|Overall Study|Death|2
5049704|NCT02560558|17406700|P1|Overall Study|Death|0
5049705|NCT02560558|17406699|P2|Overall Study|Adverse Event|0
5049706|NCT02560558|17406700|P1|Overall Study|Adverse Event|1
5049707|NCT02560389|17406752|P3|Overall Study|Tested positive for illicit substance|0
5049708|NCT02560389|17406753|P2|Overall Study|Tested positive for illicit substance|1
5049709|NCT02560389|17406754|P1|Overall Study|Tested positive for illicit substance|0
5049710|NCT02560389|17406752|P3|Overall Study|Lost to Follow-up|2
5049711|NCT02560389|17406753|P2|Overall Study|Lost to Follow-up|2
5049712|NCT02560389|17406754|P1|Overall Study|Lost to Follow-up|1
5049713|NCT02560025|17406852|P1|Overall Study|Ineligible after consent/ registration|3
5049714|NCT02560012|17406861|P1|Overall Study|Study Terminated|2
5049715|NCT02559895|17406869|P4|Overall Study|Other|3
5049716|NCT02559895|17406870|P3|Overall Study|Other|3
5049717|NCT02559895|17406871|P2|Overall Study|Other|5
5049718|NCT02559895|17406872|P1|Overall Study|Other|1
5049719|NCT02559895|17406869|P4|Overall Study|Study Burden|22
5049720|NCT02559895|17406870|P3|Overall Study|Study Burden|12
5049721|NCT02559895|17406871|P2|Overall Study|Study Burden|16
5049722|NCT02559895|17406872|P1|Overall Study|Study Burden|10
5049723|NCT02559895|17406869|P4|Overall Study|Withdrawal by Subject|9
5049724|NCT02559895|17406870|P3|Overall Study|Withdrawal by Subject|20
5049725|NCT02559895|17406871|P2|Overall Study|Withdrawal by Subject|9
5049726|NCT02559895|17406872|P1|Overall Study|Withdrawal by Subject|16
5049727|NCT02559895|17406869|P4|Overall Study|Physician Decision|0
5049728|NCT02559895|17406870|P3|Overall Study|Physician Decision|3
5049729|NCT02559895|17406871|P2|Overall Study|Physician Decision|1
5049730|NCT02559895|17406872|P1|Overall Study|Physician Decision|1
5049731|NCT02559895|17406869|P4|Overall Study|Lost to Follow-up|17
5049732|NCT02559895|17406870|P3|Overall Study|Lost to Follow-up|12
5049733|NCT02559895|17406871|P2|Overall Study|Lost to Follow-up|16
5049734|NCT02559895|17406872|P1|Overall Study|Lost to Follow-up|22
5049735|NCT02559895|17406869|P4|Overall Study|Lack of Efficacy|8
5049736|NCT02559895|17406870|P3|Overall Study|Lack of Efficacy|2
5049737|NCT02559895|17406871|P2|Overall Study|Lack of Efficacy|3
5049738|NCT02559895|17406872|P1|Overall Study|Lack of Efficacy|2
5049739|NCT02559895|17406869|P4|Overall Study|Adverse Event|1
5049740|NCT02559895|17406870|P3|Overall Study|Adverse Event|2
5049741|NCT02559895|17406871|P2|Overall Study|Adverse Event|3
5049742|NCT02559895|17406872|P1|Overall Study|Adverse Event|3
5049743|NCT02559713|17406962|P1|Overall Study|Pretreatment Event/ Adverse Event|1
5049744|NCT02559687|17406972|P1|Overall Study|Ongoing Follow-Up|14
5049745|NCT02559687|17406972|P1|Overall Study|Withdrawal by Subject|4
5049746|NCT02559687|17406972|P1|Overall Study|Death|103
5049747|NCT02559622|17406985|P4|Overall Study|Patient/guardian decision|1
5049748|NCT02559622|17406986|P3|Overall Study|Patient/guardian decision|0
5049749|NCT02559622|17406987|P2|Overall Study|Patient/guardian decision|2
5049750|NCT02559622|17406988|P1|Overall Study|Patient/guardian decision|1
5049751|NCT02559622|17406985|P4|Overall Study|Adverse Event|2
5049752|NCT02559622|17406986|P3|Overall Study|Adverse Event|2
5049753|NCT02559622|17406987|P2|Overall Study|Adverse Event|2
5049754|NCT02559622|17406988|P1|Overall Study|Adverse Event|0
5049755|NCT02559622|17406985|P4|Overall Study|Progressive disease|0
5049756|NCT02559622|17406986|P3|Overall Study|Progressive disease|0
5049757|NCT02559622|17406987|P2|Overall Study|Progressive disease|1
5049758|NCT02559622|17406988|P1|Overall Study|Progressive disease|0
5049759|NCT02559570|17407072|P5|Overall Study|Other Miscellaneous Reasons|0
5049760|NCT02559570|17407073|P4|Overall Study|Other Miscellaneous Reasons|0
5049761|NCT02559570|17407074|P3|Overall Study|Other Miscellaneous Reasons|1
5049762|NCT02559570|17407075|P2|Overall Study|Other Miscellaneous Reasons|0
5049763|NCT02559570|17407076|P1|Overall Study|Other Miscellaneous Reasons|0
5049764|NCT02559570|17407072|P5|Overall Study|Protocol Violation|1
5049765|NCT02559570|17407073|P4|Overall Study|Protocol Violation|0
5049766|NCT02559570|17407074|P3|Overall Study|Protocol Violation|0
5049767|NCT02559570|17407075|P2|Overall Study|Protocol Violation|0
5049768|NCT02559570|17407076|P1|Overall Study|Protocol Violation|1
5049769|NCT02559570|17407072|P5|Overall Study|Lost to Follow-up|0
5049770|NCT02559570|17407073|P4|Overall Study|Lost to Follow-up|0
5049771|NCT02559570|17407074|P3|Overall Study|Lost to Follow-up|0
5049772|NCT02559570|17407075|P2|Overall Study|Lost to Follow-up|0
5049773|NCT02559570|17407076|P1|Overall Study|Lost to Follow-up|1
5049774|NCT02559570|17407072|P5|Overall Study|Withdrawal of Consent|1
5049775|NCT02559570|17407073|P4|Overall Study|Withdrawal of Consent|2
5049776|NCT02559570|17407074|P3|Overall Study|Withdrawal of Consent|1
5049777|NCT02559570|17407075|P2|Overall Study|Withdrawal of Consent|0
5049778|NCT02559570|17407076|P1|Overall Study|Withdrawal of Consent|0
5049779|NCT02559570|17407072|P5|Overall Study|Adverse Event|0
5049780|NCT02559570|17407073|P4|Overall Study|Adverse Event|1
5049781|NCT02559570|17407074|P3|Overall Study|Adverse Event|0
5049782|NCT02559570|17407075|P2|Overall Study|Adverse Event|2
5049783|NCT02559570|17407076|P1|Overall Study|Adverse Event|0
5049784|NCT02559414|17407114|P3|Overall Study|Other|1
5049785|NCT02559414|17407115|P2|Overall Study|Other|1
5049786|NCT02559414|17407116|P1|Overall Study|Other|0
5049787|NCT02559414|17407114|P3|Overall Study|Withdrawal by Subject|1
5049788|NCT02559414|17407115|P2|Overall Study|Withdrawal by Subject|0
5049789|NCT02559414|17407116|P1|Overall Study|Withdrawal by Subject|1
5049790|NCT02559414|17407114|P3|Overall Study|Lost to Follow-up|0
5049791|NCT02559414|17407115|P2|Overall Study|Lost to Follow-up|1
5049792|NCT02559414|17407116|P1|Overall Study|Lost to Follow-up|0
5049793|NCT02559310|17407156|P2|Overall Study|Randomized but not treated|2
5049794|NCT02559310|17407157|P1|Overall Study|Randomized but not treated|3
5049795|NCT02559310|17407156|P2|Overall Study|Sponsor Decision|1
5049796|NCT02559310|17407157|P1|Overall Study|Sponsor Decision|0
5049797|NCT02559310|17407156|P2|Overall Study|Withdrawal by Subject|9
5049798|NCT02559310|17407157|P1|Overall Study|Withdrawal by Subject|13
5049799|NCT02559310|17407156|P2|Overall Study|Physician Decision|1
5049800|NCT02559310|17407157|P1|Overall Study|Physician Decision|2
5049801|NCT02559310|17407156|P2|Overall Study|Lost to Follow-up|3
5049802|NCT02559310|17407157|P1|Overall Study|Lost to Follow-up|5
5049803|NCT02559310|17407156|P2|Overall Study|Death|3
5049804|NCT02559310|17407157|P1|Overall Study|Death|4
5049805|NCT02559206|17407175|P8|Overall Study|Other Not Specified|0
5049806|NCT02559206|17407176|P7|Overall Study|Other Not Specified|0
5049807|NCT02559206|17407177|P6|Overall Study|Other Not Specified|0
5049808|NCT02559206|17407178|P5|Overall Study|Other Not Specified|0
5049809|NCT02559206|17407179|P4|Overall Study|Other Not Specified|1
5049810|NCT02559206|17407180|P3|Overall Study|Other Not Specified|0
5049811|NCT02559206|17407181|P2|Overall Study|Other Not Specified|0
5049812|NCT02559206|17407182|P1|Overall Study|Other Not Specified|0
5049813|NCT02559206|17407175|P8|Overall Study|Lack of Efficacy|3
5049814|NCT02559206|17407176|P7|Overall Study|Lack of Efficacy|3
5049815|NCT02559206|17407177|P6|Overall Study|Lack of Efficacy|3
5049816|NCT02559206|17407178|P5|Overall Study|Lack of Efficacy|2
5049817|NCT02559206|17407179|P4|Overall Study|Lack of Efficacy|2
5049818|NCT02559206|17407180|P3|Overall Study|Lack of Efficacy|3
5049819|NCT02559206|17407181|P2|Overall Study|Lack of Efficacy|0
5049820|NCT02559206|17407182|P1|Overall Study|Lack of Efficacy|1
5049821|NCT02559206|17407175|P8|Overall Study|Lost to Follow-up|4
5049822|NCT02559206|17407176|P7|Overall Study|Lost to Follow-up|1
5049823|NCT02559206|17407177|P6|Overall Study|Lost to Follow-up|5
5049824|NCT02559206|17407178|P5|Overall Study|Lost to Follow-up|2
5049825|NCT02559206|17407179|P4|Overall Study|Lost to Follow-up|3
5049826|NCT02559206|17407180|P3|Overall Study|Lost to Follow-up|3
5049827|NCT02559206|17407181|P2|Overall Study|Lost to Follow-up|5
5049828|NCT02559206|17407182|P1|Overall Study|Lost to Follow-up|3
5049829|NCT02559206|17407175|P8|Overall Study|Withdrawal by Subject|2
5049830|NCT02559206|17407176|P7|Overall Study|Withdrawal by Subject|1
5049831|NCT02559206|17407177|P6|Overall Study|Withdrawal by Subject|4
5049832|NCT02559206|17407178|P5|Overall Study|Withdrawal by Subject|5
5049833|NCT02559206|17407179|P4|Overall Study|Withdrawal by Subject|3
5049834|NCT02559206|17407180|P3|Overall Study|Withdrawal by Subject|1
5049835|NCT02559206|17407181|P2|Overall Study|Withdrawal by Subject|3
5049836|NCT02559206|17407182|P1|Overall Study|Withdrawal by Subject|3
5049837|NCT02559206|17407175|P8|Overall Study|Protocol Violation|0
5049838|NCT02559206|17407176|P7|Overall Study|Protocol Violation|0
5049839|NCT02559206|17407177|P6|Overall Study|Protocol Violation|2
5049840|NCT02559206|17407178|P5|Overall Study|Protocol Violation|0
5049841|NCT02559206|17407179|P4|Overall Study|Protocol Violation|0
5049842|NCT02559206|17407180|P3|Overall Study|Protocol Violation|1
5049843|NCT02559206|17407181|P2|Overall Study|Protocol Violation|0
5049844|NCT02559206|17407182|P1|Overall Study|Protocol Violation|1
5049845|NCT02559206|17407175|P8|Overall Study|Adverse Event|0
5049846|NCT02559206|17407176|P7|Overall Study|Adverse Event|1
5049847|NCT02559206|17407177|P6|Overall Study|Adverse Event|0
5049848|NCT02559206|17407178|P5|Overall Study|Adverse Event|3
5049849|NCT02559206|17407179|P4|Overall Study|Adverse Event|5
5049850|NCT02559206|17407180|P3|Overall Study|Adverse Event|1
5049851|NCT02559206|17407181|P2|Overall Study|Adverse Event|4
5049852|NCT02559206|17407182|P1|Overall Study|Adverse Event|0
5049853|NCT02558894|17407224|P2|Overall Study|Closure of Part A|1
5049854|NCT02558894|17407225|P1|Overall Study|Closure of Part A|2
5049855|NCT02558894|17407224|P2|Overall Study|Withdrawal by Subject|1
5049856|NCT02558894|17407225|P1|Overall Study|Withdrawal by Subject|2
5049857|NCT02558894|17407224|P2|Overall Study|Death; any cause, entire study duration|31
5049858|NCT02558894|17407225|P1|Overall Study|Death; any cause, entire study duration|28
5049859|NCT02558790|17407286|P1|Overall Study|Screen Fail|3
5049860|NCT02558790|17407286|P1|Overall Study|Withdrawal by Subject|1
5049861|NCT02558790|17407286|P1|Overall Study|Physician Decision|1
5049862|NCT02558790|17407286|P1|Overall Study|Lost to Follow-up|2
5049863|NCT02558400|17407293|P3|Overall Study|Ineligible for the study|0
5049864|NCT02558400|17407294|P2|Overall Study|Ineligible for the study|2
5049865|NCT02558400|17407295|P1|Overall Study|Ineligible for the study|0
5049866|NCT02558400|17407293|P3|Overall Study|Death|0
5049867|NCT02558400|17407294|P2|Overall Study|Death|1
5049868|NCT02558400|17407295|P1|Overall Study|Death|0
5049869|NCT02558400|17407293|P3|Overall Study|Protocol Violation|8
5049870|NCT02558400|17407294|P2|Overall Study|Protocol Violation|3
5049871|NCT02558400|17407295|P1|Overall Study|Protocol Violation|6
5049872|NCT02558400|17407293|P3|Overall Study|Physician Decision|0
5049873|NCT02558400|17407294|P2|Overall Study|Physician Decision|2
5049874|NCT02558400|17407295|P1|Overall Study|Physician Decision|2
5049875|NCT02558400|17407293|P3|Overall Study|Disallowed Concurrent Medication|5
5049876|NCT02558400|17407294|P2|Overall Study|Disallowed Concurrent Medication|7
5049877|NCT02558400|17407295|P1|Overall Study|Disallowed Concurrent Medication|6
5049878|NCT02558400|17407293|P3|Overall Study|Lack of Efficacy|1
5049879|NCT02558400|17407294|P2|Overall Study|Lack of Efficacy|13
5049880|NCT02558400|17407295|P1|Overall Study|Lack of Efficacy|0
5049881|NCT02558400|17407293|P3|Overall Study|Lost to Follow-up|4
5049882|NCT02558400|17407294|P2|Overall Study|Lost to Follow-up|5
5049883|NCT02558400|17407295|P1|Overall Study|Lost to Follow-up|5
5049884|NCT02558400|17407293|P3|Overall Study|Non-Compliant|3
5049885|NCT02558400|17407294|P2|Overall Study|Non-Compliant|1
5049886|NCT02558400|17407295|P1|Overall Study|Non-Compliant|0
5049887|NCT02558400|17407293|P3|Overall Study|Withdrawal by Subject|8
5049888|NCT02558400|17407294|P2|Overall Study|Withdrawal by Subject|9
5049889|NCT02558400|17407295|P1|Overall Study|Withdrawal by Subject|13
5049890|NCT02558400|17407293|P3|Overall Study|Adverse Event|4
5049891|NCT02558400|17407294|P2|Overall Study|Adverse Event|53
5049892|NCT02558400|17407295|P1|Overall Study|Adverse Event|47
5049893|NCT02558231|17407319|P2|Overall Study|Ongoing|104
5049894|NCT02558231|17407320|P1|Overall Study|Ongoing|109
5049895|NCT02558231|17407319|P2|Overall Study|Sponsor Decision|1
5049896|NCT02558231|17407320|P1|Overall Study|Sponsor Decision|0
5049897|NCT02558231|17407319|P2|Overall Study|Physician Decision|5
5049898|NCT02558231|17407320|P1|Overall Study|Physician Decision|6
5049899|NCT02558231|17407319|P2|Overall Study|Withdrawal by Subject|3
5049900|NCT02558231|17407320|P1|Overall Study|Withdrawal by Subject|4
5049901|NCT02558231|17407319|P2|Overall Study|Lost to Follow-up|2
5049902|NCT02558231|17407320|P1|Overall Study|Lost to Follow-up|2
5049903|NCT02558231|17407319|P2|Overall Study|Death|9
5049904|NCT02558231|17407320|P1|Overall Study|Death|2
5049905|NCT02557646|17407411|P1|Overall Study|Other|14
5049906|NCT02557646|17407411|P1|Overall Study|Lost to Follow-up|17
5049907|NCT02557646|17407411|P1|Overall Study|Withdrawal by Subject|18
5049908|NCT02557646|17407411|P1|Overall Study|Lack of Efficacy|186
5049909|NCT02557646|17407411|P1|Overall Study|Death|1
5049910|NCT02557646|17407411|P1|Overall Study|Adverse Event|40
5049911|NCT02557516|17407438|P4|Overall Study|Sponsor decision|8
5049912|NCT02557516|17407439|P3|Overall Study|Sponsor decision|2
5049913|NCT02557516|17407440|P2|Overall Study|Sponsor decision|1
5049914|NCT02557516|17407441|P1|Overall Study|Sponsor decision|0
5049915|NCT02557516|17407438|P4|Overall Study|Physician Decision|0
5049916|NCT02557516|17407439|P3|Overall Study|Physician Decision|0
5049917|NCT02557516|17407440|P2|Overall Study|Physician Decision|2
5049918|NCT02557516|17407441|P1|Overall Study|Physician Decision|0
5049919|NCT02557516|17407438|P4|Overall Study|Disease progression|0
5049920|NCT02557516|17407439|P3|Overall Study|Disease progression|0
5049921|NCT02557516|17407440|P2|Overall Study|Disease progression|2
5049922|NCT02557516|17407441|P1|Overall Study|Disease progression|0
5049923|NCT02557516|17407438|P4|Overall Study|Adverse Event|1
5049924|NCT02557516|17407439|P3|Overall Study|Adverse Event|2
5049925|NCT02557516|17407440|P2|Overall Study|Adverse Event|0
5049926|NCT02557516|17407441|P1|Overall Study|Adverse Event|1
5049927|NCT02557399|17407462|P2|Overall Study|Withdrawal by Subject|1
5049928|NCT02557399|17407463|P1|Overall Study|Withdrawal by Subject|1
5049929|NCT02557399|17407462|P2|Overall Study|Protocol-defined stopping criteria|1
5049930|NCT02557399|17407463|P1|Overall Study|Protocol-defined stopping criteria|0
5049931|NCT02557399|17407462|P2|Overall Study|Protocol Violation|1
5049932|NCT02557399|17407463|P1|Overall Study|Protocol Violation|0
5049933|NCT02557399|17407462|P2|Overall Study|Adverse Event|5
5049934|NCT02557399|17407463|P1|Overall Study|Adverse Event|6
5049935|NCT02557100|17407498|P3|Cumulative Abatacept Period|Request to Discontinue|1
5049936|NCT02557100|17407499|P2|Cumulative Abatacept Period|Request to Discontinue|0
5049937|NCT02557100|17407500|P1|Cumulative Abatacept Period|Request to Discontinue|0
5049938|NCT02557100|17407498|P3|Cumulative Abatacept Period|Lost to Follow-up|2
5049939|NCT02557100|17407499|P2|Cumulative Abatacept Period|Lost to Follow-up|0
5049940|NCT02557100|17407500|P1|Cumulative Abatacept Period|Lost to Follow-up|0
5049941|NCT02557100|17407498|P3|Cumulative Abatacept Period|Other Reasons|1
5049942|NCT02557100|17407499|P2|Cumulative Abatacept Period|Other Reasons|0
5049943|NCT02557100|17407500|P1|Cumulative Abatacept Period|Other Reasons|0
5049944|NCT02557100|17407498|P3|Transition to Open Label|Entered Cumulative Abatacept Period|0
5049945|NCT02557100|17407499|P2|Transition to Open Label|Entered Cumulative Abatacept Period|36
5049946|NCT02557100|17407500|P1|Transition to Open Label|Entered Cumulative Abatacept Period|40
5049947|NCT02557100|17407498|P3|Single Blind Treatment Period|Adverse Event|0
5049948|NCT02557100|17407499|P2|Single Blind Treatment Period|Adverse Event|1
5049949|NCT02557100|17407500|P1|Single Blind Treatment Period|Adverse Event|0
5049950|NCT02557100|17407498|P3|Single Blind Treatment Period|Request to Discontinue|0
5049951|NCT02557100|17407499|P2|Single Blind Treatment Period|Request to Discontinue|1
5049952|NCT02557100|17407500|P1|Single Blind Treatment Period|Request to Discontinue|0
5049953|NCT02557100|17407498|P3|Single Blind Treatment Period|Death|0
5049954|NCT02557100|17407499|P2|Single Blind Treatment Period|Death|1
5049955|NCT02557100|17407500|P1|Single Blind Treatment Period|Death|0
5049956|NCT02557100|17407498|P3|Single Blind Treatment Period|Lost to Follow-up|0
5049957|NCT02557100|17407499|P2|Single Blind Treatment Period|Lost to Follow-up|1
5049958|NCT02557100|17407500|P1|Single Blind Treatment Period|Lost to Follow-up|0
5049959|NCT02556918|17407553|P2|Overall Study|Withdrawal by Subject|4
5049960|NCT02556918|17407554|P1|Overall Study|Withdrawal by Subject|4
5049961|NCT02556918|17407553|P2|Overall Study|Protocol Violation|6
5049962|NCT02556918|17407554|P1|Overall Study|Protocol Violation|5
5049963|NCT02556801|17407614|P4|Overall Study|Personal reasons patient|1
5049964|NCT02556801|17407615|P3|Overall Study|Personal reasons patient|0
5049965|NCT02556801|17407616|P2|Overall Study|Personal reasons patient|0
5049966|NCT02556801|17407617|P1|Overall Study|Personal reasons patient|0
5049967|NCT02556801|17407614|P4|Overall Study|Pregnancy|0
5049968|NCT02556801|17407615|P3|Overall Study|Pregnancy|0
5049969|NCT02556801|17407616|P2|Overall Study|Pregnancy|1
5049970|NCT02556801|17407617|P1|Overall Study|Pregnancy|0
5049971|NCT02556801|17407614|P4|Overall Study|Adverse Event|3
5049972|NCT02556801|17407615|P3|Overall Study|Adverse Event|0
5049973|NCT02556801|17407616|P2|Overall Study|Adverse Event|2
5049974|NCT02556801|17407617|P1|Overall Study|Adverse Event|0
5049975|NCT02556801|17407614|P4|Overall Study|Protocol Violation|1
5049976|NCT02556801|17407615|P3|Overall Study|Protocol Violation|1
5049977|NCT02556801|17407616|P2|Overall Study|Protocol Violation|3
5049978|NCT02556801|17407617|P1|Overall Study|Protocol Violation|0
5049979|NCT02556801|17407614|P4|Overall Study|Withdrawal by Subject|0
5049980|NCT02556801|17407615|P3|Overall Study|Withdrawal by Subject|1
5049981|NCT02556801|17407616|P2|Overall Study|Withdrawal by Subject|1
5049982|NCT02556801|17407617|P1|Overall Study|Withdrawal by Subject|1
5049983|NCT02556801|17407614|P4|Overall Study|Lost to Follow-up|0
5049984|NCT02556801|17407615|P3|Overall Study|Lost to Follow-up|2
5049985|NCT02556801|17407616|P2|Overall Study|Lost to Follow-up|0
5049986|NCT02556801|17407617|P1|Overall Study|Lost to Follow-up|1
5049987|NCT02556632|17407679|P3|Overall Study|Treatment or Change Delay|1
5049988|NCT02556632|17407680|P2|Overall Study|Treatment or Change Delay|0
5049989|NCT02556632|17407681|P1|Overall Study|Treatment or Change Delay|0
5049990|NCT02556632|17407679|P3|Overall Study|Disliked Study Procedures|1
5049991|NCT02556632|17407680|P2|Overall Study|Disliked Study Procedures|0
5049992|NCT02556632|17407681|P1|Overall Study|Disliked Study Procedures|0
5049993|NCT02556632|17407679|P3|Overall Study|Ineligible|0
5049994|NCT02556632|17407680|P2|Overall Study|Ineligible|1
5049995|NCT02556632|17407681|P1|Overall Study|Ineligible|0
5049996|NCT02556632|17407679|P3|Overall Study|Did Not Start RT|0
5049997|NCT02556632|17407680|P2|Overall Study|Did Not Start RT|1
5049998|NCT02556632|17407681|P1|Overall Study|Did Not Start RT|0
5049999|NCT02556632|17407679|P3|Overall Study|Possibly Related Adverse Event|1
5050000|NCT02556632|17407680|P2|Overall Study|Possibly Related Adverse Event|0
5050001|NCT02556632|17407681|P1|Overall Study|Possibly Related Adverse Event|0
5050002|NCT02556632|17407679|P3|Overall Study|Related Adverse Event|0
5050003|NCT02556632|17407680|P2|Overall Study|Related Adverse Event|1
5050004|NCT02556632|17407681|P1|Overall Study|Related Adverse Event|0
5050005|NCT02556632|17407679|P3|Overall Study|Unrelated Adverse Event|3
5050006|NCT02556632|17407680|P2|Overall Study|Unrelated Adverse Event|0
5050007|NCT02556632|17407681|P1|Overall Study|Unrelated Adverse Event|1
5050008|NCT02556632|17407679|P3|Overall Study|Withdrew (Unrelated Medical)|0
5050009|NCT02556632|17407680|P2|Overall Study|Withdrew (Unrelated Medical)|0
5050010|NCT02556632|17407681|P1|Overall Study|Withdrew (Unrelated Medical)|1
5050011|NCT02556632|17407679|P3|Overall Study|Changed Mind|0
5050012|NCT02556632|17407680|P2|Overall Study|Changed Mind|1
5050013|NCT02556632|17407681|P1|Overall Study|Changed Mind|0
5050014|NCT02556632|17407679|P3|Overall Study|Personal Issues|1
5050015|NCT02556632|17407680|P2|Overall Study|Personal Issues|1
5050016|NCT02556632|17407681|P1|Overall Study|Personal Issues|0
5050017|NCT02556632|17407679|P3|Overall Study|No Reason|1
5050018|NCT02556632|17407680|P2|Overall Study|No Reason|0
5050019|NCT02556632|17407681|P1|Overall Study|No Reason|1
5050020|NCT02556632|17407679|P3|Overall Study|Disliked Intervention|1
5050021|NCT02556632|17407680|P2|Overall Study|Disliked Intervention|1
5050022|NCT02556632|17407681|P1|Overall Study|Disliked Intervention|1
5050023|NCT02556632|17407679|P3|Overall Study|Lost to Follow-up|0
5050024|NCT02556632|17407680|P2|Overall Study|Lost to Follow-up|0
5050025|NCT02556632|17407681|P1|Overall Study|Lost to Follow-up|1
5050026|NCT02556307|17407721|P1|Overall Study|Enrolled but not treated|2
5050027|NCT02556307|17407721|P1|Overall Study|Change to triple therapy|4
5050028|NCT02556307|17407721|P1|Overall Study|Lost to Follow-up|36
5050029|NCT02556307|17407721|P1|Overall Study|Premature treatment interruption|11
5050030|NCT02556255|17407731|P1|Overall Study|Lost to Follow-up|4
5050031|NCT02556203|17407746|P2|Overall Study|Adverse Event|0
5050032|NCT02556203|17407747|P1|Overall Study|Adverse Event|1
5050033|NCT02556203|17407746|P2|Overall Study|Lost to Follow-up|5
5050034|NCT02556203|17407747|P1|Overall Study|Lost to Follow-up|5
5050035|NCT02556203|17407746|P2|Overall Study|Withdrawal by Subject|21
5050036|NCT02556203|17407747|P1|Overall Study|Withdrawal by Subject|21
5050037|NCT02556177|17407769|P2|Overall Study|Subjects did not complete all 4 visits|61
5050038|NCT02556177|17407770|P1|Overall Study|Subjects did not complete all 4 visits|283
5050039|NCT02556138|17407778|P1|Overall Study|Withdrawal by Subject|1
5050040|NCT02555878|17407814|P2|Overall Study|Other|17
5050041|NCT02555878|17407815|P1|Overall Study|Other|17
5050042|NCT02555878|17407814|P2|Overall Study|Physician Decision|13
5050043|NCT02555878|17407815|P1|Overall Study|Physician Decision|12
5050044|NCT02555878|17407814|P2|Overall Study|Protocol Violation|2
5050045|NCT02555878|17407815|P1|Overall Study|Protocol Violation|1
5050046|NCT02555878|17407814|P2|Overall Study|Death|59
5050047|NCT02555878|17407815|P1|Overall Study|Death|74
5050048|NCT02555878|17407814|P2|Overall Study|Adverse Event|8
5050049|NCT02555878|17407815|P1|Overall Study|Adverse Event|12
5050050|NCT02555878|17407814|P2|Overall Study|Withdrawal by Subject|48
5050051|NCT02555878|17407815|P1|Overall Study|Withdrawal by Subject|48
5050052|NCT02555878|17407814|P2|Overall Study|Lost to Follow-up|3
5050053|NCT02555878|17407815|P1|Overall Study|Lost to Follow-up|2
5050054|NCT02555722|17407847|P2|Month 2|Lost to Follow-up|0
5050055|NCT02555722|17407848|P1|Month 2|Lost to Follow-up|1
5050056|NCT02555722|17407847|P2|Month 2|Withdrawal by Subject|0
5050057|NCT02555722|17407848|P1|Month 2|Withdrawal by Subject|3
5050058|NCT02555722|17407847|P2|Month 1|Lens Discomfort|0
5050059|NCT02555722|17407848|P1|Month 1|Lens Discomfort|1
5050060|NCT02555722|17407847|P2|Week 2|Withdrawal by Subject|0
5050061|NCT02555722|17407848|P1|Week 2|Withdrawal by Subject|1
5050062|NCT02555722|17407847|P2|Week 2|Adverse Event|1
5050063|NCT02555722|17407848|P1|Week 2|Adverse Event|0
5050064|NCT02555683|17408033|P3|Overall Study|Death post Treatment/safety period|0
5050065|NCT02555683|17408034|P2|Overall Study|Death post Treatment/safety period|1
5050066|NCT02555683|17408035|P1|Overall Study|Death post Treatment/safety period|0
5050067|NCT02555683|17408033|P3|Overall Study|Subject/guardian decision|22
5050068|NCT02555683|17408034|P2|Overall Study|Subject/guardian decision|12
5050069|NCT02555683|17408035|P1|Overall Study|Subject/guardian decision|12
5050070|NCT02555683|17408033|P3|Overall Study|Adverse Event|1
5050071|NCT02555683|17408034|P2|Overall Study|Adverse Event|0
5050072|NCT02555683|17408035|P1|Overall Study|Adverse Event|1
5050073|NCT02555683|17408033|P3|Overall Study|Death|2
5050074|NCT02555683|17408034|P2|Overall Study|Death|1
5050075|NCT02555683|17408035|P1|Overall Study|Death|0
5050076|NCT02555683|17408033|P3|Overall Study|Lack of Efficacy|0
5050077|NCT02555683|17408034|P2|Overall Study|Lack of Efficacy|0
5050078|NCT02555683|17408035|P1|Overall Study|Lack of Efficacy|2
5050079|NCT02555683|17408033|P3|Overall Study|Protocol deviation|0
5050080|NCT02555683|17408034|P2|Overall Study|Protocol deviation|1
5050081|NCT02555683|17408035|P1|Overall Study|Protocol deviation|0
5050082|NCT02555683|17408033|P3|Overall Study|Technical Problems|0
5050083|NCT02555683|17408034|P2|Overall Study|Technical Problems|1
5050084|NCT02555683|17408035|P1|Overall Study|Technical Problems|1
5050085|NCT02555683|17408033|P3|Overall Study|Lost to Follow-up|2
5050086|NCT02555683|17408034|P2|Overall Study|Lost to Follow-up|1
5050087|NCT02555683|17408035|P1|Overall Study|Lost to Follow-up|2
5050088|NCT02555683|17408033|P3|Overall Study|Physician Decision|2
5050089|NCT02555683|17408034|P2|Overall Study|Physician Decision|0
5050090|NCT02555683|17408035|P1|Overall Study|Physician Decision|1
5050091|NCT02555657|17408066|P2|Overall Study|Status Not Recorded|31
5050092|NCT02555657|17408067|P1|Overall Study|Status Not Recorded|44
5050093|NCT02555657|17408066|P2|Overall Study|Withdrawal by Subject|32
5050094|NCT02555657|17408067|P1|Overall Study|Withdrawal by Subject|11
5050095|NCT02555657|17408066|P2|Overall Study|Death|247
5050096|NCT02555657|17408067|P1|Overall Study|Death|257
5050097|NCT02555618|17408114|P2|Overall Study|Sponsor's Circumstances|0
5050098|NCT02555618|17408115|P1|Overall Study|Sponsor's Circumstances|1
5050099|NCT02555371|17408157|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5050100|NCT02555371|17408158|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
5050101|NCT02555371|17408159|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5050102|NCT02555371|17408160|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5050103|NCT02555371|17408161|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5050104|NCT02555371|17408157|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
5050105|NCT02555371|17408158|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5050106|NCT02555371|17408159|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5050107|NCT02555371|17408160|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5050108|NCT02555371|17408161|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5050109|NCT02555371|17408157|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
5050110|NCT02555371|17408158|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5050111|NCT02555371|17408159|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5050112|NCT02555371|17408160|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5050113|NCT02555371|17408161|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5050114|NCT02555371|17408157|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5050115|NCT02555371|17408158|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
5050116|NCT02555371|17408159|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5050117|NCT02555371|17408160|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5050118|NCT02555371|17408161|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5050119|NCT02555371|17408157|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5050120|NCT02555371|17408158|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
5050121|NCT02555371|17408159|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5050122|NCT02555371|17408160|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5050123|NCT02555371|17408161|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5050124|NCT02555371|17408157|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
5050125|NCT02555371|17408158|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
5050126|NCT02555371|17408159|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
5050127|NCT02555371|17408160|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
5050128|NCT02555371|17408161|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
5050129|NCT02555371|17408157|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5050130|NCT02555371|17408158|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5050131|NCT02555371|17408159|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5050132|NCT02555371|17408160|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
5050133|NCT02555371|17408161|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5050134|NCT02555371|17408157|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5050135|NCT02555371|17408158|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5050136|NCT02555371|17408159|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
5050137|NCT02555371|17408160|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
5050138|NCT02555371|17408161|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5050139|NCT02555371|17408157|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5050140|NCT02555371|17408158|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5050141|NCT02555371|17408159|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
5050142|NCT02555371|17408160|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
5050143|NCT02555371|17408161|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5050144|NCT02555371|17408157|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5050145|NCT02555371|17408158|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5050146|NCT02555371|17408159|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5050147|NCT02555371|17408160|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5050148|NCT02555371|17408161|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
5050149|NCT02555371|17408157|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5050150|NCT02555371|17408158|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5050151|NCT02555371|17408159|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5050152|NCT02555371|17408160|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5050153|NCT02555371|17408161|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
5050154|NCT02555371|17408157|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5050155|NCT02555371|17408158|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5050156|NCT02555371|17408159|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5050157|NCT02555371|17408160|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5050158|NCT02555371|17408161|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
5050159|NCT02555371|17408157|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5050160|NCT02555371|17408158|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5050161|NCT02555371|17408159|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5050162|NCT02555371|17408160|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5050163|NCT02555371|17408161|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
5050164|NCT02555371|17408157|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5050165|NCT02555371|17408158|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5050166|NCT02555371|17408159|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5050167|NCT02555371|17408160|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5050168|NCT02555371|17408161|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
5050169|NCT02555215|17408212|P1|Overall Study|Investigator Decision|2
5050170|NCT02555215|17408212|P1|Overall Study|Other|1
5050171|NCT02554981|17408244|P1|Overall Study|Other Miscellaneous Reasons|3
5050172|NCT02554981|17408244|P1|Overall Study|Administrative Reasons|1
5050173|NCT02554981|17408244|P1|Overall Study|Adverse Event|1
5050174|NCT02554929|17408270|P2|Overall Study|Withdrawal by Subject|8
5050175|NCT02554929|17408271|P1|Overall Study|Withdrawal by Subject|2
5050176|NCT02554929|17408270|P2|Overall Study|Lost to Follow-up|4
5050177|NCT02554929|17408271|P1|Overall Study|Lost to Follow-up|4
5050178|NCT02554890|17408289|P2|Open-label|Withdrawal by Subject|1
5050179|NCT02554890|17408290|P1|Open-label|Withdrawal by Subject|0
5050180|NCT02554890|17408289|P2|Open-label|Technical problems|1
5050181|NCT02554890|17408290|P1|Open-label|Technical problems|0
5050182|NCT02554890|17408289|P2|Open-label|Lost to Follow-up|7
5050183|NCT02554890|17408290|P1|Open-label|Lost to Follow-up|0
5050184|NCT02554890|17408289|P2|Open-label|Subject/Guardian decision|11
5050185|NCT02554890|17408290|P1|Open-label|Subject/Guardian decision|0
5050186|NCT02554890|17408289|P2|Open-label|Physician Decision|1
5050187|NCT02554890|17408290|P1|Open-label|Physician Decision|0
5050188|NCT02554890|17408289|P2|Open-label|Death|1
5050189|NCT02554890|17408290|P1|Open-label|Death|0
5050190|NCT02554890|17408289|P2|Open-label|Adverse Event|30
5050191|NCT02554890|17408290|P1|Open-label|Adverse Event|0
5050192|NCT02554890|17408289|P2|Double-blind|Noncompliance with study treatment|5
5050193|NCT02554890|17408290|P1|Double-blind|Noncompliance with study treatment|6
5050194|NCT02554890|17408289|P2|Double-blind|Withdrawal by Subject|6
5050195|NCT02554890|17408290|P1|Double-blind|Withdrawal by Subject|5
5050196|NCT02554890|17408289|P2|Double-blind|Technical problems|0
5050197|NCT02554890|17408290|P1|Double-blind|Technical problems|1
5050198|NCT02554890|17408289|P2|Double-blind|Lost to Follow-up|5
5050199|NCT02554890|17408290|P1|Double-blind|Lost to Follow-up|7
5050200|NCT02554890|17408289|P2|Double-blind|Subject/Guardian decision|16
5050201|NCT02554890|17408290|P1|Double-blind|Subject/Guardian decision|21
5050202|NCT02554890|17408289|P2|Double-blind|Physician Decision|3
5050203|NCT02554890|17408290|P1|Double-blind|Physician Decision|4
5050204|NCT02554890|17408289|P2|Double-blind|Protocol Violation|1
5050205|NCT02554890|17408290|P1|Double-blind|Protocol Violation|1
5050206|NCT02554890|17408289|P2|Double-blind|Death|4
5050207|NCT02554890|17408290|P1|Double-blind|Death|6
5050208|NCT02554890|17408289|P2|Double-blind|Adverse Event|51
5050209|NCT02554890|17408290|P1|Double-blind|Adverse Event|45
5050210|NCT02554877|17408318|P4|Overall Study|No longer willing to participate|0
5050211|NCT02554877|17408319|P3|Overall Study|No longer willing to participate|2
5050212|NCT02554877|17408320|P2|Overall Study|No longer willing to participate|2
5050213|NCT02554877|17408321|P1|Overall Study|No longer willing to participate|0
5050214|NCT02554877|17408318|P4|Overall Study|Insufficient clinical response|0
5050215|NCT02554877|17408319|P3|Overall Study|Insufficient clinical response|0
5050216|NCT02554877|17408320|P2|Overall Study|Insufficient clinical response|0
5050217|NCT02554877|17408321|P1|Overall Study|Insufficient clinical response|4
5050218|NCT02554877|17408318|P4|Overall Study|Other|3
5050219|NCT02554877|17408319|P3|Overall Study|Other|0
5050220|NCT02554877|17408320|P2|Overall Study|Other|3
5050221|NCT02554877|17408321|P1|Overall Study|Other|1
5050222|NCT02554877|17408318|P4|Overall Study|Protocol Violation|0
5050223|NCT02554877|17408319|P3|Overall Study|Protocol Violation|1
5050224|NCT02554877|17408320|P2|Overall Study|Protocol Violation|1
5050225|NCT02554877|17408321|P1|Overall Study|Protocol Violation|3
5050226|NCT02554877|17408318|P4|Overall Study|No longer met eligibility criteria|1
5050227|NCT02554877|17408319|P3|Overall Study|No longer met eligibility criteria|1
5050228|NCT02554877|17408320|P2|Overall Study|No longer met eligibility criteria|0
5050229|NCT02554877|17408321|P1|Overall Study|No longer met eligibility criteria|1
5050230|NCT02554877|17408318|P4|Overall Study|Did not meet entrance criteria|0
5050231|NCT02554877|17408319|P3|Overall Study|Did not meet entrance criteria|1
5050232|NCT02554877|17408320|P2|Overall Study|Did not meet entrance criteria|0
5050233|NCT02554877|17408321|P1|Overall Study|Did not meet entrance criteria|0
5050234|NCT02554877|17408318|P4|Overall Study|Lost to Follow-up|2
5050235|NCT02554877|17408319|P3|Overall Study|Lost to Follow-up|1
5050236|NCT02554877|17408320|P2|Overall Study|Lost to Follow-up|1
5050237|NCT02554877|17408321|P1|Overall Study|Lost to Follow-up|1
5050238|NCT02554877|17408318|P4|Overall Study|Adverse Event|1
5050239|NCT02554877|17408319|P3|Overall Study|Adverse Event|0
5050240|NCT02554877|17408320|P2|Overall Study|Adverse Event|0
5050241|NCT02554877|17408321|P1|Overall Study|Adverse Event|2
5050242|NCT02554786|17408409|P5|Overall Study|Pregnancy|1
5050243|NCT02554786|17408410|P4|Overall Study|Pregnancy|1
5050244|NCT02554786|17408411|P3|Overall Study|Pregnancy|0
5050245|NCT02554786|17408412|P2|Overall Study|Pregnancy|0
5050246|NCT02554786|17408413|P1|Overall Study|Pregnancy|0
5050247|NCT02554786|17408409|P5|Overall Study|Physician Decision|1
5050248|NCT02554786|17408410|P4|Overall Study|Physician Decision|1
5050249|NCT02554786|17408411|P3|Overall Study|Physician Decision|4
5050250|NCT02554786|17408412|P2|Overall Study|Physician Decision|1
5050251|NCT02554786|17408413|P1|Overall Study|Physician Decision|0
5050252|NCT02554786|17408409|P5|Overall Study|Non-compliance with study treatment|1
5050253|NCT02554786|17408410|P4|Overall Study|Non-compliance with study treatment|0
5050254|NCT02554786|17408411|P3|Overall Study|Non-compliance with study treatment|1
5050255|NCT02554786|17408412|P2|Overall Study|Non-compliance with study treatment|1
5050256|NCT02554786|17408413|P1|Overall Study|Non-compliance with study treatment|0
5050257|NCT02554786|17408409|P5|Overall Study|Death|0
5050258|NCT02554786|17408410|P4|Overall Study|Death|1
5050259|NCT02554786|17408411|P3|Overall Study|Death|0
5050260|NCT02554786|17408412|P2|Overall Study|Death|0
5050261|NCT02554786|17408413|P1|Overall Study|Death|0
5050262|NCT02554786|17408409|P5|Overall Study|Adverse Event|2
5050263|NCT02554786|17408410|P4|Overall Study|Adverse Event|0
5050264|NCT02554786|17408411|P3|Overall Study|Adverse Event|0
5050265|NCT02554786|17408412|P2|Overall Study|Adverse Event|0
5050266|NCT02554786|17408413|P1|Overall Study|Adverse Event|0
5050267|NCT02554786|17408409|P5|Overall Study|Technical problems|1
5050268|NCT02554786|17408410|P4|Overall Study|Technical problems|2
5050269|NCT02554786|17408411|P3|Overall Study|Technical problems|0
5050270|NCT02554786|17408412|P2|Overall Study|Technical problems|1
5050271|NCT02554786|17408413|P1|Overall Study|Technical problems|1
5050272|NCT02554786|17408409|P5|Overall Study|Protocol deviation|2
5050273|NCT02554786|17408410|P4|Overall Study|Protocol deviation|4
5050274|NCT02554786|17408411|P3|Overall Study|Protocol deviation|3
5050275|NCT02554786|17408412|P2|Overall Study|Protocol deviation|3
5050276|NCT02554786|17408413|P1|Overall Study|Protocol deviation|1
5050277|NCT02554786|17408409|P5|Overall Study|Lost to Follow-up|2
5050278|NCT02554786|17408410|P4|Overall Study|Lost to Follow-up|2
5050279|NCT02554786|17408411|P3|Overall Study|Lost to Follow-up|4
5050280|NCT02554786|17408412|P2|Overall Study|Lost to Follow-up|3
5050281|NCT02554786|17408413|P1|Overall Study|Lost to Follow-up|4
5050282|NCT02554786|17408409|P5|Overall Study|Subject/guardian decision|20
5050283|NCT02554786|17408410|P4|Overall Study|Subject/guardian decision|30
5050284|NCT02554786|17408411|P3|Overall Study|Subject/guardian decision|18
5050285|NCT02554786|17408412|P2|Overall Study|Subject/guardian decision|17
5050286|NCT02554786|17408413|P1|Overall Study|Subject/guardian decision|29
5050287|NCT02554682|17408575|P10|Overall Study|Physician Decision|0
5050288|NCT02554682|17408576|P9|Overall Study|Physician Decision|0
5050289|NCT02554682|17408577|P8|Overall Study|Physician Decision|0
5050290|NCT02554682|17408578|P7|Overall Study|Physician Decision|0
5050291|NCT02554682|17408579|P6|Overall Study|Physician Decision|0
5050292|NCT02554682|17408580|P5|Overall Study|Physician Decision|0
5050293|NCT02554682|17408581|P4|Overall Study|Physician Decision|0
5050294|NCT02554682|17408582|P3|Overall Study|Physician Decision|0
5050295|NCT02554682|17408583|P2|Overall Study|Physician Decision|2
5050296|NCT02554682|17408584|P1|Overall Study|Physician Decision|2
5050297|NCT02554682|17408575|P10|Overall Study|Withdrawal by Subject|0
5050298|NCT02554682|17408576|P9|Overall Study|Withdrawal by Subject|0
5050299|NCT02554682|17408577|P8|Overall Study|Withdrawal by Subject|0
5050300|NCT02554682|17408578|P7|Overall Study|Withdrawal by Subject|0
5050301|NCT02554682|17408579|P6|Overall Study|Withdrawal by Subject|0
5050302|NCT02554682|17408580|P5|Overall Study|Withdrawal by Subject|0
5050303|NCT02554682|17408581|P4|Overall Study|Withdrawal by Subject|0
5050304|NCT02554682|17408582|P3|Overall Study|Withdrawal by Subject|0
5050305|NCT02554682|17408583|P2|Overall Study|Withdrawal by Subject|1
5050306|NCT02554682|17408584|P1|Overall Study|Withdrawal by Subject|2
5050307|NCT02554682|17408575|P10|Overall Study|Lost to Follow-up|2
5050308|NCT02554682|17408576|P9|Overall Study|Lost to Follow-up|2
5050309|NCT02554682|17408577|P8|Overall Study|Lost to Follow-up|6
5050310|NCT02554682|17408578|P7|Overall Study|Lost to Follow-up|6
5050311|NCT02554682|17408579|P6|Overall Study|Lost to Follow-up|1
5050312|NCT02554682|17408580|P5|Overall Study|Lost to Follow-up|2
5050313|NCT02554682|17408581|P4|Overall Study|Lost to Follow-up|3
5050314|NCT02554682|17408582|P3|Overall Study|Lost to Follow-up|4
5050315|NCT02554682|17408583|P2|Overall Study|Lost to Follow-up|9
5050316|NCT02554682|17408584|P1|Overall Study|Lost to Follow-up|11
5050317|NCT02554656|17408633|P1|Overall Study|Protocol Violation|3
5050318|NCT02554279|17408678|P2|Overall Study|Other reason|6
5050319|NCT02554279|17408679|P1|Overall Study|Other reason|19
5050320|NCT02554279|17408678|P2|Overall Study|Protocol Violation|1
5050321|NCT02554279|17408679|P1|Overall Study|Protocol Violation|2
5050322|NCT02554279|17408678|P2|Overall Study|Withdrawal by Subject|4
5050323|NCT02554279|17408679|P1|Overall Study|Withdrawal by Subject|6
5050324|NCT02554279|17408678|P2|Overall Study|Lost to Follow-up|2
5050325|NCT02554279|17408679|P1|Overall Study|Lost to Follow-up|3
5050326|NCT02554279|17408678|P2|Overall Study|Adverse Event|5
5050327|NCT02554279|17408679|P1|Overall Study|Adverse Event|2
5050328|NCT02554019|17408714|P3|Overall Study|Adverse Event|0
5050329|NCT02554019|17408715|P2|Overall Study|Adverse Event|0
5050330|NCT02554019|17408716|P1|Overall Study|Adverse Event|1
5050331|NCT02554019|17408714|P3|Overall Study|Withdrawal by Subject|2
5050332|NCT02554019|17408715|P2|Overall Study|Withdrawal by Subject|0
5050333|NCT02554019|17408716|P1|Overall Study|Withdrawal by Subject|1
5050334|NCT02553928|17408738|P2|Overall Study|Administrative reason(s)|1
5050335|NCT02553928|17408739|P1|Overall Study|Administrative reason(s)|0
5050336|NCT02553928|17408738|P2|Overall Study|Lost to Follow-up|1
5050337|NCT02553928|17408739|P1|Overall Study|Lost to Follow-up|0
5050338|NCT02553928|17408738|P2|Overall Study|Adverse Event|1
5050339|NCT02553928|17408739|P1|Overall Study|Adverse Event|2
5050340|NCT02553772|17408793|P2|Overall Study|Other Miscellaneous Reasons|1
5050341|NCT02553772|17408794|P1|Overall Study|Other Miscellaneous Reasons|0
5050342|NCT02553772|17408793|P2|Overall Study|Lack of Efficacy|0
5050343|NCT02553772|17408794|P1|Overall Study|Lack of Efficacy|1
5050344|NCT02553772|17408793|P2|Overall Study|Withdrawal of Consent|1
5050345|NCT02553772|17408794|P1|Overall Study|Withdrawal of Consent|1
5050346|NCT02553772|17408793|P2|Overall Study|Lost to Follow-up|1
5050347|NCT02553772|17408794|P1|Overall Study|Lost to Follow-up|2
5050348|NCT02553772|17408793|P2|Overall Study|Adverse Event|3
5050349|NCT02553772|17408794|P1|Overall Study|Adverse Event|2
5050350|NCT02553629|17408839|P2|Overall Study|Logistic reasons|6
5050351|NCT02553629|17408840|P1|Overall Study|Logistic reasons|3
5050352|NCT02553538|17408856|P2|Overall Study|Died or Left Network|56
5050353|NCT02553538|17408857|P1|Overall Study|Died or Left Network|54
5050354|NCT02553538|17408856|P2|Overall Study|Could Not Reach by Telephone|0
5050355|NCT02553538|17408857|P1|Overall Study|Could Not Reach by Telephone|133
5050356|NCT02553499|17408891|P14|Overall Study|Withdrawal by Subject|0
5050357|NCT02553499|17408892|P13|Overall Study|Withdrawal by Subject|0
5050358|NCT02553499|17408893|P12|Overall Study|Withdrawal by Subject|0
5050359|NCT02553499|17408894|P11|Overall Study|Withdrawal by Subject|1
5050360|NCT02553499|17408895|P10|Overall Study|Withdrawal by Subject|0
5050361|NCT02553499|17408896|P9|Overall Study|Withdrawal by Subject|1
5050362|NCT02553499|17408897|P8|Overall Study|Withdrawal by Subject|1
5050363|NCT02553499|17408898|P7|Overall Study|Withdrawal by Subject|0
5050364|NCT02553499|17408899|P6|Overall Study|Withdrawal by Subject|0
5050365|NCT02553499|17408900|P5|Overall Study|Withdrawal by Subject|0
5050366|NCT02553499|17408901|P4|Overall Study|Withdrawal by Subject|0
5050367|NCT02553499|17408902|P3|Overall Study|Withdrawal by Subject|0
5050368|NCT02553499|17408903|P2|Overall Study|Withdrawal by Subject|0
5050369|NCT02553499|17408904|P1|Overall Study|Withdrawal by Subject|2
5050370|NCT02553499|17408891|P14|Overall Study|Study Terminated by Sponsor|0
5050371|NCT02553499|17408892|P13|Overall Study|Study Terminated by Sponsor|0
5050372|NCT02553499|17408893|P12|Overall Study|Study Terminated by Sponsor|0
5050373|NCT02553499|17408894|P11|Overall Study|Study Terminated by Sponsor|0
5050374|NCT02553499|17408895|P10|Overall Study|Study Terminated by Sponsor|0
5050375|NCT02553499|17408896|P9|Overall Study|Study Terminated by Sponsor|1
5050376|NCT02553499|17408897|P8|Overall Study|Study Terminated by Sponsor|0
5050377|NCT02553499|17408898|P7|Overall Study|Study Terminated by Sponsor|0
5050378|NCT02553499|17408899|P6|Overall Study|Study Terminated by Sponsor|0
5050379|NCT02553499|17408900|P5|Overall Study|Study Terminated by Sponsor|0
5050380|NCT02553499|17408901|P4|Overall Study|Study Terminated by Sponsor|0
5050381|NCT02553499|17408902|P3|Overall Study|Study Terminated by Sponsor|0
5050382|NCT02553499|17408903|P2|Overall Study|Study Terminated by Sponsor|0
5050383|NCT02553499|17408904|P1|Overall Study|Study Terminated by Sponsor|0
5050384|NCT02553499|17408891|P14|Overall Study|Progressive Disease|1
5050385|NCT02553499|17408892|P13|Overall Study|Progressive Disease|2
5050386|NCT02553499|17408893|P12|Overall Study|Progressive Disease|0
5050387|NCT02553499|17408894|P11|Overall Study|Progressive Disease|0
5050388|NCT02553499|17408895|P10|Overall Study|Progressive Disease|1
5050389|NCT02553499|17408896|P9|Overall Study|Progressive Disease|0
5050390|NCT02553499|17408897|P8|Overall Study|Progressive Disease|0
5050391|NCT02553499|17408898|P7|Overall Study|Progressive Disease|1
5050392|NCT02553499|17408899|P6|Overall Study|Progressive Disease|1
5050393|NCT02553499|17408900|P5|Overall Study|Progressive Disease|1
5050394|NCT02553499|17408901|P4|Overall Study|Progressive Disease|2
5050395|NCT02553499|17408902|P3|Overall Study|Progressive Disease|0
5050396|NCT02553499|17408903|P2|Overall Study|Progressive Disease|0
5050397|NCT02553499|17408904|P1|Overall Study|Progressive Disease|0
5050398|NCT02553499|17408891|P14|Overall Study|Physician Decision|0
5050399|NCT02553499|17408892|P13|Overall Study|Physician Decision|1
5050400|NCT02553499|17408893|P12|Overall Study|Physician Decision|3
5050401|NCT02553499|17408894|P11|Overall Study|Physician Decision|1
5050402|NCT02553499|17408895|P10|Overall Study|Physician Decision|2
5050403|NCT02553499|17408896|P9|Overall Study|Physician Decision|1
5050404|NCT02553499|17408897|P8|Overall Study|Physician Decision|1
5050405|NCT02553499|17408898|P7|Overall Study|Physician Decision|0
5050406|NCT02553499|17408899|P6|Overall Study|Physician Decision|0
5050407|NCT02553499|17408900|P5|Overall Study|Physician Decision|1
5050408|NCT02553499|17408901|P4|Overall Study|Physician Decision|0
5050409|NCT02553499|17408902|P3|Overall Study|Physician Decision|1
5050410|NCT02553499|17408903|P2|Overall Study|Physician Decision|1
5050411|NCT02553499|17408904|P1|Overall Study|Physician Decision|0
5050412|NCT02553499|17408891|P14|Overall Study|Lost to Follow-up|0
5050413|NCT02553499|17408892|P13|Overall Study|Lost to Follow-up|0
5050414|NCT02553499|17408893|P12|Overall Study|Lost to Follow-up|0
5050415|NCT02553499|17408894|P11|Overall Study|Lost to Follow-up|0
5050416|NCT02553499|17408895|P10|Overall Study|Lost to Follow-up|0
5050417|NCT02553499|17408896|P9|Overall Study|Lost to Follow-up|0
5050418|NCT02553499|17408897|P8|Overall Study|Lost to Follow-up|0
5050419|NCT02553499|17408898|P7|Overall Study|Lost to Follow-up|1
5050420|NCT02553499|17408899|P6|Overall Study|Lost to Follow-up|0
5050421|NCT02553499|17408900|P5|Overall Study|Lost to Follow-up|0
5050422|NCT02553499|17408901|P4|Overall Study|Lost to Follow-up|0
5050423|NCT02553499|17408902|P3|Overall Study|Lost to Follow-up|0
5050424|NCT02553499|17408903|P2|Overall Study|Lost to Follow-up|0
5050425|NCT02553499|17408904|P1|Overall Study|Lost to Follow-up|0
5050426|NCT02553499|17408891|P14|Overall Study|Death|0
5050427|NCT02553499|17408892|P13|Overall Study|Death|0
5050428|NCT02553499|17408893|P12|Overall Study|Death|0
5050429|NCT02553499|17408894|P11|Overall Study|Death|1
5050430|NCT02553499|17408895|P10|Overall Study|Death|0
5050431|NCT02553499|17408896|P9|Overall Study|Death|0
5050432|NCT02553499|17408897|P8|Overall Study|Death|0
5050433|NCT02553499|17408898|P7|Overall Study|Death|0
5050434|NCT02553499|17408899|P6|Overall Study|Death|2
5050435|NCT02553499|17408900|P5|Overall Study|Death|1
5050436|NCT02553499|17408901|P4|Overall Study|Death|0
5050437|NCT02553499|17408902|P3|Overall Study|Death|1
5050438|NCT02553499|17408903|P2|Overall Study|Death|1
5050439|NCT02553499|17408904|P1|Overall Study|Death|0
5050440|NCT02553499|17408891|P14|Overall Study|Adverse Event|1
5050441|NCT02553499|17408892|P13|Overall Study|Adverse Event|0
5050442|NCT02553499|17408893|P12|Overall Study|Adverse Event|0
5050443|NCT02553499|17408894|P11|Overall Study|Adverse Event|0
5050444|NCT02553499|17408895|P10|Overall Study|Adverse Event|0
5050445|NCT02553499|17408896|P9|Overall Study|Adverse Event|0
5050446|NCT02553499|17408897|P8|Overall Study|Adverse Event|1
5050447|NCT02553499|17408898|P7|Overall Study|Adverse Event|1
5050448|NCT02553499|17408899|P6|Overall Study|Adverse Event|0
5050449|NCT02553499|17408900|P5|Overall Study|Adverse Event|0
5050450|NCT02553499|17408901|P4|Overall Study|Adverse Event|0
5050451|NCT02553499|17408902|P3|Overall Study|Adverse Event|0
5050452|NCT02553499|17408903|P2|Overall Study|Adverse Event|0
5050453|NCT02553499|17408904|P1|Overall Study|Adverse Event|0
5050454|NCT02553421|17409006|P2|Overall Study|Improper Device Placement|0
5050455|NCT02553421|17409007|P1|Overall Study|Improper Device Placement|3
5050456|NCT02553421|17409006|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
5050457|NCT02553421|17409007|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
5050458|NCT02553421|17409006|P2|Overall Study|Lost to Follow-up|1
5050459|NCT02553421|17409007|P1|Overall Study|Lost to Follow-up|21
5050460|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
5050461|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
5050462|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
5050463|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
5050464|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
5050465|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
5050466|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
5050467|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
5050468|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
5050469|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
5050470|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Adverse Event|5
5050471|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Adverse Event|6
5050472|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Death|3
5050473|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Death|1
5050474|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
5050475|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
5050476|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Physician Decision|4
5050477|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Physician Decision|2
5050478|NCT02553317|17409017|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
5050479|NCT02553317|17409018|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
5050480|NCT02552966|17409048|P1|Overall Study|Withdrawal by Subject|3
5050481|NCT02552966|17409048|P1|Overall Study|Lost to Follow-up|2
5050482|NCT02552732|17409074|P1|Overall Study|Withdrawal by Subject|6
5050483|NCT02552732|17409074|P1|Overall Study|Day 1 SpO2 > 96%|1
5050484|NCT02552732|17409074|P1|Overall Study|Physician Decision|1
5050485|NCT02552732|17409074|P1|Overall Study|Lost to Follow-up|2
5050486|NCT02552355|17409110|P4|Overall Study|Withdrawal by Subject|1
5050487|NCT02552355|17409111|P3|Overall Study|Withdrawal by Subject|0
5050488|NCT02552355|17409112|P2|Overall Study|Withdrawal by Subject|0
5050489|NCT02552355|17409113|P1|Overall Study|Withdrawal by Subject|0
5050490|NCT02552355|17409110|P4|Overall Study|Adverse Event|0
5050491|NCT02552355|17409111|P3|Overall Study|Adverse Event|2
5050492|NCT02552355|17409112|P2|Overall Study|Adverse Event|2
5050493|NCT02552355|17409113|P1|Overall Study|Adverse Event|0
5050494|NCT02552303|17409159|P4|Follow-Up|ineligible|0
5050495|NCT02552303|17409160|P3|Follow-Up|ineligible|0
5050496|NCT02552303|17409161|P2|Follow-Up|ineligible|2
5050497|NCT02552303|17409162|P1|Follow-Up|ineligible|0
5050498|NCT02552303|17409159|P4|Follow-Up|Lost to Follow-up|0
5050499|NCT02552303|17409160|P3|Follow-Up|Lost to Follow-up|1
5050500|NCT02552303|17409161|P2|Follow-Up|Lost to Follow-up|0
5050501|NCT02552303|17409162|P1|Follow-Up|Lost to Follow-up|0
5050502|NCT02552303|17409159|P4|Allocation|ineligible|0
5050503|NCT02552303|17409160|P3|Allocation|ineligible|0
5050504|NCT02552303|17409161|P2|Allocation|ineligible|1
5050505|NCT02552303|17409162|P1|Allocation|ineligible|1
5050506|NCT02552303|17409159|P4|Allocation|Withdrawal by Subject|1
5050507|NCT02552303|17409160|P3|Allocation|Withdrawal by Subject|1
5050508|NCT02552303|17409161|P2|Allocation|Withdrawal by Subject|1
5050509|NCT02552303|17409162|P1|Allocation|Withdrawal by Subject|2
5050510|NCT02552238|17409176|P1|Overall Study|Adverse Event|2
5050511|NCT02552212|17409189|P2|Overall Study|Missing/Unspecified|0
5050512|NCT02552212|17409190|P1|Overall Study|Missing/Unspecified|1
5050513|NCT02552212|17409189|P2|Overall Study|Not eligible|1
5050514|NCT02552212|17409190|P1|Overall Study|Not eligible|0
5050515|NCT02552212|17409189|P2|Overall Study|As per suggestion|1
5050516|NCT02552212|17409190|P1|Overall Study|As per suggestion|0
5050517|NCT02552212|17409189|P2|Overall Study|Patient's decision|1
5050518|NCT02552212|17409190|P1|Overall Study|Patient's decision|0
5050519|NCT02552212|17409189|P2|Overall Study|Study non-compliance|1
5050520|NCT02552212|17409190|P1|Overall Study|Study non-compliance|1
5050521|NCT02552212|17409189|P2|Overall Study|Withdrawal by Subject|7
5050522|NCT02552212|17409190|P1|Overall Study|Withdrawal by Subject|3
5050523|NCT02552212|17409189|P2|Overall Study|Lost to Follow-up|0
5050524|NCT02552212|17409190|P1|Overall Study|Lost to Follow-up|1
5050525|NCT02552212|17409189|P2|Overall Study|Protocol Violation|1
5050526|NCT02552212|17409190|P1|Overall Study|Protocol Violation|1
5050527|NCT02552212|17409189|P2|Overall Study|Lack of Efficacy|2
5050528|NCT02552212|17409190|P1|Overall Study|Lack of Efficacy|2
5050529|NCT02552212|17409189|P2|Overall Study|Adverse Event|3
5050530|NCT02552212|17409190|P1|Overall Study|Adverse Event|6
5050531|NCT02552147|17409264|P2|Second Intervention (7 Days)|Protocol Violation|0
5050532|NCT02552147|17409265|P1|Second Intervention (7 Days)|Protocol Violation|2
5050533|NCT02552147|17409264|P2|First Intervention (7 Days)|Protocol Violation|0
5050534|NCT02552147|17409265|P1|First Intervention (7 Days)|Protocol Violation|1
5050535|NCT02552121|17409299|P8|Part 2: Cohort Expansion|Death|0
5050536|NCT02552121|17409300|P7|Part 2: Cohort Expansion|Death|0
5050537|NCT02552121|17409301|P6|Part 2: Cohort Expansion|Death|0
5050538|NCT02552121|17409302|P5|Part 2: Cohort Expansion|Death|0
5050539|NCT02552121|17409303|P4|Part 2: Cohort Expansion|Death|0
5050540|NCT02552121|17409304|P3|Part 2: Cohort Expansion|Death|1
5050541|NCT02552121|17409305|P2|Part 2: Cohort Expansion|Death|0
5050542|NCT02552121|17409306|P1|Part 2: Cohort Expansion|Death|0
5050543|NCT02552121|17409299|P8|Part 2: Cohort Expansion|Adverse Event|0
5050544|NCT02552121|17409300|P7|Part 2: Cohort Expansion|Adverse Event|0
5050545|NCT02552121|17409301|P6|Part 2: Cohort Expansion|Adverse Event|0
5050546|NCT02552121|17409302|P5|Part 2: Cohort Expansion|Adverse Event|0
5050547|NCT02552121|17409303|P4|Part 2: Cohort Expansion|Adverse Event|1
5050548|NCT02552121|17409304|P3|Part 2: Cohort Expansion|Adverse Event|6
5050549|NCT02552121|17409305|P2|Part 2: Cohort Expansion|Adverse Event|0
5050550|NCT02552121|17409306|P1|Part 2: Cohort Expansion|Adverse Event|0
5050551|NCT02552121|17409299|P8|Part 2: Cohort Expansion|Disease Progression|3
5050552|NCT02552121|17409300|P7|Part 2: Cohort Expansion|Disease Progression|0
5050553|NCT02552121|17409301|P6|Part 2: Cohort Expansion|Disease Progression|4
5050554|NCT02552121|17409302|P5|Part 2: Cohort Expansion|Disease Progression|1
5050555|NCT02552121|17409303|P4|Part 2: Cohort Expansion|Disease Progression|2
5050556|NCT02552121|17409304|P3|Part 2: Cohort Expansion|Disease Progression|3
5050557|NCT02552121|17409305|P2|Part 2: Cohort Expansion|Disease Progression|0
5050558|NCT02552121|17409306|P1|Part 2: Cohort Expansion|Disease Progression|0
5050559|NCT02552121|17409299|P8|Part 2: Cohort Expansion|Patient Choice|0
5050560|NCT02552121|17409300|P7|Part 2: Cohort Expansion|Patient Choice|1
5050561|NCT02552121|17409301|P6|Part 2: Cohort Expansion|Patient Choice|0
5050562|NCT02552121|17409302|P5|Part 2: Cohort Expansion|Patient Choice|0
5050563|NCT02552121|17409303|P4|Part 2: Cohort Expansion|Patient Choice|0
5050564|NCT02552121|17409304|P3|Part 2: Cohort Expansion|Patient Choice|1
5050565|NCT02552121|17409305|P2|Part 2: Cohort Expansion|Patient Choice|0
5050566|NCT02552121|17409306|P1|Part 2: Cohort Expansion|Patient Choice|0
5050567|NCT02552121|17409299|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050568|NCT02552121|17409300|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050569|NCT02552121|17409301|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050570|NCT02552121|17409302|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050571|NCT02552121|17409303|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050572|NCT02552121|17409304|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050573|NCT02552121|17409305|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
5050574|NCT02552121|17409306|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5050575|NCT02552121|17409299|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050576|NCT02552121|17409300|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050577|NCT02552121|17409301|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050578|NCT02552121|17409302|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050579|NCT02552121|17409303|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050580|NCT02552121|17409304|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050581|NCT02552121|17409305|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
5050582|NCT02552121|17409306|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5050583|NCT02552121|17409299|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050584|NCT02552121|17409300|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050585|NCT02552121|17409301|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050586|NCT02552121|17409302|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050587|NCT02552121|17409303|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050588|NCT02552121|17409304|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050589|NCT02552121|17409305|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
5050590|NCT02552121|17409306|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5050591|NCT02552121|17409299|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050592|NCT02552121|17409300|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050593|NCT02552121|17409301|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050594|NCT02552121|17409302|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050595|NCT02552121|17409303|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050596|NCT02552121|17409304|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050597|NCT02552121|17409305|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
5050598|NCT02552121|17409306|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5050599|NCT02552121|17409299|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050600|NCT02552121|17409300|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050601|NCT02552121|17409301|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050602|NCT02552121|17409302|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050603|NCT02552121|17409303|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050604|NCT02552121|17409304|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050605|NCT02552121|17409305|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5050606|NCT02552121|17409306|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
5050607|NCT02552121|17409299|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050608|NCT02552121|17409300|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050609|NCT02552121|17409301|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050610|NCT02552121|17409302|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050611|NCT02552121|17409303|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050612|NCT02552121|17409304|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050613|NCT02552121|17409305|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5050614|NCT02552121|17409306|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
5050615|NCT02551874|17409567|P2|Overall Study|Did not enter long-term study|25
5050616|NCT02551874|17409568|P1|Overall Study|Did not enter long-term study|18
5050617|NCT02551874|17409567|P2|Overall Study|Did not receive randomized treatment|7
5050618|NCT02551874|17409568|P1|Overall Study|Did not receive randomized treatment|0
5050619|NCT02551874|17409567|P2|Overall Study|Reason not reported|4
5050620|NCT02551874|17409568|P1|Overall Study|Reason not reported|10
5050621|NCT02551874|17409567|P2|Overall Study|Pregnancy|1
5050622|NCT02551874|17409568|P1|Overall Study|Pregnancy|0
5050623|NCT02551874|17409567|P2|Overall Study|Lost to Follow-up|2
5050624|NCT02551874|17409568|P1|Overall Study|Lost to Follow-up|0
5050625|NCT02551731|17409650|P1|Overall Study|Withdrawal by Subject|2
5050626|NCT02551692|17409670|P3|Overall Study|Withdrawal by Subject|1
5050627|NCT02551692|17409671|P2|Overall Study|Withdrawal by Subject|0
5050628|NCT02551692|17409672|P1|Overall Study|Withdrawal by Subject|1
5050629|NCT02551692|17409670|P3|Overall Study|Lost to Follow-up|4
5050630|NCT02551692|17409671|P2|Overall Study|Lost to Follow-up|1
5050631|NCT02551692|17409672|P1|Overall Study|Lost to Follow-up|0
5050632|NCT02551666|17409688|P2|Overall Study|Withdrawal by Subject|3
5050633|NCT02551666|17409689|P1|Overall Study|Withdrawal by Subject|1
5050634|NCT02551055|17409779|P8|Overall Study|Reason not specified|0
5050635|NCT02551055|17409780|P7|Overall Study|Reason not specified|1
5050636|NCT02551055|17409781|P6|Overall Study|Reason not specified|0
5050637|NCT02551055|17409782|P5|Overall Study|Reason not specified|1
5050638|NCT02551055|17409783|P4|Overall Study|Reason not specified|0
5050639|NCT02551055|17409784|P3|Overall Study|Reason not specified|0
5050640|NCT02551055|17409785|P2|Overall Study|Reason not specified|0
5050641|NCT02551055|17409786|P1|Overall Study|Reason not specified|0
5050642|NCT02551055|17409779|P8|Overall Study|Withdrawal by Subject|0
5050643|NCT02551055|17409780|P7|Overall Study|Withdrawal by Subject|0
5050644|NCT02551055|17409781|P6|Overall Study|Withdrawal by Subject|0
5050645|NCT02551055|17409782|P5|Overall Study|Withdrawal by Subject|2
5050646|NCT02551055|17409783|P4|Overall Study|Withdrawal by Subject|1
5050647|NCT02551055|17409784|P3|Overall Study|Withdrawal by Subject|0
5050648|NCT02551055|17409785|P2|Overall Study|Withdrawal by Subject|1
5050649|NCT02551055|17409786|P1|Overall Study|Withdrawal by Subject|1
5050650|NCT02551055|17409779|P8|Overall Study|Study Terminated by Sponsor|0
5050651|NCT02551055|17409780|P7|Overall Study|Study Terminated by Sponsor|0
5050652|NCT02551055|17409781|P6|Overall Study|Study Terminated by Sponsor|0
5050653|NCT02551055|17409782|P5|Overall Study|Study Terminated by Sponsor|2
5050654|NCT02551055|17409783|P4|Overall Study|Study Terminated by Sponsor|2
5050655|NCT02551055|17409784|P3|Overall Study|Study Terminated by Sponsor|0
5050656|NCT02551055|17409785|P2|Overall Study|Study Terminated by Sponsor|1
5050657|NCT02551055|17409786|P1|Overall Study|Study Terminated by Sponsor|1
5050658|NCT02551055|17409779|P8|Overall Study|Death|0
5050659|NCT02551055|17409780|P7|Overall Study|Death|2
5050660|NCT02551055|17409781|P6|Overall Study|Death|1
5050661|NCT02551055|17409782|P5|Overall Study|Death|2
5050662|NCT02551055|17409783|P4|Overall Study|Death|2
5050663|NCT02551055|17409784|P3|Overall Study|Death|2
5050664|NCT02551055|17409785|P2|Overall Study|Death|4
5050665|NCT02551055|17409786|P1|Overall Study|Death|2
5050666|NCT02550873|17409861|P3|Open Label Extension|Study ongoing|111
5050667|NCT02550873|17409862|P2|Open Label Extension|Study ongoing|0
5050668|NCT02550873|17409863|P1|Open Label Extension|Study ongoing|0
5050669|NCT02550873|17409861|P3|Randomized Double Blind|Disease progression|0
5050670|NCT02550873|17409862|P2|Randomized Double Blind|Disease progression|1
5050671|NCT02550873|17409863|P1|Randomized Double Blind|Disease progression|1
5050672|NCT02550873|17409861|P3|Randomized Double Blind|Adverse Event|0
5050673|NCT02550873|17409862|P2|Randomized Double Blind|Adverse Event|1
5050674|NCT02550873|17409863|P1|Randomized Double Blind|Adverse Event|3
5050675|NCT02550795|17409944|P3|Overall Study|Physician Decision|0
5050676|NCT02550795|17409945|P2|Overall Study|Physician Decision|1
5050677|NCT02550795|17409946|P1|Overall Study|Physician Decision|0
5050678|NCT02550652|17409962|P2|Overall Study|Ongoing in study|56
5050679|NCT02550652|17409963|P1|Overall Study|Ongoing in study|59
5050680|NCT02550652|17409962|P2|Overall Study|Withdrawal by Subject|4
5050681|NCT02550652|17409963|P1|Overall Study|Withdrawal by Subject|3
5050682|NCT02550652|17409962|P2|Overall Study|Lack of Efficacy|0
5050683|NCT02550652|17409963|P1|Overall Study|Lack of Efficacy|1
5050684|NCT02550652|17409962|P2|Overall Study|Death|2
5050685|NCT02550652|17409963|P1|Overall Study|Death|0
5050686|NCT02550288|17410010|P5|Overall Study|Withdrawal by Subject|0
5050687|NCT02550288|17410011|P4|Overall Study|Withdrawal by Subject|1
5050688|NCT02550288|17410012|P3|Overall Study|Withdrawal by Subject|0
5050689|NCT02550288|17410013|P2|Overall Study|Withdrawal by Subject|0
5050690|NCT02550288|17410014|P1|Overall Study|Withdrawal by Subject|0
5050691|NCT02550288|17410010|P5|Overall Study|Participant moved|0
5050692|NCT02550288|17410011|P4|Overall Study|Participant moved|1
5050693|NCT02550288|17410012|P3|Overall Study|Participant moved|0
5050694|NCT02550288|17410013|P2|Overall Study|Participant moved|0
5050695|NCT02550288|17410014|P1|Overall Study|Participant moved|0
5050696|NCT02550288|17410010|P5|Overall Study|Protocol Violation|3
5050697|NCT02550288|17410011|P4|Overall Study|Protocol Violation|0
5050698|NCT02550288|17410012|P3|Overall Study|Protocol Violation|1
5050699|NCT02550288|17410013|P2|Overall Study|Protocol Violation|2
5050700|NCT02550288|17410014|P1|Overall Study|Protocol Violation|2
5050701|NCT02550288|17410010|P5|Overall Study|Physician Decision|0
5050702|NCT02550288|17410011|P4|Overall Study|Physician Decision|1
5050703|NCT02550288|17410012|P3|Overall Study|Physician Decision|0
5050704|NCT02550288|17410013|P2|Overall Study|Physician Decision|0
5050705|NCT02550288|17410014|P1|Overall Study|Physician Decision|0
5050706|NCT02550288|17410010|P5|Overall Study|Adverse Event|0
5050707|NCT02550288|17410011|P4|Overall Study|Adverse Event|0
5050708|NCT02550288|17410012|P3|Overall Study|Adverse Event|0
5050709|NCT02550288|17410013|P2|Overall Study|Adverse Event|1
5050710|NCT02550288|17410014|P1|Overall Study|Adverse Event|0
5050711|NCT02550106|17410170|P1|Overall Study|Withdrawal by Subject|2
5050712|NCT02550106|17410170|P1|Overall Study|Protocol Violation|6
5050713|NCT02550106|17410170|P1|Overall Study|Lack of Efficacy|3
5050714|NCT02550106|17410170|P1|Overall Study|Adverse Event|1
5050715|NCT02549859|17410194|P1|Long-term 60 Hz DBS|Study Closed|1
5050716|NCT02549573|17410280|P2|Overall Study|Protocol Violation|1
5050717|NCT02549573|17410281|P1|Overall Study|Protocol Violation|0
5050718|NCT02549573|17410280|P2|Overall Study|Withdrawal by Subject|2
5050719|NCT02549573|17410281|P1|Overall Study|Withdrawal by Subject|0
5050720|NCT02549352|17410348|P2|12-month Follow-up|Other|3
5050721|NCT02549352|17410349|P1|12-month Follow-up|Other|1
5050722|NCT02549352|17410348|P2|12-month Follow-up|Protocol Violation|1
5050723|NCT02549352|17410349|P1|12-month Follow-up|Protocol Violation|0
5050724|NCT02549352|17410348|P2|12-month Follow-up|Death|1
5050725|NCT02549352|17410349|P1|12-month Follow-up|Death|0
5050726|NCT02549352|17410348|P2|12-month Follow-up|Lost to Follow-up|2
5050727|NCT02549352|17410349|P1|12-month Follow-up|Lost to Follow-up|3
5050728|NCT02549352|17410348|P2|12-month Follow-up|Withdrawal by Subject|5
5050729|NCT02549352|17410349|P1|12-month Follow-up|Withdrawal by Subject|4
5050730|NCT02549352|17410348|P2|3-day Treatment and 8-week Follow-up|Other|2
5050731|NCT02549352|17410349|P1|3-day Treatment and 8-week Follow-up|Other|0
5050732|NCT02549352|17410348|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
5050733|NCT02549352|17410349|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
5050734|NCT02549352|17410348|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
5050735|NCT02549352|17410349|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
5050736|NCT02549339|17410365|P2|12-month Follow-up|Other|3
5050737|NCT02549339|17410366|P1|12-month Follow-up|Other|0
5050738|NCT02549339|17410365|P2|12-month Follow-up|Lost to Follow-up|3
5050739|NCT02549339|17410366|P1|12-month Follow-up|Lost to Follow-up|1
5050740|NCT02549339|17410365|P2|12-month Follow-up|Withdrawal by Subject|3
5050741|NCT02549339|17410366|P1|12-month Follow-up|Withdrawal by Subject|8
5050742|NCT02549339|17410365|P2|12-month Follow-up|Lack of Efficacy|2
5050743|NCT02549339|17410366|P1|12-month Follow-up|Lack of Efficacy|0
5050744|NCT02549339|17410365|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
5050745|NCT02549339|17410366|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
5050746|NCT02549339|17410365|P2|3-day Treatment and 8-week Follow-up|Other|0
5050747|NCT02549339|17410366|P1|3-day Treatment and 8-week Follow-up|Other|1
5050748|NCT02549339|17410365|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
5050749|NCT02549339|17410366|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
5050750|NCT02549339|17410365|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
5050751|NCT02549339|17410366|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
5050752|NCT02549287|17410382|P2|Overall Study|Withdrawal by Subject|6
5050753|NCT02549287|17410383|P1|Overall Study|Withdrawal by Subject|15
5050754|NCT02549287|17410382|P2|Overall Study|Lost to Follow-up|26
5050755|NCT02549287|17410383|P1|Overall Study|Lost to Follow-up|65
5050756|NCT02549196|17410417|P4|Overall Study|Withdrawal by Subject|0
5050757|NCT02549196|17410418|P3|Overall Study|Withdrawal by Subject|1
5050758|NCT02549196|17410419|P2|Overall Study|Withdrawal by Subject|0
5050759|NCT02549196|17410420|P1|Overall Study|Withdrawal by Subject|1
5050760|NCT02549196|17410417|P4|Overall Study|Protocol Violation|1
5050761|NCT02549196|17410418|P3|Overall Study|Protocol Violation|0
5050762|NCT02549196|17410419|P2|Overall Study|Protocol Violation|0
5050763|NCT02549196|17410420|P1|Overall Study|Protocol Violation|0
5050764|NCT02549027|17410476|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5050765|NCT02549027|17410477|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
5050766|NCT02549027|17410478|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5050767|NCT02549027|17410479|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5050768|NCT02549027|17410480|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5050769|NCT02549027|17410481|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5050770|NCT02549027|17410476|P6|Washout After Period 4|Withdrawal by Subject|0
5050771|NCT02549027|17410477|P5|Washout After Period 4|Withdrawal by Subject|0
5050772|NCT02549027|17410478|P4|Washout After Period 4|Withdrawal by Subject|1
5050773|NCT02549027|17410479|P3|Washout After Period 4|Withdrawal by Subject|1
5050774|NCT02549027|17410480|P2|Washout After Period 4|Withdrawal by Subject|1
5050775|NCT02549027|17410481|P1|Washout After Period 4|Withdrawal by Subject|0
5050776|NCT02548962|17410611|P2|Overall Study|Withdrawal by Subject|0
5050777|NCT02548962|17410612|P1|Overall Study|Withdrawal by Subject|1
5050778|NCT02548650|17410664|P2|Double Therapy|Withdrawal by Subject|1
5050779|NCT02548650|17410665|P1|Double Therapy|Withdrawal by Subject|0
5050780|NCT02548650|17410664|P2|Double Therapy|Adverse Event|1
5050781|NCT02548650|17410665|P1|Double Therapy|Adverse Event|1
5050782|NCT02548650|17410664|P2|Triple Therapy|Withdrawal by Subject|4
5050783|NCT02548650|17410665|P1|Triple Therapy|Withdrawal by Subject|0
5050784|NCT02548650|17410664|P2|Triple Therapy|Adverse Event|0
5050785|NCT02548650|17410665|P1|Triple Therapy|Adverse Event|1
5050786|NCT02548585|17410680|P7|Overall Study|Randomized but not treated|0
5050787|NCT02548585|17410681|P6|Overall Study|Randomized but not treated|1
5050788|NCT02548585|17410682|P5|Overall Study|Randomized but not treated|0
5050789|NCT02548585|17410683|P4|Overall Study|Randomized but not treated|0
5050790|NCT02548585|17410684|P3|Overall Study|Randomized but not treated|0
5050791|NCT02548585|17410685|P2|Overall Study|Randomized but not treated|0
5050792|NCT02548585|17410686|P1|Overall Study|Randomized but not treated|0
5050793|NCT02548585|17410680|P7|Overall Study|Other|1
5050794|NCT02548585|17410681|P6|Overall Study|Other|0
5050795|NCT02548585|17410682|P5|Overall Study|Other|3
5050796|NCT02548585|17410683|P4|Overall Study|Other|2
5050797|NCT02548585|17410684|P3|Overall Study|Other|0
5050798|NCT02548585|17410685|P2|Overall Study|Other|0
5050799|NCT02548585|17410686|P1|Overall Study|Other|1
5050800|NCT02548585|17410680|P7|Overall Study|Lost to Follow-up|0
5050801|NCT02548585|17410681|P6|Overall Study|Lost to Follow-up|0
5050802|NCT02548585|17410682|P5|Overall Study|Lost to Follow-up|0
5050803|NCT02548585|17410683|P4|Overall Study|Lost to Follow-up|0
5050804|NCT02548585|17410684|P3|Overall Study|Lost to Follow-up|0
5050805|NCT02548585|17410685|P2|Overall Study|Lost to Follow-up|0
5050806|NCT02548585|17410686|P1|Overall Study|Lost to Follow-up|1
5050807|NCT02548585|17410680|P7|Overall Study|Withdrawal by Subject|0
5050808|NCT02548585|17410681|P6|Overall Study|Withdrawal by Subject|1
5050809|NCT02548585|17410682|P5|Overall Study|Withdrawal by Subject|0
5050810|NCT02548585|17410683|P4|Overall Study|Withdrawal by Subject|0
5050811|NCT02548585|17410684|P3|Overall Study|Withdrawal by Subject|0
5050812|NCT02548585|17410685|P2|Overall Study|Withdrawal by Subject|0
5050813|NCT02548585|17410686|P1|Overall Study|Withdrawal by Subject|0
5050814|NCT02548455|17410904|P1|Overall Study|Visit not completed|173
5050815|NCT02548455|17410904|P1|Overall Study|Lost to Follow-up|14
5050816|NCT02548455|17410904|P1|Overall Study|Death|26
5050817|NCT02548455|17410904|P1|Overall Study|Withdrawal by Subject|27
5050818|NCT02548156|17410965|P6|Washout Period 1|Lost to Follow-up|0
5050819|NCT02548156|17410966|P5|Washout Period 1|Lost to Follow-up|1
5050820|NCT02548156|17410967|P4|Washout Period 1|Lost to Follow-up|0
5050821|NCT02548156|17410968|P3|Washout Period 1|Lost to Follow-up|0
5050822|NCT02548156|17410969|P2|Washout Period 1|Lost to Follow-up|0
5050823|NCT02548156|17410970|P1|Washout Period 1|Lost to Follow-up|0
5050824|NCT02548143|17410989|P2|Overall Study|Withdrawal by Subject|1
5050825|NCT02548143|17410990|P1|Overall Study|Withdrawal by Subject|0
5050826|NCT02548143|17410989|P2|Overall Study|Adverse Event|0
5050827|NCT02548143|17410990|P1|Overall Study|Adverse Event|1
5050828|NCT02548078|17411002|P2|Overall Study|Lost to Follow-up|3
5050829|NCT02548078|17411003|P1|Overall Study|Lost to Follow-up|1
5050830|NCT02548078|17411002|P2|Overall Study|Moved from study area|3
5050831|NCT02548078|17411003|P1|Overall Study|Moved from study area|3
5050832|NCT02548078|17411002|P2|Overall Study|Serious adverse event/Adverse event|0
5050833|NCT02548078|17411003|P1|Overall Study|Serious adverse event/Adverse event|1
5050834|NCT02547987|17411191|P1|Overall Study|Adverse Event|2
5050835|NCT02547987|17411191|P1|Overall Study|Withdrawal by Subject|1
5050836|NCT02547974|17411199|P4|Overall Study|Withdrawal by Subject|0
5050837|NCT02547974|17411200|P3|Overall Study|Withdrawal by Subject|0
5050838|NCT02547974|17411201|P2|Overall Study|Withdrawal by Subject|0
5050839|NCT02547974|17411202|P1|Overall Study|Withdrawal by Subject|1
5050840|NCT02547935|17411289|P3|Overall Study|Death|0
5050841|NCT02547935|17411290|P2|Overall Study|Death|1
5050842|NCT02547935|17411291|P1|Overall Study|Death|1
5050843|NCT02547935|17411289|P3|Overall Study|Lost to Follow-up|1
5050844|NCT02547935|17411290|P2|Overall Study|Lost to Follow-up|2
5050845|NCT02547935|17411291|P1|Overall Study|Lost to Follow-up|0
5050846|NCT02547935|17411289|P3|Overall Study|Physician Decision|0
5050847|NCT02547935|17411290|P2|Overall Study|Physician Decision|1
5050848|NCT02547935|17411291|P1|Overall Study|Physician Decision|0
5050849|NCT02547935|17411289|P3|Overall Study|Screen Failure|0
5050850|NCT02547935|17411290|P2|Overall Study|Screen Failure|0
5050851|NCT02547935|17411291|P1|Overall Study|Screen Failure|2
5050852|NCT02547935|17411289|P3|Overall Study|Withdrawal by Subject|4
5050853|NCT02547935|17411290|P2|Overall Study|Withdrawal by Subject|3
5050854|NCT02547935|17411291|P1|Overall Study|Withdrawal by Subject|2
5050855|NCT02547935|17411289|P3|Overall Study|Other|0
5050856|NCT02547935|17411290|P2|Overall Study|Other|1
5050857|NCT02547935|17411291|P1|Overall Study|Other|0
5050858|NCT02547766|17411329|P1|Overall Study|Withdrawal by Subject|1
5050859|NCT02547649|17411349|P3|Overall Study|Withdrawal by Subject|2
5050860|NCT02547649|17411350|P2|Overall Study|Withdrawal by Subject|4
5050861|NCT02547649|17411351|P1|Overall Study|Withdrawal by Subject|0
5050862|NCT02547649|17411349|P3|Overall Study|Not vaccinated|1
5050863|NCT02547649|17411350|P2|Overall Study|Not vaccinated|0
5050864|NCT02547649|17411351|P1|Overall Study|Not vaccinated|0
5050865|NCT02547649|17411349|P3|Overall Study|Lost to Follow-up|1
5050866|NCT02547649|17411350|P2|Overall Study|Lost to Follow-up|1
5050867|NCT02547649|17411351|P1|Overall Study|Lost to Follow-up|3
5050868|NCT02547454|17411416|P1|Overall Study|No data|11
5050869|NCT02547454|17411416|P1|Overall Study|Other|39
5050870|NCT02547454|17411416|P1|Overall Study|Lost to Follow-up|26
5050871|NCT02547454|17411416|P1|Overall Study|Death|38
5050872|NCT02547454|17411416|P1|Overall Study|Due to no further need to treat|4
5050873|NCT02547454|17411416|P1|Overall Study|Due to transplantation|1
5050874|NCT02547454|17411416|P1|Overall Study|Due to hemodialysis|53
5050875|NCT02547363|17411446|P2|12-month Follow-up|Other|0
5050876|NCT02547363|17411447|P1|12-month Follow-up|Other|1
5050877|NCT02547363|17411446|P2|12-month Follow-up|Lack of Efficacy|1
5050878|NCT02547363|17411447|P1|12-month Follow-up|Lack of Efficacy|1
5050879|NCT02547363|17411446|P2|12-month Follow-up|Lost to Follow-up|1
5050880|NCT02547363|17411447|P1|12-month Follow-up|Lost to Follow-up|4
5050881|NCT02547363|17411446|P2|12-month Follow-up|Withdrawal by Subject|3
5050882|NCT02547363|17411447|P1|12-month Follow-up|Withdrawal by Subject|4
5050883|NCT02547363|17411446|P2|3-day Treatment and 8-week Follow-up|Other|1
5050884|NCT02547363|17411447|P1|3-day Treatment and 8-week Follow-up|Other|1
5050885|NCT02547363|17411446|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5050886|NCT02547363|17411447|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5050887|NCT02547363|17411446|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
5050888|NCT02547363|17411447|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
5050889|NCT02547363|17411446|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
5050890|NCT02547363|17411447|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
5050891|NCT02547233|17411463|P2|12-month Follow-up|Other|1
5050892|NCT02547233|17411464|P1|12-month Follow-up|Other|0
5050893|NCT02547233|17411463|P2|12-month Follow-up|Protocol Violation|1
5050894|NCT02547233|17411464|P1|12-month Follow-up|Protocol Violation|0
5050895|NCT02547233|17411463|P2|12-month Follow-up|Lack of Efficacy|2
5050896|NCT02547233|17411464|P1|12-month Follow-up|Lack of Efficacy|1
5050897|NCT02547233|17411463|P2|12-month Follow-up|Lost to Follow-up|3
5050898|NCT02547233|17411464|P1|12-month Follow-up|Lost to Follow-up|3
5050899|NCT02547233|17411463|P2|12-month Follow-up|Withdrawal by Subject|10
5050900|NCT02547233|17411464|P1|12-month Follow-up|Withdrawal by Subject|10
5050901|NCT02547233|17411463|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5050902|NCT02547233|17411464|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
5050903|NCT02547233|17411463|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
5050904|NCT02547233|17411464|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
5050905|NCT02547233|17411463|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
5050906|NCT02547233|17411464|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
5050907|NCT02547233|17411463|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
5050908|NCT02547233|17411464|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
5050909|NCT02547220|17411480|P2|Overall Study|Study terminated by sponsor|20
5050910|NCT02547220|17411481|P1|Overall Study|Study terminated by sponsor|18
5050911|NCT02547220|17411480|P2|Overall Study|Withdrawal by Subject|0
5050912|NCT02547220|17411481|P1|Overall Study|Withdrawal by Subject|1
5050913|NCT02547129|17411517|P2|Overall Study|Difficulty with ongoing infection|0
5050914|NCT02547129|17411518|P1|Overall Study|Difficulty with ongoing infection|1
5050915|NCT02547038|17411561|P2|Overall Study|Lost to Follow-up|2
5050916|NCT02547038|17411562|P1|Overall Study|Lost to Follow-up|3
5050917|NCT02546986|17411579|P2|Survival Follow-Up Phase|Lost to Follow-up|2
5050918|NCT02546986|17411580|P1|Survival Follow-Up Phase|Lost to Follow-up|2
5050919|NCT02546986|17411579|P2|Survival Follow-Up Phase|Alive|16
5050920|NCT02546986|17411580|P1|Survival Follow-Up Phase|Alive|13
5050921|NCT02546986|17411579|P2|Survival Follow-Up Phase|Death|12
5050922|NCT02546986|17411580|P1|Survival Follow-Up Phase|Death|18
5050923|NCT02546986|17411579|P2|Survival Follow-Up Phase|Missing Status|5
5050924|NCT02546986|17411580|P1|Survival Follow-Up Phase|Missing Status|3
5050925|NCT02546986|17411579|P2|Treatment Period|Miscellaneous|9
5050926|NCT02546986|17411580|P1|Treatment Period|Miscellaneous|7
5050927|NCT02546986|17411579|P2|Treatment Period|Study Terminated by Sponsor|1
5050928|NCT02546986|17411580|P1|Treatment Period|Study Terminated by Sponsor|0
5050929|NCT02546986|17411579|P2|Treatment Period|Non-compliance with Study Drug|1
5050930|NCT02546986|17411580|P1|Treatment Period|Non-compliance with Study Drug|0
5050931|NCT02546986|17411579|P2|Treatment Period|Withdrawal by Subject|1
5050932|NCT02546986|17411580|P1|Treatment Period|Withdrawal by Subject|1
5050933|NCT02546986|17411579|P2|Treatment Period|Protocol Violation|0
5050934|NCT02546986|17411580|P1|Treatment Period|Protocol Violation|1
5050935|NCT02546986|17411579|P2|Treatment Period|Physician Decision|2
5050936|NCT02546986|17411580|P1|Treatment Period|Physician Decision|1
5050937|NCT02546986|17411579|P2|Treatment Period|Death|4
5050938|NCT02546986|17411580|P1|Treatment Period|Death|3
5050939|NCT02546986|17411579|P2|Treatment Period|Symptomatic Deterioration|3
5050940|NCT02546986|17411580|P1|Treatment Period|Symptomatic Deterioration|4
5050941|NCT02546986|17411579|P2|Treatment Period|Adverse Event|6
5050942|NCT02546986|17411580|P1|Treatment Period|Adverse Event|14
5050943|NCT02546986|17411579|P2|Treatment Period|Progressive Disease|22
5050944|NCT02546986|17411580|P1|Treatment Period|Progressive Disease|20
5050945|NCT02546856|17411605|P2|6 Months Evaluation|reasons not due to titration|1
5050946|NCT02546856|17411606|P1|6 Months Evaluation|reasons not due to titration|0
5050947|NCT02546856|17411605|P2|6 Months Evaluation|Working or living abroad|4
5050948|NCT02546856|17411606|P1|6 Months Evaluation|Working or living abroad|6
5050949|NCT02546856|17411605|P2|6 Months Evaluation|Lost to Follow-up|1
5050950|NCT02546856|17411606|P1|6 Months Evaluation|Lost to Follow-up|1
5050951|NCT02546856|17411605|P2|6 Months Evaluation|Death|1
5050952|NCT02546856|17411606|P1|6 Months Evaluation|Death|1
5050953|NCT02546856|17411605|P2|4 Months Evaluation|HF Unit not active in summer|0
5050954|NCT02546856|17411606|P1|4 Months Evaluation|HF Unit not active in summer|1
5050955|NCT02546856|17411605|P2|4 Months Evaluation|reasons not due to titration|1
5050956|NCT02546856|17411606|P1|4 Months Evaluation|reasons not due to titration|4
5050957|NCT02546856|17411605|P2|4 Months Evaluation|Working or living abroad|1
5050958|NCT02546856|17411606|P1|4 Months Evaluation|Working or living abroad|5
5050959|NCT02546856|17411605|P2|4 Months Evaluation|Physician Decision|0
5050960|NCT02546856|17411606|P1|4 Months Evaluation|Physician Decision|3
5050961|NCT02546856|17411605|P2|4 Months Evaluation|Lost to Follow-up|3
5050962|NCT02546856|17411606|P1|4 Months Evaluation|Lost to Follow-up|3
5050963|NCT02546856|17411605|P2|4 Months Evaluation|Withdrawal by Subject|3
5050964|NCT02546856|17411606|P1|4 Months Evaluation|Withdrawal by Subject|2
5050965|NCT02546856|17411605|P2|4 Months Evaluation|Death|3
5050966|NCT02546856|17411606|P1|4 Months Evaluation|Death|2
5050967|NCT02546765|17411656|P4|Overall Study|Withdrawal by Subject|0
5050968|NCT02546765|17411657|P3|Overall Study|Withdrawal by Subject|0
5050969|NCT02546765|17411658|P2|Overall Study|Withdrawal by Subject|1
5050970|NCT02546765|17411659|P1|Overall Study|Withdrawal by Subject|0
5050971|NCT02546609|17411700|P3|Overall Study|travel or work schedule restriction|2
5050972|NCT02546609|17411701|P2|Overall Study|travel or work schedule restriction|0
5050973|NCT02546609|17411702|P1|Overall Study|travel or work schedule restriction|0
5050974|NCT02546609|17411700|P3|Overall Study|Lost to Follow-up|1
5050975|NCT02546609|17411701|P2|Overall Study|Lost to Follow-up|3
5050976|NCT02546609|17411702|P1|Overall Study|Lost to Follow-up|2
5050977|NCT02546609|17411700|P3|Overall Study|Protocol Violation|1
5050978|NCT02546609|17411701|P2|Overall Study|Protocol Violation|1
5050979|NCT02546609|17411702|P1|Overall Study|Protocol Violation|0
5050980|NCT02546609|17411700|P3|Overall Study|Adverse Event|1
5050981|NCT02546609|17411701|P2|Overall Study|Adverse Event|6
5050982|NCT02546609|17411702|P1|Overall Study|Adverse Event|0
5050983|NCT02546609|17411700|P3|Overall Study|Withdrawal by Subject|2
5050984|NCT02546609|17411701|P2|Overall Study|Withdrawal by Subject|1
5050985|NCT02546609|17411702|P1|Overall Study|Withdrawal by Subject|0
5050986|NCT02546544|17411782|P1|Overall Study|Withdrawal by Subject|1
5050987|NCT02546544|17411782|P1|Overall Study|Adverse Event|1
5050988|NCT02546544|17411782|P1|Overall Study|Disease Progression|14
5050989|NCT02546362|17411823|P1|12-week Treatment Period|Change in medication|1
5050990|NCT02546362|17411823|P1|12-week Treatment Period|Lost to Follow-up|2
5050991|NCT02546362|17411823|P1|12-week Treatment Period|Withdrawal by Subject|6
5050992|NCT02546362|17411823|P1|4-week Treatment Period|Change in medication|2
5050993|NCT02546362|17411823|P1|4-week Treatment Period|Lost to Follow-up|1
5050994|NCT02546323|17411844|P2|Overall Study|Met Withdrawal Criteria|14
5050995|NCT02546323|17411845|P1|Overall Study|Met Withdrawal Criteria|2
5050996|NCT02546323|17411844|P2|Overall Study|Non-compliance with Study Drug|2
5050997|NCT02546323|17411845|P1|Overall Study|Non-compliance with Study Drug|2
5050998|NCT02546323|17411844|P2|Overall Study|Lost to Follow-up|3
5050999|NCT02546323|17411845|P1|Overall Study|Lost to Follow-up|2
5051000|NCT02546323|17411844|P2|Overall Study|Patient Specific Reasons|2
5051001|NCT02546323|17411845|P1|Overall Study|Patient Specific Reasons|1
5051002|NCT02546323|17411844|P2|Overall Study|Adverse Event|11
5051003|NCT02546323|17411845|P1|Overall Study|Adverse Event|17
5051004|NCT02546323|17411844|P2|Overall Study|Eligibility Criteria not Fulfilled|1
5051005|NCT02546323|17411845|P1|Overall Study|Eligibility Criteria not Fulfilled|0
5051006|NCT02546323|17411844|P2|Overall Study|Withdrawal by Subject|33
5051007|NCT02546323|17411845|P1|Overall Study|Withdrawal by Subject|36
5051008|NCT02546193|17411865|P4|Overall Study|Not eligible at time of induction|0
5051009|NCT02546193|17411866|P3|Overall Study|Not eligible at time of induction|1
5051010|NCT02546193|17411867|P2|Overall Study|Not eligible at time of induction|6
5051011|NCT02546193|17411868|P1|Overall Study|Not eligible at time of induction|4
5051012|NCT02546193|17411865|P4|Overall Study|Withdrawal by Subject|0
5051013|NCT02546193|17411866|P3|Overall Study|Withdrawal by Subject|1
5051014|NCT02546193|17411867|P2|Overall Study|Withdrawal by Subject|0
5051015|NCT02546193|17411868|P1|Overall Study|Withdrawal by Subject|2
5051016|NCT02545933|17411905|P3|Overall Study|Protocol Violation|1
5051017|NCT02545933|17411906|P2|Overall Study|Protocol Violation|0
5051018|NCT02545933|17411907|P1|Overall Study|Protocol Violation|1
5051019|NCT02545933|17411905|P3|Overall Study|Withdrawal by Subject|3
5051020|NCT02545933|17411906|P2|Overall Study|Withdrawal by Subject|3
5051021|NCT02545933|17411907|P1|Overall Study|Withdrawal by Subject|2
5051022|NCT02545933|17411905|P3|Overall Study|Adverse Event|0
5051023|NCT02545933|17411906|P2|Overall Study|Adverse Event|0
5051024|NCT02545933|17411907|P1|Overall Study|Adverse Event|3
5051025|NCT02545868|17411918|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
5051026|NCT02545868|17411919|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
5051027|NCT02545868|17411920|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
5051028|NCT02545543|17412003|P2|Overall Study|Enrolment of subject at >1 study site|1
5051029|NCT02545543|17412004|P1|Overall Study|Enrolment of subject at >1 study site|1
5051030|NCT02545543|17412003|P2|Overall Study|Noncomplaince|0
5051031|NCT02545543|17412004|P1|Overall Study|Noncomplaince|1
5051032|NCT02545543|17412003|P2|Overall Study|Withdrawal by Subject|8
5051033|NCT02545543|17412004|P1|Overall Study|Withdrawal by Subject|9
5051034|NCT02545543|17412003|P2|Overall Study|Physician Decision|0
5051035|NCT02545543|17412004|P1|Overall Study|Physician Decision|3
5051036|NCT02545543|17412003|P2|Overall Study|Lost to Follow-up|25
5051037|NCT02545543|17412004|P1|Overall Study|Lost to Follow-up|67
5051038|NCT02545504|17412030|P2|Overall Study|Lost to Follow-up|2
5051039|NCT02545504|17412031|P1|Overall Study|Lost to Follow-up|2
5051040|NCT02545504|17412030|P2|Overall Study|Investigator's discretion|1
5051041|NCT02545504|17412031|P1|Overall Study|Investigator's discretion|3
5051042|NCT02545504|17412030|P2|Overall Study|Withdrew consent|11
5051043|NCT02545504|17412031|P1|Overall Study|Withdrew consent|9
5051044|NCT02545504|17412030|P2|Overall Study|Unknown reason|32
5051045|NCT02545504|17412031|P1|Overall Study|Unknown reason|30
5051046|NCT02545504|17412030|P2|Overall Study|Death|168
5051047|NCT02545504|17412031|P1|Overall Study|Death|174
5051048|NCT02545322|17412045|P1|Overall Study|Withdrawal by Subject|3
5051049|NCT02545270|17412053|P3|Overall Study|Videos being too similar to other|2
5051050|NCT02545270|17412054|P2|Overall Study|Videos being too similar to other|0
5051051|NCT02545270|17412055|P1|Overall Study|Videos being too similar to other|0
5051052|NCT02545270|17412053|P3|Overall Study|technical difficulties|0
5051053|NCT02545270|17412054|P2|Overall Study|technical difficulties|1
5051054|NCT02545270|17412055|P1|Overall Study|technical difficulties|0
5051055|NCT02545075|17412084|P2|Treatment|Completed treatment|12
5051056|NCT02545075|17412085|P1|Treatment|Completed treatment|40
5051057|NCT02545075|17412084|P2|Treatment|Participant drug toxicity|0
5051058|NCT02545075|17412085|P1|Treatment|Participant drug toxicity|1
5051059|NCT02545075|17412084|P2|Treatment|Death|0
5051060|NCT02545075|17412085|P1|Treatment|Death|1
5051061|NCT02545075|17412084|P2|Treatment|Adverse event not related to study drug|0
5051062|NCT02545075|17412085|P1|Treatment|Adverse event not related to study drug|1
5051063|NCT02545075|17412084|P2|Treatment|Withdrawal by Subject|0
5051064|NCT02545075|17412085|P1|Treatment|Withdrawal by Subject|1
5051065|NCT02545075|17412084|P2|Treatment|Participant dicontinued study treatment|9
5051066|NCT02545075|17412085|P1|Treatment|Participant dicontinued study treatment|7
5051067|NCT02545075|17412084|P2|Treatment|Disease progression|32
5051068|NCT02545075|17412085|P1|Treatment|Disease progression|71
5051069|NCT02545075|17412084|P2|Randomization|Withdrawal by Subject|6
5051070|NCT02545075|17412085|P1|Randomization|Withdrawal by Subject|0
5051071|NCT02545075|17412084|P2|Randomization|Lost to Follow-up|1
5051072|NCT02545075|17412085|P1|Randomization|Lost to Follow-up|0
5051073|NCT02544763|17412121|P3|Overall Study|Difficulties taking IMP|0
5051074|NCT02544763|17412122|P2|Overall Study|Difficulties taking IMP|0
5051075|NCT02544763|17412123|P1|Overall Study|Difficulties taking IMP|1
5051076|NCT02544763|17412121|P3|Overall Study|Physician Decision|0
5051077|NCT02544763|17412122|P2|Overall Study|Physician Decision|1
5051078|NCT02544763|17412123|P1|Overall Study|Physician Decision|0
5051079|NCT02544763|17412121|P3|Overall Study|Met withdrawal criteria|0
5051080|NCT02544763|17412122|P2|Overall Study|Met withdrawal criteria|2
5051081|NCT02544763|17412123|P1|Overall Study|Met withdrawal criteria|0
5051082|NCT02544763|17412121|P3|Overall Study|Withdrawn by parent/guardian|1
5051083|NCT02544763|17412122|P2|Overall Study|Withdrawn by parent/guardian|1
5051084|NCT02544763|17412123|P1|Overall Study|Withdrawn by parent/guardian|1
5051085|NCT02544763|17412121|P3|Overall Study|Adverse Event|0
5051086|NCT02544763|17412122|P2|Overall Study|Adverse Event|8
5051087|NCT02544763|17412123|P1|Overall Study|Adverse Event|8
5051088|NCT02544633|17412147|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
5051089|NCT02544633|17412148|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
5051090|NCT02544633|17412149|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
5051091|NCT02544633|17412150|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
5051092|NCT02544633|17412147|P4|Survival Follow-up Period|Withdrawal by Subject|0
5051093|NCT02544633|17412148|P3|Survival Follow-up Period|Withdrawal by Subject|1
5051094|NCT02544633|17412149|P2|Survival Follow-up Period|Withdrawal by Subject|0
5051095|NCT02544633|17412150|P1|Survival Follow-up Period|Withdrawal by Subject|4
5051096|NCT02544633|17412147|P4|Survival Follow-up Period|Lost to Follow-up|0
5051097|NCT02544633|17412148|P3|Survival Follow-up Period|Lost to Follow-up|1
5051098|NCT02544633|17412149|P2|Survival Follow-up Period|Lost to Follow-up|1
5051099|NCT02544633|17412150|P1|Survival Follow-up Period|Lost to Follow-up|0
5051100|NCT02544633|17412147|P4|Survival Follow-up Period|Death|9
5051101|NCT02544633|17412148|P3|Survival Follow-up Period|Death|3
5051102|NCT02544633|17412149|P2|Survival Follow-up Period|Death|14
5051103|NCT02544633|17412150|P1|Survival Follow-up Period|Death|12
5051104|NCT02544633|17412147|P4|Treatment Period|Clinical Disease Progression|1
5051105|NCT02544633|17412148|P3|Treatment Period|Clinical Disease Progression|0
5051106|NCT02544633|17412149|P2|Treatment Period|Clinical Disease Progression|0
5051107|NCT02544633|17412150|P1|Treatment Period|Clinical Disease Progression|0
5051108|NCT02544633|17412147|P4|Treatment Period|Non-compliance|0
5051109|NCT02544633|17412148|P3|Treatment Period|Non-compliance|1
5051110|NCT02544633|17412149|P2|Treatment Period|Non-compliance|0
5051111|NCT02544633|17412150|P1|Treatment Period|Non-compliance|0
5051112|NCT02544633|17412147|P4|Treatment Period|Death|0
5051113|NCT02544633|17412148|P3|Treatment Period|Death|1
5051114|NCT02544633|17412149|P2|Treatment Period|Death|0
5051115|NCT02544633|17412150|P1|Treatment Period|Death|0
5051116|NCT02544633|17412147|P4|Treatment Period|Lost to Follow-up|0
5051117|NCT02544633|17412148|P3|Treatment Period|Lost to Follow-up|0
5051118|NCT02544633|17412149|P2|Treatment Period|Lost to Follow-up|1
5051119|NCT02544633|17412150|P1|Treatment Period|Lost to Follow-up|0
5051120|NCT02544633|17412147|P4|Treatment Period|Withdrawal by Subject|0
5051121|NCT02544633|17412148|P3|Treatment Period|Withdrawal by Subject|0
5051122|NCT02544633|17412149|P2|Treatment Period|Withdrawal by Subject|0
5051123|NCT02544633|17412150|P1|Treatment Period|Withdrawal by Subject|1
5051124|NCT02544633|17412147|P4|Treatment Period|Global Deterioration of Health|1
5051125|NCT02544633|17412148|P3|Treatment Period|Global Deterioration of Health|0
5051126|NCT02544633|17412149|P2|Treatment Period|Global Deterioration of Health|3
5051127|NCT02544633|17412150|P1|Treatment Period|Global Deterioration of Health|3
5051128|NCT02544633|17412147|P4|Treatment Period|Lack of Efficacy|5
5051129|NCT02544633|17412148|P3|Treatment Period|Lack of Efficacy|5
5051130|NCT02544633|17412149|P2|Treatment Period|Lack of Efficacy|11
5051131|NCT02544633|17412150|P1|Treatment Period|Lack of Efficacy|17
5051132|NCT02544633|17412147|P4|Treatment Period|Adverse Event|5
5051133|NCT02544633|17412148|P3|Treatment Period|Adverse Event|0
5051134|NCT02544633|17412149|P2|Treatment Period|Adverse Event|4
5051135|NCT02544633|17412150|P1|Treatment Period|Adverse Event|7
5051136|NCT02544633|17412147|P4|Treatment Period|Patient Still on Treatment/Study|0
5051137|NCT02544633|17412148|P3|Treatment Period|Patient Still on Treatment/Study|1
5051138|NCT02544633|17412149|P2|Treatment Period|Patient Still on Treatment/Study|1
5051139|NCT02544633|17412150|P1|Treatment Period|Patient Still on Treatment/Study|0
5051140|NCT02544451|17412234|P3|Overall Study|Other|0
5051141|NCT02544451|17412235|P2|Overall Study|Other|4
5051142|NCT02544451|17412236|P1|Overall Study|Other|4
5051143|NCT02544451|17412234|P3|Overall Study|Physician Decision|0
5051144|NCT02544451|17412235|P2|Overall Study|Physician Decision|0
5051145|NCT02544451|17412236|P1|Overall Study|Physician Decision|4
5051146|NCT02544451|17412234|P3|Overall Study|Lost to Follow-up|0
5051147|NCT02544451|17412235|P2|Overall Study|Lost to Follow-up|0
5051148|NCT02544451|17412236|P1|Overall Study|Lost to Follow-up|2
5051149|NCT02544451|17412234|P3|Overall Study|Withdrawal of consent (not due to AE)|1
5051150|NCT02544451|17412235|P2|Overall Study|Withdrawal of consent (not due to AE)|2
5051151|NCT02544451|17412236|P1|Overall Study|Withdrawal of consent (not due to AE)|3
5051152|NCT02544451|17412234|P3|Overall Study|Adverse Event|0
5051153|NCT02544451|17412235|P2|Overall Study|Adverse Event|6
5051154|NCT02544451|17412236|P1|Overall Study|Adverse Event|1
5051155|NCT02544217|17412285|P6|Overall Study|Withdrawal by Subject|0
5051156|NCT02544217|17412286|P5|Overall Study|Withdrawal by Subject|0
5051157|NCT02544217|17412287|P4|Overall Study|Withdrawal by Subject|0
5051158|NCT02544217|17412288|P3|Overall Study|Withdrawal by Subject|0
5051159|NCT02544217|17412289|P2|Overall Study|Withdrawal by Subject|1
5051160|NCT02544217|17412290|P1|Overall Study|Withdrawal by Subject|1
5051161|NCT02544152|17413085|P2|Overall Study|Other|0
5051162|NCT02544152|17413086|P1|Overall Study|Other|1
5051163|NCT02544152|17413085|P2|Overall Study|Withdrawal by Subject|3
5051164|NCT02544152|17413086|P1|Overall Study|Withdrawal by Subject|0
5051165|NCT02544152|17413085|P2|Overall Study|Adverse Event|4
5051166|NCT02544152|17413086|P1|Overall Study|Adverse Event|0
5051167|NCT02544074|17413129|P21|Overall Study|Tablet error|0
5051168|NCT02544074|17413130|P20|Overall Study|Tablet error|0
5051169|NCT02544074|17413131|P19|Overall Study|Tablet error|0
5051170|NCT02544074|17413132|P18|Overall Study|Tablet error|0
5051171|NCT02544074|17413133|P17|Overall Study|Tablet error|0
5051172|NCT02544074|17413134|P16|Overall Study|Tablet error|0
5051173|NCT02544074|17413135|P15|Overall Study|Tablet error|0
5051174|NCT02544074|17413136|P14|Overall Study|Tablet error|0
5051175|NCT02544074|17413137|P13|Overall Study|Tablet error|0
5051176|NCT02544074|17413138|P12|Overall Study|Tablet error|0
5051177|NCT02544074|17413139|P11|Overall Study|Tablet error|0
5051178|NCT02544074|17413140|P10|Overall Study|Tablet error|1
5051179|NCT02544074|17413141|P9|Overall Study|Tablet error|0
5051180|NCT02544074|17413142|P8|Overall Study|Tablet error|0
5051181|NCT02544074|17413143|P7|Overall Study|Tablet error|0
5051182|NCT02544074|17413144|P6|Overall Study|Tablet error|1
5051183|NCT02544074|17413145|P5|Overall Study|Tablet error|0
5051184|NCT02544074|17413146|P4|Overall Study|Tablet error|0
5051185|NCT02544074|17413147|P3|Overall Study|Tablet error|0
5051186|NCT02544074|17413148|P2|Overall Study|Tablet error|0
5051187|NCT02544074|17413149|P1|Overall Study|Tablet error|0
5051188|NCT02544074|17413129|P21|Overall Study|Withdrawal by Subject|0
5051189|NCT02544074|17413130|P20|Overall Study|Withdrawal by Subject|0
5051190|NCT02544074|17413131|P19|Overall Study|Withdrawal by Subject|0
5051191|NCT02544074|17413132|P18|Overall Study|Withdrawal by Subject|0
5051192|NCT02544074|17413133|P17|Overall Study|Withdrawal by Subject|0
5051193|NCT02544074|17413134|P16|Overall Study|Withdrawal by Subject|0
5051194|NCT02544074|17413135|P15|Overall Study|Withdrawal by Subject|0
5051195|NCT02544074|17413136|P14|Overall Study|Withdrawal by Subject|0
5051196|NCT02544074|17413137|P13|Overall Study|Withdrawal by Subject|0
5051197|NCT02544074|17413138|P12|Overall Study|Withdrawal by Subject|0
5051198|NCT02544074|17413139|P11|Overall Study|Withdrawal by Subject|0
5051199|NCT02544074|17413140|P10|Overall Study|Withdrawal by Subject|0
5051200|NCT02544074|17413141|P9|Overall Study|Withdrawal by Subject|0
5051201|NCT02544074|17413142|P8|Overall Study|Withdrawal by Subject|0
5051202|NCT02544074|17413143|P7|Overall Study|Withdrawal by Subject|0
5051203|NCT02544074|17413144|P6|Overall Study|Withdrawal by Subject|0
5051204|NCT02544074|17413145|P5|Overall Study|Withdrawal by Subject|0
5051205|NCT02544074|17413146|P4|Overall Study|Withdrawal by Subject|0
5051206|NCT02544074|17413147|P3|Overall Study|Withdrawal by Subject|0
5051207|NCT02544074|17413148|P2|Overall Study|Withdrawal by Subject|1
5051208|NCT02544074|17413149|P1|Overall Study|Withdrawal by Subject|0
5051209|NCT02543918|17413185|P2|Overall Study|Adverse Event|1
5051210|NCT02543918|17413186|P1|Overall Study|Adverse Event|1
5051211|NCT02543918|17413185|P2|Overall Study|Withdrawal by Subject|1
5051212|NCT02543918|17413186|P1|Overall Study|Withdrawal by Subject|1
5051213|NCT02543918|17413185|P2|Overall Study|Lost to Follow-up|1
5051214|NCT02543918|17413186|P1|Overall Study|Lost to Follow-up|1
5051215|NCT02543918|17413185|P2|Overall Study|Never treated|1
5051216|NCT02543918|17413186|P1|Overall Study|Never treated|0
5051217|NCT02543892|17413200|P8|Had Immunology Data|Withdrawal by Subject|0
5051218|NCT02543892|17413201|P7|Had Immunology Data|Withdrawal by Subject|1
5051219|NCT02543892|17413202|P6|Had Immunology Data|Withdrawal by Subject|0
5051220|NCT02543892|17413203|P5|Had Immunology Data|Withdrawal by Subject|0
5051221|NCT02543892|17413204|P4|Had Immunology Data|Withdrawal by Subject|0
5051222|NCT02543892|17413205|P3|Had Immunology Data|Withdrawal by Subject|0
5051223|NCT02543892|17413206|P2|Had Immunology Data|Withdrawal by Subject|0
5051224|NCT02543892|17413207|P1|Had Immunology Data|Withdrawal by Subject|0
5051225|NCT02543892|17413200|P8|Received Vaccination 2|Adverse Event|0
5051226|NCT02543892|17413201|P7|Received Vaccination 2|Adverse Event|0
5051227|NCT02543892|17413202|P6|Received Vaccination 2|Adverse Event|0
5051228|NCT02543892|17413203|P5|Received Vaccination 2|Adverse Event|0
5051229|NCT02543892|17413204|P4|Received Vaccination 2|Adverse Event|0
5051230|NCT02543892|17413205|P3|Received Vaccination 2|Adverse Event|0
5051231|NCT02543892|17413206|P2|Received Vaccination 2|Adverse Event|1
5051232|NCT02543892|17413207|P1|Received Vaccination 2|Adverse Event|0
5051233|NCT02543892|17413200|P8|Received Vaccination 2|Physician Decision|0
5051234|NCT02543892|17413201|P7|Received Vaccination 2|Physician Decision|0
5051235|NCT02543892|17413202|P6|Received Vaccination 2|Physician Decision|1
5051236|NCT02543892|17413203|P5|Received Vaccination 2|Physician Decision|0
5051237|NCT02543892|17413204|P4|Received Vaccination 2|Physician Decision|0
5051238|NCT02543892|17413205|P3|Received Vaccination 2|Physician Decision|0
5051239|NCT02543892|17413206|P2|Received Vaccination 2|Physician Decision|0
5051240|NCT02543892|17413207|P1|Received Vaccination 2|Physician Decision|0
5051241|NCT02543892|17413200|P8|Received Vaccination 2|Withdrawal by Subject|1
5051242|NCT02543892|17413201|P7|Received Vaccination 2|Withdrawal by Subject|0
5051243|NCT02543892|17413202|P6|Received Vaccination 2|Withdrawal by Subject|0
5051244|NCT02543892|17413203|P5|Received Vaccination 2|Withdrawal by Subject|0
5051245|NCT02543892|17413204|P4|Received Vaccination 2|Withdrawal by Subject|0
5051246|NCT02543892|17413205|P3|Received Vaccination 2|Withdrawal by Subject|0
5051247|NCT02543892|17413206|P2|Received Vaccination 2|Withdrawal by Subject|0
5051248|NCT02543892|17413207|P1|Received Vaccination 2|Withdrawal by Subject|1
5051249|NCT02543801|17413274|P4|Overall Study|Protocol Violation|0
5051250|NCT02543801|17413275|P3|Overall Study|Protocol Violation|0
5051251|NCT02543801|17413276|P2|Overall Study|Protocol Violation|2
5051252|NCT02543801|17413277|P1|Overall Study|Protocol Violation|1
5051253|NCT02543658|17413297|P2|Overall Study|Lack of Efficacy|4
5051254|NCT02543658|17413298|P1|Overall Study|Lack of Efficacy|0
5051255|NCT02543528|17413335|P5|Extended Wear Period|Withdrawal by Subject|0
5051256|NCT02543528|17413336|P4|Extended Wear Period|Withdrawal by Subject|5
5051257|NCT02543528|17413337|P3|Extended Wear Period|Withdrawal by Subject|4
5051258|NCT02543528|17413338|P2|Extended Wear Period|Withdrawal by Subject|9
5051259|NCT02543528|17413339|P1|Extended Wear Period|Withdrawal by Subject|10
5051260|NCT02543528|17413335|P5|Extended Wear Period|Lost to Follow-up|0
5051261|NCT02543528|17413336|P4|Extended Wear Period|Lost to Follow-up|1
5051262|NCT02543528|17413337|P3|Extended Wear Period|Lost to Follow-up|2
5051263|NCT02543528|17413338|P2|Extended Wear Period|Lost to Follow-up|1
5051264|NCT02543528|17413339|P1|Extended Wear Period|Lost to Follow-up|0
5051265|NCT02543528|17413335|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
5051266|NCT02543528|17413336|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
5051267|NCT02543528|17413337|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
5051268|NCT02543528|17413338|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
5051269|NCT02543528|17413339|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
5051270|NCT02543528|17413335|P5|Extended Wear Period|Missed too many scheduled visits|0
5051271|NCT02543528|17413336|P4|Extended Wear Period|Missed too many scheduled visits|3
5051272|NCT02543528|17413337|P3|Extended Wear Period|Missed too many scheduled visits|1
5051273|NCT02543528|17413338|P2|Extended Wear Period|Missed too many scheduled visits|0
5051274|NCT02543528|17413339|P1|Extended Wear Period|Missed too many scheduled visits|0
5051275|NCT02543528|17413335|P5|Extended Wear Period|Adverse Event|0
5051276|NCT02543528|17413336|P4|Extended Wear Period|Adverse Event|3
5051277|NCT02543528|17413337|P3|Extended Wear Period|Adverse Event|16
5051278|NCT02543528|17413338|P2|Extended Wear Period|Adverse Event|11
5051279|NCT02543528|17413339|P1|Extended Wear Period|Adverse Event|17
5051280|NCT02543528|17413335|P5|Adaptation Period|Adverse Event|2
5051281|NCT02543528|17413336|P4|Adaptation Period|Adverse Event|0
5051282|NCT02543528|17413337|P3|Adaptation Period|Adverse Event|0
5051283|NCT02543528|17413338|P2|Adaptation Period|Adverse Event|0
5051284|NCT02543528|17413339|P1|Adaptation Period|Adverse Event|0
5051285|NCT02543528|17413335|P5|Adaptation Period|Lost to Follow-up|14
5051286|NCT02543528|17413336|P4|Adaptation Period|Lost to Follow-up|0
5051287|NCT02543528|17413337|P3|Adaptation Period|Lost to Follow-up|0
5051288|NCT02543528|17413338|P2|Adaptation Period|Lost to Follow-up|0
5051289|NCT02543528|17413339|P1|Adaptation Period|Lost to Follow-up|0
5051290|NCT02543528|17413335|P5|Adaptation Period|Lens Handling Difficultes|8
5051291|NCT02543528|17413336|P4|Adaptation Period|Lens Handling Difficultes|0
5051292|NCT02543528|17413337|P3|Adaptation Period|Lens Handling Difficultes|0
5051293|NCT02543528|17413338|P2|Adaptation Period|Lens Handling Difficultes|0
5051294|NCT02543528|17413339|P1|Adaptation Period|Lens Handling Difficultes|0
5051295|NCT02543528|17413335|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
5051296|NCT02543528|17413336|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
5051297|NCT02543528|17413337|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
5051298|NCT02543528|17413338|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
5051299|NCT02543528|17413339|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
5051300|NCT02543346|17413372|P4|Second Priming Visit|Adverse Event|0
5051301|NCT02543346|17413373|P3|Second Priming Visit|Adverse Event|0
5051302|NCT02543346|17413374|P2|Second Priming Visit|Adverse Event|0
5051303|NCT02543346|17413375|P1|Second Priming Visit|Adverse Event|1
5051304|NCT02543346|17413372|P4|Second Priming Visit|Withdrawal by Subject|2
5051305|NCT02543346|17413373|P3|Second Priming Visit|Withdrawal by Subject|2
5051306|NCT02543346|17413374|P2|Second Priming Visit|Withdrawal by Subject|2
5051307|NCT02543346|17413375|P1|Second Priming Visit|Withdrawal by Subject|0
5051308|NCT02543294|17413401|P1|Overall Study|Withdrawal by Subject|7
5051309|NCT02543294|17413401|P1|Overall Study|Physician Decision|2
5051310|NCT02543294|17413401|P1|Overall Study|Lost to Follow-up|3
5051311|NCT02542943|17413409|P3|Overall Study|Withdrawal by Subject|0
5051312|NCT02542943|17413410|P2|Overall Study|Withdrawal by Subject|1
5051313|NCT02542943|17413411|P1|Overall Study|Withdrawal by Subject|0
5051314|NCT02542943|17413409|P3|Overall Study|Lost to Follow-up|0
5051315|NCT02542943|17413410|P2|Overall Study|Lost to Follow-up|0
5051316|NCT02542943|17413411|P1|Overall Study|Lost to Follow-up|1
5051317|NCT02542865|17413438|P2|Overall Study|Withdrawal by Subject|0
5051318|NCT02542865|17413439|P1|Overall Study|Withdrawal by Subject|16
5051319|NCT02542865|17413438|P2|Overall Study|Identified as screen failure|0
5051320|NCT02542865|17413439|P1|Overall Study|Identified as screen failure|1
5051321|NCT02542631|17413502|P2|Overall Study|Used Prohibited Medication|1
5051322|NCT02542631|17413503|P1|Overall Study|Used Prohibited Medication|2
5051323|NCT02542631|17413502|P2|Overall Study|Other|1
5051324|NCT02542631|17413503|P1|Overall Study|Other|2
5051325|NCT02542631|17413502|P2|Overall Study|Death|2
5051326|NCT02542631|17413503|P1|Overall Study|Death|1
5051327|NCT02542631|17413502|P2|Overall Study|Lost to Follow-up|5
5051328|NCT02542631|17413503|P1|Overall Study|Lost to Follow-up|6
5051329|NCT02542631|17413502|P2|Overall Study|Physician Decision|4
5051330|NCT02542631|17413503|P1|Overall Study|Physician Decision|6
5051331|NCT02542631|17413502|P2|Overall Study|Protocol Violation|1
5051332|NCT02542631|17413503|P1|Overall Study|Protocol Violation|1
5051333|NCT02542631|17413502|P2|Overall Study|Withdrawal by Subject|16
5051334|NCT02542631|17413503|P1|Overall Study|Withdrawal by Subject|11
5051335|NCT02542631|17413502|P2|Overall Study|Sponsor Termination|0
5051336|NCT02542631|17413503|P1|Overall Study|Sponsor Termination|1
5051337|NCT02542631|17413502|P2|Overall Study|Adverse Event|1
5051338|NCT02542631|17413503|P1|Overall Study|Adverse Event|1
5051339|NCT02542605|17413525|P3|Part B: Randomization Phase|Withdrawal by Subject|1
5051340|NCT02542605|17413526|P2|Part B: Randomization Phase|Withdrawal by Subject|0
5051341|NCT02542605|17413527|P1|Part B: Randomization Phase|Withdrawal by Subject|0
5051342|NCT02542605|17413525|P3|Part B: Challenge Phase|Sponsor decision|0
5051343|NCT02542605|17413526|P2|Part B: Challenge Phase|Sponsor decision|0
5051344|NCT02542605|17413527|P1|Part B: Challenge Phase|Sponsor decision|1
5051345|NCT02542267|17413615|P1|Overall Study|Other|5
5051346|NCT02542267|17413615|P1|Overall Study|Surgical Bypass of All Study Devices|12
5051347|NCT02542267|17413615|P1|Overall Study|Death|12
5051348|NCT02542267|17413615|P1|Overall Study|Lost to Follow-up|4
5051349|NCT02542267|17413615|P1|Overall Study|Physician Decision|5
5051350|NCT02542267|17413615|P1|Overall Study|Withdrawal by Subject|8
5051351|NCT02542267|17413615|P1|Overall Study|Ongoing|31
5051352|NCT02542072|17413623|P2|Second Intervention (1 Month)|Lens discomfort|0
5051353|NCT02542072|17413624|P1|Second Intervention (1 Month)|Lens discomfort|1
5051354|NCT02542072|17413623|P2|Second Intervention (1 Month)|Lost to Follow-up|0
5051355|NCT02542072|17413624|P1|Second Intervention (1 Month)|Lost to Follow-up|1
5051356|NCT02542072|17413623|P2|First Intervention (1 Month)|Protocol Violation|0
5051357|NCT02542072|17413624|P1|First Intervention (1 Month)|Protocol Violation|1
5051358|NCT02542072|17413623|P2|First Intervention (1 Month)|Lens discomfort|2
5051359|NCT02542072|17413624|P1|First Intervention (1 Month)|Lens discomfort|1
5051360|NCT02542072|17413623|P2|First Intervention (1 Month)|Lost to Follow-up|0
5051361|NCT02542072|17413624|P1|First Intervention (1 Month)|Lost to Follow-up|2
5051362|NCT02542072|17413623|P2|First Intervention (1 Month)|Adverse Event|1
5051363|NCT02542072|17413624|P1|First Intervention (1 Month)|Adverse Event|1
5051364|NCT02541903|17413748|P1|Overall Study|Death|1
5051365|NCT02541669|17413779|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
5051366|NCT02541669|17413780|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
5051367|NCT02541669|17413781|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
5051368|NCT02541669|17413782|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
5051369|NCT02541669|17413783|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
5051370|NCT02541604|17413830|P12|Overall Study|Medical condition may jeopardize safety|0
5051371|NCT02541604|17413831|P11|Overall Study|Medical condition may jeopardize safety|0
5051372|NCT02541604|17413832|P10|Overall Study|Medical condition may jeopardize safety|0
5051373|NCT02541604|17413833|P9|Overall Study|Medical condition may jeopardize safety|0
5051374|NCT02541604|17413834|P8|Overall Study|Medical condition may jeopardize safety|1
5051375|NCT02541604|17413835|P7|Overall Study|Medical condition may jeopardize safety|0
5051376|NCT02541604|17413836|P6|Overall Study|Medical condition may jeopardize safety|0
5051377|NCT02541604|17413837|P5|Overall Study|Medical condition may jeopardize safety|0
5051378|NCT02541604|17413838|P4|Overall Study|Medical condition may jeopardize safety|0
5051379|NCT02541604|17413839|P3|Overall Study|Medical condition may jeopardize safety|0
5051380|NCT02541604|17413840|P2|Overall Study|Medical condition may jeopardize safety|0
5051381|NCT02541604|17413841|P1|Overall Study|Medical condition may jeopardize safety|0
5051382|NCT02541604|17413830|P12|Overall Study|Study Terminated by Sponsor|0
5051383|NCT02541604|17413831|P11|Overall Study|Study Terminated by Sponsor|0
5051384|NCT02541604|17413832|P10|Overall Study|Study Terminated by Sponsor|0
5051385|NCT02541604|17413833|P9|Overall Study|Study Terminated by Sponsor|0
5051386|NCT02541604|17413834|P8|Overall Study|Study Terminated by Sponsor|0
5051387|NCT02541604|17413835|P7|Overall Study|Study Terminated by Sponsor|0
5051388|NCT02541604|17413836|P6|Overall Study|Study Terminated by Sponsor|0
5051389|NCT02541604|17413837|P5|Overall Study|Study Terminated by Sponsor|0
5051390|NCT02541604|17413838|P4|Overall Study|Study Terminated by Sponsor|1
5051391|NCT02541604|17413839|P3|Overall Study|Study Terminated by Sponsor|2
5051392|NCT02541604|17413840|P2|Overall Study|Study Terminated by Sponsor|4
5051393|NCT02541604|17413841|P1|Overall Study|Study Terminated by Sponsor|1
5051394|NCT02541604|17413830|P12|Overall Study|Withdrawal by Subject|0
5051395|NCT02541604|17413831|P11|Overall Study|Withdrawal by Subject|0
5051396|NCT02541604|17413832|P10|Overall Study|Withdrawal by Subject|0
5051397|NCT02541604|17413833|P9|Overall Study|Withdrawal by Subject|1
5051398|NCT02541604|17413834|P8|Overall Study|Withdrawal by Subject|0
5051399|NCT02541604|17413835|P7|Overall Study|Withdrawal by Subject|0
5051400|NCT02541604|17413836|P6|Overall Study|Withdrawal by Subject|1
5051401|NCT02541604|17413837|P5|Overall Study|Withdrawal by Subject|1
5051402|NCT02541604|17413838|P4|Overall Study|Withdrawal by Subject|0
5051403|NCT02541604|17413839|P3|Overall Study|Withdrawal by Subject|1
5051404|NCT02541604|17413840|P2|Overall Study|Withdrawal by Subject|0
5051405|NCT02541604|17413841|P1|Overall Study|Withdrawal by Subject|2
5051406|NCT02541604|17413830|P12|Overall Study|Lost to Follow-up|0
5051407|NCT02541604|17413831|P11|Overall Study|Lost to Follow-up|0
5051408|NCT02541604|17413832|P10|Overall Study|Lost to Follow-up|0
5051409|NCT02541604|17413833|P9|Overall Study|Lost to Follow-up|0
5051410|NCT02541604|17413834|P8|Overall Study|Lost to Follow-up|0
5051411|NCT02541604|17413835|P7|Overall Study|Lost to Follow-up|1
5051412|NCT02541604|17413836|P6|Overall Study|Lost to Follow-up|1
5051413|NCT02541604|17413837|P5|Overall Study|Lost to Follow-up|0
5051414|NCT02541604|17413838|P4|Overall Study|Lost to Follow-up|0
5051415|NCT02541604|17413839|P3|Overall Study|Lost to Follow-up|1
5051416|NCT02541604|17413840|P2|Overall Study|Lost to Follow-up|0
5051417|NCT02541604|17413841|P1|Overall Study|Lost to Follow-up|2
5051418|NCT02541604|17413830|P12|Overall Study|Death|3
5051419|NCT02541604|17413831|P11|Overall Study|Death|2
5051420|NCT02541604|17413832|P10|Overall Study|Death|4
5051421|NCT02541604|17413833|P9|Overall Study|Death|3
5051422|NCT02541604|17413834|P8|Overall Study|Death|9
5051423|NCT02541604|17413835|P7|Overall Study|Death|9
5051424|NCT02541604|17413836|P6|Overall Study|Death|8
5051425|NCT02541604|17413837|P5|Overall Study|Death|9
5051426|NCT02541604|17413838|P4|Overall Study|Death|2
5051427|NCT02541604|17413839|P3|Overall Study|Death|7
5051428|NCT02541604|17413840|P2|Overall Study|Death|5
5051429|NCT02541604|17413841|P1|Overall Study|Death|6
5051430|NCT02540850|17413960|P3|Overall Study|Lost to Follow-up|34
5051431|NCT02540850|17413961|P2|Overall Study|Lost to Follow-up|66
5051432|NCT02540850|17413962|P1|Overall Study|Lost to Follow-up|69
5051433|NCT02540668|17414003|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
5051434|NCT02540668|17414004|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
5051435|NCT02540538|17414035|P3|Overall Study|Pregnancy|0
5051436|NCT02540538|17414036|P2|Overall Study|Pregnancy|1
5051437|NCT02540538|17414037|P1|Overall Study|Pregnancy|0
5051438|NCT02540356|17414105|P2|Overall Study|Terminated due to disease progression|0
5051439|NCT02540356|17414106|P1|Overall Study|Terminated due to disease progression|1
5051440|NCT02540291|17414141|P4|Overall Study|Other|0
5051441|NCT02540291|17414142|P3|Overall Study|Other|1
5051442|NCT02540291|17414143|P2|Overall Study|Other|0
5051443|NCT02540291|17414144|P1|Overall Study|Other|0
5051444|NCT02540291|17414141|P4|Overall Study|Study Terminated By Sponsor|0
5051445|NCT02540291|17414142|P3|Overall Study|Study Terminated By Sponsor|0
5051446|NCT02540291|17414143|P2|Overall Study|Study Terminated By Sponsor|0
5051447|NCT02540291|17414144|P1|Overall Study|Study Terminated By Sponsor|1
5051448|NCT02540291|17414141|P4|Overall Study|Withdrawal Of Consent|0
5051449|NCT02540291|17414142|P3|Overall Study|Withdrawal Of Consent|0
5051450|NCT02540291|17414143|P2|Overall Study|Withdrawal Of Consent|1
5051451|NCT02540291|17414144|P1|Overall Study|Withdrawal Of Consent|0
5051452|NCT02540291|17414141|P4|Overall Study|Lost to Follow-up|0
5051453|NCT02540291|17414142|P3|Overall Study|Lost to Follow-up|1
5051454|NCT02540291|17414143|P2|Overall Study|Lost to Follow-up|0
5051455|NCT02540291|17414144|P1|Overall Study|Lost to Follow-up|0
5051456|NCT02540291|17414141|P4|Overall Study|Death|7
5051457|NCT02540291|17414142|P3|Overall Study|Death|5
5051458|NCT02540291|17414143|P2|Overall Study|Death|7
5051459|NCT02540291|17414144|P1|Overall Study|Death|7
5051460|NCT02540265|17414179|P3|Overall Study|Lost to Follow-up|1
5051461|NCT02540265|17414180|P2|Overall Study|Lost to Follow-up|0
5051462|NCT02540265|17414181|P1|Overall Study|Lost to Follow-up|0
5051463|NCT02540213|17414236|P1|Overall Study|Enrolled but not treated|2
5051464|NCT02540213|17414236|P1|Overall Study|Consent withdrawn|7
5051465|NCT02540213|17414236|P1|Overall Study|Lack of Efficacy|6
5051466|NCT02540213|17414236|P1|Overall Study|Kidney transplant|3
5051467|NCT02540213|17414236|P1|Overall Study|Administrative reasons|3
5051468|NCT02540213|17414236|P1|Overall Study|Death/adverse event|18
5051469|NCT02540083|17414290|P1|Overall Study|Withdrawal by Subject|16
5051470|NCT02539797|17414331|P3|Overall Study|Lost to Follow-up|0
5051471|NCT02539797|17414332|P2|Overall Study|Lost to Follow-up|1
5051472|NCT02539797|17414333|P1|Overall Study|Lost to Follow-up|0
5051473|NCT02539368|17414385|P5|Overall Study|Missing|0
5051474|NCT02539368|17414386|P4|Overall Study|Missing|0
5051475|NCT02539368|17414387|P3|Overall Study|Missing|0
5051476|NCT02539368|17414388|P2|Overall Study|Missing|3
5051477|NCT02539368|17414389|P1|Overall Study|Missing|10
5051478|NCT02539368|17414385|P5|Overall Study|Other|3
5051479|NCT02539368|17414386|P4|Overall Study|Other|1
5051480|NCT02539368|17414387|P3|Overall Study|Other|24
5051481|NCT02539368|17414388|P2|Overall Study|Other|18
5051482|NCT02539368|17414389|P1|Overall Study|Other|145
5051483|NCT02539368|17414385|P5|Overall Study|Participant Non-compliant|0
5051484|NCT02539368|17414386|P4|Overall Study|Participant Non-compliant|1
5051485|NCT02539368|17414387|P3|Overall Study|Participant Non-compliant|1
5051486|NCT02539368|17414388|P2|Overall Study|Participant Non-compliant|2
5051487|NCT02539368|17414389|P1|Overall Study|Participant Non-compliant|13
5051488|NCT02539368|17414385|P5|Overall Study|Adverse Event|3
5051489|NCT02539368|17414386|P4|Overall Study|Adverse Event|0
5051490|NCT02539368|17414387|P3|Overall Study|Adverse Event|9
5051491|NCT02539368|17414388|P2|Overall Study|Adverse Event|5
5051492|NCT02539368|17414389|P1|Overall Study|Adverse Event|44
5051493|NCT02539368|17414385|P5|Overall Study|Lost to Follow-up|3
5051494|NCT02539368|17414386|P4|Overall Study|Lost to Follow-up|4
5051495|NCT02539368|17414387|P3|Overall Study|Lost to Follow-up|16
5051496|NCT02539368|17414388|P2|Overall Study|Lost to Follow-up|21
5051497|NCT02539368|17414389|P1|Overall Study|Lost to Follow-up|96
5051498|NCT02539368|17414385|P5|Overall Study|Physician Decision|2
5051499|NCT02539368|17414386|P4|Overall Study|Physician Decision|0
5051500|NCT02539368|17414387|P3|Overall Study|Physician Decision|7
5051501|NCT02539368|17414388|P2|Overall Study|Physician Decision|15
5051502|NCT02539368|17414389|P1|Overall Study|Physician Decision|49
5051503|NCT02539368|17414385|P5|Overall Study|Withdrawal by Subject|3
5051504|NCT02539368|17414386|P4|Overall Study|Withdrawal by Subject|1
5051505|NCT02539368|17414387|P3|Overall Study|Withdrawal by Subject|9
5051506|NCT02539368|17414388|P2|Overall Study|Withdrawal by Subject|35
5051507|NCT02539368|17414389|P1|Overall Study|Withdrawal by Subject|44
5051508|NCT02539368|17414385|P5|Overall Study|Death|0
5051509|NCT02539368|17414386|P4|Overall Study|Death|0
5051510|NCT02539368|17414387|P3|Overall Study|Death|1
5051511|NCT02539368|17414388|P2|Overall Study|Death|2
5051512|NCT02539368|17414389|P1|Overall Study|Death|4
5051513|NCT02539225|17414522|P2|Part B|Physician Decision|9
5051514|NCT02539225|17414523|P1|Part B|Physician Decision|0
5051515|NCT02539225|17414522|P2|Part B|Withdrawal by Subject|3
5051516|NCT02539225|17414523|P1|Part B|Withdrawal by Subject|0
5051517|NCT02539225|17414522|P2|Part B|Adverse Event|4
5051518|NCT02539225|17414523|P1|Part B|Adverse Event|4
5051519|NCT02539225|17414522|P2|Pre Treatment for Part B|Physician Decision|0
5051520|NCT02539225|17414523|P1|Pre Treatment for Part B|Physician Decision|2
5051521|NCT02539225|17414522|P2|Pre Treatment for Part B|Withdrawal by Subject|0
5051522|NCT02539225|17414523|P1|Pre Treatment for Part B|Withdrawal by Subject|1
5051523|NCT02539225|17414522|P2|Pre Treatment for Part B|Adverse Event|1
5051524|NCT02539225|17414523|P1|Pre Treatment for Part B|Adverse Event|1
5051525|NCT02539225|17414522|P2|Pre Treatment for Part B|Progressive disease|1
5051526|NCT02539225|17414523|P1|Pre Treatment for Part B|Progressive disease|1
5051527|NCT02539225|17414522|P2|Part A|Did Not Receive study Drug|1
5051528|NCT02539225|17414523|P1|Part A|Did Not Receive study Drug|1
5051529|NCT02539225|17414522|P2|Part A|Physician Decision|7
5051530|NCT02539225|17414523|P1|Part A|Physician Decision|4
5051531|NCT02539225|17414522|P2|Part A|Withdrawal by Subject|4
5051532|NCT02539225|17414523|P1|Part A|Withdrawal by Subject|2
5051533|NCT02539225|17414522|P2|Part A|Adverse Event|4
5051534|NCT02539225|17414523|P1|Part A|Adverse Event|13
5051535|NCT02539134|17414550|P6|Overall Study|Lost to Follow-up|0
5051536|NCT02539134|17414551|P5|Overall Study|Lost to Follow-up|0
5051537|NCT02539134|17414552|P4|Overall Study|Lost to Follow-up|0
5051538|NCT02539134|17414553|P3|Overall Study|Lost to Follow-up|0
5051539|NCT02539134|17414554|P2|Overall Study|Lost to Follow-up|0
5051540|NCT02539134|17414555|P1|Overall Study|Lost to Follow-up|1
5051541|NCT02538965|17414624|P1|Follow-Up Period|Withdrawal by Parent|4
5051542|NCT02538965|17414624|P1|Follow-Up Period|Other = Death due to disease progression|13
5051543|NCT02538965|17414624|P1|Treatment Period|Physician Decision|2
5051544|NCT02538965|17414624|P1|Treatment Period|Disease Progression|1
5051545|NCT02538965|17414624|P1|Treatment Period|Treatment Failure|9
5051546|NCT02538965|17414624|P1|Treatment Period|Withdrawal by Parent/Guardian|2
5051547|NCT02538965|17414624|P1|Treatment Period|Adverse Event|2
5051548|NCT02538965|17414624|P1|Treatment Period|Other = Death due to disease progression|1
5051549|NCT02538666|17414670|P3|Overall Study|Withdrew Consent|1
5051550|NCT02538666|17414671|P2|Overall Study|Withdrew Consent|1
5051551|NCT02538666|17414672|P1|Overall Study|Withdrew Consent|0
5051552|NCT02538666|17414670|P3|Overall Study|no longer meets study criteria|0
5051553|NCT02538666|17414671|P2|Overall Study|no longer meets study criteria|0
5051554|NCT02538666|17414672|P1|Overall Study|no longer meets study criteria|1
5051555|NCT02538666|17414670|P3|Overall Study|Disease progression|0
5051556|NCT02538666|17414671|P2|Overall Study|Disease progression|0
5051557|NCT02538666|17414672|P1|Overall Study|Disease progression|1
5051558|NCT02538614|17414691|P1|Overall Study|Progressive Disease|2
5051559|NCT02538471|17414731|P1|Overall Study|Progression of disease|2
5051560|NCT02538107|17414767|P1|Overall Study|Not recorded|7
5051561|NCT02538107|17414767|P1|Overall Study|Other|7
5051562|NCT02538107|17414767|P1|Overall Study|Surgery|1
5051563|NCT02538107|17414767|P1|Overall Study|Adverse Event|4
5051564|NCT02538107|17414767|P1|Overall Study|Administrative reason|5
5051565|NCT02538107|17414767|P1|Overall Study|Death|4
5051566|NCT02538107|17414767|P1|Overall Study|Withdrawal by Subject|17
5051567|NCT02538107|17414767|P1|Overall Study|No further treatment necessary|18
5051568|NCT02538107|17414767|P1|Overall Study|Administration of other ESA|11
5051569|NCT02538107|17414767|P1|Overall Study|Necessity of dialysis|20
5051570|NCT02538107|17414767|P1|Overall Study|Missing|5
5051571|NCT02538107|17414767|P1|Overall Study|Did not receive any Mircera dose|11
5051572|NCT02538094|17414787|P2|Washout (4 Weeks)|Withdrawal by Subject|1
5051573|NCT02538094|17414788|P1|Washout (4 Weeks)|Withdrawal by Subject|0
5051574|NCT02538094|17414787|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
5051575|NCT02538094|17414788|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
5051576|NCT02538029|17414818|P3|Overall Study|unable to complete cognitive assessments|1
5051577|NCT02538029|17414819|P2|Overall Study|unable to complete cognitive assessments|0
5051578|NCT02538029|17414820|P1|Overall Study|unable to complete cognitive assessments|1
5051579|NCT02537574|17414911|P3|Overall Study|Noncompliance with Protocol|1
5051580|NCT02537574|17414912|P2|Overall Study|Noncompliance with Protocol|0
5051581|NCT02537574|17414913|P1|Overall Study|Noncompliance with Protocol|0
5051582|NCT02537574|17414911|P3|Overall Study|Subject did not want last Vivitrol Injec|1
5051583|NCT02537574|17414912|P2|Overall Study|Subject did not want last Vivitrol Injec|0
5051584|NCT02537574|17414913|P1|Overall Study|Subject did not want last Vivitrol Injec|0
5051585|NCT02537574|17414911|P3|Overall Study|Transportation Issues|1
5051586|NCT02537574|17414912|P2|Overall Study|Transportation Issues|0
5051587|NCT02537574|17414913|P1|Overall Study|Transportation Issues|0
5051588|NCT02537574|17414911|P3|Overall Study|Failed Naloxone Challenge|0
5051589|NCT02537574|17414912|P2|Overall Study|Failed Naloxone Challenge|1
5051590|NCT02537574|17414913|P1|Overall Study|Failed Naloxone Challenge|0
5051591|NCT02537574|17414911|P3|Overall Study|Incarceration|0
5051592|NCT02537574|17414912|P2|Overall Study|Incarceration|1
5051593|NCT02537574|17414913|P1|Overall Study|Incarceration|0
5051594|NCT02537574|17414911|P3|Overall Study|Patient not Stable|0
5051595|NCT02537574|17414912|P2|Overall Study|Patient not Stable|1
5051596|NCT02537574|17414913|P1|Overall Study|Patient not Stable|0
5051597|NCT02537574|17414911|P3|Overall Study|Duplicate Patient|0
5051598|NCT02537574|17414912|P2|Overall Study|Duplicate Patient|0
5051599|NCT02537574|17414913|P1|Overall Study|Duplicate Patient|1
5051600|NCT02537574|17414911|P3|Overall Study|Lack of Efficacy|15
5051601|NCT02537574|17414912|P2|Overall Study|Lack of Efficacy|16
5051602|NCT02537574|17414913|P1|Overall Study|Lack of Efficacy|14
5051603|NCT02537574|17414911|P3|Overall Study|Withdrawal by Subject|29
5051604|NCT02537574|17414912|P2|Overall Study|Withdrawal by Subject|27
5051605|NCT02537574|17414913|P1|Overall Study|Withdrawal by Subject|37
5051606|NCT02537574|17414911|P3|Overall Study|Protocol Violation|3
5051607|NCT02537574|17414912|P2|Overall Study|Protocol Violation|2
5051608|NCT02537574|17414913|P1|Overall Study|Protocol Violation|4
5051609|NCT02537574|17414911|P3|Overall Study|Physician Decision|0
5051610|NCT02537574|17414912|P2|Overall Study|Physician Decision|0
5051611|NCT02537574|17414913|P1|Overall Study|Physician Decision|2
5051612|NCT02537574|17414911|P3|Overall Study|Noncompliance with study drug|1
5051613|NCT02537574|17414912|P2|Overall Study|Noncompliance with study drug|1
5051614|NCT02537574|17414913|P1|Overall Study|Noncompliance with study drug|0
5051615|NCT02537574|17414911|P3|Overall Study|Lost to Follow-up|55
5051616|NCT02537574|17414912|P2|Overall Study|Lost to Follow-up|51
5051617|NCT02537574|17414913|P1|Overall Study|Lost to Follow-up|40
5051618|NCT02537574|17414911|P3|Overall Study|Adverse Event|2
5051619|NCT02537574|17414912|P2|Overall Study|Adverse Event|3
5051620|NCT02537574|17414913|P1|Overall Study|Adverse Event|1
5051621|NCT02537522|17414939|P4|Phase II - Period 1 Bilateral|Adverse Event|1
5051622|NCT02537522|17414940|P3|Phase II - Period 1 Bilateral|Adverse Event|0
5051623|NCT02537522|17414941|P2|Phase II - Period 1 Bilateral|Adverse Event|0
5051624|NCT02537522|17414942|P1|Phase II - Period 1 Bilateral|Adverse Event|0
5051625|NCT02537522|17414939|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
5051626|NCT02537522|17414940|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
5051627|NCT02537522|17414941|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
5051628|NCT02537522|17414942|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
5051629|NCT02537522|17414939|P4|Phase I - Contralateral|incorrect randomization|0
5051630|NCT02537522|17414940|P3|Phase I - Contralateral|incorrect randomization|0
5051631|NCT02537522|17414941|P2|Phase I - Contralateral|incorrect randomization|1
5051632|NCT02537522|17414942|P1|Phase I - Contralateral|incorrect randomization|0
5051633|NCT02537522|17414939|P4|Phase I - Contralateral|Withdrawal by Subject|0
5051634|NCT02537522|17414940|P3|Phase I - Contralateral|Withdrawal by Subject|0
5051635|NCT02537522|17414941|P2|Phase I - Contralateral|Withdrawal by Subject|1
5051636|NCT02537522|17414942|P1|Phase I - Contralateral|Withdrawal by Subject|0
5051637|NCT02537522|17414939|P4|Phase I - Contralateral|Subject no longer eligible|0
5051638|NCT02537522|17414940|P3|Phase I - Contralateral|Subject no longer eligible|0
5051639|NCT02537522|17414941|P2|Phase I - Contralateral|Subject no longer eligible|7
5051640|NCT02537522|17414942|P1|Phase I - Contralateral|Subject no longer eligible|15
5051641|NCT02537431|17414959|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
5051642|NCT02537015|17414988|P1|Overall Study|Other Miscellaneous Reasons|1
5051643|NCT02537015|17414988|P1|Overall Study|Withdrawal by Subject|2
5051644|NCT02537015|17414988|P1|Overall Study|Adverse Event|3
5051645|NCT02536976|17414994|P2|Overall Study|Physician Decision|1
5051646|NCT02536976|17414995|P1|Overall Study|Physician Decision|0
5051647|NCT02536963|17415005|P1|Overall Study|Withdrawal by Subject|18
5051648|NCT02536833|17415013|P4|Overall Study|Withdrawal by Subject|11
5051649|NCT02536833|17415014|P3|Overall Study|Withdrawal by Subject|5
5051650|NCT02536833|17415015|P2|Overall Study|Withdrawal by Subject|3
5051651|NCT02536833|17415016|P1|Overall Study|Withdrawal by Subject|4
5051652|NCT02536833|17415013|P4|Overall Study|Subject Non-Compliance|0
5051653|NCT02536833|17415014|P3|Overall Study|Subject Non-Compliance|1
5051654|NCT02536833|17415015|P2|Overall Study|Subject Non-Compliance|1
5051655|NCT02536833|17415016|P1|Overall Study|Subject Non-Compliance|0
5051656|NCT02536833|17415013|P4|Overall Study|Site Terminated by Sponsor|2
5051657|NCT02536833|17415014|P3|Overall Study|Site Terminated by Sponsor|2
5051658|NCT02536833|17415015|P2|Overall Study|Site Terminated by Sponsor|2
5051659|NCT02536833|17415016|P1|Overall Study|Site Terminated by Sponsor|2
5051660|NCT02536833|17415013|P4|Overall Study|Physician Decision|1
5051661|NCT02536833|17415014|P3|Overall Study|Physician Decision|0
5051662|NCT02536833|17415015|P2|Overall Study|Physician Decision|0
5051663|NCT02536833|17415016|P1|Overall Study|Physician Decision|0
5051664|NCT02536833|17415013|P4|Overall Study|Lost to Follow-up|2
5051665|NCT02536833|17415014|P3|Overall Study|Lost to Follow-up|2
5051666|NCT02536833|17415015|P2|Overall Study|Lost to Follow-up|1
5051667|NCT02536833|17415016|P1|Overall Study|Lost to Follow-up|2
5051668|NCT02536833|17415013|P4|Overall Study|Adverse Event|1
5051669|NCT02536833|17415014|P3|Overall Study|Adverse Event|4
5051670|NCT02536833|17415015|P2|Overall Study|Adverse Event|3
5051671|NCT02536833|17415016|P1|Overall Study|Adverse Event|1
5051672|NCT02536833|17415013|P4|Overall Study|Discontinued Before Treatment|2
5051673|NCT02536833|17415014|P3|Overall Study|Discontinued Before Treatment|1
5051674|NCT02536833|17415015|P2|Overall Study|Discontinued Before Treatment|0
5051675|NCT02536833|17415016|P1|Overall Study|Discontinued Before Treatment|0
5051676|NCT02536781|17415077|P2|Overall Study|Lost to Follow-up|0
5051677|NCT02536781|17415078|P1|Overall Study|Lost to Follow-up|2
5051678|NCT02536664|17415088|P2|Overall Study|Missing|20
5051679|NCT02536664|17415089|P1|Overall Study|Missing|53
5051680|NCT02536664|17415088|P2|Overall Study|Other|24
5051681|NCT02536664|17415089|P1|Overall Study|Other|18
5051682|NCT02536664|17415088|P2|Overall Study|Withdrawal by Subject|5
5051683|NCT02536664|17415089|P1|Overall Study|Withdrawal by Subject|8
5051684|NCT02536664|17415088|P2|Overall Study|Intolerability|6
5051685|NCT02536664|17415089|P1|Overall Study|Intolerability|8
5051686|NCT02536664|17415088|P2|Overall Study|Death due to other reason|2
5051687|NCT02536664|17415089|P1|Overall Study|Death due to other reason|3
5051688|NCT02536664|17415088|P2|Overall Study|Death due to lymphoma|1
5051689|NCT02536664|17415089|P1|Overall Study|Death due to lymphoma|2
5051690|NCT02536664|17415088|P2|Overall Study|Progression|18
5051691|NCT02536664|17415089|P1|Overall Study|Progression|13
5051692|NCT02536664|17415088|P2|Overall Study|Inadequate completion of documentation|4
5051693|NCT02536664|17415089|P1|Overall Study|Inadequate completion of documentation|2
5051694|NCT02536378|17415109|P2|Overall Study|Patient refused further follow up|2
5051695|NCT02536378|17415110|P1|Overall Study|Patient refused further follow up|6
5051696|NCT02536378|17415109|P2|Overall Study|Death|2
5051697|NCT02536378|17415110|P1|Overall Study|Death|1
5051698|NCT02536378|17415109|P2|Overall Study|Withdrawal by Subject|1
5051699|NCT02536378|17415110|P1|Overall Study|Withdrawal by Subject|0
5051700|NCT02536378|17415109|P2|Overall Study|Physician Decision|2
5051701|NCT02536378|17415110|P1|Overall Study|Physician Decision|0
5051702|NCT02536339|17415124|P1|Overall Study|Death|20
5051703|NCT02536339|17415124|P1|Overall Study|Withdrawal by Subject|3
5051704|NCT02536339|17415124|P1|Overall Study|Lost to Follow-up|2
5051705|NCT02536339|17415124|P1|Overall Study|Treatment Ongoing|2
5051706|NCT02536339|17415124|P1|Overall Study|In Survival Follow-Up|4
5051707|NCT02536313|17415150|P2|Overall Study|Lack of Efficacy|1
5051708|NCT02536313|17415151|P1|Overall Study|Lack of Efficacy|0
5051709|NCT02535741|17415220|P1|Overall Study|Missing data|6
5051710|NCT02535741|17415220|P1|Overall Study|Exclusion criteria: Bilateral implant|4
5051711|NCT02535741|17415220|P1|Overall Study|Lost to Follow-up|10
5051712|NCT02535741|17415220|P1|Overall Study|Withdrawal by Subject|9
5051713|NCT02535741|17415220|P1|Overall Study|Adverse Event|3
5051714|NCT02535715|17415228|P3|Overall Study|Withdrawal by Subject|1
5051715|NCT02535715|17415229|P2|Overall Study|Withdrawal by Subject|0
5051716|NCT02535715|17415230|P1|Overall Study|Withdrawal by Subject|0
5051717|NCT02535416|17415293|P9|Overall Study|Family bereavement overseas|0
5051718|NCT02535416|17415294|P8|Overall Study|Family bereavement overseas|0
5051719|NCT02535416|17415295|P7|Overall Study|Family bereavement overseas|0
5051720|NCT02535416|17415296|P6|Overall Study|Family bereavement overseas|0
5051721|NCT02535416|17415297|P5|Overall Study|Family bereavement overseas|0
5051722|NCT02535416|17415298|P4|Overall Study|Family bereavement overseas|0
5051723|NCT02535416|17415299|P3|Overall Study|Family bereavement overseas|0
5051724|NCT02535416|17415300|P2|Overall Study|Family bereavement overseas|0
5051725|NCT02535416|17415301|P1|Overall Study|Family bereavement overseas|1
5051726|NCT02535364|17415353|P1|12-Month Follow-up Period|Subject transferred to hospice|1
5051727|NCT02535364|17415353|P1|12-Month Follow-up Period|Subject received alternative therapy|2
5051728|NCT02535364|17415353|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
5051729|NCT02535364|17415353|P1|12-Month Follow-up Period|Death|5
5051730|NCT02535364|17415353|P1|12-Month Follow-up Period|Disease progression|22
5051731|NCT02535364|17415353|P1|Study Treatment|Study placed on clinical hold by FDA|1
5051732|NCT02535364|17415353|P1|Study Treatment|Death|1
5051733|NCT02535364|17415353|P1|Part B Screening|Change in diagnosis, no longer eligible|2
5051734|NCT02535364|17415353|P1|Part B Screening|Adverse Event|1
5051735|NCT02535364|17415353|P1|Part B Screening|Withdrawal by Subject|1
5051736|NCT02535364|17415353|P1|Part B Screening|Physician Decision|1
5051737|NCT02535364|17415353|P1|Part B Screening|Death|2
5051738|NCT02535364|17415353|P1|Part B Screening|Unable to manufacture JCAR015|3
5051739|NCT02535364|17415353|P1|Part B Screening|Study placed on clinical hold by FDA|7
5051740|NCT02535364|17415353|P1|Part A Screening Through Leukapheresis|Disease progression|1
5051741|NCT02535364|17415353|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
5051742|NCT02535364|17415353|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
5051743|NCT02535000|17415437|P2|Overall Study|Cancellation of surgery.|2
5051744|NCT02535000|17415438|P1|Overall Study|Cancellation of surgery.|1
5051745|NCT02534935|17415449|P3|Overall Study|Lost to Follow-up|1
5051746|NCT02534935|17415450|P2|Overall Study|Lost to Follow-up|1
5051747|NCT02534935|17415451|P1|Overall Study|Lost to Follow-up|0
5051748|NCT02534935|17415449|P3|Overall Study|Adverse Event|0
5051749|NCT02534935|17415450|P2|Overall Study|Adverse Event|2
5051750|NCT02534935|17415451|P1|Overall Study|Adverse Event|0
5051751|NCT02534935|17415449|P3|Overall Study|No longer meets the eligibility criteria|0
5051752|NCT02534935|17415450|P2|Overall Study|No longer meets the eligibility criteria|3
5051753|NCT02534935|17415451|P1|Overall Study|No longer meets the eligibility criteria|0
5051754|NCT02534935|17415449|P3|Overall Study|Withdrawal by Subject|3
5051755|NCT02534935|17415450|P2|Overall Study|Withdrawal by Subject|3
5051756|NCT02534935|17415451|P1|Overall Study|Withdrawal by Subject|0
5051757|NCT02534935|17415449|P3|Overall Study|No longer willing to participate|1
5051758|NCT02534935|17415450|P2|Overall Study|No longer willing to participate|1
5051759|NCT02534935|17415451|P1|Overall Study|No longer willing to participate|0
5051760|NCT02534896|17415612|P3|Overall Study|Insufficient therapeutic response|0
5051761|NCT02534896|17415613|P2|Overall Study|Insufficient therapeutic response|0
5051762|NCT02534896|17415614|P1|Overall Study|Insufficient therapeutic response|2
5051763|NCT02534896|17415612|P3|Overall Study|Adverse Event|1
5051764|NCT02534896|17415613|P2|Overall Study|Adverse Event|1
5051765|NCT02534896|17415614|P1|Overall Study|Adverse Event|2
5051766|NCT02534883|17415633|P2|Overall Study|Early Termination|3
5051767|NCT02534883|17415634|P1|Overall Study|Early Termination|8
5051768|NCT02534493|17415650|P1|Overall Study|Withdrawal by Subject|1
5051769|NCT02534493|17415650|P1|Overall Study|Lost to Follow-up|1
5051770|NCT02534350|17415661|P2|Overall Study|Withdrew Consent|0
5051771|NCT02534350|17415662|P1|Overall Study|Withdrew Consent|2
5051772|NCT02534350|17415661|P2|Overall Study|Protocol Violation|0
5051773|NCT02534350|17415662|P1|Overall Study|Protocol Violation|1
5051774|NCT02534350|17415661|P2|Overall Study|Randomized But Not Treated|0
5051775|NCT02534350|17415662|P1|Overall Study|Randomized But Not Treated|1
5051776|NCT02534324|17415676|P2|Overall Study|Adverse Event|0
5051777|NCT02534324|17415677|P1|Overall Study|Adverse Event|1
5051778|NCT02534324|17415676|P2|Overall Study|Lost to Follow-up|7
5051779|NCT02534324|17415677|P1|Overall Study|Lost to Follow-up|20
5051780|NCT02534324|17415676|P2|Overall Study|Protocol Violation|1
5051781|NCT02534324|17415677|P1|Overall Study|Protocol Violation|4
5051782|NCT02533999|17415742|P2|Overall Study|Randomized but intervention not received|1
5051783|NCT02533999|17415743|P1|Overall Study|Randomized but intervention not received|0
5051784|NCT02533999|17415742|P2|Overall Study|Adverse Event|1
5051785|NCT02533999|17415743|P1|Overall Study|Adverse Event|0
5051786|NCT02533999|17415742|P2|Overall Study|Protocol Violation|0
5051787|NCT02533999|17415743|P1|Overall Study|Protocol Violation|3
5051788|NCT02533999|17415742|P2|Overall Study|Lost to Follow-up|5
5051789|NCT02533999|17415743|P1|Overall Study|Lost to Follow-up|3
5051790|NCT02533570|17415794|P3|Overall Study|Adverse Event|1
5051791|NCT02533570|17415795|P2|Overall Study|Adverse Event|1
5051792|NCT02533570|17415796|P1|Overall Study|Adverse Event|0
5051793|NCT02533531|17415807|P1|Overall Study|Device did not turn on|1
5051794|NCT02533453|17415870|P1|Overall Study|Withdrawal by Subject|2
5051795|NCT02533453|17415870|P1|Overall Study|Protocol Violation|1
5051796|NCT02533453|17415870|P1|Overall Study|Adverse Event|6
5051797|NCT02533401|17415929|P1|Overall Study|Violation of Selection Criteria|1
5051798|NCT02533401|17415929|P1|Overall Study|Lost to Follow-up|1
5051799|NCT02533401|17415929|P1|Overall Study|Insufficient Response/Progressed Disease|1
5051800|NCT02533401|17415929|P1|Overall Study|Death|5
5051801|NCT02533401|17415929|P1|Overall Study|Adverse Event/Intercurrent Disease|3
5051802|NCT02533375|17415937|P1|Overall Study|Adverse Event|2
5051803|NCT02533375|17415937|P1|Overall Study|Lack of Efficacy|3
5051804|NCT02533258|17415969|P1|Overall Study|Lack of Efficacy|2
5051805|NCT02533258|17415969|P1|Overall Study|Progression of pleural effusion|1
5051806|NCT02533258|17415969|P1|Overall Study|Economic factor|1
5051807|NCT02533258|17415969|P1|Overall Study|Other|1
5051808|NCT02533258|17415969|P1|Overall Study|Death|2
5051809|NCT02533258|17415969|P1|Overall Study|Adverse Event|1
5051810|NCT02532972|17416110|P1|Overall Study|Withdrawal by Subject|1
5051811|NCT02532855|17416127|P2|Overall Study|Withdrawal by Subject|8
5051812|NCT02532855|17416128|P1|Overall Study|Withdrawal by Subject|4
5051813|NCT02532855|17416127|P2|Overall Study|Lost to Follow-up|3
5051814|NCT02532855|17416128|P1|Overall Study|Lost to Follow-up|4
5051815|NCT02532764|17416162|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5051816|NCT02532764|17416163|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5051817|NCT02532764|17416164|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5051818|NCT02532764|17416165|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051819|NCT02532764|17416166|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051820|NCT02532764|17416167|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051821|NCT02532764|17416168|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051822|NCT02532764|17416169|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051823|NCT02532764|17416170|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051824|NCT02532764|17416171|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5051825|NCT02532647|17416322|P3|Overall Study|Did not receive trial medication|1
5051826|NCT02532647|17416323|P2|Overall Study|Did not receive trial medication|0
5051827|NCT02532647|17416324|P1|Overall Study|Did not receive trial medication|1
5051828|NCT02532543|17416366|P4|Overall Study|Lost to Follow-up|0
5051829|NCT02532543|17416367|P3|Overall Study|Lost to Follow-up|1
5051830|NCT02532543|17416368|P2|Overall Study|Lost to Follow-up|0
5051831|NCT02532543|17416369|P1|Overall Study|Lost to Follow-up|0
5051832|NCT02532517|17416403|P1|Overall Study|Death|4
5051833|NCT02532517|17416403|P1|Overall Study|Withdrawal by Subject|4
5051834|NCT02532517|17416403|P1|Overall Study|Lost to Follow-up|4
5051835|NCT02532517|17416403|P1|Overall Study|Failed Angiographic eligibility|1
5051836|NCT02532517|17416403|P1|Overall Study|Did not complete 24-Month visit|4
5051837|NCT02532465|17416423|P2|Overall Study|Lack of Efficacy|1
5051838|NCT02532465|17416424|P1|Overall Study|Lack of Efficacy|0
5051839|NCT02532465|17416423|P2|Overall Study|Protocol Violation|0
5051840|NCT02532465|17416424|P1|Overall Study|Protocol Violation|1
5051841|NCT02532374|17416434|P1|Overall Study|Physician Decision|1
5051842|NCT02532374|17416434|P1|Overall Study|Withdrawal by Subject|1
5051843|NCT02532283|17416460|P2|Overall Study|Withdrawal by Subject|3
5051844|NCT02532283|17416461|P1|Overall Study|Withdrawal by Subject|8
5051845|NCT02532283|17416460|P2|Overall Study|Lost to Follow-up|1
5051846|NCT02532283|17416461|P1|Overall Study|Lost to Follow-up|0
5051847|NCT02532283|17416460|P2|Overall Study|Death|0
5051848|NCT02532283|17416461|P1|Overall Study|Death|1
5051849|NCT02532283|17416460|P2|Overall Study|Adverse Event|1
5051850|NCT02532283|17416461|P1|Overall Study|Adverse Event|0
5051851|NCT02532179|17416503|P1|Overall Study|Subject received depot steroid injection|1
5051852|NCT02532179|17416503|P1|Overall Study|Pregnancy|1
5051853|NCT02532179|17416503|P1|Overall Study|Lost to Follow-up|1
5051854|NCT02531802|17416573|P21|Received Vaccination 2|Withdrawal by Subject|0
5051855|NCT02531802|17416574|P20|Received Vaccination 2|Withdrawal by Subject|1
5051856|NCT02531802|17416575|P19|Received Vaccination 2|Withdrawal by Subject|1
5051857|NCT02531802|17416576|P18|Received Vaccination 2|Withdrawal by Subject|1
5051858|NCT02531802|17416577|P17|Received Vaccination 2|Withdrawal by Subject|0
5051859|NCT02531802|17416578|P16|Received Vaccination 2|Withdrawal by Subject|0
5051860|NCT02531802|17416579|P15|Received Vaccination 2|Withdrawal by Subject|1
5051861|NCT02531802|17416580|P14|Received Vaccination 2|Withdrawal by Subject|1
5051862|NCT02531802|17416581|P13|Received Vaccination 2|Withdrawal by Subject|1
5051863|NCT02531802|17416582|P12|Received Vaccination 2|Withdrawal by Subject|0
5051864|NCT02531802|17416583|P11|Received Vaccination 2|Withdrawal by Subject|1
5051865|NCT02531802|17416584|P10|Received Vaccination 2|Withdrawal by Subject|0
5051866|NCT02531802|17416585|P9|Received Vaccination 2|Withdrawal by Subject|0
5051867|NCT02531802|17416586|P8|Received Vaccination 2|Withdrawal by Subject|0
5051868|NCT02531802|17416587|P7|Received Vaccination 2|Withdrawal by Subject|0
5051869|NCT02531802|17416588|P6|Received Vaccination 2|Withdrawal by Subject|0
5051870|NCT02531802|17416589|P5|Received Vaccination 2|Withdrawal by Subject|0
5051871|NCT02531802|17416590|P4|Received Vaccination 2|Withdrawal by Subject|0
5051872|NCT02531802|17416591|P3|Received Vaccination 2|Withdrawal by Subject|0
5051873|NCT02531802|17416592|P2|Received Vaccination 2|Withdrawal by Subject|0
5051874|NCT02531802|17416593|P1|Received Vaccination 2|Withdrawal by Subject|0
5051875|NCT02531802|17416573|P21|Received Vaccination 2|Adverse Event|1
5051876|NCT02531802|17416574|P20|Received Vaccination 2|Adverse Event|0
5051877|NCT02531802|17416575|P19|Received Vaccination 2|Adverse Event|1
5051878|NCT02531802|17416576|P18|Received Vaccination 2|Adverse Event|2
5051879|NCT02531802|17416577|P17|Received Vaccination 2|Adverse Event|0
5051880|NCT02531802|17416578|P16|Received Vaccination 2|Adverse Event|0
5051881|NCT02531802|17416579|P15|Received Vaccination 2|Adverse Event|0
5051882|NCT02531802|17416580|P14|Received Vaccination 2|Adverse Event|0
5051883|NCT02531802|17416581|P13|Received Vaccination 2|Adverse Event|0
5051884|NCT02531802|17416582|P12|Received Vaccination 2|Adverse Event|0
5051885|NCT02531802|17416583|P11|Received Vaccination 2|Adverse Event|0
5051886|NCT02531802|17416584|P10|Received Vaccination 2|Adverse Event|0
5051887|NCT02531802|17416585|P9|Received Vaccination 2|Adverse Event|0
5051888|NCT02531802|17416586|P8|Received Vaccination 2|Adverse Event|0
5051889|NCT02531802|17416587|P7|Received Vaccination 2|Adverse Event|0
5051890|NCT02531802|17416588|P6|Received Vaccination 2|Adverse Event|2
5051891|NCT02531802|17416589|P5|Received Vaccination 2|Adverse Event|0
5051892|NCT02531802|17416590|P4|Received Vaccination 2|Adverse Event|0
5051893|NCT02531802|17416591|P3|Received Vaccination 2|Adverse Event|0
5051894|NCT02531802|17416592|P2|Received Vaccination 2|Adverse Event|0
5051895|NCT02531802|17416593|P1|Received Vaccination 2|Adverse Event|0
5051896|NCT02531802|17416573|P21|Received Vaccination 2|Physician Decision|0
5051897|NCT02531802|17416574|P20|Received Vaccination 2|Physician Decision|0
5051898|NCT02531802|17416575|P19|Received Vaccination 2|Physician Decision|0
5051899|NCT02531802|17416576|P18|Received Vaccination 2|Physician Decision|1
5051900|NCT02531802|17416577|P17|Received Vaccination 2|Physician Decision|0
5051901|NCT02531802|17416578|P16|Received Vaccination 2|Physician Decision|0
5051902|NCT02531802|17416579|P15|Received Vaccination 2|Physician Decision|0
5051903|NCT02531802|17416580|P14|Received Vaccination 2|Physician Decision|1
5051904|NCT02531802|17416581|P13|Received Vaccination 2|Physician Decision|0
5051905|NCT02531802|17416582|P12|Received Vaccination 2|Physician Decision|0
5051906|NCT02531802|17416583|P11|Received Vaccination 2|Physician Decision|0
5051907|NCT02531802|17416584|P10|Received Vaccination 2|Physician Decision|2
5051908|NCT02531802|17416585|P9|Received Vaccination 2|Physician Decision|0
5051909|NCT02531802|17416586|P8|Received Vaccination 2|Physician Decision|0
5051910|NCT02531802|17416587|P7|Received Vaccination 2|Physician Decision|0
5051911|NCT02531802|17416588|P6|Received Vaccination 2|Physician Decision|1
5051912|NCT02531802|17416589|P5|Received Vaccination 2|Physician Decision|0
5051913|NCT02531802|17416590|P4|Received Vaccination 2|Physician Decision|0
5051914|NCT02531802|17416591|P3|Received Vaccination 2|Physician Decision|0
5051915|NCT02531802|17416592|P2|Received Vaccination 2|Physician Decision|0
5051916|NCT02531802|17416593|P1|Received Vaccination 2|Physician Decision|0
5051917|NCT02531802|17416573|P21|Received Vaccination 2|Medication interfering with study taken|0
5051918|NCT02531802|17416574|P20|Received Vaccination 2|Medication interfering with study taken|0
5051919|NCT02531802|17416575|P19|Received Vaccination 2|Medication interfering with study taken|1
5051920|NCT02531802|17416576|P18|Received Vaccination 2|Medication interfering with study taken|0
5051921|NCT02531802|17416577|P17|Received Vaccination 2|Medication interfering with study taken|0
5051922|NCT02531802|17416578|P16|Received Vaccination 2|Medication interfering with study taken|0
5051923|NCT02531802|17416579|P15|Received Vaccination 2|Medication interfering with study taken|0
5051924|NCT02531802|17416580|P14|Received Vaccination 2|Medication interfering with study taken|0
5051925|NCT02531802|17416581|P13|Received Vaccination 2|Medication interfering with study taken|1
5051926|NCT02531802|17416582|P12|Received Vaccination 2|Medication interfering with study taken|0
5051927|NCT02531802|17416583|P11|Received Vaccination 2|Medication interfering with study taken|1
5051928|NCT02531802|17416584|P10|Received Vaccination 2|Medication interfering with study taken|1
5051929|NCT02531802|17416585|P9|Received Vaccination 2|Medication interfering with study taken|0
5051930|NCT02531802|17416586|P8|Received Vaccination 2|Medication interfering with study taken|0
5051931|NCT02531802|17416587|P7|Received Vaccination 2|Medication interfering with study taken|0
5051932|NCT02531802|17416588|P6|Received Vaccination 2|Medication interfering with study taken|0
5051933|NCT02531802|17416589|P5|Received Vaccination 2|Medication interfering with study taken|0
5051934|NCT02531802|17416590|P4|Received Vaccination 2|Medication interfering with study taken|0
5051935|NCT02531802|17416591|P3|Received Vaccination 2|Medication interfering with study taken|1
5051936|NCT02531802|17416592|P2|Received Vaccination 2|Medication interfering with study taken|0
5051937|NCT02531802|17416593|P1|Received Vaccination 2|Medication interfering with study taken|0
5051938|NCT02531698|17417025|P2|Overall Study|Lost to Follow-up|0
5051939|NCT02531698|17417026|P1|Overall Study|Lost to Follow-up|1
5051940|NCT02531698|17417025|P2|Overall Study|Protocol Violation|0
5051941|NCT02531698|17417026|P1|Overall Study|Protocol Violation|2
5051942|NCT02531698|17417025|P2|Overall Study|Withdrawal by Subject|1
5051943|NCT02531698|17417026|P1|Overall Study|Withdrawal by Subject|6
5051944|NCT02531698|17417025|P2|Overall Study|Adverse Event|1
5051945|NCT02531698|17417026|P1|Overall Study|Adverse Event|2
5051946|NCT02531646|17417273|P3|Overall Study|equip. image processing issue|0
5051947|NCT02531646|17417274|P2|Overall Study|equip. image processing issue|1
5051948|NCT02531646|17417275|P1|Overall Study|equip. image processing issue|5
5051949|NCT02531633|17417294|P10|Part B (104 Weeks)|Lost to Follow-up|0
5051950|NCT02531633|17417295|P9|Part B (104 Weeks)|Lost to Follow-up|0
5051951|NCT02531633|17417296|P8|Part B (104 Weeks)|Lost to Follow-up|1
5051952|NCT02531633|17417297|P7|Part B (104 Weeks)|Lost to Follow-up|0
5051953|NCT02531633|17417298|P6|Part B (104 Weeks)|Lost to Follow-up|0
5051954|NCT02531633|17417299|P5|Part B (104 Weeks)|Lost to Follow-up|0
5051955|NCT02531633|17417300|P4|Part B (104 Weeks)|Lost to Follow-up|0
5051956|NCT02531633|17417301|P3|Part B (104 Weeks)|Lost to Follow-up|0
5051957|NCT02531633|17417302|P2|Part B (104 Weeks)|Lost to Follow-up|0
5051958|NCT02531633|17417303|P1|Part B (104 Weeks)|Lost to Follow-up|0
5051959|NCT02531633|17417294|P10|Part B (104 Weeks)|Sponsor request|4
5051960|NCT02531633|17417295|P9|Part B (104 Weeks)|Sponsor request|5
5051961|NCT02531633|17417296|P8|Part B (104 Weeks)|Sponsor request|3
5051962|NCT02531633|17417297|P7|Part B (104 Weeks)|Sponsor request|5
5051963|NCT02531633|17417298|P6|Part B (104 Weeks)|Sponsor request|8
5051964|NCT02531633|17417299|P5|Part B (104 Weeks)|Sponsor request|0
5051965|NCT02531633|17417300|P4|Part B (104 Weeks)|Sponsor request|0
5051966|NCT02531633|17417301|P3|Part B (104 Weeks)|Sponsor request|0
5051967|NCT02531633|17417302|P2|Part B (104 Weeks)|Sponsor request|0
5051968|NCT02531633|17417303|P1|Part B (104 Weeks)|Sponsor request|0
5051969|NCT02531633|17417294|P10|Part A (52 Weeks)|Other|0
5051970|NCT02531633|17417295|P9|Part A (52 Weeks)|Other|0
5051971|NCT02531633|17417296|P8|Part A (52 Weeks)|Other|0
5051972|NCT02531633|17417297|P7|Part A (52 Weeks)|Other|0
5051973|NCT02531633|17417298|P6|Part A (52 Weeks)|Other|0
5051974|NCT02531633|17417299|P5|Part A (52 Weeks)|Other|0
5051975|NCT02531633|17417300|P4|Part A (52 Weeks)|Other|0
5051976|NCT02531633|17417301|P3|Part A (52 Weeks)|Other|0
5051977|NCT02531633|17417302|P2|Part A (52 Weeks)|Other|0
5051978|NCT02531633|17417303|P1|Part A (52 Weeks)|Other|2
5051979|NCT02531633|17417294|P10|Part A (52 Weeks)|Withdrawal by Subject|0
5051980|NCT02531633|17417295|P9|Part A (52 Weeks)|Withdrawal by Subject|0
5051981|NCT02531633|17417296|P8|Part A (52 Weeks)|Withdrawal by Subject|0
5051982|NCT02531633|17417297|P7|Part A (52 Weeks)|Withdrawal by Subject|0
5051983|NCT02531633|17417298|P6|Part A (52 Weeks)|Withdrawal by Subject|0
5051984|NCT02531633|17417299|P5|Part A (52 Weeks)|Withdrawal by Subject|3
5051985|NCT02531633|17417300|P4|Part A (52 Weeks)|Withdrawal by Subject|3
5051986|NCT02531633|17417301|P3|Part A (52 Weeks)|Withdrawal by Subject|1
5051987|NCT02531633|17417302|P2|Part A (52 Weeks)|Withdrawal by Subject|6
5051988|NCT02531633|17417303|P1|Part A (52 Weeks)|Withdrawal by Subject|6
5051989|NCT02531633|17417294|P10|Part A (52 Weeks)|Physician Decision|0
5051990|NCT02531633|17417295|P9|Part A (52 Weeks)|Physician Decision|0
5051991|NCT02531633|17417296|P8|Part A (52 Weeks)|Physician Decision|0
5051992|NCT02531633|17417297|P7|Part A (52 Weeks)|Physician Decision|0
5051993|NCT02531633|17417298|P6|Part A (52 Weeks)|Physician Decision|0
5051994|NCT02531633|17417299|P5|Part A (52 Weeks)|Physician Decision|0
5051995|NCT02531633|17417300|P4|Part A (52 Weeks)|Physician Decision|1
5051996|NCT02531633|17417301|P3|Part A (52 Weeks)|Physician Decision|3
5051997|NCT02531633|17417302|P2|Part A (52 Weeks)|Physician Decision|4
5051998|NCT02531633|17417303|P1|Part A (52 Weeks)|Physician Decision|1
5051999|NCT02531633|17417294|P10|Part A (52 Weeks)|Lost to Follow-up|0
5052000|NCT02531633|17417295|P9|Part A (52 Weeks)|Lost to Follow-up|0
5052001|NCT02531633|17417296|P8|Part A (52 Weeks)|Lost to Follow-up|0
5052002|NCT02531633|17417297|P7|Part A (52 Weeks)|Lost to Follow-up|0
5052003|NCT02531633|17417298|P6|Part A (52 Weeks)|Lost to Follow-up|0
5052004|NCT02531633|17417299|P5|Part A (52 Weeks)|Lost to Follow-up|1
5052005|NCT02531633|17417300|P4|Part A (52 Weeks)|Lost to Follow-up|0
5052006|NCT02531633|17417301|P3|Part A (52 Weeks)|Lost to Follow-up|0
5052007|NCT02531633|17417302|P2|Part A (52 Weeks)|Lost to Follow-up|0
5052008|NCT02531633|17417303|P1|Part A (52 Weeks)|Lost to Follow-up|0
5052009|NCT02531633|17417294|P10|Part A (52 Weeks)|Protocol Violation|0
5052010|NCT02531633|17417295|P9|Part A (52 Weeks)|Protocol Violation|0
5052011|NCT02531633|17417296|P8|Part A (52 Weeks)|Protocol Violation|0
5052012|NCT02531633|17417297|P7|Part A (52 Weeks)|Protocol Violation|0
5052013|NCT02531633|17417298|P6|Part A (52 Weeks)|Protocol Violation|0
5052014|NCT02531633|17417299|P5|Part A (52 Weeks)|Protocol Violation|0
5052015|NCT02531633|17417300|P4|Part A (52 Weeks)|Protocol Violation|0
5052016|NCT02531633|17417301|P3|Part A (52 Weeks)|Protocol Violation|0
5052017|NCT02531633|17417302|P2|Part A (52 Weeks)|Protocol Violation|0
5052018|NCT02531633|17417303|P1|Part A (52 Weeks)|Protocol Violation|1
5052019|NCT02531633|17417294|P10|Part A (52 Weeks)|Sponsor request|0
5052020|NCT02531633|17417295|P9|Part A (52 Weeks)|Sponsor request|0
5052021|NCT02531633|17417296|P8|Part A (52 Weeks)|Sponsor request|0
5052022|NCT02531633|17417297|P7|Part A (52 Weeks)|Sponsor request|0
5052023|NCT02531633|17417298|P6|Part A (52 Weeks)|Sponsor request|0
5052024|NCT02531633|17417299|P5|Part A (52 Weeks)|Sponsor request|19
5052025|NCT02531633|17417300|P4|Part A (52 Weeks)|Sponsor request|18
5052026|NCT02531633|17417301|P3|Part A (52 Weeks)|Sponsor request|18
5052027|NCT02531633|17417302|P2|Part A (52 Weeks)|Sponsor request|24
5052028|NCT02531633|17417303|P1|Part A (52 Weeks)|Sponsor request|24
5052029|NCT02531438|17417782|P2|Overall Study|Randomized with Exclusion Criteria|0
5052030|NCT02531438|17417783|P1|Overall Study|Randomized with Exclusion Criteria|1
5052031|NCT02531438|17417782|P2|Overall Study|Missed EOT/PTE Visit|2
5052032|NCT02531438|17417783|P1|Overall Study|Missed EOT/PTE Visit|5
5052033|NCT02531438|17417782|P2|Overall Study|Randomized, but Not Treated|0
5052034|NCT02531438|17417783|P1|Overall Study|Randomized, but Not Treated|4
5052035|NCT02531438|17417782|P2|Overall Study|Death|3
5052036|NCT02531438|17417783|P1|Overall Study|Death|6
5052037|NCT02531438|17417782|P2|Overall Study|Physician Decision|1
5052038|NCT02531438|17417783|P1|Overall Study|Physician Decision|0
5052039|NCT02531438|17417782|P2|Overall Study|Withdrawal by Subject|8
5052040|NCT02531438|17417783|P1|Overall Study|Withdrawal by Subject|7
5052041|NCT02531438|17417782|P2|Overall Study|Lost to Follow-up|3
5052042|NCT02531438|17417783|P1|Overall Study|Lost to Follow-up|0
5052043|NCT02531438|17417782|P2|Overall Study|Adverse Event|9
5052044|NCT02531438|17417783|P1|Overall Study|Adverse Event|7
5052045|NCT02531373|17417802|P9|Overall Study|Withdrawal by Subject|0
5052046|NCT02531373|17417803|P8|Overall Study|Withdrawal by Subject|0
5052047|NCT02531373|17417804|P7|Overall Study|Withdrawal by Subject|0
5052048|NCT02531373|17417805|P6|Overall Study|Withdrawal by Subject|0
5052049|NCT02531373|17417806|P5|Overall Study|Withdrawal by Subject|3
5052050|NCT02531373|17417807|P4|Overall Study|Withdrawal by Subject|0
5052051|NCT02531373|17417808|P3|Overall Study|Withdrawal by Subject|0
5052052|NCT02531373|17417809|P2|Overall Study|Withdrawal by Subject|0
5052053|NCT02531373|17417810|P1|Overall Study|Withdrawal by Subject|0
5052054|NCT02531373|17417802|P9|Overall Study|Withdrawal by Parent/Guardian|3
5052055|NCT02531373|17417803|P8|Overall Study|Withdrawal by Parent/Guardian|1
5052056|NCT02531373|17417804|P7|Overall Study|Withdrawal by Parent/Guardian|4
5052057|NCT02531373|17417805|P6|Overall Study|Withdrawal by Parent/Guardian|3
5052058|NCT02531373|17417806|P5|Overall Study|Withdrawal by Parent/Guardian|0
5052059|NCT02531373|17417807|P4|Overall Study|Withdrawal by Parent/Guardian|0
5052060|NCT02531373|17417808|P3|Overall Study|Withdrawal by Parent/Guardian|0
5052061|NCT02531373|17417809|P2|Overall Study|Withdrawal by Parent/Guardian|0
5052062|NCT02531373|17417810|P1|Overall Study|Withdrawal by Parent/Guardian|0
5052063|NCT02531373|17417802|P9|Overall Study|Protocol Violation|1
5052064|NCT02531373|17417803|P8|Overall Study|Protocol Violation|0
5052065|NCT02531373|17417804|P7|Overall Study|Protocol Violation|1
5052066|NCT02531373|17417805|P6|Overall Study|Protocol Violation|1
5052067|NCT02531373|17417806|P5|Overall Study|Protocol Violation|0
5052068|NCT02531373|17417807|P4|Overall Study|Protocol Violation|0
5052069|NCT02531373|17417808|P3|Overall Study|Protocol Violation|0
5052070|NCT02531373|17417809|P2|Overall Study|Protocol Violation|0
5052071|NCT02531373|17417810|P1|Overall Study|Protocol Violation|0
5052072|NCT02531373|17417802|P9|Overall Study|Physician Decision|0
5052073|NCT02531373|17417803|P8|Overall Study|Physician Decision|0
5052074|NCT02531373|17417804|P7|Overall Study|Physician Decision|0
5052075|NCT02531373|17417805|P6|Overall Study|Physician Decision|1
5052076|NCT02531373|17417806|P5|Overall Study|Physician Decision|2
5052077|NCT02531373|17417807|P4|Overall Study|Physician Decision|0
5052078|NCT02531373|17417808|P3|Overall Study|Physician Decision|0
5052079|NCT02531373|17417809|P2|Overall Study|Physician Decision|0
5052080|NCT02531373|17417810|P1|Overall Study|Physician Decision|0
5052081|NCT02531373|17417802|P9|Overall Study|Lost to Follow-up|0
5052082|NCT02531373|17417803|P8|Overall Study|Lost to Follow-up|0
5052083|NCT02531373|17417804|P7|Overall Study|Lost to Follow-up|2
5052084|NCT02531373|17417805|P6|Overall Study|Lost to Follow-up|2
5052085|NCT02531373|17417806|P5|Overall Study|Lost to Follow-up|0
5052086|NCT02531373|17417807|P4|Overall Study|Lost to Follow-up|0
5052087|NCT02531373|17417808|P3|Overall Study|Lost to Follow-up|0
5052088|NCT02531373|17417809|P2|Overall Study|Lost to Follow-up|0
5052089|NCT02531373|17417810|P1|Overall Study|Lost to Follow-up|0
5052090|NCT02531373|17417802|P9|Overall Study|Lack of Efficacy|5
5052091|NCT02531373|17417803|P8|Overall Study|Lack of Efficacy|8
5052092|NCT02531373|17417804|P7|Overall Study|Lack of Efficacy|4
5052093|NCT02531373|17417805|P6|Overall Study|Lack of Efficacy|2
5052094|NCT02531373|17417806|P5|Overall Study|Lack of Efficacy|3
5052095|NCT02531373|17417807|P4|Overall Study|Lack of Efficacy|0
5052096|NCT02531373|17417808|P3|Overall Study|Lack of Efficacy|0
5052097|NCT02531373|17417809|P2|Overall Study|Lack of Efficacy|0
5052098|NCT02531373|17417810|P1|Overall Study|Lack of Efficacy|0
5052099|NCT02531113|17417882|P1|Extension Period: Week 12 up to Week 160|Pregnancy|1
5052100|NCT02531113|17417882|P1|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
5052101|NCT02531113|17417882|P1|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
5052102|NCT02531113|17417882|P1|Extension Period: Week 12 up to Week 160|Adverse Event|5
5052103|NCT02531113|17417882|P1|Extension Period: Week 12 up to Week 160|Physician Decision|2
5052104|NCT02531113|17417882|P1|Induction Period: Week 0 to 12|Withdrawal by Subject|3
5052105|NCT02531113|17417882|P1|Induction Period: Week 0 to 12|Lack of Efficacy|4
5052106|NCT02531113|17417882|P1|Induction Period: Week 0 to 12|Adverse Event|4
5052107|NCT02531035|17417914|P2|Overall Study|Randomized, not treated|1
5052108|NCT02531035|17417915|P1|Overall Study|Randomized, not treated|2
5052109|NCT02531035|17417914|P2|Overall Study|Lost to Follow-up|10
5052110|NCT02531035|17417915|P1|Overall Study|Lost to Follow-up|8
5052111|NCT02531035|17417914|P2|Overall Study|Withdrawal by Subject|32
5052112|NCT02531035|17417915|P1|Overall Study|Withdrawal by Subject|42
5052113|NCT02531035|17417914|P2|Overall Study|Other|2
5052114|NCT02531035|17417915|P1|Overall Study|Other|3
5052115|NCT02531035|17417914|P2|Overall Study|Adverse Event|45
5052116|NCT02531035|17417915|P1|Overall Study|Adverse Event|16
5052117|NCT02531035|17417914|P2|Overall Study|Physician Decision|0
5052118|NCT02531035|17417915|P1|Overall Study|Physician Decision|1
5052119|NCT02531035|17417914|P2|Overall Study|Noncompliance with study drug|3
5052120|NCT02531035|17417915|P1|Overall Study|Noncompliance with study drug|8
5052121|NCT02531035|17417914|P2|Overall Study|Protocol Violation|1
5052122|NCT02531035|17417915|P1|Overall Study|Protocol Violation|1
5052123|NCT02531035|17417914|P2|Overall Study|Death|1
5052124|NCT02531035|17417915|P1|Overall Study|Death|0
5052125|NCT02530970|17417940|P1|Overall Study|Relocation|3
5052126|NCT02530970|17417940|P1|Overall Study|Change in Provider|5
5052127|NCT02530970|17417940|P1|Overall Study|Explant|2
5052128|NCT02530970|17417940|P1|Overall Study|Insurance|2
5052129|NCT02530970|17417940|P1|Overall Study|Hospitalization|1
5052130|NCT02530970|17417940|P1|Overall Study|Death|6
5052131|NCT02530970|17417940|P1|Overall Study|Withdrawal by Subject|14
5052132|NCT02530970|17417940|P1|Overall Study|Physician Decision|5
5052133|NCT02530970|17417940|P1|Overall Study|Lost to Follow-up|88
5052134|NCT02530970|17417940|P1|Overall Study|Adverse Event|8
5052135|NCT02530671|17417947|P2|Overall Study|Withdrawal by Subject|0
5052136|NCT02530671|17417948|P1|Overall Study|Withdrawal by Subject|1
5052137|NCT02530671|17417947|P2|Overall Study|Lost to Follow-up|0
5052138|NCT02530671|17417948|P1|Overall Study|Lost to Follow-up|2
5052139|NCT02530385|17418036|P2|Overall Study|Withdrawal by Subject|1
5052140|NCT02530385|17418037|P1|Overall Study|Withdrawal by Subject|0
5052141|NCT02530242|17418089|P2|Overall Study|excluded due to asthma and oxcarbazepine|1
5052142|NCT02530242|17418090|P1|Overall Study|excluded due to asthma and oxcarbazepine|0
5052143|NCT02530125|17418109|P1|Followed for Survival for 2 Years|Early termination of study|3
5052144|NCT02530125|17418109|P1|Completed Treatment|Early termination of study|1
5052145|NCT02529995|17418123|P2|Part B|Discontinued Study|5
5052146|NCT02529995|17418124|P1|Part B|Discontinued Study|6
5052147|NCT02529995|17418123|P2|Part B|Ongoing Study at Data Cut-off|7
5052148|NCT02529995|17418124|P1|Part B|Ongoing Study at Data Cut-off|0
5052149|NCT02529995|17418123|P2|Part A|Discontinued Study|0
5052150|NCT02529995|17418124|P1|Part A|Discontinued Study|1
5052151|NCT02529995|17418123|P2|Part A|Ongoing Study at Data Cut-off|16
5052152|NCT02529995|17418124|P1|Part A|Ongoing Study at Data Cut-off|14
5052153|NCT02529553|17418167|P9|Overall Study|Withdrawal by Subject|0
5052154|NCT02529553|17418168|P8|Overall Study|Withdrawal by Subject|1
5052155|NCT02529553|17418169|P7|Overall Study|Withdrawal by Subject|0
5052156|NCT02529553|17418170|P6|Overall Study|Withdrawal by Subject|1
5052157|NCT02529553|17418171|P5|Overall Study|Withdrawal by Subject|0
5052158|NCT02529553|17418172|P4|Overall Study|Withdrawal by Subject|0
5052159|NCT02529553|17418173|P3|Overall Study|Withdrawal by Subject|0
5052160|NCT02529553|17418174|P2|Overall Study|Withdrawal by Subject|0
5052161|NCT02529553|17418175|P1|Overall Study|Withdrawal by Subject|0
5052162|NCT02529553|17418167|P9|Overall Study|Physician Decision|0
5052163|NCT02529553|17418168|P8|Overall Study|Physician Decision|0
5052164|NCT02529553|17418169|P7|Overall Study|Physician Decision|0
5052165|NCT02529553|17418170|P6|Overall Study|Physician Decision|0
5052166|NCT02529553|17418171|P5|Overall Study|Physician Decision|1
5052167|NCT02529553|17418172|P4|Overall Study|Physician Decision|0
5052168|NCT02529553|17418173|P3|Overall Study|Physician Decision|0
5052169|NCT02529553|17418174|P2|Overall Study|Physician Decision|1
5052170|NCT02529553|17418175|P1|Overall Study|Physician Decision|0
5052171|NCT02529553|17418167|P9|Overall Study|Progressive Disease|3
5052172|NCT02529553|17418168|P8|Overall Study|Progressive Disease|5
5052173|NCT02529553|17418169|P7|Overall Study|Progressive Disease|3
5052174|NCT02529553|17418170|P6|Overall Study|Progressive Disease|3
5052175|NCT02529553|17418171|P5|Overall Study|Progressive Disease|2
5052176|NCT02529553|17418172|P4|Overall Study|Progressive Disease|3
5052177|NCT02529553|17418173|P3|Overall Study|Progressive Disease|1
5052178|NCT02529553|17418174|P2|Overall Study|Progressive Disease|0
5052179|NCT02529553|17418175|P1|Overall Study|Progressive Disease|1
5052180|NCT02529488|17418214|P1|Overall Study|Death|3
5052181|NCT02529488|17418214|P1|Overall Study|Adverse Event|1
5052182|NCT02529137|17418222|P1|Overall Study|Discontinuation for different reasons|8
5052183|NCT02528643|17418259|P2|Overall Study|No End of Study Information Available|0
5052184|NCT02528643|17418260|P1|Overall Study|No End of Study Information Available|1
5052185|NCT02528643|17418259|P2|Overall Study|Miscellaneous|1
5052186|NCT02528643|17418260|P1|Overall Study|Miscellaneous|0
5052187|NCT02528643|17418259|P2|Overall Study|Withdrawal by Subject|7
5052188|NCT02528643|17418260|P1|Overall Study|Withdrawal by Subject|0
5052189|NCT02528643|17418259|P2|Overall Study|Lost to Follow-up|1
5052190|NCT02528643|17418260|P1|Overall Study|Lost to Follow-up|0
5052191|NCT02528643|17418259|P2|Overall Study|Death|76
5052192|NCT02528643|17418260|P1|Overall Study|Death|38
5052193|NCT02528331|17418302|P1|Overall Study|Withdrawal by Subject|2
5052194|NCT02528305|17418370|P1|Overall Study|Physician Decision|1
5052195|NCT02528305|17418370|P1|Overall Study|Adverse Event|1
5052196|NCT02528305|17418370|P1|Overall Study|Withdrawal by Subject|1
5052197|NCT02528253|17418417|P5|Overall Study|Withdrawn Due to Pregnancy|1
5052198|NCT02528253|17418418|P4|Overall Study|Withdrawn Due to Pregnancy|0
5052199|NCT02528253|17418419|P3|Overall Study|Withdrawn Due to Pregnancy|0
5052200|NCT02528253|17418420|P2|Overall Study|Withdrawn Due to Pregnancy|1
5052201|NCT02528253|17418421|P1|Overall Study|Withdrawn Due to Pregnancy|0
5052202|NCT02528253|17418417|P5|Overall Study|Protocol Violation|4
5052203|NCT02528253|17418418|P4|Overall Study|Protocol Violation|0
5052204|NCT02528253|17418419|P3|Overall Study|Protocol Violation|4
5052205|NCT02528253|17418420|P2|Overall Study|Protocol Violation|2
5052206|NCT02528253|17418421|P1|Overall Study|Protocol Violation|1
5052207|NCT02528253|17418417|P5|Overall Study|Withdrawal by Subject|73
5052208|NCT02528253|17418418|P4|Overall Study|Withdrawal by Subject|48
5052209|NCT02528253|17418419|P3|Overall Study|Withdrawal by Subject|29
5052210|NCT02528253|17418420|P2|Overall Study|Withdrawal by Subject|20
5052211|NCT02528253|17418421|P1|Overall Study|Withdrawal by Subject|25
5052212|NCT02528253|17418417|P5|Overall Study|Other|76
5052213|NCT02528253|17418418|P4|Overall Study|Other|52
5052214|NCT02528253|17418419|P3|Overall Study|Other|58
5052215|NCT02528253|17418420|P2|Overall Study|Other|22
5052216|NCT02528253|17418421|P1|Overall Study|Other|21
5052217|NCT02528253|17418417|P5|Overall Study|Lost to Follow-up|34
5052218|NCT02528253|17418418|P4|Overall Study|Lost to Follow-up|16
5052219|NCT02528253|17418419|P3|Overall Study|Lost to Follow-up|31
5052220|NCT02528253|17418420|P2|Overall Study|Lost to Follow-up|9
5052221|NCT02528253|17418421|P1|Overall Study|Lost to Follow-up|16
5052222|NCT02528253|17418417|P5|Overall Study|Insufficient clinical response|16
5052223|NCT02528253|17418418|P4|Overall Study|Insufficient clinical response|12
5052224|NCT02528253|17418419|P3|Overall Study|Insufficient clinical response|13
5052225|NCT02528253|17418420|P2|Overall Study|Insufficient clinical response|10
5052226|NCT02528253|17418421|P1|Overall Study|Insufficient clinical response|7
5052227|NCT02528253|17418417|P5|Overall Study|Death|1
5052228|NCT02528253|17418418|P4|Overall Study|Death|0
5052229|NCT02528253|17418419|P3|Overall Study|Death|1
5052230|NCT02528253|17418420|P2|Overall Study|Death|2
5052231|NCT02528253|17418421|P1|Overall Study|Death|2
5052232|NCT02528253|17418417|P5|Overall Study|Adverse Event|18
5052233|NCT02528253|17418418|P4|Overall Study|Adverse Event|8
5052234|NCT02528253|17418419|P3|Overall Study|Adverse Event|4
5052235|NCT02528253|17418420|P2|Overall Study|Adverse Event|4
5052236|NCT02528253|17418421|P1|Overall Study|Adverse Event|3
5052237|NCT02528214|17418714|P2|Overall Study|Other than specified above|1
5052238|NCT02528214|17418715|P1|Overall Study|Other than specified above|0
5052239|NCT02528214|17418714|P2|Overall Study|Adverse Event|1
5052240|NCT02528214|17418715|P1|Overall Study|Adverse Event|0
5052241|NCT02528214|17418714|P2|Overall Study|Protocol Violation|1
5052242|NCT02528214|17418715|P1|Overall Study|Protocol Violation|0
5052243|NCT02528188|17418750|P3|Overall Study|Randomized but not treated|12
5052244|NCT02528188|17418751|P2|Overall Study|Randomized but not treated|7
5052245|NCT02528188|17418752|P1|Overall Study|Randomized but not treated|6
5052246|NCT02528188|17418750|P3|Overall Study|Other|74
5052247|NCT02528188|17418751|P2|Overall Study|Other|91
5052248|NCT02528188|17418752|P1|Overall Study|Other|89
5052249|NCT02528188|17418750|P3|Overall Study|Death|0
5052250|NCT02528188|17418751|P2|Overall Study|Death|4
5052251|NCT02528188|17418752|P1|Overall Study|Death|4
5052252|NCT02528188|17418750|P3|Overall Study|Lost to Follow-up|31
5052253|NCT02528188|17418751|P2|Overall Study|Lost to Follow-up|21
5052254|NCT02528188|17418752|P1|Overall Study|Lost to Follow-up|25
5052255|NCT02528188|17418750|P3|Overall Study|Withdrawal by Subject|100
5052256|NCT02528188|17418751|P2|Overall Study|Withdrawal by Subject|104
5052257|NCT02528188|17418752|P1|Overall Study|Withdrawal by Subject|97
5052258|NCT02528188|17418750|P3|Overall Study|Lack of Efficacy|22
5052259|NCT02528188|17418751|P2|Overall Study|Lack of Efficacy|21
5052260|NCT02528188|17418752|P1|Overall Study|Lack of Efficacy|19
5052261|NCT02528188|17418750|P3|Overall Study|Protocol Violation|4
5052262|NCT02528188|17418751|P2|Overall Study|Protocol Violation|6
5052263|NCT02528188|17418752|P1|Overall Study|Protocol Violation|4
5052264|NCT02528188|17418750|P3|Overall Study|Adverse Event|8
5052265|NCT02528188|17418751|P2|Overall Study|Adverse Event|22
5052266|NCT02528188|17418752|P1|Overall Study|Adverse Event|23
5052267|NCT02527434|17419027|P3|Overall Study|Site closure|0
5052268|NCT02527434|17419028|P2|Overall Study|Site closure|0
5052269|NCT02527434|17419029|P1|Overall Study|Site closure|1
5052270|NCT02527434|17419027|P3|Overall Study|Reason Not Specified|0
5052271|NCT02527434|17419028|P2|Overall Study|Reason Not Specified|0
5052272|NCT02527434|17419029|P1|Overall Study|Reason Not Specified|1
5052273|NCT02527434|17419027|P3|Overall Study|Withdrawal by Subject|3
5052274|NCT02527434|17419028|P2|Overall Study|Withdrawal by Subject|3
5052275|NCT02527434|17419029|P1|Overall Study|Withdrawal by Subject|5
5052276|NCT02527434|17419027|P3|Overall Study|Death|17
5052277|NCT02527434|17419028|P2|Overall Study|Death|6
5052278|NCT02527434|17419029|P1|Overall Study|Death|19
5052279|NCT02527434|17419027|P3|Overall Study|Lost to Follow-up|0
5052280|NCT02527434|17419028|P2|Overall Study|Lost to Follow-up|2
5052281|NCT02527434|17419029|P1|Overall Study|Lost to Follow-up|2
5052282|NCT02527161|17419087|P1|Overall Study|Lost to Follow-up|6
5052283|NCT02527161|17419087|P1|Overall Study|Adverse Event|1
5052284|NCT02527161|17419087|P1|Overall Study|Physician Decision|1
5052285|NCT02527161|17419087|P1|Overall Study|Only Recruited to Part A|27
5052286|NCT02527161|17419087|P1|Overall Study|Consent violation|4
5052287|NCT02527161|17419087|P1|Overall Study|MRI contraindication|6
5052288|NCT02527161|17419087|P1|Overall Study|Delay in or unfit for surgery|16
5052289|NCT02527161|17419087|P1|Overall Study|Withdrawal by Subject|19
5052290|NCT02527161|17419087|P1|Overall Study|Failed MRI|52
5052291|NCT02527148|17419106|P2|Overall Study|Did not receive study intervention|0
5052292|NCT02527148|17419107|P1|Overall Study|Did not receive study intervention|1
5052293|NCT02526693|17419137|P2|Overall Study|Physician Decision|1
5052294|NCT02526693|17419138|P1|Overall Study|Physician Decision|3
5052295|NCT02526550|17419183|P1|Overall Study|Lost to Follow-up|1
5052296|NCT02526524|17419195|P6|Overall Study|Sponsor Decision|0
5052297|NCT02526524|17419196|P5|Overall Study|Sponsor Decision|0
5052298|NCT02526524|17419197|P4|Overall Study|Sponsor Decision|0
5052299|NCT02526524|17419198|P3|Overall Study|Sponsor Decision|0
5052300|NCT02526524|17419199|P2|Overall Study|Sponsor Decision|0
5052301|NCT02526524|17419200|P1|Overall Study|Sponsor Decision|1
5052302|NCT02526524|17419195|P6|Overall Study|Physician Decision|0
5052303|NCT02526524|17419196|P5|Overall Study|Physician Decision|1
5052304|NCT02526524|17419197|P4|Overall Study|Physician Decision|0
5052305|NCT02526524|17419198|P3|Overall Study|Physician Decision|0
5052306|NCT02526524|17419199|P2|Overall Study|Physician Decision|0
5052307|NCT02526524|17419200|P1|Overall Study|Physician Decision|0
5052308|NCT02526524|17419195|P6|Overall Study|Loss of Glucose Control|0
5052309|NCT02526524|17419196|P5|Overall Study|Loss of Glucose Control|2
5052310|NCT02526524|17419197|P4|Overall Study|Loss of Glucose Control|0
5052311|NCT02526524|17419198|P3|Overall Study|Loss of Glucose Control|3
5052312|NCT02526524|17419199|P2|Overall Study|Loss of Glucose Control|0
5052313|NCT02526524|17419200|P1|Overall Study|Loss of Glucose Control|0
5052314|NCT02526524|17419195|P6|Overall Study|Protocol Violation|3
5052315|NCT02526524|17419196|P5|Overall Study|Protocol Violation|4
5052316|NCT02526524|17419197|P4|Overall Study|Protocol Violation|3
5052317|NCT02526524|17419198|P3|Overall Study|Protocol Violation|5
5052318|NCT02526524|17419199|P2|Overall Study|Protocol Violation|1
5052319|NCT02526524|17419200|P1|Overall Study|Protocol Violation|3
5052320|NCT02526524|17419195|P6|Overall Study|Lost to Follow-up|5
5052321|NCT02526524|17419196|P5|Overall Study|Lost to Follow-up|2
5052322|NCT02526524|17419197|P4|Overall Study|Lost to Follow-up|1
5052323|NCT02526524|17419198|P3|Overall Study|Lost to Follow-up|8
5052324|NCT02526524|17419199|P2|Overall Study|Lost to Follow-up|3
5052325|NCT02526524|17419200|P1|Overall Study|Lost to Follow-up|2
5052326|NCT02526524|17419195|P6|Overall Study|Adverse Event|8
5052327|NCT02526524|17419196|P5|Overall Study|Adverse Event|6
5052328|NCT02526524|17419197|P4|Overall Study|Adverse Event|2
5052329|NCT02526524|17419198|P3|Overall Study|Adverse Event|4
5052330|NCT02526524|17419199|P2|Overall Study|Adverse Event|2
5052331|NCT02526524|17419200|P1|Overall Study|Adverse Event|3
5052332|NCT02526524|17419195|P6|Overall Study|Withdrawal by Subject|5
5052333|NCT02526524|17419196|P5|Overall Study|Withdrawal by Subject|9
5052334|NCT02526524|17419197|P4|Overall Study|Withdrawal by Subject|1
5052335|NCT02526524|17419198|P3|Overall Study|Withdrawal by Subject|6
5052336|NCT02526524|17419199|P2|Overall Study|Withdrawal by Subject|3
5052337|NCT02526524|17419200|P1|Overall Study|Withdrawal by Subject|3
5052338|NCT02526290|17419214|P1|Overall Study|Physician Decision|1
5052339|NCT02526290|17419214|P1|Overall Study|Withdrawal by Subject|4
5052340|NCT02526290|17419214|P1|Overall Study|Adverse Event|3
5052341|NCT02526212|17419248|P2|Overall Study|Death|1
5052342|NCT02526212|17419249|P1|Overall Study|Death|0
5052343|NCT02526212|17419248|P2|Overall Study|Lost to Follow-up|0
5052344|NCT02526212|17419249|P1|Overall Study|Lost to Follow-up|1
5052345|NCT02526212|17419248|P2|Overall Study|Incarceration|0
5052346|NCT02526212|17419249|P1|Overall Study|Incarceration|1
5052347|NCT02525874|17419263|P1|Overall Study|New lesions in Brain|1
5052348|NCT02525874|17419263|P1|Overall Study|Alternative Treatment for MS|2
5052349|NCT02525874|17419263|P1|Overall Study|Disease relapse|4
5052350|NCT02525874|17419263|P1|Overall Study|Disease progression, defined by protocol|2
5052351|NCT02525874|17419263|P1|Overall Study|Lost to Follow-up|7
5052352|NCT02525874|17419263|P1|Overall Study|Adverse Event|17
5052353|NCT02525874|17419263|P1|Overall Study|Non-compliance with study drug|3
5052354|NCT02525874|17419263|P1|Overall Study|Consent withdrawn|22
5052355|NCT02525874|17419263|P1|Overall Study|Investigator Decision|1
5052356|NCT02525874|17419263|P1|Overall Study|Other|1
5052357|NCT02525744|17419276|P4|Period 5|Physician Decision|0
5052358|NCT02525744|17419277|P3|Period 5|Physician Decision|0
5052359|NCT02525744|17419278|P2|Period 5|Physician Decision|0
5052360|NCT02525744|17419279|P1|Period 5|Physician Decision|1
5052361|NCT02525744|17419276|P4|Period 4|Withdrawal by Subject|0
5052362|NCT02525744|17419277|P3|Period 4|Withdrawal by Subject|0
5052363|NCT02525744|17419278|P2|Period 4|Withdrawal by Subject|0
5052364|NCT02525744|17419279|P1|Period 4|Withdrawal by Subject|1
5052365|NCT02525744|17419276|P4|Period 3|Adverse Event|0
5052366|NCT02525744|17419277|P3|Period 3|Adverse Event|0
5052367|NCT02525744|17419278|P2|Period 3|Adverse Event|1
5052368|NCT02525744|17419279|P1|Period 3|Adverse Event|0
5052369|NCT02525744|17419276|P4|Period 1|Physician Decision|0
5052370|NCT02525744|17419277|P3|Period 1|Physician Decision|1
5052371|NCT02525744|17419278|P2|Period 1|Physician Decision|0
5052372|NCT02525744|17419279|P1|Period 1|Physician Decision|0
5052373|NCT02525627|17419315|P2|Overall Study|Site terminated|10
5052374|NCT02525627|17419316|P1|Overall Study|Site terminated|11
5052375|NCT02525627|17419315|P2|Overall Study|Death|0
5052376|NCT02525627|17419316|P1|Overall Study|Death|1
5052377|NCT02525627|17419315|P2|Overall Study|Withdrawal by Subject|2
5052378|NCT02525627|17419316|P1|Overall Study|Withdrawal by Subject|1
5052379|NCT02525627|17419315|P2|Overall Study|Revision|1
5052380|NCT02525627|17419316|P1|Overall Study|Revision|1
5052381|NCT02525588|17419328|P2|Overall Study|Adverse Event|1
5052382|NCT02525588|17419329|P1|Overall Study|Adverse Event|0
5052383|NCT02525588|17419328|P2|Overall Study|Withdrawal by Subject|1
5052384|NCT02525588|17419329|P1|Overall Study|Withdrawal by Subject|1
5052385|NCT02525588|17419328|P2|Overall Study|Lost to Follow-up|0
5052386|NCT02525588|17419329|P1|Overall Study|Lost to Follow-up|2
5052387|NCT02525588|17419328|P2|Overall Study|Death|1
5052388|NCT02525588|17419329|P1|Overall Study|Death|3
5052389|NCT02525094|17419441|P2|Overall Study|Not Treated|1
5052390|NCT02525094|17419442|P1|Overall Study|Not Treated|1
5052391|NCT02525094|17419441|P2|Overall Study|Withdrawal by Subject|6
5052392|NCT02525094|17419442|P1|Overall Study|Withdrawal by Subject|5
5052393|NCT02525094|17419441|P2|Overall Study|Lost to Follow-up|1
5052394|NCT02525094|17419442|P1|Overall Study|Lost to Follow-up|2
5052395|NCT02524847|17419505|P1|Overall Study|Reason not Specified|1
5052396|NCT02524847|17419505|P1|Overall Study|Death|1
5052397|NCT02524847|17419505|P1|Overall Study|Condition no Longer Requires Treatment|4
5052398|NCT02524847|17419505|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
5052399|NCT02524847|17419505|P1|Overall Study|Adverse Event|4
5052400|NCT02524665|17419517|P1|Overall Study|Lost to Follow-up|1
5052401|NCT02524288|17419568|P1|Overall Study|Physician Decision|2
5052402|NCT02524288|17419568|P1|Overall Study|Pregnancy|22
5052403|NCT02524288|17419568|P1|Overall Study|Withdrawal by Subject|76
5052404|NCT02524288|17419568|P1|Overall Study|Subject Moved|32
5052405|NCT02524288|17419568|P1|Overall Study|Study Terminated By Sponsor|1417
5052406|NCT02524288|17419568|P1|Overall Study|Site Discontinued Study Participation|1
5052407|NCT02524288|17419568|P1|Overall Study|Screen Failure|2
5052408|NCT02524288|17419568|P1|Overall Study|Protocol Violation|6
5052409|NCT02524288|17419568|P1|Overall Study|Pregnancy Wish|6
5052410|NCT02524288|17419568|P1|Overall Study|Non-Compliance With Study Drug|14
5052411|NCT02524288|17419568|P1|Overall Study|Non-Compliance With Protocol|32
5052412|NCT02524288|17419568|P1|Overall Study|Lost to Follow-up|216
5052413|NCT02524288|17419568|P1|Overall Study|Adverse Event|115
5052414|NCT02524158|17419578|P2|6-month Assessment|Lost to Follow-up|20
5052415|NCT02524158|17419579|P1|6-month Assessment|Lost to Follow-up|21
5052416|NCT02524158|17419578|P2|6-month Assessment|Withdrawal by Subject|1
5052417|NCT02524158|17419579|P1|6-month Assessment|Withdrawal by Subject|1
5052418|NCT02524158|17419578|P2|12-weeks Assessment|Lost to Follow-up|12
5052419|NCT02524158|17419579|P1|12-weeks Assessment|Lost to Follow-up|18
5052420|NCT02524158|17419578|P2|12-weeks Assessment|Withdrawal by Subject|1
5052421|NCT02524158|17419579|P1|12-weeks Assessment|Withdrawal by Subject|1
5052422|NCT02524145|17419621|P3|Overall Study|Withdrawal by Subject|3
5052423|NCT02524145|17419622|P2|Overall Study|Withdrawal by Subject|2
5052424|NCT02524145|17419623|P1|Overall Study|Withdrawal by Subject|2
5052425|NCT02522884|17419720|P1|Overall Study|Missed 12-month Follow-up|9
5052426|NCT02522884|17419720|P1|Overall Study|Death|3
5052427|NCT02522884|17419720|P1|Overall Study|Withdrawal by Subject|6
5052428|NCT02522728|17419752|P2|Overall Study|Did not receive randomized study device|1
5052429|NCT02522728|17419753|P1|Overall Study|Did not receive randomized study device|0
5052430|NCT02522728|17419752|P2|Overall Study|Adverse Event|1
5052431|NCT02522728|17419753|P1|Overall Study|Adverse Event|2
5052432|NCT02522728|17419752|P2|Overall Study|Death|3
5052433|NCT02522728|17419753|P1|Overall Study|Death|4
5052434|NCT02522728|17419752|P2|Overall Study|Withdrawal by Subject|6
5052435|NCT02522728|17419753|P1|Overall Study|Withdrawal by Subject|6
5052436|NCT02522624|17419769|P2|Overall Study|Technical failure|0
5052437|NCT02522624|17419770|P1|Overall Study|Technical failure|1
5052438|NCT02522481|17419786|P1|Overall Study|Not dosed|1
5052439|NCT02522481|17419786|P1|Overall Study|discontinued|1
5052440|NCT02522403|17419816|P2|Overall Study|Withdrawal by Subject|4
5052441|NCT02522403|17419817|P1|Overall Study|Withdrawal by Subject|2
5052442|NCT02522403|17419816|P2|Overall Study|Lost to Follow-up|2
5052443|NCT02522403|17419817|P1|Overall Study|Lost to Follow-up|2
5052444|NCT02522377|17419829|P2|Overall Study|Remission Achieved|0
5052445|NCT02522377|17419830|P1|Overall Study|Remission Achieved|3
5052446|NCT02522377|17419829|P2|Overall Study|Withdrawal by Subject|0
5052447|NCT02522377|17419830|P1|Overall Study|Withdrawal by Subject|1
5052448|NCT02522325|17419846|P2|Overall Study|Adverse Event|1
5052449|NCT02522325|17419847|P1|Overall Study|Adverse Event|0
5052450|NCT02522299|17419855|P2|Overall Study|Withdrawal by Subject|0
5052451|NCT02522299|17419856|P1|Overall Study|Withdrawal by Subject|2
5052452|NCT02522299|17419855|P2|Overall Study|Physician Decision|1
5052453|NCT02522299|17419856|P1|Overall Study|Physician Decision|0
5052454|NCT02522299|17419855|P2|Overall Study|Adverse Event|0
5052455|NCT02522299|17419856|P1|Overall Study|Adverse Event|2
5052456|NCT02522286|17419939|P4|Overall Study|Withdrawal by Subject|3
5052457|NCT02522286|17419940|P3|Overall Study|Withdrawal by Subject|0
5052458|NCT02522286|17419941|P2|Overall Study|Withdrawal by Subject|0
5052459|NCT02522286|17419942|P1|Overall Study|Withdrawal by Subject|3
5052460|NCT02521948|17419978|P1|Overall Study|Did not attend one or both follow-ups|6
5052461|NCT02521948|17419978|P1|Overall Study|Lost to Follow-up|1
5052462|NCT02521948|17419978|P1|Overall Study|Death|4
5052463|NCT02521948|17419978|P1|Overall Study|Adverse Event|2
5052464|NCT02521792|17419987|P1|Overall Study|Study Terminated|6
5052465|NCT02521376|17420037|P4|Overall Study|Enrolled, But Not Treated|0
5052466|NCT02521376|17420038|P3|Overall Study|Enrolled, But Not Treated|0
5052467|NCT02521376|17420039|P2|Overall Study|Enrolled, But Not Treated|0
5052468|NCT02521376|17420040|P1|Overall Study|Enrolled, But Not Treated|1
5052469|NCT02520726|17420094|P2|Overall Study|Lost to Follow-up|2
5052470|NCT02520726|17420095|P1|Overall Study|Lost to Follow-up|3
5052471|NCT02520531|17420105|P2|Overall Study|Not study device|0
5052472|NCT02520531|17420106|P1|Overall Study|Not study device|1
5052473|NCT02520531|17420105|P2|Overall Study|Withdrawal by Subject|0
5052474|NCT02520531|17420106|P1|Overall Study|Withdrawal by Subject|1
5052475|NCT02520531|17420105|P2|Overall Study|Meet exclusion criterion|1
5052476|NCT02520531|17420106|P1|Overall Study|Meet exclusion criterion|0
5052477|NCT02520531|17420105|P2|Overall Study|Lost to Follow-up|1
5052478|NCT02520531|17420106|P1|Overall Study|Lost to Follow-up|1
5052479|NCT02520531|17420105|P2|Overall Study|Death|2
5052480|NCT02520531|17420106|P1|Overall Study|Death|1
5052481|NCT02520531|17420105|P2|Overall Study|Revision of study device components|2
5052482|NCT02520531|17420106|P1|Overall Study|Revision of study device components|2
5052483|NCT02520388|17420191|P2|Overall Study|Other (reason not defined)|4
5052484|NCT02520388|17420192|P1|Overall Study|Other (reason not defined)|4
5052485|NCT02520388|17420191|P2|Overall Study|Lost to Follow-up|2
5052486|NCT02520388|17420192|P1|Overall Study|Lost to Follow-up|3
5052487|NCT02520388|17420191|P2|Overall Study|Adverse Event|4
5052488|NCT02520388|17420192|P1|Overall Study|Adverse Event|1
5052489|NCT02520388|17420191|P2|Overall Study|Subject or parent/guardian request|6
5052490|NCT02520388|17420192|P1|Overall Study|Subject or parent/guardian request|0
5052491|NCT02520388|17420191|P2|Overall Study|Physician Decision|0
5052492|NCT02520388|17420192|P1|Overall Study|Physician Decision|1
5052493|NCT02520310|17420200|P1|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
5052494|NCT02520310|17420200|P1|AT 3 Year Clinical Follow-up|Death|2
5052495|NCT02520310|17420200|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
5052496|NCT02520310|17420200|P1|At 6 Months Clinical Follow-up|Death|1
5052497|NCT02520284|17420381|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
5052498|NCT02520284|17420382|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
5052499|NCT02520284|17420383|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
5052500|NCT02520284|17420381|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
5052501|NCT02520284|17420382|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
5052502|NCT02520284|17420383|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
5052503|NCT02520284|17420381|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
5052504|NCT02520284|17420382|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
5052505|NCT02520284|17420383|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
5052506|NCT02520284|17420381|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
5052507|NCT02520284|17420382|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
5052508|NCT02520284|17420383|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
5052509|NCT02520284|17420381|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
5052510|NCT02520284|17420382|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
5052511|NCT02520284|17420383|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
5052512|NCT02520284|17420381|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
5052513|NCT02520284|17420382|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
5052514|NCT02520284|17420383|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
5052515|NCT02520284|17420381|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
5052516|NCT02520284|17420382|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
5052517|NCT02520284|17420383|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
5052518|NCT02520284|17420381|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
5052519|NCT02520284|17420382|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
5052520|NCT02520284|17420383|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
5052521|NCT02520284|17420381|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
5052522|NCT02520284|17420382|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
5052602|NCT02518971|17420742|P1|Overall Study|Physician Decision|6
5052523|NCT02520284|17420383|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
5052524|NCT02520284|17420381|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5052525|NCT02520284|17420382|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5052526|NCT02520284|17420383|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5052527|NCT02520284|17420381|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
5052528|NCT02520284|17420382|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
5052529|NCT02520284|17420383|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
5052530|NCT02520089|17420417|P2|Overall Study|Lost to Follow-up|4
5052531|NCT02520089|17420418|P1|Overall Study|Lost to Follow-up|3
5052532|NCT02519855|17420428|P2|Overall Study|Lost to Follow-up|3
5052533|NCT02519855|17420429|P1|Overall Study|Lost to Follow-up|3
5052534|NCT02519855|17420428|P2|Overall Study|Adverse Event|1
5052535|NCT02519855|17420429|P1|Overall Study|Adverse Event|0
5052536|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
5052537|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
5052538|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
5052539|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
5052540|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
5052541|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
5052542|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
5052543|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
5052544|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
5052545|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
5052546|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
5052547|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
5052548|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Death|1
5052549|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Death|0
5052550|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Death|0
5052551|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
5052552|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
5052553|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
5052554|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
5052555|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
5052556|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
5052557|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Adverse Event|1
5052558|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Adverse Event|0
5052559|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Adverse Event|0
5052560|NCT02519842|17420447|P3|Optional Extension: Cycles 2-6|Physician Decision|5
5052561|NCT02519842|17420448|P2|Optional Extension: Cycles 2-6|Physician Decision|0
5052562|NCT02519842|17420449|P1|Optional Extension: Cycles 2-6|Physician Decision|0
5052563|NCT02519842|17420447|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
5052564|NCT02519842|17420448|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
5052565|NCT02519842|17420449|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
5052566|NCT02519842|17420447|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
5052567|NCT02519842|17420448|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
5052568|NCT02519842|17420449|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
5052569|NCT02519842|17420447|P3|Base Study: Cycle 1|Adverse Event|0
5052570|NCT02519842|17420448|P2|Base Study: Cycle 1|Adverse Event|0
5052571|NCT02519842|17420449|P1|Base Study: Cycle 1|Adverse Event|1
5052572|NCT02519842|17420447|P3|Base Study: Cycle 1|Screening Failure|0
5052573|NCT02519842|17420448|P2|Base Study: Cycle 1|Screening Failure|1
5052574|NCT02519842|17420449|P1|Base Study: Cycle 1|Screening Failure|1
5052575|NCT02519712|17420468|P1|Overall Study|Accruals are donors|2
5052576|NCT02519712|17420468|P1|Overall Study|Disease Progression|1
5052577|NCT02519712|17420468|P1|Overall Study|Disease Relapse|1
5052578|NCT02519595|17420497|P3|Overall Study|Protocol Violation|16
5052579|NCT02519595|17420498|P2|Overall Study|Protocol Violation|22
5052580|NCT02519595|17420499|P1|Overall Study|Protocol Violation|8
5052581|NCT02519504|17420524|P2|Overall Study|Did not participate in direct testing|86
5052582|NCT02519504|17420525|P1|Overall Study|Did not participate in direct testing|95
5052583|NCT02519504|17420524|P2|Overall Study|Ineligible for direct testing|12
5052584|NCT02519504|17420525|P1|Overall Study|Ineligible for direct testing|12
5052585|NCT02519504|17420524|P2|Overall Study|Protocol Violation|5
5052586|NCT02519504|17420525|P1|Overall Study|Protocol Violation|6
5052587|NCT02519231|17420624|P2|Overall Study|Withdrawal by Subject|1
5052588|NCT02519231|17420625|P1|Overall Study|Withdrawal by Subject|0
5052589|NCT02519231|17420624|P2|Overall Study|Lost to Follow-up|5
5052590|NCT02519231|17420625|P1|Overall Study|Lost to Follow-up|2
5052591|NCT02518971|17420741|P2|Overall Study|eligibility criteria no longer met|3
5052592|NCT02518971|17420742|P1|Overall Study|eligibility criteria no longer met|6
5052593|NCT02518971|17420741|P2|Overall Study|medication lost in mail|1
5052594|NCT02518971|17420742|P1|Overall Study|medication lost in mail|0
5052595|NCT02518971|17420741|P2|Overall Study|Side effects|0
5052596|NCT02518971|17420742|P1|Overall Study|Side effects|1
5052597|NCT02518971|17420741|P2|Overall Study|Withdrawal by Subject|5
5052598|NCT02518971|17420742|P1|Overall Study|Withdrawal by Subject|4
5052599|NCT02518971|17420741|P2|Overall Study|Protocol Violation|4
5052600|NCT02518971|17420742|P1|Overall Study|Protocol Violation|6
5052601|NCT02518971|17420741|P2|Overall Study|Physician Decision|6
5052603|NCT02518971|17420741|P2|Overall Study|Lost to Follow-up|1
5052604|NCT02518971|17420742|P1|Overall Study|Lost to Follow-up|0
5052605|NCT02518919|17420762|P3|Overall Study|Protocol Violation|2
5052606|NCT02518919|17420763|P2|Overall Study|Protocol Violation|1
5052607|NCT02518919|17420764|P1|Overall Study|Protocol Violation|1
5052608|NCT02518685|17420794|P2|Overall Study|Lost to Follow-up|4
5052609|NCT02518685|17420795|P1|Overall Study|Lost to Follow-up|1
5052610|NCT02518685|17420794|P2|Overall Study|Physician Decision|0
5052611|NCT02518685|17420795|P1|Overall Study|Physician Decision|1
5052612|NCT02518685|17420794|P2|Overall Study|Pregnancy|0
5052613|NCT02518685|17420795|P1|Overall Study|Pregnancy|1
5052614|NCT02518685|17420794|P2|Overall Study|relocation, study fatigue|2
5052615|NCT02518685|17420795|P1|Overall Study|relocation, study fatigue|7
5052616|NCT02518685|17420794|P2|Overall Study|Withdrawal by Subject|3
5052617|NCT02518685|17420795|P1|Overall Study|Withdrawal by Subject|10
5052618|NCT02518685|17420794|P2|Overall Study|Adverse Event|1
5052619|NCT02518685|17420795|P1|Overall Study|Adverse Event|29
5052620|NCT02518620|17420804|P2|Overall Study|Relocation|1
5052621|NCT02518620|17420805|P1|Overall Study|Relocation|2
5052622|NCT02518620|17420804|P2|Overall Study|Pregnancy|0
5052623|NCT02518620|17420805|P1|Overall Study|Pregnancy|1
5052624|NCT02518620|17420804|P2|Overall Study|Pregnancy Wish|0
5052625|NCT02518620|17420805|P1|Overall Study|Pregnancy Wish|3
5052626|NCT02518620|17420804|P2|Overall Study|Death|0
5052627|NCT02518620|17420805|P1|Overall Study|Death|1
5052628|NCT02518620|17420804|P2|Overall Study|Withdrawal by Subject|9
5052629|NCT02518620|17420805|P1|Overall Study|Withdrawal by Subject|17
5052630|NCT02518620|17420804|P2|Overall Study|Lost to Follow-up|1
5052631|NCT02518620|17420805|P1|Overall Study|Lost to Follow-up|1
5052632|NCT02518620|17420804|P2|Overall Study|Sponsor's Decision|3
5052633|NCT02518620|17420805|P1|Overall Study|Sponsor's Decision|0
5052634|NCT02518620|17420804|P2|Overall Study|Physician Decision|1
5052635|NCT02518620|17420805|P1|Overall Study|Physician Decision|1
5052636|NCT02518620|17420804|P2|Overall Study|Non-Compliance with Study Drug|0
5052637|NCT02518620|17420805|P1|Overall Study|Non-Compliance with Study Drug|1
5052638|NCT02518620|17420804|P2|Overall Study|Lack of Efficacy|0
5052639|NCT02518620|17420805|P1|Overall Study|Lack of Efficacy|2
5052640|NCT02518620|17420804|P2|Overall Study|Adverse Event|11
5052641|NCT02518620|17420805|P1|Overall Study|Adverse Event|23
5052642|NCT02518490|17420828|P2|Overall Study|Withdrawal by Subject|1
5052643|NCT02518490|17420829|P1|Overall Study|Withdrawal by Subject|1
5052644|NCT02518464|17420847|P1|Overall Study|Adverse Event|2
5052645|NCT02518113|17420868|P4|Overall Study|Progressive Disease|0
5052646|NCT02518113|17420869|P3|Overall Study|Progressive Disease|3
5052647|NCT02518113|17420870|P2|Overall Study|Progressive Disease|2
5052648|NCT02518113|17420871|P1|Overall Study|Progressive Disease|1
5052649|NCT02518113|17420868|P4|Overall Study|Physician Decision|0
5052650|NCT02518113|17420869|P3|Overall Study|Physician Decision|0
5052651|NCT02518113|17420870|P2|Overall Study|Physician Decision|1
5052652|NCT02518113|17420871|P1|Overall Study|Physician Decision|0
5052653|NCT02518113|17420868|P4|Overall Study|Death|0
5052654|NCT02518113|17420869|P3|Overall Study|Death|0
5052655|NCT02518113|17420870|P2|Overall Study|Death|2
5052656|NCT02518113|17420871|P1|Overall Study|Death|1
5052657|NCT02518113|17420868|P4|Overall Study|Adverse Event|0
5052658|NCT02518113|17420869|P3|Overall Study|Adverse Event|1
5052659|NCT02518113|17420870|P2|Overall Study|Adverse Event|0
5052660|NCT02518113|17420871|P1|Overall Study|Adverse Event|1
5052661|NCT02518048|17420912|P1|Overall Study|Withdrawal by Subject|1
5052662|NCT02517866|17420938|P3|Overall Study|Reason not specified|0
5052663|NCT02517866|17420939|P2|Overall Study|Reason not specified|0
5052664|NCT02517866|17420940|P1|Overall Study|Reason not specified|2
5052665|NCT02517866|17420938|P3|Overall Study|Investigator Decision|0
5052666|NCT02517866|17420939|P2|Overall Study|Investigator Decision|1
5052667|NCT02517866|17420940|P1|Overall Study|Investigator Decision|2
5052668|NCT02517866|17420938|P3|Overall Study|Voluntary Withdrawal|0
5052669|NCT02517866|17420939|P2|Overall Study|Voluntary Withdrawal|2
5052670|NCT02517866|17420940|P1|Overall Study|Voluntary Withdrawal|2
5052671|NCT02517866|17420938|P3|Overall Study|Lost to Follow-up|0
5052672|NCT02517866|17420939|P2|Overall Study|Lost to Follow-up|0
5052673|NCT02517866|17420940|P1|Overall Study|Lost to Follow-up|1
5052674|NCT02517866|17420938|P3|Overall Study|Significant Protocol Deviation|0
5052675|NCT02517866|17420939|P2|Overall Study|Significant Protocol Deviation|1
5052676|NCT02517866|17420940|P1|Overall Study|Significant Protocol Deviation|4
5052677|NCT02517866|17420938|P3|Overall Study|Pretreatment Event/Adverse Event|0
5052678|NCT02517866|17420939|P2|Overall Study|Pretreatment Event/Adverse Event|2
5052679|NCT02517866|17420940|P1|Overall Study|Pretreatment Event/Adverse Event|9
5052680|NCT02517541|17421011|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
5052681|NCT02517541|17421011|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
5052682|NCT02517541|17421011|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
5052683|NCT02517541|17421011|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
5052684|NCT02517541|17421011|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
5052685|NCT02517541|17421011|P1|Baseline Period (Own Product)|Protocol Violation|1
5052686|NCT02517528|17421017|P1|Overall Study|Withdrawal by Subject|1
5052687|NCT02517515|17421027|P2|Overall Study|Other|0
5052688|NCT02517515|17421028|P1|Overall Study|Other|1
5052689|NCT02517515|17421027|P2|Overall Study|Lost to Follow-up|0
5052690|NCT02517515|17421028|P1|Overall Study|Lost to Follow-up|1
5052691|NCT02517515|17421027|P2|Overall Study|Withdrew Consent|1
5052692|NCT02517515|17421028|P1|Overall Study|Withdrew Consent|0
5052693|NCT02517515|17421027|P2|Overall Study|Adverse Event|1
5052694|NCT02517515|17421028|P1|Overall Study|Adverse Event|0
5052695|NCT02517463|17421045|P2|Overall Study|Lost to Follow-up|2
5052696|NCT02517463|17421046|P1|Overall Study|Lost to Follow-up|5
5052697|NCT02517268|17421058|P2|Overall Study|Withdrawal by Subject|0
5052698|NCT02517268|17421059|P1|Overall Study|Withdrawal by Subject|1
5052699|NCT02516982|17421111|P4|Overall Study|Did not install the app|47
5052700|NCT02516982|17421112|P3|Overall Study|Did not install the app|46
5052701|NCT02516982|17421113|P2|Overall Study|Did not install the app|0
5052702|NCT02516982|17421114|P1|Overall Study|Did not install the app|0
5052703|NCT02516982|17421111|P4|Overall Study|Protocol Violation|1
5052704|NCT02516982|17421112|P3|Overall Study|Protocol Violation|1
5052705|NCT02516982|17421113|P2|Overall Study|Protocol Violation|0
5052706|NCT02516982|17421114|P1|Overall Study|Protocol Violation|0
5052707|NCT02516982|17421111|P4|Overall Study|Withdrawal by Subject|2
5052708|NCT02516982|17421112|P3|Overall Study|Withdrawal by Subject|1
5052709|NCT02516982|17421113|P2|Overall Study|Withdrawal by Subject|0
5052710|NCT02516982|17421114|P1|Overall Study|Withdrawal by Subject|0
5052711|NCT02516982|17421111|P4|Overall Study|Called in to antenatal appointment|0
5052712|NCT02516982|17421112|P3|Overall Study|Called in to antenatal appointment|0
5052713|NCT02516982|17421113|P2|Overall Study|Called in to antenatal appointment|35
5052714|NCT02516982|17421114|P1|Overall Study|Called in to antenatal appointment|32
5052715|NCT02516605|17421141|P5|Overall Study|Withdrawal by Subject|0
5052716|NCT02516605|17421142|P4|Overall Study|Withdrawal by Subject|1
5052717|NCT02516605|17421143|P3|Overall Study|Withdrawal by Subject|0
5052718|NCT02516605|17421144|P2|Overall Study|Withdrawal by Subject|0
5052719|NCT02516605|17421145|P1|Overall Study|Withdrawal by Subject|0
5052720|NCT02516605|17421141|P5|Overall Study|Protocol Violation|1
5052721|NCT02516605|17421142|P4|Overall Study|Protocol Violation|0
5052722|NCT02516605|17421143|P3|Overall Study|Protocol Violation|0
5052723|NCT02516605|17421144|P2|Overall Study|Protocol Violation|0
5052724|NCT02516605|17421145|P1|Overall Study|Protocol Violation|0
5052725|NCT02516592|17421216|P2|Overall Study|Death|1
5052726|NCT02516592|17421217|P1|Overall Study|Death|1
5052727|NCT02516592|17421216|P2|Overall Study|Abnormal test procedure result|0
5052728|NCT02516592|17421217|P1|Overall Study|Abnormal test procedure result|1
5052729|NCT02516592|17421216|P2|Overall Study|Adverse Event|2
5052730|NCT02516592|17421217|P1|Overall Study|Adverse Event|1
5052731|NCT02516592|17421216|P2|Overall Study|Patient/guardian decision|1
5052732|NCT02516592|17421217|P1|Overall Study|Patient/guardian decision|2
5052733|NCT02516592|17421216|P2|Overall Study|Lost to Follow-up|3
5052734|NCT02516592|17421217|P1|Overall Study|Lost to Follow-up|2
5052735|NCT02516592|17421216|P2|Overall Study|Protocol deviation|4
5052736|NCT02516592|17421217|P1|Overall Study|Protocol deviation|4
5052737|NCT02516592|17421216|P2|Overall Study|Patient withdrew consent|2
5052738|NCT02516592|17421217|P1|Overall Study|Patient withdrew consent|5
5052739|NCT02516410|17421239|P2|Overall Study|Withdrawal by Subject|1
5052740|NCT02516410|17421240|P1|Overall Study|Withdrawal by Subject|0
5052741|NCT02516410|17421239|P2|Overall Study|Adverse Event|1
5052742|NCT02516410|17421240|P1|Overall Study|Adverse Event|0
5052743|NCT02516306|17421269|P2|Period 2: Day 8 - 91|Protocol Violation|2
5052744|NCT02516306|17421270|P1|Period 2: Day 8 - 91|Protocol Violation|1
5052745|NCT02516228|17421276|P1|Overall Study|Physician Decision|1
5052746|NCT02516228|17421276|P1|Overall Study|Withdrawal by Subject|1
5052747|NCT02516228|17421276|P1|Overall Study|Lost to Follow-up|1
5052748|NCT02516202|17421287|P3|Overall Study|Stopped Follow-up|1
5052749|NCT02516202|17421288|P2|Overall Study|Stopped Follow-up|0
5052750|NCT02516202|17421289|P1|Overall Study|Stopped Follow-up|0
5052751|NCT02516202|17421287|P3|Overall Study|Lost to Follow-up|1
5052752|NCT02516202|17421288|P2|Overall Study|Lost to Follow-up|1
5052753|NCT02516202|17421289|P1|Overall Study|Lost to Follow-up|1
5052754|NCT02516202|17421287|P3|Overall Study|Withdrawal by Subject|1
5052755|NCT02516202|17421288|P2|Overall Study|Withdrawal by Subject|0
5052756|NCT02516202|17421289|P1|Overall Study|Withdrawal by Subject|1
5052757|NCT02516163|17421315|P1|Overall Study|MRI contraindication exclusion|6
5052758|NCT02516163|17421315|P1|Overall Study|Data not recorded|2
5052759|NCT02516163|17421315|P1|Overall Study|Use of incorrect measurement technique|5
5052760|NCT02516163|17421315|P1|Overall Study|Unfit/delay in surgery|3
5052761|NCT02516163|17421315|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
5052762|NCT02516163|17421315|P1|Overall Study|Withdrawal by Subject|1
5052763|NCT02516098|17421329|P2|Period 2|Withdrawal by Subject|1
5052764|NCT02516098|17421330|P1|Period 2|Withdrawal by Subject|0
5052765|NCT02516098|17421329|P2|Washout After Period 1|Adverse Event|1
5052766|NCT02516098|17421330|P1|Washout After Period 1|Adverse Event|0
5052767|NCT02516098|17421329|P2|Period 1|Protocol Violation|0
5052768|NCT02516098|17421330|P1|Period 1|Protocol Violation|1
5052769|NCT02515994|17421358|P2|Overall Study|Withdrawal by Subject|0
5052770|NCT02515994|17421359|P1|Overall Study|Withdrawal by Subject|2
5052771|NCT02515994|17421358|P2|Overall Study|Adverse Event|1
5052772|NCT02515994|17421359|P1|Overall Study|Adverse Event|3
5052773|NCT02515994|17421358|P2|Overall Study|No Longer Meets Eligibility Criteria|1
5052774|NCT02515994|17421359|P1|Overall Study|No Longer Meets Eligibility Criteria|2
5052775|NCT02515994|17421358|P2|Overall Study|Protocol Violation|5
5052776|NCT02515994|17421359|P1|Overall Study|Protocol Violation|3
5052777|NCT02515942|17421374|P3|Overall Study|Withdrawal by Subject|2
5052778|NCT02515942|17421375|P2|Overall Study|Withdrawal by Subject|3
5052779|NCT02515942|17421376|P1|Overall Study|Withdrawal by Subject|0
5052780|NCT02515942|17421374|P3|Overall Study|Lost to Follow-up|0
5052781|NCT02515942|17421375|P2|Overall Study|Lost to Follow-up|0
5052782|NCT02515942|17421376|P1|Overall Study|Lost to Follow-up|2
5052783|NCT02515942|17421374|P3|Overall Study|Lack of Efficacy|1
5052784|NCT02515942|17421375|P2|Overall Study|Lack of Efficacy|0
5052785|NCT02515942|17421376|P1|Overall Study|Lack of Efficacy|0
5052786|NCT02515942|17421374|P3|Overall Study|Death|1
5052787|NCT02515942|17421375|P2|Overall Study|Death|0
5052788|NCT02515942|17421376|P1|Overall Study|Death|0
5052789|NCT02515942|17421374|P3|Overall Study|Adverse Event|0
5052790|NCT02515942|17421375|P2|Overall Study|Adverse Event|0
5052791|NCT02515942|17421376|P1|Overall Study|Adverse Event|5
5052792|NCT02515669|17421462|P4|228 Week Open-Label Phase|Missing|2
5052793|NCT02515669|17421463|P3|228 Week Open-Label Phase|Missing|2
5052794|NCT02515669|17421464|P2|228 Week Open-Label Phase|Missing|2
5052795|NCT02515669|17421465|P1|228 Week Open-Label Phase|Missing|0
5052796|NCT02515669|17421462|P4|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
5052797|NCT02515669|17421463|P3|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
5052798|NCT02515669|17421464|P2|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
5052799|NCT02515669|17421465|P1|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
5052800|NCT02515669|17421462|P4|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
5052801|NCT02515669|17421463|P3|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
5052802|NCT02515669|17421464|P2|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
5052803|NCT02515669|17421465|P1|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
5052804|NCT02515669|17421462|P4|228 Week Open-Label Phase|Lack of Efficacy|0
5052805|NCT02515669|17421463|P3|228 Week Open-Label Phase|Lack of Efficacy|1
5052806|NCT02515669|17421464|P2|228 Week Open-Label Phase|Lack of Efficacy|0
5052807|NCT02515669|17421465|P1|228 Week Open-Label Phase|Lack of Efficacy|0
5052808|NCT02515669|17421462|P4|228 Week Open-Label Phase|Other|4
5052809|NCT02515669|17421463|P3|228 Week Open-Label Phase|Other|1
5052810|NCT02515669|17421464|P2|228 Week Open-Label Phase|Other|0
5052811|NCT02515669|17421465|P1|228 Week Open-Label Phase|Other|0
5052812|NCT02515331|17421563|P3|Overall Study|Adverse Event|0
5052813|NCT02515331|17421564|P2|Overall Study|Adverse Event|0
5052814|NCT02515331|17421565|P1|Overall Study|Adverse Event|2
5052815|NCT02515331|17421563|P3|Overall Study|Protocol deviation|3
5052816|NCT02515331|17421564|P2|Overall Study|Protocol deviation|0
5052817|NCT02515331|17421565|P1|Overall Study|Protocol deviation|0
5052818|NCT02515331|17421563|P3|Overall Study|Withdrawal by Subject|1
5052819|NCT02515331|17421564|P2|Overall Study|Withdrawal by Subject|0
5052820|NCT02515331|17421565|P1|Overall Study|Withdrawal by Subject|0
5052821|NCT02515279|17421602|P1|Overall Study|Other|22
5052822|NCT02515279|17421602|P1|Overall Study|End-of-treatment visit not attended|17
5052823|NCT02515279|17421602|P1|Overall Study|Withdrawal by Subject|18
5052824|NCT02515279|17421602|P1|Overall Study|Lost to Follow-up|9
5052825|NCT02515279|17421602|P1|Overall Study|Lack of Efficacy|31
5052826|NCT02515279|17421602|P1|Overall Study|Adverse Event|7
5052827|NCT02515097|17421621|P2|Overall Study|Adverse Event|1
5052828|NCT02515097|17421622|P1|Overall Study|Adverse Event|2
5052829|NCT02515097|17421621|P2|Overall Study|Withdrawal by Subject|3
5052830|NCT02515097|17421622|P1|Overall Study|Withdrawal by Subject|1
5052831|NCT02515097|17421621|P2|Overall Study|Lost to Follow-up|2
5052832|NCT02515097|17421622|P1|Overall Study|Lost to Follow-up|4
5052833|NCT02515045|17421643|P3|Overall Study|Lost to Follow-up|1
5052834|NCT02515045|17421644|P2|Overall Study|Lost to Follow-up|1
5052835|NCT02515045|17421645|P1|Overall Study|Lost to Follow-up|0
5052836|NCT02515045|17421643|P3|Overall Study|Adverse Event|3
5052837|NCT02515045|17421644|P2|Overall Study|Adverse Event|3
5052838|NCT02515045|17421645|P1|Overall Study|Adverse Event|0
5052839|NCT02514772|17421682|P2|Overall Study|Withdrawal by Subject|1
5052840|NCT02514772|17421683|P1|Overall Study|Withdrawal by Subject|2
5052841|NCT02514772|17421682|P2|Overall Study|Death|1
5052842|NCT02514772|17421683|P1|Overall Study|Death|0
5052843|NCT02514772|17421682|P2|Overall Study|Adverse Event|0
5052844|NCT02514772|17421683|P1|Overall Study|Adverse Event|1
5052845|NCT02514746|17421697|P2|Overall Study|Other|1
5052846|NCT02514746|17421698|P1|Overall Study|Other|5
5052847|NCT02514746|17421697|P2|Overall Study|Withdrawal by Subject|10
5052848|NCT02514746|17421698|P1|Overall Study|Withdrawal by Subject|12
5052849|NCT02514746|17421697|P2|Overall Study|Physician Decision|2
5052850|NCT02514746|17421698|P1|Overall Study|Physician Decision|4
5052851|NCT02514746|17421697|P2|Overall Study|Chronically Ill|2
5052852|NCT02514746|17421698|P1|Overall Study|Chronically Ill|1
5052853|NCT02514577|17421735|P2|Overall Study|Adverse Event|1
5052854|NCT02514577|17421736|P1|Overall Study|Adverse Event|1
5052855|NCT02514577|17421735|P2|Overall Study|Withdrawal by Subject|6
5052856|NCT02514577|17421736|P1|Overall Study|Withdrawal by Subject|6
5052857|NCT02514577|17421735|P2|Overall Study|Protocol Violation|0
5052858|NCT02514577|17421736|P1|Overall Study|Protocol Violation|1
5052859|NCT02514577|17421735|P2|Overall Study|Lost to Follow-up|6
5052860|NCT02514577|17421736|P1|Overall Study|Lost to Follow-up|6
5052861|NCT02514551|17421746|P2|Overall Study|Participant Never Treated|2
5052862|NCT02514551|17421747|P1|Overall Study|Participant Never Treated|0
5052863|NCT02514551|17421746|P2|Overall Study|Lost to Follow-up|1
5052864|NCT02514551|17421747|P1|Overall Study|Lost to Follow-up|0
5052865|NCT02514473|17421764|P2|Overall Study|Other|1
5052866|NCT02514473|17421765|P1|Overall Study|Other|1
5052867|NCT02514473|17421764|P2|Overall Study|Lost to Follow-up|1
5052868|NCT02514473|17421765|P1|Overall Study|Lost to Follow-up|0
5052869|NCT02514473|17421764|P2|Overall Study|Withdrawal by Subject|1
5052870|NCT02514473|17421765|P1|Overall Study|Withdrawal by Subject|2
5052871|NCT02514473|17421764|P2|Overall Study|Adverse Event|2
5052872|NCT02514473|17421765|P1|Overall Study|Adverse Event|0
5052873|NCT02514174|17421806|P1|Overall Study|Treated off study with Afatinib.|1
5052874|NCT02514174|17421806|P1|Overall Study|Treatment change|1
5052875|NCT02514174|17421806|P1|Overall Study|Progressive disease|11
5052876|NCT02514174|17421806|P1|Overall Study|Study closed by sponsor|9
5052877|NCT02514174|17421806|P1|Overall Study|Adverse Event|2
5052878|NCT02514174|17421806|P1|Overall Study|Patient refused to continue medication|1
5052879|NCT02514122|17421817|P2|Overall Study|Withdrawal by Subject|0
5052880|NCT02514122|17421818|P1|Overall Study|Withdrawal by Subject|2
5052881|NCT02514083|17421826|P1|Overall Study|Adverse Event|1
5052882|NCT02513823|17421870|P1|Overall Study|Physician Decision|1
5052883|NCT02513823|17421870|P1|Overall Study|Lost to Follow-up|4
5052884|NCT02513771|17421877|P2|Overall Study|Not being able to get to clinic|0
5052885|NCT02513771|17421878|P1|Overall Study|Not being able to get to clinic|1
5052886|NCT02513771|17421877|P2|Overall Study|Lost to Follow-up|1
5052887|NCT02513771|17421878|P1|Overall Study|Lost to Follow-up|1
5052888|NCT02513745|17421916|P2|Overall Study|Criteria at time of surgery not met.|3
5052889|NCT02513745|17421917|P1|Overall Study|Criteria at time of surgery not met.|3
5052890|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Labor Reasons|0
5052891|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Labor Reasons|0
5052892|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Labor Reasons|0
5052893|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Labor Reasons|1
5052894|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Labor Reasons|0
5052895|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Labor Reasons|0
5052896|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5052897|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5052898|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5052899|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
5052900|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5052901|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5052902|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Subject move out of town|0
5052903|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Subject move out of town|0
5052904|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Subject move out of town|0
5052905|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Subject move out of town|1
5052906|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Subject move out of town|0
5052907|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Subject move out of town|0
5052908|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Death|0
5052909|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Death|0
5052910|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Death|0
5052911|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Death|1
5052912|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Death|0
5052913|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Death|0
5052914|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Physician Decision|0
5052915|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Physician Decision|0
5052916|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Physician Decision|0
5052917|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Physician Decision|0
5052918|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Physician Decision|0
5052919|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Physician Decision|2
5052920|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Adverse Event|0
5052921|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Adverse Event|0
5052922|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Adverse Event|0
5052923|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Adverse Event|4
5052924|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Adverse Event|1
5052925|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Adverse Event|1
5052926|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
5052927|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
5052928|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
5052929|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
5052930|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
5052931|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
5052932|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5052933|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5052934|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5052935|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
5052936|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
5052937|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
5052938|NCT02513550|17422171|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5052939|NCT02513550|17422172|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5052940|NCT02513550|17422173|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5052941|NCT02513550|17422174|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
5052942|NCT02513550|17422175|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
5052943|NCT02513550|17422176|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
5052944|NCT02513550|17422171|P6|Double Blind Treatment Period|Death|0
5052945|NCT02513550|17422172|P5|Double Blind Treatment Period|Death|0
5052946|NCT02513550|17422173|P4|Double Blind Treatment Period|Death|0
5052947|NCT02513550|17422174|P3|Double Blind Treatment Period|Death|2
5052948|NCT02513550|17422175|P2|Double Blind Treatment Period|Death|0
5052949|NCT02513550|17422176|P1|Double Blind Treatment Period|Death|1
5052950|NCT02513550|17422171|P6|Double Blind Treatment Period|Due to personal business|0
5052951|NCT02513550|17422172|P5|Double Blind Treatment Period|Due to personal business|0
5052952|NCT02513550|17422173|P4|Double Blind Treatment Period|Due to personal business|0
5052953|NCT02513550|17422174|P3|Double Blind Treatment Period|Due to personal business|1
5052954|NCT02513550|17422175|P2|Double Blind Treatment Period|Due to personal business|0
5052955|NCT02513550|17422176|P1|Double Blind Treatment Period|Due to personal business|2
5052956|NCT02513550|17422171|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5052957|NCT02513550|17422172|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5052958|NCT02513550|17422173|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5052959|NCT02513550|17422174|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
5052960|NCT02513550|17422175|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5052961|NCT02513550|17422176|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5052962|NCT02513550|17422171|P6|Double Blind Treatment Period|Site terminated by sponsor|0
5052963|NCT02513550|17422172|P5|Double Blind Treatment Period|Site terminated by sponsor|0
5052964|NCT02513550|17422173|P4|Double Blind Treatment Period|Site terminated by sponsor|0
5052965|NCT02513550|17422174|P3|Double Blind Treatment Period|Site terminated by sponsor|3
5052966|NCT02513550|17422175|P2|Double Blind Treatment Period|Site terminated by sponsor|1
5052967|NCT02513550|17422176|P1|Double Blind Treatment Period|Site terminated by sponsor|1
5052968|NCT02513550|17422171|P6|Double Blind Treatment Period|Physician Decision|0
5052969|NCT02513550|17422172|P5|Double Blind Treatment Period|Physician Decision|0
5052970|NCT02513550|17422173|P4|Double Blind Treatment Period|Physician Decision|0
5052971|NCT02513550|17422174|P3|Double Blind Treatment Period|Physician Decision|4
5052972|NCT02513550|17422175|P2|Double Blind Treatment Period|Physician Decision|0
5052973|NCT02513550|17422176|P1|Double Blind Treatment Period|Physician Decision|2
5052974|NCT02513550|17422171|P6|Double Blind Treatment Period|Protocol Violation|0
5052975|NCT02513550|17422172|P5|Double Blind Treatment Period|Protocol Violation|0
5052976|NCT02513550|17422173|P4|Double Blind Treatment Period|Protocol Violation|0
5052977|NCT02513550|17422174|P3|Double Blind Treatment Period|Protocol Violation|4
5052978|NCT02513550|17422175|P2|Double Blind Treatment Period|Protocol Violation|1
5052979|NCT02513550|17422176|P1|Double Blind Treatment Period|Protocol Violation|1
5052980|NCT02513550|17422171|P6|Double Blind Treatment Period|Lack of Efficacy|0
5052981|NCT02513550|17422172|P5|Double Blind Treatment Period|Lack of Efficacy|0
5052982|NCT02513550|17422173|P4|Double Blind Treatment Period|Lack of Efficacy|0
5052983|NCT02513550|17422174|P3|Double Blind Treatment Period|Lack of Efficacy|6
5052984|NCT02513550|17422175|P2|Double Blind Treatment Period|Lack of Efficacy|5
5052985|NCT02513550|17422176|P1|Double Blind Treatment Period|Lack of Efficacy|4
5052986|NCT02513550|17422171|P6|Double Blind Treatment Period|Lost to Follow-up|1
5052987|NCT02513550|17422172|P5|Double Blind Treatment Period|Lost to Follow-up|0
5052988|NCT02513550|17422173|P4|Double Blind Treatment Period|Lost to Follow-up|0
5052989|NCT02513550|17422174|P3|Double Blind Treatment Period|Lost to Follow-up|11
5052990|NCT02513550|17422175|P2|Double Blind Treatment Period|Lost to Follow-up|7
5052991|NCT02513550|17422176|P1|Double Blind Treatment Period|Lost to Follow-up|9
5052992|NCT02513550|17422171|P6|Double Blind Treatment Period|Adverse Event|0
5052993|NCT02513550|17422172|P5|Double Blind Treatment Period|Adverse Event|1
5052994|NCT02513550|17422173|P4|Double Blind Treatment Period|Adverse Event|0
5052995|NCT02513550|17422174|P3|Double Blind Treatment Period|Adverse Event|17
5052996|NCT02513550|17422175|P2|Double Blind Treatment Period|Adverse Event|13
5052997|NCT02513550|17422176|P1|Double Blind Treatment Period|Adverse Event|5
5052998|NCT02513550|17422171|P6|Double Blind Treatment Period|Withdrawal by Subject|0
5052999|NCT02513550|17422172|P5|Double Blind Treatment Period|Withdrawal by Subject|0
5053000|NCT02513550|17422173|P4|Double Blind Treatment Period|Withdrawal by Subject|0
5053001|NCT02513550|17422174|P3|Double Blind Treatment Period|Withdrawal by Subject|25
5053002|NCT02513550|17422175|P2|Double Blind Treatment Period|Withdrawal by Subject|11
5053003|NCT02513550|17422176|P1|Double Blind Treatment Period|Withdrawal by Subject|11
5053004|NCT02513472|17422270|P2|Overall Study|Other|3
5053005|NCT02513472|17422271|P1|Overall Study|Other|3
5053006|NCT02513472|17422270|P2|Overall Study|Treatment Completed as per Protocol|1
5053007|NCT02513472|17422271|P1|Overall Study|Treatment Completed as per Protocol|3
5053008|NCT02513472|17422270|P2|Overall Study|Subject Choice|6
5053009|NCT02513472|17422271|P1|Overall Study|Subject Choice|2
5053010|NCT02513472|17422270|P2|Overall Study|Withdrawal by Subject|4
5053011|NCT02513472|17422271|P1|Overall Study|Withdrawal by Subject|0
5053012|NCT02513472|17422270|P2|Overall Study|Adverse Event|11
5053013|NCT02513472|17422271|P1|Overall Study|Adverse Event|7
5053014|NCT02513472|17422270|P2|Overall Study|Clinical Disease Progression|12
5053015|NCT02513472|17422271|P1|Overall Study|Clinical Disease Progression|5
5053016|NCT02513472|17422270|P2|Overall Study|Radiological Disease Progression|56
5053017|NCT02513472|17422271|P1|Overall Study|Radiological Disease Progression|45
5053018|NCT02513459|17422306|P1|Overall Study|Surgery planned-- not done|1
5053019|NCT02513459|17422306|P1|Overall Study|Reproductive plans|1
5053020|NCT02513459|17422306|P1|Overall Study|Lack of response|1
5053021|NCT02513459|17422306|P1|Overall Study|Subject decision|2
5053022|NCT02513459|17422306|P1|Overall Study|Pregnancy|2
5053023|NCT02513459|17422306|P1|Overall Study|Loss of efficacy|2
5053024|NCT02513459|17422306|P1|Overall Study|Withdrew consent|5
5053025|NCT02513459|17422306|P1|Overall Study|Adverse Event|7
5053026|NCT02513160|17422374|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5053027|NCT02513160|17422375|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5053028|NCT02513160|17422376|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
5053029|NCT02513160|17422377|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5053030|NCT02513160|17422374|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5053031|NCT02513160|17422375|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5053032|NCT02513160|17422376|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5053033|NCT02513160|17422377|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
5053034|NCT02513160|17422374|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5053035|NCT02513160|17422375|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5053036|NCT02513160|17422376|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5053037|NCT02513160|17422377|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
5053038|NCT02513160|17422374|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5053039|NCT02513160|17422375|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5053040|NCT02513160|17422376|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5053041|NCT02513160|17422377|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
5053042|NCT02513160|17422374|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
5053043|NCT02513160|17422375|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
5053044|NCT02513160|17422376|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
5053045|NCT02513160|17422377|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
5053046|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5053047|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5053048|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5053049|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
5053050|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5053051|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5053052|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5053053|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
5053054|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5053055|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5053056|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5053057|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
5053058|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5053059|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5053060|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5053061|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
5053062|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5053063|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5053064|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5053065|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
5053066|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5053067|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5053068|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5053069|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
5053070|NCT02513160|17422374|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5053071|NCT02513160|17422375|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5053072|NCT02513160|17422376|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5053073|NCT02513160|17422377|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
5053074|NCT02513095|17422435|P2|Overall Study|Stampede resulted in transfers out of ER|16
5053075|NCT02513095|17422436|P1|Overall Study|Stampede resulted in transfers out of ER|14
5053076|NCT02512861|17422487|P2|Overall Study|Withdrawal by Subject|1
5053077|NCT02512861|17422488|P1|Overall Study|Withdrawal by Subject|0
5053078|NCT02512861|17422487|P2|Overall Study|Physician Decision|1
5053079|NCT02512861|17422488|P1|Overall Study|Physician Decision|3
5053080|NCT02512861|17422487|P2|Overall Study|Protocol Violation|7
5053081|NCT02512861|17422488|P1|Overall Study|Protocol Violation|3
5053082|NCT02512302|17422766|P10|Period 4|Adverse Event|0
5053083|NCT02512302|17422767|P9|Period 4|Adverse Event|0
5053084|NCT02512302|17422768|P8|Period 4|Adverse Event|0
5053085|NCT02512302|17422769|P7|Period 4|Adverse Event|1
5053086|NCT02512302|17422770|P6|Period 4|Adverse Event|0
5053087|NCT02512302|17422771|P5|Period 4|Adverse Event|0
5053088|NCT02512302|17422772|P4|Period 4|Adverse Event|0
5053089|NCT02512302|17422773|P3|Period 4|Adverse Event|0
5053090|NCT02512302|17422774|P2|Period 4|Adverse Event|0
5053091|NCT02512302|17422775|P1|Period 4|Adverse Event|0
5053092|NCT02512302|17422766|P10|Period 3|Lost to Follow-up|0
5053093|NCT02512302|17422767|P9|Period 3|Lost to Follow-up|0
5053094|NCT02512302|17422768|P8|Period 3|Lost to Follow-up|0
5053095|NCT02512302|17422769|P7|Period 3|Lost to Follow-up|0
5053096|NCT02512302|17422770|P6|Period 3|Lost to Follow-up|0
5053097|NCT02512302|17422771|P5|Period 3|Lost to Follow-up|0
5053098|NCT02512302|17422772|P4|Period 3|Lost to Follow-up|0
5053099|NCT02512302|17422773|P3|Period 3|Lost to Follow-up|1
5053100|NCT02512302|17422774|P2|Period 3|Lost to Follow-up|0
5053101|NCT02512302|17422775|P1|Period 3|Lost to Follow-up|0
5053102|NCT02512302|17422766|P10|Period 2|Adverse Event|1
5053103|NCT02512302|17422767|P9|Period 2|Adverse Event|0
5053104|NCT02512302|17422768|P8|Period 2|Adverse Event|0
5053105|NCT02512302|17422769|P7|Period 2|Adverse Event|0
5053106|NCT02512302|17422770|P6|Period 2|Adverse Event|0
5053107|NCT02512302|17422771|P5|Period 2|Adverse Event|0
5053108|NCT02512302|17422772|P4|Period 2|Adverse Event|0
5053109|NCT02512302|17422773|P3|Period 2|Adverse Event|0
5053110|NCT02512302|17422774|P2|Period 2|Adverse Event|0
5053111|NCT02512302|17422775|P1|Period 2|Adverse Event|0
5053112|NCT02512302|17422766|P10|Period 1|Adverse Event|0
5053113|NCT02512302|17422767|P9|Period 1|Adverse Event|0
5053114|NCT02512302|17422768|P8|Period 1|Adverse Event|0
5053115|NCT02512302|17422769|P7|Period 1|Adverse Event|0
5053116|NCT02512302|17422770|P6|Period 1|Adverse Event|0
5053117|NCT02512302|17422771|P5|Period 1|Adverse Event|0
5053118|NCT02512302|17422772|P4|Period 1|Adverse Event|0
5053119|NCT02512302|17422773|P3|Period 1|Adverse Event|0
5053120|NCT02512302|17422774|P2|Period 1|Adverse Event|1
5053121|NCT02512302|17422775|P1|Period 1|Adverse Event|0
5053122|NCT02512068|17422891|P2|Overall Study|Reason Not Specified|5
5053123|NCT02512068|17422892|P1|Overall Study|Reason Not Specified|3
5053124|NCT02512068|17422891|P2|Overall Study|Lack of Efficacy|1
5053125|NCT02512068|17422892|P1|Overall Study|Lack of Efficacy|0
5053126|NCT02512068|17422891|P2|Overall Study|Voluntary Withdrawal|1
5053127|NCT02512068|17422892|P1|Overall Study|Voluntary Withdrawal|0
5053128|NCT02512068|17422891|P2|Overall Study|Major Protocol Deviation|0
5053129|NCT02512068|17422892|P1|Overall Study|Major Protocol Deviation|1
5053130|NCT02512068|17422891|P2|Overall Study|Pretreatment Event/Adverse Event|6
5053131|NCT02512068|17422892|P1|Overall Study|Pretreatment Event/Adverse Event|8
5053132|NCT02512042|17422918|P2|Overall Study|Other|11
5053133|NCT02512042|17422919|P1|Overall Study|Other|11
5053134|NCT02512042|17422918|P2|Overall Study|Lost to Follow-up|2
5053135|NCT02512042|17422919|P1|Overall Study|Lost to Follow-up|5
5053136|NCT02512042|17422918|P2|Overall Study|Non-compliance with study drug|2
5053137|NCT02512042|17422919|P1|Overall Study|Non-compliance with study drug|1
5053138|NCT02512042|17422918|P2|Overall Study|Withdrawal by Subject|6
5053139|NCT02512042|17422919|P1|Overall Study|Withdrawal by Subject|6
5053140|NCT02512042|17422918|P2|Overall Study|Adverse Event|4
5053141|NCT02512042|17422919|P1|Overall Study|Adverse Event|0
5053142|NCT02511782|17422928|P3|Overall Study|Withdrawal by Subject|0
5053143|NCT02511782|17422929|P2|Overall Study|Withdrawal by Subject|0
5053144|NCT02511782|17422930|P1|Overall Study|Withdrawal by Subject|1
5053145|NCT02511678|17422956|P1|Overall Study|Received Radiation Treatment|1
5053146|NCT02511678|17422956|P1|Overall Study|Protocol Violation|1
5053147|NCT02511678|17422956|P1|Overall Study|Biopsy was Negative|1
5053148|NCT02511678|17422956|P1|Overall Study|Required Radiofrequency Ablation|1
5053149|NCT02511678|17422956|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
5053150|NCT02511678|17422956|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
5053151|NCT02511678|17422956|P1|Overall Study|Adverse Event|1
5053152|NCT02511678|17422956|P1|Overall Study|Death|19
5053153|NCT02511678|17422956|P1|Overall Study|Lost to Follow-up|4
5053154|NCT02511678|17422956|P1|Overall Study|Withdrawal by Subject|2
5053155|NCT02511431|17423038|P6|Treatment|Lost to Follow-up|1
5053156|NCT02511431|17423039|P5|Treatment|Lost to Follow-up|0
5053157|NCT02511431|17423040|P4|Treatment|Lost to Follow-up|0
5053158|NCT02511431|17423041|P3|Treatment|Lost to Follow-up|1
5053159|NCT02511431|17423042|P2|Treatment|Lost to Follow-up|0
5053160|NCT02511431|17423043|P1|Treatment|Lost to Follow-up|0
5053161|NCT02511184|17423070|P2|Overall Study|Withdrawal by Subject|1
5053162|NCT02511184|17423071|P1|Overall Study|Withdrawal by Subject|0
5053163|NCT02511184|17423070|P2|Overall Study|Study terminated by sponsor|5
5053164|NCT02511184|17423071|P1|Overall Study|Study terminated by sponsor|1
5053165|NCT02511184|17423070|P2|Overall Study|Lost to Follow-up|1
5053166|NCT02511184|17423071|P1|Overall Study|Lost to Follow-up|0
5053167|NCT02511184|17423070|P2|Overall Study|Death|0
5053168|NCT02511184|17423071|P1|Overall Study|Death|1
5053169|NCT02510820|17423121|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5053170|NCT02510820|17423122|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5053171|NCT02510820|17423121|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
5053172|NCT02510820|17423122|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
5053173|NCT02510664|17423163|P3|Overall Study|Time Constraints|0
5053174|NCT02510664|17423164|P2|Overall Study|Time Constraints|1
5053175|NCT02510664|17423165|P1|Overall Study|Time Constraints|1
5053176|NCT02510664|17423163|P3|Overall Study|Provider Retired/No Time to Reschedule|0
5053177|NCT02510664|17423164|P2|Overall Study|Provider Retired/No Time to Reschedule|10
5053178|NCT02510664|17423165|P1|Overall Study|Provider Retired/No Time to Reschedule|10
5053179|NCT02510664|17423163|P3|Overall Study|Transferred Care|0
5053180|NCT02510664|17423164|P2|Overall Study|Transferred Care|9
5053181|NCT02510664|17423165|P1|Overall Study|Transferred Care|9
5053182|NCT02510014|17423207|P2|Treatment Period|Incarceration, pregnancy, misc|5
5053183|NCT02510014|17423208|P1|Treatment Period|Incarceration, pregnancy, misc|29
5053184|NCT02510014|17423207|P2|Treatment Period|Protocol Violation|4
5053185|NCT02510014|17423208|P1|Treatment Period|Protocol Violation|4
5053186|NCT02510014|17423207|P2|Treatment Period|Withdrawn by the investigator|1
5053187|NCT02510014|17423208|P1|Treatment Period|Withdrawn by the investigator|7
5053188|NCT02510014|17423207|P2|Treatment Period|Withdrawal by Subject|24
5053189|NCT02510014|17423208|P1|Treatment Period|Withdrawal by Subject|67
5053190|NCT02510014|17423207|P2|Treatment Period|Physician Decision|0
5053191|NCT02510014|17423208|P1|Treatment Period|Physician Decision|5
5053192|NCT02510014|17423207|P2|Treatment Period|Lost to Follow-up|19
5053193|NCT02510014|17423208|P1|Treatment Period|Lost to Follow-up|80
5053194|NCT02510014|17423207|P2|Treatment Period|Withdrawal symptoms|0
5053195|NCT02510014|17423208|P1|Treatment Period|Withdrawal symptoms|3
5053196|NCT02510014|17423207|P2|Treatment Period|Adverse Event|4
5053197|NCT02510014|17423208|P1|Treatment Period|Adverse Event|11
5053198|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Other|1
5053199|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Other|19
5053200|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
5053201|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
5053202|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
5053203|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
5053204|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
5053205|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
5053206|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
5053207|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
5053208|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
5053209|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
5053210|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
5053211|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
5053212|NCT02510014|17423207|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
5053213|NCT02510014|17423208|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
5053214|NCT02509156|17423303|P2|Randomized Phase|Withdrawal by Subject|1
5053215|NCT02509156|17423304|P1|Randomized Phase|Withdrawal by Subject|1
5053216|NCT02509156|17423303|P2|Randomized Phase|Death|0
5053217|NCT02509156|17423304|P1|Randomized Phase|Death|1
5053218|NCT02509117|17423374|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
5053219|NCT02509117|17423375|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053220|NCT02509117|17423376|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053221|NCT02509117|17423377|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053222|NCT02509117|17423378|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053223|NCT02509117|17423379|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053224|NCT02509117|17423380|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053225|NCT02509117|17423381|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053226|NCT02509117|17423382|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053227|NCT02509117|17423383|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5053228|NCT02509117|17423374|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
5053229|NCT02509117|17423375|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053230|NCT02509117|17423376|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053231|NCT02509117|17423377|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053232|NCT02509117|17423378|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053233|NCT02509117|17423379|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053234|NCT02509117|17423380|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053235|NCT02509117|17423381|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053236|NCT02509117|17423382|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053237|NCT02509117|17423383|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5053238|NCT02509117|17423374|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053239|NCT02509117|17423375|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053240|NCT02509117|17423376|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053241|NCT02509117|17423377|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053242|NCT02509117|17423378|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053243|NCT02509117|17423379|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053244|NCT02509117|17423380|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053245|NCT02509117|17423381|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053246|NCT02509117|17423382|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
5053247|NCT02509117|17423383|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5053248|NCT02509078|17423594|P2|Overall Study|Protocol Violation|1
5053249|NCT02509078|17423595|P1|Overall Study|Protocol Violation|1
5053250|NCT02509026|17423738|P1|Retreatment Period (12 Weeks)|Enrolled but not treated|1
5053251|NCT02509026|17423738|P1|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
5053252|NCT02509026|17423738|P1|Retreatment Period (12 Weeks)|Lost to Follow-up|1
5053253|NCT02509026|17423738|P1|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
5053254|NCT02509026|17423738|P1|Withdrawal Period (40 Weeks)|Protocol Violation|2
5053255|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Enrolled but not treated|1
5053256|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Withdrawal by Subject|1
5053257|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Protocol Violation|1
5053258|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Other|2
5053259|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Lost to Follow-up|1
5053260|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Lack of Efficacy|6
5053261|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Eligibility Criteria|5
5053262|NCT02509026|17423738|P1|Induction Period (24 Weeks)|Adverse Event|5
5053263|NCT02508935|17423935|P1|Overall Study|Trial terminated by sponsor|5
5053264|NCT02508935|17423935|P1|Overall Study|Physician Decision|1
5053265|NCT02508935|17423935|P1|Overall Study|Protocol Violation|1
5053266|NCT02508935|17423935|P1|Overall Study|Adverse Event|3
5053267|NCT02508935|17423935|P1|Overall Study|Emesis|3
5053268|NCT02508935|17423935|P1|Overall Study|Pain Score <4|1
5053269|NCT02508935|17423935|P1|Overall Study|Withdrawal by Caregiver|8
5053270|NCT02508935|17423935|P1|Overall Study|Withdrawal by Subject|1
5053271|NCT02508701|17423951|P4|Overall Study|Lost to Follow-up|3
5053272|NCT02508701|17423952|P3|Overall Study|Lost to Follow-up|5
5053273|NCT02508701|17423953|P2|Overall Study|Lost to Follow-up|5
5053274|NCT02508701|17423954|P1|Overall Study|Lost to Follow-up|9
5053275|NCT02508194|17424039|P2|Overall Study|Principal Investigator Decision|2
5053276|NCT02508194|17424040|P1|Overall Study|Principal Investigator Decision|1
5053277|NCT02508194|17424039|P2|Overall Study|Error in Randomization|3
5053278|NCT02508194|17424040|P1|Overall Study|Error in Randomization|1
5053279|NCT02508194|17424039|P2|Overall Study|Withdrawal by Subject|18
5053280|NCT02508194|17424040|P1|Overall Study|Withdrawal by Subject|20
5053281|NCT02508194|17424039|P2|Overall Study|Lost to Follow-up|18
5053282|NCT02508194|17424040|P1|Overall Study|Lost to Follow-up|25
5053283|NCT02508194|17424039|P2|Overall Study|Death|3
5053284|NCT02508194|17424040|P1|Overall Study|Death|5
5053285|NCT02508116|17424080|P2|Overall Study|Physician Decision|0
5053286|NCT02508116|17424081|P1|Overall Study|Physician Decision|2
5053287|NCT02508116|17424080|P2|Overall Study|Protocol Violation|2
5053288|NCT02508116|17424081|P1|Overall Study|Protocol Violation|1
5053289|NCT02508116|17424080|P2|Overall Study|Withdrawal by Subject|2
5053290|NCT02508116|17424081|P1|Overall Study|Withdrawal by Subject|3
5053291|NCT02508116|17424080|P2|Overall Study|Lost to Follow-up|3
5053292|NCT02508116|17424081|P1|Overall Study|Lost to Follow-up|2
5053293|NCT02507973|17424108|P1|Overall Study|Adverse Event|1
5053294|NCT02507752|17424114|P1|Overall Study|Participant didn't perform visit Week 24|1
5053295|NCT02507752|17424114|P1|Overall Study|Participant didn't perform visit Week 12|1
5053296|NCT02507752|17424114|P1|Overall Study|Infusion reaction at first infusion|1
5053297|NCT02507752|17424114|P1|Overall Study|Lost to Follow-up|7
5053298|NCT02507752|17424114|P1|Overall Study|Protocol Violation|6
5053299|NCT02507752|17424114|P1|Overall Study|Adverse Event|1
5053300|NCT02507375|17424158|P2|Overall Study|Adverse Event|1
5053301|NCT02507375|17424159|P1|Overall Study|Adverse Event|0
5053302|NCT02507375|17424158|P2|Overall Study|Refused treatment|1
5053303|NCT02507375|17424159|P1|Overall Study|Refused treatment|0
5053304|NCT02507375|17424158|P2|Overall Study|Death|1
5053305|NCT02507375|17424159|P1|Overall Study|Death|0
5053306|NCT02507375|17424158|P2|Overall Study|Progressive Disease|5
5053307|NCT02507375|17424159|P1|Overall Study|Progressive Disease|4
5053308|NCT02507349|17424178|P2|Overall Study|Lost to Follow-up|144
5053309|NCT02507349|17424179|P1|Overall Study|Lost to Follow-up|174
5053310|NCT02507349|17424178|P2|Overall Study|Withdrawal by Subject|1
5053311|NCT02507349|17424179|P1|Overall Study|Withdrawal by Subject|1
5053312|NCT02507349|17424178|P2|Overall Study|Death|16
5053313|NCT02507349|17424179|P1|Overall Study|Death|12
5053314|NCT02507219|17424203|P6|Overall Study|Withdrawal by Subject|0
5053315|NCT02507219|17424204|P5|Overall Study|Withdrawal by Subject|1
5053316|NCT02507219|17424205|P4|Overall Study|Withdrawal by Subject|0
5053317|NCT02507219|17424206|P3|Overall Study|Withdrawal by Subject|0
5053318|NCT02507219|17424207|P2|Overall Study|Withdrawal by Subject|0
5053319|NCT02507219|17424208|P1|Overall Study|Withdrawal by Subject|0
5053320|NCT02507219|17424203|P6|Overall Study|Physician Decision|0
5053321|NCT02507219|17424204|P5|Overall Study|Physician Decision|0
5053322|NCT02507219|17424205|P4|Overall Study|Physician Decision|0
5053323|NCT02507219|17424206|P3|Overall Study|Physician Decision|0
5053324|NCT02507219|17424207|P2|Overall Study|Physician Decision|0
5053325|NCT02507219|17424208|P1|Overall Study|Physician Decision|1
5053326|NCT02506881|17424244|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
5053327|NCT02506881|17424245|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
5053328|NCT02506881|17424246|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
5053329|NCT02506881|17424247|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
5053330|NCT02506881|17424244|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5053331|NCT02506881|17424245|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5053332|NCT02506881|17424246|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5053333|NCT02506881|17424247|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5053334|NCT02506881|17424244|P4|First Intervention (Day 1)|Protocol Violation|0
5053335|NCT02506881|17424245|P3|First Intervention (Day 1)|Protocol Violation|1
5053336|NCT02506881|17424246|P2|First Intervention (Day 1)|Protocol Violation|0
5053337|NCT02506881|17424247|P1|First Intervention (Day 1)|Protocol Violation|0
5053338|NCT02506816|17424320|P1|Overall Study|Adverse Event|3
5053339|NCT02506257|17424446|P4|Overall Study|Protocol Violation|0
5053340|NCT02506257|17424447|P3|Overall Study|Protocol Violation|1
5053341|NCT02506257|17424448|P2|Overall Study|Protocol Violation|0
5053342|NCT02506257|17424449|P1|Overall Study|Protocol Violation|0
5053343|NCT02506257|17424446|P4|Overall Study|Adverse Event|0
5053344|NCT02506257|17424447|P3|Overall Study|Adverse Event|3
5053345|NCT02506257|17424448|P2|Overall Study|Adverse Event|2
5053346|NCT02506257|17424449|P1|Overall Study|Adverse Event|0
5053347|NCT02506101|17424481|P2|Overall Study|No enrollment and staff unavailability|0
5053348|NCT02506101|17424482|P1|Overall Study|No enrollment and staff unavailability|1
5053349|NCT02506101|17424481|P2|Overall Study|Transportation issues|0
5053350|NCT02506101|17424482|P1|Overall Study|Transportation issues|1
5053351|NCT02506036|17424498|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
5053352|NCT02506036|17424499|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
5053353|NCT02506036|17424498|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
5053354|NCT02506036|17424499|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
5053355|NCT02506036|17424498|P2|First Intervention (4-6 Weeks)|Death|0
5053356|NCT02506036|17424499|P1|First Intervention (4-6 Weeks)|Death|1
5053357|NCT02505945|17424507|P2|Overall Study|Lost to Follow-up|1
5053358|NCT02505945|17424508|P1|Overall Study|Lost to Follow-up|6
5053359|NCT02505945|17424507|P2|Overall Study|Physician Decision|1
5053360|NCT02505945|17424508|P1|Overall Study|Physician Decision|2
5053361|NCT02505945|17424507|P2|Overall Study|Adverse Event|0
5053362|NCT02505945|17424508|P1|Overall Study|Adverse Event|1
5053363|NCT02505945|17424507|P2|Overall Study|Withdrawal by Subject|2
5053364|NCT02505945|17424508|P1|Overall Study|Withdrawal by Subject|13
5053365|NCT02505867|17424529|P2|Overall Study|Lack of Efficacy|6
5053366|NCT02505867|17424530|P1|Overall Study|Lack of Efficacy|6
5053367|NCT02505542|17424536|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
5053368|NCT02505542|17424537|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
5053369|NCT02505542|17424538|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
5053370|NCT02505542|17424539|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
5053371|NCT02505542|17424536|P4|Part B: Double-Blind Period|Miscalculation|0
5053372|NCT02505542|17424537|P3|Part B: Double-Blind Period|Miscalculation|0
5053373|NCT02505542|17424538|P2|Part B: Double-Blind Period|Miscalculation|1
5053374|NCT02505542|17424539|P1|Part B: Double-Blind Period|Miscalculation|0
5053375|NCT02505542|17424536|P4|Part B: Double-Blind Period|Lack of Efficacy|0
5053376|NCT02505542|17424537|P3|Part B: Double-Blind Period|Lack of Efficacy|0
5053377|NCT02505542|17424538|P2|Part B: Double-Blind Period|Lack of Efficacy|1
5053378|NCT02505542|17424539|P1|Part B: Double-Blind Period|Lack of Efficacy|0
5053379|NCT02505542|17424536|P4|Part B: Double-Blind Period|Patient was moved from the country|1
5053380|NCT02505542|17424537|P3|Part B: Double-Blind Period|Patient was moved from the country|0
5053381|NCT02505542|17424538|P2|Part B: Double-Blind Period|Patient was moved from the country|0
5053382|NCT02505542|17424539|P1|Part B: Double-Blind Period|Patient was moved from the country|0
5053383|NCT02505542|17424536|P4|Part B: Double-Blind Period|Week 94 missed|0
5053384|NCT02505542|17424537|P3|Part B: Double-Blind Period|Week 94 missed|1
5053385|NCT02505542|17424538|P2|Part B: Double-Blind Period|Week 94 missed|0
5053386|NCT02505542|17424539|P1|Part B: Double-Blind Period|Week 94 missed|0
5053387|NCT02505542|17424536|P4|Part B: Double-Blind Period|Planning pregnancy|0
5053388|NCT02505542|17424537|P3|Part B: Double-Blind Period|Planning pregnancy|0
5053389|NCT02505542|17424538|P2|Part B: Double-Blind Period|Planning pregnancy|1
5053390|NCT02505542|17424539|P1|Part B: Double-Blind Period|Planning pregnancy|0
5053391|NCT02505542|17424536|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
5053392|NCT02505542|17424537|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
5053393|NCT02505542|17424538|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
5053394|NCT02505542|17424539|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
5053395|NCT02505542|17424536|P4|Part B: Double-Blind Period|Lost to Follow-up|1
5053396|NCT02505542|17424537|P3|Part B: Double-Blind Period|Lost to Follow-up|0
5053397|NCT02505542|17424538|P2|Part B: Double-Blind Period|Lost to Follow-up|0
5053398|NCT02505542|17424539|P1|Part B: Double-Blind Period|Lost to Follow-up|0
5053399|NCT02505542|17424536|P4|Part B: Double-Blind Period|Adverse Event|3
5053400|NCT02505542|17424537|P3|Part B: Double-Blind Period|Adverse Event|1
5053401|NCT02505542|17424538|P2|Part B: Double-Blind Period|Adverse Event|0
5053402|NCT02505542|17424539|P1|Part B: Double-Blind Period|Adverse Event|0
5053403|NCT02505542|17424536|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5053404|NCT02505542|17424537|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5053405|NCT02505542|17424538|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5053406|NCT02505542|17424539|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
5053407|NCT02505542|17424536|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5053408|NCT02505542|17424537|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5053409|NCT02505542|17424538|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5053410|NCT02505542|17424539|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
5053411|NCT02505542|17424536|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5053412|NCT02505542|17424537|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5053413|NCT02505542|17424538|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5053414|NCT02505542|17424539|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
5053415|NCT02505542|17424536|P4|Part A: Open-Label Period|Non-compliance|0
5053416|NCT02505542|17424537|P3|Part A: Open-Label Period|Non-compliance|0
5053417|NCT02505542|17424538|P2|Part A: Open-Label Period|Non-compliance|0
5053418|NCT02505542|17424539|P1|Part A: Open-Label Period|Non-compliance|1
5053419|NCT02505542|17424536|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
5053420|NCT02505542|17424537|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
5053421|NCT02505542|17424538|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
5053422|NCT02505542|17424539|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
5053423|NCT02505542|17424536|P4|Part A: Open-Label Period|Medical monitor decision|0
5053424|NCT02505542|17424537|P3|Part A: Open-Label Period|Medical monitor decision|0
5053425|NCT02505542|17424538|P2|Part A: Open-Label Period|Medical monitor decision|0
5053426|NCT02505542|17424539|P1|Part A: Open-Label Period|Medical monitor decision|1
5053427|NCT02505542|17424536|P4|Part A: Open-Label Period|Sponsor directive|0
5053428|NCT02505542|17424537|P3|Part A: Open-Label Period|Sponsor directive|0
5053429|NCT02505542|17424538|P2|Part A: Open-Label Period|Sponsor directive|0
5053430|NCT02505542|17424539|P1|Part A: Open-Label Period|Sponsor directive|1
5053431|NCT02505542|17424536|P4|Part A: Open-Label Period|Pregnancy|0
5053432|NCT02505542|17424537|P3|Part A: Open-Label Period|Pregnancy|0
5053433|NCT02505542|17424538|P2|Part A: Open-Label Period|Pregnancy|0
5053434|NCT02505542|17424539|P1|Part A: Open-Label Period|Pregnancy|2
5053435|NCT02505542|17424536|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5053436|NCT02505542|17424537|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5053437|NCT02505542|17424538|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5053438|NCT02505542|17424539|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
5053439|NCT02505542|17424536|P4|Part A: Open-Label Period|New medical history available|0
5053440|NCT02505542|17424537|P3|Part A: Open-Label Period|New medical history available|0
5053441|NCT02505542|17424538|P2|Part A: Open-Label Period|New medical history available|0
5053442|NCT02505542|17424539|P1|Part A: Open-Label Period|New medical history available|1
5053443|NCT02505542|17424536|P4|Part A: Open-Label Period|Withdrawal by Subject|0
5053444|NCT02505542|17424537|P3|Part A: Open-Label Period|Withdrawal by Subject|0
5053445|NCT02505542|17424538|P2|Part A: Open-Label Period|Withdrawal by Subject|0
5053446|NCT02505542|17424539|P1|Part A: Open-Label Period|Withdrawal by Subject|27
5053447|NCT02505542|17424536|P4|Part A: Open-Label Period|Lost to Follow-up|0
5053448|NCT02505542|17424537|P3|Part A: Open-Label Period|Lost to Follow-up|0
5053449|NCT02505542|17424538|P2|Part A: Open-Label Period|Lost to Follow-up|0
5053450|NCT02505542|17424539|P1|Part A: Open-Label Period|Lost to Follow-up|5
5053451|NCT02505542|17424536|P4|Part A: Open-Label Period|Protocol Violation|0
5053452|NCT02505542|17424537|P3|Part A: Open-Label Period|Protocol Violation|0
5053453|NCT02505542|17424538|P2|Part A: Open-Label Period|Protocol Violation|0
5053454|NCT02505542|17424539|P1|Part A: Open-Label Period|Protocol Violation|1
5053455|NCT02505542|17424536|P4|Part A: Open-Label Period|Lack of Efficacy|0
5053456|NCT02505542|17424537|P3|Part A: Open-Label Period|Lack of Efficacy|0
5053457|NCT02505542|17424538|P2|Part A: Open-Label Period|Lack of Efficacy|0
5053458|NCT02505542|17424539|P1|Part A: Open-Label Period|Lack of Efficacy|5
5053459|NCT02505542|17424536|P4|Part A: Open-Label Period|Adverse Event|0
5053460|NCT02505542|17424537|P3|Part A: Open-Label Period|Adverse Event|0
5053461|NCT02505542|17424538|P2|Part A: Open-Label Period|Adverse Event|0
5053462|NCT02505542|17424539|P1|Part A: Open-Label Period|Adverse Event|31
5053463|NCT02505334|17424647|P2|Extension Treatment Period|Unclassified|0
5053464|NCT02505334|17424648|P1|Extension Treatment Period|Unclassified|3
5053465|NCT02505334|17424647|P2|Extension Treatment Period|Withdrawal by Subject|0
5053466|NCT02505334|17424648|P1|Extension Treatment Period|Withdrawal by Subject|6
5053467|NCT02505334|17424647|P2|Extension Treatment Period|Lack of Efficacy|0
5053468|NCT02505334|17424648|P1|Extension Treatment Period|Lack of Efficacy|4
5053469|NCT02505334|17424647|P2|Extension Treatment Period|Adverse Event|0
5053470|NCT02505334|17424648|P1|Extension Treatment Period|Adverse Event|5
5053471|NCT02505334|17424647|P2|Main Treatment Period|Unclassified|10
5053472|NCT02505334|17424648|P1|Main Treatment Period|Unclassified|4
5053473|NCT02505334|17424647|P2|Main Treatment Period|Withdrawal by Subject|8
5053474|NCT02505334|17424648|P1|Main Treatment Period|Withdrawal by Subject|1
5053475|NCT02505334|17424647|P2|Main Treatment Period|Protocol Violation|1
5053476|NCT02505334|17424648|P1|Main Treatment Period|Protocol Violation|0
5053477|NCT02505334|17424647|P2|Main Treatment Period|Lack of Efficacy|17
5053478|NCT02505334|17424648|P1|Main Treatment Period|Lack of Efficacy|7
5053479|NCT02505334|17424647|P2|Main Treatment Period|Adverse Event|3
5053480|NCT02505334|17424648|P1|Main Treatment Period|Adverse Event|3
5053481|NCT02505217|17424781|P2|Overall Study|Withdrawal by Subject|2
5053482|NCT02505217|17424782|P1|Overall Study|Withdrawal by Subject|1
5053483|NCT02504892|17424801|P1|Overall Study|Adverse event-pneumonitis|2
5053484|NCT02504827|17424808|P1|Overall Study|Could not produce sputum|1
5053485|NCT02504671|17424847|P6|Overall Study|Protocol defined stopping criteria|3
5053486|NCT02504671|17424848|P5|Overall Study|Protocol defined stopping criteria|3
5053487|NCT02504671|17424849|P4|Overall Study|Protocol defined stopping criteria|5
5053488|NCT02504671|17424850|P3|Overall Study|Protocol defined stopping criteria|3
5053489|NCT02504671|17424851|P2|Overall Study|Protocol defined stopping criteria|4
5053490|NCT02504671|17424852|P1|Overall Study|Protocol defined stopping criteria|7
5053491|NCT02504671|17424847|P6|Overall Study|Lost to Follow-up|1
5053492|NCT02504671|17424848|P5|Overall Study|Lost to Follow-up|0
5053493|NCT02504671|17424849|P4|Overall Study|Lost to Follow-up|0
5053494|NCT02504671|17424850|P3|Overall Study|Lost to Follow-up|2
5053495|NCT02504671|17424851|P2|Overall Study|Lost to Follow-up|0
5053496|NCT02504671|17424852|P1|Overall Study|Lost to Follow-up|0
5053497|NCT02504671|17424847|P6|Overall Study|Protocol Violation|1
5053498|NCT02504671|17424848|P5|Overall Study|Protocol Violation|0
5053499|NCT02504671|17424849|P4|Overall Study|Protocol Violation|0
5053500|NCT02504671|17424850|P3|Overall Study|Protocol Violation|0
5053501|NCT02504671|17424851|P2|Overall Study|Protocol Violation|1
5053502|NCT02504671|17424852|P1|Overall Study|Protocol Violation|2
5053503|NCT02504671|17424847|P6|Overall Study|Adverse Event|2
5053504|NCT02504671|17424848|P5|Overall Study|Adverse Event|0
5053505|NCT02504671|17424849|P4|Overall Study|Adverse Event|1
5053506|NCT02504671|17424850|P3|Overall Study|Adverse Event|0
5053507|NCT02504671|17424851|P2|Overall Study|Adverse Event|1
5053508|NCT02504671|17424852|P1|Overall Study|Adverse Event|1
5053509|NCT02504671|17424847|P6|Overall Study|Lack of Efficacy|4
5053510|NCT02504671|17424848|P5|Overall Study|Lack of Efficacy|4
5053511|NCT02504671|17424849|P4|Overall Study|Lack of Efficacy|0
5053512|NCT02504671|17424850|P3|Overall Study|Lack of Efficacy|1
5053513|NCT02504671|17424851|P2|Overall Study|Lack of Efficacy|3
5053514|NCT02504671|17424852|P1|Overall Study|Lack of Efficacy|1
5053515|NCT02504671|17424847|P6|Overall Study|Withdrawal by Subject|3
5053516|NCT02504671|17424848|P5|Overall Study|Withdrawal by Subject|5
5053517|NCT02504671|17424849|P4|Overall Study|Withdrawal by Subject|4
5053518|NCT02504671|17424850|P3|Overall Study|Withdrawal by Subject|4
5053519|NCT02504671|17424851|P2|Overall Study|Withdrawal by Subject|5
5053520|NCT02504671|17424852|P1|Overall Study|Withdrawal by Subject|1
5053521|NCT02504541|17425024|P1|Overall Study|Multiple|5
5053522|NCT02504541|17425024|P1|Overall Study|Other|2
5053523|NCT02504541|17425024|P1|Overall Study|Termination by Sponsor|1
5053524|NCT02504541|17425024|P1|Overall Study|Protocol Violation|2
5053525|NCT02504541|17425024|P1|Overall Study|Met Stopping Criteria|1
5053526|NCT02504541|17425024|P1|Overall Study|Lost to Follow-up|1
5053527|NCT02504541|17425024|P1|Overall Study|Withdrawal by Subject|4
5053528|NCT02504541|17425024|P1|Overall Study|Adverse Event|4
5053529|NCT02504502|17425030|P2|Crossover to Enhanced Report|Lost to Follow-up|0
5053530|NCT02504502|17425031|P1|Crossover to Enhanced Report|Lost to Follow-up|5
5053531|NCT02504502|17425030|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
5053532|NCT02504502|17425031|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
5053533|NCT02504424|17425037|P1|Overall Study|Withdrawal by Subject|2
5053534|NCT02504320|17425046|P4|Treatment Period 3|Adverse Event|0
5053535|NCT02504320|17425047|P3|Treatment Period 3|Adverse Event|1
5053536|NCT02504320|17425048|P2|Treatment Period 3|Adverse Event|0
5053537|NCT02504320|17425049|P1|Treatment Period 3|Adverse Event|0
5053538|NCT02504320|17425046|P4|Treatment Period 3|Positive Drug Screen|1
5053539|NCT02504320|17425047|P3|Treatment Period 3|Positive Drug Screen|0
5053540|NCT02504320|17425048|P2|Treatment Period 3|Positive Drug Screen|0
5053541|NCT02504320|17425049|P1|Treatment Period 3|Positive Drug Screen|0
5053542|NCT02504320|17425046|P4|Treatment Period 2|Positive Drug Screen|0
5053543|NCT02504320|17425047|P3|Treatment Period 2|Positive Drug Screen|0
5053544|NCT02504320|17425048|P2|Treatment Period 2|Positive Drug Screen|1
5053545|NCT02504320|17425049|P1|Treatment Period 2|Positive Drug Screen|0
5053546|NCT02504320|17425046|P4|Treatment Period 1|Positive Drug Screen|0
5053547|NCT02504320|17425047|P3|Treatment Period 1|Positive Drug Screen|1
5053548|NCT02504320|17425048|P2|Treatment Period 1|Positive Drug Screen|0
5053549|NCT02504320|17425049|P1|Treatment Period 1|Positive Drug Screen|0
5053550|NCT02504294|17425069|P2|Overall Study|Lost to Follow-up|7
5053551|NCT02504294|17425070|P1|Overall Study|Lost to Follow-up|6
5053552|NCT02504294|17425069|P2|Overall Study|Physician Decision|2
5053553|NCT02504294|17425070|P1|Overall Study|Physician Decision|1
5053554|NCT02504294|17425069|P2|Overall Study|Protocol Violation|26
5053555|NCT02504294|17425070|P1|Overall Study|Protocol Violation|27
5053556|NCT02504294|17425069|P2|Overall Study|Withdrawal by Subject|1
5053557|NCT02504294|17425070|P1|Overall Study|Withdrawal by Subject|7
5053558|NCT02504294|17425069|P2|Overall Study|Adverse Event|12
5053559|NCT02504294|17425070|P1|Overall Study|Adverse Event|15
5053560|NCT02504268|17425080|P2|Overall Study|Not Disclosed|0
5053561|NCT02504268|17425081|P1|Overall Study|Not Disclosed|1
5053562|NCT02504268|17425080|P2|Overall Study|Poor/Non-Compliance|2
5053563|NCT02504268|17425081|P1|Overall Study|Poor/Non-Compliance|3
5053564|NCT02504268|17425080|P2|Overall Study|Lack of Efficacy|35
5053565|NCT02504268|17425081|P1|Overall Study|Lack of Efficacy|11
5053566|NCT02504268|17425080|P2|Overall Study|No Longer Meets Study Criteria|3
5053567|NCT02504268|17425081|P1|Overall Study|No Longer Meets Study Criteria|2
5053568|NCT02504268|17425080|P2|Overall Study|Subject Request to Discontinue|3
5053569|NCT02504268|17425081|P1|Overall Study|Subject Request to Discontinue|11
5053570|NCT02504268|17425080|P2|Overall Study|Death|1
5053571|NCT02504268|17425081|P1|Overall Study|Death|1
5053572|NCT02504268|17425080|P2|Overall Study|Lost to Follow-up|6
5053573|NCT02504268|17425081|P1|Overall Study|Lost to Follow-up|3
5053574|NCT02504268|17425080|P2|Overall Study|Pregnancy|0
5053575|NCT02504268|17425081|P1|Overall Study|Pregnancy|2
5053576|NCT02504268|17425080|P2|Overall Study|Withdrawal of Consent|10
5053577|NCT02504268|17425081|P1|Overall Study|Withdrawal of Consent|11
5053578|NCT02504268|17425080|P2|Overall Study|Adverse Event|8
5053579|NCT02504268|17425081|P1|Overall Study|Adverse Event|18
5053580|NCT02503865|17425116|P3|Overall Study|Refused treatment|2
5053581|NCT02503865|17425117|P2|Overall Study|Refused treatment|39
5053582|NCT02503865|17425118|P1|Overall Study|Refused treatment|4
5053583|NCT02503865|17425116|P3|Overall Study|Moved out of area|0
5053584|NCT02503865|17425117|P2|Overall Study|Moved out of area|8
5053585|NCT02503865|17425118|P1|Overall Study|Moved out of area|1
5053586|NCT02503787|17425163|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
5053587|NCT02503787|17425163|P1|Implant to 3 Month Endpoint|Adverse Event|2
5053588|NCT02503787|17425163|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
5053589|NCT02503787|17425163|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
5053590|NCT02503787|17425163|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
5053591|NCT02503787|17425163|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
5053592|NCT02503787|17425163|P1|Enrollment|Unable to be programmed|1
5053593|NCT02503787|17425163|P1|Enrollment|Inability to implant system|1
5053594|NCT02503787|17425163|P1|Enrollment|Protocol Violation|1
5053595|NCT02503787|17425163|P1|Enrollment|Adverse Event|1
5053596|NCT02503787|17425163|P1|Enrollment|Study closure|1
5053597|NCT02503787|17425163|P1|Enrollment|Lost to Follow-up|1
5053598|NCT02503787|17425163|P1|Enrollment|Insurance issue|2
5053599|NCT02503787|17425163|P1|Enrollment|Physician Decision|2
5053600|NCT02503787|17425163|P1|Enrollment|Inclusion/exclusion criteria not met|4
5053601|NCT02503787|17425163|P1|Enrollment|Withdrawal by Subject|6
5053602|NCT02503540|17425180|P1|Overall Study|Withdrawal by Subject|1
5053603|NCT02503540|17425180|P1|Overall Study|Death|2
5053604|NCT02503501|17425201|P2|Overall Study|Withdrawal by Subject|2
5053605|NCT02503501|17425202|P1|Overall Study|Withdrawal by Subject|0
5053606|NCT02503501|17425201|P2|Overall Study|Protocol Violation|1
5053607|NCT02503501|17425202|P1|Overall Study|Protocol Violation|0
5053608|NCT02503501|17425201|P2|Overall Study|Physician Decision|0
5053609|NCT02503501|17425202|P1|Overall Study|Physician Decision|1
5053610|NCT02503332|17425238|P4|Overall Study|Other|1
5053611|NCT02503332|17425239|P3|Overall Study|Other|1
5053612|NCT02503332|17425240|P2|Overall Study|Other|6
5053613|NCT02503332|17425241|P1|Overall Study|Other|5
5053614|NCT02503332|17425238|P4|Overall Study|Death|0
5053615|NCT02503332|17425239|P3|Overall Study|Death|2
5053616|NCT02503332|17425240|P2|Overall Study|Death|2
5053617|NCT02503332|17425241|P1|Overall Study|Death|0
5053618|NCT02503332|17425238|P4|Overall Study|Subject Request|1
5053619|NCT02503332|17425239|P3|Overall Study|Subject Request|2
5053620|NCT02503332|17425240|P2|Overall Study|Subject Request|5
5053621|NCT02503332|17425241|P1|Overall Study|Subject Request|6
5053622|NCT02503332|17425238|P4|Overall Study|Sponsor's Decision|1
5053623|NCT02503332|17425239|P3|Overall Study|Sponsor's Decision|0
5053624|NCT02503332|17425240|P2|Overall Study|Sponsor's Decision|0
5053625|NCT02503332|17425241|P1|Overall Study|Sponsor's Decision|1
5053626|NCT02503332|17425238|P4|Overall Study|Investigator's Decision|0
5053627|NCT02503332|17425239|P3|Overall Study|Investigator's Decision|0
5053628|NCT02503332|17425240|P2|Overall Study|Investigator's Decision|1
5053629|NCT02503332|17425241|P1|Overall Study|Investigator's Decision|5
5053630|NCT02503332|17425238|P4|Overall Study|Adverse Event|1
5053631|NCT02503332|17425239|P3|Overall Study|Adverse Event|3
5053632|NCT02503332|17425240|P2|Overall Study|Adverse Event|5
5053633|NCT02503332|17425241|P1|Overall Study|Adverse Event|17
5053634|NCT02503215|17425292|P1|Overall Study|Unable to use positive airway pressure|2
5053635|NCT02503215|17425292|P1|Overall Study|Unable to wear compression stockings|1
5053636|NCT02503202|17425303|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
5053637|NCT02503202|17425304|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
5053638|NCT02503202|17425305|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
5053639|NCT02503202|17425306|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
5053640|NCT02503202|17425307|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
5053641|NCT02503202|17425303|P5|Extension: Month 6 to 24|Physician Decision|0
5053642|NCT02503202|17425304|P4|Extension: Month 6 to 24|Physician Decision|3
5053643|NCT02503202|17425305|P3|Extension: Month 6 to 24|Physician Decision|1
5053644|NCT02503202|17425306|P2|Extension: Month 6 to 24|Physician Decision|0
5053645|NCT02503202|17425307|P1|Extension: Month 6 to 24|Physician Decision|1
5053646|NCT02503202|17425303|P5|Extension: Month 6 to 24|Lost to Follow-up|1
5053647|NCT02503202|17425304|P4|Extension: Month 6 to 24|Lost to Follow-up|10
5053648|NCT02503202|17425305|P3|Extension: Month 6 to 24|Lost to Follow-up|6
5053649|NCT02503202|17425306|P2|Extension: Month 6 to 24|Lost to Follow-up|8
5053650|NCT02503202|17425307|P1|Extension: Month 6 to 24|Lost to Follow-up|4
5053651|NCT02503202|17425303|P5|Extension: Month 6 to 24|Death|0
5053652|NCT02503202|17425304|P4|Extension: Month 6 to 24|Death|0
5053653|NCT02503202|17425305|P3|Extension: Month 6 to 24|Death|0
5053654|NCT02503202|17425306|P2|Extension: Month 6 to 24|Death|0
5053655|NCT02503202|17425307|P1|Extension: Month 6 to 24|Death|1
5053656|NCT02503202|17425303|P5|Extension: Month 6 to 24|Protocol Violation|0
5053657|NCT02503202|17425304|P4|Extension: Month 6 to 24|Protocol Violation|1
5053658|NCT02503202|17425305|P3|Extension: Month 6 to 24|Protocol Violation|0
5053659|NCT02503202|17425306|P2|Extension: Month 6 to 24|Protocol Violation|0
5053660|NCT02503202|17425307|P1|Extension: Month 6 to 24|Protocol Violation|0
5053661|NCT02503202|17425303|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
5053662|NCT02503202|17425304|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
5053663|NCT02503202|17425305|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
5053664|NCT02503202|17425306|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
5053665|NCT02503202|17425307|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
5053666|NCT02503202|17425303|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
5053667|NCT02503202|17425304|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
5053668|NCT02503202|17425305|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
5053669|NCT02503202|17425306|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
5053670|NCT02503202|17425307|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
5053671|NCT02503202|17425303|P5|Base Study: Up to Month 6|Physician Decision|1
5053672|NCT02503202|17425304|P4|Base Study: Up to Month 6|Physician Decision|0
5053673|NCT02503202|17425305|P3|Base Study: Up to Month 6|Physician Decision|0
5053674|NCT02503202|17425306|P2|Base Study: Up to Month 6|Physician Decision|0
5053675|NCT02503202|17425307|P1|Base Study: Up to Month 6|Physician Decision|0
5053676|NCT02503202|17425303|P5|Base Study: Up to Month 6|Lost to Follow-up|1
5053677|NCT02503202|17425304|P4|Base Study: Up to Month 6|Lost to Follow-up|5
5053678|NCT02503202|17425305|P3|Base Study: Up to Month 6|Lost to Follow-up|10
5053679|NCT02503202|17425306|P2|Base Study: Up to Month 6|Lost to Follow-up|8
5053680|NCT02503202|17425307|P1|Base Study: Up to Month 6|Lost to Follow-up|11
5053681|NCT02503202|17425303|P5|Base Study: Up to Month 6|Death|0
5053682|NCT02503202|17425304|P4|Base Study: Up to Month 6|Death|0
5053683|NCT02503202|17425305|P3|Base Study: Up to Month 6|Death|0
5053684|NCT02503202|17425306|P2|Base Study: Up to Month 6|Death|1
5053685|NCT02503202|17425307|P1|Base Study: Up to Month 6|Death|1
5053686|NCT02503085|17425349|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
5053687|NCT02503085|17425350|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
5053688|NCT02503085|17425351|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
5053689|NCT02503085|17425352|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
5053690|NCT02502864|17425391|P1|Overall Study|Withdrawal by Subject|1
5053691|NCT02502734|17425400|P2|Washout Period|Adverse Event|0
5053692|NCT02502734|17425401|P1|Washout Period|Adverse Event|1
5053693|NCT02502734|17425400|P2|Double-blind Treatment Period 1|Adverse Event|0
5053694|NCT02502734|17425401|P1|Double-blind Treatment Period 1|Adverse Event|1
5053695|NCT02502526|17425412|P3|Overall Study|Enrollment suspension|1
5053696|NCT02502526|17425413|P2|Overall Study|Enrollment suspension|1
5053697|NCT02502526|17425414|P1|Overall Study|Enrollment suspension|4
5053698|NCT02502526|17425412|P3|Overall Study|Disqualified due to cataract grading|1
5053699|NCT02502526|17425413|P2|Overall Study|Disqualified due to cataract grading|0
5053700|NCT02502526|17425414|P1|Overall Study|Disqualified due to cataract grading|0
5053701|NCT02502526|17425412|P3|Overall Study|Withdrawal by Subject|1
5053702|NCT02502526|17425413|P2|Overall Study|Withdrawal by Subject|1
5053703|NCT02502526|17425414|P1|Overall Study|Withdrawal by Subject|0
5053704|NCT02502526|17425412|P3|Overall Study|Lost to Follow-up|3
5053705|NCT02502526|17425413|P2|Overall Study|Lost to Follow-up|2
5053706|NCT02502526|17425414|P1|Overall Study|Lost to Follow-up|2
5053707|NCT02502149|17425511|P5|Intermediate|Discontinued prematurely|0
5053708|NCT02502149|17425512|P4|Intermediate|Discontinued prematurely|0
5053709|NCT02502149|17425513|P3|Intermediate|Discontinued prematurely|0
5053710|NCT02502149|17425514|P2|Intermediate|Discontinued prematurely|0
5053711|NCT02502149|17425515|P1|Intermediate|Discontinued prematurely|1
5053712|NCT02501928|17425650|P6|Overall Study|Withdrawal By Parent/Guardian|0
5053713|NCT02501928|17425651|P5|Overall Study|Withdrawal By Parent/Guardian|1
5053714|NCT02501928|17425652|P4|Overall Study|Withdrawal By Parent/Guardian|0
5053715|NCT02501928|17425653|P3|Overall Study|Withdrawal By Parent/Guardian|0
5053716|NCT02501928|17425654|P2|Overall Study|Withdrawal By Parent/Guardian|0
5053717|NCT02501928|17425655|P1|Overall Study|Withdrawal By Parent/Guardian|0
5053718|NCT02501629|17425881|P2|Overall Study|Subject did not return to site|1
5053719|NCT02501629|17425882|P1|Overall Study|Subject did not return to site|0
5053720|NCT02501629|17425881|P2|Overall Study|Withdrawal by Subject|5
5053721|NCT02501629|17425882|P1|Overall Study|Withdrawal by Subject|3
5053722|NCT02501629|17425881|P2|Overall Study|Early termination by sponsor|0
5053723|NCT02501629|17425882|P1|Overall Study|Early termination by sponsor|1
5053724|NCT02501629|17425881|P2|Overall Study|Withdrawn from study by sponsor|0
5053725|NCT02501629|17425882|P1|Overall Study|Withdrawn from study by sponsor|1
5053726|NCT02501629|17425881|P2|Overall Study|Death|1
5053727|NCT02501629|17425882|P1|Overall Study|Death|0
5053728|NCT02501473|17425928|P8|Overall Study|Reason not specified|0
5053729|NCT02501473|17425929|P7|Overall Study|Reason not specified|0
5053730|NCT02501473|17425930|P6|Overall Study|Reason not specified|0
5053731|NCT02501473|17425931|P5|Overall Study|Reason not specified|0
5053732|NCT02501473|17425932|P4|Overall Study|Reason not specified|1
5053733|NCT02501473|17425933|P3|Overall Study|Reason not specified|1
5053734|NCT02501473|17425934|P2|Overall Study|Reason not specified|0
5053735|NCT02501473|17425935|P1|Overall Study|Reason not specified|0
5053736|NCT02501473|17425928|P8|Overall Study|Lost to Follow-up|0
5053737|NCT02501473|17425929|P7|Overall Study|Lost to Follow-up|0
5053738|NCT02501473|17425930|P6|Overall Study|Lost to Follow-up|1
5053739|NCT02501473|17425931|P5|Overall Study|Lost to Follow-up|0
5053740|NCT02501473|17425932|P4|Overall Study|Lost to Follow-up|0
5053741|NCT02501473|17425933|P3|Overall Study|Lost to Follow-up|1
5053742|NCT02501473|17425934|P2|Overall Study|Lost to Follow-up|0
5053743|NCT02501473|17425935|P1|Overall Study|Lost to Follow-up|1
5053744|NCT02501473|17425928|P8|Overall Study|Death|0
5053745|NCT02501473|17425929|P7|Overall Study|Death|0
5053746|NCT02501473|17425930|P6|Overall Study|Death|1
5053747|NCT02501473|17425931|P5|Overall Study|Death|0
5053748|NCT02501473|17425932|P4|Overall Study|Death|1
5053749|NCT02501473|17425933|P3|Overall Study|Death|1
5053750|NCT02501473|17425934|P2|Overall Study|Death|0
5053751|NCT02501473|17425935|P1|Overall Study|Death|0
5053752|NCT02501473|17425928|P8|Overall Study|Withdrawal by Subject|0
5053753|NCT02501473|17425929|P7|Overall Study|Withdrawal by Subject|0
5053754|NCT02501473|17425930|P6|Overall Study|Withdrawal by Subject|2
5053755|NCT02501473|17425931|P5|Overall Study|Withdrawal by Subject|2
5053756|NCT02501473|17425932|P4|Overall Study|Withdrawal by Subject|3
5053757|NCT02501473|17425933|P3|Overall Study|Withdrawal by Subject|3
5053758|NCT02501473|17425934|P2|Overall Study|Withdrawal by Subject|0
5053759|NCT02501473|17425935|P1|Overall Study|Withdrawal by Subject|0
5053760|NCT02501473|17425928|P8|Overall Study|Study Terminated|0
5053761|NCT02501473|17425929|P7|Overall Study|Study Terminated|1
5053762|NCT02501473|17425930|P6|Overall Study|Study Terminated|10
5053763|NCT02501473|17425931|P5|Overall Study|Study Terminated|2
5053764|NCT02501473|17425932|P4|Overall Study|Study Terminated|9
5053765|NCT02501473|17425933|P3|Overall Study|Study Terminated|7
5053766|NCT02501473|17425934|P2|Overall Study|Study Terminated|3
5053767|NCT02501473|17425935|P1|Overall Study|Study Terminated|2
5053768|NCT02501161|17426030|P2|Overall Study|Other|0
5053769|NCT02501161|17426031|P1|Overall Study|Other|3
5053770|NCT02501161|17426030|P2|Overall Study|Withdrawal by Subject|15
5053771|NCT02501161|17426031|P1|Overall Study|Withdrawal by Subject|10
5053772|NCT02501161|17426030|P2|Overall Study|Lost to Follow-up|4
5053773|NCT02501161|17426031|P1|Overall Study|Lost to Follow-up|7
5053774|NCT02501161|17426030|P2|Overall Study|Adverse Event|6
5053775|NCT02501161|17426031|P1|Overall Study|Adverse Event|2
5053776|NCT02500979|17426155|P2|Period 2|Change in risk|0
5053777|NCT02500979|17426156|P1|Period 2|Change in risk|1
5053778|NCT02500979|17426155|P2|Period 1|Subject decision|0
5053779|NCT02500979|17426156|P1|Period 1|Subject decision|2
5053780|NCT02500979|17426155|P2|Period 1|Adverse Event|0
5053781|NCT02500979|17426156|P1|Period 1|Adverse Event|1
5053782|NCT02500979|17426155|P2|Period 1|Severe non-compliance to protocol|1
5053783|NCT02500979|17426156|P1|Period 1|Severe non-compliance to protocol|0
5053784|NCT02500979|17426155|P2|Period 1|Hyperglycemia|0
5053785|NCT02500979|17426156|P1|Period 1|Hyperglycemia|1
5053786|NCT02500901|17426190|P1|Overall Study|Disease ProgressionDD|2
5053787|NCT02500797|17426218|P8|Overall Study|Withdrawal by Subject|0
5053788|NCT02500797|17426219|P7|Overall Study|Withdrawal by Subject|0
5053789|NCT02500797|17426220|P6|Overall Study|Withdrawal by Subject|0
5053790|NCT02500797|17426221|P5|Overall Study|Withdrawal by Subject|0
5053791|NCT02500797|17426222|P4|Overall Study|Withdrawal by Subject|0
5053792|NCT02500797|17426223|P3|Overall Study|Withdrawal by Subject|0
5053793|NCT02500797|17426224|P2|Overall Study|Withdrawal by Subject|0
5053794|NCT02500797|17426225|P1|Overall Study|Withdrawal by Subject|1
5053795|NCT02500797|17426218|P8|Overall Study|Cancel (rapid disease progression)|0
5053796|NCT02500797|17426219|P7|Overall Study|Cancel (rapid disease progression)|0
5053797|NCT02500797|17426220|P6|Overall Study|Cancel (rapid disease progression)|1
5053798|NCT02500797|17426221|P5|Overall Study|Cancel (rapid disease progression)|1
5053799|NCT02500797|17426222|P4|Overall Study|Cancel (rapid disease progression)|0
5053800|NCT02500797|17426223|P3|Overall Study|Cancel (rapid disease progression)|0
5053801|NCT02500797|17426224|P2|Overall Study|Cancel (rapid disease progression)|0
5053802|NCT02500797|17426225|P1|Overall Study|Cancel (rapid disease progression)|0
5053803|NCT02500758|17426285|P2|Second Intervention (2 Minutes)|Protocol Violation|1
5053804|NCT02500758|17426286|P1|Second Intervention (2 Minutes)|Protocol Violation|1
5053805|NCT02500758|17426285|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
5053806|NCT02500758|17426286|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
5053807|NCT02500758|17426285|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
5053808|NCT02500758|17426286|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
5053809|NCT02500758|17426285|P2|Washout (1 Week)|Lost to Follow-up|2
5053810|NCT02500758|17426286|P1|Washout (1 Week)|Lost to Follow-up|2
5053811|NCT02500758|17426285|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
5053812|NCT02500758|17426286|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
5053813|NCT02500732|17426296|P2|Overall Study|Physician Decision|1
5053814|NCT02500732|17426297|P1|Overall Study|Physician Decision|0
5053815|NCT02500706|17426314|P3|Overall Study|Unclassified|1
5053816|NCT02500706|17426315|P2|Overall Study|Unclassified|0
5053817|NCT02500706|17426316|P1|Overall Study|Unclassified|0
5053818|NCT02500706|17426314|P3|Overall Study|Withdrawal by Subject|4
5053819|NCT02500706|17426315|P2|Overall Study|Withdrawal by Subject|6
5053820|NCT02500706|17426316|P1|Overall Study|Withdrawal by Subject|4
5053821|NCT02500706|17426314|P3|Overall Study|Lost to Follow-up|1
5053822|NCT02500706|17426315|P2|Overall Study|Lost to Follow-up|1
5053823|NCT02500706|17426316|P1|Overall Study|Lost to Follow-up|0
5053824|NCT02500706|17426314|P3|Overall Study|Adverse Event|1
5053825|NCT02500706|17426315|P2|Overall Study|Adverse Event|0
5053826|NCT02500706|17426316|P1|Overall Study|Adverse Event|0
5053827|NCT02500641|17426470|P2|Overall Study|Non compliance to study drug|1
5053828|NCT02500641|17426471|P1|Overall Study|Non compliance to study drug|0
5053829|NCT02500641|17426470|P2|Overall Study|Sponsor decision|0
5053830|NCT02500641|17426471|P1|Overall Study|Sponsor decision|1
5053831|NCT02500641|17426470|P2|Overall Study|Lost to Follow-up|0
5053832|NCT02500641|17426471|P1|Overall Study|Lost to Follow-up|1
5053833|NCT02500641|17426470|P2|Overall Study|Protocol Violation|2
5053834|NCT02500641|17426471|P1|Overall Study|Protocol Violation|1
5053835|NCT02500641|17426470|P2|Overall Study|Unable to follow study procedures|2
5053836|NCT02500641|17426471|P1|Overall Study|Unable to follow study procedures|3
5053837|NCT02500641|17426470|P2|Overall Study|Withdrawal by Subject|5
5053838|NCT02500641|17426471|P1|Overall Study|Withdrawal by Subject|4
5053839|NCT02500641|17426470|P2|Overall Study|Adverse Event|2
5053840|NCT02500641|17426471|P1|Overall Study|Adverse Event|0
5053841|NCT02500537|17426492|P2|Overall Study|Withdrawal by Subject|0
5053842|NCT02500537|17426493|P1|Overall Study|Withdrawal by Subject|1
5053843|NCT02500537|17426492|P2|Overall Study|Lost to Follow-up|1
5053844|NCT02500537|17426493|P1|Overall Study|Lost to Follow-up|0
5053845|NCT02500537|17426492|P2|Overall Study|Death|0
5053846|NCT02500537|17426493|P1|Overall Study|Death|2
5053847|NCT02500056|17426562|P2|Overall Study|Death|1
5053848|NCT02500056|17426563|P1|Overall Study|Death|3
5053849|NCT02500056|17426562|P2|Overall Study|Recurrence|0
5053850|NCT02500056|17426563|P1|Overall Study|Recurrence|1
5053851|NCT02500056|17426562|P2|Overall Study|Lost to Follow-up|7
5053852|NCT02500056|17426563|P1|Overall Study|Lost to Follow-up|3
5053853|NCT02499952|17426573|P1|Overall Study|Death|9
5053854|NCT02499952|17426573|P1|Overall Study|Lost to Follow-up|1
5053855|NCT02499900|17426582|P2|Extension Study Period|Other|2
5053856|NCT02499900|17426583|P1|Extension Study Period|Other|0
5053857|NCT02499900|17426582|P2|Extension Study Period|Lost to Follow-up|5
5053858|NCT02499900|17426583|P1|Extension Study Period|Lost to Follow-up|2
5053859|NCT02499900|17426582|P2|Extension Study Period|Pregnancy|2
5053860|NCT02499900|17426583|P1|Extension Study Period|Pregnancy|1
5053861|NCT02499900|17426582|P2|Extension Study Period|Physician Decision|5
5053862|NCT02499900|17426583|P1|Extension Study Period|Physician Decision|2
5053863|NCT02499900|17426582|P2|Extension Study Period|Withdrawal by Subject|2
5053864|NCT02499900|17426583|P1|Extension Study Period|Withdrawal by Subject|5
5053865|NCT02499900|17426582|P2|Extension Study Period|Adverse Event|4
5053866|NCT02499900|17426583|P1|Extension Study Period|Adverse Event|2
5053867|NCT02499900|17426582|P2|Completed Core, Continued Into Extension|Personal motivation|0
5053868|NCT02499900|17426583|P1|Completed Core, Continued Into Extension|Personal motivation|1
5053869|NCT02499900|17426582|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
5053870|NCT02499900|17426583|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
5053871|NCT02499900|17426582|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
5053872|NCT02499900|17426583|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
5053873|NCT02499900|17426582|P2|Completed Core, Continued Into Extension|Physician Decision|0
5053874|NCT02499900|17426583|P1|Completed Core, Continued Into Extension|Physician Decision|1
5053875|NCT02499900|17426582|P2|Core Study Period|Death|1
5053876|NCT02499900|17426583|P1|Core Study Period|Death|0
5053877|NCT02499900|17426582|P2|Core Study Period|Adverse Event|14
5053878|NCT02499900|17426583|P1|Core Study Period|Adverse Event|18
5053879|NCT02499900|17426582|P2|Core Study Period|Withdrawal by Subject|10
5053880|NCT02499900|17426583|P1|Core Study Period|Withdrawal by Subject|11
5053881|NCT02499900|17426582|P2|Core Study Period|Protocol Violation|0
5053882|NCT02499900|17426583|P1|Core Study Period|Protocol Violation|3
5053883|NCT02499900|17426582|P2|Core Study Period|Pregnancy|0
5053884|NCT02499900|17426583|P1|Core Study Period|Pregnancy|1
5053885|NCT02499900|17426582|P2|Core Study Period|Per sponsor request|1
5053886|NCT02499900|17426583|P1|Core Study Period|Per sponsor request|0
5053887|NCT02499900|17426582|P2|Core Study Period|Lost to Follow-up|2
5053888|NCT02499900|17426583|P1|Core Study Period|Lost to Follow-up|1
5053889|NCT02499900|17426582|P2|Core Study Period|Other|4
5053890|NCT02499900|17426583|P1|Core Study Period|Other|1
5053891|NCT02499783|17426614|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
5053892|NCT02499783|17426615|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
5053893|NCT02499783|17426616|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
5053894|NCT02499783|17426614|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
5053895|NCT02499783|17426615|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
5053896|NCT02499783|17426616|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
5053897|NCT02499783|17426614|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
5053898|NCT02499783|17426615|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
5053899|NCT02499783|17426616|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
5053900|NCT02499783|17426614|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
5053901|NCT02499783|17426615|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
5053902|NCT02499783|17426616|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
5053903|NCT02499783|17426614|P3|DB Period: Weeks 0-8|Other|0
5053904|NCT02499783|17426615|P2|DB Period: Weeks 0-8|Other|1
5053905|NCT02499783|17426616|P1|DB Period: Weeks 0-8|Other|1
5053906|NCT02499783|17426614|P3|DB Period: Weeks 0-8|Withdrew Consent|0
5053907|NCT02499783|17426615|P2|DB Period: Weeks 0-8|Withdrew Consent|0
5053908|NCT02499783|17426616|P1|DB Period: Weeks 0-8|Withdrew Consent|1
5053909|NCT02499783|17426614|P3|DB Period: Weeks 0-8|Adverse Event|0
5053910|NCT02499783|17426615|P2|DB Period: Weeks 0-8|Adverse Event|6
5053911|NCT02499783|17426616|P1|DB Period: Weeks 0-8|Adverse Event|8
5053912|NCT02499783|17426614|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
5053913|NCT02499783|17426615|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
5053914|NCT02499783|17426616|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
5053915|NCT02499783|17426614|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
5053916|NCT02499783|17426615|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
5053917|NCT02499783|17426616|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
5053918|NCT02499783|17426614|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
5053919|NCT02499783|17426615|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
5053920|NCT02499783|17426616|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
5053921|NCT02499770|17426665|P2|Overall Study|Randomized but not enrolled|1
5053922|NCT02499770|17426666|P1|Overall Study|Randomized but not enrolled|0
5053923|NCT02499770|17426665|P2|Overall Study|Withdrawn by PI for compassionate reason|1
5053924|NCT02499770|17426666|P1|Overall Study|Withdrawn by PI for compassionate reason|0
5053925|NCT02499770|17426665|P2|Overall Study|Subject declined further treatment|0
5053926|NCT02499770|17426666|P1|Overall Study|Subject declined further treatment|1
5053927|NCT02499770|17426665|P2|Overall Study|Lost to Follow-up|2
5053928|NCT02499770|17426666|P1|Overall Study|Lost to Follow-up|0
5053929|NCT02499770|17426665|P2|Overall Study|Withdrawal by Subject|7
5053930|NCT02499770|17426666|P1|Overall Study|Withdrawal by Subject|0
5053931|NCT02499770|17426665|P2|Overall Study|Study completion|10
5053932|NCT02499770|17426666|P1|Overall Study|Study completion|1
5053933|NCT02499770|17426665|P2|Overall Study|Death|56
5053934|NCT02499770|17426666|P1|Overall Study|Death|17
5053935|NCT02499575|17426786|P2|Overall Study|Protocol Violation|1
5053936|NCT02499575|17426787|P1|Overall Study|Protocol Violation|0
5053937|NCT02499406|17426797|P1|Overall Study|missed 3 treatment sessions|4
5053938|NCT02499263|17426818|P1|Overall Study|Pregnancy|1
5053939|NCT02499263|17426818|P1|Overall Study|Participant's decision|3
5053940|NCT02499263|17426818|P1|Overall Study|Adverse Events/Serious Adverse Events|11
5053941|NCT02499263|17426818|P1|Overall Study|investigator's judgment|12
5053942|NCT02499263|17426818|P1|Overall Study|Lack of Efficacy|22
5053943|NCT02499263|17426818|P1|Overall Study|Participant's withdrawal of consent|4
5053944|NCT02499263|17426818|P1|Overall Study|Lost to Follow-up|9
5053945|NCT02499172|17426855|P4|Overall Study|Lost to Follow-up|0
5053946|NCT02499172|17426856|P3|Overall Study|Lost to Follow-up|0
5053947|NCT02499172|17426857|P2|Overall Study|Lost to Follow-up|64
5053948|NCT02499172|17426858|P1|Overall Study|Lost to Follow-up|65
5053949|NCT02499172|17426855|P4|Overall Study|Financial reason|436
5053950|NCT02499172|17426856|P3|Overall Study|Financial reason|523
5053951|NCT02499172|17426857|P2|Overall Study|Financial reason|0
5053952|NCT02499172|17426858|P1|Overall Study|Financial reason|0
5053953|NCT02499159|17426870|P2|30-Day Follow-Up Phone Call|Other|0
5053954|NCT02499159|17426871|P1|30-Day Follow-Up Phone Call|Other|1
5053955|NCT02499159|17426870|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
5053956|NCT02499159|17426871|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
5053957|NCT02499159|17426870|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
5053958|NCT02499159|17426871|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
5053959|NCT02499159|17426870|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
5053960|NCT02499159|17426871|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
5053961|NCT02499159|17426870|P2|Randomization|Protocol Violation|1
5053962|NCT02499159|17426871|P1|Randomization|Protocol Violation|1
5053963|NCT02499146|17426895|P1|Overall Study|Began other treatment/therapy|13
5053964|NCT02499146|17426895|P1|Overall Study|Ongoing at date of cut-off|9
5053965|NCT02499146|17426895|P1|Overall Study|Other|2
5053966|NCT02499146|17426895|P1|Overall Study|Withdrawal by Subject|1
5053967|NCT02499146|17426895|P1|Overall Study|Lost to Follow-up|1
5053968|NCT02499120|17426935|P2|Overall Study|Ongoing on study|11
5053969|NCT02499120|17426936|P1|Overall Study|Ongoing on study|15
5053970|NCT02499120|17426935|P2|Overall Study|Other|0
5053971|NCT02499120|17426936|P1|Overall Study|Other|1
5053972|NCT02499120|17426935|P2|Overall Study|Withdrawal by Subject|5
5053973|NCT02499120|17426936|P1|Overall Study|Withdrawal by Subject|2
5053974|NCT02499120|17426935|P2|Overall Study|Participant refused further follow-up|0
5053975|NCT02499120|17426936|P1|Overall Study|Participant refused further follow-up|1
5053976|NCT02499120|17426935|P2|Overall Study|Lost to Follow-up|2
5053977|NCT02499120|17426936|P1|Overall Study|Lost to Follow-up|1
5053978|NCT02499120|17426935|P2|Overall Study|Death|42
5053979|NCT02499120|17426936|P1|Overall Study|Death|45
5053980|NCT02499029|17426967|P2|Overall Study|Death|0
5053981|NCT02499029|17426968|P1|Overall Study|Death|1
5053982|NCT02499029|17426967|P2|Overall Study|Physician Decision|1
5053983|NCT02499029|17426968|P1|Overall Study|Physician Decision|2
5053984|NCT02499029|17426967|P2|Overall Study|Lost to Follow-up|2
5053985|NCT02499029|17426968|P1|Overall Study|Lost to Follow-up|2
5053986|NCT02498821|17426995|P2|Overall Study|Screen failure|5
5053987|NCT02498821|17426996|P1|Overall Study|Screen failure|3
5053988|NCT02498678|17427040|P2|Overall Study|interference from the surgical team|2
5053989|NCT02498678|17427041|P1|Overall Study|interference from the surgical team|0
5053990|NCT02498652|17427057|P2|Overall Study|Protocol Violation|1
5053991|NCT02498652|17427058|P1|Overall Study|Protocol Violation|0
5053992|NCT02498418|17427201|P3|Overall Study|Participant taken prohibited medication|1
5053993|NCT02498418|17427202|P2|Overall Study|Participant taken prohibited medication|1
5053994|NCT02498418|17427203|P1|Overall Study|Participant taken prohibited medication|0
5053995|NCT02498418|17427201|P3|Overall Study|Lost to Follow-up|1
5053996|NCT02498418|17427202|P2|Overall Study|Lost to Follow-up|1
5053997|NCT02498418|17427203|P1|Overall Study|Lost to Follow-up|0
5053998|NCT02498418|17427201|P3|Overall Study|Withdrawal by Subject|3
5053999|NCT02498418|17427202|P2|Overall Study|Withdrawal by Subject|0
5054000|NCT02498418|17427203|P1|Overall Study|Withdrawal by Subject|2
5054001|NCT02498418|17427201|P3|Overall Study|Lack of Efficacy|1
5054002|NCT02498418|17427202|P2|Overall Study|Lack of Efficacy|0
5054003|NCT02498418|17427203|P1|Overall Study|Lack of Efficacy|0
5054004|NCT02498236|17427227|P8|Overall Study|Withdrawal by Subject|0
5054005|NCT02498236|17427228|P7|Overall Study|Withdrawal by Subject|0
5054006|NCT02498236|17427229|P6|Overall Study|Withdrawal by Subject|0
5054007|NCT02498236|17427230|P5|Overall Study|Withdrawal by Subject|1
5054008|NCT02498236|17427231|P4|Overall Study|Withdrawal by Subject|0
5054009|NCT02498236|17427232|P3|Overall Study|Withdrawal by Subject|0
5054010|NCT02498236|17427233|P2|Overall Study|Withdrawal by Subject|0
5054011|NCT02498236|17427234|P1|Overall Study|Withdrawal by Subject|0
5054012|NCT02498236|17427227|P8|Overall Study|Equipment failure|0
5054013|NCT02498236|17427228|P7|Overall Study|Equipment failure|1
5054014|NCT02498236|17427229|P6|Overall Study|Equipment failure|0
5054015|NCT02498236|17427230|P5|Overall Study|Equipment failure|0
5054016|NCT02498236|17427231|P4|Overall Study|Equipment failure|0
5054017|NCT02498236|17427232|P3|Overall Study|Equipment failure|0
5054018|NCT02498236|17427233|P2|Overall Study|Equipment failure|0
5054019|NCT02498236|17427234|P1|Overall Study|Equipment failure|0
5054020|NCT02498236|17427227|P8|Overall Study|Did not show for testing|1
5054021|NCT02498236|17427228|P7|Overall Study|Did not show for testing|0
5054022|NCT02498236|17427229|P6|Overall Study|Did not show for testing|0
5054023|NCT02498236|17427230|P5|Overall Study|Did not show for testing|0
5054024|NCT02498236|17427231|P4|Overall Study|Did not show for testing|0
5054025|NCT02498236|17427232|P3|Overall Study|Did not show for testing|0
5054026|NCT02498236|17427233|P2|Overall Study|Did not show for testing|0
5054027|NCT02498236|17427234|P1|Overall Study|Did not show for testing|1
5054028|NCT02498067|17427263|P1|Overall Study|Did not meet inclusion criteria|11
5054029|NCT02498067|17427263|P1|Overall Study|Lost to Follow-up|22
5054030|NCT02497976|17427284|P2|Overall Study|Moved out of area|1
5054031|NCT02497976|17427285|P1|Overall Study|Moved out of area|0
5054032|NCT02497976|17427284|P2|Overall Study|Withdrawal by Subject|0
5054033|NCT02497976|17427285|P1|Overall Study|Withdrawal by Subject|2
5054034|NCT02497781|17427380|P2|Overall Study|Lost to Follow-up|1
5054035|NCT02497781|17427381|P1|Overall Study|Lost to Follow-up|1
5054036|NCT02497781|17427380|P2|Overall Study|Randomised but not treated|1
5054037|NCT02497781|17427381|P1|Overall Study|Randomised but not treated|1
5054038|NCT02497781|17427380|P2|Overall Study|Lack of Efficacy|1
5054039|NCT02497781|17427381|P1|Overall Study|Lack of Efficacy|0
5054040|NCT02497781|17427380|P2|Overall Study|Withdrawal by Subject|0
5054041|NCT02497781|17427381|P1|Overall Study|Withdrawal by Subject|2
5054042|NCT02497755|17427444|P2|Overall Study|Protocol Violation|0
5054043|NCT02497755|17427445|P1|Overall Study|Protocol Violation|1
5054044|NCT02497612|17427462|P4|Overall Study|Not eligible|1
5054045|NCT02497612|17427463|P3|Overall Study|Not eligible|0
5054046|NCT02497612|17427464|P2|Overall Study|Not eligible|0
5054047|NCT02497612|17427465|P1|Overall Study|Not eligible|1
5054048|NCT02497612|17427462|P4|Overall Study|Other unspecified|0
5054049|NCT02497612|17427463|P3|Overall Study|Other unspecified|2
5054050|NCT02497612|17427464|P2|Overall Study|Other unspecified|1
5054051|NCT02497612|17427465|P1|Overall Study|Other unspecified|1
5054052|NCT02497612|17427462|P4|Overall Study|Lost to Follow-up|1
5054053|NCT02497612|17427463|P3|Overall Study|Lost to Follow-up|0
5054054|NCT02497612|17427464|P2|Overall Study|Lost to Follow-up|1
5054055|NCT02497612|17427465|P1|Overall Study|Lost to Follow-up|1
5054056|NCT02497612|17427462|P4|Overall Study|Adverse Event|1
5054057|NCT02497612|17427463|P3|Overall Study|Adverse Event|4
5054058|NCT02497612|17427464|P2|Overall Study|Adverse Event|1
5054059|NCT02497612|17427465|P1|Overall Study|Adverse Event|3
5054060|NCT02497612|17427462|P4|Overall Study|Investigator's judgement|2
5054061|NCT02497612|17427463|P3|Overall Study|Investigator's judgement|0
5054062|NCT02497612|17427464|P2|Overall Study|Investigator's judgement|0
5054063|NCT02497612|17427465|P1|Overall Study|Investigator's judgement|1
5054064|NCT02497612|17427462|P4|Overall Study|Participant's request|1
5054065|NCT02497612|17427463|P3|Overall Study|Participant's request|4
5054066|NCT02497612|17427464|P2|Overall Study|Participant's request|3
5054067|NCT02497612|17427465|P1|Overall Study|Participant's request|2
5054068|NCT02497612|17427462|P4|Overall Study|Met >=1 anti-malarial treatment criteria|41
5054069|NCT02497612|17427463|P3|Overall Study|Met >=1 anti-malarial treatment criteria|39
5054070|NCT02497612|17427464|P2|Overall Study|Met >=1 anti-malarial treatment criteria|51
5054071|NCT02497612|17427465|P1|Overall Study|Met >=1 anti-malarial treatment criteria|57
5054072|NCT02497469|17427593|P2|Overall Study|Reason not Specified|6
5054073|NCT02497469|17427594|P1|Overall Study|Reason not Specified|6
5054074|NCT02497469|17427593|P2|Overall Study|Lack of Efficacy|40
5054075|NCT02497469|17427594|P1|Overall Study|Lack of Efficacy|86
5054076|NCT02497469|17427593|P2|Overall Study|Pregnancy|1
5054077|NCT02497469|17427594|P1|Overall Study|Pregnancy|1
5054078|NCT02497469|17427593|P2|Overall Study|Voluntary Withdrawal|41
5054079|NCT02497469|17427594|P1|Overall Study|Voluntary Withdrawal|39
5054080|NCT02497469|17427593|P2|Overall Study|Lost to Follow-up|4
5054081|NCT02497469|17427594|P1|Overall Study|Lost to Follow-up|14
5054082|NCT02497469|17427593|P2|Overall Study|Significant Protocol Deviation|5
5054083|NCT02497469|17427594|P1|Overall Study|Significant Protocol Deviation|4
5054084|NCT02497469|17427593|P2|Overall Study|Leukopenia or Lymphopenia|0
5054085|NCT02497469|17427594|P1|Overall Study|Leukopenia or Lymphopenia|1
5054086|NCT02497469|17427593|P2|Overall Study|Pretreatment Event/Adverse Event|16
5054087|NCT02497469|17427594|P1|Overall Study|Pretreatment Event/Adverse Event|18
5054088|NCT02497469|17427593|P2|Overall Study|Randomized but not Treated|2
5054089|NCT02497469|17427594|P1|Overall Study|Randomized but not Treated|0
5054090|NCT02497391|17427604|P6|Period 3 (14 Days)|Withdrawal by Subject|0
5054091|NCT02497391|17427605|P5|Period 3 (14 Days)|Withdrawal by Subject|0
5054092|NCT02497391|17427606|P4|Period 3 (14 Days)|Withdrawal by Subject|0
5054093|NCT02497391|17427607|P3|Period 3 (14 Days)|Withdrawal by Subject|1
5054094|NCT02497391|17427608|P2|Period 3 (14 Days)|Withdrawal by Subject|0
5054095|NCT02497391|17427609|P1|Period 3 (14 Days)|Withdrawal by Subject|0
5054096|NCT02497391|17427604|P6|Period 3 (14 Days)|Sponsor Decision|0
5054097|NCT02497391|17427605|P5|Period 3 (14 Days)|Sponsor Decision|1
5054098|NCT02497391|17427606|P4|Period 3 (14 Days)|Sponsor Decision|0
5054099|NCT02497391|17427607|P3|Period 3 (14 Days)|Sponsor Decision|0
5054100|NCT02497391|17427608|P2|Period 3 (14 Days)|Sponsor Decision|0
5054101|NCT02497391|17427609|P1|Period 3 (14 Days)|Sponsor Decision|0
5054102|NCT02497391|17427604|P6|Period 3 (14 Days)|Adverse Event|0
5054103|NCT02497391|17427605|P5|Period 3 (14 Days)|Adverse Event|0
5054104|NCT02497391|17427606|P4|Period 3 (14 Days)|Adverse Event|0
5054105|NCT02497391|17427607|P3|Period 3 (14 Days)|Adverse Event|0
5054106|NCT02497391|17427608|P2|Period 3 (14 Days)|Adverse Event|1
5054107|NCT02497391|17427609|P1|Period 3 (14 Days)|Adverse Event|0
5054108|NCT02497391|17427604|P6|Period 2 (14 Days)|Sponsor Decision|3
5054109|NCT02497391|17427605|P5|Period 2 (14 Days)|Sponsor Decision|2
5054110|NCT02497391|17427606|P4|Period 2 (14 Days)|Sponsor Decision|3
5054111|NCT02497391|17427607|P3|Period 2 (14 Days)|Sponsor Decision|2
5054112|NCT02497391|17427608|P2|Period 2 (14 Days)|Sponsor Decision|1
5054113|NCT02497391|17427609|P1|Period 2 (14 Days)|Sponsor Decision|3
5054114|NCT02497391|17427604|P6|Period 2 (14 Days)|Withdrawal by Subject|0
5054115|NCT02497391|17427605|P5|Period 2 (14 Days)|Withdrawal by Subject|0
5054116|NCT02497391|17427606|P4|Period 2 (14 Days)|Withdrawal by Subject|0
5054117|NCT02497391|17427607|P3|Period 2 (14 Days)|Withdrawal by Subject|1
5054118|NCT02497391|17427608|P2|Period 2 (14 Days)|Withdrawal by Subject|0
5054119|NCT02497391|17427609|P1|Period 2 (14 Days)|Withdrawal by Subject|1
5054120|NCT02497287|17427620|P1|Follow-up Phase (4 Week)|Other|1
5054121|NCT02497287|17427620|P1|Follow-up Phase (4 Week)|Adverse Event|3
5054122|NCT02497287|17427620|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
5054123|NCT02497287|17427620|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
5054124|NCT02497287|17427620|P1|Follow-up Phase (4 Week)|PI Decision|12
5054125|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
5054126|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Death|2
5054127|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
5054128|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
5054129|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
5054130|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
5054131|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Other|21
5054132|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
5054133|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
5054134|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
5054135|NCT02497287|17427620|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
5054136|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
5054137|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Protocol Violation|1
5054138|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
5054139|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Other|13
5054140|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
5054141|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
5054142|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Adverse Event|52
5054143|NCT02497287|17427620|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
5054144|NCT02496884|17427715|P4|Overall Study|Withdrawal by Subject|0
5054145|NCT02496884|17427716|P3|Overall Study|Withdrawal by Subject|0
5054146|NCT02496884|17427717|P2|Overall Study|Withdrawal by Subject|3
5054147|NCT02496884|17427718|P1|Overall Study|Withdrawal by Subject|0
5054148|NCT02496884|17427715|P4|Overall Study|Counted twice as enrolled|0
5054149|NCT02496884|17427716|P3|Overall Study|Counted twice as enrolled|0
5054150|NCT02496884|17427717|P2|Overall Study|Counted twice as enrolled|0
5054151|NCT02496884|17427718|P1|Overall Study|Counted twice as enrolled|2
5054152|NCT02496767|17427744|P8|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5054153|NCT02496767|17427745|P7|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5054154|NCT02496767|17427746|P6|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5054155|NCT02496767|17427747|P5|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5054156|NCT02496767|17427748|P4|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5054157|NCT02496767|17427749|P3|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5054158|NCT02496767|17427750|P2|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5054159|NCT02496767|17427751|P1|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5054160|NCT02496767|17427744|P8|Double-blind, Withdrawal Phase|Death|2
5054161|NCT02496767|17427745|P7|Double-blind, Withdrawal Phase|Death|1
5054162|NCT02496767|17427746|P6|Double-blind, Withdrawal Phase|Death|0
5054163|NCT02496767|17427747|P5|Double-blind, Withdrawal Phase|Death|0
5054164|NCT02496767|17427748|P4|Double-blind, Withdrawal Phase|Death|0
5054165|NCT02496767|17427749|P3|Double-blind, Withdrawal Phase|Death|0
5054166|NCT02496767|17427750|P2|Double-blind, Withdrawal Phase|Death|0
5054167|NCT02496767|17427751|P1|Double-blind, Withdrawal Phase|Death|0
5054168|NCT02496767|17427744|P8|Double-blind, Withdrawal Phase|Adverse Event|1
5054169|NCT02496767|17427745|P7|Double-blind, Withdrawal Phase|Adverse Event|2
5054170|NCT02496767|17427746|P6|Double-blind, Withdrawal Phase|Adverse Event|1
5054171|NCT02496767|17427747|P5|Double-blind, Withdrawal Phase|Adverse Event|0
5054172|NCT02496767|17427748|P4|Double-blind, Withdrawal Phase|Adverse Event|0
5054173|NCT02496767|17427749|P3|Double-blind, Withdrawal Phase|Adverse Event|0
5054174|NCT02496767|17427750|P2|Double-blind, Withdrawal Phase|Adverse Event|0
5054175|NCT02496767|17427751|P1|Double-blind, Withdrawal Phase|Adverse Event|0
5054176|NCT02496767|17427744|P8|Double-blind, Withdrawal Phase|Progressive disease|1
5054177|NCT02496767|17427745|P7|Double-blind, Withdrawal Phase|Progressive disease|0
5054178|NCT02496767|17427746|P6|Double-blind, Withdrawal Phase|Progressive disease|4
5054179|NCT02496767|17427747|P5|Double-blind, Withdrawal Phase|Progressive disease|0
5054180|NCT02496767|17427748|P4|Double-blind, Withdrawal Phase|Progressive disease|0
5054181|NCT02496767|17427749|P3|Double-blind, Withdrawal Phase|Progressive disease|0
5054182|NCT02496767|17427750|P2|Double-blind, Withdrawal Phase|Progressive disease|0
5054183|NCT02496767|17427751|P1|Double-blind, Withdrawal Phase|Progressive disease|0
5054184|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054185|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054186|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054187|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054188|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054189|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054190|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Protocol Violation|1
5054191|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5054192|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5054193|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5054194|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5054195|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
5054196|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5054197|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5054198|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5054199|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5054200|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Physician Decision|0
5054201|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Physician Decision|0
5054202|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Physician Decision|0
5054203|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Physician Decision|0
5054204|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Physician Decision|0
5054205|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Physician Decision|1
5054206|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Physician Decision|4
5054207|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
5054208|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5054209|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5054210|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5054211|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
5054212|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
5054213|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
5054214|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
5054215|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5054216|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Various|0
5054217|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Various|0
5054218|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Various|0
5054219|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Various|2
5054220|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Various|5
5054221|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Various|4
5054222|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Various|9
5054223|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Various|0
5054224|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Death|0
5054225|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Death|0
5054226|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Death|0
5054227|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Death|4
5054228|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Death|2
5054229|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Death|6
5054230|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Death|10
5054231|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Death|0
5054232|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Progressive disease|0
5054233|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Progressive disease|0
5054234|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Progressive disease|0
5054235|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Progressive disease|14
5054236|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Progressive disease|8
5054237|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Progressive disease|9
5054238|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Progressive disease|13
5054239|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Progressive disease|0
5054240|NCT02496767|17427744|P8|Double-blind, Placebo-controlled Phase|Adverse Event|0
5054241|NCT02496767|17427745|P7|Double-blind, Placebo-controlled Phase|Adverse Event|0
5054242|NCT02496767|17427746|P6|Double-blind, Placebo-controlled Phase|Adverse Event|0
5054243|NCT02496767|17427747|P5|Double-blind, Placebo-controlled Phase|Adverse Event|43
5054244|NCT02496767|17427748|P4|Double-blind, Placebo-controlled Phase|Adverse Event|43
5054245|NCT02496767|17427749|P3|Double-blind, Placebo-controlled Phase|Adverse Event|23
5054246|NCT02496767|17427750|P2|Double-blind, Placebo-controlled Phase|Adverse Event|13
5054247|NCT02496767|17427751|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
5054248|NCT02496767|17427744|P8|Open-label Lead-in Phase|Lost to Follow-up|0
5054249|NCT02496767|17427745|P7|Open-label Lead-in Phase|Lost to Follow-up|0
5054250|NCT02496767|17427746|P6|Open-label Lead-in Phase|Lost to Follow-up|0
5054251|NCT02496767|17427747|P5|Open-label Lead-in Phase|Lost to Follow-up|0
5054252|NCT02496767|17427748|P4|Open-label Lead-in Phase|Lost to Follow-up|0
5054253|NCT02496767|17427749|P3|Open-label Lead-in Phase|Lost to Follow-up|0
5054254|NCT02496767|17427750|P2|Open-label Lead-in Phase|Lost to Follow-up|0
5054255|NCT02496767|17427751|P1|Open-label Lead-in Phase|Lost to Follow-up|1
5054256|NCT02496767|17427744|P8|Open-label Lead-in Phase|Protocol Violation|0
5054257|NCT02496767|17427745|P7|Open-label Lead-in Phase|Protocol Violation|0
5054258|NCT02496767|17427746|P6|Open-label Lead-in Phase|Protocol Violation|0
5054259|NCT02496767|17427747|P5|Open-label Lead-in Phase|Protocol Violation|0
5054260|NCT02496767|17427748|P4|Open-label Lead-in Phase|Protocol Violation|0
5054261|NCT02496767|17427749|P3|Open-label Lead-in Phase|Protocol Violation|0
5054262|NCT02496767|17427750|P2|Open-label Lead-in Phase|Protocol Violation|0
5054263|NCT02496767|17427751|P1|Open-label Lead-in Phase|Protocol Violation|2
5054264|NCT02496767|17427744|P8|Open-label Lead-in Phase|Adverse Event|0
5054265|NCT02496767|17427745|P7|Open-label Lead-in Phase|Adverse Event|0
5054266|NCT02496767|17427746|P6|Open-label Lead-in Phase|Adverse Event|0
5054267|NCT02496767|17427747|P5|Open-label Lead-in Phase|Adverse Event|0
5054268|NCT02496767|17427748|P4|Open-label Lead-in Phase|Adverse Event|0
5054269|NCT02496767|17427749|P3|Open-label Lead-in Phase|Adverse Event|0
5054270|NCT02496767|17427750|P2|Open-label Lead-in Phase|Adverse Event|0
5054271|NCT02496767|17427751|P1|Open-label Lead-in Phase|Adverse Event|176
5054272|NCT02496702|17427791|P2|Overall Study|Only partially tested|2
5054273|NCT02496702|17427792|P1|Overall Study|Only partially tested|0
5054274|NCT02496702|17427791|P2|Overall Study|Lost to Follow-up|6
5054275|NCT02496702|17427792|P1|Overall Study|Lost to Follow-up|8
5054276|NCT02496533|17427814|P2|Overall Study|Late for radiologic testing|2
5054277|NCT02496533|17427815|P1|Overall Study|Late for radiologic testing|0
5054278|NCT02496533|17427814|P2|Overall Study|Patient did not complete all measures|4
5054279|NCT02496533|17427815|P1|Overall Study|Patient did not complete all measures|0
5054280|NCT02496533|17427814|P2|Overall Study|Lack of data on outcome|0
5054281|NCT02496533|17427815|P1|Overall Study|Lack of data on outcome|3
5054282|NCT02496221|17427827|P2|Treatment Period 2 - 4 Days|Physician Decision|0
5054283|NCT02496221|17427828|P1|Treatment Period 2 - 4 Days|Physician Decision|1
5054284|NCT02496221|17427827|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
5054285|NCT02496221|17427828|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
5054286|NCT02496221|17427827|P2|Treatment Period 2 - 4 Days|Adverse Event|1
5054287|NCT02496221|17427828|P1|Treatment Period 2 - 4 Days|Adverse Event|0
5054288|NCT02496091|17427862|P1|Overall Study|Eligibility criteria not fulfilled|2
5054289|NCT02496039|17427871|P1|Overall Study|Protocol Violation|1
5054290|NCT02496039|17427871|P1|Overall Study|Adverse Event|3
5054291|NCT02496000|17427886|P3|Overall Study|undetermined|0
5054292|NCT02496000|17427887|P2|Overall Study|undetermined|1
5054293|NCT02496000|17427888|P1|Overall Study|undetermined|0
5054294|NCT02496000|17427886|P3|Overall Study|Non-compliance or lack of cooperation|0
5054295|NCT02496000|17427887|P2|Overall Study|Non-compliance or lack of cooperation|2
5054296|NCT02496000|17427888|P1|Overall Study|Non-compliance or lack of cooperation|0
5054297|NCT02496000|17427886|P3|Overall Study|Protocol Violation|1
5054298|NCT02496000|17427887|P2|Overall Study|Protocol Violation|0
5054299|NCT02496000|17427888|P1|Overall Study|Protocol Violation|0
5054300|NCT02496000|17427886|P3|Overall Study|Lost to Follow-up|1
5054301|NCT02496000|17427887|P2|Overall Study|Lost to Follow-up|0
5054302|NCT02496000|17427888|P1|Overall Study|Lost to Follow-up|1
5054303|NCT02496000|17427886|P3|Overall Study|Withdrawal by Subject|0
5054304|NCT02496000|17427887|P2|Overall Study|Withdrawal by Subject|2
5054305|NCT02496000|17427888|P1|Overall Study|Withdrawal by Subject|1
5054306|NCT02495948|17427909|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
5054307|NCT02495948|17427910|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
5054308|NCT02495948|17427909|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5054309|NCT02495948|17427910|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5054310|NCT02495857|17427920|P3|Overall Study|Other|2
5054311|NCT02495857|17427921|P2|Overall Study|Other|3
5054312|NCT02495857|17427922|P1|Overall Study|Other|3
5054313|NCT02495857|17427920|P3|Overall Study|Lost to Follow-up|3
5054314|NCT02495857|17427921|P2|Overall Study|Lost to Follow-up|5
5054315|NCT02495857|17427922|P1|Overall Study|Lost to Follow-up|4
5054316|NCT02495857|17427920|P3|Overall Study|Protocol Violation|2
5054317|NCT02495857|17427921|P2|Overall Study|Protocol Violation|1
5054318|NCT02495857|17427922|P1|Overall Study|Protocol Violation|1
5054319|NCT02495857|17427920|P3|Overall Study|Physician Decision|0
5054320|NCT02495857|17427921|P2|Overall Study|Physician Decision|1
5054321|NCT02495857|17427922|P1|Overall Study|Physician Decision|0
5054322|NCT02495857|17427920|P3|Overall Study|Withdrawal by Subject|10
5054323|NCT02495857|17427921|P2|Overall Study|Withdrawal by Subject|6
5054324|NCT02495857|17427922|P1|Overall Study|Withdrawal by Subject|9
5054325|NCT02495857|17427920|P3|Overall Study|Adverse Event|1
5054326|NCT02495857|17427921|P2|Overall Study|Adverse Event|0
5054327|NCT02495857|17427922|P1|Overall Study|Adverse Event|5
5054328|NCT02495844|17427938|P2|Overall Study|Hepatitis Positivity|1
5054329|NCT02495844|17427939|P1|Overall Study|Hepatitis Positivity|0
5054330|NCT02495844|17427938|P2|Overall Study|AE, non-fatal|1
5054331|NCT02495844|17427939|P1|Overall Study|AE, non-fatal|0
5054332|NCT02495844|17427938|P2|Overall Study|Lack of Efficacy|2
5054333|NCT02495844|17427939|P1|Overall Study|Lack of Efficacy|1
5054334|NCT02495389|17428041|P1|Overall Study|Withdrawal by Subject|40
5054335|NCT02495233|17428079|P2|Overall Study|Miscellaneous|1
5054336|NCT02495233|17428080|P1|Overall Study|Miscellaneous|0
5054337|NCT02495168|17428109|P3|Overall Study|Lack of Efficacy|3
5054338|NCT02495168|17428110|P2|Overall Study|Lack of Efficacy|0
5054339|NCT02495168|17428111|P1|Overall Study|Lack of Efficacy|0
5054340|NCT02495168|17428109|P3|Overall Study|Adverse Event|3
5054341|NCT02495168|17428110|P2|Overall Study|Adverse Event|8
5054342|NCT02495168|17428111|P1|Overall Study|Adverse Event|4
5054343|NCT02495168|17428109|P3|Overall Study|Protocol Violation|1
5054344|NCT02495168|17428110|P2|Overall Study|Protocol Violation|10
5054345|NCT02495168|17428111|P1|Overall Study|Protocol Violation|0
5054346|NCT02495168|17428109|P3|Overall Study|Withdrawal by Subject|2
5054347|NCT02495168|17428110|P2|Overall Study|Withdrawal by Subject|4
5054348|NCT02495168|17428111|P1|Overall Study|Withdrawal by Subject|1
5054349|NCT02495168|17428109|P3|Overall Study|Lost to Follow-up|1
5054350|NCT02495168|17428110|P2|Overall Study|Lost to Follow-up|6
5054351|NCT02495168|17428111|P1|Overall Study|Lost to Follow-up|10
5054352|NCT02495168|17428109|P3|Overall Study|Physician Decision|0
5054353|NCT02495168|17428110|P2|Overall Study|Physician Decision|1
5054354|NCT02495168|17428111|P1|Overall Study|Physician Decision|1
5054355|NCT02495168|17428109|P3|Overall Study|Did not Complete Final Visit On Time|2
5054356|NCT02495168|17428110|P2|Overall Study|Did not Complete Final Visit On Time|3
5054357|NCT02495168|17428111|P1|Overall Study|Did not Complete Final Visit On Time|4
5054358|NCT02495168|17428109|P3|Overall Study|Other than Specified|5
5054359|NCT02495168|17428110|P2|Overall Study|Other than Specified|22
5054360|NCT02495168|17428111|P1|Overall Study|Other than Specified|18
5054361|NCT02495025|17428170|P2|Overall Study|Withdrawal by Subject|0
5054362|NCT02495025|17428171|P1|Overall Study|Withdrawal by Subject|5
5054363|NCT02495025|17428170|P2|Overall Study|Lost to Follow-up|14
5054364|NCT02495025|17428171|P1|Overall Study|Lost to Follow-up|21
5054365|NCT02494596|17428223|P3|Overall Study|Refused Treatment|0
5054366|NCT02494596|17428224|P2|Overall Study|Refused Treatment|1
5054367|NCT02494596|17428225|P1|Overall Study|Refused Treatment|0
5054368|NCT02494596|17428223|P3|Overall Study|Adverse Event|0
5054369|NCT02494596|17428224|P2|Overall Study|Adverse Event|1
5054370|NCT02494596|17428225|P1|Overall Study|Adverse Event|0
5054371|NCT02494596|17428223|P3|Overall Study|Insufficient Therapeutic Response|1
5054372|NCT02494596|17428224|P2|Overall Study|Insufficient Therapeutic Response|3
5054373|NCT02494596|17428225|P1|Overall Study|Insufficient Therapeutic Response|3
5054374|NCT02494583|17428253|P3|Overall Study|Ongoing in Study|34
5054375|NCT02494583|17428254|P2|Overall Study|Ongoing in Study|51
5054376|NCT02494583|17428255|P1|Overall Study|Ongoing in Study|56
5054377|NCT02494583|17428253|P3|Overall Study|Withdrawal by Subject|15
5054378|NCT02494583|17428254|P2|Overall Study|Withdrawal by Subject|15
5054379|NCT02494583|17428255|P1|Overall Study|Withdrawal by Subject|3
5054380|NCT02494583|17428253|P3|Overall Study|Protocol Violation|0
5054381|NCT02494583|17428254|P2|Overall Study|Protocol Violation|2
5054382|NCT02494583|17428255|P1|Overall Study|Protocol Violation|1
5054383|NCT02494583|17428253|P3|Overall Study|Lost to Follow-up|0
5054384|NCT02494583|17428254|P2|Overall Study|Lost to Follow-up|0
5054385|NCT02494583|17428255|P1|Overall Study|Lost to Follow-up|1
5054386|NCT02494583|17428253|P3|Overall Study|Death|201
5054387|NCT02494583|17428254|P2|Overall Study|Death|189
5054388|NCT02494583|17428255|P1|Overall Study|Death|195
5054389|NCT02494401|17428353|P2|Overall Study|Withdrawal by Subject|2
5054390|NCT02494401|17428354|P1|Overall Study|Withdrawal by Subject|3
5054391|NCT02494401|17428353|P2|Overall Study|Lost to Follow-up|25
5054392|NCT02494401|17428354|P1|Overall Study|Lost to Follow-up|22
5054393|NCT02494206|17428406|P1|Overall Study|Disease Progression|1
5054394|NCT02494206|17428406|P1|Overall Study|Adverse Event|1
5054395|NCT02493946|17428460|P3|Open Label Period|Site error|1
5054396|NCT02493946|17428461|P2|Open Label Period|Site error|0
5054397|NCT02493946|17428462|P1|Open Label Period|Site error|0
5054398|NCT02493946|17428460|P3|Open Label Period|Pregnancy|3
5054399|NCT02493946|17428461|P2|Open Label Period|Pregnancy|0
5054400|NCT02493946|17428462|P1|Open Label Period|Pregnancy|0
5054401|NCT02493946|17428460|P3|Open Label Period|Investigator decision, non-availability|1
5054402|NCT02493946|17428461|P2|Open Label Period|Investigator decision, non-availability|0
5054403|NCT02493946|17428462|P1|Open Label Period|Investigator decision, non-availability|0
5054404|NCT02493946|17428460|P3|Open Label Period|Investigator decision, non-compliance|2
5054405|NCT02493946|17428461|P2|Open Label Period|Investigator decision, non-compliance|0
5054406|NCT02493946|17428462|P1|Open Label Period|Investigator decision, non-compliance|0
5054407|NCT02493946|17428460|P3|Open Label Period|Lost to Follow-up|1
5054408|NCT02493946|17428461|P2|Open Label Period|Lost to Follow-up|0
5054409|NCT02493946|17428462|P1|Open Label Period|Lost to Follow-up|0
5054410|NCT02493946|17428460|P3|Open Label Period|Adverse Event|4
5054411|NCT02493946|17428461|P2|Open Label Period|Adverse Event|0
5054412|NCT02493946|17428462|P1|Open Label Period|Adverse Event|0
5054413|NCT02493946|17428460|P3|Open Label Period|Withdrawal by Subject|74
5054414|NCT02493946|17428461|P2|Open Label Period|Withdrawal by Subject|0
5054415|NCT02493946|17428462|P1|Open Label Period|Withdrawal by Subject|0
5054416|NCT02493946|17428460|P3|DB Period|Withdrawal by Subject|0
5054417|NCT02493946|17428461|P2|DB Period|Withdrawal by Subject|5
5054418|NCT02493946|17428462|P1|DB Period|Withdrawal by Subject|8
5054419|NCT02493868|17428495|P2|Follow-up Phase|Other|1
5054420|NCT02493868|17428496|P1|Follow-up Phase|Other|2
5054421|NCT02493868|17428495|P2|Follow-up Phase|Investigator Decision|1
5054422|NCT02493868|17428496|P1|Follow-up Phase|Investigator Decision|5
5054423|NCT02493868|17428495|P2|Follow-up Phase|Withdrawal by Subject|0
5054424|NCT02493868|17428496|P1|Follow-up Phase|Withdrawal by Subject|3
5054425|NCT02493868|17428495|P2|Follow-up Phase|Lost to Follow-up|0
5054426|NCT02493868|17428496|P1|Follow-up Phase|Lost to Follow-up|1
5054427|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Other|9
5054428|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Other|4
5054429|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
5054430|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
5054431|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
5054432|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
5054433|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
5054434|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
5054435|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
5054436|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
5054437|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
5054438|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
5054439|NCT02493868|17428495|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
5054440|NCT02493868|17428496|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
5054441|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Other|2
5054442|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Other|10
5054443|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
5054444|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
5054445|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
5054446|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
5054447|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
5054448|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
5054449|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
5054450|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
5054451|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
5054452|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
5054453|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
5054454|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
5054455|NCT02493868|17428495|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
5054456|NCT02493868|17428496|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
5054457|NCT02493868|17428495|P2|Induction Phase: DE Participants|Other|0
5054458|NCT02493868|17428496|P1|Induction Phase: DE Participants|Other|8
5054459|NCT02493868|17428495|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
5054460|NCT02493868|17428496|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
5054461|NCT02493868|17428495|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
5054462|NCT02493868|17428496|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
5054463|NCT02493868|17428495|P2|Induction Phase: DE Participants|Protocol Violation|0
5054464|NCT02493868|17428496|P1|Induction Phase: DE Participants|Protocol Violation|2
5054465|NCT02493868|17428495|P2|Induction Phase: DE Participants|Lack of Efficacy|0
5054466|NCT02493868|17428496|P1|Induction Phase: DE Participants|Lack of Efficacy|2
5054467|NCT02493868|17428495|P2|Induction Phase: DE Participants|Lost to Follow-up|0
5054468|NCT02493868|17428496|P1|Induction Phase: DE Participants|Lost to Follow-up|1
5054469|NCT02493868|17428495|P2|Induction Phase: DE Participants|Adverse Event|0
5054470|NCT02493868|17428496|P1|Induction Phase: DE Participants|Adverse Event|22
5054471|NCT02493855|17428545|P3|Overall Study|Withdrawal by Subject|0
5054472|NCT02493855|17428546|P2|Overall Study|Withdrawal by Subject|0
5054473|NCT02493855|17428547|P1|Overall Study|Withdrawal by Subject|1
5054474|NCT02493855|17428545|P3|Overall Study|Adverse Event|0
5054475|NCT02493855|17428546|P2|Overall Study|Adverse Event|1
5054476|NCT02493855|17428547|P1|Overall Study|Adverse Event|0
5054477|NCT02493855|17428545|P3|Overall Study|Non-compliance|0
5054478|NCT02493855|17428546|P2|Overall Study|Non-compliance|0
5054479|NCT02493855|17428547|P1|Overall Study|Non-compliance|1
5054480|NCT02493777|17428557|P2|Overall Study|Lost to Follow-up|1
5054481|NCT02493777|17428558|P1|Overall Study|Lost to Follow-up|0
5054482|NCT02493764|17428568|P2|Overall Study|Withdrawal by Subject|7
5054483|NCT02493764|17428569|P1|Overall Study|Withdrawal by Subject|11
5054484|NCT02493764|17428568|P2|Overall Study|Withdrawal parent/guardian|1
5054485|NCT02493764|17428569|P1|Overall Study|Withdrawal parent/guardian|0
5054486|NCT02493764|17428568|P2|Overall Study|Participant moved|5
5054487|NCT02493764|17428569|P1|Overall Study|Participant moved|17
5054488|NCT02493764|17428568|P2|Overall Study|Physician Decision|1
5054489|NCT02493764|17428569|P1|Overall Study|Physician Decision|1
5054490|NCT02493764|17428568|P2|Overall Study|Protocol Violation|7
5054491|NCT02493764|17428569|P1|Overall Study|Protocol Violation|6
5054492|NCT02493764|17428568|P2|Overall Study|Lost to Follow-up|1
5054493|NCT02493764|17428569|P1|Overall Study|Lost to Follow-up|2
5054494|NCT02493764|17428568|P2|Overall Study|Death|58
5054495|NCT02493764|17428569|P1|Overall Study|Death|44
5054496|NCT02493764|17428568|P2|Overall Study|Adverse Event|2
5054497|NCT02493764|17428569|P1|Overall Study|Adverse Event|2
5054498|NCT02493751|17428619|P2|Overall Study|Ongoing|23
5054499|NCT02493751|17428620|P1|Overall Study|Ongoing|11
5054500|NCT02493751|17428619|P2|Overall Study|Withdrawal by Subject|5
5054501|NCT02493751|17428620|P1|Overall Study|Withdrawal by Subject|2
5054502|NCT02493751|17428619|P2|Overall Study|Lost to Follow-up|1
5054503|NCT02493751|17428620|P1|Overall Study|Lost to Follow-up|0
5054504|NCT02493712|17428628|P3|Overall Study|Lack of Efficacy|3
5054505|NCT02493712|17428629|P2|Overall Study|Lack of Efficacy|5
5054506|NCT02493712|17428630|P1|Overall Study|Lack of Efficacy|0
5054507|NCT02493712|17428628|P3|Overall Study|Physician Decision|0
5054508|NCT02493712|17428629|P2|Overall Study|Physician Decision|1
5054509|NCT02493712|17428630|P1|Overall Study|Physician Decision|0
5054510|NCT02493712|17428628|P3|Overall Study|Lost to Follow-up|0
5054511|NCT02493712|17428629|P2|Overall Study|Lost to Follow-up|0
5054512|NCT02493712|17428630|P1|Overall Study|Lost to Follow-up|1
5054513|NCT02493712|17428628|P3|Overall Study|Protocol Violation|1
5054514|NCT02493712|17428629|P2|Overall Study|Protocol Violation|0
5054515|NCT02493712|17428630|P1|Overall Study|Protocol Violation|0
5054516|NCT02493712|17428628|P3|Overall Study|Withdrawal by Subject|2
5054517|NCT02493712|17428629|P2|Overall Study|Withdrawal by Subject|0
5054518|NCT02493712|17428630|P1|Overall Study|Withdrawal by Subject|1
5054519|NCT02493517|17428667|P2|Overall Study|Missed study visit|1
5054520|NCT02493517|17428668|P1|Overall Study|Missed study visit|0
5054521|NCT02493517|17428667|P2|Overall Study|Adverse Event|2
5054522|NCT02493517|17428668|P1|Overall Study|Adverse Event|0
5054523|NCT02493517|17428667|P2|Overall Study|Withdrawal by Subject|2
5054524|NCT02493517|17428668|P1|Overall Study|Withdrawal by Subject|1
5054525|NCT02493517|17428667|P2|Overall Study|Protocol Violation|2
5054526|NCT02493517|17428668|P1|Overall Study|Protocol Violation|1
5054527|NCT02493127|17428748|P2|Overall Study|Lost to Follow-up|1
5054528|NCT02493127|17428749|P1|Overall Study|Lost to Follow-up|1
5054529|NCT02493062|17428767|P1|Overall Study|Physician Decision|12
5054530|NCT02492997|17428790|P2|Overall Study|Lost to Follow-up|1
5054531|NCT02492997|17428791|P1|Overall Study|Lost to Follow-up|0
5054532|NCT02492997|17428790|P2|Overall Study|Gained Weight|0
5054533|NCT02492997|17428791|P1|Overall Study|Gained Weight|1
5054534|NCT02492997|17428790|P2|Overall Study|Withdrawal by Subject|0
5054535|NCT02492997|17428791|P1|Overall Study|Withdrawal by Subject|1
5054536|NCT02492984|17428801|P2|Overall Study|Withdrawal by Subject|0
5054537|NCT02492984|17428802|P1|Overall Study|Withdrawal by Subject|1
5054538|NCT02492984|17428801|P2|Overall Study|Protocol Violation|0
5054539|NCT02492984|17428802|P1|Overall Study|Protocol Violation|1
5054540|NCT02492984|17428801|P2|Overall Study|Adverse Event|0
5054541|NCT02492984|17428802|P1|Overall Study|Adverse Event|1
5054542|NCT02492958|17428826|P4|Overall Study|Adverse Event|0
5054543|NCT02492958|17428827|P3|Overall Study|Adverse Event|1
5054544|NCT02492958|17428828|P2|Overall Study|Adverse Event|0
5054545|NCT02492958|17428829|P1|Overall Study|Adverse Event|1
5054546|NCT02492958|17428826|P4|Overall Study|Withdrawal by Subject|0
5054547|NCT02492958|17428827|P3|Overall Study|Withdrawal by Subject|1
5054548|NCT02492958|17428828|P2|Overall Study|Withdrawal by Subject|0
5054549|NCT02492958|17428829|P1|Overall Study|Withdrawal by Subject|0
5054550|NCT02492880|17428915|P1|Overall Study|Protocol Violation|1
5054551|NCT02492880|17428915|P1|Overall Study|Lost to Follow-up|1
5054552|NCT02492841|17428922|P3|Overall Study|Lost to Follow-up|35
5054553|NCT02492841|17428923|P2|Overall Study|Lost to Follow-up|31
5054554|NCT02492841|17428924|P1|Overall Study|Lost to Follow-up|34
5054555|NCT02492763|17428943|P4|Overall Study|Study Terminated by Sponsor|10
5054556|NCT02492763|17428944|P3|Overall Study|Study Terminated by Sponsor|6
5054557|NCT02492763|17428945|P2|Overall Study|Study Terminated by Sponsor|10
5054558|NCT02492763|17428946|P1|Overall Study|Study Terminated by Sponsor|13
5054559|NCT02492763|17428943|P4|Overall Study|Screen Failure|1
5054560|NCT02492763|17428944|P3|Overall Study|Screen Failure|0
5054561|NCT02492763|17428945|P2|Overall Study|Screen Failure|0
5054562|NCT02492763|17428946|P1|Overall Study|Screen Failure|0
5054563|NCT02492763|17428943|P4|Overall Study|Non-Compliance With Study Drug|0
5054564|NCT02492763|17428944|P3|Overall Study|Non-Compliance With Study Drug|0
5054565|NCT02492763|17428945|P2|Overall Study|Non-Compliance With Study Drug|1
5054566|NCT02492763|17428946|P1|Overall Study|Non-Compliance With Study Drug|0
5054567|NCT02492763|17428943|P4|Overall Study|Lost to Follow-up|0
5054568|NCT02492763|17428944|P3|Overall Study|Lost to Follow-up|1
5054569|NCT02492763|17428945|P2|Overall Study|Lost to Follow-up|0
5054570|NCT02492763|17428946|P1|Overall Study|Lost to Follow-up|0
5054571|NCT02492763|17428943|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
5054572|NCT02492763|17428944|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
5054573|NCT02492763|17428945|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
5054574|NCT02492763|17428946|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
5054575|NCT02492763|17428943|P4|Overall Study|Death|0
5054576|NCT02492763|17428944|P3|Overall Study|Death|1
5054577|NCT02492763|17428945|P2|Overall Study|Death|0
5054578|NCT02492763|17428946|P1|Overall Study|Death|0
5054579|NCT02492763|17428943|P4|Overall Study|Adverse Event|2
5054580|NCT02492763|17428944|P3|Overall Study|Adverse Event|1
5054581|NCT02492763|17428945|P2|Overall Study|Adverse Event|1
5054582|NCT02492763|17428946|P1|Overall Study|Adverse Event|3
5054583|NCT02492763|17428943|P4|Overall Study|Withdrawal by Subject|0
5054584|NCT02492763|17428944|P3|Overall Study|Withdrawal by Subject|1
5054585|NCT02492763|17428945|P2|Overall Study|Withdrawal by Subject|2
5054586|NCT02492763|17428946|P1|Overall Study|Withdrawal by Subject|0
5054587|NCT02492165|17429051|P4|Overall Study|Withdrawal by Subject|0
5054588|NCT02492165|17429052|P3|Overall Study|Withdrawal by Subject|0
5054589|NCT02492165|17429053|P2|Overall Study|Withdrawal by Subject|1
5054590|NCT02492165|17429054|P1|Overall Study|Withdrawal by Subject|0
5054591|NCT02492100|17429076|P1|Overall Study|Death|1
5054592|NCT02491892|17429105|P2|Overall Study|Lost to Follow-up|0
5054593|NCT02491892|17429106|P1|Overall Study|Lost to Follow-up|1
5054594|NCT02491892|17429105|P2|Overall Study|Refused Treatment|0
5054595|NCT02491892|17429106|P1|Overall Study|Refused Treatment|1
5054596|NCT02491892|17429105|P2|Overall Study|Lack of Efficacy|36
5054597|NCT02491892|17429106|P1|Overall Study|Lack of Efficacy|37
5054598|NCT02491892|17429105|P2|Overall Study|Death|1
5054599|NCT02491892|17429106|P1|Overall Study|Death|1
5054600|NCT02491892|17429105|P2|Overall Study|Adverse Event|1
5054601|NCT02491892|17429106|P1|Overall Study|Adverse Event|1
5054602|NCT02491684|17429161|P2|Treatment Phase|Investigator and Sponsor decision|1
5054603|NCT02491684|17429162|P1|Treatment Phase|Investigator and Sponsor decision|0
5054604|NCT02491684|17429161|P2|Treatment Phase|Incorrect randomisation|0
5054605|NCT02491684|17429162|P1|Treatment Phase|Incorrect randomisation|1
5054606|NCT02491684|17429161|P2|Treatment Phase|Adverse Event|2
5054607|NCT02491684|17429162|P1|Treatment Phase|Adverse Event|2
5054608|NCT02491463|17429200|P4|Overall Study|Lost to Follow-up|0
5054609|NCT02491463|17429201|P3|Overall Study|Lost to Follow-up|3
5054610|NCT02491463|17429202|P2|Overall Study|Lost to Follow-up|3
5054611|NCT02491463|17429203|P1|Overall Study|Lost to Follow-up|0
5054612|NCT02491463|17429200|P4|Overall Study|Migrated/moved from study area|1
5054613|NCT02491463|17429201|P3|Overall Study|Migrated/moved from study area|1
5054614|NCT02491463|17429202|P2|Overall Study|Migrated/moved from study area|5
5054615|NCT02491463|17429203|P1|Overall Study|Migrated/moved from study area|1
5054616|NCT02491463|17429200|P4|Overall Study|Withdrawal by Subject|0
5054617|NCT02491463|17429201|P3|Overall Study|Withdrawal by Subject|0
5054618|NCT02491463|17429202|P2|Overall Study|Withdrawal by Subject|2
5054619|NCT02491463|17429203|P1|Overall Study|Withdrawal by Subject|1
5054620|NCT02491411|17429306|P1|Overall Study|Physician Decision|4
5054621|NCT02491073|17429337|P2|Overall Study|screen failure|0
5054622|NCT02491073|17429338|P1|Overall Study|screen failure|1
5054623|NCT02490475|17429390|P4|Period 2: Extension Phase|Adverse Event|0
5054624|NCT02490475|17429391|P3|Period 2: Extension Phase|Adverse Event|1
5054625|NCT02490475|17429392|P2|Period 2: Extension Phase|Adverse Event|0
5054626|NCT02490475|17429393|P1|Period 2: Extension Phase|Adverse Event|0
5054627|NCT02490475|17429390|P4|Period 2: Extension Phase|Refused Treatment|1
5054628|NCT02490475|17429391|P3|Period 2: Extension Phase|Refused Treatment|0
5054629|NCT02490475|17429392|P2|Period 2: Extension Phase|Refused Treatment|0
5054630|NCT02490475|17429393|P1|Period 2: Extension Phase|Refused Treatment|0
5054631|NCT02490475|17429390|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
5054632|NCT02490475|17429391|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
5054633|NCT02490475|17429392|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
5054634|NCT02490475|17429393|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
5054635|NCT02490475|17429390|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
5054636|NCT02490475|17429391|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
5054637|NCT02490475|17429392|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
5054638|NCT02490475|17429393|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
5054639|NCT02490475|17429390|P4|Period 1: First 6 Cycles|Refused Treatment|0
5054640|NCT02490475|17429391|P3|Period 1: First 6 Cycles|Refused Treatment|0
5054641|NCT02490475|17429392|P2|Period 1: First 6 Cycles|Refused Treatment|0
5054642|NCT02490475|17429393|P1|Period 1: First 6 Cycles|Refused Treatment|1
5054643|NCT02490475|17429390|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5054644|NCT02490475|17429391|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5054645|NCT02490475|17429392|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
5054646|NCT02490475|17429393|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5054647|NCT02490475|17429390|P4|Period 1: First 6 Cycles|Adverse Event|1
5054648|NCT02490475|17429391|P3|Period 1: First 6 Cycles|Adverse Event|0
5054649|NCT02490475|17429392|P2|Period 1: First 6 Cycles|Adverse Event|1
5054650|NCT02490475|17429393|P1|Period 1: First 6 Cycles|Adverse Event|2
5054651|NCT02490371|17429471|P2|Overall Study|Lost to Follow-up|1
5054652|NCT02490371|17429472|P1|Overall Study|Lost to Follow-up|1
5054653|NCT02489981|17429499|P1|Overall Study|Other than listed|28
5054654|NCT02489981|17429499|P1|Overall Study|Lost to Follow-up|31
5054655|NCT02489981|17429499|P1|Overall Study|Improved|31
5054656|NCT02489981|17429499|P1|Overall Study|Insufficient effectiveness|16
5054657|NCT02489981|17429499|P1|Overall Study|Adverse Event|21
5054658|NCT02489968|17429506|P6|Double-blind Treatment Period|Other than specified above|0
5054659|NCT02489968|17429507|P5|Double-blind Treatment Period|Other than specified above|1
5054660|NCT02489968|17429508|P4|Double-blind Treatment Period|Other than specified above|0
5054661|NCT02489968|17429509|P3|Double-blind Treatment Period|Other than specified above|0
5054662|NCT02489968|17429510|P2|Double-blind Treatment Period|Other than specified above|0
5054663|NCT02489968|17429511|P1|Double-blind Treatment Period|Other than specified above|0
5054664|NCT02489968|17429506|P6|Double-blind Treatment Period|Withdrawal by Subject|2
5054665|NCT02489968|17429507|P5|Double-blind Treatment Period|Withdrawal by Subject|0
5054666|NCT02489968|17429508|P4|Double-blind Treatment Period|Withdrawal by Subject|2
5054667|NCT02489968|17429509|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5054749|NCT02488330|17429722|P1|Overall Study|Adverse Event|1
5054668|NCT02489968|17429510|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5054669|NCT02489968|17429511|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5054670|NCT02489968|17429506|P6|Double-blind Treatment Period|Protocol Violation|1
5054671|NCT02489968|17429507|P5|Double-blind Treatment Period|Protocol Violation|1
5054672|NCT02489968|17429508|P4|Double-blind Treatment Period|Protocol Violation|0
5054673|NCT02489968|17429509|P3|Double-blind Treatment Period|Protocol Violation|0
5054674|NCT02489968|17429510|P2|Double-blind Treatment Period|Protocol Violation|0
5054675|NCT02489968|17429511|P1|Double-blind Treatment Period|Protocol Violation|0
5054676|NCT02489968|17429506|P6|Double-blind Treatment Period|Adverse Event|5
5054677|NCT02489968|17429507|P5|Double-blind Treatment Period|Adverse Event|4
5054678|NCT02489968|17429508|P4|Double-blind Treatment Period|Adverse Event|6
5054679|NCT02489968|17429509|P3|Double-blind Treatment Period|Adverse Event|2
5054680|NCT02489968|17429510|P2|Double-blind Treatment Period|Adverse Event|0
5054681|NCT02489968|17429511|P1|Double-blind Treatment Period|Adverse Event|0
5054682|NCT02489968|17429506|P6|Open-label Treatment Period|Other than specified above|0
5054683|NCT02489968|17429507|P5|Open-label Treatment Period|Other than specified above|0
5054684|NCT02489968|17429508|P4|Open-label Treatment Period|Other than specified above|0
5054685|NCT02489968|17429509|P3|Open-label Treatment Period|Other than specified above|0
5054686|NCT02489968|17429510|P2|Open-label Treatment Period|Other than specified above|189
5054687|NCT02489968|17429511|P1|Open-label Treatment Period|Other than specified above|204
5054688|NCT02489968|17429506|P6|Open-label Treatment Period|Withdrawal by Subject|0
5054689|NCT02489968|17429507|P5|Open-label Treatment Period|Withdrawal by Subject|0
5054690|NCT02489968|17429508|P4|Open-label Treatment Period|Withdrawal by Subject|0
5054691|NCT02489968|17429509|P3|Open-label Treatment Period|Withdrawal by Subject|0
5054692|NCT02489968|17429510|P2|Open-label Treatment Period|Withdrawal by Subject|7
5054693|NCT02489968|17429511|P1|Open-label Treatment Period|Withdrawal by Subject|4
5054694|NCT02489968|17429506|P6|Open-label Treatment Period|Lost to Follow-up|0
5054695|NCT02489968|17429507|P5|Open-label Treatment Period|Lost to Follow-up|0
5054696|NCT02489968|17429508|P4|Open-label Treatment Period|Lost to Follow-up|0
5054697|NCT02489968|17429509|P3|Open-label Treatment Period|Lost to Follow-up|0
5054698|NCT02489968|17429510|P2|Open-label Treatment Period|Lost to Follow-up|3
5054699|NCT02489968|17429511|P1|Open-label Treatment Period|Lost to Follow-up|0
5054700|NCT02489968|17429506|P6|Open-label Treatment Period|Protocol Violation|0
5054701|NCT02489968|17429507|P5|Open-label Treatment Period|Protocol Violation|0
5054702|NCT02489968|17429508|P4|Open-label Treatment Period|Protocol Violation|0
5054703|NCT02489968|17429509|P3|Open-label Treatment Period|Protocol Violation|0
5054704|NCT02489968|17429510|P2|Open-label Treatment Period|Protocol Violation|2
5054705|NCT02489968|17429511|P1|Open-label Treatment Period|Protocol Violation|2
5054706|NCT02489968|17429506|P6|Open-label Treatment Period|Adverse Event|0
5054707|NCT02489968|17429507|P5|Open-label Treatment Period|Adverse Event|0
5054708|NCT02489968|17429508|P4|Open-label Treatment Period|Adverse Event|0
5054709|NCT02489968|17429509|P3|Open-label Treatment Period|Adverse Event|0
5054710|NCT02489968|17429510|P2|Open-label Treatment Period|Adverse Event|7
5054711|NCT02489968|17429511|P1|Open-label Treatment Period|Adverse Event|14
5054712|NCT02489799|17429525|P2|Overall Study|Death|1
5054713|NCT02489799|17429526|P1|Overall Study|Death|0
5054714|NCT02489799|17429525|P2|Overall Study|Withdrawal by Subject|1
5054715|NCT02489799|17429526|P1|Overall Study|Withdrawal by Subject|1
5054716|NCT02489799|17429525|P2|Overall Study|Failure to Maintain Eligibility|6
5054717|NCT02489799|17429526|P1|Overall Study|Failure to Maintain Eligibility|4
5054718|NCT02489799|17429525|P2|Overall Study|Lost to Follow-up|1
5054719|NCT02489799|17429526|P1|Overall Study|Lost to Follow-up|4
5054720|NCT02489773|17429552|P2|Overall Study|Leave the country or the state|1
5054721|NCT02489773|17429553|P1|Overall Study|Leave the country or the state|1
5054722|NCT02489773|17429552|P2|Overall Study|Withdrawal by Subject|0
5054723|NCT02489773|17429553|P1|Overall Study|Withdrawal by Subject|1
5054724|NCT02489773|17429552|P2|Overall Study|Physician Decision|0
5054725|NCT02489773|17429553|P1|Overall Study|Physician Decision|1
5054726|NCT02489773|17429552|P2|Overall Study|Lost to Follow-up|1
5054727|NCT02489773|17429553|P1|Overall Study|Lost to Follow-up|4
5054728|NCT02489500|17429563|P2|Overall Study|Death|1
5054729|NCT02489500|17429564|P1|Overall Study|Death|1
5054730|NCT02489344|17429582|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
5054731|NCT02489344|17429582|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
5054732|NCT02489344|17429582|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
5054733|NCT02489344|17429582|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
5054734|NCT02489279|17429624|P2|Overall Study|Lost to Follow-up|10
5054735|NCT02489279|17429625|P1|Overall Study|Lost to Follow-up|12
5054736|NCT02488980|17429666|P3|Overall Study|Protocol Violation|2
5054737|NCT02488980|17429667|P2|Overall Study|Protocol Violation|2
5054738|NCT02488980|17429668|P1|Overall Study|Protocol Violation|2
5054739|NCT02488915|17429685|P1|Overall Study|Withdrawal by Subject|1
5054740|NCT02488915|17429685|P1|Overall Study|Lost to Follow-up|4
5054741|NCT02488915|17429685|P1|Overall Study|Death|21
5054742|NCT02488824|17429703|P2|Overall Study|Adverse Event|1
5054743|NCT02488824|17429704|P1|Overall Study|Adverse Event|1
5054744|NCT02488681|17429718|P1|Overall Study|Implant unsuccessful|7
5054745|NCT02488330|17429722|P1|Overall Study|Study Termination by Sponsor|4
5054746|NCT02488330|17429722|P1|Overall Study|Disease Progression|3
5054747|NCT02488330|17429722|P1|Overall Study|Death|2
5054748|NCT02488330|17429722|P1|Overall Study|Physician Decision|2
5054750|NCT02488239|17429743|P1|Overall Study|Did not undergo implant procedure|1
5054751|NCT02488239|17429743|P1|Overall Study|Consent ineligible|1
5054752|NCT02488239|17429743|P1|Overall Study|Physician Decision|2
5054753|NCT02488239|17429743|P1|Overall Study|Withdrawal by Subject|3
5054754|NCT02488239|17429743|P1|Overall Study|Death|3
5054755|NCT02488005|17429760|P1|Overall Study|Lost to Follow-up|2
5054756|NCT02487979|17429770|P1|Overall Study|Progressive Disease|17
5054757|NCT02487979|17429770|P1|Overall Study|Withdrawal by Subject|2
5054758|NCT02487979|17429770|P1|Overall Study|Physician Decision|2
5054759|NCT02487810|17429782|P2|Overall Study|Withdrawal by Subject|0
5054760|NCT02487810|17429783|P1|Overall Study|Withdrawal by Subject|1
5054761|NCT02487771|17429815|P2|Overall Study|Withdrawal by Subject|5
5054762|NCT02487771|17429816|P1|Overall Study|Withdrawal by Subject|3
5054763|NCT02487771|17429815|P2|Overall Study|Moved out of area|6
5054764|NCT02487771|17429816|P1|Overall Study|Moved out of area|5
5054765|NCT02487771|17429815|P2|Overall Study|Lost to Follow-up|3
5054766|NCT02487771|17429816|P1|Overall Study|Lost to Follow-up|2
5054767|NCT02487498|17429982|P2|Period: Period 2|Physician Decision|0
5054768|NCT02487498|17429983|P1|Period: Period 2|Physician Decision|1
5054769|NCT02487498|17429982|P2|Period: Period 2|Death|1
5054770|NCT02487498|17429983|P1|Period: Period 2|Death|0
5054771|NCT02487498|17429982|P2|Period: Period 2|Lost to Follow-up|1
5054772|NCT02487498|17429983|P1|Period: Period 2|Lost to Follow-up|1
5054773|NCT02487498|17429982|P2|Period: Period 2|Subject/guardian decision|1
5054774|NCT02487498|17429983|P1|Period: Period 2|Subject/guardian decision|2
5054775|NCT02487498|17429982|P2|Period: Period 2|Adverse Event|2
5054776|NCT02487498|17429983|P1|Period: Period 2|Adverse Event|2
5054777|NCT02487498|17429982|P2|Period: Washout|Non-compliance with study treatment|1
5054778|NCT02487498|17429983|P1|Period: Washout|Non-compliance with study treatment|0
5054779|NCT02487498|17429982|P2|Period: Washout|Physician Decision|0
5054780|NCT02487498|17429983|P1|Period: Washout|Physician Decision|1
5054781|NCT02487498|17429982|P2|Period: Washout|Lack of Efficacy|1
5054782|NCT02487498|17429983|P1|Period: Washout|Lack of Efficacy|1
5054783|NCT02487498|17429982|P2|Period: Washout|Subject/guardian decision|5
5054784|NCT02487498|17429983|P1|Period: Washout|Subject/guardian decision|0
5054785|NCT02487498|17429982|P2|Period: Period 1|Protocol deviation|0
5054786|NCT02487498|17429983|P1|Period: Period 1|Protocol deviation|1
5054787|NCT02487498|17429982|P2|Period: Period 1|Physician Decision|1
5054788|NCT02487498|17429983|P1|Period: Period 1|Physician Decision|0
5054789|NCT02487498|17429982|P2|Period: Period 1|Lack of Efficacy|0
5054790|NCT02487498|17429983|P1|Period: Period 1|Lack of Efficacy|1
5054791|NCT02487498|17429982|P2|Period: Period 1|Lost to Follow-up|2
5054792|NCT02487498|17429983|P1|Period: Period 1|Lost to Follow-up|0
5054793|NCT02487498|17429982|P2|Period: Period 1|Subject/guardian decision|4
5054794|NCT02487498|17429983|P1|Period: Period 1|Subject/guardian decision|2
5054795|NCT02487498|17429982|P2|Period: Period 1|Adverse Event|4
5054796|NCT02487498|17429983|P1|Period: Period 1|Adverse Event|2
5054797|NCT02487472|17430027|P1|Overall Study|Other|2
5054798|NCT02487472|17430027|P1|Overall Study|Did not complete telephonic interviews|9
5054799|NCT02487446|17430043|P2|Period 2|Adverse Event|2
5054800|NCT02487446|17430044|P1|Period 2|Adverse Event|6
5054801|NCT02487446|17430043|P2|Period 2|Withdrawal by Subject|1
5054802|NCT02487446|17430044|P1|Period 2|Withdrawal by Subject|1
5054803|NCT02487446|17430043|P2|Period 2|Lost to Follow-up|1
5054804|NCT02487446|17430044|P1|Period 2|Lost to Follow-up|1
5054805|NCT02487446|17430043|P2|Period 2|Protocol deviation|1
5054806|NCT02487446|17430044|P1|Period 2|Protocol deviation|0
5054807|NCT02487446|17430043|P2|Washout|Adverse Event|2
5054808|NCT02487446|17430044|P1|Washout|Adverse Event|2
5054809|NCT02487446|17430043|P2|Washout|Withdrawal by Subject|4
5054810|NCT02487446|17430044|P1|Washout|Withdrawal by Subject|1
5054811|NCT02487446|17430043|P2|Washout|Lost to Follow-up|2
5054812|NCT02487446|17430044|P1|Washout|Lost to Follow-up|0
5054813|NCT02487446|17430043|P2|Period 1|Adverse Event|5
5054814|NCT02487446|17430044|P1|Period 1|Adverse Event|5
5054815|NCT02487446|17430043|P2|Period 1|Withdrawal by Subject|0
5054816|NCT02487446|17430044|P1|Period 1|Withdrawal by Subject|2
5054817|NCT02487446|17430043|P2|Period 1|Lost to Follow-up|0
5054818|NCT02487446|17430044|P1|Period 1|Lost to Follow-up|2
5054819|NCT02487446|17430043|P2|Period 1|Protocol deviation|2
5054820|NCT02487446|17430044|P1|Period 1|Protocol deviation|3
5054821|NCT02487446|17430043|P2|Period 1|Lack of Efficacy|0
5054822|NCT02487446|17430044|P1|Period 1|Lack of Efficacy|1
5054823|NCT02487446|17430043|P2|Period 1|Physician Decision|1
5054824|NCT02487446|17430044|P1|Period 1|Physician Decision|0
5054825|NCT02487199|17430124|P2|Overall Study|Withdrew Consent|1
5054826|NCT02487199|17430125|P1|Overall Study|Withdrew Consent|0
5054827|NCT02487030|17430150|P7|Overall Study|Death|0
5054828|NCT02487030|17430151|P6|Overall Study|Death|0
5054829|NCT02487030|17430152|P5|Overall Study|Death|1
5054830|NCT02487030|17430153|P4|Overall Study|Death|0
5054831|NCT02487030|17430154|P3|Overall Study|Death|0
5054832|NCT02487030|17430155|P2|Overall Study|Death|0
5054833|NCT02487030|17430156|P1|Overall Study|Death|0
5054834|NCT02487030|17430150|P7|Overall Study|Adverse Event|0
5054835|NCT02487030|17430151|P6|Overall Study|Adverse Event|0
5054836|NCT02487030|17430152|P5|Overall Study|Adverse Event|0
5054837|NCT02487030|17430153|P4|Overall Study|Adverse Event|1
5054838|NCT02487030|17430154|P3|Overall Study|Adverse Event|0
5054839|NCT02487030|17430155|P2|Overall Study|Adverse Event|0
5054840|NCT02487030|17430156|P1|Overall Study|Adverse Event|0
5054841|NCT02487030|17430150|P7|Overall Study|Lost to Follow-up|0
5054842|NCT02487030|17430151|P6|Overall Study|Lost to Follow-up|1
5054843|NCT02487030|17430152|P5|Overall Study|Lost to Follow-up|0
5054844|NCT02487030|17430153|P4|Overall Study|Lost to Follow-up|1
5054845|NCT02487030|17430154|P3|Overall Study|Lost to Follow-up|1
5054846|NCT02487030|17430155|P2|Overall Study|Lost to Follow-up|0
5054847|NCT02487030|17430156|P1|Overall Study|Lost to Follow-up|0
5054848|NCT02487030|17430150|P7|Overall Study|Lack of Efficacy|0
5054849|NCT02487030|17430151|P6|Overall Study|Lack of Efficacy|0
5054850|NCT02487030|17430152|P5|Overall Study|Lack of Efficacy|1
5054851|NCT02487030|17430153|P4|Overall Study|Lack of Efficacy|0
5054852|NCT02487030|17430154|P3|Overall Study|Lack of Efficacy|1
5054853|NCT02487030|17430155|P2|Overall Study|Lack of Efficacy|4
5054854|NCT02487030|17430156|P1|Overall Study|Lack of Efficacy|2
5054855|NCT02486952|17430187|P1|Overall Study|Other|2
5054856|NCT02486952|17430187|P1|Overall Study|Lost to Follow-up|26
5054857|NCT02486952|17430187|P1|Overall Study|Lack of Efficacy|3
5054858|NCT02486952|17430187|P1|Overall Study|Death|15
5054859|NCT02486952|17430187|P1|Overall Study|Adverse Event|1
5054860|NCT02486952|17430187|P1|Overall Study|Not Started Induction Therapy|3
5054861|NCT02486796|17430205|P2|Overall Study|Physician Decision|0
5054862|NCT02486796|17430206|P1|Overall Study|Physician Decision|1
5054863|NCT02486796|17430205|P2|Overall Study|Withdrawal by Subject|1
5054864|NCT02486796|17430206|P1|Overall Study|Withdrawal by Subject|1
5054865|NCT02486757|17430218|P1|Overall Study|Lost to Follow-up|1
5054866|NCT02486692|17430224|P2|Overall Study|did not login for randomization|7
5054867|NCT02486692|17430225|P1|Overall Study|did not login for randomization|4
5054868|NCT02486653|17430237|P2|Overall Study|surgery cancelled|1
5054869|NCT02486653|17430238|P1|Overall Study|surgery cancelled|4
5054870|NCT02486653|17430237|P2|Overall Study|Protocol Violation|0
5054871|NCT02486653|17430238|P1|Overall Study|Protocol Violation|1
5054872|NCT02486653|17430237|P2|Overall Study|Withdrawal by Subject|3
5054873|NCT02486653|17430238|P1|Overall Study|Withdrawal by Subject|1
5054874|NCT02486627|17430262|P2|Overall Study|Lost to Follow-up|3
5054875|NCT02486627|17430263|P1|Overall Study|Lost to Follow-up|1
5054876|NCT02486627|17430262|P2|Overall Study|Significant Participant Noncompliance|1
5054877|NCT02486627|17430263|P1|Overall Study|Significant Participant Noncompliance|1
5054878|NCT02486627|17430262|P2|Overall Study|Consent Withdrawn by Participant|3
5054879|NCT02486627|17430263|P1|Overall Study|Consent Withdrawn by Participant|4
5054880|NCT02486627|17430262|P2|Overall Study|Other Unspecified|2
5054881|NCT02486627|17430263|P1|Overall Study|Other Unspecified|0
5054882|NCT02486627|17430262|P2|Overall Study|Death|0
5054883|NCT02486627|17430263|P1|Overall Study|Death|1
5054884|NCT02486588|17430286|P6|Overall Study|Randomized in error- ineligible|746
5054885|NCT02486588|17430287|P5|Overall Study|Randomized in error- ineligible|746
5054886|NCT02486588|17430288|P4|Overall Study|Randomized in error- ineligible|738
5054887|NCT02486588|17430289|P3|Overall Study|Randomized in error- ineligible|755
5054888|NCT02486588|17430290|P2|Overall Study|Randomized in error- ineligible|750
5054889|NCT02486588|17430291|P1|Overall Study|Randomized in error- ineligible|738
5054890|NCT02486302|17430366|P1|Overall Study|Not treated|3
5054891|NCT02486302|17430366|P1|Overall Study|Excluded due to legal reasons|8
5054892|NCT02486302|17430366|P1|Overall Study|Documentation not completed|255
5054893|NCT02486302|17430366|P1|Overall Study|Discontinued prematurely|410
5054894|NCT02485925|17430463|P1|Overall Study|Lost to Follow-up|11
5054895|NCT02485925|17430463|P1|Overall Study|Death|1
5054896|NCT02485925|17430463|P1|Overall Study|Withdrawal by Subject|3
5054897|NCT02485717|17430495|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
5054898|NCT02485717|17430496|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
5054899|NCT02485717|17430497|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
5054900|NCT02485717|17430495|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
5054901|NCT02485717|17430496|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
5054902|NCT02485717|17430497|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
5054903|NCT02485717|17430495|P3|Overall Study|Withdrawal by Subject|1
5054904|NCT02485717|17430496|P2|Overall Study|Withdrawal by Subject|0
5054905|NCT02485717|17430497|P1|Overall Study|Withdrawal by Subject|0
5054906|NCT02485717|17430495|P3|Overall Study|Lost to Follow-up|0
5054907|NCT02485717|17430496|P2|Overall Study|Lost to Follow-up|0
5054908|NCT02485717|17430497|P1|Overall Study|Lost to Follow-up|6
5054909|NCT02485704|17430512|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
5054910|NCT02485704|17430513|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
5054911|NCT02485704|17430512|P2|Overall Study|Withdrawal by Subject|3
5054912|NCT02485704|17430513|P1|Overall Study|Withdrawal by Subject|0
5054913|NCT02485704|17430512|P2|Overall Study|Lost to Follow-up|5
5054914|NCT02485704|17430513|P1|Overall Study|Lost to Follow-up|4
5054915|NCT02485483|17430561|P2|Overall Study|Discontinued after baseline|0
5054916|NCT02485483|17430562|P1|Overall Study|Discontinued after baseline|39
5054917|NCT02485483|17430561|P2|Overall Study|Depression at baseline|0
5054918|NCT02485483|17430562|P1|Overall Study|Depression at baseline|15
5054919|NCT02485353|17430577|P1|Overall Study|Disease Progression|1
5054920|NCT02485353|17430577|P1|Overall Study|Death|1
5054921|NCT02485301|17430584|P2|Overall Study|Other|4
5054922|NCT02485301|17430585|P1|Overall Study|Other|3
5054923|NCT02485301|17430584|P2|Overall Study|Lost to Follow-up|17
5054924|NCT02485301|17430585|P1|Overall Study|Lost to Follow-up|17
5054925|NCT02485301|17430584|P2|Overall Study|Migrated/moved from study area|19
5054926|NCT02485301|17430585|P1|Overall Study|Migrated/moved from study area|10
5054927|NCT02485301|17430584|P2|Overall Study|Withdrawal by Subject|7
5054928|NCT02485301|17430585|P1|Overall Study|Withdrawal by Subject|6
5054929|NCT02485301|17430584|P2|Overall Study|Protocol Violation|1
5054930|NCT02485301|17430585|P1|Overall Study|Protocol Violation|0
5054931|NCT02485301|17430584|P2|Overall Study|Serious Adverse Events|1
5054932|NCT02485301|17430585|P1|Overall Study|Serious Adverse Events|2
5054933|NCT02485158|17430635|P1|Overall Study|expected drug side effect|1
5054934|NCT02485158|17430635|P1|Overall Study|Withdrawal by Subject|3
5054935|NCT02484911|17430724|P2|Overall Study|Protocol Violation|1
5054936|NCT02484911|17430725|P1|Overall Study|Protocol Violation|2
5054937|NCT02484911|17430724|P2|Overall Study|Withdrawal by Subject|1
5054938|NCT02484911|17430725|P1|Overall Study|Withdrawal by Subject|2
5054939|NCT02484729|17430815|P10|Overall Study|Failure of IntelliCap Error|1
5054940|NCT02484729|17430816|P9|Overall Study|Failure of IntelliCap Error|0
5054941|NCT02484729|17430817|P8|Overall Study|Failure of IntelliCap Error|0
5054942|NCT02484729|17430818|P7|Overall Study|Failure of IntelliCap Error|0
5054943|NCT02484729|17430819|P6|Overall Study|Failure of IntelliCap Error|0
5054944|NCT02484729|17430820|P5|Overall Study|Failure of IntelliCap Error|0
5054945|NCT02484729|17430821|P4|Overall Study|Failure of IntelliCap Error|0
5054946|NCT02484729|17430822|P3|Overall Study|Failure of IntelliCap Error|0
5054947|NCT02484729|17430823|P2|Overall Study|Failure of IntelliCap Error|0
5054948|NCT02484729|17430824|P1|Overall Study|Failure of IntelliCap Error|0
5054949|NCT02484690|17431025|P5|Overall Study|Lost to Follow-up|0
5054950|NCT02484690|17431026|P4|Overall Study|Lost to Follow-up|0
5054951|NCT02484690|17431027|P3|Overall Study|Lost to Follow-up|1
5054952|NCT02484690|17431028|P2|Overall Study|Lost to Follow-up|0
5054953|NCT02484690|17431029|P1|Overall Study|Lost to Follow-up|0
5054954|NCT02484690|17431025|P5|Overall Study|Physician Decision|0
5054955|NCT02484690|17431026|P4|Overall Study|Physician Decision|0
5054956|NCT02484690|17431027|P3|Overall Study|Physician Decision|1
5054957|NCT02484690|17431028|P2|Overall Study|Physician Decision|0
5054958|NCT02484690|17431029|P1|Overall Study|Physician Decision|2
5054959|NCT02484690|17431025|P5|Overall Study|Withdrawal by Subject|0
5054960|NCT02484690|17431026|P4|Overall Study|Withdrawal by Subject|2
5054961|NCT02484690|17431027|P3|Overall Study|Withdrawal by Subject|1
5054962|NCT02484690|17431028|P2|Overall Study|Withdrawal by Subject|3
5054963|NCT02484690|17431029|P1|Overall Study|Withdrawal by Subject|1
5054964|NCT02484690|17431025|P5|Overall Study|Death|1
5054965|NCT02484690|17431026|P4|Overall Study|Death|0
5054966|NCT02484690|17431027|P3|Overall Study|Death|0
5054967|NCT02484690|17431028|P2|Overall Study|Death|0
5054968|NCT02484690|17431029|P1|Overall Study|Death|0
5054969|NCT02484690|17431025|P5|Overall Study|Adverse Event|5
5054970|NCT02484690|17431026|P4|Overall Study|Adverse Event|0
5054971|NCT02484690|17431027|P3|Overall Study|Adverse Event|0
5054972|NCT02484690|17431028|P2|Overall Study|Adverse Event|3
5054973|NCT02484690|17431029|P1|Overall Study|Adverse Event|1
5054974|NCT02484651|17431173|P2|Overall Study|Time of the procedure less than 90 min.|2
5054975|NCT02484651|17431174|P1|Overall Study|Time of the procedure less than 90 min.|1
5054976|NCT02484651|17431173|P2|Overall Study|BIS monitoring failed.|1
5054977|NCT02484651|17431174|P1|Overall Study|BIS monitoring failed.|1
5054978|NCT02484651|17431173|P2|Overall Study|Patients' data files were corrupted.|1
5054979|NCT02484651|17431174|P1|Overall Study|Patients' data files were corrupted.|1
5054980|NCT02483975|17431208|P2|Overall Study|Physician Decision|0
5054981|NCT02483975|17431209|P1|Overall Study|Physician Decision|2
5054982|NCT02483975|17431208|P2|Overall Study|Lost to Follow-up|1
5054983|NCT02483975|17431209|P1|Overall Study|Lost to Follow-up|0
5054984|NCT02483975|17431208|P2|Overall Study|Adverse Event|1
5054985|NCT02483975|17431209|P1|Overall Study|Adverse Event|0
5054986|NCT02483611|17431247|P3|Overall Study|Protocol Violation|1
5054987|NCT02483611|17431248|P2|Overall Study|Protocol Violation|0
5054988|NCT02483611|17431249|P1|Overall Study|Protocol Violation|0
5054989|NCT02483585|17431346|P2|Open-label Treatment Phase|Lost to Follow-up|5
5054990|NCT02483585|17431347|P1|Open-label Treatment Phase|Lost to Follow-up|3
5054991|NCT02483585|17431346|P2|Open-label Treatment Phase|Withdrawal by Subject|14
5054992|NCT02483585|17431347|P1|Open-label Treatment Phase|Withdrawal by Subject|18
5054993|NCT02483585|17431346|P2|Open-label Treatment Phase|Decision by Sponsor|1
5054994|NCT02483585|17431347|P1|Open-label Treatment Phase|Decision by Sponsor|0
5054995|NCT02483585|17431346|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
5054996|NCT02483585|17431347|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
5054997|NCT02483585|17431346|P2|Double-blind Treatment Phase|Lost to Follow-up|2
5054998|NCT02483585|17431347|P1|Double-blind Treatment Phase|Lost to Follow-up|3
5054999|NCT02483585|17431346|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
5055000|NCT02483585|17431347|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
5055001|NCT02483585|17431346|P2|Double-blind Treatment Phase|Decision by Sponsor|1
5055002|NCT02483585|17431347|P1|Double-blind Treatment Phase|Decision by Sponsor|1
5055003|NCT02483572|17431369|P2|Overall Study|Physician Decision|1
5055004|NCT02483572|17431370|P1|Overall Study|Physician Decision|0
5055005|NCT02483572|17431369|P2|Overall Study|Lost to Follow-up|0
5055006|NCT02483572|17431370|P1|Overall Study|Lost to Follow-up|1
5055007|NCT02483572|17431369|P2|Overall Study|Withdrawal by Subject|0
5055008|NCT02483572|17431370|P1|Overall Study|Withdrawal by Subject|1
5055009|NCT02483533|17431384|P2|Overall Study|Lack of Efficacy|50
5055010|NCT02483533|17431385|P1|Overall Study|Lack of Efficacy|50
5055011|NCT02483520|17431395|P2|Overall Study|Moved to LTC|3
5055012|NCT02483520|17431396|P1|Overall Study|Moved to LTC|2
5055013|NCT02483520|17431395|P2|Overall Study|Hospitalized|3
5055014|NCT02483520|17431396|P1|Overall Study|Hospitalized|2
5055015|NCT02483520|17431395|P2|Overall Study|Withdrawal by Subject|14
5055016|NCT02483520|17431396|P1|Overall Study|Withdrawal by Subject|4
5055017|NCT02483520|17431395|P2|Overall Study|Lost to Follow-up|4
5055018|NCT02483520|17431396|P1|Overall Study|Lost to Follow-up|3
5055019|NCT02483416|17431436|P2|Overall Study|Treatment stop|0
5055020|NCT02483416|17431437|P1|Overall Study|Treatment stop|3
5055021|NCT02483416|17431436|P2|Overall Study|Other reason|1
5055022|NCT02483416|17431437|P1|Overall Study|Other reason|0
5055023|NCT02482935|17431501|P2|Period 1|Withdrawal by Subject|0
5055024|NCT02482935|17431502|P1|Period 1|Withdrawal by Subject|1
5055025|NCT02482805|17431530|P3|Overall Study|Lost to Follow-up|0
5055026|NCT02482805|17431531|P2|Overall Study|Lost to Follow-up|4
5055027|NCT02482805|17431532|P1|Overall Study|Lost to Follow-up|4
5055028|NCT02482571|17431651|P1|Overall Study|Withdrawal by Subject|4
5055029|NCT02482571|17431651|P1|Overall Study|Scanner or Respiract failure|3
5055030|NCT02482571|17431651|P1|Overall Study|Adverse Event|1
5055031|NCT02482428|17431663|P5|Overall Study|subject/guardian decision|2
5055032|NCT02482428|17431664|P4|Overall Study|subject/guardian decision|0
5055033|NCT02482428|17431665|P3|Overall Study|subject/guardian decision|0
5055034|NCT02482428|17431666|P2|Overall Study|subject/guardian decision|2
5055035|NCT02482428|17431667|P1|Overall Study|subject/guardian decision|4
5055036|NCT02482428|17431663|P5|Overall Study|protocol deviation|0
5055037|NCT02482428|17431664|P4|Overall Study|protocol deviation|0
5055038|NCT02482428|17431665|P3|Overall Study|protocol deviation|0
5055039|NCT02482428|17431666|P2|Overall Study|protocol deviation|1
5055040|NCT02482428|17431667|P1|Overall Study|protocol deviation|1
5055041|NCT02482428|17431663|P5|Overall Study|Physician Decision|1
5055042|NCT02482428|17431664|P4|Overall Study|Physician Decision|0
5055043|NCT02482428|17431665|P3|Overall Study|Physician Decision|0
5055044|NCT02482428|17431666|P2|Overall Study|Physician Decision|0
5055045|NCT02482428|17431667|P1|Overall Study|Physician Decision|0
5055046|NCT02482428|17431663|P5|Overall Study|Lost to Follow-up|4
5055047|NCT02482428|17431664|P4|Overall Study|Lost to Follow-up|2
5055048|NCT02482428|17431665|P3|Overall Study|Lost to Follow-up|1
5055049|NCT02482428|17431666|P2|Overall Study|Lost to Follow-up|9
5055050|NCT02482428|17431667|P1|Overall Study|Lost to Follow-up|4
5055051|NCT02482298|17431690|P3|Overall Study|Lost to Follow-up|0
5055052|NCT02482298|17431691|P2|Overall Study|Lost to Follow-up|1
5055053|NCT02482298|17431692|P1|Overall Study|Lost to Follow-up|0
5055054|NCT02482298|17431690|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
5055055|NCT02482298|17431691|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5055056|NCT02482298|17431692|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5055057|NCT02482298|17431690|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
5055058|NCT02482298|17431691|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
5055059|NCT02482298|17431692|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
5055060|NCT02482298|17431690|P3|Overall Study|Withdrawal by Subject|2
5055061|NCT02482298|17431691|P2|Overall Study|Withdrawal by Subject|1
5055062|NCT02482298|17431692|P1|Overall Study|Withdrawal by Subject|2
5055063|NCT02482233|17431714|P2|Overall Study|Lost to Follow-up|1
5055064|NCT02482233|17431715|P1|Overall Study|Lost to Follow-up|1
5055065|NCT02482129|17431751|P2|Overall Study|Criteria not met|0
5055066|NCT02482129|17431752|P1|Overall Study|Criteria not met|1
5055067|NCT02482129|17431751|P2|Overall Study|Withdrawal by Subject|0
5055068|NCT02482129|17431752|P1|Overall Study|Withdrawal by Subject|2
5055069|NCT02482129|17431751|P2|Overall Study|Adverse Event|0
5055070|NCT02482129|17431752|P1|Overall Study|Adverse Event|1
5055071|NCT02482129|17431751|P2|Overall Study|Criteria not met-prior to treatment|0
5055072|NCT02482129|17431752|P1|Overall Study|Criteria not met-prior to treatment|1
5055073|NCT02482129|17431751|P2|Overall Study|Unable to draw blood-prior to treatment|0
5055074|NCT02482129|17431752|P1|Overall Study|Unable to draw blood-prior to treatment|1
5055075|NCT02482129|17431751|P2|Overall Study|Withdrawal by subject-prior to treatment|1
5055076|NCT02482129|17431752|P1|Overall Study|Withdrawal by subject-prior to treatment|0
5055077|NCT02482129|17431751|P2|Overall Study|Adverse Event-prior to treatment|1
5055078|NCT02482129|17431752|P1|Overall Study|Adverse Event-prior to treatment|0
5055079|NCT02481947|17431792|P2|Overall Study|Protocol Violation|5
5055080|NCT02481947|17431793|P1|Overall Study|Protocol Violation|1
5055081|NCT02481947|17431792|P2|Overall Study|Physician Decision|5
5055082|NCT02481947|17431793|P1|Overall Study|Physician Decision|4
5055083|NCT02481947|17431792|P2|Overall Study|Adverse Event|11
5055084|NCT02481947|17431793|P1|Overall Study|Adverse Event|6
5055085|NCT02481947|17431792|P2|Overall Study|Lost to Follow-up|5
5055086|NCT02481947|17431793|P1|Overall Study|Lost to Follow-up|11
5055087|NCT02481947|17431792|P2|Overall Study|Withdrawal by Subject|10
5055088|NCT02481947|17431793|P1|Overall Study|Withdrawal by Subject|24
5055089|NCT02481934|17431799|P1|Overall Study|Death|2
5055090|NCT02481830|17431806|P2|Overall Study|Participant not eligible for trial|1
5055091|NCT02481830|17431807|P1|Overall Study|Participant not eligible for trial|0
5055092|NCT02481830|17431806|P2|Overall Study|Disease Progression|1
5055093|NCT02481830|17431807|P1|Overall Study|Disease Progression|1
5055094|NCT02481830|17431806|P2|Overall Study|Withdrawal by Subject|14
5055095|NCT02481830|17431807|P1|Overall Study|Withdrawal by Subject|0
5055096|NCT02481830|17431806|P2|Overall Study|No longer meets Study Criteria|4
5055097|NCT02481830|17431807|P1|Overall Study|No longer meets Study Criteria|1
5055098|NCT02481050|17431982|P1|Overall Study|Other|3
5055099|NCT02481050|17431982|P1|Overall Study|Withdrawal by Subject|7
5055100|NCT02481050|17431982|P1|Overall Study|Disease Progression|47
5055101|NCT02481050|17431982|P1|Overall Study|Adverse Event|1
5055102|NCT02480764|17432013|P3|Overall Study|Reason not Specified|0
5055103|NCT02480764|17432014|P2|Overall Study|Reason not Specified|1
5055104|NCT02480764|17432015|P1|Overall Study|Reason not Specified|0
5055105|NCT02480764|17432013|P3|Overall Study|Lack of Efficacy|3
5055106|NCT02480764|17432014|P2|Overall Study|Lack of Efficacy|3
5055107|NCT02480764|17432015|P1|Overall Study|Lack of Efficacy|0
5055108|NCT02480764|17432013|P3|Overall Study|Voluntary Withdrawal|10
5055109|NCT02480764|17432014|P2|Overall Study|Voluntary Withdrawal|5
5055110|NCT02480764|17432015|P1|Overall Study|Voluntary Withdrawal|6
5055111|NCT02480764|17432013|P3|Overall Study|Lost to Follow-up|2
5055112|NCT02480764|17432014|P2|Overall Study|Lost to Follow-up|1
5055113|NCT02480764|17432015|P1|Overall Study|Lost to Follow-up|0
5055114|NCT02480764|17432013|P3|Overall Study|Major Protocol Deviation|3
5055115|NCT02480764|17432014|P2|Overall Study|Major Protocol Deviation|4
5055116|NCT02480764|17432015|P1|Overall Study|Major Protocol Deviation|1
5055117|NCT02480764|17432013|P3|Overall Study|Pretreatment Event/Adverse Event|3
5055118|NCT02480764|17432014|P2|Overall Study|Pretreatment Event/Adverse Event|6
5055119|NCT02480764|17432015|P1|Overall Study|Pretreatment Event/Adverse Event|3
5055120|NCT02480712|17432041|P1|Overall Study|Lack of Efficacy|1
5055121|NCT02480712|17432041|P1|Overall Study|Death|1
5055122|NCT02480712|17432041|P1|Overall Study|Withdrew Consent|3
5055123|NCT02480712|17432041|P1|Overall Study|Lost to Follow-up|5
5055124|NCT02480712|17432041|P1|Overall Study|Enrolled but Never Treated|1
5055125|NCT02480621|17432060|P2|Follow Up|Lost to Follow-up|2
5055126|NCT02480621|17432061|P1|Follow Up|Lost to Follow-up|4
5055127|NCT02480621|17432060|P2|Randomization|Surgeon did not give intervention|1
5055128|NCT02480621|17432061|P1|Randomization|Surgeon did not give intervention|0
5055129|NCT02480621|17432060|P2|Randomization|Withdrawal by Subject|0
5055130|NCT02480621|17432061|P1|Randomization|Withdrawal by Subject|1
5055131|NCT02480153|17432138|P3|Period 3: Week 52 Dosing to Week 78|Death|0
5055132|NCT02480153|17432139|P2|Period 3: Week 52 Dosing to Week 78|Death|1
5055133|NCT02480153|17432140|P1|Period 3: Week 52 Dosing to Week 78|Death|0
5055134|NCT02480153|17432138|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
5055135|NCT02480153|17432139|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
5055136|NCT02480153|17432140|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
5055137|NCT02480153|17432138|P3|Period 3: Week 52 Dosing to Week 78|Other|1
5055138|NCT02480153|17432139|P2|Period 3: Week 52 Dosing to Week 78|Other|0
5055139|NCT02480153|17432140|P1|Period 3: Week 52 Dosing to Week 78|Other|0
5055140|NCT02480153|17432138|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
5055141|NCT02480153|17432139|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
5055142|NCT02480153|17432140|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
5055143|NCT02480153|17432138|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
5055144|NCT02480153|17432139|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
5055145|NCT02480153|17432140|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
5055146|NCT02480153|17432138|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
5055147|NCT02480153|17432139|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
5055148|NCT02480153|17432140|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
5055149|NCT02480153|17432138|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
5055150|NCT02480153|17432139|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
5055151|NCT02480153|17432140|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
5055152|NCT02480153|17432138|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
5055153|NCT02480153|17432139|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
5055154|NCT02480153|17432140|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
5055155|NCT02480153|17432138|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
5055156|NCT02480153|17432139|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
5055157|NCT02480153|17432140|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
5055158|NCT02480153|17432138|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
5055159|NCT02480153|17432139|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
5055160|NCT02480153|17432140|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
5055161|NCT02480153|17432138|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
5055162|NCT02480153|17432139|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
5055163|NCT02480153|17432140|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
5055164|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
5055165|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
5055166|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
5055167|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
5055168|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
5055169|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
5055170|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
5055171|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
5055172|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
5055173|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
5055174|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
5055175|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
5055176|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
5055177|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
5055178|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
5055179|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
5055180|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
5055181|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
5055182|NCT02480153|17432138|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
5055183|NCT02480153|17432139|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
5055184|NCT02480153|17432140|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
5055185|NCT02480114|17432317|P2|Overall Study|Not eligible|1
5055186|NCT02480114|17432318|P1|Overall Study|Not eligible|0
5055187|NCT02480114|17432317|P2|Overall Study|Improper completion of survey|1
5055188|NCT02480114|17432318|P1|Overall Study|Improper completion of survey|1
5055189|NCT02480114|17432317|P2|Overall Study|Disease progression|0
5055190|NCT02480114|17432318|P1|Overall Study|Disease progression|3
5055191|NCT02480114|17432317|P2|Overall Study|Withdrawal by Subject|4
5055192|NCT02480114|17432318|P1|Overall Study|Withdrawal by Subject|2
5055193|NCT02480114|17432317|P2|Overall Study|Not completing surveys|2
5055194|NCT02480114|17432318|P1|Overall Study|Not completing surveys|3
5055195|NCT02480010|17432330|P2|Overall Study|Refused Treatment|3
5055196|NCT02480010|17432331|P1|Overall Study|Refused Treatment|0
5055197|NCT02480010|17432330|P2|Overall Study|Insufficient therapeutic response|29
5055198|NCT02480010|17432331|P1|Overall Study|Insufficient therapeutic response|31
5055199|NCT02480010|17432330|P2|Overall Study|Death|0
5055200|NCT02480010|17432331|P1|Overall Study|Death|1
5055201|NCT02480010|17432330|P2|Overall Study|Adverse Event|1
5055202|NCT02480010|17432331|P1|Overall Study|Adverse Event|3
5055203|NCT02479880|17432377|P2|Overall Study|Pregnancy|1
5055204|NCT02479880|17432378|P1|Overall Study|Pregnancy|0
5055205|NCT02479880|17432377|P2|Overall Study|Study Terminated by Sponsor|12
5055206|NCT02479880|17432378|P1|Overall Study|Study Terminated by Sponsor|13
5055207|NCT02479802|17432384|P1|Overall Study|Adverse Event|1
5055208|NCT02479802|17432384|P1|Overall Study|Lost to Follow-up|1
5055209|NCT02479412|17432411|P9|Overall Study|Randomization to wrong PK sampling group|0
5055210|NCT02479412|17432412|P8|Overall Study|Randomization to wrong PK sampling group|0
5055211|NCT02479412|17432413|P7|Overall Study|Randomization to wrong PK sampling group|0
5055212|NCT02479412|17432414|P6|Overall Study|Randomization to wrong PK sampling group|0
5055213|NCT02479412|17432415|P5|Overall Study|Randomization to wrong PK sampling group|1
5055214|NCT02479412|17432416|P4|Overall Study|Randomization to wrong PK sampling group|0
5055215|NCT02479412|17432417|P3|Overall Study|Randomization to wrong PK sampling group|0
5055216|NCT02479412|17432418|P2|Overall Study|Randomization to wrong PK sampling group|0
5055217|NCT02479412|17432419|P1|Overall Study|Randomization to wrong PK sampling group|0
5055218|NCT02479412|17432411|P9|Overall Study|Study-specific withdrawal criteria|1
5055219|NCT02479412|17432412|P8|Overall Study|Study-specific withdrawal criteria|1
5055220|NCT02479412|17432413|P7|Overall Study|Study-specific withdrawal criteria|0
5055221|NCT02479412|17432414|P6|Overall Study|Study-specific withdrawal criteria|0
5055222|NCT02479412|17432415|P5|Overall Study|Study-specific withdrawal criteria|0
5055223|NCT02479412|17432416|P4|Overall Study|Study-specific withdrawal criteria|1
5055224|NCT02479412|17432417|P3|Overall Study|Study-specific withdrawal criteria|1
5055225|NCT02479412|17432418|P2|Overall Study|Study-specific withdrawal criteria|0
5055226|NCT02479412|17432419|P1|Overall Study|Study-specific withdrawal criteria|0
5055227|NCT02479412|17432411|P9|Overall Study|Adverse Event|0
5055228|NCT02479412|17432412|P8|Overall Study|Adverse Event|0
5055229|NCT02479412|17432413|P7|Overall Study|Adverse Event|0
5055230|NCT02479412|17432414|P6|Overall Study|Adverse Event|0
5055231|NCT02479412|17432415|P5|Overall Study|Adverse Event|0
5055232|NCT02479412|17432416|P4|Overall Study|Adverse Event|0
5055233|NCT02479412|17432417|P3|Overall Study|Adverse Event|1
5055234|NCT02479412|17432418|P2|Overall Study|Adverse Event|0
5055235|NCT02479412|17432419|P1|Overall Study|Adverse Event|0
5055236|NCT02479139|17432496|P6|Overall Study|Other Miscellaneous Reasons|0
5055237|NCT02479139|17432497|P5|Overall Study|Other Miscellaneous Reasons|1
5055238|NCT02479139|17432498|P4|Overall Study|Other Miscellaneous Reasons|1
5055239|NCT02479139|17432499|P3|Overall Study|Other Miscellaneous Reasons|1
5055240|NCT02479139|17432500|P2|Overall Study|Other Miscellaneous Reasons|0
5055241|NCT02479139|17432501|P1|Overall Study|Other Miscellaneous Reasons|1
5055242|NCT02479139|17432496|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
5055243|NCT02479139|17432497|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
5055244|NCT02479139|17432498|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
5055245|NCT02479139|17432499|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
5055246|NCT02479139|17432500|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
5055247|NCT02479139|17432501|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
5055248|NCT02479139|17432496|P6|Overall Study|Withdrew Consent|1
5055249|NCT02479139|17432497|P5|Overall Study|Withdrew Consent|1
5055250|NCT02479139|17432498|P4|Overall Study|Withdrew Consent|4
5055251|NCT02479139|17432499|P3|Overall Study|Withdrew Consent|1
5055252|NCT02479139|17432500|P2|Overall Study|Withdrew Consent|6
5055253|NCT02479139|17432501|P1|Overall Study|Withdrew Consent|5
5055254|NCT02479139|17432496|P6|Overall Study|Lost to Follow-up|5
5055255|NCT02479139|17432497|P5|Overall Study|Lost to Follow-up|3
5055256|NCT02479139|17432498|P4|Overall Study|Lost to Follow-up|2
5055257|NCT02479139|17432499|P3|Overall Study|Lost to Follow-up|4
5055258|NCT02479139|17432500|P2|Overall Study|Lost to Follow-up|4
5055259|NCT02479139|17432501|P1|Overall Study|Lost to Follow-up|2
5055260|NCT02478632|17432534|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
5055261|NCT02478632|17432535|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
5055262|NCT02478632|17432534|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
5055263|NCT02478632|17432535|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
5055264|NCT02478632|17432534|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
5055265|NCT02478632|17432535|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
5055266|NCT02478463|17432570|P1|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
5055267|NCT02478463|17432570|P1|Washout Period (Up to 42 Days)|Lost to Follow-up|1
5055268|NCT02478463|17432570|P1|Treatment Period 1 (Up to Day 29)|Physician Decision|1
5055269|NCT02478398|17432687|P2|Overall Study|Withdrawal By Participant|4
5055270|NCT02478398|17432688|P1|Overall Study|Withdrawal By Participant|10
5055271|NCT02478398|17432687|P2|Overall Study|Withdrawal By Parent/Guardian|6
5055272|NCT02478398|17432688|P1|Overall Study|Withdrawal By Parent/Guardian|9
5055273|NCT02478398|17432687|P2|Overall Study|Protocol Violation|1
5055274|NCT02478398|17432688|P1|Overall Study|Protocol Violation|3
5055275|NCT02478398|17432687|P2|Overall Study|Non-Compliance With Study Drug|1
5055276|NCT02478398|17432688|P1|Overall Study|Non-Compliance With Study Drug|5
5055277|NCT02478398|17432687|P2|Overall Study|Lost to Follow-up|4
5055278|NCT02478398|17432688|P1|Overall Study|Lost to Follow-up|5
5055279|NCT02478398|17432687|P2|Overall Study|Adverse Event|5
5055280|NCT02478398|17432688|P1|Overall Study|Adverse Event|20
5055281|NCT02478372|17432708|P2|Overall Study|Death|2
5055282|NCT02478372|17432709|P1|Overall Study|Death|0
5055283|NCT02478372|17432708|P2|Overall Study|Lost to Follow-up|4
5055284|NCT02478372|17432709|P1|Overall Study|Lost to Follow-up|1
5055285|NCT02478372|17432708|P2|Overall Study|Protocol Violation|8
5055286|NCT02478372|17432709|P1|Overall Study|Protocol Violation|12
5055287|NCT02478359|17432733|P2|Overall Study|Disenrolled from health plan|65
5055288|NCT02478359|17432734|P1|Overall Study|Disenrolled from health plan|106
5055289|NCT02478164|17432806|P1|Overall Study|Withdrawal by Subject|1
5055290|NCT02478164|17432806|P1|Overall Study|Adverse Event|1
5055291|NCT02478164|17432806|P1|Overall Study|Lack of Efficacy|13
5055292|NCT02477670|17432819|P7|Stage 2|Withdrawal by Subject|0
5055293|NCT02477670|17432820|P6|Stage 2|Withdrawal by Subject|0
5055294|NCT02477670|17432821|P5|Stage 2|Withdrawal by Subject|0
5055295|NCT02477670|17432822|P4|Stage 2|Withdrawal by Subject|1
5055296|NCT02477670|17432823|P3|Stage 2|Withdrawal by Subject|0
5055297|NCT02477670|17432824|P2|Stage 2|Withdrawal by Subject|0
5055298|NCT02477670|17432825|P1|Stage 2|Withdrawal by Subject|0
5055299|NCT02477670|17432819|P7|Stage 2|Antipsychotic Medication Changed|0
5055300|NCT02477670|17432820|P6|Stage 2|Antipsychotic Medication Changed|0
5055301|NCT02477670|17432821|P5|Stage 2|Antipsychotic Medication Changed|0
5055302|NCT02477670|17432822|P4|Stage 2|Antipsychotic Medication Changed|0
5055303|NCT02477670|17432823|P3|Stage 2|Antipsychotic Medication Changed|1
5055304|NCT02477670|17432824|P2|Stage 2|Antipsychotic Medication Changed|0
5055305|NCT02477670|17432825|P1|Stage 2|Antipsychotic Medication Changed|0
5055306|NCT02477670|17432819|P7|Stage 2|Adverse Event|0
5055307|NCT02477670|17432820|P6|Stage 2|Adverse Event|0
5055308|NCT02477670|17432821|P5|Stage 2|Adverse Event|0
5055309|NCT02477670|17432822|P4|Stage 2|Adverse Event|0
5055310|NCT02477670|17432823|P3|Stage 2|Adverse Event|1
5055311|NCT02477670|17432824|P2|Stage 2|Adverse Event|0
5055312|NCT02477670|17432825|P1|Stage 2|Adverse Event|0
5055313|NCT02477670|17432819|P7|Stage 1|Non-compliance with Study Drug|0
5055314|NCT02477670|17432820|P6|Stage 1|Non-compliance with Study Drug|0
5055315|NCT02477670|17432821|P5|Stage 1|Non-compliance with Study Drug|0
5055316|NCT02477670|17432822|P4|Stage 1|Non-compliance with Study Drug|0
5055317|NCT02477670|17432823|P3|Stage 1|Non-compliance with Study Drug|0
5055318|NCT02477670|17432824|P2|Stage 1|Non-compliance with Study Drug|2
5055319|NCT02477670|17432825|P1|Stage 1|Non-compliance with Study Drug|1
5055320|NCT02477670|17432819|P7|Stage 1|Withdrawal by Subject|0
5055321|NCT02477670|17432820|P6|Stage 1|Withdrawal by Subject|0
5055322|NCT02477670|17432821|P5|Stage 1|Withdrawal by Subject|0
5055323|NCT02477670|17432822|P4|Stage 1|Withdrawal by Subject|0
5055324|NCT02477670|17432823|P3|Stage 1|Withdrawal by Subject|0
5055325|NCT02477670|17432824|P2|Stage 1|Withdrawal by Subject|2
5055326|NCT02477670|17432825|P1|Stage 1|Withdrawal by Subject|1
5055327|NCT02477670|17432819|P7|Stage 1|Lost to Follow-up|0
5055328|NCT02477670|17432820|P6|Stage 1|Lost to Follow-up|0
5055329|NCT02477670|17432821|P5|Stage 1|Lost to Follow-up|0
5055330|NCT02477670|17432822|P4|Stage 1|Lost to Follow-up|0
5055331|NCT02477670|17432823|P3|Stage 1|Lost to Follow-up|0
5055332|NCT02477670|17432824|P2|Stage 1|Lost to Follow-up|2
5055333|NCT02477670|17432825|P1|Stage 1|Lost to Follow-up|0
5055334|NCT02477670|17432819|P7|Stage 1|Adverse Event|0
5055335|NCT02477670|17432820|P6|Stage 1|Adverse Event|0
5055336|NCT02477670|17432821|P5|Stage 1|Adverse Event|0
5055337|NCT02477670|17432822|P4|Stage 1|Adverse Event|0
5055338|NCT02477670|17432823|P3|Stage 1|Adverse Event|0
5055339|NCT02477670|17432824|P2|Stage 1|Adverse Event|7
5055340|NCT02477670|17432825|P1|Stage 1|Adverse Event|2
5055341|NCT02477618|17433041|P2|Overall Study|Left Study Site for Rehabilitation|1
5055342|NCT02477618|17433042|P1|Overall Study|Left Study Site for Rehabilitation|0
5055343|NCT02477618|17433041|P2|Overall Study|Transferred Away from Study Site|0
5055344|NCT02477618|17433042|P1|Overall Study|Transferred Away from Study Site|1
5055345|NCT02477618|17433041|P2|Overall Study|Adverse Event|1
5055346|NCT02477618|17433042|P1|Overall Study|Adverse Event|1
5055347|NCT02477618|17433041|P2|Overall Study|Died in Double-Blind Treatment Period|11
5055348|NCT02477618|17433042|P1|Overall Study|Died in Double-Blind Treatment Period|11
5055349|NCT02477618|17433041|P2|Overall Study|Completed Visits but Discontinued Drug|1
5055350|NCT02477618|17433042|P1|Overall Study|Completed Visits but Discontinued Drug|2
5055351|NCT02477605|17433066|P2|Overall Study|Administered gas during surgery|1
5055352|NCT02477605|17433067|P1|Overall Study|Administered gas during surgery|0
5055353|NCT02477605|17433066|P2|Overall Study|Withdrawal by Subject|1
5055354|NCT02477605|17433067|P1|Overall Study|Withdrawal by Subject|0
5055355|NCT02477605|17433066|P2|Overall Study|Lost to Follow-up|2
5055356|NCT02477605|17433067|P1|Overall Study|Lost to Follow-up|0
5055357|NCT02477605|17433066|P2|Overall Study|Discontinued prior to treatment|0
5055358|NCT02477605|17433067|P1|Overall Study|Discontinued prior to treatment|1
5055359|NCT02477553|17433083|P2|Overall Study|patient deceased|0
5055360|NCT02477553|17433084|P1|Overall Study|patient deceased|1
5055361|NCT02477553|17433083|P2|Overall Study|MD advised against screening|3
5055362|NCT02477553|17433084|P1|Overall Study|MD advised against screening|1
5055363|NCT02477553|17433083|P2|Overall Study|Elevated risk for CRC|2
5055364|NCT02477553|17433084|P1|Overall Study|Elevated risk for CRC|2
5055365|NCT02477553|17433083|P2|Overall Study|Technical issues with intervention|0
5055366|NCT02477553|17433084|P1|Overall Study|Technical issues with intervention|2
5055367|NCT02477553|17433083|P2|Overall Study|Workup consistent w/CRC|1
5055368|NCT02477553|17433084|P1|Overall Study|Workup consistent w/CRC|1
5055369|NCT02477553|17433083|P2|Overall Study|No MD visit|1
5055370|NCT02477553|17433084|P1|Overall Study|No MD visit|1
5055371|NCT02477553|17433083|P2|Overall Study|Screening up-to-date|13
5055372|NCT02477553|17433084|P1|Overall Study|Screening up-to-date|12
5055373|NCT02477527|17433104|P1|Overall Study|Screen Failure|3
5055374|NCT02477527|17433104|P1|Overall Study|Withdrawal by Subject|1
5055375|NCT02477527|17433104|P1|Overall Study|Lost to Follow-up|2
5055376|NCT02477332|17433139|P6|Overall Study|Withdrawal by Subject|0
5055377|NCT02477332|17433140|P5|Overall Study|Withdrawal by Subject|1
5055378|NCT02477332|17433141|P4|Overall Study|Withdrawal by Subject|2
5055379|NCT02477332|17433142|P3|Overall Study|Withdrawal by Subject|1
5055380|NCT02477332|17433143|P2|Overall Study|Withdrawal by Subject|3
5055381|NCT02477332|17433144|P1|Overall Study|Withdrawal by Subject|0
5055382|NCT02477332|17433139|P6|Overall Study|Physician Decision|1
5055383|NCT02477332|17433140|P5|Overall Study|Physician Decision|0
5055384|NCT02477332|17433141|P4|Overall Study|Physician Decision|3
5055385|NCT02477332|17433142|P3|Overall Study|Physician Decision|1
5055386|NCT02477332|17433143|P2|Overall Study|Physician Decision|0
5055387|NCT02477332|17433144|P1|Overall Study|Physician Decision|0
5055388|NCT02477332|17433139|P6|Overall Study|Lost to Follow-up|0
5055389|NCT02477332|17433140|P5|Overall Study|Lost to Follow-up|0
5055390|NCT02477332|17433141|P4|Overall Study|Lost to Follow-up|0
5055391|NCT02477332|17433142|P3|Overall Study|Lost to Follow-up|2
5055392|NCT02477332|17433143|P2|Overall Study|Lost to Follow-up|0
5055393|NCT02477332|17433144|P1|Overall Study|Lost to Follow-up|0
5055394|NCT02477332|17433139|P6|Overall Study|Technical problems|0
5055395|NCT02477332|17433140|P5|Overall Study|Technical problems|0
5055396|NCT02477332|17433141|P4|Overall Study|Technical problems|0
5055397|NCT02477332|17433142|P3|Overall Study|Technical problems|1
5055398|NCT02477332|17433143|P2|Overall Study|Technical problems|0
5055399|NCT02477332|17433144|P1|Overall Study|Technical problems|0
5055400|NCT02477332|17433139|P6|Overall Study|Protocol Violation|1
5055401|NCT02477332|17433140|P5|Overall Study|Protocol Violation|1
5055402|NCT02477332|17433141|P4|Overall Study|Protocol Violation|3
5055403|NCT02477332|17433142|P3|Overall Study|Protocol Violation|3
5055404|NCT02477332|17433143|P2|Overall Study|Protocol Violation|0
5055405|NCT02477332|17433144|P1|Overall Study|Protocol Violation|2
5055406|NCT02477332|17433139|P6|Overall Study|Pregnancy|0
5055407|NCT02477332|17433140|P5|Overall Study|Pregnancy|0
5055408|NCT02477332|17433141|P4|Overall Study|Pregnancy|1
5055409|NCT02477332|17433142|P3|Overall Study|Pregnancy|0
5055410|NCT02477332|17433143|P2|Overall Study|Pregnancy|0
5055411|NCT02477332|17433144|P1|Overall Study|Pregnancy|0
5055412|NCT02477332|17433139|P6|Overall Study|Non-compliance with study treatment|0
5055413|NCT02477332|17433140|P5|Overall Study|Non-compliance with study treatment|0
5055414|NCT02477332|17433141|P4|Overall Study|Non-compliance with study treatment|0
5055415|NCT02477332|17433142|P3|Overall Study|Non-compliance with study treatment|2
5055416|NCT02477332|17433143|P2|Overall Study|Non-compliance with study treatment|1
5055417|NCT02477332|17433144|P1|Overall Study|Non-compliance with study treatment|0
5055418|NCT02477332|17433139|P6|Overall Study|Lack of Efficacy|1
5055419|NCT02477332|17433140|P5|Overall Study|Lack of Efficacy|1
5055420|NCT02477332|17433141|P4|Overall Study|Lack of Efficacy|2
5055421|NCT02477332|17433142|P3|Overall Study|Lack of Efficacy|1
5055422|NCT02477332|17433143|P2|Overall Study|Lack of Efficacy|2
5055423|NCT02477332|17433144|P1|Overall Study|Lack of Efficacy|1
5055424|NCT02477332|17433139|P6|Overall Study|Adverse Event|2
5055425|NCT02477332|17433140|P5|Overall Study|Adverse Event|1
5055426|NCT02477332|17433141|P4|Overall Study|Adverse Event|2
5055427|NCT02477332|17433142|P3|Overall Study|Adverse Event|1
5055428|NCT02477332|17433143|P2|Overall Study|Adverse Event|1
5055429|NCT02477332|17433144|P1|Overall Study|Adverse Event|0
5055430|NCT02477215|17433236|P3|Fixed Dose Phase|Physician Decision|0
5055431|NCT02477215|17433237|P2|Fixed Dose Phase|Physician Decision|7
5055432|NCT02477215|17433238|P1|Fixed Dose Phase|Physician Decision|0
5055433|NCT02477215|17433236|P3|Dose Escalation Phase|Physician Decision|0
5055434|NCT02477215|17433237|P2|Dose Escalation Phase|Physician Decision|2
5055435|NCT02477215|17433238|P1|Dose Escalation Phase|Physician Decision|1
5055436|NCT02477020|17433254|P2|Overall Study|Lack of Efficacy|5
5055437|NCT02477020|17433255|P1|Overall Study|Lack of Efficacy|14
5055438|NCT02477020|17433254|P2|Overall Study|Reason not Specified|1
5055439|NCT02477020|17433255|P1|Overall Study|Reason not Specified|3
5055440|NCT02477020|17433254|P2|Overall Study|Voluntary Withdrawal|16
5055441|NCT02477020|17433255|P1|Overall Study|Voluntary Withdrawal|7
5055442|NCT02477020|17433254|P2|Overall Study|Pretreatment Event/Adverse Event|6
5055443|NCT02477020|17433255|P1|Overall Study|Pretreatment Event/Adverse Event|6
5055444|NCT02476994|17433285|P2|Overall Study|Based on feedback from FDA|0
5055445|NCT02476994|17433286|P1|Overall Study|Based on feedback from FDA|1
5055446|NCT02476916|17433314|P2|Extension Period|On Treatment|17
5055447|NCT02476916|17433315|P1|Extension Period|On Treatment|12
5055448|NCT02476916|17433314|P2|Extension Period|Prematurely Discontinued Treatment|1
5055449|NCT02476916|17433315|P1|Extension Period|Prematurely Discontinued Treatment|6
5055450|NCT02476916|17433314|P2|Core Period|Withdrawal by Subject|0
5055451|NCT02476916|17433315|P1|Core Period|Withdrawal by Subject|3
5055452|NCT02476916|17433314|P2|Core Period|Investigator decision|1
5055453|NCT02476916|17433315|P1|Core Period|Investigator decision|1
5055454|NCT02476916|17433314|P2|Core Period|Adverse Event|2
5055455|NCT02476916|17433315|P1|Core Period|Adverse Event|2
5055456|NCT02476617|17433400|P1|Overall Study|Lost to Follow-up|1
5055457|NCT02476617|17433400|P1|Overall Study|Adverse Event|1
5055458|NCT02476578|17433406|P2|Overall Study|Lost to Follow-up|13
5055459|NCT02476578|17433407|P1|Overall Study|Lost to Follow-up|6
5055460|NCT02476578|17433406|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
5055461|NCT02476578|17433407|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
5055462|NCT02476422|17433469|P2|Overall Study|Subject/guardian decision|1
5055463|NCT02476422|17433470|P1|Overall Study|Subject/guardian decision|0
5055464|NCT02476201|17433511|P1|Overall Study|Unsuccessful implant|1
5055465|NCT02476201|17433511|P1|Overall Study|Withdrawal by Subject|1
5055466|NCT02476201|17433511|P1|Overall Study|MPP programmed to OFF|2
5055467|NCT02476201|17433511|P1|Overall Study|Lost to Follow-up|2
5055468|NCT02476201|17433511|P1|Overall Study|Death|2
5055469|NCT02476201|17433511|P1|Overall Study|Adverse Event|4
5055470|NCT02476201|17433511|P1|Overall Study|Study echo not performed|5
5055471|NCT02476201|17433511|P1|Overall Study|Unable to program MPP|9
5055472|NCT02476175|17433519|P1|Overall Study|Adverse Event|2
5055473|NCT02476006|17433543|P1|Overall Study|Enrolled but not treated|4
5055474|NCT02476006|17433543|P1|Overall Study|Protocol Violation|1
5055475|NCT02476006|17433543|P1|Overall Study|Excluded from study|1
5055476|NCT02476006|17433543|P1|Overall Study|Switched to commercial drug|4
5055477|NCT02476006|17433543|P1|Overall Study|Study ended treatment not available|4
5055478|NCT02476006|17433543|P1|Overall Study|Physician Decision|5
5055479|NCT02476006|17433543|P1|Overall Study|Lost to Follow-up|5
5055480|NCT02476006|17433543|P1|Overall Study|Sponsor decision|6
5055481|NCT02476006|17433543|P1|Overall Study|Poor compliance to study protocol|3
5055482|NCT02476006|17433543|P1|Overall Study|Adverse Event|41
5055483|NCT02476006|17433543|P1|Overall Study|Participant did not wish to continue|39
5055484|NCT02476006|17433543|P1|Overall Study|Pregnancy|1
5055485|NCT02476006|17433543|P1|Overall Study|Lack of treatment efficacy|2
5055486|NCT02476006|17433543|P1|Overall Study|Death|4
5055487|NCT02475980|17433557|P1|Overall Study|Withdrawal by Subject|1
5055488|NCT02475980|17433557|P1|Overall Study|Lost to Follow-up|4
5055489|NCT02475733|17433583|P2|Overall Study|Physician Decision|0
5055490|NCT02475733|17433584|P1|Overall Study|Physician Decision|1
5055491|NCT02475733|17433583|P2|Overall Study|Withdrawal by Subject|0
5055492|NCT02475733|17433584|P1|Overall Study|Withdrawal by Subject|1
5055493|NCT02475655|17433641|P2|Overall Study|Lost to Follow-up|1
5055494|NCT02475655|17433642|P1|Overall Study|Lost to Follow-up|0
5055495|NCT02475629|17433794|P1|Overall Study|Subject non-compliance|1
5055496|NCT02475629|17433794|P1|Overall Study|Lost to Follow-up|1
5055497|NCT02475629|17433794|P1|Overall Study|Withdrawal by Subject|1
5055498|NCT02475629|17433794|P1|Overall Study|Physician Decision|1
5055499|NCT02475629|17433794|P1|Overall Study|Death|4
5055500|NCT02475629|17433794|P1|Overall Study|Adverse Event|1
5055501|NCT02475564|17433817|P2|Overall Study|Intense Menstrual bleeding|0
5055502|NCT02475564|17433818|P1|Overall Study|Intense Menstrual bleeding|1
5055503|NCT02475564|17433817|P2|Overall Study|Lost to Follow-up|1
5055504|NCT02475564|17433818|P1|Overall Study|Lost to Follow-up|2
5055505|NCT02475564|17433817|P2|Overall Study|Withdrawal by Subject|0
5055506|NCT02475564|17433818|P1|Overall Study|Withdrawal by Subject|1
5055507|NCT02475395|17433830|P2|Overall Study|Protocol Violation|3
5055508|NCT02475395|17433831|P1|Overall Study|Protocol Violation|30
5055509|NCT02475278|17433841|P1|Overall Study|Reason Not Specified|1
5055510|NCT02475278|17433841|P1|Overall Study|Lost to Follow-up|1
5055511|NCT02475265|17433852|P1|Overall Study|Withdrawal by Subject|2
5055512|NCT02475265|17433852|P1|Overall Study|Physician Decision|1
5055513|NCT02474589|17433903|P2|Overall Study|Inability to complete study procedures|1
5055597|NCT02473445|17434184|P1|Overall Study|Sponsor Decision|20
5055514|NCT02474589|17433904|P1|Overall Study|Inability to complete study procedures|5
5055515|NCT02474589|17433903|P2|Overall Study|Withdrawal by Subject|0
5055516|NCT02474589|17433904|P1|Overall Study|Withdrawal by Subject|4
5055517|NCT02474589|17433903|P2|Overall Study|Protocol Violation|1
5055518|NCT02474589|17433904|P1|Overall Study|Protocol Violation|4
5055519|NCT02474589|17433903|P2|Overall Study|Lost to Follow-up|1
5055520|NCT02474589|17433904|P1|Overall Study|Lost to Follow-up|6
5055521|NCT02474589|17433903|P2|Overall Study|Adverse Event|2
5055522|NCT02474589|17433904|P1|Overall Study|Adverse Event|6
5055523|NCT02474082|17433963|P2|Overall Study|Protocol deviation|1
5055524|NCT02474082|17433964|P1|Overall Study|Protocol deviation|0
5055525|NCT02474082|17433963|P2|Overall Study|Non-compliance with study treatment|2
5055526|NCT02474082|17433964|P1|Overall Study|Non-compliance with study treatment|0
5055527|NCT02474082|17433963|P2|Overall Study|Participant/guardian decision|2
5055528|NCT02474082|17433964|P1|Overall Study|Participant/guardian decision|1
5055529|NCT02474082|17433963|P2|Overall Study|Dose tapering not achieved|4
5055530|NCT02474082|17433964|P1|Overall Study|Dose tapering not achieved|0
5055531|NCT02474082|17433963|P2|Overall Study|Lost to Follow-up|2
5055532|NCT02474082|17433964|P1|Overall Study|Lost to Follow-up|2
5055533|NCT02474082|17433963|P2|Overall Study|Withdrawal of informed consent|11
5055534|NCT02474082|17433964|P1|Overall Study|Withdrawal of informed consent|1
5055535|NCT02474082|17433963|P2|Overall Study|Adverse Event|32
5055536|NCT02474082|17433964|P1|Overall Study|Adverse Event|2
5055537|NCT02474069|17433998|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
5055538|NCT02474069|17433999|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
5055539|NCT02474069|17434000|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
5055540|NCT02474069|17433998|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
5055541|NCT02474069|17433999|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
5055542|NCT02474069|17434000|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
5055543|NCT02474069|17433998|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
5055544|NCT02474069|17433999|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
5055545|NCT02474069|17434000|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
5055546|NCT02474069|17433998|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
5055547|NCT02474069|17433999|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
5055548|NCT02474069|17434000|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
5055549|NCT02474069|17433998|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
5055550|NCT02474069|17433999|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
5055551|NCT02474069|17434000|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
5055552|NCT02474069|17433998|P3|Selection Phase (SP)|Withdrawal by Subject|0
5055553|NCT02474069|17433999|P2|Selection Phase (SP)|Withdrawal by Subject|0
5055554|NCT02474069|17434000|P1|Selection Phase (SP)|Withdrawal by Subject|3
5055555|NCT02474069|17433998|P3|Selection Phase (SP)|Technical Problem|0
5055556|NCT02474069|17433999|P2|Selection Phase (SP)|Technical Problem|0
5055557|NCT02474069|17434000|P1|Selection Phase (SP)|Technical Problem|1
5055558|NCT02474069|17433998|P3|Selection Phase (SP)|No longer requires treatment|0
5055559|NCT02474069|17433999|P2|Selection Phase (SP)|No longer requires treatment|0
5055560|NCT02474069|17434000|P1|Selection Phase (SP)|No longer requires treatment|1
5055561|NCT02474069|17433998|P3|Selection Phase (SP)|Protocol Violation|0
5055562|NCT02474069|17433999|P2|Selection Phase (SP)|Protocol Violation|0
5055563|NCT02474069|17434000|P1|Selection Phase (SP)|Protocol Violation|1
5055564|NCT02474069|17433998|P3|Selection Phase (SP)|Physician Decision|0
5055565|NCT02474069|17433999|P2|Selection Phase (SP)|Physician Decision|0
5055566|NCT02474069|17434000|P1|Selection Phase (SP)|Physician Decision|1
5055567|NCT02474069|17433998|P3|Selection Phase (SP)|Lost to Follow-up|0
5055568|NCT02474069|17433999|P2|Selection Phase (SP)|Lost to Follow-up|0
5055569|NCT02474069|17434000|P1|Selection Phase (SP)|Lost to Follow-up|4
5055570|NCT02474069|17433998|P3|Selection Phase (SP)|Lack of Efficacy|0
5055571|NCT02474069|17433999|P2|Selection Phase (SP)|Lack of Efficacy|0
5055572|NCT02474069|17434000|P1|Selection Phase (SP)|Lack of Efficacy|1
5055573|NCT02474069|17433998|P3|Selection Phase (SP)|Adverse Event|0
5055574|NCT02474069|17433999|P2|Selection Phase (SP)|Adverse Event|0
5055575|NCT02474069|17434000|P1|Selection Phase (SP)|Adverse Event|8
5055576|NCT02473965|17434033|P2|Overall Study|Physician Decision|2
5055577|NCT02473965|17434034|P1|Overall Study|Physician Decision|0
5055578|NCT02473965|17434033|P2|Overall Study|Withdrawal by Subject|3
5055579|NCT02473965|17434034|P1|Overall Study|Withdrawal by Subject|2
5055580|NCT02473965|17434033|P2|Overall Study|MG worsening|1
5055581|NCT02473965|17434034|P1|Overall Study|MG worsening|4
5055582|NCT02473965|17434033|P2|Overall Study|Adverse Event|4
5055583|NCT02473965|17434034|P1|Overall Study|Adverse Event|6
5055584|NCT02473952|17434046|P2|Overall Study|Withdrawal by Subject|6
5055585|NCT02473952|17434047|P1|Overall Study|Withdrawal by Subject|0
5055586|NCT02473952|17434046|P2|Overall Study|Adverse Event|2
5055587|NCT02473952|17434047|P1|Overall Study|Adverse Event|2
5055588|NCT02473913|17434055|P2|Overall Study|Lost to Follow-up|3
5055589|NCT02473913|17434056|P1|Overall Study|Lost to Follow-up|3
5055590|NCT02473640|17434108|P1|Treatment Period 1|Adverse Event|1
5055591|NCT02473523|17434117|P1|Overall Study|Lost to Follow-up|1
5055592|NCT02473523|17434117|P1|Overall Study|Death|1
5055593|NCT02473510|17434138|P2|Overall Study|Lost to Follow-up|2
5055594|NCT02473510|17434139|P1|Overall Study|Lost to Follow-up|1
5055595|NCT02473471|17434153|P1|Overall Study|Lost to Follow-up|1
5055596|NCT02473471|17434153|P1|Overall Study|poor oral hygiene|2
5055598|NCT02473445|17434184|P1|Overall Study|Withdrawal by Subject|2
5055599|NCT02473367|17434190|P1|Period 4|Lost to Follow-up|1
5055600|NCT02473367|17434190|P1|Wait 1|Withdrawal by Subject|1
5055601|NCT02473289|17434210|P2|Overall Study|Other|0
5055602|NCT02473289|17434211|P1|Overall Study|Other|2
5055603|NCT02473289|17434210|P2|Overall Study|Treatment Unblinded + Adverse event|1
5055604|NCT02473289|17434211|P1|Overall Study|Treatment Unblinded + Adverse event|0
5055605|NCT02473289|17434210|P2|Overall Study|Withdrawal of consent|7
5055606|NCT02473289|17434211|P1|Overall Study|Withdrawal of consent|6
5055607|NCT02473289|17434210|P2|Overall Study|Protocol Violation|1
5055608|NCT02473289|17434211|P1|Overall Study|Protocol Violation|0
5055609|NCT02473289|17434210|P2|Overall Study|Lost to Follow-up|1
5055610|NCT02473289|17434211|P1|Overall Study|Lost to Follow-up|1
5055611|NCT02473289|17434210|P2|Overall Study|Adverse Event|3
5055612|NCT02473289|17434211|P1|Overall Study|Adverse Event|2
5055613|NCT02472977|17434236|P3|Overall Study|Subject request to discontinue treatment|0
5055614|NCT02472977|17434237|P2|Overall Study|Subject request to discontinue treatment|1
5055615|NCT02472977|17434238|P1|Overall Study|Subject request to discontinue treatment|0
5055616|NCT02472977|17434236|P3|Overall Study|Study drug toxicity|2
5055617|NCT02472977|17434237|P2|Overall Study|Study drug toxicity|0
5055618|NCT02472977|17434238|P1|Overall Study|Study drug toxicity|2
5055619|NCT02472977|17434236|P3|Overall Study|Withdrawal by Subject|0
5055620|NCT02472977|17434237|P2|Overall Study|Withdrawal by Subject|1
5055621|NCT02472977|17434238|P1|Overall Study|Withdrawal by Subject|0
5055622|NCT02472977|17434236|P3|Overall Study|Disease progression|6
5055623|NCT02472977|17434237|P2|Overall Study|Disease progression|25
5055624|NCT02472977|17434238|P1|Overall Study|Disease progression|4
5055625|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
5055626|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
5055627|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
5055628|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
5055629|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
5055630|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
5055631|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Physician Decision|1
5055632|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Physician Decision|1
5055633|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Death|1
5055634|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Death|0
5055635|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Disease Progression|56
5055636|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Disease Progression|52
5055637|NCT02472964|17434263|P2|Part 2 (Week 24-week 48)|Adverse Event|2
5055638|NCT02472964|17434264|P1|Part 2 (Week 24-week 48)|Adverse Event|4
5055639|NCT02472964|17434263|P2|Part 1 (up to Week 24)|Other|1
5055640|NCT02472964|17434264|P1|Part 1 (up to Week 24)|Other|2
5055641|NCT02472964|17434263|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
5055642|NCT02472964|17434264|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
5055643|NCT02472964|17434263|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
5055644|NCT02472964|17434264|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
5055645|NCT02472964|17434263|P2|Part 1 (up to Week 24)|Physician Decision|1
5055646|NCT02472964|17434264|P1|Part 1 (up to Week 24)|Physician Decision|3
5055647|NCT02472964|17434263|P2|Part 1 (up to Week 24)|Death|6
5055648|NCT02472964|17434264|P1|Part 1 (up to Week 24)|Death|3
5055649|NCT02472964|17434263|P2|Part 1 (up to Week 24)|disease progression|47
5055650|NCT02472964|17434264|P1|Part 1 (up to Week 24)|disease progression|58
5055651|NCT02472964|17434263|P2|Part 1 (up to Week 24)|Adverse Event|4
5055652|NCT02472964|17434264|P1|Part 1 (up to Week 24)|Adverse Event|2
5055653|NCT02472886|17434273|P3|Overall Study|Lack of Efficacy|1
5055654|NCT02472886|17434274|P2|Overall Study|Lack of Efficacy|2
5055655|NCT02472886|17434275|P1|Overall Study|Lack of Efficacy|0
5055656|NCT02472847|17434303|P2|Overall Study|Withdrawal by Subject|5
5055657|NCT02472847|17434304|P1|Overall Study|Withdrawal by Subject|1
5055658|NCT02472795|17434315|P5|Overall Study|Withdrawal by Subject|1
5055659|NCT02472795|17434316|P4|Overall Study|Withdrawal by Subject|0
5055660|NCT02472795|17434317|P3|Overall Study|Withdrawal by Subject|0
5055661|NCT02472795|17434318|P2|Overall Study|Withdrawal by Subject|0
5055662|NCT02472795|17434319|P1|Overall Study|Withdrawal by Subject|0
5055663|NCT02472795|17434315|P5|Overall Study|Adverse Event|2
5055664|NCT02472795|17434316|P4|Overall Study|Adverse Event|0
5055665|NCT02472795|17434317|P3|Overall Study|Adverse Event|0
5055666|NCT02472795|17434318|P2|Overall Study|Adverse Event|1
5055667|NCT02472795|17434319|P1|Overall Study|Adverse Event|0
5055668|NCT02472756|17434351|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
5055669|NCT02472756|17434351|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
5055670|NCT02472756|17434351|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
5055671|NCT02472756|17434351|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
5055672|NCT02472756|17434351|P1|Induction (Approximately 6 Months)|Adverse Event|1
5055673|NCT02472652|17434372|P1|Overall Study|Lost to Follow-up|1
5055674|NCT02472639|17434379|P2|Overall Study|Physician Decision|3
5055675|NCT02472639|17434380|P1|Overall Study|Physician Decision|4
5055676|NCT02472405|17434436|P1|Overall Study|Adverse Event|1
5055677|NCT02472405|17434436|P1|Overall Study|Lost to Follow-up|9
5055678|NCT02472366|17434444|P2|Overall Study|Lost to Follow-up|0
5055679|NCT02472366|17434445|P1|Overall Study|Lost to Follow-up|1
5055680|NCT02472353|17434461|P2|Overall Study|Study Termination|4
5055681|NCT02472353|17434462|P1|Overall Study|Study Termination|1
5055682|NCT02472353|17434461|P2|Overall Study|Withdrawal by Subject|1
5055683|NCT02472353|17434462|P1|Overall Study|Withdrawal by Subject|2
5055684|NCT02472353|17434461|P2|Overall Study|Lost to Follow-up|1
5055685|NCT02472353|17434462|P1|Overall Study|Lost to Follow-up|1
5055686|NCT02472145|17434499|P3|Overall Study|Other|43
5055687|NCT02472145|17434500|P2|Overall Study|Other|45
5055688|NCT02472145|17434501|P1|Overall Study|Other|0
5055689|NCT02472145|17434499|P3|Overall Study|Sponsor decision|2
5055690|NCT02472145|17434500|P2|Overall Study|Sponsor decision|3
5055691|NCT02472145|17434501|P1|Overall Study|Sponsor decision|0
5055692|NCT02472145|17434499|P3|Overall Study|Withdrawal by Subject|13
5055693|NCT02472145|17434500|P2|Overall Study|Withdrawal by Subject|9
5055694|NCT02472145|17434501|P1|Overall Study|Withdrawal by Subject|0
5055695|NCT02472145|17434499|P3|Overall Study|Lost to Follow-up|0
5055696|NCT02472145|17434500|P2|Overall Study|Lost to Follow-up|1
5055697|NCT02472145|17434501|P1|Overall Study|Lost to Follow-up|0
5055698|NCT02472145|17434499|P3|Overall Study|Death|99
5055699|NCT02472145|17434500|P2|Overall Study|Death|101
5055700|NCT02472145|17434501|P1|Overall Study|Death|10
5055701|NCT02471755|17434522|P2|Overall Study|Lost to Follow-up|1
5055702|NCT02471755|17434523|P1|Overall Study|Lost to Follow-up|0
5055703|NCT02471755|17434522|P2|Overall Study|Withdrawal by Subject|0
5055704|NCT02471755|17434523|P1|Overall Study|Withdrawal by Subject|1
5055705|NCT02471612|17434552|P1|Overall Study|Lost to Follow-up|2
5055706|NCT02471404|17434583|P3|Overall Study|Other reasons not specified|12
5055707|NCT02471404|17434584|P2|Overall Study|Other reasons not specified|7
5055708|NCT02471404|17434585|P1|Overall Study|Other reasons not specified|10
5055709|NCT02471404|17434583|P3|Overall Study|Withdrawal by Subject|5
5055710|NCT02471404|17434584|P2|Overall Study|Withdrawal by Subject|4
5055711|NCT02471404|17434585|P1|Overall Study|Withdrawal by Subject|8
5055712|NCT02471404|17434583|P3|Overall Study|Protocol Violation|0
5055713|NCT02471404|17434584|P2|Overall Study|Protocol Violation|0
5055714|NCT02471404|17434585|P1|Overall Study|Protocol Violation|1
5055715|NCT02471404|17434583|P3|Overall Study|Lost to Follow-up|3
5055716|NCT02471404|17434584|P2|Overall Study|Lost to Follow-up|1
5055717|NCT02471404|17434585|P1|Overall Study|Lost to Follow-up|1
5055718|NCT02471404|17434583|P3|Overall Study|Failure to Meet Randomization Criteria|1
5055719|NCT02471404|17434584|P2|Overall Study|Failure to Meet Randomization Criteria|0
5055720|NCT02471404|17434585|P1|Overall Study|Failure to Meet Randomization Criteria|2
5055721|NCT02471404|17434583|P3|Overall Study|Developed Study Withdrawal Criteria|2
5055722|NCT02471404|17434584|P2|Overall Study|Developed Study Withdrawal Criteria|1
5055723|NCT02471404|17434585|P1|Overall Study|Developed Study Withdrawal Criteria|4
5055724|NCT02471404|17434583|P3|Overall Study|Adverse Event|2
5055725|NCT02471404|17434584|P2|Overall Study|Adverse Event|1
5055726|NCT02471404|17434585|P1|Overall Study|Adverse Event|7
5055727|NCT02471183|17434617|P1|Extended Treatment Period|Lack of Efficacy|1
5055728|NCT02471183|17434617|P1|Main Treatment Period|Withdrawal by Subject|1
5055729|NCT02471183|17434617|P1|Main Treatment Period|Adverse Event|1
5055730|NCT02470806|17434652|P2|Overall Study|Lack of Efficacy|15
5055731|NCT02470806|17434653|P1|Overall Study|Lack of Efficacy|5
5055732|NCT02470806|17434652|P2|Overall Study|Withdrawal by Subject|10
5055733|NCT02470806|17434653|P1|Overall Study|Withdrawal by Subject|3
5055734|NCT02470806|17434652|P2|Overall Study|Physician Decision|3
5055735|NCT02470806|17434653|P1|Overall Study|Physician Decision|0
5055736|NCT02470806|17434652|P2|Overall Study|Protocol Violation|11
5055737|NCT02470806|17434653|P1|Overall Study|Protocol Violation|4
5055738|NCT02470806|17434652|P2|Overall Study|Adverse Event|2
5055739|NCT02470806|17434653|P1|Overall Study|Adverse Event|5
5055740|NCT02470806|17434652|P2|Overall Study|Lost to Follow-up|1
5055741|NCT02470806|17434653|P1|Overall Study|Lost to Follow-up|1
5055742|NCT02470585|17434706|P3|Overall Study|Other|6
5055743|NCT02470585|17434707|P2|Overall Study|Other|4
5055744|NCT02470585|17434708|P1|Overall Study|Other|4
5055745|NCT02470585|17434706|P3|Overall Study|Lost to Follow-up|4
5055746|NCT02470585|17434707|P2|Overall Study|Lost to Follow-up|5
5055747|NCT02470585|17434708|P1|Overall Study|Lost to Follow-up|2
5055748|NCT02470585|17434706|P3|Overall Study|Withdrawal by Subject|29
5055749|NCT02470585|17434707|P2|Overall Study|Withdrawal by Subject|21
5055750|NCT02470585|17434708|P1|Overall Study|Withdrawal by Subject|19
5055751|NCT02470585|17434706|P3|Overall Study|Death|86
5055752|NCT02470585|17434707|P2|Overall Study|Death|87
5055753|NCT02470585|17434708|P1|Overall Study|Death|82
5055754|NCT02470429|17434741|P2|Overall Study|Withdrawal by Subject|0
5055755|NCT02470429|17434742|P1|Overall Study|Withdrawal by Subject|1
5055756|NCT02470429|17434741|P2|Overall Study|Adverse Event|0
5055757|NCT02470429|17434742|P1|Overall Study|Adverse Event|1
5055758|NCT02470403|17434760|P5|Overall Study|Subject/guardian decision|0
5055759|NCT02470403|17434761|P4|Overall Study|Subject/guardian decision|4
5055760|NCT02470403|17434762|P3|Overall Study|Subject/guardian decision|0
5055761|NCT02470403|17434763|P2|Overall Study|Subject/guardian decision|0
5055762|NCT02470403|17434764|P1|Overall Study|Subject/guardian decision|1
5055763|NCT02470403|17434760|P5|Overall Study|Lost to Follow-up|0
5055764|NCT02470403|17434761|P4|Overall Study|Lost to Follow-up|0
5055765|NCT02470403|17434762|P3|Overall Study|Lost to Follow-up|0
5055766|NCT02470403|17434763|P2|Overall Study|Lost to Follow-up|1
5055767|NCT02470403|17434764|P1|Overall Study|Lost to Follow-up|0
5055768|NCT02470403|17434760|P5|Overall Study|Adverse Event|0
5055769|NCT02470403|17434761|P4|Overall Study|Adverse Event|0
5055770|NCT02470403|17434762|P3|Overall Study|Adverse Event|0
5055771|NCT02470403|17434763|P2|Overall Study|Adverse Event|0
5055772|NCT02470403|17434764|P1|Overall Study|Adverse Event|1
5055773|NCT02469961|17434844|P2|Overall Study|Physician Decision|1
5055774|NCT02469961|17434845|P1|Overall Study|Physician Decision|4
5055775|NCT02469896|17434859|P2|Overall Study|Withdrawal by Subject|0
5055776|NCT02469896|17434860|P1|Overall Study|Withdrawal by Subject|2
5055777|NCT02469623|17434930|P1|Overall Study|Death|3
5055778|NCT02469623|17434930|P1|Overall Study|Withdrawal by Subject|2
5055779|NCT02469623|17434930|P1|Overall Study|Lost to Follow-up|4
5055780|NCT02469623|17434930|P1|Overall Study|Not consented for long-term follow-up|4
5055781|NCT02469610|17434937|P2|Overall Study|exclusion criteria|1
5055782|NCT02469610|17434938|P1|Overall Study|exclusion criteria|2
5055783|NCT02469610|17434937|P2|Overall Study|Lost to Follow-up|0
5055784|NCT02469610|17434938|P1|Overall Study|Lost to Follow-up|1
5055785|NCT02469610|17434937|P2|Overall Study|Death|0
5055786|NCT02469610|17434938|P1|Overall Study|Death|1
5055787|NCT02469415|17434965|P1|Overall Study|Investigational agent placed on hold|2
5055788|NCT02469415|17434965|P1|Overall Study|Withdrawal by Subject|1
5055789|NCT02469298|17434973|P4|Overall Study|Withdrawal by Subject|1
5055790|NCT02469298|17434974|P3|Overall Study|Withdrawal by Subject|0
5055791|NCT02469298|17434975|P2|Overall Study|Withdrawal by Subject|0
5055792|NCT02469298|17434976|P1|Overall Study|Withdrawal by Subject|0
5055793|NCT02469298|17434973|P4|Overall Study|Physician Decision|1
5055794|NCT02469298|17434974|P3|Overall Study|Physician Decision|0
5055795|NCT02469298|17434975|P2|Overall Study|Physician Decision|0
5055796|NCT02469298|17434976|P1|Overall Study|Physician Decision|0
5055797|NCT02469298|17434973|P4|Overall Study|Lost to Follow-up|0
5055798|NCT02469298|17434974|P3|Overall Study|Lost to Follow-up|1
5055799|NCT02469298|17434975|P2|Overall Study|Lost to Follow-up|0
5055800|NCT02469298|17434976|P1|Overall Study|Lost to Follow-up|1
5055801|NCT02469298|17434973|P4|Overall Study|Protocol Violation|0
5055802|NCT02469298|17434974|P3|Overall Study|Protocol Violation|1
5055803|NCT02469298|17434975|P2|Overall Study|Protocol Violation|1
5055804|NCT02469298|17434976|P1|Overall Study|Protocol Violation|0
5055805|NCT02469246|17435116|P2|Double-Blind Phase|Lost to Follow-up|5
5055806|NCT02469246|17435117|P1|Double-Blind Phase|Lost to Follow-up|9
5055807|NCT02469246|17435116|P2|Double-Blind Phase|Withdrew Consent|25
5055808|NCT02469246|17435117|P1|Double-Blind Phase|Withdrew Consent|25
5055809|NCT02469246|17435116|P2|Double-Blind Phase|Protocol Violation|1
5055810|NCT02469246|17435117|P1|Double-Blind Phase|Protocol Violation|1
5055811|NCT02469246|17435116|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5055812|NCT02469246|17435117|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
5055813|NCT02469246|17435116|P2|Double-Blind Phase|Investigator's Discretion|8
5055814|NCT02469246|17435117|P1|Double-Blind Phase|Investigator's Discretion|8
5055815|NCT02469246|17435116|P2|Double-Blind Phase|Lack of Efficacy|1
5055816|NCT02469246|17435117|P1|Double-Blind Phase|Lack of Efficacy|2
5055817|NCT02469246|17435116|P2|Double-Blind Phase|Death|0
5055818|NCT02469246|17435117|P1|Double-Blind Phase|Death|2
5055819|NCT02469246|17435116|P2|Double-Blind Phase|Adverse Event|9
5055820|NCT02469246|17435117|P1|Double-Blind Phase|Adverse Event|12
5055821|NCT02469246|17435116|P2|Double-Blind Phase|Randomized and Never Treated|6
5055822|NCT02469246|17435117|P1|Double-Blind Phase|Randomized and Never Treated|5
5055823|NCT02469168|17435149|P2|Overall Study|Trial closed|0
5055824|NCT02469168|17435150|P1|Overall Study|Trial closed|1
5055825|NCT02469090|17435170|P3|Period 2: Maintenance Treatment Phase|Death|1
5055826|NCT02469090|17435171|P2|Period 2: Maintenance Treatment Phase|Death|0
5055827|NCT02469090|17435172|P1|Period 2: Maintenance Treatment Phase|Death|0
5055828|NCT02469090|17435170|P3|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
5055829|NCT02469090|17435171|P2|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
5055830|NCT02469090|17435172|P1|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
5055831|NCT02469090|17435170|P3|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
5055832|NCT02469090|17435171|P2|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
5055833|NCT02469090|17435172|P1|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
5055834|NCT02469090|17435170|P3|Period 2: Maintenance Treatment Phase|Adverse Event|15
5055835|NCT02469090|17435171|P2|Period 2: Maintenance Treatment Phase|Adverse Event|5
5055836|NCT02469090|17435172|P1|Period 2: Maintenance Treatment Phase|Adverse Event|0
5055837|NCT02469090|17435170|P3|Period 1: Dose Titration Phase|Lack of Efficacy|0
5055838|NCT02469090|17435171|P2|Period 1: Dose Titration Phase|Lack of Efficacy|0
5055839|NCT02469090|17435172|P1|Period 1: Dose Titration Phase|Lack of Efficacy|11
5055840|NCT02469090|17435170|P3|Period 1: Dose Titration Phase|Lost to Follow-up|0
5055841|NCT02469090|17435171|P2|Period 1: Dose Titration Phase|Lost to Follow-up|0
5055842|NCT02469090|17435172|P1|Period 1: Dose Titration Phase|Lost to Follow-up|1
5055843|NCT02469090|17435170|P3|Period 1: Dose Titration Phase|Withdrawal by Subject|0
5055844|NCT02469090|17435171|P2|Period 1: Dose Titration Phase|Withdrawal by Subject|0
5055845|NCT02469090|17435172|P1|Period 1: Dose Titration Phase|Withdrawal by Subject|8
5055846|NCT02469090|17435170|P3|Period 1: Dose Titration Phase|Adverse Event|0
5055847|NCT02469090|17435171|P2|Period 1: Dose Titration Phase|Adverse Event|0
5055848|NCT02469090|17435172|P1|Period 1: Dose Titration Phase|Adverse Event|12
5055849|NCT02469077|17435199|P2|Post Intervention /Followup|Withdrawal by Subject|1
5055850|NCT02469077|17435200|P1|Post Intervention /Followup|Withdrawal by Subject|2
5055851|NCT02469077|17435199|P2|Post Randomization/Intervention Period|Conflicting health issues|1
5055852|NCT02469077|17435200|P1|Post Randomization/Intervention Period|Conflicting health issues|0
5055853|NCT02469077|17435199|P2|Post Randomization/Intervention Period|Relocated|1
5055854|NCT02469077|17435200|P1|Post Randomization/Intervention Period|Relocated|1
5055855|NCT02469077|17435199|P2|Post Randomization/Intervention Period|Scheduling issues|2
5055856|NCT02469077|17435200|P1|Post Randomization/Intervention Period|Scheduling issues|3
5055857|NCT02469064|17435232|P2|Overall Study|Request not to receive intervention.|3
5055858|NCT02469064|17435233|P1|Overall Study|Request not to receive intervention.|1
5055859|NCT02468934|17435241|P1|Overall Study|Screen Failure|3
5055860|NCT02468934|17435241|P1|Overall Study|Withdrawal by Subject|4
5055861|NCT02468674|17435292|P9|Overall Study|Protocol Deviation|1
5055862|NCT02468674|17435293|P8|Overall Study|Protocol Deviation|1
5055863|NCT02468674|17435294|P7|Overall Study|Protocol Deviation|0
5055864|NCT02468674|17435295|P6|Overall Study|Protocol Deviation|0
5055865|NCT02468674|17435296|P5|Overall Study|Protocol Deviation|0
5055866|NCT02468674|17435297|P4|Overall Study|Protocol Deviation|0
5055867|NCT02468674|17435298|P3|Overall Study|Protocol Deviation|0
5055868|NCT02468674|17435299|P2|Overall Study|Protocol Deviation|0
5055869|NCT02468674|17435300|P1|Overall Study|Protocol Deviation|0
5055870|NCT02468674|17435292|P9|Overall Study|Patient/Guardian Decision|1
5055871|NCT02468674|17435293|P8|Overall Study|Patient/Guardian Decision|2
5055872|NCT02468674|17435294|P7|Overall Study|Patient/Guardian Decision|0
5055873|NCT02468674|17435295|P6|Overall Study|Patient/Guardian Decision|0
5055874|NCT02468674|17435296|P5|Overall Study|Patient/Guardian Decision|1
5055875|NCT02468674|17435297|P4|Overall Study|Patient/Guardian Decision|0
5055876|NCT02468674|17435298|P3|Overall Study|Patient/Guardian Decision|0
5055877|NCT02468674|17435299|P2|Overall Study|Patient/Guardian Decision|0
5055878|NCT02468674|17435300|P1|Overall Study|Patient/Guardian Decision|0
5055879|NCT02468674|17435292|P9|Overall Study|Physician Decision|0
5055880|NCT02468674|17435293|P8|Overall Study|Physician Decision|0
5055881|NCT02468674|17435294|P7|Overall Study|Physician Decision|1
5055882|NCT02468674|17435295|P6|Overall Study|Physician Decision|0
5055883|NCT02468674|17435296|P5|Overall Study|Physician Decision|0
5055884|NCT02468674|17435297|P4|Overall Study|Physician Decision|0
5055885|NCT02468674|17435298|P3|Overall Study|Physician Decision|0
5055886|NCT02468674|17435299|P2|Overall Study|Physician Decision|0
5055887|NCT02468674|17435300|P1|Overall Study|Physician Decision|0
5055888|NCT02468674|17435292|P9|Overall Study|Lost to Follow-up|1
5055889|NCT02468674|17435293|P8|Overall Study|Lost to Follow-up|1
5055890|NCT02468674|17435294|P7|Overall Study|Lost to Follow-up|0
5055891|NCT02468674|17435295|P6|Overall Study|Lost to Follow-up|0
5055892|NCT02468674|17435296|P5|Overall Study|Lost to Follow-up|0
5055893|NCT02468674|17435297|P4|Overall Study|Lost to Follow-up|0
5055894|NCT02468674|17435298|P3|Overall Study|Lost to Follow-up|0
5055895|NCT02468674|17435299|P2|Overall Study|Lost to Follow-up|0
5055896|NCT02468674|17435300|P1|Overall Study|Lost to Follow-up|1
5055897|NCT02468674|17435292|P9|Overall Study|Adverse Event|0
5055898|NCT02468674|17435293|P8|Overall Study|Adverse Event|0
5055899|NCT02468674|17435294|P7|Overall Study|Adverse Event|0
5055900|NCT02468674|17435295|P6|Overall Study|Adverse Event|1
5055901|NCT02468674|17435296|P5|Overall Study|Adverse Event|0
5055902|NCT02468674|17435297|P4|Overall Study|Adverse Event|1
5055903|NCT02468674|17435298|P3|Overall Study|Adverse Event|0
5055904|NCT02468674|17435299|P2|Overall Study|Adverse Event|0
5055905|NCT02468674|17435300|P1|Overall Study|Adverse Event|0
5055906|NCT02468648|17435356|P1|Overall Study|Death|1
5055907|NCT02468414|17435423|P2|Overall Study|Screen Failure|0
5055908|NCT02468414|17435424|P1|Overall Study|Screen Failure|1
5055909|NCT02468414|17435423|P2|Overall Study|Poor in-vitro secreting TARGTs|0
5055910|NCT02468414|17435424|P1|Overall Study|Poor in-vitro secreting TARGTs|1
5055911|NCT02468414|17435423|P2|Overall Study|Early Study Termination by Sponsor|0
5055912|NCT02468414|17435424|P1|Overall Study|Early Study Termination by Sponsor|1
5055913|NCT02468193|17435430|P1|Overall Study|Subject/ Guardian decision|2
5055914|NCT02468193|17435430|P1|Overall Study|Adverse Event|4
5055915|NCT02466659|17435752|P2|Overall Study|Lost to Follow-up|2
5055916|NCT02466659|17435753|P1|Overall Study|Lost to Follow-up|5
5055917|NCT02466555|17435807|P1|Overall Study|Lost to Follow-up|2
5055918|NCT02466516|17435819|P5|Overall Study|Lost to Follow-up|0
5055919|NCT02466516|17435820|P4|Overall Study|Lost to Follow-up|0
5055920|NCT02466516|17435821|P3|Overall Study|Lost to Follow-up|1
5055921|NCT02466516|17435822|P2|Overall Study|Lost to Follow-up|0
5055922|NCT02466516|17435823|P1|Overall Study|Lost to Follow-up|2
5055923|NCT02466516|17435819|P5|Overall Study|Withdrew Consent|0
5055924|NCT02466516|17435820|P4|Overall Study|Withdrew Consent|0
5055925|NCT02466516|17435821|P3|Overall Study|Withdrew Consent|0
5055926|NCT02466516|17435822|P2|Overall Study|Withdrew Consent|0
5055927|NCT02466516|17435823|P1|Overall Study|Withdrew Consent|1
5055928|NCT02466516|17435819|P5|Overall Study|Adverse Event|0
5055929|NCT02466516|17435820|P4|Overall Study|Adverse Event|0
5055930|NCT02466516|17435821|P3|Overall Study|Adverse Event|0
5055931|NCT02466516|17435822|P2|Overall Study|Adverse Event|1
5055932|NCT02466516|17435823|P1|Overall Study|Adverse Event|1
5055933|NCT02466425|17435842|P2|Overall Study|Withdrawal by Parent/Guardian|0
5055934|NCT02466425|17435843|P1|Overall Study|Withdrawal by Parent/Guardian|2
5055935|NCT02466425|17435842|P2|Overall Study|Other|3
5055936|NCT02466425|17435843|P1|Overall Study|Other|1
5055937|NCT02466425|17435842|P2|Overall Study|Withdrawal by Subject|1
5055938|NCT02466425|17435843|P1|Overall Study|Withdrawal by Subject|0
5055939|NCT02466425|17435842|P2|Overall Study|Protocol Violation|0
5055940|NCT02466425|17435843|P1|Overall Study|Protocol Violation|1
5055941|NCT02466425|17435842|P2|Overall Study|Lost to Follow-up|0
5055942|NCT02466425|17435843|P1|Overall Study|Lost to Follow-up|3
5055943|NCT02466425|17435842|P2|Overall Study|Lack of Efficacy|1
5055944|NCT02466425|17435843|P1|Overall Study|Lack of Efficacy|4
5055945|NCT02466425|17435842|P2|Overall Study|Adverse Event|11
5055946|NCT02466425|17435843|P1|Overall Study|Adverse Event|3
5055947|NCT02466399|17435865|P2|Overall Study|Early exit due to family emergency|0
5055948|NCT02466399|17435866|P1|Overall Study|Early exit due to family emergency|1
5055949|NCT02466399|17435865|P2|Overall Study|Adverse Event|0
5055950|NCT02466399|17435866|P1|Overall Study|Adverse Event|1
5055951|NCT02465931|17435890|P2|Overall Study|Withdrawal by Subject|0
5055952|NCT02465931|17435891|P1|Overall Study|Withdrawal by Subject|1
5055953|NCT02465931|17435890|P2|Overall Study|Protocol Violation|0
5055954|NCT02465931|17435891|P1|Overall Study|Protocol Violation|1
5055955|NCT02465931|17435890|P2|Overall Study|Lost to Follow-up|11
5055956|NCT02465931|17435891|P1|Overall Study|Lost to Follow-up|9
5055957|NCT02465866|17435897|P4|Period 3|Withdrawal by Subject|0
5055958|NCT02465866|17435898|P3|Period 3|Withdrawal by Subject|0
5055959|NCT02465866|17435899|P2|Period 3|Withdrawal by Subject|1
5055960|NCT02465866|17435900|P1|Period 3|Withdrawal by Subject|0
5055961|NCT02465528|17435990|P4|Overall Study|Physician Decision|0
5055962|NCT02465528|17435991|P3|Overall Study|Physician Decision|1
5055963|NCT02465528|17435992|P2|Overall Study|Physician Decision|0
5055964|NCT02465528|17435993|P1|Overall Study|Physician Decision|0
5055965|NCT02465528|17435990|P4|Overall Study|Adverse Event|1
5055966|NCT02465528|17435991|P3|Overall Study|Adverse Event|0
5055967|NCT02465528|17435992|P2|Overall Study|Adverse Event|0
5055968|NCT02465528|17435993|P1|Overall Study|Adverse Event|0
5055969|NCT02465528|17435990|P4|Overall Study|Withdrawal by Subject|0
5055970|NCT02465528|17435991|P3|Overall Study|Withdrawal by Subject|2
5055971|NCT02465528|17435992|P2|Overall Study|Withdrawal by Subject|0
5055972|NCT02465528|17435993|P1|Overall Study|Withdrawal by Subject|0
5055973|NCT02465528|17435990|P4|Overall Study|Study terminated by sponsor|0
5055974|NCT02465528|17435991|P3|Overall Study|Study terminated by sponsor|0
5055975|NCT02465528|17435992|P2|Overall Study|Study terminated by sponsor|2
5055976|NCT02465528|17435993|P1|Overall Study|Study terminated by sponsor|1
5055977|NCT02465528|17435990|P4|Overall Study|Progressive disease|4
5055978|NCT02465528|17435991|P3|Overall Study|Progressive disease|9
5055979|NCT02465528|17435992|P2|Overall Study|Progressive disease|2
5055980|NCT02465528|17435993|P1|Overall Study|Progressive disease|0
5055981|NCT02465515|17436026|P2|Overall Study|Lost to Follow-up|51
5055982|NCT02465515|17436027|P1|Overall Study|Lost to Follow-up|68
5055983|NCT02465515|17436026|P2|Overall Study|Physician Decision|12
5055984|NCT02465515|17436027|P1|Overall Study|Physician Decision|8
5055985|NCT02465515|17436026|P2|Overall Study|Withdrawal by Subject|43
5055986|NCT02465515|17436027|P1|Overall Study|Withdrawal by Subject|74
5055987|NCT02465515|17436026|P2|Overall Study|Investigator site closed|5
5055988|NCT02465515|17436027|P1|Overall Study|Investigator site closed|4
5055989|NCT02465489|17436073|P1|Overall Study|Adverse Event|5
5055990|NCT02465463|17436102|P2|Overall Study|Protocol Violation|0
5055991|NCT02465463|17436103|P1|Overall Study|Protocol Violation|1
5055992|NCT02465463|17436102|P2|Overall Study|Death|0
5055993|NCT02465463|17436103|P1|Overall Study|Death|1
5055994|NCT02465463|17436102|P2|Overall Study|Lost to Follow-up|1
5055995|NCT02465463|17436103|P1|Overall Study|Lost to Follow-up|2
5055996|NCT02465437|17436151|P4|Overall Study|Adverse Event|0
5055997|NCT02465437|17436152|P3|Overall Study|Adverse Event|0
5055998|NCT02465437|17436153|P2|Overall Study|Adverse Event|1
5055999|NCT02465437|17436154|P1|Overall Study|Adverse Event|0
5056000|NCT02465437|17436151|P4|Overall Study|Withdrawal by Subject|1
5056001|NCT02465437|17436152|P3|Overall Study|Withdrawal by Subject|0
5056002|NCT02465437|17436153|P2|Overall Study|Withdrawal by Subject|0
5056003|NCT02465437|17436154|P1|Overall Study|Withdrawal by Subject|1
5056004|NCT02465437|17436151|P4|Overall Study|Physician Decision|0
5056005|NCT02465437|17436152|P3|Overall Study|Physician Decision|1
5056006|NCT02465437|17436153|P2|Overall Study|Physician Decision|0
5056007|NCT02465437|17436154|P1|Overall Study|Physician Decision|0
5056008|NCT02465203|17436214|P3|Overall Study|Patient/guardian decision|1
5056009|NCT02465203|17436215|P2|Overall Study|Patient/guardian decision|1
5056010|NCT02465203|17436216|P1|Overall Study|Patient/guardian decision|1
5056011|NCT02465203|17436214|P3|Overall Study|New therapy for study indication|0
5056012|NCT02465203|17436215|P2|Overall Study|New therapy for study indication|0
5056013|NCT02465203|17436216|P1|Overall Study|New therapy for study indication|4
5056014|NCT02465203|17436214|P3|Overall Study|Study terminated by sponsor|11
5056015|NCT02465203|17436215|P2|Overall Study|Study terminated by sponsor|34
5056016|NCT02465203|17436216|P1|Overall Study|Study terminated by sponsor|50
5056017|NCT02465203|17436214|P3|Overall Study|Protocol Violation|1
5056018|NCT02465203|17436215|P2|Overall Study|Protocol Violation|1
5056019|NCT02465203|17436216|P1|Overall Study|Protocol Violation|1
5056020|NCT02464059|17436336|P1|Overall Study|Lost to Follow-up|6
5056021|NCT02463409|17436395|P1|Overall Study|Screen failure|1
5056022|NCT02463409|17436395|P1|Overall Study|Withdrawal by Subject|1
5056023|NCT02463331|17436403|P2|Overall Study|Physician Decision|0
5056024|NCT02463331|17436404|P1|Overall Study|Physician Decision|3
5056025|NCT02463331|17436403|P2|Overall Study|Lack of Efficacy|0
5056026|NCT02463331|17436404|P1|Overall Study|Lack of Efficacy|6
5056027|NCT02463331|17436403|P2|Overall Study|Pregnancy|3
5056028|NCT02463331|17436404|P1|Overall Study|Pregnancy|2
5056029|NCT02463331|17436403|P2|Overall Study|Lost to Follow-up|1
5056030|NCT02463331|17436404|P1|Overall Study|Lost to Follow-up|1
5056031|NCT02463331|17436403|P2|Overall Study|Adverse Event|2
5056032|NCT02463331|17436404|P1|Overall Study|Adverse Event|4
5056033|NCT02463097|17436420|P1|Overall Study|Withdrawal by Subject|1
5056034|NCT02463071|17436429|P3|Overall Study|Lost to Follow-up|1
5056035|NCT02463071|17436430|P2|Overall Study|Lost to Follow-up|0
5056036|NCT02463071|17436431|P1|Overall Study|Lost to Follow-up|0
5056037|NCT02463071|17436429|P3|Overall Study|Protocol Violation|0
5056038|NCT02463071|17436430|P2|Overall Study|Protocol Violation|2
5056039|NCT02463071|17436431|P1|Overall Study|Protocol Violation|0
5056040|NCT02463071|17436429|P3|Overall Study|Reason not specified|4
5056041|NCT02463071|17436430|P2|Overall Study|Reason not specified|9
5056042|NCT02463071|17436431|P1|Overall Study|Reason not specified|7
5056043|NCT02463071|17436429|P3|Overall Study|Eligibility criteria not fulfilled|0
5056044|NCT02463071|17436430|P2|Overall Study|Eligibility criteria not fulfilled|0
5056045|NCT02463071|17436431|P1|Overall Study|Eligibility criteria not fulfilled|1
5056046|NCT02463071|17436429|P3|Overall Study|Death|0
5056047|NCT02463071|17436430|P2|Overall Study|Death|0
5056048|NCT02463071|17436431|P1|Overall Study|Death|1
5056049|NCT02463071|17436429|P3|Overall Study|Adverse Event|1
5056050|NCT02463071|17436430|P2|Overall Study|Adverse Event|5
5056051|NCT02463071|17436431|P1|Overall Study|Adverse Event|3
5056052|NCT02462928|17436491|P3|Overall Study|Reason not Specified|5
5056053|NCT02462928|17436492|P2|Overall Study|Reason not Specified|6
5056054|NCT02462928|17436493|P1|Overall Study|Reason not Specified|4
5056055|NCT02462928|17436491|P3|Overall Study|Protocol Violation|0
5056056|NCT02462928|17436492|P2|Overall Study|Protocol Violation|1
5056057|NCT02462928|17436493|P1|Overall Study|Protocol Violation|0
5056058|NCT02462928|17436491|P3|Overall Study|Withdrawal by Patient|21
5056059|NCT02462928|17436492|P2|Overall Study|Withdrawal by Patient|21
5056060|NCT02462928|17436493|P1|Overall Study|Withdrawal by Patient|31
5056061|NCT02462928|17436491|P3|Overall Study|Lost to Follow-up|1
5056062|NCT02462928|17436492|P2|Overall Study|Lost to Follow-up|4
5056063|NCT02462928|17436493|P1|Overall Study|Lost to Follow-up|4
5056064|NCT02462928|17436491|P3|Overall Study|Lack of Efficacy|3
5056065|NCT02462928|17436492|P2|Overall Study|Lack of Efficacy|8
5056066|NCT02462928|17436493|P1|Overall Study|Lack of Efficacy|3
5056067|NCT02462928|17436491|P3|Overall Study|Adverse Event|25
5056068|NCT02462928|17436492|P2|Overall Study|Adverse Event|51
5056069|NCT02462928|17436493|P1|Overall Study|Adverse Event|47
5056070|NCT02462928|17436491|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|2
5056071|NCT02462928|17436492|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5056072|NCT02462928|17436493|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5056073|NCT02462876|17436513|P1|Overall Study|Ongoing|10
5056074|NCT02462876|17436513|P1|Overall Study|Other|6
5056075|NCT02462876|17436513|P1|Overall Study|Amputation Above the Metatarsals|1
5056076|NCT02462876|17436513|P1|Overall Study|Surgical Bypass|9
5056077|NCT02462876|17436513|P1|Overall Study|Lost to Follow-up|4
5056078|NCT02462876|17436513|P1|Overall Study|Death|3
5056079|NCT02462759|17436523|P3|Part 1: Double Blind|Death|0
5056080|NCT02462759|17436524|P2|Part 1: Double Blind|Death|0
5056081|NCT02462759|17436525|P1|Part 1: Double Blind|Death|1
5056082|NCT02462720|17436573|P2|Part 2|Protocol Violation|1
5056083|NCT02462720|17436574|P1|Part 2|Protocol Violation|0
5056084|NCT02462720|17436573|P2|Part 2|Withdrawal by Subject|0
5056085|NCT02462720|17436574|P1|Part 2|Withdrawal by Subject|1
5056086|NCT02462486|17436587|P3|Overall Study|Reason not Specified|3
5056087|NCT02462486|17436588|P2|Overall Study|Reason not Specified|4
5056088|NCT02462486|17436589|P1|Overall Study|Reason not Specified|3
5056089|NCT02462486|17436587|P3|Overall Study|Protocol Violation|1
5056090|NCT02462486|17436588|P2|Overall Study|Protocol Violation|1
5056091|NCT02462486|17436589|P1|Overall Study|Protocol Violation|3
5056092|NCT02462486|17436587|P3|Overall Study|Withdrawal by Subject|19
5056093|NCT02462486|17436588|P2|Overall Study|Withdrawal by Subject|22
5056094|NCT02462486|17436589|P1|Overall Study|Withdrawal by Subject|25
5056095|NCT02462486|17436587|P3|Overall Study|Lost to Follow-up|2
5056096|NCT02462486|17436588|P2|Overall Study|Lost to Follow-up|4
5056097|NCT02462486|17436589|P1|Overall Study|Lost to Follow-up|3
5056098|NCT02462486|17436587|P3|Overall Study|Lack of Efficacy|3
5056099|NCT02462486|17436588|P2|Overall Study|Lack of Efficacy|12
5056100|NCT02462486|17436589|P1|Overall Study|Lack of Efficacy|6
5056101|NCT02462486|17436587|P3|Overall Study|Adverse Event|21
5056102|NCT02462486|17436588|P2|Overall Study|Adverse Event|48
5056103|NCT02462486|17436589|P1|Overall Study|Adverse Event|53
5056104|NCT02462486|17436587|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|3
5056105|NCT02462486|17436588|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5056106|NCT02462486|17436589|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5056107|NCT02462473|17436609|P1|Overall Study|Other|3
5056108|NCT02462473|17436609|P1|Overall Study|Death|1
5056109|NCT02462083|17436700|P1|Overall Study|Other than specified|45
5056110|NCT02462083|17436700|P1|Overall Study|Worsening condition|16
5056111|NCT02462083|17436700|P1|Overall Study|Adverse Event|33
5056112|NCT02462083|17436700|P1|Overall Study|Protocol Violation|6
5056113|NCT02462083|17436700|P1|Overall Study|Pregnancy|1
5056114|NCT02462083|17436700|P1|Overall Study|Lack of Efficacy|151
5056115|NCT02462083|17436700|P1|Overall Study|Lost to Follow-up|41
5056116|NCT02462083|17436700|P1|Overall Study|Withdrawal by Subject|87
5056117|NCT02462083|17436700|P1|Overall Study|Sponsor request|39
5056118|NCT02462057|17436720|P5|Overall Study|Joined HealthyFood Before Intervention|17
5056119|NCT02462057|17436721|P4|Overall Study|Joined HealthyFood Before Intervention|16
5056208|NCT02461160|17437053|P1|Overall Study|Lost to Follow-up|0
5056120|NCT02462057|17436722|P3|Overall Study|Joined HealthyFood Before Intervention|23
5056121|NCT02462057|17436723|P2|Overall Study|Joined HealthyFood Before Intervention|13
5056122|NCT02462057|17436724|P1|Overall Study|Joined HealthyFood Before Intervention|22
5056123|NCT02462057|17436720|P5|Overall Study|Left Vitality|33
5056124|NCT02462057|17436721|P4|Overall Study|Left Vitality|35
5056125|NCT02462057|17436722|P3|Overall Study|Left Vitality|23
5056126|NCT02462057|17436723|P2|Overall Study|Left Vitality|27
5056127|NCT02462057|17436724|P1|Overall Study|Left Vitality|32
5056128|NCT02461758|17436810|P4|Overall Study|Lost to Follow-up|0
5056129|NCT02461758|17436811|P3|Overall Study|Lost to Follow-up|1
5056130|NCT02461758|17436812|P2|Overall Study|Lost to Follow-up|1
5056131|NCT02461758|17436813|P1|Overall Study|Lost to Follow-up|0
5056132|NCT02461628|17436854|P2|Overall Study|Refused to complete survey|7
5056133|NCT02461628|17436855|P1|Overall Study|Refused to complete survey|4
5056134|NCT02461589|17436879|P10|Overall Study|Withdrawal from trial before exposure|1
5056135|NCT02461589|17436880|P9|Overall Study|Withdrawal from trial before exposure|0
5056136|NCT02461589|17436881|P8|Overall Study|Withdrawal from trial before exposure|0
5056137|NCT02461589|17436882|P7|Overall Study|Withdrawal from trial before exposure|0
5056138|NCT02461589|17436883|P6|Overall Study|Withdrawal from trial before exposure|0
5056139|NCT02461589|17436884|P5|Overall Study|Withdrawal from trial before exposure|0
5056140|NCT02461589|17436885|P4|Overall Study|Withdrawal from trial before exposure|0
5056141|NCT02461589|17436886|P3|Overall Study|Withdrawal from trial before exposure|0
5056142|NCT02461589|17436887|P2|Overall Study|Withdrawal from trial before exposure|0
5056143|NCT02461589|17436888|P1|Overall Study|Withdrawal from trial before exposure|0
5056144|NCT02461589|17436879|P10|Overall Study|Missing follow-up information|0
5056145|NCT02461589|17436880|P9|Overall Study|Missing follow-up information|0
5056146|NCT02461589|17436881|P8|Overall Study|Missing follow-up information|0
5056147|NCT02461589|17436882|P7|Overall Study|Missing follow-up information|1
5056148|NCT02461589|17436883|P6|Overall Study|Missing follow-up information|0
5056149|NCT02461589|17436884|P5|Overall Study|Missing follow-up information|0
5056150|NCT02461589|17436885|P4|Overall Study|Missing follow-up information|0
5056151|NCT02461589|17436886|P3|Overall Study|Missing follow-up information|0
5056152|NCT02461589|17436887|P2|Overall Study|Missing follow-up information|1
5056153|NCT02461589|17436888|P1|Overall Study|Missing follow-up information|1
5056154|NCT02461589|17436879|P10|Overall Study|Unclassified|2
5056155|NCT02461589|17436880|P9|Overall Study|Unclassified|0
5056156|NCT02461589|17436881|P8|Overall Study|Unclassified|0
5056157|NCT02461589|17436882|P7|Overall Study|Unclassified|1
5056158|NCT02461589|17436883|P6|Overall Study|Unclassified|0
5056159|NCT02461589|17436884|P5|Overall Study|Unclassified|0
5056160|NCT02461589|17436885|P4|Overall Study|Unclassified|0
5056161|NCT02461589|17436886|P3|Overall Study|Unclassified|0
5056162|NCT02461589|17436887|P2|Overall Study|Unclassified|0
5056163|NCT02461589|17436888|P1|Overall Study|Unclassified|0
5056164|NCT02461589|17436879|P10|Overall Study|Death|0
5056165|NCT02461589|17436880|P9|Overall Study|Death|0
5056166|NCT02461589|17436881|P8|Overall Study|Death|1
5056167|NCT02461589|17436882|P7|Overall Study|Death|0
5056168|NCT02461589|17436883|P6|Overall Study|Death|0
5056169|NCT02461589|17436884|P5|Overall Study|Death|0
5056170|NCT02461589|17436885|P4|Overall Study|Death|0
5056171|NCT02461589|17436886|P3|Overall Study|Death|0
5056172|NCT02461589|17436887|P2|Overall Study|Death|0
5056173|NCT02461589|17436888|P1|Overall Study|Death|0
5056174|NCT02461589|17436879|P10|Overall Study|Lost to Follow-up|1
5056175|NCT02461589|17436880|P9|Overall Study|Lost to Follow-up|3
5056176|NCT02461589|17436881|P8|Overall Study|Lost to Follow-up|1
5056177|NCT02461589|17436882|P7|Overall Study|Lost to Follow-up|3
5056178|NCT02461589|17436883|P6|Overall Study|Lost to Follow-up|1
5056179|NCT02461589|17436884|P5|Overall Study|Lost to Follow-up|1
5056180|NCT02461589|17436885|P4|Overall Study|Lost to Follow-up|3
5056181|NCT02461589|17436886|P3|Overall Study|Lost to Follow-up|2
5056182|NCT02461589|17436887|P2|Overall Study|Lost to Follow-up|0
5056183|NCT02461589|17436888|P1|Overall Study|Lost to Follow-up|0
5056184|NCT02461589|17436879|P10|Overall Study|Withdrawal by Subject|1
5056185|NCT02461589|17436880|P9|Overall Study|Withdrawal by Subject|3
5056186|NCT02461589|17436881|P8|Overall Study|Withdrawal by Subject|3
5056187|NCT02461589|17436882|P7|Overall Study|Withdrawal by Subject|1
5056188|NCT02461589|17436883|P6|Overall Study|Withdrawal by Subject|2
5056189|NCT02461589|17436884|P5|Overall Study|Withdrawal by Subject|1
5056190|NCT02461589|17436885|P4|Overall Study|Withdrawal by Subject|2
5056191|NCT02461589|17436886|P3|Overall Study|Withdrawal by Subject|3
5056192|NCT02461589|17436887|P2|Overall Study|Withdrawal by Subject|1
5056193|NCT02461589|17436888|P1|Overall Study|Withdrawal by Subject|5
5056194|NCT02461290|17437021|P1|Overall Study|Lost to Follow-up|3
5056195|NCT02461290|17437021|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
5056196|NCT02461160|17437041|P13|Overall Study|Lost to Follow-up|0
5056197|NCT02461160|17437042|P12|Overall Study|Lost to Follow-up|0
5056198|NCT02461160|17437043|P11|Overall Study|Lost to Follow-up|0
5056199|NCT02461160|17437044|P10|Overall Study|Lost to Follow-up|0
5056200|NCT02461160|17437045|P9|Overall Study|Lost to Follow-up|0
5056201|NCT02461160|17437046|P8|Overall Study|Lost to Follow-up|1
5056202|NCT02461160|17437047|P7|Overall Study|Lost to Follow-up|0
5056203|NCT02461160|17437048|P6|Overall Study|Lost to Follow-up|0
5056204|NCT02461160|17437049|P5|Overall Study|Lost to Follow-up|0
5056205|NCT02461160|17437050|P4|Overall Study|Lost to Follow-up|0
5056206|NCT02461160|17437051|P3|Overall Study|Lost to Follow-up|0
5056207|NCT02461160|17437052|P2|Overall Study|Lost to Follow-up|0
5056209|NCT02461134|17437264|P1|Overall Study|Adverse Event|1
5056210|NCT02460991|17437272|P2|Overall Study|Withdrawal by Subject|2
5056211|NCT02460991|17437273|P1|Overall Study|Withdrawal by Subject|0
5056212|NCT02460978|17437290|P3|Overall Study|Pregnancy|2
5056213|NCT02460978|17437291|P2|Overall Study|Pregnancy|0
5056214|NCT02460978|17437292|P1|Overall Study|Pregnancy|0
5056215|NCT02460978|17437290|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
5056216|NCT02460978|17437291|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
5056217|NCT02460978|17437292|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
5056218|NCT02460978|17437290|P3|Overall Study|Protocol Violation|1
5056219|NCT02460978|17437291|P2|Overall Study|Protocol Violation|1
5056220|NCT02460978|17437292|P1|Overall Study|Protocol Violation|1
5056221|NCT02460978|17437290|P3|Overall Study|Lost to Follow-up|1
5056222|NCT02460978|17437291|P2|Overall Study|Lost to Follow-up|3
5056223|NCT02460978|17437292|P1|Overall Study|Lost to Follow-up|2
5056224|NCT02460978|17437290|P3|Overall Study|Withdrawal by Subject|14
5056225|NCT02460978|17437291|P2|Overall Study|Withdrawal by Subject|5
5056226|NCT02460978|17437292|P1|Overall Study|Withdrawal by Subject|5
5056227|NCT02460978|17437290|P3|Overall Study|Adverse Event|11
5056228|NCT02460978|17437291|P2|Overall Study|Adverse Event|11
5056229|NCT02460978|17437292|P1|Overall Study|Adverse Event|17
5056230|NCT02460822|17437318|P1|Overall Study|Withdrawal by Subject|1
5056231|NCT02460679|17437327|P1|Overall Study|Withdrawal by Subject|4
5056232|NCT02460679|17437327|P1|Overall Study|Investigator Decision|1
5056233|NCT02460575|17437352|P2|Overall Study|Lost to Follow-up|0
5056234|NCT02460575|17437353|P1|Overall Study|Lost to Follow-up|1
5056235|NCT02460562|17437363|P2|Overall Study|Lost to Follow-up|16
5056236|NCT02460562|17437364|P1|Overall Study|Lost to Follow-up|15
5056237|NCT02460380|17437380|P2|Overall Study|Withdrawal by Subject|5
5056238|NCT02460380|17437381|P1|Overall Study|Withdrawal by Subject|10
5056239|NCT02460263|17437401|P1|Transition Period|Death|1
5056240|NCT02460263|17437401|P1|Transition Period|Withdrawal by Subject|1
5056241|NCT02460198|17437414|P2|Overall Study|Ongoing|30
5056242|NCT02460198|17437415|P1|Overall Study|Ongoing|25
5056243|NCT02460198|17437414|P2|Overall Study|Withdrawal by Subject|4
5056244|NCT02460198|17437415|P1|Overall Study|Withdrawal by Subject|2
5056245|NCT02460198|17437414|P2|Overall Study|Lost to Follow-up|1
5056246|NCT02460198|17437415|P1|Overall Study|Lost to Follow-up|1
5056247|NCT02460198|17437414|P2|Overall Study|Death|25
5056248|NCT02460198|17437415|P1|Overall Study|Death|32
5056249|NCT02460198|17437414|P2|Overall Study|Adverse Event|3
5056250|NCT02460198|17437415|P1|Overall Study|Adverse Event|1
5056251|NCT02460159|17437449|P2|Overall Study|Withdrawal by Subject|0
5056252|NCT02460159|17437450|P1|Overall Study|Withdrawal by Subject|2
5056253|NCT02460159|17437449|P2|Overall Study|Adverse Event|1
5056254|NCT02460159|17437450|P1|Overall Study|Adverse Event|4
5056255|NCT02459951|17437478|P1|Overall Study|Unable to meet holding requirement|1
5056256|NCT02459899|17437489|P4|Overall Study|Withdrawal by Subject|0
5056257|NCT02459899|17437490|P3|Overall Study|Withdrawal by Subject|0
5056258|NCT02459899|17437491|P2|Overall Study|Withdrawal by Subject|3
5056259|NCT02459899|17437492|P1|Overall Study|Withdrawal by Subject|1
5056260|NCT02459899|17437489|P4|Overall Study|Non-compliance with the treatment|1
5056261|NCT02459899|17437490|P3|Overall Study|Non-compliance with the treatment|0
5056262|NCT02459899|17437491|P2|Overall Study|Non-compliance with the treatment|0
5056263|NCT02459899|17437492|P1|Overall Study|Non-compliance with the treatment|0
5056264|NCT02459899|17437489|P4|Overall Study|Lost to Follow-up|1
5056265|NCT02459899|17437490|P3|Overall Study|Lost to Follow-up|0
5056266|NCT02459899|17437491|P2|Overall Study|Lost to Follow-up|2
5056267|NCT02459899|17437492|P1|Overall Study|Lost to Follow-up|1
5056268|NCT02459899|17437489|P4|Overall Study|Adverse Event|0
5056269|NCT02459899|17437490|P3|Overall Study|Adverse Event|0
5056270|NCT02459899|17437491|P2|Overall Study|Adverse Event|1
5056271|NCT02459899|17437492|P1|Overall Study|Adverse Event|1
5056272|NCT02459665|17437526|P4|Overall Study|Withdrawal by Subject|2
5056273|NCT02459665|17437527|P3|Overall Study|Withdrawal by Subject|1
5056274|NCT02459665|17437528|P2|Overall Study|Withdrawal by Subject|1
5056275|NCT02459665|17437529|P1|Overall Study|Withdrawal by Subject|0
5056276|NCT02459418|17437560|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
5056277|NCT02459418|17437561|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
5056278|NCT02459418|17437560|P2|Overall Study|Elevated Creatine Kinase|0
5056279|NCT02459418|17437561|P1|Overall Study|Elevated Creatine Kinase|1
5056280|NCT02459418|17437560|P2|Overall Study|Withdrawal by Subject|1
5056281|NCT02459418|17437561|P1|Overall Study|Withdrawal by Subject|1
5056282|NCT02459418|17437560|P2|Overall Study|Adverse Event|1
5056283|NCT02459418|17437561|P1|Overall Study|Adverse Event|0
5056284|NCT02459418|17437560|P2|Overall Study|Endometrial thickness of >5 mm|0
5056285|NCT02459418|17437561|P1|Overall Study|Endometrial thickness of >5 mm|1
5056286|NCT02459418|17437560|P2|Overall Study|Physician Decision|2
5056287|NCT02459418|17437561|P1|Overall Study|Physician Decision|0
5056288|NCT02459418|17437560|P2|Overall Study|Protocol Violation|2
5056289|NCT02459418|17437561|P1|Overall Study|Protocol Violation|0
5056290|NCT02459418|17437560|P2|Overall Study|Exclusion Criteria|0
5056291|NCT02459418|17437561|P1|Overall Study|Exclusion Criteria|4
5056292|NCT02459093|17437627|P2|Overall Study|Lost to Follow-up|7
5056293|NCT02459093|17437628|P1|Overall Study|Lost to Follow-up|6
5056294|NCT02459093|17437627|P2|Overall Study|Protocol Violation|11
5056295|NCT02459093|17437628|P1|Overall Study|Protocol Violation|6
5056296|NCT02458469|17437682|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
5056297|NCT02458469|17437683|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5056298|NCT02458469|17437684|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5056299|NCT02458469|17437685|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5056300|NCT02458469|17437686|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5056301|NCT02458469|17437687|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5056302|NCT02458469|17437682|P6|First Intervention (2 Weeks)|Physician Decision|0
5056303|NCT02458469|17437683|P5|First Intervention (2 Weeks)|Physician Decision|0
5056304|NCT02458469|17437684|P4|First Intervention (2 Weeks)|Physician Decision|0
5056305|NCT02458469|17437685|P3|First Intervention (2 Weeks)|Physician Decision|0
5056306|NCT02458469|17437686|P2|First Intervention (2 Weeks)|Physician Decision|0
5056307|NCT02458469|17437687|P1|First Intervention (2 Weeks)|Physician Decision|1
5056308|NCT02458469|17437682|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
5056309|NCT02458469|17437683|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
5056310|NCT02458469|17437684|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
5056311|NCT02458469|17437685|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
5056312|NCT02458469|17437686|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
5056313|NCT02458469|17437687|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
5056314|NCT02458287|17437733|P4|Overall Study|Relocated Out of State|1
5056315|NCT02458287|17437734|P3|Overall Study|Relocated Out of State|0
5056316|NCT02458287|17437735|P2|Overall Study|Relocated Out of State|0
5056317|NCT02458287|17437736|P1|Overall Study|Relocated Out of State|0
5056318|NCT02458287|17437733|P4|Overall Study|Withdrawal by Subject|1
5056319|NCT02458287|17437734|P3|Overall Study|Withdrawal by Subject|2
5056320|NCT02458287|17437735|P2|Overall Study|Withdrawal by Subject|2
5056321|NCT02458287|17437736|P1|Overall Study|Withdrawal by Subject|0
5056322|NCT02458287|17437733|P4|Overall Study|Protocol Violation|0
5056323|NCT02458287|17437734|P3|Overall Study|Protocol Violation|0
5056324|NCT02458287|17437735|P2|Overall Study|Protocol Violation|1
5056325|NCT02458287|17437736|P1|Overall Study|Protocol Violation|0
5056326|NCT02458287|17437733|P4|Overall Study|Lost to Follow-up|0
5056327|NCT02458287|17437734|P3|Overall Study|Lost to Follow-up|1
5056328|NCT02458287|17437735|P2|Overall Study|Lost to Follow-up|1
5056329|NCT02458287|17437736|P1|Overall Study|Lost to Follow-up|0
5056330|NCT02458287|17437733|P4|Overall Study|Adverse Event|1
5056331|NCT02458287|17437734|P3|Overall Study|Adverse Event|0
5056332|NCT02458287|17437735|P2|Overall Study|Adverse Event|0
5056333|NCT02458287|17437736|P1|Overall Study|Adverse Event|0
5056334|NCT02458092|17437794|P2|Overall Study|Withdrawal by Subject|0
5056335|NCT02458092|17437795|P1|Overall Study|Withdrawal by Subject|1
5056336|NCT02457910|17437813|P6|Overall Study|Death|0
5056337|NCT02457910|17437814|P5|Overall Study|Death|0
5056338|NCT02457910|17437815|P4|Overall Study|Death|0
5056339|NCT02457910|17437816|P3|Overall Study|Death|1
5056340|NCT02457910|17437817|P2|Overall Study|Death|0
5056341|NCT02457910|17437818|P1|Overall Study|Death|0
5056342|NCT02457910|17437813|P6|Overall Study|Other complicating illness|1
5056343|NCT02457910|17437814|P5|Overall Study|Other complicating illness|0
5056344|NCT02457910|17437815|P4|Overall Study|Other complicating illness|0
5056345|NCT02457910|17437816|P3|Overall Study|Other complicating illness|0
5056346|NCT02457910|17437817|P2|Overall Study|Other complicating illness|0
5056347|NCT02457910|17437818|P1|Overall Study|Other complicating illness|0
5056348|NCT02457910|17437813|P6|Overall Study|Disease progression|6
5056349|NCT02457910|17437814|P5|Overall Study|Disease progression|4
5056350|NCT02457910|17437815|P4|Overall Study|Disease progression|1
5056351|NCT02457910|17437816|P3|Overall Study|Disease progression|1
5056352|NCT02457910|17437817|P2|Overall Study|Disease progression|3
5056353|NCT02457910|17437818|P1|Overall Study|Disease progression|3
5056354|NCT02457910|17437813|P6|Overall Study|Adverse Event|3
5056355|NCT02457910|17437814|P5|Overall Study|Adverse Event|1
5056356|NCT02457910|17437815|P4|Overall Study|Adverse Event|1
5056357|NCT02457910|17437816|P3|Overall Study|Adverse Event|1
5056358|NCT02457910|17437817|P2|Overall Study|Adverse Event|2
5056359|NCT02457910|17437818|P1|Overall Study|Adverse Event|0
5056360|NCT02457910|17437813|P6|Overall Study|Withdrawal by Subject|1
5056361|NCT02457910|17437814|P5|Overall Study|Withdrawal by Subject|0
5056362|NCT02457910|17437815|P4|Overall Study|Withdrawal by Subject|0
5056363|NCT02457910|17437816|P3|Overall Study|Withdrawal by Subject|0
5056364|NCT02457910|17437817|P2|Overall Study|Withdrawal by Subject|0
5056365|NCT02457910|17437818|P1|Overall Study|Withdrawal by Subject|0
5056366|NCT02457819|17437842|P1|Overall Study|Adverse Event|33
5056367|NCT02457819|17437842|P1|Overall Study|Lack of Efficacy|19
5056368|NCT02457819|17437842|P1|Overall Study|Lost to Follow-up|10
5056369|NCT02457819|17437842|P1|Overall Study|non compliance with study drug|4
5056370|NCT02457819|17437842|P1|Overall Study|Protocol Violation|1
5056371|NCT02457819|17437842|P1|Overall Study|Withdrawal by Subject|24
5056372|NCT02457819|17437842|P1|Overall Study|reason not given|8
5056373|NCT02457793|17437854|P6|Overall Study|Physician Decision|3
5056374|NCT02457793|17437855|P5|Overall Study|Physician Decision|1
5056375|NCT02457793|17437856|P4|Overall Study|Physician Decision|1
5056376|NCT02457793|17437857|P3|Overall Study|Physician Decision|1
5056377|NCT02457793|17437858|P2|Overall Study|Physician Decision|0
5056378|NCT02457793|17437859|P1|Overall Study|Physician Decision|1
5056379|NCT02457793|17437854|P6|Overall Study|Adverse Event|0
5056380|NCT02457793|17437855|P5|Overall Study|Adverse Event|0
5056381|NCT02457793|17437856|P4|Overall Study|Adverse Event|1
5056382|NCT02457793|17437857|P3|Overall Study|Adverse Event|0
5056383|NCT02457793|17437858|P2|Overall Study|Adverse Event|0
5056384|NCT02457793|17437859|P1|Overall Study|Adverse Event|0
5056385|NCT02457793|17437854|P6|Overall Study|Withdrawal by Subject|2
5056386|NCT02457793|17437855|P5|Overall Study|Withdrawal by Subject|2
5056387|NCT02457793|17437856|P4|Overall Study|Withdrawal by Subject|2
5056388|NCT02457793|17437857|P3|Overall Study|Withdrawal by Subject|2
5056389|NCT02457793|17437858|P2|Overall Study|Withdrawal by Subject|4
5056390|NCT02457793|17437859|P1|Overall Study|Withdrawal by Subject|0
5056391|NCT02457793|17437854|P6|Overall Study|Reason not specified|1
5056392|NCT02457793|17437855|P5|Overall Study|Reason not specified|1
5056393|NCT02457793|17437856|P4|Overall Study|Reason not specified|1
5056394|NCT02457793|17437857|P3|Overall Study|Reason not specified|0
5056395|NCT02457793|17437858|P2|Overall Study|Reason not specified|0
5056396|NCT02457793|17437859|P1|Overall Study|Reason not specified|0
5056397|NCT02457637|17438003|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
5056398|NCT02457611|17438011|P1|Overall Study|Lost to Follow-up|3
5056399|NCT02457546|17438025|P2|Overall Study|Adverse Event|1
5056400|NCT02457546|17438026|P1|Overall Study|Adverse Event|0
5056401|NCT02457546|17438025|P2|Overall Study|Lost to Follow-up|1
5056402|NCT02457546|17438026|P1|Overall Study|Lost to Follow-up|4
5056403|NCT02457546|17438025|P2|Overall Study|Refused to complete study/procedures|1
5056404|NCT02457546|17438026|P1|Overall Study|Refused to complete study/procedures|1
5056405|NCT02457546|17438025|P2|Overall Study|Other reasons|1
5056406|NCT02457546|17438026|P1|Overall Study|Other reasons|4
5056407|NCT02457325|17438036|P2|First Intervention (1 Day)|Lost to Follow-up|2
5056408|NCT02457325|17438037|P1|First Intervention (1 Day)|Lost to Follow-up|2
5056409|NCT02457247|17438110|P4|Period 2|Voluntary Withdrawal|0
5056410|NCT02457247|17438111|P3|Period 2|Voluntary Withdrawal|0
5056411|NCT02457247|17438112|P2|Period 2|Voluntary Withdrawal|1
5056412|NCT02457247|17438113|P1|Period 2|Voluntary Withdrawal|1
5056413|NCT02457247|17438110|P4|Period 2|Lost to Follow-up|0
5056414|NCT02457247|17438111|P3|Period 2|Lost to Follow-up|0
5056415|NCT02457247|17438112|P2|Period 2|Lost to Follow-up|1
5056416|NCT02457247|17438113|P1|Period 2|Lost to Follow-up|0
5056417|NCT02457247|17438110|P4|Period 2|Significant Protocol Deviation|0
5056418|NCT02457247|17438111|P3|Period 2|Significant Protocol Deviation|0
5056419|NCT02457247|17438112|P2|Period 2|Significant Protocol Deviation|0
5056420|NCT02457247|17438113|P1|Period 2|Significant Protocol Deviation|1
5056421|NCT02457247|17438110|P4|Period 2|Pretreatment Event/Adverse Event|0
5056422|NCT02457247|17438111|P3|Period 2|Pretreatment Event/Adverse Event|0
5056423|NCT02457247|17438112|P2|Period 2|Pretreatment Event/Adverse Event|1
5056424|NCT02457247|17438113|P1|Period 2|Pretreatment Event/Adverse Event|0
5056425|NCT02457247|17438110|P4|Period 1|Voluntary Withdrawal|0
5056426|NCT02457247|17438111|P3|Period 1|Voluntary Withdrawal|0
5056427|NCT02457247|17438112|P2|Period 1|Voluntary Withdrawal|0
5056428|NCT02457247|17438113|P1|Period 1|Voluntary Withdrawal|1
5056429|NCT02457247|17438110|P4|Period 1|Significant Protocol Deviation|0
5056430|NCT02457247|17438111|P3|Period 1|Significant Protocol Deviation|0
5056431|NCT02457247|17438112|P2|Period 1|Significant Protocol Deviation|1
5056432|NCT02457247|17438113|P1|Period 1|Significant Protocol Deviation|1
5056433|NCT02457247|17438110|P4|Period 1|Pretreatment Event/Adverse Event|0
5056434|NCT02457247|17438111|P3|Period 1|Pretreatment Event/Adverse Event|0
5056435|NCT02457247|17438112|P2|Period 1|Pretreatment Event/Adverse Event|1
5056436|NCT02457247|17438113|P1|Period 1|Pretreatment Event/Adverse Event|0
5056437|NCT02457195|17438133|P1|Overall Study|Withdrawal by Subject|4
5056438|NCT02457195|17438133|P1|Overall Study|Protocol Violation|2
5056439|NCT02457195|17438133|P1|Overall Study|Adverse Event|3
5056440|NCT02457182|17438139|P2|Overall Study|Lost to Follow-up|0
5056441|NCT02457182|17438140|P1|Overall Study|Lost to Follow-up|1
5056442|NCT02457065|17438158|P2|Overall Study|Lost to Follow-up|11
5056443|NCT02457065|17438159|P1|Overall Study|Lost to Follow-up|9
5056444|NCT02456740|17438181|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
5056445|NCT02456740|17438182|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
5056446|NCT02456740|17438183|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5056447|NCT02456740|17438184|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
5056448|NCT02456740|17438185|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
5056449|NCT02456740|17438186|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
5056450|NCT02456740|17438187|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5056451|NCT02456740|17438188|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5056452|NCT02456740|17438189|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5056453|NCT02456740|17438181|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056454|NCT02456740|17438182|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
5056455|NCT02456740|17438183|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056456|NCT02456740|17438184|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056457|NCT02456740|17438185|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056458|NCT02456740|17438186|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056459|NCT02456740|17438187|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056460|NCT02456740|17438188|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056461|NCT02456740|17438189|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
5056462|NCT02456740|17438181|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
5056463|NCT02456740|17438182|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
5056464|NCT02456740|17438183|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
5056465|NCT02456740|17438184|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
5056466|NCT02456740|17438185|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
5056467|NCT02456740|17438186|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
5056468|NCT02456740|17438187|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5056469|NCT02456740|17438188|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5056470|NCT02456740|17438189|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5056471|NCT02456740|17438181|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
5056472|NCT02456740|17438182|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5056473|NCT02456740|17438183|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5056474|NCT02456740|17438184|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5056475|NCT02456740|17438185|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
5056476|NCT02456740|17438186|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
5056477|NCT02456740|17438187|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5056478|NCT02456740|17438188|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5056479|NCT02456740|17438189|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5056480|NCT02456740|17438181|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5056481|NCT02456740|17438182|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5056482|NCT02456740|17438183|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5056483|NCT02456740|17438184|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5056484|NCT02456740|17438185|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5056485|NCT02456740|17438186|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5056486|NCT02456740|17438187|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
5056487|NCT02456740|17438188|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
5056488|NCT02456740|17438189|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
5056489|NCT02456740|17438181|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5056490|NCT02456740|17438182|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5056491|NCT02456740|17438183|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5056492|NCT02456740|17438184|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5056493|NCT02456740|17438185|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5056494|NCT02456740|17438186|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5056495|NCT02456740|17438187|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
5056496|NCT02456740|17438188|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
5056497|NCT02456740|17438189|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
5056498|NCT02456740|17438181|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5056499|NCT02456740|17438182|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5056500|NCT02456740|17438183|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5056501|NCT02456740|17438184|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5056502|NCT02456740|17438185|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5056503|NCT02456740|17438186|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5056504|NCT02456740|17438187|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5056505|NCT02456740|17438188|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5056506|NCT02456740|17438189|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5056507|NCT02456727|17438213|P2|Overall Study|Never Initiated Treatment|30
5056508|NCT02456727|17438214|P1|Overall Study|Never Initiated Treatment|43
5056509|NCT02456727|17438213|P2|Overall Study|Withdrawal by Subject|10
5056510|NCT02456727|17438214|P1|Overall Study|Withdrawal by Subject|1
5056511|NCT02456727|17438213|P2|Overall Study|Death|1
5056512|NCT02456727|17438214|P1|Overall Study|Death|2
5056513|NCT02456727|17438213|P2|Overall Study|Lost to Follow-up|65
5056514|NCT02456727|17438214|P1|Overall Study|Lost to Follow-up|63
5056515|NCT02456662|17438296|P2|Overall Study|Lost to Follow-up|1
5056516|NCT02456662|17438297|P1|Overall Study|Lost to Follow-up|2
5056517|NCT02456636|17438306|P3|Overall Study|Lost to Follow-up|50
5056518|NCT02456636|17438307|P2|Overall Study|Lost to Follow-up|44
5056519|NCT02456636|17438308|P1|Overall Study|Lost to Follow-up|50
5056520|NCT02456636|17438306|P3|Overall Study|Withdrawal by Subject|16
5056521|NCT02456636|17438307|P2|Overall Study|Withdrawal by Subject|14
5056522|NCT02456636|17438308|P1|Overall Study|Withdrawal by Subject|13
5056523|NCT02456636|17438306|P3|Overall Study|Physician Decision|4
5056524|NCT02456636|17438307|P2|Overall Study|Physician Decision|5
5056525|NCT02456636|17438308|P1|Overall Study|Physician Decision|4
5056526|NCT02456636|17438306|P3|Overall Study|Pregnancy|5
5056527|NCT02456636|17438307|P2|Overall Study|Pregnancy|3
5056528|NCT02456636|17438308|P1|Overall Study|Pregnancy|1
5056529|NCT02456636|17438306|P3|Overall Study|Death|0
5056530|NCT02456636|17438307|P2|Overall Study|Death|3
5056531|NCT02456636|17438308|P1|Overall Study|Death|0
5056532|NCT02456103|17438358|P1|Overall Study|Withdrawal by Subject|24
5056533|NCT02456103|17438358|P1|Overall Study|Lost to Follow-up|1
5056534|NCT02456103|17438358|P1|Overall Study|Abnormal Laboratory Value|2
5056535|NCT02456103|17438358|P1|Overall Study|Adverse Event|5
5056536|NCT02456103|17438358|P1|Overall Study|Protocol Violation|1
5056537|NCT02456103|17438358|P1|Overall Study|Required prohibited medications|5
5056538|NCT02456103|17438358|P1|Overall Study|Physician Decision|1
5056539|NCT02456103|17438358|P1|Overall Study|Study Closure|207
5056540|NCT02455518|17438371|P4|Overall Study|Protocol Violation|3
5056541|NCT02455518|17438372|P3|Overall Study|Protocol Violation|1
5056542|NCT02455518|17438373|P2|Overall Study|Protocol Violation|1
5056543|NCT02455518|17438374|P1|Overall Study|Protocol Violation|0
5056544|NCT02455388|17438396|P3|Overall Study|Withdrawal by Subject|7
5056545|NCT02455388|17438397|P2|Overall Study|Withdrawal by Subject|0
5056546|NCT02455388|17438398|P1|Overall Study|Withdrawal by Subject|0
5056547|NCT02455388|17438396|P3|Overall Study|Protocol Violation|4
5056548|NCT02455388|17438397|P2|Overall Study|Protocol Violation|0
5056549|NCT02455388|17438398|P1|Overall Study|Protocol Violation|1
5056550|NCT02455336|17438409|P2|Overall Study|Non-responder to treatment|0
5056551|NCT02455336|17438410|P1|Overall Study|Non-responder to treatment|2
5056552|NCT02455336|17438409|P2|Overall Study|Adverse Event|0
5056553|NCT02455336|17438410|P1|Overall Study|Adverse Event|3
5056554|NCT02455336|17438409|P2|Overall Study|Withdrawal by Subject|2
5056555|NCT02455336|17438410|P1|Overall Study|Withdrawal by Subject|0
5056556|NCT02455076|17438425|P5|Outpatient|Lost to Follow-up|12
5056557|NCT02455076|17438426|P4|Outpatient|Lost to Follow-up|1
5056558|NCT02455076|17438427|P3|Outpatient|Lost to Follow-up|0
5056559|NCT02455076|17438428|P2|Outpatient|Lost to Follow-up|0
5056560|NCT02455076|17438429|P1|Outpatient|Lost to Follow-up|0
5056561|NCT02455076|17438425|P5|Outpatient|Adverse Event|0
5056562|NCT02455076|17438426|P4|Outpatient|Adverse Event|5
5056563|NCT02455076|17438427|P3|Outpatient|Adverse Event|0
5056564|NCT02455076|17438428|P2|Outpatient|Adverse Event|0
5056565|NCT02455076|17438429|P1|Outpatient|Adverse Event|0
5056566|NCT02455076|17438425|P5|Inpatient|Adverse Event|0
5056567|NCT02455076|17438426|P4|Inpatient|Adverse Event|0
5056568|NCT02455076|17438427|P3|Inpatient|Adverse Event|0
5056569|NCT02455076|17438428|P2|Inpatient|Adverse Event|0
5056570|NCT02455076|17438429|P1|Inpatient|Adverse Event|3
5056571|NCT02455076|17438425|P5|Inpatient|Discharged <24 h after admission|0
5056572|NCT02455076|17438426|P4|Inpatient|Discharged <24 h after admission|0
5056573|NCT02455076|17438427|P3|Inpatient|Discharged <24 h after admission|0
5056574|NCT02455076|17438428|P2|Inpatient|Discharged <24 h after admission|1
5056575|NCT02455076|17438429|P1|Inpatient|Discharged <24 h after admission|0
5056576|NCT02455076|17438425|P5|Inpatient|Withdrawal by Subject|0
5056577|NCT02455076|17438426|P4|Inpatient|Withdrawal by Subject|0
5056578|NCT02455076|17438427|P3|Inpatient|Withdrawal by Subject|0
5056579|NCT02455076|17438428|P2|Inpatient|Withdrawal by Subject|0
5056580|NCT02455076|17438429|P1|Inpatient|Withdrawal by Subject|1
5056581|NCT02455050|17438515|P4|Treatment Period 2|Lost to Follow-up|1
5056582|NCT02455050|17438516|P3|Treatment Period 2|Lost to Follow-up|2
5056583|NCT02455050|17438517|P2|Treatment Period 2|Lost to Follow-up|0
5056584|NCT02455050|17438518|P1|Treatment Period 2|Lost to Follow-up|1
5056585|NCT02455050|17438515|P4|Treatment Period 1|Lost to Follow-up|2
5056586|NCT02455050|17438516|P3|Treatment Period 1|Lost to Follow-up|1
5056587|NCT02455050|17438517|P2|Treatment Period 1|Lost to Follow-up|1
5056588|NCT02455050|17438518|P1|Treatment Period 1|Lost to Follow-up|1
5056589|NCT02454959|17438582|P1|Overall Study|Adverse Event|2
5056590|NCT02454959|17438582|P1|Overall Study|Withdrawal by Subject|3
5056591|NCT02454959|17438582|P1|Overall Study|Physician Decision|1
5056592|NCT02454959|17438582|P1|Overall Study|Protocol-Specified Criteria|3
5056593|NCT02454933|17438602|P2|Overall Study|Withdrawal by Subject|2
5056594|NCT02454933|17438603|P1|Overall Study|Withdrawal by Subject|0
5056595|NCT02454933|17438602|P2|Overall Study|Adverse Event|1
5056596|NCT02454933|17438603|P1|Overall Study|Adverse Event|1
5056597|NCT02454933|17438602|P2|Overall Study|Progressive disease|5
5056598|NCT02454933|17438603|P1|Overall Study|Progressive disease|7
5056599|NCT02454608|17438611|P3|Open Label Period|Withdrawal by Subject|8
5056600|NCT02454608|17438612|P2|Open Label Period|Withdrawal by Subject|0
5056601|NCT02454608|17438613|P1|Open Label Period|Withdrawal by Subject|0
5056602|NCT02454608|17438611|P3|Open Label Period|Lost to Follow-up|11
5056603|NCT02454608|17438612|P2|Open Label Period|Lost to Follow-up|0
5056604|NCT02454608|17438613|P1|Open Label Period|Lost to Follow-up|0
5056605|NCT02454608|17438611|P3|Double-Blind Period|Lack of Efficacy|0
5056606|NCT02454608|17438612|P2|Double-Blind Period|Lack of Efficacy|2
5056607|NCT02454608|17438613|P1|Double-Blind Period|Lack of Efficacy|0
5056608|NCT02454530|17438636|P2|Overall Study|Lost to Follow-up|4
5056609|NCT02454530|17438637|P1|Overall Study|Lost to Follow-up|4
5056610|NCT02454530|17438636|P2|Overall Study|Death|41
5056611|NCT02454530|17438637|P1|Overall Study|Death|2
5056612|NCT02454530|17438636|P2|Overall Study|Missing information|69
5056613|NCT02454530|17438637|P1|Overall Study|Missing information|56
5056614|NCT02454530|17438636|P2|Overall Study|Other|13
5056615|NCT02454530|17438637|P1|Overall Study|Other|8
5056616|NCT02454478|17438674|P1|Overall Study|Incomplete DLT Evaluation|1
5056617|NCT02454101|17438768|P2|Overall Study|Lost to Follow-up|4
5056618|NCT02454101|17438769|P1|Overall Study|Lost to Follow-up|3
5056619|NCT02454101|17438768|P2|Overall Study|Adverse Event|3
5056620|NCT02454101|17438769|P1|Overall Study|Adverse Event|2
5056621|NCT02453841|17438791|P1|Overall Study|Unable to obtain blood samples|2
5056622|NCT02453841|17438791|P1|Overall Study|Protocol Violation|1
5056623|NCT02453711|17438814|P9|Overall Study|Unclassified|0
5056624|NCT02453711|17438815|P8|Overall Study|Unclassified|0
5056625|NCT02453711|17438816|P7|Overall Study|Unclassified|0
5056626|NCT02453711|17438817|P6|Overall Study|Unclassified|0
5056627|NCT02453711|17438818|P5|Overall Study|Unclassified|0
5056628|NCT02453711|17438819|P4|Overall Study|Unclassified|0
5056629|NCT02453711|17438820|P3|Overall Study|Unclassified|1
5056630|NCT02453711|17438821|P2|Overall Study|Unclassified|0
5056631|NCT02453711|17438822|P1|Overall Study|Unclassified|1
5056632|NCT02453711|17438814|P9|Overall Study|Death|0
5056633|NCT02453711|17438815|P8|Overall Study|Death|0
5056634|NCT02453711|17438816|P7|Overall Study|Death|1
5056635|NCT02453711|17438817|P6|Overall Study|Death|0
5056636|NCT02453711|17438818|P5|Overall Study|Death|0
5056637|NCT02453711|17438819|P4|Overall Study|Death|0
5056638|NCT02453711|17438820|P3|Overall Study|Death|0
5056639|NCT02453711|17438821|P2|Overall Study|Death|0
5056640|NCT02453711|17438822|P1|Overall Study|Death|0
5056641|NCT02453711|17438814|P9|Overall Study|Lost to Follow-up|6
5056642|NCT02453711|17438815|P8|Overall Study|Lost to Follow-up|6
5056643|NCT02453711|17438816|P7|Overall Study|Lost to Follow-up|2
5056644|NCT02453711|17438817|P6|Overall Study|Lost to Follow-up|5
5056645|NCT02453711|17438818|P5|Overall Study|Lost to Follow-up|1
5056646|NCT02453711|17438819|P4|Overall Study|Lost to Follow-up|3
5056647|NCT02453711|17438820|P3|Overall Study|Lost to Follow-up|2
5056648|NCT02453711|17438821|P2|Overall Study|Lost to Follow-up|3
5056649|NCT02453711|17438822|P1|Overall Study|Lost to Follow-up|5
5056650|NCT02453711|17438814|P9|Overall Study|Withdrawal by Subject|7
5056651|NCT02453711|17438815|P8|Overall Study|Withdrawal by Subject|1
5056652|NCT02453711|17438816|P7|Overall Study|Withdrawal by Subject|0
5056653|NCT02453711|17438817|P6|Overall Study|Withdrawal by Subject|1
5056654|NCT02453711|17438818|P5|Overall Study|Withdrawal by Subject|1
5056655|NCT02453711|17438819|P4|Overall Study|Withdrawal by Subject|4
5056656|NCT02453711|17438820|P3|Overall Study|Withdrawal by Subject|6
5056657|NCT02453711|17438821|P2|Overall Study|Withdrawal by Subject|4
5056658|NCT02453711|17438822|P1|Overall Study|Withdrawal by Subject|5
5056659|NCT02453685|17439166|P2|Overall Study|Unclassified|2
5056660|NCT02453685|17439167|P1|Overall Study|Unclassified|4
5056661|NCT02453685|17439166|P2|Overall Study|Withdrawal by Subject|4
5056662|NCT02453685|17439167|P1|Overall Study|Withdrawal by Subject|8
5056663|NCT02453685|17439166|P2|Overall Study|Lost to Follow-up|1
5056664|NCT02453685|17439167|P1|Overall Study|Lost to Follow-up|0
5056665|NCT02453685|17439166|P2|Overall Study|Protocol Violation|4
5056666|NCT02453685|17439167|P1|Overall Study|Protocol Violation|7
5056667|NCT02453685|17439166|P2|Overall Study|Adverse Event|1
5056668|NCT02453685|17439167|P1|Overall Study|Adverse Event|0
5056669|NCT02453555|17439225|P6|Extension Period|Withdrawal by Subject|0
5056670|NCT02453555|17439226|P5|Extension Period|Withdrawal by Subject|0
5056671|NCT02453555|17439227|P4|Extension Period|Withdrawal by Subject|0
5056672|NCT02453555|17439228|P3|Extension Period|Withdrawal by Subject|1
5056673|NCT02453555|17439229|P2|Extension Period|Withdrawal by Subject|0
5056674|NCT02453555|17439230|P1|Extension Period|Withdrawal by Subject|0
5056675|NCT02453555|17439225|P6|Extension Period|Protocol Violation|0
5056676|NCT02453555|17439226|P5|Extension Period|Protocol Violation|0
5056677|NCT02453555|17439227|P4|Extension Period|Protocol Violation|0
5056678|NCT02453555|17439228|P3|Extension Period|Protocol Violation|1
5056679|NCT02453555|17439229|P2|Extension Period|Protocol Violation|0
5056680|NCT02453555|17439230|P1|Extension Period|Protocol Violation|0
5056681|NCT02453555|17439225|P6|Extension Period|Adverse Event|1
5056682|NCT02453555|17439226|P5|Extension Period|Adverse Event|1
5056683|NCT02453555|17439227|P4|Extension Period|Adverse Event|2
5056684|NCT02453555|17439228|P3|Extension Period|Adverse Event|1
5056685|NCT02453555|17439229|P2|Extension Period|Adverse Event|0
5056686|NCT02453555|17439230|P1|Extension Period|Adverse Event|0
5056687|NCT02453555|17439225|P6|24-week Double-blind Treatment Period|Other than specified above|0
5056688|NCT02453555|17439226|P5|24-week Double-blind Treatment Period|Other than specified above|0
5056689|NCT02453555|17439227|P4|24-week Double-blind Treatment Period|Other than specified above|0
5056690|NCT02453555|17439228|P3|24-week Double-blind Treatment Period|Other than specified above|0
5056691|NCT02453555|17439229|P2|24-week Double-blind Treatment Period|Other than specified above|3
5056692|NCT02453555|17439230|P1|24-week Double-blind Treatment Period|Other than specified above|0
5056693|NCT02453555|17439225|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5056694|NCT02453555|17439226|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5056695|NCT02453555|17439227|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5056696|NCT02453555|17439228|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5056697|NCT02453555|17439229|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
5056698|NCT02453555|17439230|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
5056699|NCT02453555|17439225|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
5056700|NCT02453555|17439226|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
5056701|NCT02453555|17439227|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
5056702|NCT02453555|17439228|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
5056703|NCT02453555|17439229|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
5056704|NCT02453555|17439230|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
5056705|NCT02453555|17439225|P6|24-week Double-blind Treatment Period|Adverse Event|0
5056706|NCT02453555|17439226|P5|24-week Double-blind Treatment Period|Adverse Event|0
5056707|NCT02453555|17439227|P4|24-week Double-blind Treatment Period|Adverse Event|0
5056708|NCT02453555|17439228|P3|24-week Double-blind Treatment Period|Adverse Event|0
5056709|NCT02453555|17439229|P2|24-week Double-blind Treatment Period|Adverse Event|0
5056710|NCT02453555|17439230|P1|24-week Double-blind Treatment Period|Adverse Event|2
5056711|NCT02453386|17439246|P3|Overall Study|Other|1
5056712|NCT02453386|17439247|P2|Overall Study|Other|0
5056713|NCT02453386|17439248|P1|Overall Study|Other|1
5056714|NCT02453386|17439246|P3|Overall Study|Lost to Follow-up|1
5056715|NCT02453386|17439247|P2|Overall Study|Lost to Follow-up|0
5056716|NCT02453386|17439248|P1|Overall Study|Lost to Follow-up|0
5056717|NCT02453386|17439246|P3|Overall Study|Sponsor Terminated by Investigator|2
5056718|NCT02453386|17439247|P2|Overall Study|Sponsor Terminated by Investigator|1
5056719|NCT02453386|17439248|P1|Overall Study|Sponsor Terminated by Investigator|0
5056720|NCT02453386|17439246|P3|Overall Study|Subject Terminated by Sponsor|1
5056721|NCT02453386|17439247|P2|Overall Study|Subject Terminated by Sponsor|1
5056722|NCT02453386|17439248|P1|Overall Study|Subject Terminated by Sponsor|1
5056723|NCT02453386|17439246|P3|Overall Study|Sponsor Terminated Study|11
5056724|NCT02453386|17439247|P2|Overall Study|Sponsor Terminated Study|8
5056725|NCT02453386|17439248|P1|Overall Study|Sponsor Terminated Study|14
5056726|NCT02453386|17439246|P3|Overall Study|Withdrawal by Subject|9
5056727|NCT02453386|17439247|P2|Overall Study|Withdrawal by Subject|9
5056728|NCT02453386|17439248|P1|Overall Study|Withdrawal by Subject|10
5056729|NCT02453386|17439246|P3|Overall Study|Protocol Violation|1
5056730|NCT02453386|17439247|P2|Overall Study|Protocol Violation|0
5056731|NCT02453386|17439248|P1|Overall Study|Protocol Violation|1
5056732|NCT02453386|17439246|P3|Overall Study|Adverse Event|15
5056733|NCT02453386|17439247|P2|Overall Study|Adverse Event|30
5056734|NCT02453386|17439248|P1|Overall Study|Adverse Event|22
5056735|NCT02453321|17439312|P3|Overall Study|Deep Venous Thrombosis|0
5056736|NCT02453321|17439313|P2|Overall Study|Deep Venous Thrombosis|1
5056737|NCT02453321|17439314|P1|Overall Study|Deep Venous Thrombosis|0
5056738|NCT02453321|17439312|P3|Overall Study|Weakness|2
5056739|NCT02453321|17439313|P2|Overall Study|Weakness|1
5056740|NCT02453321|17439314|P1|Overall Study|Weakness|1
5056741|NCT02453282|17439334|P3|Overall Study|Other|1
5056742|NCT02453282|17439335|P2|Overall Study|Other|1
5056743|NCT02453282|17439336|P1|Overall Study|Other|1
5056744|NCT02453282|17439334|P3|Overall Study|Participants ongoing at data cut-off|62
5056745|NCT02453282|17439335|P2|Overall Study|Participants ongoing at data cut-off|84
5056746|NCT02453282|17439336|P1|Overall Study|Participants ongoing at data cut-off|85
5056747|NCT02453282|17439334|P3|Overall Study|Withdrawal by Subject|11
5056748|NCT02453282|17439335|P2|Overall Study|Withdrawal by Subject|10
5056749|NCT02453282|17439336|P1|Overall Study|Withdrawal by Subject|12
5056750|NCT02453282|17439334|P3|Overall Study|Lost to Follow-up|2
5056751|NCT02453282|17439335|P2|Overall Study|Lost to Follow-up|0
5056752|NCT02453282|17439336|P1|Overall Study|Lost to Follow-up|1
5056753|NCT02453282|17439334|P3|Overall Study|Death|296
5056754|NCT02453282|17439335|P2|Overall Study|Death|277
5056755|NCT02453282|17439336|P1|Overall Study|Death|275
5056756|NCT02453256|17439417|P2|Open Label Period|Withdrawal by Subject|1
5056757|NCT02453256|17439418|P1|Open Label Period|Withdrawal by Subject|5
5056758|NCT02453256|17439417|P2|Open Label Period|Other|2
5056759|NCT02453256|17439418|P1|Open Label Period|Other|0
5056760|NCT02453256|17439417|P2|Open Label Period|Lost to Follow-up|0
5056761|NCT02453256|17439418|P1|Open Label Period|Lost to Follow-up|1
5056762|NCT02453256|17439417|P2|Open Label Period|Death|1
5056763|NCT02453256|17439418|P1|Open Label Period|Death|0
5056764|NCT02453256|17439417|P2|Open Label Period|Adverse Event|3
5056765|NCT02453256|17439418|P1|Open Label Period|Adverse Event|1
5056766|NCT02453256|17439417|P2|Double Blind Period|Other|1
5056767|NCT02453256|17439418|P1|Double Blind Period|Other|0
5056768|NCT02453256|17439417|P2|Double Blind Period|Withdrawal by Subject|5
5056769|NCT02453256|17439418|P1|Double Blind Period|Withdrawal by Subject|9
5056770|NCT02453256|17439417|P2|Double Blind Period|Adverse Event|2
5056771|NCT02453256|17439418|P1|Double Blind Period|Adverse Event|3
5056772|NCT02453256|17439417|P2|Double Blind Period|Death|1
5056773|NCT02453256|17439418|P1|Double Blind Period|Death|1
5056774|NCT02453191|17439538|P1|Overall Study|Withdrawal by Subject|1
5056775|NCT02453048|17439555|P5|Overall Study|Lost to Follow-up|0
5056776|NCT02453048|17439556|P4|Overall Study|Lost to Follow-up|0
5056777|NCT02453048|17439557|P3|Overall Study|Lost to Follow-up|2
5056778|NCT02453048|17439558|P2|Overall Study|Lost to Follow-up|1
5056779|NCT02453048|17439559|P1|Overall Study|Lost to Follow-up|0
5056780|NCT02453048|17439555|P5|Overall Study|Only part of initial 6 mo. study|6
5056781|NCT02453048|17439556|P4|Overall Study|Only part of initial 6 mo. study|0
5056782|NCT02453048|17439557|P3|Overall Study|Only part of initial 6 mo. study|0
5056783|NCT02453048|17439558|P2|Overall Study|Only part of initial 6 mo. study|0
5056784|NCT02453048|17439559|P1|Overall Study|Only part of initial 6 mo. study|0
5056785|NCT02452892|17439619|P4|Follow-up|Subject left town on Day 42|0
5056786|NCT02452892|17439620|P3|Follow-up|Subject left town on Day 42|0
5056787|NCT02452892|17439621|P2|Follow-up|Subject left town on Day 42|0
5056788|NCT02452892|17439622|P1|Follow-up|Subject left town on Day 42|1
5056789|NCT02452892|17439619|P4|Follow-up|Withdrawal by Subject|1
5056790|NCT02452892|17439620|P3|Follow-up|Withdrawal by Subject|0
5056791|NCT02452892|17439621|P2|Follow-up|Withdrawal by Subject|0
5056792|NCT02452892|17439622|P1|Follow-up|Withdrawal by Subject|0
5056793|NCT02452892|17439619|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5056794|NCT02452892|17439620|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5056795|NCT02452892|17439621|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5056796|NCT02452892|17439622|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
5056797|NCT02452892|17439619|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
5056798|NCT02452892|17439620|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5056799|NCT02452892|17439621|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5056800|NCT02452892|17439622|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5056801|NCT02452892|17439619|P4|Week 1 Initial Randommization|Lost to Follow-up|0
5056802|NCT02452892|17439620|P3|Week 1 Initial Randommization|Lost to Follow-up|1
5056803|NCT02452892|17439621|P2|Week 1 Initial Randommization|Lost to Follow-up|0
5056804|NCT02452892|17439622|P1|Week 1 Initial Randommization|Lost to Follow-up|0
5056805|NCT02452892|17439619|P4|Week 1 Initial Randommization|Adverse Event|0
5056806|NCT02452892|17439620|P3|Week 1 Initial Randommization|Adverse Event|0
5056807|NCT02452892|17439621|P2|Week 1 Initial Randommization|Adverse Event|0
5056808|NCT02452892|17439622|P1|Week 1 Initial Randommization|Adverse Event|1
5056809|NCT02452554|17439657|P6|Overall Study|Never Received Treatment|0
5056810|NCT02452554|17439658|P5|Overall Study|Never Received Treatment|0
5056811|NCT02452554|17439659|P4|Overall Study|Never Received Treatment|0
5056812|NCT02452554|17439660|P3|Overall Study|Never Received Treatment|0
5056813|NCT02452554|17439661|P2|Overall Study|Never Received Treatment|0
5056814|NCT02452554|17439662|P1|Overall Study|Never Received Treatment|1
5056815|NCT02452554|17439657|P6|Overall Study|Ineligible|0
5056816|NCT02452554|17439658|P5|Overall Study|Ineligible|0
5056817|NCT02452554|17439659|P4|Overall Study|Ineligible|0
5056818|NCT02452554|17439660|P3|Overall Study|Ineligible|0
5056819|NCT02452554|17439661|P2|Overall Study|Ineligible|1
5056820|NCT02452554|17439662|P1|Overall Study|Ineligible|0
5056821|NCT02452554|17439657|P6|Overall Study|Withdrawal by Subject|1
5056822|NCT02452554|17439658|P5|Overall Study|Withdrawal by Subject|0
5056823|NCT02452554|17439659|P4|Overall Study|Withdrawal by Subject|0
5056824|NCT02452554|17439660|P3|Overall Study|Withdrawal by Subject|2
5056825|NCT02452554|17439661|P2|Overall Study|Withdrawal by Subject|0
5056826|NCT02452554|17439662|P1|Overall Study|Withdrawal by Subject|1
5056827|NCT02452554|17439657|P6|Overall Study|Physician Decision|0
5056828|NCT02452554|17439658|P5|Overall Study|Physician Decision|0
5056829|NCT02452554|17439659|P4|Overall Study|Physician Decision|0
5056830|NCT02452554|17439660|P3|Overall Study|Physician Decision|0
5056831|NCT02452554|17439661|P2|Overall Study|Physician Decision|1
5056832|NCT02452554|17439662|P1|Overall Study|Physician Decision|0
5056833|NCT02452554|17439657|P6|Overall Study|Lack of Efficacy|8
5056834|NCT02452554|17439658|P5|Overall Study|Lack of Efficacy|5
5056835|NCT02452554|17439659|P4|Overall Study|Lack of Efficacy|1
5056836|NCT02452554|17439660|P3|Overall Study|Lack of Efficacy|9
5056837|NCT02452554|17439661|P2|Overall Study|Lack of Efficacy|14
5056838|NCT02452554|17439662|P1|Overall Study|Lack of Efficacy|13
5056839|NCT02452554|17439657|P6|Overall Study|Death|0
5056840|NCT02452554|17439658|P5|Overall Study|Death|0
5056841|NCT02452554|17439659|P4|Overall Study|Death|0
5056842|NCT02452554|17439660|P3|Overall Study|Death|0
5056843|NCT02452554|17439661|P2|Overall Study|Death|1
5056844|NCT02452554|17439662|P1|Overall Study|Death|2
5056845|NCT02452463|17439715|P3|Overall Study|Withdrawal by Subject|0
5056846|NCT02452463|17439716|P2|Overall Study|Withdrawal by Subject|1
5056847|NCT02452463|17439717|P1|Overall Study|Withdrawal by Subject|0
5056848|NCT02452463|17439715|P3|Overall Study|Recommended by DSMB|0
5056849|NCT02452463|17439716|P2|Overall Study|Recommended by DSMB|1
5056850|NCT02452463|17439717|P1|Overall Study|Recommended by DSMB|0
5056851|NCT02452463|17439715|P3|Overall Study|Study Suspended|0
5056852|NCT02452463|17439716|P2|Overall Study|Study Suspended|0
5056853|NCT02452463|17439717|P1|Overall Study|Study Suspended|1
5056854|NCT02452463|17439715|P3|Overall Study|Death|0
5056855|NCT02452463|17439716|P2|Overall Study|Death|0
5056856|NCT02452463|17439717|P1|Overall Study|Death|1
5056857|NCT02452424|17439760|P11|Overall Study|Adverse Event|1
5056858|NCT02452424|17439761|P10|Overall Study|Adverse Event|0
5056859|NCT02452424|17439762|P9|Overall Study|Adverse Event|0
5056860|NCT02452424|17439763|P8|Overall Study|Adverse Event|0
5056861|NCT02452424|17439764|P7|Overall Study|Adverse Event|0
5056862|NCT02452424|17439765|P6|Overall Study|Adverse Event|0
5056863|NCT02452424|17439766|P5|Overall Study|Adverse Event|0
5056864|NCT02452424|17439767|P4|Overall Study|Adverse Event|0
5056865|NCT02452424|17439768|P3|Overall Study|Adverse Event|0
5056866|NCT02452424|17439769|P2|Overall Study|Adverse Event|0
5056867|NCT02452424|17439770|P1|Overall Study|Adverse Event|0
5056868|NCT02452424|17439760|P11|Overall Study|Progressive disease (per RECIST)|0
5056869|NCT02452424|17439761|P10|Overall Study|Progressive disease (per RECIST)|0
5056870|NCT02452424|17439762|P9|Overall Study|Progressive disease (per RECIST)|2
5056871|NCT02452424|17439763|P8|Overall Study|Progressive disease (per RECIST)|0
5056872|NCT02452424|17439764|P7|Overall Study|Progressive disease (per RECIST)|0
5056873|NCT02452424|17439765|P6|Overall Study|Progressive disease (per RECIST)|0
5056874|NCT02452424|17439766|P5|Overall Study|Progressive disease (per RECIST)|0
5056875|NCT02452424|17439767|P4|Overall Study|Progressive disease (per RECIST)|0
5056876|NCT02452424|17439768|P3|Overall Study|Progressive disease (per RECIST)|0
5056877|NCT02452424|17439769|P2|Overall Study|Progressive disease (per RECIST)|0
5056878|NCT02452424|17439770|P1|Overall Study|Progressive disease (per RECIST)|0
5056879|NCT02452424|17439760|P11|Overall Study|Other|1
5056880|NCT02452424|17439761|P10|Overall Study|Other|0
5056881|NCT02452424|17439762|P9|Overall Study|Other|0
5056882|NCT02452424|17439763|P8|Overall Study|Other|3
5056883|NCT02452424|17439764|P7|Overall Study|Other|4
5056884|NCT02452424|17439765|P6|Overall Study|Other|1
5056885|NCT02452424|17439766|P5|Overall Study|Other|0
5056886|NCT02452424|17439767|P4|Overall Study|Other|0
5056887|NCT02452424|17439768|P3|Overall Study|Other|1
5056888|NCT02452424|17439769|P2|Overall Study|Other|0
5056889|NCT02452424|17439770|P1|Overall Study|Other|0
5056890|NCT02452424|17439760|P11|Overall Study|Withdrawal by Subject|0
5056891|NCT02452424|17439761|P10|Overall Study|Withdrawal by Subject|1
5056892|NCT02452424|17439762|P9|Overall Study|Withdrawal by Subject|1
5056893|NCT02452424|17439763|P8|Overall Study|Withdrawal by Subject|0
5056894|NCT02452424|17439764|P7|Overall Study|Withdrawal by Subject|1
5056895|NCT02452424|17439765|P6|Overall Study|Withdrawal by Subject|0
5056896|NCT02452424|17439766|P5|Overall Study|Withdrawal by Subject|0
5056897|NCT02452424|17439767|P4|Overall Study|Withdrawal by Subject|2
5056898|NCT02452424|17439768|P3|Overall Study|Withdrawal by Subject|3
5056899|NCT02452424|17439769|P2|Overall Study|Withdrawal by Subject|0
5056900|NCT02452424|17439770|P1|Overall Study|Withdrawal by Subject|0
5056901|NCT02452424|17439760|P11|Overall Study|Lost to Follow-up|0
5056902|NCT02452424|17439761|P10|Overall Study|Lost to Follow-up|0
5056903|NCT02452424|17439762|P9|Overall Study|Lost to Follow-up|0
5056904|NCT02452424|17439763|P8|Overall Study|Lost to Follow-up|0
5056905|NCT02452424|17439764|P7|Overall Study|Lost to Follow-up|0
5056906|NCT02452424|17439765|P6|Overall Study|Lost to Follow-up|0
5056907|NCT02452424|17439766|P5|Overall Study|Lost to Follow-up|0
5056908|NCT02452424|17439767|P4|Overall Study|Lost to Follow-up|0
5056909|NCT02452424|17439768|P3|Overall Study|Lost to Follow-up|1
5056910|NCT02452424|17439769|P2|Overall Study|Lost to Follow-up|1
5056911|NCT02452424|17439770|P1|Overall Study|Lost to Follow-up|0
5056912|NCT02452424|17439760|P11|Overall Study|Death|0
5056913|NCT02452424|17439761|P10|Overall Study|Death|1
5056914|NCT02452424|17439762|P9|Overall Study|Death|3
5056915|NCT02452424|17439763|P8|Overall Study|Death|1
5056916|NCT02452424|17439764|P7|Overall Study|Death|5
5056917|NCT02452424|17439765|P6|Overall Study|Death|0
5056918|NCT02452424|17439766|P5|Overall Study|Death|2
5056919|NCT02452424|17439767|P4|Overall Study|Death|6
5056920|NCT02452424|17439768|P3|Overall Study|Death|2
5056921|NCT02452424|17439769|P2|Overall Study|Death|2
5056922|NCT02452424|17439770|P1|Overall Study|Death|2
5056923|NCT02452398|17439805|P1|Overall Study|Moved away|4
5056924|NCT02452398|17439805|P1|Overall Study|Withdrawal by Subject|6
5056925|NCT02452398|17439805|P1|Overall Study|Physician Decision|2
5056926|NCT02452398|17439805|P1|Overall Study|Lost to Follow-up|28
5056927|NCT02452398|17439805|P1|Overall Study|Adverse Event|1
5056928|NCT02452359|17439809|P1|Overall Study|Withdrawal by Subject|4
5056929|NCT02452359|17439809|P1|Overall Study|Pregnancy|1
5056930|NCT02452359|17439809|P1|Overall Study|Lost to Follow-up|15
5056931|NCT02452359|17439809|P1|Overall Study|Adverse Event|1
5056932|NCT02452320|17439821|P2|Overall Study|Adverse Event|1
5056933|NCT02452320|17439822|P1|Overall Study|Adverse Event|0
5056934|NCT02452190|17439834|P2|Overall Study|Death|1
5056935|NCT02452190|17439835|P1|Overall Study|Death|0
5056936|NCT02452190|17439834|P2|Overall Study|Participant traveled abroad|0
5056937|NCT02452190|17439835|P1|Overall Study|Participant traveled abroad|1
5056938|NCT02452190|17439834|P2|Overall Study|Noncompliance with study drug|0
5056939|NCT02452190|17439835|P1|Overall Study|Noncompliance with study drug|1
5056940|NCT02452190|17439834|P2|Overall Study|Withdrawal by Subject|11
5056941|NCT02452190|17439835|P1|Overall Study|Withdrawal by Subject|20
5056942|NCT02452190|17439834|P2|Overall Study|Adverse Event|5
5056943|NCT02452190|17439835|P1|Overall Study|Adverse Event|2
5056944|NCT02452190|17439834|P2|Overall Study|Lost to Follow-up|3
5056945|NCT02452190|17439835|P1|Overall Study|Lost to Follow-up|4
5056946|NCT02452190|17439834|P2|Overall Study|Lack of Efficacy|1
5056947|NCT02452190|17439835|P1|Overall Study|Lack of Efficacy|3
5056948|NCT02452190|17439834|P2|Overall Study|Investigator's Decision|0
5056949|NCT02452190|17439835|P1|Overall Study|Investigator's Decision|2
5056950|NCT02452190|17439834|P2|Overall Study|Pregnancy|0
5056951|NCT02452190|17439835|P1|Overall Study|Pregnancy|1
5056952|NCT02452190|17439834|P2|Overall Study|Withdrawal by Sponsor|3
5056953|NCT02452190|17439835|P1|Overall Study|Withdrawal by Sponsor|1
5056954|NCT02452047|17439873|P3|Overall Study|Withdrawal by Subject|0
5056955|NCT02452047|17439874|P2|Overall Study|Withdrawal by Subject|0
5056956|NCT02452047|17439875|P1|Overall Study|Withdrawal by Subject|1
5056957|NCT02452047|17439873|P3|Overall Study|Lost to Follow-up|0
5056958|NCT02452047|17439874|P2|Overall Study|Lost to Follow-up|1
5056959|NCT02452047|17439875|P1|Overall Study|Lost to Follow-up|1
5056960|NCT02452047|17439873|P3|Overall Study|Physician Decision|0
5056961|NCT02452047|17439874|P2|Overall Study|Physician Decision|0
5056962|NCT02452047|17439875|P1|Overall Study|Physician Decision|1
5056963|NCT02452047|17439873|P3|Overall Study|Death|1
5056964|NCT02452047|17439874|P2|Overall Study|Death|3
5056965|NCT02452047|17439875|P1|Overall Study|Death|1
5056966|NCT02452047|17439873|P3|Overall Study|Adverse Event|1
5056967|NCT02452047|17439874|P2|Overall Study|Adverse Event|1
5056968|NCT02452047|17439875|P1|Overall Study|Adverse Event|0
5056969|NCT02452034|17439940|P6|Overall Study|Withdrawn by Parent/Guardian|0
5056970|NCT02452034|17439941|P5|Overall Study|Withdrawn by Parent/Guardian|0
5056971|NCT02452034|17439942|P4|Overall Study|Withdrawn by Parent/Guardian|0
5056972|NCT02452034|17439943|P3|Overall Study|Withdrawn by Parent/Guardian|0
5056973|NCT02452034|17439944|P2|Overall Study|Withdrawn by Parent/Guardian|0
5056974|NCT02452034|17439945|P1|Overall Study|Withdrawn by Parent/Guardian|1
5056975|NCT02452034|17439940|P6|Overall Study|Screen Failure|0
5056976|NCT02452034|17439941|P5|Overall Study|Screen Failure|0
5056977|NCT02452034|17439942|P4|Overall Study|Screen Failure|1
5056978|NCT02452034|17439943|P3|Overall Study|Screen Failure|0
5056979|NCT02452034|17439944|P2|Overall Study|Screen Failure|0
5056980|NCT02452034|17439945|P1|Overall Study|Screen Failure|1
5056981|NCT02452034|17439940|P6|Overall Study|Protocol Violation|1
5056982|NCT02452034|17439941|P5|Overall Study|Protocol Violation|0
5056983|NCT02452034|17439942|P4|Overall Study|Protocol Violation|0
5056984|NCT02452034|17439943|P3|Overall Study|Protocol Violation|0
5056985|NCT02452034|17439944|P2|Overall Study|Protocol Violation|0
5056986|NCT02452034|17439945|P1|Overall Study|Protocol Violation|0
5056987|NCT02452034|17439940|P6|Overall Study|Physician Decision|0
5056988|NCT02452034|17439941|P5|Overall Study|Physician Decision|0
5056989|NCT02452034|17439942|P4|Overall Study|Physician Decision|0
5056990|NCT02452034|17439943|P3|Overall Study|Physician Decision|1
5056991|NCT02452034|17439944|P2|Overall Study|Physician Decision|1
5056992|NCT02452034|17439945|P1|Overall Study|Physician Decision|0
5056993|NCT02452034|17439940|P6|Overall Study|Death|1
5056994|NCT02452034|17439941|P5|Overall Study|Death|1
5056995|NCT02452034|17439942|P4|Overall Study|Death|0
5056996|NCT02452034|17439943|P3|Overall Study|Death|0
5056997|NCT02452034|17439944|P2|Overall Study|Death|0
5056998|NCT02452034|17439945|P1|Overall Study|Death|0
5056999|NCT02452034|17439940|P6|Overall Study|Adverse Event|1
5057000|NCT02452034|17439941|P5|Overall Study|Adverse Event|0
5057001|NCT02452034|17439942|P4|Overall Study|Adverse Event|0
5057002|NCT02452034|17439943|P3|Overall Study|Adverse Event|0
5057003|NCT02452034|17439944|P2|Overall Study|Adverse Event|0
5057004|NCT02452034|17439945|P1|Overall Study|Adverse Event|0
5057005|NCT02451943|17440018|P2|Overall Study|Lost to Follow-up|4
5057006|NCT02451943|17440019|P1|Overall Study|Lost to Follow-up|3
5057007|NCT02451943|17440018|P2|Overall Study|Withdrawal by Subject|16
5057008|NCT02451943|17440019|P1|Overall Study|Withdrawal by Subject|13
5057009|NCT02451943|17440018|P2|Overall Study|On Treatment|4
5057010|NCT02451943|17440019|P1|Overall Study|On Treatment|4
5057011|NCT02451930|17440048|P2|Overall Study|Other|1
5057012|NCT02451930|17440049|P1|Overall Study|Other|0
5057013|NCT02451930|17440048|P2|Overall Study|Withdrawal by Subject|1
5057014|NCT02451930|17440049|P1|Overall Study|Withdrawal by Subject|0
5057015|NCT02451930|17440048|P2|Overall Study|Sponsor Decision|10
5057016|NCT02451930|17440049|P1|Overall Study|Sponsor Decision|2
5057017|NCT02451930|17440048|P2|Overall Study|Lost to Follow-up|3
5057018|NCT02451930|17440049|P1|Overall Study|Lost to Follow-up|0
5057019|NCT02451930|17440048|P2|Overall Study|Death|15
5057020|NCT02451930|17440049|P1|Overall Study|Death|0
5057021|NCT02451917|17440072|P2|First Intervention (24 Weeks)|Adverse Event|2
5057022|NCT02451917|17440073|P1|First Intervention (24 Weeks)|Adverse Event|0
5057023|NCT02451917|17440072|P2|First Intervention (24 Weeks)|Death|1
5057024|NCT02451917|17440073|P1|First Intervention (24 Weeks)|Death|0
5057025|NCT02451917|17440072|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
5057026|NCT02451917|17440073|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
5057027|NCT02451670|17440115|P2|Overall Study|Did not have qualifying follow-up visit.|696
5057028|NCT02451670|17440116|P1|Overall Study|Did not have qualifying follow-up visit.|714
5057029|NCT02451358|17440226|P4|Overall Study|Protocol Violation|0
5057030|NCT02451358|17440227|P3|Overall Study|Protocol Violation|1
5057031|NCT02451358|17440228|P2|Overall Study|Protocol Violation|1
5057032|NCT02451358|17440229|P1|Overall Study|Protocol Violation|0
5057033|NCT02451358|17440226|P4|Overall Study|Withdrawal by Subject|0
5057034|NCT02451358|17440227|P3|Overall Study|Withdrawal by Subject|0
5057035|NCT02451358|17440228|P2|Overall Study|Withdrawal by Subject|1
5057036|NCT02451358|17440229|P1|Overall Study|Withdrawal by Subject|1
5057037|NCT02451137|17440317|P2|Overall Study|Other than specified above|3
5057038|NCT02451137|17440318|P1|Overall Study|Other than specified above|2
5057039|NCT02451137|17440317|P2|Overall Study|Withdrawal by Subject|63
5057040|NCT02451137|17440318|P1|Overall Study|Withdrawal by Subject|40
5057041|NCT02451137|17440317|P2|Overall Study|Sponsor decision|25
5057042|NCT02451137|17440318|P1|Overall Study|Sponsor decision|13
5057043|NCT02451137|17440317|P2|Overall Study|Physician Decision|5
5057044|NCT02451137|17440318|P1|Overall Study|Physician Decision|6
5057045|NCT02451137|17440317|P2|Overall Study|Lost to Follow-up|61
5057046|NCT02451137|17440318|P1|Overall Study|Lost to Follow-up|53
5057047|NCT02451137|17440317|P2|Overall Study|Investigator's decision|19
5057048|NCT02451137|17440318|P1|Overall Study|Investigator's decision|23
5057049|NCT02451137|17440317|P2|Overall Study|Hypoglycemia|1
5057050|NCT02451137|17440318|P1|Overall Study|Hypoglycemia|2
5057051|NCT02451137|17440317|P2|Overall Study|Participant decision:discontinue insulin|43
5057052|NCT02451137|17440318|P1|Overall Study|Participant decision:discontinue insulin|41
5057053|NCT02451137|17440317|P2|Overall Study|Lack of Efficacy|9
5057054|NCT02451137|17440318|P1|Overall Study|Lack of Efficacy|4
5057055|NCT02451137|17440317|P2|Overall Study|Adverse Event|42
5057056|NCT02451137|17440318|P1|Overall Study|Adverse Event|43
5057057|NCT02451137|17440317|P2|Overall Study|Randomized but not treated|27
5057058|NCT02451137|17440318|P1|Overall Study|Randomized but not treated|19
5057059|NCT02451124|17440348|P1|Overall Study|Withdrawal by Subject|1
5057060|NCT02451007|17440359|P1|Overall Study|Disease Progression|2
5057061|NCT02451007|17440359|P1|Overall Study|Adverse Event|1
5057062|NCT02451007|17440359|P1|Overall Study|Withdrawal by Subject|4
5057063|NCT02450552|17440398|P3|Overall Study|Physician Decision|1
5057064|NCT02450552|17440399|P2|Overall Study|Physician Decision|0
5057065|NCT02450552|17440400|P1|Overall Study|Physician Decision|1
5057066|NCT02450552|17440398|P3|Overall Study|Withdrawal by Subject|4
5057067|NCT02450552|17440399|P2|Overall Study|Withdrawal by Subject|0
5057068|NCT02450552|17440400|P1|Overall Study|Withdrawal by Subject|4
5057069|NCT02450539|17440443|P2|Overall Study|On study treatment/follow up|25
5057070|NCT02450539|17440444|P1|Overall Study|On study treatment/follow up|27
5057071|NCT02450539|17440443|P2|Overall Study|Lost to Follow-up|1
5057072|NCT02450539|17440444|P1|Overall Study|Lost to Follow-up|4
5057073|NCT02450539|17440443|P2|Overall Study|Withdrawal by Subject|7
5057074|NCT02450539|17440444|P1|Overall Study|Withdrawal by Subject|19
5057075|NCT02450526|17440468|P5|OL Period (Cycles 2-5)|Protocol Violation|7
5057076|NCT02450526|17440469|P4|OL Period (Cycles 2-5)|Protocol Violation|0
5057077|NCT02450526|17440470|P3|OL Period (Cycles 2-5)|Protocol Violation|0
5057078|NCT02450526|17440471|P2|OL Period (Cycles 2-5)|Protocol Violation|0
5057079|NCT02450526|17440472|P1|OL Period (Cycles 2-5)|Protocol Violation|0
5057080|NCT02450526|17440468|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
5057081|NCT02450526|17440469|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
5057082|NCT02450526|17440470|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
5057083|NCT02450526|17440471|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
5057084|NCT02450526|17440472|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
5057085|NCT02450526|17440468|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
5057086|NCT02450526|17440469|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5057087|NCT02450526|17440470|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5057088|NCT02450526|17440471|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5057089|NCT02450526|17440472|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5057090|NCT02450526|17440468|P5|OL Period (Cycles 2-5)|Adverse Event|2
5057091|NCT02450526|17440469|P4|OL Period (Cycles 2-5)|Adverse Event|0
5057092|NCT02450526|17440470|P3|OL Period (Cycles 2-5)|Adverse Event|0
5057093|NCT02450526|17440471|P2|OL Period (Cycles 2-5)|Adverse Event|0
5057094|NCT02450526|17440472|P1|OL Period (Cycles 2-5)|Adverse Event|0
5057095|NCT02450526|17440468|P5|DB Period (Cycle 1)|Protocol Violation|0
5057096|NCT02450526|17440469|P4|DB Period (Cycle 1)|Protocol Violation|1
5057097|NCT02450526|17440470|P3|DB Period (Cycle 1)|Protocol Violation|0
5057098|NCT02450526|17440471|P2|DB Period (Cycle 1)|Protocol Violation|0
5057099|NCT02450526|17440472|P1|DB Period (Cycle 1)|Protocol Violation|2
5057100|NCT02450526|17440468|P5|DB Period (Cycle 1)|Lost to Follow-up|0
5057101|NCT02450526|17440469|P4|DB Period (Cycle 1)|Lost to Follow-up|0
5057102|NCT02450526|17440470|P3|DB Period (Cycle 1)|Lost to Follow-up|0
5057103|NCT02450526|17440471|P2|DB Period (Cycle 1)|Lost to Follow-up|0
5057104|NCT02450526|17440472|P1|DB Period (Cycle 1)|Lost to Follow-up|1
5057105|NCT02450526|17440468|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
5057106|NCT02450526|17440469|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
5057107|NCT02450526|17440470|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
5057108|NCT02450526|17440471|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
5057109|NCT02450526|17440472|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
5057110|NCT02450526|17440468|P5|DB Period (Cycle 1)|Adverse Event|0
5057111|NCT02450526|17440469|P4|DB Period (Cycle 1)|Adverse Event|0
5057112|NCT02450526|17440470|P3|DB Period (Cycle 1)|Adverse Event|2
5057113|NCT02450526|17440471|P2|DB Period (Cycle 1)|Adverse Event|0
5057114|NCT02450526|17440472|P1|DB Period (Cycle 1)|Adverse Event|0
5057115|NCT02450487|17440557|P1|Overall Study|Lost to Follow-up|3
5057116|NCT02450331|17440579|P2|Overall Study|On-Study Status: In Survival follow-up|38
5057117|NCT02450331|17440580|P1|Overall Study|On-Study Status: In Survival follow-up|45
5057118|NCT02450331|17440579|P2|Overall Study|On-Study Status: In Disease recurrence follow-up|208
5057119|NCT02450331|17440580|P1|Overall Study|On-Study Status: In Disease recurrence follow-up|179
5057120|NCT02450331|17440579|P2|Overall Study|Withdrawal by Subject|39
5057121|NCT02450331|17440580|P1|Overall Study|Withdrawal by Subject|50
5057122|NCT02450331|17440579|P2|Overall Study|Lost to Follow-up|7
5057123|NCT02450331|17440580|P1|Overall Study|Lost to Follow-up|9
5057124|NCT02450331|17440579|P2|Overall Study|Death|114
5057125|NCT02450331|17440580|P1|Overall Study|Death|120
5057126|NCT02449915|17440603|P2|Overall Study|Abnormal preop lab|1
5057127|NCT02449915|17440604|P1|Overall Study|Abnormal preop lab|0
5057128|NCT02449915|17440603|P2|Overall Study|Intraoperative surgical findings|1
5057129|NCT02449915|17440604|P1|Overall Study|Intraoperative surgical findings|1
5057130|NCT02449915|17440603|P2|Overall Study|Withdrawal by Subject|2
5057131|NCT02449915|17440604|P1|Overall Study|Withdrawal by Subject|0
5057132|NCT02449915|17440603|P2|Overall Study|Exclusion criteria - drug use|0
5057133|NCT02449915|17440604|P1|Overall Study|Exclusion criteria - drug use|1
5057134|NCT02449902|17440612|P2|Overall Study|Withdrawal by Subject|1
5057135|NCT02449902|17440613|P1|Overall Study|Withdrawal by Subject|0
5057136|NCT02449902|17440612|P2|Overall Study|Adverse Event|1
5057137|NCT02449902|17440613|P1|Overall Study|Adverse Event|0
5057138|NCT02449889|17440640|P3|Overall Study|Protocol Violation|1
5057139|NCT02449889|17440641|P2|Overall Study|Protocol Violation|4
5057140|NCT02449889|17440642|P1|Overall Study|Protocol Violation|0
5057141|NCT02449889|17440640|P3|Overall Study|Adverse Event|0
5057142|NCT02449889|17440641|P2|Overall Study|Adverse Event|2
5057143|NCT02449889|17440642|P1|Overall Study|Adverse Event|1
5057144|NCT02449044|17440776|P1|Overall Study|Sponsor Discontinued Trial|3
5057145|NCT02449044|17440776|P1|Overall Study|Physician Decision|9
5057146|NCT02449044|17440776|P1|Overall Study|Met Withdrawal Criteria|7
5057147|NCT02449044|17440776|P1|Overall Study|Adverse Event|30
5057148|NCT02449044|17440776|P1|Overall Study|Withdrawal by Subject|13
5057149|NCT02449044|17440776|P1|Overall Study|Lost to Follow-up|2
5057150|NCT02449018|17440797|P2|Overall Study|Patient decision|0
5057151|NCT02449018|17440798|P1|Overall Study|Patient decision|2
5057152|NCT02449018|17440797|P2|Overall Study|Protocol deviation|0
5057153|NCT02449018|17440798|P1|Overall Study|Protocol deviation|4
5057154|NCT02449018|17440797|P2|Overall Study|Adverse Event|1
5057155|NCT02449018|17440798|P1|Overall Study|Adverse Event|5
5057156|NCT02449018|17440797|P2|Overall Study|Administrative problems|0
5057157|NCT02449018|17440798|P1|Overall Study|Administrative problems|1
5057158|NCT02449018|17440797|P2|Overall Study|Abnormal laboratory value|1
5057159|NCT02449018|17440798|P1|Overall Study|Abnormal laboratory value|0
5057160|NCT02448875|17440845|P3|Overall Study|Withdrawal by Subject|0
5057161|NCT02448875|17440846|P2|Overall Study|Withdrawal by Subject|0
5057162|NCT02448875|17440847|P1|Overall Study|Withdrawal by Subject|1
5057163|NCT02448875|17440845|P3|Overall Study|Investigator Decision|1
5057164|NCT02448875|17440846|P2|Overall Study|Investigator Decision|0
5057165|NCT02448875|17440847|P1|Overall Study|Investigator Decision|3
5057166|NCT02448875|17440845|P3|Overall Study|Lost to Follow-up|0
5057167|NCT02448875|17440846|P2|Overall Study|Lost to Follow-up|0
5057168|NCT02448875|17440847|P1|Overall Study|Lost to Follow-up|1
5057169|NCT02448875|17440845|P3|Overall Study|Adverse Event|0
5057170|NCT02448875|17440846|P2|Overall Study|Adverse Event|1
5057171|NCT02448875|17440847|P1|Overall Study|Adverse Event|2
5057172|NCT02448810|17440895|P8|Overall Study|Other (unspecified)|0
5057173|NCT02448810|17440896|P7|Overall Study|Other (unspecified)|2
5057174|NCT02448810|17440897|P6|Overall Study|Other (unspecified)|0
5057175|NCT02448810|17440898|P5|Overall Study|Other (unspecified)|0
5057176|NCT02448810|17440899|P4|Overall Study|Other (unspecified)|0
5057177|NCT02448810|17440900|P3|Overall Study|Other (unspecified)|0
5057178|NCT02448810|17440901|P2|Overall Study|Other (unspecified)|0
5057179|NCT02448810|17440902|P1|Overall Study|Other (unspecified)|0
5057180|NCT02448810|17440895|P8|Overall Study|Lost to Follow-up|0
5057181|NCT02448810|17440896|P7|Overall Study|Lost to Follow-up|0
5057182|NCT02448810|17440897|P6|Overall Study|Lost to Follow-up|0
5057183|NCT02448810|17440898|P5|Overall Study|Lost to Follow-up|0
5057184|NCT02448810|17440899|P4|Overall Study|Lost to Follow-up|0
5057185|NCT02448810|17440900|P3|Overall Study|Lost to Follow-up|0
5057186|NCT02448810|17440901|P2|Overall Study|Lost to Follow-up|1
5057187|NCT02448810|17440902|P1|Overall Study|Lost to Follow-up|0
5057188|NCT02448810|17440895|P8|Overall Study|Other (Progressive disease)|5
5057189|NCT02448810|17440896|P7|Overall Study|Other (Progressive disease)|14
5057190|NCT02448810|17440897|P6|Overall Study|Other (Progressive disease)|9
5057191|NCT02448810|17440898|P5|Overall Study|Other (Progressive disease)|23
5057192|NCT02448810|17440899|P4|Overall Study|Other (Progressive disease)|3
5057193|NCT02448810|17440900|P3|Overall Study|Other (Progressive disease)|0
5057194|NCT02448810|17440901|P2|Overall Study|Other (Progressive disease)|2
5057195|NCT02448810|17440902|P1|Overall Study|Other (Progressive disease)|2
5057196|NCT02448810|17440895|P8|Overall Study|Death|0
5057197|NCT02448810|17440896|P7|Overall Study|Death|0
5057198|NCT02448810|17440897|P6|Overall Study|Death|0
5057199|NCT02448810|17440898|P5|Overall Study|Death|1
5057200|NCT02448810|17440899|P4|Overall Study|Death|0
5057201|NCT02448810|17440900|P3|Overall Study|Death|1
5057202|NCT02448810|17440901|P2|Overall Study|Death|0
5057203|NCT02448810|17440902|P1|Overall Study|Death|1
5057204|NCT02448810|17440895|P8|Overall Study|Other (study terminated by sponsor)|1
5057205|NCT02448810|17440896|P7|Overall Study|Other (study terminated by sponsor)|2
5057206|NCT02448810|17440897|P6|Overall Study|Other (study terminated by sponsor)|2
5057207|NCT02448810|17440898|P5|Overall Study|Other (study terminated by sponsor)|4
5057208|NCT02448810|17440899|P4|Overall Study|Other (study terminated by sponsor)|0
5057209|NCT02448810|17440900|P3|Overall Study|Other (study terminated by sponsor)|0
5057210|NCT02448810|17440901|P2|Overall Study|Other (study terminated by sponsor)|0
5057211|NCT02448810|17440902|P1|Overall Study|Other (study terminated by sponsor)|0
5057212|NCT02448810|17440895|P8|Overall Study|Withdrawal by Subject|2
5057213|NCT02448810|17440896|P7|Overall Study|Withdrawal by Subject|0
5057214|NCT02448810|17440897|P6|Overall Study|Withdrawal by Subject|5
5057215|NCT02448810|17440898|P5|Overall Study|Withdrawal by Subject|3
5057216|NCT02448810|17440899|P4|Overall Study|Withdrawal by Subject|0
5057217|NCT02448810|17440900|P3|Overall Study|Withdrawal by Subject|1
5057218|NCT02448810|17440901|P2|Overall Study|Withdrawal by Subject|0
5057219|NCT02448810|17440902|P1|Overall Study|Withdrawal by Subject|0
5057220|NCT02448810|17440895|P8|Overall Study|Adverse Event|0
5057221|NCT02448810|17440896|P7|Overall Study|Adverse Event|0
5057222|NCT02448810|17440897|P6|Overall Study|Adverse Event|0
5057223|NCT02448810|17440898|P5|Overall Study|Adverse Event|0
5057224|NCT02448810|17440899|P4|Overall Study|Adverse Event|0
5057225|NCT02448810|17440900|P3|Overall Study|Adverse Event|1
5057226|NCT02448810|17440901|P2|Overall Study|Adverse Event|0
5057227|NCT02448810|17440902|P1|Overall Study|Adverse Event|0
5057228|NCT02448719|17440979|P11|Overall Study|Withdrawal by Subject|0
5057229|NCT02448719|17440980|P10|Overall Study|Withdrawal by Subject|0
5057230|NCT02448719|17440981|P9|Overall Study|Withdrawal by Subject|0
5057231|NCT02448719|17440982|P8|Overall Study|Withdrawal by Subject|0
5057232|NCT02448719|17440983|P7|Overall Study|Withdrawal by Subject|0
5057233|NCT02448719|17440984|P6|Overall Study|Withdrawal by Subject|0
5057234|NCT02448719|17440985|P5|Overall Study|Withdrawal by Subject|1
5057235|NCT02448719|17440986|P4|Overall Study|Withdrawal by Subject|0
5057236|NCT02448719|17440987|P3|Overall Study|Withdrawal by Subject|0
5057237|NCT02448719|17440988|P2|Overall Study|Withdrawal by Subject|0
5057238|NCT02448719|17440989|P1|Overall Study|Withdrawal by Subject|0
5057239|NCT02448706|17441213|P2|Overall Study|Protocol Violation|1
5057240|NCT02448706|17441214|P1|Overall Study|Protocol Violation|1
5057241|NCT02448706|17441213|P2|Overall Study|Withdrawal by Subject|3
5057242|NCT02448706|17441214|P1|Overall Study|Withdrawal by Subject|4
5057243|NCT02448680|17441228|P2|Overall Study|Withdrawal by Subject|2
5057244|NCT02448680|17441229|P1|Overall Study|Withdrawal by Subject|0
5057245|NCT02448680|17441228|P2|Overall Study|Physician Decision|1
5057246|NCT02448680|17441229|P1|Overall Study|Physician Decision|1
5057247|NCT02448563|17441298|P2|Overall Study|Withdrawal by Subject|1
5057248|NCT02448563|17441299|P1|Overall Study|Withdrawal by Subject|0
5057249|NCT02448563|17441298|P2|Overall Study|Lost to Follow-up|10
5057250|NCT02448563|17441299|P1|Overall Study|Lost to Follow-up|16
5057251|NCT02448537|17441321|P3|Overall Study|Withdrawal by Subject|1
5057252|NCT02448537|17441322|P2|Overall Study|Withdrawal by Subject|1
5057253|NCT02448537|17441323|P1|Overall Study|Withdrawal by Subject|1
5057254|NCT02448043|17441437|P2|Overall Study|Protocol Violation|2
5057255|NCT02448043|17441438|P1|Overall Study|Protocol Violation|1
5057256|NCT02448043|17441437|P2|Overall Study|Withdrawal by Subject|2
5057257|NCT02448043|17441438|P1|Overall Study|Withdrawal by Subject|2
5057258|NCT02447952|17441456|P1|Overall Study|Withdrawal by Subject|4
5057259|NCT02447952|17441456|P1|Overall Study|Physician Decision|1
5057260|NCT02447952|17441456|P1|Overall Study|Adverse Event|2
5057261|NCT02447887|17441513|P1|Overall Study|Study was terminated|3
5057262|NCT02447848|17441526|P1|Overall Study|Withdrawal by Subject|4
5057263|NCT02447848|17441526|P1|Overall Study|Lack of Efficacy|4
5057264|NCT02447848|17441526|P1|Overall Study|Patient discharged|3
5057265|NCT02447497|17441540|P4|Overall Study|Did not meet treatment day baseline|2
5057266|NCT02447497|17441541|P3|Overall Study|Did not meet treatment day baseline|2
5057267|NCT02447497|17441542|P2|Overall Study|Did not meet treatment day baseline|6
5057268|NCT02447497|17441543|P1|Overall Study|Did not meet treatment day baseline|6
5057269|NCT02447458|17441567|P6|Overall Study|Other|0
5057270|NCT02447458|17441568|P5|Overall Study|Other|0
5057271|NCT02447458|17441569|P4|Overall Study|Other|0
5057272|NCT02447458|17441570|P3|Overall Study|Other|1
5057273|NCT02447458|17441571|P2|Overall Study|Other|0
5057274|NCT02447458|17441572|P1|Overall Study|Other|0
5057275|NCT02447432|17441670|P2|Epoch 001|Lost to Follow-up|3
5057276|NCT02447432|17441671|P1|Epoch 001|Lost to Follow-up|1
5057277|NCT02447432|17441670|P2|Epoch 001|Migrated/moved from study area|5
5057278|NCT02447432|17441671|P1|Epoch 001|Migrated/moved from study area|3
5057279|NCT02447432|17441670|P2|Epoch 001|Withdrawal by Subject|4
5057280|NCT02447432|17441671|P1|Epoch 001|Withdrawal by Subject|0
5057281|NCT02447432|17441670|P2|Epoch 001|Adverse Event|1
5057282|NCT02447432|17441671|P1|Epoch 001|Adverse Event|1
5057283|NCT02447328|17441703|P1|Overall Study|Withdrawal by Subject|1
5057284|NCT02447250|17441707|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
5057285|NCT02447250|17441707|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
5057286|NCT02447250|17441707|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
5057287|NCT02447081|17441724|P1|Overall Study|unsuccessful implant procedure|10
5057288|NCT02447081|17441724|P1|Overall Study|Visit not completed|17
5057289|NCT02447081|17441724|P1|Overall Study|Lost to Follow-up|36
5057290|NCT02447081|17441724|P1|Overall Study|Death|161
5057291|NCT02447029|17441740|P2|Overall Study|Withdrawal by Subject|2
5057292|NCT02447029|17441741|P1|Overall Study|Withdrawal by Subject|3
5057293|NCT02446990|17441761|P2|Overall Study|Withdrawal by Subject|199
5057294|NCT02446990|17441762|P1|Overall Study|Withdrawal by Subject|231
5057295|NCT02446990|17441761|P2|Overall Study|Physician Decision|0
5057296|NCT02446990|17441762|P1|Overall Study|Physician Decision|1
5057297|NCT02446990|17441761|P2|Overall Study|Lost to Follow-up|1
5057298|NCT02446990|17441762|P1|Overall Study|Lost to Follow-up|3
5057299|NCT02446990|17441761|P2|Overall Study|Death|458
5057300|NCT02446990|17441762|P1|Overall Study|Death|485
5057301|NCT02446912|17441797|P3|Overall Study|Miscellaneous|4
5057302|NCT02446912|17441798|P2|Overall Study|Miscellaneous|2
5057303|NCT02446912|17441799|P1|Overall Study|Miscellaneous|2
5057304|NCT02446912|17441797|P3|Overall Study|Withdrawal by Subject|15
5057305|NCT02446912|17441798|P2|Overall Study|Withdrawal by Subject|15
5057306|NCT02446912|17441799|P1|Overall Study|Withdrawal by Subject|10
5057307|NCT02446912|17441797|P3|Overall Study|Severe non-compliance to protocol|1
5057308|NCT02446912|17441798|P2|Overall Study|Severe non-compliance to protocol|0
5057309|NCT02446912|17441799|P1|Overall Study|Severe non-compliance to protocol|1
5057310|NCT02446912|17441797|P3|Overall Study|Lost to Follow-up|2
5057311|NCT02446912|17441798|P2|Overall Study|Lost to Follow-up|0
5057312|NCT02446912|17441799|P1|Overall Study|Lost to Follow-up|0
5057313|NCT02446912|17441797|P3|Overall Study|Lack of Efficacy|7
5057314|NCT02446912|17441798|P2|Overall Study|Lack of Efficacy|4
5057315|NCT02446912|17441799|P1|Overall Study|Lack of Efficacy|1
5057316|NCT02446912|17441797|P3|Overall Study|Study-specific withdrawal criteria|0
5057317|NCT02446912|17441798|P2|Overall Study|Study-specific withdrawal criteria|0
5057318|NCT02446912|17441799|P1|Overall Study|Study-specific withdrawal criteria|1
5057319|NCT02446912|17441797|P3|Overall Study|Condition under investigation worsened|1
5057320|NCT02446912|17441798|P2|Overall Study|Condition under investigation worsened|1
5057321|NCT02446912|17441799|P1|Overall Study|Condition under investigation worsened|0
5057322|NCT02446912|17441797|P3|Overall Study|Adverse Event|5
5057323|NCT02446912|17441798|P2|Overall Study|Adverse Event|13
5057324|NCT02446912|17441799|P1|Overall Study|Adverse Event|3
5057325|NCT02446899|17441872|P2|Overall Study|Failure to Meet Randomization Criteria|2
5057326|NCT02446899|17441873|P1|Overall Study|Failure to Meet Randomization Criteria|0
5057327|NCT02446899|17441872|P2|Overall Study|Miscellaneous|4
5057328|NCT02446899|17441873|P1|Overall Study|Miscellaneous|5
5057329|NCT02446899|17441872|P2|Overall Study|Withdrawal by Subject|19
5057330|NCT02446899|17441873|P1|Overall Study|Withdrawal by Subject|11
5057331|NCT02446899|17441872|P2|Overall Study|Severe Non-Compliance to Protocol|1
5057332|NCT02446899|17441873|P1|Overall Study|Severe Non-Compliance to Protocol|0
5057333|NCT02446899|17441872|P2|Overall Study|Lost to Follow-up|3
5057334|NCT02446899|17441873|P1|Overall Study|Lost to Follow-up|1
5057335|NCT02446899|17441872|P2|Overall Study|Lack of Efficacy|8
5057336|NCT02446899|17441873|P1|Overall Study|Lack of Efficacy|2
5057337|NCT02446899|17441872|P2|Overall Study|Study Specific Withdrawal Criteria|0
5057338|NCT02446899|17441873|P1|Overall Study|Study Specific Withdrawal Criteria|1
5057339|NCT02446899|17441872|P2|Overall Study|Condition Under Investigation Worsened|4
5057340|NCT02446899|17441873|P1|Overall Study|Condition Under Investigation Worsened|1
5057341|NCT02446899|17441872|P2|Overall Study|Adverse Event|7
5057342|NCT02446899|17441873|P1|Overall Study|Adverse Event|4
5057343|NCT02446769|17441910|P3|Study Period|Randomized in Error|0
5057344|NCT02446769|17441911|P2|Study Period|Randomized in Error|2
5057345|NCT02446769|17441912|P1|Study Period|Randomized in Error|0
5057346|NCT02446769|17441910|P3|Screening Period|Screen Failure|0
5057347|NCT02446769|17441911|P2|Screening Period|Screen Failure|0
5057348|NCT02446769|17441912|P1|Screening Period|Screen Failure|11
5057349|NCT02446743|17441935|P2|Overall Study|Other|3
5057350|NCT02446743|17441936|P1|Overall Study|Other|2
5057351|NCT02446743|17441935|P2|Overall Study|Adverse Event|1
5057352|NCT02446743|17441936|P1|Overall Study|Adverse Event|1
5057353|NCT02446743|17441935|P2|Overall Study|Lost to Follow-up|0
5057354|NCT02446743|17441936|P1|Overall Study|Lost to Follow-up|1
5057355|NCT02446743|17441935|P2|Overall Study|Withdrawal by Subject|1
5057356|NCT02446743|17441936|P1|Overall Study|Withdrawal by Subject|1
5057357|NCT02446717|17442091|P5|Overall Study|Withdrew consent|0
5057358|NCT02446717|17442092|P4|Overall Study|Withdrew consent|1
5057359|NCT02446717|17442093|P3|Overall Study|Withdrew consent|0
5057360|NCT02446717|17442094|P2|Overall Study|Withdrew consent|0
5057361|NCT02446717|17442095|P1|Overall Study|Withdrew consent|0
5057362|NCT02446717|17442091|P5|Overall Study|Lost to Follow-up|1
5057363|NCT02446717|17442092|P4|Overall Study|Lost to Follow-up|0
5057364|NCT02446717|17442093|P3|Overall Study|Lost to Follow-up|1
5057365|NCT02446717|17442094|P2|Overall Study|Lost to Follow-up|1
5057366|NCT02446717|17442095|P1|Overall Study|Lost to Follow-up|0
5057367|NCT02446717|17442091|P5|Overall Study|Adverse Event|0
5057368|NCT02446717|17442092|P4|Overall Study|Adverse Event|0
5057369|NCT02446717|17442093|P3|Overall Study|Adverse Event|1
5057370|NCT02446717|17442094|P2|Overall Study|Adverse Event|0
5057371|NCT02446717|17442095|P1|Overall Study|Adverse Event|0
5057372|NCT02446691|17442122|P1|Overall Study|Protocol Violation|1
5057373|NCT02446691|17442122|P1|Overall Study|Lost to Follow-up|8
5057374|NCT02446691|17442122|P1|Overall Study|Withdrawal by Subject|2
5057375|NCT02446418|17442192|P2|Overall Study|Protocol defined stopping criteria reach|0
5057376|NCT02446418|17442193|P1|Overall Study|Protocol defined stopping criteria reach|1
5057377|NCT02446418|17442192|P2|Overall Study|Lack of Efficacy|0
5057378|NCT02446418|17442193|P1|Overall Study|Lack of Efficacy|2
5057379|NCT02446418|17442192|P2|Overall Study|Protocol Violation|2
5057380|NCT02446418|17442193|P1|Overall Study|Protocol Violation|1
5057381|NCT02446418|17442192|P2|Overall Study|Lost to Follow-up|2
5057382|NCT02446418|17442193|P1|Overall Study|Lost to Follow-up|2
5057383|NCT02446418|17442192|P2|Overall Study|Withdrawal by Subject|3
5057384|NCT02446418|17442193|P1|Overall Study|Withdrawal by Subject|3
5057385|NCT02446418|17442192|P2|Overall Study|Physician Decision|1
5057386|NCT02446418|17442193|P1|Overall Study|Physician Decision|5
5057387|NCT02446418|17442192|P2|Overall Study|Adverse Event|8
5057388|NCT02446418|17442193|P1|Overall Study|Adverse Event|4
5057389|NCT02446171|17442264|P4|Overall Study|Withdrawal by Subject|0
5057390|NCT02446171|17442265|P3|Overall Study|Withdrawal by Subject|2
5057391|NCT02446171|17442266|P2|Overall Study|Withdrawal by Subject|0
5057392|NCT02446171|17442267|P1|Overall Study|Withdrawal by Subject|0
5057393|NCT02446015|17442338|P2|Overall Study|Withdrawal by Subject|0
5057394|NCT02446015|17442339|P1|Overall Study|Withdrawal by Subject|1
5057395|NCT02446015|17442338|P2|Overall Study|Adverse Event|1
5057396|NCT02446015|17442339|P1|Overall Study|Adverse Event|0
5057397|NCT02445963|17442354|P4|Overall Study|Symptoms post-vaccination|0
5057398|NCT02445963|17442355|P3|Overall Study|Symptoms post-vaccination|1
5057399|NCT02445963|17442356|P2|Overall Study|Symptoms post-vaccination|0
5057400|NCT02445963|17442357|P1|Overall Study|Symptoms post-vaccination|0
5057401|NCT02445963|17442354|P4|Overall Study|Change in employment|0
5057402|NCT02445963|17442355|P3|Overall Study|Change in employment|0
5057403|NCT02445963|17442356|P2|Overall Study|Change in employment|0
5057404|NCT02445963|17442357|P1|Overall Study|Change in employment|1
5057405|NCT02445963|17442354|P4|Overall Study|Lost to Follow-up|0
5057406|NCT02445963|17442355|P3|Overall Study|Lost to Follow-up|0
5057407|NCT02445963|17442356|P2|Overall Study|Lost to Follow-up|0
5057408|NCT02445963|17442357|P1|Overall Study|Lost to Follow-up|1
5057409|NCT02445794|17442482|P4|Overall Study|Adverse Event|0
5057410|NCT02445794|17442483|P3|Overall Study|Adverse Event|2
5057411|NCT02445794|17442484|P2|Overall Study|Adverse Event|0
5057412|NCT02445794|17442485|P1|Overall Study|Adverse Event|0
5057413|NCT02445755|17442515|P1|Overall Study|Screen Failure|5
5057414|NCT02445755|17442515|P1|Overall Study|Protocol Violation|6
5057415|NCT02445755|17442515|P1|Overall Study|Withdrawal by Subject|2
5057416|NCT02445586|17442529|P1|Overall Study|Medical Condition|1
5057417|NCT02445586|17442529|P1|Overall Study|Protocol Violation|1
5057418|NCT02445586|17442529|P1|Overall Study|Disease Progression|10
5057419|NCT02445586|17442529|P1|Overall Study|Withdrawal by Subject|13
5057420|NCT02445586|17442529|P1|Overall Study|Death|14
5057421|NCT02445573|17442569|P2|Overall Study|Lost to Follow-up|1
5057422|NCT02445573|17442570|P1|Overall Study|Lost to Follow-up|0
5057423|NCT02445573|17442569|P2|Overall Study|Withdrawal by Subject|1
5057424|NCT02445573|17442570|P1|Overall Study|Withdrawal by Subject|1
5057425|NCT02444793|17442667|P4|Overall Study|Objective progression or relapse|3
5057426|NCT02444793|17442668|P3|Overall Study|Objective progression or relapse|2
5057427|NCT02444793|17442669|P2|Overall Study|Objective progression or relapse|1
5057428|NCT02444793|17442670|P1|Overall Study|Objective progression or relapse|9
5057429|NCT02444793|17442667|P4|Overall Study|Other|0
5057430|NCT02444793|17442668|P3|Overall Study|Other|2
5057431|NCT02444793|17442669|P2|Overall Study|Other|0
5057432|NCT02444793|17442670|P1|Overall Study|Other|0
5057433|NCT02444793|17442667|P4|Overall Study|Death|0
5057434|NCT02444793|17442668|P3|Overall Study|Death|0
5057435|NCT02444793|17442669|P2|Overall Study|Death|3
5057436|NCT02444793|17442670|P1|Overall Study|Death|0
5057437|NCT02444793|17442667|P4|Overall Study|Lost to Follow-up|0
5057438|NCT02444793|17442668|P3|Overall Study|Lost to Follow-up|0
5057439|NCT02444793|17442669|P2|Overall Study|Lost to Follow-up|2
5057440|NCT02444793|17442670|P1|Overall Study|Lost to Follow-up|2
5057441|NCT02444533|17442829|P2|Overall Study|Only gave post-procedure complications|2
5057442|NCT02444533|17442830|P1|Overall Study|Only gave post-procedure complications|2
5057443|NCT02444533|17442829|P2|Overall Study|Not able to complete forms|2
5057444|NCT02444533|17442830|P1|Overall Study|Not able to complete forms|0
5057445|NCT02444182|17442863|P2|Overall Study|Lost to Follow-up|4
5057446|NCT02444182|17442864|P1|Overall Study|Lost to Follow-up|0
5057447|NCT02444182|17442863|P2|Overall Study|non-compliance|1
5057448|NCT02444182|17442864|P1|Overall Study|non-compliance|2
5057449|NCT02443883|17442887|P4|Overall Study|Randomized, but never treated|0
5057450|NCT02443883|17442888|P3|Overall Study|Randomized, but never treated|0
5057451|NCT02443883|17442889|P2|Overall Study|Randomized, but never treated|0
5057452|NCT02443883|17442890|P1|Overall Study|Randomized, but never treated|1
5057453|NCT02443883|17442887|P4|Overall Study|Withdrawal by Subject|2
5057454|NCT02443883|17442888|P3|Overall Study|Withdrawal by Subject|0
5057455|NCT02443883|17442889|P2|Overall Study|Withdrawal by Subject|0
5057456|NCT02443883|17442890|P1|Overall Study|Withdrawal by Subject|1
5057457|NCT02443883|17442887|P4|Overall Study|Physician Decision|3
5057458|NCT02443883|17442888|P3|Overall Study|Physician Decision|0
5057459|NCT02443883|17442889|P2|Overall Study|Physician Decision|1
5057460|NCT02443883|17442890|P1|Overall Study|Physician Decision|1
5057461|NCT02443883|17442887|P4|Overall Study|Lost to Follow-up|0
5057462|NCT02443883|17442888|P3|Overall Study|Lost to Follow-up|1
5057463|NCT02443883|17442889|P2|Overall Study|Lost to Follow-up|2
5057464|NCT02443883|17442890|P1|Overall Study|Lost to Follow-up|3
5057465|NCT02443883|17442887|P4|Overall Study|Adverse Event|0
5057466|NCT02443883|17442888|P3|Overall Study|Adverse Event|0
5057467|NCT02443883|17442889|P2|Overall Study|Adverse Event|1
5057468|NCT02443883|17442890|P1|Overall Study|Adverse Event|0
5057469|NCT02443805|17442910|P2|Overall Study|Any other reason not above-mentioned|2
5057470|NCT02443805|17442911|P1|Overall Study|Any other reason not above-mentioned|3
5057471|NCT02443805|17442910|P2|Overall Study|Withdrawal by parent/guardian|5
5057472|NCT02443805|17442911|P1|Overall Study|Withdrawal by parent/guardian|3
5057473|NCT02443805|17442910|P2|Overall Study|Non-compliance with study drug|4
5057474|NCT02443805|17442911|P1|Overall Study|Non-compliance with study drug|6
5057475|NCT02443805|17442910|P2|Overall Study|Lack of Efficacy|1
5057476|NCT02443805|17442911|P1|Overall Study|Lack of Efficacy|1
5057477|NCT02443805|17442910|P2|Overall Study|Protocol Violation|4
5057478|NCT02443805|17442911|P1|Overall Study|Protocol Violation|2
5057479|NCT02443805|17442910|P2|Overall Study|Pregnancy|5
5057480|NCT02443805|17442911|P1|Overall Study|Pregnancy|6
5057481|NCT02443805|17442910|P2|Overall Study|Lost to Follow-up|14
5057482|NCT02443805|17442911|P1|Overall Study|Lost to Follow-up|19
5057483|NCT02443805|17442910|P2|Overall Study|Withdrawal by Subject|74
5057484|NCT02443805|17442911|P1|Overall Study|Withdrawal by Subject|73
5057485|NCT02443805|17442910|P2|Overall Study|Adverse Event|18
5057486|NCT02443805|17442911|P1|Overall Study|Adverse Event|100
5057487|NCT02443740|17442942|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057488|NCT02443740|17442943|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057489|NCT02443740|17442944|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057490|NCT02443740|17442945|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057491|NCT02443740|17442946|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057492|NCT02443740|17442947|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
5057493|NCT02443740|17442948|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057494|NCT02443740|17442949|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057495|NCT02443740|17442950|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057496|NCT02443740|17442951|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057497|NCT02443740|17442952|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5057498|NCT02443740|17442942|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
5057499|NCT02443740|17442943|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
5057500|NCT02443740|17442944|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
5057501|NCT02443740|17442945|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
5057502|NCT02443740|17442946|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
5057503|NCT02443740|17442947|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
5057504|NCT02443740|17442948|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
5057505|NCT02443740|17442949|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
5057506|NCT02443740|17442950|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
5057677|NCT02439320|17443933|P3|Overall Study|Randomization Failure|34
5057507|NCT02443740|17442951|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
5057508|NCT02443740|17442952|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
5057509|NCT02443740|17442942|P11|Intervention Period 1 (3 Days)|Adverse Event|0
5057510|NCT02443740|17442943|P10|Intervention Period 1 (3 Days)|Adverse Event|0
5057511|NCT02443740|17442944|P9|Intervention Period 1 (3 Days)|Adverse Event|0
5057512|NCT02443740|17442945|P8|Intervention Period 1 (3 Days)|Adverse Event|0
5057513|NCT02443740|17442946|P7|Intervention Period 1 (3 Days)|Adverse Event|0
5057514|NCT02443740|17442947|P6|Intervention Period 1 (3 Days)|Adverse Event|1
5057515|NCT02443740|17442948|P5|Intervention Period 1 (3 Days)|Adverse Event|0
5057516|NCT02443740|17442949|P4|Intervention Period 1 (3 Days)|Adverse Event|0
5057517|NCT02443740|17442950|P3|Intervention Period 1 (3 Days)|Adverse Event|0
5057518|NCT02443740|17442951|P2|Intervention Period 1 (3 Days)|Adverse Event|0
5057519|NCT02443740|17442952|P1|Intervention Period 1 (3 Days)|Adverse Event|0
5057520|NCT02443688|17443134|P3|Overall Study|Sponsor Request|0
5057521|NCT02443688|17443135|P2|Overall Study|Sponsor Request|1
5057522|NCT02443688|17443136|P1|Overall Study|Sponsor Request|2
5057523|NCT02443688|17443134|P3|Overall Study|Non-compliance with study drug|4
5057524|NCT02443688|17443135|P2|Overall Study|Non-compliance with study drug|2
5057525|NCT02443688|17443136|P1|Overall Study|Non-compliance with study drug|1
5057526|NCT02443688|17443134|P3|Overall Study|Withdrawal by Subject|4
5057527|NCT02443688|17443135|P2|Overall Study|Withdrawal by Subject|3
5057528|NCT02443688|17443136|P1|Overall Study|Withdrawal by Subject|3
5057529|NCT02443688|17443134|P3|Overall Study|Pregnancy|1
5057530|NCT02443688|17443135|P2|Overall Study|Pregnancy|0
5057531|NCT02443688|17443136|P1|Overall Study|Pregnancy|0
5057532|NCT02443688|17443134|P3|Overall Study|Physician Decision|1
5057533|NCT02443688|17443135|P2|Overall Study|Physician Decision|0
5057534|NCT02443688|17443136|P1|Overall Study|Physician Decision|3
5057535|NCT02443688|17443134|P3|Overall Study|Lost to Follow-up|0
5057536|NCT02443688|17443135|P2|Overall Study|Lost to Follow-up|0
5057537|NCT02443688|17443136|P1|Overall Study|Lost to Follow-up|1
5057538|NCT02443688|17443134|P3|Overall Study|Adverse Event|2
5057539|NCT02443688|17443135|P2|Overall Study|Adverse Event|3
5057540|NCT02443688|17443136|P1|Overall Study|Adverse Event|2
5057541|NCT02443402|17443246|P2|Overall Study|Screen Failure|2
5057542|NCT02443402|17443247|P1|Overall Study|Screen Failure|1
5057543|NCT02443402|17443246|P2|Overall Study|Withdrawal by Subject|1
5057544|NCT02443402|17443247|P1|Overall Study|Withdrawal by Subject|3
5057545|NCT02443298|17443309|P2|Overall Study|Withdrawal by Subject|2
5057546|NCT02443298|17443310|P1|Overall Study|Withdrawal by Subject|1
5057547|NCT02443298|17443309|P2|Overall Study|Adverse Event|3
5057548|NCT02443298|17443310|P1|Overall Study|Adverse Event|3
5057549|NCT02443103|17443330|P1|Overall Study|Noncompliance|1
5057550|NCT02443103|17443330|P1|Overall Study|Adverse Event|2
5057551|NCT02442830|17443343|P2|Overall Study|Technical Failure|1
5057552|NCT02442830|17443344|P1|Overall Study|Technical Failure|0
5057553|NCT02442804|17443354|P2|Overall Study|Adverse Event|0
5057554|NCT02442804|17443355|P1|Overall Study|Adverse Event|1
5057555|NCT02442804|17443354|P2|Overall Study|Withdrawal by Subject|1
5057556|NCT02442804|17443355|P1|Overall Study|Withdrawal by Subject|0
5057557|NCT02442622|17443462|P2|Overall Study|Withdrawal by Subject|1
5057558|NCT02442622|17443463|P1|Overall Study|Withdrawal by Subject|3
5057559|NCT02442349|17443473|P1|Overall Study|On-going Study at Data Cut-off|149
5057560|NCT02442349|17443473|P1|Overall Study|Withdrawal by Subject|8
5057561|NCT02442349|17443473|P1|Overall Study|Death|14
5057562|NCT02442310|17443478|P1|Overall Study|Withdrawal by Subject|1
5057563|NCT02442310|17443478|P1|Overall Study|Adverse Event|2
5057564|NCT02442284|17443500|P1|Overall Study|Other|1
5057565|NCT02442284|17443500|P1|Overall Study|Lost to Follow-up|3
5057566|NCT02442284|17443500|P1|Overall Study|Withdrew Consent|2
5057567|NCT02442284|17443500|P1|Overall Study|Adverse Event|1
5057568|NCT02442271|17443507|P1|Overall Study|Other|1
5057569|NCT02442271|17443507|P1|Overall Study|Lost to Follow-up|1
5057570|NCT02442271|17443507|P1|Overall Study|Withdrew Consent|1
5057571|NCT02442271|17443507|P1|Overall Study|Adverse Event|1
5057572|NCT02442206|17443533|P2|Period 2|Adverse Event|0
5057573|NCT02442206|17443534|P1|Period 2|Adverse Event|1
5057574|NCT02442206|17443533|P2|Period 1|COPD exacerbation|1
5057575|NCT02442206|17443534|P1|Period 1|COPD exacerbation|0
5057576|NCT02442206|17443533|P2|Period 1|withdrew consent|1
5057577|NCT02442206|17443534|P1|Period 1|withdrew consent|0
5057578|NCT02442206|17443533|P2|Period 1|Adverse Event|1
5057579|NCT02442206|17443534|P1|Period 1|Adverse Event|1
5057580|NCT02441946|17443566|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
5057581|NCT02441946|17443567|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
5057582|NCT02441946|17443568|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
5057583|NCT02441946|17443566|P3|Extension Period (8 Weeks)|Adverse Event|0
5057584|NCT02441946|17443567|P2|Extension Period (8 Weeks)|Adverse Event|0
5057585|NCT02441946|17443568|P1|Extension Period (8 Weeks)|Adverse Event|1
5057586|NCT02441946|17443566|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5057587|NCT02441946|17443567|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5057588|NCT02441946|17443568|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
5057589|NCT02441946|17443566|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5057590|NCT02441946|17443567|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5057591|NCT02441946|17443568|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
5057592|NCT02441946|17443566|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5057593|NCT02441946|17443567|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5057594|NCT02441946|17443568|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
5057595|NCT02441946|17443566|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5057596|NCT02441946|17443567|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5057597|NCT02441946|17443568|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
5057598|NCT02441946|17443566|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5057599|NCT02441946|17443567|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5057600|NCT02441946|17443568|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
5057601|NCT02441946|17443566|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5057602|NCT02441946|17443567|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
5057603|NCT02441946|17443568|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5057604|NCT02441946|17443566|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5057605|NCT02441946|17443567|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
5057606|NCT02441946|17443568|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5057607|NCT02441946|17443566|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5057608|NCT02441946|17443567|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5057609|NCT02441946|17443568|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
5057610|NCT02441946|17443566|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
5057611|NCT02441946|17443567|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5057612|NCT02441946|17443568|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5057613|NCT02441517|17443589|P1|Overall Study|Study Terminated by Sponsor|1
5057614|NCT02441517|17443589|P1|Overall Study|Withdrawal by Subject|2
5057615|NCT02441517|17443589|P1|Overall Study|Lost to Follow-up|1
5057616|NCT02441309|17443602|P3|Overall Study|Withdrawal by Subject|1
5057617|NCT02441309|17443603|P2|Overall Study|Withdrawal by Subject|0
5057618|NCT02441309|17443604|P1|Overall Study|Withdrawal by Subject|1
5057619|NCT02441309|17443602|P3|Overall Study|Adverse Event|0
5057620|NCT02441309|17443603|P2|Overall Study|Adverse Event|1
5057621|NCT02441309|17443604|P1|Overall Study|Adverse Event|0
5057622|NCT02441309|17443602|P3|Overall Study|Disease progression|2
5057623|NCT02441309|17443603|P2|Overall Study|Disease progression|1
5057624|NCT02441309|17443604|P1|Overall Study|Disease progression|2
5057625|NCT02441283|17443633|P1|Overall Study|Other, not specified|32
5057626|NCT02441283|17443633|P1|Overall Study|Death|1
5057627|NCT02441283|17443633|P1|Overall Study|Lost to Follow-up|42
5057628|NCT02441283|17443633|P1|Overall Study|Withdrew consent|15
5057629|NCT02441218|17443646|P2|Overall Study|Lost to Follow-up|1
5057630|NCT02441218|17443647|P1|Overall Study|Lost to Follow-up|2
5057631|NCT02441218|17443646|P2|Overall Study|Withdrawal by Subject|58
5057632|NCT02441218|17443647|P1|Overall Study|Withdrawal by Subject|73
5057633|NCT02441218|17443646|P2|Overall Study|Death|553
5057634|NCT02441218|17443647|P1|Overall Study|Death|503
5057635|NCT02441179|17443673|P2|Overall Study|Withdrawal by Subject|1
5057636|NCT02441179|17443674|P1|Overall Study|Withdrawal by Subject|1
5057637|NCT02441114|17443692|P1|Washout2|Withdrawal by Subject|4
5057638|NCT02441036|17443703|P5|Overall Study|No tissue resected|0
5057639|NCT02441036|17443704|P4|Overall Study|No tissue resected|1
5057640|NCT02441036|17443705|P3|Overall Study|No tissue resected|0
5057641|NCT02441036|17443706|P2|Overall Study|No tissue resected|1
5057642|NCT02441036|17443707|P1|Overall Study|No tissue resected|0
5057643|NCT02440789|17443734|P1|Overall Study|Not willing to adhere to reqs|1
5057644|NCT02440789|17443734|P1|Overall Study|Withdrawal by Subject|3
5057645|NCT02440594|17443809|P8|Overall Study|Administratively w/drawn|1
5057646|NCT02440594|17443810|P7|Overall Study|Administratively w/drawn|2
5057647|NCT02440594|17443811|P6|Overall Study|Administratively w/drawn|0
5057648|NCT02440594|17443812|P5|Overall Study|Administratively w/drawn|0
5057649|NCT02440594|17443813|P4|Overall Study|Administratively w/drawn|0
5057650|NCT02440594|17443814|P3|Overall Study|Administratively w/drawn|0
5057651|NCT02440594|17443815|P2|Overall Study|Administratively w/drawn|2
5057652|NCT02440594|17443816|P1|Overall Study|Administratively w/drawn|3
5057653|NCT02440594|17443809|P8|Overall Study|Withdrawal by Subject|7
5057654|NCT02440594|17443810|P7|Overall Study|Withdrawal by Subject|7
5057655|NCT02440594|17443811|P6|Overall Study|Withdrawal by Subject|2
5057656|NCT02440594|17443812|P5|Overall Study|Withdrawal by Subject|2
5057657|NCT02440594|17443813|P4|Overall Study|Withdrawal by Subject|38
5057658|NCT02440594|17443814|P3|Overall Study|Withdrawal by Subject|59
5057659|NCT02440594|17443815|P2|Overall Study|Withdrawal by Subject|67
5057660|NCT02440594|17443816|P1|Overall Study|Withdrawal by Subject|81
5057661|NCT02440594|17443809|P8|Overall Study|Cognitive Impairment/Communication Issue|0
5057662|NCT02440594|17443810|P7|Overall Study|Cognitive Impairment/Communication Issue|0
5057663|NCT02440594|17443811|P6|Overall Study|Cognitive Impairment/Communication Issue|1
5057664|NCT02440594|17443812|P5|Overall Study|Cognitive Impairment/Communication Issue|2
5057665|NCT02440594|17443813|P4|Overall Study|Cognitive Impairment/Communication Issue|4
5057666|NCT02440594|17443814|P3|Overall Study|Cognitive Impairment/Communication Issue|4
5057667|NCT02440594|17443815|P2|Overall Study|Cognitive Impairment/Communication Issue|6
5057668|NCT02440594|17443816|P1|Overall Study|Cognitive Impairment/Communication Issue|14
5057669|NCT02440594|17443809|P8|Overall Study|Lost to Follow-up|48
5057670|NCT02440594|17443810|P7|Overall Study|Lost to Follow-up|28
5057671|NCT02440594|17443811|P6|Overall Study|Lost to Follow-up|4
5057672|NCT02440594|17443812|P5|Overall Study|Lost to Follow-up|5
5057673|NCT02440594|17443813|P4|Overall Study|Lost to Follow-up|47
5057674|NCT02440594|17443814|P3|Overall Study|Lost to Follow-up|54
5057675|NCT02440594|17443815|P2|Overall Study|Lost to Follow-up|33
5057676|NCT02440594|17443816|P1|Overall Study|Lost to Follow-up|34
5057678|NCT02439320|17443934|P2|Overall Study|Randomization Failure|46
5057679|NCT02439320|17443935|P1|Overall Study|Randomization Failure|35
5057680|NCT02439320|17443933|P3|Overall Study|Sponsor Request|1
5057681|NCT02439320|17443934|P2|Overall Study|Sponsor Request|2
5057682|NCT02439320|17443935|P1|Overall Study|Sponsor Request|0
5057683|NCT02439320|17443933|P3|Overall Study|Physician Decision|0
5057684|NCT02439320|17443934|P2|Overall Study|Physician Decision|1
5057685|NCT02439320|17443935|P1|Overall Study|Physician Decision|2
5057686|NCT02439320|17443933|P3|Overall Study|Withdrawal by Subject|14
5057687|NCT02439320|17443934|P2|Overall Study|Withdrawal by Subject|16
5057688|NCT02439320|17443935|P1|Overall Study|Withdrawal by Subject|12
5057689|NCT02439320|17443933|P3|Overall Study|Pregnancy|1
5057690|NCT02439320|17443934|P2|Overall Study|Pregnancy|1
5057691|NCT02439320|17443935|P1|Overall Study|Pregnancy|0
5057692|NCT02439320|17443933|P3|Overall Study|Noncompliance with Protocol|7
5057693|NCT02439320|17443934|P2|Overall Study|Noncompliance with Protocol|11
5057694|NCT02439320|17443935|P1|Overall Study|Noncompliance with Protocol|10
5057695|NCT02439320|17443933|P3|Overall Study|Death|0
5057696|NCT02439320|17443934|P2|Overall Study|Death|1
5057697|NCT02439320|17443935|P1|Overall Study|Death|0
5057698|NCT02439320|17443933|P3|Overall Study|Lost to Follow-up|42
5057699|NCT02439320|17443934|P2|Overall Study|Lost to Follow-up|34
5057700|NCT02439320|17443935|P1|Overall Study|Lost to Follow-up|37
5057701|NCT02439320|17443933|P3|Overall Study|Adverse Event|0
5057702|NCT02439320|17443934|P2|Overall Study|Adverse Event|2
5057703|NCT02439320|17443935|P1|Overall Study|Adverse Event|0
5057704|NCT02439138|17444015|P1|Overall Study|PI decision to terminate the study|2
5057705|NCT02439138|17444015|P1|Overall Study|Adverse Event|1
5057706|NCT02438826|17444028|P4|Post-Treatment Phase|Withdrawal by Subject|0
5057707|NCT02438826|17444029|P3|Post-Treatment Phase|Withdrawal by Subject|0
5057708|NCT02438826|17444030|P2|Post-Treatment Phase|Withdrawal by Subject|1
5057709|NCT02438826|17444031|P1|Post-Treatment Phase|Withdrawal by Subject|1
5057710|NCT02438826|17444028|P4|Post-Treatment Phase|Physician Decision|0
5057711|NCT02438826|17444029|P3|Post-Treatment Phase|Physician Decision|0
5057712|NCT02438826|17444030|P2|Post-Treatment Phase|Physician Decision|0
5057713|NCT02438826|17444031|P1|Post-Treatment Phase|Physician Decision|1
5057714|NCT02438826|17444028|P4|Post-Treatment Phase|Lack of Efficacy|0
5057715|NCT02438826|17444029|P3|Post-Treatment Phase|Lack of Efficacy|0
5057716|NCT02438826|17444030|P2|Post-Treatment Phase|Lack of Efficacy|0
5057717|NCT02438826|17444031|P1|Post-Treatment Phase|Lack of Efficacy|4
5057718|NCT02438826|17444028|P4|Post-Treatment Phase|Adverse Event|0
5057719|NCT02438826|17444029|P3|Post-Treatment Phase|Adverse Event|0
5057720|NCT02438826|17444030|P2|Post-Treatment Phase|Adverse Event|0
5057721|NCT02438826|17444031|P1|Post-Treatment Phase|Adverse Event|3
5057722|NCT02438826|17444028|P4|Open-Label Treatment Phase|Withdrawal by Subject|0
5057723|NCT02438826|17444029|P3|Open-Label Treatment Phase|Withdrawal by Subject|0
5057724|NCT02438826|17444030|P2|Open-Label Treatment Phase|Withdrawal by Subject|7
5057725|NCT02438826|17444031|P1|Open-Label Treatment Phase|Withdrawal by Subject|6
5057726|NCT02438826|17444028|P4|Open-Label Treatment Phase|Lost to Follow-up|0
5057727|NCT02438826|17444029|P3|Open-Label Treatment Phase|Lost to Follow-up|0
5057728|NCT02438826|17444030|P2|Open-Label Treatment Phase|Lost to Follow-up|2
5057729|NCT02438826|17444031|P1|Open-Label Treatment Phase|Lost to Follow-up|0
5057730|NCT02438826|17444028|P4|Open-Label Treatment Phase|Lack of Efficacy|0
5057731|NCT02438826|17444029|P3|Open-Label Treatment Phase|Lack of Efficacy|0
5057732|NCT02438826|17444030|P2|Open-Label Treatment Phase|Lack of Efficacy|18
5057733|NCT02438826|17444031|P1|Open-Label Treatment Phase|Lack of Efficacy|27
5057734|NCT02438826|17444028|P4|Open-Label Treatment Phase|Adverse Event|0
5057735|NCT02438826|17444029|P3|Open-Label Treatment Phase|Adverse Event|0
5057736|NCT02438826|17444030|P2|Open-Label Treatment Phase|Adverse Event|6
5057737|NCT02438826|17444031|P1|Open-Label Treatment Phase|Adverse Event|11
5057738|NCT02438826|17444028|P4|Double-Blind Treatment Phase|Screen Failure|0
5057739|NCT02438826|17444029|P3|Double-Blind Treatment Phase|Screen Failure|0
5057740|NCT02438826|17444030|P2|Double-Blind Treatment Phase|Screen Failure|0
5057741|NCT02438826|17444031|P1|Double-Blind Treatment Phase|Screen Failure|2
5057742|NCT02438826|17444028|P4|Double-Blind Treatment Phase|Protocol Violation|0
5057743|NCT02438826|17444029|P3|Double-Blind Treatment Phase|Protocol Violation|0
5057744|NCT02438826|17444030|P2|Double-Blind Treatment Phase|Protocol Violation|2
5057745|NCT02438826|17444031|P1|Double-Blind Treatment Phase|Protocol Violation|1
5057746|NCT02438826|17444028|P4|Double-Blind Treatment Phase|Withdrawal by Subject|0
5057747|NCT02438826|17444029|P3|Double-Blind Treatment Phase|Withdrawal by Subject|0
5057748|NCT02438826|17444030|P2|Double-Blind Treatment Phase|Withdrawal by Subject|1
5057749|NCT02438826|17444031|P1|Double-Blind Treatment Phase|Withdrawal by Subject|1
5057750|NCT02438826|17444028|P4|Double-Blind Treatment Phase|Lack of Efficacy|0
5057751|NCT02438826|17444029|P3|Double-Blind Treatment Phase|Lack of Efficacy|0
5057752|NCT02438826|17444030|P2|Double-Blind Treatment Phase|Lack of Efficacy|0
5057753|NCT02438826|17444031|P1|Double-Blind Treatment Phase|Lack of Efficacy|1
5057754|NCT02438826|17444028|P4|Double-Blind Treatment Phase|Adverse Event|0
5057755|NCT02438826|17444029|P3|Double-Blind Treatment Phase|Adverse Event|0
5057756|NCT02438826|17444030|P2|Double-Blind Treatment Phase|Adverse Event|1
5057757|NCT02438826|17444031|P1|Double-Blind Treatment Phase|Adverse Event|1
5057758|NCT02438813|17444065|P1|Overall Study|Patients Not Treated/No EOT Visit|249
5057759|NCT02438813|17444065|P1|Overall Study|Study Ended by Sponsor|80
5057760|NCT02438813|17444065|P1|Overall Study|Patient Lost to Follow-Up|137
5057761|NCT02438813|17444065|P1|Overall Study|Patient Decision|59
5057762|NCT02438787|17444117|P3|Overall Study|Site terminated by sponsor|1
5057763|NCT02438787|17444118|P2|Overall Study|Site terminated by sponsor|0
5057764|NCT02438787|17444119|P1|Overall Study|Site terminated by sponsor|0
5057765|NCT02438787|17444117|P3|Overall Study|Other|0
5057766|NCT02438787|17444118|P2|Overall Study|Other|1
5057767|NCT02438787|17444119|P1|Overall Study|Other|0
5057768|NCT02438787|17444117|P3|Overall Study|Study discontinued by sponsor|69
5057769|NCT02438787|17444118|P2|Overall Study|Study discontinued by sponsor|72
5057770|NCT02438787|17444119|P1|Overall Study|Study discontinued by sponsor|64
5057771|NCT02438787|17444117|P3|Overall Study|Withdrawal by Subject|10
5057772|NCT02438787|17444118|P2|Overall Study|Withdrawal by Subject|7
5057773|NCT02438787|17444119|P1|Overall Study|Withdrawal by Subject|15
5057774|NCT02438787|17444117|P3|Overall Study|Protocol Violation|1
5057775|NCT02438787|17444118|P2|Overall Study|Protocol Violation|0
5057776|NCT02438787|17444119|P1|Overall Study|Protocol Violation|0
5057777|NCT02438787|17444117|P3|Overall Study|Lost to Follow-up|0
5057778|NCT02438787|17444118|P2|Overall Study|Lost to Follow-up|1
5057779|NCT02438787|17444119|P1|Overall Study|Lost to Follow-up|0
5057780|NCT02438787|17444117|P3|Overall Study|Lack of Efficacy|0
5057781|NCT02438787|17444118|P2|Overall Study|Lack of Efficacy|2
5057782|NCT02438787|17444119|P1|Overall Study|Lack of Efficacy|1
5057783|NCT02438787|17444117|P3|Overall Study|Adverse Event|2
5057784|NCT02438787|17444118|P2|Overall Study|Adverse Event|0
5057785|NCT02438787|17444119|P1|Overall Study|Adverse Event|1
5057786|NCT02438384|17444252|P3|Overall Study|Lost to Follow-up|4
5057787|NCT02438384|17444253|P2|Overall Study|Lost to Follow-up|6
5057788|NCT02438384|17444254|P1|Overall Study|Lost to Follow-up|8
5057789|NCT02438280|17444273|P2|Overall Study|Physician Decision|0
5057790|NCT02438280|17444274|P1|Overall Study|Physician Decision|1
5057791|NCT02438137|17444284|P2|Overall Study|Physician Decision|1
5057792|NCT02438137|17444285|P1|Overall Study|Physician Decision|0
5057793|NCT02438137|17444284|P2|Overall Study|Withdrawal by Subject|3
5057794|NCT02438137|17444285|P1|Overall Study|Withdrawal by Subject|4
5057795|NCT02438137|17444284|P2|Overall Study|Adverse Event|0
5057796|NCT02438137|17444285|P1|Overall Study|Adverse Event|1
5057797|NCT02438137|17444284|P2|Overall Study|Lost to Follow-up|2
5057798|NCT02438137|17444285|P1|Overall Study|Lost to Follow-up|3
5057799|NCT02437903|17444293|P1|Overall Study|Lost to Follow-up|3
5057800|NCT02437903|17444293|P1|Overall Study|Withdrawal by Subject|1
5057801|NCT02437903|17444293|P1|Overall Study|Adverse Event|1
5057802|NCT02437890|17444306|P5|Overall Study|Death|0
5057803|NCT02437890|17444307|P4|Overall Study|Death|2
5057804|NCT02437890|17444308|P3|Overall Study|Death|0
5057805|NCT02437890|17444309|P2|Overall Study|Death|0
5057806|NCT02437890|17444310|P1|Overall Study|Death|0
5057807|NCT02437890|17444306|P5|Overall Study|Withdrawal by Subject|5
5057808|NCT02437890|17444307|P4|Overall Study|Withdrawal by Subject|5
5057809|NCT02437890|17444308|P3|Overall Study|Withdrawal by Subject|6
5057810|NCT02437890|17444309|P2|Overall Study|Withdrawal by Subject|2
5057811|NCT02437890|17444310|P1|Overall Study|Withdrawal by Subject|1
5057812|NCT02437890|17444306|P5|Overall Study|Adverse Event|7
5057813|NCT02437890|17444307|P4|Overall Study|Adverse Event|11
5057814|NCT02437890|17444308|P3|Overall Study|Adverse Event|5
5057815|NCT02437890|17444309|P2|Overall Study|Adverse Event|9
5057816|NCT02437890|17444310|P1|Overall Study|Adverse Event|4
5057817|NCT02437890|17444306|P5|Overall Study|Lack of Efficacy|1
5057818|NCT02437890|17444307|P4|Overall Study|Lack of Efficacy|3
5057819|NCT02437890|17444308|P3|Overall Study|Lack of Efficacy|0
5057820|NCT02437890|17444309|P2|Overall Study|Lack of Efficacy|3
5057821|NCT02437890|17444310|P1|Overall Study|Lack of Efficacy|1
5057822|NCT02437890|17444306|P5|Overall Study|Unable to attend visit(s)|0
5057823|NCT02437890|17444307|P4|Overall Study|Unable to attend visit(s)|0
5057824|NCT02437890|17444308|P3|Overall Study|Unable to attend visit(s)|0
5057825|NCT02437890|17444309|P2|Overall Study|Unable to attend visit(s)|0
5057826|NCT02437890|17444310|P1|Overall Study|Unable to attend visit(s)|1
5057827|NCT02437890|17444306|P5|Overall Study|Physician Decision|0
5057828|NCT02437890|17444307|P4|Overall Study|Physician Decision|1
5057829|NCT02437890|17444308|P3|Overall Study|Physician Decision|0
5057830|NCT02437890|17444309|P2|Overall Study|Physician Decision|0
5057831|NCT02437890|17444310|P1|Overall Study|Physician Decision|0
5057832|NCT02437890|17444306|P5|Overall Study|Sponsor's decision|2
5057833|NCT02437890|17444307|P4|Overall Study|Sponsor's decision|0
5057834|NCT02437890|17444308|P3|Overall Study|Sponsor's decision|4
5057835|NCT02437890|17444309|P2|Overall Study|Sponsor's decision|1
5057836|NCT02437890|17444310|P1|Overall Study|Sponsor's decision|1
5057837|NCT02437890|17444306|P5|Overall Study|Non-compliance to study drug|1
5057838|NCT02437890|17444307|P4|Overall Study|Non-compliance to study drug|0
5057839|NCT02437890|17444308|P3|Overall Study|Non-compliance to study drug|0
5057840|NCT02437890|17444309|P2|Overall Study|Non-compliance to study drug|1
5057841|NCT02437890|17444310|P1|Overall Study|Non-compliance to study drug|0
5057842|NCT02437864|17444523|P2|Overall Study|Protocol Violation|0
5057843|NCT02437864|17444524|P1|Overall Study|Protocol Violation|4
5057844|NCT02437513|17444545|P1|Overall Study|Withdrawal by Subject|2
5057845|NCT02437409|17444570|P1|Overall Study|Screening failure|12
5057846|NCT02437409|17444570|P1|Overall Study|Withdrawal by Subject|3
5057847|NCT02437318|17444663|P2|Overall Study|Untreated|1
5057848|NCT02437318|17444664|P1|Overall Study|Untreated|0
5057849|NCT02437318|17444663|P2|Overall Study|Protocol Violation|6
5057850|NCT02437318|17444664|P1|Overall Study|Protocol Violation|5
5057851|NCT02437318|17444663|P2|Overall Study|Death|4
5057852|NCT02437318|17444664|P1|Overall Study|Death|4
5057853|NCT02437318|17444663|P2|Overall Study|Adverse Event|3
5057854|NCT02437318|17444664|P1|Overall Study|Adverse Event|14
5057855|NCT02437318|17444663|P2|Overall Study|Physician Decision|10
5057856|NCT02437318|17444664|P1|Overall Study|Physician Decision|11
5057857|NCT02437318|17444663|P2|Overall Study|Subject/guardian decision|10
5057858|NCT02437318|17444664|P1|Overall Study|Subject/guardian decision|22
5057859|NCT02437318|17444663|P2|Overall Study|Progressive disease|208
5057860|NCT02437318|17444664|P1|Overall Study|Progressive disease|173
5057861|NCT02437305|17444672|P2|Overall Study|Lost to Follow-up|12
5057862|NCT02437305|17444673|P1|Overall Study|Lost to Follow-up|18
5057863|NCT02437188|17444700|P2|Overall Study|Adverse Event|1
5057864|NCT02437188|17444701|P1|Overall Study|Adverse Event|0
5057865|NCT02437188|17444700|P2|Overall Study|Randomized but did not receive surgery|8
5057866|NCT02437188|17444701|P1|Overall Study|Randomized but did not receive surgery|4
5057867|NCT02437162|17444718|P3|Overall Study|Other|1
5057868|NCT02437162|17444719|P2|Overall Study|Other|0
5057869|NCT02437162|17444720|P1|Overall Study|Other|0
5057870|NCT02437162|17444718|P3|Overall Study|Death|0
5057871|NCT02437162|17444719|P2|Overall Study|Death|1
5057872|NCT02437162|17444720|P1|Overall Study|Death|0
5057873|NCT02437162|17444718|P3|Overall Study|Lost to Follow-up|1
5057874|NCT02437162|17444719|P2|Overall Study|Lost to Follow-up|0
5057875|NCT02437162|17444720|P1|Overall Study|Lost to Follow-up|1
5057876|NCT02437162|17444718|P3|Overall Study|Adverse Event|0
5057877|NCT02437162|17444719|P2|Overall Study|Adverse Event|1
5057878|NCT02437162|17444720|P1|Overall Study|Adverse Event|0
5057879|NCT02437162|17444718|P3|Overall Study|Withdrawal by Subject|9
5057880|NCT02437162|17444719|P2|Overall Study|Withdrawal by Subject|7
5057881|NCT02437162|17444720|P1|Overall Study|Withdrawal by Subject|13
5057882|NCT02437162|17444718|P3|Overall Study|Study discontinued by Sponsor|97
5057883|NCT02437162|17444719|P2|Overall Study|Study discontinued by Sponsor|98
5057884|NCT02437162|17444720|P1|Overall Study|Study discontinued by Sponsor|93
5057885|NCT02437162|17444718|P3|Overall Study|Randomized but not treated|1
5057886|NCT02437162|17444719|P2|Overall Study|Randomized but not treated|0
5057887|NCT02437162|17444720|P1|Overall Study|Randomized but not treated|0
5057888|NCT02437162|17444718|P3|Overall Study|Protocol Violation|0
5057889|NCT02437162|17444719|P2|Overall Study|Protocol Violation|1
5057890|NCT02437162|17444720|P1|Overall Study|Protocol Violation|0
5057891|NCT02436915|17444840|P2|Overall Study|Withdrawal by Subject|1
5057892|NCT02436915|17444841|P1|Overall Study|Withdrawal by Subject|0
5057893|NCT02436889|17444863|P2|Overall Study|Does not like/could not tolerate medicat|1
5057894|NCT02436889|17444864|P1|Overall Study|Does not like/could not tolerate medicat|0
5057895|NCT02436889|17444863|P2|Overall Study|No improvement in symptoms|0
5057896|NCT02436889|17444864|P1|Overall Study|No improvement in symptoms|1
5057897|NCT02436811|17444883|P3|Overall Study|Lost to Follow-up|7
5057898|NCT02436811|17444884|P2|Overall Study|Lost to Follow-up|9
5057899|NCT02436811|17444885|P1|Overall Study|Lost to Follow-up|2
5057900|NCT02436759|17444895|P2|Overall Study|Withdrawal by Subject|1
5057901|NCT02436759|17444896|P1|Overall Study|Withdrawal by Subject|0
5057902|NCT02436759|17444895|P2|Overall Study|Protocol Violation|0
5057903|NCT02436759|17444896|P1|Overall Study|Protocol Violation|1
5057904|NCT02436759|17444895|P2|Overall Study|Adverse Event|0
5057905|NCT02436759|17444896|P1|Overall Study|Adverse Event|3
5057906|NCT02436681|17444904|P1|Overall Study|Death|2
5057907|NCT02436681|17444904|P1|Overall Study|Withdrawal by Subject|2
5057908|NCT02436681|17444904|P1|Overall Study|Lost to Follow-up|10
5057909|NCT02436577|17444944|P6|Overall Study|Protocol Deviation|0
5057910|NCT02436577|17444945|P5|Overall Study|Protocol Deviation|0
5057911|NCT02436577|17444946|P4|Overall Study|Protocol Deviation|0
5057912|NCT02436577|17444947|P3|Overall Study|Protocol Deviation|0
5057913|NCT02436577|17444948|P2|Overall Study|Protocol Deviation|1
5057914|NCT02436577|17444949|P1|Overall Study|Protocol Deviation|0
5057915|NCT02436356|17445005|P3|Overall Study|Withdrawal by Subject|0
5057916|NCT02436356|17445006|P2|Overall Study|Withdrawal by Subject|0
5057917|NCT02436356|17445007|P1|Overall Study|Withdrawal by Subject|1
5057918|NCT02436356|17445005|P3|Overall Study|Excluded due to other medical conditions|0
5057919|NCT02436356|17445006|P2|Overall Study|Excluded due to other medical conditions|0
5057920|NCT02436356|17445007|P1|Overall Study|Excluded due to other medical conditions|3
5057921|NCT02436356|17445005|P3|Overall Study|Surgical Approach (Dorsal not volar)|0
5057922|NCT02436356|17445006|P2|Overall Study|Surgical Approach (Dorsal not volar)|0
5057923|NCT02436356|17445007|P1|Overall Study|Surgical Approach (Dorsal not volar)|1
5057924|NCT02436356|17445005|P3|Overall Study|Lost to Follow-up|0
5057925|NCT02436356|17445006|P2|Overall Study|Lost to Follow-up|1
5057926|NCT02436356|17445007|P1|Overall Study|Lost to Follow-up|0
5057927|NCT02436356|17445005|P3|Overall Study|Excluded by MRI Screening|2
5057928|NCT02436356|17445006|P2|Overall Study|Excluded by MRI Screening|0
5057929|NCT02436356|17445007|P1|Overall Study|Excluded by MRI Screening|0
5057930|NCT02436330|17445038|P2|Cohort 6|Withdrawal by Subject|1
5057931|NCT02436330|17445039|P1|Cohort 6|Withdrawal by Subject|1
5057932|NCT02436330|17445038|P2|Cohort 6|Lost to Follow-up|0
5057933|NCT02436330|17445039|P1|Cohort 6|Lost to Follow-up|2
5057934|NCT02436330|17445038|P2|Cohort 5|Withdrawal by Subject|2
5057935|NCT02436330|17445039|P1|Cohort 5|Withdrawal by Subject|3
5057936|NCT02436330|17445038|P2|Cohort 5|Lost to Follow-up|2
5057937|NCT02436330|17445039|P1|Cohort 5|Lost to Follow-up|3
5057938|NCT02436330|17445038|P2|Cohort 4|Withdrawal by Subject|0
5057939|NCT02436330|17445039|P1|Cohort 4|Withdrawal by Subject|1
5057940|NCT02436330|17445038|P2|Cohort 4|Lost to Follow-up|0
5057941|NCT02436330|17445039|P1|Cohort 4|Lost to Follow-up|1
5057942|NCT02436330|17445038|P2|Cohort 3|Withdrawal by Subject|0
5057943|NCT02436330|17445039|P1|Cohort 3|Withdrawal by Subject|4
5057944|NCT02436330|17445038|P2|Cohort 3|Lost to Follow-up|0
5057945|NCT02436330|17445039|P1|Cohort 3|Lost to Follow-up|1
5057946|NCT02436330|17445038|P2|Cohort 2|Withdrawal by Subject|3
5057947|NCT02436330|17445039|P1|Cohort 2|Withdrawal by Subject|2
5057948|NCT02436330|17445038|P2|Cohort 2|Lost to Follow-up|0
5057949|NCT02436330|17445039|P1|Cohort 2|Lost to Follow-up|2
5057950|NCT02436330|17445038|P2|Cohort 1|Withdrawal by Subject|1
5057951|NCT02436330|17445039|P1|Cohort 1|Withdrawal by Subject|0
5057952|NCT02436330|17445038|P2|Cohort 1|Lost to Follow-up|2
5057953|NCT02436330|17445039|P1|Cohort 1|Lost to Follow-up|5
5057954|NCT02436304|17445084|P3|Overall Study|Randomized in error didn't meet I/E crit|1
5057955|NCT02436304|17445085|P2|Overall Study|Randomized in error didn't meet I/E crit|0
5057956|NCT02436304|17445086|P1|Overall Study|Randomized in error didn't meet I/E crit|0
5057957|NCT02436304|17445084|P3|Overall Study|Withdrawal by Subject|0
5057958|NCT02436304|17445085|P2|Overall Study|Withdrawal by Subject|1
5057959|NCT02436304|17445086|P1|Overall Study|Withdrawal by Subject|0
5057960|NCT02436304|17445084|P3|Overall Study|Lost to Follow-up|0
5057961|NCT02436304|17445085|P2|Overall Study|Lost to Follow-up|1
5057962|NCT02436304|17445086|P1|Overall Study|Lost to Follow-up|0
5057963|NCT02436239|17445105|P4|Down-Taper Period|Withdrawal by Subject|2
5057964|NCT02436239|17445106|P3|Down-Taper Period|Withdrawal by Subject|1
5057965|NCT02436239|17445107|P2|Down-Taper Period|Withdrawal by Subject|4
5057966|NCT02436239|17445108|P1|Down-Taper Period|Withdrawal by Subject|4
5057967|NCT02436239|17445105|P4|Open-Lable Treatment Period|Other Reason|0
5057968|NCT02436239|17445106|P3|Open-Lable Treatment Period|Other Reason|0
5057969|NCT02436239|17445107|P2|Open-Lable Treatment Period|Other Reason|1
5057970|NCT02436239|17445108|P1|Open-Lable Treatment Period|Other Reason|1
5057971|NCT02436239|17445105|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
5057972|NCT02436239|17445106|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
5057973|NCT02436239|17445107|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
5057974|NCT02436239|17445108|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
5057975|NCT02436239|17445105|P4|Open-Lable Treatment Period|Protocol Violation|0
5057976|NCT02436239|17445106|P3|Open-Lable Treatment Period|Protocol Violation|1
5057977|NCT02436239|17445107|P2|Open-Lable Treatment Period|Protocol Violation|1
5057978|NCT02436239|17445108|P1|Open-Lable Treatment Period|Protocol Violation|0
5057979|NCT02436239|17445105|P4|Open-Lable Treatment Period|Lost to Follow-up|1
5057980|NCT02436239|17445106|P3|Open-Lable Treatment Period|Lost to Follow-up|4
5057981|NCT02436239|17445107|P2|Open-Lable Treatment Period|Lost to Follow-up|2
5057982|NCT02436239|17445108|P1|Open-Lable Treatment Period|Lost to Follow-up|4
5057983|NCT02436239|17445105|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
5057984|NCT02436239|17445106|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
5057985|NCT02436239|17445107|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
5057986|NCT02436239|17445108|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
5057987|NCT02436239|17445105|P4|Open-Lable Treatment Period|Lack of Efficacy|1
5057988|NCT02436239|17445106|P3|Open-Lable Treatment Period|Lack of Efficacy|6
5057989|NCT02436239|17445107|P2|Open-Lable Treatment Period|Lack of Efficacy|6
5057990|NCT02436239|17445108|P1|Open-Lable Treatment Period|Lack of Efficacy|1
5057991|NCT02436239|17445105|P4|Open-Lable Treatment Period|Adverse Event|2
5057992|NCT02436239|17445106|P3|Open-Lable Treatment Period|Adverse Event|4
5057993|NCT02436239|17445107|P2|Open-Lable Treatment Period|Adverse Event|3
5057994|NCT02436239|17445108|P1|Open-Lable Treatment Period|Adverse Event|12
5057995|NCT02436200|17445130|P1|Overall Study|Significant outlier|1
5057996|NCT02436135|17445137|P2|Overall Study|Study Terminated By Sponsor|1
5057997|NCT02436135|17445138|P1|Overall Study|Study Terminated By Sponsor|0
5057998|NCT02436135|17445137|P2|Overall Study|Withdrawal by Participant|0
5057999|NCT02436135|17445138|P1|Overall Study|Withdrawal by Participant|1
5058000|NCT02436135|17445137|P2|Overall Study|Adverse Event|0
5058001|NCT02436135|17445138|P1|Overall Study|Adverse Event|1
5058002|NCT02436135|17445137|P2|Overall Study|Investigator Discretion|2
5058003|NCT02436135|17445138|P1|Overall Study|Investigator Discretion|1
5058004|NCT02436135|17445137|P2|Overall Study|Progressive Disease|1
5058005|NCT02436135|17445138|P1|Overall Study|Progressive Disease|3
5058006|NCT02436005|17445173|P2|Second Intervention|Adverse Event|1
5058007|NCT02436005|17445174|P1|Second Intervention|Adverse Event|0
5058008|NCT02435966|17445239|P3|Overall Study|Withdrawal by Subject|0
5058009|NCT02435966|17445240|P2|Overall Study|Withdrawal by Subject|1
5058010|NCT02435966|17445241|P1|Overall Study|Withdrawal by Subject|0
5058011|NCT02435914|17445253|P4|Overall Study|Other Miscellaneous Reason|0
5058012|NCT02435914|17445254|P3|Overall Study|Other Miscellaneous Reason|1
5058013|NCT02435914|17445255|P2|Overall Study|Other Miscellaneous Reason|0
5058014|NCT02435914|17445256|P1|Overall Study|Other Miscellaneous Reason|0
5058015|NCT02435914|17445253|P4|Overall Study|Withdrawal by Subject|0
5058016|NCT02435914|17445254|P3|Overall Study|Withdrawal by Subject|0
5058017|NCT02435914|17445255|P2|Overall Study|Withdrawal by Subject|1
5058018|NCT02435914|17445256|P1|Overall Study|Withdrawal by Subject|0
5058019|NCT02435914|17445253|P4|Overall Study|Ocular Adverse Event|0
5058020|NCT02435914|17445254|P3|Overall Study|Ocular Adverse Event|0
5058021|NCT02435914|17445255|P2|Overall Study|Ocular Adverse Event|0
5058022|NCT02435914|17445256|P1|Overall Study|Ocular Adverse Event|1
5058023|NCT02435836|17445284|P1|Overall Study|AE of Worsening Schizophrenia|96
5058024|NCT02435836|17445284|P1|Overall Study|Met Withdrawal Criteria|7
5058025|NCT02435836|17445284|P1|Overall Study|Protocol Violation|6
5058026|NCT02435836|17445284|P1|Overall Study|Noncompliance|27
5058027|NCT02435836|17445284|P1|Overall Study|Sponsor discontinued trial|167
5058028|NCT02435836|17445284|P1|Overall Study|Adverse Event|44
5058029|NCT02435836|17445284|P1|Overall Study|Insufficient Clinical Response|26
5058030|NCT02435836|17445284|P1|Overall Study|Withdrawal by Subject|236
5058031|NCT02435836|17445284|P1|Overall Study|Lack of Efficacy|1
5058032|NCT02435836|17445284|P1|Overall Study|Lost to Follow-up|21
5058033|NCT02435433|17445343|P5|Overall Study|Lost to Follow-up|0
5058034|NCT02435433|17445344|P4|Overall Study|Lost to Follow-up|0
5058035|NCT02435433|17445345|P3|Overall Study|Lost to Follow-up|0
5058036|NCT02435433|17445346|P2|Overall Study|Lost to Follow-up|2
5058037|NCT02435433|17445347|P1|Overall Study|Lost to Follow-up|2
5058038|NCT02435433|17445343|P5|Overall Study|Withdrawal by Subject|0
5058039|NCT02435433|17445344|P4|Overall Study|Withdrawal by Subject|0
5058040|NCT02435433|17445345|P3|Overall Study|Withdrawal by Subject|0
5058041|NCT02435433|17445346|P2|Overall Study|Withdrawal by Subject|3
5058042|NCT02435433|17445347|P1|Overall Study|Withdrawal by Subject|2
5058043|NCT02435433|17445343|P5|Overall Study|On Treatment|0
5058044|NCT02435433|17445344|P4|Overall Study|On Treatment|0
5058045|NCT02435433|17445345|P3|Overall Study|On Treatment|0
5058046|NCT02435433|17445346|P2|Overall Study|On Treatment|0
5058047|NCT02435433|17445347|P1|Overall Study|On Treatment|11
5058048|NCT02435277|17445373|P4|Overall Study|Withdrawal by Subject|0
5058049|NCT02435277|17445374|P3|Overall Study|Withdrawal by Subject|0
5058050|NCT02435277|17445375|P2|Overall Study|Withdrawal by Subject|0
5058051|NCT02435277|17445376|P1|Overall Study|Withdrawal by Subject|1
5058052|NCT02435277|17445373|P4|Overall Study|Adverse Event|0
5058053|NCT02435277|17445374|P3|Overall Study|Adverse Event|0
5058054|NCT02435277|17445375|P2|Overall Study|Adverse Event|1
5058055|NCT02435277|17445376|P1|Overall Study|Adverse Event|1
5058056|NCT02435147|17445390|P1|Overall Study|non-evaluable DXA scan|11
5058057|NCT02435069|17445395|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
5058058|NCT02435069|17445396|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
5058059|NCT02435069|17445397|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
5058060|NCT02435069|17445398|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
5058061|NCT02435069|17445399|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
5058062|NCT02435069|17445395|P5|Dose Response - First Intervention|Adverse Event|0
5058063|NCT02435069|17445396|P4|Dose Response - First Intervention|Adverse Event|0
5058064|NCT02435069|17445397|P3|Dose Response - First Intervention|Adverse Event|1
5058065|NCT02435069|17445398|P2|Dose Response - First Intervention|Adverse Event|1
5058066|NCT02435069|17445399|P1|Dose Response - First Intervention|Adverse Event|0
5058067|NCT02434939|17445421|P2|Overall Study|Adverse Event|1
5058068|NCT02434939|17445422|P1|Overall Study|Adverse Event|0
5058069|NCT02434939|17445421|P2|Overall Study|Withdrawal by Subject|0
5058070|NCT02434939|17445422|P1|Overall Study|Withdrawal by Subject|3
5058071|NCT02434939|17445421|P2|Overall Study|Lack of Efficacy|48
5058072|NCT02434939|17445422|P1|Overall Study|Lack of Efficacy|34
5058073|NCT02434770|17445437|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
5058074|NCT02434770|17445438|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
5058075|NCT02434770|17445439|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
5058076|NCT02434770|17445437|P3|Week 18 to Week|Withdrawal by Subject|2
5058077|NCT02434770|17445438|P2|Week 18 to Week|Withdrawal by Subject|0
5058078|NCT02434770|17445439|P1|Week 18 to Week|Withdrawal by Subject|0
5058079|NCT02434770|17445437|P3|Week 18 to Week|Lost to Follow-up|1
5058080|NCT02434770|17445438|P2|Week 18 to Week|Lost to Follow-up|2
5058081|NCT02434770|17445439|P1|Week 18 to Week|Lost to Follow-up|2
5058082|NCT02434770|17445437|P3|Week 1 to Week 18|Death|0
5058083|NCT02434770|17445438|P2|Week 1 to Week 18|Death|0
5058084|NCT02434770|17445439|P1|Week 1 to Week 18|Death|1
5058085|NCT02434770|17445437|P3|Week 1 to Week 18|Relocated Out of Study Area|1
5058086|NCT02434770|17445438|P2|Week 1 to Week 18|Relocated Out of Study Area|0
5058087|NCT02434770|17445439|P1|Week 1 to Week 18|Relocated Out of Study Area|0
5058088|NCT02434770|17445437|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
5058089|NCT02434770|17445438|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
5058090|NCT02434770|17445439|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
5058091|NCT02434770|17445437|P3|Week 1 to Week 18|Withdrawal by Subject|5
5058092|NCT02434770|17445438|P2|Week 1 to Week 18|Withdrawal by Subject|12
5058093|NCT02434770|17445439|P1|Week 1 to Week 18|Withdrawal by Subject|6
5058094|NCT02434770|17445437|P3|Week 1 to Week 18|Lost to Follow-up|2
5058095|NCT02434770|17445438|P2|Week 1 to Week 18|Lost to Follow-up|0
5058096|NCT02434770|17445439|P1|Week 1 to Week 18|Lost to Follow-up|0
5058097|NCT02434471|17445589|P1|Overall Study|Physician Decision|9
5058098|NCT02434328|17445598|P2|Overall Study|Other|1
5058099|NCT02434328|17445599|P1|Overall Study|Other|4
5058100|NCT02434328|17445598|P2|Overall Study|Lost to Follow-up|6
5058101|NCT02434328|17445599|P1|Overall Study|Lost to Follow-up|1
5058102|NCT02434328|17445598|P2|Overall Study|Death|7
5058103|NCT02434328|17445599|P1|Overall Study|Death|4
5058104|NCT02434328|17445598|P2|Overall Study|Withdrawal by Subject|21
5058105|NCT02434328|17445599|P1|Overall Study|Withdrawal by Subject|12
5058106|NCT02434328|17445598|P2|Overall Study|Physician Decision|1
5058107|NCT02434328|17445599|P1|Overall Study|Physician Decision|0
5058108|NCT02434328|17445598|P2|Overall Study|Lack of Efficacy|2
5058109|NCT02434328|17445599|P1|Overall Study|Lack of Efficacy|0
5058110|NCT02434328|17445598|P2|Overall Study|Adverse Event|4
5058111|NCT02434328|17445599|P1|Overall Study|Adverse Event|9
5058112|NCT02433834|17445674|P1|Overall Study|Physician Decision|1
5058113|NCT02433834|17445674|P1|Overall Study|Adverse Event|6
5058114|NCT02433834|17445674|P1|Overall Study|Withdrawal by Subject|14
5058115|NCT02433834|17445674|P1|Overall Study|Lost to Follow-up|6
5058116|NCT02433834|17445674|P1|Overall Study|Protocol Violation|3
5058117|NCT02433834|17445674|P1|Overall Study|Protocol-specified criteria|7
5058118|NCT02433678|17445734|P2|Overall Study|Lost to Follow-up|2
5058119|NCT02433678|17445735|P1|Overall Study|Lost to Follow-up|1
5058120|NCT02433483|17445828|P1|Overall Study|Other antineoplastic therapy/HSCT|1
5058121|NCT02433483|17445828|P1|Overall Study|Unacceptable toxicity|1
5058122|NCT02433340|17445855|P4|Overall Study|Other|0
5058123|NCT02433340|17445856|P3|Overall Study|Other|0
5058124|NCT02433340|17445857|P2|Overall Study|Other|1
5058125|NCT02433340|17445858|P1|Overall Study|Other|0
5058126|NCT02433340|17445855|P4|Overall Study|Required Alternative/Prohibited Therapy|0
5058127|NCT02433340|17445856|P3|Overall Study|Required Alternative/Prohibited Therapy|0
5058128|NCT02433340|17445857|P2|Overall Study|Required Alternative/Prohibited Therapy|0
5058129|NCT02433340|17445858|P1|Overall Study|Required Alternative/Prohibited Therapy|1
5058130|NCT02433340|17445855|P4|Overall Study|Lost to Follow-up|0
5058131|NCT02433340|17445856|P3|Overall Study|Lost to Follow-up|0
5058132|NCT02433340|17445857|P2|Overall Study|Lost to Follow-up|1
5058133|NCT02433340|17445858|P1|Overall Study|Lost to Follow-up|0
5058134|NCT02433340|17445855|P4|Overall Study|Withdrawal by Subject|2
5058135|NCT02433340|17445856|P3|Overall Study|Withdrawal by Subject|1
5058136|NCT02433340|17445857|P2|Overall Study|Withdrawal by Subject|0
5058137|NCT02433340|17445858|P1|Overall Study|Withdrawal by Subject|1
5058138|NCT02433340|17445855|P4|Overall Study|Adverse Event|0
5058139|NCT02433340|17445856|P3|Overall Study|Adverse Event|1
5058140|NCT02433340|17445857|P2|Overall Study|Adverse Event|0
5058141|NCT02433340|17445858|P1|Overall Study|Adverse Event|0
5058142|NCT02433288|17446752|P2|Overall Study|Death|3
5058143|NCT02433288|17446753|P1|Overall Study|Death|0
5058144|NCT02433288|17446752|P2|Overall Study|Lost to Follow-up|14
5058145|NCT02433288|17446753|P1|Overall Study|Lost to Follow-up|2
5058146|NCT02433288|17446752|P2|Overall Study|Withdrawal by Subject|99
5058147|NCT02433288|17446753|P1|Overall Study|Withdrawal by Subject|101
5058148|NCT02433288|17446752|P2|Overall Study|Eligibility criteria not fullfilled|3
5058149|NCT02433288|17446753|P1|Overall Study|Eligibility criteria not fullfilled|7
5058150|NCT02433288|17446752|P2|Overall Study|Severe non-compliance to protocol|7
5058151|NCT02433288|17446753|P1|Overall Study|Severe non-compliance to protocol|13
5058152|NCT02433080|17446769|P2|Overall Study|Withdrawal by Subject|2
5058153|NCT02433080|17446770|P1|Overall Study|Withdrawal by Subject|0
5058154|NCT02433080|17446769|P2|Overall Study|Lost to Follow-up|2
5058155|NCT02433080|17446770|P1|Overall Study|Lost to Follow-up|1
5058156|NCT02432274|17446890|P8|Overall Study|Ongoing|7
5058157|NCT02432274|17446891|P7|Overall Study|Ongoing|0
5058158|NCT02432274|17446892|P6|Overall Study|Ongoing|0
5058159|NCT02432274|17446893|P5|Overall Study|Ongoing|3
5058160|NCT02432274|17446894|P4|Overall Study|Ongoing|1
5058161|NCT02432274|17446895|P3|Overall Study|Ongoing|1
5058162|NCT02432274|17446896|P2|Overall Study|Ongoing|0
5058163|NCT02432274|17446897|P1|Overall Study|Ongoing|0
5058164|NCT02432274|17446890|P8|Overall Study|Other than specified|1
5058165|NCT02432274|17446891|P7|Overall Study|Other than specified|0
5058166|NCT02432274|17446892|P6|Overall Study|Other than specified|1
5058167|NCT02432274|17446893|P5|Overall Study|Other than specified|0
5058168|NCT02432274|17446894|P4|Overall Study|Other than specified|0
5058169|NCT02432274|17446895|P3|Overall Study|Other than specified|0
5058170|NCT02432274|17446896|P2|Overall Study|Other than specified|1
5058171|NCT02432274|17446897|P1|Overall Study|Other than specified|0
5058172|NCT02432274|17446890|P8|Overall Study|Participant Choice|0
5058173|NCT02432274|17446891|P7|Overall Study|Participant Choice|1
5058174|NCT02432274|17446892|P6|Overall Study|Participant Choice|0
5058175|NCT02432274|17446893|P5|Overall Study|Participant Choice|0
5058176|NCT02432274|17446894|P4|Overall Study|Participant Choice|0
5058177|NCT02432274|17446895|P3|Overall Study|Participant Choice|1
5058178|NCT02432274|17446896|P2|Overall Study|Participant Choice|0
5058179|NCT02432274|17446897|P1|Overall Study|Participant Choice|0
5058180|NCT02432274|17446890|P8|Overall Study|Withdrawal by Subject|2
5058181|NCT02432274|17446891|P7|Overall Study|Withdrawal by Subject|1
5058182|NCT02432274|17446892|P6|Overall Study|Withdrawal by Subject|0
5058183|NCT02432274|17446893|P5|Overall Study|Withdrawal by Subject|2
5058184|NCT02432274|17446894|P4|Overall Study|Withdrawal by Subject|0
5058185|NCT02432274|17446895|P3|Overall Study|Withdrawal by Subject|0
5058186|NCT02432274|17446896|P2|Overall Study|Withdrawal by Subject|0
5058187|NCT02432274|17446897|P1|Overall Study|Withdrawal by Subject|0
5058188|NCT02432274|17446890|P8|Overall Study|Adverse Event|0
5058189|NCT02432274|17446891|P7|Overall Study|Adverse Event|2
5058190|NCT02432274|17446892|P6|Overall Study|Adverse Event|0
5058191|NCT02432274|17446893|P5|Overall Study|Adverse Event|1
5058192|NCT02432274|17446894|P4|Overall Study|Adverse Event|0
5058193|NCT02432274|17446895|P3|Overall Study|Adverse Event|1
5058194|NCT02432274|17446896|P2|Overall Study|Adverse Event|0
5058195|NCT02432274|17446897|P1|Overall Study|Adverse Event|0
5058196|NCT02432274|17446890|P8|Overall Study|Clinical Disease Progression|1
5058197|NCT02432274|17446891|P7|Overall Study|Clinical Disease Progression|0
5058198|NCT02432274|17446892|P6|Overall Study|Clinical Disease Progression|0
5058199|NCT02432274|17446893|P5|Overall Study|Clinical Disease Progression|1
5058200|NCT02432274|17446894|P4|Overall Study|Clinical Disease Progression|0
5058201|NCT02432274|17446895|P3|Overall Study|Clinical Disease Progression|1
5058202|NCT02432274|17446896|P2|Overall Study|Clinical Disease Progression|4
5058203|NCT02432274|17446897|P1|Overall Study|Clinical Disease Progression|0
5058204|NCT02432274|17446890|P8|Overall Study|Radiological Disease Progression|9
5058205|NCT02432274|17446891|P7|Overall Study|Radiological Disease Progression|11
5058206|NCT02432274|17446892|P6|Overall Study|Radiological Disease Progression|6
5058207|NCT02432274|17446893|P5|Overall Study|Radiological Disease Progression|24
5058208|NCT02432274|17446894|P4|Overall Study|Radiological Disease Progression|0
5058209|NCT02432274|17446895|P3|Overall Study|Radiological Disease Progression|7
5058210|NCT02432274|17446896|P2|Overall Study|Radiological Disease Progression|4
5058211|NCT02432274|17446897|P1|Overall Study|Radiological Disease Progression|3
5058212|NCT02432196|17447010|P1|Overall Study|On Study|20
5058213|NCT02432196|17447010|P1|Overall Study|Reoperation|3
5058214|NCT02432196|17447010|P1|Overall Study|Death|2
5058215|NCT02432196|17447010|P1|Overall Study|Not Implanted with Device|1
5058216|NCT02432144|17447018|P1|Overall Study|Participant Non-Compliance|1
5058217|NCT02432105|17447026|P3|Overall Study|Randomized in error|2
5058218|NCT02432105|17447027|P2|Overall Study|Randomized in error|0
5058219|NCT02432105|17447028|P1|Overall Study|Randomized in error|0
5058220|NCT02432105|17447026|P3|Overall Study|Culture positive for yeast|0
5058221|NCT02432105|17447027|P2|Overall Study|Culture positive for yeast|1
5058222|NCT02432105|17447028|P1|Overall Study|Culture positive for yeast|0
5058223|NCT02432105|17447026|P3|Overall Study|Withdrawal by Subject|1
5058224|NCT02432105|17447027|P2|Overall Study|Withdrawal by Subject|0
5058225|NCT02432105|17447028|P1|Overall Study|Withdrawal by Subject|1
5058226|NCT02432105|17447026|P3|Overall Study|Lost to Follow-up|0
5058227|NCT02432105|17447027|P2|Overall Study|Lost to Follow-up|1
5058228|NCT02432105|17447028|P1|Overall Study|Lost to Follow-up|1
5058229|NCT02432040|17447045|P2|Overall Study|Physician Decision|1
5058230|NCT02432040|17447046|P1|Overall Study|Physician Decision|1
5058231|NCT02432040|17447045|P2|Overall Study|Lost to Follow-up|5
5058232|NCT02432040|17447046|P1|Overall Study|Lost to Follow-up|4
5058233|NCT02432040|17447045|P2|Overall Study|Lack of Efficacy|0
5058234|NCT02432040|17447046|P1|Overall Study|Lack of Efficacy|3
5058235|NCT02431806|17447070|P4|Double-blind Treatment Period|Reason Not Specified|2
5058236|NCT02431806|17447071|P3|Double-blind Treatment Period|Reason Not Specified|5
5058237|NCT02431806|17447072|P2|Double-blind Treatment Period|Reason Not Specified|1
5058238|NCT02431806|17447073|P1|Double-blind Treatment Period|Reason Not Specified|0
5058239|NCT02431806|17447070|P4|Double-blind Treatment Period|Investigational Product Non-compliance|1
5058240|NCT02431806|17447071|P3|Double-blind Treatment Period|Investigational Product Non-compliance|3
5058241|NCT02431806|17447072|P2|Double-blind Treatment Period|Investigational Product Non-compliance|0
5058242|NCT02431806|17447073|P1|Double-blind Treatment Period|Investigational Product Non-compliance|1
5058243|NCT02431806|17447070|P4|Double-blind Treatment Period|Lost to Follow-up|8
5058244|NCT02431806|17447071|P3|Double-blind Treatment Period|Lost to Follow-up|5
5058245|NCT02431806|17447072|P2|Double-blind Treatment Period|Lost to Follow-up|4
5058246|NCT02431806|17447073|P1|Double-blind Treatment Period|Lost to Follow-up|7
5058247|NCT02431806|17447070|P4|Double-blind Treatment Period|Withdrawal of Consent|5
5058248|NCT02431806|17447071|P3|Double-blind Treatment Period|Withdrawal of Consent|5
5058249|NCT02431806|17447072|P2|Double-blind Treatment Period|Withdrawal of Consent|7
5058250|NCT02431806|17447073|P1|Double-blind Treatment Period|Withdrawal of Consent|10
5058251|NCT02431806|17447070|P4|Double-blind Treatment Period|Lack of Efficacy|2
5058252|NCT02431806|17447071|P3|Double-blind Treatment Period|Lack of Efficacy|2
5058253|NCT02431806|17447072|P2|Double-blind Treatment Period|Lack of Efficacy|0
5058254|NCT02431806|17447073|P1|Double-blind Treatment Period|Lack of Efficacy|2
5058255|NCT02431806|17447070|P4|Double-blind Treatment Period|Adverse Event|7
5058256|NCT02431806|17447071|P3|Double-blind Treatment Period|Adverse Event|11
5058257|NCT02431806|17447072|P2|Double-blind Treatment Period|Adverse Event|7
5058258|NCT02431806|17447073|P1|Double-blind Treatment Period|Adverse Event|4
5058259|NCT02431806|17447070|P4|Double-blind Treatment Period|Did not Receive Treatment|1
5058260|NCT02431806|17447071|P3|Double-blind Treatment Period|Did not Receive Treatment|1
5058261|NCT02431806|17447072|P2|Double-blind Treatment Period|Did not Receive Treatment|2
5058262|NCT02431806|17447073|P1|Double-blind Treatment Period|Did not Receive Treatment|1
5058263|NCT02431793|17447090|P3|Overall Study|Lost to Follow-up|104
5058264|NCT02431793|17447091|P2|Overall Study|Lost to Follow-up|122
5058265|NCT02431793|17447092|P1|Overall Study|Lost to Follow-up|101
5058266|NCT02431793|17447090|P3|Overall Study|Withdrawal by Subject|5
5058267|NCT02431793|17447091|P2|Overall Study|Withdrawal by Subject|5
5058268|NCT02431793|17447092|P1|Overall Study|Withdrawal by Subject|7
5058269|NCT02431793|17447090|P3|Overall Study|Ineligible doe to not filling Rx|8
5058270|NCT02431793|17447091|P2|Overall Study|Ineligible doe to not filling Rx|7
5058271|NCT02431793|17447092|P1|Overall Study|Ineligible doe to not filling Rx|11
5058272|NCT02431676|17447140|P3|Overall Study|no lab obtained|2
5058273|NCT02431676|17447141|P2|Overall Study|no lab obtained|1
5058274|NCT02431676|17447142|P1|Overall Study|no lab obtained|0
5058275|NCT02431559|17447218|P4|Overall Study|Physician Decision|1
5058276|NCT02431559|17447219|P3|Overall Study|Physician Decision|0
5058277|NCT02431559|17447220|P2|Overall Study|Physician Decision|0
5058278|NCT02431559|17447221|P1|Overall Study|Physician Decision|0
5058279|NCT02431559|17447218|P4|Overall Study|Withdrawal by Subject|4
5058280|NCT02431559|17447219|P3|Overall Study|Withdrawal by Subject|0
5058281|NCT02431559|17447220|P2|Overall Study|Withdrawal by Subject|1
5058282|NCT02431559|17447221|P1|Overall Study|Withdrawal by Subject|0
5058283|NCT02431559|17447218|P4|Overall Study|Progressive disease|22
5058284|NCT02431559|17447219|P3|Overall Study|Progressive disease|4
5058285|NCT02431559|17447220|P2|Overall Study|Progressive disease|1
5058286|NCT02431559|17447221|P1|Overall Study|Progressive disease|2
5058287|NCT02431559|17447218|P4|Overall Study|Adverse Event|4
5058288|NCT02431559|17447219|P3|Overall Study|Adverse Event|0
5058289|NCT02431559|17447220|P2|Overall Study|Adverse Event|1
5058290|NCT02431559|17447221|P1|Overall Study|Adverse Event|0
5058291|NCT02431533|17447245|P2|Overall Study|Developed Exclusionary criteria|0
5058292|NCT02431533|17447246|P1|Overall Study|Developed Exclusionary criteria|1
5058293|NCT02431533|17447245|P2|Overall Study|Withdrawal by Subject|3
5058294|NCT02431533|17447246|P1|Overall Study|Withdrawal by Subject|1
5058295|NCT02431468|17447312|P3|Overall Study|noncompliance, investigator termination,|2
5058296|NCT02431468|17447313|P2|Overall Study|noncompliance, investigator termination,|2
5058297|NCT02431468|17447314|P1|Overall Study|noncompliance, investigator termination,|2
5058298|NCT02431468|17447312|P3|Overall Study|Withdrawal by Subject|2
5058299|NCT02431468|17447313|P2|Overall Study|Withdrawal by Subject|12
5058300|NCT02431468|17447314|P1|Overall Study|Withdrawal by Subject|4
5058301|NCT02431468|17447312|P3|Overall Study|Adverse Event|5
5058302|NCT02431468|17447313|P2|Overall Study|Adverse Event|4
5058303|NCT02431468|17447314|P1|Overall Study|Adverse Event|2
5058304|NCT02431260|17447405|P14|Overall Study|Other Unspecified|0
5058305|NCT02431260|17447406|P13|Overall Study|Other Unspecified|1
5058306|NCT02431260|17447407|P12|Overall Study|Other Unspecified|1
5058307|NCT02431260|17447408|P11|Overall Study|Other Unspecified|0
5058308|NCT02431260|17447409|P10|Overall Study|Other Unspecified|0
5058309|NCT02431260|17447410|P9|Overall Study|Other Unspecified|0
5058310|NCT02431260|17447411|P8|Overall Study|Other Unspecified|0
5058311|NCT02431260|17447412|P7|Overall Study|Other Unspecified|0
5058312|NCT02431260|17447413|P6|Overall Study|Other Unspecified|0
5058313|NCT02431260|17447414|P5|Overall Study|Other Unspecified|0
5058314|NCT02431260|17447415|P4|Overall Study|Other Unspecified|0
5058315|NCT02431260|17447416|P3|Overall Study|Other Unspecified|0
5058316|NCT02431260|17447417|P2|Overall Study|Other Unspecified|0
5058317|NCT02431260|17447418|P1|Overall Study|Other Unspecified|0
5058318|NCT02431260|17447405|P14|Overall Study|Physician Decision|0
5058319|NCT02431260|17447406|P13|Overall Study|Physician Decision|0
5058320|NCT02431260|17447407|P12|Overall Study|Physician Decision|0
5058321|NCT02431260|17447408|P11|Overall Study|Physician Decision|0
5058322|NCT02431260|17447409|P10|Overall Study|Physician Decision|0
5058323|NCT02431260|17447410|P9|Overall Study|Physician Decision|0
5058324|NCT02431260|17447411|P8|Overall Study|Physician Decision|0
5058325|NCT02431260|17447412|P7|Overall Study|Physician Decision|0
5058326|NCT02431260|17447413|P6|Overall Study|Physician Decision|1
5058327|NCT02431260|17447414|P5|Overall Study|Physician Decision|0
5058328|NCT02431260|17447415|P4|Overall Study|Physician Decision|0
5058329|NCT02431260|17447416|P3|Overall Study|Physician Decision|0
5058330|NCT02431260|17447417|P2|Overall Study|Physician Decision|0
5058331|NCT02431260|17447418|P1|Overall Study|Physician Decision|0
5058332|NCT02431260|17447405|P14|Overall Study|Study Terminated by the Sponsor|0
5058333|NCT02431260|17447406|P13|Overall Study|Study Terminated by the Sponsor|4
5058334|NCT02431260|17447407|P12|Overall Study|Study Terminated by the Sponsor|0
5058335|NCT02431260|17447408|P11|Overall Study|Study Terminated by the Sponsor|1
5058336|NCT02431260|17447409|P10|Overall Study|Study Terminated by the Sponsor|1
5058337|NCT02431260|17447410|P9|Overall Study|Study Terminated by the Sponsor|1
5058338|NCT02431260|17447411|P8|Overall Study|Study Terminated by the Sponsor|2
5058339|NCT02431260|17447412|P7|Overall Study|Study Terminated by the Sponsor|1
5058340|NCT02431260|17447413|P6|Overall Study|Study Terminated by the Sponsor|0
5058341|NCT02431260|17447414|P5|Overall Study|Study Terminated by the Sponsor|1
5058342|NCT02431260|17447415|P4|Overall Study|Study Terminated by the Sponsor|1
5058343|NCT02431260|17447416|P3|Overall Study|Study Terminated by the Sponsor|2
5058344|NCT02431260|17447417|P2|Overall Study|Study Terminated by the Sponsor|0
5058345|NCT02431260|17447418|P1|Overall Study|Study Terminated by the Sponsor|0
5058346|NCT02431260|17447405|P14|Overall Study|Lost to Follow-up|0
5058347|NCT02431260|17447406|P13|Overall Study|Lost to Follow-up|0
5058348|NCT02431260|17447407|P12|Overall Study|Lost to Follow-up|0
5058349|NCT02431260|17447408|P11|Overall Study|Lost to Follow-up|0
5058350|NCT02431260|17447409|P10|Overall Study|Lost to Follow-up|0
5058351|NCT02431260|17447410|P9|Overall Study|Lost to Follow-up|0
5058352|NCT02431260|17447411|P8|Overall Study|Lost to Follow-up|0
5058353|NCT02431260|17447412|P7|Overall Study|Lost to Follow-up|0
5058354|NCT02431260|17447413|P6|Overall Study|Lost to Follow-up|1
5058355|NCT02431260|17447414|P5|Overall Study|Lost to Follow-up|0
5058356|NCT02431260|17447415|P4|Overall Study|Lost to Follow-up|0
5058357|NCT02431260|17447416|P3|Overall Study|Lost to Follow-up|0
5058358|NCT02431260|17447417|P2|Overall Study|Lost to Follow-up|0
5058359|NCT02431260|17447418|P1|Overall Study|Lost to Follow-up|0
5058360|NCT02431260|17447405|P14|Overall Study|Death|1
5058361|NCT02431260|17447406|P13|Overall Study|Death|5
5058362|NCT02431260|17447407|P12|Overall Study|Death|2
5058363|NCT02431260|17447408|P11|Overall Study|Death|3
5058364|NCT02431260|17447409|P10|Overall Study|Death|6
5058365|NCT02431260|17447410|P9|Overall Study|Death|6
5058366|NCT02431260|17447411|P8|Overall Study|Death|1
5058367|NCT02431260|17447412|P7|Overall Study|Death|3
5058368|NCT02431260|17447413|P6|Overall Study|Death|2
5058369|NCT02431260|17447414|P5|Overall Study|Death|2
5058370|NCT02431260|17447415|P4|Overall Study|Death|4
5058371|NCT02431260|17447416|P3|Overall Study|Death|3
5058372|NCT02431260|17447417|P2|Overall Study|Death|4
5058373|NCT02431260|17447418|P1|Overall Study|Death|4
5058374|NCT02431260|17447405|P14|Overall Study|Subject Decision|0
5058375|NCT02431260|17447406|P13|Overall Study|Subject Decision|0
5058376|NCT02431260|17447407|P12|Overall Study|Subject Decision|1
5058377|NCT02431260|17447408|P11|Overall Study|Subject Decision|0
5058378|NCT02431260|17447409|P10|Overall Study|Subject Decision|1
5058379|NCT02431260|17447410|P9|Overall Study|Subject Decision|1
5058380|NCT02431260|17447411|P8|Overall Study|Subject Decision|0
5058381|NCT02431260|17447412|P7|Overall Study|Subject Decision|0
5058382|NCT02431260|17447413|P6|Overall Study|Subject Decision|0
5058383|NCT02431260|17447414|P5|Overall Study|Subject Decision|0
5058384|NCT02431260|17447415|P4|Overall Study|Subject Decision|0
5058385|NCT02431260|17447416|P3|Overall Study|Subject Decision|1
5058386|NCT02431260|17447417|P2|Overall Study|Subject Decision|1
5058387|NCT02431260|17447418|P1|Overall Study|Subject Decision|0
5058388|NCT02431247|17447511|P2|Overall Study|Non-compliance with study drug|0
5058389|NCT02431247|17447512|P1|Overall Study|Non-compliance with study drug|1
5058390|NCT02431247|17447511|P2|Overall Study|Ongoing|336
5058391|NCT02431247|17447512|P1|Overall Study|Ongoing|339
5058392|NCT02431247|17447511|P2|Overall Study|Other|1
5058393|NCT02431247|17447512|P1|Overall Study|Other|2
5058394|NCT02431247|17447511|P2|Overall Study|Withdrawal by Subject|6
5058395|NCT02431247|17447512|P1|Overall Study|Withdrawal by Subject|4
5058396|NCT02431247|17447511|P2|Overall Study|Physician Decision|0
5058397|NCT02431247|17447512|P1|Overall Study|Physician Decision|3
5058398|NCT02431247|17447511|P2|Overall Study|Adverse Event|15
5058399|NCT02431247|17447512|P1|Overall Study|Adverse Event|8
5058400|NCT02431247|17447511|P2|Overall Study|Lost to Follow-up|5
5058401|NCT02431247|17447512|P1|Overall Study|Lost to Follow-up|5
5058402|NCT02430870|17447605|P8|Part 2|Other Reason Not Specified|1
5058403|NCT02430870|17447606|P7|Part 2|Other Reason Not Specified|0
5058404|NCT02430870|17447607|P6|Part 2|Other Reason Not Specified|0
5058405|NCT02430870|17447608|P5|Part 2|Other Reason Not Specified|0
5058406|NCT02430870|17447609|P4|Part 2|Other Reason Not Specified|0
5058407|NCT02430870|17447610|P3|Part 2|Other Reason Not Specified|0
5058408|NCT02430870|17447611|P2|Part 2|Other Reason Not Specified|0
5058409|NCT02430870|17447612|P1|Part 2|Other Reason Not Specified|0
5058410|NCT02430870|17447605|P8|Part 2|Voluntary Withdrawal|0
5058411|NCT02430870|17447606|P7|Part 2|Voluntary Withdrawal|1
5058412|NCT02430870|17447607|P6|Part 2|Voluntary Withdrawal|0
5058413|NCT02430870|17447608|P5|Part 2|Voluntary Withdrawal|0
5058414|NCT02430870|17447609|P4|Part 2|Voluntary Withdrawal|0
5058415|NCT02430870|17447610|P3|Part 2|Voluntary Withdrawal|0
5058416|NCT02430870|17447611|P2|Part 2|Voluntary Withdrawal|0
5058417|NCT02430870|17447612|P1|Part 2|Voluntary Withdrawal|0
5058418|NCT02430532|17447699|P2|Overall Study|Adverse Event|1
5058419|NCT02430532|17447700|P1|Overall Study|Adverse Event|0
5058420|NCT02430532|17447699|P2|Overall Study|Consent Withdrawn|2
5058421|NCT02430532|17447700|P1|Overall Study|Consent Withdrawn|0
5058422|NCT02430532|17447699|P2|Overall Study|Sponsor Decision to Stop Study Early|25
5058423|NCT02430532|17447700|P1|Overall Study|Sponsor Decision to Stop Study Early|30
5058424|NCT02430480|17447714|P1|Overall Study|Progressed on treatment|1
5058425|NCT02430480|17447714|P1|Overall Study|Anesthesia concerns|1
5058426|NCT02430480|17447714|P1|Overall Study|Death|1
5058427|NCT02430311|17447757|P2|Part B|Death|0
5058428|NCT02430311|17447758|P1|Part B|Death|1
5058429|NCT02430311|17447757|P2|Part B|Adverse Event|0
5058430|NCT02430311|17447758|P1|Part B|Adverse Event|1
5058431|NCT02430311|17447757|P2|Part B|Withdrawal by Subject|2
5058432|NCT02430311|17447758|P1|Part B|Withdrawal by Subject|2
5058433|NCT02430311|17447757|P2|Part B|Meet study-specific withdrawal criteria|6
5058434|NCT02430311|17447758|P1|Part B|Meet study-specific withdrawal criteria|6
5058435|NCT02430311|17447757|P2|Part A|Withdrawal by Subject|0
5058436|NCT02430311|17447758|P1|Part A|Withdrawal by Subject|1
5058437|NCT02430311|17447757|P2|Part A|Adverse Event|1
5058438|NCT02430311|17447758|P1|Part A|Adverse Event|0
5058439|NCT02429856|17447812|P2|Overall Study|Withdrawal by Subject|1
5058440|NCT02429856|17447813|P1|Overall Study|Withdrawal by Subject|1
5058441|NCT02429856|17447812|P2|Overall Study|Lost to Follow-up|5
5058442|NCT02429856|17447813|P1|Overall Study|Lost to Follow-up|6
5058443|NCT02429856|17447812|P2|Overall Study|Death|13
5058444|NCT02429856|17447813|P1|Overall Study|Death|12
5058445|NCT02429791|17447831|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
5058446|NCT02429791|17447832|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
5058447|NCT02429791|17447831|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5058448|NCT02429791|17447832|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5058449|NCT02429791|17447831|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
5058450|NCT02429791|17447832|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
5058451|NCT02429791|17447831|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
5058452|NCT02429791|17447832|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
5058453|NCT02429791|17447831|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
5058454|NCT02429791|17447832|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
5058455|NCT02429791|17447831|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
5058456|NCT02429791|17447832|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
5058457|NCT02429791|17447831|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
5058458|NCT02429791|17447832|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
5058459|NCT02429791|17447831|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
5058460|NCT02429791|17447832|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
5058461|NCT02429791|17447831|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
5058462|NCT02429791|17447832|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5058463|NCT02429791|17447831|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
5058464|NCT02429791|17447832|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
5058465|NCT02429791|17447831|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
5058466|NCT02429791|17447832|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
5058467|NCT02429791|17447831|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
5058468|NCT02429791|17447832|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
5058469|NCT02429778|17447920|P2|Overall Study|Withdrawal by Subject|0
5058470|NCT02429778|17447921|P1|Overall Study|Withdrawal by Subject|5
5058471|NCT02429778|17447920|P2|Overall Study|Lost to Follow-up|0
5058472|NCT02429778|17447921|P1|Overall Study|Lost to Follow-up|2
5058473|NCT02429427|17447952|P2|Overall Study|Other|41
5058474|NCT02429427|17447953|P1|Overall Study|Other|62
5058475|NCT02429427|17447952|P2|Overall Study|Withdrawal by Subject|34
5058476|NCT02429427|17447953|P1|Overall Study|Withdrawal by Subject|64
5058477|NCT02429427|17447952|P2|Overall Study|Lost to Follow-up|6
5058478|NCT02429427|17447953|P1|Overall Study|Lost to Follow-up|15
5058479|NCT02429427|17447952|P2|Overall Study|Protocol Violation|6
5058480|NCT02429427|17447953|P1|Overall Study|Protocol Violation|10
5058481|NCT02429427|17447952|P2|Overall Study|Adverse Event|92
5058482|NCT02429427|17447953|P1|Overall Study|Adverse Event|220
5058483|NCT02429310|17447967|P2|Overall Study|Protocol Violation|1
5058484|NCT02429310|17447968|P1|Overall Study|Protocol Violation|1
5058485|NCT02429310|17447967|P2|Overall Study|Lost to Follow-up|2
5058486|NCT02429310|17447968|P1|Overall Study|Lost to Follow-up|1
5058487|NCT02429258|17447978|P2|Overall Study|Protocol Violation|1
5058488|NCT02429258|17447979|P1|Overall Study|Protocol Violation|0
5058489|NCT02429258|17447978|P2|Overall Study|Withdrawal by Subject|0
5058490|NCT02429258|17447979|P1|Overall Study|Withdrawal by Subject|2
5058491|NCT02428855|17448033|P1|Overall Study|Withdrawal by Subject|2
5058492|NCT02428699|17448040|P2|Washout Period 1|Screen Failure|2
5058493|NCT02428699|17448041|P1|Washout Period 1|Screen Failure|1
5058494|NCT02428608|17448069|P1|Overall Study|various|16
5058495|NCT02428608|17448069|P1|Overall Study|Death|1
5058496|NCT02428608|17448069|P1|Overall Study|moved away|10
5058497|NCT02428608|17448069|P1|Overall Study|scheduling conflicts|15
5058498|NCT02428608|17448069|P1|Overall Study|Withdrawal by Subject|2
5058499|NCT02428608|17448069|P1|Overall Study|Lost to Follow-up|37
5058500|NCT02428608|17448069|P1|Overall Study|Pregnancy|2
5058501|NCT02428413|17448101|P2|Overall Study|Nurse Refusal|0
5058502|NCT02428413|17448102|P1|Overall Study|Nurse Refusal|1
5058503|NCT02428413|17448101|P2|Overall Study|Missed Cases|2
5058504|NCT02428413|17448102|P1|Overall Study|Missed Cases|1
5058505|NCT02428413|17448101|P2|Overall Study|Case Cancelled|0
5058506|NCT02428413|17448102|P1|Overall Study|Case Cancelled|2
5058507|NCT02428413|17448101|P2|Overall Study|Protocol Violation|2
5058508|NCT02428413|17448102|P1|Overall Study|Protocol Violation|1
5058509|NCT02428413|17448101|P2|Overall Study|Device to measure WAG malfunctioned|5
5058510|NCT02428413|17448102|P1|Overall Study|Device to measure WAG malfunctioned|3
5058511|NCT02428296|17448137|P1|Overall Study|Withdrawal by Subject|2
5058512|NCT02428296|17448137|P1|Overall Study|Adverse Event|7
5058513|NCT02428231|17448149|P2|Overall Study|Adverse Event|0
5058514|NCT02428231|17448150|P1|Overall Study|Adverse Event|3
5058515|NCT02428231|17448149|P2|Overall Study|Required Symptomatic Therapy|1
5058516|NCT02428231|17448150|P1|Overall Study|Required Symptomatic Therapy|0
5058517|NCT02428231|17448149|P2|Overall Study|Other|16
5058518|NCT02428231|17448150|P1|Overall Study|Other|10
5058519|NCT02427984|17448182|P3|Overall Study|Lost to Follow-up|18
5058520|NCT02427984|17448183|P2|Overall Study|Lost to Follow-up|5
5058521|NCT02427984|17448184|P1|Overall Study|Lost to Follow-up|13
5058522|NCT02427958|17448198|P1|Overall Study|Lack of Efficacy|1
5058523|NCT02427958|17448198|P1|Overall Study|Withdrawal by Subject|14
5058524|NCT02427958|17448198|P1|Overall Study|Lost to Follow-up|6
5058525|NCT02427958|17448198|P1|Overall Study|Pretreatment Event (PTE) or AE|3
5058526|NCT02427646|17448291|P2|Overall Study|Bothersome hand weakness|4
5058527|NCT02427646|17448292|P1|Overall Study|Bothersome hand weakness|2
5058528|NCT02427646|17448291|P2|Overall Study|Protocol Violation|3
5058529|NCT02427646|17448292|P1|Overall Study|Protocol Violation|3
5058530|NCT02427646|17448291|P2|Overall Study|Physician Decision|4
5058531|NCT02427646|17448292|P1|Overall Study|Physician Decision|1
5058532|NCT02427646|17448291|P2|Overall Study|Lack of Efficacy|3
5058533|NCT02427646|17448292|P1|Overall Study|Lack of Efficacy|2
5058534|NCT02427607|17448300|P1|Overall Study|Withdrawal by Subject|1
5058535|NCT02427477|17448306|P2|Period 1|Adverse Event|0
5058536|NCT02427477|17448307|P1|Period 1|Adverse Event|1
5058537|NCT02427399|17448320|P5|Overall Study|Protocol Violation|15
5058538|NCT02427399|17448321|P4|Overall Study|Protocol Violation|18
5058539|NCT02427399|17448322|P3|Overall Study|Protocol Violation|12
5058540|NCT02427399|17448323|P2|Overall Study|Protocol Violation|16
5058541|NCT02427399|17448324|P1|Overall Study|Protocol Violation|14
5058542|NCT02427100|17448348|P2|Overall Study|Lost to Follow-up|2
5058543|NCT02427100|17448349|P1|Overall Study|Lost to Follow-up|0
5058544|NCT02426918|17448360|P3|Overall Study|Other|9
5058545|NCT02426918|17448361|P2|Overall Study|Other|11
5058546|NCT02426918|17448362|P1|Overall Study|Other|9
5058547|NCT02426918|17448360|P3|Overall Study|Withdrawal by Subject|4
5058548|NCT02426918|17448361|P2|Overall Study|Withdrawal by Subject|5
5058549|NCT02426918|17448362|P1|Overall Study|Withdrawal by Subject|5
5058550|NCT02426918|17448360|P3|Overall Study|Physician Decision|1
5058551|NCT02426918|17448361|P2|Overall Study|Physician Decision|1
5058552|NCT02426918|17448362|P1|Overall Study|Physician Decision|1
5058553|NCT02426918|17448360|P3|Overall Study|Adverse Event|0
5058554|NCT02426918|17448361|P2|Overall Study|Adverse Event|2
5058555|NCT02426918|17448362|P1|Overall Study|Adverse Event|2
5058556|NCT02426658|17448397|P1|Overall Study|Patient expired before treatment|2
5058557|NCT02426658|17448397|P1|Overall Study|Withdrawal by Subject|1
5058558|NCT02426580|17448404|P2|Overall Study|Allergic to egg white|0
5058559|NCT02426580|17448405|P1|Overall Study|Allergic to egg white|1
5058560|NCT02426580|17448404|P2|Overall Study|Kidney transplant|0
5058561|NCT02426580|17448405|P1|Overall Study|Kidney transplant|3
5058562|NCT02426580|17448404|P2|Overall Study|transfer to hemodialysis|5
5058563|NCT02426580|17448405|P1|Overall Study|transfer to hemodialysis|5
5058564|NCT02426580|17448404|P2|Overall Study|Lost to Follow-up|9
5058565|NCT02426580|17448405|P1|Overall Study|Lost to Follow-up|0
5058566|NCT02426580|17448404|P2|Overall Study|Death|2
5058567|NCT02426580|17448405|P1|Overall Study|Death|2
5058568|NCT02426541|17448413|P2|Overall Study|Protocol Violation|0
5058569|NCT02426541|17448414|P1|Overall Study|Protocol Violation|1
5058570|NCT02426138|17448426|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
5058571|NCT02426138|17448427|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5058572|NCT02426125|17448467|P2|Overall Study|Withdrawal by Subject|16
5058573|NCT02426125|17448468|P1|Overall Study|Withdrawal by Subject|16
5058574|NCT02426125|17448467|P2|Overall Study|Protocol Violation|0
5058575|NCT02426125|17448468|P1|Overall Study|Protocol Violation|1
5058576|NCT02426125|17448467|P2|Overall Study|Lost to Follow-up|10
5058577|NCT02426125|17448468|P1|Overall Study|Lost to Follow-up|12
5058578|NCT02425826|17448499|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
5058579|NCT02425826|17448500|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
5058580|NCT02425826|17448501|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
5058581|NCT02425826|17448499|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
5058582|NCT02425826|17448500|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
5058583|NCT02425826|17448501|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
5058584|NCT02425826|17448499|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
5058585|NCT02425826|17448500|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
5058586|NCT02425826|17448501|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
5058587|NCT02425826|17448499|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
5058588|NCT02425826|17448500|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
5058589|NCT02425826|17448501|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
5058590|NCT02425826|17448499|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
5058591|NCT02425826|17448500|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
5058592|NCT02425826|17448501|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
5058593|NCT02425826|17448499|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
5058594|NCT02425826|17448500|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
5058595|NCT02425826|17448501|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
5058596|NCT02425826|17448499|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
5058597|NCT02425826|17448500|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
5058598|NCT02425826|17448501|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
5058599|NCT02425826|17448499|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
5058600|NCT02425826|17448500|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
5058601|NCT02425826|17448501|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
5058602|NCT02425826|17448499|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
5058603|NCT02425826|17448500|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
5058604|NCT02425826|17448501|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
5058605|NCT02425826|17448499|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
5058606|NCT02425826|17448500|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
5058607|NCT02425826|17448501|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
5058608|NCT02425111|17448555|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
5058609|NCT02425111|17448555|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
5058610|NCT02425111|17448555|P1|Part A: Treatment Period|Lost to Follow-up|2
5058611|NCT02425111|17448555|P1|Part A: Treatment Period|Voluntary Withdrawal|4
5058612|NCT02425111|17448555|P1|Part A: Treatment Period|Lack of Efficacy|15
5058613|NCT02425111|17448555|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
5058614|NCT02425098|17448576|P2|Overall Study|Reason not Specified|1
5058615|NCT02425098|17448577|P1|Overall Study|Reason not Specified|0
5058616|NCT02425098|17448576|P2|Overall Study|Pregnancy|0
5058617|NCT02425098|17448577|P1|Overall Study|Pregnancy|2
5058618|NCT02425098|17448576|P2|Overall Study|Withdrawal by Subject|8
5058619|NCT02425098|17448577|P1|Overall Study|Withdrawal by Subject|4
5058620|NCT02425098|17448576|P2|Overall Study|Lost to Follow-up|7
5058621|NCT02425098|17448577|P1|Overall Study|Lost to Follow-up|7
5058622|NCT02424734|17448729|P3|Overall Study|Treatment stopped to be discharged home|0
5058623|NCT02424734|17448730|P2|Overall Study|Treatment stopped to be discharged home|2
5058624|NCT02424734|17448731|P1|Overall Study|Treatment stopped to be discharged home|2
5058625|NCT02424630|17448750|P2|Overall Study|Open procedure|1
5058626|NCT02424630|17448751|P1|Overall Study|Open procedure|0
5058627|NCT02424630|17448750|P2|Overall Study|No rotator cuff tear|2
5058628|NCT02424630|17448751|P1|Overall Study|No rotator cuff tear|1
5058629|NCT02424591|17448761|P2|Overall Study|Protocol Violation|3
5058630|NCT02424591|17448762|P1|Overall Study|Protocol Violation|2
5058631|NCT02424578|17448774|P2|Overall Study|Withdrawal by Subject|1
5058632|NCT02424578|17448775|P1|Overall Study|Withdrawal by Subject|0
5058633|NCT02424565|17448781|P2|Period 1 (D0)|Protocol Violation|1
5058634|NCT02424565|17448782|P1|Period 1 (D0)|Protocol Violation|0
5058635|NCT02424539|17448791|P3|Overall Study|Other: Reached stopping criteria|6
5058636|NCT02424539|17448792|P2|Overall Study|Other: Reached stopping criteria|7
5058637|NCT02424539|17448793|P1|Overall Study|Other: Reached stopping criteria|11
5058638|NCT02424539|17448791|P3|Overall Study|Withdrawal by Subject|0
5058639|NCT02424539|17448792|P2|Overall Study|Withdrawal by Subject|1
5058640|NCT02424539|17448793|P1|Overall Study|Withdrawal by Subject|3
5058641|NCT02424539|17448791|P3|Overall Study|Physician Decision|1
5058642|NCT02424539|17448792|P2|Overall Study|Physician Decision|0
5058643|NCT02424539|17448793|P1|Overall Study|Physician Decision|0
5058644|NCT02424539|17448791|P3|Overall Study|Adverse Event|1
5058645|NCT02424539|17448792|P2|Overall Study|Adverse Event|0
5058646|NCT02424539|17448793|P1|Overall Study|Adverse Event|0
5058647|NCT02424383|17448876|P1|Overall Study|Ineligible for Major Protocol Deviation|39
5058648|NCT02424383|17448876|P1|Overall Study|Other|7
5058649|NCT02424383|17448876|P1|Overall Study|Lost to Follow-up|81
5058650|NCT02424383|17448876|P1|Overall Study|Investigator's decision|44
5058651|NCT02424383|17448876|P1|Overall Study|Sponsor's decision|3
5058652|NCT02424383|17448876|P1|Overall Study|Death|170
5058653|NCT02424383|17448876|P1|Overall Study|Withdrawal by Subject|32
5058654|NCT02424344|17448900|P2|Overall Study|Adverse Event|8
5058655|NCT02424344|17448901|P1|Overall Study|Adverse Event|4
5058656|NCT02424344|17448900|P2|Overall Study|Lost to Follow-up|0
5058657|NCT02424344|17448901|P1|Overall Study|Lost to Follow-up|1
5058658|NCT02424344|17448900|P2|Overall Study|Withdrawal by Subject|1
5058659|NCT02424344|17448901|P1|Overall Study|Withdrawal by Subject|2
5058660|NCT02424344|17448900|P2|Overall Study|Lack of Efficacy|1
5058661|NCT02424344|17448901|P1|Overall Study|Lack of Efficacy|0
5058662|NCT02424149|17448919|P2|Overall Study|Withdrawal by Subject|1
5058663|NCT02424149|17448920|P1|Overall Study|Withdrawal by Subject|0
5058664|NCT02424149|17448919|P2|Overall Study|surgery cancelled|0
5058665|NCT02424149|17448920|P1|Overall Study|surgery cancelled|2
5058666|NCT02424097|17448936|P2|Overall Study|Lost to Follow-up|2
5058667|NCT02424097|17448937|P1|Overall Study|Lost to Follow-up|1
5058668|NCT02423798|17448992|P1|Overall Study|Withdrawal by Subject|3
5058669|NCT02423291|17449058|P1|Overall Study|Adverse Event|1
5058670|NCT02423291|17449058|P1|Overall Study|Lack of Efficacy|14
5058671|NCT02423109|17449088|P2|Lens 1|Adverse Event|0
5058672|NCT02423109|17449089|P1|Lens 1|Adverse Event|1
5058673|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
5058674|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5058675|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
5058676|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
5058677|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
5058678|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
5058679|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
5058680|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
5058681|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
5058682|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
5058683|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
5058684|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
5058685|NCT02422797|17449122|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
5058686|NCT02422797|17449123|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
5058687|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
5058688|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
5058689|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
5058690|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
5058691|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
5058692|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
5058693|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5058694|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5058695|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
5058696|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
5058697|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
5058698|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
5058699|NCT02422797|17449122|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
5058700|NCT02422797|17449123|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
5058701|NCT02422615|17449211|P2|Overall Study|Technical problems|1
5058702|NCT02422615|17449212|P1|Overall Study|Technical problems|0
5058703|NCT02422615|17449211|P2|Overall Study|Protocol Violation|1
5058704|NCT02422615|17449212|P1|Overall Study|Protocol Violation|1
5058705|NCT02422615|17449211|P2|Overall Study|Death|0
5058706|NCT02422615|17449212|P1|Overall Study|Death|2
5058707|NCT02422615|17449211|P2|Overall Study|Subject/guardian decision|5
5058708|NCT02422615|17449212|P1|Overall Study|Subject/guardian decision|21
5058709|NCT02422615|17449211|P2|Overall Study|Physician Decision|7
5058710|NCT02422615|17449212|P1|Overall Study|Physician Decision|22
5058711|NCT02422615|17449211|P2|Overall Study|Adverse Event|10
5058712|NCT02422615|17449212|P1|Overall Study|Adverse Event|41
5058713|NCT02422615|17449211|P2|Overall Study|Progressive disease|142
5058714|NCT02422615|17449212|P1|Overall Study|Progressive disease|193
5058715|NCT02422303|17449229|P2|Overall Study|Lost to Follow-up|1
5058716|NCT02422303|17449230|P1|Overall Study|Lost to Follow-up|1
5058717|NCT02422264|17449245|P2|Overall Study|Subject vaccinated outside of the study|1
5058718|NCT02422264|17449246|P1|Overall Study|Subject vaccinated outside of the study|0
5058719|NCT02422264|17449245|P2|Overall Study|Migrated/moved from study area|1
5058720|NCT02422264|17449246|P1|Overall Study|Migrated/moved from study area|3
5058721|NCT02422264|17449245|P2|Overall Study|Withdrawal by Subject|2
5058722|NCT02422264|17449246|P1|Overall Study|Withdrawal by Subject|1
5058723|NCT02422264|17449245|P2|Overall Study|Serious Adverse Event|0
5058724|NCT02422264|17449246|P1|Overall Study|Serious Adverse Event|1
5058725|NCT02422186|17449292|P2|Follow-up Phase (2 Weeks)|Other|0
5058726|NCT02422186|17449293|P1|Follow-up Phase (2 Weeks)|Other|3
5058727|NCT02422186|17449292|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
5058728|NCT02422186|17449293|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
5058729|NCT02422186|17449292|P2|Double-blind Induction Phase (4 Weeks)|Other|0
5058730|NCT02422186|17449293|P1|Double-blind Induction Phase (4 Weeks)|Other|1
5058731|NCT02422186|17449292|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
5058732|NCT02422186|17449293|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
5058733|NCT02422186|17449292|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5058734|NCT02422186|17449293|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
5058735|NCT02422186|17449292|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
5058736|NCT02422186|17449293|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5058737|NCT02422186|17449292|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5058738|NCT02422186|17449293|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
5058739|NCT02422186|17449292|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5058740|NCT02422186|17449293|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
5058741|NCT02421952|17449315|P1|Overall Study|Surgery cancelled|1
5058742|NCT02421952|17449315|P1|Overall Study|Subject uncooperative for baseline test|2
5058743|NCT02421952|17449315|P1|Overall Study|Failed seriation task|13
5058744|NCT02421952|17449315|P1|Overall Study|Diary Not Returned|93
5058745|NCT02421939|17449324|P2|Overall Study|Protocol deviation|1
5058746|NCT02421939|17449325|P1|Overall Study|Protocol deviation|1
5058747|NCT02421939|17449324|P2|Overall Study|Miscellaneous|5
5058748|NCT02421939|17449325|P1|Overall Study|Miscellaneous|4
5058749|NCT02421939|17449324|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
5058750|NCT02421939|17449325|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
5058751|NCT02421939|17449324|P2|Overall Study|Physician Decision|11
5058752|NCT02421939|17449325|P1|Overall Study|Physician Decision|11
5058753|NCT02421939|17449324|P2|Overall Study|Withdrawal by Subject|24
5058754|NCT02421939|17449325|P1|Overall Study|Withdrawal by Subject|5
5058755|NCT02421939|17449324|P2|Overall Study|Adverse Event|5
5058756|NCT02421939|17449325|P1|Overall Study|Adverse Event|28
5058757|NCT02421939|17449324|P2|Overall Study|Disease relapse|2
5058758|NCT02421939|17449325|P1|Overall Study|Disease relapse|33
5058759|NCT02421939|17449324|P2|Overall Study|Death|10
5058760|NCT02421939|17449325|P1|Overall Study|Death|36
5058761|NCT02421939|17449324|P2|Overall Study|Lack of Efficacy|31
5058762|NCT02421939|17449325|P1|Overall Study|Lack of Efficacy|21
5058763|NCT02421939|17449324|P2|Overall Study|Progressive disease|16
5058764|NCT02421939|17449325|P1|Overall Study|Progressive disease|70
5058765|NCT02421887|17449353|P2|Overall Study|Adverse Event|0
5058766|NCT02421887|17449354|P1|Overall Study|Adverse Event|2
5058767|NCT02421887|17449353|P2|Overall Study|Physician Decision|4
5058768|NCT02421887|17449354|P1|Overall Study|Physician Decision|2
5058769|NCT02421887|17449353|P2|Overall Study|Withdrawal by Subject|5
5058770|NCT02421887|17449354|P1|Overall Study|Withdrawal by Subject|8
5058771|NCT02421887|17449353|P2|Overall Study|Lost to Follow-up|0
5058772|NCT02421887|17449354|P1|Overall Study|Lost to Follow-up|5
5058773|NCT02421666|17449380|P2|12-month Follow-up|Withdrawal by Subject|11
5058774|NCT02421666|17449381|P1|12-month Follow-up|Withdrawal by Subject|6
5058775|NCT02421666|17449380|P2|12-month Follow-up|Lost to Follow-up|5
5058776|NCT02421666|17449381|P1|12-month Follow-up|Lost to Follow-up|5
5058777|NCT02421666|17449380|P2|6-month Follow-up|Withdrawal by Subject|6
5058778|NCT02421666|17449381|P1|6-month Follow-up|Withdrawal by Subject|5
5058779|NCT02421666|17449380|P2|6-month Follow-up|Lost to Follow-up|7
5058780|NCT02421666|17449381|P1|6-month Follow-up|Lost to Follow-up|8
5058781|NCT02421588|17449389|P2|Overall Study|Not treated|8
5058782|NCT02421588|17449390|P1|Overall Study|Not treated|2
5058783|NCT02421588|17449389|P2|Overall Study|Withdrawal by Subject|16
5058784|NCT02421588|17449390|P1|Overall Study|Withdrawal by Subject|14
5058785|NCT02421588|17449389|P2|Overall Study|Treatment-related AE|14
5058786|NCT02421588|17449390|P1|Overall Study|Treatment-related AE|10
5058787|NCT02421588|17449389|P2|Overall Study|Symptomatic deterioration|19
5058788|NCT02421588|17449390|P1|Overall Study|Symptomatic deterioration|13
5058789|NCT02421588|17449389|P2|Overall Study|Other reason not specified|1
5058790|NCT02421588|17449390|P1|Overall Study|Other reason not specified|3
5058791|NCT02421588|17449389|P2|Overall Study|Physician Decision|17
5058792|NCT02421588|17449390|P1|Overall Study|Physician Decision|8
5058793|NCT02421588|17449389|P2|Overall Study|Death|3
5058794|NCT02421588|17449390|P1|Overall Study|Death|11
5058795|NCT02421588|17449389|P2|Overall Study|Progressive disease|135
5058796|NCT02421588|17449390|P1|Overall Study|Progressive disease|152
5058797|NCT02421588|17449389|P2|Overall Study|Non-treatment-related AE|8
5058798|NCT02421588|17449390|P1|Overall Study|Non-treatment-related AE|8
5058799|NCT02421510|17449413|P3|Overall Study|Lost to Follow-up|0
5058800|NCT02421510|17449414|P2|Overall Study|Lost to Follow-up|1
5058801|NCT02421510|17449415|P1|Overall Study|Lost to Follow-up|1
5058802|NCT02421510|17449413|P3|Overall Study|Withdrawal by Subject|12
5058803|NCT02421510|17449414|P2|Overall Study|Withdrawal by Subject|18
5058804|NCT02421510|17449415|P1|Overall Study|Withdrawal by Subject|14
5058805|NCT02421510|17449413|P3|Overall Study|Pregnancy|0
5058806|NCT02421510|17449414|P2|Overall Study|Pregnancy|1
5058807|NCT02421510|17449415|P1|Overall Study|Pregnancy|1
5058808|NCT02421510|17449413|P3|Overall Study|Adverse Event|18
5058809|NCT02421510|17449414|P2|Overall Study|Adverse Event|10
5058810|NCT02421510|17449415|P1|Overall Study|Adverse Event|9
5058811|NCT02421510|17449413|P3|Overall Study|Physician Decision|3
5058812|NCT02421510|17449414|P2|Overall Study|Physician Decision|1
5058813|NCT02421510|17449415|P1|Overall Study|Physician Decision|1
5058814|NCT02421510|17449413|P3|Overall Study|Noncompliance with study drug|0
5058815|NCT02421510|17449414|P2|Overall Study|Noncompliance with study drug|0
5058816|NCT02421510|17449415|P1|Overall Study|Noncompliance with study drug|1
5058817|NCT02421510|17449413|P3|Overall Study|Death|0
5058818|NCT02421510|17449414|P2|Overall Study|Death|0
5058819|NCT02421510|17449415|P1|Overall Study|Death|1
5058820|NCT02421510|17449413|P3|Overall Study|Protocol Violation|0
5058821|NCT02421510|17449414|P2|Overall Study|Protocol Violation|2
5058822|NCT02421510|17449415|P1|Overall Study|Protocol Violation|1
5058823|NCT02421510|17449413|P3|Overall Study|Other|3
5058824|NCT02421510|17449414|P2|Overall Study|Other|2
5058825|NCT02421510|17449415|P1|Overall Study|Other|4
5058826|NCT02421419|17449447|P3|Overall Study|Physician Decision|1
5058827|NCT02421419|17449448|P2|Overall Study|Physician Decision|0
5058828|NCT02421419|17449449|P1|Overall Study|Physician Decision|0
5058829|NCT02421172|17449574|P5|Period 2|Patient/guardian decision|1
5058830|NCT02421172|17449575|P4|Period 2|Patient/guardian decision|2
5058831|NCT02421172|17449576|P3|Period 2|Patient/guardian decision|3
5058832|NCT02421172|17449577|P2|Period 2|Patient/guardian decision|0
5058833|NCT02421172|17449578|P1|Period 2|Patient/guardian decision|0
5058834|NCT02421172|17449574|P5|Period 2|Lost to Follow-up|0
5058835|NCT02421172|17449575|P4|Period 2|Lost to Follow-up|1
5058836|NCT02421172|17449576|P3|Period 2|Lost to Follow-up|0
5058837|NCT02421172|17449577|P2|Period 2|Lost to Follow-up|0
5058838|NCT02421172|17449578|P1|Period 2|Lost to Follow-up|0
5058839|NCT02421172|17449574|P5|Period 2|Adverse Event|0
5058840|NCT02421172|17449575|P4|Period 2|Adverse Event|0
5058841|NCT02421172|17449576|P3|Period 2|Adverse Event|4
5058842|NCT02421172|17449577|P2|Period 2|Adverse Event|0
5058843|NCT02421172|17449578|P1|Period 2|Adverse Event|0
5058844|NCT02421172|17449574|P5|Period 1|Patient/guardian decision|0
5058845|NCT02421172|17449575|P4|Period 1|Patient/guardian decision|0
5058846|NCT02421172|17449576|P3|Period 1|Patient/guardian decision|0
5058847|NCT02421172|17449577|P2|Period 1|Patient/guardian decision|1
5058848|NCT02421172|17449578|P1|Period 1|Patient/guardian decision|0
5058849|NCT02421172|17449574|P5|Period 1|Lost to Follow-up|0
5058850|NCT02421172|17449575|P4|Period 1|Lost to Follow-up|0
5058851|NCT02421172|17449576|P3|Period 1|Lost to Follow-up|0
5058852|NCT02421172|17449577|P2|Period 1|Lost to Follow-up|1
5058853|NCT02421172|17449578|P1|Period 1|Lost to Follow-up|3
5058854|NCT02421172|17449574|P5|Period 1|Adverse Event|0
5058855|NCT02421172|17449575|P4|Period 1|Adverse Event|0
5058856|NCT02421172|17449576|P3|Period 1|Adverse Event|0
5058857|NCT02421172|17449577|P2|Period 1|Adverse Event|0
5058858|NCT02421172|17449578|P1|Period 1|Adverse Event|1
5058859|NCT02421120|17449622|P1|Overall Study|Adverse Event|1
5058860|NCT02420821|17449706|P2|Overall Study|Death|116
5058861|NCT02420821|17449707|P1|Overall Study|Death|129
5058862|NCT02420821|17449706|P2|Overall Study|Withdrawal by Subject|17
5058863|NCT02420821|17449707|P1|Overall Study|Withdrawal by Subject|31
5058864|NCT02420821|17449706|P2|Overall Study|Physician Decision|2
5058865|NCT02420821|17449707|P1|Overall Study|Physician Decision|5
5058866|NCT02420821|17449706|P2|Overall Study|Non-compliance|2
5058867|NCT02420821|17449707|P1|Overall Study|Non-compliance|1
5058868|NCT02420821|17449706|P2|Overall Study|Lost to Follow-up|0
5058869|NCT02420821|17449707|P1|Overall Study|Lost to Follow-up|2
5058870|NCT02420691|17449775|P1|Overall Study|Withdrawal by Subject|3
5058871|NCT02420691|17449775|P1|Overall Study|Adverse Event|3
5058872|NCT02420379|17449785|P2|Overall Study|Transitioned to commercial drug|0
5058873|NCT02420379|17449786|P1|Overall Study|Transitioned to commercial drug|1
5058874|NCT02420379|17449785|P2|Overall Study|Unable to complete due to schooling|1
5058875|NCT02420379|17449786|P1|Overall Study|Unable to complete due to schooling|0
5058876|NCT02420379|17449785|P2|Overall Study|Withdrawal by Subject|3
5058877|NCT02420379|17449786|P1|Overall Study|Withdrawal by Subject|0
5058878|NCT02420353|17449804|P2|Overall Study|Withdrawal by Subject|1
5058879|NCT02420353|17449805|P1|Overall Study|Withdrawal by Subject|0
5058880|NCT02420327|17449897|P1|Overall Study|Protocol Violation|1
5058881|NCT02420327|17449897|P1|Overall Study|Lost to Follow-up|1
5058882|NCT02420327|17449897|P1|Overall Study|Withdrawal by Subject|6
5058883|NCT02420327|17449897|P1|Overall Study|Pregnancy|1
5058884|NCT02420327|17449897|P1|Overall Study|Adverse Event|7
5058885|NCT02420262|17449933|P2|Overall Study|Unclassified|1
5058886|NCT02420262|17449934|P1|Overall Study|Unclassified|0
5058887|NCT02420262|17449933|P2|Overall Study|Withdrawal by Subject|4
5058888|NCT02420262|17449934|P1|Overall Study|Withdrawal by Subject|1
5058889|NCT02420262|17449933|P2|Overall Study|Adverse Event|0
5058890|NCT02420262|17449934|P1|Overall Study|Adverse Event|1
5058891|NCT02420093|17449960|P2|Overall Study|Withdrawal by Subject|1
5058892|NCT02420093|17449961|P1|Overall Study|Withdrawal by Subject|1
5058893|NCT02419937|17450023|P2|Overall Study|Lost to Follow-up|0
5058894|NCT02419937|17450024|P1|Overall Study|Lost to Follow-up|1
5058895|NCT02419807|17450037|P1|Overall Study|Protocol Violation|5
5058896|NCT02419807|17450037|P1|Overall Study|Physician Decision|1
5058897|NCT02419807|17450037|P1|Overall Study|Withdrawal by Subject|4
5058898|NCT02419755|17450043|P2|Overall Study|Withdrawal by Subject|0
5058899|NCT02419755|17450044|P1|Overall Study|Withdrawal by Subject|1
5058900|NCT02419755|17450043|P2|Overall Study|Ineligible|0
5058901|NCT02419755|17450044|P1|Overall Study|Ineligible|1
5058902|NCT02419755|17450043|P2|Overall Study|Relapse|1
5058903|NCT02419755|17450044|P1|Overall Study|Relapse|0
5058904|NCT02419755|17450043|P2|Overall Study|Death|3
5058905|NCT02419755|17450044|P1|Overall Study|Death|1
5058906|NCT02419612|17450085|P2|Long-term Treatment Period|Withdrawal by Subject|2
5058907|NCT02419612|17450086|P1|Long-term Treatment Period|Withdrawal by Subject|8
5058908|NCT02419612|17450085|P2|Long-term Treatment Period|Subject Decision|4
5058909|NCT02419612|17450086|P1|Long-term Treatment Period|Subject Decision|2
5058910|NCT02419612|17450085|P2|Long-term Treatment Period|Other|4
5058911|NCT02419612|17450086|P1|Long-term Treatment Period|Other|4
5058912|NCT02419612|17450085|P2|Long-term Treatment Period|Adverse Event|5
5058913|NCT02419612|17450086|P1|Long-term Treatment Period|Adverse Event|0
5058914|NCT02419612|17450085|P2|Long-term Treatment Period|Death|1
5058915|NCT02419612|17450086|P1|Long-term Treatment Period|Death|0
5058916|NCT02419612|17450085|P2|Long-term Treatment Period|Lack of Efficacy|1
5058917|NCT02419612|17450086|P1|Long-term Treatment Period|Lack of Efficacy|1
5058918|NCT02419612|17450085|P2|Long-term Treatment Period|Lost to Follow-up|4
5058919|NCT02419612|17450086|P1|Long-term Treatment Period|Lost to Follow-up|6
5058920|NCT02419612|17450085|P2|Long-term Treatment Period|Non-compliance with Study Drug|1
5058921|NCT02419612|17450086|P1|Long-term Treatment Period|Non-compliance with Study Drug|1
5058922|NCT02419612|17450085|P2|Short-term Treatment Period|Subject moved out of state|1
5058923|NCT02419612|17450086|P1|Short-term Treatment Period|Subject moved out of state|0
5058924|NCT02419612|17450085|P2|Short-term Treatment Period|Worsening of liver function|1
5058925|NCT02419612|17450086|P1|Short-term Treatment Period|Worsening of liver function|0
5058926|NCT02419612|17450085|P2|Short-term Treatment Period|Non-compliance with Study Drug|2
5058927|NCT02419612|17450086|P1|Short-term Treatment Period|Non-compliance with Study Drug|0
5058928|NCT02419612|17450085|P2|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
5058929|NCT02419612|17450086|P1|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
5058930|NCT02419612|17450085|P2|Short-term Treatment Period|Withdrawal by Subject|9
5058931|NCT02419612|17450086|P1|Short-term Treatment Period|Withdrawal by Subject|9
5058932|NCT02419612|17450085|P2|Short-term Treatment Period|Lost to Follow-up|6
5058933|NCT02419612|17450086|P1|Short-term Treatment Period|Lost to Follow-up|6
5058934|NCT02419612|17450085|P2|Short-term Treatment Period|Death|2
5058935|NCT02419612|17450086|P1|Short-term Treatment Period|Death|0
5058936|NCT02419612|17450085|P2|Short-term Treatment Period|Adverse Event|1
5058937|NCT02419612|17450086|P1|Short-term Treatment Period|Adverse Event|1
5058938|NCT02419573|17450108|P2|Overall Study|Withdrawal by Subject|0
5058939|NCT02419573|17450109|P1|Overall Study|Withdrawal by Subject|1
5058940|NCT02419573|17450108|P2|Overall Study|Lost to Follow-up|0
5058941|NCT02419573|17450109|P1|Overall Study|Lost to Follow-up|3
5058942|NCT02419508|17450139|P2|Overall Study|Other - Reason not specified|1
5058943|NCT02419508|17450140|P1|Overall Study|Other - Reason not specified|0
5058944|NCT02419508|17450139|P2|Overall Study|Withdrawal by Subject|0
5058945|NCT02419508|17450140|P1|Overall Study|Withdrawal by Subject|1
5058946|NCT02419508|17450139|P2|Overall Study|Adverse Event|3
5058947|NCT02419508|17450140|P1|Overall Study|Adverse Event|9
5058948|NCT02419469|17450158|P1|Overall Study|Withdrawal by Subject|1
5058949|NCT02419313|17450162|P2|Second Intervention|Lost to Follow-up|0
5058950|NCT02419313|17450163|P1|Second Intervention|Lost to Follow-up|1
5058951|NCT02419313|17450162|P2|First Intervention|Lost to Follow-up|0
5058952|NCT02419313|17450163|P1|First Intervention|Lost to Follow-up|2
5058953|NCT02419001|17450175|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
5058954|NCT02419001|17450176|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
5058955|NCT02418910|17450186|P1|Overall Study|Withdrawal by Subject|4
5058956|NCT02418910|17450186|P1|Overall Study|Lost to Follow-up|3
5058957|NCT02418819|17450194|P4|Overall Study|No longer willing to participate|1
5058958|NCT02418819|17450195|P3|Overall Study|No longer willing to participate|2
5058959|NCT02418819|17450196|P2|Overall Study|No longer willing to participate|0
5058960|NCT02418819|17450197|P1|Overall Study|No longer willing to participate|0
5058961|NCT02418819|17450194|P4|Overall Study|No longer meets eligibility criteria|0
5058962|NCT02418819|17450195|P3|Overall Study|No longer meets eligibility criteria|1
5058963|NCT02418819|17450196|P2|Overall Study|No longer meets eligibility criteria|0
5058964|NCT02418819|17450197|P1|Overall Study|No longer meets eligibility criteria|0
5058965|NCT02418819|17450194|P4|Overall Study|Lost to Follow-up|0
5058966|NCT02418819|17450195|P3|Overall Study|Lost to Follow-up|0
5058967|NCT02418819|17450196|P2|Overall Study|Lost to Follow-up|0
5058968|NCT02418819|17450197|P1|Overall Study|Lost to Follow-up|1
5058969|NCT02418819|17450194|P4|Overall Study|Adverse Event|0
5058970|NCT02418819|17450195|P3|Overall Study|Adverse Event|1
5058971|NCT02418819|17450196|P2|Overall Study|Adverse Event|0
5058972|NCT02418819|17450197|P1|Overall Study|Adverse Event|0
5058973|NCT02418754|17450240|P5|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5058974|NCT02418754|17450241|P4|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
5058975|NCT02418754|17450242|P3|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5058976|NCT02418754|17450243|P2|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
5058977|NCT02418754|17450244|P1|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5058978|NCT02418754|17450240|P5|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
5058979|NCT02418754|17450241|P4|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
5058980|NCT02418754|17450242|P3|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
5058981|NCT02418754|17450243|P2|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
5058982|NCT02418754|17450244|P1|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
5058983|NCT02418754|17450240|P5|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
5058984|NCT02418754|17450241|P4|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
5058985|NCT02418754|17450242|P3|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
5058986|NCT02418754|17450243|P2|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
5058987|NCT02418754|17450244|P1|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
5058988|NCT02418754|17450240|P5|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
5058989|NCT02418754|17450241|P4|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
5058990|NCT02418754|17450242|P3|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
5058991|NCT02418754|17450243|P2|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
5058992|NCT02418754|17450244|P1|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
5058993|NCT02418754|17450240|P5|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5058994|NCT02418754|17450241|P4|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5058995|NCT02418754|17450242|P3|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5058996|NCT02418754|17450243|P2|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5058997|NCT02418754|17450244|P1|Period 2 (Day 1 to Week 52/End of Study)|Death|1
5058998|NCT02418754|17450240|P5|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
5058999|NCT02418754|17450241|P4|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
5059000|NCT02418754|17450242|P3|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
5059001|NCT02418754|17450243|P2|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
5059002|NCT02418754|17450244|P1|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
5059003|NCT02418754|17450240|P5|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5059004|NCT02418754|17450241|P4|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5059005|NCT02418754|17450242|P3|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
5059006|NCT02418754|17450243|P2|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5059007|NCT02418754|17450244|P1|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5059008|NCT02418754|17450240|P5|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5059009|NCT02418754|17450241|P4|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5059010|NCT02418754|17450242|P3|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
5059011|NCT02418754|17450243|P2|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
5059012|NCT02418754|17450244|P1|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5059013|NCT02418754|17450240|P5|Period 1 (Day 1 to Week 12)|Physician Decision|0
5059014|NCT02418754|17450241|P4|Period 1 (Day 1 to Week 12)|Physician Decision|0
5059015|NCT02418754|17450242|P3|Period 1 (Day 1 to Week 12)|Physician Decision|0
5059016|NCT02418754|17450243|P2|Period 1 (Day 1 to Week 12)|Physician Decision|0
5059017|NCT02418754|17450244|P1|Period 1 (Day 1 to Week 12)|Physician Decision|1
5059018|NCT02418754|17450240|P5|Period 1 (Day 1 to Week 12)|Death|0
5059019|NCT02418754|17450241|P4|Period 1 (Day 1 to Week 12)|Death|0
5059020|NCT02418754|17450242|P3|Period 1 (Day 1 to Week 12)|Death|0
5059021|NCT02418754|17450243|P2|Period 1 (Day 1 to Week 12)|Death|0
5059022|NCT02418754|17450244|P1|Period 1 (Day 1 to Week 12)|Death|1
5059023|NCT02418754|17450240|P5|Period 1 (Day 1 to Week 12)|Adverse Event|0
5059024|NCT02418754|17450241|P4|Period 1 (Day 1 to Week 12)|Adverse Event|0
5059025|NCT02418754|17450242|P3|Period 1 (Day 1 to Week 12)|Adverse Event|0
5059026|NCT02418754|17450243|P2|Period 1 (Day 1 to Week 12)|Adverse Event|2
5059027|NCT02418754|17450244|P1|Period 1 (Day 1 to Week 12)|Adverse Event|0
5059028|NCT02418585|17450293|P2|Follow-up Phase (24 Weeks)|Other|2
5059029|NCT02418585|17450294|P1|Follow-up Phase (24 Weeks)|Other|3
5059030|NCT02418585|17450293|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
5059031|NCT02418585|17450294|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
5059032|NCT02418585|17450293|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
5059033|NCT02418585|17450294|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
5059034|NCT02418585|17450293|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
5059035|NCT02418585|17450294|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
5059036|NCT02418585|17450293|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
5059037|NCT02418585|17450294|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
5059038|NCT02418585|17450293|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
5059039|NCT02418585|17450294|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
5059040|NCT02418585|17450293|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
5059041|NCT02418585|17450294|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
5059042|NCT02418585|17450293|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
5059043|NCT02418585|17450294|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
5059044|NCT02418585|17450293|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
5059045|NCT02418585|17450294|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
5059046|NCT02418585|17450293|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
5059047|NCT02418585|17450294|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
5059048|NCT02418468|17450350|P2|Overall Study|Withdrawal of informed consent|1
5059049|NCT02418468|17450351|P1|Overall Study|Withdrawal of informed consent|1
5059050|NCT02418468|17450350|P2|Overall Study|Adverse Event|0
5059051|NCT02418468|17450351|P1|Overall Study|Adverse Event|1
5059052|NCT02418455|17450357|P1|Continuation Period|Sponsor Decision|7
5059053|NCT02418455|17450357|P1|48-Week Treatment Period|Other- Not Specified|1
5059054|NCT02418182|17450400|P2|Overall Study|Lost to Follow-up|2
5059055|NCT02418182|17450401|P1|Overall Study|Lost to Follow-up|0
5059056|NCT02418182|17450400|P2|Overall Study|Unable to re-consent|15
5059057|NCT02418182|17450401|P1|Overall Study|Unable to re-consent|18
5059058|NCT02418156|17450413|P1|Overall Study|Subject refused to return|1
5059059|NCT02418156|17450413|P1|Overall Study|Withdrawal by Subject|1
5059060|NCT02418156|17450413|P1|Overall Study|Physician Decision|1
5059061|NCT02418156|17450413|P1|Overall Study|Death|2
5059062|NCT02418156|17450413|P1|Overall Study|Lost to Follow-up|12
5059063|NCT02418000|17450455|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
5059064|NCT02418000|17450456|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059065|NCT02418000|17450457|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059066|NCT02418000|17450458|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059067|NCT02418000|17450459|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059068|NCT02418000|17450455|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
5059069|NCT02418000|17450456|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5059070|NCT02418000|17450457|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5059071|NCT02418000|17450458|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5059072|NCT02418000|17450459|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5059073|NCT02418000|17450455|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059074|NCT02418000|17450456|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
5059075|NCT02418000|17450457|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059076|NCT02418000|17450458|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059077|NCT02418000|17450459|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059078|NCT02418000|17450455|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059079|NCT02418000|17450456|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059080|NCT02418000|17450457|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
5059081|NCT02418000|17450458|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059082|NCT02418000|17450459|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5059083|NCT02418000|17450455|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5059084|NCT02418000|17450456|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5059085|NCT02418000|17450457|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5059086|NCT02418000|17450458|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
5059087|NCT02418000|17450459|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5059088|NCT02418000|17450455|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5059089|NCT02418000|17450456|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5059090|NCT02418000|17450457|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5059091|NCT02418000|17450458|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
5059092|NCT02418000|17450459|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5059093|NCT02418000|17450455|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5059094|NCT02418000|17450456|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5059095|NCT02418000|17450457|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5059096|NCT02418000|17450458|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5059097|NCT02418000|17450459|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
5059098|NCT02418000|17450455|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5059099|NCT02418000|17450456|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5059100|NCT02418000|17450457|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5059101|NCT02418000|17450458|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5059102|NCT02418000|17450459|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
5059103|NCT02418000|17450455|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5059104|NCT02418000|17450456|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5059105|NCT02418000|17450457|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5059106|NCT02418000|17450458|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5059107|NCT02418000|17450459|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
5059108|NCT02417961|17450577|P1|Overall Study|Withdrawal by Subject|2
5059109|NCT02417961|17450577|P1|Overall Study|Lost to Follow-up|1
5059110|NCT02417961|17450577|P1|Overall Study|Adverse Event|1
5059111|NCT02417935|17450589|P2|Treatment Period|Physician Decision|1
5059112|NCT02417935|17450590|P1|Treatment Period|Physician Decision|3
5059113|NCT02417935|17450589|P2|Treatment Period|Withdrawal by Subject|3
5059114|NCT02417935|17450590|P1|Treatment Period|Withdrawal by Subject|3
5059115|NCT02417935|17450589|P2|Treatment Period|Protocol Violation|1
5059116|NCT02417935|17450590|P1|Treatment Period|Protocol Violation|2
5059117|NCT02417935|17450589|P2|Treatment Period|Entry Criteria not met|1
5059118|NCT02417935|17450590|P1|Treatment Period|Entry Criteria not met|0
5059119|NCT02417935|17450589|P2|Treatment Period|Lost to Follow-up|0
5059120|NCT02417935|17450590|P1|Treatment Period|Lost to Follow-up|1
5059121|NCT02417935|17450589|P2|Treatment Period|Adverse Event|10
5059122|NCT02417935|17450590|P1|Treatment Period|Adverse Event|12
5059123|NCT02417753|17450648|P1|Overall Study|Death|1
5059124|NCT02417441|17450668|P2|Overall Study|Inconclusive due to missing data|19
5059125|NCT02417441|17450669|P1|Overall Study|Inconclusive due to missing data|52
5059126|NCT02417246|17450737|P2|Phase 2 1st Generic Administered|Physician Decision|0
5059127|NCT02417246|17450738|P1|Phase 2 1st Generic Administered|Physician Decision|1
5059128|NCT02417246|17450737|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
5059129|NCT02417246|17450738|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
5059130|NCT02417246|17450737|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
5059131|NCT02417246|17450738|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
5059132|NCT02417246|17450737|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
5059133|NCT02417246|17450738|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
5059134|NCT02417233|17450761|P3|Overall Study|Mentally unstable|0
5059135|NCT02417233|17450762|P2|Overall Study|Mentally unstable|1
5059136|NCT02417233|17450763|P1|Overall Study|Mentally unstable|0
5059137|NCT02417233|17450761|P3|Overall Study|Relocation out of study area|1
5059138|NCT02417233|17450762|P2|Overall Study|Relocation out of study area|0
5059139|NCT02417233|17450763|P1|Overall Study|Relocation out of study area|1
5059140|NCT02417233|17450761|P3|Overall Study|Withdrawal by Subject|8
5059141|NCT02417233|17450762|P2|Overall Study|Withdrawal by Subject|1
5059142|NCT02417233|17450763|P1|Overall Study|Withdrawal by Subject|2
5059143|NCT02417233|17450761|P3|Overall Study|Protocol Violation|2
5059144|NCT02417233|17450762|P2|Overall Study|Protocol Violation|0
5059145|NCT02417233|17450763|P1|Overall Study|Protocol Violation|2
5059146|NCT02417233|17450761|P3|Overall Study|Lost to Follow-up|34
5059147|NCT02417233|17450762|P2|Overall Study|Lost to Follow-up|39
5059148|NCT02417233|17450763|P1|Overall Study|Lost to Follow-up|27
5059149|NCT02417233|17450761|P3|Overall Study|Death|14
5059150|NCT02417233|17450762|P2|Overall Study|Death|10
5059151|NCT02417233|17450763|P1|Overall Study|Death|4
5059152|NCT02417064|17450800|P3|Follow-up Phase (24 Weeks)|Other|3
5059153|NCT02417064|17450801|P2|Follow-up Phase (24 Weeks)|Other|2
5059154|NCT02417064|17450802|P1|Follow-up Phase (24 Weeks)|Other|2
5059155|NCT02417064|17450800|P3|Follow-up Phase (24 Weeks)|PI Decision|44
5059156|NCT02417064|17450801|P2|Follow-up Phase (24 Weeks)|PI Decision|29
5059157|NCT02417064|17450802|P1|Follow-up Phase (24 Weeks)|PI Decision|34
5059158|NCT02417064|17450800|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
5059159|NCT02417064|17450801|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
5059160|NCT02417064|17450802|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
5059161|NCT02417064|17450800|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
5059162|NCT02417064|17450801|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
5059163|NCT02417064|17450802|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
5059164|NCT02417064|17450800|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
5059165|NCT02417064|17450801|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
5059166|NCT02417064|17450802|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
5059167|NCT02417064|17450800|P3|Double-blind Induction Phase (4 Weeks)|Other|2
5059168|NCT02417064|17450801|P2|Double-blind Induction Phase (4 Weeks)|Other|4
5059169|NCT02417064|17450802|P1|Double-blind Induction Phase (4 Weeks)|Other|1
5059170|NCT02417064|17450800|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5059171|NCT02417064|17450801|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
5059172|NCT02417064|17450802|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5059173|NCT02417064|17450800|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5059174|NCT02417064|17450801|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5059175|NCT02417064|17450802|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
5059176|NCT02417064|17450800|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5059177|NCT02417064|17450801|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
5059178|NCT02417064|17450802|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5059179|NCT02417064|17450800|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
5059180|NCT02417064|17450801|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5059181|NCT02417064|17450802|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5059182|NCT02417064|17450800|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
5059183|NCT02417064|17450801|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
5059184|NCT02417064|17450802|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
5059185|NCT02416934|17450873|P2|Overall Study|re-operation|0
5059186|NCT02416934|17450874|P1|Overall Study|re-operation|1
5059187|NCT02416934|17450873|P2|Overall Study|surgery started late|1
5059188|NCT02416934|17450874|P1|Overall Study|surgery started late|0
5059189|NCT02416934|17450873|P2|Overall Study|Protocol Violation|1
5059190|NCT02416934|17450874|P1|Overall Study|Protocol Violation|0
5059191|NCT02416934|17450873|P2|Overall Study|recruited during continuing renewal proc|1
5059192|NCT02416934|17450874|P1|Overall Study|recruited during continuing renewal proc|0
5059193|NCT02416934|17450873|P2|Overall Study|Withdrawal by Subject|0
5059194|NCT02416934|17450874|P1|Overall Study|Withdrawal by Subject|1
5059195|NCT02416934|17450873|P2|Overall Study|Lost to Follow-up|2
5059196|NCT02416934|17450874|P1|Overall Study|Lost to Follow-up|0
5059197|NCT02416934|17450873|P2|Overall Study|given steroids|2
5059198|NCT02416934|17450874|P1|Overall Study|given steroids|1
5059199|NCT02416908|17450889|P4|Dose Escalation Phase|Withdrawal by Subject|0
5059200|NCT02416908|17450890|P3|Dose Escalation Phase|Withdrawal by Subject|1
5059201|NCT02416908|17450891|P2|Dose Escalation Phase|Withdrawal by Subject|0
5059202|NCT02416908|17450892|P1|Dose Escalation Phase|Withdrawal by Subject|0
5059203|NCT02416908|17450889|P4|Dose Escalation Phase|Adverse Event|0
5059204|NCT02416908|17450890|P3|Dose Escalation Phase|Adverse Event|3
5059205|NCT02416908|17450891|P2|Dose Escalation Phase|Adverse Event|0
5059206|NCT02416908|17450892|P1|Dose Escalation Phase|Adverse Event|0
5059207|NCT02416791|17450910|P3|6 Months|Lost to Follow-up|1
5059208|NCT02416791|17450911|P2|6 Months|Lost to Follow-up|0
5059209|NCT02416791|17450912|P1|6 Months|Lost to Follow-up|0
5059210|NCT02416180|17451010|P1|Overall Study|Withdrawal by Subject|1
5059211|NCT02415959|17451071|P5|Overall Study|Protocol Violation|0
5059212|NCT02415959|17451072|P4|Overall Study|Protocol Violation|1
5059213|NCT02415959|17451073|P3|Overall Study|Protocol Violation|0
5059214|NCT02415959|17451074|P2|Overall Study|Protocol Violation|0
5059215|NCT02415959|17451075|P1|Overall Study|Protocol Violation|0
5059216|NCT02415959|17451071|P5|Overall Study|Adverse Event|0
5059217|NCT02415959|17451072|P4|Overall Study|Adverse Event|0
5059218|NCT02415959|17451073|P3|Overall Study|Adverse Event|0
5059219|NCT02415959|17451074|P2|Overall Study|Adverse Event|1
5059220|NCT02415959|17451075|P1|Overall Study|Adverse Event|0
5059221|NCT02415595|17451521|P4|Overall Study|Other|0
5059222|NCT02415595|17451522|P3|Overall Study|Other|1
5059223|NCT02415595|17451523|P2|Overall Study|Other|1
5059224|NCT02415595|17451524|P1|Overall Study|Other|0
5059225|NCT02415595|17451521|P4|Overall Study|Withdrawal by Subject|3
5059226|NCT02415595|17451522|P3|Overall Study|Withdrawal by Subject|1
5059227|NCT02415595|17451523|P2|Overall Study|Withdrawal by Subject|0
5059228|NCT02415595|17451524|P1|Overall Study|Withdrawal by Subject|4
5059229|NCT02415595|17451521|P4|Overall Study|Reached stopping criteria|0
5059230|NCT02415595|17451522|P3|Overall Study|Reached stopping criteria|1
5059231|NCT02415595|17451523|P2|Overall Study|Reached stopping criteria|1
5059232|NCT02415595|17451524|P1|Overall Study|Reached stopping criteria|0
5059233|NCT02415595|17451521|P4|Overall Study|Poor/Non-compliance|0
5059234|NCT02415595|17451522|P3|Overall Study|Poor/Non-compliance|1
5059235|NCT02415595|17451523|P2|Overall Study|Poor/Non-compliance|0
5059236|NCT02415595|17451524|P1|Overall Study|Poor/Non-compliance|1
5059237|NCT02415595|17451521|P4|Overall Study|Lost to Follow-up|1
5059238|NCT02415595|17451522|P3|Overall Study|Lost to Follow-up|1
5059239|NCT02415595|17451523|P2|Overall Study|Lost to Follow-up|3
5059240|NCT02415595|17451524|P1|Overall Study|Lost to Follow-up|1
5059241|NCT02415595|17451521|P4|Overall Study|Lack of Efficacy|0
5059242|NCT02415595|17451522|P3|Overall Study|Lack of Efficacy|0
5059243|NCT02415595|17451523|P2|Overall Study|Lack of Efficacy|4
5059244|NCT02415595|17451524|P1|Overall Study|Lack of Efficacy|4
5059245|NCT02415595|17451521|P4|Overall Study|Adverse Event|10
5059246|NCT02415595|17451522|P3|Overall Study|Adverse Event|5
5059247|NCT02415595|17451523|P2|Overall Study|Adverse Event|3
5059248|NCT02415595|17451524|P1|Overall Study|Adverse Event|1
5059249|NCT02415595|17451521|P4|Overall Study|Administrative reason by sponsor|39
5059250|NCT02415595|17451522|P3|Overall Study|Administrative reason by sponsor|41
5059251|NCT02415595|17451523|P2|Overall Study|Administrative reason by sponsor|40
5059252|NCT02415595|17451524|P1|Overall Study|Administrative reason by sponsor|39
5059253|NCT02415400|17451666|P4|Overall Study|Site closure; participant won't transfer|1
5059254|NCT02415400|17451667|P3|Overall Study|Site closure; participant won't transfer|0
5059255|NCT02415400|17451668|P2|Overall Study|Site closure; participant won't transfer|0
5059256|NCT02415400|17451669|P1|Overall Study|Site closure; participant won't transfer|0
5059257|NCT02415400|17451666|P4|Overall Study|Investigator decision|1
5059258|NCT02415400|17451667|P3|Overall Study|Investigator decision|1
5059259|NCT02415400|17451668|P2|Overall Study|Investigator decision|0
5059260|NCT02415400|17451669|P1|Overall Study|Investigator decision|0
5059261|NCT02415400|17451666|P4|Overall Study|Participant in jail|0
5059262|NCT02415400|17451667|P3|Overall Study|Participant in jail|1
5059263|NCT02415400|17451668|P2|Overall Study|Participant in jail|0
5059264|NCT02415400|17451669|P1|Overall Study|Participant in jail|0
5059265|NCT02415400|17451666|P4|Overall Study|Poor treatment monitoring|0
5059266|NCT02415400|17451667|P3|Overall Study|Poor treatment monitoring|1
5059267|NCT02415400|17451668|P2|Overall Study|Poor treatment monitoring|0
5059268|NCT02415400|17451669|P1|Overall Study|Poor treatment monitoring|0
5059269|NCT02415400|17451666|P4|Overall Study|State regulations prevent participation|0
5059270|NCT02415400|17451667|P3|Overall Study|State regulations prevent participation|1
5059271|NCT02415400|17451668|P2|Overall Study|State regulations prevent participation|0
5059272|NCT02415400|17451669|P1|Overall Study|State regulations prevent participation|0
5059273|NCT02415400|17451666|P4|Overall Study|Coagulation values cannot be set|0
5059274|NCT02415400|17451667|P3|Overall Study|Coagulation values cannot be set|1
5059275|NCT02415400|17451668|P2|Overall Study|Coagulation values cannot be set|0
5059276|NCT02415400|17451669|P1|Overall Study|Coagulation values cannot be set|0
5059277|NCT02415400|17451666|P4|Overall Study|Stroke and stroke rehabilitation|0
5059278|NCT02415400|17451667|P3|Overall Study|Stroke and stroke rehabilitation|1
5059279|NCT02415400|17451668|P2|Overall Study|Stroke and stroke rehabilitation|0
5059280|NCT02415400|17451669|P1|Overall Study|Stroke and stroke rehabilitation|0
5059281|NCT02415400|17451666|P4|Overall Study|No study drug on site|0
5059282|NCT02415400|17451667|P3|Overall Study|No study drug on site|0
5059283|NCT02415400|17451668|P2|Overall Study|No study drug on site|1
5059284|NCT02415400|17451669|P1|Overall Study|No study drug on site|0
5059285|NCT02415400|17451666|P4|Overall Study|Randomized in error|0
5059286|NCT02415400|17451667|P3|Overall Study|Randomized in error|0
5059287|NCT02415400|17451668|P2|Overall Study|Randomized in error|0
5059288|NCT02415400|17451669|P1|Overall Study|Randomized in error|2
5059289|NCT02415400|17451666|P4|Overall Study|Participant wanted home visits|0
5059290|NCT02415400|17451667|P3|Overall Study|Participant wanted home visits|0
5059291|NCT02415400|17451668|P2|Overall Study|Participant wanted home visits|0
5059292|NCT02415400|17451669|P1|Overall Study|Participant wanted home visits|1
5059293|NCT02415400|17451666|P4|Overall Study|Participant doesn't answer phone|0
5059294|NCT02415400|17451667|P3|Overall Study|Participant doesn't answer phone|0
5059295|NCT02415400|17451668|P2|Overall Study|Participant doesn't answer phone|0
5059296|NCT02415400|17451669|P1|Overall Study|Participant doesn't answer phone|1
5059297|NCT02415400|17451666|P4|Overall Study|Participant no longer meets criteria|1
5059298|NCT02415400|17451667|P3|Overall Study|Participant no longer meets criteria|0
5059299|NCT02415400|17451668|P2|Overall Study|Participant no longer meets criteria|0
5059300|NCT02415400|17451669|P1|Overall Study|Participant no longer meets criteria|2
5059301|NCT02415400|17451666|P4|Overall Study|Poor/Non-Compliance|4
5059302|NCT02415400|17451667|P3|Overall Study|Poor/Non-Compliance|3
5059303|NCT02415400|17451668|P2|Overall Study|Poor/Non-Compliance|1
5059304|NCT02415400|17451669|P1|Overall Study|Poor/Non-Compliance|0
5059305|NCT02415400|17451666|P4|Overall Study|Lost to Follow-up|5
5059306|NCT02415400|17451667|P3|Overall Study|Lost to Follow-up|2
5059307|NCT02415400|17451668|P2|Overall Study|Lost to Follow-up|3
5059308|NCT02415400|17451669|P1|Overall Study|Lost to Follow-up|3
5059309|NCT02415400|17451666|P4|Overall Study|Death|42
5059310|NCT02415400|17451667|P3|Overall Study|Death|35
5059311|NCT02415400|17451668|P2|Overall Study|Death|41
5059312|NCT02415400|17451669|P1|Overall Study|Death|39
5059313|NCT02415400|17451666|P4|Overall Study|Participant withdrew consent|21
5059314|NCT02415400|17451667|P3|Overall Study|Participant withdrew consent|30
5059315|NCT02415400|17451668|P2|Overall Study|Participant withdrew consent|12
5059316|NCT02415400|17451669|P1|Overall Study|Participant withdrew consent|14
5059317|NCT02415400|17451666|P4|Overall Study|Participant request to stop therapy|6
5059318|NCT02415400|17451667|P3|Overall Study|Participant request to stop therapy|8
5059319|NCT02415400|17451668|P2|Overall Study|Participant request to stop therapy|3
5059320|NCT02415400|17451669|P1|Overall Study|Participant request to stop therapy|4
5059321|NCT02415400|17451666|P4|Overall Study|Adverse Event|2
5059322|NCT02415400|17451667|P3|Overall Study|Adverse Event|1
5059323|NCT02415400|17451668|P2|Overall Study|Adverse Event|1
5059324|NCT02415400|17451669|P1|Overall Study|Adverse Event|0
5059325|NCT02415127|17451737|P2|Overall Study|Adverse Event|0
5059326|NCT02415127|17451738|P1|Overall Study|Adverse Event|1
5059327|NCT02414958|17451755|P3|Overall Study|Other than specified|5
5059328|NCT02414958|17451756|P2|Overall Study|Other than specified|4
5059329|NCT02414958|17451757|P1|Overall Study|Other than specified|4
5059330|NCT02414958|17451755|P3|Overall Study|Withdrawal by Subject|5
5059331|NCT02414958|17451756|P2|Overall Study|Withdrawal by Subject|3
5059332|NCT02414958|17451757|P1|Overall Study|Withdrawal by Subject|5
5059333|NCT02414958|17451755|P3|Overall Study|Lost to Follow-up|0
5059334|NCT02414958|17451756|P2|Overall Study|Lost to Follow-up|4
5059335|NCT02414958|17451757|P1|Overall Study|Lost to Follow-up|7
5059336|NCT02414958|17451755|P3|Overall Study|Protocol Violation|1
5059337|NCT02414958|17451756|P2|Overall Study|Protocol Violation|3
5059338|NCT02414958|17451757|P1|Overall Study|Protocol Violation|10
5059339|NCT02414958|17451755|P3|Overall Study|Adverse Event|3
5059340|NCT02414958|17451756|P2|Overall Study|Adverse Event|6
5059341|NCT02414958|17451757|P1|Overall Study|Adverse Event|6
5059342|NCT02414854|17451790|P4|Overall Study|Other than specified above|37
5059343|NCT02414854|17451791|P3|Overall Study|Other than specified above|17
5059344|NCT02414854|17451792|P2|Overall Study|Other than specified above|37
5059345|NCT02414854|17451793|P1|Overall Study|Other than specified above|12
5059346|NCT02414854|17451790|P4|Overall Study|Poor compliance to protocol|2
5059347|NCT02414854|17451791|P3|Overall Study|Poor compliance to protocol|2
5059348|NCT02414854|17451792|P2|Overall Study|Poor compliance to protocol|1
5059349|NCT02414854|17451793|P1|Overall Study|Poor compliance to protocol|1
5059350|NCT02414854|17451790|P4|Overall Study|Adverse Event|12
5059351|NCT02414854|17451791|P3|Overall Study|Adverse Event|1
5059352|NCT02414854|17451792|P2|Overall Study|Adverse Event|7
5059353|NCT02414854|17451793|P1|Overall Study|Adverse Event|9
5059354|NCT02414841|17451957|P2|Overall Study|Randomized But Not Treated|4
5059355|NCT02414841|17451958|P1|Overall Study|Randomized But Not Treated|6
5059356|NCT02414841|17451957|P2|Overall Study|Received a Kidney Transplant|4
5059357|NCT02414841|17451958|P1|Overall Study|Received a Kidney Transplant|13
5059358|NCT02414841|17451957|P2|Overall Study|Death|14
5059359|NCT02414841|17451958|P1|Overall Study|Death|17
5059360|NCT02414841|17451957|P2|Overall Study|Lost to Follow-up|6
5059361|NCT02414841|17451958|P1|Overall Study|Lost to Follow-up|13
5059362|NCT02414841|17451957|P2|Overall Study|Withdrawal by Subject|5
5059363|NCT02414841|17451958|P1|Overall Study|Withdrawal by Subject|7
5059364|NCT02414828|17451970|P4|Overall Study|Lost to Follow-up|2
5059365|NCT02414828|17451971|P3|Overall Study|Lost to Follow-up|1
5059366|NCT02414828|17451972|P2|Overall Study|Lost to Follow-up|1
5059367|NCT02414828|17451973|P1|Overall Study|Lost to Follow-up|0
5059368|NCT02414152|17452066|P1|Overall Study|Lack of Efficacy|1
5059369|NCT02414152|17452066|P1|Overall Study|Withdrawal by Subject|1
5059370|NCT02413996|17452072|P2|Overall Study|not comfortable with the intervention|2
5059371|NCT02413996|17452073|P1|Overall Study|not comfortable with the intervention|9
5059372|NCT02413593|17452118|P1|Overall Study|Adverse Event|1
5059373|NCT02413593|17452118|P1|Overall Study|Lost to Follow-up|3
5059374|NCT02413489|17452137|P3|Overall Study|Study Terminated By Sponsor|1
5059375|NCT02413489|17452138|P2|Overall Study|Study Terminated By Sponsor|13
5059376|NCT02413489|17452139|P1|Overall Study|Study Terminated By Sponsor|2
5059377|NCT02413489|17452137|P3|Overall Study|Withdrawal by Subject|0
5059378|NCT02413489|17452138|P2|Overall Study|Withdrawal by Subject|0
5059379|NCT02413489|17452139|P1|Overall Study|Withdrawal by Subject|2
5059380|NCT02413489|17452137|P3|Overall Study|Death|4
5059381|NCT02413489|17452138|P2|Overall Study|Death|3
5059382|NCT02413489|17452139|P1|Overall Study|Death|11
5059383|NCT02413398|17452180|P2|Overall Study|Other Eligibility criteria|2
5059384|NCT02413398|17452181|P1|Overall Study|Other Eligibility criteria|1
5059385|NCT02413398|17452180|P2|Overall Study|Withdrawal by Subject|1
5059386|NCT02413398|17452181|P1|Overall Study|Withdrawal by Subject|1
5059387|NCT02413398|17452180|P2|Overall Study|Lost to Follow-up|4
5059388|NCT02413398|17452181|P1|Overall Study|Lost to Follow-up|2
5059389|NCT02413372|17452196|P3|Follow-up|Subject unable to return for visit|1
5059390|NCT02413372|17452197|P2|Follow-up|Subject unable to return for visit|0
5059391|NCT02413372|17452198|P1|Follow-up|Subject unable to return for visit|0
5059392|NCT02413372|17452196|P3|Follow-up|Subject Withdrew Consent|1
5059393|NCT02413372|17452197|P2|Follow-up|Subject Withdrew Consent|0
5059394|NCT02413372|17452198|P1|Follow-up|Subject Withdrew Consent|1
5059395|NCT02413372|17452196|P3|Follow-up|Lost to Follow-up|0
5059396|NCT02413372|17452197|P2|Follow-up|Lost to Follow-up|1
5059397|NCT02413372|17452198|P1|Follow-up|Lost to Follow-up|1
5059398|NCT02413372|17452196|P3|Treatment|Withdrawal by Subject|0
5059399|NCT02413372|17452197|P2|Treatment|Withdrawal by Subject|0
5059400|NCT02413372|17452198|P1|Treatment|Withdrawal by Subject|1
5059401|NCT02413372|17452196|P3|Treatment|Lost to Follow-up|1
5059402|NCT02413372|17452197|P2|Treatment|Lost to Follow-up|2
5059403|NCT02413372|17452198|P1|Treatment|Lost to Follow-up|0
5059404|NCT02413346|17452247|P2|Overall Study|Other Miscellaneous Reasons|3
5059405|NCT02413346|17452248|P1|Overall Study|Other Miscellaneous Reasons|4
5059406|NCT02413346|17452247|P2|Overall Study|Protocol Violation|0
5059407|NCT02413346|17452248|P1|Overall Study|Protocol Violation|2
5059408|NCT02413346|17452247|P2|Overall Study|Lost to Follow-up|21
5059409|NCT02413346|17452248|P1|Overall Study|Lost to Follow-up|17
5059410|NCT02413346|17452247|P2|Overall Study|Withdrawal by Subject|40
5059411|NCT02413346|17452248|P1|Overall Study|Withdrawal by Subject|30
5059412|NCT02413346|17452247|P2|Overall Study|Adverse Event|6
5059413|NCT02413346|17452248|P1|Overall Study|Adverse Event|6
5059414|NCT02413333|17452258|P2|Period 2|Protocol Deviation|0
5059415|NCT02413333|17452259|P1|Period 2|Protocol Deviation|1
5059416|NCT02413333|17452258|P2|Period 1|Reason Not Specified|1
5059417|NCT02413333|17452259|P1|Period 1|Reason Not Specified|0
5059418|NCT02413333|17452258|P2|Period 1|Adverse Event|0
5059419|NCT02413333|17452259|P1|Period 1|Adverse Event|1
5059420|NCT02413294|17452267|P1|Overall Study|Withdrawal by Subject|1
5059421|NCT02413255|17452302|P17|Overall Study|Voluntary Withdrawal|0
5059422|NCT02413255|17452303|P16|Overall Study|Voluntary Withdrawal|0
5059423|NCT02413255|17452304|P15|Overall Study|Voluntary Withdrawal|1
5059424|NCT02413255|17452305|P14|Overall Study|Voluntary Withdrawal|0
5059425|NCT02413255|17452306|P13|Overall Study|Voluntary Withdrawal|0
5059426|NCT02413255|17452307|P12|Overall Study|Voluntary Withdrawal|0
5059427|NCT02413255|17452308|P11|Overall Study|Voluntary Withdrawal|0
5059428|NCT02413255|17452309|P10|Overall Study|Voluntary Withdrawal|0
5059429|NCT02413255|17452310|P9|Overall Study|Voluntary Withdrawal|0
5059430|NCT02413255|17452311|P8|Overall Study|Voluntary Withdrawal|0
5059431|NCT02413255|17452312|P7|Overall Study|Voluntary Withdrawal|0
5059432|NCT02413255|17452313|P6|Overall Study|Voluntary Withdrawal|0
5059433|NCT02413255|17452314|P5|Overall Study|Voluntary Withdrawal|0
5059434|NCT02413255|17452315|P4|Overall Study|Voluntary Withdrawal|0
5059435|NCT02413255|17452316|P3|Overall Study|Voluntary Withdrawal|0
5059436|NCT02413255|17452317|P2|Overall Study|Voluntary Withdrawal|0
5059437|NCT02413255|17452318|P1|Overall Study|Voluntary Withdrawal|0
5059438|NCT02413229|17452674|P8|Overall Study|Progressive Disease|1
5059439|NCT02413229|17452675|P7|Overall Study|Progressive Disease|0
5059440|NCT02413229|17452676|P6|Overall Study|Progressive Disease|0
5059441|NCT02413229|17452677|P5|Overall Study|Progressive Disease|0
5059442|NCT02413229|17452678|P4|Overall Study|Progressive Disease|0
5059443|NCT02413229|17452679|P3|Overall Study|Progressive Disease|0
5059444|NCT02413229|17452680|P2|Overall Study|Progressive Disease|0
5059445|NCT02413229|17452681|P1|Overall Study|Progressive Disease|0
5059446|NCT02413229|17452674|P8|Overall Study|Withdrawal by Subject|2
5059447|NCT02413229|17452675|P7|Overall Study|Withdrawal by Subject|0
5059448|NCT02413229|17452676|P6|Overall Study|Withdrawal by Subject|0
5059449|NCT02413229|17452677|P5|Overall Study|Withdrawal by Subject|1
5059450|NCT02413229|17452678|P4|Overall Study|Withdrawal by Subject|0
5059451|NCT02413229|17452679|P3|Overall Study|Withdrawal by Subject|0
5059452|NCT02413229|17452680|P2|Overall Study|Withdrawal by Subject|1
5059453|NCT02413229|17452681|P1|Overall Study|Withdrawal by Subject|1
5059454|NCT02413229|17452674|P8|Overall Study|Lost to Follow-up|0
5059455|NCT02413229|17452675|P7|Overall Study|Lost to Follow-up|0
5059456|NCT02413229|17452676|P6|Overall Study|Lost to Follow-up|0
5059457|NCT02413229|17452677|P5|Overall Study|Lost to Follow-up|2
5059458|NCT02413229|17452678|P4|Overall Study|Lost to Follow-up|0
5059459|NCT02413229|17452679|P3|Overall Study|Lost to Follow-up|1
5059460|NCT02413229|17452680|P2|Overall Study|Lost to Follow-up|0
5059461|NCT02413229|17452681|P1|Overall Study|Lost to Follow-up|0
5059462|NCT02413229|17452674|P8|Overall Study|Adverse Event|1
5059463|NCT02413229|17452675|P7|Overall Study|Adverse Event|0
5059464|NCT02413229|17452676|P6|Overall Study|Adverse Event|0
5059465|NCT02413229|17452677|P5|Overall Study|Adverse Event|0
5059466|NCT02413229|17452678|P4|Overall Study|Adverse Event|1
5059467|NCT02413229|17452679|P3|Overall Study|Adverse Event|0
5059468|NCT02413229|17452680|P2|Overall Study|Adverse Event|0
5059469|NCT02413229|17452681|P1|Overall Study|Adverse Event|0
5059470|NCT02412878|17452820|P2|Overall Study|Lost to Follow-up|3
5059471|NCT02412878|17452821|P1|Overall Study|Lost to Follow-up|2
5059472|NCT02412878|17452820|P2|Overall Study|Withdrawal by Subject|10
5059473|NCT02412878|17452821|P1|Overall Study|Withdrawal by Subject|19
5059474|NCT02412852|17452839|P4|Overall Study|Physician Decision|1
5059475|NCT02412852|17452840|P3|Overall Study|Physician Decision|0
5059476|NCT02412852|17452841|P2|Overall Study|Physician Decision|0
5059477|NCT02412852|17452842|P1|Overall Study|Physician Decision|0
5059478|NCT02412852|17452839|P4|Overall Study|Withdrawal by Subject|0
5059479|NCT02412852|17452840|P3|Overall Study|Withdrawal by Subject|0
5059480|NCT02412852|17452841|P2|Overall Study|Withdrawal by Subject|1
5059481|NCT02412852|17452842|P1|Overall Study|Withdrawal by Subject|0
5059482|NCT02412761|17452868|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
5059483|NCT02412761|17452869|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
5059484|NCT02412761|17452870|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
5059485|NCT02412761|17452871|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
5059486|NCT02412761|17452872|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
5059487|NCT02412761|17452873|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
5059488|NCT02412722|17452887|P6|Overall Study|Reason not Specified|6
5059489|NCT02412722|17452888|P5|Overall Study|Reason not Specified|2
5059490|NCT02412722|17452889|P4|Overall Study|Reason not Specified|1
5059491|NCT02412722|17452890|P3|Overall Study|Reason not Specified|2
5059492|NCT02412722|17452891|P2|Overall Study|Reason not Specified|0
5059493|NCT02412722|17452892|P1|Overall Study|Reason not Specified|3
5059494|NCT02412722|17452887|P6|Overall Study|Received drug in run-in and discontinued|0
5059495|NCT02412722|17452888|P5|Overall Study|Received drug in run-in and discontinued|0
5059496|NCT02412722|17452889|P4|Overall Study|Received drug in run-in and discontinued|0
5059497|NCT02412722|17452890|P3|Overall Study|Received drug in run-in and discontinued|0
5059498|NCT02412722|17452891|P2|Overall Study|Received drug in run-in and discontinued|2
5059499|NCT02412722|17452892|P1|Overall Study|Received drug in run-in and discontinued|0
5059500|NCT02412722|17452887|P6|Overall Study|Lost to Follow-up|0
5059501|NCT02412722|17452888|P5|Overall Study|Lost to Follow-up|1
5059502|NCT02412722|17452889|P4|Overall Study|Lost to Follow-up|0
5059503|NCT02412722|17452890|P3|Overall Study|Lost to Follow-up|0
5059504|NCT02412722|17452891|P2|Overall Study|Lost to Follow-up|0
5059505|NCT02412722|17452892|P1|Overall Study|Lost to Follow-up|0
5059506|NCT02412722|17452887|P6|Overall Study|Withdrawal by Subject|1
5059507|NCT02412722|17452888|P5|Overall Study|Withdrawal by Subject|1
5059508|NCT02412722|17452889|P4|Overall Study|Withdrawal by Subject|2
5059509|NCT02412722|17452890|P3|Overall Study|Withdrawal by Subject|1
5059510|NCT02412722|17452891|P2|Overall Study|Withdrawal by Subject|0
5059511|NCT02412722|17452892|P1|Overall Study|Withdrawal by Subject|2
5059512|NCT02412722|17452887|P6|Overall Study|Progressive Disease|3
5059513|NCT02412722|17452888|P5|Overall Study|Progressive Disease|3
5059514|NCT02412722|17452889|P4|Overall Study|Progressive Disease|9
5059515|NCT02412722|17452890|P3|Overall Study|Progressive Disease|4
5059516|NCT02412722|17452891|P2|Overall Study|Progressive Disease|4
5059517|NCT02412722|17452892|P1|Overall Study|Progressive Disease|6
5059518|NCT02412722|17452887|P6|Overall Study|Adverse Event|3
5059519|NCT02412722|17452888|P5|Overall Study|Adverse Event|0
5059520|NCT02412722|17452889|P4|Overall Study|Adverse Event|3
5059521|NCT02412722|17452890|P3|Overall Study|Adverse Event|0
5059522|NCT02412722|17452891|P2|Overall Study|Adverse Event|2
5059523|NCT02412722|17452892|P1|Overall Study|Adverse Event|0
5059524|NCT02412657|17452963|P3|Overall Study|Protocol Violation|3
5059525|NCT02412657|17452964|P2|Overall Study|Protocol Violation|2
5059526|NCT02412657|17452965|P1|Overall Study|Protocol Violation|0
5059527|NCT02412657|17452963|P3|Overall Study|Lost to Follow-up|0
5059528|NCT02412657|17452964|P2|Overall Study|Lost to Follow-up|0
5059529|NCT02412657|17452965|P1|Overall Study|Lost to Follow-up|1
5059530|NCT02412488|17453009|P1|Overall Study|Reveal LINQ explant|1
5059531|NCT02412488|17453009|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
5059532|NCT02412488|17453009|P1|Overall Study|Physician Decision|1
5059533|NCT02412488|17453009|P1|Overall Study|Withdrawal by Subject|5
5059534|NCT02412488|17453009|P1|Overall Study|Lost to Follow-up|10
5059535|NCT02412436|17453013|P1|Overall Study|Not Willing to Adhere to Requirements|1
5059536|NCT02412436|17453013|P1|Overall Study|Death|1
5059537|NCT02412436|17453013|P1|Overall Study|Unable to get to clinic|3
5059538|NCT02412436|17453013|P1|Overall Study|Lost to Follow-up|6
5059709|NCT02410278|17453676|P1|Run-in Period|Lost to Follow-up|1
5059539|NCT02412436|17453013|P1|Overall Study|Protocol-mandated Discontinuation|7
5059540|NCT02412371|17453033|P6|Overall Study|Other|3
5059541|NCT02412371|17453034|P5|Overall Study|Other|1
5059542|NCT02412371|17453035|P4|Overall Study|Other|0
5059543|NCT02412371|17453036|P3|Overall Study|Other|0
5059544|NCT02412371|17453037|P2|Overall Study|Other|1
5059545|NCT02412371|17453038|P1|Overall Study|Other|2
5059546|NCT02412371|17453033|P6|Overall Study|Death|2
5059547|NCT02412371|17453034|P5|Overall Study|Death|5
5059548|NCT02412371|17453035|P4|Overall Study|Death|3
5059549|NCT02412371|17453036|P3|Overall Study|Death|1
5059550|NCT02412371|17453037|P2|Overall Study|Death|2
5059551|NCT02412371|17453038|P1|Overall Study|Death|4
5059552|NCT02412371|17453033|P6|Overall Study|Sponsor Discontinued Study|0
5059553|NCT02412371|17453034|P5|Overall Study|Sponsor Discontinued Study|5
5059554|NCT02412371|17453035|P4|Overall Study|Sponsor Discontinued Study|4
5059555|NCT02412371|17453036|P3|Overall Study|Sponsor Discontinued Study|6
5059556|NCT02412371|17453037|P2|Overall Study|Sponsor Discontinued Study|4
5059557|NCT02412371|17453038|P1|Overall Study|Sponsor Discontinued Study|1
5059558|NCT02412371|17453033|P6|Overall Study|Withdrawal by Subject|0
5059559|NCT02412371|17453034|P5|Overall Study|Withdrawal by Subject|1
5059560|NCT02412371|17453035|P4|Overall Study|Withdrawal by Subject|1
5059561|NCT02412371|17453036|P3|Overall Study|Withdrawal by Subject|0
5059562|NCT02412371|17453037|P2|Overall Study|Withdrawal by Subject|2
5059563|NCT02412371|17453038|P1|Overall Study|Withdrawal by Subject|0
5059564|NCT02412306|17453066|P5|Overall Study|Death|2
5059565|NCT02412306|17453067|P4|Overall Study|Death|0
5059566|NCT02412306|17453068|P3|Overall Study|Death|15
5059567|NCT02412306|17453069|P2|Overall Study|Death|7
5059568|NCT02412306|17453070|P1|Overall Study|Death|5
5059569|NCT02412306|17453066|P5|Overall Study|Withdrawal by Subject|0
5059570|NCT02412306|17453067|P4|Overall Study|Withdrawal by Subject|0
5059571|NCT02412306|17453068|P3|Overall Study|Withdrawal by Subject|1
5059572|NCT02412306|17453069|P2|Overall Study|Withdrawal by Subject|0
5059573|NCT02412306|17453070|P1|Overall Study|Withdrawal by Subject|0
5059574|NCT02412306|17453066|P5|Overall Study|Lost to Follow-up|0
5059575|NCT02412306|17453067|P4|Overall Study|Lost to Follow-up|0
5059576|NCT02412306|17453068|P3|Overall Study|Lost to Follow-up|0
5059577|NCT02412306|17453069|P2|Overall Study|Lost to Follow-up|1
5059578|NCT02412306|17453070|P1|Overall Study|Lost to Follow-up|0
5059579|NCT02412111|17453132|P3|Active Comparator Period (8 Weeks)|Other|2
5059580|NCT02412111|17453133|P2|Active Comparator Period (8 Weeks)|Other|0
5059581|NCT02412111|17453134|P1|Active Comparator Period (8 Weeks)|Other|0
5059582|NCT02412111|17453132|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
5059583|NCT02412111|17453133|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
5059584|NCT02412111|17453134|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
5059585|NCT02412111|17453132|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
5059586|NCT02412111|17453133|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
5059587|NCT02412111|17453134|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
5059588|NCT02412111|17453132|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
5059589|NCT02412111|17453133|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
5059590|NCT02412111|17453134|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
5059591|NCT02412111|17453132|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
5059592|NCT02412111|17453133|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
5059593|NCT02412111|17453134|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
5059594|NCT02412111|17453132|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
5059595|NCT02412111|17453133|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
5059596|NCT02412111|17453134|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
5059597|NCT02412111|17453132|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
5059598|NCT02412111|17453133|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
5059599|NCT02412111|17453134|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
5059600|NCT02411747|17453217|P2|Overall Study|Protocol Violation|4
5059601|NCT02411747|17453218|P1|Overall Study|Protocol Violation|2
5059602|NCT02411747|17453217|P2|Overall Study|Withdrawal by Subject|0
5059603|NCT02411747|17453218|P1|Overall Study|Withdrawal by Subject|1
5059604|NCT02411591|17453234|P3|Overall Study|Physician Decision|1
5059605|NCT02411591|17453235|P2|Overall Study|Physician Decision|3
5059606|NCT02411591|17453236|P1|Overall Study|Physician Decision|0
5059607|NCT02411591|17453234|P3|Overall Study|Withdrawal by Subject|0
5059608|NCT02411591|17453235|P2|Overall Study|Withdrawal by Subject|3
5059609|NCT02411591|17453236|P1|Overall Study|Withdrawal by Subject|0
5059610|NCT02411591|17453234|P3|Overall Study|Adverse Event|2
5059611|NCT02411591|17453235|P2|Overall Study|Adverse Event|4
5059612|NCT02411591|17453236|P1|Overall Study|Adverse Event|0
5059613|NCT02411578|17453268|P2|Crossover Trial Phase|Pregnancy|1
5059614|NCT02411578|17453269|P1|Crossover Trial Phase|Pregnancy|0
5059615|NCT02411539|17453326|P2|Overall Study|Confounding medical condition|1
5059616|NCT02411539|17453327|P1|Overall Study|Confounding medical condition|0
5059617|NCT02411539|17453326|P2|Overall Study|Lost to Follow-up|0
5059618|NCT02411539|17453327|P1|Overall Study|Lost to Follow-up|2
5059619|NCT02411448|17453418|P3|Overall Study|Alive on study treatment|43
5059620|NCT02411448|17453419|P2|Overall Study|Alive on study treatment|64
5059621|NCT02411448|17453420|P1|Overall Study|Alive on study treatment|3
5059622|NCT02411448|17453418|P3|Overall Study|Did not receive study treatment|0
5059623|NCT02411448|17453419|P2|Overall Study|Did not receive study treatment|3
5059624|NCT02411448|17453420|P1|Overall Study|Did not receive study treatment|0
5059625|NCT02411448|17453418|P3|Overall Study|Other|0
5059626|NCT02411448|17453419|P2|Overall Study|Other|2
5059627|NCT02411448|17453420|P1|Overall Study|Other|0
5059628|NCT02411448|17453418|P3|Overall Study|Withdrawal by Subject|9
5059629|NCT02411448|17453419|P2|Overall Study|Withdrawal by Subject|14
5059630|NCT02411448|17453420|P1|Overall Study|Withdrawal by Subject|1
5059631|NCT02411396|17453449|P1|Overall Study|Death|10
5059632|NCT02411396|17453449|P1|Overall Study|Lost to Follow-up|31
5059633|NCT02411292|17453462|P1|Overall Study|Lost to Follow-up|3
5059634|NCT02411292|17453462|P1|Overall Study|Death|2
5059635|NCT02411292|17453462|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
5059636|NCT02411201|17453468|P1|Overall Study|Age group completed|2
5059637|NCT02411201|17453468|P1|Overall Study|Withdrawal by Subject|2
5059638|NCT02411201|17453468|P1|Overall Study|Adverse Event|2
5059639|NCT02411110|17453481|P2|Treatment Period 2|Personal Reasons|2
5059640|NCT02411110|17453482|P1|Treatment Period 2|Personal Reasons|0
5059641|NCT02411110|17453481|P2|Treatment Period 2|Lost to Follow-up|2
5059642|NCT02411110|17453482|P1|Treatment Period 2|Lost to Follow-up|0
5059643|NCT02411110|17453481|P2|Treatment Period 2|Adverse Event|0
5059644|NCT02411110|17453482|P1|Treatment Period 2|Adverse Event|1
5059645|NCT02411110|17453481|P2|Treatment Period 1|Other Miscellaneous Reasons|0
5059646|NCT02411110|17453482|P1|Treatment Period 1|Other Miscellaneous Reasons|2
5059647|NCT02411110|17453481|P2|Treatment Period 1|Personal Reasons|5
5059648|NCT02411110|17453482|P1|Treatment Period 1|Personal Reasons|2
5059649|NCT02411110|17453481|P2|Treatment Period 1|Lost to Follow-up|0
5059650|NCT02411110|17453482|P1|Treatment Period 1|Lost to Follow-up|1
5059651|NCT02411110|17453481|P2|Treatment Period 1|Adverse Event|2
5059652|NCT02411110|17453482|P1|Treatment Period 1|Adverse Event|4
5059653|NCT02411084|17453492|P2|Overall Study|Other reasons|5
5059654|NCT02411084|17453493|P1|Overall Study|Other reasons|0
5059655|NCT02411084|17453492|P2|Overall Study|Adverse Event|1
5059656|NCT02411084|17453493|P1|Overall Study|Adverse Event|2
5059657|NCT02411084|17453492|P2|Overall Study|Death|4
5059658|NCT02411084|17453493|P1|Overall Study|Death|5
5059659|NCT02411084|17453492|P2|Overall Study|Lack of Efficacy|3
5059660|NCT02411084|17453493|P1|Overall Study|Lack of Efficacy|6
5059661|NCT02410824|17453525|P2|First Intervention (One Week)|Headache|1
5059662|NCT02410824|17453526|P1|First Intervention (One Week)|Headache|0
5059663|NCT02410811|17453562|P4|Overall Study|Withdrawal by Subject|0
5059664|NCT02410811|17453563|P3|Overall Study|Withdrawal by Subject|1
5059665|NCT02410811|17453564|P2|Overall Study|Withdrawal by Subject|0
5059666|NCT02410811|17453565|P1|Overall Study|Withdrawal by Subject|0
5059667|NCT02410629|17453592|P2|Overall Study|Subject underwent heart surgery|1
5059668|NCT02410629|17453593|P1|Overall Study|Subject underwent heart surgery|0
5059669|NCT02410629|17453592|P2|Overall Study|Subject moved back to home country|1
5059670|NCT02410629|17453593|P1|Overall Study|Subject moved back to home country|0
5059671|NCT02410629|17453592|P2|Overall Study|Subject returned to work|0
5059672|NCT02410629|17453593|P1|Overall Study|Subject returned to work|1
5059673|NCT02410629|17453592|P2|Overall Study|Family cannot commit to the study|1
5059674|NCT02410629|17453593|P1|Overall Study|Family cannot commit to the study|2
5059675|NCT02410551|17453609|P1|Overall Study|FDA Clinical hold-patients taken off|2
5059676|NCT02410551|17453609|P1|Overall Study|Withdrawal by Subject|1
5059677|NCT02410551|17453609|P1|Overall Study|Adverse Event|1
5059678|NCT02410343|17453627|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
5059679|NCT02410343|17453628|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
5059680|NCT02410343|17453627|P2|Extension Period (12 Months)|Adverse Event|0
5059681|NCT02410343|17453628|P1|Extension Period (12 Months)|Adverse Event|1
5059682|NCT02410343|17453627|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
5059683|NCT02410343|17453628|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
5059684|NCT02410343|17453627|P2|Core Period (24 Weeks)|Adverse Event|0
5059685|NCT02410343|17453628|P1|Core Period (24 Weeks)|Adverse Event|1
5059686|NCT02410278|17453674|P3|Study Treatment Period|GSRS Threshold Not Met|0
5059687|NCT02410278|17453675|P2|Study Treatment Period|GSRS Threshold Not Met|1
5059688|NCT02410278|17453676|P1|Study Treatment Period|GSRS Threshold Not Met|0
5059689|NCT02410278|17453674|P3|Study Treatment Period|Other|0
5059690|NCT02410278|17453675|P2|Study Treatment Period|Other|3
5059691|NCT02410278|17453676|P1|Study Treatment Period|Other|0
5059692|NCT02410278|17453674|P3|Study Treatment Period|Withdrawal by Subject|0
5059693|NCT02410278|17453675|P2|Study Treatment Period|Withdrawal by Subject|1
5059694|NCT02410278|17453676|P1|Study Treatment Period|Withdrawal by Subject|0
5059695|NCT02410278|17453674|P3|Study Treatment Period|Physician Decision|1
5059696|NCT02410278|17453675|P2|Study Treatment Period|Physician Decision|0
5059697|NCT02410278|17453676|P1|Study Treatment Period|Physician Decision|0
5059698|NCT02410278|17453674|P3|Study Treatment Period|Adverse Event|3
5059699|NCT02410278|17453675|P2|Study Treatment Period|Adverse Event|6
5059700|NCT02410278|17453676|P1|Study Treatment Period|Adverse Event|0
5059701|NCT02410278|17453674|P3|Run-in Period|Pregnancy|0
5059702|NCT02410278|17453675|P2|Run-in Period|Pregnancy|0
5059703|NCT02410278|17453676|P1|Run-in Period|Pregnancy|1
5059704|NCT02410278|17453674|P3|Run-in Period|Withdrawal by Subject|0
5059705|NCT02410278|17453675|P2|Run-in Period|Withdrawal by Subject|0
5059706|NCT02410278|17453676|P1|Run-in Period|Withdrawal by Subject|1
5059707|NCT02410278|17453674|P3|Run-in Period|Lost to Follow-up|0
5059708|NCT02410278|17453675|P2|Run-in Period|Lost to Follow-up|0
5059710|NCT02410278|17453674|P3|Run-in Period|GSRS Threshold Not Met|0
5059711|NCT02410278|17453675|P2|Run-in Period|GSRS Threshold Not Met|0
5059712|NCT02410278|17453676|P1|Run-in Period|GSRS Threshold Not Met|30
5059713|NCT02410278|17453674|P3|Run-in Period|Adverse Event|0
5059714|NCT02410278|17453675|P2|Run-in Period|Adverse Event|0
5059715|NCT02410278|17453676|P1|Run-in Period|Adverse Event|5
5059716|NCT02410252|17453701|P1|Overall Study|Physician Decision|2
5059717|NCT02410252|17453701|P1|Overall Study|Withdrawal by Subject|4
5059718|NCT02410200|17453714|P1|Overall Study|Adverse Event|2
5059719|NCT02409732|17453784|P1|Overall Study|Lost to Follow-up|2
5059720|NCT02409732|17453784|P1|Overall Study|Withdrawal by Subject|4
5059721|NCT02409719|17453794|P2|Overall Study|Lost to Follow-up|3
5059722|NCT02409719|17453795|P1|Overall Study|Lost to Follow-up|3
5059723|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5059724|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5059725|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
5059726|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5059727|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5059728|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
5059729|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5059730|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
5059731|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5059732|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5059733|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
5059734|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
5059735|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
5059736|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
5059737|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
5059738|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5059739|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5059740|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
5059741|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
5059742|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5059743|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
5059744|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
5059745|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
5059746|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
5059747|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
5059748|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5059749|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
5059750|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5059751|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5059752|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5059753|NCT02409667|17453805|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
5059754|NCT02409667|17453806|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
5059755|NCT02409667|17453807|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
5059756|NCT02409667|17453808|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
5059757|NCT02409667|17453809|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
5059758|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5059759|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5059760|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5059761|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5059762|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
5059763|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5059764|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5059765|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5059766|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5059767|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
5059768|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5059769|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5059770|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5059771|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5059772|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
5059773|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5059774|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5059775|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5059776|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5059777|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
5059778|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5059779|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5059780|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5059781|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5059782|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
5059783|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5059784|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5059785|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5059786|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5059787|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
5059788|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5059789|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5059790|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5059791|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5059792|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
5059793|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5059794|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5059795|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5059796|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5059797|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
5059798|NCT02409667|17453805|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5059799|NCT02409667|17453806|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5059800|NCT02409667|17453807|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5059801|NCT02409667|17453808|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5059802|NCT02409667|17453809|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
5059803|NCT02409355|17453871|P2|Overall Study|Study terminated by Sponsor|3
5059804|NCT02409355|17453872|P1|Overall Study|Study terminated by Sponsor|2
5059805|NCT02409355|17453871|P2|Overall Study|Death|1
5059806|NCT02409355|17453872|P1|Overall Study|Death|1
5059807|NCT02409355|17453871|P2|Overall Study|Withdrawal by Subject|0
5059808|NCT02409355|17453872|P1|Overall Study|Withdrawal by Subject|1
5059809|NCT02408523|17453995|P2|Overall Study|Did not satisfy extension conditions|1
5059810|NCT02408523|17453996|P1|Overall Study|Did not satisfy extension conditions|0
5059811|NCT02408523|17453995|P2|Overall Study|Sponsor request|0
5059812|NCT02408523|17453996|P1|Overall Study|Sponsor request|1
5059813|NCT02408523|17453995|P2|Overall Study|Withdrawal by Subject|1
5059814|NCT02408523|17453996|P1|Overall Study|Withdrawal by Subject|3
5059815|NCT02408523|17453995|P2|Overall Study|Lost to Follow-up|3
5059816|NCT02408523|17453996|P1|Overall Study|Lost to Follow-up|2
5059817|NCT02408523|17453995|P2|Overall Study|Protocol Violation|2
5059818|NCT02408523|17453996|P1|Overall Study|Protocol Violation|1
5059819|NCT02408523|17453995|P2|Overall Study|Lack of Efficacy|1
5059820|NCT02408523|17453996|P1|Overall Study|Lack of Efficacy|0
5059821|NCT02408523|17453995|P2|Overall Study|Adverse Event|10
5059822|NCT02408523|17453996|P1|Overall Study|Adverse Event|4
5059823|NCT02408484|17454016|P1|Overall Study|Not treated during study period|1
5059824|NCT02408484|17454016|P1|Overall Study|Withdrawal by Subject|3
5059825|NCT02408068|17454119|P6|Treatment 3 (1.5 Days)|Adverse Event|0
5059826|NCT02408068|17454120|P5|Treatment 3 (1.5 Days)|Adverse Event|0
5059827|NCT02408068|17454121|P4|Treatment 3 (1.5 Days)|Adverse Event|0
5059828|NCT02408068|17454122|P3|Treatment 3 (1.5 Days)|Adverse Event|1
5059829|NCT02408068|17454123|P2|Treatment 3 (1.5 Days)|Adverse Event|0
5059830|NCT02408068|17454124|P1|Treatment 3 (1.5 Days)|Adverse Event|0
5059831|NCT02407704|17454196|P4|Overall Study|Withdrawal by Subject|0
5059832|NCT02407704|17454197|P3|Overall Study|Withdrawal by Subject|1
5059833|NCT02407704|17454198|P2|Overall Study|Withdrawal by Subject|0
5059834|NCT02407704|17454199|P1|Overall Study|Withdrawal by Subject|0
5059835|NCT02407704|17454196|P4|Overall Study|Protocol Violation|1
5059836|NCT02407704|17454197|P3|Overall Study|Protocol Violation|0
5059837|NCT02407704|17454198|P2|Overall Study|Protocol Violation|0
5059838|NCT02407704|17454199|P1|Overall Study|Protocol Violation|0
5059839|NCT02407704|17454196|P4|Overall Study|Lost to Follow-up|2
5059840|NCT02407704|17454197|P3|Overall Study|Lost to Follow-up|0
5059841|NCT02407704|17454198|P2|Overall Study|Lost to Follow-up|0
5059842|NCT02407704|17454199|P1|Overall Study|Lost to Follow-up|0
5059843|NCT02407249|17454242|P1|Overall Study|Not treated|13
5059844|NCT02407249|17454242|P1|Overall Study|Did not complete 12-month follow-up|13
5059845|NCT02407236|17454258|P8|Maintenance Study (44 Weeks)|Other|1
5059846|NCT02407236|17454259|P7|Maintenance Study (44 Weeks)|Other|2
5059847|NCT02407236|17454260|P6|Maintenance Study (44 Weeks)|Other|1
5059848|NCT02407236|17454261|P5|Maintenance Study (44 Weeks)|Other|1
5059849|NCT02407236|17454262|P4|Maintenance Study (44 Weeks)|Other|0
5059850|NCT02407236|17454263|P3|Maintenance Study (44 Weeks)|Other|0
5059851|NCT02407236|17454264|P2|Maintenance Study (44 Weeks)|Other|0
5059852|NCT02407236|17454265|P1|Maintenance Study (44 Weeks)|Other|0
5059853|NCT02407236|17454258|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
5059854|NCT02407236|17454259|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
5059855|NCT02407236|17454260|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
5059856|NCT02407236|17454261|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
5059857|NCT02407236|17454262|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
5059858|NCT02407236|17454263|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
5059859|NCT02407236|17454264|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
5059860|NCT02407236|17454265|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
5059861|NCT02407236|17454258|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
5059862|NCT02407236|17454259|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
5059863|NCT02407236|17454260|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
5059864|NCT02407236|17454261|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
5059865|NCT02407236|17454262|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
5059866|NCT02407236|17454263|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
5059867|NCT02407236|17454264|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
5059868|NCT02407236|17454265|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
5059869|NCT02407236|17454258|P8|Maintenance Study (44 Weeks)|Death|1
5059870|NCT02407236|17454259|P7|Maintenance Study (44 Weeks)|Death|0
5059871|NCT02407236|17454260|P6|Maintenance Study (44 Weeks)|Death|0
5059872|NCT02407236|17454261|P5|Maintenance Study (44 Weeks)|Death|0
5059873|NCT02407236|17454262|P4|Maintenance Study (44 Weeks)|Death|0
5059874|NCT02407236|17454263|P3|Maintenance Study (44 Weeks)|Death|0
5059875|NCT02407236|17454264|P2|Maintenance Study (44 Weeks)|Death|0
5059876|NCT02407236|17454265|P1|Maintenance Study (44 Weeks)|Death|0
5059877|NCT02407236|17454258|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5059878|NCT02407236|17454259|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5059879|NCT02407236|17454260|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5059880|NCT02407236|17454261|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5059881|NCT02407236|17454262|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5059882|NCT02407236|17454263|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5059883|NCT02407236|17454264|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5059884|NCT02407236|17454265|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5059885|NCT02407236|17454258|P8|Induction Study (8 Weeks)|Other|0
5059886|NCT02407236|17454259|P7|Induction Study (8 Weeks)|Other|0
5059887|NCT02407236|17454260|P6|Induction Study (8 Weeks)|Other|0
5059888|NCT02407236|17454261|P5|Induction Study (8 Weeks)|Other|0
5059889|NCT02407236|17454262|P4|Induction Study (8 Weeks)|Other|0
5059890|NCT02407236|17454263|P3|Induction Study (8 Weeks)|Other|5
5059891|NCT02407236|17454264|P2|Induction Study (8 Weeks)|Other|1
5059892|NCT02407236|17454265|P1|Induction Study (8 Weeks)|Other|2
5059893|NCT02407236|17454258|P8|Induction Study (8 Weeks)|Physician Decision|0
5059894|NCT02407236|17454259|P7|Induction Study (8 Weeks)|Physician Decision|0
5059895|NCT02407236|17454260|P6|Induction Study (8 Weeks)|Physician Decision|0
5059896|NCT02407236|17454261|P5|Induction Study (8 Weeks)|Physician Decision|0
5059897|NCT02407236|17454262|P4|Induction Study (8 Weeks)|Physician Decision|0
5059898|NCT02407236|17454263|P3|Induction Study (8 Weeks)|Physician Decision|0
5059899|NCT02407236|17454264|P2|Induction Study (8 Weeks)|Physician Decision|1
5059900|NCT02407236|17454265|P1|Induction Study (8 Weeks)|Physician Decision|1
5059901|NCT02407236|17454258|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
5059902|NCT02407236|17454259|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
5059903|NCT02407236|17454260|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
5059904|NCT02407236|17454261|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
5059905|NCT02407236|17454262|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
5059906|NCT02407236|17454263|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
5059907|NCT02407236|17454264|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
5059908|NCT02407236|17454265|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
5059909|NCT02407236|17454258|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
5059910|NCT02407236|17454259|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
5059911|NCT02407236|17454260|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
5059912|NCT02407236|17454261|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
5059913|NCT02407236|17454262|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
5059914|NCT02407236|17454263|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
5059915|NCT02407236|17454264|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
5059916|NCT02407236|17454265|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
5059917|NCT02407236|17454258|P8|Induction Study (8 Weeks)|Death|0
5059918|NCT02407236|17454259|P7|Induction Study (8 Weeks)|Death|0
5059919|NCT02407236|17454260|P6|Induction Study (8 Weeks)|Death|0
5059920|NCT02407236|17454261|P5|Induction Study (8 Weeks)|Death|0
5059921|NCT02407236|17454262|P4|Induction Study (8 Weeks)|Death|0
5059922|NCT02407236|17454263|P3|Induction Study (8 Weeks)|Death|1
5059923|NCT02407236|17454264|P2|Induction Study (8 Weeks)|Death|0
5059924|NCT02407236|17454265|P1|Induction Study (8 Weeks)|Death|0
5059925|NCT02407236|17454258|P8|Induction Study (8 Weeks)|Adverse Event|0
5059926|NCT02407236|17454259|P7|Induction Study (8 Weeks)|Adverse Event|0
5059927|NCT02407236|17454260|P6|Induction Study (8 Weeks)|Adverse Event|0
5059928|NCT02407236|17454261|P5|Induction Study (8 Weeks)|Adverse Event|0
5059929|NCT02407236|17454262|P4|Induction Study (8 Weeks)|Adverse Event|0
5059930|NCT02407236|17454263|P3|Induction Study (8 Weeks)|Adverse Event|1
5059931|NCT02407236|17454264|P2|Induction Study (8 Weeks)|Adverse Event|0
5059932|NCT02407236|17454265|P1|Induction Study (8 Weeks)|Adverse Event|3
5059933|NCT02407223|17454505|P3|Overall Study|Other|25
5059934|NCT02407223|17454506|P2|Overall Study|Other|27
5059935|NCT02407223|17454507|P1|Overall Study|Other|29
5059936|NCT02407223|17454505|P3|Overall Study|Subject Refused Further Study Treatment|0
5059937|NCT02407223|17454506|P2|Overall Study|Subject Refused Further Study Treatment|1
5059938|NCT02407223|17454507|P1|Overall Study|Subject Refused Further Study Treatment|0
5059939|NCT02407223|17454505|P3|Overall Study|Study Terminated by Sponsor|86
5059940|NCT02407223|17454506|P2|Overall Study|Study Terminated by Sponsor|80
5059941|NCT02407223|17454507|P1|Overall Study|Study Terminated by Sponsor|77
5059942|NCT02407223|17454505|P3|Overall Study|Withdrawal by Subject|4
5059943|NCT02407223|17454506|P2|Overall Study|Withdrawal by Subject|4
5059944|NCT02407223|17454507|P1|Overall Study|Withdrawal by Subject|2
5059945|NCT02407223|17454505|P3|Overall Study|Lost to Follow-up|2
5059946|NCT02407223|17454506|P2|Overall Study|Lost to Follow-up|0
5059947|NCT02407223|17454507|P1|Overall Study|Lost to Follow-up|1
5059948|NCT02407223|17454505|P3|Overall Study|Lack of Efficacy|4
5059949|NCT02407223|17454506|P2|Overall Study|Lack of Efficacy|6
5059950|NCT02407223|17454507|P1|Overall Study|Lack of Efficacy|6
5059951|NCT02407223|17454505|P3|Overall Study|Adverse Event|1
5059952|NCT02407223|17454506|P2|Overall Study|Adverse Event|0
5059953|NCT02407223|17454507|P1|Overall Study|Adverse Event|1
5059954|NCT02406677|17454644|P2|Overall Study|Withdrawal by Subject|0
5059955|NCT02406677|17454645|P1|Overall Study|Withdrawal by Subject|1
5059956|NCT02406677|17454644|P2|Overall Study|Discharged on prasugrel|587
5059957|NCT02406677|17454645|P1|Overall Study|Discharged on prasugrel|283
5059958|NCT02406677|17454644|P2|Overall Study|Discharged without P2Y12|3
5059959|NCT02406677|17454645|P1|Overall Study|Discharged without P2Y12|1
5059960|NCT02406677|17454644|P2|Overall Study|Death|8
5059961|NCT02406677|17454645|P1|Overall Study|Death|16
5059962|NCT02406612|17454659|P2|Overall Study|Guidewire Failure|1
5059963|NCT02406612|17454660|P1|Overall Study|Guidewire Failure|0
5059964|NCT02406612|17454659|P2|Overall Study|Intra-procedural Exclusion|3
5059965|NCT02406612|17454660|P1|Overall Study|Intra-procedural Exclusion|1
5059966|NCT02406612|17454659|P2|Overall Study|Screening Failure|0
5059967|NCT02406612|17454660|P1|Overall Study|Screening Failure|3
5059968|NCT02406586|17454675|P3|Overall Study|Withdrawal by Subject|0
5059969|NCT02406586|17454676|P2|Overall Study|Withdrawal by Subject|0
5059970|NCT02406586|17454677|P1|Overall Study|Withdrawal by Subject|1
5059971|NCT02406586|17454675|P3|Overall Study|Lost to Follow-up|2
5059972|NCT02406586|17454676|P2|Overall Study|Lost to Follow-up|4
5059973|NCT02406586|17454677|P1|Overall Study|Lost to Follow-up|0
5059974|NCT02406261|17454819|P2|Period 2|Withdrawal by Subject|1
5059975|NCT02406261|17454820|P1|Period 2|Withdrawal by Subject|0
5059976|NCT02406261|17454819|P2|Period 2|Protocol Violation|1
5059977|NCT02406261|17454820|P1|Period 2|Protocol Violation|0
5059978|NCT02406261|17454819|P2|Period 2|Physician Decision|1
5059979|NCT02406261|17454820|P1|Period 2|Physician Decision|0
5059980|NCT02406261|17454819|P2|Period 1|Adverse Event|0
5059981|NCT02406261|17454820|P1|Period 1|Adverse Event|1
5059982|NCT02406261|17454819|P2|Period 1|Lost to Follow-up|0
5059983|NCT02406261|17454820|P1|Period 1|Lost to Follow-up|2
5059984|NCT02406248|17454832|P1|Overall Study|Withdrawal by Subject|2
5059985|NCT02406248|17454832|P1|Overall Study|Death|7
5059986|NCT02406027|17454843|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5059987|NCT02406027|17454844|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5059988|NCT02406027|17454845|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
5059989|NCT02406027|17454846|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5059990|NCT02406027|17454847|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5059991|NCT02406027|17454848|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5059992|NCT02406027|17454849|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5059993|NCT02406027|17454843|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5059994|NCT02406027|17454844|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
5059995|NCT02406027|17454845|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5059996|NCT02406027|17454846|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5059997|NCT02406027|17454847|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5059998|NCT02406027|17454848|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5059999|NCT02406027|17454849|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5060000|NCT02406027|17454843|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
5060001|NCT02406027|17454844|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
5060002|NCT02406027|17454845|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
5060003|NCT02406027|17454846|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
5060004|NCT02406027|17454847|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5060005|NCT02406027|17454848|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5060006|NCT02406027|17454849|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5060007|NCT02406027|17454843|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
5060008|NCT02406027|17454844|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
5060009|NCT02406027|17454845|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
5060010|NCT02406027|17454846|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
5060011|NCT02406027|17454847|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
5060012|NCT02406027|17454848|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
5060013|NCT02406027|17454849|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
5060014|NCT02406027|17454843|P7|Open-label Phase (Period 2)|Physician Decision|1
5060015|NCT02406027|17454844|P6|Open-label Phase (Period 2)|Physician Decision|1
5060016|NCT02406027|17454845|P5|Open-label Phase (Period 2)|Physician Decision|0
5060017|NCT02406027|17454846|P4|Open-label Phase (Period 2)|Physician Decision|0
5060018|NCT02406027|17454847|P3|Open-label Phase (Period 2)|Physician Decision|0
5060019|NCT02406027|17454848|P2|Open-label Phase (Period 2)|Physician Decision|0
5060020|NCT02406027|17454849|P1|Open-label Phase (Period 2)|Physician Decision|0
5060021|NCT02406027|17454843|P7|Open-label Phase (Period 2)|Adverse Event|0
5060022|NCT02406027|17454844|P6|Open-label Phase (Period 2)|Adverse Event|0
5060023|NCT02406027|17454845|P5|Open-label Phase (Period 2)|Adverse Event|2
5060024|NCT02406027|17454846|P4|Open-label Phase (Period 2)|Adverse Event|2
5060025|NCT02406027|17454847|P3|Open-label Phase (Period 2)|Adverse Event|0
5060026|NCT02406027|17454848|P2|Open-label Phase (Period 2)|Adverse Event|0
5060027|NCT02406027|17454849|P1|Open-label Phase (Period 2)|Adverse Event|0
5060028|NCT02406027|17454843|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5060029|NCT02406027|17454844|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5060030|NCT02406027|17454845|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5060031|NCT02406027|17454846|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5060032|NCT02406027|17454847|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
5060033|NCT02406027|17454848|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5060034|NCT02406027|17454849|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
5060035|NCT02406027|17454843|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5060036|NCT02406027|17454844|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5060037|NCT02406027|17454845|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5060038|NCT02406027|17454846|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5060039|NCT02406027|17454847|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
5060040|NCT02406027|17454848|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
5060041|NCT02406027|17454849|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
5060042|NCT02406027|17454843|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5060043|NCT02406027|17454844|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5060044|NCT02406027|17454845|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5060045|NCT02406027|17454846|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5060046|NCT02406027|17454847|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
5060047|NCT02406027|17454848|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5060048|NCT02406027|17454849|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
5060049|NCT02406027|17454843|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5060050|NCT02406027|17454844|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5060051|NCT02406027|17454845|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5060052|NCT02406027|17454846|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5060053|NCT02406027|17454847|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
5060054|NCT02406027|17454848|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
5060055|NCT02406027|17454849|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5060056|NCT02405962|17454879|P2|Overall Study|A participant has moved to another place|1
5060057|NCT02405962|17454880|P1|Overall Study|A participant has moved to another place|0
5060058|NCT02405962|17454879|P2|Overall Study|Lost to Follow-up|4
5060059|NCT02405962|17454880|P1|Overall Study|Lost to Follow-up|1
5060060|NCT02405780|17454918|P4|Period II|Non-compliance with study procedures|4
5060061|NCT02405780|17454919|P3|Period II|Non-compliance with study procedures|7
5060062|NCT02405780|17454920|P2|Period II|Non-compliance with study procedures|2
5060063|NCT02405780|17454921|P1|Period II|Non-compliance with study procedures|5
5060064|NCT02405780|17454918|P4|Period II|Withdrawal by Subject|3
5060065|NCT02405780|17454919|P3|Period II|Withdrawal by Subject|0
5060066|NCT02405780|17454920|P2|Period II|Withdrawal by Subject|4
5060067|NCT02405780|17454921|P1|Period II|Withdrawal by Subject|7
5060068|NCT02405780|17454918|P4|Period II|Pregnancy|0
5060069|NCT02405780|17454919|P3|Period II|Pregnancy|1
5060070|NCT02405780|17454920|P2|Period II|Pregnancy|0
5060071|NCT02405780|17454921|P1|Period II|Pregnancy|0
5060072|NCT02405780|17454918|P4|Period II|Medical reason|0
5060073|NCT02405780|17454919|P3|Period II|Medical reason|0
5060074|NCT02405780|17454920|P2|Period II|Medical reason|1
5060075|NCT02405780|17454921|P1|Period II|Medical reason|0
5060076|NCT02405780|17454918|P4|Period II|Adverse Event|11
5060077|NCT02405780|17454919|P3|Period II|Adverse Event|4
5060078|NCT02405780|17454920|P2|Period II|Adverse Event|5
5060079|NCT02405780|17454921|P1|Period II|Adverse Event|3
5060080|NCT02405780|17454918|P4|Period I|Non-compliance with study procedures|11
5060081|NCT02405780|17454919|P3|Period I|Non-compliance with study procedures|8
5060082|NCT02405780|17454920|P2|Period I|Non-compliance with study procedures|6
5060083|NCT02405780|17454921|P1|Period I|Non-compliance with study procedures|8
5060084|NCT02405780|17454918|P4|Period I|Withdrawal by Subject|4
5060085|NCT02405780|17454919|P3|Period I|Withdrawal by Subject|3
5060086|NCT02405780|17454920|P2|Period I|Withdrawal by Subject|1
5060087|NCT02405780|17454921|P1|Period I|Withdrawal by Subject|9
5060088|NCT02405780|17454918|P4|Period I|Screening Failure|0
5060089|NCT02405780|17454919|P3|Period I|Screening Failure|1
5060090|NCT02405780|17454920|P2|Period I|Screening Failure|0
5060091|NCT02405780|17454921|P1|Period I|Screening Failure|1
5060092|NCT02405780|17454918|P4|Period I|Medical reasons|1
5060093|NCT02405780|17454919|P3|Period I|Medical reasons|0
5060094|NCT02405780|17454920|P2|Period I|Medical reasons|1
5060095|NCT02405780|17454921|P1|Period I|Medical reasons|1
5060096|NCT02405780|17454918|P4|Period I|Adverse Event|7
5060097|NCT02405780|17454919|P3|Period I|Adverse Event|3
5060098|NCT02405780|17454920|P2|Period I|Adverse Event|0
5060099|NCT02405780|17454921|P1|Period I|Adverse Event|8
5060100|NCT02405442|17454984|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5060101|NCT02405442|17454985|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5060102|NCT02405442|17454986|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5060103|NCT02405442|17454987|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
5060104|NCT02405442|17454984|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5060105|NCT02405442|17454985|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5060106|NCT02405442|17454986|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
5060107|NCT02405442|17454987|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5060108|NCT02405442|17454984|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5060109|NCT02405442|17454985|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5060110|NCT02405442|17454986|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
5060111|NCT02405442|17454987|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5060112|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5060113|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5060114|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
5060115|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5060116|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5060117|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5060118|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
5060119|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5060120|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5060121|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5060122|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
5060123|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5060124|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
5060125|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
5060126|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
5060127|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
5060128|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
5060129|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
5060130|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
5060131|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
5060132|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
5060133|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
5060134|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
5060135|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
5060136|NCT02405442|17454984|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
5060137|NCT02405442|17454985|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
5060138|NCT02405442|17454986|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
5060139|NCT02405442|17454987|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
5060140|NCT02405442|17454984|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5060141|NCT02405442|17454985|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5060142|NCT02405442|17454986|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
5060143|NCT02405442|17454987|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5060144|NCT02405442|17454984|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
5060145|NCT02405442|17454985|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
5060146|NCT02405442|17454986|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
5060147|NCT02405442|17454987|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
5060148|NCT02405442|17454984|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
5060149|NCT02405442|17454985|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
5060150|NCT02405442|17454986|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
5060151|NCT02405442|17454987|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
5060152|NCT02405442|17454984|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
5060153|NCT02405442|17454985|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
5060154|NCT02405442|17454986|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
5060155|NCT02405442|17454987|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
5060156|NCT02405091|17455041|P3|Overall Study|Physician Decision|0
5060157|NCT02405091|17455042|P2|Overall Study|Physician Decision|2
5060158|NCT02405091|17455043|P1|Overall Study|Physician Decision|2
5060159|NCT02405091|17455041|P3|Overall Study|Lost to Follow-up|0
5060160|NCT02405091|17455042|P2|Overall Study|Lost to Follow-up|6
5060161|NCT02405091|17455043|P1|Overall Study|Lost to Follow-up|5
5060162|NCT02405091|17455041|P3|Overall Study|Death|0
5060163|NCT02405091|17455042|P2|Overall Study|Death|1
5060164|NCT02405091|17455043|P1|Overall Study|Death|0
5060165|NCT02405091|17455041|P3|Overall Study|Withdrawal by Subject|0
5060166|NCT02405091|17455042|P2|Overall Study|Withdrawal by Subject|8
5060167|NCT02405091|17455043|P1|Overall Study|Withdrawal by Subject|4
5060168|NCT02405091|17455041|P3|Overall Study|Noncompliance|2
5060169|NCT02405091|17455042|P2|Overall Study|Noncompliance|6
5060170|NCT02405091|17455043|P1|Overall Study|Noncompliance|1
5060171|NCT02405091|17455041|P3|Overall Study|Protocol Violation|0
5060172|NCT02405091|17455042|P2|Overall Study|Protocol Violation|0
5060173|NCT02405091|17455043|P1|Overall Study|Protocol Violation|1
5060174|NCT02405091|17455041|P3|Overall Study|Adverse Event|0
5060175|NCT02405091|17455042|P2|Overall Study|Adverse Event|10
5060176|NCT02405091|17455043|P1|Overall Study|Adverse Event|16
5060177|NCT02404649|17455079|P2|Overall Study|Adverse Event|2
5060178|NCT02404649|17455080|P1|Overall Study|Adverse Event|1
5060179|NCT02404545|17455099|P2|Overall Study|Sponsor Termination|6
5060180|NCT02404545|17455100|P1|Overall Study|Sponsor Termination|6
5060181|NCT02404493|17455119|P2|Overall Study|Adverse Event|1
5060182|NCT02404493|17455120|P1|Overall Study|Adverse Event|1
5060183|NCT02404389|17455365|P5|Overall Study|Subject/guardian decision|1
5060184|NCT02404389|17455366|P4|Overall Study|Subject/guardian decision|1
5060185|NCT02404389|17455367|P3|Overall Study|Subject/guardian decision|0
5060186|NCT02404389|17455368|P2|Overall Study|Subject/guardian decision|0
5060187|NCT02404389|17455369|P1|Overall Study|Subject/guardian decision|1
5060188|NCT02404389|17455365|P5|Overall Study|Adverse Event|2
5060189|NCT02404389|17455366|P4|Overall Study|Adverse Event|0
5060190|NCT02404389|17455367|P3|Overall Study|Adverse Event|1
5060191|NCT02404389|17455368|P2|Overall Study|Adverse Event|0
5060192|NCT02404389|17455369|P1|Overall Study|Adverse Event|1
5060193|NCT02404350|17455409|P4|Overall Study|Due to Technical problems|1
5060194|NCT02404350|17455410|P3|Overall Study|Due to Technical problems|0
5060195|NCT02404350|17455411|P2|Overall Study|Due to Technical problems|0
5060196|NCT02404350|17455412|P1|Overall Study|Due to Technical problems|0
5060197|NCT02404350|17455409|P4|Overall Study|Due to Non-compliance with treatment|1
5060198|NCT02404350|17455410|P3|Overall Study|Due to Non-compliance with treatment|0
5060199|NCT02404350|17455411|P2|Overall Study|Due to Non-compliance with treatment|0
5060200|NCT02404350|17455412|P1|Overall Study|Due to Non-compliance with treatment|0
5060201|NCT02404350|17455409|P4|Overall Study|Withdrawal by Subject|19
5060202|NCT02404350|17455410|P3|Overall Study|Withdrawal by Subject|3
5060203|NCT02404350|17455411|P2|Overall Study|Withdrawal by Subject|3
5060204|NCT02404350|17455412|P1|Overall Study|Withdrawal by Subject|7
5060205|NCT02404350|17455409|P4|Overall Study|Pregnancy|1
5060206|NCT02404350|17455410|P3|Overall Study|Pregnancy|0
5060207|NCT02404350|17455411|P2|Overall Study|Pregnancy|0
5060208|NCT02404350|17455412|P1|Overall Study|Pregnancy|0
5060209|NCT02404350|17455409|P4|Overall Study|Physician Decision|2
5060210|NCT02404350|17455410|P3|Overall Study|Physician Decision|0
5060211|NCT02404350|17455411|P2|Overall Study|Physician Decision|0
5060212|NCT02404350|17455412|P1|Overall Study|Physician Decision|1
5060213|NCT02404350|17455409|P4|Overall Study|Lost to Follow-up|1
5060214|NCT02404350|17455410|P3|Overall Study|Lost to Follow-up|0
5060215|NCT02404350|17455411|P2|Overall Study|Lost to Follow-up|0
5060216|NCT02404350|17455412|P1|Overall Study|Lost to Follow-up|2
5060217|NCT02404350|17455409|P4|Overall Study|Lack of Efficacy|3
5060218|NCT02404350|17455410|P3|Overall Study|Lack of Efficacy|0
5060219|NCT02404350|17455411|P2|Overall Study|Lack of Efficacy|1
5060220|NCT02404350|17455412|P1|Overall Study|Lack of Efficacy|3
5060221|NCT02404350|17455409|P4|Overall Study|Adverse Event|9
5060222|NCT02404350|17455410|P3|Overall Study|Adverse Event|3
5060223|NCT02404350|17455411|P2|Overall Study|Adverse Event|2
5060224|NCT02404350|17455412|P1|Overall Study|Adverse Event|2
5060225|NCT02404311|17455460|P5|Part A: Month 0-18|Participant unable to adhere|0
5060226|NCT02404311|17455461|P4|Part A: Month 0-18|Participant unable to adhere|0
5060227|NCT02404311|17455462|P3|Part A: Month 0-18|Participant unable to adhere|0
5060228|NCT02404311|17455463|P2|Part A: Month 0-18|Participant unable to adhere|0
5060229|NCT02404311|17455464|P1|Part A: Month 0-18|Participant unable to adhere|7
5060230|NCT02404311|17455460|P5|Part A: Month 0-18|HIV Infection|0
5060231|NCT02404311|17455461|P4|Part A: Month 0-18|HIV Infection|0
5060232|NCT02404311|17455462|P3|Part A: Month 0-18|HIV Infection|0
5060233|NCT02404311|17455463|P2|Part A: Month 0-18|HIV Infection|2
5060234|NCT02404311|17455464|P1|Part A: Month 0-18|HIV Infection|6
5060235|NCT02404311|17455460|P5|Part A: Month 0-18|Withdrawal by Subject|0
5060236|NCT02404311|17455461|P4|Part A: Month 0-18|Withdrawal by Subject|0
5060237|NCT02404311|17455462|P3|Part A: Month 0-18|Withdrawal by Subject|0
5060238|NCT02404311|17455463|P2|Part A: Month 0-18|Withdrawal by Subject|2
5060239|NCT02404311|17455464|P1|Part A: Month 0-18|Withdrawal by Subject|6
5060240|NCT02404311|17455460|P5|Part A: Month 0-18|Lost to Follow-up|0
5060241|NCT02404311|17455461|P4|Part A: Month 0-18|Lost to Follow-up|0
5060242|NCT02404311|17455462|P3|Part A: Month 0-18|Lost to Follow-up|0
5060243|NCT02404311|17455463|P2|Part A: Month 0-18|Lost to Follow-up|2
5060244|NCT02404311|17455464|P1|Part A: Month 0-18|Lost to Follow-up|4
5060245|NCT02404311|17455460|P5|Part A: Month 0-18|Physician Decision|0
5060246|NCT02404311|17455461|P4|Part A: Month 0-18|Physician Decision|0
5060247|NCT02404311|17455462|P3|Part A: Month 0-18|Physician Decision|0
5060248|NCT02404311|17455463|P2|Part A: Month 0-18|Physician Decision|0
5060249|NCT02404311|17455464|P1|Part A: Month 0-18|Physician Decision|1
5060250|NCT02404311|17455460|P5|Part A: Month 0-18|Death|0
5060251|NCT02404311|17455461|P4|Part A: Month 0-18|Death|0
5060252|NCT02404311|17455462|P3|Part A: Month 0-18|Death|0
5060253|NCT02404311|17455463|P2|Part A: Month 0-18|Death|0
5060254|NCT02404311|17455464|P1|Part A: Month 0-18|Death|2
5060255|NCT02404220|17455605|P4|Overall Study|Enrolled but Never Treated|0
5060256|NCT02404220|17455606|P3|Overall Study|Enrolled but Never Treated|0
5060257|NCT02404220|17455607|P2|Overall Study|Enrolled but Never Treated|2
5060258|NCT02404220|17455608|P1|Overall Study|Enrolled but Never Treated|0
5060259|NCT02404220|17455605|P4|Overall Study|Withdrawal by Subject|0
5060260|NCT02404220|17455606|P3|Overall Study|Withdrawal by Subject|0
5060261|NCT02404220|17455607|P2|Overall Study|Withdrawal by Subject|1
5060262|NCT02404220|17455608|P1|Overall Study|Withdrawal by Subject|0
5060263|NCT02404220|17455605|P4|Overall Study|Study Terminated by Sponsor|1
5060264|NCT02404220|17455606|P3|Overall Study|Study Terminated by Sponsor|2
5060265|NCT02404220|17455607|P2|Overall Study|Study Terminated by Sponsor|0
5060266|NCT02404220|17455608|P1|Overall Study|Study Terminated by Sponsor|0
5060267|NCT02404220|17455605|P4|Overall Study|Progressive Disease|1
5060268|NCT02404220|17455606|P3|Overall Study|Progressive Disease|1
5060269|NCT02404220|17455607|P2|Overall Study|Progressive Disease|0
5060270|NCT02404220|17455608|P1|Overall Study|Progressive Disease|0
5060271|NCT02404220|17455605|P4|Overall Study|Death|8
5060272|NCT02404220|17455606|P3|Overall Study|Death|3
5060273|NCT02404220|17455607|P2|Overall Study|Death|5
5060274|NCT02404220|17455608|P1|Overall Study|Death|5
5060275|NCT02404220|17455605|P4|Overall Study|Adverse Event|0
5060276|NCT02404220|17455606|P3|Overall Study|Adverse Event|1
5060277|NCT02404220|17455607|P2|Overall Study|Adverse Event|0
5060278|NCT02404220|17455608|P1|Overall Study|Adverse Event|0
5060279|NCT02404103|17455644|P2|Overall Study|Lost to Follow-up|3
5060280|NCT02404103|17455645|P1|Overall Study|Lost to Follow-up|3
5060281|NCT02404103|17455644|P2|Overall Study|Adverse Event|0
5060282|NCT02404103|17455645|P1|Overall Study|Adverse Event|1
5060283|NCT02404025|17455665|P1|Overall Study|Lack of Efficacy|3
5060284|NCT02404025|17455665|P1|Overall Study|Adverse Event|1
5060285|NCT02403817|17455747|P2|Overall Study|Withdrawal by Subject|0
5060286|NCT02403817|17455748|P1|Overall Study|Withdrawal by Subject|5
5060287|NCT02403674|17455779|P2|Overall Study|Protocol Violation|2
5060288|NCT02403674|17455780|P1|Overall Study|Protocol Violation|4
5060289|NCT02403674|17455779|P2|Overall Study|Pregnancy|1
5060290|NCT02403674|17455780|P1|Overall Study|Pregnancy|1
5060291|NCT02403674|17455779|P2|Overall Study|Not treated with study drug|2
5060292|NCT02403674|17455780|P1|Overall Study|Not treated with study drug|4
5060293|NCT02403674|17455779|P2|Overall Study|Physician Decision|2
5060294|NCT02403674|17455780|P1|Overall Study|Physician Decision|2
5060295|NCT02403674|17455779|P2|Overall Study|Withdrawal by Subject|11
5060296|NCT02403674|17455780|P1|Overall Study|Withdrawal by Subject|8
5060297|NCT02403674|17455779|P2|Overall Study|Noncompliance with study drug|2
5060298|NCT02403674|17455780|P1|Overall Study|Noncompliance with study drug|1
5060299|NCT02403674|17455779|P2|Overall Study|Lost to Follow-up|7
5060300|NCT02403674|17455780|P1|Overall Study|Lost to Follow-up|6
5060301|NCT02403674|17455779|P2|Overall Study|Lack of Efficacy|10
5060302|NCT02403674|17455780|P1|Overall Study|Lack of Efficacy|18
5060303|NCT02403674|17455779|P2|Overall Study|Death|3
5060304|NCT02403674|17455780|P1|Overall Study|Death|1
5060305|NCT02403674|17455779|P2|Overall Study|Adverse Event|23
5060306|NCT02403674|17455780|P1|Overall Study|Adverse Event|10
5060307|NCT02403635|17455819|P1|Overall Study|Not eligible|9
5060308|NCT02403271|17455896|P2|Period 2|Other varied reasons|10
5060309|NCT02403271|17455897|P1|Period 2|Other varied reasons|0
5060310|NCT02403271|17455896|P2|Period 2|Study Terminated by Sponsor|14
5060311|NCT02403271|17455897|P1|Period 2|Study Terminated by Sponsor|0
5060312|NCT02403271|17455896|P2|Period 2|Lost to Follow-up|2
5060313|NCT02403271|17455897|P1|Period 2|Lost to Follow-up|0
5060314|NCT02403271|17455896|P2|Period 2|Death|84
5060315|NCT02403271|17455897|P1|Period 2|Death|0
5060316|NCT02403271|17455896|P2|Period 2|Withdrawal by Subject|14
5060317|NCT02403271|17455897|P1|Period 2|Withdrawal by Subject|0
5060318|NCT02403271|17455896|P2|Period 1|Other varied reasons|0
5060319|NCT02403271|17455897|P1|Period 1|Other varied reasons|1
5060320|NCT02403206|17455911|P2|Overall Study|Reason not given|4
5060321|NCT02403206|17455912|P1|Overall Study|Reason not given|2
5060322|NCT02403206|17455911|P2|Overall Study|Withdrawal by Subject|3
5060323|NCT02403206|17455912|P1|Overall Study|Withdrawal by Subject|3
5060324|NCT02403206|17455911|P2|Overall Study|Physician Decision|0
5060325|NCT02403206|17455912|P1|Overall Study|Physician Decision|2
5060326|NCT02403206|17455911|P2|Overall Study|Lost to Follow-up|3
5060327|NCT02403206|17455912|P1|Overall Study|Lost to Follow-up|4
5060328|NCT02403180|17455923|P2|Period 2 (5 Days)|Withdrawal by Subject|1
5060329|NCT02403180|17455924|P1|Period 2 (5 Days)|Withdrawal by Subject|0
5060330|NCT02403180|17455923|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
5060331|NCT02403180|17455924|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
5060332|NCT02402933|17455953|P1|Overall Study|Discontinued; Site Termination|10
5060333|NCT02402933|17455953|P1|Overall Study|Withdrawal by Subject|4
5060334|NCT02402907|17455962|P2|Overall Study|Lost to follow up after C-Section|23
5060335|NCT02402907|17455963|P1|Overall Study|Lost to follow up after C-Section|10
5060336|NCT02402907|17455962|P2|Overall Study|Delivered outside of Sinai|1
5060337|NCT02402907|17455963|P1|Overall Study|Delivered outside of Sinai|1
5060338|NCT02402907|17455962|P2|Overall Study|Delivered vaginally|3
5060339|NCT02402907|17455963|P1|Overall Study|Delivered vaginally|9
5060340|NCT02402322|17456018|P3|Follow-up|Withdrawal by Subject|24
5060341|NCT02402322|17456019|P2|Follow-up|Withdrawal by Subject|3
5060342|NCT02402322|17456020|P1|Follow-up|Withdrawal by Subject|6
5060343|NCT02402322|17456018|P3|Pretreatment|Withdrawal by Subject|1
5060344|NCT02402322|17456019|P2|Pretreatment|Withdrawal by Subject|1
5060345|NCT02402322|17456020|P1|Pretreatment|Withdrawal by Subject|3
5060346|NCT02402218|17456070|P3|Overall Study|Withdrawal by Subject|1
5060347|NCT02402218|17456071|P2|Overall Study|Withdrawal by Subject|1
5060348|NCT02402218|17456072|P1|Overall Study|Withdrawal by Subject|1
5060349|NCT02402218|17456070|P3|Overall Study|Adverse Event|1
5060350|NCT02402218|17456071|P2|Overall Study|Adverse Event|2
5060351|NCT02402218|17456072|P1|Overall Study|Adverse Event|0
5060352|NCT02402218|17456070|P3|Overall Study|Reinfection|1
5060353|NCT02402218|17456071|P2|Overall Study|Reinfection|0
5060354|NCT02402218|17456072|P1|Overall Study|Reinfection|0
5060355|NCT02402218|17456070|P3|Overall Study|Death|0
5060356|NCT02402218|17456071|P2|Overall Study|Death|0
5060357|NCT02402218|17456072|P1|Overall Study|Death|1
5060358|NCT02402218|17456070|P3|Overall Study|Lack of Efficacy|1
5060359|NCT02402218|17456071|P2|Overall Study|Lack of Efficacy|1
5060360|NCT02402218|17456072|P1|Overall Study|Lack of Efficacy|0
5060361|NCT02402218|17456070|P3|Overall Study|Did not pickup study medication|13
5060362|NCT02402218|17456071|P2|Overall Study|Did not pickup study medication|9
5060363|NCT02402218|17456072|P1|Overall Study|Did not pickup study medication|12
5060364|NCT02402166|17456095|P1|Overall Study|Lost to Follow-up|1
5060365|NCT02402166|17456095|P1|Overall Study|Withdrawal by Subject|2
5060366|NCT02402166|17456095|P1|Overall Study|Adverse Event|2
5060367|NCT02401867|17456162|P1|Analysis|Cervical assay could not be conducted|9
5060368|NCT02401867|17456162|P1|Specimen Collection|Didn't receive 1 or more tests|10
5060369|NCT02401672|17456169|P2|Overall Study|Withdrawal by Subject|3
5060370|NCT02401672|17456170|P1|Overall Study|Withdrawal by Subject|1
5060371|NCT02401529|17456212|P2|Overall Study|Protocol Violation|0
5060372|NCT02401529|17456213|P1|Overall Study|Protocol Violation|5
5060373|NCT02401529|17456212|P2|Overall Study|Physician Decision|6
5060374|NCT02401529|17456213|P1|Overall Study|Physician Decision|2
5060375|NCT02401529|17456212|P2|Overall Study|Lost to Follow-up|1
5060376|NCT02401529|17456213|P1|Overall Study|Lost to Follow-up|2
5060377|NCT02401412|17456280|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
5060378|NCT02401412|17456281|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
5060379|NCT02401412|17456280|P2|Overall Study|Subject withdrawal prior to intervention|1
5060380|NCT02401412|17456281|P1|Overall Study|Subject withdrawal prior to intervention|0
5060381|NCT02401412|17456280|P2|Overall Study|Withdrawal by Subject|4
5060382|NCT02401412|17456281|P1|Overall Study|Withdrawal by Subject|4
5060383|NCT02401412|17456280|P2|Overall Study|Discontinued Intervention|21
5060384|NCT02401412|17456281|P1|Overall Study|Discontinued Intervention|15
5060385|NCT02401412|17456280|P2|Overall Study|Lost to Follow-up|0
5060386|NCT02401412|17456281|P1|Overall Study|Lost to Follow-up|1
5060387|NCT02401256|17456289|P1|Overall Study|Withdrawal by Subject|12
5060388|NCT02401256|17456289|P1|Overall Study|Adverse Event|5
5060389|NCT02401230|17456298|P3|Overall Study|Lost to Follow-up|3
5060390|NCT02401230|17456299|P2|Overall Study|Lost to Follow-up|3
5060391|NCT02401230|17456300|P1|Overall Study|Lost to Follow-up|1
5060392|NCT02401230|17456298|P3|Overall Study|Withdrawal by Subject|1
5060393|NCT02401230|17456299|P2|Overall Study|Withdrawal by Subject|1
5060394|NCT02401230|17456300|P1|Overall Study|Withdrawal by Subject|2
5060395|NCT02401230|17456298|P3|Overall Study|Adverse Event|0
5060396|NCT02401230|17456299|P2|Overall Study|Adverse Event|2
5060397|NCT02401230|17456300|P1|Overall Study|Adverse Event|3
5060398|NCT02400905|17456379|P1|Overall Study|Subject refused visit|1
5060399|NCT02400905|17456379|P1|Overall Study|Death|3
5060400|NCT02400905|17456379|P1|Overall Study|Withdrawal by Subject|5
5060401|NCT02400905|17456379|P1|Overall Study|Lost to Follow-up|6
5060402|NCT02400905|17456379|P1|Overall Study|Ongoing Follow-up|256
5060403|NCT02400749|17456389|P2|Week 17 - 32|Adverse Event|1
5060404|NCT02400749|17456390|P1|Week 17 - 32|Adverse Event|2
5060405|NCT02400749|17456389|P2|Week 17 - 32|Withdrawal by Subject|2
5060406|NCT02400749|17456390|P1|Week 17 - 32|Withdrawal by Subject|3
5060407|NCT02400749|17456389|P2|Week 0 -16|Protocol Violation|0
5060408|NCT02400749|17456390|P1|Week 0 -16|Protocol Violation|1
5060409|NCT02400749|17456389|P2|Week 0 -16|Lost to Follow-up|0
5060410|NCT02400749|17456390|P1|Week 0 -16|Lost to Follow-up|2
5060411|NCT02400749|17456389|P2|Week 0 -16|Adverse Event|1
5060412|NCT02400749|17456390|P1|Week 0 -16|Adverse Event|3
5060413|NCT02400749|17456389|P2|Week 0 -16|Withdrawal by Subject|5
5060414|NCT02400749|17456390|P1|Week 0 -16|Withdrawal by Subject|5
5060415|NCT02400580|17456417|P2|Overall Study|Adverse Event|0
5060416|NCT02400580|17456418|P1|Overall Study|Adverse Event|1
5060417|NCT02400580|17456417|P2|Overall Study|Withdrawal by Subject|1
5060418|NCT02400580|17456418|P1|Overall Study|Withdrawal by Subject|1
5060419|NCT02400346|17456451|P1|Overall Study|Lost to Follow-up|1
5060420|NCT02400346|17456451|P1|Overall Study|Administrative or other reason(s)|2
5060421|NCT02400346|17456451|P1|Overall Study|Withdrawal by Subject|7
5060422|NCT02400346|17456451|P1|Overall Study|Non-compliance with IMP|1
5060423|NCT02400346|17456451|P1|Overall Study|Lack of Efficacy|9
5060424|NCT02400346|17456451|P1|Overall Study|Adverse Event|24
5060425|NCT02400333|17456459|P4|Overall Study|Protocol Violation|1
5060426|NCT02400333|17456460|P3|Overall Study|Protocol Violation|2
5060427|NCT02400333|17456461|P2|Overall Study|Protocol Violation|0
5060428|NCT02400333|17456462|P1|Overall Study|Protocol Violation|1
5060429|NCT02400333|17456459|P4|Overall Study|Withdrawal by Subject|1
5060430|NCT02400333|17456460|P3|Overall Study|Withdrawal by Subject|0
5060431|NCT02400333|17456461|P2|Overall Study|Withdrawal by Subject|1
5060432|NCT02400333|17456462|P1|Overall Study|Withdrawal by Subject|0
5060433|NCT02400307|17456522|P2|Overall Study|Enrolled and Never Dosed|0
5060434|NCT02400307|17456523|P1|Overall Study|Enrolled and Never Dosed|1
5060435|NCT02399254|17456577|P1|Overall Study|Physician Decision|2
5060436|NCT02399163|17456584|P1|Overall Study|Withdrawal by Participant|5
5060437|NCT02399163|17456584|P1|Overall Study|Protocol Deviation|2
5060438|NCT02399163|17456584|P1|Overall Study|Adverse Event|2
5060439|NCT02398227|17456654|P2|Overall Study|Removed from treatment and dropped out|0
5060440|NCT02398227|17456655|P1|Overall Study|Removed from treatment and dropped out|1
5060441|NCT02398227|17456654|P2|Overall Study|Withdrawal by Subject|6
5060442|NCT02398227|17456655|P1|Overall Study|Withdrawal by Subject|5
5060443|NCT02398227|17456654|P2|Overall Study|Lost to Follow-up|12
5060444|NCT02398227|17456655|P1|Overall Study|Lost to Follow-up|21
5060445|NCT02398188|17456665|P2|Overall Study|Withdrawal by Subject|16
5060446|NCT02398188|17456666|P1|Overall Study|Withdrawal by Subject|7
5060447|NCT02398188|17456665|P2|Overall Study|Pregnancy|0
5060448|NCT02398188|17456666|P1|Overall Study|Pregnancy|1
5060449|NCT02398188|17456665|P2|Overall Study|Sponsor Decision|1
5060450|NCT02398188|17456666|P1|Overall Study|Sponsor Decision|2
5060451|NCT02398188|17456665|P2|Overall Study|Protocol Violation|10
5060452|NCT02398188|17456666|P1|Overall Study|Protocol Violation|6
5060453|NCT02398188|17456665|P2|Overall Study|Non-compliance|4
5060454|NCT02398188|17456666|P1|Overall Study|Non-compliance|4
5060455|NCT02398188|17456665|P2|Overall Study|Lost to Follow-up|0
5060456|NCT02398188|17456666|P1|Overall Study|Lost to Follow-up|5
5060457|NCT02398188|17456665|P2|Overall Study|Adverse Event|3
5060458|NCT02398188|17456666|P1|Overall Study|Adverse Event|2
5060459|NCT02397915|17456684|P4|Period 1|Physician Decision|0
5060460|NCT02397915|17456685|P3|Period 1|Physician Decision|0
5060461|NCT02397915|17456686|P2|Period 1|Physician Decision|0
5060462|NCT02397915|17456687|P1|Period 1|Physician Decision|1
5060463|NCT02397915|17456684|P4|Period 1|Protocol Violation|0
5060464|NCT02397915|17456685|P3|Period 1|Protocol Violation|0
5060465|NCT02397915|17456686|P2|Period 1|Protocol Violation|1
5060466|NCT02397915|17456687|P1|Period 1|Protocol Violation|0
5060467|NCT02397837|17456739|P2|Overall Study|Physician Decision|1
5060468|NCT02397837|17456740|P1|Overall Study|Physician Decision|1
5060469|NCT02397837|17456739|P2|Overall Study|Withdrawal by Subject|5
5060470|NCT02397837|17456740|P1|Overall Study|Withdrawal by Subject|6
5060471|NCT02397694|17456835|P2|Open Label Extension Phase|Lost to Follow-up|0
5060472|NCT02397694|17456836|P1|Open Label Extension Phase|Lost to Follow-up|4
5060473|NCT02397694|17456835|P2|Open Label Extension Phase|Withdrew Consent|1
5060474|NCT02397694|17456836|P1|Open Label Extension Phase|Withdrew Consent|3
5060475|NCT02397694|17456835|P2|Open Label Extension Phase|Protocol Violation|0
5060476|NCT02397694|17456836|P1|Open Label Extension Phase|Protocol Violation|1
5060477|NCT02397694|17456835|P2|Double-Blinded Phase|Lost to Follow-up|1
5060478|NCT02397694|17456836|P1|Double-Blinded Phase|Lost to Follow-up|1
5060479|NCT02397694|17456835|P2|Double-Blinded Phase|Withdrawal by Subject|0
5060480|NCT02397694|17456836|P1|Double-Blinded Phase|Withdrawal by Subject|1
5060481|NCT02397694|17456835|P2|Double-Blinded Phase|Non-compliance with study drug|2
5060482|NCT02397694|17456836|P1|Double-Blinded Phase|Non-compliance with study drug|0
5060483|NCT02397694|17456835|P2|Double-Blinded Phase|Adverse Event|0
5060484|NCT02397694|17456836|P1|Double-Blinded Phase|Adverse Event|1
5060485|NCT02397655|17456874|P1|Overall Study|data not completed|1301
5060486|NCT02397473|17456885|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5060487|NCT02397473|17456886|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5060488|NCT02397473|17456885|P2|Post Treatment Follow-up Phase|Protocol Violation|0
5060489|NCT02397473|17456886|P1|Post Treatment Follow-up Phase|Protocol Violation|1
5060490|NCT02397473|17456885|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
5060491|NCT02397473|17456886|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
5060492|NCT02397473|17456885|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
5060493|NCT02397473|17456886|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
5060494|NCT02397473|17456885|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
5060495|NCT02397473|17456886|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
5060496|NCT02397473|17456885|P2|Treatment Phase|Withdrawal by Subject|1
5060497|NCT02397473|17456886|P1|Treatment Phase|Withdrawal by Subject|2
5060498|NCT02397473|17456885|P2|Treatment Phase|Lost to Follow-up|0
5060499|NCT02397473|17456886|P1|Treatment Phase|Lost to Follow-up|1
5060500|NCT02397473|17456885|P2|Treatment Phase|Lack of Efficacy|1
5060501|NCT02397473|17456886|P1|Treatment Phase|Lack of Efficacy|8
5060502|NCT02397473|17456885|P2|Treatment Phase|Adverse Event|2
5060503|NCT02397473|17456886|P1|Treatment Phase|Adverse Event|1
5060504|NCT02397447|17456916|P2|Overall Study|Lost to Follow-up|2
5060505|NCT02397447|17456917|P1|Overall Study|Lost to Follow-up|2
5060506|NCT02397408|17456963|P1|Overall Study|Surgery not completed within protocol timeframe|2
5060507|NCT02397408|17456963|P1|Overall Study|Physician Decision|4
5060508|NCT02397096|17457012|P2|Study Extensions|Ongoing|202
5060509|NCT02397096|17457013|P1|Study Extensions|Ongoing|399
5060510|NCT02397096|17457012|P2|Week 24 to Week 48|Lost to Follow-up|0
5060511|NCT02397096|17457013|P1|Week 24 to Week 48|Lost to Follow-up|2
5060512|NCT02397096|17457012|P2|Week 24 to Week 48|Withdrawal by Subject|2
5060513|NCT02397096|17457013|P1|Week 24 to Week 48|Withdrawal by Subject|5
5060514|NCT02397096|17457012|P2|Week 24 to Week 48|Physician Decision|1
5060515|NCT02397096|17457013|P1|Week 24 to Week 48|Physician Decision|2
5060516|NCT02397096|17457012|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
5060517|NCT02397096|17457013|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
5060518|NCT02397096|17457012|P2|Week 24 to Week 48|Lack of Efficacy|1
5060519|NCT02397096|17457013|P1|Week 24 to Week 48|Lack of Efficacy|5
5060520|NCT02397096|17457012|P2|Week 24 to Week 48|Adverse Event|2
5060521|NCT02397096|17457013|P1|Week 24 to Week 48|Adverse Event|6
5060522|NCT02397096|17457012|P2|Day 1 to Week 24|Withdrawal by Subject|1
5060523|NCT02397096|17457013|P1|Day 1 to Week 24|Withdrawal by Subject|6
5060524|NCT02397096|17457012|P2|Day 1 to Week 24|Protocol Violation|4
5060525|NCT02397096|17457013|P1|Day 1 to Week 24|Protocol Violation|1
5060526|NCT02397096|17457012|P2|Day 1 to Week 24|Physician Decision|3
5060527|NCT02397096|17457013|P1|Day 1 to Week 24|Physician Decision|2
5060528|NCT02397096|17457012|P2|Day 1 to Week 24|Lost to Follow-up|4
5060529|NCT02397096|17457013|P1|Day 1 to Week 24|Lost to Follow-up|3
5060530|NCT02397096|17457012|P2|Day 1 to Week 24|Lack of Efficacy|1
5060531|NCT02397096|17457013|P1|Day 1 to Week 24|Lack of Efficacy|0
5060532|NCT02397096|17457012|P2|Day 1 to Week 24|Death|0
5060533|NCT02397096|17457013|P1|Day 1 to Week 24|Death|1
5060534|NCT02397096|17457012|P2|Day 1 to Week 24|Adverse Event|1
5060535|NCT02397096|17457013|P1|Day 1 to Week 24|Adverse Event|7
5060536|NCT02396953|17457046|P3|Overall Study|Personal Reasons|0
5060537|NCT02396953|17457047|P2|Overall Study|Personal Reasons|1
5060538|NCT02396953|17457048|P1|Overall Study|Personal Reasons|1
5060539|NCT02396953|17457046|P3|Overall Study|Insulin like Growth Factor-1 increased|2
5060540|NCT02396953|17457047|P2|Overall Study|Insulin like Growth Factor-1 increased|2
5060541|NCT02396953|17457048|P1|Overall Study|Insulin like Growth Factor-1 increased|3
5060542|NCT02396953|17457046|P3|Overall Study|Withdrawal by Subject|1
5060543|NCT02396953|17457047|P2|Overall Study|Withdrawal by Subject|0
5060544|NCT02396953|17457048|P1|Overall Study|Withdrawal by Subject|0
5060545|NCT02396537|17457123|P2|Overall Study|Protocol Violation|1
5060546|NCT02396537|17457124|P1|Overall Study|Protocol Violation|0
5060547|NCT02396420|17457136|P1|Overall Study|Death|1
5060548|NCT02396381|17457160|P2|Overall Study|Randomization/Screening Error|1
5060549|NCT02396381|17457161|P1|Overall Study|Randomization/Screening Error|3
5060550|NCT02396381|17457160|P2|Overall Study|Possible conflict of interest|0
5060551|NCT02396381|17457161|P1|Overall Study|Possible conflict of interest|1
5060552|NCT02396381|17457160|P2|Overall Study|Could not complete visit|0
5060553|NCT02396381|17457161|P1|Overall Study|Could not complete visit|1
5060554|NCT02396381|17457160|P2|Overall Study|Moved out of town/state|3
5060555|NCT02396381|17457161|P1|Overall Study|Moved out of town/state|1
5060556|NCT02396381|17457160|P2|Overall Study|Non-compliance with study procedures|0
5060557|NCT02396381|17457161|P1|Overall Study|Non-compliance with study procedures|1
5060558|NCT02396381|17457160|P2|Overall Study|Pregnancy|0
5060559|NCT02396381|17457161|P1|Overall Study|Pregnancy|2
5060560|NCT02396381|17457160|P2|Overall Study|Physician Decision|5
5060561|NCT02396381|17457161|P1|Overall Study|Physician Decision|5
5060562|NCT02396381|17457160|P2|Overall Study|Site terminated by sponsor|8
5060563|NCT02396381|17457161|P1|Overall Study|Site terminated by sponsor|7
5060564|NCT02396381|17457160|P2|Overall Study|Protocol Violation|0
5060565|NCT02396381|17457161|P1|Overall Study|Protocol Violation|1
5060566|NCT02396381|17457160|P2|Overall Study|Lost to Follow-up|31
5060567|NCT02396381|17457161|P1|Overall Study|Lost to Follow-up|49
5060568|NCT02396381|17457160|P2|Overall Study|Withdrawal by Subject|24
5060569|NCT02396381|17457161|P1|Overall Study|Withdrawal by Subject|33
5060570|NCT02396381|17457160|P2|Overall Study|Adverse Event|2
5060571|NCT02396381|17457161|P1|Overall Study|Adverse Event|3
5060572|NCT02396316|17457200|P2|Overall Study|Treatment unblinded|1
5060573|NCT02396316|17457201|P1|Overall Study|Treatment unblinded|0
5060574|NCT02396316|17457200|P2|Overall Study|Protocol Violation|1
5060575|NCT02396316|17457201|P1|Overall Study|Protocol Violation|0
5060576|NCT02396316|17457200|P2|Overall Study|Progressive disease|3
5060577|NCT02396316|17457201|P1|Overall Study|Progressive disease|6
5060578|NCT02396316|17457200|P2|Overall Study|Physician Decision|0
5060579|NCT02396316|17457201|P1|Overall Study|Physician Decision|1
5060580|NCT02396212|17457220|P1|Overall Study|Lack of Efficacy|2
5060581|NCT02396212|17457220|P1|Overall Study|Adverse Event|1
5060582|NCT02395822|17457373|P1|Overall Study|Death|1
5060583|NCT02395822|17457373|P1|Overall Study|Withdrawal by Subject|1
5060584|NCT02395666|17457394|P2|Overall Study|Withdrawal by Subject|1
5060585|NCT02395666|17457395|P1|Overall Study|Withdrawal by Subject|2
5060586|NCT02395666|17457394|P2|Overall Study|Lost to Follow-up|0
5060587|NCT02395666|17457395|P1|Overall Study|Lost to Follow-up|1
5060588|NCT02395666|17457394|P2|Overall Study|Physician Decision|0
5060589|NCT02395666|17457395|P1|Overall Study|Physician Decision|3
5060590|NCT02395653|17457409|P1|Overall Study|Lost to Follow-up|1
5060591|NCT02395653|17457409|P1|Overall Study|Withdrawal by Subject|1
5060592|NCT02395653|17457409|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
5060593|NCT02395653|17457409|P1|Overall Study|Investigator Decision at Screening|1
5060594|NCT02395653|17457409|P1|Overall Study|SSEC Application But With 0 Dose|1
5060595|NCT02395653|17457409|P1|Overall Study|Consent Withdrawn at Screening|1
5060596|NCT02395653|17457409|P1|Overall Study|Exclusion Criteria Met at Screening|4
5060597|NCT02395627|17457419|P3|Overall Study|Did not receive pembrolizumab|0
5060598|NCT02395627|17457420|P2|Overall Study|Did not receive pembrolizumab|1
5060599|NCT02395627|17457421|P1|Overall Study|Did not receive pembrolizumab|3
5060600|NCT02395627|17457419|P3|Overall Study|Withdrawal by Subject|0
5060601|NCT02395627|17457420|P2|Overall Study|Withdrawal by Subject|2
5060602|NCT02395627|17457421|P1|Overall Study|Withdrawal by Subject|0
5060603|NCT02395536|17457449|P2|Overall Study|Insurance issue|1
5060604|NCT02395536|17457450|P1|Overall Study|Insurance issue|0
5060605|NCT02395536|17457449|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
5060606|NCT02395536|17457450|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
5060607|NCT02395536|17457449|P2|Overall Study|Withdrawal by Subject|17
5060608|NCT02395536|17457450|P1|Overall Study|Withdrawal by Subject|9
5060609|NCT02395536|17457449|P2|Overall Study|Physician Decision|6
5060610|NCT02395536|17457450|P1|Overall Study|Physician Decision|4
5060611|NCT02395536|17457449|P2|Overall Study|Death|0
5060612|NCT02395536|17457450|P1|Overall Study|Death|2
5060613|NCT02395536|17457449|P2|Overall Study|Lost to Follow-up|4
5060614|NCT02395536|17457450|P1|Overall Study|Lost to Follow-up|4
5060615|NCT02395471|17457458|P2|Overall Study|Subject not eligible|0
5060616|NCT02395471|17457459|P1|Overall Study|Subject not eligible|1
5060617|NCT02395471|17457458|P2|Overall Study|Patient did not return for procedure|1
5060618|NCT02395471|17457459|P1|Overall Study|Patient did not return for procedure|0
5060619|NCT02395471|17457458|P2|Overall Study|Failure to swollow sponge twice|0
5060620|NCT02395471|17457459|P1|Overall Study|Failure to swollow sponge twice|1
5060621|NCT02395471|17457458|P2|Overall Study|Protocol Violation|1
5060622|NCT02395471|17457459|P1|Overall Study|Protocol Violation|0
5060623|NCT02395471|17457458|P2|Overall Study|Physician Decision|0
5060624|NCT02395471|17457459|P1|Overall Study|Physician Decision|1
5060625|NCT02395471|17457458|P2|Overall Study|Withdrawal by Subject|1
5060626|NCT02395471|17457459|P1|Overall Study|Withdrawal by Subject|2
5060627|NCT02395471|17457458|P2|Overall Study|Lost to Follow-up|0
5060628|NCT02395471|17457459|P1|Overall Study|Lost to Follow-up|2
5060629|NCT02395302|17457474|P1|Overall Study|Physician Decision|2
5060630|NCT02395302|17457474|P1|Overall Study|Withdrawal by Subject|2
5060631|NCT02395302|17457474|P1|Overall Study|Run In Failure|7
5060632|NCT02395302|17457474|P1|Overall Study|Screen Failure|3
5060633|NCT02395172|17457494|P2|Overall Study|Participants randomized but not treated|31
5060634|NCT02395172|17457495|P1|Overall Study|Participants randomized but not treated|3
5060635|NCT02395133|17457534|P4|Overall Study|Other than specified above|4
5060636|NCT02395133|17457535|P3|Overall Study|Other than specified above|2
5060637|NCT02395133|17457536|P2|Overall Study|Other than specified above|2
5060638|NCT02395133|17457537|P1|Overall Study|Other than specified above|5
5060639|NCT02395133|17457534|P4|Overall Study|Sponsor decision|1
5060640|NCT02395133|17457535|P3|Overall Study|Sponsor decision|0
5060641|NCT02395133|17457536|P2|Overall Study|Sponsor decision|0
5060642|NCT02395133|17457537|P1|Overall Study|Sponsor decision|2
5060643|NCT02395133|17457534|P4|Overall Study|Consent withdrawn with personal reason|3
5060644|NCT02395133|17457535|P3|Overall Study|Consent withdrawn with personal reason|0
5060645|NCT02395133|17457536|P2|Overall Study|Consent withdrawn with personal reason|1
5060646|NCT02395133|17457537|P1|Overall Study|Consent withdrawn with personal reason|0
5060647|NCT02395133|17457534|P4|Overall Study|Consent withdrawn with no reason given|2
5060648|NCT02395133|17457535|P3|Overall Study|Consent withdrawn with no reason given|0
5060649|NCT02395133|17457536|P2|Overall Study|Consent withdrawn with no reason given|3
5060650|NCT02395133|17457537|P1|Overall Study|Consent withdrawn with no reason given|1
5060651|NCT02395133|17457534|P4|Overall Study|Pregnancy|0
5060652|NCT02395133|17457535|P3|Overall Study|Pregnancy|3
5060653|NCT02395133|17457536|P2|Overall Study|Pregnancy|0
5060654|NCT02395133|17457537|P1|Overall Study|Pregnancy|0
5060655|NCT02395133|17457534|P4|Overall Study|Lost to Follow-up|0
5060656|NCT02395133|17457535|P3|Overall Study|Lost to Follow-up|1
5060657|NCT02395133|17457536|P2|Overall Study|Lost to Follow-up|1
5060658|NCT02395133|17457537|P1|Overall Study|Lost to Follow-up|0
5060659|NCT02395133|17457534|P4|Overall Study|Protocol Violation|3
5060660|NCT02395133|17457535|P3|Overall Study|Protocol Violation|0
5060661|NCT02395133|17457536|P2|Overall Study|Protocol Violation|1
5060662|NCT02395133|17457537|P1|Overall Study|Protocol Violation|1
5060663|NCT02395133|17457534|P4|Overall Study|Lack of Efficacy|1
5060664|NCT02395133|17457535|P3|Overall Study|Lack of Efficacy|1
5060665|NCT02395133|17457536|P2|Overall Study|Lack of Efficacy|0
5060666|NCT02395133|17457537|P1|Overall Study|Lack of Efficacy|1
5060667|NCT02395133|17457534|P4|Overall Study|Adverse Event|0
5060668|NCT02395133|17457535|P3|Overall Study|Adverse Event|3
5060669|NCT02395133|17457536|P2|Overall Study|Adverse Event|1
5060670|NCT02395133|17457537|P1|Overall Study|Adverse Event|4
5060671|NCT02395055|17457625|P2|Overall Study|Withdrawal by Subject|3
5060672|NCT02395055|17457626|P1|Overall Study|Withdrawal by Subject|7
5060673|NCT02395042|17457639|P3|Treatment 2 Period|Lack of Efficacy|0
5060674|NCT02395042|17457640|P2|Treatment 2 Period|Lack of Efficacy|1
5060675|NCT02395042|17457641|P1|Treatment 2 Period|Lack of Efficacy|1
5060676|NCT02395042|17457639|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
5060677|NCT02395042|17457640|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
5060678|NCT02395042|17457641|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
5060679|NCT02395042|17457639|P3|Treatment 1 Period|Lost to Follow-up|0
5060680|NCT02395042|17457640|P2|Treatment 1 Period|Lost to Follow-up|0
5060681|NCT02395042|17457641|P1|Treatment 1 Period|Lost to Follow-up|1
5060682|NCT02395042|17457639|P3|Treatment 1 Period|Lack of Efficacy|0
5060683|NCT02395042|17457640|P2|Treatment 1 Period|Lack of Efficacy|1
5060684|NCT02395042|17457641|P1|Treatment 1 Period|Lack of Efficacy|1
5060685|NCT02395042|17457639|P3|Treatment 1 Period|Adverse Event|1
5060686|NCT02395042|17457640|P2|Treatment 1 Period|Adverse Event|3
5060687|NCT02395042|17457641|P1|Treatment 1 Period|Adverse Event|1
5060688|NCT02394925|17457679|P1|Overall Study|Unsatisfactory Visual Response|5
5060689|NCT02394925|17457679|P1|Overall Study|No longer meet eligibility criteria|1
5060690|NCT02394925|17457679|P1|Overall Study|Protocol Violation|5
5060691|NCT02394925|17457679|P1|Overall Study|Lost to Follow-up|9
5060692|NCT02394925|17457679|P1|Overall Study|Lens handling difficulities|5
5060693|NCT02394925|17457679|P1|Overall Study|Lens Discomfort|3
5060694|NCT02394925|17457679|P1|Overall Study|Adverse Event|1
5060695|NCT02394808|17457689|P2|Period 2|Lost to Follow-up|0
5060696|NCT02394808|17457690|P1|Period 2|Lost to Follow-up|1
5060697|NCT02394808|17457689|P2|Period 1|Unsatisfactory lens fitting|1
5060698|NCT02394808|17457690|P1|Period 1|Unsatisfactory lens fitting|0
5060699|NCT02394756|17457698|P6|Period 2|Unsatisfactory Visual Response|0
5060700|NCT02394756|17457699|P5|Period 2|Unsatisfactory Visual Response|1
5060701|NCT02394756|17457700|P4|Period 2|Unsatisfactory Visual Response|0
5060702|NCT02394756|17457701|P3|Period 2|Unsatisfactory Visual Response|0
5060703|NCT02394756|17457702|P2|Period 2|Unsatisfactory Visual Response|0
5060704|NCT02394756|17457703|P1|Period 2|Unsatisfactory Visual Response|0
5060705|NCT02394756|17457698|P6|Period 1|Withdrawal by Subject|0
5060706|NCT02394756|17457699|P5|Period 1|Withdrawal by Subject|0
5060707|NCT02394756|17457700|P4|Period 1|Withdrawal by Subject|1
5060708|NCT02394756|17457701|P3|Period 1|Withdrawal by Subject|1
5060709|NCT02394756|17457702|P2|Period 1|Withdrawal by Subject|1
5060710|NCT02394756|17457703|P1|Period 1|Withdrawal by Subject|0
5060711|NCT02394756|17457698|P6|Period 1|Lens Discomfort|1
5060712|NCT02394756|17457699|P5|Period 1|Lens Discomfort|0
5060713|NCT02394756|17457700|P4|Period 1|Lens Discomfort|0
5060714|NCT02394756|17457701|P3|Period 1|Lens Discomfort|0
5060715|NCT02394756|17457702|P2|Period 1|Lens Discomfort|0
5060716|NCT02394756|17457703|P1|Period 1|Lens Discomfort|0
5060717|NCT02394730|17457716|P2|Overall Study|Withdrawal by Subject|1
5060718|NCT02394730|17457717|P1|Overall Study|Withdrawal by Subject|0
5060719|NCT02394730|17457716|P2|Overall Study|Lost to Follow-up|0
5060720|NCT02394730|17457717|P1|Overall Study|Lost to Follow-up|1
5060721|NCT02394665|17457754|P3|Overall Study|Physician Decision|0
5060722|NCT02394665|17457755|P2|Overall Study|Physician Decision|0
5060723|NCT02394665|17457756|P1|Overall Study|Physician Decision|1
5060724|NCT02394600|17457778|P2|Overall Study|Protocol Violation|0
5060725|NCT02394600|17457779|P1|Overall Study|Protocol Violation|1
5060726|NCT02394600|17457778|P2|Overall Study|Withdrawal by Subject|1
5060727|NCT02394600|17457779|P1|Overall Study|Withdrawal by Subject|0
5060728|NCT02394600|17457778|P2|Overall Study|Lost to Follow-up|1
5060729|NCT02394600|17457779|P1|Overall Study|Lost to Follow-up|0
5060730|NCT02394600|17457778|P2|Overall Study|Adverse Event|0
5060731|NCT02394600|17457779|P1|Overall Study|Adverse Event|3
5060732|NCT02394561|17457789|P2|Extension Phase|Lack of Efficacy|3
5060733|NCT02394561|17457790|P1|Extension Phase|Lack of Efficacy|3
5060734|NCT02394561|17457789|P2|Extension Phase|Withdrawal by Subject|5
5060735|NCT02394561|17457790|P1|Extension Phase|Withdrawal by Subject|0
5060736|NCT02394561|17457789|P2|Extension Phase|Physician Decision|2
5060737|NCT02394561|17457790|P1|Extension Phase|Physician Decision|0
5060738|NCT02394561|17457789|P2|Extension Phase|Lost to Follow-up|0
5060739|NCT02394561|17457790|P1|Extension Phase|Lost to Follow-up|1
5060740|NCT02394561|17457789|P2|Extension Phase|Protocol Violation|0
5060741|NCT02394561|17457790|P1|Extension Phase|Protocol Violation|1
5060742|NCT02394561|17457789|P2|Extension Phase|Death|1
5060743|NCT02394561|17457790|P1|Extension Phase|Death|0
5060744|NCT02394561|17457789|P2|Extension Phase|Adverse Event|1
5060745|NCT02394561|17457790|P1|Extension Phase|Adverse Event|6
5060746|NCT02394561|17457789|P2|CORE Phase|Lack of Efficacy|6
5060747|NCT02394561|17457790|P1|CORE Phase|Lack of Efficacy|1
5060748|NCT02394561|17457789|P2|CORE Phase|Withdrawal by Subject|2
5060749|NCT02394561|17457790|P1|CORE Phase|Withdrawal by Subject|2
5060750|NCT02394561|17457789|P2|CORE Phase|Physician Decision|1
5060751|NCT02394561|17457790|P1|CORE Phase|Physician Decision|1
5060752|NCT02394561|17457789|P2|CORE Phase|Lost to Follow-up|0
5060753|NCT02394561|17457790|P1|CORE Phase|Lost to Follow-up|1
5060754|NCT02394561|17457789|P2|CORE Phase|Pregnancy|0
5060755|NCT02394561|17457790|P1|CORE Phase|Pregnancy|1
5060756|NCT02394561|17457789|P2|CORE Phase|Death|1
5060757|NCT02394561|17457790|P1|CORE Phase|Death|0
5060758|NCT02394561|17457789|P2|CORE Phase|Adverse Event|9
5060759|NCT02394561|17457790|P1|CORE Phase|Adverse Event|7
5060760|NCT02394340|17457837|P1|Overall Study|Adverse Event|1
5060761|NCT02394340|17457837|P1|Overall Study|Failed drug screen test|1
5060762|NCT02393950|17457844|P2|Overall Study|Withdrawal by Subject|1
5060763|NCT02393950|17457845|P1|Overall Study|Withdrawal by Subject|0
5060764|NCT02393950|17457844|P2|Overall Study|Adverse Event|0
5060765|NCT02393950|17457845|P1|Overall Study|Adverse Event|1
5060766|NCT02393859|17457912|P2|Overall Study|Continuing Study|43
5060767|NCT02393859|17457913|P1|Overall Study|Continuing Study|32
5060768|NCT02393859|17457912|P2|Overall Study|Death|8
5060769|NCT02393859|17457913|P1|Overall Study|Death|16
5060770|NCT02393859|17457912|P2|Overall Study|Withdrawal by Subject|2
5060771|NCT02393859|17457913|P1|Overall Study|Withdrawal by Subject|5
5060772|NCT02393859|17457912|P2|Overall Study|Decision by Sponsor|1
5060773|NCT02393859|17457913|P1|Overall Study|Decision by Sponsor|1
5060774|NCT02393755|17457938|P2|Overall Study|Physician Decision|2
5060775|NCT02393755|17457939|P1|Overall Study|Physician Decision|0
5060776|NCT02393755|17457938|P2|Overall Study|Adverse Event|2
5060777|NCT02393755|17457939|P1|Overall Study|Adverse Event|0
5060778|NCT02393755|17457938|P2|Overall Study|Withdrawal by Subject|3
5060779|NCT02393755|17457939|P1|Overall Study|Withdrawal by Subject|0
5060780|NCT02393547|17457958|P1|Overall Study|Lost to Follow-up|1
5060781|NCT02393547|17457958|P1|Overall Study|Withdrawal by Subject|3
5060782|NCT02393547|17457958|P1|Overall Study|Adverse Event|2
5060783|NCT02393209|17458049|P4|Overall Study|Lost to Follow-up|0
5060784|NCT02393209|17458050|P3|Overall Study|Lost to Follow-up|0
5060785|NCT02393209|17458051|P2|Overall Study|Lost to Follow-up|1
5060786|NCT02393209|17458052|P1|Overall Study|Lost to Follow-up|0
5060787|NCT02393209|17458049|P4|Overall Study|Patient Seen by Another Oncologist|0
5060788|NCT02393209|17458050|P3|Overall Study|Patient Seen by Another Oncologist|0
5060789|NCT02393209|17458051|P2|Overall Study|Patient Seen by Another Oncologist|1
5060790|NCT02393209|17458052|P1|Overall Study|Patient Seen by Another Oncologist|0
5060791|NCT02393209|17458049|P4|Overall Study|Death from Legionella Infection|0
5060792|NCT02393209|17458050|P3|Overall Study|Death from Legionella Infection|0
5060793|NCT02393209|17458051|P2|Overall Study|Death from Legionella Infection|1
5060794|NCT02393209|17458052|P1|Overall Study|Death from Legionella Infection|0
5060795|NCT02393209|17458049|P4|Overall Study|Death due to Disease Progression|0
5060796|NCT02393209|17458050|P3|Overall Study|Death due to Disease Progression|0
5060797|NCT02393209|17458051|P2|Overall Study|Death due to Disease Progression|2
5060798|NCT02393209|17458052|P1|Overall Study|Death due to Disease Progression|2
5060799|NCT02393209|17458049|P4|Overall Study|Death|0
5060800|NCT02393209|17458050|P3|Overall Study|Death|0
5060801|NCT02393209|17458051|P2|Overall Study|Death|2
5060802|NCT02393209|17458052|P1|Overall Study|Death|2
5060803|NCT02393209|17458049|P4|Overall Study|Withdrawal by Patient|0
5060804|NCT02393209|17458050|P3|Overall Study|Withdrawal by Patient|0
5060805|NCT02393209|17458051|P2|Overall Study|Withdrawal by Patient|0
5060806|NCT02393209|17458052|P1|Overall Study|Withdrawal by Patient|1
5060807|NCT02393209|17458049|P4|Overall Study|Study Terminated by Sponsor|0
5060808|NCT02393209|17458050|P3|Overall Study|Study Terminated by Sponsor|0
5060809|NCT02393209|17458051|P2|Overall Study|Study Terminated by Sponsor|1
5060810|NCT02393209|17458052|P1|Overall Study|Study Terminated by Sponsor|1
5060811|NCT02392624|17458141|P3|Overall Study|Other|1
5060812|NCT02392624|17458142|P2|Overall Study|Other|1
5060813|NCT02392624|17458143|P1|Overall Study|Other|49
5060814|NCT02392624|17458141|P3|Overall Study|Sponsor/Investigator Decision|0
5060815|NCT02392624|17458142|P2|Overall Study|Sponsor/Investigator Decision|1
5060816|NCT02392624|17458143|P1|Overall Study|Sponsor/Investigator Decision|2
5060817|NCT02392624|17458141|P3|Overall Study|Protocol Violation|1
5060818|NCT02392624|17458142|P2|Overall Study|Protocol Violation|0
5060819|NCT02392624|17458143|P1|Overall Study|Protocol Violation|0
5060820|NCT02392624|17458141|P3|Overall Study|Pregnancy|0
5060821|NCT02392624|17458142|P2|Overall Study|Pregnancy|0
5060822|NCT02392624|17458143|P1|Overall Study|Pregnancy|1
5060823|NCT02392624|17458141|P3|Overall Study|Adverse Event|2
5060824|NCT02392624|17458142|P2|Overall Study|Adverse Event|1
5060825|NCT02392624|17458143|P1|Overall Study|Adverse Event|4
5060826|NCT02392624|17458141|P3|Overall Study|Withdrawal by Subject|9
5060827|NCT02392624|17458142|P2|Overall Study|Withdrawal by Subject|12
5060828|NCT02392624|17458143|P1|Overall Study|Withdrawal by Subject|15
5060829|NCT02392559|17458158|P2|Overall Study|Withdrawal by Subject|1
5060830|NCT02392559|17458159|P1|Overall Study|Withdrawal by Subject|0
5060831|NCT02392507|17458190|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|1
5060832|NCT02392507|17458190|P1|Maintenance Regimen|Death|1
5060833|NCT02392507|17458190|P1|Induction Regimen|Withdrawal by Subject|2
5060834|NCT02392507|17458190|P1|Induction Regimen|Physician Decision|1
5060835|NCT02392507|17458190|P1|Induction Regimen|On Study Treatment at Study Conclusion|1
5060836|NCT02392507|17458190|P1|Induction Regimen|Death|3
5060837|NCT02392481|17458229|P4|Overall Study|Withdrawal by Subject|0
5060838|NCT02392481|17458230|P3|Overall Study|Withdrawal by Subject|1
5060839|NCT02392481|17458231|P2|Overall Study|Withdrawal by Subject|0
5060840|NCT02392481|17458232|P1|Overall Study|Withdrawal by Subject|0
5060841|NCT02392481|17458229|P4|Overall Study|Adverse Event|2
5060842|NCT02392481|17458230|P3|Overall Study|Adverse Event|1
5060843|NCT02392481|17458231|P2|Overall Study|Adverse Event|0
5060844|NCT02392481|17458232|P1|Overall Study|Adverse Event|0
5060845|NCT02392403|17458254|P1|Overall Study|Withdrawal by Subject|1
5060846|NCT02392403|17458254|P1|Overall Study|Death|1
5060847|NCT02392403|17458254|P1|Overall Study|Adverse Event|1
5060848|NCT02392377|17458268|P2|Overall Study|Withdrawal by Subject|1
5060849|NCT02392377|17458269|P1|Overall Study|Withdrawal by Subject|0
5060850|NCT02392247|17458361|P1|Overall Study|Surgery cancelled; no data|1
5060851|NCT02392247|17458361|P1|Overall Study|Withdrawal by Subject|1
5060852|NCT02392234|17458372|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
5060853|NCT02392234|17458373|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
5060854|NCT02392234|17458374|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
5060855|NCT02392234|17458375|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
5060856|NCT02392234|17458376|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
5060857|NCT02392234|17458377|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
5060858|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5060859|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
5060860|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5060861|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
5060862|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5060863|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5060864|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Other|0
5060865|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Other|0
5060866|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Other|0
5060867|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Other|0
5060868|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Other|0
5060869|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Other|1
5060870|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
5060871|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
5060872|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
5060873|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
5060874|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
5060875|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
5060876|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
5060877|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
5060878|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
5060879|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
5060880|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
5060881|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
5060882|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
5060883|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5060884|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5060885|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5060886|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5060887|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5060888|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5060889|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
5060890|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5060891|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5060892|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5060893|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5060894|NCT02392234|17458372|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
5060895|NCT02392234|17458373|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
5060896|NCT02392234|17458374|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
5060897|NCT02392234|17458375|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
5060898|NCT02392234|17458376|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
5060899|NCT02392234|17458377|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
5060900|NCT02392104|17458409|P1|Overall Study|INRs drawn by visiting nurse services|1
5060901|NCT02392104|17458409|P1|Overall Study|admitted to skilled nursing facility|3
5060902|NCT02392104|17458409|P1|Overall Study|INR goal range changed|1
5060903|NCT02392104|17458409|P1|Overall Study|transferred care to another doctor|2
5060904|NCT02392104|17458409|P1|Overall Study|bleeding event|1
5060905|NCT02392104|17458409|P1|Overall Study|discontinuation of warfarin|3
5060906|NCT02392000|17458420|P1|Overall Study|Lost to Follow-up|8
5060907|NCT02392000|17458420|P1|Overall Study|Withdrawal by Subject|1
5060908|NCT02392000|17458420|P1|Overall Study|Greater than mild sleep apnea exclusion|18
5060909|NCT02391961|17458443|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5060910|NCT02391961|17458444|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5060911|NCT02391961|17458443|P2|Washout (2 Weeks)|Withdrawal by Subject|1
5060912|NCT02391961|17458444|P1|Washout (2 Weeks)|Withdrawal by Subject|1
5060913|NCT02391961|17458443|P2|First Intervention (4 Weeks)|Adverse Event|0
5060914|NCT02391961|17458444|P1|First Intervention (4 Weeks)|Adverse Event|2
5060915|NCT02391948|17458467|P5|24-month Assessment|Not able to schedule visit in timeframe|8
5060916|NCT02391948|17458468|P4|24-month Assessment|Not able to schedule visit in timeframe|9
5060917|NCT02391948|17458469|P3|24-month Assessment|Not able to schedule visit in timeframe|2
5060918|NCT02391948|17458470|P2|24-month Assessment|Not able to schedule visit in timeframe|5
5060919|NCT02391948|17458471|P1|24-month Assessment|Not able to schedule visit in timeframe|8
5060920|NCT02391948|17458467|P5|24-month Assessment|Medical issue/illness|0
5060921|NCT02391948|17458468|P4|24-month Assessment|Medical issue/illness|0
5060922|NCT02391948|17458469|P3|24-month Assessment|Medical issue/illness|1
5060923|NCT02391948|17458470|P2|24-month Assessment|Medical issue/illness|0
5060924|NCT02391948|17458471|P1|24-month Assessment|Medical issue/illness|0
5060925|NCT02391948|17458467|P5|24-month Assessment|Lost to Follow-up|0
5060926|NCT02391948|17458468|P4|24-month Assessment|Lost to Follow-up|0
5060927|NCT02391948|17458469|P3|24-month Assessment|Lost to Follow-up|0
5060928|NCT02391948|17458470|P2|24-month Assessment|Lost to Follow-up|4
5060929|NCT02391948|17458471|P1|24-month Assessment|Lost to Follow-up|5
5060930|NCT02391948|17458467|P5|24-month Assessment|Withdrawal by Subject|1
5060931|NCT02391948|17458468|P4|24-month Assessment|Withdrawal by Subject|0
5060932|NCT02391948|17458469|P3|24-month Assessment|Withdrawal by Subject|0
5060933|NCT02391948|17458470|P2|24-month Assessment|Withdrawal by Subject|1
5060934|NCT02391948|17458471|P1|24-month Assessment|Withdrawal by Subject|1
5060935|NCT02391948|17458467|P5|24-month Assessment|Death|1
5060936|NCT02391948|17458468|P4|24-month Assessment|Death|0
5060937|NCT02391948|17458469|P3|24-month Assessment|Death|0
5060938|NCT02391948|17458470|P2|24-month Assessment|Death|0
5060939|NCT02391948|17458471|P1|24-month Assessment|Death|0
5060940|NCT02391948|17458467|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
5060941|NCT02391948|17458468|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
5060942|NCT02391948|17458469|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
5060943|NCT02391948|17458470|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
5060944|NCT02391948|17458471|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
5060945|NCT02391948|17458467|P5|18-month Assessment|Not able to schedule visit in timeframe|4
5060946|NCT02391948|17458468|P4|18-month Assessment|Not able to schedule visit in timeframe|1
5060947|NCT02391948|17458469|P3|18-month Assessment|Not able to schedule visit in timeframe|2
5060948|NCT02391948|17458470|P2|18-month Assessment|Not able to schedule visit in timeframe|3
5060949|NCT02391948|17458471|P1|18-month Assessment|Not able to schedule visit in timeframe|3
5060950|NCT02391948|17458467|P5|18-month Assessment|Lost to Follow-up|3
5060951|NCT02391948|17458468|P4|18-month Assessment|Lost to Follow-up|2
5060952|NCT02391948|17458469|P3|18-month Assessment|Lost to Follow-up|2
5060953|NCT02391948|17458470|P2|18-month Assessment|Lost to Follow-up|6
5060954|NCT02391948|17458471|P1|18-month Assessment|Lost to Follow-up|2
5060955|NCT02391948|17458467|P5|18-month Assessment|Withdrawal by Subject|0
5060956|NCT02391948|17458468|P4|18-month Assessment|Withdrawal by Subject|1
5060957|NCT02391948|17458469|P3|18-month Assessment|Withdrawal by Subject|0
5060958|NCT02391948|17458470|P2|18-month Assessment|Withdrawal by Subject|0
5060959|NCT02391948|17458471|P1|18-month Assessment|Withdrawal by Subject|1
5060960|NCT02391948|17458467|P5|18-month Assessment|Death|1
5060961|NCT02391948|17458468|P4|18-month Assessment|Death|1
5060962|NCT02391948|17458469|P3|18-month Assessment|Death|0
5060963|NCT02391948|17458470|P2|18-month Assessment|Death|0
5060964|NCT02391948|17458471|P1|18-month Assessment|Death|0
5060965|NCT02391948|17458467|P5|12-month Assessment|Not able to schedule visit in timeframe|1
5060966|NCT02391948|17458468|P4|12-month Assessment|Not able to schedule visit in timeframe|2
5060967|NCT02391948|17458469|P3|12-month Assessment|Not able to schedule visit in timeframe|0
5060968|NCT02391948|17458470|P2|12-month Assessment|Not able to schedule visit in timeframe|4
5060969|NCT02391948|17458471|P1|12-month Assessment|Not able to schedule visit in timeframe|2
5060970|NCT02391948|17458467|P5|12-month Assessment|Medical issue/illness|0
5060971|NCT02391948|17458468|P4|12-month Assessment|Medical issue/illness|1
5060972|NCT02391948|17458469|P3|12-month Assessment|Medical issue/illness|0
5060973|NCT02391948|17458470|P2|12-month Assessment|Medical issue/illness|1
5060974|NCT02391948|17458471|P1|12-month Assessment|Medical issue/illness|0
5060975|NCT02391948|17458467|P5|12-month Assessment|Lost to Follow-up|5
5060976|NCT02391948|17458468|P4|12-month Assessment|Lost to Follow-up|4
5060977|NCT02391948|17458469|P3|12-month Assessment|Lost to Follow-up|4
5060978|NCT02391948|17458470|P2|12-month Assessment|Lost to Follow-up|4
5060979|NCT02391948|17458471|P1|12-month Assessment|Lost to Follow-up|5
5060980|NCT02391948|17458467|P5|12-month Assessment|Withdrawal by Subject|0
5060981|NCT02391948|17458468|P4|12-month Assessment|Withdrawal by Subject|1
5060982|NCT02391948|17458469|P3|12-month Assessment|Withdrawal by Subject|0
5060983|NCT02391948|17458470|P2|12-month Assessment|Withdrawal by Subject|0
5060984|NCT02391948|17458471|P1|12-month Assessment|Withdrawal by Subject|1
5060985|NCT02391948|17458467|P5|12-month Assessment|Death|0
5060986|NCT02391948|17458468|P4|12-month Assessment|Death|1
5060987|NCT02391948|17458469|P3|12-month Assessment|Death|0
5060988|NCT02391948|17458470|P2|12-month Assessment|Death|0
5060989|NCT02391948|17458471|P1|12-month Assessment|Death|0
5060990|NCT02391948|17458467|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
5060991|NCT02391948|17458468|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
5060992|NCT02391948|17458469|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
5060993|NCT02391948|17458470|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
5060994|NCT02391948|17458471|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
5060995|NCT02391948|17458467|P5|6-month Assessment|Not able to schedule visit in timeframe|0
5060996|NCT02391948|17458468|P4|6-month Assessment|Not able to schedule visit in timeframe|5
5060997|NCT02391948|17458469|P3|6-month Assessment|Not able to schedule visit in timeframe|4
5060998|NCT02391948|17458470|P2|6-month Assessment|Not able to schedule visit in timeframe|8
5060999|NCT02391948|17458471|P1|6-month Assessment|Not able to schedule visit in timeframe|6
5061000|NCT02391948|17458467|P5|6-month Assessment|Medical issue/illness|0
5061001|NCT02391948|17458468|P4|6-month Assessment|Medical issue/illness|0
5061002|NCT02391948|17458469|P3|6-month Assessment|Medical issue/illness|0
5061003|NCT02391948|17458470|P2|6-month Assessment|Medical issue/illness|1
5061004|NCT02391948|17458471|P1|6-month Assessment|Medical issue/illness|1
5061005|NCT02391948|17458467|P5|6-month Assessment|Lost to Follow-up|1
5061006|NCT02391948|17458468|P4|6-month Assessment|Lost to Follow-up|3
5061007|NCT02391948|17458469|P3|6-month Assessment|Lost to Follow-up|2
5061008|NCT02391948|17458470|P2|6-month Assessment|Lost to Follow-up|5
5061009|NCT02391948|17458471|P1|6-month Assessment|Lost to Follow-up|4
5061010|NCT02391948|17458467|P5|6-month Assessment|Withdrawal by Subject|0
5061011|NCT02391948|17458468|P4|6-month Assessment|Withdrawal by Subject|2
5061012|NCT02391948|17458469|P3|6-month Assessment|Withdrawal by Subject|1
5061013|NCT02391948|17458470|P2|6-month Assessment|Withdrawal by Subject|0
5061014|NCT02391948|17458471|P1|6-month Assessment|Withdrawal by Subject|0
5061015|NCT02391948|17458467|P5|6-month Assessment|Death|1
5061016|NCT02391948|17458468|P4|6-month Assessment|Death|0
5061017|NCT02391948|17458469|P3|6-month Assessment|Death|0
5061018|NCT02391948|17458470|P2|6-month Assessment|Death|0
5061019|NCT02391948|17458471|P1|6-month Assessment|Death|0
5061020|NCT02391584|17458595|P2|12 Month (End of Study)|Lost to Follow-up|0
5061021|NCT02391584|17458596|P1|12 Month (End of Study)|Lost to Follow-up|2
5061022|NCT02391584|17458595|P2|6 Month|Withdrawal by Subject|0
5061023|NCT02391584|17458596|P1|6 Month|Withdrawal by Subject|1
5061024|NCT02391584|17458595|P2|3 Month|Lost to Follow-up|0
5061025|NCT02391584|17458596|P1|3 Month|Lost to Follow-up|1
5061026|NCT02391584|17458595|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
5061027|NCT02391584|17458596|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
5061028|NCT02391584|17458595|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
5061029|NCT02391584|17458596|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
5061030|NCT02391545|17458613|P2|Overall Study|Other Reasons|4
5061031|NCT02391545|17458614|P1|Overall Study|Other Reasons|6
5061032|NCT02391545|17458613|P2|Overall Study|Withdrawal by Subject|1
5061033|NCT02391545|17458614|P1|Overall Study|Withdrawal by Subject|0
5061034|NCT02391545|17458613|P2|Overall Study|Termination of study by sponsor|20
5061035|NCT02391545|17458614|P1|Overall Study|Termination of study by sponsor|20
5061036|NCT02391545|17458613|P2|Overall Study|Lost to Follow-up|1
5061037|NCT02391545|17458614|P1|Overall Study|Lost to Follow-up|0
5061038|NCT02391545|17458613|P2|Overall Study|Death|2
5061039|NCT02391545|17458614|P1|Overall Study|Death|0
5061040|NCT02391363|17458634|P2|Overall Study|Withdrawal by Subject|3
5061041|NCT02391363|17458635|P1|Overall Study|Withdrawal by Subject|6
5061042|NCT02391363|17458634|P2|Overall Study|Lost to Follow-up|5
5061043|NCT02391363|17458635|P1|Overall Study|Lost to Follow-up|5
5061044|NCT02391311|17458701|P2|Overall Study|deemed ineligible after baseline|1
5061045|NCT02391311|17458702|P1|Overall Study|deemed ineligible after baseline|1
5061046|NCT02391311|17458701|P2|Overall Study|Lost to Follow-up|1
5061047|NCT02391311|17458702|P1|Overall Study|Lost to Follow-up|2
5061048|NCT02391116|17458710|P1|Survival Follow-up|Switching to Other Therapy|1
5061049|NCT02391116|17458710|P1|Survival Follow-up|Withdrawal by Subject|3
5061050|NCT02391116|17458710|P1|Active Follow-up|Switching to Other Therapy|2
5061051|NCT02391116|17458710|P1|Active Follow-up|Withdrawal by Subject|1
5061052|NCT02391116|17458710|P1|Safety Follow-up|Deterioration of General Conditions|3
5061053|NCT02391116|17458710|P1|Safety Follow-up|No Follow Up|1
5061054|NCT02391116|17458710|P1|Safety Follow-up|Switching to Other Therapy|4
5061055|NCT02391116|17458710|P1|Safety Follow-up|Withdrawal by Subject|4
5061056|NCT02391116|17458710|P1|Safety Follow-up|Adverse Event|1
5061057|NCT02391116|17458710|P1|Treatment|AE with Clinical PD|3
5061058|NCT02391116|17458710|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
5061059|NCT02391116|17458710|P1|Treatment|Protocol Violation|1
5061060|NCT02391116|17458710|P1|Treatment|Withdrawal by Subject|1
5061061|NCT02391038|17458764|P3|Overall Study|Progressive disease|6
5061062|NCT02391038|17458765|P2|Overall Study|Progressive disease|3
5061063|NCT02391038|17458766|P1|Overall Study|Progressive disease|3
5061064|NCT02390557|17458910|P3|Wave 2|Survey non-respondent|23
5061065|NCT02390557|17458911|P2|Wave 2|Survey non-respondent|41
5061066|NCT02390557|17458912|P1|Wave 2|Survey non-respondent|72
5061067|NCT02390362|17458922|P2|Overall Study|Withdrawal by Subject|1
5061068|NCT02390362|17458923|P1|Overall Study|Withdrawal by Subject|0
5061069|NCT02390219|17458931|P1|Overall Study|Other|2
5061070|NCT02390219|17458931|P1|Overall Study|Lost to Follow-up|2
5061071|NCT02390219|17458931|P1|Overall Study|Withdrawal by Subject|1
5061072|NCT02390219|17458931|P1|Overall Study|Adverse Event|6
5061073|NCT02390219|17458931|P1|Overall Study|Physician Decision|1
5061074|NCT02390219|17458931|P1|Overall Study|Death|1
5061075|NCT02390167|17458941|P1|Overall Study|Lost to Follow-up|1
5061076|NCT02390076|17458963|P3|Overall Study|Lost to Follow-up|4
5061077|NCT02390076|17458964|P2|Overall Study|Lost to Follow-up|1
5061078|NCT02390076|17458965|P1|Overall Study|Lost to Follow-up|2
5061079|NCT02389894|17458994|P3|Overall Study|Lost to Follow-up|1
5061080|NCT02389894|17458995|P2|Overall Study|Lost to Follow-up|1
5061081|NCT02389894|17458996|P1|Overall Study|Lost to Follow-up|2
5061082|NCT02389894|17458994|P3|Overall Study|Withdrawal by Subject|5
5061083|NCT02389894|17458995|P2|Overall Study|Withdrawal by Subject|4
5061084|NCT02389894|17458996|P1|Overall Study|Withdrawal by Subject|2
5061085|NCT02389894|17458994|P3|Overall Study|Death|3
5061086|NCT02389894|17458995|P2|Overall Study|Death|5
5061087|NCT02389894|17458996|P1|Overall Study|Death|4
5061088|NCT02389829|17459128|P2|Overall Study|Lost to Follow-up|1
5061089|NCT02389829|17459129|P1|Overall Study|Lost to Follow-up|0
5061090|NCT02389816|17459144|P3|Overall Study|Reason not Specified|0
5061091|NCT02389816|17459145|P2|Overall Study|Reason not Specified|2
5061092|NCT02389816|17459146|P1|Overall Study|Reason not Specified|0
5061093|NCT02389816|17459144|P3|Overall Study|Non Compliance with Study Drug|1
5061094|NCT02389816|17459145|P2|Overall Study|Non Compliance with Study Drug|1
5061095|NCT02389816|17459146|P1|Overall Study|Non Compliance with Study Drug|1
5061096|NCT02389816|17459144|P3|Overall Study|Lack of Efficacy|0
5061097|NCT02389816|17459145|P2|Overall Study|Lack of Efficacy|0
5061098|NCT02389816|17459146|P1|Overall Study|Lack of Efficacy|1
5061099|NCT02389816|17459144|P3|Overall Study|Withdrawal of Consent|4
5061100|NCT02389816|17459145|P2|Overall Study|Withdrawal of Consent|4
5061101|NCT02389816|17459146|P1|Overall Study|Withdrawal of Consent|6
5061102|NCT02389816|17459144|P3|Overall Study|Lost to Follow-up|0
5061103|NCT02389816|17459145|P2|Overall Study|Lost to Follow-up|0
5061104|NCT02389816|17459146|P1|Overall Study|Lost to Follow-up|1
5061105|NCT02389816|17459144|P3|Overall Study|Major Protocol Deviation|0
5061106|NCT02389816|17459145|P2|Overall Study|Major Protocol Deviation|0
5061107|NCT02389816|17459146|P1|Overall Study|Major Protocol Deviation|1
5061108|NCT02389816|17459144|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
5061109|NCT02389816|17459145|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
5061110|NCT02389816|17459146|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
5061111|NCT02389816|17459144|P3|Overall Study|Randomized but Not Treated|0
5061112|NCT02389816|17459145|P2|Overall Study|Randomized but Not Treated|0
5061113|NCT02389816|17459146|P1|Overall Study|Randomized but Not Treated|1
5061114|NCT02389764|17459178|P1|Overall Study|Lack of Efficacy|9
5061115|NCT02389621|17459213|P2|Posttreatment Period|Other - Miscellaneous|0
5061116|NCT02389621|17459214|P1|Posttreatment Period|Other - Miscellaneous|2
5061117|NCT02389621|17459213|P2|Posttreatment Period|Lost to Follow-up|1
5061118|NCT02389621|17459214|P1|Posttreatment Period|Lost to Follow-up|1
5061119|NCT02389621|17459213|P2|Posttreatment Period|Withdrawal by Subject|2
5061120|NCT02389621|17459214|P1|Posttreatment Period|Withdrawal by Subject|3
5061121|NCT02389621|17459213|P2|Posttreatment Period|Adverse Event|1
5061122|NCT02389621|17459214|P1|Posttreatment Period|Adverse Event|3
5061123|NCT02389621|17459213|P2|Treatment Period|Withdrawal by Subject|1
5061124|NCT02389621|17459214|P1|Treatment Period|Withdrawal by Subject|1
5061125|NCT02389452|17459244|P1|Overall Study|Enrolled but Not Eligible for Study|6
5061126|NCT02389452|17459244|P1|Overall Study|Withdrawal by Subject|5
5061127|NCT02389452|17459244|P1|Overall Study|Adverse Event|1
5061128|NCT02389452|17459244|P1|Overall Study|Lost to Follow-up|13
5061129|NCT02388997|17459356|P2|Overall Study|Tested positive for virus during run-in|1
5061130|NCT02388997|17459357|P1|Overall Study|Tested positive for virus during run-in|0
5061131|NCT02388997|17459356|P2|Overall Study|Lung function exclusion criteria|2
5061132|NCT02388997|17459357|P1|Overall Study|Lung function exclusion criteria|0
5061133|NCT02388997|17459356|P2|Overall Study|Withdrawal by Subject|1
5061134|NCT02388997|17459357|P1|Overall Study|Withdrawal by Subject|2
5061135|NCT02388997|17459356|P2|Overall Study|Adverse Event|2
5061136|NCT02388997|17459357|P1|Overall Study|Adverse Event|1
5061137|NCT02388932|17459375|P1|Overall Study|Death|1
5061138|NCT02388776|17459396|P1|Overall Study|Lost to Follow-up|1
5061139|NCT02388776|17459396|P1|Overall Study|Death|1
5061140|NCT02388763|17459401|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
5061141|NCT02388763|17459402|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
5061142|NCT02388763|17459401|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
5061143|NCT02388763|17459402|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
5061144|NCT02388737|17459416|P3|Overall Study|Reason Not Specified|4
5061145|NCT02388737|17459417|P2|Overall Study|Reason Not Specified|5
5061146|NCT02388737|17459418|P1|Overall Study|Reason Not Specified|5
5061147|NCT02388737|17459416|P3|Overall Study|Lack of Efficacy|3
5061148|NCT02388737|17459417|P2|Overall Study|Lack of Efficacy|0
5061149|NCT02388737|17459418|P1|Overall Study|Lack of Efficacy|3
5061150|NCT02388737|17459416|P3|Overall Study|Voluntary Withdrawal|17
5061151|NCT02388737|17459417|P2|Overall Study|Voluntary Withdrawal|18
5061152|NCT02388737|17459418|P1|Overall Study|Voluntary Withdrawal|10
5061153|NCT02388737|17459416|P3|Overall Study|Lost to Follow-up|4
5061154|NCT02388737|17459417|P2|Overall Study|Lost to Follow-up|1
5061155|NCT02388737|17459418|P1|Overall Study|Lost to Follow-up|5
5061156|NCT02388737|17459416|P3|Overall Study|Major Protocol Deviation|22
5061157|NCT02388737|17459417|P2|Overall Study|Major Protocol Deviation|25
5061158|NCT02388737|17459418|P1|Overall Study|Major Protocol Deviation|18
5061159|NCT02388737|17459416|P3|Overall Study|Pretreatment Event/Adverse Event|12
5061160|NCT02388737|17459417|P2|Overall Study|Pretreatment Event/Adverse Event|11
5061161|NCT02388737|17459418|P1|Overall Study|Pretreatment Event/Adverse Event|13
5061162|NCT02388724|17459452|P2|Overall Study|Randomized but not Treated|2
5061163|NCT02388724|17459453|P1|Overall Study|Randomized but not Treated|0
5061164|NCT02388724|17459452|P2|Overall Study|Voluntary Withdrawal|5
5061165|NCT02388724|17459453|P1|Overall Study|Voluntary Withdrawal|6
5061166|NCT02388724|17459452|P2|Overall Study|Pretreatment Event/Adverse Event|2
5061167|NCT02388724|17459453|P1|Overall Study|Pretreatment Event/Adverse Event|3
5061168|NCT02388724|17459452|P2|Overall Study|Major Protocol Deviation|3
5061169|NCT02388724|17459453|P1|Overall Study|Major Protocol Deviation|3
5061170|NCT02388724|17459452|P2|Overall Study|Reason not Specified|1
5061171|NCT02388724|17459453|P1|Overall Study|Reason not Specified|0
5061172|NCT02388347|17459507|P5|Overall Study|Withdrawal by Subject|0
5061173|NCT02388347|17459508|P4|Overall Study|Withdrawal by Subject|0
5061174|NCT02388347|17459509|P3|Overall Study|Withdrawal by Subject|1
5061175|NCT02388347|17459510|P2|Overall Study|Withdrawal by Subject|0
5061176|NCT02388347|17459511|P1|Overall Study|Withdrawal by Subject|0
5061177|NCT02388295|17459590|P3|Treatment Weeks 3 to 12|Adverse Event|0
5061178|NCT02388295|17459591|P2|Treatment Weeks 3 to 12|Adverse Event|1
5061179|NCT02388295|17459592|P1|Treatment Weeks 3 to 12|Adverse Event|1
5061180|NCT02388295|17459590|P3|Dose Escalation Week 2|Determined not eligible|1
5061181|NCT02388295|17459591|P2|Dose Escalation Week 2|Determined not eligible|1
5061182|NCT02388295|17459592|P1|Dose Escalation Week 2|Determined not eligible|1
5061183|NCT02388295|17459590|P3|Dose Escalation Week 2|Protocol Violation|0
5061184|NCT02388295|17459591|P2|Dose Escalation Week 2|Protocol Violation|1
5061185|NCT02388295|17459592|P1|Dose Escalation Week 2|Protocol Violation|0
5061186|NCT02388295|17459590|P3|Dose Escalation Week 1|Determined not eligible|1
5061187|NCT02388295|17459591|P2|Dose Escalation Week 1|Determined not eligible|1
5061188|NCT02388295|17459592|P1|Dose Escalation Week 1|Determined not eligible|1
5061189|NCT02388295|17459590|P3|Dose Escalation Week 1|Adverse Event|1
5061190|NCT02388295|17459591|P2|Dose Escalation Week 1|Adverse Event|2
5061191|NCT02388295|17459592|P1|Dose Escalation Week 1|Adverse Event|1
5061192|NCT02388269|17459610|P3|Overall Study|Screen Failure|10
5061193|NCT02388269|17459611|P2|Overall Study|Screen Failure|0
5061194|NCT02388269|17459612|P1|Overall Study|Screen Failure|0
5061195|NCT02388269|17459610|P3|Overall Study|Protocol Violation|0
5061196|NCT02388269|17459611|P2|Overall Study|Protocol Violation|0
5061197|NCT02388269|17459612|P1|Overall Study|Protocol Violation|2
5061198|NCT02388269|17459610|P3|Overall Study|no diary data|0
5061199|NCT02388269|17459611|P2|Overall Study|no diary data|0
5061200|NCT02388269|17459612|P1|Overall Study|no diary data|3
5061201|NCT02388269|17459610|P3|Overall Study|less than 50% stimulations|0
5061202|NCT02388269|17459611|P2|Overall Study|less than 50% stimulations|0
5061203|NCT02388269|17459612|P1|Overall Study|less than 50% stimulations|1
5061204|NCT02388269|17459610|P3|Overall Study|Withdrawal by Subject|0
5061205|NCT02388269|17459611|P2|Overall Study|Withdrawal by Subject|2
5061206|NCT02388269|17459612|P1|Overall Study|Withdrawal by Subject|1
5061207|NCT02388269|17459610|P3|Overall Study|Adverse Event|0
5061208|NCT02388269|17459611|P2|Overall Study|Adverse Event|0
5061209|NCT02388269|17459612|P1|Overall Study|Adverse Event|2
5061210|NCT02388191|17459644|P2|Overall Study|Patient did not receive IUD|0
5061211|NCT02388191|17459645|P1|Overall Study|Patient did not receive IUD|1
5061212|NCT02388165|17459661|P2|Overall Study|Did not meet entrance criteria|2
5061213|NCT02388165|17459662|P1|Overall Study|Did not meet entrance criteria|5
5061214|NCT02388165|17459661|P2|Overall Study|Adverse Event|5
5061215|NCT02388165|17459662|P1|Overall Study|Adverse Event|3
5061216|NCT02388165|17459661|P2|Overall Study|Death|10
5061217|NCT02388165|17459662|P1|Overall Study|Death|13
5061218|NCT02388165|17459661|P2|Overall Study|Lost to Follow-up|20
5061219|NCT02388165|17459662|P1|Overall Study|Lost to Follow-up|19
5061220|NCT02388165|17459661|P2|Overall Study|Withdrawal of consent|32
5061221|NCT02388165|17459662|P1|Overall Study|Withdrawal of consent|31
5061222|NCT02388165|17459661|P2|Overall Study|No longer meet eligibility criteria|43
5061223|NCT02388165|17459662|P1|Overall Study|No longer meet eligibility criteria|40
5061224|NCT02388165|17459661|P2|Overall Study|Other|13
5061225|NCT02388165|17459662|P1|Overall Study|Other|11
5061226|NCT02388165|17459661|P2|Overall Study|Study terminated by sponsor|5
5061227|NCT02388165|17459662|P1|Overall Study|Study terminated by sponsor|5
5061228|NCT02388074|17459692|P1|Overall Study|Sample Not Returned|1
5061229|NCT02388074|17459692|P1|Overall Study|Lost in Transit|2
5061230|NCT02387996|17459696|P1|Overall Study|Poor/Non-Compliance|1
5061231|NCT02387996|17459696|P1|Overall Study|Lost to Follow-up|1
5061232|NCT02387996|17459696|P1|Overall Study|Subject Withdrew Consent|1
5061233|NCT02387996|17459696|P1|Overall Study|Subject Request to Discontinue Treatment|9
5061234|NCT02387996|17459696|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
5061235|NCT02387996|17459696|P1|Overall Study|Study Drug Toxicity|14
5061236|NCT02387996|17459696|P1|Overall Study|Disease Progression|144
5061237|NCT02387983|17459707|P1|Overall Study|Withdrawal by Subject|2
5061238|NCT02387983|17459707|P1|Overall Study|Protocol Violation|1
5061239|NCT02387983|17459707|P1|Overall Study|Adverse Event|4
5061240|NCT02387970|17459721|P2|Overall Study|Did not complete 1-year follow up|2
5061241|NCT02387970|17459722|P1|Overall Study|Did not complete 1-year follow up|1
5061242|NCT02387957|17459743|P3|Overall Study|The study was discontinued|20
5061243|NCT02387957|17459744|P2|Overall Study|The study was discontinued|21
5061244|NCT02387957|17459745|P1|Overall Study|The study was discontinued|21
5061245|NCT02387762|17459816|P2|Overall Study|Withdrawal by Subject|0
5061246|NCT02387762|17459817|P1|Overall Study|Withdrawal by Subject|1
5061247|NCT02387580|17459849|P6|Overall Study|Withdrawal by Subject|0
5061248|NCT02387580|17459850|P5|Overall Study|Withdrawal by Subject|0
5061249|NCT02387580|17459851|P4|Overall Study|Withdrawal by Subject|1
5061250|NCT02387580|17459852|P3|Overall Study|Withdrawal by Subject|0
5061251|NCT02387580|17459853|P2|Overall Study|Withdrawal by Subject|0
5061252|NCT02387580|17459854|P1|Overall Study|Withdrawal by Subject|0
5061253|NCT02387372|17459947|P2|Overall Study|Not Treated|0
5061254|NCT02387372|17459948|P1|Overall Study|Not Treated|1
5061255|NCT02387164|17460038|P2|Overall Study|Diagnosed|2
5061256|NCT02387164|17460039|P1|Overall Study|Diagnosed|1
5061257|NCT02387164|17460038|P2|Overall Study|Lost to Follow-up|0
5061258|NCT02387164|17460039|P1|Overall Study|Lost to Follow-up|2
5061259|NCT02386345|17460083|P1|Overall Study|Did not complete 12-month follow-up|72
5061260|NCT02386345|17460083|P1|Overall Study|Repeat Procedure|10
5061261|NCT02386345|17460083|P1|Overall Study|Adverse Event|5
5061262|NCT02386345|17460083|P1|Overall Study|Lost to Follow-up|1
5061263|NCT02386345|17460083|P1|Overall Study|Not treated|14
5061264|NCT02386189|17460093|P2|Overall Study|Death|0
5061265|NCT02386189|17460094|P1|Overall Study|Death|1
5061266|NCT02386189|17460093|P2|Overall Study|Withdrawal by Subject|0
5061267|NCT02386189|17460094|P1|Overall Study|Withdrawal by Subject|1
5061268|NCT02386189|17460093|P2|Overall Study|Lost to Follow-up|3
5061269|NCT02386189|17460094|P1|Overall Study|Lost to Follow-up|2
5061270|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5061271|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5061272|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5061273|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
5061274|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
5061275|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Other|0
5061276|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Other|0
5061277|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Other|0
5061278|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Other|0
5061279|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Other|1
5061280|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5061281|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5061282|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5061283|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
5061284|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
5061285|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5061286|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5061287|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5061288|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
5061289|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5061290|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
5061291|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
5061292|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
5061293|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
5061294|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
5061295|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Adverse Event|0
5061296|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Adverse Event|0
5061297|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Adverse Event|0
5061298|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Adverse Event|1
5061299|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Adverse Event|2
5061300|NCT02386098|17460117|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5061301|NCT02386098|17460118|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5061302|NCT02386098|17460119|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5061303|NCT02386098|17460120|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
5061304|NCT02386098|17460121|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
5061305|NCT02385799|17460200|P2|Overall Study|Withdrawal by Subject|4
5061306|NCT02385799|17460201|P1|Overall Study|Withdrawal by Subject|0
5061307|NCT02385799|17460200|P2|Overall Study|Adverse Event|2
5061308|NCT02385799|17460201|P1|Overall Study|Adverse Event|4
5061309|NCT02385799|17460200|P2|Overall Study|Lost to Follow-up|2
5061310|NCT02385799|17460201|P1|Overall Study|Lost to Follow-up|1
5061311|NCT02385708|17460242|P2|Overall Study|Protocol Violation|1
5061312|NCT02385708|17460243|P1|Overall Study|Protocol Violation|1
5061313|NCT02385708|17460242|P2|Overall Study|Investigator decision|7
5061314|NCT02385708|17460243|P1|Overall Study|Investigator decision|5
5061315|NCT02385708|17460242|P2|Overall Study|Withdrawn - surgery canceled|5
5061316|NCT02385708|17460243|P1|Overall Study|Withdrawn - surgery canceled|2
5061317|NCT02385708|17460242|P2|Overall Study|Withdrawal by Subject|2
5061318|NCT02385708|17460243|P1|Overall Study|Withdrawal by Subject|0
5061319|NCT02385669|17460249|P1|Overall Study|Adverse Event|2
5061320|NCT02385526|17460257|P3|Overall Study|Protocol Violation|0
5061321|NCT02385526|17460258|P2|Overall Study|Protocol Violation|0
5061322|NCT02385526|17460259|P1|Overall Study|Protocol Violation|1
5061323|NCT02385526|17460257|P3|Overall Study|Physician Decision|0
5061324|NCT02385526|17460258|P2|Overall Study|Physician Decision|0
5061325|NCT02385526|17460259|P1|Overall Study|Physician Decision|1
5061326|NCT02385526|17460257|P3|Overall Study|Lost to Follow-up|0
5061327|NCT02385526|17460258|P2|Overall Study|Lost to Follow-up|1
5061328|NCT02385526|17460259|P1|Overall Study|Lost to Follow-up|0
5061329|NCT02385526|17460257|P3|Overall Study|Withdrawal by Subject|0
5061330|NCT02385526|17460258|P2|Overall Study|Withdrawal by Subject|2
5061331|NCT02385526|17460259|P1|Overall Study|Withdrawal by Subject|0
5061332|NCT02385084|17460267|P6|Period 2|Protocol Violation|0
5061333|NCT02385084|17460268|P5|Period 2|Protocol Violation|0
5061334|NCT02385084|17460269|P4|Period 2|Protocol Violation|0
5061335|NCT02385084|17460270|P3|Period 2|Protocol Violation|1
5061336|NCT02385084|17460271|P2|Period 2|Protocol Violation|0
5061337|NCT02385084|17460272|P1|Period 2|Protocol Violation|0
5061338|NCT02384993|17460285|P2|Overall Study|Adverse Event|1
5061339|NCT02384993|17460286|P1|Overall Study|Adverse Event|0
5061340|NCT02384941|17460312|P3|Overall Study|Other than specified above|1
5061341|NCT02384941|17460313|P2|Overall Study|Other than specified above|0
5061342|NCT02384941|17460314|P1|Overall Study|Other than specified above|4
5061343|NCT02384941|17460312|P3|Overall Study|Pregnancy|1
5061344|NCT02384941|17460313|P2|Overall Study|Pregnancy|0
5061345|NCT02384941|17460314|P1|Overall Study|Pregnancy|0
5061346|NCT02384941|17460312|P3|Overall Study|Withdrawal by Subject|20
5061347|NCT02384941|17460313|P2|Overall Study|Withdrawal by Subject|19
5061348|NCT02384941|17460314|P1|Overall Study|Withdrawal by Subject|26
5061349|NCT02384941|17460312|P3|Overall Study|Protocol Violation|0
5061350|NCT02384941|17460313|P2|Overall Study|Protocol Violation|0
5061351|NCT02384941|17460314|P1|Overall Study|Protocol Violation|3
5061352|NCT02384941|17460312|P3|Overall Study|Physician Decision|0
5061353|NCT02384941|17460313|P2|Overall Study|Physician Decision|1
5061354|NCT02384941|17460314|P1|Overall Study|Physician Decision|1
5061355|NCT02384941|17460312|P3|Overall Study|Non-Compliance With Study Drug|1
5061356|NCT02384941|17460313|P2|Overall Study|Non-Compliance With Study Drug|0
5061357|NCT02384941|17460314|P1|Overall Study|Non-Compliance With Study Drug|2
5061358|NCT02384941|17460312|P3|Overall Study|Lost to Follow-up|1
5061359|NCT02384941|17460313|P2|Overall Study|Lost to Follow-up|2
5061360|NCT02384941|17460314|P1|Overall Study|Lost to Follow-up|3
5061361|NCT02384941|17460312|P3|Overall Study|Adverse Event|17
5061362|NCT02384941|17460313|P2|Overall Study|Adverse Event|13
5061363|NCT02384941|17460314|P1|Overall Study|Adverse Event|11
5061364|NCT02384538|17460345|P2|Overall Study|Other|3
5061365|NCT02384538|17460346|P1|Overall Study|Other|1
5061366|NCT02384538|17460345|P2|Overall Study|Withdrew Consent|4
5061367|NCT02384538|17460346|P1|Overall Study|Withdrew Consent|0
5061368|NCT02384538|17460345|P2|Overall Study|Lack of Efficacy|4
5061369|NCT02384538|17460346|P1|Overall Study|Lack of Efficacy|4
5061370|NCT02384538|17460345|P2|Overall Study|Adverse Event|4
5061371|NCT02384538|17460346|P1|Overall Study|Adverse Event|1
5061372|NCT02384460|17460366|P2|Overall Study|Non-compliance|0
5061373|NCT02384460|17460367|P1|Overall Study|Non-compliance|1
5061374|NCT02384460|17460366|P2|Overall Study|Elective medical treatment|0
5061375|NCT02384460|17460367|P1|Overall Study|Elective medical treatment|1
5061376|NCT02384460|17460366|P2|Overall Study|Withdrawal by Subject|3
5061377|NCT02384460|17460367|P1|Overall Study|Withdrawal by Subject|0
5061378|NCT02384460|17460366|P2|Overall Study|Adverse Event|2
5061379|NCT02384460|17460367|P1|Overall Study|Adverse Event|5
5061380|NCT02384460|17460366|P2|Overall Study|Returned to previous therapeutic regimen|1
5061381|NCT02384460|17460367|P1|Overall Study|Returned to previous therapeutic regimen|0
5061382|NCT02384460|17460366|P2|Overall Study|Protocol Violation|1
5061383|NCT02384460|17460367|P1|Overall Study|Protocol Violation|0
5061384|NCT02384382|17460385|P1|Overall Study|Disease progression|16
5061385|NCT02384382|17460385|P1|Overall Study|Adverse Event|1
5061386|NCT02384382|17460385|P1|Overall Study|Death|1
5061387|NCT02384382|17460385|P1|Overall Study|Transitioned to study-NCT02960022|5
5061388|NCT02383966|17460457|P2|Overall Study|Randomized, but not treated|3
5061389|NCT02383966|17460458|P1|Overall Study|Randomized, but not treated|1
5061390|NCT02383966|17460457|P2|Overall Study|Ongoing at clinical cut-off date|4
5061391|NCT02383966|17460458|P1|Overall Study|Ongoing at clinical cut-off date|25
5061392|NCT02383940|17460478|P2|Overall Study|Other than specified above|0
5061393|NCT02383940|17460479|P1|Overall Study|Other than specified above|1
5061394|NCT02383940|17460478|P2|Overall Study|Randomized but not treated|0
5061395|NCT02383940|17460479|P1|Overall Study|Randomized but not treated|2
5061396|NCT02383940|17460478|P2|Overall Study|Withdrawal by Subject|1
5061397|NCT02383940|17460479|P1|Overall Study|Withdrawal by Subject|1
5061398|NCT02383940|17460478|P2|Overall Study|Physician Decision|0
5061399|NCT02383940|17460479|P1|Overall Study|Physician Decision|2
5061400|NCT02383940|17460478|P2|Overall Study|Lost to Follow-up|2
5061401|NCT02383940|17460479|P1|Overall Study|Lost to Follow-up|2
5061402|NCT02383940|17460478|P2|Overall Study|Adverse Event|0
5061403|NCT02383940|17460479|P1|Overall Study|Adverse Event|1
5061404|NCT02383862|17460495|P2|3 Month Follow up|Lost to Follow-up|21
5061405|NCT02383862|17460496|P1|3 Month Follow up|Lost to Follow-up|23
5061406|NCT02383758|17460529|P2|Overall Study|Withdrawal by Subject|2
5061407|NCT02383758|17460530|P1|Overall Study|Withdrawal by Subject|0
5061408|NCT02383589|17460558|P2|Safety Follow-up (SFU)|Treated by not accepted treatment|1
5061409|NCT02383589|17460559|P1|Safety Follow-up (SFU)|Treated by not accepted treatment|0
5061410|NCT02383589|17460558|P2|Safety Follow-up (SFU)|Withdrawal by Subject|0
5061411|NCT02383589|17460559|P1|Safety Follow-up (SFU)|Withdrawal by Subject|5
5061412|NCT02383589|17460558|P2|Safety Follow-up (SFU)|Lost to Follow-up|4
5061413|NCT02383589|17460559|P1|Safety Follow-up (SFU)|Lost to Follow-up|2
5061414|NCT02383589|17460558|P2|Treatment Period|Non-compliance with study drug|1
5061415|NCT02383589|17460559|P1|Treatment Period|Non-compliance with study drug|0
5061416|NCT02383589|17460558|P2|Treatment Period|Withdrawal by Subject|5
5061417|NCT02383589|17460559|P1|Treatment Period|Withdrawal by Subject|0
5061418|NCT02383589|17460558|P2|Treatment Period|Lost to Follow-up|1
5061419|NCT02383589|17460559|P1|Treatment Period|Lost to Follow-up|0
5061420|NCT02383589|17460558|P2|Treatment Period|Adverse Event|3
5061421|NCT02383589|17460559|P1|Treatment Period|Adverse Event|1
5061422|NCT02383576|17460584|P2|Overall Study|Administrative/Other|4
5061423|NCT02383576|17460585|P1|Overall Study|Administrative/Other|2
5061424|NCT02383576|17460584|P2|Overall Study|Investigator's Decision|1
5061425|NCT02383576|17460585|P1|Overall Study|Investigator's Decision|0
5061426|NCT02383576|17460584|P2|Overall Study|Withdrew Consent|6
5061427|NCT02383576|17460585|P1|Overall Study|Withdrew Consent|1
5061428|NCT02383576|17460584|P2|Overall Study|Lost to Follow-up|1
5061429|NCT02383576|17460585|P1|Overall Study|Lost to Follow-up|7
5061430|NCT02383576|17460584|P2|Overall Study|Death|33
5061431|NCT02383576|17460585|P1|Overall Study|Death|53
5061432|NCT02383472|17460601|P2|Overall Study|Withdrawal by Subject|1
5061433|NCT02383472|17460602|P1|Overall Study|Withdrawal by Subject|1
5061434|NCT02383433|17460616|P1|Overall Study|Disease progression|2
5061435|NCT02383355|17460635|P2|Overall Study|Adverse Event|0
5061436|NCT02383355|17460636|P1|Overall Study|Adverse Event|2
5061437|NCT02383056|17460652|P2|Overall Study|Lost to Follow-up|2
5061438|NCT02383056|17460653|P1|Overall Study|Lost to Follow-up|0
5061439|NCT02383056|17460652|P2|Overall Study|Adverse Event|0
5061440|NCT02383056|17460653|P1|Overall Study|Adverse Event|1
5061441|NCT02382991|17460679|P2|Overall Study|Withdrawal by Subject|1
5061442|NCT02382991|17460680|P1|Overall Study|Withdrawal by Subject|0
5061443|NCT02382991|17460679|P2|Overall Study|Lost to Follow-up|0
5061444|NCT02382991|17460680|P1|Overall Study|Lost to Follow-up|1
5061445|NCT02382991|17460679|P2|Overall Study|Adverse Event|2
5061446|NCT02382991|17460680|P1|Overall Study|Adverse Event|1
5061447|NCT02382939|17460692|P2|Overall Study|Withdrawal by Subject|2
5061448|NCT02382939|17460693|P1|Overall Study|Withdrawal by Subject|2
5061449|NCT02382939|17460692|P2|Overall Study|Adverse Event|1
5061450|NCT02382939|17460693|P1|Overall Study|Adverse Event|1
5061451|NCT02382796|17460776|P1|Overall Study|Commercial dacomitinib became available|3
5061452|NCT02382796|17460776|P1|Overall Study|Objective progression or relapse|3
5061453|NCT02382796|17460776|P1|Overall Study|Global deterioration of health status|1
5061454|NCT02382640|17460826|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5061455|NCT02382640|17460827|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5061456|NCT02382640|17460828|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5061457|NCT02382640|17460829|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
5061458|NCT02382276|17460870|P3|Overall Study|Physician Decision|2
5061459|NCT02382276|17460871|P2|Overall Study|Physician Decision|0
5061460|NCT02382276|17460872|P1|Overall Study|Physician Decision|0
5061461|NCT02382276|17460870|P3|Overall Study|Adverse Event|32
5061462|NCT02382276|17460871|P2|Overall Study|Adverse Event|2
5061463|NCT02382276|17460872|P1|Overall Study|Adverse Event|7
5061464|NCT02382276|17460870|P3|Overall Study|Withdrawal by Subject|5
5061465|NCT02382276|17460871|P2|Overall Study|Withdrawal by Subject|8
5061466|NCT02382276|17460872|P1|Overall Study|Withdrawal by Subject|4
5061467|NCT02382133|17460884|P1|Overall Study|pressure injury both sites|1
5061468|NCT02382133|17460884|P1|Overall Study|arterial catheter loss|4
5061469|NCT02382133|17460884|P1|Overall Study|Physician Decision|2
5061470|NCT02382133|17460884|P1|Overall Study|transfer out of ICU|4
5061471|NCT02382133|17460884|P1|Overall Study|Death|22
5061472|NCT02382016|17460891|P2|OL Extension Period|Withdrawal by Subject|0
5061473|NCT02382016|17460892|P1|OL Extension Period|Withdrawal by Subject|1
5061474|NCT02382016|17460891|P2|OL Extension Period|Death|0
5061475|NCT02382016|17460892|P1|OL Extension Period|Death|2
5061476|NCT02382016|17460891|P2|OL Extension Period|Physician Decision|0
5061477|NCT02382016|17460892|P1|OL Extension Period|Physician Decision|3
5061478|NCT02382016|17460891|P2|Open-label (OL) Treatment Period|Death|0
5061479|NCT02382016|17460892|P1|Open-label (OL) Treatment Period|Death|4
5061480|NCT02382016|17460891|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
5061481|NCT02382016|17460892|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
5061482|NCT02382016|17460891|P2|Open-label (OL) Treatment Period|Physician Decision|0
5061483|NCT02382016|17460892|P1|Open-label (OL) Treatment Period|Physician Decision|3
5061484|NCT02382016|17460891|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
5061485|NCT02382016|17460892|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
5061486|NCT02382016|17460891|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
5061487|NCT02382016|17460892|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
5061488|NCT02382016|17460891|P2|Double-blind (DB) Treatment Period|Physician Decision|0
5061489|NCT02382016|17460892|P1|Double-blind (DB) Treatment Period|Physician Decision|3
5061490|NCT02381795|17460916|P1|Overall Study|Study Terminated|2
5061491|NCT02381795|17460916|P1|Overall Study|Withdrawal by Subject|1
5061492|NCT02381652|17460931|P3|Overall Study|Withdrawal by Subject|1
5061493|NCT02381652|17460932|P2|Overall Study|Withdrawal by Subject|0
5061494|NCT02381652|17460933|P1|Overall Study|Withdrawal by Subject|0
5061495|NCT02380859|17461036|P2|Overall Study|Withdrawal by Subject|0
5061496|NCT02380859|17461037|P1|Overall Study|Withdrawal by Subject|2
5061497|NCT02380742|17461073|P2|Overall Study|Withdrawal by Subject|0
5061498|NCT02380742|17461074|P1|Overall Study|Withdrawal by Subject|1
5061499|NCT02380690|17461088|P2|Overall Study|Withdrawal by Subject|8
5061500|NCT02380690|17461089|P1|Overall Study|Withdrawal by Subject|20
5061501|NCT02380690|17461088|P2|Overall Study|Lost to Follow-up|4
5061502|NCT02380690|17461089|P1|Overall Study|Lost to Follow-up|14
5061503|NCT02380677|17461137|P12|Overall Study|Other|0
5061504|NCT02380677|17461138|P11|Overall Study|Other|0
5061505|NCT02380677|17461139|P10|Overall Study|Other|0
5061506|NCT02380677|17461140|P9|Overall Study|Other|0
5061507|NCT02380677|17461141|P8|Overall Study|Other|0
5061508|NCT02380677|17461142|P7|Overall Study|Other|0
5061509|NCT02380677|17461143|P6|Overall Study|Other|1
5061510|NCT02380677|17461144|P5|Overall Study|Other|1
5061511|NCT02380677|17461145|P4|Overall Study|Other|1
5061512|NCT02380677|17461146|P3|Overall Study|Other|0
5061513|NCT02380677|17461147|P2|Overall Study|Other|0
5061514|NCT02380677|17461148|P1|Overall Study|Other|0
5061515|NCT02380677|17461137|P12|Overall Study|Withdrawal by Subject|3
5061516|NCT02380677|17461138|P11|Overall Study|Withdrawal by Subject|0
5061517|NCT02380677|17461139|P10|Overall Study|Withdrawal by Subject|1
5061518|NCT02380677|17461140|P9|Overall Study|Withdrawal by Subject|0
5061519|NCT02380677|17461141|P8|Overall Study|Withdrawal by Subject|0
5061520|NCT02380677|17461142|P7|Overall Study|Withdrawal by Subject|0
5061521|NCT02380677|17461143|P6|Overall Study|Withdrawal by Subject|0
5061522|NCT02380677|17461144|P5|Overall Study|Withdrawal by Subject|0
5061523|NCT02380677|17461145|P4|Overall Study|Withdrawal by Subject|0
5061524|NCT02380677|17461146|P3|Overall Study|Withdrawal by Subject|0
5061525|NCT02380677|17461147|P2|Overall Study|Withdrawal by Subject|0
5061526|NCT02380677|17461148|P1|Overall Study|Withdrawal by Subject|0
5061527|NCT02380677|17461137|P12|Overall Study|Lack of Efficacy|1
5061528|NCT02380677|17461138|P11|Overall Study|Lack of Efficacy|2
5061529|NCT02380677|17461139|P10|Overall Study|Lack of Efficacy|0
5061530|NCT02380677|17461140|P9|Overall Study|Lack of Efficacy|2
5061531|NCT02380677|17461141|P8|Overall Study|Lack of Efficacy|2
5061532|NCT02380677|17461142|P7|Overall Study|Lack of Efficacy|1
5061533|NCT02380677|17461143|P6|Overall Study|Lack of Efficacy|1
5061534|NCT02380677|17461144|P5|Overall Study|Lack of Efficacy|4
5061535|NCT02380677|17461145|P4|Overall Study|Lack of Efficacy|0
5061536|NCT02380677|17461146|P3|Overall Study|Lack of Efficacy|2
5061537|NCT02380677|17461147|P2|Overall Study|Lack of Efficacy|1
5061538|NCT02380677|17461148|P1|Overall Study|Lack of Efficacy|0
5061539|NCT02380677|17461137|P12|Overall Study|Physician Decision|0
5061540|NCT02380677|17461138|P11|Overall Study|Physician Decision|0
5061541|NCT02380677|17461139|P10|Overall Study|Physician Decision|0
5061542|NCT02380677|17461140|P9|Overall Study|Physician Decision|0
5061543|NCT02380677|17461141|P8|Overall Study|Physician Decision|0
5061544|NCT02380677|17461142|P7|Overall Study|Physician Decision|0
5061545|NCT02380677|17461143|P6|Overall Study|Physician Decision|0
5061546|NCT02380677|17461144|P5|Overall Study|Physician Decision|0
5061547|NCT02380677|17461145|P4|Overall Study|Physician Decision|1
5061548|NCT02380677|17461146|P3|Overall Study|Physician Decision|1
5061549|NCT02380677|17461147|P2|Overall Study|Physician Decision|0
5061550|NCT02380677|17461148|P1|Overall Study|Physician Decision|1
5061551|NCT02380677|17461137|P12|Overall Study|Adverse Event|1
5061552|NCT02380677|17461138|P11|Overall Study|Adverse Event|2
5061553|NCT02380677|17461139|P10|Overall Study|Adverse Event|1
5061554|NCT02380677|17461140|P9|Overall Study|Adverse Event|2
5061555|NCT02380677|17461141|P8|Overall Study|Adverse Event|2
5061556|NCT02380677|17461142|P7|Overall Study|Adverse Event|2
5061557|NCT02380677|17461143|P6|Overall Study|Adverse Event|4
5061558|NCT02380677|17461144|P5|Overall Study|Adverse Event|1
5061559|NCT02380677|17461145|P4|Overall Study|Adverse Event|1
5061560|NCT02380677|17461146|P3|Overall Study|Adverse Event|0
5061561|NCT02380677|17461147|P2|Overall Study|Adverse Event|0
5061562|NCT02380677|17461148|P1|Overall Study|Adverse Event|0
5061563|NCT02380287|17461204|P8|Overall Study|Adverse Event|0
5061564|NCT02380287|17461205|P7|Overall Study|Adverse Event|0
5061565|NCT02380287|17461206|P6|Overall Study|Adverse Event|0
5061566|NCT02380287|17461207|P5|Overall Study|Adverse Event|0
5061567|NCT02380287|17461208|P4|Overall Study|Adverse Event|0
5061568|NCT02380287|17461209|P3|Overall Study|Adverse Event|1
5061569|NCT02380287|17461210|P2|Overall Study|Adverse Event|0
5061570|NCT02380287|17461211|P1|Overall Study|Adverse Event|0
5061571|NCT02380248|17461227|P1|Overall Study|Withdrawal by Subject|3
5061572|NCT02380248|17461227|P1|Overall Study|Lost to Follow-up|11
5061573|NCT02379923|17461243|P1|Overall Study|Death|5
5061574|NCT02379728|17461272|P4|Overall Study|Protocol Violation|0
5061575|NCT02379728|17461273|P3|Overall Study|Protocol Violation|2
5061576|NCT02379728|17461274|P2|Overall Study|Protocol Violation|0
5061577|NCT02379728|17461275|P1|Overall Study|Protocol Violation|0
5061578|NCT02379728|17461272|P4|Overall Study|Withdrawal by Subject|3
5061579|NCT02379728|17461273|P3|Overall Study|Withdrawal by Subject|5
5061580|NCT02379728|17461274|P2|Overall Study|Withdrawal by Subject|0
5061581|NCT02379728|17461275|P1|Overall Study|Withdrawal by Subject|5
5061582|NCT02379728|17461272|P4|Overall Study|Lost to Follow-up|0
5061583|NCT02379728|17461273|P3|Overall Study|Lost to Follow-up|3
5061584|NCT02379728|17461274|P2|Overall Study|Lost to Follow-up|0
5061585|NCT02379728|17461275|P1|Overall Study|Lost to Follow-up|1
5061586|NCT02379637|17461331|P2|Overall Study|Withdrawal by Subject|0
5061587|NCT02379637|17461332|P1|Overall Study|Withdrawal by Subject|1
5061588|NCT02379637|17461331|P2|Overall Study|Adverse Event|0
5061589|NCT02379637|17461332|P1|Overall Study|Adverse Event|1
5061590|NCT02379637|17461331|P2|Overall Study|Protocol Violation|1
5061591|NCT02379637|17461332|P1|Overall Study|Protocol Violation|0
5061592|NCT02379390|17461371|P2|Overall Study|Study Termination|1
5061593|NCT02379390|17461372|P1|Overall Study|Study Termination|0
5061594|NCT02379390|17461371|P2|Overall Study|Investigator's decision|0
5061595|NCT02379390|17461372|P1|Overall Study|Investigator's decision|1
5061596|NCT02379390|17461371|P2|Overall Study|Adverse Event|1
5061597|NCT02379390|17461372|P1|Overall Study|Adverse Event|1
5061598|NCT02379221|17461400|P1|Overall Study|Lost to Follow-up|1
5061599|NCT02379091|17461436|P4|Overall Study|Lack of Efficacy|0
5061600|NCT02379091|17461437|P3|Overall Study|Lack of Efficacy|0
5061601|NCT02379091|17461438|P2|Overall Study|Lack of Efficacy|0
5061602|NCT02379091|17461439|P1|Overall Study|Lack of Efficacy|3
5061603|NCT02379091|17461436|P4|Overall Study|Study Termination|8
5061604|NCT02379091|17461437|P3|Overall Study|Study Termination|5
5061605|NCT02379091|17461438|P2|Overall Study|Study Termination|2
5061606|NCT02379091|17461439|P1|Overall Study|Study Termination|7
5061607|NCT02379091|17461436|P4|Overall Study|Voluntary Withdrawal|4
5061608|NCT02379091|17461437|P3|Overall Study|Voluntary Withdrawal|2
5061609|NCT02379091|17461438|P2|Overall Study|Voluntary Withdrawal|5
5061610|NCT02379091|17461439|P1|Overall Study|Voluntary Withdrawal|2
5061611|NCT02379091|17461436|P4|Overall Study|Lost to Follow-up|1
5061612|NCT02379091|17461437|P3|Overall Study|Lost to Follow-up|0
5061613|NCT02379091|17461438|P2|Overall Study|Lost to Follow-up|0
5061614|NCT02379091|17461439|P1|Overall Study|Lost to Follow-up|0
5061615|NCT02379091|17461436|P4|Overall Study|Principal Investigator Discretion|0
5061616|NCT02379091|17461437|P3|Overall Study|Principal Investigator Discretion|0
5061617|NCT02379091|17461438|P2|Overall Study|Principal Investigator Discretion|1
5061618|NCT02379091|17461439|P1|Overall Study|Principal Investigator Discretion|0
5061619|NCT02379091|17461436|P4|Overall Study|Pretreatment Event/Adverse Event|1
5061620|NCT02379091|17461437|P3|Overall Study|Pretreatment Event/Adverse Event|0
5061621|NCT02379091|17461438|P2|Overall Study|Pretreatment Event/Adverse Event|2
5061622|NCT02379091|17461439|P1|Overall Study|Pretreatment Event/Adverse Event|0
5061623|NCT02379052|17461477|P2|Overall Study|Subject was Incarcerated|1
5061624|NCT02379052|17461478|P1|Overall Study|Subject was Incarcerated|0
5061625|NCT02379052|17461477|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
5061626|NCT02379052|17461478|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
5061627|NCT02379052|17461477|P2|Overall Study|Lost to Follow-up|1
5061628|NCT02379052|17461478|P1|Overall Study|Lost to Follow-up|2
5061629|NCT02379052|17461477|P2|Overall Study|Withdrawal by Subject|0
5061630|NCT02379052|17461478|P1|Overall Study|Withdrawal by Subject|2
5061631|NCT02379052|17461477|P2|Overall Study|Physician Decision|1
5061632|NCT02379052|17461478|P1|Overall Study|Physician Decision|1
5061633|NCT02379052|17461477|P2|Overall Study|Adverse Event|1
5061634|NCT02379052|17461478|P1|Overall Study|Adverse Event|0
5061635|NCT02379052|17461477|P2|Overall Study|Protocol Violation|1
5061636|NCT02379052|17461478|P1|Overall Study|Protocol Violation|0
5061637|NCT02378961|17461520|P4|Overall Study|Death|0
5061638|NCT02378961|17461521|P3|Overall Study|Death|1
5061639|NCT02378961|17461522|P2|Overall Study|Death|0
5061640|NCT02378961|17461523|P1|Overall Study|Death|0
5061641|NCT02378961|17461520|P4|Overall Study|Lack of Efficacy|1
5061642|NCT02378961|17461521|P3|Overall Study|Lack of Efficacy|0
5061643|NCT02378961|17461522|P2|Overall Study|Lack of Efficacy|2
5061644|NCT02378961|17461523|P1|Overall Study|Lack of Efficacy|4
5061645|NCT02378935|17461560|P7|Overall Study|Death|0
5061646|NCT02378935|17461561|P6|Overall Study|Death|0
5061647|NCT02378935|17461562|P5|Overall Study|Death|0
5061648|NCT02378935|17461563|P4|Overall Study|Death|0
5061649|NCT02378935|17461564|P3|Overall Study|Death|1
5061650|NCT02378935|17461565|P2|Overall Study|Death|0
5061651|NCT02378935|17461566|P1|Overall Study|Death|0
5061652|NCT02378935|17461560|P7|Overall Study|Lack of Efficacy|0
5061653|NCT02378935|17461561|P6|Overall Study|Lack of Efficacy|0
5061654|NCT02378935|17461562|P5|Overall Study|Lack of Efficacy|0
5061655|NCT02378935|17461563|P4|Overall Study|Lack of Efficacy|6
5061656|NCT02378935|17461564|P3|Overall Study|Lack of Efficacy|2
5061657|NCT02378935|17461565|P2|Overall Study|Lack of Efficacy|0
5061658|NCT02378935|17461566|P1|Overall Study|Lack of Efficacy|10
5061659|NCT02378883|17461617|P1|12 Months Follow-Up|Death|2
5061660|NCT02378883|17461617|P1|12 Months Follow-Up|Lost to Follow-up|3
5061661|NCT02378883|17461617|P1|30 Day Follow-Up|Death|1
5061662|NCT02378883|17461617|P1|30 Day Follow-Up|Missed Visit|2
5061663|NCT02378883|17461617|P1|30 Day Follow-Up|Physician Decision|2
5061664|NCT02378883|17461617|P1|30 Day Follow-Up|Withdrawal by Subject|1
5061665|NCT02378883|17461617|P1|Enrollment|Attempt to use Apollo was not performed|3
5061666|NCT02378883|17461617|P1|Enrollment|Subject did not meet Inclusion criteria|6
5061667|NCT02378662|17461683|P2|Overall Study|Early Discontinuation|0
5061668|NCT02378662|17461684|P1|Overall Study|Early Discontinuation|2
5061669|NCT02378506|17461690|P1|Overall Study|Randomized But Not Treated|1
5061670|NCT02378506|17461690|P1|Overall Study|Adverse Event|14
5061671|NCT02378506|17461690|P1|Overall Study|Death|1
5061672|NCT02378506|17461690|P1|Overall Study|Protocol Violation|2
5061673|NCT02378506|17461690|P1|Overall Study|Withdrawal by Subject|4
5061674|NCT02378506|17461690|P1|Overall Study|Lack of Efficacy|3
5061675|NCT02378480|17461709|P2|Overall Study|Lost to Follow-up|18
5061676|NCT02378480|17461710|P1|Overall Study|Lost to Follow-up|10
5061677|NCT02378480|17461709|P2|Overall Study|Withdrawal by Subject|4
5061678|NCT02378480|17461710|P1|Overall Study|Withdrawal by Subject|9
5061679|NCT02378480|17461709|P2|Overall Study|Missed EOT/PTE Visit|2
5061680|NCT02378480|17461710|P1|Overall Study|Missed EOT/PTE Visit|1
5061681|NCT02378480|17461709|P2|Overall Study|Adverse Event|1
5061682|NCT02378480|17461710|P1|Overall Study|Adverse Event|0
5061683|NCT02378480|17461709|P2|Overall Study|Randomized, but Not Treated|4
5061684|NCT02378480|17461710|P1|Overall Study|Randomized, but Not Treated|6
5061685|NCT02378480|17461709|P2|Overall Study|Death|2
5061686|NCT02378480|17461710|P1|Overall Study|Death|1
5061687|NCT02378480|17461709|P2|Overall Study|Physician Decision|1
5061688|NCT02378480|17461710|P1|Overall Study|Physician Decision|1
5061689|NCT02378220|17461737|P2|Overall Study|Death|1
5061690|NCT02378220|17461738|P1|Overall Study|Death|6
5061691|NCT02377921|17461836|P2|Overall Study|Subject non-compliance|1
5061692|NCT02377921|17461837|P1|Overall Study|Subject non-compliance|1
5061693|NCT02377817|17461861|P2|Overall Study|Unrelated injury prevented lateral sleep|0
5061694|NCT02377817|17461862|P1|Overall Study|Unrelated injury prevented lateral sleep|1
5061695|NCT02377817|17461861|P2|Overall Study|Transportation/childcare barriers.|0
5061696|NCT02377817|17461862|P1|Overall Study|Transportation/childcare barriers.|2
5061697|NCT02377466|17461937|P2|Overall Study|Other: Randomized and not treated|2
5061698|NCT02377466|17461938|P1|Overall Study|Other: Randomized and not treated|0
5061699|NCT02377427|17462056|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5061700|NCT02377427|17462057|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5061701|NCT02377427|17462058|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
5061702|NCT02377427|17462059|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5061703|NCT02377427|17462060|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5061704|NCT02377427|17462056|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
5061705|NCT02377427|17462057|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
5061706|NCT02377427|17462058|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
5061707|NCT02377427|17462059|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
5061708|NCT02377427|17462060|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
5061709|NCT02377427|17462056|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5061710|NCT02377427|17462057|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5061711|NCT02377427|17462058|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5061712|NCT02377427|17462059|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5061713|NCT02377427|17462060|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
5061714|NCT02377427|17462056|P5|Part A (Up to Week 20)|Physician Decision|0
5061715|NCT02377427|17462057|P4|Part A (Up to Week 20)|Physician Decision|0
5061716|NCT02377427|17462058|P3|Part A (Up to Week 20)|Physician Decision|0
5061717|NCT02377427|17462059|P2|Part A (Up to Week 20)|Physician Decision|0
5061718|NCT02377427|17462060|P1|Part A (Up to Week 20)|Physician Decision|1
5061719|NCT02377362|17462133|P13|Part B Overall|Withdrawal by Subject|0
5061720|NCT02377362|17462134|P12|Part B Overall|Withdrawal by Subject|1
5061721|NCT02377362|17462135|P11|Part B Overall|Withdrawal by Subject|0
5061722|NCT02377362|17462136|P10|Part B Overall|Withdrawal by Subject|0
5061723|NCT02377362|17462137|P9|Part B Overall|Withdrawal by Subject|0
5061724|NCT02377362|17462138|P8|Part B Overall|Withdrawal by Subject|0
5061725|NCT02377362|17462139|P7|Part B Overall|Withdrawal by Subject|1
5061726|NCT02377362|17462140|P6|Part B Overall|Withdrawal by Subject|0
5061727|NCT02377362|17462141|P5|Part B Overall|Withdrawal by Subject|0
5061728|NCT02377362|17462142|P4|Part B Overall|Withdrawal by Subject|0
5061729|NCT02377362|17462143|P3|Part B Overall|Withdrawal by Subject|0
5061730|NCT02377362|17462144|P2|Part B Overall|Withdrawal by Subject|0
5061731|NCT02377362|17462145|P1|Part B Overall|Withdrawal by Subject|0
5061732|NCT02377362|17462133|P13|Part B Overall|Adverse Event|0
5061733|NCT02377362|17462134|P12|Part B Overall|Adverse Event|0
5061734|NCT02377362|17462135|P11|Part B Overall|Adverse Event|0
5061735|NCT02377362|17462136|P10|Part B Overall|Adverse Event|0
5061736|NCT02377362|17462137|P9|Part B Overall|Adverse Event|0
5061737|NCT02377362|17462138|P8|Part B Overall|Adverse Event|1
5061738|NCT02377362|17462139|P7|Part B Overall|Adverse Event|1
5061739|NCT02377362|17462140|P6|Part B Overall|Adverse Event|0
5061740|NCT02377362|17462141|P5|Part B Overall|Adverse Event|0
5061741|NCT02377362|17462142|P4|Part B Overall|Adverse Event|0
5061742|NCT02377362|17462143|P3|Part B Overall|Adverse Event|0
5061743|NCT02377362|17462144|P2|Part B Overall|Adverse Event|0
5061744|NCT02377362|17462145|P1|Part B Overall|Adverse Event|0
5061745|NCT02377362|17462133|P13|Part B Overall|Protocol Violation|0
5061746|NCT02377362|17462134|P12|Part B Overall|Protocol Violation|0
5061747|NCT02377362|17462135|P11|Part B Overall|Protocol Violation|0
5061748|NCT02377362|17462136|P10|Part B Overall|Protocol Violation|1
5061749|NCT02377362|17462137|P9|Part B Overall|Protocol Violation|0
5061750|NCT02377362|17462138|P8|Part B Overall|Protocol Violation|0
5061751|NCT02377362|17462139|P7|Part B Overall|Protocol Violation|0
5061752|NCT02377362|17462140|P6|Part B Overall|Protocol Violation|0
5061753|NCT02377362|17462141|P5|Part B Overall|Protocol Violation|0
5061754|NCT02377362|17462142|P4|Part B Overall|Protocol Violation|0
5061755|NCT02377362|17462143|P3|Part B Overall|Protocol Violation|0
5061756|NCT02377362|17462144|P2|Part B Overall|Protocol Violation|0
5061757|NCT02377362|17462145|P1|Part B Overall|Protocol Violation|0
5061758|NCT02377362|17462133|P13|Part A Third Treatment|Highest dose level 1200 not used|0
5061759|NCT02377362|17462134|P12|Part A Third Treatment|Highest dose level 1200 not used|0
5061760|NCT02377362|17462135|P11|Part A Third Treatment|Highest dose level 1200 not used|0
5061761|NCT02377362|17462136|P10|Part A Third Treatment|Highest dose level 1200 not used|0
5061762|NCT02377362|17462137|P9|Part A Third Treatment|Highest dose level 1200 not used|0
5061763|NCT02377362|17462138|P8|Part A Third Treatment|Highest dose level 1200 not used|0
5061764|NCT02377362|17462139|P7|Part A Third Treatment|Highest dose level 1200 not used|0
5061765|NCT02377362|17462140|P6|Part A Third Treatment|Highest dose level 1200 not used|4
5061766|NCT02377362|17462141|P5|Part A Third Treatment|Highest dose level 1200 not used|3
5061767|NCT02377362|17462142|P4|Part A Third Treatment|Highest dose level 1200 not used|4
5061768|NCT02377362|17462143|P3|Part A Third Treatment|Highest dose level 1200 not used|0
5061769|NCT02377362|17462144|P2|Part A Third Treatment|Highest dose level 1200 not used|0
5061770|NCT02377362|17462145|P1|Part A Third Treatment|Highest dose level 1200 not used|0
5061771|NCT02377362|17462133|P13|Part A Second Treatment|Protocol Violation|0
5061772|NCT02377362|17462134|P12|Part A Second Treatment|Protocol Violation|0
5061773|NCT02377362|17462135|P11|Part A Second Treatment|Protocol Violation|0
5061774|NCT02377362|17462136|P10|Part A Second Treatment|Protocol Violation|0
5061775|NCT02377362|17462137|P9|Part A Second Treatment|Protocol Violation|0
5061776|NCT02377362|17462138|P8|Part A Second Treatment|Protocol Violation|0
5061777|NCT02377362|17462139|P7|Part A Second Treatment|Protocol Violation|0
5061778|NCT02377362|17462140|P6|Part A Second Treatment|Protocol Violation|0
5061779|NCT02377362|17462141|P5|Part A Second Treatment|Protocol Violation|1
5061780|NCT02377362|17462142|P4|Part A Second Treatment|Protocol Violation|0
5061781|NCT02377362|17462143|P3|Part A Second Treatment|Protocol Violation|0
5061782|NCT02377362|17462144|P2|Part A Second Treatment|Protocol Violation|0
5061783|NCT02377362|17462145|P1|Part A Second Treatment|Protocol Violation|0
5061784|NCT02377349|17462354|P2|Overall Study|Other|1
5061785|NCT02377349|17462355|P1|Overall Study|Other|0
5061786|NCT02377349|17462354|P2|Overall Study|Lost to follow-up (complete vaccination)|5
5061787|NCT02377349|17462355|P1|Overall Study|Lost to follow-up (complete vaccination)|6
5061788|NCT02377349|17462354|P2|Overall Study|Lost to follow-up (partial vaccination)|0
5061789|NCT02377349|17462355|P1|Overall Study|Lost to follow-up (partial vaccination)|1
5061790|NCT02377349|17462354|P2|Overall Study|Withdrawal by Subject|3
5061791|NCT02377349|17462355|P1|Overall Study|Withdrawal by Subject|5
5061792|NCT02377349|17462354|P2|Overall Study|Protocol Violation|2
5061793|NCT02377349|17462355|P1|Overall Study|Protocol Violation|3
5061794|NCT02377349|17462354|P2|Overall Study|Serious Adverse Event|0
5061795|NCT02377349|17462355|P1|Overall Study|Serious Adverse Event|1
5061796|NCT02377063|17462393|P1|Overall Study|Non-compliance|5
5061797|NCT02376790|17462411|P3|Overall Study|Lost to Follow-up|12
5061798|NCT02376790|17462412|P2|Overall Study|Lost to Follow-up|10
5061799|NCT02376790|17462413|P1|Overall Study|Lost to Follow-up|15
5061800|NCT02376790|17462411|P3|Overall Study|Decision by Sponsor|4
5061801|NCT02376790|17462412|P2|Overall Study|Decision by Sponsor|1
5061802|NCT02376790|17462413|P1|Overall Study|Decision by Sponsor|2
5061803|NCT02376790|17462411|P3|Overall Study|Withdrawal by Subject|37
5061804|NCT02376790|17462412|P2|Overall Study|Withdrawal by Subject|36
5061805|NCT02376790|17462413|P1|Overall Study|Withdrawal by Subject|43
5061806|NCT02376166|17462604|P1|Overall Study|Discontinued metformin early|2
5061807|NCT02376166|17462604|P1|Overall Study|Adverse Event|1
5061808|NCT02375971|17462632|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
5061809|NCT02375971|17462633|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
5061810|NCT02375971|17462634|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
5061811|NCT02375971|17462632|P3|Follow-Up Phase (up to Day 169)|Death|4
5061812|NCT02375971|17462633|P2|Follow-Up Phase (up to Day 169)|Death|4
5061813|NCT02375971|17462634|P1|Follow-Up Phase (up to Day 169)|Death|4
5061814|NCT02375971|17462632|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
5061815|NCT02375971|17462633|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
5061816|NCT02375971|17462634|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
5061817|NCT02375971|17462632|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
5061818|NCT02375971|17462633|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
5061819|NCT02375971|17462634|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
5061820|NCT02375971|17462632|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
5061821|NCT02375971|17462633|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
5061822|NCT02375971|17462634|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
5061823|NCT02375971|17462632|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
5061824|NCT02375971|17462633|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
5061825|NCT02375971|17462634|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
5061826|NCT02375971|17462632|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
5061827|NCT02375971|17462633|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
5061828|NCT02375971|17462634|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
5061829|NCT02375971|17462632|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
5061830|NCT02375971|17462633|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
5061831|NCT02375971|17462634|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
5061832|NCT02375724|17462676|P2|Overall Study|Adverse Event|4
5061833|NCT02375724|17462677|P1|Overall Study|Adverse Event|2
5061834|NCT02375724|17462676|P2|Overall Study|Protocol Violation|0
5061835|NCT02375724|17462677|P1|Overall Study|Protocol Violation|1
5061836|NCT02375724|17462676|P2|Overall Study|Lost to Follow-up|0
5061837|NCT02375724|17462677|P1|Overall Study|Lost to Follow-up|1
5061838|NCT02375724|17462676|P2|Overall Study|Withdrawal by Subject|1
5061839|NCT02375724|17462677|P1|Overall Study|Withdrawal by Subject|1
5061840|NCT02375724|17462676|P2|Overall Study|Lack of Efficacy|1
5061841|NCT02375724|17462677|P1|Overall Study|Lack of Efficacy|1
5061842|NCT02375698|17462689|P2|Overall Study|Physician Decision|0
5061843|NCT02375698|17462690|P1|Overall Study|Physician Decision|2
5061844|NCT02375698|17462689|P2|Overall Study|Withdrawal by Subject|2
5061845|NCT02375698|17462690|P1|Overall Study|Withdrawal by Subject|0
5061846|NCT02375373|17462698|P1|Overall Study|Withdrawal by Subject|11
5061847|NCT02375347|17462702|P1|Overall Study|Protocol Violation|1
5061848|NCT02374957|17462708|P2|Overall Study|Patient did not complete forms correctly|0
5061849|NCT02374957|17462709|P1|Overall Study|Patient did not complete forms correctly|1
5061850|NCT02374671|17462738|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5061851|NCT02374671|17462739|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5061852|NCT02374671|17462740|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
5061853|NCT02374671|17462738|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
5061854|NCT02374671|17462739|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
5061855|NCT02374671|17462740|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
5061856|NCT02374671|17462738|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
5061857|NCT02374671|17462739|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
5061858|NCT02374671|17462740|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
5061859|NCT02374671|17462738|P3|Observation (Deferred Implantation)|Adverse Event|1
5061860|NCT02374671|17462739|P2|Observation (Deferred Implantation)|Adverse Event|0
5061861|NCT02374671|17462740|P1|Observation (Deferred Implantation)|Adverse Event|0
5061862|NCT02374671|17462738|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
5061863|NCT02374671|17462739|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
5061864|NCT02374671|17462740|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
5061865|NCT02374593|17462748|P2|Overall Study|non-compliant|0
5061866|NCT02374593|17462749|P1|Overall Study|non-compliant|2
5061867|NCT02374463|17462761|P2|Overall Study|Withdrawal by Subject|3
5061868|NCT02374463|17462762|P1|Overall Study|Withdrawal by Subject|3
5061869|NCT02374346|17462811|P1|Overall Study|operated or discharged during weekend|48
5061870|NCT02374307|17462819|P2|6-months Follow-up|Withdrawal by Subject|3
5061871|NCT02374307|17462820|P1|6-months Follow-up|Withdrawal by Subject|0
5061872|NCT02374307|17462819|P2|6-months Follow-up|Death|1
5061873|NCT02374307|17462820|P1|6-months Follow-up|Death|2
5061874|NCT02374307|17462819|P2|6-months Follow-up|Lost to Follow-up|2
5061875|NCT02374307|17462820|P1|6-months Follow-up|Lost to Follow-up|1
5061876|NCT02374307|17462819|P2|3-months Follow-up|Missed first follow-up|1
5061877|NCT02374307|17462820|P1|3-months Follow-up|Missed first follow-up|5
5061878|NCT02374307|17462819|P2|3-months Follow-up|Death|2
5061879|NCT02374307|17462820|P1|3-months Follow-up|Death|1
5061880|NCT02374307|17462819|P2|3-months Follow-up|Withdrawal by Subject|4
5061881|NCT02374307|17462820|P1|3-months Follow-up|Withdrawal by Subject|1
5061882|NCT02374307|17462819|P2|3-months Follow-up|Lost to Follow-up|2
5061883|NCT02374307|17462820|P1|3-months Follow-up|Lost to Follow-up|1
5061884|NCT02374255|17462851|P4|Overall Study|Withdrawal by Subject|0
5061885|NCT02374255|17462852|P3|Overall Study|Withdrawal by Subject|0
5061886|NCT02374255|17462853|P2|Overall Study|Withdrawal by Subject|0
5061887|NCT02374255|17462854|P1|Overall Study|Withdrawal by Subject|2
5061888|NCT02374099|17462955|P2|Overall Study|Study Terminated by Sponsor|4
5061889|NCT02374099|17462956|P1|Overall Study|Study Terminated by Sponsor|3
5061890|NCT02374099|17462955|P2|Overall Study|Randomized, but not treated|1
5061891|NCT02374099|17462956|P1|Overall Study|Randomized, but not treated|2
5061892|NCT02374099|17462955|P2|Overall Study|Miscellaneous|3
5061893|NCT02374099|17462956|P1|Overall Study|Miscellaneous|2
5061894|NCT02374099|17462955|P2|Overall Study|Withdrawal by Subject|1
5061895|NCT02374099|17462956|P1|Overall Study|Withdrawal by Subject|5
5061896|NCT02374099|17462955|P2|Overall Study|Progressive Disease|40
5061897|NCT02374099|17462956|P1|Overall Study|Progressive Disease|35
5061898|NCT02374099|17462955|P2|Overall Study|Adverse Event|0
5061899|NCT02374099|17462956|P1|Overall Study|Adverse Event|1
5061900|NCT02373202|17463064|P4|Overall Study|Other|0
5061901|NCT02373202|17463065|P3|Overall Study|Other|0
5061902|NCT02373202|17463066|P2|Overall Study|Other|1
5061903|NCT02373202|17463067|P1|Overall Study|Other|0
5061904|NCT02373202|17463064|P4|Overall Study|Lack of Efficacy|0
5061905|NCT02373202|17463065|P3|Overall Study|Lack of Efficacy|1
5061906|NCT02373202|17463066|P2|Overall Study|Lack of Efficacy|0
5061907|NCT02373202|17463067|P1|Overall Study|Lack of Efficacy|0
5061908|NCT02373202|17463064|P4|Overall Study|Adverse Event|1
5061909|NCT02373202|17463065|P3|Overall Study|Adverse Event|2
5061910|NCT02373202|17463066|P2|Overall Study|Adverse Event|5
5061911|NCT02373202|17463067|P1|Overall Study|Adverse Event|2
5061912|NCT02373098|17463158|P2|Overall Study|Adverse Event|0
5061913|NCT02373098|17463159|P1|Overall Study|Adverse Event|3
5061914|NCT02373098|17463158|P2|Overall Study|Withdrawal by Subject|0
5061915|NCT02373098|17463159|P1|Overall Study|Withdrawal by Subject|5
5061916|NCT02373098|17463158|P2|Overall Study|Protocol Violation|0
5061917|NCT02373098|17463159|P1|Overall Study|Protocol Violation|3
5061918|NCT02373098|17463158|P2|Overall Study|Lost to Follow-up|0
5061919|NCT02373098|17463159|P1|Overall Study|Lost to Follow-up|1
5061920|NCT02372799|17463187|P3|Down-taper Period|Lost to Follow-up|2
5061921|NCT02372799|17463188|P2|Down-taper Period|Lost to Follow-up|2
5061922|NCT02372799|17463189|P1|Down-taper Period|Lost to Follow-up|1
5061923|NCT02372799|17463187|P3|Treatment Period|Miscellaneous Reasons|0
5061924|NCT02372799|17463188|P2|Treatment Period|Miscellaneous Reasons|1
5061925|NCT02372799|17463189|P1|Treatment Period|Miscellaneous Reasons|1
5061926|NCT02372799|17463187|P3|Treatment Period|Non-compliance with study drug|4
5061927|NCT02372799|17463188|P2|Treatment Period|Non-compliance with study drug|4
5061928|NCT02372799|17463189|P1|Treatment Period|Non-compliance with study drug|4
5061929|NCT02372799|17463187|P3|Treatment Period|Protocol Violation|0
5061930|NCT02372799|17463188|P2|Treatment Period|Protocol Violation|0
5061931|NCT02372799|17463189|P1|Treatment Period|Protocol Violation|3
5061932|NCT02372799|17463187|P3|Treatment Period|Lost to Follow-up|3
5061933|NCT02372799|17463188|P2|Treatment Period|Lost to Follow-up|5
5061934|NCT02372799|17463189|P1|Treatment Period|Lost to Follow-up|11
5061935|NCT02372799|17463187|P3|Treatment Period|Withdrawal by Subject|2
5061936|NCT02372799|17463188|P2|Treatment Period|Withdrawal by Subject|10
5061937|NCT02372799|17463189|P1|Treatment Period|Withdrawal by Subject|10
5061938|NCT02372799|17463187|P3|Treatment Period|Insufficient therapeutic response|0
5061939|NCT02372799|17463188|P2|Treatment Period|Insufficient therapeutic response|2
5061940|NCT02372799|17463189|P1|Treatment Period|Insufficient therapeutic response|2
5061941|NCT02372799|17463187|P3|Treatment Period|Adverse Event|6
5061942|NCT02372799|17463188|P2|Treatment Period|Adverse Event|10
5061943|NCT02372799|17463189|P1|Treatment Period|Adverse Event|3
5061944|NCT02372396|17463218|P2|Overall Study|Lost to Follow-up|9
5061945|NCT02372396|17463219|P1|Overall Study|Lost to Follow-up|7
5061946|NCT02372253|17463243|P2|Overall Study|Non Compliance|0
5061947|NCT02372253|17463244|P1|Overall Study|Non Compliance|2
5061948|NCT02372071|17463289|P1|Overall Study|Protocol Violation|18
5061949|NCT02372058|17463294|P1|Overall Study|Withdrawal by Subject|3
5061950|NCT02371980|17463300|P5|Double-blind Period|Missing|0
5061951|NCT02371980|17463301|P4|Double-blind Period|Missing|0
5061952|NCT02371980|17463302|P3|Double-blind Period|Missing|0
5061953|NCT02371980|17463303|P2|Double-blind Period|Missing|1
5061954|NCT02371980|17463304|P1|Double-blind Period|Missing|0
5061955|NCT02371980|17463300|P5|Double-blind Period|Reason not Specified|1
5061956|NCT02371980|17463301|P4|Double-blind Period|Reason not Specified|2
5061957|NCT02371980|17463302|P3|Double-blind Period|Reason not Specified|3
5061958|NCT02371980|17463303|P2|Double-blind Period|Reason not Specified|3
5061959|NCT02371980|17463304|P1|Double-blind Period|Reason not Specified|0
5061960|NCT02371980|17463300|P5|Double-blind Period|Relapse|26
5061961|NCT02371980|17463301|P4|Double-blind Period|Relapse|25
5061962|NCT02371980|17463302|P3|Double-blind Period|Relapse|25
5061963|NCT02371980|17463303|P2|Double-blind Period|Relapse|50
5061964|NCT02371980|17463304|P1|Double-blind Period|Relapse|0
5061965|NCT02371980|17463300|P5|Double-blind Period|Voluntary Withdrawal|11
5061966|NCT02371980|17463301|P4|Double-blind Period|Voluntary Withdrawal|9
5061967|NCT02371980|17463302|P3|Double-blind Period|Voluntary Withdrawal|8
5061968|NCT02371980|17463303|P2|Double-blind Period|Voluntary Withdrawal|12
5061969|NCT02371980|17463304|P1|Double-blind Period|Voluntary Withdrawal|0
5061970|NCT02371980|17463300|P5|Double-blind Period|Lost to Follow-up|5
5061971|NCT02371980|17463301|P4|Double-blind Period|Lost to Follow-up|6
5061972|NCT02371980|17463302|P3|Double-blind Period|Lost to Follow-up|8
5061973|NCT02371980|17463303|P2|Double-blind Period|Lost to Follow-up|8
5061974|NCT02371980|17463304|P1|Double-blind Period|Lost to Follow-up|0
5061975|NCT02371980|17463300|P5|Double-blind Period|Noncompliance with Study Drug|3
5062058|NCT02371629|17463637|P2|Overall Study|Protocol deviation|1
5061976|NCT02371980|17463301|P4|Double-blind Period|Noncompliance with Study Drug|2
5061977|NCT02371980|17463302|P3|Double-blind Period|Noncompliance with Study Drug|2
5061978|NCT02371980|17463303|P2|Double-blind Period|Noncompliance with Study Drug|1
5061979|NCT02371980|17463304|P1|Double-blind Period|Noncompliance with Study Drug|0
5061980|NCT02371980|17463300|P5|Double-blind Period|Significant Protocol Deviation|3
5061981|NCT02371980|17463301|P4|Double-blind Period|Significant Protocol Deviation|3
5061982|NCT02371980|17463302|P3|Double-blind Period|Significant Protocol Deviation|7
5061983|NCT02371980|17463303|P2|Double-blind Period|Significant Protocol Deviation|2
5061984|NCT02371980|17463304|P1|Double-blind Period|Significant Protocol Deviation|0
5061985|NCT02371980|17463300|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
5061986|NCT02371980|17463301|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
5061987|NCT02371980|17463302|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
5061988|NCT02371980|17463303|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
5061989|NCT02371980|17463304|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
5061990|NCT02371980|17463300|P5|Open-label Period|Reason not Specified|0
5061991|NCT02371980|17463301|P4|Open-label Period|Reason not Specified|0
5061992|NCT02371980|17463302|P3|Open-label Period|Reason not Specified|0
5061993|NCT02371980|17463303|P2|Open-label Period|Reason not Specified|0
5061994|NCT02371980|17463304|P1|Open-label Period|Reason not Specified|9
5061995|NCT02371980|17463300|P5|Open-label Period|Did not Meet Randomization Criteria|0
5061996|NCT02371980|17463301|P4|Open-label Period|Did not Meet Randomization Criteria|0
5061997|NCT02371980|17463302|P3|Open-label Period|Did not Meet Randomization Criteria|0
5061998|NCT02371980|17463303|P2|Open-label Period|Did not Meet Randomization Criteria|0
5061999|NCT02371980|17463304|P1|Open-label Period|Did not Meet Randomization Criteria|162
5062000|NCT02371980|17463300|P5|Open-label Period|Lack of Efficacy|0
5062001|NCT02371980|17463301|P4|Open-label Period|Lack of Efficacy|0
5062002|NCT02371980|17463302|P3|Open-label Period|Lack of Efficacy|0
5062003|NCT02371980|17463303|P2|Open-label Period|Lack of Efficacy|0
5062004|NCT02371980|17463304|P1|Open-label Period|Lack of Efficacy|116
5062005|NCT02371980|17463300|P5|Open-label Period|Pregnancy|0
5062006|NCT02371980|17463301|P4|Open-label Period|Pregnancy|0
5062007|NCT02371980|17463302|P3|Open-label Period|Pregnancy|0
5062008|NCT02371980|17463303|P2|Open-label Period|Pregnancy|0
5062009|NCT02371980|17463304|P1|Open-label Period|Pregnancy|1
5062010|NCT02371980|17463300|P5|Open-label Period|Voluntary Withdrawal|0
5062011|NCT02371980|17463301|P4|Open-label Period|Voluntary Withdrawal|0
5062012|NCT02371980|17463302|P3|Open-label Period|Voluntary Withdrawal|0
5062013|NCT02371980|17463303|P2|Open-label Period|Voluntary Withdrawal|0
5062014|NCT02371980|17463304|P1|Open-label Period|Voluntary Withdrawal|91
5062015|NCT02371980|17463300|P5|Open-label Period|Lost to Follow-up|0
5062016|NCT02371980|17463301|P4|Open-label Period|Lost to Follow-up|0
5062017|NCT02371980|17463302|P3|Open-label Period|Lost to Follow-up|0
5062018|NCT02371980|17463303|P2|Open-label Period|Lost to Follow-up|0
5062019|NCT02371980|17463304|P1|Open-label Period|Lost to Follow-up|55
5062020|NCT02371980|17463300|P5|Open-label Period|Noncompliance with Study Drug|0
5062021|NCT02371980|17463301|P4|Open-label Period|Noncompliance with Study Drug|0
5062022|NCT02371980|17463302|P3|Open-label Period|Noncompliance with Study Drug|0
5062023|NCT02371980|17463303|P2|Open-label Period|Noncompliance with Study Drug|0
5062024|NCT02371980|17463304|P1|Open-label Period|Noncompliance with Study Drug|10
5062025|NCT02371980|17463300|P5|Open-label Period|Significant Protocol Deviation|0
5062026|NCT02371980|17463301|P4|Open-label Period|Significant Protocol Deviation|0
5062027|NCT02371980|17463302|P3|Open-label Period|Significant Protocol Deviation|0
5062028|NCT02371980|17463303|P2|Open-label Period|Significant Protocol Deviation|0
5062029|NCT02371980|17463304|P1|Open-label Period|Significant Protocol Deviation|19
5062030|NCT02371980|17463300|P5|Open-label Period|Pretreatment Event/Adverse Event|0
5062031|NCT02371980|17463301|P4|Open-label Period|Pretreatment Event/Adverse Event|0
5062032|NCT02371980|17463302|P3|Open-label Period|Pretreatment Event/Adverse Event|0
5062033|NCT02371980|17463303|P2|Open-label Period|Pretreatment Event/Adverse Event|0
5062034|NCT02371980|17463304|P1|Open-label Period|Pretreatment Event/Adverse Event|63
5062035|NCT02371759|17463364|P8|Overall Study|Withdrawal by Subject|1
5062036|NCT02371759|17463365|P7|Overall Study|Withdrawal by Subject|0
5062037|NCT02371759|17463366|P6|Overall Study|Withdrawal by Subject|0
5062038|NCT02371759|17463367|P5|Overall Study|Withdrawal by Subject|0
5062039|NCT02371759|17463368|P4|Overall Study|Withdrawal by Subject|0
5062040|NCT02371759|17463369|P3|Overall Study|Withdrawal by Subject|0
5062041|NCT02371759|17463370|P2|Overall Study|Withdrawal by Subject|0
5062042|NCT02371759|17463371|P1|Overall Study|Withdrawal by Subject|0
5062043|NCT02371759|17463364|P8|Overall Study|Protocol Violation|3
5062044|NCT02371759|17463365|P7|Overall Study|Protocol Violation|0
5062045|NCT02371759|17463366|P6|Overall Study|Protocol Violation|1
5062046|NCT02371759|17463367|P5|Overall Study|Protocol Violation|3
5062047|NCT02371759|17463368|P4|Overall Study|Protocol Violation|0
5062048|NCT02371759|17463369|P3|Overall Study|Protocol Violation|1
5062049|NCT02371759|17463370|P2|Overall Study|Protocol Violation|1
5062050|NCT02371759|17463371|P1|Overall Study|Protocol Violation|3
5062051|NCT02371746|17463588|P7|Overall Study|Consent withdrawn|1
5062052|NCT02371746|17463589|P6|Overall Study|Consent withdrawn|0
5062053|NCT02371746|17463590|P5|Overall Study|Consent withdrawn|0
5062054|NCT02371746|17463591|P4|Overall Study|Consent withdrawn|0
5062055|NCT02371746|17463592|P3|Overall Study|Consent withdrawn|0
5062056|NCT02371746|17463593|P2|Overall Study|Consent withdrawn|0
5062057|NCT02371746|17463594|P1|Overall Study|Consent withdrawn|0
5062059|NCT02371629|17463638|P1|Overall Study|Protocol deviation|0
5062060|NCT02371629|17463637|P2|Overall Study|Lack of Efficacy|2
5062061|NCT02371629|17463638|P1|Overall Study|Lack of Efficacy|0
5062062|NCT02371629|17463637|P2|Overall Study|Noncompliance with study treatment|0
5062063|NCT02371629|17463638|P1|Overall Study|Noncompliance with study treatment|1
5062064|NCT02371629|17463637|P2|Overall Study|Death|1
5062065|NCT02371629|17463638|P1|Overall Study|Death|1
5062066|NCT02371629|17463637|P2|Overall Study|Physician Decision|3
5062067|NCT02371629|17463638|P1|Overall Study|Physician Decision|2
5062068|NCT02371629|17463637|P2|Overall Study|Adverse Event|8
5062069|NCT02371629|17463638|P1|Overall Study|Adverse Event|8
5062070|NCT02371629|17463637|P2|Overall Study|Patient decision|10
5062071|NCT02371629|17463638|P1|Overall Study|Patient decision|14
5062072|NCT02371616|17463674|P2|Overall Study|Other (Not specified)|5
5062073|NCT02371616|17463675|P1|Overall Study|Other (Not specified)|1
5062074|NCT02371616|17463674|P2|Overall Study|Withdrawal of Consent|0
5062075|NCT02371616|17463675|P1|Overall Study|Withdrawal of Consent|1
5062076|NCT02371616|17463674|P2|Overall Study|Adverse Event|1
5062077|NCT02371616|17463675|P1|Overall Study|Adverse Event|0
5062078|NCT02371616|17463674|P2|Overall Study|Protocol Violation|1
5062079|NCT02371616|17463675|P1|Overall Study|Protocol Violation|2
5062080|NCT02371369|17463693|P2|Part 2|Death|1
5062081|NCT02371369|17463694|P1|Part 2|Death|0
5062082|NCT02371369|17463693|P2|Part 2|Physician Decision|0
5062083|NCT02371369|17463694|P1|Part 2|Physician Decision|1
5062084|NCT02371369|17463693|P2|Part 2|Withdrawal by Subject|1
5062085|NCT02371369|17463694|P1|Part 2|Withdrawal by Subject|5
5062086|NCT02371369|17463693|P2|Part 2|Adverse Event|2
5062087|NCT02371369|17463694|P1|Part 2|Adverse Event|3
5062088|NCT02371369|17463693|P2|Part 1|Protocol Violation|1
5062089|NCT02371369|17463694|P1|Part 1|Protocol Violation|0
5062090|NCT02371369|17463693|P2|Part 1|Disease progression|1
5062091|NCT02371369|17463694|P1|Part 1|Disease progression|0
5062092|NCT02371369|17463693|P2|Part 1|Withdrawal by Subject|6
5062093|NCT02371369|17463694|P1|Part 1|Withdrawal by Subject|1
5062094|NCT02371369|17463693|P2|Part 1|Adverse Event|0
5062095|NCT02371369|17463694|P1|Part 1|Adverse Event|8
5062096|NCT02371369|17463693|P2|Part 1|Physician Decision|3
5062097|NCT02371369|17463694|P1|Part 1|Physician Decision|0
5062098|NCT02370914|17463785|P1|Overall Study|Protocol Violation|2
5062099|NCT02370888|17463793|P1|Overall Study|did not meet chimerism criteria|6
5062100|NCT02370888|17463793|P1|Overall Study|disease progression|2
5062101|NCT02370784|17463803|P2|Overall Study|Patient started prohibited medication|1
5062102|NCT02370784|17463804|P1|Overall Study|Patient started prohibited medication|0
5062103|NCT02370667|17463819|P3|Overall Study|Lost to Follow-up|0
5062104|NCT02370667|17463820|P2|Overall Study|Lost to Follow-up|1
5062105|NCT02370667|17463821|P1|Overall Study|Lost to Follow-up|0
5062106|NCT02370641|17463885|P2|Overall Study|dropped study|2
5062107|NCT02370641|17463886|P1|Overall Study|dropped study|4
5062108|NCT02370615|17463894|P2|Overall Study|Adverse Event|0
5062109|NCT02370615|17463895|P1|Overall Study|Adverse Event|1
5062110|NCT02370602|17463938|P6|Overall Study|Pretreatment Event/Adverse Event|0
5062111|NCT02370602|17463939|P5|Overall Study|Pretreatment Event/Adverse Event|0
5062112|NCT02370602|17463940|P4|Overall Study|Pretreatment Event/Adverse Event|0
5062113|NCT02370602|17463941|P3|Overall Study|Pretreatment Event/Adverse Event|0
5062114|NCT02370602|17463942|P2|Overall Study|Pretreatment Event/Adverse Event|0
5062115|NCT02370602|17463943|P1|Overall Study|Pretreatment Event/Adverse Event|1
5062116|NCT02370537|17464037|P3|Part B|Withdrawal by Subject|0
5062117|NCT02370537|17464038|P2|Part B|Withdrawal by Subject|1
5062118|NCT02370537|17464039|P1|Part B|Withdrawal by Subject|0
5062119|NCT02370537|17464037|P3|Part B|Not randomised to receive treatment|259
5062120|NCT02370537|17464038|P2|Part B|Not randomised to receive treatment|2
5062121|NCT02370537|17464039|P1|Part B|Not randomised to receive treatment|1
5062122|NCT02370537|17464037|P3|Part A (Open-label Recruitment)|Adverse Event|1
5062123|NCT02370537|17464038|P2|Part A (Open-label Recruitment)|Adverse Event|0
5062124|NCT02370537|17464039|P1|Part A (Open-label Recruitment)|Adverse Event|0
5062125|NCT02370537|17464037|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
5062126|NCT02370537|17464038|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
5062127|NCT02370537|17464039|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
5062128|NCT02370498|17464088|P2|Overall Study|Ongoing In Trial|33
5062129|NCT02370498|17464089|P1|Overall Study|Ongoing In Trial|56
5062130|NCT02370498|17464088|P2|Overall Study|Withdrawal by Subject|11
5062131|NCT02370498|17464089|P1|Overall Study|Withdrawal by Subject|6
5062132|NCT02370498|17464088|P2|Overall Study|Protocol Violation|2
5062133|NCT02370498|17464089|P1|Overall Study|Protocol Violation|1
5062134|NCT02370498|17464088|P2|Overall Study|Lost to Follow-up|0
5062135|NCT02370498|17464089|P1|Overall Study|Lost to Follow-up|1
5062136|NCT02370498|17464088|P2|Overall Study|Death|242
5062137|NCT02370498|17464089|P1|Overall Study|Death|222
5062138|NCT02370498|17464088|P2|Overall Study|Adverse Event|8
5062139|NCT02370498|17464089|P1|Overall Study|Adverse Event|10
5062140|NCT02370420|17464143|P2|Overall Study|Lost to Follow-up|9
5062141|NCT02370420|17464144|P1|Overall Study|Lost to Follow-up|11
5062142|NCT02370420|17464143|P2|Overall Study|Physician Decision|3
5062143|NCT02370420|17464144|P1|Overall Study|Physician Decision|3
5062144|NCT02370394|17464181|P2|Overall Study|Withdrawal by Subject|1
5062145|NCT02370394|17464182|P1|Overall Study|Withdrawal by Subject|0
5062146|NCT02370394|17464181|P2|Overall Study|Lost to Follow-up|1
5062147|NCT02370394|17464182|P1|Overall Study|Lost to Follow-up|2
5062148|NCT02370368|17464198|P2|Overall Study|Withdrawal by Subject|4
5062149|NCT02370368|17464199|P1|Overall Study|Withdrawal by Subject|5
5062150|NCT02370368|17464198|P2|Overall Study|Adverse Event|2
5062151|NCT02370368|17464199|P1|Overall Study|Adverse Event|1
5062152|NCT02370251|17464209|P1|Overall Study|Death|4
5062153|NCT02370251|17464209|P1|Overall Study|Received less than 8 days of Omegaven|7
5062154|NCT02370160|17464215|P3|Overall Study|Death|1
5062155|NCT02370160|17464216|P2|Overall Study|Death|4
5062156|NCT02370160|17464217|P1|Overall Study|Death|3
5062157|NCT02370121|17464241|P2|Overall Study|Lost to Follow-up|1
5062158|NCT02370121|17464242|P1|Overall Study|Lost to Follow-up|1
5062159|NCT02370095|17464282|P2|Overall Study|Withdrawal by Subject|1
5062160|NCT02370095|17464283|P1|Overall Study|Withdrawal by Subject|0
5062161|NCT02370043|17464313|P6|Overall Study|Withdrawal by Subject|1
5062162|NCT02370043|17464314|P5|Overall Study|Withdrawal by Subject|1
5062163|NCT02370043|17464315|P4|Overall Study|Withdrawal by Subject|0
5062164|NCT02370043|17464316|P3|Overall Study|Withdrawal by Subject|0
5062165|NCT02370043|17464317|P2|Overall Study|Withdrawal by Subject|0
5062166|NCT02370043|17464318|P1|Overall Study|Withdrawal by Subject|0
5062167|NCT02369874|17464459|P3|Overall Study|Participant Ongoing|32
5062168|NCT02369874|17464460|P2|Overall Study|Participant Ongoing|45
5062169|NCT02369874|17464461|P1|Overall Study|Participant Ongoing|34
5062170|NCT02369874|17464459|P3|Overall Study|Miscellaneous|0
5062171|NCT02369874|17464460|P2|Overall Study|Miscellaneous|1
5062172|NCT02369874|17464461|P1|Overall Study|Miscellaneous|1
5062173|NCT02369874|17464459|P3|Overall Study|Withdrawal by Subject|27
5062174|NCT02369874|17464460|P2|Overall Study|Withdrawal by Subject|9
5062175|NCT02369874|17464461|P1|Overall Study|Withdrawal by Subject|7
5062176|NCT02369874|17464459|P3|Overall Study|Lost to Follow-up|2
5062177|NCT02369874|17464460|P2|Overall Study|Lost to Follow-up|2
5062178|NCT02369874|17464461|P1|Overall Study|Lost to Follow-up|2
5062179|NCT02369848|17464508|P1|Overall Study|Lost to Follow-up|1
5062180|NCT02369848|17464508|P1|Overall Study|Withdrawal by Subject|2
5062181|NCT02369848|17464508|P1|Overall Study|Death|1
5062182|NCT02369510|17464601|P3|Overall Study|Epidural Activation|5
5062183|NCT02369510|17464602|P2|Overall Study|Epidural Activation|1
5062184|NCT02369510|17464603|P1|Overall Study|Epidural Activation|1
5062185|NCT02369510|17464601|P3|Overall Study|Spilled Medication|1
5062186|NCT02369510|17464602|P2|Overall Study|Spilled Medication|2
5062187|NCT02369510|17464603|P1|Overall Study|Spilled Medication|1
5062188|NCT02369341|17464642|P2|Overall Study|Migrated/moved from study area|0
5062189|NCT02369341|17464643|P1|Overall Study|Migrated/moved from study area|1
5062190|NCT02368886|17464819|P4|Overall Study|Ineligible|1
5062191|NCT02368886|17464820|P3|Overall Study|Ineligible|0
5062192|NCT02368886|17464821|P2|Overall Study|Ineligible|0
5062193|NCT02368886|17464822|P1|Overall Study|Ineligible|0
5062194|NCT02368886|17464819|P4|Overall Study|Cancel|3
5062195|NCT02368886|17464820|P3|Overall Study|Cancel|1
5062196|NCT02368886|17464821|P2|Overall Study|Cancel|1
5062197|NCT02368886|17464822|P1|Overall Study|Cancel|1
5062198|NCT02368691|17464840|P1|Overall Study|Physician Decision|4
5062199|NCT02368691|17464840|P1|Overall Study|Lack of Efficacy|15
5062200|NCT02368691|17464840|P1|Overall Study|Death|13
5062201|NCT02368314|17464885|P2|Overall Study|Adverse Event|2
5062202|NCT02368314|17464886|P1|Overall Study|Adverse Event|1
5062203|NCT02368314|17464885|P2|Overall Study|Withdrawal by Subject|1
5062204|NCT02368314|17464886|P1|Overall Study|Withdrawal by Subject|2
5062205|NCT02368210|17464898|P2|Overall Study|Adverse Event|1
5062206|NCT02368210|17464899|P1|Overall Study|Adverse Event|0
5062207|NCT02368210|17464898|P2|Overall Study|Withdrawal by Subject|0
5062208|NCT02368210|17464899|P1|Overall Study|Withdrawal by Subject|1
5062209|NCT02367911|17464926|P2|Overall Study|Lost to Follow-up|2
5062210|NCT02367911|17464927|P1|Overall Study|Lost to Follow-up|2
5062211|NCT02367911|17464926|P2|Overall Study|Withdrawal by Subject|2
5062212|NCT02367911|17464927|P1|Overall Study|Withdrawal by Subject|3
5062213|NCT02367885|17464938|P3|Overall Study|Withdrawal by Subject|0
5062214|NCT02367885|17464939|P2|Overall Study|Withdrawal by Subject|0
5062215|NCT02367885|17464940|P1|Overall Study|Withdrawal by Subject|1
5062216|NCT02367885|17464938|P3|Overall Study|Lost to Follow-up|0
5062217|NCT02367885|17464939|P2|Overall Study|Lost to Follow-up|0
5062218|NCT02367885|17464940|P1|Overall Study|Lost to Follow-up|1
5062219|NCT02367833|17465183|P3|Overall Study|Withdrawal by Subject|0
5062220|NCT02367833|17465184|P2|Overall Study|Withdrawal by Subject|1
5062221|NCT02367833|17465185|P1|Overall Study|Withdrawal by Subject|1
5062222|NCT02367794|17465224|P3|Overall Study|Hypercalcemia prior to C1D1|1
5062223|NCT02367794|17465225|P2|Overall Study|Hypercalcemia prior to C1D1|0
5062224|NCT02367794|17465226|P1|Overall Study|Hypercalcemia prior to C1D1|0
5062225|NCT02367794|17465224|P3|Overall Study|Patient unable to receive carboplatin|1
5062226|NCT02367794|17465225|P2|Overall Study|Patient unable to receive carboplatin|0
5062227|NCT02367794|17465226|P1|Overall Study|Patient unable to receive carboplatin|0
5062228|NCT02367794|17465224|P3|Overall Study|Randomized in error|1
5062229|NCT02367794|17465225|P2|Overall Study|Randomized in error|0
5062230|NCT02367794|17465226|P1|Overall Study|Randomized in error|0
5062231|NCT02367794|17465224|P3|Overall Study|Brain metastasis|0
5062232|NCT02367794|17465225|P2|Overall Study|Brain metastasis|0
5062233|NCT02367794|17465226|P1|Overall Study|Brain metastasis|1
5062234|NCT02367794|17465224|P3|Overall Study|Withdrawal by Subject|14
5062235|NCT02367794|17465225|P2|Overall Study|Withdrawal by Subject|12
5062236|NCT02367794|17465226|P1|Overall Study|Withdrawal by Subject|25
5062237|NCT02367794|17465224|P3|Overall Study|Protocol Violation|1
5062238|NCT02367794|17465225|P2|Overall Study|Protocol Violation|0
5062239|NCT02367794|17465226|P1|Overall Study|Protocol Violation|1
5062240|NCT02367794|17465224|P3|Overall Study|Physician Decision|1
5062241|NCT02367794|17465225|P2|Overall Study|Physician Decision|3
5062242|NCT02367794|17465226|P1|Overall Study|Physician Decision|0
5062243|NCT02367794|17465224|P3|Overall Study|Lost to Follow-up|1
5062244|NCT02367794|17465225|P2|Overall Study|Lost to Follow-up|2
5062245|NCT02367794|17465226|P1|Overall Study|Lost to Follow-up|1
5062246|NCT02367794|17465224|P3|Overall Study|Death|229
5062247|NCT02367794|17465225|P2|Overall Study|Death|223
5062248|NCT02367794|17465226|P1|Overall Study|Death|230
5062249|NCT02367781|17465239|P2|Overall Study|Administrative-Change Facility|0
5062250|NCT02367781|17465240|P1|Overall Study|Administrative-Change Facility|1
5062251|NCT02367781|17465239|P2|Overall Study|Death Prior First Dose|0
5062252|NCT02367781|17465240|P1|Overall Study|Death Prior First Dose|1
5062253|NCT02367781|17465239|P2|Overall Study|Prolonged Hospitalization|0
5062254|NCT02367781|17465240|P1|Overall Study|Prolonged Hospitalization|1
5062255|NCT02367781|17465239|P2|Overall Study|On-going in study|88
5062256|NCT02367781|17465240|P1|Overall Study|On-going in study|214
5062257|NCT02367781|17465239|P2|Overall Study|Death|136
5062258|NCT02367781|17465240|P1|Overall Study|Death|240
5062259|NCT02367781|17465239|P2|Overall Study|Lost to Follow-up|1
5062260|NCT02367781|17465240|P1|Overall Study|Lost to Follow-up|0
5062261|NCT02367781|17465239|P2|Overall Study|Non-Compliance|0
5062262|NCT02367781|17465240|P1|Overall Study|Non-Compliance|1
5062263|NCT02367781|17465239|P2|Overall Study|Randomized in Error|4
5062264|NCT02367781|17465240|P1|Overall Study|Randomized in Error|5
5062265|NCT02367781|17465239|P2|Overall Study|Physician Decision|0
5062266|NCT02367781|17465240|P1|Overall Study|Physician Decision|1
5062267|NCT02367781|17465239|P2|Overall Study|Protocol Violation|1
5062268|NCT02367781|17465240|P1|Overall Study|Protocol Violation|0
5062269|NCT02367781|17465239|P2|Overall Study|Withdrawal by Subject|10
5062270|NCT02367781|17465240|P1|Overall Study|Withdrawal by Subject|19
5062271|NCT02367729|17465250|P2|Overall Study|Withdrawal by Subject|5
5062272|NCT02367729|17465251|P1|Overall Study|Withdrawal by Subject|0
5062273|NCT02367729|17465250|P2|Overall Study|Adverse Event|2
5062274|NCT02367729|17465251|P1|Overall Study|Adverse Event|1
5062275|NCT02367729|17465250|P2|Overall Study|Organic disorder diagnosed|1
5062276|NCT02367729|17465251|P1|Overall Study|Organic disorder diagnosed|2
5062277|NCT02367716|17465267|P1|Overall Study|Patient did not meet inclusion criteria|1
5062278|NCT02367521|17465291|P2|Overall Study|unable to find transportation|0
5062279|NCT02367521|17465292|P1|Overall Study|unable to find transportation|2
5062280|NCT02367521|17465291|P2|Overall Study|severe headache after intervention|0
5062281|NCT02367521|17465292|P1|Overall Study|severe headache after intervention|2
5062282|NCT02367352|17465370|P3|Overall Study|Adverse Event|0
5062283|NCT02367352|17465371|P2|Overall Study|Adverse Event|0
5062284|NCT02367352|17465372|P1|Overall Study|Adverse Event|1
5062285|NCT02367352|17465370|P3|Overall Study|Participant Received Alternative Therapy|0
5062286|NCT02367352|17465371|P2|Overall Study|Participant Received Alternative Therapy|0
5062287|NCT02367352|17465372|P1|Overall Study|Participant Received Alternative Therapy|1
5062288|NCT02367352|17465370|P3|Overall Study|Progressive disease|0
5062289|NCT02367352|17465371|P2|Overall Study|Progressive disease|0
5062290|NCT02367352|17465372|P1|Overall Study|Progressive disease|7
5062291|NCT02367131|17465422|P1|Overall Study|Other than stated above|20
5062292|NCT02367131|17465422|P1|Overall Study|No change/progressive disease|78
5062293|NCT02367131|17465422|P1|Overall Study|Improvement/remission|2
5062294|NCT02367131|17465422|P1|Overall Study|Request by patient|54
5062295|NCT02367131|17465422|P1|Overall Study|No visit since the first visit|4
5062296|NCT02367131|17465422|P1|Overall Study|Adverse Event|64
5062297|NCT02366936|17465683|P1|Overall Study|Physician Decision|2
5062298|NCT02366936|17465683|P1|Overall Study|Lost to Follow-up|4
5062299|NCT02366936|17465683|P1|Overall Study|Withdrawal by Subject|2
5062300|NCT02366923|17465688|P1|Overall Study|High Astigmatism|3
5062301|NCT02366923|17465688|P1|Overall Study|Positive Slit Lamp Findings|2
5062302|NCT02366923|17465688|P1|Overall Study|Withdrawal by Subject|1
5062303|NCT02366910|17465701|P1|Overall Study|Screen Failure|3
5062304|NCT02366910|17465701|P1|Overall Study|Withdrawal by Subject|2
5062305|NCT02366767|17465749|P2|Overall Study|left for home after 1 day at camp|0
5062306|NCT02366767|17465750|P1|Overall Study|left for home after 1 day at camp|1
5062307|NCT02366689|17465763|P3|Overall Study|Pregnancy|1
5062308|NCT02366689|17465764|P2|Overall Study|Pregnancy|1
5062309|NCT02366689|17465765|P1|Overall Study|Pregnancy|0
5062310|NCT02366689|17465763|P3|Overall Study|Lost to Follow-up|0
5062311|NCT02366689|17465764|P2|Overall Study|Lost to Follow-up|2
5062312|NCT02366689|17465765|P1|Overall Study|Lost to Follow-up|3
5062313|NCT02366689|17465763|P3|Overall Study|Withdrawal by Subject|1
5062314|NCT02366689|17465764|P2|Overall Study|Withdrawal by Subject|0
5062315|NCT02366689|17465765|P1|Overall Study|Withdrawal by Subject|1
5062316|NCT02366637|17465817|P2|Second Intervention Period|Study Terminated by Sponsor|1
5062317|NCT02366637|17465818|P1|Second Intervention Period|Study Terminated by Sponsor|1
5062318|NCT02366637|17465817|P2|First Intervention Period|Study Terminated by Sponsor|4
5062319|NCT02366637|17465818|P1|First Intervention Period|Study Terminated by Sponsor|6
5062320|NCT02366637|17465817|P2|First Intervention Period|Adverse Event|1
5062321|NCT02366637|17465818|P1|First Intervention Period|Adverse Event|0
5062322|NCT02366468|17465844|P2|Overall Study|Other|2
5062323|NCT02366468|17465845|P1|Overall Study|Other|0
5062324|NCT02366468|17465844|P2|Overall Study|Death|2
5062325|NCT02366468|17465845|P1|Overall Study|Death|1
5062326|NCT02366468|17465844|P2|Overall Study|Lost to Follow-up|0
5062327|NCT02366468|17465845|P1|Overall Study|Lost to Follow-up|2
5062328|NCT02366468|17465844|P2|Overall Study|Withdrawal by Subject|5
5062329|NCT02366468|17465845|P1|Overall Study|Withdrawal by Subject|1
5062330|NCT02366468|17465844|P2|Overall Study|Adverse Event|0
5062331|NCT02366468|17465845|P1|Overall Study|Adverse Event|2
5062332|NCT02366195|17465876|P1|Overall Study|Death|26
5062333|NCT02366195|17465876|P1|Overall Study|Lost to Follow-up|1
5062334|NCT02366195|17465876|P1|Overall Study|Withdrawal by Subject|6
5062335|NCT02366195|17465876|P1|Overall Study|Continuing Study|79
5062336|NCT02366143|17465897|P3|Overall Study|Ineligible|0
5062337|NCT02366143|17465898|P2|Overall Study|Ineligible|0
5062338|NCT02366143|17465899|P1|Overall Study|Ineligible|1
5062339|NCT02366143|17465897|P3|Overall Study|PI Move and Site Closure|1
5062340|NCT02366143|17465898|P2|Overall Study|PI Move and Site Closure|1
5062341|NCT02366143|17465899|P1|Overall Study|PI Move and Site Closure|0
5062342|NCT02366143|17465897|P3|Overall Study|Randomization Error|1
5062343|NCT02366143|17465898|P2|Overall Study|Randomization Error|0
5062344|NCT02366143|17465899|P1|Overall Study|Randomization Error|0
5062345|NCT02366143|17465897|P3|Overall Study|Increased Microscopic RBCS on Urinalysis|0
5062346|NCT02366143|17465898|P2|Overall Study|Increased Microscopic RBCS on Urinalysis|0
5062347|NCT02366143|17465899|P1|Overall Study|Increased Microscopic RBCS on Urinalysis|1
5062348|NCT02366143|17465897|P3|Overall Study|On-Going in Study|79
5062349|NCT02366143|17465898|P2|Overall Study|On-Going in Study|101
5062350|NCT02366143|17465899|P1|Overall Study|On-Going in Study|107
5062351|NCT02366143|17465897|P3|Overall Study|Withdrawal by Subject|16
5062352|NCT02366143|17465898|P2|Overall Study|Withdrawal by Subject|21
5062353|NCT02366143|17465899|P1|Overall Study|Withdrawal by Subject|15
5062354|NCT02366143|17465897|P3|Overall Study|Protocol Violation|0
5062355|NCT02366143|17465898|P2|Overall Study|Protocol Violation|2
5062356|NCT02366143|17465899|P1|Overall Study|Protocol Violation|0
5062357|NCT02366143|17465897|P3|Overall Study|Physician Decision|1
5062358|NCT02366143|17465898|P2|Overall Study|Physician Decision|1
5062359|NCT02366143|17465899|P1|Overall Study|Physician Decision|2
5062360|NCT02366143|17465897|P3|Overall Study|Lost to Follow-up|1
5062361|NCT02366143|17465898|P2|Overall Study|Lost to Follow-up|1
5062362|NCT02366143|17465899|P1|Overall Study|Lost to Follow-up|2
5062363|NCT02366143|17465897|P3|Overall Study|Death|301
5062364|NCT02366143|17465898|P2|Overall Study|Death|275
5062365|NCT02366143|17465899|P1|Overall Study|Death|272
5062366|NCT02365636|17466003|P3|Overall Study|Other|0
5062367|NCT02365636|17466004|P2|Overall Study|Other|0
5062368|NCT02365636|17466005|P1|Overall Study|Other|2
5062369|NCT02365636|17466003|P3|Overall Study|Lost to Follow-up|1
5062370|NCT02365636|17466004|P2|Overall Study|Lost to Follow-up|0
5062371|NCT02365636|17466005|P1|Overall Study|Lost to Follow-up|0
5062372|NCT02365636|17466003|P3|Overall Study|Protocol Violation|0
5062373|NCT02365636|17466004|P2|Overall Study|Protocol Violation|4
5062374|NCT02365636|17466005|P1|Overall Study|Protocol Violation|1
5062375|NCT02365636|17466003|P3|Overall Study|Adverse Event|2
5062376|NCT02365636|17466004|P2|Overall Study|Adverse Event|3
5062377|NCT02365636|17466005|P1|Overall Study|Adverse Event|3
5062378|NCT02365584|17466051|P2|Overall Study|Disease Progression|12
5062379|NCT02365584|17466052|P1|Overall Study|Disease Progression|9
5062380|NCT02365584|17466051|P2|Overall Study|Withdrawal by Subject|0
5062381|NCT02365584|17466052|P1|Overall Study|Withdrawal by Subject|1
5062382|NCT02365584|17466051|P2|Overall Study|Adverse Event|2
5062383|NCT02365584|17466052|P1|Overall Study|Adverse Event|2
5062384|NCT02365558|17466076|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
5062385|NCT02365558|17466077|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
5062386|NCT02365558|17466076|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
5062387|NCT02365558|17466077|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
5062388|NCT02365519|17466090|P3|Randomized and Treated|Withdrawal by Subject|1
5062389|NCT02365519|17466091|P2|Randomized and Treated|Withdrawal by Subject|1
5062390|NCT02365519|17466092|P1|Randomized and Treated|Withdrawal by Subject|0
5062391|NCT02365519|17466090|P3|Randomized and Treated|Adverse Event|0
5062392|NCT02365519|17466091|P2|Randomized and Treated|Adverse Event|1
5062393|NCT02365519|17466092|P1|Randomized and Treated|Adverse Event|0
5062394|NCT02365298|17466113|P2|Period 2|Protocol Violation|1
5062395|NCT02365298|17466114|P1|Period 2|Protocol Violation|0
5062396|NCT02365298|17466113|P2|Period 2|Test Article longer available|1
5062397|NCT02365298|17466114|P1|Period 2|Test Article longer available|0
5062398|NCT02365298|17466113|P2|Period 2|Discontinued at request of Sponsor|0
5062399|NCT02365298|17466114|P1|Period 2|Discontinued at request of Sponsor|1
5062400|NCT02365298|17466113|P2|Period 2|incorrect Rx dispensed|0
5062401|NCT02365298|17466114|P1|Period 2|incorrect Rx dispensed|1
5062402|NCT02365285|17466134|P4|Overall Study|Adverse Event|2
5062403|NCT02365285|17466135|P3|Overall Study|Adverse Event|0
5062404|NCT02365285|17466136|P2|Overall Study|Adverse Event|0
5062405|NCT02365285|17466137|P1|Overall Study|Adverse Event|0
5062406|NCT02365285|17466134|P4|Overall Study|Physician Decision|0
5062407|NCT02365285|17466135|P3|Overall Study|Physician Decision|1
5062408|NCT02365285|17466136|P2|Overall Study|Physician Decision|1
5062409|NCT02365285|17466137|P1|Overall Study|Physician Decision|0
5062410|NCT02365233|17466154|P3|Overall Study|IRB withheld the data|2
5062411|NCT02365233|17466155|P2|Overall Study|IRB withheld the data|2
5062412|NCT02365233|17466156|P1|Overall Study|IRB withheld the data|1
5062413|NCT02365207|17466164|P1|Overall Study|Physician Decision|1
5062414|NCT02365207|17466164|P1|Overall Study|Withdrawal by Subject|1
5062415|NCT02364999|17466170|P2|Overall Study|Randomized but did not receive treatment|3
5062416|NCT02364999|17466171|P1|Overall Study|Randomized but did not receive treatment|2
5062417|NCT02364999|17466170|P2|Overall Study|Other|1
5062418|NCT02364999|17466171|P1|Overall Study|Other|0
5062419|NCT02364999|17466170|P2|Overall Study|Withdrawal by Subject|14
5062420|NCT02364999|17466171|P1|Overall Study|Withdrawal by Subject|14
5062421|NCT02364999|17466170|P2|Overall Study|Protocol Violation|2
5062422|NCT02364999|17466171|P1|Overall Study|Protocol Violation|3
5062423|NCT02364999|17466170|P2|Overall Study|Lost to Follow-up|15
5062424|NCT02364999|17466171|P1|Overall Study|Lost to Follow-up|10
5062425|NCT02364999|17466170|P2|Overall Study|Death|138
5062426|NCT02364999|17466171|P1|Overall Study|Death|136
5062427|NCT02364947|17466197|P3|Overall Study|Death|0
5062428|NCT02364947|17466198|P2|Overall Study|Death|1
5062429|NCT02364947|17466199|P1|Overall Study|Death|0
5062430|NCT02364947|17466197|P3|Overall Study|Physician Decision|5
5062431|NCT02364947|17466198|P2|Overall Study|Physician Decision|2
5062432|NCT02364947|17466199|P1|Overall Study|Physician Decision|3
5062433|NCT02364947|17466197|P3|Overall Study|Protocol Violation|1
5062434|NCT02364947|17466198|P2|Overall Study|Protocol Violation|1
5062435|NCT02364947|17466199|P1|Overall Study|Protocol Violation|1
5062436|NCT02364947|17466197|P3|Overall Study|Adverse Event|11
5062437|NCT02364947|17466198|P2|Overall Study|Adverse Event|33
5062438|NCT02364947|17466199|P1|Overall Study|Adverse Event|45
5062439|NCT02364947|17466197|P3|Overall Study|Withdrawal by Subject|9
5062440|NCT02364947|17466198|P2|Overall Study|Withdrawal by Subject|8
5062441|NCT02364947|17466199|P1|Overall Study|Withdrawal by Subject|10
5062442|NCT02364388|17466368|P1|Overall Study|No Biopsy|2
5062443|NCT02364388|17466368|P1|Overall Study|No OA/US data|2
5062444|NCT02364388|17466368|P1|Overall Study|Technical Failure|3
5062445|NCT02364388|17466368|P1|Overall Study|Protocol Violation|1
5062446|NCT02364336|17466375|P2|Overall Study|Adverse Event|1
5062447|NCT02364336|17466376|P1|Overall Study|Adverse Event|0
5062448|NCT02364180|17466389|P1|Overall Study|Screen Fail|1
5062449|NCT02364037|17466402|P2|Overall Study|Lost to Follow-up|49
5062450|NCT02364037|17466403|P1|Overall Study|Lost to Follow-up|37
5062451|NCT02364037|17466402|P2|Overall Study|Withdrawal by Subject|4
5062452|NCT02364037|17466403|P1|Overall Study|Withdrawal by Subject|7
5062453|NCT02363959|17466423|P2|Overall Study|Medical instability|0
5062454|NCT02363959|17466424|P1|Overall Study|Medical instability|1
5062455|NCT02363946|17466453|P13|Overall Study|Lost to Follow-up|0
5062456|NCT02363946|17466454|P12|Overall Study|Lost to Follow-up|0
5062457|NCT02363946|17466455|P11|Overall Study|Lost to Follow-up|0
5062458|NCT02363946|17466456|P10|Overall Study|Lost to Follow-up|0
5062459|NCT02363946|17466457|P9|Overall Study|Lost to Follow-up|0
5062460|NCT02363946|17466458|P8|Overall Study|Lost to Follow-up|1
5062461|NCT02363946|17466459|P7|Overall Study|Lost to Follow-up|0
5062462|NCT02363946|17466460|P6|Overall Study|Lost to Follow-up|0
5062463|NCT02363946|17466461|P5|Overall Study|Lost to Follow-up|0
5062464|NCT02363946|17466462|P4|Overall Study|Lost to Follow-up|0
5062465|NCT02363946|17466463|P3|Overall Study|Lost to Follow-up|0
5062466|NCT02363946|17466464|P2|Overall Study|Lost to Follow-up|0
5062467|NCT02363946|17466465|P1|Overall Study|Lost to Follow-up|0
5062468|NCT02363478|17466694|P1|Overall Study|Adverse Event|4
5062469|NCT02363478|17466694|P1|Overall Study|Lost to Follow-up|4
5062470|NCT02363439|17466701|P1|Overall Study|Lack of Efficacy|4
5062471|NCT02363322|17466707|P2|Overall Study|Lost to Follow-up|0
5062472|NCT02363322|17466708|P1|Overall Study|Lost to Follow-up|1
5062473|NCT02363283|17466718|P1|Overall Study|Not eligible due to transaminitis|1
5062474|NCT02363283|17466718|P1|Overall Study|Withdrawal by Subject|1
5062475|NCT02362789|17466737|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
5062476|NCT02362789|17466738|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
5062477|NCT02362789|17466739|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
5062478|NCT02362789|17466737|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
5062479|NCT02362789|17466738|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
5062480|NCT02362789|17466739|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
5062481|NCT02362789|17466737|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
5062482|NCT02362789|17466738|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
5062483|NCT02362789|17466739|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
5062484|NCT02362789|17466737|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
5062485|NCT02362789|17466738|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
5062486|NCT02362789|17466739|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
5062487|NCT02362789|17466737|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
5062488|NCT02362789|17466738|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
5062489|NCT02362789|17466739|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
5062490|NCT02362724|17466748|P2|Overall Study|Adverse Event|0
5062491|NCT02362724|17466749|P1|Overall Study|Adverse Event|3
5062492|NCT02362724|17466748|P2|Overall Study|Withdrawal by Subject|1
5062493|NCT02362724|17466749|P1|Overall Study|Withdrawal by Subject|3
5062494|NCT02362646|17466808|P2|Overall Study|received transplant|14
5062495|NCT02362646|17466809|P1|Overall Study|received transplant|21
5062496|NCT02362646|17466808|P2|Overall Study|Withdrawal by Subject|2
5062497|NCT02362646|17466809|P1|Overall Study|Withdrawal by Subject|2
5062498|NCT02362646|17466808|P2|Overall Study|Death|8
5062499|NCT02362646|17466809|P1|Overall Study|Death|15
5062500|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
5062501|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
5062502|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
5062503|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
5062504|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
5062505|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
5062506|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
5062507|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
5062508|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
5062509|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
5062510|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
5062511|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
5062512|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
5062513|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
5062514|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
5062515|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
5062516|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
5062517|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
5062518|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
5062519|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
5062520|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
5062521|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
5062522|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
5062523|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
5062524|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
5062525|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
5062526|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
5062527|NCT02362503|17466841|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
5062528|NCT02362503|17466842|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
5062529|NCT02362503|17466843|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
5062530|NCT02362503|17466841|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
5062531|NCT02362503|17466842|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
5062532|NCT02362503|17466843|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
5062533|NCT02362503|17466841|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
5062534|NCT02362503|17466842|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
5062535|NCT02362503|17466843|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
5062536|NCT02362503|17466841|P3|Double-blind Period-Up to 8 Days|Death|0
5062537|NCT02362503|17466842|P2|Double-blind Period-Up to 8 Days|Death|1
5062538|NCT02362503|17466843|P1|Double-blind Period-Up to 8 Days|Death|1
5062539|NCT02362503|17466841|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
5062540|NCT02362503|17466842|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
5062541|NCT02362503|17466843|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
5062542|NCT02362425|17466872|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5062543|NCT02362425|17466873|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
5062544|NCT02362425|17466874|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5062545|NCT02362425|17466875|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5062546|NCT02362425|17466872|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
5062547|NCT02362425|17466873|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5062548|NCT02362425|17466874|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5062549|NCT02362425|17466875|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5062550|NCT02362425|17466872|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
5062551|NCT02362425|17466873|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5062552|NCT02362425|17466874|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5062553|NCT02362425|17466875|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5062554|NCT02362425|17466872|P4|Phase 1 (up to 6 Months)|Study closure|0
5062555|NCT02362425|17466873|P3|Phase 1 (up to 6 Months)|Study closure|0
5062556|NCT02362425|17466874|P2|Phase 1 (up to 6 Months)|Study closure|0
5062557|NCT02362425|17466875|P1|Phase 1 (up to 6 Months)|Study closure|9
5062558|NCT02362425|17466872|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5062559|NCT02362425|17466873|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5062560|NCT02362425|17466874|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5062561|NCT02362425|17466875|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
5062562|NCT02362425|17466872|P4|Phase 1 (up to 6 Months)|Screening failure|0
5062563|NCT02362425|17466873|P3|Phase 1 (up to 6 Months)|Screening failure|0
5062564|NCT02362425|17466874|P2|Phase 1 (up to 6 Months)|Screening failure|0
5062565|NCT02362425|17466875|P1|Phase 1 (up to 6 Months)|Screening failure|1
5062566|NCT02362425|17466872|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5062567|NCT02362425|17466873|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5062568|NCT02362425|17466874|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5062569|NCT02362425|17466875|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
5062570|NCT02362425|17466872|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5062571|NCT02362425|17466873|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5062572|NCT02362425|17466874|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5062573|NCT02362425|17466875|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
5062574|NCT02362412|17466993|P2|Treatment Period III|Lost to Follow-up|1
5062575|NCT02362412|17466994|P1|Treatment Period III|Lost to Follow-up|0
5062576|NCT02362360|17467028|P2|Period 1|Withdrawal by Subject|1
5062577|NCT02362360|17467029|P1|Period 1|Withdrawal by Subject|2
5062578|NCT02362360|17467028|P2|Period 1|Lack of Efficacy|0
5062579|NCT02362360|17467029|P1|Period 1|Lack of Efficacy|1
5062580|NCT02362282|17467046|P2|Overall Study|Withdrawal by Subject|0
5062581|NCT02362282|17467047|P1|Overall Study|Withdrawal by Subject|1
5062582|NCT02362269|17467055|P2|Overall Study|Lost to Follow-up|6
5062583|NCT02362269|17467056|P1|Overall Study|Lost to Follow-up|0
5062584|NCT02362269|17467055|P2|Overall Study|Moved|0
5062585|NCT02362269|17467056|P1|Overall Study|Moved|1
5062586|NCT02361762|17467078|P2|Overall Study|Lost to Follow-up|1
5062587|NCT02361762|17467079|P1|Overall Study|Lost to Follow-up|0
5062588|NCT02361762|17467078|P2|Overall Study|Withdrawal by Subject|1
5062589|NCT02361762|17467079|P1|Overall Study|Withdrawal by Subject|0
5062590|NCT02361580|17467130|P2|Overall Study|Lost to Follow-up|3
5062591|NCT02361580|17467131|P1|Overall Study|Lost to Follow-up|6
5062592|NCT02361216|17467160|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
5062593|NCT02361216|17467161|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
5062594|NCT02361216|17467160|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
5062595|NCT02361216|17467161|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
5062596|NCT02361216|17467160|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
5062597|NCT02361216|17467161|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
5062598|NCT02361216|17467160|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
5062599|NCT02361216|17467161|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
5062600|NCT02361216|17467160|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
5062601|NCT02361216|17467161|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
5062602|NCT02361216|17467160|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
5062603|NCT02361216|17467161|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
5062604|NCT02360995|17467176|P3|Overall Study|Withdrawal by Subject|0
5062605|NCT02360995|17467177|P2|Overall Study|Withdrawal by Subject|1
5062606|NCT02360995|17467178|P1|Overall Study|Withdrawal by Subject|0
5062607|NCT02360995|17467176|P3|Overall Study|Lost to Follow-up|2
5062608|NCT02360995|17467177|P2|Overall Study|Lost to Follow-up|0
5062609|NCT02360995|17467178|P1|Overall Study|Lost to Follow-up|2
5062610|NCT02360475|17467242|P4|Overall Study|Migrated/moved from study area|1
5062611|NCT02360475|17467243|P3|Overall Study|Migrated/moved from study area|0
5062612|NCT02360475|17467244|P2|Overall Study|Migrated/moved from study area|0
5062613|NCT02360475|17467245|P1|Overall Study|Migrated/moved from study area|0
5062614|NCT02360475|17467242|P4|Overall Study|Withdrawal by Subject|0
5062615|NCT02360475|17467243|P3|Overall Study|Withdrawal by Subject|2
5062616|NCT02360475|17467244|P2|Overall Study|Withdrawal by Subject|1
5062617|NCT02360475|17467245|P1|Overall Study|Withdrawal by Subject|0
5062618|NCT02360475|17467242|P4|Overall Study|Lost to Follow-up|4
5062619|NCT02360475|17467243|P3|Overall Study|Lost to Follow-up|6
5062620|NCT02360475|17467244|P2|Overall Study|Lost to Follow-up|12
5062621|NCT02360475|17467245|P1|Overall Study|Lost to Follow-up|4
5062622|NCT02360397|17467303|P1|Overall Study|Adverse Event|1
5062623|NCT02360397|17467303|P1|Overall Study|Incomplete screening|3
5062624|NCT02360293|17467329|P2|Overall Study|Excluded|0
5062625|NCT02360293|17467330|P1|Overall Study|Excluded|1
5062626|NCT02360293|17467329|P2|Overall Study|Withdrawal by Subject|1
5062627|NCT02360293|17467330|P1|Overall Study|Withdrawal by Subject|2
5062628|NCT02360293|17467329|P2|Overall Study|Lost to Follow-up|95
5062629|NCT02360293|17467330|P1|Overall Study|Lost to Follow-up|73
5062630|NCT02360280|17467344|P2|Overall Study|Lost to Follow-up|0
5062631|NCT02360280|17467345|P1|Overall Study|Lost to Follow-up|1
5062632|NCT02360280|17467344|P2|Overall Study|Adverse Event|1
5062633|NCT02360280|17467345|P1|Overall Study|Adverse Event|0
5062634|NCT02360280|17467344|P2|Overall Study|Withdrawal by Subject|0
5062635|NCT02360280|17467345|P1|Overall Study|Withdrawal by Subject|2
5062636|NCT02360228|17467360|P3|Overall Study|Unstable symptoms during screening|1
5062637|NCT02360228|17467361|P2|Overall Study|Unstable symptoms during screening|0
5062638|NCT02360228|17467362|P1|Overall Study|Unstable symptoms during screening|0
5062639|NCT02360228|17467360|P3|Overall Study|Self-discontinued medication|0
5062640|NCT02360228|17467361|P2|Overall Study|Self-discontinued medication|1
5062641|NCT02360228|17467362|P1|Overall Study|Self-discontinued medication|0
5062642|NCT02360228|17467360|P3|Overall Study|Withdrawal by Subject|0
5062643|NCT02360228|17467361|P2|Overall Study|Withdrawal by Subject|0
5062644|NCT02360228|17467362|P1|Overall Study|Withdrawal by Subject|1
5062645|NCT02360111|17467457|P1|Overall Study|Death|2
5062646|NCT02360098|17467467|P1|Overall Study|Physician Decision|7
5062647|NCT02359903|17467535|P2|Overall Study|Adverse Event|2
5062648|NCT02359903|17467536|P1|Overall Study|Adverse Event|0
5062649|NCT02359890|17467544|P1|Overall Study|Never treated with study catheter|6
5062650|NCT02359890|17467544|P1|Overall Study|Not meeting eligibility|4
5062651|NCT02359877|17467555|P4|Overall Study|Adverse Event|1
5062652|NCT02359877|17467556|P3|Overall Study|Adverse Event|0
5062653|NCT02359877|17467557|P2|Overall Study|Adverse Event|0
5062654|NCT02359877|17467558|P1|Overall Study|Adverse Event|0
5062655|NCT02359877|17467555|P4|Overall Study|Withdrawal by Subject|2
5062656|NCT02359877|17467556|P3|Overall Study|Withdrawal by Subject|0
5062657|NCT02359877|17467557|P2|Overall Study|Withdrawal by Subject|0
5062658|NCT02359877|17467558|P1|Overall Study|Withdrawal by Subject|1
5062659|NCT02359851|17467608|P1|Overall Study|Disease progression|1
5062660|NCT02359851|17467608|P1|Overall Study|Death|1
5062661|NCT02359552|17467618|P2|Overall Study|Lost to Follow-up|4
5062662|NCT02359552|17467619|P1|Overall Study|Lost to Follow-up|3
5062663|NCT02359435|17467641|P2|Overall Study|Lost to Follow-up|4
5062664|NCT02359435|17467642|P1|Overall Study|Lost to Follow-up|4
5062665|NCT02359045|17467702|P2|Overall Study|Adverse Event|1
5062666|NCT02359045|17467703|P1|Overall Study|Adverse Event|0
5062667|NCT02359045|17467702|P2|Overall Study|Lost to Follow-up|1
5062668|NCT02359045|17467703|P1|Overall Study|Lost to Follow-up|1
5062669|NCT02359045|17467702|P2|Overall Study|Eligibility criteria not fulfilled|1
5062670|NCT02359045|17467703|P1|Overall Study|Eligibility criteria not fulfilled|3
5062671|NCT02358863|17468011|P1|Overall Study|Physician Decision|3
5062672|NCT02358668|17468018|P3|Overall Study|Withdrawal by Subject|0
5062673|NCT02358668|17468019|P2|Overall Study|Withdrawal by Subject|1
5062674|NCT02358668|17468020|P1|Overall Study|Withdrawal by Subject|0
5062675|NCT02358668|17468018|P3|Overall Study|Adverse Event|0
5062676|NCT02358668|17468019|P2|Overall Study|Adverse Event|0
5062677|NCT02358668|17468020|P1|Overall Study|Adverse Event|2
5062678|NCT02358473|17468169|P1|Overall Study|Physician Decision|2
5062679|NCT02358473|17468169|P1|Overall Study|Withdrawal by Subject|2
5062680|NCT02358473|17468169|P1|Overall Study|Adverse Event|3
5062681|NCT02358473|17468169|P1|Overall Study|Disease Progession|6
5062682|NCT02358369|17468181|P5|Treatment Period C|Adverse Event|7
5062683|NCT02358369|17468182|P4|Treatment Period C|Adverse Event|0
5062684|NCT02358369|17468183|P3|Treatment Period C|Adverse Event|0
5062685|NCT02358369|17468184|P2|Treatment Period C|Adverse Event|0
5062686|NCT02358369|17468185|P1|Treatment Period C|Adverse Event|0
5062687|NCT02358369|17468181|P5|Treatment Period A/B|Withdrawal by Subject|0
5062688|NCT02358369|17468182|P4|Treatment Period A/B|Withdrawal by Subject|2
5062689|NCT02358369|17468183|P3|Treatment Period A/B|Withdrawal by Subject|0
5062690|NCT02358369|17468184|P2|Treatment Period A/B|Withdrawal by Subject|2
5062691|NCT02358369|17468185|P1|Treatment Period A/B|Withdrawal by Subject|0
5062692|NCT02358369|17468181|P5|Treatment Period A/B|Death|0
5062693|NCT02358369|17468182|P4|Treatment Period A/B|Death|0
5062694|NCT02358369|17468183|P3|Treatment Period A/B|Death|1
5062695|NCT02358369|17468184|P2|Treatment Period A/B|Death|0
5062696|NCT02358369|17468185|P1|Treatment Period A/B|Death|0
5062697|NCT02358369|17468181|P5|Treatment Period A/B|Adverse Event|0
5062698|NCT02358369|17468182|P4|Treatment Period A/B|Adverse Event|2
5062699|NCT02358369|17468183|P3|Treatment Period A/B|Adverse Event|1
5062700|NCT02358369|17468184|P2|Treatment Period A/B|Adverse Event|0
5062701|NCT02358369|17468185|P1|Treatment Period A/B|Adverse Event|0
5062702|NCT02358369|17468181|P5|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5062703|NCT02358369|17468182|P4|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5062704|NCT02358369|17468183|P3|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5062705|NCT02358369|17468184|P2|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5062706|NCT02358369|17468185|P1|Pre-Randomization Washout Period|Not Qualified for Randomization|35
5062707|NCT02358343|17468231|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5062708|NCT02358343|17468232|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5062709|NCT02358343|17468233|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
5062710|NCT02358343|17468234|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5062711|NCT02358343|17468235|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5062712|NCT02358343|17468231|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5062713|NCT02358343|17468232|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5062714|NCT02358343|17468233|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5062715|NCT02358343|17468234|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
5062716|NCT02358343|17468235|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
5062717|NCT02358343|17468231|P5|Comparative Efficacy Trial / Observation|Death|0
5062718|NCT02358343|17468232|P4|Comparative Efficacy Trial / Observation|Death|0
5062719|NCT02358343|17468233|P3|Comparative Efficacy Trial / Observation|Death|2
5062720|NCT02358343|17468234|P2|Comparative Efficacy Trial / Observation|Death|0
5062721|NCT02358343|17468235|P1|Comparative Efficacy Trial / Observation|Death|0
5062722|NCT02358343|17468231|P5|Screening Intervention|Determined Ineligible|0
5062723|NCT02358343|17468232|P4|Screening Intervention|Determined Ineligible|0
5062724|NCT02358343|17468233|P3|Screening Intervention|Determined Ineligible|0
5062725|NCT02358343|17468234|P2|Screening Intervention|Determined Ineligible|6
5062726|NCT02358343|17468235|P1|Screening Intervention|Determined Ineligible|5
5062727|NCT02358343|17468231|P5|Screening Intervention|Withdrawal by Subject|0
5062728|NCT02358343|17468232|P4|Screening Intervention|Withdrawal by Subject|0
5062729|NCT02358343|17468233|P3|Screening Intervention|Withdrawal by Subject|0
5062730|NCT02358343|17468234|P2|Screening Intervention|Withdrawal by Subject|0
5062731|NCT02358343|17468235|P1|Screening Intervention|Withdrawal by Subject|1
5062732|NCT02358343|17468231|P5|Screening Intervention|Death|0
5062733|NCT02358343|17468232|P4|Screening Intervention|Death|0
5062734|NCT02358343|17468233|P3|Screening Intervention|Death|0
5062735|NCT02358343|17468234|P2|Screening Intervention|Death|2
5062736|NCT02358343|17468235|P1|Screening Intervention|Death|0
5062737|NCT02358044|17468291|P2|Overall Study|Withdrawal by Subject|4
5062738|NCT02358044|17468292|P1|Overall Study|Withdrawal by Subject|0
5062739|NCT02358044|17468291|P2|Overall Study|Physician Decision|1
5062740|NCT02358044|17468292|P1|Overall Study|Physician Decision|0
5062741|NCT02358044|17468291|P2|Overall Study|Lost to Follow-up|1
5062742|NCT02358044|17468292|P1|Overall Study|Lost to Follow-up|2
5062743|NCT02358044|17468291|P2|Overall Study|Adverse Event|1
5062744|NCT02358044|17468292|P1|Overall Study|Adverse Event|0
5062745|NCT02358031|17468311|P3|Overall Study|Ongoing in Study|33
5062746|NCT02358031|17468312|P2|Overall Study|Ongoing in Study|64
5062747|NCT02358031|17468313|P1|Overall Study|Ongoing in Study|61
5062748|NCT02358031|17468311|P3|Overall Study|Withdrawal by Subject|17
5062749|NCT02358031|17468312|P2|Overall Study|Withdrawal by Subject|12
5062750|NCT02358031|17468313|P1|Overall Study|Withdrawal by Subject|14
5062751|NCT02358031|17468311|P3|Overall Study|Lost to Follow-up|1
5062752|NCT02358031|17468312|P2|Overall Study|Lost to Follow-up|1
5062753|NCT02358031|17468313|P1|Overall Study|Lost to Follow-up|0
5062754|NCT02358031|17468311|P3|Overall Study|Death|249
5062755|NCT02358031|17468312|P2|Overall Study|Death|204
5062756|NCT02358031|17468313|P1|Overall Study|Death|226
5062757|NCT02357940|17468440|P2|Overall Study|Investigator's judgement|1
5062758|NCT02357940|17468441|P1|Overall Study|Investigator's judgement|0
5062759|NCT02357940|17468440|P2|Overall Study|Adverse Event|1
5062760|NCT02357940|17468441|P1|Overall Study|Adverse Event|0
5062761|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
5062762|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
5062763|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
5062764|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
5062765|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
5062766|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
5062767|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
5062768|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
5062769|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
5062770|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
5062771|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
5062772|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
5062773|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
5062774|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
5062775|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
5062776|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
5062777|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
5062778|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
5062779|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
5062780|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
5062781|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
5062782|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
5062783|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
5062784|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
5062785|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
5062786|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
5062787|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
5062788|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
5062789|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
5062790|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
5062791|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
5062792|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
5062793|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
5062794|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
5062795|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
5062796|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
5062797|NCT02357901|17468568|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
5062798|NCT02357901|17468569|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
5062799|NCT02357901|17468570|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
5062800|NCT02357901|17468571|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
5062801|NCT02357901|17468568|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5062802|NCT02357901|17468569|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5062803|NCT02357901|17468570|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5062804|NCT02357901|17468571|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
5062805|NCT02357810|17468621|P1|Follow-up at Treatment Discontinuation|Still in Follow-up|11
5062806|NCT02357810|17468621|P1|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
5062807|NCT02357810|17468621|P1|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
5062808|NCT02357810|17468621|P1|12 Week Response and Further Treatment|Wound Complications|1
5062809|NCT02357810|17468621|P1|12 Week Response and Further Treatment|Progressive Disease|15
5062810|NCT02357810|17468621|P1|12 Week Response and Further Treatment|Withdrawal by Subject|1
5062811|NCT02357810|17468621|P1|12 Week Response and Further Treatment|Adverse Event|5
5062812|NCT02357810|17468621|P1|Reached 12 Weeks Response|Other|1
5062813|NCT02357810|17468621|P1|Reached 12 Weeks Response|Physician Decision|1
5062814|NCT02357810|17468621|P1|Reached 12 Weeks Response|Death|1
5062815|NCT02357810|17468621|P1|Reached 12 Weeks Response|Protocol Violation|1
5062816|NCT02357810|17468621|P1|Reached 12 Weeks Response|Withdrawal by Subject|8
5062817|NCT02357810|17468621|P1|Reached 12 Weeks Response|Progressive Disease|39
5062818|NCT02357810|17468621|P1|Reached 12 Weeks Response|Adverse Event|5
5062819|NCT02357810|17468621|P1|Registered and Started Treatment|Found not to be eligible for the study|26
5062820|NCT02357810|17468621|P1|Registered and Started Treatment|Withdrawal by Subject|1
5062821|NCT02357576|17468671|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
5062822|NCT02357576|17468672|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
5062823|NCT02357576|17468671|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
5062824|NCT02357576|17468672|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
5062825|NCT02357576|17468671|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
5062826|NCT02357576|17468672|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
5062827|NCT02357576|17468671|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
5062828|NCT02357576|17468672|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
5062829|NCT02357576|17468671|P2|Treatment Period|Physician Decision|1
5062830|NCT02357576|17468672|P1|Treatment Period|Physician Decision|0
5062831|NCT02357576|17468671|P2|Treatment Period|Withdrawal by Subject|1
5062832|NCT02357576|17468672|P1|Treatment Period|Withdrawal by Subject|0
5062833|NCT02357459|17468713|P3|Overall Study|Job Commitments|1
5062834|NCT02357459|17468714|P2|Overall Study|Job Commitments|0
5062835|NCT02357459|17468715|P1|Overall Study|Job Commitments|0
5062836|NCT02357459|17468713|P3|Overall Study|Pre-planned Knee surgery|2
5062837|NCT02357459|17468714|P2|Overall Study|Pre-planned Knee surgery|0
5062838|NCT02357459|17468715|P1|Overall Study|Pre-planned Knee surgery|0
5062839|NCT02357459|17468713|P3|Overall Study|Incarceration|1
5062840|NCT02357459|17468714|P2|Overall Study|Incarceration|0
5062841|NCT02357459|17468715|P1|Overall Study|Incarceration|0
5062842|NCT02357459|17468713|P3|Overall Study|Instruction from PCP|0
5062843|NCT02357459|17468714|P2|Overall Study|Instruction from PCP|0
5062844|NCT02357459|17468715|P1|Overall Study|Instruction from PCP|1
5062845|NCT02357459|17468713|P3|Overall Study|Patient Relocated|0
5062846|NCT02357459|17468714|P2|Overall Study|Patient Relocated|0
5062847|NCT02357459|17468715|P1|Overall Study|Patient Relocated|2
5062848|NCT02357459|17468713|P3|Overall Study|Lack of Efficacy|4
5062849|NCT02357459|17468714|P2|Overall Study|Lack of Efficacy|4
5062850|NCT02357459|17468715|P1|Overall Study|Lack of Efficacy|7
5062851|NCT02357459|17468713|P3|Overall Study|Lost to Follow-up|0
5062852|NCT02357459|17468714|P2|Overall Study|Lost to Follow-up|3
5062853|NCT02357459|17468715|P1|Overall Study|Lost to Follow-up|1
5062854|NCT02357459|17468713|P3|Overall Study|Protocol Violation|0
5062855|NCT02357459|17468714|P2|Overall Study|Protocol Violation|1
5062856|NCT02357459|17468715|P1|Overall Study|Protocol Violation|1
5062857|NCT02357459|17468713|P3|Overall Study|Physician Decision|0
5062858|NCT02357459|17468714|P2|Overall Study|Physician Decision|2
5062859|NCT02357459|17468715|P1|Overall Study|Physician Decision|0
5062860|NCT02357459|17468713|P3|Overall Study|Withdrawal by Subject|3
5062861|NCT02357459|17468714|P2|Overall Study|Withdrawal by Subject|3
5062862|NCT02357459|17468715|P1|Overall Study|Withdrawal by Subject|5
5062863|NCT02357459|17468713|P3|Overall Study|Adverse Event|1
5062864|NCT02357459|17468714|P2|Overall Study|Adverse Event|1
5062865|NCT02357459|17468715|P1|Overall Study|Adverse Event|0
5062866|NCT02357420|17468761|P4|Overall Study|Lost to Follow-up|3
5062867|NCT02357420|17468762|P3|Overall Study|Lost to Follow-up|2
5062868|NCT02357420|17468763|P2|Overall Study|Lost to Follow-up|0
5062869|NCT02357420|17468764|P1|Overall Study|Lost to Follow-up|3
5062870|NCT02357420|17468761|P4|Overall Study|Withdrawn Consent|6
5062871|NCT02357420|17468762|P3|Overall Study|Withdrawn Consent|6
5062872|NCT02357420|17468763|P2|Overall Study|Withdrawn Consent|8
5062873|NCT02357420|17468764|P1|Overall Study|Withdrawn Consent|4
5062874|NCT02357420|17468761|P4|Overall Study|Protocol Non-compliance|1
5062875|NCT02357420|17468762|P3|Overall Study|Protocol Non-compliance|0
5062876|NCT02357420|17468763|P2|Overall Study|Protocol Non-compliance|0
5062877|NCT02357420|17468764|P1|Overall Study|Protocol Non-compliance|0
5062878|NCT02357420|17468761|P4|Overall Study|Prohibited Medication|0
5062879|NCT02357420|17468762|P3|Overall Study|Prohibited Medication|0
5062880|NCT02357420|17468763|P2|Overall Study|Prohibited Medication|1
5062881|NCT02357420|17468764|P1|Overall Study|Prohibited Medication|1
5062882|NCT02357420|17468761|P4|Overall Study|Investigator Decision|0
5062883|NCT02357420|17468762|P3|Overall Study|Investigator Decision|0
5062884|NCT02357420|17468763|P2|Overall Study|Investigator Decision|0
5062885|NCT02357420|17468764|P1|Overall Study|Investigator Decision|1
5062886|NCT02357420|17468761|P4|Overall Study|Adverse Event|9
5062887|NCT02357420|17468762|P3|Overall Study|Adverse Event|8
5062888|NCT02357420|17468763|P2|Overall Study|Adverse Event|3
5062889|NCT02357420|17468764|P1|Overall Study|Adverse Event|3
5062890|NCT02357368|17468827|P4|Overall Study|Withdrawal by Subject|2
5062891|NCT02357368|17468828|P3|Overall Study|Withdrawal by Subject|1
5062892|NCT02357368|17468829|P2|Overall Study|Withdrawal by Subject|1
5062893|NCT02357368|17468830|P1|Overall Study|Withdrawal by Subject|3
5062894|NCT02357368|17468827|P4|Overall Study|Pregnancy|0
5062895|NCT02357368|17468828|P3|Overall Study|Pregnancy|0
5062896|NCT02357368|17468829|P2|Overall Study|Pregnancy|2
5062897|NCT02357368|17468830|P1|Overall Study|Pregnancy|3
5062898|NCT02357368|17468827|P4|Overall Study|Lost to Follow-up|1
5062899|NCT02357368|17468828|P3|Overall Study|Lost to Follow-up|0
5062900|NCT02357368|17468829|P2|Overall Study|Lost to Follow-up|0
5062901|NCT02357368|17468830|P1|Overall Study|Lost to Follow-up|0
5062902|NCT02357342|17468854|P2|First 6 Months|Death|0
5062903|NCT02357342|17468855|P1|First 6 Months|Death|2
5062904|NCT02357147|17468903|P2|Maintenance Treatment Phase|Not Treated|0
5062905|NCT02357147|17468904|P1|Maintenance Treatment Phase|Not Treated|1
5062906|NCT02357147|17468903|P2|Maintenance Treatment Phase|Sponsor Decision|15
5062907|NCT02357147|17468904|P1|Maintenance Treatment Phase|Sponsor Decision|0
5062908|NCT02357147|17468903|P2|Maintenance Treatment Phase|Adverse Event|3
5062909|NCT02357147|17468904|P1|Maintenance Treatment Phase|Adverse Event|0
5062910|NCT02357147|17468903|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
5062911|NCT02357147|17468904|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
5062912|NCT02357147|17468903|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
5062913|NCT02357147|17468904|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5062914|NCT02357147|17468903|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
5062915|NCT02357147|17468904|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
5062916|NCT02357147|17468903|P2|Combination Treatment Phase|Not treated|2
5062917|NCT02357147|17468904|P1|Combination Treatment Phase|Not treated|0
5062918|NCT02357147|17468903|P2|Combination Treatment Phase|Other|0
5062919|NCT02357147|17468904|P1|Combination Treatment Phase|Other|1
5062920|NCT02357147|17468903|P2|Combination Treatment Phase|Sponsor Decision|12
5062921|NCT02357147|17468904|P1|Combination Treatment Phase|Sponsor Decision|0
5062922|NCT02357147|17468903|P2|Combination Treatment Phase|Death|1
5062923|NCT02357147|17468904|P1|Combination Treatment Phase|Death|1
5062924|NCT02357147|17468903|P2|Combination Treatment Phase|Adverse Event|4
5062925|NCT02357147|17468904|P1|Combination Treatment Phase|Adverse Event|12
5062926|NCT02357147|17468903|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
5062927|NCT02357147|17468904|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
5062928|NCT02357147|17468903|P2|Combination Treatment Phase|Withdrawal by Subject|2
5062929|NCT02357147|17468904|P1|Combination Treatment Phase|Withdrawal by Subject|4
5062930|NCT02357147|17468903|P2|Combination Treatment Phase|Investigator Discretion|1
5062931|NCT02357147|17468904|P1|Combination Treatment Phase|Investigator Discretion|1
5062932|NCT02357147|17468903|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
5062933|NCT02357147|17468904|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
5062934|NCT02357147|17468903|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
5062935|NCT02357147|17468904|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
5062936|NCT02356887|17468935|P1|Overall Study|poor compliance|2
5062937|NCT02356783|17468952|P2|Overall Study|Lost to Follow-up|3
5062938|NCT02356783|17468953|P1|Overall Study|Lost to Follow-up|1
5062939|NCT02356588|17468974|P2|Overall Study|Protocol Violation|1
5062940|NCT02356588|17468975|P1|Overall Study|Protocol Violation|0
5062941|NCT02356588|17468974|P2|Overall Study|Withdrawal by Subject|0
5062942|NCT02356588|17468975|P1|Overall Study|Withdrawal by Subject|1
5062943|NCT02356588|17468974|P2|Overall Study|Adverse Event|2
5062944|NCT02356588|17468975|P1|Overall Study|Adverse Event|0
5062945|NCT02356588|17468974|P2|Overall Study|Lack of Efficacy|10
5062946|NCT02356588|17468975|P1|Overall Study|Lack of Efficacy|4
5062947|NCT02356562|17469092|P2|Overall Study|site closure|0
5062948|NCT02356562|17469093|P1|Overall Study|site closure|1
5062949|NCT02356562|17469092|P2|Overall Study|Re-entered treatment in a previous study|0
5062950|NCT02356562|17469093|P1|Overall Study|Re-entered treatment in a previous study|1
5062951|NCT02356562|17469092|P2|Overall Study|Withdrawal by Subject|1
5062952|NCT02356562|17469093|P1|Overall Study|Withdrawal by Subject|0
5062953|NCT02356211|17469122|P2|Overall Study|ineligible|8
5062954|NCT02356211|17469123|P1|Overall Study|ineligible|1
5062955|NCT02356211|17469122|P2|Overall Study|Withdrawal by Subject|2
5062956|NCT02356211|17469123|P1|Overall Study|Withdrawal by Subject|2
5062957|NCT02355743|17469188|P1|Overall Study|Lost to Follow-up|1
5062958|NCT02355743|17469188|P1|Overall Study|Withdrawal by Subject|1
5062959|NCT02355691|17469196|P2|Overall Study|Loss of Research Personnel|9
5062960|NCT02355691|17469197|P1|Overall Study|Loss of Research Personnel|7
5062961|NCT02355665|17469207|P2|Overall Study|Compliance, PI decision, move, eligible|3
5062962|NCT02355665|17469208|P1|Overall Study|Compliance, PI decision, move, eligible|6
5062963|NCT02355665|17469207|P2|Overall Study|Death|2
5062964|NCT02355665|17469208|P1|Overall Study|Death|4
5062965|NCT02355665|17469207|P2|Overall Study|Lost to Follow-up|103
5062966|NCT02355665|17469208|P1|Overall Study|Lost to Follow-up|131
5062967|NCT02355665|17469207|P2|Overall Study|Withdrawal by Subject|100
5062968|NCT02355665|17469208|P1|Overall Study|Withdrawal by Subject|90
5062969|NCT02355665|17469207|P2|Overall Study|Protocol Violation|0
5062970|NCT02355665|17469208|P1|Overall Study|Protocol Violation|2
5062971|NCT02355665|17469207|P2|Overall Study|Adverse Event|24
5062972|NCT02355665|17469208|P1|Overall Study|Adverse Event|16
5062973|NCT02355028|17469666|P2|Overall Study|Deemed ineligible after randomization|4
5062974|NCT02355028|17469667|P1|Overall Study|Deemed ineligible after randomization|8
5062975|NCT02355028|17469666|P2|Overall Study|Withdrawal by Subject|1
5062976|NCT02355028|17469667|P1|Overall Study|Withdrawal by Subject|1
5062977|NCT02355028|17469666|P2|Overall Study|Adverse Event|0
5062978|NCT02355028|17469667|P1|Overall Study|Adverse Event|2
5062979|NCT02354976|17469703|P3|Overall Study|Adverse Event|2
5062980|NCT02354976|17469704|P2|Overall Study|Adverse Event|0
5062981|NCT02354976|17469705|P1|Overall Study|Adverse Event|1
5062982|NCT02354976|17469703|P3|Overall Study|Study-specifc withdrawal criteria|0
5062983|NCT02354976|17469704|P2|Overall Study|Study-specifc withdrawal criteria|1
5062984|NCT02354976|17469705|P1|Overall Study|Study-specifc withdrawal criteria|0
5062985|NCT02354976|17469703|P3|Overall Study|Other - reason not specified|1
5062986|NCT02354976|17469704|P2|Overall Study|Other - reason not specified|0
5062987|NCT02354976|17469705|P1|Overall Study|Other - reason not specified|1
5062988|NCT02354690|17469768|P1|Overall Study|Physician Decision|1
5062989|NCT02354599|17469782|P6|Overall Study|Withdrawal by Subject|0
5062990|NCT02354599|17469783|P5|Overall Study|Withdrawal by Subject|0
5062991|NCT02354599|17469784|P4|Overall Study|Withdrawal by Subject|0
5062992|NCT02354599|17469785|P3|Overall Study|Withdrawal by Subject|0
5062993|NCT02354599|17469786|P2|Overall Study|Withdrawal by Subject|1
5062994|NCT02354599|17469787|P1|Overall Study|Withdrawal by Subject|1
5062995|NCT02354599|17469782|P6|Overall Study|Pretreatment Event/Adverse Event|1
5062996|NCT02354599|17469783|P5|Overall Study|Pretreatment Event/Adverse Event|0
5062997|NCT02354599|17469784|P4|Overall Study|Pretreatment Event/Adverse Event|0
5062998|NCT02354599|17469785|P3|Overall Study|Pretreatment Event/Adverse Event|0
5062999|NCT02354599|17469786|P2|Overall Study|Pretreatment Event/Adverse Event|0
5063000|NCT02354599|17469787|P1|Overall Study|Pretreatment Event/Adverse Event|0
5063001|NCT02354586|17469857|P1|Overall Study|Disease progression|116
5063002|NCT02354586|17469857|P1|Overall Study|Lost to Follow-up|6
5063003|NCT02354586|17469857|P1|Overall Study|Withdrawal by Subject|51
5063004|NCT02354586|17469857|P1|Overall Study|Death|168
5063005|NCT02354508|17469876|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
5063006|NCT02354508|17469877|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
5063007|NCT02354508|17469878|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
5063008|NCT02354508|17469876|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
5063009|NCT02354508|17469877|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
5063010|NCT02354508|17469878|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
5063011|NCT02354508|17469876|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
5063012|NCT02354508|17469877|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
5063013|NCT02354508|17469878|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
5063014|NCT02354508|17469876|P3|Period 2: Extension Phase|Physician Decision|1
5063015|NCT02354508|17469877|P2|Period 2: Extension Phase|Physician Decision|0
5063016|NCT02354508|17469878|P1|Period 2: Extension Phase|Physician Decision|5
5063017|NCT02354508|17469876|P3|Period 2: Extension Phase|Withdrawal by Subject|0
5063018|NCT02354508|17469877|P2|Period 2: Extension Phase|Withdrawal by Subject|1
5063019|NCT02354508|17469878|P1|Period 2: Extension Phase|Withdrawal by Subject|0
5063020|NCT02354508|17469876|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
5063021|NCT02354508|17469877|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
5063022|NCT02354508|17469878|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
5063023|NCT02354508|17469876|P3|Period 1: Core Phase|Withdrawal by Subject|2
5063024|NCT02354508|17469877|P2|Period 1: Core Phase|Withdrawal by Subject|1
5063025|NCT02354508|17469878|P1|Period 1: Core Phase|Withdrawal by Subject|0
5063026|NCT02354508|17469876|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
5063027|NCT02354508|17469877|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
5063028|NCT02354508|17469878|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
5063029|NCT02354508|17469876|P3|Period 1: Core Phase|Adverse Event|2
5063030|NCT02354508|17469877|P2|Period 1: Core Phase|Adverse Event|1
5063031|NCT02354508|17469878|P1|Period 1: Core Phase|Adverse Event|1
5063032|NCT02354417|17469980|P1|Overall Study|Physician Decision|1
5063033|NCT02354235|17470047|P2|Overall Study|Conflict with the stopping criteria|1
5063034|NCT02354235|17470048|P1|Overall Study|Conflict with the stopping criteria|0
5063035|NCT02354235|17470047|P2|Overall Study|Withdrawal by Subject|3
5063036|NCT02354235|17470048|P1|Overall Study|Withdrawal by Subject|1
5063037|NCT02354235|17470047|P2|Overall Study|Physician Decision|1
5063038|NCT02354235|17470048|P1|Overall Study|Physician Decision|0
5063039|NCT02354235|17470047|P2|Overall Study|Adverse Event|2
5063040|NCT02354235|17470048|P1|Overall Study|Adverse Event|2
5063041|NCT02354222|17470064|P2|Overall Study|Conflict with the stopping criteria|4
5063042|NCT02354222|17470065|P1|Overall Study|Conflict with the stopping criteria|0
5063043|NCT02354222|17470064|P2|Overall Study|Withdrawal by Subject|3
5063044|NCT02354222|17470065|P1|Overall Study|Withdrawal by Subject|2
5063045|NCT02354222|17470064|P2|Overall Study|Pregnancy|0
5063046|NCT02354222|17470065|P1|Overall Study|Pregnancy|1
5063047|NCT02354222|17470064|P2|Overall Study|Physician Decision|1
5063048|NCT02354222|17470065|P1|Overall Study|Physician Decision|1
5063049|NCT02354222|17470064|P2|Overall Study|Adverse Event|3
5063050|NCT02354222|17470065|P1|Overall Study|Adverse Event|0
5063051|NCT02353871|17470096|P2|Overall Study|Lost to Follow-up|0
5063052|NCT02353871|17470097|P1|Overall Study|Lost to Follow-up|2
5063053|NCT02353871|17470096|P2|Overall Study|Consent withdrawn|8
5063054|NCT02353871|17470097|P1|Overall Study|Consent withdrawn|1
5063055|NCT02353871|17470096|P2|Overall Study|Protocol deviation|1
5063056|NCT02353871|17470097|P1|Overall Study|Protocol deviation|0
5063057|NCT02353572|17470190|P1|Overall Study|Study terminated|2
5063058|NCT02353572|17470190|P1|Overall Study|Withdrawal by Subject|1
5063059|NCT02353468|17470194|P1|Overall Study|Study terminated|3
5063060|NCT02353442|17470200|P2|Overall Study|Withdrawal by Subject|4
5063061|NCT02353442|17470201|P1|Overall Study|Withdrawal by Subject|3
5063062|NCT02353169|17470256|P4|Overall Study|Pre-op medication|0
5063063|NCT02353169|17470257|P3|Overall Study|Pre-op medication|1
5063064|NCT02353169|17470258|P2|Overall Study|Pre-op medication|0
5063065|NCT02353169|17470259|P1|Overall Study|Pre-op medication|0
5063066|NCT02353169|17470256|P4|Overall Study|ECG data error|2
5063067|NCT02353169|17470257|P3|Overall Study|ECG data error|2
5063068|NCT02353169|17470258|P2|Overall Study|ECG data error|3
5063069|NCT02353169|17470259|P1|Overall Study|ECG data error|0
5063070|NCT02353169|17470256|P4|Overall Study|Inhalational induction|0
5063071|NCT02353169|17470257|P3|Overall Study|Inhalational induction|0
5063072|NCT02353169|17470258|P2|Overall Study|Inhalational induction|2
5063073|NCT02353169|17470259|P1|Overall Study|Inhalational induction|0
5063074|NCT02353169|17470256|P4|Overall Study|OR team declined|0
5063075|NCT02353169|17470257|P3|Overall Study|OR team declined|0
5063076|NCT02353169|17470258|P2|Overall Study|OR team declined|0
5063077|NCT02353169|17470259|P1|Overall Study|OR team declined|2
5063078|NCT02353169|17470256|P4|Overall Study|QTc > 450 msec|1
5063079|NCT02353169|17470257|P3|Overall Study|QTc > 450 msec|1
5063080|NCT02353169|17470258|P2|Overall Study|QTc > 450 msec|1
5063081|NCT02353169|17470259|P1|Overall Study|QTc > 450 msec|1
5063082|NCT02352948|17470351|P6|Overall Study|Other|0
5063083|NCT02352948|17470352|P5|Overall Study|Other|0
5063084|NCT02352948|17470353|P4|Overall Study|Other|0
5063085|NCT02352948|17470354|P3|Overall Study|Other|2
5063086|NCT02352948|17470355|P2|Overall Study|Other|0
5063087|NCT02352948|17470356|P1|Overall Study|Other|0
5063088|NCT02352948|17470351|P6|Overall Study|Eligibility criteria not fulfilled|0
5063089|NCT02352948|17470352|P5|Overall Study|Eligibility criteria not fulfilled|0
5063090|NCT02352948|17470353|P4|Overall Study|Eligibility criteria not fulfilled|1
5063091|NCT02352948|17470354|P3|Overall Study|Eligibility criteria not fulfilled|0
5063092|NCT02352948|17470355|P2|Overall Study|Eligibility criteria not fulfilled|1
5063093|NCT02352948|17470356|P1|Overall Study|Eligibility criteria not fulfilled|0
5063094|NCT02352948|17470351|P6|Overall Study|Withdrawal by Subject|4
5063095|NCT02352948|17470352|P5|Overall Study|Withdrawal by Subject|9
5063096|NCT02352948|17470353|P4|Overall Study|Withdrawal by Subject|23
5063097|NCT02352948|17470354|P3|Overall Study|Withdrawal by Subject|11
5063098|NCT02352948|17470355|P2|Overall Study|Withdrawal by Subject|10
5063099|NCT02352948|17470356|P1|Overall Study|Withdrawal by Subject|1
5063100|NCT02352948|17470351|P6|Overall Study|Lost to Follow-up|1
5063101|NCT02352948|17470352|P5|Overall Study|Lost to Follow-up|2
5063102|NCT02352948|17470353|P4|Overall Study|Lost to Follow-up|1
5063103|NCT02352948|17470354|P3|Overall Study|Lost to Follow-up|2
5063104|NCT02352948|17470355|P2|Overall Study|Lost to Follow-up|0
5063105|NCT02352948|17470356|P1|Overall Study|Lost to Follow-up|1
5063106|NCT02352948|17470351|P6|Overall Study|Death|44
5063107|NCT02352948|17470352|P5|Overall Study|Death|77
5063108|NCT02352948|17470353|P4|Overall Study|Death|74
5063109|NCT02352948|17470354|P3|Overall Study|Death|114
5063110|NCT02352948|17470355|P2|Overall Study|Death|48
5063111|NCT02352948|17470356|P1|Overall Study|Death|47
5063112|NCT02352779|17470481|P3|Overall Study|No Reason|1
5063113|NCT02352779|17470482|P2|Overall Study|No Reason|0
5063114|NCT02352779|17470483|P1|Overall Study|No Reason|0
5063115|NCT02352779|17470481|P3|Overall Study|Other Medical Reason|1
5063116|NCT02352779|17470482|P2|Overall Study|Other Medical Reason|0
5063117|NCT02352779|17470483|P1|Overall Study|Other Medical Reason|0
5063118|NCT02352779|17470481|P3|Overall Study|Absence of Symptoms|0
5063119|NCT02352779|17470482|P2|Overall Study|Absence of Symptoms|0
5063120|NCT02352779|17470483|P1|Overall Study|Absence of Symptoms|1
5063121|NCT02352779|17470481|P3|Overall Study|Study Related Symptoms|0
5063122|NCT02352779|17470482|P2|Overall Study|Study Related Symptoms|0
5063123|NCT02352779|17470483|P1|Overall Study|Study Related Symptoms|1
5063124|NCT02352779|17470481|P3|Overall Study|Changed Mind|0
5063125|NCT02352779|17470482|P2|Overall Study|Changed Mind|0
5063126|NCT02352779|17470483|P1|Overall Study|Changed Mind|1
5063127|NCT02352779|17470481|P3|Overall Study|Disliked Intervention|0
5063128|NCT02352779|17470482|P2|Overall Study|Disliked Intervention|0
5063129|NCT02352779|17470483|P1|Overall Study|Disliked Intervention|1
5063130|NCT02352779|17470481|P3|Overall Study|Feeling Overwhelmed|0
5063131|NCT02352779|17470482|P2|Overall Study|Feeling Overwhelmed|0
5063132|NCT02352779|17470483|P1|Overall Study|Feeling Overwhelmed|1
5063133|NCT02352779|17470481|P3|Overall Study|Too Many Forms|0
5063134|NCT02352779|17470482|P2|Overall Study|Too Many Forms|0
5063135|NCT02352779|17470483|P1|Overall Study|Too Many Forms|2
5063136|NCT02352779|17470481|P3|Overall Study|Personal Issues|0
5063137|NCT02352779|17470482|P2|Overall Study|Personal Issues|1
5063138|NCT02352779|17470483|P1|Overall Study|Personal Issues|1
5063139|NCT02352493|17470509|P18|Overall Study|Lost to Follow-up|0
5063140|NCT02352493|17470510|P17|Overall Study|Lost to Follow-up|0
5063141|NCT02352493|17470511|P16|Overall Study|Lost to Follow-up|0
5063142|NCT02352493|17470512|P15|Overall Study|Lost to Follow-up|0
5063143|NCT02352493|17470513|P14|Overall Study|Lost to Follow-up|2
5063144|NCT02352493|17470514|P13|Overall Study|Lost to Follow-up|1
5063145|NCT02352493|17470515|P12|Overall Study|Lost to Follow-up|0
5063146|NCT02352493|17470516|P11|Overall Study|Lost to Follow-up|0
5063147|NCT02352493|17470517|P10|Overall Study|Lost to Follow-up|1
5063148|NCT02352493|17470518|P9|Overall Study|Lost to Follow-up|0
5063149|NCT02352493|17470519|P8|Overall Study|Lost to Follow-up|0
5063150|NCT02352493|17470520|P7|Overall Study|Lost to Follow-up|0
5063151|NCT02352493|17470521|P6|Overall Study|Lost to Follow-up|0
5063152|NCT02352493|17470522|P5|Overall Study|Lost to Follow-up|0
5063153|NCT02352493|17470523|P4|Overall Study|Lost to Follow-up|0
5063154|NCT02352493|17470524|P3|Overall Study|Lost to Follow-up|0
5063155|NCT02352493|17470525|P2|Overall Study|Lost to Follow-up|0
5063156|NCT02352493|17470526|P1|Overall Study|Lost to Follow-up|0
5063157|NCT02352493|17470509|P18|Overall Study|Withdrawal by Subject|0
5063158|NCT02352493|17470510|P17|Overall Study|Withdrawal by Subject|0
5063159|NCT02352493|17470511|P16|Overall Study|Withdrawal by Subject|0
5063160|NCT02352493|17470512|P15|Overall Study|Withdrawal by Subject|1
5063161|NCT02352493|17470513|P14|Overall Study|Withdrawal by Subject|0
5063162|NCT02352493|17470514|P13|Overall Study|Withdrawal by Subject|0
5063163|NCT02352493|17470515|P12|Overall Study|Withdrawal by Subject|0
5063164|NCT02352493|17470516|P11|Overall Study|Withdrawal by Subject|0
5063165|NCT02352493|17470517|P10|Overall Study|Withdrawal by Subject|0
5063166|NCT02352493|17470518|P9|Overall Study|Withdrawal by Subject|1
5063167|NCT02352493|17470519|P8|Overall Study|Withdrawal by Subject|0
5063168|NCT02352493|17470520|P7|Overall Study|Withdrawal by Subject|0
5063169|NCT02352493|17470521|P6|Overall Study|Withdrawal by Subject|0
5063170|NCT02352493|17470522|P5|Overall Study|Withdrawal by Subject|0
5063171|NCT02352493|17470523|P4|Overall Study|Withdrawal by Subject|0
5063172|NCT02352493|17470524|P3|Overall Study|Withdrawal by Subject|0
5063173|NCT02352493|17470525|P2|Overall Study|Withdrawal by Subject|0
5063174|NCT02352493|17470526|P1|Overall Study|Withdrawal by Subject|0
5063175|NCT02352493|17470509|P18|Overall Study|Pregnancy|0
5063176|NCT02352493|17470510|P17|Overall Study|Pregnancy|0
5063177|NCT02352493|17470511|P16|Overall Study|Pregnancy|0
5063178|NCT02352493|17470512|P15|Overall Study|Pregnancy|0
5063179|NCT02352493|17470513|P14|Overall Study|Pregnancy|0
5063180|NCT02352493|17470514|P13|Overall Study|Pregnancy|0
5063181|NCT02352493|17470515|P12|Overall Study|Pregnancy|0
5063182|NCT02352493|17470516|P11|Overall Study|Pregnancy|0
5063183|NCT02352493|17470517|P10|Overall Study|Pregnancy|0
5063184|NCT02352493|17470518|P9|Overall Study|Pregnancy|1
5063185|NCT02352493|17470519|P8|Overall Study|Pregnancy|0
5063186|NCT02352493|17470520|P7|Overall Study|Pregnancy|1
5063187|NCT02352493|17470521|P6|Overall Study|Pregnancy|0
5063188|NCT02352493|17470522|P5|Overall Study|Pregnancy|0
5063189|NCT02352493|17470523|P4|Overall Study|Pregnancy|0
5063190|NCT02352493|17470524|P3|Overall Study|Pregnancy|0
5063191|NCT02352493|17470525|P2|Overall Study|Pregnancy|0
5063192|NCT02352493|17470526|P1|Overall Study|Pregnancy|0
5063193|NCT02351960|17470759|P2|Overall Study|Significant Protocol Deviation|5
5063194|NCT02351960|17470760|P1|Overall Study|Significant Protocol Deviation|0
5063195|NCT02351960|17470759|P2|Overall Study|Voluntary Withdrawal|4
5063196|NCT02351960|17470760|P1|Overall Study|Voluntary Withdrawal|5
5063197|NCT02351960|17470759|P2|Overall Study|Pretreatment Event/Adverse Event|3
5063198|NCT02351960|17470760|P1|Overall Study|Pretreatment Event/Adverse Event|6
5063199|NCT02351934|17470781|P2|Follow-Up|2 ERAS Components Noncompliant|4
5063200|NCT02351934|17470782|P1|Follow-Up|2 ERAS Components Noncompliant|0
5063201|NCT02351934|17470781|P2|Follow-Up|1 ERAS Component Noncompliant|6
5063202|NCT02351934|17470782|P1|Follow-Up|1 ERAS Component Noncompliant|0
5063203|NCT02351934|17470781|P2|Follow-Up|No documentation|0
5063204|NCT02351934|17470782|P1|Follow-Up|No documentation|2
5063205|NCT02351934|17470781|P2|Follow-Up|Hypotension|0
5063206|NCT02351934|17470782|P1|Follow-Up|Hypotension|3
5063207|NCT02351934|17470781|P2|Follow-Up|Early dismissal|0
5063208|NCT02351934|17470782|P1|Follow-Up|Early dismissal|3
5063209|NCT02351934|17470781|P2|Follow-Up|Acute Kidney Injury|0
5063210|NCT02351934|17470782|P1|Follow-Up|Acute Kidney Injury|1
5063211|NCT02351934|17470781|P2|Follow-Up|POD weight<pre-op weight|0
5063212|NCT02351934|17470782|P1|Follow-Up|POD weight<pre-op weight|3
5063213|NCT02351934|17470781|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
5063214|NCT02351934|17470782|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
5063215|NCT02351934|17470781|P2|Allocation|Hypotension preventing administration|0
5063216|NCT02351934|17470782|P1|Allocation|Hypotension preventing administration|2
5063217|NCT02351934|17470781|P2|Allocation|POD weight<pre-op weight|0
5063218|NCT02351934|17470782|P1|Allocation|POD weight<pre-op weight|3
5063219|NCT02351817|17470798|P2|Period 2|Protocol Violation|0
5063220|NCT02351817|17470799|P1|Period 2|Protocol Violation|1
5063221|NCT02351817|17470798|P2|Period 2|Adverse Event|2
5063222|NCT02351817|17470799|P1|Period 2|Adverse Event|0
5063223|NCT02351817|17470798|P2|Period 1|Lack of Efficacy|1
5063224|NCT02351817|17470799|P1|Period 1|Lack of Efficacy|0
5063225|NCT02351817|17470798|P2|Period 1|Adverse Event|2
5063226|NCT02351817|17470799|P1|Period 1|Adverse Event|1
5063227|NCT02351167|17470860|P3|Overall Study|Withdrawal by Subject|21
5063228|NCT02351167|17470861|P2|Overall Study|Withdrawal by Subject|18
5063229|NCT02351167|17470862|P1|Overall Study|Withdrawal by Subject|19
5063230|NCT02350478|17471050|P2|Overall Study|Lost to Follow-up|1
5063231|NCT02350478|17471051|P1|Overall Study|Lost to Follow-up|5
5063232|NCT02350309|17471073|P6|Treatment Period 4 (2 Days)|Death in the Family|1
5063233|NCT02350309|17471074|P5|Treatment Period 4 (2 Days)|Death in the Family|0
5063234|NCT02350309|17471075|P4|Treatment Period 4 (2 Days)|Death in the Family|0
5063235|NCT02350309|17471076|P3|Treatment Period 4 (2 Days)|Death in the Family|0
5063236|NCT02350309|17471077|P2|Treatment Period 4 (2 Days)|Death in the Family|0
5063237|NCT02350309|17471078|P1|Treatment Period 4 (2 Days)|Death in the Family|0
5063238|NCT02350309|17471073|P6|Treatment Period 1 (2 Days)|Physician Decision|0
5063239|NCT02350309|17471074|P5|Treatment Period 1 (2 Days)|Physician Decision|0
5063240|NCT02350309|17471075|P4|Treatment Period 1 (2 Days)|Physician Decision|0
5063241|NCT02350309|17471076|P3|Treatment Period 1 (2 Days)|Physician Decision|1
5063242|NCT02350309|17471077|P2|Treatment Period 1 (2 Days)|Physician Decision|0
5063243|NCT02350309|17471078|P1|Treatment Period 1 (2 Days)|Physician Decision|0
5063244|NCT02350127|17471119|P2|8-Month Assessment|Withdrawal by Subject|8
5063245|NCT02350127|17471120|P1|8-Month Assessment|Withdrawal by Subject|5
5063246|NCT02350127|17471119|P2|8-Month Assessment|Death|1
5063247|NCT02350127|17471120|P1|8-Month Assessment|Death|1
5063248|NCT02350127|17471119|P2|4-Month Assessment|Death|0
5063249|NCT02350127|17471120|P1|4-Month Assessment|Death|1
5063250|NCT02350127|17471119|P2|4-Month Assessment|Withdrawal by Subject|9
5063251|NCT02350127|17471120|P1|4-Month Assessment|Withdrawal by Subject|10
5063252|NCT02349789|17471159|P1|Overall Study|Withdrawal by Subject|2
5063253|NCT02349711|17471170|P2|Overall Study|Lost to Follow-up|1
5063254|NCT02349711|17471171|P1|Overall Study|Lost to Follow-up|1
5063255|NCT02349711|17471170|P2|Overall Study|Withdrawal by Subject|1
5063256|NCT02349711|17471171|P1|Overall Study|Withdrawal by Subject|2
5063257|NCT02349542|17471204|P1|Overall Study|Withdrawal by Subject|5
5063258|NCT02349451|17471228|P4|Overall Study|Withdrawal by Subject|1
5063259|NCT02349451|17471229|P3|Overall Study|Withdrawal by Subject|2
5063260|NCT02349451|17471230|P2|Overall Study|Withdrawal by Subject|1
5063261|NCT02349451|17471231|P1|Overall Study|Withdrawal by Subject|0
5063262|NCT02349425|17471282|P4|Period 2|Adverse Event|0
5063263|NCT02349425|17471283|P3|Period 2|Adverse Event|1
5063264|NCT02349425|17471284|P2|Period 2|Adverse Event|1
5063265|NCT02349425|17471285|P1|Period 2|Adverse Event|0
5063266|NCT02349425|17471282|P4|Period 1|Adverse Event|0
5063267|NCT02349425|17471283|P3|Period 1|Adverse Event|0
5063268|NCT02349425|17471284|P2|Period 1|Adverse Event|1
5063269|NCT02349425|17471285|P1|Period 1|Adverse Event|1
5063270|NCT02349412|17471459|P2|Overall Study|Withdrawal by Subject|7
5063271|NCT02349412|17471460|P1|Overall Study|Withdrawal by Subject|7
5063272|NCT02349360|17471476|P2|Overall Study|Withdrawal by Subject|1
5063273|NCT02349360|17471477|P1|Overall Study|Withdrawal by Subject|0
5063274|NCT02349295|17471488|P14|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063275|NCT02349295|17471489|P13|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063276|NCT02349295|17471490|P12|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
5063277|NCT02349295|17471491|P11|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063278|NCT02349295|17471492|P10|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063279|NCT02349295|17471493|P9|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063280|NCT02349295|17471494|P8|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063281|NCT02349295|17471495|P7|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063282|NCT02349295|17471496|P6|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063283|NCT02349295|17471497|P5|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063284|NCT02349295|17471498|P4|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063285|NCT02349295|17471499|P3|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063286|NCT02349295|17471500|P2|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063287|NCT02349295|17471501|P1|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5063288|NCT02349295|17471488|P14|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063289|NCT02349295|17471489|P13|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063290|NCT02349295|17471490|P12|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
5063291|NCT02349295|17471491|P11|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063292|NCT02349295|17471492|P10|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063293|NCT02349295|17471493|P9|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063294|NCT02349295|17471494|P8|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063295|NCT02349295|17471495|P7|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063296|NCT02349295|17471496|P6|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063297|NCT02349295|17471497|P5|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063298|NCT02349295|17471498|P4|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063299|NCT02349295|17471499|P3|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063300|NCT02349295|17471500|P2|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063301|NCT02349295|17471501|P1|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5063302|NCT02349295|17471488|P14|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063303|NCT02349295|17471489|P13|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
5063304|NCT02349295|17471490|P12|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
5063305|NCT02349295|17471491|P11|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063306|NCT02349295|17471492|P10|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063307|NCT02349295|17471493|P9|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063308|NCT02349295|17471494|P8|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063309|NCT02349295|17471495|P7|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063310|NCT02349295|17471496|P6|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063311|NCT02349295|17471497|P5|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063312|NCT02349295|17471498|P4|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063313|NCT02349295|17471499|P3|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063314|NCT02349295|17471500|P2|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063315|NCT02349295|17471501|P1|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5063316|NCT02349295|17471488|P14|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063317|NCT02349295|17471489|P13|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
5063318|NCT02349295|17471490|P12|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
5063319|NCT02349295|17471491|P11|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063320|NCT02349295|17471492|P10|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063321|NCT02349295|17471493|P9|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063322|NCT02349295|17471494|P8|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063323|NCT02349295|17471495|P7|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063324|NCT02349295|17471496|P6|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063325|NCT02349295|17471497|P5|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063326|NCT02349295|17471498|P4|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063327|NCT02349295|17471499|P3|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063328|NCT02349295|17471500|P2|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063329|NCT02349295|17471501|P1|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5063330|NCT02349295|17471488|P14|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
5063331|NCT02349295|17471489|P13|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
5063332|NCT02349295|17471490|P12|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
5063333|NCT02349295|17471491|P11|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063334|NCT02349295|17471492|P10|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063335|NCT02349295|17471493|P9|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063336|NCT02349295|17471494|P8|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063337|NCT02349295|17471495|P7|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063338|NCT02349295|17471496|P6|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063339|NCT02349295|17471497|P5|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063340|NCT02349295|17471498|P4|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063341|NCT02349295|17471499|P3|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063342|NCT02349295|17471500|P2|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063343|NCT02349295|17471501|P1|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5063344|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063345|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063346|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063347|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063348|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063349|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Physician Decision|2
5063350|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Physician Decision|2
5063351|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063352|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063353|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063354|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063355|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063356|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063357|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5063358|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063359|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063360|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063361|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063362|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063363|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
5063364|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
5063365|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063366|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063367|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063368|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063369|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063370|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063371|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5063372|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063373|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063374|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063375|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
5063376|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
5063377|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
5063378|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
5063379|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063380|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063381|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063382|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063383|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063384|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063385|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5063386|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Death|0
5063387|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Death|0
5063388|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Death|0
5063389|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Death|0
5063390|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Death|1
5063391|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Death|1
5063392|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Death|1
5063393|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Death|0
5063394|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Death|0
5063395|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Death|0
5063396|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Death|0
5063397|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Death|0
5063398|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Death|0
5063399|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Death|0
5063400|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063401|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063402|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063403|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063404|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
5063405|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063406|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
5063407|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063408|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063409|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063410|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063411|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063412|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063413|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5063414|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063415|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063416|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063417|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Adverse Event|2
5063418|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Adverse Event|2
5063419|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Adverse Event|9
5063420|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Adverse Event|9
5063421|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063422|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063423|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063424|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063425|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063426|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063427|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5063428|NCT02349295|17471488|P14|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063429|NCT02349295|17471489|P13|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063430|NCT02349295|17471490|P12|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063431|NCT02349295|17471491|P11|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
5063432|NCT02349295|17471492|P10|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
5063433|NCT02349295|17471493|P9|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
5063434|NCT02349295|17471494|P8|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
5063435|NCT02349295|17471495|P7|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063436|NCT02349295|17471496|P6|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063437|NCT02349295|17471497|P5|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063438|NCT02349295|17471498|P4|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063439|NCT02349295|17471499|P3|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063440|NCT02349295|17471500|P2|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063441|NCT02349295|17471501|P1|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5063442|NCT02349295|17471488|P14|IR (Week 16-24)|Lack of Efficacy|0
5063443|NCT02349295|17471489|P13|IR (Week 16-24)|Lack of Efficacy|0
5063444|NCT02349295|17471490|P12|IR (Week 16-24)|Lack of Efficacy|0
5063445|NCT02349295|17471491|P11|IR (Week 16-24)|Lack of Efficacy|0
5063446|NCT02349295|17471492|P10|IR (Week 16-24)|Lack of Efficacy|0
5063447|NCT02349295|17471493|P9|IR (Week 16-24)|Lack of Efficacy|0
5063448|NCT02349295|17471494|P8|IR (Week 16-24)|Lack of Efficacy|0
5063449|NCT02349295|17471495|P7|IR (Week 16-24)|Lack of Efficacy|0
5063450|NCT02349295|17471496|P6|IR (Week 16-24)|Lack of Efficacy|0
5063451|NCT02349295|17471497|P5|IR (Week 16-24)|Lack of Efficacy|0
5063452|NCT02349295|17471498|P4|IR (Week 16-24)|Lack of Efficacy|1
5063453|NCT02349295|17471499|P3|IR (Week 16-24)|Lack of Efficacy|0
5063454|NCT02349295|17471500|P2|IR (Week 16-24)|Lack of Efficacy|0
5063455|NCT02349295|17471501|P1|IR (Week 16-24)|Lack of Efficacy|0
5063456|NCT02349295|17471488|P14|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063457|NCT02349295|17471489|P13|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063458|NCT02349295|17471490|P12|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063459|NCT02349295|17471491|P11|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063614|NCT02347774|17472075|P1|On Study Treatment|ranomized in error|0
5063460|NCT02349295|17471492|P10|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063461|NCT02349295|17471493|P9|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063462|NCT02349295|17471494|P8|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063463|NCT02349295|17471495|P7|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063464|NCT02349295|17471496|P6|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063465|NCT02349295|17471497|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063466|NCT02349295|17471498|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063467|NCT02349295|17471499|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
5063468|NCT02349295|17471500|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
5063469|NCT02349295|17471501|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5063470|NCT02349295|17471488|P14|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063471|NCT02349295|17471489|P13|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063472|NCT02349295|17471490|P12|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063473|NCT02349295|17471491|P11|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063474|NCT02349295|17471492|P10|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063475|NCT02349295|17471493|P9|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063476|NCT02349295|17471494|P8|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063477|NCT02349295|17471495|P7|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063478|NCT02349295|17471496|P6|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063479|NCT02349295|17471497|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063480|NCT02349295|17471498|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5063481|NCT02349295|17471499|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
5063482|NCT02349295|17471500|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
5063483|NCT02349295|17471501|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
5063484|NCT02349295|17471488|P14|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063485|NCT02349295|17471489|P13|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063486|NCT02349295|17471490|P12|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063487|NCT02349295|17471491|P11|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063488|NCT02349295|17471492|P10|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063489|NCT02349295|17471493|P9|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063490|NCT02349295|17471494|P8|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063491|NCT02349295|17471495|P7|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063492|NCT02349295|17471496|P6|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063493|NCT02349295|17471497|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063494|NCT02349295|17471498|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5063495|NCT02349295|17471499|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
5063496|NCT02349295|17471500|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
5063497|NCT02349295|17471501|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
5063498|NCT02349295|17471488|P14|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063499|NCT02349295|17471489|P13|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063500|NCT02349295|17471490|P12|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063501|NCT02349295|17471491|P11|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063502|NCT02349295|17471492|P10|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063503|NCT02349295|17471493|P9|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063504|NCT02349295|17471494|P8|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063505|NCT02349295|17471495|P7|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063506|NCT02349295|17471496|P6|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063507|NCT02349295|17471497|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063508|NCT02349295|17471498|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5063509|NCT02349295|17471499|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
5063510|NCT02349295|17471500|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
5063511|NCT02349295|17471501|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
5063512|NCT02349295|17471488|P14|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063513|NCT02349295|17471489|P13|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063514|NCT02349295|17471490|P12|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063515|NCT02349295|17471491|P11|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063516|NCT02349295|17471492|P10|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063517|NCT02349295|17471493|P9|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063518|NCT02349295|17471494|P8|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063519|NCT02349295|17471495|P7|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063520|NCT02349295|17471496|P6|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063521|NCT02349295|17471497|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063522|NCT02349295|17471498|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
5063523|NCT02349295|17471499|P3|Double Blind Treatment (Week 0-24)|Adverse Event|5
5063524|NCT02349295|17471500|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
5063525|NCT02349295|17471501|P1|Double Blind Treatment (Week 0-24)|Adverse Event|7
5063526|NCT02349061|17471641|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
5063527|NCT02349061|17471642|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
5063528|NCT02349061|17471643|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
5063529|NCT02349061|17471641|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
5063530|NCT02349061|17471642|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
5063531|NCT02349061|17471643|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
5063532|NCT02349061|17471641|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
5063533|NCT02349061|17471642|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
5063534|NCT02349061|17471643|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
5063535|NCT02349061|17471641|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
5063536|NCT02349061|17471642|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
5063537|NCT02349061|17471643|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
5063538|NCT02349061|17471641|P3|Main Study: Week 24 to 56|Physician Decision|1
5063539|NCT02349061|17471642|P2|Main Study: Week 24 to 56|Physician Decision|0
5063540|NCT02349061|17471643|P1|Main Study: Week 24 to 56|Physician Decision|0
5063541|NCT02349061|17471641|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
5063542|NCT02349061|17471642|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
5063543|NCT02349061|17471643|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
5063544|NCT02349061|17471641|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
5063545|NCT02349061|17471642|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
5063546|NCT02349061|17471643|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
5063547|NCT02349061|17471641|P3|Main Study: Week 24 to 56|Adverse Event|1
5063548|NCT02349061|17471642|P2|Main Study: Week 24 to 56|Adverse Event|2
5063549|NCT02349061|17471643|P1|Main Study: Week 24 to 56|Adverse Event|0
5063550|NCT02349061|17471641|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
5063551|NCT02349061|17471642|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
5063552|NCT02349061|17471643|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
5063553|NCT02349061|17471641|P3|Main Study: PCP (Up to Week 24)|Other|0
5063554|NCT02349061|17471642|P2|Main Study: PCP (Up to Week 24)|Other|1
5063555|NCT02349061|17471643|P1|Main Study: PCP (Up to Week 24)|Other|1
5063556|NCT02349061|17471641|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
5063557|NCT02349061|17471642|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
5063558|NCT02349061|17471643|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
5063559|NCT02349061|17471641|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
5063560|NCT02349061|17471642|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
5063561|NCT02349061|17471643|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
5063562|NCT02349061|17471641|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
5063563|NCT02349061|17471642|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
5063564|NCT02349061|17471643|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
5063565|NCT02349048|17471663|P2|Overall Study|Lost to Follow-up|0
5063566|NCT02349048|17471664|P1|Overall Study|Lost to Follow-up|1
5063567|NCT02349048|17471663|P2|Overall Study|Withdrawal by Subject|0
5063568|NCT02349048|17471664|P1|Overall Study|Withdrawal by Subject|4
5063569|NCT02348840|17471725|P4|Overall Study|Withdrawal by Subject|0
5063570|NCT02348840|17471726|P3|Overall Study|Withdrawal by Subject|0
5063571|NCT02348840|17471727|P2|Overall Study|Withdrawal by Subject|1
5063572|NCT02348840|17471728|P1|Overall Study|Withdrawal by Subject|2
5063573|NCT02348723|17471742|P2|Overall Study|Adverse Event|1
5063574|NCT02348723|17471743|P1|Overall Study|Adverse Event|3
5063575|NCT02348723|17471742|P2|Overall Study|Reason other than specified|1
5063576|NCT02348723|17471743|P1|Overall Study|Reason other than specified|1
5063577|NCT02348723|17471742|P2|Overall Study|Consent withdrawn|3
5063578|NCT02348723|17471743|P1|Overall Study|Consent withdrawn|1
5063579|NCT02348723|17471742|P2|Overall Study|Lost to Follow-up|1
5063580|NCT02348723|17471743|P1|Overall Study|Lost to Follow-up|1
5063581|NCT02348723|17471742|P2|Overall Study|Non-compliant with Protocol|0
5063582|NCT02348723|17471743|P1|Overall Study|Non-compliant with Protocol|1
5063583|NCT02348723|17471742|P2|Overall Study|No ablation|20
5063584|NCT02348723|17471743|P1|Overall Study|No ablation|21
5063585|NCT02348008|17471969|P3|Overall Study|Symptomatic Deterioration|0
5063586|NCT02348008|17471970|P2|Overall Study|Symptomatic Deterioration|1
5063587|NCT02348008|17471971|P1|Overall Study|Symptomatic Deterioration|0
5063588|NCT02348008|17471969|P3|Overall Study|Withdrawal by Subject|0
5063589|NCT02348008|17471970|P2|Overall Study|Withdrawal by Subject|1
5063590|NCT02348008|17471971|P1|Overall Study|Withdrawal by Subject|0
5063591|NCT02348008|17471969|P3|Overall Study|Disease Progression|16
5063592|NCT02348008|17471970|P2|Overall Study|Disease Progression|5
5063593|NCT02348008|17471971|P1|Overall Study|Disease Progression|1
5063594|NCT02348008|17471969|P3|Overall Study|Adverse Event|3
5063595|NCT02348008|17471970|P2|Overall Study|Adverse Event|3
5063596|NCT02348008|17471971|P1|Overall Study|Adverse Event|2
5063597|NCT02347943|17471987|P3|Overall Study|Study was cancelled|45
5063598|NCT02347943|17471988|P2|Overall Study|Study was cancelled|67
5063599|NCT02347943|17471989|P1|Overall Study|Study was cancelled|140
5063600|NCT02347813|17471999|P2|First Intervention, 24 Weeks|Adverse Event|1
5063601|NCT02347813|17472000|P1|First Intervention, 24 Weeks|Adverse Event|1
5063602|NCT02347813|17471999|P2|First Intervention, 24 Weeks|Withdrawal by Subject|1
5063603|NCT02347813|17472000|P1|First Intervention, 24 Weeks|Withdrawal by Subject|1
5063604|NCT02347787|17472010|P2|9 Month Follow-Up|Withdrawal by Subject|12
5063605|NCT02347787|17472011|P1|9 Month Follow-Up|Withdrawal by Subject|9
5063606|NCT02347787|17472010|P2|9 Month Follow-Up|Lost to Follow-up|59
5063607|NCT02347787|17472011|P1|9 Month Follow-Up|Lost to Follow-up|52
5063608|NCT02347787|17472010|P2|6 Month Follow-Up|Withdrawal by Subject|9
5063609|NCT02347787|17472011|P1|6 Month Follow-Up|Withdrawal by Subject|3
5063610|NCT02347787|17472010|P2|6 Month Follow-Up|Lost to Follow-up|47
5063611|NCT02347787|17472011|P1|6 Month Follow-Up|Lost to Follow-up|63
5063612|NCT02347774|17472073|P3|On Study Treatment|ranomized in error|1
5063613|NCT02347774|17472074|P2|On Study Treatment|ranomized in error|0
5063615|NCT02347774|17472073|P3|On Study Treatment|Met Prolonged QT criteria|0
5063616|NCT02347774|17472074|P2|On Study Treatment|Met Prolonged QT criteria|0
5063617|NCT02347774|17472075|P1|On Study Treatment|Met Prolonged QT criteria|1
5063618|NCT02347774|17472073|P3|On Study Treatment|Lost to Follow-up|1
5063619|NCT02347774|17472074|P2|On Study Treatment|Lost to Follow-up|6
5063620|NCT02347774|17472075|P1|On Study Treatment|Lost to Follow-up|2
5063621|NCT02347774|17472073|P3|On Study Treatment|withdrew consent|12
5063622|NCT02347774|17472074|P2|On Study Treatment|withdrew consent|8
5063623|NCT02347774|17472075|P1|On Study Treatment|withdrew consent|9
5063624|NCT02347774|17472073|P3|On Study Treatment|Protocol Violation|1
5063625|NCT02347774|17472074|P2|On Study Treatment|Protocol Violation|0
5063626|NCT02347774|17472075|P1|On Study Treatment|Protocol Violation|0
5063627|NCT02347774|17472073|P3|On Study Treatment|non-complicance with study medication|0
5063628|NCT02347774|17472074|P2|On Study Treatment|non-complicance with study medication|2
5063629|NCT02347774|17472075|P1|On Study Treatment|non-complicance with study medication|0
5063630|NCT02347774|17472073|P3|On Study Treatment|Lack of Efficacy|2
5063631|NCT02347774|17472074|P2|On Study Treatment|Lack of Efficacy|0
5063632|NCT02347774|17472075|P1|On Study Treatment|Lack of Efficacy|3
5063633|NCT02347774|17472073|P3|On Study Treatment|Adverse Event|19
5063634|NCT02347774|17472074|P2|On Study Treatment|Adverse Event|15
5063635|NCT02347774|17472075|P1|On Study Treatment|Adverse Event|9
5063636|NCT02347774|17472073|P3|Study Participation|randomized in error|1
5063637|NCT02347774|17472074|P2|Study Participation|randomized in error|0
5063638|NCT02347774|17472075|P1|Study Participation|randomized in error|0
5063639|NCT02347774|17472073|P3|Study Participation|incarceration|0
5063640|NCT02347774|17472074|P2|Study Participation|incarceration|0
5063641|NCT02347774|17472075|P1|Study Participation|incarceration|1
5063642|NCT02347774|17472073|P3|Study Participation|non-compliance with study drug|0
5063643|NCT02347774|17472074|P2|Study Participation|non-compliance with study drug|1
5063644|NCT02347774|17472075|P1|Study Participation|non-compliance with study drug|0
5063645|NCT02347774|17472073|P3|Study Participation|Met Prolonged QT criteria|0
5063646|NCT02347774|17472074|P2|Study Participation|Met Prolonged QT criteria|0
5063647|NCT02347774|17472075|P1|Study Participation|Met Prolonged QT criteria|1
5063648|NCT02347774|17472073|P3|Study Participation|withdrew consent|1
5063649|NCT02347774|17472074|P2|Study Participation|withdrew consent|1
5063650|NCT02347774|17472075|P1|Study Participation|withdrew consent|1
5063651|NCT02347774|17472073|P3|Study Participation|Adverse Event|6
5063652|NCT02347774|17472074|P2|Study Participation|Adverse Event|4
5063653|NCT02347774|17472075|P1|Study Participation|Adverse Event|1
5063654|NCT02347774|17472073|P3|Study Participation|Withdrawal by Subject|15
5063655|NCT02347774|17472074|P2|Study Participation|Withdrawal by Subject|9
5063656|NCT02347774|17472075|P1|Study Participation|Withdrawal by Subject|8
5063657|NCT02347774|17472073|P3|Study Participation|Lost to Follow-up|2
5063658|NCT02347774|17472074|P2|Study Participation|Lost to Follow-up|6
5063659|NCT02347774|17472075|P1|Study Participation|Lost to Follow-up|3
5063660|NCT02347761|17472131|P3|On Study Treatment|Adverse Event|20
5063661|NCT02347761|17472132|P2|On Study Treatment|Adverse Event|8
5063662|NCT02347761|17472133|P1|On Study Treatment|Adverse Event|10
5063663|NCT02347761|17472131|P3|On Study Treatment|durg not working|1
5063664|NCT02347761|17472132|P2|On Study Treatment|durg not working|1
5063665|NCT02347761|17472133|P1|On Study Treatment|durg not working|0
5063666|NCT02347761|17472131|P3|On Study Treatment|investigator discretion|0
5063667|NCT02347761|17472132|P2|On Study Treatment|investigator discretion|0
5063668|NCT02347761|17472133|P1|On Study Treatment|investigator discretion|2
5063669|NCT02347761|17472131|P3|On Study Treatment|Lost to Follow-up|1
5063670|NCT02347761|17472132|P2|On Study Treatment|Lost to Follow-up|1
5063671|NCT02347761|17472133|P1|On Study Treatment|Lost to Follow-up|2
5063672|NCT02347761|17472131|P3|On Study Treatment|dissastisfaction with device|4
5063673|NCT02347761|17472132|P2|On Study Treatment|dissastisfaction with device|1
5063674|NCT02347761|17472133|P1|On Study Treatment|dissastisfaction with device|2
5063675|NCT02347761|17472131|P3|On Study Treatment|move/travel|5
5063676|NCT02347761|17472132|P2|On Study Treatment|move/travel|6
5063677|NCT02347761|17472133|P1|On Study Treatment|move/travel|2
5063678|NCT02347761|17472131|P3|On Study Treatment|Withdrawal by Subject|5
5063679|NCT02347761|17472132|P2|On Study Treatment|Withdrawal by Subject|3
5063680|NCT02347761|17472133|P1|On Study Treatment|Withdrawal by Subject|7
5063681|NCT02347761|17472131|P3|On Study Treatment|non-compliance with study medication|2
5063682|NCT02347761|17472132|P2|On Study Treatment|non-compliance with study medication|0
5063683|NCT02347761|17472133|P1|On Study Treatment|non-compliance with study medication|0
5063684|NCT02347761|17472131|P3|On Study Treatment|Lack of Efficacy|4
5063685|NCT02347761|17472132|P2|On Study Treatment|Lack of Efficacy|3
5063686|NCT02347761|17472133|P1|On Study Treatment|Lack of Efficacy|2
5063687|NCT02347761|17472131|P3|All Collected|moved/travel|0
5063688|NCT02347761|17472132|P2|All Collected|moved/travel|1
5063689|NCT02347761|17472133|P1|All Collected|moved/travel|0
5063690|NCT02347761|17472131|P3|All Collected|exacerbation of COPD|1
5063691|NCT02347761|17472132|P2|All Collected|exacerbation of COPD|0
5063692|NCT02347761|17472133|P1|All Collected|exacerbation of COPD|0
5063693|NCT02347761|17472131|P3|All Collected|instillation site pain|1
5063694|NCT02347761|17472132|P2|All Collected|instillation site pain|0
5063695|NCT02347761|17472133|P1|All Collected|instillation site pain|0
5063696|NCT02347761|17472131|P3|All Collected|invetigator disretion|0
5063697|NCT02347761|17472132|P2|All Collected|invetigator disretion|0
5063698|NCT02347761|17472133|P1|All Collected|invetigator disretion|2
5063699|NCT02347761|17472131|P3|All Collected|Withdrawal by Subject|22
5063700|NCT02347761|17472132|P2|All Collected|Withdrawal by Subject|11
5063701|NCT02347761|17472133|P1|All Collected|Withdrawal by Subject|11
5063702|NCT02347761|17472131|P3|All Collected|Lost to Follow-up|3
5063703|NCT02347761|17472132|P2|All Collected|Lost to Follow-up|2
5063704|NCT02347761|17472133|P1|All Collected|Lost to Follow-up|3
5063705|NCT02347761|17472131|P3|All Collected|Death|0
5063706|NCT02347761|17472132|P2|All Collected|Death|0
5063707|NCT02347761|17472133|P1|All Collected|Death|1
5063708|NCT02347657|17472194|P2|Overall Study|Other|3
5063709|NCT02347657|17472195|P1|Overall Study|Other|3
5063710|NCT02347657|17472194|P2|Overall Study|Randomized but not treated|0
5063711|NCT02347657|17472195|P1|Overall Study|Randomized but not treated|1
5063712|NCT02347657|17472194|P2|Overall Study|Withdrawal by Subject|7
5063713|NCT02347657|17472195|P1|Overall Study|Withdrawal by Subject|6
5063714|NCT02347657|17472194|P2|Overall Study|Adverse Event|4
5063715|NCT02347657|17472195|P1|Overall Study|Adverse Event|8
5063716|NCT02347657|17472194|P2|Overall Study|Physician Decision|1
5063717|NCT02347657|17472195|P1|Overall Study|Physician Decision|0
5063718|NCT02347332|17472273|P2|Overall Study|Switch Post-Trial program|1
5063719|NCT02347332|17472274|P1|Overall Study|Switch Post-Trial program|0
5063720|NCT02347332|17472273|P2|Overall Study|Protocol requirement|1
5063721|NCT02347332|17472274|P1|Overall Study|Protocol requirement|1
5063722|NCT02347332|17472273|P2|Overall Study|Withdrawal by Subject|14
5063723|NCT02347332|17472274|P1|Overall Study|Withdrawal by Subject|20
5063724|NCT02347332|17472273|P2|Overall Study|Physician Decision|3
5063725|NCT02347332|17472274|P1|Overall Study|Physician Decision|4
5063726|NCT02347332|17472273|P2|Overall Study|Lost to Follow-up|1
5063727|NCT02347332|17472274|P1|Overall Study|Lost to Follow-up|2
5063728|NCT02347332|17472273|P2|Overall Study|Protocol Violation|1
5063729|NCT02347332|17472274|P1|Overall Study|Protocol Violation|1
5063730|NCT02347332|17472273|P2|Overall Study|Death (Unknown, Various reasons)|6
5063731|NCT02347332|17472274|P1|Overall Study|Death (Unknown, Various reasons)|6
5063732|NCT02347332|17472273|P2|Overall Study|Adverse Event|41
5063733|NCT02347332|17472274|P1|Overall Study|Adverse Event|50
5063734|NCT02347332|17472273|P2|Overall Study|Progressive disease|159
5063735|NCT02347332|17472274|P1|Overall Study|Progressive disease|141
5063736|NCT02347332|17472273|P2|Overall Study|Not treated|2
5063737|NCT02347332|17472274|P1|Overall Study|Not treated|5
5063738|NCT02347189|17472288|P1|Overall Study|No primary outcome data available|2
5063739|NCT02347189|17472288|P1|Overall Study|No implant attempted of study device|9
5063740|NCT02347176|17472307|P4|Overall Study|Other|0
5063741|NCT02347176|17472308|P3|Overall Study|Other|2
5063742|NCT02347176|17472309|P2|Overall Study|Other|2
5063743|NCT02347176|17472310|P1|Overall Study|Other|1
5063744|NCT02347176|17472307|P4|Overall Study|Withdrawal by Subject|3
5063745|NCT02347176|17472308|P3|Overall Study|Withdrawal by Subject|5
5063746|NCT02347176|17472309|P2|Overall Study|Withdrawal by Subject|5
5063747|NCT02347176|17472310|P1|Overall Study|Withdrawal by Subject|9
5063748|NCT02347176|17472307|P4|Overall Study|Lost to Follow-up|1
5063749|NCT02347176|17472308|P3|Overall Study|Lost to Follow-up|1
5063750|NCT02347176|17472309|P2|Overall Study|Lost to Follow-up|3
5063751|NCT02347176|17472310|P1|Overall Study|Lost to Follow-up|2
5063752|NCT02347098|17472395|P2|Overall Study|no visit due to illness|1
5063753|NCT02347098|17472396|P1|Overall Study|no visit due to illness|2
5063754|NCT02347098|17472395|P2|Overall Study|Refuse Follow-up Visit|5
5063755|NCT02347098|17472396|P1|Overall Study|Refuse Follow-up Visit|1
5063756|NCT02347098|17472395|P2|Overall Study|Lost to Follow-up|2
5063757|NCT02347098|17472396|P1|Overall Study|Lost to Follow-up|2
5063758|NCT02347098|17472395|P2|Overall Study|Withdrawal by Subject|0
5063759|NCT02347098|17472396|P1|Overall Study|Withdrawal by Subject|1
5063760|NCT02347098|17472395|P2|Overall Study|Death|0
5063761|NCT02347098|17472396|P1|Overall Study|Death|1
5063762|NCT02347085|17472408|P1|Overall Study|Protocol Criteria|2
5063763|NCT02347085|17472408|P1|Overall Study|Lost to Follow-up|1
5063764|NCT02347085|17472408|P1|Overall Study|Withdrawal by Subject|4
5063765|NCT02347085|17472408|P1|Overall Study|Lack of Efficacy|1
5063766|NCT02347085|17472408|P1|Overall Study|Adverse Event|2
5063767|NCT02347072|17472430|P1|Overall Study|Disc due to Protocol-specified Criteria|6
5063768|NCT02347072|17472430|P1|Overall Study|Protocol Violation|1
5063769|NCT02347072|17472430|P1|Overall Study|Lost to Follow-up|2
5063770|NCT02347072|17472430|P1|Overall Study|Physician Decision|1
5063771|NCT02347072|17472430|P1|Overall Study|Withdrawal by Subject|6
5063772|NCT02347072|17472430|P1|Overall Study|Adverse Event|2
5063773|NCT02346877|17472464|P2|Overall Study|Missing|0
5063774|NCT02346877|17472465|P1|Overall Study|Missing|5
5063775|NCT02346877|17472464|P2|Overall Study|Sponsor Decision|0
5063776|NCT02346877|17472465|P1|Overall Study|Sponsor Decision|12
5063777|NCT02346877|17472464|P2|Overall Study|Administrative Decision|0
5063778|NCT02346877|17472465|P1|Overall Study|Administrative Decision|1
5063779|NCT02346877|17472464|P2|Overall Study|Adverse Event|0
5063780|NCT02346877|17472465|P1|Overall Study|Adverse Event|1
5063781|NCT02346721|17472475|P1|Overall Study|Lack of Efficacy|1
5063782|NCT02346721|17472475|P1|Overall Study|Withdrew Consent|3
5063783|NCT02346370|17472514|P3|Overall Study|Physician Decision|0
5063784|NCT02346370|17472515|P2|Overall Study|Physician Decision|1
5063785|NCT02346370|17472516|P1|Overall Study|Physician Decision|0
5063786|NCT02346370|17472514|P3|Overall Study|Radiologic progression|1
5063787|NCT02346370|17472515|P2|Overall Study|Radiologic progression|0
5063788|NCT02346370|17472516|P1|Overall Study|Radiologic progression|0
5063789|NCT02346370|17472514|P3|Overall Study|Sponsor discontinued study|2
5063790|NCT02346370|17472515|P2|Overall Study|Sponsor discontinued study|0
5063791|NCT02346370|17472516|P1|Overall Study|Sponsor discontinued study|5
5063792|NCT02346370|17472514|P3|Overall Study|Death|1
5063793|NCT02346370|17472515|P2|Overall Study|Death|3
5063794|NCT02346370|17472516|P1|Overall Study|Death|1
5063795|NCT02346370|17472514|P3|Overall Study|Withdrawal of consent|0
5063796|NCT02346370|17472515|P2|Overall Study|Withdrawal of consent|0
5063797|NCT02346370|17472516|P1|Overall Study|Withdrawal of consent|1
5063798|NCT02346370|17472514|P3|Overall Study|Not treated|0
5063799|NCT02346370|17472515|P2|Overall Study|Not treated|0
5063800|NCT02346370|17472516|P1|Overall Study|Not treated|1
5063801|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063802|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063803|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063804|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063805|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063806|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
5063807|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063808|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063809|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063810|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063811|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063812|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063813|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063814|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063815|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063816|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063817|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063818|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063819|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063820|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063821|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063822|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063823|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063824|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5063825|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
5063826|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
5063827|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
5063828|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063829|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063830|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
5063831|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063832|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063833|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063834|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063835|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063836|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063837|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063838|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063839|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063840|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063841|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063842|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063843|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063844|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063845|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063846|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063847|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063848|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5063849|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5063850|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5063851|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
5063852|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063853|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5063854|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
5063855|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063856|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063857|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063858|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063859|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063860|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063861|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063862|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063863|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063864|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063865|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063866|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063867|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063868|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063869|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063870|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063871|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063872|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5063873|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5063874|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5063875|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5063876|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063877|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
5063878|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
5063879|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
5063880|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063881|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063882|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063883|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063884|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063885|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063886|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063887|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063888|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063889|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063890|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063891|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063892|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063893|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063894|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063895|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063896|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5063897|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063898|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063899|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
5063900|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063901|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063902|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063903|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063904|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063905|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063906|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063907|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063908|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063909|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063910|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063911|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063912|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063913|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063914|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063915|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063916|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063917|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063918|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063919|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063920|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5063921|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063922|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063923|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
5063924|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063925|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063926|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
5063927|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063928|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063929|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063930|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063931|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063932|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063933|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063934|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063935|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063936|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063937|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063938|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063939|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063940|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063941|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063942|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063943|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063944|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5063945|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|Death|0
5063946|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|Death|0
5063947|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|Death|1
5063948|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|Death|0
5063949|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|Death|1
5063950|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|Death|1
5063951|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|Death|0
5063952|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|Death|0
5063953|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|Death|0
5063954|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|Death|0
5063955|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|Death|0
5063956|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|Death|0
5063957|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|Death|0
5063958|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|Death|0
5063959|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|Death|0
5063960|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|Death|0
5063961|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|Death|0
5063962|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|Death|0
5063963|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|Death|0
5063964|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|Death|0
5063965|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|Death|0
5063966|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|Death|0
5063967|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|Death|0
5063968|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|Death|0
5063969|NCT02346240|17472565|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5063970|NCT02346240|17472566|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5063971|NCT02346240|17472567|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
5063972|NCT02346240|17472568|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5063973|NCT02346240|17472569|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
5063974|NCT02346240|17472570|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
5063975|NCT02346240|17472571|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
5063976|NCT02346240|17472572|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063977|NCT02346240|17472573|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063978|NCT02346240|17472574|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063979|NCT02346240|17472575|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063980|NCT02346240|17472576|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063981|NCT02346240|17472577|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063982|NCT02346240|17472578|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063983|NCT02346240|17472579|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063984|NCT02346240|17472580|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063985|NCT02346240|17472581|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063986|NCT02346240|17472582|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063987|NCT02346240|17472583|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063988|NCT02346240|17472584|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063989|NCT02346240|17472585|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063990|NCT02346240|17472586|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063991|NCT02346240|17472587|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063992|NCT02346240|17472588|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5063993|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5063994|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5063995|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5063996|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5063997|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5063998|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5063999|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064000|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064001|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064002|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
5064003|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064004|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064005|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064006|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064007|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064008|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064009|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064010|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064011|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064012|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064013|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064014|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064015|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064016|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5064017|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064018|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064019|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064020|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064021|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064022|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064023|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064024|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064025|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064026|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
5064027|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064028|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064029|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064030|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064031|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064032|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064033|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064034|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064035|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064036|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064037|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064038|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064039|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064040|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5064041|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064042|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064043|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064044|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064045|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064046|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064047|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064048|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064049|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064050|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
5064051|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064052|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064053|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064054|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064055|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064056|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064057|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064058|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064059|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064060|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064061|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064062|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064063|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064064|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5064065|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064066|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064067|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064068|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064069|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064070|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064071|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064072|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064073|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064074|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064075|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064076|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064077|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064078|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
5064079|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064080|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064081|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064082|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064083|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064084|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064085|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064086|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064087|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064088|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5064089|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064090|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064091|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064092|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064093|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064094|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064095|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064096|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064097|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064098|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064099|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064100|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064101|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064102|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064103|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
5064104|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064105|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064106|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064107|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064108|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064109|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064110|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064111|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064112|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5064113|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064114|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064115|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064116|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064117|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064118|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064119|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064120|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064121|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064122|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5064123|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5064124|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064125|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5064126|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064127|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064128|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5064129|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064130|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064131|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064132|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064133|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064134|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064135|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064136|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5064137|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064138|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064139|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064140|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064141|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064142|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064143|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064144|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064145|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064146|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064147|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064148|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064149|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064150|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064151|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064152|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064153|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064154|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
5064155|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064156|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064157|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064158|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064159|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064160|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5064161|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064162|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064163|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064164|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064165|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064166|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064167|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064168|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
5064169|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
5064170|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
5064171|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
5064172|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064173|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064174|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064175|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064176|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064177|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064178|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064179|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064180|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064181|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064182|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064183|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064184|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5064185|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064186|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064187|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064188|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064189|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064190|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064191|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064192|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5064193|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5064194|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
5064195|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5064196|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064197|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5064198|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5064199|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064200|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5064201|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5064202|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5064203|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5064204|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064205|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064206|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064207|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064208|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5064209|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064210|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064211|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064212|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064213|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064214|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064215|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064216|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064217|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064218|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
5064219|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064220|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064221|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064222|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064223|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064224|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064225|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064226|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064227|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064228|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064229|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064230|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064231|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064232|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5064233|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064234|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064235|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064236|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064237|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064238|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064239|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064240|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064241|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
5064242|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064243|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5064244|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064245|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064246|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064247|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064248|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064249|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064250|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064251|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064252|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064253|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064254|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064255|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064256|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5064257|NCT02346240|17472565|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064258|NCT02346240|17472566|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064259|NCT02346240|17472567|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064260|NCT02346240|17472568|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064261|NCT02346240|17472569|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064262|NCT02346240|17472570|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064263|NCT02346240|17472571|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064264|NCT02346240|17472572|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5064265|NCT02346240|17472573|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5064266|NCT02346240|17472574|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
5064267|NCT02346240|17472575|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5064268|NCT02346240|17472576|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064269|NCT02346240|17472577|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064270|NCT02346240|17472578|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064271|NCT02346240|17472579|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064272|NCT02346240|17472580|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5064273|NCT02346240|17472581|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5064274|NCT02346240|17472582|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064275|NCT02346240|17472583|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064276|NCT02346240|17472584|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064277|NCT02346240|17472585|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064278|NCT02346240|17472586|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064279|NCT02346240|17472587|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064280|NCT02346240|17472588|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5064281|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064282|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064283|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064284|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064285|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064286|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064287|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064288|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064289|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064290|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064291|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064292|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064293|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064294|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064295|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064296|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064297|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064298|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064299|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064300|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064301|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064302|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
5064303|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064304|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5064305|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
5064306|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
5064307|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
5064308|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
5064309|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
5064310|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
5064311|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
5064312|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
5064313|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
5064314|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
5064315|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
5064316|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
5064317|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
5064318|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
5064319|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
5064320|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
5064321|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
5064322|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
5064323|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
5064324|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
5064325|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
5064326|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
5064327|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
5064328|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
5064329|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064330|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064331|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064332|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064333|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064334|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064335|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064336|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064337|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064338|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064339|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064340|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064341|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064342|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064343|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064344|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064345|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064346|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064347|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064348|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5064349|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
5064350|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
5064351|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
5064352|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
5064353|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064354|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064355|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064356|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064357|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064358|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064359|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064360|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064361|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064362|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064363|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064364|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064365|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064366|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064367|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064368|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064369|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064370|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064371|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064372|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5064373|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
5064374|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
5064375|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
5064376|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
5064377|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064378|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064379|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064380|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064381|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064382|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064383|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064384|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064385|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064386|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064387|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064388|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064389|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064390|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064391|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064392|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064393|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064394|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064395|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064396|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064397|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064398|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064399|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
5064400|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
5064401|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064402|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064403|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064404|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064405|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064406|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064407|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064408|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064409|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064410|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064411|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064412|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064413|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064414|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064415|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064416|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064417|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064418|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064419|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064420|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064421|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064422|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064423|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
5064424|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5064425|NCT02346240|17472565|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
5064426|NCT02346240|17472566|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
5064427|NCT02346240|17472567|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
5064428|NCT02346240|17472568|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
5064429|NCT02346240|17472569|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
5064430|NCT02346240|17472570|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
5064431|NCT02346240|17472571|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
5064432|NCT02346240|17472572|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
5064433|NCT02346240|17472573|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
5064434|NCT02346240|17472574|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
5064435|NCT02346240|17472575|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
5064436|NCT02346240|17472576|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
5064437|NCT02346240|17472577|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
5064438|NCT02346240|17472578|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
5064439|NCT02346240|17472579|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
5064440|NCT02346240|17472580|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
5064441|NCT02346240|17472581|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
5064442|NCT02346240|17472582|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
5064443|NCT02346240|17472583|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
5064444|NCT02346240|17472584|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
5064445|NCT02346240|17472585|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
5064446|NCT02346240|17472586|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
5064447|NCT02346240|17472587|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
5064448|NCT02346240|17472588|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
5064449|NCT02346136|17472627|P2|Overall Study|Study termination|18
5064450|NCT02346136|17472628|P1|Overall Study|Study termination|14
5064451|NCT02346136|17472627|P2|Overall Study|Death|0
5064452|NCT02346136|17472628|P1|Overall Study|Death|1
5064453|NCT02346136|17472627|P2|Overall Study|Withdrawal by Subject|5
5064454|NCT02346136|17472628|P1|Overall Study|Withdrawal by Subject|7
5064455|NCT02345889|17472664|P4|Overall Study|Cecum not intubated|0
5064456|NCT02345889|17472665|P3|Overall Study|Cecum not intubated|0
5064457|NCT02345889|17472666|P2|Overall Study|Cecum not intubated|0
5064458|NCT02345889|17472667|P1|Overall Study|Cecum not intubated|1
5064459|NCT02345889|17472664|P4|Overall Study|Ulcerative Colitis identified|0
5064460|NCT02345889|17472665|P3|Overall Study|Ulcerative Colitis identified|0
5064461|NCT02345889|17472666|P2|Overall Study|Ulcerative Colitis identified|0
5064462|NCT02345889|17472667|P1|Overall Study|Ulcerative Colitis identified|1
5064463|NCT02345889|17472664|P4|Overall Study|Recognized ineligible post-randomization|1
5064464|NCT02345889|17472665|P3|Overall Study|Recognized ineligible post-randomization|2
5064465|NCT02345889|17472666|P2|Overall Study|Recognized ineligible post-randomization|0
5064466|NCT02345889|17472667|P1|Overall Study|Recognized ineligible post-randomization|1
5064467|NCT02345889|17472664|P4|Overall Study|Polyposis identified during procedure|1
5064468|NCT02345889|17472665|P3|Overall Study|Polyposis identified during procedure|0
5064469|NCT02345889|17472666|P2|Overall Study|Polyposis identified during procedure|1
5064470|NCT02345889|17472667|P1|Overall Study|Polyposis identified during procedure|1
5064471|NCT02345889|17472664|P4|Overall Study|Inadequate Bowel Prep|14
5064472|NCT02345889|17472665|P3|Overall Study|Inadequate Bowel Prep|18
5064473|NCT02345889|17472666|P2|Overall Study|Inadequate Bowel Prep|16
5064474|NCT02345889|17472667|P1|Overall Study|Inadequate Bowel Prep|17
5064475|NCT02345811|17472733|P2|First Intervention|Withdrawal by Subject|1
5064476|NCT02345811|17472734|P1|First Intervention|Withdrawal by Subject|1
5064477|NCT02345512|17472785|P1|Overall Study|Withdrawal by Subject|1
5064478|NCT02345512|17472785|P1|Overall Study|Adverse Event|1
5064479|NCT02345330|17472879|P1|Overall Study|Progressive Disease|2
5064480|NCT02345330|17472879|P1|Overall Study|Death|1
5064481|NCT02345252|17472891|P2|Double-Blind Phase|Randomized but Never Treated|2
5064482|NCT02345252|17472892|P1|Double-Blind Phase|Randomized but Never Treated|0
5064483|NCT02345252|17472891|P2|Double-Blind Phase|Lost to Follow-up|10
5064484|NCT02345252|17472892|P1|Double-Blind Phase|Lost to Follow-up|8
5064485|NCT02345252|17472891|P2|Double-Blind Phase|Withdrew Consent|23
5064486|NCT02345252|17472892|P1|Double-Blind Phase|Withdrew Consent|21
5064487|NCT02345252|17472891|P2|Double-Blind Phase|Protocol Violation|1
5064488|NCT02345252|17472892|P1|Double-Blind Phase|Protocol Violation|2
5064489|NCT02345252|17472891|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
5064490|NCT02345252|17472892|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5064491|NCT02345252|17472891|P2|Double-Blind Phase|Investigator's Discretion|6
5064492|NCT02345252|17472892|P1|Double-Blind Phase|Investigator's Discretion|4
5064493|NCT02345252|17472891|P2|Double-Blind Phase|Lack of Efficacy|0
5064494|NCT02345252|17472892|P1|Double-Blind Phase|Lack of Efficacy|1
5064495|NCT02345252|17472891|P2|Double-Blind Phase|Death|2
5064496|NCT02345252|17472892|P1|Double-Blind Phase|Death|1
5064497|NCT02345252|17472891|P2|Double-Blind Phase|Adverse Event|3
5064498|NCT02345252|17472892|P1|Double-Blind Phase|Adverse Event|2
5064499|NCT02345226|17472920|P2|Open-Label Extension Phase|Lost to Follow-up|1
5064500|NCT02345226|17472921|P1|Open-Label Extension Phase|Lost to Follow-up|0
5064501|NCT02345226|17472920|P2|Double-Blind Phase|Randomized but Never Treated|4
5064502|NCT02345226|17472921|P1|Double-Blind Phase|Randomized but Never Treated|2
5064503|NCT02345226|17472920|P2|Double-Blind Phase|Lost to Follow-up|16
5064504|NCT02345226|17472921|P1|Double-Blind Phase|Lost to Follow-up|12
5064505|NCT02345226|17472920|P2|Double-Blind Phase|Withdrew Consent|39
5064506|NCT02345226|17472921|P1|Double-Blind Phase|Withdrew Consent|41
5064507|NCT02345226|17472920|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
5064508|NCT02345226|17472921|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5064509|NCT02345226|17472920|P2|Double-Blind Phase|Investigator's Discretion|3
5064510|NCT02345226|17472921|P1|Double-Blind Phase|Investigator's Discretion|4
5064511|NCT02345226|17472920|P2|Double-Blind Phase|Lack of Efficacy|0
5064512|NCT02345226|17472921|P1|Double-Blind Phase|Lack of Efficacy|1
5064513|NCT02345226|17472920|P2|Double-Blind Phase|Pregnancy|1
5064514|NCT02345226|17472921|P1|Double-Blind Phase|Pregnancy|0
5064515|NCT02345226|17472920|P2|Double-Blind Phase|Death|0
5064516|NCT02345226|17472921|P1|Double-Blind Phase|Death|3
5064517|NCT02345226|17472920|P2|Double-Blind Phase|Adverse Event|6
5064518|NCT02345226|17472921|P1|Double-Blind Phase|Adverse Event|5
5064519|NCT02345161|17472953|P2|Overall Study|Lost to Follow-up|1
5064520|NCT02345161|17472954|P1|Overall Study|Lost to Follow-up|0
5064521|NCT02345161|17472953|P2|Overall Study|Physician Decision|4
5064522|NCT02345161|17472954|P1|Overall Study|Physician Decision|4
5064523|NCT02345161|17472953|P2|Overall Study|Adverse Event|19
5064524|NCT02345161|17472954|P1|Overall Study|Adverse Event|16
5064525|NCT02345161|17472953|P2|Overall Study|Withdrawal by Subject|33
5064526|NCT02345161|17472954|P1|Overall Study|Withdrawal by Subject|25
5064527|NCT02345070|17473059|P3|Overall Study|Other than specified above|7
5064528|NCT02345070|17473060|P2|Overall Study|Other than specified above|3
5064529|NCT02345070|17473061|P1|Overall Study|Other than specified above|6
5064530|NCT02345070|17473059|P3|Overall Study|Poor compliance to protocol|0
5064531|NCT02345070|17473060|P2|Overall Study|Poor compliance to protocol|0
5064532|NCT02345070|17473061|P1|Overall Study|Poor compliance to protocol|2
5064533|NCT02345070|17473059|P3|Overall Study|Adverse Event|16
5064534|NCT02345070|17473060|P2|Overall Study|Adverse Event|8
5064535|NCT02345070|17473061|P1|Overall Study|Adverse Event|12
5064536|NCT02344745|17473094|P2|Overall Study|Data collection sheets were lost|0
5064537|NCT02344745|17473095|P1|Overall Study|Data collection sheets were lost|2
5064538|NCT02344576|17473124|P4|6-Month Follow-Up|Lost to Follow-up|6
5064539|NCT02344576|17473125|P3|6-Month Follow-Up|Lost to Follow-up|13
5064540|NCT02344576|17473126|P2|6-Month Follow-Up|Lost to Follow-up|5
5064541|NCT02344576|17473127|P1|6-Month Follow-Up|Lost to Follow-up|4
5064542|NCT02344576|17473124|P4|6-Month Follow-Up|Withdrawal by Subject|2
5064543|NCT02344576|17473125|P3|6-Month Follow-Up|Withdrawal by Subject|1
5064544|NCT02344576|17473126|P2|6-Month Follow-Up|Withdrawal by Subject|0
5064545|NCT02344576|17473127|P1|6-Month Follow-Up|Withdrawal by Subject|1
5064546|NCT02344576|17473124|P4|6-Month Follow-Up|Death|0
5064547|NCT02344576|17473125|P3|6-Month Follow-Up|Death|0
5064548|NCT02344576|17473126|P2|6-Month Follow-Up|Death|14
5064549|NCT02344576|17473127|P1|6-Month Follow-Up|Death|14
5064550|NCT02344576|17473124|P4|1-Month Follow-Up|Lost to Follow-up|3
5064551|NCT02344576|17473125|P3|1-Month Follow-Up|Lost to Follow-up|11
5064552|NCT02344576|17473126|P2|1-Month Follow-Up|Lost to Follow-up|5
5064553|NCT02344576|17473127|P1|1-Month Follow-Up|Lost to Follow-up|2
5064554|NCT02344576|17473124|P4|1-Month Follow-Up|Withdrawal by Subject|10
5064555|NCT02344576|17473125|P3|1-Month Follow-Up|Withdrawal by Subject|8
5064556|NCT02344576|17473126|P2|1-Month Follow-Up|Withdrawal by Subject|14
5064557|NCT02344576|17473127|P1|1-Month Follow-Up|Withdrawal by Subject|3
5064558|NCT02344576|17473124|P4|1-Month Follow-Up|Death|0
5064559|NCT02344576|17473125|P3|1-Month Follow-Up|Death|0
5064560|NCT02344576|17473126|P2|1-Month Follow-Up|Death|8
5064561|NCT02344576|17473127|P1|1-Month Follow-Up|Death|13
5064562|NCT02344576|17473124|P4|Enrollment|Agreed to Medical Record Review Only|0
5064563|NCT02344576|17473125|P3|Enrollment|Agreed to Medical Record Review Only|0
5064564|NCT02344576|17473126|P2|Enrollment|Agreed to Medical Record Review Only|8
5064565|NCT02344576|17473127|P1|Enrollment|Agreed to Medical Record Review Only|7
5064566|NCT02344342|17473190|P4|Overall Study|Industry partner dropped out|10
5064567|NCT02344342|17473191|P3|Overall Study|Industry partner dropped out|14
5064568|NCT02344342|17473192|P2|Overall Study|Industry partner dropped out|9
5064569|NCT02344342|17473193|P1|Overall Study|Industry partner dropped out|11
5064570|NCT02344173|17473259|P1|12-month Visit|Lost to Follow-up|58
5064571|NCT02344173|17473259|P1|12-month Visit|Withdrawal by Subject|30
5064572|NCT02344173|17473259|P1|12-month Visit|Death|8
5064573|NCT02344173|17473259|P1|Procedure|Ablation Procedure Not Performed|7
5064574|NCT02344004|17473267|P2|Overall Study|Protocol Violation|0
5064575|NCT02344004|17473268|P1|Overall Study|Protocol Violation|1
5064576|NCT02344004|17473267|P2|Overall Study|Other Not Specified|0
5064577|NCT02344004|17473268|P1|Overall Study|Other Not Specified|12
5064578|NCT02344004|17473267|P2|Overall Study|Rescue Medication|0
5064579|NCT02344004|17473268|P1|Overall Study|Rescue Medication|2
5064580|NCT02344004|17473267|P2|Overall Study|Withdrawal by Subject|5
5064581|NCT02344004|17473268|P1|Overall Study|Withdrawal by Subject|22
5064582|NCT02344004|17473267|P2|Overall Study|Physician Decision|1
5064583|NCT02344004|17473268|P1|Overall Study|Physician Decision|4
5064584|NCT02344004|17473267|P2|Overall Study|Death|7
5064585|NCT02344004|17473268|P1|Overall Study|Death|9
5064586|NCT02344004|17473267|P2|Overall Study|Adverse Event|1
5064587|NCT02344004|17473268|P1|Overall Study|Adverse Event|11
5064588|NCT02343939|17473295|P9|Overall Study|Never Treated With ENTO|0
5064589|NCT02343939|17473296|P8|Overall Study|Never Treated With ENTO|2
5064590|NCT02343939|17473297|P7|Overall Study|Never Treated With ENTO|1
5064591|NCT02343939|17473298|P6|Overall Study|Never Treated With ENTO|0
5064592|NCT02343939|17473299|P5|Overall Study|Never Treated With ENTO|0
5064593|NCT02343939|17473300|P4|Overall Study|Never Treated With ENTO|0
5064594|NCT02343939|17473301|P3|Overall Study|Never Treated With ENTO|0
5064595|NCT02343939|17473302|P2|Overall Study|Never Treated With ENTO|0
5064596|NCT02343939|17473303|P1|Overall Study|Never Treated With ENTO|0
5064597|NCT02343939|17473295|P9|Overall Study|Adverse Event|0
5064598|NCT02343939|17473296|P8|Overall Study|Adverse Event|0
5064599|NCT02343939|17473297|P7|Overall Study|Adverse Event|0
5064600|NCT02343939|17473298|P6|Overall Study|Adverse Event|1
5064601|NCT02343939|17473299|P5|Overall Study|Adverse Event|0
5064602|NCT02343939|17473300|P4|Overall Study|Adverse Event|0
5064603|NCT02343939|17473301|P3|Overall Study|Adverse Event|0
5064604|NCT02343939|17473302|P2|Overall Study|Adverse Event|0
5064605|NCT02343939|17473303|P1|Overall Study|Adverse Event|0
5064606|NCT02343939|17473295|P9|Overall Study|Investigator's discretion|0
5064607|NCT02343939|17473296|P8|Overall Study|Investigator's discretion|0
5064608|NCT02343939|17473297|P7|Overall Study|Investigator's discretion|1
5064609|NCT02343939|17473298|P6|Overall Study|Investigator's discretion|0
5064610|NCT02343939|17473299|P5|Overall Study|Investigator's discretion|0
5064611|NCT02343939|17473300|P4|Overall Study|Investigator's discretion|1
5064612|NCT02343939|17473301|P3|Overall Study|Investigator's discretion|0
5064613|NCT02343939|17473302|P2|Overall Study|Investigator's discretion|0
5064614|NCT02343939|17473303|P1|Overall Study|Investigator's discretion|0
5064615|NCT02343939|17473295|P9|Overall Study|Treatment failure|0
5064616|NCT02343939|17473296|P8|Overall Study|Treatment failure|1
5064617|NCT02343939|17473297|P7|Overall Study|Treatment failure|2
5064618|NCT02343939|17473298|P6|Overall Study|Treatment failure|0
5064619|NCT02343939|17473299|P5|Overall Study|Treatment failure|0
5064620|NCT02343939|17473300|P4|Overall Study|Treatment failure|0
5064621|NCT02343939|17473301|P3|Overall Study|Treatment failure|0
5064622|NCT02343939|17473302|P2|Overall Study|Treatment failure|0
5064623|NCT02343939|17473303|P1|Overall Study|Treatment failure|0
5064624|NCT02343939|17473295|P9|Overall Study|Withdrew consent|6
5064625|NCT02343939|17473296|P8|Overall Study|Withdrew consent|8
5064626|NCT02343939|17473297|P7|Overall Study|Withdrew consent|0
5064627|NCT02343939|17473298|P6|Overall Study|Withdrew consent|0
5064628|NCT02343939|17473299|P5|Overall Study|Withdrew consent|2
5064629|NCT02343939|17473300|P4|Overall Study|Withdrew consent|2
5064630|NCT02343939|17473301|P3|Overall Study|Withdrew consent|1
5064631|NCT02343939|17473302|P2|Overall Study|Withdrew consent|6
5064632|NCT02343939|17473303|P1|Overall Study|Withdrew consent|3
5064633|NCT02343939|17473295|P9|Overall Study|Study terminated by sponsor|0
5064634|NCT02343939|17473296|P8|Overall Study|Study terminated by sponsor|4
5064635|NCT02343939|17473297|P7|Overall Study|Study terminated by sponsor|3
5064636|NCT02343939|17473298|P6|Overall Study|Study terminated by sponsor|5
5064637|NCT02343939|17473299|P5|Overall Study|Study terminated by sponsor|1
5064638|NCT02343939|17473300|P4|Overall Study|Study terminated by sponsor|1
5064639|NCT02343939|17473301|P3|Overall Study|Study terminated by sponsor|0
5064640|NCT02343939|17473302|P2|Overall Study|Study terminated by sponsor|27
5064641|NCT02343939|17473303|P1|Overall Study|Study terminated by sponsor|0
5064642|NCT02343939|17473295|P9|Overall Study|Death|1
5064643|NCT02343939|17473296|P8|Overall Study|Death|22
5064644|NCT02343939|17473297|P7|Overall Study|Death|8
5064645|NCT02343939|17473298|P6|Overall Study|Death|11
5064646|NCT02343939|17473299|P5|Overall Study|Death|5
5064647|NCT02343939|17473300|P4|Overall Study|Death|2
5064648|NCT02343939|17473301|P3|Overall Study|Death|4
5064649|NCT02343939|17473302|P2|Overall Study|Death|15
5064650|NCT02343939|17473303|P1|Overall Study|Death|0
5064651|NCT02343458|17473445|P4|Overall Study|Protocol Specified Criteria|8
5064652|NCT02343458|17473446|P3|Overall Study|Protocol Specified Criteria|14
5064653|NCT02343458|17473447|P2|Overall Study|Protocol Specified Criteria|13
5064654|NCT02343458|17473448|P1|Overall Study|Protocol Specified Criteria|17
5064655|NCT02343458|17473445|P4|Overall Study|Protocol Violation|2
5064656|NCT02343458|17473446|P3|Overall Study|Protocol Violation|2
5064657|NCT02343458|17473447|P2|Overall Study|Protocol Violation|5
5064658|NCT02343458|17473448|P1|Overall Study|Protocol Violation|2
5064659|NCT02343458|17473445|P4|Overall Study|Lost to Follow-up|1
5064660|NCT02343458|17473446|P3|Overall Study|Lost to Follow-up|3
5064661|NCT02343458|17473447|P2|Overall Study|Lost to Follow-up|5
5064662|NCT02343458|17473448|P1|Overall Study|Lost to Follow-up|5
5064663|NCT02343458|17473445|P4|Overall Study|Physician Decision|2
5064664|NCT02343458|17473446|P3|Overall Study|Physician Decision|2
5064665|NCT02343458|17473447|P2|Overall Study|Physician Decision|4
5064666|NCT02343458|17473448|P1|Overall Study|Physician Decision|1
5064667|NCT02343458|17473445|P4|Overall Study|Withdrawal by Subject|14
5064668|NCT02343458|17473446|P3|Overall Study|Withdrawal by Subject|23
5064669|NCT02343458|17473447|P2|Overall Study|Withdrawal by Subject|17
5064670|NCT02343458|17473448|P1|Overall Study|Withdrawal by Subject|18
5064671|NCT02343458|17473445|P4|Overall Study|Lack of Efficacy|8
5064672|NCT02343458|17473446|P3|Overall Study|Lack of Efficacy|4
5064673|NCT02343458|17473447|P2|Overall Study|Lack of Efficacy|8
5064674|NCT02343458|17473448|P1|Overall Study|Lack of Efficacy|3
5064675|NCT02343458|17473445|P4|Overall Study|Adverse Event|3
5064676|NCT02343458|17473446|P3|Overall Study|Adverse Event|15
5064677|NCT02343458|17473447|P2|Overall Study|Adverse Event|14
5064678|NCT02343458|17473448|P1|Overall Study|Adverse Event|15
5064679|NCT02343406|17473527|P5|Overall Study|Other, not specified|0
5064680|NCT02343406|17473528|P4|Overall Study|Other, not specified|4
5064681|NCT02343406|17473529|P3|Overall Study|Other, not specified|1
5064682|NCT02343406|17473530|P2|Overall Study|Other, not specified|1
5064683|NCT02343406|17473531|P1|Overall Study|Other, not specified|2
5064684|NCT02343406|17473527|P5|Overall Study|Other primary malignancy|0
5064685|NCT02343406|17473528|P4|Overall Study|Other primary malignancy|0
5064686|NCT02343406|17473529|P3|Overall Study|Other primary malignancy|0
5064687|NCT02343406|17473530|P2|Overall Study|Other primary malignancy|1
5064688|NCT02343406|17473531|P1|Overall Study|Other primary malignancy|0
5064689|NCT02343406|17473527|P5|Overall Study|Start of a new anti-cancer treatment|0
5064690|NCT02343406|17473528|P4|Overall Study|Start of a new anti-cancer treatment|1
5064691|NCT02343406|17473529|P3|Overall Study|Start of a new anti-cancer treatment|0
5064692|NCT02343406|17473530|P2|Overall Study|Start of a new anti-cancer treatment|1
5064693|NCT02343406|17473531|P1|Overall Study|Start of a new anti-cancer treatment|0
5064694|NCT02343406|17473527|P5|Overall Study|Death|0
5064695|NCT02343406|17473528|P4|Overall Study|Death|0
5064696|NCT02343406|17473529|P3|Overall Study|Death|0
5064697|NCT02343406|17473530|P2|Overall Study|Death|1
5064698|NCT02343406|17473531|P1|Overall Study|Death|2
5064699|NCT02343406|17473527|P5|Overall Study|Withdrawal by Subject|0
5064700|NCT02343406|17473528|P4|Overall Study|Withdrawal by Subject|3
5064701|NCT02343406|17473529|P3|Overall Study|Withdrawal by Subject|8
5064702|NCT02343406|17473530|P2|Overall Study|Withdrawal by Subject|4
5064703|NCT02343406|17473531|P1|Overall Study|Withdrawal by Subject|6
5064704|NCT02343406|17473527|P5|Overall Study|Adverse Event|0
5064705|NCT02343406|17473528|P4|Overall Study|Adverse Event|3
5064706|NCT02343406|17473529|P3|Overall Study|Adverse Event|6
5064707|NCT02343406|17473530|P2|Overall Study|Adverse Event|8
5064708|NCT02343406|17473531|P1|Overall Study|Adverse Event|6
5064709|NCT02343406|17473527|P5|Overall Study|Progressive disease|5
5064710|NCT02343406|17473528|P4|Overall Study|Progressive disease|15
5064711|NCT02343406|17473529|P3|Overall Study|Progressive disease|43
5064712|NCT02343406|17473530|P2|Overall Study|Progressive disease|70
5064713|NCT02343406|17473531|P1|Overall Study|Progressive disease|72
5064714|NCT02343263|17473599|P3|Overall Study|Physician Decision|1
5064715|NCT02343263|17473600|P2|Overall Study|Physician Decision|3
5064716|NCT02343263|17473601|P1|Overall Study|Physician Decision|5
5064717|NCT02343159|17473630|P3|Overall Study|Enrollment Error|0
5064718|NCT02343159|17473631|P2|Overall Study|Enrollment Error|0
5064719|NCT02343159|17473632|P1|Overall Study|Enrollment Error|1
5064720|NCT02343159|17473630|P3|Overall Study|Sponsor Decision|0
5064721|NCT02343159|17473631|P2|Overall Study|Sponsor Decision|1
5064722|NCT02343159|17473632|P1|Overall Study|Sponsor Decision|0
5064723|NCT02343159|17473630|P3|Overall Study|Adverse Event|2
5064724|NCT02343159|17473631|P2|Overall Study|Adverse Event|4
5064725|NCT02343159|17473632|P1|Overall Study|Adverse Event|4
5064726|NCT02343159|17473630|P3|Overall Study|Lost to Follow-up|2
5064727|NCT02343159|17473631|P2|Overall Study|Lost to Follow-up|2
5064728|NCT02343159|17473632|P1|Overall Study|Lost to Follow-up|0
5064729|NCT02343159|17473630|P3|Overall Study|Withdrawal by Subject|2
5064730|NCT02343159|17473631|P2|Overall Study|Withdrawal by Subject|0
5064731|NCT02343159|17473632|P1|Overall Study|Withdrawal by Subject|3
5064732|NCT02343159|17473630|P3|Overall Study|Physician Decision|1
5064733|NCT02343159|17473631|P2|Overall Study|Physician Decision|0
5064734|NCT02343159|17473632|P1|Overall Study|Physician Decision|2
5064735|NCT02343159|17473630|P3|Overall Study|Early Study Termination|23
5064736|NCT02343159|17473631|P2|Overall Study|Early Study Termination|19
5064737|NCT02343159|17473632|P1|Overall Study|Early Study Termination|16
5064738|NCT02343003|17473676|P2|Overall Study|terminated by sponsor|0
5064739|NCT02343003|17473677|P1|Overall Study|terminated by sponsor|2
5064740|NCT02343003|17473676|P2|Overall Study|exclusion criteria met|1
5064741|NCT02343003|17473677|P1|Overall Study|exclusion criteria met|1
5064742|NCT02343003|17473676|P2|Overall Study|Death|1
5064743|NCT02343003|17473677|P1|Overall Study|Death|0
5064744|NCT02343003|17473676|P2|Overall Study|Protocol Violation|0
5064745|NCT02343003|17473677|P1|Overall Study|Protocol Violation|1
5064746|NCT02343003|17473676|P2|Overall Study|Lost to Follow-up|1
5064747|NCT02343003|17473677|P1|Overall Study|Lost to Follow-up|5
5064748|NCT02343003|17473676|P2|Overall Study|Withdrawal by Subject|4
5064749|NCT02343003|17473677|P1|Overall Study|Withdrawal by Subject|9
5064750|NCT02342886|17473698|P5|Overall Study|Protocol Violation|0
5064751|NCT02342886|17473699|P4|Overall Study|Protocol Violation|2
5064752|NCT02342886|17473700|P3|Overall Study|Protocol Violation|0
5064753|NCT02342886|17473701|P2|Overall Study|Protocol Violation|0
5064754|NCT02342886|17473702|P1|Overall Study|Protocol Violation|0
5064755|NCT02342886|17473698|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
5064756|NCT02342886|17473699|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
5064757|NCT02342886|17473700|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
5064758|NCT02342886|17473701|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
5064759|NCT02342886|17473702|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
5064760|NCT02342886|17473698|P5|Overall Study|Pregnancy|0
5064761|NCT02342886|17473699|P4|Overall Study|Pregnancy|0
5064762|NCT02342886|17473700|P3|Overall Study|Pregnancy|2
5064763|NCT02342886|17473701|P2|Overall Study|Pregnancy|0
5064764|NCT02342886|17473702|P1|Overall Study|Pregnancy|0
5064765|NCT02342886|17473698|P5|Overall Study|Investigator/sponsor decision|1
5064766|NCT02342886|17473699|P4|Overall Study|Investigator/sponsor decision|3
5064767|NCT02342886|17473700|P3|Overall Study|Investigator/sponsor decision|0
5064768|NCT02342886|17473701|P2|Overall Study|Investigator/sponsor decision|2
5064769|NCT02342886|17473702|P1|Overall Study|Investigator/sponsor decision|0
5064770|NCT02342886|17473698|P5|Overall Study|Withdrawal by Subject|0
5064771|NCT02342886|17473699|P4|Overall Study|Withdrawal by Subject|1
5064772|NCT02342886|17473700|P3|Overall Study|Withdrawal by Subject|0
5064773|NCT02342886|17473701|P2|Overall Study|Withdrawal by Subject|1
5064774|NCT02342886|17473702|P1|Overall Study|Withdrawal by Subject|0
5064775|NCT02342886|17473698|P5|Overall Study|Death|1
5064776|NCT02342886|17473699|P4|Overall Study|Death|0
5064777|NCT02342886|17473700|P3|Overall Study|Death|1
5064778|NCT02342886|17473701|P2|Overall Study|Death|2
5064779|NCT02342886|17473702|P1|Overall Study|Death|1
5064780|NCT02342886|17473698|P5|Overall Study|Lost to Follow-up|0
5064781|NCT02342886|17473699|P4|Overall Study|Lost to Follow-up|0
5064782|NCT02342886|17473700|P3|Overall Study|Lost to Follow-up|0
5064783|NCT02342886|17473701|P2|Overall Study|Lost to Follow-up|0
5064784|NCT02342886|17473702|P1|Overall Study|Lost to Follow-up|1
5064785|NCT02342886|17473698|P5|Overall Study|Adverse event/specific toxicity|1
5064786|NCT02342886|17473699|P4|Overall Study|Adverse event/specific toxicity|2
5064787|NCT02342886|17473700|P3|Overall Study|Adverse event/specific toxicity|11
5064788|NCT02342886|17473701|P2|Overall Study|Adverse event/specific toxicity|3
5064789|NCT02342886|17473702|P1|Overall Study|Adverse event/specific toxicity|4
5064790|NCT02342886|17473698|P5|Overall Study|Late exclusion: rifampicin resistance|0
5064791|NCT02342886|17473699|P4|Overall Study|Late exclusion: rifampicin resistance|0
5064792|NCT02342886|17473700|P3|Overall Study|Late exclusion: rifampicin resistance|0
5064793|NCT02342886|17473701|P2|Overall Study|Late exclusion: rifampicin resistance|0
5064794|NCT02342886|17473702|P1|Overall Study|Late exclusion: rifampicin resistance|1
5064795|NCT02342886|17473698|P5|Overall Study|Treatment non-compliance|0
5064796|NCT02342886|17473699|P4|Overall Study|Treatment non-compliance|1
5064797|NCT02342886|17473700|P3|Overall Study|Treatment non-compliance|0
5064798|NCT02342886|17473701|P2|Overall Study|Treatment non-compliance|0
5064799|NCT02342886|17473702|P1|Overall Study|Treatment non-compliance|1
5064800|NCT02342743|17473719|P1|Treatment Period|Change in prophylactic medication|1
5064801|NCT02342743|17473719|P1|Treatment Period|Lost to Follow-up|8
5064802|NCT02342743|17473719|P1|Treatment Period|Withdrawal by Subject|2
5064803|NCT02342743|17473719|P1|Baseline Period|Screening failure regarding baseline|7
5064804|NCT02342743|17473719|P1|Baseline Period|Change in prophylactic medication|3
5064805|NCT02342743|17473719|P1|Baseline Period|Lost to Follow-up|2
5064806|NCT02342743|17473719|P1|Baseline Period|Withdrawal by Subject|3
5064807|NCT02342704|17473732|P2|Overall Study|Adverse Event|3
5064808|NCT02342704|17473733|P1|Overall Study|Adverse Event|1
5064809|NCT02342704|17473732|P2|Overall Study|Lost to Follow-up|1
5064810|NCT02342704|17473733|P1|Overall Study|Lost to Follow-up|2
5064811|NCT02342704|17473732|P2|Overall Study|Withdrawal by Subject|0
5064812|NCT02342704|17473733|P1|Overall Study|Withdrawal by Subject|1
5064813|NCT02342704|17473732|P2|Overall Study|Other|1
5064814|NCT02342704|17473733|P1|Overall Study|Other|0
5064815|NCT02342704|17473732|P2|Overall Study|Sponsor Termination|43
5064816|NCT02342704|17473733|P1|Overall Study|Sponsor Termination|49
5064817|NCT02342704|17473732|P2|Overall Study|Physician Decision|3
5064818|NCT02342704|17473733|P1|Overall Study|Physician Decision|0
5064819|NCT02342678|17473761|P2|Overall Study|Illness/medical reason|1
5064820|NCT02342678|17473762|P1|Overall Study|Illness/medical reason|1
5064821|NCT02342678|17473761|P2|Overall Study|Family illness/emergency|1
5064822|NCT02342678|17473762|P1|Overall Study|Family illness/emergency|0
5064823|NCT02342678|17473761|P2|Overall Study|Too busy to complete study|2
5064824|NCT02342678|17473762|P1|Overall Study|Too busy to complete study|0
5064825|NCT02342678|17473761|P2|Overall Study|Lost to Follow-up|1
5064826|NCT02342678|17473762|P1|Overall Study|Lost to Follow-up|0
5064827|NCT02342548|17473793|P3|Overall Study|Other|1
5064828|NCT02342548|17473794|P2|Overall Study|Other|1
5064829|NCT02342548|17473795|P1|Overall Study|Other|1
5064830|NCT02342548|17473793|P3|Overall Study|Withdrawal by Subject|4
5064831|NCT02342548|17473794|P2|Overall Study|Withdrawal by Subject|3
5064832|NCT02342548|17473795|P1|Overall Study|Withdrawal by Subject|1
5064833|NCT02342548|17473793|P3|Overall Study|Protocol Violation|0
5064834|NCT02342548|17473794|P2|Overall Study|Protocol Violation|1
5064835|NCT02342548|17473795|P1|Overall Study|Protocol Violation|0
5064836|NCT02342548|17473793|P3|Overall Study|Study terminated by sponsor|25
5064837|NCT02342548|17473794|P2|Overall Study|Study terminated by sponsor|39
5064838|NCT02342548|17473795|P1|Overall Study|Study terminated by sponsor|20
5064839|NCT02342548|17473793|P3|Overall Study|Lost to Follow-up|0
5064840|NCT02342548|17473794|P2|Overall Study|Lost to Follow-up|1
5064841|NCT02342548|17473795|P1|Overall Study|Lost to Follow-up|0
5064842|NCT02342548|17473793|P3|Overall Study|Adverse Event|13
5064843|NCT02342548|17473794|P2|Overall Study|Adverse Event|17
5064844|NCT02342548|17473795|P1|Overall Study|Adverse Event|12
5064845|NCT02342418|17473839|P2|Overall Study|Adverse Event|1
5064846|NCT02342418|17473840|P1|Overall Study|Adverse Event|0
5064847|NCT02342288|17474019|P2|Overall Study|coordinator not available|2
5064848|NCT02342288|17474020|P1|Overall Study|coordinator not available|0
5064849|NCT02342288|17474019|P2|Overall Study|subject cannot tolerate numbing drops|1
5064850|NCT02342288|17474020|P1|Overall Study|subject cannot tolerate numbing drops|0
5064851|NCT02342288|17474019|P2|Overall Study|coordinator contaminated with blood|1
5064852|NCT02342288|17474020|P1|Overall Study|coordinator contaminated with blood|0
5064853|NCT02342288|17474019|P2|Overall Study|Withdrawal by Subject|0
5064854|NCT02342288|17474020|P1|Overall Study|Withdrawal by Subject|1
5064855|NCT02342288|17474019|P2|Overall Study|anesthesia leak in system|0
5064856|NCT02342288|17474020|P1|Overall Study|anesthesia leak in system|1
5064857|NCT02342288|17474019|P2|Overall Study|no protocol anesthesiologist available|2
5064858|NCT02342288|17474020|P1|Overall Study|no protocol anesthesiologist available|3
5064859|NCT02342223|17474026|P1|Overall Study|Lost to Follow-up|1
5064860|NCT02342171|17474046|P2|Overall Study|Missing age data|1
5064861|NCT02342171|17474047|P1|Overall Study|Missing age data|0
5064862|NCT02342171|17474046|P2|Overall Study|Unknown outcome|1
5064863|NCT02342171|17474047|P1|Overall Study|Unknown outcome|0
5064864|NCT02342171|17474046|P2|Overall Study|Missing cycle treshold value|0
5064865|NCT02342171|17474047|P1|Overall Study|Missing cycle treshold value|1
5064866|NCT02342171|17474046|P2|Overall Study|Received favipiravir|0
5064867|NCT02342171|17474047|P1|Overall Study|Received favipiravir|10
5064868|NCT02342171|17474046|P2|Overall Study|Death|87
5064869|NCT02342171|17474047|P1|Overall Study|Death|4
5064870|NCT02341482|17474301|P1|Overall Study|Adverse Event|1
5064871|NCT02341456|17474330|P3|Overall Study|Physician Decision|0
5064872|NCT02341456|17474331|P2|Overall Study|Physician Decision|0
5064873|NCT02341456|17474332|P1|Overall Study|Physician Decision|1
5064874|NCT02341456|17474330|P3|Overall Study|Moved to local access programme.|1
5064875|NCT02341456|17474331|P2|Overall Study|Moved to local access programme.|1
5064876|NCT02341456|17474332|P1|Overall Study|Moved to local access programme.|0
5064877|NCT02341456|17474330|P3|Overall Study|Withdrawal by Subject|1
5064878|NCT02341456|17474331|P2|Overall Study|Withdrawal by Subject|1
5064879|NCT02341456|17474332|P1|Overall Study|Withdrawal by Subject|0
5064880|NCT02341456|17474330|P3|Overall Study|Death|1
5064881|NCT02341456|17474331|P2|Overall Study|Death|1
5064882|NCT02341456|17474332|P1|Overall Study|Death|1
5064883|NCT02341456|17474330|P3|Overall Study|Disease progression|1
5064884|NCT02341456|17474331|P2|Overall Study|Disease progression|3
5064885|NCT02341456|17474332|P1|Overall Study|Disease progression|2
5064886|NCT02341417|17474457|P3|Overall Study|Death|1
5064887|NCT02341417|17474458|P2|Overall Study|Death|0
5064888|NCT02341417|17474459|P1|Overall Study|Death|0
5064889|NCT02341417|17474457|P3|Overall Study|Decision by sponsor|0
5064890|NCT02341417|17474458|P2|Overall Study|Decision by sponsor|0
5064891|NCT02341417|17474459|P1|Overall Study|Decision by sponsor|2
5064892|NCT02341417|17474457|P3|Overall Study|Withdrawal by Subject|0
5064893|NCT02341417|17474458|P2|Overall Study|Withdrawal by Subject|2
5064894|NCT02341417|17474459|P1|Overall Study|Withdrawal by Subject|0
5064895|NCT02340975|17474524|P6|Overall Study|Other|6
5064896|NCT02340975|17474525|P5|Overall Study|Other|0
5064897|NCT02340975|17474526|P4|Overall Study|Other|2
5064898|NCT02340975|17474527|P3|Overall Study|Other|0
5064899|NCT02340975|17474528|P2|Overall Study|Other|4
5064900|NCT02340975|17474529|P1|Overall Study|Other|0
5064901|NCT02340975|17474524|P6|Overall Study|Withdrawal by Subject|0
5064902|NCT02340975|17474525|P5|Overall Study|Withdrawal by Subject|2
5064903|NCT02340975|17474526|P4|Overall Study|Withdrawal by Subject|3
5064904|NCT02340975|17474527|P3|Overall Study|Withdrawal by Subject|3
5064905|NCT02340975|17474528|P2|Overall Study|Withdrawal by Subject|0
5064906|NCT02340975|17474529|P1|Overall Study|Withdrawal by Subject|0
5064907|NCT02340975|17474524|P6|Overall Study|Lost to Follow-up|0
5064908|NCT02340975|17474525|P5|Overall Study|Lost to Follow-up|2
5064909|NCT02340975|17474526|P4|Overall Study|Lost to Follow-up|0
5064910|NCT02340975|17474527|P3|Overall Study|Lost to Follow-up|0
5064911|NCT02340975|17474528|P2|Overall Study|Lost to Follow-up|0
5064912|NCT02340975|17474529|P1|Overall Study|Lost to Follow-up|0
5064913|NCT02340975|17474524|P6|Overall Study|Death|13
5064914|NCT02340975|17474525|P5|Overall Study|Death|21
5064915|NCT02340975|17474526|P4|Overall Study|Death|7
5064916|NCT02340975|17474527|P3|Overall Study|Death|21
5064917|NCT02340975|17474528|P2|Overall Study|Death|23
5064918|NCT02340975|17474529|P1|Overall Study|Death|6
5064919|NCT02340962|17474643|P2|Overall Study|Lost to Follow-up|0
5064920|NCT02340962|17474644|P1|Overall Study|Lost to Follow-up|1
5064921|NCT02340819|17474664|P1|Overall Study|Discontinued with other reason|1
5064922|NCT02340819|17474664|P1|Overall Study|Withdrawal by Subject|2
5064923|NCT02340819|17474664|P1|Overall Study|Adverse Event|1
5064924|NCT02340806|17474693|P2|Overall Study|re-dose < 90 min of CSE|3
5064925|NCT02340806|17474694|P1|Overall Study|re-dose < 90 min of CSE|1
5064926|NCT02340806|17474693|P2|Overall Study|history of chronic pain medication|0
5064927|NCT02340806|17474694|P1|Overall Study|history of chronic pain medication|1
5064928|NCT02340806|17474693|P2|Overall Study|epidural catheter replaced|1
5064929|NCT02340806|17474694|P1|Overall Study|epidural catheter replaced|2
5064930|NCT02340806|17474693|P2|Overall Study|Protocol Violation|0
5064931|NCT02340806|17474694|P1|Overall Study|Protocol Violation|2
5064932|NCT02340780|17474720|P1|Overall Study|Ineligible|1
5064933|NCT02340663|17474788|P2|Overall Study|Withdrawal by Subject|1
5064934|NCT02340663|17474789|P1|Overall Study|Withdrawal by Subject|3
5064935|NCT02340663|17474788|P2|Overall Study|Protocol Violation|0
5064936|NCT02340663|17474789|P1|Overall Study|Protocol Violation|1
5064937|NCT02340663|17474788|P2|Overall Study|Lost to Follow-up|0
5064938|NCT02340663|17474789|P1|Overall Study|Lost to Follow-up|1
5064939|NCT02340520|17474845|P1|Overall Study|Withdrawal by Subject|1
5064940|NCT02340520|17474845|P1|Overall Study|Patient did not take drug as specified|1
5064941|NCT02340520|17474845|P1|Overall Study|Lost to Follow-up|1
5064942|NCT02340221|17474897|P2|Overall Study|Continued on study|290
5064943|NCT02340221|17474898|P1|Overall Study|Continued on study|140
5064944|NCT02340221|17474897|P2|Overall Study|Reason Not Specified|1
5064945|NCT02340221|17474898|P1|Overall Study|Reason Not Specified|0
5064946|NCT02340221|17474897|P2|Overall Study|Lost to Follow-up|3
5064947|NCT02340221|17474898|P1|Overall Study|Lost to Follow-up|2
5064948|NCT02340221|17474897|P2|Overall Study|Withdrawal by Participant|22
5064949|NCT02340221|17474898|P1|Overall Study|Withdrawal by Participant|14
5064950|NCT02340221|17474897|P2|Overall Study|Death|101
5064951|NCT02340221|17474898|P1|Overall Study|Death|58
5064952|NCT02340078|17474932|P1|Overall Study|Protocol Violation|1
5064953|NCT02340000|17474939|P2|Time Period 2|Lost to Follow-up|8
5064954|NCT02340000|17474940|P1|Time Period 2|Lost to Follow-up|10
5064955|NCT02340000|17474939|P2|Time Period 2|Withdrawal by Subject|7
5064956|NCT02340000|17474940|P1|Time Period 2|Withdrawal by Subject|9
5064957|NCT02340000|17474939|P2|Time Period 1|Lost to Follow-up|7
5064958|NCT02340000|17474940|P1|Time Period 1|Lost to Follow-up|6
5064959|NCT02340000|17474939|P2|Time Period 1|Withdrawal by Subject|8
5064960|NCT02340000|17474940|P1|Time Period 1|Withdrawal by Subject|6
5064961|NCT02339909|17474970|P3|Overall Study|Became ineligible after randomisation|71
5064962|NCT02339909|17474971|P2|Overall Study|Became ineligible after randomisation|63
5064963|NCT02339909|17474972|P1|Overall Study|Became ineligible after randomisation|89
5064964|NCT02339584|17475010|P2|Overall Study|Withdrawal by Subject|4
5064965|NCT02339584|17475011|P1|Overall Study|Withdrawal by Subject|2
5064966|NCT02339584|17475010|P2|Overall Study|Protocol Violation|1
5064967|NCT02339584|17475011|P1|Overall Study|Protocol Violation|1
5064968|NCT02339584|17475010|P2|Overall Study|Physician Decision|2
5064969|NCT02339584|17475011|P1|Overall Study|Physician Decision|1
5064970|NCT02339584|17475010|P2|Overall Study|Lack of Efficacy|1
5064971|NCT02339584|17475011|P1|Overall Study|Lack of Efficacy|0
5064972|NCT02339584|17475010|P2|Overall Study|Adverse Event|7
5064973|NCT02339584|17475011|P1|Overall Study|Adverse Event|11
5064974|NCT02339506|17475031|P2|Washout (Period 2)|Withdrawal by Subject|0
5064975|NCT02339506|17475032|P1|Washout (Period 2)|Withdrawal by Subject|2
5064976|NCT02339506|17475031|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
5064977|NCT02339506|17475032|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
5064978|NCT02339285|17475061|P3|Overall Study|Protocol Deviation|0
5064979|NCT02339285|17475062|P2|Overall Study|Protocol Deviation|1
5064980|NCT02339285|17475063|P1|Overall Study|Protocol Deviation|0
5064981|NCT02339285|17475061|P3|Overall Study|Lost to Follow-up|1
5064982|NCT02339285|17475062|P2|Overall Study|Lost to Follow-up|1
5064983|NCT02339285|17475063|P1|Overall Study|Lost to Follow-up|1
5064984|NCT02339285|17475061|P3|Overall Study|Withdrawal by Subject|1
5064985|NCT02339285|17475062|P2|Overall Study|Withdrawal by Subject|1
5064986|NCT02339285|17475063|P1|Overall Study|Withdrawal by Subject|0
5064987|NCT02339155|17475109|P2|Overall Study|Withdrawal by Subject|4
5064988|NCT02339155|17475110|P1|Overall Study|Withdrawal by Subject|4
5064989|NCT02339155|17475109|P2|Overall Study|Physician Decision|1
5064990|NCT02339155|17475110|P1|Overall Study|Physician Decision|2
5064991|NCT02339155|17475109|P2|Overall Study|Lost to Follow-up|9
5064992|NCT02339155|17475110|P1|Overall Study|Lost to Follow-up|8
5064993|NCT02339155|17475109|P2|Overall Study|Death|1
5064994|NCT02339155|17475110|P1|Overall Study|Death|1
5064995|NCT02339155|17475109|P2|Overall Study|Adverse Event|6
5064996|NCT02339155|17475110|P1|Overall Study|Adverse Event|0
5064997|NCT02338882|17475316|P2|Overall Study|Lost to Follow-up|3
5064998|NCT02338882|17475317|P1|Overall Study|Lost to Follow-up|6
5064999|NCT02338882|17475316|P2|Overall Study|Death|0
5065000|NCT02338882|17475317|P1|Overall Study|Death|1
5065001|NCT02338843|17475355|P2|Overall Study|Discontinued prior to randomizat|0
5065002|NCT02338843|17475356|P1|Overall Study|Discontinued prior to randomizat|1
5065003|NCT02338843|17475355|P2|Overall Study|Subject Recovered|2
5065004|NCT02338843|17475356|P1|Overall Study|Subject Recovered|0
5065005|NCT02338843|17475355|P2|Overall Study|Withdrawal by Subject|2
5065006|NCT02338843|17475356|P1|Overall Study|Withdrawal by Subject|0
5065007|NCT02338843|17475355|P2|Overall Study|Physician Decision|0
5065008|NCT02338843|17475356|P1|Overall Study|Physician Decision|1
5065009|NCT02338843|17475355|P2|Overall Study|Death|53
5065010|NCT02338843|17475356|P1|Overall Study|Death|40
5065011|NCT02338843|17475355|P2|Overall Study|Adverse Event|1
5065012|NCT02338843|17475356|P1|Overall Study|Adverse Event|2
5065013|NCT02338492|17475384|P1|Overall Study|Reason not captured above|6
5065014|NCT02338492|17475384|P1|Overall Study|Lost to Follow-up|4
5065015|NCT02338492|17475384|P1|Overall Study|Adverse Event|3
5065016|NCT02338492|17475384|P1|Overall Study|Death|32
5065017|NCT02338362|17475400|P2|Overall Study|Withdrawal by Subject|1
5065018|NCT02338362|17475401|P1|Overall Study|Withdrawal by Subject|1
5065019|NCT02338193|17475431|P3|Overall Study|intolerant of side effects|0
5065020|NCT02338193|17475432|P2|Overall Study|intolerant of side effects|0
5065021|NCT02338193|17475433|P1|Overall Study|intolerant of side effects|1
5065022|NCT02338193|17475431|P3|Overall Study|moved out of state|0
5065023|NCT02338193|17475432|P2|Overall Study|moved out of state|1
5065024|NCT02338193|17475433|P1|Overall Study|moved out of state|0
5065025|NCT02338193|17475431|P3|Overall Study|Noncompliant with visits|7
5065026|NCT02338193|17475432|P2|Overall Study|Noncompliant with visits|2
5065027|NCT02338193|17475433|P1|Overall Study|Noncompliant with visits|2
5065028|NCT02338193|17475431|P3|Overall Study|Pregnancy|1
5065029|NCT02338193|17475432|P2|Overall Study|Pregnancy|1
5065030|NCT02338193|17475433|P1|Overall Study|Pregnancy|0
5065031|NCT02338193|17475431|P3|Overall Study|Withdrawal by Subject|2
5065032|NCT02338193|17475432|P2|Overall Study|Withdrawal by Subject|0
5065033|NCT02338193|17475433|P1|Overall Study|Withdrawal by Subject|0
5065034|NCT02338154|17475486|P1|Overall Study|Missing Exit Reason on Exit Form|1
5065035|NCT02338154|17475486|P1|Overall Study|Patients Without Exit Form|47
5065036|NCT02338154|17475486|P1|Overall Study|Other Reason|3
5065037|NCT02338154|17475486|P1|Overall Study|Lost to Follow-up|8
5065038|NCT02338154|17475486|P1|Overall Study|Withdrawal by Subject or by Investigator|10
5065039|NCT02338154|17475486|P1|Overall Study|Valve Explant|11
5065040|NCT02338154|17475486|P1|Overall Study|Valve Implant Failure|17
5065041|NCT02338154|17475486|P1|Overall Study|Death|46
5065042|NCT02337946|17475610|P3|Protocol Treatment 2 Period|Reason not specified|4
5065043|NCT02337946|17475611|P2|Protocol Treatment 2 Period|Reason not specified|4
5065044|NCT02337946|17475612|P1|Protocol Treatment 2 Period|Reason not specified|0
5065045|NCT02337946|17475610|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
5065046|NCT02337946|17475611|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
5065047|NCT02337946|17475612|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
5065048|NCT02337946|17475610|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
5065049|NCT02337946|17475611|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
5065050|NCT02337946|17475612|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
5065051|NCT02337946|17475610|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
5065052|NCT02337946|17475611|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
5065053|NCT02337946|17475612|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
5065054|NCT02337946|17475610|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
5065055|NCT02337946|17475611|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
5065056|NCT02337946|17475612|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
5065057|NCT02337946|17475610|P3|Protocol Treatment 2 Period|Adverse Event|9
5065058|NCT02337946|17475611|P2|Protocol Treatment 2 Period|Adverse Event|9
5065059|NCT02337946|17475612|P1|Protocol Treatment 2 Period|Adverse Event|0
5065060|NCT02337946|17475610|P3|In-between Period|Without Informed Consent|0
5065061|NCT02337946|17475611|P2|In-between Period|Without Informed Consent|0
5065062|NCT02337946|17475612|P1|In-between Period|Without Informed Consent|1
5065063|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Reason not specified|0
5065064|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Reason not specified|0
5065065|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Reason not specified|8
5065066|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
5065067|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
5065068|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
5065069|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
5065070|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
5065071|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
5065072|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
5065073|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
5065074|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
5065075|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
5065076|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
5065077|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
5065078|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
5065079|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
5065080|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
5065081|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
5065166|NCT02337387|17475839|P3|Overall Study|Adverse Event|0
5065082|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
5065083|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
5065084|NCT02337946|17475610|P3|Protocol Treatment 1 Period|Adverse Event|0
5065085|NCT02337946|17475611|P2|Protocol Treatment 1 Period|Adverse Event|0
5065086|NCT02337946|17475612|P1|Protocol Treatment 1 Period|Adverse Event|7
5065087|NCT02337907|17475673|P6|Overall Study|Adverse Event|0
5065088|NCT02337907|17475674|P5|Overall Study|Adverse Event|4
5065089|NCT02337907|17475675|P4|Overall Study|Adverse Event|1
5065090|NCT02337907|17475676|P3|Overall Study|Adverse Event|1
5065091|NCT02337907|17475677|P2|Overall Study|Adverse Event|1
5065092|NCT02337907|17475678|P1|Overall Study|Adverse Event|1
5065093|NCT02337907|17475673|P6|Overall Study|Lost to Follow-up|1
5065094|NCT02337907|17475674|P5|Overall Study|Lost to Follow-up|0
5065095|NCT02337907|17475675|P4|Overall Study|Lost to Follow-up|0
5065096|NCT02337907|17475676|P3|Overall Study|Lost to Follow-up|0
5065097|NCT02337907|17475677|P2|Overall Study|Lost to Follow-up|0
5065098|NCT02337907|17475678|P1|Overall Study|Lost to Follow-up|0
5065099|NCT02337907|17475673|P6|Overall Study|Withdrawal by Subject|0
5065100|NCT02337907|17475674|P5|Overall Study|Withdrawal by Subject|5
5065101|NCT02337907|17475675|P4|Overall Study|Withdrawal by Subject|2
5065102|NCT02337907|17475676|P3|Overall Study|Withdrawal by Subject|0
5065103|NCT02337907|17475677|P2|Overall Study|Withdrawal by Subject|3
5065104|NCT02337907|17475678|P1|Overall Study|Withdrawal by Subject|2
5065105|NCT02337907|17475673|P6|Overall Study|Other than listed|0
5065106|NCT02337907|17475674|P5|Overall Study|Other than listed|1
5065107|NCT02337907|17475675|P4|Overall Study|Other than listed|1
5065108|NCT02337907|17475676|P3|Overall Study|Other than listed|0
5065109|NCT02337907|17475677|P2|Overall Study|Other than listed|0
5065110|NCT02337907|17475678|P1|Overall Study|Other than listed|1
5065111|NCT02337764|17475713|P1|Overall Study|Lack of Efficacy|2
5065112|NCT02337764|17475713|P1|Overall Study|Voluntary Withdrawal|12
5065113|NCT02337764|17475713|P1|Overall Study|Pretreatment Event/Adverse Event|46
5065114|NCT02337751|17475726|P2|Overall Study|Investigator's Judgement|0
5065115|NCT02337751|17475727|P1|Overall Study|Investigator's Judgement|1
5065116|NCT02337751|17475726|P2|Overall Study|Lack of Efficacy|5
5065117|NCT02337751|17475727|P1|Overall Study|Lack of Efficacy|2
5065118|NCT02337751|17475726|P2|Overall Study|Voluntary Withdrawal|8
5065119|NCT02337751|17475727|P1|Overall Study|Voluntary Withdrawal|6
5065120|NCT02337751|17475726|P2|Overall Study|Pretreatment Event/Adverse Event|3
5065121|NCT02337751|17475727|P1|Overall Study|Pretreatment Event/Adverse Event|2
5065122|NCT02337738|17475746|P3|Overall Study|Investigator's Judgment|3
5065123|NCT02337738|17475747|P2|Overall Study|Investigator's Judgment|1
5065124|NCT02337738|17475748|P1|Overall Study|Investigator's Judgment|1
5065125|NCT02337738|17475746|P3|Overall Study|Lack of Efficacy|0
5065126|NCT02337738|17475747|P2|Overall Study|Lack of Efficacy|4
5065127|NCT02337738|17475748|P1|Overall Study|Lack of Efficacy|2
5065128|NCT02337738|17475746|P3|Overall Study|Voluntary Withdrawal|2
5065129|NCT02337738|17475747|P2|Overall Study|Voluntary Withdrawal|5
5065130|NCT02337738|17475748|P1|Overall Study|Voluntary Withdrawal|10
5065131|NCT02337738|17475746|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
5065132|NCT02337738|17475747|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
5065133|NCT02337738|17475748|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
5065134|NCT02337738|17475746|P3|Overall Study|Pretreatment Event/Adverse Event|21
5065135|NCT02337738|17475747|P2|Overall Study|Pretreatment Event/Adverse Event|18
5065136|NCT02337738|17475748|P1|Overall Study|Pretreatment Event/Adverse Event|9
5065137|NCT02337738|17475746|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
5065138|NCT02337738|17475747|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
5065139|NCT02337738|17475748|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
5065140|NCT02337725|17475788|P2|Overall Study|Lack of Efficacy|0
5065141|NCT02337725|17475789|P1|Overall Study|Lack of Efficacy|4
5065142|NCT02337725|17475788|P2|Overall Study|Voluntary Withdrawal|3
5065143|NCT02337725|17475789|P1|Overall Study|Voluntary Withdrawal|14
5065144|NCT02337725|17475788|P2|Overall Study|Major Protocol Deviation|1
5065145|NCT02337725|17475789|P1|Overall Study|Major Protocol Deviation|0
5065146|NCT02337725|17475788|P2|Overall Study|Pretreatment Event/AE in Treatment|3
5065147|NCT02337725|17475789|P1|Overall Study|Pretreatment Event/AE in Treatment|8
5065148|NCT02337725|17475788|P2|Overall Study|Pretreatment Event/AE before Treatment|1
5065149|NCT02337725|17475789|P1|Overall Study|Pretreatment Event/AE before Treatment|0
5065150|NCT02337491|17475813|P2|Overall Study|On Treatment|0
5065151|NCT02337491|17475814|P1|Overall Study|On Treatment|2
5065152|NCT02337491|17475813|P2|Overall Study|Progressive Disease|28
5065153|NCT02337491|17475814|P1|Overall Study|Progressive Disease|44
5065154|NCT02337491|17475813|P2|Overall Study|Withdrawal by Subject|0
5065155|NCT02337491|17475814|P1|Overall Study|Withdrawal by Subject|3
5065156|NCT02337491|17475813|P2|Overall Study|Adverse Event|1
5065157|NCT02337491|17475814|P1|Overall Study|Adverse Event|0
5065158|NCT02337491|17475813|P2|Overall Study|Death|1
5065159|NCT02337491|17475814|P1|Overall Study|Death|1
5065160|NCT02337478|17475828|P1|Overall Study|Lack of Efficacy|5
5065161|NCT02337387|17475838|P4|Overall Study|Sponsor Decision to Terminate Study|3
5065162|NCT02337387|17475839|P3|Overall Study|Sponsor Decision to Terminate Study|3
5065163|NCT02337387|17475840|P2|Overall Study|Sponsor Decision to Terminate Study|7
5065164|NCT02337387|17475841|P1|Overall Study|Sponsor Decision to Terminate Study|14
5065165|NCT02337387|17475838|P4|Overall Study|Adverse Event|0
5065167|NCT02337387|17475840|P2|Overall Study|Adverse Event|1
5065168|NCT02337387|17475841|P1|Overall Study|Adverse Event|0
5065169|NCT02337361|17475859|P2|6-month Follow-up|Lost to Follow-up|4
5065170|NCT02337361|17475860|P1|6-month Follow-up|Lost to Follow-up|2
5065171|NCT02337361|17475859|P2|3-month Follow-up|Lost to Follow-up|14
5065172|NCT02337361|17475860|P1|3-month Follow-up|Lost to Follow-up|19
5065173|NCT02336815|17475923|P2|Overall Study|Other|5
5065174|NCT02336815|17475924|P1|Overall Study|Other|1
5065175|NCT02336815|17475923|P2|Overall Study|Lost to Follow-up|3
5065176|NCT02336815|17475924|P1|Overall Study|Lost to Follow-up|1
5065177|NCT02336815|17475923|P2|Overall Study|Withdrawal by Subject|2
5065178|NCT02336815|17475924|P1|Overall Study|Withdrawal by Subject|3
5065179|NCT02336815|17475923|P2|Overall Study|Physician Decision|4
5065180|NCT02336815|17475924|P1|Overall Study|Physician Decision|11
5065181|NCT02336815|17475923|P2|Overall Study|Adverse Event|39
5065182|NCT02336815|17475924|P1|Overall Study|Adverse Event|18
5065183|NCT02336815|17475923|P2|Overall Study|Disease Progression|70
5065184|NCT02336815|17475924|P1|Overall Study|Disease Progression|45
5065185|NCT02336737|17475961|P1|Overall Study|Physician Decision|8
5065186|NCT02336737|17475961|P1|Overall Study|Withdrawal by Subject|5
5065187|NCT02336607|17475972|P4|Overall Study|Withdrawal by Subject|20
5065188|NCT02336607|17475973|P3|Overall Study|Withdrawal by Subject|0
5065189|NCT02336607|17475974|P2|Overall Study|Withdrawal by Subject|2
5065190|NCT02336607|17475975|P1|Overall Study|Withdrawal by Subject|0
5065191|NCT02336607|17475972|P4|Overall Study|Adverse Event|26
5065192|NCT02336607|17475973|P3|Overall Study|Adverse Event|2
5065193|NCT02336607|17475974|P2|Overall Study|Adverse Event|2
5065194|NCT02336607|17475975|P1|Overall Study|Adverse Event|0
5065195|NCT02336607|17475972|P4|Overall Study|Protocol Violation|3
5065196|NCT02336607|17475973|P3|Overall Study|Protocol Violation|1
5065197|NCT02336607|17475974|P2|Overall Study|Protocol Violation|1
5065198|NCT02336607|17475975|P1|Overall Study|Protocol Violation|0
5065199|NCT02336607|17475972|P4|Overall Study|Lost to Follow-up|21
5065200|NCT02336607|17475973|P3|Overall Study|Lost to Follow-up|0
5065201|NCT02336607|17475974|P2|Overall Study|Lost to Follow-up|1
5065202|NCT02336607|17475975|P1|Overall Study|Lost to Follow-up|2
5065203|NCT02336607|17475972|P4|Overall Study|Lack of Efficacy|2
5065204|NCT02336607|17475973|P3|Overall Study|Lack of Efficacy|0
5065205|NCT02336607|17475974|P2|Overall Study|Lack of Efficacy|0
5065206|NCT02336607|17475975|P1|Overall Study|Lack of Efficacy|1
5065207|NCT02336607|17475972|P4|Overall Study|Physician Decision|15
5065208|NCT02336607|17475973|P3|Overall Study|Physician Decision|3
5065209|NCT02336607|17475974|P2|Overall Study|Physician Decision|4
5065210|NCT02336607|17475975|P1|Overall Study|Physician Decision|1
5065211|NCT02336555|17476078|P2|Treatment Period 2 (28 Days)|Adverse Event|1
5065212|NCT02336555|17476079|P1|Treatment Period 2 (28 Days)|Adverse Event|0
5065213|NCT02336555|17476078|P2|Treatment Period 1 (28 Days)|Physician Decision|0
5065214|NCT02336555|17476079|P1|Treatment Period 1 (28 Days)|Physician Decision|2
5065215|NCT02336555|17476078|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5065216|NCT02336555|17476079|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5065217|NCT02336451|17476092|P5|Overall Study|Patient/guardian decision|1
5065218|NCT02336451|17476093|P4|Overall Study|Patient/guardian decision|2
5065219|NCT02336451|17476094|P3|Overall Study|Patient/guardian decision|0
5065220|NCT02336451|17476095|P2|Overall Study|Patient/guardian decision|4
5065221|NCT02336451|17476096|P1|Overall Study|Patient/guardian decision|2
5065222|NCT02336451|17476092|P5|Overall Study|Protocol Violation|0
5065223|NCT02336451|17476093|P4|Overall Study|Protocol Violation|0
5065224|NCT02336451|17476094|P3|Overall Study|Protocol Violation|0
5065225|NCT02336451|17476095|P2|Overall Study|Protocol Violation|0
5065226|NCT02336451|17476096|P1|Overall Study|Protocol Violation|1
5065227|NCT02336451|17476092|P5|Overall Study|Progressive disease|4
5065228|NCT02336451|17476093|P4|Overall Study|Progressive disease|14
5065229|NCT02336451|17476094|P3|Overall Study|Progressive disease|2
5065230|NCT02336451|17476095|P2|Overall Study|Progressive disease|26
5065231|NCT02336451|17476096|P1|Overall Study|Progressive disease|23
5065232|NCT02336451|17476092|P5|Overall Study|Physician Decision|3
5065233|NCT02336451|17476093|P4|Overall Study|Physician Decision|16
5065234|NCT02336451|17476094|P3|Overall Study|Physician Decision|7
5065235|NCT02336451|17476095|P2|Overall Study|Physician Decision|6
5065236|NCT02336451|17476096|P1|Overall Study|Physician Decision|9
5065237|NCT02336451|17476092|P5|Overall Study|Death|6
5065238|NCT02336451|17476093|P4|Overall Study|Death|6
5065239|NCT02336451|17476094|P3|Overall Study|Death|3
5065240|NCT02336451|17476095|P2|Overall Study|Death|2
5065241|NCT02336451|17476096|P1|Overall Study|Death|6
5065242|NCT02336451|17476092|P5|Overall Study|Adverse Event|4
5065243|NCT02336451|17476093|P4|Overall Study|Adverse Event|6
5065244|NCT02336451|17476094|P3|Overall Study|Adverse Event|0
5065245|NCT02336451|17476095|P2|Overall Study|Adverse Event|2
5065246|NCT02336451|17476096|P1|Overall Study|Adverse Event|1
5065247|NCT02336425|17476253|P4|Overall Study|Study terminated.|3
5065248|NCT02336425|17476254|P3|Overall Study|Study terminated.|3
5065249|NCT02336425|17476255|P2|Overall Study|Study terminated.|2
5065250|NCT02336425|17476256|P1|Overall Study|Study terminated.|2
5065251|NCT02336373|17476306|P1|Overall Study|Physician Decision|14
5065252|NCT02336373|17476306|P1|Overall Study|Protocol closed early|4
5065253|NCT02336282|17476325|P1|Overall Study|Not enough time to complete sessions|2
5065254|NCT02336282|17476325|P1|Overall Study|Lost to Follow-up|1
5065255|NCT02336282|17476325|P1|Overall Study|Uncomfortable with technology|1
5065256|NCT02336282|17476325|P1|Overall Study|Unrelated illness|1
5065257|NCT02336178|17476349|P1|Overall Study|Other|1
5065258|NCT02336178|17476349|P1|Overall Study|Withdrawal by Subject|1
5065259|NCT02336178|17476349|P1|Overall Study|Protocol Violation|1
5065260|NCT02336178|17476349|P1|Overall Study|Lost to Follow-up|1
5065261|NCT02336165|17476440|P5|Overall Study|Other|0
5065262|NCT02336165|17476441|P4|Overall Study|Other|1
5065263|NCT02336165|17476442|P3|Overall Study|Other|0
5065264|NCT02336165|17476443|P2|Overall Study|Other|0
5065265|NCT02336165|17476444|P1|Overall Study|Other|1
5065266|NCT02336165|17476440|P5|Overall Study|Non-compliance|0
5065267|NCT02336165|17476441|P4|Overall Study|Non-compliance|1
5065268|NCT02336165|17476442|P3|Overall Study|Non-compliance|0
5065269|NCT02336165|17476443|P2|Overall Study|Non-compliance|0
5065270|NCT02336165|17476444|P1|Overall Study|Non-compliance|1
5065271|NCT02336165|17476440|P5|Overall Study|Progressive disease|19
5065272|NCT02336165|17476441|P4|Overall Study|Progressive disease|24
5065273|NCT02336165|17476442|P3|Overall Study|Progressive disease|27
5065274|NCT02336165|17476443|P2|Overall Study|Progressive disease|22
5065275|NCT02336165|17476444|P1|Overall Study|Progressive disease|23
5065276|NCT02336165|17476440|P5|Overall Study|Adverse Event|1
5065277|NCT02336165|17476441|P4|Overall Study|Adverse Event|4
5065278|NCT02336165|17476442|P3|Overall Study|Adverse Event|2
5065279|NCT02336165|17476443|P2|Overall Study|Adverse Event|1
5065280|NCT02336165|17476444|P1|Overall Study|Adverse Event|4
5065281|NCT02336165|17476440|P5|Overall Study|Withdrawal by Subject|1
5065282|NCT02336165|17476441|P4|Overall Study|Withdrawal by Subject|0
5065283|NCT02336165|17476442|P3|Overall Study|Withdrawal by Subject|1
5065284|NCT02336165|17476443|P2|Overall Study|Withdrawal by Subject|0
5065285|NCT02336165|17476444|P1|Overall Study|Withdrawal by Subject|0
5065286|NCT02336165|17476440|P5|Overall Study|Physician Decision|0
5065287|NCT02336165|17476441|P4|Overall Study|Physician Decision|1
5065288|NCT02336165|17476442|P3|Overall Study|Physician Decision|1
5065289|NCT02336165|17476443|P2|Overall Study|Physician Decision|2
5065290|NCT02336165|17476444|P1|Overall Study|Physician Decision|2
5065291|NCT02336165|17476440|P5|Overall Study|Death|1
5065292|NCT02336165|17476441|P4|Overall Study|Death|0
5065293|NCT02336165|17476442|P3|Overall Study|Death|0
5065294|NCT02336165|17476443|P2|Overall Study|Death|0
5065295|NCT02336165|17476444|P1|Overall Study|Death|3
5065296|NCT02336074|17476478|P2|Overall Study|Adverse Event|2
5065297|NCT02336074|17476479|P1|Overall Study|Adverse Event|0
5065298|NCT02335983|17476502|P6|Overall Study|Protocol Specified Criteria|21
5065299|NCT02335983|17476503|P5|Overall Study|Protocol Specified Criteria|5
5065300|NCT02335983|17476504|P4|Overall Study|Protocol Specified Criteria|7
5065301|NCT02335983|17476505|P3|Overall Study|Protocol Specified Criteria|27
5065302|NCT02335983|17476506|P2|Overall Study|Protocol Specified Criteria|7
5065303|NCT02335983|17476507|P1|Overall Study|Protocol Specified Criteria|5
5065304|NCT02335983|17476502|P6|Overall Study|Lost to Follow-up|1
5065305|NCT02335983|17476503|P5|Overall Study|Lost to Follow-up|0
5065306|NCT02335983|17476504|P4|Overall Study|Lost to Follow-up|0
5065307|NCT02335983|17476505|P3|Overall Study|Lost to Follow-up|0
5065308|NCT02335983|17476506|P2|Overall Study|Lost to Follow-up|0
5065309|NCT02335983|17476507|P1|Overall Study|Lost to Follow-up|0
5065310|NCT02335983|17476502|P6|Overall Study|Death|0
5065311|NCT02335983|17476503|P5|Overall Study|Death|0
5065312|NCT02335983|17476504|P4|Overall Study|Death|0
5065313|NCT02335983|17476505|P3|Overall Study|Death|2
5065314|NCT02335983|17476506|P2|Overall Study|Death|0
5065315|NCT02335983|17476507|P1|Overall Study|Death|0
5065316|NCT02335983|17476502|P6|Overall Study|Withdrawal by Subject|9
5065317|NCT02335983|17476503|P5|Overall Study|Withdrawal by Subject|3
5065318|NCT02335983|17476504|P4|Overall Study|Withdrawal by Subject|1
5065319|NCT02335983|17476505|P3|Overall Study|Withdrawal by Subject|2
5065320|NCT02335983|17476506|P2|Overall Study|Withdrawal by Subject|2
5065321|NCT02335983|17476507|P1|Overall Study|Withdrawal by Subject|3
5065322|NCT02335983|17476502|P6|Overall Study|Sponsor Decision|1
5065323|NCT02335983|17476503|P5|Overall Study|Sponsor Decision|0
5065324|NCT02335983|17476504|P4|Overall Study|Sponsor Decision|1
5065325|NCT02335983|17476505|P3|Overall Study|Sponsor Decision|1
5065326|NCT02335983|17476506|P2|Overall Study|Sponsor Decision|0
5065327|NCT02335983|17476507|P1|Overall Study|Sponsor Decision|0
5065328|NCT02335658|17476614|P2|Overall Study|other reason|3
5065329|NCT02335658|17476615|P1|Overall Study|other reason|2
5065330|NCT02335658|17476614|P2|Overall Study|non-compliance|3
5065331|NCT02335658|17476615|P1|Overall Study|non-compliance|2
5065332|NCT02335658|17476614|P2|Overall Study|Withdrawal by Subject|21
5065333|NCT02335658|17476615|P1|Overall Study|Withdrawal by Subject|13
5065334|NCT02335658|17476614|P2|Overall Study|Pregnancy|0
5065335|NCT02335658|17476615|P1|Overall Study|Pregnancy|1
5065336|NCT02335658|17476614|P2|Overall Study|Lack of Efficacy|5
5065337|NCT02335658|17476615|P1|Overall Study|Lack of Efficacy|4
5065338|NCT02335658|17476614|P2|Overall Study|Adverse Event|12
5065339|NCT02335658|17476615|P1|Overall Study|Adverse Event|18
5065340|NCT02335489|17476630|P1|Overall Study|Lack of Efficacy|1
5065341|NCT02335489|17476630|P1|Overall Study|Physician Decision|2
5065342|NCT02335489|17476630|P1|Overall Study|Withdrawal by Subject|2
5065343|NCT02335489|17476630|P1|Overall Study|Lost to Follow-up|1
5065344|NCT02335489|17476630|P1|Overall Study|Sponsor terminated study|4
5065345|NCT02335450|17476634|P1|Overall Study|Pregnancy|1
5065346|NCT02335424|17476638|P1|Overall Study|Not treated|4
5065347|NCT02335424|17476638|P1|Overall Study|Physician Decision|3
5065348|NCT02335424|17476638|P1|Overall Study|Lost to Follow-up|2
5065349|NCT02335424|17476638|P1|Overall Study|Death|239
5065350|NCT02335424|17476638|P1|Overall Study|Adverse Event|25
5065351|NCT02335424|17476638|P1|Overall Study|Ongoing In Study|89
5065352|NCT02335424|17476638|P1|Overall Study|Withdrawal by Subject|12
5065353|NCT02335346|17476671|P1|Overall Study|Withdrawal by Subject|1
5065354|NCT02335346|17476671|P1|Overall Study|Adverse Event|11
5065355|NCT02334748|17476993|P1|Overall Study|Lack of Efficacy|4
5065356|NCT02334748|17476993|P1|Overall Study|Patient no longer required study drug|2
5065357|NCT02334748|17476993|P1|Overall Study|Inclusion in the CACZ8852306 study|1
5065358|NCT02334748|17476993|P1|Overall Study|Adverse Event|1
5065359|NCT02334423|17477024|P2|Overall Study|Protocol Violation|3
5065360|NCT02334423|17477025|P1|Overall Study|Protocol Violation|10
5065361|NCT02334384|17477039|P2|Overall Study|Lost to Follow-up|1
5065362|NCT02334384|17477040|P1|Overall Study|Lost to Follow-up|1
5065363|NCT02334306|17477052|P2|Double-blind Period|Withdrawal by Subject|1
5065364|NCT02334306|17477053|P1|Double-blind Period|Withdrawal by Subject|1
5065365|NCT02334306|17477052|P2|Double-blind Period|Adverse Event|1
5065366|NCT02334306|17477053|P1|Double-blind Period|Adverse Event|0
5065367|NCT02334215|17477091|P3|Overall Study|Incarcerated|7
5065368|NCT02334215|17477092|P2|Overall Study|Incarcerated|0
5065369|NCT02334215|17477093|P1|Overall Study|Incarcerated|0
5065370|NCT02334215|17477091|P3|Overall Study|Not released from incarceration on time|3
5065371|NCT02334215|17477092|P2|Overall Study|Not released from incarceration on time|3
5065372|NCT02334215|17477093|P1|Overall Study|Not released from incarceration on time|3
5065373|NCT02334215|17477091|P3|Overall Study|Withdrawal by Subject|1
5065374|NCT02334215|17477092|P2|Overall Study|Withdrawal by Subject|2
5065375|NCT02334215|17477093|P1|Overall Study|Withdrawal by Subject|2
5065376|NCT02334215|17477091|P3|Overall Study|Lost to Follow-up|4
5065377|NCT02334215|17477092|P2|Overall Study|Lost to Follow-up|0
5065378|NCT02334215|17477093|P1|Overall Study|Lost to Follow-up|1
5065379|NCT02334215|17477091|P3|Overall Study|Death|0
5065380|NCT02334215|17477092|P2|Overall Study|Death|1
5065381|NCT02334215|17477093|P1|Overall Study|Death|1
5065382|NCT02333630|17477173|P2|Overall Study|Lost to Follow-up|2
5065383|NCT02333630|17477174|P1|Overall Study|Lost to Follow-up|5
5065384|NCT02333487|17477189|P3|Overall Study|Adverse Event|0
5065385|NCT02333487|17477190|P2|Overall Study|Adverse Event|2
5065386|NCT02333487|17477191|P1|Overall Study|Adverse Event|0
5065387|NCT02333383|17477202|P1|Overall Study|Transfer to another hospital|2
5065388|NCT02333383|17477202|P1|Overall Study|Withdrawal by Subject|3
5065389|NCT02333383|17477202|P1|Overall Study|Lost to Follow-up|15
5065390|NCT02333383|17477202|P1|Overall Study|Adalimumab discontinuation|21
5065391|NCT02333331|17477216|P4|Overall Study|Patient/Guardian Decision|1
5065392|NCT02333331|17477217|P3|Overall Study|Patient/Guardian Decision|9
5065393|NCT02333331|17477218|P2|Overall Study|Patient/Guardian Decision|2
5065394|NCT02333331|17477219|P1|Overall Study|Patient/Guardian Decision|1
5065395|NCT02333331|17477216|P4|Overall Study|Protocol Deviation|1
5065396|NCT02333331|17477217|P3|Overall Study|Protocol Deviation|2
5065397|NCT02333331|17477218|P2|Overall Study|Protocol Deviation|3
5065398|NCT02333331|17477219|P1|Overall Study|Protocol Deviation|0
5065399|NCT02333331|17477216|P4|Overall Study|Physician Decision|0
5065400|NCT02333331|17477217|P3|Overall Study|Physician Decision|0
5065401|NCT02333331|17477218|P2|Overall Study|Physician Decision|1
5065402|NCT02333331|17477219|P1|Overall Study|Physician Decision|0
5065403|NCT02333331|17477216|P4|Overall Study|Lost to Follow-up|0
5065404|NCT02333331|17477217|P3|Overall Study|Lost to Follow-up|1
5065405|NCT02333331|17477218|P2|Overall Study|Lost to Follow-up|0
5065406|NCT02333331|17477219|P1|Overall Study|Lost to Follow-up|0
5065407|NCT02333331|17477216|P4|Overall Study|Death|0
5065408|NCT02333331|17477217|P3|Overall Study|Death|2
5065409|NCT02333331|17477218|P2|Overall Study|Death|0
5065410|NCT02333331|17477219|P1|Overall Study|Death|0
5065411|NCT02333331|17477216|P4|Overall Study|Adverse Event|1
5065412|NCT02333331|17477217|P3|Overall Study|Adverse Event|4
5065413|NCT02333331|17477218|P2|Overall Study|Adverse Event|0
5065414|NCT02333331|17477219|P1|Overall Study|Adverse Event|1
5065415|NCT02332915|17477260|P2|Overall Study|did not meet inclusion criteria|4
5065416|NCT02332915|17477261|P1|Overall Study|did not meet inclusion criteria|2
5065417|NCT02332915|17477260|P2|Overall Study|Travel distance prohibitive|1
5065418|NCT02332915|17477261|P1|Overall Study|Travel distance prohibitive|0
5065419|NCT02332915|17477260|P2|Overall Study|Unrelated illness|1
5065420|NCT02332915|17477261|P1|Overall Study|Unrelated illness|1
5065421|NCT02332915|17477260|P2|Overall Study|Moved out of region|0
5065422|NCT02332915|17477261|P1|Overall Study|Moved out of region|3
5065423|NCT02332889|17477274|P1|Overall Study|Physician Decision|1
5065424|NCT02332876|17477280|P2|Overall Study|Lost to Follow-up|1
5065425|NCT02332876|17477281|P1|Overall Study|Lost to Follow-up|1
5065426|NCT02332824|17477293|P6|Overall Study|Transfer|0
5065427|NCT02332824|17477294|P5|Overall Study|Transfer|0
5065428|NCT02332824|17477295|P4|Overall Study|Transfer|1
5065429|NCT02332824|17477296|P3|Overall Study|Transfer|1
5065430|NCT02332824|17477297|P2|Overall Study|Transfer|0
5065431|NCT02332824|17477298|P1|Overall Study|Transfer|0
5065432|NCT02332824|17477293|P6|Overall Study|Inconvenient schedule|0
5065433|NCT02332824|17477294|P5|Overall Study|Inconvenient schedule|0
5065434|NCT02332824|17477295|P4|Overall Study|Inconvenient schedule|0
5065435|NCT02332824|17477296|P3|Overall Study|Inconvenient schedule|0
5065436|NCT02332824|17477297|P2|Overall Study|Inconvenient schedule|1
5065437|NCT02332824|17477298|P1|Overall Study|Inconvenient schedule|1
5065438|NCT02332824|17477293|P6|Overall Study|Voluntary Withdrawal|0
5065439|NCT02332824|17477294|P5|Overall Study|Voluntary Withdrawal|0
5065440|NCT02332824|17477295|P4|Overall Study|Voluntary Withdrawal|0
5065441|NCT02332824|17477296|P3|Overall Study|Voluntary Withdrawal|0
5065442|NCT02332824|17477297|P2|Overall Study|Voluntary Withdrawal|0
5065443|NCT02332824|17477298|P1|Overall Study|Voluntary Withdrawal|1
5065444|NCT02332824|17477293|P6|Overall Study|Pretreatment Event/Adverse Event|1
5065445|NCT02332824|17477294|P5|Overall Study|Pretreatment Event/Adverse Event|4
5065446|NCT02332824|17477295|P4|Overall Study|Pretreatment Event/Adverse Event|1
5065447|NCT02332824|17477296|P3|Overall Study|Pretreatment Event/Adverse Event|1
5065448|NCT02332824|17477297|P2|Overall Study|Pretreatment Event/Adverse Event|0
5065449|NCT02332824|17477298|P1|Overall Study|Pretreatment Event/Adverse Event|4
5065450|NCT02332798|17477339|P3|Overall Study|Abnormal Laboratory Findings|0
5065451|NCT02332798|17477340|P2|Overall Study|Abnormal Laboratory Findings|0
5065452|NCT02332798|17477341|P1|Overall Study|Abnormal Laboratory Findings|1
5065453|NCT02332798|17477339|P3|Overall Study|Positive Urine Drug Test|0
5065454|NCT02332798|17477340|P2|Overall Study|Positive Urine Drug Test|1
5065455|NCT02332798|17477341|P1|Overall Study|Positive Urine Drug Test|0
5065456|NCT02332798|17477339|P3|Overall Study|Unwilling to Participate in Study|1
5065457|NCT02332798|17477340|P2|Overall Study|Unwilling to Participate in Study|1
5065458|NCT02332798|17477341|P1|Overall Study|Unwilling to Participate in Study|0
5065459|NCT02332720|17477414|P23|Part A and Part B|Withdrawal by Subject|0
5065460|NCT02332720|17477415|P22|Part A and Part B|Withdrawal by Subject|0
5065461|NCT02332720|17477416|P21|Part A and Part B|Withdrawal by Subject|0
5065462|NCT02332720|17477417|P20|Part A and Part B|Withdrawal by Subject|1
5065463|NCT02332720|17477418|P19|Part A and Part B|Withdrawal by Subject|0
5065464|NCT02332720|17477419|P18|Part A and Part B|Withdrawal by Subject|0
5065465|NCT02332720|17477420|P17|Part A and Part B|Withdrawal by Subject|0
5065466|NCT02332720|17477421|P16|Part A and Part B|Withdrawal by Subject|0
5065467|NCT02332720|17477422|P15|Part A and Part B|Withdrawal by Subject|0
5065468|NCT02332720|17477423|P14|Part A and Part B|Withdrawal by Subject|0
5065469|NCT02332720|17477424|P13|Part A and Part B|Withdrawal by Subject|0
5065470|NCT02332720|17477425|P12|Part A and Part B|Withdrawal by Subject|0
5065471|NCT02332720|17477426|P11|Part A and Part B|Withdrawal by Subject|0
5065472|NCT02332720|17477427|P10|Part A and Part B|Withdrawal by Subject|0
5065473|NCT02332720|17477428|P9|Part A and Part B|Withdrawal by Subject|0
5065474|NCT02332720|17477429|P8|Part A and Part B|Withdrawal by Subject|0
5065475|NCT02332720|17477430|P7|Part A and Part B|Withdrawal by Subject|0
5065476|NCT02332720|17477431|P6|Part A and Part B|Withdrawal by Subject|1
5065477|NCT02332720|17477432|P5|Part A and Part B|Withdrawal by Subject|0
5065478|NCT02332720|17477433|P4|Part A and Part B|Withdrawal by Subject|0
5065479|NCT02332720|17477434|P3|Part A and Part B|Withdrawal by Subject|0
5065480|NCT02332720|17477435|P2|Part A and Part B|Withdrawal by Subject|0
5065481|NCT02332720|17477436|P1|Part A and Part B|Withdrawal by Subject|0
5065482|NCT02332720|17477414|P23|Part A and Part B|Physician Decision|0
5065483|NCT02332720|17477415|P22|Part A and Part B|Physician Decision|0
5065484|NCT02332720|17477416|P21|Part A and Part B|Physician Decision|0
5065485|NCT02332720|17477417|P20|Part A and Part B|Physician Decision|0
5065486|NCT02332720|17477418|P19|Part A and Part B|Physician Decision|1
5065487|NCT02332720|17477419|P18|Part A and Part B|Physician Decision|0
5065488|NCT02332720|17477420|P17|Part A and Part B|Physician Decision|0
5065489|NCT02332720|17477421|P16|Part A and Part B|Physician Decision|0
5065490|NCT02332720|17477422|P15|Part A and Part B|Physician Decision|0
5065491|NCT02332720|17477423|P14|Part A and Part B|Physician Decision|0
5065492|NCT02332720|17477424|P13|Part A and Part B|Physician Decision|0
5065493|NCT02332720|17477425|P12|Part A and Part B|Physician Decision|0
5065494|NCT02332720|17477426|P11|Part A and Part B|Physician Decision|0
5065495|NCT02332720|17477427|P10|Part A and Part B|Physician Decision|0
5065496|NCT02332720|17477428|P9|Part A and Part B|Physician Decision|0
5065497|NCT02332720|17477429|P8|Part A and Part B|Physician Decision|0
5065498|NCT02332720|17477430|P7|Part A and Part B|Physician Decision|0
5065499|NCT02332720|17477431|P6|Part A and Part B|Physician Decision|0
5065500|NCT02332720|17477432|P5|Part A and Part B|Physician Decision|0
5065501|NCT02332720|17477433|P4|Part A and Part B|Physician Decision|0
5065502|NCT02332720|17477434|P3|Part A and Part B|Physician Decision|0
5065503|NCT02332720|17477435|P2|Part A and Part B|Physician Decision|0
5065504|NCT02332720|17477436|P1|Part A and Part B|Physician Decision|0
5065505|NCT02332720|17477414|P23|Part A and Part B|Adverse Event|0
5065506|NCT02332720|17477415|P22|Part A and Part B|Adverse Event|0
5065507|NCT02332720|17477416|P21|Part A and Part B|Adverse Event|0
5065508|NCT02332720|17477417|P20|Part A and Part B|Adverse Event|0
5065509|NCT02332720|17477418|P19|Part A and Part B|Adverse Event|0
5065510|NCT02332720|17477419|P18|Part A and Part B|Adverse Event|1
5065511|NCT02332720|17477420|P17|Part A and Part B|Adverse Event|0
5065512|NCT02332720|17477421|P16|Part A and Part B|Adverse Event|0
5065513|NCT02332720|17477422|P15|Part A and Part B|Adverse Event|0
5065514|NCT02332720|17477423|P14|Part A and Part B|Adverse Event|0
5065515|NCT02332720|17477424|P13|Part A and Part B|Adverse Event|0
5065516|NCT02332720|17477425|P12|Part A and Part B|Adverse Event|0
5065517|NCT02332720|17477426|P11|Part A and Part B|Adverse Event|0
5065518|NCT02332720|17477427|P10|Part A and Part B|Adverse Event|0
5065519|NCT02332720|17477428|P9|Part A and Part B|Adverse Event|0
5065520|NCT02332720|17477429|P8|Part A and Part B|Adverse Event|0
5065521|NCT02332720|17477430|P7|Part A and Part B|Adverse Event|0
5065522|NCT02332720|17477431|P6|Part A and Part B|Adverse Event|0
5065523|NCT02332720|17477432|P5|Part A and Part B|Adverse Event|0
5065524|NCT02332720|17477433|P4|Part A and Part B|Adverse Event|0
5065525|NCT02332720|17477434|P3|Part A and Part B|Adverse Event|0
5065526|NCT02332720|17477435|P2|Part A and Part B|Adverse Event|0
5065527|NCT02332720|17477436|P1|Part A and Part B|Adverse Event|0
5065528|NCT02332720|17477414|P23|Part A and Part B|Lost to Follow-up|0
5065529|NCT02332720|17477415|P22|Part A and Part B|Lost to Follow-up|0
5065530|NCT02332720|17477416|P21|Part A and Part B|Lost to Follow-up|0
5065531|NCT02332720|17477417|P20|Part A and Part B|Lost to Follow-up|0
5065532|NCT02332720|17477418|P19|Part A and Part B|Lost to Follow-up|0
5065533|NCT02332720|17477419|P18|Part A and Part B|Lost to Follow-up|0
5065534|NCT02332720|17477420|P17|Part A and Part B|Lost to Follow-up|0
5065535|NCT02332720|17477421|P16|Part A and Part B|Lost to Follow-up|1
5065536|NCT02332720|17477422|P15|Part A and Part B|Lost to Follow-up|0
5065537|NCT02332720|17477423|P14|Part A and Part B|Lost to Follow-up|0
5065538|NCT02332720|17477424|P13|Part A and Part B|Lost to Follow-up|0
5065539|NCT02332720|17477425|P12|Part A and Part B|Lost to Follow-up|0
5065540|NCT02332720|17477426|P11|Part A and Part B|Lost to Follow-up|0
5065541|NCT02332720|17477427|P10|Part A and Part B|Lost to Follow-up|0
5065542|NCT02332720|17477428|P9|Part A and Part B|Lost to Follow-up|0
5065543|NCT02332720|17477429|P8|Part A and Part B|Lost to Follow-up|1
5065544|NCT02332720|17477430|P7|Part A and Part B|Lost to Follow-up|1
5065545|NCT02332720|17477431|P6|Part A and Part B|Lost to Follow-up|2
5065546|NCT02332720|17477432|P5|Part A and Part B|Lost to Follow-up|0
5065547|NCT02332720|17477433|P4|Part A and Part B|Lost to Follow-up|0
5065548|NCT02332720|17477434|P3|Part A and Part B|Lost to Follow-up|0
5065549|NCT02332720|17477435|P2|Part A and Part B|Lost to Follow-up|0
5065550|NCT02332720|17477436|P1|Part A and Part B|Lost to Follow-up|1
5065551|NCT02332707|17477572|P18|Overall Study|Withdrawal by Subject|0
5065552|NCT02332707|17477573|P17|Overall Study|Withdrawal by Subject|0
5065553|NCT02332707|17477574|P16|Overall Study|Withdrawal by Subject|0
5065554|NCT02332707|17477575|P15|Overall Study|Withdrawal by Subject|0
5065555|NCT02332707|17477576|P14|Overall Study|Withdrawal by Subject|0
5065556|NCT02332707|17477577|P13|Overall Study|Withdrawal by Subject|0
5065557|NCT02332707|17477578|P12|Overall Study|Withdrawal by Subject|0
5065558|NCT02332707|17477579|P11|Overall Study|Withdrawal by Subject|0
5065559|NCT02332707|17477580|P10|Overall Study|Withdrawal by Subject|3
5065560|NCT02332707|17477581|P9|Overall Study|Withdrawal by Subject|0
5065561|NCT02332707|17477582|P8|Overall Study|Withdrawal by Subject|0
5065562|NCT02332707|17477583|P7|Overall Study|Withdrawal by Subject|0
5065563|NCT02332707|17477584|P6|Overall Study|Withdrawal by Subject|0
5065564|NCT02332707|17477585|P5|Overall Study|Withdrawal by Subject|0
5065565|NCT02332707|17477586|P4|Overall Study|Withdrawal by Subject|0
5065566|NCT02332707|17477587|P3|Overall Study|Withdrawal by Subject|1
5065567|NCT02332707|17477588|P2|Overall Study|Withdrawal by Subject|0
5065568|NCT02332707|17477589|P1|Overall Study|Withdrawal by Subject|0
5065569|NCT02332707|17477572|P18|Overall Study|Physician Decision|0
5065570|NCT02332707|17477573|P17|Overall Study|Physician Decision|0
5065571|NCT02332707|17477574|P16|Overall Study|Physician Decision|0
5065572|NCT02332707|17477575|P15|Overall Study|Physician Decision|0
5065573|NCT02332707|17477576|P14|Overall Study|Physician Decision|0
5065574|NCT02332707|17477577|P13|Overall Study|Physician Decision|1
5065575|NCT02332707|17477578|P12|Overall Study|Physician Decision|0
5065576|NCT02332707|17477579|P11|Overall Study|Physician Decision|0
5065577|NCT02332707|17477580|P10|Overall Study|Physician Decision|0
5065578|NCT02332707|17477581|P9|Overall Study|Physician Decision|0
5065579|NCT02332707|17477582|P8|Overall Study|Physician Decision|0
5065580|NCT02332707|17477583|P7|Overall Study|Physician Decision|0
5065581|NCT02332707|17477584|P6|Overall Study|Physician Decision|0
5065582|NCT02332707|17477585|P5|Overall Study|Physician Decision|0
5065583|NCT02332707|17477586|P4|Overall Study|Physician Decision|1
5065584|NCT02332707|17477587|P3|Overall Study|Physician Decision|0
5065585|NCT02332707|17477588|P2|Overall Study|Physician Decision|0
5065586|NCT02332707|17477589|P1|Overall Study|Physician Decision|0
5065587|NCT02332707|17477572|P18|Overall Study|Lost to Follow-up|0
5065588|NCT02332707|17477573|P17|Overall Study|Lost to Follow-up|0
5065589|NCT02332707|17477574|P16|Overall Study|Lost to Follow-up|0
5065590|NCT02332707|17477575|P15|Overall Study|Lost to Follow-up|0
5065591|NCT02332707|17477576|P14|Overall Study|Lost to Follow-up|0
5065592|NCT02332707|17477577|P13|Overall Study|Lost to Follow-up|3
5065593|NCT02332707|17477578|P12|Overall Study|Lost to Follow-up|0
5065594|NCT02332707|17477579|P11|Overall Study|Lost to Follow-up|2
5065595|NCT02332707|17477580|P10|Overall Study|Lost to Follow-up|0
5065596|NCT02332707|17477581|P9|Overall Study|Lost to Follow-up|0
5065597|NCT02332707|17477582|P8|Overall Study|Lost to Follow-up|0
5065598|NCT02332707|17477583|P7|Overall Study|Lost to Follow-up|0
5065599|NCT02332707|17477584|P6|Overall Study|Lost to Follow-up|1
5065600|NCT02332707|17477585|P5|Overall Study|Lost to Follow-up|0
5065601|NCT02332707|17477586|P4|Overall Study|Lost to Follow-up|0
5065602|NCT02332707|17477587|P3|Overall Study|Lost to Follow-up|0
5065603|NCT02332707|17477588|P2|Overall Study|Lost to Follow-up|0
5065604|NCT02332707|17477589|P1|Overall Study|Lost to Follow-up|0
5065605|NCT02332707|17477572|P18|Overall Study|Adverse Event|0
5065606|NCT02332707|17477573|P17|Overall Study|Adverse Event|0
5065607|NCT02332707|17477574|P16|Overall Study|Adverse Event|0
5065608|NCT02332707|17477575|P15|Overall Study|Adverse Event|0
5065609|NCT02332707|17477576|P14|Overall Study|Adverse Event|0
5065610|NCT02332707|17477577|P13|Overall Study|Adverse Event|1
5065611|NCT02332707|17477578|P12|Overall Study|Adverse Event|0
5065612|NCT02332707|17477579|P11|Overall Study|Adverse Event|0
5065613|NCT02332707|17477580|P10|Overall Study|Adverse Event|0
5065614|NCT02332707|17477581|P9|Overall Study|Adverse Event|0
5065615|NCT02332707|17477582|P8|Overall Study|Adverse Event|0
5065616|NCT02332707|17477583|P7|Overall Study|Adverse Event|0
5065617|NCT02332707|17477584|P6|Overall Study|Adverse Event|0
5065618|NCT02332707|17477585|P5|Overall Study|Adverse Event|0
5065619|NCT02332707|17477586|P4|Overall Study|Adverse Event|0
5065620|NCT02332707|17477587|P3|Overall Study|Adverse Event|0
5065621|NCT02332707|17477588|P2|Overall Study|Adverse Event|0
5065622|NCT02332707|17477589|P1|Overall Study|Adverse Event|0
5065623|NCT02332590|17477683|P2|Overall Study|Other than specified above|5
5065624|NCT02332590|17477684|P1|Overall Study|Other than specified above|6
5065625|NCT02332590|17477683|P2|Overall Study|Randomized but not treated|0
5065626|NCT02332590|17477684|P1|Overall Study|Randomized but not treated|1
5065627|NCT02332590|17477683|P2|Overall Study|Poor compliance to protocol|1
5065628|NCT02332590|17477684|P1|Overall Study|Poor compliance to protocol|3
5065629|NCT02332590|17477683|P2|Overall Study|Lack of Efficacy|2
5065630|NCT02332590|17477684|P1|Overall Study|Lack of Efficacy|4
5065631|NCT02332590|17477683|P2|Overall Study|Adverse Event|11
5065632|NCT02332590|17477684|P1|Overall Study|Adverse Event|15
5065633|NCT02332239|17477748|P2|Overall Study|Lost to Follow-up|6
5065634|NCT02332239|17477749|P1|Overall Study|Lost to Follow-up|4
5065635|NCT02331680|17477785|P3|Overall Study|Protocol Violation|3
5065636|NCT02331680|17477786|P2|Overall Study|Protocol Violation|0
5065637|NCT02331680|17477787|P1|Overall Study|Protocol Violation|0
5065638|NCT02331680|17477785|P3|Overall Study|Non-compliance with study drug|1
5065639|NCT02331680|17477786|P2|Overall Study|Non-compliance with study drug|0
5065640|NCT02331680|17477787|P1|Overall Study|Non-compliance with study drug|0
5065641|NCT02331680|17477785|P3|Overall Study|Met withdrawal criteria|5
5065642|NCT02331680|17477786|P2|Overall Study|Met withdrawal criteria|2
5065643|NCT02331680|17477787|P1|Overall Study|Met withdrawal criteria|2
5065644|NCT02331680|17477785|P3|Overall Study|Withdrawal by Subject|2
5065645|NCT02331680|17477786|P2|Overall Study|Withdrawal by Subject|1
5065646|NCT02331680|17477787|P1|Overall Study|Withdrawal by Subject|0
5065647|NCT02331680|17477785|P3|Overall Study|Physician Decision|2
5065648|NCT02331680|17477786|P2|Overall Study|Physician Decision|1
5065649|NCT02331680|17477787|P1|Overall Study|Physician Decision|1
5065650|NCT02331680|17477785|P3|Overall Study|Adverse Event|2
5065651|NCT02331680|17477786|P2|Overall Study|Adverse Event|0
5065652|NCT02331680|17477787|P1|Overall Study|Adverse Event|3
5065653|NCT02331446|17477817|P4|Overall Study|Lost before baseline analysis|0
5065654|NCT02331446|17477818|P3|Overall Study|Lost before baseline analysis|1
5065655|NCT02331446|17477819|P2|Overall Study|Lost before baseline analysis|1
5065656|NCT02331446|17477820|P1|Overall Study|Lost before baseline analysis|0
5065657|NCT02331446|17477817|P4|Overall Study|Physician Decision|1
5065658|NCT02331446|17477818|P3|Overall Study|Physician Decision|0
5065659|NCT02331446|17477819|P2|Overall Study|Physician Decision|1
5065660|NCT02331446|17477820|P1|Overall Study|Physician Decision|0
5065661|NCT02331446|17477817|P4|Overall Study|Disease|1
5065662|NCT02331446|17477818|P3|Overall Study|Disease|2
5065663|NCT02331446|17477819|P2|Overall Study|Disease|2
5065664|NCT02331446|17477820|P1|Overall Study|Disease|0
5065665|NCT02331446|17477817|P4|Overall Study|Personal Problem|0
5065666|NCT02331446|17477818|P3|Overall Study|Personal Problem|0
5065667|NCT02331446|17477819|P2|Overall Study|Personal Problem|0
5065668|NCT02331446|17477820|P1|Overall Study|Personal Problem|2
5065669|NCT02331446|17477817|P4|Overall Study|Lost to Follow-up|1
5065670|NCT02331446|17477818|P3|Overall Study|Lost to Follow-up|0
5065671|NCT02331446|17477819|P2|Overall Study|Lost to Follow-up|1
5065672|NCT02331446|17477820|P1|Overall Study|Lost to Follow-up|2
5065673|NCT02331394|17477896|P1|Overall Study|Disease progression|1
5065674|NCT02331368|17477907|P1|Overall Study|Withdrawal by Subject|3
5065675|NCT02330549|17478032|P2|Overall Study|Failure to meet randomization criteria|0
5065676|NCT02330549|17478033|P1|Overall Study|Failure to meet randomization criteria|1
5065677|NCT02330549|17478032|P2|Overall Study|Subject withdrew consent|1
5065678|NCT02330549|17478033|P1|Overall Study|Subject withdrew consent|2
5065679|NCT02330549|17478032|P2|Overall Study|Adverse Event|0
5065680|NCT02330549|17478033|P1|Overall Study|Adverse Event|1
5065681|NCT02330081|17478249|P1|Overall Study|Protocol Violation|6
5065682|NCT02330081|17478249|P1|Overall Study|Donation did not meet criteria|1
5065683|NCT02330081|17478249|P1|Overall Study|Adverse Event|1
5065684|NCT02330055|17478270|P2|Overall Study|participant did not sleep|1
5065685|NCT02330055|17478271|P1|Overall Study|participant did not sleep|0
5065686|NCT02330055|17478270|P2|Overall Study|data for less than 60 minutes|3
5065687|NCT02330055|17478271|P1|Overall Study|data for less than 60 minutes|3
5065688|NCT02330055|17478270|P2|Overall Study|participant forgot to wear device|5
5065689|NCT02330055|17478271|P1|Overall Study|participant forgot to wear device|5
5065690|NCT02330055|17478270|P2|Overall Study|technical issues|0
5065691|NCT02330055|17478271|P1|Overall Study|technical issues|2
5065692|NCT02329743|17478317|P3|Overall Study|Other|3
5065693|NCT02329743|17478318|P2|Overall Study|Other|2
5065694|NCT02329743|17478319|P1|Overall Study|Other|0
5065695|NCT02329743|17478317|P3|Overall Study|Withdrawal by Subject|1
5065696|NCT02329743|17478318|P2|Overall Study|Withdrawal by Subject|4
5065697|NCT02329743|17478319|P1|Overall Study|Withdrawal by Subject|4
5065698|NCT02329743|17478317|P3|Overall Study|Lost to Follow-up|1
5065699|NCT02329743|17478318|P2|Overall Study|Lost to Follow-up|0
5065700|NCT02329743|17478319|P1|Overall Study|Lost to Follow-up|1
5065701|NCT02329743|17478317|P3|Overall Study|Adverse Event|3
5065702|NCT02329743|17478318|P2|Overall Study|Adverse Event|1
5065703|NCT02329743|17478319|P1|Overall Study|Adverse Event|1
5065704|NCT02329730|17478334|P12|Overall Study|Withdrawal by Subject|0
5065705|NCT02329730|17478335|P11|Overall Study|Withdrawal by Subject|0
5065706|NCT02329730|17478336|P10|Overall Study|Withdrawal by Subject|1
5065707|NCT02329730|17478337|P9|Overall Study|Withdrawal by Subject|1
5065708|NCT02329730|17478338|P8|Overall Study|Withdrawal by Subject|1
5065709|NCT02329730|17478339|P7|Overall Study|Withdrawal by Subject|1
5065710|NCT02329730|17478340|P6|Overall Study|Withdrawal by Subject|0
5065711|NCT02329730|17478341|P5|Overall Study|Withdrawal by Subject|1
5065712|NCT02329730|17478342|P4|Overall Study|Withdrawal by Subject|0
5065713|NCT02329730|17478343|P3|Overall Study|Withdrawal by Subject|0
5065714|NCT02329730|17478344|P2|Overall Study|Withdrawal by Subject|0
5065715|NCT02329730|17478345|P1|Overall Study|Withdrawal by Subject|0
5065716|NCT02329730|17478334|P12|Overall Study|Protocol Violation|0
5065717|NCT02329730|17478335|P11|Overall Study|Protocol Violation|0
5065718|NCT02329730|17478336|P10|Overall Study|Protocol Violation|0
5065719|NCT02329730|17478337|P9|Overall Study|Protocol Violation|0
5065720|NCT02329730|17478338|P8|Overall Study|Protocol Violation|0
5065721|NCT02329730|17478339|P7|Overall Study|Protocol Violation|0
5065722|NCT02329730|17478340|P6|Overall Study|Protocol Violation|2
5065723|NCT02329730|17478341|P5|Overall Study|Protocol Violation|2
5065724|NCT02329730|17478342|P4|Overall Study|Protocol Violation|0
5065725|NCT02329730|17478343|P3|Overall Study|Protocol Violation|0
5065726|NCT02329730|17478344|P2|Overall Study|Protocol Violation|0
5065727|NCT02329730|17478345|P1|Overall Study|Protocol Violation|0
5065728|NCT02329431|17478456|P2|Overall Study|Lost to Follow-up|13
5065729|NCT02329431|17478457|P1|Overall Study|Lost to Follow-up|20
5065730|NCT02329223|17478476|P3|Overall Study|Adverse Event|0
5065731|NCT02329223|17478477|P2|Overall Study|Adverse Event|1
5065732|NCT02329223|17478478|P1|Overall Study|Adverse Event|0
5065733|NCT02329223|17478476|P3|Overall Study|Physician Decision|1
5065734|NCT02329223|17478477|P2|Overall Study|Physician Decision|0
5065735|NCT02329223|17478478|P1|Overall Study|Physician Decision|0
5065736|NCT02329223|17478476|P3|Overall Study|Withdrawal by Subject|5
5065737|NCT02329223|17478477|P2|Overall Study|Withdrawal by Subject|2
5065738|NCT02329223|17478478|P1|Overall Study|Withdrawal by Subject|1
5065739|NCT02328937|17478528|P6|Period 2|Adverse Event|0
5065740|NCT02328937|17478529|P5|Period 2|Adverse Event|0
5065741|NCT02328937|17478530|P4|Period 2|Adverse Event|0
5065742|NCT02328937|17478531|P3|Period 2|Adverse Event|1
5065743|NCT02328937|17478532|P2|Period 2|Adverse Event|0
5065744|NCT02328937|17478533|P1|Period 2|Adverse Event|0
5065745|NCT02328937|17478528|P6|Period 1|Lost to Follow-up|0
5065746|NCT02328937|17478529|P5|Period 1|Lost to Follow-up|0
5065747|NCT02328937|17478530|P4|Period 1|Lost to Follow-up|1
5065748|NCT02328937|17478531|P3|Period 1|Lost to Follow-up|0
5065749|NCT02328937|17478532|P2|Period 1|Lost to Follow-up|0
5065750|NCT02328937|17478533|P1|Period 1|Lost to Follow-up|0
5065751|NCT02328547|17478553|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
5065752|NCT02328547|17478554|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
5065753|NCT02328547|17478553|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
5065754|NCT02328547|17478554|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
5065755|NCT02328326|17478631|P2|Overall Study|Lost to Follow-up|4
5065756|NCT02328326|17478632|P1|Overall Study|Lost to Follow-up|10
5065757|NCT02328326|17478631|P2|Overall Study|Death|1
5065758|NCT02328326|17478632|P1|Overall Study|Death|2
5065759|NCT02328326|17478631|P2|Overall Study|Withdrawal by Subject|3
5065760|NCT02328326|17478632|P1|Overall Study|Withdrawal by Subject|10
5065761|NCT02328105|17478640|P1|Overall Study|Still On Study in Follow-Up|4
5065762|NCT02328105|17478640|P1|Overall Study|Withdrawal by Subject|1
5065763|NCT02328105|17478640|P1|Overall Study|Death|6
5065764|NCT02328040|17478645|P2|First Intervention (2 Days)|Withdrawal by Subject|1
5065765|NCT02328040|17478646|P1|First Intervention (2 Days)|Withdrawal by Subject|1
5065766|NCT02328027|17478656|P2|Overall Study|Withdrawal by Subject|1
5065767|NCT02328027|17478657|P1|Overall Study|Withdrawal by Subject|0
5065768|NCT02327325|17478716|P3|Overall Study|Excluded by Study Team|1
5065769|NCT02327325|17478717|P2|Overall Study|Excluded by Study Team|0
5065770|NCT02327325|17478718|P1|Overall Study|Excluded by Study Team|0
5065771|NCT02327325|17478716|P3|Overall Study|Withdrawal by Subject|4
5065772|NCT02327325|17478717|P2|Overall Study|Withdrawal by Subject|4
5065773|NCT02327325|17478718|P1|Overall Study|Withdrawal by Subject|1
5065774|NCT02327260|17478741|P3|Overall Study|cognitive concerns|0
5065775|NCT02327260|17478742|P2|Overall Study|cognitive concerns|0
5065776|NCT02327260|17478743|P1|Overall Study|cognitive concerns|1
5065777|NCT02327260|17478741|P3|Overall Study|non-adherence to protocol|0
5065778|NCT02327260|17478742|P2|Overall Study|non-adherence to protocol|0
5065779|NCT02327260|17478743|P1|Overall Study|non-adherence to protocol|2
5065780|NCT02327260|17478741|P3|Overall Study|invalid phone number|0
5065781|NCT02327260|17478742|P2|Overall Study|invalid phone number|1
5065782|NCT02327260|17478743|P1|Overall Study|invalid phone number|1
5065783|NCT02327260|17478741|P3|Overall Study|Lost to Follow-up|2
5065784|NCT02327260|17478742|P2|Overall Study|Lost to Follow-up|3
5065785|NCT02327260|17478743|P1|Overall Study|Lost to Follow-up|2
5065786|NCT02327169|17478790|P15|Overall Study|Lost to Follow-up|0
5065787|NCT02327169|17478791|P14|Overall Study|Lost to Follow-up|0
5065788|NCT02327169|17478792|P13|Overall Study|Lost to Follow-up|0
5065789|NCT02327169|17478793|P12|Overall Study|Lost to Follow-up|0
5065790|NCT02327169|17478794|P11|Overall Study|Lost to Follow-up|0
5065791|NCT02327169|17478795|P10|Overall Study|Lost to Follow-up|0
5065792|NCT02327169|17478796|P9|Overall Study|Lost to Follow-up|0
5065793|NCT02327169|17478797|P8|Overall Study|Lost to Follow-up|0
5065794|NCT02327169|17478798|P7|Overall Study|Lost to Follow-up|0
5065795|NCT02327169|17478799|P6|Overall Study|Lost to Follow-up|0
5065796|NCT02327169|17478800|P5|Overall Study|Lost to Follow-up|1
5065797|NCT02327169|17478801|P4|Overall Study|Lost to Follow-up|0
5065798|NCT02327169|17478802|P3|Overall Study|Lost to Follow-up|0
5065799|NCT02327169|17478803|P2|Overall Study|Lost to Follow-up|0
5065800|NCT02327169|17478804|P1|Overall Study|Lost to Follow-up|0
5065801|NCT02327169|17478790|P15|Overall Study|Withdrawal by Subject|3
5065802|NCT02327169|17478791|P14|Overall Study|Withdrawal by Subject|0
5065803|NCT02327169|17478792|P13|Overall Study|Withdrawal by Subject|0
5065804|NCT02327169|17478793|P12|Overall Study|Withdrawal by Subject|0
5065805|NCT02327169|17478794|P11|Overall Study|Withdrawal by Subject|0
5065806|NCT02327169|17478795|P10|Overall Study|Withdrawal by Subject|0
5065807|NCT02327169|17478796|P9|Overall Study|Withdrawal by Subject|0
5065808|NCT02327169|17478797|P8|Overall Study|Withdrawal by Subject|1
5065809|NCT02327169|17478798|P7|Overall Study|Withdrawal by Subject|0
5065810|NCT02327169|17478799|P6|Overall Study|Withdrawal by Subject|0
5065811|NCT02327169|17478800|P5|Overall Study|Withdrawal by Subject|1
5065812|NCT02327169|17478801|P4|Overall Study|Withdrawal by Subject|0
5065813|NCT02327169|17478802|P3|Overall Study|Withdrawal by Subject|0
5065814|NCT02327169|17478803|P2|Overall Study|Withdrawal by Subject|0
5065815|NCT02327169|17478804|P1|Overall Study|Withdrawal by Subject|1
5065816|NCT02327169|17478790|P15|Overall Study|Reason Not Specified|2
5065817|NCT02327169|17478791|P14|Overall Study|Reason Not Specified|0
5065818|NCT02327169|17478792|P13|Overall Study|Reason Not Specified|0
5065819|NCT02327169|17478793|P12|Overall Study|Reason Not Specified|1
5065820|NCT02327169|17478794|P11|Overall Study|Reason Not Specified|2
5065821|NCT02327169|17478795|P10|Overall Study|Reason Not Specified|1
5065822|NCT02327169|17478796|P9|Overall Study|Reason Not Specified|0
5065823|NCT02327169|17478797|P8|Overall Study|Reason Not Specified|0
5065824|NCT02327169|17478798|P7|Overall Study|Reason Not Specified|0
5065825|NCT02327169|17478799|P6|Overall Study|Reason Not Specified|0
5065826|NCT02327169|17478800|P5|Overall Study|Reason Not Specified|0
5065827|NCT02327169|17478801|P4|Overall Study|Reason Not Specified|0
5065828|NCT02327169|17478802|P3|Overall Study|Reason Not Specified|1
5065829|NCT02327169|17478803|P2|Overall Study|Reason Not Specified|0
5065830|NCT02327169|17478804|P1|Overall Study|Reason Not Specified|0
5065831|NCT02327169|17478790|P15|Overall Study|Symptomatic Deterioration|1
5065832|NCT02327169|17478791|P14|Overall Study|Symptomatic Deterioration|2
5065833|NCT02327169|17478792|P13|Overall Study|Symptomatic Deterioration|0
5065834|NCT02327169|17478793|P12|Overall Study|Symptomatic Deterioration|0
5065835|NCT02327169|17478794|P11|Overall Study|Symptomatic Deterioration|0
5065836|NCT02327169|17478795|P10|Overall Study|Symptomatic Deterioration|1
5065837|NCT02327169|17478796|P9|Overall Study|Symptomatic Deterioration|2
5065838|NCT02327169|17478797|P8|Overall Study|Symptomatic Deterioration|0
5065839|NCT02327169|17478798|P7|Overall Study|Symptomatic Deterioration|0
5065840|NCT02327169|17478799|P6|Overall Study|Symptomatic Deterioration|1
5065841|NCT02327169|17478800|P5|Overall Study|Symptomatic Deterioration|1
5065842|NCT02327169|17478801|P4|Overall Study|Symptomatic Deterioration|0
5065843|NCT02327169|17478802|P3|Overall Study|Symptomatic Deterioration|1
5065844|NCT02327169|17478803|P2|Overall Study|Symptomatic Deterioration|0
5065845|NCT02327169|17478804|P1|Overall Study|Symptomatic Deterioration|0
5065846|NCT02327169|17478790|P15|Overall Study|Adverse Event|1
5065847|NCT02327169|17478791|P14|Overall Study|Adverse Event|2
5065848|NCT02327169|17478792|P13|Overall Study|Adverse Event|0
5065849|NCT02327169|17478793|P12|Overall Study|Adverse Event|3
5065850|NCT02327169|17478794|P11|Overall Study|Adverse Event|0
5065851|NCT02327169|17478795|P10|Overall Study|Adverse Event|2
5065852|NCT02327169|17478796|P9|Overall Study|Adverse Event|0
5065853|NCT02327169|17478797|P8|Overall Study|Adverse Event|0
5065854|NCT02327169|17478798|P7|Overall Study|Adverse Event|0
5065855|NCT02327169|17478799|P6|Overall Study|Adverse Event|0
5065856|NCT02327169|17478800|P5|Overall Study|Adverse Event|1
5065857|NCT02327169|17478801|P4|Overall Study|Adverse Event|0
5065858|NCT02327169|17478802|P3|Overall Study|Adverse Event|1
5065859|NCT02327169|17478803|P2|Overall Study|Adverse Event|0
5065860|NCT02327169|17478804|P1|Overall Study|Adverse Event|2
5065861|NCT02327169|17478790|P15|Overall Study|Progressive Disease|3
5065862|NCT02327169|17478791|P14|Overall Study|Progressive Disease|3
5065863|NCT02327169|17478792|P13|Overall Study|Progressive Disease|1
5065864|NCT02327169|17478793|P12|Overall Study|Progressive Disease|3
5065865|NCT02327169|17478794|P11|Overall Study|Progressive Disease|4
5065866|NCT02327169|17478795|P10|Overall Study|Progressive Disease|4
5065867|NCT02327169|17478796|P9|Overall Study|Progressive Disease|4
5065868|NCT02327169|17478797|P8|Overall Study|Progressive Disease|3
5065869|NCT02327169|17478798|P7|Overall Study|Progressive Disease|3
5065870|NCT02327169|17478799|P6|Overall Study|Progressive Disease|3
5065871|NCT02327169|17478800|P5|Overall Study|Progressive Disease|4
5065872|NCT02327169|17478801|P4|Overall Study|Progressive Disease|3
5065873|NCT02327169|17478802|P3|Overall Study|Progressive Disease|4
5065874|NCT02327169|17478803|P2|Overall Study|Progressive Disease|3
5065875|NCT02327169|17478804|P1|Overall Study|Progressive Disease|1
5065876|NCT02327130|17479034|P1|Overall Study|Met exclusion criteria|3
5065877|NCT02327130|17479034|P1|Overall Study|Incorrectly place ventilator adaptor|1
5065878|NCT02327130|17479034|P1|Overall Study|Unable to provide breath sample|1
5065879|NCT02327130|17479034|P1|Overall Study|Physician Decision|2
5065880|NCT02327130|17479034|P1|Overall Study|Discharged in less than 5 days|5
5065881|NCT02327013|17479053|P5|Overall Study|Withdrawal before treatment|0
5065882|NCT02327013|17479054|P4|Overall Study|Withdrawal before treatment|0
5065883|NCT02327013|17479055|P3|Overall Study|Withdrawal before treatment|5
5065884|NCT02327013|17479056|P2|Overall Study|Withdrawal before treatment|1
5065885|NCT02327013|17479057|P1|Overall Study|Withdrawal before treatment|2
5065886|NCT02327013|17479053|P5|Overall Study|Protocol Violation|1
5065887|NCT02327013|17479054|P4|Overall Study|Protocol Violation|0
5065888|NCT02327013|17479055|P3|Overall Study|Protocol Violation|3
5065889|NCT02327013|17479056|P2|Overall Study|Protocol Violation|0
5065890|NCT02327013|17479057|P1|Overall Study|Protocol Violation|0
5065891|NCT02327013|17479053|P5|Overall Study|Administrative or other reason(s)|1
5065892|NCT02327013|17479054|P4|Overall Study|Administrative or other reason(s)|1
5065893|NCT02327013|17479055|P3|Overall Study|Administrative or other reason(s)|11
5065894|NCT02327013|17479056|P2|Overall Study|Administrative or other reason(s)|5
5065895|NCT02327013|17479057|P1|Overall Study|Administrative or other reason(s)|1
5065896|NCT02327013|17479053|P5|Overall Study|Lost to Follow-up|0
5065897|NCT02327013|17479054|P4|Overall Study|Lost to Follow-up|0
5065898|NCT02327013|17479055|P3|Overall Study|Lost to Follow-up|5
5065899|NCT02327013|17479056|P2|Overall Study|Lost to Follow-up|4
5065900|NCT02327013|17479057|P1|Overall Study|Lost to Follow-up|2
5065901|NCT02327013|17479053|P5|Overall Study|Withdrawal of Consent|0
5065902|NCT02327013|17479054|P4|Overall Study|Withdrawal of Consent|0
5065903|NCT02327013|17479055|P3|Overall Study|Withdrawal of Consent|3
5065904|NCT02327013|17479056|P2|Overall Study|Withdrawal of Consent|0
5065905|NCT02327013|17479057|P1|Overall Study|Withdrawal of Consent|1
5065906|NCT02327013|17479053|P5|Overall Study|Non-compliance with IMP|0
5065907|NCT02327013|17479054|P4|Overall Study|Non-compliance with IMP|0
5065908|NCT02327013|17479055|P3|Overall Study|Non-compliance with IMP|7
5065909|NCT02327013|17479056|P2|Overall Study|Non-compliance with IMP|2
5065910|NCT02327013|17479057|P1|Overall Study|Non-compliance with IMP|1
5065911|NCT02327013|17479053|P5|Overall Study|Lack of Efficacy|1
5065912|NCT02327013|17479054|P4|Overall Study|Lack of Efficacy|0
5065913|NCT02327013|17479055|P3|Overall Study|Lack of Efficacy|5
5065914|NCT02327013|17479056|P2|Overall Study|Lack of Efficacy|0
5065915|NCT02327013|17479057|P1|Overall Study|Lack of Efficacy|2
5065916|NCT02327013|17479053|P5|Overall Study|Adverse Event|1
5065917|NCT02327013|17479054|P4|Overall Study|Adverse Event|0
5065918|NCT02327013|17479055|P3|Overall Study|Adverse Event|3
5065919|NCT02327013|17479056|P2|Overall Study|Adverse Event|4
5065920|NCT02327013|17479057|P1|Overall Study|Adverse Event|4
5065921|NCT02326597|17479245|P2|Overall Study|Lost to Follow-up|32
5065922|NCT02326597|17479246|P1|Overall Study|Lost to Follow-up|42
5065923|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
5065924|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
5065925|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
5065926|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065927|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065928|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065929|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065930|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065931|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065932|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065933|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065934|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065935|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065936|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5065937|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5065938|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
5065939|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
5065940|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065941|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065942|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065943|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065944|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065945|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065946|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065947|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065948|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065949|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065950|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5065951|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5066887|NCT02322775|17480420|P2|Overall Study|Lost to Follow-up|1
5065952|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
5065953|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
5065954|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065955|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065956|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065957|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065958|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065959|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065960|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065961|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065962|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065963|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065964|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5065965|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
5065966|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065967|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065968|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065969|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065970|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065971|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065972|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065973|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065974|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065975|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065976|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065977|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065978|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5065979|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065980|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5065981|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5065982|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065983|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065984|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065985|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065986|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065987|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065988|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065989|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065990|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065991|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065992|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5065993|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5065994|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5065995|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5065996|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5065997|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5065998|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5065999|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066000|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066001|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066002|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066003|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066004|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066005|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066006|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066007|NCT02326298|17479292|P14|Open-label Period (Week 48 to Week 144)|Death|0
5066008|NCT02326298|17479293|P13|Open-label Period (Week 48 to Week 144)|Death|0
5066009|NCT02326298|17479294|P12|Open-label Period (Week 48 to Week 144)|Death|1
5066010|NCT02326298|17479295|P11|Open-label Period (Week 48 to Week 144)|Death|0
5066011|NCT02326298|17479296|P10|Open-label Period (Week 48 to Week 144)|Death|0
5066012|NCT02326298|17479297|P9|Open-label Period (Week 48 to Week 144)|Death|0
5066013|NCT02326298|17479298|P8|Open-label Period (Week 48 to Week 144)|Death|0
5066014|NCT02326298|17479299|P7|Open-label Period (Week 48 to Week 144)|Death|0
5066015|NCT02326298|17479300|P6|Open-label Period (Week 48 to Week 144)|Death|0
5066016|NCT02326298|17479301|P5|Open-label Period (Week 48 to Week 144)|Death|0
5066017|NCT02326298|17479302|P4|Open-label Period (Week 48 to Week 144)|Death|0
5066018|NCT02326298|17479303|P3|Open-label Period (Week 48 to Week 144)|Death|0
5066019|NCT02326298|17479304|P2|Open-label Period (Week 48 to Week 144)|Death|0
5066020|NCT02326298|17479305|P1|Open-label Period (Week 48 to Week 144)|Death|0
5066021|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066022|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066023|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066024|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066025|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066026|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066027|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066028|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066029|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
5066030|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066031|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066032|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066033|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066034|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5066035|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066036|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066037|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066038|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066039|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066040|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066041|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5066042|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066043|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066044|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066045|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066046|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066047|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066048|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066049|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066050|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066051|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066052|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066053|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066054|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066055|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5066056|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
5066057|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066058|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066059|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066060|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066061|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066062|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066063|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066064|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066065|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066066|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066067|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066068|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066069|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
5066070|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066071|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066072|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066073|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066074|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066075|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066076|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5066077|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066078|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066079|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066080|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066081|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066082|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066083|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066084|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
5066085|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066086|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066087|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066088|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066089|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066090|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066091|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066092|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066093|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066094|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066095|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066096|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066097|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066098|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066099|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
5066100|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066101|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066102|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066103|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066104|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5066105|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066106|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066107|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066108|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066109|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066110|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
5066111|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066112|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
5066113|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
5066114|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066115|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066116|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066117|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066118|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5066119|NCT02326298|17479292|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066120|NCT02326298|17479293|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066121|NCT02326298|17479294|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066122|NCT02326298|17479295|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066123|NCT02326298|17479296|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066124|NCT02326298|17479297|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066125|NCT02326298|17479298|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066126|NCT02326298|17479299|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
5066127|NCT02326298|17479300|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066128|NCT02326298|17479301|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066129|NCT02326298|17479302|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066130|NCT02326298|17479303|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066131|NCT02326298|17479304|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066132|NCT02326298|17479305|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066133|NCT02326298|17479292|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066134|NCT02326298|17479293|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066135|NCT02326298|17479294|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066136|NCT02326298|17479295|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066137|NCT02326298|17479296|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066138|NCT02326298|17479297|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066139|NCT02326298|17479298|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066140|NCT02326298|17479299|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066141|NCT02326298|17479300|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066142|NCT02326298|17479301|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066143|NCT02326298|17479302|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066144|NCT02326298|17479303|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
5066145|NCT02326298|17479304|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066146|NCT02326298|17479305|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5066147|NCT02326298|17479292|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066148|NCT02326298|17479293|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066149|NCT02326298|17479294|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066150|NCT02326298|17479295|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066151|NCT02326298|17479296|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066152|NCT02326298|17479297|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066153|NCT02326298|17479298|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066154|NCT02326298|17479299|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066155|NCT02326298|17479300|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066156|NCT02326298|17479301|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066157|NCT02326298|17479302|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066158|NCT02326298|17479303|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066159|NCT02326298|17479304|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
5066160|NCT02326298|17479305|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
5066161|NCT02326298|17479292|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066162|NCT02326298|17479293|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066163|NCT02326298|17479294|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066164|NCT02326298|17479295|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066165|NCT02326298|17479296|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066166|NCT02326298|17479297|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066167|NCT02326298|17479298|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066168|NCT02326298|17479299|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066169|NCT02326298|17479300|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066170|NCT02326298|17479301|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066171|NCT02326298|17479302|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066172|NCT02326298|17479303|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066173|NCT02326298|17479304|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5066174|NCT02326298|17479305|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5066175|NCT02326298|17479292|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066176|NCT02326298|17479293|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066177|NCT02326298|17479294|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066178|NCT02326298|17479295|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066179|NCT02326298|17479296|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066180|NCT02326298|17479297|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066181|NCT02326298|17479298|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066182|NCT02326298|17479299|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066183|NCT02326298|17479300|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066184|NCT02326298|17479301|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066185|NCT02326298|17479302|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066186|NCT02326298|17479303|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066187|NCT02326298|17479304|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5066188|NCT02326298|17479305|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
5066189|NCT02326298|17479292|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066190|NCT02326298|17479293|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066191|NCT02326298|17479294|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066192|NCT02326298|17479295|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066193|NCT02326298|17479296|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066194|NCT02326298|17479297|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066195|NCT02326298|17479298|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066196|NCT02326298|17479299|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066197|NCT02326298|17479300|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066198|NCT02326298|17479301|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066199|NCT02326298|17479302|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066200|NCT02326298|17479303|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5066201|NCT02326298|17479304|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066202|NCT02326298|17479305|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066203|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066204|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066205|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
5066206|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066207|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066208|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066209|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066210|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066211|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066212|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066213|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066214|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066215|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066216|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066217|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5066218|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066219|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066220|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066221|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
5066222|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066223|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066224|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066225|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066226|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066227|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066228|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066229|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066230|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066231|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066232|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5066233|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5066234|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066235|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5066236|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
5066237|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066238|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066239|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066240|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066241|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066242|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066243|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066244|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066245|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066246|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066247|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5066248|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
5066249|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066250|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066251|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
5066252|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066253|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066254|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066255|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066256|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066257|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066258|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066259|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066260|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066261|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066262|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5066263|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
5066264|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066265|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
5066266|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066267|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
5066268|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066269|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066270|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066271|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066272|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066273|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066274|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066275|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066276|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066277|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5066278|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066279|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066280|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066281|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
5066282|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066283|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066284|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066285|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066286|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066287|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066288|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066289|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066290|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066291|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066292|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5066293|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066294|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066295|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5066296|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066297|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5066298|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066299|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066300|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066301|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066302|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066303|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066304|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066305|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066306|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066307|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5066308|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
5066309|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066310|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5066311|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
5066312|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
5066313|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066314|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066315|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066316|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066317|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066318|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066319|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066320|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066321|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066322|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5066323|NCT02326272|17479328|P15|Open-label Period (Week 48 to Week 144)|Death|0
5066324|NCT02326272|17479329|P14|Open-label Period (Week 48 to Week 144)|Death|0
5066325|NCT02326272|17479330|P13|Open-label Period (Week 48 to Week 144)|Death|1
5066326|NCT02326272|17479331|P12|Open-label Period (Week 48 to Week 144)|Death|0
5066327|NCT02326272|17479332|P11|Open-label Period (Week 48 to Week 144)|Death|0
5066328|NCT02326272|17479333|P10|Open-label Period (Week 48 to Week 144)|Death|0
5066329|NCT02326272|17479334|P9|Open-label Period (Week 48 to Week 144)|Death|0
5066330|NCT02326272|17479335|P8|Open-label Period (Week 48 to Week 144)|Death|0
5066331|NCT02326272|17479336|P7|Open-label Period (Week 48 to Week 144)|Death|0
5066332|NCT02326272|17479337|P6|Open-label Period (Week 48 to Week 144)|Death|0
5066333|NCT02326272|17479338|P5|Open-label Period (Week 48 to Week 144)|Death|0
5066334|NCT02326272|17479339|P4|Open-label Period (Week 48 to Week 144)|Death|0
5066335|NCT02326272|17479340|P3|Open-label Period (Week 48 to Week 144)|Death|0
5066336|NCT02326272|17479341|P2|Open-label Period (Week 48 to Week 144)|Death|0
5066337|NCT02326272|17479342|P1|Open-label Period (Week 48 to Week 144)|Death|0
5066338|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066339|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066340|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066341|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066342|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066343|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066344|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066345|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066346|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
5066347|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066348|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066349|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066350|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066351|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066352|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5066353|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066354|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066355|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066356|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066357|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066358|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066359|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066360|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066361|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066362|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
5066363|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066364|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066365|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066366|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066367|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5066368|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066369|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066370|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066371|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066372|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066373|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066374|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
5066375|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
5066376|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
5066377|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
5066378|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066379|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066380|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066381|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066382|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5066383|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066384|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066385|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066386|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066387|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066388|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066389|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
5066390|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066391|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066392|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066393|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066394|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066395|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066396|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066397|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5066398|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066399|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066400|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066401|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066402|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066403|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066404|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066405|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066406|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
5066407|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066408|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066409|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066410|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066411|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066412|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5066413|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066414|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066415|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066416|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066417|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066418|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066419|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066420|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
5066421|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066422|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066423|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066424|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066425|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066426|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066427|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5066428|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066429|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066430|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066431|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066432|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066433|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066434|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066435|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066436|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066437|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
5066438|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066439|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5066440|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066441|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066442|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5066443|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066444|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066445|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066446|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066447|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066448|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066449|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066450|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5066451|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066452|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5066453|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066454|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066455|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066456|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066457|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5066458|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066459|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066460|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066461|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066462|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066463|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5066464|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5066465|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066466|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5066467|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
5066468|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066469|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066470|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066471|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066472|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5066473|NCT02326272|17479328|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066474|NCT02326272|17479329|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066475|NCT02326272|17479330|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066476|NCT02326272|17479331|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066477|NCT02326272|17479332|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066478|NCT02326272|17479333|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066479|NCT02326272|17479334|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5066480|NCT02326272|17479335|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5066481|NCT02326272|17479336|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
5066482|NCT02326272|17479337|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
5066483|NCT02326272|17479338|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5066484|NCT02326272|17479339|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066485|NCT02326272|17479340|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066486|NCT02326272|17479341|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066487|NCT02326272|17479342|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5066488|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066489|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066490|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066491|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066492|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066493|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066494|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066495|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066496|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066497|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066498|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066499|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066500|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
5066501|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066502|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5066503|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066504|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066505|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066506|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066507|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066508|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066509|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066510|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066511|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066512|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066513|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066514|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066515|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
5066516|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066517|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5066518|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066519|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066520|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066521|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066522|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066523|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066524|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066525|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066526|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066527|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066528|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066529|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066530|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
5066531|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066532|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
5066533|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066534|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066535|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066536|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066537|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066538|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066539|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066540|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066541|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066542|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066543|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066544|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066545|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
5066546|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066547|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5066548|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066549|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066550|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066551|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066552|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066553|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066554|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066555|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066556|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066557|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066558|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066559|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5066560|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5066561|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
5066562|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
5066563|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066564|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066565|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066566|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066567|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066568|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066569|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066570|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066571|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066572|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066573|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066574|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066575|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5066576|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
5066577|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5066578|NCT02326272|17479328|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066579|NCT02326272|17479329|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066580|NCT02326272|17479330|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066581|NCT02326272|17479331|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066582|NCT02326272|17479332|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066583|NCT02326272|17479333|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066584|NCT02326272|17479334|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066585|NCT02326272|17479335|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066586|NCT02326272|17479336|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066587|NCT02326272|17479337|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066588|NCT02326272|17479338|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066589|NCT02326272|17479339|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066590|NCT02326272|17479340|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5066591|NCT02326272|17479341|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
5066592|NCT02326272|17479342|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
5066593|NCT02326220|17479379|P3|Open-label Treatment Period|Lost to Follow-up|1
5066594|NCT02326220|17479380|P2|Open-label Treatment Period|Lost to Follow-up|0
5066595|NCT02326220|17479381|P1|Open-label Treatment Period|Lost to Follow-up|0
5066596|NCT02326220|17479379|P3|Open-label Treatment Period|Withdrawal by Subject|1
5066597|NCT02326220|17479380|P2|Open-label Treatment Period|Withdrawal by Subject|0
5066598|NCT02326220|17479381|P1|Open-label Treatment Period|Withdrawal by Subject|0
5066599|NCT02326220|17479379|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5066600|NCT02326220|17479380|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5066601|NCT02326220|17479381|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5066602|NCT02326220|17479379|P3|Double-blind Treatment Period|Protocol Violation|0
5066603|NCT02326220|17479380|P2|Double-blind Treatment Period|Protocol Violation|1
5066604|NCT02326220|17479381|P1|Double-blind Treatment Period|Protocol Violation|0
5066605|NCT02326220|17479379|P3|Double-blind Treatment Period|Adverse Event|0
5066606|NCT02326220|17479380|P2|Double-blind Treatment Period|Adverse Event|2
5066607|NCT02326220|17479381|P1|Double-blind Treatment Period|Adverse Event|1
5066608|NCT02326025|17479434|P2|Overall Study|Protocol Violation|1
5066609|NCT02326025|17479435|P1|Overall Study|Protocol Violation|0
5066610|NCT02326025|17479434|P2|Overall Study|Withdrawal by Subject|2
5066611|NCT02326025|17479435|P1|Overall Study|Withdrawal by Subject|0
5066612|NCT02326025|17479434|P2|Overall Study|Physician and Participant Decision|0
5066613|NCT02326025|17479435|P1|Overall Study|Physician and Participant Decision|1
5066614|NCT02326025|17479434|P2|Overall Study|Physician Decision|2
5066615|NCT02326025|17479435|P1|Overall Study|Physician Decision|1
5066616|NCT02326025|17479434|P2|Overall Study|Adverse Event|0
5066617|NCT02326025|17479435|P1|Overall Study|Adverse Event|3
5066618|NCT02325791|17479482|P4|Overall Study|Withdrawal by Subject|16
5066619|NCT02325791|17479483|P3|Overall Study|Withdrawal by Subject|8
5066620|NCT02325791|17479484|P2|Overall Study|Withdrawal by Subject|5
5066621|NCT02325791|17479485|P1|Overall Study|Withdrawal by Subject|0
5066622|NCT02325791|17479482|P4|Overall Study|Protocol Violation|0
5066623|NCT02325791|17479483|P3|Overall Study|Protocol Violation|1
5066624|NCT02325791|17479484|P2|Overall Study|Protocol Violation|0
5066625|NCT02325791|17479485|P1|Overall Study|Protocol Violation|0
5066626|NCT02325791|17479482|P4|Overall Study|Physician Decision|0
5066627|NCT02325791|17479483|P3|Overall Study|Physician Decision|1
5066628|NCT02325791|17479484|P2|Overall Study|Physician Decision|1
5066629|NCT02325791|17479485|P1|Overall Study|Physician Decision|0
5066630|NCT02325791|17479482|P4|Overall Study|Lost to Follow-up|9
5066631|NCT02325791|17479483|P3|Overall Study|Lost to Follow-up|14
5066632|NCT02325791|17479484|P2|Overall Study|Lost to Follow-up|15
5066633|NCT02325791|17479485|P1|Overall Study|Lost to Follow-up|0
5066634|NCT02325791|17479482|P4|Overall Study|Death|1
5066635|NCT02325791|17479483|P3|Overall Study|Death|0
5066636|NCT02325791|17479484|P2|Overall Study|Death|3
5066637|NCT02325791|17479485|P1|Overall Study|Death|0
5066638|NCT02325791|17479482|P4|Overall Study|Adverse Event|0
5066639|NCT02325791|17479483|P3|Overall Study|Adverse Event|1
5066640|NCT02325791|17479484|P2|Overall Study|Adverse Event|1
5066641|NCT02325791|17479485|P1|Overall Study|Adverse Event|0
5066642|NCT02325713|17479520|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066643|NCT02325713|17479521|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066644|NCT02325713|17479522|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066645|NCT02325713|17479523|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066646|NCT02325713|17479524|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066647|NCT02325713|17479525|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066648|NCT02325713|17479526|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
5066649|NCT02325713|17479527|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066650|NCT02325713|17479528|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066651|NCT02325713|17479529|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066652|NCT02325713|17479530|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066653|NCT02325713|17479531|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066654|NCT02325713|17479532|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066655|NCT02325713|17479533|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066656|NCT02325713|17479534|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066657|NCT02325713|17479535|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5066658|NCT02325713|17479520|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066659|NCT02325713|17479521|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066660|NCT02325713|17479522|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066661|NCT02325713|17479523|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066662|NCT02325713|17479524|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066663|NCT02325713|17479525|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066664|NCT02325713|17479526|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066665|NCT02325713|17479527|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066666|NCT02325713|17479528|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066667|NCT02325713|17479529|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066668|NCT02325713|17479530|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066669|NCT02325713|17479531|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066670|NCT02325713|17479532|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066671|NCT02325713|17479533|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066672|NCT02325713|17479534|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5066673|NCT02325713|17479535|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
5066674|NCT02325713|17479520|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066675|NCT02325713|17479521|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066676|NCT02325713|17479522|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066677|NCT02325713|17479523|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066678|NCT02325713|17479524|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066679|NCT02325713|17479525|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
5066680|NCT02325713|17479526|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066681|NCT02325713|17479527|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066682|NCT02325713|17479528|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066683|NCT02325713|17479529|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066684|NCT02325713|17479530|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066685|NCT02325713|17479531|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066686|NCT02325713|17479532|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066687|NCT02325713|17479533|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066688|NCT02325713|17479534|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066689|NCT02325713|17479535|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5066690|NCT02325518|17479649|P2|Overall Study|Withdrawal by Subject|1
5066691|NCT02325518|17479650|P1|Overall Study|Withdrawal by Subject|0
5066692|NCT02325518|17479649|P2|Overall Study|Physician Decision|1
5066693|NCT02325518|17479650|P1|Overall Study|Physician Decision|0
5066694|NCT02325518|17479649|P2|Overall Study|Adverse Event|1
5066695|NCT02325518|17479650|P1|Overall Study|Adverse Event|4
5066696|NCT02325401|17479659|P3|Overall Study|Withdrawal by Subject|1
5066697|NCT02325401|17479660|P2|Overall Study|Withdrawal by Subject|1
5066698|NCT02325401|17479661|P1|Overall Study|Withdrawal by Subject|0
5066699|NCT02325219|17479684|P5|After Controlled Period (Week 16 - 52)|Pregnancy|0
5066700|NCT02325219|17479685|P4|After Controlled Period (Week 16 - 52)|Pregnancy|0
5066701|NCT02325219|17479686|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
5066702|NCT02325219|17479687|P2|After Controlled Period (Week 16 - 52)|Pregnancy|1
5066703|NCT02325219|17479688|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
5066704|NCT02325219|17479684|P5|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5066705|NCT02325219|17479685|P4|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5066706|NCT02325219|17479686|P3|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5066707|NCT02325219|17479687|P2|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
5066708|NCT02325219|17479688|P1|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5066709|NCT02325219|17479684|P5|After Controlled Period (Week 16 - 52)|Adverse Event|1
5066710|NCT02325219|17479685|P4|After Controlled Period (Week 16 - 52)|Adverse Event|0
5066711|NCT02325219|17479686|P3|After Controlled Period (Week 16 - 52)|Adverse Event|0
5066712|NCT02325219|17479687|P2|After Controlled Period (Week 16 - 52)|Adverse Event|0
5066713|NCT02325219|17479688|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
5066714|NCT02325219|17479684|P5|Controlled Period (Week 0 - 16)|Other|0
5066715|NCT02325219|17479685|P4|Controlled Period (Week 0 - 16)|Other|0
5066716|NCT02325219|17479686|P3|Controlled Period (Week 0 - 16)|Other|1
5066717|NCT02325219|17479687|P2|Controlled Period (Week 0 - 16)|Other|0
5066718|NCT02325219|17479688|P1|Controlled Period (Week 0 - 16)|Other|0
5066719|NCT02325219|17479684|P5|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5066720|NCT02325219|17479685|P4|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5066721|NCT02325219|17479686|P3|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5066722|NCT02325219|17479687|P2|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
5066723|NCT02325219|17479688|P1|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
5066724|NCT02325219|17479684|P5|Controlled Period (Week 0 - 16)|Adverse Event|0
5066725|NCT02325219|17479685|P4|Controlled Period (Week 0 - 16)|Adverse Event|0
5066726|NCT02325219|17479686|P3|Controlled Period (Week 0 - 16)|Adverse Event|0
5066727|NCT02325219|17479687|P2|Controlled Period (Week 0 - 16)|Adverse Event|1
5066728|NCT02325219|17479688|P1|Controlled Period (Week 0 - 16)|Adverse Event|6
5066729|NCT02324842|17479880|P3|Overall Study|Lost to Follow-up|2
5066730|NCT02324842|17479881|P2|Overall Study|Lost to Follow-up|1
5066731|NCT02324842|17479882|P1|Overall Study|Lost to Follow-up|1
5066732|NCT02324699|17479916|P1|Overall Study|study terminated|1
5066733|NCT02324569|17480036|P2|Overall Study|Inconvenient Schedule|0
5066734|NCT02324569|17480037|P1|Overall Study|Inconvenient Schedule|2
5066735|NCT02324569|17480036|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
5066736|NCT02324569|17480037|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
5066737|NCT02324569|17480036|P2|Overall Study|Lack of Efficacy|3
5066738|NCT02324569|17480037|P1|Overall Study|Lack of Efficacy|2
5066739|NCT02324569|17480036|P2|Overall Study|Voluntary Withdrawal|6
5066740|NCT02324569|17480037|P1|Overall Study|Voluntary Withdrawal|3
5066741|NCT02324569|17480036|P2|Overall Study|Pretreatment Event/Adverse Event|10
5066742|NCT02324569|17480037|P1|Overall Study|Pretreatment Event/Adverse Event|9
5066743|NCT02324465|17480095|P2|Overall Study|device failure|1
5066744|NCT02324465|17480096|P1|Overall Study|device failure|0
5066745|NCT02324361|17480110|P2|Overall Study|Lost to Follow-up|2
5066746|NCT02324361|17480111|P1|Overall Study|Lost to Follow-up|5
5066747|NCT02324270|17480141|P3|Overall Study|Non Compliance with Study Drug|0
5066748|NCT02324270|17480142|P2|Overall Study|Non Compliance with Study Drug|2
5066749|NCT02324270|17480143|P1|Overall Study|Non Compliance with Study Drug|1
5066750|NCT02324270|17480141|P3|Overall Study|Protocol Violation|1
5066751|NCT02324270|17480142|P2|Overall Study|Protocol Violation|1
5066752|NCT02324270|17480143|P1|Overall Study|Protocol Violation|0
5066753|NCT02324270|17480141|P3|Overall Study|Lost to Follow-up|4
5066754|NCT02324270|17480142|P2|Overall Study|Lost to Follow-up|3
5066755|NCT02324270|17480143|P1|Overall Study|Lost to Follow-up|4
5066756|NCT02324270|17480141|P3|Overall Study|Withdrawal by Subject|0
5066757|NCT02324270|17480142|P2|Overall Study|Withdrawal by Subject|1
5066758|NCT02324270|17480143|P1|Overall Study|Withdrawal by Subject|0
5066759|NCT02324205|17480153|P1|Overall Study|Withdrawal by Subject|37
5066760|NCT02324153|17480165|P2|Overall Study|Developed delirium preoperatively|0
5066761|NCT02324153|17480166|P1|Overall Study|Developed delirium preoperatively|1
5066762|NCT02324153|17480165|P2|Overall Study|Surgery postponed after randomization|0
5066763|NCT02324153|17480166|P1|Overall Study|Surgery postponed after randomization|3
5066764|NCT02324153|17480165|P2|Overall Study|Withdrawal by Subject|1
5066765|NCT02324153|17480166|P1|Overall Study|Withdrawal by Subject|4
5066766|NCT02324049|17480197|P1|Part C|Study terminated|11
5066767|NCT02323646|17480210|P3|Treatment Course 2|Non-compliance|1
5066768|NCT02323646|17480211|P2|Treatment Course 2|Non-compliance|1
5066769|NCT02323646|17480212|P1|Treatment Course 2|Non-compliance|0
5066770|NCT02323646|17480210|P3|Treatment Course 2|Lost to Follow-up|1
5066771|NCT02323646|17480211|P2|Treatment Course 2|Lost to Follow-up|0
5066772|NCT02323646|17480212|P1|Treatment Course 2|Lost to Follow-up|0
5066773|NCT02323646|17480210|P3|Treatment Course 2|Adverse Event|1
5066774|NCT02323646|17480211|P2|Treatment Course 2|Adverse Event|0
5066775|NCT02323646|17480212|P1|Treatment Course 2|Adverse Event|1
5066776|NCT02323646|17480210|P3|Treatment Course 1|Withdrawal by Subject|0
5066777|NCT02323646|17480211|P2|Treatment Course 1|Withdrawal by Subject|2
5066778|NCT02323646|17480212|P1|Treatment Course 1|Withdrawal by Subject|0
5066779|NCT02323646|17480210|P3|Treatment Course 1|Lost to Follow-up|2
5066780|NCT02323646|17480211|P2|Treatment Course 1|Lost to Follow-up|0
5066781|NCT02323646|17480212|P1|Treatment Course 1|Lost to Follow-up|1
5066782|NCT02323646|17480210|P3|Treatment Course 1|Heavy Bleeding|0
5066783|NCT02323646|17480211|P2|Treatment Course 1|Heavy Bleeding|1
5066784|NCT02323646|17480212|P1|Treatment Course 1|Heavy Bleeding|1
5066785|NCT02323646|17480210|P3|Treatment Course 1|Adverse Event|1
5066786|NCT02323646|17480211|P2|Treatment Course 1|Adverse Event|0
5066787|NCT02323646|17480212|P1|Treatment Course 1|Adverse Event|1
5066788|NCT02323204|17480260|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
5066789|NCT02323204|17480261|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
5066790|NCT02323204|17480262|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
5066791|NCT02323204|17480263|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
5066792|NCT02323204|17480260|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
5066793|NCT02323204|17480261|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
5066794|NCT02323204|17480262|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
5066795|NCT02323204|17480263|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
5066796|NCT02323204|17480260|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
5066797|NCT02323204|17480261|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
5066798|NCT02323204|17480262|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
5066799|NCT02323204|17480263|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
5066800|NCT02323204|17480260|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
5066801|NCT02323204|17480261|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
5066802|NCT02323204|17480262|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
5066803|NCT02323204|17480263|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
5066804|NCT02323204|17480260|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
5066805|NCT02323204|17480261|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
5066806|NCT02323204|17480262|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
5066807|NCT02323204|17480263|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
5066808|NCT02323204|17480260|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
5066809|NCT02323204|17480261|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
5066810|NCT02323204|17480262|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
5066811|NCT02323204|17480263|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
5066812|NCT02323204|17480260|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
5066813|NCT02323204|17480261|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
5066814|NCT02323204|17480262|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
5066815|NCT02323204|17480263|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
5066816|NCT02323204|17480260|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
5066817|NCT02323204|17480261|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
5066818|NCT02323204|17480262|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
5066819|NCT02323204|17480263|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
5066820|NCT02323204|17480260|P4|Baseline Survey Completion|Withdrawal by Subject|3
5066821|NCT02323204|17480261|P3|Baseline Survey Completion|Withdrawal by Subject|5
5066822|NCT02323204|17480262|P2|Baseline Survey Completion|Withdrawal by Subject|9
5066823|NCT02323204|17480263|P1|Baseline Survey Completion|Withdrawal by Subject|10
5066824|NCT02322892|17480336|P2|Overall Study|Protocol Violation|0
5066825|NCT02322892|17480337|P1|Overall Study|Protocol Violation|1
5066826|NCT02322892|17480336|P2|Overall Study|Met exclusion criteria|1
5066827|NCT02322892|17480337|P1|Overall Study|Met exclusion criteria|0
5066828|NCT02322892|17480336|P2|Overall Study|Surgery cancelled|2
5066829|NCT02322892|17480337|P1|Overall Study|Surgery cancelled|1
5066830|NCT02322879|17480353|P2|First Intervention|Physician Decision|0
5066831|NCT02322879|17480354|P1|First Intervention|Physician Decision|1
5066832|NCT02322866|17480362|P2|Overall Study|Other Miscellaneous Reasons|6
5066833|NCT02322866|17480363|P1|Overall Study|Other Miscellaneous Reasons|6
5066834|NCT02322866|17480362|P2|Overall Study|Lack of Efficacy|1
5066835|NCT02322866|17480363|P1|Overall Study|Lack of Efficacy|3
5066836|NCT02322866|17480362|P2|Overall Study|Noncompliance with Treatment|4
5066837|NCT02322866|17480363|P1|Overall Study|Noncompliance with Treatment|3
5066838|NCT02322866|17480362|P2|Overall Study|Protocol Violation|0
5066839|NCT02322866|17480363|P1|Overall Study|Protocol Violation|1
5066840|NCT02322866|17480362|P2|Overall Study|Lost to Follow-up|39
5066841|NCT02322866|17480363|P1|Overall Study|Lost to Follow-up|36
5066842|NCT02322866|17480362|P2|Overall Study|Withdrawal of Consent|25
5066843|NCT02322866|17480363|P1|Overall Study|Withdrawal of Consent|16
5066844|NCT02322866|17480362|P2|Overall Study|Adverse Event|11
5066845|NCT02322866|17480363|P1|Overall Study|Adverse Event|6
5066846|NCT02322814|17480390|P5|Overall Study|Withdrawal by Subject|3
5066847|NCT02322814|17480391|P4|Overall Study|Withdrawal by Subject|1
5066848|NCT02322814|17480392|P3|Overall Study|Withdrawal by Subject|2
5066849|NCT02322814|17480393|P2|Overall Study|Withdrawal by Subject|4
5066850|NCT02322814|17480394|P1|Overall Study|Withdrawal by Subject|5
5066851|NCT02322814|17480390|P5|Overall Study|Death|6
5066852|NCT02322814|17480391|P4|Overall Study|Death|10
5066853|NCT02322814|17480392|P3|Overall Study|Death|30
5066854|NCT02322814|17480393|P2|Overall Study|Death|22
5066855|NCT02322814|17480394|P1|Overall Study|Death|7
5066856|NCT02322814|17480390|P5|Overall Study|Protocol Violation|0
5066857|NCT02322814|17480391|P4|Overall Study|Protocol Violation|0
5066858|NCT02322814|17480392|P3|Overall Study|Protocol Violation|0
5066859|NCT02322814|17480393|P2|Overall Study|Protocol Violation|0
5066860|NCT02322814|17480394|P1|Overall Study|Protocol Violation|1
5066861|NCT02322814|17480390|P5|Overall Study|Other|0
5066862|NCT02322814|17480391|P4|Overall Study|Other|0
5066863|NCT02322814|17480392|P3|Overall Study|Other|0
5066864|NCT02322814|17480393|P2|Overall Study|Other|0
5066865|NCT02322814|17480394|P1|Overall Study|Other|2
5066866|NCT02322814|17480390|P5|Overall Study|Lost to Follow-up|0
5066867|NCT02322814|17480391|P4|Overall Study|Lost to Follow-up|0
5066868|NCT02322814|17480392|P3|Overall Study|Lost to Follow-up|1
5066869|NCT02322814|17480393|P2|Overall Study|Lost to Follow-up|2
5066870|NCT02322814|17480394|P1|Overall Study|Lost to Follow-up|1
5066871|NCT02322814|17480390|P5|Overall Study|Progressive Disease|0
5066872|NCT02322814|17480391|P4|Overall Study|Progressive Disease|1
5066873|NCT02322814|17480392|P3|Overall Study|Progressive Disease|0
5066874|NCT02322814|17480393|P2|Overall Study|Progressive Disease|2
5066875|NCT02322814|17480394|P1|Overall Study|Progressive Disease|0
5066876|NCT02322814|17480390|P5|Overall Study|Ongoing Study|22
5066877|NCT02322814|17480391|P4|Overall Study|Ongoing Study|20
5066878|NCT02322814|17480392|P3|Overall Study|Ongoing Study|14
5066879|NCT02322814|17480393|P2|Overall Study|Ongoing Study|13
5066880|NCT02322814|17480394|P1|Overall Study|Ongoing Study|0
5066881|NCT02322775|17480420|P2|Overall Study|Not willing to perform all FU visits|1
5066882|NCT02322775|17480421|P1|Overall Study|Not willing to perform all FU visits|0
5066883|NCT02322775|17480420|P2|Overall Study|Withdrawal by Subject|4
5066884|NCT02322775|17480421|P1|Overall Study|Withdrawal by Subject|3
5066885|NCT02322775|17480420|P2|Overall Study|Protocol Violation|0
5066886|NCT02322775|17480421|P1|Overall Study|Protocol Violation|1
5066888|NCT02322775|17480421|P1|Overall Study|Lost to Follow-up|0
5066889|NCT02322775|17480420|P2|Overall Study|Adverse Event|0
5066890|NCT02322775|17480421|P1|Overall Study|Adverse Event|1
5066891|NCT02322749|17480447|P6|Period 3|Withdrawal by Subject|0
5066892|NCT02322749|17480448|P5|Period 3|Withdrawal by Subject|0
5066893|NCT02322749|17480449|P4|Period 3|Withdrawal by Subject|0
5066894|NCT02322749|17480450|P3|Period 3|Withdrawal by Subject|1
5066895|NCT02322749|17480451|P2|Period 3|Withdrawal by Subject|0
5066896|NCT02322749|17480452|P1|Period 3|Withdrawal by Subject|0
5066897|NCT02322749|17480447|P6|Period 2|Withdrawal by Subject|0
5066898|NCT02322749|17480448|P5|Period 2|Withdrawal by Subject|0
5066899|NCT02322749|17480449|P4|Period 2|Withdrawal by Subject|1
5066900|NCT02322749|17480450|P3|Period 2|Withdrawal by Subject|0
5066901|NCT02322749|17480451|P2|Period 2|Withdrawal by Subject|0
5066902|NCT02322749|17480452|P1|Period 2|Withdrawal by Subject|0
5066903|NCT02322749|17480447|P6|Period 2|Adverse Event|0
5066904|NCT02322749|17480448|P5|Period 2|Adverse Event|0
5066905|NCT02322749|17480449|P4|Period 2|Adverse Event|1
5066906|NCT02322749|17480450|P3|Period 2|Adverse Event|0
5066907|NCT02322749|17480451|P2|Period 2|Adverse Event|0
5066908|NCT02322749|17480452|P1|Period 2|Adverse Event|0
5066909|NCT02322710|17480477|P2|Overall Study|Protocol Violation|25
5066910|NCT02322710|17480478|P1|Overall Study|Protocol Violation|20
5066911|NCT02322710|17480477|P2|Overall Study|No efficacy assessment post-baseline|1
5066912|NCT02322710|17480478|P1|Overall Study|No efficacy assessment post-baseline|0
5066913|NCT02322411|17480491|P2|Overall Study|Withdrawal by Subject|0
5066914|NCT02322411|17480492|P1|Overall Study|Withdrawal by Subject|1
5066915|NCT02322411|17480491|P2|Overall Study|Lost to Follow-up|7
5066916|NCT02322411|17480492|P1|Overall Study|Lost to Follow-up|4
5066917|NCT02322281|17480561|P3|Overall Study|Miscellaneous|4
5066918|NCT02322281|17480562|P2|Overall Study|Miscellaneous|0
5066919|NCT02322281|17480563|P1|Overall Study|Miscellaneous|0
5066920|NCT02322281|17480561|P3|Overall Study|Missing|1
5066921|NCT02322281|17480562|P2|Overall Study|Missing|0
5066922|NCT02322281|17480563|P1|Overall Study|Missing|0
5066923|NCT02322281|17480561|P3|Overall Study|Study Terminated by Sponsor|0
5066924|NCT02322281|17480562|P2|Overall Study|Study Terminated by Sponsor|0
5066925|NCT02322281|17480563|P1|Overall Study|Study Terminated by Sponsor|2
5066926|NCT02322281|17480561|P3|Overall Study|Physician Decision|5
5066927|NCT02322281|17480562|P2|Overall Study|Physician Decision|0
5066928|NCT02322281|17480563|P1|Overall Study|Physician Decision|2
5066929|NCT02322281|17480561|P3|Overall Study|Withdrawal by Subject|6
5066930|NCT02322281|17480562|P2|Overall Study|Withdrawal by Subject|1
5066931|NCT02322281|17480563|P1|Overall Study|Withdrawal by Subject|1
5066932|NCT02322281|17480561|P3|Overall Study|Death|3
5066933|NCT02322281|17480562|P2|Overall Study|Death|3
5066934|NCT02322281|17480563|P1|Overall Study|Death|3
5066935|NCT02322281|17480561|P3|Overall Study|Adverse Event|6
5066936|NCT02322281|17480562|P2|Overall Study|Adverse Event|4
5066937|NCT02322281|17480563|P1|Overall Study|Adverse Event|3
5066938|NCT02322281|17480561|P3|Overall Study|Progressive Disease|49
5066939|NCT02322281|17480562|P2|Overall Study|Progressive Disease|14
5066940|NCT02322281|17480563|P1|Overall Study|Progressive Disease|42
5066941|NCT02322229|17480611|P1|Overall Study|Physician Decision|2
5066942|NCT02322216|17480623|P2|Overall Study|Withdrawal by Subject|4
5066943|NCT02322216|17480624|P1|Overall Study|Withdrawal by Subject|1
5066944|NCT02322216|17480623|P2|Overall Study|Adverse Event|0
5066945|NCT02322216|17480624|P1|Overall Study|Adverse Event|1
5066946|NCT02322190|17480631|P2|Overall Study|Death on study|0
5066947|NCT02322190|17480632|P1|Overall Study|Death on study|1
5066948|NCT02321930|17480640|P1|Overall Study|Lost to Follow-up|1
5066949|NCT02321800|17480650|P2|Overall Study|Other, Miscellaneous|1
5066950|NCT02321800|17480651|P1|Overall Study|Other, Miscellaneous|3
5066951|NCT02321800|17480650|P2|Overall Study|Adverse Event|3
5066952|NCT02321800|17480651|P1|Overall Study|Adverse Event|2
5066953|NCT02321800|17480650|P2|Overall Study|Lost to Follow-up|4
5066954|NCT02321800|17480651|P1|Overall Study|Lost to Follow-up|10
5066955|NCT02321800|17480650|P2|Overall Study|Protocol Violation|0
5066956|NCT02321800|17480651|P1|Overall Study|Protocol Violation|1
5066957|NCT02321800|17480650|P2|Overall Study|Death|0
5066958|NCT02321800|17480651|P1|Overall Study|Death|1
5066959|NCT02321800|17480650|P2|Overall Study|Withdrawal by Subject|3
5066960|NCT02321800|17480651|P1|Overall Study|Withdrawal by Subject|3
5066961|NCT02321462|17480740|P2|Overall Study|Subject withdrawn before any treatment|1
5066962|NCT02321462|17480741|P1|Overall Study|Subject withdrawn before any treatment|1
5066963|NCT02321462|17480740|P2|Overall Study|Withdrawal by Subject|2
5066964|NCT02321462|17480741|P1|Overall Study|Withdrawal by Subject|5
5066965|NCT02321436|17480763|P2|Overall Study|Lost to Follow-up|1
5066966|NCT02321436|17480764|P1|Overall Study|Lost to Follow-up|0
5066967|NCT02321436|17480763|P2|Overall Study|Withdrawal by Subject|0
5066968|NCT02321436|17480764|P1|Overall Study|Withdrawal by Subject|1
5066969|NCT02321319|17480780|P1|Overall Study|Product discontinued|5
5066970|NCT02321098|17480812|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
5066971|NCT02321098|17480813|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
5066972|NCT02321098|17480814|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
5066973|NCT02321098|17480812|P3|Additional 15 Months Treatment|Lost to Follow-up|1
5066974|NCT02321098|17480813|P2|Additional 15 Months Treatment|Lost to Follow-up|0
5066975|NCT02321098|17480814|P1|Additional 15 Months Treatment|Lost to Follow-up|0
5066976|NCT02321098|17480812|P3|Additional 15 Months Treatment|Lack of Efficacy|6
5066977|NCT02321098|17480813|P2|Additional 15 Months Treatment|Lack of Efficacy|0
5066978|NCT02321098|17480814|P1|Additional 15 Months Treatment|Lack of Efficacy|0
5066979|NCT02321098|17480812|P3|12 Weeks Treament|Lost to Follow-up|0
5066980|NCT02321098|17480813|P2|12 Weeks Treament|Lost to Follow-up|1
5066981|NCT02321098|17480814|P1|12 Weeks Treament|Lost to Follow-up|1
5066982|NCT02320903|17480826|P3|Overall Study|Lost to Follow-up|5
5066983|NCT02320903|17480827|P2|Overall Study|Lost to Follow-up|5
5066984|NCT02320903|17480828|P1|Overall Study|Lost to Follow-up|0
5066985|NCT02320903|17480826|P3|Overall Study|Exited therapy; no longer eligible|2
5066986|NCT02320903|17480827|P2|Overall Study|Exited therapy; no longer eligible|2
5066987|NCT02320903|17480828|P1|Overall Study|Exited therapy; no longer eligible|8
5066988|NCT02320903|17480826|P3|Overall Study|Withdrawal by Subject|9
5066989|NCT02320903|17480827|P2|Overall Study|Withdrawal by Subject|9
5066990|NCT02320903|17480828|P1|Overall Study|Withdrawal by Subject|0
5066991|NCT02320721|17480953|P2|Overall Study|Other than specified above|20
5066992|NCT02320721|17480954|P1|Overall Study|Other than specified above|15
5066993|NCT02320721|17480953|P2|Overall Study|Hypoglycemia|0
5066994|NCT02320721|17480954|P1|Overall Study|Hypoglycemia|1
5066995|NCT02320721|17480953|P2|Overall Study|Randomized but not treated|1
5066996|NCT02320721|17480954|P1|Overall Study|Randomized but not treated|0
5066997|NCT02320721|17480953|P2|Overall Study|Poor compliance to protocol|7
5066998|NCT02320721|17480954|P1|Overall Study|Poor compliance to protocol|3
5066999|NCT02320721|17480953|P2|Overall Study|Lack of Efficacy|0
5067000|NCT02320721|17480954|P1|Overall Study|Lack of Efficacy|2
5067001|NCT02320721|17480953|P2|Overall Study|Adverse Event|6
5067002|NCT02320721|17480954|P1|Overall Study|Adverse Event|6
5067003|NCT02320487|17481009|P1|Overall Study|Adverse Event|11
5067004|NCT02320487|17481009|P1|Overall Study|Death|3
5067005|NCT02320487|17481009|P1|Overall Study|Withdrawal by Subject|1
5067006|NCT02320487|17481009|P1|Overall Study|Physician Decision|5
5067007|NCT02320487|17481009|P1|Overall Study|Reason not Specified|1
5067008|NCT02320396|17481029|P2|Overall Study|Withdrawal by Subject|0
5067009|NCT02320396|17481030|P1|Overall Study|Withdrawal by Subject|2
5067010|NCT02320396|17481029|P2|Overall Study|Protocol Violation|1
5067011|NCT02320396|17481030|P1|Overall Study|Protocol Violation|0
5067012|NCT02320396|17481029|P2|Overall Study|Pregnancy|1
5067013|NCT02320396|17481030|P1|Overall Study|Pregnancy|0
5067014|NCT02320396|17481029|P2|Overall Study|Adverse Event|2
5067015|NCT02320396|17481030|P1|Overall Study|Adverse Event|2
5067016|NCT02320149|17481089|P2|Overall Study|Other Miscellaneous Reasons|3
5067017|NCT02320149|17481090|P1|Overall Study|Other Miscellaneous Reasons|2
5067018|NCT02320149|17481089|P2|Overall Study|Lack of Efficacy|1
5067019|NCT02320149|17481090|P1|Overall Study|Lack of Efficacy|0
5067020|NCT02320149|17481089|P2|Overall Study|Noncompliance with Study Treatment|2
5067021|NCT02320149|17481090|P1|Overall Study|Noncompliance with Study Treatment|7
5067022|NCT02320149|17481089|P2|Overall Study|Protocol Violation|1
5067023|NCT02320149|17481090|P1|Overall Study|Protocol Violation|2
5067024|NCT02320149|17481089|P2|Overall Study|Lost to Follow-up|34
5067025|NCT02320149|17481090|P1|Overall Study|Lost to Follow-up|21
5067026|NCT02320149|17481089|P2|Overall Study|Withdrawal of Consent|32
5067027|NCT02320149|17481090|P1|Overall Study|Withdrawal of Consent|28
5067028|NCT02320149|17481089|P2|Overall Study|Adverse Event|7
5067029|NCT02320149|17481090|P1|Overall Study|Adverse Event|3
5067030|NCT02320123|17481130|P2|Overall Study|Death|5
5067031|NCT02320123|17481131|P1|Overall Study|Death|6
5067032|NCT02320123|17481130|P2|Overall Study|Lost to Follow-up|6
5067033|NCT02320123|17481131|P1|Overall Study|Lost to Follow-up|4
5067034|NCT02319759|17481222|P5|Week 24 - 56|Lost to Follow-up|1
5067035|NCT02319759|17481223|P4|Week 24 - 56|Lost to Follow-up|0
5067036|NCT02319759|17481224|P3|Week 24 - 56|Lost to Follow-up|0
5067037|NCT02319759|17481225|P2|Week 24 - 56|Lost to Follow-up|0
5067038|NCT02319759|17481226|P1|Week 24 - 56|Lost to Follow-up|0
5067039|NCT02319759|17481222|P5|Week 24 - 56|Withdrawal by Subject|0
5067040|NCT02319759|17481223|P4|Week 24 - 56|Withdrawal by Subject|0
5067041|NCT02319759|17481224|P3|Week 24 - 56|Withdrawal by Subject|0
5067042|NCT02319759|17481225|P2|Week 24 - 56|Withdrawal by Subject|1
5067043|NCT02319759|17481226|P1|Week 24 - 56|Withdrawal by Subject|0
5067044|NCT02319759|17481222|P5|Week 24 - 56|Lack of Efficacy|1
5067045|NCT02319759|17481223|P4|Week 24 - 56|Lack of Efficacy|2
5067046|NCT02319759|17481224|P3|Week 24 - 56|Lack of Efficacy|0
5067047|NCT02319759|17481225|P2|Week 24 - 56|Lack of Efficacy|0
5067048|NCT02319759|17481226|P1|Week 24 - 56|Lack of Efficacy|0
5067049|NCT02319759|17481222|P5|Week 24 - 56|Adverse Event|0
5067050|NCT02319759|17481223|P4|Week 24 - 56|Adverse Event|0
5067051|NCT02319759|17481224|P3|Week 24 - 56|Adverse Event|2
5067052|NCT02319759|17481225|P2|Week 24 - 56|Adverse Event|0
5067053|NCT02319759|17481226|P1|Week 24 - 56|Adverse Event|0
5067054|NCT02319759|17481222|P5|Week 16 - 24|Withdrawal by Subject|0
5067055|NCT02319759|17481223|P4|Week 16 - 24|Withdrawal by Subject|0
5067056|NCT02319759|17481224|P3|Week 16 - 24|Withdrawal by Subject|2
5067057|NCT02319759|17481225|P2|Week 16 - 24|Withdrawal by Subject|0
5067058|NCT02319759|17481226|P1|Week 16 - 24|Withdrawal by Subject|0
5067059|NCT02319759|17481222|P5|Week 16 - 24|Lost to Follow-up|0
5067060|NCT02319759|17481223|P4|Week 16 - 24|Lost to Follow-up|0
5067061|NCT02319759|17481224|P3|Week 16 - 24|Lost to Follow-up|0
5067062|NCT02319759|17481225|P2|Week 16 - 24|Lost to Follow-up|0
5067063|NCT02319759|17481226|P1|Week 16 - 24|Lost to Follow-up|1
5067064|NCT02319759|17481222|P5|Week 16 - 24|Lack of Efficacy|0
5067065|NCT02319759|17481223|P4|Week 16 - 24|Lack of Efficacy|0
5067066|NCT02319759|17481224|P3|Week 16 - 24|Lack of Efficacy|1
5067067|NCT02319759|17481225|P2|Week 16 - 24|Lack of Efficacy|0
5067068|NCT02319759|17481226|P1|Week 16 - 24|Lack of Efficacy|1
5067069|NCT02319759|17481222|P5|Week 0 - 16|Not met all Inclusion Criteria|0
5067070|NCT02319759|17481223|P4|Week 0 - 16|Not met all Inclusion Criteria|0
5067071|NCT02319759|17481224|P3|Week 0 - 16|Not met all Inclusion Criteria|1
5067072|NCT02319759|17481225|P2|Week 0 - 16|Not met all Inclusion Criteria|0
5067073|NCT02319759|17481226|P1|Week 0 - 16|Not met all Inclusion Criteria|0
5067074|NCT02319759|17481222|P5|Week 0 - 16|Lack of Efficacy|0
5067075|NCT02319759|17481223|P4|Week 0 - 16|Lack of Efficacy|0
5067076|NCT02319759|17481224|P3|Week 0 - 16|Lack of Efficacy|0
5067077|NCT02319759|17481225|P2|Week 0 - 16|Lack of Efficacy|0
5067078|NCT02319759|17481226|P1|Week 0 - 16|Lack of Efficacy|1
5067079|NCT02319668|17481323|P2|Overall Study|Other (Not specified)|2
5067080|NCT02319668|17481324|P1|Overall Study|Other (Not specified)|0
5067081|NCT02319642|17481338|P2|Overall Study|Withdrawal by Subject|1
5067082|NCT02319642|17481339|P1|Overall Study|Withdrawal by Subject|1
5067083|NCT02319642|17481338|P2|Overall Study|Lack of Efficacy|1
5067084|NCT02319642|17481339|P1|Overall Study|Lack of Efficacy|1
5067085|NCT02319642|17481338|P2|Overall Study|Adverse Event|4
5067086|NCT02319642|17481339|P1|Overall Study|Adverse Event|2
5067087|NCT02319525|17481359|P2|Overall Study|Withdrawal by Subject|1
5067088|NCT02319525|17481360|P1|Overall Study|Withdrawal by Subject|2
5067089|NCT02319148|17481402|P4|Second Intervention Period|Other|1
5067090|NCT02319148|17481403|P3|Second Intervention Period|Other|0
5067091|NCT02319148|17481404|P2|Second Intervention Period|Other|0
5067092|NCT02319148|17481405|P1|Second Intervention Period|Other|0
5067093|NCT02319148|17481402|P4|Second Intervention Period|No longer willing to participate|0
5067094|NCT02319148|17481403|P3|Second Intervention Period|No longer willing to participate|0
5067095|NCT02319148|17481404|P2|Second Intervention Period|No longer willing to participate|1
5067096|NCT02319148|17481405|P1|Second Intervention Period|No longer willing to participate|0
5067097|NCT02319148|17481402|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
5067098|NCT02319148|17481403|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
5067099|NCT02319148|17481404|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
5067100|NCT02319148|17481405|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
5067101|NCT02319044|17481468|P3|Overall Study|Not treated|2
5067102|NCT02319044|17481469|P2|Overall Study|Not treated|2
5067103|NCT02319044|17481470|P1|Overall Study|Not treated|0
5067104|NCT02319044|17481468|P3|Overall Study|Study specific discontinuation criteria|1
5067105|NCT02319044|17481469|P2|Overall Study|Study specific discontinuation criteria|2
5067106|NCT02319044|17481470|P1|Overall Study|Study specific discontinuation criteria|2
5067107|NCT02319044|17481468|P3|Overall Study|Adverse Event|8
5067108|NCT02319044|17481469|P2|Overall Study|Adverse Event|2
5067109|NCT02319044|17481470|P1|Overall Study|Adverse Event|17
5067110|NCT02319044|17481468|P3|Overall Study|Condition under investigation worsened|46
5067111|NCT02319044|17481469|P2|Overall Study|Condition under investigation worsened|50
5067112|NCT02319044|17481470|P1|Overall Study|Condition under investigation worsened|100
5067113|NCT02319044|17481468|P3|Overall Study|Withdrawal by Subject|6
5067114|NCT02319044|17481469|P2|Overall Study|Withdrawal by Subject|3
5067115|NCT02319044|17481470|P1|Overall Study|Withdrawal by Subject|3
5067116|NCT02319044|17481468|P3|Overall Study|Death, PI/sponsor decision, med history|4
5067117|NCT02319044|17481469|P2|Overall Study|Death, PI/sponsor decision, med history|1
5067118|NCT02319044|17481470|P1|Overall Study|Death, PI/sponsor decision, med history|0
5067119|NCT02319031|17481526|P2|Treatment Period|Death|0
5067120|NCT02319031|17481527|P1|Treatment Period|Death|1
5067121|NCT02318940|17481591|P2|Overall Study|lost the record|0
5067122|NCT02318940|17481592|P1|Overall Study|lost the record|1
5067123|NCT02318797|17481634|P2|Overall Study|Lost to Follow-up|96
5067124|NCT02318797|17481635|P1|Overall Study|Lost to Follow-up|85
5067125|NCT02318797|17481634|P2|Overall Study|Death|6
5067126|NCT02318797|17481635|P1|Overall Study|Death|3
5067127|NCT02318719|17481677|P5|Open-label Extension Phase|Other|7
5067128|NCT02318719|17481678|P4|Open-label Extension Phase|Other|0
5067129|NCT02318719|17481679|P3|Open-label Extension Phase|Other|0
5067130|NCT02318719|17481680|P2|Open-label Extension Phase|Other|0
5067131|NCT02318719|17481681|P1|Open-label Extension Phase|Other|0
5067132|NCT02318719|17481677|P5|Open-label Extension Phase|Withdrawal by Subject|31
5067133|NCT02318719|17481678|P4|Open-label Extension Phase|Withdrawal by Subject|0
5067134|NCT02318719|17481679|P3|Open-label Extension Phase|Withdrawal by Subject|0
5067135|NCT02318719|17481680|P2|Open-label Extension Phase|Withdrawal by Subject|0
5067136|NCT02318719|17481681|P1|Open-label Extension Phase|Withdrawal by Subject|0
5067137|NCT02318719|17481677|P5|Open-label Extension Phase|Lack of Efficacy|1
5067138|NCT02318719|17481678|P4|Open-label Extension Phase|Lack of Efficacy|0
5067139|NCT02318719|17481679|P3|Open-label Extension Phase|Lack of Efficacy|0
5067140|NCT02318719|17481680|P2|Open-label Extension Phase|Lack of Efficacy|0
5067141|NCT02318719|17481681|P1|Open-label Extension Phase|Lack of Efficacy|0
5067142|NCT02318719|17481677|P5|Open-label Extension Phase|Death|1
5067143|NCT02318719|17481678|P4|Open-label Extension Phase|Death|0
5067144|NCT02318719|17481679|P3|Open-label Extension Phase|Death|0
5067145|NCT02318719|17481680|P2|Open-label Extension Phase|Death|0
5067146|NCT02318719|17481681|P1|Open-label Extension Phase|Death|0
5067147|NCT02318719|17481677|P5|Open-label Extension Phase|Adverse Event|15
5067148|NCT02318719|17481678|P4|Open-label Extension Phase|Adverse Event|0
5067149|NCT02318719|17481679|P3|Open-label Extension Phase|Adverse Event|0
5067150|NCT02318719|17481680|P2|Open-label Extension Phase|Adverse Event|0
5067151|NCT02318719|17481681|P1|Open-label Extension Phase|Adverse Event|0
5067152|NCT02318719|17481677|P5|Double-blind Phase|Other|0
5067153|NCT02318719|17481678|P4|Double-blind Phase|Other|0
5067154|NCT02318719|17481679|P3|Double-blind Phase|Other|0
5067155|NCT02318719|17481680|P2|Double-blind Phase|Other|2
5067156|NCT02318719|17481681|P1|Double-blind Phase|Other|1
5067157|NCT02318719|17481677|P5|Double-blind Phase|Withdrawal by Subject|0
5067158|NCT02318719|17481678|P4|Double-blind Phase|Withdrawal by Subject|10
5067159|NCT02318719|17481679|P3|Double-blind Phase|Withdrawal by Subject|9
5067160|NCT02318719|17481680|P2|Double-blind Phase|Withdrawal by Subject|7
5067161|NCT02318719|17481681|P1|Double-blind Phase|Withdrawal by Subject|25
5067162|NCT02318719|17481677|P5|Double-blind Phase|Protocol Violation|0
5067163|NCT02318719|17481678|P4|Double-blind Phase|Protocol Violation|0
5067164|NCT02318719|17481679|P3|Double-blind Phase|Protocol Violation|3
5067165|NCT02318719|17481680|P2|Double-blind Phase|Protocol Violation|1
5067166|NCT02318719|17481681|P1|Double-blind Phase|Protocol Violation|0
5067167|NCT02318719|17481677|P5|Double-blind Phase|Lack of Efficacy|0
5067168|NCT02318719|17481678|P4|Double-blind Phase|Lack of Efficacy|1
5067169|NCT02318719|17481679|P3|Double-blind Phase|Lack of Efficacy|1
5067170|NCT02318719|17481680|P2|Double-blind Phase|Lack of Efficacy|0
5067171|NCT02318719|17481681|P1|Double-blind Phase|Lack of Efficacy|5
5067172|NCT02318719|17481677|P5|Double-blind Phase|Adverse Event|0
5067173|NCT02318719|17481678|P4|Double-blind Phase|Adverse Event|4
5067174|NCT02318719|17481679|P3|Double-blind Phase|Adverse Event|12
5067175|NCT02318719|17481680|P2|Double-blind Phase|Adverse Event|6
5067176|NCT02318719|17481681|P1|Double-blind Phase|Adverse Event|7
5067177|NCT02318706|17481697|P5|Open-label Extension Phase|Withdrawal by Subject|19
5067178|NCT02318706|17481698|P4|Open-label Extension Phase|Withdrawal by Subject|0
5067179|NCT02318706|17481699|P3|Open-label Extension Phase|Withdrawal by Subject|0
5067180|NCT02318706|17481700|P2|Open-label Extension Phase|Withdrawal by Subject|0
5067181|NCT02318706|17481701|P1|Open-label Extension Phase|Withdrawal by Subject|0
5067182|NCT02318706|17481697|P5|Open-label Extension Phase|Death|1
5067183|NCT02318706|17481698|P4|Open-label Extension Phase|Death|0
5067184|NCT02318706|17481699|P3|Open-label Extension Phase|Death|0
5067185|NCT02318706|17481700|P2|Open-label Extension Phase|Death|0
5067186|NCT02318706|17481701|P1|Open-label Extension Phase|Death|0
5067187|NCT02318706|17481697|P5|Open-label Extension Phase|Lack of Efficacy|1
5067188|NCT02318706|17481698|P4|Open-label Extension Phase|Lack of Efficacy|0
5067189|NCT02318706|17481699|P3|Open-label Extension Phase|Lack of Efficacy|0
5067190|NCT02318706|17481700|P2|Open-label Extension Phase|Lack of Efficacy|0
5067191|NCT02318706|17481701|P1|Open-label Extension Phase|Lack of Efficacy|0
5067192|NCT02318706|17481697|P5|Open-label Extension Phase|Adverse Event|21
5067193|NCT02318706|17481698|P4|Open-label Extension Phase|Adverse Event|0
5067194|NCT02318706|17481699|P3|Open-label Extension Phase|Adverse Event|0
5067195|NCT02318706|17481700|P2|Open-label Extension Phase|Adverse Event|0
5067196|NCT02318706|17481701|P1|Open-label Extension Phase|Adverse Event|0
5067197|NCT02318706|17481697|P5|Double-blind Phase|Death|0
5067198|NCT02318706|17481698|P4|Double-blind Phase|Death|0
5067199|NCT02318706|17481699|P3|Double-blind Phase|Death|2
5067200|NCT02318706|17481700|P2|Double-blind Phase|Death|0
5067201|NCT02318706|17481701|P1|Double-blind Phase|Death|0
5067202|NCT02318706|17481697|P5|Double-blind Phase|Other|0
5067203|NCT02318706|17481698|P4|Double-blind Phase|Other|1
5067204|NCT02318706|17481699|P3|Double-blind Phase|Other|2
5067205|NCT02318706|17481700|P2|Double-blind Phase|Other|1
5067206|NCT02318706|17481701|P1|Double-blind Phase|Other|4
5067207|NCT02318706|17481697|P5|Double-blind Phase|Withdrawal by Subject|0
5067208|NCT02318706|17481698|P4|Double-blind Phase|Withdrawal by Subject|10
5067209|NCT02318706|17481699|P3|Double-blind Phase|Withdrawal by Subject|7
5067210|NCT02318706|17481700|P2|Double-blind Phase|Withdrawal by Subject|5
5067211|NCT02318706|17481701|P1|Double-blind Phase|Withdrawal by Subject|9
5067212|NCT02318706|17481697|P5|Double-blind Phase|Protocol Violation|0
5067213|NCT02318706|17481698|P4|Double-blind Phase|Protocol Violation|3
5067214|NCT02318706|17481699|P3|Double-blind Phase|Protocol Violation|4
5067215|NCT02318706|17481700|P2|Double-blind Phase|Protocol Violation|2
5067216|NCT02318706|17481701|P1|Double-blind Phase|Protocol Violation|4
5067217|NCT02318706|17481697|P5|Double-blind Phase|Lost to Follow-up|0
5067218|NCT02318706|17481698|P4|Double-blind Phase|Lost to Follow-up|0
5067219|NCT02318706|17481699|P3|Double-blind Phase|Lost to Follow-up|0
5067220|NCT02318706|17481700|P2|Double-blind Phase|Lost to Follow-up|0
5067221|NCT02318706|17481701|P1|Double-blind Phase|Lost to Follow-up|1
5067222|NCT02318706|17481697|P5|Double-blind Phase|Adverse Event|0
5067223|NCT02318706|17481698|P4|Double-blind Phase|Adverse Event|10
5067224|NCT02318706|17481699|P3|Double-blind Phase|Adverse Event|3
5067225|NCT02318706|17481700|P2|Double-blind Phase|Adverse Event|4
5067226|NCT02318706|17481701|P1|Double-blind Phase|Adverse Event|7
5067227|NCT02318693|17481715|P2|Overall Study|Protocol Violation|1
5067228|NCT02318693|17481716|P1|Overall Study|Protocol Violation|0
5067229|NCT02318667|17481730|P1|Overall Study|Protocol Violation|2
5067230|NCT02318667|17481730|P1|Overall Study|Lack of Efficacy|6
5067231|NCT02318667|17481730|P1|Overall Study|Adverse Event|1
5067232|NCT02318602|17481749|P3|Overall Study|Guardian decision to withdraw|1
5067233|NCT02318602|17481750|P2|Overall Study|Guardian decision to withdraw|0
5067234|NCT02318602|17481751|P1|Overall Study|Guardian decision to withdraw|0
5067235|NCT02318602|17481749|P3|Overall Study|Death|0
5067236|NCT02318602|17481750|P2|Overall Study|Death|0
5067237|NCT02318602|17481751|P1|Overall Study|Death|1
5067238|NCT02318602|17481749|P3|Overall Study|Withdrawal by Subject|0
5067239|NCT02318602|17481750|P2|Overall Study|Withdrawal by Subject|3
5067240|NCT02318602|17481751|P1|Overall Study|Withdrawal by Subject|0
5067241|NCT02318602|17481749|P3|Overall Study|Adverse Event|1
5067242|NCT02318602|17481750|P2|Overall Study|Adverse Event|1
5067243|NCT02318602|17481751|P1|Overall Study|Adverse Event|0
5067244|NCT02318368|17481784|P2|Overall Study|Death|1
5067245|NCT02318368|17481785|P1|Overall Study|Death|0
5067246|NCT02318368|17481784|P2|Overall Study|Study terminated by the sponsor|2
5067247|NCT02318368|17481785|P1|Overall Study|Study terminated by the sponsor|5
5067248|NCT02318368|17481784|P2|Overall Study|Withdrawal by Subject|0
5067249|NCT02318368|17481785|P1|Overall Study|Withdrawal by Subject|2
5067250|NCT02318329|17481803|P10|Overall Study|Other|1
5067251|NCT02318329|17481804|P9|Overall Study|Other|1
5067252|NCT02318329|17481805|P8|Overall Study|Other|0
5067253|NCT02318329|17481806|P7|Overall Study|Other|0
5067254|NCT02318329|17481807|P6|Overall Study|Other|0
5067255|NCT02318329|17481808|P5|Overall Study|Other|0
5067256|NCT02318329|17481809|P4|Overall Study|Other|0
5067257|NCT02318329|17481810|P3|Overall Study|Other|1
5067258|NCT02318329|17481811|P2|Overall Study|Other|1
5067259|NCT02318329|17481812|P1|Overall Study|Other|1
5067260|NCT02318329|17481803|P10|Overall Study|Withdrawal by Subject|6
5067261|NCT02318329|17481804|P9|Overall Study|Withdrawal by Subject|0
5067262|NCT02318329|17481805|P8|Overall Study|Withdrawal by Subject|0
5067263|NCT02318329|17481806|P7|Overall Study|Withdrawal by Subject|0
5067264|NCT02318329|17481807|P6|Overall Study|Withdrawal by Subject|0
5067265|NCT02318329|17481808|P5|Overall Study|Withdrawal by Subject|0
5067266|NCT02318329|17481809|P4|Overall Study|Withdrawal by Subject|0
5067267|NCT02318329|17481810|P3|Overall Study|Withdrawal by Subject|0
5067268|NCT02318329|17481811|P2|Overall Study|Withdrawal by Subject|0
5067269|NCT02318329|17481812|P1|Overall Study|Withdrawal by Subject|0
5067270|NCT02318329|17481803|P10|Overall Study|Lost to Follow-up|1
5067271|NCT02318329|17481804|P9|Overall Study|Lost to Follow-up|0
5067272|NCT02318329|17481805|P8|Overall Study|Lost to Follow-up|0
5067273|NCT02318329|17481806|P7|Overall Study|Lost to Follow-up|0
5067274|NCT02318329|17481807|P6|Overall Study|Lost to Follow-up|0
5067275|NCT02318329|17481808|P5|Overall Study|Lost to Follow-up|0
5067276|NCT02318329|17481809|P4|Overall Study|Lost to Follow-up|0
5067277|NCT02318329|17481810|P3|Overall Study|Lost to Follow-up|0
5067278|NCT02318329|17481811|P2|Overall Study|Lost to Follow-up|0
5067279|NCT02318329|17481812|P1|Overall Study|Lost to Follow-up|0
5067280|NCT02318329|17481803|P10|Overall Study|Death|5
5067281|NCT02318329|17481804|P9|Overall Study|Death|0
5067282|NCT02318329|17481805|P8|Overall Study|Death|0
5067283|NCT02318329|17481806|P7|Overall Study|Death|0
5067284|NCT02318329|17481807|P6|Overall Study|Death|0
5067285|NCT02318329|17481808|P5|Overall Study|Death|0
5067286|NCT02318329|17481809|P4|Overall Study|Death|0
5067287|NCT02318329|17481810|P3|Overall Study|Death|0
5067288|NCT02318329|17481811|P2|Overall Study|Death|0
5067289|NCT02318329|17481812|P1|Overall Study|Death|0
5067290|NCT02318329|17481803|P10|Overall Study|Progressive Disease|39
5067291|NCT02318329|17481804|P9|Overall Study|Progressive Disease|5
5067292|NCT02318329|17481805|P8|Overall Study|Progressive Disease|1
5067293|NCT02318329|17481806|P7|Overall Study|Progressive Disease|1
5067294|NCT02318329|17481807|P6|Overall Study|Progressive Disease|3
5067295|NCT02318329|17481808|P5|Overall Study|Progressive Disease|3
5067296|NCT02318329|17481809|P4|Overall Study|Progressive Disease|3
5067297|NCT02318329|17481810|P3|Overall Study|Progressive Disease|2
5067298|NCT02318329|17481811|P2|Overall Study|Progressive Disease|3
5067299|NCT02318329|17481812|P1|Overall Study|Progressive Disease|2
5067300|NCT02317809|17481897|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
5067301|NCT02317809|17481898|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
5067302|NCT02317809|17481897|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
5067303|NCT02317809|17481898|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
5067304|NCT02317614|17481986|P2|Overall Study|Death|1
5067305|NCT02317614|17481987|P1|Overall Study|Death|1
5067306|NCT02317614|17481986|P2|Overall Study|Withdrawal by Subject|0
5067307|NCT02317614|17481987|P1|Overall Study|Withdrawal by Subject|1
5067308|NCT02317614|17481986|P2|Overall Study|Lost to Follow-up|1
5067309|NCT02317614|17481987|P1|Overall Study|Lost to Follow-up|1
5067310|NCT02317575|17482003|P5|Period 1|Withdrawal by Subject|0
5067311|NCT02317575|17482004|P4|Period 1|Withdrawal by Subject|0
5067312|NCT02317575|17482005|P3|Period 1|Withdrawal by Subject|0
5067313|NCT02317575|17482006|P2|Period 1|Withdrawal by Subject|0
5067314|NCT02317575|17482007|P1|Period 1|Withdrawal by Subject|1
5067315|NCT02317575|17482003|P5|Period 1|Difficulty with venous cannulation|0
5067316|NCT02317575|17482004|P4|Period 1|Difficulty with venous cannulation|0
5067317|NCT02317575|17482005|P3|Period 1|Difficulty with venous cannulation|0
5067318|NCT02317575|17482006|P2|Period 1|Difficulty with venous cannulation|1
5067319|NCT02317575|17482007|P1|Period 1|Difficulty with venous cannulation|0
5067320|NCT02317510|17482042|P2|Overall Study|Adverse Event|1
5067321|NCT02317510|17482043|P1|Overall Study|Adverse Event|0
5067322|NCT02317016|17482075|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
5067323|NCT02317016|17482075|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
5067324|NCT02317016|17482075|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
5067414|NCT02315703|17482531|P7|Overall Study|Pregnancy|0
5067325|NCT02317016|17482075|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
5067326|NCT02317016|17482075|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
5067327|NCT02317016|17482075|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
5067328|NCT02317016|17482075|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
5067329|NCT02316847|17482103|P2|Overall Study|Withdrawn due to termination by Sponsor|67
5067330|NCT02316847|17482104|P1|Overall Study|Withdrawn due to termination by Sponsor|7
5067331|NCT02316847|17482103|P2|Overall Study|Noncompliance with study drug|3
5067332|NCT02316847|17482104|P1|Overall Study|Noncompliance with study drug|0
5067333|NCT02316847|17482103|P2|Overall Study|Withdrawal by Subject|9
5067334|NCT02316847|17482104|P1|Overall Study|Withdrawal by Subject|2
5067335|NCT02316847|17482103|P2|Overall Study|Pregnancy|1
5067336|NCT02316847|17482104|P1|Overall Study|Pregnancy|0
5067337|NCT02316847|17482103|P2|Overall Study|Physician Decision|1
5067338|NCT02316847|17482104|P1|Overall Study|Physician Decision|0
5067339|NCT02316847|17482103|P2|Overall Study|Lost to Follow-up|2
5067340|NCT02316847|17482104|P1|Overall Study|Lost to Follow-up|0
5067341|NCT02316847|17482103|P2|Overall Study|Adverse Event|3
5067342|NCT02316847|17482104|P1|Overall Study|Adverse Event|0
5067343|NCT02316769|17482115|P2|Overall Study|Withdrawal by Subject|0
5067344|NCT02316769|17482116|P1|Overall Study|Withdrawal by Subject|1
5067345|NCT02316769|17482115|P2|Overall Study|Physician Decision|0
5067346|NCT02316769|17482116|P1|Overall Study|Physician Decision|1
5067347|NCT02316717|17482127|P3|Overall Study|TBC|0
5067348|NCT02316717|17482128|P2|Overall Study|TBC|0
5067349|NCT02316717|17482129|P1|Overall Study|TBC|1
5067350|NCT02316717|17482127|P3|Overall Study|Physician Decision|0
5067351|NCT02316717|17482128|P2|Overall Study|Physician Decision|1
5067352|NCT02316717|17482129|P1|Overall Study|Physician Decision|0
5067353|NCT02316717|17482127|P3|Overall Study|Death|1
5067354|NCT02316717|17482128|P2|Overall Study|Death|0
5067355|NCT02316717|17482129|P1|Overall Study|Death|0
5067356|NCT02316717|17482127|P3|Overall Study|Withdrawal by Subject|1
5067357|NCT02316717|17482128|P2|Overall Study|Withdrawal by Subject|1
5067358|NCT02316717|17482129|P1|Overall Study|Withdrawal by Subject|2
5067359|NCT02316717|17482127|P3|Overall Study|Protocol Violation|0
5067360|NCT02316717|17482128|P2|Overall Study|Protocol Violation|0
5067361|NCT02316717|17482129|P1|Overall Study|Protocol Violation|2
5067362|NCT02316717|17482127|P3|Overall Study|Non compliance|0
5067363|NCT02316717|17482128|P2|Overall Study|Non compliance|1
5067364|NCT02316717|17482129|P1|Overall Study|Non compliance|3
5067365|NCT02316717|17482127|P3|Overall Study|Lost to Follow-up|1
5067366|NCT02316717|17482128|P2|Overall Study|Lost to Follow-up|2
5067367|NCT02316717|17482129|P1|Overall Study|Lost to Follow-up|1
5067368|NCT02316717|17482127|P3|Overall Study|Adverse Event|0
5067369|NCT02316717|17482128|P2|Overall Study|Adverse Event|2
5067370|NCT02316717|17482129|P1|Overall Study|Adverse Event|2
5067371|NCT02316613|17482266|P1|Overall Study|Did not met selection criteria|14
5067372|NCT02316613|17482266|P1|Overall Study|No data and duplicate cases|5
5067373|NCT02316613|17482266|P1|Overall Study|Participant moved/changed medical team|11
5067374|NCT02316613|17482266|P1|Overall Study|Lymphoma transformation|2
5067375|NCT02316613|17482266|P1|Overall Study|Lost to Follow-up|9
5067376|NCT02316613|17482266|P1|Overall Study|Death|63
5067377|NCT02316548|17482305|P2|Overall Study|Protocol Violation|1
5067378|NCT02316548|17482306|P1|Overall Study|Protocol Violation|0
5067379|NCT02316353|17482436|P2|Overall Study|Withdrawal by Subject|2
5067380|NCT02316353|17482437|P1|Overall Study|Withdrawal by Subject|6
5067381|NCT02316353|17482436|P2|Overall Study|Adverse Event|3
5067382|NCT02316353|17482437|P1|Overall Study|Adverse Event|1
5067383|NCT02316353|17482436|P2|Overall Study|Pregnancy|3
5067384|NCT02316353|17482437|P1|Overall Study|Pregnancy|1
5067385|NCT02316171|17482457|P4|Overall Study|difficulties with urinary catheter|0
5067386|NCT02316171|17482458|P3|Overall Study|difficulties with urinary catheter|0
5067387|NCT02316171|17482459|P2|Overall Study|difficulties with urinary catheter|0
5067388|NCT02316171|17482460|P1|Overall Study|difficulties with urinary catheter|1
5067389|NCT02315703|17482530|P8|Overall Study|Other|2
5067390|NCT02315703|17482531|P7|Overall Study|Other|8
5067391|NCT02315703|17482532|P6|Overall Study|Other|2
5067392|NCT02315703|17482533|P5|Overall Study|Other|1
5067393|NCT02315703|17482534|P4|Overall Study|Other|2
5067394|NCT02315703|17482535|P3|Overall Study|Other|2
5067395|NCT02315703|17482536|P2|Overall Study|Other|2
5067396|NCT02315703|17482537|P1|Overall Study|Other|4
5067397|NCT02315703|17482530|P8|Overall Study|Physician Decision|0
5067398|NCT02315703|17482531|P7|Overall Study|Physician Decision|1
5067399|NCT02315703|17482532|P6|Overall Study|Physician Decision|2
5067400|NCT02315703|17482533|P5|Overall Study|Physician Decision|0
5067401|NCT02315703|17482534|P4|Overall Study|Physician Decision|0
5067402|NCT02315703|17482535|P3|Overall Study|Physician Decision|0
5067403|NCT02315703|17482536|P2|Overall Study|Physician Decision|0
5067404|NCT02315703|17482537|P1|Overall Study|Physician Decision|0
5067405|NCT02315703|17482530|P8|Overall Study|Withdrawal by Subject|2
5067406|NCT02315703|17482531|P7|Overall Study|Withdrawal by Subject|1
5067407|NCT02315703|17482532|P6|Overall Study|Withdrawal by Subject|1
5067408|NCT02315703|17482533|P5|Overall Study|Withdrawal by Subject|4
5067409|NCT02315703|17482534|P4|Overall Study|Withdrawal by Subject|3
5067410|NCT02315703|17482535|P3|Overall Study|Withdrawal by Subject|0
5067411|NCT02315703|17482536|P2|Overall Study|Withdrawal by Subject|3
5067412|NCT02315703|17482537|P1|Overall Study|Withdrawal by Subject|1
5067413|NCT02315703|17482530|P8|Overall Study|Pregnancy|1
5067415|NCT02315703|17482532|P6|Overall Study|Pregnancy|0
5067416|NCT02315703|17482533|P5|Overall Study|Pregnancy|0
5067417|NCT02315703|17482534|P4|Overall Study|Pregnancy|0
5067418|NCT02315703|17482535|P3|Overall Study|Pregnancy|0
5067419|NCT02315703|17482536|P2|Overall Study|Pregnancy|0
5067420|NCT02315703|17482537|P1|Overall Study|Pregnancy|0
5067421|NCT02315703|17482530|P8|Overall Study|Lost to Follow-up|2
5067422|NCT02315703|17482531|P7|Overall Study|Lost to Follow-up|2
5067423|NCT02315703|17482532|P6|Overall Study|Lost to Follow-up|1
5067424|NCT02315703|17482533|P5|Overall Study|Lost to Follow-up|2
5067425|NCT02315703|17482534|P4|Overall Study|Lost to Follow-up|3
5067426|NCT02315703|17482535|P3|Overall Study|Lost to Follow-up|3
5067427|NCT02315703|17482536|P2|Overall Study|Lost to Follow-up|5
5067428|NCT02315703|17482537|P1|Overall Study|Lost to Follow-up|1
5067429|NCT02315703|17482530|P8|Overall Study|Adverse Event|0
5067430|NCT02315703|17482531|P7|Overall Study|Adverse Event|1
5067431|NCT02315703|17482532|P6|Overall Study|Adverse Event|0
5067432|NCT02315703|17482533|P5|Overall Study|Adverse Event|1
5067433|NCT02315703|17482534|P4|Overall Study|Adverse Event|1
5067434|NCT02315703|17482535|P3|Overall Study|Adverse Event|0
5067435|NCT02315703|17482536|P2|Overall Study|Adverse Event|0
5067436|NCT02315703|17482537|P1|Overall Study|Adverse Event|0
5067437|NCT02315664|17482637|P2|Overall Study|Withdrawal by Subject|3
5067438|NCT02315664|17482638|P1|Overall Study|Withdrawal by Subject|0
5067439|NCT02315664|17482637|P2|Overall Study|Lost to Follow-up|1
5067440|NCT02315664|17482638|P1|Overall Study|Lost to Follow-up|1
5067441|NCT02315625|17482660|P2|Second Intervention|Disease Progression|0
5067442|NCT02315625|17482661|P1|Second Intervention|Disease Progression|1
5067443|NCT02315625|17482660|P2|Second Intervention|Study closure|0
5067444|NCT02315625|17482661|P1|Second Intervention|Study closure|1
5067445|NCT02315625|17482660|P2|Second Intervention|Physician Decision|1
5067446|NCT02315625|17482661|P1|Second Intervention|Physician Decision|2
5067447|NCT02315625|17482660|P2|First Intervention|Disease Progression|0
5067448|NCT02315625|17482661|P1|First Intervention|Disease Progression|1
5067449|NCT02315560|17482675|P1|Overall Study|noncompliance by subjects|3
5067450|NCT02314923|17482934|P10|Overall Study|Participant relocation|0
5067451|NCT02314923|17482935|P9|Overall Study|Participant relocation|0
5067452|NCT02314923|17482936|P8|Overall Study|Participant relocation|1
5067453|NCT02314923|17482937|P7|Overall Study|Participant relocation|0
5067454|NCT02314923|17482938|P6|Overall Study|Participant relocation|0
5067455|NCT02314923|17482939|P5|Overall Study|Participant relocation|0
5067456|NCT02314923|17482940|P4|Overall Study|Participant relocation|0
5067457|NCT02314923|17482941|P3|Overall Study|Participant relocation|0
5067458|NCT02314923|17482942|P2|Overall Study|Participant relocation|0
5067459|NCT02314923|17482943|P1|Overall Study|Participant relocation|1
5067460|NCT02314923|17482934|P10|Overall Study|Screen failure|0
5067461|NCT02314923|17482935|P9|Overall Study|Screen failure|0
5067462|NCT02314923|17482936|P8|Overall Study|Screen failure|0
5067463|NCT02314923|17482937|P7|Overall Study|Screen failure|1
5067464|NCT02314923|17482938|P6|Overall Study|Screen failure|0
5067465|NCT02314923|17482939|P5|Overall Study|Screen failure|0
5067466|NCT02314923|17482940|P4|Overall Study|Screen failure|0
5067467|NCT02314923|17482941|P3|Overall Study|Screen failure|0
5067468|NCT02314923|17482942|P2|Overall Study|Screen failure|0
5067469|NCT02314923|17482943|P1|Overall Study|Screen failure|0
5067470|NCT02314923|17482934|P10|Overall Study|Participant unavailable|0
5067471|NCT02314923|17482935|P9|Overall Study|Participant unavailable|0
5067472|NCT02314923|17482936|P8|Overall Study|Participant unavailable|0
5067473|NCT02314923|17482937|P7|Overall Study|Participant unavailable|0
5067474|NCT02314923|17482938|P6|Overall Study|Participant unavailable|1
5067475|NCT02314923|17482939|P5|Overall Study|Participant unavailable|0
5067476|NCT02314923|17482940|P4|Overall Study|Participant unavailable|0
5067477|NCT02314923|17482941|P3|Overall Study|Participant unavailable|0
5067478|NCT02314923|17482942|P2|Overall Study|Participant unavailable|0
5067479|NCT02314923|17482943|P1|Overall Study|Participant unavailable|0
5067480|NCT02314923|17482934|P10|Overall Study|Physician Decision|0
5067481|NCT02314923|17482935|P9|Overall Study|Physician Decision|0
5067482|NCT02314923|17482936|P8|Overall Study|Physician Decision|0
5067483|NCT02314923|17482937|P7|Overall Study|Physician Decision|0
5067484|NCT02314923|17482938|P6|Overall Study|Physician Decision|0
5067485|NCT02314923|17482939|P5|Overall Study|Physician Decision|0
5067486|NCT02314923|17482940|P4|Overall Study|Physician Decision|0
5067487|NCT02314923|17482941|P3|Overall Study|Physician Decision|0
5067488|NCT02314923|17482942|P2|Overall Study|Physician Decision|1
5067489|NCT02314923|17482943|P1|Overall Study|Physician Decision|0
5067490|NCT02314923|17482934|P10|Overall Study|Withdrawal by Subject|0
5067491|NCT02314923|17482935|P9|Overall Study|Withdrawal by Subject|0
5067492|NCT02314923|17482936|P8|Overall Study|Withdrawal by Subject|0
5067493|NCT02314923|17482937|P7|Overall Study|Withdrawal by Subject|1
5067494|NCT02314923|17482938|P6|Overall Study|Withdrawal by Subject|0
5067495|NCT02314923|17482939|P5|Overall Study|Withdrawal by Subject|1
5067496|NCT02314923|17482940|P4|Overall Study|Withdrawal by Subject|0
5067497|NCT02314923|17482941|P3|Overall Study|Withdrawal by Subject|1
5067498|NCT02314923|17482942|P2|Overall Study|Withdrawal by Subject|0
5067499|NCT02314923|17482943|P1|Overall Study|Withdrawal by Subject|0
5067500|NCT02314923|17482934|P10|Overall Study|Lost to Follow-up|0
5067501|NCT02314923|17482935|P9|Overall Study|Lost to Follow-up|2
5067502|NCT02314923|17482936|P8|Overall Study|Lost to Follow-up|4
5067503|NCT02314923|17482937|P7|Overall Study|Lost to Follow-up|3
5067504|NCT02314923|17482938|P6|Overall Study|Lost to Follow-up|0
5067505|NCT02314923|17482939|P5|Overall Study|Lost to Follow-up|0
5067506|NCT02314923|17482940|P4|Overall Study|Lost to Follow-up|0
5067507|NCT02314923|17482941|P3|Overall Study|Lost to Follow-up|1
5067508|NCT02314923|17482942|P2|Overall Study|Lost to Follow-up|3
5067509|NCT02314923|17482943|P1|Overall Study|Lost to Follow-up|2
5067510|NCT02314923|17482934|P10|Overall Study|Death|0
5067511|NCT02314923|17482935|P9|Overall Study|Death|0
5067512|NCT02314923|17482936|P8|Overall Study|Death|0
5067513|NCT02314923|17482937|P7|Overall Study|Death|0
5067514|NCT02314923|17482938|P6|Overall Study|Death|0
5067515|NCT02314923|17482939|P5|Overall Study|Death|0
5067516|NCT02314923|17482940|P4|Overall Study|Death|1
5067517|NCT02314923|17482941|P3|Overall Study|Death|0
5067518|NCT02314923|17482942|P2|Overall Study|Death|0
5067519|NCT02314923|17482943|P1|Overall Study|Death|0
5067520|NCT02314637|17483042|P2|Overall Study|Other Reason|0
5067521|NCT02314637|17483043|P1|Overall Study|Other Reason|1
5067522|NCT02314637|17483042|P2|Overall Study|Withdrawal by Subject|4
5067523|NCT02314637|17483043|P1|Overall Study|Withdrawal by Subject|5
5067524|NCT02314637|17483042|P2|Overall Study|Physician Decision|2
5067525|NCT02314637|17483043|P1|Overall Study|Physician Decision|5
5067526|NCT02314637|17483042|P2|Overall Study|Lack of Efficacy|0
5067527|NCT02314637|17483043|P1|Overall Study|Lack of Efficacy|1
5067528|NCT02314637|17483042|P2|Overall Study|Adverse Event|8
5067529|NCT02314637|17483043|P1|Overall Study|Adverse Event|4
5067530|NCT02314247|17483114|P3|Overall Study|Progression of Disease|0
5067531|NCT02314247|17483115|P2|Overall Study|Progression of Disease|2
5067532|NCT02314247|17483116|P1|Overall Study|Progression of Disease|6
5067533|NCT02314247|17483114|P3|Overall Study|Withdrawal by Subject|1
5067534|NCT02314247|17483115|P2|Overall Study|Withdrawal by Subject|3
5067535|NCT02314247|17483116|P1|Overall Study|Withdrawal by Subject|1
5067536|NCT02314247|17483114|P3|Overall Study|Adverse Event|0
5067537|NCT02314247|17483115|P2|Overall Study|Adverse Event|1
5067538|NCT02314247|17483116|P1|Overall Study|Adverse Event|2
5067539|NCT02314143|17483141|P3|Overall Study|Withdrawal by Subject|1
5067540|NCT02314143|17483142|P2|Overall Study|Withdrawal by Subject|0
5067541|NCT02314143|17483143|P1|Overall Study|Withdrawal by Subject|1
5067542|NCT02314143|17483141|P3|Overall Study|Physician Decision|0
5067543|NCT02314143|17483142|P2|Overall Study|Physician Decision|1
5067544|NCT02314143|17483143|P1|Overall Study|Physician Decision|2
5067545|NCT02314143|17483141|P3|Overall Study|Other (Study Closed/Terminated)|4
5067546|NCT02314143|17483142|P2|Overall Study|Other (Study Closed/Terminated)|3
5067547|NCT02314143|17483143|P1|Overall Study|Other (Study Closed/Terminated)|5
5067548|NCT02314143|17483141|P3|Overall Study|Adverse Event|4
5067549|NCT02314143|17483142|P2|Overall Study|Adverse Event|6
5067550|NCT02314143|17483143|P1|Overall Study|Adverse Event|0
5067551|NCT02314117|17483189|P2|Overall Study|No post-discontinuation follow-up|19
5067552|NCT02314117|17483190|P1|Overall Study|No post-discontinuation follow-up|21
5067553|NCT02314117|17483189|P2|Overall Study|Withdrawal by Subject|2
5067554|NCT02314117|17483190|P1|Overall Study|Withdrawal by Subject|2
5067555|NCT02314117|17483189|P2|Overall Study|On Treatment|6
5067556|NCT02314117|17483190|P1|Overall Study|On Treatment|10
5067557|NCT02314117|17483189|P2|Overall Study|Lost to Follow-up|11
5067558|NCT02314117|17483190|P1|Overall Study|Lost to Follow-up|8
5067559|NCT02314052|17483243|P6|Cycle One|Adverse Event|0
5067560|NCT02314052|17483244|P5|Cycle One|Adverse Event|0
5067561|NCT02314052|17483245|P4|Cycle One|Adverse Event|1
5067562|NCT02314052|17483246|P3|Cycle One|Adverse Event|0
5067563|NCT02314052|17483247|P2|Cycle One|Adverse Event|0
5067564|NCT02314052|17483248|P1|Cycle One|Adverse Event|0
5067565|NCT02314026|17483316|P1|Overall Study|Protocol Violation|28
5067566|NCT02313909|17483334|P2|Overall Study|Lost to Follow-up|17
5067567|NCT02313909|17483335|P1|Overall Study|Lost to Follow-up|24
5067568|NCT02313909|17483334|P2|Overall Study|Consent withdrawn by participant|33
5067569|NCT02313909|17483335|P1|Overall Study|Consent withdrawn by participant|33
5067570|NCT02313766|17483358|P3|Overall Study|Adverse Event|0
5067571|NCT02313766|17483359|P2|Overall Study|Adverse Event|1
5067572|NCT02313766|17483360|P1|Overall Study|Adverse Event|0
5067573|NCT02313766|17483358|P3|Overall Study|Lost to Follow-up|0
5067574|NCT02313766|17483359|P2|Overall Study|Lost to Follow-up|2
5067575|NCT02313766|17483360|P1|Overall Study|Lost to Follow-up|0
5067576|NCT02313766|17483358|P3|Overall Study|surgery cancelled|0
5067577|NCT02313766|17483359|P2|Overall Study|surgery cancelled|0
5067578|NCT02313766|17483360|P1|Overall Study|surgery cancelled|1
5067579|NCT02313558|17483397|P2|Overall Study|Lost to Follow-up|4
5067580|NCT02313558|17483398|P1|Overall Study|Lost to Follow-up|4
5067581|NCT02313558|17483397|P2|Overall Study|Withdrawal by Subject|0
5067582|NCT02313558|17483398|P1|Overall Study|Withdrawal by Subject|2
5067583|NCT02313233|17483444|P2|Overall Study|Administrative reason|1
5067584|NCT02313233|17483445|P1|Overall Study|Administrative reason|1
5067585|NCT02313233|17483444|P2|Overall Study|Withdrawal by Subject|2
5067586|NCT02313233|17483445|P1|Overall Study|Withdrawal by Subject|1
5067587|NCT02313155|17483467|P2|Overall Study|Lost to Follow-up|1
5067588|NCT02313155|17483468|P1|Overall Study|Lost to Follow-up|0
5067589|NCT02312934|17483518|P2|Overall Study|Physician Decision|0
5067590|NCT02312934|17483519|P1|Overall Study|Physician Decision|1
5067591|NCT02312934|17483518|P2|Overall Study|Lost to Follow-up|0
5067592|NCT02312934|17483519|P1|Overall Study|Lost to Follow-up|1
5067593|NCT02312856|17483531|P1|Overall Study|Lost to Follow-up|3
5067594|NCT02312856|17483531|P1|Overall Study|Death|1
5067595|NCT02312687|17483624|P1|Overall Study|Other, Not Specified|1
5067596|NCT02312258|17483716|P2|Overall Study|Participants Ongoing Treatment|83
5067597|NCT02312258|17483717|P1|Overall Study|Participants Ongoing Treatment|43
5067598|NCT02312258|17483716|P2|Overall Study|Reason not Specified|31
5067599|NCT02312258|17483717|P1|Overall Study|Reason not Specified|11
5067600|NCT02312258|17483716|P2|Overall Study|Withdrawal by Subject|9
5067601|NCT02312258|17483717|P1|Overall Study|Withdrawal by Subject|8
5067602|NCT02312258|17483716|P2|Overall Study|Progressive Disease|188
5067603|NCT02312258|17483717|P1|Overall Study|Progressive Disease|174
5067604|NCT02312258|17483716|P2|Overall Study|Lost to Follow-up|1
5067605|NCT02312258|17483717|P1|Overall Study|Lost to Follow-up|0
5067606|NCT02312258|17483716|P2|Overall Study|Adverse Event|47
5067607|NCT02312258|17483717|P1|Overall Study|Adverse Event|15
5067608|NCT02312219|17483725|P2|Overall Study|Not randomized. Ineligible|1
5067609|NCT02312219|17483726|P1|Overall Study|Not randomized. Ineligible|0
5067610|NCT02312219|17483725|P2|Overall Study|Other|1
5067611|NCT02312219|17483726|P1|Overall Study|Other|0
5067612|NCT02312219|17483725|P2|Overall Study|could not schedule imaging in time|2
5067613|NCT02312219|17483726|P1|Overall Study|could not schedule imaging in time|0
5067614|NCT02312219|17483725|P2|Overall Study|Withdrawal by Subject|2
5067615|NCT02312219|17483726|P1|Overall Study|Withdrawal by Subject|1
5067616|NCT02312206|17483736|P2|Overall Study|Subject missed 3 consecutive tx visits|1
5067617|NCT02312206|17483737|P1|Overall Study|Subject missed 3 consecutive tx visits|0
5067618|NCT02312206|17483736|P2|Overall Study|Patient transferred to hospice|1
5067619|NCT02312206|17483737|P1|Overall Study|Patient transferred to hospice|0
5067620|NCT02312206|17483736|P2|Overall Study|Patient progression and new therapy|0
5067621|NCT02312206|17483737|P1|Overall Study|Patient progression and new therapy|1
5067622|NCT02312206|17483736|P2|Overall Study|Disease Progression|0
5067623|NCT02312206|17483737|P1|Overall Study|Disease Progression|1
5067624|NCT02312206|17483736|P2|Overall Study|Study Terminated by Sponsor|74
5067625|NCT02312206|17483737|P1|Overall Study|Study Terminated by Sponsor|81
5067626|NCT02312206|17483736|P2|Overall Study|Death|36
5067627|NCT02312206|17483737|P1|Overall Study|Death|30
5067628|NCT02312206|17483736|P2|Overall Study|Physician Decision|6
5067629|NCT02312206|17483737|P1|Overall Study|Physician Decision|7
5067630|NCT02312206|17483736|P2|Overall Study|Withdrawal by Subject|6
5067631|NCT02312206|17483737|P1|Overall Study|Withdrawal by Subject|7
5067632|NCT02312206|17483736|P2|Overall Study|Adverse Event|6
5067633|NCT02312206|17483737|P1|Overall Study|Adverse Event|3
5067634|NCT02312063|17483760|P2|Overall Study|Withdrawal by Subject|1
5067635|NCT02312063|17483761|P1|Overall Study|Withdrawal by Subject|0
5067636|NCT02311894|17483814|P1|Overall Study|Withdrawal by Subject|1
5067637|NCT02311894|17483814|P1|Overall Study|Adverse Event|1
5067638|NCT02311894|17483814|P1|Overall Study|Lost to Follow-up|1
5067639|NCT02311894|17483814|P1|Overall Study|Discontinued in error|1
5067640|NCT02311881|17483826|P3|Overall Study|Serious Adverse Event|0
5067641|NCT02311881|17483827|P2|Overall Study|Serious Adverse Event|1
5067642|NCT02311881|17483828|P1|Overall Study|Serious Adverse Event|0
5067643|NCT02311881|17483826|P3|Overall Study|Participant taking another medication|1
5067644|NCT02311881|17483827|P2|Overall Study|Participant taking another medication|0
5067645|NCT02311881|17483828|P1|Overall Study|Participant taking another medication|0
5067646|NCT02311881|17483826|P3|Overall Study|Medical Monitor Discretion|1
5067647|NCT02311881|17483827|P2|Overall Study|Medical Monitor Discretion|0
5067648|NCT02311881|17483828|P1|Overall Study|Medical Monitor Discretion|0
5067649|NCT02311881|17483826|P3|Overall Study|Physician Decision|1
5067650|NCT02311881|17483827|P2|Overall Study|Physician Decision|0
5067651|NCT02311881|17483828|P1|Overall Study|Physician Decision|0
5067652|NCT02311881|17483826|P3|Overall Study|Non-Compliance|2
5067653|NCT02311881|17483827|P2|Overall Study|Non-Compliance|0
5067654|NCT02311881|17483828|P1|Overall Study|Non-Compliance|1
5067655|NCT02311881|17483826|P3|Overall Study|Protocol Deviation|0
5067656|NCT02311881|17483827|P2|Overall Study|Protocol Deviation|0
5067657|NCT02311881|17483828|P1|Overall Study|Protocol Deviation|1
5067658|NCT02311881|17483826|P3|Overall Study|Sponsor Decision|1
5067659|NCT02311881|17483827|P2|Overall Study|Sponsor Decision|1
5067660|NCT02311881|17483828|P1|Overall Study|Sponsor Decision|1
5067661|NCT02311881|17483826|P3|Overall Study|Withdrawal by Subject|4
5067662|NCT02311881|17483827|P2|Overall Study|Withdrawal by Subject|1
5067663|NCT02311881|17483828|P1|Overall Study|Withdrawal by Subject|3
5067664|NCT02311881|17483826|P3|Overall Study|Subject has border line pregnancy test|0
5067665|NCT02311881|17483827|P2|Overall Study|Subject has border line pregnancy test|0
5067666|NCT02311881|17483828|P1|Overall Study|Subject has border line pregnancy test|1
5067667|NCT02311881|17483826|P3|Overall Study|Lack of Efficacy|0
5067668|NCT02311881|17483827|P2|Overall Study|Lack of Efficacy|2
5067669|NCT02311881|17483828|P1|Overall Study|Lack of Efficacy|1
5067670|NCT02311881|17483826|P3|Overall Study|Other|1
5067671|NCT02311881|17483827|P2|Overall Study|Other|0
5067672|NCT02311881|17483828|P1|Overall Study|Other|0
5067673|NCT02311881|17483826|P3|Overall Study|Withdrawal of consent|17
5067674|NCT02311881|17483827|P2|Overall Study|Withdrawal of consent|16
5067675|NCT02311881|17483828|P1|Overall Study|Withdrawal of consent|14
5067676|NCT02311881|17483826|P3|Overall Study|Protocol Violation|3
5067677|NCT02311881|17483827|P2|Overall Study|Protocol Violation|2
5067678|NCT02311881|17483828|P1|Overall Study|Protocol Violation|1
5067679|NCT02311881|17483826|P3|Overall Study|Lost to Follow-up|2
5067680|NCT02311881|17483827|P2|Overall Study|Lost to Follow-up|3
5067681|NCT02311881|17483828|P1|Overall Study|Lost to Follow-up|3
5067682|NCT02311881|17483826|P3|Overall Study|Adverse Event|8
5067683|NCT02311881|17483827|P2|Overall Study|Adverse Event|15
5067684|NCT02311881|17483828|P1|Overall Study|Adverse Event|7
5067685|NCT02311881|17483826|P3|Overall Study|Did not meet the study criteria|0
5067686|NCT02311881|17483827|P2|Overall Study|Did not meet the study criteria|2
5067687|NCT02311881|17483828|P1|Overall Study|Did not meet the study criteria|2
5067688|NCT02311478|17483863|P1|Overall Study|Failed IUD Insertion|1
5067689|NCT02311478|17483863|P1|Overall Study|Lost to Follow-up|5
5067690|NCT02311478|17483863|P1|Overall Study|Withdrawal by Subject|1
5067691|NCT02311361|17483872|P4|Overall Study|Did not receive treatment|1
5067692|NCT02311361|17483873|P3|Overall Study|Did not receive treatment|0
5067693|NCT02311361|17483874|P2|Overall Study|Did not receive treatment|1
5067694|NCT02311361|17483875|P1|Overall Study|Did not receive treatment|0
5067695|NCT02311153|17483927|P2|Overall Study|Lost to Follow-up|7
5067696|NCT02311153|17483928|P1|Overall Study|Lost to Follow-up|5
5067697|NCT02310906|17483948|P4|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
5067698|NCT02310906|17483949|P3|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5067699|NCT02310906|17483950|P2|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5067700|NCT02310906|17483951|P1|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5067701|NCT02310906|17483948|P4|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
5067702|NCT02310906|17483949|P3|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5067703|NCT02310906|17483950|P2|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5067704|NCT02310906|17483951|P1|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5067705|NCT02310906|17483948|P4|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
5067706|NCT02310906|17483949|P3|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
5067707|NCT02310906|17483950|P2|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
5067708|NCT02310906|17483951|P1|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
5067709|NCT02310906|17483948|P4|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
5067710|NCT02310906|17483949|P3|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5067711|NCT02310906|17483950|P2|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5067712|NCT02310906|17483951|P1|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5067713|NCT02310789|17484030|P1|Overall Study|Adverse Event|1
5067714|NCT02310763|17484042|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5067715|NCT02310763|17484043|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5067716|NCT02310763|17484044|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5067717|NCT02310763|17484042|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
5067718|NCT02310763|17484043|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
5067719|NCT02310763|17484044|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
5067720|NCT02310763|17484042|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
5067721|NCT02310763|17484043|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
5067722|NCT02310763|17484044|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
5067723|NCT02310763|17484042|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
5067724|NCT02310763|17484043|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
5067725|NCT02310763|17484044|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
5067726|NCT02310763|17484042|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5067727|NCT02310763|17484043|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5067728|NCT02310763|17484044|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5067729|NCT02310750|17484247|P16|HP Washout 2|Lost to Follow-up|0
5067730|NCT02310750|17484248|P15|HP Washout 2|Lost to Follow-up|0
5067731|NCT02310750|17484249|P14|HP Washout 2|Lost to Follow-up|0
5067732|NCT02310750|17484250|P13|HP Washout 2|Lost to Follow-up|0
5067733|NCT02310750|17484251|P12|HP Washout 2|Lost to Follow-up|0
5067734|NCT02310750|17484252|P11|HP Washout 2|Lost to Follow-up|0
5067735|NCT02310750|17484253|P10|HP Washout 2|Lost to Follow-up|0
5067736|NCT02310750|17484254|P9|HP Washout 2|Lost to Follow-up|0
5067737|NCT02310750|17484255|P8|HP Washout 2|Lost to Follow-up|0
5067738|NCT02310750|17484256|P7|HP Washout 2|Lost to Follow-up|7
5067739|NCT02310750|17484257|P6|HP Washout 2|Lost to Follow-up|0
5067740|NCT02310750|17484258|P5|HP Washout 2|Lost to Follow-up|1
5067741|NCT02310750|17484259|P4|HP Washout 2|Lost to Follow-up|0
5067742|NCT02310750|17484260|P3|HP Washout 2|Lost to Follow-up|0
5067743|NCT02310750|17484261|P2|HP Washout 2|Lost to Follow-up|0
5067744|NCT02310750|17484262|P1|HP Washout 2|Lost to Follow-up|0
5067745|NCT02310750|17484247|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067746|NCT02310750|17484248|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067747|NCT02310750|17484249|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067748|NCT02310750|17484250|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067749|NCT02310750|17484251|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067750|NCT02310750|17484252|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067751|NCT02310750|17484253|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067752|NCT02310750|17484254|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
5067753|NCT02310750|17484255|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
5067754|NCT02310750|17484256|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067755|NCT02310750|17484257|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067756|NCT02310750|17484258|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067757|NCT02310750|17484259|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067836|NCT02310750|17484258|P5|HP Period 1|Withdrawal by Subject|0
5067758|NCT02310750|17484260|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067759|NCT02310750|17484261|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067760|NCT02310750|17484262|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5067761|NCT02310750|17484247|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067762|NCT02310750|17484248|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067763|NCT02310750|17484249|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067764|NCT02310750|17484250|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067765|NCT02310750|17484251|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067766|NCT02310750|17484252|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067767|NCT02310750|17484253|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5067768|NCT02310750|17484254|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5067769|NCT02310750|17484255|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5067770|NCT02310750|17484256|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067771|NCT02310750|17484257|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067772|NCT02310750|17484258|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067773|NCT02310750|17484259|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067774|NCT02310750|17484260|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067775|NCT02310750|17484261|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067776|NCT02310750|17484262|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5067777|NCT02310750|17484247|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067778|NCT02310750|17484248|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067779|NCT02310750|17484249|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067780|NCT02310750|17484250|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067781|NCT02310750|17484251|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067782|NCT02310750|17484252|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067783|NCT02310750|17484253|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
5067784|NCT02310750|17484254|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067785|NCT02310750|17484255|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067786|NCT02310750|17484256|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067787|NCT02310750|17484257|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067788|NCT02310750|17484258|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067789|NCT02310750|17484259|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067790|NCT02310750|17484260|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067791|NCT02310750|17484261|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067792|NCT02310750|17484262|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5067793|NCT02310750|17484247|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067794|NCT02310750|17484248|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067795|NCT02310750|17484249|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067796|NCT02310750|17484250|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067797|NCT02310750|17484251|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067798|NCT02310750|17484252|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067799|NCT02310750|17484253|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
5067800|NCT02310750|17484254|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
5067801|NCT02310750|17484255|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067802|NCT02310750|17484256|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067803|NCT02310750|17484257|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
5067804|NCT02310750|17484258|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067805|NCT02310750|17484259|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
5067806|NCT02310750|17484260|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067807|NCT02310750|17484261|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067808|NCT02310750|17484262|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5067809|NCT02310750|17484247|P16|HP Washout 1|Lost to Follow-up|0
5067810|NCT02310750|17484248|P15|HP Washout 1|Lost to Follow-up|0
5067811|NCT02310750|17484249|P14|HP Washout 1|Lost to Follow-up|0
5067812|NCT02310750|17484250|P13|HP Washout 1|Lost to Follow-up|0
5067813|NCT02310750|17484251|P12|HP Washout 1|Lost to Follow-up|0
5067814|NCT02310750|17484252|P11|HP Washout 1|Lost to Follow-up|0
5067815|NCT02310750|17484253|P10|HP Washout 1|Lost to Follow-up|0
5067816|NCT02310750|17484254|P9|HP Washout 1|Lost to Follow-up|0
5067817|NCT02310750|17484255|P8|HP Washout 1|Lost to Follow-up|0
5067818|NCT02310750|17484256|P7|HP Washout 1|Lost to Follow-up|3
5067819|NCT02310750|17484257|P6|HP Washout 1|Lost to Follow-up|2
5067820|NCT02310750|17484258|P5|HP Washout 1|Lost to Follow-up|2
5067821|NCT02310750|17484259|P4|HP Washout 1|Lost to Follow-up|1
5067822|NCT02310750|17484260|P3|HP Washout 1|Lost to Follow-up|1
5067823|NCT02310750|17484261|P2|HP Washout 1|Lost to Follow-up|0
5067824|NCT02310750|17484262|P1|HP Washout 1|Lost to Follow-up|0
5067825|NCT02310750|17484247|P16|HP Period 1|Withdrawal by Subject|0
5067826|NCT02310750|17484248|P15|HP Period 1|Withdrawal by Subject|0
5067827|NCT02310750|17484249|P14|HP Period 1|Withdrawal by Subject|0
5067828|NCT02310750|17484250|P13|HP Period 1|Withdrawal by Subject|0
5067829|NCT02310750|17484251|P12|HP Period 1|Withdrawal by Subject|0
5067830|NCT02310750|17484252|P11|HP Period 1|Withdrawal by Subject|0
5067831|NCT02310750|17484253|P10|HP Period 1|Withdrawal by Subject|0
5067832|NCT02310750|17484254|P9|HP Period 1|Withdrawal by Subject|0
5067833|NCT02310750|17484255|P8|HP Period 1|Withdrawal by Subject|0
5067834|NCT02310750|17484256|P7|HP Period 1|Withdrawal by Subject|0
5067835|NCT02310750|17484257|P6|HP Period 1|Withdrawal by Subject|0
5067837|NCT02310750|17484259|P4|HP Period 1|Withdrawal by Subject|1
5067838|NCT02310750|17484260|P3|HP Period 1|Withdrawal by Subject|0
5067839|NCT02310750|17484261|P2|HP Period 1|Withdrawal by Subject|0
5067840|NCT02310750|17484262|P1|HP Period 1|Withdrawal by Subject|1
5067841|NCT02310750|17484247|P16|HP Period 1|Lost to Follow-up|0
5067842|NCT02310750|17484248|P15|HP Period 1|Lost to Follow-up|0
5067843|NCT02310750|17484249|P14|HP Period 1|Lost to Follow-up|0
5067844|NCT02310750|17484250|P13|HP Period 1|Lost to Follow-up|0
5067845|NCT02310750|17484251|P12|HP Period 1|Lost to Follow-up|0
5067846|NCT02310750|17484252|P11|HP Period 1|Lost to Follow-up|0
5067847|NCT02310750|17484253|P10|HP Period 1|Lost to Follow-up|0
5067848|NCT02310750|17484254|P9|HP Period 1|Lost to Follow-up|0
5067849|NCT02310750|17484255|P8|HP Period 1|Lost to Follow-up|0
5067850|NCT02310750|17484256|P7|HP Period 1|Lost to Follow-up|1
5067851|NCT02310750|17484257|P6|HP Period 1|Lost to Follow-up|0
5067852|NCT02310750|17484258|P5|HP Period 1|Lost to Follow-up|0
5067853|NCT02310750|17484259|P4|HP Period 1|Lost to Follow-up|0
5067854|NCT02310750|17484260|P3|HP Period 1|Lost to Follow-up|0
5067855|NCT02310750|17484261|P2|HP Period 1|Lost to Follow-up|0
5067856|NCT02310750|17484262|P1|HP Period 1|Lost to Follow-up|0
5067857|NCT02310672|17484701|P1|Overall Study|Sponsor's decision|12
5067858|NCT02310672|17484701|P1|Overall Study|Withdrawal by Subject|1
5067859|NCT02310672|17484701|P1|Overall Study|Lost to Follow-up|1
5067860|NCT02310672|17484701|P1|Overall Study|Death|1
5067861|NCT02310646|17484714|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
5067862|NCT02310646|17484715|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
5067863|NCT02310646|17484714|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
5067864|NCT02310646|17484715|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
5067865|NCT02310581|17484743|P4|Overall Study|Withdrawal by Subject|1
5067866|NCT02310581|17484744|P3|Overall Study|Withdrawal by Subject|0
5067867|NCT02310581|17484745|P2|Overall Study|Withdrawal by Subject|1
5067868|NCT02310581|17484746|P1|Overall Study|Withdrawal by Subject|2
5067869|NCT02310581|17484743|P4|Overall Study|Adverse Event|0
5067870|NCT02310581|17484744|P3|Overall Study|Adverse Event|1
5067871|NCT02310581|17484745|P2|Overall Study|Adverse Event|1
5067872|NCT02310581|17484746|P1|Overall Study|Adverse Event|1
5067873|NCT02310568|17484785|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
5067874|NCT02310568|17484786|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
5067875|NCT02310568|17484787|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
5067876|NCT02310568|17484788|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
5067877|NCT02310568|17484789|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
5067878|NCT02310568|17484785|P5|Stage 2 (4 Weeks)|Protocol Violation|0
5067879|NCT02310568|17484786|P4|Stage 2 (4 Weeks)|Protocol Violation|1
5067880|NCT02310568|17484787|P3|Stage 2 (4 Weeks)|Protocol Violation|0
5067881|NCT02310568|17484788|P2|Stage 2 (4 Weeks)|Protocol Violation|0
5067882|NCT02310568|17484789|P1|Stage 2 (4 Weeks)|Protocol Violation|0
5067883|NCT02310568|17484785|P5|Stage 2 (4 Weeks)|Adverse Event|1
5067884|NCT02310568|17484786|P4|Stage 2 (4 Weeks)|Adverse Event|1
5067885|NCT02310568|17484787|P3|Stage 2 (4 Weeks)|Adverse Event|0
5067886|NCT02310568|17484788|P2|Stage 2 (4 Weeks)|Adverse Event|0
5067887|NCT02310568|17484789|P1|Stage 2 (4 Weeks)|Adverse Event|0
5067888|NCT02310568|17484785|P5|Stage 2 (4 Weeks)|Other|0
5067889|NCT02310568|17484786|P4|Stage 2 (4 Weeks)|Other|0
5067890|NCT02310568|17484787|P3|Stage 2 (4 Weeks)|Other|1
5067891|NCT02310568|17484788|P2|Stage 2 (4 Weeks)|Other|1
5067892|NCT02310568|17484789|P1|Stage 2 (4 Weeks)|Other|0
5067893|NCT02310568|17484785|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5067894|NCT02310568|17484786|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
5067895|NCT02310568|17484787|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5067896|NCT02310568|17484788|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5067897|NCT02310568|17484789|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
5067898|NCT02310568|17484785|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5067899|NCT02310568|17484786|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
5067900|NCT02310568|17484787|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5067901|NCT02310568|17484788|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5067902|NCT02310568|17484789|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5067903|NCT02310568|17484785|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5067904|NCT02310568|17484786|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
5067905|NCT02310568|17484787|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5067906|NCT02310568|17484788|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5067907|NCT02310568|17484789|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5067908|NCT02310568|17484785|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
5067909|NCT02310568|17484786|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
5067910|NCT02310568|17484787|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
5067911|NCT02310568|17484788|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
5067912|NCT02310568|17484789|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
5067913|NCT02310568|17484785|P5|Stage 1 ( 4 Weeks)|Other|0
5067914|NCT02310568|17484786|P4|Stage 1 ( 4 Weeks)|Other|0
5067915|NCT02310568|17484787|P3|Stage 1 ( 4 Weeks)|Other|0
5067916|NCT02310568|17484788|P2|Stage 1 ( 4 Weeks)|Other|1
5067917|NCT02310568|17484789|P1|Stage 1 ( 4 Weeks)|Other|1
5067918|NCT02310568|17484785|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5067919|NCT02310568|17484786|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5067920|NCT02310568|17484787|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5067921|NCT02310568|17484788|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5067922|NCT02310568|17484789|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
5067923|NCT02310568|17484785|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
5067924|NCT02310568|17484786|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5067925|NCT02310568|17484787|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5067926|NCT02310568|17484788|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5067927|NCT02310568|17484789|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5067928|NCT02310126|17484869|P2|Period 1 (15 Minutes)|Protocol Violation|1
5067929|NCT02310126|17484870|P1|Period 1 (15 Minutes)|Protocol Violation|0
5067930|NCT02310126|17484869|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
5067931|NCT02310126|17484870|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
5067932|NCT02310100|17484876|P1|Overall Study|Lost to Follow-up|2
5067933|NCT02310100|17484876|P1|Overall Study|Visit compliance|1
5067934|NCT02310100|17484876|P1|Overall Study|Unapproved ablation operator|1
5067935|NCT02310100|17484876|P1|Overall Study|Enrollment closure|1
5067936|NCT02310100|17484876|P1|Overall Study|Withdrawal by Subject|10
5067937|NCT02310100|17484876|P1|Overall Study|Physician Decision|3
5067938|NCT02309723|17484895|P3|Overall Study|Withdrawal by Subject|24
5067939|NCT02309723|17484896|P2|Overall Study|Withdrawal by Subject|23
5067940|NCT02309723|17484897|P1|Overall Study|Withdrawal by Subject|24
5067941|NCT02309411|17484940|P3|Overall Study|Withdrawal by Subject|0
5067942|NCT02309411|17484941|P2|Overall Study|Withdrawal by Subject|1
5067943|NCT02309411|17484942|P1|Overall Study|Withdrawal by Subject|1
5067944|NCT02309411|17484940|P3|Overall Study|Physician Decision|0
5067945|NCT02309411|17484941|P2|Overall Study|Physician Decision|0
5067946|NCT02309411|17484942|P1|Overall Study|Physician Decision|1
5067947|NCT02309372|17484963|P2|Overall Study|Lost to Follow-up|2
5067948|NCT02309372|17484964|P1|Overall Study|Lost to Follow-up|3
5067949|NCT02309359|17484981|P5|Overall Study|Other|2
5067950|NCT02309359|17484982|P4|Overall Study|Other|3
5067951|NCT02309359|17484983|P3|Overall Study|Other|2
5067952|NCT02309359|17484984|P2|Overall Study|Other|0
5067953|NCT02309359|17484985|P1|Overall Study|Other|2
5067954|NCT02309359|17484981|P5|Overall Study|Lost to Follow-up|0
5067955|NCT02309359|17484982|P4|Overall Study|Lost to Follow-up|1
5067956|NCT02309359|17484983|P3|Overall Study|Lost to Follow-up|0
5067957|NCT02309359|17484984|P2|Overall Study|Lost to Follow-up|0
5067958|NCT02309359|17484985|P1|Overall Study|Lost to Follow-up|0
5067959|NCT02309359|17484981|P5|Overall Study|Lack of Efficacy|3
5067960|NCT02309359|17484982|P4|Overall Study|Lack of Efficacy|0
5067961|NCT02309359|17484983|P3|Overall Study|Lack of Efficacy|0
5067962|NCT02309359|17484984|P2|Overall Study|Lack of Efficacy|1
5067963|NCT02309359|17484985|P1|Overall Study|Lack of Efficacy|3
5067964|NCT02309359|17484981|P5|Overall Study|Withdrawal by Subject|0
5067965|NCT02309359|17484982|P4|Overall Study|Withdrawal by Subject|4
5067966|NCT02309359|17484983|P3|Overall Study|Withdrawal by Subject|4
5067967|NCT02309359|17484984|P2|Overall Study|Withdrawal by Subject|2
5067968|NCT02309359|17484985|P1|Overall Study|Withdrawal by Subject|2
5067969|NCT02309359|17484981|P5|Overall Study|Death|0
5067970|NCT02309359|17484982|P4|Overall Study|Death|0
5067971|NCT02309359|17484983|P3|Overall Study|Death|0
5067972|NCT02309359|17484984|P2|Overall Study|Death|0
5067973|NCT02309359|17484985|P1|Overall Study|Death|1
5067974|NCT02309359|17484981|P5|Overall Study|Adverse Event|4
5067975|NCT02309359|17484982|P4|Overall Study|Adverse Event|4
5067976|NCT02309359|17484983|P3|Overall Study|Adverse Event|5
5067977|NCT02309359|17484984|P2|Overall Study|Adverse Event|5
5067978|NCT02309359|17484985|P1|Overall Study|Adverse Event|4
5067979|NCT02309294|17485112|P1|Overall Study|Withdrawal by Subject|2
5067980|NCT02309138|17485118|P2|Overall Study|delivered before visit 2|1
5067981|NCT02309138|17485119|P1|Overall Study|delivered before visit 2|0
5067982|NCT02309138|17485118|P2|Overall Study|Protocol Violation|2
5067983|NCT02309138|17485119|P1|Overall Study|Protocol Violation|4
5067984|NCT02309138|17485118|P2|Overall Study|Withdrawal by Subject|15
5067985|NCT02309138|17485119|P1|Overall Study|Withdrawal by Subject|44
5067986|NCT02309112|17485142|P3|Overall Study|Lost to Follow-up|0
5067987|NCT02309112|17485143|P2|Overall Study|Lost to Follow-up|1
5067988|NCT02309112|17485144|P1|Overall Study|Lost to Follow-up|0
5067989|NCT02309112|17485142|P3|Overall Study|Withdrawal by Subject|1
5067990|NCT02309112|17485143|P2|Overall Study|Withdrawal by Subject|0
5067991|NCT02309112|17485144|P1|Overall Study|Withdrawal by Subject|1
5067992|NCT02309099|17485167|P2|Overall Study|Adverse Event|0
5067993|NCT02309099|17485168|P1|Overall Study|Adverse Event|2
5067994|NCT02308748|17485239|P10|Period 5|Adverse Event|0
5067995|NCT02308748|17485240|P9|Period 5|Adverse Event|1
5067996|NCT02308748|17485241|P8|Period 5|Adverse Event|0
5067997|NCT02308748|17485242|P7|Period 5|Adverse Event|0
5067998|NCT02308748|17485243|P6|Period 5|Adverse Event|0
5067999|NCT02308748|17485244|P5|Period 5|Adverse Event|0
5068000|NCT02308748|17485245|P4|Period 5|Adverse Event|0
5068001|NCT02308748|17485246|P3|Period 5|Adverse Event|0
5068002|NCT02308748|17485247|P2|Period 5|Adverse Event|0
5068003|NCT02308748|17485248|P1|Period 5|Adverse Event|1
5068004|NCT02308748|17485239|P10|Period 3|Protocol Violation|1
5068005|NCT02308748|17485240|P9|Period 3|Protocol Violation|0
5068006|NCT02308748|17485241|P8|Period 3|Protocol Violation|0
5068007|NCT02308748|17485242|P7|Period 3|Protocol Violation|0
5068008|NCT02308748|17485243|P6|Period 3|Protocol Violation|0
5068009|NCT02308748|17485244|P5|Period 3|Protocol Violation|0
5068010|NCT02308748|17485245|P4|Period 3|Protocol Violation|0
5068011|NCT02308748|17485246|P3|Period 3|Protocol Violation|0
5068012|NCT02308748|17485247|P2|Period 3|Protocol Violation|0
5068013|NCT02308748|17485248|P1|Period 3|Protocol Violation|0
5068014|NCT02308748|17485239|P10|Period 2|Adverse Event|0
5068015|NCT02308748|17485240|P9|Period 2|Adverse Event|0
5068016|NCT02308748|17485241|P8|Period 2|Adverse Event|1
5068017|NCT02308748|17485242|P7|Period 2|Adverse Event|0
5068018|NCT02308748|17485243|P6|Period 2|Adverse Event|0
5068019|NCT02308748|17485244|P5|Period 2|Adverse Event|0
5068020|NCT02308748|17485245|P4|Period 2|Adverse Event|0
5068021|NCT02308748|17485246|P3|Period 2|Adverse Event|0
5068022|NCT02308748|17485247|P2|Period 2|Adverse Event|0
5068023|NCT02308748|17485248|P1|Period 2|Adverse Event|0
5068024|NCT02308748|17485239|P10|Period 1|Withdrawal by Subject|0
5068025|NCT02308748|17485240|P9|Period 1|Withdrawal by Subject|0
5068026|NCT02308748|17485241|P8|Period 1|Withdrawal by Subject|0
5068027|NCT02308748|17485242|P7|Period 1|Withdrawal by Subject|0
5068028|NCT02308748|17485243|P6|Period 1|Withdrawal by Subject|0
5068029|NCT02308748|17485244|P5|Period 1|Withdrawal by Subject|0
5068030|NCT02308748|17485245|P4|Period 1|Withdrawal by Subject|0
5068031|NCT02308748|17485246|P3|Period 1|Withdrawal by Subject|1
5068032|NCT02308748|17485247|P2|Period 1|Withdrawal by Subject|0
5068033|NCT02308748|17485248|P1|Period 1|Withdrawal by Subject|0
5068034|NCT02308696|17485262|P2|Overall Study|Moved to a Higher Level of Care|6
5068035|NCT02308696|17485263|P1|Overall Study|Moved to a Higher Level of Care|17
5068036|NCT02308696|17485262|P2|Overall Study|Death|4
5068037|NCT02308696|17485263|P1|Overall Study|Death|8
5068038|NCT02308696|17485262|P2|Overall Study|Lost to Follow-up|21
5068039|NCT02308696|17485263|P1|Overall Study|Lost to Follow-up|28
5068040|NCT02308540|17485297|P6|Overall Study|Lost to Follow-up|1
5068041|NCT02308540|17485298|P5|Overall Study|Lost to Follow-up|0
5068042|NCT02308540|17485299|P4|Overall Study|Lost to Follow-up|0
5068043|NCT02308540|17485300|P3|Overall Study|Lost to Follow-up|0
5068044|NCT02308540|17485301|P2|Overall Study|Lost to Follow-up|0
5068045|NCT02308540|17485302|P1|Overall Study|Lost to Follow-up|0
5068046|NCT02308228|17485391|P2|Overall Study|Withdrawal by Subject|3
5068047|NCT02308228|17485392|P1|Overall Study|Withdrawal by Subject|5
5068048|NCT02308228|17485391|P2|Overall Study|Adverse Event|4
5068049|NCT02308228|17485392|P1|Overall Study|Adverse Event|3
5068050|NCT02308163|17485421|P5|Overall Study|Miscellaneous|5
5068051|NCT02308163|17485422|P4|Overall Study|Miscellaneous|0
5068052|NCT02308163|17485423|P3|Overall Study|Miscellaneous|1
5068053|NCT02308163|17485424|P2|Overall Study|Miscellaneous|2
5068054|NCT02308163|17485425|P1|Overall Study|Miscellaneous|2
5068055|NCT02308163|17485421|P5|Overall Study|Lab data met discontinuation criteria|0
5068056|NCT02308163|17485422|P4|Overall Study|Lab data met discontinuation criteria|2
5068057|NCT02308163|17485423|P3|Overall Study|Lab data met discontinuation criteria|0
5068058|NCT02308163|17485424|P2|Overall Study|Lab data met discontinuation criteria|0
5068059|NCT02308163|17485425|P1|Overall Study|Lab data met discontinuation criteria|3
5068060|NCT02308163|17485421|P5|Overall Study|Protocol Violation|5
5068061|NCT02308163|17485422|P4|Overall Study|Protocol Violation|2
5068062|NCT02308163|17485423|P3|Overall Study|Protocol Violation|3
5068063|NCT02308163|17485424|P2|Overall Study|Protocol Violation|3
5068064|NCT02308163|17485425|P1|Overall Study|Protocol Violation|3
5068065|NCT02308163|17485421|P5|Overall Study|Withdrawal of consent|6
5068066|NCT02308163|17485422|P4|Overall Study|Withdrawal of consent|2
5068067|NCT02308163|17485423|P3|Overall Study|Withdrawal of consent|0
5068068|NCT02308163|17485424|P2|Overall Study|Withdrawal of consent|3
5068069|NCT02308163|17485425|P1|Overall Study|Withdrawal of consent|2
5068070|NCT02308163|17485421|P5|Overall Study|Lack of Efficacy|6
5068071|NCT02308163|17485422|P4|Overall Study|Lack of Efficacy|4
5068072|NCT02308163|17485423|P3|Overall Study|Lack of Efficacy|8
5068073|NCT02308163|17485424|P2|Overall Study|Lack of Efficacy|3
5068074|NCT02308163|17485425|P1|Overall Study|Lack of Efficacy|11
5068075|NCT02308163|17485421|P5|Overall Study|Adverse Event|11
5068076|NCT02308163|17485422|P4|Overall Study|Adverse Event|2
5068077|NCT02308163|17485423|P3|Overall Study|Adverse Event|2
5068078|NCT02308163|17485424|P2|Overall Study|Adverse Event|5
5068079|NCT02308163|17485425|P1|Overall Study|Adverse Event|9
5068080|NCT02308163|17485421|P5|Overall Study|Not fulfill eligible criteria|1
5068081|NCT02308163|17485422|P4|Overall Study|Not fulfill eligible criteria|1
5068082|NCT02308163|17485423|P3|Overall Study|Not fulfill eligible criteria|0
5068083|NCT02308163|17485424|P2|Overall Study|Not fulfill eligible criteria|2
5068084|NCT02308163|17485425|P1|Overall Study|Not fulfill eligible criteria|1
5068085|NCT02308124|17485735|P3|Overall Study|Adverse Event|2
5068086|NCT02308124|17485736|P2|Overall Study|Adverse Event|2
5068087|NCT02308124|17485737|P1|Overall Study|Adverse Event|0
5068088|NCT02308124|17485735|P3|Overall Study|Lost to Follow-up|6
5068089|NCT02308124|17485736|P2|Overall Study|Lost to Follow-up|6
5068090|NCT02308124|17485737|P1|Overall Study|Lost to Follow-up|6
5068091|NCT02308046|17485759|P2|Overall Study|Lost to Follow-up|3
5068092|NCT02308046|17485760|P1|Overall Study|Lost to Follow-up|1
5068093|NCT02308046|17485759|P2|Overall Study|Positive for STD at Baseline|2
5068094|NCT02308046|17485760|P1|Overall Study|Positive for STD at Baseline|1
5068095|NCT02308046|17485759|P2|Overall Study|Negative yeast culture at Baseline|33
5068096|NCT02308046|17485760|P1|Overall Study|Negative yeast culture at Baseline|32
5068097|NCT02308033|17485776|P2|Overall Study|Lost to Follow-up|5
5068098|NCT02308033|17485777|P1|Overall Study|Lost to Follow-up|6
5068099|NCT02308033|17485776|P2|Overall Study|Positive for STD at Baseline|4
5068100|NCT02308033|17485777|P1|Overall Study|Positive for STD at Baseline|7
5068101|NCT02308033|17485776|P2|Overall Study|Normal Gram stain at Baseline|10
5068102|NCT02308033|17485777|P1|Overall Study|Normal Gram stain at Baseline|13
5068103|NCT02308020|17485797|P6|Overall Study|On treatment|0
5068104|NCT02308020|17485798|P5|Overall Study|On treatment|0
5068105|NCT02308020|17485799|P4|Overall Study|On treatment|0
5068106|NCT02308020|17485800|P3|Overall Study|On treatment|0
5068107|NCT02308020|17485801|P2|Overall Study|On treatment|3
5068108|NCT02308020|17485802|P1|Overall Study|On treatment|0
5068109|NCT02308020|17485797|P6|Overall Study|Withdrawal by Subject|0
5068110|NCT02308020|17485798|P5|Overall Study|Withdrawal by Subject|2
5068111|NCT02308020|17485799|P4|Overall Study|Withdrawal by Subject|3
5068112|NCT02308020|17485800|P3|Overall Study|Withdrawal by Subject|0
5068113|NCT02308020|17485801|P2|Overall Study|Withdrawal by Subject|4
5068114|NCT02308020|17485802|P1|Overall Study|Withdrawal by Subject|0
5068115|NCT02308020|17485797|P6|Overall Study|Physician Decision|1
5068116|NCT02308020|17485798|P5|Overall Study|Physician Decision|0
5068117|NCT02308020|17485799|P4|Overall Study|Physician Decision|0
5068118|NCT02308020|17485800|P3|Overall Study|Physician Decision|0
5068119|NCT02308020|17485801|P2|Overall Study|Physician Decision|0
5068120|NCT02308020|17485802|P1|Overall Study|Physician Decision|0
5068121|NCT02308020|17485797|P6|Overall Study|Protocol Violation|0
5068122|NCT02308020|17485798|P5|Overall Study|Protocol Violation|0
5068123|NCT02308020|17485799|P4|Overall Study|Protocol Violation|0
5068124|NCT02308020|17485800|P3|Overall Study|Protocol Violation|1
5068125|NCT02308020|17485801|P2|Overall Study|Protocol Violation|0
5068126|NCT02308020|17485802|P1|Overall Study|Protocol Violation|0
5068127|NCT02308020|17485797|P6|Overall Study|Adverse Event|1
5068128|NCT02308020|17485798|P5|Overall Study|Adverse Event|0
5068129|NCT02308020|17485799|P4|Overall Study|Adverse Event|1
5068130|NCT02308020|17485800|P3|Overall Study|Adverse Event|0
5068131|NCT02308020|17485801|P2|Overall Study|Adverse Event|5
5068132|NCT02308020|17485802|P1|Overall Study|Adverse Event|3
5068133|NCT02308007|17485855|P3|Overall Study|Lost to Follow-up|1
5068134|NCT02308007|17485856|P2|Overall Study|Lost to Follow-up|0
5068135|NCT02308007|17485857|P1|Overall Study|Lost to Follow-up|3
5068136|NCT02308007|17485855|P3|Overall Study|Positive for STD at Baseline|7
5068137|NCT02308007|17485856|P2|Overall Study|Positive for STD at Baseline|11
5068138|NCT02308007|17485857|P1|Overall Study|Positive for STD at Baseline|7
5068139|NCT02308007|17485855|P3|Overall Study|Normal Gram stain or neg yeast culture|67
5068140|NCT02308007|17485856|P2|Overall Study|Normal Gram stain or neg yeast culture|64
5068141|NCT02308007|17485857|P1|Overall Study|Normal Gram stain or neg yeast culture|66
5068142|NCT02307682|17485948|P3|Overall Study|Other|0
5068143|NCT02307682|17485949|P2|Overall Study|Other|1
5068144|NCT02307682|17485950|P1|Overall Study|Other|1
5068145|NCT02307682|17485948|P3|Overall Study|Protocol Deviation|2
5068146|NCT02307682|17485949|P2|Overall Study|Protocol Deviation|0
5068147|NCT02307682|17485950|P1|Overall Study|Protocol Deviation|0
5068148|NCT02307682|17485948|P3|Overall Study|Lost to Follow-up|6
5068149|NCT02307682|17485949|P2|Overall Study|Lost to Follow-up|5
5068150|NCT02307682|17485950|P1|Overall Study|Lost to Follow-up|1
5068151|NCT02307682|17485948|P3|Overall Study|Death|12
5068152|NCT02307682|17485949|P2|Overall Study|Death|7
5068153|NCT02307682|17485950|P1|Overall Study|Death|9
5068154|NCT02307682|17485948|P3|Overall Study|Withdrawal by Subject|23
5068155|NCT02307682|17485949|P2|Overall Study|Withdrawal by Subject|34
5068156|NCT02307682|17485950|P1|Overall Study|Withdrawal by Subject|26
5068157|NCT02307682|17485948|P3|Overall Study|Progressive Disease|0
5068158|NCT02307682|17485949|P2|Overall Study|Progressive Disease|0
5068159|NCT02307682|17485950|P1|Overall Study|Progressive Disease|1
5068160|NCT02307682|17485948|P3|Overall Study|Physician Decision|8
5068161|NCT02307682|17485949|P2|Overall Study|Physician Decision|2
5068162|NCT02307682|17485950|P1|Overall Study|Physician Decision|2
5068163|NCT02307682|17485948|P3|Overall Study|Lack of Efficacy|1
5068164|NCT02307682|17485949|P2|Overall Study|Lack of Efficacy|0
5068165|NCT02307682|17485950|P1|Overall Study|Lack of Efficacy|1
5068166|NCT02307682|17485948|P3|Overall Study|Adverse Event|12
5068167|NCT02307682|17485949|P2|Overall Study|Adverse Event|8
5068168|NCT02307682|17485950|P1|Overall Study|Adverse Event|9
5068169|NCT02307513|17486066|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
5068170|NCT02307513|17486067|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
5068171|NCT02307513|17486066|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
5068172|NCT02307513|17486067|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
5068173|NCT02307513|17486066|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
5068174|NCT02307513|17486067|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
5068175|NCT02307513|17486066|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
5068176|NCT02307513|17486067|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
5068177|NCT02307513|17486066|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
5068178|NCT02307513|17486067|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
5068179|NCT02307513|17486066|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
5068180|NCT02307513|17486067|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
5068181|NCT02307513|17486066|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
5068182|NCT02307513|17486067|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
5068183|NCT02307513|17486066|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
5068184|NCT02307513|17486067|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
5068185|NCT02307513|17486066|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
5068186|NCT02307513|17486067|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
5068187|NCT02307513|17486066|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
5068188|NCT02307513|17486067|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
5068189|NCT02307513|17486066|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
5068190|NCT02307513|17486067|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
5068191|NCT02307513|17486066|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
5068192|NCT02307513|17486067|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
5068193|NCT02307266|17486118|P3|Overall Study|Lost to Follow-up|0
5068194|NCT02307266|17486119|P2|Overall Study|Lost to Follow-up|0
5068195|NCT02307266|17486120|P1|Overall Study|Lost to Follow-up|3
5068196|NCT02307266|17486118|P3|Overall Study|Withdrawal by Subject|1
5068197|NCT02307266|17486119|P2|Overall Study|Withdrawal by Subject|0
5068198|NCT02307266|17486120|P1|Overall Study|Withdrawal by Subject|2
5068199|NCT02307266|17486118|P3|Overall Study|Adverse Event|5
5068200|NCT02307266|17486119|P2|Overall Study|Adverse Event|1
5068201|NCT02307266|17486120|P1|Overall Study|Adverse Event|3
5068202|NCT02306850|17486145|P1|Overall Study|Lack of Efficacy|2
5068203|NCT02306694|17486167|P1|Overall Study|Lost to Follow-up|1
5068204|NCT02306694|17486167|P1|Overall Study|Withdrawal by Subject|3
5068205|NCT02306265|17486177|P1|Overall Study|Withdrawal by Subject|1
5068206|NCT02305888|17486186|P3|Overall Study|Adverse Event|0
5068207|NCT02305888|17486187|P2|Overall Study|Adverse Event|1
5068208|NCT02305888|17486188|P1|Overall Study|Adverse Event|0
5068209|NCT02305888|17486186|P3|Overall Study|Lost to Follow-up|1
5068210|NCT02305888|17486187|P2|Overall Study|Lost to Follow-up|0
5068211|NCT02305888|17486188|P1|Overall Study|Lost to Follow-up|0
5068212|NCT02305849|17486208|P4|Overall Study|Not fulfill eligibility criteria|0
5068213|NCT02305849|17486209|P3|Overall Study|Not fulfill eligibility criteria|0
5068214|NCT02305849|17486210|P2|Overall Study|Not fulfill eligibility criteria|1
5068215|NCT02305849|17486211|P1|Overall Study|Not fulfill eligibility criteria|1
5068216|NCT02305849|17486208|P4|Overall Study|Miscellaneous|1
5068217|NCT02305849|17486209|P3|Overall Study|Miscellaneous|4
5068218|NCT02305849|17486210|P2|Overall Study|Miscellaneous|2
5068219|NCT02305849|17486211|P1|Overall Study|Miscellaneous|1
5068220|NCT02305849|17486208|P4|Overall Study|Lab data met discontinuation criteria|1
5068221|NCT02305849|17486209|P3|Overall Study|Lab data met discontinuation criteria|2
5068222|NCT02305849|17486210|P2|Overall Study|Lab data met discontinuation criteria|1
5068223|NCT02305849|17486211|P1|Overall Study|Lab data met discontinuation criteria|0
5068224|NCT02305849|17486208|P4|Overall Study|Protocol Violation|1
5068225|NCT02305849|17486209|P3|Overall Study|Protocol Violation|1
5068226|NCT02305849|17486210|P2|Overall Study|Protocol Violation|2
5068227|NCT02305849|17486211|P1|Overall Study|Protocol Violation|3
5068228|NCT02305849|17486208|P4|Overall Study|Lost to Follow-up|0
5068229|NCT02305849|17486209|P3|Overall Study|Lost to Follow-up|0
5068230|NCT02305849|17486210|P2|Overall Study|Lost to Follow-up|2
5068231|NCT02305849|17486211|P1|Overall Study|Lost to Follow-up|0
5068232|NCT02305849|17486208|P4|Overall Study|Withdrawal by Subject|4
5068233|NCT02305849|17486209|P3|Overall Study|Withdrawal by Subject|1
5068234|NCT02305849|17486210|P2|Overall Study|Withdrawal by Subject|2
5068235|NCT02305849|17486211|P1|Overall Study|Withdrawal by Subject|2
5068236|NCT02305849|17486208|P4|Overall Study|Lack of Efficacy|9
5068237|NCT02305849|17486209|P3|Overall Study|Lack of Efficacy|3
5068238|NCT02305849|17486210|P2|Overall Study|Lack of Efficacy|6
5068239|NCT02305849|17486211|P1|Overall Study|Lack of Efficacy|10
5068240|NCT02305849|17486208|P4|Overall Study|Adverse Event|3
5068241|NCT02305849|17486209|P3|Overall Study|Adverse Event|7
5068242|NCT02305849|17486210|P2|Overall Study|Adverse Event|12
5068243|NCT02305849|17486211|P1|Overall Study|Adverse Event|10
5068244|NCT02305797|17486445|P2|Overall Study|Reason not collected|1
5068245|NCT02305797|17486446|P1|Overall Study|Reason not collected|0
5068246|NCT02305797|17486445|P2|Overall Study|Noncompliance|12
5068247|NCT02305797|17486446|P1|Overall Study|Noncompliance|14
5068248|NCT02305797|17486445|P2|Overall Study|Pregnancy|2
5068249|NCT02305797|17486446|P1|Overall Study|Pregnancy|0
5068250|NCT02305797|17486445|P2|Overall Study|Lost to Follow-up|11
5068251|NCT02305797|17486446|P1|Overall Study|Lost to Follow-up|5
5068252|NCT02305797|17486445|P2|Overall Study|Lack of Efficacy|0
5068253|NCT02305797|17486446|P1|Overall Study|Lack of Efficacy|6
5068254|NCT02305797|17486445|P2|Overall Study|Withdrawal by Subject|10
5068255|NCT02305797|17486446|P1|Overall Study|Withdrawal by Subject|9
5068256|NCT02305797|17486445|P2|Overall Study|Adverse Event|2
5068257|NCT02305797|17486446|P1|Overall Study|Adverse Event|11
5068258|NCT02305758|17486456|P2|Overall Study|Other, not specified|1
5068259|NCT02305758|17486457|P1|Overall Study|Other, not specified|2
5068260|NCT02305758|17486456|P2|Overall Study|Study Terminated by Sponsor|34
5068261|NCT02305758|17486457|P1|Overall Study|Study Terminated by Sponsor|21
5068262|NCT02305758|17486456|P2|Overall Study|Lost to Follow-up|1
5068263|NCT02305758|17486457|P1|Overall Study|Lost to Follow-up|6
5068264|NCT02305758|17486456|P2|Overall Study|Withdrew consent|2
5068265|NCT02305758|17486457|P1|Overall Study|Withdrew consent|9
5068266|NCT02305758|17486456|P2|Overall Study|Death|27
5068267|NCT02305758|17486457|P1|Overall Study|Death|27
5068268|NCT02305446|17486475|P1|Overall Study|Adverse Event|1
5068269|NCT02305381|17486483|P3|Overall Study|Unclassified|7
5068270|NCT02305381|17486484|P2|Overall Study|Unclassified|5
5068271|NCT02305381|17486485|P1|Overall Study|Unclassified|5
5068272|NCT02305238|17486598|P3|Overall Study|Required procedure failed|0
5068273|NCT02305238|17486599|P2|Overall Study|Required procedure failed|1
5068274|NCT02305238|17486600|P1|Overall Study|Required procedure failed|0
5068275|NCT02305238|17486598|P3|Overall Study|Randomized failure|8
5068276|NCT02305238|17486599|P2|Overall Study|Randomized failure|0
5068277|NCT02305238|17486600|P1|Overall Study|Randomized failure|0
5068278|NCT02305238|17486598|P3|Overall Study|Withdrawal by Subject|0
5068279|NCT02305238|17486599|P2|Overall Study|Withdrawal by Subject|4
5068280|NCT02305238|17486600|P1|Overall Study|Withdrawal by Subject|3
5068281|NCT02305238|17486598|P3|Overall Study|Adverse Event|0
5068282|NCT02305238|17486599|P2|Overall Study|Adverse Event|2
5068283|NCT02305238|17486600|P1|Overall Study|Adverse Event|4
5068284|NCT02305238|17486598|P3|Overall Study|Physician Decision|0
5068285|NCT02305238|17486599|P2|Overall Study|Physician Decision|1
5068286|NCT02305238|17486600|P1|Overall Study|Physician Decision|2
5068287|NCT02305238|17486598|P3|Overall Study|Protocol Violation|0
5068288|NCT02305238|17486599|P2|Overall Study|Protocol Violation|3
5068289|NCT02305238|17486600|P1|Overall Study|Protocol Violation|0
5068290|NCT02305238|17486598|P3|Overall Study|Logistical difficulties|0
5068291|NCT02305238|17486599|P2|Overall Study|Logistical difficulties|3
5068292|NCT02305238|17486600|P1|Overall Study|Logistical difficulties|1
5068293|NCT02305238|17486598|P3|Overall Study|Progressive disease|0
5068294|NCT02305238|17486599|P2|Overall Study|Progressive disease|4
5068295|NCT02305238|17486600|P1|Overall Study|Progressive disease|4
5068296|NCT02305238|17486598|P3|Overall Study|Death|0
5068297|NCT02305238|17486599|P2|Overall Study|Death|1
5068298|NCT02305238|17486600|P1|Overall Study|Death|2
5068299|NCT02304926|17486632|P2|Overall Study|Lost to Follow-up|1
5068300|NCT02304926|17486633|P1|Overall Study|Lost to Follow-up|2
5068301|NCT02304705|17486679|P2|Overall Study|Lost to Follow-up|2
5068302|NCT02304705|17486680|P1|Overall Study|Lost to Follow-up|0
5068303|NCT02304705|17486679|P2|Overall Study|Death|1
5068304|NCT02304705|17486680|P1|Overall Study|Death|0
5068305|NCT02304705|17486679|P2|Overall Study|Physician Decision|4
5068306|NCT02304705|17486680|P1|Overall Study|Physician Decision|2
5068307|NCT02304705|17486679|P2|Overall Study|Withdrawal by Subject|0
5068308|NCT02304705|17486680|P1|Overall Study|Withdrawal by Subject|2
5068309|NCT02304484|17486686|P1|Overall Study|Lost to Follow-up|2
5068310|NCT02304484|17486686|P1|Overall Study|Withdrawal by Subject|14
5068311|NCT02304484|17486686|P1|Overall Study|Death|9
5068312|NCT02304380|17486749|P6|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5068313|NCT02304380|17486750|P5|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5068314|NCT02304380|17486751|P4|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
5068315|NCT02304380|17486752|P3|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5068316|NCT02304380|17486753|P2|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5068317|NCT02304380|17486754|P1|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5068318|NCT02304367|17486804|P1|Overall Study|Ongoing in Study|12
5068319|NCT02304367|17486804|P1|Overall Study|Death|1
5068320|NCT02304367|17486804|P1|Overall Study|Sponsor Decision|3
5068321|NCT02304367|17486804|P1|Overall Study|Lack of Phosphorus Increase|1
5068322|NCT02303704|17486888|P2|Overall Study|Protocol Violation|9
5068323|NCT02303704|17486889|P1|Overall Study|Protocol Violation|5
5068324|NCT02303574|17486917|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068325|NCT02303574|17486918|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068326|NCT02303574|17486919|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
5068327|NCT02303574|17486920|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068328|NCT02303574|17486921|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068329|NCT02303574|17486922|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068330|NCT02303574|17486923|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068331|NCT02303574|17486924|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068332|NCT02303574|17486925|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068333|NCT02303574|17486926|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5068334|NCT02303574|17486917|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068335|NCT02303574|17486918|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068336|NCT02303574|17486919|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068337|NCT02303574|17486920|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068338|NCT02303574|17486921|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068339|NCT02303574|17486922|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068340|NCT02303574|17486923|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068341|NCT02303574|17486924|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
5068342|NCT02303574|17486925|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068343|NCT02303574|17486926|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5068344|NCT02303262|17487147|P1|Overall Study|Withdrawal by Subject|2
5068345|NCT02303041|17487155|P2|Overall Study|Adverse Event|2
5068346|NCT02303041|17487156|P1|Overall Study|Adverse Event|1
5068347|NCT02302859|17487172|P2|Overall Study|Withdrawal by Subject|1
5068348|NCT02302859|17487173|P1|Overall Study|Withdrawal by Subject|0
5068349|NCT02302859|17487172|P2|Overall Study|Lost Phone|1
5068350|NCT02302859|17487173|P1|Overall Study|Lost Phone|1
5068351|NCT02302846|17487179|P1|Overall Study|Withdrawal by Subject|1
5068352|NCT02302807|17487185|P2|Overall Study|Physician Decision|1
5068353|NCT02302807|17487186|P1|Overall Study|Physician Decision|0
5068354|NCT02302807|17487185|P2|Overall Study|Study Terminated By Sponsor|64
5068355|NCT02302807|17487186|P1|Overall Study|Study Terminated By Sponsor|35
5068356|NCT02302807|17487185|P2|Overall Study|Death|385
5068357|NCT02302807|17487186|P1|Overall Study|Death|397
5068358|NCT02302807|17487185|P2|Overall Study|Lost to Follow-up|6
5068359|NCT02302807|17487186|P1|Overall Study|Lost to Follow-up|4
5068360|NCT02302807|17487185|P2|Overall Study|Withdrawal by Subject|11
5068361|NCT02302807|17487186|P1|Overall Study|Withdrawal by Subject|28
5068362|NCT02302716|17487233|P2|Overall Study|Protocol Violation|1
5068363|NCT02302716|17487234|P1|Overall Study|Protocol Violation|0
5068364|NCT02302716|17487233|P2|Overall Study|Withdrawal by Subject|7
5068365|NCT02302716|17487234|P1|Overall Study|Withdrawal by Subject|13
5068366|NCT02302716|17487233|P2|Overall Study|Physician Decision|4
5068367|NCT02302716|17487234|P1|Overall Study|Physician Decision|3
5068368|NCT02302716|17487233|P2|Overall Study|Lost to Follow-up|4
5068369|NCT02302716|17487234|P1|Overall Study|Lost to Follow-up|2
5068370|NCT02302716|17487233|P2|Overall Study|Lack of Efficacy|1
5068371|NCT02302716|17487234|P1|Overall Study|Lack of Efficacy|0
5068372|NCT02302716|17487233|P2|Overall Study|Death|1
5068373|NCT02302716|17487234|P1|Overall Study|Death|0
5068374|NCT02302716|17487233|P2|Overall Study|Adverse Event|1
5068375|NCT02302716|17487234|P1|Overall Study|Adverse Event|1
5068376|NCT02302339|17487282|P4|Overall Study|Withdrawal by Subject|0
5068377|NCT02302339|17487283|P3|Overall Study|Withdrawal by Subject|1
5068378|NCT02302339|17487284|P2|Overall Study|Withdrawal by Subject|2
5068379|NCT02302339|17487285|P1|Overall Study|Withdrawal by Subject|0
5068380|NCT02302339|17487282|P4|Overall Study|Lost to Follow-up|0
5068381|NCT02302339|17487283|P3|Overall Study|Lost to Follow-up|0
5068382|NCT02302339|17487284|P2|Overall Study|Lost to Follow-up|0
5068383|NCT02302339|17487285|P1|Overall Study|Lost to Follow-up|1
5068384|NCT02302222|17487318|P2|Overall Study|Withdrawn prior to any treatment|1
5068385|NCT02302222|17487319|P1|Overall Study|Withdrawn prior to any treatment|0
5068386|NCT02302222|17487318|P2|Overall Study|Treatment discontinued before day 5|1
5068387|NCT02302222|17487319|P1|Overall Study|Treatment discontinued before day 5|0
5068388|NCT02302222|17487318|P2|Overall Study|Lost to Follow-up|0
5068389|NCT02302222|17487319|P1|Overall Study|Lost to Follow-up|1
5068390|NCT02302222|17487318|P2|Overall Study|Physician Decision|4
5068391|NCT02302222|17487319|P1|Overall Study|Physician Decision|0
5068392|NCT02302066|17487358|P4|Overall Study|Reason Not Specified|1
5068393|NCT02302066|17487359|P3|Overall Study|Reason Not Specified|9
5068394|NCT02302066|17487360|P2|Overall Study|Reason Not Specified|1
5068395|NCT02302066|17487361|P1|Overall Study|Reason Not Specified|1
5068396|NCT02302066|17487358|P4|Overall Study|Pregnancy|0
5068397|NCT02302066|17487359|P3|Overall Study|Pregnancy|12
5068398|NCT02302066|17487360|P2|Overall Study|Pregnancy|10
5068399|NCT02302066|17487361|P1|Overall Study|Pregnancy|2
5068400|NCT02302066|17487358|P4|Overall Study|Withdrawal by Subject|33
5068401|NCT02302066|17487359|P3|Overall Study|Withdrawal by Subject|124
5068402|NCT02302066|17487360|P2|Overall Study|Withdrawal by Subject|58
5068403|NCT02302066|17487361|P1|Overall Study|Withdrawal by Subject|25
5068404|NCT02302066|17487358|P4|Overall Study|Lost to Follow-up|7
5068405|NCT02302066|17487359|P3|Overall Study|Lost to Follow-up|24
5068406|NCT02302066|17487360|P2|Overall Study|Lost to Follow-up|5
5068407|NCT02302066|17487361|P1|Overall Study|Lost to Follow-up|4
5068408|NCT02302066|17487358|P4|Overall Study|Adverse Event|0
5068409|NCT02302066|17487359|P3|Overall Study|Adverse Event|3
5068410|NCT02302066|17487360|P2|Overall Study|Adverse Event|1
5068411|NCT02302066|17487361|P1|Overall Study|Adverse Event|1
5068412|NCT02301988|17487405|P2|Overall Study|Adverse Event|1
5068413|NCT02301988|17487406|P1|Overall Study|Adverse Event|1
5068414|NCT02301988|17487405|P2|Overall Study|Death|0
5068415|NCT02301988|17487406|P1|Overall Study|Death|1
5068416|NCT02301988|17487405|P2|Overall Study|Lack of Efficacy|2
5068417|NCT02301988|17487406|P1|Overall Study|Lack of Efficacy|3
5068418|NCT02301988|17487405|P2|Overall Study|Unknown Reason|3
5068419|NCT02301988|17487406|P1|Overall Study|Unknown Reason|1
5068420|NCT02301988|17487405|P2|Overall Study|Physician Decision|2
5068421|NCT02301988|17487406|P1|Overall Study|Physician Decision|2
5068422|NCT02301988|17487405|P2|Overall Study|Withdrawal by Subject|1
5068423|NCT02301988|17487406|P1|Overall Study|Withdrawal by Subject|2
5068424|NCT02301975|17487439|P3|Overall Study|Withdrawal by Subject|11
5068425|NCT02301975|17487440|P2|Overall Study|Withdrawal by Subject|12
5068426|NCT02301975|17487441|P1|Overall Study|Withdrawal by Subject|15
5068427|NCT02301975|17487439|P3|Overall Study|Physician Decision|3
5068428|NCT02301975|17487440|P2|Overall Study|Physician Decision|2
5068429|NCT02301975|17487441|P1|Overall Study|Physician Decision|4
5068430|NCT02301975|17487439|P3|Overall Study|Lost to Follow-up|2
5068431|NCT02301975|17487440|P2|Overall Study|Lost to Follow-up|2
5068432|NCT02301975|17487441|P1|Overall Study|Lost to Follow-up|0
5068433|NCT02301975|17487439|P3|Overall Study|Protocol Violation|3
5068434|NCT02301975|17487440|P2|Overall Study|Protocol Violation|5
5068435|NCT02301975|17487441|P1|Overall Study|Protocol Violation|3
5068436|NCT02301975|17487439|P3|Overall Study|Lack of Efficacy|1
5068437|NCT02301975|17487440|P2|Overall Study|Lack of Efficacy|1
5068438|NCT02301975|17487441|P1|Overall Study|Lack of Efficacy|1
5068439|NCT02301975|17487439|P3|Overall Study|Adverse Event|2
5068440|NCT02301975|17487440|P2|Overall Study|Adverse Event|3
5068441|NCT02301975|17487441|P1|Overall Study|Adverse Event|8
5068442|NCT02301936|17487469|P2|Overall Study|Lost to Follow-up|0
5068443|NCT02301936|17487470|P1|Overall Study|Lost to Follow-up|1
5068444|NCT02301897|17487495|P3|Treatment Course 2|Other Miscellaneous Reasons|0
5068445|NCT02301897|17487496|P2|Treatment Course 2|Other Miscellaneous Reasons|0
5068446|NCT02301897|17487497|P1|Treatment Course 2|Other Miscellaneous Reasons|1
5068447|NCT02301897|17487495|P3|Treatment Course 2|Withdrawal by Subject|0
5068448|NCT02301897|17487496|P2|Treatment Course 2|Withdrawal by Subject|2
5068449|NCT02301897|17487497|P1|Treatment Course 2|Withdrawal by Subject|0
5068450|NCT02301897|17487495|P3|Treatment Course 2|Pregnancy|1
5068451|NCT02301897|17487496|P2|Treatment Course 2|Pregnancy|1
5068452|NCT02301897|17487497|P1|Treatment Course 2|Pregnancy|0
5068453|NCT02301897|17487495|P3|Treatment Course 2|Lost to Follow-up|0
5068454|NCT02301897|17487496|P2|Treatment Course 2|Lost to Follow-up|2
5068455|NCT02301897|17487497|P1|Treatment Course 2|Lost to Follow-up|0
5068456|NCT02301897|17487495|P3|Treatment Course 1|Other Miscellaneous Reasons|0
5068457|NCT02301897|17487496|P2|Treatment Course 1|Other Miscellaneous Reasons|0
5068458|NCT02301897|17487497|P1|Treatment Course 1|Other Miscellaneous Reasons|1
5068459|NCT02301897|17487495|P3|Treatment Course 1|Withdrawal by Subject|2
5068460|NCT02301897|17487496|P2|Treatment Course 1|Withdrawal by Subject|0
5068461|NCT02301897|17487497|P1|Treatment Course 1|Withdrawal by Subject|0
5068462|NCT02301897|17487495|P3|Treatment Course 1|Withdrawal by Sponsor|2
5068463|NCT02301897|17487496|P2|Treatment Course 1|Withdrawal by Sponsor|0
5068464|NCT02301897|17487497|P1|Treatment Course 1|Withdrawal by Sponsor|0
5068465|NCT02301897|17487495|P3|Treatment Course 1|Lost to Follow-up|1
5068466|NCT02301897|17487496|P2|Treatment Course 1|Lost to Follow-up|2
5068467|NCT02301897|17487497|P1|Treatment Course 1|Lost to Follow-up|1
5068468|NCT02301897|17487495|P3|Treatment Course 1|Adverse Event|0
5068469|NCT02301897|17487496|P2|Treatment Course 1|Adverse Event|1
5068470|NCT02301897|17487497|P1|Treatment Course 1|Adverse Event|1
5068471|NCT02301897|17487495|P3|Treatment Course 1|Non-Compliance|1
5068472|NCT02301897|17487496|P2|Treatment Course 1|Non-Compliance|0
5068473|NCT02301897|17487497|P1|Treatment Course 1|Non-Compliance|0
5068474|NCT02301624|17487563|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
5068475|NCT02301624|17487564|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
5068476|NCT02301624|17487563|P2|Open-label Maintenance Phase|Death|1
5068477|NCT02301624|17487564|P1|Open-label Maintenance Phase|Death|2
5068478|NCT02301624|17487563|P2|Open-label Maintenance Phase|Physician Decision|3
5068479|NCT02301624|17487564|P1|Open-label Maintenance Phase|Physician Decision|3
5068480|NCT02301624|17487563|P2|Open-label Maintenance Phase|Adverse Event|5
5068481|NCT02301624|17487564|P1|Open-label Maintenance Phase|Adverse Event|2
5068482|NCT02301624|17487563|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
5068483|NCT02301624|17487564|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
5068484|NCT02301624|17487563|P2|Blind Induction Phase|Withdrawal by Subject|0
5068485|NCT02301624|17487564|P1|Blind Induction Phase|Withdrawal by Subject|1
5068486|NCT02301546|17487575|P2|Long Term Effectiveness (~1 Year)|moved away|2
5068487|NCT02301546|17487576|P1|Long Term Effectiveness (~1 Year)|moved away|1
5068488|NCT02301546|17487575|P2|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
5068489|NCT02301546|17487576|P1|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
5068490|NCT02301546|17487575|P2|Long Term Effectiveness (~1 Year)|Death|0
5068491|NCT02301546|17487576|P1|Long Term Effectiveness (~1 Year)|Death|2
5068492|NCT02301546|17487575|P2|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
5068493|NCT02301546|17487576|P1|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
5068494|NCT02301546|17487575|P2|Short-term Effectiveness (~13 Weeks)|screen fail|0
5068495|NCT02301546|17487576|P1|Short-term Effectiveness (~13 Weeks)|screen fail|1
5068496|NCT02301546|17487575|P2|Short-term Effectiveness (~13 Weeks)|non-compliant|7
5068497|NCT02301546|17487576|P1|Short-term Effectiveness (~13 Weeks)|non-compliant|10
5068498|NCT02301546|17487575|P2|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
5068499|NCT02301546|17487576|P1|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
5068500|NCT02301429|17487582|P1|Overall Study|not acceptable vascular anatomy|3
5068501|NCT02301403|17487628|P2|Overall Study|Withdrawal by Subject|41
5068502|NCT02301403|17487629|P1|Overall Study|Withdrawal by Subject|28
5068503|NCT02301390|17487637|P2|Overall Study|study terminated|0
5068504|NCT02301390|17487638|P1|Overall Study|study terminated|2
5068505|NCT02301390|17487637|P2|Overall Study|Missed multiple visits|1
5068506|NCT02301390|17487638|P1|Overall Study|Missed multiple visits|1
5068507|NCT02301390|17487637|P2|Overall Study|Procedure not completed|4
5068508|NCT02301390|17487638|P1|Overall Study|Procedure not completed|0
5068509|NCT02301390|17487637|P2|Overall Study|Death|2
5068510|NCT02301390|17487638|P1|Overall Study|Death|2
5068511|NCT02301390|17487637|P2|Overall Study|Lost to Follow-up|1
5068512|NCT02301390|17487638|P1|Overall Study|Lost to Follow-up|0
5068513|NCT02301390|17487637|P2|Overall Study|Physician Decision|0
5068514|NCT02301390|17487638|P1|Overall Study|Physician Decision|1
5068515|NCT02301390|17487637|P2|Overall Study|Protocol Violation|0
5068516|NCT02301390|17487638|P1|Overall Study|Protocol Violation|1
5068517|NCT02301390|17487637|P2|Overall Study|Withdrawal by Subject|5
5068518|NCT02301390|17487638|P1|Overall Study|Withdrawal by Subject|3
5068519|NCT02301169|17487679|P2|Overall Study|Adverse Event|0
5068520|NCT02301169|17487680|P1|Overall Study|Adverse Event|1
5068521|NCT02301143|17487694|P2|Investigator's Choice|Unresectable Surgery|1
5068522|NCT02301143|17487695|P1|Investigator's Choice|Unresectable Surgery|0
5068523|NCT02301143|17487694|P2|Investigator's Choice|Other|1
5068524|NCT02301143|17487695|P1|Investigator's Choice|Other|0
5068525|NCT02301143|17487694|P2|Investigator's Choice|Symptomatic Deterioration|1
5068526|NCT02301143|17487695|P1|Investigator's Choice|Symptomatic Deterioration|0
5068527|NCT02301143|17487694|P2|Investigator's Choice|Noncompliance With Study Drug|1
5068528|NCT02301143|17487695|P1|Investigator's Choice|Noncompliance With Study Drug|0
5068529|NCT02301143|17487694|P2|Investigator's Choice|Progressive Disease|3
5068530|NCT02301143|17487695|P1|Investigator's Choice|Progressive Disease|0
5068531|NCT02301143|17487694|P2|Investigator's Choice|Adverse Event|3
5068532|NCT02301143|17487695|P1|Investigator's Choice|Adverse Event|0
5068533|NCT02301143|17487694|P2|Induction Period|Other|0
5068534|NCT02301143|17487695|P1|Induction Period|Other|1
5068535|NCT02301143|17487694|P2|Induction Period|Protocol Violation|0
5068536|NCT02301143|17487695|P1|Induction Period|Protocol Violation|2
5068537|NCT02301143|17487694|P2|Induction Period|Symptomatic Deterioration|0
5068538|NCT02301143|17487695|P1|Induction Period|Symptomatic Deterioration|2
5068539|NCT02301143|17487694|P2|Induction Period|Physician Decision|0
5068540|NCT02301143|17487695|P1|Induction Period|Physician Decision|4
5068541|NCT02301143|17487694|P2|Induction Period|Noncompliance with Study Drug|0
5068542|NCT02301143|17487695|P1|Induction Period|Noncompliance with Study Drug|1
5068543|NCT02301143|17487694|P2|Induction Period|Withdrawal by Subject|0
5068544|NCT02301143|17487695|P1|Induction Period|Withdrawal by Subject|3
5068545|NCT02301143|17487694|P2|Induction Period|Progressive Disease|0
5068546|NCT02301143|17487695|P1|Induction Period|Progressive Disease|8
5068547|NCT02301143|17487694|P2|Induction Period|Adverse Event|0
5068548|NCT02301143|17487695|P1|Induction Period|Adverse Event|22
5068549|NCT02301143|17487694|P2|Induction Period|Death|0
5068550|NCT02301143|17487695|P1|Induction Period|Death|1
5068551|NCT02301143|17487694|P2|Induction Period|Enrolled But Not Treated|0
5068552|NCT02301143|17487695|P1|Induction Period|Enrolled But Not Treated|1
5068553|NCT02300987|17487738|P2|Secondary Phase : Cross-over to LEE011|Adverse Event|1
5068554|NCT02300987|17487739|P1|Secondary Phase : Cross-over to LEE011|Adverse Event|0
5068555|NCT02300987|17487738|P2|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
5068556|NCT02300987|17487739|P1|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
5068557|NCT02300987|17487738|P2|Primary Phase : Prior to Cross-over|progressive disease|2
5068558|NCT02300987|17487739|P1|Primary Phase : Prior to Cross-over|progressive disease|3
5068559|NCT02300987|17487738|P2|Primary Phase : Prior to Cross-over|Physician Decision|0
5068560|NCT02300987|17487739|P1|Primary Phase : Prior to Cross-over|Physician Decision|2
5068561|NCT02300987|17487738|P2|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
5068562|NCT02300987|17487739|P1|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
5068563|NCT02300610|17487786|P3|Overall Study|Withdrawal by Subject|1
5068564|NCT02300610|17487787|P2|Overall Study|Withdrawal by Subject|0
5068565|NCT02300610|17487788|P1|Overall Study|Withdrawal by Subject|1
5068566|NCT02300558|17487803|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
5068567|NCT02300558|17487803|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
5068568|NCT02300558|17487803|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
5068569|NCT02300558|17487803|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
5068570|NCT02300311|17487825|P2|Overall Study|Refused to continue taking medication|0
5068571|NCT02300311|17487826|P1|Overall Study|Refused to continue taking medication|18
5068572|NCT02300311|17487825|P2|Overall Study|Other than the reason specified|0
5068573|NCT02300311|17487826|P1|Overall Study|Other than the reason specified|1
5068574|NCT02300298|17487838|P2|Disposition for Docetaxel|other adverse event|4
5068575|NCT02300298|17487839|P1|Disposition for Docetaxel|other adverse event|0
5068576|NCT02300298|17487838|P2|Disposition for Docetaxel|Progressive disease|6
5068577|NCT02300298|17487839|P1|Disposition for Docetaxel|Progressive disease|0
5068578|NCT02300298|17487838|P2|Disposition for Nintedanib|Progressive disease|0
5068579|NCT02300298|17487839|P1|Disposition for Nintedanib|Progressive disease|10
5068580|NCT02300259|17487852|P3|Period 2|Withdrawal by Subject|1
5068581|NCT02300259|17487853|P2|Period 2|Withdrawal by Subject|0
5068582|NCT02300259|17487854|P1|Period 2|Withdrawal by Subject|0
5068583|NCT02300259|17487852|P3|Period 2|Adverse Event|0
5068584|NCT02300259|17487853|P2|Period 2|Adverse Event|0
5068585|NCT02300259|17487854|P1|Period 2|Adverse Event|1
5068586|NCT02300259|17487852|P3|Period 1|Withdrawal by Subject|1
5068587|NCT02300259|17487853|P2|Period 1|Withdrawal by Subject|0
5068588|NCT02300259|17487854|P1|Period 1|Withdrawal by Subject|0
5068589|NCT02300259|17487852|P3|Period 1|Adverse Event|1
5068590|NCT02300259|17487853|P2|Period 1|Adverse Event|0
5068591|NCT02300259|17487854|P1|Period 1|Adverse Event|0
5068592|NCT02300129|17487883|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5068593|NCT02300129|17487884|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5068594|NCT02300129|17487885|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5068595|NCT02300129|17487886|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
5068596|NCT02300129|17487883|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
5068597|NCT02300129|17487884|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5068598|NCT02300129|17487885|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5068599|NCT02300129|17487886|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5068600|NCT02300129|17487883|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5068601|NCT02300129|17487884|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5068602|NCT02300129|17487885|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
5068603|NCT02300129|17487886|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5068604|NCT02300103|17487896|P1|Overall Study|Withdrew Consent|2
5068605|NCT02300103|17487896|P1|Overall Study|Protocol Violation|1
5068606|NCT02300103|17487896|P1|Overall Study|Lack of Efficacy|3
5068607|NCT02299934|17487976|P1|Overall Study|Termination of study|13
5068608|NCT02299635|17488026|P1|Overall Study|Other|3
5068609|NCT02299635|17488026|P1|Overall Study|Withdrawal by Subject|2
5068610|NCT02299635|17488026|P1|Overall Study|Objective progression or relapse|10
5068611|NCT02299635|17488026|P1|Overall Study|Global deterioration of health status|1
5068612|NCT02299635|17488026|P1|Overall Study|Death|1
5068613|NCT02299635|17488026|P1|Overall Study|Adverse Event|2
5068614|NCT02299427|17488066|P2|Overall Study|not adherent to dog website use|0
5068615|NCT02299427|17488067|P1|Overall Study|not adherent to dog website use|21
5068616|NCT02299427|17488066|P2|Overall Study|Lost to Follow-up|3
5068617|NCT02299427|17488067|P1|Overall Study|Lost to Follow-up|1
5068618|NCT02299427|17488066|P2|Overall Study|Withdrawal by Subject|0
5068619|NCT02299427|17488067|P1|Overall Study|Withdrawal by Subject|1
5068620|NCT02299388|17488077|P2|Overall Study|Withdrawal by Subject|1
5068621|NCT02299388|17488078|P1|Overall Study|Withdrawal by Subject|0
5068622|NCT02299375|17488088|P2|Overall Study|Withdrawal by Subject|4
5068623|NCT02299375|17488089|P1|Overall Study|Withdrawal by Subject|1
5068624|NCT02299375|17488088|P2|Overall Study|Physician Decision|1
5068625|NCT02299375|17488089|P1|Overall Study|Physician Decision|1
5068626|NCT02299375|17488088|P2|Overall Study|Lost to Follow-up|2
5068627|NCT02299375|17488089|P1|Overall Study|Lost to Follow-up|0
5068628|NCT02299375|17488088|P2|Overall Study|Other: Study closed/terminated|55
5068629|NCT02299375|17488089|P1|Overall Study|Other: Study closed/terminated|66
5068630|NCT02299375|17488088|P2|Overall Study|Other: Met stopping criteria|0
5068631|NCT02299375|17488089|P1|Overall Study|Other: Met stopping criteria|1
5068632|NCT02299375|17488088|P2|Overall Study|Protocol Violation|3
5068633|NCT02299375|17488089|P1|Overall Study|Protocol Violation|1
5068634|NCT02299375|17488088|P2|Overall Study|Lack of Efficacy|3
5068635|NCT02299375|17488089|P1|Overall Study|Lack of Efficacy|1
5068636|NCT02299375|17488088|P2|Overall Study|Adverse Event, non-fatal|9
5068637|NCT02299375|17488089|P1|Overall Study|Adverse Event, non-fatal|8
5068638|NCT02299375|17488088|P2|Overall Study|Adverse Event, serious fatal|3
5068639|NCT02299375|17488089|P1|Overall Study|Adverse Event, serious fatal|1
5068640|NCT02299336|17488148|P1|Overall Study|Lost to Follow-up|1
5068641|NCT02299336|17488148|P1|Overall Study|Death|1
5068642|NCT02299336|17488148|P1|Overall Study|Adverse Event|1
5068643|NCT02299336|17488148|P1|Overall Study|Withdrawal by Subject|11
5068644|NCT02299206|17488183|P1|Overall Study|Withdrawal by Subject|1
5068645|NCT02299206|17488183|P1|Overall Study|Lost to Follow-up|1
5068646|NCT02299167|17488191|P1|Overall Study|patients were excluded from the study|11
5068647|NCT02299076|17488252|P2|Overall Study|Fraudulent Entries|14
5068648|NCT02299076|17488253|P1|Overall Study|Fraudulent Entries|20
5068649|NCT02298946|17488274|P2|Overall Study|Unevaluable|1
5068650|NCT02298946|17488275|P1|Overall Study|Unevaluable|2
5068651|NCT02298946|17488274|P2|Overall Study|Did not receive treatment|0
5068652|NCT02298946|17488275|P1|Overall Study|Did not receive treatment|2
5068653|NCT02298868|17488303|P1|Overall Study|Patient underwent transplant|1
5068654|NCT02298868|17488303|P1|Overall Study|Death|1
5068655|NCT02298868|17488303|P1|Overall Study|Adverse Event|1
5068656|NCT02298192|17488381|P2|Overall Study|Adverse Event|2
5068657|NCT02298192|17488382|P1|Overall Study|Adverse Event|6
5068658|NCT02298192|17488381|P2|Overall Study|Lost to Follow-up|1
5068659|NCT02298192|17488382|P1|Overall Study|Lost to Follow-up|2
5068660|NCT02298192|17488381|P2|Overall Study|Withdrawal by Subject|1
5068661|NCT02298192|17488382|P1|Overall Study|Withdrawal by Subject|6
5068662|NCT02298192|17488381|P2|Overall Study|Withdrawal criteria|0
5068663|NCT02298192|17488382|P1|Overall Study|Withdrawal criteria|2
5068664|NCT02298192|17488381|P2|Overall Study|Unclassified|2
5068665|NCT02298192|17488382|P1|Overall Study|Unclassified|3
5068666|NCT02298179|17488406|P12|Overall Study|Lost to Follow-up|0
5068667|NCT02298179|17488407|P11|Overall Study|Lost to Follow-up|0
5068668|NCT02298179|17488408|P10|Overall Study|Lost to Follow-up|0
5068669|NCT02298179|17488409|P9|Overall Study|Lost to Follow-up|0
5068670|NCT02298179|17488410|P8|Overall Study|Lost to Follow-up|1
5068671|NCT02298179|17488411|P7|Overall Study|Lost to Follow-up|0
5068672|NCT02298179|17488412|P6|Overall Study|Lost to Follow-up|0
5068673|NCT02298179|17488413|P5|Overall Study|Lost to Follow-up|0
5068674|NCT02298179|17488414|P4|Overall Study|Lost to Follow-up|0
5068675|NCT02298179|17488415|P3|Overall Study|Lost to Follow-up|1
5068676|NCT02298179|17488416|P2|Overall Study|Lost to Follow-up|0
5068677|NCT02298179|17488417|P1|Overall Study|Lost to Follow-up|0
5068678|NCT02297841|17488659|P1|Overall Study|Protocol Violation|7
5068679|NCT02297841|17488659|P1|Overall Study|Withdrawal by Subject|1
5068680|NCT02297815|17488665|P2|Overall Study|Lost to Follow-up|140
5068681|NCT02297815|17488666|P1|Overall Study|Lost to Follow-up|236
5068682|NCT02297516|17488684|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
5068683|NCT02297516|17488685|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
5068684|NCT02297516|17488684|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
5068685|NCT02297516|17488685|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
5068686|NCT02297516|17488684|P2|Single Treatment Phase (6 Months)|Medical reason|0
5068687|NCT02297516|17488685|P1|Single Treatment Phase (6 Months)|Medical reason|1
5068688|NCT02297503|17488706|P2|Overall Study|Medical reason|1
5068689|NCT02297503|17488707|P1|Overall Study|Medical reason|0
5068690|NCT02297503|17488706|P2|Overall Study|Lost to Follow-up|1
5068691|NCT02297503|17488707|P1|Overall Study|Lost to Follow-up|0
5068692|NCT02297503|17488706|P2|Overall Study|Pregnancy|1
5068693|NCT02297503|17488707|P1|Overall Study|Pregnancy|0
5068694|NCT02297503|17488706|P2|Overall Study|Protocol Violation|0
5068695|NCT02297503|17488707|P1|Overall Study|Protocol Violation|1
5068696|NCT02297503|17488706|P2|Overall Study|Withdrawal by Subject|1
5068697|NCT02297503|17488707|P1|Overall Study|Withdrawal by Subject|1
5068698|NCT02297412|17488734|P2|Overall Study|Canceled|1
5068699|NCT02297412|17488735|P1|Overall Study|Canceled|1
5068700|NCT02296931|17488796|P2|Overall Study|Protocol Violation|2
5068701|NCT02296931|17488797|P1|Overall Study|Protocol Violation|0
5068702|NCT02296892|17488806|P3|Overall Study|Lost to Follow-up|1
5068703|NCT02296892|17488807|P2|Overall Study|Lost to Follow-up|0
5068704|NCT02296892|17488808|P1|Overall Study|Lost to Follow-up|5
5068705|NCT02296892|17488806|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
5068706|NCT02296892|17488807|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
5068707|NCT02296892|17488808|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
5068708|NCT02296840|17488827|P2|Overall Study|Lost to Follow-up|17
5068709|NCT02296840|17488828|P1|Overall Study|Lost to Follow-up|6
5068710|NCT02296840|17488827|P2|Overall Study|Protocol Violation|1
5068711|NCT02296840|17488828|P1|Overall Study|Protocol Violation|2
5068712|NCT02296840|17488827|P2|Overall Study|Adverse Event|1
5068713|NCT02296840|17488828|P1|Overall Study|Adverse Event|1
5068714|NCT02296476|17488936|P3|Overall Study|Disease Progression|2
5068715|NCT02296476|17488937|P2|Overall Study|Disease Progression|4
5068716|NCT02296476|17488938|P1|Overall Study|Disease Progression|6
5068717|NCT02296424|17488993|P4|Part 2|Lost to Follow-up|0
5068718|NCT02296424|17488994|P3|Part 2|Lost to Follow-up|1
5068719|NCT02296424|17488995|P2|Part 2|Lost to Follow-up|0
5068720|NCT02296424|17488996|P1|Part 2|Lost to Follow-up|0
5068721|NCT02296424|17488993|P4|Part 2|Adverse Event|0
5068722|NCT02296424|17488994|P3|Part 2|Adverse Event|1
5068723|NCT02296424|17488995|P2|Part 2|Adverse Event|0
5068724|NCT02296424|17488996|P1|Part 2|Adverse Event|0
5068725|NCT02296424|17488993|P4|Part 2|Lack of Efficacy|0
5068726|NCT02296424|17488994|P3|Part 2|Lack of Efficacy|1
5068727|NCT02296424|17488995|P2|Part 2|Lack of Efficacy|0
5068728|NCT02296424|17488996|P1|Part 2|Lack of Efficacy|0
5068729|NCT02296424|17488993|P4|Part 1|16 directly started part II|0
5068730|NCT02296424|17488994|P3|Part 1|16 directly started part II|0
5068731|NCT02296424|17488995|P2|Part 1|16 directly started part II|0
5068732|NCT02296424|17488996|P1|Part 1|16 directly started part II|16
5068733|NCT02296424|17488993|P4|Part 1|Lack of Efficacy|0
5068734|NCT02296424|17488994|P3|Part 1|Lack of Efficacy|0
5068735|NCT02296424|17488995|P2|Part 1|Lack of Efficacy|17
5068736|NCT02296424|17488996|P1|Part 1|Lack of Efficacy|5
5068737|NCT02296424|17488993|P4|Part 1|Adverse Event|0
5068738|NCT02296424|17488994|P3|Part 1|Adverse Event|0
5068739|NCT02296424|17488995|P2|Part 1|Adverse Event|11
5068740|NCT02296424|17488996|P1|Part 1|Adverse Event|2
5068741|NCT02296424|17488993|P4|Part 1|Study terminated by sponsor|0
5068742|NCT02296424|17488994|P3|Part 1|Study terminated by sponsor|0
5068743|NCT02296424|17488995|P2|Part 1|Study terminated by sponsor|1
5068744|NCT02296424|17488996|P1|Part 1|Study terminated by sponsor|0
5068745|NCT02296424|17488993|P4|Part 1|Withdrawal by Subject|0
5068746|NCT02296424|17488994|P3|Part 1|Withdrawal by Subject|0
5068747|NCT02296424|17488995|P2|Part 1|Withdrawal by Subject|2
5068748|NCT02296424|17488996|P1|Part 1|Withdrawal by Subject|0
5068749|NCT02296424|17488993|P4|Part 1|Protocol Violation|0
5068750|NCT02296424|17488994|P3|Part 1|Protocol Violation|0
5068751|NCT02296424|17488995|P2|Part 1|Protocol Violation|1
5068752|NCT02296424|17488996|P1|Part 1|Protocol Violation|0
5068753|NCT02296424|17488993|P4|Part 1|New therapy for study indication|0
5068754|NCT02296424|17488994|P3|Part 1|New therapy for study indication|0
5068755|NCT02296424|17488995|P2|Part 1|New therapy for study indication|1
5068756|NCT02296424|17488996|P1|Part 1|New therapy for study indication|0
5068757|NCT02296320|17489021|P3|Overall Study|Not - specified|1
5068758|NCT02296320|17489022|P2|Overall Study|Not - specified|0
5068759|NCT02296320|17489023|P1|Overall Study|Not - specified|0
5068760|NCT02296320|17489021|P3|Overall Study|Not treated|0
5068761|NCT02296320|17489022|P2|Overall Study|Not treated|0
5068762|NCT02296320|17489023|P1|Overall Study|Not treated|2
5068763|NCT02296320|17489021|P3|Overall Study|Lost to Follow-up|7
5068764|NCT02296320|17489022|P2|Overall Study|Lost to Follow-up|2
5068765|NCT02296320|17489023|P1|Overall Study|Lost to Follow-up|5
5068766|NCT02296320|17489021|P3|Overall Study|Death|27
5068767|NCT02296320|17489022|P2|Overall Study|Death|3
5068768|NCT02296320|17489023|P1|Overall Study|Death|24
5068769|NCT02296320|17489021|P3|Overall Study|Withdrawal by Subject|2
5068770|NCT02296320|17489022|P2|Overall Study|Withdrawal by Subject|0
5068771|NCT02296320|17489023|P1|Overall Study|Withdrawal by Subject|4
5068772|NCT02296242|17489062|P5|Overall Study|Lack of Efficacy|3
5068773|NCT02296242|17489063|P4|Overall Study|Lack of Efficacy|0
5068774|NCT02296242|17489064|P3|Overall Study|Lack of Efficacy|0
5068775|NCT02296242|17489065|P2|Overall Study|Lack of Efficacy|0
5068776|NCT02296242|17489066|P1|Overall Study|Lack of Efficacy|0
5068777|NCT02296242|17489062|P5|Overall Study|Adverse Event|0
5068778|NCT02296242|17489063|P4|Overall Study|Adverse Event|1
5068779|NCT02296242|17489064|P3|Overall Study|Adverse Event|0
5068780|NCT02296242|17489065|P2|Overall Study|Adverse Event|0
5068781|NCT02296242|17489066|P1|Overall Study|Adverse Event|0
5068782|NCT02296242|17489062|P5|Overall Study|Alternative Treatment|0
5068783|NCT02296242|17489063|P4|Overall Study|Alternative Treatment|1
5068784|NCT02296242|17489064|P3|Overall Study|Alternative Treatment|0
5068785|NCT02296242|17489065|P2|Overall Study|Alternative Treatment|0
5068786|NCT02296242|17489066|P1|Overall Study|Alternative Treatment|0
5068787|NCT02296242|17489062|P5|Overall Study|Physician Decision|0
5068788|NCT02296242|17489063|P4|Overall Study|Physician Decision|1
5068789|NCT02296242|17489064|P3|Overall Study|Physician Decision|0
5068790|NCT02296242|17489065|P2|Overall Study|Physician Decision|1
5068791|NCT02296242|17489066|P1|Overall Study|Physician Decision|0
5068792|NCT02296242|17489062|P5|Overall Study|Screened for Other Protocol|0
5068793|NCT02296242|17489063|P4|Overall Study|Screened for Other Protocol|0
5068794|NCT02296242|17489064|P3|Overall Study|Screened for Other Protocol|0
5068795|NCT02296242|17489065|P2|Overall Study|Screened for Other Protocol|1
5068796|NCT02296242|17489066|P1|Overall Study|Screened for Other Protocol|0
5068797|NCT02296242|17489062|P5|Overall Study|Need for Hydroxyurea|0
5068798|NCT02296242|17489063|P4|Overall Study|Need for Hydroxyurea|0
5068799|NCT02296242|17489064|P3|Overall Study|Need for Hydroxyurea|0
5068800|NCT02296242|17489065|P2|Overall Study|Need for Hydroxyurea|0
5068801|NCT02296242|17489066|P1|Overall Study|Need for Hydroxyurea|2
5068802|NCT02296242|17489062|P5|Overall Study|Lost to Follow-up|0
5068803|NCT02296242|17489063|P4|Overall Study|Lost to Follow-up|0
5068804|NCT02296242|17489064|P3|Overall Study|Lost to Follow-up|0
5068805|NCT02296242|17489065|P2|Overall Study|Lost to Follow-up|0
5068806|NCT02296242|17489066|P1|Overall Study|Lost to Follow-up|1
5068807|NCT02296242|17489062|P5|Overall Study|At Least 3 Drug Interruptions|1
5068808|NCT02296242|17489063|P4|Overall Study|At Least 3 Drug Interruptions|1
5068809|NCT02296242|17489064|P3|Overall Study|At Least 3 Drug Interruptions|1
5068810|NCT02296242|17489065|P2|Overall Study|At Least 3 Drug Interruptions|0
5068811|NCT02296242|17489066|P1|Overall Study|At Least 3 Drug Interruptions|0
5068812|NCT02296242|17489062|P5|Overall Study|Patient Condition Changed|1
5068813|NCT02296242|17489063|P4|Overall Study|Patient Condition Changed|0
5068814|NCT02296242|17489064|P3|Overall Study|Patient Condition Changed|2
5068815|NCT02296242|17489065|P2|Overall Study|Patient Condition Changed|0
5068816|NCT02296242|17489066|P1|Overall Study|Patient Condition Changed|0
5068817|NCT02296242|17489062|P5|Overall Study|Unacceptable Toxicity|1
5068818|NCT02296242|17489063|P4|Overall Study|Unacceptable Toxicity|0
5068819|NCT02296242|17489064|P3|Overall Study|Unacceptable Toxicity|0
5068820|NCT02296242|17489065|P2|Overall Study|Unacceptable Toxicity|0
5068821|NCT02296242|17489066|P1|Overall Study|Unacceptable Toxicity|0
5068822|NCT02296242|17489062|P5|Overall Study|Disease Progression|11
5068823|NCT02296242|17489063|P4|Overall Study|Disease Progression|8
5068824|NCT02296242|17489064|P3|Overall Study|Disease Progression|2
5068825|NCT02296242|17489065|P2|Overall Study|Disease Progression|3
5068826|NCT02296242|17489066|P1|Overall Study|Disease Progression|1
5068827|NCT02296242|17489062|P5|Overall Study|Withdrawal by Subject|3
5068828|NCT02296242|17489063|P4|Overall Study|Withdrawal by Subject|1
5068829|NCT02296242|17489064|P3|Overall Study|Withdrawal by Subject|1
5068830|NCT02296242|17489065|P2|Overall Study|Withdrawal by Subject|0
5068831|NCT02296242|17489066|P1|Overall Study|Withdrawal by Subject|0
5068832|NCT02296242|17489062|P5|Overall Study|Death|1
5068833|NCT02296242|17489063|P4|Overall Study|Death|1
5068834|NCT02296242|17489064|P3|Overall Study|Death|1
5068835|NCT02296242|17489065|P2|Overall Study|Death|1
5068836|NCT02296242|17489066|P1|Overall Study|Death|1
5068837|NCT02296138|17489094|P2|Overall Study|Other than specified|13
5068838|NCT02296138|17489095|P1|Overall Study|Other than specified|15
5068839|NCT02296138|17489094|P2|Overall Study|Patients with data irregularities|11
5068840|NCT02296138|17489095|P1|Overall Study|Patients with data irregularities|10
5068841|NCT02296138|17489094|P2|Overall Study|Not Treated|1
5068842|NCT02296138|17489095|P1|Overall Study|Not Treated|1
5068843|NCT02296138|17489094|P2|Overall Study|Withdrawal by Subject|131
5068844|NCT02296138|17489095|P1|Overall Study|Withdrawal by Subject|184
5068845|NCT02296138|17489094|P2|Overall Study|Lost to Follow-up|12
5068846|NCT02296138|17489095|P1|Overall Study|Lost to Follow-up|9
5068847|NCT02296138|17489094|P2|Overall Study|Protocol Violation|36
5068848|NCT02296138|17489095|P1|Overall Study|Protocol Violation|35
5068849|NCT02296138|17489094|P2|Overall Study|Lack of Efficacy|37
5068850|NCT02296138|17489095|P1|Overall Study|Lack of Efficacy|59
5068851|NCT02296138|17489094|P2|Overall Study|Adverse Event|259
5068852|NCT02296138|17489095|P1|Overall Study|Adverse Event|348
5068853|NCT02296125|17489111|P4|Overall Study|Any reason not specifically recorded|0
5068854|NCT02296125|17489112|P3|Overall Study|Any reason not specifically recorded|0
5068855|NCT02296125|17489113|P2|Overall Study|Any reason not specifically recorded|3
5068856|NCT02296125|17489114|P1|Overall Study|Any reason not specifically recorded|3
5068857|NCT02296125|17489111|P4|Overall Study|Condition under investigation worsened|39
5068858|NCT02296125|17489112|P3|Overall Study|Condition under investigation worsened|24
5068859|NCT02296125|17489113|P2|Overall Study|Condition under investigation worsened|151
5068860|NCT02296125|17489114|P1|Overall Study|Condition under investigation worsened|87
5068861|NCT02296125|17489111|P4|Overall Study|Severe non-compliance to protocol|0
5068862|NCT02296125|17489112|P3|Overall Study|Severe non-compliance to protocol|0
5068863|NCT02296125|17489113|P2|Overall Study|Severe non-compliance to protocol|1
5068864|NCT02296125|17489114|P1|Overall Study|Severe non-compliance to protocol|0
5068865|NCT02296125|17489111|P4|Overall Study|Adverse Event|4
5068866|NCT02296125|17489112|P3|Overall Study|Adverse Event|9
5068867|NCT02296125|17489113|P2|Overall Study|Adverse Event|50
5068868|NCT02296125|17489114|P1|Overall Study|Adverse Event|36
5068869|NCT02296125|17489111|P4|Overall Study|Withdrawal by Subject|1
5068870|NCT02296125|17489112|P3|Overall Study|Withdrawal by Subject|5
5068871|NCT02296125|17489113|P2|Overall Study|Withdrawal by Subject|8
5068872|NCT02296125|17489114|P1|Overall Study|Withdrawal by Subject|12
5068873|NCT02296112|17489166|P1|Overall Study|Began an alternate therapy|1
5068874|NCT02296112|17489166|P1|Overall Study|Toxicity|1
5068875|NCT02296112|17489166|P1|Overall Study|Disease progression|7
5068876|NCT02295995|17489208|P2|Overall Study|Lost to Follow-up|1
5068877|NCT02295995|17489209|P1|Overall Study|Lost to Follow-up|5
5068878|NCT02295774|17489220|P1|Overall Study|Withdrawal by Subject|2
5068879|NCT02295774|17489220|P1|Overall Study|Physician Decision|1
5068880|NCT02295644|17489260|P4|Overall Study|Did not meet inclusion criterion|2
5068881|NCT02295644|17489261|P3|Overall Study|Did not meet inclusion criterion|1
5068882|NCT02295644|17489262|P2|Overall Study|Did not meet inclusion criterion|0
5068883|NCT02295644|17489263|P1|Overall Study|Did not meet inclusion criterion|0
5068884|NCT02295280|17489312|P2|Overall Study|Adverse Event|1
5068885|NCT02295280|17489313|P1|Overall Study|Adverse Event|0
5068886|NCT02295020|17489321|P2|Overall Study|Withdrawal by Subject|2
5068887|NCT02295020|17489322|P1|Overall Study|Withdrawal by Subject|3
5068888|NCT02295020|17489321|P2|Overall Study|Adverse Event|1
5068889|NCT02295020|17489322|P1|Overall Study|Adverse Event|0
5068890|NCT02294981|17489352|P1|Overall Study|Lost to Follow-up|1
5068891|NCT02294786|17489358|P2|Overall Study|Death|3
5068892|NCT02294786|17489359|P1|Overall Study|Death|2
5068893|NCT02294786|17489358|P2|Overall Study|Adverse Event|1
5068894|NCT02294786|17489359|P1|Overall Study|Adverse Event|1
5068895|NCT02294786|17489358|P2|Overall Study|Protocol Violation|0
5068896|NCT02294786|17489359|P1|Overall Study|Protocol Violation|1
5068897|NCT02294786|17489358|P2|Overall Study|Lost to Follow-up|2
5068898|NCT02294786|17489359|P1|Overall Study|Lost to Follow-up|1
5068899|NCT02294786|17489358|P2|Overall Study|Physician Decision|7
5068900|NCT02294786|17489359|P1|Overall Study|Physician Decision|6
5068901|NCT02294786|17489358|P2|Overall Study|Withdrawal by Subject|1
5068902|NCT02294786|17489359|P1|Overall Study|Withdrawal by Subject|0
5068903|NCT02294773|17489406|P2|Overall Study|Withdrawal by Subject|2
5068904|NCT02294773|17489407|P1|Overall Study|Withdrawal by Subject|0
5068905|NCT02294734|17489423|P2|Overall Study|Withdrawal by Subject|2
5068906|NCT02294734|17489424|P1|Overall Study|Withdrawal by Subject|4
5068907|NCT02294734|17489423|P2|Overall Study|Physician Decision|1
5068908|NCT02294734|17489424|P1|Overall Study|Physician Decision|2
5068909|NCT02294734|17489423|P2|Overall Study|Lost to Follow-up|0
5068910|NCT02294734|17489424|P1|Overall Study|Lost to Follow-up|2
5068911|NCT02294734|17489423|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
5068912|NCT02294734|17489424|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
5068913|NCT02294734|17489423|P2|Overall Study|Adverse Event|5
5068914|NCT02294734|17489424|P1|Overall Study|Adverse Event|5
5068915|NCT02294682|17489476|P2|Overall Study|Could not swallow pills|0
5068916|NCT02294682|17489477|P1|Overall Study|Could not swallow pills|1
5068917|NCT02294604|17489520|P3|Overall Study|Culture contamination|0
5068918|NCT02294604|17489521|P2|Overall Study|Culture contamination|2
5068919|NCT02294604|17489522|P1|Overall Study|Culture contamination|1
5068920|NCT02294604|17489520|P3|Overall Study|Did not provide samples for culture|0
5068921|NCT02294604|17489521|P2|Overall Study|Did not provide samples for culture|1
5068922|NCT02294604|17489522|P1|Overall Study|Did not provide samples for culture|0
5068923|NCT02294474|17489541|P2|Overall Study|Other than specified above|12
5068924|NCT02294474|17489542|P1|Overall Study|Other than specified above|12
5068925|NCT02294474|17489541|P2|Overall Study|Protocol Violation|2
5068926|NCT02294474|17489542|P1|Overall Study|Protocol Violation|4
5068927|NCT02294474|17489541|P2|Overall Study|Lack of Efficacy|1
5068928|NCT02294474|17489542|P1|Overall Study|Lack of Efficacy|2
5068929|NCT02294474|17489541|P2|Overall Study|Adverse Event|7
5068930|NCT02294474|17489542|P1|Overall Study|Adverse Event|7
5068931|NCT02294461|17489566|P2|Overall Study|Miscellaneous|32
5068932|NCT02294461|17489567|P1|Overall Study|Miscellaneous|11
5068933|NCT02294461|17489566|P2|Overall Study|Adverse Event|10
5068934|NCT02294461|17489567|P1|Overall Study|Adverse Event|11
5068935|NCT02294461|17489566|P2|Overall Study|Disease Progression|39
5068936|NCT02294461|17489567|P1|Overall Study|Disease Progression|23
5068937|NCT02294461|17489566|P2|Overall Study|Withdrawal by Subject|45
5068938|NCT02294461|17489567|P1|Overall Study|Withdrawal by Subject|14
5068939|NCT02294461|17489566|P2|Overall Study|Protocol Violation|2
5068940|NCT02294461|17489567|P1|Overall Study|Protocol Violation|0
5068941|NCT02294461|17489566|P2|Overall Study|Death|3
5068942|NCT02294461|17489567|P1|Overall Study|Death|3
5068943|NCT02294396|17489623|P4|Overall Study|Miscellaneous|2
5068944|NCT02294396|17489624|P3|Overall Study|Miscellaneous|5
5068945|NCT02294396|17489625|P2|Overall Study|Miscellaneous|0
5068946|NCT02294396|17489626|P1|Overall Study|Miscellaneous|2
5068947|NCT02294396|17489623|P4|Overall Study|Protocol Deviation|1
5068948|NCT02294396|17489624|P3|Overall Study|Protocol Deviation|2
5068949|NCT02294396|17489625|P2|Overall Study|Protocol Deviation|2
5068950|NCT02294396|17489626|P1|Overall Study|Protocol Deviation|3
5068951|NCT02294396|17489623|P4|Overall Study|Lost to Follow-up|1
5068952|NCT02294396|17489624|P3|Overall Study|Lost to Follow-up|1
5068953|NCT02294396|17489625|P2|Overall Study|Lost to Follow-up|0
5068954|NCT02294396|17489626|P1|Overall Study|Lost to Follow-up|0
5068955|NCT02294396|17489623|P4|Overall Study|Withdrawal by Subject|8
5068956|NCT02294396|17489624|P3|Overall Study|Withdrawal by Subject|6
5068957|NCT02294396|17489625|P2|Overall Study|Withdrawal by Subject|6
5068958|NCT02294396|17489626|P1|Overall Study|Withdrawal by Subject|8
5068959|NCT02294396|17489623|P4|Overall Study|Electrocardiogram adviser's judgment|1
5068960|NCT02294396|17489624|P3|Overall Study|Electrocardiogram adviser's judgment|0
5068961|NCT02294396|17489625|P2|Overall Study|Electrocardiogram adviser's judgment|0
5068962|NCT02294396|17489626|P1|Overall Study|Electrocardiogram adviser's judgment|1
5068963|NCT02294396|17489623|P4|Overall Study|Adverse Event|24
5068964|NCT02294396|17489624|P3|Overall Study|Adverse Event|21
5068965|NCT02294396|17489625|P2|Overall Study|Adverse Event|25
5068966|NCT02294396|17489626|P1|Overall Study|Adverse Event|26
5068967|NCT02294318|17489698|P2|Overall Study|Not exposed to intervention|2
5068968|NCT02294318|17489699|P1|Overall Study|Not exposed to intervention|0
5068969|NCT02294318|17489698|P2|Overall Study|Worsening of drinking|0
5068970|NCT02294318|17489699|P1|Overall Study|Worsening of drinking|3
5068971|NCT02294227|17489718|P3|Overall Study|Adverse Event|2
5068972|NCT02294227|17489719|P2|Overall Study|Adverse Event|8
5068973|NCT02294227|17489720|P1|Overall Study|Adverse Event|6
5068974|NCT02294227|17489718|P3|Overall Study|Lack of Efficacy|8
5068975|NCT02294227|17489719|P2|Overall Study|Lack of Efficacy|12
5068976|NCT02294227|17489720|P1|Overall Study|Lack of Efficacy|11
5068977|NCT02294227|17489718|P3|Overall Study|Lost to Follow-up|0
5068978|NCT02294227|17489719|P2|Overall Study|Lost to Follow-up|0
5068979|NCT02294227|17489720|P1|Overall Study|Lost to Follow-up|1
5068980|NCT02294227|17489718|P3|Overall Study|Physician Decision|1
5068981|NCT02294227|17489719|P2|Overall Study|Physician Decision|2
5068982|NCT02294227|17489720|P1|Overall Study|Physician Decision|1
5068983|NCT02294227|17489718|P3|Overall Study|Subject/Guardian Decision|7
5068984|NCT02294227|17489719|P2|Overall Study|Subject/Guardian Decision|3
5068985|NCT02294227|17489720|P1|Overall Study|Subject/Guardian Decision|6
5068986|NCT02294227|17489718|P3|Overall Study|Death|1
5068987|NCT02294227|17489719|P2|Overall Study|Death|0
5068988|NCT02294227|17489720|P1|Overall Study|Death|0
5068989|NCT02294175|17489746|P2|Overall Study|wound healed|2
5068990|NCT02294175|17489747|P1|Overall Study|wound healed|0
5068991|NCT02294175|17489746|P2|Overall Study|Lost to Follow-up|1
5068992|NCT02294175|17489747|P1|Overall Study|Lost to Follow-up|0
5068993|NCT02294175|17489746|P2|Overall Study|Protocol Violation|0
5068994|NCT02294175|17489747|P1|Overall Study|Protocol Violation|1
5068995|NCT02294175|17489746|P2|Overall Study|pt taking excluded medication|1
5068996|NCT02294175|17489747|P1|Overall Study|pt taking excluded medication|3
5068997|NCT02294175|17489746|P2|Overall Study|Withdrawal by Subject|2
5068998|NCT02294175|17489747|P1|Overall Study|Withdrawal by Subject|1
5068999|NCT02294058|17489774|P3|Overall Study|Miscellaneous|1
5069000|NCT02294058|17489775|P2|Overall Study|Miscellaneous|1
5069001|NCT02294058|17489776|P1|Overall Study|Miscellaneous|4
5069002|NCT02294058|17489774|P3|Overall Study|Physician Decision|0
5069003|NCT02294058|17489775|P2|Overall Study|Physician Decision|1
5069004|NCT02294058|17489776|P1|Overall Study|Physician Decision|2
5069005|NCT02294058|17489774|P3|Overall Study|Withdrawal by Subject|13
5069006|NCT02294058|17489775|P2|Overall Study|Withdrawal by Subject|14
5069007|NCT02294058|17489776|P1|Overall Study|Withdrawal by Subject|10
5069008|NCT02294058|17489774|P3|Overall Study|Lost to Follow-up|2
5069009|NCT02294058|17489775|P2|Overall Study|Lost to Follow-up|0
5069010|NCT02294058|17489776|P1|Overall Study|Lost to Follow-up|1
5069011|NCT02294058|17489774|P3|Overall Study|Lack of Efficacy|0
5069012|NCT02294058|17489775|P2|Overall Study|Lack of Efficacy|3
5069013|NCT02294058|17489776|P1|Overall Study|Lack of Efficacy|3
5069014|NCT02294058|17489774|P3|Overall Study|Adverse Event|13
5069015|NCT02294058|17489775|P2|Overall Study|Adverse Event|7
5069016|NCT02294058|17489776|P1|Overall Study|Adverse Event|16
5069017|NCT02294019|17489814|P1|Overall Study|Withdrawal by Subject|1
5069018|NCT02294019|17489814|P1|Overall Study|Other|1
5069019|NCT02294019|17489814|P1|Overall Study|Lost to Follow-up|31
5069020|NCT02294019|17489814|P1|Overall Study|Protocol Violation|68
5069021|NCT02294019|17489814|P1|Overall Study|Adverse Event|2
5069022|NCT02293902|17489822|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5069023|NCT02293902|17489823|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5069024|NCT02293902|17489824|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
5069025|NCT02293902|17489825|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
5069026|NCT02293902|17489826|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5069027|NCT02293902|17489822|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
5069028|NCT02293902|17489823|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
5069029|NCT02293902|17489824|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
5069030|NCT02293902|17489825|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
5069031|NCT02293902|17489826|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
5069032|NCT02293902|17489822|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5069033|NCT02293902|17489823|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5069034|NCT02293902|17489824|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5069035|NCT02293902|17489825|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5069036|NCT02293902|17489826|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
5069037|NCT02293902|17489822|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
5069038|NCT02293902|17489823|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
5069039|NCT02293902|17489824|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
5069040|NCT02293902|17489825|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
5069041|NCT02293902|17489826|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
5069042|NCT02293902|17489822|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
5069043|NCT02293902|17489823|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
5069044|NCT02293902|17489824|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
5069045|NCT02293902|17489825|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
5069046|NCT02293902|17489826|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
5069047|NCT02293863|17489888|P3|Overall Study|Reason Not Specified|2
5069048|NCT02293863|17489889|P2|Overall Study|Reason Not Specified|2
5069049|NCT02293863|17489890|P1|Overall Study|Reason Not Specified|0
5069050|NCT02293863|17489888|P3|Overall Study|Withdrawal by Subject|1
5069051|NCT02293863|17489889|P2|Overall Study|Withdrawal by Subject|3
5069052|NCT02293863|17489890|P1|Overall Study|Withdrawal by Subject|3
5069053|NCT02293863|17489888|P3|Overall Study|Lost to Follow-up|2
5069054|NCT02293863|17489889|P2|Overall Study|Lost to Follow-up|2
5069055|NCT02293863|17489890|P1|Overall Study|Lost to Follow-up|2
5069056|NCT02293863|17489888|P3|Overall Study|Death|4
5069057|NCT02293863|17489889|P2|Overall Study|Death|6
5069058|NCT02293863|17489890|P1|Overall Study|Death|4
5069059|NCT02293538|17489959|P2|Overall Study|Withdrawal by Subject|1
5069060|NCT02293538|17489960|P1|Overall Study|Withdrawal by Subject|0
5069061|NCT02293538|17489959|P2|Overall Study|Lost to Follow-up|0
5069062|NCT02293538|17489960|P1|Overall Study|Lost to Follow-up|1
5069063|NCT02293538|17489959|P2|Overall Study|Adverse Event|1
5069064|NCT02293538|17489960|P1|Overall Study|Adverse Event|0
5069065|NCT02293460|17489990|P1|Overall Study|Withdrawal by Subject|1
5069066|NCT02293460|17489990|P1|Overall Study|Adverse Event|2
5069067|NCT02293460|17489990|P1|Overall Study|Lack of Efficacy|2
5069068|NCT02293460|17489990|P1|Overall Study|Protocol Violation|1
5069069|NCT02293395|17489996|P2|Overall Study|Withdrawal by Subject|7
5069070|NCT02293395|17489997|P1|Overall Study|Withdrawal by Subject|8
5069071|NCT02293395|17489996|P2|Overall Study|Lost to Follow-up|0
5069072|NCT02293395|17489997|P1|Overall Study|Lost to Follow-up|1
5069073|NCT02292927|17490010|P2|Overall Study|Protocol Violation|7
5069074|NCT02292927|17490011|P1|Overall Study|Protocol Violation|13
5069075|NCT02292849|17490028|P3|Overall Study|Physician Decision|0
5069076|NCT02292849|17490029|P2|Overall Study|Physician Decision|0
5069077|NCT02292849|17490030|P1|Overall Study|Physician Decision|4
5069078|NCT02292849|17490028|P3|Overall Study|Lost to Follow-up|2
5069079|NCT02292849|17490029|P2|Overall Study|Lost to Follow-up|2
5069080|NCT02292849|17490030|P1|Overall Study|Lost to Follow-up|0
5069081|NCT02292784|17490041|P3|Overall Study|Withdrawal by Subject|3
5069082|NCT02292784|17490042|P2|Overall Study|Withdrawal by Subject|3
5069083|NCT02292784|17490043|P1|Overall Study|Withdrawal by Subject|0
5069084|NCT02292784|17490041|P3|Overall Study|Lost to Follow-up|18
5069085|NCT02292784|17490042|P2|Overall Study|Lost to Follow-up|17
5069086|NCT02292784|17490043|P1|Overall Study|Lost to Follow-up|1
5069087|NCT02292771|17490110|P2|Overall Study|Lost to Follow-up|1
5069088|NCT02292771|17490111|P1|Overall Study|Lost to Follow-up|2
5069089|NCT02292771|17490110|P2|Overall Study|Withdrawal by Subject|1
5069090|NCT02292771|17490111|P1|Overall Study|Withdrawal by Subject|2
5069091|NCT02292719|17490234|P6|Overall Study|Subject enrolled in new study.|0
5069092|NCT02292719|17490235|P5|Overall Study|Subject enrolled in new study.|0
5069093|NCT02292719|17490236|P4|Overall Study|Subject enrolled in new study.|0
5069094|NCT02292719|17490237|P3|Overall Study|Subject enrolled in new study.|1
5069095|NCT02292719|17490238|P2|Overall Study|Subject enrolled in new study.|0
5069096|NCT02292719|17490239|P1|Overall Study|Subject enrolled in new study.|0
5069097|NCT02292719|17490234|P6|Overall Study|Withdrawal by Subject|0
5069098|NCT02292719|17490235|P5|Overall Study|Withdrawal by Subject|1
5069099|NCT02292719|17490236|P4|Overall Study|Withdrawal by Subject|1
5069100|NCT02292719|17490237|P3|Overall Study|Withdrawal by Subject|0
5069101|NCT02292719|17490238|P2|Overall Study|Withdrawal by Subject|0
5069102|NCT02292719|17490239|P1|Overall Study|Withdrawal by Subject|0
5069103|NCT02292446|17490302|P1|Overall Study|Withdrawal by Subject|3
5069104|NCT02292446|17490302|P1|Overall Study|Subject/guardian decision|2
5069105|NCT02292446|17490302|P1|Overall Study|Disease progression|2
5069106|NCT02292446|17490302|P1|Overall Study|Death|1
5069107|NCT02292446|17490302|P1|Overall Study|Adverse Event|12
5069108|NCT02292212|17490391|P1|ViE Phase|Protocol Violation|2
5069109|NCT02292212|17490391|P1|ViE Phase|Withdrawal by Subject|1
5069110|NCT02291913|17490460|P1|Overall Study|Protocol Violation|1
5069111|NCT02291913|17490460|P1|Overall Study|Withdrawal by Subject|1
5069112|NCT02291913|17490460|P1|Overall Study|Physician Decision|1
5069113|NCT02291913|17490460|P1|Overall Study|Death|2
5069114|NCT02291913|17490460|P1|Overall Study|Adverse Event|11
5069115|NCT02291913|17490460|P1|Overall Study|Progressive Disease|32
5069116|NCT02291861|17490473|P4|Overall Study|Other|1
5069117|NCT02291861|17490474|P3|Overall Study|Other|0
5069118|NCT02291861|17490475|P2|Overall Study|Other|0
5069119|NCT02291861|17490476|P1|Overall Study|Other|0
5069120|NCT02291861|17490473|P4|Overall Study|Lost to Follow-up|0
5069121|NCT02291861|17490474|P3|Overall Study|Lost to Follow-up|4
5069122|NCT02291861|17490475|P2|Overall Study|Lost to Follow-up|1
5069123|NCT02291861|17490476|P1|Overall Study|Lost to Follow-up|2
5069124|NCT02291861|17490473|P4|Overall Study|Noncompliance|1
5069125|NCT02291861|17490474|P3|Overall Study|Noncompliance|2
5069126|NCT02291861|17490475|P2|Overall Study|Noncompliance|1
5069127|NCT02291861|17490476|P1|Overall Study|Noncompliance|1
5069128|NCT02291861|17490473|P4|Overall Study|Withdrawal by Subject|4
5069129|NCT02291861|17490474|P3|Overall Study|Withdrawal by Subject|1
5069130|NCT02291861|17490475|P2|Overall Study|Withdrawal by Subject|2
5069131|NCT02291861|17490476|P1|Overall Study|Withdrawal by Subject|1
5069132|NCT02291861|17490473|P4|Overall Study|Protocol Violation|1
5069133|NCT02291861|17490474|P3|Overall Study|Protocol Violation|0
5069134|NCT02291861|17490475|P2|Overall Study|Protocol Violation|0
5069135|NCT02291861|17490476|P1|Overall Study|Protocol Violation|1
5069136|NCT02291861|17490473|P4|Overall Study|Death|1
5069137|NCT02291861|17490474|P3|Overall Study|Death|1
5069138|NCT02291861|17490475|P2|Overall Study|Death|0
5069139|NCT02291861|17490476|P1|Overall Study|Death|0
5069140|NCT02291861|17490473|P4|Overall Study|Adverse Event|2
5069141|NCT02291861|17490474|P3|Overall Study|Adverse Event|1
5069142|NCT02291861|17490475|P2|Overall Study|Adverse Event|4
5069143|NCT02291861|17490476|P1|Overall Study|Adverse Event|2
5069144|NCT02291679|17490539|P3|Overall Study|Other|2
5069145|NCT02291679|17490540|P2|Overall Study|Other|4
5069146|NCT02291679|17490541|P1|Overall Study|Other|2
5069147|NCT02291679|17490539|P3|Overall Study|Insufficient Therapeutic Response|7
5069148|NCT02291679|17490540|P2|Overall Study|Insufficient Therapeutic Response|5
5069149|NCT02291679|17490541|P1|Overall Study|Insufficient Therapeutic Response|5
5069150|NCT02291679|17490539|P3|Overall Study|Lost to Follow-up|9
5069151|NCT02291679|17490540|P2|Overall Study|Lost to Follow-up|10
5069152|NCT02291679|17490541|P1|Overall Study|Lost to Follow-up|12
5069153|NCT02291679|17490539|P3|Overall Study|Withdrew Consent|15
5069154|NCT02291679|17490540|P2|Overall Study|Withdrew Consent|10
5069155|NCT02291679|17490541|P1|Overall Study|Withdrew Consent|18
5069156|NCT02291679|17490539|P3|Overall Study|Protocol Violation|7
5069157|NCT02291679|17490540|P2|Overall Study|Protocol Violation|1
5069158|NCT02291679|17490541|P1|Overall Study|Protocol Violation|5
5069159|NCT02291679|17490539|P3|Overall Study|Adverse Event|19
5069160|NCT02291679|17490540|P2|Overall Study|Adverse Event|12
5069161|NCT02291679|17490541|P1|Overall Study|Adverse Event|2
5069162|NCT02291549|17490572|P2|Overall Study|Withdrawal by Subject|1
5069163|NCT02291549|17490573|P1|Overall Study|Withdrawal by Subject|0
5069164|NCT02291549|17490572|P2|Overall Study|Lost to Follow-up|0
5069165|NCT02291549|17490573|P1|Overall Study|Lost to Follow-up|1
5069166|NCT02291510|17490595|P4|Overall Study|Adverse Event|1
5069167|NCT02291510|17490596|P3|Overall Study|Adverse Event|0
5069168|NCT02291510|17490597|P2|Overall Study|Adverse Event|0
5069169|NCT02291510|17490598|P1|Overall Study|Adverse Event|0
5069170|NCT02291419|17490614|P2|Overall Study|Early study termination|5
5069171|NCT02291419|17490615|P1|Overall Study|Early study termination|1
5069172|NCT02291289|17490652|P12|Maintenance Treatment Phase|No Treatment Received|0
5069173|NCT02291289|17490653|P11|Maintenance Treatment Phase|No Treatment Received|1
5069174|NCT02291289|17490654|P10|Maintenance Treatment Phase|No Treatment Received|0
5069175|NCT02291289|17490655|P9|Maintenance Treatment Phase|No Treatment Received|0
5069176|NCT02291289|17490656|P8|Maintenance Treatment Phase|No Treatment Received|0
5069177|NCT02291289|17490657|P7|Maintenance Treatment Phase|No Treatment Received|0
5069178|NCT02291289|17490658|P6|Maintenance Treatment Phase|No Treatment Received|5
5069179|NCT02291289|17490659|P5|Maintenance Treatment Phase|No Treatment Received|4
5069180|NCT02291289|17490660|P4|Maintenance Treatment Phase|No Treatment Received|0
5069181|NCT02291289|17490661|P3|Maintenance Treatment Phase|No Treatment Received|2
5069182|NCT02291289|17490662|P2|Maintenance Treatment Phase|No Treatment Received|0
5069183|NCT02291289|17490663|P1|Maintenance Treatment Phase|No Treatment Received|0
5069184|NCT02291289|17490652|P12|Maintenance Treatment Phase|Multiple Reasons|0
5069185|NCT02291289|17490653|P11|Maintenance Treatment Phase|Multiple Reasons|0
5069186|NCT02291289|17490654|P10|Maintenance Treatment Phase|Multiple Reasons|0
5069187|NCT02291289|17490655|P9|Maintenance Treatment Phase|Multiple Reasons|0
5069188|NCT02291289|17490656|P8|Maintenance Treatment Phase|Multiple Reasons|0
5069189|NCT02291289|17490657|P7|Maintenance Treatment Phase|Multiple Reasons|0
5069190|NCT02291289|17490658|P6|Maintenance Treatment Phase|Multiple Reasons|1
5069191|NCT02291289|17490659|P5|Maintenance Treatment Phase|Multiple Reasons|4
5069192|NCT02291289|17490660|P4|Maintenance Treatment Phase|Multiple Reasons|0
5069193|NCT02291289|17490661|P3|Maintenance Treatment Phase|Multiple Reasons|0
5069194|NCT02291289|17490662|P2|Maintenance Treatment Phase|Multiple Reasons|0
5069195|NCT02291289|17490663|P1|Maintenance Treatment Phase|Multiple Reasons|0
5069196|NCT02291289|17490652|P12|Maintenance Treatment Phase|Physician Decision|1
5069197|NCT02291289|17490653|P11|Maintenance Treatment Phase|Physician Decision|0
5069198|NCT02291289|17490654|P10|Maintenance Treatment Phase|Physician Decision|0
5069199|NCT02291289|17490655|P9|Maintenance Treatment Phase|Physician Decision|0
5069200|NCT02291289|17490656|P8|Maintenance Treatment Phase|Physician Decision|0
5069201|NCT02291289|17490657|P7|Maintenance Treatment Phase|Physician Decision|0
5069202|NCT02291289|17490658|P6|Maintenance Treatment Phase|Physician Decision|0
5069203|NCT02291289|17490659|P5|Maintenance Treatment Phase|Physician Decision|2
5069204|NCT02291289|17490660|P4|Maintenance Treatment Phase|Physician Decision|0
5069205|NCT02291289|17490661|P3|Maintenance Treatment Phase|Physician Decision|0
5069206|NCT02291289|17490662|P2|Maintenance Treatment Phase|Physician Decision|0
5069207|NCT02291289|17490663|P1|Maintenance Treatment Phase|Physician Decision|0
5069208|NCT02291289|17490652|P12|Maintenance Treatment Phase|Other|0
5069209|NCT02291289|17490653|P11|Maintenance Treatment Phase|Other|0
5069210|NCT02291289|17490654|P10|Maintenance Treatment Phase|Other|0
5069211|NCT02291289|17490655|P9|Maintenance Treatment Phase|Other|1
5069212|NCT02291289|17490656|P8|Maintenance Treatment Phase|Other|0
5069213|NCT02291289|17490657|P7|Maintenance Treatment Phase|Other|0
5069214|NCT02291289|17490658|P6|Maintenance Treatment Phase|Other|8
5069215|NCT02291289|17490659|P5|Maintenance Treatment Phase|Other|29
5069216|NCT02291289|17490660|P4|Maintenance Treatment Phase|Other|0
5069217|NCT02291289|17490661|P3|Maintenance Treatment Phase|Other|1
5069218|NCT02291289|17490662|P2|Maintenance Treatment Phase|Other|0
5069219|NCT02291289|17490663|P1|Maintenance Treatment Phase|Other|0
5069220|NCT02291289|17490652|P12|Maintenance Treatment Phase|Lost to Follow-up|1
5069221|NCT02291289|17490653|P11|Maintenance Treatment Phase|Lost to Follow-up|2
5069222|NCT02291289|17490654|P10|Maintenance Treatment Phase|Lost to Follow-up|0
5069223|NCT02291289|17490655|P9|Maintenance Treatment Phase|Lost to Follow-up|0
5069224|NCT02291289|17490656|P8|Maintenance Treatment Phase|Lost to Follow-up|1
5069225|NCT02291289|17490657|P7|Maintenance Treatment Phase|Lost to Follow-up|0
5069226|NCT02291289|17490658|P6|Maintenance Treatment Phase|Lost to Follow-up|3
5069227|NCT02291289|17490659|P5|Maintenance Treatment Phase|Lost to Follow-up|12
5069228|NCT02291289|17490660|P4|Maintenance Treatment Phase|Lost to Follow-up|0
5069229|NCT02291289|17490661|P3|Maintenance Treatment Phase|Lost to Follow-up|0
5069230|NCT02291289|17490662|P2|Maintenance Treatment Phase|Lost to Follow-up|0
5069231|NCT02291289|17490663|P1|Maintenance Treatment Phase|Lost to Follow-up|0
5069232|NCT02291289|17490652|P12|Maintenance Treatment Phase|Adverse Event|0
5069233|NCT02291289|17490653|P11|Maintenance Treatment Phase|Adverse Event|0
5069234|NCT02291289|17490654|P10|Maintenance Treatment Phase|Adverse Event|0
5069235|NCT02291289|17490655|P9|Maintenance Treatment Phase|Adverse Event|0
5069236|NCT02291289|17490656|P8|Maintenance Treatment Phase|Adverse Event|0
5069237|NCT02291289|17490657|P7|Maintenance Treatment Phase|Adverse Event|0
5069238|NCT02291289|17490658|P6|Maintenance Treatment Phase|Adverse Event|0
5069239|NCT02291289|17490659|P5|Maintenance Treatment Phase|Adverse Event|1
5069240|NCT02291289|17490660|P4|Maintenance Treatment Phase|Adverse Event|0
5069241|NCT02291289|17490661|P3|Maintenance Treatment Phase|Adverse Event|0
5069242|NCT02291289|17490662|P2|Maintenance Treatment Phase|Adverse Event|0
5069243|NCT02291289|17490663|P1|Maintenance Treatment Phase|Adverse Event|0
5069244|NCT02291289|17490652|P12|Maintenance Treatment Phase|Death|11
5069245|NCT02291289|17490653|P11|Maintenance Treatment Phase|Death|26
5069246|NCT02291289|17490654|P10|Maintenance Treatment Phase|Death|0
5069247|NCT02291289|17490655|P9|Maintenance Treatment Phase|Death|1
5069248|NCT02291289|17490656|P8|Maintenance Treatment Phase|Death|1
5069249|NCT02291289|17490657|P7|Maintenance Treatment Phase|Death|0
5069250|NCT02291289|17490658|P6|Maintenance Treatment Phase|Death|100
5069251|NCT02291289|17490659|P5|Maintenance Treatment Phase|Death|185
5069252|NCT02291289|17490660|P4|Maintenance Treatment Phase|Death|0
5069253|NCT02291289|17490661|P3|Maintenance Treatment Phase|Death|13
5069254|NCT02291289|17490662|P2|Maintenance Treatment Phase|Death|23
5069255|NCT02291289|17490663|P1|Maintenance Treatment Phase|Death|0
5069256|NCT02291289|17490652|P12|Maintenance Treatment Phase|Protocol Violation|0
5069257|NCT02291289|17490653|P11|Maintenance Treatment Phase|Protocol Violation|0
5069258|NCT02291289|17490654|P10|Maintenance Treatment Phase|Protocol Violation|0
5069259|NCT02291289|17490655|P9|Maintenance Treatment Phase|Protocol Violation|0
5069260|NCT02291289|17490656|P8|Maintenance Treatment Phase|Protocol Violation|0
5069261|NCT02291289|17490657|P7|Maintenance Treatment Phase|Protocol Violation|0
5069262|NCT02291289|17490658|P6|Maintenance Treatment Phase|Protocol Violation|1
5069263|NCT02291289|17490659|P5|Maintenance Treatment Phase|Protocol Violation|2
5069264|NCT02291289|17490660|P4|Maintenance Treatment Phase|Protocol Violation|0
5069265|NCT02291289|17490661|P3|Maintenance Treatment Phase|Protocol Violation|0
5069266|NCT02291289|17490662|P2|Maintenance Treatment Phase|Protocol Violation|1
5069267|NCT02291289|17490663|P1|Maintenance Treatment Phase|Protocol Violation|0
5069268|NCT02291289|17490652|P12|Maintenance Treatment Phase|Withdrawal by Subject|3
5069269|NCT02291289|17490653|P11|Maintenance Treatment Phase|Withdrawal by Subject|2
5069270|NCT02291289|17490654|P10|Maintenance Treatment Phase|Withdrawal by Subject|0
5069271|NCT02291289|17490655|P9|Maintenance Treatment Phase|Withdrawal by Subject|0
5069272|NCT02291289|17490656|P8|Maintenance Treatment Phase|Withdrawal by Subject|0
5069273|NCT02291289|17490657|P7|Maintenance Treatment Phase|Withdrawal by Subject|0
5069274|NCT02291289|17490658|P6|Maintenance Treatment Phase|Withdrawal by Subject|11
5069275|NCT02291289|17490659|P5|Maintenance Treatment Phase|Withdrawal by Subject|13
5069276|NCT02291289|17490660|P4|Maintenance Treatment Phase|Withdrawal by Subject|0
5069277|NCT02291289|17490661|P3|Maintenance Treatment Phase|Withdrawal by Subject|0
5069278|NCT02291289|17490662|P2|Maintenance Treatment Phase|Withdrawal by Subject|0
5069279|NCT02291289|17490663|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5069280|NCT02291289|17490652|P12|Induction Treatment|Not Dosed|0
5069281|NCT02291289|17490653|P11|Induction Treatment|Not Dosed|0
5069282|NCT02291289|17490654|P10|Induction Treatment|Not Dosed|1
5069283|NCT02291289|17490655|P9|Induction Treatment|Not Dosed|0
5069284|NCT02291289|17490656|P8|Induction Treatment|Not Dosed|0
5069285|NCT02291289|17490657|P7|Induction Treatment|Not Dosed|0
5069286|NCT02291289|17490658|P6|Induction Treatment|Not Dosed|0
5069287|NCT02291289|17490659|P5|Induction Treatment|Not Dosed|0
5069288|NCT02291289|17490660|P4|Induction Treatment|Not Dosed|9
5069289|NCT02291289|17490661|P3|Induction Treatment|Not Dosed|0
5069290|NCT02291289|17490662|P2|Induction Treatment|Not Dosed|0
5069291|NCT02291289|17490663|P1|Induction Treatment|Not Dosed|2
5069292|NCT02291237|17490727|P2|Overall Study|Subject Required Prohibited Medication|0
5069293|NCT02291237|17490728|P1|Overall Study|Subject Required Prohibited Medication|2
5069294|NCT02291237|17490727|P2|Overall Study|Lost to Follow-up|2
5069295|NCT02291237|17490728|P1|Overall Study|Lost to Follow-up|0
5069296|NCT02291237|17490727|P2|Overall Study|Withdrew Consent|11
5069297|NCT02291237|17490728|P1|Overall Study|Withdrew Consent|11
5069298|NCT02291237|17490727|P2|Overall Study|Investigator's Discretion|3
5069299|NCT02291237|17490728|P1|Overall Study|Investigator's Discretion|0
5069300|NCT02291237|17490727|P2|Overall Study|Adverse Event|3
5069301|NCT02291237|17490728|P1|Overall Study|Adverse Event|1
5069302|NCT02291237|17490727|P2|Overall Study|Study Terminated by Sponsor|67
5069303|NCT02291237|17490728|P1|Overall Study|Study Terminated by Sponsor|72
5069304|NCT02291029|17490750|P6|Overall Study|Adverse Event|0
5069305|NCT02291029|17490751|P5|Overall Study|Adverse Event|0
5069306|NCT02291029|17490752|P4|Overall Study|Adverse Event|0
5069307|NCT02291029|17490753|P3|Overall Study|Adverse Event|0
5069308|NCT02291029|17490754|P2|Overall Study|Adverse Event|1
5069309|NCT02291029|17490755|P1|Overall Study|Adverse Event|0
5069310|NCT02291029|17490750|P6|Overall Study|Withdrawal by Subject|0
5069311|NCT02291029|17490751|P5|Overall Study|Withdrawal by Subject|0
5069312|NCT02291029|17490752|P4|Overall Study|Withdrawal by Subject|0
5069313|NCT02291029|17490753|P3|Overall Study|Withdrawal by Subject|1
5069314|NCT02291029|17490754|P2|Overall Study|Withdrawal by Subject|0
5069315|NCT02291029|17490755|P1|Overall Study|Withdrawal by Subject|0
5069316|NCT02290925|17490826|P2|Second Period of 3 Months|insulin started|1
5069317|NCT02290925|17490827|P1|Second Period of 3 Months|insulin started|0
5069318|NCT02290925|17490826|P2|Second Period of 3 Months|Lost to Follow-up|3
5069319|NCT02290925|17490827|P1|Second Period of 3 Months|Lost to Follow-up|1
5069320|NCT02290925|17490826|P2|First Period of Three Months|Insulin Started|1
5069321|NCT02290925|17490827|P1|First Period of Three Months|Insulin Started|1
5069322|NCT02290925|17490826|P2|First Period of Three Months|Death|0
5069323|NCT02290925|17490827|P1|First Period of Three Months|Death|1
5069324|NCT02290925|17490826|P2|First Period of Three Months|Lost to Follow-up|1
5069325|NCT02290925|17490827|P1|First Period of Three Months|Lost to Follow-up|2
5069326|NCT02290873|17490842|P3|Overall Study|Protocol Violation|1
5069327|NCT02290873|17490843|P2|Overall Study|Protocol Violation|0
5069328|NCT02290873|17490844|P1|Overall Study|Protocol Violation|0
5069329|NCT02290873|17490842|P3|Overall Study|Esophagogastroduodenoscopy was added|0
5069330|NCT02290873|17490843|P2|Overall Study|Esophagogastroduodenoscopy was added|0
5069331|NCT02290873|17490844|P1|Overall Study|Esophagogastroduodenoscopy was added|1
5069332|NCT02290873|17490842|P3|Overall Study|Nellcor device error|0
5069333|NCT02290873|17490843|P2|Overall Study|Nellcor device error|0
5069334|NCT02290873|17490844|P1|Overall Study|Nellcor device error|1
5069335|NCT02290873|17490842|P3|Overall Study|Withdrawal by Subject|1
5069336|NCT02290873|17490843|P2|Overall Study|Withdrawal by Subject|1
5069337|NCT02290873|17490844|P1|Overall Study|Withdrawal by Subject|0
5069338|NCT02290821|17490863|P2|Overall Study|Lost to Follow-up|2
5069339|NCT02290821|17490864|P1|Overall Study|Lost to Follow-up|3
5069340|NCT02290821|17490863|P2|Overall Study|Unable or unwilling to cooperate with|0
5069341|NCT02290821|17490864|P1|Overall Study|Unable or unwilling to cooperate with|2
5069342|NCT02290821|17490863|P2|Overall Study|Withdrawal by Subject|1
5069343|NCT02290821|17490864|P1|Overall Study|Withdrawal by Subject|1
5069344|NCT02290691|17490872|P2|Overall Study|Lost to Follow-up|7
5069345|NCT02290691|17490873|P1|Overall Study|Lost to Follow-up|7
5069346|NCT02290691|17490872|P2|Overall Study|Withdrawal by Subject|1
5069347|NCT02290691|17490873|P1|Overall Study|Withdrawal by Subject|1
5069348|NCT02290691|17490872|P2|Overall Study|Noncompliance|1
5069349|NCT02290691|17490873|P1|Overall Study|Noncompliance|0
5069350|NCT02290431|17490986|P1|Overall Study|Physician Decision|2
5069351|NCT02290431|17490986|P1|Overall Study|Study terminated by Sponsor|1
5069352|NCT02290431|17490986|P1|Overall Study|Progressive disease|4
5069353|NCT02290431|17490986|P1|Overall Study|Adverse Event|20
5069354|NCT02290340|17491009|P4|Overall Study|Other|1
5069355|NCT02290340|17491010|P3|Overall Study|Other|0
5069356|NCT02290340|17491011|P2|Overall Study|Other|0
5069357|NCT02290340|17491012|P1|Overall Study|Other|1
5069358|NCT02290340|17491009|P4|Overall Study|Withdrawal by Subject|0
5069359|NCT02290340|17491010|P3|Overall Study|Withdrawal by Subject|0
5069360|NCT02290340|17491011|P2|Overall Study|Withdrawal by Subject|0
5069361|NCT02290340|17491012|P1|Overall Study|Withdrawal by Subject|1
5069362|NCT02290340|17491009|P4|Overall Study|Lost to Follow-up|1
5069363|NCT02290340|17491010|P3|Overall Study|Lost to Follow-up|0
5069364|NCT02290340|17491011|P2|Overall Study|Lost to Follow-up|0
5069365|NCT02290340|17491012|P1|Overall Study|Lost to Follow-up|0
5069366|NCT02290223|17491057|P2|12 Months|Refusal|1
5069367|NCT02290223|17491058|P1|12 Months|Refusal|0
5069368|NCT02290223|17491057|P2|12 Months|Lost to Follow-up|10
5069369|NCT02290223|17491058|P1|12 Months|Lost to Follow-up|16
5069370|NCT02290223|17491057|P2|6 Months|deceased (not related to study)|0
5069371|NCT02290223|17491058|P1|6 Months|deceased (not related to study)|2
5069372|NCT02290223|17491057|P2|6 Months|Withdrawal by Subject|0
5069373|NCT02290223|17491058|P1|6 Months|Withdrawal by Subject|5
5069374|NCT02290223|17491057|P2|6 Months|Lost to Follow-up|6
5069375|NCT02290223|17491058|P1|6 Months|Lost to Follow-up|9
5069376|NCT02289963|17491173|P2|Overall Study|Other than specified above|2
5069377|NCT02289963|17491174|P1|Overall Study|Other than specified above|0
5069378|NCT02289963|17491173|P2|Overall Study|End treatment visit outside visit window|4
5069379|NCT02289963|17491174|P1|Overall Study|End treatment visit outside visit window|0
5069380|NCT02289963|17491173|P2|Overall Study|Last injection missed|2
5069381|NCT02289963|17491174|P1|Overall Study|Last injection missed|2
5069382|NCT02289963|17491173|P2|Overall Study|Withdrawal by Subject|0
5069383|NCT02289963|17491174|P1|Overall Study|Withdrawal by Subject|1
5069384|NCT02289963|17491173|P2|Overall Study|Poor compliance to protocol|0
5069385|NCT02289963|17491174|P1|Overall Study|Poor compliance to protocol|1
5069386|NCT02289963|17491173|P2|Overall Study|Adverse Event|2
5069387|NCT02289963|17491174|P1|Overall Study|Adverse Event|1
5069388|NCT02289898|17491225|P3|Overall Study|Other|10
5069389|NCT02289898|17491226|P2|Overall Study|Other|7
5069390|NCT02289898|17491227|P1|Overall Study|Other|8
5069391|NCT02289898|17491225|P3|Overall Study|Use of another anticancer therapy|1
5069392|NCT02289898|17491226|P2|Overall Study|Use of another anticancer therapy|0
5069393|NCT02289898|17491227|P1|Overall Study|Use of another anticancer therapy|0
5069394|NCT02289898|17491225|P3|Overall Study|Disease progression|34
5069395|NCT02289898|17491226|P2|Overall Study|Disease progression|28
5069396|NCT02289898|17491227|P1|Overall Study|Disease progression|34
5069397|NCT02289898|17491225|P3|Overall Study|Adverse Event|5
5069398|NCT02289898|17491226|P2|Overall Study|Adverse Event|5
5069399|NCT02289898|17491227|P1|Overall Study|Adverse Event|3
5069400|NCT02289898|17491225|P3|Overall Study|Withdrawal by Subject|1
5069401|NCT02289898|17491226|P2|Overall Study|Withdrawal by Subject|4
5069402|NCT02289898|17491227|P1|Overall Study|Withdrawal by Subject|0
5069403|NCT02289898|17491225|P3|Overall Study|Physician Decision|2
5069404|NCT02289898|17491226|P2|Overall Study|Physician Decision|5
5069405|NCT02289898|17491227|P1|Overall Study|Physician Decision|2
5069406|NCT02289898|17491225|P3|Overall Study|Death|3
5069407|NCT02289898|17491226|P2|Overall Study|Death|4
5069408|NCT02289898|17491227|P1|Overall Study|Death|5
5069409|NCT02289833|17491236|P2|Overall Study|Death|16
5069410|NCT02289833|17491237|P1|Overall Study|Death|23
5069411|NCT02289833|17491236|P2|Overall Study|Lost to Follow-up|0
5069412|NCT02289833|17491237|P1|Overall Study|Lost to Follow-up|4
5069413|NCT02289833|17491236|P2|Overall Study|Study discontinuation|1
5069414|NCT02289833|17491237|P1|Overall Study|Study discontinuation|0
5069415|NCT02289820|17491273|P7|Overall Study|withdrawal of consent|0
5069416|NCT02289820|17491274|P6|Overall Study|withdrawal of consent|0
5069417|NCT02289820|17491275|P5|Overall Study|withdrawal of consent|0
5069418|NCT02289820|17491276|P4|Overall Study|withdrawal of consent|0
5069419|NCT02289820|17491277|P3|Overall Study|withdrawal of consent|0
5069420|NCT02289820|17491278|P2|Overall Study|withdrawal of consent|1
5069421|NCT02289820|17491279|P1|Overall Study|withdrawal of consent|0
5069422|NCT02289820|17491273|P7|Overall Study|Lost to Follow-up|1
5069423|NCT02289820|17491274|P6|Overall Study|Lost to Follow-up|1
5069424|NCT02289820|17491275|P5|Overall Study|Lost to Follow-up|0
5069425|NCT02289820|17491276|P4|Overall Study|Lost to Follow-up|1
5069426|NCT02289820|17491277|P3|Overall Study|Lost to Follow-up|3
5069427|NCT02289820|17491278|P2|Overall Study|Lost to Follow-up|0
5069428|NCT02289820|17491279|P1|Overall Study|Lost to Follow-up|0
5069429|NCT02289820|17491273|P7|Overall Study|Death|0
5069430|NCT02289820|17491274|P6|Overall Study|Death|0
5069431|NCT02289820|17491275|P5|Overall Study|Death|0
5069432|NCT02289820|17491276|P4|Overall Study|Death|0
5069433|NCT02289820|17491277|P3|Overall Study|Death|1
5069434|NCT02289820|17491278|P2|Overall Study|Death|0
5069435|NCT02289820|17491279|P1|Overall Study|Death|0
5069436|NCT02289820|17491273|P7|Overall Study|Withdrawal by Subject|1
5069437|NCT02289820|17491274|P6|Overall Study|Withdrawal by Subject|0
5069438|NCT02289820|17491275|P5|Overall Study|Withdrawal by Subject|0
5069439|NCT02289820|17491276|P4|Overall Study|Withdrawal by Subject|1
5069440|NCT02289820|17491277|P3|Overall Study|Withdrawal by Subject|2
5069441|NCT02289820|17491278|P2|Overall Study|Withdrawal by Subject|1
5069442|NCT02289820|17491279|P1|Overall Study|Withdrawal by Subject|2
5069443|NCT02289742|17491397|P4|Third Wear Period|Reason not given|1
5069444|NCT02289742|17491398|P3|Third Wear Period|Reason not given|0
5069445|NCT02289742|17491399|P2|Third Wear Period|Reason not given|0
5069446|NCT02289742|17491400|P1|Third Wear Period|Reason not given|0
5069447|NCT02289742|17491397|P4|Third Wear Period|Adverse Event|0
5069448|NCT02289742|17491398|P3|Third Wear Period|Adverse Event|0
5069449|NCT02289742|17491399|P2|Third Wear Period|Adverse Event|1
5069450|NCT02289742|17491400|P1|Third Wear Period|Adverse Event|0
5069451|NCT02289742|17491397|P4|First Wear Period|Other prior to treatment|1
5069452|NCT02289742|17491398|P3|First Wear Period|Other prior to treatment|0
5069453|NCT02289742|17491399|P2|First Wear Period|Other prior to treatment|0
5069454|NCT02289742|17491400|P1|First Wear Period|Other prior to treatment|0
5069455|NCT02289742|17491397|P4|First Wear Period|Adverse Event|0
5069456|NCT02289742|17491398|P3|First Wear Period|Adverse Event|1
5069457|NCT02289742|17491399|P2|First Wear Period|Adverse Event|0
5069458|NCT02289742|17491400|P1|First Wear Period|Adverse Event|0
5069459|NCT02289742|17491397|P4|First Wear Period|Adverse event prior to treatment|0
5069460|NCT02289742|17491398|P3|First Wear Period|Adverse event prior to treatment|0
5069461|NCT02289742|17491399|P2|First Wear Period|Adverse event prior to treatment|1
5069462|NCT02289742|17491400|P1|First Wear Period|Adverse event prior to treatment|0
5069463|NCT02289729|17491417|P1|Overall Study|Death|1
5069464|NCT02289729|17491417|P1|Overall Study|Withdrawal by Subject|1
5069465|NCT02289729|17491417|P1|Overall Study|Very Narrow Therapeutic Margin|1
5069466|NCT02289729|17491417|P1|Overall Study|Lack of Efficacy|3
5069467|NCT02289690|17491481|P10|Overall Study|Other|1
5069468|NCT02289690|17491482|P9|Overall Study|Other|3
5069469|NCT02289690|17491483|P8|Overall Study|Other|2
5069470|NCT02289690|17491484|P7|Overall Study|Other|1
5069471|NCT02289690|17491485|P6|Overall Study|Other|0
5069472|NCT02289690|17491486|P5|Overall Study|Other|1
5069473|NCT02289690|17491487|P4|Overall Study|Other|1
5069474|NCT02289690|17491488|P3|Overall Study|Other|0
5069475|NCT02289690|17491489|P2|Overall Study|Other|0
5069476|NCT02289690|17491490|P1|Overall Study|Other|0
5069477|NCT02289690|17491481|P10|Overall Study|Sponsor Discontinued Study|15
5069478|NCT02289690|17491482|P9|Overall Study|Sponsor Discontinued Study|7
5069479|NCT02289690|17491483|P8|Overall Study|Sponsor Discontinued Study|9
5069480|NCT02289690|17491484|P7|Overall Study|Sponsor Discontinued Study|0
5069481|NCT02289690|17491485|P6|Overall Study|Sponsor Discontinued Study|0
5069482|NCT02289690|17491486|P5|Overall Study|Sponsor Discontinued Study|0
5069483|NCT02289690|17491487|P4|Overall Study|Sponsor Discontinued Study|0
5069484|NCT02289690|17491488|P3|Overall Study|Sponsor Discontinued Study|0
5069485|NCT02289690|17491489|P2|Overall Study|Sponsor Discontinued Study|0
5069486|NCT02289690|17491490|P1|Overall Study|Sponsor Discontinued Study|0
5069487|NCT02289690|17491481|P10|Overall Study|Death|41
5069488|NCT02289690|17491482|P9|Overall Study|Death|45
5069489|NCT02289690|17491483|P8|Overall Study|Death|49
5069490|NCT02289690|17491484|P7|Overall Study|Death|0
5069491|NCT02289690|17491485|P6|Overall Study|Death|0
5069492|NCT02289690|17491486|P5|Overall Study|Death|0
5069493|NCT02289690|17491487|P4|Overall Study|Death|0
5069494|NCT02289690|17491488|P3|Overall Study|Death|0
5069495|NCT02289690|17491489|P2|Overall Study|Death|0
5069496|NCT02289690|17491490|P1|Overall Study|Death|0
5069497|NCT02289690|17491481|P10|Overall Study|Lost to Follow-up|2
5069498|NCT02289690|17491482|P9|Overall Study|Lost to Follow-up|0
5069499|NCT02289690|17491483|P8|Overall Study|Lost to Follow-up|1
5069500|NCT02289690|17491484|P7|Overall Study|Lost to Follow-up|0
5069501|NCT02289690|17491485|P6|Overall Study|Lost to Follow-up|0
5069502|NCT02289690|17491486|P5|Overall Study|Lost to Follow-up|0
5069503|NCT02289690|17491487|P4|Overall Study|Lost to Follow-up|0
5069504|NCT02289690|17491488|P3|Overall Study|Lost to Follow-up|0
5069505|NCT02289690|17491489|P2|Overall Study|Lost to Follow-up|0
5069506|NCT02289690|17491490|P1|Overall Study|Lost to Follow-up|0
5069507|NCT02289690|17491481|P10|Overall Study|Progressive Disease, Per Protocol|0
5069508|NCT02289690|17491482|P9|Overall Study|Progressive Disease, Per Protocol|0
5069509|NCT02289690|17491483|P8|Overall Study|Progressive Disease, Per Protocol|0
5069510|NCT02289690|17491484|P7|Overall Study|Progressive Disease, Per Protocol|2
5069511|NCT02289690|17491485|P6|Overall Study|Progressive Disease, Per Protocol|13
5069512|NCT02289690|17491486|P5|Overall Study|Progressive Disease, Per Protocol|5
5069513|NCT02289690|17491487|P4|Overall Study|Progressive Disease, Per Protocol|2
5069514|NCT02289690|17491488|P3|Overall Study|Progressive Disease, Per Protocol|3
5069515|NCT02289690|17491489|P2|Overall Study|Progressive Disease, Per Protocol|2
5069516|NCT02289690|17491490|P1|Overall Study|Progressive Disease, Per Protocol|3
5069517|NCT02289690|17491481|P10|Overall Study|Withdrawal by Subject|2
5069518|NCT02289690|17491482|P9|Overall Study|Withdrawal by Subject|4
5069519|NCT02289690|17491483|P8|Overall Study|Withdrawal by Subject|0
5069520|NCT02289690|17491484|P7|Overall Study|Withdrawal by Subject|0
5069521|NCT02289690|17491485|P6|Overall Study|Withdrawal by Subject|1
5069522|NCT02289690|17491486|P5|Overall Study|Withdrawal by Subject|1
5069523|NCT02289690|17491487|P4|Overall Study|Withdrawal by Subject|0
5069524|NCT02289690|17491488|P3|Overall Study|Withdrawal by Subject|0
5069525|NCT02289690|17491489|P2|Overall Study|Withdrawal by Subject|0
5069526|NCT02289690|17491490|P1|Overall Study|Withdrawal by Subject|1
5069527|NCT02289690|17491481|P10|Overall Study|Adverse Event Related to Progression|0
5069528|NCT02289690|17491482|P9|Overall Study|Adverse Event Related to Progression|0
5069529|NCT02289690|17491483|P8|Overall Study|Adverse Event Related to Progression|0
5069530|NCT02289690|17491484|P7|Overall Study|Adverse Event Related to Progression|1
5069531|NCT02289690|17491485|P6|Overall Study|Adverse Event Related to Progression|0
5069532|NCT02289690|17491486|P5|Overall Study|Adverse Event Related to Progression|1
5069533|NCT02289690|17491487|P4|Overall Study|Adverse Event Related to Progression|0
5069534|NCT02289690|17491488|P3|Overall Study|Adverse Event Related to Progression|1
5069535|NCT02289690|17491489|P2|Overall Study|Adverse Event Related to Progression|1
5069536|NCT02289690|17491490|P1|Overall Study|Adverse Event Related to Progression|0
5069537|NCT02289469|17491578|P2|Overall Study|Unable to match a control|0
5069538|NCT02289469|17491579|P1|Overall Study|Unable to match a control|6
5069539|NCT02289456|17491587|P1|Monotherapy Period|Miscellaneous|1
5069540|NCT02289456|17491587|P1|Monotherapy Period|Study Terminated by Sponsor|2
5069541|NCT02289456|17491587|P1|Monotherapy Period|Withdrawal by Subject|2
5069542|NCT02289456|17491587|P1|Monotherapy Period|Symptomatic Deterioration|1
5069543|NCT02289456|17491587|P1|Monotherapy Period|Progressive Disease (PD)|8
5069544|NCT02289456|17491587|P1|Monotherapy Period|Adverse Event|1
5069545|NCT02289456|17491587|P1|Monotherapy Period|Death|1
5069546|NCT02289456|17491587|P1|Induction Period|Miscellaneous|1
5069547|NCT02289456|17491587|P1|Induction Period|Withdrawal by Subject|2
5069548|NCT02289456|17491587|P1|Induction Period|Symptomatic Deterioration|4
5069549|NCT02289456|17491587|P1|Induction Period|Progressive Disease (PD)|4
5069550|NCT02289456|17491587|P1|Induction Period|Adverse Event|11
5069551|NCT02289456|17491587|P1|Induction Period|Death|2
5069552|NCT02289417|17491610|P9|Extension Phase Weeks 52-104|Miscellaneous|0
5069553|NCT02289417|17491611|P8|Extension Phase Weeks 52-104|Miscellaneous|1
5069554|NCT02289417|17491612|P7|Extension Phase Weeks 52-104|Miscellaneous|0
5069555|NCT02289417|17491613|P6|Extension Phase Weeks 52-104|Miscellaneous|0
5069556|NCT02289417|17491614|P5|Extension Phase Weeks 52-104|Miscellaneous|0
5069557|NCT02289417|17491615|P4|Extension Phase Weeks 52-104|Miscellaneous|0
5069558|NCT02289417|17491616|P3|Extension Phase Weeks 52-104|Miscellaneous|0
5069559|NCT02289417|17491617|P2|Extension Phase Weeks 52-104|Miscellaneous|0
5069560|NCT02289417|17491618|P1|Extension Phase Weeks 52-104|Miscellaneous|0
5069561|NCT02289417|17491610|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
5069562|NCT02289417|17491611|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
5069563|NCT02289417|17491612|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069564|NCT02289417|17491613|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069565|NCT02289417|17491614|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069566|NCT02289417|17491615|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069567|NCT02289417|17491616|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069568|NCT02289417|17491617|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069569|NCT02289417|17491618|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5069570|NCT02289417|17491610|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
5069571|NCT02289417|17491611|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
5069572|NCT02289417|17491612|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069573|NCT02289417|17491613|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069574|NCT02289417|17491614|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069575|NCT02289417|17491615|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069576|NCT02289417|17491616|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069577|NCT02289417|17491617|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069578|NCT02289417|17491618|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
5069579|NCT02289417|17491610|P9|Extension Phase Weeks 52-104|Adverse Event|3
5069580|NCT02289417|17491611|P8|Extension Phase Weeks 52-104|Adverse Event|2
5069581|NCT02289417|17491612|P7|Extension Phase Weeks 52-104|Adverse Event|0
5069582|NCT02289417|17491613|P6|Extension Phase Weeks 52-104|Adverse Event|0
5069583|NCT02289417|17491614|P5|Extension Phase Weeks 52-104|Adverse Event|0
5069584|NCT02289417|17491615|P4|Extension Phase Weeks 52-104|Adverse Event|0
5069585|NCT02289417|17491616|P3|Extension Phase Weeks 52-104|Adverse Event|0
5069586|NCT02289417|17491617|P2|Extension Phase Weeks 52-104|Adverse Event|0
5069587|NCT02289417|17491618|P1|Extension Phase Weeks 52-104|Adverse Event|0
5069588|NCT02289417|17491610|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069589|NCT02289417|17491611|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069590|NCT02289417|17491612|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
5069591|NCT02289417|17491613|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069592|NCT02289417|17491614|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069593|NCT02289417|17491615|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
5069594|NCT02289417|17491616|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069595|NCT02289417|17491617|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069596|NCT02289417|17491618|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5069597|NCT02289417|17491610|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069598|NCT02289417|17491611|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069599|NCT02289417|17491612|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
5069600|NCT02289417|17491613|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069601|NCT02289417|17491614|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069602|NCT02289417|17491615|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069603|NCT02289417|17491616|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069604|NCT02289417|17491617|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069605|NCT02289417|17491618|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5069606|NCT02289417|17491610|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5069607|NCT02289417|17491611|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5069608|NCT02289417|17491612|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5069609|NCT02289417|17491613|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5069610|NCT02289417|17491614|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5069611|NCT02289417|17491615|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5069612|NCT02289417|17491616|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5069613|NCT02289417|17491617|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5069614|NCT02289417|17491618|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5069615|NCT02289417|17491610|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5069616|NCT02289417|17491611|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5069617|NCT02289417|17491612|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5069618|NCT02289417|17491613|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
5069619|NCT02289417|17491614|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
5069620|NCT02289417|17491615|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
5069621|NCT02289417|17491616|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
5069622|NCT02289417|17491617|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
5069623|NCT02289417|17491618|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5069624|NCT02289417|17491610|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069625|NCT02289417|17491611|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069626|NCT02289417|17491612|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069627|NCT02289417|17491613|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069628|NCT02289417|17491614|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069629|NCT02289417|17491615|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069630|NCT02289417|17491616|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
5069631|NCT02289417|17491617|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069632|NCT02289417|17491618|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
5069633|NCT02289417|17491610|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
5069634|NCT02289417|17491611|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
5069635|NCT02289417|17491612|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
5069636|NCT02289417|17491613|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
5069637|NCT02289417|17491614|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
5069638|NCT02289417|17491615|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
5069639|NCT02289417|17491616|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
5069640|NCT02289417|17491617|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
5069641|NCT02289417|17491618|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
5069642|NCT02289417|17491610|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069643|NCT02289417|17491611|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069644|NCT02289417|17491612|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069645|NCT02289417|17491613|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069646|NCT02289417|17491614|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069647|NCT02289417|17491615|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069648|NCT02289417|17491616|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069649|NCT02289417|17491617|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5069650|NCT02289417|17491618|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
5069651|NCT02289417|17491610|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069652|NCT02289417|17491611|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069653|NCT02289417|17491612|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069654|NCT02289417|17491613|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069655|NCT02289417|17491614|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069656|NCT02289417|17491615|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069657|NCT02289417|17491616|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069658|NCT02289417|17491617|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
5069659|NCT02289417|17491618|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5069660|NCT02289417|17491610|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5069661|NCT02289417|17491611|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5069662|NCT02289417|17491612|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5069663|NCT02289417|17491613|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5069664|NCT02289417|17491614|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5069665|NCT02289417|17491615|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5069666|NCT02289417|17491616|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
5069667|NCT02289417|17491617|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
5069668|NCT02289417|17491618|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
5069669|NCT02289417|17491610|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069670|NCT02289417|17491611|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069671|NCT02289417|17491612|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069672|NCT02289417|17491613|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069673|NCT02289417|17491614|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069674|NCT02289417|17491615|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069675|NCT02289417|17491616|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
5069676|NCT02289417|17491617|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5069677|NCT02289417|17491618|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
5069678|NCT02289352|17491667|P3|Overall Study|Withdrawal by Subject|0
5069679|NCT02289352|17491668|P2|Overall Study|Withdrawal by Subject|1
5069680|NCT02289352|17491669|P1|Overall Study|Withdrawal by Subject|1
5069681|NCT02289079|17491736|P2|Overall Study|Lost to Follow-up|1
5069682|NCT02289079|17491737|P1|Overall Study|Lost to Follow-up|0
5069683|NCT02289079|17491736|P2|Overall Study|Physician Decision|0
5069684|NCT02289079|17491737|P1|Overall Study|Physician Decision|2
5069685|NCT02288559|17491766|P4|Overall Study|Reason Not Specified|0
5069686|NCT02288559|17491767|P3|Overall Study|Reason Not Specified|3
5069687|NCT02288559|17491768|P2|Overall Study|Reason Not Specified|0
5069688|NCT02288559|17491769|P1|Overall Study|Reason Not Specified|0
5069689|NCT02288559|17491766|P4|Overall Study|Withdrawal by Subject|1
5069690|NCT02288559|17491767|P3|Overall Study|Withdrawal by Subject|2
5069691|NCT02288559|17491768|P2|Overall Study|Withdrawal by Subject|0
5069692|NCT02288559|17491769|P1|Overall Study|Withdrawal by Subject|0
5069693|NCT02288559|17491766|P4|Overall Study|Lost to Follow-up|1
5069694|NCT02288559|17491767|P3|Overall Study|Lost to Follow-up|0
5069695|NCT02288559|17491768|P2|Overall Study|Lost to Follow-up|0
5069696|NCT02288559|17491769|P1|Overall Study|Lost to Follow-up|0
5069697|NCT02288559|17491766|P4|Overall Study|Death|0
5069698|NCT02288559|17491767|P3|Overall Study|Death|1
5069699|NCT02288559|17491768|P2|Overall Study|Death|0
5069700|NCT02288559|17491769|P1|Overall Study|Death|0
5069701|NCT02288559|17491766|P4|Overall Study|Adverse Event|0
5069702|NCT02288559|17491767|P3|Overall Study|Adverse Event|5
5069703|NCT02288559|17491768|P2|Overall Study|Adverse Event|1
5069704|NCT02288559|17491769|P1|Overall Study|Adverse Event|1
5069705|NCT02288325|17491820|P3|Double-blind Treatment Period|Multiple Reasons|2
5069706|NCT02288325|17491821|P2|Double-blind Treatment Period|Multiple Reasons|8
5069707|NCT02288325|17491822|P1|Double-blind Treatment Period|Multiple Reasons|0
5069708|NCT02288325|17491820|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
5069709|NCT02288325|17491821|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
5069710|NCT02288325|17491822|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
5069711|NCT02288325|17491820|P3|Double-blind Treatment Period|Protocol Violation|2
5069712|NCT02288325|17491821|P2|Double-blind Treatment Period|Protocol Violation|1
5069713|NCT02288325|17491822|P1|Double-blind Treatment Period|Protocol Violation|0
5069714|NCT02288325|17491820|P3|Double-blind Treatment Period|Lost to Follow-up|5
5069715|NCT02288325|17491821|P2|Double-blind Treatment Period|Lost to Follow-up|4
5069716|NCT02288325|17491822|P1|Double-blind Treatment Period|Lost to Follow-up|0
5069717|NCT02288325|17491820|P3|Double-blind Treatment Period|Withdrawal of Consent|8
5069718|NCT02288325|17491821|P2|Double-blind Treatment Period|Withdrawal of Consent|8
5069719|NCT02288325|17491822|P1|Double-blind Treatment Period|Withdrawal of Consent|0
5069720|NCT02288325|17491820|P3|Double-blind Treatment Period|Adverse Event|5
5069721|NCT02288325|17491821|P2|Double-blind Treatment Period|Adverse Event|2
5069722|NCT02288325|17491822|P1|Double-blind Treatment Period|Adverse Event|0
5069723|NCT02288325|17491820|P3|Stabilization Period|Reason not Specified|0
5069724|NCT02288325|17491821|P2|Stabilization Period|Reason not Specified|0
5069725|NCT02288325|17491822|P1|Stabilization Period|Reason not Specified|15
5069726|NCT02288325|17491820|P3|Stabilization Period|Non-Compliance With Study Drug|0
5069727|NCT02288325|17491821|P2|Stabilization Period|Non-Compliance With Study Drug|0
5069728|NCT02288325|17491822|P1|Stabilization Period|Non-Compliance With Study Drug|5
5069729|NCT02288325|17491820|P3|Stabilization Period|Protocol Violation|0
5069730|NCT02288325|17491821|P2|Stabilization Period|Protocol Violation|0
5069731|NCT02288325|17491822|P1|Stabilization Period|Protocol Violation|8
5069732|NCT02288325|17491820|P3|Stabilization Period|Lost to Follow-up|0
5069733|NCT02288325|17491821|P2|Stabilization Period|Lost to Follow-up|0
5069734|NCT02288325|17491822|P1|Stabilization Period|Lost to Follow-up|12
5069735|NCT02288325|17491820|P3|Stabilization Period|Withdrawal of Consent|0
5069736|NCT02288325|17491821|P2|Stabilization Period|Withdrawal of Consent|0
5069737|NCT02288325|17491822|P1|Stabilization Period|Withdrawal of Consent|23
5069738|NCT02288325|17491820|P3|Stabilization Period|Lack of Efficacy|0
5069739|NCT02288325|17491821|P2|Stabilization Period|Lack of Efficacy|0
5069740|NCT02288325|17491822|P1|Stabilization Period|Lack of Efficacy|22
5069741|NCT02288325|17491820|P3|Stabilization Period|Adverse Event|0
5069742|NCT02288325|17491821|P2|Stabilization Period|Adverse Event|0
5069743|NCT02288325|17491822|P1|Stabilization Period|Adverse Event|13
5069744|NCT02288325|17491820|P3|Run-in Period|Reason not Specified|0
5069745|NCT02288325|17491821|P2|Run-in Period|Reason not Specified|0
5069746|NCT02288325|17491822|P1|Run-in Period|Reason not Specified|8
5069747|NCT02288325|17491820|P3|Run-in Period|Non-Compliance With Study Drug|0
5069748|NCT02288325|17491821|P2|Run-in Period|Non-Compliance With Study Drug|0
5069749|NCT02288325|17491822|P1|Run-in Period|Non-Compliance With Study Drug|3
5069750|NCT02288325|17491820|P3|Run-in Period|Protocol Violation|0
5069751|NCT02288325|17491821|P2|Run-in Period|Protocol Violation|0
5069752|NCT02288325|17491822|P1|Run-in Period|Protocol Violation|17
5069753|NCT02288325|17491820|P3|Run-in Period|Lost to Follow-up|0
5069754|NCT02288325|17491821|P2|Run-in Period|Lost to Follow-up|0
5069755|NCT02288325|17491822|P1|Run-in Period|Lost to Follow-up|25
5069756|NCT02288325|17491820|P3|Run-in Period|Withdrawal of Consent|0
5069757|NCT02288325|17491821|P2|Run-in Period|Withdrawal of Consent|0
5069758|NCT02288325|17491822|P1|Run-in Period|Withdrawal of Consent|28
5069759|NCT02288325|17491820|P3|Run-in Period|Lack of Efficacy|0
5069760|NCT02288325|17491821|P2|Run-in Period|Lack of Efficacy|0
5069761|NCT02288325|17491822|P1|Run-in Period|Lack of Efficacy|16
5069762|NCT02288325|17491820|P3|Run-in Period|Adverse Event|0
5069763|NCT02288325|17491821|P2|Run-in Period|Adverse Event|0
5069764|NCT02288325|17491822|P1|Run-in Period|Adverse Event|48
5069765|NCT02288312|17491832|P3|Overall Study|Pregnancy|0
5069766|NCT02288312|17491833|P2|Overall Study|Pregnancy|0
5069767|NCT02288312|17491834|P1|Overall Study|Pregnancy|1
5069768|NCT02288182|17491874|P2|Overall Study|Lost to Follow-up|1
5069769|NCT02288182|17491875|P1|Overall Study|Lost to Follow-up|0
5069770|NCT02288182|17491874|P2|Overall Study|Adverse Event|1
5069771|NCT02288182|17491875|P1|Overall Study|Adverse Event|0
5069772|NCT02288091|17491887|P1|Overall Study|Screen fail|7
5069773|NCT02288091|17491887|P1|Overall Study|Lost to Follow-up|1
5069774|NCT02287922|17491899|P4|Overall Study|Other|0
5069775|NCT02287922|17491900|P3|Overall Study|Other|2
5069776|NCT02287922|17491901|P2|Overall Study|Other|0
5069777|NCT02287922|17491902|P1|Overall Study|Other|1
5069778|NCT02287922|17491899|P4|Overall Study|Sponsor's decision|1
5069779|NCT02287922|17491900|P3|Overall Study|Sponsor's decision|0
5069780|NCT02287922|17491901|P2|Overall Study|Sponsor's decision|0
5069781|NCT02287922|17491902|P1|Overall Study|Sponsor's decision|0
5069782|NCT02287922|17491899|P4|Overall Study|Lost to Follow-up|0
5069783|NCT02287922|17491900|P3|Overall Study|Lost to Follow-up|1
5069784|NCT02287922|17491901|P2|Overall Study|Lost to Follow-up|0
5069785|NCT02287922|17491902|P1|Overall Study|Lost to Follow-up|0
5069786|NCT02287922|17491899|P4|Overall Study|Withdrawal by Subject|2
5069787|NCT02287922|17491900|P3|Overall Study|Withdrawal by Subject|1
5069788|NCT02287922|17491901|P2|Overall Study|Withdrawal by Subject|1
5069789|NCT02287922|17491902|P1|Overall Study|Withdrawal by Subject|1
5069790|NCT02287922|17491899|P4|Overall Study|Adverse Event|4
5069791|NCT02287922|17491900|P3|Overall Study|Adverse Event|3
5069792|NCT02287922|17491901|P2|Overall Study|Adverse Event|1
5069793|NCT02287922|17491902|P1|Overall Study|Adverse Event|1
5069794|NCT02287896|17492010|P2|Second Injection Visit|Withdrawal by Subject|1
5069795|NCT02287896|17492011|P1|Second Injection Visit|Withdrawal by Subject|0
5069796|NCT02287883|17492029|P2|Overall Study|Non-response to survey|237
5069797|NCT02287883|17492030|P1|Overall Study|Non-response to survey|229
5069798|NCT02287883|17492029|P2|Overall Study|No longer eligible|182
5069799|NCT02287883|17492030|P1|Overall Study|No longer eligible|222
5069800|NCT02287883|17492029|P2|Overall Study|Death|7
5069801|NCT02287883|17492030|P1|Overall Study|Death|8
5069802|NCT02287623|17492241|P2|Overall Study|Protocol Violation|1
5069803|NCT02287623|17492242|P1|Overall Study|Protocol Violation|0
5069804|NCT02287610|17492258|P1|Overall Study|Excluded-investigator non-responsiveness|5
5069805|NCT02287610|17492258|P1|Overall Study|Withdrawal by Subject|8
5069806|NCT02287610|17492258|P1|Overall Study|Lost to Follow-up|3
5069807|NCT02287467|17492293|P2|Overall Study|Protocol Violation|9
5069808|NCT02287467|17492294|P1|Overall Study|Protocol Violation|12
5069809|NCT02287402|17492342|P1|Follow-up|Voluntary Withdrawal|2
5069810|NCT02287402|17492342|P1|Follow-up|Lost to Follow-up|1
5069811|NCT02287402|17492342|P1|Treatment Period|Voluntary Withdrawal|10
5069812|NCT02287402|17492342|P1|Treatment Period|Adverse Event|17
5069813|NCT02287038|17492447|P2|Overall Study|Abnormal ECG after starting medication|0
5069814|NCT02287038|17492448|P1|Overall Study|Abnormal ECG after starting medication|1
5069815|NCT02287038|17492447|P2|Overall Study|Nausea after starting medication|0
5069816|NCT02287038|17492448|P1|Overall Study|Nausea after starting medication|1
5069817|NCT02287038|17492447|P2|Overall Study|Anxiety after starting medication|1
5069818|NCT02287038|17492448|P1|Overall Study|Anxiety after starting medication|0
5069819|NCT02287038|17492447|P2|Overall Study|Stopped attending appointments|2
5069820|NCT02287038|17492448|P1|Overall Study|Stopped attending appointments|3
5069821|NCT02287025|17492458|P2|Overall Study|Screening failed|1
5069822|NCT02287025|17492459|P1|Overall Study|Screening failed|1
5069823|NCT02287025|17492458|P2|Overall Study|Withdrawal by Subject|2
5069824|NCT02287025|17492459|P1|Overall Study|Withdrawal by Subject|2
5069825|NCT02287025|17492458|P2|Overall Study|Adverse Event|4
5069826|NCT02287025|17492459|P1|Overall Study|Adverse Event|2
5069827|NCT02287025|17492458|P2|Overall Study|Progression of disease|2
5069828|NCT02287025|17492459|P1|Overall Study|Progression of disease|3
5069829|NCT02287025|17492458|P2|Overall Study|Not treated|0
5069830|NCT02287025|17492459|P1|Overall Study|Not treated|2
5069831|NCT02286960|17492470|P2|Overall Study|Lost to Follow-up|3
5069832|NCT02286960|17492471|P1|Overall Study|Lost to Follow-up|3
5069833|NCT02286947|17492483|P1|Overall Study|Withdrawal by Subject|2
5069834|NCT02286895|17492529|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
5069835|NCT02286895|17492530|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
5069836|NCT02286895|17492529|P2|Assessed for Measles Seroconversion|Missing measurement|3
5069837|NCT02286895|17492530|P1|Assessed for Measles Seroconversion|Missing measurement|6
5069838|NCT02286895|17492529|P2|Assessed for Measles Seroconversion|Protocol Violation|4
5069839|NCT02286895|17492530|P1|Assessed for Measles Seroconversion|Protocol Violation|1
5069840|NCT02286713|17492574|P2|Six Month Follow-Up|Lost to Follow-up|27
5069841|NCT02286713|17492575|P1|Six Month Follow-Up|Lost to Follow-up|30
5069842|NCT02286713|17492574|P2|Six Month Follow-Up|Death|0
5069843|NCT02286713|17492575|P1|Six Month Follow-Up|Death|2
5069844|NCT02286713|17492574|P2|Three Month Follow-Up|Withdrawal by Subject|1
5069845|NCT02286713|17492575|P1|Three Month Follow-Up|Withdrawal by Subject|1
5069846|NCT02286713|17492574|P2|Three Month Follow-Up|Lost to Follow-up|24
5069847|NCT02286713|17492575|P1|Three Month Follow-Up|Lost to Follow-up|26
5069848|NCT02286713|17492574|P2|Three Month Follow-Up|Death|1
5069849|NCT02286713|17492575|P1|Three Month Follow-Up|Death|1
5069850|NCT02286713|17492574|P2|One Week Follow-Up|Withdrawal by Subject|3
5069851|NCT02286713|17492575|P1|One Week Follow-Up|Withdrawal by Subject|6
5069852|NCT02286713|17492574|P2|One Week Follow-Up|Lost to Follow-up|21
5069853|NCT02286713|17492575|P1|One Week Follow-Up|Lost to Follow-up|17
5069854|NCT02286713|17492574|P2|One Week Follow-Up|Death|0
5069855|NCT02286713|17492575|P1|One Week Follow-Up|Death|1
5069856|NCT02286466|17492756|P2|Overall Study|Declined Clinician Assessment|1
5069857|NCT02286466|17492757|P1|Overall Study|Declined Clinician Assessment|0
5069858|NCT02286466|17492756|P2|Overall Study|Lost to Follow-up|4
5069859|NCT02286466|17492757|P1|Overall Study|Lost to Follow-up|1
5069860|NCT02286466|17492756|P2|Overall Study|Withdrawal by Subject|2
5069861|NCT02286466|17492757|P1|Overall Study|Withdrawal by Subject|5
5069862|NCT02286466|17492756|P2|Overall Study|Death|3
5069863|NCT02286466|17492757|P1|Overall Study|Death|1
5069864|NCT02286193|17492769|P1|Overall Study|Referred: Declined service|38
5069865|NCT02286193|17492769|P1|Overall Study|Referred: unable to reach/resource sent|104
5069866|NCT02286193|17492769|P1|Overall Study|Referred: CRS unable to make contact|62
5069867|NCT02286102|17492776|P2|Overall Study|Screen Failure|1
5069868|NCT02286102|17492777|P1|Overall Study|Screen Failure|1
5069869|NCT02285998|17492789|P2|Overall Study|Other Reasons|10
5069870|NCT02285998|17492790|P1|Overall Study|Other Reasons|7
5069871|NCT02285998|17492789|P2|Overall Study|Withdrawal by Subject|61
5069872|NCT02285998|17492790|P1|Overall Study|Withdrawal by Subject|53
5069873|NCT02285998|17492789|P2|Overall Study|Lost to Follow-up|172
5069874|NCT02285998|17492790|P1|Overall Study|Lost to Follow-up|176
5069875|NCT02285998|17492789|P2|Overall Study|Physician Decision|2
5069876|NCT02285998|17492790|P1|Overall Study|Physician Decision|1
5069877|NCT02285998|17492789|P2|Overall Study|Adverse Event|8
5069878|NCT02285998|17492790|P1|Overall Study|Adverse Event|9
5069879|NCT02285920|17492818|P4|Overall Study|Death|1
5069880|NCT02285920|17492819|P3|Overall Study|Death|2
5069881|NCT02285920|17492820|P2|Overall Study|Death|0
5069882|NCT02285920|17492821|P1|Overall Study|Death|2
5069883|NCT02285920|17492818|P4|Overall Study|Dialysis discontinuation|0
5069884|NCT02285920|17492819|P3|Overall Study|Dialysis discontinuation|0
5069885|NCT02285920|17492820|P2|Overall Study|Dialysis discontinuation|1
5069886|NCT02285920|17492821|P1|Overall Study|Dialysis discontinuation|0
5069887|NCT02285920|17492818|P4|Overall Study|Transfer to non-participating unit|0
5069888|NCT02285920|17492819|P3|Overall Study|Transfer to non-participating unit|0
5069889|NCT02285920|17492820|P2|Overall Study|Transfer to non-participating unit|1
5069890|NCT02285920|17492821|P1|Overall Study|Transfer to non-participating unit|0
5069891|NCT02285920|17492818|P4|Overall Study|Change to peritoneal dialysis|0
5069892|NCT02285920|17492819|P3|Overall Study|Change to peritoneal dialysis|1
5069893|NCT02285920|17492820|P2|Overall Study|Change to peritoneal dialysis|0
5069894|NCT02285920|17492821|P1|Overall Study|Change to peritoneal dialysis|0
5069895|NCT02285920|17492818|P4|Overall Study|Kidney transplantation|0
5069896|NCT02285920|17492819|P3|Overall Study|Kidney transplantation|2
5069897|NCT02285920|17492820|P2|Overall Study|Kidney transplantation|2
5069898|NCT02285920|17492821|P1|Overall Study|Kidney transplantation|2
5069899|NCT02285855|17492911|P2|Overall Study|Withdrawal by Subject|1
5069900|NCT02285855|17492912|P1|Overall Study|Withdrawal by Subject|2
5069901|NCT02285777|17492920|P2|Overall Study|Lost to Follow-up|2
5069902|NCT02285777|17492921|P1|Overall Study|Lost to Follow-up|4
5069903|NCT02285777|17492920|P2|Overall Study|Withdrawal by Subject|1
5069904|NCT02285777|17492921|P1|Overall Study|Withdrawal by Subject|1
5069905|NCT02285270|17493013|P1|Overall Study|Determined to be ineligible|1
5069906|NCT02285270|17493013|P1|Overall Study|Physician Decision|3
5069907|NCT02285270|17493013|P1|Overall Study|Lost to Follow-up|1
5069908|NCT02285153|17493021|P2|Overall Study|Adverse Event|0
5069909|NCT02285153|17493022|P1|Overall Study|Adverse Event|1
5069910|NCT02285062|17493036|P2|Overall Study|Lost to Follow-up|5
5069911|NCT02285062|17493037|P1|Overall Study|Lost to Follow-up|8
5069912|NCT02285062|17493036|P2|Overall Study|Death|62
5069913|NCT02285062|17493037|P1|Overall Study|Death|58
5069914|NCT02285062|17493036|P2|Overall Study|Withdrawal by Subject|17
5069915|NCT02285062|17493037|P1|Overall Study|Withdrawal by Subject|12
5069916|NCT02285010|17493085|P2|Overall Study|Not spinal anesthesia|1
5069917|NCT02285010|17493086|P1|Overall Study|Not spinal anesthesia|3
5069918|NCT02285010|17493085|P2|Overall Study|not abdominal hysterectomy|0
5069919|NCT02285010|17493086|P1|Overall Study|not abdominal hysterectomy|2
5069920|NCT02284906|17493103|P3|Overall Study|Reason not Specified|0
5069921|NCT02284906|17493104|P2|Overall Study|Reason not Specified|1
5069922|NCT02284906|17493105|P1|Overall Study|Reason not Specified|1
5069923|NCT02284906|17493103|P3|Overall Study|Study Termination|14
5069924|NCT02284906|17493104|P2|Overall Study|Study Termination|11
5069925|NCT02284906|17493105|P1|Overall Study|Study Termination|0
5069926|NCT02284906|17493103|P3|Overall Study|Voluntary Withdrawal|5
5069927|NCT02284906|17493104|P2|Overall Study|Voluntary Withdrawal|4
5069928|NCT02284906|17493105|P1|Overall Study|Voluntary Withdrawal|2
5069929|NCT02284906|17493103|P3|Overall Study|Major Protocol Deviation|0
5069930|NCT02284906|17493104|P2|Overall Study|Major Protocol Deviation|1
5069931|NCT02284906|17493105|P1|Overall Study|Major Protocol Deviation|0
5069932|NCT02284906|17493103|P3|Overall Study|Pretreatment Event/Adverse Event|0
5069933|NCT02284906|17493104|P2|Overall Study|Pretreatment Event/Adverse Event|1
5069934|NCT02284906|17493105|P1|Overall Study|Pretreatment Event/Adverse Event|0
5069935|NCT02284893|17493118|P2|52 Week (Long Term)|Non-Compliance|3
5069936|NCT02284893|17493119|P1|52 Week (Long Term)|Non-Compliance|2
5069937|NCT02284893|17493118|P2|52 Week (Long Term)|Lost to Follow-up|2
5069938|NCT02284893|17493119|P1|52 Week (Long Term)|Lost to Follow-up|2
5069939|NCT02284893|17493118|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
5069940|NCT02284893|17493119|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
5069941|NCT02284893|17493118|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
5069942|NCT02284893|17493119|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
5069943|NCT02284893|17493118|P2|52 Week (Long Term)|Adverse Event|1
5069944|NCT02284893|17493119|P1|52 Week (Long Term)|Adverse Event|3
5069945|NCT02284893|17493118|P2|26 Week (Short Term)|Other|1
5069946|NCT02284893|17493119|P1|26 Week (Short Term)|Other|1
5069947|NCT02284893|17493118|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
5069948|NCT02284893|17493119|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
5069949|NCT02284893|17493118|P2|26 Week (Short Term)|Lost to Follow-up|1
5069950|NCT02284893|17493119|P1|26 Week (Short Term)|Lost to Follow-up|3
5069951|NCT02284893|17493118|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
5069952|NCT02284893|17493119|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
5069953|NCT02284893|17493118|P2|26 Week (Short Term)|Discontinuation by the subject|2
5069954|NCT02284893|17493119|P1|26 Week (Short Term)|Discontinuation by the subject|2
5069955|NCT02284893|17493118|P2|26 Week (Short Term)|Adverse Event|9
5069956|NCT02284893|17493119|P1|26 Week (Short Term)|Adverse Event|1
5069957|NCT02284568|17493196|P3|Overall Study|Withdrew before taking study drug|0
5069958|NCT02284568|17493197|P2|Overall Study|Withdrew before taking study drug|1
5069959|NCT02284568|17493198|P1|Overall Study|Withdrew before taking study drug|0
5069960|NCT02284568|17493196|P3|Overall Study|Other|0
5069961|NCT02284568|17493197|P2|Overall Study|Other|2
5069962|NCT02284568|17493198|P1|Overall Study|Other|1
5069963|NCT02284568|17493196|P3|Overall Study|Lack of Efficacy|0
5069964|NCT02284568|17493197|P2|Overall Study|Lack of Efficacy|7
5069965|NCT02284568|17493198|P1|Overall Study|Lack of Efficacy|4
5069966|NCT02284568|17493196|P3|Overall Study|Lost to Follow-up|0
5069967|NCT02284568|17493197|P2|Overall Study|Lost to Follow-up|3
5069968|NCT02284568|17493198|P1|Overall Study|Lost to Follow-up|0
5069969|NCT02284568|17493196|P3|Overall Study|Sponsor requested patient stop treatment|90
5069970|NCT02284568|17493197|P2|Overall Study|Sponsor requested patient stop treatment|0
5069971|NCT02284568|17493198|P1|Overall Study|Sponsor requested patient stop treatment|0
5069972|NCT02284568|17493196|P3|Overall Study|Protocol Violation|0
5069973|NCT02284568|17493197|P2|Overall Study|Protocol Violation|1
5069974|NCT02284568|17493198|P1|Overall Study|Protocol Violation|0
5069975|NCT02284568|17493196|P3|Overall Study|Noncompliance|0
5069976|NCT02284568|17493197|P2|Overall Study|Noncompliance|0
5069977|NCT02284568|17493198|P1|Overall Study|Noncompliance|1
5069978|NCT02284568|17493196|P3|Overall Study|Noncompliance with study drug admin|0
5069979|NCT02284568|17493197|P2|Overall Study|Noncompliance with study drug admin|2
5069980|NCT02284568|17493198|P1|Overall Study|Noncompliance with study drug admin|1
5069981|NCT02284568|17493196|P3|Overall Study|Withdrawal by Subject|1
5069982|NCT02284568|17493197|P2|Overall Study|Withdrawal by Subject|21
5069983|NCT02284568|17493198|P1|Overall Study|Withdrawal by Subject|22
5069984|NCT02284568|17493196|P3|Overall Study|Adverse Event|4
5069985|NCT02284568|17493197|P2|Overall Study|Adverse Event|9
5069986|NCT02284568|17493198|P1|Overall Study|Adverse Event|2
5069987|NCT02284373|17493292|P3|Overall Study|Lost to Follow-up|0
5069988|NCT02284373|17493293|P2|Overall Study|Lost to Follow-up|1
5069989|NCT02284373|17493294|P1|Overall Study|Lost to Follow-up|0
5069990|NCT02284373|17493292|P3|Overall Study|Other|0
5069991|NCT02284373|17493293|P2|Overall Study|Other|1
5069992|NCT02284373|17493294|P1|Overall Study|Other|0
5069993|NCT02284373|17493292|P3|Overall Study|Withdrawal by Subject|0
5069994|NCT02284373|17493293|P2|Overall Study|Withdrawal by Subject|1
5069995|NCT02284373|17493294|P1|Overall Study|Withdrawal by Subject|0
5069996|NCT02284347|17493302|P1|Overall Study|Withdrawn prior to treatment|1
5069997|NCT02284347|17493302|P1|Overall Study|Lost to Follow-up|2
5069998|NCT02284243|17493310|P2|Overall Study|Adverse Event|0
5069999|NCT02284243|17493311|P1|Overall Study|Adverse Event|1
5070000|NCT02284243|17493310|P2|Overall Study|Lack of Efficacy|3
5070001|NCT02284243|17493311|P1|Overall Study|Lack of Efficacy|3
5070002|NCT02284178|17493331|P2|Overall Study|Met exclusion criteria|54
5070003|NCT02284178|17493332|P1|Overall Study|Met exclusion criteria|49
5070004|NCT02284009|17493375|P2|Overall Study|Withdrawal by Subject|5
5070005|NCT02284009|17493376|P1|Overall Study|Withdrawal by Subject|2
5070006|NCT02284009|17493375|P2|Overall Study|Physician Decision|2
5070007|NCT02284009|17493376|P1|Overall Study|Physician Decision|0
5070008|NCT02284009|17493375|P2|Overall Study|Lost to Follow-up|3
5070009|NCT02284009|17493376|P1|Overall Study|Lost to Follow-up|1
5070010|NCT02284009|17493375|P2|Overall Study|Adverse Event|0
5070011|NCT02284009|17493376|P1|Overall Study|Adverse Event|3
5070012|NCT02283788|17493475|P4|Overall Study|Withdrawal by Subject|1
5070013|NCT02283788|17493476|P3|Overall Study|Withdrawal by Subject|0
5070014|NCT02283788|17493477|P2|Overall Study|Withdrawal by Subject|1
5070015|NCT02283788|17493478|P1|Overall Study|Withdrawal by Subject|0
5070016|NCT02283788|17493475|P4|Overall Study|Adverse Event|1
5070017|NCT02283788|17493476|P3|Overall Study|Adverse Event|5
5070018|NCT02283788|17493477|P2|Overall Study|Adverse Event|3
5070019|NCT02283788|17493478|P1|Overall Study|Adverse Event|1
5070020|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Physician Decision|2
5070021|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Physician Decision|1
5070022|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
5070023|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
5070024|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
5070025|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
5070026|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
5070027|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
5070028|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
5070029|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
5070030|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
5070031|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
5070032|NCT02283762|17493490|P2|Long-term Extension Phase (LTE)|Adverse Event|6
5070033|NCT02283762|17493491|P1|Long-term Extension Phase (LTE)|Adverse Event|2
5070034|NCT02283762|17493490|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
5070035|NCT02283762|17493491|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
5070036|NCT02283762|17493490|P2|Main Treatment Phase (MT)|Pregnancy|1
5070037|NCT02283762|17493491|P1|Main Treatment Phase (MT)|Pregnancy|0
5070038|NCT02283762|17493490|P2|Main Treatment Phase (MT)|Physician Decision|1
5070039|NCT02283762|17493491|P1|Main Treatment Phase (MT)|Physician Decision|1
5070040|NCT02283762|17493490|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
5070041|NCT02283762|17493491|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
5070042|NCT02283762|17493490|P2|Main Treatment Phase (MT)|Adverse Event|9
5070043|NCT02283762|17493491|P1|Main Treatment Phase (MT)|Adverse Event|9
5070044|NCT02283658|17493515|P1|Overall Study|Withdrawal by Subject|1
5070045|NCT02283411|17493537|P1|Overall Study|Screen Failed|28
5070046|NCT02283411|17493537|P1|Overall Study|Withdrawal by Subject|3
5070047|NCT02283268|17493545|P1|Overall Study|Withdrawal by Subject|1
5070048|NCT02282982|17493606|P1|Overall Study|Other, not specified|18
5070049|NCT02282982|17493606|P1|Overall Study|Palivizumab is ended|11
5070050|NCT02282982|17493606|P1|Overall Study|Lack of product|156
5070051|NCT02282982|17493606|P1|Overall Study|Death|4
5070052|NCT02282982|17493606|P1|Overall Study|Withdrew consent|2
5070053|NCT02282982|17493606|P1|Overall Study|Lost to Follow-up|15
5070054|NCT02282813|17493634|P3|Overall Study|Administrative reasons|0
5070055|NCT02282813|17493635|P2|Overall Study|Administrative reasons|1
5070056|NCT02282813|17493636|P1|Overall Study|Administrative reasons|0
5070057|NCT02282813|17493634|P3|Overall Study|Lack of Efficacy|0
5070058|NCT02282813|17493635|P2|Overall Study|Lack of Efficacy|0
5070059|NCT02282813|17493636|P1|Overall Study|Lack of Efficacy|1
5070060|NCT02282813|17493634|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
5070061|NCT02282813|17493635|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
5070062|NCT02282813|17493636|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
5070063|NCT02282813|17493634|P3|Overall Study|Lost to Follow-up|1
5070064|NCT02282813|17493635|P2|Overall Study|Lost to Follow-up|0
5070065|NCT02282813|17493636|P1|Overall Study|Lost to Follow-up|2
5070066|NCT02282813|17493634|P3|Overall Study|Physician Decision|1
5070067|NCT02282813|17493635|P2|Overall Study|Physician Decision|3
5070068|NCT02282813|17493636|P1|Overall Study|Physician Decision|0
5070069|NCT02282813|17493634|P3|Overall Study|Subject non-compliance|0
5070070|NCT02282813|17493635|P2|Overall Study|Subject non-compliance|4
5070071|NCT02282813|17493636|P1|Overall Study|Subject non-compliance|1
5070072|NCT02282813|17493634|P3|Overall Study|Adverse Event|1
5070073|NCT02282813|17493635|P2|Overall Study|Adverse Event|10
5070074|NCT02282813|17493636|P1|Overall Study|Adverse Event|3
5070075|NCT02282813|17493634|P3|Overall Study|Withdrawal by Subject|0
5070076|NCT02282813|17493635|P2|Overall Study|Withdrawal by Subject|5
5070077|NCT02282813|17493636|P1|Overall Study|Withdrawal by Subject|4
5070078|NCT02282631|17493682|P2|Overall Study|Lost to Follow-up|0
5070079|NCT02282631|17493683|P1|Overall Study|Lost to Follow-up|2
5070080|NCT02282605|17493724|P3|Overall Study|negative SA result on Day -1|0
5070081|NCT02282605|17493725|P2|Overall Study|negative SA result on Day -1|0
5070082|NCT02282605|17493726|P1|Overall Study|negative SA result on Day -1|3
5070083|NCT02282527|17493748|P2|Overall Study|Lack of home health aid|0
5070084|NCT02282527|17493749|P1|Overall Study|Lack of home health aid|1
5070085|NCT02282527|17493748|P2|Overall Study|Lost to Follow-up|1
5070086|NCT02282527|17493749|P1|Overall Study|Lost to Follow-up|0
5070087|NCT02282293|17493761|P2|Overall Study|Moved out of study area|1
5070088|NCT02282293|17493762|P1|Overall Study|Moved out of study area|0
5070089|NCT02282293|17493761|P2|Overall Study|Unable to comply with study procedures|0
5070090|NCT02282293|17493762|P1|Overall Study|Unable to comply with study procedures|1
5070091|NCT02282293|17493761|P2|Overall Study|Lost to Follow-up|2
5070092|NCT02282293|17493762|P1|Overall Study|Lost to Follow-up|2
5070093|NCT02282163|17493780|P1|Overall Study|Protocol Violation|1
5070094|NCT02282020|17493812|P2|Overall Study|Withdrew Consent Prior to Dosing|12
5070095|NCT02282020|17493813|P1|Overall Study|Withdrew Consent Prior to Dosing|0
5070096|NCT02282020|17493812|P2|Overall Study|Developed Discontinuation Criteria|3
5070097|NCT02282020|17493813|P1|Overall Study|Developed Discontinuation Criteria|1
5070098|NCT02282020|17493812|P2|Overall Study|Severe Non-compliance to Protocol|0
5070099|NCT02282020|17493813|P1|Overall Study|Severe Non-compliance to Protocol|1
5070100|NCT02282020|17493812|P2|Overall Study|Miscellaneous|17
5070101|NCT02282020|17493813|P1|Overall Study|Miscellaneous|4
5070102|NCT02282020|17493812|P2|Overall Study|Withdrawal by Subject|10
5070103|NCT02282020|17493813|P1|Overall Study|Withdrawal by Subject|5
5070104|NCT02282020|17493812|P2|Overall Study|Adverse Event|15
5070105|NCT02282020|17493813|P1|Overall Study|Adverse Event|13
5070106|NCT02282020|17493812|P2|Overall Study|Objective Disease Progression|30
5070107|NCT02282020|17493813|P1|Overall Study|Objective Disease Progression|111
5070108|NCT02281773|17493872|P5|Overall Study|Other Reason|1
5070109|NCT02281773|17493873|P4|Overall Study|Other Reason|3
5070110|NCT02281773|17493874|P3|Overall Study|Other Reason|2
5070111|NCT02281773|17493875|P2|Overall Study|Other Reason|4
5070112|NCT02281773|17493876|P1|Overall Study|Other Reason|0
5070113|NCT02281773|17493872|P5|Overall Study|Withdrawal by Subject|8
5070114|NCT02281773|17493873|P4|Overall Study|Withdrawal by Subject|6
5070115|NCT02281773|17493874|P3|Overall Study|Withdrawal by Subject|6
5070116|NCT02281773|17493875|P2|Overall Study|Withdrawal by Subject|8
5070117|NCT02281773|17493876|P1|Overall Study|Withdrawal by Subject|2
5070118|NCT02281773|17493872|P5|Overall Study|Lost to Follow-up|10
5070119|NCT02281773|17493873|P4|Overall Study|Lost to Follow-up|2
5070120|NCT02281773|17493874|P3|Overall Study|Lost to Follow-up|6
5070121|NCT02281773|17493875|P2|Overall Study|Lost to Follow-up|2
5070122|NCT02281773|17493876|P1|Overall Study|Lost to Follow-up|2
5070123|NCT02281773|17493872|P5|Overall Study|Protocol Violation|2
5070124|NCT02281773|17493873|P4|Overall Study|Protocol Violation|2
5070125|NCT02281773|17493874|P3|Overall Study|Protocol Violation|0
5070126|NCT02281773|17493875|P2|Overall Study|Protocol Violation|0
5070127|NCT02281773|17493876|P1|Overall Study|Protocol Violation|1
5070128|NCT02281773|17493872|P5|Overall Study|Adverse Event|9
5070129|NCT02281773|17493873|P4|Overall Study|Adverse Event|8
5070130|NCT02281773|17493874|P3|Overall Study|Adverse Event|4
5070131|NCT02281773|17493875|P2|Overall Study|Adverse Event|1
5070132|NCT02281773|17493876|P1|Overall Study|Adverse Event|6
5070133|NCT02281552|17493964|P2|Overall Study|Adverse Event|9
5070134|NCT02281552|17493965|P1|Overall Study|Adverse Event|3
5070135|NCT02281552|17493964|P2|Overall Study|Insufficient clinical response|1
5070136|NCT02281552|17493965|P1|Overall Study|Insufficient clinical response|0
5070137|NCT02281552|17493964|P2|Overall Study|Medication error|0
5070138|NCT02281552|17493965|P1|Overall Study|Medication error|1
5070139|NCT02281357|17494087|P2|Overall Study|Withdrawal by Subject|3
5070140|NCT02281357|17494088|P1|Overall Study|Withdrawal by Subject|4
5070141|NCT02281357|17494087|P2|Overall Study|Lost to Follow-up|0
5070142|NCT02281357|17494088|P1|Overall Study|Lost to Follow-up|1
5070143|NCT02281357|17494087|P2|Overall Study|Adverse Event|1
5070144|NCT02281357|17494088|P1|Overall Study|Adverse Event|2
5070145|NCT02281318|17494107|P2|Overall Study|Withdrawal by Subject|2
5070146|NCT02281318|17494108|P1|Overall Study|Withdrawal by Subject|6
5070147|NCT02281318|17494107|P2|Overall Study|Physician Decision|0
5070148|NCT02281318|17494108|P1|Overall Study|Physician Decision|2
5070149|NCT02281318|17494107|P2|Overall Study|Lost to Follow-up|1
5070150|NCT02281318|17494108|P1|Overall Study|Lost to Follow-up|2
5070151|NCT02281318|17494107|P2|Overall Study|Lack of Efficacy|0
5070152|NCT02281318|17494108|P1|Overall Study|Lack of Efficacy|2
5070153|NCT02281318|17494107|P2|Overall Study|Adverse Event|2
5070154|NCT02281318|17494108|P1|Overall Study|Adverse Event|2
5070155|NCT02281084|17494156|P4|Overall Study|Physician Decision|0
5070156|NCT02281084|17494157|P3|Overall Study|Physician Decision|1
5070157|NCT02281084|17494158|P2|Overall Study|Physician Decision|0
5070158|NCT02281084|17494159|P1|Overall Study|Physician Decision|0
5070159|NCT02281084|17494156|P4|Overall Study|Death|5
5070160|NCT02281084|17494157|P3|Overall Study|Death|3
5070161|NCT02281084|17494158|P2|Overall Study|Death|16
5070162|NCT02281084|17494159|P1|Overall Study|Death|20
5070163|NCT02281084|17494156|P4|Overall Study|Withdrawal by Subject|0
5070164|NCT02281084|17494157|P3|Overall Study|Withdrawal by Subject|0
5070165|NCT02281084|17494158|P2|Overall Study|Withdrawal by Subject|2
5070166|NCT02281084|17494159|P1|Overall Study|Withdrawal by Subject|1
5070167|NCT02281084|17494156|P4|Overall Study|Adverse Event|0
5070168|NCT02281084|17494157|P3|Overall Study|Adverse Event|0
5070169|NCT02281084|17494158|P2|Overall Study|Adverse Event|0
5070170|NCT02281084|17494159|P1|Overall Study|Adverse Event|1
5070171|NCT02280863|17494215|P2|Integrated Platform|Met stopping criteria|1
5070172|NCT02280863|17494216|P1|Integrated Platform|Met stopping criteria|0
5070173|NCT02280499|17494300|P1|Overall Study|Adverse Event|5
5070174|NCT02280499|17494300|P1|Overall Study|Lost to Follow-up|42
5070175|NCT02280499|17494300|P1|Overall Study|Death|14
5070176|NCT02280473|17494308|P2|Overall Study|Lost to Follow-up|1
5070177|NCT02280473|17494309|P1|Overall Study|Lost to Follow-up|0
5070178|NCT02280473|17494308|P2|Overall Study|Lack of Efficacy|1
5070179|NCT02280473|17494309|P1|Overall Study|Lack of Efficacy|0
5070180|NCT02280473|17494308|P2|Overall Study|Adverse Event|1
5070181|NCT02280473|17494309|P1|Overall Study|Adverse Event|1
5070182|NCT02280421|17494325|P2|Washout (2 Weeks)|Withdrawal by Subject|0
5070183|NCT02280421|17494326|P1|Washout (2 Weeks)|Withdrawal by Subject|1
5070184|NCT02280421|17494325|P2|Washout (2 Weeks)|Adverse Event|1
5070185|NCT02280421|17494326|P1|Washout (2 Weeks)|Adverse Event|0
5070186|NCT02280408|17494392|P4|Overall Study|Lost to Follow-up|0
5070187|NCT02280408|17494393|P3|Overall Study|Lost to Follow-up|0
5070188|NCT02280408|17494394|P2|Overall Study|Lost to Follow-up|2
5070189|NCT02280408|17494395|P1|Overall Study|Lost to Follow-up|0
5070190|NCT02280304|17494467|P2|Overall Study|Lost to Follow-up|8
5070191|NCT02280304|17494468|P1|Overall Study|Lost to Follow-up|7
5070192|NCT02280291|17494489|P4|Overall Study|Other|0
5070193|NCT02280291|17494490|P3|Overall Study|Other|0
5070194|NCT02280291|17494491|P2|Overall Study|Other|1
5070195|NCT02280291|17494492|P1|Overall Study|Other|1
5070196|NCT02280291|17494489|P4|Overall Study|Protocol Violation|0
5070197|NCT02280291|17494490|P3|Overall Study|Protocol Violation|0
5070198|NCT02280291|17494491|P2|Overall Study|Protocol Violation|0
5070199|NCT02280291|17494492|P1|Overall Study|Protocol Violation|1
5070200|NCT02280291|17494489|P4|Overall Study|Lost to Follow-up|8
5070201|NCT02280291|17494490|P3|Overall Study|Lost to Follow-up|3
5070202|NCT02280291|17494491|P2|Overall Study|Lost to Follow-up|1
5070203|NCT02280291|17494492|P1|Overall Study|Lost to Follow-up|2
5070204|NCT02280187|17494533|P1|Overall Study|Lost to Follow-up|218
5070205|NCT02280096|17494561|P2|Overall Study|Lack of attachment|1
5070206|NCT02280096|17494562|P1|Overall Study|Lack of attachment|0
5070207|NCT02280096|17494561|P2|Overall Study|Functional neurological disorder|0
5070208|NCT02280096|17494562|P1|Overall Study|Functional neurological disorder|1
5070209|NCT02280096|17494561|P2|Overall Study|Pregnancy|0
5070210|NCT02280096|17494562|P1|Overall Study|Pregnancy|1
5070211|NCT02280044|17494592|P2|Overall Study|Planned alternate|2
5070212|NCT02280044|17494593|P1|Overall Study|Planned alternate|0
5070213|NCT02279862|17494603|P2|Overall Study|Withdrawal by Subject|0
5070214|NCT02279862|17494604|P1|Overall Study|Withdrawal by Subject|1
5070215|NCT02279862|17494603|P2|Overall Study|Other|2
5070216|NCT02279862|17494604|P1|Overall Study|Other|1
5070217|NCT02279862|17494603|P2|Overall Study|Study closed by sponsor|13
5070218|NCT02279862|17494604|P1|Overall Study|Study closed by sponsor|16
5070219|NCT02279862|17494603|P2|Overall Study|Disease progression|2
5070220|NCT02279862|17494604|P1|Overall Study|Disease progression|5
5070221|NCT02279862|17494603|P2|Overall Study|Administrative reason by sponsor|1
5070222|NCT02279862|17494604|P1|Overall Study|Administrative reason by sponsor|0
5070223|NCT02279862|17494603|P2|Overall Study|No longer meets criteria|1
5070224|NCT02279862|17494604|P1|Overall Study|No longer meets criteria|0
5070225|NCT02279862|17494603|P2|Overall Study|Study drug toxicity|6
5070226|NCT02279862|17494604|P1|Overall Study|Study drug toxicity|3
5070227|NCT02279732|17494622|P2|Overall Study|Other|3
5070228|NCT02279732|17494623|P1|Overall Study|Other|3
5070229|NCT02279732|17494622|P2|Overall Study|Other|67
5070230|NCT02279732|17494623|P1|Overall Study|Other|53
5070231|NCT02279732|17494622|P2|Overall Study|Subject Requested to Discontinue|1
5070232|NCT02279732|17494623|P1|Overall Study|Subject Requested to Discontinue|0
5070233|NCT02279732|17494622|P2|Overall Study|Maximum Clinical Benefit|0
5070234|NCT02279732|17494623|P1|Overall Study|Maximum Clinical Benefit|1
5070235|NCT02279732|17494622|P2|Overall Study|Lost to Follow-up|1
5070236|NCT02279732|17494623|P1|Overall Study|Lost to Follow-up|0
5070237|NCT02279732|17494622|P2|Overall Study|Study Drug Toxicity|0
5070238|NCT02279732|17494623|P1|Overall Study|Study Drug Toxicity|2
5070239|NCT02279732|17494622|P2|Overall Study|Administrative Reason By Sponsor|2
5070240|NCT02279732|17494623|P1|Overall Study|Administrative Reason By Sponsor|0
5070241|NCT02279732|17494622|P2|Overall Study|Adverse Event|2
5070242|NCT02279732|17494623|P1|Overall Study|Adverse Event|1
5070243|NCT02279732|17494622|P2|Overall Study|Withdrawal by Subject|7
5070244|NCT02279732|17494623|P1|Overall Study|Withdrawal by Subject|2
5070245|NCT02279732|17494622|P2|Overall Study|Disease Progression|3
5070246|NCT02279732|17494623|P1|Overall Study|Disease Progression|13
5070247|NCT02279732|17494622|P2|Overall Study|Death|20
5070248|NCT02279732|17494623|P1|Overall Study|Death|23
5070249|NCT02279498|17494715|P2|Overall Study|Undefined|1
5070250|NCT02279498|17494716|P1|Overall Study|Undefined|2
5070251|NCT02279498|17494715|P2|Overall Study|Withdrawal by Subject|2
5070252|NCT02279498|17494716|P1|Overall Study|Withdrawal by Subject|9
5070253|NCT02279498|17494715|P2|Overall Study|Lost to Follow-up|1
5070254|NCT02279498|17494716|P1|Overall Study|Lost to Follow-up|0
5070255|NCT02279498|17494715|P2|Overall Study|Lack of Efficacy|0
5070256|NCT02279498|17494716|P1|Overall Study|Lack of Efficacy|4
5070257|NCT02279498|17494715|P2|Overall Study|Adverse Event|0
5070258|NCT02279498|17494716|P1|Overall Study|Adverse Event|3
5070259|NCT02279420|17494725|P1|Overall Study|Lost to Follow-up|23
5070260|NCT02279407|17494733|P4|Overall Study|Adverse Event|0
5070261|NCT02279407|17494734|P3|Overall Study|Adverse Event|2
5070262|NCT02279407|17494735|P2|Overall Study|Adverse Event|1
5070263|NCT02279407|17494736|P1|Overall Study|Adverse Event|1
5070264|NCT02279407|17494733|P4|Overall Study|Withdrawal by Subject|1
5070265|NCT02279407|17494734|P3|Overall Study|Withdrawal by Subject|1
5070266|NCT02279407|17494735|P2|Overall Study|Withdrawal by Subject|0
5070267|NCT02279407|17494736|P1|Overall Study|Withdrawal by Subject|1
5070268|NCT02279407|17494733|P4|Overall Study|Couldn't swallow IP; noncompliance|0
5070269|NCT02279407|17494734|P3|Overall Study|Couldn't swallow IP; noncompliance|2
5070270|NCT02279407|17494735|P2|Overall Study|Couldn't swallow IP; noncompliance|0
5070271|NCT02279407|17494736|P1|Overall Study|Couldn't swallow IP; noncompliance|0
5070272|NCT02279173|17494747|P1|Overall Study|Lost to Follow-up|3
5070273|NCT02279173|17494747|P1|Overall Study|Decision by Sponsor|4
5070274|NCT02279173|17494747|P1|Overall Study|Withdrawal by Subject|20
5070275|NCT02279173|17494747|P1|Overall Study|Protocol-specified Criteria|67
5070276|NCT02279043|17494807|P3|Overall Study|Lost to Follow-up|0
5070277|NCT02279043|17494808|P2|Overall Study|Lost to Follow-up|88
5070278|NCT02279043|17494809|P1|Overall Study|Lost to Follow-up|46
5070279|NCT02279043|17494807|P3|Overall Study|Post-rand. exclusion - not eligible|0
5070280|NCT02279043|17494808|P2|Overall Study|Post-rand. exclusion - not eligible|1
5070281|NCT02279043|17494809|P1|Overall Study|Post-rand. exclusion - not eligible|1
5070282|NCT02278952|17494839|P1|Overall Study|Insufficient Sample|6
5070283|NCT02278939|17494851|P2|Overall Study|family emergency unable to commit|0
5070284|NCT02278939|17494852|P1|Overall Study|family emergency unable to commit|2
5070285|NCT02278939|17494851|P2|Overall Study|death in family|0
5070286|NCT02278939|17494852|P1|Overall Study|death in family|1
5070287|NCT02278939|17494851|P2|Overall Study|Lost to Follow-up|1
5070288|NCT02278939|17494852|P1|Overall Study|Lost to Follow-up|1
5070289|NCT02278939|17494851|P2|Overall Study|lack of time|0
5070290|NCT02278939|17494852|P1|Overall Study|lack of time|1
5070291|NCT02278614|17494880|P2|Overall Study|left eye was not eligible|0
5070292|NCT02278614|17494881|P1|Overall Study|left eye was not eligible|1
5070293|NCT02278614|17494880|P2|Overall Study|Adverse Event|0
5070294|NCT02278614|17494881|P1|Overall Study|Adverse Event|1
5070295|NCT02278614|17494880|P2|Overall Study|Withdrawal by Subject|5
5070296|NCT02278614|17494881|P1|Overall Study|Withdrawal by Subject|3
5070297|NCT02278471|17494915|P2|Overall Study|Withdrawal by Subject|3
5070298|NCT02278471|17494916|P1|Overall Study|Withdrawal by Subject|0
5070299|NCT02278471|17494915|P2|Overall Study|Death|2
5070300|NCT02278471|17494916|P1|Overall Study|Death|2
5070301|NCT02278471|17494915|P2|Overall Study|Lost to Follow-up|15
5070302|NCT02278471|17494916|P1|Overall Study|Lost to Follow-up|6
5070303|NCT02278367|17494934|P2|Overall Study|Withdrawal by Subject|0
5070304|NCT02278367|17494935|P1|Overall Study|Withdrawal by Subject|5
5070305|NCT02278367|17494934|P2|Overall Study|Physician Decision|0
5070306|NCT02278367|17494935|P1|Overall Study|Physician Decision|5
5070307|NCT02278354|17494945|P2|Overall Study|<10 professional fights|0
5070308|NCT02278354|17494946|P1|Overall Study|<10 professional fights|2
5070309|NCT02278354|17494945|P2|Overall Study|Withdrawal by Subject|1
5070310|NCT02278354|17494946|P1|Overall Study|Withdrawal by Subject|0
5070311|NCT02278354|17494945|P2|Overall Study|Lost to Follow-up|2
5070312|NCT02278354|17494946|P1|Overall Study|Lost to Follow-up|2
5070313|NCT02278341|17494960|P2|Overall Study|Miscellaneous|14
5070314|NCT02278341|17494961|P1|Overall Study|Miscellaneous|15
5070315|NCT02278341|17494960|P2|Overall Study|Physician Decision|1
5070316|NCT02278341|17494961|P1|Overall Study|Physician Decision|1
5070317|NCT02278341|17494960|P2|Overall Study|Lost to Follow-up|1
5070318|NCT02278341|17494961|P1|Overall Study|Lost to Follow-up|0
5070319|NCT02278341|17494960|P2|Overall Study|Withdrawal by Subject|19
5070320|NCT02278341|17494961|P1|Overall Study|Withdrawal by Subject|30
5070321|NCT02278341|17494960|P2|Overall Study|Death|56
5070322|NCT02278341|17494961|P1|Overall Study|Death|68
5070323|NCT02278341|17494960|P2|Overall Study|Adverse Event|0
5070324|NCT02278341|17494961|P1|Overall Study|Adverse Event|3
5070325|NCT02278341|17494960|P2|Overall Study|Randomized but never received study drug|1
5070326|NCT02278341|17494961|P1|Overall Study|Randomized but never received study drug|1
5070327|NCT02278328|17495055|P3|Neuropsych Screening|incomplete consent|2
5070328|NCT02278328|17495056|P2|Neuropsych Screening|incomplete consent|0
5070329|NCT02278328|17495057|P1|Neuropsych Screening|incomplete consent|0
5070330|NCT02278328|17495055|P3|Neuropsych Screening|Withdrawal by Subject|0
5070331|NCT02278328|17495056|P2|Neuropsych Screening|Withdrawal by Subject|1
5070332|NCT02278328|17495057|P1|Neuropsych Screening|Withdrawal by Subject|0
5070333|NCT02278328|17495055|P3|Neuropsych Screening|found ineligible on neuropsych|0
5070334|NCT02278328|17495056|P2|Neuropsych Screening|found ineligible on neuropsych|0
5070335|NCT02278328|17495057|P1|Neuropsych Screening|found ineligible on neuropsych|1
5070336|NCT02278263|17495070|P3|Overall Study|Protocol Violation|9
5070337|NCT02278263|17495071|P2|Overall Study|Protocol Violation|0
5070338|NCT02278263|17495072|P1|Overall Study|Protocol Violation|7
5070339|NCT02278120|17495117|P2|Overall Study|Protocol Violation|2
5070340|NCT02278120|17495118|P1|Overall Study|Protocol Violation|0
5070341|NCT02278120|17495117|P2|Overall Study|Lost to Follow-up|0
5070342|NCT02278120|17495118|P1|Overall Study|Lost to Follow-up|2
5070343|NCT02278120|17495117|P2|Overall Study|Death|3
5070344|NCT02278120|17495118|P1|Overall Study|Death|3
5070345|NCT02278120|17495117|P2|Overall Study|Physician Decision|19
5070346|NCT02278120|17495118|P1|Overall Study|Physician Decision|8
5070347|NCT02278120|17495117|P2|Overall Study|Adverse Event|10
5070348|NCT02278120|17495118|P1|Overall Study|Adverse Event|12
5070349|NCT02278120|17495117|P2|Overall Study|Patient/guardian decision|8
5070350|NCT02278120|17495118|P1|Overall Study|Patient/guardian decision|14
5070351|NCT02278120|17495117|P2|Overall Study|Progressive disease|174
5070352|NCT02278120|17495118|P1|Overall Study|Progressive disease|122
5070353|NCT02278003|17495134|P2|Overall Study|Recognition task improperly completed|0
5070354|NCT02278003|17495135|P1|Overall Study|Recognition task improperly completed|7
5070355|NCT02278003|17495134|P2|Overall Study|Not Treated|0
5070356|NCT02278003|17495135|P1|Overall Study|Not Treated|1
5070357|NCT02278003|17495134|P2|Overall Study|Withdrawal by Subject|0
5070358|NCT02278003|17495135|P1|Overall Study|Withdrawal by Subject|11
5070359|NCT02277990|17495145|P2|Overall Study|Had other reason|32
5070360|NCT02277990|17495146|P1|Overall Study|Had other reason|26
5070361|NCT02277990|17495145|P2|Overall Study|Lost to Follow-up|69
5070362|NCT02277990|17495146|P1|Overall Study|Lost to Follow-up|66
5070363|NCT02277990|17495145|P2|Overall Study|Physician Decision|34
5070364|NCT02277990|17495146|P1|Overall Study|Physician Decision|40
5070365|NCT02277990|17495145|P2|Overall Study|Withdrawal by Subject|53
5070366|NCT02277990|17495146|P1|Overall Study|Withdrawal by Subject|64
5070367|NCT02277990|17495145|P2|Overall Study|Death|188
5070368|NCT02277990|17495146|P1|Overall Study|Death|170
5070369|NCT02277769|17495174|P3|Overall Study|Other than specified above|5
5070370|NCT02277769|17495175|P2|Overall Study|Other than specified above|8
5070371|NCT02277769|17495176|P1|Overall Study|Other than specified above|12
5070372|NCT02277769|17495174|P3|Overall Study|Adverse Event|4
5070373|NCT02277769|17495175|P2|Overall Study|Adverse Event|2
5070374|NCT02277769|17495176|P1|Overall Study|Adverse Event|14
5070375|NCT02277769|17495174|P3|Overall Study|Lack of Efficacy|4
5070376|NCT02277769|17495175|P2|Overall Study|Lack of Efficacy|0
5070377|NCT02277769|17495176|P1|Overall Study|Lack of Efficacy|17
5070378|NCT02277769|17495174|P3|Overall Study|Protocol Violation|5
5070379|NCT02277769|17495175|P2|Overall Study|Protocol Violation|3
5070380|NCT02277769|17495176|P1|Overall Study|Protocol Violation|3
5070381|NCT02277743|17495247|P3|Overall Study|Other than specified above|16
5070382|NCT02277743|17495248|P2|Overall Study|Other than specified above|5
5070383|NCT02277743|17495249|P1|Overall Study|Other than specified above|18
5070384|NCT02277743|17495247|P3|Overall Study|Lack of Efficacy|3
5070385|NCT02277743|17495248|P2|Overall Study|Lack of Efficacy|4
5070386|NCT02277743|17495249|P1|Overall Study|Lack of Efficacy|11
5070387|NCT02277743|17495247|P3|Overall Study|Adverse Event|6
5070388|NCT02277743|17495248|P2|Overall Study|Adverse Event|6
5070389|NCT02277743|17495249|P1|Overall Study|Adverse Event|10
5070390|NCT02277743|17495247|P3|Overall Study|Protocol Violation|1
5070391|NCT02277743|17495248|P2|Overall Study|Protocol Violation|1
5070392|NCT02277743|17495249|P1|Overall Study|Protocol Violation|1
5070393|NCT02277691|17495317|P1|Overall Study|Used Other Antihypertensive Drug|1
5070394|NCT02277691|17495317|P1|Overall Study|Lack of Efficacy|5
5070395|NCT02277691|17495317|P1|Overall Study|Voluntary Withdrawal|7
5070396|NCT02277691|17495317|P1|Overall Study|Pretreatment Event/Adverse Event|33
5070397|NCT02277444|17495379|P1|Overall Study|Ongoing|113
5070398|NCT02277444|17495379|P1|Overall Study|Enrolled and not Treated|3
5070399|NCT02277444|17495379|P1|Overall Study|Other|1
5070400|NCT02277444|17495379|P1|Overall Study|Withdrawal by Subject|3
5070401|NCT02277444|17495379|P1|Overall Study|Adverse Event|10
5070402|NCT02277119|17495398|P3|Overall Study|Protocol Violation|7
5070403|NCT02277119|17495399|P2|Overall Study|Protocol Violation|3
5070404|NCT02277119|17495400|P1|Overall Study|Protocol Violation|2
5070405|NCT02277119|17495398|P3|Overall Study|Lack of Efficacy|1
5070406|NCT02277119|17495399|P2|Overall Study|Lack of Efficacy|1
5070407|NCT02277119|17495400|P1|Overall Study|Lack of Efficacy|1
5070408|NCT02276872|17495438|P3|Overall Study|Adverse Event|0
5070409|NCT02276872|17495439|P2|Overall Study|Adverse Event|0
5070410|NCT02276872|17495440|P1|Overall Study|Adverse Event|1
5070411|NCT02276807|17495516|P2|Overall Study|Lost to Follow-up|10
5070412|NCT02276807|17495517|P1|Overall Study|Lost to Follow-up|10
5070413|NCT02276807|17495516|P2|Overall Study|Withdrawal by Subject|7
5070414|NCT02276807|17495517|P1|Overall Study|Withdrawal by Subject|8
5070415|NCT02276612|17495552|P2|Overall Study|Lost to Follow-up|0
5070416|NCT02276612|17495553|P1|Overall Study|Lost to Follow-up|1
5070417|NCT02276612|17495552|P2|Overall Study|Withdrew Consent|0
5070418|NCT02276612|17495553|P1|Overall Study|Withdrew Consent|1
5070419|NCT02276612|17495552|P2|Overall Study|Pregnancy|0
5070420|NCT02276612|17495553|P1|Overall Study|Pregnancy|1
5070421|NCT02276612|17495552|P2|Overall Study|Death|0
5070422|NCT02276612|17495553|P1|Overall Study|Death|1
5070423|NCT02276560|17495576|P3|Overall Study|Adverse Event|0
5070424|NCT02276560|17495577|P2|Overall Study|Adverse Event|0
5070425|NCT02276560|17495578|P1|Overall Study|Adverse Event|1
5070426|NCT02276482|17495588|P2|Overall Study|Reason not specified|1
5070427|NCT02276482|17495589|P1|Overall Study|Reason not specified|0
5070428|NCT02276482|17495588|P2|Overall Study|Gram-negative infection|0
5070429|NCT02276482|17495589|P1|Overall Study|Gram-negative infection|1
5070430|NCT02276482|17495588|P2|Overall Study|Withdrawal by Subject|0
5070431|NCT02276482|17495589|P1|Overall Study|Withdrawal by Subject|1
5070432|NCT02276482|17495588|P2|Overall Study|Adverse Event|0
5070433|NCT02276482|17495589|P1|Overall Study|Adverse Event|1
5070434|NCT02276222|17495724|P2|Overall Study|subject withdrew after randomization|0
5070435|NCT02276222|17495725|P1|Overall Study|subject withdrew after randomization|1
5070436|NCT02276222|17495724|P2|Overall Study|sheduling conflict|0
5070437|NCT02276222|17495725|P1|Overall Study|sheduling conflict|1
5070438|NCT02276222|17495724|P2|Overall Study|Physician Decision|1
5070439|NCT02276222|17495725|P1|Overall Study|Physician Decision|2
5070440|NCT02276222|17495724|P2|Overall Study|Lost to Follow-up|5
5070441|NCT02276222|17495725|P1|Overall Study|Lost to Follow-up|15
5070442|NCT02276222|17495724|P2|Overall Study|sponsor decision|3
5070443|NCT02276222|17495725|P1|Overall Study|sponsor decision|0
5070444|NCT02276222|17495724|P2|Overall Study|non compliance with study medication|2
5070445|NCT02276222|17495725|P1|Overall Study|non compliance with study medication|6
5070446|NCT02276222|17495724|P2|Overall Study|Withdrawal by Subject|33
5070447|NCT02276222|17495725|P1|Overall Study|Withdrawal by Subject|79
5070448|NCT02276222|17495724|P2|Overall Study|Protocol Violation|2
5070449|NCT02276222|17495725|P1|Overall Study|Protocol Violation|3
5070450|NCT02276222|17495724|P2|Overall Study|Lack of Efficacy|3
5070451|NCT02276222|17495725|P1|Overall Study|Lack of Efficacy|13
5070452|NCT02276222|17495724|P2|Overall Study|Death|4
5070453|NCT02276222|17495725|P1|Overall Study|Death|3
5070454|NCT02276222|17495724|P2|Overall Study|Adverse Event|11
5070455|NCT02276222|17495725|P1|Overall Study|Adverse Event|62
5070456|NCT02276053|17495749|P1|Overall Study|Patient needs to increase baseline AED|1
5070457|NCT02276053|17495749|P1|Overall Study|Patient does not meet selection criteria|3
5070458|NCT02276053|17495749|P1|Overall Study|Withdrawal by Subject|1
5070459|NCT02276053|17495749|P1|Overall Study|Lack of Efficacy|2
5070460|NCT02276053|17495749|P1|Overall Study|Adverse Event|5
5070461|NCT02276053|17495749|P1|Overall Study|Death|2
5070462|NCT02276040|17495765|P1|Overall Study|Physician Decision|15
5070463|NCT02275780|17495776|P2|Extension Study: up to 192 Weeks|Ongoing|233
5070464|NCT02275780|17495777|P1|Extension Study: up to 192 Weeks|Ongoing|260
5070465|NCT02275780|17495776|P2|Base Study: 96 Weeks|Randomized not treated|1
5070466|NCT02275780|17495777|P1|Base Study: 96 Weeks|Randomized not treated|2
5070467|NCT02275780|17495776|P2|Base Study: 96 Weeks|Pregnancy|1
5070468|NCT02275780|17495777|P1|Base Study: 96 Weeks|Pregnancy|2
5070469|NCT02275780|17495776|P2|Base Study: 96 Weeks|Physician Decision|4
5070470|NCT02275780|17495777|P1|Base Study: 96 Weeks|Physician Decision|2
5070471|NCT02275780|17495776|P2|Base Study: 96 Weeks|Noncompliance with drug|6
5070472|NCT02275780|17495777|P1|Base Study: 96 Weeks|Noncompliance with drug|9
5070473|NCT02275780|17495776|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
5070474|NCT02275780|17495777|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
5070475|NCT02275780|17495776|P2|Base Study: 96 Weeks|Protocol Violation|6
5070476|NCT02275780|17495777|P1|Base Study: 96 Weeks|Protocol Violation|1
5070477|NCT02275780|17495776|P2|Base Study: 96 Weeks|Lost to Follow-up|24
5070478|NCT02275780|17495777|P1|Base Study: 96 Weeks|Lost to Follow-up|28
5070479|NCT02275780|17495776|P2|Base Study: 96 Weeks|Lack of Efficacy|32
5070480|NCT02275780|17495777|P1|Base Study: 96 Weeks|Lack of Efficacy|21
5070481|NCT02275780|17495776|P2|Base Study: 96 Weeks|Death|1
5070482|NCT02275780|17495777|P1|Base Study: 96 Weeks|Death|3
5070483|NCT02275780|17495776|P2|Base Study: 96 Weeks|Adverse Event|14
5070484|NCT02275780|17495777|P1|Base Study: 96 Weeks|Adverse Event|6
5070485|NCT02275611|17495833|P4|Inpatient Withdrawal|Withdrawal by Subject|0
5070486|NCT02275611|17495834|P3|Inpatient Withdrawal|Withdrawal by Subject|0
5070487|NCT02275611|17495835|P2|Inpatient Withdrawal|Withdrawal by Subject|0
5070488|NCT02275611|17495836|P1|Inpatient Withdrawal|Withdrawal by Subject|1
5070489|NCT02275546|17495848|P2|Treatment Period 2|Protocol Violation|1
5070490|NCT02275546|17495849|P1|Treatment Period 2|Protocol Violation|0
5070491|NCT02275546|17495848|P2|Treatment Period 2|Withdrawal by Subject|1
5070492|NCT02275546|17495849|P1|Treatment Period 2|Withdrawal by Subject|2
5070493|NCT02275481|17495859|P2|Overall Study|Physician Decision|1
5070494|NCT02275481|17495860|P1|Overall Study|Physician Decision|0
5070495|NCT02275481|17495859|P2|Overall Study|all other reasons combined|1
5070496|NCT02275481|17495860|P1|Overall Study|all other reasons combined|2
5070497|NCT02275481|17495859|P2|Overall Study|Withdrawal by Subject|0
5070498|NCT02275481|17495860|P1|Overall Study|Withdrawal by Subject|3
5070499|NCT02275481|17495859|P2|Overall Study|Lost to Follow-up|0
5070500|NCT02275481|17495860|P1|Overall Study|Lost to Follow-up|2
5070501|NCT02275481|17495859|P2|Overall Study|Death|1
5070502|NCT02275481|17495860|P1|Overall Study|Death|2
5070503|NCT02275364|17495866|P2|Period 1|Other reason|0
5070504|NCT02275364|17495867|P1|Period 1|Other reason|1
5070505|NCT02275364|17495866|P2|Period 1|Withdrawal by Subject|0
5070506|NCT02275364|17495867|P1|Period 1|Withdrawal by Subject|1
5070507|NCT02275338|17495896|P1|Overall Study|Does not meet entry criteria|1
5070508|NCT02275338|17495896|P1|Overall Study|Reason not specified|5
5070509|NCT02275338|17495896|P1|Overall Study|Ineligible to start Phase 2|4
5070510|NCT02275338|17495896|P1|Overall Study|Disease progression (death)|1
5070511|NCT02275338|17495896|P1|Overall Study|Withdrawal by Subject|4
5070512|NCT02275338|17495896|P1|Overall Study|Lack of Efficacy|3
5070513|NCT02275338|17495896|P1|Overall Study|Adverse Event|15
5070514|NCT02275117|17495945|P5|Overall Study|Other|2
5070515|NCT02275117|17495946|P4|Overall Study|Other|0
5070516|NCT02275117|17495947|P3|Overall Study|Other|0
5070517|NCT02275117|17495948|P2|Overall Study|Other|0
5070518|NCT02275117|17495949|P1|Overall Study|Other|1
5070519|NCT02275117|17495945|P5|Overall Study|Study Burden|7
5070520|NCT02275117|17495946|P4|Overall Study|Study Burden|5
5070521|NCT02275117|17495947|P3|Overall Study|Study Burden|7
5070522|NCT02275117|17495948|P2|Overall Study|Study Burden|4
5070523|NCT02275117|17495949|P1|Overall Study|Study Burden|5
5070524|NCT02275117|17495945|P5|Overall Study|Worsening of Study Indication|0
5070525|NCT02275117|17495946|P4|Overall Study|Worsening of Study Indication|0
5070526|NCT02275117|17495947|P3|Overall Study|Worsening of Study Indication|2
5070527|NCT02275117|17495948|P2|Overall Study|Worsening of Study Indication|1
5070528|NCT02275117|17495949|P1|Overall Study|Worsening of Study Indication|0
5070529|NCT02275117|17495945|P5|Overall Study|Terminated by Sponsor|4
5070530|NCT02275117|17495946|P4|Overall Study|Terminated by Sponsor|6
5070531|NCT02275117|17495947|P3|Overall Study|Terminated by Sponsor|4
5070532|NCT02275117|17495948|P2|Overall Study|Terminated by Sponsor|4
5070533|NCT02275117|17495949|P1|Overall Study|Terminated by Sponsor|4
5070534|NCT02275117|17495945|P5|Overall Study|Withdrawal by Subject|3
5070535|NCT02275117|17495946|P4|Overall Study|Withdrawal by Subject|3
5070536|NCT02275117|17495947|P3|Overall Study|Withdrawal by Subject|7
5070537|NCT02275117|17495948|P2|Overall Study|Withdrawal by Subject|4
5070538|NCT02275117|17495949|P1|Overall Study|Withdrawal by Subject|6
5070539|NCT02275117|17495945|P5|Overall Study|Protocol Violation|0
5070540|NCT02275117|17495946|P4|Overall Study|Protocol Violation|1
5070541|NCT02275117|17495947|P3|Overall Study|Protocol Violation|1
5070542|NCT02275117|17495948|P2|Overall Study|Protocol Violation|0
5070543|NCT02275117|17495949|P1|Overall Study|Protocol Violation|1
5070544|NCT02275117|17495945|P5|Overall Study|Physician Decision|1
5070545|NCT02275117|17495946|P4|Overall Study|Physician Decision|0
5070546|NCT02275117|17495947|P3|Overall Study|Physician Decision|1
5070547|NCT02275117|17495948|P2|Overall Study|Physician Decision|1
5070548|NCT02275117|17495949|P1|Overall Study|Physician Decision|0
5070549|NCT02275117|17495945|P5|Overall Study|Lost to Follow-up|8
5070550|NCT02275117|17495946|P4|Overall Study|Lost to Follow-up|16
5070551|NCT02275117|17495947|P3|Overall Study|Lost to Follow-up|15
5070552|NCT02275117|17495948|P2|Overall Study|Lost to Follow-up|16
5070553|NCT02275117|17495949|P1|Overall Study|Lost to Follow-up|11
5070554|NCT02275117|17495945|P5|Overall Study|Lack of Efficacy|10
5070555|NCT02275117|17495946|P4|Overall Study|Lack of Efficacy|2
5070556|NCT02275117|17495947|P3|Overall Study|Lack of Efficacy|5
5070557|NCT02275117|17495948|P2|Overall Study|Lack of Efficacy|7
5070558|NCT02275117|17495949|P1|Overall Study|Lack of Efficacy|6
5070559|NCT02275117|17495945|P5|Overall Study|Adverse Event|1
5070560|NCT02275117|17495946|P4|Overall Study|Adverse Event|0
5070561|NCT02275117|17495947|P3|Overall Study|Adverse Event|0
5070562|NCT02275117|17495948|P2|Overall Study|Adverse Event|0
5070563|NCT02275117|17495949|P1|Overall Study|Adverse Event|0
5070564|NCT02275065|17496061|P5|Overall Study|Randomized but not treated|0
5070565|NCT02275065|17496062|P4|Overall Study|Randomized but not treated|1
5070566|NCT02275065|17496063|P3|Overall Study|Randomized but not treated|1
5070567|NCT02275065|17496064|P2|Overall Study|Randomized but not treated|0
5070568|NCT02275065|17496065|P1|Overall Study|Randomized but not treated|1
5070569|NCT02275052|17496146|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
5070570|NCT02275052|17496147|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5070571|NCT02275052|17496148|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5070572|NCT02275052|17496149|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5070573|NCT02275052|17496146|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
5070574|NCT02275052|17496147|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5070575|NCT02275052|17496148|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5070576|NCT02275052|17496149|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5070577|NCT02275052|17496146|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
5070578|NCT02275052|17496147|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5070579|NCT02275052|17496148|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5070580|NCT02275052|17496149|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5070581|NCT02275052|17496146|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
5070582|NCT02275052|17496147|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
5070583|NCT02275052|17496148|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
5070584|NCT02275052|17496149|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
5070585|NCT02275052|17496146|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
5070586|NCT02275052|17496147|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
5070587|NCT02275052|17496148|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
5070588|NCT02275052|17496149|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
5070589|NCT02275052|17496146|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
5070590|NCT02275052|17496147|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
5070591|NCT02275052|17496148|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
5070592|NCT02275052|17496149|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
5070593|NCT02275052|17496146|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5070594|NCT02275052|17496147|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5070595|NCT02275052|17496148|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5070596|NCT02275052|17496149|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
5070597|NCT02275052|17496146|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5070598|NCT02275052|17496147|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5070599|NCT02275052|17496148|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5070600|NCT02275052|17496149|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
5070601|NCT02275052|17496146|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5070602|NCT02275052|17496147|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5070603|NCT02275052|17496148|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
5070604|NCT02275052|17496149|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
5070605|NCT02275052|17496146|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5070606|NCT02275052|17496147|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5070607|NCT02275052|17496148|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
5070608|NCT02275052|17496149|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5070609|NCT02275052|17496146|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5070610|NCT02275052|17496147|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5070611|NCT02275052|17496148|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5070612|NCT02275052|17496149|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5070613|NCT02274948|17496163|P2|Overall Study|Left the area|3
5070614|NCT02274948|17496164|P1|Overall Study|Left the area|4
5070615|NCT02274948|17496163|P2|Overall Study|Stopped on family Practitioner advice|5
5070616|NCT02274948|17496164|P1|Overall Study|Stopped on family Practitioner advice|2
5070617|NCT02274948|17496163|P2|Overall Study|Withdrawal by Subject|58
5070618|NCT02274948|17496164|P1|Overall Study|Withdrawal by Subject|64
5070619|NCT02274948|17496163|P2|Overall Study|Lost to Follow-up|25
5070620|NCT02274948|17496164|P1|Overall Study|Lost to Follow-up|28
5070621|NCT02274857|17496207|P2|Overall Study|Other|0
5070622|NCT02274857|17496208|P1|Overall Study|Other|2
5070623|NCT02274857|17496207|P2|Overall Study|Withdrawal by Subject|2
5070624|NCT02274857|17496208|P1|Overall Study|Withdrawal by Subject|11
5070625|NCT02274857|17496207|P2|Overall Study|Trial screen failure|2
5070626|NCT02274857|17496208|P1|Overall Study|Trial screen failure|0
5070627|NCT02274857|17496207|P2|Overall Study|Physician Decision|0
5070628|NCT02274857|17496208|P1|Overall Study|Physician Decision|2
5070629|NCT02274857|17496207|P2|Overall Study|Lost to Follow-up|0
5070630|NCT02274857|17496208|P1|Overall Study|Lost to Follow-up|3
5070631|NCT02274857|17496207|P2|Overall Study|Death|2
5070632|NCT02274857|17496208|P1|Overall Study|Death|1
5070633|NCT02274857|17496207|P2|Overall Study|Adverse Event|0
5070634|NCT02274857|17496208|P1|Overall Study|Adverse Event|1
5070635|NCT02274792|17496260|P1|Overall Study|Sponsor Decision|2
5070636|NCT02274792|17496260|P1|Overall Study|Protocol Specified Criteria|2
5070637|NCT02274792|17496260|P1|Overall Study|Lost to Follow-up|8
5070638|NCT02274792|17496260|P1|Overall Study|Withdrawal by Subject|13
5070639|NCT02274766|17496270|P2|Overall Study|Adverse Event|1
5070640|NCT02274766|17496271|P1|Overall Study|Adverse Event|0
5070641|NCT02274766|17496270|P2|Overall Study|Subject Unwilling to Proceed|1
5070642|NCT02274766|17496271|P1|Overall Study|Subject Unwilling to Proceed|0
5070643|NCT02274766|17496270|P2|Overall Study|Did Not Receive Study Drug|1
5070644|NCT02274766|17496271|P1|Overall Study|Did Not Receive Study Drug|1
5070645|NCT02274766|17496270|P2|Overall Study|Withdrawal by Subject|6
5070646|NCT02274766|17496271|P1|Overall Study|Withdrawal by Subject|3
5070647|NCT02274558|17496338|P3|Overall Study|Physician Decision|1
5070648|NCT02274558|17496339|P2|Overall Study|Physician Decision|2
5070649|NCT02274558|17496340|P1|Overall Study|Physician Decision|0
5070650|NCT02274558|17496338|P3|Overall Study|Lost to Follow-up|1
5070651|NCT02274558|17496339|P2|Overall Study|Lost to Follow-up|1
5070652|NCT02274558|17496340|P1|Overall Study|Lost to Follow-up|2
5070653|NCT02274558|17496338|P3|Overall Study|Death|1
5070654|NCT02274558|17496339|P2|Overall Study|Death|0
5070655|NCT02274558|17496340|P1|Overall Study|Death|0
5070656|NCT02274558|17496338|P3|Overall Study|Withdrawal by Subject|4
5070657|NCT02274558|17496339|P2|Overall Study|Withdrawal by Subject|5
5070658|NCT02274558|17496340|P1|Overall Study|Withdrawal by Subject|1
5070659|NCT02274558|17496338|P3|Overall Study|Non-compliance|0
5070660|NCT02274558|17496339|P2|Overall Study|Non-compliance|1
5070661|NCT02274558|17496340|P1|Overall Study|Non-compliance|2
5070662|NCT02274558|17496338|P3|Overall Study|Adverse Event|2
5070663|NCT02274558|17496339|P2|Overall Study|Adverse Event|4
5070664|NCT02274558|17496340|P1|Overall Study|Adverse Event|2
5070665|NCT02274493|17496354|P1|Overall Study|Withdrawal by Subject|1
5070666|NCT02274311|17496361|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
5070667|NCT02273973|17496369|P2|Overall Study|Reason not specified|1
5070668|NCT02273973|17496370|P1|Overall Study|Reason not specified|0
5070669|NCT02273973|17496369|P2|Overall Study|Physician Decision|1
5070670|NCT02273973|17496370|P1|Overall Study|Physician Decision|0
5070671|NCT02273973|17496369|P2|Overall Study|Lost to Follow-up|1
5070672|NCT02273973|17496370|P1|Overall Study|Lost to Follow-up|0
5070673|NCT02273973|17496369|P2|Overall Study|Progression of disease|2
5070674|NCT02273973|17496370|P1|Overall Study|Progression of disease|0
5070675|NCT02273973|17496369|P2|Overall Study|Protocol Violation|0
5070676|NCT02273973|17496370|P1|Overall Study|Protocol Violation|1
5070677|NCT02273973|17496369|P2|Overall Study|Non-compliance|0
5070678|NCT02273973|17496370|P1|Overall Study|Non-compliance|1
5070679|NCT02273973|17496369|P2|Overall Study|Death|0
5070680|NCT02273973|17496370|P1|Overall Study|Death|1
5070681|NCT02273973|17496369|P2|Overall Study|Withdrawal by Subject|3
5070682|NCT02273973|17496370|P1|Overall Study|Withdrawal by Subject|2
5070683|NCT02273973|17496369|P2|Overall Study|Adverse Event|0
5070684|NCT02273973|17496370|P1|Overall Study|Adverse Event|4
5070685|NCT02273960|17496414|P4|Long Term Extension|Death|1
5070686|NCT02273960|17496415|P3|Long Term Extension|Death|0
5070687|NCT02273960|17496416|P2|Long Term Extension|Death|0
5070688|NCT02273960|17496417|P1|Long Term Extension|Death|0
5070689|NCT02273960|17496414|P4|Short Term Period|ST complete, not entering LTE|5
5070690|NCT02273960|17496415|P3|Short Term Period|ST complete, not entering LTE|4
5070691|NCT02273960|17496416|P2|Short Term Period|ST complete, not entering LTE|6
5070692|NCT02273960|17496417|P1|Short Term Period|ST complete, not entering LTE|4
5070693|NCT02273960|17496414|P4|Short Term Period|Lack of Efficacy|1
5070694|NCT02273960|17496415|P3|Short Term Period|Lack of Efficacy|0
5070695|NCT02273960|17496416|P2|Short Term Period|Lack of Efficacy|0
5070696|NCT02273960|17496417|P1|Short Term Period|Lack of Efficacy|0
5070697|NCT02273960|17496414|P4|Short Term Period|Lost to Follow-up|0
5070698|NCT02273960|17496415|P3|Short Term Period|Lost to Follow-up|0
5070699|NCT02273960|17496416|P2|Short Term Period|Lost to Follow-up|0
5070700|NCT02273960|17496417|P1|Short Term Period|Lost to Follow-up|1
5070701|NCT02273908|17496461|P2|Overall Study|Withdrawal by Subject|2
5070702|NCT02273908|17496462|P1|Overall Study|Withdrawal by Subject|4
5070703|NCT02273908|17496461|P2|Overall Study|Did not meet entrance criteria|2
5070704|NCT02273908|17496462|P1|Overall Study|Did not meet entrance criteria|3
5070705|NCT02273908|17496461|P2|Overall Study|Lost to Follow-up|1
5070706|NCT02273908|17496462|P1|Overall Study|Lost to Follow-up|10
5070707|NCT02273908|17496461|P2|Overall Study|Adverse Event|0
5070708|NCT02273908|17496462|P1|Overall Study|Adverse Event|16
5070709|NCT02273752|17496484|P1|Overall Study|Trial was terminated early|2
5070710|NCT02273180|17496575|P2|Overall Study|Other than specified above|10
5070711|NCT02273180|17496576|P1|Overall Study|Other than specified above|21
5070712|NCT02273180|17496575|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
5070713|NCT02273180|17496576|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
5070714|NCT02273180|17496575|P2|Overall Study|Randomized but not treated|0
5070715|NCT02273180|17496576|P1|Overall Study|Randomized but not treated|1
5070716|NCT02273180|17496575|P2|Overall Study|Protocol Violation|7
5070717|NCT02273180|17496576|P1|Overall Study|Protocol Violation|1
5070718|NCT02273180|17496575|P2|Overall Study|Lack of Efficacy|0
5070719|NCT02273180|17496576|P1|Overall Study|Lack of Efficacy|1
5070720|NCT02273180|17496575|P2|Overall Study|Adverse Event|2
5070721|NCT02273180|17496576|P1|Overall Study|Adverse Event|2
5070722|NCT02273167|17496601|P3|Overall Study|Various|8
5070723|NCT02273167|17496602|P2|Overall Study|Various|9
5070724|NCT02273167|17496603|P1|Overall Study|Various|10
5070725|NCT02273167|17496601|P3|Overall Study|Withdrawal by Subject|11
5070726|NCT02273167|17496602|P2|Overall Study|Withdrawal by Subject|12
5070727|NCT02273167|17496603|P1|Overall Study|Withdrawal by Subject|10
5070728|NCT02273167|17496601|P3|Overall Study|Lost to Follow-up|1
5070729|NCT02273167|17496602|P2|Overall Study|Lost to Follow-up|1
5070730|NCT02273167|17496603|P1|Overall Study|Lost to Follow-up|0
5070731|NCT02273167|17496601|P3|Overall Study|Protocol Violation|1
5070732|NCT02273167|17496602|P2|Overall Study|Protocol Violation|1
5070733|NCT02273167|17496603|P1|Overall Study|Protocol Violation|3
5070734|NCT02273167|17496601|P3|Overall Study|Adverse Event|0
5070735|NCT02273167|17496602|P2|Overall Study|Adverse Event|0
5070736|NCT02273167|17496603|P1|Overall Study|Adverse Event|1
5070737|NCT02273141|17496628|P2|Overall Study|Various|6
5070738|NCT02273141|17496629|P1|Overall Study|Various|6
5070739|NCT02273141|17496628|P2|Overall Study|Withdrawal by Subject|15
5070740|NCT02273141|17496629|P1|Overall Study|Withdrawal by Subject|10
5070741|NCT02273141|17496628|P2|Overall Study|Lost to Follow-up|3
5070742|NCT02273141|17496629|P1|Overall Study|Lost to Follow-up|1
5070743|NCT02273141|17496628|P2|Overall Study|Adverse Event|1
5070744|NCT02273141|17496629|P1|Overall Study|Adverse Event|0
5070745|NCT02273050|17496702|P3|Overall Study|Protocol Violation|4
5070746|NCT02273050|17496703|P2|Overall Study|Protocol Violation|1
5070747|NCT02273050|17496704|P1|Overall Study|Protocol Violation|3
5070748|NCT02273050|17496702|P3|Overall Study|Lost to Follow-up|3
5070749|NCT02273050|17496703|P2|Overall Study|Lost to Follow-up|2
5070750|NCT02273050|17496704|P1|Overall Study|Lost to Follow-up|0
5070751|NCT02273050|17496702|P3|Overall Study|Withdrawal by Subject|16
5070752|NCT02273050|17496703|P2|Overall Study|Withdrawal by Subject|14
5070753|NCT02273050|17496704|P1|Overall Study|Withdrawal by Subject|17
5070754|NCT02273050|17496702|P3|Overall Study|Lack of Efficacy|1
5070755|NCT02273050|17496703|P2|Overall Study|Lack of Efficacy|1
5070756|NCT02273050|17496704|P1|Overall Study|Lack of Efficacy|0
5070757|NCT02273050|17496702|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
5070758|NCT02273050|17496703|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
5070759|NCT02273050|17496704|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
5070760|NCT02273050|17496702|P3|Overall Study|Death|1
5070761|NCT02273050|17496703|P2|Overall Study|Death|0
5070762|NCT02273050|17496704|P1|Overall Study|Death|0
5070763|NCT02273050|17496702|P3|Overall Study|Adverse Event|3
5070764|NCT02273050|17496703|P2|Overall Study|Adverse Event|3
5070765|NCT02273050|17496704|P1|Overall Study|Adverse Event|4
5070766|NCT02273037|17496732|P2|Overall Study|Other complication|0
5070767|NCT02273037|17496733|P1|Overall Study|Other complication|2
5070768|NCT02273037|17496732|P2|Overall Study|Multiple delivery|2
5070769|NCT02273037|17496733|P1|Overall Study|Multiple delivery|2
5070770|NCT02273037|17496732|P2|Overall Study|Breech delivery|3
5070771|NCT02273037|17496733|P1|Overall Study|Breech delivery|2
5070772|NCT02273037|17496732|P2|Overall Study|Delivered before monitoring initiated|3
5070773|NCT02273037|17496733|P1|Overall Study|Delivered before monitoring initiated|1
5070774|NCT02273037|17496732|P2|Overall Study|Lost to Follow-up|0
5070775|NCT02273037|17496733|P1|Overall Study|Lost to Follow-up|1
5070776|NCT02272985|17496743|P1|Overall Study|kidney transplantation|1
5070777|NCT02272985|17496743|P1|Overall Study|hip fracture|1
5070778|NCT02272985|17496743|P1|Overall Study|Withdrawal by Subject|1
5070779|NCT02272816|17496748|P1|Overall Study|Adverse Event|1
5070780|NCT02272803|17496756|P2|Overall Study|Withdrawal by Subject|0
5070781|NCT02272803|17496757|P1|Overall Study|Withdrawal by Subject|1
5070782|NCT02272803|17496756|P2|Overall Study|Poor/non-compliance|1
5070783|NCT02272803|17496757|P1|Overall Study|Poor/non-compliance|0
5070784|NCT02272803|17496756|P2|Overall Study|Subject moved to care facility|1
5070785|NCT02272803|17496757|P1|Overall Study|Subject moved to care facility|0
5070786|NCT02272803|17496756|P2|Overall Study|Maximum clinical benefit|1
5070787|NCT02272803|17496757|P1|Overall Study|Maximum clinical benefit|1
5070788|NCT02272803|17496756|P2|Overall Study|Subj request to discontinue study trt|4
5070789|NCT02272803|17496757|P1|Overall Study|Subj request to discontinue study trt|1
5070790|NCT02272803|17496756|P2|Overall Study|Study drug toxicity|4
5070791|NCT02272803|17496757|P1|Overall Study|Study drug toxicity|1
5070792|NCT02272803|17496756|P2|Overall Study|Adverse Event unrelated to study drug|4
5070793|NCT02272803|17496757|P1|Overall Study|Adverse Event unrelated to study drug|1
5070794|NCT02272803|17496756|P2|Overall Study|Disease progression|2
5070795|NCT02272803|17496757|P1|Overall Study|Disease progression|4
5070796|NCT02272790|17496774|P6|Overall Study|Physician Decision|0
5070797|NCT02272790|17496775|P5|Overall Study|Physician Decision|0
5070798|NCT02272790|17496776|P4|Overall Study|Physician Decision|0
5070799|NCT02272790|17496777|P3|Overall Study|Physician Decision|0
5070800|NCT02272790|17496778|P2|Overall Study|Physician Decision|1
5070801|NCT02272790|17496779|P1|Overall Study|Physician Decision|0
5070802|NCT02272777|17496915|P2|Overall Study|Other|0
5070803|NCT02272777|17496916|P1|Overall Study|Other|2
5070804|NCT02272777|17496915|P2|Overall Study|Lost to Follow-up|0
5070805|NCT02272777|17496916|P1|Overall Study|Lost to Follow-up|2
5070806|NCT02272777|17496915|P2|Overall Study|Withdrawal by Subject|3
5070807|NCT02272777|17496916|P1|Overall Study|Withdrawal by Subject|0
5070808|NCT02272777|17496915|P2|Overall Study|Adverse Event|1
5070809|NCT02272777|17496916|P1|Overall Study|Adverse Event|0
5070810|NCT02272725|17496924|P2|Overall Study|equipment malfunction|0
5070811|NCT02272725|17496925|P1|Overall Study|equipment malfunction|2
5070812|NCT02272413|17496942|P2|Post-switch Period|Other than listed|5
5070813|NCT02272413|17496943|P1|Post-switch Period|Other than listed|4
5070814|NCT02272413|17496942|P2|Post-switch Period|Study terminated by sponsor|11
5070815|NCT02272413|17496943|P1|Post-switch Period|Study terminated by sponsor|8
5070816|NCT02272413|17496942|P2|Post-switch Period|Progressive disease|21
5070817|NCT02272413|17496943|P1|Post-switch Period|Progressive disease|21
5070818|NCT02272413|17496942|P2|Post-switch Period|Physician Decision|1
5070819|NCT02272413|17496943|P1|Post-switch Period|Physician Decision|1
5070820|NCT02272413|17496942|P2|Post-switch Period|Withdrawal by Subject|2
5070821|NCT02272413|17496943|P1|Post-switch Period|Withdrawal by Subject|1
5070822|NCT02272413|17496942|P2|Post-switch Period|Death|2
5070823|NCT02272413|17496943|P1|Post-switch Period|Death|3
5070824|NCT02272413|17496942|P2|Post-switch Period|Adverse Event|4
5070825|NCT02272413|17496943|P1|Post-switch Period|Adverse Event|4
5070826|NCT02272413|17496942|P2|Pre-switch Period|Other than listed|11
5070827|NCT02272413|17496943|P1|Pre-switch Period|Other than listed|10
5070828|NCT02272413|17496942|P2|Pre-switch Period|Protocol Violation|0
5070829|NCT02272413|17496943|P1|Pre-switch Period|Protocol Violation|1
5070830|NCT02272413|17496942|P2|Pre-switch Period|Lost to Follow-up|2
5070831|NCT02272413|17496943|P1|Pre-switch Period|Lost to Follow-up|0
5070832|NCT02272413|17496942|P2|Pre-switch Period|Progressive disease|173
5070833|NCT02272413|17496943|P1|Pre-switch Period|Progressive disease|185
5070834|NCT02272413|17496942|P2|Pre-switch Period|Physician Decision|18
5070835|NCT02272413|17496943|P1|Pre-switch Period|Physician Decision|6
5070836|NCT02272413|17496942|P2|Pre-switch Period|Withdrawal by Subject|15
5070837|NCT02272413|17496943|P1|Pre-switch Period|Withdrawal by Subject|27
5070838|NCT02272413|17496942|P2|Pre-switch Period|Death|26
5070839|NCT02272413|17496943|P1|Pre-switch Period|Death|26
5070840|NCT02272413|17496942|P2|Pre-switch Period|Adverse Event|37
5070841|NCT02272413|17496943|P1|Pre-switch Period|Adverse Event|38
5070842|NCT02272413|17496942|P2|Randomized Through Treatment Start|Not treated|5
5070843|NCT02272413|17496943|P1|Randomized Through Treatment Start|Not treated|3
5070844|NCT02271984|17496974|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070845|NCT02271984|17496975|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070846|NCT02271984|17496976|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070847|NCT02271984|17496977|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070848|NCT02271984|17496978|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
5070849|NCT02271984|17496979|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070850|NCT02271984|17496980|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
5070851|NCT02271984|17496981|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070852|NCT02271984|17496982|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070853|NCT02271984|17496983|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070854|NCT02271984|17496984|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070855|NCT02271984|17496985|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5070856|NCT02271945|17497074|P2|Overall Study|Other|1
5070857|NCT02271945|17497075|P1|Overall Study|Other|1
5070858|NCT02271945|17497074|P2|Overall Study|Withdrawal by Subject|1
5070859|NCT02271945|17497075|P1|Overall Study|Withdrawal by Subject|1
5070860|NCT02271945|17497074|P2|Overall Study|Death|3
5070861|NCT02271945|17497075|P1|Overall Study|Death|3
5070862|NCT02271880|17497118|P2|Overall Study|Premature discontinuation of study|4
5070863|NCT02271880|17497119|P1|Overall Study|Premature discontinuation of study|3
5070864|NCT02271854|17497149|P1|Overall Study|Lost to Follow-up|1
5070865|NCT02271854|17497149|P1|Overall Study|Unable or unwilling to cooperate with st|1
5070866|NCT02271854|17497149|P1|Overall Study|Withdrawal by Subject|2
5070867|NCT02271529|17497189|P1|Overall Study|Withdrawal by Subject|1
5070868|NCT02270983|17497310|P3|Overall Study|moved away from study site|0
5070869|NCT02270983|17497311|P2|Overall Study|moved away from study site|1
5070870|NCT02270983|17497312|P1|Overall Study|moved away from study site|0
5070871|NCT02270983|17497310|P3|Overall Study|study procedure non-compliance|0
5070872|NCT02270983|17497311|P2|Overall Study|study procedure non-compliance|0
5070873|NCT02270983|17497312|P1|Overall Study|study procedure non-compliance|1
5070874|NCT02270983|17497310|P3|Overall Study|family emergency|0
5070875|NCT02270983|17497311|P2|Overall Study|family emergency|1
5070876|NCT02270983|17497312|P1|Overall Study|family emergency|0
5070877|NCT02270983|17497310|P3|Overall Study|Protocol Violation|1
5070878|NCT02270983|17497311|P2|Overall Study|Protocol Violation|1
5070879|NCT02270983|17497312|P1|Overall Study|Protocol Violation|1
5070880|NCT02270983|17497310|P3|Overall Study|Lost to Follow-up|2
5070881|NCT02270983|17497311|P2|Overall Study|Lost to Follow-up|1
5070882|NCT02270983|17497312|P1|Overall Study|Lost to Follow-up|1
5070883|NCT02270983|17497310|P3|Overall Study|Withdrawal by Subject|2
5070884|NCT02270983|17497311|P2|Overall Study|Withdrawal by Subject|0
5070885|NCT02270983|17497312|P1|Overall Study|Withdrawal by Subject|1
5070886|NCT02270983|17497310|P3|Overall Study|Lack of Efficacy|1
5070887|NCT02270983|17497311|P2|Overall Study|Lack of Efficacy|1
5070888|NCT02270983|17497312|P1|Overall Study|Lack of Efficacy|2
5070889|NCT02270983|17497310|P3|Overall Study|Adverse Event|6
5070890|NCT02270983|17497311|P2|Overall Study|Adverse Event|2
5070891|NCT02270983|17497312|P1|Overall Study|Adverse Event|3
5070892|NCT02270957|17497337|P2|Overall Study|Adverse Event|0
5070893|NCT02270957|17497338|P1|Overall Study|Adverse Event|2
5070894|NCT02270957|17497337|P2|Overall Study|Lack of Efficacy|4
5070895|NCT02270957|17497338|P1|Overall Study|Lack of Efficacy|2
5070896|NCT02270944|17497350|P2|Overall Study|Withdrawal by Subject|1
5070897|NCT02270944|17497351|P1|Overall Study|Withdrawal by Subject|2
5070898|NCT02270944|17497350|P2|Overall Study|Lost to Follow-up|4
5070899|NCT02270944|17497351|P1|Overall Study|Lost to Follow-up|9
5070900|NCT02270684|17497369|P2|Overall Study|Study terminated|0
5070901|NCT02270684|17497370|P1|Overall Study|Study terminated|1
5070902|NCT02270684|17497369|P2|Overall Study|Lost to Follow-up|3
5070903|NCT02270684|17497370|P1|Overall Study|Lost to Follow-up|0
5070904|NCT02270671|17497378|P2|Overall Study|Lost to Follow-up|1
5070905|NCT02270671|17497379|P1|Overall Study|Lost to Follow-up|2
5070906|NCT02270671|17497378|P2|Overall Study|Missed Post-intervention Data Collection|2
5070907|NCT02270671|17497379|P1|Overall Study|Missed Post-intervention Data Collection|2
5070908|NCT02270671|17497378|P2|Overall Study|Protocol Violation|1
5070909|NCT02270671|17497379|P1|Overall Study|Protocol Violation|0
5070910|NCT02270671|17497378|P2|Overall Study|Withdrawal by Subject|1
5070911|NCT02270671|17497379|P1|Overall Study|Withdrawal by Subject|1
5070912|NCT02270515|17497404|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
5070913|NCT02270515|17497404|P1|Intervention Period 3: 12-18 Months|Death|3
5070914|NCT02270515|17497404|P1|Intervention Period 3: 12-18 Months|Received transplant|2
5070915|NCT02270515|17497404|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
5070916|NCT02270515|17497404|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
5070917|NCT02270515|17497404|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
5070918|NCT02270515|17497404|P1|Intervention Period 2: 6-12 Months|Death|5
5070919|NCT02270515|17497404|P1|Intervention Period 2: 6-12 Months|Received transplant|1
5070920|NCT02270515|17497404|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
5070921|NCT02270515|17497404|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
5070922|NCT02270515|17497404|P1|Intervention Period 1: 0-6 Months|Death|7
5070923|NCT02270515|17497404|P1|Intervention Period 1: 0-6 Months|Received transplant|3
5070924|NCT02270515|17497404|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
5070925|NCT02270515|17497404|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
5070926|NCT02270242|17497432|P2|Overall Study|Physician Decision|1
5070927|NCT02270242|17497433|P1|Overall Study|Physician Decision|0
5070928|NCT02270242|17497432|P2|Overall Study|Lost to Follow-up|27
5070929|NCT02270242|17497433|P1|Overall Study|Lost to Follow-up|41
5070930|NCT02270242|17497432|P2|Overall Study|Withdrawal by Subject|25
5070931|NCT02270242|17497433|P1|Overall Study|Withdrawal by Subject|18
5070932|NCT02269943|17497474|P2|Follow-Up Survival Period|Alive|8
5070933|NCT02269943|17497475|P1|Follow-Up Survival Period|Alive|2
5070934|NCT02269943|17497474|P2|Follow-Up Survival Period|Lost to Follow-up|2
5070935|NCT02269943|17497475|P1|Follow-Up Survival Period|Lost to Follow-up|0
5070936|NCT02269943|17497474|P2|Follow-Up Survival Period|Death|16
5070937|NCT02269943|17497475|P1|Follow-Up Survival Period|Death|3
5070938|NCT02269943|17497474|P2|Treatment Period|Symptomatic Deterioration|2
5070939|NCT02269943|17497475|P1|Treatment Period|Symptomatic Deterioration|0
5070940|NCT02269943|17497474|P2|Treatment Period|Progressive Disease|17
5070941|NCT02269943|17497475|P1|Treatment Period|Progressive Disease|5
5070942|NCT02269943|17497474|P2|Treatment Period|Adverse Event|10
5070943|NCT02269943|17497475|P1|Treatment Period|Adverse Event|1
5070944|NCT02269943|17497474|P2|Treatment Period|Death|1
5070945|NCT02269943|17497475|P1|Treatment Period|Death|0
5070946|NCT02269917|17497505|P2|Overall Study|Randomized but not treated|5
5070947|NCT02269917|17497506|P1|Overall Study|Randomized but not treated|3
5070948|NCT02269917|17497505|P2|Overall Study|Non-compliance with study drug|0
5070949|NCT02269917|17497506|P1|Overall Study|Non-compliance with study drug|2
5070950|NCT02269917|17497505|P2|Overall Study|Adverse Event|4
5070951|NCT02269917|17497506|P1|Overall Study|Adverse Event|11
5070952|NCT02269917|17497505|P2|Overall Study|Withdrawal by Subject|8
5070953|NCT02269917|17497506|P1|Overall Study|Withdrawal by Subject|9
5070954|NCT02269917|17497505|P2|Overall Study|Other|3
5070955|NCT02269917|17497506|P1|Overall Study|Other|6
5070956|NCT02269917|17497505|P2|Overall Study|Ongoing|360
5070957|NCT02269917|17497506|P1|Overall Study|Ongoing|731
5070958|NCT02269917|17497505|P2|Overall Study|Lost to Follow-up|3
5070959|NCT02269917|17497506|P1|Overall Study|Lost to Follow-up|4
5070960|NCT02269787|17497559|P2|Overall Study|Incapacitated|1
5070961|NCT02269787|17497560|P1|Overall Study|Incapacitated|0
5070962|NCT02269787|17497559|P2|Overall Study|Death|3
5070963|NCT02269787|17497560|P1|Overall Study|Death|2
5070964|NCT02269787|17497559|P2|Overall Study|Lost to Follow-up|6
5070965|NCT02269787|17497560|P1|Overall Study|Lost to Follow-up|20
5070966|NCT02269709|17497566|P1|Six Month Follow-up|Lost to Follow-up|12
5070967|NCT02269709|17497566|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
5070968|NCT02269709|17497566|P1|Time of Enrollment|Withdrawal by Subject|3
5070969|NCT02269657|17497571|P1|Overall Study|Protocol Violation|3
5070970|NCT02269475|17497608|P2|Overall Study|Withdrawal by Subject|1
5070971|NCT02269475|17497609|P1|Overall Study|Withdrawal by Subject|0
5070972|NCT02269475|17497608|P2|Overall Study|Meet Exclusion Criteria No. 17|0
5070973|NCT02269475|17497609|P1|Overall Study|Meet Exclusion Criteria No. 17|3
5070974|NCT02269423|17497624|P4|Overall Study|Discontinued due to change in residence|1
5070975|NCT02269423|17497625|P3|Overall Study|Discontinued due to change in residence|0
5070976|NCT02269423|17497626|P2|Overall Study|Discontinued due to change in residence|1
5070977|NCT02269423|17497627|P1|Overall Study|Discontinued due to change in residence|0
5070978|NCT02269241|17497689|P1|Overall Study|Screening failures|546
5070979|NCT02269241|17497689|P1|Overall Study|Several reasons not classified|53
5070980|NCT02269241|17497689|P1|Overall Study|At the specific request of the sponsor|20
5070981|NCT02269241|17497689|P1|Overall Study|Adverse Event|113
5070982|NCT02269241|17497689|P1|Overall Study|Development of an exclusion criteria|16
5070983|NCT02269241|17497689|P1|Overall Study|Wish for pregnancy|5
5070984|NCT02269241|17497689|P1|Overall Study|Pregnancy|15
5070985|NCT02269241|17497689|P1|Overall Study|Physician Decision|7
5070986|NCT02269241|17497689|P1|Overall Study|Protocol Violation|1
5070987|NCT02269241|17497689|P1|Overall Study|Withdrawal by Subject|155
5070988|NCT02269241|17497689|P1|Overall Study|Lost to Follow-up|269
5070989|NCT02269098|17497703|P2|Overall Study|Lost to Follow-up|9
5070990|NCT02269098|17497704|P1|Overall Study|Lost to Follow-up|14
5070991|NCT02268864|17497765|P3|Overall Study|Death|0
5070992|NCT02268864|17497766|P2|Overall Study|Death|1
5070993|NCT02268864|17497767|P1|Overall Study|Death|0
5070994|NCT02268864|17497765|P3|Overall Study|Withdrawal by Subject|0
5070995|NCT02268864|17497766|P2|Overall Study|Withdrawal by Subject|0
5070996|NCT02268864|17497767|P1|Overall Study|Withdrawal by Subject|2
5070997|NCT02268851|17497795|P6|Overall Study|Co-Morbid Condition|1
5070998|NCT02268851|17497796|P5|Overall Study|Co-Morbid Condition|1
5070999|NCT02268851|17497797|P4|Overall Study|Co-Morbid Condition|0
5071000|NCT02268851|17497798|P3|Overall Study|Co-Morbid Condition|0
5071001|NCT02268851|17497799|P2|Overall Study|Co-Morbid Condition|0
5071002|NCT02268851|17497800|P1|Overall Study|Co-Morbid Condition|0
5071003|NCT02268851|17497795|P6|Overall Study|Patient Compliance|1
5071004|NCT02268851|17497796|P5|Overall Study|Patient Compliance|1
5071005|NCT02268851|17497797|P4|Overall Study|Patient Compliance|0
5071006|NCT02268851|17497798|P3|Overall Study|Patient Compliance|0
5071007|NCT02268851|17497799|P2|Overall Study|Patient Compliance|0
5071008|NCT02268851|17497800|P1|Overall Study|Patient Compliance|0
5071009|NCT02268851|17497795|P6|Overall Study|Physician Decision|1
5071010|NCT02268851|17497796|P5|Overall Study|Physician Decision|0
5071011|NCT02268851|17497797|P4|Overall Study|Physician Decision|0
5071012|NCT02268851|17497798|P3|Overall Study|Physician Decision|1
5071013|NCT02268851|17497799|P2|Overall Study|Physician Decision|0
5071014|NCT02268851|17497800|P1|Overall Study|Physician Decision|0
5071015|NCT02268851|17497795|P6|Overall Study|Progressive Disease|4
5071016|NCT02268851|17497796|P5|Overall Study|Progressive Disease|1
5071017|NCT02268851|17497797|P4|Overall Study|Progressive Disease|0
5071018|NCT02268851|17497798|P3|Overall Study|Progressive Disease|0
5071019|NCT02268851|17497799|P2|Overall Study|Progressive Disease|3
5071020|NCT02268851|17497800|P1|Overall Study|Progressive Disease|1
5071021|NCT02268851|17497795|P6|Overall Study|Withdrawal by Subject|1
5071022|NCT02268851|17497796|P5|Overall Study|Withdrawal by Subject|0
5071023|NCT02268851|17497797|P4|Overall Study|Withdrawal by Subject|2
5071024|NCT02268851|17497798|P3|Overall Study|Withdrawal by Subject|0
5071025|NCT02268851|17497799|P2|Overall Study|Withdrawal by Subject|0
5071026|NCT02268851|17497800|P1|Overall Study|Withdrawal by Subject|0
5071027|NCT02268851|17497795|P6|Overall Study|Adverse Event|2
5071028|NCT02268851|17497796|P5|Overall Study|Adverse Event|2
5071029|NCT02268851|17497797|P4|Overall Study|Adverse Event|0
5071030|NCT02268851|17497798|P3|Overall Study|Adverse Event|0
5071031|NCT02268851|17497799|P2|Overall Study|Adverse Event|0
5071032|NCT02268851|17497800|P1|Overall Study|Adverse Event|0
5071033|NCT02268851|17497795|P6|Overall Study|Death|1
5071034|NCT02268851|17497796|P5|Overall Study|Death|2
5071035|NCT02268851|17497797|P4|Overall Study|Death|1
5071036|NCT02268851|17497798|P3|Overall Study|Death|0
5071037|NCT02268851|17497799|P2|Overall Study|Death|0
5071038|NCT02268851|17497800|P1|Overall Study|Death|0
5071039|NCT02268812|17497818|P4|Overall Study|Other|3
5071040|NCT02268812|17497819|P3|Overall Study|Other|1
5071041|NCT02268812|17497820|P2|Overall Study|Other|4
5071042|NCT02268812|17497821|P1|Overall Study|Other|5
5071043|NCT02268812|17497818|P4|Overall Study|Physician Decision|1
5071044|NCT02268812|17497819|P3|Overall Study|Physician Decision|0
5071045|NCT02268812|17497820|P2|Overall Study|Physician Decision|1
5071046|NCT02268812|17497821|P1|Overall Study|Physician Decision|3
5071047|NCT02268812|17497818|P4|Overall Study|Withdrawal by Subject|0
5071048|NCT02268812|17497819|P3|Overall Study|Withdrawal by Subject|0
5071049|NCT02268812|17497820|P2|Overall Study|Withdrawal by Subject|1
5071050|NCT02268812|17497821|P1|Overall Study|Withdrawal by Subject|0
5071051|NCT02268812|17497818|P4|Overall Study|Protocol deviation|0
5071052|NCT02268812|17497819|P3|Overall Study|Protocol deviation|1
5071053|NCT02268812|17497820|P2|Overall Study|Protocol deviation|0
5071054|NCT02268812|17497821|P1|Overall Study|Protocol deviation|0
5071055|NCT02268812|17497818|P4|Overall Study|Adverse Event|10
5071056|NCT02268812|17497819|P3|Overall Study|Adverse Event|7
5071057|NCT02268812|17497820|P2|Overall Study|Adverse Event|26
5071058|NCT02268812|17497821|P1|Overall Study|Adverse Event|8
5071059|NCT02268786|17497853|P2|Overall Study|Protocol Violation|0
5071060|NCT02268786|17497854|P1|Overall Study|Protocol Violation|1
5071061|NCT02268786|17497853|P2|Overall Study|Thaw Failure|4
5071062|NCT02268786|17497854|P1|Overall Study|Thaw Failure|6
5071063|NCT02268786|17497853|P2|Overall Study|Withdrawal by Subject|14
5071064|NCT02268786|17497854|P1|Overall Study|Withdrawal by Subject|7
5071065|NCT02268786|17497853|P2|Overall Study|No Euploid Embryos available|0
5071066|NCT02268786|17497854|P1|Overall Study|No Euploid Embryos available|42
5071067|NCT02268526|17497863|P3|Overall Study|Subject/guardian decision|3
5071068|NCT02268526|17497864|P2|Overall Study|Subject/guardian decision|7
5071069|NCT02268526|17497865|P1|Overall Study|Subject/guardian decision|0
5071070|NCT02268526|17497863|P3|Overall Study|Physician Decision|1
5071071|NCT02268526|17497864|P2|Overall Study|Physician Decision|0
5071072|NCT02268526|17497865|P1|Overall Study|Physician Decision|0
5071073|NCT02268526|17497863|P3|Overall Study|protocol deviation|0
5071074|NCT02268526|17497864|P2|Overall Study|protocol deviation|1
5071075|NCT02268526|17497865|P1|Overall Study|protocol deviation|0
5071076|NCT02268526|17497863|P3|Overall Study|Death|0
5071077|NCT02268526|17497864|P2|Overall Study|Death|11
5071078|NCT02268526|17497865|P1|Overall Study|Death|1
5071079|NCT02268526|17497863|P3|Overall Study|Adverse Event|1
5071080|NCT02268526|17497864|P2|Overall Study|Adverse Event|2
5071081|NCT02268526|17497865|P1|Overall Study|Adverse Event|0
5071082|NCT02268396|17497886|P1|Overall Study|2 Subjects no Day 29 Assessment|2
5071083|NCT02268396|17497886|P1|Overall Study|Protocol-Specified Criteria|2
5071084|NCT02268396|17497886|P1|Overall Study|Lost to Follow-up|2
5071085|NCT02268396|17497886|P1|Overall Study|Withdrawal by Subject|1
5071086|NCT02268396|17497886|P1|Overall Study|Administrative|2
5071087|NCT02268396|17497886|P1|Overall Study|Adverse Event|3
5071088|NCT02268214|17497898|P3|Overall Study|Not entering long-term period|5
5071089|NCT02268214|17497899|P2|Overall Study|Not entering long-term period|3
5071090|NCT02268214|17497900|P1|Overall Study|Not entering long-term period|2
5071091|NCT02268214|17497898|P3|Overall Study|Other reasons|3
5071092|NCT02268214|17497899|P2|Overall Study|Other reasons|3
5071093|NCT02268214|17497900|P1|Overall Study|Other reasons|7
5071094|NCT02268214|17497898|P3|Overall Study|Poor/non-compliance|2
5071095|NCT02268214|17497899|P2|Overall Study|Poor/non-compliance|1
5071096|NCT02268214|17497900|P1|Overall Study|Poor/non-compliance|2
5071097|NCT02268214|17497898|P3|Overall Study|Subject request to discontinue treatment|6
5071098|NCT02268214|17497899|P2|Overall Study|Subject request to discontinue treatment|8
5071099|NCT02268214|17497900|P1|Overall Study|Subject request to discontinue treatment|10
5071100|NCT02268214|17497898|P3|Overall Study|Withdrawal by Subject|10
5071101|NCT02268214|17497899|P2|Overall Study|Withdrawal by Subject|5
5071102|NCT02268214|17497900|P1|Overall Study|Withdrawal by Subject|4
5071103|NCT02268214|17497898|P3|Overall Study|Adverse Event|9
5071104|NCT02268214|17497899|P2|Overall Study|Adverse Event|14
5071105|NCT02268214|17497900|P1|Overall Study|Adverse Event|11
5071106|NCT02268214|17497898|P3|Overall Study|Lack of Efficacy|2
5071107|NCT02268214|17497899|P2|Overall Study|Lack of Efficacy|0
5071108|NCT02268214|17497900|P1|Overall Study|Lack of Efficacy|1
5071109|NCT02268214|17497898|P3|Overall Study|Lost to Follow-up|4
5071110|NCT02268214|17497899|P2|Overall Study|Lost to Follow-up|3
5071111|NCT02268214|17497900|P1|Overall Study|Lost to Follow-up|3
5071112|NCT02268214|17497898|P3|Overall Study|Pregnancy|1
5071113|NCT02268214|17497899|P2|Overall Study|Pregnancy|2
5071114|NCT02268214|17497900|P1|Overall Study|Pregnancy|2
5071115|NCT02268214|17497898|P3|Overall Study|Subject no longer meets study criteria|0
5071116|NCT02268214|17497899|P2|Overall Study|Subject no longer meets study criteria|2
5071117|NCT02268214|17497900|P1|Overall Study|Subject no longer meets study criteria|0
5071118|NCT02268058|17497947|P4|Overall Study|Protocol Violation|0
5071119|NCT02268058|17497948|P3|Overall Study|Protocol Violation|0
5071120|NCT02268058|17497949|P2|Overall Study|Protocol Violation|0
5071121|NCT02268058|17497950|P1|Overall Study|Protocol Violation|1
5071122|NCT02268045|17497974|P2|Overall Study|Protocol Violation|1
5071123|NCT02268045|17497975|P1|Overall Study|Protocol Violation|1
5071124|NCT02268045|17497974|P2|Overall Study|Physician Decision|1
5071125|NCT02268045|17497975|P1|Overall Study|Physician Decision|0
5071126|NCT02268045|17497974|P2|Overall Study|Withdrawal by Subject|6
5071127|NCT02268045|17497975|P1|Overall Study|Withdrawal by Subject|2
5071128|NCT02268045|17497974|P2|Overall Study|Adverse Event|7
5071129|NCT02268045|17497975|P1|Overall Study|Adverse Event|7
5071130|NCT02268045|17497974|P2|Overall Study|Disease Progression|1
5071131|NCT02268045|17497975|P1|Overall Study|Disease Progression|2
5071132|NCT02268045|17497974|P2|Overall Study|Death|4
5071133|NCT02268045|17497975|P1|Overall Study|Death|4
5071134|NCT02267824|17498017|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
5071135|NCT02267824|17498018|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
5071136|NCT02267824|17498017|P2|Overall Study|Protocol Violation|0
5071137|NCT02267824|17498018|P1|Overall Study|Protocol Violation|3
5071138|NCT02267824|17498017|P2|Overall Study|Lost to Follow-up|0
5071139|NCT02267824|17498018|P1|Overall Study|Lost to Follow-up|4
5071140|NCT02267824|17498017|P2|Overall Study|Pregnancy|1
5071141|NCT02267824|17498018|P1|Overall Study|Pregnancy|1
5071142|NCT02267746|17498040|P3|Overall Study|Miscellaneous|1
5071143|NCT02267746|17498041|P2|Overall Study|Miscellaneous|0
5071144|NCT02267746|17498042|P1|Overall Study|Miscellaneous|1
5071145|NCT02267746|17498040|P3|Overall Study|Protocol Violation|1
5071146|NCT02267746|17498041|P2|Overall Study|Protocol Violation|2
5071147|NCT02267746|17498042|P1|Overall Study|Protocol Violation|1
5071148|NCT02267746|17498040|P3|Overall Study|Lack of Efficacy|15
5071149|NCT02267746|17498041|P2|Overall Study|Lack of Efficacy|11
5071150|NCT02267746|17498042|P1|Overall Study|Lack of Efficacy|11
5071151|NCT02267746|17498040|P3|Overall Study|Protocol Violation|3
5071152|NCT02267746|17498041|P2|Overall Study|Protocol Violation|7
5071153|NCT02267746|17498042|P1|Overall Study|Protocol Violation|8
5071154|NCT02267746|17498040|P3|Overall Study|Adverse Event|1
5071155|NCT02267746|17498041|P2|Overall Study|Adverse Event|2
5071156|NCT02267746|17498042|P1|Overall Study|Adverse Event|0
5071157|NCT02267317|17498152|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5071158|NCT02267317|17498153|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5071159|NCT02267317|17498154|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5071160|NCT02267317|17498155|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5071161|NCT02267317|17498156|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5071162|NCT02267317|17498157|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
5071163|NCT02267317|17498152|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5071164|NCT02267317|17498153|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5071165|NCT02267317|17498154|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5071166|NCT02267317|17498155|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5071167|NCT02267317|17498156|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5071168|NCT02267317|17498157|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
5071169|NCT02267278|17498207|P1|Overall Study|prescribed prohibited medication|1
5071170|NCT02267278|17498207|P1|Overall Study|Developed new cancer diagnoses|2
5071171|NCT02267278|17498207|P1|Overall Study|transformation to acute leukemia (AML)|1
5071172|NCT02267278|17498207|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
5071173|NCT02267187|17498231|P1|Overall Study|Screen fail|3
5071174|NCT02267187|17498231|P1|Overall Study|Physician Decision|2
5071175|NCT02267135|17498239|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
5071176|NCT02267135|17498240|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
5071177|NCT02267135|17498239|P2|Period 2 (Randomized Set)|Adverse Event|0
5071178|NCT02267135|17498240|P1|Period 2 (Randomized Set)|Adverse Event|2
5071179|NCT02267135|17498239|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
5071180|NCT02267135|17498240|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
5071181|NCT02267135|17498239|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
5071182|NCT02267135|17498240|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
5071183|NCT02267135|17498239|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
5071184|NCT02267135|17498240|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
5071185|NCT02266888|17498284|P4|Overall Study|Transfer of care|0
5071186|NCT02266888|17498285|P3|Overall Study|Transfer of care|1
5071187|NCT02266888|17498286|P2|Overall Study|Transfer of care|0
5071188|NCT02266888|17498287|P1|Overall Study|Transfer of care|0
5071189|NCT02266888|17498284|P4|Overall Study|Personnel unavailable at transplant|1
5071190|NCT02266888|17498285|P3|Overall Study|Personnel unavailable at transplant|0
5071191|NCT02266888|17498286|P2|Overall Study|Personnel unavailable at transplant|0
5071192|NCT02266888|17498287|P1|Overall Study|Personnel unavailable at transplant|0
5071193|NCT02266888|17498284|P4|Overall Study|Randomization Closed|0
5071194|NCT02266888|17498285|P3|Overall Study|Randomization Closed|4
5071195|NCT02266888|17498286|P2|Overall Study|Randomization Closed|0
5071196|NCT02266888|17498287|P1|Overall Study|Randomization Closed|0
5071197|NCT02266888|17498284|P4|Overall Study|No Longer Eligible|2
5071198|NCT02266888|17498285|P3|Overall Study|No Longer Eligible|0
5071199|NCT02266888|17498286|P2|Overall Study|No Longer Eligible|0
5071200|NCT02266888|17498287|P1|Overall Study|No Longer Eligible|0
5071201|NCT02266888|17498284|P4|Overall Study|Study Terminated|0
5071202|NCT02266888|17498285|P3|Overall Study|Study Terminated|0
5071203|NCT02266888|17498286|P2|Overall Study|Study Terminated|1
5071204|NCT02266888|17498287|P1|Overall Study|Study Terminated|5
5071205|NCT02266888|17498284|P4|Overall Study|Physician Decision|2
5071206|NCT02266888|17498285|P3|Overall Study|Physician Decision|2
5071207|NCT02266888|17498286|P2|Overall Study|Physician Decision|1
5071208|NCT02266888|17498287|P1|Overall Study|Physician Decision|0
5071209|NCT02266888|17498284|P4|Overall Study|Death|2
5071210|NCT02266888|17498285|P3|Overall Study|Death|4
5071211|NCT02266888|17498286|P2|Overall Study|Death|2
5071212|NCT02266888|17498287|P1|Overall Study|Death|2
5071213|NCT02266875|17498321|P2|Overall Study|Lost to Follow-up|0
5071214|NCT02266875|17498322|P1|Overall Study|Lost to Follow-up|2
5071215|NCT02266875|17498321|P2|Overall Study|Withdrawal by Subject|0
5071216|NCT02266875|17498322|P1|Overall Study|Withdrawal by Subject|9
5071217|NCT02266706|17498387|P9|Overall Study|Enrollment in another study|0
5071218|NCT02266706|17498388|P8|Overall Study|Enrollment in another study|0
5071219|NCT02266706|17498389|P7|Overall Study|Enrollment in another study|0
5071220|NCT02266706|17498390|P6|Overall Study|Enrollment in another study|0
5071221|NCT02266706|17498391|P5|Overall Study|Enrollment in another study|0
5071222|NCT02266706|17498392|P4|Overall Study|Enrollment in another study|1
5071223|NCT02266706|17498393|P3|Overall Study|Enrollment in another study|0
5071224|NCT02266706|17498394|P2|Overall Study|Enrollment in another study|0
5071225|NCT02266706|17498395|P1|Overall Study|Enrollment in another study|0
5071226|NCT02266706|17498387|P9|Overall Study|Screen failure|0
5071227|NCT02266706|17498388|P8|Overall Study|Screen failure|0
5071228|NCT02266706|17498389|P7|Overall Study|Screen failure|1
5071229|NCT02266706|17498390|P6|Overall Study|Screen failure|1
5071230|NCT02266706|17498391|P5|Overall Study|Screen failure|0
5071231|NCT02266706|17498392|P4|Overall Study|Screen failure|0
5071232|NCT02266706|17498393|P3|Overall Study|Screen failure|0
5071233|NCT02266706|17498394|P2|Overall Study|Screen failure|0
5071234|NCT02266706|17498395|P1|Overall Study|Screen failure|0
5071235|NCT02266706|17498387|P9|Overall Study|Withdrawal by Subject|0
5071236|NCT02266706|17498388|P8|Overall Study|Withdrawal by Subject|0
5071237|NCT02266706|17498389|P7|Overall Study|Withdrawal by Subject|0
5071238|NCT02266706|17498390|P6|Overall Study|Withdrawal by Subject|1
5071239|NCT02266706|17498391|P5|Overall Study|Withdrawal by Subject|0
5071240|NCT02266706|17498392|P4|Overall Study|Withdrawal by Subject|0
5071241|NCT02266706|17498393|P3|Overall Study|Withdrawal by Subject|1
5071242|NCT02266706|17498394|P2|Overall Study|Withdrawal by Subject|1
5071243|NCT02266706|17498395|P1|Overall Study|Withdrawal by Subject|0
5071244|NCT02266433|17498626|P2|Overall Study|Withdrawal by Subject|7
5071245|NCT02266433|17498627|P1|Overall Study|Withdrawal by Subject|5
5071246|NCT02266433|17498626|P2|Overall Study|Lost to Follow-up|46
5071247|NCT02266433|17498627|P1|Overall Study|Lost to Follow-up|54
5071248|NCT02266381|17498744|P3|Overall Study|Physician Decision|4
5071249|NCT02266381|17498745|P2|Overall Study|Physician Decision|5
5071250|NCT02266381|17498746|P1|Overall Study|Physician Decision|3
5071251|NCT02266225|17498796|P1|Overall Study|Withdrawal by Subject|13
5071252|NCT02266225|17498796|P1|Overall Study|Death|1
5071253|NCT02266225|17498796|P1|Overall Study|Lost to Follow-up|2
5071254|NCT02266147|17498821|P4|PART 2: Dose Expansion|Study Terminated by Sponsor|8
5071255|NCT02266147|17498822|P3|PART 2: Dose Expansion|Study Terminated by Sponsor|0
5071256|NCT02266147|17498823|P2|PART 2: Dose Expansion|Study Terminated by Sponsor|0
5071257|NCT02266147|17498824|P1|PART 2: Dose Expansion|Study Terminated by Sponsor|6
5071258|NCT02266147|17498821|P4|PART 2: Dose Expansion|Lack of Efficacy|1
5071259|NCT02266147|17498822|P3|PART 2: Dose Expansion|Lack of Efficacy|0
5071260|NCT02266147|17498823|P2|PART 2: Dose Expansion|Lack of Efficacy|0
5071261|NCT02266147|17498824|P1|PART 2: Dose Expansion|Lack of Efficacy|1
5071262|NCT02266147|17498821|P4|PART 1: Dose Escalation|Other|0
5071263|NCT02266147|17498822|P3|PART 1: Dose Escalation|Other|0
5071264|NCT02266147|17498823|P2|PART 1: Dose Escalation|Other|1
5071265|NCT02266147|17498824|P1|PART 1: Dose Escalation|Other|1
5071266|NCT02266147|17498821|P4|PART 1: Dose Escalation|Study Terminated by Sponsor|3
5071267|NCT02266147|17498822|P3|PART 1: Dose Escalation|Study Terminated by Sponsor|1
5071268|NCT02266147|17498823|P2|PART 1: Dose Escalation|Study Terminated by Sponsor|0
5071269|NCT02266147|17498824|P1|PART 1: Dose Escalation|Study Terminated by Sponsor|0
5071270|NCT02266147|17498821|P4|PART 1: Dose Escalation|Lack of Efficacy|1
5071271|NCT02266147|17498822|P3|PART 1: Dose Escalation|Lack of Efficacy|1
5071272|NCT02266147|17498823|P2|PART 1: Dose Escalation|Lack of Efficacy|2
5071273|NCT02266147|17498824|P1|PART 1: Dose Escalation|Lack of Efficacy|0
5071274|NCT02266147|17498821|P4|PART 1: Dose Escalation|Physician Decision|0
5071275|NCT02266147|17498822|P3|PART 1: Dose Escalation|Physician Decision|1
5071276|NCT02266147|17498823|P2|PART 1: Dose Escalation|Physician Decision|0
5071277|NCT02266147|17498824|P1|PART 1: Dose Escalation|Physician Decision|0
5071278|NCT02266004|17498867|P1|Overall Study|Physician Decision|1
5071279|NCT02266004|17498867|P1|Overall Study|unrelated adverse event|1
5071280|NCT02265952|17498905|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
5071281|NCT02265952|17498906|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
5071282|NCT02265952|17498905|P2|Open Label Extension (OLE) Period|Physician Decision|7
5071283|NCT02265952|17498906|P1|Open Label Extension (OLE) Period|Physician Decision|0
5071284|NCT02265796|17498949|P2|Overall Study|Withdrawal by Subject|1
5071285|NCT02265796|17498950|P1|Overall Study|Withdrawal by Subject|1
5071286|NCT02265796|17498949|P2|Overall Study|started on excluded medication|0
5071287|NCT02265796|17498950|P1|Overall Study|started on excluded medication|1
5071288|NCT02265796|17498949|P2|Overall Study|Death|0
5071289|NCT02265796|17498950|P1|Overall Study|Death|1
5071290|NCT02265744|17498969|P5|Overall Study|Pregnancy|0
5071291|NCT02265744|17498970|P4|Overall Study|Pregnancy|1
5071292|NCT02265744|17498971|P3|Overall Study|Pregnancy|1
5071293|NCT02265744|17498972|P2|Overall Study|Pregnancy|2
5071294|NCT02265744|17498973|P1|Overall Study|Pregnancy|1
5071295|NCT02265744|17498969|P5|Overall Study|Subject no longer meets study criteria|1
5071296|NCT02265744|17498970|P4|Overall Study|Subject no longer meets study criteria|0
5071297|NCT02265744|17498971|P3|Overall Study|Subject no longer meets study criteria|0
5071298|NCT02265744|17498972|P2|Overall Study|Subject no longer meets study criteria|0
5071299|NCT02265744|17498973|P1|Overall Study|Subject no longer meets study criteria|0
5071300|NCT02265744|17498969|P5|Overall Study|Administrative reason by sponsor|3
5071301|NCT02265744|17498970|P4|Overall Study|Administrative reason by sponsor|3
5071302|NCT02265744|17498971|P3|Overall Study|Administrative reason by sponsor|2
5071303|NCT02265744|17498972|P2|Overall Study|Administrative reason by sponsor|2
5071304|NCT02265744|17498973|P1|Overall Study|Administrative reason by sponsor|3
5071305|NCT02265744|17498969|P5|Overall Study|Reason not provided by Investigator|0
5071306|NCT02265744|17498970|P4|Overall Study|Reason not provided by Investigator|2
5071307|NCT02265744|17498971|P3|Overall Study|Reason not provided by Investigator|0
5071308|NCT02265744|17498972|P2|Overall Study|Reason not provided by Investigator|0
5071309|NCT02265744|17498973|P1|Overall Study|Reason not provided by Investigator|1
5071310|NCT02265744|17498969|P5|Overall Study|Lack of Efficacy|5
5071311|NCT02265744|17498970|P4|Overall Study|Lack of Efficacy|4
5071312|NCT02265744|17498971|P3|Overall Study|Lack of Efficacy|3
5071313|NCT02265744|17498972|P2|Overall Study|Lack of Efficacy|4
5071314|NCT02265744|17498973|P1|Overall Study|Lack of Efficacy|2
5071315|NCT02265744|17498969|P5|Overall Study|Adverse Event|2
5071316|NCT02265744|17498970|P4|Overall Study|Adverse Event|8
5071317|NCT02265744|17498971|P3|Overall Study|Adverse Event|9
5071318|NCT02265744|17498972|P2|Overall Study|Adverse Event|4
5071319|NCT02265744|17498973|P1|Overall Study|Adverse Event|8
5071320|NCT02265744|17498969|P5|Overall Study|Participant request to discontinue|0
5071321|NCT02265744|17498970|P4|Overall Study|Participant request to discontinue|0
5071322|NCT02265744|17498971|P3|Overall Study|Participant request to discontinue|2
5071323|NCT02265744|17498972|P2|Overall Study|Participant request to discontinue|2
5071324|NCT02265744|17498973|P1|Overall Study|Participant request to discontinue|2
5071325|NCT02265744|17498969|P5|Overall Study|Withdrawal by Subject|0
5071326|NCT02265744|17498970|P4|Overall Study|Withdrawal by Subject|2
5071327|NCT02265744|17498971|P3|Overall Study|Withdrawal by Subject|0
5071328|NCT02265744|17498972|P2|Overall Study|Withdrawal by Subject|0
5071329|NCT02265744|17498973|P1|Overall Study|Withdrawal by Subject|2
5071330|NCT02265744|17498969|P5|Overall Study|Death|0
5071331|NCT02265744|17498970|P4|Overall Study|Death|2
5071332|NCT02265744|17498971|P3|Overall Study|Death|0
5071333|NCT02265744|17498972|P2|Overall Study|Death|0
5071334|NCT02265744|17498973|P1|Overall Study|Death|0
5071335|NCT02265744|17498969|P5|Overall Study|Lost to Follow-up|0
5071336|NCT02265744|17498970|P4|Overall Study|Lost to Follow-up|1
5071337|NCT02265744|17498971|P3|Overall Study|Lost to Follow-up|0
5071338|NCT02265744|17498972|P2|Overall Study|Lost to Follow-up|0
5071339|NCT02265744|17498973|P1|Overall Study|Lost to Follow-up|0
5071340|NCT02265744|17498969|P5|Overall Study|Poor/Non-compliance|2
5071341|NCT02265744|17498970|P4|Overall Study|Poor/Non-compliance|0
5071342|NCT02265744|17498971|P3|Overall Study|Poor/Non-compliance|0
5071343|NCT02265744|17498972|P2|Overall Study|Poor/Non-compliance|1
5071344|NCT02265744|17498973|P1|Overall Study|Poor/Non-compliance|1
5071345|NCT02265705|17499152|P7|Follow-up Period|Withdrawal by Subject|1
5071346|NCT02265705|17499153|P6|Follow-up Period|Withdrawal by Subject|0
5071347|NCT02265705|17499154|P5|Follow-up Period|Withdrawal by Subject|0
5071348|NCT02265705|17499155|P4|Follow-up Period|Withdrawal by Subject|0
5071349|NCT02265705|17499156|P3|Follow-up Period|Withdrawal by Subject|0
5071350|NCT02265705|17499157|P2|Follow-up Period|Withdrawal by Subject|0
5071351|NCT02265705|17499158|P1|Follow-up Period|Withdrawal by Subject|0
5071352|NCT02265705|17499152|P7|Follow-up Period|Physician Decision|1
5071353|NCT02265705|17499153|P6|Follow-up Period|Physician Decision|0
5071354|NCT02265705|17499154|P5|Follow-up Period|Physician Decision|0
5071355|NCT02265705|17499155|P4|Follow-up Period|Physician Decision|0
5071356|NCT02265705|17499156|P3|Follow-up Period|Physician Decision|0
5071357|NCT02265705|17499157|P2|Follow-up Period|Physician Decision|0
5071358|NCT02265705|17499158|P1|Follow-up Period|Physician Decision|0
5071359|NCT02265705|17499152|P7|Follow-up Period|Adverse Event|3
5071360|NCT02265705|17499153|P6|Follow-up Period|Adverse Event|0
5071361|NCT02265705|17499154|P5|Follow-up Period|Adverse Event|0
5071362|NCT02265705|17499155|P4|Follow-up Period|Adverse Event|0
5071363|NCT02265705|17499156|P3|Follow-up Period|Adverse Event|0
5071364|NCT02265705|17499157|P2|Follow-up Period|Adverse Event|0
5071365|NCT02265705|17499158|P1|Follow-up Period|Adverse Event|0
5071366|NCT02265705|17499152|P7|Follow-up Period|Sponsor Decision|6
5071367|NCT02265705|17499153|P6|Follow-up Period|Sponsor Decision|1
5071368|NCT02265705|17499154|P5|Follow-up Period|Sponsor Decision|0
5071369|NCT02265705|17499155|P4|Follow-up Period|Sponsor Decision|0
5071370|NCT02265705|17499156|P3|Follow-up Period|Sponsor Decision|0
5071371|NCT02265705|17499157|P2|Follow-up Period|Sponsor Decision|0
5071372|NCT02265705|17499158|P1|Follow-up Period|Sponsor Decision|0
5071373|NCT02265705|17499152|P7|Open Label Period|Withdrawal by Subject|0
5071374|NCT02265705|17499153|P6|Open Label Period|Withdrawal by Subject|0
5071375|NCT02265705|17499154|P5|Open Label Period|Withdrawal by Subject|2
5071376|NCT02265705|17499155|P4|Open Label Period|Withdrawal by Subject|0
5071377|NCT02265705|17499156|P3|Open Label Period|Withdrawal by Subject|0
5071378|NCT02265705|17499157|P2|Open Label Period|Withdrawal by Subject|0
5071379|NCT02265705|17499158|P1|Open Label Period|Withdrawal by Subject|0
5071380|NCT02265705|17499152|P7|Open Label Period|Physician Decision|0
5071381|NCT02265705|17499153|P6|Open Label Period|Physician Decision|0
5071382|NCT02265705|17499154|P5|Open Label Period|Physician Decision|1
5071383|NCT02265705|17499155|P4|Open Label Period|Physician Decision|0
5071384|NCT02265705|17499156|P3|Open Label Period|Physician Decision|0
5071385|NCT02265705|17499157|P2|Open Label Period|Physician Decision|0
5071386|NCT02265705|17499158|P1|Open Label Period|Physician Decision|0
5071387|NCT02265705|17499152|P7|Open Label Period|Adverse Event|0
5071388|NCT02265705|17499153|P6|Open Label Period|Adverse Event|0
5071389|NCT02265705|17499154|P5|Open Label Period|Adverse Event|2
5071390|NCT02265705|17499155|P4|Open Label Period|Adverse Event|2
5071391|NCT02265705|17499156|P3|Open Label Period|Adverse Event|0
5071392|NCT02265705|17499157|P2|Open Label Period|Adverse Event|0
5071393|NCT02265705|17499158|P1|Open Label Period|Adverse Event|0
5071394|NCT02265705|17499152|P7|Rescue Period|Lack of Efficacy|0
5071395|NCT02265705|17499153|P6|Rescue Period|Lack of Efficacy|0
5071396|NCT02265705|17499154|P5|Rescue Period|Lack of Efficacy|0
5071397|NCT02265705|17499155|P4|Rescue Period|Lack of Efficacy|0
5071398|NCT02265705|17499156|P3|Rescue Period|Lack of Efficacy|1
5071399|NCT02265705|17499157|P2|Rescue Period|Lack of Efficacy|0
5071400|NCT02265705|17499158|P1|Rescue Period|Lack of Efficacy|0
5071401|NCT02265705|17499152|P7|Rescue Period|Death|0
5071402|NCT02265705|17499153|P6|Rescue Period|Death|0
5071403|NCT02265705|17499154|P5|Rescue Period|Death|0
5071404|NCT02265705|17499155|P4|Rescue Period|Death|0
5071405|NCT02265705|17499156|P3|Rescue Period|Death|1
5071406|NCT02265705|17499157|P2|Rescue Period|Death|0
5071407|NCT02265705|17499158|P1|Rescue Period|Death|0
5071408|NCT02265705|17499152|P7|Rescue Period|Withdrawal by Subject|0
5071409|NCT02265705|17499153|P6|Rescue Period|Withdrawal by Subject|0
5071410|NCT02265705|17499154|P5|Rescue Period|Withdrawal by Subject|0
5071411|NCT02265705|17499155|P4|Rescue Period|Withdrawal by Subject|0
5071412|NCT02265705|17499156|P3|Rescue Period|Withdrawal by Subject|1
5071413|NCT02265705|17499157|P2|Rescue Period|Withdrawal by Subject|0
5071414|NCT02265705|17499158|P1|Rescue Period|Withdrawal by Subject|0
5071415|NCT02265705|17499152|P7|Treatment Period Week 0-24|Lack of Efficacy|0
5071416|NCT02265705|17499153|P6|Treatment Period Week 0-24|Lack of Efficacy|0
5071417|NCT02265705|17499154|P5|Treatment Period Week 0-24|Lack of Efficacy|0
5071418|NCT02265705|17499155|P4|Treatment Period Week 0-24|Lack of Efficacy|0
5071419|NCT02265705|17499156|P3|Treatment Period Week 0-24|Lack of Efficacy|0
5071420|NCT02265705|17499157|P2|Treatment Period Week 0-24|Lack of Efficacy|1
5071421|NCT02265705|17499158|P1|Treatment Period Week 0-24|Lack of Efficacy|0
5071422|NCT02265705|17499152|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
5071423|NCT02265705|17499153|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
5071424|NCT02265705|17499154|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
5071425|NCT02265705|17499155|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
5071426|NCT02265705|17499156|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
5071427|NCT02265705|17499157|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
5071428|NCT02265705|17499158|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
5071429|NCT02265705|17499152|P7|Treatment Period Week 0-24|Physician Decision|0
5071430|NCT02265705|17499153|P6|Treatment Period Week 0-24|Physician Decision|0
5071431|NCT02265705|17499154|P5|Treatment Period Week 0-24|Physician Decision|0
5071432|NCT02265705|17499155|P4|Treatment Period Week 0-24|Physician Decision|0
5071433|NCT02265705|17499156|P3|Treatment Period Week 0-24|Physician Decision|0
5071434|NCT02265705|17499157|P2|Treatment Period Week 0-24|Physician Decision|0
5071435|NCT02265705|17499158|P1|Treatment Period Week 0-24|Physician Decision|1
5071436|NCT02265705|17499152|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
5071437|NCT02265705|17499153|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
5071438|NCT02265705|17499154|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
5071439|NCT02265705|17499155|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
5071440|NCT02265705|17499156|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
5071441|NCT02265705|17499157|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
5071442|NCT02265705|17499158|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
5071443|NCT02265705|17499152|P7|Treatment Period Week 0-24|Adverse Event|0
5071444|NCT02265705|17499153|P6|Treatment Period Week 0-24|Adverse Event|0
5071445|NCT02265705|17499154|P5|Treatment Period Week 0-24|Adverse Event|0
5071446|NCT02265705|17499155|P4|Treatment Period Week 0-24|Adverse Event|0
5071447|NCT02265705|17499156|P3|Treatment Period Week 0-24|Adverse Event|0
5071448|NCT02265705|17499157|P2|Treatment Period Week 0-24|Adverse Event|2
5071449|NCT02265705|17499158|P1|Treatment Period Week 0-24|Adverse Event|3
5071450|NCT02265510|17499197|P14|Overall Study|Study Terminated by Sponsor|2
5071451|NCT02265510|17499198|P13|Overall Study|Study Terminated by Sponsor|1
5071452|NCT02265510|17499199|P12|Overall Study|Study Terminated by Sponsor|4
5071453|NCT02265510|17499200|P11|Overall Study|Study Terminated by Sponsor|1
5071454|NCT02265510|17499201|P10|Overall Study|Study Terminated by Sponsor|2
5071455|NCT02265510|17499202|P9|Overall Study|Study Terminated by Sponsor|1
5071456|NCT02265510|17499203|P8|Overall Study|Study Terminated by Sponsor|1
5071457|NCT02265510|17499204|P7|Overall Study|Study Terminated by Sponsor|1
5071458|NCT02265510|17499205|P6|Overall Study|Study Terminated by Sponsor|1
5071459|NCT02265510|17499206|P5|Overall Study|Study Terminated by Sponsor|0
5071460|NCT02265510|17499207|P4|Overall Study|Study Terminated by Sponsor|0
5071461|NCT02265510|17499208|P3|Overall Study|Study Terminated by Sponsor|0
5071462|NCT02265510|17499209|P2|Overall Study|Study Terminated by Sponsor|0
5071463|NCT02265510|17499210|P1|Overall Study|Study Terminated by Sponsor|0
5071464|NCT02265510|17499197|P14|Overall Study|Other|0
5071465|NCT02265510|17499198|P13|Overall Study|Other|0
5071466|NCT02265510|17499199|P12|Overall Study|Other|0
5071467|NCT02265510|17499200|P11|Overall Study|Other|0
5071468|NCT02265510|17499201|P10|Overall Study|Other|0
5071469|NCT02265510|17499202|P9|Overall Study|Other|0
5071470|NCT02265510|17499203|P8|Overall Study|Other|0
5071471|NCT02265510|17499204|P7|Overall Study|Other|0
5071472|NCT02265510|17499205|P6|Overall Study|Other|0
5071473|NCT02265510|17499206|P5|Overall Study|Other|0
5071474|NCT02265510|17499207|P4|Overall Study|Other|0
5071475|NCT02265510|17499208|P3|Overall Study|Other|0
5071476|NCT02265510|17499209|P2|Overall Study|Other|1
5071477|NCT02265510|17499210|P1|Overall Study|Other|0
5071478|NCT02265510|17499197|P14|Overall Study|Lost to Follow-up|2
5071479|NCT02265510|17499198|P13|Overall Study|Lost to Follow-up|0
5071480|NCT02265510|17499199|P12|Overall Study|Lost to Follow-up|0
5071481|NCT02265510|17499200|P11|Overall Study|Lost to Follow-up|0
5071482|NCT02265510|17499201|P10|Overall Study|Lost to Follow-up|2
5071483|NCT02265510|17499202|P9|Overall Study|Lost to Follow-up|0
5071484|NCT02265510|17499203|P8|Overall Study|Lost to Follow-up|0
5071485|NCT02265510|17499204|P7|Overall Study|Lost to Follow-up|0
5071486|NCT02265510|17499205|P6|Overall Study|Lost to Follow-up|0
5071487|NCT02265510|17499206|P5|Overall Study|Lost to Follow-up|1
5071488|NCT02265510|17499207|P4|Overall Study|Lost to Follow-up|0
5071489|NCT02265510|17499208|P3|Overall Study|Lost to Follow-up|0
5071490|NCT02265510|17499209|P2|Overall Study|Lost to Follow-up|0
5071491|NCT02265510|17499210|P1|Overall Study|Lost to Follow-up|0
5071492|NCT02265510|17499197|P14|Overall Study|Death|6
5071493|NCT02265510|17499198|P13|Overall Study|Death|7
5071494|NCT02265510|17499199|P12|Overall Study|Death|12
5071495|NCT02265510|17499200|P11|Overall Study|Death|4
5071496|NCT02265510|17499201|P10|Overall Study|Death|3
5071497|NCT02265510|17499202|P9|Overall Study|Death|3
5071498|NCT02265510|17499203|P8|Overall Study|Death|1
5071499|NCT02265510|17499204|P7|Overall Study|Death|2
5071500|NCT02265510|17499205|P6|Overall Study|Death|3
5071501|NCT02265510|17499206|P5|Overall Study|Death|1
5071502|NCT02265510|17499207|P4|Overall Study|Death|2
5071503|NCT02265510|17499208|P3|Overall Study|Death|2
5071504|NCT02265510|17499209|P2|Overall Study|Death|0
5071505|NCT02265510|17499210|P1|Overall Study|Death|2
5071506|NCT02265510|17499197|P14|Overall Study|Disease Progression|0
5071507|NCT02265510|17499198|P13|Overall Study|Disease Progression|0
5071508|NCT02265510|17499199|P12|Overall Study|Disease Progression|0
5071509|NCT02265510|17499200|P11|Overall Study|Disease Progression|0
5071510|NCT02265510|17499201|P10|Overall Study|Disease Progression|0
5071511|NCT02265510|17499202|P9|Overall Study|Disease Progression|0
5071512|NCT02265510|17499203|P8|Overall Study|Disease Progression|0
5071513|NCT02265510|17499204|P7|Overall Study|Disease Progression|0
5071514|NCT02265510|17499205|P6|Overall Study|Disease Progression|0
5071515|NCT02265510|17499206|P5|Overall Study|Disease Progression|1
5071516|NCT02265510|17499207|P4|Overall Study|Disease Progression|1
5071517|NCT02265510|17499208|P3|Overall Study|Disease Progression|2
5071518|NCT02265510|17499209|P2|Overall Study|Disease Progression|1
5071519|NCT02265510|17499210|P1|Overall Study|Disease Progression|0
5071520|NCT02265510|17499197|P14|Overall Study|Withdrawal by Subject|0
5071521|NCT02265510|17499198|P13|Overall Study|Withdrawal by Subject|1
5071522|NCT02265510|17499199|P12|Overall Study|Withdrawal by Subject|0
5071523|NCT02265510|17499200|P11|Overall Study|Withdrawal by Subject|0
5071524|NCT02265510|17499201|P10|Overall Study|Withdrawal by Subject|0
5071525|NCT02265510|17499202|P9|Overall Study|Withdrawal by Subject|0
5071526|NCT02265510|17499203|P8|Overall Study|Withdrawal by Subject|2
5071527|NCT02265510|17499204|P7|Overall Study|Withdrawal by Subject|0
5071528|NCT02265510|17499205|P6|Overall Study|Withdrawal by Subject|2
5071529|NCT02265510|17499206|P5|Overall Study|Withdrawal by Subject|0
5071530|NCT02265510|17499207|P4|Overall Study|Withdrawal by Subject|1
5071531|NCT02265510|17499208|P3|Overall Study|Withdrawal by Subject|2
5071532|NCT02265510|17499209|P2|Overall Study|Withdrawal by Subject|1
5071533|NCT02265510|17499210|P1|Overall Study|Withdrawal by Subject|1
5071534|NCT02265237|17499310|P4|As Treated (Overall Study)|Other|1
5071535|NCT02265237|17499311|P3|As Treated (Overall Study)|Other|3
5071536|NCT02265237|17499312|P2|As Treated (Overall Study)|Other|0
5071537|NCT02265237|17499313|P1|As Treated (Overall Study)|Other|2
5071538|NCT02265237|17499310|P4|As Treated (Overall Study)|Lost to Follow-up|0
5071539|NCT02265237|17499311|P3|As Treated (Overall Study)|Lost to Follow-up|6
5071540|NCT02265237|17499312|P2|As Treated (Overall Study)|Lost to Follow-up|2
5071541|NCT02265237|17499313|P1|As Treated (Overall Study)|Lost to Follow-up|1
5071542|NCT02265237|17499310|P4|As Treated (Overall Study)|Withdrawal by Subject|0
5071543|NCT02265237|17499311|P3|As Treated (Overall Study)|Withdrawal by Subject|1
5071544|NCT02265237|17499312|P2|As Treated (Overall Study)|Withdrawal by Subject|0
5071545|NCT02265237|17499313|P1|As Treated (Overall Study)|Withdrawal by Subject|1
5071546|NCT02265237|17499310|P4|As Treated (Overall Study)|Adverse Event|0
5071547|NCT02265237|17499311|P3|As Treated (Overall Study)|Adverse Event|0
5071548|NCT02265237|17499312|P2|As Treated (Overall Study)|Adverse Event|1
5071549|NCT02265237|17499313|P1|As Treated (Overall Study)|Adverse Event|1
5071550|NCT02264821|17499343|P3|Overall Study|Protocol Violation|6
5071551|NCT02264821|17499344|P2|Overall Study|Protocol Violation|3
5071552|NCT02264821|17499345|P1|Overall Study|Protocol Violation|1
5071553|NCT02264574|17499358|P2|Overall Study|Other, Not Specified|3
5071554|NCT02264574|17499359|P1|Overall Study|Other, Not Specified|0
5071555|NCT02264574|17499358|P2|Overall Study|Withdrawal by Subject|6
5071556|NCT02264574|17499359|P1|Overall Study|Withdrawal by Subject|8
5071557|NCT02264574|17499358|P2|Overall Study|Death|21
5071558|NCT02264574|17499359|P1|Overall Study|Death|21
5071559|NCT02263547|17499455|P1|Overall Study|Lost to Follow-up|2
5071560|NCT02263547|17499455|P1|Overall Study|Adverse Event|1
5071561|NCT02263365|17499462|P2|Overall Study|Physician Decision|18
5071562|NCT02263365|17499463|P1|Overall Study|Physician Decision|22
5071563|NCT02263326|17499477|P2|Overall Study|Lost to Follow-up|1
5071564|NCT02263326|17499478|P1|Overall Study|Lost to Follow-up|1
5071565|NCT02263079|17499551|P3|Overall Study|Withdrawal by Subject|0
5071566|NCT02263079|17499552|P2|Overall Study|Withdrawal by Subject|8
5071567|NCT02263079|17499553|P1|Overall Study|Withdrawal by Subject|2
5071568|NCT02263079|17499551|P3|Overall Study|Physician Decision|0
5071569|NCT02263079|17499552|P2|Overall Study|Physician Decision|0
5071570|NCT02263079|17499553|P1|Overall Study|Physician Decision|1
5071571|NCT02262754|17499624|P3|Overall Study|Other|2
5071572|NCT02262754|17499625|P2|Overall Study|Other|0
5071573|NCT02262754|17499626|P1|Overall Study|Other|4
5071574|NCT02262754|17499624|P3|Overall Study|Withdrawal by Subject|1
5071575|NCT02262754|17499625|P2|Overall Study|Withdrawal by Subject|0
5071576|NCT02262754|17499626|P1|Overall Study|Withdrawal by Subject|1
5071577|NCT02262754|17499624|P3|Overall Study|Protocol Violation|0
5071578|NCT02262754|17499625|P2|Overall Study|Protocol Violation|0
5071579|NCT02262754|17499626|P1|Overall Study|Protocol Violation|1
5071580|NCT02262754|17499624|P3|Overall Study|Study terminated by sponsor|4
5071581|NCT02262754|17499625|P2|Overall Study|Study terminated by sponsor|4
5071582|NCT02262754|17499626|P1|Overall Study|Study terminated by sponsor|5
5071583|NCT02262754|17499624|P3|Overall Study|No longer meets eligibility criteria|0
5071584|NCT02262754|17499625|P2|Overall Study|No longer meets eligibility criteria|1
5071585|NCT02262754|17499626|P1|Overall Study|No longer meets eligibility criteria|0
5071586|NCT02262754|17499624|P3|Overall Study|Lost to Follow-up|1
5071587|NCT02262754|17499625|P2|Overall Study|Lost to Follow-up|0
5071588|NCT02262754|17499626|P1|Overall Study|Lost to Follow-up|0
5071589|NCT02262754|17499624|P3|Overall Study|Lack of Efficacy|1
5071590|NCT02262754|17499625|P2|Overall Study|Lack of Efficacy|0
5071591|NCT02262754|17499626|P1|Overall Study|Lack of Efficacy|2
5071592|NCT02262754|17499624|P3|Overall Study|Adverse Event|0
5071593|NCT02262754|17499625|P2|Overall Study|Adverse Event|4
5071594|NCT02262754|17499626|P1|Overall Study|Adverse Event|3
5071595|NCT02262728|17499701|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
5071596|NCT02262728|17499702|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
5071597|NCT02262728|17499701|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
5071598|NCT02262728|17499702|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
5071599|NCT02262728|17499701|P2|Follow-up Phase (3 Years)|Death|1
5071600|NCT02262728|17499702|P1|Follow-up Phase (3 Years)|Death|0
5071601|NCT02262377|17499734|P2|Overall Study|Withdrawal by Subject|0
5071602|NCT02262377|17499735|P1|Overall Study|Withdrawal by Subject|4
5071603|NCT02262377|17499734|P2|Overall Study|Found ineligible after enrollment|0
5071604|NCT02262377|17499735|P1|Overall Study|Found ineligible after enrollment|3
5071605|NCT02262377|17499734|P2|Overall Study|Lost to Follow-up|6
5071606|NCT02262377|17499735|P1|Overall Study|Lost to Follow-up|5
5071607|NCT02262364|17499750|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
5071608|NCT02262260|17499759|P2|Overall Study|Protocol deviation|5
5071609|NCT02262260|17499760|P1|Overall Study|Protocol deviation|2
5071610|NCT02262260|17499759|P2|Overall Study|Lost to Follow-up|2
5071611|NCT02262260|17499760|P1|Overall Study|Lost to Follow-up|1
5071612|NCT02262260|17499759|P2|Overall Study|Withdrawal of consent|2
5071613|NCT02262260|17499760|P1|Overall Study|Withdrawal of consent|4
5071614|NCT02262260|17499759|P2|Overall Study|Adverse Event|1
5071615|NCT02262260|17499760|P1|Overall Study|Adverse Event|4
5071616|NCT02261974|17499818|P2|Overall Study|Adverse Event|0
5071617|NCT02261974|17499819|P1|Overall Study|Adverse Event|1
5071618|NCT02261974|17499818|P2|Overall Study|Lost to Follow-up|0
5071619|NCT02261974|17499819|P1|Overall Study|Lost to Follow-up|2
5071620|NCT02261974|17499818|P2|Overall Study|Received partial treatment; FU to 1 mo|1
5071621|NCT02261974|17499819|P1|Overall Study|Received partial treatment; FU to 1 mo|3
5071622|NCT02261974|17499818|P2|Overall Study|Missed treatment cut-off date|3
5071623|NCT02261974|17499819|P1|Overall Study|Missed treatment cut-off date|6
5071624|NCT02261974|17499818|P2|Overall Study|Pregnancy|1
5071625|NCT02261974|17499819|P1|Overall Study|Pregnancy|0
5071626|NCT02261974|17499818|P2|Overall Study|Withdrawal by Subject|2
5071627|NCT02261974|17499819|P1|Overall Study|Withdrawal by Subject|3
5071628|NCT02261493|17499883|P3|Overall Study|Adverse Event|0
5071629|NCT02261493|17499884|P2|Overall Study|Adverse Event|1
5071630|NCT02261493|17499885|P1|Overall Study|Adverse Event|0
5071631|NCT02261493|17499883|P3|Overall Study|Lack of Efficacy|0
5071632|NCT02261493|17499884|P2|Overall Study|Lack of Efficacy|1
5071633|NCT02261493|17499885|P1|Overall Study|Lack of Efficacy|0
5071634|NCT02261493|17499883|P3|Overall Study|Pregnancy|0
5071635|NCT02261493|17499884|P2|Overall Study|Pregnancy|2
5071636|NCT02261493|17499885|P1|Overall Study|Pregnancy|1
5071637|NCT02261493|17499883|P3|Overall Study|Lost to Follow-up|8
5071638|NCT02261493|17499884|P2|Overall Study|Lost to Follow-up|27
5071639|NCT02261493|17499885|P1|Overall Study|Lost to Follow-up|14
5071640|NCT02261493|17499883|P3|Overall Study|Personal Reasons|16
5071641|NCT02261493|17499884|P2|Overall Study|Personal Reasons|14
5071642|NCT02261493|17499885|P1|Overall Study|Personal Reasons|14
5071643|NCT02261493|17499883|P3|Overall Study|Protocol Violation|0
5071644|NCT02261493|17499884|P2|Overall Study|Protocol Violation|0
5071645|NCT02261493|17499885|P1|Overall Study|Protocol Violation|1
5071646|NCT02261493|17499883|P3|Overall Study|Undisclosed alcohol abuse|0
5071647|NCT02261493|17499884|P2|Overall Study|Undisclosed alcohol abuse|1
5071648|NCT02261493|17499885|P1|Overall Study|Undisclosed alcohol abuse|0
5071649|NCT02261493|17499883|P3|Overall Study|Physician Decision|0
5071650|NCT02261493|17499884|P2|Overall Study|Physician Decision|1
5071651|NCT02261493|17499885|P1|Overall Study|Physician Decision|0
5071652|NCT02261493|17499883|P3|Overall Study|Noncompliance|2
5071653|NCT02261493|17499884|P2|Overall Study|Noncompliance|0
5071654|NCT02261493|17499885|P1|Overall Study|Noncompliance|0
5071655|NCT02261467|17499913|P2|Overall Study|Adverse Event|1
5071656|NCT02261467|17499914|P1|Overall Study|Adverse Event|1
5071657|NCT02261467|17499913|P2|Overall Study|Lost to Follow-up|13
5071658|NCT02261467|17499914|P1|Overall Study|Lost to Follow-up|2
5071659|NCT02261467|17499913|P2|Overall Study|Personal Reasons|22
5071660|NCT02261467|17499914|P1|Overall Study|Personal Reasons|17
5071661|NCT02261467|17499913|P2|Overall Study|Protocol Violation|1
5071662|NCT02261467|17499914|P1|Overall Study|Protocol Violation|0
5071663|NCT02261467|17499913|P2|Overall Study|Enrolled in Error|0
5071664|NCT02261467|17499914|P1|Overall Study|Enrolled in Error|1
5071665|NCT02260986|17499956|P3|Overall Study|Pregnancy|0
5071666|NCT02260986|17499957|P2|Overall Study|Pregnancy|0
5071667|NCT02260986|17499958|P1|Overall Study|Pregnancy|2
5071668|NCT02260986|17499956|P3|Overall Study|Lost to Follow-up|3
5071669|NCT02260986|17499957|P2|Overall Study|Lost to Follow-up|0
5071670|NCT02260986|17499958|P1|Overall Study|Lost to Follow-up|4
5071671|NCT02260986|17499956|P3|Overall Study|Lack of investigation product supply|1
5071672|NCT02260986|17499957|P2|Overall Study|Lack of investigation product supply|0
5071673|NCT02260986|17499958|P1|Overall Study|Lack of investigation product supply|2
5071674|NCT02260986|17499956|P3|Overall Study|Incorrect randomization|0
5071675|NCT02260986|17499957|P2|Overall Study|Incorrect randomization|1
5071676|NCT02260986|17499958|P1|Overall Study|Incorrect randomization|0
5071677|NCT02260986|17499956|P3|Overall Study|Withdrawal by Subject|9
5071678|NCT02260986|17499957|P2|Overall Study|Withdrawal by Subject|4
5071679|NCT02260986|17499958|P1|Overall Study|Withdrawal by Subject|17
5071680|NCT02260986|17499956|P3|Overall Study|Car accident|1
5071681|NCT02260986|17499957|P2|Overall Study|Car accident|0
5071682|NCT02260986|17499958|P1|Overall Study|Car accident|0
5071683|NCT02260986|17499956|P3|Overall Study|Protocol Violation|16
5071684|NCT02260986|17499957|P2|Overall Study|Protocol Violation|5
5071685|NCT02260986|17499958|P1|Overall Study|Protocol Violation|14
5071686|NCT02260986|17499956|P3|Overall Study|Lack of Efficacy|0
5071687|NCT02260986|17499957|P2|Overall Study|Lack of Efficacy|3
5071688|NCT02260986|17499958|P1|Overall Study|Lack of Efficacy|27
5071689|NCT02260986|17499956|P3|Overall Study|Adverse Event|11
5071690|NCT02260986|17499957|P2|Overall Study|Adverse Event|0
5071691|NCT02260986|17499958|P1|Overall Study|Adverse Event|24
5071692|NCT02260934|17500076|P2|Overall Study|Site error|1
5071693|NCT02260934|17500077|P1|Overall Study|Site error|0
5071694|NCT02260934|17500076|P2|Overall Study|Participant Relocated|0
5071695|NCT02260934|17500077|P1|Overall Study|Participant Relocated|1
5071696|NCT02260934|17500076|P2|Overall Study|Withdrawal by Subject|2
5071697|NCT02260934|17500077|P1|Overall Study|Withdrawal by Subject|0
5071698|NCT02260934|17500076|P2|Overall Study|Lost to Follow-up|1
5071699|NCT02260934|17500077|P1|Overall Study|Lost to Follow-up|2
5071700|NCT02260882|17500115|P2|Overall Study|Protocol Violation|1
5071701|NCT02260882|17500116|P1|Overall Study|Protocol Violation|0
5071702|NCT02260817|17500140|P2|Overall Study|Protocol Violation|14
5071703|NCT02260817|17500141|P1|Overall Study|Protocol Violation|0
5071704|NCT02260817|17500140|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
5071705|NCT02260817|17500141|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
5071706|NCT02260817|17500140|P2|Overall Study|Observation, no biopsy|1
5071707|NCT02260817|17500141|P1|Overall Study|Observation, no biopsy|0
5071708|NCT02260817|17500140|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
5071709|NCT02260817|17500141|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
5071710|NCT02260817|17500140|P2|Overall Study|Lost to Follow-up|14
5071711|NCT02260817|17500141|P1|Overall Study|Lost to Follow-up|0
5071712|NCT02260791|17500189|P2|Overall Study|Protocol deviation|3
5071713|NCT02260791|17500190|P1|Overall Study|Protocol deviation|2
5071714|NCT02260791|17500189|P2|Overall Study|Screen failure|1
5071715|NCT02260791|17500190|P1|Overall Study|Screen failure|0
5071716|NCT02260791|17500189|P2|Overall Study|Withdrawal by Subject|16
5071717|NCT02260791|17500190|P1|Overall Study|Withdrawal by Subject|11
5071718|NCT02260791|17500189|P2|Overall Study|Death|0
5071719|NCT02260791|17500190|P1|Overall Study|Death|1
5071720|NCT02260791|17500189|P2|Overall Study|Adverse Event|9
5071721|NCT02260791|17500190|P1|Overall Study|Adverse Event|13
5071722|NCT02260791|17500189|P2|Overall Study|Lack of Efficacy|1
5071723|NCT02260791|17500190|P1|Overall Study|Lack of Efficacy|2
5071724|NCT02260791|17500189|P2|Overall Study|Lost to Follow-up|4
5071725|NCT02260791|17500190|P1|Overall Study|Lost to Follow-up|4
5071726|NCT02260648|17500229|P3|Overall Study|Discontinue Due to Study Termination|7
5071727|NCT02260648|17500230|P2|Overall Study|Discontinue Due to Study Termination|12
5071728|NCT02260648|17500231|P1|Overall Study|Discontinue Due to Study Termination|13
5071729|NCT02260648|17500229|P3|Overall Study|Protocol Violation|0
5071730|NCT02260648|17500230|P2|Overall Study|Protocol Violation|0
5071731|NCT02260648|17500231|P1|Overall Study|Protocol Violation|1
5071732|NCT02260648|17500229|P3|Overall Study|Withdrawal by Subject|0
5071733|NCT02260648|17500230|P2|Overall Study|Withdrawal by Subject|1
5071734|NCT02260648|17500231|P1|Overall Study|Withdrawal by Subject|1
5071735|NCT02260648|17500229|P3|Overall Study|Adverse Event|1
5071736|NCT02260648|17500230|P2|Overall Study|Adverse Event|0
5071737|NCT02260648|17500231|P1|Overall Study|Adverse Event|3
5071738|NCT02260635|17500259|P2|Open-Label Extension|Withdrawal by Subject|0
5071739|NCT02260635|17500260|P1|Open-Label Extension|Withdrawal by Subject|1
5071740|NCT02260635|17500259|P2|Open-Label Extension|Study Termination|25
5071741|NCT02260635|17500260|P1|Open-Label Extension|Study Termination|25
5071742|NCT02260635|17500259|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
5071743|NCT02260635|17500260|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
5071744|NCT02260492|17500312|P3|Overall Study|Withdrawal by Subject|2
5071745|NCT02260492|17500313|P2|Overall Study|Withdrawal by Subject|2
5071746|NCT02260492|17500314|P1|Overall Study|Withdrawal by Subject|3
5071747|NCT02260492|17500312|P3|Overall Study|Physician Decision|1
5071748|NCT02260492|17500313|P2|Overall Study|Physician Decision|0
5071749|NCT02260492|17500314|P1|Overall Study|Physician Decision|2
5071750|NCT02260492|17500312|P3|Overall Study|Lost to Follow-up|0
5071751|NCT02260492|17500313|P2|Overall Study|Lost to Follow-up|9
5071752|NCT02260492|17500314|P1|Overall Study|Lost to Follow-up|12
5071753|NCT02260492|17500312|P3|Overall Study|Death|0
5071754|NCT02260492|17500313|P2|Overall Study|Death|1
5071755|NCT02260492|17500314|P1|Overall Study|Death|0
5071756|NCT02260492|17500312|P3|Overall Study|Adverse Event|2
5071757|NCT02260492|17500313|P2|Overall Study|Adverse Event|1
5071758|NCT02260492|17500314|P1|Overall Study|Adverse Event|6
5071759|NCT02260388|17500347|P4|Overall Study|Lost to Follow-up|4
5071760|NCT02260388|17500348|P3|Overall Study|Lost to Follow-up|3
5071761|NCT02260388|17500349|P2|Overall Study|Lost to Follow-up|8
5071762|NCT02260388|17500350|P1|Overall Study|Lost to Follow-up|2
5071763|NCT02260180|17500379|P3|Overall Study|Adverse Event|1
5071764|NCT02260180|17500380|P2|Overall Study|Adverse Event|0
5071765|NCT02260180|17500381|P1|Overall Study|Adverse Event|2
5071766|NCT02260154|17500392|P1|Overall Study|Screening failure|2
5071767|NCT02259582|17500432|P3|Overall Study|Lack of Subject Adherence to Protocol|1
5071768|NCT02259582|17500433|P2|Overall Study|Lack of Subject Adherence to Protocol|1
5071769|NCT02259582|17500434|P1|Overall Study|Lack of Subject Adherence to Protocol|1
5071770|NCT02259582|17500432|P3|Overall Study|Disease progression|17
5071771|NCT02259582|17500433|P2|Overall Study|Disease progression|15
5071772|NCT02259582|17500434|P1|Overall Study|Disease progression|14
5071773|NCT02259582|17500432|P3|Overall Study|Withdrawal by Subject|1
5071774|NCT02259582|17500433|P2|Overall Study|Withdrawal by Subject|0
5071775|NCT02259582|17500434|P1|Overall Study|Withdrawal by Subject|0
5071776|NCT02259582|17500432|P3|Overall Study|Adverse Event|1
5071777|NCT02259582|17500433|P2|Overall Study|Adverse Event|0
5071778|NCT02259582|17500434|P1|Overall Study|Adverse Event|1
5071779|NCT02259582|17500432|P3|Overall Study|Death|1
5071780|NCT02259582|17500433|P2|Overall Study|Death|0
5071781|NCT02259582|17500434|P1|Overall Study|Death|0
5071782|NCT02259582|17500432|P3|Overall Study|Physician Decision|0
5071783|NCT02259582|17500433|P2|Overall Study|Physician Decision|1
5071784|NCT02259582|17500434|P1|Overall Study|Physician Decision|0
5071785|NCT02259400|17500444|P2|Overall Study|Death|2
5071786|NCT02259400|17500445|P1|Overall Study|Death|0
5071787|NCT02259348|17500477|P1|Overall Study|Death|4
5071788|NCT02259348|17500477|P1|Overall Study|Donors|6
5071789|NCT02259114|17500494|P5|Overall Study|Not Treated|0
5071790|NCT02259114|17500495|P4|Overall Study|Not Treated|0
5071791|NCT02259114|17500496|P3|Overall Study|Not Treated|0
5071792|NCT02259114|17500497|P2|Overall Study|Not Treated|0
5071793|NCT02259114|17500498|P1|Overall Study|Not Treated|1
5071794|NCT02259114|17500494|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
5071795|NCT02259114|17500495|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
5071796|NCT02259114|17500496|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
5071797|NCT02259114|17500497|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
5071798|NCT02259114|17500498|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
5071799|NCT02259114|17500494|P5|Overall Study|Withdrawal by Subject|0
5071800|NCT02259114|17500495|P4|Overall Study|Withdrawal by Subject|1
5071801|NCT02259114|17500496|P3|Overall Study|Withdrawal by Subject|1
5071802|NCT02259114|17500497|P2|Overall Study|Withdrawal by Subject|0
5071803|NCT02259114|17500498|P1|Overall Study|Withdrawal by Subject|0
5071804|NCT02259114|17500494|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5071805|NCT02259114|17500495|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5071806|NCT02259114|17500496|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
5071807|NCT02259114|17500497|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5071808|NCT02259114|17500498|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5071809|NCT02259114|17500494|P5|Overall Study|Death|0
5071810|NCT02259114|17500495|P4|Overall Study|Death|0
5071811|NCT02259114|17500496|P3|Overall Study|Death|1
5071812|NCT02259114|17500497|P2|Overall Study|Death|0
5071813|NCT02259114|17500498|P1|Overall Study|Death|3
5071814|NCT02259114|17500494|P5|Overall Study|Adverse Event|1
5071815|NCT02259114|17500495|P4|Overall Study|Adverse Event|0
5071816|NCT02259114|17500496|P3|Overall Study|Adverse Event|0
5071817|NCT02259114|17500497|P2|Overall Study|Adverse Event|1
5071818|NCT02259114|17500498|P1|Overall Study|Adverse Event|2
5071819|NCT02259114|17500494|P5|Overall Study|Progressive Disease|5
5071820|NCT02259114|17500495|P4|Overall Study|Progressive Disease|2
5071821|NCT02259114|17500496|P3|Overall Study|Progressive Disease|10
5071822|NCT02259114|17500497|P2|Overall Study|Progressive Disease|2
5071823|NCT02259114|17500498|P1|Overall Study|Progressive Disease|14
5071824|NCT02259088|17500557|P2|Overall Study|Subject/guardian decision|8
5071825|NCT02259088|17500558|P1|Overall Study|Subject/guardian decision|8
5071826|NCT02259088|17500557|P2|Overall Study|Protocol deviation|0
5071827|NCT02259088|17500558|P1|Overall Study|Protocol deviation|5
5071828|NCT02259088|17500557|P2|Overall Study|Physician Decision|2
5071829|NCT02259088|17500558|P1|Overall Study|Physician Decision|5
5071830|NCT02259088|17500557|P2|Overall Study|Death|0
5071831|NCT02259088|17500558|P1|Overall Study|Death|2
5071832|NCT02259088|17500557|P2|Overall Study|Lost to Follow-up|0
5071833|NCT02259088|17500558|P1|Overall Study|Lost to Follow-up|2
5071834|NCT02259088|17500557|P2|Overall Study|Adverse Event|4
5071835|NCT02259088|17500558|P1|Overall Study|Adverse Event|6
5071836|NCT02259010|17500603|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
5071837|NCT02258542|17500632|P4|Overall Study|Eligibility criteria not fulfilled|0
5071838|NCT02258542|17500633|P3|Overall Study|Eligibility criteria not fulfilled|0
5071839|NCT02258542|17500634|P2|Overall Study|Eligibility criteria not fulfilled|2
5071840|NCT02258542|17500635|P1|Overall Study|Eligibility criteria not fulfilled|0
5071841|NCT02258542|17500632|P4|Overall Study|Protocol Violation|0
5071842|NCT02258542|17500633|P3|Overall Study|Protocol Violation|0
5071843|NCT02258542|17500634|P2|Overall Study|Protocol Violation|2
5071844|NCT02258542|17500635|P1|Overall Study|Protocol Violation|1
5071845|NCT02258542|17500632|P4|Overall Study|Adverse Event|0
5071846|NCT02258542|17500633|P3|Overall Study|Adverse Event|0
5071847|NCT02258542|17500634|P2|Overall Study|Adverse Event|4
5071848|NCT02258542|17500635|P1|Overall Study|Adverse Event|3
5071849|NCT02258542|17500632|P4|Overall Study|Death|1
5071850|NCT02258542|17500633|P3|Overall Study|Death|0
5071851|NCT02258542|17500634|P2|Overall Study|Death|4
5071852|NCT02258542|17500635|P1|Overall Study|Death|5
5071853|NCT02258542|17500632|P4|Overall Study|Lost to Follow-up|2
5071854|NCT02258542|17500633|P3|Overall Study|Lost to Follow-up|1
5071855|NCT02258542|17500634|P2|Overall Study|Lost to Follow-up|12
5071856|NCT02258542|17500635|P1|Overall Study|Lost to Follow-up|5
5071857|NCT02258542|17500632|P4|Overall Study|Withdrawal by Subject|1
5071858|NCT02258542|17500633|P3|Overall Study|Withdrawal by Subject|7
5071859|NCT02258542|17500634|P2|Overall Study|Withdrawal by Subject|20
5071860|NCT02258542|17500635|P1|Overall Study|Withdrawal by Subject|20
5071861|NCT02258542|17500632|P4|Overall Study|study specific discount. criteria|0
5071862|NCT02258542|17500633|P3|Overall Study|study specific discount. criteria|0
5071863|NCT02258542|17500634|P2|Overall Study|study specific discount. criteria|1
5071864|NCT02258542|17500635|P1|Overall Study|study specific discount. criteria|1
5071865|NCT02258542|17500632|P4|Overall Study|eg. not made to the visit|1
5071866|NCT02258542|17500633|P3|Overall Study|eg. not made to the visit|0
5071867|NCT02258542|17500634|P2|Overall Study|eg. not made to the visit|4
5071868|NCT02258542|17500635|P1|Overall Study|eg. not made to the visit|7
5071869|NCT02258529|17500859|P1|Overall Study|Adverse Event|1
5071870|NCT02258529|17500859|P1|Overall Study|Study Terminated by Sponsor|9
5071871|NCT02258464|17500891|P2|Overall Study|AE related to clinical PD|0
5071872|NCT02258464|17500892|P1|Overall Study|AE related to clinical PD|1
5071873|NCT02258464|17500891|P2|Overall Study|Withdrawal by Subject|4
5071874|NCT02258464|17500892|P1|Overall Study|Withdrawal by Subject|5
5071875|NCT02258464|17500891|P2|Overall Study|AE not related to clinical PD|3
5071876|NCT02258464|17500892|P1|Overall Study|AE not related to clinical PD|1
5071877|NCT02258464|17500891|P2|Overall Study|Study drug never administered|1
5071878|NCT02258464|17500892|P1|Overall Study|Study drug never administered|1
5071879|NCT02258464|17500891|P2|Overall Study|Progressive disease (PD)|17
5071880|NCT02258464|17500892|P1|Overall Study|Progressive disease (PD)|9
5071881|NCT02258334|17500973|P4|Overall Study|Adverse Event|0
5071882|NCT02258334|17500974|P3|Overall Study|Adverse Event|0
5071883|NCT02258334|17500975|P2|Overall Study|Adverse Event|0
5071884|NCT02258334|17500976|P1|Overall Study|Adverse Event|1
5071885|NCT02257918|17501068|P3|Overall Study|Pregnancy|1
5071886|NCT02257918|17501069|P2|Overall Study|Pregnancy|0
5071887|NCT02257918|17501070|P1|Overall Study|Pregnancy|0
5071888|NCT02257918|17501068|P3|Overall Study|Withdrawal by Subject|1
5071889|NCT02257918|17501069|P2|Overall Study|Withdrawal by Subject|0
5071890|NCT02257918|17501070|P1|Overall Study|Withdrawal by Subject|0
5071891|NCT02257918|17501068|P3|Overall Study|Lost to Follow-up|0
5071892|NCT02257918|17501069|P2|Overall Study|Lost to Follow-up|1
5071893|NCT02257918|17501070|P1|Overall Study|Lost to Follow-up|4
5071894|NCT02257684|17501120|P1|Overall Study|Sponsor's Decision|1
5071895|NCT02257684|17501120|P1|Overall Study|Lack of Efficacy|1
5071896|NCT02257684|17501120|P1|Overall Study|Adverse Event|2
5071897|NCT02257632|17501130|P2|Overall Study|Adverse Event|2
5071898|NCT02257632|17501131|P1|Overall Study|Adverse Event|1
5071899|NCT02257632|17501130|P2|Overall Study|Withdrawal by Subject|1
5071900|NCT02257632|17501131|P1|Overall Study|Withdrawal by Subject|0
5071901|NCT02257528|17501171|P1|Overall Study|Never received study treatment|1
5071902|NCT02257489|17501187|P9|Overall Study|Withdrawal by Subject|0
5071903|NCT02257489|17501188|P8|Overall Study|Withdrawal by Subject|0
5071904|NCT02257489|17501189|P7|Overall Study|Withdrawal by Subject|0
5071905|NCT02257489|17501190|P6|Overall Study|Withdrawal by Subject|0
5071906|NCT02257489|17501191|P5|Overall Study|Withdrawal by Subject|0
5071907|NCT02257489|17501192|P4|Overall Study|Withdrawal by Subject|1
5071908|NCT02257489|17501193|P3|Overall Study|Withdrawal by Subject|0
5071909|NCT02257489|17501194|P2|Overall Study|Withdrawal by Subject|0
5071910|NCT02257489|17501195|P1|Overall Study|Withdrawal by Subject|0
5071911|NCT02257385|17501231|P2|Overall Study|Withdrawal by Subject|4
5071912|NCT02257385|17501232|P1|Overall Study|Withdrawal by Subject|4
5071913|NCT02257385|17501231|P2|Overall Study|Lost to Follow-up|1
5071914|NCT02257385|17501232|P1|Overall Study|Lost to Follow-up|0
5071915|NCT02257385|17501231|P2|Overall Study|Protocol Violation|7
5071916|NCT02257385|17501232|P1|Overall Study|Protocol Violation|5
5071917|NCT02257385|17501231|P2|Overall Study|Lack of Efficacy|2
5071918|NCT02257385|17501232|P1|Overall Study|Lack of Efficacy|1
5071919|NCT02257385|17501231|P2|Overall Study|Adverse Event|8
5071920|NCT02257385|17501232|P1|Overall Study|Adverse Event|12
5071921|NCT02257372|17501242|P2|Overall Study|Withdrew consent|0
5071922|NCT02257372|17501243|P1|Overall Study|Withdrew consent|1
5071923|NCT02257372|17501242|P2|Overall Study|Lost to Follow-up|1
5071924|NCT02257372|17501243|P1|Overall Study|Lost to Follow-up|0
5071925|NCT02257372|17501242|P2|Overall Study|Protocol Violation|1
5071926|NCT02257372|17501243|P1|Overall Study|Protocol Violation|1
5071927|NCT02257372|17501242|P2|Overall Study|Lack of Efficacy|1
5071928|NCT02257372|17501243|P1|Overall Study|Lack of Efficacy|2
5071929|NCT02257372|17501242|P2|Overall Study|Adverse Event|7
5071930|NCT02257372|17501243|P1|Overall Study|Adverse Event|3
5071931|NCT02256982|17501260|P2|Overall Study|Disease Progression|1
5071932|NCT02256982|17501261|P1|Overall Study|Disease Progression|0
5071933|NCT02256969|17501270|P3|Overall Study|Screenfailed or withdrew|1
5071934|NCT02256969|17501271|P2|Overall Study|Screenfailed or withdrew|1
5071935|NCT02256969|17501272|P1|Overall Study|Screenfailed or withdrew|2
5071936|NCT02256917|17501289|P1|Prophylactic Treatment Phase II|Discontinued medication|1
5071937|NCT02256917|17501289|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
5071938|NCT02256917|17501289|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
5071939|NCT02256917|17501289|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
5071940|NCT02256917|17501289|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
5071941|NCT02256891|17501310|P2|Overall Study|Equipment Malfunction|1
5071942|NCT02256891|17501311|P1|Overall Study|Equipment Malfunction|0
5071943|NCT02256891|17501310|P2|Overall Study|Screen Fail|4
5071944|NCT02256891|17501311|P1|Overall Study|Screen Fail|5
5071945|NCT02256891|17501310|P2|Overall Study|Physician Decision|3
5071946|NCT02256891|17501311|P1|Overall Study|Physician Decision|7
5071947|NCT02256891|17501310|P2|Overall Study|Lost to Follow-up|3
5071948|NCT02256891|17501311|P1|Overall Study|Lost to Follow-up|0
5071949|NCT02256891|17501310|P2|Overall Study|Death|2
5071950|NCT02256891|17501311|P1|Overall Study|Death|0
5071951|NCT02256839|17501337|P2|Overall Study|Did not meet Eligibility Criteria|3
5071952|NCT02256839|17501338|P1|Overall Study|Did not meet Eligibility Criteria|2
5071953|NCT02256553|17501344|P1|Period III|Adverse Event|3
5071954|NCT02256553|17501344|P1|Period II|Subject Moved|1
5071955|NCT02256553|17501344|P1|Period II|Adverse Event|1
5071956|NCT02256553|17501344|P1|Period I|Protocol Violation|1
5071957|NCT02256553|17501344|P1|Period I|Adverse Event|5
5071958|NCT02256540|17501353|P3|Overall Study|Back pain preventing exercise|1
5071959|NCT02256540|17501354|P2|Overall Study|Back pain preventing exercise|0
5071960|NCT02256540|17501355|P1|Overall Study|Back pain preventing exercise|0
5071961|NCT02256540|17501353|P3|Overall Study|Withdrawal by Subject|1
5071962|NCT02256540|17501354|P2|Overall Study|Withdrawal by Subject|1
5071963|NCT02256540|17501355|P1|Overall Study|Withdrawal by Subject|0
5071964|NCT02256488|17501373|P4|Overall Study|Withdrawal by Subject|2
5071965|NCT02256488|17501374|P3|Overall Study|Withdrawal by Subject|0
5071966|NCT02256488|17501375|P2|Overall Study|Withdrawal by Subject|0
5071967|NCT02256488|17501376|P1|Overall Study|Withdrawal by Subject|1
5071968|NCT02256488|17501373|P4|Overall Study|OTHER|1
5071969|NCT02256488|17501374|P3|Overall Study|OTHER|1
5071970|NCT02256488|17501375|P2|Overall Study|OTHER|0
5071971|NCT02256488|17501376|P1|Overall Study|OTHER|1
5071972|NCT02256488|17501373|P4|Overall Study|Lost to Follow-up|3
5071973|NCT02256488|17501374|P3|Overall Study|Lost to Follow-up|9
5071974|NCT02256488|17501375|P2|Overall Study|Lost to Follow-up|6
5071975|NCT02256488|17501376|P1|Overall Study|Lost to Follow-up|6
5071976|NCT02256436|17501392|P2|Overall Study|Ongoing in Study|67
5071977|NCT02256436|17501393|P1|Overall Study|Ongoing in Study|108
5071978|NCT02256436|17501392|P2|Overall Study|Withdrawal by Subject|30
5071979|NCT02256436|17501393|P1|Overall Study|Withdrawal by Subject|7
5071980|NCT02256436|17501392|P2|Overall Study|Protocol Violation|0
5071981|NCT02256436|17501393|P1|Overall Study|Protocol Violation|1
5071982|NCT02256436|17501392|P2|Overall Study|Physician Decision|3
5071983|NCT02256436|17501393|P1|Overall Study|Physician Decision|1
5071984|NCT02256436|17501392|P2|Overall Study|Lost to Follow-up|1
5071985|NCT02256436|17501393|P1|Overall Study|Lost to Follow-up|1
5071986|NCT02256436|17501392|P2|Overall Study|Death|158
5071987|NCT02256436|17501393|P1|Overall Study|Death|137
5071988|NCT02256436|17501392|P2|Overall Study|Adverse Event|13
5071989|NCT02256436|17501393|P1|Overall Study|Adverse Event|15
5071990|NCT02256384|17501429|P1|Overall Study|Equipment not capturing data|2
5071991|NCT02256384|17501429|P1|Overall Study|Withdrawal by Subject|12
5071992|NCT02256267|17501462|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
5071993|NCT02256267|17501462|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
5071994|NCT02255981|17501535|P1|Overall Study|Withdrawal by Subject|1
5071995|NCT02255981|17501535|P1|Overall Study|Lost to Follow-up|3
5071996|NCT02255760|17501550|P5|Overall Study|Lost to Follow-up|0
5071997|NCT02255760|17501551|P4|Overall Study|Lost to Follow-up|0
5071998|NCT02255760|17501552|P3|Overall Study|Lost to Follow-up|0
5071999|NCT02255760|17501553|P2|Overall Study|Lost to Follow-up|1
5072000|NCT02255760|17501554|P1|Overall Study|Lost to Follow-up|0
5072001|NCT02255565|17501609|P3|Overall Study|Withdrawal by Subject|0
5072002|NCT02255565|17501610|P2|Overall Study|Withdrawal by Subject|1
5072003|NCT02255565|17501611|P1|Overall Study|Withdrawal by Subject|0
5072004|NCT02255552|17501672|P2|Overall Study|Withdrawal by Subject|4
5072005|NCT02255552|17501673|P1|Overall Study|Withdrawal by Subject|1
5072006|NCT02255552|17501672|P2|Overall Study|Participants enrolled into another study|11
5072007|NCT02255552|17501673|P1|Overall Study|Participants enrolled into another study|0
5072008|NCT02255500|17501690|P2|Overall Study|Withdrawal by Subject|0
5072009|NCT02255500|17501691|P1|Overall Study|Withdrawal by Subject|1
5072010|NCT02255461|17501712|P5|Overall Study|Not meet dose reduction BSA requirement|0
5072011|NCT02255461|17501713|P4|Overall Study|Not meet dose reduction BSA requirement|0
5072012|NCT02255461|17501714|P3|Overall Study|Not meet dose reduction BSA requirement|0
5072013|NCT02255461|17501715|P2|Overall Study|Not meet dose reduction BSA requirement|1
5072014|NCT02255461|17501716|P1|Overall Study|Not meet dose reduction BSA requirement|0
5072015|NCT02255461|17501712|P5|Overall Study|Withdrawal by Subject|1
5072016|NCT02255461|17501713|P4|Overall Study|Withdrawal by Subject|0
5072017|NCT02255461|17501714|P3|Overall Study|Withdrawal by Subject|1
5072018|NCT02255461|17501715|P2|Overall Study|Withdrawal by Subject|0
5072019|NCT02255461|17501716|P1|Overall Study|Withdrawal by Subject|0
5072020|NCT02255461|17501712|P5|Overall Study|Adverse Event|1
5072021|NCT02255461|17501713|P4|Overall Study|Adverse Event|0
5072022|NCT02255461|17501714|P3|Overall Study|Adverse Event|0
5072023|NCT02255461|17501715|P2|Overall Study|Adverse Event|1
5072024|NCT02255461|17501716|P1|Overall Study|Adverse Event|0
5072025|NCT02255422|17501795|P7|Overall Study|Lost to Follow-up|0
5072026|NCT02255422|17501796|P6|Overall Study|Lost to Follow-up|0
5072027|NCT02255422|17501797|P5|Overall Study|Lost to Follow-up|0
5072028|NCT02255422|17501798|P4|Overall Study|Lost to Follow-up|0
5072029|NCT02255422|17501799|P3|Overall Study|Lost to Follow-up|1
5072030|NCT02255422|17501800|P2|Overall Study|Lost to Follow-up|0
5072031|NCT02255422|17501801|P1|Overall Study|Lost to Follow-up|0
5072032|NCT02255422|17501795|P7|Overall Study|Withdrawal by Subject|2
5072033|NCT02255422|17501796|P6|Overall Study|Withdrawal by Subject|0
5072034|NCT02255422|17501797|P5|Overall Study|Withdrawal by Subject|0
5072035|NCT02255422|17501798|P4|Overall Study|Withdrawal by Subject|0
5072036|NCT02255422|17501799|P3|Overall Study|Withdrawal by Subject|0
5072037|NCT02255422|17501800|P2|Overall Study|Withdrawal by Subject|0
5072038|NCT02255422|17501801|P1|Overall Study|Withdrawal by Subject|0
5072039|NCT02255279|17501835|P2|Overall Study|Withdrawal by Subject|6
5072040|NCT02255279|17501836|P1|Overall Study|Withdrawal by Subject|3
5072041|NCT02255279|17501835|P2|Overall Study|Protocol Violation|1
5072042|NCT02255279|17501836|P1|Overall Study|Protocol Violation|0
5072043|NCT02255279|17501835|P2|Overall Study|Lost to Follow-up|2
5072044|NCT02255279|17501836|P1|Overall Study|Lost to Follow-up|2
5072045|NCT02255149|17501889|P1|Overall Study|Implant Failure|1
5072046|NCT02255149|17501889|P1|Overall Study|Withdrawal by PI|1
5072047|NCT02255149|17501889|P1|Overall Study|Withdrawal by Subject|1
5072048|NCT02255149|17501889|P1|Overall Study|Lost to Follow-up|2
5072049|NCT02255097|17501905|P1|Overall Study|Treatment Ongoing|36
5072050|NCT02255097|17501905|P1|Overall Study|Allocated but not treated|1
5072051|NCT02255097|17501905|P1|Overall Study|Withdrawal by Subject|2
5072052|NCT02255097|17501905|P1|Overall Study|Progressive Disease|80
5072053|NCT02255097|17501905|P1|Overall Study|Physician Decision|1
5072054|NCT02255097|17501905|P1|Overall Study|Lost to Follow-up|1
5072055|NCT02255097|17501905|P1|Overall Study|Death|2
5072056|NCT02255097|17501905|P1|Overall Study|Excluded Medication|1
5072057|NCT02255097|17501905|P1|Overall Study|Complete Response|1
5072058|NCT02255097|17501905|P1|Overall Study|Clinical Progression|23
5072059|NCT02255097|17501905|P1|Overall Study|Adverse Event|24
5072060|NCT02254772|17501926|P1|Overall Study|Withdrawal by Subject|1
5072061|NCT02254772|17501926|P1|Overall Study|Ineligible|1
5072062|NCT02254681|17501932|P1|Overall Study|Lack of Efficacy|6
5072063|NCT02254551|17501942|P1|Dose Escalation|Dose-limiting toxicity|2
5072064|NCT02254551|17501942|P1|Dose Escalation|Physician Decision|1
5072065|NCT02254486|17501952|P2|Overall Study|Various|12
5072066|NCT02254486|17501953|P1|Overall Study|Various|12
5072067|NCT02254486|17501952|P2|Overall Study|GFR<60mL/min|21
5072068|NCT02254486|17501953|P1|Overall Study|GFR<60mL/min|16
5072069|NCT02254486|17501952|P2|Overall Study|Withdrawal by Subject|15
5072070|NCT02254486|17501953|P1|Overall Study|Withdrawal by Subject|17
5072071|NCT02254486|17501952|P2|Overall Study|Protocol Violation|2
5072072|NCT02254486|17501953|P1|Overall Study|Protocol Violation|1
5072073|NCT02254486|17501952|P2|Overall Study|Lost to Follow-up|4
5072074|NCT02254486|17501953|P1|Overall Study|Lost to Follow-up|2
5072075|NCT02254486|17501952|P2|Overall Study|Lack of Efficacy|0
5072076|NCT02254486|17501953|P1|Overall Study|Lack of Efficacy|1
5072077|NCT02254486|17501952|P2|Overall Study|Adverse Event|1
5072078|NCT02254486|17501953|P1|Overall Study|Adverse Event|1
5072079|NCT02254460|17501992|P2|Overall Study|Adverse Event|0
5072080|NCT02254460|17501993|P1|Overall Study|Adverse Event|1
5072081|NCT02254421|17502001|P2|Overall Study|Withdrew Consent|1
5072082|NCT02254421|17502002|P1|Overall Study|Withdrew Consent|1
5072083|NCT02254421|17502001|P2|Overall Study|Death|2
5072084|NCT02254421|17502002|P1|Overall Study|Death|0
5072085|NCT02254421|17502001|P2|Overall Study|Randomized but Not Treated|0
5072086|NCT02254421|17502002|P1|Overall Study|Randomized but Not Treated|1
5072087|NCT02254408|17502016|P2|Overall Study|Lost to Follow-up|0
5072088|NCT02254408|17502017|P1|Overall Study|Lost to Follow-up|1
5072089|NCT02254408|17502016|P2|Overall Study|Withdrawal by Subject|3
5072090|NCT02254408|17502017|P1|Overall Study|Withdrawal by Subject|3
5072091|NCT02254408|17502016|P2|Overall Study|Investigator's Discretion|1
5072092|NCT02254408|17502017|P1|Overall Study|Investigator's Discretion|0
5072093|NCT02254408|17502016|P2|Overall Study|Death|3
5072094|NCT02254408|17502017|P1|Overall Study|Death|2
5072095|NCT02254408|17502016|P2|Overall Study|Adverse Event|0
5072096|NCT02254408|17502017|P1|Overall Study|Adverse Event|1
5072097|NCT02254408|17502016|P2|Overall Study|Randomized But Not Treated|3
5072098|NCT02254408|17502017|P1|Overall Study|Randomized But Not Treated|1
5072099|NCT02254304|17502029|P2|Overall Study|Personal decision|0
5072100|NCT02254304|17502030|P1|Overall Study|Personal decision|1
5072101|NCT02254304|17502029|P2|Overall Study|Personal causes|1
5072102|NCT02254304|17502030|P1|Overall Study|Personal causes|4
5072103|NCT02254304|17502029|P2|Overall Study|Injection site pain and Injection fear|0
5072104|NCT02254304|17502030|P1|Overall Study|Injection site pain and Injection fear|1
5072105|NCT02254304|17502029|P2|Overall Study|Withdrawal by Subject|0
5072106|NCT02254304|17502030|P1|Overall Study|Withdrawal by Subject|3
5072107|NCT02254304|17502029|P2|Overall Study|Protocol Violation|0
5072108|NCT02254304|17502030|P1|Overall Study|Protocol Violation|1
5072109|NCT02254304|17502029|P2|Overall Study|Lost to Follow-up|2
5072110|NCT02254304|17502030|P1|Overall Study|Lost to Follow-up|2
5072111|NCT02254304|17502029|P2|Overall Study|Adverse Event|1
5072112|NCT02254304|17502030|P1|Overall Study|Adverse Event|2
5072113|NCT02254291|17502090|P3|Overall Study|Missing follow-up information|1
5072114|NCT02254291|17502091|P2|Overall Study|Missing follow-up information|0
5072115|NCT02254291|17502092|P1|Overall Study|Missing follow-up information|0
5072116|NCT02254291|17502090|P3|Overall Study|Withdrawal by Subject|1
5072117|NCT02254291|17502091|P2|Overall Study|Withdrawal by Subject|3
5072118|NCT02254291|17502092|P1|Overall Study|Withdrawal by Subject|0
5072119|NCT02254278|17502108|P2|Overall Study|Protocol Violation|1
5072120|NCT02254278|17502109|P1|Overall Study|Protocol Violation|1
5072121|NCT02253992|17502170|P3|Overall Study|Other|1
5072122|NCT02253992|17502171|P2|Overall Study|Other|0
5072123|NCT02253992|17502172|P1|Overall Study|Other|0
5072124|NCT02253992|17502170|P3|Overall Study|Completed treatment as per protocol|22
5072125|NCT02253992|17502171|P2|Overall Study|Completed treatment as per protocol|1
5072126|NCT02253992|17502172|P1|Overall Study|Completed treatment as per protocol|0
5072127|NCT02253992|17502170|P3|Overall Study|Subject discontinued study drug|1
5072128|NCT02253992|17502171|P2|Overall Study|Subject discontinued study drug|0
5072129|NCT02253992|17502172|P1|Overall Study|Subject discontinued study drug|1
5072130|NCT02253992|17502170|P3|Overall Study|Death|1
5072131|NCT02253992|17502171|P2|Overall Study|Death|0
5072132|NCT02253992|17502172|P1|Overall Study|Death|0
5072133|NCT02253992|17502170|P3|Overall Study|Adverse Event|8
5072134|NCT02253992|17502171|P2|Overall Study|Adverse Event|0
5072135|NCT02253992|17502172|P1|Overall Study|Adverse Event|0
5072136|NCT02253992|17502170|P3|Overall Study|Withdrawal by Subject|3
5072137|NCT02253992|17502171|P2|Overall Study|Withdrawal by Subject|0
5072138|NCT02253992|17502172|P1|Overall Study|Withdrawal by Subject|0
5072139|NCT02253992|17502170|P3|Overall Study|Disease progression|98
5072140|NCT02253992|17502171|P2|Overall Study|Disease progression|3
5072141|NCT02253992|17502172|P1|Overall Study|Disease progression|4
5072142|NCT02253992|17502170|P3|Overall Study|Study drug toxicity|10
5072143|NCT02253992|17502171|P2|Overall Study|Study drug toxicity|0
5072144|NCT02253992|17502172|P1|Overall Study|Study drug toxicity|1
5072145|NCT02253654|17502238|P2|Overall Study|Did Not Receive Study Treatment|1
5072146|NCT02253654|17502239|P1|Overall Study|Did Not Receive Study Treatment|4
5072147|NCT02253654|17502238|P2|Overall Study|Death|7
5072148|NCT02253654|17502239|P1|Overall Study|Death|4
5072149|NCT02253654|17502238|P2|Overall Study|Lost to Follow-up|5
5072150|NCT02253654|17502239|P1|Overall Study|Lost to Follow-up|2
5072151|NCT02253654|17502238|P2|Overall Study|Decision by Sponsor|1
5072152|NCT02253654|17502239|P1|Overall Study|Decision by Sponsor|1
5072153|NCT02253654|17502238|P2|Overall Study|Withdrawal by Subject|4
5072154|NCT02253654|17502239|P1|Overall Study|Withdrawal by Subject|12
5072155|NCT02253433|17502265|P2|Overall Study|Medical or Other Concerns|2
5072156|NCT02253433|17502266|P1|Overall Study|Medical or Other Concerns|1
5072157|NCT02253433|17502265|P2|Overall Study|Too Busy|4
5072158|NCT02253433|17502266|P1|Overall Study|Too Busy|0
5072159|NCT02253433|17502265|P2|Overall Study|Unstable Housing/Homeless|7
5072160|NCT02253433|17502266|P1|Overall Study|Unstable Housing/Homeless|0
5072161|NCT02253433|17502265|P2|Overall Study|Uncomfortable with home visitors|3
5072162|NCT02253433|17502266|P1|Overall Study|Uncomfortable with home visitors|0
5072163|NCT02253433|17502265|P2|Overall Study|Out of Study Area|7
5072164|NCT02253433|17502266|P1|Overall Study|Out of Study Area|2
5072165|NCT02253433|17502265|P2|Overall Study|No Longer Interested|15
5072166|NCT02253433|17502266|P1|Overall Study|No Longer Interested|3
5072167|NCT02253433|17502265|P2|Overall Study|Death|1
5072168|NCT02253433|17502266|P1|Overall Study|Death|1
5072169|NCT02253433|17502265|P2|Overall Study|Unable to Contact|16
5072170|NCT02253433|17502266|P1|Overall Study|Unable to Contact|9
5072171|NCT02253147|17502525|P1|Overall Study|Withdrawal by Subject|1
5072172|NCT02253147|17502525|P1|Overall Study|Lost to Follow-up|2
5072173|NCT02253147|17502525|P1|Overall Study|Conditional re-treatment at W52|5
5072174|NCT02253147|17502525|P1|Overall Study|Did not consent to study extension|9
5072175|NCT02253147|17502525|P1|Overall Study|Protocol Violation|30
5072176|NCT02252965|17502559|P2|Overall Study|Other|5
5072177|NCT02252965|17502560|P1|Overall Study|Other|4
5072178|NCT02252965|17502559|P2|Overall Study|Withdrawal by Subject|9
5072179|NCT02252965|17502560|P1|Overall Study|Withdrawal by Subject|7
5072180|NCT02252965|17502559|P2|Overall Study|Lack of Efficacy|2
5072181|NCT02252965|17502560|P1|Overall Study|Lack of Efficacy|0
5072182|NCT02252965|17502559|P2|Overall Study|Protocol Violation|5
5072183|NCT02252965|17502560|P1|Overall Study|Protocol Violation|4
5072184|NCT02252965|17502559|P2|Overall Study|Lost to Follow-up|8
5072185|NCT02252965|17502560|P1|Overall Study|Lost to Follow-up|16
5072186|NCT02252965|17502559|P2|Overall Study|Adverse Event|14
5072187|NCT02252965|17502560|P1|Overall Study|Adverse Event|9
5072188|NCT02252939|17502587|P1|Overall Study|Lost to Follow-up|3
5072189|NCT02252536|17502644|P2|Overall Study|Lost to Follow-up|3
5072190|NCT02252536|17502645|P1|Overall Study|Lost to Follow-up|5
5072191|NCT02252406|17502706|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
5072192|NCT02252406|17502707|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
5072193|NCT02252406|17502706|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
5072194|NCT02252406|17502707|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
5072195|NCT02252406|17502706|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
5072196|NCT02252406|17502707|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
5072197|NCT02252406|17502706|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
5072198|NCT02252406|17502707|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
5072199|NCT02252406|17502706|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
5072200|NCT02252406|17502707|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
5072201|NCT02252211|17502765|P3|Overall Study|Serious Adverse Event During Screening|1
5072202|NCT02252211|17502766|P2|Overall Study|Serious Adverse Event During Screening|0
5072203|NCT02252211|17502767|P1|Overall Study|Serious Adverse Event During Screening|1
5072204|NCT02252211|17502765|P3|Overall Study|Withdrawal by Subject|0
5072205|NCT02252211|17502766|P2|Overall Study|Withdrawal by Subject|0
5072206|NCT02252211|17502767|P1|Overall Study|Withdrawal by Subject|1
5072207|NCT02252211|17502765|P3|Overall Study|Progressive disease|0
5072208|NCT02252211|17502766|P2|Overall Study|Progressive disease|2
5072209|NCT02252211|17502767|P1|Overall Study|Progressive disease|3
5072210|NCT02252211|17502765|P3|Overall Study|Adverse Event|0
5072211|NCT02252211|17502766|P2|Overall Study|Adverse Event|1
5072212|NCT02252211|17502767|P1|Overall Study|Adverse Event|0
5072213|NCT02252172|17502804|P2|Overall Study|Ongoing|298
5072214|NCT02252172|17502805|P1|Overall Study|Ongoing|276
5072215|NCT02252172|17502804|P2|Overall Study|Lost to Follow-up|1
5072216|NCT02252172|17502805|P1|Overall Study|Lost to Follow-up|3
5072217|NCT02252146|17502817|P1|Overall Study|Inability to travel to study site|1
5072218|NCT02252146|17502817|P1|Overall Study|Entered hospice care|1
5072219|NCT02252146|17502817|P1|Overall Study|Lack of Efficacy|4
5072220|NCT02252042|17502858|P2|Overall Study|Ongoing in study|35
5072221|NCT02252042|17502859|P1|Overall Study|Ongoing in study|64
5072222|NCT02252042|17502858|P2|Overall Study|Withdrawal by Subject|20
5072223|NCT02252042|17502859|P1|Overall Study|Withdrawal by Subject|13
5072224|NCT02252042|17502858|P2|Overall Study|Physician Decision|1
5072225|NCT02252042|17502859|P1|Overall Study|Physician Decision|0
5072226|NCT02252042|17502858|P2|Overall Study|Death|192
5072227|NCT02252042|17502859|P1|Overall Study|Death|170
5072228|NCT02252016|17502899|P2|Overall Study|Withdrawal by Subject|2
5072229|NCT02252016|17502900|P1|Overall Study|Withdrawal by Subject|0
5072230|NCT02252016|17502899|P2|Overall Study|Physician Decision|0
5072231|NCT02252016|17502900|P1|Overall Study|Physician Decision|1
5072232|NCT02252016|17502899|P2|Overall Study|Lost to Follow-up|1
5072233|NCT02252016|17502900|P1|Overall Study|Lost to Follow-up|2
5072234|NCT02251990|17502914|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
5072235|NCT02251990|17502915|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
5072236|NCT02251990|17502914|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
5072237|NCT02251990|17502915|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
5072238|NCT02251990|17502914|P2|Period 1 (Double-blind [DB])|Not Treated|0
5072239|NCT02251990|17502915|P1|Period 1 (Double-blind [DB])|Not Treated|1
5072240|NCT02251990|17502914|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
5072241|NCT02251990|17502915|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
5072242|NCT02251990|17502914|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
5072243|NCT02251990|17502915|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
5072244|NCT02251990|17502914|P2|Period 1 (Double-blind [DB])|Adverse Event|1
5072245|NCT02251990|17502915|P1|Period 1 (Double-blind [DB])|Adverse Event|1
5072246|NCT02251912|17502943|P2|Overall Study|Adverse Event|2
5072247|NCT02251912|17502944|P1|Overall Study|Adverse Event|0
5072248|NCT02251912|17502943|P2|Overall Study|Withdrawal by Subject|3
5072249|NCT02251912|17502944|P1|Overall Study|Withdrawal by Subject|2
5072250|NCT02251743|17502973|P2|Overall Study|Withdrawal by Subject|1
5072251|NCT02251743|17502974|P1|Overall Study|Withdrawal by Subject|1
5072252|NCT02251717|17502982|P2|Overall Study|Withdrew Consent|0
5072253|NCT02251717|17502983|P1|Overall Study|Withdrew Consent|1
5072254|NCT02251717|17502982|P2|Overall Study|Adverse Event|1
5072255|NCT02251717|17502983|P1|Overall Study|Adverse Event|0
5072256|NCT02251652|17502995|P1|Overall Study|Withdrawal by Subject|1
5072257|NCT02251275|17503051|P5|Overall Study|Withdrawal by Subject|0
5072258|NCT02251275|17503052|P4|Overall Study|Withdrawal by Subject|1
5072259|NCT02251275|17503053|P3|Overall Study|Withdrawal by Subject|35
5072260|NCT02251275|17503054|P2|Overall Study|Withdrawal by Subject|51
5072261|NCT02251275|17503055|P1|Overall Study|Withdrawal by Subject|25
5072262|NCT02251275|17503051|P5|Overall Study|Protocol Deviation|0
5072263|NCT02251275|17503052|P4|Overall Study|Protocol Deviation|0
5072264|NCT02251275|17503053|P3|Overall Study|Protocol Deviation|1
5072265|NCT02251275|17503054|P2|Overall Study|Protocol Deviation|0
5072266|NCT02251275|17503055|P1|Overall Study|Protocol Deviation|0
5072267|NCT02251275|17503051|P5|Overall Study|Physician Decision|1
5072268|NCT02251275|17503052|P4|Overall Study|Physician Decision|0
5072269|NCT02251275|17503053|P3|Overall Study|Physician Decision|26
5072270|NCT02251275|17503054|P2|Overall Study|Physician Decision|30
5072271|NCT02251275|17503055|P1|Overall Study|Physician Decision|19
5072272|NCT02251275|17503051|P5|Overall Study|Lost to Follow-up|0
5072273|NCT02251275|17503052|P4|Overall Study|Lost to Follow-up|0
5072274|NCT02251275|17503053|P3|Overall Study|Lost to Follow-up|4
5072275|NCT02251275|17503054|P2|Overall Study|Lost to Follow-up|6
5072276|NCT02251275|17503055|P1|Overall Study|Lost to Follow-up|5
5072277|NCT02251275|17503051|P5|Overall Study|Adverse Event|0
5072278|NCT02251275|17503052|P4|Overall Study|Adverse Event|0
5072279|NCT02251275|17503053|P3|Overall Study|Adverse Event|28
5072280|NCT02251275|17503054|P2|Overall Study|Adverse Event|60
5072281|NCT02251275|17503055|P1|Overall Study|Adverse Event|23
5072282|NCT02250443|17503159|P1|Overall Study|Adverse Event|3
5072283|NCT02250443|17503159|P1|Overall Study|Administrative problems|7
5072284|NCT02250326|17503188|P3|Follow-Up Period|Lost to Follow-up|3
5072285|NCT02250326|17503189|P2|Follow-Up Period|Lost to Follow-up|1
5072286|NCT02250326|17503190|P1|Follow-Up Period|Lost to Follow-up|1
5072287|NCT02250326|17503188|P3|Follow-Up Period|Unknown or Missing|3
5072288|NCT02250326|17503189|P2|Follow-Up Period|Unknown or Missing|3
5072289|NCT02250326|17503190|P1|Follow-Up Period|Unknown or Missing|2
5072290|NCT02250326|17503188|P3|Follow-Up Period|Death|32
5072291|NCT02250326|17503189|P2|Follow-Up Period|Death|26
5072292|NCT02250326|17503190|P1|Follow-Up Period|Death|46
5072293|NCT02250326|17503188|P3|Treatment Period|Randomized or assigned; not treated|1
5072294|NCT02250326|17503189|P2|Treatment Period|Randomized or assigned; not treated|1
5072295|NCT02250326|17503190|P1|Treatment Period|Randomized or assigned; not treated|2
5072296|NCT02250326|17503188|P3|Treatment Period|Miscellaneous|7
5072297|NCT02250326|17503189|P2|Treatment Period|Miscellaneous|2
5072298|NCT02250326|17503190|P1|Treatment Period|Miscellaneous|8
5072299|NCT02250326|17503188|P3|Treatment Period|Withdrawal by Subject|4
5072300|NCT02250326|17503189|P2|Treatment Period|Withdrawal by Subject|5
5072301|NCT02250326|17503190|P1|Treatment Period|Withdrawal by Subject|11
5072302|NCT02250326|17503188|P3|Treatment Period|Symptomatic Deterioration|10
5072303|NCT02250326|17503189|P2|Treatment Period|Symptomatic Deterioration|4
5072304|NCT02250326|17503190|P1|Treatment Period|Symptomatic Deterioration|9
5072305|NCT02250326|17503188|P3|Treatment Period|Progressive Disease|45
5072306|NCT02250326|17503189|P2|Treatment Period|Progressive Disease|36
5072307|NCT02250326|17503190|P1|Treatment Period|Progressive Disease|42
5072308|NCT02250326|17503188|P3|Treatment Period|Adverse Event|8
5072309|NCT02250326|17503189|P2|Treatment Period|Adverse Event|4
5072310|NCT02250326|17503190|P1|Treatment Period|Adverse Event|8
5072311|NCT02250326|17503188|P3|Treatment Period|Death|2
5072312|NCT02250326|17503189|P2|Treatment Period|Death|12
5072313|NCT02250326|17503190|P1|Treatment Period|Death|1
5072314|NCT02250274|17503223|P2|Overall Study|Insufficient blood draw amount|6
5072315|NCT02250274|17503224|P1|Overall Study|Insufficient blood draw amount|7
5072316|NCT02250183|17503240|P1|Overall Study|Lost to Follow-up|1
5072317|NCT02250183|17503240|P1|Overall Study|Adverse Event|5
5072318|NCT02250183|17503240|P1|Overall Study|Withdrawal by Subject|2
5072319|NCT02249949|17503262|P1|Overall Study|Cancelled prior to treatment|2
5072320|NCT02249832|17503269|P1|Overall Study|Lost to Follow-up|10
5072321|NCT02249832|17503269|P1|Overall Study|Withdrawal by Subject|3
5072322|NCT02249767|17503313|P3|Overall Study|Did not use medication|8
5072323|NCT02249767|17503314|P2|Overall Study|Did not use medication|9
5072324|NCT02249767|17503315|P1|Overall Study|Did not use medication|8
5072325|NCT02249182|17503381|P5|Treatment Phase|Lost to Follow-up|0
5072326|NCT02249182|17503382|P4|Treatment Phase|Lost to Follow-up|0
5072327|NCT02249182|17503383|P3|Treatment Phase|Lost to Follow-up|0
5072328|NCT02249182|17503384|P2|Treatment Phase|Lost to Follow-up|0
5072329|NCT02249182|17503385|P1|Treatment Phase|Lost to Follow-up|4
5072330|NCT02248974|17503535|P2|1-Month Follow-Up|Lost to Follow-up|3
5072331|NCT02248974|17503536|P1|1-Month Follow-Up|Lost to Follow-up|2
5072332|NCT02248974|17503535|P2|1-Week Follow-Up|Lost to Follow-up|8
5072333|NCT02248974|17503536|P1|1-Week Follow-Up|Lost to Follow-up|0
5072334|NCT02248974|17503535|P2|1-Week Follow-Up|Withdrawal by Subject|2
5072335|NCT02248974|17503536|P1|1-Week Follow-Up|Withdrawal by Subject|0
5072336|NCT02248974|17503535|P2|1-Week Follow-Up|Timing: implanted before survey|2
5072337|NCT02248974|17503536|P1|1-Week Follow-Up|Timing: implanted before survey|0
5072338|NCT02248974|17503535|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
5072339|NCT02248974|17503536|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
5072340|NCT02248974|17503535|P2|1-Week Follow-Up|Excluded because of age|1
5072341|NCT02248974|17503536|P1|1-Week Follow-Up|Excluded because of age|0
5072342|NCT02248974|17503535|P2|1-Week Follow-Up|Death|1
5072343|NCT02248974|17503536|P1|1-Week Follow-Up|Death|1
5072344|NCT02248974|17503535|P2|1-Week Follow-Up|Cognitive Difficulty|0
5072345|NCT02248974|17503536|P1|1-Week Follow-Up|Cognitive Difficulty|1
5072346|NCT02248974|17503535|P2|1-Week Follow-Up|Transferred to another facility|0
5072347|NCT02248974|17503536|P1|1-Week Follow-Up|Transferred to another facility|1
5072348|NCT02248974|17503535|P2|1-Week Follow-Up|Enrolled in another study|1
5072349|NCT02248974|17503536|P1|1-Week Follow-Up|Enrolled in another study|1
5072350|NCT02248974|17503535|P2|1-Week Follow-Up|Became ineligible for LVAD|1
5072351|NCT02248974|17503536|P1|1-Week Follow-Up|Became ineligible for LVAD|4
5072352|NCT02248974|17503535|P2|1-Day Follow-Up|Enrolled in another study|0
5072353|NCT02248974|17503536|P1|1-Day Follow-Up|Enrolled in another study|1
5072354|NCT02248974|17503535|P2|1-Day Follow-Up|Withdrawal by Subject|0
5072355|NCT02248974|17503536|P1|1-Day Follow-Up|Withdrawal by Subject|5
5072356|NCT02248974|17503535|P2|1-Day Follow-Up|Lost to Follow-up|0
5072357|NCT02248974|17503536|P1|1-Day Follow-Up|Lost to Follow-up|4
5072358|NCT02248961|17503614|P2|Overall Study|Unmet inclusion/exclusion criteria|0
5072359|NCT02248961|17503615|P1|Overall Study|Unmet inclusion/exclusion criteria|1
5072360|NCT02248961|17503614|P2|Overall Study|Withdrawal by Subject|2
5072361|NCT02248961|17503615|P1|Overall Study|Withdrawal by Subject|1
5072362|NCT02248961|17503614|P2|Overall Study|Adverse Event|0
5072363|NCT02248961|17503615|P1|Overall Study|Adverse Event|1
5072364|NCT02248857|17503650|P3|6 Month|Death|0
5072365|NCT02248857|17503651|P2|6 Month|Death|0
5072366|NCT02248857|17503652|P1|6 Month|Death|1
5072367|NCT02248857|17503650|P3|6 Month|Withdrawal by Subject|2
5072368|NCT02248857|17503651|P2|6 Month|Withdrawal by Subject|2
5072369|NCT02248857|17503652|P1|6 Month|Withdrawal by Subject|0
5072370|NCT02248857|17503650|P3|6 Month|Partially completed, unable to finish|0
5072371|NCT02248857|17503651|P2|6 Month|Partially completed, unable to finish|1
5072372|NCT02248857|17503652|P1|6 Month|Partially completed, unable to finish|0
5072373|NCT02248857|17503650|P3|6 Month|Lost to Follow-up|15
5072374|NCT02248857|17503651|P2|6 Month|Lost to Follow-up|26
5072375|NCT02248857|17503652|P1|6 Month|Lost to Follow-up|27
5072376|NCT02248857|17503650|P3|3 Month|Partially completed, unable to finish|1
5072377|NCT02248857|17503651|P2|3 Month|Partially completed, unable to finish|2
5072378|NCT02248857|17503652|P1|3 Month|Partially completed, unable to finish|2
5072379|NCT02248857|17503650|P3|3 Month|Unable to reach for 3 month|26
5072380|NCT02248857|17503651|P2|3 Month|Unable to reach for 3 month|29
5072381|NCT02248857|17503652|P1|3 Month|Unable to reach for 3 month|35
5072382|NCT02248857|17503650|P3|3 Month|Withdrawal by Subject|4
5072383|NCT02248857|17503651|P2|3 Month|Withdrawal by Subject|3
5072384|NCT02248857|17503652|P1|3 Month|Withdrawal by Subject|9
5072385|NCT02248818|17503689|P9|Randomised Study|Administrative - randomization error|0
5072386|NCT02248818|17503690|P8|Randomised Study|Administrative - randomization error|0
5072387|NCT02248818|17503691|P7|Randomised Study|Administrative - randomization error|0
5072388|NCT02248818|17503692|P6|Randomised Study|Administrative - randomization error|8
5072389|NCT02248818|17503693|P5|Randomised Study|Administrative - randomization error|0
5072390|NCT02248818|17503694|P4|Randomised Study|Administrative - randomization error|0
5072391|NCT02248818|17503695|P3|Randomised Study|Administrative - randomization error|0
5072392|NCT02248818|17503696|P2|Randomised Study|Administrative - randomization error|0
5072393|NCT02248818|17503697|P1|Randomised Study|Administrative - randomization error|0
5072394|NCT02248818|17503689|P9|Screening|Lost to Follow-up|7
5072395|NCT02248818|17503690|P8|Screening|Lost to Follow-up|0
5072396|NCT02248818|17503691|P7|Screening|Lost to Follow-up|0
5072397|NCT02248818|17503692|P6|Screening|Lost to Follow-up|0
5072398|NCT02248818|17503693|P5|Screening|Lost to Follow-up|0
5072399|NCT02248818|17503694|P4|Screening|Lost to Follow-up|0
5072400|NCT02248818|17503695|P3|Screening|Lost to Follow-up|0
5072401|NCT02248818|17503696|P2|Screening|Lost to Follow-up|0
5072402|NCT02248818|17503697|P1|Screening|Lost to Follow-up|0
5072403|NCT02248818|17503689|P9|Screening|Withdrawal by Subject|6
5072404|NCT02248818|17503690|P8|Screening|Withdrawal by Subject|0
5072405|NCT02248818|17503691|P7|Screening|Withdrawal by Subject|0
5072406|NCT02248818|17503692|P6|Screening|Withdrawal by Subject|0
5072407|NCT02248818|17503693|P5|Screening|Withdrawal by Subject|0
5072408|NCT02248818|17503694|P4|Screening|Withdrawal by Subject|0
5072409|NCT02248818|17503695|P3|Screening|Withdrawal by Subject|0
5072410|NCT02248818|17503696|P2|Screening|Withdrawal by Subject|0
5072411|NCT02248818|17503697|P1|Screening|Withdrawal by Subject|0
5072412|NCT02248818|17503689|P9|Screening|Physician Decision|73
5072413|NCT02248818|17503690|P8|Screening|Physician Decision|0
5072414|NCT02248818|17503691|P7|Screening|Physician Decision|0
5072415|NCT02248818|17503692|P6|Screening|Physician Decision|0
5072416|NCT02248818|17503693|P5|Screening|Physician Decision|0
5072417|NCT02248818|17503694|P4|Screening|Physician Decision|0
5072418|NCT02248818|17503695|P3|Screening|Physician Decision|0
5072419|NCT02248818|17503696|P2|Screening|Physician Decision|0
5072420|NCT02248818|17503697|P1|Screening|Physician Decision|0
5072421|NCT02248818|17503689|P9|Screening|Study fully enrolled|14
5072422|NCT02248818|17503690|P8|Screening|Study fully enrolled|0
5072423|NCT02248818|17503691|P7|Screening|Study fully enrolled|0
5072424|NCT02248818|17503692|P6|Screening|Study fully enrolled|0
5072425|NCT02248818|17503693|P5|Screening|Study fully enrolled|0
5072426|NCT02248818|17503694|P4|Screening|Study fully enrolled|0
5072427|NCT02248818|17503695|P3|Screening|Study fully enrolled|0
5072428|NCT02248818|17503696|P2|Screening|Study fully enrolled|0
5072429|NCT02248818|17503697|P1|Screening|Study fully enrolled|0
5072430|NCT02248818|17503689|P9|Screening|Protocol Violation|7
5072431|NCT02248818|17503690|P8|Screening|Protocol Violation|0
5072432|NCT02248818|17503691|P7|Screening|Protocol Violation|0
5072433|NCT02248818|17503692|P6|Screening|Protocol Violation|0
5072434|NCT02248818|17503693|P5|Screening|Protocol Violation|0
5072435|NCT02248818|17503694|P4|Screening|Protocol Violation|0
5072436|NCT02248818|17503695|P3|Screening|Protocol Violation|0
5072437|NCT02248818|17503696|P2|Screening|Protocol Violation|0
5072438|NCT02248818|17503697|P1|Screening|Protocol Violation|0
5072439|NCT02248675|17503912|P2|Overall Study|Lost to Follow-up|1
5072440|NCT02248675|17503913|P1|Overall Study|Lost to Follow-up|3
5072441|NCT02248649|17503940|P2|Overall Study|Lost to Follow-up|10
5072442|NCT02248649|17503941|P1|Overall Study|Lost to Follow-up|14
5072443|NCT02248649|17503940|P2|Overall Study|Death|11
5072444|NCT02248649|17503941|P1|Overall Study|Death|7
5072445|NCT02248480|17503985|P2|Overall Study|Other:Physician Decision|1
5072446|NCT02248480|17503986|P1|Overall Study|Other:Physician Decision|0
5072447|NCT02248480|17503985|P2|Overall Study|Entry Criteria Not Met|1
5072448|NCT02248480|17503986|P1|Overall Study|Entry Criteria Not Met|0
5072449|NCT02248480|17503985|P2|Overall Study|Withdrawal by Subject|4
5072450|NCT02248480|17503986|P1|Overall Study|Withdrawal by Subject|2
5072451|NCT02248480|17503985|P2|Overall Study|Adverse Event|2
5072452|NCT02248480|17503986|P1|Overall Study|Adverse Event|11
5072453|NCT02248480|17503985|P2|Overall Study|Lack of Efficacy|6
5072454|NCT02248480|17503986|P1|Overall Study|Lack of Efficacy|4
5072455|NCT02247960|17504053|P2|Catheter Removed|Lost to Follow-up|10
5072456|NCT02247960|17504054|P1|Catheter Removed|Lost to Follow-up|7
5072457|NCT02247960|17504053|P2|Patient Consent and Randomization|Withdrawal by Subject|4
5072458|NCT02247960|17504054|P1|Patient Consent and Randomization|Withdrawal by Subject|0
5072459|NCT02247960|17504053|P2|Patient Consent and Randomization|Physician Decision|2
5072460|NCT02247960|17504054|P1|Patient Consent and Randomization|Physician Decision|2
5072461|NCT02247804|17504067|P3|Treatment Period 3|Reason not Specified|3
5072462|NCT02247804|17504068|P2|Treatment Period 3|Reason not Specified|1
5072463|NCT02247804|17504069|P1|Treatment Period 3|Reason not Specified|2
5072464|NCT02247804|17504067|P3|Treatment Period 3|Personal Reasons|2
5072465|NCT02247804|17504068|P2|Treatment Period 3|Personal Reasons|3
5072466|NCT02247804|17504069|P1|Treatment Period 3|Personal Reasons|4
5072467|NCT02247804|17504067|P3|Treatment Period 3|Lost to Follow-up|2
5072468|NCT02247804|17504068|P2|Treatment Period 3|Lost to Follow-up|2
5072469|NCT02247804|17504069|P1|Treatment Period 3|Lost to Follow-up|1
5072470|NCT02247804|17504067|P3|Treatment Period 3|Lack of Efficacy|0
5072471|NCT02247804|17504068|P2|Treatment Period 3|Lack of Efficacy|1
5072472|NCT02247804|17504069|P1|Treatment Period 3|Lack of Efficacy|0
5072473|NCT02247804|17504067|P3|Treatment Period 3|Adverse Event|3
5072474|NCT02247804|17504068|P2|Treatment Period 3|Adverse Event|3
5072475|NCT02247804|17504069|P1|Treatment Period 3|Adverse Event|4
5072476|NCT02247804|17504067|P3|Treatment Period 2|Reason not Specified|2
5072477|NCT02247804|17504068|P2|Treatment Period 2|Reason not Specified|0
5072478|NCT02247804|17504069|P1|Treatment Period 2|Reason not Specified|0
5072479|NCT02247804|17504067|P3|Treatment Period 2|Personal Reasons|1
5072480|NCT02247804|17504068|P2|Treatment Period 2|Personal Reasons|1
5072481|NCT02247804|17504069|P1|Treatment Period 2|Personal Reasons|2
5072482|NCT02247804|17504067|P3|Treatment Period 2|Lost to Follow-up|1
5072483|NCT02247804|17504068|P2|Treatment Period 2|Lost to Follow-up|1
5072484|NCT02247804|17504069|P1|Treatment Period 2|Lost to Follow-up|0
5072485|NCT02247804|17504067|P3|Treatment Period 2|Lack of Efficacy|1
5072486|NCT02247804|17504068|P2|Treatment Period 2|Lack of Efficacy|0
5072487|NCT02247804|17504069|P1|Treatment Period 2|Lack of Efficacy|0
5072488|NCT02247804|17504067|P3|Treatment Period 2|Adverse Event|3
5072489|NCT02247804|17504068|P2|Treatment Period 2|Adverse Event|3
5072490|NCT02247804|17504069|P1|Treatment Period 2|Adverse Event|6
5072491|NCT02247804|17504067|P3|Treatment Period 1|Randomized but not Treated|1
5072492|NCT02247804|17504068|P2|Treatment Period 1|Randomized but not Treated|1
5072493|NCT02247804|17504069|P1|Treatment Period 1|Randomized but not Treated|5
5072494|NCT02247804|17504067|P3|Treatment Period 1|Protocol Deviation|1
5072495|NCT02247804|17504068|P2|Treatment Period 1|Protocol Deviation|0
5072496|NCT02247804|17504069|P1|Treatment Period 1|Protocol Deviation|0
5072497|NCT02247804|17504067|P3|Treatment Period 1|Personal Reasons|2
5072498|NCT02247804|17504068|P2|Treatment Period 1|Personal Reasons|1
5072499|NCT02247804|17504069|P1|Treatment Period 1|Personal Reasons|7
5072500|NCT02247804|17504067|P3|Treatment Period 1|Lost to Follow-up|2
5072501|NCT02247804|17504068|P2|Treatment Period 1|Lost to Follow-up|0
5072502|NCT02247804|17504069|P1|Treatment Period 1|Lost to Follow-up|1
5072503|NCT02247804|17504067|P3|Treatment Period 1|Lack of Efficacy|2
5072504|NCT02247804|17504068|P2|Treatment Period 1|Lack of Efficacy|0
5072505|NCT02247804|17504069|P1|Treatment Period 1|Lack of Efficacy|0
5072506|NCT02247804|17504067|P3|Treatment Period 1|Adverse Event|0
5072507|NCT02247804|17504068|P2|Treatment Period 1|Adverse Event|2
5072508|NCT02247804|17504069|P1|Treatment Period 1|Adverse Event|9
5072509|NCT02247531|17504127|P3|Overall Study|Unspecified Reason|4
5072510|NCT02247531|17504128|P2|Overall Study|Unspecified Reason|3
5072511|NCT02247531|17504129|P1|Overall Study|Unspecified Reason|2
5072512|NCT02247531|17504127|P3|Overall Study|Physician Decision|2
5072513|NCT02247531|17504128|P2|Overall Study|Physician Decision|2
5072514|NCT02247531|17504129|P1|Overall Study|Physician Decision|0
5072515|NCT02247531|17504127|P3|Overall Study|Study Terminated by Sponsor|62
5072516|NCT02247531|17504128|P2|Overall Study|Study Terminated by Sponsor|66
5072517|NCT02247531|17504129|P1|Overall Study|Study Terminated by Sponsor|64
5072518|NCT02247531|17504127|P3|Overall Study|Withdrawal by Subject|25
5072519|NCT02247531|17504128|P2|Overall Study|Withdrawal by Subject|31
5072520|NCT02247531|17504129|P1|Overall Study|Withdrawal by Subject|26
5072521|NCT02247531|17504127|P3|Overall Study|Non-compliance|0
5072522|NCT02247531|17504128|P2|Overall Study|Non-compliance|2
5072523|NCT02247531|17504129|P1|Overall Study|Non-compliance|2
5072524|NCT02247531|17504127|P3|Overall Study|Lost to Follow-up|3
5072525|NCT02247531|17504128|P2|Overall Study|Lost to Follow-up|8
5072526|NCT02247531|17504129|P1|Overall Study|Lost to Follow-up|1
5072527|NCT02247531|17504127|P3|Overall Study|Death|5
5072528|NCT02247531|17504128|P2|Overall Study|Death|9
5072529|NCT02247531|17504129|P1|Overall Study|Death|8
5072530|NCT02247531|17504127|P3|Overall Study|Adverse Event|9
5072531|NCT02247531|17504128|P2|Overall Study|Adverse Event|4
5072532|NCT02247531|17504129|P1|Overall Study|Adverse Event|3
5072533|NCT02247479|17504179|P3|Overall Study|Unspecified Reason|2
5072534|NCT02247479|17504180|P2|Overall Study|Unspecified Reason|5
5072535|NCT02247479|17504181|P1|Overall Study|Unspecified Reason|2
5072536|NCT02247479|17504179|P3|Overall Study|Physician Decision|2
5072537|NCT02247479|17504180|P2|Overall Study|Physician Decision|0
5072538|NCT02247479|17504181|P1|Overall Study|Physician Decision|1
5072539|NCT02247479|17504179|P3|Overall Study|Study Terminated by Sponsor|94
5072540|NCT02247479|17504180|P2|Overall Study|Study Terminated by Sponsor|88
5072541|NCT02247479|17504181|P1|Overall Study|Study Terminated by Sponsor|98
5072542|NCT02247479|17504179|P3|Overall Study|Withdrawal by Subject|24
5072543|NCT02247479|17504180|P2|Overall Study|Withdrawal by Subject|29
5072544|NCT02247479|17504181|P1|Overall Study|Withdrawal by Subject|25
5072545|NCT02247479|17504179|P3|Overall Study|Non-compliance|1
5072546|NCT02247479|17504180|P2|Overall Study|Non-compliance|0
5072547|NCT02247479|17504181|P1|Overall Study|Non-compliance|0
5072548|NCT02247479|17504179|P3|Overall Study|Lost to Follow-up|1
5072549|NCT02247479|17504180|P2|Overall Study|Lost to Follow-up|3
5072550|NCT02247479|17504181|P1|Overall Study|Lost to Follow-up|3
5072551|NCT02247479|17504179|P3|Overall Study|Death|6
5072552|NCT02247479|17504180|P2|Overall Study|Death|4
5072553|NCT02247479|17504181|P1|Overall Study|Death|5
5072554|NCT02247479|17504179|P3|Overall Study|Adverse Event|8
5072555|NCT02247479|17504180|P2|Overall Study|Adverse Event|9
5072556|NCT02247479|17504181|P1|Overall Study|Adverse Event|8
5072557|NCT02247466|17504230|P2|Overall Study|Procedure changed to open surgery|3
5072558|NCT02247466|17504231|P1|Overall Study|Procedure changed to open surgery|0
5072559|NCT02247440|17504249|P1|Overall Study|Lack of Efficacy|3
5072560|NCT02247440|17504249|P1|Overall Study|Withdrawal by Subject|1
5072561|NCT02247401|17504262|P3|Overall Study|Lost to Follow-up|1
5072562|NCT02247401|17504263|P2|Overall Study|Lost to Follow-up|1
5072563|NCT02247401|17504264|P1|Overall Study|Lost to Follow-up|1
5072564|NCT02247401|17504262|P3|Overall Study|Withdrawal by Subject|1
5072565|NCT02247401|17504263|P2|Overall Study|Withdrawal by Subject|1
5072566|NCT02247401|17504264|P1|Overall Study|Withdrawal by Subject|4
5072567|NCT02247401|17504262|P3|Overall Study|Adverse Event|0
5072568|NCT02247401|17504263|P2|Overall Study|Adverse Event|0
5072569|NCT02247401|17504264|P1|Overall Study|Adverse Event|1
5072570|NCT02247011|17504311|P1|Overall Study|Poor quality of radiological results|125
5072571|NCT02246998|17504332|P4|Overall Study|Randomized but Never Dosed|1
5072572|NCT02246998|17504333|P3|Overall Study|Randomized but Never Dosed|2
5072573|NCT02246998|17504334|P2|Overall Study|Randomized but Never Dosed|2
5072574|NCT02246998|17504335|P1|Overall Study|Randomized but Never Dosed|1
5072575|NCT02246998|17504332|P4|Overall Study|Lost to Follow-up|1
5072576|NCT02246998|17504333|P3|Overall Study|Lost to Follow-up|0
5072577|NCT02246998|17504334|P2|Overall Study|Lost to Follow-up|0
5072578|NCT02246998|17504335|P1|Overall Study|Lost to Follow-up|1
5072579|NCT02246998|17504332|P4|Overall Study|Adverse Event|0
5072580|NCT02246998|17504333|P3|Overall Study|Adverse Event|1
5072581|NCT02246998|17504334|P2|Overall Study|Adverse Event|1
5072582|NCT02246998|17504335|P1|Overall Study|Adverse Event|0
5072583|NCT02246777|17504445|P1|Overall Study|Change of residence|1
5072584|NCT02246777|17504445|P1|Overall Study|Adverse Event|2
5072585|NCT02246764|17504461|P3|Overall Study|Protocol Violation|1
5072586|NCT02246764|17504462|P2|Overall Study|Protocol Violation|1
5072587|NCT02246764|17504463|P1|Overall Study|Protocol Violation|2
5072588|NCT02246764|17504461|P3|Overall Study|Physician Decision|1
5072589|NCT02246764|17504462|P2|Overall Study|Physician Decision|2
5072590|NCT02246764|17504463|P1|Overall Study|Physician Decision|0
5072591|NCT02246764|17504461|P3|Overall Study|Disallowed Concomitant Medication|0
5072592|NCT02246764|17504462|P2|Overall Study|Disallowed Concomitant Medication|0
5072593|NCT02246764|17504463|P1|Overall Study|Disallowed Concomitant Medication|1
5072594|NCT02246764|17504461|P3|Overall Study|Withdrawal by Subject|1
5072595|NCT02246764|17504462|P2|Overall Study|Withdrawal by Subject|0
5072596|NCT02246764|17504463|P1|Overall Study|Withdrawal by Subject|0
5072597|NCT02246764|17504461|P3|Overall Study|Adverse Event|1
5072598|NCT02246764|17504462|P2|Overall Study|Adverse Event|29
5072599|NCT02246764|17504463|P1|Overall Study|Adverse Event|15
5072600|NCT02246673|17504476|P5|Overall Study|Protocol Violation|0
5072601|NCT02246673|17504477|P4|Overall Study|Protocol Violation|1
5072602|NCT02246673|17504478|P3|Overall Study|Protocol Violation|0
5072603|NCT02246673|17504479|P2|Overall Study|Protocol Violation|0
5072604|NCT02246673|17504480|P1|Overall Study|Protocol Violation|0
5072605|NCT02246673|17504476|P5|Overall Study|Lost to Follow-up|0
5072606|NCT02246673|17504477|P4|Overall Study|Lost to Follow-up|1
5072607|NCT02246673|17504478|P3|Overall Study|Lost to Follow-up|0
5072608|NCT02246673|17504479|P2|Overall Study|Lost to Follow-up|0
5072609|NCT02246673|17504480|P1|Overall Study|Lost to Follow-up|0
5072610|NCT02246673|17504476|P5|Overall Study|Withdrawal by Subject|1
5072611|NCT02246673|17504477|P4|Overall Study|Withdrawal by Subject|0
5072612|NCT02246673|17504478|P3|Overall Study|Withdrawal by Subject|0
5072613|NCT02246673|17504479|P2|Overall Study|Withdrawal by Subject|0
5072614|NCT02246673|17504480|P1|Overall Study|Withdrawal by Subject|0
5072615|NCT02246673|17504476|P5|Overall Study|Sponsor Decision|0
5072616|NCT02246673|17504477|P4|Overall Study|Sponsor Decision|0
5072617|NCT02246673|17504478|P3|Overall Study|Sponsor Decision|0
5072618|NCT02246673|17504479|P2|Overall Study|Sponsor Decision|0
5072619|NCT02246673|17504480|P1|Overall Study|Sponsor Decision|1
5072620|NCT02246660|17504588|P3|Overall Study|Death|1
5072621|NCT02246660|17504589|P2|Overall Study|Death|0
5072622|NCT02246660|17504590|P1|Overall Study|Death|0
5072623|NCT02246660|17504588|P3|Overall Study|Withdrawal by Subject|0
5072624|NCT02246660|17504589|P2|Overall Study|Withdrawal by Subject|1
5072625|NCT02246660|17504590|P1|Overall Study|Withdrawal by Subject|0
5072626|NCT02246647|17504600|P2|Overall Study|Withdrawal by Subject|1
5072627|NCT02246647|17504601|P1|Overall Study|Withdrawal by Subject|1
5072628|NCT02246621|17504635|P2|Overall Study|On Study Treatment/ Follow Up|133
5072629|NCT02246621|17504636|P1|Overall Study|On Study Treatment/ Follow Up|257
5072630|NCT02246621|17504635|P2|Overall Study|Lost to Follow-up|1
5072631|NCT02246621|17504636|P1|Overall Study|Lost to Follow-up|3
5072632|NCT02246621|17504635|P2|Overall Study|Withdrawal by Subject|14
5072633|NCT02246621|17504636|P1|Overall Study|Withdrawal by Subject|36
5072634|NCT02246582|17504673|P2|Overall Study|Withdrawal by Subject|4
5072635|NCT02246582|17504674|P1|Overall Study|Withdrawal by Subject|3
5072636|NCT02246439|17504682|P2|Overall Study|Withdrawal by Subject|0
5072637|NCT02246439|17504683|P1|Overall Study|Withdrawal by Subject|1
5072638|NCT02246439|17504682|P2|Overall Study|Unkonwn|3
5072639|NCT02246439|17504683|P1|Overall Study|Unkonwn|1
5072640|NCT02246439|17504682|P2|Overall Study|Physician Decision|1
5072641|NCT02246439|17504683|P1|Overall Study|Physician Decision|0
5072642|NCT02246439|17504682|P2|Overall Study|Protocol Violation|2
5072643|NCT02246439|17504683|P1|Overall Study|Protocol Violation|0
5072644|NCT02246439|17504682|P2|Overall Study|Lost to Follow-up|5
5072645|NCT02246439|17504683|P1|Overall Study|Lost to Follow-up|7
5072646|NCT02246439|17504682|P2|Overall Study|Adverse Event|0
5072647|NCT02246439|17504683|P1|Overall Study|Adverse Event|3
5072648|NCT02246218|17504815|P2|Overall Study|Lost to Follow-up|0
5072649|NCT02246218|17504816|P1|Overall Study|Lost to Follow-up|1
5072650|NCT02246218|17504815|P2|Overall Study|Adverse Event|1
5072651|NCT02246218|17504816|P1|Overall Study|Adverse Event|1
5072652|NCT02246218|17504815|P2|Overall Study|Stopping Rule: Liver Transplant|4
5072653|NCT02246218|17504816|P1|Overall Study|Stopping Rule: Liver Transplant|2
5072654|NCT02246218|17504815|P2|Overall Study|Withdrawal by Parent/Guardian|1
5072655|NCT02246218|17504816|P1|Overall Study|Withdrawal by Parent/Guardian|0
5072656|NCT02246166|17504876|P2|Overall Study|Protocol Violation|0
5072657|NCT02246166|17504877|P1|Overall Study|Protocol Violation|1
5072658|NCT02246114|17504913|P2|Overall Study|miscarriage|0
5072659|NCT02246114|17504914|P1|Overall Study|miscarriage|1
5072660|NCT02245737|17504965|P3|Overall Study|Sponsor Decision|432
5072661|NCT02245737|17504966|P2|Overall Study|Sponsor Decision|430
5072662|NCT02245737|17504967|P1|Overall Study|Sponsor Decision|445
5072663|NCT02245737|17504965|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
5072664|NCT02245737|17504966|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
5072665|NCT02245737|17504967|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
5072666|NCT02245737|17504965|P3|Overall Study|Withdrawal by Subject|44
5072667|NCT02245737|17504966|P2|Overall Study|Withdrawal by Subject|41
5072668|NCT02245737|17504967|P1|Overall Study|Withdrawal by Subject|40
5072669|NCT02245737|17504965|P3|Overall Study|Protocol Violation|3
5072670|NCT02245737|17504966|P2|Overall Study|Protocol Violation|2
5072671|NCT02245737|17504967|P1|Overall Study|Protocol Violation|3
5072672|NCT02245737|17504965|P3|Overall Study|Physician Decision|6
5072673|NCT02245737|17504966|P2|Overall Study|Physician Decision|3
5072674|NCT02245737|17504967|P1|Overall Study|Physician Decision|6
5072675|NCT02245737|17504965|P3|Overall Study|Other-determined by Investigator|10
5072676|NCT02245737|17504966|P2|Overall Study|Other-determined by Investigator|10
5072677|NCT02245737|17504967|P1|Overall Study|Other-determined by Investigator|9
5072678|NCT02245737|17504965|P3|Overall Study|Lost to Follow-up|4
5072679|NCT02245737|17504966|P2|Overall Study|Lost to Follow-up|5
5072680|NCT02245737|17504967|P1|Overall Study|Lost to Follow-up|2
5072681|NCT02245737|17504965|P3|Overall Study|Initiation of Symptomatic AD medication|0
5072682|NCT02245737|17504966|P2|Overall Study|Initiation of Symptomatic AD medication|0
5072683|NCT02245737|17504967|P1|Overall Study|Initiation of Symptomatic AD medication|2
5072684|NCT02245737|17504965|P3|Overall Study|Eligibility Criteria No Longer Met|4
5072685|NCT02245737|17504966|P2|Overall Study|Eligibility Criteria No Longer Met|4
5072686|NCT02245737|17504967|P1|Overall Study|Eligibility Criteria No Longer Met|2
5072687|NCT02245737|17504965|P3|Overall Study|Death|4
5072688|NCT02245737|17504966|P2|Overall Study|Death|4
5072689|NCT02245737|17504967|P1|Overall Study|Death|2
5072690|NCT02245737|17504965|P3|Overall Study|Condition Worsened|9
5072691|NCT02245737|17504966|P2|Overall Study|Condition Worsened|10
5072692|NCT02245737|17504967|P1|Overall Study|Condition Worsened|9
5072693|NCT02245737|17504965|P3|Overall Study|Adverse Event|33
5072694|NCT02245737|17504966|P2|Overall Study|Adverse Event|26
5072695|NCT02245737|17504967|P1|Overall Study|Adverse Event|23
5072696|NCT02245620|17505024|P2|Overall Study|Physician Decision|1
5072697|NCT02245620|17505025|P1|Overall Study|Physician Decision|1
5072698|NCT02245568|17505037|P1|Overall Study|Lost to Follow-up|5
5072699|NCT02245568|17505037|P1|Overall Study|Intolerance/dosing issues/interruption|5
5072700|NCT02245568|17505037|P1|Overall Study|Worsening dementia/caregiver withdrawal|6
5072701|NCT02245568|17505037|P1|Overall Study|Blue staining|6
5072702|NCT02245568|17505037|P1|Overall Study|Death|9
5072703|NCT02245568|17505037|P1|Overall Study|Non-compliance with study drug|11
5072704|NCT02245568|17505037|P1|Overall Study|Physician Decision|14
5072705|NCT02245568|17505037|P1|Overall Study|Missing (Site closure)|16
5072706|NCT02245568|17505037|P1|Overall Study|Withdrawal by Legal Representative|31
5072707|NCT02245568|17505037|P1|Overall Study|Withdrawal by Subject|77
5072708|NCT02245568|17505037|P1|Overall Study|Withdrawal by Caregiver|85
5072709|NCT02245568|17505037|P1|Overall Study|Lack of Efficacy|98
5072710|NCT02245568|17505037|P1|Overall Study|Adverse Event|144
5072711|NCT02245568|17505037|P1|Overall Study|Study terminated by Sponsor|346
5072712|NCT02245412|17505044|P3|Follow-Up Period|Other - Terminated by Sponsor|1
5072713|NCT02245412|17505045|P2|Follow-Up Period|Other - Terminated by Sponsor|0
5072714|NCT02245412|17505046|P1|Follow-Up Period|Other - Terminated by Sponsor|0
5072715|NCT02245412|17505044|P3|Follow-Up Period|Physician Decision|0
5072716|NCT02245412|17505045|P2|Follow-Up Period|Physician Decision|0
5072717|NCT02245412|17505046|P1|Follow-Up Period|Physician Decision|1
5072718|NCT02245412|17505044|P3|Follow-Up Period|Death|1
5072719|NCT02245412|17505045|P2|Follow-Up Period|Death|2
5072720|NCT02245412|17505046|P1|Follow-Up Period|Death|4
5072721|NCT02245412|17505044|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
5072722|NCT02245412|17505045|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
5072723|NCT02245412|17505046|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
5072724|NCT02245412|17505044|P3|Treatment Period|Withdrawal by Subject|0
5072725|NCT02245412|17505045|P2|Treatment Period|Withdrawal by Subject|1
5072726|NCT02245412|17505046|P1|Treatment Period|Withdrawal by Subject|2
5072727|NCT02245412|17505044|P3|Treatment Period|Physician Decision|0
5072728|NCT02245412|17505045|P2|Treatment Period|Physician Decision|1
5072729|NCT02245412|17505046|P1|Treatment Period|Physician Decision|1
5072730|NCT02245412|17505044|P3|Treatment Period|Death|0
5072731|NCT02245412|17505045|P2|Treatment Period|Death|1
5072732|NCT02245412|17505046|P1|Treatment Period|Death|1
5072733|NCT02244996|17505093|P2|Overall Study|Lack of Efficacy|6
5072734|NCT02244996|17505094|P1|Overall Study|Lack of Efficacy|2
5072735|NCT02244957|17505108|P2|Overall Study|Lack of Efficacy|0
5072736|NCT02244957|17505109|P1|Overall Study|Lack of Efficacy|1
5072737|NCT02244944|17505153|P1|Overall Study|Study Terminated|1
5072738|NCT02244944|17505153|P1|Overall Study|Withdrawal by Subject|1
5072739|NCT02244619|17505184|P2|Overall Study|Did not receive study intervention|21
5072740|NCT02244619|17505185|P1|Overall Study|Did not receive study intervention|8
5072741|NCT02244580|17505203|P1|Overall Study|No cancer tissues available|241
5072742|NCT02244424|17505213|P2|Overall Study|Lost to Follow-up|10
5072743|NCT02244424|17505214|P1|Overall Study|Lost to Follow-up|20
5072744|NCT02243696|17505233|P1|Overall Study|Study Terminated for EP PASSION|961
5072745|NCT02243696|17505233|P1|Overall Study|Subject Withdrawn by Investigator|273
5072746|NCT02243696|17505233|P1|Overall Study|Subject No Longer has Study System|42
5072747|NCT02243696|17505233|P1|Overall Study|Lost to Follow-up|57
5072748|NCT02243696|17505233|P1|Overall Study|Withdrawal by Subject|79
5072749|NCT02243696|17505233|P1|Overall Study|Death|282
5072750|NCT02243605|17505245|P2|Stage 2 - Final Analysis Population|Progression|1
5072751|NCT02243605|17505246|P1|Stage 2 - Final Analysis Population|Progression|0
5072752|NCT02243605|17505245|P2|Stage 2 - Final Analysis Population|Adverse Event|1
5072753|NCT02243605|17505246|P1|Stage 2 - Final Analysis Population|Adverse Event|1
5072754|NCT02243605|17505245|P2|Stage 2 - Final Analysis Population|Protocol Violation|1
5072755|NCT02243605|17505246|P1|Stage 2 - Final Analysis Population|Protocol Violation|5
5072756|NCT02243605|17505245|P2|Stage 1 - Interim Analysis Population|Adverse Event|0
5072757|NCT02243605|17505246|P1|Stage 1 - Interim Analysis Population|Adverse Event|1
5072758|NCT02243605|17505245|P2|Stage 1 - Interim Analysis Population|Protocol Violation|1
5072759|NCT02243605|17505246|P1|Stage 1 - Interim Analysis Population|Protocol Violation|1
5072760|NCT02243371|17505280|P2|Overall Study|Withdrawal by Subject|2
5072761|NCT02243371|17505281|P1|Overall Study|Withdrawal by Subject|0
5072762|NCT02243371|17505280|P2|Overall Study|Lack of Clinical Benefit|1
5072763|NCT02243371|17505281|P1|Overall Study|Lack of Clinical Benefit|0
5072764|NCT02243371|17505280|P2|Overall Study|Adverse Event (unrelated)|1
5072765|NCT02243371|17505281|P1|Overall Study|Adverse Event (unrelated)|0
5072766|NCT02243371|17505280|P2|Overall Study|Death (unrelated)|4
5072767|NCT02243371|17505281|P1|Overall Study|Death (unrelated)|2
5072768|NCT02243371|17505280|P2|Overall Study|Progressive Disease (clinic & radio)|24
5072769|NCT02243371|17505281|P1|Overall Study|Progressive Disease (clinic & radio)|35
5072770|NCT02243306|17505301|P2|Overall Study|Physician Decision|1
5072771|NCT02243306|17505302|P1|Overall Study|Physician Decision|0
5072772|NCT02243306|17505301|P2|Overall Study|Other: Reached stopping criteria|1
5072773|NCT02243306|17505302|P1|Overall Study|Other: Reached stopping criteria|0
5072774|NCT02243306|17505301|P2|Overall Study|Adverse Event|1
5072775|NCT02243306|17505302|P1|Overall Study|Adverse Event|0
5072776|NCT02243293|17505377|P22|Overall Study|Randomized but did'nt receive study drug|0
5072777|NCT02243293|17505378|P21|Overall Study|Randomized but did'nt receive study drug|0
5072778|NCT02243293|17505379|P20|Overall Study|Randomized but did'nt receive study drug|1
5072779|NCT02243293|17505380|P19|Overall Study|Randomized but did'nt receive study drug|0
5072780|NCT02243293|17505381|P18|Overall Study|Randomized but did'nt receive study drug|0
5072781|NCT02243293|17505382|P17|Overall Study|Randomized but did'nt receive study drug|0
5072782|NCT02243293|17505383|P16|Overall Study|Randomized but did'nt receive study drug|0
5072783|NCT02243293|17505384|P15|Overall Study|Randomized but did'nt receive study drug|0
5072784|NCT02243293|17505385|P14|Overall Study|Randomized but did'nt receive study drug|0
5072785|NCT02243293|17505386|P13|Overall Study|Randomized but did'nt receive study drug|0
5072786|NCT02243293|17505387|P12|Overall Study|Randomized but did'nt receive study drug|0
5072787|NCT02243293|17505388|P11|Overall Study|Randomized but did'nt receive study drug|0
5072788|NCT02243293|17505389|P10|Overall Study|Randomized but did'nt receive study drug|1
5072789|NCT02243293|17505390|P9|Overall Study|Randomized but did'nt receive study drug|0
5072790|NCT02243293|17505391|P8|Overall Study|Randomized but did'nt receive study drug|0
5072791|NCT02243293|17505392|P7|Overall Study|Randomized but did'nt receive study drug|0
5072792|NCT02243293|17505393|P6|Overall Study|Randomized but did'nt receive study drug|0
5072793|NCT02243293|17505394|P5|Overall Study|Randomized but did'nt receive study drug|1
5072794|NCT02243293|17505395|P4|Overall Study|Randomized but did'nt receive study drug|0
5072795|NCT02243293|17505396|P3|Overall Study|Randomized but did'nt receive study drug|0
5072796|NCT02243293|17505397|P2|Overall Study|Randomized but did'nt receive study drug|0
5072797|NCT02243293|17505398|P1|Overall Study|Randomized but did'nt receive study drug|0
5072798|NCT02243293|17505377|P22|Overall Study|Enrolled into a Re-treatment Study|0
5072799|NCT02243293|17505378|P21|Overall Study|Enrolled into a Re-treatment Study|0
5072800|NCT02243293|17505379|P20|Overall Study|Enrolled into a Re-treatment Study|0
5072801|NCT02243293|17505380|P19|Overall Study|Enrolled into a Re-treatment Study|0
5072802|NCT02243293|17505381|P18|Overall Study|Enrolled into a Re-treatment Study|0
5072803|NCT02243293|17505382|P17|Overall Study|Enrolled into a Re-treatment Study|0
5072804|NCT02243293|17505383|P16|Overall Study|Enrolled into a Re-treatment Study|0
5072805|NCT02243293|17505384|P15|Overall Study|Enrolled into a Re-treatment Study|1
5072806|NCT02243293|17505385|P14|Overall Study|Enrolled into a Re-treatment Study|0
5072807|NCT02243293|17505386|P13|Overall Study|Enrolled into a Re-treatment Study|0
5072808|NCT02243293|17505387|P12|Overall Study|Enrolled into a Re-treatment Study|0
5072809|NCT02243293|17505388|P11|Overall Study|Enrolled into a Re-treatment Study|0
5072810|NCT02243293|17505389|P10|Overall Study|Enrolled into a Re-treatment Study|0
5072811|NCT02243293|17505390|P9|Overall Study|Enrolled into a Re-treatment Study|0
5072812|NCT02243293|17505391|P8|Overall Study|Enrolled into a Re-treatment Study|0
5072813|NCT02243293|17505392|P7|Overall Study|Enrolled into a Re-treatment Study|0
5072814|NCT02243293|17505393|P6|Overall Study|Enrolled into a Re-treatment Study|0
5072815|NCT02243293|17505394|P5|Overall Study|Enrolled into a Re-treatment Study|0
5072816|NCT02243293|17505395|P4|Overall Study|Enrolled into a Re-treatment Study|0
5072817|NCT02243293|17505396|P3|Overall Study|Enrolled into a Re-treatment Study|0
5072818|NCT02243293|17505397|P2|Overall Study|Enrolled into a Re-treatment Study|0
5072819|NCT02243293|17505398|P1|Overall Study|Enrolled into a Re-treatment Study|0
5072820|NCT02243293|17505377|P22|Overall Study|Lost to Follow-up|2
5072821|NCT02243293|17505378|P21|Overall Study|Lost to Follow-up|1
5072822|NCT02243293|17505379|P20|Overall Study|Lost to Follow-up|0
5072823|NCT02243293|17505380|P19|Overall Study|Lost to Follow-up|0
5072824|NCT02243293|17505381|P18|Overall Study|Lost to Follow-up|1
5072825|NCT02243293|17505382|P17|Overall Study|Lost to Follow-up|3
5072826|NCT02243293|17505383|P16|Overall Study|Lost to Follow-up|0
5072827|NCT02243293|17505384|P15|Overall Study|Lost to Follow-up|0
5072828|NCT02243293|17505385|P14|Overall Study|Lost to Follow-up|0
5072829|NCT02243293|17505386|P13|Overall Study|Lost to Follow-up|0
5072830|NCT02243293|17505387|P12|Overall Study|Lost to Follow-up|2
5072831|NCT02243293|17505388|P11|Overall Study|Lost to Follow-up|0
5072832|NCT02243293|17505389|P10|Overall Study|Lost to Follow-up|0
5072833|NCT02243293|17505390|P9|Overall Study|Lost to Follow-up|0
5072834|NCT02243293|17505391|P8|Overall Study|Lost to Follow-up|0
5072835|NCT02243293|17505392|P7|Overall Study|Lost to Follow-up|3
5072836|NCT02243293|17505393|P6|Overall Study|Lost to Follow-up|0
5072837|NCT02243293|17505394|P5|Overall Study|Lost to Follow-up|0
5072838|NCT02243293|17505395|P4|Overall Study|Lost to Follow-up|1
5072839|NCT02243293|17505396|P3|Overall Study|Lost to Follow-up|1
5072840|NCT02243293|17505397|P2|Overall Study|Lost to Follow-up|1
5072841|NCT02243293|17505398|P1|Overall Study|Lost to Follow-up|0
5072842|NCT02243293|17505377|P22|Overall Study|Withdrawal by Subject|1
5072843|NCT02243293|17505378|P21|Overall Study|Withdrawal by Subject|0
5072844|NCT02243293|17505379|P20|Overall Study|Withdrawal by Subject|0
5072845|NCT02243293|17505380|P19|Overall Study|Withdrawal by Subject|0
5072846|NCT02243293|17505381|P18|Overall Study|Withdrawal by Subject|0
5072847|NCT02243293|17505382|P17|Overall Study|Withdrawal by Subject|0
5072848|NCT02243293|17505383|P16|Overall Study|Withdrawal by Subject|0
5072849|NCT02243293|17505384|P15|Overall Study|Withdrawal by Subject|0
5072850|NCT02243293|17505385|P14|Overall Study|Withdrawal by Subject|0
5072851|NCT02243293|17505386|P13|Overall Study|Withdrawal by Subject|0
5072852|NCT02243293|17505387|P12|Overall Study|Withdrawal by Subject|1
5072853|NCT02243293|17505388|P11|Overall Study|Withdrawal by Subject|0
5072854|NCT02243293|17505389|P10|Overall Study|Withdrawal by Subject|1
5072855|NCT02243293|17505390|P9|Overall Study|Withdrawal by Subject|0
5072856|NCT02243293|17505391|P8|Overall Study|Withdrawal by Subject|0
5072857|NCT02243293|17505392|P7|Overall Study|Withdrawal by Subject|0
5072858|NCT02243293|17505393|P6|Overall Study|Withdrawal by Subject|0
5072859|NCT02243293|17505394|P5|Overall Study|Withdrawal by Subject|0
5072860|NCT02243293|17505395|P4|Overall Study|Withdrawal by Subject|0
5072861|NCT02243293|17505396|P3|Overall Study|Withdrawal by Subject|0
5072862|NCT02243293|17505397|P2|Overall Study|Withdrawal by Subject|0
5072863|NCT02243293|17505398|P1|Overall Study|Withdrawal by Subject|1
5072864|NCT02243293|17505377|P22|Overall Study|Adverse Event|0
5072865|NCT02243293|17505378|P21|Overall Study|Adverse Event|1
5072866|NCT02243293|17505379|P20|Overall Study|Adverse Event|0
5072867|NCT02243293|17505380|P19|Overall Study|Adverse Event|0
5072868|NCT02243293|17505381|P18|Overall Study|Adverse Event|0
5072869|NCT02243293|17505382|P17|Overall Study|Adverse Event|0
5072870|NCT02243293|17505383|P16|Overall Study|Adverse Event|1
5072871|NCT02243293|17505384|P15|Overall Study|Adverse Event|0
5072872|NCT02243293|17505385|P14|Overall Study|Adverse Event|0
5072873|NCT02243293|17505386|P13|Overall Study|Adverse Event|0
5072874|NCT02243293|17505387|P12|Overall Study|Adverse Event|0
5072875|NCT02243293|17505388|P11|Overall Study|Adverse Event|0
5072876|NCT02243293|17505389|P10|Overall Study|Adverse Event|0
5072877|NCT02243293|17505390|P9|Overall Study|Adverse Event|0
5072878|NCT02243293|17505391|P8|Overall Study|Adverse Event|0
5072879|NCT02243293|17505392|P7|Overall Study|Adverse Event|0
5072880|NCT02243293|17505393|P6|Overall Study|Adverse Event|0
5072881|NCT02243293|17505394|P5|Overall Study|Adverse Event|0
5072882|NCT02243293|17505395|P4|Overall Study|Adverse Event|0
5072883|NCT02243293|17505396|P3|Overall Study|Adverse Event|0
5072884|NCT02243293|17505397|P2|Overall Study|Adverse Event|0
5072885|NCT02243293|17505398|P1|Overall Study|Adverse Event|1
5072886|NCT02243280|17505497|P11|Treated|Lost to Follow-up|2
5072887|NCT02243280|17505498|P10|Treated|Lost to Follow-up|0
5072888|NCT02243280|17505499|P9|Treated|Lost to Follow-up|1
5072889|NCT02243280|17505500|P8|Treated|Lost to Follow-up|0
5072890|NCT02243280|17505501|P7|Treated|Lost to Follow-up|0
5072891|NCT02243280|17505502|P6|Treated|Lost to Follow-up|0
5072892|NCT02243280|17505503|P5|Treated|Lost to Follow-up|0
5072893|NCT02243280|17505504|P4|Treated|Lost to Follow-up|0
5072894|NCT02243280|17505505|P3|Treated|Lost to Follow-up|0
5072895|NCT02243280|17505506|P2|Treated|Lost to Follow-up|0
5072896|NCT02243280|17505507|P1|Treated|Lost to Follow-up|0
5072897|NCT02243280|17505497|P11|Treated|Adverse Event|1
5072898|NCT02243280|17505498|P10|Treated|Adverse Event|0
5072899|NCT02243280|17505499|P9|Treated|Adverse Event|0
5072900|NCT02243280|17505500|P8|Treated|Adverse Event|0
5072901|NCT02243280|17505501|P7|Treated|Adverse Event|0
5072902|NCT02243280|17505502|P6|Treated|Adverse Event|0
5072903|NCT02243280|17505503|P5|Treated|Adverse Event|0
5072904|NCT02243280|17505504|P4|Treated|Adverse Event|0
5072905|NCT02243280|17505505|P3|Treated|Adverse Event|0
5072906|NCT02243280|17505506|P2|Treated|Adverse Event|0
5072907|NCT02243280|17505507|P1|Treated|Adverse Event|1
5072908|NCT02243202|17505562|P4|Overall Study|Randomized but not received treatment|1
5072909|NCT02243202|17505563|P3|Overall Study|Randomized but not received treatment|0
5072910|NCT02243202|17505564|P2|Overall Study|Randomized but not received treatment|0
5072911|NCT02243202|17505565|P1|Overall Study|Randomized but not received treatment|0
5072912|NCT02243202|17505562|P4|Overall Study|Other|2
5072913|NCT02243202|17505563|P3|Overall Study|Other|1
5072914|NCT02243202|17505564|P2|Overall Study|Other|3
5072915|NCT02243202|17505565|P1|Overall Study|Other|1
5072916|NCT02243202|17505562|P4|Overall Study|Withdrawal by Subject|4
5072917|NCT02243202|17505563|P3|Overall Study|Withdrawal by Subject|4
5072918|NCT02243202|17505564|P2|Overall Study|Withdrawal by Subject|6
5072919|NCT02243202|17505565|P1|Overall Study|Withdrawal by Subject|7
5072920|NCT02243202|17505562|P4|Overall Study|Protocol Violation|1
5072921|NCT02243202|17505563|P3|Overall Study|Protocol Violation|2
5072922|NCT02243202|17505564|P2|Overall Study|Protocol Violation|1
5072923|NCT02243202|17505565|P1|Overall Study|Protocol Violation|3
5072924|NCT02243202|17505562|P4|Overall Study|Lost to Follow-up|11
5072925|NCT02243202|17505563|P3|Overall Study|Lost to Follow-up|14
5072926|NCT02243202|17505564|P2|Overall Study|Lost to Follow-up|9
5072927|NCT02243202|17505565|P1|Overall Study|Lost to Follow-up|9
5072928|NCT02243202|17505562|P4|Overall Study|Adverse Event|4
5072929|NCT02243202|17505563|P3|Overall Study|Adverse Event|10
5072930|NCT02243202|17505564|P2|Overall Study|Adverse Event|6
5072931|NCT02243202|17505565|P1|Overall Study|Adverse Event|5
5072932|NCT02243176|17505601|P2|Overall Study|Adverse Event|2
5072933|NCT02243176|17505602|P1|Overall Study|Adverse Event|2
5072934|NCT02243176|17505601|P2|Overall Study|Withdrawal by Subject|7
5072935|NCT02243176|17505602|P1|Overall Study|Withdrawal by Subject|8
5072936|NCT02243176|17505601|P2|Overall Study|Protocol Violation|1
5072937|NCT02243176|17505602|P1|Overall Study|Protocol Violation|2
5072938|NCT02243176|17505601|P2|Overall Study|protocol specified withdrawal critera|3
5072939|NCT02243176|17505602|P1|Overall Study|protocol specified withdrawal critera|1
5072940|NCT02243176|17505601|P2|Overall Study|Other reason|2
5072941|NCT02243176|17505602|P1|Overall Study|Other reason|1
5072942|NCT02243046|17505627|P3|Overall Study|Lost to Follow-up|4
5072943|NCT02243046|17505628|P2|Overall Study|Lost to Follow-up|1
5072944|NCT02243046|17505629|P1|Overall Study|Lost to Follow-up|1
5072945|NCT02242981|17505693|P1|Overall Study|Withdrawal by Subject|1
5072946|NCT02242942|17505704|P3|Overall Study|On-going in Study|11
5072947|NCT02242942|17505705|P2|Overall Study|On-going in Study|186
5072948|NCT02242942|17505706|P1|Overall Study|On-going in Study|190
5072949|NCT02242942|17505704|P3|Overall Study|Withdrawal by Subject|0
5072950|NCT02242942|17505705|P2|Overall Study|Withdrawal by Subject|10
5072951|NCT02242942|17505706|P1|Overall Study|Withdrawal by Subject|8
5072952|NCT02242942|17505704|P3|Overall Study|Physician Decision|0
5072953|NCT02242942|17505705|P2|Overall Study|Physician Decision|0
5072954|NCT02242942|17505706|P1|Overall Study|Physician Decision|1
5072955|NCT02242942|17505704|P3|Overall Study|Death|2
5072956|NCT02242942|17505705|P2|Overall Study|Death|20
5072957|NCT02242942|17505706|P1|Overall Study|Death|17
5072958|NCT02242903|17505740|P7|Overall Study|Withdrawal by Subject|0
5072959|NCT02242903|17505741|P6|Overall Study|Withdrawal by Subject|0
5072960|NCT02242903|17505742|P5|Overall Study|Withdrawal by Subject|0
5072961|NCT02242903|17505743|P4|Overall Study|Withdrawal by Subject|0
5072962|NCT02242903|17505744|P3|Overall Study|Withdrawal by Subject|0
5072963|NCT02242903|17505745|P2|Overall Study|Withdrawal by Subject|0
5072964|NCT02242903|17505746|P1|Overall Study|Withdrawal by Subject|1
5072965|NCT02242643|17505776|P2|Overall Study|Withdrawal by subject at Visit 2|1
5072966|NCT02242643|17505777|P1|Overall Study|Withdrawal by subject at Visit 2|0
5072967|NCT02242643|17505776|P2|Overall Study|Language barrier|0
5072968|NCT02242643|17505777|P1|Overall Study|Language barrier|1
5072969|NCT02242643|17505776|P2|Overall Study|Protocol requirements not followed|0
5072970|NCT02242643|17505777|P1|Overall Study|Protocol requirements not followed|1
5072971|NCT02242643|17505776|P2|Overall Study|Consent withdrawal by parent|0
5072972|NCT02242643|17505777|P1|Overall Study|Consent withdrawal by parent|1
5072973|NCT02242643|17505776|P2|Overall Study|Non-compliance|0
5072974|NCT02242643|17505777|P1|Overall Study|Non-compliance|1
5072975|NCT02242643|17505776|P2|Overall Study|Child placed in foster care by family|1
5072976|NCT02242643|17505777|P1|Overall Study|Child placed in foster care by family|0
5072977|NCT02242643|17505776|P2|Overall Study|Lost to Follow-up|61
5072978|NCT02242643|17505777|P1|Overall Study|Lost to Follow-up|54
5072979|NCT02242643|17505776|P2|Overall Study|Migrated/moved from study area|3
5072980|NCT02242643|17505777|P1|Overall Study|Migrated/moved from study area|1
5072981|NCT02242643|17505776|P2|Overall Study|Withdrawal by Subject|10
5072982|NCT02242643|17505777|P1|Overall Study|Withdrawal by Subject|15
5072983|NCT02242643|17505776|P2|Overall Study|Protocol Violation|2
5072984|NCT02242643|17505777|P1|Overall Study|Protocol Violation|1
5072985|NCT02242487|17505832|P2|Overall Study|Withdrawal by Subject|19
5072986|NCT02242487|17505833|P1|Overall Study|Withdrawal by Subject|37
5072987|NCT02242487|17505832|P2|Overall Study|Other - Miscellaneous|6
5072988|NCT02242487|17505833|P1|Overall Study|Other - Miscellaneous|4
5072989|NCT02242487|17505832|P2|Overall Study|Lost to Follow-up|1
5072990|NCT02242487|17505833|P1|Overall Study|Lost to Follow-up|2
5072991|NCT02242487|17505832|P2|Overall Study|Protocol Violation|0
5072992|NCT02242487|17505833|P1|Overall Study|Protocol Violation|2
5072993|NCT02242487|17505832|P2|Overall Study|Lack of Efficacy|6
5072994|NCT02242487|17505833|P1|Overall Study|Lack of Efficacy|4
5072995|NCT02242487|17505832|P2|Overall Study|Adverse Event|15
5072996|NCT02242487|17505833|P1|Overall Study|Adverse Event|13
5072997|NCT02242305|17505849|P2|Overall Study|Lost to Follow-up|0
5072998|NCT02242305|17505850|P1|Overall Study|Lost to Follow-up|2
5072999|NCT02242305|17505849|P2|Overall Study|Subject withdraws inform consent|4
5073000|NCT02242305|17505850|P1|Overall Study|Subject withdraws inform consent|0
5073001|NCT02242305|17505849|P2|Overall Study|Non-compliance dosing regimen or visit|2
5073002|NCT02242305|17505850|P1|Overall Study|Non-compliance dosing regimen or visit|2
5073003|NCT02242305|17505849|P2|Overall Study|Adverse Event|0
5073004|NCT02242305|17505850|P1|Overall Study|Adverse Event|1
5073005|NCT02242305|17505849|P2|Overall Study|Without spasm-like pain during 3 weeks|4
5073006|NCT02242305|17505850|P1|Overall Study|Without spasm-like pain during 3 weeks|1
5073007|NCT02242201|17505871|P3|Overall Study|preoperative opioid consumption|0
5073008|NCT02242201|17505872|P2|Overall Study|preoperative opioid consumption|1
5073009|NCT02242201|17505873|P1|Overall Study|preoperative opioid consumption|0
5073010|NCT02242201|17505871|P3|Overall Study|postponed surgery|1
5073011|NCT02242201|17505872|P2|Overall Study|postponed surgery|0
5073012|NCT02242201|17505873|P1|Overall Study|postponed surgery|0
5073013|NCT02242201|17505871|P3|Overall Study|changed surgical procedure|0
5073014|NCT02242201|17505872|P2|Overall Study|changed surgical procedure|0
5073015|NCT02242201|17505873|P1|Overall Study|changed surgical procedure|1
5073016|NCT02242201|17505871|P3|Overall Study|planned post-op anticoagulation|0
5073017|NCT02242201|17505872|P2|Overall Study|planned post-op anticoagulation|0
5073018|NCT02242201|17505873|P1|Overall Study|planned post-op anticoagulation|1
5073019|NCT02242201|17505871|P3|Overall Study|preoperative identified neuropathy|0
5073020|NCT02242201|17505872|P2|Overall Study|preoperative identified neuropathy|0
5073021|NCT02242201|17505873|P1|Overall Study|preoperative identified neuropathy|2
5073022|NCT02241889|17505911|P6|Overall Study|Withdrawal by Subject|1
5073023|NCT02241889|17505912|P5|Overall Study|Withdrawal by Subject|0
5073024|NCT02241889|17505913|P4|Overall Study|Withdrawal by Subject|0
5073025|NCT02241889|17505914|P3|Overall Study|Withdrawal by Subject|0
5073026|NCT02241889|17505915|P2|Overall Study|Withdrawal by Subject|0
5073027|NCT02241889|17505916|P1|Overall Study|Withdrawal by Subject|0
5073028|NCT02241889|17505911|P6|Overall Study|device issues|0
5073029|NCT02241889|17505912|P5|Overall Study|device issues|0
5073030|NCT02241889|17505913|P4|Overall Study|device issues|0
5073031|NCT02241889|17505914|P3|Overall Study|device issues|1
5073032|NCT02241889|17505915|P2|Overall Study|device issues|0
5073033|NCT02241889|17505916|P1|Overall Study|device issues|0
5073034|NCT02241785|17505951|P1|Overall Study|Adverse Event|1
5073035|NCT02241785|17505951|P1|Overall Study|Lost to Follow-up|2
5073036|NCT02241785|17505951|P1|Overall Study|Withdrawal by Subject|1
5073037|NCT02241785|17505951|P1|Overall Study|Sponsor Termination|43
5073038|NCT02241733|17505961|P2|Overall Study|Death|2
5073039|NCT02241733|17505962|P1|Overall Study|Death|0
5073040|NCT02241733|17505961|P2|Overall Study|Withdrawal by Subject|2
5073041|NCT02241733|17505962|P1|Overall Study|Withdrawal by Subject|0
5073042|NCT02241733|17505961|P2|Overall Study|Physician Decision|2
5073043|NCT02241733|17505962|P1|Overall Study|Physician Decision|6
5073044|NCT02241733|17505961|P2|Overall Study|Lost to Follow-up|4
5073045|NCT02241733|17505962|P1|Overall Study|Lost to Follow-up|9
5073046|NCT02241551|17506001|P2|Overall Study|Adverse Event|0
5073047|NCT02241551|17506002|P1|Overall Study|Adverse Event|1
5073048|NCT02241512|17506024|P2|Overall Study|Pump malfunction, drug not delivered|0
5073049|NCT02241512|17506025|P1|Overall Study|Pump malfunction, drug not delivered|1
5073050|NCT02241343|17506041|P1|Overall Study|Adverse Event|1
5073051|NCT02241187|17506046|P1|Overall Study|Protocol closed due to lack of accrual.|2
5073052|NCT02240693|17506078|P5|Overall Study|Other than specified|0
5073053|NCT02240693|17506079|P4|Overall Study|Other than specified|0
5073054|NCT02240693|17506080|P3|Overall Study|Other than specified|2
5073055|NCT02240693|17506081|P2|Overall Study|Other than specified|0
5073056|NCT02240693|17506082|P1|Overall Study|Other than specified|0
5073057|NCT02240693|17506078|P5|Overall Study|Withdrawal by Subject|0
5073058|NCT02240693|17506079|P4|Overall Study|Withdrawal by Subject|1
5073059|NCT02240693|17506080|P3|Overall Study|Withdrawal by Subject|2
5073060|NCT02240693|17506081|P2|Overall Study|Withdrawal by Subject|0
5073061|NCT02240693|17506082|P1|Overall Study|Withdrawal by Subject|0
5073062|NCT02240693|17506078|P5|Overall Study|Adverse Event|1
5073063|NCT02240693|17506079|P4|Overall Study|Adverse Event|0
5073064|NCT02240693|17506080|P3|Overall Study|Adverse Event|0
5073065|NCT02240693|17506081|P2|Overall Study|Adverse Event|0
5073066|NCT02240693|17506082|P1|Overall Study|Adverse Event|0
5073067|NCT02240680|17506118|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5073068|NCT02240680|17506119|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
5073069|NCT02240680|17506120|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5073070|NCT02240680|17506121|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5073071|NCT02240680|17506118|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5073072|NCT02240680|17506119|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
5073073|NCT02240680|17506120|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5073074|NCT02240680|17506121|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5073075|NCT02240680|17506118|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
5073076|NCT02240680|17506119|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
5073077|NCT02240680|17506120|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
5073078|NCT02240680|17506121|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
5073079|NCT02240680|17506118|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
5073080|NCT02240680|17506119|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
5073081|NCT02240680|17506120|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
5073082|NCT02240680|17506121|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
5073083|NCT02240680|17506118|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
5073084|NCT02240680|17506119|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
5073085|NCT02240680|17506120|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
5073086|NCT02240680|17506121|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
5073087|NCT02240680|17506118|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5073088|NCT02240680|17506119|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5073089|NCT02240680|17506120|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5073090|NCT02240680|17506121|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
5073091|NCT02240680|17506118|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
5073092|NCT02240680|17506119|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
5073093|NCT02240680|17506120|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
5073094|NCT02240680|17506121|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
5073095|NCT02240680|17506118|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
5073096|NCT02240680|17506119|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
5073097|NCT02240680|17506120|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
5073098|NCT02240680|17506121|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
5073099|NCT02240628|17506175|P2|Overall Study|Physician Decision|5
5073100|NCT02240628|17506176|P1|Overall Study|Physician Decision|6
5073101|NCT02240368|17506210|P3|Overall Study|Entropy failed to detect more than 50%|1
5073102|NCT02240368|17506211|P2|Overall Study|Entropy failed to detect more than 50%|0
5073103|NCT02240368|17506212|P1|Overall Study|Entropy failed to detect more than 50%|0
5073104|NCT02240368|17506210|P3|Overall Study|Surgery lasted less then 20 minutes|0
5073105|NCT02240368|17506211|P2|Overall Study|Surgery lasted less then 20 minutes|0
5073106|NCT02240368|17506212|P1|Overall Study|Surgery lasted less then 20 minutes|1
5073107|NCT02240121|17506244|P2|Overall Study|Other than specified|3
5073108|NCT02240121|17506245|P1|Overall Study|Other than specified|1
5073109|NCT02240121|17506244|P2|Overall Study|Lost to Follow-up|4
5073110|NCT02240121|17506245|P1|Overall Study|Lost to Follow-up|3
5073111|NCT02240121|17506244|P2|Overall Study|Withdrawal by Subject|2
5073112|NCT02240121|17506245|P1|Overall Study|Withdrawal by Subject|6
5073113|NCT02240121|17506244|P2|Overall Study|Adverse Event|4
5073114|NCT02240121|17506245|P1|Overall Study|Adverse Event|2
5073115|NCT02240121|17506244|P2|Overall Study|Pregnancy|0
5073116|NCT02240121|17506245|P1|Overall Study|Pregnancy|1
5073117|NCT02240121|17506244|P2|Overall Study|Site closed|1
5073118|NCT02240121|17506245|P1|Overall Study|Site closed|1
5073119|NCT02240121|17506244|P2|Overall Study|Lack of Efficacy|3
5073120|NCT02240121|17506245|P1|Overall Study|Lack of Efficacy|2
5073121|NCT02240121|17506244|P2|Overall Study|Change in protocol interpretation|0
5073122|NCT02240121|17506245|P1|Overall Study|Change in protocol interpretation|1
5073123|NCT02240121|17506244|P2|Overall Study|Physician Decision|1
5073124|NCT02240121|17506245|P1|Overall Study|Physician Decision|0
5073125|NCT02240121|17506244|P2|Overall Study|Protocol Violation|2
5073126|NCT02240121|17506245|P1|Overall Study|Protocol Violation|1
5073127|NCT02240108|17506273|P2|Overall Study|StudyTerminated by Sponsor|1
5073128|NCT02240108|17506274|P1|Overall Study|StudyTerminated by Sponsor|0
5073129|NCT02240108|17506273|P2|Overall Study|Withdrawal by Subject|9
5073130|NCT02240108|17506274|P1|Overall Study|Withdrawal by Subject|4
5073131|NCT02240108|17506273|P2|Overall Study|Pregnancy|0
5073132|NCT02240108|17506274|P1|Overall Study|Pregnancy|1
5073133|NCT02240108|17506273|P2|Overall Study|Adverse Event|9
5073134|NCT02240108|17506274|P1|Overall Study|Adverse Event|1
5073135|NCT02240108|17506273|P2|Overall Study|Other than specified|6
5073136|NCT02240108|17506274|P1|Overall Study|Other than specified|8
5073137|NCT02239978|17506329|P2|Overall Study|Withdrawal by Subject|0
5073138|NCT02239978|17506330|P1|Overall Study|Withdrawal by Subject|2
5073139|NCT02239939|17506347|P2|Overall Study|Lost to Follow-up|1
5073140|NCT02239939|17506348|P1|Overall Study|Lost to Follow-up|0
5073141|NCT02239939|17506347|P2|Overall Study|Withdrawal by Subject|1
5073142|NCT02239939|17506348|P1|Overall Study|Withdrawal by Subject|1
5073143|NCT02239939|17506347|P2|Overall Study|Adverse Event|0
5073144|NCT02239939|17506348|P1|Overall Study|Adverse Event|1
5073145|NCT02239926|17506364|P2|Overall Study|Withdrawal by Subject|1
5073146|NCT02239926|17506365|P1|Overall Study|Withdrawal by Subject|0
5073147|NCT02239692|17506427|P2|Overall Study|Other reason|0
5073148|NCT02239692|17506428|P1|Overall Study|Other reason|1
5073149|NCT02239692|17506427|P2|Overall Study|Withdrawal by Subject|5
5073150|NCT02239692|17506428|P1|Overall Study|Withdrawal by Subject|3
5073151|NCT02239692|17506427|P2|Overall Study|Lost to Follow-up|4
5073152|NCT02239692|17506428|P1|Overall Study|Lost to Follow-up|1
5073153|NCT02239692|17506427|P2|Overall Study|Physician Decision|1
5073154|NCT02239692|17506428|P1|Overall Study|Physician Decision|0
5073155|NCT02239692|17506427|P2|Overall Study|Adverse Event|1
5073156|NCT02239692|17506428|P1|Overall Study|Adverse Event|0
5073157|NCT02239692|17506427|P2|Overall Study|Incomplete colonoscopy|2
5073158|NCT02239692|17506428|P1|Overall Study|Incomplete colonoscopy|1
5073159|NCT02239679|17506447|P3|Overall Study|Withdrawal by Subject|1
5073160|NCT02239679|17506448|P2|Overall Study|Withdrawal by Subject|3
5073161|NCT02239679|17506449|P1|Overall Study|Withdrawal by Subject|2
5073162|NCT02239679|17506447|P3|Overall Study|Lost to Follow-up|0
5073163|NCT02239679|17506448|P2|Overall Study|Lost to Follow-up|0
5073164|NCT02239679|17506449|P1|Overall Study|Lost to Follow-up|1
5073165|NCT02239640|17506661|P1|Overall Study|Death|142
5073166|NCT02239640|17506661|P1|Overall Study|Lost to Follow-up|72
5073167|NCT02239640|17506661|P1|Overall Study|Withdrawal by Subject|3
5073168|NCT02239601|17506673|P2|Overall Study|Protocol Violation|2
5073169|NCT02239601|17506674|P1|Overall Study|Protocol Violation|4
5073170|NCT02239601|17506673|P2|Overall Study|Withdrawal by Subject|4
5073171|NCT02239601|17506674|P1|Overall Study|Withdrawal by Subject|3
5073172|NCT02239536|17506727|P2|Overall Study|Non-neoplastic polyp|17
5073173|NCT02239536|17506728|P1|Overall Study|Non-neoplastic polyp|23
5073174|NCT02239510|17506738|P2|Overall Study|Lost to Follow-up|1
5073175|NCT02239510|17506739|P1|Overall Study|Lost to Follow-up|2
5073176|NCT02239328|17506761|P1|Overall Study|Equipment or website malfunction|2
5073177|NCT02239328|17506761|P1|Overall Study|Benign disease noted at time of surgery|6
5073178|NCT02239120|17506786|P2|Overall Study|Lost to Follow-up|14
5073179|NCT02239120|17506787|P1|Overall Study|Lost to Follow-up|19
5073180|NCT02239120|17506786|P2|Overall Study|Death|58
5073181|NCT02239120|17506787|P1|Overall Study|Death|56
5073182|NCT02239094|17506811|P1|Overall Study|Remitted before started|1
5073183|NCT02239094|17506811|P1|Overall Study|Withdrawal by Subject|1
5073184|NCT02238483|17506866|P2|Overall Study|Illness in family member|0
5073185|NCT02238483|17506867|P1|Overall Study|Illness in family member|1
5073186|NCT02238483|17506866|P2|Overall Study|Completion status not recorded|1
5073187|NCT02238483|17506867|P1|Overall Study|Completion status not recorded|1
5073188|NCT02238483|17506866|P2|Overall Study|Withdrawn due to physician decision|0
5073189|NCT02238483|17506867|P1|Overall Study|Withdrawn due to physician decision|1
5073190|NCT02238483|17506866|P2|Overall Study|Adverse Event|3
5073191|NCT02238483|17506867|P1|Overall Study|Adverse Event|7
5073192|NCT02238483|17506866|P2|Overall Study|Death|0
5073193|NCT02238483|17506867|P1|Overall Study|Death|1
5073194|NCT02238483|17506866|P2|Overall Study|Protocol Violation|2
5073195|NCT02238483|17506867|P1|Overall Study|Protocol Violation|1
5073196|NCT02238483|17506866|P2|Overall Study|Lost to Follow-up|1
5073197|NCT02238483|17506867|P1|Overall Study|Lost to Follow-up|1
5073198|NCT02238483|17506866|P2|Overall Study|Withdrawal by Subject|7
5073199|NCT02238483|17506867|P1|Overall Study|Withdrawal by Subject|2
5073200|NCT02238379|17506905|P2|Overall Study|Lost to Follow-up|0
5073201|NCT02238379|17506906|P1|Overall Study|Lost to Follow-up|1
5073202|NCT02238080|17506932|P1|Overall Study|Other|4
5073203|NCT02238080|17506932|P1|Overall Study|Withdrawal by Subject|2
5073204|NCT02238080|17506932|P1|Overall Study|Treatment interrupted|6
5073205|NCT02238080|17506932|P1|Overall Study|Death|13
5073206|NCT02238067|17506946|P1|Overall Study|Not completed survey at Month 6|45
5073207|NCT02237911|17507034|P3|Overall Study|Lost to Follow-up|1
5073208|NCT02237911|17507035|P2|Overall Study|Lost to Follow-up|1
5073209|NCT02237911|17507036|P1|Overall Study|Lost to Follow-up|3
5073210|NCT02237911|17507034|P3|Overall Study|Withdrawal by Subject|2
5073211|NCT02237911|17507035|P2|Overall Study|Withdrawal by Subject|7
5073212|NCT02237911|17507036|P1|Overall Study|Withdrawal by Subject|4
5073213|NCT02237196|17507076|P4|Overall Study|Site Error|2
5073214|NCT02237196|17507077|P3|Overall Study|Site Error|0
5073215|NCT02237196|17507078|P2|Overall Study|Site Error|2
5073216|NCT02237196|17507079|P1|Overall Study|Site Error|1
5073217|NCT02237196|17507076|P4|Overall Study|Withdrawal by Subject|1
5073218|NCT02237196|17507077|P3|Overall Study|Withdrawal by Subject|4
5073219|NCT02237196|17507078|P2|Overall Study|Withdrawal by Subject|1
5073220|NCT02237196|17507079|P1|Overall Study|Withdrawal by Subject|1
5073221|NCT02237196|17507076|P4|Overall Study|Pregnancy|1
5073222|NCT02237196|17507077|P3|Overall Study|Pregnancy|1
5073223|NCT02237196|17507078|P2|Overall Study|Pregnancy|0
5073224|NCT02237196|17507079|P1|Overall Study|Pregnancy|0
5073225|NCT02237196|17507076|P4|Overall Study|Physician Decision|1
5073226|NCT02237196|17507077|P3|Overall Study|Physician Decision|0
5073227|NCT02237196|17507078|P2|Overall Study|Physician Decision|0
5073228|NCT02237196|17507079|P1|Overall Study|Physician Decision|2
5073229|NCT02237196|17507076|P4|Overall Study|Lost to Follow-up|6
5073230|NCT02237196|17507077|P3|Overall Study|Lost to Follow-up|4
5073231|NCT02237196|17507078|P2|Overall Study|Lost to Follow-up|2
5073232|NCT02237196|17507079|P1|Overall Study|Lost to Follow-up|4
5073233|NCT02237196|17507076|P4|Overall Study|Adverse Event|0
5073234|NCT02237196|17507077|P3|Overall Study|Adverse Event|1
5073235|NCT02237196|17507078|P2|Overall Study|Adverse Event|1
5073236|NCT02237196|17507079|P1|Overall Study|Adverse Event|0
5073237|NCT02237118|17507123|P2|Overall Study|consent withdrawn|0
5073238|NCT02237118|17507124|P1|Overall Study|consent withdrawn|1
5073239|NCT02237118|17507123|P2|Overall Study|Protocol Violation|1
5073240|NCT02237118|17507124|P1|Overall Study|Protocol Violation|0
5073241|NCT02237001|17507155|P1|Overall Study|Incarceration|1
5073242|NCT02237001|17507155|P1|Overall Study|Re-operation|4
5073243|NCT02237001|17507155|P1|Overall Study|Eligibility criteria/Late Screen Failure|3
5073244|NCT02237001|17507155|P1|Overall Study|Withdrawal by Subject|1
5073245|NCT02237001|17507155|P1|Overall Study|Lost to Follow-up|2
5073246|NCT02236611|17507173|P2|Overall Study|Withdrew consent|4
5073247|NCT02236611|17507174|P1|Overall Study|Withdrew consent|9
5073248|NCT02236611|17507173|P2|Overall Study|Protocol deviation|5
5073249|NCT02236611|17507174|P1|Overall Study|Protocol deviation|3
5073250|NCT02236611|17507173|P2|Overall Study|Lost to Follow-up|2
5073251|NCT02236611|17507174|P1|Overall Study|Lost to Follow-up|0
5073252|NCT02236611|17507173|P2|Overall Study|Lack of Efficacy|7
5073253|NCT02236611|17507174|P1|Overall Study|Lack of Efficacy|4
5073254|NCT02236611|17507173|P2|Overall Study|Adverse Event|16
5073255|NCT02236611|17507174|P1|Overall Study|Adverse Event|10
5073256|NCT02236598|17507182|P2|Overall Study|Withdrawal by Subject|1
5073257|NCT02236598|17507183|P1|Overall Study|Withdrawal by Subject|0
5073258|NCT02236598|17507182|P2|Overall Study|Adverse Event|1
5073259|NCT02236598|17507183|P1|Overall Study|Adverse Event|0
5073260|NCT02236559|17507197|P2|Overall Study|Withdrawal by Subject|0
5073261|NCT02236559|17507198|P1|Overall Study|Withdrawal by Subject|1
5073262|NCT02236559|17507197|P2|Overall Study|Physician Decision|1
5073263|NCT02236559|17507198|P1|Overall Study|Physician Decision|1
5073264|NCT02236559|17507197|P2|Overall Study|Subject Did Not Consent|2
5073265|NCT02236559|17507198|P1|Overall Study|Subject Did Not Consent|4
5073266|NCT02236559|17507197|P2|Overall Study|Did not Meet Inclusion|3
5073267|NCT02236559|17507198|P1|Overall Study|Did not Meet Inclusion|3
5073268|NCT02236559|17507197|P2|Overall Study|Met Exclusion|6
5073269|NCT02236559|17507198|P1|Overall Study|Met Exclusion|3
5073270|NCT02236520|17507235|P4|Overall Study|Pregnancy|0
5073271|NCT02236520|17507236|P3|Overall Study|Pregnancy|0
5073272|NCT02236520|17507237|P2|Overall Study|Pregnancy|0
5073273|NCT02236520|17507238|P1|Overall Study|Pregnancy|1
5073274|NCT02236520|17507235|P4|Overall Study|Withdrawal by Subject|1
5073275|NCT02236520|17507236|P3|Overall Study|Withdrawal by Subject|0
5073276|NCT02236520|17507237|P2|Overall Study|Withdrawal by Subject|0
5073277|NCT02236520|17507238|P1|Overall Study|Withdrawal by Subject|1
5073278|NCT02236520|17507235|P4|Overall Study|Physician Decision|0
5073279|NCT02236520|17507236|P3|Overall Study|Physician Decision|0
5073280|NCT02236520|17507237|P2|Overall Study|Physician Decision|5
5073281|NCT02236520|17507238|P1|Overall Study|Physician Decision|0
5073282|NCT02236130|17507265|P2|Overall Study|Lost to Follow-up|12
5073283|NCT02236130|17507266|P1|Overall Study|Lost to Follow-up|7
5073284|NCT02235454|17507316|P1|Overall Study|Withdrawal by Subject|2
5073285|NCT02235311|17507322|P2|Overall Study|Protocol Violation|1
5073286|NCT02235311|17507323|P1|Overall Study|Protocol Violation|0
5073287|NCT02235311|17507322|P2|Overall Study|Lost to Follow-up|1
5073288|NCT02235311|17507323|P1|Overall Study|Lost to Follow-up|0
5073289|NCT02235077|17507341|P2|Overall Study|Physician Decision|1
5073290|NCT02235077|17507342|P1|Overall Study|Physician Decision|0
5073291|NCT02235077|17507341|P2|Overall Study|Withdrawal by Subject|5
5073292|NCT02235077|17507342|P1|Overall Study|Withdrawal by Subject|8
5073293|NCT02235077|17507341|P2|Overall Study|Lost to Follow-up|6
5073294|NCT02235077|17507342|P1|Overall Study|Lost to Follow-up|5
5073295|NCT02235077|17507341|P2|Overall Study|Death|7
5073296|NCT02235077|17507342|P1|Overall Study|Death|5
5073297|NCT02234843|17507407|P10|Overall Study|Lost to Follow-up|0
5073298|NCT02234843|17507408|P9|Overall Study|Lost to Follow-up|0
5073299|NCT02234843|17507409|P8|Overall Study|Lost to Follow-up|0
5073300|NCT02234843|17507410|P7|Overall Study|Lost to Follow-up|1
5073301|NCT02234843|17507411|P6|Overall Study|Lost to Follow-up|0
5073302|NCT02234843|17507412|P5|Overall Study|Lost to Follow-up|0
5073303|NCT02234843|17507413|P4|Overall Study|Lost to Follow-up|0
5073304|NCT02234843|17507414|P3|Overall Study|Lost to Follow-up|0
5073305|NCT02234843|17507415|P2|Overall Study|Lost to Follow-up|1
5073306|NCT02234843|17507416|P1|Overall Study|Lost to Follow-up|0
5073307|NCT02234843|17507407|P10|Overall Study|Non-compliance with study drug|0
5073308|NCT02234843|17507408|P9|Overall Study|Non-compliance with study drug|0
5073309|NCT02234843|17507409|P8|Overall Study|Non-compliance with study drug|0
5073310|NCT02234843|17507410|P7|Overall Study|Non-compliance with study drug|1
5073311|NCT02234843|17507411|P6|Overall Study|Non-compliance with study drug|1
5073312|NCT02234843|17507412|P5|Overall Study|Non-compliance with study drug|0
5073313|NCT02234843|17507413|P4|Overall Study|Non-compliance with study drug|0
5073314|NCT02234843|17507414|P3|Overall Study|Non-compliance with study drug|0
5073315|NCT02234843|17507415|P2|Overall Study|Non-compliance with study drug|0
5073316|NCT02234843|17507416|P1|Overall Study|Non-compliance with study drug|1
5073317|NCT02234843|17507407|P10|Overall Study|Adverse Event|0
5073318|NCT02234843|17507408|P9|Overall Study|Adverse Event|1
5073319|NCT02234843|17507409|P8|Overall Study|Adverse Event|0
5073320|NCT02234843|17507410|P7|Overall Study|Adverse Event|0
5073321|NCT02234843|17507411|P6|Overall Study|Adverse Event|1
5073322|NCT02234843|17507412|P5|Overall Study|Adverse Event|2
5073323|NCT02234843|17507413|P4|Overall Study|Adverse Event|3
5073324|NCT02234843|17507414|P3|Overall Study|Adverse Event|1
5073325|NCT02234843|17507415|P2|Overall Study|Adverse Event|1
5073326|NCT02234843|17507416|P1|Overall Study|Adverse Event|5
5073327|NCT02234843|17507407|P10|Overall Study|Physician Decision|0
5073328|NCT02234843|17507408|P9|Overall Study|Physician Decision|0
5073329|NCT02234843|17507409|P8|Overall Study|Physician Decision|1
5073330|NCT02234843|17507410|P7|Overall Study|Physician Decision|0
5073331|NCT02234843|17507411|P6|Overall Study|Physician Decision|0
5073332|NCT02234843|17507412|P5|Overall Study|Physician Decision|0
5073333|NCT02234843|17507413|P4|Overall Study|Physician Decision|1
5073334|NCT02234843|17507414|P3|Overall Study|Physician Decision|0
5073335|NCT02234843|17507415|P2|Overall Study|Physician Decision|1
5073336|NCT02234843|17507416|P1|Overall Study|Physician Decision|4
5073337|NCT02234843|17507407|P10|Overall Study|Other|0
5073338|NCT02234843|17507408|P9|Overall Study|Other|0
5073339|NCT02234843|17507409|P8|Overall Study|Other|1
5073340|NCT02234843|17507410|P7|Overall Study|Other|0
5073341|NCT02234843|17507411|P6|Overall Study|Other|1
5073342|NCT02234843|17507412|P5|Overall Study|Other|0
5073343|NCT02234843|17507413|P4|Overall Study|Other|1
5073344|NCT02234843|17507414|P3|Overall Study|Other|0
5073345|NCT02234843|17507415|P2|Overall Study|Other|2
5073346|NCT02234843|17507416|P1|Overall Study|Other|0
5073347|NCT02234843|17507407|P10|Overall Study|Recovery|0
5073348|NCT02234843|17507408|P9|Overall Study|Recovery|0
5073349|NCT02234843|17507409|P8|Overall Study|Recovery|0
5073350|NCT02234843|17507410|P7|Overall Study|Recovery|0
5073351|NCT02234843|17507411|P6|Overall Study|Recovery|0
5073352|NCT02234843|17507412|P5|Overall Study|Recovery|0
5073353|NCT02234843|17507413|P4|Overall Study|Recovery|0
5073354|NCT02234843|17507414|P3|Overall Study|Recovery|0
5073355|NCT02234843|17507415|P2|Overall Study|Recovery|0
5073356|NCT02234843|17507416|P1|Overall Study|Recovery|1
5073357|NCT02234843|17507407|P10|Overall Study|Withdrawal by Subject|0
5073358|NCT02234843|17507408|P9|Overall Study|Withdrawal by Subject|0
5073359|NCT02234843|17507409|P8|Overall Study|Withdrawal by Subject|0
5073360|NCT02234843|17507410|P7|Overall Study|Withdrawal by Subject|0
5073361|NCT02234843|17507411|P6|Overall Study|Withdrawal by Subject|7
5073362|NCT02234843|17507412|P5|Overall Study|Withdrawal by Subject|0
5073363|NCT02234843|17507413|P4|Overall Study|Withdrawal by Subject|0
5073364|NCT02234843|17507414|P3|Overall Study|Withdrawal by Subject|1
5073365|NCT02234843|17507415|P2|Overall Study|Withdrawal by Subject|1
5073366|NCT02234843|17507416|P1|Overall Study|Withdrawal by Subject|5
5073367|NCT02234843|17507407|P10|Overall Study|Patient convenience|0
5073368|NCT02234843|17507408|P9|Overall Study|Patient convenience|0
5073369|NCT02234843|17507409|P8|Overall Study|Patient convenience|0
5073370|NCT02234843|17507410|P7|Overall Study|Patient convenience|0
5073371|NCT02234843|17507411|P6|Overall Study|Patient convenience|1
5073372|NCT02234843|17507412|P5|Overall Study|Patient convenience|0
5073373|NCT02234843|17507413|P4|Overall Study|Patient convenience|0
5073374|NCT02234843|17507414|P3|Overall Study|Patient convenience|0
5073375|NCT02234843|17507415|P2|Overall Study|Patient convenience|0
5073376|NCT02234843|17507416|P1|Overall Study|Patient convenience|2
5073377|NCT02234843|17507407|P10|Overall Study|Efficacy outcome reached|0
5073378|NCT02234843|17507408|P9|Overall Study|Efficacy outcome reached|0
5073379|NCT02234843|17507409|P8|Overall Study|Efficacy outcome reached|0
5073380|NCT02234843|17507410|P7|Overall Study|Efficacy outcome reached|0
5073381|NCT02234843|17507411|P6|Overall Study|Efficacy outcome reached|2
5073382|NCT02234843|17507412|P5|Overall Study|Efficacy outcome reached|0
5073383|NCT02234843|17507413|P4|Overall Study|Efficacy outcome reached|0
5073384|NCT02234843|17507414|P3|Overall Study|Efficacy outcome reached|0
5073385|NCT02234843|17507415|P2|Overall Study|Efficacy outcome reached|0
5073386|NCT02234843|17507416|P1|Overall Study|Efficacy outcome reached|2
5073387|NCT02234843|17507407|P10|Overall Study|Protocol Violation|0
5073388|NCT02234843|17507408|P9|Overall Study|Protocol Violation|0
5073389|NCT02234843|17507409|P8|Overall Study|Protocol Violation|0
5073390|NCT02234843|17507410|P7|Overall Study|Protocol Violation|0
5073391|NCT02234843|17507411|P6|Overall Study|Protocol Violation|0
5073392|NCT02234843|17507412|P5|Overall Study|Protocol Violation|0
5073393|NCT02234843|17507413|P4|Overall Study|Protocol Violation|0
5073394|NCT02234843|17507414|P3|Overall Study|Protocol Violation|1
5073395|NCT02234843|17507415|P2|Overall Study|Protocol Violation|0
5073396|NCT02234843|17507416|P1|Overall Study|Protocol Violation|1
5073397|NCT02234843|17507407|P10|Overall Study|Death|0
5073398|NCT02234843|17507408|P9|Overall Study|Death|0
5073399|NCT02234843|17507409|P8|Overall Study|Death|0
5073400|NCT02234843|17507410|P7|Overall Study|Death|0
5073401|NCT02234843|17507411|P6|Overall Study|Death|0
5073402|NCT02234843|17507412|P5|Overall Study|Death|0
5073403|NCT02234843|17507413|P4|Overall Study|Death|0
5073404|NCT02234843|17507414|P3|Overall Study|Death|0
5073405|NCT02234843|17507415|P2|Overall Study|Death|0
5073406|NCT02234843|17507416|P1|Overall Study|Death|1
5073407|NCT02234622|17507574|P2|Overall Study|Lost to Follow-up|14
5073408|NCT02234622|17507575|P1|Overall Study|Lost to Follow-up|27
5073409|NCT02234622|17507574|P2|Overall Study|Withdrawal by Subject|22
5073410|NCT02234622|17507575|P1|Overall Study|Withdrawal by Subject|16
5073411|NCT02234583|17507595|P2|Overall Study|Other|97
5073412|NCT02234583|17507596|P1|Overall Study|Other|39
5073413|NCT02234583|17507595|P2|Overall Study|Protocol Violation|42
5073414|NCT02234583|17507596|P1|Overall Study|Protocol Violation|35
5073415|NCT02234583|17507595|P2|Overall Study|Lack of Efficacy|103
5073416|NCT02234583|17507596|P1|Overall Study|Lack of Efficacy|58
5073417|NCT02234583|17507595|P2|Overall Study|Lost to Follow-up|1
5073418|NCT02234583|17507596|P1|Overall Study|Lost to Follow-up|0
5073419|NCT02234583|17507595|P2|Overall Study|Withdrawal by Subject|157
5073420|NCT02234583|17507596|P1|Overall Study|Withdrawal by Subject|109
5073421|NCT02234583|17507595|P2|Overall Study|Adverse Event|156
5073422|NCT02234583|17507596|P1|Overall Study|Adverse Event|172
5073423|NCT02234479|17507715|P2|Overall Study|Withdrawal by Subject|3
5073424|NCT02234479|17507716|P1|Overall Study|Withdrawal by Subject|1
5073425|NCT02234362|17507726|P1|Overall Study|Withdrawal by Subject|3
5073426|NCT02234362|17507726|P1|Overall Study|Lost to Follow-up|6
5073427|NCT02234362|17507726|P1|Overall Study|Not eligible after first screening visit|17
5073428|NCT02234323|17507743|P1|All Treated|Other|7
5073429|NCT02234323|17507743|P1|All Treated|Exceeded lab value limit|2
5073430|NCT02234323|17507743|P1|All Treated|Lack of Efficacy|3
5073431|NCT02234323|17507743|P1|All Treated|Physician Decision|5
5073432|NCT02234323|17507743|P1|All Treated|Death|1
5073433|NCT02234323|17507743|P1|All Enrolled|Not Treated: Exceeded lab value limit|1
5073434|NCT02234323|17507743|P1|All Enrolled|Not Treated:Consent withdrawn by subject|2
5073435|NCT02234323|17507743|P1|All Enrolled|Not Treated: Completed study in database|2
5073436|NCT02234310|17507756|P1|Overall Study|Withdrawal by Subject|2
5073437|NCT02234310|17507756|P1|Overall Study|Eligibility Criteria not fulfilled|2
5073438|NCT02234310|17507756|P1|Overall Study|Adverse Event|1
5073439|NCT02234310|17507756|P1|Overall Study|Physician Decision|1
5073440|NCT02234284|17507770|P2|Overall Study|Lost to Follow-up|7
5073441|NCT02234284|17507771|P1|Overall Study|Lost to Follow-up|20
5073442|NCT02234284|17507770|P2|Overall Study|Withdrawal by Subject|0
5073443|NCT02234284|17507771|P1|Overall Study|Withdrawal by Subject|1
5073444|NCT02234284|17507770|P2|Overall Study|Death|2
5073445|NCT02234284|17507771|P1|Overall Study|Death|4
5073446|NCT02234141|17507830|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
5073447|NCT02234141|17507831|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
5073448|NCT02234141|17507832|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
5073449|NCT02234141|17507833|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
5073450|NCT02234141|17507834|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
5073451|NCT02234141|17507835|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
5073452|NCT02234141|17507836|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
5073453|NCT02234141|17507830|P7|Long-Term Treatment Period|Withdrew Consent|0
5073454|NCT02234141|17507831|P6|Long-Term Treatment Period|Withdrew Consent|0
5073455|NCT02234141|17507832|P5|Long-Term Treatment Period|Withdrew Consent|0
5073456|NCT02234141|17507833|P4|Long-Term Treatment Period|Withdrew Consent|0
5073457|NCT02234141|17507834|P3|Long-Term Treatment Period|Withdrew Consent|1
5073458|NCT02234141|17507835|P2|Long-Term Treatment Period|Withdrew Consent|1
5073459|NCT02234141|17507836|P1|Long-Term Treatment Period|Withdrew Consent|0
5073460|NCT02234141|17507830|P7|Long-Term Treatment Period|Adverse Event|1
5073461|NCT02234141|17507831|P6|Long-Term Treatment Period|Adverse Event|1
5073462|NCT02234141|17507832|P5|Long-Term Treatment Period|Adverse Event|1
5073463|NCT02234141|17507833|P4|Long-Term Treatment Period|Adverse Event|0
5073464|NCT02234141|17507834|P3|Long-Term Treatment Period|Adverse Event|5
5073465|NCT02234141|17507835|P2|Long-Term Treatment Period|Adverse Event|0
5073466|NCT02234141|17507836|P1|Long-Term Treatment Period|Adverse Event|4
5073467|NCT02234141|17507830|P7|Long-Term Treatment Period|Investigator's discretion|1
5073468|NCT02234141|17507831|P6|Long-Term Treatment Period|Investigator's discretion|0
5073469|NCT02234141|17507832|P5|Long-Term Treatment Period|Investigator's discretion|0
5073470|NCT02234141|17507833|P4|Long-Term Treatment Period|Investigator's discretion|0
5073471|NCT02234141|17507834|P3|Long-Term Treatment Period|Investigator's discretion|2
5073472|NCT02234141|17507835|P2|Long-Term Treatment Period|Investigator's discretion|3
5073473|NCT02234141|17507836|P1|Long-Term Treatment Period|Investigator's discretion|1
5073474|NCT02234141|17507830|P7|Long-Term Treatment Period|Death|0
5073475|NCT02234141|17507831|P6|Long-Term Treatment Period|Death|1
5073476|NCT02234141|17507832|P5|Long-Term Treatment Period|Death|0
5073477|NCT02234141|17507833|P4|Long-Term Treatment Period|Death|0
5073478|NCT02234141|17507834|P3|Long-Term Treatment Period|Death|0
5073479|NCT02234141|17507835|P2|Long-Term Treatment Period|Death|0
5073480|NCT02234141|17507836|P1|Long-Term Treatment Period|Death|0
5073481|NCT02234141|17507830|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
5073482|NCT02234141|17507831|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
5073483|NCT02234141|17507832|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
5073484|NCT02234141|17507833|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
5073485|NCT02234141|17507834|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
5073486|NCT02234141|17507835|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
5073487|NCT02234141|17507836|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
5073488|NCT02234141|17507830|P7|Treatment Period (24 Weeks)|Adverse Event|0
5073489|NCT02234141|17507831|P6|Treatment Period (24 Weeks)|Adverse Event|0
5073490|NCT02234141|17507832|P5|Treatment Period (24 Weeks)|Adverse Event|0
5073491|NCT02234141|17507833|P4|Treatment Period (24 Weeks)|Adverse Event|3
5073492|NCT02234141|17507834|P3|Treatment Period (24 Weeks)|Adverse Event|2
5073493|NCT02234141|17507835|P2|Treatment Period (24 Weeks)|Adverse Event|1
5073494|NCT02234141|17507836|P1|Treatment Period (24 Weeks)|Adverse Event|3
5073495|NCT02234141|17507830|P7|Treatment Period (24 Weeks)|Death|0
5073496|NCT02234141|17507831|P6|Treatment Period (24 Weeks)|Death|0
5073497|NCT02234141|17507832|P5|Treatment Period (24 Weeks)|Death|0
5073498|NCT02234141|17507833|P4|Treatment Period (24 Weeks)|Death|1
5073499|NCT02234141|17507834|P3|Treatment Period (24 Weeks)|Death|0
5073500|NCT02234141|17507835|P2|Treatment Period (24 Weeks)|Death|2
5073501|NCT02234141|17507836|P1|Treatment Period (24 Weeks)|Death|1
5073502|NCT02234141|17507830|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
5073503|NCT02234141|17507831|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
5073504|NCT02234141|17507832|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
5073505|NCT02234141|17507833|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
5073506|NCT02234141|17507834|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
5073507|NCT02234141|17507835|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
5073508|NCT02234141|17507836|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
5073509|NCT02234141|17507830|P7|Treatment Period (24 Weeks)|Protocol Violation|0
5073510|NCT02234141|17507831|P6|Treatment Period (24 Weeks)|Protocol Violation|0
5073511|NCT02234141|17507832|P5|Treatment Period (24 Weeks)|Protocol Violation|0
5073512|NCT02234141|17507833|P4|Treatment Period (24 Weeks)|Protocol Violation|1
5073513|NCT02234141|17507834|P3|Treatment Period (24 Weeks)|Protocol Violation|0
5073514|NCT02234141|17507835|P2|Treatment Period (24 Weeks)|Protocol Violation|0
5073515|NCT02234141|17507836|P1|Treatment Period (24 Weeks)|Protocol Violation|0
5073516|NCT02234063|17507941|P2|Overall Study|Withdrawal by Subject|1
5073517|NCT02234063|17507942|P1|Overall Study|Withdrawal by Subject|20
5073518|NCT02234063|17507941|P2|Overall Study|Lost to Follow-up|42
5073519|NCT02234063|17507942|P1|Overall Study|Lost to Follow-up|235
5073520|NCT02233803|17508021|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
5073521|NCT02233803|17508022|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
5073522|NCT02233803|17508021|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
5073523|NCT02233803|17508022|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
5073524|NCT02233803|17508021|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
5073525|NCT02233803|17508022|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
5073526|NCT02233803|17508021|P2|Washout Period (4-Wks)|Physician Decision|0
5073527|NCT02233803|17508022|P1|Washout Period (4-Wks)|Physician Decision|1
5073528|NCT02233803|17508021|P2|Washout Period (4-Wks)|Lost to Follow-up|1
5073529|NCT02233803|17508022|P1|Washout Period (4-Wks)|Lost to Follow-up|0
5073530|NCT02233803|17508021|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
5073531|NCT02233803|17508022|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
5073532|NCT02233803|17508021|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
5073533|NCT02233803|17508022|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
5073534|NCT02233803|17508021|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
5073535|NCT02233803|17508022|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
5073536|NCT02233803|17508021|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
5073625|NCT02232087|17508538|P4|Overall Study|poor inhalation technique|0
5073537|NCT02233803|17508022|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
5073538|NCT02233738|17508055|P2|Overall Study|Did not return after Baseline|2
5073539|NCT02233738|17508056|P1|Overall Study|Did not return after Baseline|3
5073540|NCT02233738|17508055|P2|Overall Study|Withdrawal by Subject|1
5073541|NCT02233738|17508056|P1|Overall Study|Withdrawal by Subject|0
5073542|NCT02233738|17508055|P2|Overall Study|Death|1
5073543|NCT02233738|17508056|P1|Overall Study|Death|0
5073544|NCT02233738|17508055|P2|Overall Study|Lost to Follow-up|12
5073545|NCT02233738|17508056|P1|Overall Study|Lost to Follow-up|5
5073546|NCT02233647|17508226|P1|Overall Study|Adverse Event|1
5073547|NCT02233543|17508255|P2|Period 2|COPD exacerbation|0
5073548|NCT02233543|17508256|P1|Period 2|COPD exacerbation|1
5073549|NCT02233543|17508255|P2|Period 2|Participant required other treatment.|1
5073550|NCT02233543|17508256|P1|Period 2|Participant required other treatment.|0
5073551|NCT02233543|17508255|P2|Period 2|Adverse Event|0
5073552|NCT02233543|17508256|P1|Period 2|Adverse Event|1
5073553|NCT02233543|17508255|P2|Period 1|Participants required other treatment.|3
5073554|NCT02233543|17508256|P1|Period 1|Participants required other treatment.|2
5073555|NCT02233543|17508255|P2|Period 1|Withdrawal by Subject|0
5073556|NCT02233543|17508256|P1|Period 1|Withdrawal by Subject|1
5073557|NCT02233309|17508306|P1|Overall Study|Physician Decision|5
5073558|NCT02232984|17508340|P1|Overall Study|Protocol Violation|1
5073559|NCT02232984|17508340|P1|Overall Study|not disclosed by site|7
5073560|NCT02232984|17508340|P1|Overall Study|Device implant unsuccessful|53
5073561|NCT02232984|17508340|P1|Overall Study|Investigator withdrawal|10
5073562|NCT02232984|17508340|P1|Overall Study|Death|1
5073563|NCT02232984|17508340|P1|Overall Study|Withdrawal by Subject|5
5073564|NCT02232893|17508351|P2|Overall Study|Other|3
5073565|NCT02232893|17508352|P1|Overall Study|Other|0
5073566|NCT02232893|17508351|P2|Overall Study|Developed exclusion criteria|1
5073567|NCT02232893|17508352|P1|Overall Study|Developed exclusion criteria|0
5073568|NCT02232893|17508351|P2|Overall Study|Sponsor request early termination|1
5073569|NCT02232893|17508352|P1|Overall Study|Sponsor request early termination|0
5073570|NCT02232893|17508351|P2|Overall Study|Adverse Event|1
5073571|NCT02232893|17508352|P1|Overall Study|Adverse Event|0
5073572|NCT02232893|17508351|P2|Overall Study|Withdrawal by Subject|1
5073573|NCT02232893|17508352|P1|Overall Study|Withdrawal by Subject|4
5073574|NCT02232880|17508358|P1|Overall Study|study stopped prior to randomization|1
5073575|NCT02232802|17508367|P2|Period 1|Adverse Event|1
5073576|NCT02232802|17508368|P1|Period 1|Adverse Event|1
5073577|NCT02232802|17508367|P2|Period 1|Sponsor request|0
5073578|NCT02232802|17508368|P1|Period 1|Sponsor request|1
5073579|NCT02232698|17508434|P2|Overall Study|Withdrawal by Subject|11
5073580|NCT02232698|17508435|P1|Overall Study|Withdrawal by Subject|0
5073581|NCT02232698|17508434|P2|Overall Study|Allocated to control group|3
5073582|NCT02232698|17508435|P1|Overall Study|Allocated to control group|0
5073583|NCT02232698|17508434|P2|Overall Study|Non-compliance with study device|4
5073584|NCT02232698|17508435|P1|Overall Study|Non-compliance with study device|1
5073585|NCT02232698|17508434|P2|Overall Study|Had device-associated symptoms|0
5073586|NCT02232698|17508435|P1|Overall Study|Had device-associated symptoms|7
5073587|NCT02232698|17508434|P2|Overall Study|Met exclusion criteria|1
5073588|NCT02232698|17508435|P1|Overall Study|Met exclusion criteria|1
5073589|NCT02232698|17508434|P2|Overall Study|Pregnancy|1
5073590|NCT02232698|17508435|P1|Overall Study|Pregnancy|1
5073591|NCT02232425|17508458|P2|Overall Study|Lack of Efficacy|0
5073592|NCT02232425|17508459|P1|Overall Study|Lack of Efficacy|1
5073593|NCT02232425|17508458|P2|Overall Study|Withdrawal by Subject|6
5073594|NCT02232425|17508459|P1|Overall Study|Withdrawal by Subject|5
5073595|NCT02232425|17508458|P2|Overall Study|Adverse Event|0
5073596|NCT02232425|17508459|P1|Overall Study|Adverse Event|2
5073597|NCT02232425|17508458|P2|Overall Study|Lost to Follow-up|2
5073598|NCT02232425|17508459|P1|Overall Study|Lost to Follow-up|6
5073599|NCT02232243|17508492|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
5073600|NCT02232243|17508493|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
5073601|NCT02232243|17508494|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
5073602|NCT02232178|17508506|P3|Overall Study|surgical complication|0
5073603|NCT02232178|17508507|P2|Overall Study|surgical complication|0
5073604|NCT02232178|17508508|P1|Overall Study|surgical complication|1
5073605|NCT02232178|17508506|P3|Overall Study|ineligibility|1
5073606|NCT02232178|17508507|P2|Overall Study|ineligibility|0
5073607|NCT02232178|17508508|P1|Overall Study|ineligibility|0
5073608|NCT02232178|17508506|P3|Overall Study|Lost to Follow-up|0
5073609|NCT02232178|17508507|P2|Overall Study|Lost to Follow-up|1
5073610|NCT02232178|17508508|P1|Overall Study|Lost to Follow-up|0
5073611|NCT02232087|17508536|P6|Overall Study|Adverse Event|0
5073612|NCT02232087|17508537|P5|Overall Study|Adverse Event|1
5073613|NCT02232087|17508538|P4|Overall Study|Adverse Event|0
5073614|NCT02232087|17508539|P3|Overall Study|Adverse Event|0
5073615|NCT02232087|17508540|P2|Overall Study|Adverse Event|0
5073616|NCT02232087|17508541|P1|Overall Study|Adverse Event|0
5073617|NCT02232087|17508536|P6|Overall Study|protocol stop criteria|0
5073618|NCT02232087|17508537|P5|Overall Study|protocol stop criteria|0
5073619|NCT02232087|17508538|P4|Overall Study|protocol stop criteria|1
5073620|NCT02232087|17508539|P3|Overall Study|protocol stop criteria|0
5073621|NCT02232087|17508540|P2|Overall Study|protocol stop criteria|1
5073622|NCT02232087|17508541|P1|Overall Study|protocol stop criteria|0
5073623|NCT02232087|17508536|P6|Overall Study|poor inhalation technique|2
5073624|NCT02232087|17508537|P5|Overall Study|poor inhalation technique|0
5073626|NCT02232087|17508539|P3|Overall Study|poor inhalation technique|0
5073627|NCT02232087|17508540|P2|Overall Study|poor inhalation technique|1
5073628|NCT02232087|17508541|P1|Overall Study|poor inhalation technique|0
5073629|NCT02232087|17508536|P6|Overall Study|Withdrawal by Subject|1
5073630|NCT02232087|17508537|P5|Overall Study|Withdrawal by Subject|0
5073631|NCT02232087|17508538|P4|Overall Study|Withdrawal by Subject|0
5073632|NCT02232087|17508539|P3|Overall Study|Withdrawal by Subject|0
5073633|NCT02232087|17508540|P2|Overall Study|Withdrawal by Subject|0
5073634|NCT02232087|17508541|P1|Overall Study|Withdrawal by Subject|2
5073635|NCT02232074|17508577|P2|Overall Study|deemed ineligible|1
5073636|NCT02232074|17508578|P1|Overall Study|deemed ineligible|0
5073637|NCT02232074|17508577|P2|Overall Study|No legal concerns at baseline|41
5073638|NCT02232074|17508578|P1|Overall Study|No legal concerns at baseline|36
5073639|NCT02232074|17508577|P2|Overall Study|Withdrawal by Subject|3
5073640|NCT02232074|17508578|P1|Overall Study|Withdrawal by Subject|5
5073641|NCT02231918|17508645|P3|Overall Study|Adverse Event|1
5073642|NCT02231918|17508646|P2|Overall Study|Adverse Event|0
5073643|NCT02231918|17508647|P1|Overall Study|Adverse Event|0
5073644|NCT02231918|17508645|P3|Overall Study|Withdrawal by Subject|0
5073645|NCT02231918|17508646|P2|Overall Study|Withdrawal by Subject|1
5073646|NCT02231918|17508647|P1|Overall Study|Withdrawal by Subject|0
5073647|NCT02231892|17508712|P3|Overall Study|Could not find reliable motor hotspot|1
5073648|NCT02231892|17508713|P2|Overall Study|Could not find reliable motor hotspot|0
5073649|NCT02231892|17508714|P1|Overall Study|Could not find reliable motor hotspot|0
5073650|NCT02231892|17508712|P3|Overall Study|Could not find motor threshold|1
5073651|NCT02231892|17508713|P2|Overall Study|Could not find motor threshold|0
5073652|NCT02231892|17508714|P1|Overall Study|Could not find motor threshold|2
5073653|NCT02231892|17508712|P3|Overall Study|Participant motor threshold was >83%|9
5073654|NCT02231892|17508713|P2|Overall Study|Participant motor threshold was >83%|0
5073655|NCT02231892|17508714|P1|Overall Study|Participant motor threshold was >83%|0
5073656|NCT02231892|17508712|P3|Overall Study|Motor activity when stimulating ante ACC|12
5073657|NCT02231892|17508713|P2|Overall Study|Motor activity when stimulating ante ACC|7
5073658|NCT02231892|17508714|P1|Overall Study|Motor activity when stimulating ante ACC|4
5073659|NCT02231892|17508712|P3|Overall Study|Physician Decision|4
5073660|NCT02231892|17508713|P2|Overall Study|Physician Decision|2
5073661|NCT02231892|17508714|P1|Overall Study|Physician Decision|0
5073662|NCT02231892|17508712|P3|Overall Study|Withdrawal by Subject|15
5073663|NCT02231892|17508713|P2|Overall Study|Withdrawal by Subject|3
5073664|NCT02231892|17508714|P1|Overall Study|Withdrawal by Subject|4
5073665|NCT02231892|17508712|P3|Overall Study|Lost to Follow-up|3
5073666|NCT02231892|17508713|P2|Overall Study|Lost to Follow-up|0
5073667|NCT02231892|17508714|P1|Overall Study|Lost to Follow-up|1
5073668|NCT02231762|17508731|P4|Maintenance Phase|Adverse Event|2
5073669|NCT02231762|17508732|P3|Maintenance Phase|Adverse Event|1
5073670|NCT02231762|17508733|P2|Maintenance Phase|Adverse Event|0
5073671|NCT02231762|17508734|P1|Maintenance Phase|Adverse Event|0
5073672|NCT02231762|17508731|P4|Maintenance Phase|Disease progression|3
5073673|NCT02231762|17508732|P3|Maintenance Phase|Disease progression|4
5073674|NCT02231762|17508733|P2|Maintenance Phase|Disease progression|3
5073675|NCT02231762|17508734|P1|Maintenance Phase|Disease progression|0
5073676|NCT02231762|17508731|P4|Combination Phase|Protocol Violation|0
5073677|NCT02231762|17508732|P3|Combination Phase|Protocol Violation|0
5073678|NCT02231762|17508733|P2|Combination Phase|Protocol Violation|0
5073679|NCT02231762|17508734|P1|Combination Phase|Protocol Violation|1
5073680|NCT02231762|17508731|P4|Combination Phase|Did not meet inclusion criteria|0
5073681|NCT02231762|17508732|P3|Combination Phase|Did not meet inclusion criteria|0
5073682|NCT02231762|17508733|P2|Combination Phase|Did not meet inclusion criteria|0
5073683|NCT02231762|17508734|P1|Combination Phase|Did not meet inclusion criteria|1
5073684|NCT02231762|17508731|P4|Combination Phase|Disease Progression|0
5073685|NCT02231762|17508732|P3|Combination Phase|Disease Progression|0
5073686|NCT02231762|17508733|P2|Combination Phase|Disease Progression|0
5073687|NCT02231762|17508734|P1|Combination Phase|Disease Progression|6
5073688|NCT02231762|17508731|P4|Combination Phase|Withdrawal by Subject|0
5073689|NCT02231762|17508732|P3|Combination Phase|Withdrawal by Subject|0
5073690|NCT02231762|17508733|P2|Combination Phase|Withdrawal by Subject|0
5073691|NCT02231762|17508734|P1|Combination Phase|Withdrawal by Subject|2
5073692|NCT02231762|17508731|P4|Combination Phase|Adverse Event|0
5073693|NCT02231762|17508732|P3|Combination Phase|Adverse Event|0
5073694|NCT02231762|17508733|P2|Combination Phase|Adverse Event|0
5073695|NCT02231762|17508734|P1|Combination Phase|Adverse Event|10
5073696|NCT02231749|17508767|P2|Overall Study|No longer meets Study Criteria|0
5073697|NCT02231749|17508768|P1|Overall Study|No longer meets Study Criteria|1
5073698|NCT02231749|17508767|P2|Overall Study|other|8
5073699|NCT02231749|17508768|P1|Overall Study|other|0
5073700|NCT02231749|17508767|P2|Overall Study|Pregnancy|0
5073701|NCT02231749|17508768|P1|Overall Study|Pregnancy|1
5073702|NCT02231749|17508767|P2|Overall Study|Poor/Non-Compliance|3
5073703|NCT02231749|17508768|P1|Overall Study|Poor/Non-Compliance|0
5073704|NCT02231749|17508767|P2|Overall Study|Maximum Clinical Benefit|8
5073705|NCT02231749|17508768|P1|Overall Study|Maximum Clinical Benefit|5
5073706|NCT02231749|17508767|P2|Overall Study|Lost to Follow-up|2
5073707|NCT02231749|17508768|P1|Overall Study|Lost to Follow-up|1
5073708|NCT02231749|17508767|P2|Overall Study|Participant withdrew Consent|15
5073709|NCT02231749|17508768|P1|Overall Study|Participant withdrew Consent|8
5073710|NCT02231749|17508767|P2|Overall Study|Participant's request to discontinue|21
5073711|NCT02231749|17508768|P1|Overall Study|Participant's request to discontinue|10
5073712|NCT02231749|17508767|P2|Overall Study|AE unrelated to Study drug|31
5073713|NCT02231749|17508768|P1|Overall Study|AE unrelated to Study drug|32
5073714|NCT02231749|17508767|P2|Overall Study|Death|1
5073715|NCT02231749|17508768|P1|Overall Study|Death|1
5073716|NCT02231749|17508767|P2|Overall Study|Study Drug Toxicity|63
5073717|NCT02231749|17508768|P1|Overall Study|Study Drug Toxicity|134
5073718|NCT02231749|17508767|P2|Overall Study|Disease progression|297
5073719|NCT02231749|17508768|P1|Overall Study|Disease progression|229
5073720|NCT02231580|17508786|P2|Overall Study|Adverse Event|0
5073721|NCT02231580|17508787|P1|Overall Study|Adverse Event|5
5073722|NCT02231164|17508904|P2|Overall Study|Withdrawal by Subject|2
5073723|NCT02231164|17508905|P1|Overall Study|Withdrawal by Subject|1
5073724|NCT02231164|17508904|P2|Overall Study|Lack of Efficacy|3
5073725|NCT02231164|17508905|P1|Overall Study|Lack of Efficacy|4
5073726|NCT02231164|17508904|P2|Overall Study|Adverse Event|1
5073727|NCT02231164|17508905|P1|Overall Study|Adverse Event|1
5073728|NCT02230956|17508933|P3|Overall Study|Other Miscellaneous Reason|2
5073729|NCT02230956|17508934|P2|Overall Study|Other Miscellaneous Reason|1
5073730|NCT02230956|17508935|P1|Overall Study|Other Miscellaneous Reason|0
5073731|NCT02230956|17508933|P3|Overall Study|Protocol Violation|1
5073732|NCT02230956|17508934|P2|Overall Study|Protocol Violation|1
5073733|NCT02230956|17508935|P1|Overall Study|Protocol Violation|0
5073734|NCT02230956|17508933|P3|Overall Study|Personal Reasons|1
5073735|NCT02230956|17508934|P2|Overall Study|Personal Reasons|1
5073736|NCT02230956|17508935|P1|Overall Study|Personal Reasons|2
5073737|NCT02230956|17508933|P3|Overall Study|Lost to Follow-up|2
5073738|NCT02230956|17508934|P2|Overall Study|Lost to Follow-up|1
5073739|NCT02230956|17508935|P1|Overall Study|Lost to Follow-up|1
5073740|NCT02230956|17508933|P3|Overall Study|Lack of Efficacy|1
5073741|NCT02230956|17508934|P2|Overall Study|Lack of Efficacy|1
5073742|NCT02230956|17508935|P1|Overall Study|Lack of Efficacy|1
5073743|NCT02230956|17508933|P3|Overall Study|Adverse Event|0
5073744|NCT02230956|17508934|P2|Overall Study|Adverse Event|1
5073745|NCT02230956|17508935|P1|Overall Study|Adverse Event|1
5073746|NCT02230904|17508957|P2|Overall Study|Safety follow up could not take place|1
5073747|NCT02230904|17508958|P1|Overall Study|Safety follow up could not take place|0
5073748|NCT02230683|17508991|P1|Overall Study|Adverse Event|1
5073749|NCT02230670|17509008|P2|Overall Study|Progression to Child-Pugh C|2
5073750|NCT02230670|17509009|P1|Overall Study|Progression to Child-Pugh C|1
5073751|NCT02230670|17509008|P2|Overall Study|Protocol Violation|1
5073752|NCT02230670|17509009|P1|Overall Study|Protocol Violation|0
5073753|NCT02230670|17509008|P2|Overall Study|Physician Decision|1
5073754|NCT02230670|17509009|P1|Overall Study|Physician Decision|0
5073755|NCT02230670|17509008|P2|Overall Study|Withdrawal by Subject|2
5073756|NCT02230670|17509009|P1|Overall Study|Withdrawal by Subject|2
5073757|NCT02230670|17509008|P2|Overall Study|Adverse Event|2
5073758|NCT02230670|17509009|P1|Overall Study|Adverse Event|1
5073759|NCT02230384|17509095|P2|Phase 2 - Switch|Adverse Event|0
5073760|NCT02230384|17509096|P1|Phase 2 - Switch|Adverse Event|2
5073761|NCT02230384|17509095|P2|Phase 2 - Switch|Lost to Follow-up|0
5073762|NCT02230384|17509096|P1|Phase 2 - Switch|Lost to Follow-up|1
5073763|NCT02230384|17509095|P2|Phase 2 - Switch|Withdrawal by Subject|1
5073764|NCT02230384|17509096|P1|Phase 2 - Switch|Withdrawal by Subject|0
5073765|NCT02230384|17509095|P2|Phase 1|Physician Decision|1
5073766|NCT02230384|17509096|P1|Phase 1|Physician Decision|0
5073767|NCT02230384|17509095|P2|Phase 1|Lost to Follow-up|0
5073768|NCT02230384|17509096|P1|Phase 1|Lost to Follow-up|1
5073769|NCT02230332|17509116|P2|Overall Study|Protocol Violation|0
5073770|NCT02230332|17509117|P1|Overall Study|Protocol Violation|1
5073771|NCT02230332|17509116|P2|Overall Study|Lost to Follow-up|0
5073772|NCT02230332|17509117|P1|Overall Study|Lost to Follow-up|1
5073773|NCT02230332|17509116|P2|Overall Study|Adverse Event|1
5073774|NCT02230332|17509117|P1|Overall Study|Adverse Event|2
5073775|NCT02230306|17509133|P1|Overall Study|Did not receive study treatment|1
5073776|NCT02230085|17509144|P1|Overall Study|Withdrawal by Subject|3
5073777|NCT02230085|17509144|P1|Overall Study|Physician Decision|1
5073778|NCT02229864|17509148|P1|3 - Year Visit|Death|2
5073779|NCT02229864|17509148|P1|2 - Year Visit|Missed Visits|1
5073780|NCT02229851|17509203|P7|Extension Phase (Open-label Phase)|Death|1
5073781|NCT02229851|17509204|P6|Extension Phase (Open-label Phase)|Death|1
5073782|NCT02229851|17509205|P5|Extension Phase (Open-label Phase)|Death|0
5073783|NCT02229851|17509206|P4|Extension Phase (Open-label Phase)|Death|1
5073784|NCT02229851|17509207|P3|Extension Phase (Open-label Phase)|Death|0
5073785|NCT02229851|17509208|P2|Extension Phase (Open-label Phase)|Death|0
5073786|NCT02229851|17509209|P1|Extension Phase (Open-label Phase)|Death|0
5073787|NCT02229851|17509203|P7|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
5073788|NCT02229851|17509204|P6|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
5073789|NCT02229851|17509205|P5|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
5073790|NCT02229851|17509206|P4|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
5073791|NCT02229851|17509207|P3|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5073792|NCT02229851|17509208|P2|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5073793|NCT02229851|17509209|P1|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5073794|NCT02229851|17509203|P7|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5073795|NCT02229851|17509204|P6|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5073796|NCT02229851|17509205|P5|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5073797|NCT02229851|17509206|P4|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5073798|NCT02229851|17509207|P3|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5073799|NCT02229851|17509208|P2|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5073800|NCT02229851|17509209|P1|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5073801|NCT02229851|17509203|P7|Main Phase (Double-blind Phase)|Death|0
5073802|NCT02229851|17509204|P6|Main Phase (Double-blind Phase)|Death|0
5073803|NCT02229851|17509205|P5|Main Phase (Double-blind Phase)|Death|0
5073804|NCT02229851|17509206|P4|Main Phase (Double-blind Phase)|Death|0
5073805|NCT02229851|17509207|P3|Main Phase (Double-blind Phase)|Death|0
5073806|NCT02229851|17509208|P2|Main Phase (Double-blind Phase)|Death|1
5073807|NCT02229851|17509209|P1|Main Phase (Double-blind Phase)|Death|1
5073808|NCT02229851|17509203|P7|Main Phase (Double-blind Phase)|Protocol Violation|0
5073809|NCT02229851|17509204|P6|Main Phase (Double-blind Phase)|Protocol Violation|0
5073810|NCT02229851|17509205|P5|Main Phase (Double-blind Phase)|Protocol Violation|0
5073811|NCT02229851|17509206|P4|Main Phase (Double-blind Phase)|Protocol Violation|0
5073812|NCT02229851|17509207|P3|Main Phase (Double-blind Phase)|Protocol Violation|2
5073813|NCT02229851|17509208|P2|Main Phase (Double-blind Phase)|Protocol Violation|0
5073814|NCT02229851|17509209|P1|Main Phase (Double-blind Phase)|Protocol Violation|0
5073815|NCT02229851|17509203|P7|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5073816|NCT02229851|17509204|P6|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5073817|NCT02229851|17509205|P5|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5073818|NCT02229851|17509206|P4|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5073819|NCT02229851|17509207|P3|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
5073820|NCT02229851|17509208|P2|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
5073821|NCT02229851|17509209|P1|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
5073822|NCT02229851|17509203|P7|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5073823|NCT02229851|17509204|P6|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5073824|NCT02229851|17509205|P5|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5073825|NCT02229851|17509206|P4|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5073826|NCT02229851|17509207|P3|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5073827|NCT02229851|17509208|P2|Main Phase (Double-blind Phase)|Lost to Follow-up|1
5073828|NCT02229851|17509209|P1|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5073829|NCT02229851|17509203|P7|Main Phase (Double-blind Phase)|Unclassified|0
5073830|NCT02229851|17509204|P6|Main Phase (Double-blind Phase)|Unclassified|0
5073831|NCT02229851|17509205|P5|Main Phase (Double-blind Phase)|Unclassified|0
5073832|NCT02229851|17509206|P4|Main Phase (Double-blind Phase)|Unclassified|0
5073833|NCT02229851|17509207|P3|Main Phase (Double-blind Phase)|Unclassified|0
5073834|NCT02229851|17509208|P2|Main Phase (Double-blind Phase)|Unclassified|2
5073835|NCT02229851|17509209|P1|Main Phase (Double-blind Phase)|Unclassified|1
5073836|NCT02229552|17509641|P1|2-Year Follow up|Lost to Follow-up|17
5073837|NCT02229552|17509641|P1|2-Year Follow up|Withdrawal by Subject|9
5073838|NCT02229552|17509641|P1|1-year Follow up|Lost to Follow-up|18
5073839|NCT02229552|17509641|P1|1-year Follow up|Withdrawal by Subject|7
5073840|NCT02229552|17509641|P1|Baseline|Withdrawal by Subject|6
5073841|NCT02229539|17509648|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
5073842|NCT02229539|17509649|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
5073843|NCT02229539|17509650|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
5073844|NCT02229539|17509648|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
5073845|NCT02229539|17509649|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
5073846|NCT02229539|17509650|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
5073847|NCT02229539|17509648|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
5073848|NCT02229539|17509649|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
5073849|NCT02229539|17509650|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
5073850|NCT02229539|17509648|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
5073851|NCT02229539|17509649|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
5073852|NCT02229539|17509650|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
5073853|NCT02229539|17509648|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
5073854|NCT02229539|17509649|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
5073855|NCT02229539|17509650|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
5073856|NCT02229539|17509648|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
5073857|NCT02229539|17509649|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
5073858|NCT02229539|17509650|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
5073859|NCT02229539|17509648|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
5073860|NCT02229539|17509649|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
5073861|NCT02229539|17509650|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
5073862|NCT02229539|17509648|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
5073863|NCT02229539|17509649|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
5073864|NCT02229539|17509650|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
5073865|NCT02229539|17509648|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
5073866|NCT02229539|17509649|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
5073867|NCT02229539|17509650|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
5073868|NCT02229396|17509781|P3|Overall Study|Withdrew; No Record on Termination Page|1
5073869|NCT02229396|17509782|P2|Overall Study|Withdrew; No Record on Termination Page|0
5073870|NCT02229396|17509783|P1|Overall Study|Withdrew; No Record on Termination Page|2
5073871|NCT02229396|17509781|P3|Overall Study|Study-Specific Withdrawal Criteria|3
5073872|NCT02229396|17509782|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5073873|NCT02229396|17509783|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5073874|NCT02229396|17509781|P3|Overall Study|Withdrawal by Subject|41
5073875|NCT02229396|17509782|P2|Overall Study|Withdrawal by Subject|28
5073876|NCT02229396|17509783|P1|Overall Study|Withdrawal by Subject|42
5073877|NCT02229396|17509781|P3|Overall Study|Other|15
5073878|NCT02229396|17509782|P2|Overall Study|Other|18
5073879|NCT02229396|17509783|P1|Overall Study|Other|10
5073880|NCT02229396|17509781|P3|Overall Study|Patient Incorrectly Randomized|1
5073881|NCT02229396|17509782|P2|Overall Study|Patient Incorrectly Randomized|0
5073882|NCT02229396|17509783|P1|Overall Study|Patient Incorrectly Randomized|0
5073883|NCT02229396|17509781|P3|Overall Study|Protocol Violation|0
5073884|NCT02229396|17509782|P2|Overall Study|Protocol Violation|1
5073885|NCT02229396|17509783|P1|Overall Study|Protocol Violation|2
5073886|NCT02229396|17509781|P3|Overall Study|Lost to Follow-up|21
5073887|NCT02229396|17509782|P2|Overall Study|Lost to Follow-up|14
5073888|NCT02229396|17509783|P1|Overall Study|Lost to Follow-up|14
5073889|NCT02229396|17509781|P3|Overall Study|Death|1
5073890|NCT02229396|17509782|P2|Overall Study|Death|3
5073891|NCT02229396|17509783|P1|Overall Study|Death|2
5073892|NCT02229396|17509781|P3|Overall Study|Adverse Event|12
5073893|NCT02229396|17509782|P2|Overall Study|Adverse Event|12
5073894|NCT02229396|17509783|P1|Overall Study|Adverse Event|6
5073895|NCT02229383|17509814|P2|Overall Study|Other|8
5073896|NCT02229383|17509815|P1|Overall Study|Other|3
5073897|NCT02229383|17509814|P2|Overall Study|Did not receive treatment|0
5073898|NCT02229383|17509815|P1|Overall Study|Did not receive treatment|1
5073899|NCT02229383|17509814|P2|Overall Study|Withdrawal by Subject|6
5073900|NCT02229383|17509815|P1|Overall Study|Withdrawal by Subject|4
5073901|NCT02229383|17509814|P2|Overall Study|Lost to Follow-up|3
5073902|NCT02229383|17509815|P1|Overall Study|Lost to Follow-up|5
5073903|NCT02229383|17509814|P2|Overall Study|Death|1
5073904|NCT02229383|17509815|P1|Overall Study|Death|0
5073905|NCT02229383|17509814|P2|Overall Study|Adverse Event|4
5073906|NCT02229383|17509815|P1|Overall Study|Adverse Event|7
5073907|NCT02229227|17509840|P2|Overall Study|Physician Decision|12
5073908|NCT02229227|17509841|P1|Overall Study|Physician Decision|5
5073909|NCT02229227|17509840|P2|Overall Study|Other|1
5073910|NCT02229227|17509841|P1|Overall Study|Other|0
5073911|NCT02229227|17509840|P2|Overall Study|Withdrawal by Subject|12
5073912|NCT02229227|17509841|P1|Overall Study|Withdrawal by Subject|8
5073913|NCT02229227|17509840|P2|Overall Study|Study terminated by sponsor|11
5073914|NCT02229227|17509841|P1|Overall Study|Study terminated by sponsor|11
5073915|NCT02229227|17509840|P2|Overall Study|Lost to Follow-up|3
5073916|NCT02229227|17509841|P1|Overall Study|Lost to Follow-up|3
5073917|NCT02229227|17509840|P2|Overall Study|Protocol defined stopping criteria|3
5073918|NCT02229227|17509841|P1|Overall Study|Protocol defined stopping criteria|1
5073919|NCT02229227|17509840|P2|Overall Study|Protocol Violation|8
5073920|NCT02229227|17509841|P1|Overall Study|Protocol Violation|6
5073921|NCT02229227|17509840|P2|Overall Study|Lack of Efficacy|3
5073922|NCT02229227|17509841|P1|Overall Study|Lack of Efficacy|3
5073923|NCT02229227|17509840|P2|Overall Study|Adverse Event|9
5073924|NCT02229227|17509841|P1|Overall Study|Adverse Event|14
5073925|NCT02229214|17509926|P2|Overall Study|Withdrawal by Subject|0
5073926|NCT02229214|17509927|P1|Overall Study|Withdrawal by Subject|4
5073927|NCT02229214|17509926|P2|Overall Study|Adverse Event|0
5073928|NCT02229214|17509927|P1|Overall Study|Adverse Event|2
5073929|NCT02228980|17509951|P4|Overall Study|Withdrawal by Subject|3
5073930|NCT02228980|17509952|P3|Overall Study|Withdrawal by Subject|2
5073931|NCT02228980|17509953|P2|Overall Study|Withdrawal by Subject|3
5073932|NCT02228980|17509954|P1|Overall Study|Withdrawal by Subject|3
5073933|NCT02228980|17509951|P4|Overall Study|Protocol Violation|0
5073934|NCT02228980|17509952|P3|Overall Study|Protocol Violation|0
5073935|NCT02228980|17509953|P2|Overall Study|Protocol Violation|0
5073936|NCT02228980|17509954|P1|Overall Study|Protocol Violation|7
5073937|NCT02228980|17509951|P4|Overall Study|Adverse Event|0
5073938|NCT02228980|17509952|P3|Overall Study|Adverse Event|0
5073939|NCT02228980|17509953|P2|Overall Study|Adverse Event|0
5073940|NCT02228980|17509954|P1|Overall Study|Adverse Event|14
5073941|NCT02228967|17509978|P2|Overall Study|Withdrawal by Subject|18
5073942|NCT02228967|17509979|P1|Overall Study|Withdrawal by Subject|13
5073943|NCT02228967|17509978|P2|Overall Study|Lost to Follow-up|142
5073944|NCT02228967|17509979|P1|Overall Study|Lost to Follow-up|146
5073945|NCT02228720|17510040|P1|Open Label - Day 30|Lost to Follow-up|1
5073946|NCT02228590|17510063|P1|Overall Study|Withdrawal by Subject|1
5073947|NCT02228564|17510076|P1|Overall Study|Other|6
5073948|NCT02228564|17510076|P1|Overall Study|Lost to Follow-up|17
5073949|NCT02228564|17510076|P1|Overall Study|Physician Decision|5
5073950|NCT02228564|17510076|P1|Overall Study|Death|11
5073951|NCT02228564|17510076|P1|Overall Study|Withdrawal by Subject|10
5073952|NCT02228460|17510100|P1|Overall Study|Lost to Follow-up|1
5073953|NCT02228460|17510100|P1|Overall Study|Adverse Event|1
5073954|NCT02228395|17510123|P3|First Intervention Period|Unable to comply with study dates|1
5073955|NCT02228395|17510124|P2|First Intervention Period|Unable to comply with study dates|1
5073956|NCT02228395|17510125|P1|First Intervention Period|Unable to comply with study dates|0
5073957|NCT02228395|17510123|P3|First Intervention Period|No longer willing to participate|0
5073958|NCT02228395|17510124|P2|First Intervention Period|No longer willing to participate|0
5073959|NCT02228395|17510125|P1|First Intervention Period|No longer willing to participate|1
5073960|NCT02228096|17510211|P1|Overall Study|Enrolled, not infused|11
5073961|NCT02228096|17510211|P1|Overall Study|New therapy for study indication|1
5073962|NCT02228096|17510211|P1|Overall Study|Subject/guardian decision|2
5073963|NCT02228096|17510211|P1|Overall Study|Physician Decision|3
5073964|NCT02228096|17510211|P1|Overall Study|Death|12
5073965|NCT02228096|17510211|P1|Overall Study|Lack of Efficacy|18
5073966|NCT02228096|17510211|P1|Overall Study|Study terminated by Sponsor|24
5073967|NCT02227875|17510313|P2|Overall Study|Lost to Follow-up|10
5073968|NCT02227875|17510314|P1|Overall Study|Lost to Follow-up|10
5073969|NCT02227875|17510313|P2|Overall Study|Withdrawal by Subject|13
5073970|NCT02227875|17510314|P1|Overall Study|Withdrawal by Subject|12
5073971|NCT02227875|17510313|P2|Overall Study|Adverse Event|0
5073972|NCT02227875|17510314|P1|Overall Study|Adverse Event|3
5073973|NCT02227875|17510313|P2|Overall Study|Physician Decision|0
5073974|NCT02227875|17510314|P1|Overall Study|Physician Decision|1
5073975|NCT02227875|17510313|P2|Overall Study|Other|3
5073976|NCT02227875|17510314|P1|Overall Study|Other|1
5073977|NCT02227875|17510313|P2|Overall Study|Protocol Violation|7
5073978|NCT02227875|17510314|P1|Overall Study|Protocol Violation|10
5073979|NCT02227862|17510334|P2|Overall Study|Lost to Follow-up|2
5073980|NCT02227862|17510335|P1|Overall Study|Lost to Follow-up|1
5073981|NCT02227862|17510334|P2|Overall Study|Withdrawal by Subject|6
5073982|NCT02227862|17510335|P1|Overall Study|Withdrawal by Subject|7
5073983|NCT02227862|17510334|P2|Overall Study|Adverse Event|3
5073984|NCT02227862|17510335|P1|Overall Study|Adverse Event|4
5073985|NCT02227862|17510334|P2|Overall Study|Other|2
5073986|NCT02227862|17510335|P1|Overall Study|Other|0
5073987|NCT02227862|17510334|P2|Overall Study|Protocol Violation|9
5073988|NCT02227862|17510335|P1|Overall Study|Protocol Violation|7
5073989|NCT02227849|17510365|P1|Overall Study|Withdrawal by Subject|3
5073990|NCT02227849|17510365|P1|Overall Study|Physician Decision|1
5073991|NCT02227849|17510365|P1|Overall Study|Adverse Event|4
5073992|NCT02227784|17510396|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
5073993|NCT02227784|17510397|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5073994|NCT02227784|17510398|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5073995|NCT02227784|17510399|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5073996|NCT02227784|17510400|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5073997|NCT02227784|17510396|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
5073998|NCT02227784|17510397|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5073999|NCT02227784|17510398|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5074000|NCT02227784|17510399|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5074001|NCT02227784|17510400|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5074002|NCT02227784|17510396|P5|Open-Label Extension Phase (OLE)|Death|1
5074003|NCT02227784|17510397|P4|Open-Label Extension Phase (OLE)|Death|0
5074004|NCT02227784|17510398|P3|Open-Label Extension Phase (OLE)|Death|0
5074005|NCT02227784|17510399|P2|Open-Label Extension Phase (OLE)|Death|0
5074006|NCT02227784|17510400|P1|Open-Label Extension Phase (OLE)|Death|0
5074007|NCT02227784|17510396|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
5074008|NCT02227784|17510397|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
5074009|NCT02227784|17510398|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
5074010|NCT02227784|17510399|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
5074011|NCT02227784|17510400|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
5074012|NCT02227784|17510396|P5|Double-Blind Phase|Withdrawal by Subject|0
5074013|NCT02227784|17510397|P4|Double-Blind Phase|Withdrawal by Subject|2
5074014|NCT02227784|17510398|P3|Double-Blind Phase|Withdrawal by Subject|5
5074015|NCT02227784|17510399|P2|Double-Blind Phase|Withdrawal by Subject|1
5074016|NCT02227784|17510400|P1|Double-Blind Phase|Withdrawal by Subject|2
5074017|NCT02227784|17510396|P5|Double-Blind Phase|Sponsor Decision|0
5074018|NCT02227784|17510397|P4|Double-Blind Phase|Sponsor Decision|32
5074019|NCT02227784|17510398|P3|Double-Blind Phase|Sponsor Decision|14
5074020|NCT02227784|17510399|P2|Double-Blind Phase|Sponsor Decision|15
5074021|NCT02227784|17510400|P1|Double-Blind Phase|Sponsor Decision|34
5074022|NCT02227784|17510396|P5|Double-Blind Phase|Protocol Violation|0
5074023|NCT02227784|17510397|P4|Double-Blind Phase|Protocol Violation|1
5074024|NCT02227784|17510398|P3|Double-Blind Phase|Protocol Violation|1
5074025|NCT02227784|17510399|P2|Double-Blind Phase|Protocol Violation|0
5074026|NCT02227784|17510400|P1|Double-Blind Phase|Protocol Violation|0
5074027|NCT02227784|17510396|P5|Double-Blind Phase|Physician Decision|0
5074028|NCT02227784|17510397|P4|Double-Blind Phase|Physician Decision|1
5074029|NCT02227784|17510398|P3|Double-Blind Phase|Physician Decision|0
5074030|NCT02227784|17510399|P2|Double-Blind Phase|Physician Decision|0
5074031|NCT02227784|17510400|P1|Double-Blind Phase|Physician Decision|1
5074032|NCT02227784|17510396|P5|Double-Blind Phase|Adverse Event|0
5074033|NCT02227784|17510397|P4|Double-Blind Phase|Adverse Event|3
5074034|NCT02227784|17510398|P3|Double-Blind Phase|Adverse Event|1
5074035|NCT02227784|17510399|P2|Double-Blind Phase|Adverse Event|2
5074036|NCT02227784|17510400|P1|Double-Blind Phase|Adverse Event|3
5074037|NCT02227368|17510574|P2|Overall Study|Adverse Event|0
5074038|NCT02227368|17510575|P1|Overall Study|Adverse Event|1
5074039|NCT02227368|17510574|P2|Overall Study|Lost to Follow-up|0
5074040|NCT02227368|17510575|P1|Overall Study|Lost to Follow-up|1
5074041|NCT02227368|17510574|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
5074042|NCT02227368|17510575|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
5074043|NCT02227238|17510631|P2|Overall Study|Lost to Follow-up|5
5074044|NCT02227238|17510632|P1|Overall Study|Lost to Follow-up|7
5074045|NCT02227238|17510631|P2|Overall Study|Physician Decision|9
5074046|NCT02227238|17510632|P1|Overall Study|Physician Decision|0
5074047|NCT02227238|17510631|P2|Overall Study|Withdrawal by Subject|4
5074048|NCT02227238|17510632|P1|Overall Study|Withdrawal by Subject|5
5074049|NCT02227238|17510631|P2|Overall Study|Protocol Violation|8
5074050|NCT02227238|17510632|P1|Overall Study|Protocol Violation|7
5074051|NCT02227238|17510631|P2|Overall Study|Lack of Efficacy|22
5074052|NCT02227238|17510632|P1|Overall Study|Lack of Efficacy|10
5074053|NCT02227238|17510631|P2|Overall Study|Adverse Event|18
5074054|NCT02227238|17510632|P1|Overall Study|Adverse Event|8
5074055|NCT02227238|17510631|P2|Overall Study|Other: Reached stopping criteria|1
5074056|NCT02227238|17510632|P1|Overall Study|Other: Reached stopping criteria|0
5074057|NCT02227147|17510698|P2|Follow-up Period|Other|5
5074058|NCT02227147|17510699|P1|Follow-up Period|Other|3
5074059|NCT02227147|17510698|P2|Controlled Treatment Period|Other|0
5074060|NCT02227147|17510699|P1|Controlled Treatment Period|Other|2
5074061|NCT02227147|17510698|P2|Controlled Treatment Period|Adverse Event|3
5074062|NCT02227147|17510699|P1|Controlled Treatment Period|Adverse Event|4
5074063|NCT02227108|17510726|P1|Overall Study|Adverse Event|6
5074064|NCT02227108|17510726|P1|Overall Study|Investigator discretion|1
5074065|NCT02227108|17510726|P1|Overall Study|Initiation of alternative therapy|2
5074066|NCT02227108|17510726|P1|Overall Study|Progressive disease|17
5074067|NCT02227108|17510726|P1|Overall Study|Other|3
5074068|NCT02227108|17510726|P1|Overall Study|Did not receive treatment|2
5074069|NCT02226653|17510765|P2|Treatment Period 5 Fed State|Adverse Event|1
5074070|NCT02226653|17510766|P1|Treatment Period 5 Fed State|Adverse Event|0
5074071|NCT02226653|17510765|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
5074072|NCT02226653|17510766|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
5074073|NCT02226562|17510790|P2|Overall Study|Lost to Follow-up|1
5074074|NCT02226562|17510791|P1|Overall Study|Lost to Follow-up|0
5074075|NCT02226549|17510809|P2|Overall Study|Lost to Follow-up|1
5074076|NCT02226549|17510810|P1|Overall Study|Lost to Follow-up|0
5074077|NCT02226549|17510809|P2|Overall Study|Randomized but Never Treated|0
5074078|NCT02226549|17510810|P1|Overall Study|Randomized but Never Treated|1
5074079|NCT02226198|17510820|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
5074080|NCT02226198|17510821|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
5074081|NCT02226198|17510822|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
5074082|NCT02226198|17510820|P3|Lead-in Phase|Protocol Violation|0
5074083|NCT02226198|17510821|P2|Lead-in Phase|Protocol Violation|0
5074084|NCT02226198|17510822|P1|Lead-in Phase|Protocol Violation|1
5074085|NCT02226172|17510895|P1|Overall Study|Adverse Event|6
5074086|NCT02226172|17510895|P1|Overall Study|Study terminated by sponsor|1
5074087|NCT02226172|17510895|P1|Overall Study|Death|1
5074088|NCT02226172|17510895|P1|Overall Study|Other|5
5074089|NCT02226172|17510895|P1|Overall Study|Participant refused further follow-up|4
5074090|NCT02226120|17510959|P1|Overall Study|missing treatment disposition pages|2
5074091|NCT02226120|17510959|P1|Overall Study|Protocol deviation|1
5074092|NCT02226120|17510959|P1|Overall Study|Non-compliance with study drug|10
5074093|NCT02226120|17510959|P1|Overall Study|Withdrawal by parent/guardian|36
5074094|NCT02226120|17510959|P1|Overall Study|Physician Decision|21
5074095|NCT02226120|17510959|P1|Overall Study|Lost to Follow-up|13
5074096|NCT02226120|17510959|P1|Overall Study|Technical problems|4
5074097|NCT02226120|17510959|P1|Overall Study|Study terminated by sponsor|1
5074098|NCT02226120|17510959|P1|Overall Study|Death|172
5074099|NCT02226120|17510959|P1|Overall Study|Adverse Event|60
5074100|NCT02226003|17510966|P3|Overall Study|Withdrawal by Subject|3
5074101|NCT02226003|17510967|P2|Overall Study|Withdrawal by Subject|0
5074102|NCT02226003|17510968|P1|Overall Study|Withdrawal by Subject|0
5074103|NCT02226003|17510966|P3|Overall Study|Lost to Follow-up|3
5074104|NCT02226003|17510967|P2|Overall Study|Lost to Follow-up|1
5074105|NCT02226003|17510968|P1|Overall Study|Lost to Follow-up|2
5074106|NCT02225743|17511024|P1|Overall Study|Withdrawal by Subject|18
5074107|NCT02225587|17511030|P2|Overall Study|Withdrawal by Subject|28
5074108|NCT02225587|17511031|P1|Overall Study|Withdrawal by Subject|13
5074109|NCT02225587|17511030|P2|Overall Study|Participant Moved|0
5074110|NCT02225587|17511031|P1|Overall Study|Participant Moved|1
5074111|NCT02225587|17511030|P2|Overall Study|Protocol Violation|0
5074112|NCT02225587|17511031|P1|Overall Study|Protocol Violation|1
5074113|NCT02225587|17511030|P2|Overall Study|Physician Decision|0
5074114|NCT02225587|17511031|P1|Overall Study|Physician Decision|2
5074115|NCT02225587|17511030|P2|Overall Study|Non-Compliance With Study Drug|0
5074116|NCT02225587|17511031|P1|Overall Study|Non-Compliance With Study Drug|1
5074117|NCT02225587|17511030|P2|Overall Study|Lost to Follow-up|5
5074118|NCT02225587|17511031|P1|Overall Study|Lost to Follow-up|5
5074119|NCT02225587|17511030|P2|Overall Study|Adverse Event|5
5074120|NCT02225587|17511031|P1|Overall Study|Adverse Event|5
5074121|NCT02225353|17511060|P3|Overall Study|Protocol Violation|12
5074122|NCT02225353|17511061|P2|Overall Study|Protocol Violation|5
5074123|NCT02225353|17511062|P1|Overall Study|Protocol Violation|4
5074124|NCT02225353|17511060|P3|Overall Study|Lost to Follow-up|3
5074125|NCT02225353|17511061|P2|Overall Study|Lost to Follow-up|1
5074126|NCT02225353|17511062|P1|Overall Study|Lost to Follow-up|0
5074127|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
5074128|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
5074129|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
5074130|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
5074131|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
5074132|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
5074133|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
5074134|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
5074135|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
5074136|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
5074137|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Death|0
5074138|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Death|1
5074139|NCT02224846|17511103|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
5074140|NCT02224846|17511104|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
5074141|NCT02224846|17511103|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
5074142|NCT02224846|17511104|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
5074143|NCT02224846|17511103|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
5074144|NCT02224846|17511104|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
5074145|NCT02224846|17511103|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
5074146|NCT02224846|17511104|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
5074147|NCT02224846|17511103|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
5074148|NCT02224846|17511104|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
5074149|NCT02224846|17511103|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
5074150|NCT02224846|17511104|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
5074151|NCT02224846|17511103|P2|Period 1 (Month 3)|Sponsor Decision|1
5074152|NCT02224846|17511104|P1|Period 1 (Month 3)|Sponsor Decision|2
5074153|NCT02224846|17511103|P2|Period 1 (Month 3)|Withdrawal by Subject|18
5074154|NCT02224846|17511104|P1|Period 1 (Month 3)|Withdrawal by Subject|8
5074155|NCT02224846|17511103|P2|Period 1 (Month 3)|Protocol Violation|8
5074156|NCT02224846|17511104|P1|Period 1 (Month 3)|Protocol Violation|4
5074157|NCT02224846|17511103|P2|Period 1 (Month 3)|Lost to Follow-up|8
5074158|NCT02224846|17511104|P1|Period 1 (Month 3)|Lost to Follow-up|3
5074159|NCT02224846|17511103|P2|Period 1 (Month 3)|Adverse Event|1
5074160|NCT02224846|17511104|P1|Period 1 (Month 3)|Adverse Event|2
5074161|NCT02224755|17511134|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
5074162|NCT02224755|17511135|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
5074163|NCT02224755|17511134|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
5074164|NCT02224755|17511135|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
5074165|NCT02224755|17511134|P2|Two Year Follow up Post-implant|Heart transplant|119
5074166|NCT02224755|17511135|P1|Two Year Follow up Post-implant|Heart transplant|137
5074167|NCT02224755|17511134|P2|Two Year Follow up Post-implant|Death|98
5074168|NCT02224755|17511135|P1|Two Year Follow up Post-implant|Death|103
5074169|NCT02224755|17511134|P2|Randomization to Device Implant|Withdrawn prior to implant|1
5074170|NCT02224755|17511135|P1|Randomization to Device Implant|Withdrawn prior to implant|7
5074171|NCT02224703|17511170|P3|Overall Study|Lack of Efficacy|0
5074172|NCT02224703|17511171|P2|Overall Study|Lack of Efficacy|0
5074173|NCT02224703|17511172|P1|Overall Study|Lack of Efficacy|1
5074174|NCT02224703|17511170|P3|Overall Study|Withdrawn by parent/guardian|0
5074175|NCT02224703|17511171|P2|Overall Study|Withdrawn by parent/guardian|1
5074176|NCT02224703|17511172|P1|Overall Study|Withdrawn by parent/guardian|0
5074177|NCT02224703|17511170|P3|Overall Study|Advised by medical monitor|0
5074178|NCT02224703|17511171|P2|Overall Study|Advised by medical monitor|0
5074179|NCT02224703|17511172|P1|Overall Study|Advised by medical monitor|1
5074180|NCT02224703|17511170|P3|Overall Study|Withdrawn by investigator|0
5074181|NCT02224703|17511171|P2|Overall Study|Withdrawn by investigator|0
5074182|NCT02224703|17511172|P1|Overall Study|Withdrawn by investigator|1
5074183|NCT02224703|17511170|P3|Overall Study|Adverse Event|0
5074184|NCT02224703|17511171|P2|Overall Study|Adverse Event|5
5074185|NCT02224703|17511172|P1|Overall Study|Adverse Event|0
5074186|NCT02224690|17511191|P2|Overall Study|Did not meet eligibility criteria|0
5074187|NCT02224690|17511192|P1|Overall Study|Did not meet eligibility criteria|1
5074188|NCT02224690|17511191|P2|Overall Study|Use of G-tube|0
5074189|NCT02224690|17511192|P1|Overall Study|Use of G-tube|1
5074190|NCT02224690|17511191|P2|Overall Study|Met Withdrawal Criteria|0
5074191|NCT02224690|17511192|P1|Overall Study|Met Withdrawal Criteria|4
5074192|NCT02224690|17511191|P2|Overall Study|Adverse Event|1
5074193|NCT02224690|17511192|P1|Overall Study|Adverse Event|8
5074194|NCT02224664|17511204|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
5074195|NCT02224664|17511205|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
5074196|NCT02224664|17511206|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5074197|NCT02224664|17511207|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5074198|NCT02224664|17511208|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5074199|NCT02224664|17511204|P5|Dose Escalation Period (21 Days)|Adverse Event|7
5074200|NCT02224664|17511205|P4|Dose Escalation Period (21 Days)|Adverse Event|2
5074201|NCT02224664|17511206|P3|Dose Escalation Period (21 Days)|Adverse Event|2
5074202|NCT02224664|17511207|P2|Dose Escalation Period (21 Days)|Adverse Event|0
5074203|NCT02224664|17511208|P1|Dose Escalation Period (21 Days)|Adverse Event|0
5074204|NCT02224664|17511204|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5074205|NCT02224664|17511205|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5074206|NCT02224664|17511206|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5074207|NCT02224664|17511207|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5074208|NCT02224664|17511208|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
5074209|NCT02224638|17511290|P2|Overall Study|Adverse Event|1
5074210|NCT02224638|17511291|P1|Overall Study|Adverse Event|1
5074211|NCT02224625|17511299|P1|Sensitization|Adverse Event|55
5074212|NCT02224625|17511299|P1|Irritation|Adverse Event|6
5074213|NCT02224599|17511320|P1|Overall Study|Progression of Disease|1
5074214|NCT02224599|17511320|P1|Overall Study|Physician Decision|1
5074215|NCT02224560|17511329|P3|Overall Study|Withdrawn by Investigator|0
5074216|NCT02224560|17511330|P2|Overall Study|Withdrawn by Investigator|1
5074217|NCT02224560|17511331|P1|Overall Study|Withdrawn by Investigator|1
5074218|NCT02224560|17511329|P3|Overall Study|Adverse Event|1
5074219|NCT02224560|17511330|P2|Overall Study|Adverse Event|1
5074220|NCT02224560|17511331|P1|Overall Study|Adverse Event|4
5074221|NCT02224560|17511329|P3|Overall Study|Met Withdrawal Criteria|0
5074222|NCT02224560|17511330|P2|Overall Study|Met Withdrawal Criteria|0
5074223|NCT02224560|17511331|P1|Overall Study|Met Withdrawal Criteria|1
5074224|NCT02224560|17511329|P3|Overall Study|Withdrawal by Subject|1
5074225|NCT02224560|17511330|P2|Overall Study|Withdrawal by Subject|0
5074226|NCT02224560|17511331|P1|Overall Study|Withdrawal by Subject|2
5074227|NCT02224560|17511329|P3|Overall Study|Protocol Deviation|0
5074228|NCT02224560|17511330|P2|Overall Study|Protocol Deviation|0
5074229|NCT02224560|17511331|P1|Overall Study|Protocol Deviation|1
5074230|NCT02224274|17511379|P2|Overall Study|Death|0
5074231|NCT02224274|17511380|P1|Overall Study|Death|1
5074232|NCT02224157|17511392|P2|Overall Study|Adverse Event|3
5074233|NCT02224157|17511393|P1|Overall Study|Adverse Event|1
5074234|NCT02224157|17511392|P2|Overall Study|Death|1
5074235|NCT02224157|17511393|P1|Overall Study|Death|1
5074236|NCT02224157|17511392|P2|Overall Study|Lost to Follow-up|35
5074237|NCT02224157|17511393|P1|Overall Study|Lost to Follow-up|27
5074238|NCT02224157|17511392|P2|Overall Study|Eligibility criteria not fulfilled|8
5074239|NCT02224157|17511393|P1|Overall Study|Eligibility criteria not fulfilled|4
5074240|NCT02224157|17511392|P2|Overall Study|Prematurely closed site|2
5074241|NCT02224157|17511393|P1|Overall Study|Prematurely closed site|4
5074242|NCT02224157|17511392|P2|Overall Study|Subject decision|50
5074243|NCT02224157|17511393|P1|Overall Study|Subject decision|58
5074244|NCT02224157|17511392|P2|Overall Study|Other|10
5074245|NCT02224157|17511393|P1|Overall Study|Other|13
5074246|NCT02224157|17511392|P2|Overall Study|Severe non-compliance to protocol|2
5074247|NCT02224157|17511393|P1|Overall Study|Severe non-compliance to protocol|2
5074248|NCT02224053|17511417|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
5074249|NCT02224053|17511417|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
5074250|NCT02224053|17511417|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
5074251|NCT02224053|17511417|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
5074252|NCT02224053|17511417|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
5074253|NCT02223858|17511463|P2|Overall Study|Refused|9
5074254|NCT02223858|17511464|P1|Overall Study|Refused|9
5074255|NCT02223858|17511463|P2|Overall Study|Withdrawal by Subject|5
5074256|NCT02223858|17511464|P1|Overall Study|Withdrawal by Subject|8
5074257|NCT02223858|17511463|P2|Overall Study|Lost to Follow-up|11
5074258|NCT02223858|17511464|P1|Overall Study|Lost to Follow-up|6
5074259|NCT02223858|17511463|P2|Overall Study|Death|1
5074260|NCT02223858|17511464|P1|Overall Study|Death|1
5074261|NCT02223793|17511477|P3|Overall Study|Moved/studycenter unable to participate|8
5074262|NCT02223793|17511478|P2|Overall Study|Moved/studycenter unable to participate|6
5074263|NCT02223793|17511479|P1|Overall Study|Moved/studycenter unable to participate|4
5074264|NCT02223793|17511477|P3|Overall Study|Withdrawal by Subject|3
5074265|NCT02223793|17511478|P2|Overall Study|Withdrawal by Subject|2
5074266|NCT02223793|17511479|P1|Overall Study|Withdrawal by Subject|3
5074267|NCT02223793|17511477|P3|Overall Study|Lost to Follow-up|2
5074268|NCT02223793|17511478|P2|Overall Study|Lost to Follow-up|1
5074269|NCT02223793|17511479|P1|Overall Study|Lost to Follow-up|10
5074270|NCT02223754|17511492|P2|Period 2|Test Article No Longer Available|1
5074271|NCT02223754|17511493|P1|Period 2|Test Article No Longer Available|0
5074272|NCT02223754|17511492|P2|Period 2|Lost to Follow-up|0
5074273|NCT02223754|17511493|P1|Period 2|Lost to Follow-up|1
5074274|NCT02223754|17511492|P2|Period 2|Lens Discomfort|1
5074275|NCT02223754|17511493|P1|Period 2|Lens Discomfort|1
5074276|NCT02223754|17511492|P2|Period 2|Protocol Violation|0
5074277|NCT02223754|17511493|P1|Period 2|Protocol Violation|1
5074278|NCT02223754|17511492|P2|Period 2|Adverse Event|1
5074279|NCT02223754|17511493|P1|Period 2|Adverse Event|0
5074280|NCT02223754|17511492|P2|Period 1|Unsatisfactory Visual Response|1
5074281|NCT02223754|17511493|P1|Period 1|Unsatisfactory Visual Response|0
5074282|NCT02223754|17511492|P2|Period 1|Test Article No Longer Available|5
5074283|NCT02223754|17511493|P1|Period 1|Test Article No Longer Available|1
5074284|NCT02223754|17511492|P2|Period 1|Withdrawal by Subject|4
5074285|NCT02223754|17511493|P1|Period 1|Withdrawal by Subject|0
5074286|NCT02223754|17511492|P2|Period 1|Protocol Violation|4
5074287|NCT02223754|17511493|P1|Period 1|Protocol Violation|2
5074288|NCT02223754|17511492|P2|Period 1|Lost to Follow-up|1
5074289|NCT02223754|17511493|P1|Period 1|Lost to Follow-up|0
5074290|NCT02223754|17511492|P2|Period 1|Adverse Event|0
5074291|NCT02223754|17511493|P1|Period 1|Adverse Event|1
5074292|NCT02223715|17511513|P1|Overall Study|Lost to Follow-up|73
5074293|NCT02223715|17511513|P1|Overall Study|Death|31
5074294|NCT02223390|17511656|P2|Overall Study|Lost to Follow-up|4
5074295|NCT02223390|17511657|P1|Overall Study|Lost to Follow-up|9
5074296|NCT02223364|17511668|P3|Overall Study|Physician Decision|0
5074297|NCT02223364|17511669|P2|Overall Study|Physician Decision|0
5074298|NCT02223364|17511670|P1|Overall Study|Physician Decision|1
5074299|NCT02223364|17511668|P3|Overall Study|subject expired before surgery|0
5074300|NCT02223364|17511669|P2|Overall Study|subject expired before surgery|0
5074301|NCT02223364|17511670|P1|Overall Study|subject expired before surgery|1
5074302|NCT02223364|17511668|P3|Overall Study|Protocol Violation|3
5074303|NCT02223364|17511669|P2|Overall Study|Protocol Violation|0
5074304|NCT02223364|17511670|P1|Overall Study|Protocol Violation|3
5074305|NCT02222818|17511846|P2|Period 1|Eligibility criteria not met|3
5074306|NCT02222818|17511847|P1|Period 1|Eligibility criteria not met|0
5074307|NCT02222714|17511859|P5|Overall Study|Withdrawal by Subject|1
5074308|NCT02222714|17511860|P4|Overall Study|Withdrawal by Subject|0
5074309|NCT02222714|17511861|P3|Overall Study|Withdrawal by Subject|1
5074310|NCT02222714|17511862|P2|Overall Study|Withdrawal by Subject|0
5074311|NCT02222714|17511863|P1|Overall Study|Withdrawal by Subject|0
5074312|NCT02222714|17511859|P5|Overall Study|Death|6
5074313|NCT02222714|17511860|P4|Overall Study|Death|4
5074314|NCT02222714|17511861|P3|Overall Study|Death|3
5074315|NCT02222714|17511862|P2|Overall Study|Death|2
5074316|NCT02222714|17511863|P1|Overall Study|Death|0
5074317|NCT02222688|17511909|P7|Overall Study|Disease progression|0
5074318|NCT02222688|17511910|P6|Overall Study|Disease progression|0
5074319|NCT02222688|17511911|P5|Overall Study|Disease progression|0
5074320|NCT02222688|17511912|P4|Overall Study|Disease progression|0
5074321|NCT02222688|17511913|P3|Overall Study|Disease progression|0
5074322|NCT02222688|17511914|P2|Overall Study|Disease progression|0
5074323|NCT02222688|17511915|P1|Overall Study|Disease progression|1
5074324|NCT02222688|17511909|P7|Overall Study|Withdrawal by Subject|1
5074325|NCT02222688|17511910|P6|Overall Study|Withdrawal by Subject|0
5074326|NCT02222688|17511911|P5|Overall Study|Withdrawal by Subject|1
5074327|NCT02222688|17511912|P4|Overall Study|Withdrawal by Subject|2
5074328|NCT02222688|17511913|P3|Overall Study|Withdrawal by Subject|0
5074329|NCT02222688|17511914|P2|Overall Study|Withdrawal by Subject|0
5074330|NCT02222688|17511915|P1|Overall Study|Withdrawal by Subject|0
5074331|NCT02222558|17511953|P6|Period 3|Withdrawal by Subject|1
5074332|NCT02222558|17511954|P5|Period 3|Withdrawal by Subject|0
5074333|NCT02222558|17511955|P4|Period 3|Withdrawal by Subject|0
5074334|NCT02222558|17511956|P3|Period 3|Withdrawal by Subject|0
5074335|NCT02222558|17511957|P2|Period 3|Withdrawal by Subject|0
5074336|NCT02222558|17511958|P1|Period 3|Withdrawal by Subject|0
5074337|NCT02222558|17511953|P6|Period 1: Single Dose|Withdrawal by Subject|0
5074338|NCT02222558|17511954|P5|Period 1: Single Dose|Withdrawal by Subject|0
5074339|NCT02222558|17511955|P4|Period 1: Single Dose|Withdrawal by Subject|0
5074340|NCT02222558|17511956|P3|Period 1: Single Dose|Withdrawal by Subject|0
5074341|NCT02222558|17511957|P2|Period 1: Single Dose|Withdrawal by Subject|0
5074342|NCT02222558|17511958|P1|Period 1: Single Dose|Withdrawal by Subject|4
5074343|NCT02222493|17511974|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
5074344|NCT02222493|17511975|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
5074345|NCT02222493|17511974|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
5074346|NCT02222493|17511975|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
5074347|NCT02222493|17511974|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
5074348|NCT02222493|17511975|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
5074349|NCT02222493|17511974|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
5074350|NCT02222493|17511975|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
5074351|NCT02222493|17511974|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
5074352|NCT02222493|17511975|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
5074353|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
5074354|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
5074355|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
5074356|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
5074357|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
5074358|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
5074359|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
5074360|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
5074361|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
5074362|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
5074363|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
5074364|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
5074365|NCT02222493|17511974|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
5074366|NCT02222493|17511975|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
5074367|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
5074368|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
5074369|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
5074370|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
5074371|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
5074372|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
5074373|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
5074374|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
5074375|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
5074376|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
5074377|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
5074378|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
5074379|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
5074380|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
5074381|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
5074382|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
5074383|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
5074384|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
5074385|NCT02222493|17511974|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
5074386|NCT02222493|17511975|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
5074387|NCT02222246|17512126|P2|Overall Study|Physician Decision|1
5074388|NCT02222246|17512127|P1|Overall Study|Physician Decision|0
5074389|NCT02222246|17512126|P2|Overall Study|No Emergency Department Visits|26
5074390|NCT02222246|17512127|P1|Overall Study|No Emergency Department Visits|27
5074391|NCT02222207|17512155|P1|Overall Study|Adverse Event|1
5074392|NCT02222207|17512155|P1|Overall Study|Other reasons|2
5074393|NCT02222207|17512155|P1|Overall Study|Death|1
5074394|NCT02221882|17512202|P6|Overall Study|Death|0
5074395|NCT02221882|17512203|P5|Overall Study|Death|0
5074396|NCT02221882|17512204|P4|Overall Study|Death|0
5074397|NCT02221882|17512205|P3|Overall Study|Death|0
5074398|NCT02221882|17512206|P2|Overall Study|Death|1
5074399|NCT02221882|17512207|P1|Overall Study|Death|0
5074400|NCT02221882|17512202|P6|Overall Study|Withdrawal by Subject|2
5074401|NCT02221882|17512203|P5|Overall Study|Withdrawal by Subject|2
5074402|NCT02221882|17512204|P4|Overall Study|Withdrawal by Subject|2
5074403|NCT02221882|17512205|P3|Overall Study|Withdrawal by Subject|4
5074404|NCT02221882|17512206|P2|Overall Study|Withdrawal by Subject|0
5074405|NCT02221882|17512207|P1|Overall Study|Withdrawal by Subject|0
5074406|NCT02221674|17512274|P3|Overall Study|Lost to Follow-up|0
5074407|NCT02221674|17512275|P2|Overall Study|Lost to Follow-up|0
5074408|NCT02221674|17512276|P1|Overall Study|Lost to Follow-up|1
5074409|NCT02221648|17512292|P2|Overall Study|Withdrawal by Subject|3
5074410|NCT02221648|17512293|P1|Overall Study|Withdrawal by Subject|3
5074411|NCT02221284|17512322|P1|Overall Study|Protocol Deviation|5
5074412|NCT02221284|17512322|P1|Overall Study|Case Report Forms Uncollected|56
5074413|NCT02221037|17512354|P4|Overall Study|Physician Decision|0
5074414|NCT02221037|17512355|P3|Overall Study|Physician Decision|1
5074415|NCT02221037|17512356|P2|Overall Study|Physician Decision|0
5074416|NCT02221037|17512357|P1|Overall Study|Physician Decision|0
5074417|NCT02220998|17512443|P2|Overall Study|Lost to Follow-up|4
5074418|NCT02220998|17512444|P1|Overall Study|Lost to Follow-up|4
5074419|NCT02220998|17512443|P2|Overall Study|Lack of Efficacy|5
5074420|NCT02220998|17512444|P1|Overall Study|Lack of Efficacy|0
5074421|NCT02220998|17512443|P2|Overall Study|Death|0
5074422|NCT02220998|17512444|P1|Overall Study|Death|2
5074423|NCT02220998|17512443|P2|Overall Study|Randomized but Never Treated|2
5074424|NCT02220998|17512444|P1|Overall Study|Randomized but Never Treated|1
5074425|NCT02220920|17512462|P2|Overall Study|Conflict with the stopping criteria|2
5074426|NCT02220920|17512463|P1|Overall Study|Conflict with the stopping criteria|1
5074427|NCT02220920|17512462|P2|Overall Study|Withdrawal by Subject|0
5074428|NCT02220920|17512463|P1|Overall Study|Withdrawal by Subject|1
5074429|NCT02220920|17512462|P2|Overall Study|Lack of Efficacy|1
5074430|NCT02220920|17512463|P1|Overall Study|Lack of Efficacy|0
5074431|NCT02220920|17512462|P2|Overall Study|Adverse Event|0
5074432|NCT02220920|17512463|P1|Overall Study|Adverse Event|1
5074433|NCT02220907|17512477|P1|Overall Study|Conflict with the stopping criteria|1
5074434|NCT02220907|17512477|P1|Overall Study|Withdrawal by Subject|2
5074435|NCT02220907|17512477|P1|Overall Study|Physician Decision|1
5074436|NCT02220907|17512477|P1|Overall Study|Adverse Event|7
5074437|NCT02220894|17512486|P2|Overall Study|Ongoing in Study|183
5074438|NCT02220894|17512487|P1|Overall Study|Ongoing in Study|265
5074439|NCT02220894|17512486|P2|Overall Study|Withdrawal by Subject|13
5074440|NCT02220894|17512487|P1|Overall Study|Withdrawal by Subject|2
5074441|NCT02220894|17512486|P2|Overall Study|Withdrawal by Parent/Guardian|1
5074442|NCT02220894|17512487|P1|Overall Study|Withdrawal by Parent/Guardian|0
5074443|NCT02220894|17512486|P2|Overall Study|Lost to Follow-up|2
5074444|NCT02220894|17512487|P1|Overall Study|Lost to Follow-up|0
5074445|NCT02220894|17512486|P2|Overall Study|Death|368
5074446|NCT02220894|17512487|P1|Overall Study|Death|252
5074447|NCT02220894|17512486|P2|Overall Study|Adverse Event|70
5074448|NCT02220894|17512487|P1|Overall Study|Adverse Event|118
5074449|NCT02220855|17512513|P1|Overall Study|Withdrawal by Subject|1
5074450|NCT02220855|17512513|P1|Overall Study|Disease Progression|5
5074451|NCT02220855|17512513|P1|Overall Study|Adverse Event|8
5074452|NCT02220764|17512523|P2|Overall Study|Death|0
5074453|NCT02220764|17512524|P1|Overall Study|Death|1
5074454|NCT02220764|17512523|P2|Overall Study|Lost to Follow-up|1
5074455|NCT02220764|17512524|P1|Overall Study|Lost to Follow-up|3
5074456|NCT02220725|17512538|P4|Overall Study|Withdrawal by Subject|1
5074457|NCT02220725|17512539|P3|Overall Study|Withdrawal by Subject|0
5074458|NCT02220725|17512540|P2|Overall Study|Withdrawal by Subject|0
5074459|NCT02220725|17512541|P1|Overall Study|Withdrawal by Subject|0
5074460|NCT02220725|17512538|P4|Overall Study|Lost to Follow-up|1
5074461|NCT02220725|17512539|P3|Overall Study|Lost to Follow-up|0
5074462|NCT02220725|17512540|P2|Overall Study|Lost to Follow-up|0
5074463|NCT02220725|17512541|P1|Overall Study|Lost to Follow-up|0
5074464|NCT02220205|17512571|P2|Overall Study|Withdrawal by Subject|0
5074465|NCT02220205|17512572|P1|Overall Study|Withdrawal by Subject|1
5074466|NCT02219932|17512597|P2|Overall Study|Adverse Event|21
5074467|NCT02219932|17512598|P1|Overall Study|Adverse Event|23
5074468|NCT02219932|17512597|P2|Overall Study|Lost to Follow-up|2
5074469|NCT02219932|17512598|P1|Overall Study|Lost to Follow-up|4
5074470|NCT02219932|17512597|P2|Overall Study|Pregnancy|0
5074471|NCT02219932|17512598|P1|Overall Study|Pregnancy|1
5074472|NCT02219932|17512597|P2|Overall Study|Protocol Violation|6
5074473|NCT02219932|17512598|P1|Overall Study|Protocol Violation|10
5074474|NCT02219932|17512597|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
5074475|NCT02219932|17512598|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
5074476|NCT02219932|17512597|P2|Overall Study|Consent Withdrawn|7
5074477|NCT02219932|17512598|P1|Overall Study|Consent Withdrawn|11
5074478|NCT02219932|17512597|P2|Overall Study|Investigator Decision|1
5074479|NCT02219932|17512598|P1|Overall Study|Investigator Decision|0
5074480|NCT02219932|17512597|P2|Overall Study|Death|1
5074481|NCT02219932|17512598|P1|Overall Study|Death|1
5074482|NCT02219932|17512597|P2|Overall Study|Other|11
5074483|NCT02219932|17512598|P1|Overall Study|Other|5
5074484|NCT02219685|17512614|P2|Blinded Treatment Phase|Withdrew Consent|0
5074485|NCT02219685|17512615|P1|Blinded Treatment Phase|Withdrew Consent|1
5074486|NCT02219685|17512614|P2|Blinded Treatment Phase|Lost to Follow-up|0
5074487|NCT02219685|17512615|P1|Blinded Treatment Phase|Lost to Follow-up|1
5074488|NCT02219477|17512721|P3|Overall Study|Withdrawal by Subject|0
5074489|NCT02219477|17512722|P2|Overall Study|Withdrawal by Subject|1
5074490|NCT02219477|17512723|P1|Overall Study|Withdrawal by Subject|0
5074491|NCT02219477|17512721|P3|Overall Study|Adverse Event|1
5074492|NCT02219477|17512722|P2|Overall Study|Adverse Event|1
5074493|NCT02219477|17512723|P1|Overall Study|Adverse Event|0
5074494|NCT02219464|17512751|P2|Overall Study|catheter malfunction|0
5074495|NCT02219464|17512752|P1|Overall Study|catheter malfunction|1
5074496|NCT02219464|17512751|P2|Overall Study|case cancelled|0
5074497|NCT02219464|17512752|P1|Overall Study|case cancelled|1
5074498|NCT02219464|17512751|P2|Overall Study|Withdrawal by Subject|0
5074499|NCT02219464|17512752|P1|Overall Study|Withdrawal by Subject|1
5074500|NCT02219334|17512762|P2|Overall Study|Protocol Violation|3
5074501|NCT02219334|17512763|P1|Overall Study|Protocol Violation|7
5074502|NCT02219334|17512762|P2|Overall Study|Withdrawal by Subject|0
5074503|NCT02219334|17512763|P1|Overall Study|Withdrawal by Subject|1
5074504|NCT02219308|17512786|P2|Overall Study|Withdrawal by Subject|2
5074505|NCT02219308|17512787|P1|Overall Study|Withdrawal by Subject|1
5074506|NCT02219087|17512947|P2|Overall Study|Randomization envelope pulled out of seq|1
5074507|NCT02219087|17512948|P1|Overall Study|Randomization envelope pulled out of seq|0
5074508|NCT02219048|17512968|P2|Overall Study|Other|1
5074509|NCT02219048|17512969|P1|Overall Study|Other|0
5074510|NCT02219048|17512968|P2|Overall Study|Withdrawal by Subject|0
5074511|NCT02219048|17512969|P1|Overall Study|Withdrawal by Subject|2
5074512|NCT02219048|17512968|P2|Overall Study|Study terminated by sponsor|15
5074513|NCT02219048|17512969|P1|Overall Study|Study terminated by sponsor|16
5074514|NCT02219048|17512968|P2|Overall Study|No longer meets eligibility criteria|0
5074515|NCT02219048|17512969|P1|Overall Study|No longer meets eligibility criteria|1
5074516|NCT02219048|17512968|P2|Overall Study|Adverse Event|5
5074517|NCT02219048|17512969|P1|Overall Study|Adverse Event|2
5074518|NCT02219009|17512995|P2|Overall Study|Physician Decision|1
5074519|NCT02219009|17512996|P1|Overall Study|Physician Decision|0
5074520|NCT02219009|17512995|P2|Overall Study|Protocol deviation|0
5074521|NCT02219009|17512996|P1|Overall Study|Protocol deviation|1
5074522|NCT02219009|17512995|P2|Overall Study|Lost to Follow-up|2
5074523|NCT02219009|17512996|P1|Overall Study|Lost to Follow-up|2
5074524|NCT02219009|17512995|P2|Overall Study|Adverse Event|4
5074525|NCT02219009|17512996|P1|Overall Study|Adverse Event|2
5074526|NCT02219009|17512995|P2|Overall Study|Withdrawal by Subject|1
5074527|NCT02219009|17512996|P1|Overall Study|Withdrawal by Subject|5
5074528|NCT02218736|17513008|P2|Overall Study|Protocol Violation|0
5074529|NCT02218736|17513009|P1|Overall Study|Protocol Violation|2
5074530|NCT02218736|17513008|P2|Overall Study|Withdrawal by Subject|9
5074531|NCT02218736|17513009|P1|Overall Study|Withdrawal by Subject|10
5074532|NCT02218697|17513021|P2|Overall Study|Withdrawal by Subject|3
5074533|NCT02218697|17513022|P1|Overall Study|Withdrawal by Subject|2
5074534|NCT02218697|17513021|P2|Overall Study|Unwilling to be vaccinated in left arm|1
5074535|NCT02218697|17513022|P1|Overall Study|Unwilling to be vaccinated in left arm|0
5074536|NCT02218697|17513021|P2|Overall Study|Adverse Event|2
5074537|NCT02218697|17513022|P1|Overall Study|Adverse Event|0
5074538|NCT02218541|17513062|P2|Overall Study|Implant Failure|1
5074539|NCT02218541|17513063|P1|Overall Study|Implant Failure|4
5074540|NCT02218541|17513062|P2|Overall Study|Lost to Follow-up|1
5074541|NCT02218541|17513063|P1|Overall Study|Lost to Follow-up|2
5074542|NCT02218372|17513109|P2|Overall Study|Withdrawal by Parent/Guardian|1
5074543|NCT02218372|17513110|P1|Overall Study|Withdrawal by Parent/Guardian|0
5074544|NCT02218372|17513109|P2|Overall Study|Randomized but did not receive treatment|3
5074545|NCT02218372|17513110|P1|Overall Study|Randomized but did not receive treatment|2
5074546|NCT02218372|17513109|P2|Overall Study|Miscellaneous|1
5074547|NCT02218372|17513110|P1|Overall Study|Miscellaneous|2
5074548|NCT02218372|17513109|P2|Overall Study|Adverse Event|1
5074549|NCT02218372|17513110|P1|Overall Study|Adverse Event|1
5074550|NCT02218268|17513190|P2|24 Hour Washout|Physician Decision|9
5074551|NCT02218268|17513191|P1|24 Hour Washout|Physician Decision|11
5074552|NCT02218216|17513203|P3|Overall Study|Study terminated before completed|0
5074553|NCT02218216|17513204|P2|Overall Study|Study terminated before completed|0
5074554|NCT02218216|17513205|P1|Overall Study|Study terminated before completed|6
5074555|NCT02218008|17513258|P6|Stage 2 (S2)|Lost to Follow-up|1
5074556|NCT02218008|17513259|P5|Stage 2 (S2)|Lost to Follow-up|0
5074557|NCT02218008|17513260|P4|Stage 2 (S2)|Lost to Follow-up|0
5074558|NCT02218008|17513261|P3|Stage 2 (S2)|Lost to Follow-up|0
5074559|NCT02218008|17513262|P2|Stage 2 (S2)|Lost to Follow-up|0
5074560|NCT02218008|17513263|P1|Stage 2 (S2)|Lost to Follow-up|0
5074561|NCT02218008|17513258|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5074562|NCT02218008|17513259|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5074563|NCT02218008|17513260|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
5074564|NCT02218008|17513261|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5074565|NCT02218008|17513262|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5074566|NCT02218008|17513263|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5074567|NCT02218008|17513258|P6|Stage 2 (S2)|Lack of Efficacy|2
5074568|NCT02218008|17513259|P5|Stage 2 (S2)|Lack of Efficacy|0
5074569|NCT02218008|17513260|P4|Stage 2 (S2)|Lack of Efficacy|0
5074570|NCT02218008|17513261|P3|Stage 2 (S2)|Lack of Efficacy|0
5074571|NCT02218008|17513262|P2|Stage 2 (S2)|Lack of Efficacy|0
5074572|NCT02218008|17513263|P1|Stage 2 (S2)|Lack of Efficacy|0
5074573|NCT02218008|17513258|P6|Stage 2 (S2)|Withdrawal by Subject|0
5074574|NCT02218008|17513259|P5|Stage 2 (S2)|Withdrawal by Subject|1
5074575|NCT02218008|17513260|P4|Stage 2 (S2)|Withdrawal by Subject|1
5074576|NCT02218008|17513261|P3|Stage 2 (S2)|Withdrawal by Subject|0
5074577|NCT02218008|17513262|P2|Stage 2 (S2)|Withdrawal by Subject|0
5074578|NCT02218008|17513263|P1|Stage 2 (S2)|Withdrawal by Subject|0
5074579|NCT02218008|17513258|P6|Stage 2 (S2)|Adverse Event|3
5074580|NCT02218008|17513259|P5|Stage 2 (S2)|Adverse Event|3
5074581|NCT02218008|17513260|P4|Stage 2 (S2)|Adverse Event|2
5074582|NCT02218008|17513261|P3|Stage 2 (S2)|Adverse Event|0
5074583|NCT02218008|17513262|P2|Stage 2 (S2)|Adverse Event|0
5074584|NCT02218008|17513263|P1|Stage 2 (S2)|Adverse Event|0
5074585|NCT02218008|17513258|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5074586|NCT02218008|17513259|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5074587|NCT02218008|17513260|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5074588|NCT02218008|17513261|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5074589|NCT02218008|17513262|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5074590|NCT02218008|17513263|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
5074591|NCT02218008|17513258|P6|Stage 1 (S1)|Protocol Violation|0
5074592|NCT02218008|17513259|P5|Stage 1 (S1)|Protocol Violation|0
5074593|NCT02218008|17513260|P4|Stage 1 (S1)|Protocol Violation|0
5074594|NCT02218008|17513261|P3|Stage 1 (S1)|Protocol Violation|1
5074595|NCT02218008|17513262|P2|Stage 1 (S1)|Protocol Violation|0
5074596|NCT02218008|17513263|P1|Stage 1 (S1)|Protocol Violation|0
5074597|NCT02218008|17513258|P6|Stage 1 (S1)|Pregnancy|0
5074598|NCT02218008|17513259|P5|Stage 1 (S1)|Pregnancy|0
5074599|NCT02218008|17513260|P4|Stage 1 (S1)|Pregnancy|0
5074600|NCT02218008|17513261|P3|Stage 1 (S1)|Pregnancy|1
5074601|NCT02218008|17513262|P2|Stage 1 (S1)|Pregnancy|0
5074602|NCT02218008|17513263|P1|Stage 1 (S1)|Pregnancy|0
5074603|NCT02218008|17513258|P6|Stage 1 (S1)|Non-compliance; drug use|0
5074604|NCT02218008|17513259|P5|Stage 1 (S1)|Non-compliance; drug use|0
5074605|NCT02218008|17513260|P4|Stage 1 (S1)|Non-compliance; drug use|0
5074606|NCT02218008|17513261|P3|Stage 1 (S1)|Non-compliance; drug use|0
5074607|NCT02218008|17513262|P2|Stage 1 (S1)|Non-compliance; drug use|0
5074608|NCT02218008|17513263|P1|Stage 1 (S1)|Non-compliance; drug use|1
5074609|NCT02218008|17513258|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
5074610|NCT02218008|17513259|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
5074611|NCT02218008|17513260|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
5074612|NCT02218008|17513261|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
5074613|NCT02218008|17513262|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
5074614|NCT02218008|17513263|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
5074615|NCT02218008|17513258|P6|Stage 1 (S1)|Lost to Follow-up|0
5074616|NCT02218008|17513259|P5|Stage 1 (S1)|Lost to Follow-up|0
5074617|NCT02218008|17513260|P4|Stage 1 (S1)|Lost to Follow-up|0
5074618|NCT02218008|17513261|P3|Stage 1 (S1)|Lost to Follow-up|1
5074619|NCT02218008|17513262|P2|Stage 1 (S1)|Lost to Follow-up|0
5074620|NCT02218008|17513263|P1|Stage 1 (S1)|Lost to Follow-up|3
5074621|NCT02218008|17513258|P6|Stage 1 (S1)|Lack of Efficacy|0
5074622|NCT02218008|17513259|P5|Stage 1 (S1)|Lack of Efficacy|0
5074623|NCT02218008|17513260|P4|Stage 1 (S1)|Lack of Efficacy|0
5074624|NCT02218008|17513261|P3|Stage 1 (S1)|Lack of Efficacy|0
5074625|NCT02218008|17513262|P2|Stage 1 (S1)|Lack of Efficacy|0
5074626|NCT02218008|17513263|P1|Stage 1 (S1)|Lack of Efficacy|3
5074627|NCT02218008|17513258|P6|Stage 1 (S1)|Withdrawal by Subject|0
5074628|NCT02218008|17513259|P5|Stage 1 (S1)|Withdrawal by Subject|0
5074629|NCT02218008|17513260|P4|Stage 1 (S1)|Withdrawal by Subject|0
5074630|NCT02218008|17513261|P3|Stage 1 (S1)|Withdrawal by Subject|1
5074631|NCT02218008|17513262|P2|Stage 1 (S1)|Withdrawal by Subject|1
5074632|NCT02218008|17513263|P1|Stage 1 (S1)|Withdrawal by Subject|6
5074633|NCT02218008|17513258|P6|Stage 1 (S1)|Adverse Event|0
5074634|NCT02218008|17513259|P5|Stage 1 (S1)|Adverse Event|0
5074635|NCT02218008|17513260|P4|Stage 1 (S1)|Adverse Event|0
5074636|NCT02218008|17513261|P3|Stage 1 (S1)|Adverse Event|11
5074637|NCT02218008|17513262|P2|Stage 1 (S1)|Adverse Event|5
5074638|NCT02218008|17513263|P1|Stage 1 (S1)|Adverse Event|6
5074639|NCT02217982|17513309|P2|Overall Study|Adverse Event|1
5074640|NCT02217982|17513310|P1|Overall Study|Adverse Event|0
5074641|NCT02217982|17513309|P2|Overall Study|Trial discontinued|0
5074642|NCT02217982|17513310|P1|Overall Study|Trial discontinued|1
5074643|NCT02217878|17513393|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
5074644|NCT02217878|17513394|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
5074645|NCT02217878|17513393|P2|Overall Study|required morphine due to chest pain|2
5074646|NCT02217878|17513394|P1|Overall Study|required morphine due to chest pain|1
5074647|NCT02217566|17513492|P1|Overall Study|Early study termination|6
5074648|NCT02217566|17513492|P1|Overall Study|Death|3
5074649|NCT02217566|17513492|P1|Overall Study|Lost to Follow-up|2
5074650|NCT02217527|17513503|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
5074651|NCT02217527|17513504|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
5074652|NCT02217527|17513503|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
5074653|NCT02217527|17513504|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
5074654|NCT02217475|17513517|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
5074655|NCT02217475|17513518|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
5074656|NCT02217475|17513519|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
5074657|NCT02217475|17513517|P3|Treatment Period 2 (Year 2)|Physician Decision|2
5074658|NCT02217475|17513518|P2|Treatment Period 2 (Year 2)|Physician Decision|0
5074659|NCT02217475|17513519|P1|Treatment Period 2 (Year 2)|Physician Decision|0
5074660|NCT02217475|17513517|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
5074661|NCT02217475|17513518|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
5074662|NCT02217475|17513519|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
5074663|NCT02217475|17513517|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
5074664|NCT02217475|17513518|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
5074665|NCT02217475|17513519|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
5074666|NCT02217475|17513517|P3|Treatment Period 2 (Year 2)|Adverse Event|5
5074667|NCT02217475|17513518|P2|Treatment Period 2 (Year 2)|Adverse Event|1
5074668|NCT02217475|17513519|P1|Treatment Period 2 (Year 2)|Adverse Event|0
5074669|NCT02217475|17513517|P3|Discontinued After Period 1|Physician Decision|1
5074670|NCT02217475|17513518|P2|Discontinued After Period 1|Physician Decision|0
5074671|NCT02217475|17513519|P1|Discontinued After Period 1|Physician Decision|0
5074672|NCT02217475|17513517|P3|Discontinued After Period 1|Participant Withdrew Consent|2
5074673|NCT02217475|17513518|P2|Discontinued After Period 1|Participant Withdrew Consent|1
5074674|NCT02217475|17513519|P1|Discontinued After Period 1|Participant Withdrew Consent|1
5074675|NCT02217475|17513517|P3|Discontinued After Period 1|Adverse Event|0
5074676|NCT02217475|17513518|P2|Discontinued After Period 1|Adverse Event|2
5074677|NCT02217475|17513519|P1|Discontinued After Period 1|Adverse Event|1
5074678|NCT02217475|17513517|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
5074679|NCT02217475|17513518|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
5074680|NCT02217475|17513519|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
5074681|NCT02217475|17513517|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
5074682|NCT02217475|17513518|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
5074683|NCT02217475|17513519|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
5074684|NCT02217475|17513517|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
5074685|NCT02217475|17513518|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
5074686|NCT02217475|17513519|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
5074687|NCT02217475|17513517|P3|Treatment Period 1 (Year 1)|Adverse Event|9
5074688|NCT02217475|17513518|P2|Treatment Period 1 (Year 1)|Adverse Event|5
5074689|NCT02217475|17513519|P1|Treatment Period 1 (Year 1)|Adverse Event|4
5074690|NCT02217475|17513517|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
5074691|NCT02217475|17513518|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
5074692|NCT02217475|17513519|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
5074693|NCT02217436|17513636|P2|Overall Study|Incomplete data|1
5074694|NCT02217436|17513637|P1|Overall Study|Incomplete data|0
5074695|NCT02217436|17513636|P2|Overall Study|Protocol Violation|1
5074696|NCT02217436|17513637|P1|Overall Study|Protocol Violation|1
5074697|NCT02217410|17513648|P3|Overall Study|Physician Decision|0
5074698|NCT02217410|17513649|P2|Overall Study|Physician Decision|3
5074699|NCT02217410|17513650|P1|Overall Study|Physician Decision|1
5074700|NCT02217410|17513648|P3|Overall Study|Lack of Efficacy|0
5074701|NCT02217410|17513649|P2|Overall Study|Lack of Efficacy|1
5074702|NCT02217410|17513650|P1|Overall Study|Lack of Efficacy|0
5074703|NCT02217410|17513648|P3|Overall Study|Lost to Follow-up|1
5074704|NCT02217410|17513649|P2|Overall Study|Lost to Follow-up|0
5074705|NCT02217410|17513650|P1|Overall Study|Lost to Follow-up|0
5074706|NCT02217410|17513648|P3|Overall Study|Withdrawal by Subject|2
5074707|NCT02217410|17513649|P2|Overall Study|Withdrawal by Subject|0
5074708|NCT02217410|17513650|P1|Overall Study|Withdrawal by Subject|0
5074709|NCT02217410|17513648|P3|Overall Study|Graft Loss|2
5074710|NCT02217410|17513649|P2|Overall Study|Graft Loss|0
5074711|NCT02217410|17513650|P1|Overall Study|Graft Loss|0
5074712|NCT02217280|17513673|P1|Overall Study|Post-consent sceen fail|2
5074713|NCT02217280|17513673|P1|Overall Study|Withdrawal by Subject|2
5074714|NCT02216812|17513680|P2|Overall Study|Lost to Follow-up|5
5074715|NCT02216812|17513681|P1|Overall Study|Lost to Follow-up|10
5074716|NCT02216773|17513697|P2|Overall Study|Abandoned|3
5074717|NCT02216773|17513698|P1|Overall Study|Abandoned|4
5074718|NCT02216773|17513697|P2|Overall Study|Insufficient FLRV|0
5074719|NCT02216773|17513698|P1|Overall Study|Insufficient FLRV|4
5074720|NCT02216773|17513697|P2|Overall Study|Disease progression|2
5074721|NCT02216773|17513698|P1|Overall Study|Disease progression|4
5074722|NCT02216591|17513719|P2|Overall Study|Lost to Follow-up|1
5074723|NCT02216591|17513720|P1|Overall Study|Lost to Follow-up|0
5074724|NCT02216526|17513733|P3|Overall Study|Hospitalization|3
5074725|NCT02216526|17513734|P2|Overall Study|Hospitalization|1
5074726|NCT02216526|17513735|P1|Overall Study|Hospitalization|2
5074727|NCT02216526|17513733|P3|Overall Study|Protocol Violation|2
5074728|NCT02216526|17513734|P2|Overall Study|Protocol Violation|0
5074729|NCT02216526|17513735|P1|Overall Study|Protocol Violation|2
5074730|NCT02216526|17513733|P3|Overall Study|Death|3
5074731|NCT02216526|17513734|P2|Overall Study|Death|1
5074732|NCT02216526|17513735|P1|Overall Study|Death|0
5074733|NCT02216526|17513733|P3|Overall Study|Adverse Event|0
5074734|NCT02216526|17513734|P2|Overall Study|Adverse Event|1
5074735|NCT02216526|17513735|P1|Overall Study|Adverse Event|1
5074736|NCT02216357|17513853|P2|Overall Study|Inclusion or exclusion criteria not met|1
5074737|NCT02216357|17513854|P1|Overall Study|Inclusion or exclusion criteria not met|2
5074738|NCT02216214|17513880|P2|Overall Study|Miscellaneous|1
5074739|NCT02216214|17513881|P1|Overall Study|Miscellaneous|1
5074740|NCT02216214|17513880|P2|Overall Study|Study Terminated By Sponsor|1
5074741|NCT02216214|17513881|P1|Overall Study|Study Terminated By Sponsor|0
5074742|NCT02216214|17513880|P2|Overall Study|Withdrawal by Subject|20
5074743|NCT02216214|17513881|P1|Overall Study|Withdrawal by Subject|22
5074744|NCT02216214|17513880|P2|Overall Study|Protocol Violation|2
5074745|NCT02216214|17513881|P1|Overall Study|Protocol Violation|4
5074746|NCT02216214|17513880|P2|Overall Study|Lost to Follow-up|2
5074747|NCT02216214|17513881|P1|Overall Study|Lost to Follow-up|3
5074748|NCT02216214|17513880|P2|Overall Study|Lack of Efficacy|2
5074749|NCT02216214|17513881|P1|Overall Study|Lack of Efficacy|2
5074750|NCT02216214|17513880|P2|Overall Study|Adverse Event|8
5074751|NCT02216214|17513881|P1|Overall Study|Adverse Event|10
5074752|NCT02216214|17513880|P2|Overall Study|Randomized Never Received Study Drug|0
5074753|NCT02216214|17513881|P1|Overall Study|Randomized Never Received Study Drug|1
5074754|NCT02216123|17513952|P2|Overall Study|Withdrawal by Subject|0
5074755|NCT02216123|17513953|P1|Overall Study|Withdrawal by Subject|2
5074756|NCT02216123|17513952|P2|Overall Study|Lost to Follow-up|2
5074757|NCT02216123|17513953|P1|Overall Study|Lost to Follow-up|4
5074758|NCT02215967|17514046|P4|Overall Study|Patient did not get CAR T-Cells|0
5074759|NCT02215967|17514047|P3|Overall Study|Patient did not get CAR T-Cells|1
5074760|NCT02215967|17514048|P2|Overall Study|Patient did not get CAR T-Cells|0
5074761|NCT02215967|17514049|P1|Overall Study|Patient did not get CAR T-Cells|0
5074762|NCT02215967|17514046|P4|Overall Study|Patient became ineligible for treatment|3
5074763|NCT02215967|17514047|P3|Overall Study|Patient became ineligible for treatment|0
5074764|NCT02215967|17514048|P2|Overall Study|Patient became ineligible for treatment|0
5074765|NCT02215967|17514049|P1|Overall Study|Patient became ineligible for treatment|0
5074766|NCT02215954|17514070|P3|Overall Study|Not exposed|3
5074767|NCT02215954|17514071|P2|Overall Study|Not exposed|1
5074768|NCT02215954|17514072|P1|Overall Study|Not exposed|1
5074769|NCT02215954|17514070|P3|Overall Study|Withdrawal by Subject|2
5074770|NCT02215954|17514071|P2|Overall Study|Withdrawal by Subject|0
5074771|NCT02215954|17514072|P1|Overall Study|Withdrawal by Subject|0
5074772|NCT02215954|17514070|P3|Overall Study|Adverse Event|1
5074773|NCT02215954|17514071|P2|Overall Study|Adverse Event|0
5074774|NCT02215954|17514072|P1|Overall Study|Adverse Event|0
5074775|NCT02215616|17514096|P4|Overall Study|Other than specified|1
5074776|NCT02215616|17514097|P3|Overall Study|Other than specified|1
5074777|NCT02215616|17514098|P2|Overall Study|Other than specified|0
5074778|NCT02215616|17514099|P1|Overall Study|Other than specified|1
5074779|NCT02215616|17514096|P4|Overall Study|Lost to Follow-up|1
5074780|NCT02215616|17514097|P3|Overall Study|Lost to Follow-up|0
5074781|NCT02215616|17514098|P2|Overall Study|Lost to Follow-up|1
5074782|NCT02215616|17514099|P1|Overall Study|Lost to Follow-up|1
5074783|NCT02215616|17514096|P4|Overall Study|Protocol Violation|0
5074784|NCT02215616|17514097|P3|Overall Study|Protocol Violation|0
5074785|NCT02215616|17514098|P2|Overall Study|Protocol Violation|2
5074786|NCT02215616|17514099|P1|Overall Study|Protocol Violation|0
5074787|NCT02215616|17514096|P4|Overall Study|Non-compliance|0
5074788|NCT02215616|17514097|P3|Overall Study|Non-compliance|1
5074789|NCT02215616|17514098|P2|Overall Study|Non-compliance|2
5074790|NCT02215616|17514099|P1|Overall Study|Non-compliance|0
5074791|NCT02215616|17514096|P4|Overall Study|Withdrawal by Subject|5
5074792|NCT02215616|17514097|P3|Overall Study|Withdrawal by Subject|2
5074793|NCT02215616|17514098|P2|Overall Study|Withdrawal by Subject|8
5074794|NCT02215616|17514099|P1|Overall Study|Withdrawal by Subject|1
5074795|NCT02215616|17514096|P4|Overall Study|Adverse Event|2
5074796|NCT02215616|17514097|P3|Overall Study|Adverse Event|9
5074797|NCT02215616|17514098|P2|Overall Study|Adverse Event|4
5074798|NCT02215616|17514099|P1|Overall Study|Adverse Event|7
5074799|NCT02215616|17514096|P4|Overall Study|Death|0
5074800|NCT02215616|17514097|P3|Overall Study|Death|0
5074801|NCT02215616|17514098|P2|Overall Study|Death|0
5074802|NCT02215616|17514099|P1|Overall Study|Death|1
5074803|NCT02215616|17514096|P4|Overall Study|Sponsor requested to stop study drug|4
5074804|NCT02215616|17514097|P3|Overall Study|Sponsor requested to stop study drug|1
5074805|NCT02215616|17514098|P2|Overall Study|Sponsor requested to stop study drug|0
5074806|NCT02215616|17514099|P1|Overall Study|Sponsor requested to stop study drug|0
5074807|NCT02215252|17514121|P3|Overall Study|Other|1
5074808|NCT02215252|17514122|P2|Overall Study|Other|1
5074809|NCT02215252|17514123|P1|Overall Study|Other|0
5074810|NCT02215252|17514121|P3|Overall Study|Withdrawal by Subject|0
5074811|NCT02215252|17514122|P2|Overall Study|Withdrawal by Subject|0
5074812|NCT02215252|17514123|P1|Overall Study|Withdrawal by Subject|1
5074813|NCT02215252|17514121|P3|Overall Study|Protocol Violation|0
5074814|NCT02215252|17514122|P2|Overall Study|Protocol Violation|1
5074815|NCT02215252|17514123|P1|Overall Study|Protocol Violation|0
5074816|NCT02215252|17514121|P3|Overall Study|Does not Meet Entrance Criteria|0
5074817|NCT02215252|17514122|P2|Overall Study|Does not Meet Entrance Criteria|1
5074818|NCT02215252|17514123|P1|Overall Study|Does not Meet Entrance Criteria|0
5074819|NCT02215252|17514121|P3|Overall Study|Lost to Follow-up|1
5074820|NCT02215252|17514122|P2|Overall Study|Lost to Follow-up|0
5074821|NCT02215252|17514123|P1|Overall Study|Lost to Follow-up|0
5074822|NCT02215252|17514121|P3|Overall Study|Adverse Event|2
5074823|NCT02215252|17514122|P2|Overall Study|Adverse Event|5
5074824|NCT02215252|17514123|P1|Overall Study|Adverse Event|1
5074825|NCT02215096|17514211|P5|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
5074826|NCT02215096|17514212|P4|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
5074827|NCT02215096|17514213|P3|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
5074828|NCT02215096|17514214|P2|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
5074829|NCT02215096|17514215|P1|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
5074830|NCT02215096|17514211|P5|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5074831|NCT02215096|17514212|P4|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
5074832|NCT02215096|17514213|P3|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5074833|NCT02215096|17514214|P2|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5074834|NCT02215096|17514215|P1|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5074835|NCT02215096|17514211|P5|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
5074836|NCT02215096|17514212|P4|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5074837|NCT02215096|17514213|P3|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5074838|NCT02215096|17514214|P2|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5074839|NCT02215096|17514215|P1|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5074840|NCT02215096|17514211|P5|Run-In Period (Up to Week 2)|Adverse Event|0
5074841|NCT02215096|17514212|P4|Run-In Period (Up to Week 2)|Adverse Event|0
5074842|NCT02215096|17514213|P3|Run-In Period (Up to Week 2)|Adverse Event|0
5074843|NCT02215096|17514214|P2|Run-In Period (Up to Week 2)|Adverse Event|0
5074844|NCT02215096|17514215|P1|Run-In Period (Up to Week 2)|Adverse Event|1
5074845|NCT02214225|17514366|P3|Overall Study|randomized in error, not vaccinated|1
5074846|NCT02214225|17514367|P2|Overall Study|randomized in error, not vaccinated|1
5074847|NCT02214225|17514368|P1|Overall Study|randomized in error, not vaccinated|2
5074848|NCT02214225|17514366|P3|Overall Study|Death|1
5074849|NCT02214225|17514367|P2|Overall Study|Death|0
5074850|NCT02214225|17514368|P1|Overall Study|Death|5
5074851|NCT02214225|17514366|P3|Overall Study|Withdrawal by Subject|2
5074852|NCT02214225|17514367|P2|Overall Study|Withdrawal by Subject|0
5074853|NCT02214225|17514368|P1|Overall Study|Withdrawal by Subject|2
5074854|NCT02214225|17514366|P3|Overall Study|Lost to Follow-up|18
5074855|NCT02214225|17514367|P2|Overall Study|Lost to Follow-up|18
5074856|NCT02214225|17514368|P1|Overall Study|Lost to Follow-up|46
5074857|NCT02214186|17514427|P2|Overall Study|Protocol Violation|1
5074858|NCT02214186|17514428|P1|Overall Study|Protocol Violation|1
5074859|NCT02214186|17514427|P2|Overall Study|Lost to Follow-up|1
5074860|NCT02214186|17514428|P1|Overall Study|Lost to Follow-up|1
5074861|NCT02214121|17514496|P3|Part B|Lost to Follow-up|1
5074862|NCT02214121|17514497|P2|Part B|Lost to Follow-up|0
5074863|NCT02214121|17514498|P1|Part B|Lost to Follow-up|0
5074864|NCT02214121|17514496|P3|Part B|Dev. of study-specific withdrawal crit.|0
5074865|NCT02214121|17514497|P2|Part B|Dev. of study-specific withdrawal crit.|2
5074866|NCT02214121|17514498|P1|Part B|Dev. of study-specific withdrawal crit.|0
5074867|NCT02214121|17514496|P3|Part B|Patient decision|0
5074868|NCT02214121|17514497|P2|Part B|Patient decision|1
5074869|NCT02214121|17514498|P1|Part B|Patient decision|0
5074870|NCT02214121|17514496|P3|Part A|Other|0
5074871|NCT02214121|17514497|P2|Part A|Other|0
5074872|NCT02214121|17514498|P1|Part A|Other|1
5074873|NCT02214121|17514496|P3|Part A|Dev. of study-specific withdrawal crit.|0
5074874|NCT02214121|17514497|P2|Part A|Dev. of study-specific withdrawal crit.|0
5074875|NCT02214121|17514498|P1|Part A|Dev. of study-specific withdrawal crit.|4
5074876|NCT02214121|17514496|P3|Part A|Patient decision|0
5074877|NCT02214121|17514497|P2|Part A|Patient decision|0
5074878|NCT02214121|17514498|P1|Part A|Patient decision|2
5074879|NCT02213666|17514607|P1|Overall Study|Withdrawal by Subject|1
5074880|NCT02213510|17514613|P2|Overall Study|Lost to Follow-up|0
5074881|NCT02213510|17514614|P1|Overall Study|Lost to Follow-up|1
5074882|NCT02213510|17514613|P2|Overall Study|Death|1
5074883|NCT02213510|17514614|P1|Overall Study|Death|0
5074884|NCT02213263|17514642|P2|Overall Study|Adverse Event|3
5074885|NCT02213263|17514643|P1|Overall Study|Adverse Event|1
5074886|NCT02213263|17514642|P2|Overall Study|Protocol Violation|1
5074887|NCT02213263|17514643|P1|Overall Study|Protocol Violation|0
5074888|NCT02213263|17514642|P2|Overall Study|Progressive disease|14
5074889|NCT02213263|17514643|P1|Overall Study|Progressive disease|20
5074890|NCT02213263|17514642|P2|Overall Study|No longer willing to participate|4
5074891|NCT02213263|17514643|P1|Overall Study|No longer willing to participate|3
5074892|NCT02213263|17514642|P2|Overall Study|Lost to Follow-up|1
5074893|NCT02213263|17514643|P1|Overall Study|Lost to Follow-up|0
5074894|NCT02213263|17514642|P2|Overall Study|Insufficient clinical response|3
5074895|NCT02213263|17514643|P1|Overall Study|Insufficient clinical response|4
5074896|NCT02213198|17514711|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
5074897|NCT02213198|17514712|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
5074898|NCT02213198|17514711|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
5074899|NCT02213198|17514712|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
5074900|NCT02213198|17514711|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
5074901|NCT02213198|17514712|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
5074902|NCT02213198|17514711|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
5074903|NCT02213198|17514712|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
5074904|NCT02213198|17514711|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
5074905|NCT02213198|17514712|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
5074906|NCT02213198|17514711|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5074907|NCT02213198|17514712|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5074908|NCT02213198|17514711|P2|Baseline|incarcerated,violent|1
5074909|NCT02213198|17514712|P1|Baseline|incarcerated,violent|0
5074910|NCT02213198|17514711|P2|Baseline|Lost to Follow-up|21
5074911|NCT02213198|17514712|P1|Baseline|Lost to Follow-up|40
5074912|NCT02213198|17514711|P2|Baseline|transferred out of clinic|9
5074913|NCT02213198|17514712|P1|Baseline|transferred out of clinic|7
5074914|NCT02213198|17514711|P2|Baseline|Withdrawal by Subject|11
5074915|NCT02213198|17514712|P1|Baseline|Withdrawal by Subject|34
5074916|NCT02213198|17514711|P2|Baseline|No show for intake|9
5074917|NCT02213198|17514712|P1|Baseline|No show for intake|7
5074918|NCT02213094|17514722|P2|Overall Study|Adverse Event|0
5074919|NCT02213094|17514723|P1|Overall Study|Adverse Event|1
5074920|NCT02213055|17514731|P2|Overall Study|Did not Return to School|0
5074921|NCT02213055|17514732|P1|Overall Study|Did not Return to School|5
5074922|NCT02213055|17514731|P2|Overall Study|Did not meet Inclusion Criteria|0
5074923|NCT02213055|17514732|P1|Overall Study|Did not meet Inclusion Criteria|6
5074924|NCT02213055|17514731|P2|Overall Study|Had another Treatment during the Study|0
5074925|NCT02213055|17514732|P1|Overall Study|Had another Treatment during the Study|3
5074926|NCT02213055|17514731|P2|Overall Study|Did not have Live Lice|0
5074927|NCT02213055|17514732|P1|Overall Study|Did not have Live Lice|8
5074928|NCT02213055|17514731|P2|Overall Study|Documentation Issue during Study|0
5074929|NCT02213055|17514732|P1|Overall Study|Documentation Issue during Study|10
5074930|NCT02213055|17514731|P2|Overall Study|Documentation Issue at Enrollment|0
5074931|NCT02213055|17514732|P1|Overall Study|Documentation Issue at Enrollment|1
5074932|NCT02213055|17514731|P2|Overall Study|Protocol was not Followed during Study|0
5074933|NCT02213055|17514732|P1|Overall Study|Protocol was not Followed during Study|1
5074934|NCT02213055|17514731|P2|Overall Study|Protocol was not Followed at Enrollment|0
5074935|NCT02213055|17514732|P1|Overall Study|Protocol was not Followed at Enrollment|5
5074936|NCT02212730|17514766|P2|Overall Study|Disease progression prior to RCC surgery|1
5074937|NCT02212730|17514767|P1|Overall Study|Disease progression prior to RCC surgery|0
5074938|NCT02212730|17514766|P2|Overall Study|Withdrawal by Subject|0
5074939|NCT02212730|17514767|P1|Overall Study|Withdrawal by Subject|1
5074940|NCT02212730|17514766|P2|Overall Study|Tumor not of the required cell histology|0
5074941|NCT02212730|17514767|P1|Overall Study|Tumor not of the required cell histology|1
5074942|NCT02212678|17514789|P1|Overall Study|Adverse Event|1
5074943|NCT02212457|17514809|P6|Overall Study|Other|1
5074944|NCT02212457|17514810|P5|Overall Study|Other|0
5074945|NCT02212457|17514811|P4|Overall Study|Other|1
5074946|NCT02212457|17514812|P3|Overall Study|Other|2
5074947|NCT02212457|17514813|P2|Overall Study|Other|1
5074948|NCT02212457|17514814|P1|Overall Study|Other|2
5074949|NCT02212457|17514809|P6|Overall Study|Protocol Violation|3
5074950|NCT02212457|17514810|P5|Overall Study|Protocol Violation|2
5074951|NCT02212457|17514811|P4|Overall Study|Protocol Violation|1
5074952|NCT02212457|17514812|P3|Overall Study|Protocol Violation|0
5074953|NCT02212457|17514813|P2|Overall Study|Protocol Violation|1
5074954|NCT02212457|17514814|P1|Overall Study|Protocol Violation|2
5074955|NCT02212457|17514809|P6|Overall Study|Lost to Follow-up|4
5074956|NCT02212457|17514810|P5|Overall Study|Lost to Follow-up|8
5074957|NCT02212457|17514811|P4|Overall Study|Lost to Follow-up|1
5074958|NCT02212457|17514812|P3|Overall Study|Lost to Follow-up|4
5074959|NCT02212457|17514813|P2|Overall Study|Lost to Follow-up|7
5074960|NCT02212457|17514814|P1|Overall Study|Lost to Follow-up|6
5074961|NCT02212457|17514809|P6|Overall Study|Withdrawal by Subject|4
5074962|NCT02212457|17514810|P5|Overall Study|Withdrawal by Subject|5
5074963|NCT02212457|17514811|P4|Overall Study|Withdrawal by Subject|6
5074964|NCT02212457|17514812|P3|Overall Study|Withdrawal by Subject|8
5074965|NCT02212457|17514813|P2|Overall Study|Withdrawal by Subject|10
5074966|NCT02212457|17514814|P1|Overall Study|Withdrawal by Subject|8
5074967|NCT02212457|17514809|P6|Overall Study|Adverse Event|1
5074968|NCT02212457|17514810|P5|Overall Study|Adverse Event|0
5074969|NCT02212457|17514811|P4|Overall Study|Adverse Event|2
5074970|NCT02212457|17514812|P3|Overall Study|Adverse Event|2
5074971|NCT02212457|17514813|P2|Overall Study|Adverse Event|2
5074972|NCT02212457|17514814|P1|Overall Study|Adverse Event|1
5074973|NCT02212301|17514938|P2|Period 1|Lost to Follow-up|1
5074974|NCT02212301|17514939|P1|Period 1|Lost to Follow-up|0
5074975|NCT02212197|17514950|P3|Overall Study|Need for radiotherapy|0
5074976|NCT02212197|17514951|P2|Overall Study|Need for radiotherapy|0
5074977|NCT02212197|17514952|P1|Overall Study|Need for radiotherapy|1
5074978|NCT02211638|17515005|P1|Overall Study|Protocol Violation|692
5074979|NCT02211638|17515005|P1|Overall Study|Case Report Forms Uncollected|291
5074980|NCT02211313|17515052|P2|Overall Study|No Follow up Questionnaires|1
5074981|NCT02211313|17515053|P1|Overall Study|No Follow up Questionnaires|1
5074982|NCT02211313|17515052|P2|Overall Study|Treatment Failure|2
5074983|NCT02211313|17515053|P1|Overall Study|Treatment Failure|5
5074984|NCT02211261|17515070|P11|Overall Study|Lost to Follow-up|0
5074985|NCT02211261|17515071|P10|Overall Study|Lost to Follow-up|0
5074986|NCT02211261|17515072|P9|Overall Study|Lost to Follow-up|0
5074987|NCT02211261|17515073|P8|Overall Study|Lost to Follow-up|1
5074988|NCT02211261|17515074|P7|Overall Study|Lost to Follow-up|0
5074989|NCT02211261|17515075|P6|Overall Study|Lost to Follow-up|0
5074990|NCT02211261|17515076|P5|Overall Study|Lost to Follow-up|0
5074991|NCT02211261|17515077|P4|Overall Study|Lost to Follow-up|0
5074992|NCT02211261|17515078|P3|Overall Study|Lost to Follow-up|0
5074993|NCT02211261|17515079|P2|Overall Study|Lost to Follow-up|0
5074994|NCT02211261|17515080|P1|Overall Study|Lost to Follow-up|0
5074995|NCT02211261|17515070|P11|Overall Study|Other|0
5074996|NCT02211261|17515071|P10|Overall Study|Other|2
5074997|NCT02211261|17515072|P9|Overall Study|Other|0
5074998|NCT02211261|17515073|P8|Overall Study|Other|0
5074999|NCT02211261|17515074|P7|Overall Study|Other|0
5075000|NCT02211261|17515075|P6|Overall Study|Other|1
5075001|NCT02211261|17515076|P5|Overall Study|Other|0
5075002|NCT02211261|17515077|P4|Overall Study|Other|0
5075003|NCT02211261|17515078|P3|Overall Study|Other|0
5075004|NCT02211261|17515079|P2|Overall Study|Other|0
5075005|NCT02211261|17515080|P1|Overall Study|Other|0
5075006|NCT02211261|17515070|P11|Overall Study|Withdrawal by Subject|0
5075007|NCT02211261|17515071|P10|Overall Study|Withdrawal by Subject|0
5075008|NCT02211261|17515072|P9|Overall Study|Withdrawal by Subject|0
5075009|NCT02211261|17515073|P8|Overall Study|Withdrawal by Subject|0
5075010|NCT02211261|17515074|P7|Overall Study|Withdrawal by Subject|0
5075011|NCT02211261|17515075|P6|Overall Study|Withdrawal by Subject|0
5075012|NCT02211261|17515076|P5|Overall Study|Withdrawal by Subject|2
5075013|NCT02211261|17515077|P4|Overall Study|Withdrawal by Subject|0
5075014|NCT02211261|17515078|P3|Overall Study|Withdrawal by Subject|1
5075015|NCT02211261|17515079|P2|Overall Study|Withdrawal by Subject|0
5075016|NCT02211261|17515080|P1|Overall Study|Withdrawal by Subject|0
5075017|NCT02211131|17515203|P2|Overall Study|Continuing on Study|60
5075018|NCT02211131|17515204|P1|Overall Study|Continuing on Study|49
5075019|NCT02211131|17515203|P2|Overall Study|Withdrawal by Subject|4
5075020|NCT02211131|17515204|P1|Overall Study|Withdrawal by Subject|3
5075021|NCT02211131|17515203|P2|Overall Study|Decision by Sponsor|1
5075022|NCT02211131|17515204|P1|Overall Study|Decision by Sponsor|1
5075023|NCT02211131|17515203|P2|Overall Study|Lost to Follow-up|0
5075024|NCT02211131|17515204|P1|Overall Study|Lost to Follow-up|1
5075025|NCT02211131|17515203|P2|Overall Study|Death|11
5075026|NCT02211131|17515204|P1|Overall Study|Death|20
5075027|NCT02211014|17515238|P2|Overall Study|In agreement with patient, no benefit|1
5075028|NCT02211014|17515239|P1|Overall Study|In agreement with patient, no benefit|0
5075029|NCT02211014|17515238|P2|Overall Study|Withdrawal by Subject|1
5075030|NCT02211014|17515239|P1|Overall Study|Withdrawal by Subject|0
5075031|NCT02211014|17515238|P2|Overall Study|Started another cancer therapy|0
5075032|NCT02211014|17515239|P1|Overall Study|Started another cancer therapy|1
5075033|NCT02211014|17515238|P2|Overall Study|Physician Decision|2
5075034|NCT02211014|17515239|P1|Overall Study|Physician Decision|1
5075035|NCT02211014|17515238|P2|Overall Study|Adverse Event|2
5075036|NCT02211014|17515239|P1|Overall Study|Adverse Event|0
5075037|NCT02210780|17515265|P2|Overall Study|Other than specified above|1
5075038|NCT02210780|17515266|P1|Overall Study|Other than specified above|0
5075039|NCT02210780|17515265|P2|Overall Study|Protocol Violation|0
5075040|NCT02210780|17515266|P1|Overall Study|Protocol Violation|1
5075041|NCT02210780|17515265|P2|Overall Study|Physician Decision|0
5075042|NCT02210780|17515266|P1|Overall Study|Physician Decision|1
5075043|NCT02210780|17515265|P2|Overall Study|Withdrawal by Subject|1
5075044|NCT02210780|17515266|P1|Overall Study|Withdrawal by Subject|1
5075045|NCT02210780|17515265|P2|Overall Study|Lost to Follow-up|1
5075046|NCT02210780|17515266|P1|Overall Study|Lost to Follow-up|2
5075047|NCT02210780|17515265|P2|Overall Study|Adverse Event|5
5075048|NCT02210780|17515266|P1|Overall Study|Adverse Event|0
5075049|NCT02210689|17515295|P3|Overall Study|Other|8
5075050|NCT02210689|17515296|P2|Overall Study|Other|21
5075051|NCT02210689|17515297|P1|Overall Study|Other|25
5075052|NCT02210689|17515295|P3|Overall Study|Negative Nugent score at baseline|2
5075053|NCT02210689|17515296|P2|Overall Study|Negative Nugent score at baseline|2
5075054|NCT02210689|17515297|P1|Overall Study|Negative Nugent score at baseline|6
5075055|NCT02210689|17515295|P3|Overall Study|Prohibited medication|1
5075056|NCT02210689|17515296|P2|Overall Study|Prohibited medication|8
5075057|NCT02210689|17515297|P1|Overall Study|Prohibited medication|2
5075058|NCT02210689|17515295|P3|Overall Study|Lack of Efficacy|5
5075059|NCT02210689|17515296|P2|Overall Study|Lack of Efficacy|1
5075060|NCT02210689|17515297|P1|Overall Study|Lack of Efficacy|0
5075061|NCT02210689|17515295|P3|Overall Study|Pregnancy|0
5075062|NCT02210689|17515296|P2|Overall Study|Pregnancy|1
5075063|NCT02210689|17515297|P1|Overall Study|Pregnancy|0
5075064|NCT02210689|17515295|P3|Overall Study|Lost to Follow-up|5
5075065|NCT02210689|17515296|P2|Overall Study|Lost to Follow-up|9
5075066|NCT02210689|17515297|P1|Overall Study|Lost to Follow-up|11
5075067|NCT02210689|17515295|P3|Overall Study|Protocol Violation|0
5075068|NCT02210689|17515296|P2|Overall Study|Protocol Violation|0
5075069|NCT02210689|17515297|P1|Overall Study|Protocol Violation|1
5075070|NCT02210689|17515295|P3|Overall Study|Adverse Event|0
5075071|NCT02210689|17515296|P2|Overall Study|Adverse Event|1
5075072|NCT02210689|17515297|P1|Overall Study|Adverse Event|0
5075073|NCT02210689|17515295|P3|Overall Study|Withdrawal by Subject|2
5075074|NCT02210689|17515296|P2|Overall Study|Withdrawal by Subject|4
5075075|NCT02210689|17515297|P1|Overall Study|Withdrawal by Subject|7
5075076|NCT02210221|17515305|P1|Overall Study|Withdrawal by Subject|43
5075077|NCT02210221|17515305|P1|Overall Study|Lack of Efficacy|7
5075078|NCT02210208|17515311|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
5075079|NCT02210208|17515311|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
5075080|NCT02210208|17515311|P1|Period A (Graft Site)|Withdrawal by Subject|1
5075081|NCT02210091|17515331|P2|Overall Study|Withdrawal by Sponsor|1
5075082|NCT02210091|17515332|P1|Overall Study|Withdrawal by Sponsor|0
5075083|NCT02210091|17515331|P2|Overall Study|Physician Decision|1
5075084|NCT02210091|17515332|P1|Overall Study|Physician Decision|0
5075085|NCT02210000|17515419|P2|Overall Study|Physician Decision|1
5075086|NCT02210000|17515420|P1|Overall Study|Physician Decision|0
5075087|NCT02210000|17515419|P2|Overall Study|Lost to Follow-up|2
5075088|NCT02210000|17515420|P1|Overall Study|Lost to Follow-up|0
5075089|NCT02210000|17515419|P2|Overall Study|Adverse Event|5
5075090|NCT02210000|17515420|P1|Overall Study|Adverse Event|1
5075091|NCT02210000|17515419|P2|Overall Study|Withdrawal by Subject|1
5075092|NCT02210000|17515420|P1|Overall Study|Withdrawal by Subject|7
5075093|NCT02210000|17515419|P2|Overall Study|Study Terminated|12
5075094|NCT02210000|17515420|P1|Overall Study|Study Terminated|11
5075095|NCT02209766|17515446|P5|Overall Study|Withdrawal by Subject|0
5075096|NCT02209766|17515447|P4|Overall Study|Withdrawal by Subject|1
5075097|NCT02209766|17515448|P3|Overall Study|Withdrawal by Subject|0
5075098|NCT02209766|17515449|P2|Overall Study|Withdrawal by Subject|0
5075099|NCT02209766|17515450|P1|Overall Study|Withdrawal by Subject|0
5075100|NCT02209597|17515509|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
5075101|NCT02209597|17515509|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
5075102|NCT02209597|17515509|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
5075103|NCT02209597|17515509|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
5075104|NCT02209506|17515554|P5|Overall Study|Withdrawal by Subject|1
5075105|NCT02209506|17515555|P4|Overall Study|Withdrawal by Subject|0
5075106|NCT02209506|17515556|P3|Overall Study|Withdrawal by Subject|0
5075107|NCT02209506|17515557|P2|Overall Study|Withdrawal by Subject|0
5075108|NCT02209506|17515558|P1|Overall Study|Withdrawal by Subject|0
5075109|NCT02209454|17515633|P2|Second Period|Adverse Event|0
5075110|NCT02209454|17515634|P1|Second Period|Adverse Event|1
5075111|NCT02209181|17515684|P4|Overall Study|Withdrawal by Subject|0
5075112|NCT02209181|17515685|P3|Overall Study|Withdrawal by Subject|0
5075113|NCT02209181|17515686|P2|Overall Study|Withdrawal by Subject|1
5075114|NCT02209181|17515687|P1|Overall Study|Withdrawal by Subject|0
5075115|NCT02209181|17515684|P4|Overall Study|Adverse Event|0
5075116|NCT02209181|17515685|P3|Overall Study|Adverse Event|1
5075117|NCT02209181|17515686|P2|Overall Study|Adverse Event|0
5075118|NCT02209181|17515687|P1|Overall Study|Adverse Event|1
5075119|NCT02208999|17515858|P1|Overall Study|Lost to Follow-up|1
5075120|NCT02208843|17515880|P1|Overall Study|Switched to commercial afatinib|20
5075121|NCT02208843|17515880|P1|Overall Study|Withdrawal by Subject|1
5075122|NCT02208843|17515880|P1|Overall Study|Protocol Violation|1
5075123|NCT02208843|17515880|P1|Overall Study|Adverse Event|12
5075124|NCT02208843|17515880|P1|Overall Study|Progression disease according to RECIST|24
5075125|NCT02208843|17515880|P1|Overall Study|Clinical symptoms of progression|2
5075126|NCT02208089|17515951|P2|Overall Study|Lost to Follow-up|0
5075127|NCT02208089|17515952|P1|Overall Study|Lost to Follow-up|6
5075128|NCT02208089|17515951|P2|Overall Study|Withdrawal by Subject|0
5075129|NCT02208089|17515952|P1|Overall Study|Withdrawal by Subject|1
5075130|NCT02208063|17515968|P2|Overall Study|Lost to Follow-up|0
5075131|NCT02208063|17515969|P1|Overall Study|Lost to Follow-up|1
5075132|NCT02208063|17515968|P2|Overall Study|Withdrawal by Subject|2
5075133|NCT02208063|17515969|P1|Overall Study|Withdrawal by Subject|5
5075134|NCT02208063|17515968|P2|Overall Study|Not Specified in report|4
5075135|NCT02208063|17515969|P1|Overall Study|Not Specified in report|3
5075136|NCT02208063|17515968|P2|Overall Study|Death|5
5075137|NCT02208063|17515969|P1|Overall Study|Death|3
5075138|NCT02207907|17516048|P2|Overall Study|Pregnancy|1
5075139|NCT02207907|17516049|P1|Overall Study|Pregnancy|0
5075140|NCT02207907|17516048|P2|Overall Study|Did not meet study criteria|0
5075141|NCT02207907|17516049|P1|Overall Study|Did not meet study criteria|3
5075142|NCT02207907|17516048|P2|Overall Study|Withdrawal by Subject|6
5075143|NCT02207907|17516049|P1|Overall Study|Withdrawal by Subject|5
5075144|NCT02207907|17516048|P2|Overall Study|Lost to Follow-up|1
5075145|NCT02207907|17516049|P1|Overall Study|Lost to Follow-up|3
5075146|NCT02207829|17516067|P2|Overall Study|Withdrew consent|14
5075147|NCT02207829|17516068|P1|Overall Study|Withdrew consent|18
5075148|NCT02207829|17516067|P2|Overall Study|Protocol deviation|4
5075149|NCT02207829|17516068|P1|Overall Study|Protocol deviation|5
5075150|NCT02207829|17516067|P2|Overall Study|Lost to Follow-up|2
5075151|NCT02207829|17516068|P1|Overall Study|Lost to Follow-up|2
5075152|NCT02207829|17516067|P2|Overall Study|Lack of Efficacy|5
5075153|NCT02207829|17516068|P1|Overall Study|Lack of Efficacy|7
5075154|NCT02207829|17516067|P2|Overall Study|Adverse Event|9
5075155|NCT02207829|17516068|P1|Overall Study|Adverse Event|10
5075156|NCT02207816|17516077|P3|Overall Study|Other|4
5075157|NCT02207816|17516078|P2|Overall Study|Other|2
5075158|NCT02207816|17516079|P1|Overall Study|Other|1
5075159|NCT02207816|17516077|P3|Overall Study|Lost to Follow-up|1
5075160|NCT02207816|17516078|P2|Overall Study|Lost to Follow-up|9
5075161|NCT02207816|17516079|P1|Overall Study|Lost to Follow-up|3
5075162|NCT02207816|17516077|P3|Overall Study|Migrated/Moved From Study Area|51
5075163|NCT02207816|17516078|P2|Overall Study|Migrated/Moved From Study Area|60
5075164|NCT02207816|17516079|P1|Overall Study|Migrated/Moved From Study Area|41
5075165|NCT02207816|17516077|P3|Overall Study|Withdrawal by Subject|7
5075166|NCT02207816|17516078|P2|Overall Study|Withdrawal by Subject|9
5075167|NCT02207816|17516079|P1|Overall Study|Withdrawal by Subject|4
5075168|NCT02207816|17516077|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
5075169|NCT02207816|17516078|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
5075170|NCT02207816|17516079|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
5075171|NCT02207816|17516077|P3|Overall Study|Serious Adverse Event|2
5075172|NCT02207816|17516078|P2|Overall Study|Serious Adverse Event|5
5075173|NCT02207816|17516079|P1|Overall Study|Serious Adverse Event|0
5075174|NCT02207725|17516237|P4|Overall Study|Did Not Receive Treatment|1
5075175|NCT02207725|17516238|P3|Overall Study|Did Not Receive Treatment|1
5075176|NCT02207725|17516239|P2|Overall Study|Did Not Receive Treatment|1
5075177|NCT02207725|17516240|P1|Overall Study|Did Not Receive Treatment|0
5075178|NCT02207634|17516270|P2|Overall Study|Lost to Follow-up|0
5075179|NCT02207634|17516271|P1|Overall Study|Lost to Follow-up|1
5075180|NCT02207634|17516270|P2|Overall Study|Withdrawal by Subject|31
5075181|NCT02207634|17516271|P1|Overall Study|Withdrawal by Subject|21
5075182|NCT02207621|17516286|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
5075183|NCT02207621|17516287|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
5075184|NCT02207621|17516288|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
5075185|NCT02207621|17516286|P3|Overall Study|Death|0
5075186|NCT02207621|17516287|P2|Overall Study|Death|0
5075187|NCT02207621|17516288|P1|Overall Study|Death|2
5075188|NCT02207621|17516286|P3|Overall Study|Protocol Violation|6
5075189|NCT02207621|17516287|P2|Overall Study|Protocol Violation|10
5075190|NCT02207621|17516288|P1|Overall Study|Protocol Violation|4
5075191|NCT02207621|17516286|P3|Overall Study|Physician Decision|2
5075192|NCT02207621|17516287|P2|Overall Study|Physician Decision|2
5075193|NCT02207621|17516288|P1|Overall Study|Physician Decision|1
5075194|NCT02207621|17516286|P3|Overall Study|Disallowed Concurrent Medication|2
5075195|NCT02207621|17516287|P2|Overall Study|Disallowed Concurrent Medication|5
5075196|NCT02207621|17516288|P1|Overall Study|Disallowed Concurrent Medication|2
5075197|NCT02207621|17516286|P3|Overall Study|Lack of Efficacy|4
5075198|NCT02207621|17516287|P2|Overall Study|Lack of Efficacy|2
5075199|NCT02207621|17516288|P1|Overall Study|Lack of Efficacy|10
5075200|NCT02207621|17516286|P3|Overall Study|Lost to Follow-up|3
5075201|NCT02207621|17516287|P2|Overall Study|Lost to Follow-up|0
5075202|NCT02207621|17516288|P1|Overall Study|Lost to Follow-up|1
5075203|NCT02207621|17516286|P3|Overall Study|Non-Compliant|1
5075204|NCT02207621|17516287|P2|Overall Study|Non-Compliant|3
5075205|NCT02207621|17516288|P1|Overall Study|Non-Compliant|3
5075206|NCT02207621|17516286|P3|Overall Study|Withdrawal by Subject|13
5075207|NCT02207621|17516287|P2|Overall Study|Withdrawal by Subject|9
5075208|NCT02207621|17516288|P1|Overall Study|Withdrawal by Subject|9
5075209|NCT02207621|17516286|P3|Overall Study|Adverse Event|132
5075210|NCT02207621|17516287|P2|Overall Study|Adverse Event|15
5075211|NCT02207621|17516288|P1|Overall Study|Adverse Event|71
5075212|NCT02207608|17516301|P2|Overall Study|Adverse Event|0
5075213|NCT02207608|17516302|P1|Overall Study|Adverse Event|1
5075214|NCT02207556|17516328|P2|Overall Study|Death|5
5075215|NCT02207556|17516329|P1|Overall Study|Death|0
5075216|NCT02207556|17516328|P2|Overall Study|Withdrawal by Subject|0
5075217|NCT02207556|17516329|P1|Overall Study|Withdrawal by Subject|1
5075218|NCT02207556|17516328|P2|Overall Study|Physician Decision|0
5075219|NCT02207556|17516329|P1|Overall Study|Physician Decision|1
5075220|NCT02207530|17516334|P1|Overall Study|Adverse Event|8
5075221|NCT02207530|17516334|P1|Overall Study|Patient decision to stop study treatment|5
5075222|NCT02207530|17516334|P1|Overall Study|Worsening condition under investigation|78
5075223|NCT02207491|17516348|P2|Overall Study|Protocol Violation|5
5075224|NCT02207491|17516349|P1|Overall Study|Protocol Violation|3
5075225|NCT02207491|17516348|P2|Overall Study|Physician Decision|0
5075226|NCT02207491|17516349|P1|Overall Study|Physician Decision|2
5075227|NCT02207491|17516348|P2|Overall Study|Lack of Efficacy|0
5075228|NCT02207491|17516349|P1|Overall Study|Lack of Efficacy|3
5075229|NCT02207491|17516348|P2|Overall Study|Lost to Follow-up|1
5075230|NCT02207491|17516349|P1|Overall Study|Lost to Follow-up|0
5075231|NCT02207491|17516348|P2|Overall Study|Non-compliant|1
5075232|NCT02207491|17516349|P1|Overall Study|Non-compliant|0
5075233|NCT02207491|17516348|P2|Overall Study|Withdrawal by Subject|2
5075234|NCT02207491|17516349|P1|Overall Study|Withdrawal by Subject|3
5075235|NCT02207491|17516348|P2|Overall Study|Adverse Event|4
5075236|NCT02207491|17516349|P1|Overall Study|Adverse Event|20
5075237|NCT02207413|17516374|P6|Overall Study|Migrated/moved from study area|0
5075238|NCT02207413|17516375|P5|Overall Study|Migrated/moved from study area|1
5075239|NCT02207413|17516376|P4|Overall Study|Migrated/moved from study area|0
5075240|NCT02207413|17516377|P3|Overall Study|Migrated/moved from study area|0
5075241|NCT02207413|17516378|P2|Overall Study|Migrated/moved from study area|0
5075242|NCT02207413|17516379|P1|Overall Study|Migrated/moved from study area|0
5075243|NCT02207413|17516374|P6|Overall Study|Adverse Event|1
5075244|NCT02207413|17516375|P5|Overall Study|Adverse Event|2
5075245|NCT02207413|17516376|P4|Overall Study|Adverse Event|0
5075246|NCT02207413|17516377|P3|Overall Study|Adverse Event|0
5075247|NCT02207413|17516378|P2|Overall Study|Adverse Event|0
5075248|NCT02207413|17516379|P1|Overall Study|Adverse Event|0
5075249|NCT02207413|17516374|P6|Overall Study|Lost to Follow-up|5
5075250|NCT02207413|17516375|P5|Overall Study|Lost to Follow-up|1
5075251|NCT02207413|17516376|P4|Overall Study|Lost to Follow-up|1
5075252|NCT02207413|17516377|P3|Overall Study|Lost to Follow-up|0
5075253|NCT02207413|17516378|P2|Overall Study|Lost to Follow-up|0
5075254|NCT02207413|17516379|P1|Overall Study|Lost to Follow-up|0
5075255|NCT02207413|17516374|P6|Overall Study|Withdrawal by Subject|7
5075256|NCT02207413|17516375|P5|Overall Study|Withdrawal by Subject|3
5075257|NCT02207413|17516376|P4|Overall Study|Withdrawal by Subject|0
5075258|NCT02207413|17516377|P3|Overall Study|Withdrawal by Subject|0
5075259|NCT02207413|17516378|P2|Overall Study|Withdrawal by Subject|0
5075260|NCT02207413|17516379|P1|Overall Study|Withdrawal by Subject|1
5075261|NCT02207400|17516475|P2|Overall Study|Positive Urine Pregnancy Test|1
5075262|NCT02207400|17516476|P1|Overall Study|Positive Urine Pregnancy Test|0
5075263|NCT02207400|17516475|P2|Overall Study|Withdrawal by Subject|4
5075264|NCT02207400|17516476|P1|Overall Study|Withdrawal by Subject|8
5075265|NCT02207400|17516475|P2|Overall Study|Protocol Violation|1
5075266|NCT02207400|17516476|P1|Overall Study|Protocol Violation|1
5075267|NCT02207400|17516475|P2|Overall Study|Lost to Follow-up|7
5075268|NCT02207400|17516476|P1|Overall Study|Lost to Follow-up|6
5075269|NCT02207400|17516475|P2|Overall Study|Adverse Event|1
5075270|NCT02207400|17516476|P1|Overall Study|Adverse Event|1
5075271|NCT02207374|17516497|P3|Overall Study|Missing follow-up information|1
5075272|NCT02207374|17516498|P2|Overall Study|Missing follow-up information|1
5075273|NCT02207374|17516499|P1|Overall Study|Missing follow-up information|0
5075274|NCT02207374|17516497|P3|Overall Study|Death|1
5075275|NCT02207374|17516498|P2|Overall Study|Death|0
5075276|NCT02207374|17516499|P1|Overall Study|Death|1
5075277|NCT02207374|17516497|P3|Overall Study|Withdrawal by Subject|4
5075278|NCT02207374|17516498|P2|Overall Study|Withdrawal by Subject|9
5075279|NCT02207374|17516499|P1|Overall Study|Withdrawal by Subject|5
5075280|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
5075281|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
5075282|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
5075283|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
5075284|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
5075285|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
5075286|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
5075287|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
5075288|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
5075289|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075290|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075291|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
5075292|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075293|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075294|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075295|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075296|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075297|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5075298|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075299|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075300|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
5075301|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075302|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075303|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075304|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075305|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075306|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5075307|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
5075308|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
5075309|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
5075310|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5075311|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5075312|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5075313|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5075314|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5075315|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5075316|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
5075317|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
5075318|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
5075319|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5075320|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5075321|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5075322|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5075323|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5075324|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5075325|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
5075326|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
5075327|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075328|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075329|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075330|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075331|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075332|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075333|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5075334|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075335|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
5075336|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075337|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075338|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075339|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075340|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075341|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075342|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5075343|NCT02207244|17516563|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
5075344|NCT02207244|17516564|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
5075345|NCT02207244|17516565|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
5075346|NCT02207244|17516566|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5075347|NCT02207244|17516567|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5075348|NCT02207244|17516568|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5075349|NCT02207244|17516569|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5075350|NCT02207244|17516570|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5075351|NCT02207244|17516571|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5075352|NCT02207244|17516563|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075353|NCT02207244|17516564|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075354|NCT02207244|17516565|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075355|NCT02207244|17516566|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075356|NCT02207244|17516567|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075357|NCT02207244|17516568|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
5075358|NCT02207244|17516569|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075359|NCT02207244|17516570|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075360|NCT02207244|17516571|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
5075361|NCT02207244|17516563|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075362|NCT02207244|17516564|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075363|NCT02207244|17516565|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075364|NCT02207244|17516566|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
5075365|NCT02207244|17516567|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075366|NCT02207244|17516568|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
5075367|NCT02207244|17516569|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075368|NCT02207244|17516570|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075369|NCT02207244|17516571|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5075370|NCT02207244|17516563|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5075371|NCT02207244|17516564|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5075372|NCT02207244|17516565|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5075373|NCT02207244|17516566|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
5075374|NCT02207244|17516567|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
5075375|NCT02207244|17516568|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
5075376|NCT02207244|17516569|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5075377|NCT02207244|17516570|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5075378|NCT02207244|17516571|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5075379|NCT02207244|17516563|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5075380|NCT02207244|17516564|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5075381|NCT02207244|17516565|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5075382|NCT02207244|17516566|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
5075383|NCT02207244|17516567|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
5075384|NCT02207244|17516568|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
5075618|NCT02204293|17517258|P1|Core Study Part I|Adverse Event|1
5075385|NCT02207244|17516569|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5075386|NCT02207244|17516570|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5075387|NCT02207244|17516571|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5075388|NCT02207244|17516563|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075389|NCT02207244|17516564|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075390|NCT02207244|17516565|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075391|NCT02207244|17516566|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
5075392|NCT02207244|17516567|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075393|NCT02207244|17516568|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075394|NCT02207244|17516569|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075395|NCT02207244|17516570|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075396|NCT02207244|17516571|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5075397|NCT02207244|17516563|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075398|NCT02207244|17516564|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075399|NCT02207244|17516565|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075400|NCT02207244|17516566|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
5075401|NCT02207244|17516567|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
5075402|NCT02207244|17516568|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075403|NCT02207244|17516569|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075404|NCT02207244|17516570|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075405|NCT02207244|17516571|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5075406|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Other|0
5075407|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Other|0
5075408|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Other|0
5075409|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Other|0
5075410|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Other|0
5075411|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Other|0
5075412|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Other|0
5075413|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Other|1
5075414|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Other|0
5075415|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075416|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075417|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075418|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075419|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075420|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075421|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
5075422|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
5075423|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5075424|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075425|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075426|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075427|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075428|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075429|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075430|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5075431|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
5075432|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5075433|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075434|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075435|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075436|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075437|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075438|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075439|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075440|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
5075441|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
5075442|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5075443|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5075444|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5075445|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5075446|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5075447|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5075448|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
5075449|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
5075450|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5075451|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075452|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075453|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075454|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075455|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075456|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075457|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
5075458|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075459|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
5075460|NCT02207244|17516563|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5075461|NCT02207244|17516564|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5075462|NCT02207244|17516565|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5075463|NCT02207244|17516566|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5075464|NCT02207244|17516567|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5075465|NCT02207244|17516568|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5075466|NCT02207244|17516569|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
5075467|NCT02207244|17516570|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
5075468|NCT02207244|17516571|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5075469|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
5075470|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
5075471|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
5075472|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Other|3
5075473|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Other|2
5075474|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Other|0
5075475|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
5075476|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
5075477|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
5075478|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
5075479|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
5075480|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
5075481|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
5075482|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
5075483|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
5075484|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
5075485|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
5075486|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
5075487|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
5075488|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
5075489|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
5075490|NCT02207231|17516612|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
5075491|NCT02207231|17516613|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
5075492|NCT02207231|17516614|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
5075493|NCT02207231|17516612|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
5075494|NCT02207231|17516613|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
5075495|NCT02207231|17516614|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
5075496|NCT02207231|17516612|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5075497|NCT02207231|17516613|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075498|NCT02207231|17516614|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5075499|NCT02207231|17516612|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
5075500|NCT02207231|17516613|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5075501|NCT02207231|17516614|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
5075502|NCT02207231|17516612|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5075503|NCT02207231|17516613|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5075504|NCT02207231|17516614|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5075505|NCT02207231|17516612|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
5075506|NCT02207231|17516613|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5075507|NCT02207231|17516614|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
5075508|NCT02207231|17516612|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5075509|NCT02207231|17516613|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
5075510|NCT02207231|17516614|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5075511|NCT02207088|17516646|P1|Overall Study|Adverse Event|2
5075512|NCT02206828|17516652|P1|Overall Study|Lost to Follow-up|7
5075513|NCT02206620|17516688|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
5075514|NCT02206620|17516689|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
5075515|NCT02206620|17516688|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
5075516|NCT02206620|17516689|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
5075517|NCT02206607|17516705|P5|Second Intervention Period|Insufficient Clinical Response|0
5075518|NCT02206607|17516706|P4|Second Intervention Period|Insufficient Clinical Response|1
5075519|NCT02206607|17516707|P3|Second Intervention Period|Insufficient Clinical Response|0
5075520|NCT02206607|17516708|P2|Second Intervention Period|Insufficient Clinical Response|0
5075521|NCT02206607|17516709|P1|Second Intervention Period|Insufficient Clinical Response|0
5075522|NCT02206607|17516705|P5|Open-Label Run-In|Withdrawal by Subject|0
5075523|NCT02206607|17516706|P4|Open-Label Run-In|Withdrawal by Subject|0
5075524|NCT02206607|17516707|P3|Open-Label Run-In|Withdrawal by Subject|0
5075525|NCT02206607|17516708|P2|Open-Label Run-In|Withdrawal by Subject|0
5075526|NCT02206607|17516709|P1|Open-Label Run-In|Withdrawal by Subject|3
5075527|NCT02206152|17516772|P1|Pre-Randomization|Withdrawal by Subject|2
5075528|NCT02205814|17516799|P4|Overall Study|not compliant with study procedures|0
5075529|NCT02205814|17516800|P3|Overall Study|not compliant with study procedures|1
5075530|NCT02205814|17516801|P2|Overall Study|not compliant with study procedures|0
5075531|NCT02205814|17516802|P1|Overall Study|not compliant with study procedures|0
5075532|NCT02205814|17516799|P4|Overall Study|Withdrawal by Subject|1
5075533|NCT02205814|17516800|P3|Overall Study|Withdrawal by Subject|2
5075534|NCT02205814|17516801|P2|Overall Study|Withdrawal by Subject|1
5075535|NCT02205814|17516802|P1|Overall Study|Withdrawal by Subject|0
5075536|NCT02205814|17516799|P4|Overall Study|Protocol Violation|1
5075537|NCT02205814|17516800|P3|Overall Study|Protocol Violation|0
5075538|NCT02205814|17516801|P2|Overall Study|Protocol Violation|0
5075539|NCT02205814|17516802|P1|Overall Study|Protocol Violation|1
5075540|NCT02205814|17516799|P4|Overall Study|Physician Decision|0
5075541|NCT02205814|17516800|P3|Overall Study|Physician Decision|1
5075542|NCT02205814|17516801|P2|Overall Study|Physician Decision|0
5075543|NCT02205814|17516802|P1|Overall Study|Physician Decision|0
5075544|NCT02205814|17516799|P4|Overall Study|Lack of Efficacy|1
5075545|NCT02205814|17516800|P3|Overall Study|Lack of Efficacy|1
5075546|NCT02205814|17516801|P2|Overall Study|Lack of Efficacy|0
5075547|NCT02205814|17516802|P1|Overall Study|Lack of Efficacy|1
5075548|NCT02205814|17516799|P4|Overall Study|Lost to Follow-up|1
5075549|NCT02205814|17516800|P3|Overall Study|Lost to Follow-up|0
5075550|NCT02205814|17516801|P2|Overall Study|Lost to Follow-up|0
5075551|NCT02205814|17516802|P1|Overall Study|Lost to Follow-up|0
5075552|NCT02205476|17516855|P2|Overall Study|Study termination by Sponsor|3
5075553|NCT02205476|17516856|P1|Overall Study|Study termination by Sponsor|7
5075554|NCT02205333|17516895|P9|Overall Study|Withdrawal by Subject|0
5075555|NCT02205333|17516896|P8|Overall Study|Withdrawal by Subject|0
5075556|NCT02205333|17516897|P7|Overall Study|Withdrawal by Subject|2
5075557|NCT02205333|17516898|P6|Overall Study|Withdrawal by Subject|0
5075558|NCT02205333|17516899|P5|Overall Study|Withdrawal by Subject|0
5075559|NCT02205333|17516900|P4|Overall Study|Withdrawal by Subject|1
5075560|NCT02205333|17516901|P3|Overall Study|Withdrawal by Subject|0
5075561|NCT02205333|17516902|P2|Overall Study|Withdrawal by Subject|0
5075562|NCT02205333|17516903|P1|Overall Study|Withdrawal by Subject|1
5075563|NCT02205333|17516895|P9|Overall Study|Death|0
5075564|NCT02205333|17516896|P8|Overall Study|Death|2
5075565|NCT02205333|17516897|P7|Overall Study|Death|3
5075566|NCT02205333|17516898|P6|Overall Study|Death|3
5075567|NCT02205333|17516899|P5|Overall Study|Death|5
5075568|NCT02205333|17516900|P4|Overall Study|Death|6
5075569|NCT02205333|17516901|P3|Overall Study|Death|2
5075570|NCT02205333|17516902|P2|Overall Study|Death|6
5075571|NCT02205333|17516903|P1|Overall Study|Death|5
5075572|NCT02204982|17517102|P2|Overall Study|Termination of Study bySponsor|1
5075573|NCT02204982|17517103|P1|Overall Study|Termination of Study bySponsor|0
5075574|NCT02204982|17517102|P2|Overall Study|Protocol-Specified Disease Progression|4
5075575|NCT02204982|17517103|P1|Overall Study|Protocol-Specified Disease Progression|0
5075576|NCT02204982|17517102|P2|Overall Study|Physician Decision|2
5075577|NCT02204982|17517103|P1|Overall Study|Physician Decision|0
5075578|NCT02204982|17517102|P2|Overall Study|Adverse Event and Investigator decision|0
5075579|NCT02204982|17517103|P1|Overall Study|Adverse Event and Investigator decision|1
5075580|NCT02204982|17517102|P2|Overall Study|Adverse Event|0
5075581|NCT02204982|17517103|P1|Overall Study|Adverse Event|1
5075582|NCT02204982|17517102|P2|Overall Study|Withdrawal by Subject|0
5075583|NCT02204982|17517103|P1|Overall Study|Withdrawal by Subject|1
5075584|NCT02204982|17517102|P2|Overall Study|Patient ineligible-medical monitor|0
5075585|NCT02204982|17517103|P1|Overall Study|Patient ineligible-medical monitor|1
5075586|NCT02204917|17517111|P1|Overall Study|Protocol Violation|1
5075587|NCT02204579|17517148|P1|Overall Study|Screen failures|2
5075588|NCT02204449|17517206|P2|Overall Study|Withdrawal by Subject|1
5075589|NCT02204449|17517207|P1|Overall Study|Withdrawal by Subject|0
5075590|NCT02204449|17517206|P2|Overall Study|Death|1
5075591|NCT02204449|17517207|P1|Overall Study|Death|0
5075592|NCT02204449|17517206|P2|Overall Study|Lost to Follow-up|9
5075593|NCT02204449|17517207|P1|Overall Study|Lost to Follow-up|7
5075594|NCT02204410|17517217|P1|Overall Study|Withdrawal by Subject|3
5075595|NCT02204410|17517217|P1|Overall Study|Protocol Violation|1
5075596|NCT02204410|17517217|P1|Overall Study|Physician Decision|2
5075597|NCT02204410|17517217|P1|Overall Study|Lost to Follow-up|5
5075598|NCT02204371|17517222|P1|Overall Study|Adverse Event|1
5075599|NCT02204319|17517245|P1|Overall Study|Withdrawal by Subject|2
5075600|NCT02204319|17517245|P1|Overall Study|Pregnancy|1
5075601|NCT02204293|17517253|P6|LTE Phase|Study Suspended|7
5075602|NCT02204293|17517254|P5|LTE Phase|Study Suspended|0
5075603|NCT02204293|17517255|P4|LTE Phase|Study Suspended|0
5075604|NCT02204293|17517256|P3|LTE Phase|Study Suspended|0
5075605|NCT02204293|17517257|P2|LTE Phase|Study Suspended|0
5075606|NCT02204293|17517258|P1|LTE Phase|Study Suspended|0
5075607|NCT02204293|17517253|P6|Core Study Part I|Physician Decision|0
5075608|NCT02204293|17517254|P5|Core Study Part I|Physician Decision|0
5075609|NCT02204293|17517255|P4|Core Study Part I|Physician Decision|0
5075610|NCT02204293|17517256|P3|Core Study Part I|Physician Decision|0
5075611|NCT02204293|17517257|P2|Core Study Part I|Physician Decision|3
5075612|NCT02204293|17517258|P1|Core Study Part I|Physician Decision|0
5075613|NCT02204293|17517253|P6|Core Study Part I|Adverse Event|0
5075614|NCT02204293|17517254|P5|Core Study Part I|Adverse Event|0
5075615|NCT02204293|17517255|P4|Core Study Part I|Adverse Event|0
5075616|NCT02204293|17517256|P3|Core Study Part I|Adverse Event|0
5075617|NCT02204293|17517257|P2|Core Study Part I|Adverse Event|0
5075619|NCT02204293|17517253|P6|Core Study Part I|Met one or more exclusion criteria|0
5075620|NCT02204293|17517254|P5|Core Study Part I|Met one or more exclusion criteria|0
5075621|NCT02204293|17517255|P4|Core Study Part I|Met one or more exclusion criteria|0
5075622|NCT02204293|17517256|P3|Core Study Part I|Met one or more exclusion criteria|0
5075623|NCT02204293|17517257|P2|Core Study Part I|Met one or more exclusion criteria|0
5075624|NCT02204293|17517258|P1|Core Study Part I|Met one or more exclusion criteria|1
5075625|NCT02204007|17517379|P2|Overall Study|Surgery Canceled|1
5075626|NCT02204007|17517380|P1|Overall Study|Surgery Canceled|1
5075627|NCT02203916|17517391|P3|Overall Study|Reason Not Specified|1
5075628|NCT02203916|17517392|P2|Overall Study|Reason Not Specified|2
5075629|NCT02203916|17517393|P1|Overall Study|Reason Not Specified|0
5075630|NCT02203916|17517391|P3|Overall Study|Lack of Efficacy|0
5075631|NCT02203916|17517392|P2|Overall Study|Lack of Efficacy|0
5075632|NCT02203916|17517393|P1|Overall Study|Lack of Efficacy|3
5075633|NCT02203916|17517391|P3|Overall Study|Voluntary Withdrawal|8
5075634|NCT02203916|17517392|P2|Overall Study|Voluntary Withdrawal|3
5075635|NCT02203916|17517393|P1|Overall Study|Voluntary Withdrawal|3
5075636|NCT02203916|17517391|P3|Overall Study|Lost to Follow-up|0
5075637|NCT02203916|17517392|P2|Overall Study|Lost to Follow-up|1
5075638|NCT02203916|17517393|P1|Overall Study|Lost to Follow-up|0
5075639|NCT02203916|17517391|P3|Overall Study|Major Protocol Deviation|0
5075640|NCT02203916|17517392|P2|Overall Study|Major Protocol Deviation|1
5075641|NCT02203916|17517393|P1|Overall Study|Major Protocol Deviation|1
5075642|NCT02203916|17517391|P3|Overall Study|Pretreatment Event/Adverse Event|2
5075643|NCT02203916|17517392|P2|Overall Study|Pretreatment Event/Adverse Event|3
5075644|NCT02203916|17517393|P1|Overall Study|Pretreatment Event/Adverse Event|1
5075645|NCT02203851|17517413|P1|Overall Study|Other|1
5075646|NCT02203851|17517413|P1|Overall Study|Withdrawal by Subject|6
5075647|NCT02203851|17517413|P1|Overall Study|Lost to Follow-up|4
5075648|NCT02203838|17517451|P4|Overall Study|Other|0
5075649|NCT02203838|17517452|P3|Overall Study|Other|0
5075650|NCT02203838|17517453|P2|Overall Study|Other|0
5075651|NCT02203838|17517454|P1|Overall Study|Other|1
5075652|NCT02203838|17517451|P4|Overall Study|Physician Decision|3
5075653|NCT02203838|17517452|P3|Overall Study|Physician Decision|2
5075654|NCT02203838|17517453|P2|Overall Study|Physician Decision|0
5075655|NCT02203838|17517454|P1|Overall Study|Physician Decision|27
5075656|NCT02203838|17517451|P4|Overall Study|Withdrawal by Subject|11
5075657|NCT02203838|17517452|P3|Overall Study|Withdrawal by Subject|8
5075658|NCT02203838|17517453|P2|Overall Study|Withdrawal by Subject|10
5075659|NCT02203838|17517454|P1|Overall Study|Withdrawal by Subject|83
5075660|NCT02203838|17517451|P4|Overall Study|Protocol Violation|0
5075661|NCT02203838|17517452|P3|Overall Study|Protocol Violation|0
5075662|NCT02203838|17517453|P2|Overall Study|Protocol Violation|3
5075663|NCT02203838|17517454|P1|Overall Study|Protocol Violation|7
5075664|NCT02203838|17517451|P4|Overall Study|Lost to Follow-up|1
5075665|NCT02203838|17517452|P3|Overall Study|Lost to Follow-up|2
5075666|NCT02203838|17517453|P2|Overall Study|Lost to Follow-up|3
5075667|NCT02203838|17517454|P1|Overall Study|Lost to Follow-up|39
5075668|NCT02203838|17517451|P4|Overall Study|Adverse Event|2
5075669|NCT02203838|17517452|P3|Overall Study|Adverse Event|3
5075670|NCT02203838|17517453|P2|Overall Study|Adverse Event|6
5075671|NCT02203838|17517454|P1|Overall Study|Adverse Event|46
5075672|NCT02203838|17517451|P4|Overall Study|Lack of Efficacy|1
5075673|NCT02203838|17517452|P3|Overall Study|Lack of Efficacy|1
5075674|NCT02203838|17517453|P2|Overall Study|Lack of Efficacy|0
5075675|NCT02203838|17517454|P1|Overall Study|Lack of Efficacy|7
5075676|NCT02203721|17517534|P2|Overall Study|Illness|1
5075677|NCT02203721|17517535|P1|Overall Study|Illness|0
5075678|NCT02203721|17517534|P2|Overall Study|Death|2
5075679|NCT02203721|17517535|P1|Overall Study|Death|0
5075680|NCT02203721|17517534|P2|Overall Study|Lost to Follow-up|0
5075681|NCT02203721|17517535|P1|Overall Study|Lost to Follow-up|1
5075682|NCT02203591|17517624|P8|Overall Study|Discontinued early due to compromised test sites|1
5075683|NCT02203591|17517625|P7|Overall Study|Discontinued early due to compromised test sites|0
5075684|NCT02203591|17517626|P6|Overall Study|Discontinued early due to compromised test sites|0
5075685|NCT02203591|17517627|P5|Overall Study|Discontinued early due to compromised test sites|1
5075686|NCT02203591|17517628|P4|Overall Study|Discontinued early due to compromised test sites|0
5075687|NCT02203591|17517629|P3|Overall Study|Discontinued early due to compromised test sites|1
5075688|NCT02203591|17517630|P2|Overall Study|Discontinued early due to compromised test sites|1
5075689|NCT02203591|17517631|P1|Overall Study|Discontinued early due to compromised test sites|0
5075690|NCT02203591|17517624|P8|Overall Study|Did not meet treatment day baseline|12
5075691|NCT02203591|17517625|P7|Overall Study|Did not meet treatment day baseline|29
5075692|NCT02203591|17517626|P6|Overall Study|Did not meet treatment day baseline|35
5075693|NCT02203591|17517627|P5|Overall Study|Did not meet treatment day baseline|33
5075694|NCT02203591|17517628|P4|Overall Study|Did not meet treatment day baseline|45
5075695|NCT02203591|17517629|P3|Overall Study|Did not meet treatment day baseline|150
5075696|NCT02203591|17517630|P2|Overall Study|Did not meet treatment day baseline|141
5075697|NCT02203591|17517631|P1|Overall Study|Did not meet treatment day baseline|147
5075698|NCT02203357|17517735|P3|Overall Study|Lost to Follow-up|70
5075699|NCT02203357|17517736|P2|Overall Study|Lost to Follow-up|66
5075700|NCT02203357|17517737|P1|Overall Study|Lost to Follow-up|58
5075701|NCT02203331|17517760|P6|Overall Study|Lost to Follow-up|0
5075702|NCT02203331|17517761|P5|Overall Study|Lost to Follow-up|1
5075703|NCT02203331|17517762|P4|Overall Study|Lost to Follow-up|0
5075704|NCT02203331|17517763|P3|Overall Study|Lost to Follow-up|0
5075705|NCT02203331|17517764|P2|Overall Study|Lost to Follow-up|0
5075706|NCT02203331|17517765|P1|Overall Study|Lost to Follow-up|0
5075707|NCT02203331|17517760|P6|Overall Study|Protocol Violation|0
5075708|NCT02203331|17517761|P5|Overall Study|Protocol Violation|1
5075709|NCT02203331|17517762|P4|Overall Study|Protocol Violation|1
5075710|NCT02203331|17517763|P3|Overall Study|Protocol Violation|0
5075711|NCT02203331|17517764|P2|Overall Study|Protocol Violation|2
5075712|NCT02203331|17517765|P1|Overall Study|Protocol Violation|0
5075713|NCT02203331|17517760|P6|Overall Study|Lack of Efficacy|1
5075714|NCT02203331|17517761|P5|Overall Study|Lack of Efficacy|0
5075715|NCT02203331|17517762|P4|Overall Study|Lack of Efficacy|0
5075716|NCT02203331|17517763|P3|Overall Study|Lack of Efficacy|1
5075717|NCT02203331|17517764|P2|Overall Study|Lack of Efficacy|2
5075718|NCT02203331|17517765|P1|Overall Study|Lack of Efficacy|0
5075719|NCT02203331|17517760|P6|Overall Study|Other Reasons|0
5075720|NCT02203331|17517761|P5|Overall Study|Other Reasons|0
5075721|NCT02203331|17517762|P4|Overall Study|Other Reasons|2
5075722|NCT02203331|17517763|P3|Overall Study|Other Reasons|0
5075723|NCT02203331|17517764|P2|Overall Study|Other Reasons|2
5075724|NCT02203331|17517765|P1|Overall Study|Other Reasons|1
5075725|NCT02203331|17517760|P6|Overall Study|Adverse Event|3
5075726|NCT02203331|17517761|P5|Overall Study|Adverse Event|3
5075727|NCT02203331|17517762|P4|Overall Study|Adverse Event|4
5075728|NCT02203331|17517763|P3|Overall Study|Adverse Event|3
5075729|NCT02203331|17517764|P2|Overall Study|Adverse Event|8
5075730|NCT02203331|17517765|P1|Overall Study|Adverse Event|4
5075731|NCT02203331|17517760|P6|Overall Study|Withdrawal by Subject|3
5075732|NCT02203331|17517761|P5|Overall Study|Withdrawal by Subject|0
5075733|NCT02203331|17517762|P4|Overall Study|Withdrawal by Subject|0
5075734|NCT02203331|17517763|P3|Overall Study|Withdrawal by Subject|1
5075735|NCT02203331|17517764|P2|Overall Study|Withdrawal by Subject|0
5075736|NCT02203331|17517765|P1|Overall Study|Withdrawal by Subject|1
5075737|NCT02203331|17517760|P6|Overall Study|Pregnancy|0
5075738|NCT02203331|17517761|P5|Overall Study|Pregnancy|2
5075739|NCT02203331|17517762|P4|Overall Study|Pregnancy|0
5075740|NCT02203331|17517763|P3|Overall Study|Pregnancy|0
5075741|NCT02203331|17517764|P2|Overall Study|Pregnancy|0
5075742|NCT02203331|17517765|P1|Overall Study|Pregnancy|1
5075743|NCT02203149|17517824|P5|Part 2|Adverse Event|1
5075744|NCT02203149|17517825|P4|Part 2|Adverse Event|1
5075745|NCT02203149|17517826|P3|Part 2|Adverse Event|0
5075746|NCT02203149|17517827|P2|Part 2|Adverse Event|0
5075747|NCT02203149|17517828|P1|Part 2|Adverse Event|0
5075748|NCT02203149|17517824|P5|Part 2|Withdrawal by Subject|0
5075749|NCT02203149|17517825|P4|Part 2|Withdrawal by Subject|1
5075750|NCT02203149|17517826|P3|Part 2|Withdrawal by Subject|0
5075751|NCT02203149|17517827|P2|Part 2|Withdrawal by Subject|0
5075752|NCT02203149|17517828|P1|Part 2|Withdrawal by Subject|0
5075753|NCT02203149|17517824|P5|Part 2|Death|0
5075754|NCT02203149|17517825|P4|Part 2|Death|1
5075755|NCT02203149|17517826|P3|Part 2|Death|1
5075756|NCT02203149|17517827|P2|Part 2|Death|0
5075757|NCT02203149|17517828|P1|Part 2|Death|0
5075758|NCT02203149|17517824|P5|Part 1|Adverse Event|0
5075759|NCT02203149|17517825|P4|Part 1|Adverse Event|0
5075760|NCT02203149|17517826|P3|Part 1|Adverse Event|0
5075761|NCT02203149|17517827|P2|Part 1|Adverse Event|1
5075762|NCT02203149|17517828|P1|Part 1|Adverse Event|0
5075763|NCT02203071|17517863|P2|Overall Study|Lost to Follow-up|1
5075764|NCT02203071|17517864|P1|Overall Study|Lost to Follow-up|3
5075765|NCT02203032|17517880|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
5075766|NCT02203032|17517881|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
5075767|NCT02203032|17517882|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
5075768|NCT02203032|17517883|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
5075769|NCT02203032|17517880|P4|Blinded Phase (Week 16 to Week 44)|Death|1
5075770|NCT02203032|17517881|P3|Blinded Phase (Week 16 to Week 44)|Death|0
5075771|NCT02203032|17517882|P2|Blinded Phase (Week 16 to Week 44)|Death|0
5075772|NCT02203032|17517883|P1|Blinded Phase (Week 16 to Week 44)|Death|0
5075773|NCT02203032|17517880|P4|Blinded Phase (Week 16 to Week 44)|Other|15
5075774|NCT02203032|17517881|P3|Blinded Phase (Week 16 to Week 44)|Other|1
5075775|NCT02203032|17517882|P2|Blinded Phase (Week 16 to Week 44)|Other|4
5075776|NCT02203032|17517883|P1|Blinded Phase (Week 16 to Week 44)|Other|0
5075777|NCT02203032|17517880|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
5075778|NCT02203032|17517881|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
5075779|NCT02203032|17517882|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
5075780|NCT02203032|17517883|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
5075781|NCT02203032|17517880|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
5075782|NCT02203032|17517881|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
5075783|NCT02203032|17517882|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
5075784|NCT02203032|17517883|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
5075785|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5075786|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5075787|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5075788|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
5075789|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
5075790|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
5075791|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
5075792|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
5075793|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5075794|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5075795|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5075796|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
5075797|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5075798|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5075799|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5075800|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
5075801|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5075802|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5075803|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5075804|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
5075805|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5075806|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5075807|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5075808|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
5075809|NCT02203032|17517880|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5075810|NCT02203032|17517881|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5075811|NCT02203032|17517882|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5075812|NCT02203032|17517883|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
5075813|NCT02202980|17517926|P14|Overall Study|Withdrew Consent|0
5075814|NCT02202980|17517927|P13|Overall Study|Withdrew Consent|0
5075815|NCT02202980|17517928|P12|Overall Study|Withdrew Consent|0
5075816|NCT02202980|17517929|P11|Overall Study|Withdrew Consent|0
5075817|NCT02202980|17517930|P10|Overall Study|Withdrew Consent|0
5075818|NCT02202980|17517931|P9|Overall Study|Withdrew Consent|1
5075819|NCT02202980|17517932|P8|Overall Study|Withdrew Consent|0
5075820|NCT02202980|17517933|P7|Overall Study|Withdrew Consent|0
5075821|NCT02202980|17517934|P6|Overall Study|Withdrew Consent|0
5075822|NCT02202980|17517935|P5|Overall Study|Withdrew Consent|0
5075823|NCT02202980|17517936|P4|Overall Study|Withdrew Consent|0
5075824|NCT02202980|17517937|P3|Overall Study|Withdrew Consent|2
5075825|NCT02202980|17517938|P2|Overall Study|Withdrew Consent|1
5075826|NCT02202980|17517939|P1|Overall Study|Withdrew Consent|0
5075827|NCT02202980|17517926|P14|Overall Study|Lost to Follow-up|0
5075828|NCT02202980|17517927|P13|Overall Study|Lost to Follow-up|1
5075829|NCT02202980|17517928|P12|Overall Study|Lost to Follow-up|0
5075830|NCT02202980|17517929|P11|Overall Study|Lost to Follow-up|0
5075831|NCT02202980|17517930|P10|Overall Study|Lost to Follow-up|0
5075832|NCT02202980|17517931|P9|Overall Study|Lost to Follow-up|1
5075833|NCT02202980|17517932|P8|Overall Study|Lost to Follow-up|1
5075834|NCT02202980|17517933|P7|Overall Study|Lost to Follow-up|0
5075835|NCT02202980|17517934|P6|Overall Study|Lost to Follow-up|0
5075836|NCT02202980|17517935|P5|Overall Study|Lost to Follow-up|0
5075837|NCT02202980|17517936|P4|Overall Study|Lost to Follow-up|1
5075838|NCT02202980|17517937|P3|Overall Study|Lost to Follow-up|1
5075839|NCT02202980|17517938|P2|Overall Study|Lost to Follow-up|1
5075840|NCT02202980|17517939|P1|Overall Study|Lost to Follow-up|0
5075841|NCT02202980|17517926|P14|Overall Study|Protocol Violation|0
5075842|NCT02202980|17517927|P13|Overall Study|Protocol Violation|0
5075843|NCT02202980|17517928|P12|Overall Study|Protocol Violation|0
5075844|NCT02202980|17517929|P11|Overall Study|Protocol Violation|0
5075845|NCT02202980|17517930|P10|Overall Study|Protocol Violation|0
5075846|NCT02202980|17517931|P9|Overall Study|Protocol Violation|0
5075847|NCT02202980|17517932|P8|Overall Study|Protocol Violation|0
5075848|NCT02202980|17517933|P7|Overall Study|Protocol Violation|0
5075849|NCT02202980|17517934|P6|Overall Study|Protocol Violation|0
5075850|NCT02202980|17517935|P5|Overall Study|Protocol Violation|3
5075851|NCT02202980|17517936|P4|Overall Study|Protocol Violation|3
5075852|NCT02202980|17517937|P3|Overall Study|Protocol Violation|0
5075853|NCT02202980|17517938|P2|Overall Study|Protocol Violation|0
5075854|NCT02202980|17517939|P1|Overall Study|Protocol Violation|0
5075855|NCT02202980|17517926|P14|Overall Study|Lack of Efficacy|0
5075856|NCT02202980|17517927|P13|Overall Study|Lack of Efficacy|10
5075857|NCT02202980|17517928|P12|Overall Study|Lack of Efficacy|3
5075858|NCT02202980|17517929|P11|Overall Study|Lack of Efficacy|0
5075859|NCT02202980|17517930|P10|Overall Study|Lack of Efficacy|0
5075860|NCT02202980|17517931|P9|Overall Study|Lack of Efficacy|2
5075861|NCT02202980|17517932|P8|Overall Study|Lack of Efficacy|2
5075862|NCT02202980|17517933|P7|Overall Study|Lack of Efficacy|11
5075863|NCT02202980|17517934|P6|Overall Study|Lack of Efficacy|1
5075864|NCT02202980|17517935|P5|Overall Study|Lack of Efficacy|3
5075865|NCT02202980|17517936|P4|Overall Study|Lack of Efficacy|0
5075866|NCT02202980|17517937|P3|Overall Study|Lack of Efficacy|7
5075867|NCT02202980|17517938|P2|Overall Study|Lack of Efficacy|0
5075868|NCT02202980|17517939|P1|Overall Study|Lack of Efficacy|1
5075869|NCT02202850|17518027|P2|Overall Study|Lost to Follow-up|1
5075870|NCT02202850|17518028|P1|Overall Study|Lost to Follow-up|7
5075871|NCT02202850|17518027|P2|Overall Study|Enbrel treatment discontinued|3
5075872|NCT02202850|17518028|P1|Overall Study|Enbrel treatment discontinued|15
5075873|NCT02202850|17518027|P2|Overall Study|Other|2
5075874|NCT02202850|17518028|P1|Overall Study|Other|2
5075875|NCT02202837|17518080|P2|Overall Study|Lost to Follow-up|1
5075876|NCT02202837|17518081|P1|Overall Study|Lost to Follow-up|7
5075877|NCT02202837|17518080|P2|Overall Study|Other|0
5075878|NCT02202837|17518081|P1|Overall Study|Other|10
5075879|NCT02202837|17518080|P2|Overall Study|Enbrel treatment discontinued|4
5075880|NCT02202837|17518081|P1|Overall Study|Enbrel treatment discontinued|36
5075881|NCT02202785|17518132|P3|Overall Study|Reason not Specified|13
5075882|NCT02202785|17518133|P2|Overall Study|Reason not Specified|7
5075883|NCT02202785|17518134|P1|Overall Study|Reason not Specified|10
5075884|NCT02202785|17518132|P3|Overall Study|Lost to Follow-up|0
5075885|NCT02202785|17518133|P2|Overall Study|Lost to Follow-up|1
5075886|NCT02202785|17518134|P1|Overall Study|Lost to Follow-up|0
5075887|NCT02202785|17518132|P3|Overall Study|Withdrawal by Subject|0
5075888|NCT02202785|17518133|P2|Overall Study|Withdrawal by Subject|1
5075889|NCT02202785|17518134|P1|Overall Study|Withdrawal by Subject|0
5075890|NCT02202785|17518132|P3|Overall Study|Study Terminated by Sponsor|4
5075891|NCT02202785|17518133|P2|Overall Study|Study Terminated by Sponsor|6
5075892|NCT02202785|17518134|P1|Overall Study|Study Terminated by Sponsor|1
5075893|NCT02202759|17518171|P3|Overall Study|Reason not Specified|10
5075894|NCT02202759|17518172|P2|Overall Study|Reason not Specified|11
5075895|NCT02202759|17518173|P1|Overall Study|Reason not Specified|4
5075896|NCT02202759|17518171|P3|Overall Study|Withdrawal by Subject|1
5075897|NCT02202759|17518172|P2|Overall Study|Withdrawal by Subject|1
5075898|NCT02202759|17518173|P1|Overall Study|Withdrawal by Subject|2
5075899|NCT02202759|17518171|P3|Overall Study|Study Terminated by Sponsor|3
5075900|NCT02202759|17518172|P2|Overall Study|Study Terminated by Sponsor|3
5075901|NCT02202759|17518173|P1|Overall Study|Study Terminated by Sponsor|3
5075902|NCT02202616|17518240|P1|Overall Study|Unsatisfactory therapeutic effect|1
5075903|NCT02202616|17518240|P1|Overall Study|Abnormal test procedure result|1
5075904|NCT02202616|17518240|P1|Overall Study|Administrative problems|6
5075905|NCT02202616|17518240|P1|Overall Study|Lost to Follow-up|6
5075906|NCT02202616|17518240|P1|Overall Study|Patient withdrew consent|12
5075907|NCT02202616|17518240|P1|Overall Study|Protocol deviation|18
5075908|NCT02202616|17518240|P1|Overall Study|Adverse Event|32
5075909|NCT02202616|17518240|P1|Overall Study|Screen failed|24
5075910|NCT02202551|17518255|P4|Overall Study|eGFR<50mL/min/m2|1
5075911|NCT02202551|17518256|P3|Overall Study|eGFR<50mL/min/m2|0
5075912|NCT02202551|17518257|P2|Overall Study|eGFR<50mL/min/m2|2
5075913|NCT02202551|17518258|P1|Overall Study|eGFR<50mL/min/m2|2
5075914|NCT02202551|17518255|P4|Overall Study|Subject consent withdrawn|2
5075915|NCT02202551|17518256|P3|Overall Study|Subject consent withdrawn|1
5075916|NCT02202551|17518257|P2|Overall Study|Subject consent withdrawn|3
5075917|NCT02202551|17518258|P1|Overall Study|Subject consent withdrawn|0
5075918|NCT02202551|17518255|P4|Overall Study|Subject unwilling to proceed|5
5075919|NCT02202551|17518256|P3|Overall Study|Subject unwilling to proceed|3
5075920|NCT02202551|17518257|P2|Overall Study|Subject unwilling to proceed|5
5075921|NCT02202551|17518258|P1|Overall Study|Subject unwilling to proceed|1
5075922|NCT02202551|17518255|P4|Overall Study|Sponsor's decision|0
5075923|NCT02202551|17518256|P3|Overall Study|Sponsor's decision|0
5075924|NCT02202551|17518257|P2|Overall Study|Sponsor's decision|0
5075925|NCT02202551|17518258|P1|Overall Study|Sponsor's decision|2
5075926|NCT02202551|17518255|P4|Overall Study|Protocol Violation|0
5075927|NCT02202551|17518256|P3|Overall Study|Protocol Violation|0
5075928|NCT02202551|17518257|P2|Overall Study|Protocol Violation|1
5075929|NCT02202551|17518258|P1|Overall Study|Protocol Violation|0
5075930|NCT02202551|17518255|P4|Overall Study|Worsening Dyskinesia|1
5075931|NCT02202551|17518256|P3|Overall Study|Worsening Dyskinesia|0
5075932|NCT02202551|17518257|P2|Overall Study|Worsening Dyskinesia|0
5075933|NCT02202551|17518258|P1|Overall Study|Worsening Dyskinesia|0
5075934|NCT02202551|17518255|P4|Overall Study|Unable to complete visits per protocol|0
5075935|NCT02202551|17518256|P3|Overall Study|Unable to complete visits per protocol|0
5075936|NCT02202551|17518257|P2|Overall Study|Unable to complete visits per protocol|0
5075937|NCT02202551|17518258|P1|Overall Study|Unable to complete visits per protocol|1
5075938|NCT02202551|17518255|P4|Overall Study|Site closure|1
5075939|NCT02202551|17518256|P3|Overall Study|Site closure|0
5075940|NCT02202551|17518257|P2|Overall Study|Site closure|0
5075941|NCT02202551|17518258|P1|Overall Study|Site closure|3
5075942|NCT02202551|17518255|P4|Overall Study|Physician Decision|0
5075943|NCT02202551|17518256|P3|Overall Study|Physician Decision|0
5075944|NCT02202551|17518257|P2|Overall Study|Physician Decision|0
5075945|NCT02202551|17518258|P1|Overall Study|Physician Decision|1
5075946|NCT02202551|17518255|P4|Overall Study|Lack of Efficacy|0
5075947|NCT02202551|17518256|P3|Overall Study|Lack of Efficacy|0
5075948|NCT02202551|17518257|P2|Overall Study|Lack of Efficacy|1
5075949|NCT02202551|17518258|P1|Overall Study|Lack of Efficacy|0
5075950|NCT02202551|17518255|P4|Overall Study|Dyskinesia upon taper|0
5075951|NCT02202551|17518256|P3|Overall Study|Dyskinesia upon taper|0
5075952|NCT02202551|17518257|P2|Overall Study|Dyskinesia upon taper|0
5075953|NCT02202551|17518258|P1|Overall Study|Dyskinesia upon taper|1
5075954|NCT02202551|17518255|P4|Overall Study|DBS surgery|0
5075955|NCT02202551|17518256|P3|Overall Study|DBS surgery|0
5075956|NCT02202551|17518257|P2|Overall Study|DBS surgery|0
5075957|NCT02202551|17518258|P1|Overall Study|DBS surgery|3
5075958|NCT02202551|17518255|P4|Overall Study|Subject moved away|0
5075959|NCT02202551|17518256|P3|Overall Study|Subject moved away|0
5075960|NCT02202551|17518257|P2|Overall Study|Subject moved away|1
5075961|NCT02202551|17518258|P1|Overall Study|Subject moved away|0
5075962|NCT02202551|17518255|P4|Overall Study|Needed to take excluded medication|1
5075963|NCT02202551|17518256|P3|Overall Study|Needed to take excluded medication|0
5075964|NCT02202551|17518257|P2|Overall Study|Needed to take excluded medication|2
5075965|NCT02202551|17518258|P1|Overall Study|Needed to take excluded medication|0
5075966|NCT02202551|17518255|P4|Overall Study|Lost to Follow-up|1
5075967|NCT02202551|17518256|P3|Overall Study|Lost to Follow-up|0
5075968|NCT02202551|17518257|P2|Overall Study|Lost to Follow-up|1
5075969|NCT02202551|17518258|P1|Overall Study|Lost to Follow-up|0
5075970|NCT02202551|17518255|P4|Overall Study|Death|1
5075971|NCT02202551|17518256|P3|Overall Study|Death|1
5075972|NCT02202551|17518257|P2|Overall Study|Death|2
5075973|NCT02202551|17518258|P1|Overall Study|Death|3
5075974|NCT02202551|17518255|P4|Overall Study|Adverse Event|9
5075975|NCT02202551|17518256|P3|Overall Study|Adverse Event|5
5075976|NCT02202551|17518257|P2|Overall Study|Adverse Event|19
5075977|NCT02202551|17518258|P1|Overall Study|Adverse Event|8
5075978|NCT02202538|17518276|P1|Overall Study|Investigator Decision|1
5075979|NCT02202538|17518276|P1|Overall Study|Did not meet all inclusion criteria|2
5075980|NCT02202538|17518276|P1|Overall Study|Withdrawal by Subject|5
5075981|NCT02202499|17518290|P3|Overall Study|Auto accident|0
5075982|NCT02202499|17518291|P2|Overall Study|Auto accident|0
5075983|NCT02202499|17518292|P1|Overall Study|Auto accident|1
5075984|NCT02202499|17518290|P3|Overall Study|Declined before randomization|0
5075985|NCT02202499|17518291|P2|Overall Study|Declined before randomization|0
5075986|NCT02202499|17518292|P1|Overall Study|Declined before randomization|1
5075987|NCT02202499|17518290|P3|Overall Study|Moved from area|1
5075988|NCT02202499|17518291|P2|Overall Study|Moved from area|0
5075989|NCT02202499|17518292|P1|Overall Study|Moved from area|0
5075990|NCT02202499|17518290|P3|Overall Study|Cancer diagnosis|1
5075991|NCT02202499|17518291|P2|Overall Study|Cancer diagnosis|0
5075992|NCT02202499|17518292|P1|Overall Study|Cancer diagnosis|0
5075993|NCT02202434|17518319|P4|Overall Study|Other|1
5075994|NCT02202434|17518320|P3|Overall Study|Other|0
5075995|NCT02202434|17518321|P2|Overall Study|Other|0
5075996|NCT02202434|17518322|P1|Overall Study|Other|1
5075997|NCT02202434|17518319|P4|Overall Study|Visit Missed|5
5075998|NCT02202434|17518320|P3|Overall Study|Visit Missed|0
5075999|NCT02202434|17518321|P2|Overall Study|Visit Missed|12
5076000|NCT02202434|17518322|P1|Overall Study|Visit Missed|21
5076001|NCT02202434|17518319|P4|Overall Study|Completed Study|0
5076002|NCT02202434|17518320|P3|Overall Study|Completed Study|0
5076003|NCT02202434|17518321|P2|Overall Study|Completed Study|0
5076004|NCT02202434|17518322|P1|Overall Study|Completed Study|1
5076005|NCT02202434|17518319|P4|Overall Study|Withdrawal by Subject|4
5076006|NCT02202434|17518320|P3|Overall Study|Withdrawal by Subject|1
5076007|NCT02202434|17518321|P2|Overall Study|Withdrawal by Subject|14
5076008|NCT02202434|17518322|P1|Overall Study|Withdrawal by Subject|13
5076009|NCT02202434|17518319|P4|Overall Study|Physician Decision|0
5076010|NCT02202434|17518320|P3|Overall Study|Physician Decision|0
5076011|NCT02202434|17518321|P2|Overall Study|Physician Decision|3
5076012|NCT02202434|17518322|P1|Overall Study|Physician Decision|2
5076013|NCT02202434|17518319|P4|Overall Study|Lost to Follow-up|0
5076014|NCT02202434|17518320|P3|Overall Study|Lost to Follow-up|1
5076015|NCT02202434|17518321|P2|Overall Study|Lost to Follow-up|1
5076016|NCT02202434|17518322|P1|Overall Study|Lost to Follow-up|1
5076017|NCT02202434|17518319|P4|Overall Study|Death|27
5076018|NCT02202434|17518320|P3|Overall Study|Death|13
5076019|NCT02202434|17518321|P2|Overall Study|Death|39
5076020|NCT02202434|17518322|P1|Overall Study|Death|70
5076021|NCT02202317|17518446|P1|Overall Study|Lost to Follow-up|1
5076022|NCT02202161|17518473|P8|Overall Study|Withdrawal by Subject|0
5076023|NCT02202161|17518474|P7|Overall Study|Withdrawal by Subject|0
5076024|NCT02202161|17518475|P6|Overall Study|Withdrawal by Subject|0
5076025|NCT02202161|17518476|P5|Overall Study|Withdrawal by Subject|1
5076026|NCT02202161|17518477|P4|Overall Study|Withdrawal by Subject|0
5076027|NCT02202161|17518478|P3|Overall Study|Withdrawal by Subject|0
5076028|NCT02202161|17518479|P2|Overall Study|Withdrawal by Subject|0
5076029|NCT02202161|17518480|P1|Overall Study|Withdrawal by Subject|0
5076030|NCT02202161|17518473|P8|Overall Study|Physician Decision|3
5076031|NCT02202161|17518474|P7|Overall Study|Physician Decision|0
5076032|NCT02202161|17518475|P6|Overall Study|Physician Decision|0
5076033|NCT02202161|17518476|P5|Overall Study|Physician Decision|0
5076034|NCT02202161|17518477|P4|Overall Study|Physician Decision|0
5076035|NCT02202161|17518478|P3|Overall Study|Physician Decision|0
5076036|NCT02202161|17518479|P2|Overall Study|Physician Decision|0
5076037|NCT02202161|17518480|P1|Overall Study|Physician Decision|0
5076038|NCT02202161|17518473|P8|Overall Study|Did not meet continuation criteria|3
5076039|NCT02202161|17518474|P7|Overall Study|Did not meet continuation criteria|0
5076040|NCT02202161|17518475|P6|Overall Study|Did not meet continuation criteria|0
5076041|NCT02202161|17518476|P5|Overall Study|Did not meet continuation criteria|0
5076042|NCT02202161|17518477|P4|Overall Study|Did not meet continuation criteria|0
5076043|NCT02202161|17518478|P3|Overall Study|Did not meet continuation criteria|0
5076044|NCT02202161|17518479|P2|Overall Study|Did not meet continuation criteria|0
5076045|NCT02202161|17518480|P1|Overall Study|Did not meet continuation criteria|0
5076046|NCT02202161|17518473|P8|Overall Study|Adverse Event|0
5076047|NCT02202161|17518474|P7|Overall Study|Adverse Event|0
5076048|NCT02202161|17518475|P6|Overall Study|Adverse Event|1
5076049|NCT02202161|17518476|P5|Overall Study|Adverse Event|0
5076050|NCT02202161|17518477|P4|Overall Study|Adverse Event|0
5076051|NCT02202161|17518478|P3|Overall Study|Adverse Event|0
5076052|NCT02202161|17518479|P2|Overall Study|Adverse Event|1
5076053|NCT02202161|17518480|P1|Overall Study|Adverse Event|1
5076054|NCT02202109|17518640|P2|Overall Study|Withdrawal by Subject|0
5076055|NCT02202109|17518641|P1|Overall Study|Withdrawal by Subject|2
5076056|NCT02202109|17518640|P2|Overall Study|Lost to Follow-up|87
5076057|NCT02202109|17518641|P1|Overall Study|Lost to Follow-up|88
5076058|NCT02202031|17518658|P2|Overall Study|Intolerance/Lack of Improvement|0
5076059|NCT02202031|17518659|P1|Overall Study|Intolerance/Lack of Improvement|3
5076060|NCT02202031|17518658|P2|Overall Study|Illness/Medical Reason|2
5076061|NCT02202031|17518659|P1|Overall Study|Illness/Medical Reason|0
5076062|NCT02202031|17518658|P2|Overall Study|Too Busy|3
5076063|NCT02202031|17518659|P1|Overall Study|Too Busy|1
5076064|NCT02202031|17518658|P2|Overall Study|Lost to Follow-up|0
5076065|NCT02202031|17518659|P1|Overall Study|Lost to Follow-up|1
5076066|NCT02201953|17518707|P2|Overall Study|Death|3
5076067|NCT02201953|17518708|P1|Overall Study|Death|0
5076068|NCT02201953|17518707|P2|Overall Study|Adverse Event|5
5076069|NCT02201953|17518708|P1|Overall Study|Adverse Event|0
5076070|NCT02201953|17518707|P2|Overall Study|Withdrew Consent|5
5076071|NCT02201953|17518708|P1|Overall Study|Withdrew Consent|2
5076072|NCT02201953|17518707|P2|Overall Study|Lost to Follow-up|8
5076073|NCT02201953|17518708|P1|Overall Study|Lost to Follow-up|8
5076074|NCT02201953|17518707|P2|Overall Study|Lack of Efficacy|30
5076075|NCT02201953|17518708|P1|Overall Study|Lack of Efficacy|9
5076076|NCT02201953|17518707|P2|Overall Study|Randomized but Never Treated|5
5076077|NCT02201953|17518708|P1|Overall Study|Randomized but Never Treated|1
5076078|NCT02201940|17518726|P2|Overall Study|Adverse Event|1
5076079|NCT02201940|17518727|P1|Overall Study|Adverse Event|0
5076080|NCT02201940|17518726|P2|Overall Study|Death|0
5076081|NCT02201940|17518727|P1|Overall Study|Death|1
5076082|NCT02201940|17518726|P2|Overall Study|Investigator's Discretion|1
5076083|NCT02201940|17518727|P1|Overall Study|Investigator's Discretion|1
5076084|NCT02201940|17518726|P2|Overall Study|Withdrew Consent|1
5076085|NCT02201940|17518727|P1|Overall Study|Withdrew Consent|2
5076086|NCT02201940|17518726|P2|Overall Study|Lost to Follow-up|0
5076087|NCT02201940|17518727|P1|Overall Study|Lost to Follow-up|5
5076088|NCT02201940|17518726|P2|Overall Study|Lack of Efficacy|113
5076089|NCT02201940|17518727|P1|Overall Study|Lack of Efficacy|2
5076090|NCT02201940|17518726|P2|Overall Study|Randomized/Enrolled but Never Treated|0
5076091|NCT02201940|17518727|P1|Overall Study|Randomized/Enrolled but Never Treated|1
5076092|NCT02201901|17518746|P3|Overall Study|Adverse Event|0
5076093|NCT02201901|17518747|P2|Overall Study|Adverse Event|1
5076094|NCT02201901|17518748|P1|Overall Study|Adverse Event|1
5076095|NCT02201901|17518746|P3|Overall Study|Withdrew Consent|2
5076096|NCT02201901|17518747|P2|Overall Study|Withdrew Consent|0
5076097|NCT02201901|17518748|P1|Overall Study|Withdrew Consent|2
5076098|NCT02201901|17518746|P3|Overall Study|Lost to Follow-up|2
5076099|NCT02201901|17518747|P2|Overall Study|Lost to Follow-up|3
5076100|NCT02201901|17518748|P1|Overall Study|Lost to Follow-up|2
5076101|NCT02201901|17518746|P3|Overall Study|Death|3
5076102|NCT02201901|17518747|P2|Overall Study|Death|3
5076103|NCT02201901|17518748|P1|Overall Study|Death|3
5076104|NCT02201901|17518746|P3|Overall Study|Lack of Efficacy|6
5076105|NCT02201901|17518747|P2|Overall Study|Lack of Efficacy|1
5076106|NCT02201901|17518748|P1|Overall Study|Lack of Efficacy|7
5076107|NCT02201901|17518746|P3|Overall Study|Randomized but never treated|0
5076108|NCT02201901|17518747|P2|Overall Study|Randomized but never treated|1
5076109|NCT02201901|17518748|P1|Overall Study|Randomized but never treated|0
5076110|NCT02201784|17518779|P2|Overall Study|Failure to achieve adequate block|0
5076111|NCT02201784|17518780|P1|Overall Study|Failure to achieve adequate block|2
5076112|NCT02201771|17518797|P3|Overall Study|Protocol Violation|10
5076113|NCT02201771|17518798|P2|Overall Study|Protocol Violation|8
5076114|NCT02201771|17518799|P1|Overall Study|Protocol Violation|10
5076115|NCT02201771|17518797|P3|Overall Study|Death|0
5076116|NCT02201771|17518798|P2|Overall Study|Death|2
5076117|NCT02201771|17518799|P1|Overall Study|Death|3
5076118|NCT02201524|17518826|P4|Overall Study|Other|0
5076119|NCT02201524|17518827|P3|Overall Study|Other|0
5076120|NCT02201524|17518828|P2|Overall Study|Other|1
5076121|NCT02201524|17518829|P1|Overall Study|Other|1
5076122|NCT02201524|17518826|P4|Overall Study|Withdrawal by Subject|1
5076123|NCT02201524|17518827|P3|Overall Study|Withdrawal by Subject|1
5076124|NCT02201524|17518828|P2|Overall Study|Withdrawal by Subject|0
5076125|NCT02201524|17518829|P1|Overall Study|Withdrawal by Subject|0
5076126|NCT02201524|17518826|P4|Overall Study|Protocol Violation|1
5076127|NCT02201524|17518827|P3|Overall Study|Protocol Violation|0
5076128|NCT02201524|17518828|P2|Overall Study|Protocol Violation|0
5076129|NCT02201524|17518829|P1|Overall Study|Protocol Violation|0
5076130|NCT02201524|17518826|P4|Overall Study|No longer meets eligibility criteria|2
5076131|NCT02201524|17518827|P3|Overall Study|No longer meets eligibility criteria|0
5076132|NCT02201524|17518828|P2|Overall Study|No longer meets eligibility criteria|0
5076133|NCT02201524|17518829|P1|Overall Study|No longer meets eligibility criteria|0
5076134|NCT02201524|17518826|P4|Overall Study|Lost to Follow-up|0
5076135|NCT02201524|17518827|P3|Overall Study|Lost to Follow-up|2
5076136|NCT02201524|17518828|P2|Overall Study|Lost to Follow-up|0
5076137|NCT02201524|17518829|P1|Overall Study|Lost to Follow-up|0
5076138|NCT02201524|17518826|P4|Overall Study|Insufficient clinical response|0
5076139|NCT02201524|17518827|P3|Overall Study|Insufficient clinical response|0
5076140|NCT02201524|17518828|P2|Overall Study|Insufficient clinical response|0
5076141|NCT02201524|17518829|P1|Overall Study|Insufficient clinical response|1
5076142|NCT02201524|17518826|P4|Overall Study|Adverse Event|0
5076143|NCT02201524|17518827|P3|Overall Study|Adverse Event|1
5076144|NCT02201524|17518828|P2|Overall Study|Adverse Event|2
5076145|NCT02201524|17518829|P1|Overall Study|Adverse Event|0
5076146|NCT02201472|17518911|P1|Overall Study|Lack of Efficacy|2
5076147|NCT02201329|17518958|P1|Overall Study|Withdrawal by Subject|2
5076148|NCT02201329|17518958|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
5076149|NCT02201290|17518966|P1|Overall Study|Adverse Event|1
5076150|NCT02201290|17518966|P1|Overall Study|Lack of Efficacy|2
5076151|NCT02201290|17518966|P1|Overall Study|Withdrawal by Subject|2
5076152|NCT02201277|17518972|P2|Overall Study|Physician Decision|0
5076153|NCT02201277|17518973|P1|Overall Study|Physician Decision|1
5076154|NCT02201277|17518972|P2|Overall Study|Failed retrieval|0
5076155|NCT02201277|17518973|P1|Overall Study|Failed retrieval|1
5076156|NCT02201277|17518972|P2|Overall Study|Lost to Follow-up|1
5076157|NCT02201277|17518973|P1|Overall Study|Lost to Follow-up|2
5076158|NCT02201277|17518972|P2|Overall Study|Death|4
5076159|NCT02201277|17518973|P1|Overall Study|Death|3
5076160|NCT02201108|17519003|P2|Overall Study|Withdrawal by Subject|0
5076161|NCT02201108|17519004|P1|Overall Study|Withdrawal by Subject|2
5076162|NCT02201108|17519003|P2|Overall Study|Lack of Efficacy|1
5076163|NCT02201108|17519004|P1|Overall Study|Lack of Efficacy|2
5076164|NCT02201108|17519003|P2|Overall Study|Adverse Event|6
5076165|NCT02201108|17519004|P1|Overall Study|Adverse Event|0
5076166|NCT02200770|17519119|P2|Open-label Period (OLP)|Participants ongoing|162
5076167|NCT02200770|17519120|P1|Open-label Period (OLP)|Participants ongoing|51
5076168|NCT02200770|17519119|P2|Randomized-controlled Period (RCP)|Other|2
5076169|NCT02200770|17519120|P1|Randomized-controlled Period (RCP)|Other|1
5076170|NCT02200770|17519119|P2|Randomized-controlled Period (RCP)|Not treated|1
5076171|NCT02200770|17519120|P1|Randomized-controlled Period (RCP)|Not treated|0
5076172|NCT02200770|17519119|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
5076173|NCT02200770|17519120|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
5076174|NCT02200770|17519119|P2|Randomized-controlled Period (RCP)|Adverse Event|2
5076175|NCT02200770|17519120|P1|Randomized-controlled Period (RCP)|Adverse Event|0
5076176|NCT02200614|17519151|P2|Open Label|Protocol deviation|1
5076177|NCT02200614|17519152|P1|Open Label|Protocol deviation|1
5076178|NCT02200614|17519151|P2|Open Label|Personal reason|3
5076179|NCT02200614|17519152|P1|Open Label|Personal reason|29
5076180|NCT02200614|17519151|P2|Open Label|Other reason|1
5076181|NCT02200614|17519152|P1|Open Label|Other reason|6
5076182|NCT02200614|17519151|P2|Open Label|Metastasis by local reading|10
5076183|NCT02200614|17519152|P1|Open Label|Metastasis by local reading|58
5076184|NCT02200614|17519151|P2|Open Label|Judgment of the investigator|0
5076185|NCT02200614|17519152|P1|Open Label|Judgment of the investigator|15
5076186|NCT02200614|17519151|P2|Open Label|Confirmed metastasis|0
5076187|NCT02200614|17519152|P1|Open Label|Confirmed metastasis|1
5076188|NCT02200614|17519151|P2|Open Label|Adverse Event|8
5076189|NCT02200614|17519152|P1|Open Label|Adverse Event|15
5076190|NCT02200614|17519151|P2|Double Blind Treatment|Not treated|0
5076191|NCT02200614|17519152|P1|Double Blind Treatment|Not treated|1
5076192|NCT02200614|17519151|P2|Double Blind Treatment|Protocol deviation|7
5076193|NCT02200614|17519152|P1|Double Blind Treatment|Protocol deviation|14
5076194|NCT02200614|17519151|P2|Double Blind Treatment|Personal reason|85
5076195|NCT02200614|17519152|P1|Double Blind Treatment|Personal reason|77
5076196|NCT02200614|17519151|P2|Double Blind Treatment|Other reason|2
5076197|NCT02200614|17519152|P1|Double Blind Treatment|Other reason|6
5076198|NCT02200614|17519151|P2|Double Blind Treatment|Metastasis by local reading|3
5076199|NCT02200614|17519152|P1|Double Blind Treatment|Metastasis by local reading|1
5076200|NCT02200614|17519151|P2|Double Blind Treatment|Judgment of the investigator|99
5076201|NCT02200614|17519152|P1|Double Blind Treatment|Judgment of the investigator|60
5076202|NCT02200614|17519151|P2|Double Blind Treatment|Confirmed metastasis|140
5076203|NCT02200614|17519152|P1|Double Blind Treatment|Confirmed metastasis|119
5076204|NCT02200614|17519151|P2|Double Blind Treatment|Adverse Event|48
5076205|NCT02200614|17519152|P1|Double Blind Treatment|Adverse Event|86
5076206|NCT02200510|17519201|P2|Overall Study|potential COI - joined study team|0
5076207|NCT02200510|17519202|P1|Overall Study|potential COI - joined study team|1
5076208|NCT02200510|17519201|P2|Overall Study|Lost to Follow-up|1
5076209|NCT02200510|17519202|P1|Overall Study|Lost to Follow-up|7
5076210|NCT02200510|17519201|P2|Overall Study|Protocol Violation|1
5076211|NCT02200510|17519202|P1|Overall Study|Protocol Violation|0
5076212|NCT02200510|17519201|P2|Overall Study|Death|1
5076213|NCT02200510|17519202|P1|Overall Study|Death|1
5076214|NCT02200211|17519227|P4|Overall Study|Withdrawal by Subject|0
5076215|NCT02200211|17519228|P3|Overall Study|Withdrawal by Subject|0
5076216|NCT02200211|17519229|P2|Overall Study|Withdrawal by Subject|0
5076217|NCT02200211|17519230|P1|Overall Study|Withdrawal by Subject|1
5076218|NCT02200211|17519227|P4|Overall Study|Lost to Follow-up|2
5076219|NCT02200211|17519228|P3|Overall Study|Lost to Follow-up|1
5076220|NCT02200211|17519229|P2|Overall Study|Lost to Follow-up|7
5076221|NCT02200211|17519230|P1|Overall Study|Lost to Follow-up|7
5076222|NCT02200042|17519343|P2|Overall Study|Withdrawal by Subject|1
5076223|NCT02200042|17519344|P1|Overall Study|Withdrawal by Subject|0
5076224|NCT02199795|17519373|P2|Overall Study|withdrew due to shoulder pain|0
5076225|NCT02199795|17519374|P1|Overall Study|withdrew due to shoulder pain|1
5076226|NCT02199795|17519373|P2|Overall Study|no longer met inclusion criteria|0
5076227|NCT02199795|17519374|P1|Overall Study|no longer met inclusion criteria|1
5076228|NCT02199691|17519397|P4|Overall Study|Lost to Follow-up|10
5076229|NCT02199691|17519398|P3|Overall Study|Lost to Follow-up|9
5076230|NCT02199691|17519399|P2|Overall Study|Lost to Follow-up|1
5076231|NCT02199691|17519400|P1|Overall Study|Lost to Follow-up|2
5076232|NCT02199691|17519397|P4|Overall Study|Withdrawal by Subject|13
5076233|NCT02199691|17519398|P3|Overall Study|Withdrawal by Subject|12
5076234|NCT02199691|17519399|P2|Overall Study|Withdrawal by Subject|3
5076235|NCT02199691|17519400|P1|Overall Study|Withdrawal by Subject|5
5076236|NCT02199691|17519397|P4|Overall Study|Protocol Violation|7
5076237|NCT02199691|17519398|P3|Overall Study|Protocol Violation|6
5076238|NCT02199691|17519399|P2|Overall Study|Protocol Violation|3
5076239|NCT02199691|17519400|P1|Overall Study|Protocol Violation|3
5076240|NCT02199509|17519442|P2|Overall Study|Misunderstood titration schedule|0
5076241|NCT02199509|17519443|P1|Overall Study|Misunderstood titration schedule|1
5076242|NCT02199509|17519442|P2|Overall Study|Suicidal Ideation|1
5076243|NCT02199509|17519443|P1|Overall Study|Suicidal Ideation|0
5076244|NCT02199314|17519466|P1|Overall Study|Physician Decision|10
5076245|NCT02199314|17519466|P1|Overall Study|Withdrawal by Subject|6
5076246|NCT02199080|17519493|P1|Overall Study|Protocol Violation|12
5076247|NCT02199028|17519518|P2|Week 3|Adverse Event|0
5076248|NCT02199028|17519519|P1|Week 3|Adverse Event|1
5076249|NCT02199028|17519518|P2|Week 1|Adverse Event|0
5076250|NCT02199028|17519519|P1|Week 1|Adverse Event|1
5076251|NCT02198963|17519528|P1|Overall Study|Withdrawal by Subject|6
5076252|NCT02198963|17519528|P1|Overall Study|Adverse Event|1
5076253|NCT02198651|17519552|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5076254|NCT02198651|17519553|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
5076255|NCT02198651|17519554|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5076256|NCT02198651|17519555|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5076257|NCT02198651|17519556|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5076258|NCT02198651|17519552|P5|Open-label Rescue Period|Withdrew consent|0
5076259|NCT02198651|17519553|P4|Open-label Rescue Period|Withdrew consent|2
5076260|NCT02198651|17519554|P3|Open-label Rescue Period|Withdrew consent|0
5076261|NCT02198651|17519555|P2|Open-label Rescue Period|Withdrew consent|0
5076262|NCT02198651|17519556|P1|Open-label Rescue Period|Withdrew consent|0
5076263|NCT02198651|17519552|P5|Double-blind Period|Other, not specified|0
5076264|NCT02198651|17519553|P4|Double-blind Period|Other, not specified|0
5076265|NCT02198651|17519554|P3|Double-blind Period|Other, not specified|1
5076266|NCT02198651|17519555|P2|Double-blind Period|Other, not specified|4
5076267|NCT02198651|17519556|P1|Double-blind Period|Other, not specified|0
5076268|NCT02198651|17519552|P5|Double-blind Period|Adverse Event|0
5076269|NCT02198651|17519553|P4|Double-blind Period|Adverse Event|0
5076270|NCT02198651|17519554|P3|Double-blind Period|Adverse Event|0
5076271|NCT02198651|17519555|P2|Double-blind Period|Adverse Event|1
5076272|NCT02198651|17519556|P1|Double-blind Period|Adverse Event|0
5076273|NCT02198651|17519552|P5|Double-blind Period|Withdrew consent|0
5076274|NCT02198651|17519553|P4|Double-blind Period|Withdrew consent|0
5076275|NCT02198651|17519554|P3|Double-blind Period|Withdrew consent|0
5076276|NCT02198651|17519555|P2|Double-blind Period|Withdrew consent|4
5076277|NCT02198651|17519556|P1|Double-blind Period|Withdrew consent|0
5076278|NCT02198651|17519552|P5|Lead-in Period|Other, not specified|0
5076279|NCT02198651|17519553|P4|Lead-in Period|Other, not specified|0
5076280|NCT02198651|17519554|P3|Lead-in Period|Other, not specified|0
5076281|NCT02198651|17519555|P2|Lead-in Period|Other, not specified|0
5076282|NCT02198651|17519556|P1|Lead-in Period|Other, not specified|22
5076283|NCT02198651|17519552|P5|Lead-in Period|Adverse Event|0
5076284|NCT02198651|17519553|P4|Lead-in Period|Adverse Event|0
5076285|NCT02198651|17519554|P3|Lead-in Period|Adverse Event|0
5076286|NCT02198651|17519555|P2|Lead-in Period|Adverse Event|0
5076287|NCT02198651|17519556|P1|Lead-in Period|Adverse Event|2
5076288|NCT02198651|17519552|P5|Lead-in Period|Withdrew consent|0
5076289|NCT02198651|17519553|P4|Lead-in Period|Withdrew consent|0
5076290|NCT02198651|17519554|P3|Lead-in Period|Withdrew consent|0
5076291|NCT02198651|17519555|P2|Lead-in Period|Withdrew consent|0
5076292|NCT02198651|17519556|P1|Lead-in Period|Withdrew consent|13
5076293|NCT02198235|17519657|P3|Overall Study|Lost to Follow-up|2
5076294|NCT02198235|17519658|P2|Overall Study|Lost to Follow-up|2
5076295|NCT02198235|17519659|P1|Overall Study|Lost to Follow-up|3
5076296|NCT02198040|17519679|P3|Overall Study|Withdrawal by Subject|1
5076297|NCT02198040|17519680|P2|Overall Study|Withdrawal by Subject|0
5076298|NCT02198040|17519681|P1|Overall Study|Withdrawal by Subject|0
5076299|NCT02198040|17519679|P3|Overall Study|Work reasons|0
5076300|NCT02198040|17519680|P2|Overall Study|Work reasons|1
5076301|NCT02198040|17519681|P1|Overall Study|Work reasons|0
5076302|NCT02197806|17519711|P4|Overall Study|Adverse Event|1
5076303|NCT02197806|17519712|P3|Overall Study|Adverse Event|0
5076304|NCT02197806|17519713|P2|Overall Study|Adverse Event|1
5076305|NCT02197806|17519714|P1|Overall Study|Adverse Event|0
5076306|NCT02197572|17519729|P1|Overall Study|Reason Not Specified|4
5076307|NCT02197572|17519729|P1|Overall Study|Adverse Event|3
5076308|NCT02197572|17519729|P1|Overall Study|Withdrawal by Subject|9
5076309|NCT02197572|17519729|P1|Overall Study|Progressive Disease|28
5076310|NCT02197520|17519746|P2|Period 2|Withdrawal by Subject|0
5076311|NCT02197520|17519747|P1|Period 2|Withdrawal by Subject|1
5076312|NCT02197520|17519746|P2|Period 2|Adverse Event|2
5076313|NCT02197520|17519747|P1|Period 2|Adverse Event|0
5076314|NCT02197520|17519746|P2|Period 1|Withdrawal by Subject|0
5076315|NCT02197520|17519747|P1|Period 1|Withdrawal by Subject|1
5076316|NCT02197416|17519794|P3|Overall Study|Adverse Event|1
5076317|NCT02197416|17519795|P2|Overall Study|Adverse Event|0
5076318|NCT02197416|17519796|P1|Overall Study|Adverse Event|0
5076319|NCT02197416|17519794|P3|Overall Study|Protocol Violation|1
5076320|NCT02197416|17519795|P2|Overall Study|Protocol Violation|0
5076321|NCT02197416|17519796|P1|Overall Study|Protocol Violation|1
5076322|NCT02197416|17519794|P3|Overall Study|Withdrawal by Subject|1
5076323|NCT02197416|17519795|P2|Overall Study|Withdrawal by Subject|2
5076324|NCT02197416|17519796|P1|Overall Study|Withdrawal by Subject|0
5076325|NCT02197416|17519794|P3|Overall Study|Other reasons|5
5076326|NCT02197416|17519795|P2|Overall Study|Other reasons|2
5076327|NCT02197416|17519796|P1|Overall Study|Other reasons|0
5076328|NCT02197377|17519834|P2|Overall Study|Insertion Failure|3
5076329|NCT02197377|17519835|P1|Overall Study|Insertion Failure|0
5076330|NCT02197247|17519856|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
5076331|NCT02197247|17519856|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
5076332|NCT02197247|17519856|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
5076333|NCT02197247|17519856|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
5076334|NCT02197247|17519856|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
5076335|NCT02197247|17519856|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
5076336|NCT02197247|17519856|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
5076337|NCT02197247|17519856|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
5076338|NCT02197234|17519901|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
5076339|NCT02197234|17519901|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
5076340|NCT02197234|17519901|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
5076341|NCT02197234|17519901|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
5076342|NCT02197234|17519901|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
5076343|NCT02197234|17519901|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
5076344|NCT02197234|17519901|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
5076345|NCT02197130|17519923|P3|Overall Study|Other|3
5076346|NCT02197130|17519924|P2|Overall Study|Other|0
5076347|NCT02197130|17519925|P1|Overall Study|Other|1
5076348|NCT02197130|17519923|P3|Overall Study|Withdrawal by Subject|4
5076349|NCT02197130|17519924|P2|Overall Study|Withdrawal by Subject|3
5076350|NCT02197130|17519925|P1|Overall Study|Withdrawal by Subject|0
5076351|NCT02197130|17519923|P3|Overall Study|Does not meet entrance criteria|1
5076352|NCT02197130|17519924|P2|Overall Study|Does not meet entrance criteria|0
5076353|NCT02197130|17519925|P1|Overall Study|Does not meet entrance criteria|0
5076354|NCT02197130|17519923|P3|Overall Study|Lost to Follow-up|1
5076355|NCT02197130|17519924|P2|Overall Study|Lost to Follow-up|0
5076356|NCT02197130|17519925|P1|Overall Study|Lost to Follow-up|2
5076357|NCT02197130|17519923|P3|Overall Study|Death|0
5076358|NCT02197130|17519924|P2|Overall Study|Death|1
5076359|NCT02197130|17519925|P1|Overall Study|Death|0
5076360|NCT02197130|17519923|P3|Overall Study|Adverse Event|23
5076361|NCT02197130|17519924|P2|Overall Study|Adverse Event|4
5076362|NCT02197130|17519925|P1|Overall Study|Adverse Event|13
5076363|NCT02196714|17520171|P4|Overall Study|Protocol Violation|0
5076364|NCT02196714|17520172|P3|Overall Study|Protocol Violation|1
5076365|NCT02196714|17520173|P2|Overall Study|Protocol Violation|0
5076366|NCT02196714|17520174|P1|Overall Study|Protocol Violation|0
5076367|NCT02196701|17520296|P1|Overall Study|Non-adherence to Protocol|1
5076368|NCT02196701|17520296|P1|Overall Study|Lost to Follow-up|1
5076369|NCT02196701|17520296|P1|Overall Study|Adverse Event|1
5076370|NCT02196675|17520370|P3|Overall Study|Death|1
5076371|NCT02196675|17520371|P2|Overall Study|Death|0
5076372|NCT02196675|17520372|P1|Overall Study|Death|0
5076373|NCT02196675|17520370|P3|Overall Study|Protocol Violation|0
5076374|NCT02196675|17520371|P2|Overall Study|Protocol Violation|1
5076375|NCT02196675|17520372|P1|Overall Study|Protocol Violation|0
5076376|NCT02196675|17520370|P3|Overall Study|Intra-operative surgical exclusion|0
5076377|NCT02196675|17520371|P2|Overall Study|Intra-operative surgical exclusion|1
5076378|NCT02196675|17520372|P1|Overall Study|Intra-operative surgical exclusion|1
5076379|NCT02196675|17520370|P3|Overall Study|Withdrawal by Subject|0
5076380|NCT02196675|17520371|P2|Overall Study|Withdrawal by Subject|0
5076381|NCT02196675|17520372|P1|Overall Study|Withdrawal by Subject|1
5076382|NCT02196558|17520395|P3|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5076383|NCT02196558|17520396|P2|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5076384|NCT02196558|17520397|P1|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5076385|NCT02196558|17520395|P3|Extension Phase (40 Weeks)|Adverse Event|0
5076386|NCT02196558|17520396|P2|Extension Phase (40 Weeks)|Adverse Event|2
5076387|NCT02196558|17520397|P1|Extension Phase (40 Weeks)|Adverse Event|1
5076388|NCT02196558|17520395|P3|Treatment Phase (12 Weeks)|Progression of Disease|1
5076389|NCT02196558|17520396|P2|Treatment Phase (12 Weeks)|Progression of Disease|0
5076390|NCT02196558|17520397|P1|Treatment Phase (12 Weeks)|Progression of Disease|0
5076391|NCT02196558|17520395|P3|Treatment Phase (12 Weeks)|Participant Choice|1
5076392|NCT02196558|17520396|P2|Treatment Phase (12 Weeks)|Participant Choice|1
5076393|NCT02196558|17520397|P1|Treatment Phase (12 Weeks)|Participant Choice|0
5076394|NCT02196558|17520395|P3|Treatment Phase (12 Weeks)|Adverse Event|0
5076395|NCT02196558|17520396|P2|Treatment Phase (12 Weeks)|Adverse Event|2
5076396|NCT02196558|17520397|P1|Treatment Phase (12 Weeks)|Adverse Event|0
5076397|NCT02196506|17520413|P4|Phase A+|Participant withdrawn by investigator|1
5076398|NCT02196506|17520414|P3|Phase A+|Participant withdrawn by investigator|0
5076399|NCT02196506|17520415|P2|Phase A+|Participant withdrawn by investigator|0
5076400|NCT02196506|17520416|P1|Phase A+|Participant withdrawn by investigator|0
5076401|NCT02196506|17520413|P4|Phase A+|Lost to Follow-up|6
5076402|NCT02196506|17520414|P3|Phase A+|Lost to Follow-up|0
5076403|NCT02196506|17520415|P2|Phase A+|Lost to Follow-up|0
5076404|NCT02196506|17520416|P1|Phase A+|Lost to Follow-up|0
5076405|NCT02196506|17520413|P4|Phase A+|Adverse Event|1
5076406|NCT02196506|17520414|P3|Phase A+|Adverse Event|0
5076407|NCT02196506|17520415|P2|Phase A+|Adverse Event|0
5076408|NCT02196506|17520416|P1|Phase A+|Adverse Event|0
5076409|NCT02196506|17520413|P4|Phase A+|Withdrawal by Participant|5
5076410|NCT02196506|17520414|P3|Phase A+|Withdrawal by Participant|0
5076411|NCT02196506|17520415|P2|Phase A+|Withdrawal by Participant|0
5076412|NCT02196506|17520416|P1|Phase A+|Withdrawal by Participant|0
5076413|NCT02196506|17520413|P4|Phase A+|Participant Met Withdrawal Criteria|1
5076414|NCT02196506|17520414|P3|Phase A+|Participant Met Withdrawal Criteria|0
5076415|NCT02196506|17520415|P2|Phase A+|Participant Met Withdrawal Criteria|0
5076416|NCT02196506|17520416|P1|Phase A+|Participant Met Withdrawal Criteria|0
5076417|NCT02196506|17520413|P4|Phase B|Lost to Follow-up|0
5076418|NCT02196506|17520414|P3|Phase B|Lost to Follow-up|1
5076419|NCT02196506|17520415|P2|Phase B|Lost to Follow-up|2
5076420|NCT02196506|17520416|P1|Phase B|Lost to Follow-up|0
5076421|NCT02196506|17520413|P4|Phase B|Adverse Event|0
5076422|NCT02196506|17520414|P3|Phase B|Adverse Event|1
5076423|NCT02196506|17520415|P2|Phase B|Adverse Event|4
5076424|NCT02196506|17520416|P1|Phase B|Adverse Event|0
5076425|NCT02196506|17520413|P4|Phase B|Withdrawal by Participant|0
5076426|NCT02196506|17520414|P3|Phase B|Withdrawal by Participant|1
5076427|NCT02196506|17520415|P2|Phase B|Withdrawal by Participant|8
5076428|NCT02196506|17520416|P1|Phase B|Withdrawal by Participant|0
5076429|NCT02196506|17520413|P4|Phase B|Lack of Efficacy|0
5076430|NCT02196506|17520414|P3|Phase B|Lack of Efficacy|2
5076431|NCT02196506|17520415|P2|Phase B|Lack of Efficacy|1
5076432|NCT02196506|17520416|P1|Phase B|Lack of Efficacy|0
5076433|NCT02196506|17520413|P4|Phase B|Participant Met Withdrawal Criteria|0
5076434|NCT02196506|17520414|P3|Phase B|Participant Met Withdrawal Criteria|1
5076435|NCT02196506|17520415|P2|Phase B|Participant Met Withdrawal Criteria|0
5076436|NCT02196506|17520416|P1|Phase B|Participant Met Withdrawal Criteria|0
5076437|NCT02196506|17520413|P4|Phase A|Participant withdrawn by investigator|0
5076438|NCT02196506|17520414|P3|Phase A|Participant withdrawn by investigator|0
5076439|NCT02196506|17520415|P2|Phase A|Participant withdrawn by investigator|0
5076440|NCT02196506|17520416|P1|Phase A|Participant withdrawn by investigator|10
5076441|NCT02196506|17520413|P4|Phase A|Protocol deviation|0
5076442|NCT02196506|17520414|P3|Phase A|Protocol deviation|0
5076443|NCT02196506|17520415|P2|Phase A|Protocol deviation|0
5076444|NCT02196506|17520416|P1|Phase A|Protocol deviation|12
5076445|NCT02196506|17520413|P4|Phase A|Lost to Follow-up|0
5076446|NCT02196506|17520414|P3|Phase A|Lost to Follow-up|0
5076447|NCT02196506|17520415|P2|Phase A|Lost to Follow-up|0
5076448|NCT02196506|17520416|P1|Phase A|Lost to Follow-up|9
5076449|NCT02196506|17520413|P4|Phase A|Adverse Event|0
5076450|NCT02196506|17520414|P3|Phase A|Adverse Event|0
5076451|NCT02196506|17520415|P2|Phase A|Adverse Event|0
5076452|NCT02196506|17520416|P1|Phase A|Adverse Event|22
5076453|NCT02196506|17520413|P4|Phase A|Withdrawal by Subject|0
5076454|NCT02196506|17520414|P3|Phase A|Withdrawal by Subject|0
5076455|NCT02196506|17520415|P2|Phase A|Withdrawal by Subject|0
5076456|NCT02196506|17520416|P1|Phase A|Withdrawal by Subject|34
5076457|NCT02196506|17520413|P4|Phase A|Participant Met Withdrawal Criteria|0
5076458|NCT02196506|17520414|P3|Phase A|Participant Met Withdrawal Criteria|0
5076459|NCT02196506|17520415|P2|Phase A|Participant Met Withdrawal Criteria|0
5076460|NCT02196506|17520416|P1|Phase A|Participant Met Withdrawal Criteria|34
5076461|NCT02196259|17520431|P3|Overall Study|Partial data analysis|0
5076462|NCT02196259|17520432|P2|Overall Study|Partial data analysis|3
5076463|NCT02196259|17520433|P1|Overall Study|Partial data analysis|0
5076464|NCT02196259|17520431|P3|Overall Study|Researcher choice|1
5076465|NCT02196259|17520432|P2|Overall Study|Researcher choice|0
5076466|NCT02196259|17520433|P1|Overall Study|Researcher choice|0
5076467|NCT02196077|17520461|P1|Overall Study|Protocol Violation|24
5076468|NCT02196077|17520461|P1|Overall Study|Lost to Follow-up|3
5076469|NCT02196077|17520461|P1|Overall Study|Physician Decision|1
5076470|NCT02196077|17520461|P1|Overall Study|Withdrawal by Subject|14
5076471|NCT02196077|17520461|P1|Overall Study|Lack of Efficacy|1
5076472|NCT02196077|17520461|P1|Overall Study|Adverse Event|4
5076473|NCT02195986|17520511|P3|Overall Study|Non-compliance|0
5076474|NCT02195986|17520512|P2|Overall Study|Non-compliance|1
5076475|NCT02195986|17520513|P1|Overall Study|Non-compliance|0
5076476|NCT02195986|17520511|P3|Overall Study|Protocol Violation|1
5076477|NCT02195986|17520512|P2|Overall Study|Protocol Violation|1
5076478|NCT02195986|17520513|P1|Overall Study|Protocol Violation|0
5076479|NCT02195986|17520511|P3|Overall Study|Family Emergency|1
5076480|NCT02195986|17520512|P2|Overall Study|Family Emergency|0
5076481|NCT02195986|17520513|P1|Overall Study|Family Emergency|0
5076482|NCT02195986|17520511|P3|Overall Study|Withdrawal by Subject|0
5076483|NCT02195986|17520512|P2|Overall Study|Withdrawal by Subject|3
5076484|NCT02195986|17520513|P1|Overall Study|Withdrawal by Subject|0
5076485|NCT02195986|17520511|P3|Overall Study|Adverse Event|0
5076486|NCT02195986|17520512|P2|Overall Study|Adverse Event|0
5076487|NCT02195986|17520513|P1|Overall Study|Adverse Event|3
5076488|NCT02195869|17520536|P1|Overall Study|Noncompliance with study drug|2
5076489|NCT02195869|17520536|P1|Overall Study|Study Terminated by Sponsor|7
5076490|NCT02195869|17520536|P1|Overall Study|Physician Decision|4
5076491|NCT02195869|17520536|P1|Overall Study|Withdrawal by Subject|7
5076492|NCT02195869|17520536|P1|Overall Study|Adverse Event|15
5076493|NCT02195869|17520536|P1|Overall Study|Malignancy Progression/relapse|2
5076494|NCT02195869|17520536|P1|Overall Study|cGVHD Progression|5
5076495|NCT02195700|17520558|P2|Overall Study|Lost to Follow-up|1
5076496|NCT02195700|17520559|P1|Overall Study|Lost to Follow-up|1
5076497|NCT02195700|17520558|P2|Overall Study|Withdrawal by Subject|2
5076498|NCT02195700|17520559|P1|Overall Study|Withdrawal by Subject|3
5076499|NCT02195700|17520558|P2|Overall Study|Adverse Event|2
5076500|NCT02195700|17520559|P1|Overall Study|Adverse Event|1
5076501|NCT02195700|17520558|P2|Overall Study|Noncompliance|0
5076502|NCT02195700|17520559|P1|Overall Study|Noncompliance|1
5076503|NCT02195700|17520558|P2|Overall Study|Protocol Violation|2
5076504|NCT02195700|17520559|P1|Overall Study|Protocol Violation|0
5076505|NCT02195687|17520581|P2|Overall Study|Lost to Follow-up|1
5076506|NCT02195687|17520582|P1|Overall Study|Lost to Follow-up|4
5076507|NCT02195687|17520581|P2|Overall Study|Personal Reasons|1
5076508|NCT02195687|17520582|P1|Overall Study|Personal Reasons|1
5076509|NCT02195583|17520607|P1|Overall Study|Other Reason|2
5076510|NCT02195583|17520607|P1|Overall Study|Adverse Event|2
5076511|NCT02195583|17520607|P1|Overall Study|Withdrawal by Subject|4
5076512|NCT02195583|17520607|P1|Overall Study|Lost to Follow-up|1
5076513|NCT02195531|17520642|P3|Overall Study|Withdrawal by Subject|1
5076514|NCT02195531|17520643|P2|Overall Study|Withdrawal by Subject|1
5076515|NCT02195531|17520644|P1|Overall Study|Withdrawal by Subject|1
5076516|NCT02195518|17520669|P1|Overall Study|Lost to Follow-up|1
5076517|NCT02195518|17520669|P1|Overall Study|Withdrawal by Subject|1
5076518|NCT02195518|17520669|P1|Overall Study|Pregnancy|2
5076519|NCT02195518|17520669|P1|Overall Study|Protocol Violation|4
5076520|NCT02195518|17520669|P1|Overall Study|Adverse Event|1
5076521|NCT02195479|17520692|P2|Overall Study|Ongoing|297
5076522|NCT02195479|17520693|P1|Overall Study|Ongoing|291
5076523|NCT02195479|17520692|P2|Overall Study|Other|2
5076524|NCT02195479|17520693|P1|Overall Study|Other|2
5076525|NCT02195479|17520692|P2|Overall Study|Withdrawal by Subject|6
5076526|NCT02195479|17520693|P1|Overall Study|Withdrawal by Subject|11
5076527|NCT02195479|17520692|P2|Overall Study|Physician Decision|0
5076528|NCT02195479|17520693|P1|Overall Study|Physician Decision|1
5076529|NCT02195479|17520692|P2|Overall Study|Death|45
5076530|NCT02195479|17520693|P1|Overall Study|Death|48
5076531|NCT02195479|17520692|P2|Overall Study|Lost to Follow-up|0
5076532|NCT02195479|17520693|P1|Overall Study|Lost to Follow-up|3
5076533|NCT02195427|17520731|P2|Overall Study|Conditional re-treatment at W52|1
5076534|NCT02195427|17520732|P1|Overall Study|Conditional re-treatment at W52|2
5076535|NCT02195427|17520731|P2|Overall Study|Protocol Violation|14
5076536|NCT02195427|17520732|P1|Overall Study|Protocol Violation|7
5076537|NCT02195427|17520731|P2|Overall Study|Lost to Follow-up|1
5076538|NCT02195427|17520732|P1|Overall Study|Lost to Follow-up|0
5076539|NCT02195427|17520731|P2|Overall Study|Withdrawal by Subject|2
5076540|NCT02195427|17520732|P1|Overall Study|Withdrawal by Subject|4
5076541|NCT02195427|17520731|P2|Overall Study|Did not consent to study extension|9
5076542|NCT02195427|17520732|P1|Overall Study|Did not consent to study extension|13
5076543|NCT02195011|17521097|P2|Overall Study|Withdrawal by Subject|0
5076544|NCT02195011|17521098|P1|Overall Study|Withdrawal by Subject|3
5076545|NCT02195011|17521097|P2|Overall Study|Progressive Disease|1
5076546|NCT02195011|17521098|P1|Overall Study|Progressive Disease|18
5076547|NCT02195011|17521097|P2|Overall Study|Adverse Event|0
5076548|NCT02195011|17521098|P1|Overall Study|Adverse Event|4
5076549|NCT02194998|17521114|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
5076550|NCT02194998|17521115|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
5076551|NCT02194998|17521116|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
5076552|NCT02194998|17521117|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
5076553|NCT02194998|17521114|P4|On-HCV Treatment|Did not pick up study medication|0
5076554|NCT02194998|17521115|P3|On-HCV Treatment|Did not pick up study medication|0
5076555|NCT02194998|17521116|P2|On-HCV Treatment|Did not pick up study medication|1
5076556|NCT02194998|17521117|P1|On-HCV Treatment|Did not pick up study medication|0
5076557|NCT02194933|17521181|P2|Overall Study|Lack of Efficacy|2
5076558|NCT02194933|17521182|P1|Overall Study|Lack of Efficacy|1
5076559|NCT02194933|17521181|P2|Overall Study|Withdrawal by Subject|2
5076560|NCT02194933|17521182|P1|Overall Study|Withdrawal by Subject|0
5076561|NCT02194933|17521181|P2|Overall Study|Participant met withdrawal criteria|3
5076562|NCT02194933|17521182|P1|Overall Study|Participant met withdrawal criteria|1
5076563|NCT02194933|17521181|P2|Overall Study|Lost to Follow-up|2
5076564|NCT02194933|17521182|P1|Overall Study|Lost to Follow-up|1
5076565|NCT02194699|17521236|P2|With Potential to Receive 52 Weeks of IP|Other|16
5076566|NCT02194699|17521237|P1|With Potential to Receive 52 Weeks of IP|Other|24
5076567|NCT02194699|17521236|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
5076568|NCT02194699|17521237|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
5076569|NCT02194699|17521236|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
5076570|NCT02194699|17521237|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
5076571|NCT02194699|17521236|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
5076572|NCT02194699|17521237|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
5076573|NCT02194699|17521236|P2|With Potential to Receive 52 Weeks of IP|Death|3
5076574|NCT02194699|17521237|P1|With Potential to Receive 52 Weeks of IP|Death|1
5076575|NCT02194699|17521236|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
5076576|NCT02194699|17521237|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
5076577|NCT02194699|17521236|P2|Randomised|Duplicate patient|1
5076578|NCT02194699|17521237|P1|Randomised|Duplicate patient|2
5076579|NCT02194699|17521236|P2|Randomised|Without potential for 52 weeks of IP|5
5076580|NCT02194699|17521237|P1|Randomised|Without potential for 52 weeks of IP|5
5076581|NCT02194699|17521236|P2|Randomised|Did not receive treatment|5
5076582|NCT02194699|17521237|P1|Randomised|Did not receive treatment|1
5076583|NCT02194621|17521345|P3|Overall Study|Withdrawal by Subject|7
5076584|NCT02194621|17521346|P2|Overall Study|Withdrawal by Subject|4
5076585|NCT02194621|17521347|P1|Overall Study|Withdrawal by Subject|4
5076586|NCT02194621|17521345|P3|Overall Study|6 withdrew prior to randomization|2
5076587|NCT02194621|17521346|P2|Overall Study|6 withdrew prior to randomization|2
5076588|NCT02194621|17521347|P1|Overall Study|6 withdrew prior to randomization|2
5076589|NCT02194465|17521371|P7|Overall Study|Discontinued follow-up period|0
5076590|NCT02194465|17521372|P6|Overall Study|Discontinued follow-up period|0
5076591|NCT02194465|17521373|P5|Overall Study|Discontinued follow-up period|2
5076592|NCT02194465|17521374|P4|Overall Study|Discontinued follow-up period|0
5076593|NCT02194465|17521375|P3|Overall Study|Discontinued follow-up period|1
5076594|NCT02194465|17521376|P2|Overall Study|Discontinued follow-up period|2
5076595|NCT02194465|17521377|P1|Overall Study|Discontinued follow-up period|0
5076596|NCT02194465|17521371|P7|Overall Study|Withdrawal by Subject|2
5076597|NCT02194465|17521372|P6|Overall Study|Withdrawal by Subject|1
5076598|NCT02194465|17521373|P5|Overall Study|Withdrawal by Subject|2
5076599|NCT02194465|17521374|P4|Overall Study|Withdrawal by Subject|2
5076600|NCT02194465|17521375|P3|Overall Study|Withdrawal by Subject|1
5076601|NCT02194465|17521376|P2|Overall Study|Withdrawal by Subject|3
5076602|NCT02194465|17521377|P1|Overall Study|Withdrawal by Subject|1
5076603|NCT02194465|17521371|P7|Overall Study|Protocol Violation|0
5076604|NCT02194465|17521372|P6|Overall Study|Protocol Violation|0
5076605|NCT02194465|17521373|P5|Overall Study|Protocol Violation|1
5076606|NCT02194465|17521374|P4|Overall Study|Protocol Violation|1
5076607|NCT02194465|17521375|P3|Overall Study|Protocol Violation|2
5076608|NCT02194465|17521376|P2|Overall Study|Protocol Violation|1
5076609|NCT02194465|17521377|P1|Overall Study|Protocol Violation|1
5076610|NCT02194465|17521371|P7|Overall Study|Physician Decision|0
5076611|NCT02194465|17521372|P6|Overall Study|Physician Decision|0
5076612|NCT02194465|17521373|P5|Overall Study|Physician Decision|0
5076613|NCT02194465|17521374|P4|Overall Study|Physician Decision|0
5076614|NCT02194465|17521375|P3|Overall Study|Physician Decision|0
5076615|NCT02194465|17521376|P2|Overall Study|Physician Decision|0
5076616|NCT02194465|17521377|P1|Overall Study|Physician Decision|1
5076617|NCT02194465|17521371|P7|Overall Study|Lost to Follow-up|0
5076618|NCT02194465|17521372|P6|Overall Study|Lost to Follow-up|1
5076619|NCT02194465|17521373|P5|Overall Study|Lost to Follow-up|0
5076620|NCT02194465|17521374|P4|Overall Study|Lost to Follow-up|1
5076621|NCT02194465|17521375|P3|Overall Study|Lost to Follow-up|0
5076622|NCT02194465|17521376|P2|Overall Study|Lost to Follow-up|0
5076623|NCT02194465|17521377|P1|Overall Study|Lost to Follow-up|0
5076624|NCT02194465|17521371|P7|Overall Study|Adverse Event|0
5076625|NCT02194465|17521372|P6|Overall Study|Adverse Event|2
5076626|NCT02194465|17521373|P5|Overall Study|Adverse Event|4
5076627|NCT02194465|17521374|P4|Overall Study|Adverse Event|4
5076628|NCT02194465|17521375|P3|Overall Study|Adverse Event|4
5076629|NCT02194465|17521376|P2|Overall Study|Adverse Event|1
5076630|NCT02194465|17521377|P1|Overall Study|Adverse Event|6
5076631|NCT02194062|17521434|P3|Overall Study|Lost to Follow-up|5
5076632|NCT02194062|17521435|P2|Overall Study|Lost to Follow-up|2
5076633|NCT02194062|17521436|P1|Overall Study|Lost to Follow-up|2
5076634|NCT02193880|17521447|P1|Overall Study|patients did not collect enough HPC|3
5076635|NCT02193867|17521452|P1|Overall Study|Sponsor Study Termination|2
5076636|NCT02193867|17521452|P1|Overall Study|Death|2
5076637|NCT02193828|17521470|P4|Overall Study|Withdrawal by Subject|1
5076638|NCT02193828|17521471|P3|Overall Study|Withdrawal by Subject|1
5076639|NCT02193828|17521472|P2|Overall Study|Withdrawal by Subject|0
5076640|NCT02193828|17521473|P1|Overall Study|Withdrawal by Subject|0
5076641|NCT02193776|17521550|P4|Overall Study|Adverse event/Specific toxicity|2
5076642|NCT02193776|17521551|P3|Overall Study|Adverse event/Specific toxicity|2
5076643|NCT02193776|17521552|P2|Overall Study|Adverse event/Specific toxicity|5
5076644|NCT02193776|17521553|P1|Overall Study|Adverse event/Specific toxicity|5
5076645|NCT02193776|17521550|P4|Overall Study|Death|0
5076646|NCT02193776|17521551|P3|Overall Study|Death|0
5076647|NCT02193776|17521552|P2|Overall Study|Death|0
5076648|NCT02193776|17521553|P1|Overall Study|Death|1
5076649|NCT02193776|17521550|P4|Overall Study|Investigator/Sponsor decision|0
5076650|NCT02193776|17521551|P3|Overall Study|Investigator/Sponsor decision|0
5076651|NCT02193776|17521552|P2|Overall Study|Investigator/Sponsor decision|1
5076652|NCT02193776|17521553|P1|Overall Study|Investigator/Sponsor decision|1
5076653|NCT02193776|17521550|P4|Overall Study|Failure to comply with protocol|0
5076654|NCT02193776|17521551|P3|Overall Study|Failure to comply with protocol|0
5076655|NCT02193776|17521552|P2|Overall Study|Failure to comply with protocol|1
5076656|NCT02193776|17521553|P1|Overall Study|Failure to comply with protocol|0
5076657|NCT02193776|17521550|P4|Overall Study|Consent withdrawn|0
5076658|NCT02193776|17521551|P3|Overall Study|Consent withdrawn|0
5076659|NCT02193776|17521552|P2|Overall Study|Consent withdrawn|0
5076660|NCT02193776|17521553|P1|Overall Study|Consent withdrawn|1
5076661|NCT02193178|17521580|P1|Overall Study|Dry eyes|1
5076662|NCT02193178|17521580|P1|Overall Study|Lost to Follow-up|1
5076663|NCT02193165|17521630|P3|6 Week Product Use|Lost to Follow-up|0
5076664|NCT02193165|17521631|P2|6 Week Product Use|Lost to Follow-up|1
5076665|NCT02193165|17521632|P1|6 Week Product Use|Lost to Follow-up|0
5076666|NCT02193165|17521630|P3|4 Week Product Use|Lost to Follow-up|1
5076667|NCT02193165|17521631|P2|4 Week Product Use|Lost to Follow-up|1
5076668|NCT02193165|17521632|P1|4 Week Product Use|Lost to Follow-up|1
5076669|NCT02193087|17521667|P4|Overall Study|Did Not Receive Any Vaccination|1
5076670|NCT02193087|17521668|P3|Overall Study|Did Not Receive Any Vaccination|0
5076671|NCT02193087|17521669|P2|Overall Study|Did Not Receive Any Vaccination|3
5076672|NCT02193087|17521670|P1|Overall Study|Did Not Receive Any Vaccination|2
5076673|NCT02193087|17521667|P4|Overall Study|Other Reason Not Specified|9
5076674|NCT02193087|17521668|P3|Overall Study|Other Reason Not Specified|1
5076675|NCT02193087|17521669|P2|Overall Study|Other Reason Not Specified|2
5076676|NCT02193087|17521670|P1|Overall Study|Other Reason Not Specified|7
5076677|NCT02193087|17521667|P4|Overall Study|Withdrawal by Subject|19
5076678|NCT02193087|17521668|P3|Overall Study|Withdrawal by Subject|1
5076679|NCT02193087|17521669|P2|Overall Study|Withdrawal by Subject|3
5076680|NCT02193087|17521670|P1|Overall Study|Withdrawal by Subject|10
5076681|NCT02193087|17521667|P4|Overall Study|Protocol Violation|2
5076682|NCT02193087|17521668|P3|Overall Study|Protocol Violation|1
5076683|NCT02193087|17521669|P2|Overall Study|Protocol Violation|0
5076684|NCT02193087|17521670|P1|Overall Study|Protocol Violation|2
5076685|NCT02193087|17521667|P4|Overall Study|Lost to Follow-up|37
5076686|NCT02193087|17521668|P3|Overall Study|Lost to Follow-up|4
5076687|NCT02193087|17521669|P2|Overall Study|Lost to Follow-up|6
5076688|NCT02193087|17521670|P1|Overall Study|Lost to Follow-up|14
5076689|NCT02193087|17521667|P4|Overall Study|Adverse Event|11
5076690|NCT02193087|17521668|P3|Overall Study|Adverse Event|0
5076691|NCT02193087|17521669|P2|Overall Study|Adverse Event|0
5076692|NCT02193087|17521670|P1|Overall Study|Adverse Event|2
5076693|NCT02193074|17521715|P2|Overall Study|Adverse Event|13
5076694|NCT02193074|17521716|P1|Overall Study|Adverse Event|16
5076695|NCT02193074|17521715|P2|Overall Study|Withdrawal by Subject|2
5076696|NCT02193074|17521716|P1|Overall Study|Withdrawal by Subject|1
5076697|NCT02192905|17521748|P1|Overall Study|Lost to Follow-up|1
5076698|NCT02192606|17521816|P2|Overall Study|3D equipment rep unable to join|1
5076699|NCT02192606|17521817|P1|Overall Study|3D equipment rep unable to join|0
5076700|NCT02192606|17521816|P2|Overall Study|Physician Decision|2
5076701|NCT02192606|17521817|P1|Overall Study|Physician Decision|1
5076702|NCT02192606|17521816|P2|Overall Study|surgery type was changed|1
5076703|NCT02192606|17521817|P1|Overall Study|surgery type was changed|1
5076704|NCT02192190|17521865|P6|Overall Study|Inadequate Pain Relief|0
5076705|NCT02192190|17521866|P5|Overall Study|Inadequate Pain Relief|0
5076706|NCT02192190|17521867|P4|Overall Study|Inadequate Pain Relief|0
5076707|NCT02192190|17521868|P3|Overall Study|Inadequate Pain Relief|1
5076708|NCT02192190|17521869|P2|Overall Study|Inadequate Pain Relief|1
5076709|NCT02192190|17521870|P1|Overall Study|Inadequate Pain Relief|0
5076710|NCT02192190|17521865|P6|Overall Study|Positive Drug Screen|0
5076711|NCT02192190|17521866|P5|Overall Study|Positive Drug Screen|0
5076712|NCT02192190|17521867|P4|Overall Study|Positive Drug Screen|1
5076713|NCT02192190|17521868|P3|Overall Study|Positive Drug Screen|0
5076714|NCT02192190|17521869|P2|Overall Study|Positive Drug Screen|0
5076715|NCT02192190|17521870|P1|Overall Study|Positive Drug Screen|0
5076716|NCT02192190|17521865|P6|Overall Study|Could not Keep Visit Schedule|0
5076717|NCT02192190|17521866|P5|Overall Study|Could not Keep Visit Schedule|0
5076718|NCT02192190|17521867|P4|Overall Study|Could not Keep Visit Schedule|0
5076719|NCT02192190|17521868|P3|Overall Study|Could not Keep Visit Schedule|0
5076720|NCT02192190|17521869|P2|Overall Study|Could not Keep Visit Schedule|0
5076721|NCT02192190|17521870|P1|Overall Study|Could not Keep Visit Schedule|1
5076722|NCT02192190|17521865|P6|Overall Study|Withdrawal by Subject|3
5076723|NCT02192190|17521866|P5|Overall Study|Withdrawal by Subject|5
5076724|NCT02192190|17521867|P4|Overall Study|Withdrawal by Subject|1
5076725|NCT02192190|17521868|P3|Overall Study|Withdrawal by Subject|2
5076726|NCT02192190|17521869|P2|Overall Study|Withdrawal by Subject|1
5076727|NCT02192190|17521870|P1|Overall Study|Withdrawal by Subject|4
5076728|NCT02192190|17521865|P6|Overall Study|Terminated by Sponsor|23
5076729|NCT02192190|17521866|P5|Overall Study|Terminated by Sponsor|21
5076730|NCT02192190|17521867|P4|Overall Study|Terminated by Sponsor|23
5076731|NCT02192190|17521868|P3|Overall Study|Terminated by Sponsor|20
5076732|NCT02192190|17521869|P2|Overall Study|Terminated by Sponsor|23
5076733|NCT02192190|17521870|P1|Overall Study|Terminated by Sponsor|43
5076734|NCT02192190|17521865|P6|Overall Study|Physician Decision|0
5076735|NCT02192190|17521866|P5|Overall Study|Physician Decision|0
5076736|NCT02192190|17521867|P4|Overall Study|Physician Decision|0
5076737|NCT02192190|17521868|P3|Overall Study|Physician Decision|0
5076738|NCT02192190|17521869|P2|Overall Study|Physician Decision|0
5076739|NCT02192190|17521870|P1|Overall Study|Physician Decision|2
5076740|NCT02192190|17521865|P6|Overall Study|Lost to Follow-up|3
5076741|NCT02192190|17521866|P5|Overall Study|Lost to Follow-up|4
5076742|NCT02192190|17521867|P4|Overall Study|Lost to Follow-up|1
5076743|NCT02192190|17521868|P3|Overall Study|Lost to Follow-up|2
5076744|NCT02192190|17521869|P2|Overall Study|Lost to Follow-up|3
5076745|NCT02192190|17521870|P1|Overall Study|Lost to Follow-up|3
5076746|NCT02192190|17521865|P6|Overall Study|Adverse Event|0
5076747|NCT02192190|17521866|P5|Overall Study|Adverse Event|0
5076748|NCT02192190|17521867|P4|Overall Study|Adverse Event|0
5076749|NCT02192190|17521868|P3|Overall Study|Adverse Event|0
5076750|NCT02192190|17521869|P2|Overall Study|Adverse Event|1
5076751|NCT02192190|17521870|P1|Overall Study|Adverse Event|1
5076752|NCT02192164|17521914|P1|Overall Study|Did not meet the exclusion criteria|1
5076753|NCT02192164|17521914|P1|Overall Study|Physician Decision|4
5076754|NCT02192164|17521914|P1|Overall Study|Withdrawal by Subject|1
5076755|NCT02192164|17521914|P1|Overall Study|Other|8
5076756|NCT02192099|17521930|P1|Overall Study|Miscellaneous Reasons|5
5076757|NCT02192099|17521930|P1|Overall Study|Withdrawal by Subject|11
5076758|NCT02192099|17521930|P1|Overall Study|Study Terminated by Sponsor|32
5076759|NCT02192099|17521930|P1|Overall Study|Protocol Violation|8
5076760|NCT02192099|17521930|P1|Overall Study|Pregnancy|1
5076761|NCT02192099|17521930|P1|Overall Study|Physician Decision|1
5076762|NCT02192099|17521930|P1|Overall Study|Lost to Follow-up|2
5076763|NCT02192099|17521930|P1|Overall Study|Adverse Event|1
5076764|NCT02191618|17521959|P1|Overall Study|Missed Visit|4
5076765|NCT02191618|17521959|P1|Overall Study|Withdrawal by Subject|3
5076766|NCT02191605|17521969|P5|Overall Study|Lost to Follow-up|4
5076767|NCT02191605|17521970|P4|Overall Study|Lost to Follow-up|3
5076768|NCT02191605|17521971|P3|Overall Study|Lost to Follow-up|7
5076769|NCT02191605|17521972|P2|Overall Study|Lost to Follow-up|4
5076770|NCT02191605|17521973|P1|Overall Study|Lost to Follow-up|9
5076771|NCT02191579|17521992|P2|Treatment 2|Multiple Reasons Specified|25
5076772|NCT02191579|17521993|P1|Treatment 2|Multiple Reasons Specified|0
5076773|NCT02191579|17521992|P2|Treatment 1|Multiple Reasons Specified|58
5076774|NCT02191579|17521993|P1|Treatment 1|Multiple Reasons Specified|27
5076775|NCT02191397|17522007|P2|Overall Study|Withdrawal by Subject|27
5076776|NCT02191397|17522008|P1|Overall Study|Withdrawal by Subject|22
5076777|NCT02191397|17522007|P2|Overall Study|Physician Decision|3
5076778|NCT02191397|17522008|P1|Overall Study|Physician Decision|8
5076779|NCT02191397|17522007|P2|Overall Study|Lost to Follow-up|11
5076780|NCT02191397|17522008|P1|Overall Study|Lost to Follow-up|10
5076781|NCT02191397|17522007|P2|Overall Study|Met protocol-defined stopping criteria|4
5076782|NCT02191397|17522008|P1|Overall Study|Met protocol-defined stopping criteria|5
5076783|NCT02191397|17522007|P2|Overall Study|Protocol Violation|3
5076784|NCT02191397|17522008|P1|Overall Study|Protocol Violation|0
5076785|NCT02191397|17522007|P2|Overall Study|Lack of Efficacy|5
5076786|NCT02191397|17522008|P1|Overall Study|Lack of Efficacy|10
5076787|NCT02191397|17522007|P2|Overall Study|Adverse Event|17
5076788|NCT02191397|17522008|P1|Overall Study|Adverse Event|28
5076789|NCT02191267|17522069|P3|Overall Study|Withdrawal by Subject|0
5076790|NCT02191267|17522070|P2|Overall Study|Withdrawal by Subject|0
5076791|NCT02191267|17522071|P1|Overall Study|Withdrawal by Subject|1
5076792|NCT02191137|17522082|P1|Follow-up|Adverse Event|1
5076793|NCT02191137|17522082|P1|Follow-up|Ongoing/unknown|2
5076794|NCT02191137|17522082|P1|Follow-up|Lost to Follow-up|2
5076795|NCT02191137|17522082|P1|Treatment|Other|1
5076796|NCT02191137|17522082|P1|Treatment|Adverse Event|2
5076797|NCT02191137|17522082|P1|Treatment|Withdrawal by Subject|3
5076798|NCT02191137|17522082|P1|Treatment|Death|4
5076799|NCT02191046|17522112|P2|Overall Study|low compliance|1
5076800|NCT02191046|17522113|P1|Overall Study|low compliance|5
5076801|NCT02190721|17522220|P3|Overall Study|Patient was out of the city|0
5076802|NCT02190721|17522221|P2|Overall Study|Patient was out of the city|1
5076803|NCT02190721|17522222|P1|Overall Study|Patient was out of the city|0
5076804|NCT02190604|17522345|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076805|NCT02190604|17522346|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076806|NCT02190604|17522347|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076807|NCT02190604|17522348|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076808|NCT02190604|17522349|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076809|NCT02190604|17522350|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
5076810|NCT02190604|17522351|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076811|NCT02190604|17522352|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076812|NCT02190604|17522353|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076813|NCT02190604|17522354|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076814|NCT02190604|17522355|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076815|NCT02190604|17522356|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076816|NCT02190604|17522357|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076817|NCT02190604|17522358|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076818|NCT02190604|17522359|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076819|NCT02190604|17522360|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076820|NCT02190604|17522361|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076821|NCT02190604|17522362|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076822|NCT02190604|17522363|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5076823|NCT02190604|17522345|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076824|NCT02190604|17522346|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076825|NCT02190604|17522347|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076826|NCT02190604|17522348|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076827|NCT02190604|17522349|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
5076828|NCT02190604|17522350|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076829|NCT02190604|17522351|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076830|NCT02190604|17522352|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076831|NCT02190604|17522353|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076832|NCT02190604|17522354|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076833|NCT02190604|17522355|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076834|NCT02190604|17522356|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076835|NCT02190604|17522357|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076836|NCT02190604|17522358|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076837|NCT02190604|17522359|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076838|NCT02190604|17522360|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076839|NCT02190604|17522361|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076840|NCT02190604|17522362|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076841|NCT02190604|17522363|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5076842|NCT02190591|17522554|P2|Overall Study|face presentation so she was ineligible|1
5076843|NCT02190591|17522555|P1|Overall Study|face presentation so she was ineligible|0
5076844|NCT02190591|17522554|P2|Overall Study|did not use peanut ball as instructed|2
5076845|NCT02190591|17522555|P1|Overall Study|did not use peanut ball as instructed|0
5076846|NCT02190591|17522554|P2|Overall Study|Protocol Violation|0
5076847|NCT02190591|17522555|P1|Overall Study|Protocol Violation|1
5076848|NCT02190591|17522554|P2|Overall Study|Withdrawal by Subject|8
5076849|NCT02190591|17522555|P1|Overall Study|Withdrawal by Subject|1
5076850|NCT02190435|17522578|P2|Overall Study|3 consented screen fails|0
5076851|NCT02190435|17522579|P1|Overall Study|3 consented screen fails|3
5076852|NCT02190435|17522578|P2|Overall Study|First 12 patients were lead-ins|0
5076853|NCT02190435|17522579|P1|Overall Study|First 12 patients were lead-ins|12
5076854|NCT02190279|17522590|P3|Overall Study|Screening failure|1
5076855|NCT02190279|17522591|P2|Overall Study|Screening failure|0
5076856|NCT02190279|17522592|P1|Overall Study|Screening failure|0
5076857|NCT02190279|17522590|P3|Overall Study|Refused further treatment|1
5076858|NCT02190279|17522591|P2|Overall Study|Refused further treatment|0
5076859|NCT02190279|17522592|P1|Overall Study|Refused further treatment|0
5076860|NCT02190279|17522590|P3|Overall Study|Lost to Follow-up|0
5076861|NCT02190279|17522591|P2|Overall Study|Lost to Follow-up|0
5076862|NCT02190279|17522592|P1|Overall Study|Lost to Follow-up|2
5076863|NCT02190279|17522590|P3|Overall Study|Withdrawal consent|1
5076864|NCT02190279|17522591|P2|Overall Study|Withdrawal consent|0
5076865|NCT02190279|17522592|P1|Overall Study|Withdrawal consent|1
5076866|NCT02189941|17522631|P3|Overall Study|Non-compliance|1
5076867|NCT02189941|17522632|P2|Overall Study|Non-compliance|0
5076868|NCT02189941|17522633|P1|Overall Study|Non-compliance|0
5076869|NCT02189863|17522678|P2|First 2 Weeks|Motion Sickness|2
5076870|NCT02189863|17522679|P1|First 2 Weeks|Motion Sickness|4
5076871|NCT02189837|17522694|P4|Overall Study|Sponsor Decision|1
5076872|NCT02189837|17522695|P3|Overall Study|Sponsor Decision|0
5076873|NCT02189837|17522696|P2|Overall Study|Sponsor Decision|0
5076874|NCT02189837|17522697|P1|Overall Study|Sponsor Decision|0
5076875|NCT02189837|17522694|P4|Overall Study|Withdrawal by Subject|1
5076876|NCT02189837|17522695|P3|Overall Study|Withdrawal by Subject|3
5076877|NCT02189837|17522696|P2|Overall Study|Withdrawal by Subject|1
5076878|NCT02189837|17522697|P1|Overall Study|Withdrawal by Subject|2
5076879|NCT02189759|17522727|P4|Overall Study|Lost to Follow-up|5
5076880|NCT02189759|17522728|P3|Overall Study|Lost to Follow-up|2
5076881|NCT02189759|17522729|P2|Overall Study|Lost to Follow-up|0
5076882|NCT02189759|17522730|P1|Overall Study|Lost to Follow-up|0
5076883|NCT02189473|17522766|P2|Overall Study|Lost to Follow-up|2
5076884|NCT02189473|17522767|P1|Overall Study|Lost to Follow-up|1
5076885|NCT02189473|17522766|P2|Overall Study|Death|23
5076886|NCT02189473|17522767|P1|Overall Study|Death|22
5076887|NCT02189252|17522815|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5076888|NCT02189252|17522816|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5076889|NCT02189252|17522817|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
5076890|NCT02189252|17522818|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5076891|NCT02189252|17522815|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5076892|NCT02189252|17522816|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5076893|NCT02189252|17522817|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
5076894|NCT02189252|17522818|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5076895|NCT02188849|17522877|P2|Overall Study|Lost to Follow-up|8
5076896|NCT02188849|17522878|P1|Overall Study|Lost to Follow-up|3
5076897|NCT02188784|17522892|P2|Overall Study|Physician Decision|3
5076898|NCT02188784|17522893|P1|Overall Study|Physician Decision|2
5076899|NCT02188784|17522892|P2|Overall Study|Withdrawal by Subject|9
5076900|NCT02188784|17522893|P1|Overall Study|Withdrawal by Subject|3
5076901|NCT02188784|17522892|P2|Overall Study|Lost to Follow-up|0
5076902|NCT02188784|17522893|P1|Overall Study|Lost to Follow-up|1
5076903|NCT02188784|17522892|P2|Overall Study|Death|1
5076904|NCT02188784|17522893|P1|Overall Study|Death|3
5076905|NCT02188719|17522913|P4|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5076906|NCT02188719|17522914|P3|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5076907|NCT02188719|17522915|P2|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
5076908|NCT02188719|17522916|P1|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5076909|NCT02188589|17522940|P1|Overall Study|Withdrawal by Subject|5
5076910|NCT02187861|17522972|P4|Overall Study|Other|1
5076911|NCT02187861|17522973|P3|Overall Study|Other|7
5076912|NCT02187861|17522974|P2|Overall Study|Other|1
5076913|NCT02187861|17522975|P1|Overall Study|Other|0
5076914|NCT02187861|17522972|P4|Overall Study|Withdrawal by Subject|3
5076915|NCT02187861|17522973|P3|Overall Study|Withdrawal by Subject|3
5076916|NCT02187861|17522974|P2|Overall Study|Withdrawal by Subject|0
5076917|NCT02187861|17522975|P1|Overall Study|Withdrawal by Subject|0
5076918|NCT02187861|17522972|P4|Overall Study|Progressive Disease|22
5076919|NCT02187861|17522973|P3|Overall Study|Progressive Disease|19
5076920|NCT02187861|17522974|P2|Overall Study|Progressive Disease|42
5076921|NCT02187861|17522975|P1|Overall Study|Progressive Disease|4
5076922|NCT02187861|17522972|P4|Overall Study|Physician Decision|3
5076923|NCT02187861|17522973|P3|Overall Study|Physician Decision|0
5076924|NCT02187861|17522974|P2|Overall Study|Physician Decision|1
5076925|NCT02187861|17522975|P1|Overall Study|Physician Decision|0
5076926|NCT02187861|17522972|P4|Overall Study|Death|2
5076927|NCT02187861|17522973|P3|Overall Study|Death|1
5076928|NCT02187861|17522974|P2|Overall Study|Death|3
5076929|NCT02187861|17522975|P1|Overall Study|Death|0
5076930|NCT02187861|17522972|P4|Overall Study|Adverse Event|1
5076931|NCT02187861|17522973|P3|Overall Study|Adverse Event|2
5076932|NCT02187861|17522974|P2|Overall Study|Adverse Event|1
5076933|NCT02187861|17522975|P1|Overall Study|Adverse Event|2
5076934|NCT02187809|17523071|P1|Overall Study|The study was terminated|3
5076935|NCT02187783|17523081|P1|Overall Study|Study terminated by sponsor|1
5076936|NCT02187783|17523081|P1|Overall Study|Withdrawal by Subject|9
5076937|NCT02187783|17523081|P1|Overall Study|Physician Decision|2
5076938|NCT02187783|17523081|P1|Overall Study|Protocol Violation|3
5076939|NCT02187783|17523081|P1|Overall Study|Progressive disease|80
5076940|NCT02187783|17523081|P1|Overall Study|Death|3
5076941|NCT02187783|17523081|P1|Overall Study|Adverse Event|8
5076942|NCT02187744|17523092|P2|Treatment|Participant refused continued treatment|1
5076943|NCT02187744|17523093|P1|Treatment|Participant refused continued treatment|1
5076944|NCT02187744|17523092|P2|Treatment|Other|0
5076945|NCT02187744|17523093|P1|Treatment|Other|2
5076946|NCT02187744|17523092|P2|Treatment|Lost to Follow-up|1
5076947|NCT02187744|17523093|P1|Treatment|Lost to Follow-up|0
5076948|NCT02187744|17523092|P2|Treatment|Related adverse event, not serious|2
5076949|NCT02187744|17523093|P1|Treatment|Related adverse event, not serious|0
5076950|NCT02187744|17523092|P2|Treatment|Related adverse event, serious non-fatal|1
5076951|NCT02187744|17523093|P1|Treatment|Related adverse event, serious non-fatal|0
5076952|NCT02187744|17523092|P2|Treatment|Death|0
5076953|NCT02187744|17523093|P1|Treatment|Death|1
5076954|NCT02187744|17523092|P2|Study|Related adverse event, serious non-fatal|1
5076955|NCT02187744|17523093|P1|Study|Related adverse event, serious non-fatal|0
5076956|NCT02187744|17523092|P2|Study|Death|0
5076957|NCT02187744|17523093|P1|Study|Death|1
5076958|NCT02187744|17523092|P2|Study|Related adverse event, not serious|2
5076959|NCT02187744|17523093|P1|Study|Related adverse event, not serious|0
5076960|NCT02187744|17523092|P2|Study|Lost to Follow-up|2
5076961|NCT02187744|17523093|P1|Study|Lost to Follow-up|0
5076962|NCT02187744|17523092|P2|Study|Other|1
5076963|NCT02187744|17523093|P1|Study|Other|2
5076964|NCT02187744|17523092|P2|Study|Participant refused further follow-up|0
5076965|NCT02187744|17523093|P1|Study|Participant refused further follow-up|1
5076966|NCT02187471|17523113|P4|Overall Study|Other|4
5076967|NCT02187471|17523114|P3|Overall Study|Other|3
5076968|NCT02187471|17523115|P2|Overall Study|Other|5
5076969|NCT02187471|17523116|P1|Overall Study|Other|7
5076970|NCT02187471|17523113|P4|Overall Study|Withdrawal by Subject|24
5076971|NCT02187471|17523114|P3|Overall Study|Withdrawal by Subject|22
5076972|NCT02187471|17523115|P2|Overall Study|Withdrawal by Subject|29
5076973|NCT02187471|17523116|P1|Overall Study|Withdrawal by Subject|23
5076974|NCT02187471|17523113|P4|Overall Study|Adverse Event|36
5076975|NCT02187471|17523114|P3|Overall Study|Adverse Event|44
5076976|NCT02187471|17523115|P2|Overall Study|Adverse Event|34
5076977|NCT02187471|17523116|P1|Overall Study|Adverse Event|24
5076978|NCT02187471|17523113|P4|Overall Study|Lack of Efficacy|11
5076979|NCT02187471|17523114|P3|Overall Study|Lack of Efficacy|13
5076980|NCT02187471|17523115|P2|Overall Study|Lack of Efficacy|9
5076981|NCT02187471|17523116|P1|Overall Study|Lack of Efficacy|18
5076982|NCT02187471|17523113|P4|Overall Study|Missing|1
5076983|NCT02187471|17523114|P3|Overall Study|Missing|0
5076984|NCT02187471|17523115|P2|Overall Study|Missing|0
5076985|NCT02187471|17523116|P1|Overall Study|Missing|0
5076986|NCT02187471|17523113|P4|Overall Study|Protocol Violation|4
5076987|NCT02187471|17523114|P3|Overall Study|Protocol Violation|4
5076988|NCT02187471|17523115|P2|Overall Study|Protocol Violation|5
5076989|NCT02187471|17523116|P1|Overall Study|Protocol Violation|4
5076990|NCT02187172|17523172|P2|Overall Study|Physician Decision|1
5076991|NCT02187172|17523173|P1|Overall Study|Physician Decision|1
5076992|NCT02187172|17523172|P2|Overall Study|Adverse Event|1
5076993|NCT02187172|17523173|P1|Overall Study|Adverse Event|0
5076994|NCT02187172|17523172|P2|Overall Study|Lack of Efficacy|2
5076995|NCT02187172|17523173|P1|Overall Study|Lack of Efficacy|1
5076996|NCT02187172|17523172|P2|Overall Study|Lost to Follow-up|2
5076997|NCT02187172|17523173|P1|Overall Study|Lost to Follow-up|1
5076998|NCT02187159|17523341|P4|Overall Study|Other|9
5076999|NCT02187159|17523342|P3|Overall Study|Other|3
5077000|NCT02187159|17523343|P2|Overall Study|Other|7
5077001|NCT02187159|17523344|P1|Overall Study|Other|3
5077002|NCT02187159|17523341|P4|Overall Study|Withdrawal by Subject|26
5077003|NCT02187159|17523342|P3|Overall Study|Withdrawal by Subject|25
5077004|NCT02187159|17523343|P2|Overall Study|Withdrawal by Subject|28
5077005|NCT02187159|17523344|P1|Overall Study|Withdrawal by Subject|24
5077006|NCT02187159|17523341|P4|Overall Study|Adverse Event|50
5077007|NCT02187159|17523342|P3|Overall Study|Adverse Event|42
5077008|NCT02187159|17523343|P2|Overall Study|Adverse Event|33
5077009|NCT02187159|17523344|P1|Overall Study|Adverse Event|28
5077010|NCT02187159|17523341|P4|Overall Study|Lack of Efficacy|7
5077011|NCT02187159|17523342|P3|Overall Study|Lack of Efficacy|4
5077012|NCT02187159|17523343|P2|Overall Study|Lack of Efficacy|5
5077013|NCT02187159|17523344|P1|Overall Study|Lack of Efficacy|10
5077014|NCT02187159|17523341|P4|Overall Study|Protocol Violation|4
5077015|NCT02187159|17523342|P3|Overall Study|Protocol Violation|3
5077016|NCT02187159|17523343|P2|Overall Study|Protocol Violation|6
5077017|NCT02187159|17523344|P1|Overall Study|Protocol Violation|4
5077018|NCT02187055|17523401|P3|Overall Study|Death|0
5077019|NCT02187055|17523402|P2|Overall Study|Death|0
5077020|NCT02187055|17523403|P1|Overall Study|Death|2
5077021|NCT02187055|17523401|P3|Overall Study|Adverse Event|36
5077022|NCT02187055|17523402|P2|Overall Study|Adverse Event|26
5077023|NCT02187055|17523403|P1|Overall Study|Adverse Event|21
5077024|NCT02187055|17523401|P3|Overall Study|Withdrawal by Subject|11
5077025|NCT02187055|17523402|P2|Overall Study|Withdrawal by Subject|11
5077026|NCT02187055|17523403|P1|Overall Study|Withdrawal by Subject|11
5077027|NCT02187055|17523401|P3|Overall Study|Pregnancy|0
5077028|NCT02187055|17523402|P2|Overall Study|Pregnancy|1
5077029|NCT02187055|17523403|P1|Overall Study|Pregnancy|3
5077030|NCT02187055|17523401|P3|Overall Study|Protocol Violation|4
5077031|NCT02187055|17523402|P2|Overall Study|Protocol Violation|9
5077032|NCT02187055|17523403|P1|Overall Study|Protocol Violation|9
5077033|NCT02187055|17523401|P3|Overall Study|Other|3
5077034|NCT02187055|17523402|P2|Overall Study|Other|6
5077035|NCT02187055|17523403|P1|Overall Study|Other|5
5077036|NCT02187055|17523401|P3|Overall Study|No longer willing to participate|10
5077037|NCT02187055|17523402|P2|Overall Study|No longer willing to participate|8
5077038|NCT02187055|17523403|P1|Overall Study|No longer willing to participate|6
5077039|NCT02187055|17523401|P3|Overall Study|No longer meets eligibility criteria|0
5077040|NCT02187055|17523402|P2|Overall Study|No longer meets eligibility criteria|2
5077041|NCT02187055|17523403|P1|Overall Study|No longer meets eligibility criteria|0
5077042|NCT02187055|17523401|P3|Overall Study|Lost to Follow-up|3
5077043|NCT02187055|17523402|P2|Overall Study|Lost to Follow-up|7
5077044|NCT02187055|17523403|P1|Overall Study|Lost to Follow-up|2
5077045|NCT02187055|17523401|P3|Overall Study|Lack of Efficacy|7
5077046|NCT02187055|17523402|P2|Overall Study|Lack of Efficacy|3
5077047|NCT02187055|17523403|P1|Overall Study|Lack of Efficacy|10
5077048|NCT02187042|17523503|P2|Overall Study|Progressive disease|8
5077049|NCT02187042|17523504|P1|Overall Study|Progressive disease|4
5077050|NCT02187042|17523503|P2|Overall Study|Doctor choice|0
5077051|NCT02187042|17523504|P1|Overall Study|Doctor choice|1
5077052|NCT02187042|17523503|P2|Overall Study|Participant choice|0
5077053|NCT02187042|17523504|P1|Overall Study|Participant choice|1
5077054|NCT02187042|17523503|P2|Overall Study|Toxicity|5
5077055|NCT02187042|17523504|P1|Overall Study|Toxicity|6
5077056|NCT02187042|17523503|P2|Overall Study|Death|1
5077057|NCT02187042|17523504|P1|Overall Study|Death|1
5077058|NCT02187029|17523550|P4|Overall Study|Withdrawal by Subject|0
5077059|NCT02187029|17523551|P3|Overall Study|Withdrawal by Subject|0
5077060|NCT02187029|17523552|P2|Overall Study|Withdrawal by Subject|0
5077061|NCT02187029|17523553|P1|Overall Study|Withdrawal by Subject|1
5077062|NCT02187029|17523550|P4|Overall Study|Study Terminated by Sponsor|3
5077063|NCT02187029|17523551|P3|Overall Study|Study Terminated by Sponsor|10
5077064|NCT02187029|17523552|P2|Overall Study|Study Terminated by Sponsor|0
5077065|NCT02187029|17523553|P1|Overall Study|Study Terminated by Sponsor|0
5077066|NCT02187029|17523550|P4|Overall Study|Adverse Event|0
5077067|NCT02187029|17523551|P3|Overall Study|Adverse Event|1
5077068|NCT02187029|17523552|P2|Overall Study|Adverse Event|1
5077069|NCT02187029|17523553|P1|Overall Study|Adverse Event|0
5077070|NCT02186873|17523675|P2|Overall Study|Withdrawal by Subject|2
5077071|NCT02186873|17523676|P1|Overall Study|Withdrawal by Subject|7
5077072|NCT02186873|17523675|P2|Overall Study|Lost to Follow-up|2
5077073|NCT02186873|17523676|P1|Overall Study|Lost to Follow-up|1
5077074|NCT02186873|17523675|P2|Overall Study|Lack of Efficacy|1
5077075|NCT02186873|17523676|P1|Overall Study|Lack of Efficacy|0
5077076|NCT02186873|17523675|P2|Overall Study|Adverse Event|3
5077077|NCT02186873|17523676|P1|Overall Study|Adverse Event|1
5077078|NCT02186847|17523701|P2|Overall Study|Protocol Violation|0
5077079|NCT02186847|17523702|P1|Overall Study|Protocol Violation|3
5077080|NCT02186834|17523716|P6|Treatment at RP2D|Died prior to treatment|1
5077081|NCT02186834|17523717|P5|Treatment at RP2D|Died prior to treatment|0
5077082|NCT02186834|17523718|P4|Treatment at RP2D|Died prior to treatment|0
5077083|NCT02186834|17523719|P3|Treatment at RP2D|Died prior to treatment|0
5077084|NCT02186834|17523720|P2|Treatment at RP2D|Died prior to treatment|0
5077085|NCT02186834|17523721|P1|Treatment at RP2D|Died prior to treatment|0
5077086|NCT02186834|17523716|P6|Dose Escalation|Death|0
5077087|NCT02186834|17523717|P5|Dose Escalation|Death|0
5077088|NCT02186834|17523718|P4|Dose Escalation|Death|1
5077089|NCT02186834|17523719|P3|Dose Escalation|Death|0
5077090|NCT02186834|17523720|P2|Dose Escalation|Death|0
5077091|NCT02186834|17523721|P1|Dose Escalation|Death|0
5077092|NCT02186652|17523757|P2|Overall Study|Lost to Follow-up|0
5077093|NCT02186652|17523758|P1|Overall Study|Lost to Follow-up|2
5077094|NCT02186561|17523791|P1|1- Year Post Index Procedure Visit|Missed|1
5077095|NCT02186561|17523791|P1|1- Year Post Index Procedure Visit|Death|1
5077096|NCT02186561|17523791|P1|30-Day Post Index Procedure Visit|Death|1
5077097|NCT02186561|17523791|P1|Enrollment|Investigator Withdrew Consent|1
5077098|NCT02186561|17523791|P1|Enrollment|Withdrawal by Subject|2
5077099|NCT02186561|17523791|P1|Enrollment|Insurance Denial|2
5077100|NCT02186561|17523791|P1|Enrollment|Enrollment Cap Reached|5
5077101|NCT02186561|17523791|P1|Enrollment|Did Not Meet Inclusion Criteria|46
5077102|NCT02186301|17523811|P3|Overall Study|Other|1
5077103|NCT02186301|17523812|P2|Overall Study|Other|0
5077104|NCT02186301|17523813|P1|Overall Study|Other|0
5077105|NCT02186301|17523811|P3|Overall Study|Missing|2
5077106|NCT02186301|17523812|P2|Overall Study|Missing|0
5077107|NCT02186301|17523813|P1|Overall Study|Missing|0
5077108|NCT02186301|17523811|P3|Overall Study|Protocol Deviation|0
5077109|NCT02186301|17523812|P2|Overall Study|Protocol Deviation|2
5077110|NCT02186301|17523813|P1|Overall Study|Protocol Deviation|0
5077111|NCT02186301|17523811|P3|Overall Study|Study Terminated by Sponsor|11
5077112|NCT02186301|17523812|P2|Overall Study|Study Terminated by Sponsor|0
5077113|NCT02186301|17523813|P1|Overall Study|Study Terminated by Sponsor|1
5077114|NCT02186301|17523811|P3|Overall Study|Physician Decision|1
5077115|NCT02186301|17523812|P2|Overall Study|Physician Decision|0
5077116|NCT02186301|17523813|P1|Overall Study|Physician Decision|1
5077117|NCT02186301|17523811|P3|Overall Study|Withdrawal by Subject|3
5077118|NCT02186301|17523812|P2|Overall Study|Withdrawal by Subject|1
5077119|NCT02186301|17523813|P1|Overall Study|Withdrawal by Subject|5
5077120|NCT02186301|17523811|P3|Overall Study|Death|0
5077121|NCT02186301|17523812|P2|Overall Study|Death|0
5077122|NCT02186301|17523813|P1|Overall Study|Death|1
5077123|NCT02186301|17523811|P3|Overall Study|Adverse Event|5
5077124|NCT02186301|17523812|P2|Overall Study|Adverse Event|5
5077125|NCT02186301|17523813|P1|Overall Study|Adverse Event|5
5077126|NCT02186301|17523811|P3|Overall Study|Progressive Disease|27
5077127|NCT02186301|17523812|P2|Overall Study|Progressive Disease|22
5077128|NCT02186301|17523813|P1|Overall Study|Progressive Disease|7
5077129|NCT02186223|17523829|P1|Overall Study|Device in place less than 48 hours|9
5077130|NCT02186223|17523829|P1|Overall Study|Death|3
5077131|NCT02186223|17523829|P1|Overall Study|Unable to obtain femoral access|3
5077132|NCT02186223|17523829|P1|Overall Study|Not eligible for device placement|6
5077133|NCT02186171|17523851|P2|Overall Study|Protocol-specified Criteria|2
5077134|NCT02186171|17523852|P1|Overall Study|Protocol-specified Criteria|0
5077135|NCT02186171|17523851|P2|Overall Study|Death|2
5077136|NCT02186171|17523852|P1|Overall Study|Death|1
5077137|NCT02186171|17523851|P2|Overall Study|Lost to Follow-up|2
5077138|NCT02186171|17523852|P1|Overall Study|Lost to Follow-up|2
5077139|NCT02186171|17523851|P2|Overall Study|Withdrawal by Subject|9
5077140|NCT02186171|17523852|P1|Overall Study|Withdrawal by Subject|1
5077141|NCT02185794|17523874|P6|Overall Study|Lost to Follow-up|1
5077142|NCT02185794|17523875|P5|Overall Study|Lost to Follow-up|0
5077143|NCT02185794|17523876|P4|Overall Study|Lost to Follow-up|3
5077144|NCT02185794|17523877|P3|Overall Study|Lost to Follow-up|2
5077145|NCT02185794|17523878|P2|Overall Study|Lost to Follow-up|2
5077146|NCT02185794|17523879|P1|Overall Study|Lost to Follow-up|1
5077147|NCT02185794|17523874|P6|Overall Study|Withdrew Consent|0
5077148|NCT02185794|17523875|P5|Overall Study|Withdrew Consent|0
5077149|NCT02185794|17523876|P4|Overall Study|Withdrew Consent|2
5077150|NCT02185794|17523877|P3|Overall Study|Withdrew Consent|10
5077151|NCT02185794|17523878|P2|Overall Study|Withdrew Consent|5
5077152|NCT02185794|17523879|P1|Overall Study|Withdrew Consent|2
5077153|NCT02185794|17523874|P6|Overall Study|Investigator's Discretion|15
5077154|NCT02185794|17523875|P5|Overall Study|Investigator's Discretion|2
5077155|NCT02185794|17523876|P4|Overall Study|Investigator's Discretion|2
5077156|NCT02185794|17523877|P3|Overall Study|Investigator's Discretion|1
5077157|NCT02185794|17523878|P2|Overall Study|Investigator's Discretion|0
5077158|NCT02185794|17523879|P1|Overall Study|Investigator's Discretion|1
5077159|NCT02185794|17523874|P6|Overall Study|Enrolled but Never Dosed|0
5077160|NCT02185794|17523875|P5|Overall Study|Enrolled but Never Dosed|1
5077161|NCT02185794|17523876|P4|Overall Study|Enrolled but Never Dosed|1
5077162|NCT02185794|17523877|P3|Overall Study|Enrolled but Never Dosed|3
5077163|NCT02185794|17523878|P2|Overall Study|Enrolled but Never Dosed|6
5077164|NCT02185794|17523879|P1|Overall Study|Enrolled but Never Dosed|1
5077165|NCT02185534|17523972|P6|First Washout Period|Protocol Violation|1
5077166|NCT02185534|17523973|P5|First Washout Period|Protocol Violation|0
5077167|NCT02185534|17523974|P4|First Washout Period|Protocol Violation|0
5077168|NCT02185534|17523975|P3|First Washout Period|Protocol Violation|0
5077169|NCT02185534|17523976|P2|First Washout Period|Protocol Violation|0
5077170|NCT02185534|17523977|P1|First Washout Period|Protocol Violation|0
5077171|NCT02185534|17523972|P6|First Washout Period|Withdrawal by Subject|0
5077172|NCT02185534|17523973|P5|First Washout Period|Withdrawal by Subject|1
5077173|NCT02185534|17523974|P4|First Washout Period|Withdrawal by Subject|0
5077174|NCT02185534|17523975|P3|First Washout Period|Withdrawal by Subject|0
5077175|NCT02185534|17523976|P2|First Washout Period|Withdrawal by Subject|0
5077176|NCT02185534|17523977|P1|First Washout Period|Withdrawal by Subject|1
5077177|NCT02185534|17523972|P6|First Period|Withdrawal by Subject|0
5077178|NCT02185534|17523973|P5|First Period|Withdrawal by Subject|0
5077179|NCT02185534|17523974|P4|First Period|Withdrawal by Subject|1
5077180|NCT02185534|17523975|P3|First Period|Withdrawal by Subject|0
5077181|NCT02185534|17523976|P2|First Period|Withdrawal by Subject|0
5077182|NCT02185534|17523977|P1|First Period|Withdrawal by Subject|0
5077183|NCT02185521|17523992|P1|Overall Study|Protocol Violation|1
5077184|NCT02185521|17523992|P1|Overall Study|Withdrawal by Subject|1
5077185|NCT02185053|17524080|P3|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
5077186|NCT02185053|17524081|P2|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
5077187|NCT02185053|17524082|P1|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
5077188|NCT02185053|17524080|P3|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
5077189|NCT02185053|17524081|P2|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
5077190|NCT02185053|17524082|P1|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
5077191|NCT02185053|17524080|P3|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
5077192|NCT02185053|17524081|P2|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
5077193|NCT02185053|17524082|P1|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
5077194|NCT02185053|17524080|P3|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
5077195|NCT02185053|17524081|P2|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
5077196|NCT02185053|17524082|P1|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
5077197|NCT02185053|17524080|P3|Donepezil Dose Escalation Phase|Adverse Event|0
5077198|NCT02185053|17524081|P2|Donepezil Dose Escalation Phase|Adverse Event|1
5077199|NCT02185053|17524082|P1|Donepezil Dose Escalation Phase|Adverse Event|0
5077200|NCT02185053|17524080|P3|Donepezil Dose Escalation Phase|Cardiac symptoms|0
5077201|NCT02185053|17524081|P2|Donepezil Dose Escalation Phase|Cardiac symptoms|1
5077202|NCT02185053|17524082|P1|Donepezil Dose Escalation Phase|Cardiac symptoms|0
5077203|NCT02185053|17524080|P3|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
5077204|NCT02185053|17524081|P2|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
5077205|NCT02185053|17524082|P1|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
5077206|NCT02185053|17524080|P3|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
5077207|NCT02185053|17524081|P2|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
5077208|NCT02185053|17524082|P1|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
5077209|NCT02185040|17524096|P7|Active Treatment Extension Phase|Lost to Follow-up|2
5077210|NCT02185040|17524097|P6|Active Treatment Extension Phase|Lost to Follow-up|0
5077211|NCT02185040|17524098|P5|Active Treatment Extension Phase|Lost to Follow-up|0
5077212|NCT02185040|17524099|P4|Active Treatment Extension Phase|Lost to Follow-up|0
5077213|NCT02185040|17524100|P3|Active Treatment Extension Phase|Lost to Follow-up|0
5077214|NCT02185040|17524101|P2|Active Treatment Extension Phase|Lost to Follow-up|0
5077215|NCT02185040|17524102|P1|Active Treatment Extension Phase|Lost to Follow-up|0
5077216|NCT02185040|17524096|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
5077217|NCT02185040|17524097|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
5077218|NCT02185040|17524098|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
5077219|NCT02185040|17524099|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
5077220|NCT02185040|17524100|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
5077221|NCT02185040|17524101|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
5077222|NCT02185040|17524102|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
5077223|NCT02185040|17524096|P7|Active Treatment Extension Phase|Adverse Event|4
5077224|NCT02185040|17524097|P6|Active Treatment Extension Phase|Adverse Event|1
5077225|NCT02185040|17524098|P5|Active Treatment Extension Phase|Adverse Event|0
5077226|NCT02185040|17524099|P4|Active Treatment Extension Phase|Adverse Event|0
5077227|NCT02185040|17524100|P3|Active Treatment Extension Phase|Adverse Event|0
5077228|NCT02185040|17524101|P2|Active Treatment Extension Phase|Adverse Event|0
5077229|NCT02185040|17524102|P1|Active Treatment Extension Phase|Adverse Event|0
5077230|NCT02185040|17524096|P7|Active Treatment Extension Phase|Miscellaneous|0
5077231|NCT02185040|17524097|P6|Active Treatment Extension Phase|Miscellaneous|1
5077232|NCT02185040|17524098|P5|Active Treatment Extension Phase|Miscellaneous|0
5077233|NCT02185040|17524099|P4|Active Treatment Extension Phase|Miscellaneous|0
5077234|NCT02185040|17524100|P3|Active Treatment Extension Phase|Miscellaneous|0
5077235|NCT02185040|17524101|P2|Active Treatment Extension Phase|Miscellaneous|0
5077236|NCT02185040|17524102|P1|Active Treatment Extension Phase|Miscellaneous|0
5077237|NCT02185040|17524096|P7|Part 1 Treatment Phase|Lost to Follow-up|0
5077238|NCT02185040|17524097|P6|Part 1 Treatment Phase|Lost to Follow-up|0
5077239|NCT02185040|17524098|P5|Part 1 Treatment Phase|Lost to Follow-up|0
5077240|NCT02185040|17524099|P4|Part 1 Treatment Phase|Lost to Follow-up|0
5077241|NCT02185040|17524100|P3|Part 1 Treatment Phase|Lost to Follow-up|0
5077242|NCT02185040|17524101|P2|Part 1 Treatment Phase|Lost to Follow-up|1
5077243|NCT02185040|17524102|P1|Part 1 Treatment Phase|Lost to Follow-up|0
5077244|NCT02185040|17524096|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
5077245|NCT02185040|17524097|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
5077246|NCT02185040|17524098|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
5077247|NCT02185040|17524099|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
5077248|NCT02185040|17524100|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
5077249|NCT02185040|17524101|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
5077250|NCT02185040|17524102|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
5077251|NCT02185040|17524096|P7|Part 1 Treatment Phase|Adverse Event|0
5077252|NCT02185040|17524097|P6|Part 1 Treatment Phase|Adverse Event|0
5077253|NCT02185040|17524098|P5|Part 1 Treatment Phase|Adverse Event|3
5077254|NCT02185040|17524099|P4|Part 1 Treatment Phase|Adverse Event|2
5077255|NCT02185040|17524100|P3|Part 1 Treatment Phase|Adverse Event|0
5077256|NCT02185040|17524101|P2|Part 1 Treatment Phase|Adverse Event|0
5077257|NCT02185040|17524102|P1|Part 1 Treatment Phase|Adverse Event|1
5077258|NCT02185040|17524096|P7|Part 1 Treatment Phase|Miscellaneous|0
5077259|NCT02185040|17524097|P6|Part 1 Treatment Phase|Miscellaneous|0
5077260|NCT02185040|17524098|P5|Part 1 Treatment Phase|Miscellaneous|0
5077261|NCT02185040|17524099|P4|Part 1 Treatment Phase|Miscellaneous|0
5077262|NCT02185040|17524100|P3|Part 1 Treatment Phase|Miscellaneous|1
5077263|NCT02185040|17524101|P2|Part 1 Treatment Phase|Miscellaneous|0
5077264|NCT02185040|17524102|P1|Part 1 Treatment Phase|Miscellaneous|0
5077265|NCT02185014|17524156|P1|Overall Study|Other|4
5077266|NCT02185014|17524156|P1|Overall Study|Subject Noncompliance|1
5077267|NCT02185014|17524156|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
5077268|NCT02185014|17524156|P1|Overall Study|Lack of Efficacy|14
5077269|NCT02185014|17524156|P1|Overall Study|Lost to Follow-up|4
5077270|NCT02185014|17524156|P1|Overall Study|Withdrew Consent|8
5077271|NCT02185014|17524156|P1|Overall Study|Adverse Event|18
5077272|NCT02184988|17524160|P1|Overall Study|Lost to Follow-up|32
5077273|NCT02184988|17524160|P1|Overall Study|various other reasons|9
5077274|NCT02184988|17524160|P1|Overall Study|work scheduling issues|4
5077275|NCT02184988|17524160|P1|Overall Study|moving away/travelling/unable to complet|6
5077276|NCT02184988|17524160|P1|Overall Study|Adverse Event|2
5077277|NCT02184988|17524160|P1|Overall Study|Pregnancy|2
5077278|NCT02184611|17524218|P2|Overall Study|Protocol defined stopping criteria|1
5077279|NCT02184611|17524219|P1|Overall Study|Protocol defined stopping criteria|0
5077280|NCT02184611|17524218|P2|Overall Study|Protocol Violation|1
5077281|NCT02184611|17524219|P1|Overall Study|Protocol Violation|1
5077282|NCT02184611|17524218|P2|Overall Study|Adverse Event|5
5077283|NCT02184611|17524219|P1|Overall Study|Adverse Event|4
5077284|NCT02184611|17524218|P2|Overall Study|Withdrawal by Subject|6
5077285|NCT02184611|17524219|P1|Overall Study|Withdrawal by Subject|5
5077286|NCT02184611|17524218|P2|Overall Study|Lack of Efficacy|15
5077287|NCT02184611|17524219|P1|Overall Study|Lack of Efficacy|11
5077288|NCT02184572|17524255|P2|Overall Study|Withdrawal by Subject|9
5077289|NCT02184572|17524256|P1|Overall Study|Withdrawal by Subject|14
5077290|NCT02184572|17524255|P2|Overall Study|Traveling Outside The Country|0
5077291|NCT02184572|17524256|P1|Overall Study|Traveling Outside The Country|1
5077292|NCT02184572|17524255|P2|Overall Study|2nd blooddraw & diary card incomplete|0
5077293|NCT02184572|17524256|P1|Overall Study|2nd blooddraw & diary card incomplete|1
5077294|NCT02184572|17524255|P2|Overall Study|Loss Of Kaiser Insurance|0
5077295|NCT02184572|17524256|P1|Overall Study|Loss Of Kaiser Insurance|1
5077296|NCT02184572|17524255|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
5077297|NCT02184572|17524256|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
5077298|NCT02184572|17524255|P2|Overall Study|Lost to Follow-up|21
5077299|NCT02184572|17524256|P1|Overall Study|Lost to Follow-up|29
5077300|NCT02184455|17524317|P1|Overall Study|Lost to Follow-up|1
5077301|NCT02184442|17524328|P2|Overall Study|Withdrawal by Subject|11
5077302|NCT02184442|17524329|P1|Overall Study|Withdrawal by Subject|3
5077303|NCT02184442|17524328|P2|Overall Study|Death|65
5077304|NCT02184442|17524329|P1|Overall Study|Death|61
5077305|NCT02184195|17524349|P2|Overall Study|Other|2
5077306|NCT02184195|17524350|P1|Overall Study|Other|0
5077307|NCT02184195|17524349|P2|Overall Study|Lost to Follow-up|2
5077308|NCT02184195|17524350|P1|Overall Study|Lost to Follow-up|0
5077309|NCT02184195|17524349|P2|Overall Study|Death|29
5077310|NCT02184195|17524350|P1|Overall Study|Death|40
5077311|NCT02184195|17524349|P2|Overall Study|Eligibility criteria not fulfilled|1
5077312|NCT02184195|17524350|P1|Overall Study|Eligibility criteria not fulfilled|0
5077313|NCT02184195|17524349|P2|Overall Study|Patient decision|1
5077314|NCT02184195|17524350|P1|Overall Study|Patient decision|3
5077315|NCT02184143|17524387|P2|Overall Study|Death|0
5077316|NCT02184143|17524388|P1|Overall Study|Death|1
5077317|NCT02184143|17524387|P2|Overall Study|Lost to Follow-up|3
5077318|NCT02184143|17524388|P1|Overall Study|Lost to Follow-up|5
5077319|NCT02184143|17524387|P2|Overall Study|Withdrawal by Subject|4
5077320|NCT02184143|17524388|P1|Overall Study|Withdrawal by Subject|4
5077321|NCT02183675|17524417|P6|Treatment Period 2 (10 Days)|Adverse Event|2
5077322|NCT02183675|17524418|P5|Treatment Period 2 (10 Days)|Adverse Event|0
5077323|NCT02183675|17524419|P4|Treatment Period 2 (10 Days)|Adverse Event|0
5077324|NCT02183675|17524420|P3|Treatment Period 2 (10 Days)|Adverse Event|0
5077325|NCT02183675|17524421|P2|Treatment Period 2 (10 Days)|Adverse Event|0
5077326|NCT02183675|17524422|P1|Treatment Period 2 (10 Days)|Adverse Event|0
5077327|NCT02183519|17524446|P2|Overall Study|Did not respond to cough inducter|3
5077328|NCT02183519|17524447|P1|Overall Study|Did not respond to cough inducter|0
5077329|NCT02183519|17524446|P2|Overall Study|computer error|0
5077330|NCT02183519|17524447|P1|Overall Study|computer error|3
5077331|NCT02182999|17524455|P2|Overall Study|Physician Decision|0
5077332|NCT02182999|17524456|P1|Overall Study|Physician Decision|1
5077333|NCT02182999|17524455|P2|Overall Study|Adverse Event|3
5077334|NCT02182999|17524456|P1|Overall Study|Adverse Event|4
5077335|NCT02182973|17524472|P2|Overall Study|Withdrawal by Subject|0
5077336|NCT02182973|17524473|P1|Overall Study|Withdrawal by Subject|3
5077337|NCT02182895|17524485|P2|Overall Study|Discharged from hospital within 24 hours|4
5077338|NCT02182895|17524486|P1|Overall Study|Discharged from hospital within 24 hours|2
5077339|NCT02182843|17524506|P1|Overall Study|Adverse Event|1
5077340|NCT02182843|17524506|P1|Overall Study|Lost to Follow-up|2
5077341|NCT02182843|17524506|P1|Overall Study|Withdrawal by Subject|7
5077342|NCT02182830|17524513|P2|Overall Study|Lost to Follow-up|3
5077343|NCT02182830|17524514|P1|Overall Study|Lost to Follow-up|3
5077344|NCT02182830|17524513|P2|Overall Study|Consent withdrawn|8
5077345|NCT02182830|17524514|P1|Overall Study|Consent withdrawn|8
5077346|NCT02182830|17524513|P2|Overall Study|Trial stopped, reason missing|3
5077347|NCT02182830|17524514|P1|Overall Study|Trial stopped, reason missing|3
5077348|NCT02182830|17524513|P2|Overall Study|Not Treated|1
5077349|NCT02182830|17524514|P1|Overall Study|Not Treated|1
5077350|NCT02182440|17524559|P4|Overall Study|different, e.g adm other hospital|10
5077351|NCT02182440|17524560|P3|Overall Study|different, e.g adm other hospital|3
5077352|NCT02182440|17524561|P2|Overall Study|different, e.g adm other hospital|3
5077353|NCT02182440|17524562|P1|Overall Study|different, e.g adm other hospital|12
5077354|NCT02182440|17524559|P4|Overall Study|Withdrawal by Subject|4
5077355|NCT02182440|17524560|P3|Overall Study|Withdrawal by Subject|3
5077356|NCT02182440|17524561|P2|Overall Study|Withdrawal by Subject|1
5077357|NCT02182440|17524562|P1|Overall Study|Withdrawal by Subject|1
5077358|NCT02182440|17524559|P4|Overall Study|Physician Decision|0
5077359|NCT02182440|17524560|P3|Overall Study|Physician Decision|0
5077360|NCT02182440|17524561|P2|Overall Study|Physician Decision|0
5077361|NCT02182440|17524562|P1|Overall Study|Physician Decision|1
5077362|NCT02182440|17524559|P4|Overall Study|Protocol Violation|0
5077363|NCT02182440|17524560|P3|Overall Study|Protocol Violation|0
5077364|NCT02182440|17524561|P2|Overall Study|Protocol Violation|1
5077365|NCT02182440|17524562|P1|Overall Study|Protocol Violation|0
5077366|NCT02182440|17524559|P4|Overall Study|Death|16
5077367|NCT02182440|17524560|P3|Overall Study|Death|5
5077368|NCT02182440|17524561|P2|Overall Study|Death|8
5077369|NCT02182440|17524562|P1|Overall Study|Death|31
5077370|NCT02182440|17524559|P4|Overall Study|Adverse Event|0
5077371|NCT02182440|17524560|P3|Overall Study|Adverse Event|0
5077372|NCT02182440|17524561|P2|Overall Study|Adverse Event|1
5077373|NCT02182440|17524562|P1|Overall Study|Adverse Event|0
5077374|NCT02181842|17524601|P1|Overall Study|Case Report Forms Uncollected|2
5077375|NCT02181816|17524618|P1|Overall Study|Protocol Deviation|21
5077376|NCT02181816|17524618|P1|Overall Study|Case Report Forms Uncollected|38
5077377|NCT02181803|17524633|P9|Overall Study|Adverse Event|0
5077378|NCT02181803|17524634|P8|Overall Study|Adverse Event|0
5077379|NCT02181803|17524635|P7|Overall Study|Adverse Event|1
5077380|NCT02181803|17524636|P6|Overall Study|Adverse Event|0
5077381|NCT02181803|17524637|P5|Overall Study|Adverse Event|0
5077382|NCT02181803|17524638|P4|Overall Study|Adverse Event|1
5077383|NCT02181803|17524639|P3|Overall Study|Adverse Event|0
5077384|NCT02181803|17524640|P2|Overall Study|Adverse Event|2
5077385|NCT02181803|17524641|P1|Overall Study|Adverse Event|0
5077386|NCT02181803|17524633|P9|Overall Study|Physician Decision|0
5077387|NCT02181803|17524634|P8|Overall Study|Physician Decision|1
5077388|NCT02181803|17524635|P7|Overall Study|Physician Decision|0
5077389|NCT02181803|17524636|P6|Overall Study|Physician Decision|0
5077390|NCT02181803|17524637|P5|Overall Study|Physician Decision|0
5077391|NCT02181803|17524638|P4|Overall Study|Physician Decision|1
5077392|NCT02181803|17524639|P3|Overall Study|Physician Decision|0
5077393|NCT02181803|17524640|P2|Overall Study|Physician Decision|0
5077394|NCT02181803|17524641|P1|Overall Study|Physician Decision|0
5077395|NCT02181803|17524633|P9|Overall Study|Withdrawal by Subject|0
5077396|NCT02181803|17524634|P8|Overall Study|Withdrawal by Subject|0
5077397|NCT02181803|17524635|P7|Overall Study|Withdrawal by Subject|0
5077398|NCT02181803|17524636|P6|Overall Study|Withdrawal by Subject|0
5077399|NCT02181803|17524637|P5|Overall Study|Withdrawal by Subject|0
5077400|NCT02181803|17524638|P4|Overall Study|Withdrawal by Subject|0
5077401|NCT02181803|17524639|P3|Overall Study|Withdrawal by Subject|0
5077402|NCT02181803|17524640|P2|Overall Study|Withdrawal by Subject|2
5077403|NCT02181803|17524641|P1|Overall Study|Withdrawal by Subject|0
5077404|NCT02181790|17524792|P2|Overall Study|study terminated|0
5077405|NCT02181790|17524793|P1|Overall Study|study terminated|2
5077406|NCT02181738|17524805|P4|Overall Study|Patient Return to Home Country|0
5077407|NCT02181738|17524806|P3|Overall Study|Patient Return to Home Country|0
5077408|NCT02181738|17524807|P2|Overall Study|Patient Return to Home Country|1
5077409|NCT02181738|17524808|P1|Overall Study|Patient Return to Home Country|0
5077410|NCT02181738|17524805|P4|Overall Study|Lost to Follow-up|0
5077411|NCT02181738|17524806|P3|Overall Study|Lost to Follow-up|2
5077412|NCT02181738|17524807|P2|Overall Study|Lost to Follow-up|4
5077413|NCT02181738|17524808|P1|Overall Study|Lost to Follow-up|0
5077414|NCT02181738|17524805|P4|Overall Study|Subject Withdrew Consent|1
5077415|NCT02181738|17524806|P3|Overall Study|Subject Withdrew Consent|2
5077416|NCT02181738|17524807|P2|Overall Study|Subject Withdrew Consent|3
5077417|NCT02181738|17524808|P1|Overall Study|Subject Withdrew Consent|1
5077418|NCT02181738|17524805|P4|Overall Study|Death|1
5077419|NCT02181738|17524806|P3|Overall Study|Death|6
5077420|NCT02181738|17524807|P2|Overall Study|Death|1
5077421|NCT02181738|17524808|P1|Overall Study|Death|1
5077422|NCT02181673|17524849|P3|Week 24-Week 60|Physician Decision|1
5077423|NCT02181673|17524850|P2|Week 24-Week 60|Physician Decision|0
5077424|NCT02181673|17524851|P1|Week 24-Week 60|Physician Decision|0
5077425|NCT02181673|17524849|P3|Week 24-Week 60|Lost to Follow-up|1
5077426|NCT02181673|17524850|P2|Week 24-Week 60|Lost to Follow-up|0
5077427|NCT02181673|17524851|P1|Week 24-Week 60|Lost to Follow-up|0
5077428|NCT02181673|17524849|P3|Week 24-Week 60|Lack of Efficacy|1
5077429|NCT02181673|17524850|P2|Week 24-Week 60|Lack of Efficacy|0
5077430|NCT02181673|17524851|P1|Week 24-Week 60|Lack of Efficacy|0
5077431|NCT02181673|17524849|P3|Week 24-Week 60|Pregnancy|1
5077432|NCT02181673|17524850|P2|Week 24-Week 60|Pregnancy|0
5077433|NCT02181673|17524851|P1|Week 24-Week 60|Pregnancy|0
5077434|NCT02181673|17524849|P3|Week 24-Week 60|Withdrawal by Subject|2
5077435|NCT02181673|17524850|P2|Week 24-Week 60|Withdrawal by Subject|2
5077436|NCT02181673|17524851|P1|Week 24-Week 60|Withdrawal by Subject|0
5077437|NCT02181673|17524849|P3|Week 24-Week 60|Other|1
5077438|NCT02181673|17524850|P2|Week 24-Week 60|Other|2
5077439|NCT02181673|17524851|P1|Week 24-Week 60|Other|0
5077440|NCT02181673|17524849|P3|Week 24-Week 60|Adverse Event|10
5077441|NCT02181673|17524850|P2|Week 24-Week 60|Adverse Event|4
5077442|NCT02181673|17524851|P1|Week 24-Week 60|Adverse Event|0
5077443|NCT02181673|17524849|P3|Up to Week 24|Randomized not Treated|1
5077444|NCT02181673|17524850|P2|Up to Week 24|Randomized not Treated|0
5077445|NCT02181673|17524851|P1|Up to Week 24|Randomized not Treated|0
5077446|NCT02181673|17524849|P3|Up to Week 24|Other|3
5077447|NCT02181673|17524850|P2|Up to Week 24|Other|0
5077448|NCT02181673|17524851|P1|Up to Week 24|Other|2
5077449|NCT02181673|17524849|P3|Up to Week 24|Withdrawal by Subject|1
5077450|NCT02181673|17524850|P2|Up to Week 24|Withdrawal by Subject|0
5077451|NCT02181673|17524851|P1|Up to Week 24|Withdrawal by Subject|10
5077452|NCT02181673|17524849|P3|Up to Week 24|Physician Decision|3
5077453|NCT02181673|17524850|P2|Up to Week 24|Physician Decision|0
5077454|NCT02181673|17524851|P1|Up to Week 24|Physician Decision|0
5077455|NCT02181673|17524849|P3|Up to Week 24|Lost to Follow-up|0
5077456|NCT02181673|17524850|P2|Up to Week 24|Lost to Follow-up|0
5077457|NCT02181673|17524851|P1|Up to Week 24|Lost to Follow-up|1
5077458|NCT02181673|17524849|P3|Up to Week 24|Lack of Efficacy|0
5077459|NCT02181673|17524850|P2|Up to Week 24|Lack of Efficacy|0
5077460|NCT02181673|17524851|P1|Up to Week 24|Lack of Efficacy|1
5077461|NCT02181673|17524849|P3|Up to Week 24|Death|0
5077462|NCT02181673|17524850|P2|Up to Week 24|Death|0
5077463|NCT02181673|17524851|P1|Up to Week 24|Death|1
5077464|NCT02181673|17524849|P3|Up to Week 24|Adverse Event|3
5077465|NCT02181673|17524850|P2|Up to Week 24|Adverse Event|0
5077466|NCT02181673|17524851|P1|Up to Week 24|Adverse Event|2
5077467|NCT02181634|17524878|P1|Overall Study|Patient opted to proceed to surgery|1
5077468|NCT02181634|17524878|P1|Overall Study|Symptomatic progression|1
5077469|NCT02181634|17524878|P1|Overall Study|Max number of dose reduction|1
5077470|NCT02181634|17524878|P1|Overall Study|Ineligible|1
5077471|NCT02181634|17524878|P1|Overall Study|Treatment delayed greater than 4 weeks|3
5077472|NCT02181634|17524878|P1|Overall Study|Death|2
5077473|NCT02181634|17524878|P1|Overall Study|Withdrawal by Subject|5
5077474|NCT02181634|17524878|P1|Overall Study|Physician Decision|8
5077475|NCT02181634|17524878|P1|Overall Study|Adverse Event|17
5077476|NCT02181634|17524878|P1|Overall Study|Lack of Efficacy|33
5077477|NCT02181504|17524927|P3|Overall Study|Adverse Event|1
5077478|NCT02181504|17524928|P2|Overall Study|Adverse Event|1
5077479|NCT02181504|17524929|P1|Overall Study|Adverse Event|1
5077480|NCT02181413|17524968|P2|Overall Study|Lost to Follow-up|1
5077481|NCT02181413|17524969|P1|Overall Study|Lost to Follow-up|0
5077482|NCT02181413|17524968|P2|Overall Study|Ongoing Study Treatment|1
5077483|NCT02181413|17524969|P1|Overall Study|Ongoing Study Treatment|0
5077484|NCT02181413|17524968|P2|Overall Study|Reason Not Specified|20
5077485|NCT02181413|17524969|P1|Overall Study|Reason Not Specified|19
5077486|NCT02181413|17524968|P2|Overall Study|Withdrawal by Subject|8
5077487|NCT02181413|17524969|P1|Overall Study|Withdrawal by Subject|5
5077488|NCT02181413|17524968|P2|Overall Study|Progressive Disease|143
5077489|NCT02181413|17524969|P1|Overall Study|Progressive Disease|121
5077490|NCT02181413|17524968|P2|Overall Study|Adverse Event|24
5077491|NCT02181413|17524969|P1|Overall Study|Adverse Event|7
5077492|NCT02181296|17525014|P2|Overall Study|Lost to Follow-up|6
5077493|NCT02181296|17525015|P1|Overall Study|Lost to Follow-up|7
5077494|NCT02180867|17525137|P7|Overall Study|Refusal of further protocol therapy|0
5077495|NCT02180867|17525138|P6|Overall Study|Refusal of further protocol therapy|0
5077496|NCT02180867|17525139|P5|Overall Study|Refusal of further protocol therapy|4
5077497|NCT02180867|17525140|P4|Overall Study|Refusal of further protocol therapy|6
5077498|NCT02180867|17525141|P3|Overall Study|Refusal of further protocol therapy|2
5077499|NCT02180867|17525142|P2|Overall Study|Refusal of further protocol therapy|0
5077500|NCT02180867|17525143|P1|Overall Study|Refusal of further protocol therapy|1
5077501|NCT02180867|17525137|P7|Overall Study|Repeat Eligibility Studies|0
5077502|NCT02180867|17525138|P6|Overall Study|Repeat Eligibility Studies|0
5077503|NCT02180867|17525139|P5|Overall Study|Repeat Eligibility Studies|1
5077504|NCT02180867|17525140|P4|Overall Study|Repeat Eligibility Studies|0
5077505|NCT02180867|17525141|P3|Overall Study|Repeat Eligibility Studies|0
5077506|NCT02180867|17525142|P2|Overall Study|Repeat Eligibility Studies|0
5077507|NCT02180867|17525143|P1|Overall Study|Repeat Eligibility Studies|0
5077508|NCT02180867|17525137|P7|Overall Study|Ineligible|0
5077509|NCT02180867|17525138|P6|Overall Study|Ineligible|0
5077510|NCT02180867|17525139|P5|Overall Study|Ineligible|5
5077511|NCT02180867|17525140|P4|Overall Study|Ineligible|3
5077512|NCT02180867|17525141|P3|Overall Study|Ineligible|0
5077513|NCT02180867|17525142|P2|Overall Study|Ineligible|2
5077514|NCT02180867|17525143|P1|Overall Study|Ineligible|1
5077515|NCT02180867|17525137|P7|Overall Study|Withdrawal by Subject|0
5077516|NCT02180867|17525138|P6|Overall Study|Withdrawal by Subject|0
5077517|NCT02180867|17525139|P5|Overall Study|Withdrawal by Subject|1
5077518|NCT02180867|17525140|P4|Overall Study|Withdrawal by Subject|1
5077519|NCT02180867|17525141|P3|Overall Study|Withdrawal by Subject|0
5077520|NCT02180867|17525142|P2|Overall Study|Withdrawal by Subject|0
5077521|NCT02180867|17525143|P1|Overall Study|Withdrawal by Subject|0
5077522|NCT02180867|17525137|P7|Overall Study|Physician Decision|4
5077523|NCT02180867|17525138|P6|Overall Study|Physician Decision|3
5077524|NCT02180867|17525139|P5|Overall Study|Physician Decision|9
5077525|NCT02180867|17525140|P4|Overall Study|Physician Decision|10
5077526|NCT02180867|17525141|P3|Overall Study|Physician Decision|1
5077527|NCT02180867|17525142|P2|Overall Study|Physician Decision|3
5077528|NCT02180867|17525143|P1|Overall Study|Physician Decision|1
5077529|NCT02180867|17525137|P7|Overall Study|Lack of Efficacy|1
5077530|NCT02180867|17525138|P6|Overall Study|Lack of Efficacy|0
5077531|NCT02180867|17525139|P5|Overall Study|Lack of Efficacy|6
5077532|NCT02180867|17525140|P4|Overall Study|Lack of Efficacy|1
5077533|NCT02180867|17525141|P3|Overall Study|Lack of Efficacy|0
5077534|NCT02180867|17525142|P2|Overall Study|Lack of Efficacy|2
5077535|NCT02180867|17525143|P1|Overall Study|Lack of Efficacy|0
5077536|NCT02180867|17525137|P7|Overall Study|Death|0
5077537|NCT02180867|17525138|P6|Overall Study|Death|0
5077538|NCT02180867|17525139|P5|Overall Study|Death|1
5077539|NCT02180867|17525140|P4|Overall Study|Death|0
5077540|NCT02180867|17525141|P3|Overall Study|Death|0
5077541|NCT02180867|17525142|P2|Overall Study|Death|0
5077542|NCT02180867|17525143|P1|Overall Study|Death|0
5077543|NCT02180867|17525137|P7|Overall Study|Adverse Event|0
5077544|NCT02180867|17525138|P6|Overall Study|Adverse Event|0
5077545|NCT02180867|17525139|P5|Overall Study|Adverse Event|0
5077546|NCT02180867|17525140|P4|Overall Study|Adverse Event|5
5077547|NCT02180867|17525141|P3|Overall Study|Adverse Event|1
5077548|NCT02180867|17525142|P2|Overall Study|Adverse Event|4
5077549|NCT02180867|17525143|P1|Overall Study|Adverse Event|3
5077550|NCT02180724|17525199|P2|Overall Study|Ongoing Study|11
5077551|NCT02180724|17525200|P1|Overall Study|Ongoing Study|78
5077552|NCT02180724|17525199|P2|Overall Study|Withdrawal by Subject|2
5077553|NCT02180724|17525200|P1|Overall Study|Withdrawal by Subject|1
5077554|NCT02180724|17525199|P2|Overall Study|Lost to Follow-up|0
5077555|NCT02180724|17525200|P1|Overall Study|Lost to Follow-up|1
5077556|NCT02180724|17525199|P2|Overall Study|Death|1
5077557|NCT02180724|17525200|P1|Overall Study|Death|12
5077558|NCT02180659|17525214|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
5077559|NCT02180659|17525215|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
5077560|NCT02180659|17525214|P2|Overall Study|Withdrawal by Subject|2
5077561|NCT02180659|17525215|P1|Overall Study|Withdrawal by Subject|0
5077562|NCT02180659|17525214|P2|Overall Study|Subject incarcerated during conduct|0
5077563|NCT02180659|17525215|P1|Overall Study|Subject incarcerated during conduct|1
5077564|NCT02180659|17525214|P2|Overall Study|Lost to Follow-up|2
5077565|NCT02180659|17525215|P1|Overall Study|Lost to Follow-up|4
5077566|NCT02180659|17525214|P2|Overall Study|Adverse Event|0
5077567|NCT02180659|17525215|P1|Overall Study|Adverse Event|1
5077568|NCT02180438|17525250|P1|Overall Study|Lost to Follow-up|1
5077569|NCT02180217|17525273|P3|Overall Study|Discontinued Prior to Ext. phase|25
5077570|NCT02180217|17525274|P2|Overall Study|Discontinued Prior to Ext. phase|5
5077571|NCT02180217|17525275|P1|Overall Study|Discontinued Prior to Ext. phase|1
5077572|NCT02180217|17525273|P3|Overall Study|Subject/guardian decision|2
5077573|NCT02180217|17525274|P2|Overall Study|Subject/guardian decision|2
5077574|NCT02180217|17525275|P1|Overall Study|Subject/guardian decision|0
5077575|NCT02180217|17525273|P3|Overall Study|Withdrawal by Subject|0
5077576|NCT02180217|17525274|P2|Overall Study|Withdrawal by Subject|0
5077577|NCT02180217|17525275|P1|Overall Study|Withdrawal by Subject|1
5077578|NCT02180217|17525273|P3|Overall Study|Death|0
5077579|NCT02180217|17525274|P2|Overall Study|Death|1
5077580|NCT02180217|17525275|P1|Overall Study|Death|0
5077581|NCT02180217|17525273|P3|Overall Study|Adverse Event|5
5077582|NCT02180217|17525274|P2|Overall Study|Adverse Event|0
5077583|NCT02180217|17525275|P1|Overall Study|Adverse Event|0
5077584|NCT02180165|17525290|P4|Overall Study|Withdrawal by Subject|1
5077585|NCT02180165|17525291|P3|Overall Study|Withdrawal by Subject|2
5077586|NCT02180165|17525292|P2|Overall Study|Withdrawal by Subject|0
5077587|NCT02180165|17525293|P1|Overall Study|Withdrawal by Subject|3
5077588|NCT02180165|17525290|P4|Overall Study|Physician Decision|0
5077589|NCT02180165|17525291|P3|Overall Study|Physician Decision|5
5077590|NCT02180165|17525292|P2|Overall Study|Physician Decision|0
5077591|NCT02180165|17525293|P1|Overall Study|Physician Decision|1
5077592|NCT02180165|17525290|P4|Overall Study|Lack of Efficacy|2
5077593|NCT02180165|17525291|P3|Overall Study|Lack of Efficacy|3
5077594|NCT02180165|17525292|P2|Overall Study|Lack of Efficacy|1
5077595|NCT02180165|17525293|P1|Overall Study|Lack of Efficacy|0
5077596|NCT02180165|17525290|P4|Overall Study|Adverse Event|3
5077597|NCT02180165|17525291|P3|Overall Study|Adverse Event|18
5077598|NCT02180165|17525292|P2|Overall Study|Adverse Event|0
5077599|NCT02180165|17525293|P1|Overall Study|Adverse Event|7
5077600|NCT02180165|17525290|P4|Overall Study|Not Treated|0
5077601|NCT02180165|17525291|P3|Overall Study|Not Treated|1
5077602|NCT02180165|17525292|P2|Overall Study|Not Treated|0
5077603|NCT02180165|17525293|P1|Overall Study|Not Treated|0
5077604|NCT02180061|17525392|P2|Overall Study|Physician Decision|0
5077605|NCT02180061|17525393|P1|Overall Study|Physician Decision|1
5077606|NCT02180061|17525392|P2|Overall Study|Progressive Disease|5
5077607|NCT02180061|17525393|P1|Overall Study|Progressive Disease|15
5077608|NCT02180061|17525392|P2|Overall Study|Clinical Progression|1
5077609|NCT02180061|17525393|P1|Overall Study|Clinical Progression|5
5077610|NCT02180061|17525392|P2|Overall Study|Adverse Event|2
5077611|NCT02180061|17525393|P1|Overall Study|Adverse Event|4
5077612|NCT02179918|17525412|P5|Overall Study|Subject refused further follow-up|1
5077613|NCT02179918|17525413|P4|Overall Study|Subject refused further follow-up|0
5077614|NCT02179918|17525414|P3|Overall Study|Subject refused further follow-up|0
5077615|NCT02179918|17525415|P2|Overall Study|Subject refused further follow-up|1
5077616|NCT02179918|17525416|P1|Overall Study|Subject refused further follow-up|0
5077617|NCT02179918|17525412|P5|Overall Study|Other|1
5077618|NCT02179918|17525413|P4|Overall Study|Other|0
5077619|NCT02179918|17525414|P3|Overall Study|Other|0
5077620|NCT02179918|17525415|P2|Overall Study|Other|1
5077621|NCT02179918|17525416|P1|Overall Study|Other|0
5077622|NCT02179918|17525412|P5|Overall Study|Progressive Disease|6
5077623|NCT02179918|17525413|P4|Overall Study|Progressive Disease|2
5077624|NCT02179918|17525414|P3|Overall Study|Progressive Disease|1
5077625|NCT02179918|17525415|P2|Overall Study|Progressive Disease|1
5077626|NCT02179918|17525416|P1|Overall Study|Progressive Disease|4
5077627|NCT02179918|17525412|P5|Overall Study|Lost to Follow-up|0
5077628|NCT02179918|17525413|P4|Overall Study|Lost to Follow-up|0
5077629|NCT02179918|17525414|P3|Overall Study|Lost to Follow-up|1
5077630|NCT02179918|17525415|P2|Overall Study|Lost to Follow-up|0
5077631|NCT02179918|17525416|P1|Overall Study|Lost to Follow-up|0
5077632|NCT02179918|17525412|P5|Overall Study|Death|0
5077633|NCT02179918|17525413|P4|Overall Study|Death|1
5077634|NCT02179918|17525414|P3|Overall Study|Death|0
5077635|NCT02179918|17525415|P2|Overall Study|Death|0
5077636|NCT02179918|17525416|P1|Overall Study|Death|0
5077637|NCT02179398|17525629|P2|Overall Study|Lost to Follow-up|1
5077638|NCT02179398|17525630|P1|Overall Study|Lost to Follow-up|0
5077639|NCT02179398|17525629|P2|Overall Study|Lack of obligatory data|3
5077640|NCT02179398|17525630|P1|Overall Study|Lack of obligatory data|3
5077641|NCT02179190|17525648|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
5077642|NCT02179190|17525648|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
5077643|NCT02179190|17525648|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
5077644|NCT02179190|17525648|P1|Follow-Up Post Barrel VRD Implanted|Death|3
5077645|NCT02179190|17525648|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
5077646|NCT02179190|17525648|P1|Enrollment|Exit Prior to Device Attempt|11
5077647|NCT02179177|17525661|P2|Overall Study|Withdrawal by Subject|1
5077648|NCT02179177|17525662|P1|Overall Study|Withdrawal by Subject|1
5077649|NCT02179177|17525661|P2|Overall Study|Lost to Follow-up|1
5077650|NCT02179177|17525662|P1|Overall Study|Lost to Follow-up|1
5077651|NCT02178995|17525702|P9|Open Label|Adverse Event|0
5077652|NCT02178995|17525703|P8|Open Label|Adverse Event|0
5077653|NCT02178995|17525704|P7|Open Label|Adverse Event|0
5077654|NCT02178995|17525705|P6|Open Label|Adverse Event|0
5077655|NCT02178995|17525706|P5|Open Label|Adverse Event|0
5077656|NCT02178995|17525707|P4|Open Label|Adverse Event|0
5077657|NCT02178995|17525708|P3|Open Label|Adverse Event|0
5077658|NCT02178995|17525709|P2|Open Label|Adverse Event|0
5077659|NCT02178995|17525710|P1|Open Label|Adverse Event|2
5077660|NCT02178995|17525702|P9|Double Blind|Lost to Follow-up|0
5077661|NCT02178995|17525703|P8|Double Blind|Lost to Follow-up|1
5077662|NCT02178995|17525704|P7|Double Blind|Lost to Follow-up|0
5077663|NCT02178995|17525705|P6|Double Blind|Lost to Follow-up|0
5077664|NCT02178995|17525706|P5|Double Blind|Lost to Follow-up|0
5077665|NCT02178995|17525707|P4|Double Blind|Lost to Follow-up|0
5077666|NCT02178995|17525708|P3|Double Blind|Lost to Follow-up|0
5077667|NCT02178995|17525709|P2|Double Blind|Lost to Follow-up|1
5077668|NCT02178995|17525710|P1|Double Blind|Lost to Follow-up|0
5077669|NCT02178995|17525702|P9|Double Blind|Adverse Event|1
5077670|NCT02178995|17525703|P8|Double Blind|Adverse Event|1
5077671|NCT02178995|17525704|P7|Double Blind|Adverse Event|0
5077672|NCT02178995|17525705|P6|Double Blind|Adverse Event|1
5077673|NCT02178995|17525706|P5|Double Blind|Adverse Event|0
5077674|NCT02178995|17525707|P4|Double Blind|Adverse Event|0
5077675|NCT02178995|17525708|P3|Double Blind|Adverse Event|0
5077676|NCT02178995|17525709|P2|Double Blind|Adverse Event|0
5077677|NCT02178995|17525710|P1|Double Blind|Adverse Event|0
5077678|NCT02178787|17525818|P2|Overall Study|Physician Decision|0
5077679|NCT02178787|17525819|P1|Overall Study|Physician Decision|1
5077680|NCT02178787|17525818|P2|Overall Study|No TCD window|7
5077681|NCT02178787|17525819|P1|Overall Study|No TCD window|3
5077682|NCT02178787|17525818|P2|Overall Study|Withdrawal by Subject|2
5077683|NCT02178787|17525819|P1|Overall Study|Withdrawal by Subject|0
5077684|NCT02178787|17525818|P2|Overall Study|Lost to Follow-up|0
5077685|NCT02178787|17525819|P1|Overall Study|Lost to Follow-up|1
5077686|NCT02178722|17525832|P5|Overall Study|Participants Ongoing in study|74
5077687|NCT02178722|17525833|P4|Overall Study|Participants Ongoing in study|2
5077688|NCT02178722|17525834|P3|Overall Study|Participants Ongoing in study|4
5077689|NCT02178722|17525835|P2|Overall Study|Participants Ongoing in study|1
5077690|NCT02178722|17525836|P1|Overall Study|Participants Ongoing in study|1
5077691|NCT02178722|17525832|P5|Overall Study|Other Unspecified|1
5077692|NCT02178722|17525833|P4|Overall Study|Other Unspecified|0
5077693|NCT02178722|17525834|P3|Overall Study|Other Unspecified|0
5077694|NCT02178722|17525835|P2|Overall Study|Other Unspecified|0
5077695|NCT02178722|17525836|P1|Overall Study|Other Unspecified|0
5077696|NCT02178722|17525832|P5|Overall Study|Physician Decision|2
5077697|NCT02178722|17525833|P4|Overall Study|Physician Decision|0
5077698|NCT02178722|17525834|P3|Overall Study|Physician Decision|0
5077699|NCT02178722|17525835|P2|Overall Study|Physician Decision|0
5077700|NCT02178722|17525836|P1|Overall Study|Physician Decision|0
5077701|NCT02178722|17525832|P5|Overall Study|Study Terminated by Sponsor|65
5077702|NCT02178722|17525833|P4|Overall Study|Study Terminated by Sponsor|3
5077703|NCT02178722|17525834|P3|Overall Study|Study Terminated by Sponsor|2
5077704|NCT02178722|17525835|P2|Overall Study|Study Terminated by Sponsor|6
5077705|NCT02178722|17525836|P1|Overall Study|Study Terminated by Sponsor|1
5077706|NCT02178722|17525832|P5|Overall Study|Lost to Follow-up|11
5077707|NCT02178722|17525833|P4|Overall Study|Lost to Follow-up|2
5077708|NCT02178722|17525834|P3|Overall Study|Lost to Follow-up|0
5077709|NCT02178722|17525835|P2|Overall Study|Lost to Follow-up|0
5077710|NCT02178722|17525836|P1|Overall Study|Lost to Follow-up|0
5077711|NCT02178722|17525832|P5|Overall Study|Death|199
5077712|NCT02178722|17525833|P4|Overall Study|Death|11
5077713|NCT02178722|17525834|P3|Overall Study|Death|12
5077714|NCT02178722|17525835|P2|Overall Study|Death|13
5077715|NCT02178722|17525836|P1|Overall Study|Death|2
5077716|NCT02178722|17525832|P5|Overall Study|Participant decision|30
5077717|NCT02178722|17525833|P4|Overall Study|Participant decision|2
5077718|NCT02178722|17525834|P3|Overall Study|Participant decision|0
5077719|NCT02178722|17525835|P2|Overall Study|Participant decision|0
5077720|NCT02178722|17525836|P1|Overall Study|Participant decision|0
5077721|NCT02178709|17525848|P1|Overall Study|Disease Progression|5
5077722|NCT02178709|17525848|P1|Overall Study|Physician Decision|2
5077723|NCT02178709|17525848|P1|Overall Study|Withdrawal by Subject|2
5077724|NCT02178709|17525848|P1|Overall Study|Death|2
5077725|NCT02178709|17525848|P1|Overall Study|Adverse Event|5
5077726|NCT02178592|17525875|P2|Overall Study|Physician Decision|0
5077727|NCT02178592|17525876|P1|Overall Study|Physician Decision|1
5077728|NCT02178592|17525875|P2|Overall Study|Lost to Follow-up|3
5077729|NCT02178592|17525876|P1|Overall Study|Lost to Follow-up|11
5077730|NCT02178592|17525875|P2|Overall Study|Withdrawal by Subject|1
5077731|NCT02178592|17525876|P1|Overall Study|Withdrawal by Subject|3
5077732|NCT02178592|17525875|P2|Overall Study|Protocol Violation|2
5077733|NCT02178592|17525876|P1|Overall Study|Protocol Violation|3
5077734|NCT02178592|17525875|P2|Overall Study|Lack of Efficacy|1
5077735|NCT02178592|17525876|P1|Overall Study|Lack of Efficacy|1
5077736|NCT02178592|17525875|P2|Overall Study|Adverse Event|2
5077737|NCT02178592|17525876|P1|Overall Study|Adverse Event|0
5077738|NCT02178553|17525904|P2|Overall Study|Technical problem with injection|3
5077739|NCT02178553|17525905|P1|Overall Study|Technical problem with injection|1
5077740|NCT02178553|17525904|P2|Overall Study|Physician Decision|4
5077741|NCT02178553|17525905|P1|Overall Study|Physician Decision|0
5077742|NCT02178553|17525904|P2|Overall Study|Did not proceed to open thoracotomy|3
5077743|NCT02178553|17525905|P1|Overall Study|Did not proceed to open thoracotomy|7
5077744|NCT02178475|17525924|P1|Overall Study|Protocol-specified Criteria|99
5077745|NCT02178475|17525924|P1|Overall Study|Death|13
5077746|NCT02178475|17525924|P1|Overall Study|Lost to Follow-up|10
5077747|NCT02178475|17525924|P1|Overall Study|Withdrawal by Subject|7
5077748|NCT02178059|17525951|P2|Washout|Physician Decision|0
5077749|NCT02178059|17525952|P1|Washout|Physician Decision|1
5077750|NCT02177942|17525970|P2|Overall Study|Withdrawal by Subject|81
5077751|NCT02177942|17525971|P1|Overall Study|Withdrawal by Subject|71
5077752|NCT02177942|17525970|P2|Overall Study|Protocol Violation|6
5077753|NCT02177942|17525971|P1|Overall Study|Protocol Violation|4
5077754|NCT02177942|17525970|P2|Overall Study|Lost to Follow-up|1
5077755|NCT02177942|17525971|P1|Overall Study|Lost to Follow-up|1
5077756|NCT02177942|17525970|P2|Overall Study|Adverse Event|0
5077757|NCT02177942|17525971|P1|Overall Study|Adverse Event|1
5077758|NCT02177812|17526002|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
5077759|NCT02177812|17526003|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
5077760|NCT02177812|17526004|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
5077761|NCT02177812|17526005|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
5077762|NCT02177812|17526006|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
5077763|NCT02177812|17526007|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
5077764|NCT02177812|17526008|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
5077765|NCT02177812|17526009|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
5077766|NCT02177812|17526010|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
5077767|NCT02177812|17526002|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077768|NCT02177812|17526003|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077769|NCT02177812|17526004|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
5077770|NCT02177812|17526005|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
5077771|NCT02177812|17526006|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077772|NCT02177812|17526007|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077773|NCT02177812|17526008|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077774|NCT02177812|17526009|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077775|NCT02177812|17526010|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
5077776|NCT02177812|17526002|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5077777|NCT02177812|17526003|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
5077778|NCT02177812|17526004|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
5077779|NCT02177812|17526005|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
5077780|NCT02177812|17526006|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5077781|NCT02177812|17526007|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5077782|NCT02177812|17526008|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5077783|NCT02177812|17526009|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5077784|NCT02177812|17526010|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5077785|NCT02177786|17526227|P4|Overall Study|Missing study completion status|0
5077786|NCT02177786|17526228|P3|Overall Study|Missing study completion status|0
5077787|NCT02177786|17526229|P2|Overall Study|Missing study completion status|1
5077788|NCT02177786|17526230|P1|Overall Study|Missing study completion status|0
5077789|NCT02177786|17526227|P4|Overall Study|Progressive Disease|0
5077790|NCT02177786|17526228|P3|Overall Study|Progressive Disease|0
5077791|NCT02177786|17526229|P2|Overall Study|Progressive Disease|1
5077792|NCT02177786|17526230|P1|Overall Study|Progressive Disease|0
5077793|NCT02177786|17526227|P4|Overall Study|Protocol Violation|0
5077794|NCT02177786|17526228|P3|Overall Study|Protocol Violation|2
5077795|NCT02177786|17526229|P2|Overall Study|Protocol Violation|0
5077796|NCT02177786|17526230|P1|Overall Study|Protocol Violation|0
5077797|NCT02177786|17526227|P4|Overall Study|Non-Compliance with Study Drug|1
5077798|NCT02177786|17526228|P3|Overall Study|Non-Compliance with Study Drug|0
5077799|NCT02177786|17526229|P2|Overall Study|Non-Compliance with Study Drug|1
5077800|NCT02177786|17526230|P1|Overall Study|Non-Compliance with Study Drug|0
5077801|NCT02177786|17526227|P4|Overall Study|Lost to Follow-up|2
5077802|NCT02177786|17526228|P3|Overall Study|Lost to Follow-up|2
5077803|NCT02177786|17526229|P2|Overall Study|Lost to Follow-up|0
5077804|NCT02177786|17526230|P1|Overall Study|Lost to Follow-up|0
5077805|NCT02177786|17526227|P4|Overall Study|Death|1
5077806|NCT02177786|17526228|P3|Overall Study|Death|1
5077807|NCT02177786|17526229|P2|Overall Study|Death|1
5077808|NCT02177786|17526230|P1|Overall Study|Death|1
5077809|NCT02177786|17526227|P4|Overall Study|Adverse Event|3
5077810|NCT02177786|17526228|P3|Overall Study|Adverse Event|2
5077811|NCT02177786|17526229|P2|Overall Study|Adverse Event|1
5077812|NCT02177786|17526230|P1|Overall Study|Adverse Event|1
5077813|NCT02177786|17526227|P4|Overall Study|Progression to End Stage Renal Disease|1
5077814|NCT02177786|17526228|P3|Overall Study|Progression to End Stage Renal Disease|2
5077815|NCT02177786|17526229|P2|Overall Study|Progression to End Stage Renal Disease|3
5077816|NCT02177786|17526230|P1|Overall Study|Progression to End Stage Renal Disease|2
5077817|NCT02177786|17526227|P4|Overall Study|Withdrew Consent|5
5077818|NCT02177786|17526228|P3|Overall Study|Withdrew Consent|9
5077819|NCT02177786|17526229|P2|Overall Study|Withdrew Consent|6
5077820|NCT02177786|17526230|P1|Overall Study|Withdrew Consent|2
5077821|NCT02177266|17526253|P2|Overall Study|Withdrawal by Subject|0
5077822|NCT02177266|17526254|P1|Overall Study|Withdrawal by Subject|1
5077823|NCT02177266|17526253|P2|Overall Study|Adverse Event|1
5077824|NCT02177266|17526254|P1|Overall Study|Adverse Event|0
5077825|NCT02177136|17526276|P3|Overall Study|Protocol Violation|1
5077826|NCT02177136|17526277|P2|Overall Study|Protocol Violation|0
5077827|NCT02177136|17526278|P1|Overall Study|Protocol Violation|0
5077828|NCT02177136|17526276|P3|Overall Study|Adverse Event|3
5077829|NCT02177136|17526277|P2|Overall Study|Adverse Event|2
5077830|NCT02177136|17526278|P1|Overall Study|Adverse Event|3
5077831|NCT02177136|17526276|P3|Overall Study|Discontinued due to pruritus|0
5077832|NCT02177136|17526277|P2|Overall Study|Discontinued due to pruritus|3
5077833|NCT02177136|17526278|P1|Overall Study|Discontinued due to pruritus|1
5077834|NCT02177136|17526276|P3|Overall Study|Withdrawal by Subject|0
5077835|NCT02177136|17526277|P2|Overall Study|Withdrawal by Subject|0
5077836|NCT02177136|17526278|P1|Overall Study|Withdrawal by Subject|2
5077837|NCT02177032|17526311|P4|Overall Study|Withdrawal by Subject|0
5077838|NCT02177032|17526312|P3|Overall Study|Withdrawal by Subject|1
5077839|NCT02177032|17526313|P2|Overall Study|Withdrawal by Subject|0
5077840|NCT02177032|17526314|P1|Overall Study|Withdrawal by Subject|1
5077841|NCT02177032|17526311|P4|Overall Study|OTHER|0
5077842|NCT02177032|17526312|P3|Overall Study|OTHER|1
5077843|NCT02177032|17526313|P2|Overall Study|OTHER|0
5077844|NCT02177032|17526314|P1|Overall Study|OTHER|2
5077845|NCT02177032|17526311|P4|Overall Study|Lost to Follow-up|0
5077846|NCT02177032|17526312|P3|Overall Study|Lost to Follow-up|0
5077847|NCT02177032|17526313|P2|Overall Study|Lost to Follow-up|2
5077848|NCT02177032|17526314|P1|Overall Study|Lost to Follow-up|0
5077849|NCT02177032|17526311|P4|Overall Study|ADMINISTRATIVE REASON|0
5077850|NCT02177032|17526312|P3|Overall Study|ADMINISTRATIVE REASON|1
5077851|NCT02177032|17526313|P2|Overall Study|ADMINISTRATIVE REASON|0
5077852|NCT02177032|17526314|P1|Overall Study|ADMINISTRATIVE REASON|2
5077853|NCT02176928|17526350|P2|Overall Study|Lost to Follow-up|4
5077854|NCT02176928|17526351|P1|Overall Study|Lost to Follow-up|2
5077855|NCT02176655|17526361|P1|Overall Study|Subjects did not treat|6
5077856|NCT02176642|17526384|P2|Overall Study|Withdrawal by Subject|1
5077857|NCT02176642|17526385|P1|Overall Study|Withdrawal by Subject|0
5077858|NCT02176525|17526415|P8|Overall Study|not treated|0
5077859|NCT02176525|17526416|P7|Overall Study|not treated|0
5077860|NCT02176525|17526417|P6|Overall Study|not treated|1
5077861|NCT02176525|17526418|P5|Overall Study|not treated|0
5077862|NCT02176525|17526419|P4|Overall Study|not treated|0
5077863|NCT02176525|17526420|P3|Overall Study|not treated|0
5077864|NCT02176525|17526421|P2|Overall Study|not treated|0
5077865|NCT02176525|17526422|P1|Overall Study|not treated|1
5077866|NCT02176525|17526415|P8|Overall Study|Adverse Event|0
5077867|NCT02176525|17526416|P7|Overall Study|Adverse Event|1
5077868|NCT02176525|17526417|P6|Overall Study|Adverse Event|0
5077869|NCT02176525|17526418|P5|Overall Study|Adverse Event|1
5077870|NCT02176525|17526419|P4|Overall Study|Adverse Event|1
5077871|NCT02176525|17526420|P3|Overall Study|Adverse Event|0
5077872|NCT02176525|17526421|P2|Overall Study|Adverse Event|0
5077873|NCT02176525|17526422|P1|Overall Study|Adverse Event|0
5077874|NCT02176421|17526638|P1|Overall Study|Adverse Event|1
5077875|NCT02176421|17526638|P1|Overall Study|Lost to Follow-up|4
5077876|NCT02176356|17526670|P1|Overall Study|Other Miscellaneous Reasons|2
5077877|NCT02176356|17526670|P1|Overall Study|Personal Reasons|3
5077878|NCT02176356|17526670|P1|Overall Study|Lost to Follow-up|4
5077879|NCT02176356|17526670|P1|Overall Study|Screen Failure|14
5077880|NCT02176291|17526700|P2|Overall Study|Withdrawal by Subject|0
5077881|NCT02176291|17526701|P1|Overall Study|Withdrawal by Subject|2
5077882|NCT02176291|17526700|P2|Overall Study|non compliance with protocol|0
5077883|NCT02176291|17526701|P1|Overall Study|non compliance with protocol|2
5077884|NCT02176291|17526700|P2|Overall Study|Death|0
5077885|NCT02176291|17526701|P1|Overall Study|Death|1
5077886|NCT02176226|17526709|P1|Overall Study|Withdrew prior to treatment|6
5077887|NCT02176226|17526709|P1|Overall Study|Lost to Follow-up|3
5077888|NCT02176018|17526735|P2|Overall Study|Withdrawal by Subject|2
5077889|NCT02176018|17526736|P1|Overall Study|Withdrawal by Subject|1
5077890|NCT02176018|17526735|P2|Overall Study|Protocol Violation|1
5077891|NCT02176018|17526736|P1|Overall Study|Protocol Violation|1
5077892|NCT02176018|17526735|P2|Overall Study|Lost to Follow-up|1
5077893|NCT02176018|17526736|P1|Overall Study|Lost to Follow-up|3
5077894|NCT02176018|17526735|P2|Overall Study|Adverse Event|2
5077895|NCT02176018|17526736|P1|Overall Study|Adverse Event|0
5077896|NCT02175966|17526820|P2|Follow-up Period|Lack of Efficacy|6
5077897|NCT02175966|17526821|P1|Follow-up Period|Lack of Efficacy|10
5077898|NCT02175771|17526849|P9|Treatment Period|Other|0
5077899|NCT02175771|17526850|P8|Treatment Period|Other|2
5077900|NCT02175771|17526851|P7|Treatment Period|Other|0
5077901|NCT02175771|17526852|P6|Treatment Period|Other|0
5077902|NCT02175771|17526853|P5|Treatment Period|Other|1
5077903|NCT02175771|17526854|P4|Treatment Period|Other|3
5077904|NCT02175771|17526855|P3|Treatment Period|Other|0
5077905|NCT02175771|17526856|P2|Treatment Period|Other|1
5077906|NCT02175771|17526857|P1|Treatment Period|Other|0
5077907|NCT02175771|17526849|P9|Treatment Period|Lack of Efficacy|0
5077908|NCT02175771|17526850|P8|Treatment Period|Lack of Efficacy|1
5077909|NCT02175771|17526851|P7|Treatment Period|Lack of Efficacy|0
5077910|NCT02175771|17526852|P6|Treatment Period|Lack of Efficacy|1
5077911|NCT02175771|17526853|P5|Treatment Period|Lack of Efficacy|0
5077912|NCT02175771|17526854|P4|Treatment Period|Lack of Efficacy|0
5077913|NCT02175771|17526855|P3|Treatment Period|Lack of Efficacy|0
5077914|NCT02175771|17526856|P2|Treatment Period|Lack of Efficacy|0
5077915|NCT02175771|17526857|P1|Treatment Period|Lack of Efficacy|0
5077916|NCT02175771|17526849|P9|Treatment Period|Lost to Follow-up|2
5077917|NCT02175771|17526850|P8|Treatment Period|Lost to Follow-up|2
5077918|NCT02175771|17526851|P7|Treatment Period|Lost to Follow-up|1
5077919|NCT02175771|17526852|P6|Treatment Period|Lost to Follow-up|2
5077920|NCT02175771|17526853|P5|Treatment Period|Lost to Follow-up|1
5077921|NCT02175771|17526854|P4|Treatment Period|Lost to Follow-up|3
5077922|NCT02175771|17526855|P3|Treatment Period|Lost to Follow-up|1
5077923|NCT02175771|17526856|P2|Treatment Period|Lost to Follow-up|3
5077924|NCT02175771|17526857|P1|Treatment Period|Lost to Follow-up|0
5077925|NCT02175771|17526849|P9|Treatment Period|Disease progression|0
5077926|NCT02175771|17526850|P8|Treatment Period|Disease progression|2
5077927|NCT02175771|17526851|P7|Treatment Period|Disease progression|0
5077928|NCT02175771|17526852|P6|Treatment Period|Disease progression|0
5077929|NCT02175771|17526853|P5|Treatment Period|Disease progression|0
5077930|NCT02175771|17526854|P4|Treatment Period|Disease progression|0
5077931|NCT02175771|17526855|P3|Treatment Period|Disease progression|0
5077932|NCT02175771|17526856|P2|Treatment Period|Disease progression|0
5077933|NCT02175771|17526857|P1|Treatment Period|Disease progression|0
5077934|NCT02175771|17526849|P9|Treatment Period|Protocol Violation|0
5077935|NCT02175771|17526850|P8|Treatment Period|Protocol Violation|1
5077936|NCT02175771|17526851|P7|Treatment Period|Protocol Violation|0
5077937|NCT02175771|17526852|P6|Treatment Period|Protocol Violation|0
5077938|NCT02175771|17526853|P5|Treatment Period|Protocol Violation|0
5077939|NCT02175771|17526854|P4|Treatment Period|Protocol Violation|0
5077940|NCT02175771|17526855|P3|Treatment Period|Protocol Violation|0
5077941|NCT02175771|17526856|P2|Treatment Period|Protocol Violation|0
5077942|NCT02175771|17526857|P1|Treatment Period|Protocol Violation|0
5077943|NCT02175771|17526849|P9|Treatment Period|Noncompliance|1
5077944|NCT02175771|17526850|P8|Treatment Period|Noncompliance|0
5077945|NCT02175771|17526851|P7|Treatment Period|Noncompliance|0
5077946|NCT02175771|17526852|P6|Treatment Period|Noncompliance|0
5077947|NCT02175771|17526853|P5|Treatment Period|Noncompliance|0
5077948|NCT02175771|17526854|P4|Treatment Period|Noncompliance|0
5077949|NCT02175771|17526855|P3|Treatment Period|Noncompliance|2
5077950|NCT02175771|17526856|P2|Treatment Period|Noncompliance|1
5077951|NCT02175771|17526857|P1|Treatment Period|Noncompliance|0
5077952|NCT02175771|17526849|P9|Treatment Period|Withdrawal by Subject|2
5077953|NCT02175771|17526850|P8|Treatment Period|Withdrawal by Subject|9
5077954|NCT02175771|17526851|P7|Treatment Period|Withdrawal by Subject|2
5077955|NCT02175771|17526852|P6|Treatment Period|Withdrawal by Subject|4
5077956|NCT02175771|17526853|P5|Treatment Period|Withdrawal by Subject|2
5077957|NCT02175771|17526854|P4|Treatment Period|Withdrawal by Subject|6
5077958|NCT02175771|17526855|P3|Treatment Period|Withdrawal by Subject|3
5077959|NCT02175771|17526856|P2|Treatment Period|Withdrawal by Subject|9
5077960|NCT02175771|17526857|P1|Treatment Period|Withdrawal by Subject|0
5077961|NCT02175771|17526849|P9|Treatment Period|Adverse Event|1
5077962|NCT02175771|17526850|P8|Treatment Period|Adverse Event|0
5077963|NCT02175771|17526851|P7|Treatment Period|Adverse Event|2
5077964|NCT02175771|17526852|P6|Treatment Period|Adverse Event|3
5077965|NCT02175771|17526853|P5|Treatment Period|Adverse Event|1
5077966|NCT02175771|17526854|P4|Treatment Period|Adverse Event|1
5077967|NCT02175771|17526855|P3|Treatment Period|Adverse Event|1
5077968|NCT02175771|17526856|P2|Treatment Period|Adverse Event|2
5077969|NCT02175771|17526857|P1|Treatment Period|Adverse Event|0
5077970|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Other|0
5077971|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Other|0
5077972|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Other|0
5077973|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Other|0
5077974|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Other|0
5077975|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Other|0
5077976|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Other|0
5077977|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Other|0
5077978|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Other|8
5077979|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077980|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077981|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077982|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077983|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077984|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077985|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077986|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5077987|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
5077988|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077989|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077990|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077991|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077992|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077993|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077994|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077995|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5077996|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
5077997|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Adverse Event|0
5077998|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Adverse Event|0
5077999|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Adverse Event|0
5078000|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5078001|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5078002|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5078003|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5078004|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5078005|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Adverse Event|9
5078006|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078007|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078008|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078009|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078010|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078011|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078012|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078013|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5078014|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
5078015|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078016|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078017|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078018|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078019|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078020|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078021|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078022|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5078023|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
5078024|NCT02175771|17526849|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078025|NCT02175771|17526850|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078026|NCT02175771|17526851|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078027|NCT02175771|17526852|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078028|NCT02175771|17526853|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078029|NCT02175771|17526854|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078030|NCT02175771|17526855|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078031|NCT02175771|17526856|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5078032|NCT02175771|17526857|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
5078033|NCT02175758|17526921|P6|Treatment Phase|Adverse Event|0
5078034|NCT02175758|17526922|P5|Treatment Phase|Adverse Event|1
5078035|NCT02175758|17526923|P4|Treatment Phase|Adverse Event|0
5078036|NCT02175758|17526924|P3|Treatment Phase|Adverse Event|0
5078037|NCT02175758|17526925|P2|Treatment Phase|Adverse Event|0
5078038|NCT02175758|17526926|P1|Treatment Phase|Adverse Event|0
5078039|NCT02175758|17526921|P6|Treatment Phase|Lost to Follow-up|0
5078040|NCT02175758|17526922|P5|Treatment Phase|Lost to Follow-up|0
5078041|NCT02175758|17526923|P4|Treatment Phase|Lost to Follow-up|0
5078042|NCT02175758|17526924|P3|Treatment Phase|Lost to Follow-up|0
5078043|NCT02175758|17526925|P2|Treatment Phase|Lost to Follow-up|1
5078044|NCT02175758|17526926|P1|Treatment Phase|Lost to Follow-up|0
5078045|NCT02175745|17527029|P1|Overall Study|Not Eligible|1
5078046|NCT02175368|17527068|P1|Overall Study|Lost to Follow-up|1
5078047|NCT02175277|17527073|P1|Overall Study|Protocol-specified Criteria|1
5078048|NCT02175225|17527079|P2|Overall Study|Study drug not administered|2
5078049|NCT02175225|17527080|P1|Overall Study|Study drug not administered|1
5078050|NCT02175225|17527079|P2|Overall Study|Lost to Follow-up|7
5078051|NCT02175225|17527080|P1|Overall Study|Lost to Follow-up|6
5078052|NCT02175225|17527079|P2|Overall Study|Withdrawal by Subject|2
5078053|NCT02175225|17527080|P1|Overall Study|Withdrawal by Subject|1
5078054|NCT02175199|17527131|P2|Overall Study|Sponsor Decision|0
5078055|NCT02175199|17527132|P1|Overall Study|Sponsor Decision|1
5078056|NCT02175199|17527131|P2|Overall Study|Randomized in Error|0
5078057|NCT02175199|17527132|P1|Overall Study|Randomized in Error|1
5078058|NCT02175199|17527131|P2|Overall Study|Withdrawal by Subject|5
5078059|NCT02175199|17527132|P1|Overall Study|Withdrawal by Subject|1
5078060|NCT02175121|17527146|P5|Overall Study|Time issues|0
5078061|NCT02175121|17527147|P4|Overall Study|Time issues|0
5078062|NCT02175121|17527148|P3|Overall Study|Time issues|1
5078063|NCT02175121|17527149|P2|Overall Study|Time issues|0
5078064|NCT02175121|17527150|P1|Overall Study|Time issues|0
5078065|NCT02175121|17527146|P5|Overall Study|Schedule conflict|0
5078066|NCT02175121|17527147|P4|Overall Study|Schedule conflict|0
5078067|NCT02175121|17527148|P3|Overall Study|Schedule conflict|1
5078068|NCT02175121|17527149|P2|Overall Study|Schedule conflict|0
5078069|NCT02175121|17527150|P1|Overall Study|Schedule conflict|0
5078070|NCT02175121|17527146|P5|Overall Study|Personal emergency|1
5078071|NCT02175121|17527147|P4|Overall Study|Personal emergency|0
5078072|NCT02175121|17527148|P3|Overall Study|Personal emergency|0
5078073|NCT02175121|17527149|P2|Overall Study|Personal emergency|0
5078074|NCT02175121|17527150|P1|Overall Study|Personal emergency|0
5078075|NCT02175121|17527146|P5|Overall Study|Lost to Follow-up|0
5078076|NCT02175121|17527147|P4|Overall Study|Lost to Follow-up|1
5078077|NCT02175121|17527148|P3|Overall Study|Lost to Follow-up|0
5078078|NCT02175121|17527149|P2|Overall Study|Lost to Follow-up|1
5078079|NCT02175121|17527150|P1|Overall Study|Lost to Follow-up|0
5078080|NCT02175121|17527146|P5|Overall Study|Lack of Efficacy|0
5078081|NCT02175121|17527147|P4|Overall Study|Lack of Efficacy|0
5078082|NCT02175121|17527148|P3|Overall Study|Lack of Efficacy|0
5078083|NCT02175121|17527149|P2|Overall Study|Lack of Efficacy|0
5078084|NCT02175121|17527150|P1|Overall Study|Lack of Efficacy|1
5078085|NCT02174861|17527288|P1|Overall Study|Lost to Follow-up|26
5078086|NCT02174861|17527288|P1|Overall Study|Withdrawal by Subject|124
5078087|NCT02174861|17527288|P1|Overall Study|Decision by sponsor|8
5078088|NCT02174848|17527302|P2|Overall Study|Unable to comply with study requirements|0
5078089|NCT02174848|17527303|P1|Overall Study|Unable to comply with study requirements|1
5078090|NCT02174848|17527302|P2|Overall Study|Worsening of disease|1
5078091|NCT02174848|17527303|P1|Overall Study|Worsening of disease|1
5078092|NCT02174848|17527302|P2|Overall Study|Lost to Follow-up|1
5078093|NCT02174848|17527303|P1|Overall Study|Lost to Follow-up|0
5078094|NCT02174848|17527302|P2|Overall Study|Withdrawal by Subject|3
5078095|NCT02174848|17527303|P1|Overall Study|Withdrawal by Subject|3
5078096|NCT02174848|17527302|P2|Overall Study|Adverse Event|1
5078097|NCT02174848|17527303|P1|Overall Study|Adverse Event|2
5078098|NCT02174731|17527320|P2|Overall Study|Missing|0
5078099|NCT02174731|17527321|P1|Overall Study|Missing|2
5078100|NCT02174731|17527320|P2|Overall Study|Incorrect enrolment before randomization|1
5078101|NCT02174731|17527321|P1|Overall Study|Incorrect enrolment before randomization|0
5078102|NCT02174731|17527320|P2|Overall Study|Participant decision|64
5078103|NCT02174731|17527321|P1|Overall Study|Participant decision|67
5078104|NCT02174627|17527343|P2|Overall Study|Participant decision|128
5078105|NCT02174627|17527344|P1|Overall Study|Participant decision|84
5078106|NCT02174627|17527343|P2|Overall Study|Incorrect enrolment before randomization|1
5078107|NCT02174627|17527344|P1|Overall Study|Incorrect enrolment before randomization|0
5078108|NCT02174627|17527343|P2|Overall Study|Missing|1
5078109|NCT02174627|17527344|P1|Overall Study|Missing|0
5078110|NCT02174562|17527372|P2|Overall Study|Lost to Follow-up|3
5078111|NCT02174562|17527373|P1|Overall Study|Lost to Follow-up|0
5078112|NCT02174562|17527372|P2|Overall Study|Death|0
5078113|NCT02174562|17527373|P1|Overall Study|Death|2
5078114|NCT02174562|17527372|P2|Overall Study|Withdrawal by Subject|2
5078115|NCT02174562|17527373|P1|Overall Study|Withdrawal by Subject|7
5078116|NCT02174523|17527383|P2|Overall Study|Withdrawal by Subject|0
5078117|NCT02174523|17527384|P1|Overall Study|Withdrawal by Subject|1
5078118|NCT02174276|17527469|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
5078119|NCT02174276|17527470|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
5078120|NCT02174276|17527471|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
5078121|NCT02174276|17527472|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
5078122|NCT02174276|17527469|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
5078123|NCT02174276|17527470|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
5078124|NCT02174276|17527471|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
5078125|NCT02174276|17527472|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
5078126|NCT02174276|17527469|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5078127|NCT02174276|17527470|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
5078128|NCT02174276|17527471|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5078129|NCT02174276|17527472|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5078130|NCT02174276|17527469|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
5078131|NCT02174276|17527470|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
5078132|NCT02174276|17527471|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
5078133|NCT02174276|17527472|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
5078134|NCT02174276|17527469|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5078135|NCT02174276|17527470|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
5078136|NCT02174276|17527471|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5078137|NCT02174276|17527472|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5078138|NCT02174276|17527469|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5078139|NCT02174276|17527470|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5078140|NCT02174276|17527471|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5078141|NCT02174276|17527472|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
5078142|NCT02173769|17527579|P1|Overall Study|Protocol Violation|4
5078143|NCT02173704|17527592|P2|Overall Study|Withdrawal by Subject|4
5078144|NCT02173704|17527593|P1|Overall Study|Withdrawal by Subject|9
5078145|NCT02173704|17527592|P2|Overall Study|Protocol Violation|0
5078146|NCT02173704|17527593|P1|Overall Study|Protocol Violation|1
5078147|NCT02173704|17527592|P2|Overall Study|Other|0
5078148|NCT02173704|17527593|P1|Overall Study|Other|1
5078149|NCT02173704|17527592|P2|Overall Study|Lost to Follow-up|0
5078150|NCT02173704|17527593|P1|Overall Study|Lost to Follow-up|1
5078151|NCT02173704|17527592|P2|Overall Study|Adverse Event|0
5078152|NCT02173704|17527593|P1|Overall Study|Adverse Event|1
5078153|NCT02173548|17527621|P2|Overall Study|Withdrawal by Subject|0
5078154|NCT02173548|17527622|P1|Overall Study|Withdrawal by Subject|1
5078155|NCT02173548|17527621|P2|Overall Study|Lost to Follow-up|2
5078156|NCT02173548|17527622|P1|Overall Study|Lost to Follow-up|0
5078157|NCT02173379|17527754|P2|Overall Study|Death|22
5078158|NCT02173379|17527755|P1|Overall Study|Death|22
5078159|NCT02173379|17527754|P2|Overall Study|Physician Decision|4
5078160|NCT02173379|17527755|P1|Overall Study|Physician Decision|7
5078161|NCT02173379|17527754|P2|Overall Study|Withdrawal by Subject|17
5078162|NCT02173379|17527755|P1|Overall Study|Withdrawal by Subject|14
5078163|NCT02173379|17527754|P2|Overall Study|Lost to Follow-up|34
5078164|NCT02173379|17527755|P1|Overall Study|Lost to Follow-up|48
5078165|NCT02173158|17527999|P1|Efficacy Phase|Adverse Event|1
5078166|NCT02173054|17528016|P3|Overall Study|Withdrawal by Subject|1
5078167|NCT02173054|17528017|P2|Overall Study|Withdrawal by Subject|0
5078168|NCT02173054|17528018|P1|Overall Study|Withdrawal by Subject|0
5078169|NCT02173054|17528016|P3|Overall Study|lack of compliance|0
5078170|NCT02173054|17528017|P2|Overall Study|lack of compliance|0
5078171|NCT02173054|17528018|P1|Overall Study|lack of compliance|1
5078172|NCT02172664|17528074|P2|Overall Study|Moved out of area|1
5078173|NCT02172664|17528075|P1|Overall Study|Moved out of area|1
5078174|NCT02172664|17528074|P2|Overall Study|Death|1
5078175|NCT02172664|17528075|P1|Overall Study|Death|1
5078176|NCT02172664|17528074|P2|Overall Study|Lost to Follow-up|4
5078177|NCT02172664|17528075|P1|Overall Study|Lost to Follow-up|4
5078178|NCT02172625|17528084|P2|Overall Study|car accident|1
5078179|NCT02172625|17528085|P1|Overall Study|car accident|0
5078180|NCT02172625|17528084|P2|Overall Study|Pregnancy|1
5078181|NCT02172625|17528085|P1|Overall Study|Pregnancy|0
5078182|NCT02172625|17528084|P2|Overall Study|Adverse Event|1
5078183|NCT02172625|17528085|P1|Overall Study|Adverse Event|0
5078184|NCT02172040|17528107|P4|Overall Study|Family emergency abroad|1
5078185|NCT02172040|17528108|P3|Overall Study|Family emergency abroad|0
5078186|NCT02172040|17528109|P2|Overall Study|Family emergency abroad|0
5078187|NCT02172040|17528110|P1|Overall Study|Family emergency abroad|0
5078188|NCT02172040|17528107|P4|Overall Study|Not available for Day 13 & 14 visits|0
5078189|NCT02172040|17528108|P3|Overall Study|Not available for Day 13 & 14 visits|1
5078190|NCT02172040|17528109|P2|Overall Study|Not available for Day 13 & 14 visits|0
5078191|NCT02172040|17528110|P1|Overall Study|Not available for Day 13 & 14 visits|0
5078192|NCT02172040|17528107|P4|Overall Study|Withdrawal by Subject|0
5078193|NCT02172040|17528108|P3|Overall Study|Withdrawal by Subject|1
5078194|NCT02172040|17528109|P2|Overall Study|Withdrawal by Subject|0
5078195|NCT02172040|17528110|P1|Overall Study|Withdrawal by Subject|0
5078196|NCT02172040|17528107|P4|Overall Study|Protocol Violation|0
5078197|NCT02172040|17528108|P3|Overall Study|Protocol Violation|0
5078198|NCT02172040|17528109|P2|Overall Study|Protocol Violation|1
5078199|NCT02172040|17528110|P1|Overall Study|Protocol Violation|0
5078200|NCT02172040|17528107|P4|Overall Study|Adverse Event|0
5078201|NCT02172040|17528108|P3|Overall Study|Adverse Event|0
5078202|NCT02172040|17528109|P2|Overall Study|Adverse Event|2
5078203|NCT02172040|17528110|P1|Overall Study|Adverse Event|0
5078204|NCT02171260|17528273|P4|Overall Study|Evidence of progressive disease|4
5078205|NCT02171260|17528274|P3|Overall Study|Evidence of progressive disease|4
5078206|NCT02171260|17528275|P2|Overall Study|Evidence of progressive disease|6
5078207|NCT02171260|17528276|P1|Overall Study|Evidence of progressive disease|4
5078208|NCT02171260|17528273|P4|Overall Study|Withdrawal by Subject|0
5078209|NCT02171260|17528274|P3|Overall Study|Withdrawal by Subject|0
5078210|NCT02171260|17528275|P2|Overall Study|Withdrawal by Subject|0
5078211|NCT02171260|17528276|P1|Overall Study|Withdrawal by Subject|1
5078212|NCT02171260|17528273|P4|Overall Study|Physician Decision|0
5078213|NCT02171260|17528274|P3|Overall Study|Physician Decision|1
5078214|NCT02171260|17528275|P2|Overall Study|Physician Decision|0
5078215|NCT02171260|17528276|P1|Overall Study|Physician Decision|1
5078216|NCT02171260|17528273|P4|Overall Study|Death|1
5078217|NCT02171260|17528274|P3|Overall Study|Death|0
5078218|NCT02171260|17528275|P2|Overall Study|Death|0
5078219|NCT02171260|17528276|P1|Overall Study|Death|0
5078220|NCT02171130|17528412|P1|Overall Study|Met Exclusion Criteria|1
5078221|NCT02171130|17528412|P1|Overall Study|Lost to Follow-up|1
5078222|NCT02171130|17528412|P1|Overall Study|Physician Decision|1
5078223|NCT02171130|17528412|P1|Overall Study|Withdrawal by Subject|3
5078224|NCT02171130|17528412|P1|Overall Study|Discontinued; Site Termination|5
5078225|NCT02171130|17528412|P1|Overall Study|Discontinued; Clinical Material Issue|16
5078226|NCT02171130|17528412|P1|Overall Study|Death|1
5078227|NCT02170779|17528453|P2|Overall Study|Lost to Follow-up|1
5078228|NCT02170779|17528454|P1|Overall Study|Lost to Follow-up|0
5078229|NCT02170779|17528453|P2|Overall Study|Withdrawal by Subject|0
5078230|NCT02170779|17528454|P1|Overall Study|Withdrawal by Subject|1
5078231|NCT02170727|17528478|P2|Overall Study|Withdrawal by Subject|0
5078232|NCT02170727|17528479|P1|Overall Study|Withdrawal by Subject|2
5078233|NCT02170727|17528478|P2|Overall Study|Lost to Follow-up|0
5078234|NCT02170727|17528479|P1|Overall Study|Lost to Follow-up|1
5078235|NCT02170688|17528510|P5|Overall Study|Physician Decision|0
5078236|NCT02170688|17528511|P4|Overall Study|Physician Decision|0
5078237|NCT02170688|17528512|P3|Overall Study|Physician Decision|1
5078238|NCT02170688|17528513|P2|Overall Study|Physician Decision|0
5078239|NCT02170688|17528514|P1|Overall Study|Physician Decision|0
5078240|NCT02170688|17528510|P5|Overall Study|Full dose not received|0
5078241|NCT02170688|17528511|P4|Overall Study|Full dose not received|0
5078242|NCT02170688|17528512|P3|Overall Study|Full dose not received|0
5078243|NCT02170688|17528513|P2|Overall Study|Full dose not received|1
5078244|NCT02170688|17528514|P1|Overall Study|Full dose not received|0
5078245|NCT02170688|17528510|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
5078246|NCT02170688|17528511|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
5078247|NCT02170688|17528512|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
5078248|NCT02170688|17528513|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
5078249|NCT02170688|17528514|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
5078250|NCT02170389|17528600|P1|Overall Study|Study terminated prior to start of treat|1
5078251|NCT02170298|17528665|P2|Overall Study|unblinded, rerandomized to intervention|0
5078252|NCT02170298|17528666|P1|Overall Study|unblinded, rerandomized to intervention|1
5078253|NCT02170298|17528665|P2|Overall Study|Withdrawal by Subject|1
5078254|NCT02170298|17528666|P1|Overall Study|Withdrawal by Subject|0
5078255|NCT02170207|17528703|P1|Overall Study|Case report forms unavailable|5
5078256|NCT02170077|17528714|P3|Overall Study|Exacerbation of seizures|1
5078257|NCT02170077|17528715|P2|Overall Study|Exacerbation of seizures|2
5078258|NCT02170077|17528716|P1|Overall Study|Exacerbation of seizures|0
5078259|NCT02170077|17528714|P3|Overall Study|Exclusion criteria|5
5078260|NCT02170077|17528715|P2|Overall Study|Exclusion criteria|2
5078261|NCT02170077|17528716|P1|Overall Study|Exclusion criteria|2
5078262|NCT02170077|17528714|P3|Overall Study|Lost to Follow-up|0
5078263|NCT02170077|17528715|P2|Overall Study|Lost to Follow-up|1
5078264|NCT02170077|17528716|P1|Overall Study|Lost to Follow-up|0
5078265|NCT02170077|17528714|P3|Overall Study|Adverse Event|4
5078266|NCT02170077|17528715|P2|Overall Study|Adverse Event|4
5078267|NCT02170077|17528716|P1|Overall Study|Adverse Event|4
5078268|NCT02170077|17528714|P3|Overall Study|Withdrawal by Subject|2
5078269|NCT02170077|17528715|P2|Overall Study|Withdrawal by Subject|4
5078270|NCT02170077|17528716|P1|Overall Study|Withdrawal by Subject|3
5078271|NCT02170064|17528727|P3|Overall Study|Physician Decision|0
5078272|NCT02170064|17528728|P2|Overall Study|Physician Decision|1
5078273|NCT02170064|17528729|P1|Overall Study|Physician Decision|1
5078274|NCT02170064|17528727|P3|Overall Study|Withdrawal by Subject|1
5078275|NCT02170064|17528728|P2|Overall Study|Withdrawal by Subject|1
5078276|NCT02170064|17528729|P1|Overall Study|Withdrawal by Subject|5
5078277|NCT02170051|17528745|P2|Overall Study|Lost to Follow-up|3
5078278|NCT02170051|17528746|P1|Overall Study|Lost to Follow-up|1
5078279|NCT02170051|17528745|P2|Overall Study|Withdrawal by Subject|10
5078280|NCT02170051|17528746|P1|Overall Study|Withdrawal by Subject|10
5078281|NCT02170025|17528766|P2|Overall Study|Adverse Event|0
5078282|NCT02170025|17528767|P1|Overall Study|Adverse Event|2
5078283|NCT02169674|17528811|P2|Overall Study|Lost to Follow-up|1
5078284|NCT02169674|17528812|P1|Overall Study|Lost to Follow-up|0
5078285|NCT02169674|17528811|P2|Overall Study|Seroprotected|76
5078286|NCT02169674|17528812|P1|Overall Study|Seroprotected|30
5078287|NCT02169674|17528811|P2|Overall Study|Withdrawal by Subject|1
5078288|NCT02169674|17528812|P1|Overall Study|Withdrawal by Subject|2
5078289|NCT02169505|17528826|P1|Overall Study|Withdrawal by Subject|1
5078290|NCT02169414|17528954|P4|Overall Study|Adverse Event|0
5078291|NCT02169414|17528955|P3|Overall Study|Adverse Event|0
5078292|NCT02169414|17528956|P2|Overall Study|Adverse Event|1
5078293|NCT02169414|17528957|P1|Overall Study|Adverse Event|0
5078294|NCT02169414|17528954|P4|Overall Study|Withdrawal by Subject|0
5078295|NCT02169414|17528955|P3|Overall Study|Withdrawal by Subject|0
5078296|NCT02169414|17528956|P2|Overall Study|Withdrawal by Subject|0
5078297|NCT02169414|17528957|P1|Overall Study|Withdrawal by Subject|1
5078298|NCT02169336|17528998|P3|Overall Study|Subject declined to continue dosing|1
5078299|NCT02169336|17528999|P2|Overall Study|Subject declined to continue dosing|0
5078300|NCT02169336|17529000|P1|Overall Study|Subject declined to continue dosing|0
5078301|NCT02169336|17528998|P3|Overall Study|Physician Decision|1
5078302|NCT02169336|17528999|P2|Overall Study|Physician Decision|0
5078303|NCT02169336|17529000|P1|Overall Study|Physician Decision|0
5078304|NCT02169336|17528998|P3|Overall Study|Withdrawal by Subject|0
5078305|NCT02169336|17528999|P2|Overall Study|Withdrawal by Subject|0
5078306|NCT02169336|17529000|P1|Overall Study|Withdrawal by Subject|1
5078307|NCT02169336|17528998|P3|Overall Study|Adverse Event|1
5078308|NCT02169336|17528999|P2|Overall Study|Adverse Event|3
5078309|NCT02169336|17529000|P1|Overall Study|Adverse Event|2
5078310|NCT02169336|17528998|P3|Overall Study|Lack of Efficacy|0
5078311|NCT02169336|17528999|P2|Overall Study|Lack of Efficacy|1
5078312|NCT02169336|17529000|P1|Overall Study|Lack of Efficacy|1
5078313|NCT02169284|17529010|P2|Overall Study|Physician Decision|1
5078314|NCT02169284|17529011|P1|Overall Study|Physician Decision|0
5078315|NCT02169271|17529037|P2|Overall Study|Protocol Violation|2
5078316|NCT02169271|17529038|P1|Overall Study|Protocol Violation|1
5078317|NCT02169219|17529060|P1|Overall Study|Lack of Efficacy|6
5078318|NCT02168946|17529104|P2|Overall Study|Subject unable to come back for visits|0
5078319|NCT02168946|17529105|P1|Overall Study|Subject unable to come back for visits|1
5078320|NCT02168946|17529104|P2|Overall Study|Lost to Follow-up|0
5078321|NCT02168946|17529105|P1|Overall Study|Lost to Follow-up|3
5078322|NCT02168946|17529104|P2|Overall Study|Adverse Event|5
5078323|NCT02168946|17529105|P1|Overall Study|Adverse Event|8
5078324|NCT02168842|17529164|P2|Overall Study|Physician Decision|2
5078325|NCT02168842|17529165|P1|Overall Study|Physician Decision|1
5078326|NCT02168842|17529164|P2|Overall Study|Death|1
5078327|NCT02168842|17529165|P1|Overall Study|Death|2
5078328|NCT02168842|17529164|P2|Overall Study|Lost to Follow-up|2
5078329|NCT02168842|17529165|P1|Overall Study|Lost to Follow-up|0
5078330|NCT02168842|17529164|P2|Overall Study|Withdrawal by Subject|3
5078331|NCT02168842|17529165|P1|Overall Study|Withdrawal by Subject|5
5078332|NCT02168816|17529223|P2|Overall Study|Lost to Follow-up|2
5078333|NCT02168816|17529224|P1|Overall Study|Lost to Follow-up|2
5078334|NCT02168803|17529235|P3|Overall Study|Sponsor Decision|1
5078335|NCT02168803|17529236|P2|Overall Study|Sponsor Decision|0
5078336|NCT02168803|17529237|P1|Overall Study|Sponsor Decision|0
5078337|NCT02168803|17529235|P3|Overall Study|Death|1
5078338|NCT02168803|17529236|P2|Overall Study|Death|0
5078339|NCT02168803|17529237|P1|Overall Study|Death|0
5078340|NCT02168803|17529235|P3|Overall Study|Adverse Event|1
5078341|NCT02168803|17529236|P2|Overall Study|Adverse Event|1
5078342|NCT02168803|17529237|P1|Overall Study|Adverse Event|0
5078343|NCT02168803|17529235|P3|Overall Study|Physician Decision|0
5078344|NCT02168803|17529236|P2|Overall Study|Physician Decision|1
5078345|NCT02168803|17529237|P1|Overall Study|Physician Decision|0
5078346|NCT02168803|17529235|P3|Overall Study|Withdrawal by Subject|2
5078347|NCT02168803|17529236|P2|Overall Study|Withdrawal by Subject|1
5078348|NCT02168803|17529237|P1|Overall Study|Withdrawal by Subject|1
5078349|NCT02168803|17529235|P3|Overall Study|Lost to Follow-up|1
5078350|NCT02168803|17529236|P2|Overall Study|Lost to Follow-up|0
5078351|NCT02168803|17529237|P1|Overall Study|Lost to Follow-up|1
5078352|NCT02168777|17529267|P3|Overall Study|Other reason|0
5078353|NCT02168777|17529268|P2|Overall Study|Other reason|1
5078354|NCT02168777|17529269|P1|Overall Study|Other reason|0
5078355|NCT02168777|17529267|P3|Overall Study|Clinical disease progression|2
5078356|NCT02168777|17529268|P2|Overall Study|Clinical disease progression|1
5078357|NCT02168777|17529269|P1|Overall Study|Clinical disease progression|0
5078358|NCT02168777|17529267|P3|Overall Study|Radiological disease progression|5
5078359|NCT02168777|17529268|P2|Overall Study|Radiological disease progression|5
5078360|NCT02168777|17529269|P1|Overall Study|Radiological disease progression|0
5078361|NCT02168777|17529267|P3|Overall Study|Disease recurrence|1
5078362|NCT02168777|17529268|P2|Overall Study|Disease recurrence|0
5078363|NCT02168777|17529269|P1|Overall Study|Disease recurrence|0
5078364|NCT02168777|17529267|P3|Overall Study|Adverse Event|1
5078365|NCT02168777|17529268|P2|Overall Study|Adverse Event|0
5078366|NCT02168777|17529269|P1|Overall Study|Adverse Event|1
5078367|NCT02168777|17529267|P3|Overall Study|Withdrawal by Subject|2
5078368|NCT02168777|17529268|P2|Overall Study|Withdrawal by Subject|0
5078369|NCT02168777|17529269|P1|Overall Study|Withdrawal by Subject|1
5078370|NCT02168491|17529365|P1|Overall Study|Withdrawal by Subject|1
5078371|NCT02168478|17529371|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
5078372|NCT02168478|17529371|P1|Overall Study|Did Not Consent to Participation|2
5078373|NCT02168478|17529371|P1|Overall Study|Withdrawal by Subject|1
5078374|NCT02168439|17529377|P2|Overall Study|Protocol Violation|2
5078375|NCT02168439|17529378|P1|Overall Study|Protocol Violation|0
5078376|NCT02168387|17529396|P2|Overall Study|Death|0
5078377|NCT02168387|17529397|P1|Overall Study|Death|1
5078378|NCT02168387|17529396|P2|Overall Study|Planned exubation|3
5078379|NCT02168387|17529397|P1|Overall Study|Planned exubation|6
5078380|NCT02168270|17529429|P1|Overall Study|Lack of Efficacy|4
5078381|NCT02168101|17529456|P3|Overall Study|Death|1
5078382|NCT02168101|17529457|P2|Overall Study|Death|2
5078383|NCT02168101|17529458|P1|Overall Study|Death|2
5078384|NCT02167893|17529528|P1|Overall Study|Case report forms not collected|68
5078385|NCT02167893|17529528|P1|Overall Study|Investigator health reasons|10
5078386|NCT02167893|17529528|P1|Overall Study|Investigator transferred|85
5078387|NCT02167594|17529563|P3|Overall Study|Death|0
5078388|NCT02167594|17529564|P2|Overall Study|Death|1
5078389|NCT02167594|17529565|P1|Overall Study|Death|0
5078390|NCT02167594|17529563|P3|Overall Study|Withdrawal by Subject|0
5078391|NCT02167594|17529564|P2|Overall Study|Withdrawal by Subject|0
5078392|NCT02167594|17529565|P1|Overall Study|Withdrawal by Subject|2
5078393|NCT02167451|17529574|P1|Overall Study|Withdrawal by Subject|1
5078394|NCT02167256|17529591|P2|Overall Study|Study partner unable to participate|0
5078395|NCT02167256|17529592|P1|Overall Study|Study partner unable to participate|1
5078396|NCT02167256|17529591|P2|Overall Study|non-compliance|0
5078397|NCT02167256|17529592|P1|Overall Study|non-compliance|3
5078398|NCT02167256|17529591|P2|Overall Study|Withdrawal by Subject|4
5078399|NCT02167256|17529592|P1|Overall Study|Withdrawal by Subject|4
5078400|NCT02167256|17529591|P2|Overall Study|Adverse Event|6
5078401|NCT02167256|17529592|P1|Overall Study|Adverse Event|13
5078402|NCT02167139|17529625|P4|Transition-extension|Lost to Follow-up|0
5078403|NCT02167139|17529626|P3|Transition-extension|Lost to Follow-up|0
5078404|NCT02167139|17529627|P2|Transition-extension|Lost to Follow-up|0
5078405|NCT02167139|17529628|P1|Transition-extension|Lost to Follow-up|1
5078406|NCT02167139|17529625|P4|Transition-extension|Other|0
5078407|NCT02167139|17529626|P3|Transition-extension|Other|1
5078408|NCT02167139|17529627|P2|Transition-extension|Other|0
5078409|NCT02167139|17529628|P1|Transition-extension|Other|1
5078410|NCT02167139|17529625|P4|Transition-extension|Lack of Efficacy|1
5078411|NCT02167139|17529626|P3|Transition-extension|Lack of Efficacy|1
5078412|NCT02167139|17529627|P2|Transition-extension|Lack of Efficacy|0
5078413|NCT02167139|17529628|P1|Transition-extension|Lack of Efficacy|0
5078414|NCT02167139|17529625|P4|Transition-extension|Withdrawal by Subject|1
5078415|NCT02167139|17529626|P3|Transition-extension|Withdrawal by Subject|4
5078416|NCT02167139|17529627|P2|Transition-extension|Withdrawal by Subject|0
5078417|NCT02167139|17529628|P1|Transition-extension|Withdrawal by Subject|2
5078418|NCT02167139|17529625|P4|Transition-extension|Adverse Event|3
5078419|NCT02167139|17529626|P3|Transition-extension|Adverse Event|2
5078420|NCT02167139|17529627|P2|Transition-extension|Adverse Event|0
5078421|NCT02167139|17529628|P1|Transition-extension|Adverse Event|2
5078422|NCT02167139|17529625|P4|Randomised, Double-blind|Other|0
5078423|NCT02167139|17529626|P3|Randomised, Double-blind|Other|0
5078424|NCT02167139|17529627|P2|Randomised, Double-blind|Other|0
5078425|NCT02167139|17529628|P1|Randomised, Double-blind|Other|3
5078426|NCT02167139|17529625|P4|Randomised, Double-blind|Lack of Efficacy|0
5078427|NCT02167139|17529626|P3|Randomised, Double-blind|Lack of Efficacy|0
5078428|NCT02167139|17529627|P2|Randomised, Double-blind|Lack of Efficacy|2
5078429|NCT02167139|17529628|P1|Randomised, Double-blind|Lack of Efficacy|1
5078430|NCT02167139|17529625|P4|Randomised, Double-blind|Adverse Event|0
5078431|NCT02167139|17529626|P3|Randomised, Double-blind|Adverse Event|0
5078432|NCT02167139|17529627|P2|Randomised, Double-blind|Adverse Event|9
5078433|NCT02167139|17529628|P1|Randomised, Double-blind|Adverse Event|2
5078434|NCT02167139|17529625|P4|Randomised, Double-blind|Withdrawal by Subject|0
5078435|NCT02167139|17529626|P3|Randomised, Double-blind|Withdrawal by Subject|0
5078436|NCT02167139|17529627|P2|Randomised, Double-blind|Withdrawal by Subject|8
5078437|NCT02167139|17529628|P1|Randomised, Double-blind|Withdrawal by Subject|11
5078438|NCT02167035|17529663|P2|Overall Study|Randomized to incorrect Study Medication|1
5078439|NCT02167035|17529664|P1|Overall Study|Randomized to incorrect Study Medication|0
5078440|NCT02167035|17529663|P2|Overall Study|Lost to Follow-up|3
5078441|NCT02167035|17529664|P1|Overall Study|Lost to Follow-up|3
5078442|NCT02167035|17529663|P2|Overall Study|Adverse Event|2
5078443|NCT02167035|17529664|P1|Overall Study|Adverse Event|2
5078444|NCT02166697|17529672|P1|Overall Study|Protocol Violation|347
5078445|NCT02166606|17529681|P1|Overall Study|Enrolled after End of Enrollment|4
5078446|NCT02166606|17529681|P1|Overall Study|Device upgrade|1
5078447|NCT02166606|17529681|P1|Overall Study|Physician Decision|1
5078448|NCT02166606|17529681|P1|Overall Study|Withdrawal by Subject|1
5078449|NCT02166606|17529681|P1|Overall Study|Lost to Follow-up|30
5078450|NCT02166606|17529681|P1|Overall Study|Protocol Violation|7
5078451|NCT02166606|17529681|P1|Overall Study|Death|31
5078452|NCT02166606|17529681|P1|Overall Study|Adverse Event|3
5078453|NCT02166476|17529688|P2|Overall Study|Unable to Come for Visit|3
5078454|NCT02166476|17529689|P1|Overall Study|Unable to Come for Visit|0
5078455|NCT02166476|17529688|P2|Overall Study|Physician Decision|0
5078456|NCT02166476|17529689|P1|Overall Study|Physician Decision|1
5078457|NCT02166476|17529688|P2|Overall Study|Lost to Follow-up|10
5078458|NCT02166476|17529689|P1|Overall Study|Lost to Follow-up|5
5078459|NCT02166476|17529688|P2|Overall Study|Adverse Event|3
5078460|NCT02166476|17529689|P1|Overall Study|Adverse Event|3
5078461|NCT02166476|17529688|P2|Overall Study|Withdrawal by Subject|7
5078462|NCT02166476|17529689|P1|Overall Study|Withdrawal by Subject|5
5078463|NCT02166047|17529743|P12|Overall Study|Adverse Event|0
5078464|NCT02166047|17529744|P11|Overall Study|Adverse Event|2
5078465|NCT02166047|17529745|P10|Overall Study|Adverse Event|0
5078466|NCT02166047|17529746|P9|Overall Study|Adverse Event|0
5078467|NCT02166047|17529747|P8|Overall Study|Adverse Event|0
5078468|NCT02166047|17529748|P7|Overall Study|Adverse Event|1
5078469|NCT02166047|17529749|P6|Overall Study|Adverse Event|0
5078470|NCT02166047|17529750|P5|Overall Study|Adverse Event|1
5078471|NCT02166047|17529751|P4|Overall Study|Adverse Event|0
5078472|NCT02166047|17529752|P3|Overall Study|Adverse Event|0
5078473|NCT02166047|17529753|P2|Overall Study|Adverse Event|0
5078474|NCT02166047|17529754|P1|Overall Study|Adverse Event|0
5078475|NCT02166047|17529743|P12|Overall Study|Withdrawal by Participant|0
5078476|NCT02166047|17529744|P11|Overall Study|Withdrawal by Participant|0
5078477|NCT02166047|17529745|P10|Overall Study|Withdrawal by Participant|0
5078478|NCT02166047|17529746|P9|Overall Study|Withdrawal by Participant|0
5078479|NCT02166047|17529747|P8|Overall Study|Withdrawal by Participant|0
5078480|NCT02166047|17529748|P7|Overall Study|Withdrawal by Participant|1
5078481|NCT02166047|17529749|P6|Overall Study|Withdrawal by Participant|0
5078482|NCT02166047|17529750|P5|Overall Study|Withdrawal by Participant|0
5078483|NCT02166047|17529751|P4|Overall Study|Withdrawal by Participant|0
5078484|NCT02166047|17529752|P3|Overall Study|Withdrawal by Participant|2
5078485|NCT02166047|17529753|P2|Overall Study|Withdrawal by Participant|1
5078486|NCT02166047|17529754|P1|Overall Study|Withdrawal by Participant|0
5078487|NCT02165826|17529898|P3|Down-Titration Period|Reason Not Specified|2
5078488|NCT02165826|17529899|P2|Down-Titration Period|Reason Not Specified|0
5078489|NCT02165826|17529900|P1|Down-Titration Period|Reason Not Specified|1
5078490|NCT02165826|17529898|P3|Down-Titration Period|Voluntary Withdrawal|2
5078491|NCT02165826|17529899|P2|Down-Titration Period|Voluntary Withdrawal|1
5078492|NCT02165826|17529900|P1|Down-Titration Period|Voluntary Withdrawal|2
5078493|NCT02165826|17529898|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
5078494|NCT02165826|17529899|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
5078495|NCT02165826|17529900|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
5078496|NCT02165826|17529898|P3|Main Treatment Period|Did Not Receive Study Drug|0
5078497|NCT02165826|17529899|P2|Main Treatment Period|Did Not Receive Study Drug|2
5078498|NCT02165826|17529900|P1|Main Treatment Period|Did Not Receive Study Drug|0
5078499|NCT02165826|17529898|P3|Main Treatment Period|Reason Not Specified|16
5078500|NCT02165826|17529899|P2|Main Treatment Period|Reason Not Specified|5
5078501|NCT02165826|17529900|P1|Main Treatment Period|Reason Not Specified|8
5078502|NCT02165826|17529898|P3|Main Treatment Period|Lack of Efficacy|0
5078503|NCT02165826|17529899|P2|Main Treatment Period|Lack of Efficacy|0
5078504|NCT02165826|17529900|P1|Main Treatment Period|Lack of Efficacy|2
5078505|NCT02165826|17529898|P3|Main Treatment Period|Voluntary Withdrawal|21
5078506|NCT02165826|17529899|P2|Main Treatment Period|Voluntary Withdrawal|23
5078507|NCT02165826|17529900|P1|Main Treatment Period|Voluntary Withdrawal|23
5078508|NCT02165826|17529898|P3|Main Treatment Period|Lost to Follow-up|1
5078509|NCT02165826|17529899|P2|Main Treatment Period|Lost to Follow-up|2
5078510|NCT02165826|17529900|P1|Main Treatment Period|Lost to Follow-up|4
5078511|NCT02165826|17529898|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
5078512|NCT02165826|17529899|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
5078513|NCT02165826|17529900|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
5078514|NCT02165826|17529898|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
5078515|NCT02165826|17529899|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
5078516|NCT02165826|17529900|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
5078517|NCT02165735|17529968|P2|Overall Study|Protocol Violation|1
5078518|NCT02165735|17529969|P1|Overall Study|Protocol Violation|0
5078519|NCT02165735|17529968|P2|Overall Study|Participant indicated lack of time|3
5078520|NCT02165735|17529969|P1|Overall Study|Participant indicated lack of time|1
5078521|NCT02165735|17529968|P2|Overall Study|Withdrawal by Subject|0
5078522|NCT02165735|17529969|P1|Overall Study|Withdrawal by Subject|3
5078523|NCT02165735|17529968|P2|Overall Study|Lost to Follow-up|10
5078524|NCT02165735|17529969|P1|Overall Study|Lost to Follow-up|12
5078525|NCT02165397|17530043|P3|Overall Study|Other, Not Specified|1
5078526|NCT02165397|17530044|P2|Overall Study|Other, Not Specified|0
5078527|NCT02165397|17530045|P1|Overall Study|Other, Not Specified|0
5078528|NCT02165397|17530043|P3|Overall Study|Withdrawal by Subject|1
5078529|NCT02165397|17530044|P2|Overall Study|Withdrawal by Subject|6
5078530|NCT02165397|17530045|P1|Overall Study|Withdrawal by Subject|6
5078531|NCT02165397|17530043|P3|Overall Study|Lost to Follow-up|0
5078532|NCT02165397|17530044|P2|Overall Study|Lost to Follow-up|3
5078533|NCT02165397|17530045|P1|Overall Study|Lost to Follow-up|1
5078534|NCT02165397|17530043|P3|Overall Study|Death|8
5078535|NCT02165397|17530044|P2|Overall Study|Death|10
5078536|NCT02165397|17530045|P1|Overall Study|Death|7
5078537|NCT02165202|17530075|P2|Injection Phase|Participant unwilling to comply|0
5078538|NCT02165202|17530076|P1|Injection Phase|Participant unwilling to comply|1
5078539|NCT02165202|17530075|P2|Injection Phase|No longer interested|1
5078540|NCT02165202|17530076|P1|Injection Phase|No longer interested|0
5078541|NCT02165202|17530075|P2|Injection Phase|Study Product related Toxicity|0
5078542|NCT02165202|17530076|P1|Injection Phase|Study Product related Toxicity|1
5078543|NCT02165202|17530075|P2|Injection Phase|End of Study|1
5078544|NCT02165202|17530076|P1|Injection Phase|End of Study|2
5078545|NCT02165202|17530075|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
5078546|NCT02165202|17530076|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
5078547|NCT02165202|17530075|P2|Injection Phase|Unable to attend within Visit Window|0
5078548|NCT02165202|17530076|P1|Injection Phase|Unable to attend within Visit Window|1
5078549|NCT02165202|17530075|P2|Injection Phase|Reactive HIV or HIV Suspected|2
5078550|NCT02165202|17530076|P1|Injection Phase|Reactive HIV or HIV Suspected|0
5078551|NCT02165202|17530075|P2|Injection Phase|Abnormal Lab Value|1
5078552|NCT02165202|17530076|P1|Injection Phase|Abnormal Lab Value|5
5078553|NCT02165202|17530075|P2|Oral Phase|Abnormal EKG|1
5078554|NCT02165202|17530076|P1|Oral Phase|Abnormal EKG|0
5078555|NCT02165202|17530075|P2|Oral Phase|Relocated, no follow-up planned|0
5078556|NCT02165202|17530076|P1|Oral Phase|Relocated, no follow-up planned|1
5078557|NCT02165202|17530075|P2|Oral Phase|CMC advised termination|0
5078558|NCT02165202|17530076|P1|Oral Phase|CMC advised termination|1
5078559|NCT02165202|17530075|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
5078560|NCT02165202|17530076|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
5078561|NCT02165202|17530075|P2|Oral Phase|Clinical reasons|0
5078562|NCT02165202|17530076|P1|Oral Phase|Clinical reasons|1
5078563|NCT02165202|17530075|P2|Oral Phase|Unable to contact Participant|1
5078564|NCT02165202|17530076|P1|Oral Phase|Unable to contact Participant|1
5078565|NCT02165202|17530075|P2|Oral Phase|Study product Related Toxicity|0
5078566|NCT02165202|17530076|P1|Oral Phase|Study product Related Toxicity|1
5078567|NCT02165202|17530075|P2|Oral Phase|Refused further participation|1
5078568|NCT02165202|17530076|P1|Oral Phase|Refused further participation|5
5078569|NCT02164981|17530113|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
5078570|NCT02164981|17530114|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
5078571|NCT02164981|17530115|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
5078572|NCT02164981|17530113|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
5078573|NCT02164981|17530114|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
5078574|NCT02164981|17530115|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
5078575|NCT02164981|17530113|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
5078576|NCT02164981|17530114|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
5078577|NCT02164981|17530115|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
5078578|NCT02164981|17530113|P3|Started|Adverse Event|0
5078579|NCT02164981|17530114|P2|Started|Adverse Event|2
5078580|NCT02164981|17530115|P1|Started|Adverse Event|1
5078581|NCT02164981|17530113|P3|Started|Protocol Violation|0
5078582|NCT02164981|17530114|P2|Started|Protocol Violation|0
5078583|NCT02164981|17530115|P1|Started|Protocol Violation|2
5078584|NCT02164981|17530113|P3|Started|Withdrawal by Subject|0
5078585|NCT02164981|17530114|P2|Started|Withdrawal by Subject|1
5078586|NCT02164981|17530115|P1|Started|Withdrawal by Subject|2
5078587|NCT02164929|17530188|P4|Overall Study|Failed regional block|0
5078588|NCT02164929|17530189|P3|Overall Study|Failed regional block|1
5078589|NCT02164929|17530190|P2|Overall Study|Failed regional block|0
5078590|NCT02164929|17530191|P1|Overall Study|Failed regional block|0
5078591|NCT02164929|17530188|P4|Overall Study|Converted to open procedure|2
5078592|NCT02164929|17530189|P3|Overall Study|Converted to open procedure|0
5078593|NCT02164929|17530190|P2|Overall Study|Converted to open procedure|0
5078594|NCT02164929|17530191|P1|Overall Study|Converted to open procedure|1
5078595|NCT02164916|17530235|P2|Overall Study|Not eligible|5
5078596|NCT02164916|17530236|P1|Overall Study|Not eligible|2
5078597|NCT02164916|17530235|P2|Overall Study|Reason under review|6
5078598|NCT02164916|17530236|P1|Overall Study|Reason under review|1
5078599|NCT02164916|17530235|P2|Overall Study|Not protocol specified|1
5078600|NCT02164916|17530236|P1|Overall Study|Not protocol specified|5
5078601|NCT02164916|17530235|P2|Overall Study|Progression|26
5078602|NCT02164916|17530236|P1|Overall Study|Progression|37
5078603|NCT02164916|17530235|P2|Overall Study|Refusal unrelated to adverse event|7
5078604|NCT02164916|17530236|P1|Overall Study|Refusal unrelated to adverse event|3
5078605|NCT02164916|17530235|P2|Overall Study|Death|1
5078606|NCT02164916|17530236|P1|Overall Study|Death|1
5078607|NCT02164916|17530235|P2|Overall Study|Adverse Event|8
5078608|NCT02164916|17530236|P1|Overall Study|Adverse Event|3
5078609|NCT02164864|17530256|P3|Overall Study|Other than stated|14
5078610|NCT02164864|17530257|P2|Overall Study|Other than stated|4
5078611|NCT02164864|17530258|P1|Overall Study|Other than stated|3
5078612|NCT02164864|17530256|P3|Overall Study|Consent withdrawn, not due to AE|56
5078613|NCT02164864|17530257|P2|Overall Study|Consent withdrawn, not due to AE|8
5078614|NCT02164864|17530258|P1|Overall Study|Consent withdrawn, not due to AE|21
5078615|NCT02164864|17530256|P3|Overall Study|Lost to Follow-up|2
5078616|NCT02164864|17530257|P2|Overall Study|Lost to Follow-up|3
5078617|NCT02164864|17530258|P1|Overall Study|Lost to Follow-up|4
5078618|NCT02164864|17530256|P3|Overall Study|Protocol Violation|1
5078619|NCT02164864|17530257|P2|Overall Study|Protocol Violation|4
5078620|NCT02164864|17530258|P1|Overall Study|Protocol Violation|2
5078621|NCT02164864|17530256|P3|Overall Study|Other Adverse Event (AE)|49
5078622|NCT02164864|17530257|P2|Overall Study|Other Adverse Event (AE)|32
5078623|NCT02164864|17530258|P1|Overall Study|Other Adverse Event (AE)|52
5078624|NCT02164864|17530256|P3|Overall Study|Other pre-existing disease worsening|9
5078625|NCT02164864|17530257|P2|Overall Study|Other pre-existing disease worsening|4
5078626|NCT02164864|17530258|P1|Overall Study|Other pre-existing disease worsening|6
5078627|NCT02164864|17530256|P3|Overall Study|Trial disease worsening|1
5078628|NCT02164864|17530257|P2|Overall Study|Trial disease worsening|5
5078629|NCT02164864|17530258|P1|Overall Study|Trial disease worsening|7
5078630|NCT02164539|17530333|P7|Treatment Phase C (1 Week)|Physician Decision|1
5078631|NCT02164539|17530334|P6|Treatment Phase C (1 Week)|Physician Decision|0
5078632|NCT02164539|17530335|P5|Treatment Phase C (1 Week)|Physician Decision|0
5078633|NCT02164539|17530336|P4|Treatment Phase C (1 Week)|Physician Decision|0
5078634|NCT02164539|17530337|P3|Treatment Phase C (1 Week)|Physician Decision|0
5078635|NCT02164539|17530338|P2|Treatment Phase C (1 Week)|Physician Decision|0
5078636|NCT02164539|17530339|P1|Treatment Phase C (1 Week)|Physician Decision|0
5078637|NCT02164539|17530333|P7|Treatment Phase C (1 Week)|Adverse Event|1
5078638|NCT02164539|17530334|P6|Treatment Phase C (1 Week)|Adverse Event|0
5078639|NCT02164539|17530335|P5|Treatment Phase C (1 Week)|Adverse Event|0
5078640|NCT02164539|17530336|P4|Treatment Phase C (1 Week)|Adverse Event|0
5078641|NCT02164539|17530337|P3|Treatment Phase C (1 Week)|Adverse Event|0
5078642|NCT02164539|17530338|P2|Treatment Phase C (1 Week)|Adverse Event|0
5078643|NCT02164539|17530339|P1|Treatment Phase C (1 Week)|Adverse Event|0
5078644|NCT02164539|17530333|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5078645|NCT02164539|17530334|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5078646|NCT02164539|17530335|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5078647|NCT02164539|17530336|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5078648|NCT02164539|17530337|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5078649|NCT02164539|17530338|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5078650|NCT02164539|17530339|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
5078651|NCT02164539|17530333|P7|Treatment Phase B (1 Week)|Physician Decision|1
5078652|NCT02164539|17530334|P6|Treatment Phase B (1 Week)|Physician Decision|0
5078653|NCT02164539|17530335|P5|Treatment Phase B (1 Week)|Physician Decision|1
5078654|NCT02164539|17530336|P4|Treatment Phase B (1 Week)|Physician Decision|0
5078655|NCT02164539|17530337|P3|Treatment Phase B (1 Week)|Physician Decision|0
5078656|NCT02164539|17530338|P2|Treatment Phase B (1 Week)|Physician Decision|0
5078657|NCT02164539|17530339|P1|Treatment Phase B (1 Week)|Physician Decision|0
5078658|NCT02164539|17530333|P7|Treatment Phase B (1 Week)|Adverse Event|0
5078659|NCT02164539|17530334|P6|Treatment Phase B (1 Week)|Adverse Event|0
5078660|NCT02164539|17530335|P5|Treatment Phase B (1 Week)|Adverse Event|2
5078661|NCT02164539|17530336|P4|Treatment Phase B (1 Week)|Adverse Event|0
5078662|NCT02164539|17530337|P3|Treatment Phase B (1 Week)|Adverse Event|0
5078663|NCT02164539|17530338|P2|Treatment Phase B (1 Week)|Adverse Event|0
5078664|NCT02164539|17530339|P1|Treatment Phase B (1 Week)|Adverse Event|0
5078665|NCT02164539|17530333|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
5078666|NCT02164539|17530334|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
5078667|NCT02164539|17530335|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
5078668|NCT02164539|17530336|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
5078669|NCT02164539|17530337|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
5078670|NCT02164539|17530338|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
5078671|NCT02164539|17530339|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
5078672|NCT02164513|17530387|P3|Overall Study|Other: Reason not provided by site|0
5078673|NCT02164513|17530388|P2|Overall Study|Other: Reason not provided by site|0
5078674|NCT02164513|17530389|P1|Overall Study|Other: Reason not provided by site|1
5078675|NCT02164513|17530387|P3|Overall Study|Withdrawal by Subject|130
5078676|NCT02164513|17530388|P2|Overall Study|Withdrawal by Subject|261
5078677|NCT02164513|17530389|P1|Overall Study|Withdrawal by Subject|192
5078678|NCT02164513|17530387|P3|Overall Study|Physician Decision|28
5078679|NCT02164513|17530388|P2|Overall Study|Physician Decision|57
5078680|NCT02164513|17530389|P1|Overall Study|Physician Decision|47
5078681|NCT02164513|17530387|P3|Overall Study|Lost to Follow-up|22
5078682|NCT02164513|17530388|P2|Overall Study|Lost to Follow-up|36
5078683|NCT02164513|17530389|P1|Overall Study|Lost to Follow-up|30
5078684|NCT02164513|17530387|P3|Overall Study|Other: Study Closed or terminated|4
5078685|NCT02164513|17530388|P2|Overall Study|Other: Study Closed or terminated|2
5078686|NCT02164513|17530389|P1|Overall Study|Other: Study Closed or terminated|5
5078687|NCT02164513|17530387|P3|Overall Study|Adverse Event|111
5078688|NCT02164513|17530388|P2|Overall Study|Adverse Event|180
5078689|NCT02164513|17530389|P1|Overall Study|Adverse Event|162
5078690|NCT02164383|17530426|P2|Overall Study|Lost to Follow-up|0
5078691|NCT02164383|17530427|P1|Overall Study|Lost to Follow-up|1
5078692|NCT02164318|17530437|P4|Overall Study|Withdrawal by Subject|1
5078693|NCT02164318|17530438|P3|Overall Study|Withdrawal by Subject|0
5078694|NCT02164318|17530439|P2|Overall Study|Withdrawal by Subject|1
5078695|NCT02164318|17530440|P1|Overall Study|Withdrawal by Subject|0
5078696|NCT02163993|17530475|P5|Post-treatment Period|Withdrawal by Subject|2
5078697|NCT02163993|17530476|P4|Post-treatment Period|Withdrawal by Subject|1
5078698|NCT02163993|17530477|P3|Post-treatment Period|Withdrawal by Subject|0
5078699|NCT02163993|17530478|P2|Post-treatment Period|Withdrawal by Subject|4
5078700|NCT02163993|17530479|P1|Post-treatment Period|Withdrawal by Subject|2
5078701|NCT02163993|17530475|P5|Post-treatment Period|Protocol Violation|1
5078702|NCT02163993|17530476|P4|Post-treatment Period|Protocol Violation|0
5078703|NCT02163993|17530477|P3|Post-treatment Period|Protocol Violation|0
5078704|NCT02163993|17530478|P2|Post-treatment Period|Protocol Violation|0
5078705|NCT02163993|17530479|P1|Post-treatment Period|Protocol Violation|0
5078706|NCT02163993|17530475|P5|Post-treatment Period|Lost to Follow-up|0
5078707|NCT02163993|17530476|P4|Post-treatment Period|Lost to Follow-up|1
5078708|NCT02163993|17530477|P3|Post-treatment Period|Lost to Follow-up|3
5078709|NCT02163993|17530478|P2|Post-treatment Period|Lost to Follow-up|2
5078710|NCT02163993|17530479|P1|Post-treatment Period|Lost to Follow-up|2
5078711|NCT02163993|17530475|P5|Post-treatment Period|Adverse Event|0
5078712|NCT02163993|17530476|P4|Post-treatment Period|Adverse Event|0
5078713|NCT02163993|17530477|P3|Post-treatment Period|Adverse Event|1
5078714|NCT02163993|17530478|P2|Post-treatment Period|Adverse Event|0
5078715|NCT02163993|17530479|P1|Post-treatment Period|Adverse Event|0
5078716|NCT02163993|17530475|P5|Treatment Period|Not treated|2
5078717|NCT02163993|17530476|P4|Treatment Period|Not treated|1
5078718|NCT02163993|17530477|P3|Treatment Period|Not treated|0
5078719|NCT02163993|17530478|P2|Treatment Period|Not treated|0
5078720|NCT02163993|17530479|P1|Treatment Period|Not treated|1
5078721|NCT02163993|17530475|P5|Treatment Period|Withdrawal by Subject|1
5078722|NCT02163993|17530476|P4|Treatment Period|Withdrawal by Subject|4
5078723|NCT02163993|17530477|P3|Treatment Period|Withdrawal by Subject|1
5078724|NCT02163993|17530478|P2|Treatment Period|Withdrawal by Subject|4
5078725|NCT02163993|17530479|P1|Treatment Period|Withdrawal by Subject|6
5078726|NCT02163993|17530475|P5|Treatment Period|Protocol Violation|2
5078727|NCT02163993|17530476|P4|Treatment Period|Protocol Violation|1
5078728|NCT02163993|17530477|P3|Treatment Period|Protocol Violation|0
5078729|NCT02163993|17530478|P2|Treatment Period|Protocol Violation|1
5078730|NCT02163993|17530479|P1|Treatment Period|Protocol Violation|2
5078731|NCT02163993|17530475|P5|Treatment Period|Physician Decision|0
5078732|NCT02163993|17530476|P4|Treatment Period|Physician Decision|0
5078733|NCT02163993|17530477|P3|Treatment Period|Physician Decision|0
5078734|NCT02163993|17530478|P2|Treatment Period|Physician Decision|0
5078735|NCT02163993|17530479|P1|Treatment Period|Physician Decision|1
5078736|NCT02163993|17530475|P5|Treatment Period|Lost to Follow-up|1
5078737|NCT02163993|17530476|P4|Treatment Period|Lost to Follow-up|3
5078738|NCT02163993|17530477|P3|Treatment Period|Lost to Follow-up|1
5078739|NCT02163993|17530478|P2|Treatment Period|Lost to Follow-up|3
5078740|NCT02163993|17530479|P1|Treatment Period|Lost to Follow-up|2
5078741|NCT02163993|17530475|P5|Treatment Period|Adverse Event|1
5078742|NCT02163993|17530476|P4|Treatment Period|Adverse Event|0
5078743|NCT02163993|17530477|P3|Treatment Period|Adverse Event|0
5078744|NCT02163993|17530478|P2|Treatment Period|Adverse Event|1
5078745|NCT02163993|17530479|P1|Treatment Period|Adverse Event|0
5078746|NCT02163915|17530582|P5|Overall Study|Physician Decision|0
5078747|NCT02163915|17530583|P4|Overall Study|Physician Decision|1
5078748|NCT02163915|17530584|P3|Overall Study|Physician Decision|0
5078749|NCT02163915|17530585|P2|Overall Study|Physician Decision|0
5078750|NCT02163915|17530586|P1|Overall Study|Physician Decision|0
5078751|NCT02163915|17530582|P5|Overall Study|Study termination|2
5078752|NCT02163915|17530583|P4|Overall Study|Study termination|0
5078753|NCT02163915|17530584|P3|Overall Study|Study termination|0
5078754|NCT02163915|17530585|P2|Overall Study|Study termination|0
5078755|NCT02163915|17530586|P1|Overall Study|Study termination|1
5078756|NCT02163915|17530582|P5|Overall Study|Withdrawal by Subject|2
5078757|NCT02163915|17530583|P4|Overall Study|Withdrawal by Subject|2
5078758|NCT02163915|17530584|P3|Overall Study|Withdrawal by Subject|2
5078759|NCT02163915|17530585|P2|Overall Study|Withdrawal by Subject|0
5078760|NCT02163915|17530586|P1|Overall Study|Withdrawal by Subject|2
5078761|NCT02163902|17530641|P2|Overall Study|Administrative Decision|2
5078762|NCT02163902|17530642|P1|Overall Study|Administrative Decision|2
5078763|NCT02163902|17530641|P2|Overall Study|Lost to Follow-up|7
5078764|NCT02163902|17530642|P1|Overall Study|Lost to Follow-up|6
5078765|NCT02163902|17530641|P2|Overall Study|Subject's Request|4
5078766|NCT02163902|17530642|P1|Overall Study|Subject's Request|3
5078767|NCT02163733|17530691|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
5078768|NCT02163733|17530692|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
5078769|NCT02163733|17530693|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
5078770|NCT02163733|17530691|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
5078771|NCT02163733|17530692|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
5078772|NCT02163733|17530693|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
5078773|NCT02163538|17530795|P2|Overall Study|Physician Decision|1
5078774|NCT02163538|17530796|P1|Overall Study|Physician Decision|0
5078775|NCT02163538|17530795|P2|Overall Study|Protocol Violation|0
5078776|NCT02163538|17530796|P1|Overall Study|Protocol Violation|1
5078777|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Various reasons|16
5078778|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
5078779|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Subject Compliance|17
5078780|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Death|8
5078781|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Protocol Violation|2
5078782|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
5078783|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Physician Decision|8
5078784|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
5078785|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
5078786|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
5078787|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Hypokalemia|9
5078788|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
5078789|NCT02163499|17530812|P1|Extended Dosing Phase: ZS|Adverse Event|51
5078790|NCT02163499|17530812|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
5078791|NCT02163499|17530812|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
5078792|NCT02163499|17530812|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
5078793|NCT02163499|17530812|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
5078794|NCT02163499|17530812|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
5078795|NCT02163447|17530840|P3|Overall Study|Became HIV infected at time of delivery|0
5078796|NCT02163447|17530841|P2|Overall Study|Became HIV infected at time of delivery|0
5078797|NCT02163447|17530842|P1|Overall Study|Became HIV infected at time of delivery|1
5078798|NCT02163447|17530840|P3|Overall Study|Moved out of study area|2
5078799|NCT02163447|17530841|P2|Overall Study|Moved out of study area|3
5078800|NCT02163447|17530842|P1|Overall Study|Moved out of study area|2
5078801|NCT02163447|17530840|P3|Overall Study|Lost to Follow-up|0
5078802|NCT02163447|17530841|P2|Overall Study|Lost to Follow-up|3
5078803|NCT02163447|17530842|P1|Overall Study|Lost to Follow-up|1
5078804|NCT02163447|17530840|P3|Overall Study|Withdrawal by Subject|1
5078805|NCT02163447|17530841|P2|Overall Study|Withdrawal by Subject|0
5078806|NCT02163447|17530842|P1|Overall Study|Withdrawal by Subject|2
5078807|NCT02163395|17530917|P1|Overall Study|Adverse Event|1
5078808|NCT02163395|17530917|P1|Overall Study|Lost to Follow-up|3
5078809|NCT02163395|17530917|P1|Overall Study|Withdrawal by Subject|1
5078810|NCT02163187|17530926|P2|Overall Study|Progressive disease|0
5078811|NCT02163187|17530927|P1|Overall Study|Progressive disease|1
5078812|NCT02163187|17530926|P2|Overall Study|Device removed|0
5078813|NCT02163187|17530927|P1|Overall Study|Device removed|1
5078814|NCT02162862|17530962|P3|Overall Study|Subject did not feel the med was needed|4
5078815|NCT02162862|17530963|P2|Overall Study|Subject did not feel the med was needed|0
5078816|NCT02162862|17530964|P1|Overall Study|Subject did not feel the med was needed|0
5078817|NCT02162862|17530962|P3|Overall Study|Lost to Follow-up|0
5078818|NCT02162862|17530963|P2|Overall Study|Lost to Follow-up|11
5078819|NCT02162862|17530964|P1|Overall Study|Lost to Follow-up|0
5078820|NCT02162771|17530977|P2|Maintenance Study Period (Part 2)|Stable Disease|1
5078821|NCT02162771|17530978|P1|Maintenance Study Period (Part 2)|Stable Disease|0
5078822|NCT02162771|17530977|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
5078823|NCT02162771|17530978|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
5078824|NCT02162771|17530977|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
5078825|NCT02162771|17530978|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
5078826|NCT02162771|17530977|P2|Maintenance Study Period (Part 2)|Death|1
5078827|NCT02162771|17530978|P1|Maintenance Study Period (Part 2)|Death|2
5078828|NCT02162771|17530977|P2|Maintenance Study Period (Part 2)|Adverse Event|3
5078829|NCT02162771|17530978|P1|Maintenance Study Period (Part 2)|Adverse Event|3
5078830|NCT02162771|17530977|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
5078831|NCT02162771|17530978|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
5078832|NCT02162771|17530977|P2|Core Study Period (Part 2)|Death|0
5078833|NCT02162771|17530978|P1|Core Study Period (Part 2)|Death|1
5078834|NCT02162771|17530977|P2|Core Study Period (Part 2)|Physician Decision|2
5078835|NCT02162771|17530978|P1|Core Study Period (Part 2)|Physician Decision|0
5078836|NCT02162771|17530977|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
5078837|NCT02162771|17530978|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
5078838|NCT02162771|17530977|P2|Core Study Period (Part 2)|Adverse Event|1
5078839|NCT02162771|17530978|P1|Core Study Period (Part 2)|Adverse Event|4
5078840|NCT02162771|17530977|P2|Core Study Period (Part 2)|Progressive Disease|3
5078841|NCT02162771|17530978|P1|Core Study Period (Part 2)|Progressive Disease|2
5078842|NCT02162758|17530992|P2|Overall Study|Study termination|1
5078843|NCT02162758|17530993|P1|Overall Study|Study termination|0
5078844|NCT02161757|17531128|P3|Treatment Through Study Completion|Death|1
5078845|NCT02161757|17531129|P2|Treatment Through Study Completion|Death|1
5078846|NCT02161757|17531130|P1|Treatment Through Study Completion|Death|2
5078847|NCT02161757|17531128|P3|Treatment Through Study Completion|Other|12
5078848|NCT02161757|17531129|P2|Treatment Through Study Completion|Other|19
5078849|NCT02161757|17531130|P1|Treatment Through Study Completion|Other|20
5078850|NCT02161757|17531128|P3|Treatment Through Study Completion|Lost to Follow-up|4
5078851|NCT02161757|17531129|P2|Treatment Through Study Completion|Lost to Follow-up|2
5078852|NCT02161757|17531130|P1|Treatment Through Study Completion|Lost to Follow-up|7
5078853|NCT02161757|17531128|P3|Treatment Through Study Completion|Withdrawal by Subject|20
5078854|NCT02161757|17531129|P2|Treatment Through Study Completion|Withdrawal by Subject|19
5078855|NCT02161757|17531130|P1|Treatment Through Study Completion|Withdrawal by Subject|27
5078856|NCT02161757|17531128|P3|Treatment Through Study Completion|Protocol Violation|2
5078857|NCT02161757|17531129|P2|Treatment Through Study Completion|Protocol Violation|1
5078858|NCT02161757|17531130|P1|Treatment Through Study Completion|Protocol Violation|0
5078859|NCT02161757|17531128|P3|Treatment Through Study Completion|Adverse Event|0
5078860|NCT02161757|17531129|P2|Treatment Through Study Completion|Adverse Event|1
5078861|NCT02161757|17531130|P1|Treatment Through Study Completion|Adverse Event|1
5078862|NCT02161757|17531128|P3|Randomised Through Start Treatment|Did not receive treatment|0
5078863|NCT02161757|17531129|P2|Randomised Through Start Treatment|Did not receive treatment|2
5078864|NCT02161757|17531130|P1|Randomised Through Start Treatment|Did not receive treatment|3
5078865|NCT02161731|17531188|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
5078866|NCT02161731|17531189|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
5078867|NCT02161731|17531188|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
5078868|NCT02161731|17531189|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
5078869|NCT02161575|17531217|P1|Overall Study|Adverse Event|2
5078870|NCT02161575|17531217|P1|Overall Study|Lack of Efficacy|1
5078871|NCT02161575|17531217|P1|Overall Study|Protocol Violation|8
5078872|NCT02161562|17531237|P2|Overall Study|Participant moved out of province|0
5078873|NCT02161562|17531238|P1|Overall Study|Participant moved out of province|1
5078874|NCT02161562|17531237|P2|Overall Study|Withdrew due to being out of the country|0
5078875|NCT02161562|17531238|P1|Overall Study|Withdrew due to being out of the country|1
5078876|NCT02161562|17531237|P2|Overall Study|Participant moved back to home country|0
5078877|NCT02161562|17531238|P1|Overall Study|Participant moved back to home country|1
5078878|NCT02161562|17531237|P2|Overall Study|Adverse Event|1
5078879|NCT02161562|17531238|P1|Overall Study|Adverse Event|1
5078880|NCT02161562|17531237|P2|Overall Study|Lack of Efficacy|1
5078881|NCT02161562|17531238|P1|Overall Study|Lack of Efficacy|4
5078882|NCT02161562|17531237|P2|Overall Study|Lost to Follow-up|1
5078883|NCT02161562|17531238|P1|Overall Study|Lost to Follow-up|3
5078884|NCT02161562|17531237|P2|Overall Study|Pregnancy|2
5078885|NCT02161562|17531238|P1|Overall Study|Pregnancy|1
5078886|NCT02161562|17531237|P2|Overall Study|Protocol Violation|4
5078887|NCT02161562|17531238|P1|Overall Study|Protocol Violation|9
5078888|NCT02161562|17531237|P2|Overall Study|Withdrawal by Subject|8
5078889|NCT02161562|17531238|P1|Overall Study|Withdrawal by Subject|5
5078890|NCT02161549|17531266|P2|Overall Study|Physician Decision|2
5078891|NCT02161549|17531267|P1|Overall Study|Physician Decision|6
5078892|NCT02161458|17531315|P4|Overall Study|Lost to Follow-up|0
5078893|NCT02161458|17531316|P3|Overall Study|Lost to Follow-up|1
5078894|NCT02161458|17531317|P2|Overall Study|Lost to Follow-up|2
5078895|NCT02161458|17531318|P1|Overall Study|Lost to Follow-up|0
5078896|NCT02161458|17531315|P4|Overall Study|Withdrawal by Subject|0
5078897|NCT02161458|17531316|P3|Overall Study|Withdrawal by Subject|4
5078898|NCT02161458|17531317|P2|Overall Study|Withdrawal by Subject|4
5078899|NCT02161458|17531318|P1|Overall Study|Withdrawal by Subject|0
5078900|NCT02161406|17531330|P2|Overall Study|relocation|1
5078901|NCT02161406|17531331|P1|Overall Study|relocation|0
5078902|NCT02161406|17531330|P2|Overall Study|Lack of Efficacy|1
5078903|NCT02161406|17531331|P1|Overall Study|Lack of Efficacy|1
5078904|NCT02161406|17531330|P2|Overall Study|investigator withdrew subject|1
5078905|NCT02161406|17531331|P1|Overall Study|investigator withdrew subject|3
5078906|NCT02161406|17531330|P2|Overall Study|Withdrawal by Subject|4
5078907|NCT02161406|17531331|P1|Overall Study|Withdrawal by Subject|2
5078908|NCT02161406|17531330|P2|Overall Study|Lost to Follow-up|1
5078909|NCT02161406|17531331|P1|Overall Study|Lost to Follow-up|2
5078910|NCT02161406|17531330|P2|Overall Study|Death|1
5078911|NCT02161406|17531331|P1|Overall Study|Death|2
5078912|NCT02161185|17531405|P1|Treatment Phase|Administrative/Other|7
5078913|NCT02161146|17531415|P5|Overall Study|Other Miscellaneous Reasons|0
5078914|NCT02161146|17531416|P4|Overall Study|Other Miscellaneous Reasons|0
5078915|NCT02161146|17531417|P3|Overall Study|Other Miscellaneous Reasons|0
5078916|NCT02161146|17531418|P2|Overall Study|Other Miscellaneous Reasons|1
5078917|NCT02161146|17531419|P1|Overall Study|Other Miscellaneous Reasons|0
5078918|NCT02161146|17531415|P5|Overall Study|Personal Reasons|1
5078919|NCT02161146|17531416|P4|Overall Study|Personal Reasons|2
5078920|NCT02161146|17531417|P3|Overall Study|Personal Reasons|0
5078921|NCT02161146|17531418|P2|Overall Study|Personal Reasons|1
5078922|NCT02161146|17531419|P1|Overall Study|Personal Reasons|0
5078923|NCT02161146|17531415|P5|Overall Study|Lost to Follow-up|0
5078924|NCT02161146|17531416|P4|Overall Study|Lost to Follow-up|0
5078925|NCT02161146|17531417|P3|Overall Study|Lost to Follow-up|0
5078926|NCT02161146|17531418|P2|Overall Study|Lost to Follow-up|1
5078927|NCT02161146|17531419|P1|Overall Study|Lost to Follow-up|0
5078928|NCT02161146|17531415|P5|Overall Study|Adverse Event|0
5078929|NCT02161146|17531416|P4|Overall Study|Adverse Event|1
5078930|NCT02161146|17531417|P3|Overall Study|Adverse Event|0
5078931|NCT02161146|17531418|P2|Overall Study|Adverse Event|1
5078932|NCT02161146|17531419|P1|Overall Study|Adverse Event|1
5078933|NCT02161016|17531455|P1|Overall Study|withdrawn by IRB|1
5078934|NCT02160977|17531486|P2|Six Months After Surgery|Lost to Follow-up|1
5078935|NCT02160977|17531487|P1|Six Months After Surgery|Lost to Follow-up|2
5078936|NCT02160977|17531486|P2|Three Months After Surgery|Lost to Follow-up|2
5078937|NCT02160977|17531487|P1|Three Months After Surgery|Lost to Follow-up|0
5078938|NCT02160977|17531486|P2|Six Weeks After Surgery|Lost to Follow-up|0
5078939|NCT02160977|17531487|P1|Six Weeks After Surgery|Lost to Follow-up|1
5078940|NCT02160899|17531503|P6|Overall Study|Adverse Event or Serious Adverse Event|0
5078941|NCT02160899|17531504|P5|Overall Study|Adverse Event or Serious Adverse Event|2
5078942|NCT02160899|17531505|P4|Overall Study|Adverse Event or Serious Adverse Event|1
5078943|NCT02160899|17531506|P3|Overall Study|Adverse Event or Serious Adverse Event|0
5078944|NCT02160899|17531507|P2|Overall Study|Adverse Event or Serious Adverse Event|1
5078945|NCT02160899|17531508|P1|Overall Study|Adverse Event or Serious Adverse Event|0
5078946|NCT02160626|17531570|P3|Overall Study|Withdrawal by Subject|0
5078947|NCT02160626|17531571|P2|Overall Study|Withdrawal by Subject|1
5078948|NCT02160626|17531572|P1|Overall Study|Withdrawal by Subject|0
5078949|NCT02160626|17531570|P3|Overall Study|Schedule not conducive to study visits|1
5078950|NCT02160626|17531571|P2|Overall Study|Schedule not conducive to study visits|0
5078951|NCT02160626|17531572|P1|Overall Study|Schedule not conducive to study visits|0
5078952|NCT02160626|17531570|P3|Overall Study|Adverse Event|0
5078953|NCT02160626|17531571|P2|Overall Study|Adverse Event|0
5078954|NCT02160626|17531572|P1|Overall Study|Adverse Event|1
5078955|NCT02160314|17531595|P2|Overall Study|Lost to Follow-up|1
5078956|NCT02160314|17531596|P1|Overall Study|Lost to Follow-up|0
5078957|NCT02160314|17531595|P2|Overall Study|Withdrawal by Subject|2
5078958|NCT02160314|17531596|P1|Overall Study|Withdrawal by Subject|1
5078959|NCT02160314|17531595|P2|Overall Study|Protocol Violation|4
5078960|NCT02160314|17531596|P1|Overall Study|Protocol Violation|0
5078961|NCT02160314|17531595|P2|Overall Study|Adverse Event|6
5078962|NCT02160314|17531596|P1|Overall Study|Adverse Event|0
5078963|NCT02160145|17531631|P3|Randomized Double-blind Period|Physician Decision|5
5078964|NCT02160145|17531632|P2|Randomized Double-blind Period|Physician Decision|7
5078965|NCT02160145|17531633|P1|Randomized Double-blind Period|Physician Decision|0
5078966|NCT02160145|17531631|P3|Randomized Double-blind Period|Lost to Follow-up|3
5078967|NCT02160145|17531632|P2|Randomized Double-blind Period|Lost to Follow-up|1
5078968|NCT02160145|17531633|P1|Randomized Double-blind Period|Lost to Follow-up|0
5078969|NCT02160145|17531631|P3|Randomized Double-blind Period|Subject decision|20
5078970|NCT02160145|17531632|P2|Randomized Double-blind Period|Subject decision|21
5078971|NCT02160145|17531633|P1|Randomized Double-blind Period|Subject decision|0
5078972|NCT02160145|17531631|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
5078973|NCT02160145|17531632|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
5078974|NCT02160145|17531633|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
5078975|NCT02160145|17531631|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
5078976|NCT02160145|17531632|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
5078977|NCT02160145|17531633|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
5078978|NCT02160041|17531646|P1|Overall Study|study terminated by by sponsor|1
5078979|NCT02160041|17531646|P1|Overall Study|Withdrawal by Subject|8
5078980|NCT02160041|17531646|P1|Overall Study|Physician Decision|3
5078981|NCT02160041|17531646|P1|Overall Study|non-compliance with study|1
5078982|NCT02160041|17531646|P1|Overall Study|Protocol Violation|1
5078983|NCT02160041|17531646|P1|Overall Study|disease progression|57
5078984|NCT02160041|17531646|P1|Overall Study|Death|2
5078985|NCT02160041|17531646|P1|Overall Study|Adverse Event|11
5078986|NCT02160002|17531658|P2|Overall Study|Withdrawal by Subject|1
5078987|NCT02160002|17531659|P1|Overall Study|Withdrawal by Subject|2
5078988|NCT02159950|17531706|P2|Overall Study|Progression|1
5078989|NCT02159950|17531707|P1|Overall Study|Progression|0
5078990|NCT02159950|17531706|P2|Overall Study|Adverse Event|1
5078991|NCT02159950|17531707|P1|Overall Study|Adverse Event|0
5078992|NCT02159807|17531766|P3|Overall Study|elevated blood pressure|1
5078993|NCT02159807|17531767|P2|Overall Study|elevated blood pressure|0
5078994|NCT02159807|17531768|P1|Overall Study|elevated blood pressure|0
5078995|NCT02159807|17531766|P3|Overall Study|No CSF|1
5078996|NCT02159807|17531767|P2|Overall Study|No CSF|1
5078997|NCT02159807|17531768|P1|Overall Study|No CSF|1
5078998|NCT02159807|17531766|P3|Overall Study|Adverse Event|1
5078999|NCT02159807|17531767|P2|Overall Study|Adverse Event|0
5079000|NCT02159807|17531768|P1|Overall Study|Adverse Event|0
5079001|NCT02159729|17531789|P2|Overall Study|Other Unspecified|1
5079002|NCT02159729|17531790|P1|Overall Study|Other Unspecified|3
5079003|NCT02159729|17531789|P2|Overall Study|Non compliance|0
5079004|NCT02159729|17531790|P1|Overall Study|Non compliance|2
5079005|NCT02159729|17531789|P2|Overall Study|Lost to Follow-up|9
5079006|NCT02159729|17531790|P1|Overall Study|Lost to Follow-up|24
5079007|NCT02159729|17531789|P2|Overall Study|Subject's Request|10
5079008|NCT02159729|17531790|P1|Overall Study|Subject's Request|13
5079009|NCT02159729|17531789|P2|Overall Study|Adverse Event|1
5079010|NCT02159729|17531790|P1|Overall Study|Adverse Event|0
5079011|NCT02159521|17531817|P1|Overall Study|Other than specified|1
5079012|NCT02159521|17531817|P1|Overall Study|Death|1
5079013|NCT02159521|17531817|P1|Overall Study|Lost to Follow-up|6
5079014|NCT02159521|17531817|P1|Overall Study|Withdrawal by Subject|7
5079015|NCT02159521|17531817|P1|Overall Study|Enrolled but not treated|3
5079016|NCT02159482|17531838|P1|Overall Study|Physician Decision|3
5079017|NCT02159482|17531838|P1|Overall Study|Withdrawal by Subject|2
5079018|NCT02159469|17531843|P1|Overall Study|Multiple|29
5079019|NCT02159469|17531843|P1|Overall Study|Other|1
5079020|NCT02159469|17531843|P1|Overall Study|Met Stopping Criteria|3
5079021|NCT02159469|17531843|P1|Overall Study|Sponsor's request|2
5079022|NCT02159469|17531843|P1|Overall Study|Lost to Follow-up|1
5079023|NCT02159469|17531843|P1|Overall Study|Withdrawal by Subject|9
5079024|NCT02159469|17531843|P1|Overall Study|Non-compliance|2
5079025|NCT02159469|17531843|P1|Overall Study|Adverse Event|5
5079026|NCT02159469|17531843|P1|Overall Study|Missing Completion status|1
5079027|NCT02159365|17531848|P1|Overall Study|Lost to Follow-up|1
5079028|NCT02159365|17531848|P1|Overall Study|Death|1
5079029|NCT02159365|17531848|P1|Overall Study|Subject withdrew consent|3
5079030|NCT02159365|17531848|P1|Overall Study|Subject request to discontinue treatment|3
5079031|NCT02159365|17531848|P1|Overall Study|Maximum clinical benefit|3
5079032|NCT02159365|17531848|P1|Overall Study|Study drug toxicity|7
5079033|NCT02159365|17531848|P1|Overall Study|Adverse Event unrelated to study drug|9
5079034|NCT02159365|17531848|P1|Overall Study|Administrative reason by Sponsor|9
5079035|NCT02159365|17531848|P1|Overall Study|Other reasons|11
5079036|NCT02159365|17531848|P1|Overall Study|Disease Progression|23
5079037|NCT02159352|17531855|P2|Overall Study|Withdrawal by Subject|1
5079038|NCT02159352|17531856|P1|Overall Study|Withdrawal by Subject|0
5079039|NCT02159352|17531855|P2|Overall Study|Adverse Event|1
5079040|NCT02159352|17531856|P1|Overall Study|Adverse Event|3
5079041|NCT02159183|17531908|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
5079042|NCT02159183|17531909|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
5079043|NCT02159183|17531908|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
5079044|NCT02159183|17531909|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
5079045|NCT02159183|17531908|P2|Analysis After the 36 Months Follow-up|Death|1
5079046|NCT02159183|17531909|P1|Analysis After the 36 Months Follow-up|Death|0
5079047|NCT02159183|17531908|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
5079048|NCT02159183|17531909|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
5079049|NCT02159183|17531908|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
5079050|NCT02159183|17531909|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
5079051|NCT02159053|17531982|P3|Overall Study|Participants/guardian decision|6
5079052|NCT02159053|17531983|P2|Overall Study|Participants/guardian decision|10
5079053|NCT02159053|17531984|P1|Overall Study|Participants/guardian decision|8
5079054|NCT02159053|17531982|P3|Overall Study|Adverse Event|5
5079055|NCT02159053|17531983|P2|Overall Study|Adverse Event|6
5079056|NCT02159053|17531984|P1|Overall Study|Adverse Event|7
5079057|NCT02159053|17531982|P3|Overall Study|Lack of Efficacy|7
5079058|NCT02159053|17531983|P2|Overall Study|Lack of Efficacy|4
5079059|NCT02159053|17531984|P1|Overall Study|Lack of Efficacy|3
5079060|NCT02159053|17531982|P3|Overall Study|Physician Decision|1
5079061|NCT02159053|17531983|P2|Overall Study|Physician Decision|1
5079062|NCT02159053|17531984|P1|Overall Study|Physician Decision|0
5079063|NCT02159053|17531982|P3|Overall Study|Death|1
5079064|NCT02159053|17531983|P2|Overall Study|Death|0
5079065|NCT02159053|17531984|P1|Overall Study|Death|2
5079066|NCT02159040|17532021|P1|Overall Study|Death|1
5079067|NCT02158975|17532034|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
5079068|NCT02158949|17532044|P2|Overall Study|Lost to Follow-up|11
5079069|NCT02158949|17532045|P1|Overall Study|Lost to Follow-up|5
5079070|NCT02158949|17532044|P2|Overall Study|Withdrawal by Subject|0
5079071|NCT02158949|17532045|P1|Overall Study|Withdrawal by Subject|1
5079072|NCT02158936|17532061|P2|Overall Study|Lost to Follow-up|1
5079073|NCT02158936|17532062|P1|Overall Study|Lost to Follow-up|0
5079074|NCT02158936|17532061|P2|Overall Study|Physician Decision|13
5079075|NCT02158936|17532062|P1|Overall Study|Physician Decision|15
5079076|NCT02158936|17532061|P2|Overall Study|Withdrawal by Subject|16
5079077|NCT02158936|17532062|P1|Overall Study|Withdrawal by Subject|15
5079078|NCT02158936|17532061|P2|Overall Study|Adverse Event|24
5079079|NCT02158936|17532062|P1|Overall Study|Adverse Event|39
5079080|NCT02158936|17532061|P2|Overall Study|Azacitidine tx discontinued|46
5079081|NCT02158936|17532062|P1|Overall Study|Azacitidine tx discontinued|53
5079082|NCT02158936|17532061|P2|Overall Study|Study closed/ terminated|77
5079083|NCT02158936|17532062|P1|Overall Study|Study closed/ terminated|57
5079084|NCT02158884|17532104|P1|12 Month Assessment|Missed SMFA|17
5079085|NCT02158884|17532104|P1|6 Month Assessment|Missed SMFA|20
5079086|NCT02158884|17532104|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
5079087|NCT02158884|17532104|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
5079088|NCT02158884|17532104|P1|Baseline Assessment|Missed SMFA|1
5079089|NCT02158884|17532104|P1|Baseline Assessment|Missed performance assessment|3
5079090|NCT02158806|17532139|P2|Overall Study|Transferred to palliative care|1
5079091|NCT02158806|17532140|P1|Overall Study|Transferred to palliative care|0
5079092|NCT02158806|17532139|P2|Overall Study|Moved out of area|1
5079093|NCT02158806|17532140|P1|Overall Study|Moved out of area|0
5079094|NCT02158806|17532139|P2|Overall Study|Lost to Follow-up|3
5079095|NCT02158806|17532140|P1|Overall Study|Lost to Follow-up|0
5079096|NCT02158806|17532139|P2|Overall Study|Withdrawal by Subject|0
5079097|NCT02158806|17532140|P1|Overall Study|Withdrawal by Subject|2
5079098|NCT02158806|17532139|P2|Overall Study|Death|0
5079099|NCT02158806|17532140|P1|Overall Study|Death|2
5079100|NCT02158728|17532160|P1|Overall Study|no qualified dataset|24
5079101|NCT02158728|17532160|P1|Overall Study|no procedure according to CIP done|3
5079102|NCT02158663|17532166|P2|Overall Study|Withdrawal by Subject|4
5079103|NCT02158663|17532167|P1|Overall Study|Withdrawal by Subject|5
5079104|NCT02158546|17532190|P4|Overall Study|Site Excluded|4
5079105|NCT02158546|17532191|P3|Overall Study|Site Excluded|3
5079106|NCT02158546|17532192|P2|Overall Study|Site Excluded|5
5079107|NCT02158546|17532193|P1|Overall Study|Site Excluded|5
5079108|NCT02158546|17532190|P4|Overall Study|Lost to Follow-up|1
5079109|NCT02158546|17532191|P3|Overall Study|Lost to Follow-up|0
5079110|NCT02158546|17532192|P2|Overall Study|Lost to Follow-up|4
5079111|NCT02158546|17532193|P1|Overall Study|Lost to Follow-up|5
5079112|NCT02158546|17532190|P4|Overall Study|Withdrawal by Subject|0
5079113|NCT02158546|17532191|P3|Overall Study|Withdrawal by Subject|1
5079114|NCT02158546|17532192|P2|Overall Study|Withdrawal by Subject|2
5079115|NCT02158546|17532193|P1|Overall Study|Withdrawal by Subject|6
5079116|NCT02158546|17532190|P4|Overall Study|Adverse Event|0
5079117|NCT02158546|17532191|P3|Overall Study|Adverse Event|0
5079118|NCT02158546|17532192|P2|Overall Study|Adverse Event|2
5079119|NCT02158546|17532193|P1|Overall Study|Adverse Event|2
5079120|NCT02158546|17532190|P4|Overall Study|Lack of Efficacy|0
5079121|NCT02158546|17532191|P3|Overall Study|Lack of Efficacy|0
5079122|NCT02158546|17532192|P2|Overall Study|Lack of Efficacy|1
5079123|NCT02158546|17532193|P1|Overall Study|Lack of Efficacy|1
5079124|NCT02158546|17532190|P4|Overall Study|Failure to meet eligibility criteria|0
5079125|NCT02158546|17532191|P3|Overall Study|Failure to meet eligibility criteria|0
5079126|NCT02158546|17532192|P2|Overall Study|Failure to meet eligibility criteria|1
5079127|NCT02158546|17532193|P1|Overall Study|Failure to meet eligibility criteria|0
5079128|NCT02158546|17532190|P4|Overall Study|Non-compliance|1
5079129|NCT02158546|17532191|P3|Overall Study|Non-compliance|0
5079130|NCT02158546|17532192|P2|Overall Study|Non-compliance|1
5079131|NCT02158546|17532193|P1|Overall Study|Non-compliance|0
5079132|NCT02158546|17532190|P4|Overall Study|Physician Decision|0
5079133|NCT02158546|17532191|P3|Overall Study|Physician Decision|0
5079134|NCT02158546|17532192|P2|Overall Study|Physician Decision|1
5079135|NCT02158546|17532193|P1|Overall Study|Physician Decision|0
5079136|NCT02158533|17532212|P6|Stage 2|Non-adherence with study visits|1
5079137|NCT02158533|17532213|P5|Stage 2|Non-adherence with study visits|0
5079138|NCT02158533|17532214|P4|Stage 2|Non-adherence with study visits|0
5079139|NCT02158533|17532215|P3|Stage 2|Non-adherence with study visits|0
5079140|NCT02158533|17532216|P2|Stage 2|Non-adherence with study visits|0
5079141|NCT02158533|17532217|P1|Stage 2|Non-adherence with study visits|0
5079142|NCT02158533|17532212|P6|Stage 2|Psychiatrist decision to try new tx|0
5079143|NCT02158533|17532213|P5|Stage 2|Psychiatrist decision to try new tx|0
5079144|NCT02158533|17532214|P4|Stage 2|Psychiatrist decision to try new tx|1
5079145|NCT02158533|17532215|P3|Stage 2|Psychiatrist decision to try new tx|0
5079146|NCT02158533|17532216|P2|Stage 2|Psychiatrist decision to try new tx|0
5079147|NCT02158533|17532217|P1|Stage 2|Psychiatrist decision to try new tx|0
5079148|NCT02158533|17532212|P6|Stage 2|Pregnancy|0
5079149|NCT02158533|17532213|P5|Stage 2|Pregnancy|0
5079150|NCT02158533|17532214|P4|Stage 2|Pregnancy|1
5079151|NCT02158533|17532215|P3|Stage 2|Pregnancy|0
5079152|NCT02158533|17532216|P2|Stage 2|Pregnancy|0
5079153|NCT02158533|17532217|P1|Stage 2|Pregnancy|0
5079154|NCT02158533|17532212|P6|Stage 2|Physician Decision|0
5079155|NCT02158533|17532213|P5|Stage 2|Physician Decision|1
5079156|NCT02158533|17532214|P4|Stage 2|Physician Decision|0
5079157|NCT02158533|17532215|P3|Stage 2|Physician Decision|0
5079158|NCT02158533|17532216|P2|Stage 2|Physician Decision|0
5079159|NCT02158533|17532217|P1|Stage 2|Physician Decision|0
5079160|NCT02158533|17532212|P6|Stage 2|Withdrawal by Subject|2
5079161|NCT02158533|17532213|P5|Stage 2|Withdrawal by Subject|1
5079162|NCT02158533|17532214|P4|Stage 2|Withdrawal by Subject|0
5079163|NCT02158533|17532215|P3|Stage 2|Withdrawal by Subject|0
5079164|NCT02158533|17532216|P2|Stage 2|Withdrawal by Subject|0
5079165|NCT02158533|17532217|P1|Stage 2|Withdrawal by Subject|0
5079166|NCT02158533|17532212|P6|Stage 2|Lost to Follow-up|2
5079167|NCT02158533|17532213|P5|Stage 2|Lost to Follow-up|1
5079168|NCT02158533|17532214|P4|Stage 2|Lost to Follow-up|1
5079169|NCT02158533|17532215|P3|Stage 2|Lost to Follow-up|0
5079170|NCT02158533|17532216|P2|Stage 2|Lost to Follow-up|0
5079171|NCT02158533|17532217|P1|Stage 2|Lost to Follow-up|0
5079172|NCT02158533|17532212|P6|Stage 2|Lack of Efficacy|0
5079173|NCT02158533|17532213|P5|Stage 2|Lack of Efficacy|1
5079174|NCT02158533|17532214|P4|Stage 2|Lack of Efficacy|0
5079175|NCT02158533|17532215|P3|Stage 2|Lack of Efficacy|0
5079176|NCT02158533|17532216|P2|Stage 2|Lack of Efficacy|0
5079177|NCT02158533|17532217|P1|Stage 2|Lack of Efficacy|0
5079178|NCT02158533|17532212|P6|Stage 2|Adverse Event|1
5079179|NCT02158533|17532213|P5|Stage 2|Adverse Event|0
5079180|NCT02158533|17532214|P4|Stage 2|Adverse Event|0
5079181|NCT02158533|17532215|P3|Stage 2|Adverse Event|0
5079182|NCT02158533|17532216|P2|Stage 2|Adverse Event|0
5079183|NCT02158533|17532217|P1|Stage 2|Adverse Event|0
5079184|NCT02158533|17532212|P6|Stage 1|Non-compliance with study visits|0
5079185|NCT02158533|17532213|P5|Stage 1|Non-compliance with study visits|0
5079186|NCT02158533|17532214|P4|Stage 1|Non-compliance with study visits|0
5079187|NCT02158533|17532215|P3|Stage 1|Non-compliance with study visits|0
5079188|NCT02158533|17532216|P2|Stage 1|Non-compliance with study visits|0
5079189|NCT02158533|17532217|P1|Stage 1|Non-compliance with study visits|1
5079190|NCT02158533|17532212|P6|Stage 1|Failure to Meet Eligibility Criteria|0
5079191|NCT02158533|17532213|P5|Stage 1|Failure to Meet Eligibility Criteria|0
5079192|NCT02158533|17532214|P4|Stage 1|Failure to Meet Eligibility Criteria|0
5079193|NCT02158533|17532215|P3|Stage 1|Failure to Meet Eligibility Criteria|0
5079194|NCT02158533|17532216|P2|Stage 1|Failure to Meet Eligibility Criteria|1
5079195|NCT02158533|17532217|P1|Stage 1|Failure to Meet Eligibility Criteria|0
5079196|NCT02158533|17532212|P6|Stage 1|Lost to Follow-up|0
5079197|NCT02158533|17532213|P5|Stage 1|Lost to Follow-up|0
5079198|NCT02158533|17532214|P4|Stage 1|Lost to Follow-up|0
5079199|NCT02158533|17532215|P3|Stage 1|Lost to Follow-up|0
5079200|NCT02158533|17532216|P2|Stage 1|Lost to Follow-up|1
5079201|NCT02158533|17532217|P1|Stage 1|Lost to Follow-up|3
5079202|NCT02158533|17532212|P6|Stage 1|Lack of Efficacy|0
5079203|NCT02158533|17532213|P5|Stage 1|Lack of Efficacy|0
5079204|NCT02158533|17532214|P4|Stage 1|Lack of Efficacy|0
5079205|NCT02158533|17532215|P3|Stage 1|Lack of Efficacy|0
5079206|NCT02158533|17532216|P2|Stage 1|Lack of Efficacy|0
5079207|NCT02158533|17532217|P1|Stage 1|Lack of Efficacy|1
5079208|NCT02158533|17532212|P6|Stage 1|Withdrawal by Subject|0
5079209|NCT02158533|17532213|P5|Stage 1|Withdrawal by Subject|0
5079210|NCT02158533|17532214|P4|Stage 1|Withdrawal by Subject|0
5079211|NCT02158533|17532215|P3|Stage 1|Withdrawal by Subject|1
5079212|NCT02158533|17532216|P2|Stage 1|Withdrawal by Subject|2
5079213|NCT02158533|17532217|P1|Stage 1|Withdrawal by Subject|3
5079214|NCT02158533|17532212|P6|Stage 1|Adverse Event|0
5079215|NCT02158533|17532213|P5|Stage 1|Adverse Event|0
5079216|NCT02158533|17532214|P4|Stage 1|Adverse Event|0
5079217|NCT02158533|17532215|P3|Stage 1|Adverse Event|7
5079218|NCT02158533|17532216|P2|Stage 1|Adverse Event|4
5079219|NCT02158533|17532217|P1|Stage 1|Adverse Event|6
5079220|NCT02158442|17532293|P2|Overall Study|Perfusion staff not available|0
5079221|NCT02158442|17532294|P1|Overall Study|Perfusion staff not available|1
5079222|NCT02158442|17532293|P2|Overall Study|Withdrawal by Subject|0
5079223|NCT02158442|17532294|P1|Overall Study|Withdrawal by Subject|1
5079224|NCT02158364|17532300|P1|Overall Study|Protocol Deviation|50
5079225|NCT02158364|17532300|P1|Overall Study|Case report forms uncollected|10
5079226|NCT02158247|17532318|P1|Overall Study|Invisible vocal cords|5
5079227|NCT02158091|17532337|P3|Overall Study|DLT|0
5079228|NCT02158091|17532338|P2|Overall Study|DLT|1
5079229|NCT02158091|17532339|P1|Overall Study|DLT|2
5079230|NCT02158039|17532347|P1|Overall Study|Screen Failure|9
5079231|NCT02158039|17532347|P1|Overall Study|Withdrawal by Subject|1
5079232|NCT02157948|17532354|P2|Overall Study|Decision by Sponsor|1
5079233|NCT02157948|17532355|P1|Overall Study|Decision by Sponsor|0
5079234|NCT02157948|17532354|P2|Overall Study|Protocol Specified Criteria|1
5079235|NCT02157948|17532355|P1|Overall Study|Protocol Specified Criteria|2
5079236|NCT02157948|17532354|P2|Overall Study|Lost to Follow-up|2
5079237|NCT02157948|17532355|P1|Overall Study|Lost to Follow-up|3
5079238|NCT02157948|17532354|P2|Overall Study|Withdrawal by Subject|5
5079239|NCT02157948|17532355|P1|Overall Study|Withdrawal by Subject|4
5079240|NCT02157935|17532367|P2|Overall Study|Adverse Event|5
5079241|NCT02157935|17532368|P1|Overall Study|Adverse Event|3
5079242|NCT02157935|17532367|P2|Overall Study|Death|4
5079243|NCT02157935|17532368|P1|Overall Study|Death|4
5079244|NCT02157935|17532367|P2|Overall Study|Lack of Efficacy|1
5079245|NCT02157935|17532368|P1|Overall Study|Lack of Efficacy|0
5079246|NCT02157935|17532367|P2|Overall Study|Other|12
5079247|NCT02157935|17532368|P1|Overall Study|Other|5
5079248|NCT02157935|17532367|P2|Overall Study|Progressive disease|2
5079249|NCT02157935|17532368|P1|Overall Study|Progressive disease|0
5079250|NCT02157935|17532367|P2|Overall Study|Protocol Violation|0
5079251|NCT02157935|17532368|P1|Overall Study|Protocol Violation|1
5079252|NCT02157935|17532367|P2|Overall Study|Screen failure|2
5079253|NCT02157935|17532368|P1|Overall Study|Screen failure|1
5079254|NCT02157935|17532367|P2|Overall Study|Withdrawal by Subject|39
5079255|NCT02157935|17532368|P1|Overall Study|Withdrawal by Subject|25
5079256|NCT02157883|17532394|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
5079257|NCT02157883|17532394|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
5079258|NCT02157883|17532394|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
5079259|NCT02157883|17532394|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
5079260|NCT02157883|17532394|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
5079261|NCT02157779|17532425|P2|Overall Study|Legal issue|0
5079262|NCT02157779|17532426|P1|Overall Study|Legal issue|1
5079263|NCT02157779|17532425|P2|Overall Study|Medical|0
5079264|NCT02157779|17532426|P1|Overall Study|Medical|1
5079265|NCT02157779|17532425|P2|Overall Study|Moved|0
5079266|NCT02157779|17532426|P1|Overall Study|Moved|1
5079267|NCT02157779|17532425|P2|Overall Study|No response to outreach after Baseline|1
5079268|NCT02157779|17532426|P1|Overall Study|No response to outreach after Baseline|1
5079269|NCT02157779|17532425|P2|Overall Study|Stopped attending, reason unknown|7
5079270|NCT02157779|17532426|P1|Overall Study|Stopped attending, reason unknown|11
5079271|NCT02157779|17532425|P2|Overall Study|Logistical|3
5079272|NCT02157779|17532426|P1|Overall Study|Logistical|9
5079273|NCT02157519|17532460|P2|Overall Study|Lost to Follow-up|0
5079274|NCT02157519|17532461|P1|Overall Study|Lost to Follow-up|1
5079275|NCT02157519|17532460|P2|Overall Study|Withdrawal by Subject|0
5079276|NCT02157519|17532461|P1|Overall Study|Withdrawal by Subject|7
5079277|NCT02157519|17532460|P2|Overall Study|Death|1
5079278|NCT02157519|17532461|P1|Overall Study|Death|3
5079279|NCT02157506|17532484|P5|Overall Study|Lost to Follow-up|0
5079280|NCT02157506|17532485|P4|Overall Study|Lost to Follow-up|0
5079281|NCT02157506|17532486|P3|Overall Study|Lost to Follow-up|1
5079282|NCT02157506|17532487|P2|Overall Study|Lost to Follow-up|0
5079283|NCT02157506|17532488|P1|Overall Study|Lost to Follow-up|0
5079284|NCT02157506|17532484|P5|Overall Study|Adverse Event|0
5079285|NCT02157506|17532485|P4|Overall Study|Adverse Event|0
5079286|NCT02157506|17532486|P3|Overall Study|Adverse Event|0
5079287|NCT02157506|17532487|P2|Overall Study|Adverse Event|1
5079288|NCT02157506|17532488|P1|Overall Study|Adverse Event|0
5079289|NCT02157376|17532547|P2|Overall Study|Investigator's misjudgement|2
5079290|NCT02157376|17532548|P1|Overall Study|Investigator's misjudgement|1
5079291|NCT02157376|17532547|P2|Overall Study|Not treated|3
5079292|NCT02157376|17532548|P1|Overall Study|Not treated|8
5079293|NCT02157376|17532547|P2|Overall Study|Withdrawal by Subject|8
5079294|NCT02157376|17532548|P1|Overall Study|Withdrawal by Subject|3
5079295|NCT02157376|17532547|P2|Overall Study|Eligibility criteria not fulfilled|1
5079296|NCT02157376|17532548|P1|Overall Study|Eligibility criteria not fulfilled|0
5079297|NCT02157376|17532547|P2|Overall Study|Death|4
5079298|NCT02157376|17532548|P1|Overall Study|Death|10
5079299|NCT02157298|17532558|P2|Overall Study|Withdrawal by Subject|0
5079300|NCT02157298|17532559|P1|Overall Study|Withdrawal by Subject|1
5079301|NCT02157298|17532558|P2|Overall Study|Poor/Non-compliance|0
5079302|NCT02157298|17532559|P1|Overall Study|Poor/Non-compliance|1
5079303|NCT02157298|17532558|P2|Overall Study|Subject no longer meets study criteria|2
5079304|NCT02157298|17532559|P1|Overall Study|Subject no longer meets study criteria|1
5079305|NCT02157298|17532558|P2|Overall Study|Adverse Event|0
5079306|NCT02157298|17532559|P1|Overall Study|Adverse Event|1
5079307|NCT02157116|17532598|P1|Overall Study|Failed Screening|2
5079308|NCT02157116|17532598|P1|Overall Study|Physician Decision|3
5079309|NCT02157116|17532598|P1|Overall Study|Withdrawal by Subject|4
5079310|NCT02156804|17532624|P1|Overall Study|Withdrawal by Subject|1
5079311|NCT02156492|17532658|P3|Period 3|Adverse Event|0
5079312|NCT02156492|17532659|P2|Period 3|Adverse Event|1
5079313|NCT02156492|17532660|P1|Period 3|Adverse Event|0
5079314|NCT02156492|17532658|P3|Period 1|No Reason Given|0
5079315|NCT02156492|17532659|P2|Period 1|No Reason Given|1
5079316|NCT02156492|17532660|P1|Period 1|No Reason Given|0
5079317|NCT02156466|17532686|P5|Overall Study|Quantiferon Positivity|0
5079318|NCT02156466|17532687|P4|Overall Study|Quantiferon Positivity|1
5079319|NCT02156466|17532688|P3|Overall Study|Quantiferon Positivity|0
5079320|NCT02156466|17532689|P2|Overall Study|Quantiferon Positivity|0
5079321|NCT02156466|17532690|P1|Overall Study|Quantiferon Positivity|0
5079322|NCT02156466|17532686|P5|Overall Study|Adverse Event|0
5079323|NCT02156466|17532687|P4|Overall Study|Adverse Event|1
5079324|NCT02156466|17532688|P3|Overall Study|Adverse Event|1
5079325|NCT02156466|17532689|P2|Overall Study|Adverse Event|0
5079326|NCT02156466|17532690|P1|Overall Study|Adverse Event|0
5079327|NCT02156271|17532871|P2|Overall Study|Physician Decision|3
5079328|NCT02156271|17532872|P1|Overall Study|Physician Decision|4
5079329|NCT02156076|17532925|P4|Follow-up Period|Withdrawal by Subject|0
5079330|NCT02156076|17532926|P3|Follow-up Period|Withdrawal by Subject|0
5079331|NCT02156076|17532927|P2|Follow-up Period|Withdrawal by Subject|0
5079332|NCT02156076|17532928|P1|Follow-up Period|Withdrawal by Subject|1
5079333|NCT02156076|17532925|P4|Treatment Period|Adverse Event|1
5079334|NCT02156076|17532926|P3|Treatment Period|Adverse Event|0
5079335|NCT02156076|17532927|P2|Treatment Period|Adverse Event|0
5079336|NCT02156076|17532928|P1|Treatment Period|Adverse Event|0
5079337|NCT02156076|17532925|P4|Treatment Period|Subject request to discontinue treatment|0
5079338|NCT02156076|17532926|P3|Treatment Period|Subject request to discontinue treatment|0
5079339|NCT02156076|17532927|P2|Treatment Period|Subject request to discontinue treatment|1
5079340|NCT02156076|17532928|P1|Treatment Period|Subject request to discontinue treatment|0
5079341|NCT02156076|17532925|P4|Treatment Period|Withdrawal by Subject|0
5079342|NCT02156076|17532926|P3|Treatment Period|Withdrawal by Subject|1
5079343|NCT02156076|17532927|P2|Treatment Period|Withdrawal by Subject|0
5079344|NCT02156076|17532928|P1|Treatment Period|Withdrawal by Subject|0
5079345|NCT02156076|17532925|P4|Treatment Period|Lost to Follow-up|1
5079346|NCT02156076|17532926|P3|Treatment Period|Lost to Follow-up|0
5079347|NCT02156076|17532927|P2|Treatment Period|Lost to Follow-up|0
5079348|NCT02156076|17532928|P1|Treatment Period|Lost to Follow-up|0
5079349|NCT02156076|17532925|P4|Treatment Period|Poor/non-compliance|0
5079350|NCT02156076|17532926|P3|Treatment Period|Poor/non-compliance|0
5079351|NCT02156076|17532927|P2|Treatment Period|Poor/non-compliance|1
5079352|NCT02156076|17532928|P1|Treatment Period|Poor/non-compliance|0
5079353|NCT02156076|17532925|P4|Treatment Period|no longer meets study criteria|0
5079354|NCT02156076|17532926|P3|Treatment Period|no longer meets study criteria|1
5079355|NCT02156076|17532927|P2|Treatment Period|no longer meets study criteria|0
5079356|NCT02156076|17532928|P1|Treatment Period|no longer meets study criteria|0
5079357|NCT02155985|17532985|P3|Overall Study|Lost to Follow-up|0
5079358|NCT02155985|17532986|P2|Overall Study|Lost to Follow-up|0
5079359|NCT02155985|17532987|P1|Overall Study|Lost to Follow-up|1
5079360|NCT02155985|17532985|P3|Overall Study|Withdrawal by Subject|1
5079361|NCT02155985|17532986|P2|Overall Study|Withdrawal by Subject|0
5079362|NCT02155985|17532987|P1|Overall Study|Withdrawal by Subject|0
5079363|NCT02155881|17533054|P2|Overall Study|Inappropriately randomized|2
5079364|NCT02155881|17533055|P1|Overall Study|Inappropriately randomized|2
5079365|NCT02155881|17533054|P2|Overall Study|Withdrawal by Subject|2
5079366|NCT02155881|17533055|P1|Overall Study|Withdrawal by Subject|0
5079367|NCT02155829|17533077|P2|Overall Study|Protocol Violation|0
5079368|NCT02155829|17533078|P1|Overall Study|Protocol Violation|2
5079369|NCT02155829|17533077|P2|Overall Study|Withdrawal by Subject|3
5079370|NCT02155829|17533078|P1|Overall Study|Withdrawal by Subject|3
5079371|NCT02155829|17533077|P2|Overall Study|Adverse Event|0
5079372|NCT02155829|17533078|P1|Overall Study|Adverse Event|1
5079373|NCT02155738|17533100|P4|Overall Study|Missing critical information|1
5079374|NCT02155738|17533101|P3|Overall Study|Missing critical information|0
5079375|NCT02155738|17533102|P2|Overall Study|Missing critical information|0
5079376|NCT02155738|17533103|P1|Overall Study|Missing critical information|1
5079377|NCT02155712|17533140|P2|Primary Objective|Withdrawal by Subject|0
5079378|NCT02155712|17533141|P1|Primary Objective|Withdrawal by Subject|21
5079379|NCT02155712|17533140|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
5079380|NCT02155712|17533141|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
5079381|NCT02155712|17533140|P2|Primary Objective|No 2-Year Forms but not Terminated|0
5079382|NCT02155712|17533141|P1|Primary Objective|No 2-Year Forms but not Terminated|13
5079383|NCT02155712|17533140|P2|Primary Objective|Lost to Follow-up|0
5079384|NCT02155712|17533141|P1|Primary Objective|Lost to Follow-up|22
5079385|NCT02155712|17533140|P2|Primary Objective|Death|0
5079386|NCT02155712|17533141|P1|Primary Objective|Death|3
5079387|NCT02155660|17533151|P4|Overall Study|Withdrawal by Subject|21
5079388|NCT02155660|17533152|P3|Overall Study|Withdrawal by Subject|24
5079389|NCT02155660|17533153|P2|Overall Study|Withdrawal by Subject|31
5079390|NCT02155660|17533154|P1|Overall Study|Withdrawal by Subject|28
5079391|NCT02155660|17533151|P4|Overall Study|Death|19
5079392|NCT02155660|17533152|P3|Overall Study|Death|17
5079393|NCT02155660|17533153|P2|Overall Study|Death|19
5079394|NCT02155660|17533154|P1|Overall Study|Death|17
5079395|NCT02155660|17533151|P4|Overall Study|Lost to Follow-up|8
5079396|NCT02155660|17533152|P3|Overall Study|Lost to Follow-up|5
5079397|NCT02155660|17533153|P2|Overall Study|Lost to Follow-up|6
5079398|NCT02155660|17533154|P1|Overall Study|Lost to Follow-up|3
5079399|NCT02155660|17533151|P4|Overall Study|Adverse Event|1
5079400|NCT02155660|17533152|P3|Overall Study|Adverse Event|3
5079401|NCT02155660|17533153|P2|Overall Study|Adverse Event|6
5079402|NCT02155660|17533154|P1|Overall Study|Adverse Event|2
5079403|NCT02155660|17533151|P4|Overall Study|Severe non-compliance|1
5079404|NCT02155660|17533152|P3|Overall Study|Severe non-compliance|0
5079405|NCT02155660|17533153|P2|Overall Study|Severe non-compliance|4
5079406|NCT02155660|17533154|P1|Overall Study|Severe non-compliance|0
5079407|NCT02155660|17533151|P4|Overall Study|Study-specific withdrawal criteria|1
5079408|NCT02155660|17533152|P3|Overall Study|Study-specific withdrawal criteria|1
5079409|NCT02155660|17533153|P2|Overall Study|Study-specific withdrawal criteria|1
5079410|NCT02155660|17533154|P1|Overall Study|Study-specific withdrawal criteria|0
5079411|NCT02155660|17533151|P4|Overall Study|Other Reason|10
5079412|NCT02155660|17533152|P3|Overall Study|Other Reason|10
5079413|NCT02155660|17533153|P2|Overall Study|Other Reason|6
5079414|NCT02155660|17533154|P1|Overall Study|Other Reason|8
5079415|NCT02155647|17533237|P2|Overall Study|Off-Treatment, but follow up ongoing|26
5079416|NCT02155647|17533238|P1|Overall Study|Off-Treatment, but follow up ongoing|15
5079417|NCT02155647|17533237|P2|Overall Study|Still on Treatment|26
5079418|NCT02155647|17533238|P1|Overall Study|Still on Treatment|26
5079419|NCT02155608|17533266|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
5079420|NCT02155608|17533267|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
5079421|NCT02155608|17533266|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
5079422|NCT02155608|17533267|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
5079423|NCT02155322|17533364|P1|Overall Study|Withdrawal by Subject|4
5079424|NCT02155322|17533364|P1|Overall Study|Relapse/Recurrence|8
5079425|NCT02155322|17533364|P1|Overall Study|Physician Decision|1
5079426|NCT02155322|17533364|P1|Overall Study|Adverse Event|1
5079427|NCT02155309|17533371|P3|Overall Study|Protocol Violation|1
5079428|NCT02155309|17533372|P2|Overall Study|Protocol Violation|0
5079429|NCT02155309|17533373|P1|Overall Study|Protocol Violation|0
5079430|NCT02155283|17533380|P1|Overall Study|Protocol Violation|3
5079431|NCT02155283|17533380|P1|Overall Study|Withdrawal by Subject|1
5079432|NCT02155283|17533380|P1|Overall Study|Lost to Follow-up|3
5079433|NCT02154581|17533556|P2|Overall Study|Lost to Follow-up|8
5079434|NCT02154581|17533557|P1|Overall Study|Lost to Follow-up|7
5079435|NCT02154425|17533582|P1|Screening Period|Adverse Event|1
5079436|NCT02154347|17533627|P2|Open-label Period|Withdrawal by Subject|1
5079437|NCT02154347|17533628|P1|Open-label Period|Withdrawal by Subject|0
5079438|NCT02154347|17533627|P2|Open-label Period|Protocol Violation|1
5079439|NCT02154347|17533628|P1|Open-label Period|Protocol Violation|0
5079440|NCT02154347|17533627|P2|Open-label Period|Lack of Efficacy|19
5079441|NCT02154347|17533628|P1|Open-label Period|Lack of Efficacy|4
5079442|NCT02154347|17533627|P2|Open-label Period|Adverse Event|4
5079443|NCT02154347|17533628|P1|Open-label Period|Adverse Event|3
5079444|NCT02154347|17533627|P2|Double-blind Period|Withdrawal by Subject|1
5079445|NCT02154347|17533628|P1|Double-blind Period|Withdrawal by Subject|1
5079446|NCT02154347|17533627|P2|Double-blind Period|Physician Decision|1
5079447|NCT02154347|17533628|P1|Double-blind Period|Physician Decision|0
5079448|NCT02154347|17533627|P2|Double-blind Period|Lack of Efficacy|0
5079449|NCT02154347|17533628|P1|Double-blind Period|Lack of Efficacy|1
5079450|NCT02154347|17533627|P2|Double-blind Period|Adverse Event|2
5079451|NCT02154347|17533628|P1|Double-blind Period|Adverse Event|1
5079452|NCT02154139|17533651|P1|Overall Study|Investigator transferred|3
5079453|NCT02154139|17533651|P1|Overall Study|Other|2
5079454|NCT02154139|17533651|P1|Overall Study|Injection not administered|2
5079455|NCT02154087|17533659|P1|Overall Study|Study Termination|1
5079456|NCT02154061|17533665|P2|Overall Study|enrolled but not vaccinated|0
5079457|NCT02154061|17533666|P1|Overall Study|enrolled but not vaccinated|1
5079458|NCT02154061|17533665|P2|Overall Study|Pregnancy|0
5079459|NCT02154061|17533666|P1|Overall Study|Pregnancy|1
5079460|NCT02153918|17533713|P1|Overall Study|Refused further treatment|1
5079461|NCT02153905|17533724|P2|Overall Study|Death|0
5079462|NCT02153905|17533725|P1|Overall Study|Death|1
5079463|NCT02153827|17533743|P2|Overall Study|Lost to Follow-up|9
5079464|NCT02153827|17533744|P1|Overall Study|Lost to Follow-up|3
5079465|NCT02153788|17533760|P2|Overall Study|Physician Decision|1
5079466|NCT02153788|17533761|P1|Overall Study|Physician Decision|2
5079467|NCT02153736|17533781|P2|Overall Study|Withdrawal by Subject|1
5079468|NCT02153736|17533782|P1|Overall Study|Withdrawal by Subject|0
5079469|NCT02153736|17533781|P2|Overall Study|Death|1
5079470|NCT02153736|17533782|P1|Overall Study|Death|0
5079471|NCT02153736|17533781|P2|Overall Study|Medical status change made ineligible|0
5079472|NCT02153736|17533782|P1|Overall Study|Medical status change made ineligible|1
5079473|NCT02153736|17533781|P2|Overall Study|Lost to Follow-up|0
5079474|NCT02153736|17533782|P1|Overall Study|Lost to Follow-up|1
5079475|NCT02153398|17534009|P5|Overall Study|Adverse Event|0
5079476|NCT02153398|17534010|P4|Overall Study|Adverse Event|1
5079477|NCT02153398|17534011|P3|Overall Study|Adverse Event|1
5079478|NCT02153398|17534012|P2|Overall Study|Adverse Event|0
5079479|NCT02153398|17534013|P1|Overall Study|Adverse Event|0
5079480|NCT02153398|17534009|P5|Overall Study|Withdrawal by Subject|0
5079481|NCT02153398|17534010|P4|Overall Study|Withdrawal by Subject|0
5079482|NCT02153398|17534011|P3|Overall Study|Withdrawal by Subject|0
5079483|NCT02153398|17534012|P2|Overall Study|Withdrawal by Subject|0
5079484|NCT02153398|17534013|P1|Overall Study|Withdrawal by Subject|1
5079485|NCT02153359|17534135|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
5079486|NCT02153359|17534136|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
5079487|NCT02153346|17534170|P1|Overall Study|Lost to Follow-up|11
5079488|NCT02153112|17534187|P10|Overall Study|Reason not Specified|1
5079489|NCT02153112|17534188|P9|Overall Study|Reason not Specified|1
5079490|NCT02153112|17534189|P8|Overall Study|Reason not Specified|0
5079491|NCT02153112|17534190|P7|Overall Study|Reason not Specified|0
5079492|NCT02153112|17534191|P6|Overall Study|Reason not Specified|0
5079493|NCT02153112|17534192|P5|Overall Study|Reason not Specified|0
5079494|NCT02153112|17534193|P4|Overall Study|Reason not Specified|0
5079495|NCT02153112|17534194|P3|Overall Study|Reason not Specified|0
5079496|NCT02153112|17534195|P2|Overall Study|Reason not Specified|0
5079497|NCT02153112|17534196|P1|Overall Study|Reason not Specified|0
5079498|NCT02153112|17534187|P10|Overall Study|Withdrawal by Subject|12
5079499|NCT02153112|17534188|P9|Overall Study|Withdrawal by Subject|13
5079500|NCT02153112|17534189|P8|Overall Study|Withdrawal by Subject|2
5079501|NCT02153112|17534190|P7|Overall Study|Withdrawal by Subject|7
5079502|NCT02153112|17534191|P6|Overall Study|Withdrawal by Subject|1
5079503|NCT02153112|17534192|P5|Overall Study|Withdrawal by Subject|1
5079504|NCT02153112|17534193|P4|Overall Study|Withdrawal by Subject|2
5079505|NCT02153112|17534194|P3|Overall Study|Withdrawal by Subject|2
5079506|NCT02153112|17534195|P2|Overall Study|Withdrawal by Subject|1
5079507|NCT02153112|17534196|P1|Overall Study|Withdrawal by Subject|3
5079508|NCT02153112|17534187|P10|Overall Study|Lost to Follow-up|1
5079509|NCT02153112|17534188|P9|Overall Study|Lost to Follow-up|1
5079510|NCT02153112|17534189|P8|Overall Study|Lost to Follow-up|0
5079511|NCT02153112|17534190|P7|Overall Study|Lost to Follow-up|1
5079512|NCT02153112|17534191|P6|Overall Study|Lost to Follow-up|1
5079513|NCT02153112|17534192|P5|Overall Study|Lost to Follow-up|2
5079514|NCT02153112|17534193|P4|Overall Study|Lost to Follow-up|0
5079515|NCT02153112|17534194|P3|Overall Study|Lost to Follow-up|0
5079516|NCT02153112|17534195|P2|Overall Study|Lost to Follow-up|1
5079517|NCT02153112|17534196|P1|Overall Study|Lost to Follow-up|1
5079518|NCT02153112|17534187|P10|Overall Study|Adverse Event|0
5079519|NCT02153112|17534188|P9|Overall Study|Adverse Event|0
5079520|NCT02153112|17534189|P8|Overall Study|Adverse Event|0
5079521|NCT02153112|17534190|P7|Overall Study|Adverse Event|0
5079522|NCT02153112|17534191|P6|Overall Study|Adverse Event|0
5079523|NCT02153112|17534192|P5|Overall Study|Adverse Event|0
5079524|NCT02153112|17534193|P4|Overall Study|Adverse Event|0
5079525|NCT02153112|17534194|P3|Overall Study|Adverse Event|1
5079526|NCT02153112|17534195|P2|Overall Study|Adverse Event|0
5079527|NCT02153112|17534196|P1|Overall Study|Adverse Event|0
5079528|NCT02153086|17534535|P1|Overall Study|Other|2
5079529|NCT02153086|17534535|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
5079530|NCT02153073|17534549|P1|Overall Study|Protocol Deviation|68
5079531|NCT02153073|17534549|P1|Overall Study|Case Report Forms Uncollected|230
5079532|NCT02152761|17534577|P4|Epoch: Post-treatment Follow-up Epoch|Death|1
5079533|NCT02152761|17534578|P3|Epoch: Post-treatment Follow-up Epoch|Death|0
5079534|NCT02152761|17534579|P2|Epoch: Post-treatment Follow-up Epoch|Death|0
5079535|NCT02152761|17534580|P1|Epoch: Post-treatment Follow-up Epoch|Death|1
5079536|NCT02152761|17534577|P4|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5079537|NCT02152761|17534578|P3|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5079538|NCT02152761|17534579|P2|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5079539|NCT02152761|17534580|P1|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
5079540|NCT02152761|17534577|P4|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
5079541|NCT02152761|17534578|P3|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
5079542|NCT02152761|17534579|P2|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
5079543|NCT02152761|17534580|P1|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
5079544|NCT02152761|17534577|P4|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
5079545|NCT02152761|17534578|P3|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
5079546|NCT02152761|17534579|P2|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
5079547|NCT02152761|17534580|P1|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
5079548|NCT02152761|17534577|P4|Epoch: Treatment Epoch|Non-compliance with treatment|0
5079549|NCT02152761|17534578|P3|Epoch: Treatment Epoch|Non-compliance with treatment|0
5079550|NCT02152761|17534579|P2|Epoch: Treatment Epoch|Non-compliance with treatment|1
5079551|NCT02152761|17534580|P1|Epoch: Treatment Epoch|Non-compliance with treatment|1
5079552|NCT02152761|17534577|P4|Epoch: Treatment Epoch|Death|0
5079553|NCT02152761|17534578|P3|Epoch: Treatment Epoch|Death|1
5079554|NCT02152761|17534579|P2|Epoch: Treatment Epoch|Death|3
5079555|NCT02152761|17534580|P1|Epoch: Treatment Epoch|Death|0
5079556|NCT02152761|17534577|P4|Epoch: Treatment Epoch|Adverse Event|2
5079557|NCT02152761|17534578|P3|Epoch: Treatment Epoch|Adverse Event|1
5079558|NCT02152761|17534579|P2|Epoch: Treatment Epoch|Adverse Event|6
5079559|NCT02152761|17534580|P1|Epoch: Treatment Epoch|Adverse Event|3
5079560|NCT02152761|17534577|P4|Epoch: Treatment Epoch|Withdrawal by Subject|5
5079561|NCT02152761|17534578|P3|Epoch: Treatment Epoch|Withdrawal by Subject|3
5079562|NCT02152761|17534579|P2|Epoch: Treatment Epoch|Withdrawal by Subject|8
5079563|NCT02152761|17534580|P1|Epoch: Treatment Epoch|Withdrawal by Subject|7
5079564|NCT02152761|17534577|P4|Epoch: Treatment Epoch|Lost to Follow-up|0
5079565|NCT02152761|17534578|P3|Epoch: Treatment Epoch|Lost to Follow-up|0
5079566|NCT02152761|17534579|P2|Epoch: Treatment Epoch|Lost to Follow-up|2
5079567|NCT02152761|17534580|P1|Epoch: Treatment Epoch|Lost to Follow-up|0
5079568|NCT02152761|17534577|P4|Epoch: Treatment Epoch|Technical problems|1
5079569|NCT02152761|17534578|P3|Epoch: Treatment Epoch|Technical problems|0
5079570|NCT02152761|17534579|P2|Epoch: Treatment Epoch|Technical problems|0
5079571|NCT02152761|17534580|P1|Epoch: Treatment Epoch|Technical problems|0
5079572|NCT02152631|17534620|P2|Overall Study|On Treatment|3
5079573|NCT02152631|17534621|P1|Overall Study|On Treatment|19
5079574|NCT02152631|17534620|P2|Overall Study|Lost to Follow-up|1
5079575|NCT02152631|17534621|P1|Overall Study|Lost to Follow-up|0
5079576|NCT02152631|17534620|P2|Overall Study|Physician Decision|2
5079577|NCT02152631|17534621|P1|Overall Study|Physician Decision|1
5079578|NCT02152631|17534620|P2|Overall Study|Noncompliance with study drug|0
5079579|NCT02152631|17534621|P1|Overall Study|Noncompliance with study drug|1
5079580|NCT02152631|17534620|P2|Overall Study|Withdrawal by Subject|16
5079581|NCT02152631|17534621|P1|Overall Study|Withdrawal by Subject|13
5079582|NCT02152631|17534620|P2|Overall Study|Adverse Event|4
5079583|NCT02152631|17534621|P1|Overall Study|Adverse Event|32
5079584|NCT02152605|17534640|P2|Overall Study|Withdrew consent|2
5079585|NCT02152605|17534641|P1|Overall Study|Withdrew consent|4
5079586|NCT02152605|17534640|P2|Overall Study|Lost to Follow-up|0
5079587|NCT02152605|17534641|P1|Overall Study|Lost to Follow-up|1
5079588|NCT02152605|17534640|P2|Overall Study|Protocol deviation|4
5079589|NCT02152605|17534641|P1|Overall Study|Protocol deviation|1
5079590|NCT02152605|17534640|P2|Overall Study|Lack of Efficacy|4
5079591|NCT02152605|17534641|P1|Overall Study|Lack of Efficacy|7
5079592|NCT02152605|17534640|P2|Overall Study|Adverse Event|8
5079593|NCT02152605|17534641|P1|Overall Study|Adverse Event|6
5079594|NCT02152566|17534651|P1|Overall Study|Withdrawal by Subject|2
5079595|NCT02152566|17534651|P1|Overall Study|Lost to Follow-up|1
5079596|NCT02152384|17534664|P2|Period 1|Adverse Event|1
5079597|NCT02152384|17534665|P1|Period 1|Adverse Event|1
5079598|NCT02152384|17534664|P2|Period 1|Withdrawal by Subject|1
5079599|NCT02152384|17534665|P1|Period 1|Withdrawal by Subject|0
5079600|NCT02152371|17534685|P2|Overall Study|Reason Not Given|1
5079601|NCT02152371|17534686|P1|Overall Study|Reason Not Given|0
5079602|NCT02152371|17534685|P2|Overall Study|Physician Decision|2
5079603|NCT02152371|17534686|P1|Overall Study|Physician Decision|0
5079604|NCT02152371|17534685|P2|Overall Study|Lack of Efficacy|1
5079605|NCT02152371|17534686|P1|Overall Study|Lack of Efficacy|0
5079606|NCT02152371|17534685|P2|Overall Study|Lost to Follow-up|0
5079607|NCT02152371|17534686|P1|Overall Study|Lost to Follow-up|1
5079608|NCT02152371|17534685|P2|Overall Study|Protocol Violation|3
5079609|NCT02152371|17534686|P1|Overall Study|Protocol Violation|2
5079610|NCT02152371|17534685|P2|Overall Study|Withdrawal by Subject|7
5079611|NCT02152371|17534686|P1|Overall Study|Withdrawal by Subject|3
5079612|NCT02152371|17534685|P2|Overall Study|Adverse Event|2
5079613|NCT02152371|17534686|P1|Overall Study|Adverse Event|6
5079614|NCT02152345|17534724|P2|Overall Study|Withdrawal by Subject|1
5079615|NCT02152345|17534725|P1|Overall Study|Withdrawal by Subject|2
5079616|NCT02152345|17534724|P2|Overall Study|Case Cancellations|4
5079617|NCT02152345|17534725|P1|Overall Study|Case Cancellations|2
5079618|NCT02152137|17534737|P1|Overall Study|Originally assigned to Arm B|3
5079619|NCT02152137|17534737|P1|Overall Study|Withdrawal by Subject|1
5079620|NCT02152007|17534745|P1|Overall Study|Withdrawal by Subject|1
5079621|NCT02151981|17534806|P2|Overall Study|Eligibility criteria not fulfilled|1
5079622|NCT02151981|17534807|P1|Overall Study|Eligibility criteria not fulfilled|0
5079623|NCT02151981|17534806|P2|Overall Study|Ongoing Study at Data Cut-off|95
5079624|NCT02151981|17534807|P1|Overall Study|Ongoing Study at Data Cut-off|224
5079625|NCT02151981|17534806|P2|Overall Study|Withdrawal by Subject|18
5079626|NCT02151981|17534807|P1|Overall Study|Withdrawal by Subject|19
5079627|NCT02151981|17534806|P2|Overall Study|Lost to Follow-up|0
5079628|NCT02151981|17534807|P1|Overall Study|Lost to Follow-up|1
5079629|NCT02151981|17534806|P2|Overall Study|Death|26
5079630|NCT02151981|17534807|P1|Overall Study|Death|35
5079631|NCT02151903|17534825|P2|Overall Study|Progressive disease|1
5079632|NCT02151903|17534826|P1|Overall Study|Progressive disease|2
5079633|NCT02151903|17534825|P2|Overall Study|Withdrawal by Subject|0
5079634|NCT02151903|17534826|P1|Overall Study|Withdrawal by Subject|1
5079635|NCT02151851|17534863|P2|Overall Study|Adverse Event|28
5079636|NCT02151851|17534864|P1|Overall Study|Adverse Event|6
5079637|NCT02151851|17534863|P2|Overall Study|Subject entered into study in error|1
5079638|NCT02151851|17534864|P1|Overall Study|Subject entered into study in error|0
5079639|NCT02151851|17534863|P2|Overall Study|Low compliance to study visits|1
5079640|NCT02151851|17534864|P1|Overall Study|Low compliance to study visits|0
5079641|NCT02151851|17534863|P2|Overall Study|Medical impairment|0
5079642|NCT02151851|17534864|P1|Overall Study|Medical impairment|1
5079643|NCT02151851|17534863|P2|Overall Study|Withdrawal by Subject|5
5079644|NCT02151851|17534864|P1|Overall Study|Withdrawal by Subject|2
5079645|NCT02151851|17534863|P2|Overall Study|Protocol Violation|1
5079646|NCT02151851|17534864|P1|Overall Study|Protocol Violation|0
5079647|NCT02151851|17534863|P2|Overall Study|Lack of Efficacy|94
5079648|NCT02151851|17534864|P1|Overall Study|Lack of Efficacy|67
5079649|NCT02151786|17534876|P1|Overall Study|Unavailability of Information|8
5079650|NCT02151786|17534876|P1|Overall Study|Randomized, not Treated|1
5079651|NCT02151786|17534876|P1|Overall Study|Outside the Contract Period|1
5079652|NCT02151786|17534876|P1|Overall Study|Unavailability of Case Report Form|26
5079653|NCT02151773|17534887|P1|Overall Study|Protocol Deviation|64
5079654|NCT02151682|17534894|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
5079655|NCT02151682|17534895|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5079656|NCT02151682|17534896|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5079657|NCT02151682|17534897|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5079658|NCT02151682|17534898|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5079659|NCT02151682|17534899|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5079660|NCT02151682|17534894|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
5079661|NCT02151682|17534895|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5079662|NCT02151682|17534896|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5079663|NCT02151682|17534897|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5079664|NCT02151682|17534898|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5079665|NCT02151682|17534899|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5079666|NCT02151682|17534894|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
5079667|NCT02151682|17534895|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
5079668|NCT02151682|17534896|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
5079669|NCT02151682|17534897|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
5079670|NCT02151682|17534898|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
5079671|NCT02151682|17534899|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
5079672|NCT02151682|17534894|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
5079673|NCT02151682|17534895|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5079674|NCT02151682|17534896|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5079675|NCT02151682|17534897|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5079676|NCT02151682|17534898|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5079677|NCT02151682|17534899|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5079678|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5079679|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5079680|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5079681|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
5079682|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5079683|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5079684|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Various other|0
5079685|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Various other|0
5079686|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Various other|0
5079687|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Various other|6
5079688|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Various other|0
5079689|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Various other|0
5079690|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Missing|0
5079691|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Missing|0
5079692|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Missing|1
5079693|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Missing|0
5079694|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Missing|0
5079695|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Missing|0
5079696|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
5079697|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
5079698|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
5079699|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
5079700|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
5079701|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
5079702|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5079703|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5079704|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5079705|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
5079706|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5079707|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5079708|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5079709|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5079710|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5079711|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
5079712|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5079713|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5079714|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5079715|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5079716|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
5079717|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
5079718|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5079719|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5079720|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Death|0
5079721|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Death|0
5079722|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Death|2
5079723|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Death|0
5079724|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Death|0
5079725|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Death|0
5079726|NCT02151682|17534894|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
5079727|NCT02151682|17534895|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
5079728|NCT02151682|17534896|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
5079729|NCT02151682|17534897|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
5079730|NCT02151682|17534898|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
5079731|NCT02151682|17534899|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
5079732|NCT02151682|17534894|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5079733|NCT02151682|17534895|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5079734|NCT02151682|17534896|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5079735|NCT02151682|17534897|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5079736|NCT02151682|17534898|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5079737|NCT02151682|17534899|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
5079738|NCT02151682|17534894|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5079739|NCT02151682|17534895|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5079740|NCT02151682|17534896|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5079741|NCT02151682|17534897|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5079742|NCT02151682|17534898|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
5079743|NCT02151682|17534899|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
5079744|NCT02151682|17534894|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5079745|NCT02151682|17534895|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5079746|NCT02151682|17534896|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5079747|NCT02151682|17534897|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5079748|NCT02151682|17534898|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
5079749|NCT02151682|17534899|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5079750|NCT02151682|17534894|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5079751|NCT02151682|17534895|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5079752|NCT02151682|17534896|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5079753|NCT02151682|17534897|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5079754|NCT02151682|17534898|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
5079755|NCT02151682|17534899|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5079756|NCT02151682|17534894|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5079757|NCT02151682|17534895|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5079758|NCT02151682|17534896|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5079759|NCT02151682|17534897|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5079760|NCT02151682|17534898|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
5079761|NCT02151682|17534899|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5079762|NCT02151643|17534949|P5|Overall Study|High Ferritin levels|1
5079763|NCT02151643|17534950|P4|Overall Study|High Ferritin levels|2
5079764|NCT02151643|17534951|P3|Overall Study|High Ferritin levels|2
5079765|NCT02151643|17534952|P2|Overall Study|High Ferritin levels|3
5079766|NCT02151643|17534953|P1|Overall Study|High Ferritin levels|3
5079767|NCT02151643|17534949|P5|Overall Study|Hyperphosphataemia|1
5079768|NCT02151643|17534950|P4|Overall Study|Hyperphosphataemia|0
5079769|NCT02151643|17534951|P3|Overall Study|Hyperphosphataemia|0
5079770|NCT02151643|17534952|P2|Overall Study|Hyperphosphataemia|0
5079771|NCT02151643|17534953|P1|Overall Study|Hyperphosphataemia|1
5079772|NCT02151643|17534949|P5|Overall Study|Withdrawal by Subject|1
5079773|NCT02151643|17534950|P4|Overall Study|Withdrawal by Subject|1
5079774|NCT02151643|17534951|P3|Overall Study|Withdrawal by Subject|1
5079775|NCT02151643|17534952|P2|Overall Study|Withdrawal by Subject|1
5079776|NCT02151643|17534953|P1|Overall Study|Withdrawal by Subject|0
5079777|NCT02151643|17534949|P5|Overall Study|Adverse Event|0
5079778|NCT02151643|17534950|P4|Overall Study|Adverse Event|4
5079779|NCT02151643|17534951|P3|Overall Study|Adverse Event|1
5079780|NCT02151643|17534952|P2|Overall Study|Adverse Event|0
5079781|NCT02151643|17534953|P1|Overall Study|Adverse Event|2
5079782|NCT02151591|17534992|P2|Overall Study|Lost to Follow-up|3
5079783|NCT02151591|17534993|P1|Overall Study|Lost to Follow-up|6
5079784|NCT02151461|17535064|P4|Overall Study|Treatment discontinuation|0
5079785|NCT02151461|17535065|P3|Overall Study|Treatment discontinuation|1
5079786|NCT02151461|17535066|P2|Overall Study|Treatment discontinuation|0
5079787|NCT02151461|17535067|P1|Overall Study|Treatment discontinuation|0
5079788|NCT02151461|17535064|P4|Overall Study|Withdrawal by Subject|1
5079789|NCT02151461|17535065|P3|Overall Study|Withdrawal by Subject|1
5079790|NCT02151461|17535066|P2|Overall Study|Withdrawal by Subject|0
5079791|NCT02151461|17535067|P1|Overall Study|Withdrawal by Subject|1
5079792|NCT02151461|17535064|P4|Overall Study|Lost to Follow-up|1
5079793|NCT02151461|17535065|P3|Overall Study|Lost to Follow-up|1
5079794|NCT02151461|17535066|P2|Overall Study|Lost to Follow-up|0
5079795|NCT02151461|17535067|P1|Overall Study|Lost to Follow-up|0
5079796|NCT02151461|17535064|P4|Overall Study|Adverse Event|2
5079797|NCT02151461|17535065|P3|Overall Study|Adverse Event|0
5079798|NCT02151461|17535066|P2|Overall Study|Adverse Event|1
5079799|NCT02151461|17535067|P1|Overall Study|Adverse Event|5
5079800|NCT02151266|17535199|P3|Overall Study|Not able to exercise|4
5079801|NCT02151266|17535200|P2|Overall Study|Not able to exercise|5
5079802|NCT02151266|17535201|P1|Overall Study|Not able to exercise|4
5079803|NCT02151266|17535199|P3|Overall Study|Did NOT receive intervention|2
5079804|NCT02151266|17535200|P2|Overall Study|Did NOT receive intervention|6
5079805|NCT02151266|17535201|P1|Overall Study|Did NOT receive intervention|3
5079806|NCT02151266|17535199|P3|Overall Study|Lost to Follow-up|1
5079807|NCT02151266|17535200|P2|Overall Study|Lost to Follow-up|4
5079808|NCT02151266|17535201|P1|Overall Study|Lost to Follow-up|1
5079809|NCT02151149|17535244|P2|Follow-Up Period|Death|34
5079810|NCT02151149|17535245|P1|Follow-Up Period|Death|37
5079811|NCT02151149|17535244|P2|Follow-Up Period|Lost to Follow-up|3
5079812|NCT02151149|17535245|P1|Follow-Up Period|Lost to Follow-up|2
5079813|NCT02151149|17535244|P2|Treatment Period|Participants randomized but not treated|2
5079814|NCT02151149|17535245|P1|Treatment Period|Participants randomized but not treated|3
5079815|NCT02151149|17535244|P2|Treatment Period|Miscellaneous|7
5079816|NCT02151149|17535245|P1|Treatment Period|Miscellaneous|8
5079817|NCT02151149|17535244|P2|Treatment Period|Withdrawal by Subject|11
5079818|NCT02151149|17535245|P1|Treatment Period|Withdrawal by Subject|13
5079819|NCT02151149|17535244|P2|Treatment Period|Symptomatic Deterioration|10
5079820|NCT02151149|17535245|P1|Treatment Period|Symptomatic Deterioration|2
5079821|NCT02151149|17535244|P2|Treatment Period|Progressive Disease|24
5079822|NCT02151149|17535245|P1|Treatment Period|Progressive Disease|25
5079823|NCT02151149|17535244|P2|Treatment Period|Adverse Event|14
5079824|NCT02151149|17535245|P1|Treatment Period|Adverse Event|17
5079825|NCT02151149|17535244|P2|Treatment Period|Death|3
5079826|NCT02151149|17535245|P1|Treatment Period|Death|2
5079827|NCT02151110|17535277|P8|Overall Study|Lost to Follow-up|2
5079828|NCT02151110|17535278|P7|Overall Study|Lost to Follow-up|0
5079829|NCT02151110|17535279|P6|Overall Study|Lost to Follow-up|0
5079830|NCT02151110|17535280|P5|Overall Study|Lost to Follow-up|0
5079831|NCT02151110|17535281|P4|Overall Study|Lost to Follow-up|0
5079832|NCT02151110|17535282|P3|Overall Study|Lost to Follow-up|0
5079833|NCT02151110|17535283|P2|Overall Study|Lost to Follow-up|0
5079834|NCT02151110|17535284|P1|Overall Study|Lost to Follow-up|0
5079835|NCT02151110|17535277|P8|Overall Study|Withdrawal by Subject|1
5079836|NCT02151110|17535278|P7|Overall Study|Withdrawal by Subject|0
5079837|NCT02151110|17535279|P6|Overall Study|Withdrawal by Subject|0
5079838|NCT02151110|17535280|P5|Overall Study|Withdrawal by Subject|0
5079839|NCT02151110|17535281|P4|Overall Study|Withdrawal by Subject|0
5079840|NCT02151110|17535282|P3|Overall Study|Withdrawal by Subject|0
5079841|NCT02151110|17535283|P2|Overall Study|Withdrawal by Subject|0
5079842|NCT02151110|17535284|P1|Overall Study|Withdrawal by Subject|0
5079843|NCT02151058|17535377|P3|Overall Study|Lost to Follow-up|2
5079844|NCT02151058|17535378|P2|Overall Study|Lost to Follow-up|0
5079845|NCT02151058|17535379|P1|Overall Study|Lost to Follow-up|1
5079846|NCT02151058|17535377|P3|Overall Study|Withdrawal by Subject|3
5079847|NCT02151058|17535378|P2|Overall Study|Withdrawal by Subject|1
5079848|NCT02151058|17535379|P1|Overall Study|Withdrawal by Subject|1
5079849|NCT02150954|17535413|P2|Overall Study|Protocol Violation|0
5079850|NCT02150954|17535414|P1|Overall Study|Protocol Violation|1
5079851|NCT02150863|17535439|P3|Overall Study|Lost to Follow-up|0
5079852|NCT02150863|17535440|P2|Overall Study|Lost to Follow-up|1
5079853|NCT02150863|17535441|P1|Overall Study|Lost to Follow-up|0
5079854|NCT02150343|17535687|P4|Overall Study|Other|2
5079855|NCT02150343|17535688|P3|Overall Study|Other|0
5079856|NCT02150343|17535689|P2|Overall Study|Other|6
5079857|NCT02150343|17535690|P1|Overall Study|Other|2
5079858|NCT02150343|17535687|P4|Overall Study|Lost to Follow-up|3
5079859|NCT02150343|17535688|P3|Overall Study|Lost to Follow-up|2
5079860|NCT02150343|17535689|P2|Overall Study|Lost to Follow-up|4
5079861|NCT02150343|17535690|P1|Overall Study|Lost to Follow-up|4
5079862|NCT02150343|17535687|P4|Overall Study|Withdrawal by Subject|4
5079863|NCT02150343|17535688|P3|Overall Study|Withdrawal by Subject|9
5079864|NCT02150343|17535689|P2|Overall Study|Withdrawal by Subject|10
5079865|NCT02150343|17535690|P1|Overall Study|Withdrawal by Subject|13
5079866|NCT02150343|17535687|P4|Overall Study|Adverse Event|1
5079867|NCT02150343|17535688|P3|Overall Study|Adverse Event|1
5079868|NCT02150343|17535689|P2|Overall Study|Adverse Event|0
5079869|NCT02150343|17535690|P1|Overall Study|Adverse Event|2
5079870|NCT02150213|17535728|P1|Overall Study|Withdrawal by Subject|1
5079871|NCT02150213|17535728|P1|Overall Study|Lost to Follow-up|1
5079872|NCT02150057|17535747|P2|Overall Study|Lost to Follow-up|4
5079873|NCT02150057|17535748|P1|Overall Study|Lost to Follow-up|6
5079874|NCT02149875|17535763|P3|Overall Study|Physician Decision|2
5079875|NCT02149875|17535764|P2|Overall Study|Physician Decision|2
5079876|NCT02149875|17535765|P1|Overall Study|Physician Decision|1
5079877|NCT02149875|17535763|P3|Overall Study|Withdrawal by Subject|2
5079878|NCT02149875|17535764|P2|Overall Study|Withdrawal by Subject|2
5079879|NCT02149875|17535765|P1|Overall Study|Withdrawal by Subject|3
5079880|NCT02149875|17535763|P3|Overall Study|Lost to Follow-up|5
5079881|NCT02149875|17535764|P2|Overall Study|Lost to Follow-up|4
5079882|NCT02149875|17535765|P1|Overall Study|Lost to Follow-up|3
5079883|NCT02149836|17535776|P1|Overall Study|Withdrawal by Subject|1
5079884|NCT02149420|17535803|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
5079885|NCT02149420|17535804|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
5079886|NCT02149420|17535805|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
5079887|NCT02149420|17535803|P3|Core Study|Administrative problems|2
5079888|NCT02149420|17535804|P2|Core Study|Administrative problems|1
5079889|NCT02149420|17535805|P1|Core Study|Administrative problems|0
5079890|NCT02149264|17535881|P1|Overall Study|Protocol Violation|1
5079891|NCT02149264|17535881|P1|Overall Study|Physician Decision|3
5079892|NCT02149264|17535881|P1|Overall Study|Adverse Event|7
5079893|NCT02149264|17535881|P1|Overall Study|Withdrawal by Subject|9
5079894|NCT02149199|17535897|P3|Overall Study|Adverse Event|9
5079895|NCT02149199|17535898|P2|Overall Study|Adverse Event|15
5079896|NCT02149199|17535899|P1|Overall Study|Adverse Event|6
5079897|NCT02149199|17535897|P3|Overall Study|Death|1
5079898|NCT02149199|17535898|P2|Overall Study|Death|0
5079899|NCT02149199|17535899|P1|Overall Study|Death|0
5079900|NCT02149199|17535897|P3|Overall Study|Lost to Follow-up|11
5079901|NCT02149199|17535898|P2|Overall Study|Lost to Follow-up|12
5079902|NCT02149199|17535899|P1|Overall Study|Lost to Follow-up|3
5079903|NCT02149199|17535897|P3|Overall Study|Protocol Violation|15
5079904|NCT02149199|17535898|P2|Overall Study|Protocol Violation|13
5079905|NCT02149199|17535899|P1|Overall Study|Protocol Violation|16
5079906|NCT02149199|17535897|P3|Overall Study|Withdrawal by Subject|77
5079907|NCT02149199|17535898|P2|Overall Study|Withdrawal by Subject|93
5079908|NCT02149199|17535899|P1|Overall Study|Withdrawal by Subject|75
5079909|NCT02149199|17535897|P3|Overall Study|Eligibility criteria not fulfilled|8
5079910|NCT02149199|17535898|P2|Overall Study|Eligibility criteria not fulfilled|14
5079911|NCT02149199|17535899|P1|Overall Study|Eligibility criteria not fulfilled|9
5079912|NCT02149199|17535897|P3|Overall Study|Other|20
5079913|NCT02149199|17535898|P2|Overall Study|Other|25
5079914|NCT02149199|17535899|P1|Overall Study|Other|20
5079915|NCT02149199|17535897|P3|Overall Study|Study specific withdrawal criteria|6
5079916|NCT02149199|17535898|P2|Overall Study|Study specific withdrawal criteria|21
5079917|NCT02149199|17535899|P1|Overall Study|Study specific withdrawal criteria|4
5079918|NCT02149108|17535978|P2|Overall Study|Lost to Follow-up|0
5079919|NCT02149108|17535979|P1|Overall Study|Lost to Follow-up|1
5079920|NCT02149108|17535978|P2|Overall Study|Refusal to continue trial medication|11
5079921|NCT02149108|17535979|P1|Overall Study|Refusal to continue trial medication|15
5079922|NCT02149108|17535978|P2|Overall Study|Other not defined above|2
5079923|NCT02149108|17535979|P1|Overall Study|Other not defined above|0
5079924|NCT02149108|17535978|P2|Overall Study|Other Adverse Event (AE)|18
5079925|NCT02149108|17535979|P1|Overall Study|Other Adverse Event (AE)|8
5079926|NCT02149108|17535978|P2|Overall Study|Worsening/adverse event cancer disease|32
5079927|NCT02149108|17535979|P1|Overall Study|Worsening/adverse event cancer disease|31
5079928|NCT02149108|17535978|P2|Overall Study|Progressive Disease (PD)|318
5079929|NCT02149108|17535979|P1|Overall Study|Progressive Disease (PD)|324
5079930|NCT02149108|17535978|P2|Overall Study|Not treated|2
5079931|NCT02149108|17535979|P1|Overall Study|Not treated|1
5079932|NCT02148952|17535993|P2|Follow-Up|Withdrawal by Subject|48
5079933|NCT02148952|17535994|P1|Follow-Up|Withdrawal by Subject|46
5079934|NCT02148952|17535993|P2|Follow-Up|Lost to Follow-up|231
5079935|NCT02148952|17535994|P1|Follow-Up|Lost to Follow-up|219
5079936|NCT02148952|17535993|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
5079937|NCT02148952|17535994|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
5079938|NCT02148952|17535993|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
5079939|NCT02148952|17535994|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
5079940|NCT02148718|17536077|P1|Overall Study|Discontinued Study Prematurely|5
5079941|NCT02148718|17536077|P1|Overall Study|Protocol Violation|26
5079942|NCT02148445|17536125|P2|Overall Study|Death|3
5079943|NCT02148445|17536126|P1|Overall Study|Death|1
5079944|NCT02148250|17536177|P2|Screening|Withdrawal by Subject|0
5079945|NCT02148250|17536178|P1|Screening|Withdrawal by Subject|5
5079946|NCT02148211|17536192|P1|Overall Study|Lost to Follow-up|352
5079947|NCT02148133|17536201|P1|Overall Study|Protocol-defined stopping criteria|2
5079948|NCT02148133|17536201|P1|Overall Study|Protocol deviation|1
5079949|NCT02148133|17536201|P1|Overall Study|Lack of Efficacy|1
5079950|NCT02148133|17536201|P1|Overall Study|Investigator discretion|1
5079951|NCT02147691|17536350|P2|Overall Study|Lost to Follow-up|1
5079952|NCT02147691|17536351|P1|Overall Study|Lost to Follow-up|0
5079953|NCT02147691|17536350|P2|Overall Study|Adverse Event|0
5079954|NCT02147691|17536351|P1|Overall Study|Adverse Event|2
5079955|NCT02147691|17536350|P2|Overall Study|Withdrawal by Subject|0
5079956|NCT02147691|17536351|P1|Overall Study|Withdrawal by Subject|2
5079957|NCT02147587|17536410|P2|Overall Study|Lack of Efficacy|1
5079958|NCT02147587|17536411|P1|Overall Study|Lack of Efficacy|2
5079959|NCT02147587|17536410|P2|Overall Study|Adverse Event|4
5079960|NCT02147587|17536411|P1|Overall Study|Adverse Event|9
5079961|NCT02147561|17536431|P1|Overall Study|Subjects who didn't receive BOTOX|1
5079962|NCT02147561|17536431|P1|Overall Study|Lost to Follow-up|3
5079963|NCT02147353|17536452|P2|Overall Study|medication noncompliance|0
5079964|NCT02147353|17536453|P1|Overall Study|medication noncompliance|3
5079965|NCT02147353|17536452|P2|Overall Study|unable to make visits|0
5079966|NCT02147353|17536453|P1|Overall Study|unable to make visits|4
5079967|NCT02147353|17536452|P2|Overall Study|Lost to Follow-up|0
5079968|NCT02147353|17536453|P1|Overall Study|Lost to Follow-up|2
5079969|NCT02147288|17536486|P10|Overall Study|complications from concurrent hernia rep|0
5079970|NCT02147288|17536487|P9|Overall Study|complications from concurrent hernia rep|0
5079971|NCT02147288|17536488|P8|Overall Study|complications from concurrent hernia rep|0
5079972|NCT02147288|17536489|P7|Overall Study|complications from concurrent hernia rep|0
5079973|NCT02147288|17536490|P6|Overall Study|complications from concurrent hernia rep|0
5079974|NCT02147288|17536491|P5|Overall Study|complications from concurrent hernia rep|0
5079975|NCT02147288|17536492|P4|Overall Study|complications from concurrent hernia rep|0
5079976|NCT02147288|17536493|P3|Overall Study|complications from concurrent hernia rep|0
5079977|NCT02147288|17536494|P2|Overall Study|complications from concurrent hernia rep|1
5079978|NCT02147288|17536495|P1|Overall Study|complications from concurrent hernia rep|0
5079979|NCT02147288|17536486|P10|Overall Study|post-operative hematoma|0
5079980|NCT02147288|17536487|P9|Overall Study|post-operative hematoma|0
5079981|NCT02147288|17536488|P8|Overall Study|post-operative hematoma|0
5079982|NCT02147288|17536489|P7|Overall Study|post-operative hematoma|0
5079983|NCT02147288|17536490|P6|Overall Study|post-operative hematoma|0
5079984|NCT02147288|17536491|P5|Overall Study|post-operative hematoma|0
5079985|NCT02147288|17536492|P4|Overall Study|post-operative hematoma|0
5079986|NCT02147288|17536493|P3|Overall Study|post-operative hematoma|0
5079987|NCT02147288|17536494|P2|Overall Study|post-operative hematoma|1
5079988|NCT02147288|17536495|P1|Overall Study|post-operative hematoma|1
5079989|NCT02147197|17536504|P3|Overall Study|Other Miscellaneous Reasons|3
5079990|NCT02147197|17536505|P2|Overall Study|Other Miscellaneous Reasons|0
5079991|NCT02147197|17536506|P1|Overall Study|Other Miscellaneous Reasons|1
5079992|NCT02147197|17536504|P3|Overall Study|Protocol Violation|3
5079993|NCT02147197|17536505|P2|Overall Study|Protocol Violation|0
5079994|NCT02147197|17536506|P1|Overall Study|Protocol Violation|1
5079995|NCT02147197|17536504|P3|Overall Study|Lost to Follow-up|1
5079996|NCT02147197|17536505|P2|Overall Study|Lost to Follow-up|3
5079997|NCT02147197|17536506|P1|Overall Study|Lost to Follow-up|2
5079998|NCT02147197|17536504|P3|Overall Study|Withdrawal of Consent|2
5079999|NCT02147197|17536505|P2|Overall Study|Withdrawal of Consent|3
5080000|NCT02147197|17536506|P1|Overall Study|Withdrawal of Consent|4
5080001|NCT02147197|17536504|P3|Overall Study|Adverse Event|0
5080002|NCT02147197|17536505|P2|Overall Study|Adverse Event|0
5080003|NCT02147197|17536506|P1|Overall Study|Adverse Event|1
5080004|NCT02147184|17536525|P2|Overall Study|Other|0
5080005|NCT02147184|17536526|P1|Overall Study|Other|1
5080006|NCT02147184|17536525|P2|Overall Study|Physician Decision|2
5080007|NCT02147184|17536526|P1|Overall Study|Physician Decision|0
5080008|NCT02147184|17536525|P2|Overall Study|Moved out of state|3
5080009|NCT02147184|17536526|P1|Overall Study|Moved out of state|3
5080010|NCT02147184|17536525|P2|Overall Study|Pregnancy|0
5080011|NCT02147184|17536526|P1|Overall Study|Pregnancy|6
5080012|NCT02147184|17536525|P2|Overall Study|Study Burden|7
5080013|NCT02147184|17536526|P1|Overall Study|Study Burden|11
5080014|NCT02147184|17536525|P2|Overall Study|Lost to Follow-up|15
5080015|NCT02147184|17536526|P1|Overall Study|Lost to Follow-up|28
5080016|NCT02147158|17536550|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
5080017|NCT02147158|17536551|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
5080018|NCT02147158|17536552|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
5080019|NCT02147158|17536553|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
5080020|NCT02147158|17536554|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
5080021|NCT02147158|17536555|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
5080022|NCT02147158|17536550|P6|Off-Treatment Interval 2|Protocol Violation|0
5080023|NCT02147158|17536551|P5|Off-Treatment Interval 2|Protocol Violation|0
5080024|NCT02147158|17536552|P4|Off-Treatment Interval 2|Protocol Violation|1
5080025|NCT02147158|17536553|P3|Off-Treatment Interval 2|Protocol Violation|0
5080026|NCT02147158|17536554|P2|Off-Treatment Interval 2|Protocol Violation|0
5080027|NCT02147158|17536555|P1|Off-Treatment Interval 2|Protocol Violation|0
5080028|NCT02147158|17536550|P6|Off-Treatment Interval 2|Lost to Follow-up|2
5080029|NCT02147158|17536551|P5|Off-Treatment Interval 2|Lost to Follow-up|2
5080030|NCT02147158|17536552|P4|Off-Treatment Interval 2|Lost to Follow-up|2
5080031|NCT02147158|17536553|P3|Off-Treatment Interval 2|Lost to Follow-up|3
5080032|NCT02147158|17536554|P2|Off-Treatment Interval 2|Lost to Follow-up|0
5080033|NCT02147158|17536555|P1|Off-Treatment Interval 2|Lost to Follow-up|0
5080034|NCT02147158|17536550|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
5080035|NCT02147158|17536551|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
5080036|NCT02147158|17536552|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
5080037|NCT02147158|17536553|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
5080038|NCT02147158|17536554|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
5080039|NCT02147158|17536555|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
5080040|NCT02147158|17536550|P6|Off-Treatment Interval 2|Lack of Efficacy|0
5080041|NCT02147158|17536551|P5|Off-Treatment Interval 2|Lack of Efficacy|0
5080042|NCT02147158|17536552|P4|Off-Treatment Interval 2|Lack of Efficacy|0
5080043|NCT02147158|17536553|P3|Off-Treatment Interval 2|Lack of Efficacy|1
5080044|NCT02147158|17536554|P2|Off-Treatment Interval 2|Lack of Efficacy|1
5080045|NCT02147158|17536555|P1|Off-Treatment Interval 2|Lack of Efficacy|0
5080046|NCT02147158|17536550|P6|Treatment Course 2|Lost to Follow-up|1
5080047|NCT02147158|17536551|P5|Treatment Course 2|Lost to Follow-up|0
5080048|NCT02147158|17536552|P4|Treatment Course 2|Lost to Follow-up|1
5080049|NCT02147158|17536553|P3|Treatment Course 2|Lost to Follow-up|1
5080050|NCT02147158|17536554|P2|Treatment Course 2|Lost to Follow-up|0
5080051|NCT02147158|17536555|P1|Treatment Course 2|Lost to Follow-up|1
5080052|NCT02147158|17536550|P6|Treatment Course 2|Withdrawal of Consent|0
5080053|NCT02147158|17536551|P5|Treatment Course 2|Withdrawal of Consent|0
5080054|NCT02147158|17536552|P4|Treatment Course 2|Withdrawal of Consent|3
5080055|NCT02147158|17536553|P3|Treatment Course 2|Withdrawal of Consent|2
5080056|NCT02147158|17536554|P2|Treatment Course 2|Withdrawal of Consent|1
5080057|NCT02147158|17536555|P1|Treatment Course 2|Withdrawal of Consent|0
5080058|NCT02147158|17536550|P6|Treatment Course 2|Adverse Event|1
5080059|NCT02147158|17536551|P5|Treatment Course 2|Adverse Event|0
5080060|NCT02147158|17536552|P4|Treatment Course 2|Adverse Event|1
5080061|NCT02147158|17536553|P3|Treatment Course 2|Adverse Event|2
5080062|NCT02147158|17536554|P2|Treatment Course 2|Adverse Event|4
5080063|NCT02147158|17536555|P1|Treatment Course 2|Adverse Event|0
5080064|NCT02147158|17536550|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5080065|NCT02147158|17536551|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5080066|NCT02147158|17536552|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
5080067|NCT02147158|17536553|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
5080068|NCT02147158|17536554|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5080069|NCT02147158|17536555|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
5080070|NCT02147158|17536550|P6|Off-Treatment Interval 1|Lack of Efficacy|0
5080071|NCT02147158|17536551|P5|Off-Treatment Interval 1|Lack of Efficacy|1
5080072|NCT02147158|17536552|P4|Off-Treatment Interval 1|Lack of Efficacy|0
5080073|NCT02147158|17536553|P3|Off-Treatment Interval 1|Lack of Efficacy|2
5080074|NCT02147158|17536554|P2|Off-Treatment Interval 1|Lack of Efficacy|0
5080075|NCT02147158|17536555|P1|Off-Treatment Interval 1|Lack of Efficacy|0
5080076|NCT02147158|17536550|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
5080077|NCT02147158|17536551|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
5080078|NCT02147158|17536552|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
5080079|NCT02147158|17536553|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
5080080|NCT02147158|17536554|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
5080081|NCT02147158|17536555|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
5080082|NCT02147158|17536550|P6|Off-Treatment Interval 1|Protocol Violation|0
5080083|NCT02147158|17536551|P5|Off-Treatment Interval 1|Protocol Violation|1
5080084|NCT02147158|17536552|P4|Off-Treatment Interval 1|Protocol Violation|0
5080085|NCT02147158|17536553|P3|Off-Treatment Interval 1|Protocol Violation|2
5080086|NCT02147158|17536554|P2|Off-Treatment Interval 1|Protocol Violation|0
5080087|NCT02147158|17536555|P1|Off-Treatment Interval 1|Protocol Violation|1
5080088|NCT02147158|17536550|P6|Off-Treatment Interval 1|Lost to Follow-up|2
5080089|NCT02147158|17536551|P5|Off-Treatment Interval 1|Lost to Follow-up|4
5080090|NCT02147158|17536552|P4|Off-Treatment Interval 1|Lost to Follow-up|2
5080091|NCT02147158|17536553|P3|Off-Treatment Interval 1|Lost to Follow-up|3
5080092|NCT02147158|17536554|P2|Off-Treatment Interval 1|Lost to Follow-up|1
5080093|NCT02147158|17536555|P1|Off-Treatment Interval 1|Lost to Follow-up|2
5080094|NCT02147158|17536550|P6|Off-Treatment Interval 1|Adverse Event|0
5080095|NCT02147158|17536551|P5|Off-Treatment Interval 1|Adverse Event|0
5080096|NCT02147158|17536552|P4|Off-Treatment Interval 1|Adverse Event|1
5080097|NCT02147158|17536553|P3|Off-Treatment Interval 1|Adverse Event|0
5080098|NCT02147158|17536554|P2|Off-Treatment Interval 1|Adverse Event|0
5080099|NCT02147158|17536555|P1|Off-Treatment Interval 1|Adverse Event|1
5080100|NCT02147158|17536550|P6|Treatment Course 1|Withdrawal of Consent|2
5080101|NCT02147158|17536551|P5|Treatment Course 1|Withdrawal of Consent|3
5080102|NCT02147158|17536552|P4|Treatment Course 1|Withdrawal of Consent|5
5080103|NCT02147158|17536553|P3|Treatment Course 1|Withdrawal of Consent|1
5080104|NCT02147158|17536554|P2|Treatment Course 1|Withdrawal of Consent|1
5080105|NCT02147158|17536555|P1|Treatment Course 1|Withdrawal of Consent|1
5080106|NCT02147158|17536550|P6|Treatment Course 1|Protocol Violation|0
5080107|NCT02147158|17536551|P5|Treatment Course 1|Protocol Violation|0
5080108|NCT02147158|17536552|P4|Treatment Course 1|Protocol Violation|1
5080109|NCT02147158|17536553|P3|Treatment Course 1|Protocol Violation|1
5080110|NCT02147158|17536554|P2|Treatment Course 1|Protocol Violation|0
5080111|NCT02147158|17536555|P1|Treatment Course 1|Protocol Violation|0
5080112|NCT02147158|17536550|P6|Treatment Course 1|Lost to Follow-up|4
5080113|NCT02147158|17536551|P5|Treatment Course 1|Lost to Follow-up|2
5080114|NCT02147158|17536552|P4|Treatment Course 1|Lost to Follow-up|3
5080115|NCT02147158|17536553|P3|Treatment Course 1|Lost to Follow-up|3
5080116|NCT02147158|17536554|P2|Treatment Course 1|Lost to Follow-up|4
5080117|NCT02147158|17536555|P1|Treatment Course 1|Lost to Follow-up|2
5080118|NCT02147158|17536550|P6|Treatment Course 1|Adverse Event|2
5080119|NCT02147158|17536551|P5|Treatment Course 1|Adverse Event|1
5080120|NCT02147158|17536552|P4|Treatment Course 1|Adverse Event|4
5080121|NCT02147158|17536553|P3|Treatment Course 1|Adverse Event|3
5080122|NCT02147158|17536554|P2|Treatment Course 1|Adverse Event|4
5080123|NCT02147158|17536555|P1|Treatment Course 1|Adverse Event|1
5080124|NCT02147132|17536584|P4|Overall Study|Lost to Follow-up|0
5080125|NCT02147132|17536585|P3|Overall Study|Lost to Follow-up|0
5080126|NCT02147132|17536586|P2|Overall Study|Lost to Follow-up|0
5080127|NCT02147132|17536587|P1|Overall Study|Lost to Follow-up|1
5080128|NCT02147093|17536607|P2|Period 2|Protocol Violation|0
5080129|NCT02147093|17536608|P1|Period 2|Protocol Violation|2
5080130|NCT02147093|17536607|P2|Period 1|Lost to Follow-up|1
5080131|NCT02147093|17536608|P1|Period 1|Lost to Follow-up|0
5080132|NCT02147067|17536618|P2|Overall Study|Withdrawal by Subject|2
5080133|NCT02147067|17536619|P1|Overall Study|Withdrawal by Subject|2
5080134|NCT02146599|17536645|P1|Overall Study|Failed to meet inclusion criteria|5
5080135|NCT02146430|17536662|P4|Overall Study|Withdrawal by Subject|34
5080136|NCT02146430|17536663|P3|Overall Study|Withdrawal by Subject|30
5080137|NCT02146430|17536664|P2|Overall Study|Withdrawal by Subject|29
5080138|NCT02146430|17536665|P1|Overall Study|Withdrawal by Subject|27
5080139|NCT02146430|17536662|P4|Overall Study|Reason missing or not reported|5
5080140|NCT02146430|17536663|P3|Overall Study|Reason missing or not reported|4
5080141|NCT02146430|17536664|P2|Overall Study|Reason missing or not reported|3
5080142|NCT02146430|17536665|P1|Overall Study|Reason missing or not reported|2
5080143|NCT02146430|17536662|P4|Overall Study|Adverse Event|49
5080144|NCT02146430|17536663|P3|Overall Study|Adverse Event|32
5080145|NCT02146430|17536664|P2|Overall Study|Adverse Event|40
5080146|NCT02146430|17536665|P1|Overall Study|Adverse Event|20
5080147|NCT02146430|17536662|P4|Overall Study|Lack of Efficacy|5
5080148|NCT02146430|17536663|P3|Overall Study|Lack of Efficacy|8
5080149|NCT02146430|17536664|P2|Overall Study|Lack of Efficacy|11
5080150|NCT02146430|17536665|P1|Overall Study|Lack of Efficacy|13
5080151|NCT02146430|17536662|P4|Overall Study|Protocol Violation|6
5080152|NCT02146430|17536663|P3|Overall Study|Protocol Violation|8
5080153|NCT02146430|17536664|P2|Overall Study|Protocol Violation|4
5080154|NCT02146430|17536665|P1|Overall Study|Protocol Violation|5
5080155|NCT02146365|17536725|P8|Overall Study|Other|0
5080156|NCT02146365|17536726|P7|Overall Study|Other|0
5080157|NCT02146365|17536727|P6|Overall Study|Other|0
5080158|NCT02146365|17536728|P5|Overall Study|Other|0
5080159|NCT02146365|17536729|P4|Overall Study|Other|1
5080160|NCT02146365|17536730|P3|Overall Study|Other|2
5080161|NCT02146365|17536731|P2|Overall Study|Other|0
5080162|NCT02146365|17536732|P1|Overall Study|Other|1
5080163|NCT02146365|17536725|P8|Overall Study|Unable to Comply with Protocol|0
5080164|NCT02146365|17536726|P7|Overall Study|Unable to Comply with Protocol|0
5080165|NCT02146365|17536727|P6|Overall Study|Unable to Comply with Protocol|0
5080166|NCT02146365|17536728|P5|Overall Study|Unable to Comply with Protocol|0
5080167|NCT02146365|17536729|P4|Overall Study|Unable to Comply with Protocol|0
5080168|NCT02146365|17536730|P3|Overall Study|Unable to Comply with Protocol|1
5080169|NCT02146365|17536731|P2|Overall Study|Unable to Comply with Protocol|1
5080170|NCT02146365|17536732|P1|Overall Study|Unable to Comply with Protocol|0
5080171|NCT02146365|17536725|P8|Overall Study|Withdrawal by Subject|0
5080172|NCT02146365|17536726|P7|Overall Study|Withdrawal by Subject|0
5080173|NCT02146365|17536727|P6|Overall Study|Withdrawal by Subject|0
5080174|NCT02146365|17536728|P5|Overall Study|Withdrawal by Subject|1
5080175|NCT02146365|17536729|P4|Overall Study|Withdrawal by Subject|5
5080176|NCT02146365|17536730|P3|Overall Study|Withdrawal by Subject|1
5080177|NCT02146365|17536731|P2|Overall Study|Withdrawal by Subject|2
5080178|NCT02146365|17536732|P1|Overall Study|Withdrawal by Subject|1
5080179|NCT02146365|17536725|P8|Overall Study|Lost to Follow-up|1
5080180|NCT02146365|17536726|P7|Overall Study|Lost to Follow-up|0
5080181|NCT02146365|17536727|P6|Overall Study|Lost to Follow-up|1
5080182|NCT02146365|17536728|P5|Overall Study|Lost to Follow-up|1
5080183|NCT02146365|17536729|P4|Overall Study|Lost to Follow-up|3
5080184|NCT02146365|17536730|P3|Overall Study|Lost to Follow-up|3
5080185|NCT02146365|17536731|P2|Overall Study|Lost to Follow-up|1
5080186|NCT02146365|17536732|P1|Overall Study|Lost to Follow-up|2
5080187|NCT02146352|17536858|P1|Overall Study|Patient entered hospice care|1
5080188|NCT02146352|17536858|P1|Overall Study|Death|1
5080189|NCT02146326|17536876|P4|Overall Study|Unable to complete interview|6
5080190|NCT02146326|17536877|P3|Overall Study|Unable to complete interview|10
5080191|NCT02146326|17536878|P2|Overall Study|Unable to complete interview|0
5080192|NCT02146326|17536879|P1|Overall Study|Unable to complete interview|0
5080193|NCT02146326|17536876|P4|Overall Study|Death|4
5080194|NCT02146326|17536877|P3|Overall Study|Death|4
5080195|NCT02146326|17536878|P2|Overall Study|Death|0
5080196|NCT02146326|17536879|P1|Overall Study|Death|0
5080197|NCT02146326|17536876|P4|Overall Study|Incarcerated|8
5080198|NCT02146326|17536877|P3|Overall Study|Incarcerated|3
5080199|NCT02146326|17536878|P2|Overall Study|Incarcerated|0
5080200|NCT02146326|17536879|P1|Overall Study|Incarcerated|0
5080201|NCT02146326|17536876|P4|Overall Study|Separated from mental health center|0
5080202|NCT02146326|17536877|P3|Overall Study|Separated from mental health center|0
5080203|NCT02146326|17536878|P2|Overall Study|Separated from mental health center|33
5080204|NCT02146326|17536879|P1|Overall Study|Separated from mental health center|23
5080205|NCT02146326|17536876|P4|Overall Study|Withdrawal by Subject|11
5080206|NCT02146326|17536877|P3|Overall Study|Withdrawal by Subject|15
5080207|NCT02146326|17536878|P2|Overall Study|Withdrawal by Subject|1
5080208|NCT02146326|17536879|P1|Overall Study|Withdrawal by Subject|2
5080209|NCT02146326|17536876|P4|Overall Study|Lost to Follow-up|19
5080210|NCT02146326|17536877|P3|Overall Study|Lost to Follow-up|11
5080211|NCT02146326|17536878|P2|Overall Study|Lost to Follow-up|3
5080212|NCT02146326|17536879|P1|Overall Study|Lost to Follow-up|3
5080213|NCT02146274|17537041|P1|Overall Study|Protocol Violation|73
5080214|NCT02146248|17537048|P1|Overall Study|Withdrawal by Subject|2
5080215|NCT02146131|17537058|P2|Overall Study|Physician Decision|56
5080216|NCT02146131|17537059|P1|Overall Study|Physician Decision|61
5080217|NCT02146105|17537065|P1|Overall Study|Withdrawal by Subject|5
5080218|NCT02146105|17537065|P1|Overall Study|Adverse Event|1
5080219|NCT02145468|17537116|P2|Overall Study|Withdrawal by Subject|8
5080220|NCT02145468|17537117|P1|Overall Study|Withdrawal by Subject|5
5080221|NCT02145429|17537175|P2|Overall Study|Withdrawal by Subject|3
5080222|NCT02145429|17537176|P1|Overall Study|Withdrawal by Subject|8
5080223|NCT02145429|17537175|P2|Overall Study|Lost to Follow-up|3
5080224|NCT02145429|17537176|P1|Overall Study|Lost to Follow-up|4
5080225|NCT02145429|17537175|P2|Overall Study|Death|5
5080226|NCT02145429|17537176|P1|Overall Study|Death|4
5080227|NCT02145390|17537207|P1|Overall Study|Withdrawal by Subject|1
5080228|NCT02145182|17537256|P2|Overall Study|Withdrawal by Subject|4
5080229|NCT02145182|17537257|P1|Overall Study|Withdrawal by Subject|5
5080230|NCT02145182|17537256|P2|Overall Study|Pre-transplant Withdrawal|2
5080231|NCT02145182|17537257|P1|Overall Study|Pre-transplant Withdrawal|0
5080232|NCT02145182|17537256|P2|Overall Study|Lost to Follow-up|2
5080233|NCT02145182|17537257|P1|Overall Study|Lost to Follow-up|2
5080234|NCT02145182|17537256|P2|Overall Study|Death|7
5080235|NCT02145182|17537257|P1|Overall Study|Death|7
5080236|NCT02145182|17537256|P2|Overall Study|Adverse Event|1
5080237|NCT02145182|17537257|P1|Overall Study|Adverse Event|4
5080238|NCT02145156|17537290|P3|Overall Study|No match to vaccination records|41
5080239|NCT02145156|17537291|P2|Overall Study|No match to vaccination records|52
5080240|NCT02145156|17537292|P1|Overall Study|No match to vaccination records|60
5080241|NCT02145078|17537333|P1|Overall Study|Reason not given|3
5080242|NCT02145078|17537333|P1|Overall Study|Death|1
5080243|NCT02145026|17537350|P1|Overall Study|Physician Decision|4
5080244|NCT02145026|17537350|P1|Overall Study|Withdrawal by Subject|2
5080245|NCT02145026|17537350|P1|Overall Study|Death|4
5080246|NCT02145026|17537350|P1|Overall Study|Adverse Event|2
5080247|NCT02144701|17537381|P2|Overall Study|development of relapse, GVHD or death|3
5080248|NCT02144701|17537382|P1|Overall Study|development of relapse, GVHD or death|9
5080249|NCT02144610|17537409|P2|Overall Study|Other|1
5080250|NCT02144610|17537410|P1|Overall Study|Other|0
5080251|NCT02144610|17537409|P2|Overall Study|Study Discontinuation by Sponsor|14
5080252|NCT02144610|17537410|P1|Overall Study|Study Discontinuation by Sponsor|19
5080253|NCT02144610|17537409|P2|Overall Study|Death|2
5080254|NCT02144610|17537410|P1|Overall Study|Death|2
5080255|NCT02144610|17537409|P2|Overall Study|Withdrawal by Subject|5
5080256|NCT02144610|17537410|P1|Overall Study|Withdrawal by Subject|1
5080257|NCT02144610|17537409|P2|Overall Study|Physician Decision|0
5080258|NCT02144610|17537410|P1|Overall Study|Physician Decision|1
5080259|NCT02144337|17537451|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
5080260|NCT02144337|17537452|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
5080261|NCT02144337|17537451|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
5080262|NCT02144337|17537452|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
5080263|NCT02144337|17537451|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
5080264|NCT02144337|17537452|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
5080265|NCT02144337|17537451|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
5080266|NCT02144337|17537452|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
5080267|NCT02144337|17537451|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
5080268|NCT02144337|17537452|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
5080269|NCT02144285|17537472|P10|Overall Study|Withdrawal by Subject|0
5080270|NCT02144285|17537473|P9|Overall Study|Withdrawal by Subject|0
5080271|NCT02144285|17537474|P8|Overall Study|Withdrawal by Subject|0
5080272|NCT02144285|17537475|P7|Overall Study|Withdrawal by Subject|0
5080273|NCT02144285|17537476|P6|Overall Study|Withdrawal by Subject|0
5080274|NCT02144285|17537477|P5|Overall Study|Withdrawal by Subject|1
5080275|NCT02144285|17537478|P4|Overall Study|Withdrawal by Subject|0
5080276|NCT02144285|17537479|P3|Overall Study|Withdrawal by Subject|0
5080277|NCT02144285|17537480|P2|Overall Study|Withdrawal by Subject|0
5080278|NCT02144285|17537481|P1|Overall Study|Withdrawal by Subject|0
5080279|NCT02144220|17537607|P1|Overall Study|Protocol Violation|1
5080280|NCT02144220|17537607|P1|Overall Study|Withdrawal by Subject|2
5080281|NCT02144220|17537607|P1|Overall Study|Physician Decision|3
5080282|NCT02144220|17537607|P1|Overall Study|Lack of Efficacy|4
5080283|NCT02144220|17537607|P1|Overall Study|technology incompatibility|9
5080284|NCT02144077|17537626|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
5080285|NCT02144077|17537627|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
5080286|NCT02144077|17537626|P2|Overall Study|Death|1
5080287|NCT02144077|17537627|P1|Overall Study|Death|0
5080288|NCT02144077|17537626|P2|Overall Study|Protocol Violation|2
5080289|NCT02144077|17537627|P1|Overall Study|Protocol Violation|1
5080290|NCT02144077|17537626|P2|Overall Study|Lost to Follow-up|2
5080291|NCT02144077|17537627|P1|Overall Study|Lost to Follow-up|2
5080292|NCT02144077|17537626|P2|Overall Study|Adverse Event|3
5080293|NCT02144077|17537627|P1|Overall Study|Adverse Event|2
5080294|NCT02144077|17537626|P2|Overall Study|Withdrawal by Subject|3
5080295|NCT02144077|17537627|P1|Overall Study|Withdrawal by Subject|3
5080296|NCT02144012|17537645|P2|Overall Study|Other|0
5080297|NCT02144012|17537646|P1|Overall Study|Other|3
5080298|NCT02144012|17537645|P2|Overall Study|Study Terminated by Sponsor|12
5080299|NCT02144012|17537646|P1|Overall Study|Study Terminated by Sponsor|18
5080300|NCT02144012|17537645|P2|Overall Study|Withdrawal by Subject|3
5080301|NCT02144012|17537646|P1|Overall Study|Withdrawal by Subject|11
5080302|NCT02144012|17537645|P2|Overall Study|Death|0
5080303|NCT02144012|17537646|P1|Overall Study|Death|1
5080304|NCT02144012|17537645|P2|Overall Study|Adverse Event|0
5080305|NCT02144012|17537646|P1|Overall Study|Adverse Event|1
5080306|NCT02143947|17537687|P2|Overall Study|Lost to Follow-up|2
5080307|NCT02143947|17537688|P1|Overall Study|Lost to Follow-up|4
5080308|NCT02143843|17537700|P1|Overall Study|Withdrawal by Subject|2
5080309|NCT02143843|17537700|P1|Overall Study|Lack of Efficacy|2
5080310|NCT02143843|17537700|P1|Overall Study|Adverse Event|8
5080311|NCT02143778|17537705|P1|Overall Study|Device malfunction|1
5080312|NCT02143778|17537705|P1|Overall Study|Withdrawal by Subject|2
5080313|NCT02143713|17537714|P4|Post-treatment Follow-up (12 Months)|Other|7
5080314|NCT02143713|17537715|P3|Post-treatment Follow-up (12 Months)|Other|7
5080315|NCT02143713|17537716|P2|Post-treatment Follow-up (12 Months)|Other|4
5080316|NCT02143713|17537717|P1|Post-treatment Follow-up (12 Months)|Other|3
5080317|NCT02143713|17537714|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
5080318|NCT02143713|17537715|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
5080319|NCT02143713|17537716|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
5080320|NCT02143713|17537717|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
5080321|NCT02143713|17537714|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
5080322|NCT02143713|17537715|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
5080323|NCT02143713|17537716|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
5080324|NCT02143713|17537717|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
5080325|NCT02143713|17537714|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
5080326|NCT02143713|17537715|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
5080327|NCT02143713|17537716|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
5080328|NCT02143713|17537717|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
5080329|NCT02143713|17537714|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
5080330|NCT02143713|17537715|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
5080331|NCT02143713|17537716|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
5080332|NCT02143713|17537717|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
5080333|NCT02143713|17537714|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
5080334|NCT02143713|17537715|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5080335|NCT02143713|17537716|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
5080336|NCT02143713|17537717|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
5080337|NCT02143713|17537714|P4|Treatment Period (6 Months)|Lack of Efficacy|1
5080338|NCT02143713|17537715|P3|Treatment Period (6 Months)|Lack of Efficacy|0
5080339|NCT02143713|17537716|P2|Treatment Period (6 Months)|Lack of Efficacy|0
5080340|NCT02143713|17537717|P1|Treatment Period (6 Months)|Lack of Efficacy|1
5080341|NCT02143713|17537714|P4|Treatment Period (6 Months)|Exclusionary Medication|0
5080342|NCT02143713|17537715|P3|Treatment Period (6 Months)|Exclusionary Medication|0
5080343|NCT02143713|17537716|P2|Treatment Period (6 Months)|Exclusionary Medication|0
5080344|NCT02143713|17537717|P1|Treatment Period (6 Months)|Exclusionary Medication|2
5080345|NCT02143713|17537714|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
5080346|NCT02143713|17537715|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5080347|NCT02143713|17537716|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5080348|NCT02143713|17537717|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5080349|NCT02143713|17537714|P4|Treatment Period (6 Months)|Other|2
5080350|NCT02143713|17537715|P3|Treatment Period (6 Months)|Other|3
5080351|NCT02143713|17537716|P2|Treatment Period (6 Months)|Other|0
5080352|NCT02143713|17537717|P1|Treatment Period (6 Months)|Other|3
5080353|NCT02143713|17537714|P4|Treatment Period (6 Months)|Non-compliance|3
5080354|NCT02143713|17537715|P3|Treatment Period (6 Months)|Non-compliance|0
5080355|NCT02143713|17537716|P2|Treatment Period (6 Months)|Non-compliance|0
5080356|NCT02143713|17537717|P1|Treatment Period (6 Months)|Non-compliance|1
5080357|NCT02143713|17537714|P4|Treatment Period (6 Months)|Pregnancy|0
5080358|NCT02143713|17537715|P3|Treatment Period (6 Months)|Pregnancy|2
5080359|NCT02143713|17537716|P2|Treatment Period (6 Months)|Pregnancy|2
5080360|NCT02143713|17537717|P1|Treatment Period (6 Months)|Pregnancy|0
5080361|NCT02143713|17537714|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
5080362|NCT02143713|17537715|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
5080363|NCT02143713|17537716|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
5080364|NCT02143713|17537717|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
5080365|NCT02143713|17537714|P4|Treatment Period (6 Months)|Lost to Follow-up|3
5080366|NCT02143713|17537715|P3|Treatment Period (6 Months)|Lost to Follow-up|4
5080367|NCT02143713|17537716|P2|Treatment Period (6 Months)|Lost to Follow-up|0
5080368|NCT02143713|17537717|P1|Treatment Period (6 Months)|Lost to Follow-up|3
5080369|NCT02143713|17537714|P4|Treatment Period (6 Months)|Adverse Event|9
5080370|NCT02143713|17537715|P3|Treatment Period (6 Months)|Adverse Event|8
5080371|NCT02143713|17537716|P2|Treatment Period (6 Months)|Adverse Event|8
5080372|NCT02143713|17537717|P1|Treatment Period (6 Months)|Adverse Event|7
5080373|NCT02143713|17537714|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
5080374|NCT02143713|17537715|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
5080375|NCT02143713|17537716|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
5080376|NCT02143713|17537717|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
5080377|NCT02143583|17537811|P3|Overall Study|husband illness|1
5080378|NCT02143583|17537812|P2|Overall Study|husband illness|0
5080379|NCT02143583|17537813|P1|Overall Study|husband illness|0
5080380|NCT02143583|17537811|P3|Overall Study|Withdrawal by Subject|1
5080381|NCT02143583|17537812|P2|Overall Study|Withdrawal by Subject|0
5080382|NCT02143583|17537813|P1|Overall Study|Withdrawal by Subject|1
5080383|NCT02143141|17537836|P2|Overall Study|pain scores at 24 hours not collected|0
5080384|NCT02143141|17537837|P1|Overall Study|pain scores at 24 hours not collected|1
5080385|NCT02143102|17537849|P2|Overall Study|Lost to Follow-up|0
5080386|NCT02143102|17537850|P1|Overall Study|Lost to Follow-up|11
5080387|NCT02143024|17537860|P2|Overall Study|Withdrawal by Subject|0
5080388|NCT02143024|17537861|P1|Overall Study|Withdrawal by Subject|1
5080389|NCT02143024|17537860|P2|Overall Study|Lost to Follow-up|1
5080390|NCT02143024|17537861|P1|Overall Study|Lost to Follow-up|1
5080391|NCT02142894|17537867|P1|Overall Study|Protocol Violation|8
5080392|NCT02142738|17537873|P2|Overall Study|Ongoing in Study|82
5080393|NCT02142738|17537874|P1|Overall Study|Ongoing in Study|107
5080394|NCT02142738|17537873|P2|Overall Study|Withdrawal by Subject|5
5080395|NCT02142738|17537874|P1|Overall Study|Withdrawal by Subject|5
5080396|NCT02142738|17537873|P2|Overall Study|Progressive Disease|1
5080397|NCT02142738|17537874|P1|Overall Study|Progressive Disease|0
5080398|NCT02142738|17537873|P2|Overall Study|Death|55
5080399|NCT02142738|17537874|P1|Overall Study|Death|33
5080400|NCT02142738|17537873|P2|Overall Study|Adverse Event|8
5080401|NCT02142738|17537874|P1|Overall Study|Adverse Event|9
5080402|NCT02142712|17537887|P4|Overall Study|Lost to Follow-up|0
5080403|NCT02142712|17537888|P3|Overall Study|Lost to Follow-up|1
5080404|NCT02142712|17537889|P2|Overall Study|Lost to Follow-up|1
5080405|NCT02142712|17537890|P1|Overall Study|Lost to Follow-up|1
5080406|NCT02142504|17537918|P3|Overall Study|Reason Not Specified|4
5080407|NCT02142504|17537919|P2|Overall Study|Reason Not Specified|5
5080408|NCT02142504|17537920|P1|Overall Study|Reason Not Specified|4
5080409|NCT02142504|17537918|P3|Overall Study|Physician Decision|3
5080410|NCT02142504|17537919|P2|Overall Study|Physician Decision|1
5080411|NCT02142504|17537920|P1|Overall Study|Physician Decision|0
5080412|NCT02142504|17537918|P3|Overall Study|Pregnancy|2
5080413|NCT02142504|17537919|P2|Overall Study|Pregnancy|4
5080414|NCT02142504|17537920|P1|Overall Study|Pregnancy|4
5080415|NCT02142504|17537918|P3|Overall Study|Withdrawal by Subject|11
5080416|NCT02142504|17537919|P2|Overall Study|Withdrawal by Subject|9
5080417|NCT02142504|17537920|P1|Overall Study|Withdrawal by Subject|7
5080418|NCT02142504|17537918|P3|Overall Study|Lost to Follow-up|17
5080419|NCT02142504|17537919|P2|Overall Study|Lost to Follow-up|19
5080420|NCT02142504|17537920|P1|Overall Study|Lost to Follow-up|12
5080421|NCT02142504|17537918|P3|Overall Study|Adverse Event|4
5080422|NCT02142504|17537919|P2|Overall Study|Adverse Event|3
5080423|NCT02142504|17537920|P1|Overall Study|Adverse Event|2
5080424|NCT02142504|17537918|P3|Overall Study|Protocol Violation|2
5080425|NCT02142504|17537919|P2|Overall Study|Protocol Violation|1
5080426|NCT02142504|17537920|P1|Overall Study|Protocol Violation|2
5080427|NCT02142387|17538008|P2|Overall Study|occurred not at home|2474
5080428|NCT02142387|17538009|P1|Overall Study|occurred not at home|298
5080429|NCT02142387|17538008|P2|Overall Study|incomplete data|9
5080430|NCT02142387|17538009|P1|Overall Study|incomplete data|1
5080431|NCT02142387|17538008|P2|Overall Study|witnessed by paramedic|917
5080432|NCT02142387|17538009|P1|Overall Study|witnessed by paramedic|139
5080433|NCT02142387|17538008|P2|Overall Study|CPR not performed|473
5080434|NCT02142387|17538009|P1|Overall Study|CPR not performed|74
5080435|NCT02142387|17538008|P2|Overall Study|non-cardiac etiology|3431
5080436|NCT02142387|17538009|P1|Overall Study|non-cardiac etiology|504
5080437|NCT02142387|17538008|P2|Overall Study|<19 years old|326
5080438|NCT02142387|17538009|P1|Overall Study|<19 years old|49
5080439|NCT02142283|17538122|P2|Overall Study|Withdrawal by Subject|3
5080440|NCT02142283|17538123|P1|Overall Study|Withdrawal by Subject|1
5080441|NCT02142283|17538122|P2|Overall Study|Death|18
5080442|NCT02142283|17538123|P1|Overall Study|Death|20
5080443|NCT02141997|17538232|P4|Overall Study|Other|0
5080444|NCT02141997|17538233|P3|Overall Study|Other|0
5080445|NCT02141997|17538234|P2|Overall Study|Other|4
5080446|NCT02141997|17538235|P1|Overall Study|Other|1
5080447|NCT02141997|17538232|P4|Overall Study|Withdrew consent|0
5080448|NCT02141997|17538233|P3|Overall Study|Withdrew consent|3
5080449|NCT02141997|17538234|P2|Overall Study|Withdrew consent|0
5080450|NCT02141997|17538235|P1|Overall Study|Withdrew consent|1
5080451|NCT02141997|17538232|P4|Overall Study|Participant noncompliance|0
5080452|NCT02141997|17538233|P3|Overall Study|Participant noncompliance|0
5080453|NCT02141997|17538234|P2|Overall Study|Participant noncompliance|0
5080454|NCT02141997|17538235|P1|Overall Study|Participant noncompliance|1
5080455|NCT02141997|17538232|P4|Overall Study|Adverse Event|1
5080456|NCT02141997|17538233|P3|Overall Study|Adverse Event|0
5080457|NCT02141997|17538234|P2|Overall Study|Adverse Event|2
5080458|NCT02141997|17538235|P1|Overall Study|Adverse Event|0
5080459|NCT02141984|17538273|P1|Overall Study|Lack of Efficacy|2
5080460|NCT02141854|17538292|P6|Treatment Period|Lost to Follow-up|1
5080461|NCT02141854|17538293|P5|Treatment Period|Lost to Follow-up|0
5080462|NCT02141854|17538294|P4|Treatment Period|Lost to Follow-up|1
5080463|NCT02141854|17538295|P3|Treatment Period|Lost to Follow-up|1
5080464|NCT02141854|17538296|P2|Treatment Period|Lost to Follow-up|1
5080465|NCT02141854|17538297|P1|Treatment Period|Lost to Follow-up|0
5080466|NCT02141854|17538292|P6|Treatment Period|Disease progression|18
5080467|NCT02141854|17538293|P5|Treatment Period|Disease progression|0
5080468|NCT02141854|17538294|P4|Treatment Period|Disease progression|3
5080469|NCT02141854|17538295|P3|Treatment Period|Disease progression|1
5080470|NCT02141854|17538296|P2|Treatment Period|Disease progression|2
5080471|NCT02141854|17538297|P1|Treatment Period|Disease progression|0
5080472|NCT02141854|17538292|P6|Treatment Period|Withdrawal by Subject|7
5080473|NCT02141854|17538293|P5|Treatment Period|Withdrawal by Subject|4
5080474|NCT02141854|17538294|P4|Treatment Period|Withdrawal by Subject|3
5080475|NCT02141854|17538295|P3|Treatment Period|Withdrawal by Subject|3
5080476|NCT02141854|17538296|P2|Treatment Period|Withdrawal by Subject|2
5080477|NCT02141854|17538297|P1|Treatment Period|Withdrawal by Subject|0
5080478|NCT02141854|17538292|P6|Treatment Period|Adverse Event|2
5080479|NCT02141854|17538293|P5|Treatment Period|Adverse Event|2
5080480|NCT02141854|17538294|P4|Treatment Period|Adverse Event|0
5080481|NCT02141854|17538295|P3|Treatment Period|Adverse Event|2
5080482|NCT02141854|17538296|P2|Treatment Period|Adverse Event|2
5080483|NCT02141854|17538297|P1|Treatment Period|Adverse Event|0
5080484|NCT02141854|17538292|P6|Treatment Period|Other|2
5080485|NCT02141854|17538293|P5|Treatment Period|Other|1
5080486|NCT02141854|17538294|P4|Treatment Period|Other|0
5080487|NCT02141854|17538295|P3|Treatment Period|Other|2
5080488|NCT02141854|17538296|P2|Treatment Period|Other|1
5080489|NCT02141854|17538297|P1|Treatment Period|Other|0
5080490|NCT02141854|17538292|P6|Treatment Period|Pregnancy|0
5080491|NCT02141854|17538293|P5|Treatment Period|Pregnancy|0
5080492|NCT02141854|17538294|P4|Treatment Period|Pregnancy|0
5080493|NCT02141854|17538295|P3|Treatment Period|Pregnancy|0
5080494|NCT02141854|17538296|P2|Treatment Period|Pregnancy|1
5080495|NCT02141854|17538297|P1|Treatment Period|Pregnancy|0
5080496|NCT02141854|17538292|P6|Treatment Period|Lack of Efficacy|7
5080497|NCT02141854|17538293|P5|Treatment Period|Lack of Efficacy|1
5080498|NCT02141854|17538294|P4|Treatment Period|Lack of Efficacy|1
5080499|NCT02141854|17538295|P3|Treatment Period|Lack of Efficacy|0
5080500|NCT02141854|17538296|P2|Treatment Period|Lack of Efficacy|0
5080501|NCT02141854|17538297|P1|Treatment Period|Lack of Efficacy|0
5080502|NCT02141854|17538292|P6|Treatment Period|Noncompliance|0
5080503|NCT02141854|17538293|P5|Treatment Period|Noncompliance|0
5080504|NCT02141854|17538294|P4|Treatment Period|Noncompliance|1
5080505|NCT02141854|17538295|P3|Treatment Period|Noncompliance|0
5080506|NCT02141854|17538296|P2|Treatment Period|Noncompliance|0
5080507|NCT02141854|17538297|P1|Treatment Period|Noncompliance|0
5080508|NCT02141854|17538292|P6|Treatment Period|Protocol Violation|1
5080509|NCT02141854|17538293|P5|Treatment Period|Protocol Violation|2
5080510|NCT02141854|17538294|P4|Treatment Period|Protocol Violation|2
5080511|NCT02141854|17538295|P3|Treatment Period|Protocol Violation|0
5080512|NCT02141854|17538296|P2|Treatment Period|Protocol Violation|1
5080513|NCT02141854|17538297|P1|Treatment Period|Protocol Violation|0
5080514|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080515|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080516|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080517|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080518|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080519|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
5080520|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080521|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080522|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080523|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080524|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080525|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
5080526|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5080527|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5080528|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5080529|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5080530|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5080531|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Adverse Event|10
5080532|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Other|0
5080533|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Other|0
5080534|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Other|0
5080535|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Other|0
5080536|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Other|0
5080537|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Other|14
5080538|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080539|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080540|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080541|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080542|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080543|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
5080544|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080545|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080546|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080547|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080548|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080549|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
5080550|NCT02141854|17538292|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080551|NCT02141854|17538293|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080552|NCT02141854|17538294|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080553|NCT02141854|17538295|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080554|NCT02141854|17538296|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080555|NCT02141854|17538297|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
5080556|NCT02141659|17538355|P6|Overall Study|Pretreatment Event/ Adverse Event|1
5080557|NCT02141659|17538356|P5|Overall Study|Pretreatment Event/ Adverse Event|2
5080558|NCT02141659|17538357|P4|Overall Study|Pretreatment Event/ Adverse Event|0
5080559|NCT02141659|17538358|P3|Overall Study|Pretreatment Event/ Adverse Event|0
5080560|NCT02141659|17538359|P2|Overall Study|Pretreatment Event/ Adverse Event|0
5080561|NCT02141659|17538360|P1|Overall Study|Pretreatment Event/ Adverse Event|0
5080562|NCT02141659|17538355|P6|Overall Study|Lack of Efficacy|1
5080563|NCT02141659|17538356|P5|Overall Study|Lack of Efficacy|0
5080564|NCT02141659|17538357|P4|Overall Study|Lack of Efficacy|0
5080565|NCT02141659|17538358|P3|Overall Study|Lack of Efficacy|0
5080566|NCT02141659|17538359|P2|Overall Study|Lack of Efficacy|0
5080567|NCT02141659|17538360|P1|Overall Study|Lack of Efficacy|0
5080568|NCT02141659|17538355|P6|Overall Study|Major Protocol Deviation|0
5080569|NCT02141659|17538356|P5|Overall Study|Major Protocol Deviation|0
5080570|NCT02141659|17538357|P4|Overall Study|Major Protocol Deviation|0
5080571|NCT02141659|17538358|P3|Overall Study|Major Protocol Deviation|0
5080572|NCT02141659|17538359|P2|Overall Study|Major Protocol Deviation|1
5080573|NCT02141659|17538360|P1|Overall Study|Major Protocol Deviation|0
5080574|NCT02141633|17538416|P2|Overall Study|Physician Decision|0
5080575|NCT02141633|17538417|P1|Overall Study|Physician Decision|1
5080576|NCT02141620|17538425|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
5080577|NCT02141620|17538426|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
5080578|NCT02141516|17538518|P3|Overall Study|Other|0
5080579|NCT02141516|17538519|P2|Overall Study|Other|3
5080580|NCT02141516|17538520|P1|Overall Study|Other|0
5080581|NCT02141516|17538518|P3|Overall Study|Lost to Follow-up|0
5080582|NCT02141516|17538519|P2|Overall Study|Lost to Follow-up|1
5080583|NCT02141516|17538520|P1|Overall Study|Lost to Follow-up|0
5080584|NCT02141516|17538518|P3|Overall Study|Adverse Event|0
5080585|NCT02141516|17538519|P2|Overall Study|Adverse Event|1
5080586|NCT02141516|17538520|P1|Overall Study|Adverse Event|0
5080587|NCT02141490|17538571|P3|Overall Study|Screening failures|0
5080588|NCT02141490|17538572|P2|Overall Study|Screening failures|0
5080589|NCT02141490|17538573|P1|Overall Study|Screening failures|4
5080590|NCT02141399|17538618|P1|Overall Study|Failure to meet eligibility criteria|14
5080591|NCT02141399|17538618|P1|Overall Study|Withdrawal by Subject|238
5080592|NCT02141399|17538618|P1|Overall Study|Protocol Violation|38
5080593|NCT02141399|17538618|P1|Overall Study|Pregnancy|3
5080594|NCT02141399|17538618|P1|Overall Study|Physician Decision|17
5080595|NCT02141399|17538618|P1|Overall Study|Other|45
5080596|NCT02141399|17538618|P1|Overall Study|Non-compliance with study drug|18
5080597|NCT02141399|17538618|P1|Overall Study|Lost to Follow-up|151
5080598|NCT02141399|17538618|P1|Overall Study|Lack of Efficacy|62
5080599|NCT02141399|17538618|P1|Overall Study|Adverse Event|158
5080600|NCT02141360|17538624|P3|Overall Study|Study Terminated before Visit|0
5080601|NCT02141360|17538625|P2|Overall Study|Study Terminated before Visit|0
5080602|NCT02141360|17538626|P1|Overall Study|Study Terminated before Visit|1
5080603|NCT02141360|17538624|P3|Overall Study|Withdrawal by Subject|0
5080604|NCT02141360|17538625|P2|Overall Study|Withdrawal by Subject|0
5080605|NCT02141360|17538626|P1|Overall Study|Withdrawal by Subject|6
5080606|NCT02141295|17538637|P3|Overall Study|Withdrawal by Subject|4
5080607|NCT02141295|17538638|P2|Overall Study|Withdrawal by Subject|9
5080608|NCT02141295|17538639|P1|Overall Study|Withdrawal by Subject|0
5080609|NCT02141295|17538637|P3|Overall Study|Reason not specified|10
5080610|NCT02141295|17538638|P2|Overall Study|Reason not specified|9
5080611|NCT02141295|17538639|P1|Overall Study|Reason not specified|0
5080612|NCT02141295|17538637|P3|Overall Study|Progressive disease|50
5080613|NCT02141295|17538638|P2|Overall Study|Progressive disease|32
5080614|NCT02141295|17538639|P1|Overall Study|Progressive disease|3
5080615|NCT02141295|17538637|P3|Overall Study|Non-compliance|0
5080616|NCT02141295|17538638|P2|Overall Study|Non-compliance|1
5080617|NCT02141295|17538639|P1|Overall Study|Non-compliance|0
5080618|NCT02141295|17538637|P3|Overall Study|Study terminated by sponsor|6
5080619|NCT02141295|17538638|P2|Overall Study|Study terminated by sponsor|6
5080620|NCT02141295|17538639|P1|Overall Study|Study terminated by sponsor|0
5080621|NCT02141295|17538637|P3|Overall Study|Physician Decision|14
5080622|NCT02141295|17538638|P2|Overall Study|Physician Decision|19
5080623|NCT02141295|17538639|P1|Overall Study|Physician Decision|2
5080624|NCT02141295|17538637|P3|Overall Study|Adverse Event|11
5080625|NCT02141295|17538638|P2|Overall Study|Adverse Event|18
5080626|NCT02141295|17538639|P1|Overall Study|Adverse Event|1
5080627|NCT02141217|17538675|P2|Overall Study|Surgical Intervention|1
5080628|NCT02141217|17538676|P1|Overall Study|Surgical Intervention|1
5080629|NCT02141217|17538675|P2|Overall Study|Physician Decision|0
5080630|NCT02141217|17538676|P1|Overall Study|Physician Decision|1
5080631|NCT02141217|17538675|P2|Overall Study|Lost to Follow-up|1
5080632|NCT02141217|17538676|P1|Overall Study|Lost to Follow-up|1
5080633|NCT02141217|17538675|P2|Overall Study|Withdrawal by Subject|0
5080634|NCT02141217|17538676|P1|Overall Study|Withdrawal by Subject|6
5080635|NCT02141217|17538675|P2|Overall Study|Protocol Violation|4
5080636|NCT02141217|17538676|P1|Overall Study|Protocol Violation|1
5080637|NCT02141217|17538675|P2|Overall Study|Adverse Event|2
5080638|NCT02141217|17538676|P1|Overall Study|Adverse Event|1
5080639|NCT02140775|17538738|P2|Overall Study|Withdrawal by Subject|7
5080640|NCT02140775|17538739|P1|Overall Study|Withdrawal by Subject|30
5080641|NCT02140762|17538751|P2|Overall Study|Other|1
5080642|NCT02140762|17538752|P1|Overall Study|Other|0
5080643|NCT02140762|17538751|P2|Overall Study|Withdrawal by Subject|4
5080644|NCT02140762|17538752|P1|Overall Study|Withdrawal by Subject|6
5080645|NCT02140762|17538751|P2|Overall Study|Protocol Violation|1
5080646|NCT02140762|17538752|P1|Overall Study|Protocol Violation|1
5080647|NCT02140762|17538751|P2|Overall Study|Lost to Follow-up|5
5080648|NCT02140762|17538752|P1|Overall Study|Lost to Follow-up|9
5080649|NCT02140762|17538751|P2|Overall Study|Adverse Event|1
5080650|NCT02140762|17538752|P1|Overall Study|Adverse Event|1
5080651|NCT02140645|17538818|P6|Overall Study|Not linked|70896
5080652|NCT02140645|17538819|P5|Overall Study|Not linked|3286
5080653|NCT02140645|17538820|P4|Overall Study|Not linked|13833
5080654|NCT02140645|17538821|P3|Overall Study|Not linked|4236
5080655|NCT02140645|17538822|P2|Overall Study|Not linked|61654
5080656|NCT02140645|17538823|P1|Overall Study|Not linked|5489
5080657|NCT02140567|17538921|P1|Overall Study|Problems with recording equipment|6
5080658|NCT02140411|17538926|P1|Overall Study|Adverse Event|1
5080659|NCT02140164|17538946|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
5080660|NCT02140060|17538967|P6|Overall Study|Lack of Efficacy|0
5080661|NCT02140060|17538968|P5|Overall Study|Lack of Efficacy|0
5080662|NCT02140060|17538969|P4|Overall Study|Lack of Efficacy|1
5080663|NCT02140060|17538970|P3|Overall Study|Lack of Efficacy|0
5080664|NCT02140060|17538971|P2|Overall Study|Lack of Efficacy|0
5080665|NCT02140060|17538972|P1|Overall Study|Lack of Efficacy|0
5080666|NCT02140060|17538967|P6|Overall Study|Adverse Event|1
5080667|NCT02140060|17538968|P5|Overall Study|Adverse Event|1
5080668|NCT02140060|17538969|P4|Overall Study|Adverse Event|1
5080669|NCT02140060|17538970|P3|Overall Study|Adverse Event|0
5080670|NCT02140060|17538971|P2|Overall Study|Adverse Event|0
5080671|NCT02140060|17538972|P1|Overall Study|Adverse Event|0
5080672|NCT02139982|17538997|P10|Overall Study|Lack of Efficacy|0
5080673|NCT02139982|17538998|P9|Overall Study|Lack of Efficacy|0
5080674|NCT02139982|17538999|P8|Overall Study|Lack of Efficacy|0
5080675|NCT02139982|17539000|P7|Overall Study|Lack of Efficacy|0
5080676|NCT02139982|17539001|P6|Overall Study|Lack of Efficacy|0
5080677|NCT02139982|17539002|P5|Overall Study|Lack of Efficacy|0
5080678|NCT02139982|17539003|P4|Overall Study|Lack of Efficacy|1
5080679|NCT02139982|17539004|P3|Overall Study|Lack of Efficacy|0
5080680|NCT02139982|17539005|P2|Overall Study|Lack of Efficacy|1
5080681|NCT02139982|17539006|P1|Overall Study|Lack of Efficacy|0
5080682|NCT02139943|17539070|P3|Overall Study|eGFR Withdrawal Criteria|1
5080683|NCT02139943|17539071|P2|Overall Study|eGFR Withdrawal Criteria|0
5080684|NCT02139943|17539072|P1|Overall Study|eGFR Withdrawal Criteria|0
5080685|NCT02139943|17539070|P3|Overall Study|Participant in Poor Compliance|1
5080686|NCT02139943|17539071|P2|Overall Study|Participant in Poor Compliance|0
5080687|NCT02139943|17539072|P1|Overall Study|Participant in Poor Compliance|1
5080688|NCT02139943|17539070|P3|Overall Study|Participant wishes to discontinue|0
5080689|NCT02139943|17539071|P2|Overall Study|Participant wishes to discontinue|0
5080690|NCT02139943|17539072|P1|Overall Study|Participant wishes to discontinue|2
5080691|NCT02139943|17539070|P3|Overall Study|Other|1
5080692|NCT02139943|17539071|P2|Overall Study|Other|0
5080693|NCT02139943|17539072|P1|Overall Study|Other|0
5080694|NCT02139943|17539070|P3|Overall Study|Withdrawal by Subject|0
5080695|NCT02139943|17539071|P2|Overall Study|Withdrawal by Subject|3
5080696|NCT02139943|17539072|P1|Overall Study|Withdrawal by Subject|4
5080697|NCT02139943|17539070|P3|Overall Study|Lost to Follow-up|2
5080698|NCT02139943|17539071|P2|Overall Study|Lost to Follow-up|2
5080699|NCT02139943|17539072|P1|Overall Study|Lost to Follow-up|3
5080700|NCT02139943|17539070|P3|Overall Study|Adverse Event|2
5080701|NCT02139943|17539071|P2|Overall Study|Adverse Event|1
5080702|NCT02139943|17539072|P1|Overall Study|Adverse Event|0
5080703|NCT02139826|17539092|P1|Overall Study|Adverse Event|1
5080704|NCT02139644|17539137|P6|Treatment Period|Other|1
5080705|NCT02139644|17539138|P5|Treatment Period|Other|0
5080706|NCT02139644|17539139|P4|Treatment Period|Other|1
5080707|NCT02139644|17539140|P3|Treatment Period|Other|1
5080708|NCT02139644|17539141|P2|Treatment Period|Other|3
5080709|NCT02139644|17539142|P1|Treatment Period|Other|0
5080710|NCT02139644|17539137|P6|Treatment Period|Lack of Efficacy|4
5080711|NCT02139644|17539138|P5|Treatment Period|Lack of Efficacy|1
5080712|NCT02139644|17539139|P4|Treatment Period|Lack of Efficacy|0
5080713|NCT02139644|17539140|P3|Treatment Period|Lack of Efficacy|1
5080714|NCT02139644|17539141|P2|Treatment Period|Lack of Efficacy|0
5080715|NCT02139644|17539142|P1|Treatment Period|Lack of Efficacy|0
5080716|NCT02139644|17539137|P6|Treatment Period|Lost to Follow-up|1
5080717|NCT02139644|17539138|P5|Treatment Period|Lost to Follow-up|1
5080718|NCT02139644|17539139|P4|Treatment Period|Lost to Follow-up|1
5080719|NCT02139644|17539140|P3|Treatment Period|Lost to Follow-up|1
5080720|NCT02139644|17539141|P2|Treatment Period|Lost to Follow-up|0
5080721|NCT02139644|17539142|P1|Treatment Period|Lost to Follow-up|0
5080722|NCT02139644|17539137|P6|Treatment Period|Disease progression|2
5080723|NCT02139644|17539138|P5|Treatment Period|Disease progression|1
5080724|NCT02139644|17539139|P4|Treatment Period|Disease progression|1
5080725|NCT02139644|17539140|P3|Treatment Period|Disease progression|0
5080726|NCT02139644|17539141|P2|Treatment Period|Disease progression|0
5080727|NCT02139644|17539142|P1|Treatment Period|Disease progression|0
5080728|NCT02139644|17539137|P6|Treatment Period|Protocol Violation|1
5080729|NCT02139644|17539138|P5|Treatment Period|Protocol Violation|1
5080730|NCT02139644|17539139|P4|Treatment Period|Protocol Violation|1
5080731|NCT02139644|17539140|P3|Treatment Period|Protocol Violation|0
5080732|NCT02139644|17539141|P2|Treatment Period|Protocol Violation|0
5080733|NCT02139644|17539142|P1|Treatment Period|Protocol Violation|0
5080734|NCT02139644|17539137|P6|Treatment Period|Non-compliance|0
5080735|NCT02139644|17539138|P5|Treatment Period|Non-compliance|0
5080736|NCT02139644|17539139|P4|Treatment Period|Non-compliance|1
5080737|NCT02139644|17539140|P3|Treatment Period|Non-compliance|0
5080738|NCT02139644|17539141|P2|Treatment Period|Non-compliance|0
5080739|NCT02139644|17539142|P1|Treatment Period|Non-compliance|0
5080740|NCT02139644|17539137|P6|Treatment Period|Withdrawal by Subject|2
5080741|NCT02139644|17539138|P5|Treatment Period|Withdrawal by Subject|3
5080742|NCT02139644|17539139|P4|Treatment Period|Withdrawal by Subject|2
5080743|NCT02139644|17539140|P3|Treatment Period|Withdrawal by Subject|2
5080744|NCT02139644|17539141|P2|Treatment Period|Withdrawal by Subject|0
5080745|NCT02139644|17539142|P1|Treatment Period|Withdrawal by Subject|0
5080746|NCT02139644|17539137|P6|Treatment Period|Adverse Event|6
5080747|NCT02139644|17539138|P5|Treatment Period|Adverse Event|1
5080748|NCT02139644|17539139|P4|Treatment Period|Adverse Event|2
5080749|NCT02139644|17539140|P3|Treatment Period|Adverse Event|3
5080750|NCT02139644|17539141|P2|Treatment Period|Adverse Event|0
5080751|NCT02139644|17539142|P1|Treatment Period|Adverse Event|0
5080752|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Other|0
5080753|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Other|0
5080754|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Other|0
5080755|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Other|0
5080756|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Other|0
5080757|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Other|6
5080758|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5080759|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5080760|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5080761|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5080762|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5080763|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Adverse Event|3
5080764|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080765|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080766|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080767|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080768|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5080769|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
5080770|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080771|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080772|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080773|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080774|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5080775|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
5080776|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080777|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080778|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080779|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080780|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5080781|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
5080782|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080783|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080784|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080785|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080786|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5080787|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
5080788|NCT02139644|17539137|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080789|NCT02139644|17539138|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080790|NCT02139644|17539139|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080791|NCT02139644|17539140|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080792|NCT02139644|17539141|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5080793|NCT02139644|17539142|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
5080794|NCT02139592|17539194|P1|Overall Study|Case Report Forms Uncollected|8
5080795|NCT02139306|17539220|P2|Overall Study|Protocol Violation|0
5080796|NCT02139306|17539221|P1|Overall Study|Protocol Violation|4
5080797|NCT02139306|17539220|P2|Overall Study|Other Unspecified|3
5080798|NCT02139306|17539221|P1|Overall Study|Other Unspecified|2
5080799|NCT02139306|17539220|P2|Overall Study|Physician Decision|1
5080800|NCT02139306|17539221|P1|Overall Study|Physician Decision|0
5080801|NCT02139306|17539220|P2|Overall Study|Adverse Event|4
5080802|NCT02139306|17539221|P1|Overall Study|Adverse Event|3
5080803|NCT02139306|17539220|P2|Overall Study|Withdrawal by Subject|6
5080804|NCT02139306|17539221|P1|Overall Study|Withdrawal by Subject|4
5080805|NCT02139124|17539291|P5|Overall Study|Lost to Follow-up|4
5080806|NCT02139124|17539292|P4|Overall Study|Lost to Follow-up|5
5080807|NCT02139124|17539293|P3|Overall Study|Lost to Follow-up|0
5080808|NCT02139124|17539294|P2|Overall Study|Lost to Follow-up|2
5080809|NCT02139124|17539295|P1|Overall Study|Lost to Follow-up|3
5080810|NCT02139124|17539291|P5|Overall Study|subject moved|0
5080811|NCT02139124|17539292|P4|Overall Study|subject moved|0
5080812|NCT02139124|17539293|P3|Overall Study|subject moved|0
5080813|NCT02139124|17539294|P2|Overall Study|subject moved|0
5080814|NCT02139124|17539295|P1|Overall Study|subject moved|1
5080815|NCT02139124|17539291|P5|Overall Study|incarceration|0
5080816|NCT02139124|17539292|P4|Overall Study|incarceration|0
5080817|NCT02139124|17539293|P3|Overall Study|incarceration|1
5080818|NCT02139124|17539294|P2|Overall Study|incarceration|0
5080819|NCT02139124|17539295|P1|Overall Study|incarceration|0
5080820|NCT02139124|17539291|P5|Overall Study|non-compliant|0
5080821|NCT02139124|17539292|P4|Overall Study|non-compliant|2
5080822|NCT02139124|17539293|P3|Overall Study|non-compliant|0
5080823|NCT02139124|17539294|P2|Overall Study|non-compliant|0
5080824|NCT02139124|17539295|P1|Overall Study|non-compliant|1
5080825|NCT02139124|17539291|P5|Overall Study|Protocol Violation|1
5080826|NCT02139124|17539292|P4|Overall Study|Protocol Violation|1
5080827|NCT02139124|17539293|P3|Overall Study|Protocol Violation|0
5080828|NCT02139124|17539294|P2|Overall Study|Protocol Violation|0
5080829|NCT02139124|17539295|P1|Overall Study|Protocol Violation|0
5080830|NCT02139124|17539291|P5|Overall Study|Withdrawal by Subject|3
5080831|NCT02139124|17539292|P4|Overall Study|Withdrawal by Subject|2
5080832|NCT02139124|17539293|P3|Overall Study|Withdrawal by Subject|2
5080833|NCT02139124|17539294|P2|Overall Study|Withdrawal by Subject|2
5080834|NCT02139124|17539295|P1|Overall Study|Withdrawal by Subject|2
5080835|NCT02139124|17539291|P5|Overall Study|Adverse Event|5
5080836|NCT02139124|17539292|P4|Overall Study|Adverse Event|2
5080837|NCT02139124|17539293|P3|Overall Study|Adverse Event|1
5080838|NCT02139124|17539294|P2|Overall Study|Adverse Event|0
5080839|NCT02139124|17539295|P1|Overall Study|Adverse Event|2
5080840|NCT02139046|17539312|P5|Overall Study|Other Miscellaneous Reasons|12
5080841|NCT02139046|17539313|P4|Overall Study|Other Miscellaneous Reasons|9
5080842|NCT02139046|17539314|P3|Overall Study|Other Miscellaneous Reasons|4
5080843|NCT02139046|17539315|P2|Overall Study|Other Miscellaneous Reasons|9
5080844|NCT02139046|17539316|P1|Overall Study|Other Miscellaneous Reasons|10
5080845|NCT02139046|17539312|P5|Overall Study|Withdrawal due to a Gout Flare|1
5080846|NCT02139046|17539313|P4|Overall Study|Withdrawal due to a Gout Flare|0
5080847|NCT02139046|17539314|P3|Overall Study|Withdrawal due to a Gout Flare|1
5080848|NCT02139046|17539315|P2|Overall Study|Withdrawal due to a Gout Flare|1
5080849|NCT02139046|17539316|P1|Overall Study|Withdrawal due to a Gout Flare|1
5080850|NCT02139046|17539312|P5|Overall Study|Lack of Efficacy|2
5080851|NCT02139046|17539313|P4|Overall Study|Lack of Efficacy|1
5080852|NCT02139046|17539314|P3|Overall Study|Lack of Efficacy|2
5080853|NCT02139046|17539315|P2|Overall Study|Lack of Efficacy|1
5080854|NCT02139046|17539316|P1|Overall Study|Lack of Efficacy|0
5080855|NCT02139046|17539312|P5|Overall Study|Voluntary Withdrawal|16
5080856|NCT02139046|17539313|P4|Overall Study|Voluntary Withdrawal|15
5080857|NCT02139046|17539314|P3|Overall Study|Voluntary Withdrawal|10
5080858|NCT02139046|17539315|P2|Overall Study|Voluntary Withdrawal|8
5080859|NCT02139046|17539316|P1|Overall Study|Voluntary Withdrawal|20
5080860|NCT02139046|17539312|P5|Overall Study|Lost to Follow-up|13
5080861|NCT02139046|17539313|P4|Overall Study|Lost to Follow-up|18
5080862|NCT02139046|17539314|P3|Overall Study|Lost to Follow-up|16
5080863|NCT02139046|17539315|P2|Overall Study|Lost to Follow-up|16
5080864|NCT02139046|17539316|P1|Overall Study|Lost to Follow-up|13
5080865|NCT02139046|17539312|P5|Overall Study|Major Protocol Deviation|6
5080866|NCT02139046|17539313|P4|Overall Study|Major Protocol Deviation|12
5080867|NCT02139046|17539314|P3|Overall Study|Major Protocol Deviation|16
5080868|NCT02139046|17539315|P2|Overall Study|Major Protocol Deviation|10
5080869|NCT02139046|17539316|P1|Overall Study|Major Protocol Deviation|9
5080870|NCT02139046|17539312|P5|Overall Study|Pretreatment Event/Adverse Event|7
5080871|NCT02139046|17539313|P4|Overall Study|Pretreatment Event/Adverse Event|13
5080872|NCT02139046|17539314|P3|Overall Study|Pretreatment Event/Adverse Event|10
5080873|NCT02139046|17539315|P2|Overall Study|Pretreatment Event/Adverse Event|9
5080874|NCT02139046|17539316|P1|Overall Study|Pretreatment Event/Adverse Event|9
5080875|NCT02138916|17539357|P3|Overall Study|Adverse Event|3
5080876|NCT02138916|17539358|P2|Overall Study|Adverse Event|4
5080877|NCT02138916|17539359|P1|Overall Study|Adverse Event|4
5080878|NCT02138916|17539357|P3|Overall Study|Lost to Follow-up|3
5080879|NCT02138916|17539358|P2|Overall Study|Lost to Follow-up|2
5080880|NCT02138916|17539359|P1|Overall Study|Lost to Follow-up|4
5080881|NCT02138916|17539357|P3|Overall Study|Severe non-compliance|1
5080882|NCT02138916|17539358|P2|Overall Study|Severe non-compliance|2
5080883|NCT02138916|17539359|P1|Overall Study|Severe non-compliance|1
5080884|NCT02138916|17539357|P3|Overall Study|incorrect enrolment|0
5080885|NCT02138916|17539358|P2|Overall Study|incorrect enrolment|1
5080886|NCT02138916|17539359|P1|Overall Study|incorrect enrolment|1
5080887|NCT02138916|17539357|P3|Overall Study|Study specific withdrawal criteria|1
5080888|NCT02138916|17539358|P2|Overall Study|Study specific withdrawal criteria|0
5080889|NCT02138916|17539359|P1|Overall Study|Study specific withdrawal criteria|0
5080890|NCT02138916|17539357|P3|Overall Study|Withdrawal by Subject|32
5080891|NCT02138916|17539358|P2|Overall Study|Withdrawal by Subject|31
5080892|NCT02138916|17539359|P1|Overall Study|Withdrawal by Subject|27
5080893|NCT02138916|17539357|P3|Overall Study|Death|12
5080894|NCT02138916|17539358|P2|Overall Study|Death|11
5080895|NCT02138916|17539359|P1|Overall Study|Death|14
5080896|NCT02138916|17539357|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
5080897|NCT02138916|17539358|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
5080898|NCT02138916|17539359|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
5080899|NCT02138890|17539422|P2|Overall Study|Adverse Event|0
5080900|NCT02138890|17539423|P1|Overall Study|Adverse Event|1
5080901|NCT02138838|17539465|P2|Overall Study|Withdrawal by Subject|5
5080902|NCT02138838|17539466|P1|Overall Study|Withdrawal by Subject|1
5080903|NCT02138838|17539465|P2|Overall Study|Study Closure|6
5080904|NCT02138838|17539466|P1|Overall Study|Study Closure|7
5080905|NCT02138825|17539484|P2|Safety Follow-up|withdrawn due to lung transplant|1
5080906|NCT02138825|17539485|P1|Safety Follow-up|withdrawn due to lung transplant|0
5080907|NCT02138825|17539484|P2|Safety Follow-up|treatment unblinded|1
5080908|NCT02138825|17539485|P1|Safety Follow-up|treatment unblinded|0
5080909|NCT02138825|17539484|P2|Safety Follow-up|too unwell to attend the visit|1
5080910|NCT02138825|17539485|P1|Safety Follow-up|too unwell to attend the visit|0
5080911|NCT02138825|17539484|P2|Safety Follow-up|progressive disease|2
5080912|NCT02138825|17539485|P1|Safety Follow-up|progressive disease|0
5080913|NCT02138825|17539484|P2|Safety Follow-up|logistical difficulties|1
5080914|NCT02138825|17539485|P1|Safety Follow-up|logistical difficulties|0
5080915|NCT02138825|17539484|P2|Safety Follow-up|withdrawal by PI|0
5080916|NCT02138825|17539485|P1|Safety Follow-up|withdrawal by PI|1
5080917|NCT02138825|17539484|P2|Safety Follow-up|clinic worsening|0
5080918|NCT02138825|17539485|P1|Safety Follow-up|clinic worsening|1
5080919|NCT02138825|17539484|P2|Safety Follow-up|Withdrawal by Subject|3
5080920|NCT02138825|17539485|P1|Safety Follow-up|Withdrawal by Subject|5
5080921|NCT02138825|17539484|P2|Safety Follow-up|Death|5
5080922|NCT02138825|17539485|P1|Safety Follow-up|Death|11
5080923|NCT02138825|17539484|P2|Safety Follow-up|Adverse Event|3
5080924|NCT02138825|17539485|P1|Safety Follow-up|Adverse Event|4
5080925|NCT02138825|17539484|P2|Long-term Extension|Study termination by sponsor|38
5080926|NCT02138825|17539485|P1|Long-term Extension|Study termination by sponsor|32
5080927|NCT02138825|17539484|P2|Main Study Treatment|Medical decision|0
5080928|NCT02138825|17539485|P1|Main Study Treatment|Medical decision|1
5080929|NCT02138825|17539484|P2|Main Study Treatment|Withdrawal by Subject|1
5080930|NCT02138825|17539485|P1|Main Study Treatment|Withdrawal by Subject|3
5080931|NCT02138825|17539484|P2|Main Study Treatment|Study terminated by sponsor|9
5080932|NCT02138825|17539485|P1|Main Study Treatment|Study terminated by sponsor|10
5080933|NCT02138825|17539484|P2|Main Study Treatment|Sponsor decision|18
5080934|NCT02138825|17539485|P1|Main Study Treatment|Sponsor decision|12
5080935|NCT02138825|17539484|P2|Main Study Treatment|Protocol Violation|2
5080936|NCT02138825|17539485|P1|Main Study Treatment|Protocol Violation|2
5080937|NCT02138825|17539484|P2|Main Study Treatment|Death|2
5080938|NCT02138825|17539485|P1|Main Study Treatment|Death|1
5080939|NCT02138825|17539484|P2|Main Study Treatment|Adverse Event|3
5080940|NCT02138825|17539485|P1|Main Study Treatment|Adverse Event|11
5080941|NCT02138786|17539502|P3|Overall Study|Non-Compliance|1
5080942|NCT02138786|17539503|P2|Overall Study|Non-Compliance|0
5080943|NCT02138786|17539504|P1|Overall Study|Non-Compliance|0
5080944|NCT02138786|17539502|P3|Overall Study|Sponsor Terminated Study|1
5080945|NCT02138786|17539503|P2|Overall Study|Sponsor Terminated Study|1
5080946|NCT02138786|17539504|P1|Overall Study|Sponsor Terminated Study|0
5080947|NCT02138786|17539502|P3|Overall Study|Patient's Wish|0
5080948|NCT02138786|17539503|P2|Overall Study|Patient's Wish|2
5080949|NCT02138786|17539504|P1|Overall Study|Patient's Wish|0
5080950|NCT02138786|17539502|P3|Overall Study|Withdrawal by Subject|0
5080951|NCT02138786|17539503|P2|Overall Study|Withdrawal by Subject|2
5080952|NCT02138786|17539504|P1|Overall Study|Withdrawal by Subject|1
5080953|NCT02138786|17539502|P3|Overall Study|Disease Progression|3
5080954|NCT02138786|17539503|P2|Overall Study|Disease Progression|1
5080955|NCT02138786|17539504|P1|Overall Study|Disease Progression|1
5080956|NCT02138786|17539502|P3|Overall Study|Death|2
5080957|NCT02138786|17539503|P2|Overall Study|Death|7
5080958|NCT02138786|17539504|P1|Overall Study|Death|1
5080959|NCT02138786|17539502|P3|Overall Study|Adverse Event|1
5080960|NCT02138786|17539503|P2|Overall Study|Adverse Event|2
5080961|NCT02138786|17539504|P1|Overall Study|Adverse Event|0
5080962|NCT02138747|17539521|P4|Treatment Period 2|Other - Miscellaneous|0
5080963|NCT02138747|17539522|P3|Treatment Period 2|Other - Miscellaneous|0
5080964|NCT02138747|17539523|P2|Treatment Period 2|Other - Miscellaneous|0
5080965|NCT02138747|17539524|P1|Treatment Period 2|Other - Miscellaneous|3
5080966|NCT02138747|17539521|P4|Treatment Period 2|Withdrawal by Subject|2
5080967|NCT02138747|17539522|P3|Treatment Period 2|Withdrawal by Subject|1
5080968|NCT02138747|17539523|P2|Treatment Period 2|Withdrawal by Subject|4
5080969|NCT02138747|17539524|P1|Treatment Period 2|Withdrawal by Subject|5
5080970|NCT02138747|17539521|P4|Treatment Period 2|Protocol Violation|0
5080971|NCT02138747|17539522|P3|Treatment Period 2|Protocol Violation|0
5080972|NCT02138747|17539523|P2|Treatment Period 2|Protocol Violation|0
5080973|NCT02138747|17539524|P1|Treatment Period 2|Protocol Violation|1
5080974|NCT02138747|17539521|P4|Treatment Period 2|Lost to Follow-up|0
5080975|NCT02138747|17539522|P3|Treatment Period 2|Lost to Follow-up|0
5080976|NCT02138747|17539523|P2|Treatment Period 2|Lost to Follow-up|0
5080977|NCT02138747|17539524|P1|Treatment Period 2|Lost to Follow-up|2
5080978|NCT02138747|17539521|P4|Treatment Period 2|Adverse Event|1
5080979|NCT02138747|17539522|P3|Treatment Period 2|Adverse Event|1
5080980|NCT02138747|17539523|P2|Treatment Period 2|Adverse Event|3
5080981|NCT02138747|17539524|P1|Treatment Period 2|Adverse Event|6
5080982|NCT02138747|17539521|P4|Treatment Period 1|Other - Miscellaneous|0
5080983|NCT02138747|17539522|P3|Treatment Period 1|Other - Miscellaneous|0
5080984|NCT02138747|17539523|P2|Treatment Period 1|Other - Miscellaneous|4
5080985|NCT02138747|17539524|P1|Treatment Period 1|Other - Miscellaneous|2
5080986|NCT02138747|17539521|P4|Treatment Period 1|Withdrawal by Subject|3
5080987|NCT02138747|17539522|P3|Treatment Period 1|Withdrawal by Subject|1
5080988|NCT02138747|17539523|P2|Treatment Period 1|Withdrawal by Subject|4
5080989|NCT02138747|17539524|P1|Treatment Period 1|Withdrawal by Subject|8
5080990|NCT02138747|17539521|P4|Treatment Period 1|Protocol Violation|0
5080991|NCT02138747|17539522|P3|Treatment Period 1|Protocol Violation|0
5080992|NCT02138747|17539523|P2|Treatment Period 1|Protocol Violation|2
5080993|NCT02138747|17539524|P1|Treatment Period 1|Protocol Violation|0
5080994|NCT02138747|17539521|P4|Treatment Period 1|Lost to Follow-up|0
5080995|NCT02138747|17539522|P3|Treatment Period 1|Lost to Follow-up|1
5080996|NCT02138747|17539523|P2|Treatment Period 1|Lost to Follow-up|1
5080997|NCT02138747|17539524|P1|Treatment Period 1|Lost to Follow-up|0
5080998|NCT02138747|17539521|P4|Treatment Period 1|Adverse Event|1
5080999|NCT02138747|17539522|P3|Treatment Period 1|Adverse Event|2
5081000|NCT02138747|17539523|P2|Treatment Period 1|Adverse Event|14
5081001|NCT02138747|17539524|P1|Treatment Period 1|Adverse Event|10
5081002|NCT02138253|17539598|P2|Overall Study|Withdrawal by Subject|0
5081003|NCT02138253|17539599|P1|Overall Study|Withdrawal by Subject|1
5081004|NCT02138253|17539598|P2|Overall Study|Non compliance|0
5081005|NCT02138253|17539599|P1|Overall Study|Non compliance|1
5081006|NCT02138253|17539598|P2|Overall Study|Physician Decision|0
5081007|NCT02138253|17539599|P1|Overall Study|Physician Decision|2
5081008|NCT02138253|17539598|P2|Overall Study|Lost to Follow-up|1
5081009|NCT02138253|17539599|P1|Overall Study|Lost to Follow-up|2
5081010|NCT02138253|17539598|P2|Overall Study|Adverse Event|3
5081011|NCT02138253|17539599|P1|Overall Study|Adverse Event|3
5081012|NCT02138136|17539671|P1|Overall Study|Withdrawn by Sponsor|5
5081013|NCT02138136|17539671|P1|Overall Study|Lost to Follow-up|32
5081014|NCT02138136|17539671|P1|Overall Study|Withdrawal by Subject|36
5081015|NCT02138136|17539671|P1|Overall Study|Adverse Event|18
5081016|NCT02138136|17539671|P1|Overall Study|Pregnancy|2
5081017|NCT02138136|17539671|P1|Overall Study|Lack of Efficacy|35
5081018|NCT02138136|17539671|P1|Overall Study|Physician Decision|7
5081019|NCT02138136|17539671|P1|Overall Study|Protocol Violation|4
5081020|NCT02138110|17539678|P1|Overall Scaffold Implantation|Death|3
5081021|NCT02138110|17539678|P1|Enrolled for Scaffold Implantation|Physician Decision|1
5081022|NCT02137785|17539910|P2|Overall Study|subject moved out of state|0
5081023|NCT02137785|17539911|P1|Overall Study|subject moved out of state|1
5081024|NCT02137785|17539910|P2|Overall Study|Withdrawal by Subject|4
5081025|NCT02137785|17539911|P1|Overall Study|Withdrawal by Subject|1
5081026|NCT02137785|17539910|P2|Overall Study|Lost to Follow-up|0
5081027|NCT02137785|17539911|P1|Overall Study|Lost to Follow-up|1
5081028|NCT02137772|17540019|P2|Overall Study|Not treated|2
5081029|NCT02137772|17540020|P1|Overall Study|Not treated|3
5081030|NCT02137772|17540019|P2|Overall Study|Non-compliance with study drug|0
5081031|NCT02137772|17540020|P1|Overall Study|Non-compliance with study drug|1
5081032|NCT02137772|17540019|P2|Overall Study|Withdrawal by Subject|17
5081033|NCT02137772|17540020|P1|Overall Study|Withdrawal by Subject|28
5081034|NCT02137772|17540019|P2|Overall Study|Physician Decision|5
5081035|NCT02137772|17540020|P1|Overall Study|Physician Decision|15
5081036|NCT02137772|17540019|P2|Overall Study|Lost to Follow-up|4
5081037|NCT02137772|17540020|P1|Overall Study|Lost to Follow-up|8
5081038|NCT02137772|17540019|P2|Overall Study|Death|44
5081039|NCT02137772|17540020|P1|Overall Study|Death|71
5081040|NCT02137772|17540019|P2|Overall Study|Adverse Event|3
5081041|NCT02137772|17540020|P1|Overall Study|Adverse Event|6
5081042|NCT02137369|17540278|P2|Overall Study|Moved away|0
5081043|NCT02137369|17540279|P1|Overall Study|Moved away|2
5081044|NCT02137369|17540278|P2|Overall Study|Lost to Follow-up|0
5081045|NCT02137369|17540279|P1|Overall Study|Lost to Follow-up|1
5081046|NCT02137369|17540278|P2|Overall Study|Adverse Event|0
5081047|NCT02137369|17540279|P1|Overall Study|Adverse Event|2
5081048|NCT02137369|17540278|P2|Overall Study|Withdrawal by Subject|2
5081049|NCT02137369|17540279|P1|Overall Study|Withdrawal by Subject|3
5081050|NCT02137226|17540289|P5|Period 2 (Re - Randomization)|Other Reason|1
5081051|NCT02137226|17540290|P4|Period 2 (Re - Randomization)|Other Reason|1
5081052|NCT02137226|17540291|P3|Period 2 (Re - Randomization)|Other Reason|1
5081053|NCT02137226|17540292|P2|Period 2 (Re - Randomization)|Other Reason|0
5081054|NCT02137226|17540293|P1|Period 2 (Re - Randomization)|Other Reason|0
5081055|NCT02137226|17540289|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
5081056|NCT02137226|17540290|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
5081057|NCT02137226|17540291|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
5081058|NCT02137226|17540292|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
5081059|NCT02137226|17540293|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
5081060|NCT02137226|17540289|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
5081061|NCT02137226|17540290|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
5081062|NCT02137226|17540291|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
5081063|NCT02137226|17540292|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
5081064|NCT02137226|17540293|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
5081065|NCT02137226|17540289|P5|Period 2 (Re - Randomization)|Physician Decision|0
5081066|NCT02137226|17540290|P4|Period 2 (Re - Randomization)|Physician Decision|1
5081067|NCT02137226|17540291|P3|Period 2 (Re - Randomization)|Physician Decision|0
5081068|NCT02137226|17540292|P2|Period 2 (Re - Randomization)|Physician Decision|0
5081069|NCT02137226|17540293|P1|Period 2 (Re - Randomization)|Physician Decision|0
5081070|NCT02137226|17540289|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
5081071|NCT02137226|17540290|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
5081072|NCT02137226|17540291|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
5081073|NCT02137226|17540292|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
5081074|NCT02137226|17540293|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
5081075|NCT02137226|17540289|P5|Period 2 (Re - Randomization)|Adverse Event|4
5081076|NCT02137226|17540290|P4|Period 2 (Re - Randomization)|Adverse Event|1
5081077|NCT02137226|17540291|P3|Period 2 (Re - Randomization)|Adverse Event|3
5081078|NCT02137226|17540292|P2|Period 2 (Re - Randomization)|Adverse Event|0
5081079|NCT02137226|17540293|P1|Period 2 (Re - Randomization)|Adverse Event|0
5081080|NCT02137226|17540289|P5|Period 1 (Initial Randomization)|Other Reason|0
5081081|NCT02137226|17540290|P4|Period 1 (Initial Randomization)|Other Reason|0
5081082|NCT02137226|17540291|P3|Period 1 (Initial Randomization)|Other Reason|0
5081083|NCT02137226|17540292|P2|Period 1 (Initial Randomization)|Other Reason|3
5081084|NCT02137226|17540293|P1|Period 1 (Initial Randomization)|Other Reason|1
5081085|NCT02137226|17540289|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
5081086|NCT02137226|17540290|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
5081087|NCT02137226|17540291|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
5081088|NCT02137226|17540292|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
5081089|NCT02137226|17540293|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
5081090|NCT02137226|17540289|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
5081091|NCT02137226|17540290|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
5081092|NCT02137226|17540291|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
5081093|NCT02137226|17540292|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
5081094|NCT02137226|17540293|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
5081095|NCT02137226|17540289|P5|Period 1 (Initial Randomization)|Physician Decision|0
5081096|NCT02137226|17540290|P4|Period 1 (Initial Randomization)|Physician Decision|0
5081097|NCT02137226|17540291|P3|Period 1 (Initial Randomization)|Physician Decision|0
5081098|NCT02137226|17540292|P2|Period 1 (Initial Randomization)|Physician Decision|3
5081099|NCT02137226|17540293|P1|Period 1 (Initial Randomization)|Physician Decision|1
5081100|NCT02137226|17540289|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5081101|NCT02137226|17540290|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5081102|NCT02137226|17540291|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5081103|NCT02137226|17540292|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
5081104|NCT02137226|17540293|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
5081105|NCT02137226|17540289|P5|Period 1 (Initial Randomization)|Adverse Event|0
5081106|NCT02137226|17540290|P4|Period 1 (Initial Randomization)|Adverse Event|0
5081107|NCT02137226|17540291|P3|Period 1 (Initial Randomization)|Adverse Event|0
5081108|NCT02137226|17540292|P2|Period 1 (Initial Randomization)|Adverse Event|3
5081109|NCT02137226|17540293|P1|Period 1 (Initial Randomization)|Adverse Event|3
5081110|NCT02136914|17540311|P2|Overall Study|Death|1
5081111|NCT02136914|17540312|P1|Overall Study|Death|0
5081112|NCT02136914|17540311|P2|Overall Study|Lack of Efficacy|0
5081113|NCT02136914|17540312|P1|Overall Study|Lack of Efficacy|1
5081114|NCT02136914|17540311|P2|Overall Study|Did Not Receive Study Drug|0
5081115|NCT02136914|17540312|P1|Overall Study|Did Not Receive Study Drug|2
5081116|NCT02136914|17540311|P2|Overall Study|Lost to Follow-up|1
5081117|NCT02136914|17540312|P1|Overall Study|Lost to Follow-up|1
5081118|NCT02136914|17540311|P2|Overall Study|Subject Unwilling to Proceed|2
5081119|NCT02136914|17540312|P1|Overall Study|Subject Unwilling to Proceed|7
5081120|NCT02136914|17540311|P2|Overall Study|Withdrawal by Subject|10
5081121|NCT02136914|17540312|P1|Overall Study|Withdrawal by Subject|3
5081122|NCT02136914|17540311|P2|Overall Study|Sponsor's Decision to Stop the Study|7
5081123|NCT02136914|17540312|P1|Overall Study|Sponsor's Decision to Stop the Study|7
5081124|NCT02136680|17540332|P2|Overall Study|Study ended before interview due|3
5081125|NCT02136680|17540333|P1|Overall Study|Study ended before interview due|6
5081126|NCT02136680|17540332|P2|Overall Study|Unable to schedule|16
5081127|NCT02136680|17540333|P1|Overall Study|Unable to schedule|17
5081128|NCT02136680|17540332|P2|Overall Study|Moved away|4
5081129|NCT02136680|17540333|P1|Overall Study|Moved away|5
5081130|NCT02136680|17540332|P2|Overall Study|No longer receiving care at clinic|5
5081131|NCT02136680|17540333|P1|Overall Study|No longer receiving care at clinic|3
5081132|NCT02136680|17540332|P2|Overall Study|No Longer Interested|1
5081133|NCT02136680|17540333|P1|Overall Study|No Longer Interested|1
5081134|NCT02136134|17540408|P2|Overall Study|Subjects randomized but not treated|8
5081135|NCT02136134|17540409|P1|Overall Study|Subjects randomized but not treated|10
5081136|NCT02136134|17540408|P2|Overall Study|Ongoing|207
5081137|NCT02136134|17540409|P1|Overall Study|Ongoing|185
5081138|NCT02136134|17540408|P2|Overall Study|Other|3
5081139|NCT02136134|17540409|P1|Overall Study|Other|3
5081140|NCT02136134|17540408|P2|Overall Study|Withdrawal by Subject|4
5081141|NCT02136134|17540409|P1|Overall Study|Withdrawal by Subject|14
5081142|NCT02136134|17540408|P2|Overall Study|Death|29
5081143|NCT02136134|17540409|P1|Overall Study|Death|35
5081144|NCT02135848|17540471|P2|Overall Study|Withdrawal by Subject|1
5081145|NCT02135848|17540472|P1|Overall Study|Withdrawal by Subject|1
5081146|NCT02135848|17540471|P2|Overall Study|Adverse Event|0
5081147|NCT02135848|17540472|P1|Overall Study|Adverse Event|2
5081148|NCT02135692|17540530|P1|Overall Study|Withdrawal by Subject|15
5081149|NCT02135692|17540530|P1|Overall Study|Lost to Follow-up|4
5081150|NCT02135692|17540530|P1|Overall Study|Study closed/terminated|153
5081151|NCT02135692|17540530|P1|Overall Study|Product commercially available|159
5081152|NCT02135692|17540530|P1|Overall Study|Subject met Liver Stopping Criteria|1
5081153|NCT02135692|17540530|P1|Overall Study|Protocol Violation|2
5081154|NCT02135692|17540530|P1|Overall Study|Lack of Efficacy|2
5081155|NCT02135692|17540530|P1|Overall Study|Adverse Event|3
5081156|NCT02135614|17540549|P2|Overall Study|Lost to Follow-up|0
5081157|NCT02135614|17540550|P1|Overall Study|Lost to Follow-up|3
5081158|NCT02135614|17540549|P2|Overall Study|Withdrew Consent|2
5081159|NCT02135614|17540550|P1|Overall Study|Withdrew Consent|2
5081160|NCT02135614|17540549|P2|Overall Study|Investigator's Discretion|1
5081161|NCT02135614|17540550|P1|Overall Study|Investigator's Discretion|0
5081162|NCT02135614|17540549|P2|Overall Study|Death|0
5081163|NCT02135614|17540550|P1|Overall Study|Death|1
5081164|NCT02135614|17540549|P2|Overall Study|Adverse Event|1
5081165|NCT02135614|17540550|P1|Overall Study|Adverse Event|0
5081166|NCT02135614|17540549|P2|Overall Study|Randomized but Not Treated|1
5081167|NCT02135614|17540550|P1|Overall Study|Randomized but Not Treated|2
5081168|NCT02135445|17540564|P2|Overall Study|Withdrawal by Subject|0
5081169|NCT02135445|17540565|P1|Overall Study|Withdrawal by Subject|1
5081170|NCT02135445|17540564|P2|Overall Study|Lost to Follow-up|0
5081171|NCT02135445|17540565|P1|Overall Study|Lost to Follow-up|1
5081172|NCT02135107|17540650|P4|Maintenance Therapy Period|Other|8
5081173|NCT02135107|17540651|P3|Maintenance Therapy Period|Other|7
5081174|NCT02135107|17540652|P2|Maintenance Therapy Period|Other|0
5081175|NCT02135107|17540653|P1|Maintenance Therapy Period|Other|0
5081176|NCT02135107|17540650|P4|Maintenance Therapy Period|Pregnancy|1
5081177|NCT02135107|17540651|P3|Maintenance Therapy Period|Pregnancy|0
5081178|NCT02135107|17540652|P2|Maintenance Therapy Period|Pregnancy|0
5081179|NCT02135107|17540653|P1|Maintenance Therapy Period|Pregnancy|0
5081180|NCT02135107|17540650|P4|Maintenance Therapy Period|Withdrawal by Subject|4
5081181|NCT02135107|17540651|P3|Maintenance Therapy Period|Withdrawal by Subject|5
5081182|NCT02135107|17540652|P2|Maintenance Therapy Period|Withdrawal by Subject|0
5081183|NCT02135107|17540653|P1|Maintenance Therapy Period|Withdrawal by Subject|0
5081184|NCT02135107|17540650|P4|Maintenance Therapy Period|Adverse Event|7
5081185|NCT02135107|17540651|P3|Maintenance Therapy Period|Adverse Event|3
5081186|NCT02135107|17540652|P2|Maintenance Therapy Period|Adverse Event|0
5081187|NCT02135107|17540653|P1|Maintenance Therapy Period|Adverse Event|0
5081188|NCT02135107|17540650|P4|Treatment Period|Other|0
5081189|NCT02135107|17540651|P3|Treatment Period|Other|0
5081190|NCT02135107|17540652|P2|Treatment Period|Other|24
5081191|NCT02135107|17540653|P1|Treatment Period|Other|115
5081192|NCT02135107|17540650|P4|Treatment Period|Pregnancy|0
5081193|NCT02135107|17540651|P3|Treatment Period|Pregnancy|0
5081194|NCT02135107|17540652|P2|Treatment Period|Pregnancy|0
5081195|NCT02135107|17540653|P1|Treatment Period|Pregnancy|1
5081196|NCT02135107|17540650|P4|Treatment Period|Adverse Event|0
5081197|NCT02135107|17540651|P3|Treatment Period|Adverse Event|0
5081198|NCT02135107|17540652|P2|Treatment Period|Adverse Event|2
5081199|NCT02135107|17540653|P1|Treatment Period|Adverse Event|5
5081200|NCT02135107|17540650|P4|Treatment Period|Withdrawal by Subject|0
5081201|NCT02135107|17540651|P3|Treatment Period|Withdrawal by Subject|0
5081202|NCT02135107|17540652|P2|Treatment Period|Withdrawal by Subject|0
5081203|NCT02135107|17540653|P1|Treatment Period|Withdrawal by Subject|11
5081204|NCT02135029|17540699|P3|Overall Study|Death|0
5081205|NCT02135029|17540700|P2|Overall Study|Death|1
5081206|NCT02135029|17540701|P1|Overall Study|Death|0
5081207|NCT02135029|17540699|P3|Overall Study|Other|0
5081208|NCT02135029|17540700|P2|Overall Study|Other|1
5081209|NCT02135029|17540701|P1|Overall Study|Other|0
5081210|NCT02135029|17540699|P3|Overall Study|Withdrawal by Subject|1
5081211|NCT02135029|17540700|P2|Overall Study|Withdrawal by Subject|0
5081212|NCT02135029|17540701|P1|Overall Study|Withdrawal by Subject|2
5081213|NCT02135029|17540699|P3|Overall Study|Lost to Follow-up|0
5081214|NCT02135029|17540700|P2|Overall Study|Lost to Follow-up|1
5081215|NCT02135029|17540701|P1|Overall Study|Lost to Follow-up|0
5081216|NCT02135029|17540699|P3|Overall Study|Adverse Event|2
5081217|NCT02135029|17540700|P2|Overall Study|Adverse Event|2
5081218|NCT02135029|17540701|P1|Overall Study|Adverse Event|2
5081219|NCT02134977|17540806|P1|Overall Study|Protocol Deviation|102
5081220|NCT02134925|17540840|P2|Overall Study|Cancel|6
5081221|NCT02134925|17540841|P1|Overall Study|Cancel|1
5081222|NCT02134925|17540840|P2|Overall Study|Withdrawal by Subject|0
5081223|NCT02134925|17540841|P1|Overall Study|Withdrawal by Subject|1
5081224|NCT02134587|17540882|P1|Overall Study|Did not completed all meetings|30
5081225|NCT02134353|17540898|P2|Overall Study|Other - Patient's Choice|1
5081226|NCT02134353|17540899|P1|Overall Study|Other - Patient's Choice|0
5081227|NCT02134353|17540898|P2|Overall Study|Relocation|0
5081228|NCT02134353|17540899|P1|Overall Study|Relocation|1
5081229|NCT02134353|17540898|P2|Overall Study|Pregnancy|1
5081230|NCT02134353|17540899|P1|Overall Study|Pregnancy|0
5081231|NCT02134353|17540898|P2|Overall Study|Death|1
5081232|NCT02134353|17540899|P1|Overall Study|Death|0
5081233|NCT02134353|17540898|P2|Overall Study|Withdrawal by Subject|13
5081234|NCT02134353|17540899|P1|Overall Study|Withdrawal by Subject|12
5081235|NCT02134353|17540898|P2|Overall Study|Lack of Efficacy|1
5081236|NCT02134353|17540899|P1|Overall Study|Lack of Efficacy|2
5081237|NCT02134353|17540898|P2|Overall Study|Lost to Follow-up|1
5081238|NCT02134353|17540899|P1|Overall Study|Lost to Follow-up|1
5081239|NCT02134353|17540898|P2|Overall Study|Adverse Event|6
5081240|NCT02134353|17540899|P1|Overall Study|Adverse Event|10
5081241|NCT02134028|17541054|P8|Overall Study|Adverse Event|2
5081242|NCT02134028|17541055|P7|Overall Study|Adverse Event|1
5081243|NCT02134028|17541056|P6|Overall Study|Adverse Event|5
5081244|NCT02134028|17541057|P5|Overall Study|Adverse Event|4
5081245|NCT02134028|17541058|P4|Overall Study|Adverse Event|32
5081246|NCT02134028|17541059|P3|Overall Study|Adverse Event|13
5081247|NCT02134028|17541060|P2|Overall Study|Adverse Event|19
5081248|NCT02134028|17541061|P1|Overall Study|Adverse Event|3
5081249|NCT02134028|17541054|P8|Overall Study|Other unspecified|1
5081250|NCT02134028|17541055|P7|Overall Study|Other unspecified|2
5081251|NCT02134028|17541056|P6|Overall Study|Other unspecified|6
5081252|NCT02134028|17541057|P5|Overall Study|Other unspecified|8
5081253|NCT02134028|17541058|P4|Overall Study|Other unspecified|64
5081254|NCT02134028|17541059|P3|Overall Study|Other unspecified|33
5081255|NCT02134028|17541060|P2|Overall Study|Other unspecified|22
5081256|NCT02134028|17541061|P1|Overall Study|Other unspecified|4
5081257|NCT02134028|17541054|P8|Overall Study|Poor compliance to protocol|0
5081258|NCT02134028|17541055|P7|Overall Study|Poor compliance to protocol|0
5081259|NCT02134028|17541056|P6|Overall Study|Poor compliance to protocol|1
5081260|NCT02134028|17541057|P5|Overall Study|Poor compliance to protocol|1
5081261|NCT02134028|17541058|P4|Overall Study|Poor compliance to protocol|7
5081262|NCT02134028|17541059|P3|Overall Study|Poor compliance to protocol|3
5081263|NCT02134028|17541060|P2|Overall Study|Poor compliance to protocol|1
5081264|NCT02134028|17541061|P1|Overall Study|Poor compliance to protocol|1
5081265|NCT02134028|17541054|P8|Overall Study|Lack of Efficacy|0
5081266|NCT02134028|17541055|P7|Overall Study|Lack of Efficacy|1
5081267|NCT02134028|17541056|P6|Overall Study|Lack of Efficacy|2
5081268|NCT02134028|17541057|P5|Overall Study|Lack of Efficacy|1
5081269|NCT02134028|17541058|P4|Overall Study|Lack of Efficacy|2
5081270|NCT02134028|17541059|P3|Overall Study|Lack of Efficacy|3
5081271|NCT02134028|17541060|P2|Overall Study|Lack of Efficacy|0
5081272|NCT02134028|17541061|P1|Overall Study|Lack of Efficacy|1
5081273|NCT02134015|17541219|P2|Overall Study|Withdrawal by Subject|7
5081274|NCT02134015|17541220|P1|Overall Study|Withdrawal by Subject|3
5081275|NCT02134015|17541219|P2|Overall Study|Adverse Event|10
5081276|NCT02134015|17541220|P1|Overall Study|Adverse Event|9
5081277|NCT02134015|17541219|P2|Overall Study|Study terminated by sponsor|3
5081278|NCT02134015|17541220|P1|Overall Study|Study terminated by sponsor|2
5081279|NCT02134015|17541219|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
5081280|NCT02134015|17541220|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
5081281|NCT02134015|17541219|P2|Overall Study|Clinical progression|7
5081282|NCT02134015|17541220|P1|Overall Study|Clinical progression|14
5081283|NCT02134015|17541219|P2|Overall Study|Reason not provided|2
5081284|NCT02134015|17541220|P1|Overall Study|Reason not provided|1
5081285|NCT02134015|17541219|P2|Overall Study|Death|1
5081286|NCT02134015|17541220|P1|Overall Study|Death|2
5081287|NCT02134015|17541219|P2|Overall Study|Protocol Violation|1
5081288|NCT02134015|17541220|P1|Overall Study|Protocol Violation|0
5081289|NCT02133742|17541256|P1|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
5081290|NCT02133742|17541256|P1|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
5081291|NCT02133742|17541256|P1|Period 2:Dose Expansion Phase (1344days)|Death|13
5081292|NCT02133742|17541256|P1|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
5081293|NCT02133742|17541256|P1|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
5081294|NCT02133664|17541285|P2|Overall Study|Adverse Event|6
5081295|NCT02133664|17541286|P1|Overall Study|Adverse Event|3
5081296|NCT02133664|17541285|P2|Overall Study|Lost to Follow-up|1
5081297|NCT02133664|17541286|P1|Overall Study|Lost to Follow-up|2
5081298|NCT02133508|17541302|P1|Overall Study|Lost to Follow-up|2
5081299|NCT02133508|17541302|P1|Overall Study|Death|12
5081300|NCT02133508|17541302|P1|Overall Study|Decision of Investigator or Sponsor|1
5081301|NCT02133352|17541310|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
5081302|NCT02133131|17541341|P7|Overall Study|Protocol Violation|1
5081303|NCT02133131|17541342|P6|Overall Study|Protocol Violation|0
5081304|NCT02133131|17541343|P5|Overall Study|Protocol Violation|0
5081305|NCT02133131|17541344|P4|Overall Study|Protocol Violation|0
5081306|NCT02133131|17541345|P3|Overall Study|Protocol Violation|0
5081307|NCT02133131|17541346|P2|Overall Study|Protocol Violation|0
5081308|NCT02133131|17541347|P1|Overall Study|Protocol Violation|0
5081309|NCT02133131|17541341|P7|Overall Study|Ongoing in study|11
5081310|NCT02133131|17541342|P6|Overall Study|Ongoing in study|14
5081311|NCT02133131|17541343|P5|Overall Study|Ongoing in study|15
5081312|NCT02133131|17541344|P4|Overall Study|Ongoing in study|0
5081313|NCT02133131|17541345|P3|Overall Study|Ongoing in study|0
5081314|NCT02133131|17541346|P2|Overall Study|Ongoing in study|0
5081315|NCT02133131|17541347|P1|Overall Study|Ongoing in study|0
5081316|NCT02133131|17541341|P7|Overall Study|Status not recorded|0
5081317|NCT02133131|17541342|P6|Overall Study|Status not recorded|0
5081318|NCT02133131|17541343|P5|Overall Study|Status not recorded|0
5081319|NCT02133131|17541344|P4|Overall Study|Status not recorded|4
5081320|NCT02133131|17541345|P3|Overall Study|Status not recorded|1
5081321|NCT02133131|17541346|P2|Overall Study|Status not recorded|5
5081322|NCT02133131|17541347|P1|Overall Study|Status not recorded|4
5081323|NCT02133131|17541341|P7|Overall Study|Lost to Follow-up|0
5081324|NCT02133131|17541342|P6|Overall Study|Lost to Follow-up|0
5081325|NCT02133131|17541343|P5|Overall Study|Lost to Follow-up|0
5081326|NCT02133131|17541344|P4|Overall Study|Lost to Follow-up|1
5081327|NCT02133131|17541345|P3|Overall Study|Lost to Follow-up|0
5081328|NCT02133131|17541346|P2|Overall Study|Lost to Follow-up|0
5081329|NCT02133131|17541347|P1|Overall Study|Lost to Follow-up|1
5081330|NCT02133131|17541341|P7|Overall Study|Adverse Event|0
5081331|NCT02133131|17541342|P6|Overall Study|Adverse Event|0
5081332|NCT02133131|17541343|P5|Overall Study|Adverse Event|0
5081333|NCT02133131|17541344|P4|Overall Study|Adverse Event|1
5081334|NCT02133131|17541345|P3|Overall Study|Adverse Event|0
5081335|NCT02133131|17541346|P2|Overall Study|Adverse Event|0
5081336|NCT02133131|17541347|P1|Overall Study|Adverse Event|0
5081337|NCT02133001|17541401|P2|Follow-Up Phase (Day 26-81)|Other|1
5081338|NCT02133001|17541402|P1|Follow-Up Phase (Day 26-81)|Other|0
5081339|NCT02133001|17541401|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
5081340|NCT02133001|17541402|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
5081341|NCT02133001|17541401|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
5081342|NCT02133001|17541402|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
5081343|NCT02133001|17541401|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
5081344|NCT02133001|17541402|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
5081345|NCT02133001|17541401|P2|Double Blind (Day 1-25)|Other|2
5081346|NCT02133001|17541402|P1|Double Blind (Day 1-25)|Other|2
5081347|NCT02133001|17541401|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
5081348|NCT02133001|17541402|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
5081349|NCT02133001|17541401|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
5081350|NCT02133001|17541402|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
5081351|NCT02133001|17541401|P2|Double Blind (Day 1-25)|Adverse Event|5
5081352|NCT02133001|17541402|P1|Double Blind (Day 1-25)|Adverse Event|1
5081353|NCT02132949|17541450|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
5081354|NCT02132949|17541451|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
5081355|NCT02132949|17541450|P2|Adjuvant Treatment Period|Protocol Deviation|0
5081356|NCT02132949|17541451|P1|Adjuvant Treatment Period|Protocol Deviation|1
5081357|NCT02132949|17541450|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
5081358|NCT02132949|17541451|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
5081359|NCT02132949|17541450|P2|Adjuvant Treatment Period|Physician Decision|0
5081360|NCT02132949|17541451|P1|Adjuvant Treatment Period|Physician Decision|1
5081361|NCT02132949|17541450|P2|Adjuvant Treatment Period|Disease Relapse|1
5081362|NCT02132949|17541451|P1|Adjuvant Treatment Period|Disease Relapse|0
5081363|NCT02132949|17541450|P2|Adjuvant Treatment Period|Disease Progression|1
5081364|NCT02132949|17541451|P1|Adjuvant Treatment Period|Disease Progression|0
5081365|NCT02132949|17541450|P2|Adjuvant Treatment Period|Reason unspecified|1
5081366|NCT02132949|17541451|P1|Adjuvant Treatment Period|Reason unspecified|0
5081367|NCT02132949|17541450|P2|Adjuvant Treatment Period|Adverse Event|6
5081368|NCT02132949|17541451|P1|Adjuvant Treatment Period|Adverse Event|4
5081369|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
5081370|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
5081371|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Adverse Event|3
5081372|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Adverse Event|6
5081373|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Disease Progression|1
5081374|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Disease Progression|1
5081375|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
5081376|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
5081377|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Physician Decision|0
5081378|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Physician Decision|2
5081379|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
5081380|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
5081381|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Reason unspecified|1
5081382|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Reason unspecified|3
5081383|NCT02132949|17541450|P2|Neoadjuvant Treatment Period|Early surgery|3
5081384|NCT02132949|17541451|P1|Neoadjuvant Treatment Period|Early surgery|4
5081385|NCT02132767|17541563|P2|Overall Study|Lost to Follow-up|4
5081386|NCT02132767|17541564|P1|Overall Study|Lost to Follow-up|4
5081387|NCT02132767|17541563|P2|Overall Study|Withdrawal by Subject|9
5081388|NCT02132767|17541564|P1|Overall Study|Withdrawal by Subject|10
5081389|NCT02132767|17541563|P2|Overall Study|Death|2
5081390|NCT02132767|17541564|P1|Overall Study|Death|3
5081391|NCT02132754|17541618|P34|Overall Study|Withdrawal by Subject|2
5081392|NCT02132754|17541619|P33|Overall Study|Withdrawal by Subject|0
5081393|NCT02132754|17541620|P32|Overall Study|Withdrawal by Subject|1
5081394|NCT02132754|17541621|P31|Overall Study|Withdrawal by Subject|0
5081395|NCT02132754|17541622|P30|Overall Study|Withdrawal by Subject|0
5081396|NCT02132754|17541623|P29|Overall Study|Withdrawal by Subject|0
5081397|NCT02132754|17541624|P28|Overall Study|Withdrawal by Subject|1
5081398|NCT02132754|17541625|P27|Overall Study|Withdrawal by Subject|0
5081399|NCT02132754|17541626|P26|Overall Study|Withdrawal by Subject|0
5081400|NCT02132754|17541627|P25|Overall Study|Withdrawal by Subject|1
5081401|NCT02132754|17541628|P24|Overall Study|Withdrawal by Subject|0
5081402|NCT02132754|17541629|P23|Overall Study|Withdrawal by Subject|0
5081403|NCT02132754|17541630|P22|Overall Study|Withdrawal by Subject|0
5081404|NCT02132754|17541631|P21|Overall Study|Withdrawal by Subject|1
5081405|NCT02132754|17541632|P20|Overall Study|Withdrawal by Subject|0
5081406|NCT02132754|17541633|P19|Overall Study|Withdrawal by Subject|0
5081407|NCT02132754|17541634|P18|Overall Study|Withdrawal by Subject|0
5081408|NCT02132754|17541635|P17|Overall Study|Withdrawal by Subject|1
5081409|NCT02132754|17541636|P16|Overall Study|Withdrawal by Subject|2
5081410|NCT02132754|17541637|P15|Overall Study|Withdrawal by Subject|1
5081411|NCT02132754|17541638|P14|Overall Study|Withdrawal by Subject|0
5081412|NCT02132754|17541639|P13|Overall Study|Withdrawal by Subject|1
5081413|NCT02132754|17541640|P12|Overall Study|Withdrawal by Subject|0
5081414|NCT02132754|17541641|P11|Overall Study|Withdrawal by Subject|0
5081415|NCT02132754|17541642|P10|Overall Study|Withdrawal by Subject|1
5081416|NCT02132754|17541643|P9|Overall Study|Withdrawal by Subject|0
5081417|NCT02132754|17541644|P8|Overall Study|Withdrawal by Subject|0
5081418|NCT02132754|17541645|P7|Overall Study|Withdrawal by Subject|0
5081419|NCT02132754|17541646|P6|Overall Study|Withdrawal by Subject|0
5081420|NCT02132754|17541647|P5|Overall Study|Withdrawal by Subject|0
5081421|NCT02132754|17541648|P4|Overall Study|Withdrawal by Subject|0
5081422|NCT02132754|17541649|P3|Overall Study|Withdrawal by Subject|0
5081423|NCT02132754|17541650|P2|Overall Study|Withdrawal by Subject|0
5081424|NCT02132754|17541651|P1|Overall Study|Withdrawal by Subject|0
5081425|NCT02132754|17541618|P34|Overall Study|Transferred to Extension Study|6
5081426|NCT02132754|17541619|P33|Overall Study|Transferred to Extension Study|0
5081427|NCT02132754|17541620|P32|Overall Study|Transferred to Extension Study|0
5081428|NCT02132754|17541621|P31|Overall Study|Transferred to Extension Study|0
5081429|NCT02132754|17541622|P30|Overall Study|Transferred to Extension Study|0
5081430|NCT02132754|17541623|P29|Overall Study|Transferred to Extension Study|0
5081431|NCT02132754|17541624|P28|Overall Study|Transferred to Extension Study|0
5081432|NCT02132754|17541625|P27|Overall Study|Transferred to Extension Study|0
5081433|NCT02132754|17541626|P26|Overall Study|Transferred to Extension Study|0
5081434|NCT02132754|17541627|P25|Overall Study|Transferred to Extension Study|0
5081435|NCT02132754|17541628|P24|Overall Study|Transferred to Extension Study|0
5081436|NCT02132754|17541629|P23|Overall Study|Transferred to Extension Study|0
5081437|NCT02132754|17541630|P22|Overall Study|Transferred to Extension Study|0
5081438|NCT02132754|17541631|P21|Overall Study|Transferred to Extension Study|0
5081439|NCT02132754|17541632|P20|Overall Study|Transferred to Extension Study|0
5081440|NCT02132754|17541633|P19|Overall Study|Transferred to Extension Study|0
5081441|NCT02132754|17541634|P18|Overall Study|Transferred to Extension Study|0
5081442|NCT02132754|17541635|P17|Overall Study|Transferred to Extension Study|0
5081443|NCT02132754|17541636|P16|Overall Study|Transferred to Extension Study|0
5081444|NCT02132754|17541637|P15|Overall Study|Transferred to Extension Study|0
5081445|NCT02132754|17541638|P14|Overall Study|Transferred to Extension Study|0
5081446|NCT02132754|17541639|P13|Overall Study|Transferred to Extension Study|0
5081447|NCT02132754|17541640|P12|Overall Study|Transferred to Extension Study|0
5081448|NCT02132754|17541641|P11|Overall Study|Transferred to Extension Study|0
5081449|NCT02132754|17541642|P10|Overall Study|Transferred to Extension Study|0
5081450|NCT02132754|17541643|P9|Overall Study|Transferred to Extension Study|0
5081451|NCT02132754|17541644|P8|Overall Study|Transferred to Extension Study|0
5081452|NCT02132754|17541645|P7|Overall Study|Transferred to Extension Study|0
5081453|NCT02132754|17541646|P6|Overall Study|Transferred to Extension Study|0
5081454|NCT02132754|17541647|P5|Overall Study|Transferred to Extension Study|0
5081455|NCT02132754|17541648|P4|Overall Study|Transferred to Extension Study|0
5081456|NCT02132754|17541649|P3|Overall Study|Transferred to Extension Study|0
5081457|NCT02132754|17541650|P2|Overall Study|Transferred to Extension Study|0
5081458|NCT02132754|17541651|P1|Overall Study|Transferred to Extension Study|0
5081459|NCT02132754|17541618|P34|Overall Study|Screen Failure|0
5081460|NCT02132754|17541619|P33|Overall Study|Screen Failure|0
5081461|NCT02132754|17541620|P32|Overall Study|Screen Failure|0
5081462|NCT02132754|17541621|P31|Overall Study|Screen Failure|0
5081463|NCT02132754|17541622|P30|Overall Study|Screen Failure|0
5081464|NCT02132754|17541623|P29|Overall Study|Screen Failure|0
5081465|NCT02132754|17541624|P28|Overall Study|Screen Failure|0
5081466|NCT02132754|17541625|P27|Overall Study|Screen Failure|0
5081467|NCT02132754|17541626|P26|Overall Study|Screen Failure|0
5081468|NCT02132754|17541627|P25|Overall Study|Screen Failure|0
5081469|NCT02132754|17541628|P24|Overall Study|Screen Failure|0
5081470|NCT02132754|17541629|P23|Overall Study|Screen Failure|0
5081471|NCT02132754|17541630|P22|Overall Study|Screen Failure|1
5081472|NCT02132754|17541631|P21|Overall Study|Screen Failure|0
5081473|NCT02132754|17541632|P20|Overall Study|Screen Failure|1
5081474|NCT02132754|17541633|P19|Overall Study|Screen Failure|0
5081475|NCT02132754|17541634|P18|Overall Study|Screen Failure|0
5081476|NCT02132754|17541635|P17|Overall Study|Screen Failure|0
5081477|NCT02132754|17541636|P16|Overall Study|Screen Failure|0
5081478|NCT02132754|17541637|P15|Overall Study|Screen Failure|0
5081479|NCT02132754|17541638|P14|Overall Study|Screen Failure|0
5081480|NCT02132754|17541639|P13|Overall Study|Screen Failure|0
5081481|NCT02132754|17541640|P12|Overall Study|Screen Failure|0
5081482|NCT02132754|17541641|P11|Overall Study|Screen Failure|0
5081483|NCT02132754|17541642|P10|Overall Study|Screen Failure|0
5081484|NCT02132754|17541643|P9|Overall Study|Screen Failure|0
5081485|NCT02132754|17541644|P8|Overall Study|Screen Failure|0
5081486|NCT02132754|17541645|P7|Overall Study|Screen Failure|0
5081487|NCT02132754|17541646|P6|Overall Study|Screen Failure|0
5081488|NCT02132754|17541647|P5|Overall Study|Screen Failure|0
5081489|NCT02132754|17541648|P4|Overall Study|Screen Failure|0
5081490|NCT02132754|17541649|P3|Overall Study|Screen Failure|0
5081491|NCT02132754|17541650|P2|Overall Study|Screen Failure|0
5081492|NCT02132754|17541651|P1|Overall Study|Screen Failure|0
5081493|NCT02132754|17541618|P34|Overall Study|Progressive Disease|6
5081494|NCT02132754|17541619|P33|Overall Study|Progressive Disease|3
5081495|NCT02132754|17541620|P32|Overall Study|Progressive Disease|1
5081496|NCT02132754|17541621|P31|Overall Study|Progressive Disease|1
5081497|NCT02132754|17541622|P30|Overall Study|Progressive Disease|3
5081498|NCT02132754|17541623|P29|Overall Study|Progressive Disease|2
5081499|NCT02132754|17541624|P28|Overall Study|Progressive Disease|1
5081500|NCT02132754|17541625|P27|Overall Study|Progressive Disease|2
5081501|NCT02132754|17541626|P26|Overall Study|Progressive Disease|1
5081502|NCT02132754|17541627|P25|Overall Study|Progressive Disease|0
5081503|NCT02132754|17541628|P24|Overall Study|Progressive Disease|3
5081504|NCT02132754|17541629|P23|Overall Study|Progressive Disease|2
5081505|NCT02132754|17541630|P22|Overall Study|Progressive Disease|3
5081506|NCT02132754|17541631|P21|Overall Study|Progressive Disease|1
5081507|NCT02132754|17541632|P20|Overall Study|Progressive Disease|1
5081508|NCT02132754|17541633|P19|Overall Study|Progressive Disease|3
5081509|NCT02132754|17541634|P18|Overall Study|Progressive Disease|1
5081510|NCT02132754|17541635|P17|Overall Study|Progressive Disease|2
5081511|NCT02132754|17541636|P16|Overall Study|Progressive Disease|1
5081512|NCT02132754|17541637|P15|Overall Study|Progressive Disease|2
5081513|NCT02132754|17541638|P14|Overall Study|Progressive Disease|3
5081514|NCT02132754|17541639|P13|Overall Study|Progressive Disease|2
5081515|NCT02132754|17541640|P12|Overall Study|Progressive Disease|2
5081516|NCT02132754|17541641|P11|Overall Study|Progressive Disease|3
5081517|NCT02132754|17541642|P10|Overall Study|Progressive Disease|3
5081518|NCT02132754|17541643|P9|Overall Study|Progressive Disease|1
5081519|NCT02132754|17541644|P8|Overall Study|Progressive Disease|1
5081520|NCT02132754|17541645|P7|Overall Study|Progressive Disease|1
5081521|NCT02132754|17541646|P6|Overall Study|Progressive Disease|1
5081522|NCT02132754|17541647|P5|Overall Study|Progressive Disease|1
5081523|NCT02132754|17541648|P4|Overall Study|Progressive Disease|1
5081524|NCT02132754|17541649|P3|Overall Study|Progressive Disease|1
5081525|NCT02132754|17541650|P2|Overall Study|Progressive Disease|1
5081526|NCT02132754|17541651|P1|Overall Study|Progressive Disease|1
5081527|NCT02132754|17541618|P34|Overall Study|Physician Decision|3
5081528|NCT02132754|17541619|P33|Overall Study|Physician Decision|0
5081529|NCT02132754|17541620|P32|Overall Study|Physician Decision|1
5081530|NCT02132754|17541621|P31|Overall Study|Physician Decision|0
5081531|NCT02132754|17541622|P30|Overall Study|Physician Decision|0
5081532|NCT02132754|17541623|P29|Overall Study|Physician Decision|0
5081533|NCT02132754|17541624|P28|Overall Study|Physician Decision|0
5081534|NCT02132754|17541625|P27|Overall Study|Physician Decision|0
5081535|NCT02132754|17541626|P26|Overall Study|Physician Decision|0
5081536|NCT02132754|17541627|P25|Overall Study|Physician Decision|1
5081537|NCT02132754|17541628|P24|Overall Study|Physician Decision|0
5081538|NCT02132754|17541629|P23|Overall Study|Physician Decision|0
5081539|NCT02132754|17541630|P22|Overall Study|Physician Decision|0
5081540|NCT02132754|17541631|P21|Overall Study|Physician Decision|0
5081541|NCT02132754|17541632|P20|Overall Study|Physician Decision|0
5081542|NCT02132754|17541633|P19|Overall Study|Physician Decision|0
5081543|NCT02132754|17541634|P18|Overall Study|Physician Decision|0
5081544|NCT02132754|17541635|P17|Overall Study|Physician Decision|0
5081545|NCT02132754|17541636|P16|Overall Study|Physician Decision|1
5081546|NCT02132754|17541637|P15|Overall Study|Physician Decision|0
5081547|NCT02132754|17541638|P14|Overall Study|Physician Decision|0
5081548|NCT02132754|17541639|P13|Overall Study|Physician Decision|1
5081549|NCT02132754|17541640|P12|Overall Study|Physician Decision|1
5081550|NCT02132754|17541641|P11|Overall Study|Physician Decision|0
5081551|NCT02132754|17541642|P10|Overall Study|Physician Decision|1
5081552|NCT02132754|17541643|P9|Overall Study|Physician Decision|0
5081553|NCT02132754|17541644|P8|Overall Study|Physician Decision|0
5081554|NCT02132754|17541645|P7|Overall Study|Physician Decision|0
5081555|NCT02132754|17541646|P6|Overall Study|Physician Decision|0
5081556|NCT02132754|17541647|P5|Overall Study|Physician Decision|0
5081557|NCT02132754|17541648|P4|Overall Study|Physician Decision|0
5081558|NCT02132754|17541649|P3|Overall Study|Physician Decision|0
5081559|NCT02132754|17541650|P2|Overall Study|Physician Decision|0
5081560|NCT02132754|17541651|P1|Overall Study|Physician Decision|0
5081561|NCT02132754|17541618|P34|Overall Study|Excluded Medication|1
5081562|NCT02132754|17541619|P33|Overall Study|Excluded Medication|0
5081563|NCT02132754|17541620|P32|Overall Study|Excluded Medication|0
5081564|NCT02132754|17541621|P31|Overall Study|Excluded Medication|0
5081565|NCT02132754|17541622|P30|Overall Study|Excluded Medication|0
5081566|NCT02132754|17541623|P29|Overall Study|Excluded Medication|0
5081567|NCT02132754|17541624|P28|Overall Study|Excluded Medication|0
5081568|NCT02132754|17541625|P27|Overall Study|Excluded Medication|0
5081569|NCT02132754|17541626|P26|Overall Study|Excluded Medication|0
5081570|NCT02132754|17541627|P25|Overall Study|Excluded Medication|0
5081571|NCT02132754|17541628|P24|Overall Study|Excluded Medication|0
5081572|NCT02132754|17541629|P23|Overall Study|Excluded Medication|0
5081573|NCT02132754|17541630|P22|Overall Study|Excluded Medication|0
5081574|NCT02132754|17541631|P21|Overall Study|Excluded Medication|1
5081575|NCT02132754|17541632|P20|Overall Study|Excluded Medication|0
5081576|NCT02132754|17541633|P19|Overall Study|Excluded Medication|0
5081577|NCT02132754|17541634|P18|Overall Study|Excluded Medication|0
5081578|NCT02132754|17541635|P17|Overall Study|Excluded Medication|0
5081579|NCT02132754|17541636|P16|Overall Study|Excluded Medication|0
5081580|NCT02132754|17541637|P15|Overall Study|Excluded Medication|0
5081581|NCT02132754|17541638|P14|Overall Study|Excluded Medication|0
5081582|NCT02132754|17541639|P13|Overall Study|Excluded Medication|0
5081583|NCT02132754|17541640|P12|Overall Study|Excluded Medication|0
5081584|NCT02132754|17541641|P11|Overall Study|Excluded Medication|0
5081585|NCT02132754|17541642|P10|Overall Study|Excluded Medication|0
5081586|NCT02132754|17541643|P9|Overall Study|Excluded Medication|0
5081587|NCT02132754|17541644|P8|Overall Study|Excluded Medication|0
5081588|NCT02132754|17541645|P7|Overall Study|Excluded Medication|0
5081589|NCT02132754|17541646|P6|Overall Study|Excluded Medication|0
5081590|NCT02132754|17541647|P5|Overall Study|Excluded Medication|0
5081591|NCT02132754|17541648|P4|Overall Study|Excluded Medication|0
5081592|NCT02132754|17541649|P3|Overall Study|Excluded Medication|0
5081593|NCT02132754|17541650|P2|Overall Study|Excluded Medication|0
5081594|NCT02132754|17541651|P1|Overall Study|Excluded Medication|0
5081595|NCT02132754|17541618|P34|Overall Study|Death|2
5081596|NCT02132754|17541619|P33|Overall Study|Death|0
5081597|NCT02132754|17541620|P32|Overall Study|Death|0
5081598|NCT02132754|17541621|P31|Overall Study|Death|0
5081599|NCT02132754|17541622|P30|Overall Study|Death|0
5081600|NCT02132754|17541623|P29|Overall Study|Death|0
5081601|NCT02132754|17541624|P28|Overall Study|Death|0
5081602|NCT02132754|17541625|P27|Overall Study|Death|1
5081603|NCT02132754|17541626|P26|Overall Study|Death|0
5081604|NCT02132754|17541627|P25|Overall Study|Death|0
5081605|NCT02132754|17541628|P24|Overall Study|Death|0
5081606|NCT02132754|17541629|P23|Overall Study|Death|0
5081607|NCT02132754|17541630|P22|Overall Study|Death|1
5081608|NCT02132754|17541631|P21|Overall Study|Death|0
5081609|NCT02132754|17541632|P20|Overall Study|Death|1
5081610|NCT02132754|17541633|P19|Overall Study|Death|0
5081611|NCT02132754|17541634|P18|Overall Study|Death|0
5081612|NCT02132754|17541635|P17|Overall Study|Death|0
5081613|NCT02132754|17541636|P16|Overall Study|Death|1
5081614|NCT02132754|17541637|P15|Overall Study|Death|0
5081615|NCT02132754|17541638|P14|Overall Study|Death|0
5081616|NCT02132754|17541639|P13|Overall Study|Death|0
5081617|NCT02132754|17541640|P12|Overall Study|Death|0
5081618|NCT02132754|17541641|P11|Overall Study|Death|0
5081619|NCT02132754|17541642|P10|Overall Study|Death|0
5081620|NCT02132754|17541643|P9|Overall Study|Death|0
5081621|NCT02132754|17541644|P8|Overall Study|Death|0
5081622|NCT02132754|17541645|P7|Overall Study|Death|0
5081623|NCT02132754|17541646|P6|Overall Study|Death|0
5081624|NCT02132754|17541647|P5|Overall Study|Death|0
5081625|NCT02132754|17541648|P4|Overall Study|Death|0
5081626|NCT02132754|17541649|P3|Overall Study|Death|0
5081627|NCT02132754|17541650|P2|Overall Study|Death|0
5081628|NCT02132754|17541651|P1|Overall Study|Death|0
5081629|NCT02132754|17541618|P34|Overall Study|Clinical Progression|2
5081630|NCT02132754|17541619|P33|Overall Study|Clinical Progression|0
5081631|NCT02132754|17541620|P32|Overall Study|Clinical Progression|0
5081632|NCT02132754|17541621|P31|Overall Study|Clinical Progression|1
5081633|NCT02132754|17541622|P30|Overall Study|Clinical Progression|0
5081634|NCT02132754|17541623|P29|Overall Study|Clinical Progression|1
5081635|NCT02132754|17541624|P28|Overall Study|Clinical Progression|1
5081636|NCT02132754|17541625|P27|Overall Study|Clinical Progression|0
5081637|NCT02132754|17541626|P26|Overall Study|Clinical Progression|1
5081638|NCT02132754|17541627|P25|Overall Study|Clinical Progression|1
5081639|NCT02132754|17541628|P24|Overall Study|Clinical Progression|0
5081640|NCT02132754|17541629|P23|Overall Study|Clinical Progression|1
5081641|NCT02132754|17541630|P22|Overall Study|Clinical Progression|0
5081642|NCT02132754|17541631|P21|Overall Study|Clinical Progression|0
5081643|NCT02132754|17541632|P20|Overall Study|Clinical Progression|1
5081644|NCT02132754|17541633|P19|Overall Study|Clinical Progression|0
5081645|NCT02132754|17541634|P18|Overall Study|Clinical Progression|1
5081646|NCT02132754|17541635|P17|Overall Study|Clinical Progression|1
5081647|NCT02132754|17541636|P16|Overall Study|Clinical Progression|0
5081648|NCT02132754|17541637|P15|Overall Study|Clinical Progression|0
5081649|NCT02132754|17541638|P14|Overall Study|Clinical Progression|0
5081650|NCT02132754|17541639|P13|Overall Study|Clinical Progression|0
5081651|NCT02132754|17541640|P12|Overall Study|Clinical Progression|0
5081652|NCT02132754|17541641|P11|Overall Study|Clinical Progression|0
5081653|NCT02132754|17541642|P10|Overall Study|Clinical Progression|1
5081654|NCT02132754|17541643|P9|Overall Study|Clinical Progression|0
5081655|NCT02132754|17541644|P8|Overall Study|Clinical Progression|0
5081656|NCT02132754|17541645|P7|Overall Study|Clinical Progression|0
5081657|NCT02132754|17541646|P6|Overall Study|Clinical Progression|0
5081658|NCT02132754|17541647|P5|Overall Study|Clinical Progression|0
5081659|NCT02132754|17541648|P4|Overall Study|Clinical Progression|0
5081660|NCT02132754|17541649|P3|Overall Study|Clinical Progression|0
5081661|NCT02132754|17541650|P2|Overall Study|Clinical Progression|0
5081662|NCT02132754|17541651|P1|Overall Study|Clinical Progression|0
5081663|NCT02132754|17541618|P34|Overall Study|Adverse Event|1
5081664|NCT02132754|17541619|P33|Overall Study|Adverse Event|1
5081665|NCT02132754|17541620|P32|Overall Study|Adverse Event|0
5081666|NCT02132754|17541621|P31|Overall Study|Adverse Event|1
5081667|NCT02132754|17541622|P30|Overall Study|Adverse Event|0
5081668|NCT02132754|17541623|P29|Overall Study|Adverse Event|0
5081669|NCT02132754|17541624|P28|Overall Study|Adverse Event|0
5081670|NCT02132754|17541625|P27|Overall Study|Adverse Event|1
5081671|NCT02132754|17541626|P26|Overall Study|Adverse Event|1
5081672|NCT02132754|17541627|P25|Overall Study|Adverse Event|0
5081673|NCT02132754|17541628|P24|Overall Study|Adverse Event|0
5081674|NCT02132754|17541629|P23|Overall Study|Adverse Event|0
5081675|NCT02132754|17541630|P22|Overall Study|Adverse Event|0
5081676|NCT02132754|17541631|P21|Overall Study|Adverse Event|0
5081677|NCT02132754|17541632|P20|Overall Study|Adverse Event|0
5081678|NCT02132754|17541633|P19|Overall Study|Adverse Event|0
5081679|NCT02132754|17541634|P18|Overall Study|Adverse Event|1
5081680|NCT02132754|17541635|P17|Overall Study|Adverse Event|0
5081681|NCT02132754|17541636|P16|Overall Study|Adverse Event|0
5081682|NCT02132754|17541637|P15|Overall Study|Adverse Event|0
5081683|NCT02132754|17541638|P14|Overall Study|Adverse Event|0
5081684|NCT02132754|17541639|P13|Overall Study|Adverse Event|0
5081685|NCT02132754|17541640|P12|Overall Study|Adverse Event|0
5081686|NCT02132754|17541641|P11|Overall Study|Adverse Event|0
5081687|NCT02132754|17541642|P10|Overall Study|Adverse Event|0
5081688|NCT02132754|17541643|P9|Overall Study|Adverse Event|0
5081689|NCT02132754|17541644|P8|Overall Study|Adverse Event|0
5081690|NCT02132754|17541645|P7|Overall Study|Adverse Event|0
5081691|NCT02132754|17541646|P6|Overall Study|Adverse Event|0
5081692|NCT02132754|17541647|P5|Overall Study|Adverse Event|0
5081693|NCT02132754|17541648|P4|Overall Study|Adverse Event|0
5081694|NCT02132754|17541649|P3|Overall Study|Adverse Event|0
5081695|NCT02132754|17541650|P2|Overall Study|Adverse Event|0
5081696|NCT02132754|17541651|P1|Overall Study|Adverse Event|0
5081697|NCT02132637|17542419|P2|Study Period 2 (Crossover)|Physician Decision|0
5081698|NCT02132637|17542420|P1|Study Period 2 (Crossover)|Physician Decision|2
5081699|NCT02132637|17542419|P2|Study Period 2 (Crossover)|Adverse Event|1
5081700|NCT02132637|17542420|P1|Study Period 2 (Crossover)|Adverse Event|0
5081701|NCT02132637|17542419|P2|Study Period 1|Physician Decision|0
5081702|NCT02132637|17542420|P1|Study Period 1|Physician Decision|1
5081703|NCT02132637|17542419|P2|Study Period 1|Withdrawal by Subject|4
5081704|NCT02132637|17542420|P1|Study Period 1|Withdrawal by Subject|0
5081705|NCT02132611|17542444|P1|Overall Study|Death|2
5081706|NCT02132247|17542507|P2|Overall Study|Protocol Violation|0
5081707|NCT02132247|17542508|P1|Overall Study|Protocol Violation|1
5081708|NCT02132195|17542523|P3|Rescue Therapy|Adverse Event|2
5081709|NCT02132195|17542524|P2|Rescue Therapy|Adverse Event|0
5081710|NCT02132195|17542525|P1|Rescue Therapy|Adverse Event|0
5081711|NCT02132195|17542523|P3|Rescue Therapy|Withdrawal by Subject|1
5081712|NCT02132195|17542524|P2|Rescue Therapy|Withdrawal by Subject|0
5081713|NCT02132195|17542525|P1|Rescue Therapy|Withdrawal by Subject|0
5081714|NCT02132195|17542523|P3|Rescue Therapy|Physician Decision|1
5081715|NCT02132195|17542524|P2|Rescue Therapy|Physician Decision|0
5081716|NCT02132195|17542525|P1|Rescue Therapy|Physician Decision|0
5081717|NCT02132195|17542523|P3|Rescue Therapy|Relapsed|7
5081718|NCT02132195|17542524|P2|Rescue Therapy|Relapsed|0
5081719|NCT02132195|17542525|P1|Rescue Therapy|Relapsed|0
5081720|NCT02132195|17542523|P3|Initial Assignment|Relapsed|0
5081721|NCT02132195|17542524|P2|Initial Assignment|Relapsed|0
5081722|NCT02132195|17542525|P1|Initial Assignment|Relapsed|14
5081723|NCT02132117|17542556|P2|Overall Study|Other Miscellaneous Reasons|0
5081724|NCT02132117|17542557|P1|Overall Study|Other Miscellaneous Reasons|2
5081725|NCT02132117|17542556|P2|Overall Study|Personal Reasons|2
5081726|NCT02132117|17542557|P1|Overall Study|Personal Reasons|1
5081727|NCT02132117|17542556|P2|Overall Study|Lost to Follow-up|2
5081728|NCT02132117|17542557|P1|Overall Study|Lost to Follow-up|2
5081729|NCT02132117|17542556|P2|Overall Study|Adverse Event|1
5081730|NCT02132117|17542557|P1|Overall Study|Adverse Event|6
5081731|NCT02131766|17542573|P1|Overall Study|Withdrawal by Subject|4
5081732|NCT02131662|17542589|P5|Overall Study|Not treated|3
5081733|NCT02131662|17542590|P4|Overall Study|Not treated|2
5081734|NCT02131662|17542591|P3|Overall Study|Not treated|2
5081735|NCT02131662|17542592|P2|Overall Study|Not treated|0
5081736|NCT02131662|17542593|P1|Overall Study|Not treated|2
5081737|NCT02131662|17542589|P5|Overall Study|Lost to Follow-up|0
5081738|NCT02131662|17542590|P4|Overall Study|Lost to Follow-up|9
5081739|NCT02131662|17542591|P3|Overall Study|Lost to Follow-up|0
5081740|NCT02131662|17542592|P2|Overall Study|Lost to Follow-up|3
5081741|NCT02131662|17542593|P1|Overall Study|Lost to Follow-up|1
5081742|NCT02131662|17542589|P5|Overall Study|Withdrawal by Subject|6
5081743|NCT02131662|17542590|P4|Overall Study|Withdrawal by Subject|5
5081744|NCT02131662|17542591|P3|Overall Study|Withdrawal by Subject|1
5081745|NCT02131662|17542592|P2|Overall Study|Withdrawal by Subject|5
5081746|NCT02131662|17542593|P1|Overall Study|Withdrawal by Subject|1
5081747|NCT02131662|17542589|P5|Overall Study|Lack of Efficacy|1
5081748|NCT02131662|17542590|P4|Overall Study|Lack of Efficacy|0
5081749|NCT02131662|17542591|P3|Overall Study|Lack of Efficacy|0
5081750|NCT02131662|17542592|P2|Overall Study|Lack of Efficacy|0
5081751|NCT02131662|17542593|P1|Overall Study|Lack of Efficacy|1
5081752|NCT02131662|17542589|P5|Overall Study|Wish for pregnancy|1
5081753|NCT02131662|17542590|P4|Overall Study|Wish for pregnancy|0
5081754|NCT02131662|17542591|P3|Overall Study|Wish for pregnancy|0
5081755|NCT02131662|17542592|P2|Overall Study|Wish for pregnancy|0
5081756|NCT02131662|17542593|P1|Overall Study|Wish for pregnancy|0
5081757|NCT02131662|17542589|P5|Overall Study|Pregnancy|0
5081758|NCT02131662|17542590|P4|Overall Study|Pregnancy|1
5081759|NCT02131662|17542591|P3|Overall Study|Pregnancy|0
5081760|NCT02131662|17542592|P2|Overall Study|Pregnancy|1
5081761|NCT02131662|17542593|P1|Overall Study|Pregnancy|0
5081762|NCT02131662|17542589|P5|Overall Study|Adverse Event|3
5081763|NCT02131662|17542590|P4|Overall Study|Adverse Event|1
5081764|NCT02131662|17542591|P3|Overall Study|Adverse Event|1
5081765|NCT02131662|17542592|P2|Overall Study|Adverse Event|1
5081766|NCT02131662|17542593|P1|Overall Study|Adverse Event|0
5081767|NCT02131662|17542589|P5|Overall Study|Other|4
5081768|NCT02131662|17542590|P4|Overall Study|Other|3
5081769|NCT02131662|17542591|P3|Overall Study|Other|3
5081770|NCT02131662|17542592|P2|Overall Study|Other|4
5081771|NCT02131662|17542593|P1|Overall Study|Other|2
5081772|NCT02131662|17542589|P5|Overall Study|Protocol Violation|0
5081773|NCT02131662|17542590|P4|Overall Study|Protocol Violation|0
5081774|NCT02131662|17542591|P3|Overall Study|Protocol Violation|0
5081775|NCT02131662|17542592|P2|Overall Study|Protocol Violation|0
5081776|NCT02131662|17542593|P1|Overall Study|Protocol Violation|1
5081777|NCT02131636|17542639|P2|Overall Study|Adverse Event|1
5081778|NCT02131636|17542640|P1|Overall Study|Adverse Event|4
5081779|NCT02131636|17542639|P2|Overall Study|Lost to Follow-up|0
5081780|NCT02131636|17542640|P1|Overall Study|Lost to Follow-up|4
5081781|NCT02131636|17542639|P2|Overall Study|Personal Reasons|4
5081782|NCT02131636|17542640|P1|Overall Study|Personal Reasons|4
5081783|NCT02131532|17542656|P1|Overall Study|Other health conditions|2
5081784|NCT02131532|17542656|P1|Overall Study|Physician Decision|1
5081785|NCT02131532|17542656|P1|Overall Study|Withdrawal by Subject|1
5081786|NCT02131324|17542748|P2|Overall Study|Lost to Follow-up|1
5081787|NCT02131324|17542749|P1|Overall Study|Lost to Follow-up|1
5081788|NCT02131324|17542748|P2|Overall Study|Withdrawal by Subject|2
5081789|NCT02131324|17542749|P1|Overall Study|Withdrawal by Subject|1
5081790|NCT02131311|17542755|P1|Overall Study|Lost to Follow-up|1
5081791|NCT02131311|17542755|P1|Overall Study|Protocol Violation|1
5081792|NCT02131311|17542755|P1|Overall Study|Adverse Event|2
5081793|NCT02131272|17542767|P2|Overall Study|Withdrawal Criteria|0
5081794|NCT02131272|17542768|P1|Overall Study|Withdrawal Criteria|1
5081795|NCT02131272|17542767|P2|Overall Study|Withdrawal by Subject|1
5081796|NCT02131272|17542768|P1|Overall Study|Withdrawal by Subject|0
5081797|NCT02131272|17542767|P2|Overall Study|Withdrawal by parent|1
5081798|NCT02131272|17542768|P1|Overall Study|Withdrawal by parent|0
5081799|NCT02131259|17542786|P1|Overall Study|Missing|3
5081800|NCT02131259|17542786|P1|Overall Study|Progressive disease/AE/other|1
5081801|NCT02131259|17542786|P1|Overall Study|AE/other|1
5081802|NCT02131259|17542786|P1|Overall Study|AE/lost to follow-up|1
5081803|NCT02131259|17542786|P1|Overall Study|Progressive disease/other|2
5081804|NCT02131259|17542786|P1|Overall Study|Progressive disease/relocation|1
5081805|NCT02131259|17542786|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
5081806|NCT02131259|17542786|P1|Overall Study|Other|63
5081807|NCT02131259|17542786|P1|Overall Study|Relocation|32
5081808|NCT02131259|17542786|P1|Overall Study|Lost to Follow-up|7
5081809|NCT02131259|17542786|P1|Overall Study|Adverse Event|341
5081810|NCT02131259|17542786|P1|Overall Study|Progressive disease|751
5081811|NCT02131233|17542793|P2|Overall Study|Withdrawal by Subject|11
5081812|NCT02131233|17542794|P1|Overall Study|Withdrawal by Subject|18
5081813|NCT02131233|17542793|P2|Overall Study|Pregnancy|0
5081814|NCT02131233|17542794|P1|Overall Study|Pregnancy|4
5081815|NCT02131233|17542793|P2|Overall Study|Physician Decision|0
5081816|NCT02131233|17542794|P1|Overall Study|Physician Decision|7
5081817|NCT02131233|17542793|P2|Overall Study|Non-Compliance With Study Drug|5
5081818|NCT02131233|17542794|P1|Overall Study|Non-Compliance With Study Drug|8
5081819|NCT02131233|17542793|P2|Overall Study|Lost to Follow-up|13
5081820|NCT02131233|17542794|P1|Overall Study|Lost to Follow-up|14
5081821|NCT02131233|17542793|P2|Overall Study|Lack of Efficacy|3
5081822|NCT02131233|17542794|P1|Overall Study|Lack of Efficacy|6
5081823|NCT02131233|17542793|P2|Overall Study|Death|1
5081824|NCT02131233|17542794|P1|Overall Study|Death|0
5081825|NCT02131233|17542793|P2|Overall Study|Adverse Event|6
5081826|NCT02131233|17542794|P1|Overall Study|Adverse Event|7
5081827|NCT02131233|17542793|P2|Overall Study|Not Treated|3
5081828|NCT02131233|17542794|P1|Overall Study|Not Treated|2
5081829|NCT02131155|17542828|P2|Overall Study|Study early termination|10
5081830|NCT02131155|17542829|P1|Overall Study|Study early termination|20
5081831|NCT02131155|17542828|P2|Overall Study|Refused to continue study medication|0
5081832|NCT02131155|17542829|P1|Overall Study|Refused to continue study medication|1
5081833|NCT02131155|17542828|P2|Overall Study|Primary tumour recurrence|1
5081834|NCT02131155|17542829|P1|Overall Study|Primary tumour recurrence|2
5081835|NCT02131155|17542828|P2|Overall Study|Treatment completed|0
5081836|NCT02131155|17542829|P1|Overall Study|Treatment completed|1
5081837|NCT02131155|17542828|P2|Overall Study|Adverse Event|0
5081838|NCT02131155|17542829|P1|Overall Study|Adverse Event|1
5081839|NCT02131129|17542843|P2|Overall Study|Withdrawal by Subject|0
5081840|NCT02131129|17542844|P1|Overall Study|Withdrawal by Subject|1
5081841|NCT02131064|17542862|P2|Overall Study|Other|2
5081842|NCT02131064|17542863|P1|Overall Study|Other|2
5081843|NCT02131064|17542862|P2|Overall Study|Withdrawal by Subject|18
5081844|NCT02131064|17542863|P1|Overall Study|Withdrawal by Subject|14
5081845|NCT02131064|17542862|P2|Overall Study|Lost to Follow-up|8
5081846|NCT02131064|17542863|P1|Overall Study|Lost to Follow-up|4
5081847|NCT02131064|17542862|P2|Overall Study|Death|6
5081848|NCT02131064|17542863|P1|Overall Study|Death|5
5081849|NCT02130986|17542932|P2|Overall Study|Lost to Follow-up|160
5081850|NCT02130986|17542933|P1|Overall Study|Lost to Follow-up|151
5081851|NCT02130986|17542932|P2|Overall Study|Withdrawal by Subject|4
5081852|NCT02130986|17542933|P1|Overall Study|Withdrawal by Subject|4
5081853|NCT02130765|17542947|P4|Overall Study|Did not receive treatment|0
5081854|NCT02130765|17542948|P3|Overall Study|Did not receive treatment|0
5081855|NCT02130765|17542949|P2|Overall Study|Did not receive treatment|0
5081856|NCT02130765|17542950|P1|Overall Study|Did not receive treatment|4
5081857|NCT02130570|17543196|P2|Overall Study|Part of practice that discontinued study|5
5081858|NCT02130570|17543197|P1|Overall Study|Part of practice that discontinued study|0
5081859|NCT02130570|17543196|P2|Overall Study|Withdrawal by Subject|3
5081860|NCT02130570|17543197|P1|Overall Study|Withdrawal by Subject|6
5081861|NCT02130570|17543196|P2|Overall Study|Death|5
5081862|NCT02130570|17543197|P1|Overall Study|Death|3
5081863|NCT02130557|17543215|P2|Overall Study|Ongoing|255
5081864|NCT02130557|17543216|P1|Overall Study|Ongoing|260
5081865|NCT02130557|17543215|P2|Overall Study|Deceased|6
5081866|NCT02130557|17543216|P1|Overall Study|Deceased|1
5081867|NCT02130557|17543215|P2|Overall Study|Lost to Follow-up|2
5081868|NCT02130557|17543216|P1|Overall Study|Lost to Follow-up|2
5081869|NCT02130557|17543215|P2|Overall Study|Withdrawal by Subject|2
5081870|NCT02130557|17543216|P1|Overall Study|Withdrawal by Subject|5
5081871|NCT02130557|17543215|P2|Overall Study|Randomized, not treated|3
5081872|NCT02130557|17543216|P1|Overall Study|Randomized, not treated|0
5081873|NCT02130284|17543248|P1|Overall Study|Screen Failure|1
5081874|NCT02130284|17543248|P1|Overall Study|Subject was screened as backup for study|3
5081875|NCT02130284|17543248|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
5081876|NCT02130284|17543248|P1|Overall Study|Subject Withdrew Consent|1
5081877|NCT02130284|17543248|P1|Overall Study|Withdrawal by Subject|3
5081878|NCT02130193|17543274|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
5081879|NCT02130193|17543275|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
5081880|NCT02130193|17543276|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
5081881|NCT02130193|17543274|P3|Part B: 52-week Double-blind Period|Physician Decision|1
5081882|NCT02130193|17543275|P2|Part B: 52-week Double-blind Period|Physician Decision|0
5081883|NCT02130193|17543276|P1|Part B: 52-week Double-blind Period|Physician Decision|0
5081884|NCT02130193|17543274|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
5081885|NCT02130193|17543275|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
5081886|NCT02130193|17543276|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
5081887|NCT02130193|17543274|P3|Part B: 52-week Double-blind Period|Adverse Event|3
5081888|NCT02130193|17543275|P2|Part B: 52-week Double-blind Period|Adverse Event|5
5081889|NCT02130193|17543276|P1|Part B: 52-week Double-blind Period|Adverse Event|0
5081890|NCT02130024|17543357|P2|Overall Study|Subject Withdrew Consent|14
5081891|NCT02130024|17543358|P1|Overall Study|Subject Withdrew Consent|6
5081892|NCT02130024|17543357|P2|Overall Study|Site Administration Problems|0
5081893|NCT02130024|17543358|P1|Overall Study|Site Administration Problems|1
5081894|NCT02130024|17543357|P2|Overall Study|Protocol Deviation|0
5081895|NCT02130024|17543358|P1|Overall Study|Protocol Deviation|4
5081896|NCT02130024|17543357|P2|Overall Study|Physician Decision|3
5081897|NCT02130024|17543358|P1|Overall Study|Physician Decision|1
5081898|NCT02130024|17543357|P2|Overall Study|Lost to Follow-up|1
5081899|NCT02130024|17543358|P1|Overall Study|Lost to Follow-up|1
5081900|NCT02130024|17543357|P2|Overall Study|Death|2
5081901|NCT02130024|17543358|P1|Overall Study|Death|2
5081902|NCT02130024|17543357|P2|Overall Study|Adverse Event|11
5081903|NCT02130024|17543358|P1|Overall Study|Adverse Event|10
5081904|NCT02129777|17543395|P7|Open-Label Period|Study Termination|39
5081905|NCT02129777|17543396|P6|Open-Label Period|Study Termination|10
5081906|NCT02129777|17543397|P5|Open-Label Period|Study Termination|0
5081907|NCT02129777|17543398|P4|Open-Label Period|Study Termination|0
5081908|NCT02129777|17543399|P3|Open-Label Period|Study Termination|0
5081909|NCT02129777|17543400|P2|Open-Label Period|Study Termination|0
5081910|NCT02129777|17543401|P1|Open-Label Period|Study Termination|0
5081911|NCT02129777|17543395|P7|Open-Label Period|Withdrawal by Subject|3
5081912|NCT02129777|17543396|P6|Open-Label Period|Withdrawal by Subject|1
5081913|NCT02129777|17543397|P5|Open-Label Period|Withdrawal by Subject|0
5081914|NCT02129777|17543398|P4|Open-Label Period|Withdrawal by Subject|0
5081915|NCT02129777|17543399|P3|Open-Label Period|Withdrawal by Subject|0
5081916|NCT02129777|17543400|P2|Open-Label Period|Withdrawal by Subject|0
5081917|NCT02129777|17543401|P1|Open-Label Period|Withdrawal by Subject|0
5081918|NCT02129777|17543395|P7|Open-Label Period|Lost to Follow-up|1
5081919|NCT02129777|17543396|P6|Open-Label Period|Lost to Follow-up|1
5081920|NCT02129777|17543397|P5|Open-Label Period|Lost to Follow-up|0
5081921|NCT02129777|17543398|P4|Open-Label Period|Lost to Follow-up|0
5081922|NCT02129777|17543399|P3|Open-Label Period|Lost to Follow-up|0
5081923|NCT02129777|17543400|P2|Open-Label Period|Lost to Follow-up|0
5081924|NCT02129777|17543401|P1|Open-Label Period|Lost to Follow-up|0
5081925|NCT02129777|17543395|P7|Open-Label Period|Lack of Efficacy|5
5081926|NCT02129777|17543396|P6|Open-Label Period|Lack of Efficacy|0
5081927|NCT02129777|17543397|P5|Open-Label Period|Lack of Efficacy|0
5081928|NCT02129777|17543398|P4|Open-Label Period|Lack of Efficacy|0
5081929|NCT02129777|17543399|P3|Open-Label Period|Lack of Efficacy|0
5081930|NCT02129777|17543400|P2|Open-Label Period|Lack of Efficacy|0
5081931|NCT02129777|17543401|P1|Open-Label Period|Lack of Efficacy|0
5081932|NCT02129777|17543395|P7|Double-Blind Period|Other|0
5081933|NCT02129777|17543396|P6|Double-Blind Period|Other|0
5081934|NCT02129777|17543397|P5|Double-Blind Period|Other|0
5081935|NCT02129777|17543398|P4|Double-Blind Period|Other|0
5081936|NCT02129777|17543399|P3|Double-Blind Period|Other|0
5081937|NCT02129777|17543400|P2|Double-Blind Period|Other|2
5081938|NCT02129777|17543401|P1|Double-Blind Period|Other|1
5081939|NCT02129777|17543395|P7|Double-Blind Period|Lack of Efficacy|0
5081940|NCT02129777|17543396|P6|Double-Blind Period|Lack of Efficacy|0
5081941|NCT02129777|17543397|P5|Double-Blind Period|Lack of Efficacy|2
5081942|NCT02129777|17543398|P4|Double-Blind Period|Lack of Efficacy|3
5081943|NCT02129777|17543399|P3|Double-Blind Period|Lack of Efficacy|0
5081944|NCT02129777|17543400|P2|Double-Blind Period|Lack of Efficacy|1
5081945|NCT02129777|17543401|P1|Double-Blind Period|Lack of Efficacy|3
5081946|NCT02129777|17543395|P7|Double-Blind Period|Pregnancy|0
5081947|NCT02129777|17543396|P6|Double-Blind Period|Pregnancy|0
5081948|NCT02129777|17543397|P5|Double-Blind Period|Pregnancy|1
5081949|NCT02129777|17543398|P4|Double-Blind Period|Pregnancy|0
5081950|NCT02129777|17543399|P3|Double-Blind Period|Pregnancy|0
5081951|NCT02129777|17543400|P2|Double-Blind Period|Pregnancy|0
5081952|NCT02129777|17543401|P1|Double-Blind Period|Pregnancy|0
5081953|NCT02129777|17543395|P7|Double-Blind Period|Withdrawal by Subject|0
5081954|NCT02129777|17543396|P6|Double-Blind Period|Withdrawal by Subject|0
5081955|NCT02129777|17543397|P5|Double-Blind Period|Withdrawal by Subject|3
5081956|NCT02129777|17543398|P4|Double-Blind Period|Withdrawal by Subject|2
5081957|NCT02129777|17543399|P3|Double-Blind Period|Withdrawal by Subject|3
5081958|NCT02129777|17543400|P2|Double-Blind Period|Withdrawal by Subject|4
5081959|NCT02129777|17543401|P1|Double-Blind Period|Withdrawal by Subject|2
5081960|NCT02129777|17543395|P7|Double-Blind Period|Lost to Follow-up|0
5081961|NCT02129777|17543396|P6|Double-Blind Period|Lost to Follow-up|0
5081962|NCT02129777|17543397|P5|Double-Blind Period|Lost to Follow-up|0
5081963|NCT02129777|17543398|P4|Double-Blind Period|Lost to Follow-up|2
5081964|NCT02129777|17543399|P3|Double-Blind Period|Lost to Follow-up|1
5081965|NCT02129777|17543400|P2|Double-Blind Period|Lost to Follow-up|1
5081966|NCT02129777|17543401|P1|Double-Blind Period|Lost to Follow-up|1
5081967|NCT02129777|17543395|P7|Double-Blind Period|Adverse Event|0
5081968|NCT02129777|17543396|P6|Double-Blind Period|Adverse Event|0
5081969|NCT02129777|17543397|P5|Double-Blind Period|Adverse Event|1
5081970|NCT02129777|17543398|P4|Double-Blind Period|Adverse Event|0
5081971|NCT02129777|17543399|P3|Double-Blind Period|Adverse Event|0
5081972|NCT02129777|17543400|P2|Double-Blind Period|Adverse Event|0
5081973|NCT02129777|17543401|P1|Double-Blind Period|Adverse Event|0
5081974|NCT02129608|17543568|P3|Overall Study|Withdrawal by Subject|2
5081975|NCT02129608|17543569|P2|Overall Study|Withdrawal by Subject|0
5081976|NCT02129608|17543570|P1|Overall Study|Withdrawal by Subject|0
5081977|NCT02129608|17543568|P3|Overall Study|Lost to Follow-up|1
5081978|NCT02129608|17543569|P2|Overall Study|Lost to Follow-up|1
5081979|NCT02129608|17543570|P1|Overall Study|Lost to Follow-up|0
5081980|NCT02129205|17543627|P10|Overall Study|Other|0
5081981|NCT02129205|17543628|P9|Overall Study|Other|1
5081982|NCT02129205|17543629|P8|Overall Study|Other|2
5081983|NCT02129205|17543630|P7|Overall Study|Other|3
5081984|NCT02129205|17543631|P6|Overall Study|Other|3
5081985|NCT02129205|17543632|P5|Overall Study|Other|2
5081986|NCT02129205|17543633|P4|Overall Study|Other|0
5081987|NCT02129205|17543634|P3|Overall Study|Other|0
5081988|NCT02129205|17543635|P2|Overall Study|Other|0
5081989|NCT02129205|17543636|P1|Overall Study|Other|1
5081990|NCT02129205|17543627|P10|Overall Study|Withdrawal by Subject|0
5081991|NCT02129205|17543628|P9|Overall Study|Withdrawal by Subject|1
5081992|NCT02129205|17543629|P8|Overall Study|Withdrawal by Subject|0
5081993|NCT02129205|17543630|P7|Overall Study|Withdrawal by Subject|1
5081994|NCT02129205|17543631|P6|Overall Study|Withdrawal by Subject|1
5081995|NCT02129205|17543632|P5|Overall Study|Withdrawal by Subject|1
5081996|NCT02129205|17543633|P4|Overall Study|Withdrawal by Subject|0
5081997|NCT02129205|17543634|P3|Overall Study|Withdrawal by Subject|0
5081998|NCT02129205|17543635|P2|Overall Study|Withdrawal by Subject|0
5081999|NCT02129205|17543636|P1|Overall Study|Withdrawal by Subject|0
5082000|NCT02129192|17543789|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
5082001|NCT02129192|17543790|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
5082002|NCT02129062|17543807|P1|Overall Study|Disease Progression|2
5082003|NCT02129062|17543807|P1|Overall Study|Death|1
5082004|NCT02128997|17543814|P2|Overall Study|Lost to Follow-up|11
5082005|NCT02128997|17543815|P1|Overall Study|Lost to Follow-up|6
5082006|NCT02128932|17543830|P3|Overall Study|No reason for withdrawal|7
5082007|NCT02128932|17543831|P2|Overall Study|No reason for withdrawal|11
5082008|NCT02128932|17543832|P1|Overall Study|No reason for withdrawal|12
5082009|NCT02128932|17543830|P3|Overall Study|Lost to Follow-up|1
5082010|NCT02128932|17543831|P2|Overall Study|Lost to Follow-up|1
5082011|NCT02128932|17543832|P1|Overall Study|Lost to Follow-up|2
5082012|NCT02128932|17543830|P3|Overall Study|Death|2
5082013|NCT02128932|17543831|P2|Overall Study|Death|0
5082014|NCT02128932|17543832|P1|Overall Study|Death|2
5082015|NCT02128932|17543830|P3|Overall Study|Withdrawal by Subject|8
5082016|NCT02128932|17543831|P2|Overall Study|Withdrawal by Subject|7
5082017|NCT02128932|17543832|P1|Overall Study|Withdrawal by Subject|11
5082018|NCT02128763|17543893|P2|Overall Study|Lost to Follow-up|16
5082019|NCT02128763|17543894|P1|Overall Study|Lost to Follow-up|19
5082020|NCT02128763|17543893|P2|Overall Study|Death|0
5082021|NCT02128763|17543894|P1|Overall Study|Death|1
5082022|NCT02128724|17543940|P4|Overall Study|Withdrawal by Subject|1
5082023|NCT02128724|17543941|P3|Overall Study|Withdrawal by Subject|0
5082024|NCT02128724|17543942|P2|Overall Study|Withdrawal by Subject|0
5082025|NCT02128724|17543943|P1|Overall Study|Withdrawal by Subject|0
5082026|NCT02128724|17543940|P4|Overall Study|Physician Decision|2
5082027|NCT02128724|17543941|P3|Overall Study|Physician Decision|0
5082028|NCT02128724|17543942|P2|Overall Study|Physician Decision|0
5082029|NCT02128724|17543943|P1|Overall Study|Physician Decision|0
5082030|NCT02128724|17543940|P4|Overall Study|Adverse Event|0
5082031|NCT02128724|17543941|P3|Overall Study|Adverse Event|0
5082032|NCT02128724|17543942|P2|Overall Study|Adverse Event|1
5082033|NCT02128724|17543943|P1|Overall Study|Adverse Event|0
5082034|NCT02128724|17543940|P4|Overall Study|Death|0
5082035|NCT02128724|17543941|P3|Overall Study|Death|0
5082036|NCT02128724|17543942|P2|Overall Study|Death|0
5082037|NCT02128724|17543943|P1|Overall Study|Death|1
5082038|NCT02128542|17543998|P2|Overall Study|Withdrew Consent|0
5082039|NCT02128542|17543999|P1|Overall Study|Withdrew Consent|1
5082040|NCT02128542|17543998|P2|Overall Study|Lost to Follow-up|0
5082041|NCT02128542|17543999|P1|Overall Study|Lost to Follow-up|3
5082042|NCT02128490|17544017|P5|Overall Study|Other Miscellaneous Reasons|1
5082043|NCT02128490|17544018|P4|Overall Study|Other Miscellaneous Reasons|1
5082044|NCT02128490|17544019|P3|Overall Study|Other Miscellaneous Reasons|2
5082045|NCT02128490|17544020|P2|Overall Study|Other Miscellaneous Reasons|0
5082046|NCT02128490|17544021|P1|Overall Study|Other Miscellaneous Reasons|0
5082047|NCT02128490|17544017|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
5082048|NCT02128490|17544018|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
5082049|NCT02128490|17544019|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
5082050|NCT02128490|17544020|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
5082051|NCT02128490|17544021|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
5082052|NCT02128490|17544017|P5|Overall Study|Lack of Efficacy|0
5082053|NCT02128490|17544018|P4|Overall Study|Lack of Efficacy|0
5082054|NCT02128490|17544019|P3|Overall Study|Lack of Efficacy|0
5082055|NCT02128490|17544020|P2|Overall Study|Lack of Efficacy|1
5082056|NCT02128490|17544021|P1|Overall Study|Lack of Efficacy|0
5082057|NCT02128490|17544017|P5|Overall Study|Voluntary Withdrawal|2
5082058|NCT02128490|17544018|P4|Overall Study|Voluntary Withdrawal|1
5082059|NCT02128490|17544019|P3|Overall Study|Voluntary Withdrawal|1
5082060|NCT02128490|17544020|P2|Overall Study|Voluntary Withdrawal|3
5082061|NCT02128490|17544021|P1|Overall Study|Voluntary Withdrawal|3
5082062|NCT02128490|17544017|P5|Overall Study|Lost to Follow-up|1
5082063|NCT02128490|17544018|P4|Overall Study|Lost to Follow-up|1
5082064|NCT02128490|17544019|P3|Overall Study|Lost to Follow-up|1
5082065|NCT02128490|17544020|P2|Overall Study|Lost to Follow-up|0
5082066|NCT02128490|17544021|P1|Overall Study|Lost to Follow-up|0
5082067|NCT02128490|17544017|P5|Overall Study|Major Protocol Deviation|2
5082068|NCT02128490|17544018|P4|Overall Study|Major Protocol Deviation|2
5082069|NCT02128490|17544019|P3|Overall Study|Major Protocol Deviation|0
5082070|NCT02128490|17544020|P2|Overall Study|Major Protocol Deviation|2
5082071|NCT02128490|17544021|P1|Overall Study|Major Protocol Deviation|1
5082072|NCT02128490|17544017|P5|Overall Study|Pretreatment Event/Adverse Event|0
5082073|NCT02128490|17544018|P4|Overall Study|Pretreatment Event/Adverse Event|1
5082074|NCT02128490|17544019|P3|Overall Study|Pretreatment Event/Adverse Event|1
5082075|NCT02128490|17544020|P2|Overall Study|Pretreatment Event/Adverse Event|0
5082076|NCT02128490|17544021|P1|Overall Study|Pretreatment Event/Adverse Event|1
5082077|NCT02128269|17544043|P1|Treatment Period|Physician Decision|1
5082078|NCT02128269|17544043|P1|Treatment Period|Adverse Event|1
5082079|NCT02128217|17544049|P2|Overall Study|Lost to Follow-up|1
5082080|NCT02128217|17544050|P1|Overall Study|Lost to Follow-up|0
5082081|NCT02127970|17544098|P2|Overall Study|Subject Withdrew Consent|3
5082082|NCT02127970|17544099|P1|Overall Study|Subject Withdrew Consent|5
5082083|NCT02127970|17544098|P2|Overall Study|Pregnancy|1
5082084|NCT02127970|17544099|P1|Overall Study|Pregnancy|0
5082085|NCT02127970|17544098|P2|Overall Study|Reason not Specified|7
5082086|NCT02127970|17544099|P1|Overall Study|Reason not Specified|4
5082087|NCT02127970|17544098|P2|Overall Study|Lost to Follow-up|14
5082088|NCT02127970|17544099|P1|Overall Study|Lost to Follow-up|14
5082089|NCT02127970|17544098|P2|Overall Study|Death|1
5082090|NCT02127970|17544099|P1|Overall Study|Death|1
5082091|NCT02127970|17544098|P2|Overall Study|Adverse Event|1
5082092|NCT02127970|17544099|P1|Overall Study|Adverse Event|2
5082093|NCT02127931|17544121|P1|Overall Study|Glitch in Game|1
5082094|NCT02127372|17544247|P2|Overall Study|Withdrawal by Subject|0
5082095|NCT02127372|17544248|P1|Overall Study|Withdrawal by Subject|1
5082096|NCT02127307|17544258|P1|Overall Study|Other than specified above|169
5082097|NCT02127307|17544258|P1|Overall Study|Death|101
5082098|NCT02127307|17544258|P1|Overall Study|Lost to Follow-up|2
5082099|NCT02127307|17544258|P1|Overall Study|Protocol Violation|36
5082100|NCT02127281|17544264|P2|Overall Study|Lost to Follow-up|0
5082101|NCT02127281|17544265|P1|Overall Study|Lost to Follow-up|1
5082102|NCT02127125|17544300|P9|Overall Study|Physician Decision|0
5082103|NCT02127125|17544301|P8|Overall Study|Physician Decision|0
5082104|NCT02127125|17544302|P7|Overall Study|Physician Decision|0
5082105|NCT02127125|17544303|P6|Overall Study|Physician Decision|2
5082106|NCT02127125|17544304|P5|Overall Study|Physician Decision|1
5082107|NCT02127125|17544305|P4|Overall Study|Physician Decision|0
5082108|NCT02127125|17544306|P3|Overall Study|Physician Decision|1
5082109|NCT02127125|17544307|P2|Overall Study|Physician Decision|0
5082110|NCT02127125|17544308|P1|Overall Study|Physician Decision|0
5082111|NCT02127125|17544300|P9|Overall Study|Withdrawal by Subject|0
5082112|NCT02127125|17544301|P8|Overall Study|Withdrawal by Subject|0
5082113|NCT02127125|17544302|P7|Overall Study|Withdrawal by Subject|0
5082114|NCT02127125|17544303|P6|Overall Study|Withdrawal by Subject|0
5082115|NCT02127125|17544304|P5|Overall Study|Withdrawal by Subject|0
5082116|NCT02127125|17544305|P4|Overall Study|Withdrawal by Subject|1
5082117|NCT02127125|17544306|P3|Overall Study|Withdrawal by Subject|0
5082118|NCT02127125|17544307|P2|Overall Study|Withdrawal by Subject|0
5082119|NCT02127125|17544308|P1|Overall Study|Withdrawal by Subject|0
5082120|NCT02127125|17544300|P9|Overall Study|Lost to Follow-up|0
5082121|NCT02127125|17544301|P8|Overall Study|Lost to Follow-up|0
5082122|NCT02127125|17544302|P7|Overall Study|Lost to Follow-up|0
5082123|NCT02127125|17544303|P6|Overall Study|Lost to Follow-up|1
5082124|NCT02127125|17544304|P5|Overall Study|Lost to Follow-up|2
5082125|NCT02127125|17544305|P4|Overall Study|Lost to Follow-up|0
5082126|NCT02127125|17544306|P3|Overall Study|Lost to Follow-up|0
5082127|NCT02127125|17544307|P2|Overall Study|Lost to Follow-up|0
5082128|NCT02127125|17544308|P1|Overall Study|Lost to Follow-up|0
5082129|NCT02126969|17544348|P2|Overall Study|Withdrawal by Subject|2
5082130|NCT02126969|17544349|P1|Overall Study|Withdrawal by Subject|1
5082131|NCT02126839|17544361|P2|Overall Study|Other|5
5082132|NCT02126839|17544362|P1|Overall Study|Other|5
5082133|NCT02126839|17544361|P2|Overall Study|Lost to Follow-up|4
5082134|NCT02126839|17544362|P1|Overall Study|Lost to Follow-up|1
5082135|NCT02126839|17544361|P2|Overall Study|Sponsor request|1
5082136|NCT02126839|17544362|P1|Overall Study|Sponsor request|0
5082137|NCT02126839|17544361|P2|Overall Study|Protocol Violation|3
5082138|NCT02126839|17544362|P1|Overall Study|Protocol Violation|2
5082139|NCT02126839|17544361|P2|Overall Study|Withdrawal by parent/guardian|0
5082140|NCT02126839|17544362|P1|Overall Study|Withdrawal by parent/guardian|1
5082141|NCT02126839|17544361|P2|Overall Study|Withdrawal by Subject|0
5082142|NCT02126839|17544362|P1|Overall Study|Withdrawal by Subject|1
5082143|NCT02126839|17544361|P2|Overall Study|Adverse Event|1
5082144|NCT02126839|17544362|P1|Overall Study|Adverse Event|0
5082145|NCT02126826|17544379|P7|Overall Study|Withdrawal by Subject|0
5082146|NCT02126826|17544380|P6|Overall Study|Withdrawal by Subject|0
5082147|NCT02126826|17544381|P5|Overall Study|Withdrawal by Subject|0
5082148|NCT02126826|17544382|P4|Overall Study|Withdrawal by Subject|1
5082149|NCT02126826|17544383|P3|Overall Study|Withdrawal by Subject|0
5082150|NCT02126826|17544384|P2|Overall Study|Withdrawal by Subject|0
5082151|NCT02126826|17544385|P1|Overall Study|Withdrawal by Subject|0
5082152|NCT02126670|17544453|P4|Overall Study|Withdrawal by Subject|1
5082153|NCT02126670|17544454|P3|Overall Study|Withdrawal by Subject|0
5082154|NCT02126670|17544455|P2|Overall Study|Withdrawal by Subject|0
5082155|NCT02126670|17544456|P1|Overall Study|Withdrawal by Subject|1
5082156|NCT02125877|17544508|P2|Overall Study|Adverse Event|4
5082157|NCT02125877|17544509|P1|Overall Study|Adverse Event|6
5082158|NCT02125877|17544508|P2|Overall Study|Protocol deviation|1
5082159|NCT02125877|17544509|P1|Overall Study|Protocol deviation|4
5082160|NCT02125877|17544508|P2|Overall Study|Withdrawal by Subject|1
5082161|NCT02125877|17544509|P1|Overall Study|Withdrawal by Subject|2
5082162|NCT02125877|17544508|P2|Overall Study|Participant/guardian decision|2
5082163|NCT02125877|17544509|P1|Overall Study|Participant/guardian decision|0
5082164|NCT02125877|17544508|P2|Overall Study|Administrative problems|1
5082165|NCT02125877|17544509|P1|Overall Study|Administrative problems|0
5082166|NCT02125877|17544508|P2|Overall Study|Death|1
5082167|NCT02125877|17544509|P1|Overall Study|Death|0
5082168|NCT02125877|17544508|P2|Overall Study|Physician Decision|0
5082169|NCT02125877|17544509|P1|Overall Study|Physician Decision|1
5082170|NCT02125838|17544539|P2|Overall Study|Lost to Follow-up|4
5082171|NCT02125838|17544540|P1|Overall Study|Lost to Follow-up|4
5082172|NCT02125734|17544558|P2|Period 2|Adverse Event|1
5082173|NCT02125734|17544559|P1|Period 2|Adverse Event|0
5082174|NCT02125604|17544569|P1|Overall Study|Adverse Event|20
5082175|NCT02125604|17544569|P1|Overall Study|Consent Withdrawn|4
5082176|NCT02125604|17544569|P1|Overall Study|Lost to Follow-up|2
5082177|NCT02125604|17544569|P1|Overall Study|Investigator Decision|1
5082178|NCT02125604|17544569|P1|Overall Study|Other|4
5082179|NCT02125461|17544585|P2|Overall Study|Death|115
5082180|NCT02125461|17544586|P1|Overall Study|Death|180
5082181|NCT02125461|17544585|P2|Overall Study|Lost to Follow-up|0
5082182|NCT02125461|17544586|P1|Overall Study|Lost to Follow-up|1
5082183|NCT02125461|17544585|P2|Overall Study|Withdrawal by Subject|14
5082184|NCT02125461|17544586|P1|Overall Study|Withdrawal by Subject|22
5082185|NCT02125331|17544617|P2|Overall Study|screen failure|0
5082186|NCT02125331|17544618|P1|Overall Study|screen failure|2
5082187|NCT02125331|17544617|P2|Overall Study|technical problem|0
5082188|NCT02125331|17544618|P1|Overall Study|technical problem|2
5082189|NCT02125331|17544617|P2|Overall Study|Protocol Violation|0
5082190|NCT02125331|17544618|P1|Overall Study|Protocol Violation|1
5082191|NCT02125279|17544650|P1|Overall Study|Lost to Follow-up|4
5082192|NCT02125279|17544650|P1|Overall Study|Protocol Violation|1
5082193|NCT02125279|17544650|P1|Overall Study|Withdrawal by Subject|6
5082194|NCT02125279|17544650|P1|Overall Study|Lack of Efficacy|2
5082195|NCT02124811|17544694|P2|Overall Study|Withdrawal by Subject|0
5082196|NCT02124811|17544695|P1|Overall Study|Withdrawal by Subject|1
5082197|NCT02124811|17544694|P2|Overall Study|Early termination|2
5082198|NCT02124811|17544695|P1|Overall Study|Early termination|2
5082199|NCT02124798|17544711|P1|Overall Study|Lost to Follow-up|1
5082200|NCT02124798|17544711|P1|Overall Study|Adverse Event|3
5082201|NCT02124707|17544717|P1|Overall Study|Death|1
5082202|NCT02124707|17544717|P1|Overall Study|Physician Decision|1
5082203|NCT02124707|17544717|P1|Overall Study|Adverse Event|5
5082204|NCT02124564|17544731|P1|Treatment Period|Withdrawal by Subject|2
5082205|NCT02124564|17544731|P1|Treatment Period|Lack of Efficacy|3
5082206|NCT02124564|17544731|P1|Treatment Period|Adverse Event|2
5082207|NCT02124265|17544796|P1|Overall Study|Adverse Event|1
5082208|NCT02124161|17544802|P2|Overall Study|Lost to Follow-up|4
5082209|NCT02124161|17544803|P1|Overall Study|Lost to Follow-up|3
5082210|NCT02124161|17544802|P2|Overall Study|No longer meets eligibility criteria|4
5082211|NCT02124161|17544803|P1|Overall Study|No longer meets eligibility criteria|5
5082212|NCT02124161|17544802|P2|Overall Study|Does not meet entrance criteria|3
5082213|NCT02124161|17544803|P1|Overall Study|Does not meet entrance criteria|2
5082214|NCT02124161|17544802|P2|Overall Study|Adverse Event|0
5082215|NCT02124161|17544803|P1|Overall Study|Adverse Event|2
5082216|NCT02124161|17544802|P2|Overall Study|Withdrawal by Subject|2
5082217|NCT02124161|17544803|P1|Overall Study|Withdrawal by Subject|1
5082218|NCT02124161|17544802|P2|Overall Study|Protocol Violation|1
5082219|NCT02124161|17544803|P1|Overall Study|Protocol Violation|2
5082220|NCT02124161|17544802|P2|Overall Study|Death|0
5082221|NCT02124161|17544803|P1|Overall Study|Death|1
5082222|NCT02124161|17544802|P2|Overall Study|Other unspecified|1
5082223|NCT02124161|17544803|P1|Overall Study|Other unspecified|0
5082224|NCT02123966|17544878|P1|Overall Study|Intercurrent Illness|1
5082225|NCT02123797|17544912|P5|6-month Follow up (Cumulative Counts)|Relocation|0
5082226|NCT02123797|17544913|P4|6-month Follow up (Cumulative Counts)|Relocation|0
5082227|NCT02123797|17544914|P3|6-month Follow up (Cumulative Counts)|Relocation|0
5082228|NCT02123797|17544915|P2|6-month Follow up (Cumulative Counts)|Relocation|2
5082229|NCT02123797|17544916|P1|6-month Follow up (Cumulative Counts)|Relocation|0
5082230|NCT02123797|17544912|P5|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5082231|NCT02123797|17544913|P4|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5082232|NCT02123797|17544914|P3|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5082233|NCT02123797|17544915|P2|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
5082234|NCT02123797|17544916|P1|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
5082235|NCT02123797|17544912|P5|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5082236|NCT02123797|17544913|P4|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
5082237|NCT02123797|17544914|P3|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
5082317|NCT02123251|17545134|P1|Overall Study|Lost Medicaid eligibility|29
5082238|NCT02123797|17544915|P2|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
5082239|NCT02123797|17544916|P1|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5082240|NCT02123797|17544912|P5|6-month Follow up (Cumulative Counts)|Death|0
5082241|NCT02123797|17544913|P4|6-month Follow up (Cumulative Counts)|Death|0
5082242|NCT02123797|17544914|P3|6-month Follow up (Cumulative Counts)|Death|0
5082243|NCT02123797|17544915|P2|6-month Follow up (Cumulative Counts)|Death|97
5082244|NCT02123797|17544916|P1|6-month Follow up (Cumulative Counts)|Death|51
5082245|NCT02123797|17544912|P5|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5082246|NCT02123797|17544913|P4|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5082247|NCT02123797|17544914|P3|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5082248|NCT02123797|17544915|P2|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
5082249|NCT02123797|17544916|P1|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
5082250|NCT02123797|17544912|P5|3-month Follow up (Cumulative Counts)|Relocation|0
5082251|NCT02123797|17544913|P4|3-month Follow up (Cumulative Counts)|Relocation|0
5082252|NCT02123797|17544914|P3|3-month Follow up (Cumulative Counts)|Relocation|0
5082253|NCT02123797|17544915|P2|3-month Follow up (Cumulative Counts)|Relocation|1
5082254|NCT02123797|17544916|P1|3-month Follow up (Cumulative Counts)|Relocation|0
5082255|NCT02123797|17544912|P5|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5082256|NCT02123797|17544913|P4|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5082257|NCT02123797|17544914|P3|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5082258|NCT02123797|17544915|P2|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
5082259|NCT02123797|17544916|P1|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
5082260|NCT02123797|17544912|P5|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5082261|NCT02123797|17544913|P4|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
5082262|NCT02123797|17544914|P3|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
5082263|NCT02123797|17544915|P2|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
5082264|NCT02123797|17544916|P1|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
5082265|NCT02123797|17544912|P5|3-month Follow up (Cumulative Counts)|Death|0
5082266|NCT02123797|17544913|P4|3-month Follow up (Cumulative Counts)|Death|0
5082267|NCT02123797|17544914|P3|3-month Follow up (Cumulative Counts)|Death|0
5082268|NCT02123797|17544915|P2|3-month Follow up (Cumulative Counts)|Death|57
5082269|NCT02123797|17544916|P1|3-month Follow up (Cumulative Counts)|Death|33
5082270|NCT02123797|17544912|P5|Baseline Intervention|Other Disease|0
5082271|NCT02123797|17544913|P4|Baseline Intervention|Other Disease|0
5082272|NCT02123797|17544914|P3|Baseline Intervention|Other Disease|0
5082273|NCT02123797|17544915|P2|Baseline Intervention|Other Disease|0
5082274|NCT02123797|17544916|P1|Baseline Intervention|Other Disease|3
5082275|NCT02123797|17544912|P5|Baseline Intervention|Lost to Follow-up|0
5082276|NCT02123797|17544913|P4|Baseline Intervention|Lost to Follow-up|0
5082277|NCT02123797|17544914|P3|Baseline Intervention|Lost to Follow-up|0
5082278|NCT02123797|17544915|P2|Baseline Intervention|Lost to Follow-up|5
5082279|NCT02123797|17544916|P1|Baseline Intervention|Lost to Follow-up|0
5082280|NCT02123797|17544912|P5|Baseline Intervention|Out of window for initial survey|0
5082281|NCT02123797|17544913|P4|Baseline Intervention|Out of window for initial survey|0
5082282|NCT02123797|17544914|P3|Baseline Intervention|Out of window for initial survey|0
5082283|NCT02123797|17544915|P2|Baseline Intervention|Out of window for initial survey|13
5082284|NCT02123797|17544916|P1|Baseline Intervention|Out of window for initial survey|6
5082285|NCT02123797|17544912|P5|Baseline Intervention|Relocation|0
5082286|NCT02123797|17544913|P4|Baseline Intervention|Relocation|0
5082287|NCT02123797|17544914|P3|Baseline Intervention|Relocation|0
5082288|NCT02123797|17544915|P2|Baseline Intervention|Relocation|0
5082289|NCT02123797|17544916|P1|Baseline Intervention|Relocation|2
5082290|NCT02123797|17544912|P5|Baseline Intervention|Withdrawal by Subject|0
5082291|NCT02123797|17544913|P4|Baseline Intervention|Withdrawal by Subject|0
5082292|NCT02123797|17544914|P3|Baseline Intervention|Withdrawal by Subject|0
5082293|NCT02123797|17544915|P2|Baseline Intervention|Withdrawal by Subject|8
5082294|NCT02123797|17544916|P1|Baseline Intervention|Withdrawal by Subject|2
5082295|NCT02123797|17544912|P5|Baseline Intervention|Death|0
5082296|NCT02123797|17544913|P4|Baseline Intervention|Death|0
5082297|NCT02123797|17544914|P3|Baseline Intervention|Death|0
5082298|NCT02123797|17544915|P2|Baseline Intervention|Death|16
5082299|NCT02123797|17544916|P1|Baseline Intervention|Death|9
5082300|NCT02123576|17545025|P2|Overall Study|Adverse Event|0
5082301|NCT02123576|17545026|P1|Overall Study|Adverse Event|1
5082302|NCT02123511|17545044|P2|Overall Study|Ineligible|1
5082303|NCT02123511|17545045|P1|Overall Study|Ineligible|0
5082304|NCT02123511|17545044|P2|Overall Study|Incomplete data|3
5082305|NCT02123511|17545045|P1|Overall Study|Incomplete data|1
5082306|NCT02123511|17545044|P2|Overall Study|Cancelled treatment|0
5082307|NCT02123511|17545045|P1|Overall Study|Cancelled treatment|1
5082308|NCT02123472|17545069|P2|Period 2 (7 Days)|Withdrawal by Subject|1
5082309|NCT02123472|17545070|P1|Period 2 (7 Days)|Withdrawal by Subject|0
5082310|NCT02123459|17545080|P2|Washout Period (1 Day)|Adverse Event|0
5082311|NCT02123459|17545081|P1|Washout Period (1 Day)|Adverse Event|1
5082312|NCT02123446|17545091|P2|Washout Period (1 Day)|Physician Decision|0
5082313|NCT02123446|17545092|P1|Washout Period (1 Day)|Physician Decision|1
5082314|NCT02123251|17545133|P2|Overall Study|Switched Managed Care Organization (MCO)|4
5082315|NCT02123251|17545134|P1|Overall Study|Switched Managed Care Organization (MCO)|4
5082316|NCT02123251|17545133|P2|Overall Study|Lost Medicaid eligibility|22
5082318|NCT02123251|17545133|P2|Overall Study|Withdrawal by Subject|3
5082319|NCT02123251|17545134|P1|Overall Study|Withdrawal by Subject|0
5082320|NCT02123251|17545133|P2|Overall Study|Death|1
5082321|NCT02123251|17545134|P1|Overall Study|Death|1
5082322|NCT02123134|17545160|P2|Overall Study|Administrative decision|1
5082323|NCT02123134|17545161|P1|Overall Study|Administrative decision|0
5082324|NCT02123134|17545160|P2|Overall Study|Withdrawal of consent|2
5082325|NCT02123134|17545161|P1|Overall Study|Withdrawal of consent|3
5082326|NCT02122887|17545218|P2|Overall Study|Withdrawal by Subject|2
5082327|NCT02122887|17545219|P1|Overall Study|Withdrawal by Subject|20
5082328|NCT02122783|17545257|P2|Overall Study|Adverse Event|1
5082329|NCT02122783|17545258|P1|Overall Study|Adverse Event|0
5082330|NCT02122770|17545272|P6|Part B: Standard of Care|Progressive Disease|8
5082331|NCT02122770|17545273|P5|Part B: Standard of Care|Progressive Disease|10
5082332|NCT02122770|17545274|P4|Part B: Standard of Care|Progressive Disease|0
5082333|NCT02122770|17545275|P3|Part B: Standard of Care|Progressive Disease|0
5082334|NCT02122770|17545276|P2|Part B: Standard of Care|Progressive Disease|0
5082335|NCT02122770|17545277|P1|Part B: Standard of Care|Progressive Disease|0
5082336|NCT02122770|17545272|P6|Part B: Standard of Care|Symptomatic Deterioration|0
5082337|NCT02122770|17545273|P5|Part B: Standard of Care|Symptomatic Deterioration|5
5082338|NCT02122770|17545274|P4|Part B: Standard of Care|Symptomatic Deterioration|0
5082339|NCT02122770|17545275|P3|Part B: Standard of Care|Symptomatic Deterioration|0
5082340|NCT02122770|17545276|P2|Part B: Standard of Care|Symptomatic Deterioration|0
5082341|NCT02122770|17545277|P1|Part B: Standard of Care|Symptomatic Deterioration|0
5082342|NCT02122770|17545272|P6|Part B: Standard of Care|Withdrawal by Subject|2
5082343|NCT02122770|17545273|P5|Part B: Standard of Care|Withdrawal by Subject|4
5082344|NCT02122770|17545274|P4|Part B: Standard of Care|Withdrawal by Subject|0
5082345|NCT02122770|17545275|P3|Part B: Standard of Care|Withdrawal by Subject|0
5082346|NCT02122770|17545276|P2|Part B: Standard of Care|Withdrawal by Subject|0
5082347|NCT02122770|17545277|P1|Part B: Standard of Care|Withdrawal by Subject|0
5082348|NCT02122770|17545272|P6|Part B: Standard of Care|Other|2
5082349|NCT02122770|17545273|P5|Part B: Standard of Care|Other|0
5082350|NCT02122770|17545274|P4|Part B: Standard of Care|Other|0
5082351|NCT02122770|17545275|P3|Part B: Standard of Care|Other|0
5082352|NCT02122770|17545276|P2|Part B: Standard of Care|Other|0
5082353|NCT02122770|17545277|P1|Part B: Standard of Care|Other|0
5082354|NCT02122770|17545272|P6|Part B: Standard of Care|Adverse Event|1
5082355|NCT02122770|17545273|P5|Part B: Standard of Care|Adverse Event|4
5082356|NCT02122770|17545274|P4|Part B: Standard of Care|Adverse Event|0
5082357|NCT02122770|17545275|P3|Part B: Standard of Care|Adverse Event|0
5082358|NCT02122770|17545276|P2|Part B: Standard of Care|Adverse Event|0
5082359|NCT02122770|17545277|P1|Part B: Standard of Care|Adverse Event|0
5082360|NCT02122770|17545272|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5082361|NCT02122770|17545273|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5082362|NCT02122770|17545274|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
5082363|NCT02122770|17545275|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5082364|NCT02122770|17545276|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
5082365|NCT02122770|17545277|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
5082366|NCT02122770|17545272|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5082367|NCT02122770|17545273|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5082368|NCT02122770|17545274|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5082369|NCT02122770|17545275|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5082370|NCT02122770|17545276|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
5082371|NCT02122770|17545277|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5082372|NCT02122770|17545272|P6|Part A: Drug-drug Interaction 2|Other|0
5082373|NCT02122770|17545273|P5|Part A: Drug-drug Interaction 2|Other|0
5082374|NCT02122770|17545274|P4|Part A: Drug-drug Interaction 2|Other|0
5082375|NCT02122770|17545275|P3|Part A: Drug-drug Interaction 2|Other|1
5082376|NCT02122770|17545276|P2|Part A: Drug-drug Interaction 2|Other|0
5082377|NCT02122770|17545277|P1|Part A: Drug-drug Interaction 2|Other|0
5082378|NCT02122770|17545272|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
5082379|NCT02122770|17545273|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
5082380|NCT02122770|17545274|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
5082381|NCT02122770|17545275|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
5082382|NCT02122770|17545276|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
5082383|NCT02122770|17545277|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
5082384|NCT02122380|17545397|P2|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
5082385|NCT02122380|17545398|P1|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
5082386|NCT02122380|17545397|P2|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
5082387|NCT02122380|17545398|P1|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
5082388|NCT02122380|17545397|P2|Washout (8 Weeks)|Lost to Follow-up|0
5082389|NCT02122380|17545398|P1|Washout (8 Weeks)|Lost to Follow-up|1
5082390|NCT02122380|17545397|P2|First Intervention (30 Days)|Physician Decision|1
5082391|NCT02122380|17545398|P1|First Intervention (30 Days)|Physician Decision|0
5082392|NCT02122380|17545397|P2|First Intervention (30 Days)|Adverse Event|0
5082393|NCT02122380|17545398|P1|First Intervention (30 Days)|Adverse Event|1
5082394|NCT02122146|17545437|P8|Part 1: Dose Escalation|Other|2
5082395|NCT02122146|17545438|P7|Part 1: Dose Escalation|Other|1
5082396|NCT02122146|17545439|P6|Part 1: Dose Escalation|Other|1
5082397|NCT02122146|17545440|P5|Part 1: Dose Escalation|Other|0
5082398|NCT02122146|17545441|P4|Part 1: Dose Escalation|Other|0
5082399|NCT02122146|17545442|P3|Part 1: Dose Escalation|Other|0
5082400|NCT02122146|17545443|P2|Part 1: Dose Escalation|Other|0
5082401|NCT02122146|17545444|P1|Part 1: Dose Escalation|Other|1
5082402|NCT02122146|17545437|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
5082403|NCT02122146|17545438|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
5082404|NCT02122146|17545439|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
5082405|NCT02122146|17545440|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
5082406|NCT02122146|17545441|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
5082407|NCT02122146|17545442|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
5082408|NCT02122146|17545443|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
5082409|NCT02122146|17545444|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
5082410|NCT02122146|17545437|P8|Part 1: Dose Escalation|Lost to Follow-up|0
5082411|NCT02122146|17545438|P7|Part 1: Dose Escalation|Lost to Follow-up|0
5082412|NCT02122146|17545439|P6|Part 1: Dose Escalation|Lost to Follow-up|0
5082413|NCT02122146|17545440|P5|Part 1: Dose Escalation|Lost to Follow-up|1
5082414|NCT02122146|17545441|P4|Part 1: Dose Escalation|Lost to Follow-up|0
5082415|NCT02122146|17545442|P3|Part 1: Dose Escalation|Lost to Follow-up|1
5082416|NCT02122146|17545443|P2|Part 1: Dose Escalation|Lost to Follow-up|0
5082417|NCT02122146|17545444|P1|Part 1: Dose Escalation|Lost to Follow-up|0
5082418|NCT02122146|17545437|P8|Part 1: Dose Escalation|Death|0
5082419|NCT02122146|17545438|P7|Part 1: Dose Escalation|Death|0
5082420|NCT02122146|17545439|P6|Part 1: Dose Escalation|Death|0
5082421|NCT02122146|17545440|P5|Part 1: Dose Escalation|Death|0
5082422|NCT02122146|17545441|P4|Part 1: Dose Escalation|Death|0
5082423|NCT02122146|17545442|P3|Part 1: Dose Escalation|Death|1
5082424|NCT02122146|17545443|P2|Part 1: Dose Escalation|Death|1
5082425|NCT02122146|17545444|P1|Part 1: Dose Escalation|Death|0
5082426|NCT02121847|17545718|P1|Overall Study|Adverse Event|2
5082427|NCT02121847|17545718|P1|Overall Study|Administrative Reasons|1
5082428|NCT02121834|17545744|P7|Overall Study|Lost to Follow-up|0
5082429|NCT02121834|17545745|P6|Overall Study|Lost to Follow-up|0
5082430|NCT02121834|17545746|P5|Overall Study|Lost to Follow-up|0
5082431|NCT02121834|17545747|P4|Overall Study|Lost to Follow-up|0
5082432|NCT02121834|17545748|P3|Overall Study|Lost to Follow-up|1
5082433|NCT02121834|17545749|P2|Overall Study|Lost to Follow-up|0
5082434|NCT02121834|17545750|P1|Overall Study|Lost to Follow-up|0
5082435|NCT02121834|17545744|P7|Overall Study|Withdrawal by Subject|0
5082436|NCT02121834|17545745|P6|Overall Study|Withdrawal by Subject|0
5082437|NCT02121834|17545746|P5|Overall Study|Withdrawal by Subject|0
5082438|NCT02121834|17545747|P4|Overall Study|Withdrawal by Subject|0
5082439|NCT02121834|17545748|P3|Overall Study|Withdrawal by Subject|1
5082440|NCT02121834|17545749|P2|Overall Study|Withdrawal by Subject|1
5082441|NCT02121834|17545750|P1|Overall Study|Withdrawal by Subject|0
5082442|NCT02121834|17545744|P7|Overall Study|Protocol Violation|0
5082443|NCT02121834|17545745|P6|Overall Study|Protocol Violation|0
5082444|NCT02121834|17545746|P5|Overall Study|Protocol Violation|0
5082445|NCT02121834|17545747|P4|Overall Study|Protocol Violation|0
5082446|NCT02121834|17545748|P3|Overall Study|Protocol Violation|0
5082447|NCT02121834|17545749|P2|Overall Study|Protocol Violation|1
5082448|NCT02121834|17545750|P1|Overall Study|Protocol Violation|0
5082449|NCT02121808|17545776|P1|Overall Study|Technical problem|3
5082450|NCT02121795|17545787|P2|Open-Label Phase|Lost to Follow-up|0
5082451|NCT02121795|17545788|P1|Open-Label Phase|Lost to Follow-up|1
5082452|NCT02121795|17545787|P2|Open-Label Phase|Withdrawal by Subject|2
5082453|NCT02121795|17545788|P1|Open-Label Phase|Withdrawal by Subject|3
5082454|NCT02121795|17545787|P2|Open-Label Phase|Physician Decision|8
5082455|NCT02121795|17545788|P1|Open-Label Phase|Physician Decision|8
5082456|NCT02121795|17545787|P2|Double-Blind Phase|Death|1
5082457|NCT02121795|17545788|P1|Double-Blind Phase|Death|1
5082458|NCT02121795|17545787|P2|Double-Blind Phase|Protocol Violation|3
5082459|NCT02121795|17545788|P1|Double-Blind Phase|Protocol Violation|0
5082460|NCT02121795|17545787|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5082461|NCT02121795|17545788|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
5082462|NCT02121795|17545787|P2|Double-Blind Phase|Adverse Event|0
5082463|NCT02121795|17545788|P1|Double-Blind Phase|Adverse Event|5
5082464|NCT02121795|17545787|P2|Double-Blind Phase|Physician Decision|5
5082465|NCT02121795|17545788|P1|Double-Blind Phase|Physician Decision|2
5082466|NCT02121795|17545787|P2|Double-Blind Phase|Lost to Follow-up|4
5082467|NCT02121795|17545788|P1|Double-Blind Phase|Lost to Follow-up|7
5082468|NCT02121795|17545787|P2|Double-Blind Phase|Withdrawal by Subject|16
5082469|NCT02121795|17545788|P1|Double-Blind Phase|Withdrawal by Subject|19
5082470|NCT02121795|17545787|P2|Double-Blind Phase|Randomized but Never Treated|4
5082471|NCT02121795|17545788|P1|Double-Blind Phase|Randomized but Never Treated|1
5082472|NCT02121756|17545816|P2|Overall Study|Physician Decision|1
5082473|NCT02121756|17545817|P1|Overall Study|Physician Decision|2
5082474|NCT02121756|17545816|P2|Overall Study|Protocol Violation|1
5082475|NCT02121756|17545817|P1|Overall Study|Protocol Violation|1
5082476|NCT02121756|17545816|P2|Overall Study|Adverse Event|0
5082477|NCT02121756|17545817|P1|Overall Study|Adverse Event|3
5082478|NCT02121535|17545854|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
5082479|NCT02121535|17545855|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
5082480|NCT02121535|17545854|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
5082481|NCT02121535|17545855|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
5082482|NCT02121522|17545878|P1|Overall Study|Adverse Event|1
5082483|NCT02121509|17545885|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
5082484|NCT02121509|17545886|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
5082485|NCT02121509|17545887|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
5082486|NCT02121509|17545888|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
5082487|NCT02121509|17545885|P4|Washout Period (35 Days)|Withdrawal by Subject|0
5082488|NCT02121509|17545886|P3|Washout Period (35 Days)|Withdrawal by Subject|0
5082489|NCT02121509|17545887|P2|Washout Period (35 Days)|Withdrawal by Subject|3
5082490|NCT02121509|17545888|P1|Washout Period (35 Days)|Withdrawal by Subject|0
5082491|NCT02121509|17545885|P4|Washout Period (35 Days)|Adverse Event|0
5082492|NCT02121509|17545886|P3|Washout Period (35 Days)|Adverse Event|0
5082493|NCT02121509|17545887|P2|Washout Period (35 Days)|Adverse Event|1
5082494|NCT02121509|17545888|P1|Washout Period (35 Days)|Adverse Event|1
5082495|NCT02121392|17545959|P2|After Placement of AC Block vs Sham|Lost to Follow-up|1
5082496|NCT02121392|17545960|P1|After Placement of AC Block vs Sham|Lost to Follow-up|0
5082497|NCT02121392|17545959|P2|After Placement of AC Block vs Sham|Protocol Violation|2
5082498|NCT02121392|17545960|P1|After Placement of AC Block vs Sham|Protocol Violation|3
5082499|NCT02121392|17545959|P2|Prior to Intervention|Withdrawal by Subject|6
5082500|NCT02121392|17545960|P1|Prior to Intervention|Withdrawal by Subject|8
5082501|NCT02121392|17545959|P2|Prior to Intervention|Protocol Violation|35
5082502|NCT02121392|17545960|P1|Prior to Intervention|Protocol Violation|40
5082503|NCT02121301|17545985|P3|Overall Study|Protocol Violation|1
5082504|NCT02121301|17545986|P2|Overall Study|Protocol Violation|4
5082505|NCT02121301|17545987|P1|Overall Study|Protocol Violation|1
5082506|NCT02121262|17546000|P2|Overall Study|Consent Withdrawn|0
5082507|NCT02121262|17546001|P1|Overall Study|Consent Withdrawn|1
5082508|NCT02121262|17546000|P2|Overall Study|Participant was Deemed Unsuitable|0
5082509|NCT02121262|17546001|P1|Overall Study|Participant was Deemed Unsuitable|1
5082510|NCT02121262|17546000|P2|Overall Study|Participant Dropped-out|1
5082511|NCT02121262|17546001|P1|Overall Study|Participant Dropped-out|0
5082512|NCT02121262|17546000|P2|Overall Study|Protocol Violation|1
5082513|NCT02121262|17546001|P1|Overall Study|Protocol Violation|1
5082514|NCT02121262|17546000|P2|Overall Study|Personal Reasons|5
5082515|NCT02121262|17546001|P1|Overall Study|Personal Reasons|19
5082516|NCT02121262|17546000|P2|Overall Study|Lack of Efficacy|0
5082517|NCT02121262|17546001|P1|Overall Study|Lack of Efficacy|3
5082518|NCT02121262|17546000|P2|Overall Study|Adverse Event|3
5082519|NCT02121262|17546001|P1|Overall Study|Adverse Event|6
5082520|NCT02121210|17546015|P2|Overall Study|Other than specified above|2
5082521|NCT02121210|17546016|P1|Overall Study|Other than specified above|0
5082522|NCT02121210|17546015|P2|Overall Study|Lack of Efficacy|0
5082523|NCT02121210|17546016|P1|Overall Study|Lack of Efficacy|2
5082524|NCT02121210|17546015|P2|Overall Study|Adverse Event|7
5082525|NCT02121210|17546016|P1|Overall Study|Adverse Event|5
5082526|NCT02120950|17546041|P3|Overall Study|Lost to Follow-up|1
5082527|NCT02120950|17546042|P2|Overall Study|Lost to Follow-up|2
5082528|NCT02120950|17546043|P1|Overall Study|Lost to Follow-up|0
5082529|NCT02120950|17546041|P3|Overall Study|Other reasons|1
5082530|NCT02120950|17546042|P2|Overall Study|Other reasons|4
5082531|NCT02120950|17546043|P1|Overall Study|Other reasons|5
5082532|NCT02120950|17546041|P3|Overall Study|Protocol Violation|7
5082533|NCT02120950|17546042|P2|Overall Study|Protocol Violation|1
5082534|NCT02120950|17546043|P1|Overall Study|Protocol Violation|1
5082535|NCT02120950|17546041|P3|Overall Study|Withdrawal by Subject|2
5082536|NCT02120950|17546042|P2|Overall Study|Withdrawal by Subject|3
5082537|NCT02120950|17546043|P1|Overall Study|Withdrawal by Subject|6
5082538|NCT02120950|17546041|P3|Overall Study|Death|1
5082539|NCT02120950|17546042|P2|Overall Study|Death|0
5082540|NCT02120950|17546043|P1|Overall Study|Death|3
5082541|NCT02120950|17546041|P3|Overall Study|Adverse Event|3
5082542|NCT02120950|17546042|P2|Overall Study|Adverse Event|4
5082543|NCT02120950|17546043|P1|Overall Study|Adverse Event|5
5082544|NCT02120924|17546079|P3|Overall Study|Compliance with IP|1
5082545|NCT02120924|17546080|P2|Overall Study|Compliance with IP|1
5082546|NCT02120924|17546081|P1|Overall Study|Compliance with IP|5
5082547|NCT02120924|17546079|P3|Overall Study|Death|0
5082548|NCT02120924|17546080|P2|Overall Study|Death|0
5082549|NCT02120924|17546081|P1|Overall Study|Death|1
5082550|NCT02120924|17546079|P3|Overall Study|Physician Decision|1
5082551|NCT02120924|17546080|P2|Overall Study|Physician Decision|1
5082552|NCT02120924|17546081|P1|Overall Study|Physician Decision|0
5082553|NCT02120924|17546079|P3|Overall Study|Protocol Violation|2
5082554|NCT02120924|17546080|P2|Overall Study|Protocol Violation|7
5082555|NCT02120924|17546081|P1|Overall Study|Protocol Violation|3
5082556|NCT02120924|17546079|P3|Overall Study|Pregnancy|0
5082557|NCT02120924|17546080|P2|Overall Study|Pregnancy|0
5082558|NCT02120924|17546081|P1|Overall Study|Pregnancy|2
5082559|NCT02120924|17546079|P3|Overall Study|Lost to Follow-up|11
5082560|NCT02120924|17546080|P2|Overall Study|Lost to Follow-up|14
5082561|NCT02120924|17546081|P1|Overall Study|Lost to Follow-up|14
5082562|NCT02120924|17546079|P3|Overall Study|Withdrawal by Subject|8
5082563|NCT02120924|17546080|P2|Overall Study|Withdrawal by Subject|20
5082564|NCT02120924|17546081|P1|Overall Study|Withdrawal by Subject|16
5082565|NCT02120924|17546079|P3|Overall Study|Adverse Event|3
5082566|NCT02120924|17546080|P2|Overall Study|Adverse Event|1
5082567|NCT02120924|17546081|P1|Overall Study|Adverse Event|0
5082568|NCT02120924|17546079|P3|Overall Study|Lack of Efficacy|3
5082569|NCT02120924|17546080|P2|Overall Study|Lack of Efficacy|2
5082570|NCT02120924|17546081|P1|Overall Study|Lack of Efficacy|1
5082571|NCT02120898|17546095|P3|Overall Study|Lost to Follow-up|1
5082572|NCT02120898|17546096|P2|Overall Study|Lost to Follow-up|0
5082573|NCT02120898|17546097|P1|Overall Study|Lost to Follow-up|0
5082574|NCT02120898|17546095|P3|Overall Study|Protocol Violation|0
5082575|NCT02120898|17546096|P2|Overall Study|Protocol Violation|2
5082576|NCT02120898|17546097|P1|Overall Study|Protocol Violation|1
5082577|NCT02120898|17546095|P3|Overall Study|Adverse Event|1
5082578|NCT02120898|17546096|P2|Overall Study|Adverse Event|2
5082579|NCT02120898|17546097|P1|Overall Study|Adverse Event|1
5082580|NCT02120898|17546095|P3|Overall Study|Non-compliance with study drug|0
5082581|NCT02120898|17546096|P2|Overall Study|Non-compliance with study drug|0
5082582|NCT02120898|17546097|P1|Overall Study|Non-compliance with study drug|3
5082583|NCT02120898|17546095|P3|Overall Study|Withdrawal by Subject|2
5082584|NCT02120898|17546096|P2|Overall Study|Withdrawal by Subject|2
5082585|NCT02120898|17546097|P1|Overall Study|Withdrawal by Subject|4
5082586|NCT02120833|17546119|P2|Overall Study|Lost to Follow-up|1
5082587|NCT02120833|17546120|P1|Overall Study|Lost to Follow-up|1
5082588|NCT02120833|17546119|P2|Overall Study|Withdrawal by Subject|0
5082589|NCT02120833|17546120|P1|Overall Study|Withdrawal by Subject|2
5082590|NCT02120833|17546119|P2|Overall Study|Adverse Event|0
5082591|NCT02120833|17546120|P1|Overall Study|Adverse Event|1
5082592|NCT02120794|17546274|P1|Overall Study|Due to insurance coverage|1
5082593|NCT02120794|17546274|P1|Overall Study|Physician Decision|4
5082594|NCT02120794|17546274|P1|Overall Study|Adverse Event|10
5082595|NCT02120794|17546274|P1|Overall Study|Withdrawal by Subject|43
5082596|NCT02120664|17546298|P5|Overall Study|Withdrawal by Subject|0
5082597|NCT02120664|17546299|P4|Overall Study|Withdrawal by Subject|1
5082598|NCT02120664|17546300|P3|Overall Study|Withdrawal by Subject|0
5082599|NCT02120664|17546301|P2|Overall Study|Withdrawal by Subject|0
5082600|NCT02120664|17546302|P1|Overall Study|Withdrawal by Subject|0
5082601|NCT02120625|17546320|P1|Overall Study|Physician Decision|2
5082602|NCT02120456|17546336|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
5082603|NCT02120456|17546337|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082604|NCT02120456|17546338|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082605|NCT02120456|17546339|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082606|NCT02120456|17546340|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082607|NCT02120456|17546341|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082608|NCT02120456|17546342|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082609|NCT02120456|17546343|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082610|NCT02120456|17546344|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5082611|NCT02120456|17546336|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
5082612|NCT02120456|17546337|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
5082613|NCT02120456|17546338|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
5082614|NCT02120456|17546339|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
5082615|NCT02120456|17546340|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
5082616|NCT02120456|17546341|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
5082617|NCT02120456|17546342|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
5082618|NCT02120456|17546343|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
5082619|NCT02120456|17546344|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
5082620|NCT02120456|17546336|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
5082621|NCT02120456|17546337|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
5082622|NCT02120456|17546338|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
5082623|NCT02120456|17546339|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
5082624|NCT02120456|17546340|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
5082625|NCT02120456|17546341|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
5082626|NCT02120456|17546342|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
5082627|NCT02120456|17546343|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
5082628|NCT02120456|17546344|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
5082629|NCT02120417|17546378|P2|Overall Study|Other unspecified|4
5082630|NCT02120417|17546379|P1|Overall Study|Other unspecified|5
5082631|NCT02120417|17546378|P2|Overall Study|Physician Decision|3
5082632|NCT02120417|17546379|P1|Overall Study|Physician Decision|2
5082633|NCT02120417|17546378|P2|Overall Study|Noncompliance with study treatment|2
5082634|NCT02120417|17546379|P1|Overall Study|Noncompliance with study treatment|0
5082635|NCT02120417|17546378|P2|Overall Study|Disease progression|45
5082636|NCT02120417|17546379|P1|Overall Study|Disease progression|41
5082637|NCT02120417|17546378|P2|Overall Study|Participant decision|4
5082638|NCT02120417|17546379|P1|Overall Study|Participant decision|4
5082639|NCT02120417|17546378|P2|Overall Study|Adverse Event|9
5082640|NCT02120417|17546379|P1|Overall Study|Adverse Event|3
5082641|NCT02120417|17546378|P2|Overall Study|Death|1
5082642|NCT02120417|17546379|P1|Overall Study|Death|5
5082643|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
5082644|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
5082645|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
5082646|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
5082647|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
5082648|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
5082649|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
5082650|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
5082651|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Lost to Follow-up|1
5082652|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5082653|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5082654|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5082655|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
5082656|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
5082657|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
5082658|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
5082659|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Protocol Violation|0
5082660|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Protocol Violation|2
5082661|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Protocol Violation|0
5082662|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Protocol Violation|0
5082663|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Lack of Efficacy|1
5082664|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Lack of Efficacy|0
5082665|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Lack of Efficacy|1
5082666|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Lack of Efficacy|0
5082667|NCT02120352|17546397|P4|Maintenance Period (32 Weeks)|Adverse Event|1
5082668|NCT02120352|17546398|P3|Maintenance Period (32 Weeks)|Adverse Event|6
5082669|NCT02120352|17546399|P2|Maintenance Period (32 Weeks)|Adverse Event|0
5082670|NCT02120352|17546400|P1|Maintenance Period (32 Weeks)|Adverse Event|0
5082671|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Physician Decision|0
5082672|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Physician Decision|0
5082673|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Physician Decision|0
5082674|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Physician Decision|1
5082675|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Withdrawal by Subject|0
5082676|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Withdrawal by Subject|0
5082677|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Withdrawal by Subject|0
5082678|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Withdrawal by Subject|5
5082679|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Lost to Follow-up|0
5082680|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Lost to Follow-up|0
5082681|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Lost to Follow-up|0
5082682|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Lost to Follow-up|2
5082683|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5082684|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5082685|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5082686|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
5082687|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Protocol Violation|0
5082688|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Protocol Violation|0
5082689|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Protocol Violation|0
5082690|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Protocol Violation|2
5082691|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Lack of Efficacy|0
5082692|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Lack of Efficacy|0
5082693|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Lack of Efficacy|0
5082694|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Lack of Efficacy|5
5082695|NCT02120352|17546397|P4|Induction Period (20 Weeks)|Adverse Event|0
5082696|NCT02120352|17546398|P3|Induction Period (20 Weeks)|Adverse Event|0
5082697|NCT02120352|17546399|P2|Induction Period (20 Weeks)|Adverse Event|0
5082698|NCT02120352|17546400|P1|Induction Period (20 Weeks)|Adverse Event|3
5082699|NCT02120300|17546551|P4|Overall Study|Lost to Follow-up|0
5082700|NCT02120300|17546552|P3|Overall Study|Lost to Follow-up|0
5082701|NCT02120300|17546553|P2|Overall Study|Lost to Follow-up|0
5082702|NCT02120300|17546554|P1|Overall Study|Lost to Follow-up|1
5082703|NCT02120300|17546551|P4|Overall Study|Lack of Efficacy|1
5082704|NCT02120300|17546552|P3|Overall Study|Lack of Efficacy|0
5082705|NCT02120300|17546553|P2|Overall Study|Lack of Efficacy|0
5082706|NCT02120300|17546554|P1|Overall Study|Lack of Efficacy|0
5082707|NCT02120300|17546551|P4|Overall Study|Enrolled but Never Treated|0
5082708|NCT02120300|17546552|P3|Overall Study|Enrolled but Never Treated|0
5082709|NCT02120300|17546553|P2|Overall Study|Enrolled but Never Treated|0
5082710|NCT02120300|17546554|P1|Overall Study|Enrolled but Never Treated|2
5082711|NCT02120157|17546625|P2|Overall Study|Graft Failure before Day 100|0
5082712|NCT02120157|17546626|P1|Overall Study|Graft Failure before Day 100|2
5082713|NCT02120157|17546625|P2|Overall Study|Death|2
5082714|NCT02120157|17546626|P1|Overall Study|Death|4
5082715|NCT02120027|17546636|P2|Overall Study|Withdrawal by Subject|25
5082716|NCT02120027|17546637|P1|Overall Study|Withdrawal by Subject|33
5082717|NCT02120027|17546636|P2|Overall Study|Study terminated by Sponsor|47
5082718|NCT02120027|17546637|P1|Overall Study|Study terminated by Sponsor|45
5082719|NCT02120027|17546636|P2|Overall Study|Protocol Violation|21
5082720|NCT02120027|17546637|P1|Overall Study|Protocol Violation|18
5082721|NCT02120027|17546636|P2|Overall Study|Physician Decision|3
5082722|NCT02120027|17546637|P1|Overall Study|Physician Decision|4
5082723|NCT02120027|17546636|P2|Overall Study|Other|0
5082724|NCT02120027|17546637|P1|Overall Study|Other|4
5082725|NCT02120027|17546636|P2|Overall Study|Lost to Follow-up|13
5082726|NCT02120027|17546637|P1|Overall Study|Lost to Follow-up|5
5082727|NCT02120027|17546636|P2|Overall Study|Lack of Efficacy|5
5082728|NCT02120027|17546637|P1|Overall Study|Lack of Efficacy|3
5082729|NCT02120027|17546636|P2|Overall Study|Adverse Event|5
5082730|NCT02120027|17546637|P1|Overall Study|Adverse Event|4
5082731|NCT02119936|17546662|P1|Overall Study|Lost to Follow-up|10
5082732|NCT02119676|17546696|P4|Overall Study|Did not receive study med|5
5082733|NCT02119676|17546697|P3|Overall Study|Did not receive study med|4
5082734|NCT02119676|17546698|P2|Overall Study|Did not receive study med|2
5082735|NCT02119676|17546699|P1|Overall Study|Did not receive study med|2
5082736|NCT02119676|17546696|P4|Overall Study|Other, unspecified|4
5082737|NCT02119676|17546697|P3|Overall Study|Other, unspecified|3
5082738|NCT02119676|17546698|P2|Overall Study|Other, unspecified|1
5082739|NCT02119676|17546699|P1|Overall Study|Other, unspecified|2
5082740|NCT02119676|17546696|P4|Overall Study|Protocol deviation|0
5082741|NCT02119676|17546697|P3|Overall Study|Protocol deviation|1
5082742|NCT02119676|17546698|P2|Overall Study|Protocol deviation|0
5082743|NCT02119676|17546699|P1|Overall Study|Protocol deviation|0
5082744|NCT02119676|17546696|P4|Overall Study|Lost to Follow-up|0
5082745|NCT02119676|17546697|P3|Overall Study|Lost to Follow-up|1
5082746|NCT02119676|17546698|P2|Overall Study|Lost to Follow-up|0
5082747|NCT02119676|17546699|P1|Overall Study|Lost to Follow-up|0
5082748|NCT02119676|17546696|P4|Overall Study|Noncompliance|0
5082749|NCT02119676|17546697|P3|Overall Study|Noncompliance|0
5082750|NCT02119676|17546698|P2|Overall Study|Noncompliance|1
5082751|NCT02119676|17546699|P1|Overall Study|Noncompliance|0
5082752|NCT02119676|17546696|P4|Overall Study|Death|1
5082753|NCT02119676|17546697|P3|Overall Study|Death|2
5082754|NCT02119676|17546698|P2|Overall Study|Death|3
5082755|NCT02119676|17546699|P1|Overall Study|Death|9
5082756|NCT02119676|17546696|P4|Overall Study|Physician Decision|2
5082757|NCT02119676|17546697|P3|Overall Study|Physician Decision|3
5082758|NCT02119676|17546698|P2|Overall Study|Physician Decision|2
5082759|NCT02119676|17546699|P1|Overall Study|Physician Decision|4
5082760|NCT02119676|17546696|P4|Overall Study|Patient decision, inc. consent withdrawn|6
5082761|NCT02119676|17546697|P3|Overall Study|Patient decision, inc. consent withdrawn|5
5082762|NCT02119676|17546698|P2|Overall Study|Patient decision, inc. consent withdrawn|5
5082763|NCT02119676|17546699|P1|Overall Study|Patient decision, inc. consent withdrawn|4
5082764|NCT02119676|17546696|P4|Overall Study|Disease progression|73
5082765|NCT02119676|17546697|P3|Overall Study|Disease progression|68
5082766|NCT02119676|17546698|P2|Overall Study|Disease progression|55
5082767|NCT02119676|17546699|P1|Overall Study|Disease progression|53
5082768|NCT02119676|17546696|P4|Overall Study|Adverse Event|10
5082769|NCT02119676|17546697|P3|Overall Study|Adverse Event|10
5082770|NCT02119676|17546698|P2|Overall Study|Adverse Event|17
5082771|NCT02119676|17546699|P1|Overall Study|Adverse Event|9
5082772|NCT02119663|17546731|P2|Overall Study|Study Terminated by the Sponsor|4
5082773|NCT02119663|17546732|P1|Overall Study|Study Terminated by the Sponsor|3
5082774|NCT02119663|17546731|P2|Overall Study|Subject decision|1
5082775|NCT02119663|17546732|P1|Overall Study|Subject decision|0
5082776|NCT02119663|17546731|P2|Overall Study|Other unspecified|0
5082777|NCT02119663|17546732|P1|Overall Study|Other unspecified|2
5082778|NCT02119663|17546731|P2|Overall Study|Physician Decision|2
5082779|NCT02119663|17546732|P1|Overall Study|Physician Decision|1
5082780|NCT02119663|17546731|P2|Overall Study|Death|2
5082781|NCT02119663|17546732|P1|Overall Study|Death|3
5082782|NCT02119663|17546731|P2|Overall Study|Adverse Event|5
5082783|NCT02119663|17546732|P1|Overall Study|Adverse Event|5
5082784|NCT02119663|17546731|P2|Overall Study|Disease progression|27
5082785|NCT02119663|17546732|P1|Overall Study|Disease progression|26
5082786|NCT02119650|17546750|P2|Overall Study|Multiple reasons for termination|1
5082787|NCT02119650|17546751|P1|Overall Study|Multiple reasons for termination|2
5082788|NCT02119650|17546750|P2|Overall Study|Physician Decision|2
5082789|NCT02119650|17546751|P1|Overall Study|Physician Decision|0
5082790|NCT02119650|17546750|P2|Overall Study|Study terminated by the sponsor|0
5082791|NCT02119650|17546751|P1|Overall Study|Study terminated by the sponsor|1
5082792|NCT02119650|17546750|P2|Overall Study|Noncompliance with study treatment|1
5082793|NCT02119650|17546751|P1|Overall Study|Noncompliance with study treatment|1
5082794|NCT02119650|17546750|P2|Overall Study|Death|1
5082795|NCT02119650|17546751|P1|Overall Study|Death|5
5082796|NCT02119650|17546750|P2|Overall Study|Disease progression|14
5082797|NCT02119650|17546751|P1|Overall Study|Disease progression|11
5082798|NCT02119650|17546750|P2|Overall Study|Subject decision|3
5082799|NCT02119650|17546751|P1|Overall Study|Subject decision|2
5082800|NCT02119650|17546750|P2|Overall Study|Adverse Event|4
5082801|NCT02119650|17546751|P1|Overall Study|Adverse Event|3
5082802|NCT02119325|17546786|P2|Washout Period 1|Adverse Event|1
5082803|NCT02119325|17546787|P1|Washout Period 1|Adverse Event|0
5082804|NCT02119299|17546831|P1|Overall Study|Pregnancy|1
5082805|NCT02119299|17546831|P1|Overall Study|Lack of Efficacy|1
5082806|NCT02119299|17546831|P1|Overall Study|Withdrawal by Subject|7
5082807|NCT02119286|17546845|P3|Overall Study|Withdrawal by Subject|0
5082808|NCT02119286|17546846|P2|Overall Study|Withdrawal by Subject|1
5082809|NCT02119286|17546847|P1|Overall Study|Withdrawal by Subject|4
5082810|NCT02119286|17546845|P3|Overall Study|Lost to Follow-up|1
5082811|NCT02119286|17546846|P2|Overall Study|Lost to Follow-up|0
5082812|NCT02119286|17546847|P1|Overall Study|Lost to Follow-up|2
5082813|NCT02119286|17546845|P3|Overall Study|Lack of Efficacy|4
5082814|NCT02119286|17546846|P2|Overall Study|Lack of Efficacy|3
5082815|NCT02119286|17546847|P1|Overall Study|Lack of Efficacy|11
5082816|NCT02119286|17546845|P3|Overall Study|Adverse Event|2
5082817|NCT02119286|17546846|P2|Overall Study|Adverse Event|7
5082818|NCT02119286|17546847|P1|Overall Study|Adverse Event|9
5082819|NCT02119260|17546865|P7|Overall Study|Withdrew consent|0
5082820|NCT02119260|17546866|P6|Overall Study|Withdrew consent|0
5082821|NCT02119260|17546867|P5|Overall Study|Withdrew consent|0
5082822|NCT02119260|17546868|P4|Overall Study|Withdrew consent|0
5082823|NCT02119260|17546869|P3|Overall Study|Withdrew consent|1
5082824|NCT02119260|17546870|P2|Overall Study|Withdrew consent|1
5082825|NCT02119260|17546871|P1|Overall Study|Withdrew consent|0
5082826|NCT02119260|17546865|P7|Overall Study|Adverse Event|0
5082827|NCT02119260|17546866|P6|Overall Study|Adverse Event|0
5082828|NCT02119260|17546867|P5|Overall Study|Adverse Event|0
5082829|NCT02119260|17546868|P4|Overall Study|Adverse Event|0
5082830|NCT02119260|17546869|P3|Overall Study|Adverse Event|0
5082831|NCT02119260|17546870|P2|Overall Study|Adverse Event|0
5082832|NCT02119260|17546871|P1|Overall Study|Adverse Event|1
5082833|NCT02119156|17546944|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
5082834|NCT02119156|17546945|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
5082835|NCT02119156|17546946|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
5082836|NCT02119156|17546944|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
5082837|NCT02119156|17546945|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
5082838|NCT02119156|17546946|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
5082839|NCT02119156|17546944|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
5082840|NCT02119156|17546945|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
5082841|NCT02119156|17546946|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
5082842|NCT02119156|17546944|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
5082843|NCT02119156|17546945|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
5082844|NCT02119156|17546946|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
5082845|NCT02119156|17546944|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
5082846|NCT02119156|17546945|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
5082847|NCT02119156|17546946|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
5082848|NCT02119104|17547004|P1|Overall Study|Protocol Violation|16
5082849|NCT02119026|17547010|P2|2nd-line Treatment|Adverse Event|1
5082850|NCT02119026|17547011|P1|2nd-line Treatment|Adverse Event|4
5082851|NCT02119026|17547010|P2|2nd-line Treatment|Withdrawal by Subject|1
5082852|NCT02119026|17547011|P1|2nd-line Treatment|Withdrawal by Subject|3
5082853|NCT02119026|17547010|P2|2nd-line Treatment|Lost to Follow-up|0
5082854|NCT02119026|17547011|P1|2nd-line Treatment|Lost to Follow-up|2
5082855|NCT02119026|17547010|P2|1st-line Treatment|Death|1
5082856|NCT02119026|17547011|P1|1st-line Treatment|Death|2
5082857|NCT02119026|17547010|P2|1st-line Treatment|Surgery of metastases|1
5082858|NCT02119026|17547011|P1|1st-line Treatment|Surgery of metastases|2
5082859|NCT02119026|17547010|P2|1st-line Treatment|Patient condition or compliance|4
5082860|NCT02119026|17547011|P1|1st-line Treatment|Patient condition or compliance|6
5082861|NCT02119026|17547010|P2|1st-line Treatment|Withdrawal by Subject|10
5082862|NCT02119026|17547011|P1|1st-line Treatment|Withdrawal by Subject|4
5082863|NCT02119026|17547010|P2|1st-line Treatment|Physician Decision|8
5082864|NCT02119026|17547011|P1|1st-line Treatment|Physician Decision|3
5082865|NCT02119026|17547010|P2|1st-line Treatment|Adverse Event|14
5082866|NCT02119026|17547011|P1|1st-line Treatment|Adverse Event|9
5082867|NCT02118961|17547035|P2|Overall Study|Withdrawal by Subject|0
5082868|NCT02118961|17547036|P1|Overall Study|Withdrawal by Subject|1
5082869|NCT02118896|17547064|P10|Overall Study|Miscellaneous|0
5082870|NCT02118896|17547065|P9|Overall Study|Miscellaneous|0
5082871|NCT02118896|17547066|P8|Overall Study|Miscellaneous|0
5082872|NCT02118896|17547067|P7|Overall Study|Miscellaneous|0
5082873|NCT02118896|17547068|P6|Overall Study|Miscellaneous|4
5082874|NCT02118896|17547069|P5|Overall Study|Miscellaneous|0
5082875|NCT02118896|17547070|P4|Overall Study|Miscellaneous|2
5082876|NCT02118896|17547071|P3|Overall Study|Miscellaneous|0
5082877|NCT02118896|17547072|P2|Overall Study|Miscellaneous|2
5082878|NCT02118896|17547073|P1|Overall Study|Miscellaneous|1
5082879|NCT02118896|17547064|P10|Overall Study|Prohibited medication|0
5082880|NCT02118896|17547065|P9|Overall Study|Prohibited medication|0
5082881|NCT02118896|17547066|P8|Overall Study|Prohibited medication|0
5082882|NCT02118896|17547067|P7|Overall Study|Prohibited medication|0
5082883|NCT02118896|17547068|P6|Overall Study|Prohibited medication|3
5082884|NCT02118896|17547069|P5|Overall Study|Prohibited medication|1
5082885|NCT02118896|17547070|P4|Overall Study|Prohibited medication|0
5082886|NCT02118896|17547071|P3|Overall Study|Prohibited medication|0
5082887|NCT02118896|17547072|P2|Overall Study|Prohibited medication|0
5082888|NCT02118896|17547073|P1|Overall Study|Prohibited medication|0
5082889|NCT02118896|17547064|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
5082890|NCT02118896|17547065|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
5082891|NCT02118896|17547066|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
5082892|NCT02118896|17547067|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
5082893|NCT02118896|17547068|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
5082894|NCT02118896|17547069|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
5082895|NCT02118896|17547070|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
5082896|NCT02118896|17547071|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
5082897|NCT02118896|17547072|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
5082898|NCT02118896|17547073|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
5082899|NCT02118896|17547064|P10|Overall Study|Lost to Follow-up|0
5082900|NCT02118896|17547065|P9|Overall Study|Lost to Follow-up|0
5082901|NCT02118896|17547066|P8|Overall Study|Lost to Follow-up|0
5082902|NCT02118896|17547067|P7|Overall Study|Lost to Follow-up|0
5082903|NCT02118896|17547068|P6|Overall Study|Lost to Follow-up|1
5082904|NCT02118896|17547069|P5|Overall Study|Lost to Follow-up|2
5082905|NCT02118896|17547070|P4|Overall Study|Lost to Follow-up|0
5082906|NCT02118896|17547071|P3|Overall Study|Lost to Follow-up|1
5082907|NCT02118896|17547072|P2|Overall Study|Lost to Follow-up|2
5082908|NCT02118896|17547073|P1|Overall Study|Lost to Follow-up|1
5082909|NCT02118896|17547064|P10|Overall Study|Pregnancy|0
5082910|NCT02118896|17547065|P9|Overall Study|Pregnancy|0
5082911|NCT02118896|17547066|P8|Overall Study|Pregnancy|0
5082912|NCT02118896|17547067|P7|Overall Study|Pregnancy|1
5082913|NCT02118896|17547068|P6|Overall Study|Pregnancy|3
5082914|NCT02118896|17547069|P5|Overall Study|Pregnancy|1
5082915|NCT02118896|17547070|P4|Overall Study|Pregnancy|0
5082916|NCT02118896|17547071|P3|Overall Study|Pregnancy|0
5082917|NCT02118896|17547072|P2|Overall Study|Pregnancy|1
5082918|NCT02118896|17547073|P1|Overall Study|Pregnancy|1
5082919|NCT02118896|17547064|P10|Overall Study|Non-compliance|0
5082920|NCT02118896|17547065|P9|Overall Study|Non-compliance|0
5082921|NCT02118896|17547066|P8|Overall Study|Non-compliance|1
5082922|NCT02118896|17547067|P7|Overall Study|Non-compliance|0
5082923|NCT02118896|17547068|P6|Overall Study|Non-compliance|1
5082924|NCT02118896|17547069|P5|Overall Study|Non-compliance|0
5082925|NCT02118896|17547070|P4|Overall Study|Non-compliance|5
5082926|NCT02118896|17547071|P3|Overall Study|Non-compliance|1
5082927|NCT02118896|17547072|P2|Overall Study|Non-compliance|1
5082928|NCT02118896|17547073|P1|Overall Study|Non-compliance|2
5082929|NCT02118896|17547064|P10|Overall Study|Consent withdrawn|0
5082930|NCT02118896|17547065|P9|Overall Study|Consent withdrawn|0
5082931|NCT02118896|17547066|P8|Overall Study|Consent withdrawn|0
5082932|NCT02118896|17547067|P7|Overall Study|Consent withdrawn|0
5082933|NCT02118896|17547068|P6|Overall Study|Consent withdrawn|4
5082934|NCT02118896|17547069|P5|Overall Study|Consent withdrawn|1
5082935|NCT02118896|17547070|P4|Overall Study|Consent withdrawn|4
5082936|NCT02118896|17547071|P3|Overall Study|Consent withdrawn|3
5082937|NCT02118896|17547072|P2|Overall Study|Consent withdrawn|0
5082938|NCT02118896|17547073|P1|Overall Study|Consent withdrawn|2
5082939|NCT02118896|17547064|P10|Overall Study|Adverse Event|0
5082940|NCT02118896|17547065|P9|Overall Study|Adverse Event|4
5082941|NCT02118896|17547066|P8|Overall Study|Adverse Event|1
5082942|NCT02118896|17547067|P7|Overall Study|Adverse Event|1
5082943|NCT02118896|17547068|P6|Overall Study|Adverse Event|9
5082944|NCT02118896|17547069|P5|Overall Study|Adverse Event|5
5082945|NCT02118896|17547070|P4|Overall Study|Adverse Event|5
5082946|NCT02118896|17547071|P3|Overall Study|Adverse Event|4
5082947|NCT02118896|17547072|P2|Overall Study|Adverse Event|4
5082948|NCT02118896|17547073|P1|Overall Study|Adverse Event|5
5082949|NCT02118896|17547064|P10|Overall Study|Death|0
5082950|NCT02118896|17547065|P9|Overall Study|Death|0
5082951|NCT02118896|17547066|P8|Overall Study|Death|0
5082952|NCT02118896|17547067|P7|Overall Study|Death|0
5082953|NCT02118896|17547068|P6|Overall Study|Death|1
5082954|NCT02118896|17547069|P5|Overall Study|Death|3
5082955|NCT02118896|17547070|P4|Overall Study|Death|6
5082956|NCT02118896|17547071|P3|Overall Study|Death|4
5082957|NCT02118896|17547072|P2|Overall Study|Death|0
5082958|NCT02118896|17547073|P1|Overall Study|Death|4
5082959|NCT02118792|17547163|P2|Overall Study|Randomised but not treated|0
5082960|NCT02118792|17547164|P1|Overall Study|Randomised but not treated|1
5082961|NCT02118792|17547163|P2|Overall Study|Other|6
5082962|NCT02118792|17547164|P1|Overall Study|Other|1
5082963|NCT02118792|17547163|P2|Overall Study|Withdrawal by parent/guardian|20
5082964|NCT02118792|17547164|P1|Overall Study|Withdrawal by parent/guardian|14
5082965|NCT02118792|17547163|P2|Overall Study|Adverse Event|4
5082966|NCT02118792|17547164|P1|Overall Study|Adverse Event|5
5082967|NCT02118792|17547163|P2|Overall Study|Lost to Follow-up|4
5082968|NCT02118792|17547164|P1|Overall Study|Lost to Follow-up|4
5082969|NCT02118792|17547163|P2|Overall Study|Withdrawal by Subject|3
5082970|NCT02118792|17547164|P1|Overall Study|Withdrawal by Subject|6
5082971|NCT02118766|17547206|P2|Overall Study|Other|1
5082972|NCT02118766|17547207|P1|Overall Study|Other|3
5082973|NCT02118766|17547206|P2|Overall Study|Withdrawal by parent/guardian|18
5082974|NCT02118766|17547207|P1|Overall Study|Withdrawal by parent/guardian|12
5082975|NCT02118766|17547206|P2|Overall Study|Lost to Follow-up|4
5082976|NCT02118766|17547207|P1|Overall Study|Lost to Follow-up|5
5082977|NCT02118766|17547206|P2|Overall Study|Withdrawal by Subject|6
5082978|NCT02118766|17547207|P1|Overall Study|Withdrawal by Subject|3
5082979|NCT02118766|17547206|P2|Overall Study|Adverse Event|2
5082980|NCT02118766|17547207|P1|Overall Study|Adverse Event|7
5082981|NCT02118714|17547229|P1|Overall Study|Protocol Violation|1
5082982|NCT02118714|17547229|P1|Overall Study|Lost to Follow-up|2
5082983|NCT02118597|17547254|P1|Overall Study|Investigator's decision|1
5082984|NCT02118597|17547254|P1|Overall Study|Serious Adverse Event|1
5082985|NCT02118597|17547254|P1|Overall Study|Sponsor terminated the study|14
5082986|NCT02118428|17547285|P3|Overall Study|Screen Failure or Became Inelegible|1
5082987|NCT02118428|17547286|P2|Overall Study|Screen Failure or Became Inelegible|0
5082988|NCT02118428|17547287|P1|Overall Study|Screen Failure or Became Inelegible|1
5082989|NCT02118428|17547285|P3|Overall Study|Lost to Follow-up|0
5082990|NCT02118428|17547286|P2|Overall Study|Lost to Follow-up|1
5082991|NCT02118428|17547287|P1|Overall Study|Lost to Follow-up|3
5082992|NCT02118428|17547285|P3|Overall Study|Death|0
5082993|NCT02118428|17547286|P2|Overall Study|Death|5
5082994|NCT02118428|17547287|P1|Overall Study|Death|7
5082995|NCT02118428|17547285|P3|Overall Study|Withdrawal by Subject|0
5082996|NCT02118428|17547286|P2|Overall Study|Withdrawal by Subject|2
5082997|NCT02118428|17547287|P1|Overall Study|Withdrawal by Subject|2
5082998|NCT02118428|17547285|P3|Overall Study|Physician Decision|0
5082999|NCT02118428|17547286|P2|Overall Study|Physician Decision|1
5083000|NCT02118428|17547287|P1|Overall Study|Physician Decision|0
5083001|NCT02118012|17547327|P2|Overall Study|Physician Decision|1
5083002|NCT02118012|17547328|P1|Overall Study|Physician Decision|0
5083003|NCT02118012|17547327|P2|Overall Study|Adverse Event|1
5083004|NCT02118012|17547328|P1|Overall Study|Adverse Event|0
5083005|NCT02117687|17547372|P2|Overall Study|Other Reasons|1
5083006|NCT02117687|17547373|P1|Overall Study|Other Reasons|1
5083007|NCT02117687|17547372|P2|Overall Study|Adverse Event|2
5083008|NCT02117687|17547373|P1|Overall Study|Adverse Event|0
5083009|NCT02117687|17547372|P2|Overall Study|Lost to Follow-up|1
5083010|NCT02117687|17547373|P1|Overall Study|Lost to Follow-up|0
5083011|NCT02117648|17547405|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
5083012|NCT02117648|17547405|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
5083013|NCT02117648|17547405|P1|Abemaciclib Safety-Extension Phase|Death|3
5083014|NCT02117648|17547405|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
5083015|NCT02117648|17547405|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
5083016|NCT02117648|17547405|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
5083017|NCT02117648|17547405|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
5083018|NCT02117648|17547405|P1|Abemaciclib + Clarithromycin Period 2|Death|1
5083019|NCT02117648|17547405|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
5083020|NCT02117648|17547405|P1|Abemaciclib Alone Period 1|Adverse Event|1
5083021|NCT02117648|17547405|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
5083022|NCT02117570|17547418|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
5083023|NCT02117570|17547419|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
5083024|NCT02117570|17547420|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
5083025|NCT02117570|17547418|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
5083026|NCT02117570|17547419|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
5083027|NCT02117570|17547420|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
5083028|NCT02117570|17547418|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
5083029|NCT02117570|17547419|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
5083030|NCT02117570|17547420|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
5083031|NCT02117570|17547418|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
5083032|NCT02117570|17547419|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
5083033|NCT02117570|17547420|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
5083034|NCT02117570|17547418|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
5083035|NCT02117570|17547419|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
5083036|NCT02117570|17547420|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
5083037|NCT02117570|17547418|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
5083038|NCT02117570|17547419|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
5083039|NCT02117570|17547420|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
5083040|NCT02117570|17547418|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
5083041|NCT02117570|17547419|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
5083042|NCT02117570|17547420|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
5083043|NCT02117544|17547470|P2|Period 1|Lost to follow-up (prior to treatment)|0
5083044|NCT02117544|17547471|P1|Period 1|Lost to follow-up (prior to treatment)|2
5083045|NCT02117479|17547486|P2|Overall Study|Other unspecified|7
5083046|NCT02117479|17547487|P1|Overall Study|Other unspecified|11
5083047|NCT02117479|17547486|P2|Overall Study|Physician Decision|2
5083048|NCT02117479|17547487|P1|Overall Study|Physician Decision|7
5083049|NCT02117479|17547486|P2|Overall Study|Study terminated by the sponsor|6
5083050|NCT02117479|17547487|P1|Overall Study|Study terminated by the sponsor|4
5083051|NCT02117479|17547486|P2|Overall Study|Noncompliance with study treatment|0
5083052|NCT02117479|17547487|P1|Overall Study|Noncompliance with study treatment|1
5083053|NCT02117479|17547486|P2|Overall Study|Disease progression|108
5083054|NCT02117479|17547487|P1|Overall Study|Disease progression|104
5083055|NCT02117479|17547486|P2|Overall Study|Subject decision|9
5083056|NCT02117479|17547487|P1|Overall Study|Subject decision|8
5083057|NCT02117479|17547486|P2|Overall Study|Adverse Event|16
5083058|NCT02117479|17547487|P1|Overall Study|Adverse Event|8
5083059|NCT02117479|17547486|P2|Overall Study|Death|8
5083060|NCT02117479|17547487|P1|Overall Study|Death|13
5083061|NCT02117427|17547506|P3|Overall Study|Death|0
5083062|NCT02117427|17547507|P2|Overall Study|Death|1
5083063|NCT02117427|17547508|P1|Overall Study|Death|0
5083064|NCT02117427|17547506|P3|Overall Study|No longer meets inclusion criteria|0
5083065|NCT02117427|17547507|P2|Overall Study|No longer meets inclusion criteria|1
5083066|NCT02117427|17547508|P1|Overall Study|No longer meets inclusion criteria|0
5083067|NCT02117427|17547506|P3|Overall Study|Physician Decision|0
5083068|NCT02117427|17547507|P2|Overall Study|Physician Decision|2
5083069|NCT02117427|17547508|P1|Overall Study|Physician Decision|0
5083070|NCT02117427|17547506|P3|Overall Study|Permanent need for exogenous ESA Tx|0
5083071|NCT02117427|17547507|P2|Overall Study|Permanent need for exogenous ESA Tx|1
5083072|NCT02117427|17547508|P1|Overall Study|Permanent need for exogenous ESA Tx|3
5083073|NCT02117427|17547506|P3|Overall Study|Permanent need for exogenous EPO Tx|0
5083074|NCT02117427|17547507|P2|Overall Study|Permanent need for exogenous EPO Tx|0
5083075|NCT02117427|17547508|P1|Overall Study|Permanent need for exogenous EPO Tx|2
5083076|NCT02117414|17547518|P2|Overall Study|Withdrawal by Subject|4
5083077|NCT02117414|17547519|P1|Overall Study|Withdrawal by Subject|10
5083078|NCT02117414|17547518|P2|Overall Study|Death|2
5083079|NCT02117414|17547519|P1|Overall Study|Death|5
5083080|NCT02117349|17547539|P2|Overall Study|Death|0
5083081|NCT02117349|17547540|P1|Overall Study|Death|1
5083082|NCT02117349|17547539|P2|Overall Study|Lost to Follow-up|1
5083083|NCT02117349|17547540|P1|Overall Study|Lost to Follow-up|1
5083084|NCT02117349|17547539|P2|Overall Study|Withdrawal by Subject|0
5083085|NCT02117349|17547540|P1|Overall Study|Withdrawal by Subject|1
5083086|NCT02117050|17547576|P1|Overall Study|Subject Enrolled but not Dosed|1
5083087|NCT02117024|17547590|P2|Overall Study|Physician Decision|2
5083088|NCT02117024|17547591|P1|Overall Study|Physician Decision|0
5083089|NCT02117024|17547590|P2|Overall Study|Patient took treatment break|1
5083090|NCT02117024|17547591|P1|Overall Study|Patient took treatment break|0
5083091|NCT02117024|17547590|P2|Overall Study|Patient returned to primary oncologist|1
5083092|NCT02117024|17547591|P1|Overall Study|Patient returned to primary oncologist|0
5083093|NCT02117024|17547590|P2|Overall Study|Randomized in Error|0
5083094|NCT02117024|17547591|P1|Overall Study|Randomized in Error|1
5083095|NCT02117024|17547590|P2|Overall Study|Adverse Event|2
5083096|NCT02117024|17547591|P1|Overall Study|Adverse Event|1
5083097|NCT02117024|17547590|P2|Overall Study|Protocol Violation|0
5083098|NCT02117024|17547591|P1|Overall Study|Protocol Violation|1
5083099|NCT02117024|17547590|P2|Overall Study|Withdrawal by Subject|1
5083100|NCT02117024|17547591|P1|Overall Study|Withdrawal by Subject|3
5083101|NCT02117024|17547590|P2|Overall Study|Death|0
5083102|NCT02117024|17547591|P1|Overall Study|Death|5
5083103|NCT02117024|17547590|P2|Overall Study|Significant Clinical Progression|4
5083104|NCT02117024|17547591|P1|Overall Study|Significant Clinical Progression|7
5083105|NCT02117024|17547590|P2|Overall Study|Progressive Disease|9
5083106|NCT02117024|17547591|P1|Overall Study|Progressive Disease|26
5083107|NCT02116972|17547618|P3|Overall Study|scheduling conflicts and relocation|6
5083108|NCT02116972|17547619|P2|Overall Study|scheduling conflicts and relocation|3
5083109|NCT02116972|17547620|P1|Overall Study|scheduling conflicts and relocation|3
5083110|NCT02116972|17547618|P3|Overall Study|Lack of Efficacy|5
5083111|NCT02116972|17547619|P2|Overall Study|Lack of Efficacy|6
5083112|NCT02116972|17547620|P1|Overall Study|Lack of Efficacy|6
5083113|NCT02116972|17547618|P3|Overall Study|Lost to Follow-up|1
5083114|NCT02116972|17547619|P2|Overall Study|Lost to Follow-up|3
5083115|NCT02116972|17547620|P1|Overall Study|Lost to Follow-up|4
5083116|NCT02116972|17547618|P3|Overall Study|Protocol Violation|1
5083117|NCT02116972|17547619|P2|Overall Study|Protocol Violation|0
5083118|NCT02116972|17547620|P1|Overall Study|Protocol Violation|1
5083119|NCT02116972|17547618|P3|Overall Study|Withdrawal by Subject|5
5083120|NCT02116972|17547619|P2|Overall Study|Withdrawal by Subject|1
5083121|NCT02116972|17547620|P1|Overall Study|Withdrawal by Subject|1
5083122|NCT02116972|17547618|P3|Overall Study|Adverse Event|1
5083123|NCT02116972|17547619|P2|Overall Study|Adverse Event|4
5083124|NCT02116972|17547620|P1|Overall Study|Adverse Event|4
5083125|NCT02116803|17547652|P2|Overall Study|Death|0
5083126|NCT02116803|17547653|P1|Overall Study|Death|1
5083127|NCT02116803|17547652|P2|Overall Study|Study terminated by sponsor|1
5083128|NCT02116803|17547653|P1|Overall Study|Study terminated by sponsor|2
5083129|NCT02116803|17547652|P2|Overall Study|Progressive disease|0
5083130|NCT02116803|17547653|P1|Overall Study|Progressive disease|4
5083131|NCT02116803|17547652|P2|Overall Study|Physician Decision|0
5083132|NCT02116803|17547653|P1|Overall Study|Physician Decision|1
5083133|NCT02116803|17547652|P2|Overall Study|Adverse Event|1
5083134|NCT02116803|17547653|P1|Overall Study|Adverse Event|2
5083135|NCT02116660|17547661|P2|Overall Study|Organization reason|0
5083136|NCT02116660|17547662|P1|Overall Study|Organization reason|1
5083137|NCT02116660|17547661|P2|Overall Study|Withdrawal by Subject|2
5083138|NCT02116660|17547662|P1|Overall Study|Withdrawal by Subject|0
5083139|NCT02116660|17547661|P2|Overall Study|Adverse Event|1
5083140|NCT02116660|17547662|P1|Overall Study|Adverse Event|1
5083141|NCT02116660|17547661|P2|Overall Study|Deteriorating renal function|1
5083142|NCT02116660|17547662|P1|Overall Study|Deteriorating renal function|0
5083143|NCT02116621|17547706|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
5083144|NCT02116621|17547707|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
5083145|NCT02116621|17547706|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
5083146|NCT02116621|17547707|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
5083147|NCT02116621|17547706|P2|Twelve Month Follow-up|Lost to Follow-up|1
5083148|NCT02116621|17547707|P1|Twelve Month Follow-up|Lost to Follow-up|0
5083149|NCT02116621|17547706|P2|Twelve Month Follow-up|Withdrawal by Subject|0
5083150|NCT02116621|17547707|P1|Twelve Month Follow-up|Withdrawal by Subject|1
5083151|NCT02116621|17547706|P2|Six Month Follow-up|Did not complete follow-up survey|1
5083152|NCT02116621|17547707|P1|Six Month Follow-up|Did not complete follow-up survey|1
5083153|NCT02116621|17547706|P2|Six Month Follow-up|Lost to Follow-up|1
5083154|NCT02116621|17547707|P1|Six Month Follow-up|Lost to Follow-up|2
5083155|NCT02116621|17547706|P2|Six Month Follow-up|Withdrawal by Subject|1
5083156|NCT02116621|17547707|P1|Six Month Follow-up|Withdrawal by Subject|1
5083157|NCT02116621|17547706|P2|Three Month Follow-up|Did not complete follow-up survey|4
5083158|NCT02116621|17547707|P1|Three Month Follow-up|Did not complete follow-up survey|14
5083159|NCT02116621|17547706|P2|Three Month Follow-up|Lost to Follow-up|1
5083160|NCT02116621|17547707|P1|Three Month Follow-up|Lost to Follow-up|0
5083161|NCT02116621|17547706|P2|Three Month Follow-up|Withdrawal by Subject|1
5083162|NCT02116621|17547707|P1|Three Month Follow-up|Withdrawal by Subject|4
5083163|NCT02116621|17547706|P2|Three Month Follow-up|Death|1
5083164|NCT02116621|17547707|P1|Three Month Follow-up|Death|1
5083165|NCT02116621|17547706|P2|Baseline|Withdrawal by Subject|4
5083166|NCT02116621|17547707|P1|Baseline|Withdrawal by Subject|0
5083167|NCT02116582|17547795|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
5083168|NCT02116582|17547795|P1|Overall Study|Lost to Follow-up|1
5083169|NCT02116582|17547795|P1|Overall Study|Other: Miscellaneous|11
5083170|NCT02116582|17547795|P1|Overall Study|Withdrawal by Subject|8
5083171|NCT02116582|17547795|P1|Overall Study|Protocol Violation|3
5083172|NCT02116582|17547795|P1|Overall Study|Progressive Disease|148
5083173|NCT02116582|17547795|P1|Overall Study|Death|9
5083174|NCT02116582|17547795|P1|Overall Study|Adverse Event|22
5083175|NCT02116582|17547795|P1|Overall Study|Enrolled but Never Received Study Drug|1
5083176|NCT02116530|17547805|P2|Overall Study|Other Medical Problems|2
5083177|NCT02116530|17547806|P1|Overall Study|Other Medical Problems|2
5083178|NCT02116530|17547805|P2|Overall Study|Lost to Follow-up|0
5083179|NCT02116530|17547806|P1|Overall Study|Lost to Follow-up|1
5083180|NCT02116530|17547805|P2|Overall Study|Physician Decision|0
5083181|NCT02116530|17547806|P1|Overall Study|Physician Decision|1
5083182|NCT02116530|17547805|P2|Overall Study|Adverse Event|0
5083183|NCT02116530|17547806|P1|Overall Study|Adverse Event|4
5083184|NCT02116530|17547805|P2|Overall Study|Withdrawal by Subject|2
5083185|NCT02116530|17547806|P1|Overall Study|Withdrawal by Subject|1
5083186|NCT02116361|17547824|P4|Overall Study|Investigator Decision - Relapse|5
5083187|NCT02116361|17547825|P3|Overall Study|Investigator Decision - Relapse|8
5083188|NCT02116361|17547826|P2|Overall Study|Investigator Decision - Relapse|7
5083189|NCT02116361|17547827|P1|Overall Study|Investigator Decision - Relapse|9
5083190|NCT02116361|17547824|P4|Overall Study|Personal Reasons|9
5083191|NCT02116361|17547825|P3|Overall Study|Personal Reasons|4
5083192|NCT02116361|17547826|P2|Overall Study|Personal Reasons|6
5083193|NCT02116361|17547827|P1|Overall Study|Personal Reasons|6
5083194|NCT02116361|17547824|P4|Overall Study|Lost to Follow-up|5
5083195|NCT02116361|17547825|P3|Overall Study|Lost to Follow-up|7
5083196|NCT02116361|17547826|P2|Overall Study|Lost to Follow-up|5
5083197|NCT02116361|17547827|P1|Overall Study|Lost to Follow-up|4
5083198|NCT02116361|17547824|P4|Overall Study|Lack of Efficacy|3
5083199|NCT02116361|17547825|P3|Overall Study|Lack of Efficacy|4
5083200|NCT02116361|17547826|P2|Overall Study|Lack of Efficacy|7
5083201|NCT02116361|17547827|P1|Overall Study|Lack of Efficacy|5
5083202|NCT02116361|17547824|P4|Overall Study|Other Reasons|3
5083203|NCT02116361|17547825|P3|Overall Study|Other Reasons|3
5083204|NCT02116361|17547826|P2|Overall Study|Other Reasons|3
5083205|NCT02116361|17547827|P1|Overall Study|Other Reasons|3
5083206|NCT02116361|17547824|P4|Overall Study|Adverse Event|3
5083207|NCT02116361|17547825|P3|Overall Study|Adverse Event|0
5083208|NCT02116361|17547826|P2|Overall Study|Adverse Event|0
5083209|NCT02116361|17547827|P1|Overall Study|Adverse Event|1
5083210|NCT02116361|17547824|P4|Overall Study|Physician Decision|0
5083211|NCT02116361|17547825|P3|Overall Study|Physician Decision|0
5083212|NCT02116361|17547826|P2|Overall Study|Physician Decision|3
5083213|NCT02116361|17547827|P1|Overall Study|Physician Decision|2
5083214|NCT02116361|17547824|P4|Overall Study|Protocol Violation|2
5083215|NCT02116361|17547825|P3|Overall Study|Protocol Violation|0
5083216|NCT02116361|17547826|P2|Overall Study|Protocol Violation|0
5083217|NCT02116361|17547827|P1|Overall Study|Protocol Violation|1
5083218|NCT02116361|17547824|P4|Overall Study|Pregnancy|1
5083219|NCT02116361|17547825|P3|Overall Study|Pregnancy|0
5083220|NCT02116361|17547826|P2|Overall Study|Pregnancy|0
5083221|NCT02116361|17547827|P1|Overall Study|Pregnancy|0
5083222|NCT02116309|17547864|P2|Overall Study|Lost to Follow-up|1
5083223|NCT02116309|17547865|P1|Overall Study|Lost to Follow-up|0
5083224|NCT02115815|17547897|P7|Overall Study|Missed appointment, randomized in error|0
5083225|NCT02115815|17547898|P6|Overall Study|Missed appointment, randomized in error|1
5083226|NCT02115815|17547899|P5|Overall Study|Missed appointment, randomized in error|0
5083227|NCT02115815|17547900|P4|Overall Study|Missed appointment, randomized in error|0
5083228|NCT02115815|17547901|P3|Overall Study|Missed appointment, randomized in error|0
5083229|NCT02115815|17547902|P2|Overall Study|Missed appointment, randomized in error|0
5083230|NCT02115815|17547903|P1|Overall Study|Missed appointment, randomized in error|0
5083231|NCT02115815|17547897|P7|Overall Study|Not enough drug to dose participant|0
5083232|NCT02115815|17547898|P6|Overall Study|Not enough drug to dose participant|1
5083233|NCT02115815|17547899|P5|Overall Study|Not enough drug to dose participant|0
5083234|NCT02115815|17547900|P4|Overall Study|Not enough drug to dose participant|0
5083235|NCT02115815|17547901|P3|Overall Study|Not enough drug to dose participant|0
5083236|NCT02115815|17547902|P2|Overall Study|Not enough drug to dose participant|0
5083237|NCT02115815|17547903|P1|Overall Study|Not enough drug to dose participant|0
5083238|NCT02115815|17547897|P7|Overall Study|Withdrawal by Subject|0
5083239|NCT02115815|17547898|P6|Overall Study|Withdrawal by Subject|0
5083240|NCT02115815|17547899|P5|Overall Study|Withdrawal by Subject|0
5083241|NCT02115815|17547900|P4|Overall Study|Withdrawal by Subject|0
5083242|NCT02115815|17547901|P3|Overall Study|Withdrawal by Subject|0
5083243|NCT02115815|17547902|P2|Overall Study|Withdrawal by Subject|0
5083244|NCT02115815|17547903|P1|Overall Study|Withdrawal by Subject|2
5083245|NCT02115607|17548045|P1|Overall Study|Withdrawal by Subject|1
5083246|NCT02115386|17548071|P1|Overall Study|Administrative - trial was terminated|6
5083247|NCT02115386|17548071|P1|Overall Study|Protocol Violation|1
5083248|NCT02115321|17548174|P2|Overall Study|Death|0
5083249|NCT02115321|17548175|P1|Overall Study|Death|1
5083250|NCT02115308|17548197|P2|Overall Study|Safety Screening|2
5083251|NCT02115308|17548198|P1|Overall Study|Safety Screening|2
5083252|NCT02115269|17548214|P1|Overall Study|Didn't take study drug|2
5083253|NCT02115269|17548214|P1|Overall Study|Withdrawal by Subject|2
5083254|NCT02115269|17548214|P1|Overall Study|Moved to another city|7
5083255|NCT02115269|17548214|P1|Overall Study|Did not complete patient diary|3
5083256|NCT02115269|17548214|P1|Overall Study|Lost to Follow-up|43
5083257|NCT02115256|17548234|P2|Overall Study|Withdrawal by Subject|1
5083258|NCT02115256|17548235|P1|Overall Study|Withdrawal by Subject|0
5083259|NCT02115113|17548247|P3|Participants Randomized|Death|0
5083260|NCT02115113|17548248|P2|Participants Randomized|Death|0
5083261|NCT02115113|17548249|P1|Participants Randomized|Death|1
5083262|NCT02115113|17548247|P3|Participants Randomized|Lost to Follow-up|0
5083263|NCT02115113|17548248|P2|Participants Randomized|Lost to Follow-up|0
5083264|NCT02115113|17548249|P1|Participants Randomized|Lost to Follow-up|1
5083265|NCT02115113|17548247|P3|Participants in Run-in Period|Withdrawal by Subject|3
5083266|NCT02115113|17548248|P2|Participants in Run-in Period|Withdrawal by Subject|0
5083267|NCT02115113|17548249|P1|Participants in Run-in Period|Withdrawal by Subject|0
5083268|NCT02115113|17548247|P3|Participants in Run-in Period|Lost to Follow-up|5
5083269|NCT02115113|17548248|P2|Participants in Run-in Period|Lost to Follow-up|0
5083270|NCT02115113|17548249|P1|Participants in Run-in Period|Lost to Follow-up|0
5083271|NCT02115113|17548247|P3|Participants in Run-in Period|Administrative problems|1
5083272|NCT02115113|17548248|P2|Participants in Run-in Period|Administrative problems|0
5083273|NCT02115113|17548249|P1|Participants in Run-in Period|Administrative problems|0
5083274|NCT02115113|17548247|P3|Participants in Run-in Period|Death|1
5083275|NCT02115113|17548248|P2|Participants in Run-in Period|Death|0
5083276|NCT02115113|17548249|P1|Participants in Run-in Period|Death|0
5083277|NCT02114931|17548281|P2|Overall Study|Other|1
5083278|NCT02114931|17548282|P1|Overall Study|Other|2
5083279|NCT02114931|17548281|P2|Overall Study|Physician Decision|2
5083280|NCT02114931|17548282|P1|Overall Study|Physician Decision|1
5083281|NCT02114931|17548281|P2|Overall Study|Lost to Follow-up|3
5083282|NCT02114931|17548282|P1|Overall Study|Lost to Follow-up|3
5083283|NCT02114931|17548281|P2|Overall Study|Adverse Event|6
5083284|NCT02114931|17548282|P1|Overall Study|Adverse Event|4
5083285|NCT02114931|17548281|P2|Overall Study|Withdrawal by Subject|18
5083286|NCT02114931|17548282|P1|Overall Study|Withdrawal by Subject|15
5083287|NCT02114892|17548298|P2|Overall Study|Lost to Follow-up|2
5083288|NCT02114892|17548299|P1|Overall Study|Lost to Follow-up|1
5083289|NCT02114879|17548335|P2|Overall Study|Physician Decision|2
5083290|NCT02114879|17548336|P1|Overall Study|Physician Decision|0
5083291|NCT02114879|17548335|P2|Overall Study|Lost to Follow-up|6
5083292|NCT02114879|17548336|P1|Overall Study|Lost to Follow-up|4
5083293|NCT02114879|17548335|P2|Overall Study|Death|11
5083294|NCT02114879|17548336|P1|Overall Study|Death|6
5083295|NCT02114879|17548335|P2|Overall Study|Withdrawal by Subject|5
5083296|NCT02114879|17548336|P1|Overall Study|Withdrawal by Subject|9
5083297|NCT02114697|17548354|P2|Overall Study|Study terminated|4
5083298|NCT02114697|17548355|P1|Overall Study|Study terminated|5
5083299|NCT02114684|17548363|P2|Overall Study|Patient Incarcerated|0
5083300|NCT02114684|17548364|P1|Overall Study|Patient Incarcerated|1
5083301|NCT02114684|17548363|P2|Overall Study|Rifampicin resistant on culture|1
5083302|NCT02114684|17548364|P1|Overall Study|Rifampicin resistant on culture|0
5083303|NCT02114684|17548363|P2|Overall Study|Relocation|1
5083304|NCT02114684|17548364|P1|Overall Study|Relocation|3
5083305|NCT02114684|17548363|P2|Overall Study|Withdrawal by Subject|2
5083306|NCT02114684|17548364|P1|Overall Study|Withdrawal by Subject|1
5083307|NCT02114684|17548363|P2|Overall Study|Lost to Follow-up|2
5083308|NCT02114684|17548364|P1|Overall Study|Lost to Follow-up|1
5083309|NCT02114684|17548363|P2|Overall Study|Death|4
5083310|NCT02114684|17548364|P1|Overall Study|Death|6
5083311|NCT02114515|17548382|P2|Overall Study|Other|61
5083312|NCT02114515|17548383|P1|Overall Study|Other|65
5083313|NCT02114515|17548382|P2|Overall Study|Withdrawal by Subject|22
5083314|NCT02114515|17548383|P1|Overall Study|Withdrawal by Subject|4
5083315|NCT02114515|17548382|P2|Overall Study|Death|12
5083316|NCT02114515|17548383|P1|Overall Study|Death|12
5083317|NCT02114515|17548382|P2|Overall Study|Lost to Follow-up|55
5083318|NCT02114515|17548383|P1|Overall Study|Lost to Follow-up|52
5083319|NCT02114385|17548429|P2|Overall Study|Lost to Follow-up|6
5083320|NCT02114385|17548430|P1|Overall Study|Lost to Follow-up|0
5083321|NCT02114385|17548429|P2|Overall Study|Withdrawal by Subject|2
5083322|NCT02114385|17548430|P1|Overall Study|Withdrawal by Subject|3
5083323|NCT02114268|17548471|P6|Overall Study|Withdrawn by site due to noncompliance|0
5083324|NCT02114268|17548472|P5|Overall Study|Withdrawn by site due to noncompliance|0
5083325|NCT02114268|17548473|P4|Overall Study|Withdrawn by site due to noncompliance|0
5083326|NCT02114268|17548474|P3|Overall Study|Withdrawn by site due to noncompliance|0
5083327|NCT02114268|17548475|P2|Overall Study|Withdrawn by site due to noncompliance|0
5083328|NCT02114268|17548476|P1|Overall Study|Withdrawn by site due to noncompliance|1
5083329|NCT02114268|17548471|P6|Overall Study|Withdrawal by Subject|1
5083330|NCT02114268|17548472|P5|Overall Study|Withdrawal by Subject|0
5083331|NCT02114268|17548473|P4|Overall Study|Withdrawal by Subject|0
5083332|NCT02114268|17548474|P3|Overall Study|Withdrawal by Subject|0
5083333|NCT02114268|17548475|P2|Overall Study|Withdrawal by Subject|0
5083334|NCT02114268|17548476|P1|Overall Study|Withdrawal by Subject|1
5083335|NCT02114268|17548471|P6|Overall Study|Lost to Follow-up|2
5083336|NCT02114268|17548472|P5|Overall Study|Lost to Follow-up|0
5083337|NCT02114268|17548473|P4|Overall Study|Lost to Follow-up|0
5083338|NCT02114268|17548474|P3|Overall Study|Lost to Follow-up|1
5083339|NCT02114268|17548475|P2|Overall Study|Lost to Follow-up|1
5083340|NCT02114268|17548476|P1|Overall Study|Lost to Follow-up|4
5083341|NCT02114203|17548545|P3|Overall Study|Withdrawal by Subject|0
5083342|NCT02114203|17548546|P2|Overall Study|Withdrawal by Subject|1
5083343|NCT02114203|17548547|P1|Overall Study|Withdrawal by Subject|0
5083344|NCT02114203|17548545|P3|Overall Study|Adverse Event|0
5083345|NCT02114203|17548546|P2|Overall Study|Adverse Event|1
5083346|NCT02114203|17548547|P1|Overall Study|Adverse Event|0
5083347|NCT02114177|17548581|P2|Overall Study|Other|1
5083348|NCT02114177|17548582|P1|Overall Study|Other|2
5083349|NCT02114177|17548581|P2|Overall Study|Withdrawal by Subject|1
5083350|NCT02114177|17548582|P1|Overall Study|Withdrawal by Subject|6
5083351|NCT02114177|17548581|P2|Overall Study|Lost to Follow-up|2
5083352|NCT02114177|17548582|P1|Overall Study|Lost to Follow-up|1
5083353|NCT02114151|17548606|P1|Overall Study|Withdrawal by Subject|5
5083354|NCT02114151|17548606|P1|Overall Study|Lost to Follow-up|1
5083355|NCT02114151|17548606|P1|Overall Study|Death|1
5083356|NCT02113956|17548623|P2|3 Month Post-intervention|Lost to Follow-up|2
5083357|NCT02113956|17548624|P1|3 Month Post-intervention|Lost to Follow-up|4
5083358|NCT02113956|17548623|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
5083359|NCT02113956|17548624|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
5083360|NCT02113956|17548623|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
5083361|NCT02113956|17548624|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
5083362|NCT02113579|17548658|P2|Overall Study|Lost to Follow-up|2
5083363|NCT02113579|17548659|P1|Overall Study|Lost to Follow-up|6
5083364|NCT02113579|17548658|P2|Overall Study|Withdrawal by Subject|2
5083365|NCT02113579|17548659|P1|Overall Study|Withdrawal by Subject|3
5083366|NCT02113579|17548658|P2|Overall Study|Adverse Event|0
5083367|NCT02113579|17548659|P1|Overall Study|Adverse Event|1
5083368|NCT02113449|17548683|P1|Overall Study|Adverse Event|4
5083369|NCT02113436|17548699|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
5083370|NCT02113436|17548700|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
5083371|NCT02113436|17548701|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
5083372|NCT02113436|17548702|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
5083373|NCT02113436|17548699|P4|Period 2: 16 Weeks|Physician Decision|0
5083374|NCT02113436|17548700|P3|Period 2: 16 Weeks|Physician Decision|2
5083375|NCT02113436|17548701|P2|Period 2: 16 Weeks|Physician Decision|0
5083376|NCT02113436|17548702|P1|Period 2: 16 Weeks|Physician Decision|0
5083377|NCT02113436|17548699|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
5083378|NCT02113436|17548700|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
5083379|NCT02113436|17548701|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
5083380|NCT02113436|17548702|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
5083381|NCT02113436|17548699|P4|Period 2: 16 Weeks|Adverse Event|5
5083382|NCT02113436|17548700|P3|Period 2: 16 Weeks|Adverse Event|4
5083383|NCT02113436|17548701|P2|Period 2: 16 Weeks|Adverse Event|0
5083384|NCT02113436|17548702|P1|Period 2: 16 Weeks|Adverse Event|0
5083385|NCT02113436|17548699|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
5083386|NCT02113436|17548700|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
5083387|NCT02113436|17548701|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
5083388|NCT02113436|17548702|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
5083389|NCT02113436|17548699|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
5083390|NCT02113436|17548700|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
5083391|NCT02113436|17548701|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
5083392|NCT02113436|17548702|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
5083393|NCT02113436|17548699|P4|Period 1: 8 Weeks|Protocol Violation|0
5083394|NCT02113436|17548700|P3|Period 1: 8 Weeks|Protocol Violation|0
5083395|NCT02113436|17548701|P2|Period 1: 8 Weeks|Protocol Violation|0
5083396|NCT02113436|17548702|P1|Period 1: 8 Weeks|Protocol Violation|1
5083397|NCT02113436|17548699|P4|Period 1: 8 Weeks|Adverse Event|0
5083398|NCT02113436|17548700|P3|Period 1: 8 Weeks|Adverse Event|0
5083399|NCT02113436|17548701|P2|Period 1: 8 Weeks|Adverse Event|0
5083400|NCT02113436|17548702|P1|Period 1: 8 Weeks|Adverse Event|1
5083401|NCT02113189|17548808|P3|Overall Study|Lost to follow up|3
5083402|NCT02113189|17548809|P2|Overall Study|Lost to follow up|1
5083403|NCT02113189|17548810|P1|Overall Study|Lost to follow up|2
5083404|NCT02113124|17548826|P2|Overall Study|Unable to retrieve blood sample|1
5083405|NCT02113124|17548827|P1|Overall Study|Unable to retrieve blood sample|1
5083406|NCT02113007|17548833|P1|Overall Study|Progressive disease|2
5083407|NCT02112994|17548839|P3|Overall Study|Withdrawal by Subject|1
5083408|NCT02112994|17548840|P2|Overall Study|Withdrawal by Subject|0
5083409|NCT02112994|17548841|P1|Overall Study|Withdrawal by Subject|0
5083410|NCT02112994|17548839|P3|Overall Study|Liver Transplant|0
5083411|NCT02112994|17548840|P2|Overall Study|Liver Transplant|1
5083412|NCT02112994|17548841|P1|Overall Study|Liver Transplant|0
5083413|NCT02112994|17548839|P3|Overall Study|Pregnancy|1
5083414|NCT02112994|17548840|P2|Overall Study|Pregnancy|1
5083415|NCT02112994|17548841|P1|Overall Study|Pregnancy|0
5083416|NCT02112994|17548839|P3|Overall Study|Progressive Disease|1
5083417|NCT02112994|17548840|P2|Overall Study|Progressive Disease|0
5083418|NCT02112994|17548841|P1|Overall Study|Progressive Disease|0
5083419|NCT02112877|17548859|P2|Overall Study|Visit Missed|6
5083420|NCT02112877|17548860|P1|Overall Study|Visit Missed|1
5083421|NCT02112877|17548859|P2|Overall Study|Withdrawal by Subject|7
5083422|NCT02112877|17548860|P1|Overall Study|Withdrawal by Subject|1
5083423|NCT02112448|17548948|P2|Overall Study|required heparin so could not use ketoro|0
5083424|NCT02112448|17548949|P1|Overall Study|required heparin so could not use ketoro|1
5083425|NCT02112448|17548948|P2|Overall Study|Physician Decision|6
5083426|NCT02112448|17548949|P1|Overall Study|Physician Decision|4
5083427|NCT02112448|17548948|P2|Overall Study|Protocol Violation|2
5083428|NCT02112448|17548949|P1|Overall Study|Protocol Violation|1
5083429|NCT02112448|17548948|P2|Overall Study|lab values precluding use of ketorolac|2
5083430|NCT02112448|17548949|P1|Overall Study|lab values precluding use of ketorolac|2
5083431|NCT02112045|17548982|P2|Overall Study|Withdrawal by Subject|0
5083432|NCT02112045|17548983|P1|Overall Study|Withdrawal by Subject|1
5083433|NCT02111993|17549003|P2|Overall Study|Physician Decision|4
5083434|NCT02111993|17549004|P1|Overall Study|Physician Decision|5
5083435|NCT02111811|17549045|P2|Follow up Period (Aim 2)|Death|0
5083436|NCT02111811|17549046|P1|Follow up Period (Aim 2)|Death|2
5083437|NCT02111811|17549045|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
5083438|NCT02111811|17549046|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
5083439|NCT02111811|17549045|P2|Treatment Phase|Death|0
5083440|NCT02111811|17549046|P1|Treatment Phase|Death|2
5083441|NCT02111811|17549045|P2|Treatment Phase|Lost to Follow-up|18
5083442|NCT02111811|17549046|P1|Treatment Phase|Lost to Follow-up|22
5083443|NCT02111785|17549059|P4|Overall Study|Death|0
5083444|NCT02111785|17549060|P3|Overall Study|Death|0
5083445|NCT02111785|17549061|P2|Overall Study|Death|1
5083446|NCT02111785|17549062|P1|Overall Study|Death|0
5083447|NCT02111603|17549124|P1|Overall Study|Withdrawal by Subject|1
5083448|NCT02111564|17549135|P2|Overall Study|Withdrawal by Subject|20
5083449|NCT02111564|17549136|P1|Overall Study|Withdrawal by Subject|20
5083450|NCT02111564|17549135|P2|Overall Study|Lost to Follow-up|3
5083451|NCT02111564|17549136|P1|Overall Study|Lost to Follow-up|2
5083452|NCT02111564|17549135|P2|Overall Study|Death|120
5083453|NCT02111564|17549136|P1|Overall Study|Death|109
5083454|NCT02111369|17549175|P1|Overall Study|Withdrawal by Subject|1
5083455|NCT02111369|17549175|P1|Overall Study|Lost to Follow-up|2
5083456|NCT02111213|17549199|P2|Overall Study|Lost to Follow-up|4
5083457|NCT02111213|17549200|P1|Overall Study|Lost to Follow-up|3
5083458|NCT02111213|17549199|P2|Overall Study|Withdrawal by Subject|2
5083459|NCT02111213|17549200|P1|Overall Study|Withdrawal by Subject|3
5083460|NCT02111174|17549248|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
5083461|NCT02111174|17549249|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
5083462|NCT02111174|17549248|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
5083463|NCT02111174|17549249|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
5083464|NCT02111174|17549248|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
5083465|NCT02111174|17549249|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
5083466|NCT02111174|17549248|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
5083467|NCT02111174|17549249|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
5083468|NCT02111096|17549278|P3|Overall Study|Withdrawal by Subject|8
5083469|NCT02111096|17549279|P2|Overall Study|Withdrawal by Subject|2
5083470|NCT02111096|17549280|P1|Overall Study|Withdrawal by Subject|4
5083471|NCT02111096|17549278|P3|Overall Study|Terminated by Sponsor|54
5083472|NCT02111096|17549279|P2|Overall Study|Terminated by Sponsor|35
5083473|NCT02111096|17549280|P1|Overall Study|Terminated by Sponsor|53
5083474|NCT02111096|17549278|P3|Overall Study|Protocol Violation|1
5083475|NCT02111096|17549279|P2|Overall Study|Protocol Violation|0
5083476|NCT02111096|17549280|P1|Overall Study|Protocol Violation|1
5083477|NCT02111096|17549278|P3|Overall Study|Physician Decision|0
5083478|NCT02111096|17549279|P2|Overall Study|Physician Decision|1
5083479|NCT02111096|17549280|P1|Overall Study|Physician Decision|0
5083480|NCT02111096|17549278|P3|Overall Study|Lost to Follow Up|1
5083481|NCT02111096|17549279|P2|Overall Study|Lost to Follow Up|1
5083482|NCT02111096|17549280|P1|Overall Study|Lost to Follow Up|1
5083483|NCT02111096|17549278|P3|Overall Study|Non-Compliance with Study Drug|0
5083484|NCT02111096|17549279|P2|Overall Study|Non-Compliance with Study Drug|1
5083485|NCT02111096|17549280|P1|Overall Study|Non-Compliance with Study Drug|1
5083486|NCT02111096|17549278|P3|Overall Study|Adverse Event|2
5083487|NCT02111096|17549279|P2|Overall Study|Adverse Event|1
5083488|NCT02111096|17549280|P1|Overall Study|Adverse Event|4
5083489|NCT02111083|17549328|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
5083490|NCT02111083|17549329|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
5083491|NCT02110901|17549349|P2|Overall Study|received a kidney transplant|0
5083492|NCT02110901|17549350|P1|Overall Study|received a kidney transplant|5
5083493|NCT02110901|17549349|P2|Overall Study|Withdrawal by Subject|3
5083494|NCT02110901|17549350|P1|Overall Study|Withdrawal by Subject|7
5083495|NCT02110901|17549349|P2|Overall Study|Lost to Follow-up|8
5083496|NCT02110901|17549350|P1|Overall Study|Lost to Follow-up|12
5083497|NCT02110901|17549349|P2|Overall Study|Death|3
5083498|NCT02110901|17549350|P1|Overall Study|Death|6
5083499|NCT02110706|17549364|P2|Overall Study|Patients who didn't receive 2nd infusion|1
5083500|NCT02110706|17549365|P1|Overall Study|Patients who didn't receive 2nd infusion|3
5083501|NCT02110706|17549364|P2|Overall Study|Adverse Event|3
5083502|NCT02110706|17549365|P1|Overall Study|Adverse Event|2
5083503|NCT02110693|17549377|P2|Overall Study|Other|0
5083504|NCT02110693|17549378|P1|Overall Study|Other|1
5083505|NCT02110693|17549377|P2|Overall Study|technical difficulties|4
5083506|NCT02110693|17549378|P1|Overall Study|technical difficulties|6
5083507|NCT02110693|17549377|P2|Overall Study|skipped assessment|18
5083508|NCT02110693|17549378|P1|Overall Study|skipped assessment|15
5083509|NCT02110693|17549377|P2|Overall Study|Withdrawal by Subject|7
5083510|NCT02110693|17549378|P1|Overall Study|Withdrawal by Subject|6
5083511|NCT02110238|17549459|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
5083512|NCT02110238|17549460|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
5083513|NCT02110238|17549459|P2|14 Week Blinded Extension Phase|Protocol Violation|3
5083514|NCT02110238|17549460|P1|14 Week Blinded Extension Phase|Protocol Violation|2
5083515|NCT02110238|17549459|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
5083516|NCT02110238|17549460|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
5083517|NCT02110238|17549459|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
5083518|NCT02110238|17549460|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
5083519|NCT02110238|17549459|P2|14 Week Blinded Extension Phase|Adverse Event|1
5083520|NCT02110238|17549460|P1|14 Week Blinded Extension Phase|Adverse Event|1
5083521|NCT02110238|17549459|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
5083522|NCT02110238|17549460|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
5083523|NCT02110238|17549459|P2|12 Week Pivotal Phase|Protocol Violation|1
5083524|NCT02110238|17549460|P1|12 Week Pivotal Phase|Protocol Violation|0
5083525|NCT02110238|17549459|P2|12 Week Pivotal Phase|Physician Decision|2
5083526|NCT02110238|17549460|P1|12 Week Pivotal Phase|Physician Decision|0
5083527|NCT02110238|17549459|P2|12 Week Pivotal Phase|Lost to Follow-up|0
5083528|NCT02110238|17549460|P1|12 Week Pivotal Phase|Lost to Follow-up|2
5083529|NCT02110238|17549459|P2|12 Week Pivotal Phase|Lack of Efficacy|3
5083530|NCT02110238|17549460|P1|12 Week Pivotal Phase|Lack of Efficacy|2
5083531|NCT02110238|17549459|P2|12 Week Pivotal Phase|Adverse Event|0
5083532|NCT02110238|17549460|P1|12 Week Pivotal Phase|Adverse Event|3
5083533|NCT02110225|17549469|P3|Overall Study|Lost to Follow-up|0
5083534|NCT02110225|17549470|P2|Overall Study|Lost to Follow-up|1
5083535|NCT02110225|17549471|P1|Overall Study|Lost to Follow-up|0
5083536|NCT02109562|17549581|P3|Overall Study|Physician Decision|5
5083537|NCT02109562|17549582|P2|Overall Study|Physician Decision|4
5083538|NCT02109562|17549583|P1|Overall Study|Physician Decision|3
5083539|NCT02109562|17549581|P3|Overall Study|Withdrawal by Subject|21
5083540|NCT02109562|17549582|P2|Overall Study|Withdrawal by Subject|25
5083541|NCT02109562|17549583|P1|Overall Study|Withdrawal by Subject|20
5083542|NCT02109562|17549581|P3|Overall Study|Protocol Violation|1
5083543|NCT02109562|17549582|P2|Overall Study|Protocol Violation|3
5083544|NCT02109562|17549583|P1|Overall Study|Protocol Violation|0
5083545|NCT02109562|17549581|P3|Overall Study|Lost to Follow-up|1
5083546|NCT02109562|17549582|P2|Overall Study|Lost to Follow-up|0
5083547|NCT02109562|17549583|P1|Overall Study|Lost to Follow-up|1
5083548|NCT02109562|17549581|P3|Overall Study|Adverse Event|3
5083549|NCT02109562|17549582|P2|Overall Study|Adverse Event|2
5083550|NCT02109562|17549583|P1|Overall Study|Adverse Event|0
5083551|NCT02109562|17549581|P3|Overall Study|Insufficient clinical response|4
5083552|NCT02109562|17549582|P2|Overall Study|Insufficient clinical response|0
5083553|NCT02109562|17549583|P1|Overall Study|Insufficient clinical response|2
5083554|NCT02109484|17549610|P8|Overall Study|Moved away from study area|1
5083555|NCT02109484|17549611|P7|Overall Study|Moved away from study area|1
5083556|NCT02109484|17549612|P6|Overall Study|Moved away from study area|0
5083557|NCT02109484|17549613|P5|Overall Study|Moved away from study area|0
5083558|NCT02109484|17549614|P4|Overall Study|Moved away from study area|0
5083559|NCT02109484|17549615|P3|Overall Study|Moved away from study area|0
5083560|NCT02109484|17549616|P2|Overall Study|Moved away from study area|0
5083561|NCT02109484|17549617|P1|Overall Study|Moved away from study area|0
5083562|NCT02109484|17549610|P8|Overall Study|Death|2
5083563|NCT02109484|17549611|P7|Overall Study|Death|0
5083564|NCT02109484|17549612|P6|Overall Study|Death|0
5083565|NCT02109484|17549613|P5|Overall Study|Death|0
5083566|NCT02109484|17549614|P4|Overall Study|Death|0
5083567|NCT02109484|17549615|P3|Overall Study|Death|0
5083568|NCT02109484|17549616|P2|Overall Study|Death|0
5083569|NCT02109484|17549617|P1|Overall Study|Death|0
5083570|NCT02109484|17549610|P8|Overall Study|Physician Decision|0
5083571|NCT02109484|17549611|P7|Overall Study|Physician Decision|0
5083572|NCT02109484|17549612|P6|Overall Study|Physician Decision|0
5083573|NCT02109484|17549613|P5|Overall Study|Physician Decision|2
5083574|NCT02109484|17549614|P4|Overall Study|Physician Decision|0
5083575|NCT02109484|17549615|P3|Overall Study|Physician Decision|0
5083576|NCT02109484|17549616|P2|Overall Study|Physician Decision|0
5083577|NCT02109484|17549617|P1|Overall Study|Physician Decision|0
5083578|NCT02109484|17549610|P8|Overall Study|Withdrawal by Subject|0
5083579|NCT02109484|17549611|P7|Overall Study|Withdrawal by Subject|1
5083580|NCT02109484|17549612|P6|Overall Study|Withdrawal by Subject|1
5083581|NCT02109484|17549613|P5|Overall Study|Withdrawal by Subject|1
5083582|NCT02109484|17549614|P4|Overall Study|Withdrawal by Subject|0
5083583|NCT02109484|17549615|P3|Overall Study|Withdrawal by Subject|0
5083584|NCT02109484|17549616|P2|Overall Study|Withdrawal by Subject|0
5083585|NCT02109484|17549617|P1|Overall Study|Withdrawal by Subject|0
5083586|NCT02109484|17549610|P8|Overall Study|Lost to Follow-up|0
5083587|NCT02109484|17549611|P7|Overall Study|Lost to Follow-up|1
5083588|NCT02109484|17549612|P6|Overall Study|Lost to Follow-up|0
5083589|NCT02109484|17549613|P5|Overall Study|Lost to Follow-up|1
5083590|NCT02109484|17549614|P4|Overall Study|Lost to Follow-up|1
5083591|NCT02109484|17549615|P3|Overall Study|Lost to Follow-up|0
5083592|NCT02109484|17549616|P2|Overall Study|Lost to Follow-up|0
5083593|NCT02109484|17549617|P1|Overall Study|Lost to Follow-up|0
5083594|NCT02109445|17549673|P1|Overall Study|Adverse Event|1
5083595|NCT02109445|17549673|P1|Overall Study|Symptomatic deterioration|2
5083596|NCT02109432|17549706|P1|Overall Study|Withdrawal by Subject|1
5083597|NCT02109172|17549716|P6|Overall Study|Death|0
5083598|NCT02109172|17549717|P5|Overall Study|Death|1
5083599|NCT02109172|17549718|P4|Overall Study|Death|0
5083600|NCT02109172|17549719|P3|Overall Study|Death|0
5083601|NCT02109172|17549720|P2|Overall Study|Death|0
5083602|NCT02109172|17549721|P1|Overall Study|Death|0
5083603|NCT02109172|17549716|P6|Overall Study|Adverse Event|1
5083604|NCT02109172|17549717|P5|Overall Study|Adverse Event|0
5083605|NCT02109172|17549718|P4|Overall Study|Adverse Event|0
5083606|NCT02109172|17549719|P3|Overall Study|Adverse Event|1
5083607|NCT02109172|17549720|P2|Overall Study|Adverse Event|0
5083608|NCT02109172|17549721|P1|Overall Study|Adverse Event|0
5083609|NCT02109172|17549716|P6|Overall Study|Withdrawal by Subject|0
5083610|NCT02109172|17549717|P5|Overall Study|Withdrawal by Subject|0
5083611|NCT02109172|17549718|P4|Overall Study|Withdrawal by Subject|1
5083612|NCT02109172|17549719|P3|Overall Study|Withdrawal by Subject|0
5083613|NCT02109172|17549720|P2|Overall Study|Withdrawal by Subject|0
5083614|NCT02109172|17549721|P1|Overall Study|Withdrawal by Subject|1
5083615|NCT02109133|17549742|P2|Overall Study|Lost to Follow-up|0
5083616|NCT02109133|17549743|P1|Overall Study|Lost to Follow-up|1
5083617|NCT02109107|17549755|P1|Overall Study|Lost to Follow-up|2
5083618|NCT02109042|17549762|P1|Overall Study|Sponsor Decision|15
5083619|NCT02109029|17549771|P6|Part B|Adverse Event|1
5083620|NCT02109029|17549772|P5|Part B|Adverse Event|1
5083621|NCT02109029|17549773|P4|Part B|Adverse Event|0
5083622|NCT02109029|17549774|P3|Part B|Adverse Event|0
5083623|NCT02109029|17549775|P2|Part B|Adverse Event|0
5083624|NCT02109029|17549776|P1|Part B|Adverse Event|0
5083625|NCT02108964|17549813|P8|Overall Study|Subject/Guardian decision|1
5083626|NCT02108964|17549814|P7|Overall Study|Subject/Guardian decision|1
5083627|NCT02108964|17549815|P6|Overall Study|Subject/Guardian decision|0
5083628|NCT02108964|17549816|P5|Overall Study|Subject/Guardian decision|2
5083629|NCT02108964|17549817|P4|Overall Study|Subject/Guardian decision|0
5083630|NCT02108964|17549818|P3|Overall Study|Subject/Guardian decision|3
5083631|NCT02108964|17549819|P2|Overall Study|Subject/Guardian decision|1
5083632|NCT02108964|17549820|P1|Overall Study|Subject/Guardian decision|0
5083633|NCT02108964|17549813|P8|Overall Study|Death|1
5083634|NCT02108964|17549814|P7|Overall Study|Death|0
5083635|NCT02108964|17549815|P6|Overall Study|Death|0
5083636|NCT02108964|17549816|P5|Overall Study|Death|3
5083637|NCT02108964|17549817|P4|Overall Study|Death|0
5083638|NCT02108964|17549818|P3|Overall Study|Death|2
5083639|NCT02108964|17549819|P2|Overall Study|Death|1
5083640|NCT02108964|17549820|P1|Overall Study|Death|1
5083641|NCT02108964|17549813|P8|Overall Study|Adverse Event|1
5083642|NCT02108964|17549814|P7|Overall Study|Adverse Event|3
5083643|NCT02108964|17549815|P6|Overall Study|Adverse Event|0
5083644|NCT02108964|17549816|P5|Overall Study|Adverse Event|1
5083645|NCT02108964|17549817|P4|Overall Study|Adverse Event|0
5083646|NCT02108964|17549818|P3|Overall Study|Adverse Event|4
5083647|NCT02108964|17549819|P2|Overall Study|Adverse Event|0
5083648|NCT02108964|17549820|P1|Overall Study|Adverse Event|0
5083649|NCT02108964|17549813|P8|Overall Study|Physician Decision|0
5083650|NCT02108964|17549814|P7|Overall Study|Physician Decision|0
5083651|NCT02108964|17549815|P6|Overall Study|Physician Decision|0
5083652|NCT02108964|17549816|P5|Overall Study|Physician Decision|1
5083653|NCT02108964|17549817|P4|Overall Study|Physician Decision|0
5083654|NCT02108964|17549818|P3|Overall Study|Physician Decision|6
5083655|NCT02108964|17549819|P2|Overall Study|Physician Decision|5
5083656|NCT02108964|17549820|P1|Overall Study|Physician Decision|1
5083657|NCT02108964|17549813|P8|Overall Study|Progressive disease|9
5083658|NCT02108964|17549814|P7|Overall Study|Progressive disease|7
5083659|NCT02108964|17549815|P6|Overall Study|Progressive disease|5
5083660|NCT02108964|17549816|P5|Overall Study|Progressive disease|18
5083661|NCT02108964|17549817|P4|Overall Study|Progressive disease|6
5083662|NCT02108964|17549818|P3|Overall Study|Progressive disease|50
5083663|NCT02108964|17549819|P2|Overall Study|Progressive disease|25
5083664|NCT02108964|17549820|P1|Overall Study|Progressive disease|12
5083665|NCT02108951|17549839|P1|Overall Study|Study Terminated by Sponsor|14
5083666|NCT02108951|17549839|P1|Overall Study|Patient's/guardian's decision|1
5083667|NCT02108951|17549839|P1|Overall Study|Lost to Follow-up|1
5083668|NCT02108912|17549858|P2|Overall Study|high blood pressure|0
5083669|NCT02108912|17549859|P1|Overall Study|high blood pressure|1
5083670|NCT02108912|17549858|P2|Overall Study|lack of transportation|0
5083671|NCT02108912|17549859|P1|Overall Study|lack of transportation|1
5083672|NCT02108912|17549858|P2|Overall Study|Lost to Follow-up|1
5083673|NCT02108912|17549859|P1|Overall Study|Lost to Follow-up|1
5083674|NCT02108652|17549888|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
5083675|NCT02108652|17549888|P1|Overall Study|Withdrawal by Subject|8
5083676|NCT02108652|17549888|P1|Overall Study|Lost to Follow-up|2
5083677|NCT02108652|17549888|P1|Overall Study|Death|226
5083678|NCT02107898|17550066|P2|Overall Study|Randomized but not treated|1
5083679|NCT02107898|17550067|P1|Overall Study|Randomized but not treated|0
5083680|NCT02107898|17550066|P2|Overall Study|Consent withdrawn by participant|1
5083681|NCT02107898|17550067|P1|Overall Study|Consent withdrawn by participant|2
5083682|NCT02107898|17550066|P2|Overall Study|Participant moved|2
5083683|NCT02107898|17550067|P1|Overall Study|Participant moved|0
5083684|NCT02107898|17550066|P2|Overall Study|Poor compliance to protocol|1
5083685|NCT02107898|17550067|P1|Overall Study|Poor compliance to protocol|0
5083686|NCT02107898|17550066|P2|Overall Study|Adverse Event|7
5083687|NCT02107898|17550067|P1|Overall Study|Adverse Event|4
5083688|NCT02107859|17550119|P1|Overall Study|Other than specified|3
5083689|NCT02107859|17550119|P1|Overall Study|Study closure|41
5083690|NCT02107859|17550119|P1|Overall Study|Adverse Event|3
5083691|NCT02107859|17550119|P1|Overall Study|Withdrawal by Subject|14
5083692|NCT02107703|17550135|P2|Overall Study|On study treatment/follow up|152
5083693|NCT02107703|17550136|P1|Overall Study|On study treatment/follow up|319
5083694|NCT02107703|17550135|P2|Overall Study|Lost to Follow-up|4
5083695|NCT02107703|17550136|P1|Overall Study|Lost to Follow-up|6
5083696|NCT02107703|17550135|P2|Overall Study|Withdrawal by Subject|19
5083697|NCT02107703|17550136|P1|Overall Study|Withdrawal by Subject|36
5083698|NCT02107482|17550168|P1|Overall Study|Lack of Efficacy|1
5083699|NCT02107482|17550168|P1|Overall Study|Lost to Follow-up|1
5083700|NCT02107482|17550168|P1|Overall Study|inconveinence|2
5083701|NCT02107443|17550176|P2|Overall Study|Withdrawal: Personal Issues|3
5083702|NCT02107443|17550177|P1|Overall Study|Withdrawal: Personal Issues|0
5083703|NCT02107443|17550176|P2|Overall Study|Withdrawal: Disease Progression|2
5083704|NCT02107443|17550177|P1|Overall Study|Withdrawal: Disease Progression|4
5083705|NCT02107443|17550176|P2|Overall Study|Withdrawal: Other Medical|5
5083706|NCT02107443|17550177|P1|Overall Study|Withdrawal: Other Medical|9
5083707|NCT02107443|17550176|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
5083708|NCT02107443|17550177|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
5083709|NCT02107443|17550176|P2|Overall Study|Withdrawal: Too Time Consuming|6
5083710|NCT02107443|17550177|P1|Overall Study|Withdrawal: Too Time Consuming|3
5083711|NCT02107443|17550176|P2|Overall Study|Withdrawal: Too Many Forms|1
5083712|NCT02107443|17550177|P1|Overall Study|Withdrawal: Too Many Forms|3
5083713|NCT02107443|17550176|P2|Overall Study|Withdrawal: Changed MD/Facility|3
5083714|NCT02107443|17550177|P1|Overall Study|Withdrawal: Changed MD/Facility|1
5083715|NCT02107443|17550176|P2|Overall Study|Withdrawal: Changed Mind|0
5083716|NCT02107443|17550177|P1|Overall Study|Withdrawal: Changed Mind|2
5083717|NCT02107443|17550176|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
5083718|NCT02107443|17550177|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
5083719|NCT02107443|17550176|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
5083720|NCT02107443|17550177|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
5083721|NCT02107443|17550176|P2|Overall Study|Registered but Not Eligible|1
5083722|NCT02107443|17550177|P1|Overall Study|Registered but Not Eligible|0
5083723|NCT02107443|17550176|P2|Overall Study|Study Protocol Violation|1
5083724|NCT02107443|17550177|P1|Overall Study|Study Protocol Violation|3
5083725|NCT02107443|17550176|P2|Overall Study|Death|30
5083726|NCT02107443|17550177|P1|Overall Study|Death|42
5083727|NCT02107313|17550230|P2|Overall Study|One participant did not do the FED cohor|1
5083728|NCT02107313|17550231|P1|Overall Study|One participant did not do the FED cohor|0
5083729|NCT02107274|17550252|P2|Control Phase|Adverse Event|1
5083730|NCT02107274|17550253|P1|Control Phase|Adverse Event|0
5083731|NCT02107274|17550252|P2|Control Phase|Death|0
5083732|NCT02107274|17550253|P1|Control Phase|Death|2
5083733|NCT02107274|17550252|P2|Control Phase|Lost to Follow-up|1
5083734|NCT02107274|17550253|P1|Control Phase|Lost to Follow-up|1
5083735|NCT02107274|17550252|P2|Treatment vs. Placebo|Lost to Follow-up|2
5083736|NCT02107274|17550253|P1|Treatment vs. Placebo|Lost to Follow-up|0
5083737|NCT02107274|17550252|P2|Treatment vs. Placebo|Adverse Event|0
5083738|NCT02107274|17550253|P1|Treatment vs. Placebo|Adverse Event|3
5083739|NCT02107196|17550267|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
5083740|NCT02107196|17550268|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
5083741|NCT02107196|17550267|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
5083742|NCT02107196|17550268|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
5083743|NCT02107196|17550267|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
5083744|NCT02107196|17550268|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
5083745|NCT02107196|17550267|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
5083746|NCT02107196|17550268|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
5083747|NCT02107196|17550267|P2|12-week Treatment Period|Reason Missing|8
5083748|NCT02107196|17550268|P1|12-week Treatment Period|Reason Missing|11
5083749|NCT02107196|17550267|P2|12-week Treatment Period|Protocol Violation|8
5083750|NCT02107196|17550268|P1|12-week Treatment Period|Protocol Violation|7
5083751|NCT02107196|17550267|P2|12-week Treatment Period|Withdrawal by Subject|12
5083752|NCT02107196|17550268|P1|12-week Treatment Period|Withdrawal by Subject|15
5083753|NCT02107196|17550267|P2|12-week Treatment Period|Physician Decision|1
5083754|NCT02107196|17550268|P1|12-week Treatment Period|Physician Decision|0
5083755|NCT02107196|17550267|P2|12-week Treatment Period|Lost to Follow-up|6
5083756|NCT02107196|17550268|P1|12-week Treatment Period|Lost to Follow-up|3
5083757|NCT02107196|17550267|P2|12-week Treatment Period|Lack of Efficacy|1
5083758|NCT02107196|17550268|P1|12-week Treatment Period|Lack of Efficacy|2
5083759|NCT02107196|17550267|P2|12-week Treatment Period|Adverse Event|3
5083760|NCT02107196|17550268|P1|12-week Treatment Period|Adverse Event|6
5083761|NCT02107131|17550283|P2|Overall Study|Protocol Violation|4
5083762|NCT02107131|17550284|P1|Overall Study|Protocol Violation|0
5083763|NCT02107131|17550283|P2|Overall Study|Death|1
5083764|NCT02107131|17550284|P1|Overall Study|Death|0
5083765|NCT02107131|17550283|P2|Overall Study|mental instability|0
5083766|NCT02107131|17550284|P1|Overall Study|mental instability|1
5083767|NCT02107131|17550283|P2|Overall Study|Withdrawal by Subject|0
5083768|NCT02107131|17550284|P1|Overall Study|Withdrawal by Subject|2
5083769|NCT02107131|17550283|P2|Overall Study|Physician Decision|0
5083770|NCT02107131|17550284|P1|Overall Study|Physician Decision|1
5083771|NCT02107131|17550283|P2|Overall Study|Lost to Follow-up|4
5083772|NCT02107131|17550284|P1|Overall Study|Lost to Follow-up|4
5083773|NCT02107092|17550296|P1|Overall Study|Expected progression of CKD|12
5083774|NCT02107092|17550296|P1|Overall Study|Adverse Event|7
5083775|NCT02107092|17550296|P1|Overall Study|Withdrawal by Subject|9
5083776|NCT02107092|17550296|P1|Overall Study|Lost to Follow-up|2
5083777|NCT02107092|17550296|P1|Overall Study|Physician Decision|3
5083778|NCT02107092|17550296|P1|Overall Study|Met ECG withdrawal criteria|3
5083779|NCT02107092|17550296|P1|Overall Study|Hypo-or hyperkalemia|2
5083780|NCT02107092|17550296|P1|Overall Study|Subject compliance|3
5083781|NCT02107092|17550296|P1|Overall Study|Miscellaneous|3
5083782|NCT02107014|17550301|P1|Overall Study|Withdrew before drug: moving interstate|1
5083783|NCT02106975|17550371|P2|Overall Study|Death|39
5083784|NCT02106975|17550372|P1|Overall Study|Death|25
5083785|NCT02106923|17550432|P6|Overall Study|Protocol Violation|1
5083786|NCT02106923|17550433|P5|Overall Study|Protocol Violation|0
5083787|NCT02106923|17550434|P4|Overall Study|Protocol Violation|0
5083788|NCT02106923|17550435|P3|Overall Study|Protocol Violation|0
5083789|NCT02106923|17550436|P2|Overall Study|Protocol Violation|0
5083790|NCT02106923|17550437|P1|Overall Study|Protocol Violation|0
5083791|NCT02106910|17550483|P2|Overall Study|Lost to Follow-up|1
5083792|NCT02106910|17550484|P1|Overall Study|Lost to Follow-up|1
5083793|NCT02106884|17550500|P2|Overall Study|Change of diagnosis/exclusion|1
5083794|NCT02106884|17550501|P1|Overall Study|Change of diagnosis/exclusion|0
5083795|NCT02106832|17550525|P4|Overall Study|Technical problems|0
5083796|NCT02106832|17550526|P3|Overall Study|Technical problems|0
5083797|NCT02106832|17550527|P2|Overall Study|Technical problems|1
5083798|NCT02106832|17550528|P1|Overall Study|Technical problems|0
5083799|NCT02106832|17550525|P4|Overall Study|Withdrawal by Subject|7
5083800|NCT02106832|17550526|P3|Overall Study|Withdrawal by Subject|10
5083801|NCT02106832|17550527|P2|Overall Study|Withdrawal by Subject|17
5083802|NCT02106832|17550528|P1|Overall Study|Withdrawal by Subject|17
5083803|NCT02106832|17550525|P4|Overall Study|Protocol Violation|1
5083804|NCT02106832|17550526|P3|Overall Study|Protocol Violation|0
5083805|NCT02106832|17550527|P2|Overall Study|Protocol Violation|0
5083806|NCT02106832|17550528|P1|Overall Study|Protocol Violation|0
5083807|NCT02106832|17550525|P4|Overall Study|Physician Decision|0
5083808|NCT02106832|17550526|P3|Overall Study|Physician Decision|0
5083809|NCT02106832|17550527|P2|Overall Study|Physician Decision|0
5083810|NCT02106832|17550528|P1|Overall Study|Physician Decision|1
5083811|NCT02106832|17550525|P4|Overall Study|Lost to Follow-up|3
5083812|NCT02106832|17550526|P3|Overall Study|Lost to Follow-up|1
5083813|NCT02106832|17550527|P2|Overall Study|Lost to Follow-up|1
5083814|NCT02106832|17550528|P1|Overall Study|Lost to Follow-up|0
5083815|NCT02106832|17550525|P4|Overall Study|Deterioration of general conditions|0
5083816|NCT02106832|17550526|P3|Overall Study|Deterioration of general conditions|1
5083817|NCT02106832|17550527|P2|Overall Study|Deterioration of general conditions|0
5083818|NCT02106832|17550528|P1|Overall Study|Deterioration of general conditions|0
5083819|NCT02106832|17550525|P4|Overall Study|Death|4
5083820|NCT02106832|17550526|P3|Overall Study|Death|1
5083821|NCT02106832|17550527|P2|Overall Study|Death|4
5083822|NCT02106832|17550528|P1|Overall Study|Death|4
5083823|NCT02106832|17550525|P4|Overall Study|Adverse Event|0
5083824|NCT02106832|17550526|P3|Overall Study|Adverse Event|3
5083825|NCT02106832|17550527|P2|Overall Study|Adverse Event|2
5083826|NCT02106832|17550528|P1|Overall Study|Adverse Event|1
5083827|NCT02106455|17550595|P1|Overall Study|Protocol Deviation|2
5083828|NCT02106455|17550595|P1|Overall Study|Case Report Form Uncollected|6
5083829|NCT02106442|17550609|P1|Overall Study|Protocol Deviation|30
5083830|NCT02106442|17550609|P1|Overall Study|Case Report Forms Uncollected|7
5083831|NCT02106403|17550627|P6|Follow-Up Visit 3|Other Reason|1
5083832|NCT02106403|17550628|P5|Follow-Up Visit 3|Other Reason|0
5083833|NCT02106403|17550629|P4|Follow-Up Visit 3|Other Reason|0
5083834|NCT02106403|17550630|P3|Follow-Up Visit 3|Other Reason|0
5083835|NCT02106403|17550631|P2|Follow-Up Visit 3|Other Reason|0
5083836|NCT02106403|17550632|P1|Follow-Up Visit 3|Other Reason|0
5083837|NCT02106390|17550655|P3|Overall Study|Protocol Violation|0
5083838|NCT02106390|17550656|P2|Overall Study|Protocol Violation|1
5083839|NCT02106390|17550657|P1|Overall Study|Protocol Violation|0
5083840|NCT02106390|17550655|P3|Overall Study|Adverse Event|1
5083841|NCT02106390|17550656|P2|Overall Study|Adverse Event|2
5083842|NCT02106390|17550657|P1|Overall Study|Adverse Event|0
5083843|NCT02106390|17550655|P3|Overall Study|Other: Unspecified|2
5083844|NCT02106390|17550656|P2|Overall Study|Other: Unspecified|4
5083845|NCT02106390|17550657|P1|Overall Study|Other: Unspecified|1
5083846|NCT02106390|17550655|P3|Overall Study|Other: Administrative Reason|12
5083847|NCT02106390|17550656|P2|Overall Study|Other: Administrative Reason|5
5083848|NCT02106390|17550657|P1|Overall Study|Other: Administrative Reason|8
5083849|NCT02106390|17550655|P3|Overall Study|Lost to Follow-up|13
5083850|NCT02106390|17550656|P2|Overall Study|Lost to Follow-up|20
5083851|NCT02106390|17550657|P1|Overall Study|Lost to Follow-up|25
5083852|NCT02106390|17550655|P3|Overall Study|Withdrawal by Subject|15
5083853|NCT02106390|17550656|P2|Overall Study|Withdrawal by Subject|16
5083854|NCT02106390|17550657|P1|Overall Study|Withdrawal by Subject|15
5083855|NCT02106351|17550734|P3|Treatment Cycle 4|Other|0
5083856|NCT02106351|17550735|P2|Treatment Cycle 4|Other|1
5083857|NCT02106351|17550736|P1|Treatment Cycle 4|Other|0
5083858|NCT02106351|17550734|P3|Treatment Cycle 4|Consent withdrawn|2
5083859|NCT02106351|17550735|P2|Treatment Cycle 4|Consent withdrawn|0
5083860|NCT02106351|17550736|P1|Treatment Cycle 4|Consent withdrawn|0
5083861|NCT02106351|17550734|P3|Treatment Cycle 3|Other|3
5083862|NCT02106351|17550735|P2|Treatment Cycle 3|Other|2
5083863|NCT02106351|17550736|P1|Treatment Cycle 3|Other|0
5083864|NCT02106351|17550734|P3|Treatment Cycle 3|Lost to Follow-up|0
5083865|NCT02106351|17550735|P2|Treatment Cycle 3|Lost to Follow-up|1
5083866|NCT02106351|17550736|P1|Treatment Cycle 3|Lost to Follow-up|0
5083867|NCT02106351|17550734|P3|Treatment Cycle 3|Consent withdrawn|2
5083868|NCT02106351|17550735|P2|Treatment Cycle 3|Consent withdrawn|0
5083869|NCT02106351|17550736|P1|Treatment Cycle 3|Consent withdrawn|0
5083870|NCT02106351|17550734|P3|Treatment Cycle 3|Adverse Event|0
5083871|NCT02106351|17550735|P2|Treatment Cycle 3|Adverse Event|1
5083872|NCT02106351|17550736|P1|Treatment Cycle 3|Adverse Event|0
5083873|NCT02106351|17550734|P3|Treatment Cycle 2|Other|2
5083874|NCT02106351|17550735|P2|Treatment Cycle 2|Other|2
5083875|NCT02106351|17550736|P1|Treatment Cycle 2|Other|0
5083876|NCT02106351|17550734|P3|Treatment Cycle 2|Consent withdrawn|1
5083877|NCT02106351|17550735|P2|Treatment Cycle 2|Consent withdrawn|1
5083878|NCT02106351|17550736|P1|Treatment Cycle 2|Consent withdrawn|0
5083879|NCT02106351|17550734|P3|Treatment Cycle 2|Adverse Event|0
5083880|NCT02106351|17550735|P2|Treatment Cycle 2|Adverse Event|2
5083881|NCT02106351|17550736|P1|Treatment Cycle 2|Adverse Event|0
5083882|NCT02106351|17550734|P3|Treatment Cycle 1|Randomised but not treated|1
5083883|NCT02106351|17550735|P2|Treatment Cycle 1|Randomised but not treated|0
5083884|NCT02106351|17550736|P1|Treatment Cycle 1|Randomised but not treated|1
5083885|NCT02106351|17550734|P3|Treatment Cycle 1|Other|1
5083886|NCT02106351|17550735|P2|Treatment Cycle 1|Other|3
5083887|NCT02106351|17550736|P1|Treatment Cycle 1|Other|0
5083888|NCT02106351|17550734|P3|Treatment Cycle 1|Lost to Follow-up|0
5083889|NCT02106351|17550735|P2|Treatment Cycle 1|Lost to Follow-up|0
5083890|NCT02106351|17550736|P1|Treatment Cycle 1|Lost to Follow-up|1
5083891|NCT02106351|17550734|P3|Treatment Cycle 1|Consent withdrawn|2
5083892|NCT02106351|17550735|P2|Treatment Cycle 1|Consent withdrawn|0
5083893|NCT02106351|17550736|P1|Treatment Cycle 1|Consent withdrawn|1
5083894|NCT02106351|17550734|P3|Treatment Cycle 1|Adverse Event|0
5083895|NCT02106351|17550735|P2|Treatment Cycle 1|Adverse Event|0
5083896|NCT02106351|17550736|P1|Treatment Cycle 1|Adverse Event|2
5083897|NCT02106325|17550779|P2|Phase 3|Lost to Follow-up|1
5083898|NCT02106325|17550780|P1|Phase 3|Lost to Follow-up|2
5083899|NCT02106325|17550779|P2|Phase 2|Lost to Follow-up|3
5083900|NCT02106325|17550780|P1|Phase 2|Lost to Follow-up|2
5083901|NCT02106325|17550779|P2|Phase 1|Lost to Follow-up|2
5083902|NCT02106325|17550780|P1|Phase 1|Lost to Follow-up|2
5083903|NCT02106156|17550805|P3|Overall Study|Relocation/Change of Physician|0
5083904|NCT02106156|17550806|P2|Overall Study|Relocation/Change of Physician|1
5083905|NCT02106156|17550807|P1|Overall Study|Relocation/Change of Physician|40
5083906|NCT02106156|17550805|P3|Overall Study|Hospitalization/Surgical Intervention|0
5083907|NCT02106156|17550806|P2|Overall Study|Hospitalization/Surgical Intervention|0
5083908|NCT02106156|17550807|P1|Overall Study|Hospitalization/Surgical Intervention|6
5083909|NCT02106156|17550805|P3|Overall Study|Change of Laboratory Parameter|0
5083910|NCT02106156|17550806|P2|Overall Study|Change of Laboratory Parameter|0
5083911|NCT02106156|17550807|P1|Overall Study|Change of Laboratory Parameter|10
5083912|NCT02106156|17550805|P3|Overall Study|Unplanned Event|0
5083913|NCT02106156|17550806|P2|Overall Study|Unplanned Event|2
5083914|NCT02106156|17550807|P1|Overall Study|Unplanned Event|82
5083915|NCT02106156|17550805|P3|Overall Study|Lost to Follow-up|0
5083916|NCT02106156|17550806|P2|Overall Study|Lost to Follow-up|8
5083917|NCT02106156|17550807|P1|Overall Study|Lost to Follow-up|451
5083918|NCT02106156|17550805|P3|Overall Study|Patients Request|0
5083919|NCT02106156|17550806|P2|Overall Study|Patients Request|9
5083920|NCT02106156|17550807|P1|Overall Study|Patients Request|307
5083921|NCT02106156|17550805|P3|Overall Study|Lack of Compliance|0
5083922|NCT02106156|17550806|P2|Overall Study|Lack of Compliance|7
5083923|NCT02106156|17550807|P1|Overall Study|Lack of Compliance|211
5083924|NCT02106156|17550805|P3|Overall Study|Concomitant Disease|0
5083925|NCT02106156|17550806|P2|Overall Study|Concomitant Disease|2
5083926|NCT02106156|17550807|P1|Overall Study|Concomitant Disease|74
5083927|NCT02106156|17550805|P3|Overall Study|Lack of Virological Response|0
5083928|NCT02106156|17550806|P2|Overall Study|Lack of Virological Response|8
5083929|NCT02106156|17550807|P1|Overall Study|Lack of Virological Response|1044
5083930|NCT02106156|17550805|P3|Overall Study|Lack of Tolerability|0
5083931|NCT02106156|17550806|P2|Overall Study|Lack of Tolerability|3
5083932|NCT02106156|17550807|P1|Overall Study|Lack of Tolerability|305
5083933|NCT02106156|17550805|P3|Overall Study|Patient Died|0
5083934|NCT02106156|17550806|P2|Overall Study|Patient Died|0
5083935|NCT02106156|17550807|P1|Overall Study|Patient Died|19
5083936|NCT02105987|17550831|P6|Continuation Phase|Protocol Violation|0
5083937|NCT02105987|17550832|P5|Continuation Phase|Protocol Violation|1
5083938|NCT02105987|17550833|P4|Continuation Phase|Protocol Violation|0
5083939|NCT02105987|17550834|P3|Continuation Phase|Protocol Violation|0
5083940|NCT02105987|17550835|P2|Continuation Phase|Protocol Violation|0
5083941|NCT02105987|17550836|P1|Continuation Phase|Protocol Violation|0
5083942|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
5083943|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
5083944|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
5083945|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
5083946|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
5083947|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
5083948|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5083949|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5083950|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
5083951|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5083952|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5083953|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5083954|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
5083955|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
5083956|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
5083957|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
5083958|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
5083959|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
5083960|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5083961|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5083962|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
5083963|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
5083964|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5083965|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5083966|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5083967|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5083968|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
5083969|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
5083970|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5083971|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5083972|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
5083973|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
5083974|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
5083975|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
5083976|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
5083977|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
5083978|NCT02105987|17550831|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
5083979|NCT02105987|17550832|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
5083980|NCT02105987|17550833|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
5083981|NCT02105987|17550834|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
5083982|NCT02105987|17550835|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
5083983|NCT02105987|17550836|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
5083984|NCT02105987|17550831|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5083985|NCT02105987|17550832|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5083986|NCT02105987|17550833|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5083987|NCT02105987|17550834|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5083988|NCT02105987|17550835|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
5083989|NCT02105987|17550836|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5083990|NCT02105987|17550831|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
5083991|NCT02105987|17550832|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
5083992|NCT02105987|17550833|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
5083993|NCT02105987|17550834|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
5083994|NCT02105987|17550835|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
5083995|NCT02105987|17550836|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
5083996|NCT02105987|17550831|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5083997|NCT02105987|17550832|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5083998|NCT02105987|17550833|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5083999|NCT02105987|17550834|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5084000|NCT02105987|17550835|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
5084001|NCT02105987|17550836|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
5084002|NCT02105987|17550831|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5084003|NCT02105987|17550832|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5084004|NCT02105987|17550833|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5084005|NCT02105987|17550834|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5084006|NCT02105987|17550835|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
5084007|NCT02105987|17550836|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
5084008|NCT02105987|17550831|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
5084009|NCT02105987|17550832|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
5084010|NCT02105987|17550833|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
5084011|NCT02105987|17550834|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
5084012|NCT02105987|17550835|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
5084013|NCT02105987|17550836|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
5084014|NCT02105987|17550831|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
5084015|NCT02105987|17550832|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
5084016|NCT02105987|17550833|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
5084017|NCT02105987|17550834|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
5084018|NCT02105987|17550835|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
5084019|NCT02105987|17550836|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
5084020|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
5084021|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
5084022|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
5084023|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
5084024|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
5084025|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
5084026|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
5084027|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
5084028|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
5084029|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
5084030|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
5084031|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
5084032|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
5084033|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
5084034|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
5084035|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
5084036|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
5084037|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
5084038|NCT02105974|17550890|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
5084039|NCT02105974|17550891|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
5084040|NCT02105974|17550892|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
5084041|NCT02105974|17550890|P3|2 Week Run-in Period|Investigator discretion|0
5084042|NCT02105974|17550891|P2|2 Week Run-in Period|Investigator discretion|0
5084043|NCT02105974|17550892|P1|2 Week Run-in Period|Investigator discretion|8
5084044|NCT02105974|17550890|P3|2 Week Run-in Period|Withdrew consent|0
5084045|NCT02105974|17550891|P2|2 Week Run-in Period|Withdrew consent|0
5084046|NCT02105974|17550892|P1|2 Week Run-in Period|Withdrew consent|23
5084047|NCT02105974|17550890|P3|2 Week Run-in Period|Lost to Follow-up|0
5084048|NCT02105974|17550891|P2|2 Week Run-in Period|Lost to Follow-up|0
5084049|NCT02105974|17550892|P1|2 Week Run-in Period|Lost to Follow-up|2
5084050|NCT02105974|17550890|P3|2 Week Run-in Period|Study closed/terminated|0
5084051|NCT02105974|17550891|P2|2 Week Run-in Period|Study closed/terminated|0
5084052|NCT02105974|17550892|P1|2 Week Run-in Period|Study closed/terminated|1
5084053|NCT02105974|17550890|P3|2 Week Run-in Period|Adverse Event|0
5084054|NCT02105974|17550891|P2|2 Week Run-in Period|Adverse Event|0
5084055|NCT02105974|17550892|P1|2 Week Run-in Period|Adverse Event|6
5084056|NCT02105974|17550890|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
5084057|NCT02105974|17550891|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
5084058|NCT02105974|17550892|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
5084059|NCT02105974|17550890|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
5084060|NCT02105974|17550891|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
5084061|NCT02105974|17550892|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
5084062|NCT02105961|17550905|P3|Overall Study|Withdrawal by Subject|11
5084063|NCT02105961|17550906|P2|Overall Study|Withdrawal by Subject|7
5084064|NCT02105961|17550907|P1|Overall Study|Withdrawal by Subject|15
5084065|NCT02105961|17550905|P3|Overall Study|Physician Decision|2
5084066|NCT02105961|17550906|P2|Overall Study|Physician Decision|3
5084067|NCT02105961|17550907|P1|Overall Study|Physician Decision|3
5084068|NCT02105961|17550905|P3|Overall Study|Lost to Follow-up|1
5084069|NCT02105961|17550906|P2|Overall Study|Lost to Follow-up|0
5084070|NCT02105961|17550907|P1|Overall Study|Lost to Follow-up|2
5084071|NCT02105961|17550905|P3|Overall Study|Lack of Efficacy|3
5084072|NCT02105961|17550906|P2|Overall Study|Lack of Efficacy|0
5084073|NCT02105961|17550907|P1|Overall Study|Lack of Efficacy|3
5084074|NCT02105961|17550905|P3|Overall Study|Adverse Event|13
5084075|NCT02105961|17550906|P2|Overall Study|Adverse Event|7
5084076|NCT02105961|17550907|P1|Overall Study|Adverse Event|18
5084077|NCT02105948|17550931|P4|Overall Study|Withdrawal by Subject|11
5084078|NCT02105948|17550932|P3|Overall Study|Withdrawal by Subject|10
5084079|NCT02105948|17550933|P2|Overall Study|Withdrawal by Subject|10
5084080|NCT02105948|17550934|P1|Overall Study|Withdrawal by Subject|15
5084081|NCT02105948|17550931|P4|Overall Study|Physician Decision|2
5084082|NCT02105948|17550932|P3|Overall Study|Physician Decision|2
5084083|NCT02105948|17550933|P2|Overall Study|Physician Decision|2
5084084|NCT02105948|17550934|P1|Overall Study|Physician Decision|2
5084085|NCT02105948|17550931|P4|Overall Study|Lost to Follow-up|1
5084086|NCT02105948|17550932|P3|Overall Study|Lost to Follow-up|2
5084087|NCT02105948|17550933|P2|Overall Study|Lost to Follow-up|0
5084088|NCT02105948|17550934|P1|Overall Study|Lost to Follow-up|0
5084089|NCT02105948|17550931|P4|Overall Study|Lack of Efficacy|2
5084090|NCT02105948|17550932|P3|Overall Study|Lack of Efficacy|3
5084091|NCT02105948|17550933|P2|Overall Study|Lack of Efficacy|1
5084092|NCT02105948|17550934|P1|Overall Study|Lack of Efficacy|0
5084093|NCT02105948|17550931|P4|Overall Study|Adverse Event|11
5084094|NCT02105948|17550932|P3|Overall Study|Adverse Event|11
5084095|NCT02105948|17550933|P2|Overall Study|Adverse Event|7
5084096|NCT02105948|17550934|P1|Overall Study|Adverse Event|10
5084097|NCT02105701|17550975|P4|Overall Study|Death|0
5084098|NCT02105701|17550976|P3|Overall Study|Death|0
5084099|NCT02105701|17550977|P2|Overall Study|Death|0
5084100|NCT02105701|17550978|P1|Overall Study|Death|1
5084101|NCT02105701|17550975|P4|Overall Study|Withdrawal by Subject|1
5084102|NCT02105701|17550976|P3|Overall Study|Withdrawal by Subject|0
5084103|NCT02105701|17550977|P2|Overall Study|Withdrawal by Subject|1
5084104|NCT02105701|17550978|P1|Overall Study|Withdrawal by Subject|2
5084105|NCT02105701|17550975|P4|Overall Study|Protocol Violation|0
5084106|NCT02105701|17550976|P3|Overall Study|Protocol Violation|1
5084107|NCT02105701|17550977|P2|Overall Study|Protocol Violation|0
5084108|NCT02105701|17550978|P1|Overall Study|Protocol Violation|0
5084109|NCT02105701|17550975|P4|Overall Study|Lost to Follow-up|1
5084110|NCT02105701|17550976|P3|Overall Study|Lost to Follow-up|2
5084111|NCT02105701|17550977|P2|Overall Study|Lost to Follow-up|0
5084112|NCT02105701|17550978|P1|Overall Study|Lost to Follow-up|1
5084113|NCT02105688|17551002|P2|Part B: Observational Follow-up|Physician Decision|1
5084114|NCT02105688|17551003|P1|Part B: Observational Follow-up|Physician Decision|3
5084115|NCT02105688|17551002|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
5084116|NCT02105688|17551003|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
5084117|NCT02105688|17551002|P2|Part B: Observational Follow-up|Lost to Follow-up|15
5084118|NCT02105688|17551003|P1|Part B: Observational Follow-up|Lost to Follow-up|23
5084119|NCT02105688|17551002|P2|Part B: Observational Follow-up|Death|1
5084120|NCT02105688|17551003|P1|Part B: Observational Follow-up|Death|2
5084121|NCT02105688|17551002|P2|Part A: Double-Blind|Withdrawal by Subject|2
5084122|NCT02105688|17551003|P1|Part A: Double-Blind|Withdrawal by Subject|4
5084123|NCT02105688|17551002|P2|Part A: Double-Blind|Status Unknown|2
5084124|NCT02105688|17551003|P1|Part A: Double-Blind|Status Unknown|0
5084125|NCT02105688|17551002|P2|Part A: Double-Blind|Physician Decision|1
5084126|NCT02105688|17551003|P1|Part A: Double-Blind|Physician Decision|0
5084127|NCT02105688|17551002|P2|Part A: Double-Blind|Lost to Follow-up|11
5084128|NCT02105688|17551003|P1|Part A: Double-Blind|Lost to Follow-up|15
5084129|NCT02105688|17551002|P2|Part A: Double-Blind|Death|1
5084130|NCT02105688|17551003|P1|Part A: Double-Blind|Death|0
5084131|NCT02105688|17551002|P2|Part A: Double-Blind|Adverse Event|0
5084132|NCT02105688|17551003|P1|Part A: Double-Blind|Adverse Event|1
5084133|NCT02105662|17551016|P1|Overall Study|Withdrawal by Subject|1
5084134|NCT02105662|17551016|P1|Overall Study|Lost to Follow-up|5
5084135|NCT02105636|17551025|P2|Overall Study|Not Reported|0
5084136|NCT02105636|17551026|P1|Overall Study|Not Reported|3
5084137|NCT02105636|17551025|P2|Overall Study|Reason Not Specified|2
5084138|NCT02105636|17551026|P1|Overall Study|Reason Not Specified|0
5084139|NCT02105636|17551025|P2|Overall Study|Poor/Non-compliance|1
5084140|NCT02105636|17551026|P1|Overall Study|Poor/Non-compliance|0
5084141|NCT02105636|17551025|P2|Overall Study|Maximum Clinical Benefit|1
5084142|NCT02105636|17551026|P1|Overall Study|Maximum Clinical Benefit|1
5084143|NCT02105636|17551025|P2|Overall Study|Subject Withdrew Consent|1
5084144|NCT02105636|17551026|P1|Overall Study|Subject Withdrew Consent|4
5084145|NCT02105636|17551025|P2|Overall Study|Subject Request to Discontinue Treatment|6
5084146|NCT02105636|17551026|P1|Overall Study|Subject Request to Discontinue Treatment|4
5084147|NCT02105636|17551025|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5084148|NCT02105636|17551026|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
5084149|NCT02105636|17551025|P2|Overall Study|Study Drug Toxicity|11
5084150|NCT02105636|17551026|P1|Overall Study|Study Drug Toxicity|9
5084151|NCT02105636|17551025|P2|Overall Study|Disease Progression|83
5084152|NCT02105636|17551026|P1|Overall Study|Disease Progression|162
5084153|NCT02105467|17551069|P2|Period 3|Lost to Follow-up|1
5084154|NCT02105467|17551070|P1|Period 3|Lost to Follow-up|0
5084155|NCT02105467|17551069|P2|Period 2|Withdrawal by Subject|2
5084156|NCT02105467|17551070|P1|Period 2|Withdrawal by Subject|0
5084157|NCT02105467|17551069|P2|Period 2|Death|0
5084158|NCT02105467|17551070|P1|Period 2|Death|1
5084159|NCT02105467|17551069|P2|Period 2|Lost to Follow-up|0
5084160|NCT02105467|17551070|P1|Period 2|Lost to Follow-up|1
5084161|NCT02105467|17551069|P2|Period 1|Death|0
5084162|NCT02105467|17551070|P1|Period 1|Death|1
5084163|NCT02105467|17551069|P2|Period 1|Lost to Follow-up|0
5084164|NCT02105467|17551070|P1|Period 1|Lost to Follow-up|1
5084165|NCT02105454|17551082|P1|Overall Study|Withdrawal by Subject|1
5084166|NCT02105285|17551194|P3|Overall Study|Withdrawal by Subject|0
5084167|NCT02105285|17551195|P2|Overall Study|Withdrawal by Subject|0
5084168|NCT02105285|17551196|P1|Overall Study|Withdrawal by Subject|1
5084169|NCT02105285|17551194|P3|Overall Study|Protocol Violation|0
5084170|NCT02105285|17551195|P2|Overall Study|Protocol Violation|1
5084171|NCT02105285|17551196|P1|Overall Study|Protocol Violation|0
5084172|NCT02105285|17551194|P3|Overall Study|Adverse Event|0
5084173|NCT02105285|17551195|P2|Overall Study|Adverse Event|1
5084174|NCT02105285|17551196|P1|Overall Study|Adverse Event|1
5084175|NCT02105272|17551215|P2|Overall Study|Withdrawal by Subject|0
5084176|NCT02105272|17551216|P1|Overall Study|Withdrawal by Subject|2
5084177|NCT02105272|17551215|P2|Overall Study|Protocol Violation|0
5084178|NCT02105272|17551216|P1|Overall Study|Protocol Violation|2
5084179|NCT02105272|17551215|P2|Overall Study|Physician Decision|1
5084180|NCT02105272|17551216|P1|Overall Study|Physician Decision|0
5084181|NCT02105272|17551215|P2|Overall Study|Adverse Event|2
5084182|NCT02105272|17551216|P1|Overall Study|Adverse Event|1
5084183|NCT02105116|17551245|P1|Overall Study|Death|1
5084184|NCT02105116|17551245|P1|Overall Study|not eligible for step 2 of trial|5
5084185|NCT02105012|17551252|P1|Overall Study|Lack of Efficacy|1
5084186|NCT02105012|17551252|P1|Overall Study|Adverse Event|1
5084187|NCT02105012|17551252|P1|Overall Study|Physician Decision|3
5084188|NCT02105012|17551252|P1|Overall Study|Protocol Violation|4
5084189|NCT02105012|17551252|P1|Overall Study|Lost to Follow-up|4
5084190|NCT02105012|17551252|P1|Overall Study|Protocol Specified Criteria|9
5084191|NCT02105012|17551252|P1|Overall Study|Withdrawal by Subject|11
5084192|NCT02104947|17551286|P2|Overall Study|Other than stated above|3
5084193|NCT02104947|17551287|P1|Overall Study|Other than stated above|2
5084194|NCT02104947|17551286|P2|Overall Study|Adverse Event|38
5084195|NCT02104947|17551287|P1|Overall Study|Adverse Event|57
5084196|NCT02104947|17551286|P2|Overall Study|Protocol Violation|8
5084197|NCT02104947|17551287|P1|Overall Study|Protocol Violation|6
5084198|NCT02104947|17551286|P2|Overall Study|Lost to Follow-up|4
5084199|NCT02104947|17551287|P1|Overall Study|Lost to Follow-up|4
5084200|NCT02104947|17551286|P2|Overall Study|Withdrawal by Subject|3
5084201|NCT02104947|17551287|P1|Overall Study|Withdrawal by Subject|10
5084202|NCT02104895|17551305|P2|Overall Study|Withdrawal by Subject|14
5084203|NCT02104895|17551306|P1|Overall Study|Withdrawal by Subject|0
5084204|NCT02104804|17551346|P2|Overall Study|Withdrawal by Subject|12
5084205|NCT02104804|17551347|P1|Overall Study|Withdrawal by Subject|4
5084206|NCT02104804|17551346|P2|Overall Study|Adverse Event|3
5084207|NCT02104804|17551347|P1|Overall Study|Adverse Event|4
5084208|NCT02104804|17551346|P2|Overall Study|Protocol Violation|1
5084209|NCT02104804|17551347|P1|Overall Study|Protocol Violation|0
5084210|NCT02104804|17551346|P2|Overall Study|Other listed|1
5084211|NCT02104804|17551347|P1|Overall Study|Other listed|2
5084212|NCT02104804|17551346|P2|Overall Study|Study specific discontinuation criteria|1
5084213|NCT02104804|17551347|P1|Overall Study|Study specific discontinuation criteria|6
5084214|NCT02104804|17551346|P2|Overall Study|Did not take study medication|1
5084215|NCT02104804|17551347|P1|Overall Study|Did not take study medication|0
5084216|NCT02104765|17551370|P7|Overall Study|Withdrawal by Subject|1
5084217|NCT02104765|17551371|P6|Overall Study|Withdrawal by Subject|0
5084218|NCT02104765|17551372|P5|Overall Study|Withdrawal by Subject|1
5084219|NCT02104765|17551373|P4|Overall Study|Withdrawal by Subject|1
5084220|NCT02104765|17551374|P3|Overall Study|Withdrawal by Subject|0
5084221|NCT02104765|17551375|P2|Overall Study|Withdrawal by Subject|0
5084222|NCT02104765|17551376|P1|Overall Study|Withdrawal by Subject|0
5084223|NCT02104765|17551370|P7|Overall Study|Lost to Follow-up|0
5084224|NCT02104765|17551371|P6|Overall Study|Lost to Follow-up|0
5084225|NCT02104765|17551372|P5|Overall Study|Lost to Follow-up|0
5084226|NCT02104765|17551373|P4|Overall Study|Lost to Follow-up|0
5084227|NCT02104765|17551374|P3|Overall Study|Lost to Follow-up|1
5084228|NCT02104765|17551375|P2|Overall Study|Lost to Follow-up|0
5084229|NCT02104765|17551376|P1|Overall Study|Lost to Follow-up|0
5084230|NCT02104752|17551404|P2|Overall Study|Weight gain; unrelated anxiety|2
5084231|NCT02104752|17551405|P1|Overall Study|Weight gain; unrelated anxiety|0
5084232|NCT02104752|17551404|P2|Overall Study|Withdrawal by Subject|0
5084233|NCT02104752|17551405|P1|Overall Study|Withdrawal by Subject|1
5084234|NCT02104583|17551488|P5|Overall Study|Randomized but Never Treated|0
5084235|NCT02104583|17551489|P4|Overall Study|Randomized but Never Treated|1
5084236|NCT02104583|17551490|P3|Overall Study|Randomized but Never Treated|0
5084237|NCT02104583|17551491|P2|Overall Study|Randomized but Never Treated|0
5084238|NCT02104583|17551492|P1|Overall Study|Randomized but Never Treated|0
5084239|NCT02104583|17551488|P5|Overall Study|Lost to Follow-up|0
5084240|NCT02104583|17551489|P4|Overall Study|Lost to Follow-up|0
5084241|NCT02104583|17551490|P3|Overall Study|Lost to Follow-up|0
5084242|NCT02104583|17551491|P2|Overall Study|Lost to Follow-up|0
5084243|NCT02104583|17551492|P1|Overall Study|Lost to Follow-up|1
5084244|NCT02104583|17551488|P5|Overall Study|Adverse Event|1
5084245|NCT02104583|17551489|P4|Overall Study|Adverse Event|6
5084246|NCT02104583|17551490|P3|Overall Study|Adverse Event|6
5084247|NCT02104583|17551491|P2|Overall Study|Adverse Event|3
5084248|NCT02104583|17551492|P1|Overall Study|Adverse Event|3
5084249|NCT02104583|17551488|P5|Overall Study|Protocol Violation|0
5084250|NCT02104583|17551489|P4|Overall Study|Protocol Violation|0
5084251|NCT02104583|17551490|P3|Overall Study|Protocol Violation|1
5084252|NCT02104583|17551491|P2|Overall Study|Protocol Violation|0
5084253|NCT02104583|17551492|P1|Overall Study|Protocol Violation|0
5084254|NCT02104583|17551488|P5|Overall Study|Investigator's Discretion|0
5084255|NCT02104583|17551489|P4|Overall Study|Investigator's Discretion|0
5084256|NCT02104583|17551490|P3|Overall Study|Investigator's Discretion|0
5084257|NCT02104583|17551491|P2|Overall Study|Investigator's Discretion|0
5084258|NCT02104583|17551492|P1|Overall Study|Investigator's Discretion|1
5084259|NCT02104583|17551488|P5|Overall Study|Withdrew Consent|1
5084260|NCT02104583|17551489|P4|Overall Study|Withdrew Consent|2
5084261|NCT02104583|17551490|P3|Overall Study|Withdrew Consent|0
5084262|NCT02104583|17551491|P2|Overall Study|Withdrew Consent|2
5084263|NCT02104583|17551492|P1|Overall Study|Withdrew Consent|3
5084264|NCT02104583|17551488|P5|Overall Study|Subject required prohibited medication|1
5084265|NCT02104583|17551489|P4|Overall Study|Subject required prohibited medication|0
5084266|NCT02104583|17551490|P3|Overall Study|Subject required prohibited medication|1
5084267|NCT02104583|17551491|P2|Overall Study|Subject required prohibited medication|1
5084268|NCT02104583|17551492|P1|Overall Study|Subject required prohibited medication|0
5084269|NCT02104583|17551488|P5|Overall Study|Subject required cardiac ablation|4
5084270|NCT02104583|17551489|P4|Overall Study|Subject required cardiac ablation|5
5084271|NCT02104583|17551490|P3|Overall Study|Subject required cardiac ablation|4
5084272|NCT02104583|17551491|P2|Overall Study|Subject required cardiac ablation|4
5084273|NCT02104583|17551492|P1|Overall Study|Subject required cardiac ablation|6
5084274|NCT02104583|17551488|P5|Overall Study|Death|5
5084275|NCT02104583|17551489|P4|Overall Study|Death|3
5084276|NCT02104583|17551490|P3|Overall Study|Death|3
5084277|NCT02104583|17551491|P2|Overall Study|Death|1
5084278|NCT02104583|17551492|P1|Overall Study|Death|2
5084279|NCT02104583|17551488|P5|Overall Study|New ICD or CRT-D implanted|0
5084280|NCT02104583|17551489|P4|Overall Study|New ICD or CRT-D implanted|0
5084281|NCT02104583|17551490|P3|Overall Study|New ICD or CRT-D implanted|1
5084282|NCT02104583|17551491|P2|Overall Study|New ICD or CRT-D implanted|0
5084283|NCT02104583|17551492|P1|Overall Study|New ICD or CRT-D implanted|2
5084284|NCT02104505|17551555|P2|Second Intervention (14 Days)|Adverse Event|0
5084285|NCT02104505|17551556|P1|Second Intervention (14 Days)|Adverse Event|2
5084286|NCT02104505|17551555|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5084287|NCT02104505|17551556|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5084288|NCT02104505|17551555|P2|First Intervention (14 Days)|exclusionary condition|1
5084289|NCT02104505|17551556|P1|First Intervention (14 Days)|exclusionary condition|0
5084290|NCT02104505|17551555|P2|First Intervention (14 Days)|Lost to Follow-up|1
5084291|NCT02104505|17551556|P1|First Intervention (14 Days)|Lost to Follow-up|0
5084292|NCT02104505|17551555|P2|First Intervention (14 Days)|Withdrawal by Subject|1
5084293|NCT02104505|17551556|P1|First Intervention (14 Days)|Withdrawal by Subject|0
5084294|NCT02104505|17551555|P2|First Intervention (14 Days)|Adverse Event|0
5084295|NCT02104505|17551556|P1|First Intervention (14 Days)|Adverse Event|2
5084296|NCT02104180|17551628|P2|Overall Study|Protocol Violation|0
5084297|NCT02104180|17551629|P1|Overall Study|Protocol Violation|1
5084298|NCT02103478|17551664|P9|Overall Study|Other|2
5084299|NCT02103478|17551665|P8|Overall Study|Other|2
5084300|NCT02103478|17551666|P7|Overall Study|Other|5
5084301|NCT02103478|17551667|P6|Overall Study|Other|2
5084302|NCT02103478|17551668|P5|Overall Study|Other|1
5084303|NCT02103478|17551669|P4|Overall Study|Other|0
5084304|NCT02103478|17551670|P3|Overall Study|Other|1
5084305|NCT02103478|17551671|P2|Overall Study|Other|1
5084306|NCT02103478|17551672|P1|Overall Study|Other|1
5084307|NCT02103478|17551664|P9|Overall Study|Withdrawal by Subject|0
5084308|NCT02103478|17551665|P8|Overall Study|Withdrawal by Subject|1
5084309|NCT02103478|17551666|P7|Overall Study|Withdrawal by Subject|2
5084310|NCT02103478|17551667|P6|Overall Study|Withdrawal by Subject|2
5084311|NCT02103478|17551668|P5|Overall Study|Withdrawal by Subject|0
5084312|NCT02103478|17551669|P4|Overall Study|Withdrawal by Subject|3
5084313|NCT02103478|17551670|P3|Overall Study|Withdrawal by Subject|1
5084314|NCT02103478|17551671|P2|Overall Study|Withdrawal by Subject|0
5084315|NCT02103478|17551672|P1|Overall Study|Withdrawal by Subject|0
5084316|NCT02103478|17551664|P9|Overall Study|Bone Marrow/Stem Cell Transplant|2
5084317|NCT02103478|17551665|P8|Overall Study|Bone Marrow/Stem Cell Transplant|3
5084318|NCT02103478|17551666|P7|Overall Study|Bone Marrow/Stem Cell Transplant|2
5084319|NCT02103478|17551667|P6|Overall Study|Bone Marrow/Stem Cell Transplant|5
5084320|NCT02103478|17551668|P5|Overall Study|Bone Marrow/Stem Cell Transplant|2
5084321|NCT02103478|17551669|P4|Overall Study|Bone Marrow/Stem Cell Transplant|0
5084322|NCT02103478|17551670|P3|Overall Study|Bone Marrow/Stem Cell Transplant|1
5084323|NCT02103478|17551671|P2|Overall Study|Bone Marrow/Stem Cell Transplant|2
5084324|NCT02103478|17551672|P1|Overall Study|Bone Marrow/Stem Cell Transplant|1
5084325|NCT02103478|17551664|P9|Overall Study|Progressive Disease|4
5084326|NCT02103478|17551665|P8|Overall Study|Progressive Disease|3
5084327|NCT02103478|17551666|P7|Overall Study|Progressive Disease|7
5084328|NCT02103478|17551667|P6|Overall Study|Progressive Disease|7
5084329|NCT02103478|17551668|P5|Overall Study|Progressive Disease|10
5084330|NCT02103478|17551669|P4|Overall Study|Progressive Disease|1
5084331|NCT02103478|17551670|P3|Overall Study|Progressive Disease|2
5084332|NCT02103478|17551671|P2|Overall Study|Progressive Disease|1
5084333|NCT02103478|17551672|P1|Overall Study|Progressive Disease|2
5084334|NCT02103478|17551664|P9|Overall Study|Death|3
5084335|NCT02103478|17551665|P8|Overall Study|Death|3
5084336|NCT02103478|17551666|P7|Overall Study|Death|3
5084337|NCT02103478|17551667|P6|Overall Study|Death|3
5084338|NCT02103478|17551668|P5|Overall Study|Death|3
5084339|NCT02103478|17551669|P4|Overall Study|Death|0
5084340|NCT02103478|17551670|P3|Overall Study|Death|0
5084341|NCT02103478|17551671|P2|Overall Study|Death|0
5084342|NCT02103478|17551672|P1|Overall Study|Death|1
5084343|NCT02103478|17551664|P9|Overall Study|Adverse Event|1
5084344|NCT02103478|17551665|P8|Overall Study|Adverse Event|2
5084345|NCT02103478|17551666|P7|Overall Study|Adverse Event|2
5084346|NCT02103478|17551667|P6|Overall Study|Adverse Event|1
5084347|NCT02103478|17551668|P5|Overall Study|Adverse Event|1
5084348|NCT02103478|17551669|P4|Overall Study|Adverse Event|2
5084349|NCT02103478|17551670|P3|Overall Study|Adverse Event|1
5084350|NCT02103478|17551671|P2|Overall Study|Adverse Event|0
5084351|NCT02103478|17551672|P1|Overall Study|Adverse Event|0
5084352|NCT02103439|17551781|P2|Overall Study|Withdrawal by Subject|1
5084353|NCT02103439|17551782|P1|Overall Study|Withdrawal by Subject|3
5084354|NCT02103439|17551781|P2|Overall Study|Adverse Event|2
5084355|NCT02103439|17551782|P1|Overall Study|Adverse Event|0
5084356|NCT02103062|17551941|P2|Overall Study|Death|1
5084357|NCT02103062|17551942|P1|Overall Study|Death|0
5084358|NCT02103062|17551941|P2|Overall Study|Progressive Disease|20
5084359|NCT02103062|17551942|P1|Overall Study|Progressive Disease|17
5084360|NCT02103062|17551941|P2|Overall Study|Adverse Event|2
5084361|NCT02103062|17551942|P1|Overall Study|Adverse Event|1
5084362|NCT02102724|17552035|P2|Overall Study|surgery for brain aneurysm|1
5084363|NCT02102724|17552036|P1|Overall Study|surgery for brain aneurysm|1
5084364|NCT02102724|17552035|P2|Overall Study|Lost to Follow-up|0
5084365|NCT02102724|17552036|P1|Overall Study|Lost to Follow-up|1
5084366|NCT02102490|17552042|P1|Overall Study|Lost to Follow-up|1
5084367|NCT02102490|17552042|P1|Overall Study|Death|6
5084368|NCT02102464|17552056|P3|Randomized Study|Withdrawal by Subject|0
5084369|NCT02102464|17552057|P2|Randomized Study|Withdrawal by Subject|1
5084370|NCT02102464|17552058|P1|Randomized Study|Withdrawal by Subject|0
5084371|NCT02102399|17552077|P2|Overall Study|Withdrawal by Subject|4
5084372|NCT02102399|17552078|P1|Overall Study|Withdrawal by Subject|6
5084373|NCT02102204|17552148|P1|Overall Study|Ongoing|5
5084374|NCT02102204|17552148|P1|Overall Study|Sponsor Decision|5
5084375|NCT02102204|17552148|P1|Overall Study|Lost to Follow-up|65
5084376|NCT02102204|17552148|P1|Overall Study|Death|92
5084377|NCT02102204|17552148|P1|Overall Study|Withdrawal by Subject|137
5084378|NCT02101983|17552168|P2|Overall Study|Physician Decision|0
5084379|NCT02101983|17552169|P1|Overall Study|Physician Decision|1
5084380|NCT02101554|17552215|P3|Overall Study|Withdrawl by Parents/Guardians|0
5084381|NCT02101554|17552216|P2|Overall Study|Withdrawl by Parents/Guardians|0
5084382|NCT02101554|17552217|P1|Overall Study|Withdrawl by Parents/Guardians|1
5084383|NCT02101554|17552215|P3|Overall Study|Lost to Follow-up|0
5084384|NCT02101554|17552216|P2|Overall Study|Lost to Follow-up|1
5084385|NCT02101554|17552217|P1|Overall Study|Lost to Follow-up|0
5084386|NCT02101554|17552215|P3|Overall Study|Adverse Event|1
5084387|NCT02101554|17552216|P2|Overall Study|Adverse Event|1
5084388|NCT02101554|17552217|P1|Overall Study|Adverse Event|2
5084389|NCT02101554|17552215|P3|Overall Study|Insufficient Clinical Response|0
5084390|NCT02101554|17552216|P2|Overall Study|Insufficient Clinical Response|2
5084391|NCT02101554|17552217|P1|Overall Study|Insufficient Clinical Response|0
5084392|NCT02101554|17552215|P3|Overall Study|Protocol Violation|0
5084393|NCT02101554|17552216|P2|Overall Study|Protocol Violation|1
5084394|NCT02101554|17552217|P1|Overall Study|Protocol Violation|0
5084395|NCT02101359|17552370|P2|Overall Study|Protocol Violation|2
5084396|NCT02101359|17552371|P1|Overall Study|Protocol Violation|0
5084397|NCT02101359|17552370|P2|Overall Study|Lost to Follow-up|0
5084398|NCT02101359|17552371|P1|Overall Study|Lost to Follow-up|1
5084399|NCT02101359|17552370|P2|Overall Study|Withdrawal by Subject|4
5084400|NCT02101359|17552371|P1|Overall Study|Withdrawal by Subject|5
5084401|NCT02101359|17552370|P2|Overall Study|Not included|13
5084402|NCT02101359|17552371|P1|Overall Study|Not included|23
5084403|NCT02101294|17552377|P1|Overall Study|Lost to Follow-up|6
5084404|NCT02101294|17552377|P1|Overall Study|Withdrawal by Subject|5
5084405|NCT02101281|17552386|P2|Overall Study|Adverse Event|1
5084406|NCT02101281|17552387|P1|Overall Study|Adverse Event|0
5084407|NCT02101112|17552440|P6|Overall Study|Withdrawal by Subject|0
5084408|NCT02101112|17552441|P5|Overall Study|Withdrawal by Subject|1
5084409|NCT02101112|17552442|P4|Overall Study|Withdrawal by Subject|0
5084410|NCT02101112|17552443|P3|Overall Study|Withdrawal by Subject|0
5084411|NCT02101112|17552444|P2|Overall Study|Withdrawal by Subject|0
5084412|NCT02101112|17552445|P1|Overall Study|Withdrawal by Subject|0
5084413|NCT02101112|17552440|P6|Overall Study|Adverse Event|0
5084414|NCT02101112|17552441|P5|Overall Study|Adverse Event|0
5084415|NCT02101112|17552442|P4|Overall Study|Adverse Event|0
5084416|NCT02101112|17552443|P3|Overall Study|Adverse Event|1
5084417|NCT02101112|17552444|P2|Overall Study|Adverse Event|0
5084418|NCT02101112|17552445|P1|Overall Study|Adverse Event|0
5084419|NCT02101021|17552475|P5|Overall Study|Study Terminated by Sponsor|1
5084420|NCT02101021|17552476|P4|Overall Study|Study Terminated by Sponsor|1
5084421|NCT02101021|17552477|P3|Overall Study|Study Terminated by Sponsor|1
5084422|NCT02101021|17552478|P2|Overall Study|Study Terminated by Sponsor|0
5084423|NCT02101021|17552479|P1|Overall Study|Study Terminated by Sponsor|1
5084424|NCT02101021|17552475|P5|Overall Study|Lost to Follow-up|0
5084425|NCT02101021|17552476|P4|Overall Study|Lost to Follow-up|0
5084426|NCT02101021|17552477|P3|Overall Study|Lost to Follow-up|0
5084427|NCT02101021|17552478|P2|Overall Study|Lost to Follow-up|0
5084428|NCT02101021|17552479|P1|Overall Study|Lost to Follow-up|1
5084429|NCT02101021|17552475|P5|Overall Study|Withdrew Consent from study|0
5084430|NCT02101021|17552476|P4|Overall Study|Withdrew Consent from study|2
5084431|NCT02101021|17552477|P3|Overall Study|Withdrew Consent from study|0
5084432|NCT02101021|17552478|P2|Overall Study|Withdrew Consent from study|1
5084433|NCT02101021|17552479|P1|Overall Study|Withdrew Consent from study|1
5084434|NCT02101021|17552475|P5|Overall Study|Death|3
5084435|NCT02101021|17552476|P4|Overall Study|Death|0
5084436|NCT02101021|17552477|P3|Overall Study|Death|6
5084437|NCT02101021|17552478|P2|Overall Study|Death|3
5084438|NCT02101021|17552479|P1|Overall Study|Death|4
5084439|NCT02100969|17552526|P1|Overall Study|Did not pass screening phase|1
5084440|NCT02100839|17552545|P2|Multiple Ascending Dose|Withdrawal by Subject|0
5084441|NCT02100839|17552546|P1|Multiple Ascending Dose|Withdrawal by Subject|2
5084442|NCT02100839|17552545|P2|Multiple Ascending Dose|Adverse Event|0
5084443|NCT02100839|17552546|P1|Multiple Ascending Dose|Adverse Event|2
5084444|NCT02100813|17552577|P8|Overall Study|Adverse Event|1
5084445|NCT02100813|17552578|P7|Overall Study|Adverse Event|0
5084446|NCT02100813|17552579|P6|Overall Study|Adverse Event|0
5084447|NCT02100813|17552580|P5|Overall Study|Adverse Event|0
5084448|NCT02100813|17552581|P4|Overall Study|Adverse Event|0
5084449|NCT02100813|17552582|P3|Overall Study|Adverse Event|0
5084450|NCT02100813|17552583|P2|Overall Study|Adverse Event|0
5084451|NCT02100813|17552584|P1|Overall Study|Adverse Event|0
5084452|NCT02100670|17552661|P4|Overall Study|Withdrawal by Subject|0
5084453|NCT02100670|17552662|P3|Overall Study|Withdrawal by Subject|0
5084454|NCT02100670|17552663|P2|Overall Study|Withdrawal by Subject|0
5084455|NCT02100670|17552664|P1|Overall Study|Withdrawal by Subject|1
5084456|NCT02100670|17552661|P4|Overall Study|Physician Decision|0
5084457|NCT02100670|17552662|P3|Overall Study|Physician Decision|0
5084458|NCT02100670|17552663|P2|Overall Study|Physician Decision|1
5084459|NCT02100670|17552664|P1|Overall Study|Physician Decision|0
5084460|NCT02100670|17552661|P4|Overall Study|Poor Efficacy|0
5084461|NCT02100670|17552662|P3|Overall Study|Poor Efficacy|0
5084462|NCT02100670|17552663|P2|Overall Study|Poor Efficacy|1
5084463|NCT02100670|17552664|P1|Overall Study|Poor Efficacy|0
5084464|NCT02100670|17552661|P4|Overall Study|No swelling no pain|0
5084465|NCT02100670|17552662|P3|Overall Study|No swelling no pain|0
5084466|NCT02100670|17552663|P2|Overall Study|No swelling no pain|0
5084467|NCT02100670|17552664|P1|Overall Study|No swelling no pain|1
5084468|NCT02100670|17552661|P4|Overall Study|Withdrawal of Consent|0
5084469|NCT02100670|17552662|P3|Overall Study|Withdrawal of Consent|1
5084470|NCT02100670|17552663|P2|Overall Study|Withdrawal of Consent|1
5084471|NCT02100670|17552664|P1|Overall Study|Withdrawal of Consent|0
5084472|NCT02100670|17552661|P4|Overall Study|Protocol Violation|1
5084473|NCT02100670|17552662|P3|Overall Study|Protocol Violation|0
5084474|NCT02100670|17552663|P2|Overall Study|Protocol Violation|1
5084475|NCT02100670|17552664|P1|Overall Study|Protocol Violation|0
5084476|NCT02100670|17552661|P4|Overall Study|Lost to Follow-up|0
5084477|NCT02100670|17552662|P3|Overall Study|Lost to Follow-up|0
5084478|NCT02100670|17552663|P2|Overall Study|Lost to Follow-up|0
5084479|NCT02100670|17552664|P1|Overall Study|Lost to Follow-up|1
5084480|NCT02100670|17552661|P4|Overall Study|Adverse Event|0
5084481|NCT02100670|17552662|P3|Overall Study|Adverse Event|3
5084482|NCT02100670|17552663|P2|Overall Study|Adverse Event|3
5084483|NCT02100670|17552664|P1|Overall Study|Adverse Event|10
5084484|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Withdrawal by Subject|3
5084485|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Withdrawal by Subject|0
5084486|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Withdrawal by Subject|0
5084487|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Treatment-related adverse event|3
5084488|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Treatment-related adverse event|0
5084489|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Treatment-related adverse event|0
5084490|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Never were treated|3
5084491|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Never were treated|0
5084492|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Never were treated|0
5084493|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Physician Decision|1
5084494|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Physician Decision|0
5084495|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Physician Decision|0
5084496|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
5084497|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
5084498|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
5084499|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Death|1
5084500|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Death|0
5084501|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Death|0
5084502|NCT02100657|17552727|P3|Cohort 3: Dose Level 3|Progressive disease|15
5084503|NCT02100657|17552728|P2|Cohort 3: Dose Level 3|Progressive disease|0
5084504|NCT02100657|17552729|P1|Cohort 3: Dose Level 3|Progressive disease|0
5084505|NCT02100657|17552727|P3|Cohort 2: Dose Level 2|Treatment-related adverse event|0
5084506|NCT02100657|17552728|P2|Cohort 2: Dose Level 2|Treatment-related adverse event|1
5084507|NCT02100657|17552729|P1|Cohort 2: Dose Level 2|Treatment-related adverse event|0
5084508|NCT02100657|17552727|P3|Cohort 2: Dose Level 2|Physician Decision|0
5084509|NCT02100657|17552728|P2|Cohort 2: Dose Level 2|Physician Decision|1
5084510|NCT02100657|17552729|P1|Cohort 2: Dose Level 2|Physician Decision|0
5084511|NCT02100657|17552727|P3|Cohort 2: Dose Level 2|Progressive disease|0
5084512|NCT02100657|17552728|P2|Cohort 2: Dose Level 2|Progressive disease|2
5084513|NCT02100657|17552729|P1|Cohort 2: Dose Level 2|Progressive disease|0
5084514|NCT02100657|17552727|P3|Cohort 1: Dose Level 1|Withdrawal by Subject|0
5084515|NCT02100657|17552728|P2|Cohort 1: Dose Level 1|Withdrawal by Subject|0
5084516|NCT02100657|17552729|P1|Cohort 1: Dose Level 1|Withdrawal by Subject|1
5084517|NCT02100657|17552727|P3|Cohort 1: Dose Level 1|Treatment-related adverse event|0
5084518|NCT02100657|17552728|P2|Cohort 1: Dose Level 1|Treatment-related adverse event|0
5084519|NCT02100657|17552729|P1|Cohort 1: Dose Level 1|Treatment-related adverse event|1
5084520|NCT02100657|17552727|P3|Cohort 1: Dose Level 1|Progressive disease|0
5084521|NCT02100657|17552728|P2|Cohort 1: Dose Level 1|Progressive disease|0
5084522|NCT02100657|17552729|P1|Cohort 1: Dose Level 1|Progressive disease|6
5084523|NCT02100644|17552767|P3|LTG Escalation Phase|Withdrawal by Subject|0
5084524|NCT02100644|17552768|P2|LTG Escalation Phase|Withdrawal by Subject|0
5084525|NCT02100644|17552769|P1|LTG Escalation Phase|Withdrawal by Subject|3
5084526|NCT02100644|17552767|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
5084527|NCT02100644|17552768|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
5084528|NCT02100644|17552769|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
5084529|NCT02100644|17552767|P3|LTG Escalation Phase|Adverse Event|0
5084530|NCT02100644|17552768|P2|LTG Escalation Phase|Adverse Event|0
5084531|NCT02100644|17552769|P1|LTG Escalation Phase|Adverse Event|9
5084532|NCT02100514|17552794|P5|Extension Period|Withdrew consent|0
5084533|NCT02100514|17552795|P4|Extension Period|Withdrew consent|0
5084534|NCT02100514|17552796|P3|Extension Period|Withdrew consent|2
5084535|NCT02100514|17552797|P2|Extension Period|Withdrew consent|0
5084536|NCT02100514|17552798|P1|Extension Period|Withdrew consent|0
5084537|NCT02100514|17552794|P5|Treatment Period|Other|0
5084538|NCT02100514|17552795|P4|Treatment Period|Other|0
5084539|NCT02100514|17552796|P3|Treatment Period|Other|0
5084540|NCT02100514|17552797|P2|Treatment Period|Other|11
5084541|NCT02100514|17552798|P1|Treatment Period|Other|9
5084542|NCT02100514|17552794|P5|Treatment Period|Withdrawal by Subject|0
5084543|NCT02100514|17552795|P4|Treatment Period|Withdrawal by Subject|0
5084544|NCT02100514|17552796|P3|Treatment Period|Withdrawal by Subject|0
5084545|NCT02100514|17552797|P2|Treatment Period|Withdrawal by Subject|37
5084546|NCT02100514|17552798|P1|Treatment Period|Withdrawal by Subject|12
5084547|NCT02100514|17552794|P5|Treatment Period|Protocol Violation|0
5084548|NCT02100514|17552795|P4|Treatment Period|Protocol Violation|0
5084549|NCT02100514|17552796|P3|Treatment Period|Protocol Violation|0
5084550|NCT02100514|17552797|P2|Treatment Period|Protocol Violation|1
5084551|NCT02100514|17552798|P1|Treatment Period|Protocol Violation|1
5084552|NCT02100514|17552794|P5|Treatment Period|Did Not Meet Entrance Criteria|0
5084553|NCT02100514|17552795|P4|Treatment Period|Did Not Meet Entrance Criteria|0
5084554|NCT02100514|17552796|P3|Treatment Period|Did Not Meet Entrance Criteria|0
5084555|NCT02100514|17552797|P2|Treatment Period|Did Not Meet Entrance Criteria|1
5084556|NCT02100514|17552798|P1|Treatment Period|Did Not Meet Entrance Criteria|0
5084557|NCT02100514|17552794|P5|Treatment Period|Lost to Follow-up|0
5084558|NCT02100514|17552795|P4|Treatment Period|Lost to Follow-up|0
5084559|NCT02100514|17552796|P3|Treatment Period|Lost to Follow-up|0
5084560|NCT02100514|17552797|P2|Treatment Period|Lost to Follow-up|17
5084561|NCT02100514|17552798|P1|Treatment Period|Lost to Follow-up|5
5084562|NCT02100514|17552794|P5|Treatment Period|Death|0
5084563|NCT02100514|17552795|P4|Treatment Period|Death|0
5084564|NCT02100514|17552796|P3|Treatment Period|Death|0
5084565|NCT02100514|17552797|P2|Treatment Period|Death|2
5084566|NCT02100514|17552798|P1|Treatment Period|Death|2
5084567|NCT02100514|17552794|P5|Treatment Period|Adverse Event|0
5084568|NCT02100514|17552795|P4|Treatment Period|Adverse Event|0
5084569|NCT02100514|17552796|P3|Treatment Period|Adverse Event|0
5084570|NCT02100514|17552797|P2|Treatment Period|Adverse Event|5
5084571|NCT02100514|17552798|P1|Treatment Period|Adverse Event|0
5084572|NCT02100475|17552866|P2|Overall Study|Withdrawal criteria|0
5084573|NCT02100475|17552867|P1|Overall Study|Withdrawal criteria|1
5084574|NCT02100475|17552866|P2|Overall Study|Unclassified|2
5084575|NCT02100475|17552867|P1|Overall Study|Unclassified|1
5084576|NCT02100319|17552898|P1|Overall Study|Protocol Deviation|5
5084577|NCT02100319|17552898|P1|Overall Study|Case Report Forms Uncollected|11
5084578|NCT02100228|17552926|P2|Overall Study|Death|1
5084579|NCT02100228|17552927|P1|Overall Study|Death|1
5084580|NCT02100228|17552926|P2|Overall Study|Adverse Event|12
5084581|NCT02100228|17552927|P1|Overall Study|Adverse Event|16
5084582|NCT02100228|17552926|P2|Overall Study|Withdrawal by Subject|37
5084583|NCT02100228|17552927|P1|Overall Study|Withdrawal by Subject|27
5084584|NCT02100228|17552926|P2|Overall Study|Lost to Follow-up|1
5084585|NCT02100228|17552927|P1|Overall Study|Lost to Follow-up|0
5084586|NCT02100228|17552926|P2|Overall Study|Non-compliance|3
5084587|NCT02100228|17552927|P1|Overall Study|Non-compliance|0
5084588|NCT02100228|17552926|P2|Overall Study|Inclusion/Exclusion criteria not met|16
5084589|NCT02100228|17552927|P1|Overall Study|Inclusion/Exclusion criteria not met|12
5084590|NCT02100228|17552926|P2|Overall Study|Administrative reason|1
5084591|NCT02100228|17552927|P1|Overall Study|Administrative reason|0
5084592|NCT02100228|17552926|P2|Overall Study|Other|19
5084593|NCT02100228|17552927|P1|Overall Study|Other|19
5084594|NCT02100124|17552963|P3|Overall Study|Withdrawal by Subject|0
5084595|NCT02100124|17552964|P2|Overall Study|Withdrawal by Subject|0
5084596|NCT02100124|17552965|P1|Overall Study|Withdrawal by Subject|1
5084597|NCT02100124|17552963|P3|Overall Study|Lost to Follow-up|3
5084598|NCT02100124|17552964|P2|Overall Study|Lost to Follow-up|11
5084599|NCT02100124|17552965|P1|Overall Study|Lost to Follow-up|5
5084600|NCT02099838|17552995|P2|Overall Study|Withdrawal by Subject|1
5084601|NCT02099838|17552996|P1|Overall Study|Withdrawal by Subject|0
5084602|NCT02099838|17552995|P2|Overall Study|Lost to Follow-up|1
5084603|NCT02099838|17552996|P1|Overall Study|Lost to Follow-up|3
5084604|NCT02099838|17552995|P2|Overall Study|Death|0
5084605|NCT02099838|17552996|P1|Overall Study|Death|1
5084606|NCT02099708|17553064|P1|Overall Study|Other|29
5084607|NCT02099708|17553064|P1|Overall Study|Lost to Follow-up|141
5084608|NCT02099708|17553064|P1|Overall Study|Data Not Available|30
5084609|NCT02099682|17553075|P1|Overall Study|Other|29
5084610|NCT02099682|17553075|P1|Overall Study|Lost to Follow-up|31
5084611|NCT02099682|17553075|P1|Overall Study|Data Not Available|51
5084612|NCT02099344|17553101|P2|Overall Study|Physician Decision|0
5084613|NCT02099344|17553102|P1|Overall Study|Physician Decision|1
5084614|NCT02099110|17553139|P5|Overall Study|Physician Decision|1
5084615|NCT02099110|17553140|P4|Overall Study|Physician Decision|2
5084616|NCT02099110|17553141|P3|Overall Study|Physician Decision|1
5084617|NCT02099110|17553142|P2|Overall Study|Physician Decision|0
5084618|NCT02099110|17553143|P1|Overall Study|Physician Decision|3
5084619|NCT02099110|17553139|P5|Overall Study|Non-compliance with study drug|1
5084620|NCT02099110|17553140|P4|Overall Study|Non-compliance with study drug|0
5084621|NCT02099110|17553141|P3|Overall Study|Non-compliance with study drug|0
5084622|NCT02099110|17553142|P2|Overall Study|Non-compliance with study drug|0
5084623|NCT02099110|17553143|P1|Overall Study|Non-compliance with study drug|2
5084624|NCT02099110|17553139|P5|Overall Study|Screen failure|1
5084625|NCT02099110|17553140|P4|Overall Study|Screen failure|0
5084626|NCT02099110|17553141|P3|Overall Study|Screen failure|0
5084627|NCT02099110|17553142|P2|Overall Study|Screen failure|0
5084628|NCT02099110|17553143|P1|Overall Study|Screen failure|0
5084629|NCT02099110|17553139|P5|Overall Study|Death|0
5084630|NCT02099110|17553140|P4|Overall Study|Death|0
5084631|NCT02099110|17553141|P3|Overall Study|Death|0
5084632|NCT02099110|17553142|P2|Overall Study|Death|1
5084633|NCT02099110|17553143|P1|Overall Study|Death|0
5084634|NCT02099110|17553139|P5|Overall Study|Lost to Follow-up|6
5084635|NCT02099110|17553140|P4|Overall Study|Lost to Follow-up|5
5084636|NCT02099110|17553141|P3|Overall Study|Lost to Follow-up|11
5084637|NCT02099110|17553142|P2|Overall Study|Lost to Follow-up|12
5084638|NCT02099110|17553143|P1|Overall Study|Lost to Follow-up|6
5084639|NCT02099110|17553139|P5|Overall Study|Adverse Event|2
5084640|NCT02099110|17553140|P4|Overall Study|Adverse Event|3
5084641|NCT02099110|17553141|P3|Overall Study|Adverse Event|2
5084642|NCT02099110|17553142|P2|Overall Study|Adverse Event|5
5084643|NCT02099110|17553143|P1|Overall Study|Adverse Event|3
5084644|NCT02099110|17553139|P5|Overall Study|Withdrawal by Subject|13
5084645|NCT02099110|17553140|P4|Overall Study|Withdrawal by Subject|9
5084646|NCT02099110|17553141|P3|Overall Study|Withdrawal by Subject|13
5084647|NCT02099110|17553142|P2|Overall Study|Withdrawal by Subject|11
5084648|NCT02099110|17553143|P1|Overall Study|Withdrawal by Subject|7
5084649|NCT02099110|17553139|P5|Overall Study|Participant moved|2
5084650|NCT02099110|17553140|P4|Overall Study|Participant moved|0
5084651|NCT02099110|17553141|P3|Overall Study|Participant moved|1
5084652|NCT02099110|17553142|P2|Overall Study|Participant moved|1
5084653|NCT02099110|17553143|P1|Overall Study|Participant moved|1
5084654|NCT02099110|17553139|P5|Overall Study|Protocol Violation|1
5084655|NCT02099110|17553140|P4|Overall Study|Protocol Violation|3
5084656|NCT02099110|17553141|P3|Overall Study|Protocol Violation|0
5084657|NCT02099110|17553142|P2|Overall Study|Protocol Violation|1
5084658|NCT02099110|17553143|P1|Overall Study|Protocol Violation|2
5084659|NCT02098746|17553244|P1|Overall Study|Data Not Available After Treatment|1
5084660|NCT02098746|17553244|P1|Overall Study|Enrolled 15 Days After the First Dose|1
5084661|NCT02098746|17553244|P1|Overall Study|Other Miscellaneous Reasons|1
5084662|NCT02098746|17553244|P1|Overall Study|Changes of Investigator|2
5084663|NCT02098733|17553252|P1|Overall Study|Lost to Follow-up|5
5084664|NCT02098733|17553252|P1|Overall Study|Data Not Available|5
5084665|NCT02098395|17553266|P4|Overall Study|Unclassified|2
5084666|NCT02098395|17553267|P3|Overall Study|Unclassified|3
5084667|NCT02098395|17553268|P2|Overall Study|Unclassified|0
5084668|NCT02098395|17553269|P1|Overall Study|Unclassified|0
5084669|NCT02098395|17553266|P4|Overall Study|Lost to Follow-up|3
5084670|NCT02098395|17553267|P3|Overall Study|Lost to Follow-up|0
5084671|NCT02098395|17553268|P2|Overall Study|Lost to Follow-up|1
5084672|NCT02098395|17553269|P1|Overall Study|Lost to Follow-up|2
5084673|NCT02098395|17553266|P4|Overall Study|Adverse Event|2
5084674|NCT02098395|17553267|P3|Overall Study|Adverse Event|34
5084675|NCT02098395|17553268|P2|Overall Study|Adverse Event|19
5084676|NCT02098395|17553269|P1|Overall Study|Adverse Event|12
5084677|NCT02098395|17553266|P4|Overall Study|Withdrawal by Subject|13
5084678|NCT02098395|17553267|P3|Overall Study|Withdrawal by Subject|5
5084679|NCT02098395|17553268|P2|Overall Study|Withdrawal by Subject|10
5084680|NCT02098395|17553269|P1|Overall Study|Withdrawal by Subject|10
5084681|NCT02098395|17553266|P4|Overall Study|Protocol Violation|7
5084682|NCT02098395|17553267|P3|Overall Study|Protocol Violation|0
5084683|NCT02098395|17553268|P2|Overall Study|Protocol Violation|2
5084684|NCT02098395|17553269|P1|Overall Study|Protocol Violation|2
5084685|NCT02098369|17553290|P3|Overall Study|Other|1
5084686|NCT02098369|17553291|P2|Overall Study|Other|2
5084687|NCT02098369|17553292|P1|Overall Study|Other|0
5084688|NCT02098369|17553290|P3|Overall Study|Death|1
5084689|NCT02098369|17553291|P2|Overall Study|Death|1
5084690|NCT02098369|17553292|P1|Overall Study|Death|1
5084691|NCT02098369|17553290|P3|Overall Study|Lost to Follow-up|3
5084692|NCT02098369|17553291|P2|Overall Study|Lost to Follow-up|1
5084693|NCT02098369|17553292|P1|Overall Study|Lost to Follow-up|5
5084694|NCT02098369|17553290|P3|Overall Study|Withdrawal by Subject|0
5084695|NCT02098369|17553291|P2|Overall Study|Withdrawal by Subject|5
5084696|NCT02098369|17553292|P1|Overall Study|Withdrawal by Subject|1
5084697|NCT02098109|17553330|P2|Overall Study|Protocol Violation|0
5084698|NCT02098109|17553331|P1|Overall Study|Protocol Violation|3
5084699|NCT02097823|17553409|P2|Overall Study|Withdrawal by Subject|1
5084700|NCT02097823|17553410|P1|Overall Study|Withdrawal by Subject|1
5084701|NCT02097745|17553425|P1|Overall Study|Reason Not Specified|96
5084702|NCT02097745|17553425|P1|Overall Study|Administrative/Other|27
5084703|NCT02097745|17553425|P1|Overall Study|Failure to Return|14
5084704|NCT02097745|17553425|P1|Overall Study|Death|16
5084705|NCT02097745|17553425|P1|Overall Study|Adverse Event|25
5084706|NCT02097719|17553463|P2|Overall Study|Adverse Event|0
5084707|NCT02097719|17553464|P1|Overall Study|Adverse Event|2
5084708|NCT02097719|17553463|P2|Overall Study|Lost to Follow-up|1
5084709|NCT02097719|17553464|P1|Overall Study|Lost to Follow-up|0
5084710|NCT02097719|17553463|P2|Overall Study|Subject Withdrew Consent|0
5084711|NCT02097719|17553464|P1|Overall Study|Subject Withdrew Consent|1
5084712|NCT02097472|17553529|P8|Received Vaccination 2|Adverse Event|0
5084713|NCT02097472|17553530|P7|Received Vaccination 2|Adverse Event|1
5084714|NCT02097472|17553531|P6|Received Vaccination 2|Adverse Event|0
5084715|NCT02097472|17553532|P5|Received Vaccination 2|Adverse Event|0
5084716|NCT02097472|17553533|P4|Received Vaccination 2|Adverse Event|0
5084717|NCT02097472|17553534|P3|Received Vaccination 2|Adverse Event|0
5084718|NCT02097472|17553535|P2|Received Vaccination 2|Adverse Event|0
5084719|NCT02097472|17553536|P1|Received Vaccination 2|Adverse Event|0
5084720|NCT02097420|17553957|P1|Overall Study|Not reached 12-month visit|7
5084721|NCT02097420|17553957|P1|Overall Study|Device explanted|3
5084722|NCT02097420|17553957|P1|Overall Study|Death|4
5084723|NCT02097290|17553980|P1|Overall Study|Attempt|8
5084724|NCT02097290|17553980|P1|Overall Study|Total Withdrawals|3
5084725|NCT02097290|17553980|P1|Overall Study|Death|6
5084726|NCT02097277|17553995|P5|Overall Study|Adverse Event|0
5084727|NCT02097277|17553996|P4|Overall Study|Adverse Event|2
5084728|NCT02097277|17553997|P3|Overall Study|Adverse Event|1
5084729|NCT02097277|17553998|P2|Overall Study|Adverse Event|0
5084730|NCT02097277|17553999|P1|Overall Study|Adverse Event|0
5084731|NCT02097277|17553995|P5|Overall Study|Withdrawal by Subject|0
5084732|NCT02097277|17553996|P4|Overall Study|Withdrawal by Subject|1
5084733|NCT02097277|17553997|P3|Overall Study|Withdrawal by Subject|0
5084734|NCT02097277|17553998|P2|Overall Study|Withdrawal by Subject|1
5084735|NCT02097277|17553999|P1|Overall Study|Withdrawal by Subject|2
5084736|NCT02097277|17553995|P5|Overall Study|Lost to Follow-up|0
5084737|NCT02097277|17553996|P4|Overall Study|Lost to Follow-up|0
5084738|NCT02097277|17553997|P3|Overall Study|Lost to Follow-up|1
5084739|NCT02097277|17553998|P2|Overall Study|Lost to Follow-up|1
5084740|NCT02097277|17553999|P1|Overall Study|Lost to Follow-up|0
5084741|NCT02097277|17553995|P5|Overall Study|Subject request to discontinue treatment|1
5084742|NCT02097277|17553996|P4|Overall Study|Subject request to discontinue treatment|0
5084743|NCT02097277|17553997|P3|Overall Study|Subject request to discontinue treatment|0
5084744|NCT02097277|17553998|P2|Overall Study|Subject request to discontinue treatment|0
5084745|NCT02097277|17553999|P1|Overall Study|Subject request to discontinue treatment|0
5084746|NCT02097277|17553995|P5|Overall Study|Subject no longer meets study criteria|0
5084747|NCT02097277|17553996|P4|Overall Study|Subject no longer meets study criteria|1
5084748|NCT02097277|17553997|P3|Overall Study|Subject no longer meets study criteria|0
5084749|NCT02097277|17553998|P2|Overall Study|Subject no longer meets study criteria|1
5084750|NCT02097277|17553999|P1|Overall Study|Subject no longer meets study criteria|0
5084751|NCT02097238|17554082|P1|Overall Study|Progressive Disease|17
5084752|NCT02097238|17554082|P1|Overall Study|Physician Decision|1
5084753|NCT02097238|17554082|P1|Overall Study|Death|1
5084754|NCT02097134|17554091|P1|Overall Study|Refusal of Further Protocol Therapy|1
5084755|NCT02097134|17554091|P1|Overall Study|Progressive Disease|3
5084756|NCT02097134|17554091|P1|Overall Study|Non-Protocol Therapy|1
5084757|NCT02097134|17554091|P1|Overall Study|Physician Decision|4
5084758|NCT02097108|17554099|P1|Overall Study|patient was abroad for 6 months|1
5084759|NCT02097108|17554099|P1|Overall Study|Adverse Event|1
5084760|NCT02097056|17554106|P1|Overall Study|Other|2
5084761|NCT02097056|17554106|P1|Overall Study|Adverse Event|37
5084762|NCT02097056|17554106|P1|Overall Study|Lost to Follow-up|2
5084763|NCT02097056|17554106|P1|Overall Study|Withdrawal by Subject|15
5084764|NCT02097056|17554106|P1|Overall Study|Protocol Violation|2
5084765|NCT02097030|17554114|P2|First Intervention (3 Days)|Visual Acuity|1
5084766|NCT02097030|17554115|P1|First Intervention (3 Days)|Visual Acuity|0
5084767|NCT02097030|17554114|P2|First Intervention (3 Days)|Lost to Follow-up|0
5084768|NCT02097030|17554115|P1|First Intervention (3 Days)|Lost to Follow-up|1
5084769|NCT02096952|17554176|P1|Overall Study|Adverse Event|1
5084770|NCT02096900|17554182|P2|Overall Study|Surgery cancelled- medication received|1
5084771|NCT02096900|17554183|P1|Overall Study|Surgery cancelled- medication received|1
5084772|NCT02096900|17554182|P2|Overall Study|Did not receive medication|1
5084773|NCT02096900|17554183|P1|Overall Study|Did not receive medication|3
5084774|NCT02096835|17554235|P3|Overall Study|Lost to Follow-up|1
5084775|NCT02096835|17554236|P2|Overall Study|Lost to Follow-up|0
5084776|NCT02096835|17554237|P1|Overall Study|Lost to Follow-up|1
5084777|NCT02096835|17554235|P3|Overall Study|converted to open procedures|0
5084778|NCT02096835|17554236|P2|Overall Study|converted to open procedures|0
5084779|NCT02096835|17554237|P1|Overall Study|converted to open procedures|1
5084780|NCT02096835|17554235|P3|Overall Study|Withdrawal by Subject|0
5084781|NCT02096835|17554236|P2|Overall Study|Withdrawal by Subject|0
5084782|NCT02096835|17554237|P1|Overall Study|Withdrawal by Subject|1
5084783|NCT02096744|17554254|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
5084784|NCT02096744|17554255|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
5084785|NCT02096744|17554254|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
5084786|NCT02096744|17554255|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
5084787|NCT02096744|17554254|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
5084788|NCT02096744|17554255|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
5084789|NCT02096705|17554309|P2|Follow-up|Subjects not reporting status|2
5084790|NCT02096705|17554310|P1|Follow-up|Subjects not reporting status|1
5084791|NCT02096705|17554309|P2|Follow-up|Adverse Event|2
5084792|NCT02096705|17554310|P1|Follow-up|Adverse Event|2
5084793|NCT02096705|17554309|P2|Follow-up|Withdrawal by Subject|0
5084794|NCT02096705|17554310|P1|Follow-up|Withdrawal by Subject|1
5084795|NCT02096705|17554309|P2|Treatment|Other|1
5084796|NCT02096705|17554310|P1|Treatment|Other|1
5084797|NCT02096705|17554309|P2|Treatment|Withdrawal by Subject|0
5084798|NCT02096705|17554310|P1|Treatment|Withdrawal by Subject|1
5084799|NCT02096705|17554309|P2|Treatment|Subject request to discontinue treatment|1
5084800|NCT02096705|17554310|P1|Treatment|Subject request to discontinue treatment|1
5084801|NCT02096705|17554309|P2|Treatment|Adverse Event|3
5084802|NCT02096705|17554310|P1|Treatment|Adverse Event|6
5084803|NCT02096588|17554353|P2|Overall Study|Withdrawal by Subject|1
5084804|NCT02096588|17554354|P1|Overall Study|Withdrawal by Subject|0
5084805|NCT02096588|17554353|P2|Overall Study|Lack of Efficacy|0
5084806|NCT02096588|17554354|P1|Overall Study|Lack of Efficacy|2
5084807|NCT02096471|17554380|P1|Overall Study|Non-Compliant|2
5084808|NCT02096471|17554380|P1|Overall Study|Withdrawal by Subject|3
5084809|NCT02096471|17554380|P1|Overall Study|Lack of Efficacy|7
5084810|NCT02096471|17554380|P1|Overall Study|Adverse Event|1
5084811|NCT02096263|17554398|P3|Overall Study|Withdrawal by Subject|8
5084812|NCT02096263|17554399|P2|Overall Study|Withdrawal by Subject|7
5084813|NCT02096263|17554400|P1|Overall Study|Withdrawal by Subject|5
5084814|NCT02096263|17554398|P3|Overall Study|Protocol Violation|8
5084815|NCT02096263|17554399|P2|Overall Study|Protocol Violation|2
5084816|NCT02096263|17554400|P1|Overall Study|Protocol Violation|7
5084817|NCT02096263|17554398|P3|Overall Study|Sponsor study termination|1
5084818|NCT02096263|17554399|P2|Overall Study|Sponsor study termination|0
5084819|NCT02096263|17554400|P1|Overall Study|Sponsor study termination|0
5084820|NCT02096263|17554398|P3|Overall Study|Other|6
5084821|NCT02096263|17554399|P2|Overall Study|Other|9
5084822|NCT02096263|17554400|P1|Overall Study|Other|7
5084823|NCT02096263|17554398|P3|Overall Study|Lost to Follow-up|15
5084824|NCT02096263|17554399|P2|Overall Study|Lost to Follow-up|18
5084825|NCT02096263|17554400|P1|Overall Study|Lost to Follow-up|14
5084826|NCT02096263|17554398|P3|Overall Study|Adverse Event|1
5084827|NCT02096263|17554399|P2|Overall Study|Adverse Event|0
5084828|NCT02096263|17554400|P1|Overall Study|Adverse Event|1
5084829|NCT02096042|17554588|P3|Overall Study|Disease Progression|0
5084830|NCT02096042|17554589|P2|Overall Study|Disease Progression|0
5084831|NCT02096042|17554590|P1|Overall Study|Disease Progression|1
5084832|NCT02096003|17554612|P2|Overall Study|additional surgery|1
5084833|NCT02096003|17554613|P1|Overall Study|additional surgery|2
5084834|NCT02096003|17554612|P2|Overall Study|Protocol Violation|2
5084835|NCT02096003|17554613|P1|Overall Study|Protocol Violation|0
5084836|NCT02095951|17554629|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
5084837|NCT02095951|17554630|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
5084838|NCT02095873|17554650|P2|Second Intervention (8 Weeks)|Protocol Violation|0
5084839|NCT02095873|17554651|P1|Second Intervention (8 Weeks)|Protocol Violation|1
5084840|NCT02095873|17554650|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
5084841|NCT02095873|17554651|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
5084842|NCT02095873|17554650|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
5084843|NCT02095873|17554651|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
5084844|NCT02095691|17554663|P1|Overall Study|Physician Decision|1
5084845|NCT02095535|17554695|P1|Recruitment|Protocol Violation|2
5084846|NCT02095223|17554717|P2|Overall Study|Withdrawal by Subject|0
5084847|NCT02095223|17554718|P1|Overall Study|Withdrawal by Subject|1
5084848|NCT02095197|17554728|P2|Overall Study|Lost to Follow-up|3
5084849|NCT02095197|17554729|P1|Overall Study|Lost to Follow-up|0
5084850|NCT02095158|17554741|P1|Overall Study|Other Miscellaneous Reasons|1
5084851|NCT02095158|17554741|P1|Overall Study|Protocol Violation|1
5084852|NCT02095158|17554741|P1|Overall Study|Personal Reasons|35
5084853|NCT02095158|17554741|P1|Overall Study|Lost to Follow-up|20
5084854|NCT02095158|17554741|P1|Overall Study|Pregnancy|1
5084855|NCT02095158|17554741|P1|Overall Study|Lack of Efficacy|3
5084856|NCT02095158|17554741|P1|Overall Study|Adverse Event|14
5084857|NCT02095145|17554748|P2|Overall Study|Withdrawal by Subject|0
5084858|NCT02095145|17554749|P1|Overall Study|Withdrawal by Subject|1
5084859|NCT02095106|17554795|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5084860|NCT02095106|17554796|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5084861|NCT02094937|17554812|P4|12 Weeks in Period 2|Randomized incorrectly|0
5084862|NCT02094937|17554813|P3|12 Weeks in Period 2|Randomized incorrectly|0
5084863|NCT02094937|17554814|P2|12 Weeks in Period 2|Randomized incorrectly|1
5084864|NCT02094937|17554815|P1|12 Weeks in Period 2|Randomized incorrectly|0
5084865|NCT02094937|17554812|P4|12 Weeks in Period 2|Withdrawal by Subject|0
5084866|NCT02094937|17554813|P3|12 Weeks in Period 2|Withdrawal by Subject|2
5084867|NCT02094937|17554814|P2|12 Weeks in Period 2|Withdrawal by Subject|2
5084868|NCT02094937|17554815|P1|12 Weeks in Period 2|Withdrawal by Subject|0
5084869|NCT02094937|17554812|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
5084870|NCT02094937|17554813|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
5084871|NCT02094937|17554814|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
5084872|NCT02094937|17554815|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
5084873|NCT02094937|17554812|P4|12 Weeks in Period 2|Lack of Efficacy|0
5084874|NCT02094937|17554813|P3|12 Weeks in Period 2|Lack of Efficacy|0
5084875|NCT02094937|17554814|P2|12 Weeks in Period 2|Lack of Efficacy|1
5084876|NCT02094937|17554815|P1|12 Weeks in Period 2|Lack of Efficacy|0
5084877|NCT02094937|17554812|P4|12 Weeks in Period 2|Adverse Event|1
5084878|NCT02094937|17554813|P3|12 Weeks in Period 2|Adverse Event|4
5084879|NCT02094937|17554814|P2|12 Weeks in Period 2|Adverse Event|2
5084880|NCT02094937|17554815|P1|12 Weeks in Period 2|Adverse Event|0
5084881|NCT02094937|17554812|P4|8 Weeks in Period 1|Withdrawal by Subject|0
5084882|NCT02094937|17554813|P3|8 Weeks in Period 1|Withdrawal by Subject|0
5084883|NCT02094937|17554814|P2|8 Weeks in Period 1|Withdrawal by Subject|0
5084884|NCT02094937|17554815|P1|8 Weeks in Period 1|Withdrawal by Subject|4
5084885|NCT02094937|17554812|P4|8 Weeks in Period 1|Physician Decision|0
5084886|NCT02094937|17554813|P3|8 Weeks in Period 1|Physician Decision|0
5084887|NCT02094937|17554814|P2|8 Weeks in Period 1|Physician Decision|0
5084888|NCT02094937|17554815|P1|8 Weeks in Period 1|Physician Decision|1
5084889|NCT02094937|17554812|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
5084890|NCT02094937|17554813|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
5084891|NCT02094937|17554814|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
5084892|NCT02094937|17554815|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
5084893|NCT02094937|17554812|P4|8 Weeks in Period 1|Protocol Violation|0
5084894|NCT02094937|17554813|P3|8 Weeks in Period 1|Protocol Violation|0
5084895|NCT02094937|17554814|P2|8 Weeks in Period 1|Protocol Violation|0
5084896|NCT02094937|17554815|P1|8 Weeks in Period 1|Protocol Violation|2
5084897|NCT02094937|17554812|P4|8 Weeks in Period 1|Lack of Efficacy|0
5084898|NCT02094937|17554813|P3|8 Weeks in Period 1|Lack of Efficacy|0
5084899|NCT02094937|17554814|P2|8 Weeks in Period 1|Lack of Efficacy|0
5084900|NCT02094937|17554815|P1|8 Weeks in Period 1|Lack of Efficacy|3
5084901|NCT02094937|17554812|P4|8 Weeks in Period 1|Adverse Event|0
5084902|NCT02094937|17554813|P3|8 Weeks in Period 1|Adverse Event|0
5084903|NCT02094937|17554814|P2|8 Weeks in Period 1|Adverse Event|0
5084904|NCT02094937|17554815|P1|8 Weeks in Period 1|Adverse Event|9
5084905|NCT02094898|17554845|P1|Overall Study|Lack of Efficacy|1
5084906|NCT02094898|17554845|P1|Overall Study|Adverse Event|2
5084907|NCT02094898|17554845|P1|Overall Study|Clinical Worsening|2
5084908|NCT02094885|17554892|P2|Overall Study|Withdrawn due to age|0
5084909|NCT02094885|17554893|P1|Overall Study|Withdrawn due to age|1
5084910|NCT02094885|17554892|P2|Overall Study|Death|5
5084911|NCT02094885|17554893|P1|Overall Study|Death|1
5084912|NCT02094677|17554916|P2|Overall Study|Screening|1
5084913|NCT02094677|17554917|P1|Overall Study|Screening|3
5084914|NCT02094612|17554996|P2|Overall Study|Never started ADHD medication|23
5084915|NCT02094612|17554997|P1|Overall Study|Never started ADHD medication|32
5084916|NCT02094612|17554996|P2|Overall Study|Lost to Follow-up|47
5084917|NCT02094612|17554997|P1|Overall Study|Lost to Follow-up|47
5084918|NCT02094573|17555017|P2|Overall Study|Ongoing|76
5084919|NCT02094573|17555018|P1|Overall Study|Ongoing|64
5084920|NCT02094573|17555017|P2|Overall Study|Randomized but not treated|0
5084921|NCT02094573|17555018|P1|Overall Study|Randomized but not treated|3
5084922|NCT02094573|17555017|P2|Overall Study|Withdrawal by Subject|4
5084923|NCT02094573|17555018|P1|Overall Study|Withdrawal by Subject|2
5084924|NCT02094573|17555017|P2|Overall Study|Non-compliance with study drug|1
5084925|NCT02094573|17555018|P1|Overall Study|Non-compliance with study drug|0
5084926|NCT02094573|17555017|P2|Overall Study|Death|1
5084927|NCT02094573|17555018|P1|Overall Study|Death|7
5084928|NCT02094573|17555017|P2|Overall Study|Adverse Event|9
5084929|NCT02094573|17555018|P1|Overall Study|Adverse Event|3
5084930|NCT02094573|17555017|P2|Overall Study|Clinical Progressive Disease|3
5084931|NCT02094573|17555018|P1|Overall Study|Clinical Progressive Disease|4
5084932|NCT02094573|17555017|P2|Overall Study|Documented Progressive Disease|16
5084933|NCT02094573|17555018|P1|Overall Study|Documented Progressive Disease|29
5084934|NCT02094300|17555100|P1|Overall Study|Still be eligible for follow-up|3
5084935|NCT02094300|17555100|P1|Overall Study|Lost to Follow-up|10
5084936|NCT02094300|17555100|P1|Overall Study|Death|7
5084937|NCT02094261|17555104|P1|Overall Study|Ongoing Study at Data Cut-off|181
5084938|NCT02094261|17555104|P1|Overall Study|Withdrawal by Subject|4
5084939|NCT02094261|17555104|P1|Overall Study|Lost to Follow-up|1
5084940|NCT02094261|17555104|P1|Overall Study|Death|24
5084941|NCT02093923|17555146|P5|Overall Study|Screen failure after randomization|0
5084942|NCT02093923|17555147|P4|Overall Study|Screen failure after randomization|1
5084943|NCT02093923|17555148|P3|Overall Study|Screen failure after randomization|0
5084944|NCT02093923|17555149|P2|Overall Study|Screen failure after randomization|0
5084945|NCT02093923|17555150|P1|Overall Study|Screen failure after randomization|0
5084946|NCT02093923|17555146|P5|Overall Study|Lost to Follow-up|0
5084947|NCT02093923|17555147|P4|Overall Study|Lost to Follow-up|1
5084948|NCT02093923|17555148|P3|Overall Study|Lost to Follow-up|0
5084949|NCT02093923|17555149|P2|Overall Study|Lost to Follow-up|0
5084950|NCT02093923|17555150|P1|Overall Study|Lost to Follow-up|0
5084951|NCT02093897|17555205|P1|Overall Study|Adverse event, non-fatal|1
5084952|NCT02093897|17555205|P1|Overall Study|Planned age group closure - no's reached|17
5084953|NCT02093897|17555205|P1|Overall Study|Physician Decision|1
5084954|NCT02093689|17555321|P3|Overall Study|Physician Decision|0
5084955|NCT02093689|17555322|P2|Overall Study|Physician Decision|0
5084956|NCT02093689|17555323|P1|Overall Study|Physician Decision|4
5084957|NCT02093663|17555329|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
5084958|NCT02093663|17555330|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5084959|NCT02093663|17555331|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5084960|NCT02093663|17555332|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5084961|NCT02093663|17555333|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5084962|NCT02093663|17555329|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
5084963|NCT02093663|17555330|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
5084964|NCT02093663|17555331|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5084965|NCT02093663|17555332|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5084966|NCT02093663|17555333|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5084967|NCT02093663|17555329|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
5084968|NCT02093663|17555330|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
5084969|NCT02093663|17555331|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5084970|NCT02093663|17555332|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5084971|NCT02093663|17555333|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5084972|NCT02093663|17555329|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
5084973|NCT02093663|17555330|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
5084974|NCT02093663|17555331|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5084975|NCT02093663|17555332|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5084976|NCT02093663|17555333|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5084977|NCT02093663|17555329|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5084978|NCT02093663|17555330|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5084979|NCT02093663|17555331|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
5084980|NCT02093663|17555332|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5084981|NCT02093663|17555333|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5084982|NCT02093663|17555329|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5084983|NCT02093663|17555330|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5084984|NCT02093663|17555331|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
5084985|NCT02093663|17555332|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5084986|NCT02093663|17555333|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5084987|NCT02093663|17555329|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5084988|NCT02093663|17555330|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5084989|NCT02093663|17555331|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5084990|NCT02093663|17555332|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
5084991|NCT02093663|17555333|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
5084992|NCT02093663|17555329|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5084993|NCT02093663|17555330|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5084994|NCT02093663|17555331|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5084995|NCT02093663|17555332|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5084996|NCT02093663|17555333|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
5084997|NCT02093663|17555329|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5084998|NCT02093663|17555330|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5084999|NCT02093663|17555331|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5085000|NCT02093663|17555332|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5085001|NCT02093663|17555333|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
5085002|NCT02093520|17555362|P2|Overall Study|Not treated|22
5085003|NCT02093520|17555363|P1|Overall Study|Not treated|6
5085004|NCT02093390|17555375|P2|Overall Study|Withdrawal by Subject|1
5085005|NCT02093390|17555376|P1|Overall Study|Withdrawal by Subject|0
5085006|NCT02093351|17555415|P4|Part B|Death|1
5085007|NCT02093351|17555416|P3|Part B|Death|0
5085008|NCT02093351|17555417|P2|Part B|Death|0
5085009|NCT02093351|17555418|P1|Part B|Death|0
5085010|NCT02093351|17555415|P4|Part B|Adverse Event|2
5085011|NCT02093351|17555416|P3|Part B|Adverse Event|0
5085012|NCT02093351|17555417|P2|Part B|Adverse Event|0
5085013|NCT02093351|17555418|P1|Part B|Adverse Event|0
5085014|NCT02093351|17555415|P4|Part B|Condition under investigation worsened|39
5085015|NCT02093351|17555416|P3|Part B|Condition under investigation worsened|0
5085016|NCT02093351|17555417|P2|Part B|Condition under investigation worsened|0
5085017|NCT02093351|17555418|P1|Part B|Condition under investigation worsened|0
5085018|NCT02093351|17555415|P4|Part B|Lack of therapeutic response|12
5085019|NCT02093351|17555416|P3|Part B|Lack of therapeutic response|0
5085020|NCT02093351|17555417|P2|Part B|Lack of therapeutic response|0
5085021|NCT02093351|17555418|P1|Part B|Lack of therapeutic response|0
5085022|NCT02093351|17555415|P4|Part B|Adverse event + disease progression|1
5085023|NCT02093351|17555416|P3|Part B|Adverse event + disease progression|0
5085024|NCT02093351|17555417|P2|Part B|Adverse event + disease progression|0
5085025|NCT02093351|17555418|P1|Part B|Adverse event + disease progression|0
5085026|NCT02093351|17555415|P4|Part B|Complete response|1
5085027|NCT02093351|17555416|P3|Part B|Complete response|0
5085028|NCT02093351|17555417|P2|Part B|Complete response|0
5085029|NCT02093351|17555418|P1|Part B|Complete response|0
5085030|NCT02093351|17555415|P4|Part B|Disease progression|4
5085031|NCT02093351|17555416|P3|Part B|Disease progression|0
5085032|NCT02093351|17555417|P2|Part B|Disease progression|0
5085033|NCT02093351|17555418|P1|Part B|Disease progression|0
5085034|NCT02093351|17555415|P4|Part B|Patient decision|3
5085035|NCT02093351|17555416|P3|Part B|Patient decision|0
5085036|NCT02093351|17555417|P2|Part B|Patient decision|0
5085037|NCT02093351|17555418|P1|Part B|Patient decision|0
5085038|NCT02093351|17555415|P4|Part A|Death|0
5085039|NCT02093351|17555416|P3|Part A|Death|0
5085040|NCT02093351|17555417|P2|Part A|Death|1
5085041|NCT02093351|17555418|P1|Part A|Death|0
5085042|NCT02093351|17555415|P4|Part A|Condition under investigation worsened|0
5085043|NCT02093351|17555416|P3|Part A|Condition under investigation worsened|2
5085044|NCT02093351|17555417|P2|Part A|Condition under investigation worsened|0
5085045|NCT02093351|17555418|P1|Part A|Condition under investigation worsened|2
5085046|NCT02093351|17555415|P4|Part A|Adverse Event|0
5085047|NCT02093351|17555416|P3|Part A|Adverse Event|1
5085048|NCT02093351|17555417|P2|Part A|Adverse Event|1
5085049|NCT02093351|17555418|P1|Part A|Adverse Event|0
5085050|NCT02093221|17555475|P5|Overall Study|Study termination|7
5085051|NCT02093221|17555476|P4|Overall Study|Study termination|6
5085052|NCT02093221|17555477|P3|Overall Study|Study termination|4
5085053|NCT02093221|17555478|P2|Overall Study|Study termination|5
5085054|NCT02093221|17555479|P1|Overall Study|Study termination|6
5085055|NCT02093221|17555475|P5|Overall Study|Protocol Violation|0
5085056|NCT02093221|17555476|P4|Overall Study|Protocol Violation|0
5085057|NCT02093221|17555477|P3|Overall Study|Protocol Violation|0
5085058|NCT02093221|17555478|P2|Overall Study|Protocol Violation|1
5085059|NCT02093221|17555479|P1|Overall Study|Protocol Violation|0
5085060|NCT02093221|17555475|P5|Overall Study|Death|0
5085061|NCT02093221|17555476|P4|Overall Study|Death|0
5085062|NCT02093221|17555477|P3|Overall Study|Death|0
5085063|NCT02093221|17555478|P2|Overall Study|Death|1
5085064|NCT02093221|17555479|P1|Overall Study|Death|0
5085065|NCT02093221|17555475|P5|Overall Study|Lost to Follow-up|0
5085066|NCT02093221|17555476|P4|Overall Study|Lost to Follow-up|1
5085067|NCT02093221|17555477|P3|Overall Study|Lost to Follow-up|1
5085068|NCT02093221|17555478|P2|Overall Study|Lost to Follow-up|0
5085069|NCT02093221|17555479|P1|Overall Study|Lost to Follow-up|2
5085070|NCT02093221|17555475|P5|Overall Study|Withdrawal by Subject|1
5085071|NCT02093221|17555476|P4|Overall Study|Withdrawal by Subject|1
5085072|NCT02093221|17555477|P3|Overall Study|Withdrawal by Subject|4
5085073|NCT02093221|17555478|P2|Overall Study|Withdrawal by Subject|1
5085074|NCT02093221|17555479|P1|Overall Study|Withdrawal by Subject|1
5085075|NCT02093221|17555475|P5|Overall Study|Adverse Event|0
5085076|NCT02093221|17555476|P4|Overall Study|Adverse Event|0
5085077|NCT02093221|17555477|P3|Overall Study|Adverse Event|0
5085078|NCT02093221|17555478|P2|Overall Study|Adverse Event|0
5085079|NCT02093221|17555479|P1|Overall Study|Adverse Event|1
5085080|NCT02093026|17555516|P1|Overall Study|Other|157
5085081|NCT02093026|17555516|P1|Overall Study|Death|10
5085082|NCT02093026|17555516|P1|Overall Study|Adverse Event|26
5085083|NCT02092961|17555538|P3|Overall Study|Adverse Event|0
5085084|NCT02092961|17555539|P2|Overall Study|Adverse Event|4
5085085|NCT02092961|17555540|P1|Overall Study|Adverse Event|2
5085086|NCT02092961|17555538|P3|Overall Study|Dev. of study specific discont. criteria|0
5085087|NCT02092961|17555539|P2|Overall Study|Dev. of study specific discont. criteria|0
5085088|NCT02092961|17555540|P1|Overall Study|Dev. of study specific discont. criteria|3
5085089|NCT02092961|17555538|P3|Overall Study|Lack of therapeutic response|3
5085090|NCT02092961|17555539|P2|Overall Study|Lack of therapeutic response|1
5085091|NCT02092961|17555540|P1|Overall Study|Lack of therapeutic response|2
5085092|NCT02092961|17555538|P3|Overall Study|Study stopped|12
5085093|NCT02092961|17555539|P2|Overall Study|Study stopped|9
5085094|NCT02092961|17555540|P1|Overall Study|Study stopped|13
5085095|NCT02092961|17555538|P3|Overall Study|Not reported|1
5085096|NCT02092961|17555539|P2|Overall Study|Not reported|0
5085097|NCT02092961|17555540|P1|Overall Study|Not reported|1
5085098|NCT02092909|17555565|P4|Overall Study|Miscellaneous|1
5085099|NCT02092909|17555566|P3|Overall Study|Miscellaneous|2
5085100|NCT02092909|17555567|P2|Overall Study|Miscellaneous|1
5085101|NCT02092909|17555568|P1|Overall Study|Miscellaneous|1
5085102|NCT02092909|17555565|P4|Overall Study|Study terminated by Sponsor|2
5085103|NCT02092909|17555566|P3|Overall Study|Study terminated by Sponsor|0
5085104|NCT02092909|17555567|P2|Overall Study|Study terminated by Sponsor|0
5085105|NCT02092909|17555568|P1|Overall Study|Study terminated by Sponsor|0
5085106|NCT02092909|17555565|P4|Overall Study|Withdrawal by Subject|1
5085107|NCT02092909|17555566|P3|Overall Study|Withdrawal by Subject|2
5085108|NCT02092909|17555567|P2|Overall Study|Withdrawal by Subject|0
5085109|NCT02092909|17555568|P1|Overall Study|Withdrawal by Subject|0
5085110|NCT02092909|17555565|P4|Overall Study|Lack of Efficacy|0
5085111|NCT02092909|17555566|P3|Overall Study|Lack of Efficacy|1
5085112|NCT02092909|17555567|P2|Overall Study|Lack of Efficacy|2
5085113|NCT02092909|17555568|P1|Overall Study|Lack of Efficacy|0
5085114|NCT02092909|17555565|P4|Overall Study|Adverse Event|2
5085115|NCT02092909|17555566|P3|Overall Study|Adverse Event|4
5085116|NCT02092909|17555567|P2|Overall Study|Adverse Event|0
5085117|NCT02092909|17555568|P1|Overall Study|Adverse Event|0
5085118|NCT02092662|17555609|P2|Overall Study|Lost to Follow-up|0
5085119|NCT02092662|17555610|P1|Overall Study|Lost to Follow-up|13
5085120|NCT02092389|17555669|P1|Overall Study|Other|5
5085121|NCT02092389|17555669|P1|Overall Study|Adverse Event|1
5085122|NCT02092350|17555681|P2|Overall Study|Withdrawal by Subject|2
5085123|NCT02092350|17555682|P1|Overall Study|Withdrawal by Subject|2
5085124|NCT02092350|17555681|P2|Overall Study|Screen Failure|0
5085125|NCT02092350|17555682|P1|Overall Study|Screen Failure|1
5085126|NCT02092350|17555681|P2|Overall Study|Physician Decision|1
5085127|NCT02092350|17555682|P1|Overall Study|Physician Decision|1
5085128|NCT02092350|17555681|P2|Overall Study|Protocol Violation|0
5085129|NCT02092350|17555682|P1|Overall Study|Protocol Violation|1
5085130|NCT02092350|17555681|P2|Overall Study|Lost to Follow-up|1
5085131|NCT02092350|17555682|P1|Overall Study|Lost to Follow-up|3
5085132|NCT02092350|17555681|P2|Overall Study|Death|5
5085133|NCT02092350|17555682|P1|Overall Study|Death|2
5085134|NCT02092350|17555681|P2|Overall Study|Adverse Event|3
5085135|NCT02092350|17555682|P1|Overall Study|Adverse Event|0
5085136|NCT02092324|17555699|P1|Overall Study|Misdiagnosis|2
5085137|NCT02092324|17555699|P1|Overall Study|Physician Decision|7
5085138|NCT02092324|17555699|P1|Overall Study|Proceed to Transplant|3
5085139|NCT02092324|17555699|P1|Overall Study|Lack of Efficacy|6
5085140|NCT02092324|17555699|P1|Overall Study|Adverse Event|1
5085141|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
5085142|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
5085143|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
5085144|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Protocol Violation|11
5085145|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Pregnancy|1
5085146|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Physician Decision|10
5085147|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
5085148|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
5085149|NCT02092285|17555730|P1|Maintenance Phase & Follow-up|Adverse Event|22
5085150|NCT02092285|17555730|P1|Induction Phase|Lack of Efficacy|14
5085151|NCT02092285|17555730|P1|Induction Phase|Withdrawal by Subject|2
5085152|NCT02092285|17555730|P1|Induction Phase|Relapse/Recurrence|7
5085153|NCT02092285|17555730|P1|Induction Phase|Pregnancy|1
5085154|NCT02092285|17555730|P1|Induction Phase|Physician Decision|4
5085155|NCT02092285|17555730|P1|Induction Phase|Adverse Event|7
5085156|NCT02092220|17555734|P2|Period 2|Nausea, Anxiety, Inconvenience|1
5085157|NCT02092220|17555735|P1|Period 2|Nausea, Anxiety, Inconvenience|0
5085158|NCT02092220|17555734|P2|Period 2|Severe Hypoglycaemia|0
5085159|NCT02092220|17555735|P1|Period 2|Severe Hypoglycaemia|1
5085160|NCT02092220|17555734|P2|Period 1|Unrelated Illness|2
5085161|NCT02092220|17555735|P1|Period 1|Unrelated Illness|0
5085162|NCT02092116|17555808|P2|Overall Study|Adverse Event|1
5085163|NCT02092116|17555809|P1|Overall Study|Adverse Event|0
5085164|NCT02092116|17555808|P2|Overall Study|Withdrawal by Subject|3
5085165|NCT02092116|17555809|P1|Overall Study|Withdrawal by Subject|0
5085166|NCT02092025|17555818|P1|Overall Study|Protocol Deviation|24
5085167|NCT02092025|17555818|P1|Overall Study|Case Report Forms Uncollected|44
5085168|NCT02091986|17555827|P3|Overall Study|Adverse Event|2
5085169|NCT02091986|17555828|P2|Overall Study|Adverse Event|0
5085170|NCT02091986|17555829|P1|Overall Study|Adverse Event|0
5085171|NCT02091986|17555827|P3|Overall Study|Withdrawal by Subject|3
5085172|NCT02091986|17555828|P2|Overall Study|Withdrawal by Subject|8
5085173|NCT02091986|17555829|P1|Overall Study|Withdrawal by Subject|4
5085174|NCT02091986|17555827|P3|Overall Study|Lost to Follow-up|0
5085175|NCT02091986|17555828|P2|Overall Study|Lost to Follow-up|0
5085176|NCT02091986|17555829|P1|Overall Study|Lost to Follow-up|1
5085177|NCT02091986|17555827|P3|Overall Study|7 rand in error 1 patient decision|3
5085178|NCT02091986|17555828|P2|Overall Study|7 rand in error 1 patient decision|3
5085179|NCT02091986|17555829|P1|Overall Study|7 rand in error 1 patient decision|2
5085180|NCT02091960|17555876|P1|Overall Study|On Study at Data Cut-off|12
5085181|NCT02091960|17555876|P1|Overall Study|Miscellaneous Reasons|31
5085182|NCT02091960|17555876|P1|Overall Study|Withdrawal by Subject|1
5085183|NCT02091960|17555876|P1|Overall Study|Death|7
5085184|NCT02091921|17555887|P1|Overall Study|Adverse Event|3
5085185|NCT02091869|17555896|P2|Overall Study|Withdrawal by Subject|3
5085186|NCT02091869|17555897|P1|Overall Study|Withdrawal by Subject|0
5085187|NCT02091752|17555938|P1|Overall Study|Adverse Event|1
5085188|NCT02091752|17555938|P1|Overall Study|Study terminated by Sponsor|2
5085189|NCT02091739|17555952|P5|EP: 48 Weeks|Withdrawal by Subject|6
5085190|NCT02091739|17555953|P4|EP: 48 Weeks|Withdrawal by Subject|2
5085191|NCT02091739|17555954|P3|EP: 48 Weeks|Withdrawal by Subject|0
5085192|NCT02091739|17555955|P2|EP: 48 Weeks|Withdrawal by Subject|0
5085193|NCT02091739|17555956|P1|EP: 48 Weeks|Withdrawal by Subject|0
5085194|NCT02091739|17555952|P5|EP: 48 Weeks|Adverse Event|6
5085195|NCT02091739|17555953|P4|EP: 48 Weeks|Adverse Event|2
5085196|NCT02091739|17555954|P3|EP: 48 Weeks|Adverse Event|0
5085197|NCT02091739|17555955|P2|EP: 48 Weeks|Adverse Event|0
5085198|NCT02091739|17555956|P1|EP: 48 Weeks|Adverse Event|0
5085199|NCT02091739|17555952|P5|EP: 48 Weeks|Death|2
5085200|NCT02091739|17555953|P4|EP: 48 Weeks|Death|3
5085201|NCT02091739|17555954|P3|EP: 48 Weeks|Death|0
5085202|NCT02091739|17555955|P2|EP: 48 Weeks|Death|0
5085203|NCT02091739|17555956|P1|EP: 48 Weeks|Death|0
5085204|NCT02091739|17555952|P5|EP: 48 Weeks|Other|0
5085205|NCT02091739|17555953|P4|EP: 48 Weeks|Other|1
5085206|NCT02091739|17555954|P3|EP: 48 Weeks|Other|0
5085207|NCT02091739|17555955|P2|EP: 48 Weeks|Other|0
5085208|NCT02091739|17555956|P1|EP: 48 Weeks|Other|0
5085209|NCT02091739|17555952|P5|MP: 16 Weeks|Lost to Follow-up|0
5085210|NCT02091739|17555953|P4|MP: 16 Weeks|Lost to Follow-up|0
5085211|NCT02091739|17555954|P3|MP: 16 Weeks|Lost to Follow-up|1
5085212|NCT02091739|17555955|P2|MP: 16 Weeks|Lost to Follow-up|0
5085213|NCT02091739|17555956|P1|MP: 16 Weeks|Lost to Follow-up|0
5085214|NCT02091739|17555952|P5|MP: 16 Weeks|Withdrawal by Subject|0
5085215|NCT02091739|17555953|P4|MP: 16 Weeks|Withdrawal by Subject|0
5085216|NCT02091739|17555954|P3|MP: 16 Weeks|Withdrawal by Subject|0
5085217|NCT02091739|17555955|P2|MP: 16 Weeks|Withdrawal by Subject|4
5085218|NCT02091739|17555956|P1|MP: 16 Weeks|Withdrawal by Subject|3
5085219|NCT02091739|17555952|P5|MP: 16 Weeks|Adverse Event|0
5085220|NCT02091739|17555953|P4|MP: 16 Weeks|Adverse Event|0
5085221|NCT02091739|17555954|P3|MP: 16 Weeks|Adverse Event|1
5085222|NCT02091739|17555955|P2|MP: 16 Weeks|Adverse Event|1
5085223|NCT02091739|17555956|P1|MP: 16 Weeks|Adverse Event|1
5085224|NCT02091726|17555975|P1|Overall Study|Lost to Follow-up|6
5085225|NCT02091440|17555998|P1|Overall Study|Death|2
5085226|NCT02091414|17556008|P1|Overall Study|Death|2
5085227|NCT02091414|17556008|P1|Overall Study|Withdrawal by Subject|2
5085228|NCT02091375|17556022|P2|Overall Study|Withdrawn by the investigator|0
5085229|NCT02091375|17556023|P1|Overall Study|Withdrawn by the investigator|1
5085230|NCT02091375|17556022|P2|Overall Study|Withdrawal by Subject|1
5085231|NCT02091375|17556023|P1|Overall Study|Withdrawal by Subject|0
5085232|NCT02091375|17556022|P2|Overall Study|Lost to Follow-up|1
5085233|NCT02091375|17556023|P1|Overall Study|Lost to Follow-up|0
5085234|NCT02091375|17556022|P2|Overall Study|Adverse Event|1
5085235|NCT02091375|17556023|P1|Overall Study|Adverse Event|8
5085236|NCT02091362|17556053|P2|Period 2|Withdrawal by Subject|1
5085237|NCT02091362|17556054|P1|Period 2|Withdrawal by Subject|1
5085238|NCT02091362|17556053|P2|Period 2|Lost to Follow-up|1
5085239|NCT02091362|17556054|P1|Period 2|Lost to Follow-up|0
5085240|NCT02091362|17556053|P2|Period 2|Adverse Event|0
5085241|NCT02091362|17556054|P1|Period 2|Adverse Event|1
5085242|NCT02091362|17556053|P2|Wash-out|Withdrawal by Subject|2
5085243|NCT02091362|17556054|P1|Wash-out|Withdrawal by Subject|0
5085244|NCT02091362|17556053|P2|Wash-out|Lost to Follow-up|1
5085245|NCT02091362|17556054|P1|Wash-out|Lost to Follow-up|1
5085246|NCT02091362|17556053|P2|Period 1|Adverse Event|0
5085247|NCT02091362|17556054|P1|Period 1|Adverse Event|2
5085248|NCT02091362|17556053|P2|Period 1|Lost to Follow-up|1
5085249|NCT02091362|17556054|P1|Period 1|Lost to Follow-up|0
5085250|NCT02091362|17556053|P2|Period 1|Withdrawal by Subject|3
5085251|NCT02091362|17556054|P1|Period 1|Withdrawal by Subject|2
5085252|NCT02091362|17556053|P2|Period 1|Protocol Violation|0
5085253|NCT02091362|17556054|P1|Period 1|Protocol Violation|1
5085254|NCT02091284|17556076|P2|Overall Study|unreliable data|0
5085255|NCT02091284|17556077|P1|Overall Study|unreliable data|1
5085256|NCT02091284|17556076|P2|Overall Study|Withdrawal by Subject|1
5085257|NCT02091284|17556077|P1|Overall Study|Withdrawal by Subject|2
5085258|NCT02091206|17556099|P4|Taper Period|Lost to Follow-up|1
5085259|NCT02091206|17556100|P3|Taper Period|Lost to Follow-up|0
5085260|NCT02091206|17556101|P2|Taper Period|Lost to Follow-up|0
5085261|NCT02091206|17556102|P1|Taper Period|Lost to Follow-up|0
5085262|NCT02091206|17556099|P4|Taper Period|Participant refused study drug|1
5085263|NCT02091206|17556100|P3|Taper Period|Participant refused study drug|0
5085264|NCT02091206|17556101|P2|Taper Period|Participant refused study drug|0
5085265|NCT02091206|17556102|P1|Taper Period|Participant refused study drug|1
5085266|NCT02091206|17556099|P4|Treatment Period|Met withdrawal criteria|0
5085267|NCT02091206|17556100|P3|Treatment Period|Met withdrawal criteria|1
5085268|NCT02091206|17556101|P2|Treatment Period|Met withdrawal criteria|0
5085269|NCT02091206|17556102|P1|Treatment Period|Met withdrawal criteria|0
5085270|NCT02091206|17556099|P4|Treatment Period|Adverse Event|0
5085271|NCT02091206|17556100|P3|Treatment Period|Adverse Event|0
5085272|NCT02091206|17556101|P2|Treatment Period|Adverse Event|1
5085273|NCT02091206|17556102|P1|Treatment Period|Adverse Event|0
5085274|NCT02091167|17556121|P2|Overall Study|Lost to Follow-up|2
5085275|NCT02091167|17556122|P1|Overall Study|Lost to Follow-up|0
5085276|NCT02091089|17556138|P1|Overall Study|Lost to Follow-up|2
5085277|NCT02090959|17556146|P1|Overall Study|Other than specified|2
5085278|NCT02090959|17556146|P1|Overall Study|Switched to commercial supply|88
5085279|NCT02090959|17556146|P1|Overall Study|Entered in to other study|34
5085280|NCT02090959|17556146|P1|Overall Study|Move to medical need program|3
5085281|NCT02090959|17556146|P1|Overall Study|Transfer for compassionate use medicine|4
5085282|NCT02090959|17556146|P1|Overall Study|Enrolled but not treated|1
5085283|NCT02090959|17556146|P1|Overall Study|Study termination|6
5085284|NCT02090959|17556146|P1|Overall Study|Investigator decision|2
5085285|NCT02090959|17556146|P1|Overall Study|Adverse Event|1
5085286|NCT02090959|17556146|P1|Overall Study|Withdrawal by Subject|10
5085287|NCT02090855|17556173|P1|Overall Study|no evaluable Standard of Truth results|2
5085288|NCT02090764|17556186|P2|Overall Study|Lost to Follow-up|2
5085289|NCT02090764|17556187|P1|Overall Study|Lost to Follow-up|2
5085290|NCT02090764|17556186|P2|Overall Study|Intercurrent illness and other|1
5085291|NCT02090764|17556187|P1|Overall Study|Intercurrent illness and other|1
5085292|NCT02090764|17556186|P2|Overall Study|Withdrawal by Subject|1
5085293|NCT02090764|17556187|P1|Overall Study|Withdrawal by Subject|2
5085294|NCT02090764|17556186|P2|Overall Study|Lack of Efficacy|13
5085295|NCT02090764|17556187|P1|Overall Study|Lack of Efficacy|0
5085296|NCT02090764|17556186|P2|Overall Study|Adverse Event|3
5085297|NCT02090764|17556187|P1|Overall Study|Adverse Event|1
5085298|NCT02090725|17556193|P1|Overall Study|participants moved from area|3
5085299|NCT02090725|17556193|P1|Overall Study|Withdrawal by Subject|1
5085300|NCT02090426|17556199|P2|Overall Study|Lost to Follow-up|6
5085301|NCT02090426|17556200|P1|Overall Study|Lost to Follow-up|12
5085302|NCT02090413|17556231|P3|Overall Study|Lost to Follow-up|0
5085303|NCT02090413|17556232|P2|Overall Study|Lost to Follow-up|1
5085304|NCT02090413|17556233|P1|Overall Study|Lost to Follow-up|1
5085305|NCT02090413|17556231|P3|Overall Study|Other|0
5085306|NCT02090413|17556232|P2|Overall Study|Other|1
5085307|NCT02090413|17556233|P1|Overall Study|Other|2
5085308|NCT02090413|17556231|P3|Overall Study|Investigator Decision|0
5085309|NCT02090413|17556232|P2|Overall Study|Investigator Decision|1
5085310|NCT02090413|17556233|P1|Overall Study|Investigator Decision|1
5085311|NCT02090413|17556231|P3|Overall Study|Withdrawal by Subject|2
5085312|NCT02090413|17556232|P2|Overall Study|Withdrawal by Subject|2
5085313|NCT02090413|17556233|P1|Overall Study|Withdrawal by Subject|2
5085314|NCT02090413|17556231|P3|Overall Study|Flushing event|1
5085315|NCT02090413|17556232|P2|Overall Study|Flushing event|0
5085316|NCT02090413|17556233|P1|Overall Study|Flushing event|2
5085317|NCT02090413|17556231|P3|Overall Study|Adverse Event|20
5085318|NCT02090413|17556232|P2|Overall Study|Adverse Event|15
5085319|NCT02090413|17556233|P1|Overall Study|Adverse Event|11
5085320|NCT02090283|17556310|P3|Overall Study|Protocol Violation|0
5085321|NCT02090283|17556311|P2|Overall Study|Protocol Violation|0
5085322|NCT02090283|17556312|P1|Overall Study|Protocol Violation|2
5085323|NCT02090283|17556310|P3|Overall Study|Adverse Event|0
5085324|NCT02090283|17556311|P2|Overall Study|Adverse Event|1
5085325|NCT02090283|17556312|P1|Overall Study|Adverse Event|1
5085326|NCT02090283|17556310|P3|Overall Study|Lost to Follow-up|3
5085327|NCT02090283|17556311|P2|Overall Study|Lost to Follow-up|2
5085328|NCT02090283|17556312|P1|Overall Study|Lost to Follow-up|2
5085329|NCT02090283|17556310|P3|Overall Study|Sponsor Terminated Study|1
5085330|NCT02090283|17556311|P2|Overall Study|Sponsor Terminated Study|6
5085331|NCT02090283|17556312|P1|Overall Study|Sponsor Terminated Study|6
5085332|NCT02090283|17556310|P3|Overall Study|Withdrawal by Subject|6
5085333|NCT02090283|17556311|P2|Overall Study|Withdrawal by Subject|6
5085334|NCT02090283|17556312|P1|Overall Study|Withdrawal by Subject|6
5085335|NCT02089997|17556346|P1|Overall Study|Protocol Violation|147
5085336|NCT02089997|17556346|P1|Overall Study|Case report forms uncollected|99
5085337|NCT02089737|17556361|P1|Overall Study|Not treated|1
5085338|NCT02089737|17556361|P1|Overall Study|Survey form not completed|5
5085339|NCT02089347|17556411|P2|Overall Study|Protocol Violation|0
5085340|NCT02089347|17556412|P1|Overall Study|Protocol Violation|1
5085341|NCT02089334|17556438|P4|Overall Study|Physician Decision|1
5085342|NCT02089334|17556439|P3|Overall Study|Physician Decision|1
5085343|NCT02089334|17556440|P2|Overall Study|Physician Decision|0
5085344|NCT02089334|17556441|P1|Overall Study|Physician Decision|0
5085345|NCT02089334|17556438|P4|Overall Study|Progressive disease|2
5085346|NCT02089334|17556439|P3|Overall Study|Progressive disease|0
5085347|NCT02089334|17556440|P2|Overall Study|Progressive disease|0
5085348|NCT02089334|17556441|P1|Overall Study|Progressive disease|0
5085349|NCT02089334|17556438|P4|Overall Study|Adverse Event|2
5085350|NCT02089334|17556439|P3|Overall Study|Adverse Event|0
5085351|NCT02089334|17556440|P2|Overall Study|Adverse Event|0
5085352|NCT02089334|17556441|P1|Overall Study|Adverse Event|0
5085353|NCT02089334|17556438|P4|Overall Study|Withdrawal by Subject|2
5085354|NCT02089334|17556439|P3|Overall Study|Withdrawal by Subject|0
5085355|NCT02089334|17556440|P2|Overall Study|Withdrawal by Subject|0
5085356|NCT02089334|17556441|P1|Overall Study|Withdrawal by Subject|0
5085357|NCT02088957|17556478|P2|Overall Study|Lack of Efficacy|0
5085358|NCT02088957|17556479|P1|Overall Study|Lack of Efficacy|1
5085359|NCT02088905|17556497|P2|Overall Study|Withdrawal by Subject|1
5085360|NCT02088905|17556498|P1|Overall Study|Withdrawal by Subject|5
5085361|NCT02088541|17556534|P5|Overall Study|Other|1
5085362|NCT02088541|17556535|P4|Overall Study|Other|1
5085363|NCT02088541|17556536|P3|Overall Study|Other|3
5085364|NCT02088541|17556537|P2|Overall Study|Other|1
5085365|NCT02088541|17556538|P1|Overall Study|Other|2
5085366|NCT02088541|17556534|P5|Overall Study|Withdrawal by Subject|10
5085367|NCT02088541|17556535|P4|Overall Study|Withdrawal by Subject|7
5085368|NCT02088541|17556536|P3|Overall Study|Withdrawal by Subject|9
5085369|NCT02088541|17556537|P2|Overall Study|Withdrawal by Subject|2
5085370|NCT02088541|17556538|P1|Overall Study|Withdrawal by Subject|3
5085371|NCT02088541|17556534|P5|Overall Study|Study terminated by sponsor|6
5085372|NCT02088541|17556535|P4|Overall Study|Study terminated by sponsor|2
5085373|NCT02088541|17556536|P3|Overall Study|Study terminated by sponsor|12
5085374|NCT02088541|17556537|P2|Overall Study|Study terminated by sponsor|1
5085375|NCT02088541|17556538|P1|Overall Study|Study terminated by sponsor|1
5085376|NCT02088541|17556534|P5|Overall Study|Disease progression|1
5085377|NCT02088541|17556535|P4|Overall Study|Disease progression|3
5085378|NCT02088541|17556536|P3|Overall Study|Disease progression|2
5085379|NCT02088541|17556537|P2|Overall Study|Disease progression|1
5085380|NCT02088541|17556538|P1|Overall Study|Disease progression|7
5085381|NCT02088541|17556534|P5|Overall Study|Physician Decision|2
5085382|NCT02088541|17556535|P4|Overall Study|Physician Decision|0
5085383|NCT02088541|17556536|P3|Overall Study|Physician Decision|2
5085384|NCT02088541|17556537|P2|Overall Study|Physician Decision|1
5085385|NCT02088541|17556538|P1|Overall Study|Physician Decision|2
5085386|NCT02088541|17556534|P5|Overall Study|Lost to Follow-up|0
5085387|NCT02088541|17556535|P4|Overall Study|Lost to Follow-up|0
5085388|NCT02088541|17556536|P3|Overall Study|Lost to Follow-up|1
5085389|NCT02088541|17556537|P2|Overall Study|Lost to Follow-up|0
5085390|NCT02088541|17556538|P1|Overall Study|Lost to Follow-up|2
5085391|NCT02088541|17556534|P5|Overall Study|Death|38
5085392|NCT02088541|17556535|P4|Overall Study|Death|28
5085393|NCT02088541|17556536|P3|Overall Study|Death|85
5085394|NCT02088541|17556537|P2|Overall Study|Death|21
5085395|NCT02088541|17556538|P1|Overall Study|Death|51
5085396|NCT02088541|17556534|P5|Overall Study|Adverse Event|0
5085397|NCT02088541|17556535|P4|Overall Study|Adverse Event|3
5085398|NCT02088541|17556536|P3|Overall Study|Adverse Event|3
5085399|NCT02088541|17556537|P2|Overall Study|Adverse Event|0
5085400|NCT02088541|17556538|P1|Overall Study|Adverse Event|3
5085401|NCT02088177|17556609|P1|Overall Study|Lost to Follow-up|3
5085402|NCT02088073|17556619|P5|Maintanance Phase|Subject compliance|0
5085403|NCT02088073|17556620|P4|Maintanance Phase|Subject compliance|0
5085404|NCT02088073|17556621|P3|Maintanance Phase|Subject compliance|0
5085405|NCT02088073|17556622|P2|Maintanance Phase|Subject compliance|1
5085406|NCT02088073|17556623|P1|Maintanance Phase|Subject compliance|0
5085407|NCT02088073|17556619|P5|Maintanance Phase|Met ECG withdrawal criteria|2
5085408|NCT02088073|17556620|P4|Maintanance Phase|Met ECG withdrawal criteria|0
5085409|NCT02088073|17556621|P3|Maintanance Phase|Met ECG withdrawal criteria|1
5085410|NCT02088073|17556622|P2|Maintanance Phase|Met ECG withdrawal criteria|0
5085411|NCT02088073|17556623|P1|Maintanance Phase|Met ECG withdrawal criteria|0
5085412|NCT02088073|17556619|P5|Maintanance Phase|Miscellaneous|1
5085413|NCT02088073|17556620|P4|Maintanance Phase|Miscellaneous|2
5085414|NCT02088073|17556621|P3|Maintanance Phase|Miscellaneous|1
5085415|NCT02088073|17556622|P2|Maintanance Phase|Miscellaneous|2
5085416|NCT02088073|17556623|P1|Maintanance Phase|Miscellaneous|0
5085417|NCT02088073|17556619|P5|Maintanance Phase|Hypo- or hyperkalemia|1
5085418|NCT02088073|17556620|P4|Maintanance Phase|Hypo- or hyperkalemia|3
5085419|NCT02088073|17556621|P3|Maintanance Phase|Hypo- or hyperkalemia|0
5085420|NCT02088073|17556622|P2|Maintanance Phase|Hypo- or hyperkalemia|3
5085421|NCT02088073|17556623|P1|Maintanance Phase|Hypo- or hyperkalemia|0
5085422|NCT02088073|17556619|P5|Maintanance Phase|Sponsor's decision|1
5085423|NCT02088073|17556620|P4|Maintanance Phase|Sponsor's decision|2
5085424|NCT02088073|17556621|P3|Maintanance Phase|Sponsor's decision|0
5085425|NCT02088073|17556622|P2|Maintanance Phase|Sponsor's decision|2
5085426|NCT02088073|17556623|P1|Maintanance Phase|Sponsor's decision|0
5085427|NCT02088073|17556619|P5|Maintanance Phase|Physician Decision|1
5085428|NCT02088073|17556620|P4|Maintanance Phase|Physician Decision|0
5085429|NCT02088073|17556621|P3|Maintanance Phase|Physician Decision|0
5085430|NCT02088073|17556622|P2|Maintanance Phase|Physician Decision|0
5085431|NCT02088073|17556623|P1|Maintanance Phase|Physician Decision|0
5085432|NCT02088073|17556619|P5|Maintanance Phase|Adverse Event|1
5085433|NCT02088073|17556620|P4|Maintanance Phase|Adverse Event|0
5085434|NCT02088073|17556621|P3|Maintanance Phase|Adverse Event|3
5085435|NCT02088073|17556622|P2|Maintanance Phase|Adverse Event|0
5085436|NCT02088073|17556623|P1|Maintanance Phase|Adverse Event|0
5085437|NCT02088073|17556619|P5|Maintanance Phase|Withdrawal by Subject|0
5085438|NCT02088073|17556620|P4|Maintanance Phase|Withdrawal by Subject|0
5085439|NCT02088073|17556621|P3|Maintanance Phase|Withdrawal by Subject|0
5085440|NCT02088073|17556622|P2|Maintanance Phase|Withdrawal by Subject|2
5085441|NCT02088073|17556623|P1|Maintanance Phase|Withdrawal by Subject|0
5085442|NCT02088073|17556619|P5|Acute Phase|Hyperkalemia|0
5085443|NCT02088073|17556620|P4|Acute Phase|Hyperkalemia|0
5085444|NCT02088073|17556621|P3|Acute Phase|Hyperkalemia|0
5085445|NCT02088073|17556622|P2|Acute Phase|Hyperkalemia|0
5085446|NCT02088073|17556623|P1|Acute Phase|Hyperkalemia|2
5085447|NCT02088073|17556619|P5|Acute Phase|Withdrawal by Subject|0
5085448|NCT02088073|17556620|P4|Acute Phase|Withdrawal by Subject|0
5085449|NCT02088073|17556621|P3|Acute Phase|Withdrawal by Subject|0
5085450|NCT02088073|17556622|P2|Acute Phase|Withdrawal by Subject|0
5085451|NCT02088073|17556623|P1|Acute Phase|Withdrawal by Subject|5
5085452|NCT02088047|17556677|P2|Overall Study|Withdrawal by Subject|0
5085453|NCT02088047|17556678|P1|Overall Study|Withdrawal by Subject|1
5085454|NCT02087943|17556706|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
5085455|NCT02087943|17556707|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
5085456|NCT02087943|17556708|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
5085457|NCT02087943|17556709|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
5085458|NCT02087943|17556710|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
5085459|NCT02087943|17556706|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
5085460|NCT02087943|17556707|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5085461|NCT02087943|17556708|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5085462|NCT02087943|17556709|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5085463|NCT02087943|17556710|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5085464|NCT02087943|17556706|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5085465|NCT02087943|17556707|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5085466|NCT02087943|17556708|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
5085467|NCT02087943|17556709|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5085468|NCT02087943|17556710|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5085469|NCT02087943|17556706|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
5085470|NCT02087943|17556707|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
5085471|NCT02087943|17556708|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
5085472|NCT02087943|17556709|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
5085473|NCT02087943|17556710|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
5085474|NCT02087943|17556706|P5|Active Treatment Phase Week 12-24|Adverse Event|1
5085475|NCT02087943|17556707|P4|Active Treatment Phase Week 12-24|Adverse Event|0
5085476|NCT02087943|17556708|P3|Active Treatment Phase Week 12-24|Adverse Event|2
5085477|NCT02087943|17556709|P2|Active Treatment Phase Week 12-24|Adverse Event|1
5085478|NCT02087943|17556710|P1|Active Treatment Phase Week 12-24|Adverse Event|0
5085479|NCT02087943|17556706|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5085480|NCT02087943|17556707|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5085481|NCT02087943|17556708|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5085482|NCT02087943|17556709|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
5085483|NCT02087943|17556710|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5085484|NCT02087943|17556706|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5085485|NCT02087943|17556707|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5085486|NCT02087943|17556708|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
5085487|NCT02087943|17556709|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5085488|NCT02087943|17556710|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
5085489|NCT02087943|17556706|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
5085490|NCT02087943|17556707|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
5085491|NCT02087943|17556708|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
5085492|NCT02087943|17556709|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
5085493|NCT02087943|17556710|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
5085494|NCT02087943|17556706|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
5085495|NCT02087943|17556707|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
5085496|NCT02087943|17556708|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
5085497|NCT02087943|17556709|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
5085498|NCT02087943|17556710|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
5085499|NCT02087943|17556706|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
5085500|NCT02087943|17556707|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
5085501|NCT02087943|17556708|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
5085502|NCT02087943|17556709|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
5085503|NCT02087943|17556710|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
5085504|NCT02087904|17556738|P4|Overall Study|Lost to Follow-up|2
5085505|NCT02087904|17556739|P3|Overall Study|Lost to Follow-up|2
5085506|NCT02087904|17556740|P2|Overall Study|Lost to Follow-up|4
5085507|NCT02087904|17556741|P1|Overall Study|Lost to Follow-up|0
5085508|NCT02087904|17556738|P4|Overall Study|Withdrawal by Subject|4
5085509|NCT02087904|17556739|P3|Overall Study|Withdrawal by Subject|7
5085510|NCT02087904|17556740|P2|Overall Study|Withdrawal by Subject|3
5085511|NCT02087904|17556741|P1|Overall Study|Withdrawal by Subject|8
5085512|NCT02087904|17556738|P4|Overall Study|Other|4
5085513|NCT02087904|17556739|P3|Overall Study|Other|4
5085514|NCT02087904|17556740|P2|Overall Study|Other|2
5085515|NCT02087904|17556741|P1|Overall Study|Other|6
5085516|NCT02087904|17556738|P4|Overall Study|Lack of Efficacy|2
5085517|NCT02087904|17556739|P3|Overall Study|Lack of Efficacy|3
5085518|NCT02087904|17556740|P2|Overall Study|Lack of Efficacy|6
5085519|NCT02087904|17556741|P1|Overall Study|Lack of Efficacy|3
5085520|NCT02087904|17556738|P4|Overall Study|Adverse Event|12
5085521|NCT02087904|17556739|P3|Overall Study|Adverse Event|4
5085522|NCT02087904|17556740|P2|Overall Study|Adverse Event|4
5085523|NCT02087904|17556741|P1|Overall Study|Adverse Event|8
5085524|NCT02087904|17556738|P4|Overall Study|Did Not Receive Study Drug|1
5085525|NCT02087904|17556739|P3|Overall Study|Did Not Receive Study Drug|2
5085526|NCT02087904|17556740|P2|Overall Study|Did Not Receive Study Drug|0
5085527|NCT02087904|17556741|P1|Overall Study|Did Not Receive Study Drug|0
5085528|NCT02087774|17556857|P2|Overall Study|Were absent day of data collection|20
5085529|NCT02087774|17556858|P1|Overall Study|Were absent day of data collection|8
5085530|NCT02087670|17556878|P2|Overall Study|Withdrawal by Subject|2
5085531|NCT02087670|17556879|P1|Overall Study|Withdrawal by Subject|3
5085532|NCT02087423|17556915|P3|Overall Study|Terminated from study at final DCO|25
5085533|NCT02087423|17556916|P2|Overall Study|Terminated from study at final DCO|36
5085534|NCT02087423|17556917|P1|Overall Study|Terminated from study at final DCO|23
5085535|NCT02087423|17556915|P3|Overall Study|Lost to Follow-up|0
5085536|NCT02087423|17556916|P2|Overall Study|Lost to Follow-up|2
5085537|NCT02087423|17556917|P1|Overall Study|Lost to Follow-up|0
5085538|NCT02087423|17556915|P3|Overall Study|Death|40
5085539|NCT02087423|17556916|P2|Overall Study|Death|207
5085540|NCT02087423|17556917|P1|Overall Study|Death|68
5085541|NCT02087423|17556915|P3|Overall Study|Withdrawal by Subject|3
5085542|NCT02087423|17556916|P2|Overall Study|Withdrawal by Subject|20
5085543|NCT02087423|17556917|P1|Overall Study|Withdrawal by Subject|20
5085544|NCT02087241|17556946|P4|Overall Study|Study Terminated by Sponsor|4
5085545|NCT02087241|17556947|P3|Overall Study|Study Terminated by Sponsor|0
5085546|NCT02087241|17556948|P2|Overall Study|Study Terminated by Sponsor|2
5085547|NCT02087241|17556949|P1|Overall Study|Study Terminated by Sponsor|0
5085548|NCT02087241|17556946|P4|Overall Study|Progressive Disease|1
5085549|NCT02087241|17556947|P3|Overall Study|Progressive Disease|0
5085550|NCT02087241|17556948|P2|Overall Study|Progressive Disease|0
5085551|NCT02087241|17556949|P1|Overall Study|Progressive Disease|0
5085552|NCT02087241|17556946|P4|Overall Study|Withdrawal by Subject|1
5085553|NCT02087241|17556947|P3|Overall Study|Withdrawal by Subject|0
5085554|NCT02087241|17556948|P2|Overall Study|Withdrawal by Subject|0
5085555|NCT02087241|17556949|P1|Overall Study|Withdrawal by Subject|1
5085556|NCT02087241|17556946|P4|Overall Study|Death|1
5085557|NCT02087241|17556947|P3|Overall Study|Death|1
5085558|NCT02087241|17556948|P2|Overall Study|Death|1
5085559|NCT02087241|17556949|P1|Overall Study|Death|2
5085560|NCT02087176|17556975|P1|Overall Study|Study Terminated by Sponsor|2
5085561|NCT02087176|17556975|P1|Overall Study|Censored|19
5085562|NCT02087176|17556975|P1|Overall Study|Death|10
5085563|NCT02087176|17556975|P1|Overall Study|Withdrawal by Subject|1
5085564|NCT02087150|17556988|P3|Overall Study|Pt moved out of town|0
5085565|NCT02087150|17556989|P2|Overall Study|Pt moved out of town|1
5085566|NCT02087150|17556990|P1|Overall Study|Pt moved out of town|0
5085567|NCT02087150|17556988|P3|Overall Study|Other|0
5085568|NCT02087150|17556989|P2|Overall Study|Other|0
5085569|NCT02087150|17556990|P1|Overall Study|Other|1
5085570|NCT02087150|17556988|P3|Overall Study|F/U not completed w/in study window|1
5085571|NCT02087150|17556989|P2|Overall Study|F/U not completed w/in study window|0
5085572|NCT02087150|17556990|P1|Overall Study|F/U not completed w/in study window|0
5085573|NCT02087150|17556988|P3|Overall Study|Procedure not done|0
5085574|NCT02087150|17556989|P2|Overall Study|Procedure not done|13
5085575|NCT02087150|17556990|P1|Overall Study|Procedure not done|1
5085576|NCT02087150|17556988|P3|Overall Study|Physician Decision|0
5085577|NCT02087150|17556989|P2|Overall Study|Physician Decision|1
5085578|NCT02087150|17556990|P1|Overall Study|Physician Decision|0
5085579|NCT02087150|17556988|P3|Overall Study|Withdrawal by Subject|3
5085580|NCT02087150|17556989|P2|Overall Study|Withdrawal by Subject|5
5085581|NCT02087150|17556990|P1|Overall Study|Withdrawal by Subject|2
5085582|NCT02087150|17556988|P3|Overall Study|Lost to Follow-up|7
5085583|NCT02087150|17556989|P2|Overall Study|Lost to Follow-up|13
5085584|NCT02087150|17556990|P1|Overall Study|Lost to Follow-up|6
5085585|NCT02087150|17556988|P3|Overall Study|Death|0
5085586|NCT02087150|17556989|P2|Overall Study|Death|1
5085587|NCT02087150|17556990|P1|Overall Study|Death|0
5085588|NCT02087085|17557009|P2|Overall Study|Other Miscellaneous Reasons|4
5085589|NCT02087085|17557010|P1|Overall Study|Other Miscellaneous Reasons|3
5085590|NCT02087085|17557009|P2|Overall Study|Study Terminated by Sponsor|80
5085591|NCT02087085|17557010|P1|Overall Study|Study Terminated by Sponsor|87
5085592|NCT02087085|17557009|P2|Overall Study|Protocol Violation|0
5085593|NCT02087085|17557010|P1|Overall Study|Protocol Violation|1
5085594|NCT02087085|17557009|P2|Overall Study|Withdrawal by Subject|11
5085595|NCT02087085|17557010|P1|Overall Study|Withdrawal by Subject|9
5085596|NCT02087085|17557009|P2|Overall Study|Lost to Follow-up|4
5085597|NCT02087085|17557010|P1|Overall Study|Lost to Follow-up|6
5085598|NCT02087085|17557009|P2|Overall Study|Lack of Efficacy|3
5085599|NCT02087085|17557010|P1|Overall Study|Lack of Efficacy|4
5085600|NCT02087085|17557009|P2|Overall Study|Adverse Event|14
5085601|NCT02087085|17557010|P1|Overall Study|Adverse Event|10
5085602|NCT02087059|17557020|P1|Overall Study|Lost to Follow-up|1
5085603|NCT02087059|17557020|P1|Overall Study|Adverse Event|5
5085604|NCT02087059|17557020|P1|Overall Study|Disease Progression|1
5085605|NCT02086968|17557030|P2|Overall Study|Withdrawal by Subject|4
5085606|NCT02086968|17557031|P1|Overall Study|Withdrawal by Subject|1
5085607|NCT02086968|17557030|P2|Overall Study|Physician Decision|0
5085608|NCT02086968|17557031|P1|Overall Study|Physician Decision|4
5085609|NCT02086968|17557030|P2|Overall Study|Study drug received outside protocol|1
5085610|NCT02086968|17557031|P1|Overall Study|Study drug received outside protocol|0
5085611|NCT02086968|17557030|P2|Overall Study|Lost to Follow-up|3
5085612|NCT02086968|17557031|P1|Overall Study|Lost to Follow-up|2
5085613|NCT02086968|17557030|P2|Overall Study|Adverse Event|5
5085614|NCT02086968|17557031|P1|Overall Study|Adverse Event|1
5085615|NCT02086591|17557085|P1|Overall Study|protocol terminated|3
5085616|NCT02086591|17557085|P1|Overall Study|Withdrawal by Subject|1
5085617|NCT02086591|17557085|P1|Overall Study|Adverse Event|1
5085618|NCT02086565|17557093|P2|Overall Study|withdrawn by research team|2
5085619|NCT02086565|17557094|P1|Overall Study|withdrawn by research team|2
5085620|NCT02086565|17557093|P2|Overall Study|Death|2
5085621|NCT02086565|17557094|P1|Overall Study|Death|3
5085622|NCT02086565|17557093|P2|Overall Study|Withdrawal by Subject|1
5085623|NCT02086565|17557094|P1|Overall Study|Withdrawal by Subject|2
5085624|NCT02086565|17557093|P2|Overall Study|Lost to Follow-up|7
5085625|NCT02086565|17557094|P1|Overall Study|Lost to Follow-up|9
5085626|NCT02086552|17557108|P1|Overall Study|Withdrawal by Subject|1
5085627|NCT02086162|17557151|P2|Overall Study|Death|0
5085628|NCT02086162|17557152|P1|Overall Study|Death|1
5085629|NCT02086162|17557151|P2|Overall Study|Lost to Follow-up|2
5085630|NCT02086162|17557152|P1|Overall Study|Lost to Follow-up|4
5085631|NCT02086162|17557151|P2|Overall Study|moved|1
5085632|NCT02086162|17557152|P1|Overall Study|moved|1
5085633|NCT02086162|17557151|P2|Overall Study|Withdrawal by Subject|4
5085634|NCT02086162|17557152|P1|Overall Study|Withdrawal by Subject|4
5085635|NCT02086110|17557164|P2|Overall Study|Withdrawal by Subject|1
5085636|NCT02086110|17557165|P1|Overall Study|Withdrawal by Subject|1
5085637|NCT02085785|17557176|P2|Overall Study|Lost to Follow-up|1
5085638|NCT02085785|17557177|P1|Overall Study|Lost to Follow-up|0
5085639|NCT02085785|17557176|P2|Overall Study|Withdrawal by Subject|1
5085640|NCT02085785|17557177|P1|Overall Study|Withdrawal by Subject|2
5085641|NCT02085252|17557331|P2|Overall Study|Reason Unknown|1
5085642|NCT02085252|17557332|P1|Overall Study|Reason Unknown|0
5085643|NCT02085252|17557331|P2|Overall Study|Reason Not Specified|1
5085644|NCT02085252|17557332|P1|Overall Study|Reason Not Specified|0
5085645|NCT02085252|17557331|P2|Overall Study|Discontinuation Due to Patient Decision|1
5085646|NCT02085252|17557332|P1|Overall Study|Discontinuation Due to Patient Decision|0
5085647|NCT02085252|17557331|P2|Overall Study|Adverse Event|1
5085648|NCT02085252|17557332|P1|Overall Study|Adverse Event|0
5085649|NCT02085252|17557331|P2|Overall Study|Withdrawal of Consent|0
5085650|NCT02085252|17557332|P1|Overall Study|Withdrawal of Consent|1
5085651|NCT02085161|17557356|P4|Overall Study|Other Reason|1
5085652|NCT02085161|17557357|P3|Overall Study|Other Reason|1
5085653|NCT02085161|17557358|P2|Overall Study|Other Reason|0
5085654|NCT02085161|17557359|P1|Overall Study|Other Reason|1
5085655|NCT02085161|17557356|P4|Overall Study|Withdrawal by Subject|3
5085656|NCT02085161|17557357|P3|Overall Study|Withdrawal by Subject|0
5085657|NCT02085161|17557358|P2|Overall Study|Withdrawal by Subject|4
5085658|NCT02085161|17557359|P1|Overall Study|Withdrawal by Subject|2
5085659|NCT02085161|17557356|P4|Overall Study|Protocol Violation|1
5085660|NCT02085161|17557357|P3|Overall Study|Protocol Violation|0
5085661|NCT02085161|17557358|P2|Overall Study|Protocol Violation|1
5085662|NCT02085161|17557359|P1|Overall Study|Protocol Violation|0
5085663|NCT02085161|17557356|P4|Overall Study|Adverse Event|5
5085664|NCT02085161|17557357|P3|Overall Study|Adverse Event|4
5085665|NCT02085161|17557358|P2|Overall Study|Adverse Event|5
5085666|NCT02085161|17557359|P1|Overall Study|Adverse Event|8
5085667|NCT02085161|17557356|P4|Overall Study|Not Treated|0
5085668|NCT02085161|17557357|P3|Overall Study|Not Treated|0
5085669|NCT02085161|17557358|P2|Overall Study|Not Treated|0
5085670|NCT02085161|17557359|P1|Overall Study|Not Treated|1
5085671|NCT02085135|17557400|P2|Overall Study|Lack of Efficacy|0
5085672|NCT02085135|17557401|P1|Overall Study|Lack of Efficacy|2
5085673|NCT02085135|17557400|P2|Overall Study|Withdrawal by Subject|0
5085674|NCT02085135|17557401|P1|Overall Study|Withdrawal by Subject|3
5085675|NCT02085135|17557400|P2|Overall Study|Lost to Follow-up|2
5085676|NCT02085135|17557401|P1|Overall Study|Lost to Follow-up|2
5085677|NCT02085135|17557400|P2|Overall Study|Adverse Event|7
5085678|NCT02085135|17557401|P1|Overall Study|Adverse Event|4
5085679|NCT02084238|17557473|P1|Overall Study|Lost to Follow-up|2
5085680|NCT02084134|17557498|P2|Overall Study|Death|1
5085681|NCT02084134|17557499|P1|Overall Study|Death|0
5085682|NCT02084134|17557498|P2|Overall Study|Protocol Violation|2
5085683|NCT02084134|17557499|P1|Overall Study|Protocol Violation|4
5085684|NCT02084082|17557509|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
5085685|NCT02084082|17557510|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5085686|NCT02084082|17557511|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5085687|NCT02084082|17557512|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5085688|NCT02084082|17557509|P4|Washout Period 1 (35 Days)|Adverse Event|1
5085689|NCT02084082|17557510|P3|Washout Period 1 (35 Days)|Adverse Event|1
5085690|NCT02084082|17557511|P2|Washout Period 1 (35 Days)|Adverse Event|0
5085691|NCT02084082|17557512|P1|Washout Period 1 (35 Days)|Adverse Event|0
5085692|NCT02084056|17557553|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5085693|NCT02084056|17557554|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5085694|NCT02084056|17557555|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5085695|NCT02084056|17557556|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
5085696|NCT02084056|17557553|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5085697|NCT02084056|17557554|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5085698|NCT02084056|17557555|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5085699|NCT02084056|17557556|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5085700|NCT02083965|17557588|P2|Treatment Period|Other|0
5085701|NCT02083965|17557589|P1|Treatment Period|Other|1
5085702|NCT02083783|17557671|P2|Overall Study|Withdrawal by Subject|0
5085703|NCT02083783|17557672|P1|Overall Study|Withdrawal by Subject|1
5085704|NCT02083653|17557704|P3|Overall Study|Reason Missing|4
5085705|NCT02083653|17557705|P2|Overall Study|Reason Missing|0
5085706|NCT02083653|17557706|P1|Overall Study|Reason Missing|0
5085707|NCT02083653|17557704|P3|Overall Study|Other Events|2
5085708|NCT02083653|17557705|P2|Overall Study|Other Events|2
5085709|NCT02083653|17557706|P1|Overall Study|Other Events|0
5085710|NCT02083653|17557704|P3|Overall Study|Withdrawal by Subject|2
5085711|NCT02083653|17557705|P2|Overall Study|Withdrawal by Subject|1
5085712|NCT02083653|17557706|P1|Overall Study|Withdrawal by Subject|2
5085713|NCT02083653|17557704|P3|Overall Study|Progressive Disease|63
5085714|NCT02083653|17557705|P2|Overall Study|Progressive Disease|73
5085715|NCT02083653|17557706|P1|Overall Study|Progressive Disease|65
5085716|NCT02083653|17557704|P3|Overall Study|Death|2
5085717|NCT02083653|17557705|P2|Overall Study|Death|2
5085718|NCT02083653|17557706|P1|Overall Study|Death|2
5085719|NCT02083653|17557704|P3|Overall Study|Lost to Follow-up|0
5085720|NCT02083653|17557705|P2|Overall Study|Lost to Follow-up|0
5085721|NCT02083653|17557706|P1|Overall Study|Lost to Follow-up|1
5085722|NCT02083653|17557704|P3|Overall Study|Adverse Event|4
5085723|NCT02083653|17557705|P2|Overall Study|Adverse Event|5
5085724|NCT02083653|17557706|P1|Overall Study|Adverse Event|12
5085725|NCT02083653|17557704|P3|Overall Study|Randomized but not Treated|7
5085726|NCT02083653|17557705|P2|Overall Study|Randomized but not Treated|2
5085727|NCT02083653|17557706|P1|Overall Study|Randomized but not Treated|0
5085728|NCT02083380|17557774|P3|Overall Study|Other|6
5085729|NCT02083380|17557775|P2|Overall Study|Other|4
5085730|NCT02083380|17557776|P1|Overall Study|Other|8
5085731|NCT02083380|17557774|P3|Overall Study|Lost to Follow-up|3
5085732|NCT02083380|17557775|P2|Overall Study|Lost to Follow-up|3
5085733|NCT02083380|17557776|P1|Overall Study|Lost to Follow-up|5
5085734|NCT02083380|17557774|P3|Overall Study|Adverse Event|1
5085735|NCT02083380|17557775|P2|Overall Study|Adverse Event|0
5085736|NCT02083380|17557776|P1|Overall Study|Adverse Event|0
5085737|NCT02083380|17557774|P3|Overall Study|Physician Decision|3
5085738|NCT02083380|17557775|P2|Overall Study|Physician Decision|6
5085739|NCT02083380|17557776|P1|Overall Study|Physician Decision|1
5085740|NCT02083380|17557774|P3|Overall Study|Withdrawal by Subject|7
5085741|NCT02083380|17557775|P2|Overall Study|Withdrawal by Subject|3
5085742|NCT02083380|17557776|P1|Overall Study|Withdrawal by Subject|9
5085743|NCT02083380|17557774|P3|Overall Study|Lack of Efficacy|64
5085744|NCT02083380|17557775|P2|Overall Study|Lack of Efficacy|79
5085745|NCT02083380|17557776|P1|Overall Study|Lack of Efficacy|68
5085746|NCT02083185|17557881|P3|Overall Study|Did not Receive Study Drug|0
5085747|NCT02083185|17557882|P2|Overall Study|Did not Receive Study Drug|2
5085748|NCT02083185|17557883|P1|Overall Study|Did not Receive Study Drug|0
5085749|NCT02083185|17557881|P3|Overall Study|Study Terminated by Sponsor|0
5085750|NCT02083185|17557882|P2|Overall Study|Study Terminated by Sponsor|1
5085751|NCT02083185|17557883|P1|Overall Study|Study Terminated by Sponsor|0
5085752|NCT02083185|17557881|P3|Overall Study|Reason not Specified|5
5085753|NCT02083185|17557882|P2|Overall Study|Reason not Specified|6
5085754|NCT02083185|17557883|P1|Overall Study|Reason not Specified|9
5085755|NCT02083185|17557881|P3|Overall Study|Death|1
5085756|NCT02083185|17557882|P2|Overall Study|Death|2
5085757|NCT02083185|17557883|P1|Overall Study|Death|2
5085758|NCT02083185|17557881|P3|Overall Study|Withdrawal by Subject|1
5085759|NCT02083185|17557882|P2|Overall Study|Withdrawal by Subject|15
5085760|NCT02083185|17557883|P1|Overall Study|Withdrawal by Subject|9
5085761|NCT02083185|17557881|P3|Overall Study|Lost to Follow-up|0
5085762|NCT02083185|17557882|P2|Overall Study|Lost to Follow-up|3
5085763|NCT02083185|17557883|P1|Overall Study|Lost to Follow-up|0
5085764|NCT02082977|17557988|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085765|NCT02082977|17557989|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085766|NCT02082977|17557990|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
5085767|NCT02082977|17557991|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085768|NCT02082977|17557992|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085769|NCT02082977|17557993|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085770|NCT02082977|17557994|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085771|NCT02082977|17557995|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085772|NCT02082977|17557996|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085773|NCT02082977|17557997|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5085774|NCT02082977|17557988|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
5085775|NCT02082977|17557989|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
5085776|NCT02082977|17557990|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
5085777|NCT02082977|17557991|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
5085778|NCT02082977|17557992|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
5085779|NCT02082977|17557993|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
5085780|NCT02082977|17557994|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
5085781|NCT02082977|17557995|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
5085782|NCT02082977|17557996|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
5085783|NCT02082977|17557997|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
5085784|NCT02082977|17557988|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085785|NCT02082977|17557989|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085786|NCT02082977|17557990|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085787|NCT02082977|17557991|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085788|NCT02082977|17557992|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
5085789|NCT02082977|17557993|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085790|NCT02082977|17557994|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085791|NCT02082977|17557995|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085792|NCT02082977|17557996|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085793|NCT02082977|17557997|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5085794|NCT02082977|17557988|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085795|NCT02082977|17557989|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085796|NCT02082977|17557990|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
5085797|NCT02082977|17557991|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085798|NCT02082977|17557992|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085799|NCT02082977|17557993|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085800|NCT02082977|17557994|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085801|NCT02082977|17557995|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085802|NCT02082977|17557996|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085803|NCT02082977|17557997|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5085804|NCT02082977|17557988|P10|Part 1 (Up to 3.2 Years)|Death|0
5085805|NCT02082977|17557989|P9|Part 1 (Up to 3.2 Years)|Death|1
5085806|NCT02082977|17557990|P8|Part 1 (Up to 3.2 Years)|Death|0
5085807|NCT02082977|17557991|P7|Part 1 (Up to 3.2 Years)|Death|2
5085808|NCT02082977|17557992|P6|Part 1 (Up to 3.2 Years)|Death|1
5085809|NCT02082977|17557993|P5|Part 1 (Up to 3.2 Years)|Death|0
5085810|NCT02082977|17557994|P4|Part 1 (Up to 3.2 Years)|Death|0
5085811|NCT02082977|17557995|P3|Part 1 (Up to 3.2 Years)|Death|0
5085812|NCT02082977|17557996|P2|Part 1 (Up to 3.2 Years)|Death|0
5085813|NCT02082977|17557997|P1|Part 1 (Up to 3.2 Years)|Death|1
5085814|NCT02082912|17558251|P2|Overall Study|Physician Decision|1
5085815|NCT02082912|17558252|P1|Overall Study|Physician Decision|0
5085816|NCT02082522|17558300|P2|Overall Study|Chemotherapy change|3
5085817|NCT02082522|17558301|P1|Overall Study|Chemotherapy change|1
5085818|NCT02082522|17558300|P2|Overall Study|Disease progression|2
5085819|NCT02082522|17558301|P1|Overall Study|Disease progression|2
5085820|NCT02082522|17558300|P2|Overall Study|Physician Decision|1
5085821|NCT02082522|17558301|P1|Overall Study|Physician Decision|3
5085822|NCT02082522|17558300|P2|Overall Study|Lost to Follow-up|0
5085823|NCT02082522|17558301|P1|Overall Study|Lost to Follow-up|1
5085824|NCT02082522|17558300|P2|Overall Study|Death|0
5085825|NCT02082522|17558301|P1|Overall Study|Death|1
5085826|NCT02082522|17558300|P2|Overall Study|Withdrawal by Subject|4
5085827|NCT02082522|17558301|P1|Overall Study|Withdrawal by Subject|2
5085828|NCT02082522|17558300|P2|Overall Study|Sponsor termination|3
5085829|NCT02082522|17558301|P1|Overall Study|Sponsor termination|5
5085830|NCT02082483|17558351|P2|Overall Study|Death|3
5085831|NCT02082483|17558352|P1|Overall Study|Death|2
5085832|NCT02082483|17558351|P2|Overall Study|Physician Decision|1
5085833|NCT02082483|17558352|P1|Overall Study|Physician Decision|1
5085834|NCT02082483|17558351|P2|Overall Study|Withdrawal by Subject|1
5085835|NCT02082483|17558352|P1|Overall Study|Withdrawal by Subject|2
5085836|NCT02082483|17558351|P2|Overall Study|Lost to Follow-up|1
5085837|NCT02082483|17558352|P1|Overall Study|Lost to Follow-up|1
5085838|NCT02082340|17558404|P2|Overall Study|Lost to Follow-up|1
5085839|NCT02082340|17558405|P1|Overall Study|Lost to Follow-up|1
5085840|NCT02082262|17558415|P1|Overall Study|Adverse Event|48
5085841|NCT02082262|17558415|P1|Overall Study|Withdrawal by Subject|3
5085842|NCT02082184|17558421|P2|Overall Study|Subject non-compliance|1
5085843|NCT02082184|17558422|P1|Overall Study|Subject non-compliance|0
5085844|NCT02082184|17558421|P2|Overall Study|Lost to Follow-up|2
5085845|NCT02082184|17558422|P1|Overall Study|Lost to Follow-up|0
5085846|NCT02082184|17558421|P2|Overall Study|Protocol Violation|6
5085847|NCT02082184|17558422|P1|Overall Study|Protocol Violation|0
5085848|NCT02082184|17558421|P2|Overall Study|Withdrawal by Subject|2
5085849|NCT02082184|17558422|P1|Overall Study|Withdrawal by Subject|3
5085850|NCT02082184|17558421|P2|Overall Study|Device associated symptoms|0
5085851|NCT02082184|17558422|P1|Overall Study|Device associated symptoms|5
5085852|NCT02082184|17558421|P2|Overall Study|Medical diagnosis|2
5085853|NCT02082184|17558422|P1|Overall Study|Medical diagnosis|1
5085854|NCT02082184|17558421|P2|Overall Study|Adverse Event|0
5085855|NCT02082184|17558422|P1|Overall Study|Adverse Event|1
5085856|NCT02082158|17558447|P6|Overall Study|Failed Fit-testing|7
5085857|NCT02082158|17558448|P5|Overall Study|Failed Fit-testing|3
5085858|NCT02082158|17558449|P4|Overall Study|Failed Fit-testing|4
5085859|NCT02082158|17558450|P3|Overall Study|Failed Fit-testing|14
5085860|NCT02082158|17558451|P2|Overall Study|Failed Fit-testing|8
5085861|NCT02082158|17558452|P1|Overall Study|Failed Fit-testing|8
5085862|NCT02082158|17558447|P6|Overall Study|Withdrawal by Subject|0
5085863|NCT02082158|17558448|P5|Overall Study|Withdrawal by Subject|1
5085864|NCT02082158|17558449|P4|Overall Study|Withdrawal by Subject|0
5085865|NCT02082158|17558450|P3|Overall Study|Withdrawal by Subject|0
5085866|NCT02082158|17558451|P2|Overall Study|Withdrawal by Subject|0
5085867|NCT02082158|17558452|P1|Overall Study|Withdrawal by Subject|0
5085868|NCT02081859|17558582|P2|Overall Study|Other reasons|0
5085869|NCT02081859|17558583|P1|Overall Study|Other reasons|2
5085870|NCT02081859|17558582|P2|Overall Study|< 4 embryos|23
5085871|NCT02081859|17558583|P1|Overall Study|< 4 embryos|27
5085872|NCT02081859|17558582|P2|Overall Study|Unanticipated freeze all cycle|6
5085873|NCT02081859|17558583|P1|Overall Study|Unanticipated freeze all cycle|2
5085874|NCT02081859|17558582|P2|Overall Study|No sperm|0
5085875|NCT02081859|17558583|P1|Overall Study|No sperm|1
5085876|NCT02081859|17558582|P2|Overall Study|No fertilization|2
5085877|NCT02081859|17558583|P1|Overall Study|No fertilization|2
5085878|NCT02081846|17558593|P2|Overall Study|invalid consent|0
5085879|NCT02081846|17558594|P1|Overall Study|invalid consent|1
5085880|NCT02081846|17558593|P2|Overall Study|Withdrawal by Subject|0
5085881|NCT02081846|17558594|P1|Overall Study|Withdrawal by Subject|1
5085882|NCT02081690|17558763|P1|Overall Study|Withdrawal by Subject|1
5085883|NCT02081690|17558763|P1|Overall Study|Physician Decision|3
5085884|NCT02081690|17558763|P1|Overall Study|Death|3
5085885|NCT02081677|17558774|P4|Overall Study|Unsatisfactory Lens Fitting|0
5085886|NCT02081677|17558775|P3|Overall Study|Unsatisfactory Lens Fitting|0
5085887|NCT02081677|17558776|P2|Overall Study|Unsatisfactory Lens Fitting|1
5085888|NCT02081677|17558777|P1|Overall Study|Unsatisfactory Lens Fitting|0
5085889|NCT02081677|17558774|P4|Overall Study|Not comfortable with lens care system|0
5085890|NCT02081677|17558775|P3|Overall Study|Not comfortable with lens care system|0
5085891|NCT02081677|17558776|P2|Overall Study|Not comfortable with lens care system|0
5085892|NCT02081677|17558777|P1|Overall Study|Not comfortable with lens care system|1
5085893|NCT02081677|17558774|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5085894|NCT02081677|17558775|P3|Overall Study|No Longer Meets Eligibility Criteria|1
5085895|NCT02081677|17558776|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5085896|NCT02081677|17558777|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5085897|NCT02081677|17558774|P4|Overall Study|Adverse Event|0
5085898|NCT02081677|17558775|P3|Overall Study|Adverse Event|1
5085899|NCT02081677|17558776|P2|Overall Study|Adverse Event|0
5085900|NCT02081677|17558777|P1|Overall Study|Adverse Event|0
5085901|NCT02081599|17558869|P2|Period 2：Open-label Period|Withdrawal by Subject|0
5085902|NCT02081599|17558870|P1|Period 2：Open-label Period|Withdrawal by Subject|2
5085903|NCT02081599|17558869|P2|Period 2：Open-label Period|Physician Decision|0
5085904|NCT02081599|17558870|P1|Period 2：Open-label Period|Physician Decision|1
5085905|NCT02081599|17558869|P2|Period 2：Open-label Period|Lack of Efficacy|4
5085906|NCT02081599|17558870|P1|Period 2：Open-label Period|Lack of Efficacy|2
5085907|NCT02081599|17558869|P2|Period 2：Open-label Period|Adverse Event|0
5085908|NCT02081599|17558870|P1|Period 2：Open-label Period|Adverse Event|1
5085909|NCT02081599|17558869|P2|Period 1：Double-blind Period|stopping criteria|0
5085910|NCT02081599|17558870|P1|Period 1：Double-blind Period|stopping criteria|1
5085911|NCT02081599|17558869|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
5085912|NCT02081599|17558870|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
5085913|NCT02081599|17558869|P2|Period 1：Double-blind Period|Protocol Violation|1
5085914|NCT02081599|17558870|P1|Period 1：Double-blind Period|Protocol Violation|0
5085915|NCT02081599|17558869|P2|Period 1：Double-blind Period|Physician Decision|0
5085916|NCT02081599|17558870|P1|Period 1：Double-blind Period|Physician Decision|1
5085917|NCT02081599|17558869|P2|Period 1：Double-blind Period|Lack of Efficacy|1
5085918|NCT02081599|17558870|P1|Period 1：Double-blind Period|Lack of Efficacy|2
5085919|NCT02081599|17558869|P2|Period 1：Double-blind Period|Adverse Event|0
5085920|NCT02081599|17558870|P1|Period 1：Double-blind Period|Adverse Event|3
5085921|NCT02081586|17558888|P4|Overall Study|Head injury not related to study|0
5085922|NCT02081586|17558889|P3|Overall Study|Head injury not related to study|1
5085923|NCT02081586|17558890|P2|Overall Study|Head injury not related to study|0
5085924|NCT02081586|17558891|P1|Overall Study|Head injury not related to study|0
5085925|NCT02081586|17558888|P4|Overall Study|Lost to Follow-up|1
5085926|NCT02081586|17558889|P3|Overall Study|Lost to Follow-up|0
5085927|NCT02081586|17558890|P2|Overall Study|Lost to Follow-up|1
5085928|NCT02081586|17558891|P1|Overall Study|Lost to Follow-up|0
5085929|NCT02081534|17558934|P7|Overall Study|Lost to Follow-up|0
5085930|NCT02081534|17558935|P6|Overall Study|Lost to Follow-up|1
5085931|NCT02081534|17558936|P5|Overall Study|Lost to Follow-up|1
5085932|NCT02081534|17558937|P4|Overall Study|Lost to Follow-up|2
5085933|NCT02081534|17558938|P3|Overall Study|Lost to Follow-up|0
5085934|NCT02081534|17558939|P2|Overall Study|Lost to Follow-up|0
5085935|NCT02081534|17558940|P1|Overall Study|Lost to Follow-up|0
5085936|NCT02081534|17558934|P7|Overall Study|Protocol Violation|1
5085937|NCT02081534|17558935|P6|Overall Study|Protocol Violation|0
5085938|NCT02081534|17558936|P5|Overall Study|Protocol Violation|0
5085939|NCT02081534|17558937|P4|Overall Study|Protocol Violation|0
5085940|NCT02081534|17558938|P3|Overall Study|Protocol Violation|0
5085941|NCT02081534|17558939|P2|Overall Study|Protocol Violation|3
5085942|NCT02081534|17558940|P1|Overall Study|Protocol Violation|0
5085943|NCT02081534|17558934|P7|Overall Study|Withdrawal by Subject|1
5085944|NCT02081534|17558935|P6|Overall Study|Withdrawal by Subject|0
5085945|NCT02081534|17558936|P5|Overall Study|Withdrawal by Subject|1
5085946|NCT02081534|17558937|P4|Overall Study|Withdrawal by Subject|1
5085947|NCT02081534|17558938|P3|Overall Study|Withdrawal by Subject|1
5085948|NCT02081534|17558939|P2|Overall Study|Withdrawal by Subject|1
5085949|NCT02081534|17558940|P1|Overall Study|Withdrawal by Subject|0
5085950|NCT02081534|17558934|P7|Overall Study|Adverse Event|2
5085951|NCT02081534|17558935|P6|Overall Study|Adverse Event|8
5085952|NCT02081534|17558936|P5|Overall Study|Adverse Event|2
5085953|NCT02081534|17558937|P4|Overall Study|Adverse Event|10
5085954|NCT02081534|17558938|P3|Overall Study|Adverse Event|3
5085955|NCT02081534|17558939|P2|Overall Study|Adverse Event|4
5085956|NCT02081534|17558940|P1|Overall Study|Adverse Event|5
5085957|NCT02081417|17558993|P2|Overall Study|Did not start treatment|21
5085958|NCT02081417|17558994|P1|Overall Study|Did not start treatment|17
5085959|NCT02081417|17558993|P2|Overall Study|Admitted to Residential Treatment|0
5085960|NCT02081417|17558994|P1|Overall Study|Admitted to Residential Treatment|2
5085961|NCT02081417|17558993|P2|Overall Study|Withdrawal by Subject|0
5085962|NCT02081417|17558994|P1|Overall Study|Withdrawal by Subject|4
5085963|NCT02081417|17558993|P2|Overall Study|Death|3
5085964|NCT02081417|17558994|P1|Overall Study|Death|4
5085965|NCT02081417|17558993|P2|Overall Study|Incarcerated|2
5085966|NCT02081417|17558994|P1|Overall Study|Incarcerated|2
5085967|NCT02081417|17558993|P2|Overall Study|Moved Away|2
5085968|NCT02081417|17558994|P1|Overall Study|Moved Away|1
5085969|NCT02081417|17558993|P2|Overall Study|Lost to Follow-up|23
5085970|NCT02081417|17558994|P1|Overall Study|Lost to Follow-up|26
5085971|NCT02081391|17559014|P4|24-hour Treatment and Trial Completion|Further reasons|0
5085972|NCT02081391|17559015|P3|24-hour Treatment and Trial Completion|Further reasons|0
5085973|NCT02081391|17559016|P2|24-hour Treatment and Trial Completion|Further reasons|4
5085974|NCT02081391|17559017|P1|24-hour Treatment and Trial Completion|Further reasons|3
5085975|NCT02081391|17559014|P4|24-hour Treatment and Trial Completion|Technical Problems|0
5085976|NCT02081391|17559015|P3|24-hour Treatment and Trial Completion|Technical Problems|0
5085977|NCT02081391|17559016|P2|24-hour Treatment and Trial Completion|Technical Problems|1
5085978|NCT02081391|17559017|P1|24-hour Treatment and Trial Completion|Technical Problems|1
5085979|NCT02081391|17559014|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
5085980|NCT02081391|17559015|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
5085981|NCT02081391|17559016|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
5085982|NCT02081391|17559017|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
5085983|NCT02081391|17559014|P4|24-hour Treatment and Trial Completion|Adverse Event|0
5085984|NCT02081391|17559015|P3|24-hour Treatment and Trial Completion|Adverse Event|0
5085985|NCT02081391|17559016|P2|24-hour Treatment and Trial Completion|Adverse Event|0
5085986|NCT02081391|17559017|P1|24-hour Treatment and Trial Completion|Adverse Event|1
5085987|NCT02081391|17559014|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
5085988|NCT02081391|17559015|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
5085989|NCT02081391|17559016|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
5085990|NCT02081391|17559017|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
5085991|NCT02081391|17559014|P4|24-hour Treatment and Trial Completion|Physician Decision|0
5085992|NCT02081391|17559015|P3|24-hour Treatment and Trial Completion|Physician Decision|0
5085993|NCT02081391|17559016|P2|24-hour Treatment and Trial Completion|Physician Decision|5
5085994|NCT02081391|17559017|P1|24-hour Treatment and Trial Completion|Physician Decision|10
5085995|NCT02081391|17559014|P4|12-hour Treatment|Further reasons|0
5085996|NCT02081391|17559015|P3|12-hour Treatment|Further reasons|0
5085997|NCT02081391|17559016|P2|12-hour Treatment|Further reasons|1
5085998|NCT02081391|17559017|P1|12-hour Treatment|Further reasons|2
5085999|NCT02081391|17559014|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
5086000|NCT02081391|17559015|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
5086001|NCT02081391|17559016|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
5086002|NCT02081391|17559017|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
5086003|NCT02081391|17559014|P4|12-hour Treatment|Adverse Event|0
5086004|NCT02081391|17559015|P3|12-hour Treatment|Adverse Event|0
5086005|NCT02081391|17559016|P2|12-hour Treatment|Adverse Event|2
5086006|NCT02081391|17559017|P1|12-hour Treatment|Adverse Event|4
5086007|NCT02081391|17559014|P4|12-hour Treatment|Lack of Efficacy|0
5086008|NCT02081391|17559015|P3|12-hour Treatment|Lack of Efficacy|0
5086009|NCT02081391|17559016|P2|12-hour Treatment|Lack of Efficacy|0
5086010|NCT02081391|17559017|P1|12-hour Treatment|Lack of Efficacy|3
5086011|NCT02081391|17559014|P4|12-hour Treatment|Physician Decision|0
5086012|NCT02081391|17559015|P3|12-hour Treatment|Physician Decision|0
5086013|NCT02081391|17559016|P2|12-hour Treatment|Physician Decision|1
5086014|NCT02081391|17559017|P1|12-hour Treatment|Physician Decision|4
5086015|NCT02081391|17559014|P4|12-hour Treatment|Withdrawal by Subject|0
5086016|NCT02081391|17559015|P3|12-hour Treatment|Withdrawal by Subject|0
5086017|NCT02081391|17559016|P2|12-hour Treatment|Withdrawal by Subject|2
5086018|NCT02081391|17559017|P1|12-hour Treatment|Withdrawal by Subject|3
5086019|NCT02081183|17559111|P2|Overall Study|Other|3
5086020|NCT02081183|17559112|P1|Overall Study|Other|3
5086021|NCT02081183|17559111|P2|Overall Study|Protocol Violation|0
5086022|NCT02081183|17559112|P1|Overall Study|Protocol Violation|1
5086023|NCT02081183|17559111|P2|Overall Study|Lost to Follow-up|1
5086024|NCT02081183|17559112|P1|Overall Study|Lost to Follow-up|0
5086025|NCT02081079|17559128|P2|Overall Study|Lost to Follow-up|0
5086026|NCT02081079|17559129|P1|Overall Study|Lost to Follow-up|1
5086027|NCT02081079|17559128|P2|Overall Study|Lack of Efficacy|2
5086028|NCT02081079|17559129|P1|Overall Study|Lack of Efficacy|3
5086029|NCT02081001|17559202|P12|Overall Study|Adverse Event|0
5086030|NCT02081001|17559203|P11|Overall Study|Adverse Event|0
5086031|NCT02081001|17559204|P10|Overall Study|Adverse Event|0
5086032|NCT02081001|17559205|P9|Overall Study|Adverse Event|0
5086033|NCT02081001|17559206|P8|Overall Study|Adverse Event|0
5086034|NCT02081001|17559207|P7|Overall Study|Adverse Event|0
5086035|NCT02081001|17559208|P6|Overall Study|Adverse Event|0
5086036|NCT02081001|17559209|P5|Overall Study|Adverse Event|1
5086037|NCT02081001|17559210|P4|Overall Study|Adverse Event|0
5086038|NCT02081001|17559211|P3|Overall Study|Adverse Event|0
5086039|NCT02081001|17559212|P2|Overall Study|Adverse Event|0
5086040|NCT02081001|17559213|P1|Overall Study|Adverse Event|0
5086041|NCT02080871|17559277|P1|Overall Study|Lost to Follow-up|1
5086042|NCT02080871|17559277|P1|Overall Study|Death|1
5086043|NCT02080832|17559361|P3|Overall Study|Lost to Follow-up|2
5086044|NCT02080832|17559362|P2|Overall Study|Lost to Follow-up|2
5086045|NCT02080832|17559363|P1|Overall Study|Lost to Follow-up|0
5086046|NCT02080832|17559361|P3|Overall Study|Excluded from analysis by MRI|14
5086047|NCT02080832|17559362|P2|Overall Study|Excluded from analysis by MRI|10
5086048|NCT02080832|17559363|P1|Overall Study|Excluded from analysis by MRI|9
5086049|NCT02080481|17559435|P2|Overall Study|Never received a block.|0
5086050|NCT02080481|17559436|P1|Overall Study|Never received a block.|1
5086051|NCT02080260|17559622|P1|Overall Study|Withdrawal by Subject|1
5086052|NCT02080260|17559622|P1|Overall Study|Death|18
5086053|NCT02080091|17559639|P1|Overall Study|Other|1
5086054|NCT02080091|17559639|P1|Overall Study|Withdrawal by Subject|1
5086055|NCT02080091|17559639|P1|Overall Study|Death|1
5086056|NCT02080091|17559639|P1|Overall Study|Study Terminated|22
5086057|NCT02079909|17559667|P3|Overall Study|Relocation etc.|3
5086058|NCT02079909|17559668|P2|Overall Study|Relocation etc.|2
5086059|NCT02079909|17559669|P1|Overall Study|Relocation etc.|2
5086060|NCT02079909|17559667|P3|Overall Study|Physician Decision|1
5086061|NCT02079909|17559668|P2|Overall Study|Physician Decision|1
5086062|NCT02079909|17559669|P1|Overall Study|Physician Decision|0
5086063|NCT02079909|17559667|P3|Overall Study|Protocol Violation|1
5086064|NCT02079909|17559668|P2|Overall Study|Protocol Violation|1
5086065|NCT02079909|17559669|P1|Overall Study|Protocol Violation|0
5086066|NCT02079909|17559667|P3|Overall Study|Lack of Efficacy|1
5086067|NCT02079909|17559668|P2|Overall Study|Lack of Efficacy|0
5086068|NCT02079909|17559669|P1|Overall Study|Lack of Efficacy|0
5086069|NCT02079909|17559667|P3|Overall Study|Death|0
5086070|NCT02079909|17559668|P2|Overall Study|Death|2
5086071|NCT02079909|17559669|P1|Overall Study|Death|2
5086072|NCT02079909|17559667|P3|Overall Study|Lost to Follow-up|1
5086073|NCT02079909|17559668|P2|Overall Study|Lost to Follow-up|3
5086074|NCT02079909|17559669|P1|Overall Study|Lost to Follow-up|2
5086075|NCT02079909|17559667|P3|Overall Study|Withdrawal by Subject|4
5086076|NCT02079909|17559668|P2|Overall Study|Withdrawal by Subject|17
5086077|NCT02079909|17559669|P1|Overall Study|Withdrawal by Subject|9
5086078|NCT02079909|17559667|P3|Overall Study|Adverse Event|7
5086079|NCT02079909|17559668|P2|Overall Study|Adverse Event|23
5086080|NCT02079909|17559669|P1|Overall Study|Adverse Event|23
5086081|NCT02079844|17559686|P3|Treatment Period 2|Voluntary Withdrawal|0
5086082|NCT02079844|17559687|P2|Treatment Period 2|Voluntary Withdrawal|1
5086083|NCT02079844|17559688|P1|Treatment Period 2|Voluntary Withdrawal|0
5086084|NCT02079844|17559686|P3|Treatment Period 1|Voluntary Withdrawal|2
5086085|NCT02079844|17559687|P2|Treatment Period 1|Voluntary Withdrawal|0
5086086|NCT02079844|17559688|P1|Treatment Period 1|Voluntary Withdrawal|0
5086087|NCT02079805|17559746|P2|Overall Study|Voluntary Withdrawal|1
5086088|NCT02079805|17559747|P1|Overall Study|Voluntary Withdrawal|0
5086089|NCT02079805|17559746|P2|Overall Study|Pretreatment Event/Adverse Event|1
5086090|NCT02079805|17559747|P1|Overall Study|Pretreatment Event/Adverse Event|0
5086091|NCT02079766|17559767|P2|Overall Study|Withdrawal by Subject|0
5086092|NCT02079766|17559768|P1|Overall Study|Withdrawal by Subject|1
5086093|NCT02079766|17559767|P2|Overall Study|Physician Decision|0
5086094|NCT02079766|17559768|P1|Overall Study|Physician Decision|1
5086095|NCT02079649|17559779|P4|Overall Study|Randomization error (prior to treatment)|0
5086096|NCT02079649|17559780|P3|Overall Study|Randomization error (prior to treatment)|1
5086097|NCT02079649|17559781|P2|Overall Study|Randomization error (prior to treatment)|0
5086098|NCT02079649|17559782|P1|Overall Study|Randomization error (prior to treatment)|1
5086099|NCT02079649|17559779|P4|Overall Study|Withdrawal by Subject|1
5086100|NCT02079649|17559780|P3|Overall Study|Withdrawal by Subject|0
5086101|NCT02079649|17559781|P2|Overall Study|Withdrawal by Subject|0
5086102|NCT02079649|17559782|P1|Overall Study|Withdrawal by Subject|0
5086103|NCT02079649|17559779|P4|Overall Study|Lost to Follow-up|1
5086104|NCT02079649|17559780|P3|Overall Study|Lost to Follow-up|0
5086105|NCT02079649|17559781|P2|Overall Study|Lost to Follow-up|0
5086106|NCT02079649|17559782|P1|Overall Study|Lost to Follow-up|0
5086107|NCT02079636|17559812|P15|Overall Study|Lost to Follow-up|0
5086108|NCT02079636|17559813|P14|Overall Study|Lost to Follow-up|0
5086109|NCT02079636|17559814|P13|Overall Study|Lost to Follow-up|0
5086110|NCT02079636|17559815|P12|Overall Study|Lost to Follow-up|0
5086111|NCT02079636|17559816|P11|Overall Study|Lost to Follow-up|0
5086112|NCT02079636|17559817|P10|Overall Study|Lost to Follow-up|0
5086113|NCT02079636|17559818|P9|Overall Study|Lost to Follow-up|0
5086114|NCT02079636|17559819|P8|Overall Study|Lost to Follow-up|1
5086115|NCT02079636|17559820|P7|Overall Study|Lost to Follow-up|0
5086116|NCT02079636|17559821|P6|Overall Study|Lost to Follow-up|0
5086117|NCT02079636|17559822|P5|Overall Study|Lost to Follow-up|0
5086118|NCT02079636|17559823|P4|Overall Study|Lost to Follow-up|0
5086119|NCT02079636|17559824|P3|Overall Study|Lost to Follow-up|0
5086120|NCT02079636|17559825|P2|Overall Study|Lost to Follow-up|0
5086121|NCT02079636|17559826|P1|Overall Study|Lost to Follow-up|0
5086122|NCT02079636|17559812|P15|Overall Study|Physician Decision|1
5086123|NCT02079636|17559813|P14|Overall Study|Physician Decision|0
5086124|NCT02079636|17559814|P13|Overall Study|Physician Decision|0
5086125|NCT02079636|17559815|P12|Overall Study|Physician Decision|0
5086126|NCT02079636|17559816|P11|Overall Study|Physician Decision|1
5086127|NCT02079636|17559817|P10|Overall Study|Physician Decision|1
5086128|NCT02079636|17559818|P9|Overall Study|Physician Decision|0
5086129|NCT02079636|17559819|P8|Overall Study|Physician Decision|0
5086130|NCT02079636|17559820|P7|Overall Study|Physician Decision|0
5086131|NCT02079636|17559821|P6|Overall Study|Physician Decision|1
5086132|NCT02079636|17559822|P5|Overall Study|Physician Decision|0
5086133|NCT02079636|17559823|P4|Overall Study|Physician Decision|0
5086134|NCT02079636|17559824|P3|Overall Study|Physician Decision|0
5086135|NCT02079636|17559825|P2|Overall Study|Physician Decision|0
5086136|NCT02079636|17559826|P1|Overall Study|Physician Decision|0
5086137|NCT02079636|17559812|P15|Overall Study|Withdrawal by Subject|2
5086138|NCT02079636|17559813|P14|Overall Study|Withdrawal by Subject|0
5086139|NCT02079636|17559814|P13|Overall Study|Withdrawal by Subject|1
5086140|NCT02079636|17559815|P12|Overall Study|Withdrawal by Subject|1
5086141|NCT02079636|17559816|P11|Overall Study|Withdrawal by Subject|1
5086142|NCT02079636|17559817|P10|Overall Study|Withdrawal by Subject|2
5086143|NCT02079636|17559818|P9|Overall Study|Withdrawal by Subject|0
5086144|NCT02079636|17559819|P8|Overall Study|Withdrawal by Subject|0
5086145|NCT02079636|17559820|P7|Overall Study|Withdrawal by Subject|0
5086146|NCT02079636|17559821|P6|Overall Study|Withdrawal by Subject|1
5086147|NCT02079636|17559822|P5|Overall Study|Withdrawal by Subject|0
5086148|NCT02079636|17559823|P4|Overall Study|Withdrawal by Subject|4
5086149|NCT02079636|17559824|P3|Overall Study|Withdrawal by Subject|0
5086150|NCT02079636|17559825|P2|Overall Study|Withdrawal by Subject|0
5086151|NCT02079636|17559826|P1|Overall Study|Withdrawal by Subject|0
5086152|NCT02079636|17559812|P15|Overall Study|Progressive disease|0
5086153|NCT02079636|17559813|P14|Overall Study|Progressive disease|0
5086154|NCT02079636|17559814|P13|Overall Study|Progressive disease|1
5086155|NCT02079636|17559815|P12|Overall Study|Progressive disease|0
5086156|NCT02079636|17559816|P11|Overall Study|Progressive disease|0
5086157|NCT02079636|17559817|P10|Overall Study|Progressive disease|0
5086158|NCT02079636|17559818|P9|Overall Study|Progressive disease|0
5086159|NCT02079636|17559819|P8|Overall Study|Progressive disease|0
5086160|NCT02079636|17559820|P7|Overall Study|Progressive disease|0
5086161|NCT02079636|17559821|P6|Overall Study|Progressive disease|0
5086162|NCT02079636|17559822|P5|Overall Study|Progressive disease|0
5086163|NCT02079636|17559823|P4|Overall Study|Progressive disease|2
5086164|NCT02079636|17559824|P3|Overall Study|Progressive disease|0
5086165|NCT02079636|17559825|P2|Overall Study|Progressive disease|0
5086166|NCT02079636|17559826|P1|Overall Study|Progressive disease|0
5086167|NCT02079636|17559812|P15|Overall Study|Adverse Event|0
5086168|NCT02079636|17559813|P14|Overall Study|Adverse Event|0
5086169|NCT02079636|17559814|P13|Overall Study|Adverse Event|0
5086170|NCT02079636|17559815|P12|Overall Study|Adverse Event|0
5086171|NCT02079636|17559816|P11|Overall Study|Adverse Event|0
5086172|NCT02079636|17559817|P10|Overall Study|Adverse Event|0
5086173|NCT02079636|17559818|P9|Overall Study|Adverse Event|0
5086174|NCT02079636|17559819|P8|Overall Study|Adverse Event|0
5086175|NCT02079636|17559820|P7|Overall Study|Adverse Event|0
5086176|NCT02079636|17559821|P6|Overall Study|Adverse Event|2
5086177|NCT02079636|17559822|P5|Overall Study|Adverse Event|1
5086178|NCT02079636|17559823|P4|Overall Study|Adverse Event|1
5086179|NCT02079636|17559824|P3|Overall Study|Adverse Event|0
5086180|NCT02079636|17559825|P2|Overall Study|Adverse Event|1
5086181|NCT02079636|17559826|P1|Overall Study|Adverse Event|1
5086182|NCT02079636|17559812|P15|Overall Study|Death|2
5086183|NCT02079636|17559813|P14|Overall Study|Death|0
5086184|NCT02079636|17559814|P13|Overall Study|Death|1
5086185|NCT02079636|17559815|P12|Overall Study|Death|1
5086186|NCT02079636|17559816|P11|Overall Study|Death|0
5086187|NCT02079636|17559817|P10|Overall Study|Death|0
5086188|NCT02079636|17559818|P9|Overall Study|Death|0
5086189|NCT02079636|17559819|P8|Overall Study|Death|0
5086190|NCT02079636|17559820|P7|Overall Study|Death|1
5086191|NCT02079636|17559821|P6|Overall Study|Death|2
5086192|NCT02079636|17559822|P5|Overall Study|Death|1
5086193|NCT02079636|17559823|P4|Overall Study|Death|5
5086194|NCT02079636|17559824|P3|Overall Study|Death|0
5086195|NCT02079636|17559825|P2|Overall Study|Death|1
5086196|NCT02079636|17559826|P1|Overall Study|Death|2
5086197|NCT02079610|17559937|P2|Overall Study|Withdrawal by Subject|1
5086198|NCT02079610|17559938|P1|Overall Study|Withdrawal by Subject|1
5086199|NCT02079532|17559948|P1|Overall Study|Other|3
5086200|NCT02079532|17559948|P1|Overall Study|Inclusion into ReFIRST|3
5086201|NCT02079532|17559948|P1|Overall Study|Administrative problems|1
5086202|NCT02079532|17559948|P1|Overall Study|Withdrawal by Subject|1
5086203|NCT02079532|17559948|P1|Overall Study|Protocol Violation|3
5086204|NCT02079532|17559948|P1|Overall Study|Lack of Efficacy|9
5086205|NCT02079532|17559948|P1|Overall Study|Additional or changed therapy|2
5086206|NCT02079532|17559948|P1|Overall Study|Adverse Event|7
5086207|NCT02079519|17559970|P1|Overall Study|Adverse Event|1
5086208|NCT02079519|17559970|P1|Overall Study|Disease Progression|9
5086209|NCT02079246|17559983|P2|OLEX-MEM|Other: Moved to nursing home|3
5086210|NCT02079246|17559984|P1|OLEX-MEM|Other: Moved to nursing home|0
5086211|NCT02079246|17559983|P2|OLEX-MEM|Lost to Follow-up|1
5086212|NCT02079246|17559984|P1|OLEX-MEM|Lost to Follow-up|0
5086213|NCT02079246|17559983|P2|OLEX-MEM|Protocol Violation|2
5086214|NCT02079246|17559984|P1|OLEX-MEM|Protocol Violation|0
5086215|NCT02079246|17559983|P2|OLEX-MEM|Withdrawal by Subject|7
5086216|NCT02079246|17559984|P1|OLEX-MEM|Withdrawal by Subject|0
5086217|NCT02079246|17559983|P2|OLEX-MEM|Adverse Event|6
5086218|NCT02079246|17559984|P1|OLEX-MEM|Adverse Event|0
5086219|NCT02079246|17559983|P2|OLEX|Other: Withdrawal of caregiver consent|0
5086220|NCT02079246|17559984|P1|OLEX|Other: Withdrawal of caregiver consent|1
5086221|NCT02079246|17559983|P2|OLEX|Other: Moved to nursing home|0
5086222|NCT02079246|17559984|P1|OLEX|Other: Moved to nursing home|1
5086223|NCT02079246|17559983|P2|OLEX|Other: Worsening of condition|0
5086224|NCT02079246|17559984|P1|OLEX|Other: Worsening of condition|1
5086225|NCT02079246|17559983|P2|OLEX|Other: Coordinator decision|0
5086226|NCT02079246|17559984|P1|OLEX|Other: Coordinator decision|1
5086227|NCT02079246|17559983|P2|OLEX|Other: Caregiver unavailable|0
5086228|NCT02079246|17559984|P1|OLEX|Other: Caregiver unavailable|3
5086229|NCT02079246|17559983|P2|OLEX|Other: Insufficient compliance|0
5086230|NCT02079246|17559984|P1|OLEX|Other: Insufficient compliance|2
5086231|NCT02079246|17559983|P2|OLEX|Other: Disallowed medication|0
5086232|NCT02079246|17559984|P1|OLEX|Other: Disallowed medication|8
5086233|NCT02079246|17559983|P2|OLEX|Results of the lead-in studies|0
5086234|NCT02079246|17559984|P1|OLEX|Results of the lead-in studies|58
5086235|NCT02079246|17559983|P2|OLEX|Lack of Efficacy|0
5086236|NCT02079246|17559984|P1|OLEX|Lack of Efficacy|3
5086237|NCT02079246|17559983|P2|OLEX|Protocol Violation|0
5086238|NCT02079246|17559984|P1|OLEX|Protocol Violation|6
5086239|NCT02079246|17559983|P2|OLEX|Lost to Follow-up|0
5086240|NCT02079246|17559984|P1|OLEX|Lost to Follow-up|6
5086241|NCT02079246|17559983|P2|OLEX|Withdrawal by Subject|0
5086242|NCT02079246|17559984|P1|OLEX|Withdrawal by Subject|60
5086243|NCT02079246|17559983|P2|OLEX|Adverse Event|0
5086244|NCT02079246|17559984|P1|OLEX|Adverse Event|66
5086245|NCT02079246|17559983|P2|OLEX|Death|0
5086246|NCT02079246|17559984|P1|OLEX|Death|11
5086247|NCT02079246|17559983|P2|OLEX|Withdrawal before treatment|0
5086248|NCT02079246|17559984|P1|OLEX|Withdrawal before treatment|1
5086249|NCT02079077|17560003|P2|Overall Study|Became STIs Positive|2
5086250|NCT02079077|17560004|P1|Overall Study|Became STIs Positive|1
5086251|NCT02079077|17560003|P2|Overall Study|Lost to Follow-up|7
5086252|NCT02079077|17560004|P1|Overall Study|Lost to Follow-up|5
5086253|NCT02079038|17560014|P2|Completed 6 Months|Lost to Follow-up|1
5086254|NCT02079038|17560015|P1|Completed 6 Months|Lost to Follow-up|2
5086255|NCT02079038|17560014|P2|Modified Intent to Treat Population|Death|0
5086256|NCT02079038|17560015|P1|Modified Intent to Treat Population|Death|1
5086257|NCT02079038|17560014|P2|Modified Intent to Treat Population|Withdrawal by Subject|5
5086258|NCT02079038|17560015|P1|Modified Intent to Treat Population|Withdrawal by Subject|6
5086259|NCT02078960|17560036|P3|Follow-up Period|Lost to Follow-up|0
5086260|NCT02078960|17560037|P2|Follow-up Period|Lost to Follow-up|1
5086261|NCT02078960|17560038|P1|Follow-up Period|Lost to Follow-up|0
5086262|NCT02078960|17560036|P3|Follow-up Period|Death|0
5086263|NCT02078960|17560037|P2|Follow-up Period|Death|0
5086264|NCT02078960|17560038|P1|Follow-up Period|Death|2
5086265|NCT02078960|17560036|P3|Treatment Period|Death|1
5086266|NCT02078960|17560037|P2|Treatment Period|Death|0
5086267|NCT02078960|17560038|P1|Treatment Period|Death|0
5086268|NCT02078960|17560036|P3|Treatment Period|Adverse Event|0
5086269|NCT02078960|17560037|P2|Treatment Period|Adverse Event|0
5086270|NCT02078960|17560038|P1|Treatment Period|Adverse Event|1
5086271|NCT02078960|17560036|P3|Treatment Period|Withdrawal by Subject|1
5086272|NCT02078960|17560037|P2|Treatment Period|Withdrawal by Subject|1
5086273|NCT02078960|17560038|P1|Treatment Period|Withdrawal by Subject|0
5086274|NCT02078960|17560036|P3|Treatment Period|Disease progression - blast phase|0
5086275|NCT02078960|17560037|P2|Treatment Period|Disease progression - blast phase|0
5086276|NCT02078960|17560038|P1|Treatment Period|Disease progression - blast phase|1
5086277|NCT02078960|17560036|P3|Treatment Period|Disease progression - accelerated phase|0
5086278|NCT02078960|17560037|P2|Treatment Period|Disease progression - accelerated phase|1
5086279|NCT02078960|17560038|P1|Treatment Period|Disease progression - accelerated phase|0
5086280|NCT02078960|17560036|P3|Treatment Period|Lack of Efficacy|0
5086281|NCT02078960|17560037|P2|Treatment Period|Lack of Efficacy|1
5086282|NCT02078960|17560038|P1|Treatment Period|Lack of Efficacy|0
5086283|NCT02078960|17560036|P3|Treatment Period|Other|1
5086284|NCT02078960|17560037|P2|Treatment Period|Other|0
5086285|NCT02078960|17560038|P1|Treatment Period|Other|0
5086286|NCT02078817|17560072|P1|Overall Study|Withdrawal by Subject|1
5086287|NCT02078752|17560094|P10|Overall Study|Study terminated by sponsor|5
5086288|NCT02078752|17560095|P9|Overall Study|Study terminated by sponsor|0
5086289|NCT02078752|17560096|P8|Overall Study|Study terminated by sponsor|0
5086290|NCT02078752|17560097|P7|Overall Study|Study terminated by sponsor|0
5086291|NCT02078752|17560098|P6|Overall Study|Study terminated by sponsor|0
5086292|NCT02078752|17560099|P5|Overall Study|Study terminated by sponsor|0
5086293|NCT02078752|17560100|P4|Overall Study|Study terminated by sponsor|0
5086294|NCT02078752|17560101|P3|Overall Study|Study terminated by sponsor|0
5086295|NCT02078752|17560102|P2|Overall Study|Study terminated by sponsor|0
5086296|NCT02078752|17560103|P1|Overall Study|Study terminated by sponsor|0
5086297|NCT02078752|17560094|P10|Overall Study|Other|0
5086298|NCT02078752|17560095|P9|Overall Study|Other|0
5086299|NCT02078752|17560096|P8|Overall Study|Other|1
5086300|NCT02078752|17560097|P7|Overall Study|Other|0
5086301|NCT02078752|17560098|P6|Overall Study|Other|0
5086302|NCT02078752|17560099|P5|Overall Study|Other|1
5086303|NCT02078752|17560100|P4|Overall Study|Other|0
5086304|NCT02078752|17560101|P3|Overall Study|Other|0
5086305|NCT02078752|17560102|P2|Overall Study|Other|3
5086306|NCT02078752|17560103|P1|Overall Study|Other|0
5086307|NCT02078752|17560094|P10|Overall Study|Withdrawal by Subject|1
5086308|NCT02078752|17560095|P9|Overall Study|Withdrawal by Subject|0
5086309|NCT02078752|17560096|P8|Overall Study|Withdrawal by Subject|1
5086310|NCT02078752|17560097|P7|Overall Study|Withdrawal by Subject|2
5086311|NCT02078752|17560098|P6|Overall Study|Withdrawal by Subject|3
5086312|NCT02078752|17560099|P5|Overall Study|Withdrawal by Subject|0
5086313|NCT02078752|17560100|P4|Overall Study|Withdrawal by Subject|1
5086314|NCT02078752|17560101|P3|Overall Study|Withdrawal by Subject|1
5086315|NCT02078752|17560102|P2|Overall Study|Withdrawal by Subject|1
5086316|NCT02078752|17560103|P1|Overall Study|Withdrawal by Subject|1
5086317|NCT02078752|17560094|P10|Overall Study|Lost to Follow-up|0
5086318|NCT02078752|17560095|P9|Overall Study|Lost to Follow-up|0
5086319|NCT02078752|17560096|P8|Overall Study|Lost to Follow-up|0
5086320|NCT02078752|17560097|P7|Overall Study|Lost to Follow-up|0
5086321|NCT02078752|17560098|P6|Overall Study|Lost to Follow-up|0
5086322|NCT02078752|17560099|P5|Overall Study|Lost to Follow-up|0
5086323|NCT02078752|17560100|P4|Overall Study|Lost to Follow-up|1
5086324|NCT02078752|17560101|P3|Overall Study|Lost to Follow-up|0
5086325|NCT02078752|17560102|P2|Overall Study|Lost to Follow-up|0
5086326|NCT02078752|17560103|P1|Overall Study|Lost to Follow-up|1
5086327|NCT02078752|17560094|P10|Overall Study|Death|4
5086328|NCT02078752|17560095|P9|Overall Study|Death|0
5086329|NCT02078752|17560096|P8|Overall Study|Death|1
5086330|NCT02078752|17560097|P7|Overall Study|Death|0
5086331|NCT02078752|17560098|P6|Overall Study|Death|1
5086332|NCT02078752|17560099|P5|Overall Study|Death|0
5086333|NCT02078752|17560100|P4|Overall Study|Death|0
5086334|NCT02078752|17560101|P3|Overall Study|Death|0
5086335|NCT02078752|17560102|P2|Overall Study|Death|3
5086336|NCT02078752|17560103|P1|Overall Study|Death|0
5086337|NCT02078713|17560379|P4|Overall Study|Enrolled twice|0
5086338|NCT02078713|17560380|P3|Overall Study|Enrolled twice|0
5086339|NCT02078713|17560381|P2|Overall Study|Enrolled twice|1
5086340|NCT02078713|17560382|P1|Overall Study|Enrolled twice|0
5086341|NCT02078713|17560379|P4|Overall Study|Pregnant at baseline|0
5086342|NCT02078713|17560380|P3|Overall Study|Pregnant at baseline|0
5086343|NCT02078713|17560381|P2|Overall Study|Pregnant at baseline|5
5086344|NCT02078713|17560382|P1|Overall Study|Pregnant at baseline|3
5086345|NCT02078713|17560379|P4|Overall Study|Lost to Follow-up|0
5086346|NCT02078713|17560380|P3|Overall Study|Lost to Follow-up|0
5086347|NCT02078713|17560381|P2|Overall Study|Lost to Follow-up|55
5086348|NCT02078713|17560382|P1|Overall Study|Lost to Follow-up|49
5086349|NCT02078219|17560467|P5|Overall Study|Adverse Event|0
5086350|NCT02078219|17560468|P4|Overall Study|Adverse Event|1
5086351|NCT02078219|17560469|P3|Overall Study|Adverse Event|3
5086352|NCT02078219|17560470|P2|Overall Study|Adverse Event|1
5086353|NCT02078219|17560471|P1|Overall Study|Adverse Event|1
5086354|NCT02078219|17560467|P5|Overall Study|Death|0
5086355|NCT02078219|17560468|P4|Overall Study|Death|1
5086356|NCT02078219|17560469|P3|Overall Study|Death|0
5086357|NCT02078219|17560470|P2|Overall Study|Death|0
5086358|NCT02078219|17560471|P1|Overall Study|Death|0
5086359|NCT02078219|17560467|P5|Overall Study|Protocol Violation|0
5086360|NCT02078219|17560468|P4|Overall Study|Protocol Violation|1
5086361|NCT02078219|17560469|P3|Overall Study|Protocol Violation|0
5086362|NCT02078219|17560470|P2|Overall Study|Protocol Violation|0
5086363|NCT02078219|17560471|P1|Overall Study|Protocol Violation|0
5086364|NCT02078219|17560467|P5|Overall Study|Withdrawal by Subject|1
5086365|NCT02078219|17560468|P4|Overall Study|Withdrawal by Subject|1
5086366|NCT02078219|17560469|P3|Overall Study|Withdrawal by Subject|0
5086367|NCT02078219|17560470|P2|Overall Study|Withdrawal by Subject|1
5086368|NCT02078219|17560471|P1|Overall Study|Withdrawal by Subject|0
5086369|NCT02078219|17560467|P5|Overall Study|Other|1
5086370|NCT02078219|17560468|P4|Overall Study|Other|0
5086371|NCT02078219|17560469|P3|Overall Study|Other|3
5086372|NCT02078219|17560470|P2|Overall Study|Other|2
5086373|NCT02078219|17560471|P1|Overall Study|Other|2
5086374|NCT02077465|17560521|P2|Overall Study|Lost to Follow-up|0
5086375|NCT02077465|17560522|P1|Overall Study|Lost to Follow-up|1
5086376|NCT02077465|17560521|P2|Overall Study|Withdrew Consent|1
5086377|NCT02077465|17560522|P1|Overall Study|Withdrew Consent|0
5086378|NCT02077374|17560545|P2|Overall Study|Protocol Violation|1
5086379|NCT02077374|17560546|P1|Overall Study|Protocol Violation|0
5086380|NCT02077374|17560545|P2|Overall Study|Withdrawal by Subject|1
5086381|NCT02077374|17560546|P1|Overall Study|Withdrawal by Subject|0
5086382|NCT02077140|17560567|P5|Overall Study|Withdrawal by Subject|2
5086383|NCT02077140|17560568|P4|Overall Study|Withdrawal by Subject|2
5086384|NCT02077140|17560569|P3|Overall Study|Withdrawal by Subject|0
5086385|NCT02077140|17560570|P2|Overall Study|Withdrawal by Subject|1
5086386|NCT02077140|17560571|P1|Overall Study|Withdrawal by Subject|0
5086387|NCT02077140|17560567|P5|Overall Study|Lost to Follow-up|3
5086388|NCT02077140|17560568|P4|Overall Study|Lost to Follow-up|2
5086389|NCT02077140|17560569|P3|Overall Study|Lost to Follow-up|2
5086390|NCT02077140|17560570|P2|Overall Study|Lost to Follow-up|1
5086391|NCT02077140|17560571|P1|Overall Study|Lost to Follow-up|4
5086392|NCT02076334|17560849|P4|Overall Study|muscle soreness|1
5086393|NCT02076334|17560850|P3|Overall Study|muscle soreness|0
5086394|NCT02076334|17560851|P2|Overall Study|muscle soreness|0
5086395|NCT02076334|17560852|P1|Overall Study|muscle soreness|0
5086396|NCT02076334|17560849|P4|Overall Study|Lost to Follow-up|0
5086397|NCT02076334|17560850|P3|Overall Study|Lost to Follow-up|1
5086398|NCT02076334|17560851|P2|Overall Study|Lost to Follow-up|1
5086399|NCT02076334|17560852|P1|Overall Study|Lost to Follow-up|0
5086400|NCT02076334|17560849|P4|Overall Study|Protocol Violation|0
5086401|NCT02076334|17560850|P3|Overall Study|Protocol Violation|0
5086402|NCT02076334|17560851|P2|Overall Study|Protocol Violation|0
5086403|NCT02076334|17560852|P1|Overall Study|Protocol Violation|1
5086404|NCT02076178|17560885|P2|Injection Phase|Lost to Follow-up|1
5086405|NCT02076178|17560886|P1|Injection Phase|Lost to Follow-up|0
5086406|NCT02076178|17560885|P2|Injection Phase|Physician Decision|3
5086407|NCT02076178|17560886|P1|Injection Phase|Physician Decision|0
5086408|NCT02076178|17560885|P2|Injection Phase|Withdrawal by Subject|3
5086409|NCT02076178|17560886|P1|Injection Phase|Withdrawal by Subject|0
5086410|NCT02076178|17560885|P2|Injection Phase|Protocol defined stopping criteria|0
5086411|NCT02076178|17560886|P1|Injection Phase|Protocol defined stopping criteria|1
5086412|NCT02076178|17560885|P2|Oral Phase|Physician Decision|1
5086413|NCT02076178|17560886|P1|Oral Phase|Physician Decision|0
5086414|NCT02076178|17560885|P2|Oral Phase|Withdrawal by Subject|4
5086415|NCT02076178|17560886|P1|Oral Phase|Withdrawal by Subject|0
5086416|NCT02076178|17560885|P2|Oral Phase|Adverse Event|7
5086417|NCT02076178|17560886|P1|Oral Phase|Adverse Event|0
5086418|NCT02076165|17560920|P2|Overall Study|Refused follow-up assessment|1
5086419|NCT02076165|17560921|P1|Overall Study|Refused follow-up assessment|1
5086420|NCT02076165|17560920|P2|Overall Study|Lost to Follow-up|5
5086421|NCT02076165|17560921|P1|Overall Study|Lost to Follow-up|7
5086422|NCT02076022|17560991|P2|Overall Study|Withdrawal by Subject|0
5086423|NCT02076022|17560992|P1|Overall Study|Withdrawal by Subject|2
5086424|NCT02076009|17561004|P2|Overall Study|Subjects randomized but not treated|3
5086425|NCT02076009|17561005|P1|Overall Study|Subjects randomized but not treated|2
5086426|NCT02076009|17561004|P2|Overall Study|Ongoing|249
5086427|NCT02076009|17561005|P1|Overall Study|Ongoing|226
5086428|NCT02076009|17561004|P2|Overall Study|Progressive disease|0
5086429|NCT02076009|17561005|P1|Overall Study|Progressive disease|1
5086430|NCT02076009|17561004|P2|Overall Study|Lost to Follow-up|1
5086431|NCT02076009|17561005|P1|Overall Study|Lost to Follow-up|1
5086432|NCT02076009|17561004|P2|Overall Study|Withdrawal by Subject|3
5086433|NCT02076009|17561005|P1|Overall Study|Withdrawal by Subject|9
5086434|NCT02076009|17561004|P2|Overall Study|Death|30
5086435|NCT02076009|17561005|P1|Overall Study|Death|44
5086436|NCT02075840|17561027|P2|Overall Study|Ongoing at CCOD|82
5086437|NCT02075840|17561028|P1|Overall Study|Ongoing at CCOD|99
5086438|NCT02075840|17561027|P2|Overall Study|Physician Decision|3
5086439|NCT02075840|17561028|P1|Overall Study|Physician Decision|1
5086440|NCT02075840|17561027|P2|Overall Study|Lost to Follow-up|2
5086441|NCT02075840|17561028|P1|Overall Study|Lost to Follow-up|3
5086442|NCT02075840|17561027|P2|Overall Study|Death|40
5086443|NCT02075840|17561028|P1|Overall Study|Death|35
5086444|NCT02075840|17561027|P2|Overall Study|Adverse Event|2
5086445|NCT02075840|17561028|P1|Overall Study|Adverse Event|0
5086446|NCT02075840|17561027|P2|Overall Study|Reason not specified|0
5086447|NCT02075840|17561028|P1|Overall Study|Reason not specified|1
5086448|NCT02075840|17561027|P2|Overall Study|Withdrawal by Subject|22
5086449|NCT02075840|17561028|P1|Overall Study|Withdrawal by Subject|13
5086450|NCT02075658|17561084|P2|Overall Study|Physician Decision|2
5086451|NCT02075658|17561085|P1|Overall Study|Physician Decision|2
5086452|NCT02075632|17561095|P2|Overall Study|Withdrawal by Subject|1
5086453|NCT02075632|17561096|P1|Overall Study|Withdrawal by Subject|0
5086454|NCT02075632|17561095|P2|Overall Study|Lost to Follow-up|3
5086455|NCT02075632|17561096|P1|Overall Study|Lost to Follow-up|0
5086456|NCT02075632|17561095|P2|Overall Study|Adverse Event|1
5086457|NCT02075632|17561096|P1|Overall Study|Adverse Event|1
5086458|NCT02075606|17561106|P1|Overall Study|Increasing Symptoms|1
5086459|NCT02075606|17561106|P1|Overall Study|Symptom management|1
5086460|NCT02075606|17561106|P1|Overall Study|Investigator's decision|1
5086461|NCT02075606|17561106|P1|Overall Study|Death|1
5086462|NCT02075606|17561106|P1|Overall Study|Withdrawal by Subject|1
5086463|NCT02075606|17561106|P1|Overall Study|Adverse Event|5
5086464|NCT02075541|17561130|P2|Overall Study|Other- unable to perform study procedure|0
5086465|NCT02075541|17561131|P1|Overall Study|Other- unable to perform study procedure|1
5086466|NCT02075541|17561130|P2|Overall Study|Sponsor study termination|1
5086467|NCT02075541|17561131|P1|Overall Study|Sponsor study termination|0
5086468|NCT02075541|17561130|P2|Overall Study|Withdrawal by Subject|3
5086469|NCT02075541|17561131|P1|Overall Study|Withdrawal by Subject|1
5086470|NCT02075541|17561130|P2|Overall Study|Protocol Violation|0
5086471|NCT02075541|17561131|P1|Overall Study|Protocol Violation|1
5086472|NCT02075541|17561130|P2|Overall Study|Serious Adverse Event|4
5086473|NCT02075541|17561131|P1|Overall Study|Serious Adverse Event|1
5086474|NCT02075515|17561180|P3|Overall Study|Lost to Follow-up|6
5086475|NCT02075515|17561181|P2|Overall Study|Lost to Follow-up|3
5086476|NCT02075515|17561182|P1|Overall Study|Lost to Follow-up|1
5086477|NCT02075515|17561180|P3|Overall Study|Withdrawal by Subject|1
5086478|NCT02075515|17561181|P2|Overall Study|Withdrawal by Subject|0
5086479|NCT02075515|17561182|P1|Overall Study|Withdrawal by Subject|2
5086480|NCT02075515|17561180|P3|Overall Study|Non-Serious Adverse Event|0
5086481|NCT02075515|17561181|P2|Overall Study|Non-Serious Adverse Event|1
5086482|NCT02075515|17561182|P1|Overall Study|Non-Serious Adverse Event|0
5086483|NCT02075515|17561180|P3|Overall Study|Serious Adverse Event|1
5086484|NCT02075515|17561181|P2|Overall Study|Serious Adverse Event|1
5086485|NCT02075515|17561182|P1|Overall Study|Serious Adverse Event|1
5086486|NCT02075476|17561219|P2|Overall Study|Lost to Follow-up|3
5086487|NCT02075476|17561220|P1|Overall Study|Lost to Follow-up|1
5086488|NCT02075476|17561219|P2|Overall Study|Death|2
5086489|NCT02075476|17561220|P1|Overall Study|Death|2
5086490|NCT02075463|17561230|P1|Overall Study|Withdrawal by Subject|1
5086491|NCT02075463|17561230|P1|Overall Study|Par. reached stopping criteria|4
5086492|NCT02075463|17561230|P1|Overall Study|Adverse Event|3
5086493|NCT02075320|17561280|P1|Overall Study|Withdrawal by Subject|2
5086494|NCT02075255|17561290|P3|Overall Study|Death|0
5086495|NCT02075255|17561291|P2|Overall Study|Death|2
5086496|NCT02075255|17561292|P1|Overall Study|Death|0
5086497|NCT02075255|17561290|P3|Overall Study|Adverse Event|1
5086498|NCT02075255|17561291|P2|Overall Study|Adverse Event|0
5086499|NCT02075255|17561292|P1|Overall Study|Adverse Event|0
5086500|NCT02075255|17561290|P3|Overall Study|Lost to Follow-up|1
5086501|NCT02075255|17561291|P2|Overall Study|Lost to Follow-up|0
5086502|NCT02075255|17561292|P1|Overall Study|Lost to Follow-up|0
5086503|NCT02075255|17561290|P3|Overall Study|Withdrawal by Subject|0
5086504|NCT02075255|17561291|P2|Overall Study|Withdrawal by Subject|1
5086505|NCT02075255|17561292|P1|Overall Study|Withdrawal by Subject|4
5086506|NCT02075255|17561290|P3|Overall Study|Study specific withdrawal criteria|1
5086507|NCT02075255|17561291|P2|Overall Study|Study specific withdrawal criteria|1
5086508|NCT02075255|17561292|P1|Overall Study|Study specific withdrawal criteria|0
5086509|NCT02075203|17561402|P3|Overall Study|participant refused to use contraception|0
5086510|NCT02075203|17561403|P2|Overall Study|participant refused to use contraception|0
5086511|NCT02075203|17561404|P1|Overall Study|participant refused to use contraception|1
5086512|NCT02075203|17561402|P3|Overall Study|Adverse Event|0
5086513|NCT02075203|17561403|P2|Overall Study|Adverse Event|0
5086514|NCT02075203|17561404|P1|Overall Study|Adverse Event|1
5086515|NCT02075203|17561402|P3|Overall Study|Withdrawal by Subject|1
5086516|NCT02075203|17561403|P2|Overall Study|Withdrawal by Subject|0
5086517|NCT02075203|17561404|P1|Overall Study|Withdrawal by Subject|1
5086518|NCT02075073|17561445|P3|Overall Study|Withdrawal by Subject|0
5086519|NCT02075073|17561446|P2|Overall Study|Withdrawal by Subject|1
5086520|NCT02075073|17561447|P1|Overall Study|Withdrawal by Subject|0
5086521|NCT02075008|17561469|P1|Overall Study|Study terminated by Sponsor|159
5086522|NCT02075008|17561469|P1|Overall Study|Withdrawal by Subject|6
5086523|NCT02075008|17561469|P1|Overall Study|Adverse Event|5
5086524|NCT02075008|17561469|P1|Overall Study|Death|1
5086525|NCT02075008|17561469|P1|Overall Study|Lack of Efficacy|1
5086526|NCT02075008|17561469|P1|Overall Study|Lost to Follow-up|1
5086527|NCT02075008|17561469|P1|Overall Study|Physician Decision|1
5086528|NCT02075008|17561469|P1|Overall Study|Pregnancy|1
5086529|NCT02075008|17561469|P1|Overall Study|Technical problems|1
5086530|NCT02074982|17561492|P2|Overall Study|Death|2
5086531|NCT02074982|17561493|P1|Overall Study|Death|0
5086532|NCT02074982|17561492|P2|Overall Study|Subject/guardian decision|24
5086533|NCT02074982|17561493|P1|Overall Study|Subject/guardian decision|15
5086534|NCT02074982|17561492|P2|Overall Study|Technical problems|2
5086535|NCT02074982|17561493|P1|Overall Study|Technical problems|0
5086536|NCT02074982|17561492|P2|Overall Study|Protocol deviation|3
5086537|NCT02074982|17561493|P1|Overall Study|Protocol deviation|4
5086538|NCT02074982|17561492|P2|Overall Study|Pregnancy|2
5086539|NCT02074982|17561493|P1|Overall Study|Pregnancy|1
5086540|NCT02074982|17561492|P2|Overall Study|Physician Decision|1
5086541|NCT02074982|17561493|P1|Overall Study|Physician Decision|1
5086542|NCT02074982|17561492|P2|Overall Study|Non-compliance with study treatment|2
5086543|NCT02074982|17561493|P1|Overall Study|Non-compliance with study treatment|0
5086544|NCT02074982|17561492|P2|Overall Study|Lost to Follow-up|10
5086545|NCT02074982|17561493|P1|Overall Study|Lost to Follow-up|9
5086546|NCT02074982|17561492|P2|Overall Study|Lack of Efficacy|1
5086547|NCT02074982|17561493|P1|Overall Study|Lack of Efficacy|6
5086548|NCT02074982|17561492|P2|Overall Study|Adverse Event|7
5086549|NCT02074982|17561493|P1|Overall Study|Adverse Event|15
5086550|NCT02074553|17561540|P8|Washout Period 3|Physician Decision|1
5086551|NCT02074553|17561541|P7|Washout Period 3|Physician Decision|0
5086552|NCT02074553|17561542|P6|Washout Period 3|Physician Decision|0
5086553|NCT02074553|17561543|P5|Washout Period 3|Physician Decision|0
5086554|NCT02074553|17561544|P4|Washout Period 3|Physician Decision|0
5086555|NCT02074553|17561545|P3|Washout Period 3|Physician Decision|0
5086556|NCT02074553|17561546|P2|Washout Period 3|Physician Decision|0
5086557|NCT02074553|17561547|P1|Washout Period 3|Physician Decision|0
5086558|NCT02074553|17561540|P8|Washout Period 2|Lost to Follow-up|0
5086559|NCT02074553|17561541|P7|Washout Period 2|Lost to Follow-up|0
5086560|NCT02074553|17561542|P6|Washout Period 2|Lost to Follow-up|0
5086561|NCT02074553|17561543|P5|Washout Period 2|Lost to Follow-up|0
5086562|NCT02074553|17561544|P4|Washout Period 2|Lost to Follow-up|0
5086563|NCT02074553|17561545|P3|Washout Period 2|Lost to Follow-up|1
5086564|NCT02074553|17561546|P2|Washout Period 2|Lost to Follow-up|0
5086565|NCT02074553|17561547|P1|Washout Period 2|Lost to Follow-up|0
5086566|NCT02074553|17561540|P8|Washout Period 2|Physician Decision|0
5086567|NCT02074553|17561541|P7|Washout Period 2|Physician Decision|0
5086568|NCT02074553|17561542|P6|Washout Period 2|Physician Decision|1
5086569|NCT02074553|17561543|P5|Washout Period 2|Physician Decision|0
5086570|NCT02074553|17561544|P4|Washout Period 2|Physician Decision|0
5086571|NCT02074553|17561545|P3|Washout Period 2|Physician Decision|0
5086572|NCT02074553|17561546|P2|Washout Period 2|Physician Decision|0
5086573|NCT02074553|17561547|P1|Washout Period 2|Physician Decision|0
5086574|NCT02074553|17561540|P8|Washout Period 2|Adverse Event|0
5086575|NCT02074553|17561541|P7|Washout Period 2|Adverse Event|1
5086576|NCT02074553|17561542|P6|Washout Period 2|Adverse Event|0
5086577|NCT02074553|17561543|P5|Washout Period 2|Adverse Event|0
5086578|NCT02074553|17561544|P4|Washout Period 2|Adverse Event|0
5086579|NCT02074553|17561545|P3|Washout Period 2|Adverse Event|0
5086580|NCT02074553|17561546|P2|Washout Period 2|Adverse Event|0
5086581|NCT02074553|17561547|P1|Washout Period 2|Adverse Event|0
5086582|NCT02074553|17561540|P8|Washout Period 1|Other|0
5086583|NCT02074553|17561541|P7|Washout Period 1|Other|0
5086584|NCT02074553|17561542|P6|Washout Period 1|Other|1
5086585|NCT02074553|17561543|P5|Washout Period 1|Other|0
5086586|NCT02074553|17561544|P4|Washout Period 1|Other|0
5086587|NCT02074553|17561545|P3|Washout Period 1|Other|0
5086588|NCT02074553|17561546|P2|Washout Period 1|Other|0
5086589|NCT02074553|17561547|P1|Washout Period 1|Other|0
5086590|NCT02074553|17561540|P8|Washout Period 1|Physician Decision|0
5086591|NCT02074553|17561541|P7|Washout Period 1|Physician Decision|0
5086592|NCT02074553|17561542|P6|Washout Period 1|Physician Decision|0
5086593|NCT02074553|17561543|P5|Washout Period 1|Physician Decision|0
5086594|NCT02074553|17561544|P4|Washout Period 1|Physician Decision|1
5086595|NCT02074553|17561545|P3|Washout Period 1|Physician Decision|0
5086596|NCT02074553|17561546|P2|Washout Period 1|Physician Decision|0
5086597|NCT02074553|17561547|P1|Washout Period 1|Physician Decision|0
5086598|NCT02074553|17561540|P8|Washout Period 1|Adverse Event|0
5086599|NCT02074553|17561541|P7|Washout Period 1|Adverse Event|0
5086600|NCT02074553|17561542|P6|Washout Period 1|Adverse Event|0
5086601|NCT02074553|17561543|P5|Washout Period 1|Adverse Event|0
5086602|NCT02074553|17561544|P4|Washout Period 1|Adverse Event|0
5086603|NCT02074553|17561545|P3|Washout Period 1|Adverse Event|0
5086604|NCT02074553|17561546|P2|Washout Period 1|Adverse Event|0
5086605|NCT02074553|17561547|P1|Washout Period 1|Adverse Event|1
5086606|NCT02074553|17561540|P8|Intervention Period 1|Family Emergency|0
5086607|NCT02074553|17561541|P7|Intervention Period 1|Family Emergency|0
5086608|NCT02074553|17561542|P6|Intervention Period 1|Family Emergency|0
5086609|NCT02074553|17561543|P5|Intervention Period 1|Family Emergency|0
5086610|NCT02074553|17561544|P4|Intervention Period 1|Family Emergency|1
5086611|NCT02074553|17561545|P3|Intervention Period 1|Family Emergency|0
5086612|NCT02074553|17561546|P2|Intervention Period 1|Family Emergency|0
5086613|NCT02074553|17561547|P1|Intervention Period 1|Family Emergency|0
5086614|NCT02074514|17561729|P2|Overall Study|Withdrew Consent|1
5086615|NCT02074514|17561730|P1|Overall Study|Withdrew Consent|0
5086616|NCT02074514|17561729|P2|Overall Study|Lost to Follow-up|1
5086617|NCT02074514|17561730|P1|Overall Study|Lost to Follow-up|0
5086618|NCT02074514|17561729|P2|Overall Study|Lack of Efficacy|2
5086619|NCT02074514|17561730|P1|Overall Study|Lack of Efficacy|3
5086620|NCT02074059|17561871|P6|Overall Study|Death|1
5086621|NCT02074059|17561872|P5|Overall Study|Death|1
5086622|NCT02074059|17561873|P4|Overall Study|Death|0
5086623|NCT02074059|17561874|P3|Overall Study|Death|0
5086624|NCT02074059|17561875|P2|Overall Study|Death|0
5086625|NCT02074059|17561876|P1|Overall Study|Death|0
5086626|NCT02073929|17561920|P2|Overall Study|Withdrawal by Subject|1
5086627|NCT02073929|17561921|P1|Overall Study|Withdrawal by Subject|0
5086628|NCT02073929|17561920|P2|Overall Study|Adverse Event|1
5086629|NCT02073929|17561921|P1|Overall Study|Adverse Event|2
5086630|NCT02073929|17561920|P2|Overall Study|Lost to Follow-up|1
5086631|NCT02073929|17561921|P1|Overall Study|Lost to Follow-up|2
5086632|NCT02073682|17561958|P2|Overall Study|ID: Benefit/Risk Judgment|46
5086633|NCT02073682|17561959|P1|Overall Study|ID: Benefit/Risk Judgment|32
5086634|NCT02073682|17561958|P2|Overall Study|Lost to Follow-up|1
5086635|NCT02073682|17561959|P1|Overall Study|Lost to Follow-up|1
5086636|NCT02073682|17561958|P2|Overall Study|PD: Inconvenience of Dosing|78
5086637|NCT02073682|17561959|P1|Overall Study|PD: Inconvenience of Dosing|21
5086638|NCT02073682|17561958|P2|Overall Study|No reason provided|9
5086639|NCT02073682|17561959|P1|Overall Study|No reason provided|11
5086640|NCT02073682|17561958|P2|Overall Study|Adverse Event|62
5086641|NCT02073682|17561959|P1|Overall Study|Adverse Event|79
5086642|NCT02073682|17561958|P2|Overall Study|Protocol Violation|0
5086643|NCT02073682|17561959|P1|Overall Study|Protocol Violation|1
5086644|NCT02073682|17561958|P2|Overall Study|Cancer Progression|33
5086645|NCT02073682|17561959|P1|Overall Study|Cancer Progression|53
5086646|NCT02073682|17561958|P2|Overall Study|Start of New Chemotherapy Regimen|3
5086647|NCT02073682|17561959|P1|Overall Study|Start of New Chemotherapy Regimen|6
5086648|NCT02073682|17561958|P2|Overall Study|Withdrawal by Subject|8
5086649|NCT02073682|17561959|P1|Overall Study|Withdrawal by Subject|6
5086650|NCT02073682|17561958|P2|Overall Study|Surgery/Medical Procedure|1
5086651|NCT02073682|17561959|P1|Overall Study|Surgery/Medical Procedure|3
5086652|NCT02073682|17561958|P2|Overall Study|Platelet Count <50,000/mL|2
5086653|NCT02073682|17561959|P1|Overall Study|Platelet Count <50,000/mL|1
5086654|NCT02073682|17561958|P2|Overall Study|Prohibited Concomitant Medication Use|1
5086655|NCT02073682|17561959|P1|Overall Study|Prohibited Concomitant Medication Use|0
5086656|NCT02073682|17561958|P2|Overall Study|ID: Palliative Treatment Only|7
5086657|NCT02073682|17561959|P1|Overall Study|ID: Palliative Treatment Only|10
5086658|NCT02073682|17561958|P2|Overall Study|ID: Patient Noncompliance|2
5086659|NCT02073682|17561959|P1|Overall Study|ID: Patient Noncompliance|1
5086660|NCT02073682|17561958|P2|Overall Study|Cancer Cured|15
5086661|NCT02073682|17561959|P1|Overall Study|Cancer Cured|10
5086662|NCT02073682|17561958|P2|Overall Study|Death|100
5086663|NCT02073682|17561959|P1|Overall Study|Death|86
5086664|NCT02073682|17561958|P2|Overall Study|Low Creatinine Clearance|2
5086665|NCT02073682|17561959|P1|Overall Study|Low Creatinine Clearance|1
5086666|NCT02073656|17561977|P1|Primary Study|Withdrew Consent|1
5086667|NCT02073656|17561977|P1|Primary Study|Death|1
5086668|NCT02073656|17561977|P1|Primary Study|Lost to Follow-up|6
5086669|NCT02073643|17561993|P1|Overall Study|Lost to Follow-up|24
5086670|NCT02073565|17562004|P2|Cohort C|Lost to Follow-up|2
5086671|NCT02073565|17562005|P1|Cohort C|Lost to Follow-up|0
5086672|NCT02073565|17562004|P2|Cohort C|Withdrawal by Subject|2
5086673|NCT02073565|17562005|P1|Cohort C|Withdrawal by Subject|0
5086674|NCT02073565|17562004|P2|Cohort B|Withdrawal by Subject|2
5086675|NCT02073565|17562005|P1|Cohort B|Withdrawal by Subject|1
5086676|NCT02073565|17562004|P2|Cohort A|Withdrawal by Subject|0
5086677|NCT02073565|17562005|P1|Cohort A|Withdrawal by Subject|1
5086678|NCT02072980|17562125|P2|Period 2, Second Wear|Adverse Event|1
5086679|NCT02072980|17562126|P1|Period 2, Second Wear|Adverse Event|0
5086680|NCT02072941|17562134|P2|Overall Study|Removed by Study Staff|2
5086681|NCT02072941|17562135|P1|Overall Study|Removed by Study Staff|2
5086682|NCT02072941|17562134|P2|Overall Study|Death|2
5086683|NCT02072941|17562135|P1|Overall Study|Death|3
5086684|NCT02072941|17562134|P2|Overall Study|Lost to Follow-up|4
5086685|NCT02072941|17562135|P1|Overall Study|Lost to Follow-up|4
5086686|NCT02072941|17562134|P2|Overall Study|Withdrawal by Subject|21
5086687|NCT02072941|17562135|P1|Overall Study|Withdrawal by Subject|29
5086688|NCT02072824|17562150|P3|Overall Study|Adverse Event|1
5086689|NCT02072824|17562151|P2|Overall Study|Adverse Event|0
5086690|NCT02072824|17562152|P1|Overall Study|Adverse Event|0
5086691|NCT02072824|17562150|P3|Overall Study|Medication error|0
5086692|NCT02072824|17562151|P2|Overall Study|Medication error|1
5086693|NCT02072824|17562152|P1|Overall Study|Medication error|0
5086694|NCT02072824|17562150|P3|Overall Study|No longer willing to participate|1
5086695|NCT02072824|17562151|P2|Overall Study|No longer willing to participate|0
5086696|NCT02072824|17562152|P1|Overall Study|No longer willing to participate|1
5086697|NCT02072824|17562150|P3|Overall Study|Insufficient clinical response|1
5086698|NCT02072824|17562151|P2|Overall Study|Insufficient clinical response|0
5086699|NCT02072824|17562152|P1|Overall Study|Insufficient clinical response|1
5086700|NCT02072668|17562187|P2|Second Intervention|Lost to Follow-up|0
5086701|NCT02072668|17562188|P1|Second Intervention|Lost to Follow-up|1
5086702|NCT02072434|17562228|P2|Overall Study|Lost to Follow-up|1
5086703|NCT02072434|17562229|P1|Overall Study|Lost to Follow-up|0
5086704|NCT02072434|17562228|P2|Overall Study|Other|29
5086705|NCT02072434|17562229|P1|Overall Study|Other|14
5086706|NCT02072434|17562228|P2|Overall Study|Withdrawal by Subject|29
5086707|NCT02072434|17562229|P1|Overall Study|Withdrawal by Subject|17
5086708|NCT02072434|17562228|P2|Overall Study|Adverse Event|6
5086709|NCT02072434|17562229|P1|Overall Study|Adverse Event|7
5086710|NCT02072434|17562228|P2|Overall Study|Adverse event, serious fatal|6
5086711|NCT02072434|17562229|P1|Overall Study|Adverse event, serious fatal|1
5086712|NCT02072434|17562228|P2|Overall Study|Physician Decision|10
5086713|NCT02072434|17562229|P1|Overall Study|Physician Decision|5
5086714|NCT02072434|17562228|P2|Overall Study|Protocol Violation|9
5086715|NCT02072434|17562229|P1|Overall Study|Protocol Violation|10
5086716|NCT02072226|17562249|P2|Overall Study|Patient Withdrawal of Consent|0
5086717|NCT02072226|17562250|P1|Overall Study|Patient Withdrawal of Consent|1
5086718|NCT02072226|17562249|P2|Overall Study|Death|0
5086719|NCT02072226|17562250|P1|Overall Study|Death|1
5086720|NCT02072226|17562249|P2|Overall Study|Patient Non-compliance|3
5086721|NCT02072226|17562250|P1|Overall Study|Patient Non-compliance|2
5086722|NCT02072226|17562249|P2|Overall Study|Lost to Follow-up|7
5086723|NCT02072226|17562250|P1|Overall Study|Lost to Follow-up|11
5086724|NCT02072174|17562280|P2|Overall Study|Non-compliance with protocol requirement|0
5086725|NCT02072174|17562281|P1|Overall Study|Non-compliance with protocol requirement|2
5086726|NCT02072174|17562280|P2|Overall Study|Physician Decision|1
5086727|NCT02072174|17562281|P1|Overall Study|Physician Decision|0
5086728|NCT02072174|17562280|P2|Overall Study|Protocol Violation|23
5086729|NCT02072174|17562281|P1|Overall Study|Protocol Violation|16
5086730|NCT02072174|17562280|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
5086731|NCT02072174|17562281|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
5086732|NCT02072096|17562305|P2|Overall Study|Lost to Follow-up|0
5086733|NCT02072096|17562306|P1|Overall Study|Lost to Follow-up|1
5086734|NCT02072096|17562305|P2|Overall Study|Study Terminated by Sponsor|30
5086735|NCT02072096|17562306|P1|Overall Study|Study Terminated by Sponsor|43
5086736|NCT02072096|17562305|P2|Overall Study|Physician Decision|1
5086737|NCT02072096|17562306|P1|Overall Study|Physician Decision|0
5086738|NCT02072096|17562305|P2|Overall Study|Death|0
5086739|NCT02072096|17562306|P1|Overall Study|Death|2
5086740|NCT02072096|17562305|P2|Overall Study|No Reason Provided|2
5086741|NCT02072096|17562306|P1|Overall Study|No Reason Provided|4
5086742|NCT02072096|17562305|P2|Overall Study|Adverse Event|2
5086743|NCT02072096|17562306|P1|Overall Study|Adverse Event|5
5086744|NCT02072096|17562305|P2|Overall Study|Withdrawal by Subject|7
5086745|NCT02072096|17562306|P1|Overall Study|Withdrawal by Subject|5
5086746|NCT02072096|17562305|P2|Overall Study|Protocol Violation|7
5086747|NCT02072096|17562306|P1|Overall Study|Protocol Violation|7
5086748|NCT02072096|17562305|P2|Overall Study|Lack of Efficacy|29
5086749|NCT02072096|17562306|P1|Overall Study|Lack of Efficacy|18
5086750|NCT02071849|17562357|P1|2-year Extended Follow-up|Adverse Event|1
5086751|NCT02071849|17562357|P1|6-month Primary Endpoint|Adverse Event|1
5086752|NCT02071849|17562357|P1|6-month Primary Endpoint|Did not receive device|4
5086753|NCT02071771|17562423|P2|Period 1: First 10 Days|Unavailable lens power|0
5086754|NCT02071771|17562424|P1|Period 1: First 10 Days|Unavailable lens power|1
5086755|NCT02071771|17562423|P2|Period 1: First 10 Days|Unacceptable lens fit|0
5086756|NCT02071771|17562424|P1|Period 1: First 10 Days|Unacceptable lens fit|1
5086757|NCT02071706|17562432|P1|Overall Study|Withdrawal by Subject|2
5086758|NCT02071706|17562432|P1|Overall Study|Adverse Event|1
5086759|NCT02071290|17562448|P2|Overall Study|Physician Decision|1
5086760|NCT02071290|17562449|P1|Overall Study|Physician Decision|0
5086761|NCT02071290|17562448|P2|Overall Study|Protocol Violation|5
5086762|NCT02071290|17562449|P1|Overall Study|Protocol Violation|3
5086763|NCT02071290|17562448|P2|Overall Study|Withdrawal by Subject|1
5086764|NCT02071290|17562449|P1|Overall Study|Withdrawal by Subject|0
5086765|NCT02071290|17562448|P2|Overall Study|Death|0
5086766|NCT02071290|17562449|P1|Overall Study|Death|1
5086767|NCT02071225|17562503|P1|Overall Study|Death|25
5086768|NCT02071225|17562503|P1|Overall Study|Lost to Follow-up|2
5086769|NCT02071225|17562503|P1|Overall Study|Protocol Deviation|1
5086770|NCT02071225|17562503|P1|Overall Study|Withdrawal of Consent|2
5086771|NCT02071082|17562578|P2|Overall Study|Lost to Follow-up|1
5086772|NCT02071082|17562579|P1|Overall Study|Lost to Follow-up|1
5086773|NCT02071082|17562578|P2|Overall Study|Withdrew Consent|4
5086774|NCT02071082|17562579|P1|Overall Study|Withdrew Consent|0
5086775|NCT02071082|17562578|P2|Overall Study|Adverse Event|1
5086776|NCT02071082|17562579|P1|Overall Study|Adverse Event|0
5086777|NCT02071082|17562578|P2|Overall Study|Enrolled and Never Treated|1
5086778|NCT02071082|17562579|P1|Overall Study|Enrolled and Never Treated|1
5086779|NCT02070991|17562609|P2|Overall Study|Withdrawal by Subject|0
5086780|NCT02070991|17562610|P1|Overall Study|Withdrawal by Subject|1
5086781|NCT02070991|17562609|P2|Overall Study|Death|0
5086782|NCT02070991|17562610|P1|Overall Study|Death|2
5086783|NCT02070978|17562633|P3|Overall Study|Terminated by Sponsor|39
5086784|NCT02070978|17562634|P2|Overall Study|Terminated by Sponsor|40
5086785|NCT02070978|17562635|P1|Overall Study|Terminated by Sponsor|33
5086786|NCT02070978|17562633|P3|Overall Study|Un-specified|2
5086787|NCT02070978|17562634|P2|Overall Study|Un-specified|2
5086788|NCT02070978|17562635|P1|Overall Study|Un-specified|3
5086789|NCT02070978|17562633|P3|Overall Study|Death|2
5086790|NCT02070978|17562634|P2|Overall Study|Death|0
5086791|NCT02070978|17562635|P1|Overall Study|Death|0
5086792|NCT02070978|17562633|P3|Overall Study|Lack of Efficacy|0
5086793|NCT02070978|17562634|P2|Overall Study|Lack of Efficacy|1
5086794|NCT02070978|17562635|P1|Overall Study|Lack of Efficacy|0
5086795|NCT02070978|17562633|P3|Overall Study|Protocol Violation|3
5086796|NCT02070978|17562634|P2|Overall Study|Protocol Violation|0
5086797|NCT02070978|17562635|P1|Overall Study|Protocol Violation|1
5086798|NCT02070978|17562633|P3|Overall Study|Withdrawal by Subject|3
5086799|NCT02070978|17562634|P2|Overall Study|Withdrawal by Subject|5
5086800|NCT02070978|17562635|P1|Overall Study|Withdrawal by Subject|3
5086801|NCT02070978|17562633|P3|Overall Study|Lost to Follow-up|4
5086802|NCT02070978|17562634|P2|Overall Study|Lost to Follow-up|3
5086803|NCT02070978|17562635|P1|Overall Study|Lost to Follow-up|1
5086804|NCT02070978|17562633|P3|Overall Study|Adverse Event|0
5086805|NCT02070978|17562634|P2|Overall Study|Adverse Event|2
5086806|NCT02070978|17562635|P1|Overall Study|Adverse Event|6
5086807|NCT02070965|17562697|P3|Overall Study|Subject moved|0
5086808|NCT02070965|17562698|P2|Overall Study|Subject moved|0
5086809|NCT02070965|17562699|P1|Overall Study|Subject moved|1
5086810|NCT02070965|17562697|P3|Overall Study|Withdrawal by Subject|1
5086811|NCT02070965|17562698|P2|Overall Study|Withdrawal by Subject|1
5086812|NCT02070965|17562699|P1|Overall Study|Withdrawal by Subject|1
5086813|NCT02070965|17562697|P3|Overall Study|Lost to Follow-up|0
5086814|NCT02070965|17562698|P2|Overall Study|Lost to Follow-up|1
5086815|NCT02070965|17562699|P1|Overall Study|Lost to Follow-up|0
5086816|NCT02070757|17562709|P2|Overall Study|Discharged from Study Hospital|2
5086817|NCT02070757|17562710|P1|Overall Study|Discharged from Study Hospital|2
5086818|NCT02070757|17562709|P2|Overall Study|Investigator Decision|2
5086819|NCT02070757|17562710|P1|Overall Study|Investigator Decision|0
5086820|NCT02070757|17562709|P2|Overall Study|Withdrawal by Subject|3
5086821|NCT02070757|17562710|P1|Overall Study|Withdrawal by Subject|1
5086822|NCT02070757|17562709|P2|Overall Study|Protocol Violation|4
5086823|NCT02070757|17562710|P1|Overall Study|Protocol Violation|0
5086824|NCT02070757|17562709|P2|Overall Study|Lost to Follow-up|4
5086825|NCT02070757|17562710|P1|Overall Study|Lost to Follow-up|7
5086826|NCT02070757|17562709|P2|Overall Study|Adverse Event|99
5086827|NCT02070757|17562710|P1|Overall Study|Adverse Event|107
5086828|NCT02070744|17562744|P5|OLE Phase (48 Weeks)|Other|1
5086829|NCT02070744|17562745|P4|OLE Phase (48 Weeks)|Other|0
5086830|NCT02070744|17562746|P3|OLE Phase (48 Weeks)|Other|0
5086831|NCT02070744|17562747|P2|OLE Phase (48 Weeks)|Other|0
5086832|NCT02070744|17562748|P1|OLE Phase (48 Weeks)|Other|0
5086833|NCT02070744|17562744|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
5086834|NCT02070744|17562745|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5086835|NCT02070744|17562746|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5086836|NCT02070744|17562747|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5086837|NCT02070744|17562748|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5086838|NCT02070744|17562744|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
5086839|NCT02070744|17562745|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
5086840|NCT02070744|17562746|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
5086841|NCT02070744|17562747|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
5086842|NCT02070744|17562748|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
5086843|NCT02070588|17562831|P3|Overall Study|Adverse Event|0
5086844|NCT02070588|17562832|P2|Overall Study|Adverse Event|0
5086845|NCT02070588|17562833|P1|Overall Study|Adverse Event|1
5086846|NCT02070588|17562831|P3|Overall Study|Writhdrawal due to early termination|0
5086847|NCT02070588|17562832|P2|Overall Study|Writhdrawal due to early termination|0
5086848|NCT02070588|17562833|P1|Overall Study|Writhdrawal due to early termination|9
5086849|NCT02070588|17562831|P3|Overall Study|Withdrawal by Subject|0
5086850|NCT02070588|17562832|P2|Overall Study|Withdrawal by Subject|1
5086851|NCT02070588|17562833|P1|Overall Study|Withdrawal by Subject|29
5086852|NCT02070484|17562849|P2|Overall Study|Withdrawal by Subject|0
5086853|NCT02070484|17562850|P1|Overall Study|Withdrawal by Subject|1
5086854|NCT02070380|17562872|P4|Second Injection|Protocol Violation|5
5086855|NCT02070380|17562873|P3|Second Injection|Protocol Violation|1
5086856|NCT02070380|17562874|P2|Second Injection|Protocol Violation|1
5086857|NCT02070380|17562875|P1|Second Injection|Protocol Violation|0
5086858|NCT02070380|17562872|P4|Second Injection|Image sets missing or technically inadeq|0
5086859|NCT02070380|17562873|P3|Second Injection|Image sets missing or technically inadeq|0
5086860|NCT02070380|17562874|P2|Second Injection|Image sets missing or technically inadeq|1
5086861|NCT02070380|17562875|P1|Second Injection|Image sets missing or technically inadeq|0
5086862|NCT02070380|17562872|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
5086863|NCT02070380|17562873|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
5086864|NCT02070380|17562874|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
5086865|NCT02070380|17562875|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
5086866|NCT02069392|17563017|P2|Overall Study|Withdrawal by Subject|2
5086867|NCT02069392|17563018|P1|Overall Study|Withdrawal by Subject|4
5086868|NCT02069379|17563042|P4|Second Treatment Arm|Lost to Follow-up|0
5086869|NCT02069379|17563043|P3|Second Treatment Arm|Lost to Follow-up|1
5086870|NCT02069379|17563044|P2|Second Treatment Arm|Lost to Follow-up|0
5086871|NCT02069379|17563045|P1|Second Treatment Arm|Lost to Follow-up|0
5086872|NCT02069379|17563042|P4|Washout Period (4 Weeks)|Unrelated event|0
5086873|NCT02069379|17563043|P3|Washout Period (4 Weeks)|Unrelated event|0
5086874|NCT02069379|17563044|P2|Washout Period (4 Weeks)|Unrelated event|1
5086875|NCT02069379|17563045|P1|Washout Period (4 Weeks)|Unrelated event|0
5086876|NCT02069379|17563042|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
5086877|NCT02069379|17563043|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
5086878|NCT02069379|17563044|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
5086879|NCT02069379|17563045|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
5086880|NCT02069379|17563042|P4|First Treatment Arm|Lost to Follow-up|0
5086881|NCT02069379|17563043|P3|First Treatment Arm|Lost to Follow-up|1
5086882|NCT02069379|17563044|P2|First Treatment Arm|Lost to Follow-up|1
5086883|NCT02069379|17563045|P1|First Treatment Arm|Lost to Follow-up|0
5086884|NCT02069379|17563042|P4|Baseline Measurements|Ineligible based on initial assessments|2
5086885|NCT02069379|17563043|P3|Baseline Measurements|Ineligible based on initial assessments|0
5086886|NCT02069379|17563044|P2|Baseline Measurements|Ineligible based on initial assessments|0
5086887|NCT02069379|17563045|P1|Baseline Measurements|Ineligible based on initial assessments|2
5086888|NCT02069379|17563042|P4|Baseline Measurements|Lost to Follow-up|0
5086889|NCT02069379|17563043|P3|Baseline Measurements|Lost to Follow-up|0
5086890|NCT02069379|17563044|P2|Baseline Measurements|Lost to Follow-up|0
5086891|NCT02069379|17563045|P1|Baseline Measurements|Lost to Follow-up|1
5086892|NCT02069093|17563132|P1|Overall Study|Adverse Event|10
5086893|NCT02069093|17563132|P1|Overall Study|Abnormal laboratory values|1
5086894|NCT02069093|17563132|P1|Overall Study|Withdrawal by Subject|2
5086895|NCT02069093|17563132|P1|Overall Study|Administrative problems|1
5086896|NCT02069093|17563132|P1|Overall Study|Death|1
5086897|NCT02069093|17563132|P1|Overall Study|New cancer therapy|1
5086898|NCT02069093|17563132|P1|Overall Study|Disease progression|14
5086899|NCT02068885|17563152|P3|Overall Study|Withdrew|8
5086900|NCT02068885|17563153|P2|Overall Study|Withdrew|5
5086901|NCT02068885|17563154|P1|Overall Study|Withdrew|3
5086902|NCT02068768|17563232|P1|Overall Study|Early Termination by Sponsor|2
5086903|NCT02068768|17563232|P1|Overall Study|Lost to Follow-up|5
5086904|NCT02068599|17563241|P3|Overall Study|Noncompliance|1
5086905|NCT02068599|17563242|P2|Overall Study|Noncompliance|0
5086906|NCT02068599|17563243|P1|Overall Study|Noncompliance|0
5086907|NCT02068599|17563241|P3|Overall Study|Lack of Efficacy|3
5086908|NCT02068599|17563242|P2|Overall Study|Lack of Efficacy|0
5086909|NCT02068599|17563243|P1|Overall Study|Lack of Efficacy|0
5086910|NCT02068599|17563241|P3|Overall Study|Lost to Follow-up|0
5086911|NCT02068599|17563242|P2|Overall Study|Lost to Follow-up|0
5086912|NCT02068599|17563243|P1|Overall Study|Lost to Follow-up|1
5086913|NCT02068599|17563241|P3|Overall Study|Protocol Violation|3
5086914|NCT02068599|17563242|P2|Overall Study|Protocol Violation|2
5086915|NCT02068599|17563243|P1|Overall Study|Protocol Violation|4
5086916|NCT02068599|17563241|P3|Overall Study|Withdrawal by Subject|5
5086917|NCT02068599|17563242|P2|Overall Study|Withdrawal by Subject|7
5086918|NCT02068599|17563243|P1|Overall Study|Withdrawal by Subject|2
5086919|NCT02068599|17563241|P3|Overall Study|Adverse Event|1
5086920|NCT02068599|17563242|P2|Overall Study|Adverse Event|1
5086921|NCT02068599|17563243|P1|Overall Study|Adverse Event|4
5086922|NCT02068547|17563283|P2|Overall Study|Physician Decision|0
5086923|NCT02068547|17563284|P1|Overall Study|Physician Decision|1
5086924|NCT02068547|17563283|P2|Overall Study|Lost to Follow-up|3
5086925|NCT02068547|17563284|P1|Overall Study|Lost to Follow-up|3
5086926|NCT02068508|17563294|P1|Overall Study|Protocol Violation|4
5086927|NCT02068508|17563294|P1|Overall Study|Patient did not visit the study site|1
5086928|NCT02068508|17563294|P1|Overall Study|Case report forms uncollected|27
5086929|NCT02068495|17563304|P1|Overall Study|Protocol Deviation|49
5086930|NCT02068495|17563304|P1|Overall Study|Case Report Forms Uncollected|60
5086931|NCT02068443|17563316|P3|Overall Study|Other Reason Not Specified|0
5086932|NCT02068443|17563317|P2|Overall Study|Other Reason Not Specified|0
5086933|NCT02068443|17563318|P1|Overall Study|Other Reason Not Specified|1
5086934|NCT02068443|17563316|P3|Overall Study|Lack of Efficacy|0
5086935|NCT02068443|17563317|P2|Overall Study|Lack of Efficacy|1
5086936|NCT02068443|17563318|P1|Overall Study|Lack of Efficacy|2
5086937|NCT02068443|17563316|P3|Overall Study|Voluntary Withdrawal|1
5086938|NCT02068443|17563317|P2|Overall Study|Voluntary Withdrawal|0
5086939|NCT02068443|17563318|P1|Overall Study|Voluntary Withdrawal|4
5086940|NCT02068443|17563316|P3|Overall Study|Pretreatment Event/Adverse Event|2
5086941|NCT02068443|17563317|P2|Overall Study|Pretreatment Event/Adverse Event|5
5086942|NCT02068443|17563318|P1|Overall Study|Pretreatment Event/Adverse Event|0
5086943|NCT02068222|17563353|P1|Overall Study|Lost to Follow-up|1
5086944|NCT02067728|17563384|P2|6 Month Measurements|Unable to attend|97
5086945|NCT02067728|17563385|P1|6 Month Measurements|Unable to attend|114
5086946|NCT02067728|17563384|P2|6 Month Follow up Survey|Lost to Follow-up|60
5086947|NCT02067728|17563385|P1|6 Month Follow up Survey|Lost to Follow-up|48
5086948|NCT02067728|17563384|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
5086949|NCT02067728|17563385|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
5086950|NCT02067676|17563419|P6|Overall Study|Withdrawal by Subject|0
5086951|NCT02067676|17563420|P5|Overall Study|Withdrawal by Subject|0
5086952|NCT02067676|17563421|P4|Overall Study|Withdrawal by Subject|0
5086953|NCT02067676|17563422|P3|Overall Study|Withdrawal by Subject|0
5086954|NCT02067676|17563423|P2|Overall Study|Withdrawal by Subject|0
5086955|NCT02067676|17563424|P1|Overall Study|Withdrawal by Subject|1
5086956|NCT02067663|17563464|P2|Overall Study|Lost to Follow-up|14
5086957|NCT02067663|17563465|P1|Overall Study|Lost to Follow-up|13
5086958|NCT02067533|17563564|P2|Overall Study|Lost to Follow-up|2
5086959|NCT02067533|17563565|P1|Overall Study|Lost to Follow-up|4
5086960|NCT02067104|17563616|P2|Overall Study|Study termination due to low accrual|5
5086961|NCT02067104|17563617|P1|Overall Study|Study termination due to low accrual|4
5086962|NCT02066922|17563646|P1|Overall Study|Adverse Event|1
5086963|NCT02066467|17563715|P1|Overall Study|Not defined|4
5086964|NCT02066467|17563715|P1|Overall Study|Physician Decision|2
5086965|NCT02066467|17563715|P1|Overall Study|Withdrawal by Subject|16
5086966|NCT02066467|17563715|P1|Overall Study|Adverse Event|20
5086967|NCT02066467|17563715|P1|Overall Study|Lost to Follow-up|51
5086968|NCT02066467|17563715|P1|Overall Study|Death|54
5086969|NCT02066467|17563715|P1|Overall Study|Consent ineligible|1
5086970|NCT02066467|17563715|P1|Overall Study|Attempted to implant withoput success|43
5086971|NCT02066467|17563715|P1|Overall Study|Did not undergo implant procedure|24
5086972|NCT02066415|17563724|P3|Overall Study|Lost to Follow-up|2
5086973|NCT02066415|17563725|P2|Overall Study|Lost to Follow-up|2
5086974|NCT02066415|17563726|P1|Overall Study|Lost to Follow-up|7
5086975|NCT02066415|17563724|P3|Overall Study|Withdrawal by Subject|4
5086976|NCT02066415|17563725|P2|Overall Study|Withdrawal by Subject|1
5086977|NCT02066415|17563726|P1|Overall Study|Withdrawal by Subject|9
5086978|NCT02066415|17563724|P3|Overall Study|Decision by Sponsor|2
5086979|NCT02066415|17563725|P2|Overall Study|Decision by Sponsor|4
5086980|NCT02066415|17563726|P1|Overall Study|Decision by Sponsor|5
5086981|NCT02066402|17563751|P2|Overall Study|Protocol driven decision point|1
5086982|NCT02066402|17563752|P1|Overall Study|Protocol driven decision point|0
5086983|NCT02066402|17563751|P2|Overall Study|Progressive disease-clinical progression|1
5086984|NCT02066402|17563752|P1|Overall Study|Progressive disease-clinical progression|0
5086985|NCT02066402|17563751|P2|Overall Study|Withdrawal by Subject|11
5086986|NCT02066402|17563752|P1|Overall Study|Withdrawal by Subject|14
5086987|NCT02066402|17563751|P2|Overall Study|Lost to Follow-up|8
5086988|NCT02066402|17563752|P1|Overall Study|Lost to Follow-up|11
5086989|NCT02066402|17563751|P2|Overall Study|Adverse Event|2
5086990|NCT02066402|17563752|P1|Overall Study|Adverse Event|1
5086991|NCT02066389|17563784|P6|Overall Study|Randomized in Error|1
5086992|NCT02066389|17563785|P5|Overall Study|Randomized in Error|0
5086993|NCT02066389|17563786|P4|Overall Study|Randomized in Error|0
5086994|NCT02066389|17563787|P3|Overall Study|Randomized in Error|0
5086995|NCT02066389|17563788|P2|Overall Study|Randomized in Error|0
5086996|NCT02066389|17563789|P1|Overall Study|Randomized in Error|0
5086997|NCT02066389|17563784|P6|Overall Study|Lost to Follow-up|1
5086998|NCT02066389|17563785|P5|Overall Study|Lost to Follow-up|1
5086999|NCT02066389|17563786|P4|Overall Study|Lost to Follow-up|1
5087000|NCT02066389|17563787|P3|Overall Study|Lost to Follow-up|0
5087001|NCT02066389|17563788|P2|Overall Study|Lost to Follow-up|0
5087002|NCT02066389|17563789|P1|Overall Study|Lost to Follow-up|0
5087003|NCT02066389|17563784|P6|Overall Study|Withdrawal by Subject|2
5087004|NCT02066389|17563785|P5|Overall Study|Withdrawal by Subject|1
5087005|NCT02066389|17563786|P4|Overall Study|Withdrawal by Subject|1
5087006|NCT02066389|17563787|P3|Overall Study|Withdrawal by Subject|5
5087007|NCT02066389|17563788|P2|Overall Study|Withdrawal by Subject|0
5087008|NCT02066389|17563789|P1|Overall Study|Withdrawal by Subject|4
5087009|NCT02066389|17563784|P6|Overall Study|Adverse Event|1
5087010|NCT02066389|17563785|P5|Overall Study|Adverse Event|5
5087011|NCT02066389|17563786|P4|Overall Study|Adverse Event|1
5087012|NCT02066389|17563787|P3|Overall Study|Adverse Event|1
5087013|NCT02066389|17563788|P2|Overall Study|Adverse Event|1
5087014|NCT02066389|17563789|P1|Overall Study|Adverse Event|1
5087015|NCT02066311|17563839|P1|Overall Study|Withdrawal by Subject|1
5087016|NCT02066311|17563839|P1|Overall Study|Adverse Event|4
5087017|NCT02066298|17563849|P6|Overall Study|Physician Decision|0
5087018|NCT02066298|17563850|P5|Overall Study|Physician Decision|1
5087019|NCT02066298|17563851|P4|Overall Study|Physician Decision|0
5087020|NCT02066298|17563852|P3|Overall Study|Physician Decision|1
5087021|NCT02066298|17563853|P2|Overall Study|Physician Decision|0
5087022|NCT02066298|17563854|P1|Overall Study|Physician Decision|0
5087023|NCT02066298|17563849|P6|Overall Study|Withdrawal by Subject|8
5087024|NCT02066298|17563850|P5|Overall Study|Withdrawal by Subject|5
5087025|NCT02066298|17563851|P4|Overall Study|Withdrawal by Subject|4
5087026|NCT02066298|17563852|P3|Overall Study|Withdrawal by Subject|6
5087027|NCT02066298|17563853|P2|Overall Study|Withdrawal by Subject|6
5087028|NCT02066298|17563854|P1|Overall Study|Withdrawal by Subject|6
5087029|NCT02066298|17563849|P6|Overall Study|Lost to Follow-up|4
5087030|NCT02066298|17563850|P5|Overall Study|Lost to Follow-up|3
5087031|NCT02066298|17563851|P4|Overall Study|Lost to Follow-up|2
5087032|NCT02066298|17563852|P3|Overall Study|Lost to Follow-up|3
5087033|NCT02066298|17563853|P2|Overall Study|Lost to Follow-up|2
5087034|NCT02066298|17563854|P1|Overall Study|Lost to Follow-up|3
5087035|NCT02066233|17563878|P2|EG Scan II (Day 1)|difficulty intubating subject|6
5087036|NCT02066233|17563879|P1|EG Scan II (Day 1)|difficulty intubating subject|6
5087037|NCT02066181|17563889|P2|Overall Study|Withdrawal by Subject|1
5087038|NCT02066181|17563890|P1|Overall Study|Withdrawal by Subject|1
5087039|NCT02066129|17563912|P2|Overall Study|Physician Decision|1
5087040|NCT02066129|17563913|P1|Overall Study|Physician Decision|1
5087041|NCT02066129|17563912|P2|Overall Study|Lack of Efficacy|10
5087042|NCT02066129|17563913|P1|Overall Study|Lack of Efficacy|8
5087043|NCT02066129|17563912|P2|Overall Study|Withdrawal by Subject|10
5087044|NCT02066129|17563913|P1|Overall Study|Withdrawal by Subject|7
5087045|NCT02066129|17563912|P2|Overall Study|Lost to Follow-up|12
5087046|NCT02066129|17563913|P1|Overall Study|Lost to Follow-up|13
5087047|NCT02066051|17563927|P1|Overall Study|Subject developed active GVHD|1
5087048|NCT02065895|17563932|P6|Overall Study|Scheduling conflicts|0
5087049|NCT02065895|17563933|P5|Overall Study|Scheduling conflicts|0
5087050|NCT02065895|17563934|P4|Overall Study|Scheduling conflicts|0
5087051|NCT02065895|17563935|P3|Overall Study|Scheduling conflicts|0
5087052|NCT02065895|17563936|P2|Overall Study|Scheduling conflicts|1
5087053|NCT02065895|17563937|P1|Overall Study|Scheduling conflicts|0
5087054|NCT02065895|17563932|P6|Overall Study|Protocol Violation|0
5087055|NCT02065895|17563933|P5|Overall Study|Protocol Violation|0
5087056|NCT02065895|17563934|P4|Overall Study|Protocol Violation|1
5087057|NCT02065895|17563935|P3|Overall Study|Protocol Violation|0
5087058|NCT02065895|17563936|P2|Overall Study|Protocol Violation|0
5087059|NCT02065895|17563937|P1|Overall Study|Protocol Violation|1
5087060|NCT02065791|17563956|P2|Overall Study|Lost to Follow-up|9
5087061|NCT02065791|17563957|P1|Overall Study|Lost to Follow-up|13
5087062|NCT02065791|17563956|P2|Overall Study|Withdrawal by Subject|5
5087063|NCT02065791|17563957|P1|Overall Study|Withdrawal by Subject|11
5087064|NCT02065791|17563956|P2|Overall Study|Closed Site|1
5087065|NCT02065791|17563957|P1|Overall Study|Closed Site|1
5087066|NCT02065713|17563979|P2|Overall Study|Unsatisfactory therapeutic effect|0
5087067|NCT02065713|17563980|P1|Overall Study|Unsatisfactory therapeutic effect|1
5087068|NCT02065713|17563979|P2|Overall Study|Adverse Event|1
5087069|NCT02065713|17563980|P1|Overall Study|Adverse Event|0
5087070|NCT02065622|17563988|P5|Maintenance Study|Unknown Reason|0
5087071|NCT02065622|17563989|P4|Maintenance Study|Unknown Reason|1
5087072|NCT02065622|17563990|P3|Maintenance Study|Unknown Reason|0
5087073|NCT02065622|17563991|P2|Maintenance Study|Unknown Reason|0
5087074|NCT02065622|17563992|P1|Maintenance Study|Unknown Reason|0
5087075|NCT02065622|17563988|P5|Maintenance Study|Other, Not Specified|2
5087076|NCT02065622|17563989|P4|Maintenance Study|Other, Not Specified|14
5087077|NCT02065622|17563990|P3|Maintenance Study|Other, Not Specified|6
5087078|NCT02065622|17563991|P2|Maintenance Study|Other, Not Specified|0
5087079|NCT02065622|17563992|P1|Maintenance Study|Other, Not Specified|0
5087080|NCT02065622|17563988|P5|Maintenance Study|Subject Non-Compliance|2
5087081|NCT02065622|17563989|P4|Maintenance Study|Subject Non-Compliance|3
5087082|NCT02065622|17563990|P3|Maintenance Study|Subject Non-Compliance|1
5087083|NCT02065622|17563991|P2|Maintenance Study|Subject Non-Compliance|0
5087084|NCT02065622|17563992|P1|Maintenance Study|Subject Non-Compliance|0
5087085|NCT02065622|17563988|P5|Maintenance Study|Requires Alternative/Prohibited Therapy|4
5087086|NCT02065622|17563989|P4|Maintenance Study|Requires Alternative/Prohibited Therapy|3
5087087|NCT02065622|17563990|P3|Maintenance Study|Requires Alternative/Prohibited Therapy|7
5087088|NCT02065622|17563991|P2|Maintenance Study|Requires Alternative/Prohibited Therapy|0
5087089|NCT02065622|17563992|P1|Maintenance Study|Requires Alternative/Prohibited Therapy|0
5087090|NCT02065622|17563988|P5|Maintenance Study|Lack of Efficacy|19
5087091|NCT02065622|17563989|P4|Maintenance Study|Lack of Efficacy|55
5087092|NCT02065622|17563990|P3|Maintenance Study|Lack of Efficacy|70
5087093|NCT02065622|17563991|P2|Maintenance Study|Lack of Efficacy|0
5087094|NCT02065622|17563992|P1|Maintenance Study|Lack of Efficacy|0
5087095|NCT02065622|17563988|P5|Maintenance Study|Lost to Follow-up|1
5087096|NCT02065622|17563989|P4|Maintenance Study|Lost to Follow-up|1
5087097|NCT02065622|17563990|P3|Maintenance Study|Lost to Follow-up|4
5087098|NCT02065622|17563991|P2|Maintenance Study|Lost to Follow-up|0
5087099|NCT02065622|17563992|P1|Maintenance Study|Lost to Follow-up|0
5087100|NCT02065622|17563988|P5|Maintenance Study|Withdrawal by Subject|7
5087101|NCT02065622|17563989|P4|Maintenance Study|Withdrawal by Subject|5
5087102|NCT02065622|17563990|P3|Maintenance Study|Withdrawal by Subject|11
5087103|NCT02065622|17563991|P2|Maintenance Study|Withdrawal by Subject|0
5087104|NCT02065622|17563992|P1|Maintenance Study|Withdrawal by Subject|0
5087105|NCT02065622|17563988|P5|Maintenance Study|Adverse Event|11
5087106|NCT02065622|17563989|P4|Maintenance Study|Adverse Event|22
5087107|NCT02065622|17563990|P3|Maintenance Study|Adverse Event|25
5087108|NCT02065622|17563991|P2|Maintenance Study|Adverse Event|0
5087109|NCT02065622|17563992|P1|Maintenance Study|Adverse Event|0
5087110|NCT02065622|17563988|P5|Induction Study|Other, Not Specified|0
5087111|NCT02065622|17563989|P4|Induction Study|Other, Not Specified|0
5087112|NCT02065622|17563990|P3|Induction Study|Other, Not Specified|0
5087113|NCT02065622|17563991|P2|Induction Study|Other, Not Specified|2
5087114|NCT02065622|17563992|P1|Induction Study|Other, Not Specified|3
5087115|NCT02065622|17563988|P5|Induction Study|Subject Noncompliance|0
5087116|NCT02065622|17563989|P4|Induction Study|Subject Noncompliance|0
5087117|NCT02065622|17563990|P3|Induction Study|Subject Noncompliance|0
5087118|NCT02065622|17563991|P2|Induction Study|Subject Noncompliance|1
5087119|NCT02065622|17563992|P1|Induction Study|Subject Noncompliance|1
5087120|NCT02065622|17563988|P5|Induction Study|Requires Alternative/Prohibited Therapy|0
5087121|NCT02065622|17563989|P4|Induction Study|Requires Alternative/Prohibited Therapy|0
5087122|NCT02065622|17563990|P3|Induction Study|Requires Alternative/Prohibited Therapy|0
5087123|NCT02065622|17563991|P2|Induction Study|Requires Alternative/Prohibited Therapy|5
5087124|NCT02065622|17563992|P1|Induction Study|Requires Alternative/Prohibited Therapy|4
5087125|NCT02065622|17563988|P5|Induction Study|Lack of Efficacy|0
5087126|NCT02065622|17563989|P4|Induction Study|Lack of Efficacy|0
5087127|NCT02065622|17563990|P3|Induction Study|Lack of Efficacy|0
5087128|NCT02065622|17563991|P2|Induction Study|Lack of Efficacy|27
5087129|NCT02065622|17563992|P1|Induction Study|Lack of Efficacy|22
5087130|NCT02065622|17563988|P5|Induction Study|Lost to Follow-up|0
5087131|NCT02065622|17563989|P4|Induction Study|Lost to Follow-up|0
5087132|NCT02065622|17563990|P3|Induction Study|Lost to Follow-up|0
5087133|NCT02065622|17563991|P2|Induction Study|Lost to Follow-up|0
5087134|NCT02065622|17563992|P1|Induction Study|Lost to Follow-up|1
5087135|NCT02065622|17563988|P5|Induction Study|Withdrawal by Subject|0
5087136|NCT02065622|17563989|P4|Induction Study|Withdrawal by Subject|0
5087137|NCT02065622|17563990|P3|Induction Study|Withdrawal by Subject|0
5087138|NCT02065622|17563991|P2|Induction Study|Withdrawal by Subject|5
5087139|NCT02065622|17563992|P1|Induction Study|Withdrawal by Subject|3
5087140|NCT02065622|17563988|P5|Induction Study|Adverse Event|0
5087141|NCT02065622|17563989|P4|Induction Study|Adverse Event|0
5087142|NCT02065622|17563990|P3|Induction Study|Adverse Event|0
5087143|NCT02065622|17563991|P2|Induction Study|Adverse Event|19
5087144|NCT02065622|17563992|P1|Induction Study|Adverse Event|13
5087145|NCT02065557|17564094|P6|Maintenance Period|Subject Non-Compliance|1
5087146|NCT02065557|17564095|P5|Maintenance Period|Subject Non-Compliance|0
5087147|NCT02065557|17564096|P4|Maintenance Period|Subject Non-Compliance|0
5087148|NCT02065557|17564097|P3|Maintenance Period|Subject Non-Compliance|0
5087149|NCT02065557|17564098|P2|Maintenance Period|Subject Non-Compliance|0
5087150|NCT02065557|17564099|P1|Maintenance Period|Subject Non-Compliance|0
5087151|NCT02065557|17564094|P6|Maintenance Period|Lack of Efficacy|2
5087152|NCT02065557|17564095|P5|Maintenance Period|Lack of Efficacy|5
5087153|NCT02065557|17564096|P4|Maintenance Period|Lack of Efficacy|0
5087154|NCT02065557|17564097|P3|Maintenance Period|Lack of Efficacy|0
5087155|NCT02065557|17564098|P2|Maintenance Period|Lack of Efficacy|0
5087156|NCT02065557|17564099|P1|Maintenance Period|Lack of Efficacy|0
5087157|NCT02065557|17564094|P6|Maintenance Period|Withdrawal by Subject|1
5087158|NCT02065557|17564095|P5|Maintenance Period|Withdrawal by Subject|2
5087159|NCT02065557|17564096|P4|Maintenance Period|Withdrawal by Subject|0
5087160|NCT02065557|17564097|P3|Maintenance Period|Withdrawal by Subject|0
5087161|NCT02065557|17564098|P2|Maintenance Period|Withdrawal by Subject|0
5087162|NCT02065557|17564099|P1|Maintenance Period|Withdrawal by Subject|0
5087163|NCT02065557|17564094|P6|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5087164|NCT02065557|17564095|P5|Maintenance Period|Requires Alternative/Prohibited Therapy|1
5087165|NCT02065557|17564096|P4|Maintenance Period|Requires Alternative/Prohibited Therapy|1
5087166|NCT02065557|17564097|P3|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5087167|NCT02065557|17564098|P2|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5087168|NCT02065557|17564099|P1|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5087169|NCT02065557|17564094|P6|Induction Period|Adverse Event|0
5087170|NCT02065557|17564095|P5|Induction Period|Adverse Event|0
5087171|NCT02065557|17564096|P4|Induction Period|Adverse Event|0
5087172|NCT02065557|17564097|P3|Induction Period|Adverse Event|0
5087173|NCT02065557|17564098|P2|Induction Period|Adverse Event|1
5087174|NCT02065557|17564099|P1|Induction Period|Adverse Event|1
5087175|NCT02065557|17564094|P6|Induction Period|Non-Responder at Week 8|0
5087176|NCT02065557|17564095|P5|Induction Period|Non-Responder at Week 8|0
5087177|NCT02065557|17564096|P4|Induction Period|Non-Responder at Week 8|0
5087178|NCT02065557|17564097|P3|Induction Period|Non-Responder at Week 8|0
5087179|NCT02065557|17564098|P2|Induction Period|Non-Responder at Week 8|4
5087180|NCT02065557|17564099|P1|Induction Period|Non-Responder at Week 8|4
5087181|NCT02065557|17564094|P6|Induction Period|Requires Alternative/Prohibited Therapy|0
5087182|NCT02065557|17564095|P5|Induction Period|Requires Alternative/Prohibited Therapy|0
5087183|NCT02065557|17564096|P4|Induction Period|Requires Alternative/Prohibited Therapy|0
5087184|NCT02065557|17564097|P3|Induction Period|Requires Alternative/Prohibited Therapy|1
5087185|NCT02065557|17564098|P2|Induction Period|Requires Alternative/Prohibited Therapy|1
5087186|NCT02065557|17564099|P1|Induction Period|Requires Alternative/Prohibited Therapy|1
5087187|NCT02065557|17564094|P6|Induction Period|Lack of Efficacy|0
5087188|NCT02065557|17564095|P5|Induction Period|Lack of Efficacy|0
5087189|NCT02065557|17564096|P4|Induction Period|Lack of Efficacy|0
5087190|NCT02065557|17564097|P3|Induction Period|Lack of Efficacy|1
5087191|NCT02065557|17564098|P2|Induction Period|Lack of Efficacy|1
5087192|NCT02065557|17564099|P1|Induction Period|Lack of Efficacy|2
5087193|NCT02065557|17564094|P6|Induction Period|Withdrawal by Subject|0
5087194|NCT02065557|17564095|P5|Induction Period|Withdrawal by Subject|0
5087195|NCT02065557|17564096|P4|Induction Period|Withdrawal by Subject|0
5087196|NCT02065557|17564097|P3|Induction Period|Withdrawal by Subject|0
5087197|NCT02065557|17564098|P2|Induction Period|Withdrawal by Subject|1
5087198|NCT02065557|17564099|P1|Induction Period|Withdrawal by Subject|2
5087199|NCT02065518|17564160|P4|Overall Study|Withdrawal by Subject|2
5087200|NCT02065518|17564161|P3|Overall Study|Withdrawal by Subject|9
5087201|NCT02065518|17564162|P2|Overall Study|Withdrawal by Subject|4
5087202|NCT02065518|17564163|P1|Overall Study|Withdrawal by Subject|3
5087203|NCT02065518|17564160|P4|Overall Study|Lost to Follow-up|3
5087204|NCT02065518|17564161|P3|Overall Study|Lost to Follow-up|0
5087205|NCT02065518|17564162|P2|Overall Study|Lost to Follow-up|4
5087206|NCT02065518|17564163|P1|Overall Study|Lost to Follow-up|3
5087207|NCT02065336|17564238|P10|Extension Phase|Study Terminated by Sponsor|8
5087208|NCT02065336|17564239|P9|Extension Phase|Study Terminated by Sponsor|2
5087209|NCT02065336|17564240|P8|Extension Phase|Study Terminated by Sponsor|0
5087210|NCT02065336|17564241|P7|Extension Phase|Study Terminated by Sponsor|0
5087211|NCT02065336|17564242|P6|Extension Phase|Study Terminated by Sponsor|0
5087212|NCT02065336|17564243|P5|Extension Phase|Study Terminated by Sponsor|0
5087213|NCT02065336|17564244|P4|Extension Phase|Study Terminated by Sponsor|0
5087214|NCT02065336|17564245|P3|Extension Phase|Study Terminated by Sponsor|0
5087215|NCT02065336|17564246|P2|Extension Phase|Study Terminated by Sponsor|0
5087216|NCT02065336|17564247|P1|Extension Phase|Study Terminated by Sponsor|0
5087217|NCT02064920|17564524|P2|Overall Study|Withdrawal by Subject|3
5087218|NCT02064920|17564525|P1|Overall Study|Withdrawal by Subject|1
5087219|NCT02064920|17564524|P2|Overall Study|Technical Problems|1
5087220|NCT02064920|17564525|P1|Overall Study|Technical Problems|0
5087221|NCT02064920|17564524|P2|Overall Study|Physician Decision|1
5087222|NCT02064920|17564525|P1|Overall Study|Physician Decision|0
5087223|NCT02064920|17564524|P2|Overall Study|Adverse Event|4
5087224|NCT02064920|17564525|P1|Overall Study|Adverse Event|0
5087225|NCT02064894|17564555|P3|Overall Study|Withdrawal by Subject|115
5087226|NCT02064894|17564556|P2|Overall Study|Withdrawal by Subject|102
5087227|NCT02064894|17564557|P1|Overall Study|Withdrawal by Subject|43
5087228|NCT02064868|17564570|P2|Overall Study|Technical Problems or Missing|2
5087229|NCT02064868|17564571|P1|Overall Study|Technical Problems or Missing|5
5087230|NCT02064868|17564570|P2|Overall Study|Withdrawal by Subject|3
5087231|NCT02064868|17564571|P1|Overall Study|Withdrawal by Subject|14
5087232|NCT02064868|17564570|P2|Overall Study|Physician Decision|0
5087233|NCT02064868|17564571|P1|Overall Study|Physician Decision|1
5087234|NCT02064868|17564570|P2|Overall Study|Lost to Follow-up|8
5087235|NCT02064868|17564571|P1|Overall Study|Lost to Follow-up|14
5087236|NCT02064816|17564591|P2|Overall Study|Other|3
5087237|NCT02064816|17564592|P1|Overall Study|Other|1
5087238|NCT02064816|17564591|P2|Overall Study|Therapeutic failure|1
5087239|NCT02064816|17564592|P1|Overall Study|Therapeutic failure|0
5087240|NCT02064816|17564591|P2|Overall Study|Lost to Follow-up|1
5087241|NCT02064816|17564592|P1|Overall Study|Lost to Follow-up|2
5087242|NCT02064816|17564591|P2|Overall Study|Withdrawal by Subject|1
5087243|NCT02064816|17564592|P1|Overall Study|Withdrawal by Subject|2
5087244|NCT02064816|17564591|P2|Overall Study|Adverse Event|2
5087245|NCT02064816|17564592|P1|Overall Study|Adverse Event|3
5087246|NCT02064439|17564638|P3|Overall Study|Other|7
5087247|NCT02064439|17564639|P2|Overall Study|Other|2
5087248|NCT02064439|17564640|P1|Overall Study|Other|2
5087249|NCT02064439|17564638|P3|Overall Study|Safety outcome reached|10
5087250|NCT02064439|17564639|P2|Overall Study|Safety outcome reached|20
5087251|NCT02064439|17564640|P1|Overall Study|Safety outcome reached|12
5087252|NCT02064439|17564638|P3|Overall Study|Efficacy outcome reached|57
5087253|NCT02064439|17564639|P2|Overall Study|Efficacy outcome reached|16
5087254|NCT02064439|17564640|P1|Overall Study|Efficacy outcome reached|18
5087255|NCT02064439|17564638|P3|Overall Study|Logistical difficulties|2
5087256|NCT02064439|17564639|P2|Overall Study|Logistical difficulties|5
5087257|NCT02064439|17564640|P1|Overall Study|Logistical difficulties|6
5087258|NCT02064439|17564638|P3|Overall Study|Physician Decision|1
5087259|NCT02064439|17564639|P2|Overall Study|Physician Decision|1
5087260|NCT02064439|17564640|P1|Overall Study|Physician Decision|0
5087261|NCT02064439|17564638|P3|Overall Study|Non-compliance with study medication|23
5087262|NCT02064439|17564639|P2|Overall Study|Non-compliance with study medication|19
5087263|NCT02064439|17564640|P1|Overall Study|Non-compliance with study medication|21
5087264|NCT02064439|17564638|P3|Overall Study|Lost to Follow-up|4
5087265|NCT02064439|17564639|P2|Overall Study|Lost to Follow-up|3
5087266|NCT02064439|17564640|P1|Overall Study|Lost to Follow-up|1
5087267|NCT02064439|17564638|P3|Overall Study|Protocol Violation|3
5087268|NCT02064439|17564639|P2|Overall Study|Protocol Violation|5
5087269|NCT02064439|17564640|P1|Overall Study|Protocol Violation|3
5087270|NCT02064439|17564638|P3|Overall Study|Withdrawal by Subject|26
5087271|NCT02064439|17564639|P2|Overall Study|Withdrawal by Subject|18
5087272|NCT02064439|17564640|P1|Overall Study|Withdrawal by Subject|29
5087273|NCT02064439|17564638|P3|Overall Study|Death|3
5087274|NCT02064439|17564639|P2|Overall Study|Death|2
5087275|NCT02064439|17564640|P1|Overall Study|Death|0
5087276|NCT02064439|17564638|P3|Overall Study|Adverse Event|46
5087277|NCT02064439|17564639|P2|Overall Study|Adverse Event|47
5087278|NCT02064439|17564640|P1|Overall Study|Adverse Event|51
5087279|NCT02064387|17564669|P12|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087280|NCT02064387|17564670|P11|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
5087281|NCT02064387|17564671|P10|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087282|NCT02064387|17564672|P9|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087283|NCT02064387|17564673|P8|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087284|NCT02064387|17564674|P7|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087285|NCT02064387|17564675|P6|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087286|NCT02064387|17564676|P5|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087287|NCT02064387|17564677|P4|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087288|NCT02064387|17564678|P3|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087289|NCT02064387|17564679|P2|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087290|NCT02064387|17564680|P1|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5087291|NCT02064387|17564669|P12|Part 2 Max 35 Months Followup Duration|Death|3
5087292|NCT02064387|17564670|P11|Part 2 Max 35 Months Followup Duration|Death|5
5087293|NCT02064387|17564671|P10|Part 2 Max 35 Months Followup Duration|Death|0
5087294|NCT02064387|17564672|P9|Part 2 Max 35 Months Followup Duration|Death|0
5087295|NCT02064387|17564673|P8|Part 2 Max 35 Months Followup Duration|Death|0
5087296|NCT02064387|17564674|P7|Part 2 Max 35 Months Followup Duration|Death|0
5087297|NCT02064387|17564675|P6|Part 2 Max 35 Months Followup Duration|Death|0
5087298|NCT02064387|17564676|P5|Part 2 Max 35 Months Followup Duration|Death|0
5087299|NCT02064387|17564677|P4|Part 2 Max 35 Months Followup Duration|Death|0
5087300|NCT02064387|17564678|P3|Part 2 Max 35 Months Followup Duration|Death|0
5087301|NCT02064387|17564679|P2|Part 2 Max 35 Months Followup Duration|Death|0
5087302|NCT02064387|17564680|P1|Part 2 Max 35 Months Followup Duration|Death|0
5087303|NCT02064387|17564669|P12|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087304|NCT02064387|17564670|P11|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087305|NCT02064387|17564671|P10|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087306|NCT02064387|17564672|P9|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
5087307|NCT02064387|17564673|P8|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087308|NCT02064387|17564674|P7|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087309|NCT02064387|17564675|P6|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087310|NCT02064387|17564676|P5|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087311|NCT02064387|17564677|P4|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087312|NCT02064387|17564678|P3|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087313|NCT02064387|17564679|P2|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087314|NCT02064387|17564680|P1|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5087315|NCT02064387|17564669|P12|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087316|NCT02064387|17564670|P11|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087317|NCT02064387|17564671|P10|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087318|NCT02064387|17564672|P9|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087319|NCT02064387|17564673|P8|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
5087320|NCT02064387|17564674|P7|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087321|NCT02064387|17564675|P6|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087322|NCT02064387|17564676|P5|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087323|NCT02064387|17564677|P4|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087324|NCT02064387|17564678|P3|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087325|NCT02064387|17564679|P2|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087326|NCT02064387|17564680|P1|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5087327|NCT02064387|17564669|P12|Part 1 Max 23.5 Months Followup Duration|Death|0
5087328|NCT02064387|17564670|P11|Part 1 Max 23.5 Months Followup Duration|Death|0
5087329|NCT02064387|17564671|P10|Part 1 Max 23.5 Months Followup Duration|Death|1
5087330|NCT02064387|17564672|P9|Part 1 Max 23.5 Months Followup Duration|Death|0
5087331|NCT02064387|17564673|P8|Part 1 Max 23.5 Months Followup Duration|Death|1
5087332|NCT02064387|17564674|P7|Part 1 Max 23.5 Months Followup Duration|Death|0
5087333|NCT02064387|17564675|P6|Part 1 Max 23.5 Months Followup Duration|Death|0
5087334|NCT02064387|17564676|P5|Part 1 Max 23.5 Months Followup Duration|Death|0
5087335|NCT02064387|17564677|P4|Part 1 Max 23.5 Months Followup Duration|Death|0
5087336|NCT02064387|17564678|P3|Part 1 Max 23.5 Months Followup Duration|Death|0
5087337|NCT02064387|17564679|P2|Part 1 Max 23.5 Months Followup Duration|Death|0
5087338|NCT02064387|17564680|P1|Part 1 Max 23.5 Months Followup Duration|Death|0
5087339|NCT02064231|17565009|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
5087340|NCT02064231|17565010|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
5087341|NCT02064231|17565011|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5087342|NCT02064231|17565012|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5087343|NCT02064231|17565009|P4|First Test Period (Test A or Test C)|Adverse Event|0
5087344|NCT02064231|17565010|P3|First Test Period (Test A or Test C)|Adverse Event|1
5087345|NCT02064231|17565011|P2|First Test Period (Test A or Test C)|Adverse Event|0
5087346|NCT02064231|17565012|P1|First Test Period (Test A or Test C)|Adverse Event|1
5087347|NCT02064231|17565009|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
5087348|NCT02064231|17565010|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
5087349|NCT02064231|17565011|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5087350|NCT02064231|17565012|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5087351|NCT02064231|17565009|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
5087352|NCT02064231|17565010|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
5087353|NCT02064231|17565011|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
5087354|NCT02064231|17565012|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
5087355|NCT02064205|17565024|P1|Overall Study|Withdrawal by Subject|1
5087356|NCT02064166|17565042|P2|Overall Study|Adverse Event|0
5087357|NCT02064166|17565043|P1|Overall Study|Adverse Event|1
5087358|NCT02063880|17565073|P2|Overall Study|Ineligible|2
5087359|NCT02063880|17565074|P1|Overall Study|Ineligible|0
5087360|NCT02063880|17565073|P2|Overall Study|Lost to Follow-up|7
5087361|NCT02063880|17565074|P1|Overall Study|Lost to Follow-up|7
5087362|NCT02063880|17565073|P2|Overall Study|Death|18
5087363|NCT02063880|17565074|P1|Overall Study|Death|21
5087364|NCT02063854|17565112|P7|Overall Study|Did Not Receive Study Drug|0
5087365|NCT02063854|17565113|P6|Overall Study|Did Not Receive Study Drug|1
5087366|NCT02063854|17565114|P5|Overall Study|Did Not Receive Study Drug|0
5087367|NCT02063854|17565115|P4|Overall Study|Did Not Receive Study Drug|0
5087368|NCT02063854|17565116|P3|Overall Study|Did Not Receive Study Drug|0
5087369|NCT02063854|17565117|P2|Overall Study|Did Not Receive Study Drug|0
5087370|NCT02063854|17565118|P1|Overall Study|Did Not Receive Study Drug|0
5087371|NCT02063854|17565112|P7|Overall Study|Reason Not Specified|0
5087372|NCT02063854|17565113|P6|Overall Study|Reason Not Specified|0
5087373|NCT02063854|17565114|P5|Overall Study|Reason Not Specified|0
5087374|NCT02063854|17565115|P4|Overall Study|Reason Not Specified|0
5087375|NCT02063854|17565116|P3|Overall Study|Reason Not Specified|0
5087376|NCT02063854|17565117|P2|Overall Study|Reason Not Specified|0
5087377|NCT02063854|17565118|P1|Overall Study|Reason Not Specified|1
5087378|NCT02063854|17565112|P7|Overall Study|Surgical Dental Work Performed/Planned|1
5087379|NCT02063854|17565113|P6|Overall Study|Surgical Dental Work Performed/Planned|6
5087380|NCT02063854|17565114|P5|Overall Study|Surgical Dental Work Performed/Planned|1
5087381|NCT02063854|17565115|P4|Overall Study|Surgical Dental Work Performed/Planned|1
5087382|NCT02063854|17565116|P3|Overall Study|Surgical Dental Work Performed/Planned|6
5087383|NCT02063854|17565117|P2|Overall Study|Surgical Dental Work Performed/Planned|2
5087384|NCT02063854|17565118|P1|Overall Study|Surgical Dental Work Performed/Planned|5
5087385|NCT02063854|17565112|P7|Overall Study|Voluntary Withdrawal|1
5087386|NCT02063854|17565113|P6|Overall Study|Voluntary Withdrawal|6
5087387|NCT02063854|17565114|P5|Overall Study|Voluntary Withdrawal|3
5087388|NCT02063854|17565115|P4|Overall Study|Voluntary Withdrawal|1
5087389|NCT02063854|17565116|P3|Overall Study|Voluntary Withdrawal|8
5087390|NCT02063854|17565117|P2|Overall Study|Voluntary Withdrawal|0
5087391|NCT02063854|17565118|P1|Overall Study|Voluntary Withdrawal|2
5087392|NCT02063854|17565112|P7|Overall Study|Major Protocol Deviation|0
5087393|NCT02063854|17565113|P6|Overall Study|Major Protocol Deviation|0
5087394|NCT02063854|17565114|P5|Overall Study|Major Protocol Deviation|0
5087395|NCT02063854|17565115|P4|Overall Study|Major Protocol Deviation|0
5087396|NCT02063854|17565116|P3|Overall Study|Major Protocol Deviation|3
5087397|NCT02063854|17565117|P2|Overall Study|Major Protocol Deviation|0
5087398|NCT02063854|17565118|P1|Overall Study|Major Protocol Deviation|0
5087399|NCT02063854|17565112|P7|Overall Study|Pretreatment Event/Adverse Event|4
5087400|NCT02063854|17565113|P6|Overall Study|Pretreatment Event/Adverse Event|18
5087401|NCT02063854|17565114|P5|Overall Study|Pretreatment Event/Adverse Event|7
5087402|NCT02063854|17565115|P4|Overall Study|Pretreatment Event/Adverse Event|8
5087403|NCT02063854|17565116|P3|Overall Study|Pretreatment Event/Adverse Event|13
5087404|NCT02063854|17565117|P2|Overall Study|Pretreatment Event/Adverse Event|10
5087405|NCT02063854|17565118|P1|Overall Study|Pretreatment Event/Adverse Event|13
5087406|NCT02063737|17565202|P2|Overall Study|Lost to Follow-up|4
5087407|NCT02063737|17565203|P1|Overall Study|Lost to Follow-up|11
5087408|NCT02063724|17565235|P1|Overall Study|Disease progression|1
5087409|NCT02063698|17565243|P2|Overall Study|did not complete booklet for days 2-8|2
5087410|NCT02063698|17565244|P1|Overall Study|did not complete booklet for days 2-8|1
5087411|NCT02063672|17565268|P2|Overall Study|Withdrawal by Subject|2
5087412|NCT02063672|17565269|P1|Overall Study|Withdrawal by Subject|2
5087413|NCT02063672|17565268|P2|Overall Study|Lost to Follow-up|3
5087414|NCT02063672|17565269|P1|Overall Study|Lost to Follow-up|1
5087415|NCT02063672|17565268|P2|Overall Study|Death|3
5087416|NCT02063672|17565269|P1|Overall Study|Death|5
5087417|NCT02063672|17565268|P2|Overall Study|Ongoing Follow-up|14
5087418|NCT02063672|17565269|P1|Overall Study|Ongoing Follow-up|27
5087419|NCT02063659|17565316|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
5087420|NCT02063659|17565317|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
5087421|NCT02063659|17565318|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
5087422|NCT02063659|17565319|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
5087423|NCT02063659|17565316|P4|Open-Label Extension Period (OLE)|Adverse Event|7
5087424|NCT02063659|17565317|P3|Open-Label Extension Period (OLE)|Adverse Event|0
5087425|NCT02063659|17565318|P2|Open-Label Extension Period (OLE)|Adverse Event|0
5087426|NCT02063659|17565319|P1|Open-Label Extension Period (OLE)|Adverse Event|0
5087427|NCT02063659|17565316|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
5087428|NCT02063659|17565317|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5087429|NCT02063659|17565318|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5087430|NCT02063659|17565319|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5087431|NCT02063659|17565316|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
5087432|NCT02063659|17565317|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5087433|NCT02063659|17565318|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5087434|NCT02063659|17565319|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5087435|NCT02063659|17565316|P4|Open-Label Extension Period (OLE)|Physician Decision|1
5087436|NCT02063659|17565317|P3|Open-Label Extension Period (OLE)|Physician Decision|0
5087437|NCT02063659|17565318|P2|Open-Label Extension Period (OLE)|Physician Decision|0
5087438|NCT02063659|17565319|P1|Open-Label Extension Period (OLE)|Physician Decision|0
5087439|NCT02063659|17565316|P4|Double-Blind Treatment Period|Withdrawal of consent|0
5087440|NCT02063659|17565317|P3|Double-Blind Treatment Period|Withdrawal of consent|3
5087441|NCT02063659|17565318|P2|Double-Blind Treatment Period|Withdrawal of consent|1
5087442|NCT02063659|17565319|P1|Double-Blind Treatment Period|Withdrawal of consent|0
5087443|NCT02063659|17565316|P4|Double-Blind Treatment Period|Physician Decision|0
5087444|NCT02063659|17565317|P3|Double-Blind Treatment Period|Physician Decision|0
5087445|NCT02063659|17565318|P2|Double-Blind Treatment Period|Physician Decision|0
5087446|NCT02063659|17565319|P1|Double-Blind Treatment Period|Physician Decision|1
5087447|NCT02063659|17565316|P4|Double-Blind Treatment Period|Adverse Event|0
5087448|NCT02063659|17565317|P3|Double-Blind Treatment Period|Adverse Event|0
5087449|NCT02063659|17565318|P2|Double-Blind Treatment Period|Adverse Event|2
5087450|NCT02063659|17565319|P1|Double-Blind Treatment Period|Adverse Event|1
5087451|NCT02063217|17565402|P3|Overall Study|Withdrawal by Subject|0
5087452|NCT02063217|17565403|P2|Overall Study|Withdrawal by Subject|0
5087453|NCT02063217|17565404|P1|Overall Study|Withdrawal by Subject|1
5087454|NCT02062879|17565480|P2|Overall Study|Withdrawal by Subject|1
5087455|NCT02062879|17565481|P1|Overall Study|Withdrawal by Subject|4
5087456|NCT02062658|17565517|P1|Overall Study|Lack of Efficacy|1
5087457|NCT02062658|17565517|P1|Overall Study|Withdrawal by Subject|1
5087458|NCT02062645|17565521|P1|Overall Study|Lost to Follow-up|5
5087459|NCT02062645|17565521|P1|Overall Study|Protocol Violation|8
5087460|NCT02062645|17565521|P1|Overall Study|Adverse Event|2
5087461|NCT02062632|17565529|P1|Overall Study|No treatment data|1
5087462|NCT02062450|17565570|P1|Overall Study|No follow-up visit|124
5087463|NCT02062437|17565584|P1|Overall Study|Pt. couldn't come due to med. condition|1
5087464|NCT02062437|17565584|P1|Overall Study|Death|2
5087465|NCT02062437|17565584|P1|Overall Study|Patient not available for the 2y visit|18
5087466|NCT02062437|17565584|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
5087467|NCT02062398|17565593|P1|Overall Study|Implant removal|1
5087468|NCT02062385|17565605|P4|Overall Study|Lost to Follow-up|0
5087469|NCT02062385|17565606|P3|Overall Study|Lost to Follow-up|1
5087470|NCT02062385|17565607|P2|Overall Study|Lost to Follow-up|0
5087471|NCT02062385|17565608|P1|Overall Study|Lost to Follow-up|0
5087472|NCT02062385|17565605|P4|Overall Study|Death|1
5087473|NCT02062385|17565606|P3|Overall Study|Death|0
5087474|NCT02062385|17565607|P2|Overall Study|Death|0
5087475|NCT02062385|17565608|P1|Overall Study|Death|0
5087476|NCT02062385|17565605|P4|Overall Study|Withdrawn by parent/guardian|8
5087477|NCT02062385|17565606|P3|Overall Study|Withdrawn by parent/guardian|9
5087478|NCT02062385|17565607|P2|Overall Study|Withdrawn by parent/guardian|41
5087479|NCT02062385|17565608|P1|Overall Study|Withdrawn by parent/guardian|46
5087480|NCT02062385|17565605|P4|Overall Study|Moved|0
5087481|NCT02062385|17565606|P3|Overall Study|Moved|1
5087482|NCT02062385|17565607|P2|Overall Study|Moved|11
5087483|NCT02062385|17565608|P1|Overall Study|Moved|10
5087484|NCT02062385|17565605|P4|Overall Study|Incomplete EPI by database lock|0
5087485|NCT02062385|17565606|P3|Overall Study|Incomplete EPI by database lock|0
5087486|NCT02062385|17565607|P2|Overall Study|Incomplete EPI by database lock|0
5087487|NCT02062385|17565608|P1|Overall Study|Incomplete EPI by database lock|2
5087488|NCT02062385|17565605|P4|Overall Study|Protocol Violation|0
5087489|NCT02062385|17565606|P3|Overall Study|Protocol Violation|0
5087490|NCT02062385|17565607|P2|Overall Study|Protocol Violation|0
5087491|NCT02062385|17565608|P1|Overall Study|Protocol Violation|1
5087492|NCT02062385|17565605|P4|Overall Study|Adverse Event|0
5087493|NCT02062385|17565606|P3|Overall Study|Adverse Event|1
5087494|NCT02062385|17565607|P2|Overall Study|Adverse Event|13
5087495|NCT02062385|17565608|P1|Overall Study|Adverse Event|19
5087496|NCT02062151|17565652|P1|Overall Study|screen failure|1
5087497|NCT02061592|17565812|P2|Period 2|Lost to Follow-up|1
5087498|NCT02061592|17565813|P1|Period 2|Lost to Follow-up|0
5087499|NCT02061592|17565812|P2|Period 1|Protocol Violation|0
5087500|NCT02061592|17565813|P1|Period 1|Protocol Violation|1
5087501|NCT02061592|17565812|P2|Period 1|Withdrawal by Subject|0
5087502|NCT02061592|17565813|P1|Period 1|Withdrawal by Subject|1
5087503|NCT02061540|17565825|P1|Overall Study|Withdrawal by Subject|2
5087504|NCT02061540|17565825|P1|Overall Study|Adverse Event|2
5087505|NCT02061280|17565998|P2|Overall Study|Lost to Follow-up|1
5087506|NCT02061280|17565999|P1|Overall Study|Lost to Follow-up|5
5087507|NCT02061280|17565998|P2|Overall Study|Withdrawal by Subject|2
5087508|NCT02061280|17565999|P1|Overall Study|Withdrawal by Subject|1
5087509|NCT02061280|17565998|P2|Overall Study|moved out of state|1
5087510|NCT02061280|17565999|P1|Overall Study|moved out of state|0
5087511|NCT02061280|17565998|P2|Overall Study|Protocol Violation|8
5087512|NCT02061280|17565999|P1|Overall Study|Protocol Violation|12
5087513|NCT02061202|17566031|P2|Overall Study|Lost to Follow-up|1
5087514|NCT02061202|17566032|P1|Overall Study|Lost to Follow-up|1
5087515|NCT02060903|17566058|P2|Overall Study|Withdrawal by Subject|7
5087516|NCT02060903|17566059|P1|Overall Study|Withdrawal by Subject|0
5087517|NCT02060903|17566058|P2|Overall Study|Lost to Follow-up|0
5087518|NCT02060903|17566059|P1|Overall Study|Lost to Follow-up|4
5087519|NCT02060383|17566180|P5|Extension Phase|Protocol Violation|1
5087520|NCT02060383|17566181|P4|Extension Phase|Protocol Violation|0
5087521|NCT02060383|17566182|P3|Extension Phase|Protocol Violation|0
5087522|NCT02060383|17566183|P2|Extension Phase|Protocol Violation|0
5087523|NCT02060383|17566184|P1|Extension Phase|Protocol Violation|0
5087524|NCT02060383|17566180|P5|Extension Phase|Death|1
5087525|NCT02060383|17566181|P4|Extension Phase|Death|0
5087526|NCT02060383|17566182|P3|Extension Phase|Death|1
5087527|NCT02060383|17566183|P2|Extension Phase|Death|0
5087528|NCT02060383|17566184|P1|Extension Phase|Death|0
5087529|NCT02060383|17566180|P5|Extension Phase|Administrative problems|0
5087530|NCT02060383|17566181|P4|Extension Phase|Administrative problems|0
5087531|NCT02060383|17566182|P3|Extension Phase|Administrative problems|0
5087532|NCT02060383|17566183|P2|Extension Phase|Administrative problems|0
5087533|NCT02060383|17566184|P1|Extension Phase|Administrative problems|1
5087534|NCT02060383|17566180|P5|Extension Phase|Withdrawal by Subject|2
5087535|NCT02060383|17566181|P4|Extension Phase|Withdrawal by Subject|0
5087536|NCT02060383|17566182|P3|Extension Phase|Withdrawal by Subject|0
5087537|NCT02060383|17566183|P2|Extension Phase|Withdrawal by Subject|1
5087538|NCT02060383|17566184|P1|Extension Phase|Withdrawal by Subject|0
5087539|NCT02060383|17566180|P5|Extension Phase|Adverse Event|1
5087540|NCT02060383|17566181|P4|Extension Phase|Adverse Event|0
5087541|NCT02060383|17566182|P3|Extension Phase|Adverse Event|2
5087542|NCT02060383|17566183|P2|Extension Phase|Adverse Event|1
5087543|NCT02060383|17566184|P1|Extension Phase|Adverse Event|1
5087544|NCT02060383|17566180|P5|Extension Phase|Unsatisfactory therapeutic effect|2
5087545|NCT02060383|17566181|P4|Extension Phase|Unsatisfactory therapeutic effect|2
5087546|NCT02060383|17566182|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5087547|NCT02060383|17566183|P2|Extension Phase|Unsatisfactory therapeutic effect|1
5087548|NCT02060383|17566184|P1|Extension Phase|Unsatisfactory therapeutic effect|1
5087549|NCT02060383|17566180|P5|Core Phase|Withdrawal by Subject|2
5087550|NCT02060383|17566181|P4|Core Phase|Withdrawal by Subject|4
5087551|NCT02060383|17566182|P3|Core Phase|Withdrawal by Subject|0
5087552|NCT02060383|17566183|P2|Core Phase|Withdrawal by Subject|0
5087553|NCT02060383|17566184|P1|Core Phase|Withdrawal by Subject|0
5087554|NCT02060383|17566180|P5|Core Phase|Protocol Violation|0
5087555|NCT02060383|17566181|P4|Core Phase|Protocol Violation|1
5087556|NCT02060383|17566182|P3|Core Phase|Protocol Violation|0
5087557|NCT02060383|17566183|P2|Core Phase|Protocol Violation|0
5087558|NCT02060383|17566184|P1|Core Phase|Protocol Violation|0
5087559|NCT02060383|17566180|P5|Core Phase|Administrative problems|0
5087560|NCT02060383|17566181|P4|Core Phase|Administrative problems|0
5087561|NCT02060383|17566182|P3|Core Phase|Administrative problems|0
5087562|NCT02060383|17566183|P2|Core Phase|Administrative problems|1
5087563|NCT02060383|17566184|P1|Core Phase|Administrative problems|0
5087564|NCT02060383|17566180|P5|Core Phase|Adverse Event|6
5087565|NCT02060383|17566181|P4|Core Phase|Adverse Event|2
5087566|NCT02060383|17566182|P3|Core Phase|Adverse Event|0
5087567|NCT02060383|17566183|P2|Core Phase|Adverse Event|0
5087568|NCT02060383|17566184|P1|Core Phase|Adverse Event|2
5087569|NCT02060383|17566180|P5|Core Phase|Unsatisfactory therapeutic effect|0
5087570|NCT02060383|17566181|P4|Core Phase|Unsatisfactory therapeutic effect|0
5087571|NCT02060383|17566182|P3|Core Phase|Unsatisfactory therapeutic effect|0
5087572|NCT02060383|17566183|P2|Core Phase|Unsatisfactory therapeutic effect|5
5087573|NCT02060383|17566184|P1|Core Phase|Unsatisfactory therapeutic effect|1
5087574|NCT02060370|17566210|P1|Overall Study|Physician Decision|1
5087575|NCT02059980|17566251|P2|Overall Study|Lost to Follow-up|1
5087576|NCT02059980|17566252|P1|Overall Study|Lost to Follow-up|2
5087577|NCT02059434|17566297|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
5087578|NCT02059434|17566298|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087579|NCT02059434|17566299|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087580|NCT02059434|17566300|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087581|NCT02059434|17566301|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087582|NCT02059434|17566302|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087583|NCT02059434|17566303|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087584|NCT02059434|17566304|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087585|NCT02059434|17566305|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5087586|NCT02059434|17566297|P9|Washout Between Periods 7 and 8|Adverse Event|1
5087587|NCT02059434|17566298|P8|Washout Between Periods 7 and 8|Adverse Event|0
5087588|NCT02059434|17566299|P7|Washout Between Periods 7 and 8|Adverse Event|0
5087589|NCT02059434|17566300|P6|Washout Between Periods 7 and 8|Adverse Event|0
5087590|NCT02059434|17566301|P5|Washout Between Periods 7 and 8|Adverse Event|0
5087591|NCT02059434|17566302|P4|Washout Between Periods 7 and 8|Adverse Event|0
5087592|NCT02059434|17566303|P3|Washout Between Periods 7 and 8|Adverse Event|0
5087593|NCT02059434|17566304|P2|Washout Between Periods 7 and 8|Adverse Event|0
5087594|NCT02059434|17566305|P1|Washout Between Periods 7 and 8|Adverse Event|0
5087595|NCT02059434|17566297|P9|Washout Between Periods 6 and 7|Physician Decision|1
5087596|NCT02059434|17566298|P8|Washout Between Periods 6 and 7|Physician Decision|0
5087597|NCT02059434|17566299|P7|Washout Between Periods 6 and 7|Physician Decision|0
5087598|NCT02059434|17566300|P6|Washout Between Periods 6 and 7|Physician Decision|0
5087599|NCT02059434|17566301|P5|Washout Between Periods 6 and 7|Physician Decision|0
5087600|NCT02059434|17566302|P4|Washout Between Periods 6 and 7|Physician Decision|0
5087601|NCT02059434|17566303|P3|Washout Between Periods 6 and 7|Physician Decision|0
5087602|NCT02059434|17566304|P2|Washout Between Periods 6 and 7|Physician Decision|0
5087603|NCT02059434|17566305|P1|Washout Between Periods 6 and 7|Physician Decision|0
5087604|NCT02059434|17566297|P9|Washout Between Periods 4 and 5|Adverse Event|1
5087605|NCT02059434|17566298|P8|Washout Between Periods 4 and 5|Adverse Event|0
5087606|NCT02059434|17566299|P7|Washout Between Periods 4 and 5|Adverse Event|0
5087607|NCT02059434|17566300|P6|Washout Between Periods 4 and 5|Adverse Event|0
5087608|NCT02059434|17566301|P5|Washout Between Periods 4 and 5|Adverse Event|0
5087609|NCT02059434|17566302|P4|Washout Between Periods 4 and 5|Adverse Event|0
5087610|NCT02059434|17566303|P3|Washout Between Periods 4 and 5|Adverse Event|0
5087611|NCT02059434|17566304|P2|Washout Between Periods 4 and 5|Adverse Event|0
5087612|NCT02059434|17566305|P1|Washout Between Periods 4 and 5|Adverse Event|0
5087613|NCT02059434|17566297|P9|Washout Between Periods 1 and 2|Physician Decision|0
5087614|NCT02059434|17566298|P8|Washout Between Periods 1 and 2|Physician Decision|1
5087615|NCT02059434|17566299|P7|Washout Between Periods 1 and 2|Physician Decision|0
5087616|NCT02059434|17566300|P6|Washout Between Periods 1 and 2|Physician Decision|0
5087617|NCT02059434|17566301|P5|Washout Between Periods 1 and 2|Physician Decision|0
5087618|NCT02059434|17566302|P4|Washout Between Periods 1 and 2|Physician Decision|0
5087619|NCT02059434|17566303|P3|Washout Between Periods 1 and 2|Physician Decision|0
5087620|NCT02059434|17566304|P2|Washout Between Periods 1 and 2|Physician Decision|0
5087621|NCT02059434|17566305|P1|Washout Between Periods 1 and 2|Physician Decision|0
5087622|NCT02059408|17566370|P3|Overall Study|Did not get tested|358
5087623|NCT02059408|17566371|P2|Overall Study|Did not get tested|330
5087624|NCT02059408|17566372|P1|Overall Study|Did not get tested|0
5087625|NCT02059395|17566391|P2|Overall Study|Lost to Follow-up|4
5087626|NCT02059395|17566392|P1|Overall Study|Lost to Follow-up|2
5087627|NCT02059291|17566407|P25|Epoch 4|Lack of Efficacy|0
5087628|NCT02059291|17566408|P24|Epoch 4|Lack of Efficacy|1
5087629|NCT02059291|17566409|P23|Epoch 4|Lack of Efficacy|0
5087630|NCT02059291|17566410|P22|Epoch 4|Lack of Efficacy|0
5087631|NCT02059291|17566411|P21|Epoch 4|Lack of Efficacy|0
5087632|NCT02059291|17566412|P20|Epoch 4|Lack of Efficacy|0
5087633|NCT02059291|17566413|P19|Epoch 4|Lack of Efficacy|0
5087634|NCT02059291|17566414|P18|Epoch 4|Lack of Efficacy|0
5087635|NCT02059291|17566415|P17|Epoch 4|Lack of Efficacy|0
5087636|NCT02059291|17566416|P16|Epoch 4|Lack of Efficacy|0
5087637|NCT02059291|17566417|P15|Epoch 4|Lack of Efficacy|0
5087638|NCT02059291|17566418|P14|Epoch 4|Lack of Efficacy|0
5087639|NCT02059291|17566419|P13|Epoch 4|Lack of Efficacy|0
5087640|NCT02059291|17566420|P12|Epoch 4|Lack of Efficacy|0
5087641|NCT02059291|17566421|P11|Epoch 4|Lack of Efficacy|0
5087642|NCT02059291|17566422|P10|Epoch 4|Lack of Efficacy|0
5087643|NCT02059291|17566423|P9|Epoch 4|Lack of Efficacy|0
5087644|NCT02059291|17566424|P8|Epoch 4|Lack of Efficacy|0
5087645|NCT02059291|17566425|P7|Epoch 4|Lack of Efficacy|0
5087646|NCT02059291|17566426|P6|Epoch 4|Lack of Efficacy|0
5087647|NCT02059291|17566427|P5|Epoch 4|Lack of Efficacy|0
5087648|NCT02059291|17566428|P4|Epoch 4|Lack of Efficacy|0
5087649|NCT02059291|17566429|P3|Epoch 4|Lack of Efficacy|0
5087650|NCT02059291|17566430|P2|Epoch 4|Lack of Efficacy|0
5087651|NCT02059291|17566431|P1|Epoch 4|Lack of Efficacy|0
5087652|NCT02059291|17566407|P25|Epoch 4|Withdrawal by Subject|0
5087653|NCT02059291|17566408|P24|Epoch 4|Withdrawal by Subject|0
5087654|NCT02059291|17566409|P23|Epoch 4|Withdrawal by Subject|0
5087655|NCT02059291|17566410|P22|Epoch 4|Withdrawal by Subject|0
5087656|NCT02059291|17566411|P21|Epoch 4|Withdrawal by Subject|1
5087657|NCT02059291|17566412|P20|Epoch 4|Withdrawal by Subject|0
5087658|NCT02059291|17566413|P19|Epoch 4|Withdrawal by Subject|0
5087659|NCT02059291|17566414|P18|Epoch 4|Withdrawal by Subject|0
5087660|NCT02059291|17566415|P17|Epoch 4|Withdrawal by Subject|0
5087661|NCT02059291|17566416|P16|Epoch 4|Withdrawal by Subject|0
5087662|NCT02059291|17566417|P15|Epoch 4|Withdrawal by Subject|0
5087663|NCT02059291|17566418|P14|Epoch 4|Withdrawal by Subject|0
5087664|NCT02059291|17566419|P13|Epoch 4|Withdrawal by Subject|0
5087665|NCT02059291|17566420|P12|Epoch 4|Withdrawal by Subject|0
5087666|NCT02059291|17566421|P11|Epoch 4|Withdrawal by Subject|0
5087667|NCT02059291|17566422|P10|Epoch 4|Withdrawal by Subject|0
5087668|NCT02059291|17566423|P9|Epoch 4|Withdrawal by Subject|0
5087669|NCT02059291|17566424|P8|Epoch 4|Withdrawal by Subject|0
5087670|NCT02059291|17566425|P7|Epoch 4|Withdrawal by Subject|0
5087671|NCT02059291|17566426|P6|Epoch 4|Withdrawal by Subject|0
5087672|NCT02059291|17566427|P5|Epoch 4|Withdrawal by Subject|0
5087673|NCT02059291|17566428|P4|Epoch 4|Withdrawal by Subject|0
5087674|NCT02059291|17566429|P3|Epoch 4|Withdrawal by Subject|0
5087675|NCT02059291|17566430|P2|Epoch 4|Withdrawal by Subject|0
5087676|NCT02059291|17566431|P1|Epoch 4|Withdrawal by Subject|0
5087677|NCT02059291|17566407|P25|Epoch 4|Pregnancy|0
5087678|NCT02059291|17566408|P24|Epoch 4|Pregnancy|0
5087679|NCT02059291|17566409|P23|Epoch 4|Pregnancy|0
5087680|NCT02059291|17566410|P22|Epoch 4|Pregnancy|0
5087681|NCT02059291|17566411|P21|Epoch 4|Pregnancy|0
5087682|NCT02059291|17566412|P20|Epoch 4|Pregnancy|0
5087683|NCT02059291|17566413|P19|Epoch 4|Pregnancy|0
5087684|NCT02059291|17566414|P18|Epoch 4|Pregnancy|0
5087685|NCT02059291|17566415|P17|Epoch 4|Pregnancy|1
5087686|NCT02059291|17566416|P16|Epoch 4|Pregnancy|0
5087687|NCT02059291|17566417|P15|Epoch 4|Pregnancy|0
5087688|NCT02059291|17566418|P14|Epoch 4|Pregnancy|0
5087689|NCT02059291|17566419|P13|Epoch 4|Pregnancy|0
5087690|NCT02059291|17566420|P12|Epoch 4|Pregnancy|0
5087691|NCT02059291|17566421|P11|Epoch 4|Pregnancy|0
5087692|NCT02059291|17566422|P10|Epoch 4|Pregnancy|0
5087693|NCT02059291|17566423|P9|Epoch 4|Pregnancy|0
5087694|NCT02059291|17566424|P8|Epoch 4|Pregnancy|0
5087695|NCT02059291|17566425|P7|Epoch 4|Pregnancy|0
5087696|NCT02059291|17566426|P6|Epoch 4|Pregnancy|0
5087697|NCT02059291|17566427|P5|Epoch 4|Pregnancy|0
5087698|NCT02059291|17566428|P4|Epoch 4|Pregnancy|0
5087699|NCT02059291|17566429|P3|Epoch 4|Pregnancy|0
5087700|NCT02059291|17566430|P2|Epoch 4|Pregnancy|0
5087701|NCT02059291|17566431|P1|Epoch 4|Pregnancy|0
5087702|NCT02059291|17566407|P25|Epoch 4|Adverse Event|0
5087703|NCT02059291|17566408|P24|Epoch 4|Adverse Event|0
5087704|NCT02059291|17566409|P23|Epoch 4|Adverse Event|1
5087705|NCT02059291|17566410|P22|Epoch 4|Adverse Event|0
5087706|NCT02059291|17566411|P21|Epoch 4|Adverse Event|0
5087707|NCT02059291|17566412|P20|Epoch 4|Adverse Event|0
5087708|NCT02059291|17566413|P19|Epoch 4|Adverse Event|0
5087709|NCT02059291|17566414|P18|Epoch 4|Adverse Event|0
5087710|NCT02059291|17566415|P17|Epoch 4|Adverse Event|1
5087711|NCT02059291|17566416|P16|Epoch 4|Adverse Event|0
5087712|NCT02059291|17566417|P15|Epoch 4|Adverse Event|0
5087713|NCT02059291|17566418|P14|Epoch 4|Adverse Event|0
5087714|NCT02059291|17566419|P13|Epoch 4|Adverse Event|0
5087715|NCT02059291|17566420|P12|Epoch 4|Adverse Event|0
5087716|NCT02059291|17566421|P11|Epoch 4|Adverse Event|0
5087717|NCT02059291|17566422|P10|Epoch 4|Adverse Event|0
5087718|NCT02059291|17566423|P9|Epoch 4|Adverse Event|0
5087719|NCT02059291|17566424|P8|Epoch 4|Adverse Event|0
5087720|NCT02059291|17566425|P7|Epoch 4|Adverse Event|0
5087721|NCT02059291|17566426|P6|Epoch 4|Adverse Event|0
5087722|NCT02059291|17566427|P5|Epoch 4|Adverse Event|0
5087723|NCT02059291|17566428|P4|Epoch 4|Adverse Event|0
5087724|NCT02059291|17566429|P3|Epoch 4|Adverse Event|0
5087725|NCT02059291|17566430|P2|Epoch 4|Adverse Event|0
5087726|NCT02059291|17566431|P1|Epoch 4|Adverse Event|0
5087727|NCT02059291|17566407|P25|Epoch 3|Withdrawal by Subject|0
5087728|NCT02059291|17566408|P24|Epoch 3|Withdrawal by Subject|0
5087729|NCT02059291|17566409|P23|Epoch 3|Withdrawal by Subject|0
5087730|NCT02059291|17566410|P22|Epoch 3|Withdrawal by Subject|0
5087731|NCT02059291|17566411|P21|Epoch 3|Withdrawal by Subject|0
5087732|NCT02059291|17566412|P20|Epoch 3|Withdrawal by Subject|0
5087733|NCT02059291|17566413|P19|Epoch 3|Withdrawal by Subject|0
5087734|NCT02059291|17566414|P18|Epoch 3|Withdrawal by Subject|0
5087735|NCT02059291|17566415|P17|Epoch 3|Withdrawal by Subject|0
5087736|NCT02059291|17566416|P16|Epoch 3|Withdrawal by Subject|1
5087737|NCT02059291|17566417|P15|Epoch 3|Withdrawal by Subject|0
5087738|NCT02059291|17566418|P14|Epoch 3|Withdrawal by Subject|0
5087739|NCT02059291|17566419|P13|Epoch 3|Withdrawal by Subject|0
5087740|NCT02059291|17566420|P12|Epoch 3|Withdrawal by Subject|0
5087741|NCT02059291|17566421|P11|Epoch 3|Withdrawal by Subject|0
5087742|NCT02059291|17566422|P10|Epoch 3|Withdrawal by Subject|0
5087743|NCT02059291|17566423|P9|Epoch 3|Withdrawal by Subject|0
5087744|NCT02059291|17566424|P8|Epoch 3|Withdrawal by Subject|0
5087745|NCT02059291|17566425|P7|Epoch 3|Withdrawal by Subject|0
5087746|NCT02059291|17566426|P6|Epoch 3|Withdrawal by Subject|0
5087747|NCT02059291|17566427|P5|Epoch 3|Withdrawal by Subject|0
5087748|NCT02059291|17566428|P4|Epoch 3|Withdrawal by Subject|0
5087749|NCT02059291|17566429|P3|Epoch 3|Withdrawal by Subject|0
5087750|NCT02059291|17566430|P2|Epoch 3|Withdrawal by Subject|0
5087751|NCT02059291|17566431|P1|Epoch 3|Withdrawal by Subject|0
5087752|NCT02059291|17566407|P25|Epoch 3|Lack of Efficacy|0
5087753|NCT02059291|17566408|P24|Epoch 3|Lack of Efficacy|0
5087754|NCT02059291|17566409|P23|Epoch 3|Lack of Efficacy|0
5087755|NCT02059291|17566410|P22|Epoch 3|Lack of Efficacy|0
5087756|NCT02059291|17566411|P21|Epoch 3|Lack of Efficacy|0
5087757|NCT02059291|17566412|P20|Epoch 3|Lack of Efficacy|0
5087758|NCT02059291|17566413|P19|Epoch 3|Lack of Efficacy|0
5087759|NCT02059291|17566414|P18|Epoch 3|Lack of Efficacy|0
5087760|NCT02059291|17566415|P17|Epoch 3|Lack of Efficacy|0
5087761|NCT02059291|17566416|P16|Epoch 3|Lack of Efficacy|3
5087762|NCT02059291|17566417|P15|Epoch 3|Lack of Efficacy|0
5087763|NCT02059291|17566418|P14|Epoch 3|Lack of Efficacy|0
5087764|NCT02059291|17566419|P13|Epoch 3|Lack of Efficacy|0
5087765|NCT02059291|17566420|P12|Epoch 3|Lack of Efficacy|0
5087766|NCT02059291|17566421|P11|Epoch 3|Lack of Efficacy|0
5087767|NCT02059291|17566422|P10|Epoch 3|Lack of Efficacy|0
5087768|NCT02059291|17566423|P9|Epoch 3|Lack of Efficacy|0
5087769|NCT02059291|17566424|P8|Epoch 3|Lack of Efficacy|0
5087770|NCT02059291|17566425|P7|Epoch 3|Lack of Efficacy|0
5087771|NCT02059291|17566426|P6|Epoch 3|Lack of Efficacy|0
5087772|NCT02059291|17566427|P5|Epoch 3|Lack of Efficacy|0
5087773|NCT02059291|17566428|P4|Epoch 3|Lack of Efficacy|0
5087774|NCT02059291|17566429|P3|Epoch 3|Lack of Efficacy|0
5087775|NCT02059291|17566430|P2|Epoch 3|Lack of Efficacy|0
5087776|NCT02059291|17566431|P1|Epoch 3|Lack of Efficacy|0
5087777|NCT02059291|17566407|P25|Epoch 3|Adverse Event|0
5087778|NCT02059291|17566408|P24|Epoch 3|Adverse Event|0
5087779|NCT02059291|17566409|P23|Epoch 3|Adverse Event|0
5087780|NCT02059291|17566410|P22|Epoch 3|Adverse Event|0
5087781|NCT02059291|17566411|P21|Epoch 3|Adverse Event|0
5087782|NCT02059291|17566412|P20|Epoch 3|Adverse Event|0
5087783|NCT02059291|17566413|P19|Epoch 3|Adverse Event|0
5087784|NCT02059291|17566414|P18|Epoch 3|Adverse Event|0
5087785|NCT02059291|17566415|P17|Epoch 3|Adverse Event|0
5087786|NCT02059291|17566416|P16|Epoch 3|Adverse Event|1
5087787|NCT02059291|17566417|P15|Epoch 3|Adverse Event|0
5087788|NCT02059291|17566418|P14|Epoch 3|Adverse Event|0
5087789|NCT02059291|17566419|P13|Epoch 3|Adverse Event|0
5087790|NCT02059291|17566420|P12|Epoch 3|Adverse Event|0
5087791|NCT02059291|17566421|P11|Epoch 3|Adverse Event|0
5087792|NCT02059291|17566422|P10|Epoch 3|Adverse Event|0
5087793|NCT02059291|17566423|P9|Epoch 3|Adverse Event|0
5087794|NCT02059291|17566424|P8|Epoch 3|Adverse Event|0
5087795|NCT02059291|17566425|P7|Epoch 3|Adverse Event|0
5087796|NCT02059291|17566426|P6|Epoch 3|Adverse Event|0
5087797|NCT02059291|17566427|P5|Epoch 3|Adverse Event|0
5087798|NCT02059291|17566428|P4|Epoch 3|Adverse Event|0
5087799|NCT02059291|17566429|P3|Epoch 3|Adverse Event|0
5087800|NCT02059291|17566430|P2|Epoch 3|Adverse Event|0
5087801|NCT02059291|17566431|P1|Epoch 3|Adverse Event|0
5087802|NCT02059291|17566407|P25|Epoch 3|Physician Decision|0
5087803|NCT02059291|17566408|P24|Epoch 3|Physician Decision|0
5087804|NCT02059291|17566409|P23|Epoch 3|Physician Decision|0
5087805|NCT02059291|17566410|P22|Epoch 3|Physician Decision|0
5087806|NCT02059291|17566411|P21|Epoch 3|Physician Decision|0
5087807|NCT02059291|17566412|P20|Epoch 3|Physician Decision|0
5087808|NCT02059291|17566413|P19|Epoch 3|Physician Decision|0
5087809|NCT02059291|17566414|P18|Epoch 3|Physician Decision|0
5087810|NCT02059291|17566415|P17|Epoch 3|Physician Decision|0
5087811|NCT02059291|17566416|P16|Epoch 3|Physician Decision|1
5087812|NCT02059291|17566417|P15|Epoch 3|Physician Decision|0
5087813|NCT02059291|17566418|P14|Epoch 3|Physician Decision|1
5087814|NCT02059291|17566419|P13|Epoch 3|Physician Decision|0
5087815|NCT02059291|17566420|P12|Epoch 3|Physician Decision|0
5087816|NCT02059291|17566421|P11|Epoch 3|Physician Decision|0
5087817|NCT02059291|17566422|P10|Epoch 3|Physician Decision|0
5087818|NCT02059291|17566423|P9|Epoch 3|Physician Decision|0
5087819|NCT02059291|17566424|P8|Epoch 3|Physician Decision|0
5087820|NCT02059291|17566425|P7|Epoch 3|Physician Decision|0
5087821|NCT02059291|17566426|P6|Epoch 3|Physician Decision|0
5087822|NCT02059291|17566427|P5|Epoch 3|Physician Decision|0
5087823|NCT02059291|17566428|P4|Epoch 3|Physician Decision|0
5087824|NCT02059291|17566429|P3|Epoch 3|Physician Decision|0
5087825|NCT02059291|17566430|P2|Epoch 3|Physician Decision|0
5087826|NCT02059291|17566431|P1|Epoch 3|Physician Decision|0
5087827|NCT02059291|17566407|P25|Epoch 2|Withdrawal by Subject|0
5087828|NCT02059291|17566408|P24|Epoch 2|Withdrawal by Subject|0
5087829|NCT02059291|17566409|P23|Epoch 2|Withdrawal by Subject|0
5087830|NCT02059291|17566410|P22|Epoch 2|Withdrawal by Subject|0
5087831|NCT02059291|17566411|P21|Epoch 2|Withdrawal by Subject|0
5087832|NCT02059291|17566412|P20|Epoch 2|Withdrawal by Subject|0
5087833|NCT02059291|17566413|P19|Epoch 2|Withdrawal by Subject|0
5087834|NCT02059291|17566414|P18|Epoch 2|Withdrawal by Subject|0
5087835|NCT02059291|17566415|P17|Epoch 2|Withdrawal by Subject|0
5087836|NCT02059291|17566416|P16|Epoch 2|Withdrawal by Subject|0
5087837|NCT02059291|17566417|P15|Epoch 2|Withdrawal by Subject|0
5087838|NCT02059291|17566418|P14|Epoch 2|Withdrawal by Subject|0
5087839|NCT02059291|17566419|P13|Epoch 2|Withdrawal by Subject|0
5087840|NCT02059291|17566420|P12|Epoch 2|Withdrawal by Subject|0
5087841|NCT02059291|17566421|P11|Epoch 2|Withdrawal by Subject|0
5087842|NCT02059291|17566422|P10|Epoch 2|Withdrawal by Subject|0
5087843|NCT02059291|17566423|P9|Epoch 2|Withdrawal by Subject|1
5087844|NCT02059291|17566424|P8|Epoch 2|Withdrawal by Subject|0
5087845|NCT02059291|17566425|P7|Epoch 2|Withdrawal by Subject|0
5087846|NCT02059291|17566426|P6|Epoch 2|Withdrawal by Subject|1
5087847|NCT02059291|17566427|P5|Epoch 2|Withdrawal by Subject|0
5087848|NCT02059291|17566428|P4|Epoch 2|Withdrawal by Subject|0
5087849|NCT02059291|17566429|P3|Epoch 2|Withdrawal by Subject|0
5087850|NCT02059291|17566430|P2|Epoch 2|Withdrawal by Subject|1
5087851|NCT02059291|17566431|P1|Epoch 2|Withdrawal by Subject|0
5087852|NCT02059291|17566407|P25|Epoch 2|Adverse Event|0
5087853|NCT02059291|17566408|P24|Epoch 2|Adverse Event|0
5087854|NCT02059291|17566409|P23|Epoch 2|Adverse Event|0
5087855|NCT02059291|17566410|P22|Epoch 2|Adverse Event|0
5087856|NCT02059291|17566411|P21|Epoch 2|Adverse Event|0
5087857|NCT02059291|17566412|P20|Epoch 2|Adverse Event|0
5087858|NCT02059291|17566413|P19|Epoch 2|Adverse Event|0
5087859|NCT02059291|17566414|P18|Epoch 2|Adverse Event|0
5087860|NCT02059291|17566415|P17|Epoch 2|Adverse Event|0
5087861|NCT02059291|17566416|P16|Epoch 2|Adverse Event|0
5087862|NCT02059291|17566417|P15|Epoch 2|Adverse Event|0
5087863|NCT02059291|17566418|P14|Epoch 2|Adverse Event|0
5087864|NCT02059291|17566419|P13|Epoch 2|Adverse Event|0
5087865|NCT02059291|17566420|P12|Epoch 2|Adverse Event|0
5087866|NCT02059291|17566421|P11|Epoch 2|Adverse Event|0
5087867|NCT02059291|17566422|P10|Epoch 2|Adverse Event|0
5087868|NCT02059291|17566423|P9|Epoch 2|Adverse Event|1
5087869|NCT02059291|17566424|P8|Epoch 2|Adverse Event|1
5087870|NCT02059291|17566425|P7|Epoch 2|Adverse Event|0
5087871|NCT02059291|17566426|P6|Epoch 2|Adverse Event|0
5087872|NCT02059291|17566427|P5|Epoch 2|Adverse Event|0
5087873|NCT02059291|17566428|P4|Epoch 2|Adverse Event|1
5087874|NCT02059291|17566429|P3|Epoch 2|Adverse Event|1
5087875|NCT02059291|17566430|P2|Epoch 2|Adverse Event|0
5087876|NCT02059291|17566431|P1|Epoch 2|Adverse Event|0
5087877|NCT02059291|17566407|P25|Epoch 2|Lack of Efficacy|0
5087878|NCT02059291|17566408|P24|Epoch 2|Lack of Efficacy|0
5087879|NCT02059291|17566409|P23|Epoch 2|Lack of Efficacy|0
5087880|NCT02059291|17566410|P22|Epoch 2|Lack of Efficacy|0
5087881|NCT02059291|17566411|P21|Epoch 2|Lack of Efficacy|0
5087882|NCT02059291|17566412|P20|Epoch 2|Lack of Efficacy|0
5087883|NCT02059291|17566413|P19|Epoch 2|Lack of Efficacy|0
5087884|NCT02059291|17566414|P18|Epoch 2|Lack of Efficacy|0
5087885|NCT02059291|17566415|P17|Epoch 2|Lack of Efficacy|0
5087886|NCT02059291|17566416|P16|Epoch 2|Lack of Efficacy|0
5087887|NCT02059291|17566417|P15|Epoch 2|Lack of Efficacy|0
5087888|NCT02059291|17566418|P14|Epoch 2|Lack of Efficacy|0
5087889|NCT02059291|17566419|P13|Epoch 2|Lack of Efficacy|0
5087890|NCT02059291|17566420|P12|Epoch 2|Lack of Efficacy|0
5087891|NCT02059291|17566421|P11|Epoch 2|Lack of Efficacy|0
5087892|NCT02059291|17566422|P10|Epoch 2|Lack of Efficacy|0
5087893|NCT02059291|17566423|P9|Epoch 2|Lack of Efficacy|0
5087894|NCT02059291|17566424|P8|Epoch 2|Lack of Efficacy|0
5087895|NCT02059291|17566425|P7|Epoch 2|Lack of Efficacy|0
5087896|NCT02059291|17566426|P6|Epoch 2|Lack of Efficacy|1
5087897|NCT02059291|17566427|P5|Epoch 2|Lack of Efficacy|0
5087898|NCT02059291|17566428|P4|Epoch 2|Lack of Efficacy|1
5087899|NCT02059291|17566429|P3|Epoch 2|Lack of Efficacy|0
5087900|NCT02059291|17566430|P2|Epoch 2|Lack of Efficacy|0
5087901|NCT02059291|17566431|P1|Epoch 2|Lack of Efficacy|0
5087902|NCT02059278|17566485|P2|Overall Study|Ran out of IP and decided to discontinue|0
5087903|NCT02059278|17566486|P1|Overall Study|Ran out of IP and decided to discontinue|1
5087904|NCT02059278|17566485|P2|Overall Study|Withdrawal by Subject|3
5087905|NCT02059278|17566486|P1|Overall Study|Withdrawal by Subject|0
5087906|NCT02059278|17566485|P2|Overall Study|Lost to Follow-up|0
5087907|NCT02059278|17566486|P1|Overall Study|Lost to Follow-up|1
5087908|NCT02059278|17566485|P2|Overall Study|Adverse Event|1
5087909|NCT02059278|17566486|P1|Overall Study|Adverse Event|1
5087910|NCT02059265|17566500|P1|Overall Study|Ineligible|4
5087911|NCT02059187|17566532|P2|Overall Study|Withdrawal by Subject|8
5087912|NCT02059187|17566533|P1|Overall Study|Withdrawal by Subject|12
5087913|NCT02059187|17566532|P2|Overall Study|Protocol Violation|0
5087914|NCT02059187|17566533|P1|Overall Study|Protocol Violation|1
5087915|NCT02059187|17566532|P2|Overall Study|Physician Decision|2
5087916|NCT02059187|17566533|P1|Overall Study|Physician Decision|1
5087917|NCT02059187|17566532|P2|Overall Study|Non-compliance with study drug|0
5087918|NCT02059187|17566533|P1|Overall Study|Non-compliance with study drug|1
5087919|NCT02059187|17566532|P2|Overall Study|Lost to Follow-up|8
5087920|NCT02059187|17566533|P1|Overall Study|Lost to Follow-up|9
5087921|NCT02059187|17566532|P2|Overall Study|Death|1
5087922|NCT02059187|17566533|P1|Overall Study|Death|1
5087923|NCT02059187|17566532|P2|Overall Study|Adverse Event|3
5087924|NCT02059187|17566533|P1|Overall Study|Adverse Event|0
5087925|NCT02059174|17566559|P2|Period 3|Physician Decision|0
5087926|NCT02059174|17566560|P1|Period 3|Physician Decision|1
5087927|NCT02059174|17566559|P2|Period 2|Protocol Violation|0
5087928|NCT02059174|17566560|P1|Period 2|Protocol Violation|1
5087929|NCT02059174|17566559|P2|Period 2|Withdrawal by Subject|2
5087930|NCT02059174|17566560|P1|Period 2|Withdrawal by Subject|0
5087931|NCT02059174|17566559|P2|Period 1|Withdrawal by Subject|2
5087932|NCT02059174|17566560|P1|Period 1|Withdrawal by Subject|0
5087933|NCT02059161|17566584|P2|Overall Study|Non-compliance with study drug|2
5087934|NCT02059161|17566585|P1|Overall Study|Non-compliance with study drug|6
5087935|NCT02059161|17566584|P2|Overall Study|Randomized in error, no study drug|1
5087936|NCT02059161|17566585|P1|Overall Study|Randomized in error, no study drug|0
5087937|NCT02059161|17566584|P2|Overall Study|Withdrawal by Subject|13
5087938|NCT02059161|17566585|P1|Overall Study|Withdrawal by Subject|16
5087939|NCT02059161|17566584|P2|Overall Study|Protocol Violation|1
5087940|NCT02059161|17566585|P1|Overall Study|Protocol Violation|1
5087941|NCT02059161|17566584|P2|Overall Study|Physician Decision|4
5087942|NCT02059161|17566585|P1|Overall Study|Physician Decision|4
5087943|NCT02059161|17566584|P2|Overall Study|Lost to Follow-up|12
5087944|NCT02059161|17566585|P1|Overall Study|Lost to Follow-up|20
5087945|NCT02059161|17566584|P2|Overall Study|Adverse Event|6
5087946|NCT02059161|17566585|P1|Overall Study|Adverse Event|2
5087947|NCT02059161|17566584|P2|Overall Study|Pregnancy|2
5087948|NCT02059161|17566585|P1|Overall Study|Pregnancy|0
5087949|NCT02059148|17566645|P6|Treatment 1|Protocol Violation|1
5087950|NCT02059148|17566646|P5|Treatment 1|Protocol Violation|0
5087951|NCT02059148|17566647|P4|Treatment 1|Protocol Violation|0
5087952|NCT02059148|17566648|P3|Treatment 1|Protocol Violation|0
5087953|NCT02059148|17566649|P2|Treatment 1|Protocol Violation|0
5087954|NCT02059148|17566650|P1|Treatment 1|Protocol Violation|0
5087955|NCT02059135|17566669|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
5087956|NCT02059135|17566670|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
5087957|NCT02059135|17566669|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
5087958|NCT02059135|17566670|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
5087959|NCT02059135|17566669|P2|Neonatal Follow-up (Safety Population)|Death|2
5087960|NCT02059135|17566670|P1|Neonatal Follow-up (Safety Population)|Death|3
5087961|NCT02059135|17566669|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
5087962|NCT02059135|17566670|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
5087963|NCT02059135|17566669|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
5087964|NCT02059135|17566670|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
5087965|NCT02059135|17566669|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
5087966|NCT02059135|17566670|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
5087967|NCT02059135|17566669|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
5087968|NCT02059135|17566670|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
5087969|NCT02059135|17566669|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
5087970|NCT02059135|17566670|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
5087971|NCT02059005|17566706|P2|Overall Study|Inpatient|1
5087972|NCT02059005|17566707|P1|Overall Study|Inpatient|0
5087973|NCT02059005|17566706|P2|Overall Study|Incarceration|1
5087974|NCT02059005|17566707|P1|Overall Study|Incarceration|0
5087975|NCT02059005|17566706|P2|Overall Study|Lost to Follow-up|19
5087976|NCT02059005|17566707|P1|Overall Study|Lost to Follow-up|19
5087977|NCT02059005|17566706|P2|Overall Study|Death|3
5087978|NCT02059005|17566707|P1|Overall Study|Death|1
5087979|NCT02058992|17566717|P1|Overall Study|CRF Uncollected|20
5087980|NCT02058992|17566717|P1|Overall Study|Protocol Violation|92
5087981|NCT02058992|17566717|P1|Overall Study|Lost to Follow-up|4
5087982|NCT02058966|17566726|P1|First Intervention|Withdrawal by Subject|1
5087983|NCT02058966|17566726|P1|Open-Label Methamphetamine|Adverse Event|1
5087984|NCT02058940|17566753|P1|Overall Study|Discharged from Critical Care Unit|1
5087985|NCT02058849|17566777|P2|Overall Study|Withdrawal by Subject|0
5087986|NCT02058849|17566778|P1|Overall Study|Withdrawal by Subject|4
5087987|NCT02058849|17566777|P2|Overall Study|Lost to Follow-up|0
5087988|NCT02058849|17566778|P1|Overall Study|Lost to Follow-up|1
5087989|NCT02058849|17566777|P2|Overall Study|Death|0
5087990|NCT02058849|17566778|P1|Overall Study|Death|1
5087991|NCT02058849|17566777|P2|Overall Study|Hospitalization|1
5087992|NCT02058849|17566778|P1|Overall Study|Hospitalization|1
5087993|NCT02058836|17566806|P2|Overall Study|Withdrawal by Subject|1
5087994|NCT02058836|17566807|P1|Overall Study|Withdrawal by Subject|1
5087995|NCT02058628|17566837|P2|Overall Study|Non compliance|0
5087996|NCT02058628|17566838|P1|Overall Study|Non compliance|1
5087997|NCT02058628|17566837|P2|Overall Study|A lot of time for study for participant|0
5087998|NCT02058628|17566838|P1|Overall Study|A lot of time for study for participant|1
5087999|NCT02058628|17566837|P2|Overall Study|The visit date was not in timeline|1
5088000|NCT02058628|17566838|P1|Overall Study|The visit date was not in timeline|0
5088001|NCT02058628|17566837|P2|Overall Study|Not in time schedule|1
5088002|NCT02058628|17566838|P1|Overall Study|Not in time schedule|0
5088003|NCT02058628|17566837|P2|Overall Study|Lost to Follow-up|4
5088004|NCT02058628|17566838|P1|Overall Study|Lost to Follow-up|2
5088005|NCT02058628|17566837|P2|Overall Study|Withdrawal by Subject|2
5088006|NCT02058628|17566838|P1|Overall Study|Withdrawal by Subject|2
5088007|NCT02058628|17566837|P2|Overall Study|Adverse Event|0
5088008|NCT02058628|17566838|P1|Overall Study|Adverse Event|1
5088009|NCT02058589|17566870|P2|Overall Study|Withdrawal by Subject|1
5088010|NCT02058589|17566871|P1|Overall Study|Withdrawal by Subject|0
5088011|NCT02058589|17566870|P2|Overall Study|Non-Serious Adverse Event|0
5088012|NCT02058589|17566871|P1|Overall Study|Non-Serious Adverse Event|1
5088013|NCT02058589|17566870|P2|Overall Study|Serious Adverse Event|1
5088014|NCT02058589|17566871|P1|Overall Study|Serious Adverse Event|1
5088015|NCT02058563|17566913|P2|Overall Study|Other (patient incarcerated)|1
5088016|NCT02058563|17566914|P1|Overall Study|Other (patient incarcerated)|0
5088017|NCT02058563|17566913|P2|Overall Study|Consent Withdrawal|1
5088018|NCT02058563|17566914|P1|Overall Study|Consent Withdrawal|1
5088019|NCT02058563|17566913|P2|Overall Study|Other (vaccinated later as new subject)|0
5088020|NCT02058563|17566914|P1|Overall Study|Other (vaccinated later as new subject)|1
5088021|NCT02058563|17566913|P2|Overall Study|Lost to Follow-up|22
5088022|NCT02058563|17566914|P1|Overall Study|Lost to Follow-up|26
5088023|NCT02058537|17566950|P1|Overall Study|Withdrawal by Subject|1
5088024|NCT02058498|17566961|P1|Overall Study|Withdrawal by Subject|4
5088025|NCT02058368|17566969|P2|Overall Study|Withdrawal by Subject|26
5088026|NCT02058368|17566970|P1|Overall Study|Withdrawal by Subject|22
5088027|NCT02058368|17566969|P2|Overall Study|Physician Decision|3
5088028|NCT02058368|17566970|P1|Overall Study|Physician Decision|2
5088029|NCT02058368|17566969|P2|Overall Study|Lost to Follow-up|0
5088030|NCT02058368|17566970|P1|Overall Study|Lost to Follow-up|2
5088031|NCT02058368|17566969|P2|Overall Study|Protocol Violation|4
5088032|NCT02058368|17566970|P1|Overall Study|Protocol Violation|0
5088033|NCT02058368|17566969|P2|Overall Study|Lack of Efficacy|1
5088034|NCT02058368|17566970|P1|Overall Study|Lack of Efficacy|0
5088035|NCT02058368|17566969|P2|Overall Study|Adverse Event|20
5088036|NCT02058368|17566970|P1|Overall Study|Adverse Event|15
5088037|NCT02058290|17567022|P2|Overall Study|Withdrawal by Subject|1
5088038|NCT02058290|17567023|P1|Overall Study|Withdrawal by Subject|0
5088039|NCT02058290|17567022|P2|Overall Study|Didn't meet intraoperative criteria|7
5088040|NCT02058290|17567023|P1|Overall Study|Didn't meet intraoperative criteria|8
5088041|NCT02058290|17567022|P2|Overall Study|Physician Decision|0
5088042|NCT02058290|17567023|P1|Overall Study|Physician Decision|1
5088043|NCT02058290|17567022|P2|Overall Study|Protocol Violation|1
5088044|NCT02058290|17567023|P1|Overall Study|Protocol Violation|2
5088045|NCT02058160|17567050|P2|Overall Study|Other than specified above|6
5088046|NCT02058160|17567051|P1|Overall Study|Other than specified above|12
5088047|NCT02058160|17567050|P2|Overall Study|Lost to Follow-up|0
5088048|NCT02058160|17567051|P1|Overall Study|Lost to Follow-up|1
5088049|NCT02058160|17567050|P2|Overall Study|Adverse Event|3
5088050|NCT02058160|17567051|P1|Overall Study|Adverse Event|12
5088051|NCT02058160|17567050|P2|Overall Study|Poor compliance to protocol|1
5088052|NCT02058160|17567051|P1|Overall Study|Poor compliance to protocol|4
5088053|NCT02058160|17567050|P2|Overall Study|Randomized but not treated|4
5088054|NCT02058160|17567051|P1|Overall Study|Randomized but not treated|2
5088055|NCT02058147|17567088|P3|Overall Study|Other than specified|0
5088056|NCT02058147|17567089|P2|Overall Study|Other than specified|9
5088057|NCT02058147|17567090|P1|Overall Study|Other than specified|8
5088058|NCT02058147|17567088|P3|Overall Study|Poor compliance to protocol|4
5088059|NCT02058147|17567089|P2|Overall Study|Poor compliance to protocol|9
5088060|NCT02058147|17567090|P1|Overall Study|Poor compliance to protocol|8
5088061|NCT02058147|17567088|P3|Overall Study|Lack of Efficacy|3
5088062|NCT02058147|17567089|P2|Overall Study|Lack of Efficacy|0
5088063|NCT02058147|17567090|P1|Overall Study|Lack of Efficacy|1
5088064|NCT02058147|17567088|P3|Overall Study|Adverse Event|21
5088065|NCT02058147|17567089|P2|Overall Study|Adverse Event|9
5088066|NCT02058147|17567090|P1|Overall Study|Adverse Event|12
5088067|NCT02058147|17567088|P3|Overall Study|Randomized but not treated|1
5088068|NCT02058147|17567089|P2|Overall Study|Randomized but not treated|0
5088069|NCT02058147|17567090|P1|Overall Study|Randomized but not treated|0
5088070|NCT02058108|17567141|P2|Overall Study|Protocol Violation|1
5088071|NCT02058108|17567142|P1|Overall Study|Protocol Violation|0
5088072|NCT02058108|17567141|P2|Overall Study|Administrative problems|3
5088073|NCT02058108|17567142|P1|Overall Study|Administrative problems|3
5088074|NCT02058108|17567141|P2|Overall Study|Withdrawal by Subject|0
5088075|NCT02058108|17567142|P1|Overall Study|Withdrawal by Subject|1
5088076|NCT02058108|17567141|P2|Overall Study|No longer requires study drug|1
5088077|NCT02058108|17567142|P1|Overall Study|No longer requires study drug|0
5088078|NCT02058108|17567141|P2|Overall Study|Unsatisfactory therapeutic effect|4
5088079|NCT02058108|17567142|P1|Overall Study|Unsatisfactory therapeutic effect|37
5088080|NCT02058108|17567141|P2|Overall Study|Abnormal Laboratory Values|1
5088081|NCT02058108|17567142|P1|Overall Study|Abnormal Laboratory Values|0
5088082|NCT02058095|17567168|P2|Overall Study|Adverse Event|0
5088083|NCT02058095|17567169|P1|Overall Study|Adverse Event|1
5088084|NCT02058069|17567179|P1|Overall Study|Withdrawal by Subject|6
5088085|NCT02058069|17567179|P1|Overall Study|Exclusion due to implant size|5
5088086|NCT02057874|17567238|P1|Overall Study|participant did not return for scan|1
5088087|NCT02057835|17567256|P10|Overall Study|Withdrawal by Subject|0
5088088|NCT02057835|17567257|P9|Overall Study|Withdrawal by Subject|0
5088089|NCT02057835|17567258|P8|Overall Study|Withdrawal by Subject|0
5088090|NCT02057835|17567259|P7|Overall Study|Withdrawal by Subject|0
5088091|NCT02057835|17567260|P6|Overall Study|Withdrawal by Subject|0
5088092|NCT02057835|17567261|P5|Overall Study|Withdrawal by Subject|0
5088093|NCT02057835|17567262|P4|Overall Study|Withdrawal by Subject|0
5088094|NCT02057835|17567263|P3|Overall Study|Withdrawal by Subject|0
5088095|NCT02057835|17567264|P2|Overall Study|Withdrawal by Subject|2
5088096|NCT02057835|17567265|P1|Overall Study|Withdrawal by Subject|0
5088097|NCT02057757|17567344|P2|Overall Study|Non-compliance|0
5088098|NCT02057757|17567345|P1|Overall Study|Non-compliance|1
5088099|NCT02057757|17567344|P2|Overall Study|Lost to Follow-up|3
5088100|NCT02057757|17567345|P1|Overall Study|Lost to Follow-up|8
5088101|NCT02057757|17567344|P2|Overall Study|Death|0
5088102|NCT02057757|17567345|P1|Overall Study|Death|2
5088103|NCT02057757|17567344|P2|Overall Study|Withdrawal by Subject|5
5088104|NCT02057757|17567345|P1|Overall Study|Withdrawal by Subject|3
5088105|NCT02057692|17567399|P4|Overall Study|Lost to Follow-up|1
5088106|NCT02057692|17567400|P3|Overall Study|Lost to Follow-up|0
5088107|NCT02057692|17567401|P2|Overall Study|Lost to Follow-up|0
5088108|NCT02057692|17567402|P1|Overall Study|Lost to Follow-up|0
5088109|NCT02057692|17567399|P4|Overall Study|Adverse Event|0
5088110|NCT02057692|17567400|P3|Overall Study|Adverse Event|0
5088111|NCT02057692|17567401|P2|Overall Study|Adverse Event|0
5088112|NCT02057692|17567402|P1|Overall Study|Adverse Event|1
5088113|NCT02057575|17567448|P4|Overall Study|Protocol Violation|0
5088114|NCT02057575|17567449|P3|Overall Study|Protocol Violation|0
5088115|NCT02057575|17567450|P2|Overall Study|Protocol Violation|1
5088116|NCT02057575|17567451|P1|Overall Study|Protocol Violation|0
5088117|NCT02057575|17567448|P4|Overall Study|Dissallowed Concurrent Medication|0
5088118|NCT02057575|17567449|P3|Overall Study|Dissallowed Concurrent Medication|0
5088119|NCT02057575|17567450|P2|Overall Study|Dissallowed Concurrent Medication|1
5088120|NCT02057575|17567451|P1|Overall Study|Dissallowed Concurrent Medication|0
5088121|NCT02057575|17567448|P4|Overall Study|Withdrawal by Subject|0
5088122|NCT02057575|17567449|P3|Overall Study|Withdrawal by Subject|0
5088123|NCT02057575|17567450|P2|Overall Study|Withdrawal by Subject|0
5088124|NCT02057575|17567451|P1|Overall Study|Withdrawal by Subject|1
5088125|NCT02057575|17567448|P4|Overall Study|Adverse Event|1
5088126|NCT02057575|17567449|P3|Overall Study|Adverse Event|0
5088127|NCT02057575|17567450|P2|Overall Study|Adverse Event|2
5088128|NCT02057575|17567451|P1|Overall Study|Adverse Event|0
5088129|NCT02057549|17567463|P2|Overall Study|Withdrawal by Subject|0
5088130|NCT02057549|17567464|P1|Overall Study|Withdrawal by Subject|1
5088131|NCT02057549|17567463|P2|Overall Study|Physician Decision|0
5088132|NCT02057549|17567464|P1|Overall Study|Physician Decision|1
5088133|NCT02057549|17567463|P2|Overall Study|Lost to Follow-up|0
5088134|NCT02057549|17567464|P1|Overall Study|Lost to Follow-up|1
5088135|NCT02057523|17567484|P1|Overall Study|Lack of Efficacy|1
5088136|NCT02057523|17567484|P1|Overall Study|Withdrawal by Subject|1
5088137|NCT02057458|17567489|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
5088138|NCT02057458|17567490|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
5088139|NCT02057458|17567491|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
5088140|NCT02057458|17567489|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
5088141|NCT02057458|17567490|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
5088142|NCT02057458|17567491|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
5088143|NCT02057458|17567489|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
5088144|NCT02057458|17567490|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
5088145|NCT02057458|17567491|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
5088146|NCT02057406|17567529|P3|Overall Study|Patient transportation issues|1
5088147|NCT02057406|17567530|P2|Overall Study|Patient transportation issues|0
5088148|NCT02057406|17567531|P1|Overall Study|Patient transportation issues|0
5088149|NCT02057406|17567529|P3|Overall Study|Protocol Violation|0
5088150|NCT02057406|17567530|P2|Overall Study|Protocol Violation|1
5088151|NCT02057406|17567531|P1|Overall Study|Protocol Violation|0
5088152|NCT02057406|17567529|P3|Overall Study|Death|0
5088153|NCT02057406|17567530|P2|Overall Study|Death|0
5088154|NCT02057406|17567531|P1|Overall Study|Death|1
5088155|NCT02057406|17567529|P3|Overall Study|Lost to Follow-up|1
5088156|NCT02057406|17567530|P2|Overall Study|Lost to Follow-up|0
5088157|NCT02057406|17567531|P1|Overall Study|Lost to Follow-up|0
5088158|NCT02057406|17567529|P3|Overall Study|Withdrawal by Subject|0
5088159|NCT02057406|17567530|P2|Overall Study|Withdrawal by Subject|2
5088160|NCT02057406|17567531|P1|Overall Study|Withdrawal by Subject|0
5088161|NCT02057406|17567529|P3|Overall Study|Physician Decision|2
5088162|NCT02057406|17567530|P2|Overall Study|Physician Decision|0
5088163|NCT02057406|17567531|P1|Overall Study|Physician Decision|0
5088164|NCT02057393|17567542|P1|Overall Study|Patient did not meet criteria|1
5088165|NCT02057393|17567542|P1|Overall Study|Withdrawal by Subject|1
5088166|NCT02057250|17567563|P5|Extension Phase|Other than specified above|7
5088167|NCT02057250|17567564|P4|Extension Phase|Other than specified above|0
5088168|NCT02057250|17567565|P3|Extension Phase|Other than specified above|0
5088169|NCT02057250|17567566|P2|Extension Phase|Other than specified above|0
5088170|NCT02057250|17567567|P1|Extension Phase|Other than specified above|0
5088171|NCT02057250|17567563|P5|Extension Phase|Entered in this period but not treated|4
5088172|NCT02057250|17567564|P4|Extension Phase|Entered in this period but not treated|0
5088173|NCT02057250|17567565|P3|Extension Phase|Entered in this period but not treated|0
5088174|NCT02057250|17567566|P2|Extension Phase|Entered in this period but not treated|0
5088175|NCT02057250|17567567|P1|Extension Phase|Entered in this period but not treated|0
5088176|NCT02057250|17567563|P5|Extension Phase|Lack of Efficacy|10
5088177|NCT02057250|17567564|P4|Extension Phase|Lack of Efficacy|0
5088178|NCT02057250|17567565|P3|Extension Phase|Lack of Efficacy|0
5088179|NCT02057250|17567566|P2|Extension Phase|Lack of Efficacy|0
5088180|NCT02057250|17567567|P1|Extension Phase|Lack of Efficacy|0
5088181|NCT02057250|17567563|P5|Extension Phase|Adverse Event|15
5088182|NCT02057250|17567564|P4|Extension Phase|Adverse Event|0
5088183|NCT02057250|17567565|P3|Extension Phase|Adverse Event|0
5088184|NCT02057250|17567566|P2|Extension Phase|Adverse Event|0
5088185|NCT02057250|17567567|P1|Extension Phase|Adverse Event|0
5088186|NCT02057250|17567563|P5|AID Assessment Phase|Other than specified above|0
5088187|NCT02057250|17567564|P4|AID Assessment Phase|Other than specified above|1
5088188|NCT02057250|17567565|P3|AID Assessment Phase|Other than specified above|1
5088189|NCT02057250|17567566|P2|AID Assessment Phase|Other than specified above|1
5088190|NCT02057250|17567567|P1|AID Assessment Phase|Other than specified above|1
5088191|NCT02057250|17567563|P5|AID Assessment Phase|Adverse Event|0
5088192|NCT02057250|17567564|P4|AID Assessment Phase|Adverse Event|1
5088193|NCT02057250|17567565|P3|AID Assessment Phase|Adverse Event|6
5088194|NCT02057250|17567566|P2|AID Assessment Phase|Adverse Event|2
5088195|NCT02057250|17567567|P1|AID Assessment Phase|Adverse Event|3
5088196|NCT02057198|17567588|P3|Overall Study|Discharged early; lost to followup|0
5088197|NCT02057198|17567589|P2|Overall Study|Discharged early; lost to followup|1
5088198|NCT02057198|17567590|P1|Overall Study|Discharged early; lost to followup|0
5088199|NCT02057198|17567588|P3|Overall Study|Death|1
5088200|NCT02057198|17567589|P2|Overall Study|Death|0
5088201|NCT02057198|17567590|P1|Overall Study|Death|0
5088202|NCT02057068|17567626|P2|Overall Study|Lost to Follow-up|2
5088203|NCT02057068|17567627|P1|Overall Study|Lost to Follow-up|2
5088204|NCT02057068|17567626|P2|Overall Study|Carepartner (CP) Health|2
5088205|NCT02057068|17567627|P1|Overall Study|Carepartner (CP) Health|4
5088206|NCT02057068|17567626|P2|Overall Study|Caregiver (CG) Health|2
5088207|NCT02057068|17567627|P1|Overall Study|Caregiver (CG) Health|0
5088208|NCT02057068|17567626|P2|Overall Study|Withdrawal by Subject|2
5088209|NCT02057068|17567627|P1|Overall Study|Withdrawal by Subject|2
5088210|NCT02056834|17567656|P1|Overall Study|Lost to Follow-up|7
5088211|NCT02056652|17567677|P2|Overall Study|Lost to Follow-up|3
5088212|NCT02056652|17567678|P1|Overall Study|Lost to Follow-up|0
5088213|NCT02056652|17567677|P2|Overall Study|Withdrawal by Subject|0
5088214|NCT02056652|17567678|P1|Overall Study|Withdrawal by Subject|1
5088215|NCT02056626|17567715|P4|Overall Study|patient did not follow directions|0
5088216|NCT02056626|17567716|P3|Overall Study|patient did not follow directions|0
5088217|NCT02056626|17567717|P2|Overall Study|patient did not follow directions|1
5088218|NCT02056626|17567718|P1|Overall Study|patient did not follow directions|3
5088219|NCT02056392|17567753|P6|Overall Study|Withdrawal by Subject|0
5088220|NCT02056392|17567754|P5|Overall Study|Withdrawal by Subject|1
5088221|NCT02056392|17567755|P4|Overall Study|Withdrawal by Subject|0
5088222|NCT02056392|17567756|P3|Overall Study|Withdrawal by Subject|0
5088223|NCT02056392|17567757|P2|Overall Study|Withdrawal by Subject|0
5088224|NCT02056392|17567758|P1|Overall Study|Withdrawal by Subject|1
5088225|NCT02056392|17567753|P6|Overall Study|Protocol Violation|0
5088226|NCT02056392|17567754|P5|Overall Study|Protocol Violation|0
5088227|NCT02056392|17567755|P4|Overall Study|Protocol Violation|0
5088228|NCT02056392|17567756|P3|Overall Study|Protocol Violation|1
5088229|NCT02056392|17567757|P2|Overall Study|Protocol Violation|0
5088230|NCT02056392|17567758|P1|Overall Study|Protocol Violation|1
5088231|NCT02056392|17567753|P6|Overall Study|Lost to Follow-up|0
5088232|NCT02056392|17567754|P5|Overall Study|Lost to Follow-up|0
5088233|NCT02056392|17567755|P4|Overall Study|Lost to Follow-up|0
5088234|NCT02056392|17567756|P3|Overall Study|Lost to Follow-up|2
5088235|NCT02056392|17567757|P2|Overall Study|Lost to Follow-up|1
5088236|NCT02056392|17567758|P1|Overall Study|Lost to Follow-up|0
5088237|NCT02056340|17567795|P2|Overall Study|Withdrawal by Subject|6
5088238|NCT02056340|17567796|P1|Overall Study|Withdrawal by Subject|2
5088239|NCT02056340|17567795|P2|Overall Study|Lost to Follow-up|5
5088240|NCT02056340|17567796|P1|Overall Study|Lost to Follow-up|5
5088241|NCT02056301|17567806|P2|Overall Study|Issues with epidural|3
5088242|NCT02056301|17567807|P1|Overall Study|Issues with epidural|0
5088243|NCT02056301|17567806|P2|Overall Study|Withdrawal by Subject|1
5088244|NCT02056301|17567807|P1|Overall Study|Withdrawal by Subject|0
5088245|NCT02056301|17567806|P2|Overall Study|Surgical complications req. 2nd surgery|0
5088246|NCT02056301|17567807|P1|Overall Study|Surgical complications req. 2nd surgery|1
5088247|NCT02056301|17567806|P2|Overall Study|Protocol Violation|2
5088248|NCT02056301|17567807|P1|Overall Study|Protocol Violation|1
5088249|NCT02055976|17567839|P9|Overall Study|Lost to Follow-up|0
5088250|NCT02055976|17567840|P8|Overall Study|Lost to Follow-up|0
5088251|NCT02055976|17567841|P7|Overall Study|Lost to Follow-up|0
5088252|NCT02055976|17567842|P6|Overall Study|Lost to Follow-up|0
5088253|NCT02055976|17567843|P5|Overall Study|Lost to Follow-up|0
5088254|NCT02055976|17567844|P4|Overall Study|Lost to Follow-up|1
5088255|NCT02055976|17567845|P3|Overall Study|Lost to Follow-up|0
5088256|NCT02055976|17567846|P2|Overall Study|Lost to Follow-up|0
5088257|NCT02055976|17567847|P1|Overall Study|Lost to Follow-up|0
5088258|NCT02055976|17567839|P9|Overall Study|Does not meet entrance criteria|0
5088259|NCT02055976|17567840|P8|Overall Study|Does not meet entrance criteria|0
5088260|NCT02055976|17567841|P7|Overall Study|Does not meet entrance criteria|1
5088261|NCT02055976|17567842|P6|Overall Study|Does not meet entrance criteria|0
5088262|NCT02055976|17567843|P5|Overall Study|Does not meet entrance criteria|0
5088263|NCT02055976|17567844|P4|Overall Study|Does not meet entrance criteria|0
5088264|NCT02055976|17567845|P3|Overall Study|Does not meet entrance criteria|0
5088265|NCT02055976|17567846|P2|Overall Study|Does not meet entrance criteria|0
5088266|NCT02055976|17567847|P1|Overall Study|Does not meet entrance criteria|0
5088267|NCT02055976|17567839|P9|Overall Study|Adverse Event|0
5088268|NCT02055976|17567840|P8|Overall Study|Adverse Event|0
5088269|NCT02055976|17567841|P7|Overall Study|Adverse Event|1
5088270|NCT02055976|17567842|P6|Overall Study|Adverse Event|1
5088271|NCT02055976|17567843|P5|Overall Study|Adverse Event|0
5088272|NCT02055976|17567844|P4|Overall Study|Adverse Event|0
5088273|NCT02055976|17567845|P3|Overall Study|Adverse Event|0
5088274|NCT02055976|17567846|P2|Overall Study|Adverse Event|0
5088275|NCT02055976|17567847|P1|Overall Study|Adverse Event|0
5088276|NCT02055976|17567839|P9|Overall Study|Other|0
5088277|NCT02055976|17567840|P8|Overall Study|Other|0
5088278|NCT02055976|17567841|P7|Overall Study|Other|0
5088279|NCT02055976|17567842|P6|Overall Study|Other|0
5088280|NCT02055976|17567843|P5|Overall Study|Other|0
5088281|NCT02055976|17567844|P4|Overall Study|Other|0
5088282|NCT02055976|17567845|P3|Overall Study|Other|1
5088283|NCT02055976|17567846|P2|Overall Study|Other|0
5088284|NCT02055976|17567847|P1|Overall Study|Other|0
5088285|NCT02055898|17568268|P2|First Intervention (5 Days)|Withdrawal by Subject|1
5088286|NCT02055898|17568269|P1|First Intervention (5 Days)|Withdrawal by Subject|0
5088287|NCT02055898|17568268|P2|First Intervention (5 Days)|Physician Decision|0
5088288|NCT02055898|17568269|P1|First Intervention (5 Days)|Physician Decision|2
5088289|NCT02055820|17568291|P10|Phase II: Expansion|Withdrawal by Subject|0
5088290|NCT02055820|17568292|P9|Phase II: Expansion|Withdrawal by Subject|0
5088291|NCT02055820|17568293|P8|Phase II: Expansion|Withdrawal by Subject|0
5088292|NCT02055820|17568294|P7|Phase II: Expansion|Withdrawal by Subject|0
5088293|NCT02055820|17568295|P6|Phase II: Expansion|Withdrawal by Subject|0
5088294|NCT02055820|17568296|P5|Phase II: Expansion|Withdrawal by Subject|12
5088295|NCT02055820|17568297|P4|Phase II: Expansion|Withdrawal by Subject|0
5088296|NCT02055820|17568298|P3|Phase II: Expansion|Withdrawal by Subject|0
5088297|NCT02055820|17568299|P2|Phase II: Expansion|Withdrawal by Subject|0
5088298|NCT02055820|17568300|P1|Phase II: Expansion|Withdrawal by Subject|0
5088299|NCT02055820|17568291|P10|Phase II: Expansion|Lost to Follow-up|0
5088300|NCT02055820|17568292|P9|Phase II: Expansion|Lost to Follow-up|0
5088301|NCT02055820|17568293|P8|Phase II: Expansion|Lost to Follow-up|0
5088302|NCT02055820|17568294|P7|Phase II: Expansion|Lost to Follow-up|0
5088303|NCT02055820|17568295|P6|Phase II: Expansion|Lost to Follow-up|0
5088304|NCT02055820|17568296|P5|Phase II: Expansion|Lost to Follow-up|4
5088305|NCT02055820|17568297|P4|Phase II: Expansion|Lost to Follow-up|0
5088306|NCT02055820|17568298|P3|Phase II: Expansion|Lost to Follow-up|0
5088307|NCT02055820|17568299|P2|Phase II: Expansion|Lost to Follow-up|0
5088308|NCT02055820|17568300|P1|Phase II: Expansion|Lost to Follow-up|0
5088309|NCT02055820|17568291|P10|Phase II: Expansion|Death|0
5088310|NCT02055820|17568292|P9|Phase II: Expansion|Death|0
5088311|NCT02055820|17568293|P8|Phase II: Expansion|Death|0
5088312|NCT02055820|17568294|P7|Phase II: Expansion|Death|0
5088313|NCT02055820|17568295|P6|Phase II: Expansion|Death|0
5088314|NCT02055820|17568296|P5|Phase II: Expansion|Death|33
5088315|NCT02055820|17568297|P4|Phase II: Expansion|Death|0
5088316|NCT02055820|17568298|P3|Phase II: Expansion|Death|0
5088317|NCT02055820|17568299|P2|Phase II: Expansion|Death|0
5088318|NCT02055820|17568300|P1|Phase II: Expansion|Death|0
5088319|NCT02055820|17568291|P10|Phase I: Dose-Finding|Lost to Follow-up|0
5088320|NCT02055820|17568292|P9|Phase I: Dose-Finding|Lost to Follow-up|0
5088321|NCT02055820|17568293|P8|Phase I: Dose-Finding|Lost to Follow-up|0
5088322|NCT02055820|17568294|P7|Phase I: Dose-Finding|Lost to Follow-up|1
5088323|NCT02055820|17568295|P6|Phase I: Dose-Finding|Lost to Follow-up|0
5088324|NCT02055820|17568296|P5|Phase I: Dose-Finding|Lost to Follow-up|0
5088325|NCT02055820|17568297|P4|Phase I: Dose-Finding|Lost to Follow-up|1
5088326|NCT02055820|17568298|P3|Phase I: Dose-Finding|Lost to Follow-up|0
5088327|NCT02055820|17568299|P2|Phase I: Dose-Finding|Lost to Follow-up|0
5088328|NCT02055820|17568300|P1|Phase I: Dose-Finding|Lost to Follow-up|0
5088329|NCT02055820|17568291|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
5088330|NCT02055820|17568292|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
5088331|NCT02055820|17568293|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
5088332|NCT02055820|17568294|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
5088333|NCT02055820|17568295|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
5088334|NCT02055820|17568296|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
5088335|NCT02055820|17568297|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
5088336|NCT02055820|17568298|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
5088337|NCT02055820|17568299|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
5088338|NCT02055820|17568300|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
5088339|NCT02055820|17568291|P10|Phase I: Dose-Finding|Death|0
5088340|NCT02055820|17568292|P9|Phase I: Dose-Finding|Death|0
5088341|NCT02055820|17568293|P8|Phase I: Dose-Finding|Death|0
5088342|NCT02055820|17568294|P7|Phase I: Dose-Finding|Death|1
5088343|NCT02055820|17568295|P6|Phase I: Dose-Finding|Death|1
5088344|NCT02055820|17568296|P5|Phase I: Dose-Finding|Death|0
5088345|NCT02055820|17568297|P4|Phase I: Dose-Finding|Death|2
5088346|NCT02055820|17568298|P3|Phase I: Dose-Finding|Death|1
5088347|NCT02055820|17568299|P2|Phase I: Dose-Finding|Death|0
5088348|NCT02055820|17568300|P1|Phase I: Dose-Finding|Death|1
5088349|NCT02055547|17568411|P19|Overall Study|Lost to Follow-up|0
5088350|NCT02055547|17568412|P18|Overall Study|Lost to Follow-up|0
5088351|NCT02055547|17568413|P17|Overall Study|Lost to Follow-up|0
5088352|NCT02055547|17568414|P16|Overall Study|Lost to Follow-up|0
5088353|NCT02055547|17568415|P15|Overall Study|Lost to Follow-up|0
5088354|NCT02055547|17568416|P14|Overall Study|Lost to Follow-up|0
5088355|NCT02055547|17568417|P13|Overall Study|Lost to Follow-up|0
5088356|NCT02055547|17568418|P12|Overall Study|Lost to Follow-up|0
5088357|NCT02055547|17568419|P11|Overall Study|Lost to Follow-up|0
5088358|NCT02055547|17568420|P10|Overall Study|Lost to Follow-up|0
5088359|NCT02055547|17568421|P9|Overall Study|Lost to Follow-up|0
5088360|NCT02055547|17568422|P8|Overall Study|Lost to Follow-up|0
5088361|NCT02055547|17568423|P7|Overall Study|Lost to Follow-up|0
5088362|NCT02055547|17568424|P6|Overall Study|Lost to Follow-up|0
5088363|NCT02055547|17568425|P5|Overall Study|Lost to Follow-up|0
5088364|NCT02055547|17568426|P4|Overall Study|Lost to Follow-up|0
5088365|NCT02055547|17568427|P3|Overall Study|Lost to Follow-up|1
5088366|NCT02055547|17568428|P2|Overall Study|Lost to Follow-up|0
5088367|NCT02055547|17568429|P1|Overall Study|Lost to Follow-up|0
5088368|NCT02055547|17568411|P19|Overall Study|Withdrawal by Subject|0
5088369|NCT02055547|17568412|P18|Overall Study|Withdrawal by Subject|0
5088370|NCT02055547|17568413|P17|Overall Study|Withdrawal by Subject|0
5088371|NCT02055547|17568414|P16|Overall Study|Withdrawal by Subject|1
5088372|NCT02055547|17568415|P15|Overall Study|Withdrawal by Subject|0
5088373|NCT02055547|17568416|P14|Overall Study|Withdrawal by Subject|1
5088374|NCT02055547|17568417|P13|Overall Study|Withdrawal by Subject|0
5088375|NCT02055547|17568418|P12|Overall Study|Withdrawal by Subject|0
5088376|NCT02055547|17568419|P11|Overall Study|Withdrawal by Subject|0
5088377|NCT02055547|17568420|P10|Overall Study|Withdrawal by Subject|0
5088378|NCT02055547|17568421|P9|Overall Study|Withdrawal by Subject|1
5088379|NCT02055547|17568422|P8|Overall Study|Withdrawal by Subject|0
5088380|NCT02055547|17568423|P7|Overall Study|Withdrawal by Subject|0
5088381|NCT02055547|17568424|P6|Overall Study|Withdrawal by Subject|1
5088382|NCT02055547|17568425|P5|Overall Study|Withdrawal by Subject|0
5088383|NCT02055547|17568426|P4|Overall Study|Withdrawal by Subject|0
5088384|NCT02055547|17568427|P3|Overall Study|Withdrawal by Subject|0
5088385|NCT02055547|17568428|P2|Overall Study|Withdrawal by Subject|0
5088386|NCT02055547|17568429|P1|Overall Study|Withdrawal by Subject|0
5088387|NCT02055547|17568411|P19|Overall Study|Adverse Event|0
5088388|NCT02055547|17568412|P18|Overall Study|Adverse Event|0
5088389|NCT02055547|17568413|P17|Overall Study|Adverse Event|0
5088390|NCT02055547|17568414|P16|Overall Study|Adverse Event|0
5088391|NCT02055547|17568415|P15|Overall Study|Adverse Event|0
5088392|NCT02055547|17568416|P14|Overall Study|Adverse Event|0
5088393|NCT02055547|17568417|P13|Overall Study|Adverse Event|0
5088394|NCT02055547|17568418|P12|Overall Study|Adverse Event|0
5088395|NCT02055547|17568419|P11|Overall Study|Adverse Event|0
5088396|NCT02055547|17568420|P10|Overall Study|Adverse Event|0
5088397|NCT02055547|17568421|P9|Overall Study|Adverse Event|1
5088398|NCT02055547|17568422|P8|Overall Study|Adverse Event|0
5088399|NCT02055547|17568423|P7|Overall Study|Adverse Event|1
5088400|NCT02055547|17568424|P6|Overall Study|Adverse Event|0
5088401|NCT02055547|17568425|P5|Overall Study|Adverse Event|0
5088402|NCT02055547|17568426|P4|Overall Study|Adverse Event|0
5088403|NCT02055547|17568427|P3|Overall Study|Adverse Event|0
5088404|NCT02055547|17568428|P2|Overall Study|Adverse Event|0
5088405|NCT02055547|17568429|P1|Overall Study|Adverse Event|0
5088406|NCT02055547|17568411|P19|Overall Study|Physician Decision|0
5088407|NCT02055547|17568412|P18|Overall Study|Physician Decision|0
5088408|NCT02055547|17568413|P17|Overall Study|Physician Decision|0
5088409|NCT02055547|17568414|P16|Overall Study|Physician Decision|0
5088410|NCT02055547|17568415|P15|Overall Study|Physician Decision|0
5088411|NCT02055547|17568416|P14|Overall Study|Physician Decision|0
5088412|NCT02055547|17568417|P13|Overall Study|Physician Decision|0
5088413|NCT02055547|17568418|P12|Overall Study|Physician Decision|0
5088414|NCT02055547|17568419|P11|Overall Study|Physician Decision|1
5088415|NCT02055547|17568420|P10|Overall Study|Physician Decision|1
5088416|NCT02055547|17568421|P9|Overall Study|Physician Decision|0
5088417|NCT02055547|17568422|P8|Overall Study|Physician Decision|0
5088418|NCT02055547|17568423|P7|Overall Study|Physician Decision|0
5088419|NCT02055547|17568424|P6|Overall Study|Physician Decision|0
5088420|NCT02055547|17568425|P5|Overall Study|Physician Decision|1
5088421|NCT02055547|17568426|P4|Overall Study|Physician Decision|0
5088422|NCT02055547|17568427|P3|Overall Study|Physician Decision|1
5088423|NCT02055547|17568428|P2|Overall Study|Physician Decision|1
5088424|NCT02055547|17568429|P1|Overall Study|Physician Decision|0
5088425|NCT02055547|17568411|P19|Overall Study|Protocol Violation|0
5088426|NCT02055547|17568412|P18|Overall Study|Protocol Violation|0
5088427|NCT02055547|17568413|P17|Overall Study|Protocol Violation|0
5088428|NCT02055547|17568414|P16|Overall Study|Protocol Violation|0
5088429|NCT02055547|17568415|P15|Overall Study|Protocol Violation|0
5088430|NCT02055547|17568416|P14|Overall Study|Protocol Violation|0
5088431|NCT02055547|17568417|P13|Overall Study|Protocol Violation|0
5088432|NCT02055547|17568418|P12|Overall Study|Protocol Violation|0
5088433|NCT02055547|17568419|P11|Overall Study|Protocol Violation|0
5088434|NCT02055547|17568420|P10|Overall Study|Protocol Violation|0
5088435|NCT02055547|17568421|P9|Overall Study|Protocol Violation|0
5088436|NCT02055547|17568422|P8|Overall Study|Protocol Violation|0
5088437|NCT02055547|17568423|P7|Overall Study|Protocol Violation|1
5088438|NCT02055547|17568424|P6|Overall Study|Protocol Violation|0
5088439|NCT02055547|17568425|P5|Overall Study|Protocol Violation|0
5088440|NCT02055547|17568426|P4|Overall Study|Protocol Violation|0
5088441|NCT02055547|17568427|P3|Overall Study|Protocol Violation|1
5088442|NCT02055547|17568428|P2|Overall Study|Protocol Violation|0
5088443|NCT02055547|17568429|P1|Overall Study|Protocol Violation|0
5088444|NCT02055365|17568598|P1|Overall Study|Prematurely Withdrawn|1
5088445|NCT02055352|17568611|P2|Overall Study|Reason unknown|5
5088446|NCT02055352|17568612|P1|Overall Study|Reason unknown|1
5088447|NCT02055352|17568611|P2|Overall Study|Withdrawal of informed consent|0
5088448|NCT02055352|17568612|P1|Overall Study|Withdrawal of informed consent|1
5088449|NCT02055352|17568611|P2|Overall Study|AE, study drug would be detrimental|3
5088450|NCT02055352|17568612|P1|Overall Study|AE, study drug would be detrimental|1
5088451|NCT02055352|17568611|P2|Overall Study|Use of prohibited treatment|3
5088452|NCT02055352|17568612|P1|Overall Study|Use of prohibited treatment|0
5088453|NCT02055352|17568611|P2|Overall Study|Patient decision|1
5088454|NCT02055352|17568612|P1|Overall Study|Patient decision|1
5088455|NCT02055352|17568611|P2|Overall Study|Death|2
5088456|NCT02055352|17568612|P1|Overall Study|Death|1
5088457|NCT02055352|17568611|P2|Overall Study|Poor compliance|1
5088458|NCT02055352|17568612|P1|Overall Study|Poor compliance|1
5088459|NCT02055352|17568611|P2|Overall Study|Non-eligible|1
5088460|NCT02055352|17568612|P1|Overall Study|Non-eligible|0
5088461|NCT02055352|17568611|P2|Overall Study|Adverse Event|1
5088462|NCT02055352|17568612|P1|Overall Study|Adverse Event|0
5088463|NCT02055118|17568629|P3|Overall Study|Withdrawal by Subject|0
5088464|NCT02055118|17568630|P2|Overall Study|Withdrawal by Subject|2
5088465|NCT02055118|17568631|P1|Overall Study|Withdrawal by Subject|0
5088466|NCT02054910|17568690|P2|Overall Study|Lost to Follow-up|1
5088467|NCT02054910|17568691|P1|Overall Study|Lost to Follow-up|4
5088468|NCT02054897|17568710|P3|Overall Study|Randomized but not exposed|0
5088469|NCT02054897|17568711|P2|Overall Study|Randomized but not exposed|0
5088470|NCT02054897|17568712|P1|Overall Study|Randomized but not exposed|1
5088471|NCT02054897|17568710|P3|Overall Study|Lost to Follow-up|7
5088472|NCT02054897|17568711|P2|Overall Study|Lost to Follow-up|2
5088473|NCT02054897|17568712|P1|Overall Study|Lost to Follow-up|4
5088474|NCT02054897|17568710|P3|Overall Study|Missing follow-up information|3
5088475|NCT02054897|17568711|P2|Overall Study|Missing follow-up information|5
5088476|NCT02054897|17568712|P1|Overall Study|Missing follow-up information|3
5088477|NCT02054897|17568710|P3|Overall Study|Withdrawal by Subject|2
5088478|NCT02054897|17568711|P2|Overall Study|Withdrawal by Subject|0
5088479|NCT02054897|17568712|P1|Overall Study|Withdrawal by Subject|2
5088480|NCT02054715|17568759|P2|Follow-up 2|Treatment Change or Delay|0
5088481|NCT02054715|17568760|P1|Follow-up 2|Treatment Change or Delay|1
5088482|NCT02054715|17568759|P2|Follow-up 2|No Reason|0
5088483|NCT02054715|17568760|P1|Follow-up 2|No Reason|2
5088484|NCT02054715|17568759|P2|Follow-up 2|Changed Mind|1
5088485|NCT02054715|17568760|P1|Follow-up 2|Changed Mind|0
5088486|NCT02054715|17568759|P2|Follow-up 2|Changed MD/Facility|1
5088487|NCT02054715|17568760|P1|Follow-up 2|Changed MD/Facility|0
5088488|NCT02054715|17568759|P2|Follow-up 2|Hospitalization|2
5088489|NCT02054715|17568760|P1|Follow-up 2|Hospitalization|0
5088490|NCT02054715|17568759|P2|Follow-up 2|Death|3
5088491|NCT02054715|17568760|P1|Follow-up 2|Death|3
5088492|NCT02054715|17568759|P2|Follow-up 2|Ineligible|5
5088493|NCT02054715|17568760|P1|Follow-up 2|Ineligible|4
5088494|NCT02054715|17568759|P2|Follow-up 2|Followup Not Completed|4
5088495|NCT02054715|17568760|P1|Follow-up 2|Followup Not Completed|3
5088496|NCT02054715|17568759|P2|Follow-up 2|Refused|2
5088497|NCT02054715|17568760|P1|Follow-up 2|Refused|3
5088498|NCT02054715|17568759|P2|Follow-up 2|Lost to Followup|1
5088499|NCT02054715|17568760|P1|Follow-up 2|Lost to Followup|3
5088500|NCT02054715|17568759|P2|Baseline/Follow-up 1|Changed Mind|0
5088501|NCT02054715|17568760|P1|Baseline/Follow-up 1|Changed Mind|1
5088502|NCT02054715|17568759|P2|Baseline/Follow-up 1|Hospitalization|0
5088503|NCT02054715|17568760|P1|Baseline/Follow-up 1|Hospitalization|1
5088504|NCT02054715|17568759|P2|Baseline/Follow-up 1|Ineligible|0
5088505|NCT02054715|17568760|P1|Baseline/Follow-up 1|Ineligible|3
5088506|NCT02054715|17568759|P2|Baseline/Follow-up 1|Overwhelmed|0
5088507|NCT02054715|17568760|P1|Baseline/Follow-up 1|Overwhelmed|2
5088508|NCT02054715|17568759|P2|Baseline/Follow-up 1|No Reason|1
5088509|NCT02054715|17568760|P1|Baseline/Follow-up 1|No Reason|0
5088510|NCT02054715|17568759|P2|Baseline/Follow-up 1|Disliked Procedure|1
5088511|NCT02054715|17568760|P1|Baseline/Follow-up 1|Disliked Procedure|0
5088512|NCT02054715|17568759|P2|Baseline/Follow-up 1|Changed MD/Facility|1
5088513|NCT02054715|17568760|P1|Baseline/Follow-up 1|Changed MD/Facility|0
5088514|NCT02054715|17568759|P2|Baseline/Follow-up 1|Medical|1
5088515|NCT02054715|17568760|P1|Baseline/Follow-up 1|Medical|0
5088516|NCT02054715|17568759|P2|Baseline/Follow-up 1|Refused|3
5088517|NCT02054715|17568760|P1|Baseline/Follow-up 1|Refused|1
5088518|NCT02054702|17568774|P2|Overall Study|Withdrawal by Subject|4
5088519|NCT02054702|17568775|P1|Overall Study|Withdrawal by Subject|14
5088520|NCT02054702|17568774|P2|Overall Study|Physician Decision|1
5088521|NCT02054702|17568775|P1|Overall Study|Physician Decision|0
5088522|NCT02054702|17568774|P2|Overall Study|Met Withdrawal Criteria|1
5088523|NCT02054702|17568775|P1|Overall Study|Met Withdrawal Criteria|4
5088524|NCT02054702|17568774|P2|Overall Study|Adverse Event|1
5088525|NCT02054702|17568775|P1|Overall Study|Adverse Event|3
5088526|NCT02054702|17568774|P2|Overall Study|Lost to Follow-up|5
5088527|NCT02054702|17568775|P1|Overall Study|Lost to Follow-up|3
5088528|NCT02054520|17568832|P6|Overall Study|Study terminated by Sponsor|0
5088529|NCT02054520|17568833|P5|Overall Study|Study terminated by Sponsor|0
5088530|NCT02054520|17568834|P4|Overall Study|Study terminated by Sponsor|1
5088531|NCT02054520|17568835|P3|Overall Study|Study terminated by Sponsor|2
5088532|NCT02054520|17568836|P2|Overall Study|Study terminated by Sponsor|0
5088533|NCT02054520|17568837|P1|Overall Study|Study terminated by Sponsor|0
5088534|NCT02054520|17568832|P6|Overall Study|Physician Decision|1
5088535|NCT02054520|17568833|P5|Overall Study|Physician Decision|0
5088536|NCT02054520|17568834|P4|Overall Study|Physician Decision|1
5088537|NCT02054520|17568835|P3|Overall Study|Physician Decision|0
5088538|NCT02054520|17568836|P2|Overall Study|Physician Decision|1
5088539|NCT02054520|17568837|P1|Overall Study|Physician Decision|0
5088540|NCT02054520|17568832|P6|Overall Study|Withdrawal by Subject|0
5088541|NCT02054520|17568833|P5|Overall Study|Withdrawal by Subject|1
5088542|NCT02054520|17568834|P4|Overall Study|Withdrawal by Subject|2
5088543|NCT02054520|17568835|P3|Overall Study|Withdrawal by Subject|0
5088544|NCT02054520|17568836|P2|Overall Study|Withdrawal by Subject|0
5088545|NCT02054520|17568837|P1|Overall Study|Withdrawal by Subject|1
5088546|NCT02054520|17568832|P6|Overall Study|Lack of Efficacy|2
5088547|NCT02054520|17568833|P5|Overall Study|Lack of Efficacy|3
5088548|NCT02054520|17568834|P4|Overall Study|Lack of Efficacy|1
5088549|NCT02054520|17568835|P3|Overall Study|Lack of Efficacy|2
5088550|NCT02054520|17568836|P2|Overall Study|Lack of Efficacy|0
5088551|NCT02054520|17568837|P1|Overall Study|Lack of Efficacy|7
5088552|NCT02054520|17568832|P6|Overall Study|Adverse Event|0
5088553|NCT02054520|17568833|P5|Overall Study|Adverse Event|1
5088554|NCT02054520|17568834|P4|Overall Study|Adverse Event|1
5088555|NCT02054520|17568835|P3|Overall Study|Adverse Event|2
5088556|NCT02054520|17568836|P2|Overall Study|Adverse Event|4
5088557|NCT02054520|17568837|P1|Overall Study|Adverse Event|1
5088558|NCT02054481|17568861|P4|Overall Study|Other reason|0
5088559|NCT02054481|17568862|P3|Overall Study|Other reason|2
5088560|NCT02054481|17568863|P2|Overall Study|Other reason|1
5088561|NCT02054481|17568864|P1|Overall Study|Other reason|2
5088562|NCT02054481|17568861|P4|Overall Study|Lost to Follow-up|0
5088563|NCT02054481|17568862|P3|Overall Study|Lost to Follow-up|0
5088564|NCT02054481|17568863|P2|Overall Study|Lost to Follow-up|0
5088565|NCT02054481|17568864|P1|Overall Study|Lost to Follow-up|1
5088566|NCT02054481|17568861|P4|Overall Study|Adverse Event|1
5088567|NCT02054481|17568862|P3|Overall Study|Adverse Event|0
5088568|NCT02054481|17568863|P2|Overall Study|Adverse Event|1
5088569|NCT02054481|17568864|P1|Overall Study|Adverse Event|1
5088570|NCT02054325|17568925|P2|Overall Study|Lost to Follow-up|5
5088571|NCT02054325|17568926|P1|Overall Study|Lost to Follow-up|8
5088572|NCT02054130|17568953|P4|Overall Study|Missed dose|10
5088573|NCT02054130|17568954|P3|Overall Study|Missed dose|7
5088574|NCT02054130|17568955|P2|Overall Study|Missed dose|6
5088575|NCT02054130|17568956|P1|Overall Study|Missed dose|4
5088576|NCT02054130|17568953|P4|Overall Study|Lost to Follow-up|2
5088577|NCT02054130|17568954|P3|Overall Study|Lost to Follow-up|1
5088578|NCT02054130|17568955|P2|Overall Study|Lost to Follow-up|0
5088579|NCT02054130|17568956|P1|Overall Study|Lost to Follow-up|0
5088580|NCT02054130|17568953|P4|Overall Study|Death|0
5088581|NCT02054130|17568954|P3|Overall Study|Death|0
5088582|NCT02054130|17568955|P2|Overall Study|Death|1
5088583|NCT02054130|17568956|P1|Overall Study|Death|0
5088584|NCT02054130|17568953|P4|Overall Study|Withdrawal by Subject|10
5088585|NCT02054130|17568954|P3|Overall Study|Withdrawal by Subject|7
5088586|NCT02054130|17568955|P2|Overall Study|Withdrawal by Subject|4
5088587|NCT02054130|17568956|P1|Overall Study|Withdrawal by Subject|4
5088588|NCT02053753|17569050|P2|Overall Study|Lost to Follow-up|3
5088589|NCT02053753|17569051|P1|Overall Study|Lost to Follow-up|4
5088590|NCT02053753|17569050|P2|Overall Study|Decision by Sponsor|1
5088591|NCT02053753|17569051|P1|Overall Study|Decision by Sponsor|1
5088592|NCT02053753|17569050|P2|Overall Study|Withdrawal by Subject|4
5088593|NCT02053753|17569051|P1|Overall Study|Withdrawal by Subject|2
5088594|NCT02053610|17569075|P2|Overall Study|Violation of Selection Criteria|0
5088595|NCT02053610|17569076|P1|Overall Study|Violation of Selection Criteria|1
5088596|NCT02053610|17569075|P2|Overall Study|Insufficient Therapeutic Response|1
5088597|NCT02053610|17569076|P1|Overall Study|Insufficient Therapeutic Response|1
5088598|NCT02053610|17569075|P2|Overall Study|Did not Receive Treatment|2
5088599|NCT02053610|17569076|P1|Overall Study|Did not Receive Treatment|4
5088600|NCT02053610|17569075|P2|Overall Study|Refused treatment/Did not cooperate|3
5088601|NCT02053610|17569076|P1|Overall Study|Refused treatment/Did not cooperate|1
5088602|NCT02053610|17569075|P2|Overall Study|Disease Progression|3
5088603|NCT02053610|17569076|P1|Overall Study|Disease Progression|2
5088604|NCT02053610|17569075|P2|Overall Study|Administrative/Other|1
5088605|NCT02053610|17569076|P1|Overall Study|Administrative/Other|1
5088606|NCT02053610|17569075|P2|Overall Study|Death|5
5088607|NCT02053610|17569076|P1|Overall Study|Death|5
5088608|NCT02053610|17569075|P2|Overall Study|Withdrew Consent|9
5088609|NCT02053610|17569076|P1|Overall Study|Withdrew Consent|2
5088610|NCT02053610|17569075|P2|Overall Study|Adverse Event/Intercurrent Illness|43
5088611|NCT02053610|17569076|P1|Overall Study|Adverse Event/Intercurrent Illness|25
5088612|NCT02053493|17569108|P2|Overall Study|Withdrawal by Subject|1
5088613|NCT02053493|17569109|P1|Overall Study|Withdrawal by Subject|1
5088614|NCT02053168|17569175|P1|Overall Study|Lost to Follow-up|1
5088615|NCT02053168|17569175|P1|Overall Study|Physician Decision|1
5088616|NCT02053168|17569175|P1|Overall Study|Withdrawal by Subject|1
5088617|NCT02052596|17569254|P2|Safety Phase|Lost due to Crohn's disease|1
5088618|NCT02052596|17569255|P1|Safety Phase|Lost due to Crohn's disease|0
5088619|NCT02052596|17569254|P2|Safety Phase|Enrolled in error|0
5088620|NCT02052596|17569255|P1|Safety Phase|Enrolled in error|1
5088621|NCT02052596|17569254|P2|Safety Phase|Withdrawal by Subject|11
5088622|NCT02052596|17569255|P1|Safety Phase|Withdrawal by Subject|8
5088623|NCT02052596|17569254|P2|Safety Phase|Protocol Violation|2
5088624|NCT02052596|17569255|P1|Safety Phase|Protocol Violation|1
5088625|NCT02052596|17569254|P2|Safety Phase|Lost to Follow-up|18
5088626|NCT02052596|17569255|P1|Safety Phase|Lost to Follow-up|11
5088627|NCT02052596|17569254|P2|Safety Phase|Adverse Event|3
5088628|NCT02052596|17569255|P1|Safety Phase|Adverse Event|6
5088629|NCT02052596|17569254|P2|Active Phase|Lost due to Crohn's disease|1
5088630|NCT02052596|17569255|P1|Active Phase|Lost due to Crohn's disease|0
5088631|NCT02052596|17569254|P2|Active Phase|Enrolled in error|0
5088632|NCT02052596|17569255|P1|Active Phase|Enrolled in error|1
5088633|NCT02052596|17569254|P2|Active Phase|Withdrawal by Subject|4
5088634|NCT02052596|17569255|P1|Active Phase|Withdrawal by Subject|3
5088635|NCT02052596|17569254|P2|Active Phase|Protocol Violation|2
5088636|NCT02052596|17569255|P1|Active Phase|Protocol Violation|1
5088637|NCT02052596|17569254|P2|Active Phase|Lost to Follow-up|11
5088638|NCT02052596|17569255|P1|Active Phase|Lost to Follow-up|8
5088639|NCT02052596|17569254|P2|Active Phase|Adverse Event|2
5088640|NCT02052596|17569255|P1|Active Phase|Adverse Event|3
5088641|NCT02052466|17569285|P1|Overall Study|Acromial fracture|1
5088642|NCT02052466|17569285|P1|Overall Study|Withdrawal by Subject|1
5088643|NCT02052440|17569302|P2|Overall Study|Withdrawal by Subject|1
5088644|NCT02052440|17569303|P1|Overall Study|Withdrawal by Subject|0
5088645|NCT02052414|17569315|P1|Overall Study|Withdrawal by Subject|3
5088646|NCT02052414|17569315|P1|Overall Study|Lack of Efficacy|2
5088647|NCT02052414|17569315|P1|Overall Study|Adverse Event|12
5088648|NCT02052011|17569350|P2|Overall Study|Withdrawal by Subject|2
5088649|NCT02052011|17569351|P1|Overall Study|Withdrawal by Subject|1
5088650|NCT02052011|17569350|P2|Overall Study|Lost to Follow-up|0
5088651|NCT02052011|17569351|P1|Overall Study|Lost to Follow-up|3
5088652|NCT02051764|17569408|P2|Overall Study|Study terminated by sponsor|7
5088653|NCT02051764|17569409|P1|Overall Study|Study terminated by sponsor|0
5088654|NCT02051296|17569515|P2|Overall Study|withdraw prior to treatment|7
5088655|NCT02051296|17569516|P1|Overall Study|withdraw prior to treatment|7
5088656|NCT02051296|17569515|P2|Overall Study|Lost to Follow-up|2
5088657|NCT02051296|17569516|P1|Overall Study|Lost to Follow-up|1
5088658|NCT02050321|17569576|P1|Overall Study|Adverse Event|1
5088659|NCT02050321|17569576|P1|Overall Study|Withdrawal by Subject|1
5088660|NCT02050048|17569592|P2|Overall Study|Ineligible after ERCP|1
5088661|NCT02050048|17569593|P1|Overall Study|Ineligible after ERCP|4
5088662|NCT02050048|17569592|P2|Overall Study|Death|0
5088663|NCT02050048|17569593|P1|Overall Study|Death|1
5088664|NCT02050048|17569592|P2|Overall Study|Lost to Follow-up|1
5088665|NCT02050048|17569593|P1|Overall Study|Lost to Follow-up|0
5088666|NCT02049957|17569608|P9|Overall Study|Physician Decision|0
5088667|NCT02049957|17569609|P8|Overall Study|Physician Decision|0
5088668|NCT02049957|17569610|P7|Overall Study|Physician Decision|0
5088669|NCT02049957|17569611|P6|Overall Study|Physician Decision|1
5088670|NCT02049957|17569612|P5|Overall Study|Physician Decision|0
5088671|NCT02049957|17569613|P4|Overall Study|Physician Decision|0
5088672|NCT02049957|17569614|P3|Overall Study|Physician Decision|0
5088673|NCT02049957|17569615|P2|Overall Study|Physician Decision|0
5088674|NCT02049957|17569616|P1|Overall Study|Physician Decision|0
5088675|NCT02049957|17569608|P9|Overall Study|Withdrawal by Subject|1
5088676|NCT02049957|17569609|P8|Overall Study|Withdrawal by Subject|3
5088677|NCT02049957|17569610|P7|Overall Study|Withdrawal by Subject|0
5088678|NCT02049957|17569611|P6|Overall Study|Withdrawal by Subject|2
5088679|NCT02049957|17569612|P5|Overall Study|Withdrawal by Subject|0
5088680|NCT02049957|17569613|P4|Overall Study|Withdrawal by Subject|1
5088681|NCT02049957|17569614|P3|Overall Study|Withdrawal by Subject|0
5088682|NCT02049957|17569615|P2|Overall Study|Withdrawal by Subject|0
5088683|NCT02049957|17569616|P1|Overall Study|Withdrawal by Subject|0
5088684|NCT02049957|17569608|P9|Overall Study|Study Terminated by Sponsor|0
5088685|NCT02049957|17569609|P8|Overall Study|Study Terminated by Sponsor|0
5088686|NCT02049957|17569610|P7|Overall Study|Study Terminated by Sponsor|1
5088687|NCT02049957|17569611|P6|Overall Study|Study Terminated by Sponsor|0
5088688|NCT02049957|17569612|P5|Overall Study|Study Terminated by Sponsor|0
5088689|NCT02049957|17569613|P4|Overall Study|Study Terminated by Sponsor|0
5088690|NCT02049957|17569614|P3|Overall Study|Study Terminated by Sponsor|0
5088691|NCT02049957|17569615|P2|Overall Study|Study Terminated by Sponsor|1
5088692|NCT02049957|17569616|P1|Overall Study|Study Terminated by Sponsor|0
5088693|NCT02049957|17569608|P9|Overall Study|Adverse Event|1
5088694|NCT02049957|17569609|P8|Overall Study|Adverse Event|6
5088695|NCT02049957|17569610|P7|Overall Study|Adverse Event|0
5088696|NCT02049957|17569611|P6|Overall Study|Adverse Event|5
5088697|NCT02049957|17569612|P5|Overall Study|Adverse Event|0
5088698|NCT02049957|17569613|P4|Overall Study|Adverse Event|0
5088699|NCT02049957|17569614|P3|Overall Study|Adverse Event|1
5088700|NCT02049957|17569615|P2|Overall Study|Adverse Event|1
5088701|NCT02049957|17569616|P1|Overall Study|Adverse Event|1
5088702|NCT02049957|17569608|P9|Overall Study|Progressive Disease|6
5088703|NCT02049957|17569609|P8|Overall Study|Progressive Disease|26
5088704|NCT02049957|17569610|P7|Overall Study|Progressive Disease|7
5088705|NCT02049957|17569611|P6|Overall Study|Progressive Disease|35
5088706|NCT02049957|17569612|P5|Overall Study|Progressive Disease|6
5088707|NCT02049957|17569613|P4|Overall Study|Progressive Disease|2
5088708|NCT02049957|17569614|P3|Overall Study|Progressive Disease|2
5088709|NCT02049957|17569615|P2|Overall Study|Progressive Disease|4
5088710|NCT02049957|17569616|P1|Overall Study|Progressive Disease|5
5088711|NCT02049814|17569708|P2|Overall Study|Voluntary withdrawal|8
5088712|NCT02049814|17569709|P1|Overall Study|Voluntary withdrawal|9
5088713|NCT02049814|17569708|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
5088714|NCT02049814|17569709|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
5088715|NCT02049814|17569708|P2|Overall Study|Study Termination|1
5088716|NCT02049814|17569709|P1|Overall Study|Study Termination|0
5088717|NCT02049814|17569708|P2|Overall Study|Serious Protocol Violation|7
5088718|NCT02049814|17569709|P1|Overall Study|Serious Protocol Violation|5
5088719|NCT02049814|17569708|P2|Overall Study|Lost to Follow-up|3
5088720|NCT02049814|17569709|P1|Overall Study|Lost to Follow-up|2
5088721|NCT02049814|17569708|P2|Overall Study|Pregnancy|0
5088722|NCT02049814|17569709|P1|Overall Study|Pregnancy|1
5088723|NCT02049814|17569708|P2|Overall Study|Reason not Specified|3
5088724|NCT02049814|17569709|P1|Overall Study|Reason not Specified|4
5088725|NCT02049450|17569758|P1|Overall Study|Patients/guardian decision|1
5088726|NCT02049450|17569758|P1|Overall Study|Withdrawal by Subject|1
5088727|NCT02049450|17569758|P1|Overall Study|Adverse Event|2
5088728|NCT02048904|17569807|P1|Overall Study|Physician Decision|70
5088729|NCT02048904|17569807|P1|Overall Study|Withdrawal by Subject|7
5088730|NCT02048722|17569839|P1|Follow up for 5 Years|Still in follow up|4
5088731|NCT02048722|17569839|P1|Follow up for 5 Years|Withdrawal by Subject|3
5088732|NCT02048722|17569839|P1|Follow up for 5 Years|Death|22
5088733|NCT02048722|17569839|P1|Reached 1st Response/Continued Treatment|Progressive Disease|10
5088734|NCT02048722|17569839|P1|2 Cycles of Treatment|Progressive Disease|2
5088735|NCT02048722|17569839|P1|2 Cycles of Treatment|Withdrawal by Subject|4
5088736|NCT02048722|17569839|P1|2 Cycles of Treatment|Adverse Event|2
5088737|NCT02048241|17569862|P2|Overall Study|Withdrawal by Subject|1
5088738|NCT02048241|17569863|P1|Overall Study|Withdrawal by Subject|0
5088739|NCT02048072|17569869|P1|Overall Study|Lost to Follow-up|1
5088740|NCT02048072|17569869|P1|Overall Study|Adverse Event|3
5088741|NCT02047903|17569908|P1|Overall Study|Not Treated|9
5088742|NCT02047903|17569908|P1|Overall Study|Reason not listed|6
5088743|NCT02047903|17569908|P1|Overall Study|Lost to Follow-up|4
5088744|NCT02047903|17569908|P1|Overall Study|Withdrawal by Subject|16
5088745|NCT02047903|17569908|P1|Overall Study|Serious adverse event|10
5088746|NCT02047903|17569908|P1|Overall Study|Adverse Event|14
5088747|NCT02047253|17569963|P1|Overall Study|Lost to Follow-up|8
5088748|NCT02047227|17569973|P2|Overall Study|Other|9
5088749|NCT02047227|17569974|P1|Overall Study|Other|10
5088750|NCT02047227|17569973|P2|Overall Study|All embryos discarded|11
5088751|NCT02047227|17569974|P1|Overall Study|All embryos discarded|12
5088752|NCT02047227|17569973|P2|Overall Study|Intention to freeze all embryos|0
5088753|NCT02047227|17569974|P1|Overall Study|Intention to freeze all embryos|1
5088754|NCT02047227|17569973|P2|Overall Study|No fertilization|51
5088755|NCT02047227|17569974|P1|Overall Study|No fertilization|61
5088756|NCT02047227|17569973|P2|Overall Study|No oocytes retrieved|20
5088757|NCT02047227|17569974|P1|Overall Study|No oocytes retrieved|21
5088758|NCT02047227|17569973|P2|Overall Study|Lack of ovarian response to stimulation|32
5088759|NCT02047227|17569974|P1|Overall Study|Lack of ovarian response to stimulation|35
5088760|NCT02047227|17569973|P2|Overall Study|Spontaneous pregnancy|0
5088761|NCT02047227|17569974|P1|Overall Study|Spontaneous pregnancy|1
5088762|NCT02047227|17569973|P2|Overall Study|Protocol Violation|0
5088763|NCT02047227|17569974|P1|Overall Study|Protocol Violation|1
5088764|NCT02047227|17569973|P2|Overall Study|Lost to Follow-up|3
5088765|NCT02047227|17569974|P1|Overall Study|Lost to Follow-up|0
5088766|NCT02047227|17569973|P2|Overall Study|Adverse Event|4
5088767|NCT02047227|17569974|P1|Overall Study|Adverse Event|2
5088768|NCT02047110|17569994|P4|OLE Treatment Period|Other than specified|0
5088769|NCT02047110|17569995|P3|OLE Treatment Period|Other than specified|1
5088770|NCT02047110|17569996|P2|OLE Treatment Period|Other than specified|0
5088771|NCT02047110|17569997|P1|OLE Treatment Period|Other than specified|0
5088772|NCT02047110|17569994|P4|Escape Treatment Period|Other than specified|1
5088773|NCT02047110|17569995|P3|Escape Treatment Period|Other than specified|0
5088774|NCT02047110|17569996|P2|Escape Treatment Period|Other than specified|2
5088775|NCT02047110|17569997|P1|Escape Treatment Period|Other than specified|1
5088776|NCT02047110|17569994|P4|Escape Treatment Period|Adverse Event|0
5088777|NCT02047110|17569995|P3|Escape Treatment Period|Adverse Event|2
5088778|NCT02047110|17569996|P2|Escape Treatment Period|Adverse Event|2
5088779|NCT02047110|17569997|P1|Escape Treatment Period|Adverse Event|1
5088780|NCT02047110|17569994|P4|Escape Treatment Period|Withdrawal by Subject|1
5088781|NCT02047110|17569995|P3|Escape Treatment Period|Withdrawal by Subject|1
5088782|NCT02047110|17569996|P2|Escape Treatment Period|Withdrawal by Subject|2
5088783|NCT02047110|17569997|P1|Escape Treatment Period|Withdrawal by Subject|1
5088784|NCT02047110|17569994|P4|DB (Week 12 up to Week 24)|Other than specified|0
5088867|NCT02046369|17570330|P1|Overall Study|Adverse Event|3
5088785|NCT02047110|17569995|P3|DB (Week 12 up to Week 24)|Other than specified|1
5088786|NCT02047110|17569996|P2|DB (Week 12 up to Week 24)|Other than specified|1
5088787|NCT02047110|17569997|P1|DB (Week 12 up to Week 24)|Other than specified|0
5088788|NCT02047110|17569994|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5088789|NCT02047110|17569995|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5088790|NCT02047110|17569996|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
5088791|NCT02047110|17569997|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5088792|NCT02047110|17569994|P4|DB Treatment Period up to Week 24|Other than specified|1
5088793|NCT02047110|17569995|P3|DB Treatment Period up to Week 24|Other than specified|3
5088794|NCT02047110|17569996|P2|DB Treatment Period up to Week 24|Other than specified|2
5088795|NCT02047110|17569997|P1|DB Treatment Period up to Week 24|Other than specified|1
5088796|NCT02047110|17569994|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
5088797|NCT02047110|17569995|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
5088798|NCT02047110|17569996|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
5088799|NCT02047110|17569997|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
5088800|NCT02047110|17569994|P4|DB Treatment Period up to Week 24|Protocol Violation|0
5088801|NCT02047110|17569995|P3|DB Treatment Period up to Week 24|Protocol Violation|0
5088802|NCT02047110|17569996|P2|DB Treatment Period up to Week 24|Protocol Violation|0
5088803|NCT02047110|17569997|P1|DB Treatment Period up to Week 24|Protocol Violation|1
5088804|NCT02047110|17569994|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
5088805|NCT02047110|17569995|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
5088806|NCT02047110|17569996|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
5088807|NCT02047110|17569997|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
5088808|NCT02047110|17569994|P4|DB Treatment Period up to Week 24|Adverse Event|0
5088809|NCT02047110|17569995|P3|DB Treatment Period up to Week 24|Adverse Event|0
5088810|NCT02047110|17569996|P2|DB Treatment Period up to Week 24|Adverse Event|0
5088811|NCT02047110|17569997|P1|DB Treatment Period up to Week 24|Adverse Event|1
5088812|NCT02047045|17570040|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
5088813|NCT02047045|17570041|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
5088814|NCT02047045|17570040|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
5088815|NCT02047045|17570041|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
5088816|NCT02047045|17570040|P2|Treatment Period (8 Weeks )|Adverse Event|1
5088817|NCT02047045|17570041|P1|Treatment Period (8 Weeks )|Adverse Event|2
5088818|NCT02047045|17570040|P2|Baseline|Withdrawal by Subject|15
5088819|NCT02047045|17570041|P1|Baseline|Withdrawal by Subject|8
5088820|NCT02046993|17570105|P2|Overall Study|Lost to Follow-up|1
5088821|NCT02046993|17570106|P1|Overall Study|Lost to Follow-up|1
5088822|NCT02046993|17570105|P2|Overall Study|Withdrawal by Subject|10
5088823|NCT02046993|17570106|P1|Overall Study|Withdrawal by Subject|2
5088824|NCT02046616|17570178|P1|8-Week FU Period|Lost to Follow-up|1
5088825|NCT02046616|17570178|P1|24-Week Treatment Period|Other|1
5088826|NCT02046616|17570178|P1|24-Week Treatment Period|Physician Decision|3
5088827|NCT02046616|17570178|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
5088828|NCT02046616|17570178|P1|24-Week Treatment Period|Any Other Adverse Event|13
5088829|NCT02046616|17570178|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
5088830|NCT02046603|17570200|P2|Overall Study|Adverse Event|1
5088831|NCT02046603|17570201|P1|Overall Study|Adverse Event|0
5088832|NCT02046603|17570200|P2|Overall Study|Death|1
5088833|NCT02046603|17570201|P1|Overall Study|Death|0
5088834|NCT02046603|17570200|P2|Overall Study|Lost to Follow-up|2
5088835|NCT02046603|17570201|P1|Overall Study|Lost to Follow-up|1
5088836|NCT02046603|17570200|P2|Overall Study|Physician Decision|1
5088837|NCT02046603|17570201|P1|Overall Study|Physician Decision|2
5088838|NCT02046603|17570200|P2|Overall Study|Participant/legal guardian decision|3
5088839|NCT02046603|17570201|P1|Overall Study|Participant/legal guardian decision|1
5088840|NCT02046603|17570200|P2|Overall Study|Protocol Violation|1
5088841|NCT02046603|17570201|P1|Overall Study|Protocol Violation|0
5088842|NCT02046603|17570200|P2|Overall Study|Other|66
5088843|NCT02046603|17570201|P1|Overall Study|Other|11
5088844|NCT02046564|17570280|P2|Overall Study|Subject met withdrawal criteria|5
5088845|NCT02046564|17570281|P1|Overall Study|Subject met withdrawal criteria|2
5088846|NCT02046564|17570280|P2|Overall Study|Withdrawal by Subject|10
5088847|NCT02046564|17570281|P1|Overall Study|Withdrawal by Subject|4
5088848|NCT02046564|17570280|P2|Overall Study|Protocol Violation|1
5088849|NCT02046564|17570281|P1|Overall Study|Protocol Violation|3
5088850|NCT02046564|17570280|P2|Overall Study|Physician Decision|1
5088851|NCT02046564|17570281|P1|Overall Study|Physician Decision|0
5088852|NCT02046564|17570280|P2|Overall Study|Adverse Event|3
5088853|NCT02046564|17570281|P1|Overall Study|Adverse Event|6
5088854|NCT02046369|17570329|P2|Overall Study|non compliance|0
5088855|NCT02046369|17570330|P1|Overall Study|non compliance|1
5088856|NCT02046369|17570329|P2|Overall Study|never received study drug|1
5088857|NCT02046369|17570330|P1|Overall Study|never received study drug|0
5088858|NCT02046369|17570329|P2|Overall Study|Withdrawal by Subject|6
5088859|NCT02046369|17570330|P1|Overall Study|Withdrawal by Subject|3
5088860|NCT02046369|17570329|P2|Overall Study|Protocol Violation|2
5088861|NCT02046369|17570330|P1|Overall Study|Protocol Violation|1
5088862|NCT02046369|17570329|P2|Overall Study|Lost to Follow-up|3
5088863|NCT02046369|17570330|P1|Overall Study|Lost to Follow-up|3
5088864|NCT02046369|17570329|P2|Overall Study|Lack of Efficacy|3
5088865|NCT02046369|17570330|P1|Overall Study|Lack of Efficacy|3
5088866|NCT02046369|17570329|P2|Overall Study|Adverse Event|3
5088868|NCT02046226|17570374|P1|Overall Study|Lost to Follow-up|7
5088869|NCT02046148|17570422|P2|Overall Study|Withdrawal by Subject|2
5088870|NCT02046148|17570423|P1|Overall Study|Withdrawal by Subject|0
5088871|NCT02046148|17570422|P2|Overall Study|Lost to Follow-up|1
5088872|NCT02046148|17570423|P1|Overall Study|Lost to Follow-up|1
5088873|NCT02046122|17570483|P1|Overall Study|Withdrawal by Subject|1
5088874|NCT02046122|17570483|P1|Overall Study|Physician Decision|8
5088875|NCT02046070|17570497|P3|Overall Study|Reason not Specified|6
5088876|NCT02046070|17570498|P2|Overall Study|Reason not Specified|4
5088877|NCT02046070|17570499|P1|Overall Study|Reason not Specified|4
5088878|NCT02046070|17570497|P3|Overall Study|Study Terminated by Sponsor|1
5088879|NCT02046070|17570498|P2|Overall Study|Study Terminated by Sponsor|1
5088880|NCT02046070|17570499|P1|Overall Study|Study Terminated by Sponsor|1
5088881|NCT02046070|17570497|P3|Overall Study|Withdrawal by Subject|6
5088882|NCT02046070|17570498|P2|Overall Study|Withdrawal by Subject|2
5088883|NCT02046070|17570499|P1|Overall Study|Withdrawal by Subject|1
5088884|NCT02046070|17570497|P3|Overall Study|Adverse Event|17
5088885|NCT02046070|17570498|P2|Overall Study|Adverse Event|10
5088886|NCT02046070|17570499|P1|Overall Study|Adverse Event|8
5088887|NCT02046070|17570497|P3|Overall Study|Progressive Disease|40
5088888|NCT02046070|17570498|P2|Overall Study|Progressive Disease|11
5088889|NCT02046070|17570499|P1|Overall Study|Progressive Disease|18
5088890|NCT02045979|17570559|P3|Overall Study|not specified above|0
5088891|NCT02045979|17570560|P2|Overall Study|not specified above|1
5088892|NCT02045979|17570561|P1|Overall Study|not specified above|0
5088893|NCT02045979|17570559|P3|Overall Study|Informed Consent Withdrawn|1
5088894|NCT02045979|17570560|P2|Overall Study|Informed Consent Withdrawn|0
5088895|NCT02045979|17570561|P1|Overall Study|Informed Consent Withdrawn|2
5088896|NCT02045875|17570598|P2|Overall Study|Withdrawal by Subject|3
5088897|NCT02045875|17570599|P1|Overall Study|Withdrawal by Subject|4
5088898|NCT02045875|17570598|P2|Overall Study|Lost to Follow-up|0
5088899|NCT02045875|17570599|P1|Overall Study|Lost to Follow-up|3
5088900|NCT02045862|17570610|P3|Overall Study|Lost to Follow-up|6
5088901|NCT02045862|17570611|P2|Overall Study|Lost to Follow-up|2
5088902|NCT02045862|17570612|P1|Overall Study|Lost to Follow-up|1
5088903|NCT02045862|17570610|P3|Overall Study|Adverse Event|27
5088904|NCT02045862|17570611|P2|Overall Study|Adverse Event|5
5088905|NCT02045862|17570612|P1|Overall Study|Adverse Event|7
5088906|NCT02045862|17570610|P3|Overall Study|Randomized but not Received Study Drug|8
5088907|NCT02045862|17570611|P2|Overall Study|Randomized but not Received Study Drug|2
5088908|NCT02045862|17570612|P1|Overall Study|Randomized but not Received Study Drug|0
5088909|NCT02045862|17570610|P3|Overall Study|Lack of Efficacy|13
5088910|NCT02045862|17570611|P2|Overall Study|Lack of Efficacy|4
5088911|NCT02045862|17570612|P1|Overall Study|Lack of Efficacy|8
5088912|NCT02045862|17570610|P3|Overall Study|Protocol Violation|6
5088913|NCT02045862|17570611|P2|Overall Study|Protocol Violation|0
5088914|NCT02045862|17570612|P1|Overall Study|Protocol Violation|0
5088915|NCT02045862|17570610|P3|Overall Study|Withdrawal by Patient|57
5088916|NCT02045862|17570611|P2|Overall Study|Withdrawal by Patient|27
5088917|NCT02045862|17570612|P1|Overall Study|Withdrawal by Patient|18
5088918|NCT02045862|17570610|P3|Overall Study|Miscellaneous|8
5088919|NCT02045862|17570611|P2|Overall Study|Miscellaneous|0
5088920|NCT02045862|17570612|P1|Overall Study|Miscellaneous|5
5088921|NCT02045862|17570610|P3|Overall Study|Death|1
5088922|NCT02045862|17570611|P2|Overall Study|Death|0
5088923|NCT02045862|17570612|P1|Overall Study|Death|0
5088924|NCT02045836|17570793|P2|Overall Study|Migrated from study area|2
5088925|NCT02045836|17570794|P1|Overall Study|Migrated from study area|0
5088926|NCT02045836|17570793|P2|Overall Study|Lost to Follow-up|7
5088927|NCT02045836|17570794|P1|Overall Study|Lost to Follow-up|4
5088928|NCT02045836|17570793|P2|Overall Study|Withdrawal by Subject|1
5088929|NCT02045836|17570794|P1|Overall Study|Withdrawal by Subject|1
5088930|NCT02045836|17570793|P2|Overall Study|Adverse Event|4
5088931|NCT02045836|17570794|P1|Overall Study|Adverse Event|4
5088932|NCT02045797|17570826|P3|Overall Study|Withdrawal by Subject|0
5088933|NCT02045797|17570827|P2|Overall Study|Withdrawal by Subject|2
5088934|NCT02045797|17570828|P1|Overall Study|Withdrawal by Subject|1
5088935|NCT02045797|17570826|P3|Overall Study|Physician Decision|0
5088936|NCT02045797|17570827|P2|Overall Study|Physician Decision|1
5088937|NCT02045797|17570828|P1|Overall Study|Physician Decision|0
5088938|NCT02045797|17570826|P3|Overall Study|Lost to Follow-up|1
5088939|NCT02045797|17570827|P2|Overall Study|Lost to Follow-up|3
5088940|NCT02045797|17570828|P1|Overall Study|Lost to Follow-up|2
5088941|NCT02045797|17570826|P3|Overall Study|Lack of Efficacy|0
5088942|NCT02045797|17570827|P2|Overall Study|Lack of Efficacy|0
5088943|NCT02045797|17570828|P1|Overall Study|Lack of Efficacy|1
5088944|NCT02045797|17570826|P3|Overall Study|Adverse Event|0
5088945|NCT02045797|17570827|P2|Overall Study|Adverse Event|1
5088946|NCT02045797|17570828|P1|Overall Study|Adverse Event|3
5088947|NCT02045732|17570973|P2|Overall Study|At the discretion of the investigator|1
5088948|NCT02045732|17570974|P1|Overall Study|At the discretion of the investigator|1
5088949|NCT02045433|17571011|P1|Overall Study|Withdrawal by Subject|1
5088950|NCT02045212|17571064|P2|Overall Study|Finished 13 weeks, chose not to extend|0
5088951|NCT02045212|17571065|P1|Overall Study|Finished 13 weeks, chose not to extend|1
5088952|NCT02045212|17571064|P2|Overall Study|Withdrawal by Subject|0
5088953|NCT02045212|17571065|P1|Overall Study|Withdrawal by Subject|1
5088954|NCT02045212|17571064|P2|Overall Study|Adverse Event|1
5088955|NCT02045212|17571065|P1|Overall Study|Adverse Event|0
5088956|NCT02045095|17571130|P7|Overall Study|Adverse Event|0
5088957|NCT02045095|17571131|P6|Overall Study|Adverse Event|2
5088958|NCT02045095|17571132|P5|Overall Study|Adverse Event|0
5088959|NCT02045095|17571133|P4|Overall Study|Adverse Event|0
5088960|NCT02045095|17571134|P3|Overall Study|Adverse Event|1
5088961|NCT02045095|17571135|P2|Overall Study|Adverse Event|1
5088962|NCT02045095|17571136|P1|Overall Study|Adverse Event|0
5088963|NCT02045095|17571130|P7|Overall Study|Withdrawal by Subject|0
5088964|NCT02045095|17571131|P6|Overall Study|Withdrawal by Subject|0
5088965|NCT02045095|17571132|P5|Overall Study|Withdrawal by Subject|3
5088966|NCT02045095|17571133|P4|Overall Study|Withdrawal by Subject|0
5088967|NCT02045095|17571134|P3|Overall Study|Withdrawal by Subject|0
5088968|NCT02045095|17571135|P2|Overall Study|Withdrawal by Subject|0
5088969|NCT02045095|17571136|P1|Overall Study|Withdrawal by Subject|0
5088970|NCT02045095|17571130|P7|Overall Study|Progressive Disease|1
5088971|NCT02045095|17571131|P6|Overall Study|Progressive Disease|4
5088972|NCT02045095|17571132|P5|Overall Study|Progressive Disease|2
5088973|NCT02045095|17571133|P4|Overall Study|Progressive Disease|4
5088974|NCT02045095|17571134|P3|Overall Study|Progressive Disease|2
5088975|NCT02045095|17571135|P2|Overall Study|Progressive Disease|3
5088976|NCT02045095|17571136|P1|Overall Study|Progressive Disease|3
5088977|NCT02045095|17571130|P7|Overall Study|Other|0
5088978|NCT02045095|17571131|P6|Overall Study|Other|2
5088979|NCT02045095|17571132|P5|Overall Study|Other|0
5088980|NCT02045095|17571133|P4|Overall Study|Other|0
5088981|NCT02045095|17571134|P3|Overall Study|Other|1
5088982|NCT02045095|17571135|P2|Overall Study|Other|0
5088983|NCT02045095|17571136|P1|Overall Study|Other|0
5088984|NCT02044874|17571294|P3|Overall Study|Other|8
5088985|NCT02044874|17571295|P2|Overall Study|Other|3
5088986|NCT02044874|17571296|P1|Overall Study|Other|7
5088987|NCT02044874|17571294|P3|Overall Study|Sponsor Decision|1
5088988|NCT02044874|17571295|P2|Overall Study|Sponsor Decision|1
5088989|NCT02044874|17571296|P1|Overall Study|Sponsor Decision|0
5088990|NCT02044874|17571294|P3|Overall Study|Lost to Follow-up|21
5088991|NCT02044874|17571295|P2|Overall Study|Lost to Follow-up|27
5088992|NCT02044874|17571296|P1|Overall Study|Lost to Follow-up|10
5088993|NCT02044874|17571294|P3|Overall Study|Physician Decision|1
5088994|NCT02044874|17571295|P2|Overall Study|Physician Decision|2
5088995|NCT02044874|17571296|P1|Overall Study|Physician Decision|0
5088996|NCT02044874|17571294|P3|Overall Study|Withdrawal by Subject|23
5088997|NCT02044874|17571295|P2|Overall Study|Withdrawal by Subject|16
5088998|NCT02044874|17571296|P1|Overall Study|Withdrawal by Subject|8
5088999|NCT02044874|17571294|P3|Overall Study|Adverse Event|6
5089000|NCT02044874|17571295|P2|Overall Study|Adverse Event|6
5089001|NCT02044874|17571296|P1|Overall Study|Adverse Event|5
5089002|NCT02044848|17571318|P2|Overall Study|Administrative Problems|3
5089003|NCT02044848|17571319|P1|Overall Study|Administrative Problems|2
5089004|NCT02044822|17571325|P1|Overall Study|Lost to Follow-up|1
5089005|NCT02044822|17571325|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
5089006|NCT02044822|17571325|P1|Overall Study|Withdrew Consent|3
5089007|NCT02044822|17571325|P1|Overall Study|Investigator's Discretion|10
5089008|NCT02044822|17571325|P1|Overall Study|Study Terminated by Sponsor|77
5089009|NCT02044510|17571367|P2|Overall Study|Adverse Event|2
5089010|NCT02044510|17571368|P1|Overall Study|Adverse Event|1
5089011|NCT02044458|17571376|P2|Overall Study|Protocol Violation|8
5089012|NCT02044458|17571377|P1|Overall Study|Protocol Violation|3
5089013|NCT02044302|17571463|P2|Overall Study|study terminated|0
5089014|NCT02044302|17571464|P1|Overall Study|study terminated|2
5089015|NCT02044159|17571472|P2|Overall Study|Nurse declined to give study drug|0
5089016|NCT02044159|17571473|P1|Overall Study|Nurse declined to give study drug|1
5089017|NCT02044159|17571472|P2|Overall Study|No longer eligible, drug not given|0
5089018|NCT02044159|17571473|P1|Overall Study|No longer eligible, drug not given|1
5089019|NCT02044159|17571472|P2|Overall Study|Consent declined (deferred consent)|4
5089020|NCT02044159|17571473|P1|Overall Study|Consent declined (deferred consent)|2
5089021|NCT02044094|17571486|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
5089022|NCT02044094|17571486|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
5089023|NCT02044094|17571486|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
5089024|NCT02044094|17571486|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
5089025|NCT02044094|17571486|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
5089026|NCT02044094|17571486|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
5089027|NCT02044094|17571486|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
5089028|NCT02044094|17571486|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
5089029|NCT02043938|17571543|P1|Overall Study|Investigator decision|1
5089030|NCT02043938|17571543|P1|Overall Study|No show by subject|1
5089031|NCT02043938|17571543|P1|Overall Study|Unable to place EEG sensors on patient|1
5089032|NCT02043938|17571543|P1|Overall Study|Withdrawal by Subject|7
5089033|NCT02043782|17571598|P6|Period 1|Adverse Event|0
5089034|NCT02043782|17571599|P5|Period 1|Adverse Event|0
5089035|NCT02043782|17571600|P4|Period 1|Adverse Event|0
5089036|NCT02043782|17571601|P3|Period 1|Adverse Event|1
5089037|NCT02043782|17571602|P2|Period 1|Adverse Event|0
5089038|NCT02043782|17571603|P1|Period 1|Adverse Event|0
5089039|NCT02043678|17571646|P2|Overall Study|Ongoing with treatment|104
5089040|NCT02043678|17571647|P1|Overall Study|Ongoing with treatment|87
5089041|NCT02043678|17571646|P2|Overall Study|Withdrawal by Subject|13
5089042|NCT02043678|17571647|P1|Overall Study|Withdrawal by Subject|10
5089043|NCT02043678|17571646|P2|Overall Study|Protocol-driven decision point|45
5089044|NCT02043678|17571647|P1|Overall Study|Protocol-driven decision point|53
5089045|NCT02043678|17571646|P2|Overall Study|Radiological PD|67
5089046|NCT02043678|17571647|P1|Overall Study|Radiological PD|78
5089047|NCT02043678|17571646|P2|Overall Study|Clinical PD|112
5089048|NCT02043678|17571647|P1|Overall Study|Clinical PD|88
5089049|NCT02043678|17571646|P2|Overall Study|Other|8
5089050|NCT02043678|17571647|P1|Overall Study|Other|15
5089051|NCT02043678|17571646|P2|Overall Study|Lost to Follow-up|1
5089052|NCT02043678|17571647|P1|Overall Study|Lost to Follow-up|1
5089053|NCT02043678|17571646|P2|Overall Study|AE without clinical PD|31
5089054|NCT02043678|17571647|P1|Overall Study|AE without clinical PD|41
5089055|NCT02043678|17571646|P2|Overall Study|AE with clinical progressive disease(PD)|15
5089056|NCT02043678|17571647|P1|Overall Study|AE with clinical progressive disease(PD)|17
5089057|NCT02043678|17571646|P2|Overall Study|Never treated|9
5089058|NCT02043678|17571647|P1|Overall Study|Never treated|11
5089059|NCT02043548|17571683|P2|Overall Study|Adverse Event|1
5089060|NCT02043548|17571684|P1|Overall Study|Adverse Event|0
5089061|NCT02043548|17571683|P2|Overall Study|Lack of Efficacy|0
5089062|NCT02043548|17571684|P1|Overall Study|Lack of Efficacy|1
5089063|NCT02043509|17571702|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
5089064|NCT02043509|17571703|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
5089065|NCT02043509|17571702|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
5089066|NCT02043509|17571703|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
5089067|NCT02043509|17571702|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
5089068|NCT02043509|17571703|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
5089069|NCT02043509|17571702|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
5089070|NCT02043509|17571703|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
5089071|NCT02043366|17571791|P6|Overall Study|Lost to Follow-up|2
5089072|NCT02043366|17571792|P5|Overall Study|Lost to Follow-up|2
5089073|NCT02043366|17571793|P4|Overall Study|Lost to Follow-up|2
5089074|NCT02043366|17571794|P3|Overall Study|Lost to Follow-up|2
5089075|NCT02043366|17571795|P2|Overall Study|Lost to Follow-up|2
5089076|NCT02043366|17571796|P1|Overall Study|Lost to Follow-up|2
5089077|NCT02043301|17571819|P3|Overall Study|Discontinued|0
5089078|NCT02043301|17571820|P2|Overall Study|Discontinued|1
5089079|NCT02043301|17571821|P1|Overall Study|Discontinued|0
5089080|NCT02043132|17571918|P2|Overall Study|screen failures|8
5089081|NCT02043132|17571919|P1|Overall Study|screen failures|4
5089082|NCT02043132|17571918|P2|Overall Study|Lost to Follow-up|1
5089083|NCT02043132|17571919|P1|Overall Study|Lost to Follow-up|1
5089084|NCT02043015|17571939|P1|Overall Study|Incarceration|1
5089085|NCT02043015|17571939|P1|Overall Study|Participant moved away from study city|4
5089086|NCT02043015|17571939|P1|Overall Study|Removed once target enrollment reached|15
5089087|NCT02043015|17571939|P1|Overall Study|Withdrawal by Subject|4
5089088|NCT02043015|17571939|P1|Overall Study|Lost to Follow-up|4
5089089|NCT02042950|17571952|P1|Overall Study|Progressive Disease|4
5089090|NCT02042924|17571958|P1|Overall Study|Early Death|1
5089091|NCT02042443|17572006|P2|Overall Study|Not eligible/not analyzable|6
5089092|NCT02042443|17572007|P1|Overall Study|Not eligible/not analyzable|3
5089093|NCT02042443|17572006|P2|Overall Study|not protocol specified|1
5089094|NCT02042443|17572007|P1|Overall Study|not protocol specified|1
5089095|NCT02042443|17572006|P2|Overall Study|Progression|17
5089096|NCT02042443|17572007|P1|Overall Study|Progression|21
5089097|NCT02042443|17572006|P2|Overall Study|Withdrawal by Subject|1
5089098|NCT02042443|17572007|P1|Overall Study|Withdrawal by Subject|0
5089099|NCT02042443|17572006|P2|Overall Study|Adverse Event|1
5089100|NCT02042443|17572007|P1|Overall Study|Adverse Event|2
5089101|NCT02042404|17572019|P2|Overall Study|Inability to meet time requirements|0
5089102|NCT02042404|17572020|P1|Overall Study|Inability to meet time requirements|1
5089103|NCT02042404|17572019|P2|Overall Study|Unrelated Adverse Event|0
5089104|NCT02042404|17572020|P1|Overall Study|Unrelated Adverse Event|3
5089105|NCT02042404|17572019|P2|Overall Study|Death|0
5089106|NCT02042404|17572020|P1|Overall Study|Death|1
5089107|NCT02042183|17572038|P2|Overall Study|Lost to Follow-up|2
5089108|NCT02042183|17572039|P1|Overall Study|Lost to Follow-up|9
5089109|NCT02042183|17572038|P2|Overall Study|Site Terminated by Sponsor|1
5089110|NCT02042183|17572039|P1|Overall Study|Site Terminated by Sponsor|2
5089111|NCT02042183|17572038|P2|Overall Study|Withdrawal by Subject|16
5089112|NCT02042183|17572039|P1|Overall Study|Withdrawal by Subject|21
5089113|NCT02042183|17572038|P2|Overall Study|Other|3
5089114|NCT02042183|17572039|P1|Overall Study|Other|3
5089115|NCT02042183|17572038|P2|Overall Study|Adverse Event|6
5089116|NCT02042183|17572039|P1|Overall Study|Adverse Event|17
5089117|NCT02042183|17572038|P2|Overall Study|Non-compliance with Study Drug|3
5089118|NCT02042183|17572039|P1|Overall Study|Non-compliance with Study Drug|2
5089119|NCT02042183|17572038|P2|Overall Study|Lack of Efficacy|3
5089120|NCT02042183|17572039|P1|Overall Study|Lack of Efficacy|4
5089121|NCT02042183|17572038|P2|Overall Study|Physician Decision|2
5089122|NCT02042183|17572039|P1|Overall Study|Physician Decision|7
5089123|NCT02042014|17572069|P1|Overall Study|Physician Decision|7
5089124|NCT02042014|17572069|P1|Overall Study|Adverse Event|1
5089125|NCT02041962|17572075|P2|Overall Study|Withdrawal by Subject|11
5089126|NCT02041962|17572076|P1|Overall Study|Withdrawal by Subject|0
5089127|NCT02041962|17572075|P2|Overall Study|Lost to Follow-up|32
5089128|NCT02041962|17572076|P1|Overall Study|Lost to Follow-up|37
5089129|NCT02041962|17572075|P2|Overall Study|Death|1
5089130|NCT02041962|17572076|P1|Overall Study|Death|1
5089131|NCT02041962|17572075|P2|Overall Study|Lost Aetna Coverage|40
5089132|NCT02041962|17572076|P1|Overall Study|Lost Aetna Coverage|43
5089133|NCT02041702|17572086|P2|Overall Study|Cardiac Resynchronization Therapy|0
5089134|NCT02041702|17572087|P1|Overall Study|Cardiac Resynchronization Therapy|1
5089135|NCT02041702|17572086|P2|Overall Study|Patient not confirmed as MRI compatible|0
5089136|NCT02041702|17572087|P1|Overall Study|Patient not confirmed as MRI compatible|1
5089137|NCT02041702|17572086|P2|Overall Study|Withdrawal by Subject|3
5089138|NCT02041702|17572087|P1|Overall Study|Withdrawal by Subject|4
5089139|NCT02041702|17572086|P2|Overall Study|Death|0
5089140|NCT02041702|17572087|P1|Overall Study|Death|4
5089141|NCT02041702|17572086|P2|Overall Study|Lost to Follow-up|6
5089142|NCT02041702|17572087|P1|Overall Study|Lost to Follow-up|1
5089143|NCT02041533|17572102|P2|Overall Study|Randomized, not treated|7
5089144|NCT02041533|17572103|P1|Overall Study|Randomized, not treated|4
5089145|NCT02041533|17572102|P2|Overall Study|Completed max number of chemo cycles|29
5089146|NCT02041533|17572103|P1|Overall Study|Completed max number of chemo cycles|0
5089147|NCT02041533|17572102|P2|Overall Study|Other reasons|1
5089148|NCT02041533|17572103|P1|Overall Study|Other reasons|0
5089149|NCT02041533|17572102|P2|Overall Study|Poor/non-compliance|0
5089150|NCT02041533|17572103|P1|Overall Study|Poor/non-compliance|1
5089151|NCT02041533|17572102|P2|Overall Study|Maximum clinical benefit|18
5089152|NCT02041533|17572103|P1|Overall Study|Maximum clinical benefit|0
5089153|NCT02041533|17572102|P2|Overall Study|Withdrawal by Subject|1
5089154|NCT02041533|17572103|P1|Overall Study|Withdrawal by Subject|2
5089155|NCT02041533|17572102|P2|Overall Study|Subject request to discontinue treatment|9
5089156|NCT02041533|17572103|P1|Overall Study|Subject request to discontinue treatment|5
5089157|NCT02041533|17572102|P2|Overall Study|Adverse Event unrelated to study drug|21
5089158|NCT02041533|17572103|P1|Overall Study|Adverse Event unrelated to study drug|20
5089159|NCT02041533|17572102|P2|Overall Study|Death|0
5089160|NCT02041533|17572103|P1|Overall Study|Death|1
5089161|NCT02041533|17572102|P2|Overall Study|Study drug toxicity|30
5089162|NCT02041533|17572103|P1|Overall Study|Study drug toxicity|27
5089163|NCT02041533|17572102|P2|Overall Study|Disease Progression|142
5089164|NCT02041533|17572103|P1|Overall Study|Disease Progression|168
5089165|NCT02041520|17572125|P2|Overall Study|Hypothiroidism identified during follow-|1
5089166|NCT02041520|17572126|P1|Overall Study|Hypothiroidism identified during follow-|0
5089167|NCT02041520|17572125|P2|Overall Study|Lost to Follow-up|1
5089168|NCT02041520|17572126|P1|Overall Study|Lost to Follow-up|0
5089169|NCT02041520|17572125|P2|Overall Study|Protocol Violation|0
5089170|NCT02041520|17572126|P1|Overall Study|Protocol Violation|1
5089171|NCT02041520|17572125|P2|Overall Study|Withdrawal by Subject|4
5089172|NCT02041520|17572126|P1|Overall Study|Withdrawal by Subject|3
5089173|NCT02041520|17572125|P2|Overall Study|Adverse Event|1
5089174|NCT02041520|17572126|P1|Overall Study|Adverse Event|2
5089175|NCT02041286|17572169|P1|Overall Study|Adverse Event|1
5089176|NCT02041104|17572204|P2|Overall Study|discomfort during OGTT|3
5089177|NCT02041104|17572205|P1|Overall Study|discomfort during OGTT|0
5089178|NCT02041104|17572204|P2|Overall Study|Lost to Follow-up|4
5089179|NCT02041104|17572205|P1|Overall Study|Lost to Follow-up|1
5089180|NCT02041091|17572245|P2|Optional Safety Extension Period|Lost to Follow-up|3
5089181|NCT02041091|17572246|P1|Optional Safety Extension Period|Lost to Follow-up|2
5089182|NCT02041091|17572245|P2|Optional Safety Extension Period|Sponsor Decision|74
5089183|NCT02041091|17572246|P1|Optional Safety Extension Period|Sponsor Decision|70
5089184|NCT02041091|17572245|P2|Optional Safety Extension Period|Physician Decision|1
5089185|NCT02041091|17572246|P1|Optional Safety Extension Period|Physician Decision|2
5089186|NCT02041091|17572245|P2|Optional Safety Extension Period|Protocol Violation|0
5089187|NCT02041091|17572246|P1|Optional Safety Extension Period|Protocol Violation|2
5089188|NCT02041091|17572245|P2|Optional Safety Extension Period|Withdrawal by Subject|2
5089189|NCT02041091|17572246|P1|Optional Safety Extension Period|Withdrawal by Subject|5
5089190|NCT02041091|17572245|P2|Optional Safety Extension Period|Adverse Event|2
5089191|NCT02041091|17572246|P1|Optional Safety Extension Period|Adverse Event|4
5089192|NCT02041091|17572245|P2|Treatment|Lost to Follow-up|0
5089193|NCT02041091|17572246|P1|Treatment|Lost to Follow-up|1
5089194|NCT02041091|17572245|P2|Treatment|Sponsor Decision|16
5089195|NCT02041091|17572246|P1|Treatment|Sponsor Decision|15
5089196|NCT02041091|17572245|P2|Treatment|Physician Decision|0
5089197|NCT02041091|17572246|P1|Treatment|Physician Decision|1
5089198|NCT02041091|17572245|P2|Treatment|Withdrawal by Subject|4
5089199|NCT02041091|17572246|P1|Treatment|Withdrawal by Subject|2
5089200|NCT02041091|17572245|P2|Treatment|Adverse Event|3
5089201|NCT02041091|17572246|P1|Treatment|Adverse Event|3
5089202|NCT02040870|17572268|P1|Overall Study|Death|13
5089203|NCT02040870|17572268|P1|Overall Study|Lost to Follow-up|3
5089204|NCT02040870|17572268|P1|Overall Study|Subject/guardian decision|10
5089205|NCT02040870|17572268|P1|Overall Study|Physician Decision|6
5089206|NCT02040870|17572268|P1|Overall Study|Progressive disease|58
5089207|NCT02040870|17572268|P1|Overall Study|Adverse Event|7
5089208|NCT02040870|17572268|P1|Overall Study|Completed treatment phase|6
5089209|NCT02040844|17572292|P3|Overall Study|Concomitant medication|1
5089210|NCT02040844|17572293|P2|Overall Study|Concomitant medication|3
5089211|NCT02040844|17572294|P1|Overall Study|Concomitant medication|1
5089212|NCT02040844|17572292|P3|Overall Study|Non-specified|5
5089213|NCT02040844|17572293|P2|Overall Study|Non-specified|2
5089214|NCT02040844|17572294|P1|Overall Study|Non-specified|8
5089215|NCT02040844|17572292|P3|Overall Study|Missing|2
5089216|NCT02040844|17572293|P2|Overall Study|Missing|3
5089217|NCT02040844|17572294|P1|Overall Study|Missing|13
5089218|NCT02040844|17572292|P3|Overall Study|Lost to Follow-up|13
5089219|NCT02040844|17572293|P2|Overall Study|Lost to Follow-up|9
5089220|NCT02040844|17572294|P1|Overall Study|Lost to Follow-up|12
5089221|NCT02040844|17572292|P3|Overall Study|Withdrawal by Subject|25
5089222|NCT02040844|17572293|P2|Overall Study|Withdrawal by Subject|22
5089223|NCT02040844|17572294|P1|Overall Study|Withdrawal by Subject|16
5089224|NCT02040844|17572292|P3|Overall Study|Adverse Event|1
5089225|NCT02040844|17572293|P2|Overall Study|Adverse Event|0
5089226|NCT02040844|17572294|P1|Overall Study|Adverse Event|0
5089227|NCT02040805|17572319|P2|Overall Study|Withdrawal by Subject|41
5089228|NCT02040805|17572320|P1|Overall Study|Withdrawal by Subject|28
5089229|NCT02040805|17572319|P2|Overall Study|Lost to Follow-up|9
5089230|NCT02040805|17572320|P1|Overall Study|Lost to Follow-up|14
5089231|NCT02040779|17572356|P3|Overall Study|Lack of Efficacy|0
5089232|NCT02040779|17572357|P2|Overall Study|Lack of Efficacy|2
5089233|NCT02040779|17572358|P1|Overall Study|Lack of Efficacy|4
5089234|NCT02040779|17572356|P3|Overall Study|Lost to Follow-up|1
5089235|NCT02040779|17572357|P2|Overall Study|Lost to Follow-up|2
5089236|NCT02040779|17572358|P1|Overall Study|Lost to Follow-up|1
5089237|NCT02040779|17572356|P3|Overall Study|Protocol Violation|0
5089238|NCT02040779|17572357|P2|Overall Study|Protocol Violation|1
5089239|NCT02040779|17572358|P1|Overall Study|Protocol Violation|2
5089240|NCT02040779|17572356|P3|Overall Study|Non-compliance|0
5089241|NCT02040779|17572357|P2|Overall Study|Non-compliance|1
5089242|NCT02040779|17572358|P1|Overall Study|Non-compliance|0
5089243|NCT02040779|17572356|P3|Overall Study|Withdrawal by Subject|3
5089244|NCT02040779|17572357|P2|Overall Study|Withdrawal by Subject|1
5089245|NCT02040779|17572358|P1|Overall Study|Withdrawal by Subject|4
5089246|NCT02040779|17572356|P3|Overall Study|Adverse Event|0
5089247|NCT02040779|17572357|P2|Overall Study|Adverse Event|0
5089248|NCT02040779|17572358|P1|Overall Study|Adverse Event|1
5089249|NCT02040766|17572398|P5|Overall Study|Lack of Efficacy|5
5089250|NCT02040766|17572399|P4|Overall Study|Lack of Efficacy|6
5089251|NCT02040766|17572400|P3|Overall Study|Lack of Efficacy|4
5089252|NCT02040766|17572401|P2|Overall Study|Lack of Efficacy|3
5089253|NCT02040766|17572402|P1|Overall Study|Lack of Efficacy|6
5089254|NCT02040766|17572398|P5|Overall Study|Not reported|0
5089255|NCT02040766|17572399|P4|Overall Study|Not reported|0
5089256|NCT02040766|17572400|P3|Overall Study|Not reported|0
5089257|NCT02040766|17572401|P2|Overall Study|Not reported|0
5089258|NCT02040766|17572402|P1|Overall Study|Not reported|1
5089259|NCT02040766|17572398|P5|Overall Study|Lost to Follow-up|4
5089260|NCT02040766|17572399|P4|Overall Study|Lost to Follow-up|1
5089261|NCT02040766|17572400|P3|Overall Study|Lost to Follow-up|3
5089262|NCT02040766|17572401|P2|Overall Study|Lost to Follow-up|1
5089263|NCT02040766|17572402|P1|Overall Study|Lost to Follow-up|4
5089264|NCT02040766|17572398|P5|Overall Study|Protocol Violation|0
5089265|NCT02040766|17572399|P4|Overall Study|Protocol Violation|3
5089266|NCT02040766|17572400|P3|Overall Study|Protocol Violation|2
5089267|NCT02040766|17572401|P2|Overall Study|Protocol Violation|1
5089268|NCT02040766|17572402|P1|Overall Study|Protocol Violation|2
5089269|NCT02040766|17572398|P5|Overall Study|Non-compliance|0
5089270|NCT02040766|17572399|P4|Overall Study|Non-compliance|0
5089271|NCT02040766|17572400|P3|Overall Study|Non-compliance|0
5089272|NCT02040766|17572401|P2|Overall Study|Non-compliance|1
5089273|NCT02040766|17572402|P1|Overall Study|Non-compliance|0
5089274|NCT02040766|17572398|P5|Overall Study|Withdrawal by Subject|2
5089275|NCT02040766|17572399|P4|Overall Study|Withdrawal by Subject|3
5089276|NCT02040766|17572400|P3|Overall Study|Withdrawal by Subject|2
5089277|NCT02040766|17572401|P2|Overall Study|Withdrawal by Subject|3
5089278|NCT02040766|17572402|P1|Overall Study|Withdrawal by Subject|4
5089279|NCT02040766|17572398|P5|Overall Study|Adverse Event|2
5089280|NCT02040766|17572399|P4|Overall Study|Adverse Event|0
5089281|NCT02040766|17572400|P3|Overall Study|Adverse Event|1
5089282|NCT02040766|17572401|P2|Overall Study|Adverse Event|1
5089283|NCT02040766|17572402|P1|Overall Study|Adverse Event|1
5089284|NCT02040584|17572455|P2|Overall Study|Immunosuppressant/prohibited med use|10
5089285|NCT02040584|17572456|P1|Overall Study|Immunosuppressant/prohibited med use|7
5089286|NCT02040584|17572455|P2|Overall Study|Transplant rejection/retransplant|1
5089287|NCT02040584|17572456|P1|Overall Study|Transplant rejection/retransplant|0
5089288|NCT02040584|17572455|P2|Overall Study|Death|3
5089289|NCT02040584|17572456|P1|Overall Study|Death|6
5089290|NCT02040584|17572455|P2|Overall Study|Unsatisfactory therapeutic effect|1
5089291|NCT02040584|17572456|P1|Overall Study|Unsatisfactory therapeutic effect|0
5089292|NCT02040584|17572455|P2|Overall Study|Protocol Violation|11
5089293|NCT02040584|17572456|P1|Overall Study|Protocol Violation|9
5089294|NCT02040584|17572455|P2|Overall Study|Adverse Event|6
5089295|NCT02040584|17572456|P1|Overall Study|Adverse Event|13
5089296|NCT02040532|17572489|P1|Overall Study|Withdrawal by Subject|3
5089297|NCT02040532|17572489|P1|Overall Study|Adverse Event|4
5089298|NCT02040532|17572489|P1|Overall Study|Physician Decision|4
5089299|NCT02040532|17572489|P1|Overall Study|Lost to Follow-up|1
5089300|NCT02040428|17572502|P2|Overall Study|Withdrawal by Subject|1
5089301|NCT02040428|17572503|P1|Overall Study|Withdrawal by Subject|1
5089302|NCT02040428|17572502|P2|Overall Study|Death|3
5089303|NCT02040428|17572503|P1|Overall Study|Death|4
5089304|NCT02040259|17572515|P1|Overall Study|Withdrawal by Subject|4
5089305|NCT02040259|17572515|P1|Overall Study|Assessment not completed|3
5089306|NCT02040259|17572515|P1|Overall Study|Lost to Follow-up|76
5089307|NCT02040259|17572515|P1|Overall Study|Death|280
5089308|NCT02039908|17572589|P4|Phase 2-School Year|Withdrawal by Subject|5
5089309|NCT02039908|17572590|P3|Phase 2-School Year|Withdrawal by Subject|8
5089310|NCT02039908|17572591|P2|Phase 2-School Year|Withdrawal by Subject|0
5089311|NCT02039908|17572592|P1|Phase 2-School Year|Withdrawal by Subject|0
5089312|NCT02039908|17572589|P4|Phase 2-School Year|Protocol Violation|0
5089313|NCT02039908|17572590|P3|Phase 2-School Year|Protocol Violation|3
5089314|NCT02039908|17572591|P2|Phase 2-School Year|Protocol Violation|0
5089315|NCT02039908|17572592|P1|Phase 2-School Year|Protocol Violation|0
5089316|NCT02039908|17572589|P4|Phase 2-School Year|Lost to Follow-up|3
5089317|NCT02039908|17572590|P3|Phase 2-School Year|Lost to Follow-up|1
5089318|NCT02039908|17572591|P2|Phase 2-School Year|Lost to Follow-up|0
5089319|NCT02039908|17572592|P1|Phase 2-School Year|Lost to Follow-up|0
5089320|NCT02039908|17572589|P4|Phase 1-Summer|Protocol Violation|0
5089321|NCT02039908|17572590|P3|Phase 1-Summer|Protocol Violation|0
5089322|NCT02039908|17572591|P2|Phase 1-Summer|Protocol Violation|0
5089323|NCT02039908|17572592|P1|Phase 1-Summer|Protocol Violation|6
5089324|NCT02039908|17572589|P4|Phase 1-Summer|Withdrawal by Subject|0
5089325|NCT02039908|17572590|P3|Phase 1-Summer|Withdrawal by Subject|0
5089326|NCT02039908|17572591|P2|Phase 1-Summer|Withdrawal by Subject|6
5089327|NCT02039908|17572592|P1|Phase 1-Summer|Withdrawal by Subject|7
5089328|NCT02039856|17572606|P2|Overall Study|Withdrawal by Subject|618
5089329|NCT02039856|17572607|P1|Overall Study|Withdrawal by Subject|1573
5089330|NCT02039856|17572606|P2|Overall Study|Lost to Follow-up|206
5089331|NCT02039856|17572607|P1|Overall Study|Lost to Follow-up|388
5089332|NCT02039856|17572606|P2|Overall Study|Partial survey completion|26
5089333|NCT02039856|17572607|P1|Overall Study|Partial survey completion|61
5089334|NCT02039856|17572606|P2|Overall Study|Death|3
5089335|NCT02039856|17572607|P1|Overall Study|Death|5
5089336|NCT02039778|17572639|P1|Overall Study|Never started the protocol treatment|1
5089337|NCT02039778|17572639|P1|Overall Study|Withdrawal by Subject|1
5089338|NCT02039778|17572639|P1|Overall Study|Death|2
5089339|NCT02039687|17572662|P4|Overall Study|treatment assignment could not be confir|0
5089340|NCT02039687|17572663|P3|Overall Study|treatment assignment could not be confir|2
5089341|NCT02039687|17572664|P2|Overall Study|treatment assignment could not be confir|0
5089342|NCT02039687|17572665|P1|Overall Study|treatment assignment could not be confir|0
5089343|NCT02039687|17572662|P4|Overall Study|Withdrawal by Subject|0
5089344|NCT02039687|17572663|P3|Overall Study|Withdrawal by Subject|0
5089345|NCT02039687|17572664|P2|Overall Study|Withdrawal by Subject|1
5089346|NCT02039687|17572665|P1|Overall Study|Withdrawal by Subject|0
5089347|NCT02039687|17572662|P4|Overall Study|Adverse Event|0
5089348|NCT02039687|17572663|P3|Overall Study|Adverse Event|1
5089349|NCT02039687|17572664|P2|Overall Study|Adverse Event|0
5089350|NCT02039687|17572665|P1|Overall Study|Adverse Event|0
5089351|NCT02039674|17572705|P14|Overall Study|Ongoing in Study|3
5089352|NCT02039674|17572706|P13|Overall Study|Ongoing in Study|33
5089353|NCT02039674|17572707|P12|Overall Study|Ongoing in Study|34
5089354|NCT02039674|17572708|P11|Overall Study|Ongoing in Study|1
5089355|NCT02039674|17572709|P10|Overall Study|Ongoing in Study|6
5089356|NCT02039674|17572710|P9|Overall Study|Ongoing in Study|1
5089357|NCT02039674|17572711|P8|Overall Study|Ongoing in Study|0
5089358|NCT02039674|17572712|P7|Overall Study|Ongoing in Study|2
5089359|NCT02039674|17572713|P6|Overall Study|Ongoing in Study|1
5089360|NCT02039674|17572714|P5|Overall Study|Ongoing in Study|3
5089361|NCT02039674|17572715|P4|Overall Study|Ongoing in Study|2
5089362|NCT02039674|17572716|P3|Overall Study|Ongoing in Study|3
5089363|NCT02039674|17572717|P2|Overall Study|Ongoing in Study|2
5089364|NCT02039674|17572718|P1|Overall Study|Ongoing in Study|5
5089365|NCT02039674|17572705|P14|Overall Study|Withdrawal by Subject|2
5089366|NCT02039674|17572706|P13|Overall Study|Withdrawal by Subject|5
5089367|NCT02039674|17572707|P12|Overall Study|Withdrawal by Subject|3
5089368|NCT02039674|17572708|P11|Overall Study|Withdrawal by Subject|1
5089369|NCT02039674|17572709|P10|Overall Study|Withdrawal by Subject|2
5089370|NCT02039674|17572710|P9|Overall Study|Withdrawal by Subject|0
5089371|NCT02039674|17572711|P8|Overall Study|Withdrawal by Subject|0
5089372|NCT02039674|17572712|P7|Overall Study|Withdrawal by Subject|0
5089373|NCT02039674|17572713|P6|Overall Study|Withdrawal by Subject|0
5089374|NCT02039674|17572714|P5|Overall Study|Withdrawal by Subject|1
5089375|NCT02039674|17572715|P4|Overall Study|Withdrawal by Subject|0
5089376|NCT02039674|17572716|P3|Overall Study|Withdrawal by Subject|1
5089377|NCT02039674|17572717|P2|Overall Study|Withdrawal by Subject|2
5089378|NCT02039674|17572718|P1|Overall Study|Withdrawal by Subject|0
5089379|NCT02039674|17572705|P14|Overall Study|Progressive Disease|16
5089380|NCT02039674|17572706|P13|Overall Study|Progressive Disease|18
5089381|NCT02039674|17572707|P12|Overall Study|Progressive Disease|17
5089382|NCT02039674|17572708|P11|Overall Study|Progressive Disease|0
5089383|NCT02039674|17572709|P10|Overall Study|Progressive Disease|2
5089384|NCT02039674|17572710|P9|Overall Study|Progressive Disease|7
5089385|NCT02039674|17572711|P8|Overall Study|Progressive Disease|3
5089386|NCT02039674|17572712|P7|Overall Study|Progressive Disease|1
5089387|NCT02039674|17572713|P6|Overall Study|Progressive Disease|10
5089388|NCT02039674|17572714|P5|Overall Study|Progressive Disease|8
5089389|NCT02039674|17572715|P4|Overall Study|Progressive Disease|7
5089390|NCT02039674|17572716|P3|Overall Study|Progressive Disease|6
5089391|NCT02039674|17572717|P2|Overall Study|Progressive Disease|7
5089392|NCT02039674|17572718|P1|Overall Study|Progressive Disease|6
5089393|NCT02039674|17572705|P14|Overall Study|Physician Decision|0
5089394|NCT02039674|17572706|P13|Overall Study|Physician Decision|0
5089395|NCT02039674|17572707|P12|Overall Study|Physician Decision|1
5089396|NCT02039674|17572708|P11|Overall Study|Physician Decision|0
5089397|NCT02039674|17572709|P10|Overall Study|Physician Decision|0
5089398|NCT02039674|17572710|P9|Overall Study|Physician Decision|0
5089399|NCT02039674|17572711|P8|Overall Study|Physician Decision|0
5089400|NCT02039674|17572712|P7|Overall Study|Physician Decision|0
5089401|NCT02039674|17572713|P6|Overall Study|Physician Decision|0
5089402|NCT02039674|17572714|P5|Overall Study|Physician Decision|0
5089403|NCT02039674|17572715|P4|Overall Study|Physician Decision|0
5089404|NCT02039674|17572716|P3|Overall Study|Physician Decision|0
5089405|NCT02039674|17572717|P2|Overall Study|Physician Decision|0
5089406|NCT02039674|17572718|P1|Overall Study|Physician Decision|0
5089407|NCT02039674|17572705|P14|Overall Study|Lost to Follow-up|0
5089408|NCT02039674|17572706|P13|Overall Study|Lost to Follow-up|1
5089409|NCT02039674|17572707|P12|Overall Study|Lost to Follow-up|0
5089410|NCT02039674|17572708|P11|Overall Study|Lost to Follow-up|0
5089411|NCT02039674|17572709|P10|Overall Study|Lost to Follow-up|0
5089412|NCT02039674|17572710|P9|Overall Study|Lost to Follow-up|0
5089413|NCT02039674|17572711|P8|Overall Study|Lost to Follow-up|0
5089414|NCT02039674|17572712|P7|Overall Study|Lost to Follow-up|0
5089415|NCT02039674|17572713|P6|Overall Study|Lost to Follow-up|0
5089416|NCT02039674|17572714|P5|Overall Study|Lost to Follow-up|0
5089417|NCT02039674|17572715|P4|Overall Study|Lost to Follow-up|0
5089418|NCT02039674|17572716|P3|Overall Study|Lost to Follow-up|0
5089419|NCT02039674|17572717|P2|Overall Study|Lost to Follow-up|0
5089420|NCT02039674|17572718|P1|Overall Study|Lost to Follow-up|0
5089421|NCT02039674|17572705|P14|Overall Study|Excluded Medication|3
5089422|NCT02039674|17572706|P13|Overall Study|Excluded Medication|4
5089423|NCT02039674|17572707|P12|Overall Study|Excluded Medication|2
5089424|NCT02039674|17572708|P11|Overall Study|Excluded Medication|4
5089425|NCT02039674|17572709|P10|Overall Study|Excluded Medication|2
5089426|NCT02039674|17572710|P9|Overall Study|Excluded Medication|2
5089427|NCT02039674|17572711|P8|Overall Study|Excluded Medication|0
5089428|NCT02039674|17572712|P7|Overall Study|Excluded Medication|0
5089429|NCT02039674|17572713|P6|Overall Study|Excluded Medication|1
5089430|NCT02039674|17572714|P5|Overall Study|Excluded Medication|0
5089431|NCT02039674|17572715|P4|Overall Study|Excluded Medication|1
5089432|NCT02039674|17572716|P3|Overall Study|Excluded Medication|0
5089433|NCT02039674|17572717|P2|Overall Study|Excluded Medication|1
5089434|NCT02039674|17572718|P1|Overall Study|Excluded Medication|1
5089435|NCT02039674|17572705|P14|Overall Study|Death|8
5089436|NCT02039674|17572706|P13|Overall Study|Death|0
5089437|NCT02039674|17572707|P12|Overall Study|Death|1
5089438|NCT02039674|17572708|P11|Overall Study|Death|1
5089439|NCT02039674|17572709|P10|Overall Study|Death|0
5089440|NCT02039674|17572710|P9|Overall Study|Death|0
5089441|NCT02039674|17572711|P8|Overall Study|Death|0
5089442|NCT02039674|17572712|P7|Overall Study|Death|0
5089443|NCT02039674|17572713|P6|Overall Study|Death|0
5089444|NCT02039674|17572714|P5|Overall Study|Death|0
5089445|NCT02039674|17572715|P4|Overall Study|Death|2
5089446|NCT02039674|17572716|P3|Overall Study|Death|1
5089447|NCT02039674|17572717|P2|Overall Study|Death|0
5089448|NCT02039674|17572718|P1|Overall Study|Death|0
5089449|NCT02039674|17572705|P14|Overall Study|Adverse Event|1
5089450|NCT02039674|17572706|P13|Overall Study|Adverse Event|2
5089451|NCT02039674|17572707|P12|Overall Study|Adverse Event|2
5089452|NCT02039674|17572708|P11|Overall Study|Adverse Event|0
5089453|NCT02039674|17572709|P10|Overall Study|Adverse Event|0
5089454|NCT02039674|17572710|P9|Overall Study|Adverse Event|2
5089455|NCT02039674|17572711|P8|Overall Study|Adverse Event|0
5089456|NCT02039674|17572712|P7|Overall Study|Adverse Event|0
5089457|NCT02039674|17572713|P6|Overall Study|Adverse Event|0
5089458|NCT02039674|17572714|P5|Overall Study|Adverse Event|0
5089459|NCT02039674|17572715|P4|Overall Study|Adverse Event|1
5089460|NCT02039674|17572716|P3|Overall Study|Adverse Event|1
5089461|NCT02039674|17572717|P2|Overall Study|Adverse Event|0
5089462|NCT02039674|17572718|P1|Overall Study|Adverse Event|0
5089463|NCT02039505|17572760|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
5089464|NCT02039505|17572761|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5089465|NCT02039505|17572762|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5089466|NCT02039505|17572763|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5089467|NCT02039505|17572764|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5089468|NCT02039505|17572765|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5089469|NCT02039505|17572766|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5089470|NCT02039505|17572760|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
5089471|NCT02039505|17572761|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5089472|NCT02039505|17572762|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5089473|NCT02039505|17572763|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5089474|NCT02039505|17572764|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5089475|NCT02039505|17572765|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5089476|NCT02039505|17572766|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5089477|NCT02039505|17572760|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
5089478|NCT02039505|17572761|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5089479|NCT02039505|17572762|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5089480|NCT02039505|17572763|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5089481|NCT02039505|17572764|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5089482|NCT02039505|17572765|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5089483|NCT02039505|17572766|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5089484|NCT02039505|17572760|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
5089485|NCT02039505|17572761|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5089486|NCT02039505|17572762|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5089487|NCT02039505|17572763|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5089488|NCT02039505|17572764|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5089489|NCT02039505|17572765|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5089490|NCT02039505|17572766|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5089491|NCT02039505|17572760|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5089492|NCT02039505|17572761|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5089493|NCT02039505|17572762|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5089494|NCT02039505|17572763|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
5089495|NCT02039505|17572764|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5089496|NCT02039505|17572765|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5089497|NCT02039505|17572766|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5089498|NCT02039505|17572760|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5089499|NCT02039505|17572761|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
5089500|NCT02039505|17572762|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
5089501|NCT02039505|17572763|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
5089502|NCT02039505|17572764|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5089503|NCT02039505|17572765|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5089504|NCT02039505|17572766|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5089505|NCT02039505|17572760|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5089506|NCT02039505|17572761|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
5089507|NCT02039505|17572762|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
5089508|NCT02039505|17572763|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
5089509|NCT02039505|17572764|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5089510|NCT02039505|17572765|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5089511|NCT02039505|17572766|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5089512|NCT02039505|17572760|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5089513|NCT02039505|17572761|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
5089514|NCT02039505|17572762|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
5089515|NCT02039505|17572763|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
5089516|NCT02039505|17572764|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5089517|NCT02039505|17572765|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5089518|NCT02039505|17572766|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5089519|NCT02039505|17572760|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5089520|NCT02039505|17572761|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5089521|NCT02039505|17572762|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5089522|NCT02039505|17572763|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5089523|NCT02039505|17572764|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5089524|NCT02039505|17572765|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5089525|NCT02039505|17572766|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
5089526|NCT02039505|17572760|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5089527|NCT02039505|17572761|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5089528|NCT02039505|17572762|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5089529|NCT02039505|17572763|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5089530|NCT02039505|17572764|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
5089531|NCT02039505|17572765|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
5089532|NCT02039505|17572766|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
5089533|NCT02039505|17572760|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5089534|NCT02039505|17572761|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5089535|NCT02039505|17572762|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5089536|NCT02039505|17572763|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5089537|NCT02039505|17572764|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
5089538|NCT02039505|17572765|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
5089539|NCT02039505|17572766|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
5089540|NCT02039427|17572842|P4|Overall Study|Steroid Use|0
5089541|NCT02039427|17572843|P3|Overall Study|Steroid Use|0
5089542|NCT02039427|17572844|P2|Overall Study|Steroid Use|0
5089543|NCT02039427|17572845|P1|Overall Study|Steroid Use|1
5089544|NCT02039427|17572842|P4|Overall Study|Loss of follow - up|4
5089545|NCT02039427|17572843|P3|Overall Study|Loss of follow - up|2
5089546|NCT02039427|17572844|P2|Overall Study|Loss of follow - up|0
5089547|NCT02039427|17572845|P1|Overall Study|Loss of follow - up|1
5089548|NCT02039427|17572842|P4|Overall Study|Cancellation of surgery|0
5089549|NCT02039427|17572843|P3|Overall Study|Cancellation of surgery|1
5089550|NCT02039427|17572844|P2|Overall Study|Cancellation of surgery|0
5089551|NCT02039427|17572845|P1|Overall Study|Cancellation of surgery|0
5089552|NCT02039427|17572842|P4|Overall Study|Withdrawal on concent|1
5089553|NCT02039427|17572843|P3|Overall Study|Withdrawal on concent|0
5089554|NCT02039427|17572844|P2|Overall Study|Withdrawal on concent|0
5089555|NCT02039427|17572845|P1|Overall Study|Withdrawal on concent|0
5089556|NCT02039427|17572842|P4|Overall Study|Duration of surgery > 3h|0
5089557|NCT02039427|17572843|P3|Overall Study|Duration of surgery > 3h|0
5089558|NCT02039427|17572844|P2|Overall Study|Duration of surgery > 3h|1
5089559|NCT02039427|17572845|P1|Overall Study|Duration of surgery > 3h|1
5089560|NCT02039414|17572865|P2|Overall Study|Protocol Violation|1
5089561|NCT02039414|17572866|P1|Overall Study|Protocol Violation|3
5089562|NCT02039414|17572865|P2|Overall Study|Lost to Follow-up|0
5089563|NCT02039414|17572866|P1|Overall Study|Lost to Follow-up|2
5089564|NCT02039414|17572865|P2|Overall Study|Delivered|1
5089565|NCT02039414|17572866|P1|Overall Study|Delivered|1
5089566|NCT02039375|17572878|P1|Overall Study|Lost to Follow-up|2
5089567|NCT02039219|17572889|P2|Follow up|Adverse Event|1
5089568|NCT02039219|17572890|P1|Follow up|Adverse Event|0
5089569|NCT02039219|17572889|P2|Treatment|Death|0
5089570|NCT02039219|17572890|P1|Treatment|Death|1
5089571|NCT02039219|17572889|P2|Treatment|Protocol Violation|0
5089572|NCT02039219|17572890|P1|Treatment|Protocol Violation|1
5089573|NCT02039219|17572889|P2|Treatment|Lost to Follow-up|1
5089574|NCT02039219|17572890|P1|Treatment|Lost to Follow-up|0
5089575|NCT02039219|17572889|P2|Treatment|Physician Decision|0
5089576|NCT02039219|17572890|P1|Treatment|Physician Decision|1
5089577|NCT02039219|17572889|P2|Treatment|Adverse Event|1
5089578|NCT02039219|17572890|P1|Treatment|Adverse Event|0
5089579|NCT02039219|17572889|P2|Treatment|Withdrawal by Subject|0
5089580|NCT02039219|17572890|P1|Treatment|Withdrawal by Subject|1
5089581|NCT02038959|17572939|P2|Overall Study|Withdrawal by Subject|8
5089582|NCT02038959|17572940|P1|Overall Study|Withdrawal by Subject|6
5089583|NCT02038946|17572966|P1|Overall Study|Other reasons|1
5089584|NCT02038946|17572966|P1|Overall Study|Lost to Follow-up|2
5089585|NCT02038946|17572966|P1|Overall Study|Withdrawal by Subject|3
5089586|NCT02038946|17572966|P1|Overall Study|Death|5
5089587|NCT02038933|17572977|P1|Follow-up|Disease Progression|2
5089588|NCT02038933|17572977|P1|Follow-up|Withdrawal by Subject|1
5089589|NCT02038933|17572977|P1|Follow-up|Lost to Follow-up|1
5089590|NCT02038933|17572977|P1|Follow-up|Adverse event unrelated to study drug|4
5089591|NCT02038933|17572977|P1|Follow-up|Death|11
5089592|NCT02038933|17572977|P1|Treatment|Withdrawal by Subject|1
5089593|NCT02038933|17572977|P1|Treatment|Disease Progression|101
5089594|NCT02038933|17572977|P1|Treatment|Study Drug Toxicity|4
5089595|NCT02038933|17572977|P1|Treatment|Adverse Event Unrelated to Study Drug|6
5089596|NCT02038933|17572977|P1|Treatment|Lost to Follow-up|1
5089597|NCT02038933|17572977|P1|Treatment|No longer meets study criteria|1
5089598|NCT02038920|17572998|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
5089599|NCT02038920|17572999|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5089600|NCT02038920|17573000|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5089601|NCT02038920|17573001|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5089602|NCT02038920|17573002|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5089603|NCT02038920|17573003|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5089604|NCT02038920|17572998|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
5089605|NCT02038920|17572999|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5089606|NCT02038920|17573000|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5089607|NCT02038920|17573001|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5089608|NCT02038920|17573002|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5089609|NCT02038920|17573003|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5089610|NCT02038920|17572998|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
5089611|NCT02038920|17572999|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5089612|NCT02038920|17573000|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5089613|NCT02038920|17573001|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5089614|NCT02038920|17573002|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5089615|NCT02038920|17573003|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5089616|NCT02038920|17572998|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
5089617|NCT02038920|17572999|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5089618|NCT02038920|17573000|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5089619|NCT02038920|17573001|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5089620|NCT02038920|17573002|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5089621|NCT02038920|17573003|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5089622|NCT02038920|17572998|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
5089623|NCT02038920|17572999|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5089624|NCT02038920|17573000|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5089625|NCT02038920|17573001|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5089626|NCT02038920|17573002|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5089627|NCT02038920|17573003|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5089628|NCT02038920|17572998|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
5089629|NCT02038920|17572999|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5089630|NCT02038920|17573000|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5089631|NCT02038920|17573001|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5089632|NCT02038920|17573002|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5089633|NCT02038920|17573003|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5089634|NCT02038920|17572998|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5089635|NCT02038920|17572999|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
5089636|NCT02038920|17573000|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
5089637|NCT02038920|17573001|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
5089638|NCT02038920|17573002|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5089639|NCT02038920|17573003|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5089640|NCT02038920|17572998|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5089641|NCT02038920|17572999|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5089642|NCT02038920|17573000|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5089643|NCT02038920|17573001|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
5089644|NCT02038920|17573002|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5089645|NCT02038920|17573003|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5089646|NCT02038920|17572998|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5089647|NCT02038920|17572999|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
5089648|NCT02038920|17573000|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
5089649|NCT02038920|17573001|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
5089650|NCT02038920|17573002|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5089651|NCT02038920|17573003|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5089652|NCT02038920|17572998|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5089653|NCT02038920|17572999|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5089654|NCT02038920|17573000|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5089655|NCT02038920|17573001|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5089656|NCT02038920|17573002|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
5089657|NCT02038920|17573003|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
5089658|NCT02038920|17572998|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5089659|NCT02038920|17572999|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5089660|NCT02038920|17573000|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5089661|NCT02038920|17573001|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5089662|NCT02038920|17573002|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5089663|NCT02038920|17573003|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
5089664|NCT02038920|17572998|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5089665|NCT02038920|17572999|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5089666|NCT02038920|17573000|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5089667|NCT02038920|17573001|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5089668|NCT02038920|17573002|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
5089669|NCT02038920|17573003|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
5089670|NCT02038907|17573080|P14|Overall Study|Withdrawal by Subject|0
5089671|NCT02038907|17573081|P13|Overall Study|Withdrawal by Subject|0
5089672|NCT02038907|17573082|P12|Overall Study|Withdrawal by Subject|0
5089673|NCT02038907|17573083|P11|Overall Study|Withdrawal by Subject|1
5089674|NCT02038907|17573084|P10|Overall Study|Withdrawal by Subject|0
5089675|NCT02038907|17573085|P9|Overall Study|Withdrawal by Subject|0
5089676|NCT02038907|17573086|P8|Overall Study|Withdrawal by Subject|0
5089677|NCT02038907|17573087|P7|Overall Study|Withdrawal by Subject|0
5089678|NCT02038907|17573088|P6|Overall Study|Withdrawal by Subject|0
5089679|NCT02038907|17573089|P5|Overall Study|Withdrawal by Subject|0
5089680|NCT02038907|17573090|P4|Overall Study|Withdrawal by Subject|0
5089681|NCT02038907|17573091|P3|Overall Study|Withdrawal by Subject|0
5089682|NCT02038907|17573092|P2|Overall Study|Withdrawal by Subject|0
5089683|NCT02038907|17573093|P1|Overall Study|Withdrawal by Subject|0
5089684|NCT02038907|17573080|P14|Overall Study|Protocol Violation|0
5089685|NCT02038907|17573081|P13|Overall Study|Protocol Violation|0
5089686|NCT02038907|17573082|P12|Overall Study|Protocol Violation|0
5089687|NCT02038907|17573083|P11|Overall Study|Protocol Violation|1
5089688|NCT02038907|17573084|P10|Overall Study|Protocol Violation|0
5089689|NCT02038907|17573085|P9|Overall Study|Protocol Violation|0
5089690|NCT02038907|17573086|P8|Overall Study|Protocol Violation|0
5089691|NCT02038907|17573087|P7|Overall Study|Protocol Violation|0
5089692|NCT02038907|17573088|P6|Overall Study|Protocol Violation|0
5089693|NCT02038907|17573089|P5|Overall Study|Protocol Violation|0
5089694|NCT02038907|17573090|P4|Overall Study|Protocol Violation|0
5089695|NCT02038907|17573091|P3|Overall Study|Protocol Violation|0
5089696|NCT02038907|17573092|P2|Overall Study|Protocol Violation|0
5089697|NCT02038907|17573093|P1|Overall Study|Protocol Violation|0
5089698|NCT02038881|17573644|P3|Overall Study|incarcerated|0
5089699|NCT02038881|17573645|P2|Overall Study|incarcerated|0
5089700|NCT02038881|17573646|P1|Overall Study|incarcerated|1
5089701|NCT02038881|17573644|P3|Overall Study|Lost to Follow-up|0
5089702|NCT02038881|17573645|P2|Overall Study|Lost to Follow-up|0
5089703|NCT02038881|17573646|P1|Overall Study|Lost to Follow-up|2
5089704|NCT02038881|17573644|P3|Overall Study|Withdrawal by Subject|1
5089705|NCT02038881|17573645|P2|Overall Study|Withdrawal by Subject|0
5089706|NCT02038881|17573646|P1|Overall Study|Withdrawal by Subject|0
5089707|NCT02038829|17573719|P12|Treatment Period 6|Adverse Event|0
5089708|NCT02038829|17573720|P11|Treatment Period 6|Adverse Event|0
5089709|NCT02038829|17573721|P10|Treatment Period 6|Adverse Event|0
5089710|NCT02038829|17573722|P9|Treatment Period 6|Adverse Event|0
5089711|NCT02038829|17573723|P8|Treatment Period 6|Adverse Event|0
5089712|NCT02038829|17573724|P7|Treatment Period 6|Adverse Event|0
5089713|NCT02038829|17573725|P6|Treatment Period 6|Adverse Event|0
5089714|NCT02038829|17573726|P5|Treatment Period 6|Adverse Event|0
5089715|NCT02038829|17573727|P4|Treatment Period 6|Adverse Event|0
5089716|NCT02038829|17573728|P3|Treatment Period 6|Adverse Event|1
5089717|NCT02038829|17573729|P2|Treatment Period 6|Adverse Event|0
5089718|NCT02038829|17573730|P1|Treatment Period 6|Adverse Event|0
5089719|NCT02038829|17573719|P12|Washout Period 4|Adverse Event|0
5089720|NCT02038829|17573720|P11|Washout Period 4|Adverse Event|0
5089721|NCT02038829|17573721|P10|Washout Period 4|Adverse Event|0
5089722|NCT02038829|17573722|P9|Washout Period 4|Adverse Event|0
5089723|NCT02038829|17573723|P8|Washout Period 4|Adverse Event|0
5089724|NCT02038829|17573724|P7|Washout Period 4|Adverse Event|1
5089725|NCT02038829|17573725|P6|Washout Period 4|Adverse Event|0
5089726|NCT02038829|17573726|P5|Washout Period 4|Adverse Event|0
5089727|NCT02038829|17573727|P4|Washout Period 4|Adverse Event|0
5089728|NCT02038829|17573728|P3|Washout Period 4|Adverse Event|0
5089729|NCT02038829|17573729|P2|Washout Period 4|Adverse Event|0
5089730|NCT02038829|17573730|P1|Washout Period 4|Adverse Event|0
5089731|NCT02038829|17573719|P12|Treatment Period 4|Adverse Event|0
5089732|NCT02038829|17573720|P11|Treatment Period 4|Adverse Event|0
5089733|NCT02038829|17573721|P10|Treatment Period 4|Adverse Event|0
5089734|NCT02038829|17573722|P9|Treatment Period 4|Adverse Event|0
5089735|NCT02038829|17573723|P8|Treatment Period 4|Adverse Event|0
5089736|NCT02038829|17573724|P7|Treatment Period 4|Adverse Event|0
5089737|NCT02038829|17573725|P6|Treatment Period 4|Adverse Event|0
5089738|NCT02038829|17573726|P5|Treatment Period 4|Adverse Event|0
5089739|NCT02038829|17573727|P4|Treatment Period 4|Adverse Event|0
5089740|NCT02038829|17573728|P3|Treatment Period 4|Adverse Event|0
5089741|NCT02038829|17573729|P2|Treatment Period 4|Adverse Event|1
5089742|NCT02038829|17573730|P1|Treatment Period 4|Adverse Event|0
5089743|NCT02038829|17573719|P12|Washout Period 2|Withdrawal by Subject|0
5089744|NCT02038829|17573720|P11|Washout Period 2|Withdrawal by Subject|0
5089745|NCT02038829|17573721|P10|Washout Period 2|Withdrawal by Subject|0
5089746|NCT02038829|17573722|P9|Washout Period 2|Withdrawal by Subject|0
5089747|NCT02038829|17573723|P8|Washout Period 2|Withdrawal by Subject|0
5089748|NCT02038829|17573724|P7|Washout Period 2|Withdrawal by Subject|0
5089749|NCT02038829|17573725|P6|Washout Period 2|Withdrawal by Subject|1
5089750|NCT02038829|17573726|P5|Washout Period 2|Withdrawal by Subject|0
5089751|NCT02038829|17573727|P4|Washout Period 2|Withdrawal by Subject|0
5089752|NCT02038829|17573728|P3|Washout Period 2|Withdrawal by Subject|0
5089753|NCT02038829|17573729|P2|Washout Period 2|Withdrawal by Subject|0
5089754|NCT02038829|17573730|P1|Washout Period 2|Withdrawal by Subject|0
5089755|NCT02038829|17573719|P12|Washout Period 2|Adverse Event|0
5089756|NCT02038829|17573720|P11|Washout Period 2|Adverse Event|0
5089757|NCT02038829|17573721|P10|Washout Period 2|Adverse Event|0
5089758|NCT02038829|17573722|P9|Washout Period 2|Adverse Event|1
5089759|NCT02038829|17573723|P8|Washout Period 2|Adverse Event|0
5089760|NCT02038829|17573724|P7|Washout Period 2|Adverse Event|0
5089761|NCT02038829|17573725|P6|Washout Period 2|Adverse Event|0
5089762|NCT02038829|17573726|P5|Washout Period 2|Adverse Event|0
5089763|NCT02038829|17573727|P4|Washout Period 2|Adverse Event|0
5089764|NCT02038829|17573728|P3|Washout Period 2|Adverse Event|0
5089765|NCT02038829|17573729|P2|Washout Period 2|Adverse Event|0
5089766|NCT02038829|17573730|P1|Washout Period 2|Adverse Event|0
5089767|NCT02038829|17573719|P12|Treatment Period 2|Withdrawal by Subject|0
5089768|NCT02038829|17573720|P11|Treatment Period 2|Withdrawal by Subject|0
5089769|NCT02038829|17573721|P10|Treatment Period 2|Withdrawal by Subject|0
5089770|NCT02038829|17573722|P9|Treatment Period 2|Withdrawal by Subject|0
5089771|NCT02038829|17573723|P8|Treatment Period 2|Withdrawal by Subject|0
5089772|NCT02038829|17573724|P7|Treatment Period 2|Withdrawal by Subject|0
5089773|NCT02038829|17573725|P6|Treatment Period 2|Withdrawal by Subject|0
5089774|NCT02038829|17573726|P5|Treatment Period 2|Withdrawal by Subject|0
5089775|NCT02038829|17573727|P4|Treatment Period 2|Withdrawal by Subject|0
5089776|NCT02038829|17573728|P3|Treatment Period 2|Withdrawal by Subject|0
5089777|NCT02038829|17573729|P2|Treatment Period 2|Withdrawal by Subject|0
5089778|NCT02038829|17573730|P1|Treatment Period 2|Withdrawal by Subject|1
5089779|NCT02038829|17573719|P12|Treatment Period 2|Adverse Event|0
5089780|NCT02038829|17573720|P11|Treatment Period 2|Adverse Event|1
5089781|NCT02038829|17573721|P10|Treatment Period 2|Adverse Event|0
5089782|NCT02038829|17573722|P9|Treatment Period 2|Adverse Event|0
5089783|NCT02038829|17573723|P8|Treatment Period 2|Adverse Event|0
5089784|NCT02038829|17573724|P7|Treatment Period 2|Adverse Event|0
5089785|NCT02038829|17573725|P6|Treatment Period 2|Adverse Event|0
5089786|NCT02038829|17573726|P5|Treatment Period 2|Adverse Event|0
5089787|NCT02038829|17573727|P4|Treatment Period 2|Adverse Event|0
5089788|NCT02038829|17573728|P3|Treatment Period 2|Adverse Event|0
5089789|NCT02038829|17573729|P2|Treatment Period 2|Adverse Event|0
5089790|NCT02038829|17573730|P1|Treatment Period 2|Adverse Event|0
5089791|NCT02038829|17573719|P12|Washout Period 1|Death|0
5089792|NCT02038829|17573720|P11|Washout Period 1|Death|0
5089793|NCT02038829|17573721|P10|Washout Period 1|Death|0
5089794|NCT02038829|17573722|P9|Washout Period 1|Death|0
5089795|NCT02038829|17573723|P8|Washout Period 1|Death|0
5089796|NCT02038829|17573724|P7|Washout Period 1|Death|0
5089797|NCT02038829|17573725|P6|Washout Period 1|Death|0
5089798|NCT02038829|17573726|P5|Washout Period 1|Death|1
5089799|NCT02038829|17573727|P4|Washout Period 1|Death|0
5089800|NCT02038829|17573728|P3|Washout Period 1|Death|0
5089801|NCT02038829|17573729|P2|Washout Period 1|Death|0
5089802|NCT02038829|17573730|P1|Washout Period 1|Death|0
5089803|NCT02038790|17573764|P2|Day 0 - First Treatment|Withdrawal by Subject|1
5089804|NCT02038790|17573765|P1|Day 0 - First Treatment|Withdrawal by Subject|1
5089805|NCT02038764|17573801|P5|Overall Study|Other|0
5089806|NCT02038764|17573802|P4|Overall Study|Other|0
5089807|NCT02038764|17573803|P3|Overall Study|Other|1
5089808|NCT02038764|17573804|P2|Overall Study|Other|0
5089809|NCT02038764|17573805|P1|Overall Study|Other|1
5089810|NCT02038764|17573801|P5|Overall Study|Withdrawal by Subject|1
5089811|NCT02038764|17573802|P4|Overall Study|Withdrawal by Subject|0
5089812|NCT02038764|17573803|P3|Overall Study|Withdrawal by Subject|0
5089813|NCT02038764|17573804|P2|Overall Study|Withdrawal by Subject|0
5089814|NCT02038764|17573805|P1|Overall Study|Withdrawal by Subject|0
5089815|NCT02038764|17573801|P5|Overall Study|Lost to Follow-up|0
5089816|NCT02038764|17573802|P4|Overall Study|Lost to Follow-up|0
5089817|NCT02038764|17573803|P3|Overall Study|Lost to Follow-up|0
5089818|NCT02038764|17573804|P2|Overall Study|Lost to Follow-up|1
5089819|NCT02038764|17573805|P1|Overall Study|Lost to Follow-up|0
5089820|NCT02038764|17573801|P5|Overall Study|Adverse Event|0
5089821|NCT02038764|17573802|P4|Overall Study|Adverse Event|0
5089822|NCT02038764|17573803|P3|Overall Study|Adverse Event|1
5089823|NCT02038764|17573804|P2|Overall Study|Adverse Event|0
5089824|NCT02038764|17573805|P1|Overall Study|Adverse Event|0
5089825|NCT02038647|17573907|P2|Overall Study|Ongoing at Datacut|10
5089826|NCT02038647|17573908|P1|Overall Study|Ongoing at Datacut|9
5089827|NCT02038647|17573907|P2|Overall Study|Not Reported|1
5089828|NCT02038647|17573908|P1|Overall Study|Not Reported|0
5089829|NCT02038647|17573907|P2|Overall Study|Withdrawal by Subject|2
5089830|NCT02038647|17573908|P1|Overall Study|Withdrawal by Subject|5
5089831|NCT02038647|17573907|P2|Overall Study|Symptomatic Deterioration|7
5089832|NCT02038647|17573908|P1|Overall Study|Symptomatic Deterioration|7
5089833|NCT02038647|17573907|P2|Overall Study|Adverse Event|10
5089834|NCT02038647|17573908|P1|Overall Study|Adverse Event|18
5089835|NCT02038647|17573907|P2|Overall Study|Progressive Disease|59
5089836|NCT02038647|17573908|P1|Overall Study|Progressive Disease|50
5089837|NCT02038543|17573971|P4|Overall Study|Withdrawal by Subject|1
5089838|NCT02038543|17573972|P3|Overall Study|Withdrawal by Subject|0
5089839|NCT02038543|17573973|P2|Overall Study|Withdrawal by Subject|0
5089840|NCT02038543|17573974|P1|Overall Study|Withdrawal by Subject|0
5089841|NCT02038543|17573971|P4|Overall Study|Screen Failure|1
5089842|NCT02038543|17573972|P3|Overall Study|Screen Failure|0
5089843|NCT02038543|17573973|P2|Overall Study|Screen Failure|0
5089844|NCT02038543|17573974|P1|Overall Study|Screen Failure|0
5089845|NCT02038153|17574010|P1|Overall Study|Withdrawal by Subject|1
5089846|NCT02038075|17574017|P2|Overall Study|Withdrawal by Subject|0
5089847|NCT02038075|17574018|P1|Overall Study|Withdrawal by Subject|3
5089848|NCT02038049|17574026|P2|Overall Study|Lost to Follow-up|0
5089849|NCT02038049|17574027|P1|Overall Study|Lost to Follow-up|1
5089850|NCT02038010|17574056|P4|Follow Up|Other|0
5089851|NCT02038010|17574057|P3|Follow Up|Other|0
5089852|NCT02038010|17574058|P2|Follow Up|Other|0
5089853|NCT02038010|17574059|P1|Follow Up|Other|3
5089854|NCT02038010|17574056|P4|Follow Up|Death|0
5089855|NCT02038010|17574057|P3|Follow Up|Death|0
5089856|NCT02038010|17574058|P2|Follow Up|Death|3
5089857|NCT02038010|17574059|P1|Follow Up|Death|4
5089858|NCT02038010|17574056|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
5089859|NCT02038010|17574057|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
5089860|NCT02038010|17574058|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
5089861|NCT02038010|17574059|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
5089862|NCT02038010|17574056|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5089863|NCT02038010|17574057|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5089864|NCT02038010|17574058|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
5089865|NCT02038010|17574059|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5089866|NCT02038010|17574056|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5089867|NCT02038010|17574057|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5089868|NCT02038010|17574058|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5089869|NCT02038010|17574059|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
5089870|NCT02038010|17574056|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5089871|NCT02038010|17574057|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5089872|NCT02038010|17574058|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
5089873|NCT02038010|17574059|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5089874|NCT02037984|17574086|P8|Overall Study|Withdrawal by Subject|1
5089875|NCT02037984|17574087|P7|Overall Study|Withdrawal by Subject|0
5089876|NCT02037984|17574088|P6|Overall Study|Withdrawal by Subject|3
5089877|NCT02037984|17574089|P5|Overall Study|Withdrawal by Subject|1
5089878|NCT02037984|17574090|P4|Overall Study|Withdrawal by Subject|1
5089879|NCT02037984|17574091|P3|Overall Study|Withdrawal by Subject|0
5089880|NCT02037984|17574092|P2|Overall Study|Withdrawal by Subject|0
5089881|NCT02037984|17574093|P1|Overall Study|Withdrawal by Subject|0
5089882|NCT02037984|17574086|P8|Overall Study|Withdrawal by Parent/Guardian|2
5089883|NCT02037984|17574087|P7|Overall Study|Withdrawal by Parent/Guardian|4
5089884|NCT02037984|17574088|P6|Overall Study|Withdrawal by Parent/Guardian|1
5089885|NCT02037984|17574089|P5|Overall Study|Withdrawal by Parent/Guardian|5
5089886|NCT02037984|17574090|P4|Overall Study|Withdrawal by Parent/Guardian|2
5089887|NCT02037984|17574091|P3|Overall Study|Withdrawal by Parent/Guardian|3
5089888|NCT02037984|17574092|P2|Overall Study|Withdrawal by Parent/Guardian|0
5089889|NCT02037984|17574093|P1|Overall Study|Withdrawal by Parent/Guardian|0
5089890|NCT02037984|17574086|P8|Overall Study|Technical Problems|2
5089891|NCT02037984|17574087|P7|Overall Study|Technical Problems|4
5089892|NCT02037984|17574088|P6|Overall Study|Technical Problems|3
5089893|NCT02037984|17574089|P5|Overall Study|Technical Problems|2
5089894|NCT02037984|17574090|P4|Overall Study|Technical Problems|3
5089895|NCT02037984|17574091|P3|Overall Study|Technical Problems|3
5089896|NCT02037984|17574092|P2|Overall Study|Technical Problems|0
5089897|NCT02037984|17574093|P1|Overall Study|Technical Problems|0
5089898|NCT02037984|17574086|P8|Overall Study|Protocol Violation|0
5089899|NCT02037984|17574087|P7|Overall Study|Protocol Violation|2
5089900|NCT02037984|17574088|P6|Overall Study|Protocol Violation|1
5089901|NCT02037984|17574089|P5|Overall Study|Protocol Violation|0
5089902|NCT02037984|17574090|P4|Overall Study|Protocol Violation|0
5089903|NCT02037984|17574091|P3|Overall Study|Protocol Violation|0
5089904|NCT02037984|17574092|P2|Overall Study|Protocol Violation|0
5089905|NCT02037984|17574093|P1|Overall Study|Protocol Violation|0
5089906|NCT02037984|17574086|P8|Overall Study|Physician Decision|0
5089907|NCT02037984|17574087|P7|Overall Study|Physician Decision|1
5089908|NCT02037984|17574088|P6|Overall Study|Physician Decision|0
5089909|NCT02037984|17574089|P5|Overall Study|Physician Decision|0
5089910|NCT02037984|17574090|P4|Overall Study|Physician Decision|0
5089911|NCT02037984|17574091|P3|Overall Study|Physician Decision|0
5089912|NCT02037984|17574092|P2|Overall Study|Physician Decision|0
5089913|NCT02037984|17574093|P1|Overall Study|Physician Decision|0
5089914|NCT02037984|17574086|P8|Overall Study|Lost to Follow-up|4
5089915|NCT02037984|17574087|P7|Overall Study|Lost to Follow-up|2
5089916|NCT02037984|17574088|P6|Overall Study|Lost to Follow-up|2
5089917|NCT02037984|17574089|P5|Overall Study|Lost to Follow-up|2
5089918|NCT02037984|17574090|P4|Overall Study|Lost to Follow-up|5
5089919|NCT02037984|17574091|P3|Overall Study|Lost to Follow-up|3
5089920|NCT02037984|17574092|P2|Overall Study|Lost to Follow-up|0
5089921|NCT02037984|17574093|P1|Overall Study|Lost to Follow-up|1
5089922|NCT02037984|17574086|P8|Overall Study|Lack of Efficacy|3
5089923|NCT02037984|17574087|P7|Overall Study|Lack of Efficacy|4
5089924|NCT02037984|17574088|P6|Overall Study|Lack of Efficacy|2
5089925|NCT02037984|17574089|P5|Overall Study|Lack of Efficacy|2
5089926|NCT02037984|17574090|P4|Overall Study|Lack of Efficacy|10
5089927|NCT02037984|17574091|P3|Overall Study|Lack of Efficacy|3
5089928|NCT02037984|17574092|P2|Overall Study|Lack of Efficacy|0
5089929|NCT02037984|17574093|P1|Overall Study|Lack of Efficacy|0
5089930|NCT02037568|17574238|P2|Overall Study|Patient did not receive transplant|1
5089931|NCT02037568|17574239|P1|Overall Study|Patient did not receive transplant|0
5089932|NCT02037568|17574238|P2|Overall Study|Screen Failure|1
5089933|NCT02037568|17574239|P1|Overall Study|Screen Failure|3
5089934|NCT02037568|17574238|P2|Overall Study|Lost to Follow-up|13
5089935|NCT02037568|17574239|P1|Overall Study|Lost to Follow-up|16
5089936|NCT02037568|17574238|P2|Overall Study|Withdrawal by Subject|24
5089937|NCT02037568|17574239|P1|Overall Study|Withdrawal by Subject|17
5089938|NCT02037477|17574274|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5089939|NCT02037477|17574275|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
5089940|NCT02037477|17574276|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5089941|NCT02037477|17574277|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5089942|NCT02037295|17574372|P4|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
5089943|NCT02037295|17574373|P3|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
5089944|NCT02037295|17574374|P2|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
5089945|NCT02037295|17574375|P1|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
5089946|NCT02037165|17574431|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
5089947|NCT02037165|17574432|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5089948|NCT02037165|17574433|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5089949|NCT02037165|17574434|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5089950|NCT02037165|17574435|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5089951|NCT02036775|17574495|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
5089952|NCT02036775|17574496|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5089953|NCT02036775|17574497|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5089954|NCT02036775|17574498|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5089955|NCT02036775|17574499|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5089956|NCT02036775|17574500|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5089957|NCT02036645|17574550|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089958|NCT02036645|17574551|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089959|NCT02036645|17574552|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089960|NCT02036645|17574553|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089961|NCT02036645|17574554|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089962|NCT02036645|17574555|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089963|NCT02036645|17574556|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089964|NCT02036645|17574557|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089965|NCT02036645|17574558|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
5089966|NCT02036645|17574559|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089967|NCT02036645|17574560|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089968|NCT02036645|17574561|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5089969|NCT02036645|17574550|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089970|NCT02036645|17574551|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089971|NCT02036645|17574552|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089972|NCT02036645|17574553|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089973|NCT02036645|17574554|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089974|NCT02036645|17574555|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
5089975|NCT02036645|17574556|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089976|NCT02036645|17574557|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089977|NCT02036645|17574558|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089978|NCT02036645|17574559|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089979|NCT02036645|17574560|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089980|NCT02036645|17574561|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5089981|NCT02036580|17574666|P3|Overall Study|Adverse Event|0
5089982|NCT02036580|17574667|P2|Overall Study|Adverse Event|0
5089983|NCT02036580|17574668|P1|Overall Study|Adverse Event|1
5089984|NCT02036580|17574666|P3|Overall Study|Withdrawal by Subject|0
5089985|NCT02036580|17574667|P2|Overall Study|Withdrawal by Subject|1
5089986|NCT02036580|17574668|P1|Overall Study|Withdrawal by Subject|0
5089987|NCT02036515|17574689|P3|Overall Study|Hyperglycemia|1
5089988|NCT02036515|17574690|P2|Overall Study|Hyperglycemia|0
5089989|NCT02036515|17574691|P1|Overall Study|Hyperglycemia|0
5089990|NCT02036515|17574689|P3|Overall Study|Withdrawal by Subject|9
5089991|NCT02036515|17574690|P2|Overall Study|Withdrawal by Subject|7
5089992|NCT02036515|17574691|P1|Overall Study|Withdrawal by Subject|4
5089993|NCT02036515|17574689|P3|Overall Study|Screen failure|0
5089994|NCT02036515|17574690|P2|Overall Study|Screen failure|2
5089995|NCT02036515|17574691|P1|Overall Study|Screen failure|0
5089996|NCT02036515|17574689|P3|Overall Study|Non-compliance with study drug|2
5089997|NCT02036515|17574690|P2|Overall Study|Non-compliance with study drug|0
5089998|NCT02036515|17574691|P1|Overall Study|Non-compliance with study drug|0
5089999|NCT02036515|17574689|P3|Overall Study|Lost to Follow-up|0
5090000|NCT02036515|17574690|P2|Overall Study|Lost to Follow-up|2
5090001|NCT02036515|17574691|P1|Overall Study|Lost to Follow-up|0
5090002|NCT02036515|17574689|P3|Overall Study|Adverse Event|2
5090003|NCT02036515|17574690|P2|Overall Study|Adverse Event|1
5090004|NCT02036515|17574691|P1|Overall Study|Adverse Event|1
5090005|NCT02036294|17574792|P2|Overall Study|Withdrawal by Subject|3
5090006|NCT02036294|17574793|P1|Overall Study|Withdrawal by Subject|2
5090007|NCT02036294|17574792|P2|Overall Study|Death|8
5090008|NCT02036294|17574793|P1|Overall Study|Death|7
5090009|NCT02035748|17574809|P1|Overall Study|Progressive Disease|1
5090010|NCT02035748|17574809|P1|Overall Study|Withdrawal by Subject|6
5090011|NCT02035748|17574809|P1|Overall Study|Physician Decision|3
5090012|NCT02035748|17574809|P1|Overall Study|Lost to Follow-up|2
5090013|NCT02035748|17574809|P1|Overall Study|Death|3
5090014|NCT02035748|17574809|P1|Overall Study|Adverse Event|5
5090015|NCT02035696|17574823|P4|Overall Study|Withdrawal by Subject|1
5090016|NCT02035696|17574824|P3|Overall Study|Withdrawal by Subject|2
5090017|NCT02035696|17574825|P2|Overall Study|Withdrawal by Subject|0
5090018|NCT02035696|17574826|P1|Overall Study|Withdrawal by Subject|3
5090019|NCT02035696|17574823|P4|Overall Study|Lost to Follow-up|2
5090020|NCT02035696|17574824|P3|Overall Study|Lost to Follow-up|1
5090021|NCT02035696|17574825|P2|Overall Study|Lost to Follow-up|3
5090022|NCT02035696|17574826|P1|Overall Study|Lost to Follow-up|0
5090023|NCT02035553|17574882|P2|Overall Study|Other Reason|4
5090024|NCT02035553|17574883|P1|Overall Study|Other Reason|0
5090025|NCT02035553|17574882|P2|Overall Study|Lost to Follow-up|1
5090026|NCT02035553|17574883|P1|Overall Study|Lost to Follow-up|0
5090027|NCT02035553|17574882|P2|Overall Study|Non-compliance with Study Drug|1
5090028|NCT02035553|17574883|P1|Overall Study|Non-compliance with Study Drug|0
5090029|NCT02035553|17574882|P2|Overall Study|Withdrawal by Subject|7
5090030|NCT02035553|17574883|P1|Overall Study|Withdrawal by Subject|4
5090031|NCT02035553|17574882|P2|Overall Study|Lack of Efficacy|1
5090032|NCT02035553|17574883|P1|Overall Study|Lack of Efficacy|1
5090033|NCT02035553|17574882|P2|Overall Study|Physician Decision|2
5090034|NCT02035553|17574883|P1|Overall Study|Physician Decision|3
5090035|NCT02035553|17574882|P2|Overall Study|Adverse Event|6
5090036|NCT02035553|17574883|P1|Overall Study|Adverse Event|10
5090037|NCT02035553|17574882|P2|Overall Study|Death (See All-Cause Mortality Table)|1
5090038|NCT02035553|17574883|P1|Overall Study|Death (See All-Cause Mortality Table)|0
5090039|NCT02035475|17574889|P1|Overall Study|Equipment Error|1
5090040|NCT02035475|17574889|P1|Overall Study|Physician Decision|1
5090041|NCT02035475|17574889|P1|Overall Study|Withdrawal by Subject|4
5090042|NCT02035332|17574900|P1|Overall Study|Procedure Aborted due to Uterine Width|1
5090043|NCT02035267|17574910|P4|Overall Study|Other unspecified|0
5090044|NCT02035267|17574911|P3|Overall Study|Other unspecified|0
5090045|NCT02035267|17574912|P2|Overall Study|Other unspecified|1
5090046|NCT02035267|17574913|P1|Overall Study|Other unspecified|0
5090047|NCT02035267|17574910|P4|Overall Study|Lost to Follow-up|1
5090048|NCT02035267|17574911|P3|Overall Study|Lost to Follow-up|0
5090049|NCT02035267|17574912|P2|Overall Study|Lost to Follow-up|0
5090050|NCT02035267|17574913|P1|Overall Study|Lost to Follow-up|0
5090051|NCT02035267|17574910|P4|Overall Study|Adverse Event|0
5090052|NCT02035267|17574911|P3|Overall Study|Adverse Event|1
5090053|NCT02035267|17574912|P2|Overall Study|Adverse Event|0
5090054|NCT02035267|17574913|P1|Overall Study|Adverse Event|0
5090055|NCT02035267|17574910|P4|Overall Study|Withdrawal consent-subject convenience|0
5090056|NCT02035267|17574911|P3|Overall Study|Withdrawal consent-subject convenience|1
5090057|NCT02035267|17574912|P2|Overall Study|Withdrawal consent-subject convenience|0
5090058|NCT02035267|17574913|P1|Overall Study|Withdrawal consent-subject convenience|0
5090059|NCT02035202|17574944|P3|Overall Study|Lost to Follow-up|2
5090060|NCT02035202|17574945|P2|Overall Study|Lost to Follow-up|16
5090061|NCT02035202|17574946|P1|Overall Study|Lost to Follow-up|8
5090062|NCT02034916|17574962|P2|Overall Study|Study terminated by sponsor|5
5090063|NCT02034916|17574963|P1|Overall Study|Study terminated by sponsor|4
5090064|NCT02034916|17574962|P2|Overall Study|Lost to Follow-up|1
5090065|NCT02034916|17574963|P1|Overall Study|Lost to Follow-up|4
5090066|NCT02034916|17574962|P2|Overall Study|Withdrawal by Subject|1
5090067|NCT02034916|17574963|P1|Overall Study|Withdrawal by Subject|2
5090068|NCT02034916|17574962|P2|Overall Study|Death|28
5090069|NCT02034916|17574963|P1|Overall Study|Death|39
5090070|NCT02034877|17575000|P2|Overall Study|No Longer Willing to Participate|3
5090071|NCT02034877|17575001|P1|Overall Study|No Longer Willing to Participate|0
5090072|NCT02034877|17575000|P2|Overall Study|Lost to Follow-up|3
5090073|NCT02034877|17575001|P1|Overall Study|Lost to Follow-up|0
5090074|NCT02034799|17575019|P2|Overall Study|Death|1
5090075|NCT02034799|17575020|P1|Overall Study|Death|2
5090076|NCT02034799|17575019|P2|Overall Study|Lost to Follow-up|1
5090077|NCT02034799|17575020|P1|Overall Study|Lost to Follow-up|0
5090078|NCT02034799|17575019|P2|Overall Study|Withdrawal by Subject|2
5090079|NCT02034799|17575020|P1|Overall Study|Withdrawal by Subject|0
5090080|NCT02034708|17575034|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
5090081|NCT02034708|17575035|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
5090082|NCT02034708|17575034|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5090083|NCT02034708|17575035|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5090084|NCT02034708|17575034|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
5090085|NCT02034708|17575035|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
5090086|NCT02034708|17575034|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
5090087|NCT02034708|17575035|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
5090088|NCT02034591|17575046|P6|Overall Study|Withdrawal by Subject|0
5090089|NCT02034591|17575047|P5|Overall Study|Withdrawal by Subject|1
5090090|NCT02034591|17575048|P4|Overall Study|Withdrawal by Subject|0
5090091|NCT02034591|17575049|P3|Overall Study|Withdrawal by Subject|0
5090092|NCT02034591|17575050|P2|Overall Study|Withdrawal by Subject|0
5090093|NCT02034591|17575051|P1|Overall Study|Withdrawal by Subject|0
5090094|NCT02034565|17575106|P2|Overall Study|Adverse Event|0
5090095|NCT02034565|17575107|P1|Overall Study|Adverse Event|1
5090096|NCT02034552|17575124|P3|Overall Study|Clinical progression|9
5090097|NCT02034552|17575125|P2|Overall Study|Clinical progression|7
5090098|NCT02034552|17575126|P1|Overall Study|Clinical progression|5
5090099|NCT02034552|17575124|P3|Overall Study|Non-compliance with study drug|1
5090100|NCT02034552|17575125|P2|Overall Study|Non-compliance with study drug|0
5090101|NCT02034552|17575126|P1|Overall Study|Non-compliance with study drug|0
5090102|NCT02034552|17575124|P3|Overall Study|Withdrawal by Subject|1
5090103|NCT02034552|17575125|P2|Overall Study|Withdrawal by Subject|1
5090104|NCT02034552|17575126|P1|Overall Study|Withdrawal by Subject|2
5090105|NCT02034552|17575124|P3|Overall Study|AE associated with disease progression|0
5090106|NCT02034552|17575125|P2|Overall Study|AE associated with disease progression|1
5090107|NCT02034552|17575126|P1|Overall Study|AE associated with disease progression|0
5090108|NCT02034552|17575124|P3|Overall Study|AE not assoc. with disease progression|2
5090109|NCT02034552|17575125|P2|Overall Study|AE not assoc. with disease progression|4
5090110|NCT02034552|17575126|P1|Overall Study|AE not assoc. with disease progression|1
5090111|NCT02034552|17575124|P3|Overall Study|Radiological progression|4
5090112|NCT02034552|17575125|P2|Overall Study|Radiological progression|5
5090113|NCT02034552|17575126|P1|Overall Study|Radiological progression|3
5090114|NCT02034552|17575124|P3|Overall Study|Never treated|0
5090115|NCT02034552|17575125|P2|Overall Study|Never treated|2
5090116|NCT02034552|17575126|P1|Overall Study|Never treated|3
5090117|NCT02034513|17575157|P2|Overall Study|Unclassified|1
5090118|NCT02034513|17575158|P1|Overall Study|Unclassified|0
5090119|NCT02034513|17575157|P2|Overall Study|Withdrawal by Subject|25
5090120|NCT02034513|17575158|P1|Overall Study|Withdrawal by Subject|25
5090121|NCT02034513|17575157|P2|Overall Study|Protocol Violation|10
5090122|NCT02034513|17575158|P1|Overall Study|Protocol Violation|7
5090123|NCT02034513|17575157|P2|Overall Study|Pregnancy|3
5090124|NCT02034513|17575158|P1|Overall Study|Pregnancy|0
5090125|NCT02034513|17575157|P2|Overall Study|Lost to Follow-up|7
5090126|NCT02034513|17575158|P1|Overall Study|Lost to Follow-up|6
5090127|NCT02034513|17575157|P2|Overall Study|Lack of Efficacy|1
5090128|NCT02034513|17575158|P1|Overall Study|Lack of Efficacy|0
5090129|NCT02034513|17575157|P2|Overall Study|Adverse Event|10
5090130|NCT02034513|17575158|P1|Overall Study|Adverse Event|11
5090131|NCT02034474|17575176|P2|Overall Study|Withdrawal by Subject|2
5090132|NCT02034474|17575177|P1|Overall Study|Withdrawal by Subject|1
5090133|NCT02034474|17575176|P2|Overall Study|Adverse Event|2
5090134|NCT02034474|17575177|P1|Overall Study|Adverse Event|3
5090135|NCT02034162|17575193|P3|Double-blind|Withdrawal by Subject|0
5090136|NCT02034162|17575194|P2|Double-blind|Withdrawal by Subject|7
5090137|NCT02034162|17575195|P1|Double-blind|Withdrawal by Subject|5
5090138|NCT02034162|17575193|P3|Double-blind|Protocol Violation|0
5090139|NCT02034162|17575194|P2|Double-blind|Protocol Violation|1
5090140|NCT02034162|17575195|P1|Double-blind|Protocol Violation|0
5090141|NCT02034162|17575193|P3|Double-blind|Physician Decision|0
5090142|NCT02034162|17575194|P2|Double-blind|Physician Decision|0
5090143|NCT02034162|17575195|P1|Double-blind|Physician Decision|1
5090144|NCT02034162|17575193|P3|Double-blind|Lost to Follow-up|0
5090145|NCT02034162|17575194|P2|Double-blind|Lost to Follow-up|0
5090146|NCT02034162|17575195|P1|Double-blind|Lost to Follow-up|3
5090147|NCT02034123|17575241|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090148|NCT02034123|17575242|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090149|NCT02034123|17575243|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090150|NCT02034123|17575244|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090151|NCT02034123|17575245|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090152|NCT02034123|17575246|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090153|NCT02034123|17575247|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090154|NCT02034123|17575248|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090155|NCT02034123|17575249|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090156|NCT02034123|17575250|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090157|NCT02034123|17575251|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090158|NCT02034123|17575252|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090159|NCT02034123|17575253|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090160|NCT02034123|17575254|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
5090161|NCT02034123|17575255|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
5090162|NCT02034123|17575256|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090163|NCT02034123|17575257|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090164|NCT02034123|17575258|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5090165|NCT02034123|17575241|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090166|NCT02034123|17575242|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090167|NCT02034123|17575243|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090168|NCT02034123|17575244|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090169|NCT02034123|17575245|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090170|NCT02034123|17575246|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090171|NCT02034123|17575247|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090172|NCT02034123|17575248|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090173|NCT02034123|17575249|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090174|NCT02034123|17575250|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
5090175|NCT02034123|17575251|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090176|NCT02034123|17575252|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090177|NCT02034123|17575253|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090178|NCT02034123|17575254|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090179|NCT02034123|17575255|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090180|NCT02034123|17575256|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090181|NCT02034123|17575257|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090182|NCT02034123|17575258|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5090183|NCT02034123|17575241|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090184|NCT02034123|17575242|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090185|NCT02034123|17575243|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090186|NCT02034123|17575244|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090187|NCT02034123|17575245|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090188|NCT02034123|17575246|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090189|NCT02034123|17575247|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090190|NCT02034123|17575248|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090191|NCT02034123|17575249|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090192|NCT02034123|17575250|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090193|NCT02034123|17575251|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090194|NCT02034123|17575252|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090195|NCT02034123|17575253|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090196|NCT02034123|17575254|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090197|NCT02034123|17575255|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
5090198|NCT02034123|17575256|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090199|NCT02034123|17575257|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090200|NCT02034123|17575258|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5090201|NCT02034123|17575241|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090202|NCT02034123|17575242|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090203|NCT02034123|17575243|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090204|NCT02034123|17575244|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090205|NCT02034123|17575245|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090206|NCT02034123|17575246|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090207|NCT02034123|17575247|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090208|NCT02034123|17575248|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090209|NCT02034123|17575249|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090210|NCT02034123|17575250|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5090211|NCT02034123|17575251|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5090298|NCT02032407|17576294|P1|Overall Study|Pregnancy|1
5090212|NCT02034123|17575252|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090213|NCT02034123|17575253|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090214|NCT02034123|17575254|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5090215|NCT02034123|17575255|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090216|NCT02034123|17575256|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090217|NCT02034123|17575257|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090218|NCT02034123|17575258|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5090219|NCT02034058|17575577|P1|Overall Study|Death|3
5090220|NCT02034006|17575598|P1|Overall Study|Pregnancy|1
5090221|NCT02034006|17575598|P1|Overall Study|Death|1
5090222|NCT02034006|17575598|P1|Overall Study|Lost to Follow-up|5
5090223|NCT02034006|17575598|P1|Overall Study|Withdrawal by Subject|7
5090224|NCT02033889|17575649|P3|Overall Study|Withdrawal by Subject|13
5090225|NCT02033889|17575650|P2|Overall Study|Withdrawal by Subject|10
5090226|NCT02033889|17575651|P1|Overall Study|Withdrawal by Subject|18
5090227|NCT02033889|17575649|P3|Overall Study|Participant moved|0
5090228|NCT02033889|17575650|P2|Overall Study|Participant moved|1
5090229|NCT02033889|17575651|P1|Overall Study|Participant moved|0
5090230|NCT02033889|17575649|P3|Overall Study|Physician Decision|1
5090231|NCT02033889|17575650|P2|Overall Study|Physician Decision|1
5090232|NCT02033889|17575651|P1|Overall Study|Physician Decision|0
5090233|NCT02033889|17575649|P3|Overall Study|Non-Compliance With Study Drug|0
5090234|NCT02033889|17575650|P2|Overall Study|Non-Compliance With Study Drug|0
5090235|NCT02033889|17575651|P1|Overall Study|Non-Compliance With Study Drug|1
5090236|NCT02033889|17575649|P3|Overall Study|Lost to Follow-up|6
5090237|NCT02033889|17575650|P2|Overall Study|Lost to Follow-up|5
5090238|NCT02033889|17575651|P1|Overall Study|Lost to Follow-up|8
5090239|NCT02033889|17575649|P3|Overall Study|Excluded Medication|0
5090240|NCT02033889|17575650|P2|Overall Study|Excluded Medication|1
5090241|NCT02033889|17575651|P1|Overall Study|Excluded Medication|1
5090242|NCT02033889|17575649|P3|Overall Study|Death|2
5090243|NCT02033889|17575650|P2|Overall Study|Death|1
5090244|NCT02033889|17575651|P1|Overall Study|Death|3
5090245|NCT02033889|17575649|P3|Overall Study|Adverse Event|3
5090246|NCT02033889|17575650|P2|Overall Study|Adverse Event|1
5090247|NCT02033889|17575651|P1|Overall Study|Adverse Event|3
5090248|NCT02033850|17575828|P2|Overall Study|unrelated medical reason|1
5090249|NCT02033850|17575829|P1|Overall Study|unrelated medical reason|1
5090250|NCT02033850|17575828|P2|Overall Study|Death|0
5090251|NCT02033850|17575829|P1|Overall Study|Death|1
5090252|NCT02033759|17575853|P2|Overall Study|Protocol Violation|1
5090253|NCT02033759|17575854|P1|Overall Study|Protocol Violation|1
5090254|NCT02033759|17575853|P2|Overall Study|Withdrawal by Subject|1
5090255|NCT02033759|17575854|P1|Overall Study|Withdrawal by Subject|2
5090256|NCT02033369|17575914|P2|Overall Study|Protocol Violation|0
5090257|NCT02033369|17575915|P1|Overall Study|Protocol Violation|2
5090258|NCT02033369|17575914|P2|Overall Study|Lost to Follow-up|0
5090259|NCT02033369|17575915|P1|Overall Study|Lost to Follow-up|1
5090260|NCT02033369|17575914|P2|Overall Study|Withdrawal by Subject|1
5090261|NCT02033369|17575915|P1|Overall Study|Withdrawal by Subject|1
5090262|NCT02033369|17575914|P2|Overall Study|Not a good demographic match|2
5090263|NCT02033369|17575915|P1|Overall Study|Not a good demographic match|0
5090264|NCT02033369|17575914|P2|Overall Study|Physician Decision|2
5090265|NCT02033369|17575915|P1|Overall Study|Physician Decision|1
5090266|NCT02032901|17576009|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
5090267|NCT02032901|17576010|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
5090268|NCT02032901|17576009|P2|Treatment Period (12 Weeks)|Pregnancy|0
5090269|NCT02032901|17576010|P1|Treatment Period (12 Weeks)|Pregnancy|1
5090270|NCT02032888|17576034|P3|Follow-up Period|Other|0
5090271|NCT02032888|17576035|P2|Follow-up Period|Other|0
5090272|NCT02032888|17576036|P1|Follow-up Period|Other|1
5090273|NCT02032888|17576034|P3|Follow-up Period|Death|0
5090274|NCT02032888|17576035|P2|Follow-up Period|Death|1
5090275|NCT02032888|17576036|P1|Follow-up Period|Death|1
5090276|NCT02032888|17576034|P3|Follow-up Period|Lost to Follow-up|0
5090277|NCT02032888|17576035|P2|Follow-up Period|Lost to Follow-up|1
5090278|NCT02032888|17576036|P1|Follow-up Period|Lost to Follow-up|1
5090279|NCT02032888|17576034|P3|Treatment Period|Other|0
5090280|NCT02032888|17576035|P2|Treatment Period|Other|1
5090281|NCT02032888|17576036|P1|Treatment Period|Other|1
5090282|NCT02032888|17576034|P3|Treatment Period|Poor compliance/noncompliance|0
5090283|NCT02032888|17576035|P2|Treatment Period|Poor compliance/noncompliance|1
5090284|NCT02032888|17576036|P1|Treatment Period|Poor compliance/noncompliance|1
5090285|NCT02032875|17576067|P2|Follow-up Period|Virologic Relapse|10
5090286|NCT02032875|17576068|P1|Follow-up Period|Virologic Relapse|3
5090287|NCT02032875|17576067|P2|Follow-up Period|Death|1
5090288|NCT02032875|17576068|P1|Follow-up Period|Death|0
5090289|NCT02032875|17576067|P2|Treatment Period|Liver transplant, Treatment extension|3
5090290|NCT02032875|17576068|P1|Treatment Period|Liver transplant, Treatment extension|0
5090291|NCT02032875|17576067|P2|Treatment Period|Liver transplant, No extension needed|1
5090292|NCT02032875|17576068|P1|Treatment Period|Liver transplant, No extension needed|0
5090293|NCT02032875|17576067|P2|Treatment Period|Adverse Event|0
5090294|NCT02032875|17576068|P1|Treatment Period|Adverse Event|1
5090295|NCT02032706|17576111|P1|Overall Study|Protocol Violation|1
5090296|NCT02032706|17576111|P1|Overall Study|Did not qualify|5
5090297|NCT02032407|17576294|P1|Overall Study|Other Miscellaneous Reasons|2
5090299|NCT02032407|17576294|P1|Overall Study|Lost to Follow-up|2
5090300|NCT02032238|17576307|P2|Overall Study|Lost to Follow-up|0
5090301|NCT02032238|17576308|P1|Overall Study|Lost to Follow-up|2
5090302|NCT02032173|17576347|P1|Overall Study|Discontinuation due to sponsor decision|31
5090303|NCT02031679|17576369|P2|Overall Study|Lack of Efficacy|1
5090304|NCT02031679|17576370|P1|Overall Study|Lack of Efficacy|0
5090305|NCT02031679|17576369|P2|Overall Study|Protocol Violation|1
5090306|NCT02031679|17576370|P1|Overall Study|Protocol Violation|0
5090307|NCT02031640|17576385|P6|Double-blind Treatment Period|Lost to Follow-up|0
5090308|NCT02031640|17576386|P5|Double-blind Treatment Period|Lost to Follow-up|1
5090309|NCT02031640|17576387|P4|Double-blind Treatment Period|Lost to Follow-up|0
5090310|NCT02031640|17576388|P3|Double-blind Treatment Period|Lost to Follow-up|0
5090311|NCT02031640|17576389|P2|Double-blind Treatment Period|Lost to Follow-up|3
5090312|NCT02031640|17576390|P1|Double-blind Treatment Period|Lost to Follow-up|0
5090313|NCT02031640|17576385|P6|Double-blind Treatment Period|Withdrawal by Subject|1
5090314|NCT02031640|17576386|P5|Double-blind Treatment Period|Withdrawal by Subject|1
5090315|NCT02031640|17576387|P4|Double-blind Treatment Period|Withdrawal by Subject|1
5090316|NCT02031640|17576388|P3|Double-blind Treatment Period|Withdrawal by Subject|3
5090317|NCT02031640|17576389|P2|Double-blind Treatment Period|Withdrawal by Subject|2
5090318|NCT02031640|17576390|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5090319|NCT02031640|17576385|P6|Double-blind Treatment Period|Adverse Event|0
5090320|NCT02031640|17576386|P5|Double-blind Treatment Period|Adverse Event|0
5090321|NCT02031640|17576387|P4|Double-blind Treatment Period|Adverse Event|2
5090322|NCT02031640|17576388|P3|Double-blind Treatment Period|Adverse Event|0
5090323|NCT02031640|17576389|P2|Double-blind Treatment Period|Adverse Event|0
5090324|NCT02031640|17576390|P1|Double-blind Treatment Period|Adverse Event|0
5090325|NCT02031640|17576385|P6|Double-blind Treatment Period|Non-compliance|0
5090326|NCT02031640|17576386|P5|Double-blind Treatment Period|Non-compliance|1
5090327|NCT02031640|17576387|P4|Double-blind Treatment Period|Non-compliance|1
5090328|NCT02031640|17576388|P3|Double-blind Treatment Period|Non-compliance|0
5090329|NCT02031640|17576389|P2|Double-blind Treatment Period|Non-compliance|1
5090330|NCT02031640|17576390|P1|Double-blind Treatment Period|Non-compliance|0
5090331|NCT02031640|17576385|P6|Double-blind Treatment Period|Lack of Efficacy|1
5090332|NCT02031640|17576386|P5|Double-blind Treatment Period|Lack of Efficacy|5
5090333|NCT02031640|17576387|P4|Double-blind Treatment Period|Lack of Efficacy|2
5090334|NCT02031640|17576388|P3|Double-blind Treatment Period|Lack of Efficacy|3
5090335|NCT02031640|17576389|P2|Double-blind Treatment Period|Lack of Efficacy|14
5090336|NCT02031640|17576390|P1|Double-blind Treatment Period|Lack of Efficacy|0
5090337|NCT02031640|17576385|P6|Double-blind Treatment Period|Protocol deviation|1
5090338|NCT02031640|17576386|P5|Double-blind Treatment Period|Protocol deviation|3
5090339|NCT02031640|17576387|P4|Double-blind Treatment Period|Protocol deviation|1
5090340|NCT02031640|17576388|P3|Double-blind Treatment Period|Protocol deviation|0
5090341|NCT02031640|17576389|P2|Double-blind Treatment Period|Protocol deviation|2
5090342|NCT02031640|17576390|P1|Double-blind Treatment Period|Protocol deviation|0
5090343|NCT02031640|17576385|P6|Run-In Period|Various administrative reasons|0
5090344|NCT02031640|17576386|P5|Run-In Period|Various administrative reasons|0
5090345|NCT02031640|17576387|P4|Run-In Period|Various administrative reasons|0
5090346|NCT02031640|17576388|P3|Run-In Period|Various administrative reasons|0
5090347|NCT02031640|17576389|P2|Run-In Period|Various administrative reasons|0
5090348|NCT02031640|17576390|P1|Run-In Period|Various administrative reasons|17
5090349|NCT02031640|17576385|P6|Run-In Period|Randomization criteria not met|0
5090350|NCT02031640|17576386|P5|Run-In Period|Randomization criteria not met|0
5090351|NCT02031640|17576387|P4|Run-In Period|Randomization criteria not met|0
5090352|NCT02031640|17576388|P3|Run-In Period|Randomization criteria not met|0
5090353|NCT02031640|17576389|P2|Run-In Period|Randomization criteria not met|0
5090354|NCT02031640|17576390|P1|Run-In Period|Randomization criteria not met|85
5090355|NCT02031640|17576385|P6|Run-In Period|Exclusion criteria met|0
5090356|NCT02031640|17576386|P5|Run-In Period|Exclusion criteria met|0
5090357|NCT02031640|17576387|P4|Run-In Period|Exclusion criteria met|0
5090358|NCT02031640|17576388|P3|Run-In Period|Exclusion criteria met|0
5090359|NCT02031640|17576389|P2|Run-In Period|Exclusion criteria met|0
5090360|NCT02031640|17576390|P1|Run-In Period|Exclusion criteria met|8
5090361|NCT02031640|17576385|P6|Run-In Period|Inclusion criteria not met|0
5090362|NCT02031640|17576386|P5|Run-In Period|Inclusion criteria not met|0
5090363|NCT02031640|17576387|P4|Run-In Period|Inclusion criteria not met|0
5090364|NCT02031640|17576388|P3|Run-In Period|Inclusion criteria not met|0
5090365|NCT02031640|17576389|P2|Run-In Period|Inclusion criteria not met|0
5090366|NCT02031640|17576390|P1|Run-In Period|Inclusion criteria not met|38
5090367|NCT02031640|17576385|P6|Run-In Period|Withdrawal by Subject|0
5090368|NCT02031640|17576386|P5|Run-In Period|Withdrawal by Subject|0
5090369|NCT02031640|17576387|P4|Run-In Period|Withdrawal by Subject|0
5090370|NCT02031640|17576388|P3|Run-In Period|Withdrawal by Subject|0
5090371|NCT02031640|17576389|P2|Run-In Period|Withdrawal by Subject|0
5090372|NCT02031640|17576390|P1|Run-In Period|Withdrawal by Subject|17
5090373|NCT02031640|17576385|P6|Run-In Period|Adverse Event|0
5090374|NCT02031640|17576386|P5|Run-In Period|Adverse Event|0
5090375|NCT02031640|17576387|P4|Run-In Period|Adverse Event|0
5090376|NCT02031640|17576388|P3|Run-In Period|Adverse Event|0
5090377|NCT02031640|17576389|P2|Run-In Period|Adverse Event|0
5090378|NCT02031640|17576390|P1|Run-In Period|Adverse Event|4
5090379|NCT02031640|17576385|P6|Screening Period|Enrollment closed|0
5090380|NCT02031640|17576386|P5|Screening Period|Enrollment closed|0
5090381|NCT02031640|17576387|P4|Screening Period|Enrollment closed|0
5090382|NCT02031640|17576388|P3|Screening Period|Enrollment closed|0
5090383|NCT02031640|17576389|P2|Screening Period|Enrollment closed|0
5090384|NCT02031640|17576390|P1|Screening Period|Enrollment closed|26
5090385|NCT02031640|17576385|P6|Screening Period|Lost to Follow-up|0
5090386|NCT02031640|17576386|P5|Screening Period|Lost to Follow-up|0
5090387|NCT02031640|17576387|P4|Screening Period|Lost to Follow-up|0
5090388|NCT02031640|17576388|P3|Screening Period|Lost to Follow-up|0
5090389|NCT02031640|17576389|P2|Screening Period|Lost to Follow-up|0
5090390|NCT02031640|17576390|P1|Screening Period|Lost to Follow-up|14
5090391|NCT02031640|17576385|P6|Screening Period|Exclusion criteria met|0
5090392|NCT02031640|17576386|P5|Screening Period|Exclusion criteria met|0
5090393|NCT02031640|17576387|P4|Screening Period|Exclusion criteria met|0
5090394|NCT02031640|17576388|P3|Screening Period|Exclusion criteria met|0
5090395|NCT02031640|17576389|P2|Screening Period|Exclusion criteria met|0
5090396|NCT02031640|17576390|P1|Screening Period|Exclusion criteria met|30
5090397|NCT02031640|17576385|P6|Screening Period|Inclusion criteria not met|0
5090398|NCT02031640|17576386|P5|Screening Period|Inclusion criteria not met|0
5090399|NCT02031640|17576387|P4|Screening Period|Inclusion criteria not met|0
5090400|NCT02031640|17576388|P3|Screening Period|Inclusion criteria not met|0
5090401|NCT02031640|17576389|P2|Screening Period|Inclusion criteria not met|0
5090402|NCT02031640|17576390|P1|Screening Period|Inclusion criteria not met|312
5090403|NCT02031640|17576385|P6|Screening Period|Withdrawal by Subject|0
5090404|NCT02031640|17576386|P5|Screening Period|Withdrawal by Subject|0
5090405|NCT02031640|17576387|P4|Screening Period|Withdrawal by Subject|0
5090406|NCT02031640|17576388|P3|Screening Period|Withdrawal by Subject|0
5090407|NCT02031640|17576389|P2|Screening Period|Withdrawal by Subject|0
5090408|NCT02031640|17576390|P1|Screening Period|Withdrawal by Subject|29
5090409|NCT02031640|17576385|P6|Screening Period|Adverse Event|0
5090410|NCT02031640|17576386|P5|Screening Period|Adverse Event|0
5090411|NCT02031640|17576387|P4|Screening Period|Adverse Event|0
5090412|NCT02031640|17576388|P3|Screening Period|Adverse Event|0
5090413|NCT02031640|17576389|P2|Screening Period|Adverse Event|0
5090414|NCT02031640|17576390|P1|Screening Period|Adverse Event|1
5090415|NCT02031471|17576433|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
5090416|NCT02031471|17576433|P1|Long Term Extension (LTE) Period|Adverse Event|1
5090417|NCT02031471|17576433|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
5090418|NCT02031471|17576433|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
5090419|NCT02031471|17576433|P1|24 Week Treatment Period|Protocol Violation|1
5090420|NCT02031471|17576433|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
5090421|NCT02031471|17576433|P1|24 Week Treatment Period|Adverse Event|6
5090422|NCT02031458|17576466|P3|Baseline to May 8, 2015|Lost to Follow-up|2
5090423|NCT02031458|17576467|P2|Baseline to May 8, 2015|Lost to Follow-up|1
5090424|NCT02031458|17576468|P1|Baseline to May 8, 2015|Lost to Follow-up|1
5090425|NCT02031458|17576466|P3|Baseline to May 8, 2015|On Treatment|73
5090426|NCT02031458|17576467|P2|Baseline to May 8, 2015|On Treatment|81
5090427|NCT02031458|17576468|P1|Baseline to May 8, 2015|On Treatment|43
5090428|NCT02031458|17576466|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
5090429|NCT02031458|17576467|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
5090430|NCT02031458|17576468|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
5090431|NCT02031458|17576466|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
5090432|NCT02031458|17576467|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
5090433|NCT02031458|17576468|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
5090434|NCT02031458|17576466|P3|Baseline to May 8, 2015|Unknown Reason|2
5090435|NCT02031458|17576467|P2|Baseline to May 8, 2015|Unknown Reason|1
5090436|NCT02031458|17576468|P1|Baseline to May 8, 2015|Unknown Reason|0
5090437|NCT02031458|17576466|P3|Baseline to May 8, 2015|Physician Decision|0
5090438|NCT02031458|17576467|P2|Baseline to May 8, 2015|Physician Decision|1
5090439|NCT02031458|17576468|P1|Baseline to May 8, 2015|Physician Decision|0
5090440|NCT02031458|17576466|P3|Baseline to May 8, 2015|Protocol Violation|0
5090441|NCT02031458|17576467|P2|Baseline to May 8, 2015|Protocol Violation|4
5090442|NCT02031458|17576468|P1|Baseline to May 8, 2015|Protocol Violation|7
5090443|NCT02031458|17576466|P3|Baseline to May 8, 2015|Death|100
5090444|NCT02031458|17576467|P2|Baseline to May 8, 2015|Death|87
5090445|NCT02031458|17576468|P1|Baseline to May 8, 2015|Death|36
5090446|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
5090447|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
5090448|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
5090449|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
5090450|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
5090451|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
5090452|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
5090453|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
5090454|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
5090455|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
5090456|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
5090457|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
5090458|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
5090459|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
5090543|NCT02030834|17576677|P3|Overall Study|Manufacturing failure|1
5090460|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
5090461|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
5090462|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
5090463|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
5090464|NCT02031458|17576466|P3|May 8, 2015 to January 11, 2019|Death|198
5090465|NCT02031458|17576467|P2|May 8, 2015 to January 11, 2019|Death|193
5090466|NCT02031458|17576468|P1|May 8, 2015 to January 11, 2019|Death|89
5090467|NCT02031432|17576562|P1|Overall Study|Death|10
5090468|NCT02031432|17576562|P1|Overall Study|Inclusion/Exclusion criteria not met|5
5090469|NCT02031432|17576562|P1|Overall Study|Lost to Follow-up|1
5090470|NCT02031432|17576562|P1|Overall Study|Withdrawal by Subject|5
5090471|NCT02031432|17576562|P1|Overall Study|Adverse Event|8
5090472|NCT02031432|17576562|P1|Overall Study|Withdrawn as forbidden meds required|1
5090473|NCT02031432|17576562|P1|Overall Study|Cancer Progression|2
5090474|NCT02031432|17576562|P1|Overall Study|Lack of Efficacy|5
5090475|NCT02031432|17576562|P1|Overall Study|Protocol Violation|1
5090476|NCT02031302|17576589|P2|Overall Study|Lost to Follow-up|0
5090477|NCT02031302|17576590|P1|Overall Study|Lost to Follow-up|4
5090478|NCT02031302|17576589|P2|Overall Study|Missed Follow Up|0
5090479|NCT02031302|17576590|P1|Overall Study|Missed Follow Up|27
5090480|NCT02031302|17576589|P2|Overall Study|Not treated with study valve system|0
5090481|NCT02031302|17576590|P1|Overall Study|Not treated with study valve system|18
5090482|NCT02031302|17576589|P2|Overall Study|Death|0
5090483|NCT02031302|17576590|P1|Overall Study|Death|115
5090484|NCT02031276|17576611|P3|Period 3 Open-label Risankizumab SC|Other|1
5090485|NCT02031276|17576612|P2|Period 3 Open-label Risankizumab SC|Other|0
5090486|NCT02031276|17576613|P1|Period 3 Open-label Risankizumab SC|Other|0
5090487|NCT02031276|17576611|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5090488|NCT02031276|17576612|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5090489|NCT02031276|17576613|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5090490|NCT02031276|17576611|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
5090491|NCT02031276|17576612|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
5090492|NCT02031276|17576613|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
5090493|NCT02031276|17576611|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
5090494|NCT02031276|17576612|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
5090495|NCT02031276|17576613|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
5090496|NCT02031276|17576611|P3|Period 2 Open-label Risankizumab IV|Other|1
5090497|NCT02031276|17576612|P2|Period 2 Open-label Risankizumab IV|Other|2
5090498|NCT02031276|17576613|P1|Period 2 Open-label Risankizumab IV|Other|0
5090499|NCT02031276|17576611|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
5090500|NCT02031276|17576612|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
5090501|NCT02031276|17576613|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
5090502|NCT02031276|17576611|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
5090503|NCT02031276|17576612|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
5090504|NCT02031276|17576613|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
5090505|NCT02031276|17576611|P3|Period 1 Double-blind IV|Other|0
5090506|NCT02031276|17576612|P2|Period 1 Double-blind IV|Other|1
5090507|NCT02031276|17576613|P1|Period 1 Double-blind IV|Other|0
5090508|NCT02031276|17576611|P3|Period 1 Double-blind IV|Adverse Event|1
5090509|NCT02031276|17576612|P2|Period 1 Double-blind IV|Adverse Event|5
5090510|NCT02031276|17576613|P1|Period 1 Double-blind IV|Adverse Event|6
5090511|NCT02031237|17576647|P3|Overall Study|Alternate Treatment Given|3
5090512|NCT02031237|17576648|P2|Overall Study|Alternate Treatment Given|0
5090513|NCT02031237|17576649|P1|Overall Study|Alternate Treatment Given|0
5090514|NCT02031237|17576647|P3|Overall Study|Protocol Violation|0
5090515|NCT02031237|17576648|P2|Overall Study|Protocol Violation|6
5090516|NCT02031237|17576649|P1|Overall Study|Protocol Violation|2
5090517|NCT02031237|17576647|P3|Overall Study|Withdrawal by Subject|0
5090518|NCT02031237|17576648|P2|Overall Study|Withdrawal by Subject|2
5090519|NCT02031237|17576649|P1|Overall Study|Withdrawal by Subject|2
5090520|NCT02031237|17576647|P3|Overall Study|Physician Decision|0
5090521|NCT02031237|17576648|P2|Overall Study|Physician Decision|1
5090522|NCT02031237|17576649|P1|Overall Study|Physician Decision|0
5090523|NCT02031237|17576647|P3|Overall Study|Death|0
5090524|NCT02031237|17576648|P2|Overall Study|Death|5
5090525|NCT02031237|17576649|P1|Overall Study|Death|1
5090526|NCT02030847|17576669|P1|Overall Study|Withdrawal by Subject|1
5090527|NCT02030847|17576669|P1|Overall Study|Physician Decision|3
5090528|NCT02030847|17576669|P1|Overall Study|New Cancer Therapy|8
5090529|NCT02030847|17576669|P1|Overall Study|Disease Progression|15
5090530|NCT02030847|17576669|P1|Overall Study|Death|10
5090531|NCT02030834|17576677|P3|Overall Study|Lack of funding|0
5090532|NCT02030834|17576678|P2|Overall Study|Lack of funding|0
5090533|NCT02030834|17576679|P1|Overall Study|Lack of funding|1
5090534|NCT02030834|17576677|P3|Overall Study|Withdrawal by Subject|0
5090535|NCT02030834|17576678|P2|Overall Study|Withdrawal by Subject|0
5090536|NCT02030834|17576679|P1|Overall Study|Withdrawal by Subject|1
5090537|NCT02030834|17576677|P3|Overall Study|Lost to Follow-up|0
5090538|NCT02030834|17576678|P2|Overall Study|Lost to Follow-up|0
5090539|NCT02030834|17576679|P1|Overall Study|Lost to Follow-up|1
5090540|NCT02030834|17576677|P3|Overall Study|Disease progression|2
5090541|NCT02030834|17576678|P2|Overall Study|Disease progression|0
5090542|NCT02030834|17576679|P1|Overall Study|Disease progression|2
5090544|NCT02030834|17576678|P2|Overall Study|Manufacturing failure|0
5090545|NCT02030834|17576679|P1|Overall Study|Manufacturing failure|2
5090546|NCT02030834|17576677|P3|Overall Study|Death|0
5090547|NCT02030834|17576678|P2|Overall Study|Death|0
5090548|NCT02030834|17576679|P1|Overall Study|Death|4
5090549|NCT02030821|17576691|P4|Overall Study|Physician Decision|2
5090550|NCT02030821|17576692|P3|Overall Study|Physician Decision|5
5090551|NCT02030821|17576693|P2|Overall Study|Physician Decision|2
5090552|NCT02030821|17576694|P1|Overall Study|Physician Decision|2
5090553|NCT02030600|17576722|P2|Treatment Period 2|Unclassified|0
5090554|NCT02030600|17576723|P1|Treatment Period 2|Unclassified|1
5090555|NCT02030600|17576722|P2|Treatment Period 2|Withdrawal by Subject|9
5090556|NCT02030600|17576723|P1|Treatment Period 2|Withdrawal by Subject|13
5090557|NCT02030600|17576722|P2|Treatment Period 2|Protocol Violation|2
5090558|NCT02030600|17576723|P1|Treatment Period 2|Protocol Violation|1
5090559|NCT02030600|17576722|P2|Treatment Period 2|Lost to Follow-up|2
5090560|NCT02030600|17576723|P1|Treatment Period 2|Lost to Follow-up|4
5090561|NCT02030600|17576722|P2|Treatment Period 2|Lack of Efficacy|1
5090562|NCT02030600|17576723|P1|Treatment Period 2|Lack of Efficacy|2
5090563|NCT02030600|17576722|P2|Treatment Period 2|Adverse Event|4
5090564|NCT02030600|17576723|P1|Treatment Period 2|Adverse Event|4
5090565|NCT02030600|17576722|P2|Treatment Period 1|Unclassified|0
5090566|NCT02030600|17576723|P1|Treatment Period 1|Unclassified|1
5090567|NCT02030600|17576722|P2|Treatment Period 1|Casebook Unsigned|0
5090568|NCT02030600|17576723|P1|Treatment Period 1|Casebook Unsigned|1
5090569|NCT02030600|17576722|P2|Treatment Period 1|Withdrawal by Subject|17
5090570|NCT02030600|17576723|P1|Treatment Period 1|Withdrawal by Subject|13
5090571|NCT02030600|17576722|P2|Treatment Period 1|Protocol Violation|17
5090572|NCT02030600|17576723|P1|Treatment Period 1|Protocol Violation|22
5090573|NCT02030600|17576722|P2|Treatment Period 1|Lost to Follow-up|3
5090574|NCT02030600|17576723|P1|Treatment Period 1|Lost to Follow-up|11
5090575|NCT02030600|17576722|P2|Treatment Period 1|Lack of Efficacy|1
5090576|NCT02030600|17576723|P1|Treatment Period 1|Lack of Efficacy|0
5090577|NCT02030600|17576722|P2|Treatment Period 1|Adverse Event|7
5090578|NCT02030600|17576723|P1|Treatment Period 1|Adverse Event|5
5090579|NCT02030535|17576744|P1|Washout Period 1 (21 Days)|Adverse Event|1
5090580|NCT02030405|17576812|P1|Overall Study|Lost to Follow-up|1
5090581|NCT02030405|17576812|P1|Overall Study|Withdrawal by Subject|1
5090582|NCT02030119|17576838|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
5090583|NCT02030119|17576839|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
5090584|NCT02030119|17576840|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
5090585|NCT02030119|17576841|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
5090586|NCT02030119|17576838|P4|Overall Study|Withdrawal by Subject|3
5090587|NCT02030119|17576839|P3|Overall Study|Withdrawal by Subject|5
5090588|NCT02030119|17576840|P2|Overall Study|Withdrawal by Subject|1
5090589|NCT02030119|17576841|P1|Overall Study|Withdrawal by Subject|3
5090590|NCT02030041|17576879|P3|Overall Study|Withdrawal by Subject|1
5090591|NCT02030041|17576880|P2|Overall Study|Withdrawal by Subject|2
5090592|NCT02030041|17576881|P1|Overall Study|Withdrawal by Subject|2
5090593|NCT02029989|17576894|P2|Overall Study|Protocol Violation|0
5090594|NCT02029989|17576895|P1|Overall Study|Protocol Violation|1
5090595|NCT02029989|17576894|P2|Overall Study|Death|1
5090596|NCT02029989|17576895|P1|Overall Study|Death|0
5090597|NCT02029989|17576894|P2|Overall Study|Lost to Follow-up|7
5090598|NCT02029989|17576895|P1|Overall Study|Lost to Follow-up|9
5090599|NCT02029989|17576894|P2|Overall Study|Physician Decision|0
5090600|NCT02029989|17576895|P1|Overall Study|Physician Decision|2
5090601|NCT02029989|17576894|P2|Overall Study|Change of location|3
5090602|NCT02029989|17576895|P1|Overall Study|Change of location|2
5090603|NCT02029989|17576894|P2|Overall Study|Withdrawal: Fear of needles|0
5090604|NCT02029989|17576895|P1|Overall Study|Withdrawal: Fear of needles|1
5090605|NCT02029989|17576894|P2|Overall Study|Withdrawal by Subject|0
5090606|NCT02029989|17576895|P1|Overall Study|Withdrawal by Subject|1
5090607|NCT02029976|17576903|P2|YR-2 Follow Up vs Baseline|Moved from area|2
5090608|NCT02029976|17576904|P1|YR-2 Follow Up vs Baseline|Moved from area|0
5090609|NCT02029976|17576903|P2|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
5090610|NCT02029976|17576904|P1|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
5090611|NCT02029976|17576903|P2|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
5090612|NCT02029976|17576904|P1|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
5090613|NCT02029976|17576903|P2|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
5090614|NCT02029976|17576904|P1|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
5090615|NCT02029846|17576933|P2|Overall Study|n=1 each arm|1
5090616|NCT02029846|17576934|P1|Overall Study|n=1 each arm|1
5090617|NCT02029638|17576972|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
5090618|NCT02029638|17576973|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
5090619|NCT02029638|17576974|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
5090620|NCT02029638|17576972|P3|Overall Study|Death|1
5090621|NCT02029638|17576973|P2|Overall Study|Death|0
5090622|NCT02029638|17576974|P1|Overall Study|Death|0
5090623|NCT02029521|17577003|P2|Overall Study|Withdrawal by Subject|1
5090624|NCT02029521|17577004|P1|Overall Study|Withdrawal by Subject|1
5090625|NCT02029521|17577003|P2|Overall Study|Protocol Violation|0
5090626|NCT02029521|17577004|P1|Overall Study|Protocol Violation|1
5090627|NCT02029417|17577102|P1|Overall Study|Adverse Event|1
5090628|NCT02029417|17577102|P1|Overall Study|Death|1
5090629|NCT02029274|17577111|P4|Overall Study|Adverse Event|2
5090630|NCT02029274|17577112|P3|Overall Study|Adverse Event|2
5090631|NCT02029274|17577113|P2|Overall Study|Adverse Event|0
5090632|NCT02029274|17577114|P1|Overall Study|Adverse Event|1
5090633|NCT02029235|17577146|P2|Overall Study|Non-compliance with study meds or diary|1
5090634|NCT02029235|17577147|P1|Overall Study|Non-compliance with study meds or diary|4
5090635|NCT02028871|17577179|P2|Overall Study|Current Illness|0
5090636|NCT02028871|17577180|P1|Overall Study|Current Illness|1
5090637|NCT02028871|17577179|P2|Overall Study|IV placement difficulty|0
5090638|NCT02028871|17577180|P1|Overall Study|IV placement difficulty|1
5090639|NCT02028871|17577179|P2|Overall Study|Withdrawal by Subject|2
5090640|NCT02028871|17577180|P1|Overall Study|Withdrawal by Subject|1
5090641|NCT02028871|17577179|P2|Overall Study|Positive urine drug screen|1
5090642|NCT02028871|17577180|P1|Overall Study|Positive urine drug screen|1
5090643|NCT02028767|17577277|P2|Treatment Period 2|Reason other than those specified above|0
5090644|NCT02028767|17577278|P1|Treatment Period 2|Reason other than those specified above|1
5090645|NCT02028767|17577277|P2|Treatment Period 2|Non compliant with protocol|0
5090646|NCT02028767|17577278|P1|Treatment Period 2|Non compliant with protocol|1
5090647|NCT02028715|17577311|P2|Overall Study|Did not complete satisfaction surveys|2
5090648|NCT02028715|17577312|P1|Overall Study|Did not complete satisfaction surveys|2
5090649|NCT02028715|17577311|P2|Overall Study|Physician Decision|0
5090650|NCT02028715|17577312|P1|Overall Study|Physician Decision|1
5090651|NCT02028715|17577311|P2|Overall Study|Adverse Event|2
5090652|NCT02028715|17577312|P1|Overall Study|Adverse Event|2
5090653|NCT02028182|17577540|P1|Overall Study|Protocol Violation|2
5090654|NCT02028169|17577546|P1|Overall Study|Concomitant Medication Usage|1
5090655|NCT02028169|17577546|P1|Overall Study|Cessation of Drug|1
5090656|NCT02028169|17577546|P1|Overall Study|Adverse Event|1
5090657|NCT02028169|17577546|P1|Overall Study|Withdrawal by Subject|2
5090658|NCT02028169|17577546|P1|Overall Study|Lack of Efficacy|2
5090659|NCT02028169|17577546|P1|Overall Study|Lost to Follow-up|21
5090660|NCT02028065|17577572|P3|Treatment Through Study Completion|Adverse Event|5
5090661|NCT02028065|17577573|P2|Treatment Through Study Completion|Adverse Event|3
5090662|NCT02028065|17577574|P1|Treatment Through Study Completion|Adverse Event|3
5090663|NCT02028065|17577572|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5090664|NCT02028065|17577573|P2|Treatment Through Study Completion|Withdrawal by Subject|4
5090665|NCT02028065|17577574|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5090666|NCT02028065|17577572|P3|Treatment Through Study Completion|Protocol Violation|0
5090667|NCT02028065|17577573|P2|Treatment Through Study Completion|Protocol Violation|4
5090668|NCT02028065|17577574|P1|Treatment Through Study Completion|Protocol Violation|1
5090669|NCT02028065|17577572|P3|Treatment Through Study Completion|Physician Decision|0
5090670|NCT02028065|17577573|P2|Treatment Through Study Completion|Physician Decision|0
5090671|NCT02028065|17577574|P1|Treatment Through Study Completion|Physician Decision|1
5090672|NCT02028065|17577572|P3|Treatment Through Study Completion|Lost to Follow-up|6
5090673|NCT02028065|17577573|P2|Treatment Through Study Completion|Lost to Follow-up|4
5090674|NCT02028065|17577574|P1|Treatment Through Study Completion|Lost to Follow-up|2
5090675|NCT02028065|17577572|P3|Randomization Through Start Treatment|Not treated|3
5090676|NCT02028065|17577573|P2|Randomization Through Start Treatment|Not treated|3
5090677|NCT02028065|17577574|P1|Randomization Through Start Treatment|Not treated|1
5090678|NCT02027844|17577601|P3|Overall Study|Incomlete data|0
5090679|NCT02027844|17577602|P2|Overall Study|Incomlete data|0
5090680|NCT02027844|17577603|P1|Overall Study|Incomlete data|2
5090681|NCT02027844|17577601|P3|Overall Study|Protocol Violation|0
5090682|NCT02027844|17577602|P2|Overall Study|Protocol Violation|2
5090683|NCT02027844|17577603|P1|Overall Study|Protocol Violation|0
5090684|NCT02027844|17577601|P3|Overall Study|Lost to Follow-up|1
5090685|NCT02027844|17577602|P2|Overall Study|Lost to Follow-up|2
5090686|NCT02027844|17577603|P1|Overall Study|Lost to Follow-up|0
5090687|NCT02027844|17577601|P3|Overall Study|Withdrawal by Subject|1
5090688|NCT02027844|17577602|P2|Overall Study|Withdrawal by Subject|2
5090689|NCT02027844|17577603|P1|Overall Study|Withdrawal by Subject|3
5090690|NCT02027701|17577620|P1|Overall Study|Withdrawal by Subject|3
5090691|NCT02027701|17577620|P1|Overall Study|Physician Decision|2
5090692|NCT02027701|17577620|P1|Overall Study|Lack of Efficacy|8
5090693|NCT02027701|17577620|P1|Overall Study|Adverse Event|3
5090694|NCT02027623|17577638|P2|Overall Study|Withdrawal by Subject|9
5090695|NCT02027623|17577639|P1|Overall Study|Withdrawal by Subject|6
5090696|NCT02027623|17577638|P2|Overall Study|Lost to Follow-up|3
5090697|NCT02027623|17577639|P1|Overall Study|Lost to Follow-up|3
5090698|NCT02027558|17577735|P2|Overall Study|Refused assessment|0
5090699|NCT02027558|17577736|P1|Overall Study|Refused assessment|3
5090700|NCT02027558|17577735|P2|Overall Study|Lost to Follow-up|1
5090701|NCT02027558|17577736|P1|Overall Study|Lost to Follow-up|4
5090702|NCT02027558|17577735|P2|Overall Study|Withdrawal by Subject|0
5090703|NCT02027558|17577736|P1|Overall Study|Withdrawal by Subject|2
5090704|NCT02027558|17577735|P2|Overall Study|Death|1
5090705|NCT02027558|17577736|P1|Overall Study|Death|0
5090706|NCT02027545|17577754|P2|Overall Study|Failed to attend study visit|0
5090707|NCT02027545|17577755|P1|Overall Study|Failed to attend study visit|2
5090708|NCT02027545|17577754|P2|Overall Study|Failed to sign HIPAA|2
5090709|NCT02027545|17577755|P1|Overall Study|Failed to sign HIPAA|0
5090710|NCT02027428|17577767|P3|Survival Follow-up|Lost to Follow-up|1
5090711|NCT02027428|17577768|P2|Survival Follow-up|Lost to Follow-up|1
5090712|NCT02027428|17577769|P1|Survival Follow-up|Lost to Follow-up|0
5090713|NCT02027428|17577767|P3|Survival Follow-up|Death|45
5090714|NCT02027428|17577768|P2|Survival Follow-up|Death|78
5090715|NCT02027428|17577769|P1|Survival Follow-up|Death|0
5090716|NCT02027428|17577767|P3|Maintenance|Other|3
5090717|NCT02027428|17577768|P2|Maintenance|Other|6
5090718|NCT02027428|17577769|P1|Maintenance|Other|0
5090719|NCT02027428|17577767|P3|Maintenance|Protocol Violation|1
5090720|NCT02027428|17577768|P2|Maintenance|Protocol Violation|0
5090721|NCT02027428|17577769|P1|Maintenance|Protocol Violation|0
5090722|NCT02027428|17577767|P3|Maintenance|Withdrawal by Subject|5
5090723|NCT02027428|17577768|P2|Maintenance|Withdrawal by Subject|6
5090724|NCT02027428|17577769|P1|Maintenance|Withdrawal by Subject|0
5090725|NCT02027428|17577767|P3|Maintenance|Symptomatic deterioration|1
5090726|NCT02027428|17577768|P2|Maintenance|Symptomatic deterioration|4
5090727|NCT02027428|17577769|P1|Maintenance|Symptomatic deterioration|0
5090728|NCT02027428|17577767|P3|Maintenance|Progressive disease|47
5090729|NCT02027428|17577768|P2|Maintenance|Progressive disease|84
5090730|NCT02027428|17577769|P1|Maintenance|Progressive disease|0
5090731|NCT02027428|17577767|P3|Maintenance|Adverse Event|1
5090732|NCT02027428|17577768|P2|Maintenance|Adverse Event|21
5090733|NCT02027428|17577769|P1|Maintenance|Adverse Event|0
5090734|NCT02027428|17577767|P3|Maintenance|Death|2
5090735|NCT02027428|17577768|P2|Maintenance|Death|3
5090736|NCT02027428|17577769|P1|Maintenance|Death|0
5090737|NCT02027428|17577767|P3|Induction|Induction Treatment Ongoing|0
5090738|NCT02027428|17577768|P2|Induction|Induction Treatment Ongoing|0
5090739|NCT02027428|17577769|P1|Induction|Induction Treatment Ongoing|4
5090740|NCT02027428|17577767|P3|Induction|Miscellaneous|0
5090741|NCT02027428|17577768|P2|Induction|Miscellaneous|0
5090742|NCT02027428|17577769|P1|Induction|Miscellaneous|14
5090743|NCT02027428|17577767|P3|Induction|Protocol Violation|0
5090744|NCT02027428|17577768|P2|Induction|Protocol Violation|0
5090745|NCT02027428|17577769|P1|Induction|Protocol Violation|1
5090746|NCT02027428|17577767|P3|Induction|Study terminated by sponsor|0
5090747|NCT02027428|17577768|P2|Induction|Study terminated by sponsor|0
5090748|NCT02027428|17577769|P1|Induction|Study terminated by sponsor|12
5090749|NCT02027428|17577767|P3|Induction|Symptomatic deterioration|0
5090750|NCT02027428|17577768|P2|Induction|Symptomatic deterioration|0
5090751|NCT02027428|17577769|P1|Induction|Symptomatic deterioration|16
5090752|NCT02027428|17577767|P3|Induction|Death|0
5090753|NCT02027428|17577768|P2|Induction|Death|0
5090754|NCT02027428|17577769|P1|Induction|Death|21
5090755|NCT02027428|17577767|P3|Induction|Withdrawal by Subject|0
5090756|NCT02027428|17577768|P2|Induction|Withdrawal by Subject|0
5090757|NCT02027428|17577769|P1|Induction|Withdrawal by Subject|22
5090758|NCT02027428|17577767|P3|Induction|Adverse Event|0
5090759|NCT02027428|17577768|P2|Induction|Adverse Event|0
5090760|NCT02027428|17577769|P1|Induction|Adverse Event|51
5090761|NCT02027428|17577767|P3|Induction|Progressive disease|0
5090762|NCT02027428|17577768|P2|Induction|Progressive disease|0
5090763|NCT02027428|17577769|P1|Induction|Progressive disease|77
5090764|NCT02027428|17577767|P3|Induction|Never treated|0
5090765|NCT02027428|17577768|P2|Induction|Never treated|0
5090766|NCT02027428|17577769|P1|Induction|Never treated|7
5090767|NCT02027402|17577807|P2|Overall Study|Withdrawal by Subject|1
5090768|NCT02027402|17577808|P1|Overall Study|Withdrawal by Subject|4
5090769|NCT02027376|17577820|P3|Overall Study|Death|0
5090770|NCT02027376|17577821|P2|Overall Study|Death|0
5090771|NCT02027376|17577822|P1|Overall Study|Death|1
5090772|NCT02027311|17577848|P2|Overall Study|Protocol Violation|2
5090773|NCT02027311|17577849|P1|Overall Study|Protocol Violation|3
5090774|NCT02027025|17577869|P3|Overall Study|Sponsor's decision|0
5090775|NCT02027025|17577870|P2|Overall Study|Sponsor's decision|1
5090776|NCT02027025|17577871|P1|Overall Study|Sponsor's decision|0
5090777|NCT02027025|17577869|P3|Overall Study|Withdrawal by Subject|0
5090778|NCT02027025|17577870|P2|Overall Study|Withdrawal by Subject|1
5090779|NCT02027025|17577871|P1|Overall Study|Withdrawal by Subject|0
5090780|NCT02027025|17577869|P3|Overall Study|Lost to Follow-up|0
5090781|NCT02027025|17577870|P2|Overall Study|Lost to Follow-up|2
5090782|NCT02027025|17577871|P1|Overall Study|Lost to Follow-up|0
5090783|NCT02027025|17577869|P3|Overall Study|Protocol Violation|0
5090784|NCT02027025|17577870|P2|Overall Study|Protocol Violation|0
5090785|NCT02027025|17577871|P1|Overall Study|Protocol Violation|1
5090786|NCT02027025|17577869|P3|Overall Study|Adverse Event|1
5090787|NCT02027025|17577870|P2|Overall Study|Adverse Event|1
5090788|NCT02027025|17577871|P1|Overall Study|Adverse Event|0
5090789|NCT02026258|17577934|P2|Recieved Allocated Intervention|Lost to Follow-up|1
5090790|NCT02026258|17577935|P1|Recieved Allocated Intervention|Lost to Follow-up|0
5090791|NCT02026258|17577934|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
5090792|NCT02026258|17577935|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
5090793|NCT02026258|17577934|P2|Randomized|Presence of periodontal disease|1
5090794|NCT02026258|17577935|P1|Randomized|Presence of periodontal disease|1
5090795|NCT02026258|17577934|P2|Randomized|Change in treatment plan|0
5090796|NCT02026258|17577935|P1|Randomized|Change in treatment plan|1
5090797|NCT02026258|17577934|P2|Randomized|Did not start treatment|1
5090798|NCT02026258|17577935|P1|Randomized|Did not start treatment|2
5090799|NCT02026141|17577969|P2|Overall Study|Protocol Violation|1
5090800|NCT02026141|17577970|P1|Overall Study|Protocol Violation|0
5090801|NCT02026063|17577978|P2|Overall Study|Reason not Specified|7
5090802|NCT02026063|17577979|P1|Overall Study|Reason not Specified|2
5090803|NCT02026063|17577978|P2|Overall Study|Lost to Follow-up|1
5090804|NCT02026063|17577979|P1|Overall Study|Lost to Follow-up|0
5090805|NCT02026063|17577978|P2|Overall Study|Lack of Efficacy|4
5090806|NCT02026063|17577979|P1|Overall Study|Lack of Efficacy|0
5090807|NCT02026063|17577978|P2|Overall Study|Adverse Event|20
5090808|NCT02026063|17577979|P1|Overall Study|Adverse Event|5
5090809|NCT02026063|17577978|P2|Overall Study|Withdrawal of Consent|6
5090810|NCT02026063|17577979|P1|Overall Study|Withdrawal of Consent|1
5090811|NCT02026063|17577978|P2|Overall Study|Noncompliance with Study Drug|1
5090812|NCT02026063|17577979|P1|Overall Study|Noncompliance with Study Drug|1
5090813|NCT02026063|17577978|P2|Overall Study|Physician Decision|10
5090814|NCT02026063|17577979|P1|Overall Study|Physician Decision|0
5090815|NCT02026011|17577991|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
5090816|NCT02026011|17577992|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
5090817|NCT02026011|17577991|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
5090818|NCT02026011|17577992|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
5090819|NCT02026011|17577991|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
5090820|NCT02026011|17577992|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
5090821|NCT02026011|17577991|P2|Allocation 1 (First Set of Medication)|Side Effects|0
5090822|NCT02026011|17577992|P1|Allocation 1 (First Set of Medication)|Side Effects|6
5090823|NCT02025907|17578018|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
5090824|NCT02025907|17578019|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
5090825|NCT02025907|17578018|P2|Overall Study|Adverse Event|1
5090826|NCT02025907|17578019|P1|Overall Study|Adverse Event|3
5090827|NCT02025907|17578018|P2|Overall Study|Lost to Follow-up|2
5090828|NCT02025907|17578019|P1|Overall Study|Lost to Follow-up|2
5090829|NCT02025907|17578018|P2|Overall Study|Physician Decision|0
5090830|NCT02025907|17578019|P1|Overall Study|Physician Decision|2
5090831|NCT02025907|17578018|P2|Overall Study|Protocol Violation|0
5090832|NCT02025907|17578019|P1|Overall Study|Protocol Violation|2
5090833|NCT02025907|17578018|P2|Overall Study|Withdrawal by Subject|8
5090834|NCT02025907|17578019|P1|Overall Study|Withdrawal by Subject|15
5090835|NCT02025907|17578018|P2|Overall Study|Lack of Efficacy|0
5090836|NCT02025907|17578019|P1|Overall Study|Lack of Efficacy|1
5090837|NCT02025751|17578047|P2|Overall Study|Withdrawal by Subject|1
5090838|NCT02025751|17578048|P1|Overall Study|Withdrawal by Subject|0
5090839|NCT02025751|17578047|P2|Overall Study|Physician Decision|1
5090840|NCT02025751|17578048|P1|Overall Study|Physician Decision|0
5090841|NCT02025751|17578047|P2|Overall Study|Adverse Event|1
5090842|NCT02025751|17578048|P1|Overall Study|Adverse Event|0
5090843|NCT02025751|17578047|P2|Overall Study|Lost to Follow-up|0
5090844|NCT02025751|17578048|P1|Overall Study|Lost to Follow-up|1
5090845|NCT02025725|17578056|P2|Overall Study|Post-dose QTcB > 270 msec|1
5090846|NCT02025725|17578057|P1|Overall Study|Post-dose QTcB > 270 msec|0
5090847|NCT02025725|17578056|P2|Overall Study|Withdrawal by Subject|2
5090848|NCT02025725|17578057|P1|Overall Study|Withdrawal by Subject|3
5090849|NCT02025725|17578056|P2|Overall Study|Protocol Violation|1
5090850|NCT02025725|17578057|P1|Overall Study|Protocol Violation|1
5090851|NCT02025725|17578056|P2|Overall Study|Lost to Follow-up|0
5090852|NCT02025725|17578057|P1|Overall Study|Lost to Follow-up|2
5090853|NCT02025725|17578056|P2|Overall Study|Adverse Event|0
5090854|NCT02025725|17578057|P1|Overall Study|Adverse Event|5
5090855|NCT02025621|17578109|P2|Overall Study|Surgery initiated before infusion|3
5090856|NCT02025621|17578110|P1|Overall Study|Surgery initiated before infusion|3
5090857|NCT02025621|17578109|P2|Overall Study|No longer eligible|15
5090858|NCT02025621|17578110|P1|Overall Study|No longer eligible|10
5090859|NCT02025621|17578109|P2|Overall Study|Death|1
5090860|NCT02025621|17578110|P1|Overall Study|Death|0
5090861|NCT02025621|17578109|P2|Overall Study|Withdrawal by Subject|0
5090862|NCT02025621|17578110|P1|Overall Study|Withdrawal by Subject|1
5090863|NCT02025530|17578130|P2|Overall Study|No longer met elligibility criteria|1
5090864|NCT02025530|17578131|P1|Overall Study|No longer met elligibility criteria|5
5090865|NCT02025205|17578177|P2|Overall Study|Death|1
5090866|NCT02025205|17578178|P1|Overall Study|Death|0
5090867|NCT02025205|17578177|P2|Overall Study|Protocol Violation|1
5090868|NCT02025205|17578178|P1|Overall Study|Protocol Violation|2
5090869|NCT02025205|17578177|P2|Overall Study|Withdrawal by Subject|1
5090870|NCT02025205|17578178|P1|Overall Study|Withdrawal by Subject|1
5090871|NCT02025179|17578222|P3|Overall Study|Lost to Follow-up|1
5090872|NCT02025179|17578223|P2|Overall Study|Lost to Follow-up|0
5090873|NCT02025179|17578224|P1|Overall Study|Lost to Follow-up|0
5090874|NCT02024971|17578274|P1|Overall Study|Lost to Follow-up|6
5090875|NCT02024971|17578274|P1|Overall Study|Data Not Available|30
5090876|NCT02024932|17578287|P6|Overall Study|Abnormal laboratory value|0
5090877|NCT02024932|17578288|P5|Overall Study|Abnormal laboratory value|0
5090878|NCT02024932|17578289|P4|Overall Study|Abnormal laboratory value|2
5090879|NCT02024932|17578290|P3|Overall Study|Abnormal laboratory value|0
5090880|NCT02024932|17578291|P2|Overall Study|Abnormal laboratory value|0
5090881|NCT02024932|17578292|P1|Overall Study|Abnormal laboratory value|0
5090882|NCT02024932|17578287|P6|Overall Study|Adverse Event|0
5090883|NCT02024932|17578288|P5|Overall Study|Adverse Event|2
5090884|NCT02024932|17578289|P4|Overall Study|Adverse Event|0
5090885|NCT02024932|17578290|P3|Overall Study|Adverse Event|0
5090886|NCT02024932|17578291|P2|Overall Study|Adverse Event|3
5090887|NCT02024932|17578292|P1|Overall Study|Adverse Event|2
5090888|NCT02024867|17578351|P2|Overall Study|Lost to Follow-up|4
5090889|NCT02024867|17578352|P1|Overall Study|Lost to Follow-up|6
5090890|NCT02024867|17578351|P2|Overall Study|Protocol Violation|3
5090891|NCT02024867|17578352|P1|Overall Study|Protocol Violation|3
5090892|NCT02024750|17578370|P2|Overall Study|Withdrawal by Subject|1
5090893|NCT02024750|17578371|P1|Overall Study|Withdrawal by Subject|2
5090894|NCT02024698|17578407|P2|First Intervention (7 Days)|Withdrawal by Subject|1
5090895|NCT02024698|17578408|P1|First Intervention (7 Days)|Withdrawal by Subject|0
5090896|NCT02024555|17578449|P2|Overall Study|Withdrawal by Subject|1
5090897|NCT02024555|17578450|P1|Overall Study|Withdrawal by Subject|5
5090898|NCT02024555|17578449|P2|Overall Study|Lost to Follow-up|1
5090899|NCT02024555|17578450|P1|Overall Study|Lost to Follow-up|1
5090900|NCT02023879|17578562|P3|Extension Open Label Treatment|Other than specified above|2
5090901|NCT02023879|17578563|P2|Extension Open Label Treatment|Other than specified above|7
5090902|NCT02023879|17578564|P1|Extension Open Label Treatment|Other than specified above|2
5090903|NCT02023879|17578562|P3|Extension Open Label Treatment|Participant moved|0
5090904|NCT02023879|17578563|P2|Extension Open Label Treatment|Participant moved|2
5090905|NCT02023879|17578564|P1|Extension Open Label Treatment|Participant moved|1
5090906|NCT02023879|17578562|P3|Extension Open Label Treatment|Poor compliance to protocol|0
5090907|NCT02023879|17578563|P2|Extension Open Label Treatment|Poor compliance to protocol|1
5090908|NCT02023879|17578564|P1|Extension Open Label Treatment|Poor compliance to protocol|1
5090909|NCT02023879|17578562|P3|Extension Open Label Treatment|Adverse Event|3
5090910|NCT02023879|17578563|P2|Extension Open Label Treatment|Adverse Event|7
5090911|NCT02023879|17578564|P1|Extension Open Label Treatment|Adverse Event|1
5090912|NCT02023879|17578562|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
5090913|NCT02023879|17578563|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
5090914|NCT02023879|17578564|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
5090915|NCT02023879|17578562|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
5090916|NCT02023879|17578563|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
5090917|NCT02023879|17578564|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
5090918|NCT02023879|17578562|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
5090919|NCT02023879|17578563|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
5090920|NCT02023879|17578564|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
5090921|NCT02023879|17578562|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
5090922|NCT02023879|17578563|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
5090923|NCT02023879|17578564|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
5090924|NCT02023879|17578562|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
5090925|NCT02023879|17578563|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
5090926|NCT02023879|17578564|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
5090927|NCT02023879|17578562|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
5090928|NCT02023879|17578563|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
5090929|NCT02023879|17578564|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
5090930|NCT02023866|17578653|P1|Overall Study|Withdrawal by Subject|1
5090931|NCT02023866|17578653|P1|Overall Study|Adverse Event|3
5090932|NCT02023866|17578653|P1|Overall Study|Non-compliance|2
5090933|NCT02023697|17578675|P3|Long-term Follow-up Period|Other unspecified|5
5090934|NCT02023697|17578676|P2|Long-term Follow-up Period|Other unspecified|3
5090935|NCT02023697|17578677|P1|Long-term Follow-up Period|Other unspecified|6
5090936|NCT02023697|17578675|P3|Long-term Follow-up Period|Technical problems|1
5090937|NCT02023697|17578676|P2|Long-term Follow-up Period|Technical problems|0
5090938|NCT02023697|17578677|P1|Long-term Follow-up Period|Technical problems|0
5090939|NCT02023697|17578675|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
5090940|NCT02023697|17578676|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
5090941|NCT02023697|17578677|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
5090942|NCT02023697|17578675|P3|Long-term Follow-up Period|Lost to Follow-up|1
5090943|NCT02023697|17578676|P2|Long-term Follow-up Period|Lost to Follow-up|0
5090944|NCT02023697|17578677|P1|Long-term Follow-up Period|Lost to Follow-up|1
5090945|NCT02023697|17578675|P3|Long-term Follow-up Period|Withdrawal by Subject|0
5090946|NCT02023697|17578676|P2|Long-term Follow-up Period|Withdrawal by Subject|3
5090947|NCT02023697|17578677|P1|Long-term Follow-up Period|Withdrawal by Subject|6
5090948|NCT02023697|17578675|P3|Long-term Follow-up Period|Death|4
5090949|NCT02023697|17578676|P2|Long-term Follow-up Period|Death|6
5090950|NCT02023697|17578677|P1|Long-term Follow-up Period|Death|9
5090951|NCT02023697|17578675|P3|Active Follow-up Period|Death|87
5090952|NCT02023697|17578676|P2|Active Follow-up Period|Death|82
5090953|NCT02023697|17578677|P1|Active Follow-up Period|Death|83
5090954|NCT02023697|17578675|P3|Active Follow-up Period|Radiological progression|1
5090955|NCT02023697|17578676|P2|Active Follow-up Period|Radiological progression|0
5090956|NCT02023697|17578677|P1|Active Follow-up Period|Radiological progression|0
5090957|NCT02023697|17578675|P3|Active Follow-up Period|Clinical progression|1
5090958|NCT02023697|17578676|P2|Active Follow-up Period|Clinical progression|2
5090959|NCT02023697|17578677|P1|Active Follow-up Period|Clinical progression|0
5090960|NCT02023697|17578675|P3|Active Follow-up Period|Other unspecified|1
5090961|NCT02023697|17578676|P2|Active Follow-up Period|Other unspecified|0
5090962|NCT02023697|17578677|P1|Active Follow-up Period|Other unspecified|2
5090963|NCT02023697|17578675|P3|Active Follow-up Period|Deterioration of general condition|1
5090964|NCT02023697|17578676|P2|Active Follow-up Period|Deterioration of general condition|1
5090965|NCT02023697|17578677|P1|Active Follow-up Period|Deterioration of general condition|1
5090966|NCT02023697|17578675|P3|Active Follow-up Period|Lost to Follow-up|1
5090967|NCT02023697|17578676|P2|Active Follow-up Period|Lost to Follow-up|1
5090968|NCT02023697|17578677|P1|Active Follow-up Period|Lost to Follow-up|1
5090969|NCT02023697|17578675|P3|Active Follow-up Period|Withdrawal by Subject|7
5090970|NCT02023697|17578676|P2|Active Follow-up Period|Withdrawal by Subject|13
5090971|NCT02023697|17578677|P1|Active Follow-up Period|Withdrawal by Subject|5
5090972|NCT02023697|17578675|P3|Treatment Period|Physician Decision|1
5090973|NCT02023697|17578676|P2|Treatment Period|Physician Decision|0
5090974|NCT02023697|17578677|P1|Treatment Period|Physician Decision|0
5090975|NCT02023697|17578675|P3|Treatment Period|Safety outcome reached|0
5090976|NCT02023697|17578676|P2|Treatment Period|Safety outcome reached|1
5090977|NCT02023697|17578677|P1|Treatment Period|Safety outcome reached|0
5090978|NCT02023697|17578675|P3|Treatment Period|Withdrawal by Subject|13
5090979|NCT02023697|17578676|P2|Treatment Period|Withdrawal by Subject|5
5090980|NCT02023697|17578677|P1|Treatment Period|Withdrawal by Subject|4
5090981|NCT02023697|17578675|P3|Treatment Period|Clinical progression|28
5090982|NCT02023697|17578676|P2|Treatment Period|Clinical progression|8
5090983|NCT02023697|17578677|P1|Treatment Period|Clinical progression|10
5090984|NCT02023697|17578675|P3|Treatment Period|Logistical difficulties|1
5090985|NCT02023697|17578676|P2|Treatment Period|Logistical difficulties|1
5090986|NCT02023697|17578677|P1|Treatment Period|Logistical difficulties|1
5090987|NCT02023697|17578675|P3|Treatment Period|Adverse Event|23
5090988|NCT02023697|17578676|P2|Treatment Period|Adverse Event|25
5090989|NCT02023697|17578677|P1|Treatment Period|Adverse Event|13
5090990|NCT02023697|17578675|P3|Treatment Period|Never Treated|10
5090991|NCT02023697|17578676|P2|Treatment Period|Never Treated|6
5090992|NCT02023697|17578677|P1|Treatment Period|Never Treated|5
5090993|NCT02023697|17578675|P3|Treatment Period|Radiological progression|26
5090994|NCT02023697|17578676|P2|Treatment Period|Radiological progression|17
5090995|NCT02023697|17578677|P1|Treatment Period|Radiological progression|13
5090996|NCT02023268|17578801|P2|Overall Study|Withdrawal by Subject|1
5090997|NCT02023268|17578802|P1|Overall Study|Withdrawal by Subject|0
5090998|NCT02023268|17578801|P2|Overall Study|Adverse Event|2
5090999|NCT02023268|17578802|P1|Overall Study|Adverse Event|0
5091000|NCT02023268|17578801|P2|Overall Study|Lack of Efficacy|1
5091001|NCT02023268|17578802|P1|Overall Study|Lack of Efficacy|0
5091002|NCT02023242|17578810|P2|Overall Study|Death|1
5091003|NCT02023242|17578811|P1|Overall Study|Death|0
5091004|NCT02023242|17578810|P2|Overall Study|Lost to Follow-up|1
5091005|NCT02023242|17578811|P1|Overall Study|Lost to Follow-up|3
5091006|NCT02023151|17578825|P1|Overall Study|Lost to Follow-up|4
5091007|NCT02023112|17578895|P2|Overall Study|Withdrawal by Subject|1
5091008|NCT02023112|17578896|P1|Overall Study|Withdrawal by Subject|2
5091009|NCT02023099|17578917|P3|Overall Study|Non-treatment-emergent Fatal AE|1
5091010|NCT02023099|17578918|P2|Overall Study|Non-treatment-emergent Fatal AE|0
5091011|NCT02023099|17578919|P1|Overall Study|Non-treatment-emergent Fatal AE|0
5091012|NCT02023099|17578917|P3|Overall Study|Withdrawn Consent|1
5091013|NCT02023099|17578918|P2|Overall Study|Withdrawn Consent|0
5091014|NCT02023099|17578919|P1|Overall Study|Withdrawn Consent|3
5091015|NCT02023099|17578917|P3|Overall Study|Non-fatal Adverse Event (AE)|1
5091016|NCT02023099|17578918|P2|Overall Study|Non-fatal Adverse Event (AE)|0
5091017|NCT02023099|17578919|P1|Overall Study|Non-fatal Adverse Event (AE)|0
5091018|NCT02022748|17578942|P3|Overall Study|Withdrawal by Subject|0
5091019|NCT02022748|17578943|P2|Overall Study|Withdrawal by Subject|1
5091020|NCT02022748|17578944|P1|Overall Study|Withdrawal by Subject|0
5091021|NCT02022748|17578942|P3|Overall Study|Adverse Event|0
5091022|NCT02022748|17578943|P2|Overall Study|Adverse Event|1
5091023|NCT02022748|17578944|P1|Overall Study|Adverse Event|1
5091024|NCT02022670|17578970|P3|Overall Study|Adverse Event|1
5091025|NCT02022670|17578971|P2|Overall Study|Adverse Event|0
5091026|NCT02022670|17578972|P1|Overall Study|Adverse Event|1
5091027|NCT02022657|17578986|P6|Overall Study|Physician Decision|1
5091028|NCT02022657|17578987|P5|Overall Study|Physician Decision|0
5091029|NCT02022657|17578988|P4|Overall Study|Physician Decision|0
5091030|NCT02022657|17578989|P3|Overall Study|Physician Decision|0
5091031|NCT02022657|17578990|P2|Overall Study|Physician Decision|0
5091032|NCT02022657|17578991|P1|Overall Study|Physician Decision|0
5091033|NCT02022657|17578986|P6|Overall Study|Withdrawal by Subject|0
5091034|NCT02022657|17578987|P5|Overall Study|Withdrawal by Subject|0
5091035|NCT02022657|17578988|P4|Overall Study|Withdrawal by Subject|0
5091036|NCT02022657|17578989|P3|Overall Study|Withdrawal by Subject|1
5091037|NCT02022657|17578990|P2|Overall Study|Withdrawal by Subject|0
5091038|NCT02022657|17578991|P1|Overall Study|Withdrawal by Subject|2
5091039|NCT02022007|17579041|P3|Overall Study|Noncompliant|1
5091040|NCT02022007|17579042|P2|Overall Study|Noncompliant|0
5091041|NCT02022007|17579043|P1|Overall Study|Noncompliant|0
5091042|NCT02022007|17579041|P3|Overall Study|Withdrawal by Subject|1
5091043|NCT02022007|17579042|P2|Overall Study|Withdrawal by Subject|1
5091044|NCT02022007|17579043|P1|Overall Study|Withdrawal by Subject|1
5091045|NCT02021656|17579126|P1|Overall Study|Withdrew Consent|2
5091046|NCT02021656|17579126|P1|Overall Study|Lost to Follow-up|1
5091047|NCT02021656|17579126|P1|Overall Study|Lack of Efficacy|2
5091048|NCT02021656|17579126|P1|Overall Study|Adverse Event|1
5091049|NCT02021643|17579146|P4|Overall Study|Withdrew Consent|0
5091050|NCT02021643|17579147|P3|Overall Study|Withdrew Consent|0
5091051|NCT02021643|17579148|P2|Overall Study|Withdrew Consent|1
5091052|NCT02021643|17579149|P1|Overall Study|Withdrew Consent|0
5091053|NCT02021643|17579146|P4|Overall Study|Lost to Follow-up|0
5091054|NCT02021643|17579147|P3|Overall Study|Lost to Follow-up|0
5091055|NCT02021643|17579148|P2|Overall Study|Lost to Follow-up|1
5091056|NCT02021643|17579149|P1|Overall Study|Lost to Follow-up|0
5091057|NCT02021643|17579146|P4|Overall Study|Lack of Efficacy|12
5091058|NCT02021643|17579147|P3|Overall Study|Lack of Efficacy|0
5091059|NCT02021643|17579148|P2|Overall Study|Lack of Efficacy|6
5091060|NCT02021643|17579149|P1|Overall Study|Lack of Efficacy|7
5091061|NCT02021643|17579146|P4|Overall Study|Investigator's Discretion|0
5091062|NCT02021643|17579147|P3|Overall Study|Investigator's Discretion|0
5091063|NCT02021643|17579148|P2|Overall Study|Investigator's Discretion|0
5091064|NCT02021643|17579149|P1|Overall Study|Investigator's Discretion|1
5091065|NCT02021643|17579146|P4|Overall Study|Death|0
5091066|NCT02021643|17579147|P3|Overall Study|Death|0
5091067|NCT02021643|17579148|P2|Overall Study|Death|1
5091068|NCT02021643|17579149|P1|Overall Study|Death|0
5091069|NCT02021643|17579146|P4|Overall Study|Adverse Event|0
5091070|NCT02021643|17579147|P3|Overall Study|Adverse Event|0
5091071|NCT02021643|17579148|P2|Overall Study|Adverse Event|1
5091072|NCT02021643|17579149|P1|Overall Study|Adverse Event|0
5091073|NCT02021643|17579146|P4|Overall Study|Enrolled but Never Treated|0
5091074|NCT02021643|17579147|P3|Overall Study|Enrolled but Never Treated|0
5091075|NCT02021643|17579148|P2|Overall Study|Enrolled but Never Treated|0
5091076|NCT02021643|17579149|P1|Overall Study|Enrolled but Never Treated|1
5091077|NCT02021565|17579191|P2|3-month Follow-up|Protocol Violation|2
5091078|NCT02021565|17579192|P1|3-month Follow-up|Protocol Violation|3
5091079|NCT02021565|17579191|P2|3-month Follow-up|Withdrawal by Subject|0
5091080|NCT02021565|17579192|P1|3-month Follow-up|Withdrawal by Subject|4
5091081|NCT02021565|17579191|P2|3-month Follow-up|Death|0
5091082|NCT02021565|17579192|P1|3-month Follow-up|Death|3
5091083|NCT02021565|17579191|P2|Baseline Through Intervention|Lost to Follow-up|2
5091084|NCT02021565|17579192|P1|Baseline Through Intervention|Lost to Follow-up|4
5091085|NCT02021565|17579191|P2|Baseline Through Intervention|Protocol Violation|7
5091086|NCT02021565|17579192|P1|Baseline Through Intervention|Protocol Violation|0
5091087|NCT02021565|17579191|P2|Baseline Through Intervention|Withdrawal by Subject|8
5091088|NCT02021565|17579192|P1|Baseline Through Intervention|Withdrawal by Subject|8
5091089|NCT02021565|17579191|P2|Baseline Through Intervention|Death|1
5091090|NCT02021565|17579192|P1|Baseline Through Intervention|Death|0
5091091|NCT02021331|17579212|P2|Overall Study|Adverse Event|2
5091092|NCT02021331|17579213|P1|Overall Study|Adverse Event|0
5091093|NCT02021292|17579225|P2|Overall Study|Death|1
5091094|NCT02021292|17579226|P1|Overall Study|Death|0
5091095|NCT02021292|17579225|P2|Overall Study|Lost to Follow-up|1
5091096|NCT02021292|17579226|P1|Overall Study|Lost to Follow-up|0
5091097|NCT02021292|17579225|P2|Overall Study|Physician Decision|1
5091098|NCT02021292|17579226|P1|Overall Study|Physician Decision|0
5091099|NCT02020941|17579256|P1|Overall Study|Disease Progression|4
5091100|NCT02020941|17579256|P1|Overall Study|Withdrawal by Subject|1
5091101|NCT02020941|17579256|P1|Overall Study|Physician Decision|2
5091102|NCT02020941|17579256|P1|Overall Study|Adverse Event|1
5091103|NCT02020889|17579267|P2|Overall Study|Withdrawal by Subject|2
5091104|NCT02020889|17579268|P1|Overall Study|Withdrawal by Subject|3
5091105|NCT02020889|17579267|P2|Overall Study|Physician Decision|0
5091106|NCT02020889|17579268|P1|Overall Study|Physician Decision|2
5091107|NCT02020889|17579267|P2|Overall Study|Lost to Follow-up|0
5091108|NCT02020889|17579268|P1|Overall Study|Lost to Follow-up|1
5091109|NCT02020889|17579267|P2|Overall Study|Lack of Efficacy|0
5091110|NCT02020889|17579268|P1|Overall Study|Lack of Efficacy|1
5091111|NCT02020889|17579267|P2|Overall Study|Adverse Event|1
5091112|NCT02020889|17579268|P1|Overall Study|Adverse Event|0
5091113|NCT02020863|17579322|P1|Overall Study|Team chose not to place an a line|1
5091114|NCT02020863|17579322|P1|Overall Study|Discovery of Metastatic disease|4
5091115|NCT02020616|17579352|P7|Overall Study|Lack of Efficacy|0
5091116|NCT02020616|17579353|P6|Overall Study|Lack of Efficacy|0
5091117|NCT02020616|17579354|P5|Overall Study|Lack of Efficacy|1
5091118|NCT02020616|17579355|P4|Overall Study|Lack of Efficacy|0
5091119|NCT02020616|17579356|P3|Overall Study|Lack of Efficacy|0
5091120|NCT02020616|17579357|P2|Overall Study|Lack of Efficacy|0
5091121|NCT02020616|17579358|P1|Overall Study|Lack of Efficacy|0
5091122|NCT02020616|17579352|P7|Overall Study|Randomized in Error|0
5091123|NCT02020616|17579353|P6|Overall Study|Randomized in Error|0
5091124|NCT02020616|17579354|P5|Overall Study|Randomized in Error|0
5091125|NCT02020616|17579355|P4|Overall Study|Randomized in Error|1
5091126|NCT02020616|17579356|P3|Overall Study|Randomized in Error|0
5091127|NCT02020616|17579357|P2|Overall Study|Randomized in Error|0
5091128|NCT02020616|17579358|P1|Overall Study|Randomized in Error|0
5091129|NCT02020616|17579352|P7|Overall Study|Early Termination Criteria Met|0
5091130|NCT02020616|17579353|P6|Overall Study|Early Termination Criteria Met|1
5091131|NCT02020616|17579354|P5|Overall Study|Early Termination Criteria Met|0
5091132|NCT02020616|17579355|P4|Overall Study|Early Termination Criteria Met|0
5091133|NCT02020616|17579356|P3|Overall Study|Early Termination Criteria Met|1
5091134|NCT02020616|17579357|P2|Overall Study|Early Termination Criteria Met|0
5091135|NCT02020616|17579358|P1|Overall Study|Early Termination Criteria Met|0
5091136|NCT02020616|17579352|P7|Overall Study|Lost to Follow-up|0
5091137|NCT02020616|17579353|P6|Overall Study|Lost to Follow-up|1
5091138|NCT02020616|17579354|P5|Overall Study|Lost to Follow-up|1
5091139|NCT02020616|17579355|P4|Overall Study|Lost to Follow-up|1
5091140|NCT02020616|17579356|P3|Overall Study|Lost to Follow-up|0
5091141|NCT02020616|17579357|P2|Overall Study|Lost to Follow-up|1
5091142|NCT02020616|17579358|P1|Overall Study|Lost to Follow-up|0
5091143|NCT02020616|17579352|P7|Overall Study|Withdrawal by Subject|1
5091144|NCT02020616|17579353|P6|Overall Study|Withdrawal by Subject|1
5091145|NCT02020616|17579354|P5|Overall Study|Withdrawal by Subject|0
5091146|NCT02020616|17579355|P4|Overall Study|Withdrawal by Subject|0
5091147|NCT02020616|17579356|P3|Overall Study|Withdrawal by Subject|1
5091148|NCT02020616|17579357|P2|Overall Study|Withdrawal by Subject|0
5091149|NCT02020616|17579358|P1|Overall Study|Withdrawal by Subject|0
5091150|NCT02020616|17579352|P7|Overall Study|Physician Decision|2
5091151|NCT02020616|17579353|P6|Overall Study|Physician Decision|1
5091152|NCT02020616|17579354|P5|Overall Study|Physician Decision|0
5091153|NCT02020616|17579355|P4|Overall Study|Physician Decision|0
5091154|NCT02020616|17579356|P3|Overall Study|Physician Decision|0
5091155|NCT02020616|17579357|P2|Overall Study|Physician Decision|0
5091156|NCT02020616|17579358|P1|Overall Study|Physician Decision|0
5091157|NCT02020616|17579352|P7|Overall Study|Adverse Event|1
5091158|NCT02020616|17579353|P6|Overall Study|Adverse Event|1
5091159|NCT02020616|17579354|P5|Overall Study|Adverse Event|0
5091160|NCT02020616|17579355|P4|Overall Study|Adverse Event|0
5091161|NCT02020616|17579356|P3|Overall Study|Adverse Event|0
5091162|NCT02020616|17579357|P2|Overall Study|Adverse Event|0
5091163|NCT02020616|17579358|P1|Overall Study|Adverse Event|0
5091164|NCT02020577|17579451|P2|Overall Study|Other than stated above|1
5091165|NCT02020577|17579452|P1|Overall Study|Other than stated above|0
5091166|NCT02020577|17579451|P2|Overall Study|Withdrawal by Subject|1
5091167|NCT02020577|17579452|P1|Overall Study|Withdrawal by Subject|0
5091168|NCT02020577|17579451|P2|Overall Study|Other AE or clinical progression|15
5091169|NCT02020577|17579452|P1|Overall Study|Other AE or clinical progression|0
5091170|NCT02020577|17579451|P2|Overall Study|Progressive disease|38
5091171|NCT02020577|17579452|P1|Overall Study|Progressive disease|3
5091172|NCT02020512|17579479|P1|Overall Study|Protocol Violation|4
5091173|NCT02020512|17579479|P1|Overall Study|Lost to Follow-up|3
5091174|NCT02020512|17579479|P1|Overall Study|Adverse Event|1
5091175|NCT02020031|17579558|P2|Overall Study|Physician Decision|1
5091176|NCT02020031|17579559|P1|Overall Study|Physician Decision|1
5091177|NCT02019979|17579580|P1|Overall Study|study terminated|14
5091178|NCT02019927|17579596|P6|Overall Study|Lost to Follow-up|1
5091179|NCT02019927|17579597|P5|Overall Study|Lost to Follow-up|3
5091180|NCT02019927|17579598|P4|Overall Study|Lost to Follow-up|2
5091181|NCT02019927|17579599|P3|Overall Study|Lost to Follow-up|1
5091182|NCT02019927|17579600|P2|Overall Study|Lost to Follow-up|4
5091183|NCT02019927|17579601|P1|Overall Study|Lost to Follow-up|2
5091184|NCT02019719|17579701|P5|Overall Study|Physician Decision|0
5091185|NCT02019719|17579702|P4|Overall Study|Physician Decision|0
5091186|NCT02019719|17579703|P3|Overall Study|Physician Decision|0
5091187|NCT02019719|17579704|P2|Overall Study|Physician Decision|0
5091188|NCT02019719|17579705|P1|Overall Study|Physician Decision|2
5091189|NCT02019719|17579701|P5|Overall Study|Protocol defined stopping criteria|1
5091190|NCT02019719|17579702|P4|Overall Study|Protocol defined stopping criteria|1
5091191|NCT02019719|17579703|P3|Overall Study|Protocol defined stopping criteria|0
5091192|NCT02019719|17579704|P2|Overall Study|Protocol defined stopping criteria|0
5091193|NCT02019719|17579705|P1|Overall Study|Protocol defined stopping criteria|2
5091194|NCT02019719|17579701|P5|Overall Study|Protocol Violation|0
5091195|NCT02019719|17579702|P4|Overall Study|Protocol Violation|0
5091196|NCT02019719|17579703|P3|Overall Study|Protocol Violation|0
5091197|NCT02019719|17579704|P2|Overall Study|Protocol Violation|1
5091198|NCT02019719|17579705|P1|Overall Study|Protocol Violation|1
5091199|NCT02019719|17579701|P5|Overall Study|Adverse Event|1
5091200|NCT02019719|17579702|P4|Overall Study|Adverse Event|1
5091201|NCT02019719|17579703|P3|Overall Study|Adverse Event|0
5091202|NCT02019719|17579704|P2|Overall Study|Adverse Event|0
5091203|NCT02019719|17579705|P1|Overall Study|Adverse Event|1
5091204|NCT02019667|17579802|P2|2nd Intervention (6 Months)|Physician Decision|1
5091205|NCT02019667|17579803|P1|2nd Intervention (6 Months)|Physician Decision|0
5091206|NCT02019667|17579802|P2|2nd Intervention (6 Months)|Adverse Event|1
5091207|NCT02019667|17579803|P1|2nd Intervention (6 Months)|Adverse Event|0
5091208|NCT02019667|17579802|P2|First Intervention (6 Months)|Adverse Event|1
5091209|NCT02019667|17579803|P1|First Intervention (6 Months)|Adverse Event|0
5091210|NCT02019602|17579823|P2|Screening Period|Adverse Event|0
5091211|NCT02019602|17579824|P1|Screening Period|Adverse Event|1
5091212|NCT02019602|17579823|P2|Screening Period|Ineligibility|0
5091213|NCT02019602|17579824|P1|Screening Period|Ineligibility|4
5091214|NCT02019550|17579853|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
5091215|NCT02019550|17579854|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
5091216|NCT02019472|17579895|P3|Overall Study|Other|6
5091217|NCT02019472|17579896|P2|Overall Study|Other|8
5091218|NCT02019472|17579897|P1|Overall Study|Other|3
5091219|NCT02019472|17579895|P3|Overall Study|Withdrawal by Subject|11
5091220|NCT02019472|17579896|P2|Overall Study|Withdrawal by Subject|10
5091221|NCT02019472|17579897|P1|Overall Study|Withdrawal by Subject|11
5091222|NCT02019472|17579895|P3|Overall Study|Pregnancy|2
5091223|NCT02019472|17579896|P2|Overall Study|Pregnancy|2
5091224|NCT02019472|17579897|P1|Overall Study|Pregnancy|1
5091225|NCT02019472|17579895|P3|Overall Study|Physician Decision|0
5091226|NCT02019472|17579896|P2|Overall Study|Physician Decision|2
5091227|NCT02019472|17579897|P1|Overall Study|Physician Decision|1
5091228|NCT02019472|17579895|P3|Overall Study|Lost to Follow-up|1
5091229|NCT02019472|17579896|P2|Overall Study|Lost to Follow-up|2
5091230|NCT02019472|17579897|P1|Overall Study|Lost to Follow-up|0
5091231|NCT02019472|17579895|P3|Overall Study|Lack of Efficacy|4
5091232|NCT02019472|17579896|P2|Overall Study|Lack of Efficacy|4
5091233|NCT02019472|17579897|P1|Overall Study|Lack of Efficacy|7
5091234|NCT02019472|17579895|P3|Overall Study|Death|1
5091235|NCT02019472|17579896|P2|Overall Study|Death|1
5091236|NCT02019472|17579897|P1|Overall Study|Death|0
5091237|NCT02019472|17579895|P3|Overall Study|Adverse Event|17
5091238|NCT02019472|17579896|P2|Overall Study|Adverse Event|23
5091239|NCT02019472|17579897|P1|Overall Study|Adverse Event|14
5091240|NCT02019420|17579920|P2|Overall Study|Transferred to other care facility|1
5091241|NCT02019420|17579921|P1|Overall Study|Transferred to other care facility|1
5091242|NCT02019420|17579920|P2|Overall Study|Death|99
5091243|NCT02019420|17579921|P1|Overall Study|Death|104
5091244|NCT02019420|17579920|P2|Overall Study|At request of sponsor or investigator|1
5091245|NCT02019420|17579921|P1|Overall Study|At request of sponsor or investigator|0
5091246|NCT02019420|17579920|P2|Overall Study|Withdrawal by Subject|3
5091247|NCT02019420|17579921|P1|Overall Study|Withdrawal by Subject|1
5091248|NCT02019420|17579920|P2|Overall Study|Did not receive study drug|2
5091249|NCT02019420|17579921|P1|Overall Study|Did not receive study drug|2
5091250|NCT02019277|17579949|P1|Overall Study|Adverse Event|1
5091251|NCT02019277|17579949|P1|Overall Study|Did no Cooperate|1
5091252|NCT02019277|17579949|P1|Overall Study|Death|7
5091253|NCT02019277|17579949|P1|Overall Study|Withdrawal by Subject|3
5091254|NCT02019264|17579968|P2|Overall Study|Missing|11
5091255|NCT02019264|17579969|P1|Overall Study|Missing|14
5091256|NCT02019264|17579968|P2|Overall Study|Administrative reason|28
5091257|NCT02019264|17579969|P1|Overall Study|Administrative reason|36
5091258|NCT02019264|17579968|P2|Overall Study|Withdrawal by Subject|117
5091259|NCT02019264|17579969|P1|Overall Study|Withdrawal by Subject|142
5091260|NCT02019264|17579968|P2|Overall Study|Lost to Follow-up|47
5091261|NCT02019264|17579969|P1|Overall Study|Lost to Follow-up|50
5091262|NCT02019264|17579968|P2|Overall Study|Not treated|4
5091263|NCT02019264|17579969|P1|Overall Study|Not treated|6
5091264|NCT02019108|17580005|P2|Overall Study|Lost to Follow-up|7
5091265|NCT02019108|17580006|P1|Overall Study|Lost to Follow-up|5
5091266|NCT02018887|17580048|P11|Part C: Cohort 8 Overall|Physician Decision|1
5091267|NCT02018887|17580049|P10|Part C: Cohort 8 Overall|Physician Decision|0
5091268|NCT02018887|17580050|P9|Part C: Cohort 8 Overall|Physician Decision|2
5091269|NCT02018887|17580051|P8|Part C: Cohort 8 Overall|Physician Decision|0
5091270|NCT02018887|17580052|P7|Part C: Cohort 8 Overall|Physician Decision|0
5091271|NCT02018887|17580053|P6|Part C: Cohort 8 Overall|Physician Decision|0
5091272|NCT02018887|17580054|P5|Part C: Cohort 8 Overall|Physician Decision|0
5091273|NCT02018887|17580055|P4|Part C: Cohort 8 Overall|Physician Decision|0
5091274|NCT02018887|17580056|P3|Part C: Cohort 8 Overall|Physician Decision|0
5091275|NCT02018887|17580057|P2|Part C: Cohort 8 Overall|Physician Decision|0
5091276|NCT02018887|17580058|P1|Part C: Cohort 8 Overall|Physician Decision|0
5091277|NCT02018887|17580048|P11|Part C: Cohort 8 Overall|Adverse Event|0
5091278|NCT02018887|17580049|P10|Part C: Cohort 8 Overall|Adverse Event|3
5091279|NCT02018887|17580050|P9|Part C: Cohort 8 Overall|Adverse Event|1
5091280|NCT02018887|17580051|P8|Part C: Cohort 8 Overall|Adverse Event|0
5091281|NCT02018887|17580052|P7|Part C: Cohort 8 Overall|Adverse Event|0
5091282|NCT02018887|17580053|P6|Part C: Cohort 8 Overall|Adverse Event|0
5091283|NCT02018887|17580054|P5|Part C: Cohort 8 Overall|Adverse Event|0
5091284|NCT02018887|17580055|P4|Part C: Cohort 8 Overall|Adverse Event|0
5091285|NCT02018887|17580056|P3|Part C: Cohort 8 Overall|Adverse Event|0
5091286|NCT02018887|17580057|P2|Part C: Cohort 8 Overall|Adverse Event|0
5091287|NCT02018887|17580058|P1|Part C: Cohort 8 Overall|Adverse Event|0
5091288|NCT02018887|17580048|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091289|NCT02018887|17580049|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091290|NCT02018887|17580050|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091291|NCT02018887|17580051|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
5091292|NCT02018887|17580052|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
5091293|NCT02018887|17580053|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091294|NCT02018887|17580054|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
5091295|NCT02018887|17580055|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091296|NCT02018887|17580056|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091297|NCT02018887|17580057|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091298|NCT02018887|17580058|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
5091299|NCT02018887|17580048|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091300|NCT02018887|17580049|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091301|NCT02018887|17580050|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091302|NCT02018887|17580051|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091303|NCT02018887|17580052|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091304|NCT02018887|17580053|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091305|NCT02018887|17580054|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091306|NCT02018887|17580055|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091307|NCT02018887|17580056|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091308|NCT02018887|17580057|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5091309|NCT02018887|17580058|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
5091310|NCT02018822|17580147|P3|Overall Study|Lost to Follow-up|5
5091311|NCT02018822|17580148|P2|Overall Study|Lost to Follow-up|6
5091312|NCT02018822|17580149|P1|Overall Study|Lost to Follow-up|6
5091313|NCT02018822|17580147|P3|Overall Study|Physician Decision|1
5091314|NCT02018822|17580148|P2|Overall Study|Physician Decision|1
5091315|NCT02018822|17580149|P1|Overall Study|Physician Decision|0
5091316|NCT02018822|17580147|P3|Overall Study|filling replaced by crown|0
5091317|NCT02018822|17580148|P2|Overall Study|filling replaced by crown|1
5091318|NCT02018822|17580149|P1|Overall Study|filling replaced by crown|0
5091319|NCT02018562|17580229|P2|Overall Study|Discharged prior to study completion|0
5091320|NCT02018562|17580230|P1|Overall Study|Discharged prior to study completion|1
5091321|NCT02018562|17580229|P2|Overall Study|Withdrawal by Subject|0
5091322|NCT02018562|17580230|P1|Overall Study|Withdrawal by Subject|2
5091323|NCT02018458|17580248|P1|Overall Study|Death|4
5091324|NCT02018042|17580275|P1|Overall Study|Withdrawal by Subject|1
5091325|NCT02017964|17580281|P1|Overall Study|Patient deemed ineligible|1
5091326|NCT02017899|17580295|P6|Overall Study|Withdrawal by Subject|0
5091327|NCT02017899|17580296|P5|Overall Study|Withdrawal by Subject|1
5091328|NCT02017899|17580297|P4|Overall Study|Withdrawal by Subject|1
5091329|NCT02017899|17580298|P3|Overall Study|Withdrawal by Subject|0
5091330|NCT02017899|17580299|P2|Overall Study|Withdrawal by Subject|0
5091331|NCT02017899|17580300|P1|Overall Study|Withdrawal by Subject|0
5091332|NCT02017860|17580374|P1|Overall Study|Withdrawal by Subject|1
5091333|NCT02017860|17580374|P1|Overall Study|Adverse Event|1
5091334|NCT02017535|17580393|P4|Overall Study|Withdrawal by Subject|0
5091335|NCT02017535|17580394|P3|Overall Study|Withdrawal by Subject|0
5091336|NCT02017535|17580395|P2|Overall Study|Withdrawal by Subject|0
5091337|NCT02017535|17580396|P1|Overall Study|Withdrawal by Subject|1
5091338|NCT02017522|17580418|P1|Overall Study|Withdrawal by Subject|1
5091339|NCT02017223|17580436|P1|Overall Study|Algorithm problems|2
5091340|NCT02017171|17580482|P2|Overall Study|Miscellaneous|3
5091341|NCT02017171|17580483|P1|Overall Study|Miscellaneous|2
5091342|NCT02017171|17580482|P2|Overall Study|ESKD|2
5091343|NCT02017171|17580483|P1|Overall Study|ESKD|6
5091344|NCT02017171|17580482|P2|Overall Study|Lost to Follow-up|20
5091345|NCT02017171|17580483|P1|Overall Study|Lost to Follow-up|21
5091346|NCT02017171|17580482|P2|Overall Study|Withdrawal by Subject|17
5091347|NCT02017171|17580483|P1|Overall Study|Withdrawal by Subject|23
5091348|NCT02017171|17580482|P2|Overall Study|Death|4
5091349|NCT02017171|17580483|P1|Overall Study|Death|10
5091350|NCT02017015|17580516|P1|Overall Study|Physician Decision|2
5091351|NCT02017015|17580516|P1|Overall Study|Non-compliance with study drug|2
5091352|NCT02017015|17580516|P1|Overall Study|Progressive Disease|31
5091353|NCT02017015|17580516|P1|Overall Study|Death|4
5091354|NCT02017015|17580516|P1|Overall Study|Withdrawal by Subject|21
5091355|NCT02017015|17580516|P1|Overall Study|Adverse Event|9
5091356|NCT02016898|17580541|P2|Overall Study|Lost to Follow-up|4
5091357|NCT02016898|17580542|P1|Overall Study|Lost to Follow-up|4
5091358|NCT02016898|17580541|P2|Overall Study|Death|1
5091359|NCT02016898|17580542|P1|Overall Study|Death|1
5091360|NCT02016716|17580599|P3|Overall Study|Lost to Follow-up|1
5091361|NCT02016716|17580600|P2|Overall Study|Lost to Follow-up|2
5091362|NCT02016716|17580601|P1|Overall Study|Lost to Follow-up|1
5091363|NCT02016716|17580599|P3|Overall Study|Protocol-specified Criteria|0
5091364|NCT02016716|17580600|P2|Overall Study|Protocol-specified Criteria|1
5091365|NCT02016716|17580601|P1|Overall Study|Protocol-specified Criteria|0
5091366|NCT02016716|17580599|P3|Overall Study|Withdrawal by Subject|5
5091367|NCT02016716|17580600|P2|Overall Study|Withdrawal by Subject|5
5091368|NCT02016716|17580601|P1|Overall Study|Withdrawal by Subject|5
5091369|NCT02016690|17580622|P1|Overall Study|Hospitalized for RSV at study start|3
5091370|NCT02016690|17580622|P1|Overall Study|Did not meet inclusion criteria|13
5091371|NCT02016690|17580622|P1|Overall Study|Excluded from SAS: Ineligible for study|2
5091372|NCT02016690|17580622|P1|Overall Study|Excluded from SAS: Early treatment|2
5091373|NCT02016690|17580622|P1|Overall Study|Excluded from SAS: Duplication|2
5091374|NCT02016690|17580622|P1|Overall Study|Excluded from SAS: Enrollment violation|2
5091375|NCT02016625|17580635|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
5091376|NCT02016625|17580636|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
5091377|NCT02016625|17580635|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
5091378|NCT02016625|17580636|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
5091379|NCT02016625|17580635|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
5091380|NCT02016625|17580636|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
5091381|NCT02016482|17580724|P2|Period B|Required Alternative/Prohibited Therapy|2
5091382|NCT02016482|17580725|P1|Period B|Required Alternative/Prohibited Therapy|0
5091383|NCT02016482|17580724|P2|Period B|Other|0
5091384|NCT02016482|17580725|P1|Period B|Other|4
5091385|NCT02016482|17580724|P2|Period B|Lack of Efficacy|4
5091386|NCT02016482|17580725|P1|Period B|Lack of Efficacy|6
5091387|NCT02016482|17580724|P2|Period B|Lost to Follow-up|0
5091388|NCT02016482|17580725|P1|Period B|Lost to Follow-up|2
5091389|NCT02016482|17580724|P2|Period B|Withdrawal by Subject|1
5091390|NCT02016482|17580725|P1|Period B|Withdrawal by Subject|1
5091391|NCT02016482|17580724|P2|Period A|Required Alternative/Prohibited Therapy|1
5091392|NCT02016482|17580725|P1|Period A|Required Alternative/Prohibited Therapy|0
5091393|NCT02016482|17580724|P2|Period A|Protocol Violation|1
5091394|NCT02016482|17580725|P1|Period A|Protocol Violation|0
5091395|NCT02016482|17580724|P2|Period A|Other|0
5091396|NCT02016482|17580725|P1|Period A|Other|3
5091397|NCT02016482|17580724|P2|Period A|Lack of Efficacy|1
5091398|NCT02016482|17580725|P1|Period A|Lack of Efficacy|2
5091399|NCT02016482|17580724|P2|Period A|Lost to Follow-up|3
5091400|NCT02016482|17580725|P1|Period A|Lost to Follow-up|3
5091401|NCT02016482|17580724|P2|Period A|Withdrawal by Subject|4
5091402|NCT02016482|17580725|P1|Period A|Withdrawal by Subject|3
5091403|NCT02016482|17580724|P2|Period A|Adverse Event|5
5091404|NCT02016482|17580725|P1|Period A|Adverse Event|3
5091405|NCT02016300|17580815|P2|Overall Study|Lost to Follow-up|3
5091406|NCT02016300|17580816|P1|Overall Study|Lost to Follow-up|0
5091407|NCT02016183|17580847|P1|Overall Study|Protocol Violation|52
5091408|NCT02016183|17580847|P1|Overall Study|Case Report Forms Uncollected|13
5091409|NCT02016170|17580857|P3|Overall Study|Protocol Violation|0
5091410|NCT02016170|17580858|P2|Overall Study|Protocol Violation|0
5091411|NCT02016170|17580859|P1|Overall Study|Protocol Violation|1
5091412|NCT02016170|17580857|P3|Overall Study|Adverse Event|0
5091413|NCT02016170|17580858|P2|Overall Study|Adverse Event|1
5091414|NCT02016170|17580859|P1|Overall Study|Adverse Event|1
5091415|NCT02016105|17580870|P6|EXTENSION PERIOD|Lost to Follow-up|2
5091416|NCT02016105|17580871|P5|EXTENSION PERIOD|Lost to Follow-up|0
5091417|NCT02016105|17580872|P4|EXTENSION PERIOD|Lost to Follow-up|0
5091418|NCT02016105|17580873|P3|EXTENSION PERIOD|Lost to Follow-up|0
5091419|NCT02016105|17580874|P2|EXTENSION PERIOD|Lost to Follow-up|0
5091420|NCT02016105|17580875|P1|EXTENSION PERIOD|Lost to Follow-up|0
5091421|NCT02016105|17580870|P6|EXTENSION PERIOD|Non-compliance with study indication|0
5091422|NCT02016105|17580871|P5|EXTENSION PERIOD|Non-compliance with study indication|1
5091423|NCT02016105|17580872|P4|EXTENSION PERIOD|Non-compliance with study indication|0
5091424|NCT02016105|17580873|P3|EXTENSION PERIOD|Non-compliance with study indication|0
5091425|NCT02016105|17580874|P2|EXTENSION PERIOD|Non-compliance with study indication|0
5091426|NCT02016105|17580875|P1|EXTENSION PERIOD|Non-compliance with study indication|0
5091427|NCT02016105|17580870|P6|EXTENSION PERIOD|Withdrawal by Subject|2
5091428|NCT02016105|17580871|P5|EXTENSION PERIOD|Withdrawal by Subject|2
5091429|NCT02016105|17580872|P4|EXTENSION PERIOD|Withdrawal by Subject|2
5091430|NCT02016105|17580873|P3|EXTENSION PERIOD|Withdrawal by Subject|2
5091431|NCT02016105|17580874|P2|EXTENSION PERIOD|Withdrawal by Subject|0
5091432|NCT02016105|17580875|P1|EXTENSION PERIOD|Withdrawal by Subject|0
5091433|NCT02016105|17580870|P6|EXTENSION PERIOD|Adverse Event|0
5091434|NCT02016105|17580871|P5|EXTENSION PERIOD|Adverse Event|1
5091435|NCT02016105|17580872|P4|EXTENSION PERIOD|Adverse Event|0
5091436|NCT02016105|17580873|P3|EXTENSION PERIOD|Adverse Event|2
5091437|NCT02016105|17580874|P2|EXTENSION PERIOD|Adverse Event|0
5091438|NCT02016105|17580875|P1|EXTENSION PERIOD|Adverse Event|0
5091439|NCT02016105|17580870|P6|EXTENSION PERIOD|Lack of Efficacy|1
5091440|NCT02016105|17580871|P5|EXTENSION PERIOD|Lack of Efficacy|1
5091441|NCT02016105|17580872|P4|EXTENSION PERIOD|Lack of Efficacy|3
5091442|NCT02016105|17580873|P3|EXTENSION PERIOD|Lack of Efficacy|1
5091443|NCT02016105|17580874|P2|EXTENSION PERIOD|Lack of Efficacy|0
5091444|NCT02016105|17580875|P1|EXTENSION PERIOD|Lack of Efficacy|0
5091445|NCT02016105|17580870|P6|EXTENSION PERIOD|New therapy for study indication|1
5091446|NCT02016105|17580871|P5|EXTENSION PERIOD|New therapy for study indication|1
5091447|NCT02016105|17580872|P4|EXTENSION PERIOD|New therapy for study indication|0
5091448|NCT02016105|17580873|P3|EXTENSION PERIOD|New therapy for study indication|0
5091449|NCT02016105|17580874|P2|EXTENSION PERIOD|New therapy for study indication|0
5091450|NCT02016105|17580875|P1|EXTENSION PERIOD|New therapy for study indication|0
5091451|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
5091452|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
5091453|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
5091454|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
5091455|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
5091456|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
5091457|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
5091458|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
5091459|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
5091460|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
5091461|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
5091462|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
5091463|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Adverse Event|1
5091464|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Adverse Event|0
5091465|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Adverse Event|4
5091466|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Adverse Event|0
5091467|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Adverse Event|0
5091468|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Adverse Event|0
5091469|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Death|1
5091470|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Death|0
5091471|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Death|0
5091472|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Death|0
5091473|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Death|0
5091474|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Death|0
5091475|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Pregnancy|1
5091476|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Pregnancy|0
5091477|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Pregnancy|0
5091478|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Pregnancy|0
5091479|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Pregnancy|0
5091480|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Pregnancy|0
5091481|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
5091482|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
5091483|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
5091484|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
5091485|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
5091486|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
5091487|NCT02016105|17580870|P6|TREATMENT PERIOD 2|Non compliance study medication|1
5091488|NCT02016105|17580871|P5|TREATMENT PERIOD 2|Non compliance study medication|0
5091489|NCT02016105|17580872|P4|TREATMENT PERIOD 2|Non compliance study medication|0
5091490|NCT02016105|17580873|P3|TREATMENT PERIOD 2|Non compliance study medication|0
5091491|NCT02016105|17580874|P2|TREATMENT PERIOD 2|Non compliance study medication|0
5091492|NCT02016105|17580875|P1|TREATMENT PERIOD 2|Non compliance study medication|0
5091493|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
5091494|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
5091495|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
5091496|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
5091497|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
5091498|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
5091499|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
5091500|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
5091501|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
5091502|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
5091503|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
5091504|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
5091505|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Adverse Event|0
5091506|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Adverse Event|0
5091507|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Adverse Event|0
5091508|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Adverse Event|0
5091509|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Adverse Event|5
5091510|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Adverse Event|3
5091511|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Pregnancy|0
5091512|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Pregnancy|0
5091513|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Pregnancy|0
5091514|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Pregnancy|0
5091515|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Pregnancy|1
5091516|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Pregnancy|0
5091517|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
5091518|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
5091519|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
5091520|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
5091521|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
5091522|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
5091523|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Physician Decision|0
5091524|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Physician Decision|0
5091525|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Physician Decision|0
5091526|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Physician Decision|0
5091527|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Physician Decision|2
5091528|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Physician Decision|0
5091529|NCT02016105|17580870|P6|TREATMENT PERIOD 1|Protocol Violation|0
5091530|NCT02016105|17580871|P5|TREATMENT PERIOD 1|Protocol Violation|0
5091531|NCT02016105|17580872|P4|TREATMENT PERIOD 1|Protocol Violation|0
5091532|NCT02016105|17580873|P3|TREATMENT PERIOD 1|Protocol Violation|0
5091533|NCT02016105|17580874|P2|TREATMENT PERIOD 1|Protocol Violation|8
5091534|NCT02016105|17580875|P1|TREATMENT PERIOD 1|Protocol Violation|2
5091535|NCT02015793|17580934|P2|Overall Study|Withdrawal by Subject|1
5091536|NCT02015793|17580935|P1|Overall Study|Withdrawal by Subject|1
5091537|NCT02015793|17580934|P2|Overall Study|Adverse Event|3
5091538|NCT02015793|17580935|P1|Overall Study|Adverse Event|3
5091539|NCT02015754|17580965|P1|Overall Study|Lost to Follow-up|1
5091540|NCT02015754|17580965|P1|Overall Study|Change in treatment modality|5
5091541|NCT02015754|17580965|P1|Overall Study|Disease progression|5
5091542|NCT02015676|17580985|P3|Overall Study|Disease progression|1
5091543|NCT02015676|17580986|P2|Overall Study|Disease progression|1
5091544|NCT02015676|17580987|P1|Overall Study|Disease progression|3
5091545|NCT02015676|17580985|P3|Overall Study|Death|0
5091546|NCT02015676|17580986|P2|Overall Study|Death|1
5091547|NCT02015676|17580987|P1|Overall Study|Death|0
5091548|NCT02015676|17580985|P3|Overall Study|Administrative reasons|1
5091549|NCT02015676|17580986|P2|Overall Study|Administrative reasons|3
5091550|NCT02015676|17580987|P1|Overall Study|Administrative reasons|0
5091551|NCT02015676|17580985|P3|Overall Study|Withdrawal by Subject|1
5091552|NCT02015676|17580986|P2|Overall Study|Withdrawal by Subject|7
5091553|NCT02015676|17580987|P1|Overall Study|Withdrawal by Subject|1
5091554|NCT02015676|17580985|P3|Overall Study|Protocol Violation|0
5091555|NCT02015676|17580986|P2|Overall Study|Protocol Violation|0
5091556|NCT02015676|17580987|P1|Overall Study|Protocol Violation|1
5091557|NCT02015676|17580985|P3|Overall Study|Lack of Efficacy|0
5091558|NCT02015676|17580986|P2|Overall Study|Lack of Efficacy|4
5091559|NCT02015676|17580987|P1|Overall Study|Lack of Efficacy|2
5091560|NCT02015676|17580985|P3|Overall Study|Adverse Event|0
5091561|NCT02015676|17580986|P2|Overall Study|Adverse Event|18
5091562|NCT02015676|17580987|P1|Overall Study|Adverse Event|2
5091563|NCT02015663|17581003|P2|Overall Study|Administrative problems|11
5091564|NCT02015663|17581004|P1|Overall Study|Administrative problems|10
5091565|NCT02015663|17581003|P2|Overall Study|Adverse Event|0
5091566|NCT02015663|17581004|P1|Overall Study|Adverse Event|3
5091567|NCT02015663|17581003|P2|Overall Study|Protocol Violation|1
5091568|NCT02015663|17581004|P1|Overall Study|Protocol Violation|0
5091569|NCT02015663|17581003|P2|Overall Study|Withdrawal by Subject|0
5091570|NCT02015663|17581004|P1|Overall Study|Withdrawal by Subject|1
5091571|NCT02015663|17581003|P2|Overall Study|unsatisfactory therapeutic effect|0
5091572|NCT02015663|17581004|P1|Overall Study|unsatisfactory therapeutic effect|1
5091573|NCT02015637|17581035|P2|Overall Study|Did not take study drug|0
5091574|NCT02015637|17581036|P1|Overall Study|Did not take study drug|2
5091575|NCT02015637|17581035|P2|Overall Study|Adverse Event|0
5091576|NCT02015637|17581036|P1|Overall Study|Adverse Event|3
5091577|NCT02015637|17581035|P2|Overall Study|Lost to Follow-up|5
5091578|NCT02015637|17581036|P1|Overall Study|Lost to Follow-up|3
5091579|NCT02015546|17581047|P3|Overall Study|Screem Failure|3
5091580|NCT02015546|17581048|P2|Overall Study|Screem Failure|1
5091581|NCT02015546|17581049|P1|Overall Study|Screem Failure|2
5091582|NCT02015546|17581047|P3|Overall Study|Withdrawal by Subject|1
5091583|NCT02015546|17581048|P2|Overall Study|Withdrawal by Subject|1
5091584|NCT02015546|17581049|P1|Overall Study|Withdrawal by Subject|1
5091585|NCT02015481|17581081|P1|Overall Study|Death|1
5091586|NCT02015221|17581114|P2|Overall Study|Lost to Follow-up|0
5091587|NCT02015221|17581115|P1|Overall Study|Lost to Follow-up|1
5091588|NCT02015221|17581114|P2|Overall Study|Withdrawal by Subject|6
5091589|NCT02015221|17581115|P1|Overall Study|Withdrawal by Subject|8
5091590|NCT02015195|17581128|P7|Overall Study|Adverse Event|0
5091591|NCT02015195|17581129|P6|Overall Study|Adverse Event|0
5091592|NCT02015195|17581130|P5|Overall Study|Adverse Event|0
5091593|NCT02015195|17581131|P4|Overall Study|Adverse Event|1
5091594|NCT02015195|17581132|P3|Overall Study|Adverse Event|0
5091595|NCT02015195|17581133|P2|Overall Study|Adverse Event|0
5091596|NCT02015195|17581134|P1|Overall Study|Adverse Event|0
5091597|NCT02015104|17581157|P2|Overall Study|Withdrew consent prior to treatment|1
5091598|NCT02015104|17581158|P1|Overall Study|Withdrew consent prior to treatment|0
5091599|NCT02015104|17581157|P2|Overall Study|Withdrew consent after first dose drug|0
5091600|NCT02015104|17581158|P1|Overall Study|Withdrew consent after first dose drug|1
5091601|NCT02015065|17581175|P3|Overall Study|Death on study|1
5091602|NCT02015065|17581176|P2|Overall Study|Death on study|2
5091603|NCT02015065|17581177|P1|Overall Study|Death on study|1
5091604|NCT02015039|17581199|P2|Overall Study|Not eligible|1
5091605|NCT02015039|17581200|P1|Overall Study|Not eligible|0
5091606|NCT02014740|17581220|P2|Overall Study|Withdrawal by Subject|1
5091607|NCT02014740|17581221|P1|Overall Study|Withdrawal by Subject|2
5091608|NCT02014740|17581220|P2|Overall Study|Lost to Follow-up|4
5091609|NCT02014740|17581221|P1|Overall Study|Lost to Follow-up|4
5091610|NCT02014597|17581229|P2|Overall Study|Unable to record log contrast sensitivity|1
5091611|NCT02014597|17581230|P1|Overall Study|Unable to record log contrast sensitivity|2
5091612|NCT02014584|17581246|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5091613|NCT02014584|17581247|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
5091614|NCT02014584|17581248|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5091615|NCT02014584|17581249|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5091616|NCT02014584|17581250|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5091617|NCT02014584|17581251|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5091618|NCT02014584|17581246|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5091619|NCT02014584|17581247|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5091620|NCT02014584|17581248|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
5091621|NCT02014584|17581249|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
5091622|NCT02014584|17581250|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5091623|NCT02014584|17581251|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5091624|NCT02014584|17581246|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5091625|NCT02014584|17581247|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5091626|NCT02014584|17581248|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5091627|NCT02014584|17581249|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
5091628|NCT02014584|17581250|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5091629|NCT02014584|17581251|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5091630|NCT02014584|17581246|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5091631|NCT02014584|17581247|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5091632|NCT02014584|17581248|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5091633|NCT02014584|17581249|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5091634|NCT02014584|17581250|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
5091635|NCT02014584|17581251|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
5091636|NCT02014584|17581246|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
5091637|NCT02014584|17581247|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
5091638|NCT02014584|17581248|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
5091639|NCT02014584|17581249|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
5091640|NCT02014584|17581250|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
5091641|NCT02014584|17581251|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
5091642|NCT02014558|17581381|P13|Overall Study|Miscellaneous|1
5091643|NCT02014558|17581382|P12|Overall Study|Miscellaneous|11
5091644|NCT02014558|17581383|P11|Overall Study|Miscellaneous|12
5091645|NCT02014558|17581384|P10|Overall Study|Miscellaneous|3
5091646|NCT02014558|17581385|P9|Overall Study|Miscellaneous|1
5091647|NCT02014558|17581386|P8|Overall Study|Miscellaneous|1
5091648|NCT02014558|17581387|P7|Overall Study|Miscellaneous|0
5091649|NCT02014558|17581388|P6|Overall Study|Miscellaneous|1
5091650|NCT02014558|17581389|P5|Overall Study|Miscellaneous|0
5091651|NCT02014558|17581390|P4|Overall Study|Miscellaneous|1
5091652|NCT02014558|17581391|P3|Overall Study|Miscellaneous|1
5091653|NCT02014558|17581392|P2|Overall Study|Miscellaneous|1
5091654|NCT02014558|17581393|P1|Overall Study|Miscellaneous|2
5091655|NCT02014558|17581381|P13|Overall Study|Withdrawal by Subject|0
5091656|NCT02014558|17581382|P12|Overall Study|Withdrawal by Subject|10
5091657|NCT02014558|17581383|P11|Overall Study|Withdrawal by Subject|6
5091658|NCT02014558|17581384|P10|Overall Study|Withdrawal by Subject|2
5091659|NCT02014558|17581385|P9|Overall Study|Withdrawal by Subject|0
5091660|NCT02014558|17581386|P8|Overall Study|Withdrawal by Subject|0
5091661|NCT02014558|17581387|P7|Overall Study|Withdrawal by Subject|0
5091662|NCT02014558|17581388|P6|Overall Study|Withdrawal by Subject|0
5091663|NCT02014558|17581389|P5|Overall Study|Withdrawal by Subject|1
5091664|NCT02014558|17581390|P4|Overall Study|Withdrawal by Subject|0
5091665|NCT02014558|17581391|P3|Overall Study|Withdrawal by Subject|0
5091666|NCT02014558|17581392|P2|Overall Study|Withdrawal by Subject|0
5091667|NCT02014558|17581393|P1|Overall Study|Withdrawal by Subject|0
5091668|NCT02014558|17581381|P13|Overall Study|Progressive Disease|6
5091669|NCT02014558|17581382|P12|Overall Study|Progressive Disease|31
5091670|NCT02014558|17581383|P11|Overall Study|Progressive Disease|22
5091671|NCT02014558|17581384|P10|Overall Study|Progressive Disease|6
5091672|NCT02014558|17581385|P9|Overall Study|Progressive Disease|5
5091673|NCT02014558|17581386|P8|Overall Study|Progressive Disease|6
5091674|NCT02014558|17581387|P7|Overall Study|Progressive Disease|1
5091675|NCT02014558|17581388|P6|Overall Study|Progressive Disease|2
5091676|NCT02014558|17581389|P5|Overall Study|Progressive Disease|1
5091677|NCT02014558|17581390|P4|Overall Study|Progressive Disease|1
5091678|NCT02014558|17581391|P3|Overall Study|Progressive Disease|1
5091679|NCT02014558|17581392|P2|Overall Study|Progressive Disease|0
5091680|NCT02014558|17581393|P1|Overall Study|Progressive Disease|1
5091681|NCT02014558|17581381|P13|Overall Study|Lost to Follow-up|0
5091682|NCT02014558|17581382|P12|Overall Study|Lost to Follow-up|0
5091683|NCT02014558|17581383|P11|Overall Study|Lost to Follow-up|1
5091684|NCT02014558|17581384|P10|Overall Study|Lost to Follow-up|0
5091685|NCT02014558|17581385|P9|Overall Study|Lost to Follow-up|0
5091686|NCT02014558|17581386|P8|Overall Study|Lost to Follow-up|0
5091687|NCT02014558|17581387|P7|Overall Study|Lost to Follow-up|0
5091688|NCT02014558|17581388|P6|Overall Study|Lost to Follow-up|0
5091689|NCT02014558|17581389|P5|Overall Study|Lost to Follow-up|0
5091690|NCT02014558|17581390|P4|Overall Study|Lost to Follow-up|0
5091691|NCT02014558|17581391|P3|Overall Study|Lost to Follow-up|0
5091692|NCT02014558|17581392|P2|Overall Study|Lost to Follow-up|0
5091693|NCT02014558|17581393|P1|Overall Study|Lost to Follow-up|0
5091694|NCT02014558|17581381|P13|Overall Study|Lack of Efficacy|5
5091695|NCT02014558|17581382|P12|Overall Study|Lack of Efficacy|8
5091696|NCT02014558|17581383|P11|Overall Study|Lack of Efficacy|16
5091697|NCT02014558|17581384|P10|Overall Study|Lack of Efficacy|3
5091698|NCT02014558|17581385|P9|Overall Study|Lack of Efficacy|3
5091699|NCT02014558|17581386|P8|Overall Study|Lack of Efficacy|3
5091700|NCT02014558|17581387|P7|Overall Study|Lack of Efficacy|1
5091701|NCT02014558|17581388|P6|Overall Study|Lack of Efficacy|0
5091702|NCT02014558|17581389|P5|Overall Study|Lack of Efficacy|0
5091703|NCT02014558|17581390|P4|Overall Study|Lack of Efficacy|1
5091704|NCT02014558|17581391|P3|Overall Study|Lack of Efficacy|1
5091705|NCT02014558|17581392|P2|Overall Study|Lack of Efficacy|2
5091706|NCT02014558|17581393|P1|Overall Study|Lack of Efficacy|1
5091707|NCT02014558|17581381|P13|Overall Study|Death|2
5091708|NCT02014558|17581382|P12|Overall Study|Death|19
5091709|NCT02014558|17581383|P11|Overall Study|Death|5
5091710|NCT02014558|17581384|P10|Overall Study|Death|5
5091711|NCT02014558|17581385|P9|Overall Study|Death|2
5091712|NCT02014558|17581386|P8|Overall Study|Death|1
5091713|NCT02014558|17581387|P7|Overall Study|Death|1
5091714|NCT02014558|17581388|P6|Overall Study|Death|0
5091715|NCT02014558|17581389|P5|Overall Study|Death|0
5091716|NCT02014558|17581390|P4|Overall Study|Death|0
5091717|NCT02014558|17581391|P3|Overall Study|Death|0
5091718|NCT02014558|17581392|P2|Overall Study|Death|0
5091719|NCT02014558|17581393|P1|Overall Study|Death|1
5091720|NCT02014558|17581381|P13|Overall Study|Adverse Event|3
5091721|NCT02014558|17581382|P12|Overall Study|Adverse Event|21
5091722|NCT02014558|17581383|P11|Overall Study|Adverse Event|5
5091723|NCT02014558|17581384|P10|Overall Study|Adverse Event|2
5091724|NCT02014558|17581385|P9|Overall Study|Adverse Event|2
5091725|NCT02014558|17581386|P8|Overall Study|Adverse Event|0
5091726|NCT02014558|17581387|P7|Overall Study|Adverse Event|0
5091727|NCT02014558|17581388|P6|Overall Study|Adverse Event|0
5091728|NCT02014558|17581389|P5|Overall Study|Adverse Event|1
5091729|NCT02014558|17581390|P4|Overall Study|Adverse Event|0
5091730|NCT02014558|17581391|P3|Overall Study|Adverse Event|0
5091731|NCT02014558|17581392|P2|Overall Study|Adverse Event|0
5091732|NCT02014558|17581393|P1|Overall Study|Adverse Event|0
5091733|NCT02014558|17581381|P13|Overall Study|Never Received Study Drug|0
5091734|NCT02014558|17581382|P12|Overall Study|Never Received Study Drug|2
5091735|NCT02014558|17581383|P11|Overall Study|Never Received Study Drug|2
5091736|NCT02014558|17581384|P10|Overall Study|Never Received Study Drug|0
5091737|NCT02014558|17581385|P9|Overall Study|Never Received Study Drug|2
5091738|NCT02014558|17581386|P8|Overall Study|Never Received Study Drug|0
5091739|NCT02014558|17581387|P7|Overall Study|Never Received Study Drug|1
5091740|NCT02014558|17581388|P6|Overall Study|Never Received Study Drug|0
5091741|NCT02014558|17581389|P5|Overall Study|Never Received Study Drug|1
5091742|NCT02014558|17581390|P4|Overall Study|Never Received Study Drug|0
5091743|NCT02014558|17581391|P3|Overall Study|Never Received Study Drug|0
5091744|NCT02014558|17581392|P2|Overall Study|Never Received Study Drug|0
5091745|NCT02014558|17581393|P1|Overall Study|Never Received Study Drug|0
5091746|NCT02014480|17581758|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
5091747|NCT02014480|17581759|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5091748|NCT02014480|17581760|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5091749|NCT02014480|17581761|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5091750|NCT02014480|17581762|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5091751|NCT02014480|17581763|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5091752|NCT02014480|17581758|P6|Treatment Period 3 (14 Days)|Adverse Event|1
5091753|NCT02014480|17581759|P5|Treatment Period 3 (14 Days)|Adverse Event|0
5091754|NCT02014480|17581760|P4|Treatment Period 3 (14 Days)|Adverse Event|0
5091755|NCT02014480|17581761|P3|Treatment Period 3 (14 Days)|Adverse Event|1
5091756|NCT02014480|17581762|P2|Treatment Period 3 (14 Days)|Adverse Event|0
5091757|NCT02014480|17581763|P1|Treatment Period 3 (14 Days)|Adverse Event|0
5091758|NCT02014480|17581758|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5091759|NCT02014480|17581759|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5091760|NCT02014480|17581760|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5091761|NCT02014480|17581761|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5091762|NCT02014480|17581762|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5091763|NCT02014480|17581763|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5091764|NCT02014480|17581758|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5091765|NCT02014480|17581759|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5091766|NCT02014480|17581760|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5091767|NCT02014480|17581761|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
5091768|NCT02014480|17581762|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
5091769|NCT02014480|17581763|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
5091770|NCT02014480|17581758|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5091771|NCT02014480|17581759|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5091772|NCT02014480|17581760|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5091773|NCT02014480|17581761|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5091774|NCT02014480|17581762|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5091775|NCT02014480|17581763|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5091776|NCT02014480|17581758|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5091777|NCT02014480|17581759|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5091778|NCT02014480|17581760|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5091779|NCT02014480|17581761|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5091780|NCT02014480|17581762|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5091781|NCT02014480|17581763|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5091782|NCT02014480|17581758|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5091783|NCT02014480|17581759|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5091784|NCT02014480|17581760|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5091785|NCT02014480|17581761|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
5091786|NCT02014480|17581762|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5091787|NCT02014480|17581763|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5091788|NCT02014467|17581782|P2|Overall Study|Withdrawal by Subject|4
5091789|NCT02014467|17581783|P1|Overall Study|Withdrawal by Subject|16
5091790|NCT02014467|17581782|P2|Overall Study|Physician Decision|3
5091791|NCT02014467|17581783|P1|Overall Study|Physician Decision|2
5091792|NCT02014467|17581782|P2|Overall Study|Protocol Violation|0
5091793|NCT02014467|17581783|P1|Overall Study|Protocol Violation|3
5091794|NCT02014467|17581782|P2|Overall Study|Adverse Event|0
5091795|NCT02014467|17581783|P1|Overall Study|Adverse Event|4
5091796|NCT02014441|17581843|P1|Overall Study|Withdrawal by Subject|12
5091797|NCT02014402|17581939|P4|Overall Study|Lost to Follow-up|2
5091798|NCT02014402|17581940|P3|Overall Study|Lost to Follow-up|1
5091799|NCT02014402|17581941|P2|Overall Study|Lost to Follow-up|0
5091800|NCT02014402|17581942|P1|Overall Study|Lost to Follow-up|0
5091801|NCT02014402|17581939|P4|Overall Study|Subject did not have transportation|0
5091802|NCT02014402|17581940|P3|Overall Study|Subject did not have transportation|0
5091803|NCT02014402|17581941|P2|Overall Study|Subject did not have transportation|1
5091804|NCT02014402|17581942|P1|Overall Study|Subject did not have transportation|0
5091805|NCT02014402|17581939|P4|Overall Study|Withdrawal by Subject|1
5091806|NCT02014402|17581940|P3|Overall Study|Withdrawal by Subject|2
5091807|NCT02014402|17581941|P2|Overall Study|Withdrawal by Subject|2
5091808|NCT02014402|17581942|P1|Overall Study|Withdrawal by Subject|1
5091809|NCT02014402|17581939|P4|Overall Study|Adverse Event|0
5091810|NCT02014402|17581940|P3|Overall Study|Adverse Event|0
5091811|NCT02014402|17581941|P2|Overall Study|Adverse Event|0
5091812|NCT02014402|17581942|P1|Overall Study|Adverse Event|1
5091813|NCT02014376|17581972|P3|Overall Study|Lost to Follow-up|0
5091814|NCT02014376|17581973|P2|Overall Study|Lost to Follow-up|0
5091815|NCT02014376|17581974|P1|Overall Study|Lost to Follow-up|2
5091816|NCT02014376|17581972|P3|Overall Study|Adverse Event|0
5091817|NCT02014376|17581973|P2|Overall Study|Adverse Event|1
5091818|NCT02014376|17581974|P1|Overall Study|Adverse Event|1
5091819|NCT02014272|17582010|P2|Intervention Period 1|Adverse Event|1
5091820|NCT02014272|17582011|P1|Intervention Period 1|Adverse Event|0
5091821|NCT02014272|17582010|P2|Intervention Period 1|Withdrawal by Subject|0
5091822|NCT02014272|17582011|P1|Intervention Period 1|Withdrawal by Subject|1
5091823|NCT02014116|17582060|P9|Overall Study|Physician Decision|1
5091824|NCT02014116|17582061|P8|Overall Study|Physician Decision|0
5091825|NCT02014116|17582062|P7|Overall Study|Physician Decision|0
5091826|NCT02014116|17582063|P6|Overall Study|Physician Decision|0
5091827|NCT02014116|17582064|P5|Overall Study|Physician Decision|0
5091828|NCT02014116|17582065|P4|Overall Study|Physician Decision|0
5091829|NCT02014116|17582066|P3|Overall Study|Physician Decision|0
5091830|NCT02014116|17582067|P2|Overall Study|Physician Decision|0
5091831|NCT02014116|17582068|P1|Overall Study|Physician Decision|0
5091832|NCT02014116|17582060|P9|Overall Study|Withdrawal Caregiver Decision|0
5091833|NCT02014116|17582061|P8|Overall Study|Withdrawal Caregiver Decision|0
5091834|NCT02014116|17582062|P7|Overall Study|Withdrawal Caregiver Decision|0
5091835|NCT02014116|17582063|P6|Overall Study|Withdrawal Caregiver Decision|1
5091836|NCT02014116|17582064|P5|Overall Study|Withdrawal Caregiver Decision|0
5091837|NCT02014116|17582065|P4|Overall Study|Withdrawal Caregiver Decision|0
5091838|NCT02014116|17582066|P3|Overall Study|Withdrawal Caregiver Decision|0
5091839|NCT02014116|17582067|P2|Overall Study|Withdrawal Caregiver Decision|0
5091840|NCT02014116|17582068|P1|Overall Study|Withdrawal Caregiver Decision|0
5091841|NCT02014116|17582060|P9|Overall Study|Withdrawal by Subject|0
5091842|NCT02014116|17582061|P8|Overall Study|Withdrawal by Subject|0
5091843|NCT02014116|17582062|P7|Overall Study|Withdrawal by Subject|0
5091844|NCT02014116|17582063|P6|Overall Study|Withdrawal by Subject|1
5091845|NCT02014116|17582064|P5|Overall Study|Withdrawal by Subject|0
5091846|NCT02014116|17582065|P4|Overall Study|Withdrawal by Subject|1
5091847|NCT02014116|17582066|P3|Overall Study|Withdrawal by Subject|1
5091848|NCT02014116|17582067|P2|Overall Study|Withdrawal by Subject|0
5091849|NCT02014116|17582068|P1|Overall Study|Withdrawal by Subject|0
5091850|NCT02014116|17582060|P9|Overall Study|Death|1
5091851|NCT02014116|17582061|P8|Overall Study|Death|1
5091852|NCT02014116|17582062|P7|Overall Study|Death|0
5091853|NCT02014116|17582063|P6|Overall Study|Death|0
5091854|NCT02014116|17582064|P5|Overall Study|Death|0
5091855|NCT02014116|17582065|P4|Overall Study|Death|0
5091856|NCT02014116|17582066|P3|Overall Study|Death|0
5091857|NCT02014116|17582067|P2|Overall Study|Death|0
5091858|NCT02014116|17582068|P1|Overall Study|Death|0
5091859|NCT02014116|17582060|P9|Overall Study|Lost to Follow-up|1
5091860|NCT02014116|17582061|P8|Overall Study|Lost to Follow-up|0
5091861|NCT02014116|17582062|P7|Overall Study|Lost to Follow-up|0
5091862|NCT02014116|17582063|P6|Overall Study|Lost to Follow-up|1
5091863|NCT02014116|17582064|P5|Overall Study|Lost to Follow-up|0
5091864|NCT02014116|17582065|P4|Overall Study|Lost to Follow-up|0
5091865|NCT02014116|17582066|P3|Overall Study|Lost to Follow-up|0
5091866|NCT02014116|17582067|P2|Overall Study|Lost to Follow-up|0
5091867|NCT02014116|17582068|P1|Overall Study|Lost to Follow-up|0
5091868|NCT02014116|17582060|P9|Overall Study|Adverse Event|0
5091869|NCT02014116|17582061|P8|Overall Study|Adverse Event|1
5091870|NCT02014116|17582062|P7|Overall Study|Adverse Event|0
5091871|NCT02014116|17582063|P6|Overall Study|Adverse Event|0
5091872|NCT02014116|17582064|P5|Overall Study|Adverse Event|1
5091873|NCT02014116|17582065|P4|Overall Study|Adverse Event|0
5091874|NCT02014116|17582066|P3|Overall Study|Adverse Event|0
5091875|NCT02014116|17582067|P2|Overall Study|Adverse Event|0
5091876|NCT02014116|17582068|P1|Overall Study|Adverse Event|0
5091877|NCT02014116|17582060|P9|Overall Study|Progressive Disease|7
5091878|NCT02014116|17582061|P8|Overall Study|Progressive Disease|3
5091879|NCT02014116|17582062|P7|Overall Study|Progressive Disease|1
5091880|NCT02014116|17582063|P6|Overall Study|Progressive Disease|13
5091881|NCT02014116|17582064|P5|Overall Study|Progressive Disease|1
5091882|NCT02014116|17582065|P4|Overall Study|Progressive Disease|6
5091883|NCT02014116|17582066|P3|Overall Study|Progressive Disease|2
5091884|NCT02014116|17582067|P2|Overall Study|Progressive Disease|4
5091885|NCT02014116|17582068|P1|Overall Study|Progressive Disease|3
5091886|NCT02013830|17582133|P1|Overall Study|Refused treatment|1
5091887|NCT02013830|17582133|P1|Overall Study|Insufficient therapeutic response|25
5091888|NCT02013830|17582133|P1|Overall Study|Death|1
5091889|NCT02013830|17582133|P1|Overall Study|Adverse Event|3
5091890|NCT02013817|17582144|P1|Overall Study|Other|9
5091891|NCT02013817|17582144|P1|Overall Study|Death|2
5091892|NCT02013817|17582144|P1|Overall Study|Withdrawal by Subject|4
5091893|NCT02013817|17582144|P1|Overall Study|Adverse Event|12
5091894|NCT02013791|17582162|P9|Period 1|Other Miscellaneous Reasons|0
5091895|NCT02013791|17582163|P8|Period 1|Other Miscellaneous Reasons|0
5091896|NCT02013791|17582164|P7|Period 1|Other Miscellaneous Reasons|0
5091897|NCT02013791|17582165|P6|Period 1|Other Miscellaneous Reasons|0
5091898|NCT02013791|17582166|P5|Period 1|Other Miscellaneous Reasons|0
5091899|NCT02013791|17582167|P4|Period 1|Other Miscellaneous Reasons|0
5091900|NCT02013791|17582168|P3|Period 1|Other Miscellaneous Reasons|0
5091901|NCT02013791|17582169|P2|Period 1|Other Miscellaneous Reasons|2
5091902|NCT02013791|17582170|P1|Period 1|Other Miscellaneous Reasons|0
5091903|NCT02013791|17582162|P9|Period 1|Lost to Follow-up|0
5091904|NCT02013791|17582163|P8|Period 1|Lost to Follow-up|1
5091905|NCT02013791|17582164|P7|Period 1|Lost to Follow-up|1
5091906|NCT02013791|17582165|P6|Period 1|Lost to Follow-up|0
5091907|NCT02013791|17582166|P5|Period 1|Lost to Follow-up|0
5091908|NCT02013791|17582167|P4|Period 1|Lost to Follow-up|1
5091909|NCT02013791|17582168|P3|Period 1|Lost to Follow-up|0
5091910|NCT02013791|17582169|P2|Period 1|Lost to Follow-up|0
5091911|NCT02013791|17582170|P1|Period 1|Lost to Follow-up|0
5091912|NCT02013778|17582191|P1|Overall Study|Adverse Event|1
5091913|NCT02013778|17582191|P1|Overall Study|Physician Decision|1
5091914|NCT02013778|17582191|P1|Overall Study|Withdrawal by Subject|1
5091915|NCT02013778|17582191|P1|Overall Study|Death|4
5091916|NCT02013765|17582195|P1|Overall Study|Trial was terminated by sponsor|1
5091917|NCT02013687|17582209|P4|Overall Study|Missed visits due to patient travel|0
5091918|NCT02013687|17582210|P3|Overall Study|Missed visits due to patient travel|1
5091919|NCT02013687|17582211|P2|Overall Study|Missed visits due to patient travel|0
5091920|NCT02013687|17582212|P1|Overall Study|Missed visits due to patient travel|0
5091921|NCT02013687|17582209|P4|Overall Study|Withdrawal by Subject|1
5091922|NCT02013687|17582210|P3|Overall Study|Withdrawal by Subject|0
5091923|NCT02013687|17582211|P2|Overall Study|Withdrawal by Subject|0
5091924|NCT02013687|17582212|P1|Overall Study|Withdrawal by Subject|0
5091925|NCT02013687|17582209|P4|Overall Study|Protocol Violation|1
5091926|NCT02013687|17582210|P3|Overall Study|Protocol Violation|0
5091927|NCT02013687|17582211|P2|Overall Study|Protocol Violation|0
5091928|NCT02013687|17582212|P1|Overall Study|Protocol Violation|0
5091929|NCT02013687|17582209|P4|Overall Study|Lost to Follow-up|0
5091930|NCT02013687|17582210|P3|Overall Study|Lost to Follow-up|1
5091931|NCT02013687|17582211|P2|Overall Study|Lost to Follow-up|0
5091932|NCT02013687|17582212|P1|Overall Study|Lost to Follow-up|0
5091933|NCT02013674|17582244|P2|Overall Study|Lost to Follow-up|0
5091934|NCT02013674|17582245|P1|Overall Study|Lost to Follow-up|1
5091935|NCT02013674|17582244|P2|Overall Study|Death|1
5091936|NCT02013674|17582245|P1|Overall Study|Death|0
5091937|NCT02013622|17582295|P1|Overall Study|Lack of Efficacy|1
5091938|NCT02013622|17582295|P1|Overall Study|Protocol Deviation|1
5091939|NCT02013622|17582295|P1|Overall Study|Withdrawal by Subject|6
5091940|NCT02013622|17582295|P1|Overall Study|Met Withdrawal Criteria|3
5091941|NCT02013622|17582295|P1|Overall Study|Adverse Event|3
5091942|NCT02013622|17582295|P1|Overall Study|Lost to Follow-up|10
5091943|NCT02013609|17582315|P1|Overall Study|Met Withdrawal Criteria|3
5091944|NCT02013609|17582315|P1|Overall Study|Adverse Event|3
5091945|NCT02013609|17582315|P1|Overall Study|Lost to Follow-up|3
5091946|NCT02013609|17582315|P1|Overall Study|Withdrawal by Subject|9
5091947|NCT02013544|17582340|P2|Overall Study|Entry criteria not met/non-compliance|3
5091948|NCT02013544|17582341|P1|Overall Study|Entry criteria not met/non-compliance|2
5091949|NCT02013544|17582340|P2|Overall Study|Physician Decision|1
5091950|NCT02013544|17582341|P1|Overall Study|Physician Decision|0
5091951|NCT02013544|17582340|P2|Overall Study|Withdrawal by Subject|8
5091952|NCT02013544|17582341|P1|Overall Study|Withdrawal by Subject|2
5091953|NCT02013544|17582340|P2|Overall Study|Lost to Follow-up|3
5091954|NCT02013544|17582341|P1|Overall Study|Lost to Follow-up|2
5091955|NCT02013544|17582340|P2|Overall Study|Adverse Event|5
5091956|NCT02013544|17582341|P1|Overall Study|Adverse Event|5
5091957|NCT02013531|17582363|P1|Overall Study|Withdrawal by Subject|1
5091958|NCT02013531|17582363|P1|Overall Study|Met Withdrawal Criteria|1
5091959|NCT02013531|17582363|P1|Overall Study|Lost to Follow-up|3
5091960|NCT02013388|17582399|P8|Overall Study|work emergency|0
5091961|NCT02013388|17582400|P7|Overall Study|work emergency|0
5091962|NCT02013388|17582401|P6|Overall Study|work emergency|0
5091963|NCT02013388|17582402|P5|Overall Study|work emergency|1
5091964|NCT02013388|17582403|P4|Overall Study|work emergency|0
5091965|NCT02013388|17582404|P3|Overall Study|work emergency|0
5091966|NCT02013388|17582405|P2|Overall Study|work emergency|0
5091967|NCT02013388|17582406|P1|Overall Study|work emergency|1
5091968|NCT02013375|17582440|P1|Overall Study|Did not engraft|1
5091969|NCT02013375|17582440|P1|Overall Study|Did not engraft|1
5091970|NCT02013206|17582470|P2|Overall Study|Other reasons off treatment|2
5091971|NCT02013206|17582471|P1|Overall Study|Other reasons off treatment|5
5091972|NCT02013206|17582470|P2|Overall Study|Death|2
5091973|NCT02013206|17582471|P1|Overall Study|Death|1
5091974|NCT02013206|17582470|P2|Overall Study|Patient non-compliance|0
5091975|NCT02013206|17582471|P1|Overall Study|Patient non-compliance|1
5091976|NCT02013206|17582470|P2|Overall Study|Patient refusal|0
5091977|NCT02013206|17582471|P1|Overall Study|Patient refusal|2
5091978|NCT02013206|17582470|P2|Overall Study|Adverse Event|0
5091979|NCT02013206|17582471|P1|Overall Study|Adverse Event|1
5091980|NCT02013206|17582470|P2|Overall Study|Symptomatic deterioration|1
5091981|NCT02013206|17582471|P1|Overall Study|Symptomatic deterioration|3
5091982|NCT02013206|17582470|P2|Overall Study|Progressive disease (PD)|17
5091983|NCT02013206|17582471|P1|Overall Study|Progressive disease (PD)|14
5091984|NCT02013167|17582502|P2|Overall Study|Death|160
5091985|NCT02013167|17582503|P1|Overall Study|Death|85
5091986|NCT02013167|17582502|P2|Overall Study|Lost to Follow-up|1
5091987|NCT02013167|17582503|P1|Overall Study|Lost to Follow-up|0
5091988|NCT02013167|17582502|P2|Overall Study|Sponsor Decision|3
5091989|NCT02013167|17582503|P1|Overall Study|Sponsor Decision|1
5091990|NCT02013167|17582502|P2|Overall Study|Withdrawal by Subject|14
5091991|NCT02013167|17582503|P1|Overall Study|Withdrawal by Subject|15
5091992|NCT02012959|17582579|P5|Treatment Phase A|Adverse Event|0
5091993|NCT02012959|17582580|P4|Treatment Phase A|Adverse Event|0
5091994|NCT02012959|17582581|P3|Treatment Phase A|Adverse Event|0
5091995|NCT02012959|17582582|P2|Treatment Phase A|Adverse Event|0
5091996|NCT02012959|17582583|P1|Treatment Phase A|Adverse Event|2
5091997|NCT02012686|17582596|P2|Overall Study|electrocardiography monitoring noise|1
5091998|NCT02012686|17582597|P1|Overall Study|electrocardiography monitoring noise|0
5091999|NCT02012686|17582596|P2|Overall Study|muscle contraction|1
5092000|NCT02012686|17582597|P1|Overall Study|muscle contraction|0
5092001|NCT02012491|17582659|P2|Overall Study|Withdrawal by Subject|0
5092002|NCT02012491|17582660|P1|Overall Study|Withdrawal by Subject|1
5092003|NCT02012491|17582659|P2|Overall Study|Protocol Violation|1
5092004|NCT02012491|17582660|P1|Overall Study|Protocol Violation|0
5092005|NCT02012491|17582659|P2|Overall Study|Lost to Follow-up|0
5092006|NCT02012491|17582660|P1|Overall Study|Lost to Follow-up|1
5092007|NCT02012452|17582678|P2|Overall Study|Withdrawal by Subject|0
5092008|NCT02012452|17582679|P1|Overall Study|Withdrawal by Subject|4
5092009|NCT02012452|17582678|P2|Overall Study|Lost to Follow-up|1
5092010|NCT02012452|17582679|P1|Overall Study|Lost to Follow-up|2
5092011|NCT02012218|17582722|P5|Overall Study|Protocol Deviation|0
5092012|NCT02012218|17582723|P4|Overall Study|Protocol Deviation|0
5092013|NCT02012218|17582724|P3|Overall Study|Protocol Deviation|0
5092014|NCT02012218|17582725|P2|Overall Study|Protocol Deviation|0
5092015|NCT02012218|17582726|P1|Overall Study|Protocol Deviation|1
5092016|NCT02012218|17582722|P5|Overall Study|Protocol Specified|0
5092017|NCT02012218|17582723|P4|Overall Study|Protocol Specified|0
5092018|NCT02012218|17582724|P3|Overall Study|Protocol Specified|0
5092019|NCT02012218|17582725|P2|Overall Study|Protocol Specified|0
5092020|NCT02012218|17582726|P1|Overall Study|Protocol Specified|1
5092021|NCT02012218|17582722|P5|Overall Study|Lost to Follow-up|0
5092022|NCT02012218|17582723|P4|Overall Study|Lost to Follow-up|0
5092023|NCT02012218|17582724|P3|Overall Study|Lost to Follow-up|1
5092024|NCT02012218|17582725|P2|Overall Study|Lost to Follow-up|1
5092025|NCT02012218|17582726|P1|Overall Study|Lost to Follow-up|0
5092026|NCT02012218|17582722|P5|Overall Study|Adverse Event|0
5092027|NCT02012218|17582723|P4|Overall Study|Adverse Event|1
5092028|NCT02012218|17582724|P3|Overall Study|Adverse Event|0
5092029|NCT02012218|17582725|P2|Overall Study|Adverse Event|0
5092030|NCT02012218|17582726|P1|Overall Study|Adverse Event|1
5092031|NCT02012218|17582722|P5|Overall Study|Withdrawal by Subject|1
5092032|NCT02012218|17582723|P4|Overall Study|Withdrawal by Subject|1
5092033|NCT02012218|17582724|P3|Overall Study|Withdrawal by Subject|1
5092034|NCT02012218|17582725|P2|Overall Study|Withdrawal by Subject|0
5092035|NCT02012218|17582726|P1|Overall Study|Withdrawal by Subject|1
5092036|NCT02011945|17582750|P3|Overall Study|Sub-Optimal Response to dasatinib|0
5092037|NCT02011945|17582751|P2|Overall Study|Sub-Optimal Response to dasatinib|0
5092038|NCT02011945|17582752|P1|Overall Study|Sub-Optimal Response to dasatinib|1
5092039|NCT02011945|17582750|P3|Overall Study|Proceeded to stem cell transplant|1
5092040|NCT02011945|17582751|P2|Overall Study|Proceeded to stem cell transplant|0
5092041|NCT02011945|17582752|P1|Overall Study|Proceeded to stem cell transplant|0
5092042|NCT02011945|17582750|P3|Overall Study|No Longer Meets Study Criteria|0
5092043|NCT02011945|17582751|P2|Overall Study|No Longer Meets Study Criteria|0
5092044|NCT02011945|17582752|P1|Overall Study|No Longer Meets Study Criteria|1
5092045|NCT02011945|17582750|P3|Overall Study|Treatment Failure|6
5092046|NCT02011945|17582751|P2|Overall Study|Treatment Failure|7
5092047|NCT02011945|17582752|P1|Overall Study|Treatment Failure|0
5092048|NCT02011945|17582750|P3|Overall Study|Study Drug Toxicity|1
5092049|NCT02011945|17582751|P2|Overall Study|Study Drug Toxicity|0
5092050|NCT02011945|17582752|P1|Overall Study|Study Drug Toxicity|0
5092051|NCT02011945|17582750|P3|Overall Study|Adverse Event unrelated to Drug|1
5092052|NCT02011945|17582751|P2|Overall Study|Adverse Event unrelated to Drug|2
5092053|NCT02011945|17582752|P1|Overall Study|Adverse Event unrelated to Drug|0
5092054|NCT02011945|17582750|P3|Overall Study|Participant requested to Discontinue|1
5092055|NCT02011945|17582751|P2|Overall Study|Participant requested to Discontinue|1
5092056|NCT02011945|17582752|P1|Overall Study|Participant requested to Discontinue|0
5092057|NCT02011893|17582829|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
5092058|NCT02011893|17582830|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
5092059|NCT02011893|17582831|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
5092060|NCT02011893|17582829|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
5092061|NCT02011893|17582830|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
5092062|NCT02011893|17582831|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
5092063|NCT02011893|17582829|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
5092064|NCT02011893|17582830|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
5092065|NCT02011893|17582831|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
5092066|NCT02011893|17582829|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
5092067|NCT02011893|17582830|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
5092068|NCT02011893|17582831|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
5092069|NCT02011893|17582829|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
5092070|NCT02011893|17582830|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
5092071|NCT02011893|17582831|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
5092072|NCT02011893|17582829|P3|Enrollment to Randomization|Screening Failure|0
5092073|NCT02011893|17582830|P2|Enrollment to Randomization|Screening Failure|0
5092074|NCT02011893|17582831|P1|Enrollment to Randomization|Screening Failure|29
5092075|NCT02011893|17582829|P3|Enrollment to Randomization|Withdrawal by Subject|0
5092076|NCT02011893|17582830|P2|Enrollment to Randomization|Withdrawal by Subject|0
5092077|NCT02011893|17582831|P1|Enrollment to Randomization|Withdrawal by Subject|21
5092078|NCT02011893|17582829|P3|Enrollment to Randomization|Physician Decision|0
5092079|NCT02011893|17582830|P2|Enrollment to Randomization|Physician Decision|0
5092080|NCT02011893|17582831|P1|Enrollment to Randomization|Physician Decision|10
5092081|NCT02011893|17582829|P3|Enrollment to Randomization|Adverse Event|0
5092082|NCT02011893|17582830|P2|Enrollment to Randomization|Adverse Event|0
5092083|NCT02011893|17582831|P1|Enrollment to Randomization|Adverse Event|2
5092084|NCT02011542|17582842|P1|Overall Study|Physician Decision|1
5092085|NCT02011386|17582973|P1|Overall Study|Lack of Efficacy|3
5092086|NCT02011386|17582973|P1|Overall Study|Non-compliance|2
5092087|NCT02011113|17582987|P1|Overall Study|Study terminated by sponsor|11
5092088|NCT02011113|17582987|P1|Overall Study|Investigator's judgement- DP|3
5092089|NCT02011113|17582987|P1|Overall Study|Insufficient effect of Pomalidomide|1
5092090|NCT02011113|17582987|P1|Overall Study|Death|1
5092091|NCT02011113|17582987|P1|Overall Study|Disease Progression (DP)|16
5092092|NCT02011113|17582987|P1|Overall Study|Adverse Event|4
5092093|NCT02010775|17583019|P5|Overall Study|Personal Reasons|4
5092094|NCT02010775|17583020|P4|Overall Study|Personal Reasons|2
5092095|NCT02010775|17583021|P3|Overall Study|Personal Reasons|1
5092096|NCT02010775|17583022|P2|Overall Study|Personal Reasons|3
5092097|NCT02010775|17583023|P1|Overall Study|Personal Reasons|3
5092098|NCT02010775|17583019|P5|Overall Study|Lost to Follow-up|1
5092099|NCT02010775|17583020|P4|Overall Study|Lost to Follow-up|1
5092100|NCT02010775|17583021|P3|Overall Study|Lost to Follow-up|0
5092101|NCT02010775|17583022|P2|Overall Study|Lost to Follow-up|0
5092102|NCT02010775|17583023|P1|Overall Study|Lost to Follow-up|2
5092103|NCT02010775|17583019|P5|Overall Study|Pregnancy|0
5092104|NCT02010775|17583020|P4|Overall Study|Pregnancy|0
5092105|NCT02010775|17583021|P3|Overall Study|Pregnancy|2
5092106|NCT02010775|17583022|P2|Overall Study|Pregnancy|0
5092107|NCT02010775|17583023|P1|Overall Study|Pregnancy|0
5092108|NCT02010775|17583019|P5|Overall Study|Adverse Event|1
5092109|NCT02010775|17583020|P4|Overall Study|Adverse Event|0
5092110|NCT02010775|17583021|P3|Overall Study|Adverse Event|0
5092111|NCT02010775|17583022|P2|Overall Study|Adverse Event|0
5092112|NCT02010775|17583023|P1|Overall Study|Adverse Event|0
5092113|NCT02010684|17583064|P2|Overall Study|Withdrawal by Subject|5
5092114|NCT02010684|17583065|P1|Overall Study|Withdrawal by Subject|4
5092115|NCT02010684|17583064|P2|Overall Study|Lost to Follow-up|18
5092116|NCT02010684|17583065|P1|Overall Study|Lost to Follow-up|8
5092117|NCT02010632|17583087|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
5092118|NCT02010632|17583088|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
5092119|NCT02010567|17583099|P5|Overall Study|Adverse Event|1
5092120|NCT02010567|17583100|P4|Overall Study|Adverse Event|0
5092121|NCT02010567|17583101|P3|Overall Study|Adverse Event|1
5092122|NCT02010567|17583102|P2|Overall Study|Adverse Event|0
5092123|NCT02010567|17583103|P1|Overall Study|Adverse Event|0
5092124|NCT02010255|17583159|P14|Overall Study|Randomized but Not Treated|1
5092125|NCT02010255|17583160|P13|Overall Study|Randomized but Not Treated|0
5092126|NCT02010255|17583161|P12|Overall Study|Randomized but Not Treated|0
5092127|NCT02010255|17583162|P11|Overall Study|Randomized but Not Treated|0
5092128|NCT02010255|17583163|P10|Overall Study|Randomized but Not Treated|0
5092129|NCT02010255|17583164|P9|Overall Study|Randomized but Not Treated|0
5092130|NCT02010255|17583165|P8|Overall Study|Randomized but Not Treated|0
5092131|NCT02010255|17583166|P7|Overall Study|Randomized but Not Treated|0
5092132|NCT02010255|17583167|P6|Overall Study|Randomized but Not Treated|0
5092133|NCT02010255|17583168|P5|Overall Study|Randomized but Not Treated|0
5092134|NCT02010255|17583169|P4|Overall Study|Randomized but Not Treated|0
5092135|NCT02010255|17583170|P3|Overall Study|Randomized but Not Treated|0
5092136|NCT02010255|17583171|P2|Overall Study|Randomized but Not Treated|0
5092137|NCT02010255|17583172|P1|Overall Study|Randomized but Not Treated|0
5092138|NCT02010255|17583159|P14|Overall Study|Lost to Follow-up|0
5092139|NCT02010255|17583160|P13|Overall Study|Lost to Follow-up|0
5092140|NCT02010255|17583161|P12|Overall Study|Lost to Follow-up|0
5092141|NCT02010255|17583162|P11|Overall Study|Lost to Follow-up|0
5092142|NCT02010255|17583163|P10|Overall Study|Lost to Follow-up|0
5092143|NCT02010255|17583164|P9|Overall Study|Lost to Follow-up|0
5092144|NCT02010255|17583165|P8|Overall Study|Lost to Follow-up|0
5092145|NCT02010255|17583166|P7|Overall Study|Lost to Follow-up|0
5092146|NCT02010255|17583167|P6|Overall Study|Lost to Follow-up|0
5092147|NCT02010255|17583168|P5|Overall Study|Lost to Follow-up|1
5092148|NCT02010255|17583169|P4|Overall Study|Lost to Follow-up|0
5092149|NCT02010255|17583170|P3|Overall Study|Lost to Follow-up|1
5092150|NCT02010255|17583171|P2|Overall Study|Lost to Follow-up|0
5092151|NCT02010255|17583172|P1|Overall Study|Lost to Follow-up|0
5092152|NCT02010255|17583159|P14|Overall Study|Adverse Event|0
5092153|NCT02010255|17583160|P13|Overall Study|Adverse Event|0
5092154|NCT02010255|17583161|P12|Overall Study|Adverse Event|0
5092155|NCT02010255|17583162|P11|Overall Study|Adverse Event|0
5092156|NCT02010255|17583163|P10|Overall Study|Adverse Event|0
5092157|NCT02010255|17583164|P9|Overall Study|Adverse Event|0
5092158|NCT02010255|17583165|P8|Overall Study|Adverse Event|0
5092159|NCT02010255|17583166|P7|Overall Study|Adverse Event|0
5092160|NCT02010255|17583167|P6|Overall Study|Adverse Event|0
5092161|NCT02010255|17583168|P5|Overall Study|Adverse Event|0
5092162|NCT02010255|17583169|P4|Overall Study|Adverse Event|0
5092163|NCT02010255|17583170|P3|Overall Study|Adverse Event|0
5092164|NCT02010255|17583171|P2|Overall Study|Adverse Event|0
5092165|NCT02010255|17583172|P1|Overall Study|Adverse Event|1
5092166|NCT02010255|17583159|P14|Overall Study|Withdrew Consent|0
5092167|NCT02010255|17583160|P13|Overall Study|Withdrew Consent|0
5092168|NCT02010255|17583161|P12|Overall Study|Withdrew Consent|0
5092169|NCT02010255|17583162|P11|Overall Study|Withdrew Consent|0
5092170|NCT02010255|17583163|P10|Overall Study|Withdrew Consent|0
5092171|NCT02010255|17583164|P9|Overall Study|Withdrew Consent|0
5092172|NCT02010255|17583165|P8|Overall Study|Withdrew Consent|0
5092173|NCT02010255|17583166|P7|Overall Study|Withdrew Consent|0
5092174|NCT02010255|17583167|P6|Overall Study|Withdrew Consent|0
5092175|NCT02010255|17583168|P5|Overall Study|Withdrew Consent|0
5092176|NCT02010255|17583169|P4|Overall Study|Withdrew Consent|1
5092177|NCT02010255|17583170|P3|Overall Study|Withdrew Consent|0
5092178|NCT02010255|17583171|P2|Overall Study|Withdrew Consent|0
5092179|NCT02010255|17583172|P1|Overall Study|Withdrew Consent|1
5092180|NCT02010255|17583159|P14|Overall Study|Lack of Efficacy|0
5092181|NCT02010255|17583160|P13|Overall Study|Lack of Efficacy|0
5092182|NCT02010255|17583161|P12|Overall Study|Lack of Efficacy|0
5092183|NCT02010255|17583162|P11|Overall Study|Lack of Efficacy|1
5092184|NCT02010255|17583163|P10|Overall Study|Lack of Efficacy|0
5092185|NCT02010255|17583164|P9|Overall Study|Lack of Efficacy|0
5092186|NCT02010255|17583165|P8|Overall Study|Lack of Efficacy|0
5092187|NCT02010255|17583166|P7|Overall Study|Lack of Efficacy|0
5092188|NCT02010255|17583167|P6|Overall Study|Lack of Efficacy|0
5092189|NCT02010255|17583168|P5|Overall Study|Lack of Efficacy|1
5092190|NCT02010255|17583169|P4|Overall Study|Lack of Efficacy|1
5092191|NCT02010255|17583170|P3|Overall Study|Lack of Efficacy|2
5092192|NCT02010255|17583171|P2|Overall Study|Lack of Efficacy|1
5092193|NCT02010255|17583172|P1|Overall Study|Lack of Efficacy|4
5092194|NCT02010255|17583159|P14|Overall Study|Death|0
5092195|NCT02010255|17583160|P13|Overall Study|Death|0
5092196|NCT02010255|17583161|P12|Overall Study|Death|1
5092197|NCT02010255|17583162|P11|Overall Study|Death|1
5092198|NCT02010255|17583163|P10|Overall Study|Death|0
5092199|NCT02010255|17583164|P9|Overall Study|Death|1
5092200|NCT02010255|17583165|P8|Overall Study|Death|1
5092201|NCT02010255|17583166|P7|Overall Study|Death|1
5092202|NCT02010255|17583167|P6|Overall Study|Death|0
5092203|NCT02010255|17583168|P5|Overall Study|Death|2
5092204|NCT02010255|17583169|P4|Overall Study|Death|4
5092205|NCT02010255|17583170|P3|Overall Study|Death|4
5092206|NCT02010255|17583171|P2|Overall Study|Death|1
5092207|NCT02010255|17583172|P1|Overall Study|Death|0
5092208|NCT02009930|17583617|P1|Overall Study|withdrawn|5
5092209|NCT02009878|17583642|P3|Overall Study|Participant Met Withdrawal Criteria|0
5092210|NCT02009878|17583643|P2|Overall Study|Participant Met Withdrawal Criteria|1
5092211|NCT02009878|17583644|P1|Overall Study|Participant Met Withdrawal Criteria|0
5092212|NCT02009865|17583678|P2|Overall Study|Withdrawal by Subject|1
5092213|NCT02009865|17583679|P1|Overall Study|Withdrawal by Subject|1
5092214|NCT02009865|17583678|P2|Overall Study|Protocol Violation|2
5092215|NCT02009865|17583679|P1|Overall Study|Protocol Violation|0
5092216|NCT02009865|17583678|P2|Overall Study|Adverse Event|2
5092217|NCT02009865|17583679|P1|Overall Study|Adverse Event|0
5092218|NCT02009722|17583695|P2|Overall Study|Did not receive intervention|1
5092219|NCT02009722|17583696|P1|Overall Study|Did not receive intervention|0
5092220|NCT02009722|17583695|P2|Overall Study|Protocol Violation|2
5092221|NCT02009722|17583696|P1|Overall Study|Protocol Violation|1
5092222|NCT02009696|17583720|P1|Overall Study|Withdrawal by Subject|2
5092223|NCT02009163|17583737|P3|Randomized-withdrawal Period|Other|5
5092224|NCT02009163|17583738|P2|Randomized-withdrawal Period|Other|9
5092225|NCT02009163|17583739|P1|Randomized-withdrawal Period|Other|0
5092226|NCT02009163|17583737|P3|Randomized-withdrawal Period|Pregnancy|2
5092227|NCT02009163|17583738|P2|Randomized-withdrawal Period|Pregnancy|0
5092228|NCT02009163|17583739|P1|Randomized-withdrawal Period|Pregnancy|0
5092229|NCT02009163|17583737|P3|Randomized-withdrawal Period|Protocol Violation|2
5092230|NCT02009163|17583738|P2|Randomized-withdrawal Period|Protocol Violation|1
5092231|NCT02009163|17583739|P1|Randomized-withdrawal Period|Protocol Violation|0
5092232|NCT02009163|17583737|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
5092233|NCT02009163|17583738|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
5092234|NCT02009163|17583739|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
5092235|NCT02009163|17583737|P3|Randomized-withdrawal Period|Adverse Event|6
5092236|NCT02009163|17583738|P2|Randomized-withdrawal Period|Adverse Event|0
5092237|NCT02009163|17583739|P1|Randomized-withdrawal Period|Adverse Event|0
5092238|NCT02009163|17583737|P3|Randomized-withdrawal Period|Lost to Follow-up|6
5092239|NCT02009163|17583738|P2|Randomized-withdrawal Period|Lost to Follow-up|13
5092240|NCT02009163|17583739|P1|Randomized-withdrawal Period|Lost to Follow-up|0
5092241|NCT02009163|17583737|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
5092242|NCT02009163|17583738|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
5092243|NCT02009163|17583739|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
5092244|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Other|0
5092245|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Other|0
5092246|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Other|13
5092247|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Pregnancy|0
5092248|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Pregnancy|0
5092249|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Pregnancy|1
5092250|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Protocol Violation|0
5092251|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Protocol Violation|0
5092252|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Protocol Violation|10
5092253|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
5092254|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
5092255|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
5092256|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Adverse Event|0
5092257|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Adverse Event|0
5092258|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Adverse Event|22
5092259|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
5092260|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
5092261|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
5092262|NCT02009163|17583737|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
5092263|NCT02009163|17583738|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
5092264|NCT02009163|17583739|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
5092265|NCT02009046|17583774|P2|Overall Study|Lost to Follow-up|206
5092266|NCT02009046|17583775|P1|Overall Study|Lost to Follow-up|256
5092267|NCT02008916|17583835|P3|Week 16 - 156|Physician Decision|0
5092268|NCT02008916|17583836|P2|Week 16 - 156|Physician Decision|1
5092269|NCT02008916|17583837|P1|Week 16 - 156|Physician Decision|0
5092270|NCT02008916|17583835|P3|Week 16 - 156|Pregnancy|0
5092271|NCT02008916|17583836|P2|Week 16 - 156|Pregnancy|1
5092272|NCT02008916|17583837|P1|Week 16 - 156|Pregnancy|0
5092273|NCT02008916|17583835|P3|Week 16 - 156|Lack of Efficacy|2
5092274|NCT02008916|17583836|P2|Week 16 - 156|Lack of Efficacy|5
5092275|NCT02008916|17583837|P1|Week 16 - 156|Lack of Efficacy|3
5092276|NCT02008916|17583835|P3|Week 16 - 156|Lost to Follow-up|0
5092277|NCT02008916|17583836|P2|Week 16 - 156|Lost to Follow-up|0
5092278|NCT02008916|17583837|P1|Week 16 - 156|Lost to Follow-up|5
5092279|NCT02008916|17583835|P3|Week 16 - 156|No longer requires treatment|0
5092280|NCT02008916|17583836|P2|Week 16 - 156|No longer requires treatment|1
5092281|NCT02008916|17583837|P1|Week 16 - 156|No longer requires treatment|0
5092282|NCT02008916|17583835|P3|Week 16 - 156|Withdrawal by Subject|5
5092283|NCT02008916|17583836|P2|Week 16 - 156|Withdrawal by Subject|3
5092284|NCT02008916|17583837|P1|Week 16 - 156|Withdrawal by Subject|7
5092285|NCT02008916|17583835|P3|Week 16 - 156|Adverse Event|3
5092286|NCT02008916|17583836|P2|Week 16 - 156|Adverse Event|2
5092287|NCT02008916|17583837|P1|Week 16 - 156|Adverse Event|4
5092288|NCT02008916|17583835|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
5092289|NCT02008916|17583836|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
5092290|NCT02008916|17583837|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
5092291|NCT02008890|17583873|P5|Extension Period|Adverse Event|2
5092292|NCT02008890|17583874|P4|Extension Period|Adverse Event|0
5092293|NCT02008890|17583875|P3|Extension Period|Adverse Event|0
5092294|NCT02008890|17583876|P2|Extension Period|Adverse Event|3
5092295|NCT02008890|17583877|P1|Extension Period|Adverse Event|1
5092296|NCT02008890|17583873|P5|Extension Period|Lost to Follow-up|0
5092297|NCT02008890|17583874|P4|Extension Period|Lost to Follow-up|0
5092298|NCT02008890|17583875|P3|Extension Period|Lost to Follow-up|0
5092299|NCT02008890|17583876|P2|Extension Period|Lost to Follow-up|0
5092300|NCT02008890|17583877|P1|Extension Period|Lost to Follow-up|1
5092301|NCT02008890|17583873|P5|Extension Period|Withdrawal by Subject|2
5092302|NCT02008890|17583874|P4|Extension Period|Withdrawal by Subject|4
5092303|NCT02008890|17583875|P3|Extension Period|Withdrawal by Subject|0
5092304|NCT02008890|17583876|P2|Extension Period|Withdrawal by Subject|2
5092305|NCT02008890|17583877|P1|Extension Period|Withdrawal by Subject|3
5092306|NCT02008890|17583873|P5|Period 2|Lost to Follow-up|0
5092307|NCT02008890|17583874|P4|Period 2|Lost to Follow-up|0
5092308|NCT02008890|17583875|P3|Period 2|Lost to Follow-up|1
5092309|NCT02008890|17583876|P2|Period 2|Lost to Follow-up|0
5092310|NCT02008890|17583877|P1|Period 2|Lost to Follow-up|0
5092311|NCT02008890|17583873|P5|Period 2|Physician Decision|1
5092312|NCT02008890|17583874|P4|Period 2|Physician Decision|2
5092313|NCT02008890|17583875|P3|Period 2|Physician Decision|0
5092314|NCT02008890|17583876|P2|Period 2|Physician Decision|0
5092315|NCT02008890|17583877|P1|Period 2|Physician Decision|4
5092316|NCT02008890|17583873|P5|Period 2|Withdrawal by Subject|2
5092317|NCT02008890|17583874|P4|Period 2|Withdrawal by Subject|7
5092318|NCT02008890|17583875|P3|Period 2|Withdrawal by Subject|0
5092319|NCT02008890|17583876|P2|Period 2|Withdrawal by Subject|8
5092320|NCT02008890|17583877|P1|Period 2|Withdrawal by Subject|11
5092321|NCT02008890|17583873|P5|Period 2|Adverse Event|5
5092322|NCT02008890|17583874|P4|Period 2|Adverse Event|5
5092323|NCT02008890|17583875|P3|Period 2|Adverse Event|0
5092324|NCT02008890|17583876|P2|Period 2|Adverse Event|7
5092325|NCT02008890|17583877|P1|Period 2|Adverse Event|12
5092326|NCT02008890|17583873|P5|Period 1|Adverse Event|0
5092327|NCT02008890|17583874|P4|Period 1|Adverse Event|0
5092328|NCT02008890|17583875|P3|Period 1|Adverse Event|6
5092329|NCT02008890|17583876|P2|Period 1|Adverse Event|8
5092330|NCT02008890|17583877|P1|Period 1|Adverse Event|6
5092331|NCT02008890|17583873|P5|Period 1|Physician Decision|0
5092332|NCT02008890|17583874|P4|Period 1|Physician Decision|0
5092333|NCT02008890|17583875|P3|Period 1|Physician Decision|1
5092334|NCT02008890|17583876|P2|Period 1|Physician Decision|0
5092335|NCT02008890|17583877|P1|Period 1|Physician Decision|1
5092336|NCT02008890|17583873|P5|Period 1|Pregnancy|0
5092337|NCT02008890|17583874|P4|Period 1|Pregnancy|0
5092338|NCT02008890|17583875|P3|Period 1|Pregnancy|0
5092339|NCT02008890|17583876|P2|Period 1|Pregnancy|0
5092340|NCT02008890|17583877|P1|Period 1|Pregnancy|1
5092341|NCT02008890|17583873|P5|Period 1|Withdrawal by Subject|0
5092342|NCT02008890|17583874|P4|Period 1|Withdrawal by Subject|0
5092343|NCT02008890|17583875|P3|Period 1|Withdrawal by Subject|5
5092344|NCT02008890|17583876|P2|Period 1|Withdrawal by Subject|7
5092345|NCT02008890|17583877|P1|Period 1|Withdrawal by Subject|7
5092346|NCT02008877|17583913|P3|Overall Study|Inevaluable|0
5092347|NCT02008877|17583914|P2|Overall Study|Inevaluable|1
5092348|NCT02008877|17583915|P1|Overall Study|Inevaluable|0
5092349|NCT02008773|17583934|P4|Overall Study|Lost to Follow-up|2
5092350|NCT02008773|17583935|P3|Overall Study|Lost to Follow-up|3
5092351|NCT02008773|17583936|P2|Overall Study|Lost to Follow-up|1
5092352|NCT02008773|17583937|P1|Overall Study|Lost to Follow-up|0
5092353|NCT02008773|17583934|P4|Overall Study|Withdrawal by Subject|6
5092354|NCT02008773|17583935|P3|Overall Study|Withdrawal by Subject|7
5092355|NCT02008773|17583936|P2|Overall Study|Withdrawal by Subject|4
5092356|NCT02008773|17583937|P1|Overall Study|Withdrawal by Subject|8
5092357|NCT02008773|17583934|P4|Overall Study|Medication Non-compliance|2
5092358|NCT02008773|17583935|P3|Overall Study|Medication Non-compliance|3
5092359|NCT02008773|17583936|P2|Overall Study|Medication Non-compliance|1
5092360|NCT02008773|17583937|P1|Overall Study|Medication Non-compliance|2
5092361|NCT02008773|17583934|P4|Overall Study|Adverse Event|2
5092362|NCT02008773|17583935|P3|Overall Study|Adverse Event|1
5092363|NCT02008773|17583936|P2|Overall Study|Adverse Event|3
5092364|NCT02008773|17583937|P1|Overall Study|Adverse Event|3
5092365|NCT02008565|17584003|P4|Overall Study|Protocol Violation|0
5092366|NCT02008565|17584004|P3|Overall Study|Protocol Violation|2
5092367|NCT02008565|17584005|P2|Overall Study|Protocol Violation|1
5092368|NCT02008565|17584006|P1|Overall Study|Protocol Violation|1
5092369|NCT02008526|17584067|P3|Overall Study|Lost to Follow-up|6
5092370|NCT02008526|17584068|P2|Overall Study|Lost to Follow-up|9
5092371|NCT02008526|17584069|P1|Overall Study|Lost to Follow-up|5
5092372|NCT02008526|17584067|P3|Overall Study|Withdrawal by Subject|2
5092373|NCT02008526|17584068|P2|Overall Study|Withdrawal by Subject|3
5092374|NCT02008526|17584069|P1|Overall Study|Withdrawal by Subject|3
5092375|NCT02008526|17584067|P3|Overall Study|Death|1
5092376|NCT02008526|17584068|P2|Overall Study|Death|2
5092377|NCT02008526|17584069|P1|Overall Study|Death|0
5092378|NCT02008396|17584082|P2|Overall Study|Protocol Violation|1
5092379|NCT02008396|17584083|P1|Overall Study|Protocol Violation|0
5092380|NCT02008370|17584093|P1|Overall Study|Lost to Follow-up|7
5092381|NCT02008318|17584101|P2|Overall Study|Withdrawal by Subject|0
5092382|NCT02008318|17584102|P1|Overall Study|Withdrawal by Subject|3
5092383|NCT02008318|17584101|P2|Overall Study|Protocol Violation|1
5092384|NCT02008318|17584102|P1|Overall Study|Protocol Violation|1
5092385|NCT02008318|17584101|P2|Overall Study|Progressive Disease|0
5092386|NCT02008318|17584102|P1|Overall Study|Progressive Disease|2
5092387|NCT02008318|17584101|P2|Overall Study|Physician Decision|0
5092388|NCT02008318|17584102|P1|Overall Study|Physician Decision|2
5092389|NCT02008318|17584101|P2|Overall Study|Adverse Event|0
5092390|NCT02008318|17584102|P1|Overall Study|Adverse Event|4
5092391|NCT02008227|17584123|P2|Overall Study|Study Terminated By Sponsor|83
5092392|NCT02008227|17584124|P1|Overall Study|Study Terminated By Sponsor|44
5092393|NCT02008227|17584123|P2|Overall Study|Withdrawal by Subject|36
5092394|NCT02008227|17584124|P1|Overall Study|Withdrawal by Subject|67
5092395|NCT02008227|17584123|P2|Overall Study|Death|485
5092396|NCT02008227|17584124|P1|Overall Study|Death|494
5092397|NCT02008227|17584123|P2|Overall Study|Lost to Follow-up|9
5092398|NCT02008227|17584124|P1|Overall Study|Lost to Follow-up|7
5092399|NCT02007954|17584212|P1|Overall Study|Death|1
5092400|NCT02007954|17584212|P1|Overall Study|Disease progression and unrelated AE|1
5092401|NCT02007954|17584212|P1|Overall Study|Switch in treatment modality|2
5092402|NCT02007954|17584212|P1|Overall Study|Received liver transplant|3
5092403|NCT02007720|17584231|P2|Overall Study|patient followd less than 165 days|5
5092404|NCT02007720|17584232|P1|Overall Study|patient followd less than 165 days|11
5092405|NCT02007720|17584231|P2|Overall Study|technical problem|2
5092406|NCT02007720|17584232|P1|Overall Study|technical problem|4
5092407|NCT02007720|17584231|P2|Overall Study|study terminated by sponsor|54
5092408|NCT02007720|17584232|P1|Overall Study|study terminated by sponsor|58
5092409|NCT02007720|17584231|P2|Overall Study|Withdrawal by Subject|11
5092410|NCT02007720|17584232|P1|Overall Study|Withdrawal by Subject|9
5092411|NCT02007577|17584267|P2|Overall Study|Withdrawal by Subject|1
5092412|NCT02007577|17584268|P1|Overall Study|Withdrawal by Subject|0
5092413|NCT02007577|17584267|P2|Overall Study|Adverse Event|0
5092414|NCT02007577|17584268|P1|Overall Study|Adverse Event|1
5092415|NCT02007512|17584280|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5092416|NCT02007512|17584281|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5092417|NCT02007512|17584282|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
5092418|NCT02007512|17584283|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5092419|NCT02007512|17584280|P4|Open Label Treatment Period|Disease progression|11
5092420|NCT02007512|17584281|P3|Open Label Treatment Period|Disease progression|0
5092421|NCT02007512|17584282|P2|Open Label Treatment Period|Disease progression|17
5092422|NCT02007512|17584283|P1|Open Label Treatment Period|Disease progression|0
5092423|NCT02007512|17584280|P4|Open Label Treatment Period|Other|1
5092424|NCT02007512|17584281|P3|Open Label Treatment Period|Other|0
5092425|NCT02007512|17584282|P2|Open Label Treatment Period|Other|0
5092426|NCT02007512|17584283|P1|Open Label Treatment Period|Other|0
5092427|NCT02007512|17584280|P4|Open Label Treatment Period|Adverse Event|0
5092428|NCT02007512|17584281|P3|Open Label Treatment Period|Adverse Event|0
5092429|NCT02007512|17584282|P2|Open Label Treatment Period|Adverse Event|1
5092430|NCT02007512|17584283|P1|Open Label Treatment Period|Adverse Event|0
5092431|NCT02007512|17584280|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
5092432|NCT02007512|17584281|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
5092433|NCT02007512|17584282|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
5092434|NCT02007512|17584283|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
5092435|NCT02007512|17584280|P4|Double Blind Treatment Period|Other|2
5092436|NCT02007512|17584281|P3|Double Blind Treatment Period|Other|1
5092437|NCT02007512|17584282|P2|Double Blind Treatment Period|Other|0
5092438|NCT02007512|17584283|P1|Double Blind Treatment Period|Other|0
5092439|NCT02007512|17584280|P4|Double Blind Treatment Period|Protocol Violation|1
5092440|NCT02007512|17584281|P3|Double Blind Treatment Period|Protocol Violation|0
5092441|NCT02007512|17584282|P2|Double Blind Treatment Period|Protocol Violation|0
5092442|NCT02007512|17584283|P1|Double Blind Treatment Period|Protocol Violation|0
5092443|NCT02007512|17584280|P4|Double Blind Treatment Period|Withdrawal by Subject|3
5092444|NCT02007512|17584281|P3|Double Blind Treatment Period|Withdrawal by Subject|3
5092445|NCT02007512|17584282|P2|Double Blind Treatment Period|Withdrawal by Subject|2
5092446|NCT02007512|17584283|P1|Double Blind Treatment Period|Withdrawal by Subject|4
5092447|NCT02007512|17584280|P4|Double Blind Treatment Period|Disease progression|51
5092448|NCT02007512|17584281|P3|Double Blind Treatment Period|Disease progression|45
5092449|NCT02007512|17584282|P2|Double Blind Treatment Period|Disease progression|49
5092450|NCT02007512|17584283|P1|Double Blind Treatment Period|Disease progression|44
5092451|NCT02007512|17584280|P4|Double Blind Treatment Period|Death|0
5092452|NCT02007512|17584281|P3|Double Blind Treatment Period|Death|0
5092453|NCT02007512|17584282|P2|Double Blind Treatment Period|Death|0
5092454|NCT02007512|17584283|P1|Double Blind Treatment Period|Death|1
5092455|NCT02007512|17584280|P4|Double Blind Treatment Period|Adverse Event|2
5092456|NCT02007512|17584281|P3|Double Blind Treatment Period|Adverse Event|6
5092457|NCT02007512|17584282|P2|Double Blind Treatment Period|Adverse Event|2
5092458|NCT02007512|17584283|P1|Double Blind Treatment Period|Adverse Event|4
5092459|NCT02007434|17584361|P8|Overall Study|Non-compliance|0
5092460|NCT02007434|17584362|P7|Overall Study|Non-compliance|0
5092461|NCT02007434|17584363|P6|Overall Study|Non-compliance|0
5092462|NCT02007434|17584364|P5|Overall Study|Non-compliance|0
5092463|NCT02007434|17584365|P4|Overall Study|Non-compliance|0
5092464|NCT02007434|17584366|P3|Overall Study|Non-compliance|1
5092465|NCT02007434|17584367|P2|Overall Study|Non-compliance|0
5092466|NCT02007434|17584368|P1|Overall Study|Non-compliance|1
5092467|NCT02007434|17584361|P8|Overall Study|Lost to Follow-up|0
5092468|NCT02007434|17584362|P7|Overall Study|Lost to Follow-up|0
5092469|NCT02007434|17584363|P6|Overall Study|Lost to Follow-up|0
5092470|NCT02007434|17584364|P5|Overall Study|Lost to Follow-up|0
5092471|NCT02007434|17584365|P4|Overall Study|Lost to Follow-up|0
5092472|NCT02007434|17584366|P3|Overall Study|Lost to Follow-up|0
5092473|NCT02007434|17584367|P2|Overall Study|Lost to Follow-up|1
5092474|NCT02007434|17584368|P1|Overall Study|Lost to Follow-up|0
5092475|NCT02007278|17584499|P2|Overall Study|Mis-randomization|1
5092476|NCT02007278|17584500|P1|Overall Study|Mis-randomization|1
5092477|NCT02007278|17584499|P2|Overall Study|Incorrect medication administration|0
5092478|NCT02007278|17584500|P1|Overall Study|Incorrect medication administration|1
5092479|NCT02007278|17584499|P2|Overall Study|Ingestion of drugs not allowed in study|1
5092480|NCT02007278|17584500|P1|Overall Study|Ingestion of drugs not allowed in study|0
5092481|NCT02007278|17584499|P2|Overall Study|Failure to comply with an eligibility|1
5092482|NCT02007278|17584500|P1|Overall Study|Failure to comply with an eligibility|0
5092483|NCT02007252|17584522|P2|Overall Study|Adverse Event|4
5092484|NCT02007252|17584523|P1|Overall Study|Adverse Event|7
5092485|NCT02007252|17584522|P2|Overall Study|Abnormal laboratory value(s)|0
5092486|NCT02007252|17584523|P1|Overall Study|Abnormal laboratory value(s)|1
5092487|NCT02007252|17584522|P2|Overall Study|Administrative problems|7
5092488|NCT02007252|17584523|P1|Overall Study|Administrative problems|3
5092489|NCT02007109|17584536|P1|Overall Study|Excluded - Age<7yo|9
5092490|NCT02007109|17584536|P1|Overall Study|Diary not returned or excluded|102
5092491|NCT02007096|17584545|P2|Overall Study|no mesh placed|1
5092492|NCT02007096|17584546|P1|Overall Study|no mesh placed|0
5092493|NCT02007096|17584545|P2|Overall Study|converted to open surgery|1
5092494|NCT02007096|17584546|P1|Overall Study|converted to open surgery|1
5092495|NCT02007096|17584545|P2|Overall Study|did not follow postoperative protocol|11
5092496|NCT02007096|17584546|P1|Overall Study|did not follow postoperative protocol|8
5092497|NCT02007096|17584545|P2|Overall Study|did not inject saline|3
5092498|NCT02007096|17584546|P1|Overall Study|did not inject saline|0
5092499|NCT02007096|17584545|P2|Overall Study|medication not available|0
5092500|NCT02007096|17584546|P1|Overall Study|medication not available|2
5092501|NCT02007070|17584558|P1|Overall Study|Progressive Disease|21
5092502|NCT02007070|17584558|P1|Overall Study|Physician Decision|1
5092503|NCT02007070|17584558|P1|Overall Study|Protocol Violation|2
5092504|NCT02007070|17584558|P1|Overall Study|Death|1
5092505|NCT02007070|17584558|P1|Overall Study|Clinical Progression|4
5092506|NCT02007070|17584558|P1|Overall Study|Adverse Event|4
5092507|NCT02006979|17584579|P2|Overall Study|Protocol Violation|1
5092508|NCT02006979|17584580|P1|Overall Study|Protocol Violation|0
5092509|NCT02006979|17584579|P2|Overall Study|Withdrawal by Subject|1
5092510|NCT02006979|17584580|P1|Overall Study|Withdrawal by Subject|1
5092511|NCT02006927|17584592|P1|Overall Study|Withdrawal by Subject|1
5092512|NCT02006927|17584592|P1|Overall Study|Adverse Event|2
5092513|NCT02006758|17584631|P1|Overall Study|Other|2
5092514|NCT02006758|17584631|P1|Overall Study|Procedurally excluded|1
5092515|NCT02006758|17584631|P1|Overall Study|Withdrawal by Subject|4
5092516|NCT02006758|17584631|P1|Overall Study|Lost to Follow-up|4
5092517|NCT02006758|17584631|P1|Overall Study|Death|1
5092518|NCT02006758|17584631|P1|Overall Study|Protocol Violation|1
5092519|NCT02006732|17584662|P4|Overall Study|Withdrawal by Subject|1
5092520|NCT02006732|17584663|P3|Overall Study|Withdrawal by Subject|4
5092521|NCT02006732|17584664|P2|Overall Study|Withdrawal by Subject|0
5092522|NCT02006732|17584665|P1|Overall Study|Withdrawal by Subject|3
5092523|NCT02006732|17584662|P4|Overall Study|Lost to Follow-up|0
5092524|NCT02006732|17584663|P3|Overall Study|Lost to Follow-up|0
5092525|NCT02006732|17584664|P2|Overall Study|Lost to Follow-up|1
5092526|NCT02006732|17584665|P1|Overall Study|Lost to Follow-up|0
5092527|NCT02006732|17584662|P4|Overall Study|Protocol Violation|0
5092528|NCT02006732|17584663|P3|Overall Study|Protocol Violation|0
5092529|NCT02006732|17584664|P2|Overall Study|Protocol Violation|1
5092530|NCT02006732|17584665|P1|Overall Study|Protocol Violation|1
5092531|NCT02006732|17584662|P4|Overall Study|Lack of Efficacy|1
5092532|NCT02006732|17584663|P3|Overall Study|Lack of Efficacy|1
5092533|NCT02006732|17584664|P2|Overall Study|Lack of Efficacy|3
5092534|NCT02006732|17584665|P1|Overall Study|Lack of Efficacy|6
5092535|NCT02006732|17584662|P4|Overall Study|Adverse Event|2
5092536|NCT02006732|17584663|P3|Overall Study|Adverse Event|4
5092537|NCT02006732|17584664|P2|Overall Study|Adverse Event|7
5092538|NCT02006732|17584665|P1|Overall Study|Adverse Event|10
5092539|NCT02006719|17584705|P2|Overall Study|Other/Unknown|1
5092540|NCT02006719|17584706|P1|Overall Study|Other/Unknown|0
5092541|NCT02006719|17584705|P2|Overall Study|Adverse Event|1
5092542|NCT02006719|17584706|P1|Overall Study|Adverse Event|1
5092543|NCT02006719|17584705|P2|Overall Study|Protocol Violation|0
5092544|NCT02006719|17584706|P1|Overall Study|Protocol Violation|2
5092545|NCT02006719|17584705|P2|Overall Study|Lost to Follow-up|1
5092546|NCT02006719|17584706|P1|Overall Study|Lost to Follow-up|5
5092547|NCT02006719|17584705|P2|Overall Study|Withdrawal by Subject|2
5092548|NCT02006719|17584706|P1|Overall Study|Withdrawal by Subject|10
5092549|NCT02006706|17584736|P1|Overall Study|Lost to Follow-up|1
5092550|NCT02006693|17584743|P2|Overall Study|Patient Decision|0
5092551|NCT02006693|17584744|P1|Overall Study|Patient Decision|4
5092552|NCT02006693|17584743|P2|Overall Study|Lost to Follow-up|1
5092553|NCT02006693|17584744|P1|Overall Study|Lost to Follow-up|4
5092554|NCT02006693|17584743|P2|Overall Study|Death|2
5092555|NCT02006693|17584744|P1|Overall Study|Death|2
5092556|NCT02006693|17584743|P2|Overall Study|XEN Implant Explantation|1
5092557|NCT02006693|17584744|P1|Overall Study|XEN Implant Explantation|0
5092558|NCT02006693|17584743|P2|Overall Study|Another Glaucoma-related Surgery|1
5092559|NCT02006693|17584744|P1|Overall Study|Another Glaucoma-related Surgery|12
5092560|NCT02006693|17584743|P2|Overall Study|No Reason Specified|8
5092561|NCT02006693|17584744|P1|Overall Study|No Reason Specified|6
5092562|NCT02006667|17584756|P1|Overall Study|Withdrawal by Subject|1
5092563|NCT02006667|17584756|P1|Overall Study|Death|2
5092564|NCT02006667|17584756|P1|Overall Study|Adverse Event|3
5092565|NCT02006654|17584768|P2|Overall Study|moving out of state|1
5092566|NCT02006654|17584769|P1|Overall Study|moving out of state|0
5092567|NCT02006654|17584768|P2|Overall Study|disallowed medication|0
5092568|NCT02006654|17584769|P1|Overall Study|disallowed medication|1
5092569|NCT02006654|17584768|P2|Overall Study|mood disorder|1
5092570|NCT02006654|17584769|P1|Overall Study|mood disorder|0
5092571|NCT02006654|17584768|P2|Overall Study|faecal incontinence|1
5092572|NCT02006654|17584769|P1|Overall Study|faecal incontinence|0
5092573|NCT02006654|17584768|P2|Overall Study|worsening cognitive condition|1
5092574|NCT02006654|17584769|P1|Overall Study|worsening cognitive condition|0
5092575|NCT02006654|17584768|P2|Overall Study|insufficient compliance|0
5092576|NCT02006654|17584769|P1|Overall Study|insufficient compliance|1
5092577|NCT02006654|17584768|P2|Overall Study|patient's will|1
5092578|NCT02006654|17584769|P1|Overall Study|patient's will|2
5092579|NCT02006654|17584768|P2|Overall Study|Lost to Follow-up|0
5092580|NCT02006654|17584769|P1|Overall Study|Lost to Follow-up|1
5092581|NCT02006654|17584768|P2|Overall Study|Protocol Violation|8
5092582|NCT02006654|17584769|P1|Overall Study|Protocol Violation|5
5092583|NCT02006654|17584768|P2|Overall Study|Withdrawal by Subject|12
5092584|NCT02006654|17584769|P1|Overall Study|Withdrawal by Subject|14
5092585|NCT02006654|17584768|P2|Overall Study|Death|0
5092586|NCT02006654|17584769|P1|Overall Study|Death|1
5092587|NCT02006654|17584768|P2|Overall Study|Adverse Event|17
5092588|NCT02006654|17584769|P1|Overall Study|Adverse Event|16
5092589|NCT02006654|17584768|P2|Overall Study|Withdrawal before treatment|2
5092590|NCT02006654|17584769|P1|Overall Study|Withdrawal before treatment|4
5092591|NCT02006641|17584798|P3|Overall Study|Other reason: protocol non-compliance|1
5092592|NCT02006641|17584799|P2|Overall Study|Other reason: protocol non-compliance|0
5092593|NCT02006641|17584800|P1|Overall Study|Other reason: protocol non-compliance|0
5092594|NCT02006641|17584798|P3|Overall Study|Other reason: caregiver impossibility|1
5092595|NCT02006641|17584799|P2|Overall Study|Other reason: caregiver impossibility|0
5092596|NCT02006641|17584800|P1|Overall Study|Other reason: caregiver impossibility|0
5092597|NCT02006641|17584798|P3|Overall Study|Other reason: hospitalisation|0
5092598|NCT02006641|17584799|P2|Overall Study|Other reason: hospitalisation|1
5092599|NCT02006641|17584800|P1|Overall Study|Other reason: hospitalisation|0
5092600|NCT02006641|17584798|P3|Overall Study|Other reason: patient's wife has died|1
5092601|NCT02006641|17584799|P2|Overall Study|Other reason: patient's wife has died|0
5092602|NCT02006641|17584800|P1|Overall Study|Other reason: patient's wife has died|0
5092603|NCT02006641|17584798|P3|Overall Study|Other reason: caregiver in hospital|0
5092604|NCT02006641|17584799|P2|Overall Study|Other reason: caregiver in hospital|1
5092605|NCT02006641|17584800|P1|Overall Study|Other reason: caregiver in hospital|0
5092606|NCT02006641|17584798|P3|Overall Study|Other reason: patient has moved|1
5092607|NCT02006641|17584799|P2|Overall Study|Other reason: patient has moved|0
5092608|NCT02006641|17584800|P1|Overall Study|Other reason: patient has moved|1
5092609|NCT02006641|17584798|P3|Overall Study|Other reason:patient didn't want to come|1
5092610|NCT02006641|17584799|P2|Overall Study|Other reason:patient didn't want to come|0
5092611|NCT02006641|17584800|P1|Overall Study|Other reason:patient didn't want to come|0
5092612|NCT02006641|17584798|P3|Overall Study|Other reason: patient didn't show up|0
5092613|NCT02006641|17584799|P2|Overall Study|Other reason: patient didn't show up|0
5092614|NCT02006641|17584800|P1|Overall Study|Other reason: patient didn't show up|1
5092615|NCT02006641|17584798|P3|Overall Study|Withdrawal by Subject|11
5092616|NCT02006641|17584799|P2|Overall Study|Withdrawal by Subject|12
5092617|NCT02006641|17584800|P1|Overall Study|Withdrawal by Subject|7
5092618|NCT02006641|17584798|P3|Overall Study|Lost to Follow-up|0
5092619|NCT02006641|17584799|P2|Overall Study|Lost to Follow-up|1
5092620|NCT02006641|17584800|P1|Overall Study|Lost to Follow-up|0
5092621|NCT02006641|17584798|P3|Overall Study|Protocol Violation|2
5092622|NCT02006641|17584799|P2|Overall Study|Protocol Violation|2
5092623|NCT02006641|17584800|P1|Overall Study|Protocol Violation|0
5092624|NCT02006641|17584798|P3|Overall Study|Adverse Event|15
5092625|NCT02006641|17584799|P2|Overall Study|Adverse Event|11
5092626|NCT02006641|17584800|P1|Overall Study|Adverse Event|15
5092627|NCT02006641|17584798|P3|Overall Study|Withdrawal before treatment|3
5092628|NCT02006641|17584799|P2|Overall Study|Withdrawal before treatment|5
5092629|NCT02006641|17584800|P1|Overall Study|Withdrawal before treatment|2
5092630|NCT02006628|17584840|P2|Overall Study|Withdrawal by Subject|1
5092631|NCT02006628|17584841|P1|Overall Study|Withdrawal by Subject|2
5092632|NCT02006628|17584840|P2|Overall Study|Adverse Event|1
5092633|NCT02006628|17584841|P1|Overall Study|Adverse Event|1
5092634|NCT02006576|17584866|P3|Overall Study|Screen Failure, too sick, other|13
5092635|NCT02006576|17584867|P2|Overall Study|Screen Failure, too sick, other|1
5092636|NCT02006576|17584868|P1|Overall Study|Screen Failure, too sick, other|13
5092637|NCT02006576|17584866|P3|Overall Study|Lost to Follow-up|1
5092638|NCT02006576|17584867|P2|Overall Study|Lost to Follow-up|0
5092639|NCT02006576|17584868|P1|Overall Study|Lost to Follow-up|1
5092640|NCT02006576|17584866|P3|Overall Study|Death|1
5092641|NCT02006576|17584867|P2|Overall Study|Death|0
5092642|NCT02006576|17584868|P1|Overall Study|Death|0
5092643|NCT02006576|17584866|P3|Overall Study|Withdrawal by Subject|2
5092644|NCT02006576|17584867|P2|Overall Study|Withdrawal by Subject|6
5092645|NCT02006576|17584868|P1|Overall Study|Withdrawal by Subject|4
5092646|NCT02006121|17584951|P2|Open Label Phase|Non-compliance with study drug|0
5092647|NCT02006121|17584952|P1|Open Label Phase|Non-compliance with study drug|3
5092648|NCT02006121|17584951|P2|Open Label Phase|Withdrawal by Subject|0
5092649|NCT02006121|17584952|P1|Open Label Phase|Withdrawal by Subject|3
5092650|NCT02006121|17584951|P2|Open Label Phase|Protocol Violation|0
5092651|NCT02006121|17584952|P1|Open Label Phase|Protocol Violation|2
5092652|NCT02006121|17584951|P2|Open Label Phase|Lack of Efficacy|0
5092653|NCT02006121|17584952|P1|Open Label Phase|Lack of Efficacy|2
5092654|NCT02006121|17584951|P2|Open Label Phase|Adverse Event|0
5092655|NCT02006121|17584952|P1|Open Label Phase|Adverse Event|15
5092656|NCT02006121|17584951|P2|Double Blind Phase|Inconvenience of infusion system|1
5092657|NCT02006121|17584952|P1|Double Blind Phase|Inconvenience of infusion system|0
5092658|NCT02006121|17584951|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
5092659|NCT02006121|17584952|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
5092660|NCT02006121|17584951|P2|Double Blind Phase|Non-compliance with study drug|3
5092661|NCT02006121|17584952|P1|Double Blind Phase|Non-compliance with study drug|1
5092662|NCT02006121|17584951|P2|Double Blind Phase|Withdrawal by Subject|4
5092663|NCT02006121|17584952|P1|Double Blind Phase|Withdrawal by Subject|3
5092664|NCT02006121|17584951|P2|Double Blind Phase|Lack of Efficacy|16
5092665|NCT02006121|17584952|P1|Double Blind Phase|Lack of Efficacy|1
5092666|NCT02006121|17584951|P2|Double Blind Phase|Adverse Event|0
5092667|NCT02006121|17584952|P1|Double Blind Phase|Adverse Event|6
5092668|NCT02005887|17584985|P2|Overall Study|Protocol Violation|2
5092669|NCT02005887|17584986|P1|Overall Study|Protocol Violation|0
5092670|NCT02005692|17585004|P1|Overall Study|Discharged earlier than anticipated|5
5092671|NCT02005692|17585004|P1|Overall Study|Withdrawal by Subject|1
5092672|NCT02005692|17585004|P1|Overall Study|Protocol Violation|1
5092673|NCT02005627|17585030|P2|Overall Study|Withdrawal by Subject|2
5092674|NCT02005627|17585031|P1|Overall Study|Withdrawal by Subject|1
5092675|NCT02005627|17585030|P2|Overall Study|Lost to Follow-up|2
5092676|NCT02005627|17585031|P1|Overall Study|Lost to Follow-up|1
5092677|NCT02005562|17585060|P2|Overall Study|Physician Decision|1
5092678|NCT02005562|17585061|P1|Overall Study|Physician Decision|0
5092679|NCT02005562|17585060|P2|Overall Study|No transplant|4
5092680|NCT02005562|17585061|P1|Overall Study|No transplant|1
5092681|NCT02005562|17585060|P2|Overall Study|Withdrawal by Subject|2
5092682|NCT02005562|17585061|P1|Overall Study|Withdrawal by Subject|2
5092683|NCT02005562|17585060|P2|Overall Study|Graft loss|6
5092684|NCT02005562|17585061|P1|Overall Study|Graft loss|7
5092685|NCT02005562|17585060|P2|Overall Study|Death|2
5092686|NCT02005562|17585061|P1|Overall Study|Death|2
5092687|NCT02005484|17585122|P1|Overall Study|Sponsor decision|1
5092688|NCT02005484|17585122|P1|Overall Study|Changed to a Different Study|1
5092689|NCT02005484|17585122|P1|Overall Study|Disease progression|1
5092690|NCT02005484|17585122|P1|Overall Study|Death|1
5092691|NCT02005471|17585134|P2|Overall Study|Withdrawal by Subject|7
5092692|NCT02005471|17585135|P1|Overall Study|Withdrawal by Subject|18
5092693|NCT02005471|17585134|P2|Overall Study|Progressive Disease|0
5092694|NCT02005471|17585135|P1|Overall Study|Progressive Disease|3
5092695|NCT02005471|17585134|P2|Overall Study|Physician Decision|1
5092696|NCT02005471|17585135|P1|Overall Study|Physician Decision|2
5092697|NCT02005471|17585134|P2|Overall Study|Lost to Follow-up|0
5092698|NCT02005471|17585135|P1|Overall Study|Lost to Follow-up|1
5092699|NCT02005471|17585134|P2|Overall Study|Death|15
5092700|NCT02005471|17585135|P1|Overall Study|Death|26
5092701|NCT02005471|17585134|P2|Overall Study|Adverse Event|0
5092702|NCT02005471|17585135|P1|Overall Study|Adverse Event|1
5092703|NCT02005471|17585134|P2|Overall Study|Ongoing in Study|171
5092704|NCT02005471|17585135|P1|Overall Study|Ongoing in Study|144
5092705|NCT02005445|17585190|P2|Overall Study|Dual study enrollment|1
5092706|NCT02005445|17585191|P1|Overall Study|Dual study enrollment|0
5092707|NCT02005276|17585214|P4|Overall Study|No longer interested|3
5092708|NCT02005276|17585215|P3|Overall Study|No longer interested|3
5092709|NCT02005276|17585216|P2|Overall Study|No longer interested|2
5092710|NCT02005276|17585217|P1|Overall Study|No longer interested|5
5092711|NCT02005250|17585233|P2|Overall Study|Lost to Follow-up|5
5092712|NCT02005250|17585234|P1|Overall Study|Lost to Follow-up|15
5092713|NCT02005211|17585247|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5092714|NCT02005211|17585248|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5092715|NCT02005211|17585249|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
5092716|NCT02005211|17585250|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5092717|NCT02005211|17585251|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5092718|NCT02005211|17585252|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5092719|NCT02005211|17585253|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5092720|NCT02005029|17585288|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
5092721|NCT02005029|17585289|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
5092722|NCT02004886|17585346|P4|Overall Study|Unable to attend future visits|0
5092723|NCT02004886|17585347|P3|Overall Study|Unable to attend future visits|0
5092724|NCT02004886|17585348|P2|Overall Study|Unable to attend future visits|0
5092725|NCT02004886|17585349|P1|Overall Study|Unable to attend future visits|1
5092726|NCT02004886|17585346|P4|Overall Study|Adverse Event|0
5092727|NCT02004886|17585347|P3|Overall Study|Adverse Event|0
5092728|NCT02004886|17585348|P2|Overall Study|Adverse Event|1
5092729|NCT02004886|17585349|P1|Overall Study|Adverse Event|0
5092730|NCT02004873|17585399|P1|Overall Study|Withdrawal by Subject|1
5092731|NCT02004873|17585399|P1|Overall Study|Death|23
5092732|NCT02004873|17585399|P1|Overall Study|Missed 6-month visit|4
5092733|NCT02004873|17585399|P1|Overall Study|Awaiting 6-month visit|390
5092734|NCT02004873|17585399|P1|Overall Study|Implant unsuccessful|6
5092735|NCT02004847|17585408|P2|Overall Study|Protocol Violation|1
5092736|NCT02004847|17585409|P1|Overall Study|Protocol Violation|1
5092737|NCT02004522|17585455|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
5092738|NCT02004522|17585456|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
5092739|NCT02004522|17585455|P2|Overall Study|Disease Progression|31
5092740|NCT02004522|17585456|P1|Overall Study|Disease Progression|35
5092741|NCT02004522|17585455|P2|Overall Study|Never Dosed|4
5092742|NCT02004522|17585456|P1|Overall Study|Never Dosed|2
5092743|NCT02004522|17585455|P2|Overall Study|Other is reason listed by PI.|1
5092744|NCT02004522|17585456|P1|Overall Study|Other is reason listed by PI.|4
5092745|NCT02004522|17585455|P2|Overall Study|Protocol Violation|0
5092746|NCT02004522|17585456|P1|Overall Study|Protocol Violation|1
5092747|NCT02004522|17585455|P2|Overall Study|Physician Decision|4
5092748|NCT02004522|17585456|P1|Overall Study|Physician Decision|3
5092749|NCT02004522|17585455|P2|Overall Study|Death|3
5092750|NCT02004522|17585456|P1|Overall Study|Death|12
5092751|NCT02004522|17585455|P2|Overall Study|Withdrawal by Subject|7
5092752|NCT02004522|17585456|P1|Overall Study|Withdrawal by Subject|13
5092753|NCT02004522|17585455|P2|Overall Study|Adverse Event|6
5092754|NCT02004522|17585456|P1|Overall Study|Adverse Event|55
5092755|NCT02004262|17585577|P6|Overall Study|Study Terminated by Sponsor|5
5092756|NCT02004262|17585578|P5|Overall Study|Study Terminated by Sponsor|1
5092757|NCT02004262|17585579|P4|Overall Study|Study Terminated by Sponsor|1
5092758|NCT02004262|17585580|P3|Overall Study|Study Terminated by Sponsor|2
5092759|NCT02004262|17585581|P2|Overall Study|Study Terminated by Sponsor|3
5092760|NCT02004262|17585582|P1|Overall Study|Study Terminated by Sponsor|4
5092761|NCT02004262|17585577|P6|Overall Study|Lost to Follow-up|0
5092762|NCT02004262|17585578|P5|Overall Study|Lost to Follow-up|0
5092763|NCT02004262|17585579|P4|Overall Study|Lost to Follow-up|0
5092764|NCT02004262|17585580|P3|Overall Study|Lost to Follow-up|0
5092765|NCT02004262|17585581|P2|Overall Study|Lost to Follow-up|1
5092766|NCT02004262|17585582|P1|Overall Study|Lost to Follow-up|1
5092767|NCT02004262|17585577|P6|Overall Study|Withdrawal by Subject|3
5092768|NCT02004262|17585578|P5|Overall Study|Withdrawal by Subject|1
5092769|NCT02004262|17585579|P4|Overall Study|Withdrawal by Subject|0
5092770|NCT02004262|17585580|P3|Overall Study|Withdrawal by Subject|4
5092771|NCT02004262|17585581|P2|Overall Study|Withdrawal by Subject|0
5092772|NCT02004262|17585582|P1|Overall Study|Withdrawal by Subject|1
5092773|NCT02004262|17585577|P6|Overall Study|Death|22
5092774|NCT02004262|17585578|P5|Overall Study|Death|29
5092775|NCT02004262|17585579|P4|Overall Study|Death|28
5092776|NCT02004262|17585580|P3|Overall Study|Death|66
5092777|NCT02004262|17585581|P2|Overall Study|Death|64
5092778|NCT02004262|17585582|P1|Overall Study|Death|67
5092779|NCT02004236|17585602|P3|Overall Study|Lack of Efficacy|16
5092780|NCT02004236|17585603|P2|Overall Study|Lack of Efficacy|0
5092781|NCT02004236|17585604|P1|Overall Study|Lack of Efficacy|0
5092782|NCT02004093|17585664|P2|Overall Study|Other|1
5092783|NCT02004093|17585665|P1|Overall Study|Other|3
5092784|NCT02004093|17585664|P2|Overall Study|Withdrawal by Subject|7
5092785|NCT02004093|17585665|P1|Overall Study|Withdrawal by Subject|3
5092786|NCT02004093|17585664|P2|Overall Study|Lost to Follow-up|1
5092787|NCT02004093|17585665|P1|Overall Study|Lost to Follow-up|0
5092788|NCT02004093|17585664|P2|Overall Study|Protocol Violation|1
5092789|NCT02004093|17585665|P1|Overall Study|Protocol Violation|0
5092790|NCT02004093|17585664|P2|Overall Study|Lack of Efficacy|62
5092791|NCT02004093|17585665|P1|Overall Study|Lack of Efficacy|66
5092792|NCT02004093|17585664|P2|Overall Study|Death|1
5092793|NCT02004093|17585665|P1|Overall Study|Death|2
5092794|NCT02003963|17585697|P2|Overall Study|Lost to Follow-up|1
5092795|NCT02003963|17585698|P1|Overall Study|Lost to Follow-up|2
5092796|NCT02003924|17585720|P3|Long-term Follow-up Phase|Other|1
5092797|NCT02003924|17585721|P2|Long-term Follow-up Phase|Other|2
5092798|NCT02003924|17585722|P1|Long-term Follow-up Phase|Other|5
5092799|NCT02003924|17585720|P3|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
5092800|NCT02003924|17585721|P2|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
5092801|NCT02003924|17585722|P1|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
5092802|NCT02003924|17585720|P3|Long-term Follow-up Phase|Lost to Follow-up|1
5092803|NCT02003924|17585721|P2|Long-term Follow-up Phase|Lost to Follow-up|6
5092804|NCT02003924|17585722|P1|Long-term Follow-up Phase|Lost to Follow-up|8
5092805|NCT02003924|17585720|P3|Long-term Follow-up Phase|Death|4
5092806|NCT02003924|17585721|P2|Long-term Follow-up Phase|Death|174
5092807|NCT02003924|17585722|P1|Long-term Follow-up Phase|Death|288
5092808|NCT02003924|17585720|P3|Open-label Phase|Other|0
5092809|NCT02003924|17585721|P2|Open-label Phase|Other|0
5092810|NCT02003924|17585722|P1|Open-label Phase|Other|7
5092811|NCT02003924|17585720|P3|Open-label Phase|Adverse Event|10
5092812|NCT02003924|17585721|P2|Open-label Phase|Adverse Event|0
5092813|NCT02003924|17585722|P1|Open-label Phase|Adverse Event|25
5092814|NCT02003924|17585720|P3|Open-label Phase|Disease Progression|5
5092815|NCT02003924|17585721|P2|Open-label Phase|Disease Progression|0
5092816|NCT02003924|17585722|P1|Open-label Phase|Disease Progression|59
5092817|NCT02003924|17585720|P3|Open-label Phase|Withdrawal Consent to Continue Treatment|1
5092818|NCT02003924|17585721|P2|Open-label Phase|Withdrawal Consent to Continue Treatment|0
5092819|NCT02003924|17585722|P1|Open-label Phase|Withdrawal Consent to Continue Treatment|9
5092820|NCT02003924|17585720|P3|Open-label Phase|Lost to Follow-up|1
5092821|NCT02003924|17585721|P2|Open-label Phase|Lost to Follow-up|0
5092822|NCT02003924|17585722|P1|Open-label Phase|Lost to Follow-up|0
5092823|NCT02003924|17585720|P3|Double-blind Phase|Other|0
5092824|NCT02003924|17585721|P2|Double-blind Phase|Other|50
5092825|NCT02003924|17585722|P1|Double-blind Phase|Other|29
5092826|NCT02003924|17585720|P3|Double-blind Phase|Randomized But not Treated|0
5092827|NCT02003924|17585721|P2|Double-blind Phase|Randomized But not Treated|3
5092828|NCT02003924|17585722|P1|Double-blind Phase|Randomized But not Treated|3
5092829|NCT02003924|17585720|P3|Double-blind Phase|Adverse Event|0
5092830|NCT02003924|17585721|P2|Double-blind Phase|Adverse Event|31
5092831|NCT02003924|17585722|P1|Double-blind Phase|Adverse Event|120
5092832|NCT02003924|17585720|P3|Double-blind Phase|Disease Progression|0
5092833|NCT02003924|17585721|P2|Double-blind Phase|Disease Progression|247
5092834|NCT02003924|17585722|P1|Double-blind Phase|Disease Progression|229
5092835|NCT02003924|17585720|P3|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
5092836|NCT02003924|17585721|P2|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
5092837|NCT02003924|17585722|P1|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
5092838|NCT02003924|17585720|P3|Double-blind Phase|Protocol Violation|0
5092839|NCT02003924|17585721|P2|Double-blind Phase|Protocol Violation|2
5092840|NCT02003924|17585722|P1|Double-blind Phase|Protocol Violation|1
5092841|NCT02003924|17585720|P3|Double-blind Phase|Lost to Follow-up|0
5092842|NCT02003924|17585721|P2|Double-blind Phase|Lost to Follow-up|1
5092843|NCT02003924|17585722|P1|Double-blind Phase|Lost to Follow-up|2
5092844|NCT02003898|17585844|P1|Overall Study|Withdrawal by Subject|52
5092845|NCT02003898|17585844|P1|Overall Study|Lost to Follow-up|12
5092846|NCT02003898|17585844|P1|Overall Study|Death|3
5092847|NCT02003638|17585853|P2|Overall Study|Withdrawal by Subject|0
5092848|NCT02003638|17585854|P1|Overall Study|Withdrawal by Subject|1
5092849|NCT02003573|17585884|P3|Overall Study|Other than specified|3
5092850|NCT02003573|17585885|P2|Overall Study|Other than specified|2
5092851|NCT02003573|17585886|P1|Overall Study|Other than specified|1
5092852|NCT02003573|17585884|P3|Overall Study|Refuse to take trial medication|1
5092853|NCT02003573|17585885|P2|Overall Study|Refuse to take trial medication|1
5092854|NCT02003573|17585886|P1|Overall Study|Refuse to take trial medication|0
5092855|NCT02003573|17585884|P3|Overall Study|Other Adverse event|1
5092856|NCT02003573|17585885|P2|Overall Study|Other Adverse event|1
5092857|NCT02003573|17585886|P1|Overall Study|Other Adverse event|0
5092858|NCT02003573|17585884|P3|Overall Study|Progressive disease|1
5092859|NCT02003573|17585885|P2|Overall Study|Progressive disease|0
5092860|NCT02003573|17585886|P1|Overall Study|Progressive disease|2
5092861|NCT02003534|17585896|P1|Overall Study|Lost to Follow-up|47
5092862|NCT02003391|17585917|P2|Overall Study|Adverse Event|0
5092863|NCT02003391|17585918|P1|Overall Study|Adverse Event|1
5092864|NCT02003391|17585917|P2|Overall Study|Protocol Violation|1
5092865|NCT02003391|17585918|P1|Overall Study|Protocol Violation|0
5092866|NCT02003391|17585917|P2|Overall Study|Withdrawal by Subject|1
5092867|NCT02003391|17585918|P1|Overall Study|Withdrawal by Subject|2
5092868|NCT02003365|17585931|P3|Overall Study|Lost to Follow-up|1
5092869|NCT02003365|17585932|P2|Overall Study|Lost to Follow-up|0
5092870|NCT02003365|17585933|P1|Overall Study|Lost to Follow-up|0
5092871|NCT02003183|17585950|P2|Overall Study|Lost to Follow-up|2
5092872|NCT02003183|17585951|P1|Overall Study|Lost to Follow-up|0
5092873|NCT02003014|17585966|P1|Overall Study|Investigator's transfer|4
5092874|NCT02003014|17585966|P1|Overall Study|Patient did not visit the study site|5
5092875|NCT02003014|17585966|P1|Overall Study|Treatment started after contract period|1
5092876|NCT02003014|17585966|P1|Overall Study|Case report forms uncollected|9
5092877|NCT02002975|17585976|P1|Overall Study|Protocol Deviation|437
5092878|NCT02002975|17585976|P1|Overall Study|Case Report Forms Uncollected|135
5092879|NCT02002884|17586004|P4|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
5092880|NCT02002884|17586005|P3|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5092881|NCT02002884|17586006|P2|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5092882|NCT02002884|17586007|P1|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5092883|NCT02002884|17586004|P4|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
5092884|NCT02002884|17586005|P3|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5092885|NCT02002884|17586006|P2|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5092886|NCT02002884|17586007|P1|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5092887|NCT02002884|17586004|P4|Open-Label Extension Period (OLEX)|Adverse Event|5
5092888|NCT02002884|17586005|P3|Open-Label Extension Period (OLEX)|Adverse Event|0
5092889|NCT02002884|17586006|P2|Open-Label Extension Period (OLEX)|Adverse Event|0
5092890|NCT02002884|17586007|P1|Open-Label Extension Period (OLEX)|Adverse Event|0
5092891|NCT02002884|17586004|P4|Open-Label Extension Period (OLEX)|Physician Decision|1
5092892|NCT02002884|17586005|P3|Open-Label Extension Period (OLEX)|Physician Decision|0
5092893|NCT02002884|17586006|P2|Open-Label Extension Period (OLEX)|Physician Decision|0
5092894|NCT02002884|17586007|P1|Open-Label Extension Period (OLEX)|Physician Decision|0
5092895|NCT02002884|17586004|P4|Open-Label Extension Period (OLEX)|Other|24
5092896|NCT02002884|17586005|P3|Open-Label Extension Period (OLEX)|Other|0
5092897|NCT02002884|17586006|P2|Open-Label Extension Period (OLEX)|Other|0
5092898|NCT02002884|17586007|P1|Open-Label Extension Period (OLEX)|Other|0
5092899|NCT02002884|17586004|P4|Main Period (MP)|Lost to Follow-up|0
5092900|NCT02002884|17586005|P3|Main Period (MP)|Lost to Follow-up|2
5092901|NCT02002884|17586006|P2|Main Period (MP)|Lost to Follow-up|0
5092902|NCT02002884|17586007|P1|Main Period (MP)|Lost to Follow-up|0
5092903|NCT02002884|17586004|P4|Main Period (MP)|Withdrawal by Subject|0
5092904|NCT02002884|17586005|P3|Main Period (MP)|Withdrawal by Subject|2
5092905|NCT02002884|17586006|P2|Main Period (MP)|Withdrawal by Subject|2
5092906|NCT02002884|17586007|P1|Main Period (MP)|Withdrawal by Subject|6
5092907|NCT02002884|17586004|P4|Main Period (MP)|Adverse Event|0
5092908|NCT02002884|17586005|P3|Main Period (MP)|Adverse Event|1
5092909|NCT02002884|17586006|P2|Main Period (MP)|Adverse Event|1
5092910|NCT02002884|17586007|P1|Main Period (MP)|Adverse Event|0
5092911|NCT02002884|17586004|P4|Main Period (MP)|Other|0
5092912|NCT02002884|17586005|P3|Main Period (MP)|Other|3
5092913|NCT02002884|17586006|P2|Main Period (MP)|Other|3
5092914|NCT02002884|17586007|P1|Main Period (MP)|Other|0
5092915|NCT02002689|17586159|P1|Overall Study|Adverse Event|3
5092916|NCT02002689|17586159|P1|Overall Study|Disease Progression|7
5092917|NCT02002533|17586178|P2|Overall Study|Lost to Follow-up|1
5092918|NCT02002533|17586179|P1|Overall Study|Lost to Follow-up|0
5092919|NCT02002533|17586178|P2|Overall Study|Adverse Event|3
5092920|NCT02002533|17586179|P1|Overall Study|Adverse Event|0
5092921|NCT02002533|17586178|P2|Overall Study|Protocol Violation|1
5092922|NCT02002533|17586179|P1|Overall Study|Protocol Violation|0
5092923|NCT02002533|17586178|P2|Overall Study|Withdrawal by Subject|13
5092924|NCT02002533|17586179|P1|Overall Study|Withdrawal by Subject|6
5092925|NCT02002221|17586219|P2|Overall Study|Patient withdrew consent|1
5092926|NCT02002221|17586220|P1|Overall Study|Patient withdrew consent|0
5092927|NCT02002221|17586219|P2|Overall Study|Unsatisfactory therapeutic effect|1
5092928|NCT02002221|17586220|P1|Overall Study|Unsatisfactory therapeutic effect|0
5092929|NCT02002221|17586219|P2|Overall Study|Adverse Event|1
5092930|NCT02002221|17586220|P1|Overall Study|Adverse Event|2
5092931|NCT02002182|17586247|P2|Overall Study|Death|0
5092932|NCT02002182|17586248|P1|Overall Study|Death|1
5092933|NCT02002182|17586247|P2|Overall Study|Health Reasons|0
5092934|NCT02002182|17586248|P1|Overall Study|Health Reasons|1
5092935|NCT02002182|17586247|P2|Overall Study|Withdraw from study|1
5092936|NCT02002182|17586248|P1|Overall Study|Withdraw from study|3
5092937|NCT02002091|17586260|P2|Screening|Death|2
5092938|NCT02002091|17586261|P1|Screening|Death|3
5092939|NCT02002091|17586260|P2|Screening|Lost to Follow-up|12
5092940|NCT02002091|17586261|P1|Screening|Lost to Follow-up|10
5092941|NCT02001987|17586296|P1|LTE Period (52 Weeks)|Other|3
5092942|NCT02001987|17586296|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
5092943|NCT02001987|17586296|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
5092944|NCT02001987|17586296|P1|LTE Period (52 Weeks)|Physician Decision|2
5092945|NCT02001987|17586296|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
5092946|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
5092947|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Protocol Violation|3
5092948|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
5092949|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Physician Decision|1
5092950|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
5092951|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Death|1
5092952|NCT02001987|17586296|P1|Core Study Period (24 Weeks)|Adverse Event|9
5092953|NCT02001688|17586382|P3|Overall Study|Adverse Event|0
5092954|NCT02001688|17586383|P2|Overall Study|Adverse Event|1
5092955|NCT02001688|17586384|P1|Overall Study|Adverse Event|0
5092956|NCT02001688|17586382|P3|Overall Study|Withdrawal by Subject|1
5092957|NCT02001688|17586383|P2|Overall Study|Withdrawal by Subject|0
5092958|NCT02001688|17586384|P1|Overall Study|Withdrawal by Subject|0
5092959|NCT02001558|17586403|P2|Overall Study|Lost to Follow-up|14
5092960|NCT02001558|17586404|P1|Overall Study|Lost to Follow-up|8
5092961|NCT02001194|17586440|P4|Follow-Up Period (13 Weeks)|No longer interested|0
5092962|NCT02001194|17586441|P3|Follow-Up Period (13 Weeks)|No longer interested|1
5092963|NCT02001194|17586442|P2|Follow-Up Period (13 Weeks)|No longer interested|2
5092964|NCT02001194|17586443|P1|Follow-Up Period (13 Weeks)|No longer interested|3
5092965|NCT02001194|17586440|P4|Intervention Period (13 Weeks)|No longer interested|2
5092966|NCT02001194|17586441|P3|Intervention Period (13 Weeks)|No longer interested|2
5092967|NCT02001194|17586442|P2|Intervention Period (13 Weeks)|No longer interested|0
5092968|NCT02001194|17586443|P1|Intervention Period (13 Weeks)|No longer interested|1
5092969|NCT02001181|17586459|P2|Overall Study|Withdrawal by Subject|1
5092970|NCT02001181|17586460|P1|Overall Study|Withdrawal by Subject|0
5092971|NCT02001181|17586459|P2|Overall Study|Lost to Follow-up|0
5092972|NCT02001181|17586460|P1|Overall Study|Lost to Follow-up|1
5092973|NCT02001181|17586459|P2|Overall Study|Adverse Event|2
5092974|NCT02001181|17586460|P1|Overall Study|Adverse Event|0
5092975|NCT02001051|17586476|P2|Overall Study|Deemed not eligible following enrollment|1
5092976|NCT02001051|17586477|P1|Overall Study|Deemed not eligible following enrollment|0
5092977|NCT02000921|17586529|P3|Overall Study|Physician Decision|0
5092978|NCT02000921|17586530|P2|Overall Study|Physician Decision|2
5092979|NCT02000921|17586531|P1|Overall Study|Physician Decision|0
5092980|NCT02000921|17586529|P3|Overall Study|Lost to Follow-up|5
5092981|NCT02000921|17586530|P2|Overall Study|Lost to Follow-up|4
5092982|NCT02000921|17586531|P1|Overall Study|Lost to Follow-up|2
5092983|NCT02000921|17586529|P3|Overall Study|Withdrawal by Subject|5
5092984|NCT02000921|17586530|P2|Overall Study|Withdrawal by Subject|10
5092985|NCT02000921|17586531|P1|Overall Study|Withdrawal by Subject|3
5092986|NCT02000817|17586561|P4|Overall Study|Lost to Follow-up|0
5092987|NCT02000817|17586562|P3|Overall Study|Lost to Follow-up|1
5092988|NCT02000817|17586563|P2|Overall Study|Lost to Follow-up|0
5092989|NCT02000817|17586564|P1|Overall Study|Lost to Follow-up|0
5092990|NCT02000817|17586561|P4|Overall Study|Adverse Event|0
5092991|NCT02000817|17586562|P3|Overall Study|Adverse Event|0
5092992|NCT02000817|17586563|P2|Overall Study|Adverse Event|1
5092993|NCT02000817|17586564|P1|Overall Study|Adverse Event|0
5092994|NCT02000817|17586561|P4|Overall Study|Withdrawal by Subject|0
5092995|NCT02000817|17586562|P3|Overall Study|Withdrawal by Subject|0
5092996|NCT02000817|17586563|P2|Overall Study|Withdrawal by Subject|0
5092997|NCT02000817|17586564|P1|Overall Study|Withdrawal by Subject|2
5092998|NCT02000752|17586659|P2|Overall Study|Shift Changes|5
5092999|NCT02000752|17586660|P1|Overall Study|Shift Changes|12
5093000|NCT02000752|17586659|P2|Overall Study|Dystocic delivery|8
5093001|NCT02000752|17586660|P1|Overall Study|Dystocic delivery|19
5093002|NCT02000622|17586674|P2|Overall Study|Withdrawal by Subject|7
5093003|NCT02000622|17586675|P1|Overall Study|Withdrawal by Subject|5
5093004|NCT02000622|17586674|P2|Overall Study|Death|46
5093005|NCT02000622|17586675|P1|Overall Study|Death|94
5093006|NCT02000622|17586674|P2|Overall Study|Lost to Follow-up|0
5093007|NCT02000622|17586675|P1|Overall Study|Lost to Follow-up|1
5093008|NCT02000622|17586674|P2|Overall Study|Withdrawn due to site closure|0
5093009|NCT02000622|17586675|P1|Overall Study|Withdrawn due to site closure|1
5093010|NCT02000531|17586710|P2|Overall Study|Discontinued due to data cut-off|8
5093011|NCT02000531|17586711|P1|Overall Study|Discontinued due to data cut-off|3
5093012|NCT02000531|17586710|P2|Overall Study|Lost to Follow-up|0
5093013|NCT02000531|17586711|P1|Overall Study|Lost to Follow-up|1
5093014|NCT02000440|17586719|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
5093015|NCT02000440|17586719|P1|Overall Study|Adverse Event|3
5093016|NCT02000427|17586739|P1|Overall Study|Death|22
5093017|NCT01999972|17586793|P6|Dose Expansion Part|Changed to standard of care|0
5093018|NCT01999972|17586794|P5|Dose Expansion Part|Changed to standard of care|1
5093019|NCT01999972|17586795|P4|Dose Expansion Part|Changed to standard of care|0
5093020|NCT01999972|17586796|P3|Dose Expansion Part|Changed to standard of care|0
5093021|NCT01999972|17586797|P2|Dose Expansion Part|Changed to standard of care|0
5093022|NCT01999972|17586798|P1|Dose Expansion Part|Changed to standard of care|0
5093023|NCT01999972|17586793|P6|Dose Expansion Part|Participant refused further follow-up|0
5093024|NCT01999972|17586794|P5|Dose Expansion Part|Participant refused further follow-up|4
5093025|NCT01999972|17586795|P4|Dose Expansion Part|Participant refused further follow-up|0
5093026|NCT01999972|17586796|P3|Dose Expansion Part|Participant refused further follow-up|0
5093027|NCT01999972|17586797|P2|Dose Expansion Part|Participant refused further follow-up|0
5093028|NCT01999972|17586798|P1|Dose Expansion Part|Participant refused further follow-up|0
5093029|NCT01999972|17586793|P6|Dose Expansion Part|Participant's non-compliance|1
5093030|NCT01999972|17586794|P5|Dose Expansion Part|Participant's non-compliance|0
5093031|NCT01999972|17586795|P4|Dose Expansion Part|Participant's non-compliance|0
5093032|NCT01999972|17586796|P3|Dose Expansion Part|Participant's non-compliance|0
5093033|NCT01999972|17586797|P2|Dose Expansion Part|Participant's non-compliance|0
5093034|NCT01999972|17586798|P1|Dose Expansion Part|Participant's non-compliance|0
5093035|NCT01999972|17586793|P6|Dose Expansion Part|Adverse Event|2
5093036|NCT01999972|17586794|P5|Dose Expansion Part|Adverse Event|4
5093037|NCT01999972|17586795|P4|Dose Expansion Part|Adverse Event|0
5093038|NCT01999972|17586796|P3|Dose Expansion Part|Adverse Event|0
5093039|NCT01999972|17586797|P2|Dose Expansion Part|Adverse Event|0
5093040|NCT01999972|17586798|P1|Dose Expansion Part|Adverse Event|0
5093041|NCT01999972|17586793|P6|Dose Expansion Part|Sponsor decision|0
5093042|NCT01999972|17586794|P5|Dose Expansion Part|Sponsor decision|1
5093043|NCT01999972|17586795|P4|Dose Expansion Part|Sponsor decision|0
5093044|NCT01999972|17586796|P3|Dose Expansion Part|Sponsor decision|0
5093045|NCT01999972|17586797|P2|Dose Expansion Part|Sponsor decision|0
5093046|NCT01999972|17586798|P1|Dose Expansion Part|Sponsor decision|0
5093047|NCT01999972|17586793|P6|Dose Expansion Part|Disease progression|3
5093048|NCT01999972|17586794|P5|Dose Expansion Part|Disease progression|9
5093049|NCT01999972|17586795|P4|Dose Expansion Part|Disease progression|0
5093050|NCT01999972|17586796|P3|Dose Expansion Part|Disease progression|0
5093051|NCT01999972|17586797|P2|Dose Expansion Part|Disease progression|0
5093052|NCT01999972|17586798|P1|Dose Expansion Part|Disease progression|0
5093053|NCT01999972|17586793|P6|Dose Expansion Part|Death|1
5093054|NCT01999972|17586794|P5|Dose Expansion Part|Death|2
5093055|NCT01999972|17586795|P4|Dose Expansion Part|Death|0
5093056|NCT01999972|17586796|P3|Dose Expansion Part|Death|0
5093057|NCT01999972|17586797|P2|Dose Expansion Part|Death|0
5093058|NCT01999972|17586798|P1|Dose Expansion Part|Death|0
5093059|NCT01999972|17586793|P6|Dose Escalation Part|Global deterioration of health status|0
5093060|NCT01999972|17586794|P5|Dose Escalation Part|Global deterioration of health status|0
5093061|NCT01999972|17586795|P4|Dose Escalation Part|Global deterioration of health status|1
5093062|NCT01999972|17586796|P3|Dose Escalation Part|Global deterioration of health status|0
5093063|NCT01999972|17586797|P2|Dose Escalation Part|Global deterioration of health status|0
5093064|NCT01999972|17586798|P1|Dose Escalation Part|Global deterioration of health status|1
5093065|NCT01999972|17586793|P6|Dose Escalation Part|Adverse Event|0
5093066|NCT01999972|17586794|P5|Dose Escalation Part|Adverse Event|0
5093067|NCT01999972|17586795|P4|Dose Escalation Part|Adverse Event|2
5093068|NCT01999972|17586796|P3|Dose Escalation Part|Adverse Event|0
5093069|NCT01999972|17586797|P2|Dose Escalation Part|Adverse Event|0
5093070|NCT01999972|17586798|P1|Dose Escalation Part|Adverse Event|0
5093071|NCT01999972|17586793|P6|Dose Escalation Part|Disease progression|0
5093072|NCT01999972|17586794|P5|Dose Escalation Part|Disease progression|0
5093073|NCT01999972|17586795|P4|Dose Escalation Part|Disease progression|6
5093074|NCT01999972|17586796|P3|Dose Escalation Part|Disease progression|3
5093075|NCT01999972|17586797|P2|Dose Escalation Part|Disease progression|2
5093076|NCT01999972|17586798|P1|Dose Escalation Part|Disease progression|3
5093077|NCT01999972|17586793|P6|Dose Escalation Part|Enrolled but not treated|0
5093078|NCT01999972|17586794|P5|Dose Escalation Part|Enrolled but not treated|0
5093079|NCT01999972|17586795|P4|Dose Escalation Part|Enrolled but not treated|1
5093080|NCT01999972|17586796|P3|Dose Escalation Part|Enrolled but not treated|1
5093081|NCT01999972|17586797|P2|Dose Escalation Part|Enrolled but not treated|0
5093082|NCT01999972|17586798|P1|Dose Escalation Part|Enrolled but not treated|0
5093083|NCT01999972|17586793|P6|Dose Escalation Part|Death|0
5093084|NCT01999972|17586794|P5|Dose Escalation Part|Death|0
5093085|NCT01999972|17586795|P4|Dose Escalation Part|Death|0
5093086|NCT01999972|17586796|P3|Dose Escalation Part|Death|0
5093087|NCT01999972|17586797|P2|Dose Escalation Part|Death|1
5093088|NCT01999972|17586798|P1|Dose Escalation Part|Death|0
5093089|NCT01999972|17586793|P6|Dose Escalation Part|Participant refused further follow-up|0
5093090|NCT01999972|17586794|P5|Dose Escalation Part|Participant refused further follow-up|0
5093091|NCT01999972|17586795|P4|Dose Escalation Part|Participant refused further follow-up|1
5093092|NCT01999972|17586796|P3|Dose Escalation Part|Participant refused further follow-up|1
5093093|NCT01999972|17586797|P2|Dose Escalation Part|Participant refused further follow-up|0
5093094|NCT01999972|17586798|P1|Dose Escalation Part|Participant refused further follow-up|1
5093095|NCT01999946|17586913|P3|Overall Study|Not included in primary outcome analysis|79
5093096|NCT01999946|17586914|P2|Overall Study|Not included in primary outcome analysis|0
5093097|NCT01999946|17586915|P1|Overall Study|Not included in primary outcome analysis|0
5093098|NCT01999946|17586913|P3|Overall Study|Participant not released from jail|0
5093099|NCT01999946|17586914|P2|Overall Study|Participant not released from jail|2
5093100|NCT01999946|17586915|P1|Overall Study|Participant not released from jail|2
5093101|NCT01999894|17586941|P1|Overall Study|Inclusion/exclusion criteria not met|1
5093102|NCT01999894|17586941|P1|Overall Study|Other Reason|3
5093103|NCT01999894|17586941|P1|Overall Study|Lost to Follow-up|10
5093104|NCT01999894|17586941|P1|Overall Study|Withdrawal by Subject|7
5093105|NCT01999894|17586941|P1|Overall Study|Protocol Violation|1
5093106|NCT01999894|17586941|P1|Overall Study|Lack of Efficacy|5
5093107|NCT01999894|17586941|P1|Overall Study|Adverse Event|9
5093108|NCT01999868|17586949|P3|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
5093109|NCT01999868|17586950|P2|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
5093110|NCT01999868|17586951|P1|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
5093111|NCT01999868|17586949|P3|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
5093188|NCT01999218|17587103|P1|Overall Study|Protocol Violation|4
5093112|NCT01999868|17586950|P2|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
5093113|NCT01999868|17586951|P1|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
5093114|NCT01999868|17586949|P3|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
5093115|NCT01999868|17586950|P2|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
5093116|NCT01999868|17586951|P1|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
5093117|NCT01999868|17586949|P3|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
5093118|NCT01999868|17586950|P2|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
5093119|NCT01999868|17586951|P1|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
5093120|NCT01999868|17586949|P3|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
5093121|NCT01999868|17586950|P2|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
5093122|NCT01999868|17586951|P1|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
5093123|NCT01999868|17586949|P3|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
5093124|NCT01999868|17586950|P2|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
5093125|NCT01999868|17586951|P1|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
5093126|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
5093127|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
5093128|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
5093129|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
5093130|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
5093131|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
5093132|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
5093133|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
5093134|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
5093135|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
5093136|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
5093137|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
5093138|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
5093139|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
5093140|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
5093141|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
5093142|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
5093143|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
5093144|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
5093145|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
5093146|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
5093147|NCT01999868|17586949|P3|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
5093148|NCT01999868|17586950|P2|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
5093149|NCT01999868|17586951|P1|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
5093150|NCT01999868|17586949|P3|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
5093151|NCT01999868|17586950|P2|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
5093152|NCT01999868|17586951|P1|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
5093153|NCT01999465|17587002|P2|Overall Study|Protocol Violation|1
5093154|NCT01999465|17587003|P1|Overall Study|Protocol Violation|0
5093155|NCT01999465|17587002|P2|Overall Study|Lost to Follow-up|2
5093156|NCT01999465|17587003|P1|Overall Study|Lost to Follow-up|0
5093157|NCT01999322|17587048|P2|Overall Study|Adverse Event|0
5093158|NCT01999322|17587049|P1|Overall Study|Adverse Event|1
5093159|NCT01999218|17587101|P3|Overall Study|Treated but excluded at 1 trial site|2
5093160|NCT01999218|17587102|P2|Overall Study|Treated but excluded at 1 trial site|5
5093161|NCT01999218|17587103|P1|Overall Study|Treated but excluded at 1 trial site|3
5093162|NCT01999218|17587101|P3|Overall Study|Adverse Event|7
5093163|NCT01999218|17587102|P2|Overall Study|Adverse Event|7
5093164|NCT01999218|17587103|P1|Overall Study|Adverse Event|9
5093165|NCT01999218|17587101|P3|Overall Study|Excluded Medication|2
5093166|NCT01999218|17587102|P2|Overall Study|Excluded Medication|1
5093167|NCT01999218|17587103|P1|Overall Study|Excluded Medication|1
5093168|NCT01999218|17587101|P3|Overall Study|Death|2
5093169|NCT01999218|17587102|P2|Overall Study|Death|1
5093170|NCT01999218|17587103|P1|Overall Study|Death|7
5093171|NCT01999218|17587101|P3|Overall Study|Creatinine/eGFR|1
5093172|NCT01999218|17587102|P2|Overall Study|Creatinine/eGFR|0
5093173|NCT01999218|17587103|P1|Overall Study|Creatinine/eGFR|0
5093174|NCT01999218|17587101|P3|Overall Study|Withdrawal by Subject|34
5093175|NCT01999218|17587102|P2|Overall Study|Withdrawal by Subject|29
5093176|NCT01999218|17587103|P1|Overall Study|Withdrawal by Subject|28
5093177|NCT01999218|17587101|P3|Overall Study|Participant moves|3
5093178|NCT01999218|17587102|P2|Overall Study|Participant moves|5
5093179|NCT01999218|17587103|P1|Overall Study|Participant moves|2
5093180|NCT01999218|17587101|P3|Overall Study|Study Terminated By Sponsor|12
5093181|NCT01999218|17587102|P2|Overall Study|Study Terminated By Sponsor|5
5093182|NCT01999218|17587103|P1|Overall Study|Study Terminated By Sponsor|7
5093183|NCT01999218|17587101|P3|Overall Study|Screen failure|0
5093184|NCT01999218|17587102|P2|Overall Study|Screen failure|1
5093185|NCT01999218|17587103|P1|Overall Study|Screen failure|0
5093186|NCT01999218|17587101|P3|Overall Study|Protocol Violation|4
5093187|NCT01999218|17587102|P2|Overall Study|Protocol Violation|5
5093189|NCT01999218|17587101|P3|Overall Study|Physician Decision|6
5093190|NCT01999218|17587102|P2|Overall Study|Physician Decision|4
5093191|NCT01999218|17587103|P1|Overall Study|Physician Decision|1
5093192|NCT01999218|17587101|P3|Overall Study|Non-Compliance With Study Drug|1
5093193|NCT01999218|17587102|P2|Overall Study|Non-Compliance With Study Drug|4
5093194|NCT01999218|17587103|P1|Overall Study|Non-Compliance With Study Drug|6
5093195|NCT01999218|17587101|P3|Overall Study|Lost to Follow-up|18
5093196|NCT01999218|17587102|P2|Overall Study|Lost to Follow-up|17
5093197|NCT01999218|17587103|P1|Overall Study|Lost to Follow-up|22
5093198|NCT01999218|17587101|P3|Overall Study|Lack of Efficacy|1
5093199|NCT01999218|17587102|P2|Overall Study|Lack of Efficacy|0
5093200|NCT01999218|17587103|P1|Overall Study|Lack of Efficacy|1
5093201|NCT01999218|17587101|P3|Overall Study|Hyperglycemia|17
5093202|NCT01999218|17587102|P2|Overall Study|Hyperglycemia|17
5093203|NCT01999218|17587103|P1|Overall Study|Hyperglycemia|18
5093204|NCT01999114|17587148|P5|Overall Study|Administrative|2
5093205|NCT01999114|17587149|P4|Overall Study|Administrative|1
5093206|NCT01999114|17587150|P3|Overall Study|Administrative|1
5093207|NCT01999114|17587151|P2|Overall Study|Administrative|0
5093208|NCT01999114|17587152|P1|Overall Study|Administrative|0
5093209|NCT01999114|17587148|P5|Overall Study|Lost to Follow-up|0
5093210|NCT01999114|17587149|P4|Overall Study|Lost to Follow-up|0
5093211|NCT01999114|17587150|P3|Overall Study|Lost to Follow-up|1
5093212|NCT01999114|17587151|P2|Overall Study|Lost to Follow-up|0
5093213|NCT01999114|17587152|P1|Overall Study|Lost to Follow-up|0
5093214|NCT01999114|17587148|P5|Overall Study|Withdrawal by Subject|1
5093215|NCT01999114|17587149|P4|Overall Study|Withdrawal by Subject|0
5093216|NCT01999114|17587150|P3|Overall Study|Withdrawal by Subject|1
5093217|NCT01999114|17587151|P2|Overall Study|Withdrawal by Subject|0
5093218|NCT01999114|17587152|P1|Overall Study|Withdrawal by Subject|0
5093219|NCT01999114|17587148|P5|Overall Study|Adverse Event|1
5093220|NCT01999114|17587149|P4|Overall Study|Adverse Event|2
5093221|NCT01999114|17587150|P3|Overall Study|Adverse Event|2
5093222|NCT01999114|17587151|P2|Overall Study|Adverse Event|7
5093223|NCT01999114|17587152|P1|Overall Study|Adverse Event|8
5093224|NCT01998984|17587220|P4|Overall Study|Other|1
5093225|NCT01998984|17587221|P3|Overall Study|Other|0
5093226|NCT01998984|17587222|P2|Overall Study|Other|0
5093227|NCT01998984|17587223|P1|Overall Study|Other|0
5093228|NCT01998984|17587220|P4|Overall Study|Withdrawal by Subject|0
5093229|NCT01998984|17587221|P3|Overall Study|Withdrawal by Subject|1
5093230|NCT01998984|17587222|P2|Overall Study|Withdrawal by Subject|0
5093231|NCT01998984|17587223|P1|Overall Study|Withdrawal by Subject|0
5093232|NCT01998984|17587220|P4|Overall Study|Lost to Follow-up|1
5093233|NCT01998984|17587221|P3|Overall Study|Lost to Follow-up|0
5093234|NCT01998984|17587222|P2|Overall Study|Lost to Follow-up|1
5093235|NCT01998984|17587223|P1|Overall Study|Lost to Follow-up|0
5093236|NCT01998984|17587220|P4|Overall Study|Adverse Event|1
5093237|NCT01998984|17587221|P3|Overall Study|Adverse Event|0
5093238|NCT01998984|17587222|P2|Overall Study|Adverse Event|0
5093239|NCT01998984|17587223|P1|Overall Study|Adverse Event|0
5093240|NCT01998958|17587248|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
5093241|NCT01998958|17587249|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
5093242|NCT01998958|17587250|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
5093243|NCT01998958|17587251|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
5093244|NCT01998958|17587252|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
5093245|NCT01998958|17587253|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
5093246|NCT01998958|17587254|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
5093247|NCT01998958|17587255|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
5093248|NCT01998958|17587256|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
5093249|NCT01998958|17587257|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
5093250|NCT01998958|17587258|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
5093251|NCT01998958|17587259|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
5093252|NCT01998958|17587260|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
5093253|NCT01998958|17587261|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
5093254|NCT01998958|17587262|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
5093255|NCT01998958|17587263|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
5093256|NCT01998958|17587264|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
5093257|NCT01998958|17587265|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
5093258|NCT01998958|17587266|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
5093259|NCT01998958|17587267|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
5093260|NCT01998958|17587268|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
5093261|NCT01998958|17587269|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
5093262|NCT01998958|17587270|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
5093263|NCT01998958|17587271|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
5093264|NCT01998958|17587272|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
5093265|NCT01998958|17587273|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
5093266|NCT01998958|17587274|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
5093267|NCT01998958|17587275|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
5093268|NCT01998958|17587276|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
5093269|NCT01998958|17587277|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
5093270|NCT01998958|17587278|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
5093271|NCT01998958|17587279|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
5093272|NCT01998958|17587248|P32|Open Label Phase (Optional)|Lack of Efficacy|0
5093273|NCT01998958|17587249|P31|Open Label Phase (Optional)|Lack of Efficacy|0
5093274|NCT01998958|17587250|P30|Open Label Phase (Optional)|Lack of Efficacy|0
5093275|NCT01998958|17587251|P29|Open Label Phase (Optional)|Lack of Efficacy|0
5093276|NCT01998958|17587252|P28|Open Label Phase (Optional)|Lack of Efficacy|0
5093277|NCT01998958|17587253|P27|Open Label Phase (Optional)|Lack of Efficacy|0
5093278|NCT01998958|17587254|P26|Open Label Phase (Optional)|Lack of Efficacy|0
5093279|NCT01998958|17587255|P25|Open Label Phase (Optional)|Lack of Efficacy|0
5093280|NCT01998958|17587256|P24|Open Label Phase (Optional)|Lack of Efficacy|0
5093281|NCT01998958|17587257|P23|Open Label Phase (Optional)|Lack of Efficacy|2
5093282|NCT01998958|17587258|P22|Open Label Phase (Optional)|Lack of Efficacy|1
5093283|NCT01998958|17587259|P21|Open Label Phase (Optional)|Lack of Efficacy|0
5093284|NCT01998958|17587260|P20|Open Label Phase (Optional)|Lack of Efficacy|0
5093285|NCT01998958|17587261|P19|Open Label Phase (Optional)|Lack of Efficacy|0
5093286|NCT01998958|17587262|P18|Open Label Phase (Optional)|Lack of Efficacy|0
5093287|NCT01998958|17587263|P17|Open Label Phase (Optional)|Lack of Efficacy|0
5093288|NCT01998958|17587264|P16|Open Label Phase (Optional)|Lack of Efficacy|0
5093289|NCT01998958|17587265|P15|Open Label Phase (Optional)|Lack of Efficacy|0
5093290|NCT01998958|17587266|P14|Open Label Phase (Optional)|Lack of Efficacy|0
5093291|NCT01998958|17587267|P13|Open Label Phase (Optional)|Lack of Efficacy|0
5093292|NCT01998958|17587268|P12|Open Label Phase (Optional)|Lack of Efficacy|0
5093293|NCT01998958|17587269|P11|Open Label Phase (Optional)|Lack of Efficacy|0
5093294|NCT01998958|17587270|P10|Open Label Phase (Optional)|Lack of Efficacy|0
5093295|NCT01998958|17587271|P9|Open Label Phase (Optional)|Lack of Efficacy|0
5093296|NCT01998958|17587272|P8|Open Label Phase (Optional)|Lack of Efficacy|0
5093297|NCT01998958|17587273|P7|Open Label Phase (Optional)|Lack of Efficacy|0
5093298|NCT01998958|17587274|P6|Open Label Phase (Optional)|Lack of Efficacy|0
5093299|NCT01998958|17587275|P5|Open Label Phase (Optional)|Lack of Efficacy|0
5093300|NCT01998958|17587276|P4|Open Label Phase (Optional)|Lack of Efficacy|0
5093301|NCT01998958|17587277|P3|Open Label Phase (Optional)|Lack of Efficacy|0
5093302|NCT01998958|17587278|P2|Open Label Phase (Optional)|Lack of Efficacy|0
5093303|NCT01998958|17587279|P1|Open Label Phase (Optional)|Lack of Efficacy|0
5093304|NCT01998958|17587248|P32|Open Label Phase (Optional)|Lost to Follow-up|0
5093305|NCT01998958|17587249|P31|Open Label Phase (Optional)|Lost to Follow-up|0
5093306|NCT01998958|17587250|P30|Open Label Phase (Optional)|Lost to Follow-up|0
5093307|NCT01998958|17587251|P29|Open Label Phase (Optional)|Lost to Follow-up|0
5093308|NCT01998958|17587252|P28|Open Label Phase (Optional)|Lost to Follow-up|0
5093309|NCT01998958|17587253|P27|Open Label Phase (Optional)|Lost to Follow-up|0
5093310|NCT01998958|17587254|P26|Open Label Phase (Optional)|Lost to Follow-up|0
5093311|NCT01998958|17587255|P25|Open Label Phase (Optional)|Lost to Follow-up|0
5093312|NCT01998958|17587256|P24|Open Label Phase (Optional)|Lost to Follow-up|0
5093313|NCT01998958|17587257|P23|Open Label Phase (Optional)|Lost to Follow-up|1
5093314|NCT01998958|17587258|P22|Open Label Phase (Optional)|Lost to Follow-up|0
5093315|NCT01998958|17587259|P21|Open Label Phase (Optional)|Lost to Follow-up|0
5093316|NCT01998958|17587260|P20|Open Label Phase (Optional)|Lost to Follow-up|0
5093317|NCT01998958|17587261|P19|Open Label Phase (Optional)|Lost to Follow-up|0
5093318|NCT01998958|17587262|P18|Open Label Phase (Optional)|Lost to Follow-up|0
5093319|NCT01998958|17587263|P17|Open Label Phase (Optional)|Lost to Follow-up|0
5093320|NCT01998958|17587264|P16|Open Label Phase (Optional)|Lost to Follow-up|0
5093321|NCT01998958|17587265|P15|Open Label Phase (Optional)|Lost to Follow-up|0
5093322|NCT01998958|17587266|P14|Open Label Phase (Optional)|Lost to Follow-up|0
5093323|NCT01998958|17587267|P13|Open Label Phase (Optional)|Lost to Follow-up|0
5093324|NCT01998958|17587268|P12|Open Label Phase (Optional)|Lost to Follow-up|0
5093325|NCT01998958|17587269|P11|Open Label Phase (Optional)|Lost to Follow-up|0
5093326|NCT01998958|17587270|P10|Open Label Phase (Optional)|Lost to Follow-up|0
5093327|NCT01998958|17587271|P9|Open Label Phase (Optional)|Lost to Follow-up|0
5093328|NCT01998958|17587272|P8|Open Label Phase (Optional)|Lost to Follow-up|0
5093329|NCT01998958|17587273|P7|Open Label Phase (Optional)|Lost to Follow-up|0
5093330|NCT01998958|17587274|P6|Open Label Phase (Optional)|Lost to Follow-up|0
5093331|NCT01998958|17587275|P5|Open Label Phase (Optional)|Lost to Follow-up|0
5093332|NCT01998958|17587276|P4|Open Label Phase (Optional)|Lost to Follow-up|0
5093333|NCT01998958|17587277|P3|Open Label Phase (Optional)|Lost to Follow-up|0
5093334|NCT01998958|17587278|P2|Open Label Phase (Optional)|Lost to Follow-up|0
5093335|NCT01998958|17587279|P1|Open Label Phase (Optional)|Lost to Follow-up|0
5093336|NCT01998958|17587248|P32|Open Label Phase (Optional)|Other|0
5093337|NCT01998958|17587249|P31|Open Label Phase (Optional)|Other|0
5093338|NCT01998958|17587250|P30|Open Label Phase (Optional)|Other|0
5093339|NCT01998958|17587251|P29|Open Label Phase (Optional)|Other|0
5093340|NCT01998958|17587252|P28|Open Label Phase (Optional)|Other|0
5093341|NCT01998958|17587253|P27|Open Label Phase (Optional)|Other|0
5093342|NCT01998958|17587254|P26|Open Label Phase (Optional)|Other|0
5093343|NCT01998958|17587255|P25|Open Label Phase (Optional)|Other|0
5093344|NCT01998958|17587256|P24|Open Label Phase (Optional)|Other|1
5093345|NCT01998958|17587257|P23|Open Label Phase (Optional)|Other|5
5093346|NCT01998958|17587258|P22|Open Label Phase (Optional)|Other|0
5093347|NCT01998958|17587259|P21|Open Label Phase (Optional)|Other|0
5093348|NCT01998958|17587260|P20|Open Label Phase (Optional)|Other|0
5093349|NCT01998958|17587261|P19|Open Label Phase (Optional)|Other|0
5093350|NCT01998958|17587262|P18|Open Label Phase (Optional)|Other|0
5093351|NCT01998958|17587263|P17|Open Label Phase (Optional)|Other|0
5093352|NCT01998958|17587264|P16|Open Label Phase (Optional)|Other|0
5093353|NCT01998958|17587265|P15|Open Label Phase (Optional)|Other|0
5093354|NCT01998958|17587266|P14|Open Label Phase (Optional)|Other|0
5093355|NCT01998958|17587267|P13|Open Label Phase (Optional)|Other|0
5093356|NCT01998958|17587268|P12|Open Label Phase (Optional)|Other|0
5093357|NCT01998958|17587269|P11|Open Label Phase (Optional)|Other|0
5093358|NCT01998958|17587270|P10|Open Label Phase (Optional)|Other|0
5093359|NCT01998958|17587271|P9|Open Label Phase (Optional)|Other|0
5093360|NCT01998958|17587272|P8|Open Label Phase (Optional)|Other|0
5093361|NCT01998958|17587273|P7|Open Label Phase (Optional)|Other|0
5093362|NCT01998958|17587274|P6|Open Label Phase (Optional)|Other|0
5093363|NCT01998958|17587275|P5|Open Label Phase (Optional)|Other|0
5093364|NCT01998958|17587276|P4|Open Label Phase (Optional)|Other|0
5093365|NCT01998958|17587277|P3|Open Label Phase (Optional)|Other|0
5093366|NCT01998958|17587278|P2|Open Label Phase (Optional)|Other|0
5093367|NCT01998958|17587279|P1|Open Label Phase (Optional)|Other|0
5093368|NCT01998958|17587248|P32|Open Label Phase (Optional)|Adverse Event|0
5093369|NCT01998958|17587249|P31|Open Label Phase (Optional)|Adverse Event|0
5093370|NCT01998958|17587250|P30|Open Label Phase (Optional)|Adverse Event|0
5093371|NCT01998958|17587251|P29|Open Label Phase (Optional)|Adverse Event|0
5093372|NCT01998958|17587252|P28|Open Label Phase (Optional)|Adverse Event|0
5093373|NCT01998958|17587253|P27|Open Label Phase (Optional)|Adverse Event|0
5093374|NCT01998958|17587254|P26|Open Label Phase (Optional)|Adverse Event|0
5093375|NCT01998958|17587255|P25|Open Label Phase (Optional)|Adverse Event|0
5093376|NCT01998958|17587256|P24|Open Label Phase (Optional)|Adverse Event|1
5093377|NCT01998958|17587257|P23|Open Label Phase (Optional)|Adverse Event|0
5093378|NCT01998958|17587258|P22|Open Label Phase (Optional)|Adverse Event|0
5093379|NCT01998958|17587259|P21|Open Label Phase (Optional)|Adverse Event|0
5093380|NCT01998958|17587260|P20|Open Label Phase (Optional)|Adverse Event|0
5093381|NCT01998958|17587261|P19|Open Label Phase (Optional)|Adverse Event|0
5093382|NCT01998958|17587262|P18|Open Label Phase (Optional)|Adverse Event|0
5093383|NCT01998958|17587263|P17|Open Label Phase (Optional)|Adverse Event|0
5093384|NCT01998958|17587264|P16|Open Label Phase (Optional)|Adverse Event|0
5093385|NCT01998958|17587265|P15|Open Label Phase (Optional)|Adverse Event|0
5093386|NCT01998958|17587266|P14|Open Label Phase (Optional)|Adverse Event|0
5093387|NCT01998958|17587267|P13|Open Label Phase (Optional)|Adverse Event|0
5093388|NCT01998958|17587268|P12|Open Label Phase (Optional)|Adverse Event|0
5093389|NCT01998958|17587269|P11|Open Label Phase (Optional)|Adverse Event|0
5093390|NCT01998958|17587270|P10|Open Label Phase (Optional)|Adverse Event|0
5093391|NCT01998958|17587271|P9|Open Label Phase (Optional)|Adverse Event|0
5093392|NCT01998958|17587272|P8|Open Label Phase (Optional)|Adverse Event|0
5093393|NCT01998958|17587273|P7|Open Label Phase (Optional)|Adverse Event|0
5093394|NCT01998958|17587274|P6|Open Label Phase (Optional)|Adverse Event|0
5093395|NCT01998958|17587275|P5|Open Label Phase (Optional)|Adverse Event|0
5093396|NCT01998958|17587276|P4|Open Label Phase (Optional)|Adverse Event|0
5093397|NCT01998958|17587277|P3|Open Label Phase (Optional)|Adverse Event|0
5093398|NCT01998958|17587278|P2|Open Label Phase (Optional)|Adverse Event|0
5093399|NCT01998958|17587279|P1|Open Label Phase (Optional)|Adverse Event|0
5093400|NCT01998958|17587248|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093401|NCT01998958|17587249|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093402|NCT01998958|17587250|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093403|NCT01998958|17587251|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093404|NCT01998958|17587252|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093405|NCT01998958|17587253|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093406|NCT01998958|17587254|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093407|NCT01998958|17587255|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093408|NCT01998958|17587256|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093409|NCT01998958|17587257|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093410|NCT01998958|17587258|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093411|NCT01998958|17587259|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093412|NCT01998958|17587260|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093413|NCT01998958|17587261|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
5093414|NCT01998958|17587262|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093415|NCT01998958|17587263|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093416|NCT01998958|17587264|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093417|NCT01998958|17587265|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
5093418|NCT01998958|17587266|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093419|NCT01998958|17587267|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093420|NCT01998958|17587268|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093421|NCT01998958|17587269|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093422|NCT01998958|17587270|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093423|NCT01998958|17587271|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093424|NCT01998958|17587272|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093425|NCT01998958|17587273|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093426|NCT01998958|17587274|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093427|NCT01998958|17587275|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093428|NCT01998958|17587276|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093429|NCT01998958|17587277|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093430|NCT01998958|17587278|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093431|NCT01998958|17587279|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
5093432|NCT01998958|17587248|P32|Period 2 (Panel A and B)|Adverse Event|0
5093433|NCT01998958|17587249|P31|Period 2 (Panel A and B)|Adverse Event|0
5093434|NCT01998958|17587250|P30|Period 2 (Panel A and B)|Adverse Event|0
5093435|NCT01998958|17587251|P29|Period 2 (Panel A and B)|Adverse Event|0
5093436|NCT01998958|17587252|P28|Period 2 (Panel A and B)|Adverse Event|0
5093437|NCT01998958|17587253|P27|Period 2 (Panel A and B)|Adverse Event|0
5093438|NCT01998958|17587254|P26|Period 2 (Panel A and B)|Adverse Event|0
5093439|NCT01998958|17587255|P25|Period 2 (Panel A and B)|Adverse Event|0
5093440|NCT01998958|17587256|P24|Period 2 (Panel A and B)|Adverse Event|0
5093441|NCT01998958|17587257|P23|Period 2 (Panel A and B)|Adverse Event|0
5093442|NCT01998958|17587258|P22|Period 2 (Panel A and B)|Adverse Event|0
5093443|NCT01998958|17587259|P21|Period 2 (Panel A and B)|Adverse Event|0
5093444|NCT01998958|17587260|P20|Period 2 (Panel A and B)|Adverse Event|0
5093445|NCT01998958|17587261|P19|Period 2 (Panel A and B)|Adverse Event|0
5093446|NCT01998958|17587262|P18|Period 2 (Panel A and B)|Adverse Event|0
5093447|NCT01998958|17587263|P17|Period 2 (Panel A and B)|Adverse Event|0
5093448|NCT01998958|17587264|P16|Period 2 (Panel A and B)|Adverse Event|0
5093449|NCT01998958|17587265|P15|Period 2 (Panel A and B)|Adverse Event|1
5093450|NCT01998958|17587266|P14|Period 2 (Panel A and B)|Adverse Event|0
5093451|NCT01998958|17587267|P13|Period 2 (Panel A and B)|Adverse Event|0
5093452|NCT01998958|17587268|P12|Period 2 (Panel A and B)|Adverse Event|0
5093453|NCT01998958|17587269|P11|Period 2 (Panel A and B)|Adverse Event|1
5093454|NCT01998958|17587270|P10|Period 2 (Panel A and B)|Adverse Event|0
5093455|NCT01998958|17587271|P9|Period 2 (Panel A and B)|Adverse Event|0
5093456|NCT01998958|17587272|P8|Period 2 (Panel A and B)|Adverse Event|0
5093457|NCT01998958|17587273|P7|Period 2 (Panel A and B)|Adverse Event|0
5093458|NCT01998958|17587274|P6|Period 2 (Panel A and B)|Adverse Event|0
5093459|NCT01998958|17587275|P5|Period 2 (Panel A and B)|Adverse Event|0
5093460|NCT01998958|17587276|P4|Period 2 (Panel A and B)|Adverse Event|0
5093461|NCT01998958|17587277|P3|Period 2 (Panel A and B)|Adverse Event|0
5093462|NCT01998958|17587278|P2|Period 2 (Panel A and B)|Adverse Event|0
5093463|NCT01998958|17587279|P1|Period 2 (Panel A and B)|Adverse Event|0
5093464|NCT01998958|17587248|P32|Period 1 (Panel A and B)|Other|0
5093465|NCT01998958|17587249|P31|Period 1 (Panel A and B)|Other|0
5093466|NCT01998958|17587250|P30|Period 1 (Panel A and B)|Other|0
5093467|NCT01998958|17587251|P29|Period 1 (Panel A and B)|Other|0
5093468|NCT01998958|17587252|P28|Period 1 (Panel A and B)|Other|0
5093469|NCT01998958|17587253|P27|Period 1 (Panel A and B)|Other|0
5093470|NCT01998958|17587254|P26|Period 1 (Panel A and B)|Other|0
5093471|NCT01998958|17587255|P25|Period 1 (Panel A and B)|Other|0
5093472|NCT01998958|17587256|P24|Period 1 (Panel A and B)|Other|0
5093473|NCT01998958|17587257|P23|Period 1 (Panel A and B)|Other|0
5093474|NCT01998958|17587258|P22|Period 1 (Panel A and B)|Other|0
5093475|NCT01998958|17587259|P21|Period 1 (Panel A and B)|Other|0
5093476|NCT01998958|17587260|P20|Period 1 (Panel A and B)|Other|0
5093477|NCT01998958|17587261|P19|Period 1 (Panel A and B)|Other|0
5093478|NCT01998958|17587262|P18|Period 1 (Panel A and B)|Other|0
5093479|NCT01998958|17587263|P17|Period 1 (Panel A and B)|Other|0
5093480|NCT01998958|17587264|P16|Period 1 (Panel A and B)|Other|0
5093481|NCT01998958|17587265|P15|Period 1 (Panel A and B)|Other|0
5093482|NCT01998958|17587266|P14|Period 1 (Panel A and B)|Other|0
5093483|NCT01998958|17587267|P13|Period 1 (Panel A and B)|Other|0
5093484|NCT01998958|17587268|P12|Period 1 (Panel A and B)|Other|0
5093485|NCT01998958|17587269|P11|Period 1 (Panel A and B)|Other|0
5093486|NCT01998958|17587270|P10|Period 1 (Panel A and B)|Other|0
5093487|NCT01998958|17587271|P9|Period 1 (Panel A and B)|Other|0
5093488|NCT01998958|17587272|P8|Period 1 (Panel A and B)|Other|0
5093489|NCT01998958|17587273|P7|Period 1 (Panel A and B)|Other|0
5093490|NCT01998958|17587274|P6|Period 1 (Panel A and B)|Other|0
5093491|NCT01998958|17587275|P5|Period 1 (Panel A and B)|Other|0
5093492|NCT01998958|17587276|P4|Period 1 (Panel A and B)|Other|0
5093493|NCT01998958|17587277|P3|Period 1 (Panel A and B)|Other|0
5093494|NCT01998958|17587278|P2|Period 1 (Panel A and B)|Other|0
5093495|NCT01998958|17587279|P1|Period 1 (Panel A and B)|Other|1
5093496|NCT01998958|17587248|P32|Period 1 (Panel A and B)|Adverse Event|0
5093497|NCT01998958|17587249|P31|Period 1 (Panel A and B)|Adverse Event|0
5093498|NCT01998958|17587250|P30|Period 1 (Panel A and B)|Adverse Event|0
5093499|NCT01998958|17587251|P29|Period 1 (Panel A and B)|Adverse Event|0
5093500|NCT01998958|17587252|P28|Period 1 (Panel A and B)|Adverse Event|0
5093501|NCT01998958|17587253|P27|Period 1 (Panel A and B)|Adverse Event|0
5093502|NCT01998958|17587254|P26|Period 1 (Panel A and B)|Adverse Event|0
5093503|NCT01998958|17587255|P25|Period 1 (Panel A and B)|Adverse Event|0
5093504|NCT01998958|17587256|P24|Period 1 (Panel A and B)|Adverse Event|0
5093505|NCT01998958|17587257|P23|Period 1 (Panel A and B)|Adverse Event|0
5093506|NCT01998958|17587258|P22|Period 1 (Panel A and B)|Adverse Event|0
5093507|NCT01998958|17587259|P21|Period 1 (Panel A and B)|Adverse Event|0
5093508|NCT01998958|17587260|P20|Period 1 (Panel A and B)|Adverse Event|0
5093509|NCT01998958|17587261|P19|Period 1 (Panel A and B)|Adverse Event|0
5093510|NCT01998958|17587262|P18|Period 1 (Panel A and B)|Adverse Event|0
5093511|NCT01998958|17587263|P17|Period 1 (Panel A and B)|Adverse Event|0
5093512|NCT01998958|17587264|P16|Period 1 (Panel A and B)|Adverse Event|0
5093513|NCT01998958|17587265|P15|Period 1 (Panel A and B)|Adverse Event|0
5093514|NCT01998958|17587266|P14|Period 1 (Panel A and B)|Adverse Event|0
5093515|NCT01998958|17587267|P13|Period 1 (Panel A and B)|Adverse Event|0
5093516|NCT01998958|17587268|P12|Period 1 (Panel A and B)|Adverse Event|0
5093517|NCT01998958|17587269|P11|Period 1 (Panel A and B)|Adverse Event|0
5093518|NCT01998958|17587270|P10|Period 1 (Panel A and B)|Adverse Event|0
5093519|NCT01998958|17587271|P9|Period 1 (Panel A and B)|Adverse Event|0
5093520|NCT01998958|17587272|P8|Period 1 (Panel A and B)|Adverse Event|0
5093521|NCT01998958|17587273|P7|Period 1 (Panel A and B)|Adverse Event|0
5093522|NCT01998958|17587274|P6|Period 1 (Panel A and B)|Adverse Event|0
5093523|NCT01998958|17587275|P5|Period 1 (Panel A and B)|Adverse Event|0
5093524|NCT01998958|17587276|P4|Period 1 (Panel A and B)|Adverse Event|0
5093525|NCT01998958|17587277|P3|Period 1 (Panel A and B)|Adverse Event|0
5093526|NCT01998958|17587278|P2|Period 1 (Panel A and B)|Adverse Event|1
5093527|NCT01998958|17587279|P1|Period 1 (Panel A and B)|Adverse Event|0
5093528|NCT01998958|17587248|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
5093529|NCT01998958|17587249|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
5093530|NCT01998958|17587250|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
5093531|NCT01998958|17587251|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
5093532|NCT01998958|17587252|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
5093533|NCT01998958|17587253|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
5093534|NCT01998958|17587254|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
5093535|NCT01998958|17587255|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
5093536|NCT01998958|17587256|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
5093537|NCT01998958|17587257|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
5093538|NCT01998958|17587258|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
5093539|NCT01998958|17587259|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
5093540|NCT01998958|17587260|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
5093541|NCT01998958|17587261|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
5093542|NCT01998958|17587262|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
5093543|NCT01998958|17587263|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
5093544|NCT01998958|17587264|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
5093545|NCT01998958|17587265|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
5093546|NCT01998958|17587266|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
5093547|NCT01998958|17587267|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
5093548|NCT01998958|17587268|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
5093549|NCT01998958|17587269|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
5093550|NCT01998958|17587270|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
5093551|NCT01998958|17587271|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
5093552|NCT01998958|17587272|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
5093553|NCT01998958|17587273|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
5093554|NCT01998958|17587274|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
5093555|NCT01998958|17587275|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
5093556|NCT01998958|17587276|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
5093557|NCT01998958|17587277|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
5093558|NCT01998958|17587278|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
5093559|NCT01998958|17587279|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
5093560|NCT01998958|17587248|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093561|NCT01998958|17587249|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093562|NCT01998958|17587250|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093563|NCT01998958|17587251|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093564|NCT01998958|17587252|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093565|NCT01998958|17587253|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093566|NCT01998958|17587254|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093567|NCT01998958|17587255|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093568|NCT01998958|17587256|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093569|NCT01998958|17587257|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093570|NCT01998958|17587258|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093571|NCT01998958|17587259|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093572|NCT01998958|17587260|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093573|NCT01998958|17587261|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093574|NCT01998958|17587262|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093575|NCT01998958|17587263|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093576|NCT01998958|17587264|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093577|NCT01998958|17587265|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093578|NCT01998958|17587266|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093579|NCT01998958|17587267|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093580|NCT01998958|17587268|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093581|NCT01998958|17587269|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093582|NCT01998958|17587270|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093583|NCT01998958|17587271|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093584|NCT01998958|17587272|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093585|NCT01998958|17587273|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093586|NCT01998958|17587274|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093587|NCT01998958|17587275|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093588|NCT01998958|17587276|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093589|NCT01998958|17587277|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093590|NCT01998958|17587278|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
5093591|NCT01998958|17587279|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
5093592|NCT01998919|17587418|P2|Overall Study|Other|2
5093593|NCT01998919|17587419|P1|Overall Study|Other|5
5093594|NCT01998919|17587418|P2|Overall Study|Lost to Follow-up|0
5093595|NCT01998919|17587419|P1|Overall Study|Lost to Follow-up|2
5093596|NCT01998919|17587418|P2|Overall Study|Withdrawal by Subject|4
5093597|NCT01998919|17587419|P1|Overall Study|Withdrawal by Subject|2
5093598|NCT01998919|17587418|P2|Overall Study|Disease progression|22
5093599|NCT01998919|17587419|P1|Overall Study|Disease progression|31
5093600|NCT01998919|17587418|P2|Overall Study|Adverse Event|5
5093601|NCT01998919|17587419|P1|Overall Study|Adverse Event|0
5093602|NCT01998919|17587418|P2|Overall Study|Death|2
5093603|NCT01998919|17587419|P1|Overall Study|Death|2
5093604|NCT01998906|17587440|P3|Overall Study|Other|4
5093605|NCT01998906|17587441|P2|Overall Study|Other|8
5093606|NCT01998906|17587442|P1|Overall Study|Other|3
5093607|NCT01998906|17587440|P3|Overall Study|Administrative/Other|3
5093608|NCT01998906|17587441|P2|Overall Study|Administrative/Other|1
5093609|NCT01998906|17587442|P1|Overall Study|Administrative/Other|2
5093610|NCT01998906|17587440|P3|Overall Study|Withdrawal by Subject|3
5093611|NCT01998906|17587441|P2|Overall Study|Withdrawal by Subject|4
5093612|NCT01998906|17587442|P1|Overall Study|Withdrawal by Subject|1
5093613|NCT01998906|17587440|P3|Overall Study|Violation of Selection Criteria|1
5093614|NCT01998906|17587441|P2|Overall Study|Violation of Selection Criteria|0
5093615|NCT01998906|17587442|P1|Overall Study|Violation of Selection Criteria|0
5093616|NCT01998906|17587440|P3|Overall Study|Failure to return|4
5093617|NCT01998906|17587441|P2|Overall Study|Failure to return|2
5093618|NCT01998906|17587442|P1|Overall Study|Failure to return|0
5093619|NCT01998906|17587440|P3|Overall Study|Lack of Efficacy|8
5093620|NCT01998906|17587441|P2|Overall Study|Lack of Efficacy|9
5093621|NCT01998906|17587442|P1|Overall Study|Lack of Efficacy|10
5093622|NCT01998906|17587440|P3|Overall Study|Death|17
5093623|NCT01998906|17587441|P2|Overall Study|Death|30
5093624|NCT01998906|17587442|P1|Overall Study|Death|21
5093625|NCT01998906|17587440|P3|Overall Study|Participants ongoing in follow-up|58
5093626|NCT01998906|17587441|P2|Overall Study|Participants ongoing in follow-up|60
5093627|NCT01998906|17587442|P1|Overall Study|Participants ongoing in follow-up|77
5093628|NCT01998893|17587486|P1|Overall Study|Transformation to high-grade lymphoma|1
5093629|NCT01998893|17587486|P1|Overall Study|Withdrawal by Subject|1
5093630|NCT01998893|17587486|P1|Overall Study|Protocol Violation|2
5093631|NCT01998893|17587486|P1|Overall Study|Physician Decision|2
5093632|NCT01998893|17587486|P1|Overall Study|Lost to Follow-up|8
5093633|NCT01998893|17587486|P1|Overall Study|Death|1
5093634|NCT01998893|17587486|P1|Overall Study|Adverse Event|2
5093635|NCT01998880|17587498|P2|Overall Study|Did Not Receive Treatment|2
5093636|NCT01998880|17587499|P1|Overall Study|Did Not Receive Treatment|3
5093637|NCT01998880|17587498|P2|Overall Study|Violation of Selection Criteria at Entry|1
5093638|NCT01998880|17587499|P1|Overall Study|Violation of Selection Criteria at Entry|0
5093639|NCT01998880|17587498|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5093640|NCT01998880|17587499|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
5093641|NCT01998880|17587498|P2|Overall Study|Administrative/Other|1
5093642|NCT01998880|17587499|P1|Overall Study|Administrative/Other|1
5093643|NCT01998880|17587498|P2|Overall Study|Insufficient Therapeutic Response|5
5093644|NCT01998880|17587499|P1|Overall Study|Insufficient Therapeutic Response|1
5093645|NCT01998880|17587498|P2|Overall Study|Death|6
5093646|NCT01998880|17587499|P1|Overall Study|Death|3
5093647|NCT01998880|17587498|P2|Overall Study|Withdrew Consent|1
5093648|NCT01998880|17587499|P1|Overall Study|Withdrew Consent|2
5093649|NCT01998880|17587498|P2|Overall Study|Disease Progression|8
5093650|NCT01998880|17587499|P1|Overall Study|Disease Progression|1
5093651|NCT01998880|17587498|P2|Overall Study|Adverse Events or Intercurrent Illness|16
5093652|NCT01998880|17587499|P1|Overall Study|Adverse Events or Intercurrent Illness|16
5093653|NCT01998737|17587531|P2|Overall Study|Corrupted database|0
5093654|NCT01998737|17587532|P1|Overall Study|Corrupted database|23
5093655|NCT01998633|17587544|P1|Overall Study|Death|1
5093656|NCT01998581|17587562|P2|Overall Study|Randomized but withdrew before treatment|0
5093657|NCT01998581|17587563|P1|Overall Study|Randomized but withdrew before treatment|1
5093658|NCT01998581|17587562|P2|Overall Study|Other reasons|2
5093659|NCT01998581|17587563|P1|Overall Study|Other reasons|3
5093660|NCT01998581|17587562|P2|Overall Study|Adverse Event|1
5093661|NCT01998581|17587563|P1|Overall Study|Adverse Event|1
5093662|NCT01998581|17587562|P2|Overall Study|Lost to Follow-up|4
5093663|NCT01998581|17587563|P1|Overall Study|Lost to Follow-up|12
5093664|NCT01998581|17587562|P2|Overall Study|Withdrawal by Subject|1
5093665|NCT01998581|17587563|P1|Overall Study|Withdrawal by Subject|8
5093666|NCT01998581|17587562|P2|Overall Study|Protocol Violation|0
5093667|NCT01998581|17587563|P1|Overall Study|Protocol Violation|1
5093668|NCT01998581|17587562|P2|Overall Study|Refused repeat treatment|4
5093669|NCT01998581|17587563|P1|Overall Study|Refused repeat treatment|20
5093670|NCT01998477|17587576|P2|Overall Study|Withdrawal by Subject|0
5093671|NCT01998477|17587577|P1|Overall Study|Withdrawal by Subject|6
5093672|NCT01998477|17587576|P2|Overall Study|Lost to Follow-up|5
5093673|NCT01998477|17587577|P1|Overall Study|Lost to Follow-up|4
5093674|NCT01998399|17587623|P2|Overall Study|Withdrawal by Subject|1
5093675|NCT01998399|17587624|P1|Overall Study|Withdrawal by Subject|0
5093676|NCT01998399|17587623|P2|Overall Study|Study stopped before dosing completed|3
5093677|NCT01998399|17587624|P1|Overall Study|Study stopped before dosing completed|3
5093678|NCT01998399|17587623|P2|Overall Study|Death|2
5093679|NCT01998399|17587624|P1|Overall Study|Death|4
5093680|NCT01998399|17587623|P2|Overall Study|Lost to Follow-up|3
5093681|NCT01998399|17587624|P1|Overall Study|Lost to Follow-up|1
5093682|NCT01998243|17587679|P2|Overall Study|Withdrawal by Subject|4
5093683|NCT01998243|17587680|P1|Overall Study|Withdrawal by Subject|3
5093684|NCT01998243|17587679|P2|Overall Study|Protocol Violation|2
5093685|NCT01998243|17587680|P1|Overall Study|Protocol Violation|5
5093686|NCT01998243|17587679|P2|Overall Study|Pregnancy|1
5093687|NCT01998243|17587680|P1|Overall Study|Pregnancy|0
5093688|NCT01997892|17587703|P1|Overall Study|Study completion data not recorded|35
5093689|NCT01997892|17587703|P1|Overall Study|Other|3
5093690|NCT01997892|17587703|P1|Overall Study|Renal transplant|8
5093691|NCT01997892|17587703|P1|Overall Study|Death|14
5093692|NCT01997892|17587703|P1|Overall Study|Lost to Follow-up|6
5093693|NCT01997892|17587703|P1|Overall Study|Physician Decision|2
5093694|NCT01997333|17587877|P2|Survival Follow up|Various|2
5093695|NCT01997333|17587878|P1|Survival Follow up|Various|1
5093696|NCT01997333|17587877|P2|Survival Follow up|Lost to Follow-up|6
5093697|NCT01997333|17587878|P1|Survival Follow up|Lost to Follow-up|0
5093698|NCT01997333|17587877|P2|Survival Follow up|Withdrawal by Subject|6
5093699|NCT01997333|17587878|P1|Survival Follow up|Withdrawal by Subject|15
5093700|NCT01997333|17587877|P2|Randomization and Treatment|Did not receive treatment|5
5093701|NCT01997333|17587878|P1|Randomization and Treatment|Did not receive treatment|17
5093702|NCT01997333|17587877|P2|Randomization and Treatment|Withdrawal by Subject|3
5093703|NCT01997333|17587878|P1|Randomization and Treatment|Withdrawal by Subject|6
5093704|NCT01997333|17587877|P2|Randomization and Treatment|Physician Decision|4
5093705|NCT01997333|17587878|P1|Randomization and Treatment|Physician Decision|0
5093706|NCT01997333|17587877|P2|Randomization and Treatment|Adverse Event|32
5093707|NCT01997333|17587878|P1|Randomization and Treatment|Adverse Event|10
5093708|NCT01997333|17587877|P2|Randomization and Treatment|Disease Progression|159
5093709|NCT01997333|17587878|P1|Randomization and Treatment|Disease Progression|70
5093710|NCT01997281|17587895|P2|Overall Study|Withdrawal by Subject|0
5093711|NCT01997281|17587896|P1|Overall Study|Withdrawal by Subject|1
5093712|NCT01996982|17587922|P1|Overall Study|PI/team left institution|7
5093713|NCT01996904|17587938|P2|Overall Study|Lost to Follow-up|27
5093714|NCT01996904|17587939|P1|Overall Study|Lost to Follow-up|38
5093715|NCT01996826|17588024|P2|Overall Study|Physician Decision|1
5093716|NCT01996826|17588025|P1|Overall Study|Physician Decision|1
5093717|NCT01996826|17588024|P2|Overall Study|Lost to Follow-up|2
5093718|NCT01996826|17588025|P1|Overall Study|Lost to Follow-up|6
5093719|NCT01996748|17588048|P2|Overall Study|Lost to Follow-up|1
5093720|NCT01996748|17588049|P1|Overall Study|Lost to Follow-up|4
5093721|NCT01996748|17588048|P2|Overall Study|Withdrawal by Subject|1
5093722|NCT01996748|17588049|P1|Overall Study|Withdrawal by Subject|0
5093723|NCT01996748|17588048|P2|Overall Study|Adverse Event|4
5093724|NCT01996748|17588049|P1|Overall Study|Adverse Event|1
5093725|NCT01996748|17588048|P2|Overall Study|Physician Decision|0
5093726|NCT01996748|17588049|P1|Overall Study|Physician Decision|2
5093727|NCT01996748|17588048|P2|Overall Study|Personal reason|0
5093728|NCT01996748|17588049|P1|Overall Study|Personal reason|1
5093729|NCT01996709|17588063|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
5093730|NCT01996709|17588064|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5093731|NCT01996709|17588063|P2|Overall Study|Subject Non-Compliant|0
5093732|NCT01996709|17588064|P1|Overall Study|Subject Non-Compliant|1
5093733|NCT01996709|17588063|P2|Overall Study|Lost to Follow-up|0
5093734|NCT01996709|17588064|P1|Overall Study|Lost to Follow-up|3
5093735|NCT01996709|17588063|P2|Overall Study|Withdrawal by Subject|0
5093736|NCT01996709|17588064|P1|Overall Study|Withdrawal by Subject|1
5093737|NCT01996592|17588111|P1|Overall Study|change in mode of delivery|4
5093738|NCT01996592|17588111|P1|Overall Study|Withdrawal by Subject|5
5093739|NCT01996592|17588111|P1|Overall Study|change in surgical date|4
5093740|NCT01996592|17588111|P1|Overall Study|no response to text/no diary entry|32
5093741|NCT01996332|17588147|P1|Overall Study|Lost to Follow-up|34
5093742|NCT01996332|17588147|P1|Overall Study|Physician Decision|17
5093743|NCT01996332|17588147|P1|Overall Study|Clinical Deterioration|28
5093744|NCT01996332|17588147|P1|Overall Study|Other|20
5093745|NCT01996332|17588147|P1|Overall Study|Withdrawal by Subject|71
5093746|NCT01996332|17588147|P1|Overall Study|Protocol Violation|9
5093747|NCT01996332|17588147|P1|Overall Study|Death|264
5093748|NCT01996332|17588147|P1|Overall Study|Lack of Efficacy|1245
5093749|NCT01996332|17588147|P1|Overall Study|Adverse Event|117
5093750|NCT01996319|17588155|P2|Overall Study|Adverse Event|2
5093751|NCT01996319|17588156|P1|Overall Study|Adverse Event|2
5093752|NCT01996319|17588155|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
5093753|NCT01996319|17588156|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
5093754|NCT01996319|17588155|P2|Overall Study|Protocol Violation|0
5093755|NCT01996319|17588156|P1|Overall Study|Protocol Violation|1
5093756|NCT01996254|17588178|P3|Overall Study|Lost to Follow-up|4
5093757|NCT01996254|17588179|P2|Overall Study|Lost to Follow-up|0
5093758|NCT01996254|17588180|P1|Overall Study|Lost to Follow-up|1
5093759|NCT01996254|17588178|P3|Overall Study|Withdrawal by Subject|4
5093760|NCT01996254|17588179|P2|Overall Study|Withdrawal by Subject|3
5093761|NCT01996254|17588180|P1|Overall Study|Withdrawal by Subject|0
5093762|NCT01996254|17588178|P3|Overall Study|Change in Eligibility|0
5093763|NCT01996254|17588179|P2|Overall Study|Change in Eligibility|2
5093764|NCT01996254|17588180|P1|Overall Study|Change in Eligibility|0
5093765|NCT01996241|17588208|P2|Overall Study|Lost to Follow-up|235
5093766|NCT01996241|17588209|P1|Overall Study|Lost to Follow-up|252
5093767|NCT01996033|17588225|P1|Overall Study|Lost to Follow-up|3
5093768|NCT01996033|17588225|P1|Overall Study|Withdrawal by Subject|4
5093769|NCT01996033|17588225|P1|Overall Study|Physician Decision|1
5093770|NCT01996033|17588225|P1|Overall Study|Death|1
5093771|NCT01995838|17588245|P7|Overall Study|Other|2
5093772|NCT01995838|17588246|P6|Overall Study|Other|1
5093773|NCT01995838|17588247|P5|Overall Study|Other|1
5093774|NCT01995838|17588248|P4|Overall Study|Other|2
5093775|NCT01995838|17588249|P3|Overall Study|Other|0
5093776|NCT01995838|17588250|P2|Overall Study|Other|1
5093777|NCT01995838|17588251|P1|Overall Study|Other|3
5093778|NCT01995838|17588245|P7|Overall Study|Withdrawal by Subject|0
5093779|NCT01995838|17588246|P6|Overall Study|Withdrawal by Subject|0
5093780|NCT01995838|17588247|P5|Overall Study|Withdrawal by Subject|1
5093781|NCT01995838|17588248|P4|Overall Study|Withdrawal by Subject|0
5093782|NCT01995838|17588249|P3|Overall Study|Withdrawal by Subject|0
5093783|NCT01995838|17588250|P2|Overall Study|Withdrawal by Subject|0
5093784|NCT01995838|17588251|P1|Overall Study|Withdrawal by Subject|0
5093785|NCT01995838|17588245|P7|Overall Study|Adverse Event|1
5093786|NCT01995838|17588246|P6|Overall Study|Adverse Event|0
5093787|NCT01995838|17588247|P5|Overall Study|Adverse Event|0
5093788|NCT01995838|17588248|P4|Overall Study|Adverse Event|0
5093789|NCT01995838|17588249|P3|Overall Study|Adverse Event|0
5093790|NCT01995838|17588250|P2|Overall Study|Adverse Event|0
5093791|NCT01995838|17588251|P1|Overall Study|Adverse Event|0
5093792|NCT01995838|17588245|P7|Overall Study|Participant choice|1
5093793|NCT01995838|17588246|P6|Overall Study|Participant choice|1
5093794|NCT01995838|17588247|P5|Overall Study|Participant choice|0
5093795|NCT01995838|17588248|P4|Overall Study|Participant choice|0
5093796|NCT01995838|17588249|P3|Overall Study|Participant choice|0
5093797|NCT01995838|17588250|P2|Overall Study|Participant choice|0
5093798|NCT01995838|17588251|P1|Overall Study|Participant choice|2
5093799|NCT01995838|17588245|P7|Overall Study|Lost to Follow-up|1
5093800|NCT01995838|17588246|P6|Overall Study|Lost to Follow-up|0
5093801|NCT01995838|17588247|P5|Overall Study|Lost to Follow-up|0
5093802|NCT01995838|17588248|P4|Overall Study|Lost to Follow-up|0
5093803|NCT01995838|17588249|P3|Overall Study|Lost to Follow-up|0
5093804|NCT01995838|17588250|P2|Overall Study|Lost to Follow-up|1
5093805|NCT01995838|17588251|P1|Overall Study|Lost to Follow-up|0
5093806|NCT01995552|17588350|P1|Overall Study|Death|1
5093807|NCT01995552|17588350|P1|Overall Study|Lack of Efficacy|15
5093808|NCT01995552|17588350|P1|Overall Study|Protocol Violation|1
5093809|NCT01995539|17588356|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
5093810|NCT01995539|17588356|P1|Overall Study|Lost to Follow-up|5
5093811|NCT01995539|17588356|P1|Overall Study|Withdrawal by Subject|11
5093812|NCT01995539|17588356|P1|Overall Study|Withdrawal by Investigator|15
5093813|NCT01995539|17588356|P1|Overall Study|Screening Failure|1
5093814|NCT01995526|17588361|P1|Overall Study|Physician Decision|1
5093815|NCT01995513|17588369|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
5093816|NCT01995513|17588370|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
5093817|NCT01995513|17588371|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5093818|NCT01995513|17588369|P3|Double Blind Treatment Period|Disease Progression|93
5093819|NCT01995513|17588370|P2|Double Blind Treatment Period|Disease Progression|82
5093820|NCT01995513|17588371|P1|Double Blind Treatment Period|Disease Progression|0
5093821|NCT01995513|17588369|P3|Double Blind Treatment Period|Death|1
5093822|NCT01995513|17588370|P2|Double Blind Treatment Period|Death|0
5093823|NCT01995513|17588371|P1|Double Blind Treatment Period|Death|0
5093824|NCT01995513|17588369|P3|Double Blind Treatment Period|Withdrawal by Subject|6
5093825|NCT01995513|17588370|P2|Double Blind Treatment Period|Withdrawal by Subject|4
5093826|NCT01995513|17588371|P1|Double Blind Treatment Period|Withdrawal by Subject|0
5093827|NCT01995513|17588369|P3|Double Blind Treatment Period|Other|2
5093828|NCT01995513|17588370|P2|Double Blind Treatment Period|Other|1
5093829|NCT01995513|17588371|P1|Double Blind Treatment Period|Other|0
5093830|NCT01995513|17588369|P3|Double Blind Treatment Period|Adverse Event|5
5093831|NCT01995513|17588370|P2|Double Blind Treatment Period|Adverse Event|12
5093832|NCT01995513|17588371|P1|Double Blind Treatment Period|Adverse Event|0
5093833|NCT01995513|17588369|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5093834|NCT01995513|17588370|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5093835|NCT01995513|17588371|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
5093836|NCT01995513|17588369|P3|Open Label Treatment Period|Death|0
5093837|NCT01995513|17588370|P2|Open Label Treatment Period|Death|0
5093838|NCT01995513|17588371|P1|Open Label Treatment Period|Death|8
5093839|NCT01995513|17588369|P3|Open Label Treatment Period|Adverse Event|0
5093840|NCT01995513|17588370|P2|Open Label Treatment Period|Adverse Event|0
5093841|NCT01995513|17588371|P1|Open Label Treatment Period|Adverse Event|35
5093842|NCT01995513|17588369|P3|Open Label Treatment Period|No PSA response at week 13|0
5093843|NCT01995513|17588370|P2|Open Label Treatment Period|No PSA response at week 13|0
5093844|NCT01995513|17588371|P1|Open Label Treatment Period|No PSA response at week 13|43
5093845|NCT01995513|17588369|P3|Open Label Treatment Period|Disease Progression|0
5093846|NCT01995513|17588370|P2|Open Label Treatment Period|Disease Progression|0
5093847|NCT01995513|17588371|P1|Open Label Treatment Period|Disease Progression|64
5093848|NCT01995513|17588369|P3|Open Label Treatment Period|Protocol Violation|0
5093849|NCT01995513|17588370|P2|Open Label Treatment Period|Protocol Violation|0
5093850|NCT01995513|17588371|P1|Open Label Treatment Period|Protocol Violation|1
5093851|NCT01995513|17588369|P3|Open Label Treatment Period|Withdrawal by Subject|0
5093852|NCT01995513|17588370|P2|Open Label Treatment Period|Withdrawal by Subject|0
5093853|NCT01995513|17588371|P1|Open Label Treatment Period|Withdrawal by Subject|14
5093854|NCT01995513|17588369|P3|Open Label Treatment Period|Other|0
5093855|NCT01995513|17588370|P2|Open Label Treatment Period|Other|0
5093856|NCT01995513|17588371|P1|Open Label Treatment Period|Other|9
5093857|NCT01995461|17588414|P1|Overall Study|Withdrawal by Subject|2
5093858|NCT01995461|17588414|P1|Overall Study|Lost to Follow-up|2
5093859|NCT01995461|17588414|P1|Overall Study|Death|1
5093860|NCT01995357|17588420|P6|Period 5|Adverse Event|0
5093861|NCT01995357|17588421|P5|Period 5|Adverse Event|0
5093862|NCT01995357|17588422|P4|Period 5|Adverse Event|0
5093863|NCT01995357|17588423|P3|Period 5|Adverse Event|1
5093864|NCT01995357|17588424|P2|Period 5|Adverse Event|0
5093865|NCT01995357|17588425|P1|Period 5|Adverse Event|1
5093866|NCT01995357|17588420|P6|Period 5|Lack of Efficacy|0
5093867|NCT01995357|17588421|P5|Period 5|Lack of Efficacy|0
5093868|NCT01995357|17588422|P4|Period 5|Lack of Efficacy|0
5093869|NCT01995357|17588423|P3|Period 5|Lack of Efficacy|0
5093870|NCT01995357|17588424|P2|Period 5|Lack of Efficacy|0
5093871|NCT01995357|17588425|P1|Period 5|Lack of Efficacy|1
5093872|NCT01995266|17588441|P1|Overall Study|Adverse Event|2
5093873|NCT01995266|17588441|P1|Overall Study|Lack of Efficacy|6
5093874|NCT01995266|17588441|P1|Overall Study|Death|1
5093875|NCT01995201|17588456|P7|From Week 24 Until Week 48|Protocol Violation|0
5093876|NCT01995201|17588457|P6|From Week 24 Until Week 48|Protocol Violation|0
5093877|NCT01995201|17588458|P5|From Week 24 Until Week 48|Protocol Violation|2
5093878|NCT01995201|17588459|P4|From Week 24 Until Week 48|Protocol Violation|0
5093879|NCT01995201|17588460|P3|From Week 24 Until Week 48|Protocol Violation|1
5093880|NCT01995201|17588461|P2|From Week 24 Until Week 48|Protocol Violation|0
5093881|NCT01995201|17588462|P1|From Week 24 Until Week 48|Protocol Violation|0
5093882|NCT01995201|17588456|P7|From Week 24 Until Week 48|Physician Decision|0
5093883|NCT01995201|17588457|P6|From Week 24 Until Week 48|Physician Decision|0
5093884|NCT01995201|17588458|P5|From Week 24 Until Week 48|Physician Decision|1
5093885|NCT01995201|17588459|P4|From Week 24 Until Week 48|Physician Decision|0
5093886|NCT01995201|17588460|P3|From Week 24 Until Week 48|Physician Decision|0
5093887|NCT01995201|17588461|P2|From Week 24 Until Week 48|Physician Decision|0
5093888|NCT01995201|17588462|P1|From Week 24 Until Week 48|Physician Decision|0
5093889|NCT01995201|17588456|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
5093890|NCT01995201|17588457|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
5093891|NCT01995201|17588458|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
5093892|NCT01995201|17588459|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
5093893|NCT01995201|17588460|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
5093894|NCT01995201|17588461|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
5093895|NCT01995201|17588462|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
5093896|NCT01995201|17588456|P7|From Week 24 Until Week 48|Lost to Follow-up|0
5093897|NCT01995201|17588457|P6|From Week 24 Until Week 48|Lost to Follow-up|1
5093898|NCT01995201|17588458|P5|From Week 24 Until Week 48|Lost to Follow-up|1
5093899|NCT01995201|17588459|P4|From Week 24 Until Week 48|Lost to Follow-up|0
5093900|NCT01995201|17588460|P3|From Week 24 Until Week 48|Lost to Follow-up|0
5093901|NCT01995201|17588461|P2|From Week 24 Until Week 48|Lost to Follow-up|0
5093902|NCT01995201|17588462|P1|From Week 24 Until Week 48|Lost to Follow-up|0
5093903|NCT01995201|17588456|P7|From Week 24 Until Week 48|Lack of Efficacy|1
5093904|NCT01995201|17588457|P6|From Week 24 Until Week 48|Lack of Efficacy|2
5093905|NCT01995201|17588458|P5|From Week 24 Until Week 48|Lack of Efficacy|0
5093906|NCT01995201|17588459|P4|From Week 24 Until Week 48|Lack of Efficacy|0
5093907|NCT01995201|17588460|P3|From Week 24 Until Week 48|Lack of Efficacy|1
5093908|NCT01995201|17588461|P2|From Week 24 Until Week 48|Lack of Efficacy|0
5093909|NCT01995201|17588462|P1|From Week 24 Until Week 48|Lack of Efficacy|0
5093910|NCT01995201|17588456|P7|From Week 24 Until Week 48|Death|0
5093911|NCT01995201|17588457|P6|From Week 24 Until Week 48|Death|2
5093912|NCT01995201|17588458|P5|From Week 24 Until Week 48|Death|0
5093913|NCT01995201|17588459|P4|From Week 24 Until Week 48|Death|0
5093914|NCT01995201|17588460|P3|From Week 24 Until Week 48|Death|0
5093915|NCT01995201|17588461|P2|From Week 24 Until Week 48|Death|0
5093916|NCT01995201|17588462|P1|From Week 24 Until Week 48|Death|0
5093917|NCT01995201|17588456|P7|From Week 24 Until Week 48|Adverse Event|1
5093918|NCT01995201|17588457|P6|From Week 24 Until Week 48|Adverse Event|3
5093919|NCT01995201|17588458|P5|From Week 24 Until Week 48|Adverse Event|1
5093920|NCT01995201|17588459|P4|From Week 24 Until Week 48|Adverse Event|1
5093921|NCT01995201|17588460|P3|From Week 24 Until Week 48|Adverse Event|2
5093922|NCT01995201|17588461|P2|From Week 24 Until Week 48|Adverse Event|0
5093923|NCT01995201|17588462|P1|From Week 24 Until Week 48|Adverse Event|0
5093924|NCT01995201|17588456|P7|From Baseline Until Week 24|Protocol Violation|0
5093925|NCT01995201|17588457|P6|From Baseline Until Week 24|Protocol Violation|0
5093926|NCT01995201|17588458|P5|From Baseline Until Week 24|Protocol Violation|0
5093927|NCT01995201|17588459|P4|From Baseline Until Week 24|Protocol Violation|0
5093928|NCT01995201|17588460|P3|From Baseline Until Week 24|Protocol Violation|0
5093929|NCT01995201|17588461|P2|From Baseline Until Week 24|Protocol Violation|9
5093930|NCT01995201|17588462|P1|From Baseline Until Week 24|Protocol Violation|0
5093931|NCT01995201|17588456|P7|From Baseline Until Week 24|Physician Decision|0
5093932|NCT01995201|17588457|P6|From Baseline Until Week 24|Physician Decision|0
5093933|NCT01995201|17588458|P5|From Baseline Until Week 24|Physician Decision|0
5093934|NCT01995201|17588459|P4|From Baseline Until Week 24|Physician Decision|0
5093935|NCT01995201|17588460|P3|From Baseline Until Week 24|Physician Decision|0
5093936|NCT01995201|17588461|P2|From Baseline Until Week 24|Physician Decision|2
5093937|NCT01995201|17588462|P1|From Baseline Until Week 24|Physician Decision|0
5093938|NCT01995201|17588456|P7|From Baseline Until Week 24|Withdrawal by Subject|0
5093939|NCT01995201|17588457|P6|From Baseline Until Week 24|Withdrawal by Subject|0
5093940|NCT01995201|17588458|P5|From Baseline Until Week 24|Withdrawal by Subject|0
5093941|NCT01995201|17588459|P4|From Baseline Until Week 24|Withdrawal by Subject|0
5093942|NCT01995201|17588460|P3|From Baseline Until Week 24|Withdrawal by Subject|0
5093943|NCT01995201|17588461|P2|From Baseline Until Week 24|Withdrawal by Subject|8
5093944|NCT01995201|17588462|P1|From Baseline Until Week 24|Withdrawal by Subject|2
5093945|NCT01995201|17588456|P7|From Baseline Until Week 24|Lost to Follow-up|0
5093946|NCT01995201|17588457|P6|From Baseline Until Week 24|Lost to Follow-up|0
5093947|NCT01995201|17588458|P5|From Baseline Until Week 24|Lost to Follow-up|0
5093948|NCT01995201|17588459|P4|From Baseline Until Week 24|Lost to Follow-up|0
5093949|NCT01995201|17588460|P3|From Baseline Until Week 24|Lost to Follow-up|0
5093950|NCT01995201|17588461|P2|From Baseline Until Week 24|Lost to Follow-up|3
5093951|NCT01995201|17588462|P1|From Baseline Until Week 24|Lost to Follow-up|2
5093952|NCT01995201|17588456|P7|From Baseline Until Week 24|Lack of Efficacy|0
5093953|NCT01995201|17588457|P6|From Baseline Until Week 24|Lack of Efficacy|0
5093954|NCT01995201|17588458|P5|From Baseline Until Week 24|Lack of Efficacy|0
5093955|NCT01995201|17588459|P4|From Baseline Until Week 24|Lack of Efficacy|0
5093956|NCT01995201|17588460|P3|From Baseline Until Week 24|Lack of Efficacy|0
5093957|NCT01995201|17588461|P2|From Baseline Until Week 24|Lack of Efficacy|5
5093958|NCT01995201|17588462|P1|From Baseline Until Week 24|Lack of Efficacy|2
5093959|NCT01995201|17588456|P7|From Baseline Until Week 24|Death|0
5093960|NCT01995201|17588457|P6|From Baseline Until Week 24|Death|0
5093961|NCT01995201|17588458|P5|From Baseline Until Week 24|Death|0
5093962|NCT01995201|17588459|P4|From Baseline Until Week 24|Death|0
5093963|NCT01995201|17588460|P3|From Baseline Until Week 24|Death|0
5093964|NCT01995201|17588461|P2|From Baseline Until Week 24|Death|1
5093965|NCT01995201|17588462|P1|From Baseline Until Week 24|Death|0
5093966|NCT01995201|17588456|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5093967|NCT01995201|17588457|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5093968|NCT01995201|17588458|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5093969|NCT01995201|17588459|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5093970|NCT01995201|17588460|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5093971|NCT01995201|17588461|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
5093972|NCT01995201|17588462|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5093973|NCT01995201|17588456|P7|From Baseline Until Week 24|Adverse Event|0
5093974|NCT01995201|17588457|P6|From Baseline Until Week 24|Adverse Event|0
5093975|NCT01995201|17588458|P5|From Baseline Until Week 24|Adverse Event|0
5093976|NCT01995201|17588459|P4|From Baseline Until Week 24|Adverse Event|0
5093977|NCT01995201|17588460|P3|From Baseline Until Week 24|Adverse Event|0
5093978|NCT01995201|17588461|P2|From Baseline Until Week 24|Adverse Event|15
5093979|NCT01995201|17588462|P1|From Baseline Until Week 24|Adverse Event|4
5093980|NCT01995175|17588571|P1|Overall Study|Migrated / moved from the study area|49
5093981|NCT01995175|17588571|P1|Overall Study|Other|67
5093982|NCT01995175|17588571|P1|Overall Study|Lost to Follow-up|102
5093983|NCT01995175|17588571|P1|Overall Study|Withdrawal by Subject|35
5093984|NCT01995136|17588586|P1|Overall Study|Change in residence|1
5093985|NCT01995071|17588615|P12|Overall Study|Incarcerated|0
5093986|NCT01995071|17588616|P11|Overall Study|Incarcerated|0
5093987|NCT01995071|17588617|P10|Overall Study|Incarcerated|0
5093988|NCT01995071|17588618|P9|Overall Study|Incarcerated|0
5093989|NCT01995071|17588619|P8|Overall Study|Incarcerated|1
5093990|NCT01995071|17588620|P7|Overall Study|Incarcerated|0
5093991|NCT01995071|17588621|P6|Overall Study|Incarcerated|0
5093992|NCT01995071|17588622|P5|Overall Study|Incarcerated|0
5093993|NCT01995071|17588623|P4|Overall Study|Incarcerated|0
5093994|NCT01995071|17588624|P3|Overall Study|Incarcerated|0
5093995|NCT01995071|17588625|P2|Overall Study|Incarcerated|0
5093996|NCT01995071|17588626|P1|Overall Study|Incarcerated|0
5093997|NCT01995071|17588615|P12|Overall Study|Lost to Follow-up|0
5093998|NCT01995071|17588616|P11|Overall Study|Lost to Follow-up|0
5093999|NCT01995071|17588617|P10|Overall Study|Lost to Follow-up|0
5094000|NCT01995071|17588618|P9|Overall Study|Lost to Follow-up|1
5094001|NCT01995071|17588619|P8|Overall Study|Lost to Follow-up|1
5094002|NCT01995071|17588620|P7|Overall Study|Lost to Follow-up|0
5094003|NCT01995071|17588621|P6|Overall Study|Lost to Follow-up|0
5094004|NCT01995071|17588622|P5|Overall Study|Lost to Follow-up|0
5094005|NCT01995071|17588623|P4|Overall Study|Lost to Follow-up|0
5094006|NCT01995071|17588624|P3|Overall Study|Lost to Follow-up|0
5094007|NCT01995071|17588625|P2|Overall Study|Lost to Follow-up|0
5094008|NCT01995071|17588626|P1|Overall Study|Lost to Follow-up|1
5094009|NCT01995071|17588615|P12|Overall Study|Moved|0
5094010|NCT01995071|17588616|P11|Overall Study|Moved|1
5094011|NCT01995071|17588617|P10|Overall Study|Moved|0
5094012|NCT01995071|17588618|P9|Overall Study|Moved|0
5094013|NCT01995071|17588619|P8|Overall Study|Moved|0
5094014|NCT01995071|17588620|P7|Overall Study|Moved|0
5094015|NCT01995071|17588621|P6|Overall Study|Moved|0
5094016|NCT01995071|17588622|P5|Overall Study|Moved|1
5094017|NCT01995071|17588623|P4|Overall Study|Moved|0
5094018|NCT01995071|17588624|P3|Overall Study|Moved|1
5094019|NCT01995071|17588625|P2|Overall Study|Moved|0
5094020|NCT01995071|17588626|P1|Overall Study|Moved|0
5094021|NCT01995071|17588615|P12|Overall Study|Adverse Event|0
5094022|NCT01995071|17588616|P11|Overall Study|Adverse Event|0
5094023|NCT01995071|17588617|P10|Overall Study|Adverse Event|0
5094024|NCT01995071|17588618|P9|Overall Study|Adverse Event|0
5094025|NCT01995071|17588619|P8|Overall Study|Adverse Event|0
5094026|NCT01995071|17588620|P7|Overall Study|Adverse Event|1
5094027|NCT01995071|17588621|P6|Overall Study|Adverse Event|0
5094028|NCT01995071|17588622|P5|Overall Study|Adverse Event|0
5094029|NCT01995071|17588623|P4|Overall Study|Adverse Event|0
5094030|NCT01995071|17588624|P3|Overall Study|Adverse Event|0
5094031|NCT01995071|17588625|P2|Overall Study|Adverse Event|0
5094032|NCT01995071|17588626|P1|Overall Study|Adverse Event|0
5094033|NCT01994954|17588763|P2|Overall Study|6 Month Follow-up Not Complete|4
5094034|NCT01994954|17588764|P1|Overall Study|6 Month Follow-up Not Complete|5
5094035|NCT01994954|17588763|P2|Overall Study|Lost to Follow-up|10
5094036|NCT01994954|17588764|P1|Overall Study|Lost to Follow-up|8
5094037|NCT01994954|17588763|P2|Overall Study|Physician Decision|2
5094038|NCT01994954|17588764|P1|Overall Study|Physician Decision|2
5094039|NCT01994954|17588763|P2|Overall Study|Withdrawal by Subject|14
5094040|NCT01994954|17588764|P1|Overall Study|Withdrawal by Subject|9
5094041|NCT01994954|17588763|P2|Overall Study|Death|0
5094042|NCT01994954|17588764|P1|Overall Study|Death|1
5094043|NCT01994902|17588782|P2|Test Period 2|Other|3
5094044|NCT01994902|17588783|P1|Test Period 2|Other|0
5094045|NCT01994902|17588782|P2|Test Period 2|Lack of Efficacy|1
5094046|NCT01994902|17588783|P1|Test Period 2|Lack of Efficacy|0
5094047|NCT01994902|17588782|P2|Test Period 2|Withdrawal by Subject|2
5094048|NCT01994902|17588783|P1|Test Period 2|Withdrawal by Subject|0
5094049|NCT01994902|17588782|P2|Test Period 1|bag too small|0
5094050|NCT01994902|17588783|P1|Test Period 1|bag too small|1
5094051|NCT01994902|17588782|P2|Test Period 1|Lack of Efficacy|1
5094052|NCT01994902|17588783|P1|Test Period 1|Lack of Efficacy|0
5094053|NCT01994902|17588782|P2|Test Period 1|Adverse Event|1
5094054|NCT01994902|17588783|P1|Test Period 1|Adverse Event|2
5094055|NCT01994902|17588782|P2|Test Period 1|device deficiency with adverse event|1
5094056|NCT01994902|17588783|P1|Test Period 1|device deficiency with adverse event|0
5094057|NCT01994902|17588782|P2|Test Period 1|Withdrawal by Subject|0
5094058|NCT01994902|17588783|P1|Test Period 1|Withdrawal by Subject|3
5094059|NCT01994889|17588792|P3|Overall Study|Death|38
5094060|NCT01994889|17588793|P2|Overall Study|Death|25
5094061|NCT01994889|17588794|P1|Overall Study|Death|14
5094062|NCT01994889|17588792|P3|Overall Study|Protocol Violation|1
5094063|NCT01994889|17588793|P2|Overall Study|Protocol Violation|1
5094064|NCT01994889|17588794|P1|Overall Study|Protocol Violation|0
5094065|NCT01994889|17588792|P3|Overall Study|Lost to Follow-up|0
5094066|NCT01994889|17588793|P2|Overall Study|Lost to Follow-up|1
5094067|NCT01994889|17588794|P1|Overall Study|Lost to Follow-up|0
5094068|NCT01994889|17588792|P3|Overall Study|No longer willing to participate|37
5094069|NCT01994889|17588793|P2|Overall Study|No longer willing to participate|17
5094070|NCT01994889|17588794|P1|Overall Study|No longer willing to participate|8
5094071|NCT01994889|17588792|P3|Overall Study|Organ Transplantation|5
5094072|NCT01994889|17588793|P2|Overall Study|Organ Transplantation|5
5094073|NCT01994889|17588794|P1|Overall Study|Organ Transplantation|1
5094074|NCT01994889|17588792|P3|Overall Study|Cardiac Device Implantation|0
5094075|NCT01994889|17588793|P2|Overall Study|Cardiac Device Implantation|2
5094076|NCT01994889|17588794|P1|Overall Study|Cardiac Device Implantation|0
5094077|NCT01994889|17588792|P3|Overall Study|Adverse Event|11
5094078|NCT01994889|17588793|P2|Overall Study|Adverse Event|12
5094079|NCT01994889|17588794|P1|Overall Study|Adverse Event|5
5094080|NCT01994876|17588813|P2|Test Period 2|Protocol Violation|1
5094081|NCT01994876|17588814|P1|Test Period 2|Protocol Violation|0
5094082|NCT01994876|17588813|P2|Test Period 2|Adverse Event|0
5094083|NCT01994876|17588814|P1|Test Period 2|Adverse Event|1
5094084|NCT01994876|17588813|P2|Test Period 1|Adverse Event|1
5094085|NCT01994876|17588814|P1|Test Period 1|Adverse Event|0
5094086|NCT01994876|17588813|P2|Test Period 1|Withdrawal by Subject|1
5094087|NCT01994876|17588814|P1|Test Period 1|Withdrawal by Subject|0
5094088|NCT01994863|17588822|P2|Period 2|Withdrawal by Subject|1
5094089|NCT01994863|17588823|P1|Period 2|Withdrawal by Subject|1
5094090|NCT01994863|17588822|P2|Period 2|Lack of Efficacy|2
5094091|NCT01994863|17588823|P1|Period 2|Lack of Efficacy|0
5094092|NCT01994863|17588822|P2|Period 2|Adverse Event|1
5094093|NCT01994863|17588823|P1|Period 2|Adverse Event|0
5094094|NCT01994863|17588822|P2|Period 1|Lack of Efficacy|0
5094095|NCT01994863|17588823|P1|Period 1|Lack of Efficacy|1
5094096|NCT01994863|17588822|P2|Period 1|Trial stopped by sponsor|3
5094097|NCT01994863|17588823|P1|Period 1|Trial stopped by sponsor|1
5094098|NCT01994863|17588822|P2|Period 1|Withdrawal by Subject|0
5094099|NCT01994863|17588823|P1|Period 1|Withdrawal by Subject|1
5094100|NCT01994863|17588822|P2|Period 1|Adverse Event|0
5094101|NCT01994863|17588823|P1|Period 1|Adverse Event|4
5094102|NCT01994850|17588829|P1|Overall Study|Withdrawal by Subject|1
5094103|NCT01994850|17588829|P1|Overall Study|Physician Decision|1
5094104|NCT01994837|17588834|P1|Overall Study|Removed from study due to no response|1
5094105|NCT01994837|17588834|P1|Overall Study|Proceeded to transplant|1
5094106|NCT01994837|17588834|P1|Overall Study|Chose palliative care|1
5094107|NCT01994837|17588834|P1|Overall Study|Adverse event not related to progression|1
5094108|NCT01994837|17588834|P1|Overall Study|Fatal progressive disease|2
5094109|NCT01994837|17588834|P1|Overall Study|Adv event related to progressive disease|3
5094110|NCT01994837|17588834|P1|Overall Study|Progressive disease per protocol|23
5094111|NCT01994720|17588891|P2|Overall Study|Withdrawal by Subject|56
5094112|NCT01994720|17588892|P1|Overall Study|Withdrawal by Subject|46
5094113|NCT01994629|17588934|P2|Overall Study|Lost to Follow-up|3
5094114|NCT01994629|17588935|P1|Overall Study|Lost to Follow-up|0
5094115|NCT01994629|17588934|P2|Overall Study|Withdrawal by Subject|0
5094116|NCT01994629|17588935|P1|Overall Study|Withdrawal by Subject|1
5094117|NCT01994590|17588959|P1|Overall Study|Trial Terminated|1
5094118|NCT01994590|17588959|P1|Overall Study|Adverse Event|1
5094119|NCT01994395|17588987|P2|Overall Study|Withdrawal by Subject|2
5094120|NCT01994395|17588988|P1|Overall Study|Withdrawal by Subject|1
5094121|NCT01994291|17589013|P3|Overall Study|Other|0
5094122|NCT01994291|17589014|P2|Overall Study|Other|2
5094123|NCT01994291|17589015|P1|Overall Study|Other|1
5094124|NCT01994291|17589013|P3|Overall Study|Withdrawal by Subject|5
5094125|NCT01994291|17589014|P2|Overall Study|Withdrawal by Subject|3
5094126|NCT01994291|17589015|P1|Overall Study|Withdrawal by Subject|6
5094127|NCT01994291|17589013|P3|Overall Study|Protocol Violation|0
5094128|NCT01994291|17589014|P2|Overall Study|Protocol Violation|0
5094129|NCT01994291|17589015|P1|Overall Study|Protocol Violation|1
5094130|NCT01994291|17589013|P3|Overall Study|Medication error without associated AE|1
5094131|NCT01994291|17589014|P2|Overall Study|Medication error without associated AE|0
5094132|NCT01994291|17589015|P1|Overall Study|Medication error without associated AE|1
5094133|NCT01994291|17589013|P3|Overall Study|Does not meet entrance criteria|0
5094134|NCT01994291|17589014|P2|Overall Study|Does not meet entrance criteria|0
5094135|NCT01994291|17589015|P1|Overall Study|Does not meet entrance criteria|1
5094136|NCT01994291|17589013|P3|Overall Study|Lost to Follow-up|0
5094137|NCT01994291|17589014|P2|Overall Study|Lost to Follow-up|1
5094138|NCT01994291|17589015|P1|Overall Study|Lost to Follow-up|1
5094139|NCT01994291|17589013|P3|Overall Study|Adverse Event|3
5094140|NCT01994291|17589014|P2|Overall Study|Adverse Event|1
5094141|NCT01994291|17589015|P1|Overall Study|Adverse Event|4
5094142|NCT01994226|17589071|P2|Overall Study|Early Cessation of treatment|11
5094143|NCT01994226|17589072|P1|Overall Study|Early Cessation of treatment|6
5094144|NCT01994226|17589071|P2|Overall Study|Protocol Violation|10
5094145|NCT01994226|17589072|P1|Overall Study|Protocol Violation|13
5094146|NCT01993940|17589098|P2|Overall Study|Other - Miscellaneous|1
5094147|NCT01993940|17589099|P1|Overall Study|Other - Miscellaneous|1
5094148|NCT01993940|17589098|P2|Overall Study|Death|0
5094149|NCT01993940|17589099|P1|Overall Study|Death|1
5094150|NCT01993940|17589098|P2|Overall Study|Protocol Violation|8
5094151|NCT01993940|17589099|P1|Overall Study|Protocol Violation|5
5094152|NCT01993940|17589098|P2|Overall Study|Lost to Follow-up|5
5094153|NCT01993940|17589099|P1|Overall Study|Lost to Follow-up|2
5094154|NCT01993940|17589098|P2|Overall Study|Withdrawal by Subject|19
5094155|NCT01993940|17589099|P1|Overall Study|Withdrawal by Subject|15
5094156|NCT01993940|17589098|P2|Overall Study|Adverse Event|11
5094157|NCT01993940|17589099|P1|Overall Study|Adverse Event|16
5094158|NCT01993927|17589113|P1|Overall Study|Protocol Violation|11
5094159|NCT01993927|17589113|P1|Overall Study|Case Report Forms Uncollected|18
5094160|NCT01993888|17589121|P2|Overall Study|Withdrawal by Subject|1
5094161|NCT01993888|17589122|P1|Overall Study|Withdrawal by Subject|0
5094162|NCT01993888|17589121|P2|Overall Study|Lost to Follow-up|1
5094163|NCT01993888|17589122|P1|Overall Study|Lost to Follow-up|1
5094164|NCT01993888|17589121|P2|Overall Study|Death|1
5094165|NCT01993888|17589122|P1|Overall Study|Death|1
5094166|NCT01993836|17589171|P3|Overall Study|Withdrawal by Subject|5
5094167|NCT01993836|17589172|P2|Overall Study|Withdrawal by Subject|10
5094168|NCT01993836|17589173|P1|Overall Study|Withdrawal by Subject|12
5094169|NCT01993836|17589171|P3|Overall Study|Death|0
5094170|NCT01993836|17589172|P2|Overall Study|Death|2
5094171|NCT01993836|17589173|P1|Overall Study|Death|0
5094172|NCT01993836|17589171|P3|Overall Study|Physician Decision|0
5094173|NCT01993836|17589172|P2|Overall Study|Physician Decision|1
5094174|NCT01993836|17589173|P1|Overall Study|Physician Decision|2
5094175|NCT01993836|17589171|P3|Overall Study|Surgery Cancelled|0
5094176|NCT01993836|17589172|P2|Overall Study|Surgery Cancelled|0
5094177|NCT01993836|17589173|P1|Overall Study|Surgery Cancelled|3
5094178|NCT01993823|17589189|P2|Overall Study|Lost to Follow-up|4
5094179|NCT01993823|17589190|P1|Overall Study|Lost to Follow-up|1
5094180|NCT01993823|17589189|P2|Overall Study|Protocol Violation|1
5094181|NCT01993823|17589190|P1|Overall Study|Protocol Violation|0
5094182|NCT01993823|17589189|P2|Overall Study|Requested by the patient|11
5094183|NCT01993823|17589190|P1|Overall Study|Requested by the patient|6
5094184|NCT01993667|17589200|P2|Overall Study|Lost to Follow-up|2
5094185|NCT01993667|17589201|P1|Overall Study|Lost to Follow-up|2
5094186|NCT01993667|17589200|P2|Overall Study|Insufficient altitude reached|1
5094187|NCT01993667|17589201|P1|Overall Study|Insufficient altitude reached|3
5094188|NCT01993667|17589200|P2|Overall Study|Insufficient data to analyze|16
5094189|NCT01993667|17589201|P1|Overall Study|Insufficient data to analyze|16
5094190|NCT01993615|17589211|P2|Overall Study|Death|0
5094191|NCT01993615|17589212|P1|Overall Study|Death|1
5094192|NCT01993186|17589231|P2|Open-Label Extension Period|Subject Non-Compliance|0
5094193|NCT01993186|17589232|P1|Open-Label Extension Period|Subject Non-Compliance|1
5094194|NCT01993186|17589231|P2|Open-Label Extension Period|Withdrawal by Subject|5
5094195|NCT01993186|17589232|P1|Open-Label Extension Period|Withdrawal by Subject|4
5094196|NCT01993186|17589231|P2|Open-Label Extension Period|Principal Investigator Decision|0
5094197|NCT01993186|17589232|P1|Open-Label Extension Period|Principal Investigator Decision|1
5094198|NCT01993186|17589231|P2|Open-Label Extension Period|Adverse Event|0
5094199|NCT01993186|17589232|P1|Open-Label Extension Period|Adverse Event|1
5094200|NCT01993186|17589231|P2|Open-Label Extension Period|Other, Not Specified|1
5094201|NCT01993186|17589232|P1|Open-Label Extension Period|Other, Not Specified|0
5094202|NCT01993186|17589231|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
5094203|NCT01993186|17589232|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
5094204|NCT01993186|17589231|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
5094205|NCT01993186|17589232|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|1
5094206|NCT01993030|17589309|P2|Overall Study|Adverse Event|4
5094207|NCT01993030|17589310|P1|Overall Study|Adverse Event|0
5094208|NCT01993017|17589327|P3|Overall Study|Ineligible after randomization|5
5094209|NCT01993017|17589328|P2|Overall Study|Ineligible after randomization|5
5094210|NCT01993017|17589329|P1|Overall Study|Ineligible after randomization|4
5094211|NCT01993017|17589327|P3|Overall Study|Other reasons|7
5094212|NCT01993017|17589328|P2|Overall Study|Other reasons|11
5094213|NCT01993017|17589329|P1|Overall Study|Other reasons|17
5094214|NCT01993017|17589327|P3|Overall Study|Dropped out|11
5094215|NCT01993017|17589328|P2|Overall Study|Dropped out|6
5094216|NCT01993017|17589329|P1|Overall Study|Dropped out|19
5094217|NCT01993017|17589327|P3|Overall Study|Could not be contacted|38
5094218|NCT01993017|17589328|P2|Overall Study|Could not be contacted|42
5094219|NCT01993017|17589329|P1|Overall Study|Could not be contacted|43
5094220|NCT01993017|17589327|P3|Overall Study|Death|18
5094221|NCT01993017|17589328|P2|Overall Study|Death|26
5094222|NCT01993017|17589329|P1|Overall Study|Death|23
5094223|NCT01992757|17589370|P1|Overall Study|2 patients excluded due to FFP given.|2
5094224|NCT01992653|17589383|P8|Overall Study|Disease Progression|0
5094225|NCT01992653|17589384|P7|Overall Study|Disease Progression|4
5094226|NCT01992653|17589385|P6|Overall Study|Disease Progression|0
5094227|NCT01992653|17589386|P5|Overall Study|Disease Progression|0
5094228|NCT01992653|17589387|P4|Overall Study|Disease Progression|0
5094229|NCT01992653|17589388|P3|Overall Study|Disease Progression|0
5094230|NCT01992653|17589389|P2|Overall Study|Disease Progression|0
5094231|NCT01992653|17589390|P1|Overall Study|Disease Progression|0
5094232|NCT01992653|17589383|P8|Overall Study|Study Completed|1
5094233|NCT01992653|17589384|P7|Overall Study|Study Completed|0
5094234|NCT01992653|17589385|P6|Overall Study|Study Completed|0
5094235|NCT01992653|17589386|P5|Overall Study|Study Completed|0
5094236|NCT01992653|17589387|P4|Overall Study|Study Completed|0
5094237|NCT01992653|17589388|P3|Overall Study|Study Completed|0
5094238|NCT01992653|17589389|P2|Overall Study|Study Completed|0
5094239|NCT01992653|17589390|P1|Overall Study|Study Completed|0
5094240|NCT01992653|17589383|P8|Overall Study|Lost to Follow-up|1
5094241|NCT01992653|17589384|P7|Overall Study|Lost to Follow-up|0
5094242|NCT01992653|17589385|P6|Overall Study|Lost to Follow-up|0
5094243|NCT01992653|17589386|P5|Overall Study|Lost to Follow-up|0
5094244|NCT01992653|17589387|P4|Overall Study|Lost to Follow-up|0
5094245|NCT01992653|17589388|P3|Overall Study|Lost to Follow-up|0
5094246|NCT01992653|17589389|P2|Overall Study|Lost to Follow-up|0
5094247|NCT01992653|17589390|P1|Overall Study|Lost to Follow-up|0
5094248|NCT01992653|17589383|P8|Overall Study|Death|2
5094249|NCT01992653|17589384|P7|Overall Study|Death|4
5094250|NCT01992653|17589385|P6|Overall Study|Death|0
5094251|NCT01992653|17589386|P5|Overall Study|Death|1
5094252|NCT01992653|17589387|P4|Overall Study|Death|0
5094253|NCT01992653|17589388|P3|Overall Study|Death|1
5094254|NCT01992653|17589389|P2|Overall Study|Death|0
5094255|NCT01992653|17589390|P1|Overall Study|Death|0
5094256|NCT01992549|17589616|P1|Overall Study|Product Switch to Extend Half Life|1
5094257|NCT01992549|17589616|P1|Overall Study|Serious Adverse Event|1
5094258|NCT01992549|17589616|P1|Overall Study|Lost to Follow-up|2
5094259|NCT01992536|17589636|P10|Overall Study|Withdrawal by Subject|0
5094260|NCT01992536|17589637|P9|Overall Study|Withdrawal by Subject|0
5094261|NCT01992536|17589638|P8|Overall Study|Withdrawal by Subject|0
5094262|NCT01992536|17589639|P7|Overall Study|Withdrawal by Subject|0
5094263|NCT01992536|17589640|P6|Overall Study|Withdrawal by Subject|0
5094264|NCT01992536|17589641|P5|Overall Study|Withdrawal by Subject|0
5094265|NCT01992536|17589642|P4|Overall Study|Withdrawal by Subject|2
5094266|NCT01992536|17589643|P3|Overall Study|Withdrawal by Subject|0
5094267|NCT01992536|17589644|P2|Overall Study|Withdrawal by Subject|1
5094268|NCT01992536|17589645|P1|Overall Study|Withdrawal by Subject|0
5094269|NCT01992536|17589636|P10|Overall Study|Lost to Follow-up|1
5094270|NCT01992536|17589637|P9|Overall Study|Lost to Follow-up|1
5094271|NCT01992536|17589638|P8|Overall Study|Lost to Follow-up|0
5094272|NCT01992536|17589639|P7|Overall Study|Lost to Follow-up|0
5094273|NCT01992536|17589640|P6|Overall Study|Lost to Follow-up|1
5094274|NCT01992536|17589641|P5|Overall Study|Lost to Follow-up|0
5094275|NCT01992536|17589642|P4|Overall Study|Lost to Follow-up|0
5094276|NCT01992536|17589643|P3|Overall Study|Lost to Follow-up|1
5094277|NCT01992536|17589644|P2|Overall Study|Lost to Follow-up|2
5094278|NCT01992536|17589645|P1|Overall Study|Lost to Follow-up|4
5094279|NCT01992536|17589636|P10|Overall Study|Administrative Reason|0
5094280|NCT01992536|17589637|P9|Overall Study|Administrative Reason|0
5094281|NCT01992536|17589638|P8|Overall Study|Administrative Reason|0
5094282|NCT01992536|17589639|P7|Overall Study|Administrative Reason|7
5094283|NCT01992536|17589640|P6|Overall Study|Administrative Reason|0
5094284|NCT01992536|17589641|P5|Overall Study|Administrative Reason|0
5094285|NCT01992536|17589642|P4|Overall Study|Administrative Reason|0
5094286|NCT01992536|17589643|P3|Overall Study|Administrative Reason|0
5094287|NCT01992536|17589644|P2|Overall Study|Administrative Reason|0
5094288|NCT01992536|17589645|P1|Overall Study|Administrative Reason|0
5094289|NCT01992159|17589914|P4|Overall Study|Death|0
5094290|NCT01992159|17589915|P3|Overall Study|Death|1
5094291|NCT01992159|17589916|P2|Overall Study|Death|0
5094292|NCT01992159|17589917|P1|Overall Study|Death|0
5094293|NCT01992159|17589914|P4|Overall Study|Adverse Event|1
5094294|NCT01992159|17589915|P3|Overall Study|Adverse Event|0
5094295|NCT01992159|17589916|P2|Overall Study|Adverse Event|1
5094296|NCT01992159|17589917|P1|Overall Study|Adverse Event|0
5094297|NCT01992159|17589914|P4|Overall Study|Withdrawal by Subject|3
5094298|NCT01992159|17589915|P3|Overall Study|Withdrawal by Subject|0
5094299|NCT01992159|17589916|P2|Overall Study|Withdrawal by Subject|7
5094300|NCT01992159|17589917|P1|Overall Study|Withdrawal by Subject|4
5094301|NCT01992107|17589970|P3|Overall Study|Withdrawal by Subject|8
5094302|NCT01992107|17589971|P2|Overall Study|Withdrawal by Subject|7
5094303|NCT01992107|17589972|P1|Overall Study|Withdrawal by Subject|13
5094304|NCT01992107|17589970|P3|Overall Study|noncompliance and were unavailable|2
5094305|NCT01992107|17589971|P2|Overall Study|noncompliance and were unavailable|3
5094306|NCT01992107|17589972|P1|Overall Study|noncompliance and were unavailable|7
5094307|NCT01992107|17589970|P3|Overall Study|Lost to Follow-up|26
5094308|NCT01992107|17589971|P2|Overall Study|Lost to Follow-up|22
5094309|NCT01992107|17589972|P1|Overall Study|Lost to Follow-up|46
5094310|NCT01992107|17589970|P3|Overall Study|Adverse Event|0
5094311|NCT01992107|17589971|P2|Overall Study|Adverse Event|1
5094312|NCT01992107|17589972|P1|Overall Study|Adverse Event|0
5094313|NCT01992107|17589970|P3|Overall Study|Administrative reasons|0
5094314|NCT01992107|17589971|P2|Overall Study|Administrative reasons|0
5094315|NCT01992107|17589972|P1|Overall Study|Administrative reasons|2
5094316|NCT01992094|17590028|P3|Overall Study|Withdrawal by Subject|4
5094317|NCT01992094|17590029|P2|Overall Study|Withdrawal by Subject|3
5094318|NCT01992094|17590030|P1|Overall Study|Withdrawal by Subject|7
5094319|NCT01992094|17590028|P3|Overall Study|Protocol Violation|1
5094320|NCT01992094|17590029|P2|Overall Study|Protocol Violation|0
5094321|NCT01992094|17590030|P1|Overall Study|Protocol Violation|1
5094322|NCT01992094|17590028|P3|Overall Study|OTHER|0
5094323|NCT01992094|17590029|P2|Overall Study|OTHER|0
5094324|NCT01992094|17590030|P1|Overall Study|OTHER|4
5094325|NCT01992094|17590028|P3|Overall Study|Lost to Follow-up|13
5094326|NCT01992094|17590029|P2|Overall Study|Lost to Follow-up|9
5094327|NCT01992094|17590030|P1|Overall Study|Lost to Follow-up|26
5094328|NCT01992094|17590028|P3|Overall Study|Death|2
5094329|NCT01992094|17590029|P2|Overall Study|Death|5
5094330|NCT01992094|17590030|P1|Overall Study|Death|5
5094331|NCT01992094|17590028|P3|Overall Study|Adverse Event|0
5094332|NCT01992094|17590029|P2|Overall Study|Adverse Event|0
5094333|NCT01992094|17590030|P1|Overall Study|Adverse Event|1
5094334|NCT01992094|17590028|P3|Overall Study|ADMINISTRATIVE REASON|1
5094335|NCT01992094|17590029|P2|Overall Study|ADMINISTRATIVE REASON|7
5094336|NCT01992094|17590030|P1|Overall Study|ADMINISTRATIVE REASON|6
5094337|NCT01991977|17590138|P1|Overall Study|Withdrew after start of treatment|5
5094338|NCT01991977|17590138|P1|Overall Study|Withdrew prior to receiving treatment|7
5094339|NCT01991795|17590190|P2|Overall Study|Site prematurely closed by sponsor|25
5094340|NCT01991795|17590191|P1|Overall Study|Site prematurely closed by sponsor|26
5094341|NCT01991795|17590190|P2|Overall Study|Withdrawal by Subject|94
5094342|NCT01991795|17590191|P1|Overall Study|Withdrawal by Subject|117
5094343|NCT01991795|17590190|P2|Overall Study|Lost to Follow-up|4
5094344|NCT01991795|17590191|P1|Overall Study|Lost to Follow-up|6
5094345|NCT01991743|17590217|P4|Overall Study|external cephalic version not performed|0
5094346|NCT01991743|17590218|P3|Overall Study|external cephalic version not performed|1
5094347|NCT01991743|17590219|P2|Overall Study|external cephalic version not performed|0
5094348|NCT01991743|17590220|P1|Overall Study|external cephalic version not performed|0
5094349|NCT01991483|17590265|P4|Dose Level 1000 mg|Protocol Violation|1
5094350|NCT01991483|17590266|P3|Dose Level 1000 mg|Protocol Violation|0
5094351|NCT01991483|17590267|P2|Dose Level 1000 mg|Protocol Violation|0
5094352|NCT01991483|17590268|P1|Dose Level 1000 mg|Protocol Violation|0
5094353|NCT01991483|17590265|P4|Dose Level 600 mg|Physician Decision|0
5094354|NCT01991483|17590266|P3|Dose Level 600 mg|Physician Decision|1
5094355|NCT01991483|17590267|P2|Dose Level 600 mg|Physician Decision|0
5094356|NCT01991483|17590268|P1|Dose Level 600 mg|Physician Decision|0
5094357|NCT01991483|17590265|P4|Dose Level 600 mg|Withdrawal by Subject|0
5094358|NCT01991483|17590266|P3|Dose Level 600 mg|Withdrawal by Subject|1
5094359|NCT01991483|17590267|P2|Dose Level 600 mg|Withdrawal by Subject|0
5094360|NCT01991483|17590268|P1|Dose Level 600 mg|Withdrawal by Subject|0
5094361|NCT01991470|17590334|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
5094362|NCT01991470|17590334|P1|Enlite 3 Period|Physician Decision|8
5094363|NCT01991470|17590334|P1|Enlite 3 Period|Physician Decision|2
5094364|NCT01991470|17590334|P1|Enlite 3 Period|Lost to Follow-up|1
5094365|NCT01991470|17590334|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
5094366|NCT01991470|17590334|P1|Enlite 1 Period|Adverse Event|1
5094367|NCT01991470|17590334|P1|Enlite 1 Period|Withdrawal by Subject|18
5094368|NCT01991314|17590348|P2|Overall Study|Lost to Follow-up|10
5094369|NCT01991314|17590349|P1|Overall Study|Lost to Follow-up|6
5094370|NCT01991314|17590348|P2|Overall Study|Adverse Event|1
5094371|NCT01991314|17590349|P1|Overall Study|Adverse Event|5
5094372|NCT01991197|17590369|P2|Overall Study|Withdrawal by Subject|0
5094373|NCT01991197|17590370|P1|Overall Study|Withdrawal by Subject|2
5094374|NCT01991197|17590369|P2|Overall Study|Physician Decision|2
5094375|NCT01991197|17590370|P1|Overall Study|Physician Decision|0
5094376|NCT01991197|17590369|P2|Overall Study|Lost to Follow-up|1
5094377|NCT01991197|17590370|P1|Overall Study|Lost to Follow-up|1
5094378|NCT01991067|17590408|P2|Overall Study|Lost to Follow-up|5
5094379|NCT01991067|17590409|P1|Overall Study|Lost to Follow-up|6
5094380|NCT01990859|17590423|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
5094381|NCT01990859|17590423|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
5094382|NCT01990768|17590558|P3|6-Month Follow-up|Patient at psychiatric hospital|0
5094383|NCT01990768|17590559|P2|6-Month Follow-up|Patient at psychiatric hospital|0
5094384|NCT01990768|17590560|P1|6-Month Follow-up|Patient at psychiatric hospital|1
5094385|NCT01990768|17590558|P3|6-Month Follow-up|Prisoner at time of follow-up|0
5094386|NCT01990768|17590559|P2|6-Month Follow-up|Prisoner at time of follow-up|2
5094387|NCT01990768|17590560|P1|6-Month Follow-up|Prisoner at time of follow-up|0
5094388|NCT01990768|17590558|P3|6-Month Follow-up|Prisoner at time of enrollment|1
5094389|NCT01990768|17590559|P2|6-Month Follow-up|Prisoner at time of enrollment|0
5094390|NCT01990768|17590560|P1|6-Month Follow-up|Prisoner at time of enrollment|0
5094391|NCT01990768|17590558|P3|6-Month Follow-up|Homeless|6
5094392|NCT01990768|17590559|P2|6-Month Follow-up|Homeless|3
5094393|NCT01990768|17590560|P1|6-Month Follow-up|Homeless|4
5094394|NCT01990768|17590558|P3|6-Month Follow-up|No contact information|5
5094395|NCT01990768|17590559|P2|6-Month Follow-up|No contact information|6
5094396|NCT01990768|17590560|P1|6-Month Follow-up|No contact information|5
5094397|NCT01990768|17590558|P3|6-Month Follow-up|Calls unreturned or refused contact|20
5094398|NCT01990768|17590559|P2|6-Month Follow-up|Calls unreturned or refused contact|15
5094399|NCT01990768|17590560|P1|6-Month Follow-up|Calls unreturned or refused contact|4
5094400|NCT01990768|17590558|P3|6-Month Follow-up|Withdrawal by Subject|26
5094401|NCT01990768|17590559|P2|6-Month Follow-up|Withdrawal by Subject|25
5094402|NCT01990768|17590560|P1|6-Month Follow-up|Withdrawal by Subject|25
5094403|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
5094404|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
5094405|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
5094406|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
5094407|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
5094408|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
5094409|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
5094410|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
5094411|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
5094412|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
5094413|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
5094414|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
5094415|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
5094416|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
5094417|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
5094418|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Other safety concern|3
5094419|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Other safety concern|2
5094420|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Other safety concern|4
5094421|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Required CPR|1
5094422|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Required CPR|7
5094423|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Required CPR|3
5094424|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
5094425|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
5094426|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
5094427|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
5094428|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
5094429|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
5094430|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
5094431|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
5094432|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
5094433|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
5094434|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
5094435|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
5094436|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
5094437|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
5094438|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
5094439|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
5094440|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
5094441|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
5094442|NCT01990768|17590558|P3|In-Hospital Study Drug Infusion|Discharged|13
5094443|NCT01990768|17590559|P2|In-Hospital Study Drug Infusion|Discharged|18
5094444|NCT01990768|17590560|P1|In-Hospital Study Drug Infusion|Discharged|19
5094445|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Unknown if completed|2
5094446|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Unknown if completed|4
5094447|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Unknown if completed|1
5094448|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
5094449|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
5094450|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
5094451|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
5094452|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
5094453|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
5094454|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Discharged|0
5094455|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Discharged|1
5094456|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Discharged|2
5094457|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Death|1
5094458|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Death|1
5094459|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Death|3
5094460|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Other safety concern|1
5094461|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Other safety concern|1
5094462|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Other safety concern|2
5094463|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Required CPR|0
5094464|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Required CPR|6
5094465|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Required CPR|2
5094466|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
5094467|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
5094468|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
5094469|NCT01990768|17590558|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
5094470|NCT01990768|17590559|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
5094471|NCT01990768|17590560|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
5094472|NCT01990768|17590558|P3|Intervention Started|Discovered to be pregnant|0
5094473|NCT01990768|17590559|P2|Intervention Started|Discovered to be pregnant|1
5094474|NCT01990768|17590560|P1|Intervention Started|Discovered to be pregnant|0
5094475|NCT01990768|17590558|P3|Intervention Started|Seizure or hx of seizure|2
5094476|NCT01990768|17590559|P2|Intervention Started|Seizure or hx of seizure|0
5094477|NCT01990768|17590560|P1|Intervention Started|Seizure or hx of seizure|0
5094478|NCT01990768|17590558|P3|Intervention Started|Required CPR|0
5094479|NCT01990768|17590559|P2|Intervention Started|Required CPR|1
5094480|NCT01990768|17590560|P1|Intervention Started|Required CPR|1
5094481|NCT01990768|17590558|P3|Intervention Started|IV lost|2
5094482|NCT01990768|17590559|P2|Intervention Started|IV lost|2
5094483|NCT01990768|17590560|P1|Intervention Started|IV lost|2
5094484|NCT01990768|17590558|P3|Intervention Started|Patient care priority|3
5094485|NCT01990768|17590559|P2|Intervention Started|Patient care priority|2
5094486|NCT01990768|17590560|P1|Intervention Started|Patient care priority|1
5094487|NCT01990768|17590558|P3|Intervention Started|Not enough time for EMS to enroll|0
5094488|NCT01990768|17590559|P2|Intervention Started|Not enough time for EMS to enroll|3
5094489|NCT01990768|17590560|P1|Intervention Started|Not enough time for EMS to enroll|4
5094490|NCT01990768|17590558|P3|Intervention Started|Patient became ineligible due to vitals|2
5094491|NCT01990768|17590559|P2|Intervention Started|Patient became ineligible due to vitals|5
5094492|NCT01990768|17590560|P1|Intervention Started|Patient became ineligible due to vitals|5
5094493|NCT01990768|17590558|P3|Intervention Started|Study drug issue or kit malfunction|7
5094494|NCT01990768|17590559|P2|Intervention Started|Study drug issue or kit malfunction|6
5094495|NCT01990768|17590560|P1|Intervention Started|Study drug issue or kit malfunction|9
5094496|NCT01990768|17590558|P3|Intervention Started|Found to be ineligible|11
5094497|NCT01990768|17590559|P2|Intervention Started|Found to be ineligible|13
5094498|NCT01990768|17590560|P1|Intervention Started|Found to be ineligible|14
5094499|NCT01990742|17590625|P2|Overall Study|Facility closed|270
5094500|NCT01990742|17590626|P1|Overall Study|Facility closed|0
5094501|NCT01990742|17590625|P2|Overall Study|Withdrawal by facility|1083
5094502|NCT01990742|17590626|P1|Overall Study|Withdrawal by facility|407
5094503|NCT01990664|17590662|P2|Overall Study|Unsatisfactory Visual Response|1
5094504|NCT01990664|17590663|P1|Overall Study|Unsatisfactory Visual Response|0
5094505|NCT01990664|17590662|P2|Overall Study|Lens Handling Difficulties|0
5094506|NCT01990664|17590663|P1|Overall Study|Lens Handling Difficulties|1
5094507|NCT01990664|17590662|P2|Overall Study|Lens Discomfort|1
5094508|NCT01990664|17590663|P1|Overall Study|Lens Discomfort|1
5094509|NCT01990664|17590662|P2|Overall Study|Protocol Violation|0
5094510|NCT01990664|17590663|P1|Overall Study|Protocol Violation|1
5094511|NCT01990664|17590662|P2|Overall Study|Withdrawal by Subject|3
5094512|NCT01990664|17590663|P1|Overall Study|Withdrawal by Subject|2
5094513|NCT01990664|17590662|P2|Overall Study|Lost to Follow-up|6
5094514|NCT01990664|17590663|P1|Overall Study|Lost to Follow-up|2
5094515|NCT01990612|17590671|P2|Overall Study|Withdrawal by Subject|2
5094516|NCT01990612|17590672|P1|Overall Study|Withdrawal by Subject|5
5094517|NCT01990612|17590671|P2|Overall Study|Lost to Follow-up|1
5094518|NCT01990612|17590672|P1|Overall Study|Lost to Follow-up|2
5094519|NCT01990573|17590753|P3|Overall Study|Physician Decision|1
5094520|NCT01990573|17590754|P2|Overall Study|Physician Decision|0
5094521|NCT01990573|17590755|P1|Overall Study|Physician Decision|0
5094522|NCT01990560|17590768|P1|Overall Study|Withdrawal by Subject|1
5094523|NCT01990534|17590782|P1|Overall Study|Overall Survival Follow-up|25
5094524|NCT01990534|17590782|P1|Overall Study|Progression Free Survival Follow-up|11
5094525|NCT01990534|17590782|P1|Overall Study|Reason Not Specified|2
5094526|NCT01990534|17590782|P1|Overall Study|Withdrawal by Subject|3
5094527|NCT01990534|17590782|P1|Overall Study|Symptomatic Deterioration|1
5094528|NCT01990534|17590782|P1|Overall Study|Withdrawal of Informed Consent|2
5094529|NCT01990534|17590782|P1|Overall Study|Protocol Violation|1
5094530|NCT01990534|17590782|P1|Overall Study|Progressive disease|3
5094531|NCT01990534|17590782|P1|Overall Study|Death|12
5094532|NCT01990339|17590798|P1|Overall Study|Lost to Follow-up|861
5094533|NCT01990339|17590798|P1|Overall Study|Voluntary Withdrawal|1402
5094534|NCT01990339|17590798|P1|Overall Study|Data Not Available|49
5094535|NCT01990313|17590803|P1|Overall Study|Lost to Follow-up|1
5094536|NCT01990300|17590808|P1|Overall Study|Protocol Deviation|53
5094537|NCT01990300|17590808|P1|Overall Study|Case Report Forms Uncollected|89
5094538|NCT01990261|17590814|P1|Overall Study|Lost to Follow-up|2
5094539|NCT01990261|17590814|P1|Overall Study|Dossier not Approved|1
5094540|NCT01990261|17590814|P1|Overall Study|PD Before Treatment Start|1
5094541|NCT01990261|17590814|P1|Overall Study|Disease Progression (PD)|8
5094542|NCT01990261|17590814|P1|Overall Study|Death From other Causes|1
5094543|NCT01990261|17590814|P1|Overall Study|Death due to Disease Progression (PD)|10
5094544|NCT01990261|17590814|P1|Overall Study|Death Before Treatment Start|2
5094545|NCT01989754|17590871|P2|Overall Study|Closed Site|1
5094546|NCT01989754|17590872|P1|Overall Study|Closed Site|1
5094547|NCT01989754|17590871|P2|Overall Study|Lost to Follow-up|20
5094548|NCT01989754|17590872|P1|Overall Study|Lost to Follow-up|28
5094549|NCT01989754|17590871|P2|Overall Study|Withdrawal by Subject|14
5094550|NCT01989754|17590872|P1|Overall Study|Withdrawal by Subject|10
5094551|NCT01989689|17590884|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
5094552|NCT01989689|17590885|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
5094553|NCT01989689|17590884|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
5094554|NCT01989689|17590885|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
5094555|NCT01989676|17590897|P2|Overall Study|Discontinued|68
5094556|NCT01989676|17590898|P1|Overall Study|Discontinued|59
5094557|NCT01989676|17590897|P2|Overall Study|Ongoing at data cutoff|279
5094558|NCT01989676|17590898|P1|Overall Study|Ongoing at data cutoff|279
5094559|NCT01989572|17590924|P6|Overall Study|alternative therapy|3
5094560|NCT01989572|17590925|P5|Overall Study|alternative therapy|1
5094561|NCT01989572|17590926|P4|Overall Study|alternative therapy|0
5094562|NCT01989572|17590927|P3|Overall Study|alternative therapy|0
5094563|NCT01989572|17590928|P2|Overall Study|alternative therapy|0
5094564|NCT01989572|17590929|P1|Overall Study|alternative therapy|3
5094565|NCT01989572|17590924|P6|Overall Study|not start protocol therapy|18
5094566|NCT01989572|17590925|P5|Overall Study|not start protocol therapy|4
5094567|NCT01989572|17590926|P4|Overall Study|not start protocol therapy|3
5094568|NCT01989572|17590927|P3|Overall Study|not start protocol therapy|2
5094569|NCT01989572|17590928|P2|Overall Study|not start protocol therapy|1
5094570|NCT01989572|17590929|P1|Overall Study|not start protocol therapy|5
5094571|NCT01989572|17590924|P6|Overall Study|unknown/not specify|5
5094572|NCT01989572|17590925|P5|Overall Study|unknown/not specify|3
5094573|NCT01989572|17590926|P4|Overall Study|unknown/not specify|3
5094574|NCT01989572|17590927|P3|Overall Study|unknown/not specify|1
5094575|NCT01989572|17590928|P2|Overall Study|unknown/not specify|4
5094576|NCT01989572|17590929|P1|Overall Study|unknown/not specify|3
5094577|NCT01989572|17590924|P6|Overall Study|maximum dose reached|0
5094578|NCT01989572|17590925|P5|Overall Study|maximum dose reached|1
5094579|NCT01989572|17590926|P4|Overall Study|maximum dose reached|0
5094580|NCT01989572|17590927|P3|Overall Study|maximum dose reached|0
5094581|NCT01989572|17590928|P2|Overall Study|maximum dose reached|1
5094582|NCT01989572|17590929|P1|Overall Study|maximum dose reached|0
5094583|NCT01989572|17590924|P6|Overall Study|error|1
5094584|NCT01989572|17590925|P5|Overall Study|error|1
5094585|NCT01989572|17590926|P4|Overall Study|error|1
5094586|NCT01989572|17590927|P3|Overall Study|error|1
5094587|NCT01989572|17590928|P2|Overall Study|error|1
5094588|NCT01989572|17590929|P1|Overall Study|error|2
5094589|NCT01989572|17590924|P6|Overall Study|complicating disease|0
5094590|NCT01989572|17590925|P5|Overall Study|complicating disease|1
5094591|NCT01989572|17590926|P4|Overall Study|complicating disease|0
5094592|NCT01989572|17590927|P3|Overall Study|complicating disease|2
5094593|NCT01989572|17590928|P2|Overall Study|complicating disease|1
5094594|NCT01989572|17590929|P1|Overall Study|complicating disease|1
5094595|NCT01989572|17590924|P6|Overall Study|Withdrawal by Subject|4
5094596|NCT01989572|17590925|P5|Overall Study|Withdrawal by Subject|12
5094597|NCT01989572|17590926|P4|Overall Study|Withdrawal by Subject|1
5094598|NCT01989572|17590927|P3|Overall Study|Withdrawal by Subject|5
5094599|NCT01989572|17590928|P2|Overall Study|Withdrawal by Subject|1
5094600|NCT01989572|17590929|P1|Overall Study|Withdrawal by Subject|4
5094601|NCT01989572|17590924|P6|Overall Study|Death|0
5094602|NCT01989572|17590925|P5|Overall Study|Death|1
5094603|NCT01989572|17590926|P4|Overall Study|Death|0
5094604|NCT01989572|17590927|P3|Overall Study|Death|0
5094605|NCT01989572|17590928|P2|Overall Study|Death|0
5094606|NCT01989572|17590929|P1|Overall Study|Death|0
5094607|NCT01989572|17590924|P6|Overall Study|Adverse Event|0
5094608|NCT01989572|17590925|P5|Overall Study|Adverse Event|3
5094609|NCT01989572|17590926|P4|Overall Study|Adverse Event|0
5094610|NCT01989572|17590927|P3|Overall Study|Adverse Event|3
5094611|NCT01989572|17590928|P2|Overall Study|Adverse Event|1
5094612|NCT01989572|17590929|P1|Overall Study|Adverse Event|2
5094613|NCT01989572|17590924|P6|Overall Study|Lack of Efficacy|79
5094614|NCT01989572|17590925|P5|Overall Study|Lack of Efficacy|71
5094615|NCT01989572|17590926|P4|Overall Study|Lack of Efficacy|43
5094616|NCT01989572|17590927|P3|Overall Study|Lack of Efficacy|48
5094617|NCT01989572|17590928|P2|Overall Study|Lack of Efficacy|48
5094618|NCT01989572|17590929|P1|Overall Study|Lack of Efficacy|35
5094619|NCT01989468|17590960|P5|Overall Study|Death|0
5094620|NCT01989468|17590961|P4|Overall Study|Death|0
5094621|NCT01989468|17590962|P3|Overall Study|Death|1
5094622|NCT01989468|17590963|P2|Overall Study|Death|0
5094623|NCT01989468|17590964|P1|Overall Study|Death|3
5094624|NCT01989468|17590960|P5|Overall Study|Subject Guardian Decision|1
5094625|NCT01989468|17590961|P4|Overall Study|Subject Guardian Decision|4
5094626|NCT01989468|17590962|P3|Overall Study|Subject Guardian Decision|4
5094627|NCT01989468|17590963|P2|Overall Study|Subject Guardian Decision|6
5094628|NCT01989468|17590964|P1|Overall Study|Subject Guardian Decision|11
5094629|NCT01989468|17590960|P5|Overall Study|Technical Problems|0
5094630|NCT01989468|17590961|P4|Overall Study|Technical Problems|1
5094631|NCT01989468|17590962|P3|Overall Study|Technical Problems|3
5094632|NCT01989468|17590963|P2|Overall Study|Technical Problems|1
5094633|NCT01989468|17590964|P1|Overall Study|Technical Problems|3
5094634|NCT01989468|17590960|P5|Overall Study|Pregnancy|0
5094635|NCT01989468|17590961|P4|Overall Study|Pregnancy|0
5094636|NCT01989468|17590962|P3|Overall Study|Pregnancy|0
5094637|NCT01989468|17590963|P2|Overall Study|Pregnancy|1
5094638|NCT01989468|17590964|P1|Overall Study|Pregnancy|0
5094639|NCT01989468|17590960|P5|Overall Study|Physician Decision|0
5094640|NCT01989468|17590961|P4|Overall Study|Physician Decision|1
5094641|NCT01989468|17590962|P3|Overall Study|Physician Decision|0
5094642|NCT01989468|17590963|P2|Overall Study|Physician Decision|1
5094643|NCT01989468|17590964|P1|Overall Study|Physician Decision|4
5094644|NCT01989468|17590960|P5|Overall Study|Lost to Follow-up|1
5094645|NCT01989468|17590961|P4|Overall Study|Lost to Follow-up|1
5094646|NCT01989468|17590962|P3|Overall Study|Lost to Follow-up|0
5094647|NCT01989468|17590963|P2|Overall Study|Lost to Follow-up|2
5094648|NCT01989468|17590964|P1|Overall Study|Lost to Follow-up|5
5094649|NCT01989468|17590960|P5|Overall Study|Lack of Efficacy|2
5094650|NCT01989468|17590961|P4|Overall Study|Lack of Efficacy|4
5094651|NCT01989468|17590962|P3|Overall Study|Lack of Efficacy|7
5094652|NCT01989468|17590963|P2|Overall Study|Lack of Efficacy|11
5094653|NCT01989468|17590964|P1|Overall Study|Lack of Efficacy|11
5094654|NCT01989468|17590960|P5|Overall Study|Adverse Event|4
5094655|NCT01989468|17590961|P4|Overall Study|Adverse Event|5
5094656|NCT01989468|17590962|P3|Overall Study|Adverse Event|4
5094657|NCT01989468|17590963|P2|Overall Study|Adverse Event|15
5094658|NCT01989468|17590964|P1|Overall Study|Adverse Event|10
5094659|NCT01989455|17591006|P5|Overall Study|Technical problems with infusion|1
5094660|NCT01989455|17591007|P4|Overall Study|Technical problems with infusion|0
5094661|NCT01989455|17591008|P3|Overall Study|Technical problems with infusion|1
5094662|NCT01989455|17591009|P2|Overall Study|Technical problems with infusion|0
5094663|NCT01989455|17591010|P1|Overall Study|Technical problems with infusion|0
5094664|NCT01989455|17591006|P5|Overall Study|Withdrawal by Subject|0
5094665|NCT01989455|17591007|P4|Overall Study|Withdrawal by Subject|0
5094666|NCT01989455|17591008|P3|Overall Study|Withdrawal by Subject|0
5094667|NCT01989455|17591009|P2|Overall Study|Withdrawal by Subject|1
5094668|NCT01989455|17591010|P1|Overall Study|Withdrawal by Subject|0
5094669|NCT01989455|17591006|P5|Overall Study|Adverse Event|0
5094670|NCT01989455|17591007|P4|Overall Study|Adverse Event|0
5094671|NCT01989455|17591008|P3|Overall Study|Adverse Event|0
5094672|NCT01989455|17591009|P2|Overall Study|Adverse Event|1
5094673|NCT01989455|17591010|P1|Overall Study|Adverse Event|0
5094674|NCT01989208|17591046|P2|200 mg (7 Days)|Protocol Violation|1
5094675|NCT01989208|17591047|P1|200 mg (7 Days)|Protocol Violation|0
5094676|NCT01989169|17591075|P2|Period 2|Adverse Event|1
5094677|NCT01989169|17591076|P1|Period 2|Adverse Event|0
5094678|NCT01989156|17591089|P3|End of Study (Population at Day 90)|Employment Conflict|0
5094679|NCT01989156|17591090|P2|End of Study (Population at Day 90)|Employment Conflict|1
5094680|NCT01989156|17591091|P1|End of Study (Population at Day 90)|Employment Conflict|0
5094681|NCT01989156|17591089|P3|End of Study (Population at Day 90)|Moved out of state|0
5094682|NCT01989156|17591090|P2|End of Study (Population at Day 90)|Moved out of state|0
5094683|NCT01989156|17591091|P1|End of Study (Population at Day 90)|Moved out of state|1
5094684|NCT01989156|17591089|P3|End of Study (Population at Day 90)|Physician Decision|1
5094685|NCT01989156|17591090|P2|End of Study (Population at Day 90)|Physician Decision|0
5094686|NCT01989156|17591091|P1|End of Study (Population at Day 90)|Physician Decision|1
5094687|NCT01989156|17591089|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
5094688|NCT01989156|17591090|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
5094689|NCT01989156|17591091|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
5094690|NCT01989156|17591089|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
5094691|NCT01989156|17591090|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
5094692|NCT01989156|17591091|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
5094693|NCT01989156|17591089|P3|Confinement Period (Population at Day 5)|Adverse Event|1
5094694|NCT01989156|17591090|P2|Confinement Period (Population at Day 5)|Adverse Event|0
5094695|NCT01989156|17591091|P1|Confinement Period (Population at Day 5)|Adverse Event|0
5094696|NCT01989156|17591089|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
5094697|NCT01989156|17591090|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
5094698|NCT01989156|17591091|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
5094699|NCT01989156|17591089|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
5094700|NCT01989156|17591090|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5094701|NCT01989156|17591091|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
5094702|NCT01988779|17591151|P2|Overall Study|Protocol Violation|0
5094703|NCT01988779|17591152|P1|Overall Study|Protocol Violation|1
5094704|NCT01988779|17591151|P2|Overall Study|Withdrawal by Subject|2
5094705|NCT01988779|17591152|P1|Overall Study|Withdrawal by Subject|2
5094706|NCT01988662|17591168|P2|Overall Study|Adverse Event|1
5094707|NCT01988662|17591169|P1|Overall Study|Adverse Event|3
5094708|NCT01988662|17591168|P2|Overall Study|Subject/guardian decision|1
5094709|NCT01988662|17591169|P1|Overall Study|Subject/guardian decision|1
5094710|NCT01988493|17591191|P5|Overall Study|Ongoing|0
5094711|NCT01988493|17591192|P4|Overall Study|Ongoing|2
5094712|NCT01988493|17591193|P3|Overall Study|Ongoing|0
5094713|NCT01988493|17591194|P2|Overall Study|Ongoing|0
5094714|NCT01988493|17591195|P1|Overall Study|Ongoing|0
5094715|NCT01988493|17591191|P5|Overall Study|Randomized but not treated|1
5094716|NCT01988493|17591192|P4|Overall Study|Randomized but not treated|0
5094717|NCT01988493|17591193|P3|Overall Study|Randomized but not treated|0
5094718|NCT01988493|17591194|P2|Overall Study|Randomized but not treated|0
5094719|NCT01988493|17591195|P1|Overall Study|Randomized but not treated|0
5094720|NCT01988402|17591274|P2|Overall Study|Withdrawal by Subject|0
5094721|NCT01988402|17591275|P1|Overall Study|Withdrawal by Subject|1
5094722|NCT01988402|17591274|P2|Overall Study|Adverse Event|2
5094723|NCT01988402|17591275|P1|Overall Study|Adverse Event|1
5094724|NCT01988103|17591342|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
5094725|NCT01988103|17591343|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
5094726|NCT01988103|17591344|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
5094727|NCT01988103|17591345|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
5094728|NCT01988103|17591346|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
5094729|NCT01988103|17591342|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
5094730|NCT01988103|17591343|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
5094731|NCT01988103|17591344|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
5094732|NCT01988103|17591345|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
5094733|NCT01988103|17591346|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
5094734|NCT01988103|17591342|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5094735|NCT01988103|17591343|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5094736|NCT01988103|17591344|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
5094737|NCT01988103|17591345|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
5094738|NCT01988103|17591346|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5094739|NCT01988103|17591342|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
5094740|NCT01988103|17591343|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
5094741|NCT01988103|17591344|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
5094742|NCT01988103|17591345|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
5094743|NCT01988103|17591346|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
5094744|NCT01988103|17591342|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
5094745|NCT01988103|17591343|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
5094746|NCT01988103|17591344|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
5094747|NCT01988103|17591345|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
5094748|NCT01988103|17591346|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
5094749|NCT01988103|17591342|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
5094750|NCT01988103|17591343|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
5094751|NCT01988103|17591344|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
5094752|NCT01988103|17591345|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
5094753|NCT01988103|17591346|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
5094754|NCT01988103|17591342|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
5094755|NCT01988103|17591343|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
5094756|NCT01988103|17591344|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
5094757|NCT01988103|17591345|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
5094758|NCT01988103|17591346|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
5094759|NCT01988090|17591393|P2|Complete Study After Start|Protocol Violation|1
5094760|NCT01988090|17591394|P1|Complete Study After Start|Protocol Violation|1
5094761|NCT01988090|17591393|P2|Complete Study After Start|Withdrawal by Subject|0
5094762|NCT01988090|17591394|P1|Complete Study After Start|Withdrawal by Subject|2
5094763|NCT01988090|17591393|P2|Start Treament After Randomization|Protocol Violation|1
5094764|NCT01988090|17591394|P1|Start Treament After Randomization|Protocol Violation|0
5094765|NCT01988090|17591393|P2|Start Treament After Randomization|Withdrawal by Subject|3
5094766|NCT01988090|17591394|P1|Start Treament After Randomization|Withdrawal by Subject|2
5094767|NCT01988012|17591404|P1|Overall Study|Protocol Violation|1
5094768|NCT01988012|17591404|P1|Overall Study|Physician Decision|1
5094769|NCT01988012|17591404|P1|Overall Study|Lost to Follow-up|1
5094770|NCT01988012|17591404|P1|Overall Study|Patient Withdrawal of Consent|4
5094771|NCT01988012|17591404|P1|Overall Study|Insufficient Therapeutic Response|3
5094772|NCT01988012|17591404|P1|Overall Study|Adverse Event|5
5094773|NCT01987986|17591430|P4|Overall Study|Adverse Event|0
5094774|NCT01987986|17591431|P3|Overall Study|Adverse Event|2
5094775|NCT01987986|17591432|P2|Overall Study|Adverse Event|0
5094776|NCT01987986|17591433|P1|Overall Study|Adverse Event|1
5094777|NCT01987986|17591430|P4|Overall Study|Lost to Follow-up|0
5094778|NCT01987986|17591431|P3|Overall Study|Lost to Follow-up|0
5094779|NCT01987986|17591432|P2|Overall Study|Lost to Follow-up|0
5094780|NCT01987986|17591433|P1|Overall Study|Lost to Follow-up|1
5094781|NCT01987960|17591473|P4|Period 3|Administrative or other reason|43
5094782|NCT01987960|17591474|P3|Period 3|Administrative or other reason|0
5094783|NCT01987960|17591475|P2|Period 3|Administrative or other reason|0
5094784|NCT01987960|17591476|P1|Period 3|Administrative or other reason|0
5094785|NCT01987960|17591473|P4|Period 3|Lost to Follow-up|5
5094786|NCT01987960|17591474|P3|Period 3|Lost to Follow-up|0
5094787|NCT01987960|17591475|P2|Period 3|Lost to Follow-up|0
5094788|NCT01987960|17591476|P1|Period 3|Lost to Follow-up|0
5094789|NCT01987960|17591473|P4|Period 3|Withdrawal by Subject|9
5094790|NCT01987960|17591474|P3|Period 3|Withdrawal by Subject|0
5094791|NCT01987960|17591475|P2|Period 3|Withdrawal by Subject|0
5094792|NCT01987960|17591476|P1|Period 3|Withdrawal by Subject|0
5094793|NCT01987960|17591473|P4|Period 3|Protocol Violation|6
5094794|NCT01987960|17591474|P3|Period 3|Protocol Violation|0
5094795|NCT01987960|17591475|P2|Period 3|Protocol Violation|0
5094796|NCT01987960|17591476|P1|Period 3|Protocol Violation|0
5094797|NCT01987960|17591473|P4|Period 3|Non-compliance with IMP|1
5094798|NCT01987960|17591474|P3|Period 3|Non-compliance with IMP|0
5094799|NCT01987960|17591475|P2|Period 3|Non-compliance with IMP|0
5094800|NCT01987960|17591476|P1|Period 3|Non-compliance with IMP|0
5094801|NCT01987960|17591473|P4|Period 3|Adverse Event|7
5094802|NCT01987960|17591474|P3|Period 3|Adverse Event|0
5094803|NCT01987960|17591475|P2|Period 3|Adverse Event|0
5094804|NCT01987960|17591476|P1|Period 3|Adverse Event|0
5094805|NCT01987960|17591473|P4|Period 2|Administrative or other reason|0
5094806|NCT01987960|17591474|P3|Period 2|Administrative or other reason|7
5094807|NCT01987960|17591475|P2|Period 2|Administrative or other reason|5
5094808|NCT01987960|17591476|P1|Period 2|Administrative or other reason|0
5094809|NCT01987960|17591473|P4|Period 2|Withdrawal by Subject|0
5094810|NCT01987960|17591474|P3|Period 2|Withdrawal by Subject|1
5094811|NCT01987960|17591475|P2|Period 2|Withdrawal by Subject|0
5094812|NCT01987960|17591476|P1|Period 2|Withdrawal by Subject|0
5094813|NCT01987960|17591473|P4|Period 2|Adverse Event|0
5094814|NCT01987960|17591474|P3|Period 2|Adverse Event|1
5094815|NCT01987960|17591475|P2|Period 2|Adverse Event|0
5094816|NCT01987960|17591476|P1|Period 2|Adverse Event|0
5094817|NCT01987960|17591473|P4|Period 1|Withdrawal of consent before treatment|0
5094818|NCT01987960|17591474|P3|Period 1|Withdrawal of consent before treatment|0
5094819|NCT01987960|17591475|P2|Period 1|Withdrawal of consent before treatment|0
5094820|NCT01987960|17591476|P1|Period 1|Withdrawal of consent before treatment|4
5094821|NCT01987960|17591473|P4|Period 1|administrative or other reason|0
5094822|NCT01987960|17591474|P3|Period 1|administrative or other reason|0
5094823|NCT01987960|17591475|P2|Period 1|administrative or other reason|0
5094824|NCT01987960|17591476|P1|Period 1|administrative or other reason|75
5094825|NCT01987960|17591473|P4|Period 1|Lost to Follow-up|0
5094826|NCT01987960|17591474|P3|Period 1|Lost to Follow-up|0
5094827|NCT01987960|17591475|P2|Period 1|Lost to Follow-up|0
5094828|NCT01987960|17591476|P1|Period 1|Lost to Follow-up|40
5094829|NCT01987960|17591473|P4|Period 1|Withdrawal by Subject|0
5094830|NCT01987960|17591474|P3|Period 1|Withdrawal by Subject|0
5094831|NCT01987960|17591475|P2|Period 1|Withdrawal by Subject|0
5094832|NCT01987960|17591476|P1|Period 1|Withdrawal by Subject|21
5094833|NCT01987960|17591473|P4|Period 1|Protocol Violation|0
5094834|NCT01987960|17591474|P3|Period 1|Protocol Violation|0
5094835|NCT01987960|17591475|P2|Period 1|Protocol Violation|0
5094836|NCT01987960|17591476|P1|Period 1|Protocol Violation|12
5094837|NCT01987960|17591473|P4|Period 1|Non-compliance with IMP|0
5094838|NCT01987960|17591474|P3|Period 1|Non-compliance with IMP|0
5094839|NCT01987960|17591475|P2|Period 1|Non-compliance with IMP|0
5094840|NCT01987960|17591476|P1|Period 1|Non-compliance with IMP|6
5094841|NCT01987960|17591473|P4|Period 1|Lack of Efficacy|0
5094842|NCT01987960|17591474|P3|Period 1|Lack of Efficacy|0
5094843|NCT01987960|17591475|P2|Period 1|Lack of Efficacy|0
5094844|NCT01987960|17591476|P1|Period 1|Lack of Efficacy|4
5094845|NCT01987960|17591473|P4|Period 1|Adverse Event|0
5094846|NCT01987960|17591474|P3|Period 1|Adverse Event|0
5094847|NCT01987960|17591475|P2|Period 1|Adverse Event|0
5094848|NCT01987960|17591476|P1|Period 1|Adverse Event|24
5094849|NCT01987908|17591488|P3|Post-Treatment Observation Period|Other: Bad Veins|0
5094850|NCT01987908|17591489|P2|Post-Treatment Observation Period|Other: Bad Veins|1
5094851|NCT01987908|17591490|P1|Post-Treatment Observation Period|Other: Bad Veins|0
5094852|NCT01987908|17591488|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
5094853|NCT01987908|17591489|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
5094854|NCT01987908|17591490|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
5094855|NCT01987908|17591488|P3|Treatment Period|Adverse Event|1
5094856|NCT01987908|17591489|P2|Treatment Period|Adverse Event|1
5094857|NCT01987908|17591490|P1|Treatment Period|Adverse Event|0
5094858|NCT01987908|17591488|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
5094859|NCT01987908|17591489|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
5094860|NCT01987908|17591490|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
5094861|NCT01987908|17591488|P3|Placebo Lead-in Period|Withdrawal by Subject|0
5094862|NCT01987908|17591489|P2|Placebo Lead-in Period|Withdrawal by Subject|0
5094863|NCT01987908|17591490|P1|Placebo Lead-in Period|Withdrawal by Subject|1
5094864|NCT01987908|17591488|P3|Placebo Lead-in Period|Physician Decision|0
5094865|NCT01987908|17591489|P2|Placebo Lead-in Period|Physician Decision|0
5094866|NCT01987908|17591490|P1|Placebo Lead-in Period|Physician Decision|2
5094867|NCT01987908|17591488|P3|Placebo Lead-in Period|Adverse Event|0
5094868|NCT01987908|17591489|P2|Placebo Lead-in Period|Adverse Event|0
5094869|NCT01987908|17591490|P1|Placebo Lead-in Period|Adverse Event|2
5094870|NCT01987895|17591573|P2|Overall Study|randomized before giving IC|1
5094871|NCT01987895|17591574|P1|Overall Study|randomized before giving IC|0
5094872|NCT01987895|17591573|P2|Overall Study|Lost to Follow-up|5
5094873|NCT01987895|17591574|P1|Overall Study|Lost to Follow-up|3
5094874|NCT01987895|17591573|P2|Overall Study|Death|7
5094875|NCT01987895|17591574|P1|Overall Study|Death|7
5094876|NCT01987895|17591573|P2|Overall Study|Physician Decision|10
5094877|NCT01987895|17591574|P1|Overall Study|Physician Decision|8
5094878|NCT01987895|17591573|P2|Overall Study|Withdrawal by Subject|7
5094879|NCT01987895|17591574|P1|Overall Study|Withdrawal by Subject|12
5094880|NCT01987830|17591598|P1|Overall Study|Never received baseline scan|1
5094881|NCT01987765|17591602|P1|Overall Study|Lost to Follow-up|37
5094882|NCT01987765|17591602|P1|Overall Study|Protocol Violation|65
5094883|NCT01987609|17591612|P1|Overall Study|Adverse Event|1
5094884|NCT01987596|17591645|P2|Overall Study|Progressive Disease; missing all period|1
5094885|NCT01987596|17591646|P1|Overall Study|Progressive Disease; missing all period|0
5094886|NCT01987596|17591645|P2|Overall Study|Physician Decision|0
5094887|NCT01987596|17591646|P1|Overall Study|Physician Decision|1
5094888|NCT01987557|17591672|P3|Overall Study|Adverse Event|0
5094889|NCT01987557|17591673|P2|Overall Study|Adverse Event|2
5094890|NCT01987557|17591674|P1|Overall Study|Adverse Event|0
5094891|NCT01987557|17591672|P3|Overall Study|Withdrawal by Subject|2
5094892|NCT01987557|17591673|P2|Overall Study|Withdrawal by Subject|1
5094893|NCT01987557|17591674|P1|Overall Study|Withdrawal by Subject|2
5094894|NCT01987557|17591672|P3|Overall Study|Protocol Violation|1
5094895|NCT01987557|17591673|P2|Overall Study|Protocol Violation|0
5094896|NCT01987557|17591674|P1|Overall Study|Protocol Violation|1
5094897|NCT01987505|17591684|P1|Overall Study|Death|4
5094898|NCT01987505|17591684|P1|Overall Study|Investigator Decision|2
5094899|NCT01987505|17591684|P1|Overall Study|Lost to Follow-up|15
5094900|NCT01987505|17591684|P1|Overall Study|Other Reason|2
5094901|NCT01987505|17591684|P1|Overall Study|Withdrawal by Subject|2
5094902|NCT01987505|17591684|P1|Overall Study|Other|9
5094903|NCT01987479|17591714|P1|Overall Study|Adverse Event|7
5094904|NCT01987479|17591714|P1|Overall Study|Lost to Follow-up|1
5094905|NCT01987479|17591714|P1|Overall Study|Other|5
5094906|NCT01987479|17591714|P1|Overall Study|Participant/legal guardian decision|1
5094907|NCT01987479|17591714|P1|Overall Study|Physician Decision|2
5094908|NCT01987479|17591714|P1|Overall Study|Protocol Violation|1
5094909|NCT01987453|17591742|P3|Overall Study|Lack of Efficacy|0
5094910|NCT01987453|17591743|P2|Overall Study|Lack of Efficacy|12
5094911|NCT01987453|17591744|P1|Overall Study|Lack of Efficacy|1
5094912|NCT01987453|17591742|P3|Overall Study|Death|1
5094913|NCT01987453|17591743|P2|Overall Study|Death|0
5094914|NCT01987453|17591744|P1|Overall Study|Death|0
5094915|NCT01987427|17591770|P3|Overall Study|Other|0
5094916|NCT01987427|17591771|P2|Overall Study|Other|1
5094917|NCT01987427|17591772|P1|Overall Study|Other|1
5094918|NCT01987427|17591770|P3|Overall Study|Lack of Efficacy|0
5094919|NCT01987427|17591771|P2|Overall Study|Lack of Efficacy|0
5094920|NCT01987427|17591772|P1|Overall Study|Lack of Efficacy|1
5094921|NCT01987427|17591770|P3|Overall Study|Withdrawal by Subject|3
5094922|NCT01987427|17591771|P2|Overall Study|Withdrawal by Subject|1
5094923|NCT01987427|17591772|P1|Overall Study|Withdrawal by Subject|2
5094924|NCT01987427|17591770|P3|Overall Study|Lost to Follow-up|9
5094925|NCT01987427|17591771|P2|Overall Study|Lost to Follow-up|6
5094926|NCT01987427|17591772|P1|Overall Study|Lost to Follow-up|6
5094927|NCT01987427|17591770|P3|Overall Study|Adverse Event|8
5094928|NCT01987427|17591771|P2|Overall Study|Adverse Event|2
5094929|NCT01987427|17591772|P1|Overall Study|Adverse Event|4
5094930|NCT01987232|17591909|P5|Overall Study|Ongoing in Study|0
5094931|NCT01987232|17591910|P4|Overall Study|Ongoing in Study|1
5094932|NCT01987232|17591911|P3|Overall Study|Ongoing in Study|0
5094933|NCT01987232|17591912|P2|Overall Study|Ongoing in Study|0
5094934|NCT01987232|17591913|P1|Overall Study|Ongoing in Study|0
5094935|NCT01987102|17592002|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
5094936|NCT01987102|17592003|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
5094937|NCT01987102|17592002|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
5094938|NCT01987102|17592003|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
5094939|NCT01987102|17592002|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
5094940|NCT01987102|17592003|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
5094941|NCT01987102|17592002|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
5094942|NCT01987102|17592003|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
5094943|NCT01987102|17592002|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
5094944|NCT01987102|17592003|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
5094945|NCT01987102|17592002|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
5094946|NCT01987102|17592003|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
5094947|NCT01986985|17592050|P1|Overall Study|Scan not completed due to malfunction|3
5094948|NCT01986985|17592050|P1|Overall Study|Withdrawal by Subject|4
5094949|NCT01986920|17592087|P4|Placebo|Withdrawal by Subject|1
5094950|NCT01986920|17592088|P3|Placebo|Withdrawal by Subject|0
5094951|NCT01986920|17592089|P2|Placebo|Withdrawal by Subject|0
5094952|NCT01986920|17592090|P1|Placebo|Withdrawal by Subject|0
5094953|NCT01986920|17592087|P4|A-101 40%|Withdrawal by Subject|0
5094954|NCT01986920|17592088|P3|A-101 40%|Withdrawal by Subject|1
5094955|NCT01986920|17592089|P2|A-101 40%|Withdrawal by Subject|0
5094956|NCT01986920|17592090|P1|A-101 40%|Withdrawal by Subject|0
5094957|NCT01986920|17592087|P4|A-101 32.5%|Withdrawal by Subject|0
5094958|NCT01986920|17592088|P3|A-101 32.5%|Withdrawal by Subject|0
5094959|NCT01986920|17592089|P2|A-101 32.5%|Withdrawal by Subject|1
5094960|NCT01986920|17592090|P1|A-101 32.5%|Withdrawal by Subject|0
5094961|NCT01986920|17592087|P4|A- 101 25%|Withdrawal by Subject|0
5094962|NCT01986920|17592088|P3|A- 101 25%|Withdrawal by Subject|0
5094963|NCT01986920|17592089|P2|A- 101 25%|Withdrawal by Subject|0
5094964|NCT01986920|17592090|P1|A- 101 25%|Withdrawal by Subject|1
5094965|NCT01986907|17592104|P1|Overall Study|Death|9
5094966|NCT01986907|17592104|P1|Overall Study|Lost to Follow-up|38
5094967|NCT01986907|17592104|P1|Overall Study|Withdrawal by Subject|76
5094968|NCT01986907|17592104|P1|Overall Study|Protocol Violation|4
5094969|NCT01986907|17592104|P1|Overall Study|Unsatisfactory therapeutic effect|24
5094970|NCT01986907|17592104|P1|Overall Study|Adverse Event|11
5094971|NCT01986855|17592117|P3|Overall Study|Withdrawal by Subject|5
5094972|NCT01986855|17592118|P2|Overall Study|Withdrawal by Subject|8
5094973|NCT01986855|17592119|P1|Overall Study|Withdrawal by Subject|7
5094974|NCT01986855|17592117|P3|Overall Study|Participant Moved|2
5094975|NCT01986855|17592118|P2|Overall Study|Participant Moved|0
5094976|NCT01986855|17592119|P1|Overall Study|Participant Moved|0
5094977|NCT01986855|17592117|P3|Overall Study|Screen Failure|0
5094978|NCT01986855|17592118|P2|Overall Study|Screen Failure|1
5094979|NCT01986855|17592119|P1|Overall Study|Screen Failure|0
5094980|NCT01986855|17592117|P3|Overall Study|Lost to Follow-up|0
5094981|NCT01986855|17592118|P2|Overall Study|Lost to Follow-up|1
5094982|NCT01986855|17592119|P1|Overall Study|Lost to Follow-up|2
5094983|NCT01986855|17592117|P3|Overall Study|Death|4
5094984|NCT01986855|17592118|P2|Overall Study|Death|4
5094985|NCT01986855|17592119|P1|Overall Study|Death|3
5094986|NCT01986855|17592117|P3|Overall Study|Adverse Event|0
5094987|NCT01986855|17592118|P2|Overall Study|Adverse Event|0
5094988|NCT01986855|17592119|P1|Overall Study|Adverse Event|1
5094989|NCT01986829|17592148|P1|Overall Study|Death|1
5094990|NCT01986751|17592196|P2|Overall Study|improperly consented|2
5094991|NCT01986751|17592197|P1|Overall Study|improperly consented|10
5094992|NCT01986647|17592230|P4|Overall Study|Health|4
5094993|NCT01986647|17592231|P3|Overall Study|Health|6
5094994|NCT01986647|17592232|P2|Overall Study|Health|3
5094995|NCT01986647|17592233|P1|Overall Study|Health|5
5094996|NCT01986647|17592230|P4|Overall Study|Withdrawal by Subject|3
5094997|NCT01986647|17592231|P3|Overall Study|Withdrawal by Subject|2
5094998|NCT01986647|17592232|P2|Overall Study|Withdrawal by Subject|3
5094999|NCT01986647|17592233|P1|Overall Study|Withdrawal by Subject|1
5095000|NCT01986647|17592230|P4|Overall Study|Lost to Follow-up|4
5095001|NCT01986647|17592231|P3|Overall Study|Lost to Follow-up|4
5095002|NCT01986647|17592232|P2|Overall Study|Lost to Follow-up|1
5095003|NCT01986647|17592233|P1|Overall Study|Lost to Follow-up|4
5095004|NCT01986231|17592328|P1|Overall Study|Adverse Event|1
5095005|NCT01986140|17592335|P2|Overall Study|progression disease|1
5095006|NCT01986140|17592336|P1|Overall Study|progression disease|0
5095007|NCT01986140|17592335|P2|Overall Study|Adverse Event|1
5095008|NCT01986140|17592336|P1|Overall Study|Adverse Event|0
5095009|NCT01986140|17592335|P2|Overall Study|found not eligible|0
5095010|NCT01986140|17592336|P1|Overall Study|found not eligible|3
5095011|NCT01986140|17592335|P2|Overall Study|alternative treatment|1
5095012|NCT01986140|17592336|P1|Overall Study|alternative treatment|1
5095013|NCT01986140|17592335|P2|Overall Study|Withdrawal by Subject|25
5095014|NCT01986140|17592336|P1|Overall Study|Withdrawal by Subject|31
5095015|NCT01986114|17592342|P1|Overall Study|Other reason|7
5095016|NCT01986114|17592342|P1|Overall Study|Lost to Follow-up|5
5095017|NCT01986114|17592342|P1|Overall Study|Protocol Violation|1
5095018|NCT01986114|17592342|P1|Overall Study|Noncompliance|3
5095019|NCT01986114|17592342|P1|Overall Study|Withdrawal by Subject|58
5095020|NCT01986114|17592342|P1|Overall Study|Lack of Efficacy|23
5095021|NCT01986114|17592342|P1|Overall Study|Adverse Event|59
5095022|NCT01986062|17592381|P2|Overall Study|Withdrawal by Subject|1
5095023|NCT01986062|17592382|P1|Overall Study|Withdrawal by Subject|0
5095024|NCT01986062|17592381|P2|Overall Study|Lost to Follow-up|0
5095025|NCT01986062|17592382|P1|Overall Study|Lost to Follow-up|1
5095026|NCT01985360|17592480|P2|Overall Study|Lost to Follow-up|3
5095027|NCT01985360|17592481|P1|Overall Study|Lost to Follow-up|5
5095028|NCT01985360|17592480|P2|Overall Study|Withdrawal by Subject|0
5095029|NCT01985360|17592481|P1|Overall Study|Withdrawal by Subject|4
5095030|NCT01985334|17592497|P8|Overall Study|Lost to Follow-up|3
5095031|NCT01985334|17592498|P7|Overall Study|Lost to Follow-up|0
5095032|NCT01985334|17592499|P6|Overall Study|Lost to Follow-up|4
5095033|NCT01985334|17592500|P5|Overall Study|Lost to Follow-up|1
5095034|NCT01985334|17592501|P4|Overall Study|Lost to Follow-up|3
5095035|NCT01985334|17592502|P3|Overall Study|Lost to Follow-up|0
5095036|NCT01985334|17592503|P2|Overall Study|Lost to Follow-up|2
5095037|NCT01985334|17592504|P1|Overall Study|Lost to Follow-up|0
5095038|NCT01985334|17592497|P8|Overall Study|Investigator decision|4
5095039|NCT01985334|17592498|P7|Overall Study|Investigator decision|0
5095040|NCT01985334|17592499|P6|Overall Study|Investigator decision|1
5095041|NCT01985334|17592500|P5|Overall Study|Investigator decision|1
5095042|NCT01985334|17592501|P4|Overall Study|Investigator decision|7
5095043|NCT01985334|17592502|P3|Overall Study|Investigator decision|0
5095044|NCT01985334|17592503|P2|Overall Study|Investigator decision|3
5095045|NCT01985334|17592504|P1|Overall Study|Investigator decision|0
5095046|NCT01985334|17592497|P8|Overall Study|Use of prohibited treatment|0
5095047|NCT01985334|17592498|P7|Overall Study|Use of prohibited treatment|2
5095048|NCT01985334|17592499|P6|Overall Study|Use of prohibited treatment|6
5095049|NCT01985334|17592500|P5|Overall Study|Use of prohibited treatment|1
5095050|NCT01985334|17592501|P4|Overall Study|Use of prohibited treatment|2
5095051|NCT01985334|17592502|P3|Overall Study|Use of prohibited treatment|1
5095052|NCT01985334|17592503|P2|Overall Study|Use of prohibited treatment|4
5095053|NCT01985334|17592504|P1|Overall Study|Use of prohibited treatment|1
5095054|NCT01985334|17592497|P8|Overall Study|Medication non-compliance|3
5095055|NCT01985334|17592498|P7|Overall Study|Medication non-compliance|1
5095056|NCT01985334|17592499|P6|Overall Study|Medication non-compliance|3
5095057|NCT01985334|17592500|P5|Overall Study|Medication non-compliance|2
5095058|NCT01985334|17592501|P4|Overall Study|Medication non-compliance|6
5095059|NCT01985334|17592502|P3|Overall Study|Medication non-compliance|1
5095060|NCT01985334|17592503|P2|Overall Study|Medication non-compliance|4
5095061|NCT01985334|17592504|P1|Overall Study|Medication non-compliance|0
5095062|NCT01985334|17592497|P8|Overall Study|Other|2
5095063|NCT01985334|17592498|P7|Overall Study|Other|2
5095064|NCT01985334|17592499|P6|Overall Study|Other|6
5095065|NCT01985334|17592500|P5|Overall Study|Other|1
5095066|NCT01985334|17592501|P4|Overall Study|Other|10
5095067|NCT01985334|17592502|P3|Overall Study|Other|3
5095068|NCT01985334|17592503|P2|Overall Study|Other|2
5095069|NCT01985334|17592504|P1|Overall Study|Other|4
5095070|NCT01985334|17592497|P8|Overall Study|Adverse Event|15
5095071|NCT01985334|17592498|P7|Overall Study|Adverse Event|3
5095072|NCT01985334|17592499|P6|Overall Study|Adverse Event|18
5095073|NCT01985334|17592500|P5|Overall Study|Adverse Event|3
5095074|NCT01985334|17592501|P4|Overall Study|Adverse Event|26
5095075|NCT01985334|17592502|P3|Overall Study|Adverse Event|2
5095076|NCT01985334|17592503|P2|Overall Study|Adverse Event|8
5095077|NCT01985334|17592504|P1|Overall Study|Adverse Event|0
5095078|NCT01985334|17592497|P8|Overall Study|Subject withdrawal of consent|20
5095079|NCT01985334|17592498|P7|Overall Study|Subject withdrawal of consent|0
5095080|NCT01985334|17592499|P6|Overall Study|Subject withdrawal of consent|19
5095081|NCT01985334|17592500|P5|Overall Study|Subject withdrawal of consent|4
5095082|NCT01985334|17592501|P4|Overall Study|Subject withdrawal of consent|28
5095083|NCT01985334|17592502|P3|Overall Study|Subject withdrawal of consent|2
5095084|NCT01985334|17592503|P2|Overall Study|Subject withdrawal of consent|6
5095085|NCT01985334|17592504|P1|Overall Study|Subject withdrawal of consent|3
5095086|NCT01985334|17592497|P8|Overall Study|Moderate / severe COPD exacerbation|19
5095087|NCT01985334|17592498|P7|Overall Study|Moderate / severe COPD exacerbation|8
5095088|NCT01985334|17592499|P6|Overall Study|Moderate / severe COPD exacerbation|40
5095089|NCT01985334|17592500|P5|Overall Study|Moderate / severe COPD exacerbation|6
5095090|NCT01985334|17592501|P4|Overall Study|Moderate / severe COPD exacerbation|40
5095091|NCT01985334|17592502|P3|Overall Study|Moderate / severe COPD exacerbation|12
5095092|NCT01985334|17592503|P2|Overall Study|Moderate / severe COPD exacerbation|14
5095093|NCT01985334|17592504|P1|Overall Study|Moderate / severe COPD exacerbation|5
5095094|NCT01985334|17592497|P8|Overall Study|Protocol deviation|42
5095095|NCT01985334|17592498|P7|Overall Study|Protocol deviation|15
5095096|NCT01985334|17592499|P6|Overall Study|Protocol deviation|47
5095097|NCT01985334|17592500|P5|Overall Study|Protocol deviation|17
5095098|NCT01985334|17592501|P4|Overall Study|Protocol deviation|84
5095099|NCT01985334|17592502|P3|Overall Study|Protocol deviation|25
5095100|NCT01985334|17592503|P2|Overall Study|Protocol deviation|31
5095101|NCT01985334|17592504|P1|Overall Study|Protocol deviation|6
5095102|NCT01985334|17592497|P8|Overall Study|Other|7
5095103|NCT01985334|17592498|P7|Overall Study|Other|4
5095104|NCT01985334|17592499|P6|Overall Study|Other|8
5095105|NCT01985334|17592500|P5|Overall Study|Other|4
5095106|NCT01985334|17592501|P4|Overall Study|Other|17
5095107|NCT01985334|17592502|P3|Overall Study|Other|7
5095108|NCT01985334|17592503|P2|Overall Study|Other|9
5095109|NCT01985334|17592504|P1|Overall Study|Other|2
5095110|NCT01985334|17592497|P8|Overall Study|Worsening of disease|1
5095111|NCT01985334|17592498|P7|Overall Study|Worsening of disease|0
5095112|NCT01985334|17592499|P6|Overall Study|Worsening of disease|3
5095113|NCT01985334|17592500|P5|Overall Study|Worsening of disease|0
5095114|NCT01985334|17592501|P4|Overall Study|Worsening of disease|1
5095115|NCT01985334|17592502|P3|Overall Study|Worsening of disease|0
5095116|NCT01985334|17592503|P2|Overall Study|Worsening of disease|0
5095117|NCT01985334|17592504|P1|Overall Study|Worsening of disease|0
5095118|NCT01985334|17592497|P8|Overall Study|Death|2
5095119|NCT01985334|17592498|P7|Overall Study|Death|1
5095120|NCT01985334|17592499|P6|Overall Study|Death|0
5095121|NCT01985334|17592500|P5|Overall Study|Death|0
5095122|NCT01985334|17592501|P4|Overall Study|Death|3
5095123|NCT01985334|17592502|P3|Overall Study|Death|0
5095124|NCT01985334|17592503|P2|Overall Study|Death|0
5095125|NCT01985334|17592504|P1|Overall Study|Death|1
5095126|NCT01985334|17592497|P8|Overall Study|Administrative problems|3
5095127|NCT01985334|17592498|P7|Overall Study|Administrative problems|1
5095128|NCT01985334|17592499|P6|Overall Study|Administrative problems|1
5095129|NCT01985334|17592500|P5|Overall Study|Administrative problems|0
5095130|NCT01985334|17592501|P4|Overall Study|Administrative problems|2
5095131|NCT01985334|17592502|P3|Overall Study|Administrative problems|0
5095132|NCT01985334|17592503|P2|Overall Study|Administrative problems|1
5095133|NCT01985334|17592504|P1|Overall Study|Administrative problems|1
5095134|NCT01985321|17592572|P2|Overall Study|Subject treated wrong type of sore|0
5095135|NCT01985321|17592573|P1|Overall Study|Subject treated wrong type of sore|1
5095136|NCT01985321|17592572|P2|Overall Study|Lost to Follow-up|2
5095137|NCT01985321|17592573|P1|Overall Study|Lost to Follow-up|5
5095138|NCT01985321|17592572|P2|Overall Study|Withdrawal by Subject|0
5095139|NCT01985321|17592573|P1|Overall Study|Withdrawal by Subject|1
5095140|NCT01985321|17592572|P2|Overall Study|Protocol Violation|3
5095141|NCT01985321|17592573|P1|Overall Study|Protocol Violation|4
5095142|NCT01985126|17592583|P2|Overall Study|Withdrawal by Subject|7
5095143|NCT01985126|17592584|P1|Overall Study|Withdrawal by Subject|2
5095144|NCT01985126|17592583|P2|Overall Study|Study Terminated By Sponsor|22
5095145|NCT01985126|17592584|P1|Overall Study|Study Terminated By Sponsor|1
5095146|NCT01985126|17592583|P2|Overall Study|Lost to Follow-up|8
5095147|NCT01985126|17592584|P1|Overall Study|Lost to Follow-up|0
5095148|NCT01985126|17592583|P2|Overall Study|Death|69
5095149|NCT01985126|17592584|P1|Overall Study|Death|15
5095150|NCT01984892|17592602|P1|Overall Study|Progressive disease|7
5095151|NCT01984697|17592613|P5|Overall Study|Pregnancy|1
5095152|NCT01984697|17592614|P4|Overall Study|Pregnancy|0
5095153|NCT01984697|17592615|P3|Overall Study|Pregnancy|1
5095154|NCT01984697|17592616|P2|Overall Study|Pregnancy|0
5095155|NCT01984697|17592617|P1|Overall Study|Pregnancy|2
5095156|NCT01984697|17592613|P5|Overall Study|Death|0
5095157|NCT01984697|17592614|P4|Overall Study|Death|1
5095158|NCT01984697|17592615|P3|Overall Study|Death|0
5095159|NCT01984697|17592616|P2|Overall Study|Death|0
5095160|NCT01984697|17592617|P1|Overall Study|Death|0
5095161|NCT01984697|17592613|P5|Overall Study|Missed last follow-up visit|0
5095162|NCT01984697|17592614|P4|Overall Study|Missed last follow-up visit|0
5095163|NCT01984697|17592615|P3|Overall Study|Missed last follow-up visit|0
5095164|NCT01984697|17592616|P2|Overall Study|Missed last follow-up visit|0
5095165|NCT01984697|17592617|P1|Overall Study|Missed last follow-up visit|1
5095166|NCT01984697|17592613|P5|Overall Study|Withdrawal by Subject|13
5095167|NCT01984697|17592614|P4|Overall Study|Withdrawal by Subject|11
5095168|NCT01984697|17592615|P3|Overall Study|Withdrawal by Subject|13
5095169|NCT01984697|17592616|P2|Overall Study|Withdrawal by Subject|21
5095170|NCT01984697|17592617|P1|Overall Study|Withdrawal by Subject|15
5095171|NCT01984697|17592613|P5|Overall Study|Protocol Violation|0
5095172|NCT01984697|17592614|P4|Overall Study|Protocol Violation|2
5095173|NCT01984697|17592615|P3|Overall Study|Protocol Violation|3
5095174|NCT01984697|17592616|P2|Overall Study|Protocol Violation|5
5095175|NCT01984697|17592617|P1|Overall Study|Protocol Violation|8
5095176|NCT01984697|17592613|P5|Overall Study|Physician Decision|0
5095177|NCT01984697|17592614|P4|Overall Study|Physician Decision|1
5095178|NCT01984697|17592615|P3|Overall Study|Physician Decision|0
5095179|NCT01984697|17592616|P2|Overall Study|Physician Decision|0
5095180|NCT01984697|17592617|P1|Overall Study|Physician Decision|3
5095181|NCT01984697|17592613|P5|Overall Study|Lost to Follow-up|21
5095182|NCT01984697|17592614|P4|Overall Study|Lost to Follow-up|6
5095183|NCT01984697|17592615|P3|Overall Study|Lost to Follow-up|10
5095184|NCT01984697|17592616|P2|Overall Study|Lost to Follow-up|5
5095185|NCT01984697|17592617|P1|Overall Study|Lost to Follow-up|14
5095186|NCT01984697|17592613|P5|Overall Study|Adverse Event|0
5095187|NCT01984697|17592614|P4|Overall Study|Adverse Event|0
5095188|NCT01984697|17592615|P3|Overall Study|Adverse Event|2
5095189|NCT01984697|17592616|P2|Overall Study|Adverse Event|0
5095190|NCT01984697|17592617|P1|Overall Study|Adverse Event|0
5095191|NCT01984684|17592736|P2|Overall Study|Subject had inadequate IV access|1
5095192|NCT01984684|17592737|P1|Overall Study|Subject had inadequate IV access|0
5095193|NCT01984684|17592736|P2|Overall Study|Study drug not available at site|1
5095194|NCT01984684|17592737|P1|Overall Study|Study drug not available at site|1
5095195|NCT01984684|17592736|P2|Overall Study|Subject incarcerated|0
5095196|NCT01984684|17592737|P1|Overall Study|Subject incarcerated|1
5095197|NCT01984684|17592736|P2|Overall Study|Noncompliance with study drug|1
5095198|NCT01984684|17592737|P1|Overall Study|Noncompliance with study drug|2
5095199|NCT01984684|17592736|P2|Overall Study|Death|1
5095200|NCT01984684|17592737|P1|Overall Study|Death|0
5095201|NCT01984684|17592736|P2|Overall Study|Protocol Violation|2
5095202|NCT01984684|17592737|P1|Overall Study|Protocol Violation|4
5095203|NCT01984684|17592736|P2|Overall Study|Physician Decision|2
5095204|NCT01984684|17592737|P1|Overall Study|Physician Decision|4
5095205|NCT01984684|17592736|P2|Overall Study|Lack of Efficacy|6
5095206|NCT01984684|17592737|P1|Overall Study|Lack of Efficacy|3
5095207|NCT01984684|17592736|P2|Overall Study|Withdrawal by Subject|9
5095208|NCT01984684|17592737|P1|Overall Study|Withdrawal by Subject|9
5095209|NCT01984684|17592736|P2|Overall Study|Adverse Event|12
5095210|NCT01984684|17592737|P1|Overall Study|Adverse Event|8
5095211|NCT01984684|17592736|P2|Overall Study|Lost to Follow-up|24
5095212|NCT01984684|17592737|P1|Overall Study|Lost to Follow-up|25
5095213|NCT01984424|17592755|P2|Overall Study|Lost to Follow-up|1
5095214|NCT01984424|17592756|P1|Overall Study|Lost to Follow-up|0
5095215|NCT01984424|17592755|P2|Overall Study|Sponsor Decision|1
5095216|NCT01984424|17592756|P1|Overall Study|Sponsor Decision|0
5095217|NCT01984424|17592755|P2|Overall Study|Withdrawal by Subject|5
5095218|NCT01984424|17592756|P1|Overall Study|Withdrawal by Subject|3
5095219|NCT01984294|17592826|P3|Overall Study|Adverse Event|0
5095220|NCT01984294|17592827|P2|Overall Study|Adverse Event|1
5095221|NCT01984294|17592828|P1|Overall Study|Adverse Event|0
5095222|NCT01984294|17592826|P3|Overall Study|Lack of Efficacy|6
5095223|NCT01984294|17592827|P2|Overall Study|Lack of Efficacy|2
5095224|NCT01984294|17592828|P1|Overall Study|Lack of Efficacy|4
5095225|NCT01984294|17592826|P3|Overall Study|Randomized but Never Treated|1
5095226|NCT01984294|17592827|P2|Overall Study|Randomized but Never Treated|0
5095227|NCT01984294|17592828|P1|Overall Study|Randomized but Never Treated|0
5095228|NCT01984242|17592851|P3|Overall Study|Disease Progression|1
5095229|NCT01984242|17592852|P2|Overall Study|Disease Progression|0
5095230|NCT01984242|17592853|P1|Overall Study|Disease Progression|0
5095231|NCT01984242|17592851|P3|Overall Study|Study terminated by Sponsor|34
5095232|NCT01984242|17592852|P2|Overall Study|Study terminated by Sponsor|50
5095233|NCT01984242|17592853|P1|Overall Study|Study terminated by Sponsor|38
5095234|NCT01984242|17592851|P3|Overall Study|Non-Compliance|0
5095235|NCT01984242|17592852|P2|Overall Study|Non-Compliance|0
5095236|NCT01984242|17592853|P1|Overall Study|Non-Compliance|1
5095237|NCT01984242|17592851|P3|Overall Study|Sponsor Decision|0
5095238|NCT01984242|17592852|P2|Overall Study|Sponsor Decision|0
5095239|NCT01984242|17592853|P1|Overall Study|Sponsor Decision|1
5095240|NCT01984242|17592851|P3|Overall Study|Lost to Follow-up|3
5095241|NCT01984242|17592852|P2|Overall Study|Lost to Follow-up|0
5095242|NCT01984242|17592853|P1|Overall Study|Lost to Follow-up|4
5095243|NCT01984242|17592851|P3|Overall Study|Physician Decision|1
5095244|NCT01984242|17592852|P2|Overall Study|Physician Decision|0
5095245|NCT01984242|17592853|P1|Overall Study|Physician Decision|0
5095246|NCT01984242|17592851|P3|Overall Study|Withdrawal by Subject|10
5095247|NCT01984242|17592852|P2|Overall Study|Withdrawal by Subject|3
5095248|NCT01984242|17592853|P1|Overall Study|Withdrawal by Subject|5
5095249|NCT01984242|17592851|P3|Overall Study|Death|52
5095250|NCT01984242|17592852|P2|Overall Study|Death|50
5095251|NCT01984242|17592853|P1|Overall Study|Death|52
5095252|NCT01984229|17593003|P2|Safety Follow-up Period|Lost to Follow-up|0
5095253|NCT01984229|17593004|P1|Safety Follow-up Period|Lost to Follow-up|1
5095254|NCT01984229|17593003|P2|Safety Follow-up Period|Adverse Event|1
5095255|NCT01984229|17593004|P1|Safety Follow-up Period|Adverse Event|1
5095256|NCT01983969|17593057|P3|Overall Study|Disease Progression|0
5095257|NCT01983969|17593058|P2|Overall Study|Disease Progression|1
5095258|NCT01983969|17593059|P1|Overall Study|Disease Progression|0
5095259|NCT01983930|17593073|P2|Overall Study|Adverse Event|1
5095260|NCT01983930|17593074|P1|Overall Study|Adverse Event|0
5095261|NCT01983930|17593073|P2|Overall Study|Withdrawal by Subject|8
5095262|NCT01983930|17593074|P1|Overall Study|Withdrawal by Subject|9
5095263|NCT01983683|17593148|P2|Overall Study|Sponsor Decision|1
5095264|NCT01983683|17593149|P1|Overall Study|Sponsor Decision|1
5095265|NCT01983683|17593148|P2|Overall Study|Lost to Follow-up|8
5095266|NCT01983683|17593149|P1|Overall Study|Lost to Follow-up|4
5095267|NCT01983683|17593148|P2|Overall Study|Physician Decision|9
5095268|NCT01983683|17593149|P1|Overall Study|Physician Decision|8
5095269|NCT01983683|17593148|P2|Overall Study|Death|15
5095270|NCT01983683|17593149|P1|Overall Study|Death|11
5095271|NCT01983683|17593148|P2|Overall Study|Withdrawal by Subject|18
5095272|NCT01983683|17593149|P1|Overall Study|Withdrawal by Subject|14
5095273|NCT01983293|17593236|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
5095274|NCT01983293|17593237|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
5095275|NCT01983293|17593236|P2|Overall Study|Missing 12-month visit|3
5095276|NCT01983293|17593237|P1|Overall Study|Missing 12-month visit|3
5095277|NCT01983293|17593236|P2|Overall Study|Withdrawal by Subject|15
5095278|NCT01983293|17593237|P1|Overall Study|Withdrawal by Subject|29
5095279|NCT01983254|17593245|P2|Overall Study|too ill|8
5095280|NCT01983254|17593246|P1|Overall Study|too ill|11
5095281|NCT01983254|17593245|P2|Overall Study|Lost to Follow-up|16
5095282|NCT01983254|17593246|P1|Overall Study|Lost to Follow-up|17
5095283|NCT01983254|17593245|P2|Overall Study|Death|6
5095284|NCT01983254|17593246|P1|Overall Study|Death|6
5095285|NCT01983111|17593258|P2|Overall Study|Protocol Violation|1
5095286|NCT01983111|17593259|P1|Overall Study|Protocol Violation|0
5095287|NCT01983111|17593258|P2|Overall Study|Adverse Event|0
5095288|NCT01983111|17593259|P1|Overall Study|Adverse Event|4
5095289|NCT01983111|17593258|P2|Overall Study|Withdrawal by Subject|6
5095290|NCT01983111|17593259|P1|Overall Study|Withdrawal by Subject|8
5095291|NCT01982955|17593297|P5|Overall Study|Ongoing|0
5095292|NCT01982955|17593298|P4|Overall Study|Ongoing|0
5095293|NCT01982955|17593299|P3|Overall Study|Ongoing|4
5095294|NCT01982955|17593300|P2|Overall Study|Ongoing|0
5095295|NCT01982955|17593301|P1|Overall Study|Ongoing|0
5095296|NCT01982955|17593297|P5|Overall Study|Randomized but not treated|0
5095297|NCT01982955|17593298|P4|Overall Study|Randomized but not treated|1
5095298|NCT01982955|17593299|P3|Overall Study|Randomized but not treated|0
5095299|NCT01982955|17593300|P2|Overall Study|Randomized but not treated|0
5095300|NCT01982955|17593301|P1|Overall Study|Randomized but not treated|0
5095301|NCT01982942|17593403|P2|Overall Study|Subject bedridden, rapidly declining|1
5095302|NCT01982942|17593404|P1|Overall Study|Subject bedridden, rapidly declining|0
5095303|NCT01982942|17593403|P2|Overall Study|Chose to join a stem cell trial|1
5095304|NCT01982942|17593404|P1|Overall Study|Chose to join a stem cell trial|0
5095305|NCT01982942|17593403|P2|Overall Study|MS Relapse|1
5095306|NCT01982942|17593404|P1|Overall Study|MS Relapse|0
5095307|NCT01982942|17593403|P2|Overall Study|Too many pills|0
5095308|NCT01982942|17593404|P1|Overall Study|Too many pills|1
5095309|NCT01982942|17593403|P2|Overall Study|Left geographical area|0
5095310|NCT01982942|17593404|P1|Overall Study|Left geographical area|2
5095311|NCT01982942|17593403|P2|Overall Study|Subject declined future visits|1
5095312|NCT01982942|17593404|P1|Overall Study|Subject declined future visits|0
5095313|NCT01982942|17593403|P2|Overall Study|Wanted to try therapy not permitted|0
5095314|NCT01982942|17593404|P1|Overall Study|Wanted to try therapy not permitted|1
5095315|NCT01982942|17593403|P2|Overall Study|Multiple sclerosis progression|2
5095316|NCT01982942|17593404|P1|Overall Study|Multiple sclerosis progression|3
5095317|NCT01982942|17593403|P2|Overall Study|Lost to Follow-up|3
5095318|NCT01982942|17593404|P1|Overall Study|Lost to Follow-up|4
5095319|NCT01982942|17593403|P2|Overall Study|Adverse Event|5
5095320|NCT01982942|17593404|P1|Overall Study|Adverse Event|10
5095321|NCT01982812|17593422|P2|Overall Study|Adverse Event|5
5095322|NCT01982812|17593423|P1|Overall Study|Adverse Event|0
5095323|NCT01982812|17593422|P2|Overall Study|Death|5
5095324|NCT01982812|17593423|P1|Overall Study|Death|1
5095325|NCT01982773|17593452|P2|Overall Study|Lost to Follow-up|1
5095326|NCT01982773|17593453|P1|Overall Study|Lost to Follow-up|7
5095327|NCT01982773|17593452|P2|Overall Study|Withdrawal by Subject|3
5095328|NCT01982773|17593453|P1|Overall Study|Withdrawal by Subject|1
5095329|NCT01982682|17593474|P1|Overall Study|Physician Decision|1
5095330|NCT01982435|17593494|P2|Overall Study|Adverse Event|0
5095331|NCT01982435|17593495|P1|Overall Study|Adverse Event|1
5095332|NCT01982331|17593534|P2|Completed Study (Day 112)|Withdrawal by Subject|0
5095333|NCT01982331|17593535|P1|Completed Study (Day 112)|Withdrawal by Subject|2
5095334|NCT01982331|17593534|P2|Received Vaccination 2|Withdrawal by Subject|1
5095335|NCT01982331|17593535|P1|Received Vaccination 2|Withdrawal by Subject|0
5095336|NCT01982331|17593534|P2|Received Vaccination 2|Adverse Event|2
5095337|NCT01982331|17593535|P1|Received Vaccination 2|Adverse Event|1
5095338|NCT01982292|17593571|P2|Overall Study|Technical Problems|0
5095339|NCT01982292|17593572|P1|Overall Study|Technical Problems|2
5095340|NCT01982292|17593571|P2|Overall Study|Patient/Guardian Decision|1
5095341|NCT01982292|17593572|P1|Overall Study|Patient/Guardian Decision|3
5095342|NCT01982292|17593571|P2|Overall Study|Protocol Deviation|0
5095343|NCT01982292|17593572|P1|Overall Study|Protocol Deviation|1
5095344|NCT01982292|17593571|P2|Overall Study|Non-Compliance With Study Treatment|0
5095345|NCT01982292|17593572|P1|Overall Study|Non-Compliance With Study Treatment|1
5095346|NCT01982292|17593571|P2|Overall Study|Lost to Follow-up|0
5095347|NCT01982292|17593572|P1|Overall Study|Lost to Follow-up|2
5095348|NCT01982292|17593571|P2|Overall Study|Death|0
5095349|NCT01982292|17593572|P1|Overall Study|Death|1
5095350|NCT01982292|17593571|P2|Overall Study|Adverse Event|0
5095351|NCT01982292|17593572|P1|Overall Study|Adverse Event|2
5095352|NCT01982253|17593593|P3|Overall Study|Study terminated by sponsor|4
5095353|NCT01982253|17593594|P2|Overall Study|Study terminated by sponsor|4
5095354|NCT01982253|17593595|P1|Overall Study|Study terminated by sponsor|1
5095355|NCT01982253|17593593|P3|Overall Study|Withdrawal by Subject|0
5095356|NCT01982253|17593594|P2|Overall Study|Withdrawal by Subject|0
5095357|NCT01982253|17593595|P1|Overall Study|Withdrawal by Subject|1
5095358|NCT01981954|17593649|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
5095359|NCT01981954|17593649|P1|Titration Period|Protocol Deviation|1
5095360|NCT01981616|17593733|P2|Overall Study|Protocol Violation|0
5095361|NCT01981616|17593734|P1|Overall Study|Protocol Violation|1
5095362|NCT01981616|17593733|P2|Overall Study|Adverse Event|1
5095363|NCT01981616|17593734|P1|Overall Study|Adverse Event|0
5095364|NCT01981551|17593764|P1|Overall Study|Adverse Event|1
5095365|NCT01981551|17593764|P1|Overall Study|Refused further treatment|8
5095366|NCT01981473|17593774|P3|Overall Study|Received treatment for >24 months|6
5095367|NCT01981473|17593775|P2|Overall Study|Received treatment for >24 months|0
5095368|NCT01981473|17593776|P1|Overall Study|Received treatment for >24 months|2
5095369|NCT01981473|17593774|P3|Overall Study|Received treatment for < 6 months|1
5095370|NCT01981473|17593775|P2|Overall Study|Received treatment for < 6 months|0
5095371|NCT01981473|17593776|P1|Overall Study|Received treatment for < 6 months|0
5095372|NCT01981473|17593774|P3|Overall Study|Incorrect diagnosis of RA|1
5095373|NCT01981473|17593775|P2|Overall Study|Incorrect diagnosis of RA|0
5095374|NCT01981473|17593776|P1|Overall Study|Incorrect diagnosis of RA|0
5095375|NCT01981356|17593817|P2|Overall Study|Protocol Violation|0
5095376|NCT01981356|17593818|P1|Overall Study|Protocol Violation|2
5095377|NCT01981356|17593817|P2|Overall Study|Withdrawal by Subject|1
5095378|NCT01981356|17593818|P1|Overall Study|Withdrawal by Subject|1
5095379|NCT01981356|17593817|P2|Overall Study|Lost to Follow-up|1
5095380|NCT01981356|17593818|P1|Overall Study|Lost to Follow-up|4
5095381|NCT01981122|17593845|P2|Overall Study|Death|15
5095382|NCT01981122|17593846|P1|Overall Study|Death|14
5095383|NCT01981122|17593845|P2|Overall Study|Investigator Or Dendreon Discretion|1
5095384|NCT01981122|17593846|P1|Overall Study|Investigator Or Dendreon Discretion|0
5095385|NCT01981122|17593845|P2|Overall Study|Lost to Follow-up|1
5095386|NCT01981122|17593846|P1|Overall Study|Lost to Follow-up|0
5095387|NCT01981122|17593845|P2|Overall Study|Protocol Violation|1
5095388|NCT01981122|17593846|P1|Overall Study|Protocol Violation|0
5095389|NCT01981122|17593845|P2|Overall Study|Withdrawal by Subject|2
5095390|NCT01981122|17593846|P1|Overall Study|Withdrawal by Subject|0
5095391|NCT01981109|17593852|P1|Overall Study|No data available|2
5095392|NCT01981109|17593852|P1|Overall Study|Study Termination|100
5095393|NCT01981109|17593852|P1|Overall Study|No Discontinuation Documentation|37
5095394|NCT01981109|17593852|P1|Overall Study|Lost to Follow-up|9
5095395|NCT01981109|17593852|P1|Overall Study|Withdrawal by Subject|40
5095396|NCT01981109|17593852|P1|Overall Study|Death|36
5095397|NCT01981096|17593859|P2|Overall Study|Lost to Follow-up|0
5095398|NCT01981096|17593860|P1|Overall Study|Lost to Follow-up|2
5095399|NCT01981096|17593859|P2|Overall Study|Withdrawal by Subject|1
5095400|NCT01981096|17593860|P1|Overall Study|Withdrawal by Subject|0
5095401|NCT01981096|17593859|P2|Overall Study|Parent illness|0
5095402|NCT01981096|17593860|P1|Overall Study|Parent illness|1
5095403|NCT01980992|17593881|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
5095404|NCT01980992|17593882|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
5095405|NCT01980992|17593881|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
5095406|NCT01980992|17593882|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
5095407|NCT01980992|17593881|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
5095408|NCT01980992|17593882|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
5095409|NCT01980992|17593881|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
5095410|NCT01980992|17593882|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
5095411|NCT01980992|17593881|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
5095412|NCT01980992|17593882|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
5095413|NCT01980992|17593881|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
5095414|NCT01980992|17593882|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
5095415|NCT01980940|17593907|P8|Overall Study|Protocol Violation|0
5095416|NCT01980940|17593908|P7|Overall Study|Protocol Violation|0
5095417|NCT01980940|17593909|P6|Overall Study|Protocol Violation|2
5095418|NCT01980940|17593910|P5|Overall Study|Protocol Violation|0
5095419|NCT01980940|17593911|P4|Overall Study|Protocol Violation|0
5095420|NCT01980940|17593912|P3|Overall Study|Protocol Violation|0
5095421|NCT01980940|17593913|P2|Overall Study|Protocol Violation|0
5095422|NCT01980940|17593914|P1|Overall Study|Protocol Violation|0
5095423|NCT01980888|17593973|P2|Overall Study|Non-Compliance with Study Drug|2
5095424|NCT01980888|17593974|P1|Overall Study|Non-Compliance with Study Drug|3
5095425|NCT01980888|17593973|P2|Overall Study|Investigator's Discretion|3
5095426|NCT01980888|17593974|P1|Overall Study|Investigator's Discretion|8
5095427|NCT01980888|17593973|P2|Overall Study|Withdrew Consent|6
5095428|NCT01980888|17593974|P1|Overall Study|Withdrew Consent|17
5095429|NCT01980888|17593973|P2|Overall Study|Study Terminated by Sponsor|122
5095430|NCT01980888|17593974|P1|Overall Study|Study Terminated by Sponsor|116
5095431|NCT01980875|17593993|P3|Overall Study|Lost to Follow-up|1
5095432|NCT01980875|17593994|P2|Overall Study|Lost to Follow-up|0
5095433|NCT01980875|17593995|P1|Overall Study|Lost to Follow-up|0
5095434|NCT01980875|17593993|P3|Overall Study|Study Terminated by Sponsor|22
5095435|NCT01980875|17593994|P2|Overall Study|Study Terminated by Sponsor|24
5095436|NCT01980875|17593995|P1|Overall Study|Study Terminated by Sponsor|7
5095437|NCT01980875|17593993|P3|Overall Study|Withdrew Consent|1
5095438|NCT01980875|17593994|P2|Overall Study|Withdrew Consent|1
5095439|NCT01980875|17593995|P1|Overall Study|Withdrew Consent|1
5095440|NCT01980706|17594030|P3|Overall Study|miscellaneous|3
5095441|NCT01980706|17594031|P2|Overall Study|miscellaneous|5
5095442|NCT01980706|17594032|P1|Overall Study|miscellaneous|4
5095443|NCT01980706|17594030|P3|Overall Study|Lost to Follow-up|3
5095444|NCT01980706|17594031|P2|Overall Study|Lost to Follow-up|4
5095445|NCT01980706|17594032|P1|Overall Study|Lost to Follow-up|3
5095446|NCT01980706|17594030|P3|Overall Study|Adverse Event|5
5095447|NCT01980706|17594031|P2|Overall Study|Adverse Event|2
5095448|NCT01980706|17594032|P1|Overall Study|Adverse Event|1
5095449|NCT01980706|17594030|P3|Overall Study|Withdrawal by Subject|2
5095450|NCT01980706|17594031|P2|Overall Study|Withdrawal by Subject|6
5095451|NCT01980706|17594032|P1|Overall Study|Withdrawal by Subject|9
5095452|NCT01980628|17594072|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
5095453|NCT01980628|17594072|P1|Overall Study|Withdrawal by Subject|4
5095454|NCT01980628|17594072|P1|Overall Study|Physician Decision|5
5095455|NCT01980628|17594072|P1|Overall Study|Adverse Event|12
5095456|NCT01980095|17594131|P2|Overall Study|Randomized by mistake|0
5095457|NCT01980095|17594132|P1|Overall Study|Randomized by mistake|1
5095458|NCT01980095|17594131|P2|Overall Study|Study drug discontinued|0
5095459|NCT01980095|17594132|P1|Overall Study|Study drug discontinued|1
5095460|NCT01980095|17594131|P2|Overall Study|Safety issue|1
5095461|NCT01980095|17594132|P1|Overall Study|Safety issue|0
5095462|NCT01980095|17594131|P2|Overall Study|Poor compliance|0
5095463|NCT01980095|17594132|P1|Overall Study|Poor compliance|5
5095464|NCT01980095|17594131|P2|Overall Study|Withdrawal by Subject|3
5095465|NCT01980095|17594132|P1|Overall Study|Withdrawal by Subject|2
5095466|NCT01980095|17594131|P2|Overall Study|Lost to Follow-up|7
5095467|NCT01980095|17594132|P1|Overall Study|Lost to Follow-up|6
5095468|NCT01980056|17594143|P3|Overall Study|Death|0
5095469|NCT01980056|17594144|P2|Overall Study|Death|1
5095470|NCT01980056|17594145|P1|Overall Study|Death|1
5095471|NCT01979952|17594159|P2|Overall Study|Other than specified above|0
5095472|NCT01979952|17594160|P1|Overall Study|Other than specified above|1
5095473|NCT01979952|17594159|P2|Overall Study|Withdrawal by Subject|1
5095474|NCT01979952|17594160|P1|Overall Study|Withdrawal by Subject|2
5095475|NCT01979952|17594159|P2|Overall Study|Protocol Violation|0
5095476|NCT01979952|17594160|P1|Overall Study|Protocol Violation|1
5095477|NCT01979952|17594159|P2|Overall Study|Adverse Event|5
5095478|NCT01979952|17594160|P1|Overall Study|Adverse Event|4
5095479|NCT01979835|17594188|P1|Follow-up|Lost to Follow-up|32
5095480|NCT01979835|17594188|P1|Primary Outcome SA Measurment|failed insertion|18
5095481|NCT01979614|17594195|P2|Overall Study|Adverse Event|1
5095482|NCT01979614|17594196|P1|Overall Study|Adverse Event|1
5095483|NCT01979523|17594218|P2|Overall Study|Withdrawal by Subject|0
5095484|NCT01979523|17594219|P1|Overall Study|Withdrawal by Subject|1
5095485|NCT01979185|17594279|P2|Period 2|Other|1
5095486|NCT01979185|17594280|P1|Period 2|Other|0
5095487|NCT01979016|17594328|P2|Overall Study|Adverse Event|1
5095488|NCT01979016|17594329|P1|Overall Study|Adverse Event|0
5095489|NCT01979016|17594328|P2|Overall Study|Withdrawal by Subject|0
5095490|NCT01979016|17594329|P1|Overall Study|Withdrawal by Subject|2
5095491|NCT01978938|17594363|P2|Overall Study|Previously scheduled procedure|1
5095492|NCT01978938|17594364|P1|Overall Study|Previously scheduled procedure|0
5095493|NCT01978938|17594363|P2|Overall Study|Did not meet inclusion criteria|1
5095494|NCT01978938|17594364|P1|Overall Study|Did not meet inclusion criteria|0
5095495|NCT01978938|17594363|P2|Overall Study|Participant noncompliance|1
5095496|NCT01978938|17594364|P1|Overall Study|Participant noncompliance|1
5095497|NCT01978938|17594363|P2|Overall Study|Adverse Event, non-fatal|1
5095498|NCT01978938|17594364|P1|Overall Study|Adverse Event, non-fatal|2
5095499|NCT01978938|17594363|P2|Overall Study|Withdrawal by Subject|4
5095500|NCT01978938|17594364|P1|Overall Study|Withdrawal by Subject|8
5095501|NCT01978938|17594363|P2|Overall Study|Lost to Follow-up|6
5095502|NCT01978938|17594364|P1|Overall Study|Lost to Follow-up|12
5095503|NCT01978912|17594378|P4|Overall Study|Intradiscal Steroid Injection|0
5095504|NCT01978912|17594379|P3|Overall Study|Intradiscal Steroid Injection|0
5095505|NCT01978912|17594380|P2|Overall Study|Intradiscal Steroid Injection|1
5095506|NCT01978912|17594381|P1|Overall Study|Intradiscal Steroid Injection|0
5095507|NCT01978912|17594378|P4|Overall Study|Lumbar Surgery|0
5095508|NCT01978912|17594379|P3|Overall Study|Lumbar Surgery|1
5095509|NCT01978912|17594380|P2|Overall Study|Lumbar Surgery|0
5095510|NCT01978912|17594381|P1|Overall Study|Lumbar Surgery|1
5095511|NCT01978912|17594378|P4|Overall Study|Withdrawal by Subject|2
5095512|NCT01978912|17594379|P3|Overall Study|Withdrawal by Subject|2
5095513|NCT01978912|17594380|P2|Overall Study|Withdrawal by Subject|0
5095514|NCT01978912|17594381|P1|Overall Study|Withdrawal by Subject|1
5095515|NCT01978912|17594378|P4|Overall Study|Lost to Follow-up|1
5095516|NCT01978912|17594379|P3|Overall Study|Lost to Follow-up|0
5095517|NCT01978912|17594380|P2|Overall Study|Lost to Follow-up|1
5095518|NCT01978912|17594381|P1|Overall Study|Lost to Follow-up|1
5095519|NCT01978912|17594378|P4|Overall Study|Adverse Event|0
5095520|NCT01978912|17594379|P3|Overall Study|Adverse Event|0
5095521|NCT01978912|17594380|P2|Overall Study|Adverse Event|1
5095522|NCT01978912|17594381|P1|Overall Study|Adverse Event|0
5095523|NCT01978262|17594574|P1|Overall Study|Lost to Follow-up|2
5095524|NCT01978262|17594574|P1|Overall Study|Withdrawal by Subject|9
5095525|NCT01978236|17594579|P1|Overall Study|Discontinued due to study close|2
5095526|NCT01978184|17594600|P2|Overall Study|Withdrew- toxicities or physical decline|8
5095527|NCT01978184|17594601|P1|Overall Study|Withdrew- toxicities or physical decline|4
5095528|NCT01978184|17594600|P2|Overall Study|Death|0
5095529|NCT01978184|17594601|P1|Overall Study|Death|1
5095530|NCT01978184|17594600|P2|Overall Study|Noncompliance|2
5095531|NCT01978184|17594601|P1|Overall Study|Noncompliance|1
5095532|NCT01978184|17594600|P2|Overall Study|Physician Decision|3
5095533|NCT01978184|17594601|P1|Overall Study|Physician Decision|0
5095534|NCT01978184|17594600|P2|Overall Study|Other than PDA|2
5095535|NCT01978184|17594601|P1|Overall Study|Other than PDA|2
5095536|NCT01978184|17594600|P2|Overall Study|Progressive disease|5
5095537|NCT01978184|17594601|P1|Overall Study|Progressive disease|5
5095538|NCT01978145|17594627|P2|Treatment Period 2|Par. reached defined stopping criteria|5
5095539|NCT01978145|17594628|P1|Treatment Period 2|Par. reached defined stopping criteria|8
5095540|NCT01978145|17594627|P2|Treatment Period 2|Withdrawal by Subject|4
5095541|NCT01978145|17594628|P1|Treatment Period 2|Withdrawal by Subject|7
5095542|NCT01978145|17594627|P2|Treatment Period 2|Lost to Follow-up|1
5095543|NCT01978145|17594628|P1|Treatment Period 2|Lost to Follow-up|1
5095544|NCT01978145|17594627|P2|Treatment Period 2|Protocol Violation|1
5095545|NCT01978145|17594628|P1|Treatment Period 2|Protocol Violation|0
5095546|NCT01978145|17594627|P2|Treatment Period 2|Adverse Event|3
5095547|NCT01978145|17594628|P1|Treatment Period 2|Adverse Event|3
5095548|NCT01978145|17594627|P2|Washout Period 1|Par. reached defined stopping criteria|1
5095549|NCT01978145|17594628|P1|Washout Period 1|Par. reached defined stopping criteria|0
5095550|NCT01978145|17594627|P2|Washout Period 1|Withdrawal by Subject|1
5095551|NCT01978145|17594628|P1|Washout Period 1|Withdrawal by Subject|1
5095552|NCT01978145|17594627|P2|Washout Period 1|Adverse Event|1
5095553|NCT01978145|17594628|P1|Washout Period 1|Adverse Event|0
5095554|NCT01978145|17594627|P2|Treatment Period 1|Par. reached defined stopping criteria|3
5095555|NCT01978145|17594628|P1|Treatment Period 1|Par. reached defined stopping criteria|2
5095556|NCT01978145|17594627|P2|Treatment Period 1|Withdrawal by Subject|4
5095557|NCT01978145|17594628|P1|Treatment Period 1|Withdrawal by Subject|5
5095558|NCT01978145|17594627|P2|Treatment Period 1|Physician Decision|0
5095559|NCT01978145|17594628|P1|Treatment Period 1|Physician Decision|1
5095560|NCT01978145|17594627|P2|Treatment Period 1|Adverse Event|9
5095561|NCT01978145|17594628|P1|Treatment Period 1|Adverse Event|1
5095562|NCT01978119|17594644|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
5095563|NCT01978119|17594645|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5095564|NCT01978119|17594644|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5095565|NCT01978119|17594645|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5095566|NCT01978119|17594644|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
5095567|NCT01978119|17594645|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
5095568|NCT01978093|17594671|P2|Overall Study|N/A for vaccine administration|1
5095569|NCT01978093|17594672|P1|Overall Study|N/A for vaccine administration|0
5095570|NCT01978093|17594671|P2|Overall Study|Child was in care of grandmother|1
5095571|NCT01978093|17594672|P1|Overall Study|Child was in care of grandmother|0
5095572|NCT01978093|17594671|P2|Overall Study|Mother lost custody of child|1
5095573|NCT01978093|17594672|P1|Overall Study|Mother lost custody of child|0
5095574|NCT01978093|17594671|P2|Overall Study|Lost kaiser health plan unable to contac|0
5095575|NCT01978093|17594672|P1|Overall Study|Lost kaiser health plan unable to contac|1
5095576|NCT01978093|17594671|P2|Overall Study|Loss of kaiser coverage|10
5095577|NCT01978093|17594672|P1|Overall Study|Loss of kaiser coverage|4
5095578|NCT01978093|17594671|P2|Overall Study|Migrated/moved from study area|13
5095579|NCT01978093|17594672|P1|Overall Study|Migrated/moved from study area|11
5095580|NCT01978093|17594671|P2|Overall Study|Lost to Follow-up|15
5095581|NCT01978093|17594672|P1|Overall Study|Lost to Follow-up|11
5095582|NCT01978093|17594671|P2|Overall Study|Withdrawal by Subject|25
5095583|NCT01978093|17594672|P1|Overall Study|Withdrawal by Subject|29
5095584|NCT01978093|17594671|P2|Overall Study|Protocol Violation|2
5095585|NCT01978093|17594672|P1|Overall Study|Protocol Violation|8
5095586|NCT01978093|17594671|P2|Overall Study|Adverse Event|5
5095587|NCT01978093|17594672|P1|Overall Study|Adverse Event|0
5095588|NCT01978093|17594671|P2|Overall Study|Death|0
5095589|NCT01978093|17594672|P1|Overall Study|Death|1
5095590|NCT01977937|17594716|P2|Overall Study|Physician Decision|1
5095591|NCT01977937|17594717|P1|Overall Study|Physician Decision|0
5095592|NCT01977937|17594716|P2|Overall Study|Adverse Event|0
5095593|NCT01977937|17594717|P1|Overall Study|Adverse Event|1
5095594|NCT01977937|17594716|P2|Overall Study|Withdrawal by Subject|1
5095595|NCT01977937|17594717|P1|Overall Study|Withdrawal by Subject|2
5095596|NCT01977846|17594727|P2|Total Study - Prospective|Protocol Violation|1
5095597|NCT01977846|17594728|P1|Total Study - Prospective|Protocol Violation|0
5095598|NCT01977846|17594727|P2|Total Study - Prospective|No show|1
5095599|NCT01977846|17594728|P1|Total Study - Prospective|No show|0
5095600|NCT01977846|17594727|P2|Total Study - Prospective|Not available at time of visit|5
5095601|NCT01977846|17594728|P1|Total Study - Prospective|Not available at time of visit|0
5095602|NCT01977846|17594727|P2|Total Study - Prospective|Withdrawal by Subject|13
5095603|NCT01977846|17594728|P1|Total Study - Prospective|Withdrawal by Subject|0
5095604|NCT01977846|17594727|P2|Total Study - Prospective|Lost to Follow-up|8
5095605|NCT01977846|17594728|P1|Total Study - Prospective|Lost to Follow-up|0
5095606|NCT01977846|17594727|P2|Total Study - Prospective|Death|1
5095607|NCT01977846|17594728|P1|Total Study - Prospective|Death|0
5095608|NCT01977820|17594746|P2|Overall Study|Sponsor terminated the study|1
5095609|NCT01977820|17594747|P1|Overall Study|Sponsor terminated the study|1
5095610|NCT01977794|17594755|P2|Overall Study|Other|1
5095611|NCT01977794|17594756|P1|Overall Study|Other|0
5095612|NCT01977794|17594755|P2|Overall Study|Withdrew consent|1
5095613|NCT01977794|17594756|P1|Overall Study|Withdrew consent|2
5095614|NCT01977794|17594755|P2|Overall Study|Death|1
5095615|NCT01977794|17594756|P1|Overall Study|Death|1
5095616|NCT01977794|17594755|P2|Overall Study|Protocol Violation|0
5095617|NCT01977794|17594756|P1|Overall Study|Protocol Violation|1
5095618|NCT01977794|17594755|P2|Overall Study|Lost to Follow-up|1
5095619|NCT01977794|17594756|P1|Overall Study|Lost to Follow-up|2
5095620|NCT01977794|17594755|P2|Overall Study|Adverse Event|2
5095621|NCT01977794|17594756|P1|Overall Study|Adverse Event|2
5095622|NCT01977729|17594791|P1|Overall Study|Study terminated|1
5095623|NCT01977690|17594803|P2|Overall Study|Withdrawal by Subject|4
5095624|NCT01977690|17594804|P1|Overall Study|Withdrawal by Subject|0
5095625|NCT01977677|17594813|P3|Overall Study|Unrelated Adverse Event|1
5095626|NCT01977677|17594814|P2|Overall Study|Unrelated Adverse Event|0
5095627|NCT01977677|17594815|P1|Overall Study|Unrelated Adverse Event|0
5095628|NCT01977625|17594826|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5095629|NCT01977625|17594827|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5095630|NCT01977625|17594826|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
5095631|NCT01977625|17594827|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
5095632|NCT01977612|17594837|P2|Overall Study|Lost to Follow-up|1
5095633|NCT01977612|17594838|P1|Overall Study|Lost to Follow-up|1
5095634|NCT01977573|17594860|P4|Overall Study|Withdrawal by Subject|1
5095635|NCT01977573|17594861|P3|Overall Study|Withdrawal by Subject|1
5095636|NCT01977573|17594862|P2|Overall Study|Withdrawal by Subject|1
5095637|NCT01977573|17594863|P1|Overall Study|Withdrawal by Subject|6
5095638|NCT01977573|17594860|P4|Overall Study|Reached Defined Stopping Criteria|0
5095639|NCT01977573|17594861|P3|Overall Study|Reached Defined Stopping Criteria|1
5095640|NCT01977573|17594862|P2|Overall Study|Reached Defined Stopping Criteria|1
5095641|NCT01977573|17594863|P1|Overall Study|Reached Defined Stopping Criteria|2
5095642|NCT01977573|17594860|P4|Overall Study|Protocol Violation|0
5095643|NCT01977573|17594861|P3|Overall Study|Protocol Violation|0
5095644|NCT01977573|17594862|P2|Overall Study|Protocol Violation|1
5095645|NCT01977573|17594863|P1|Overall Study|Protocol Violation|3
5095646|NCT01977573|17594860|P4|Overall Study|Physician Decision|0
5095647|NCT01977573|17594861|P3|Overall Study|Physician Decision|0
5095648|NCT01977573|17594862|P2|Overall Study|Physician Decision|0
5095649|NCT01977573|17594863|P1|Overall Study|Physician Decision|1
5095650|NCT01977573|17594860|P4|Overall Study|Lost to Follow-up|1
5095651|NCT01977573|17594861|P3|Overall Study|Lost to Follow-up|0
5095652|NCT01977573|17594862|P2|Overall Study|Lost to Follow-up|0
5095653|NCT01977573|17594863|P1|Overall Study|Lost to Follow-up|1
5095654|NCT01977573|17594860|P4|Overall Study|Adverse Event|1
5095655|NCT01977573|17594861|P3|Overall Study|Adverse Event|2
5095656|NCT01977573|17594862|P2|Overall Study|Adverse Event|0
5095657|NCT01977573|17594863|P1|Overall Study|Adverse Event|7
5095658|NCT01977482|17594977|P6|Overall Study|Withdrawal by Subject|5
5095659|NCT01977482|17594978|P5|Overall Study|Withdrawal by Subject|1
5095660|NCT01977482|17594979|P4|Overall Study|Withdrawal by Subject|3
5095661|NCT01977482|17594980|P3|Overall Study|Withdrawal by Subject|1
5095662|NCT01977482|17594981|P2|Overall Study|Withdrawal by Subject|4
5095663|NCT01977482|17594982|P1|Overall Study|Withdrawal by Subject|2
5095664|NCT01977482|17594977|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
5095665|NCT01977482|17594978|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
5095666|NCT01977482|17594979|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
5095667|NCT01977482|17594980|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
5095668|NCT01977482|17594981|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
5095669|NCT01977482|17594982|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
5095670|NCT01977482|17594977|P6|Overall Study|Protocol Violation|0
5095671|NCT01977482|17594978|P5|Overall Study|Protocol Violation|0
5095672|NCT01977482|17594979|P4|Overall Study|Protocol Violation|0
5095673|NCT01977482|17594980|P3|Overall Study|Protocol Violation|1
5095674|NCT01977482|17594981|P2|Overall Study|Protocol Violation|0
5095675|NCT01977482|17594982|P1|Overall Study|Protocol Violation|0
5095676|NCT01977482|17594977|P6|Overall Study|Physician Decision|0
5095677|NCT01977482|17594978|P5|Overall Study|Physician Decision|0
5095678|NCT01977482|17594979|P4|Overall Study|Physician Decision|0
5095679|NCT01977482|17594980|P3|Overall Study|Physician Decision|0
5095680|NCT01977482|17594981|P2|Overall Study|Physician Decision|1
5095681|NCT01977482|17594982|P1|Overall Study|Physician Decision|0
5095682|NCT01977482|17594977|P6|Overall Study|Lost to Follow-up|0
5095683|NCT01977482|17594978|P5|Overall Study|Lost to Follow-up|0
5095684|NCT01977482|17594979|P4|Overall Study|Lost to Follow-up|0
5095685|NCT01977482|17594980|P3|Overall Study|Lost to Follow-up|0
5095686|NCT01977482|17594981|P2|Overall Study|Lost to Follow-up|0
5095687|NCT01977482|17594982|P1|Overall Study|Lost to Follow-up|1
5095688|NCT01977482|17594977|P6|Overall Study|Adverse Event|0
5095689|NCT01977482|17594978|P5|Overall Study|Adverse Event|2
5095690|NCT01977482|17594979|P4|Overall Study|Adverse Event|0
5095691|NCT01977482|17594980|P3|Overall Study|Adverse Event|1
5095692|NCT01977482|17594981|P2|Overall Study|Adverse Event|1
5095693|NCT01977482|17594982|P1|Overall Study|Adverse Event|0
5095694|NCT01977456|17595097|P1|Overall Study|Death|5
5095695|NCT01977352|17595106|P2|Overall Study|Lost to Follow-up|2
5095696|NCT01977352|17595107|P1|Overall Study|Lost to Follow-up|1
5095697|NCT01977222|17595125|P1|Overall Study|Withdrawal by Subject|1
5095698|NCT01977092|17595138|P2|Overall Study|In prison|11
5095699|NCT01977092|17595139|P1|Overall Study|In prison|3
5095700|NCT01977092|17595138|P2|Overall Study|Withdrawal by Subject|1
5095701|NCT01977092|17595139|P1|Overall Study|Withdrawal by Subject|2
5095702|NCT01977092|17595138|P2|Overall Study|Lost to Follow-up|14
5095703|NCT01977092|17595139|P1|Overall Study|Lost to Follow-up|23
5095704|NCT01977092|17595138|P2|Overall Study|Death|4
5095705|NCT01977092|17595139|P1|Overall Study|Death|3
5095706|NCT01977040|17595149|P1|Overall Study|Vasa previa not confirmed|2
5095707|NCT01976845|17595203|P3|Overall Study|Physician Decision|3
5095708|NCT01976845|17595204|P2|Overall Study|Physician Decision|8
5095709|NCT01976845|17595205|P1|Overall Study|Physician Decision|8
5095710|NCT01976806|17595230|P2|Overall Study|Withdrawal by Subject|1
5095711|NCT01976806|17595231|P1|Overall Study|Withdrawal by Subject|1
5095712|NCT01976806|17595230|P2|Overall Study|Adverse Event|1
5095713|NCT01976806|17595231|P1|Overall Study|Adverse Event|1
5095714|NCT01976806|17595230|P2|Overall Study|Lost to Follow-up|4
5095715|NCT01976806|17595231|P1|Overall Study|Lost to Follow-up|1
5095716|NCT01976741|17595269|P10|Overall Study|Adverse Event|4
5095717|NCT01976741|17595270|P9|Overall Study|Adverse Event|1
5095718|NCT01976741|17595271|P8|Overall Study|Adverse Event|8
5095719|NCT01976741|17595272|P7|Overall Study|Adverse Event|3
5095720|NCT01976741|17595273|P6|Overall Study|Adverse Event|0
5095721|NCT01976741|17595274|P5|Overall Study|Adverse Event|0
5095722|NCT01976741|17595275|P4|Overall Study|Adverse Event|0
5095723|NCT01976741|17595276|P3|Overall Study|Adverse Event|2
5095724|NCT01976741|17595277|P2|Overall Study|Adverse Event|0
5095725|NCT01976741|17595278|P1|Overall Study|Adverse Event|0
5095726|NCT01976741|17595269|P10|Overall Study|Withdrawal by Subject|0
5095727|NCT01976741|17595270|P9|Overall Study|Withdrawal by Subject|0
5095728|NCT01976741|17595271|P8|Overall Study|Withdrawal by Subject|4
5095729|NCT01976741|17595272|P7|Overall Study|Withdrawal by Subject|1
5095730|NCT01976741|17595273|P6|Overall Study|Withdrawal by Subject|0
5095731|NCT01976741|17595274|P5|Overall Study|Withdrawal by Subject|0
5095732|NCT01976741|17595275|P4|Overall Study|Withdrawal by Subject|1
5095733|NCT01976741|17595276|P3|Overall Study|Withdrawal by Subject|1
5095734|NCT01976741|17595277|P2|Overall Study|Withdrawal by Subject|0
5095735|NCT01976741|17595278|P1|Overall Study|Withdrawal by Subject|1
5095736|NCT01976663|17595516|P1|Overall Study|Lost to Follow-up|3
5095737|NCT01976663|17595516|P1|Overall Study|Adverse Event|2
5095738|NCT01976663|17595516|P1|Overall Study|Screen Failure|3
5095739|NCT01976663|17595516|P1|Overall Study|Withdrawal by Subject|4
5095740|NCT01976663|17595516|P1|Overall Study|Personal Reasons|6
5095741|NCT01976663|17595516|P1|Overall Study|Completed 18 mos but no repeat treatment|24
5095742|NCT01976624|17595535|P1|Overall Study|Participants age less than 19 years|12
5095743|NCT01976624|17595535|P1|Overall Study|Participants contraindicated|2
5095744|NCT01976507|17595563|P1|Overall Study|ablation not done, drug not given|1
5095745|NCT01976507|17595563|P1|Overall Study|Adverse Event|6
5095746|NCT01976364|17595594|P3|Sub-study (12 Months)|Adverse Event|3
5095747|NCT01976364|17595595|P2|Sub-study (12 Months)|Adverse Event|4
5095748|NCT01976364|17595596|P1|Sub-study (12 Months)|Adverse Event|0
5095749|NCT01976364|17595594|P3|Sub-study (12 Months)|Protocol Violation|1
5095750|NCT01976364|17595595|P2|Sub-study (12 Months)|Protocol Violation|1
5095751|NCT01976364|17595596|P1|Sub-study (12 Months)|Protocol Violation|0
5095752|NCT01976364|17595594|P3|Sub-study (12 Months)|Withdrawal by Subject|1
5095753|NCT01976364|17595595|P2|Sub-study (12 Months)|Withdrawal by Subject|0
5095754|NCT01976364|17595596|P1|Sub-study (12 Months)|Withdrawal by Subject|0
5095755|NCT01976364|17595594|P3|Sub-study (12 Months)|Lost to Follow-up|0
5095756|NCT01976364|17595595|P2|Sub-study (12 Months)|Lost to Follow-up|1
5095757|NCT01976364|17595596|P1|Sub-study (12 Months)|Lost to Follow-up|0
5095758|NCT01976364|17595594|P3|Main Study (36 Months)|Death|0
5095759|NCT01976364|17595595|P2|Main Study (36 Months)|Death|0
5095760|NCT01976364|17595596|P1|Main Study (36 Months)|Death|5
5095761|NCT01976364|17595594|P3|Main Study (36 Months)|Withdrawal by Subject|0
5095762|NCT01976364|17595595|P2|Main Study (36 Months)|Withdrawal by Subject|0
5095763|NCT01976364|17595596|P1|Main Study (36 Months)|Withdrawal by Subject|69
5095764|NCT01976364|17595594|P3|Main Study (36 Months)|Protocol Violation|0
5095765|NCT01976364|17595595|P2|Main Study (36 Months)|Protocol Violation|0
5095766|NCT01976364|17595596|P1|Main Study (36 Months)|Protocol Violation|13
5095767|NCT01976364|17595594|P3|Main Study (36 Months)|Lack of Efficacy|0
5095768|NCT01976364|17595595|P2|Main Study (36 Months)|Lack of Efficacy|0
5095769|NCT01976364|17595596|P1|Main Study (36 Months)|Lack of Efficacy|40
5095770|NCT01976364|17595594|P3|Main Study (36 Months)|Lost to Follow-up|0
5095771|NCT01976364|17595595|P2|Main Study (36 Months)|Lost to Follow-up|0
5095772|NCT01976364|17595596|P1|Main Study (36 Months)|Lost to Follow-up|10
5095773|NCT01976364|17595594|P3|Main Study (36 Months)|Medication error|0
5095774|NCT01976364|17595595|P2|Main Study (36 Months)|Medication error|0
5095775|NCT01976364|17595596|P1|Main Study (36 Months)|Medication error|1
5095776|NCT01976364|17595594|P3|Main Study (36 Months)|No longer met eligibility criteria|0
5095777|NCT01976364|17595595|P2|Main Study (36 Months)|No longer met eligibility criteria|0
5095778|NCT01976364|17595596|P1|Main Study (36 Months)|No longer met eligibility criteria|2
5095779|NCT01976364|17595594|P3|Main Study (36 Months)|Other|0
5095780|NCT01976364|17595595|P2|Main Study (36 Months)|Other|0
5095781|NCT01976364|17595596|P1|Main Study (36 Months)|Other|13
5095782|NCT01976364|17595594|P3|Main Study (36 Months)|Withdrawn due to pregnancy|0
5095783|NCT01976364|17595595|P2|Main Study (36 Months)|Withdrawn due to pregnancy|0
5095784|NCT01976364|17595596|P1|Main Study (36 Months)|Withdrawn due to pregnancy|5
5095785|NCT01976364|17595594|P3|Main Study (36 Months)|Adverse Event|0
5095786|NCT01976364|17595595|P2|Main Study (36 Months)|Adverse Event|0
5095787|NCT01976364|17595596|P1|Main Study (36 Months)|Adverse Event|63
5095788|NCT01976338|17595716|P2|Overall Study|Adverse Event|1
5095789|NCT01976338|17595717|P1|Overall Study|Adverse Event|5
5095790|NCT01976338|17595716|P2|Overall Study|Withdrawal by Subject|2
5095791|NCT01976338|17595717|P1|Overall Study|Withdrawal by Subject|5
5095792|NCT01976338|17595716|P2|Overall Study|Lost to Follow-up|0
5095793|NCT01976338|17595717|P1|Overall Study|Lost to Follow-up|3
5095794|NCT01976338|17595716|P2|Overall Study|Physician Decision|1
5095795|NCT01976338|17595717|P1|Overall Study|Physician Decision|0
5095796|NCT01976312|17595744|P2|Overall Study|Protocol Violation|0
5095797|NCT01976312|17595745|P1|Overall Study|Protocol Violation|2
5095798|NCT01976312|17595744|P2|Overall Study|Adverse Event|6
5095799|NCT01976312|17595745|P1|Overall Study|Adverse Event|6
5095800|NCT01976312|17595744|P2|Overall Study|Withdrawal by Subject|2
5095801|NCT01976312|17595745|P1|Overall Study|Withdrawal by Subject|7
5095802|NCT01976312|17595744|P2|Overall Study|Lost to Follow-up|0
5095803|NCT01976312|17595745|P1|Overall Study|Lost to Follow-up|2
5095804|NCT01976312|17595744|P2|Overall Study|Pregnancy|1
5095805|NCT01976312|17595745|P1|Overall Study|Pregnancy|0
5095806|NCT01976299|17595766|P2|Overall Study|See clarification above in comments|2
5095807|NCT01976299|17595767|P1|Overall Study|See clarification above in comments|9
5095808|NCT01976299|17595766|P2|Overall Study|Lost to Follow-up|1
5095809|NCT01976299|17595767|P1|Overall Study|Lost to Follow-up|7
5095810|NCT01976299|17595766|P2|Overall Study|Death|2
5095811|NCT01976299|17595767|P1|Overall Study|Death|4
5095812|NCT01976299|17595766|P2|Overall Study|Withdrawal by Subject|1
5095813|NCT01976299|17595767|P1|Overall Study|Withdrawal by Subject|3
5095814|NCT01976104|17595794|P4|Overall Study|Other|0
5095815|NCT01976104|17595795|P3|Overall Study|Other|0
5095816|NCT01976104|17595796|P2|Overall Study|Other|1
5095817|NCT01976104|17595797|P1|Overall Study|Other|0
5095818|NCT01976104|17595794|P4|Overall Study|Withdrawal by Subject|1
5095819|NCT01976104|17595795|P3|Overall Study|Withdrawal by Subject|0
5095820|NCT01976104|17595796|P2|Overall Study|Withdrawal by Subject|0
5095821|NCT01976104|17595797|P1|Overall Study|Withdrawal by Subject|3
5095822|NCT01976104|17595794|P4|Overall Study|Subject Choice|1
5095823|NCT01976104|17595795|P3|Overall Study|Subject Choice|0
5095824|NCT01976104|17595796|P2|Overall Study|Subject Choice|1
5095825|NCT01976104|17595797|P1|Overall Study|Subject Choice|0
5095826|NCT01976104|17595794|P4|Overall Study|Lost to Follow-up|1
5095827|NCT01976104|17595795|P3|Overall Study|Lost to Follow-up|1
5095828|NCT01976104|17595796|P2|Overall Study|Lost to Follow-up|0
5095829|NCT01976104|17595797|P1|Overall Study|Lost to Follow-up|3
5095830|NCT01976104|17595794|P4|Overall Study|Adverse Event|0
5095831|NCT01976104|17595795|P3|Overall Study|Adverse Event|1
5095832|NCT01976104|17595796|P2|Overall Study|Adverse Event|0
5095833|NCT01976104|17595797|P1|Overall Study|Adverse Event|0
5095834|NCT01975948|17595831|P4|Overall Study|Withdrawal by Subject|6
5095835|NCT01975948|17595832|P3|Overall Study|Withdrawal by Subject|7
5095836|NCT01975948|17595833|P2|Overall Study|Withdrawal by Subject|21
5095837|NCT01975948|17595834|P1|Overall Study|Withdrawal by Subject|17
5095838|NCT01975831|17595910|P9|Overall Study|Unable to Treat Within Protocol Windows|1
5095839|NCT01975831|17595911|P8|Overall Study|Unable to Treat Within Protocol Windows|0
5095840|NCT01975831|17595912|P7|Overall Study|Unable to Treat Within Protocol Windows|1
5095841|NCT01975831|17595913|P6|Overall Study|Unable to Treat Within Protocol Windows|0
5095842|NCT01975831|17595914|P5|Overall Study|Unable to Treat Within Protocol Windows|0
5095843|NCT01975831|17595915|P4|Overall Study|Unable to Treat Within Protocol Windows|0
5095844|NCT01975831|17595916|P3|Overall Study|Unable to Treat Within Protocol Windows|0
5095845|NCT01975831|17595917|P2|Overall Study|Unable to Treat Within Protocol Windows|0
5095846|NCT01975831|17595918|P1|Overall Study|Unable to Treat Within Protocol Windows|0
5095847|NCT01975831|17595910|P9|Overall Study|Entered Hospice|0
5095848|NCT01975831|17595911|P8|Overall Study|Entered Hospice|0
5095849|NCT01975831|17595912|P7|Overall Study|Entered Hospice|0
5095850|NCT01975831|17595913|P6|Overall Study|Entered Hospice|1
5095851|NCT01975831|17595914|P5|Overall Study|Entered Hospice|0
5095852|NCT01975831|17595915|P4|Overall Study|Entered Hospice|0
5095853|NCT01975831|17595916|P3|Overall Study|Entered Hospice|0
5095854|NCT01975831|17595917|P2|Overall Study|Entered Hospice|0
5095855|NCT01975831|17595918|P1|Overall Study|Entered Hospice|0
5095856|NCT01975831|17595910|P9|Overall Study|Initiation of Subsequent Therapy|0
5095857|NCT01975831|17595911|P8|Overall Study|Initiation of Subsequent Therapy|2
5095858|NCT01975831|17595912|P7|Overall Study|Initiation of Subsequent Therapy|0
5095859|NCT01975831|17595913|P6|Overall Study|Initiation of Subsequent Therapy|1
5095860|NCT01975831|17595914|P5|Overall Study|Initiation of Subsequent Therapy|0
5095861|NCT01975831|17595915|P4|Overall Study|Initiation of Subsequent Therapy|0
5095862|NCT01975831|17595916|P3|Overall Study|Initiation of Subsequent Therapy|0
5095863|NCT01975831|17595917|P2|Overall Study|Initiation of Subsequent Therapy|0
5095864|NCT01975831|17595918|P1|Overall Study|Initiation of Subsequent Therapy|0
5095865|NCT01975831|17595910|P9|Overall Study|Physician Decision|0
5095866|NCT01975831|17595911|P8|Overall Study|Physician Decision|1
5095867|NCT01975831|17595912|P7|Overall Study|Physician Decision|0
5095868|NCT01975831|17595913|P6|Overall Study|Physician Decision|1
5095869|NCT01975831|17595914|P5|Overall Study|Physician Decision|0
5095870|NCT01975831|17595915|P4|Overall Study|Physician Decision|0
5095871|NCT01975831|17595916|P3|Overall Study|Physician Decision|0
5095872|NCT01975831|17595917|P2|Overall Study|Physician Decision|0
5095873|NCT01975831|17595918|P1|Overall Study|Physician Decision|0
5095874|NCT01975831|17595910|P9|Overall Study|Withdrawal by Subject|0
5095875|NCT01975831|17595911|P8|Overall Study|Withdrawal by Subject|0
5095876|NCT01975831|17595912|P7|Overall Study|Withdrawal by Subject|1
5095877|NCT01975831|17595913|P6|Overall Study|Withdrawal by Subject|1
5095878|NCT01975831|17595914|P5|Overall Study|Withdrawal by Subject|3
5095879|NCT01975831|17595915|P4|Overall Study|Withdrawal by Subject|0
5095880|NCT01975831|17595916|P3|Overall Study|Withdrawal by Subject|0
5095881|NCT01975831|17595917|P2|Overall Study|Withdrawal by Subject|3
5095882|NCT01975831|17595918|P1|Overall Study|Withdrawal by Subject|0
5095883|NCT01975831|17595910|P9|Overall Study|Progressive Disease|10
5095884|NCT01975831|17595911|P8|Overall Study|Progressive Disease|8
5095885|NCT01975831|17595912|P7|Overall Study|Progressive Disease|10
5095886|NCT01975831|17595913|P6|Overall Study|Progressive Disease|9
5095887|NCT01975831|17595914|P5|Overall Study|Progressive Disease|13
5095888|NCT01975831|17595915|P4|Overall Study|Progressive Disease|4
5095889|NCT01975831|17595916|P3|Overall Study|Progressive Disease|2
5095890|NCT01975831|17595917|P2|Overall Study|Progressive Disease|3
5095891|NCT01975831|17595918|P1|Overall Study|Progressive Disease|1
5095892|NCT01975831|17595910|P9|Overall Study|Death|0
5095893|NCT01975831|17595911|P8|Overall Study|Death|0
5095894|NCT01975831|17595912|P7|Overall Study|Death|1
5095895|NCT01975831|17595913|P6|Overall Study|Death|0
5095896|NCT01975831|17595914|P5|Overall Study|Death|1
5095897|NCT01975831|17595915|P4|Overall Study|Death|0
5095898|NCT01975831|17595916|P3|Overall Study|Death|0
5095899|NCT01975831|17595917|P2|Overall Study|Death|1
5095900|NCT01975831|17595918|P1|Overall Study|Death|1
5095901|NCT01975831|17595910|P9|Overall Study|Adverse Event|1
5095902|NCT01975831|17595911|P8|Overall Study|Adverse Event|4
5095903|NCT01975831|17595912|P7|Overall Study|Adverse Event|3
5095904|NCT01975831|17595913|P6|Overall Study|Adverse Event|1
5095905|NCT01975831|17595914|P5|Overall Study|Adverse Event|1
5095906|NCT01975831|17595915|P4|Overall Study|Adverse Event|0
5095907|NCT01975831|17595916|P3|Overall Study|Adverse Event|2
5095908|NCT01975831|17595917|P2|Overall Study|Adverse Event|2
5095909|NCT01975831|17595918|P1|Overall Study|Adverse Event|1
5095910|NCT01975701|17595983|P1|Overall Study|Physician Decision|1
5095911|NCT01975701|17595983|P1|Overall Study|Death|23
5095912|NCT01975701|17595983|P1|Overall Study|Lost to Follow-up|1
5095913|NCT01975675|17595994|P4|Overall Study|Death|0
5095914|NCT01975675|17595995|P3|Overall Study|Death|0
5095915|NCT01975675|17595996|P2|Overall Study|Death|1
5095916|NCT01975675|17595997|P1|Overall Study|Death|0
5095917|NCT01975389|17596048|P2|Overall Study|Randomized, not treated|5
5095918|NCT01975389|17596049|P1|Overall Study|Randomized, not treated|4
5095919|NCT01975389|17596048|P2|Overall Study|Other|9
5095920|NCT01975389|17596049|P1|Overall Study|Other|6
5095921|NCT01975389|17596048|P2|Overall Study|Withdrawal by Subject|76
5095922|NCT01975389|17596049|P1|Overall Study|Withdrawal by Subject|90
5095923|NCT01975389|17596048|P2|Overall Study|Lost to Follow-up|86
5095924|NCT01975389|17596049|P1|Overall Study|Lost to Follow-up|81
5095925|NCT01975389|17596048|P2|Overall Study|Death|54
5095926|NCT01975389|17596049|P1|Overall Study|Death|61
5095927|NCT01975389|17596048|P2|Overall Study|Adverse Event|6
5095928|NCT01975389|17596049|P1|Overall Study|Adverse Event|10
5095929|NCT01975376|17596109|P2|Overall Study|Randomized, Not Treated|8
5095930|NCT01975376|17596110|P1|Overall Study|Randomized, Not Treated|16
5095931|NCT01975376|17596109|P2|Overall Study|Other|4
5095932|NCT01975376|17596110|P1|Overall Study|Other|2
5095933|NCT01975376|17596109|P2|Overall Study|Withdrew consent|62
5095934|NCT01975376|17596110|P1|Overall Study|Withdrew consent|68
5095935|NCT01975376|17596109|P2|Overall Study|Lost to Follow-up|66
5095936|NCT01975376|17596110|P1|Overall Study|Lost to Follow-up|70
5095937|NCT01975376|17596109|P2|Overall Study|Death|72
5095938|NCT01975376|17596110|P1|Overall Study|Death|65
5095939|NCT01975376|17596109|P2|Overall Study|Adverse Event|5
5095940|NCT01975376|17596110|P1|Overall Study|Adverse Event|5
5095941|NCT01975285|17596170|P2|Overall Study|Failed Block and follow up|2
5095942|NCT01975285|17596171|P1|Overall Study|Failed Block and follow up|2
5095943|NCT01975246|17596187|P2|Overall Study|Other than stated|1
5095944|NCT01975246|17596188|P1|Overall Study|Other than stated|0
5095945|NCT01975246|17596187|P2|Overall Study|Protocol Violation|0
5095946|NCT01975246|17596188|P1|Overall Study|Protocol Violation|1
5095947|NCT01975246|17596187|P2|Overall Study|Lack of Efficacy|0
5095948|NCT01975246|17596188|P1|Overall Study|Lack of Efficacy|1
5095949|NCT01975246|17596187|P2|Overall Study|Adverse Event|1
5095950|NCT01975246|17596188|P1|Overall Study|Adverse Event|2
5095951|NCT01975220|17596201|P6|Test Period 1|Not treated|0
5095952|NCT01975220|17596202|P5|Test Period 1|Not treated|0
5095953|NCT01975220|17596203|P4|Test Period 1|Not treated|0
5095954|NCT01975220|17596204|P3|Test Period 1|Not treated|0
5095955|NCT01975220|17596205|P2|Test Period 1|Not treated|1
5095956|NCT01975220|17596206|P1|Test Period 1|Not treated|0
5095957|NCT01974895|17596262|P2|Overall Study|Other (Reason unknown)|8
5095958|NCT01974895|17596263|P1|Overall Study|Other (Reason unknown)|9
5095959|NCT01974895|17596262|P2|Overall Study|Other (Missed Visit)|0
5095960|NCT01974895|17596263|P1|Overall Study|Other (Missed Visit)|1
5095961|NCT01974895|17596262|P2|Overall Study|Withdrawal by Subject|1
5095962|NCT01974895|17596263|P1|Overall Study|Withdrawal by Subject|0
5095963|NCT01974895|17596262|P2|Overall Study|Lost to Follow-up|6
5095964|NCT01974895|17596263|P1|Overall Study|Lost to Follow-up|4
5095965|NCT01974895|17596262|P2|Overall Study|Protocol Violation|0
5095966|NCT01974895|17596263|P1|Overall Study|Protocol Violation|1
5095967|NCT01974817|17596293|P1|Overall Study|Protocol Violation|2
5095968|NCT01974817|17596293|P1|Overall Study|Lost to Follow-up|2
5095969|NCT01974817|17596293|P1|Overall Study|Death|4
5095970|NCT01974752|17596299|P2|Overall Study|Other Eligibility Criteria|1
5095971|NCT01974752|17596300|P1|Overall Study|Other Eligibility Criteria|0
5095972|NCT01974752|17596299|P2|Overall Study|Withdrawal by Subject|3
5095973|NCT01974752|17596300|P1|Overall Study|Withdrawal by Subject|2
5095974|NCT01974752|17596299|P2|Overall Study|Lost to Follow-up|0
5095975|NCT01974752|17596300|P1|Overall Study|Lost to Follow-up|2
5095976|NCT01974752|17596299|P2|Overall Study|Death|11
5095977|NCT01974752|17596300|P1|Overall Study|Death|33
5095978|NCT01974323|17596728|P2|Overall Study|Adverse Event|2
5095979|NCT01974323|17596729|P1|Overall Study|Adverse Event|2
5095980|NCT01974323|17596728|P2|Overall Study|Lack of Efficacy|1
5095981|NCT01974323|17596729|P1|Overall Study|Lack of Efficacy|1
5095982|NCT01974323|17596728|P2|Overall Study|Pregnancy|1
5095983|NCT01974323|17596729|P1|Overall Study|Pregnancy|2
5095984|NCT01974323|17596728|P2|Overall Study|Lost to Follow-up|40
5095985|NCT01974323|17596729|P1|Overall Study|Lost to Follow-up|45
5095986|NCT01974323|17596728|P2|Overall Study|Personal Reasons|19
5095987|NCT01974323|17596729|P1|Overall Study|Personal Reasons|15
5095988|NCT01974323|17596728|P2|Overall Study|Protocol Violation|2
5095989|NCT01974323|17596729|P1|Overall Study|Protocol Violation|2
5095990|NCT01974323|17596728|P2|Overall Study|Other Reasons|28
5095991|NCT01974323|17596729|P1|Overall Study|Other Reasons|25
5095992|NCT01974141|17596769|P2|Overall Study|Adverse Event|5
5095993|NCT01974141|17596770|P1|Overall Study|Adverse Event|4
5095994|NCT01974141|17596769|P2|Overall Study|Lack of Efficacy|1
5095995|NCT01974141|17596770|P1|Overall Study|Lack of Efficacy|0
5095996|NCT01974141|17596769|P2|Overall Study|Pregnancy|3
5095997|NCT01974141|17596770|P1|Overall Study|Pregnancy|3
5095998|NCT01974141|17596769|P2|Overall Study|Lost to Follow-up|29
5095999|NCT01974141|17596770|P1|Overall Study|Lost to Follow-up|38
5096000|NCT01974141|17596769|P2|Overall Study|Personal Reasons|20
5096001|NCT01974141|17596770|P1|Overall Study|Personal Reasons|21
5096002|NCT01974141|17596769|P2|Overall Study|Protocol Violation|6
5096003|NCT01974141|17596770|P1|Overall Study|Protocol Violation|2
5096004|NCT01974141|17596769|P2|Overall Study|Other Reasons|18
5096005|NCT01974141|17596770|P1|Overall Study|Other Reasons|28
5096006|NCT01973998|17596814|P2|Overall Study|Death|2
5096007|NCT01973998|17596815|P1|Overall Study|Death|2
5096008|NCT01973595|17596877|P4|Washout|Withdrawal by Subject|0
5096009|NCT01973595|17596878|P3|Washout|Withdrawal by Subject|1
5096010|NCT01973595|17596879|P2|Washout|Withdrawal by Subject|0
5096011|NCT01973595|17596880|P1|Washout|Withdrawal by Subject|1
5096012|NCT01973569|17596897|P3|Overall Study|Did not receive study drug|3
5096013|NCT01973569|17596898|P2|Overall Study|Did not receive study drug|3
5096014|NCT01973569|17596899|P1|Overall Study|Did not receive study drug|6
5096015|NCT01973569|17596897|P3|Overall Study|Other|0
5096016|NCT01973569|17596898|P2|Overall Study|Other|1
5096017|NCT01973569|17596899|P1|Overall Study|Other|1
5096018|NCT01973569|17596897|P3|Overall Study|Disease progression|0
5096019|NCT01973569|17596898|P2|Overall Study|Disease progression|3
5096020|NCT01973569|17596899|P1|Overall Study|Disease progression|0
5096021|NCT01973569|17596897|P3|Overall Study|Prohibited concomitant d|0
5096022|NCT01973569|17596898|P2|Overall Study|Prohibited concomitant d|5
5096023|NCT01973569|17596899|P1|Overall Study|Prohibited concomitant d|1
5096024|NCT01973569|17596897|P3|Overall Study|Invasive dental treatment|6
5096025|NCT01973569|17596898|P2|Overall Study|Invasive dental treatment|5
5096026|NCT01973569|17596899|P1|Overall Study|Invasive dental treatment|3
5096027|NCT01973569|17596897|P3|Overall Study|Withdrawal by Subject|2
5096028|NCT01973569|17596898|P2|Overall Study|Withdrawal by Subject|5
5096029|NCT01973569|17596899|P1|Overall Study|Withdrawal by Subject|7
5096030|NCT01973569|17596897|P3|Overall Study|Protocol Violation|3
5096031|NCT01973569|17596898|P2|Overall Study|Protocol Violation|1
5096032|NCT01973569|17596899|P1|Overall Study|Protocol Violation|2
5096033|NCT01973569|17596897|P3|Overall Study|Adverse Event|4
5096034|NCT01973569|17596898|P2|Overall Study|Adverse Event|2
5096035|NCT01973569|17596899|P1|Overall Study|Adverse Event|9
5096036|NCT01973491|17596925|P1|Treatment Period (16 Weeks)|Adverse Event|1
5096037|NCT01973491|17596925|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
5096038|NCT01973491|17596925|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
5096039|NCT01973439|17596941|P1|Overall Study|PK curve incomplete|2
5096040|NCT01973439|17596941|P1|Overall Study|Vomiting after commencing once daily|1
5096041|NCT01973439|17596941|P1|Overall Study|Lost samples from one PK Day|2
5096042|NCT01973387|17596963|P2|Overall Study|Randomized, not treated|2
5096043|NCT01973387|17596964|P1|Overall Study|Randomized, not treated|2
5096044|NCT01973387|17596963|P2|Overall Study|Death|3
5096045|NCT01973387|17596964|P1|Overall Study|Death|4
5096046|NCT01973387|17596963|P2|Overall Study|Progressive disease or relapse|5
5096047|NCT01973387|17596964|P1|Overall Study|Progressive disease or relapse|16
5096048|NCT01973387|17596963|P2|Overall Study|Study terminated by sponsor|0
5096049|NCT01973387|17596964|P1|Overall Study|Study terminated by sponsor|63
5096050|NCT01973387|17596963|P2|Overall Study|Withdrawal by Subject|4
5096051|NCT01973387|17596964|P1|Overall Study|Withdrawal by Subject|7
5096052|NCT01973387|17596963|P2|Overall Study|Adverse Event|4
5096053|NCT01973387|17596964|P1|Overall Study|Adverse Event|14
5096054|NCT01973231|17597046|P2|Overall Study|Withdrawal by Subject|9
5096055|NCT01973231|17597047|P1|Overall Study|Withdrawal by Subject|7
5096056|NCT01973231|17597046|P2|Overall Study|unclassified|1
5096057|NCT01973231|17597047|P1|Overall Study|unclassified|2
5096058|NCT01973231|17597046|P2|Overall Study|Lost to Follow-up|1
5096059|NCT01973231|17597047|P1|Overall Study|Lost to Follow-up|1
5096060|NCT01973231|17597046|P2|Overall Study|Protocol Violation|1
5096061|NCT01973231|17597047|P1|Overall Study|Protocol Violation|1
5096062|NCT01973218|17597067|P2|Overall Study|Withdrawal by Subject|0
5096063|NCT01973218|17597068|P1|Overall Study|Withdrawal by Subject|1
5096064|NCT01973218|17597067|P2|Overall Study|Adverse Event|0
5096065|NCT01973218|17597068|P1|Overall Study|Adverse Event|1
5096066|NCT01972841|17597161|P6|Overall Study|Did not have end of treatment page|0
5096067|NCT01972841|17597162|P5|Overall Study|Did not have end of treatment page|1
5096068|NCT01972841|17597163|P4|Overall Study|Did not have end of treatment page|0
5096069|NCT01972841|17597164|P3|Overall Study|Did not have end of treatment page|0
5096070|NCT01972841|17597165|P2|Overall Study|Did not have end of treatment page|0
5096071|NCT01972841|17597166|P1|Overall Study|Did not have end of treatment page|0
5096072|NCT01972841|17597161|P6|Overall Study|Miscellaneous|4
5096073|NCT01972841|17597162|P5|Overall Study|Miscellaneous|0
5096074|NCT01972841|17597163|P4|Overall Study|Miscellaneous|1
5096075|NCT01972841|17597164|P3|Overall Study|Miscellaneous|4
5096076|NCT01972841|17597165|P2|Overall Study|Miscellaneous|0
5096077|NCT01972841|17597166|P1|Overall Study|Miscellaneous|0
5096078|NCT01972841|17597161|P6|Overall Study|Withdrawal by participants|34
5096079|NCT01972841|17597162|P5|Overall Study|Withdrawal by participants|33
5096080|NCT01972841|17597163|P4|Overall Study|Withdrawal by participants|16
5096081|NCT01972841|17597164|P3|Overall Study|Withdrawal by participants|23
5096082|NCT01972841|17597165|P2|Overall Study|Withdrawal by participants|27
5096083|NCT01972841|17597166|P1|Overall Study|Withdrawal by participants|21
5096084|NCT01972841|17597161|P6|Overall Study|Protocol Violation|4
5096085|NCT01972841|17597162|P5|Overall Study|Protocol Violation|9
5096086|NCT01972841|17597163|P4|Overall Study|Protocol Violation|5
5096087|NCT01972841|17597164|P3|Overall Study|Protocol Violation|3
5096088|NCT01972841|17597165|P2|Overall Study|Protocol Violation|2
5096089|NCT01972841|17597166|P1|Overall Study|Protocol Violation|2
5096090|NCT01972841|17597161|P6|Overall Study|Lost to Follow-up|3
5096091|NCT01972841|17597162|P5|Overall Study|Lost to Follow-up|9
5096092|NCT01972841|17597163|P4|Overall Study|Lost to Follow-up|2
5096093|NCT01972841|17597164|P3|Overall Study|Lost to Follow-up|4
5096094|NCT01972841|17597165|P2|Overall Study|Lost to Follow-up|2
5096095|NCT01972841|17597166|P1|Overall Study|Lost to Follow-up|4
5096096|NCT01972841|17597161|P6|Overall Study|Lack of Efficacy|1
5096097|NCT01972841|17597162|P5|Overall Study|Lack of Efficacy|4
5096098|NCT01972841|17597163|P4|Overall Study|Lack of Efficacy|2
5096099|NCT01972841|17597164|P3|Overall Study|Lack of Efficacy|0
5096100|NCT01972841|17597165|P2|Overall Study|Lack of Efficacy|0
5096101|NCT01972841|17597166|P1|Overall Study|Lack of Efficacy|1
5096102|NCT01972841|17597161|P6|Overall Study|Adverse Event|26
5096103|NCT01972841|17597162|P5|Overall Study|Adverse Event|21
5096104|NCT01972841|17597163|P4|Overall Study|Adverse Event|9
5096105|NCT01972841|17597164|P3|Overall Study|Adverse Event|12
5096106|NCT01972841|17597165|P2|Overall Study|Adverse Event|8
5096107|NCT01972841|17597166|P1|Overall Study|Adverse Event|13
5096108|NCT01972841|17597161|P6|Overall Study|Randomized but Never Received Treatment|13
5096109|NCT01972841|17597162|P5|Overall Study|Randomized but Never Received Treatment|6
5096110|NCT01972841|17597163|P4|Overall Study|Randomized but Never Received Treatment|2
5096111|NCT01972841|17597164|P3|Overall Study|Randomized but Never Received Treatment|4
5096112|NCT01972841|17597165|P2|Overall Study|Randomized but Never Received Treatment|5
5096113|NCT01972841|17597166|P1|Overall Study|Randomized but Never Received Treatment|2
5096114|NCT01972789|17597596|P2|Overall Study|Physician Decision|2
5096115|NCT01972789|17597597|P1|Overall Study|Physician Decision|3
5096116|NCT01972789|17597596|P2|Overall Study|Protocol deviation|0
5096117|NCT01972789|17597597|P1|Overall Study|Protocol deviation|1
5096118|NCT01972789|17597596|P2|Overall Study|Death|5
5096119|NCT01972789|17597597|P1|Overall Study|Death|7
5096120|NCT01972789|17597596|P2|Overall Study|Lost to Follow-up|7
5096121|NCT01972789|17597597|P1|Overall Study|Lost to Follow-up|4
5096122|NCT01972789|17597596|P2|Overall Study|Subject withdrew consent|12
5096123|NCT01972789|17597597|P1|Overall Study|Subject withdrew consent|14
5096124|NCT01972789|17597596|P2|Overall Study|Adverse Event|4
5096125|NCT01972789|17597597|P1|Overall Study|Adverse Event|11
5096126|NCT01972776|17597631|P6|Part 2|Administrative problems|7
5096127|NCT01972776|17597632|P5|Part 2|Administrative problems|10
5096128|NCT01972776|17597633|P4|Part 2|Administrative problems|0
5096129|NCT01972776|17597634|P3|Part 2|Administrative problems|0
5096130|NCT01972776|17597635|P2|Part 2|Administrative problems|0
5096131|NCT01972776|17597636|P1|Part 2|Administrative problems|0
5096132|NCT01972776|17597631|P6|Part 2|Adverse Event|0
5096133|NCT01972776|17597632|P5|Part 2|Adverse Event|3
5096134|NCT01972776|17597633|P4|Part 2|Adverse Event|0
5096135|NCT01972776|17597634|P3|Part 2|Adverse Event|0
5096136|NCT01972776|17597635|P2|Part 2|Adverse Event|0
5096137|NCT01972776|17597636|P1|Part 2|Adverse Event|0
5096138|NCT01972776|17597631|P6|Part 1|Adverse Event|0
5096139|NCT01972776|17597632|P5|Part 1|Adverse Event|0
5096140|NCT01972776|17597633|P4|Part 1|Adverse Event|1
5096141|NCT01972776|17597634|P3|Part 1|Adverse Event|1
5096142|NCT01972776|17597635|P2|Part 1|Adverse Event|0
5096143|NCT01972776|17597636|P1|Part 1|Adverse Event|0
5096144|NCT01972776|17597631|P6|Part 1|Withdrawal by Subject|0
5096145|NCT01972776|17597632|P5|Part 1|Withdrawal by Subject|0
5096146|NCT01972776|17597633|P4|Part 1|Withdrawal by Subject|0
5096147|NCT01972776|17597634|P3|Part 1|Withdrawal by Subject|1
5096148|NCT01972776|17597635|P2|Part 1|Withdrawal by Subject|0
5096149|NCT01972776|17597636|P1|Part 1|Withdrawal by Subject|0
5096150|NCT01972724|17597707|P3|Open-Label|Significant Protocol Deviation|2
5096151|NCT01972724|17597708|P2|Open-Label|Significant Protocol Deviation|0
5096152|NCT01972724|17597709|P1|Open-Label|Significant Protocol Deviation|0
5096153|NCT01972724|17597707|P3|Open-Label|Withdrew Consent|3
5096154|NCT01972724|17597708|P2|Open-Label|Withdrew Consent|0
5096155|NCT01972724|17597709|P1|Open-Label|Withdrew Consent|0
5096156|NCT01972724|17597707|P3|Double-Blind|Significant Protocol Deviation|0
5096157|NCT01972724|17597708|P2|Double-Blind|Significant Protocol Deviation|8
5096158|NCT01972724|17597709|P1|Double-Blind|Significant Protocol Deviation|5
5096159|NCT01972724|17597707|P3|Double-Blind|Withdrawal of Consent|0
5096160|NCT01972724|17597708|P2|Double-Blind|Withdrawal of Consent|1
5096161|NCT01972724|17597709|P1|Double-Blind|Withdrawal of Consent|2
5096162|NCT01972724|17597707|P3|Double-Blind|Adverse Event|0
5096163|NCT01972724|17597708|P2|Double-Blind|Adverse Event|0
5096164|NCT01972724|17597709|P1|Double-Blind|Adverse Event|1
5096165|NCT01972724|17597707|P3|Double-Blind|Rescue Criteria Met|0
5096166|NCT01972724|17597708|P2|Double-Blind|Rescue Criteria Met|0
5096167|NCT01972724|17597709|P1|Double-Blind|Rescue Criteria Met|1
5096168|NCT01972659|17597722|P2|Overall Study|problems realted to acceleromyograph|1
5096169|NCT01972659|17597723|P1|Overall Study|problems realted to acceleromyograph|2
5096170|NCT01972659|17597722|P2|Overall Study|Protocol Violation|2
5096171|NCT01972659|17597723|P1|Overall Study|Protocol Violation|2
5096172|NCT01972568|17597732|P3|Overall Study|Adverse Event|5
5096173|NCT01972568|17597733|P2|Overall Study|Adverse Event|6
5096174|NCT01972568|17597734|P1|Overall Study|Adverse Event|5
5096175|NCT01972568|17597732|P3|Overall Study|Lost to Follow-up|0
5096176|NCT01972568|17597733|P2|Overall Study|Lost to Follow-up|0
5096177|NCT01972568|17597734|P1|Overall Study|Lost to Follow-up|1
5096178|NCT01972568|17597732|P3|Overall Study|Withdrawal by Subject|7
5096179|NCT01972568|17597733|P2|Overall Study|Withdrawal by Subject|3
5096180|NCT01972568|17597734|P1|Overall Study|Withdrawal by Subject|6
5096181|NCT01972568|17597732|P3|Overall Study|Protocol Violation|2
5096182|NCT01972568|17597733|P2|Overall Study|Protocol Violation|2
5096183|NCT01972568|17597734|P1|Overall Study|Protocol Violation|1
5096184|NCT01972568|17597732|P3|Overall Study|Lack of Efficacy|2
5096185|NCT01972568|17597733|P2|Overall Study|Lack of Efficacy|1
5096186|NCT01972568|17597734|P1|Overall Study|Lack of Efficacy|0
5096187|NCT01972568|17597732|P3|Overall Study|Other events|0
5096188|NCT01972568|17597733|P2|Overall Study|Other events|0
5096189|NCT01972568|17597734|P1|Overall Study|Other events|3
5096190|NCT01972529|17597773|P4|Overall Study|Not treated|1
5096191|NCT01972529|17597774|P3|Overall Study|Not treated|2
5096192|NCT01972529|17597775|P2|Overall Study|Not treated|1
5096193|NCT01972529|17597776|P1|Overall Study|Not treated|0
5096194|NCT01972529|17597773|P4|Overall Study|Other|2
5096195|NCT01972529|17597774|P3|Overall Study|Other|0
5096196|NCT01972529|17597775|P2|Overall Study|Other|0
5096197|NCT01972529|17597776|P1|Overall Study|Other|0
5096198|NCT01972529|17597773|P4|Overall Study|Withdrawl of Consent|1
5096199|NCT01972529|17597774|P3|Overall Study|Withdrawl of Consent|0
5096200|NCT01972529|17597775|P2|Overall Study|Withdrawl of Consent|2
5096201|NCT01972529|17597776|P1|Overall Study|Withdrawl of Consent|1
5096202|NCT01972529|17597773|P4|Overall Study|Participant Choice|0
5096203|NCT01972529|17597774|P3|Overall Study|Participant Choice|0
5096204|NCT01972529|17597775|P2|Overall Study|Participant Choice|1
5096205|NCT01972529|17597776|P1|Overall Study|Participant Choice|0
5096206|NCT01972529|17597773|P4|Overall Study|Lost to Follow-up|0
5096207|NCT01972529|17597774|P3|Overall Study|Lost to Follow-up|0
5096208|NCT01972529|17597775|P2|Overall Study|Lost to Follow-up|0
5096209|NCT01972529|17597776|P1|Overall Study|Lost to Follow-up|1
5096210|NCT01972529|17597773|P4|Overall Study|Adverse Event|0
5096211|NCT01972529|17597774|P3|Overall Study|Adverse Event|0
5096212|NCT01972529|17597775|P2|Overall Study|Adverse Event|1
5096213|NCT01972529|17597776|P1|Overall Study|Adverse Event|0
5096214|NCT01972464|17597821|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
5096215|NCT01972464|17597822|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
5096216|NCT01972464|17597821|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
5096217|NCT01972464|17597822|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
5096218|NCT01972464|17597821|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
5096219|NCT01972464|17597822|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
5096220|NCT01972464|17597821|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
5096221|NCT01972464|17597822|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
5096222|NCT01972438|17597838|P2|Post Month 12 Study Period|Early Study Closure|4
5096223|NCT01972438|17597839|P1|Post Month 12 Study Period|Early Study Closure|3
5096224|NCT01972438|17597838|P2|Months 6-12 Study Period|Early Study Closure|2
5096225|NCT01972438|17597839|P1|Months 6-12 Study Period|Early Study Closure|2
5096226|NCT01972438|17597838|P2|Months 6-12 Study Period|Death|0
5096227|NCT01972438|17597839|P1|Months 6-12 Study Period|Death|1
5096228|NCT01972438|17597838|P2|Months 3-6 Crossover Period|Early Study Closure|1
5096229|NCT01972438|17597839|P1|Months 3-6 Crossover Period|Early Study Closure|0
5096230|NCT01972438|17597838|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
5096231|NCT01972438|17597839|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
5096232|NCT01972438|17597838|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
5096233|NCT01972438|17597839|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
5096234|NCT01972438|17597838|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
5096235|NCT01972438|17597839|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
5096236|NCT01972438|17597838|P2|Baseline-Month 3 Crossover Period|Death|0
5096237|NCT01972438|17597839|P1|Baseline-Month 3 Crossover Period|Death|1
5096238|NCT01972308|17597893|P2|Overall Study|Death|1
5096239|NCT01972308|17597894|P1|Overall Study|Death|4
5096240|NCT01972308|17597893|P2|Overall Study|Lost to Follow-up|6
5096241|NCT01972308|17597894|P1|Overall Study|Lost to Follow-up|4
5096242|NCT01972308|17597893|P2|Overall Study|Withdrawal by Subject|1
5096243|NCT01972308|17597894|P1|Overall Study|Withdrawal by Subject|0
5096244|NCT01972217|17597920|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
5096245|NCT01972217|17597921|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5096246|NCT01972217|17597922|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5096247|NCT01972217|17597923|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5096248|NCT01972217|17597920|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
5096249|NCT01972217|17597921|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
5096250|NCT01972217|17597922|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
5096251|NCT01972217|17597923|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
5096252|NCT01972217|17597920|P4|Part B Double-blind, Randomised Period|Screen failure|1
5096253|NCT01972217|17597921|P3|Part B Double-blind, Randomised Period|Screen failure|0
5096254|NCT01972217|17597922|P2|Part B Double-blind, Randomised Period|Screen failure|0
5096255|NCT01972217|17597923|P1|Part B Double-blind, Randomised Period|Screen failure|0
5096256|NCT01972217|17597920|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
5096257|NCT01972217|17597921|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
5096258|NCT01972217|17597922|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
5096259|NCT01972217|17597923|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
5096260|NCT01972217|17597920|P4|Part B Double-blind, Randomised Period|Death|44
5096261|NCT01972217|17597921|P3|Part B Double-blind, Randomised Period|Death|43
5096262|NCT01972217|17597922|P2|Part B Double-blind, Randomised Period|Death|0
5096263|NCT01972217|17597923|P1|Part B Double-blind, Randomised Period|Death|0
5096264|NCT01972217|17597920|P4|Part A: Open-label Safety Run-in Period|Death|0
5096265|NCT01972217|17597921|P3|Part A: Open-label Safety Run-in Period|Death|0
5096266|NCT01972217|17597922|P2|Part A: Open-label Safety Run-in Period|Death|1
5096267|NCT01972217|17597923|P1|Part A: Open-label Safety Run-in Period|Death|0
5096268|NCT01972217|17597920|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
5096269|NCT01972217|17597921|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
5096270|NCT01972217|17597922|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
5096271|NCT01972217|17597923|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
5096272|NCT01972217|17597920|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
5096273|NCT01972217|17597921|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
5096274|NCT01972217|17597922|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
5096275|NCT01972217|17597923|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
5096276|NCT01972217|17597920|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5096277|NCT01972217|17597921|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5096278|NCT01972217|17597922|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
5096279|NCT01972217|17597923|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5096280|NCT01972152|17597984|P6|Second Treatment Visit|Protocol Violation|0
5096281|NCT01972152|17597985|P5|Second Treatment Visit|Protocol Violation|0
5096282|NCT01972152|17597986|P4|Second Treatment Visit|Protocol Violation|0
5096283|NCT01972152|17597987|P3|Second Treatment Visit|Protocol Violation|0
5096284|NCT01972152|17597988|P2|Second Treatment Visit|Protocol Violation|1
5096285|NCT01972152|17597989|P1|Second Treatment Visit|Protocol Violation|0
5096286|NCT01972152|17597984|P6|First Treatment Visit|Lost to Follow-up|0
5096287|NCT01972152|17597985|P5|First Treatment Visit|Lost to Follow-up|0
5096288|NCT01972152|17597986|P4|First Treatment Visit|Lost to Follow-up|0
5096289|NCT01972152|17597987|P3|First Treatment Visit|Lost to Follow-up|0
5096290|NCT01972152|17597988|P2|First Treatment Visit|Lost to Follow-up|1
5096291|NCT01972152|17597989|P1|First Treatment Visit|Lost to Follow-up|0
5096292|NCT01972074|17598027|P3|Overall Study|Scanner Unavailable|1
5096293|NCT01972074|17598028|P2|Overall Study|Scanner Unavailable|0
5096294|NCT01972074|17598029|P1|Overall Study|Scanner Unavailable|0
5096295|NCT01972074|17598027|P3|Overall Study|Withdrawal by Subject|1
5096296|NCT01972074|17598028|P2|Overall Study|Withdrawal by Subject|1
5096297|NCT01972074|17598029|P1|Overall Study|Withdrawal by Subject|1
5096298|NCT01972074|17598027|P3|Overall Study|Lost to Follow-up|1
5096299|NCT01972074|17598028|P2|Overall Study|Lost to Follow-up|1
5096300|NCT01972074|17598029|P1|Overall Study|Lost to Follow-up|0
5096301|NCT01972074|17598027|P3|Overall Study|Lack of Efficacy|0
5096302|NCT01972074|17598028|P2|Overall Study|Lack of Efficacy|1
5096303|NCT01972074|17598029|P1|Overall Study|Lack of Efficacy|1
5096304|NCT01972074|17598027|P3|Overall Study|Adverse Event|0
5096305|NCT01972074|17598028|P2|Overall Study|Adverse Event|1
5096306|NCT01972074|17598029|P1|Overall Study|Adverse Event|4
5096307|NCT01971723|17598055|P2|Overall Study|Protocol Violation|2
5096308|NCT01971723|17598056|P1|Overall Study|Protocol Violation|1
5096309|NCT01971723|17598055|P2|Overall Study|Withdrawal by Subject|1
5096310|NCT01971723|17598056|P1|Overall Study|Withdrawal by Subject|1
5096311|NCT01971645|17598089|P3|Overall Study|Protocol Violation|1
5096312|NCT01971645|17598090|P2|Overall Study|Protocol Violation|0
5096313|NCT01971645|17598091|P1|Overall Study|Protocol Violation|0
5096314|NCT01971645|17598089|P3|Overall Study|Lost to Follow-up|1
5096315|NCT01971645|17598090|P2|Overall Study|Lost to Follow-up|0
5096316|NCT01971645|17598091|P1|Overall Study|Lost to Follow-up|1
5096317|NCT01971645|17598089|P3|Overall Study|Adverse Event|0
5096318|NCT01971645|17598090|P2|Overall Study|Adverse Event|0
5096319|NCT01971645|17598091|P1|Overall Study|Adverse Event|1
5096320|NCT01971567|17598125|P2|Overall Study|Lost to Follow-up|0
5096321|NCT01971567|17598126|P1|Overall Study|Lost to Follow-up|1
5096322|NCT01971567|17598125|P2|Overall Study|Withdrawal by Subject|2
5096323|NCT01971567|17598126|P1|Overall Study|Withdrawal by Subject|3
5096324|NCT01971554|17598152|P4|Overall Study|Lost to Follow-up|0
5096325|NCT01971554|17598153|P3|Overall Study|Lost to Follow-up|0
5096326|NCT01971554|17598154|P2|Overall Study|Lost to Follow-up|0
5096327|NCT01971554|17598155|P1|Overall Study|Lost to Follow-up|1
5096328|NCT01971476|17598192|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
5096329|NCT01971476|17598193|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
5096330|NCT01971476|17598194|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
5096331|NCT01971476|17598192|P3|Cohort 2: 12 to <18 Years|Other not defined|0
5096332|NCT01971476|17598193|P2|Cohort 2: 12 to <18 Years|Other not defined|3
5096333|NCT01971476|17598194|P1|Cohort 2: 12 to <18 Years|Other not defined|6
5096334|NCT01971476|17598192|P3|Cohort 1: 2 to <12 Years|Other not defined|6
5096335|NCT01971476|17598193|P2|Cohort 1: 2 to <12 Years|Other not defined|3
5096336|NCT01971476|17598194|P1|Cohort 1: 2 to <12 Years|Other not defined|3
5096337|NCT01971346|17598288|P1|Overall Study|Physician Decision|1
5096338|NCT01971346|17598288|P1|Overall Study|Withdrawal by Subject|2
5096339|NCT01971346|17598288|P1|Overall Study|Lost to Follow-up|2
5096340|NCT01971346|17598288|P1|Overall Study|Protocol Violation|3
5096341|NCT01971203|17598321|P2|Overall Study|Adverse Event|0
5096342|NCT01971203|17598322|P1|Overall Study|Adverse Event|1
5096343|NCT01971203|17598321|P2|Overall Study|Withdrawal by Subject|6
5096344|NCT01971203|17598322|P1|Overall Study|Withdrawal by Subject|5
5096345|NCT01971203|17598321|P2|Overall Study|Protocol Violation|2
5096346|NCT01971203|17598322|P1|Overall Study|Protocol Violation|3
5096347|NCT01970995|17598349|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
5096348|NCT01970995|17598350|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
5096349|NCT01970995|17598351|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
5096350|NCT01970995|17598349|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5096351|NCT01970995|17598350|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5096352|NCT01970995|17598351|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5096353|NCT01970982|17598374|P3|Overall Study|Withdrawal by Subject|2
5096354|NCT01970982|17598375|P2|Overall Study|Withdrawal by Subject|0
5096355|NCT01970982|17598376|P1|Overall Study|Withdrawal by Subject|0
5096356|NCT01970878|17598411|P4|Overall Study|No Completion Status|0
5096357|NCT01970878|17598412|P3|Overall Study|No Completion Status|0
5096358|NCT01970878|17598413|P2|Overall Study|No Completion Status|1
5096359|NCT01970878|17598414|P1|Overall Study|No Completion Status|0
5096360|NCT01970878|17598411|P4|Overall Study|Physician Decision|0
5096361|NCT01970878|17598412|P3|Overall Study|Physician Decision|1
5096362|NCT01970878|17598413|P2|Overall Study|Physician Decision|1
5096363|NCT01970878|17598414|P1|Overall Study|Physician Decision|0
5096364|NCT01970878|17598411|P4|Overall Study|Protocol Specified Criteria|6
5096365|NCT01970878|17598412|P3|Overall Study|Protocol Specified Criteria|3
5096366|NCT01970878|17598413|P2|Overall Study|Protocol Specified Criteria|4
5096367|NCT01970878|17598414|P1|Overall Study|Protocol Specified Criteria|10
5096368|NCT01970878|17598411|P4|Overall Study|Adverse Event|3
5096369|NCT01970878|17598412|P3|Overall Study|Adverse Event|4
5096370|NCT01970878|17598413|P2|Overall Study|Adverse Event|7
5096371|NCT01970878|17598414|P1|Overall Study|Adverse Event|12
5096372|NCT01970878|17598411|P4|Overall Study|Lack of Efficacy|0
5096373|NCT01970878|17598412|P3|Overall Study|Lack of Efficacy|2
5096374|NCT01970878|17598413|P2|Overall Study|Lack of Efficacy|1
5096375|NCT01970878|17598414|P1|Overall Study|Lack of Efficacy|2
5096376|NCT01970878|17598411|P4|Overall Study|Administrative Reasons|4
5096377|NCT01970878|17598412|P3|Overall Study|Administrative Reasons|0
5096378|NCT01970878|17598413|P2|Overall Study|Administrative Reasons|0
5096379|NCT01970878|17598414|P1|Overall Study|Administrative Reasons|1
5096380|NCT01970878|17598411|P4|Overall Study|Lost to Follow-up|4
5096381|NCT01970878|17598412|P3|Overall Study|Lost to Follow-up|2
5096382|NCT01970878|17598413|P2|Overall Study|Lost to Follow-up|3
5096383|NCT01970878|17598414|P1|Overall Study|Lost to Follow-up|1
5096384|NCT01970878|17598411|P4|Overall Study|Withdrawal by Subject|7
5096385|NCT01970878|17598412|P3|Overall Study|Withdrawal by Subject|14
5096386|NCT01970878|17598413|P2|Overall Study|Withdrawal by Subject|10
5096387|NCT01970878|17598414|P1|Overall Study|Withdrawal by Subject|11
5096388|NCT01970865|17598457|P17|Overall Study|Study ongoing|2
5096389|NCT01970865|17598458|P16|Overall Study|Study ongoing|29
5096390|NCT01970865|17598459|P15|Overall Study|Study ongoing|29
5096391|NCT01970865|17598460|P14|Overall Study|Study ongoing|41
5096392|NCT01970865|17598461|P13|Overall Study|Study ongoing|43
5096393|NCT01970865|17598462|P12|Overall Study|Study ongoing|22
5096394|NCT01970865|17598463|P11|Overall Study|Study ongoing|29
5096395|NCT01970865|17598464|P10|Overall Study|Study ongoing|3
5096396|NCT01970865|17598465|P9|Overall Study|Study ongoing|1
5096397|NCT01970865|17598466|P8|Overall Study|Study ongoing|0
5096398|NCT01970865|17598467|P7|Overall Study|Study ongoing|2
5096399|NCT01970865|17598468|P6|Overall Study|Study ongoing|0
5096400|NCT01970865|17598469|P5|Overall Study|Study ongoing|8
5096401|NCT01970865|17598470|P4|Overall Study|Study ongoing|6
5096402|NCT01970865|17598471|P3|Overall Study|Study ongoing|0
5096403|NCT01970865|17598472|P2|Overall Study|Study ongoing|2
5096404|NCT01970865|17598473|P1|Overall Study|Study ongoing|0
5096405|NCT01970865|17598457|P17|Overall Study|Other|0
5096406|NCT01970865|17598458|P16|Overall Study|Other|1
5096407|NCT01970865|17598459|P15|Overall Study|Other|0
5096408|NCT01970865|17598460|P14|Overall Study|Other|1
5096409|NCT01970865|17598461|P13|Overall Study|Other|0
5096410|NCT01970865|17598462|P12|Overall Study|Other|0
5096411|NCT01970865|17598463|P11|Overall Study|Other|0
5096412|NCT01970865|17598464|P10|Overall Study|Other|0
5096413|NCT01970865|17598465|P9|Overall Study|Other|0
5096414|NCT01970865|17598466|P8|Overall Study|Other|0
5096415|NCT01970865|17598467|P7|Overall Study|Other|0
5096416|NCT01970865|17598468|P6|Overall Study|Other|0
5096417|NCT01970865|17598469|P5|Overall Study|Other|0
5096418|NCT01970865|17598470|P4|Overall Study|Other|1
5096419|NCT01970865|17598471|P3|Overall Study|Other|0
5096420|NCT01970865|17598472|P2|Overall Study|Other|0
5096421|NCT01970865|17598473|P1|Overall Study|Other|0
5096422|NCT01970865|17598457|P17|Overall Study|Withdrawal by Subject|0
5096423|NCT01970865|17598458|P16|Overall Study|Withdrawal by Subject|7
5096424|NCT01970865|17598459|P15|Overall Study|Withdrawal by Subject|2
5096425|NCT01970865|17598460|P14|Overall Study|Withdrawal by Subject|5
5096426|NCT01970865|17598461|P13|Overall Study|Withdrawal by Subject|2
5096427|NCT01970865|17598462|P12|Overall Study|Withdrawal by Subject|1
5096428|NCT01970865|17598463|P11|Overall Study|Withdrawal by Subject|0
5096429|NCT01970865|17598464|P10|Overall Study|Withdrawal by Subject|0
5096430|NCT01970865|17598465|P9|Overall Study|Withdrawal by Subject|0
5096431|NCT01970865|17598466|P8|Overall Study|Withdrawal by Subject|0
5096432|NCT01970865|17598467|P7|Overall Study|Withdrawal by Subject|0
5096433|NCT01970865|17598468|P6|Overall Study|Withdrawal by Subject|0
5096434|NCT01970865|17598469|P5|Overall Study|Withdrawal by Subject|2
5096435|NCT01970865|17598470|P4|Overall Study|Withdrawal by Subject|1
5096436|NCT01970865|17598471|P3|Overall Study|Withdrawal by Subject|0
5096437|NCT01970865|17598472|P2|Overall Study|Withdrawal by Subject|0
5096438|NCT01970865|17598473|P1|Overall Study|Withdrawal by Subject|0
5096439|NCT01970865|17598457|P17|Overall Study|Lost to Follow-up|0
5096440|NCT01970865|17598458|P16|Overall Study|Lost to Follow-up|0
5096441|NCT01970865|17598459|P15|Overall Study|Lost to Follow-up|0
5096442|NCT01970865|17598460|P14|Overall Study|Lost to Follow-up|0
5096443|NCT01970865|17598461|P13|Overall Study|Lost to Follow-up|1
5096444|NCT01970865|17598462|P12|Overall Study|Lost to Follow-up|0
5096445|NCT01970865|17598463|P11|Overall Study|Lost to Follow-up|0
5096446|NCT01970865|17598464|P10|Overall Study|Lost to Follow-up|0
5096447|NCT01970865|17598465|P9|Overall Study|Lost to Follow-up|0
5096448|NCT01970865|17598466|P8|Overall Study|Lost to Follow-up|0
5096449|NCT01970865|17598467|P7|Overall Study|Lost to Follow-up|0
5096450|NCT01970865|17598468|P6|Overall Study|Lost to Follow-up|0
5096451|NCT01970865|17598469|P5|Overall Study|Lost to Follow-up|1
5096452|NCT01970865|17598470|P4|Overall Study|Lost to Follow-up|1
5096453|NCT01970865|17598471|P3|Overall Study|Lost to Follow-up|0
5096454|NCT01970865|17598472|P2|Overall Study|Lost to Follow-up|0
5096455|NCT01970865|17598473|P1|Overall Study|Lost to Follow-up|0
5096456|NCT01970865|17598457|P17|Overall Study|Death|1
5096457|NCT01970865|17598458|P16|Overall Study|Death|10
5096458|NCT01970865|17598459|P15|Overall Study|Death|15
5096459|NCT01970865|17598460|P14|Overall Study|Death|19
5096460|NCT01970865|17598461|P13|Overall Study|Death|14
5096461|NCT01970865|17598462|P12|Overall Study|Death|4
5096462|NCT01970865|17598463|P11|Overall Study|Death|1
5096463|NCT01970865|17598464|P10|Overall Study|Death|1
5096464|NCT01970865|17598465|P9|Overall Study|Death|2
5096465|NCT01970865|17598466|P8|Overall Study|Death|3
5096466|NCT01970865|17598467|P7|Overall Study|Death|1
5096467|NCT01970865|17598468|P6|Overall Study|Death|3
5096468|NCT01970865|17598469|P5|Overall Study|Death|6
5096469|NCT01970865|17598470|P4|Overall Study|Death|4
5096470|NCT01970865|17598471|P3|Overall Study|Death|3
5096471|NCT01970865|17598472|P2|Overall Study|Death|1
5096472|NCT01970865|17598473|P1|Overall Study|Death|3
5096473|NCT01970592|17598905|P1|Overall Study|Adverse Event|1
5096474|NCT01970592|17598905|P1|Overall Study|Physician Decision|1
5096475|NCT01970592|17598905|P1|Overall Study|Withdrawal by Subject|4
5096476|NCT01970540|17598913|P3|Overall Study|Clinical deterioration|0
5096477|NCT01970540|17598914|P2|Overall Study|Clinical deterioration|0
5096478|NCT01970540|17598915|P1|Overall Study|Clinical deterioration|1
5096479|NCT01970540|17598913|P3|Overall Study|Withdrawal by Subject|1
5096480|NCT01970540|17598914|P2|Overall Study|Withdrawal by Subject|0
5096481|NCT01970540|17598915|P1|Overall Study|Withdrawal by Subject|4
5096482|NCT01970540|17598913|P3|Overall Study|Treatment-related AE|2
5096483|NCT01970540|17598914|P2|Overall Study|Treatment-related AE|0
5096484|NCT01970540|17598915|P1|Overall Study|Treatment-related AE|4
5096485|NCT01970540|17598913|P3|Overall Study|Adverse Event|1
5096486|NCT01970540|17598914|P2|Overall Study|Adverse Event|2
5096487|NCT01970540|17598915|P1|Overall Study|Adverse Event|0
5096488|NCT01970540|17598913|P3|Overall Study|End of study|2
5096489|NCT01970540|17598914|P2|Overall Study|End of study|0
5096490|NCT01970540|17598915|P1|Overall Study|End of study|2
5096491|NCT01970540|17598913|P3|Overall Study|Clinical progression|1
5096492|NCT01970540|17598914|P2|Overall Study|Clinical progression|1
5096493|NCT01970540|17598915|P1|Overall Study|Clinical progression|0
5096494|NCT01970540|17598913|P3|Overall Study|Physician Decision|0
5096495|NCT01970540|17598914|P2|Overall Study|Physician Decision|2
5096496|NCT01970540|17598915|P1|Overall Study|Physician Decision|7
5096497|NCT01970540|17598913|P3|Overall Study|Treatment delay over protocol|1
5096498|NCT01970540|17598914|P2|Overall Study|Treatment delay over protocol|0
5096499|NCT01970540|17598915|P1|Overall Study|Treatment delay over protocol|0
5096500|NCT01970540|17598913|P3|Overall Study|Progressive disease|10
5096501|NCT01970540|17598914|P2|Overall Study|Progressive disease|23
5096502|NCT01970540|17598915|P1|Overall Study|Progressive disease|55
5096503|NCT01970540|17598913|P3|Overall Study|Non-treatment-related AE|1
5096504|NCT01970540|17598914|P2|Overall Study|Non-treatment-related AE|0
5096505|NCT01970540|17598915|P1|Overall Study|Non-treatment-related AE|0
5096506|NCT01970527|17598946|P2|Follow-up Clinic Visit|Lost to Follow-up|1
5096507|NCT01970527|17598947|P1|Follow-up Clinic Visit|Lost to Follow-up|0
5096508|NCT01970527|17598946|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
5096509|NCT01970527|17598947|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
5096510|NCT01970527|17598946|P2|Follow-up Clinic Visit|Disease progression|1
5096511|NCT01970527|17598947|P1|Follow-up Clinic Visit|Disease progression|1
5096512|NCT01970527|17598946|P2|Treatment|Death|1
5096513|NCT01970527|17598947|P1|Treatment|Death|0
5096514|NCT01970527|17598946|P2|Treatment|Participant did not tolerate Ipilimumab|1
5096515|NCT01970527|17598947|P1|Treatment|Participant did not tolerate Ipilimumab|0
5096516|NCT01970527|17598946|P2|Treatment|Disease progression|1
5096517|NCT01970527|17598947|P1|Treatment|Disease progression|0
5096518|NCT01970527|17598946|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
5096519|NCT01970527|17598947|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
5096520|NCT01970488|17598960|P5|Part 2: Post Week 16|Lost to Follow-up|2
5096521|NCT01970488|17598961|P4|Part 2: Post Week 16|Lost to Follow-up|1
5096522|NCT01970488|17598962|P3|Part 2: Post Week 16|Lost to Follow-up|1
5096523|NCT01970488|17598963|P2|Part 2: Post Week 16|Lost to Follow-up|0
5096524|NCT01970488|17598964|P1|Part 2: Post Week 16|Lost to Follow-up|0
5096525|NCT01970488|17598960|P5|Part 2: Post Week 16|Withdrawal by Subject|3
5096526|NCT01970488|17598961|P4|Part 2: Post Week 16|Withdrawal by Subject|3
5096527|NCT01970488|17598962|P3|Part 2: Post Week 16|Withdrawal by Subject|8
5096528|NCT01970488|17598963|P2|Part 2: Post Week 16|Withdrawal by Subject|0
5096529|NCT01970488|17598964|P1|Part 2: Post Week 16|Withdrawal by Subject|0
5096530|NCT01970488|17598960|P5|Part 2: Post Week 16|Adverse Event|1
5096531|NCT01970488|17598961|P4|Part 2: Post Week 16|Adverse Event|1
5096532|NCT01970488|17598962|P3|Part 2: Post Week 16|Adverse Event|5
5096533|NCT01970488|17598963|P2|Part 2: Post Week 16|Adverse Event|0
5096534|NCT01970488|17598964|P1|Part 2: Post Week 16|Adverse Event|0
5096535|NCT01970488|17598960|P5|Part 2: Post Week 16|Lack of Efficacy|1
5096536|NCT01970488|17598961|P4|Part 2: Post Week 16|Lack of Efficacy|3
5096537|NCT01970488|17598962|P3|Part 2: Post Week 16|Lack of Efficacy|2
5096538|NCT01970488|17598963|P2|Part 2: Post Week 16|Lack of Efficacy|0
5096539|NCT01970488|17598964|P1|Part 2: Post Week 16|Lack of Efficacy|0
5096540|NCT01970488|17598960|P5|Part 2: Post Week 16|Non-compliance|0
5096541|NCT01970488|17598961|P4|Part 2: Post Week 16|Non-compliance|0
5096542|NCT01970488|17598962|P3|Part 2: Post Week 16|Non-compliance|1
5096543|NCT01970488|17598963|P2|Part 2: Post Week 16|Non-compliance|0
5096544|NCT01970488|17598964|P1|Part 2: Post Week 16|Non-compliance|0
5096545|NCT01970488|17598960|P5|Part 2: Post Week 16|Physician Decision|1
5096546|NCT01970488|17598961|P4|Part 2: Post Week 16|Physician Decision|0
5096547|NCT01970488|17598962|P3|Part 2: Post Week 16|Physician Decision|0
5096548|NCT01970488|17598963|P2|Part 2: Post Week 16|Physician Decision|0
5096549|NCT01970488|17598964|P1|Part 2: Post Week 16|Physician Decision|0
5096550|NCT01970488|17598960|P5|Part 1: Through Week 16|Lost to Follow-up|0
5096551|NCT01970488|17598961|P4|Part 1: Through Week 16|Lost to Follow-up|0
5096552|NCT01970488|17598962|P3|Part 1: Through Week 16|Lost to Follow-up|0
5096553|NCT01970488|17598963|P2|Part 1: Through Week 16|Lost to Follow-up|2
5096554|NCT01970488|17598964|P1|Part 1: Through Week 16|Lost to Follow-up|0
5096555|NCT01970488|17598960|P5|Part 1: Through Week 16|Withdrawal by Subject|0
5096556|NCT01970488|17598961|P4|Part 1: Through Week 16|Withdrawal by Subject|0
5096557|NCT01970488|17598962|P3|Part 1: Through Week 16|Withdrawal by Subject|0
5096558|NCT01970488|17598963|P2|Part 1: Through Week 16|Withdrawal by Subject|2
5096559|NCT01970488|17598964|P1|Part 1: Through Week 16|Withdrawal by Subject|3
5096560|NCT01970488|17598960|P5|Part 1: Through Week 16|Adverse Event|0
5096561|NCT01970488|17598961|P4|Part 1: Through Week 16|Adverse Event|0
5096562|NCT01970488|17598962|P3|Part 1: Through Week 16|Adverse Event|0
5096563|NCT01970488|17598963|P2|Part 1: Through Week 16|Adverse Event|5
5096564|NCT01970488|17598964|P1|Part 1: Through Week 16|Adverse Event|6
5096565|NCT01970488|17598960|P5|Part 1: Through Week 16|Protocol Violation|0
5096566|NCT01970488|17598961|P4|Part 1: Through Week 16|Protocol Violation|0
5096567|NCT01970488|17598962|P3|Part 1: Through Week 16|Protocol Violation|0
5096568|NCT01970488|17598963|P2|Part 1: Through Week 16|Protocol Violation|2
5096569|NCT01970488|17598964|P1|Part 1: Through Week 16|Protocol Violation|1
5096570|NCT01970488|17598960|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
5096571|NCT01970488|17598961|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
5096572|NCT01970488|17598962|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
5096573|NCT01970488|17598963|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
5096574|NCT01970488|17598964|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
5096575|NCT01970475|17599031|P2|Overall Study|Protocol Violation|0
5096576|NCT01970475|17599032|P1|Overall Study|Protocol Violation|1
5096577|NCT01970475|17599031|P2|Overall Study|Lost to Follow-up|2
5096578|NCT01970475|17599032|P1|Overall Study|Lost to Follow-up|2
5096579|NCT01970475|17599031|P2|Overall Study|Adverse Event|3
5096580|NCT01970475|17599032|P1|Overall Study|Adverse Event|7
5096581|NCT01970475|17599031|P2|Overall Study|Withdrawal by Subject|6
5096582|NCT01970475|17599032|P1|Overall Study|Withdrawal by Subject|11
5096583|NCT01970462|17599052|P2|Overall Study|Lost to Follow-up|2
5096584|NCT01970462|17599053|P1|Overall Study|Lost to Follow-up|0
5096585|NCT01970397|17599067|P2|Overall Study|Protocol Violation|1
5096586|NCT01970397|17599068|P1|Overall Study|Protocol Violation|1
5096587|NCT01970397|17599067|P2|Overall Study|Personal Reasons|2
5096588|NCT01970397|17599068|P1|Overall Study|Personal Reasons|1
5096589|NCT01970397|17599067|P2|Overall Study|Lost to Follow-up|1
5096590|NCT01970397|17599068|P1|Overall Study|Lost to Follow-up|0
5096591|NCT01970397|17599067|P2|Overall Study|Adverse Event|1
5096592|NCT01970397|17599068|P1|Overall Study|Adverse Event|0
5096593|NCT01970371|17599081|P3|Overall Study|Lost to Follow-up|1
5096594|NCT01970371|17599082|P2|Overall Study|Lost to Follow-up|0
5096595|NCT01970371|17599083|P1|Overall Study|Lost to Follow-up|0
5096596|NCT01970371|17599081|P3|Overall Study|Death|12
5096597|NCT01970371|17599082|P2|Overall Study|Death|13
5096598|NCT01970371|17599083|P1|Overall Study|Death|8
5096599|NCT01970241|17599108|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
5096600|NCT01970241|17599109|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
5096601|NCT01970241|17599108|P2|Overall Study|Withdrawal by Subject|0
5096602|NCT01970241|17599109|P1|Overall Study|Withdrawal by Subject|2
5096603|NCT01969851|17599169|P3|Overall Study|Sponsor decision|1
5096604|NCT01969851|17599170|P2|Overall Study|Sponsor decision|0
5096605|NCT01969851|17599171|P1|Overall Study|Sponsor decision|0
5096606|NCT01969851|17599169|P3|Overall Study|No effective dose in Titration period|1
5096607|NCT01969851|17599170|P2|Overall Study|No effective dose in Titration period|0
5096608|NCT01969851|17599171|P1|Overall Study|No effective dose in Titration period|0
5096609|NCT01969851|17599169|P3|Overall Study|Withdrawal by Subject|1
5096610|NCT01969851|17599170|P2|Overall Study|Withdrawal by Subject|0
5096611|NCT01969851|17599171|P1|Overall Study|Withdrawal by Subject|1
5096612|NCT01969851|17599169|P3|Overall Study|Lack of Efficacy|1
5096613|NCT01969851|17599170|P2|Overall Study|Lack of Efficacy|3
5096614|NCT01969851|17599171|P1|Overall Study|Lack of Efficacy|0
5096615|NCT01969851|17599169|P3|Overall Study|Adverse Event|3
5096616|NCT01969851|17599170|P2|Overall Study|Adverse Event|0
5096617|NCT01969851|17599171|P1|Overall Study|Adverse Event|0
5096618|NCT01969799|17599193|P2|Overall Study|Physician Decision|0
5096619|NCT01969799|17599194|P1|Overall Study|Physician Decision|1
5096620|NCT01969799|17599193|P2|Overall Study|Lost to Follow-up|2
5096621|NCT01969799|17599194|P1|Overall Study|Lost to Follow-up|0
5096622|NCT01969799|17599193|P2|Overall Study|Death|11
5096623|NCT01969799|17599194|P1|Overall Study|Death|16
5096624|NCT01969799|17599193|P2|Overall Study|Adverse Event|1
5096625|NCT01969799|17599194|P1|Overall Study|Adverse Event|0
5096626|NCT01969721|17599231|P4|Overall Study|Discontinued during washout periods.|2
5096627|NCT01969721|17599232|P3|Overall Study|Discontinued during washout periods.|1
5096628|NCT01969721|17599233|P2|Overall Study|Discontinued during washout periods.|1
5096629|NCT01969721|17599234|P1|Overall Study|Discontinued during washout periods.|0
5096630|NCT01969721|17599231|P4|Overall Study|Other not defined above|0
5096631|NCT01969721|17599232|P3|Overall Study|Other not defined above|0
5096632|NCT01969721|17599233|P2|Overall Study|Other not defined above|2
5096633|NCT01969721|17599234|P1|Overall Study|Other not defined above|0
5096634|NCT01969721|17599231|P4|Overall Study|Non compliant with protocol|2
5096635|NCT01969721|17599232|P3|Overall Study|Non compliant with protocol|0
5096636|NCT01969721|17599233|P2|Overall Study|Non compliant with protocol|1
5096637|NCT01969721|17599234|P1|Overall Study|Non compliant with protocol|1
5096638|NCT01969721|17599231|P4|Overall Study|Lack of Efficacy|0
5096639|NCT01969721|17599232|P3|Overall Study|Lack of Efficacy|1
5096640|NCT01969721|17599233|P2|Overall Study|Lack of Efficacy|0
5096641|NCT01969721|17599234|P1|Overall Study|Lack of Efficacy|0
5096642|NCT01969721|17599231|P4|Overall Study|Adverse Event|2
5096643|NCT01969721|17599232|P3|Overall Study|Adverse Event|3
5096644|NCT01969721|17599233|P2|Overall Study|Adverse Event|8
5096645|NCT01969721|17599234|P1|Overall Study|Adverse Event|3
5096646|NCT01969565|17599279|P1|Overall Study|Withdrawal by Subject|1
5096647|NCT01969500|17599293|P2|Overall Study|extended hospitalization|1
5096648|NCT01969500|17599294|P1|Overall Study|extended hospitalization|1
5096649|NCT01969500|17599293|P2|Overall Study|Death|1
5096650|NCT01969500|17599294|P1|Overall Study|Death|0
5096651|NCT01969084|17599415|P2|Overall Study|Adverse Event|1
5096652|NCT01969084|17599416|P1|Overall Study|Adverse Event|0
5096653|NCT01969058|17599432|P2|Overall Study|Adverse Event|0
5096654|NCT01969058|17599433|P1|Overall Study|Adverse Event|1
5096655|NCT01969058|17599432|P2|Overall Study|Withdrawal by Subject|0
5096656|NCT01969058|17599433|P1|Overall Study|Withdrawal by Subject|2
5096657|NCT01968980|17599477|P2|Overall Study|Other unspecified|2
5096658|NCT01968980|17599478|P1|Overall Study|Other unspecified|1
5096659|NCT01968980|17599477|P2|Overall Study|Withdrawal by Subject|5
5096660|NCT01968980|17599478|P1|Overall Study|Withdrawal by Subject|13
5096661|NCT01968980|17599477|P2|Overall Study|Does not meet entry criteria|3
5096662|NCT01968980|17599478|P1|Overall Study|Does not meet entry criteria|1
5096663|NCT01968980|17599477|P2|Overall Study|Adverse Event|3
5096664|NCT01968980|17599478|P1|Overall Study|Adverse Event|1
5096665|NCT01968980|17599477|P2|Overall Study|Death|1
5096666|NCT01968980|17599478|P1|Overall Study|Death|0
5096667|NCT01968967|17599540|P5|Extension Period|Withdrew Consent|5
5096668|NCT01968967|17599541|P4|Extension Period|Withdrew Consent|0
5096669|NCT01968967|17599542|P3|Extension Period|Withdrew Consent|2
5096670|NCT01968967|17599543|P2|Extension Period|Withdrew Consent|0
5096671|NCT01968967|17599544|P1|Extension Period|Withdrew Consent|0
5096672|NCT01968967|17599540|P5|Treatment Period|Randomized Not Treated|0
5096673|NCT01968967|17599541|P4|Treatment Period|Randomized Not Treated|0
5096674|NCT01968967|17599542|P3|Treatment Period|Randomized Not Treated|0
5096675|NCT01968967|17599543|P2|Treatment Period|Randomized Not Treated|5
5096676|NCT01968967|17599544|P1|Treatment Period|Randomized Not Treated|6
5096677|NCT01968967|17599540|P5|Treatment Period|Death|0
5096678|NCT01968967|17599541|P4|Treatment Period|Death|0
5096679|NCT01968967|17599542|P3|Treatment Period|Death|0
5096680|NCT01968967|17599543|P2|Treatment Period|Death|2
5096681|NCT01968967|17599544|P1|Treatment Period|Death|9
5096682|NCT01968967|17599540|P5|Treatment Period|Adverse Event|0
5096683|NCT01968967|17599541|P4|Treatment Period|Adverse Event|0
5096684|NCT01968967|17599542|P3|Treatment Period|Adverse Event|0
5096685|NCT01968967|17599543|P2|Treatment Period|Adverse Event|8
5096686|NCT01968967|17599544|P1|Treatment Period|Adverse Event|9
5096687|NCT01968967|17599540|P5|Treatment Period|Protocol Violation|0
5096688|NCT01968967|17599541|P4|Treatment Period|Protocol Violation|0
5096689|NCT01968967|17599542|P3|Treatment Period|Protocol Violation|0
5096690|NCT01968967|17599543|P2|Treatment Period|Protocol Violation|2
5096691|NCT01968967|17599544|P1|Treatment Period|Protocol Violation|1
5096692|NCT01968967|17599540|P5|Treatment Period|Lost to Follow-up|0
5096693|NCT01968967|17599541|P4|Treatment Period|Lost to Follow-up|0
5096694|NCT01968967|17599542|P3|Treatment Period|Lost to Follow-up|0
5096695|NCT01968967|17599543|P2|Treatment Period|Lost to Follow-up|31
5096696|NCT01968967|17599544|P1|Treatment Period|Lost to Follow-up|26
5096697|NCT01968967|17599540|P5|Treatment Period|Did Not Meet Entrance Criteria|0
5096698|NCT01968967|17599541|P4|Treatment Period|Did Not Meet Entrance Criteria|0
5096699|NCT01968967|17599542|P3|Treatment Period|Did Not Meet Entrance Criteria|0
5096700|NCT01968967|17599543|P2|Treatment Period|Did Not Meet Entrance Criteria|3
5096701|NCT01968967|17599544|P1|Treatment Period|Did Not Meet Entrance Criteria|2
5096702|NCT01968967|17599540|P5|Treatment Period|Withdrawal by Subject|0
5096703|NCT01968967|17599541|P4|Treatment Period|Withdrawal by Subject|0
5096704|NCT01968967|17599542|P3|Treatment Period|Withdrawal by Subject|0
5096705|NCT01968967|17599543|P2|Treatment Period|Withdrawal by Subject|61
5096706|NCT01968967|17599544|P1|Treatment Period|Withdrawal by Subject|71
5096707|NCT01968967|17599540|P5|Treatment Period|Other|0
5096708|NCT01968967|17599541|P4|Treatment Period|Other|0
5096709|NCT01968967|17599542|P3|Treatment Period|Other|0
5096710|NCT01968967|17599543|P2|Treatment Period|Other|22
5096711|NCT01968967|17599544|P1|Treatment Period|Other|22
5096712|NCT01968954|17599613|P2|Overall Study|Did not met inclusion criteria|2
5096713|NCT01968954|17599614|P1|Overall Study|Did not met inclusion criteria|0
5096714|NCT01968954|17599613|P2|Overall Study|Protocol Violation|1
5096715|NCT01968954|17599614|P1|Overall Study|Protocol Violation|0
5096716|NCT01968954|17599613|P2|Overall Study|Other|8
5096717|NCT01968954|17599614|P1|Overall Study|Other|7
5096718|NCT01968954|17599613|P2|Overall Study|Withdrawal by Subject|23
5096719|NCT01968954|17599614|P1|Overall Study|Withdrawal by Subject|20
5096720|NCT01968954|17599613|P2|Overall Study|Lost to Follow-up|4
5096721|NCT01968954|17599614|P1|Overall Study|Lost to Follow-up|6
5096722|NCT01968954|17599613|P2|Overall Study|Death|2
5096723|NCT01968954|17599614|P1|Overall Study|Death|1
5096724|NCT01968954|17599613|P2|Overall Study|Adverse Event|3
5096725|NCT01968954|17599614|P1|Overall Study|Adverse Event|6
5096726|NCT01968811|17599678|P1|Overall Study|post op.ref. of subject to other hospita|1
5096727|NCT01968811|17599678|P1|Overall Study|Protocol Violation|4
5096728|NCT01968694|17599685|P2|Washout (1 Month)|Lost to Follow-up|1
5096729|NCT01968694|17599686|P1|Washout (1 Month)|Lost to Follow-up|0
5096730|NCT01968551|17599703|P3|Extension Phase|Lost to Follow-up|1
5096731|NCT01968551|17599704|P2|Extension Phase|Lost to Follow-up|0
5096732|NCT01968551|17599705|P1|Extension Phase|Lost to Follow-up|1
5096733|NCT01968551|17599703|P3|Extension Phase|Withdrew Consent|1
5096734|NCT01968551|17599704|P2|Extension Phase|Withdrew Consent|0
5096735|NCT01968551|17599705|P1|Extension Phase|Withdrew Consent|0
5096736|NCT01968551|17599703|P3|Extension Phase|Death|0
5096737|NCT01968551|17599704|P2|Extension Phase|Death|1
5096738|NCT01968551|17599705|P1|Extension Phase|Death|0
5096739|NCT01968551|17599703|P3|Extension Phase|Adverse Event|2
5096740|NCT01968551|17599704|P2|Extension Phase|Adverse Event|0
5096741|NCT01968551|17599705|P1|Extension Phase|Adverse Event|0
5096742|NCT01968551|17599703|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
5096743|NCT01968551|17599704|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
5096744|NCT01968551|17599705|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
5096745|NCT01968551|17599703|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
5096746|NCT01968551|17599704|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
5096747|NCT01968551|17599705|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
5096748|NCT01968551|17599703|P3|Open Label Phase (48 Weeks)|Investigator's Discretion|0
5096749|NCT01968551|17599704|P2|Open Label Phase (48 Weeks)|Investigator's Discretion|1
5096750|NCT01968551|17599705|P1|Open Label Phase (48 Weeks)|Investigator's Discretion|0
5096751|NCT01968551|17599703|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
5096752|NCT01968551|17599704|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
5096753|NCT01968551|17599705|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
5096754|NCT01968434|17599742|P2|Overall Study|Lost to Follow-up|6
5096755|NCT01968434|17599743|P1|Overall Study|Lost to Follow-up|3
5096756|NCT01968226|17599811|P1|Overall Study|[F-18] RDG-K5 was not available|2
5096757|NCT01968213|17599817|P2|Overall Study|Ongoing|9
5096758|NCT01968213|17599818|P1|Overall Study|Ongoing|90
5096759|NCT01968070|17599860|P18|Period 2|Withdrawal by Subject|0
5096760|NCT01968070|17599861|P17|Period 2|Withdrawal by Subject|0
5096761|NCT01968070|17599862|P16|Period 2|Withdrawal by Subject|0
5096762|NCT01968070|17599863|P15|Period 2|Withdrawal by Subject|0
5096763|NCT01968070|17599864|P14|Period 2|Withdrawal by Subject|0
5096764|NCT01968070|17599865|P13|Period 2|Withdrawal by Subject|0
5096765|NCT01968070|17599866|P12|Period 2|Withdrawal by Subject|0
5096766|NCT01968070|17599867|P11|Period 2|Withdrawal by Subject|0
5096767|NCT01968070|17599868|P10|Period 2|Withdrawal by Subject|0
5096768|NCT01968070|17599869|P9|Period 2|Withdrawal by Subject|0
5096769|NCT01968070|17599870|P8|Period 2|Withdrawal by Subject|0
5096770|NCT01968070|17599871|P7|Period 2|Withdrawal by Subject|0
5096771|NCT01968070|17599872|P6|Period 2|Withdrawal by Subject|0
5096772|NCT01968070|17599873|P5|Period 2|Withdrawal by Subject|1
5096773|NCT01968070|17599874|P4|Period 2|Withdrawal by Subject|0
5096774|NCT01968070|17599875|P3|Period 2|Withdrawal by Subject|0
5096775|NCT01968070|17599876|P2|Period 2|Withdrawal by Subject|0
5096776|NCT01968070|17599877|P1|Period 2|Withdrawal by Subject|0
5096777|NCT01968070|17599860|P18|Period 1|Physician Decision|0
5096778|NCT01968070|17599861|P17|Period 1|Physician Decision|0
5096779|NCT01968070|17599862|P16|Period 1|Physician Decision|0
5096780|NCT01968070|17599863|P15|Period 1|Physician Decision|0
5096781|NCT01968070|17599864|P14|Period 1|Physician Decision|0
5096782|NCT01968070|17599865|P13|Period 1|Physician Decision|0
5096783|NCT01968070|17599866|P12|Period 1|Physician Decision|1
5096784|NCT01968070|17599867|P11|Period 1|Physician Decision|0
5096785|NCT01968070|17599868|P10|Period 1|Physician Decision|0
5096786|NCT01968070|17599869|P9|Period 1|Physician Decision|0
5096787|NCT01968070|17599870|P8|Period 1|Physician Decision|0
5096788|NCT01968070|17599871|P7|Period 1|Physician Decision|0
5096789|NCT01968070|17599872|P6|Period 1|Physician Decision|0
5096790|NCT01968070|17599873|P5|Period 1|Physician Decision|0
5096791|NCT01968070|17599874|P4|Period 1|Physician Decision|0
5096792|NCT01968070|17599875|P3|Period 1|Physician Decision|0
5096793|NCT01968070|17599876|P2|Period 1|Physician Decision|0
5096794|NCT01968070|17599877|P1|Period 1|Physician Decision|0
5096795|NCT01968070|17599860|P18|Period 1|Adverse Event|0
5096796|NCT01968070|17599861|P17|Period 1|Adverse Event|0
5096797|NCT01968070|17599862|P16|Period 1|Adverse Event|0
5096798|NCT01968070|17599863|P15|Period 1|Adverse Event|0
5096799|NCT01968070|17599864|P14|Period 1|Adverse Event|0
5096800|NCT01968070|17599865|P13|Period 1|Adverse Event|0
5096801|NCT01968070|17599866|P12|Period 1|Adverse Event|0
5096802|NCT01968070|17599867|P11|Period 1|Adverse Event|0
5096803|NCT01968070|17599868|P10|Period 1|Adverse Event|0
5096804|NCT01968070|17599869|P9|Period 1|Adverse Event|0
5096805|NCT01968070|17599870|P8|Period 1|Adverse Event|0
5096806|NCT01968070|17599871|P7|Period 1|Adverse Event|1
5096807|NCT01968070|17599872|P6|Period 1|Adverse Event|0
5096808|NCT01968070|17599873|P5|Period 1|Adverse Event|0
5096809|NCT01968070|17599874|P4|Period 1|Adverse Event|0
5096810|NCT01968070|17599875|P3|Period 1|Adverse Event|0
5096811|NCT01968070|17599876|P2|Period 1|Adverse Event|0
5096812|NCT01968070|17599877|P1|Period 1|Adverse Event|0
5096813|NCT01968070|17599860|P18|Period 1|Lost to Follow-up|0
5096814|NCT01968070|17599861|P17|Period 1|Lost to Follow-up|0
5096815|NCT01968070|17599862|P16|Period 1|Lost to Follow-up|0
5096816|NCT01968070|17599863|P15|Period 1|Lost to Follow-up|0
5096817|NCT01968070|17599864|P14|Period 1|Lost to Follow-up|0
5096818|NCT01968070|17599865|P13|Period 1|Lost to Follow-up|0
5096819|NCT01968070|17599866|P12|Period 1|Lost to Follow-up|0
5096820|NCT01968070|17599867|P11|Period 1|Lost to Follow-up|0
5096821|NCT01968070|17599868|P10|Period 1|Lost to Follow-up|0
5096822|NCT01968070|17599869|P9|Period 1|Lost to Follow-up|0
5096823|NCT01968070|17599870|P8|Period 1|Lost to Follow-up|0
5096824|NCT01968070|17599871|P7|Period 1|Lost to Follow-up|0
5096825|NCT01968070|17599872|P6|Period 1|Lost to Follow-up|0
5096826|NCT01968070|17599873|P5|Period 1|Lost to Follow-up|0
5096827|NCT01968070|17599874|P4|Period 1|Lost to Follow-up|1
5096828|NCT01968070|17599875|P3|Period 1|Lost to Follow-up|0
5096829|NCT01968070|17599876|P2|Period 1|Lost to Follow-up|0
5096830|NCT01968070|17599877|P1|Period 1|Lost to Follow-up|0
5096831|NCT01968070|17599860|P18|Period 1|Protocol Violation|0
5096832|NCT01968070|17599861|P17|Period 1|Protocol Violation|0
5096833|NCT01968070|17599862|P16|Period 1|Protocol Violation|0
5096834|NCT01968070|17599863|P15|Period 1|Protocol Violation|0
5096835|NCT01968070|17599864|P14|Period 1|Protocol Violation|0
5096836|NCT01968070|17599865|P13|Period 1|Protocol Violation|0
5096837|NCT01968070|17599866|P12|Period 1|Protocol Violation|0
5096838|NCT01968070|17599867|P11|Period 1|Protocol Violation|0
5096839|NCT01968070|17599868|P10|Period 1|Protocol Violation|0
5096840|NCT01968070|17599869|P9|Period 1|Protocol Violation|0
5096841|NCT01968070|17599870|P8|Period 1|Protocol Violation|0
5096842|NCT01968070|17599871|P7|Period 1|Protocol Violation|0
5096843|NCT01968070|17599872|P6|Period 1|Protocol Violation|0
5096844|NCT01968070|17599873|P5|Period 1|Protocol Violation|1
5096845|NCT01968070|17599874|P4|Period 1|Protocol Violation|1
5096846|NCT01968070|17599875|P3|Period 1|Protocol Violation|0
5096847|NCT01968070|17599876|P2|Period 1|Protocol Violation|0
5096848|NCT01968070|17599877|P1|Period 1|Protocol Violation|0
5096849|NCT01968070|17599860|P18|Period 1|Withdrawal by Subject|0
5096850|NCT01968070|17599861|P17|Period 1|Withdrawal by Subject|0
5096851|NCT01968070|17599862|P16|Period 1|Withdrawal by Subject|1
5096852|NCT01968070|17599863|P15|Period 1|Withdrawal by Subject|0
5096853|NCT01968070|17599864|P14|Period 1|Withdrawal by Subject|0
5096854|NCT01968070|17599865|P13|Period 1|Withdrawal by Subject|0
5096855|NCT01968070|17599866|P12|Period 1|Withdrawal by Subject|0
5096856|NCT01968070|17599867|P11|Period 1|Withdrawal by Subject|0
5096857|NCT01968070|17599868|P10|Period 1|Withdrawal by Subject|0
5096858|NCT01968070|17599869|P9|Period 1|Withdrawal by Subject|0
5096859|NCT01968070|17599870|P8|Period 1|Withdrawal by Subject|0
5096860|NCT01968070|17599871|P7|Period 1|Withdrawal by Subject|1
5096861|NCT01968070|17599872|P6|Period 1|Withdrawal by Subject|0
5096862|NCT01968070|17599873|P5|Period 1|Withdrawal by Subject|0
5096863|NCT01968070|17599874|P4|Period 1|Withdrawal by Subject|0
5096864|NCT01968070|17599875|P3|Period 1|Withdrawal by Subject|0
5096865|NCT01968070|17599876|P2|Period 1|Withdrawal by Subject|1
5096866|NCT01968070|17599877|P1|Period 1|Withdrawal by Subject|0
5096867|NCT01968031|17599948|P3|Overall Study|Prohibited concomitant medication|0
5096868|NCT01968031|17599949|P2|Overall Study|Prohibited concomitant medication|0
5096869|NCT01968031|17599950|P1|Overall Study|Prohibited concomitant medication|1
5096870|NCT01968031|17599948|P3|Overall Study|Death|1
5096871|NCT01968031|17599949|P2|Overall Study|Death|0
5096872|NCT01968031|17599950|P1|Overall Study|Death|0
5096873|NCT01968031|17599948|P3|Overall Study|Failed inclusion criteria|0
5096874|NCT01968031|17599949|P2|Overall Study|Failed inclusion criteria|2
5096875|NCT01968031|17599950|P1|Overall Study|Failed inclusion criteria|0
5096876|NCT01968031|17599948|P3|Overall Study|Noncompliance|2
5096877|NCT01968031|17599949|P2|Overall Study|Noncompliance|0
5096878|NCT01968031|17599950|P1|Overall Study|Noncompliance|0
5096879|NCT01968031|17599948|P3|Overall Study|Did not meet entry criteria|1
5096880|NCT01968031|17599949|P2|Overall Study|Did not meet entry criteria|1
5096881|NCT01968031|17599950|P1|Overall Study|Did not meet entry criteria|1
5096882|NCT01968031|17599948|P3|Overall Study|Withdrawal by Subject|3
5096883|NCT01968031|17599949|P2|Overall Study|Withdrawal by Subject|7
5096884|NCT01968031|17599950|P1|Overall Study|Withdrawal by Subject|3
5096885|NCT01968031|17599948|P3|Overall Study|Adverse Event|22
5096886|NCT01968031|17599949|P2|Overall Study|Adverse Event|10
5096887|NCT01968031|17599950|P1|Overall Study|Adverse Event|13
5096888|NCT01967940|17599994|P4|Part 2|Unknown Reason|1
5096889|NCT01967940|17599995|P3|Part 2|Unknown Reason|0
5096890|NCT01967940|17599996|P2|Part 2|Unknown Reason|0
5096891|NCT01967940|17599997|P1|Part 2|Unknown Reason|0
5096892|NCT01967940|17599994|P4|Part 2|Adverse Event|1
5096893|NCT01967940|17599995|P3|Part 2|Adverse Event|0
5096894|NCT01967940|17599996|P2|Part 2|Adverse Event|0
5096895|NCT01967940|17599997|P1|Part 2|Adverse Event|0
5096896|NCT01967940|17599994|P4|Part 2|Enrolled in Part 2 and Never Treated|1
5096897|NCT01967940|17599995|P3|Part 2|Enrolled in Part 2 and Never Treated|0
5096898|NCT01967940|17599996|P2|Part 2|Enrolled in Part 2 and Never Treated|0
5096899|NCT01967940|17599997|P1|Part 2|Enrolled in Part 2 and Never Treated|0
5096900|NCT01967888|17600025|P2|Overall Study|Subject Unable To Comply With Final Day|1
5096901|NCT01967888|17600026|P1|Overall Study|Subject Unable To Comply With Final Day|0
5096902|NCT01967888|17600025|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
5096903|NCT01967888|17600026|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
5096904|NCT01967888|17600025|P2|Overall Study|Subject excluded after randomization|0
5096905|NCT01967888|17600026|P1|Overall Study|Subject excluded after randomization|1
5096906|NCT01967888|17600025|P2|Overall Study|Research visit not done, data recorded|0
5096907|NCT01967888|17600026|P1|Overall Study|Research visit not done, data recorded|1
5096908|NCT01967888|17600025|P2|Overall Study|Did Not Have Transplant|0
5096909|NCT01967888|17600026|P1|Overall Study|Did Not Have Transplant|1
5096910|NCT01967888|17600025|P2|Overall Study|Withdrawal by Subject|1
5096911|NCT01967888|17600026|P1|Overall Study|Withdrawal by Subject|1
5096912|NCT01967888|17600025|P2|Overall Study|Lost to Follow-up|4
5096913|NCT01967888|17600026|P1|Overall Study|Lost to Follow-up|6
5096914|NCT01967732|17600114|P4|First Intervention (Day 1)|Poor venous access|0
5096915|NCT01967732|17600115|P3|First Intervention (Day 1)|Poor venous access|0
5096916|NCT01967732|17600116|P2|First Intervention (Day 1)|Poor venous access|1
5096917|NCT01967732|17600117|P1|First Intervention (Day 1)|Poor venous access|0
5096918|NCT01967732|17600114|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5096919|NCT01967732|17600115|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5096920|NCT01967732|17600116|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
5096921|NCT01967732|17600117|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5096922|NCT01967719|17600131|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
5096923|NCT01967719|17600132|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
5096924|NCT01967719|17600133|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
5096925|NCT01967719|17600134|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
5096926|NCT01967719|17600131|P4|First Intervention (Day 1)|Withdrawal by Subject|1
5096927|NCT01967719|17600132|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5096928|NCT01967719|17600133|P2|First Intervention (Day 1)|Withdrawal by Subject|1
5096929|NCT01967719|17600134|P1|First Intervention (Day 1)|Withdrawal by Subject|0
5096930|NCT01967706|17600149|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5096931|NCT01967706|17600150|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5096932|NCT01967706|17600151|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5096933|NCT01967706|17600152|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5096934|NCT01967628|17600173|P2|Overall Study|Low protein concentration in sample|25
5096935|NCT01967628|17600174|P1|Overall Study|Low protein concentration in sample|20
5096936|NCT01967628|17600173|P2|Overall Study|Lost to Follow-up|0
5096937|NCT01967628|17600174|P1|Overall Study|Lost to Follow-up|1
5096938|NCT01967628|17600173|P2|Overall Study|Unable to complete bronchoscopy|6
5096939|NCT01967628|17600174|P1|Overall Study|Unable to complete bronchoscopy|4
5096940|NCT01967628|17600173|P2|Overall Study|Withdrawal by Subject|0
5096941|NCT01967628|17600174|P1|Overall Study|Withdrawal by Subject|2
5096942|NCT01967576|17600180|P1|Overall Study|Refused further treatment|1
5096943|NCT01967576|17600180|P1|Overall Study|Adverse Event|1
5096944|NCT01967576|17600180|P1|Overall Study|Study closing at site|1
5096945|NCT01967576|17600180|P1|Overall Study|Progressed/Removed from treatment|1
5096946|NCT01967576|17600180|P1|Overall Study|Withdrawal by Subject|3
5096947|NCT01967550|17600191|P2|Overall Study|Non Compliance|1
5096948|NCT01967550|17600192|P1|Overall Study|Non Compliance|0
5096949|NCT01967550|17600191|P2|Overall Study|Protocol Violation|1
5096950|NCT01967550|17600192|P1|Overall Study|Protocol Violation|2
5096951|NCT01967550|17600191|P2|Overall Study|Adverse Event|0
5096952|NCT01967550|17600192|P1|Overall Study|Adverse Event|2
5096953|NCT01967550|17600191|P2|Overall Study|Withdrawal by Subject|0
5096954|NCT01967550|17600192|P1|Overall Study|Withdrawal by Subject|1
5096955|NCT01967537|17600198|P1|Overall Study|Lost to Follow-up|6
5096956|NCT01967537|17600198|P1|Overall Study|Refuse treatment|2
5096957|NCT01967537|17600198|P1|Overall Study|Withdrawal by Subject|52
5096958|NCT01967277|17600252|P2|Overall Study|Unrelated illness|1
5096959|NCT01967277|17600253|P1|Overall Study|Unrelated illness|0
5096960|NCT01967277|17600252|P2|Overall Study|Lost to Follow-up|2
5096961|NCT01967277|17600253|P1|Overall Study|Lost to Follow-up|1
5096962|NCT01967225|17600265|P2|Overall Study|Protocol Violation|0
5096963|NCT01967225|17600266|P1|Overall Study|Protocol Violation|2
5096964|NCT01967225|17600265|P2|Overall Study|Logistical difficulties|0
5096965|NCT01967225|17600266|P1|Overall Study|Logistical difficulties|1
5096966|NCT01967225|17600265|P2|Overall Study|Protocol driven decision point|0
5096967|NCT01967225|17600266|P1|Overall Study|Protocol driven decision point|1
5096968|NCT01967225|17600265|P2|Overall Study|Switching to other therapy|0
5096969|NCT01967225|17600266|P1|Overall Study|Switching to other therapy|2
5096970|NCT01967225|17600265|P2|Overall Study|Lack of Efficacy|1
5096971|NCT01967225|17600266|P1|Overall Study|Lack of Efficacy|1
5096972|NCT01967225|17600265|P2|Overall Study|Withdrawal by Subject|1
5096973|NCT01967225|17600266|P1|Overall Study|Withdrawal by Subject|2
5096974|NCT01967225|17600265|P2|Overall Study|Adverse Event|1
5096975|NCT01967225|17600266|P1|Overall Study|Adverse Event|3
5096976|NCT01967173|17600298|P8|Overall Study|Withdrawal by Subject|12
5096977|NCT01967173|17600299|P7|Overall Study|Withdrawal by Subject|10
5096978|NCT01967173|17600300|P6|Overall Study|Withdrawal by Subject|9
5096979|NCT01967173|17600301|P5|Overall Study|Withdrawal by Subject|8
5096980|NCT01967173|17600302|P4|Overall Study|Withdrawal by Subject|7
5096981|NCT01967173|17600303|P3|Overall Study|Withdrawal by Subject|10
5096982|NCT01967173|17600304|P2|Overall Study|Withdrawal by Subject|14
5096983|NCT01967173|17600305|P1|Overall Study|Withdrawal by Subject|15
5096984|NCT01967173|17600298|P8|Overall Study|Adverse Event|1
5096985|NCT01967173|17600299|P7|Overall Study|Adverse Event|0
5096986|NCT01967173|17600300|P6|Overall Study|Adverse Event|0
5096987|NCT01967173|17600301|P5|Overall Study|Adverse Event|0
5096988|NCT01967173|17600302|P4|Overall Study|Adverse Event|0
5096989|NCT01967173|17600303|P3|Overall Study|Adverse Event|0
5096990|NCT01967173|17600304|P2|Overall Study|Adverse Event|0
5096991|NCT01967173|17600305|P1|Overall Study|Adverse Event|0
5096992|NCT01967173|17600298|P8|Overall Study|Pregnancy|1
5096993|NCT01967173|17600299|P7|Overall Study|Pregnancy|1
5096994|NCT01967173|17600300|P6|Overall Study|Pregnancy|0
5096995|NCT01967173|17600301|P5|Overall Study|Pregnancy|0
5096996|NCT01967173|17600302|P4|Overall Study|Pregnancy|0
5096997|NCT01967173|17600303|P3|Overall Study|Pregnancy|0
5096998|NCT01967173|17600304|P2|Overall Study|Pregnancy|0
5096999|NCT01967173|17600305|P1|Overall Study|Pregnancy|0
5097000|NCT01967173|17600298|P8|Overall Study|Lack of Efficacy|2
5097001|NCT01967173|17600299|P7|Overall Study|Lack of Efficacy|0
5097002|NCT01967173|17600300|P6|Overall Study|Lack of Efficacy|1
5097003|NCT01967173|17600301|P5|Overall Study|Lack of Efficacy|0
5097004|NCT01967173|17600302|P4|Overall Study|Lack of Efficacy|2
5097005|NCT01967173|17600303|P3|Overall Study|Lack of Efficacy|2
5097006|NCT01967173|17600304|P2|Overall Study|Lack of Efficacy|0
5097007|NCT01967173|17600305|P1|Overall Study|Lack of Efficacy|2
5097008|NCT01967173|17600298|P8|Overall Study|Physician Decision|0
5097009|NCT01967173|17600299|P7|Overall Study|Physician Decision|1
5097010|NCT01967173|17600300|P6|Overall Study|Physician Decision|1
5097011|NCT01967173|17600301|P5|Overall Study|Physician Decision|1
5097012|NCT01967173|17600302|P4|Overall Study|Physician Decision|1
5097013|NCT01967173|17600303|P3|Overall Study|Physician Decision|2
5097014|NCT01967173|17600304|P2|Overall Study|Physician Decision|0
5097015|NCT01967173|17600305|P1|Overall Study|Physician Decision|2
5097016|NCT01967173|17600298|P8|Overall Study|Lost to Follow-up|8
5097017|NCT01967173|17600299|P7|Overall Study|Lost to Follow-up|6
5097018|NCT01967173|17600300|P6|Overall Study|Lost to Follow-up|12
5097019|NCT01967173|17600301|P5|Overall Study|Lost to Follow-up|8
5097020|NCT01967173|17600302|P4|Overall Study|Lost to Follow-up|4
5097021|NCT01967173|17600303|P3|Overall Study|Lost to Follow-up|2
5097022|NCT01967173|17600304|P2|Overall Study|Lost to Follow-up|3
5097023|NCT01967173|17600305|P1|Overall Study|Lost to Follow-up|5
5097024|NCT01967147|17600319|P2|Overall Study|Other|5
5097025|NCT01967147|17600320|P1|Overall Study|Other|4
5097026|NCT01967147|17600319|P2|Overall Study|Non-compliance with Study Drug|3
5097027|NCT01967147|17600320|P1|Overall Study|Non-compliance with Study Drug|0
5097028|NCT01967147|17600319|P2|Overall Study|Withdrawal by Subject|4
5097029|NCT01967147|17600320|P1|Overall Study|Withdrawal by Subject|2
5097030|NCT01967147|17600319|P2|Overall Study|Lost to Follow-up|2
5097031|NCT01967147|17600320|P1|Overall Study|Lost to Follow-up|1
5097032|NCT01967147|17600319|P2|Overall Study|Lack of Efficacy|4
5097033|NCT01967147|17600320|P1|Overall Study|Lack of Efficacy|1
5097034|NCT01967147|17600319|P2|Overall Study|Adverse Event|2
5097035|NCT01967147|17600320|P1|Overall Study|Adverse Event|5
5097036|NCT01967134|17600338|P3|Overall Study|Lost to Follow-up|0
5097037|NCT01967134|17600339|P2|Overall Study|Lost to Follow-up|1
5097038|NCT01967134|17600340|P1|Overall Study|Lost to Follow-up|0
5097039|NCT01967069|17600375|P2|Overall Study|Lack of Efficacy|1
5097040|NCT01967069|17600376|P1|Overall Study|Lack of Efficacy|0
5097041|NCT01967069|17600375|P2|Overall Study|Withdrawal by Subject|3
5097042|NCT01967069|17600376|P1|Overall Study|Withdrawal by Subject|1
5097043|NCT01967069|17600375|P2|Overall Study|Lost to Follow-up|2
5097044|NCT01967069|17600376|P1|Overall Study|Lost to Follow-up|5
5097045|NCT01967069|17600375|P2|Overall Study|Adverse Event|2
5097046|NCT01967069|17600376|P1|Overall Study|Adverse Event|2
5097047|NCT01966731|17600574|P1|Overall Study|Found to be ineligible|1
5097048|NCT01966731|17600574|P1|Overall Study|Screening Failure|29
5097049|NCT01966731|17600574|P1|Overall Study|Follow up is not complete|600
5097050|NCT01966731|17600574|P1|Overall Study|Physician Decision|2
5097051|NCT01966731|17600574|P1|Overall Study|Lost to Follow-up|1
5097052|NCT01966731|17600574|P1|Overall Study|Death|2
5097053|NCT01966445|17600604|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
5097054|NCT01966445|17600605|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5097055|NCT01966445|17600606|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5097056|NCT01966445|17600607|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5097057|NCT01966445|17600608|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5097058|NCT01966445|17600609|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5097059|NCT01966445|17600610|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5097060|NCT01966445|17600604|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
5097061|NCT01966445|17600605|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5097062|NCT01966445|17600606|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5097063|NCT01966445|17600607|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5097064|NCT01966445|17600608|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5097065|NCT01966445|17600609|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5097066|NCT01966445|17600610|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5097067|NCT01966445|17600604|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5097068|NCT01966445|17600605|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5097069|NCT01966445|17600606|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
5097070|NCT01966445|17600607|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5097071|NCT01966445|17600608|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
5097072|NCT01966445|17600609|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
5097073|NCT01966445|17600610|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5097074|NCT01966445|17600604|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5097075|NCT01966445|17600605|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5097076|NCT01966445|17600606|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5097077|NCT01966445|17600607|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5097078|NCT01966445|17600608|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5097079|NCT01966445|17600609|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5097080|NCT01966445|17600610|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5097081|NCT01966445|17600604|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5097082|NCT01966445|17600605|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
5097083|NCT01966445|17600606|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5097084|NCT01966445|17600607|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
5097085|NCT01966445|17600608|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5097086|NCT01966445|17600609|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5097087|NCT01966445|17600610|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5097088|NCT01966432|17600720|P3|Overall Study|SBIRT program ended|20
5097089|NCT01966432|17600721|P2|Overall Study|SBIRT program ended|8
5097090|NCT01966432|17600722|P1|Overall Study|SBIRT program ended|1
5097091|NCT01966432|17600720|P3|Overall Study|Subject Incarcerated|1
5097092|NCT01966432|17600721|P2|Overall Study|Subject Incarcerated|0
5097093|NCT01966432|17600722|P1|Overall Study|Subject Incarcerated|0
5097094|NCT01966432|17600720|P3|Overall Study|Withdrawal by Subject|0
5097095|NCT01966432|17600721|P2|Overall Study|Withdrawal by Subject|3
5097096|NCT01966432|17600722|P1|Overall Study|Withdrawal by Subject|1
5097097|NCT01966432|17600720|P3|Overall Study|Lost to Follow-up|5
5097098|NCT01966432|17600721|P2|Overall Study|Lost to Follow-up|2
5097099|NCT01966432|17600722|P1|Overall Study|Lost to Follow-up|3
5097100|NCT01966120|17600792|P2|Overall Study|Lost to Follow-up|1
5097101|NCT01966120|17600793|P1|Overall Study|Lost to Follow-up|1
5097102|NCT01966120|17600792|P2|Overall Study|Withdrawal by Subject|5
5097103|NCT01966120|17600793|P1|Overall Study|Withdrawal by Subject|0
5097104|NCT01966107|17600817|P2|Overall Study|withdrew from the study|303
5097105|NCT01966107|17600818|P1|Overall Study|withdrew from the study|272
5097106|NCT01966107|17600817|P2|Overall Study|due to study closure|186
5097107|NCT01966107|17600818|P1|Overall Study|due to study closure|164
5097108|NCT01966107|17600817|P2|Overall Study|discontinued treatment|372
5097109|NCT01966107|17600818|P1|Overall Study|discontinued treatment|345
5097110|NCT01966107|17600817|P2|Overall Study|excluded from FAS|20
5097111|NCT01966107|17600818|P1|Overall Study|excluded from FAS|21
5097112|NCT01966068|17600832|P1|Overall Study|Lost to Follow-up|81
5097113|NCT01966068|17600832|P1|Overall Study|Withdrawal by Subject|57
5097114|NCT01966042|17600837|P1|Overall Study|Death|2
5097115|NCT01966003|17600846|P2|Overall Study|Other|1
5097116|NCT01966003|17600847|P1|Overall Study|Other|1
5097117|NCT01966003|17600846|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
5097118|NCT01966003|17600847|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
5097119|NCT01966003|17600846|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
5097120|NCT01966003|17600847|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
5097121|NCT01966003|17600846|P2|Overall Study|Withdrawal by Subject|19
5097122|NCT01966003|17600847|P1|Overall Study|Withdrawal by Subject|29
5097123|NCT01966003|17600846|P2|Overall Study|Physician Decision|13
5097124|NCT01966003|17600847|P1|Overall Study|Physician Decision|12
5097125|NCT01966003|17600846|P2|Overall Study|Lost to Follow-up|3
5097126|NCT01966003|17600847|P1|Overall Study|Lost to Follow-up|4
5097127|NCT01966003|17600846|P2|Overall Study|Protocol Violation|4
5097128|NCT01966003|17600847|P1|Overall Study|Protocol Violation|6
5097129|NCT01966003|17600846|P2|Overall Study|Death|36
5097130|NCT01966003|17600847|P1|Overall Study|Death|43
5097131|NCT01965938|17600865|P2|Overall Study|Withdrawal by Subject|0
5097132|NCT01965938|17600866|P1|Overall Study|Withdrawal by Subject|1
5097133|NCT01965834|17600897|P1|Overall Study|Lack of Efficacy|4
5097134|NCT01965652|17600938|P2|Overall Study|Pregnancy|1
5097135|NCT01965652|17600939|P1|Overall Study|Pregnancy|0
5097136|NCT01965652|17600938|P2|Overall Study|Other - Miscellaneous|21
5097137|NCT01965652|17600939|P1|Overall Study|Other - Miscellaneous|18
5097138|NCT01965652|17600938|P2|Overall Study|Death|4
5097139|NCT01965652|17600939|P1|Overall Study|Death|3
5097140|NCT01965652|17600938|P2|Overall Study|Protocol Violation|38
5097141|NCT01965652|17600939|P1|Overall Study|Protocol Violation|34
5097142|NCT01965652|17600938|P2|Overall Study|Lost to Follow-up|40
5097143|NCT01965652|17600939|P1|Overall Study|Lost to Follow-up|53
5097144|NCT01965652|17600938|P2|Overall Study|Withdrawal by Subject|69
5097145|NCT01965652|17600939|P1|Overall Study|Withdrawal by Subject|62
5097146|NCT01965652|17600938|P2|Overall Study|Adverse Event|37
5097147|NCT01965652|17600939|P1|Overall Study|Adverse Event|40
5097148|NCT01965600|17600969|P4|Second Intervention|Study terminated by Sponsor|2
5097149|NCT01965600|17600970|P3|Second Intervention|Study terminated by Sponsor|2
5097150|NCT01965600|17600971|P2|Second Intervention|Study terminated by Sponsor|0
5097151|NCT01965600|17600972|P1|Second Intervention|Study terminated by Sponsor|0
5097152|NCT01965600|17600969|P4|Washout Period of Approximately 15 Days|Adverse Event|1
5097153|NCT01965600|17600970|P3|Washout Period of Approximately 15 Days|Adverse Event|0
5097154|NCT01965600|17600971|P2|Washout Period of Approximately 15 Days|Adverse Event|0
5097155|NCT01965600|17600972|P1|Washout Period of Approximately 15 Days|Adverse Event|0
5097156|NCT01965600|17600969|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5097157|NCT01965600|17600970|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5097158|NCT01965600|17600971|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5097159|NCT01965600|17600972|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
5097160|NCT01965600|17600969|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5097161|NCT01965600|17600970|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5097162|NCT01965600|17600971|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
5097163|NCT01965600|17600972|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5097164|NCT01965600|17600969|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
5097165|NCT01965600|17600970|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
5097166|NCT01965600|17600971|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
5097167|NCT01965600|17600972|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
5097168|NCT01965535|17601029|P2|Overall Study|Lack of Efficacy|1
5097169|NCT01965535|17601030|P1|Overall Study|Lack of Efficacy|2
5097170|NCT01965431|17601044|P6|Overall Study|Other than stated above|6
5097171|NCT01965431|17601045|P5|Overall Study|Other than stated above|6
5097172|NCT01965431|17601046|P4|Overall Study|Other than stated above|6
5097173|NCT01965431|17601047|P3|Overall Study|Other than stated above|6
5097174|NCT01965431|17601048|P2|Overall Study|Other than stated above|5
5097175|NCT01965431|17601049|P1|Overall Study|Other than stated above|6
5097176|NCT01965431|17601044|P6|Overall Study|Adverse Event|0
5097177|NCT01965431|17601045|P5|Overall Study|Adverse Event|0
5097178|NCT01965431|17601046|P4|Overall Study|Adverse Event|0
5097179|NCT01965431|17601047|P3|Overall Study|Adverse Event|0
5097180|NCT01965431|17601048|P2|Overall Study|Adverse Event|1
5097181|NCT01965431|17601049|P1|Overall Study|Adverse Event|0
5097182|NCT01965327|17601073|P1|Overall Study|Physician Decision|2
5097183|NCT01965262|17601287|P2|Second Intervention (7 Days)|Poor visual acuity|0
5097184|NCT01965262|17601288|P1|Second Intervention (7 Days)|Poor visual acuity|1
5097185|NCT01965262|17601287|P2|Second Intervention (7 Days)|Poor lens fit|9
5097186|NCT01965262|17601288|P1|Second Intervention (7 Days)|Poor lens fit|0
5097187|NCT01965262|17601287|P2|Second Intervention (7 Days)|Discontinued|1
5097188|NCT01965262|17601288|P1|Second Intervention (7 Days)|Discontinued|0
5097189|NCT01965158|17601352|P2|Overall Study|Other - Miscellaneous|0
5097190|NCT01965158|17601353|P1|Overall Study|Other - Miscellaneous|3
5097191|NCT01965158|17601352|P2|Overall Study|Protocol Violation|1
5097192|NCT01965158|17601353|P1|Overall Study|Protocol Violation|1
5097193|NCT01965158|17601352|P2|Overall Study|Lost to Follow-up|5
5097194|NCT01965158|17601353|P1|Overall Study|Lost to Follow-up|7
5097195|NCT01965158|17601352|P2|Overall Study|Withdrawal by Subject|24
5097196|NCT01965158|17601353|P1|Overall Study|Withdrawal by Subject|16
5097197|NCT01965158|17601352|P2|Overall Study|Adverse Event|5
5097198|NCT01965158|17601353|P1|Overall Study|Adverse Event|14
5097199|NCT01964976|17601394|P1|Overall Study|Protocol Violation|31
5097200|NCT01964963|17601406|P1|Overall Study|Data Reliability was not Assured|5
5097201|NCT01964963|17601406|P1|Overall Study|Protocol Deviation|50
5097202|NCT01964963|17601406|P1|Overall Study|Case Report Forms Uncollected|888
5097203|NCT01964950|17601414|P1|Overall Study|Protocol Violation|25
5097204|NCT01964924|17601426|P2|Trametinib Monotherapy|Progression|0
5097205|NCT01964924|17601427|P1|Trametinib Monotherapy|Progression|19
5097206|NCT01964898|17601451|P2|Overall Study|Withdrawal by Subject|0
5097207|NCT01964898|17601452|P1|Overall Study|Withdrawal by Subject|1
5097208|NCT01964898|17601451|P2|Overall Study|Lost to Follow-up|5
5097209|NCT01964898|17601452|P1|Overall Study|Lost to Follow-up|3
5097210|NCT01964898|17601451|P2|Overall Study|did not receive the allocated interventi|1
5097211|NCT01964898|17601452|P1|Overall Study|did not receive the allocated interventi|2
5097212|NCT01964898|17601451|P2|Overall Study|ineligible post-randomization|1
5097213|NCT01964898|17601452|P1|Overall Study|ineligible post-randomization|1
5097214|NCT01964755|17601472|P1|Overall Study|Death|2
5097215|NCT01964716|17601487|P2|Overall Study|Death|0
5097216|NCT01964716|17601488|P1|Overall Study|Death|1
5097217|NCT01964716|17601487|P2|Overall Study|No longer met eligibility criteria|1
5097218|NCT01964716|17601488|P1|Overall Study|No longer met eligibility criteria|1
5097219|NCT01964716|17601487|P2|Overall Study|Lost to Follow-up|2
5097220|NCT01964716|17601488|P1|Overall Study|Lost to Follow-up|1
5097221|NCT01964716|17601487|P2|Overall Study|Withdrawal by Subject|3
5097222|NCT01964716|17601488|P1|Overall Study|Withdrawal by Subject|2
5097223|NCT01964547|17601526|P2|Overall Study|Withdrawal by Investigator|1
5097224|NCT01964547|17601527|P1|Overall Study|Withdrawal by Investigator|0
5097225|NCT01964547|17601526|P2|Overall Study|Lost to Follow-up|1
5097226|NCT01964547|17601527|P1|Overall Study|Lost to Follow-up|0
5097227|NCT01964547|17601526|P2|Overall Study|Withdrawal by Subject|7
5097228|NCT01964547|17601527|P1|Overall Study|Withdrawal by Subject|4
5097229|NCT01964547|17601526|P2|Overall Study|Adverse Event|2
5097230|NCT01964547|17601527|P1|Overall Study|Adverse Event|8
5097231|NCT01964521|17601551|P1|Overall Study|Lost to Follow-up|4
5097232|NCT01964430|17601558|P2|Overall Study|Randomized but not Treated|11
5097233|NCT01964430|17601559|P1|Overall Study|Randomized but not Treated|3
5097234|NCT01964430|17601558|P2|Overall Study|Miscellaneous|3
5097235|NCT01964430|17601559|P1|Overall Study|Miscellaneous|1
5097236|NCT01964430|17601558|P2|Overall Study|Disease Relapse|38
5097237|NCT01964430|17601559|P1|Overall Study|Disease Relapse|28
5097238|NCT01964430|17601558|P2|Overall Study|Physician Decision|4
5097239|NCT01964430|17601559|P1|Overall Study|Physician Decision|5
5097240|NCT01964430|17601558|P2|Overall Study|Protocol Deviation|1
5097241|NCT01964430|17601559|P1|Overall Study|Protocol Deviation|0
5097242|NCT01964430|17601558|P2|Overall Study|Death|3
5097243|NCT01964430|17601559|P1|Overall Study|Death|1
5097244|NCT01964430|17601558|P2|Overall Study|Withdrawal by Subject|27
5097245|NCT01964430|17601559|P1|Overall Study|Withdrawal by Subject|36
5097246|NCT01964430|17601558|P2|Overall Study|Adverse Event|37
5097247|NCT01964430|17601559|P1|Overall Study|Adverse Event|71
5097248|NCT01964378|17601571|P2|Overall Study|Other|2
5097249|NCT01964378|17601572|P1|Overall Study|Other|1
5097250|NCT01964378|17601571|P2|Overall Study|Inclusion/exclusion criteria not met|3
5097251|NCT01964378|17601572|P1|Overall Study|Inclusion/exclusion criteria not met|1
5097252|NCT01964378|17601571|P2|Overall Study|Withdrawal by Subject|5
5097253|NCT01964378|17601572|P1|Overall Study|Withdrawal by Subject|7
5097254|NCT01964378|17601571|P2|Overall Study|Lost to Follow-up|1
5097255|NCT01964378|17601572|P1|Overall Study|Lost to Follow-up|0
5097256|NCT01964378|17601571|P2|Overall Study|Protocol Violation|1
5097257|NCT01964378|17601572|P1|Overall Study|Protocol Violation|0
5097258|NCT01964378|17601571|P2|Overall Study|Lack of Efficacy|1
5097259|NCT01964378|17601572|P1|Overall Study|Lack of Efficacy|0
5097260|NCT01964378|17601571|P2|Overall Study|Adverse Event|5
5097261|NCT01964378|17601572|P1|Overall Study|Adverse Event|12
5097262|NCT01964378|17601571|P2|Overall Study|Death|2
5097263|NCT01964378|17601572|P1|Overall Study|Death|3
5097264|NCT01964378|17601571|P2|Overall Study|Disc. due to AE before first dosing|0
5097265|NCT01964378|17601572|P1|Overall Study|Disc. due to AE before first dosing|1
5097266|NCT01964378|17601571|P2|Overall Study|Disc. due to death before first dosing|1
5097267|NCT01964378|17601572|P1|Overall Study|Disc. due to death before first dosing|0
5097268|NCT01964352|17601608|P4|Overall Study|Other than stated above|2
5097269|NCT01964352|17601609|P3|Overall Study|Other than stated above|1
5097270|NCT01964352|17601610|P2|Overall Study|Other than stated above|2
5097271|NCT01964352|17601611|P1|Overall Study|Other than stated above|0
5097272|NCT01964352|17601608|P4|Overall Study|Withdrawal by Subject|0
5097273|NCT01964352|17601609|P3|Overall Study|Withdrawal by Subject|1
5097274|NCT01964352|17601610|P2|Overall Study|Withdrawal by Subject|2
5097275|NCT01964352|17601611|P1|Overall Study|Withdrawal by Subject|4
5097276|NCT01964352|17601608|P4|Overall Study|Lost to Follow-up|1
5097277|NCT01964352|17601609|P3|Overall Study|Lost to Follow-up|0
5097278|NCT01964352|17601610|P2|Overall Study|Lost to Follow-up|0
5097279|NCT01964352|17601611|P1|Overall Study|Lost to Follow-up|1
5097280|NCT01964352|17601608|P4|Overall Study|Protocol Violation|2
5097281|NCT01964352|17601609|P3|Overall Study|Protocol Violation|0
5097282|NCT01964352|17601610|P2|Overall Study|Protocol Violation|4
5097283|NCT01964352|17601611|P1|Overall Study|Protocol Violation|2
5097284|NCT01964352|17601608|P4|Overall Study|Lack of Efficacy|0
5097285|NCT01964352|17601609|P3|Overall Study|Lack of Efficacy|0
5097286|NCT01964352|17601610|P2|Overall Study|Lack of Efficacy|0
5097287|NCT01964352|17601611|P1|Overall Study|Lack of Efficacy|6
5097288|NCT01964352|17601608|P4|Overall Study|Adverse Event|3
5097289|NCT01964352|17601609|P3|Overall Study|Adverse Event|4
5097290|NCT01964352|17601610|P2|Overall Study|Adverse Event|3
5097291|NCT01964352|17601611|P1|Overall Study|Adverse Event|13
5097292|NCT01964326|17601641|P1|Overall Study|Did not meet eligibility criteria|1
5097293|NCT01964326|17601641|P1|Overall Study|Other|9
5097294|NCT01964326|17601641|P1|Overall Study|Investigator Discretion|1
5097295|NCT01964326|17601641|P1|Overall Study|Physician Decision|55
5097296|NCT01964326|17601641|P1|Overall Study|No Longer Meets Eligibility Criteria|1
5097297|NCT01964326|17601641|P1|Overall Study|Pregnancy|1
5097298|NCT01964326|17601641|P1|Overall Study|Withdrawal by Subject|87
5097299|NCT01964326|17601641|P1|Overall Study|Lost to Follow-up|88
5097300|NCT01964326|17601641|P1|Overall Study|Protocol Violation|4
5097301|NCT01964326|17601641|P1|Overall Study|Death|2
5097302|NCT01964326|17601641|P1|Overall Study|Adverse Event|48
5097303|NCT01964300|17601650|P2|Overall Study|Weight criteria not met|1
5097304|NCT01964300|17601651|P1|Overall Study|Weight criteria not met|0
5097305|NCT01964300|17601650|P2|Overall Study|Enlargement of cyst requiring drainage|0
5097306|NCT01964300|17601651|P1|Overall Study|Enlargement of cyst requiring drainage|1
5097307|NCT01964300|17601650|P2|Overall Study|To receive alternative therapy|2
5097308|NCT01964300|17601651|P1|Overall Study|To receive alternative therapy|1
5097309|NCT01964300|17601650|P2|Overall Study|Withdrawal by Subject|1
5097310|NCT01964300|17601651|P1|Overall Study|Withdrawal by Subject|0
5097311|NCT01964300|17601650|P2|Overall Study|Lack of Efficacy|5
5097312|NCT01964300|17601651|P1|Overall Study|Lack of Efficacy|3
5097313|NCT01964300|17601650|P2|Overall Study|Adverse Event|1
5097314|NCT01964300|17601651|P1|Overall Study|Adverse Event|1
5097315|NCT01964300|17601650|P2|Overall Study|Ineligible after enrollment|1
5097316|NCT01964300|17601651|P1|Overall Study|Ineligible after enrollment|0
5097317|NCT01964222|17601665|P2|Overall Study|Screening Failure|0
5097318|NCT01964222|17601666|P1|Overall Study|Screening Failure|2
5097319|NCT01964222|17601665|P2|Overall Study|Withdrawal by Subject|6
5097320|NCT01964222|17601666|P1|Overall Study|Withdrawal by Subject|6
5097321|NCT01964222|17601665|P2|Overall Study|Lost to Follow-up|5
5097322|NCT01964222|17601666|P1|Overall Study|Lost to Follow-up|7
5097323|NCT01964105|17601683|P3|Overall Study|Lost to Follow-up|0
5097324|NCT01964105|17601684|P2|Overall Study|Lost to Follow-up|13
5097325|NCT01964105|17601685|P1|Overall Study|Lost to Follow-up|2
5097326|NCT01963767|17601744|P2|Overall Study|Adverse Event|0
5097327|NCT01963767|17601745|P1|Overall Study|Adverse Event|2
5097328|NCT01963767|17601744|P2|Overall Study|Withdrawal by Subject|2
5097329|NCT01963767|17601745|P1|Overall Study|Withdrawal by Subject|4
5097330|NCT01963676|17601755|P2|Overall Study|Withdrawal by Subject|0
5097331|NCT01963676|17601756|P1|Overall Study|Withdrawal by Subject|1
5097332|NCT01963611|17601769|P5|Overall Study|Other|45
5097333|NCT01963611|17601770|P4|Overall Study|Other|45
5097334|NCT01963611|17601771|P3|Overall Study|Other|48
5097335|NCT01963611|17601772|P2|Overall Study|Other|46
5097336|NCT01963611|17601773|P1|Overall Study|Other|47
5097337|NCT01963611|17601769|P5|Overall Study|Withdrawal by Subject|3
5097338|NCT01963611|17601770|P4|Overall Study|Withdrawal by Subject|1
5097339|NCT01963611|17601771|P3|Overall Study|Withdrawal by Subject|1
5097340|NCT01963611|17601772|P2|Overall Study|Withdrawal by Subject|2
5097341|NCT01963611|17601773|P1|Overall Study|Withdrawal by Subject|3
5097342|NCT01963611|17601769|P5|Overall Study|Lack of Efficacy|0
5097343|NCT01963611|17601770|P4|Overall Study|Lack of Efficacy|1
5097344|NCT01963611|17601771|P3|Overall Study|Lack of Efficacy|0
5097345|NCT01963611|17601772|P2|Overall Study|Lack of Efficacy|0
5097346|NCT01963611|17601773|P1|Overall Study|Lack of Efficacy|0
5097347|NCT01963611|17601769|P5|Overall Study|Protocol Violation|0
5097348|NCT01963611|17601770|P4|Overall Study|Protocol Violation|1
5097349|NCT01963611|17601771|P3|Overall Study|Protocol Violation|0
5097350|NCT01963611|17601772|P2|Overall Study|Protocol Violation|0
5097351|NCT01963611|17601773|P1|Overall Study|Protocol Violation|0
5097352|NCT01963611|17601769|P5|Overall Study|Adverse Event|3
5097353|NCT01963611|17601770|P4|Overall Study|Adverse Event|4
5097354|NCT01963611|17601771|P3|Overall Study|Adverse Event|3
5097355|NCT01963611|17601772|P2|Overall Study|Adverse Event|1
5097356|NCT01963611|17601773|P1|Overall Study|Adverse Event|1
5097357|NCT01963403|17601838|P2|Overall Study|Implant removal|1
5097358|NCT01963403|17601839|P1|Overall Study|Implant removal|0
5097359|NCT01963403|17601838|P2|Overall Study|Lost to Follow-up|3
5097360|NCT01963403|17601839|P1|Overall Study|Lost to Follow-up|2
5097361|NCT01963260|17601861|P10|Overall Study|Withdrawal by Subject|0
5097362|NCT01963260|17601862|P9|Overall Study|Withdrawal by Subject|0
5097363|NCT01963260|17601863|P8|Overall Study|Withdrawal by Subject|0
5097364|NCT01963260|17601864|P7|Overall Study|Withdrawal by Subject|0
5097365|NCT01963260|17601865|P6|Overall Study|Withdrawal by Subject|0
5097366|NCT01963260|17601866|P5|Overall Study|Withdrawal by Subject|2
5097367|NCT01963260|17601867|P4|Overall Study|Withdrawal by Subject|1
5097368|NCT01963260|17601868|P3|Overall Study|Withdrawal by Subject|0
5097369|NCT01963260|17601869|P2|Overall Study|Withdrawal by Subject|0
5097370|NCT01963260|17601870|P1|Overall Study|Withdrawal by Subject|2
5097371|NCT01963117|17601984|P1|Overall Study|Death|1
5097372|NCT01962987|17602026|P3|Overall Study|Randomized in Error|2
5097373|NCT01962987|17602027|P2|Overall Study|Randomized in Error|2
5097374|NCT01962987|17602028|P1|Overall Study|Randomized in Error|4
5097375|NCT01962987|17602026|P3|Overall Study|Withdrawal by Subject|6
5097376|NCT01962987|17602027|P2|Overall Study|Withdrawal by Subject|10
5097377|NCT01962987|17602028|P1|Overall Study|Withdrawal by Subject|11
5097378|NCT01962987|17602026|P3|Overall Study|Serious Adverse Event|0
5097379|NCT01962987|17602027|P2|Overall Study|Serious Adverse Event|0
5097380|NCT01962987|17602028|P1|Overall Study|Serious Adverse Event|1
5097381|NCT01962987|17602026|P3|Overall Study|Restricted medication|1
5097382|NCT01962987|17602027|P2|Overall Study|Restricted medication|1
5097383|NCT01962987|17602028|P1|Overall Study|Restricted medication|5
5097384|NCT01962987|17602026|P3|Overall Study|Miscellaneous|2
5097385|NCT01962987|17602027|P2|Overall Study|Miscellaneous|9
5097386|NCT01962987|17602028|P1|Overall Study|Miscellaneous|1
5097387|NCT01962987|17602026|P3|Overall Study|Non compliance with dosing requirements|0
5097388|NCT01962987|17602027|P2|Overall Study|Non compliance with dosing requirements|2
5097389|NCT01962987|17602028|P1|Overall Study|Non compliance with dosing requirements|4
5097390|NCT01962987|17602026|P3|Overall Study|Lost to Follow-up|1
5097391|NCT01962987|17602027|P2|Overall Study|Lost to Follow-up|0
5097392|NCT01962987|17602028|P1|Overall Study|Lost to Follow-up|0
5097393|NCT01962987|17602026|P3|Overall Study|Adverse Event|0
5097394|NCT01962987|17602027|P2|Overall Study|Adverse Event|4
5097395|NCT01962987|17602028|P1|Overall Study|Adverse Event|4
5097396|NCT01962974|17602036|P1|Overall Study|Study termination|7
5097397|NCT01962922|17602063|P2|Extendion Portion (up to Month 6)|Physician Decision|0
5097398|NCT01962922|17602064|P1|Extendion Portion (up to Month 6)|Physician Decision|1
5097399|NCT01962922|17602063|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
5097400|NCT01962922|17602064|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
5097401|NCT01962922|17602063|P2|PK Portion Day 7|non-compliance|0
5097402|NCT01962922|17602064|P1|PK Portion Day 7|non-compliance|1
5097403|NCT01962922|17602063|P2|PK Portion Day 7|Withdrawal by Subject|0
5097404|NCT01962922|17602064|P1|PK Portion Day 7|Withdrawal by Subject|3
5097405|NCT01962896|17602086|P1|Overall Study|Lack of Efficacy|4
5097406|NCT01962493|17602208|P2|Overall Study|Withdrawal by Subject|2
5097407|NCT01962493|17602209|P1|Overall Study|Withdrawal by Subject|4
5097408|NCT01962493|17602208|P2|Overall Study|Protocol Violation|1
5097409|NCT01962493|17602209|P1|Overall Study|Protocol Violation|0
5097410|NCT01962493|17602208|P2|Overall Study|Adverse Event|2
5097411|NCT01962493|17602209|P1|Overall Study|Adverse Event|1
5097412|NCT01962441|17602232|P3|Retreatment Substudy|Lost to Follow-up|0
5097413|NCT01962441|17602233|P2|Retreatment Substudy|Lost to Follow-up|0
5097414|NCT01962441|17602234|P1|Retreatment Substudy|Lost to Follow-up|1
5097415|NCT01962441|17602232|P3|Retreatment Substudy|Lack of Efficacy|0
5097416|NCT01962441|17602233|P2|Retreatment Substudy|Lack of Efficacy|0
5097417|NCT01962441|17602234|P1|Retreatment Substudy|Lack of Efficacy|1
5097418|NCT01962441|17602232|P3|Randomized Period|Protocol Violation|0
5097419|NCT01962441|17602233|P2|Randomized Period|Protocol Violation|1
5097420|NCT01962441|17602234|P1|Randomized Period|Protocol Violation|0
5097421|NCT01962441|17602232|P3|Randomized Period|Death|2
5097422|NCT01962441|17602233|P2|Randomized Period|Death|0
5097423|NCT01962441|17602234|P1|Randomized Period|Death|0
5097424|NCT01962441|17602232|P3|Randomized Period|Adverse Event|0
5097425|NCT01962441|17602233|P2|Randomized Period|Adverse Event|1
5097426|NCT01962441|17602234|P1|Randomized Period|Adverse Event|1
5097427|NCT01962441|17602232|P3|Randomized Period|Withdrew Consent|2
5097428|NCT01962441|17602233|P2|Randomized Period|Withdrew Consent|3
5097429|NCT01962441|17602234|P1|Randomized Period|Withdrew Consent|3
5097430|NCT01962441|17602232|P3|Randomized Period|Lost to Follow-up|4
5097431|NCT01962441|17602233|P2|Randomized Period|Lost to Follow-up|4
5097432|NCT01962441|17602234|P1|Randomized Period|Lost to Follow-up|2
5097433|NCT01962441|17602232|P3|Randomized Period|Randomized but Never Treated|3
5097434|NCT01962441|17602233|P2|Randomized Period|Randomized but Never Treated|2
5097435|NCT01962441|17602234|P1|Randomized Period|Randomized but Never Treated|4
5097436|NCT01962298|17602278|P5|Overall Study|Physician Decision|1
5097437|NCT01962298|17602279|P4|Overall Study|Physician Decision|0
5097438|NCT01962298|17602280|P3|Overall Study|Physician Decision|0
5097439|NCT01962298|17602281|P2|Overall Study|Physician Decision|1
5097440|NCT01962298|17602282|P1|Overall Study|Physician Decision|0
5097441|NCT01962298|17602278|P5|Overall Study|Incorrect data recorded|0
5097442|NCT01962298|17602279|P4|Overall Study|Incorrect data recorded|0
5097443|NCT01962298|17602280|P3|Overall Study|Incorrect data recorded|0
5097444|NCT01962298|17602281|P2|Overall Study|Incorrect data recorded|1
5097445|NCT01962298|17602282|P1|Overall Study|Incorrect data recorded|0
5097446|NCT01962298|17602278|P5|Overall Study|Insufficient data|1
5097447|NCT01962298|17602279|P4|Overall Study|Insufficient data|0
5097448|NCT01962298|17602280|P3|Overall Study|Insufficient data|1
5097449|NCT01962298|17602281|P2|Overall Study|Insufficient data|2
5097450|NCT01962298|17602282|P1|Overall Study|Insufficient data|0
5097451|NCT01962298|17602278|P5|Overall Study|Data quality insufficient|4
5097452|NCT01962298|17602279|P4|Overall Study|Data quality insufficient|1
5097453|NCT01962298|17602280|P3|Overall Study|Data quality insufficient|3
5097454|NCT01962298|17602281|P2|Overall Study|Data quality insufficient|0
5097455|NCT01962298|17602282|P1|Overall Study|Data quality insufficient|2
5097456|NCT01962298|17602278|P5|Overall Study|Protocol Violation|0
5097457|NCT01962298|17602279|P4|Overall Study|Protocol Violation|1
5097458|NCT01962298|17602280|P3|Overall Study|Protocol Violation|1
5097459|NCT01962298|17602281|P2|Overall Study|Protocol Violation|0
5097460|NCT01962298|17602282|P1|Overall Study|Protocol Violation|1
5097461|NCT01962207|17602303|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
5097462|NCT01962207|17602304|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
5097463|NCT01962207|17602305|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
5097464|NCT01962207|17602306|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
5097465|NCT01962207|17602303|P4|Persistence Phase (5 Years)|Adverse Event|0
5097466|NCT01962207|17602304|P3|Persistence Phase (5 Years)|Adverse Event|1
5097467|NCT01962207|17602305|P2|Persistence Phase (5 Years)|Adverse Event|0
5097468|NCT01962207|17602306|P1|Persistence Phase (5 Years)|Adverse Event|0
5097469|NCT01962207|17602303|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
5097470|NCT01962207|17602304|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
5097471|NCT01962207|17602305|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
5097472|NCT01962207|17602306|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
5097473|NCT01962207|17602303|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
5097474|NCT01962207|17602304|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
5097475|NCT01962207|17602305|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
5097476|NCT01962207|17602306|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
5097477|NCT01962207|17602303|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
5097478|NCT01962207|17602304|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
5097479|NCT01962207|17602305|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
5097480|NCT01962207|17602306|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
5097481|NCT01962207|17602303|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
5097482|NCT01962207|17602304|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
5097483|NCT01962207|17602305|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
5097484|NCT01962207|17602306|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
5097485|NCT01962103|17602417|P9|Phase 2|Symptomatic Deterioration|0
5097486|NCT01962103|17602418|P8|Phase 2|Symptomatic Deterioration|2
5097487|NCT01962103|17602419|P7|Phase 2|Symptomatic Deterioration|2
5097488|NCT01962103|17602420|P6|Phase 2|Symptomatic Deterioration|0
5097489|NCT01962103|17602421|P5|Phase 2|Symptomatic Deterioration|0
5097490|NCT01962103|17602422|P4|Phase 2|Symptomatic Deterioration|0
5097491|NCT01962103|17602423|P3|Phase 2|Symptomatic Deterioration|0
5097492|NCT01962103|17602424|P2|Phase 2|Symptomatic Deterioration|0
5097493|NCT01962103|17602425|P1|Phase 2|Symptomatic Deterioration|0
5097494|NCT01962103|17602417|P9|Phase 2|Progressive Disease|11
5097495|NCT01962103|17602418|P8|Phase 2|Progressive Disease|12
5097496|NCT01962103|17602419|P7|Phase 2|Progressive Disease|11
5097497|NCT01962103|17602420|P6|Phase 2|Progressive Disease|0
5097498|NCT01962103|17602421|P5|Phase 2|Progressive Disease|0
5097499|NCT01962103|17602422|P4|Phase 2|Progressive Disease|0
5097500|NCT01962103|17602423|P3|Phase 2|Progressive Disease|0
5097501|NCT01962103|17602424|P2|Phase 2|Progressive Disease|0
5097502|NCT01962103|17602425|P1|Phase 2|Progressive Disease|0
5097503|NCT01962103|17602417|P9|Phase 2|Adverse Event|3
5097504|NCT01962103|17602418|P8|Phase 2|Adverse Event|0
5097505|NCT01962103|17602419|P7|Phase 2|Adverse Event|1
5097506|NCT01962103|17602420|P6|Phase 2|Adverse Event|0
5097507|NCT01962103|17602421|P5|Phase 2|Adverse Event|0
5097508|NCT01962103|17602422|P4|Phase 2|Adverse Event|0
5097509|NCT01962103|17602423|P3|Phase 2|Adverse Event|0
5097510|NCT01962103|17602424|P2|Phase 2|Adverse Event|0
5097511|NCT01962103|17602425|P1|Phase 2|Adverse Event|0
5097512|NCT01962103|17602417|P9|Phase 1|Miscellaneous|0
5097513|NCT01962103|17602418|P8|Phase 1|Miscellaneous|0
5097514|NCT01962103|17602419|P7|Phase 1|Miscellaneous|0
5097515|NCT01962103|17602420|P6|Phase 1|Miscellaneous|0
5097516|NCT01962103|17602421|P5|Phase 1|Miscellaneous|0
5097517|NCT01962103|17602422|P4|Phase 1|Miscellaneous|0
5097518|NCT01962103|17602423|P3|Phase 1|Miscellaneous|0
5097519|NCT01962103|17602424|P2|Phase 1|Miscellaneous|0
5097520|NCT01962103|17602425|P1|Phase 1|Miscellaneous|1
5097521|NCT01962103|17602417|P9|Phase 1|Symptomatic Deterioration|0
5097522|NCT01962103|17602418|P8|Phase 1|Symptomatic Deterioration|0
5097523|NCT01962103|17602419|P7|Phase 1|Symptomatic Deterioration|0
5097524|NCT01962103|17602420|P6|Phase 1|Symptomatic Deterioration|1
5097525|NCT01962103|17602421|P5|Phase 1|Symptomatic Deterioration|1
5097526|NCT01962103|17602422|P4|Phase 1|Symptomatic Deterioration|2
5097527|NCT01962103|17602423|P3|Phase 1|Symptomatic Deterioration|2
5097528|NCT01962103|17602424|P2|Phase 1|Symptomatic Deterioration|2
5097529|NCT01962103|17602425|P1|Phase 1|Symptomatic Deterioration|3
5097530|NCT01962103|17602417|P9|Phase 1|Physician Decision|0
5097531|NCT01962103|17602418|P8|Phase 1|Physician Decision|0
5097532|NCT01962103|17602419|P7|Phase 1|Physician Decision|0
5097533|NCT01962103|17602420|P6|Phase 1|Physician Decision|0
5097534|NCT01962103|17602421|P5|Phase 1|Physician Decision|0
5097535|NCT01962103|17602422|P4|Phase 1|Physician Decision|1
5097536|NCT01962103|17602423|P3|Phase 1|Physician Decision|0
5097537|NCT01962103|17602424|P2|Phase 1|Physician Decision|0
5097538|NCT01962103|17602425|P1|Phase 1|Physician Decision|0
5097539|NCT01962103|17602417|P9|Phase 1|Withdrawal by Parent/Guardian|0
5097540|NCT01962103|17602418|P8|Phase 1|Withdrawal by Parent/Guardian|0
5097541|NCT01962103|17602419|P7|Phase 1|Withdrawal by Parent/Guardian|0
5097542|NCT01962103|17602420|P6|Phase 1|Withdrawal by Parent/Guardian|0
5097543|NCT01962103|17602421|P5|Phase 1|Withdrawal by Parent/Guardian|0
5097544|NCT01962103|17602422|P4|Phase 1|Withdrawal by Parent/Guardian|1
5097545|NCT01962103|17602423|P3|Phase 1|Withdrawal by Parent/Guardian|2
5097546|NCT01962103|17602424|P2|Phase 1|Withdrawal by Parent/Guardian|0
5097547|NCT01962103|17602425|P1|Phase 1|Withdrawal by Parent/Guardian|0
5097548|NCT01962103|17602417|P9|Phase 1|Withdrawal by Subject|0
5097549|NCT01962103|17602418|P8|Phase 1|Withdrawal by Subject|0
5097550|NCT01962103|17602419|P7|Phase 1|Withdrawal by Subject|0
5097551|NCT01962103|17602420|P6|Phase 1|Withdrawal by Subject|0
5097552|NCT01962103|17602421|P5|Phase 1|Withdrawal by Subject|0
5097553|NCT01962103|17602422|P4|Phase 1|Withdrawal by Subject|2
5097554|NCT01962103|17602423|P3|Phase 1|Withdrawal by Subject|0
5097555|NCT01962103|17602424|P2|Phase 1|Withdrawal by Subject|0
5097556|NCT01962103|17602425|P1|Phase 1|Withdrawal by Subject|0
5097557|NCT01962103|17602417|P9|Phase 1|Progressive Disease|0
5097558|NCT01962103|17602418|P8|Phase 1|Progressive Disease|0
5097559|NCT01962103|17602419|P7|Phase 1|Progressive Disease|0
5097560|NCT01962103|17602420|P6|Phase 1|Progressive Disease|4
5097561|NCT01962103|17602421|P5|Phase 1|Progressive Disease|5
5097562|NCT01962103|17602422|P4|Phase 1|Progressive Disease|4
5097563|NCT01962103|17602423|P3|Phase 1|Progressive Disease|8
5097564|NCT01962103|17602424|P2|Phase 1|Progressive Disease|6
5097565|NCT01962103|17602425|P1|Phase 1|Progressive Disease|8
5097566|NCT01962103|17602417|P9|Phase 1|Adverse Event|0
5097567|NCT01962103|17602418|P8|Phase 1|Adverse Event|0
5097568|NCT01962103|17602419|P7|Phase 1|Adverse Event|0
5097569|NCT01962103|17602420|P6|Phase 1|Adverse Event|2
5097570|NCT01962103|17602421|P5|Phase 1|Adverse Event|2
5097571|NCT01962103|17602422|P4|Phase 1|Adverse Event|1
5097572|NCT01962103|17602423|P3|Phase 1|Adverse Event|2
5097573|NCT01962103|17602424|P2|Phase 1|Adverse Event|0
5097574|NCT01962103|17602425|P1|Phase 1|Adverse Event|4
5097575|NCT01961609|17602554|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
5097576|NCT01961609|17602555|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
5097577|NCT01961609|17602556|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
5097578|NCT01961609|17602557|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
5097579|NCT01961609|17602554|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
5097580|NCT01961609|17602555|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
5097581|NCT01961609|17602556|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
5097582|NCT01961609|17602557|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
5097583|NCT01961609|17602554|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5097584|NCT01961609|17602555|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5097585|NCT01961609|17602556|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
5097586|NCT01961609|17602557|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5097587|NCT01961609|17602554|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5097588|NCT01961609|17602555|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5097589|NCT01961609|17602556|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5097590|NCT01961609|17602557|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
5097591|NCT01961609|17602554|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5097592|NCT01961609|17602555|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
5097593|NCT01961609|17602556|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5097594|NCT01961609|17602557|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5097595|NCT01961609|17602554|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
5097596|NCT01961609|17602555|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
5097597|NCT01961609|17602556|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
5097598|NCT01961609|17602557|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
5097599|NCT01961609|17602554|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5097600|NCT01961609|17602555|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
5097601|NCT01961609|17602556|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5097602|NCT01961609|17602557|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5097603|NCT01961609|17602554|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
5097604|NCT01961609|17602555|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
5097605|NCT01961609|17602556|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
5097606|NCT01961609|17602557|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
5097607|NCT01961609|17602554|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
5097608|NCT01961609|17602555|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
5097609|NCT01961609|17602556|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
5097610|NCT01961609|17602557|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
5097611|NCT01961609|17602554|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
5097612|NCT01961609|17602555|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
5097613|NCT01961609|17602556|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
5097614|NCT01961609|17602557|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
5097615|NCT01961609|17602554|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
5097616|NCT01961609|17602555|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
5097617|NCT01961609|17602556|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
5097618|NCT01961609|17602557|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
5097619|NCT01961609|17602554|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
5097620|NCT01961609|17602555|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
5097621|NCT01961609|17602556|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
5097622|NCT01961609|17602557|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
5097623|NCT01961609|17602554|P4|Initiation|Randomized but not treated|0
5097624|NCT01961609|17602555|P3|Initiation|Randomized but not treated|0
5097625|NCT01961609|17602556|P2|Initiation|Randomized but not treated|1
5097626|NCT01961609|17602557|P1|Initiation|Randomized but not treated|1
5097627|NCT01961609|17602554|P4|Initiation|Adverse Event|0
5097628|NCT01961609|17602555|P3|Initiation|Adverse Event|0
5097629|NCT01961609|17602556|P2|Initiation|Adverse Event|5
5097630|NCT01961609|17602557|P1|Initiation|Adverse Event|3
5097631|NCT01961609|17602554|P4|Initiation|Abnormal lab values|0
5097632|NCT01961609|17602555|P3|Initiation|Abnormal lab values|0
5097633|NCT01961609|17602556|P2|Initiation|Abnormal lab values|1
5097634|NCT01961609|17602557|P1|Initiation|Abnormal lab values|0
5097635|NCT01961609|17602554|P4|Initiation|Lack of Efficacy|0
5097636|NCT01961609|17602555|P3|Initiation|Lack of Efficacy|0
5097637|NCT01961609|17602556|P2|Initiation|Lack of Efficacy|1
5097638|NCT01961609|17602557|P1|Initiation|Lack of Efficacy|2
5097639|NCT01961609|17602554|P4|Initiation|Withdrawal by Subject|0
5097640|NCT01961609|17602555|P3|Initiation|Withdrawal by Subject|0
5097641|NCT01961609|17602556|P2|Initiation|Withdrawal by Subject|2
5097642|NCT01961609|17602557|P1|Initiation|Withdrawal by Subject|1
5097643|NCT01961609|17602554|P4|Initiation|Administrative problems|0
5097644|NCT01961609|17602555|P3|Initiation|Administrative problems|0
5097645|NCT01961609|17602556|P2|Initiation|Administrative problems|0
5097646|NCT01961609|17602557|P1|Initiation|Administrative problems|1
5097647|NCT01961609|17602554|P4|Initiation|Death|0
5097648|NCT01961609|17602555|P3|Initiation|Death|0
5097649|NCT01961609|17602556|P2|Initiation|Death|1
5097650|NCT01961609|17602557|P1|Initiation|Death|0
5097651|NCT01961609|17602554|P4|Initiation|Protocol deviation|0
5097652|NCT01961609|17602555|P3|Initiation|Protocol deviation|0
5097653|NCT01961609|17602556|P2|Initiation|Protocol deviation|0
5097654|NCT01961609|17602557|P1|Initiation|Protocol deviation|1
5097655|NCT01961609|17602554|P4|Initiation|Missing|0
5097656|NCT01961609|17602555|P3|Initiation|Missing|0
5097657|NCT01961609|17602556|P2|Initiation|Missing|2
5097658|NCT01961609|17602557|P1|Initiation|Missing|3
5097659|NCT01961544|17602609|P1|Overall Study|Aggravation of Steral Pain|1
5097660|NCT01961544|17602609|P1|Overall Study|Poor Tolerance|1
5097661|NCT01961544|17602609|P1|Overall Study|Physician Decision|2
5097662|NCT01961544|17602609|P1|Overall Study|Adverse Event|1
5097663|NCT01961544|17602609|P1|Overall Study|Withdrawal by Subject|7
5097664|NCT01961544|17602609|P1|Overall Study|Protocol Violation|1
5097665|NCT01961349|17602628|P3|Overall Study|registration error, personal reason etc|1
5097666|NCT01961349|17602629|P2|Overall Study|registration error, personal reason etc|2
5097667|NCT01961349|17602630|P1|Overall Study|registration error, personal reason etc|2
5097668|NCT01961349|17602628|P3|Overall Study|Adverse Event|1
5097669|NCT01961349|17602629|P2|Overall Study|Adverse Event|0
5097670|NCT01961349|17602630|P1|Overall Study|Adverse Event|0
5097671|NCT01961349|17602628|P3|Overall Study|Withdrawal by Subject|0
5097672|NCT01961349|17602629|P2|Overall Study|Withdrawal by Subject|4
5097673|NCT01961349|17602630|P1|Overall Study|Withdrawal by Subject|1
5097674|NCT01961323|17602641|P1|Overall Study|screen failure|34
5097675|NCT01961323|17602641|P1|Overall Study|Lost to Follow-up|8
5097676|NCT01961323|17602641|P1|Overall Study|Withdrawal by Subject|7
5097677|NCT01961297|17602649|P2|Overall Study|unconfirmed diagnosis of SD|1
5097678|NCT01961297|17602650|P1|Overall Study|unconfirmed diagnosis of SD|2
5097679|NCT01961115|17602714|P3|Overall Study|Adverse Event|1
5097680|NCT01961115|17602715|P2|Overall Study|Adverse Event|0
5097681|NCT01961115|17602716|P1|Overall Study|Adverse Event|1
5097682|NCT01961115|17602714|P3|Overall Study|Disease Progression|3
5097683|NCT01961115|17602715|P2|Overall Study|Disease Progression|0
5097684|NCT01961115|17602716|P1|Overall Study|Disease Progression|1
5097685|NCT01960907|17602759|P2|Overall Study|Withdrawal by Subject|42
5097686|NCT01960907|17602760|P1|Overall Study|Withdrawal by Subject|32
5097687|NCT01960907|17602759|P2|Overall Study|Death|3
5097688|NCT01960907|17602760|P1|Overall Study|Death|4
5097689|NCT01960855|17602775|P5|Overall Study|Lost to Follow-up|2
5097690|NCT01960855|17602776|P4|Overall Study|Lost to Follow-up|0
5097691|NCT01960855|17602777|P3|Overall Study|Lost to Follow-up|0
5097692|NCT01960855|17602778|P2|Overall Study|Lost to Follow-up|1
5097693|NCT01960855|17602779|P1|Overall Study|Lost to Follow-up|2
5097694|NCT01960855|17602775|P5|Overall Study|Consent withdrawn by subject|1
5097695|NCT01960855|17602776|P4|Overall Study|Consent withdrawn by subject|1
5097696|NCT01960855|17602777|P3|Overall Study|Consent withdrawn by subject|2
5097697|NCT01960855|17602778|P2|Overall Study|Consent withdrawn by subject|1
5097698|NCT01960855|17602779|P1|Overall Study|Consent withdrawn by subject|3
5097699|NCT01960855|17602775|P5|Overall Study|Other|0
5097700|NCT01960855|17602776|P4|Overall Study|Other|1
5097701|NCT01960855|17602777|P3|Overall Study|Other|1
5097702|NCT01960855|17602778|P2|Overall Study|Other|1
5097703|NCT01960855|17602779|P1|Overall Study|Other|2
5097704|NCT01960855|17602775|P5|Overall Study|Lack of Efficacy|0
5097705|NCT01960855|17602776|P4|Overall Study|Lack of Efficacy|0
5097706|NCT01960855|17602777|P3|Overall Study|Lack of Efficacy|0
5097707|NCT01960855|17602778|P2|Overall Study|Lack of Efficacy|1
5097708|NCT01960855|17602779|P1|Overall Study|Lack of Efficacy|1
5097709|NCT01960855|17602775|P5|Overall Study|Adverse Event|2
5097710|NCT01960855|17602776|P4|Overall Study|Adverse Event|2
5097711|NCT01960855|17602777|P3|Overall Study|Adverse Event|6
5097712|NCT01960855|17602778|P2|Overall Study|Adverse Event|0
5097713|NCT01960855|17602779|P1|Overall Study|Adverse Event|2
5097714|NCT01960855|17602775|P5|Overall Study|Subject noncompliant|0
5097715|NCT01960855|17602776|P4|Overall Study|Subject noncompliant|0
5097716|NCT01960855|17602777|P3|Overall Study|Subject noncompliant|0
5097717|NCT01960855|17602778|P2|Overall Study|Subject noncompliant|0
5097718|NCT01960855|17602779|P1|Overall Study|Subject noncompliant|1
5097719|NCT01960842|17602811|P1|Overall Study|Withdrawal by Subject|2
5097720|NCT01960842|17602811|P1|Overall Study|Adverse Event|1
5097721|NCT01960816|17602834|P1|Overall Study|Lost to Follow-up|1
5097722|NCT01960790|17602840|P1|Overall Study|Unevaluable for safety|1
5097723|NCT01960790|17602840|P1|Overall Study|Transferred to another hospital|4
5097724|NCT01960790|17602840|P1|Overall Study|Treat with Humira outside survey period|3
5097725|NCT01960790|17602840|P1|Overall Study|Survey forms could not be recovered|3
5097726|NCT01960725|17602852|P2|Overall Study|unable to obtain blood sample|2
5097727|NCT01960725|17602853|P1|Overall Study|unable to obtain blood sample|1
5097728|NCT01960725|17602852|P2|Overall Study|Withdrawal by Subject|0
5097729|NCT01960725|17602853|P1|Overall Study|Withdrawal by Subject|1
5097730|NCT01960725|17602852|P2|Overall Study|Lost to Follow-up|3
5097731|NCT01960725|17602853|P1|Overall Study|Lost to Follow-up|4
5097732|NCT01960413|17602923|P2|Overall Study|Lost to Follow-up|0
5097733|NCT01960413|17602924|P1|Overall Study|Lost to Follow-up|2
5097734|NCT01960413|17602923|P2|Overall Study|Physician Decision|0
5097735|NCT01960413|17602924|P1|Overall Study|Physician Decision|1
5097736|NCT01960413|17602923|P2|Overall Study|Withdrawal by Subject|1
5097737|NCT01960413|17602924|P1|Overall Study|Withdrawal by Subject|1
5097738|NCT01960348|17602954|P2|Overall Study|Protocol Violation|0
5097739|NCT01960348|17602955|P1|Overall Study|Protocol Violation|1
5097740|NCT01960348|17602954|P2|Overall Study|Physician Decision|1
5097741|NCT01960348|17602955|P1|Overall Study|Physician Decision|0
5097742|NCT01960348|17602954|P2|Overall Study|Withdrawal by Subject|11
5097743|NCT01960348|17602955|P1|Overall Study|Withdrawal by Subject|1
5097744|NCT01960348|17602954|P2|Overall Study|Adverse event, serious non-fatal|3
5097745|NCT01960348|17602955|P1|Overall Study|Adverse event, serious non-fatal|0
5097746|NCT01960348|17602954|P2|Overall Study|Adverse event, serious fatal|5
5097747|NCT01960348|17602955|P1|Overall Study|Adverse event, serious fatal|6
5097748|NCT01960348|17602954|P2|Overall Study|Adverse event, not serious|2
5097749|NCT01960348|17602955|P1|Overall Study|Adverse event, not serious|2
5097750|NCT01960296|17602975|P2|Overall Study|Received different procedure|3
5097751|NCT01960296|17602976|P1|Overall Study|Received different procedure|1
5097752|NCT01960296|17602975|P2|Overall Study|Postponed surgery|0
5097753|NCT01960296|17602976|P1|Overall Study|Postponed surgery|1
5097754|NCT01960140|17602996|P1|Period 2 (Days 3-18)|Adverse Event|2
5097755|NCT01960114|17603007|P2|Overall Study|Could not swallow study medication|1
5097756|NCT01960114|17603008|P1|Overall Study|Could not swallow study medication|0
5097757|NCT01960114|17603007|P2|Overall Study|Adverse Event|0
5097758|NCT01960114|17603008|P1|Overall Study|Adverse Event|1
5097759|NCT01959932|17603115|P3|Overall Study|Withdrawal by Subject|0
5097760|NCT01959932|17603116|P2|Overall Study|Withdrawal by Subject|0
5097761|NCT01959932|17603117|P1|Overall Study|Withdrawal by Subject|1
5097762|NCT01959919|17603135|P1|Overall Study|Did not meet the eligibility criteria|2
5097763|NCT01959880|17603149|P4|Overall Study|Study completed early-FDA approved|152
5097764|NCT01959880|17603150|P3|Overall Study|Study completed early-FDA approved|179
5097765|NCT01959880|17603151|P2|Overall Study|Study completed early-FDA approved|311
5097766|NCT01959880|17603152|P1|Overall Study|Study completed early-FDA approved|1003
5097767|NCT01959880|17603149|P4|Overall Study|Explantation w/o study device reimplant.|12
5097768|NCT01959880|17603150|P3|Overall Study|Explantation w/o study device reimplant.|5
5097769|NCT01959880|17603151|P2|Overall Study|Explantation w/o study device reimplant.|17
5097770|NCT01959880|17603152|P1|Overall Study|Explantation w/o study device reimplant.|22
5097771|NCT01959880|17603149|P4|Overall Study|Lost to Follow-up|8
5097772|NCT01959880|17603150|P3|Overall Study|Lost to Follow-up|15
5097773|NCT01959880|17603151|P2|Overall Study|Lost to Follow-up|18
5097774|NCT01959880|17603152|P1|Overall Study|Lost to Follow-up|95
5097775|NCT01959880|17603149|P4|Overall Study|Death|2
5097776|NCT01959880|17603150|P3|Overall Study|Death|1
5097777|NCT01959880|17603151|P2|Overall Study|Death|10
5097778|NCT01959880|17603152|P1|Overall Study|Death|1
5097779|NCT01959880|17603149|P4|Overall Study|Withdrawal by Subject|7
5097780|NCT01959880|17603150|P3|Overall Study|Withdrawal by Subject|8
5097781|NCT01959880|17603151|P2|Overall Study|Withdrawal by Subject|13
5097782|NCT01959880|17603152|P1|Overall Study|Withdrawal by Subject|11
5097783|NCT01959841|17603177|P3|Overall Study|Platelet count below on day1 or 4|11
5097784|NCT01959841|17603178|P2|Overall Study|Platelet count below on day1 or 4|15
5097785|NCT01959841|17603179|P1|Overall Study|Platelet count below on day1 or 4|11
5097786|NCT01959841|17603177|P3|Overall Study|Clinical laboratory value|6
5097787|NCT01959841|17603178|P2|Overall Study|Clinical laboratory value|6
5097788|NCT01959841|17603179|P1|Overall Study|Clinical laboratory value|2
5097789|NCT01959841|17603177|P3|Overall Study|Withdrawal by Subject|5
5097790|NCT01959841|17603178|P2|Overall Study|Withdrawal by Subject|7
5097791|NCT01959841|17603179|P1|Overall Study|Withdrawal by Subject|7
5097792|NCT01959841|17603177|P3|Overall Study|Protocol Violation|16
5097793|NCT01959841|17603178|P2|Overall Study|Protocol Violation|23
5097794|NCT01959841|17603179|P1|Overall Study|Protocol Violation|16
5097795|NCT01959841|17603177|P3|Overall Study|Physician Decision|3
5097796|NCT01959841|17603178|P2|Overall Study|Physician Decision|2
5097797|NCT01959841|17603179|P1|Overall Study|Physician Decision|0
5097798|NCT01959841|17603177|P3|Overall Study|Lost to Follow-up|0
5097799|NCT01959841|17603178|P2|Overall Study|Lost to Follow-up|1
5097800|NCT01959841|17603179|P1|Overall Study|Lost to Follow-up|1
5097801|NCT01959841|17603177|P3|Overall Study|Lack of Efficacy|0
5097802|NCT01959841|17603178|P2|Overall Study|Lack of Efficacy|0
5097803|NCT01959841|17603179|P1|Overall Study|Lack of Efficacy|5
5097804|NCT01959841|17603177|P3|Overall Study|Adverse Event|2
5097805|NCT01959841|17603178|P2|Overall Study|Adverse Event|3
5097806|NCT01959841|17603179|P1|Overall Study|Adverse Event|1
5097807|NCT01959672|17603207|P1|Overall Study|Death|1
5097808|NCT01959607|17603218|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5097809|NCT01959607|17603219|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5097810|NCT01959607|17603220|P2|First Intervention (Day 1)|Withdrawal by Subject|1
5097811|NCT01959607|17603221|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5097812|NCT01959581|17603234|P1|Overall Study|Lost to Follow-up|5
5097813|NCT01959529|17603245|P2|Overall Study|Lack of glycaemic control|1
5097814|NCT01959529|17603246|P1|Overall Study|Lack of glycaemic control|1
5097815|NCT01959529|17603245|P2|Overall Study|Hypoglycaemia|1
5097816|NCT01959529|17603246|P1|Overall Study|Hypoglycaemia|1
5097817|NCT01959529|17603245|P2|Overall Study|Other|68
5097818|NCT01959529|17603246|P1|Overall Study|Other|70
5097819|NCT01959529|17603245|P2|Overall Study|Lost to Follow-up|1
5097820|NCT01959529|17603246|P1|Overall Study|Lost to Follow-up|4
5097821|NCT01959529|17603245|P2|Overall Study|Adverse event (not hypoglycaemia)|1
5097822|NCT01959529|17603246|P1|Overall Study|Adverse event (not hypoglycaemia)|0
5097823|NCT01959516|17603258|P2|Epoch 2|Moderate or severe COPD exacerbation|1
5097824|NCT01959516|17603259|P1|Epoch 2|Moderate or severe COPD exacerbation|0
5097825|NCT01959516|17603258|P2|Epoch 2|Subject withdrew consent|0
5097826|NCT01959516|17603259|P1|Epoch 2|Subject withdrew consent|1
5097827|NCT01959516|17603258|P2|Epoch 2|unsatisfactory therapeutic effect|0
5097828|NCT01959516|17603259|P1|Epoch 2|unsatisfactory therapeutic effect|1
5097829|NCT01959516|17603258|P2|Epoch 1|Protocol deviation|1
5097830|NCT01959516|17603259|P1|Epoch 1|Protocol deviation|0
5097831|NCT01959516|17603258|P2|Epoch 1|Moderate or severe COPD exacerbation|1
5097832|NCT01959516|17603259|P1|Epoch 1|Moderate or severe COPD exacerbation|0
5097833|NCT01959516|17603258|P2|Epoch 1|Use of prohibited treatment|0
5097834|NCT01959516|17603259|P1|Epoch 1|Use of prohibited treatment|1
5097835|NCT01959516|17603258|P2|Epoch 1|Administrative problems|0
5097836|NCT01959516|17603259|P1|Epoch 1|Administrative problems|1
5097837|NCT01959516|17603258|P2|Epoch 1|Subject withdrew consent|2
5097838|NCT01959516|17603259|P1|Epoch 1|Subject withdrew consent|3
5097839|NCT01959516|17603258|P2|Epoch 1|unsatisfactory therapeutic effect|0
5097840|NCT01959516|17603259|P1|Epoch 1|unsatisfactory therapeutic effect|1
5097841|NCT01959516|17603258|P2|Epoch 1|Adverse Event|1
5097842|NCT01959516|17603259|P1|Epoch 1|Adverse Event|4
5097843|NCT01959503|17603269|P2|Overall Study|Randomized but not treated|1
5097844|NCT01959503|17603270|P1|Overall Study|Randomized but not treated|1
5097845|NCT01959503|17603269|P2|Overall Study|Death|1
5097846|NCT01959503|17603270|P1|Overall Study|Death|2
5097847|NCT01959412|17603321|P6|Overall Study|Adverse Event|0
5097848|NCT01959412|17603322|P5|Overall Study|Adverse Event|0
5097849|NCT01959412|17603323|P4|Overall Study|Adverse Event|1
5097850|NCT01959412|17603324|P3|Overall Study|Adverse Event|0
5097851|NCT01959412|17603325|P2|Overall Study|Adverse Event|0
5097852|NCT01959412|17603326|P1|Overall Study|Adverse Event|0
5097853|NCT01959412|17603321|P6|Overall Study|Protocol deviation|0
5097854|NCT01959412|17603322|P5|Overall Study|Protocol deviation|3
5097855|NCT01959412|17603323|P4|Overall Study|Protocol deviation|1
5097856|NCT01959412|17603324|P3|Overall Study|Protocol deviation|0
5097857|NCT01959412|17603325|P2|Overall Study|Protocol deviation|1
5097858|NCT01959412|17603326|P1|Overall Study|Protocol deviation|1
5097859|NCT01959347|17603366|P2|Overall Study|Protocol Violation|7
5097860|NCT01959347|17603367|P1|Overall Study|Protocol Violation|9
5097861|NCT01959334|17603473|P2|Third Dose|Adverse Event|1
5097862|NCT01959334|17603474|P1|Third Dose|Adverse Event|0
5097863|NCT01959334|17603473|P2|Second Dose|Adverse Event|0
5097864|NCT01959334|17603474|P1|Second Dose|Adverse Event|1
5097865|NCT01959243|17603486|P2|Overall Study|Lost to Follow-up|1
5097866|NCT01959243|17603487|P1|Overall Study|Lost to Follow-up|3
5097867|NCT01959243|17603486|P2|Overall Study|Administrative reasons|1
5097868|NCT01959243|17603487|P1|Overall Study|Administrative reasons|2
5097869|NCT01959243|17603486|P2|Overall Study|Adverse Event|2
5097870|NCT01959243|17603487|P1|Overall Study|Adverse Event|5
5097871|NCT01959243|17603486|P2|Overall Study|Investigator Decision|0
5097872|NCT01959243|17603487|P1|Overall Study|Investigator Decision|3
5097873|NCT01959230|17603499|P2|Overall Study|Withdrawal by Subject|0
5097874|NCT01959230|17603500|P1|Overall Study|Withdrawal by Subject|2
5097875|NCT01959230|17603499|P2|Overall Study|Administrative reasons|0
5097876|NCT01959230|17603500|P1|Overall Study|Administrative reasons|2
5097877|NCT01959230|17603499|P2|Overall Study|Failure to follow study procedures|1
5097878|NCT01959230|17603500|P1|Overall Study|Failure to follow study procedures|0
5097879|NCT01959165|17603523|P4|Overall Study|Welfare recipient|0
5097880|NCT01959165|17603524|P3|Overall Study|Welfare recipient|0
5097881|NCT01959165|17603525|P2|Overall Study|Welfare recipient|1
5097882|NCT01959165|17603526|P1|Overall Study|Welfare recipient|0
5097883|NCT01959165|17603523|P4|Overall Study|overdose|1
5097884|NCT01959165|17603524|P3|Overall Study|overdose|0
5097885|NCT01959165|17603525|P2|Overall Study|overdose|0
5097886|NCT01959165|17603526|P1|Overall Study|overdose|0
5097887|NCT01959165|17603523|P4|Overall Study|Lack of Efficacy|0
5097888|NCT01959165|17603524|P3|Overall Study|Lack of Efficacy|0
5097889|NCT01959165|17603525|P2|Overall Study|Lack of Efficacy|0
5097890|NCT01959165|17603526|P1|Overall Study|Lack of Efficacy|1
5097891|NCT01959165|17603523|P4|Overall Study|Adverse Event|1
5097892|NCT01959165|17603524|P3|Overall Study|Adverse Event|0
5097893|NCT01959165|17603525|P2|Overall Study|Adverse Event|0
5097894|NCT01959165|17603526|P1|Overall Study|Adverse Event|0
5097895|NCT01959139|17603552|P4|Phase II|On treatment|0
5097896|NCT01959139|17603553|P3|Phase II|On treatment|4
5097897|NCT01959139|17603554|P2|Phase II|On treatment|0
5097898|NCT01959139|17603555|P1|Phase II|On treatment|0
5097899|NCT01959139|17603552|P4|Phase II|Other/Unknown|5
5097900|NCT01959139|17603553|P3|Phase II|Other/Unknown|8
5097901|NCT01959139|17603554|P2|Phase II|Other/Unknown|0
5097902|NCT01959139|17603555|P1|Phase II|Other/Unknown|0
5097903|NCT01959139|17603552|P4|Phase II|Death|1
5097904|NCT01959139|17603553|P3|Phase II|Death|3
5097905|NCT01959139|17603554|P2|Phase II|Death|0
5097906|NCT01959139|17603555|P1|Phase II|Death|0
5097907|NCT01959139|17603552|P4|Phase II|Patient Refusal|4
5097908|NCT01959139|17603553|P3|Phase II|Patient Refusal|5
5097909|NCT01959139|17603554|P2|Phase II|Patient Refusal|0
5097910|NCT01959139|17603555|P1|Phase II|Patient Refusal|0
5097911|NCT01959139|17603552|P4|Phase II|Adverse Event|11
5097912|NCT01959139|17603553|P3|Phase II|Adverse Event|10
5097913|NCT01959139|17603554|P2|Phase II|Adverse Event|0
5097914|NCT01959139|17603555|P1|Phase II|Adverse Event|0
5097915|NCT01959139|17603552|P4|Phase II|Disease progression|34
5097916|NCT01959139|17603553|P3|Phase II|Disease progression|26
5097917|NCT01959139|17603554|P2|Phase II|Disease progression|0
5097918|NCT01959139|17603555|P1|Phase II|Disease progression|0
5097919|NCT01959035|17603588|P1|Overall Study|Other (no primary reason given)|1
5097920|NCT01959035|17603588|P1|Overall Study|Lost to Follow-up|1
5097921|NCT01959035|17603588|P1|Overall Study|Withdrawal by Subject|4
5097922|NCT01959035|17603588|P1|Overall Study|Adverse Event|5
5097923|NCT01958918|17603616|P2|Overall Study|administrative problems|2
5097924|NCT01958918|17603617|P1|Overall Study|administrative problems|0
5097925|NCT01958918|17603616|P2|Overall Study|Adverse Event|12
5097926|NCT01958918|17603617|P1|Overall Study|Adverse Event|12
5097927|NCT01958918|17603616|P2|Overall Study|Lack of Efficacy|10
5097928|NCT01958918|17603617|P1|Overall Study|Lack of Efficacy|13
5097929|NCT01958918|17603616|P2|Overall Study|Withdrawal by Subject|8
5097930|NCT01958918|17603617|P1|Overall Study|Withdrawal by Subject|13
5097931|NCT01958918|17603616|P2|Overall Study|Lost to Follow-up|7
5097932|NCT01958918|17603617|P1|Overall Study|Lost to Follow-up|4
5097933|NCT01958918|17603616|P2|Overall Study|Death|3
5097934|NCT01958918|17603617|P1|Overall Study|Death|1
5097935|NCT01958827|17603631|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
5097936|NCT01958827|17603631|P1|Overall Study|Lack of Efficacy|6
5097937|NCT01958827|17603631|P1|Overall Study|Adverse Event|3
5097938|NCT01958671|17603662|P3|Overall Study|Withdrawal by Subject|13
5097939|NCT01958671|17603663|P2|Overall Study|Withdrawal by Subject|10
5097940|NCT01958671|17603664|P1|Overall Study|Withdrawal by Subject|8
5097941|NCT01958671|17603662|P3|Overall Study|Participant moved|1
5097942|NCT01958671|17603663|P2|Overall Study|Participant moved|0
5097943|NCT01958671|17603664|P1|Overall Study|Participant moved|0
5097944|NCT01958671|17603662|P3|Overall Study|Study site terminated by sponsor|1
5097945|NCT01958671|17603663|P2|Overall Study|Study site terminated by sponsor|0
5097946|NCT01958671|17603664|P1|Overall Study|Study site terminated by sponsor|1
5097947|NCT01958671|17603662|P3|Overall Study|Protocol Violation|0
5097948|NCT01958671|17603663|P2|Overall Study|Protocol Violation|1
5097949|NCT01958671|17603664|P1|Overall Study|Protocol Violation|0
5097950|NCT01958671|17603662|P3|Overall Study|Pregnancy|1
5097951|NCT01958671|17603663|P2|Overall Study|Pregnancy|0
5097952|NCT01958671|17603664|P1|Overall Study|Pregnancy|0
5097953|NCT01958671|17603662|P3|Overall Study|Non-compliance with study drug|1
5097954|NCT01958671|17603663|P2|Overall Study|Non-compliance with study drug|1
5097955|NCT01958671|17603664|P1|Overall Study|Non-compliance with study drug|1
5097956|NCT01958671|17603662|P3|Overall Study|Lost to Follow-up|7
5097957|NCT01958671|17603663|P2|Overall Study|Lost to Follow-up|11
5097958|NCT01958671|17603664|P1|Overall Study|Lost to Follow-up|7
5097959|NCT01958671|17603662|P3|Overall Study|Hyperglycemia|2
5097960|NCT01958671|17603663|P2|Overall Study|Hyperglycemia|0
5097961|NCT01958671|17603664|P1|Overall Study|Hyperglycemia|0
5097962|NCT01958671|17603662|P3|Overall Study|Excluded medication|1
5097963|NCT01958671|17603663|P2|Overall Study|Excluded medication|0
5097964|NCT01958671|17603664|P1|Overall Study|Excluded medication|0
5097965|NCT01958671|17603662|P3|Overall Study|Death|0
5097966|NCT01958671|17603663|P2|Overall Study|Death|0
5097967|NCT01958671|17603664|P1|Overall Study|Death|1
5097968|NCT01958671|17603662|P3|Overall Study|Adverse Event|5
5097969|NCT01958671|17603663|P2|Overall Study|Adverse Event|1
5097970|NCT01958671|17603664|P1|Overall Study|Adverse Event|1
5097971|NCT01958619|17603738|P4|Overall Study|Protocol Violation|0
5097972|NCT01958619|17603739|P3|Overall Study|Protocol Violation|1
5097973|NCT01958619|17603740|P2|Overall Study|Protocol Violation|0
5097974|NCT01958619|17603741|P1|Overall Study|Protocol Violation|2
5097975|NCT01958489|17603802|P2|Period 2|Adverse Event|1
5097976|NCT01958489|17603803|P1|Period 2|Adverse Event|0
5097977|NCT01958476|17603819|P2|Overall Study|Parent requested exclusion from analysis|0
5097978|NCT01958476|17603820|P1|Overall Study|Parent requested exclusion from analysis|1
5097979|NCT01958437|17603850|P4|Overall Study|Incidental MRI findings|1
5097980|NCT01958437|17603851|P3|Overall Study|Incidental MRI findings|1
5097981|NCT01958437|17603852|P2|Overall Study|Incidental MRI findings|0
5097982|NCT01958437|17603853|P1|Overall Study|Incidental MRI findings|0
5097983|NCT01958294|17603917|P1|Overall Study|Clinical Circumstances|2
5097984|NCT01958281|17603926|P3|Overall Study|Withdrew Consent|0
5097985|NCT01958281|17603927|P2|Overall Study|Withdrew Consent|0
5097986|NCT01958281|17603928|P1|Overall Study|Withdrew Consent|1
5097987|NCT01958281|17603926|P3|Overall Study|Adverse Event|0
5097988|NCT01958281|17603927|P2|Overall Study|Adverse Event|2
5097989|NCT01958281|17603928|P1|Overall Study|Adverse Event|0
5097990|NCT01958281|17603926|P3|Overall Study|Lack of Efficacy|0
5097991|NCT01958281|17603927|P2|Overall Study|Lack of Efficacy|2
5097992|NCT01958281|17603928|P1|Overall Study|Lack of Efficacy|5
5097993|NCT01958164|17604004|P2|Overall Study|Lost to Follow-up|3
5097994|NCT01958164|17604005|P1|Overall Study|Lost to Follow-up|2
5097995|NCT01958164|17604004|P2|Overall Study|Adverse Event|2
5097996|NCT01958164|17604005|P1|Overall Study|Adverse Event|0
5097997|NCT01958125|17604020|P2|Overall Study|No headache attacks|2
5097998|NCT01958125|17604021|P1|Overall Study|No headache attacks|0
5097999|NCT01958125|17604020|P2|Overall Study|Missing diary data|6
5098000|NCT01958125|17604021|P1|Overall Study|Missing diary data|2
5098001|NCT01958060|17604084|P6|Overall Study|Not treated|0
5098002|NCT01958060|17604085|P5|Overall Study|Not treated|1
5098003|NCT01958060|17604086|P4|Overall Study|Not treated|0
5098004|NCT01958060|17604087|P3|Overall Study|Not treated|0
5098005|NCT01958060|17604088|P2|Overall Study|Not treated|0
5098006|NCT01958060|17604089|P1|Overall Study|Not treated|2
5098007|NCT01958021|17604114|P2|Overall Study|Death|0
5098008|NCT01958021|17604115|P1|Overall Study|Death|2
5098009|NCT01958021|17604114|P2|Overall Study|Protocol Violation|1
5098010|NCT01958021|17604115|P1|Overall Study|Protocol Violation|3
5098011|NCT01958021|17604114|P2|Overall Study|Physician Decision|13
5098012|NCT01958021|17604115|P1|Overall Study|Physician Decision|10
5098013|NCT01958021|17604114|P2|Overall Study|Subject/guardian decision|13
5098014|NCT01958021|17604115|P1|Overall Study|Subject/guardian decision|12
5098015|NCT01958021|17604114|P2|Overall Study|Adverse Event|7
5098016|NCT01958021|17604115|P1|Overall Study|Adverse Event|25
5098017|NCT01958021|17604114|P2|Overall Study|Progressive disease|146
5098018|NCT01958021|17604115|P1|Overall Study|Progressive disease|87
5098019|NCT01958008|17604127|P4|Overall Study|Other adverse event|0
5098020|NCT01958008|17604128|P3|Overall Study|Other adverse event|0
5098021|NCT01958008|17604129|P2|Overall Study|Other adverse event|0
5098022|NCT01958008|17604130|P1|Overall Study|Other adverse event|1
5098023|NCT01958008|17604127|P4|Overall Study|Worsening of disease under study|0
5098024|NCT01958008|17604128|P3|Overall Study|Worsening of disease under study|1
5098025|NCT01958008|17604129|P2|Overall Study|Worsening of disease under study|0
5098026|NCT01958008|17604130|P1|Overall Study|Worsening of disease under study|0
5098027|NCT01957865|17604173|P3|Overall Study|Lost to Follow-up|2
5098028|NCT01957865|17604174|P2|Overall Study|Lost to Follow-up|2
5098029|NCT01957865|17604175|P1|Overall Study|Lost to Follow-up|0
5098030|NCT01957865|17604173|P3|Overall Study|Found HIV negative|1
5098031|NCT01957865|17604174|P2|Overall Study|Found HIV negative|0
5098032|NCT01957865|17604175|P1|Overall Study|Found HIV negative|0
5098033|NCT01957787|17604186|P1|Overall Study|Local therapy, not cryoablation|6
5098034|NCT01957787|17604186|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
5098035|NCT01957787|17604186|P1|Overall Study|Index Tumor(s) Resected|2
5098036|NCT01957787|17604186|P1|Overall Study|Entered Hospice or Similar Program|2
5098037|NCT01957787|17604186|P1|Overall Study|Withdrawal by Subject|3
5098038|NCT01957787|17604186|P1|Overall Study|Lost to Follow-up|3
5098039|NCT01957787|17604186|P1|Overall Study|Death|18
5098040|NCT01957709|17604205|P1|Overall Study|Patient refused to complete post-tx bx|1
5098041|NCT01957644|17604230|P5|Overall Study|Protocol Violation|0
5098042|NCT01957644|17604231|P4|Overall Study|Protocol Violation|0
5098043|NCT01957644|17604232|P3|Overall Study|Protocol Violation|0
5098044|NCT01957644|17604233|P2|Overall Study|Protocol Violation|1
5098045|NCT01957644|17604234|P1|Overall Study|Protocol Violation|0
5098046|NCT01957644|17604230|P5|Overall Study|Withdrawal by Subject|0
5098047|NCT01957644|17604231|P4|Overall Study|Withdrawal by Subject|0
5098048|NCT01957644|17604232|P3|Overall Study|Withdrawal by Subject|0
5098049|NCT01957644|17604233|P2|Overall Study|Withdrawal by Subject|0
5098050|NCT01957644|17604234|P1|Overall Study|Withdrawal by Subject|1
5098051|NCT01957644|17604230|P5|Overall Study|Other reason|0
5098052|NCT01957644|17604231|P4|Overall Study|Other reason|1
5098053|NCT01957644|17604232|P3|Overall Study|Other reason|1
5098054|NCT01957644|17604233|P2|Overall Study|Other reason|2
5098055|NCT01957644|17604234|P1|Overall Study|Other reason|1
5098056|NCT01957644|17604230|P5|Overall Study|Progressive disease / relapse|0
5098057|NCT01957644|17604231|P4|Overall Study|Progressive disease / relapse|1
5098058|NCT01957644|17604232|P3|Overall Study|Progressive disease / relapse|0
5098059|NCT01957644|17604233|P2|Overall Study|Progressive disease / relapse|1
5098060|NCT01957644|17604234|P1|Overall Study|Progressive disease / relapse|0
5098061|NCT01957644|17604230|P5|Overall Study|Adverse Event|1
5098062|NCT01957644|17604231|P4|Overall Study|Adverse Event|0
5098063|NCT01957644|17604232|P3|Overall Study|Adverse Event|0
5098064|NCT01957644|17604233|P2|Overall Study|Adverse Event|2
5098065|NCT01957644|17604234|P1|Overall Study|Adverse Event|4
5098066|NCT01957579|17604258|P4|Overall Study|Death|0
5098067|NCT01957579|17604259|P3|Overall Study|Death|2
5098068|NCT01957579|17604260|P2|Overall Study|Death|0
5098069|NCT01957579|17604261|P1|Overall Study|Death|0
5098070|NCT01957579|17604258|P4|Overall Study|Withdrawal of concent|0
5098071|NCT01957579|17604259|P3|Overall Study|Withdrawal of concent|0
5098072|NCT01957579|17604260|P2|Overall Study|Withdrawal of concent|1
5098073|NCT01957579|17604261|P1|Overall Study|Withdrawal of concent|0
5098074|NCT01957553|17604328|P2|Test Period 2 (21 +- 1 Days)|Other|0
5098075|NCT01957553|17604329|P1|Test Period 2 (21 +- 1 Days)|Other|1
5098076|NCT01957553|17604328|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
5098077|NCT01957553|17604329|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
5098078|NCT01957553|17604328|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
5098079|NCT01957553|17604329|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
5098080|NCT01957553|17604328|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
5098081|NCT01957553|17604329|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
5098082|NCT01957553|17604328|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
5098083|NCT01957553|17604329|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
5098084|NCT01957553|17604328|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
5098085|NCT01957553|17604329|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
5098086|NCT01957553|17604328|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
5098087|NCT01957553|17604329|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
5098088|NCT01957553|17604328|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
5098089|NCT01957553|17604329|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
5098090|NCT01957553|17604328|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
5098091|NCT01957553|17604329|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
5098092|NCT01957488|17604335|P6|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5098093|NCT01957488|17604336|P5|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5098094|NCT01957488|17604337|P4|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5098095|NCT01957488|17604338|P3|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5098096|NCT01957488|17604339|P2|Test Period 3 (2 Weeks)|Lack of Efficacy|1
5098097|NCT01957488|17604340|P1|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5098098|NCT01957488|17604335|P6|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5098099|NCT01957488|17604336|P5|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5098100|NCT01957488|17604337|P4|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5098101|NCT01957488|17604338|P3|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5098102|NCT01957488|17604339|P2|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5098103|NCT01957488|17604340|P1|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
5098104|NCT01957488|17604335|P6|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
5098105|NCT01957488|17604336|P5|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5098106|NCT01957488|17604337|P4|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5098107|NCT01957488|17604338|P3|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5098108|NCT01957488|17604339|P2|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5098109|NCT01957488|17604340|P1|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5098110|NCT01957488|17604335|P6|Test Period 2 (2 Weeks)|Adverse Event|0
5098111|NCT01957488|17604336|P5|Test Period 2 (2 Weeks)|Adverse Event|2
5098112|NCT01957488|17604337|P4|Test Period 2 (2 Weeks)|Adverse Event|0
5098113|NCT01957488|17604338|P3|Test Period 2 (2 Weeks)|Adverse Event|0
5098114|NCT01957488|17604339|P2|Test Period 2 (2 Weeks)|Adverse Event|0
5098115|NCT01957488|17604340|P1|Test Period 2 (2 Weeks)|Adverse Event|0
5098116|NCT01957488|17604335|P6|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5098117|NCT01957488|17604336|P5|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5098118|NCT01957488|17604337|P4|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5098119|NCT01957488|17604338|P3|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5098120|NCT01957488|17604339|P2|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
5098121|NCT01957488|17604340|P1|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5098122|NCT01957488|17604335|P6|Test Period 2 (2 Weeks)|Other|0
5098123|NCT01957488|17604336|P5|Test Period 2 (2 Weeks)|Other|0
5098124|NCT01957488|17604337|P4|Test Period 2 (2 Weeks)|Other|0
5098125|NCT01957488|17604338|P3|Test Period 2 (2 Weeks)|Other|0
5098126|NCT01957488|17604339|P2|Test Period 2 (2 Weeks)|Other|0
5098127|NCT01957488|17604340|P1|Test Period 2 (2 Weeks)|Other|1
5098128|NCT01957488|17604335|P6|Test Period 2 (2 Weeks)|Protocol Violation|0
5098129|NCT01957488|17604336|P5|Test Period 2 (2 Weeks)|Protocol Violation|0
5098130|NCT01957488|17604337|P4|Test Period 2 (2 Weeks)|Protocol Violation|1
5098131|NCT01957488|17604338|P3|Test Period 2 (2 Weeks)|Protocol Violation|1
5098132|NCT01957488|17604339|P2|Test Period 2 (2 Weeks)|Protocol Violation|0
5098133|NCT01957488|17604340|P1|Test Period 2 (2 Weeks)|Protocol Violation|2
5098134|NCT01957488|17604335|P6|Test Period 1 (2 Weeks)|screen failure|1
5098135|NCT01957488|17604336|P5|Test Period 1 (2 Weeks)|screen failure|0
5098136|NCT01957488|17604337|P4|Test Period 1 (2 Weeks)|screen failure|0
5098137|NCT01957488|17604338|P3|Test Period 1 (2 Weeks)|screen failure|0
5098138|NCT01957488|17604339|P2|Test Period 1 (2 Weeks)|screen failure|0
5098139|NCT01957488|17604340|P1|Test Period 1 (2 Weeks)|screen failure|0
5098140|NCT01957488|17604335|P6|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5098141|NCT01957488|17604336|P5|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
5098142|NCT01957488|17604337|P4|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5098143|NCT01957488|17604338|P3|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5098144|NCT01957488|17604339|P2|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5098145|NCT01957488|17604340|P1|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5098146|NCT01957488|17604335|P6|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
5098147|NCT01957488|17604336|P5|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
5098148|NCT01957488|17604337|P4|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
5098149|NCT01957488|17604338|P3|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5098150|NCT01957488|17604339|P2|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5098151|NCT01957488|17604340|P1|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5098152|NCT01957488|17604335|P6|Test Period 1 (2 Weeks)|Adverse Event|0
5098153|NCT01957488|17604336|P5|Test Period 1 (2 Weeks)|Adverse Event|1
5098154|NCT01957488|17604337|P4|Test Period 1 (2 Weeks)|Adverse Event|0
5098155|NCT01957488|17604338|P3|Test Period 1 (2 Weeks)|Adverse Event|1
5098156|NCT01957488|17604339|P2|Test Period 1 (2 Weeks)|Adverse Event|1
5098157|NCT01957488|17604340|P1|Test Period 1 (2 Weeks)|Adverse Event|0
5098158|NCT01957488|17604335|P6|Test Period 1 (2 Weeks)|Protocol Violation|3
5098159|NCT01957488|17604336|P5|Test Period 1 (2 Weeks)|Protocol Violation|0
5098160|NCT01957488|17604337|P4|Test Period 1 (2 Weeks)|Protocol Violation|1
5098161|NCT01957488|17604338|P3|Test Period 1 (2 Weeks)|Protocol Violation|2
5098162|NCT01957488|17604339|P2|Test Period 1 (2 Weeks)|Protocol Violation|2
5098163|NCT01957488|17604340|P1|Test Period 1 (2 Weeks)|Protocol Violation|1
5098164|NCT01957488|17604335|P6|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5098165|NCT01957488|17604336|P5|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5098166|NCT01957488|17604337|P4|Test Period 1 (2 Weeks)|Lost to Follow-up|1
5098167|NCT01957488|17604338|P3|Test Period 1 (2 Weeks)|Lost to Follow-up|1
5098168|NCT01957488|17604339|P2|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5098169|NCT01957488|17604340|P1|Test Period 1 (2 Weeks)|Lost to Follow-up|2
5098170|NCT01957475|17604348|P2|Test Period 2|Adverse Event|0
5098171|NCT01957475|17604349|P1|Test Period 2|Adverse Event|1
5098172|NCT01957475|17604348|P2|Test Period 1|Lack of Efficacy|1
5098173|NCT01957475|17604349|P1|Test Period 1|Lack of Efficacy|0
5098174|NCT01957475|17604348|P2|Test Period 1|Other|0
5098175|NCT01957475|17604349|P1|Test Period 1|Other|1
5098176|NCT01957475|17604348|P2|Test Period 1|Withdrawal by Subject|0
5098177|NCT01957475|17604349|P1|Test Period 1|Withdrawal by Subject|1
5098178|NCT01957462|17604355|P2|Test Period 1|Adverse Event|0
5098179|NCT01957462|17604356|P1|Test Period 1|Adverse Event|1
5098180|NCT01957462|17604355|P2|Test Period 1|Withdrawal by Subject|0
5098181|NCT01957462|17604356|P1|Test Period 1|Withdrawal by Subject|1
5098182|NCT01957397|17604367|P2|Test Period 3|the adhesive did not work|0
5098183|NCT01957397|17604368|P1|Test Period 3|the adhesive did not work|1
5098184|NCT01957397|17604367|P2|Test Period 3|Adverse Event|2
5098185|NCT01957397|17604368|P1|Test Period 3|Adverse Event|1
5098186|NCT01957397|17604367|P2|Test Period 2|Adverse Event|1
5098187|NCT01957397|17604368|P1|Test Period 2|Adverse Event|0
5098188|NCT01957397|17604367|P2|Test Period 1|Withdrawal by Subject|0
5098189|NCT01957397|17604368|P1|Test Period 1|Withdrawal by Subject|1
5098190|NCT01957397|17604367|P2|Test Period 1|sudden leakage/small bag|1
5098191|NCT01957397|17604368|P1|Test Period 1|sudden leakage/small bag|1
5098192|NCT01957215|17604393|P2|Overall Study|Withdrawal by Subject|5
5098193|NCT01957215|17604394|P1|Overall Study|Withdrawal by Subject|7
5098194|NCT01957215|17604393|P2|Overall Study|Protocol Violation|2
5098195|NCT01957215|17604394|P1|Overall Study|Protocol Violation|1
5098196|NCT01957215|17604393|P2|Overall Study|Lost to Follow-up|3
5098197|NCT01957215|17604394|P1|Overall Study|Lost to Follow-up|3
5098198|NCT01957215|17604393|P2|Overall Study|Adverse Event|2
5098199|NCT01957215|17604394|P1|Overall Study|Adverse Event|2
5098200|NCT01957202|17604422|P18|Treatment Period 3 (8 Days)|Adverse Event|0
5098201|NCT01957202|17604423|P17|Treatment Period 3 (8 Days)|Adverse Event|1
5098202|NCT01957202|17604424|P16|Treatment Period 3 (8 Days)|Adverse Event|0
5098203|NCT01957202|17604425|P15|Treatment Period 3 (8 Days)|Adverse Event|0
5098204|NCT01957202|17604426|P14|Treatment Period 3 (8 Days)|Adverse Event|0
5098205|NCT01957202|17604427|P13|Treatment Period 3 (8 Days)|Adverse Event|0
5098206|NCT01957202|17604428|P12|Treatment Period 3 (8 Days)|Adverse Event|0
5098207|NCT01957202|17604429|P11|Treatment Period 3 (8 Days)|Adverse Event|0
5098208|NCT01957202|17604430|P10|Treatment Period 3 (8 Days)|Adverse Event|0
5098209|NCT01957202|17604431|P9|Treatment Period 3 (8 Days)|Adverse Event|0
5098210|NCT01957202|17604432|P8|Treatment Period 3 (8 Days)|Adverse Event|0
5098211|NCT01957202|17604433|P7|Treatment Period 3 (8 Days)|Adverse Event|0
5098212|NCT01957202|17604434|P6|Treatment Period 3 (8 Days)|Adverse Event|0
5098213|NCT01957202|17604435|P5|Treatment Period 3 (8 Days)|Adverse Event|0
5098214|NCT01957202|17604436|P4|Treatment Period 3 (8 Days)|Adverse Event|0
5098215|NCT01957202|17604437|P3|Treatment Period 3 (8 Days)|Adverse Event|0
5098216|NCT01957202|17604438|P2|Treatment Period 3 (8 Days)|Adverse Event|0
5098217|NCT01957202|17604439|P1|Treatment Period 3 (8 Days)|Adverse Event|0
5098218|NCT01957202|17604422|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098219|NCT01957202|17604423|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
5098220|NCT01957202|17604424|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098221|NCT01957202|17604425|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098222|NCT01957202|17604426|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098223|NCT01957202|17604427|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098224|NCT01957202|17604428|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098225|NCT01957202|17604429|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098226|NCT01957202|17604430|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098227|NCT01957202|17604431|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098228|NCT01957202|17604432|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098229|NCT01957202|17604433|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098230|NCT01957202|17604434|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098231|NCT01957202|17604435|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098232|NCT01957202|17604436|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098233|NCT01957202|17604437|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098234|NCT01957202|17604438|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
5098235|NCT01957202|17604439|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5098236|NCT01957163|17604464|P3|Overall Study|Withdrawal by Subject|4
5098237|NCT01957163|17604465|P2|Overall Study|Withdrawal by Subject|2
5098238|NCT01957163|17604466|P1|Overall Study|Withdrawal by Subject|4
5098239|NCT01957163|17604464|P3|Overall Study|Lost to Follow-up|0
5098240|NCT01957163|17604465|P2|Overall Study|Lost to Follow-up|1
5098241|NCT01957163|17604466|P1|Overall Study|Lost to Follow-up|0
5098242|NCT01957163|17604464|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
5098243|NCT01957163|17604465|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
5098244|NCT01957163|17604466|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
5098245|NCT01957163|17604464|P3|Overall Study|Protocol Violation|0
5098246|NCT01957163|17604465|P2|Overall Study|Protocol Violation|2
5098247|NCT01957163|17604466|P1|Overall Study|Protocol Violation|1
5098248|NCT01957163|17604464|P3|Overall Study|Lack of Efficacy|9
5098249|NCT01957163|17604465|P2|Overall Study|Lack of Efficacy|4
5098250|NCT01957163|17604466|P1|Overall Study|Lack of Efficacy|5
5098251|NCT01957163|17604464|P3|Overall Study|Adverse Event|4
5098252|NCT01957163|17604465|P2|Overall Study|Adverse Event|2
5098253|NCT01957163|17604466|P1|Overall Study|Adverse Event|5
5098254|NCT01957150|17604479|P2|Overall Study|Lack of Efficacy|11
5098255|NCT01957150|17604480|P1|Overall Study|Lack of Efficacy|11
5098256|NCT01957150|17604479|P2|Overall Study|Protocol Violation|0
5098257|NCT01957150|17604480|P1|Overall Study|Protocol Violation|1
5098258|NCT01957150|17604479|P2|Overall Study|Lost to Follow-up|4
5098259|NCT01957150|17604480|P1|Overall Study|Lost to Follow-up|4
5098260|NCT01957150|17604479|P2|Overall Study|Physician Decision|6
5098261|NCT01957150|17604480|P1|Overall Study|Physician Decision|3
5098262|NCT01957150|17604479|P2|Overall Study|Withdrawal by Subject|17
5098263|NCT01957150|17604480|P1|Overall Study|Withdrawal by Subject|13
5098264|NCT01957150|17604479|P2|Overall Study|Adverse Event|20
5098265|NCT01957150|17604480|P1|Overall Study|Adverse Event|23
5098266|NCT01957137|17604496|P1|Randomized Portion|Withdrawal by Subject|1
5098267|NCT01957137|17604496|P1|Randomized Portion|Adverse Event|1
5098268|NCT01957111|17604526|P2|Overall Study|Withdrawal by Subject|1
5098269|NCT01957111|17604527|P1|Overall Study|Withdrawal by Subject|1
5098270|NCT01956773|17604546|P2|Overall Study|Lost to Follow-up|1
5098271|NCT01956773|17604547|P1|Overall Study|Lost to Follow-up|628
5098272|NCT01956669|17604565|P7|Overall Study|Withdrawal by Subject|1
5098273|NCT01956669|17604566|P6|Overall Study|Withdrawal by Subject|0
5098274|NCT01956669|17604567|P5|Overall Study|Withdrawal by Subject|0
5098275|NCT01956669|17604568|P4|Overall Study|Withdrawal by Subject|1
5098276|NCT01956669|17604569|P3|Overall Study|Withdrawal by Subject|1
5098277|NCT01956669|17604570|P2|Overall Study|Withdrawal by Subject|0
5098278|NCT01956669|17604571|P1|Overall Study|Withdrawal by Subject|0
5098279|NCT01956669|17604565|P7|Overall Study|Physician Decision|0
5098280|NCT01956669|17604566|P6|Overall Study|Physician Decision|1
5098281|NCT01956669|17604567|P5|Overall Study|Physician Decision|0
5098282|NCT01956669|17604568|P4|Overall Study|Physician Decision|0
5098283|NCT01956669|17604569|P3|Overall Study|Physician Decision|0
5098284|NCT01956669|17604570|P2|Overall Study|Physician Decision|2
5098285|NCT01956669|17604571|P1|Overall Study|Physician Decision|0
5098286|NCT01956669|17604565|P7|Overall Study|Adverse Event|0
5098287|NCT01956669|17604566|P6|Overall Study|Adverse Event|0
5098288|NCT01956669|17604567|P5|Overall Study|Adverse Event|0
5098289|NCT01956669|17604568|P4|Overall Study|Adverse Event|1
5098290|NCT01956669|17604569|P3|Overall Study|Adverse Event|2
5098291|NCT01956669|17604570|P2|Overall Study|Adverse Event|2
5098292|NCT01956669|17604571|P1|Overall Study|Adverse Event|0
5098293|NCT01956669|17604565|P7|Overall Study|Disease Progression|5
5098294|NCT01956669|17604566|P6|Overall Study|Disease Progression|3
5098295|NCT01956669|17604567|P5|Overall Study|Disease Progression|4
5098296|NCT01956669|17604568|P4|Overall Study|Disease Progression|8
5098297|NCT01956669|17604569|P3|Overall Study|Disease Progression|7
5098298|NCT01956669|17604570|P2|Overall Study|Disease Progression|7
5098299|NCT01956669|17604571|P1|Overall Study|Disease Progression|12
5098300|NCT01956240|17604693|P2|Overall Study|Adverse Event|4
5098301|NCT01956240|17604694|P1|Overall Study|Adverse Event|17
5098302|NCT01956240|17604693|P2|Overall Study|Lost to Follow-up|20
5098303|NCT01956240|17604694|P1|Overall Study|Lost to Follow-up|6
5098304|NCT01956123|17604704|P4|COS Cycle 3|Withdrawal by Subject|1
5098305|NCT01956123|17604705|P3|COS Cycle 3|Withdrawal by Subject|0
5098306|NCT01956123|17604706|P2|COS Cycle 3|Withdrawal by Subject|0
5098307|NCT01956123|17604707|P1|COS Cycle 3|Withdrawal by Subject|0
5098308|NCT01956123|17604704|P4|COS Cycle 3|Personal Reasons|0
5098309|NCT01956123|17604705|P3|COS Cycle 3|Personal Reasons|1
5098310|NCT01956123|17604706|P2|COS Cycle 3|Personal Reasons|0
5098311|NCT01956123|17604707|P1|COS Cycle 3|Personal Reasons|0
5098312|NCT01956123|17604704|P4|COS Cycle 3|Adverse Event|0
5098313|NCT01956123|17604705|P3|COS Cycle 3|Adverse Event|3
5098314|NCT01956123|17604706|P2|COS Cycle 3|Adverse Event|0
5098315|NCT01956123|17604707|P1|COS Cycle 3|Adverse Event|0
5098316|NCT01956123|17604704|P4|COS Cycle 3|Protocol Violation|1
5098317|NCT01956123|17604705|P3|COS Cycle 3|Protocol Violation|2
5098318|NCT01956123|17604706|P2|COS Cycle 3|Protocol Violation|0
5098319|NCT01956123|17604707|P1|COS Cycle 3|Protocol Violation|0
5098320|NCT01956123|17604704|P4|COS Cycle 2|Withdrawal by Subject|0
5098321|NCT01956123|17604705|P3|COS Cycle 2|Withdrawal by Subject|0
5098322|NCT01956123|17604706|P2|COS Cycle 2|Withdrawal by Subject|0
5098323|NCT01956123|17604707|P1|COS Cycle 2|Withdrawal by Subject|1
5098324|NCT01956123|17604704|P4|COS Cycle 2|Personal Reasons|0
5098325|NCT01956123|17604705|P3|COS Cycle 2|Personal Reasons|0
5098326|NCT01956123|17604706|P2|COS Cycle 2|Personal Reasons|0
5098327|NCT01956123|17604707|P1|COS Cycle 2|Personal Reasons|2
5098328|NCT01956123|17604704|P4|COS Cycle 2|Adverse Event|0
5098329|NCT01956123|17604705|P3|COS Cycle 2|Adverse Event|0
5098330|NCT01956123|17604706|P2|COS Cycle 2|Adverse Event|4
5098331|NCT01956123|17604707|P1|COS Cycle 2|Adverse Event|3
5098332|NCT01956123|17604704|P4|COS Cycle 2|Protocol Violation|0
5098333|NCT01956123|17604705|P3|COS Cycle 2|Protocol Violation|0
5098334|NCT01956123|17604706|P2|COS Cycle 2|Protocol Violation|3
5098335|NCT01956123|17604707|P1|COS Cycle 2|Protocol Violation|8
5098336|NCT01956110|17604759|P2|Overall Study|Personal reasons|1
5098337|NCT01956110|17604760|P1|Overall Study|Personal reasons|1
5098338|NCT01956110|17604759|P2|Overall Study|Adverse Event|10
5098339|NCT01956110|17604760|P1|Overall Study|Adverse Event|9
5098340|NCT01956110|17604759|P2|Overall Study|Protocol Violation|11
5098341|NCT01956110|17604760|P1|Overall Study|Protocol Violation|25
5098342|NCT01955733|17604926|P3|Period 2|Other not defined above|2
5098343|NCT01955733|17604927|P2|Period 2|Other not defined above|2
5098344|NCT01955733|17604928|P1|Period 2|Other not defined above|0
5098345|NCT01955733|17604926|P3|Period 2|Lost to Follow-up|0
5098346|NCT01955733|17604927|P2|Period 2|Lost to Follow-up|0
5098347|NCT01955733|17604928|P1|Period 2|Lost to Follow-up|2
5098348|NCT01955733|17604926|P3|Period 2|Study terminated by sponsor|16
5098349|NCT01955733|17604927|P2|Period 2|Study terminated by sponsor|14
5098350|NCT01955733|17604928|P1|Period 2|Study terminated by sponsor|8
5098351|NCT01955733|17604926|P3|Period 2|Withdrawal by Subject|2
5098352|NCT01955733|17604927|P2|Period 2|Withdrawal by Subject|3
5098353|NCT01955733|17604928|P1|Period 2|Withdrawal by Subject|1
5098354|NCT01955733|17604926|P3|Period 2|Physician Decision|1
5098355|NCT01955733|17604927|P2|Period 2|Physician Decision|0
5098356|NCT01955733|17604928|P1|Period 2|Physician Decision|0
5098357|NCT01955733|17604926|P3|Period 2|Adverse Event|0
5098358|NCT01955733|17604927|P2|Period 2|Adverse Event|0
5098359|NCT01955733|17604928|P1|Period 2|Adverse Event|1
5098360|NCT01955733|17604926|P3|Period 1|Lost to Follow-up|0
5098361|NCT01955733|17604927|P2|Period 1|Lost to Follow-up|0
5098362|NCT01955733|17604928|P1|Period 1|Lost to Follow-up|1
5098363|NCT01955707|17605021|P2|Overall Study|Other|2
5098364|NCT01955707|17605022|P1|Overall Study|Other|4
5098365|NCT01955707|17605021|P2|Overall Study|Death|14
5098366|NCT01955707|17605022|P1|Overall Study|Death|13
5098367|NCT01955707|17605021|P2|Overall Study|Withdrawal by Subject|3
5098368|NCT01955707|17605022|P1|Overall Study|Withdrawal by Subject|0
5098369|NCT01955707|17605021|P2|Overall Study|Lost to Follow-up|1
5098370|NCT01955707|17605022|P1|Overall Study|Lost to Follow-up|2
5098371|NCT01955707|17605021|P2|Overall Study|Adverse Event|2
5098372|NCT01955707|17605022|P1|Overall Study|Adverse Event|1
5098373|NCT01955161|17605290|P3|Overall Study|Other reason: patient's will|1
5098374|NCT01955161|17605291|P2|Overall Study|Other reason: patient's will|0
5098375|NCT01955161|17605292|P1|Overall Study|Other reason: patient's will|0
5098376|NCT01955161|17605290|P3|Overall Study|Other reason: primary biliary cirrhosis|0
5098377|NCT01955161|17605291|P2|Overall Study|Other reason: primary biliary cirrhosis|0
5098378|NCT01955161|17605292|P1|Overall Study|Other reason: primary biliary cirrhosis|1
5098379|NCT01955161|17605290|P3|Overall Study|Other reason: insufficient compliance|1
5098380|NCT01955161|17605291|P2|Overall Study|Other reason: insufficient compliance|0
5098381|NCT01955161|17605292|P1|Overall Study|Other reason: insufficient compliance|0
5098382|NCT01955161|17605290|P3|Overall Study|Other reason: moved to nursing home|0
5098383|NCT01955161|17605291|P2|Overall Study|Other reason: moved to nursing home|1
5098384|NCT01955161|17605292|P1|Overall Study|Other reason: moved to nursing home|0
5098385|NCT01955161|17605290|P3|Overall Study|Other reason: caregiver unavailable|0
5098386|NCT01955161|17605291|P2|Overall Study|Other reason: caregiver unavailable|0
5098387|NCT01955161|17605292|P1|Overall Study|Other reason: caregiver unavailable|1
5098388|NCT01955161|17605290|P3|Overall Study|Other reason: disallowed medication|1
5098389|NCT01955161|17605291|P2|Overall Study|Other reason: disallowed medication|0
5098390|NCT01955161|17605292|P1|Overall Study|Other reason: disallowed medication|1
5098391|NCT01955161|17605290|P3|Overall Study|Other reason: physician decision|1
5098392|NCT01955161|17605291|P2|Overall Study|Other reason: physician decision|1
5098393|NCT01955161|17605292|P1|Overall Study|Other reason: physician decision|0
5098394|NCT01955161|17605290|P3|Overall Study|Protocol Violation|0
5098395|NCT01955161|17605291|P2|Overall Study|Protocol Violation|0
5098396|NCT01955161|17605292|P1|Overall Study|Protocol Violation|2
5098397|NCT01955161|17605290|P3|Overall Study|Withdrawal by Subject|12
5098398|NCT01955161|17605291|P2|Overall Study|Withdrawal by Subject|8
5098399|NCT01955161|17605292|P1|Overall Study|Withdrawal by Subject|9
5098400|NCT01955161|17605290|P3|Overall Study|Death|3
5098401|NCT01955161|17605291|P2|Overall Study|Death|1
5098402|NCT01955161|17605292|P1|Overall Study|Death|1
5098403|NCT01955161|17605290|P3|Overall Study|Adverse Event|15
5098404|NCT01955161|17605291|P2|Overall Study|Adverse Event|14
5098405|NCT01955161|17605292|P1|Overall Study|Adverse Event|10
5098406|NCT01955161|17605290|P3|Overall Study|Withdrawal before treatment|1
5098407|NCT01955161|17605291|P2|Overall Study|Withdrawal before treatment|0
5098408|NCT01955161|17605292|P1|Overall Study|Withdrawal before treatment|2
5098409|NCT01955122|17605332|P2|Overall Study|Physician Decision|5
5098410|NCT01955122|17605333|P1|Overall Study|Physician Decision|5
5098411|NCT01955083|17605353|P2|Overall Study|Lost to Follow-up|1
5098412|NCT01955083|17605354|P1|Overall Study|Lost to Follow-up|1
5098413|NCT01955044|17605387|P3|Overall Study|Death|0
5098414|NCT01955044|17605388|P2|Overall Study|Death|1
5098415|NCT01955044|17605389|P1|Overall Study|Death|1
5098416|NCT01955005|17605402|P2|Overall Study|Withdrawal by Subject|5
5098417|NCT01955005|17605403|P1|Overall Study|Withdrawal by Subject|3
5098418|NCT01954927|17605415|P2|Overall Study|Withdrawal by Subject|1
5098419|NCT01954927|17605416|P1|Overall Study|Withdrawal by Subject|3
5098420|NCT01954771|17605437|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
5098421|NCT01954771|17605438|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
5098422|NCT01954771|17605439|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
5098423|NCT01954771|17605437|P3|Overall Study|Missing CGMS of end-point|0
5098424|NCT01954771|17605438|P2|Overall Study|Missing CGMS of end-point|1
5098425|NCT01954771|17605439|P1|Overall Study|Missing CGMS of end-point|1
5098426|NCT01954771|17605437|P3|Overall Study|Missing HbA1c of end-point|0
5098427|NCT01954771|17605438|P2|Overall Study|Missing HbA1c of end-point|1
5098428|NCT01954771|17605439|P1|Overall Study|Missing HbA1c of end-point|1
5098429|NCT01954745|17605456|P1|Overall Study|Death|1
5098430|NCT01954745|17605456|P1|Overall Study|Adverse Event|2
5098431|NCT01954745|17605456|P1|Overall Study|Clinical Progression|5
5098432|NCT01954745|17605456|P1|Overall Study|Radiological Progression|11
5098433|NCT01954394|17605487|P2|Overall Study|Other than specified above|21
5098434|NCT01954394|17605488|P1|Overall Study|Other than specified above|10
5098435|NCT01954394|17605487|P2|Overall Study|Related to Study Drug administration|2
5098436|NCT01954394|17605488|P1|Overall Study|Related to Study Drug administration|2
5098437|NCT01954394|17605487|P2|Overall Study|Participant Moved|4
5098438|NCT01954394|17605488|P1|Overall Study|Participant Moved|0
5098439|NCT01954394|17605487|P2|Overall Study|Poor compliance to protocol|7
5098440|NCT01954394|17605488|P1|Overall Study|Poor compliance to protocol|7
5098441|NCT01954394|17605487|P2|Overall Study|Adverse Event|23
5098442|NCT01954394|17605488|P1|Overall Study|Adverse Event|10
5098443|NCT01954394|17605487|P2|Overall Study|Enrolled but not treated|0
5098444|NCT01954394|17605488|P1|Overall Study|Enrolled but not treated|1
5098445|NCT01954342|17605542|P4|Overall Study|Unreliable Data|2
5098446|NCT01954342|17605543|P3|Overall Study|Unreliable Data|0
5098447|NCT01954342|17605544|P2|Overall Study|Unreliable Data|0
5098448|NCT01954342|17605545|P1|Overall Study|Unreliable Data|0
5098449|NCT01954342|17605542|P4|Overall Study|Pre-eclampsia|4
5098450|NCT01954342|17605543|P3|Overall Study|Pre-eclampsia|0
5098451|NCT01954342|17605544|P2|Overall Study|Pre-eclampsia|0
5098452|NCT01954342|17605545|P1|Overall Study|Pre-eclampsia|0
5098453|NCT01954342|17605542|P4|Overall Study|Preterm delivery|3
5098454|NCT01954342|17605543|P3|Overall Study|Preterm delivery|0
5098455|NCT01954342|17605544|P2|Overall Study|Preterm delivery|0
5098456|NCT01954342|17605545|P1|Overall Study|Preterm delivery|0
5098457|NCT01954342|17605542|P4|Overall Study|Lost to Follow-up|5
5098458|NCT01954342|17605543|P3|Overall Study|Lost to Follow-up|0
5098459|NCT01954342|17605544|P2|Overall Study|Lost to Follow-up|0
5098460|NCT01954342|17605545|P1|Overall Study|Lost to Follow-up|0
5098461|NCT01954342|17605542|P4|Overall Study|Miscarriage|3
5098462|NCT01954342|17605543|P3|Overall Study|Miscarriage|0
5098463|NCT01954342|17605544|P2|Overall Study|Miscarriage|0
5098464|NCT01954342|17605545|P1|Overall Study|Miscarriage|0
5098465|NCT01954342|17605542|P4|Overall Study|Missing data from 13-16week study visit|1
5098466|NCT01954342|17605543|P3|Overall Study|Missing data from 13-16week study visit|0
5098467|NCT01954342|17605544|P2|Overall Study|Missing data from 13-16week study visit|0
5098468|NCT01954342|17605545|P1|Overall Study|Missing data from 13-16week study visit|0
5098469|NCT01954251|17605647|P2|Overall Study|Withdrawal by Subject|6
5098470|NCT01954251|17605648|P1|Overall Study|Withdrawal by Subject|2
5098471|NCT01954251|17605647|P2|Overall Study|Lost to Follow-up|6
5098472|NCT01954251|17605648|P1|Overall Study|Lost to Follow-up|6
5098473|NCT01954251|17605647|P2|Overall Study|Adverse Event|7
5098474|NCT01954251|17605648|P1|Overall Study|Adverse Event|5
5098475|NCT01954121|17605745|P2|Overall Study|Subject did not follow instructions|2
5098476|NCT01954121|17605746|P1|Overall Study|Subject did not follow instructions|0
5098477|NCT01954121|17605745|P2|Overall Study|Non-compliant patient|1
5098478|NCT01954121|17605746|P1|Overall Study|Non-compliant patient|1
5098479|NCT01954121|17605745|P2|Overall Study|Non-compliant with study procedures|0
5098480|NCT01954121|17605746|P1|Overall Study|Non-compliant with study procedures|1
5098481|NCT01954121|17605745|P2|Overall Study|SAE, non-fatal|4
5098482|NCT01954121|17605746|P1|Overall Study|SAE, non-fatal|1
5098483|NCT01954121|17605745|P2|Overall Study|AE, non-serious non-fatal|22
5098484|NCT01954121|17605746|P1|Overall Study|AE, non-serious non-fatal|5
5098485|NCT01954121|17605745|P2|Overall Study|AE, serious fatal|0
5098486|NCT01954121|17605746|P1|Overall Study|AE, serious fatal|1
5098487|NCT01954121|17605745|P2|Overall Study|Pregnancy|1
5098488|NCT01954121|17605746|P1|Overall Study|Pregnancy|1
5098489|NCT01954121|17605745|P2|Overall Study|Withdrawal by Subject|12
5098490|NCT01954121|17605746|P1|Overall Study|Withdrawal by Subject|18
5098491|NCT01954121|17605745|P2|Overall Study|Lost to Follow-up|6
5098492|NCT01954121|17605746|P1|Overall Study|Lost to Follow-up|5
5098493|NCT01954121|17605745|P2|Overall Study|Protocol Violation|2
5098494|NCT01954121|17605746|P1|Overall Study|Protocol Violation|0
5098495|NCT01954121|17605745|P2|Overall Study|Lack of Efficacy|41
5098496|NCT01954121|17605746|P1|Overall Study|Lack of Efficacy|94
5098497|NCT01954082|17605762|P2|Overall Study|Randomized not Treated|2
5098498|NCT01954082|17605763|P1|Overall Study|Randomized not Treated|4
5098499|NCT01954082|17605762|P2|Overall Study|Infant Moved|1
5098500|NCT01954082|17605763|P1|Overall Study|Infant Moved|0
5098501|NCT01954082|17605762|P2|Overall Study|Comfort Care|1
5098502|NCT01954082|17605763|P1|Overall Study|Comfort Care|0
5098503|NCT01954082|17605762|P2|Overall Study|Miscalculation of Final Dose Day|3
5098504|NCT01954082|17605763|P1|Overall Study|Miscalculation of Final Dose Day|0
5098505|NCT01954082|17605762|P2|Overall Study|Redirection of Care|2
5098506|NCT01954082|17605763|P1|Overall Study|Redirection of Care|0
5098507|NCT01954082|17605762|P2|Overall Study|Discontinued Early Prior to Transfer|2
5098508|NCT01954082|17605763|P1|Overall Study|Discontinued Early Prior to Transfer|3
5098509|NCT01954082|17605762|P2|Overall Study|Withdrawal by Subject|1
5098510|NCT01954082|17605763|P1|Overall Study|Withdrawal by Subject|0
5098511|NCT01954082|17605762|P2|Overall Study|Parent Decision|0
5098512|NCT01954082|17605763|P1|Overall Study|Parent Decision|1
5098513|NCT01954082|17605762|P2|Overall Study|Physician Decision|0
5098514|NCT01954082|17605763|P1|Overall Study|Physician Decision|2
5098515|NCT01954082|17605762|P2|Overall Study|Non-compliance|4
5098516|NCT01954082|17605763|P1|Overall Study|Non-compliance|6
5098517|NCT01954082|17605762|P2|Overall Study|Intolerance|1
5098518|NCT01954082|17605763|P1|Overall Study|Intolerance|0
5098519|NCT01954082|17605762|P2|Overall Study|Adverse Event|4
5098520|NCT01954082|17605763|P1|Overall Study|Adverse Event|10
5098521|NCT01954082|17605762|P2|Overall Study|Study Suspension|36
5098522|NCT01954082|17605763|P1|Overall Study|Study Suspension|42
5098523|NCT01954056|17605783|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
5098524|NCT01954056|17605784|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
5098525|NCT01954017|17605829|P3|Overall Study|All other reasons|7
5098526|NCT01954017|17605830|P2|Overall Study|All other reasons|2
5098527|NCT01954017|17605831|P1|Overall Study|All other reasons|2
5098528|NCT01954017|17605829|P3|Overall Study|Enteral intake stopped >7 days|1
5098529|NCT01954017|17605830|P2|Overall Study|Enteral intake stopped >7 days|1
5098530|NCT01954017|17605831|P1|Overall Study|Enteral intake stopped >7 days|0
5098531|NCT01954017|17605829|P3|Overall Study|Necrotizing enterocolitis|1
5098532|NCT01954017|17605830|P2|Overall Study|Necrotizing enterocolitis|0
5098533|NCT01954017|17605831|P1|Overall Study|Necrotizing enterocolitis|1
5098534|NCT01954017|17605829|P3|Overall Study|Protocol Violation|2
5098535|NCT01954017|17605830|P2|Overall Study|Protocol Violation|3
5098536|NCT01954017|17605831|P1|Overall Study|Protocol Violation|0
5098537|NCT01954017|17605829|P3|Overall Study|Withdrawal by Subject|0
5098538|NCT01954017|17605830|P2|Overall Study|Withdrawal by Subject|1
5098539|NCT01954017|17605831|P1|Overall Study|Withdrawal by Subject|0
5098540|NCT01954017|17605829|P3|Overall Study|Death|1
5098541|NCT01954017|17605830|P2|Overall Study|Death|1
5098542|NCT01954017|17605831|P1|Overall Study|Death|2
5098543|NCT01954017|17605829|P3|Overall Study|Adverse Event|1
5098544|NCT01954017|17605830|P2|Overall Study|Adverse Event|0
5098545|NCT01954017|17605831|P1|Overall Study|Adverse Event|0
5098546|NCT01953913|17606057|P1|Overall Study|Not Treated|1
5098547|NCT01953913|17606057|P1|Overall Study|Other than listed|108
5098548|NCT01953913|17606057|P1|Overall Study|Withdrawal by Subject|32
5098549|NCT01953913|17606057|P1|Overall Study|Lost to Follow-up|4
5098550|NCT01953913|17606057|P1|Overall Study|Protocol Violation|6
5098551|NCT01953913|17606057|P1|Overall Study|Adverse Event|20
5098552|NCT01953913|17606057|P1|Overall Study|Worsening of underlying cancer|22
5098553|NCT01953913|17606057|P1|Overall Study|Disease Progression|349
5098554|NCT01953783|17606109|P1|Overall Study|Progressive disease|2
5098555|NCT01953601|17606134|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
5098556|NCT01953601|17606135|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
5098557|NCT01953601|17606136|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
5098558|NCT01953601|17606134|P3|Part 2 (Extension Study)|Subject moved|1
5098559|NCT01953601|17606135|P2|Part 2 (Extension Study)|Subject moved|0
5098560|NCT01953601|17606136|P1|Part 2 (Extension Study)|Subject moved|0
5098561|NCT01953601|17606134|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
5098562|NCT01953601|17606135|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
5098563|NCT01953601|17606136|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
5098564|NCT01953601|17606134|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
5098565|NCT01953601|17606135|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
5098566|NCT01953601|17606136|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
5098567|NCT01953601|17606134|P3|Part 2 (Extension Study)|Site discontinued study participation|1
5098568|NCT01953601|17606135|P2|Part 2 (Extension Study)|Site discontinued study participation|1
5098569|NCT01953601|17606136|P1|Part 2 (Extension Study)|Site discontinued study participation|0
5098570|NCT01953601|17606134|P3|Part 2 (Extension Study)|Physician Decision|2
5098571|NCT01953601|17606135|P2|Part 2 (Extension Study)|Physician Decision|0
5098572|NCT01953601|17606136|P1|Part 2 (Extension Study)|Physician Decision|2
5098573|NCT01953601|17606134|P3|Part 2 (Extension Study)|Lost to Follow-up|1
5098574|NCT01953601|17606135|P2|Part 2 (Extension Study)|Lost to Follow-up|1
5098575|NCT01953601|17606136|P1|Part 2 (Extension Study)|Lost to Follow-up|2
5098576|NCT01953601|17606134|P3|Part 2 (Extension Study)|Lack of Efficacy|0
5098577|NCT01953601|17606135|P2|Part 2 (Extension Study)|Lack of Efficacy|0
5098578|NCT01953601|17606136|P1|Part 2 (Extension Study)|Lack of Efficacy|2
5098579|NCT01953601|17606134|P3|Part 2 (Extension Study)|Death|0
5098580|NCT01953601|17606135|P2|Part 2 (Extension Study)|Death|3
5098581|NCT01953601|17606136|P1|Part 2 (Extension Study)|Death|0
5098582|NCT01953601|17606134|P3|Part 2 (Extension Study)|Adverse Event|10
5098583|NCT01953601|17606135|P2|Part 2 (Extension Study)|Adverse Event|1
5098584|NCT01953601|17606136|P1|Part 2 (Extension Study)|Adverse Event|1
5098585|NCT01953601|17606134|P3|Part 1 (Base Study)|Withdrawal by Subject|22
5098586|NCT01953601|17606135|P2|Part 1 (Base Study)|Withdrawal by Subject|23
5098587|NCT01953601|17606136|P1|Part 1 (Base Study)|Withdrawal by Subject|32
5098588|NCT01953601|17606134|P3|Part 1 (Base Study)|Subject moved|1
5098589|NCT01953601|17606135|P2|Part 1 (Base Study)|Subject moved|2
5098590|NCT01953601|17606136|P1|Part 1 (Base Study)|Subject moved|2
5098591|NCT01953601|17606134|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
5098592|NCT01953601|17606135|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
5098593|NCT01953601|17606136|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
5098594|NCT01953601|17606134|P3|Part 1 (Base Study)|Study terminated by sponsor|179
5098595|NCT01953601|17606135|P2|Part 1 (Base Study)|Study terminated by sponsor|169
5098596|NCT01953601|17606136|P1|Part 1 (Base Study)|Study terminated by sponsor|174
5098597|NCT01953601|17606134|P3|Part 1 (Base Study)|Site discontinued study participation|0
5098598|NCT01953601|17606135|P2|Part 1 (Base Study)|Site discontinued study participation|0
5098599|NCT01953601|17606136|P1|Part 1 (Base Study)|Site discontinued study participation|2
5098600|NCT01953601|17606134|P3|Part 1 (Base Study)|Screen failure|1
5098601|NCT01953601|17606135|P2|Part 1 (Base Study)|Screen failure|0
5098602|NCT01953601|17606136|P1|Part 1 (Base Study)|Screen failure|1
5098603|NCT01953601|17606134|P3|Part 1 (Base Study)|Physician Decision|4
5098604|NCT01953601|17606135|P2|Part 1 (Base Study)|Physician Decision|7
5098605|NCT01953601|17606136|P1|Part 1 (Base Study)|Physician Decision|3
5098606|NCT01953601|17606134|P3|Part 1 (Base Study)|Non-compliance with study drug|1
5098607|NCT01953601|17606135|P2|Part 1 (Base Study)|Non-compliance with study drug|3
5098608|NCT01953601|17606136|P1|Part 1 (Base Study)|Non-compliance with study drug|0
5098609|NCT01953601|17606134|P3|Part 1 (Base Study)|Lost to Follow-up|6
5098610|NCT01953601|17606135|P2|Part 1 (Base Study)|Lost to Follow-up|3
5098611|NCT01953601|17606136|P1|Part 1 (Base Study)|Lost to Follow-up|1
5098612|NCT01953601|17606134|P3|Part 1 (Base Study)|Lack of Efficacy|4
5098613|NCT01953601|17606135|P2|Part 1 (Base Study)|Lack of Efficacy|1
5098614|NCT01953601|17606136|P1|Part 1 (Base Study)|Lack of Efficacy|3
5098615|NCT01953601|17606134|P3|Part 1 (Base Study)|Death|3
5098616|NCT01953601|17606135|P2|Part 1 (Base Study)|Death|0
5098617|NCT01953601|17606136|P1|Part 1 (Base Study)|Death|2
5098618|NCT01953601|17606134|P3|Part 1 (Base Study)|Adverse Event|15
5098619|NCT01953601|17606135|P2|Part 1 (Base Study)|Adverse Event|37
5098620|NCT01953601|17606136|P1|Part 1 (Base Study)|Adverse Event|24
5098621|NCT01953354|17606207|P2|Overall Study|Disease Exacerbation|0
5098622|NCT01953354|17606208|P1|Overall Study|Disease Exacerbation|1
5098623|NCT01953354|17606207|P2|Overall Study|Decision of Sponsor|1
5098624|NCT01953354|17606208|P1|Overall Study|Decision of Sponsor|0
5098625|NCT01953354|17606207|P2|Overall Study|Withdrawal by Subject|1
5098626|NCT01953354|17606208|P1|Overall Study|Withdrawal by Subject|0
5098627|NCT01953328|17606236|P8|Overall Study|Lost to Follow-up|0
5098628|NCT01953328|17606237|P7|Overall Study|Lost to Follow-up|0
5098629|NCT01953328|17606238|P6|Overall Study|Lost to Follow-up|0
5098630|NCT01953328|17606239|P5|Overall Study|Lost to Follow-up|1
5098631|NCT01953328|17606240|P4|Overall Study|Lost to Follow-up|0
5098632|NCT01953328|17606241|P3|Overall Study|Lost to Follow-up|0
5098633|NCT01953328|17606242|P2|Overall Study|Lost to Follow-up|0
5098634|NCT01953328|17606243|P1|Overall Study|Lost to Follow-up|0
5098635|NCT01953328|17606236|P8|Overall Study|Withdrawal by Subject|0
5098636|NCT01953328|17606237|P7|Overall Study|Withdrawal by Subject|0
5098637|NCT01953328|17606238|P6|Overall Study|Withdrawal by Subject|0
5098638|NCT01953328|17606239|P5|Overall Study|Withdrawal by Subject|1
5098639|NCT01953328|17606240|P4|Overall Study|Withdrawal by Subject|0
5098640|NCT01953328|17606241|P3|Overall Study|Withdrawal by Subject|0
5098641|NCT01953328|17606242|P2|Overall Study|Withdrawal by Subject|0
5098642|NCT01953328|17606243|P1|Overall Study|Withdrawal by Subject|0
5098643|NCT01953224|17606456|P2|Overall Study|Withdrawal by Subject|2
5098644|NCT01953224|17606457|P1|Overall Study|Withdrawal by Subject|1
5098645|NCT01953224|17606456|P2|Overall Study|Lost to Follow-up|1
5098646|NCT01953224|17606457|P1|Overall Study|Lost to Follow-up|1
5098647|NCT01953003|17606506|P2|Overall Study|Withdrawal by Subject|4
5098648|NCT01953003|17606507|P1|Overall Study|Withdrawal by Subject|14
5098649|NCT01953003|17606506|P2|Overall Study|Protocol Violation|1
5098650|NCT01953003|17606507|P1|Overall Study|Protocol Violation|0
5098651|NCT01953003|17606506|P2|Overall Study|Non-related adverse events|2
5098652|NCT01953003|17606507|P1|Overall Study|Non-related adverse events|0
5098653|NCT01953003|17606506|P2|Overall Study|Related Adverse events|2
5098654|NCT01953003|17606507|P1|Overall Study|Related Adverse events|7
5098655|NCT01953003|17606506|P2|Overall Study|Progressive disease|45
5098656|NCT01953003|17606507|P1|Overall Study|Progressive disease|35
5098657|NCT01953003|17606506|P2|Overall Study|Not treated|1
5098658|NCT01953003|17606507|P1|Overall Study|Not treated|0
5098659|NCT01952834|17606513|P1|Overall Study|Adverse Event|1
5098660|NCT01952691|17606520|P1|Overall Study|Lost to Follow-up|2
5098661|NCT01952665|17606547|P2|Overall Study|Protocol Violation|1
5098662|NCT01952665|17606548|P1|Overall Study|Protocol Violation|0
5098663|NCT01952665|17606547|P2|Overall Study|Adverse Event|1
5098664|NCT01952665|17606548|P1|Overall Study|Adverse Event|2
5098665|NCT01952665|17606547|P2|Overall Study|Lost to Follow-up|2
5098666|NCT01952665|17606548|P1|Overall Study|Lost to Follow-up|1
5098667|NCT01952665|17606547|P2|Overall Study|Physician Decision|2
5098668|NCT01952665|17606548|P1|Overall Study|Physician Decision|3
5098669|NCT01952574|17606703|P4|Overall Study|Lost to Follow-up|0
5098670|NCT01952574|17606704|P3|Overall Study|Lost to Follow-up|1
5098671|NCT01952574|17606705|P2|Overall Study|Lost to Follow-up|0
5098672|NCT01952574|17606706|P1|Overall Study|Lost to Follow-up|2
5098673|NCT01952574|17606703|P4|Overall Study|Sponsor Decision|2
5098674|NCT01952574|17606704|P3|Overall Study|Sponsor Decision|5
5098675|NCT01952574|17606705|P2|Overall Study|Sponsor Decision|0
5098676|NCT01952574|17606706|P1|Overall Study|Sponsor Decision|6
5098677|NCT01952574|17606703|P4|Overall Study|Withdrawal by Subject|4
5098678|NCT01952574|17606704|P3|Overall Study|Withdrawal by Subject|3
5098679|NCT01952574|17606705|P2|Overall Study|Withdrawal by Subject|3
5098680|NCT01952574|17606706|P1|Overall Study|Withdrawal by Subject|9
5098681|NCT01952366|17606805|P1|Overall Study|Withdrawal by Subject|9
5098682|NCT01952366|17606805|P1|Overall Study|Death|22
5098683|NCT01952145|17606820|P2|Overall Study|Unclassified|1
5098684|NCT01952145|17606821|P1|Overall Study|Unclassified|1
5098685|NCT01952145|17606820|P2|Overall Study|Withdrawal Criteria|11
5098686|NCT01952145|17606821|P1|Overall Study|Withdrawal Criteria|16
5098687|NCT01952145|17606820|P2|Overall Study|Adverse Event|0
5098688|NCT01952145|17606821|P1|Overall Study|Adverse Event|9
5098689|NCT01952145|17606820|P2|Overall Study|Death|1
5098690|NCT01952145|17606821|P1|Overall Study|Death|0
5098691|NCT01952145|17606820|P2|Overall Study|Protocol Violation|1
5098692|NCT01952145|17606821|P1|Overall Study|Protocol Violation|2
5098693|NCT01952080|17606835|P4|Overall Study|Protocol Non-compliance|0
5098694|NCT01952080|17606836|P3|Overall Study|Protocol Non-compliance|0
5098695|NCT01952080|17606837|P2|Overall Study|Protocol Non-compliance|1
5098696|NCT01952080|17606838|P1|Overall Study|Protocol Non-compliance|0
5098697|NCT01952080|17606835|P4|Overall Study|Withdrawal by Subject|1
5098698|NCT01952080|17606836|P3|Overall Study|Withdrawal by Subject|0
5098699|NCT01952080|17606837|P2|Overall Study|Withdrawal by Subject|0
5098700|NCT01952080|17606838|P1|Overall Study|Withdrawal by Subject|0
5098701|NCT01952054|17606884|P1|Overall Study|Physician Decision|1
5098702|NCT01952041|17606892|P2|Overall Study|Death|0
5098703|NCT01952041|17606893|P1|Overall Study|Death|1
5098704|NCT01952041|17606892|P2|Overall Study|Withdrawal by Subject|5
5098705|NCT01952041|17606893|P1|Overall Study|Withdrawal by Subject|7
5098706|NCT01952041|17606892|P2|Overall Study|Lost to Follow-up|16
5098707|NCT01952041|17606893|P1|Overall Study|Lost to Follow-up|9
5098708|NCT01952015|17606907|P1|Treatment Period 3|Physician Decision|9
5098709|NCT01952015|17606907|P1|Maintenance|Adverse Event|2
5098710|NCT01952015|17606907|P1|Induction|Protocol Violation|1
5098711|NCT01951703|17606974|P2|Second Intervention|Unsatisfactory Lens fitting|1
5098712|NCT01951703|17606975|P1|Second Intervention|Unsatisfactory Lens fitting|0
5098713|NCT01951703|17606974|P2|Second Intervention|Protocol Violation|1
5098714|NCT01951703|17606975|P1|Second Intervention|Protocol Violation|0
5098715|NCT01951703|17606974|P2|First Intervention|Physician Decision|0
5098716|NCT01951703|17606975|P1|First Intervention|Physician Decision|1
5098717|NCT01951703|17606974|P2|First Intervention|Subject was not compliant|1
5098718|NCT01951703|17606975|P1|First Intervention|Subject was not compliant|1
5098719|NCT01951703|17606974|P2|First Intervention|Withdrawal by Subject|0
5098720|NCT01951703|17606975|P1|First Intervention|Withdrawal by Subject|1
5098721|NCT01951586|17607000|P2|Overall Study|Sponsor Decision|10
5098722|NCT01951586|17607001|P1|Overall Study|Sponsor Decision|9
5098723|NCT01951586|17607000|P2|Overall Study|Lost to Follow-up|1
5098724|NCT01951586|17607001|P1|Overall Study|Lost to Follow-up|0
5098725|NCT01951586|17607000|P2|Overall Study|Withdrawal by Subject|17
5098726|NCT01951586|17607001|P1|Overall Study|Withdrawal by Subject|8
5098727|NCT01951586|17607000|P2|Overall Study|Death|120
5098728|NCT01951586|17607001|P1|Overall Study|Death|61
5098729|NCT01951573|17607025|P2|Washout Period|Adverse Event|1
5098730|NCT01951573|17607026|P1|Washout Period|Adverse Event|0
5098731|NCT01951417|17607036|P1|Overall Study|Lost to Follow-up|6
5098732|NCT01951417|17607036|P1|Overall Study|Protocol Violation|2
5098733|NCT01951417|17607036|P1|Overall Study|Withdrawal by Subject|1
5098734|NCT01951378|17607072|P2|Overall Study|Study Terminated-Not completed|17
5098735|NCT01951378|17607073|P1|Overall Study|Study Terminated-Not completed|23
5098736|NCT01951261|17607150|P2|Overall Study|Protocol Violation|3
5098737|NCT01951261|17607151|P1|Overall Study|Protocol Violation|4
5098738|NCT01951261|17607150|P2|Overall Study|Lost to Follow-up|3
5098739|NCT01951261|17607151|P1|Overall Study|Lost to Follow-up|4
5098740|NCT01951261|17607150|P2|Overall Study|Death|0
5098741|NCT01951261|17607151|P1|Overall Study|Death|1
5098742|NCT01951170|17607169|P1|Overall Study|Investigator decision|1
5098743|NCT01951157|17607195|P3|Overall Study|Treatment-related death|0
5098744|NCT01951157|17607196|P2|Overall Study|Treatment-related death|2
5098745|NCT01951157|17607197|P1|Overall Study|Treatment-related death|0
5098746|NCT01951157|17607195|P3|Overall Study|Consent withdrawn by subject|3
5098747|NCT01951157|17607196|P2|Overall Study|Consent withdrawn by subject|1
5098748|NCT01951157|17607197|P1|Overall Study|Consent withdrawn by subject|0
5098749|NCT01951157|17607195|P3|Overall Study|Treatment-related AE|4
5098750|NCT01951157|17607196|P2|Overall Study|Treatment-related AE|0
5098751|NCT01951157|17607197|P1|Overall Study|Treatment-related AE|2
5098752|NCT01951157|17607195|P3|Overall Study|No treated|0
5098753|NCT01951157|17607196|P2|Overall Study|No treated|1
5098754|NCT01951157|17607197|P1|Overall Study|No treated|0
5098755|NCT01951157|17607195|P3|Overall Study|Non-treatmentrelated death|2
5098756|NCT01951157|17607196|P2|Overall Study|Non-treatmentrelated death|2
5098757|NCT01951157|17607197|P1|Overall Study|Non-treatmentrelated death|2
5098758|NCT01951157|17607195|P3|Overall Study|Physician Decision|2
5098759|NCT01951157|17607196|P2|Overall Study|Physician Decision|3
5098760|NCT01951157|17607197|P1|Overall Study|Physician Decision|5
5098761|NCT01951157|17607195|P3|Overall Study|Study Termination|1
5098762|NCT01951157|17607196|P2|Overall Study|Study Termination|0
5098763|NCT01951157|17607197|P1|Overall Study|Study Termination|0
5098764|NCT01951157|17607195|P3|Overall Study|Treatment-unrelated AE|3
5098765|NCT01951157|17607196|P2|Overall Study|Treatment-unrelated AE|0
5098766|NCT01951157|17607197|P1|Overall Study|Treatment-unrelated AE|1
5098767|NCT01951157|17607195|P3|Overall Study|Progressive Disease|10
5098768|NCT01951157|17607196|P2|Overall Study|Progressive Disease|13
5098769|NCT01951157|17607197|P1|Overall Study|Progressive Disease|12
5098770|NCT01951105|17607248|P3|Overall Study|Withdrawal by Subject|1
5098771|NCT01951105|17607249|P2|Overall Study|Withdrawal by Subject|3
5098772|NCT01951105|17607250|P1|Overall Study|Withdrawal by Subject|0
5098773|NCT01951105|17607248|P3|Overall Study|Protocol Violation|1
5098774|NCT01951105|17607249|P2|Overall Study|Protocol Violation|1
5098775|NCT01951105|17607250|P1|Overall Study|Protocol Violation|1
5098776|NCT01951105|17607248|P3|Overall Study|Lost to Follow-up|0
5098777|NCT01951105|17607249|P2|Overall Study|Lost to Follow-up|1
5098778|NCT01951105|17607250|P1|Overall Study|Lost to Follow-up|0
5098779|NCT01951105|17607248|P3|Overall Study|Adverse Event|0
5098780|NCT01951105|17607249|P2|Overall Study|Adverse Event|5
5098781|NCT01951105|17607250|P1|Overall Study|Adverse Event|0
5098782|NCT01951092|17607264|P1|Overall Study|Transfer of Care|1
5098783|NCT01951092|17607264|P1|Overall Study|Incarceration|1
5098784|NCT01951092|17607264|P1|Overall Study|Lost to Follow-up|10
5098785|NCT01950819|17607277|P2|Overall Study|Lost to Follow-up|17
5098786|NCT01950819|17607278|P1|Overall Study|Lost to Follow-up|9
5098787|NCT01950819|17607277|P2|Overall Study|Pregnancy|2
5098788|NCT01950819|17607278|P1|Overall Study|Pregnancy|0
5098789|NCT01950819|17607277|P2|Overall Study|technical problems|0
5098790|NCT01950819|17607278|P1|Overall Study|technical problems|2
5098791|NCT01950819|17607277|P2|Overall Study|Subject / Gardian decision|51
5098792|NCT01950819|17607278|P1|Overall Study|Subject / Gardian decision|54
5098793|NCT01950819|17607277|P2|Overall Study|Death|34
5098794|NCT01950819|17607278|P1|Overall Study|Death|29
5098795|NCT01950819|17607277|P2|Overall Study|Graft Loss|30
5098796|NCT01950819|17607278|P1|Overall Study|Graft Loss|35
5098797|NCT01950741|17607331|P1|Overall Study|Withdrawal by Subject|1
5098798|NCT01950741|17607331|P1|Overall Study|Death|1
5098799|NCT01950741|17607331|P1|Overall Study|Lost to Follow-up|1
5098800|NCT01950364|17607346|P2|Overall Study|Protocol Violation|1
5098801|NCT01950364|17607347|P1|Overall Study|Protocol Violation|0
5098802|NCT01950364|17607346|P2|Overall Study|Withdrawal by Subject|1
5098803|NCT01950364|17607347|P1|Overall Study|Withdrawal by Subject|0
5098804|NCT01950364|17607346|P2|Overall Study|Disease Progression|2
5098805|NCT01950364|17607347|P1|Overall Study|Disease Progression|5
5098806|NCT01950364|17607346|P2|Overall Study|Stem Cell Transplant|6
5098807|NCT01950364|17607347|P1|Overall Study|Stem Cell Transplant|2
5098808|NCT01950364|17607346|P2|Overall Study|Adverse Event|0
5098809|NCT01950364|17607347|P1|Overall Study|Adverse Event|3
5098810|NCT01950273|17607469|P2|Overall Study|Other not defined above|0
5098811|NCT01950273|17607470|P1|Overall Study|Other not defined above|1
5098812|NCT01950273|17607469|P2|Overall Study|Withdrawal by Subject|0
5098813|NCT01950273|17607470|P1|Overall Study|Withdrawal by Subject|2
5098814|NCT01950273|17607469|P2|Overall Study|Protocol Violation|0
5098815|NCT01950273|17607470|P1|Overall Study|Protocol Violation|1
5098816|NCT01950013|17607517|P3|Overall Study|Withdrawal by Subject|0
5098817|NCT01950013|17607518|P2|Overall Study|Withdrawal by Subject|2
5098818|NCT01950013|17607519|P1|Overall Study|Withdrawal by Subject|0
5098819|NCT01949870|17607530|P1|Overall Study|Eligibility requirements not fulfilled|2
5098820|NCT01949870|17607530|P1|Overall Study|Study termination|1
5098821|NCT01949870|17607530|P1|Overall Study|Adverse Event|1
5098822|NCT01949870|17607530|P1|Overall Study|Lack of Efficacy|2
5098823|NCT01949662|17607546|P2|Overall Study|Ineligible|1
5098824|NCT01949662|17607547|P1|Overall Study|Ineligible|0
5098825|NCT01949662|17607546|P2|Overall Study|Dropped out|3
5098826|NCT01949662|17607547|P1|Overall Study|Dropped out|1
5098827|NCT01949662|17607546|P2|Overall Study|Discharged before an agitation event|3
5098828|NCT01949662|17607547|P1|Overall Study|Discharged before an agitation event|8
5098829|NCT01949662|17607546|P2|Overall Study|Death|7
5098830|NCT01949662|17607547|P1|Overall Study|Death|9
5098831|NCT01949532|17607714|P2|Overall Study|On-study at the Data Cut-off Date|3
5098832|NCT01949532|17607715|P1|Overall Study|On-study at the Data Cut-off Date|3
5098833|NCT01949480|17607785|P2|Overall Study|Physician Decision|8
5098834|NCT01949480|17607786|P1|Overall Study|Physician Decision|5
5098835|NCT01949155|17607832|P2|Overall Study|Protocol Violation|0
5098836|NCT01949155|17607833|P1|Overall Study|Protocol Violation|1
5098837|NCT01949155|17607832|P2|Overall Study|Lost to Follow-up|0
5098838|NCT01949155|17607833|P1|Overall Study|Lost to Follow-up|1
5098839|NCT01949142|17607845|P2|Overall Study|Parent changed their mind|0
5098840|NCT01949142|17607846|P1|Overall Study|Parent changed their mind|1
5098841|NCT01949142|17607845|P2|Overall Study|Lost to Follow-up|1
5098842|NCT01949142|17607846|P1|Overall Study|Lost to Follow-up|1
5098843|NCT01949142|17607845|P2|Overall Study|Withdrawal of consent|0
5098844|NCT01949142|17607846|P1|Overall Study|Withdrawal of consent|1
5098845|NCT01949116|17607858|P2|Overall Study|Withdrawal by Subject|3
5098846|NCT01949116|17607859|P1|Overall Study|Withdrawal by Subject|5
5098847|NCT01949116|17607858|P2|Overall Study|Lost to Follow-up|3
5098848|NCT01949116|17607859|P1|Overall Study|Lost to Follow-up|1
5098849|NCT01949116|17607858|P2|Overall Study|Death|0
5098850|NCT01949116|17607859|P1|Overall Study|Death|2
5098851|NCT01949090|17607896|P5|Overall Study|Lost to Follow-up|1
5098852|NCT01949090|17607897|P4|Overall Study|Lost to Follow-up|1
5098853|NCT01949090|17607898|P3|Overall Study|Lost to Follow-up|0
5098854|NCT01949090|17607899|P2|Overall Study|Lost to Follow-up|1
5098855|NCT01949090|17607900|P1|Overall Study|Lost to Follow-up|2
5098856|NCT01949090|17607896|P5|Overall Study|Protocol non-compliance|1
5098857|NCT01949090|17607897|P4|Overall Study|Protocol non-compliance|0
5098858|NCT01949090|17607898|P3|Overall Study|Protocol non-compliance|0
5098859|NCT01949090|17607899|P2|Overall Study|Protocol non-compliance|0
5098860|NCT01949090|17607900|P1|Overall Study|Protocol non-compliance|0
5098861|NCT01949090|17607896|P5|Overall Study|Withdrawal by Subject|1
5098862|NCT01949090|17607897|P4|Overall Study|Withdrawal by Subject|0
5098863|NCT01949090|17607898|P3|Overall Study|Withdrawal by Subject|0
5098864|NCT01949090|17607899|P2|Overall Study|Withdrawal by Subject|0
5098865|NCT01949090|17607900|P1|Overall Study|Withdrawal by Subject|2
5098866|NCT01949090|17607896|P5|Overall Study|Serious Adverse Event|1
5098867|NCT01949090|17607897|P4|Overall Study|Serious Adverse Event|0
5098868|NCT01949090|17607898|P3|Overall Study|Serious Adverse Event|2
5098869|NCT01949090|17607899|P2|Overall Study|Serious Adverse Event|1
5098870|NCT01949090|17607900|P1|Overall Study|Serious Adverse Event|0
5098871|NCT01949051|17608077|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5098872|NCT01949051|17608078|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5098873|NCT01949051|17608079|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5098874|NCT01949051|17608080|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
5098875|NCT01949051|17608081|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5098876|NCT01949051|17608082|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5098877|NCT01949051|17608077|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5098878|NCT01949051|17608078|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5098879|NCT01949051|17608079|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5098880|NCT01949051|17608080|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5098881|NCT01949051|17608081|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
5098882|NCT01949051|17608082|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5098883|NCT01949051|17608077|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
5098884|NCT01949051|17608078|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
5098885|NCT01949051|17608079|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
5098886|NCT01949051|17608080|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
5098887|NCT01949051|17608081|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
5098888|NCT01949051|17608082|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
5098889|NCT01949051|17608077|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5098890|NCT01949051|17608078|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5098891|NCT01949051|17608079|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5098892|NCT01949051|17608080|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5098893|NCT01949051|17608081|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5098894|NCT01949051|17608082|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
5098895|NCT01949051|17608077|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
5098896|NCT01949051|17608078|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
5098897|NCT01949051|17608079|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
5098898|NCT01949051|17608080|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
5098899|NCT01949051|17608081|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
5098900|NCT01949051|17608082|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
5098901|NCT01948908|17608277|P3|Overall Study|Protocol Violation|2
5098902|NCT01948908|17608278|P2|Overall Study|Protocol Violation|0
5098903|NCT01948908|17608279|P1|Overall Study|Protocol Violation|1
5098904|NCT01948830|17608295|P2|Overall Study|Death|4
5098905|NCT01948830|17608296|P1|Overall Study|Death|3
5098906|NCT01948830|17608295|P2|Overall Study|Adverse Event|2
5098907|NCT01948830|17608296|P1|Overall Study|Adverse Event|9
5098908|NCT01948830|17608295|P2|Overall Study|Withdrawal by Subject|17
5098909|NCT01948830|17608296|P1|Overall Study|Withdrawal by Subject|14
5098910|NCT01948830|17608295|P2|Overall Study|Lost to Follow-up|4
5098911|NCT01948830|17608296|P1|Overall Study|Lost to Follow-up|5
5098912|NCT01948830|17608295|P2|Overall Study|Protocol deviation|2
5098913|NCT01948830|17608296|P1|Overall Study|Protocol deviation|1
5098914|NCT01948830|17608295|P2|Overall Study|Physician Decision|3
5098915|NCT01948830|17608296|P1|Overall Study|Physician Decision|1
5098916|NCT01948791|17608328|P1|Overall Study|Screening failure|35
5098917|NCT01948791|17608328|P1|Overall Study|Others|7
5098918|NCT01948791|17608328|P1|Overall Study|Management issues|1
5098919|NCT01948791|17608328|P1|Overall Study|Lost to Follow-up|6
5098920|NCT01948791|17608328|P1|Overall Study|Withdrawal by Subject|5
5098921|NCT01948791|17608328|P1|Overall Study|Protocol Violation|2
5098922|NCT01948791|17608328|P1|Overall Study|Lack of Efficacy|3
5098923|NCT01948791|17608328|P1|Overall Study|Adverse Event|12
5098924|NCT01948258|17608388|P1|Overall Study|Removed from statistical analysis|2
5098925|NCT01948258|17608388|P1|Overall Study|Health Care Professional|43
5098926|NCT01948258|17608388|P1|Overall Study|Withdrawal by Subject|6
5098927|NCT01948258|17608388|P1|Overall Study|Withdrawal by SPD|8
5098928|NCT01948258|17608388|P1|Overall Study|Lost to Follow-up|27
5098929|NCT01948258|17608388|P1|Overall Study|Did not complete by cut-off date|35
5098930|NCT01948258|17608388|P1|Overall Study|Pregnancy|41
5098931|NCT01948193|17608394|P1|Overall Study|Lost to Follow-up|7
5098932|NCT01948193|17608394|P1|Overall Study|Serious event|2
5098933|NCT01948076|17608416|P2|Overall Study|Withdrawal by Subject|1
5098934|NCT01948076|17608417|P1|Overall Study|Withdrawal by Subject|0
5098935|NCT01948063|17608427|P2|Overall Study|Blood samples were accidentally thawed|0
5098936|NCT01948063|17608428|P1|Overall Study|Blood samples were accidentally thawed|1
5098937|NCT01948063|17608427|P2|Overall Study|Discovered an enrollment in other study|1
5098938|NCT01948063|17608428|P1|Overall Study|Discovered an enrollment in other study|0
5098939|NCT01948063|17608427|P2|Overall Study|Boston MCI halted research protocol|1
5098940|NCT01948063|17608428|P1|Overall Study|Boston MCI halted research protocol|0
5098941|NCT01948050|17608436|P2|Overall Study|Withdrawal by Subject|1
5098942|NCT01948050|17608437|P1|Overall Study|Withdrawal by Subject|0
5098943|NCT01947894|17608505|P3|Overall Study|Switched to other growth hormone brand|23
5098944|NCT01947894|17608506|P2|Overall Study|Switched to other growth hormone brand|8
5098945|NCT01947894|17608507|P1|Overall Study|Switched to other growth hormone brand|53
5098946|NCT01947894|17608505|P3|Overall Study|Adverse Event|0
5098947|NCT01947894|17608506|P2|Overall Study|Adverse Event|1
5098948|NCT01947894|17608507|P1|Overall Study|Adverse Event|5
5098949|NCT01947894|17608505|P3|Overall Study|Physician Decision|0
5098950|NCT01947894|17608506|P2|Overall Study|Physician Decision|0
5098951|NCT01947894|17608507|P1|Overall Study|Physician Decision|2
5098952|NCT01947894|17608505|P3|Overall Study|Death|0
5098953|NCT01947894|17608506|P2|Overall Study|Death|1
5098954|NCT01947894|17608507|P1|Overall Study|Death|12
5098955|NCT01947894|17608505|P3|Overall Study|Withdrawal by Subject|1
5098956|NCT01947894|17608506|P2|Overall Study|Withdrawal by Subject|4
5098957|NCT01947894|17608507|P1|Overall Study|Withdrawal by Subject|12
5098958|NCT01947894|17608505|P3|Overall Study|Other|3
5098959|NCT01947894|17608506|P2|Overall Study|Other|4
5098960|NCT01947894|17608507|P1|Overall Study|Other|3
5098961|NCT01947855|17608572|P3|Overall Study|Withdrawal by Subject|0
5098962|NCT01947855|17608573|P2|Overall Study|Withdrawal by Subject|0
5098963|NCT01947855|17608574|P1|Overall Study|Withdrawal by Subject|1
5098964|NCT01947582|17608609|P1|Overall Study|Withdrawal by Subject|1
5098965|NCT01947517|17608618|P2|Overall Study|Withdrawal by Subject|1
5098966|NCT01947517|17608619|P1|Overall Study|Withdrawal by Subject|1
5098967|NCT01947491|17608637|P4|Overall Study|Adverse Event|2
5098968|NCT01947491|17608638|P3|Overall Study|Adverse Event|0
5098969|NCT01947491|17608639|P2|Overall Study|Adverse Event|1
5098970|NCT01947491|17608640|P1|Overall Study|Adverse Event|0
5098971|NCT01947491|17608637|P4|Overall Study|Worsening of condition|0
5098972|NCT01947491|17608638|P3|Overall Study|Worsening of condition|0
5098973|NCT01947491|17608639|P2|Overall Study|Worsening of condition|1
5098974|NCT01947491|17608640|P1|Overall Study|Worsening of condition|0
5098975|NCT01947491|17608637|P4|Overall Study|Withdrawal by Subject|0
5098976|NCT01947491|17608638|P3|Overall Study|Withdrawal by Subject|1
5098977|NCT01947491|17608639|P2|Overall Study|Withdrawal by Subject|1
5098978|NCT01947491|17608640|P1|Overall Study|Withdrawal by Subject|1
5098979|NCT01947491|17608637|P4|Overall Study|Protocol Violation|0
5098980|NCT01947491|17608638|P3|Overall Study|Protocol Violation|0
5098981|NCT01947491|17608639|P2|Overall Study|Protocol Violation|0
5098982|NCT01947491|17608640|P1|Overall Study|Protocol Violation|1
5098983|NCT01947491|17608637|P4|Overall Study|Lack of Efficacy|1
5098984|NCT01947491|17608638|P3|Overall Study|Lack of Efficacy|0
5098985|NCT01947491|17608639|P2|Overall Study|Lack of Efficacy|0
5098986|NCT01947491|17608640|P1|Overall Study|Lack of Efficacy|1
5098987|NCT01947491|17608637|P4|Overall Study|Lost to Follow-up|2
5098988|NCT01947491|17608638|P3|Overall Study|Lost to Follow-up|1
5098989|NCT01947491|17608639|P2|Overall Study|Lost to Follow-up|3
5098990|NCT01947491|17608640|P1|Overall Study|Lost to Follow-up|5
5098991|NCT01947283|17608670|P7|Overall Study|No patients were enrolled in study|1
5098992|NCT01947283|17608671|P6|Overall Study|No patients were enrolled in study|3
5098993|NCT01947283|17608672|P5|Overall Study|No patients were enrolled in study|0
5098994|NCT01947283|17608673|P4|Overall Study|No patients were enrolled in study|0
5098995|NCT01947283|17608674|P3|Overall Study|No patients were enrolled in study|0
5098996|NCT01947283|17608675|P2|Overall Study|No patients were enrolled in study|0
5098997|NCT01947283|17608676|P1|Overall Study|No patients were enrolled in study|0
5098998|NCT01947283|17608670|P7|Overall Study|Missing Follow-up Assessment|0
5098999|NCT01947283|17608671|P6|Overall Study|Missing Follow-up Assessment|2
5099000|NCT01947283|17608672|P5|Overall Study|Missing Follow-up Assessment|0
5099001|NCT01947283|17608673|P4|Overall Study|Missing Follow-up Assessment|0
5099002|NCT01947283|17608674|P3|Overall Study|Missing Follow-up Assessment|3
5099003|NCT01947283|17608675|P2|Overall Study|Missing Follow-up Assessment|2
5099004|NCT01947283|17608676|P1|Overall Study|Missing Follow-up Assessment|2
5099005|NCT01947283|17608670|P7|Overall Study|Non-coding Clinical Recording language|0
5099006|NCT01947283|17608671|P6|Overall Study|Non-coding Clinical Recording language|0
5099007|NCT01947283|17608672|P5|Overall Study|Non-coding Clinical Recording language|0
5099008|NCT01947283|17608673|P4|Overall Study|Non-coding Clinical Recording language|1
5099009|NCT01947283|17608674|P3|Overall Study|Non-coding Clinical Recording language|0
5099010|NCT01947283|17608675|P2|Overall Study|Non-coding Clinical Recording language|0
5099011|NCT01947283|17608676|P1|Overall Study|Non-coding Clinical Recording language|0
5099012|NCT01947283|17608670|P7|Overall Study|No Clinical Recording|0
5099013|NCT01947283|17608671|P6|Overall Study|No Clinical Recording|0
5099014|NCT01947283|17608672|P5|Overall Study|No Clinical Recording|0
5099015|NCT01947283|17608673|P4|Overall Study|No Clinical Recording|10
5099016|NCT01947283|17608674|P3|Overall Study|No Clinical Recording|8
5099017|NCT01947283|17608675|P2|Overall Study|No Clinical Recording|6
5099018|NCT01947283|17608676|P1|Overall Study|No Clinical Recording|12
5099019|NCT01947283|17608670|P7|Overall Study|Withdrawal by Subject|2
5099020|NCT01947283|17608671|P6|Overall Study|Withdrawal by Subject|0
5099021|NCT01947283|17608672|P5|Overall Study|Withdrawal by Subject|0
5099022|NCT01947283|17608673|P4|Overall Study|Withdrawal by Subject|1
5099023|NCT01947283|17608674|P3|Overall Study|Withdrawal by Subject|4
5099024|NCT01947283|17608675|P2|Overall Study|Withdrawal by Subject|8
5099025|NCT01947283|17608676|P1|Overall Study|Withdrawal by Subject|10
5099026|NCT01947283|17608670|P7|Overall Study|Lost to Follow-up|5
5099027|NCT01947283|17608671|P6|Overall Study|Lost to Follow-up|2
5099028|NCT01947283|17608672|P5|Overall Study|Lost to Follow-up|0
5099029|NCT01947283|17608673|P4|Overall Study|Lost to Follow-up|5
5099030|NCT01947283|17608674|P3|Overall Study|Lost to Follow-up|5
5099031|NCT01947283|17608675|P2|Overall Study|Lost to Follow-up|6
5099032|NCT01947283|17608676|P1|Overall Study|Lost to Follow-up|4
5099033|NCT01947283|17608670|P7|Overall Study|Death|0
5099034|NCT01947283|17608671|P6|Overall Study|Death|0
5099035|NCT01947283|17608672|P5|Overall Study|Death|0
5099036|NCT01947283|17608673|P4|Overall Study|Death|0
5099037|NCT01947283|17608674|P3|Overall Study|Death|1
5099038|NCT01947283|17608675|P2|Overall Study|Death|1
5099039|NCT01947283|17608676|P1|Overall Study|Death|1
5099040|NCT01947127|17608748|P2|Overall Study|Data loss|4
5099041|NCT01947127|17608749|P1|Overall Study|Data loss|4
5099042|NCT01947127|17608748|P2|Overall Study|Withdrawal by Subject|1
5099043|NCT01947127|17608749|P1|Overall Study|Withdrawal by Subject|1
5099044|NCT01947127|17608748|P2|Overall Study|Protocol Violation|38
5099045|NCT01947127|17608749|P1|Overall Study|Protocol Violation|18
5099046|NCT01946880|17608761|P2|Overall Study|Personal and Family Issues|0
5099047|NCT01946880|17608762|P1|Overall Study|Personal and Family Issues|1
5099048|NCT01946880|17608761|P2|Overall Study|Met Primary Endpoint|0
5099049|NCT01946880|17608762|P1|Overall Study|Met Primary Endpoint|1
5099050|NCT01946880|17608761|P2|Overall Study|Withdrawal by Subject|2
5099051|NCT01946880|17608762|P1|Overall Study|Withdrawal by Subject|3
5099052|NCT01946880|17608761|P2|Overall Study|Physician Decision|1
5099053|NCT01946880|17608762|P1|Overall Study|Physician Decision|1
5099054|NCT01946880|17608761|P2|Overall Study|Lost to Follow-up|0
5099055|NCT01946880|17608762|P1|Overall Study|Lost to Follow-up|1
5099056|NCT01946529|17608852|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
5099057|NCT01946529|17608853|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
5099058|NCT01946529|17608854|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
5099059|NCT01946529|17608852|P3|End of Window Therapy (2 Courses)|Physician Decision|0
5099060|NCT01946529|17608853|P2|End of Window Therapy (2 Courses)|Physician Decision|1
5099061|NCT01946529|17608854|P1|End of Window Therapy (2 Courses)|Physician Decision|0
5099062|NCT01946438|17608865|P4|Overall Study|Withdrawal by Subject|0
5099063|NCT01946438|17608866|P3|Overall Study|Withdrawal by Subject|0
5099064|NCT01946438|17608867|P2|Overall Study|Withdrawal by Subject|0
5099065|NCT01946438|17608868|P1|Overall Study|Withdrawal by Subject|1
5099066|NCT01946438|17608865|P4|Overall Study|Protocol Violation|0
5099067|NCT01946438|17608866|P3|Overall Study|Protocol Violation|1
5099068|NCT01946438|17608867|P2|Overall Study|Protocol Violation|0
5099069|NCT01946438|17608868|P1|Overall Study|Protocol Violation|0
5099070|NCT01946438|17608865|P4|Overall Study|Serious Adverse event|0
5099071|NCT01946438|17608866|P3|Overall Study|Serious Adverse event|0
5099072|NCT01946438|17608867|P2|Overall Study|Serious Adverse event|0
5099073|NCT01946438|17608868|P1|Overall Study|Serious Adverse event|1
5099074|NCT01946438|17608865|P4|Overall Study|Adverse Event|1
5099075|NCT01946438|17608866|P3|Overall Study|Adverse Event|0
5099076|NCT01946438|17608867|P2|Overall Study|Adverse Event|0
5099077|NCT01946438|17608868|P1|Overall Study|Adverse Event|0
5099078|NCT01946425|17608896|P2|Overall Study|Withdrawal by Subject|0
5099079|NCT01946425|17608897|P1|Overall Study|Withdrawal by Subject|1
5099080|NCT01946425|17608896|P2|Overall Study|Protocol Violation|0
5099081|NCT01946425|17608897|P1|Overall Study|Protocol Violation|1
5099082|NCT01946412|17608911|P1|Overall Study|Difficulty in swallowing|1
5099083|NCT01946412|17608911|P1|Overall Study|Continued with commercial Kalydeco|2
5099084|NCT01946412|17608911|P1|Overall Study|Non-Compliance|1
5099085|NCT01946412|17608911|P1|Overall Study|Adverse Event|1
5099086|NCT01946282|17608936|P3|Year 3|Did not return FIT kit|30
5099087|NCT01946282|17608937|P2|Year 3|Did not return FIT kit|43
5099088|NCT01946282|17608938|P1|Year 3|Did not return FIT kit|288
5099089|NCT01946282|17608936|P3|Year 2|Did not return FIT kit|115
5099090|NCT01946282|17608937|P2|Year 2|Did not return FIT kit|131
5099091|NCT01946282|17608938|P1|Year 2|Did not return FIT kit|803
5099092|NCT01946282|17608936|P3|Year 1|Did not return FIT kit|654
5099093|NCT01946282|17608937|P2|Year 1|Did not return FIT kit|608
5099094|NCT01946282|17608938|P1|Year 1|Did not return FIT kit|4186
5099095|NCT01946204|17608971|P2|Overall Study|Other|3
5099096|NCT01946204|17608972|P1|Overall Study|Other|7
5099097|NCT01946204|17608971|P2|Overall Study|Ongoing|687
5099098|NCT01946204|17608972|P1|Overall Study|Ongoing|316
5099099|NCT01946204|17608971|P2|Overall Study|Lost to Follow-up|7
5099100|NCT01946204|17608972|P1|Overall Study|Lost to Follow-up|3
5099101|NCT01946204|17608971|P2|Overall Study|Withdrawal by Subject|50
5099102|NCT01946204|17608972|P1|Overall Study|Withdrawal by Subject|37
5099103|NCT01946204|17608971|P2|Overall Study|Death|59
5099104|NCT01946204|17608972|P1|Overall Study|Death|38
5099105|NCT01946191|17608990|P2|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
5099106|NCT01946191|17608991|P1|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
5099107|NCT01946191|17608990|P2|Follow-Up, 24-mo Endpoint|Protocol Violation|1
5099108|NCT01946191|17608991|P1|Follow-Up, 24-mo Endpoint|Protocol Violation|0
5099109|NCT01946191|17608990|P2|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
5099110|NCT01946191|17608991|P1|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
5099111|NCT01946191|17608990|P2|Allocation|Did not complete orientation|1
5099112|NCT01946191|17608991|P1|Allocation|Did not complete orientation|1
5099113|NCT01946178|17609017|P1|Overall Study|Lost to Follow-up|1
5099114|NCT01946178|17609017|P1|Overall Study|Pregnancy|1
5099115|NCT01946165|17609027|P2|Overall Study|Withdrawal by Subject|2
5099116|NCT01946165|17609028|P1|Overall Study|Withdrawal by Subject|0
5099117|NCT01946165|17609027|P2|Overall Study|Physician Decision|0
5099118|NCT01946165|17609028|P1|Overall Study|Physician Decision|2
5099119|NCT01945996|17609055|P2|Overall Study|Lost to Follow-up|5
5099120|NCT01945996|17609056|P1|Overall Study|Lost to Follow-up|3
5099121|NCT01945944|17609132|P2|Overall Study|Withdrawal by Subject|1
5099122|NCT01945944|17609133|P1|Overall Study|Withdrawal by Subject|0
5099123|NCT01945944|17609132|P2|Overall Study|Physician Decision|0
5099124|NCT01945944|17609133|P1|Overall Study|Physician Decision|1
5099125|NCT01945944|17609132|P2|Overall Study|Adverse Event|2
5099126|NCT01945944|17609133|P1|Overall Study|Adverse Event|0
5099127|NCT01945866|17609157|P2|Overall Study|Eyes did not complete or were dropped|0
5099128|NCT01945866|17609158|P1|Overall Study|Eyes did not complete or were dropped|2
5099129|NCT01945775|17609179|P2|Overall Study|Ongoing|19
5099130|NCT01945775|17609180|P1|Overall Study|Ongoing|56
5099131|NCT01945775|17609179|P2|Overall Study|Withdrawal by Subject|21
5099132|NCT01945775|17609180|P1|Overall Study|Withdrawal by Subject|10
5099133|NCT01945775|17609179|P2|Overall Study|Lost to Follow-up|7
5099134|NCT01945775|17609180|P1|Overall Study|Lost to Follow-up|11
5099135|NCT01945775|17609179|P2|Overall Study|Death|97
5099136|NCT01945775|17609180|P1|Overall Study|Death|210
5099137|NCT01945710|17609216|P7|Overall Study|Withdrawal by Subject|0
5099138|NCT01945710|17609217|P6|Overall Study|Withdrawal by Subject|0
5099139|NCT01945710|17609218|P5|Overall Study|Withdrawal by Subject|1
5099140|NCT01945710|17609219|P4|Overall Study|Withdrawal by Subject|0
5099141|NCT01945710|17609220|P3|Overall Study|Withdrawal by Subject|1
5099142|NCT01945710|17609221|P2|Overall Study|Withdrawal by Subject|1
5099143|NCT01945710|17609222|P1|Overall Study|Withdrawal by Subject|0
5099144|NCT01945710|17609216|P7|Overall Study|Other|4
5099145|NCT01945710|17609217|P6|Overall Study|Other|0
5099146|NCT01945710|17609218|P5|Overall Study|Other|1
5099147|NCT01945710|17609219|P4|Overall Study|Other|1
5099148|NCT01945710|17609220|P3|Overall Study|Other|3
5099149|NCT01945710|17609221|P2|Overall Study|Other|0
5099150|NCT01945710|17609222|P1|Overall Study|Other|2
5099151|NCT01945710|17609216|P7|Overall Study|Adverse Event|0
5099152|NCT01945710|17609217|P6|Overall Study|Adverse Event|0
5099153|NCT01945710|17609218|P5|Overall Study|Adverse Event|0
5099154|NCT01945710|17609219|P4|Overall Study|Adverse Event|0
5099155|NCT01945710|17609220|P3|Overall Study|Adverse Event|0
5099156|NCT01945710|17609221|P2|Overall Study|Adverse Event|1
5099157|NCT01945710|17609222|P1|Overall Study|Adverse Event|0
5099158|NCT01945710|17609216|P7|Overall Study|Progressive Disease|19
5099159|NCT01945710|17609217|P6|Overall Study|Progressive Disease|3
5099160|NCT01945710|17609218|P5|Overall Study|Progressive Disease|7
5099161|NCT01945710|17609219|P4|Overall Study|Progressive Disease|2
5099162|NCT01945710|17609220|P3|Overall Study|Progressive Disease|3
5099163|NCT01945710|17609221|P2|Overall Study|Progressive Disease|4
5099164|NCT01945710|17609222|P1|Overall Study|Progressive Disease|5
5099165|NCT01945593|17609341|P4|Overall Study|Other: Screen Failure|0
5099166|NCT01945593|17609342|P3|Overall Study|Other: Screen Failure|0
5099167|NCT01945593|17609343|P2|Overall Study|Other: Screen Failure|2
5099168|NCT01945593|17609344|P1|Overall Study|Other: Screen Failure|0
5099169|NCT01945593|17609341|P4|Overall Study|Other: Surgical Procedure|6
5099170|NCT01945593|17609342|P3|Overall Study|Other: Surgical Procedure|0
5099171|NCT01945593|17609343|P2|Overall Study|Other: Surgical Procedure|2
5099172|NCT01945593|17609344|P1|Overall Study|Other: Surgical Procedure|0
5099173|NCT01945593|17609341|P4|Overall Study|Other: Terminated|1
5099174|NCT01945593|17609342|P3|Overall Study|Other: Terminated|0
5099175|NCT01945593|17609343|P2|Overall Study|Other: Terminated|0
5099176|NCT01945593|17609344|P1|Overall Study|Other: Terminated|0
5099177|NCT01945593|17609341|P4|Overall Study|Death|0
5099178|NCT01945593|17609342|P3|Overall Study|Death|1
5099179|NCT01945593|17609343|P2|Overall Study|Death|0
5099180|NCT01945593|17609344|P1|Overall Study|Death|0
5099181|NCT01945593|17609341|P4|Overall Study|Protocol Violation|3
5099182|NCT01945593|17609342|P3|Overall Study|Protocol Violation|1
5099183|NCT01945593|17609343|P2|Overall Study|Protocol Violation|2
5099184|NCT01945593|17609344|P1|Overall Study|Protocol Violation|0
5099185|NCT01945593|17609341|P4|Overall Study|Withdrawal by Subject|4
5099186|NCT01945593|17609342|P3|Overall Study|Withdrawal by Subject|0
5099187|NCT01945593|17609343|P2|Overall Study|Withdrawal by Subject|2
5099188|NCT01945593|17609344|P1|Overall Study|Withdrawal by Subject|0
5099189|NCT01945593|17609341|P4|Overall Study|Physician Decision|1
5099190|NCT01945593|17609342|P3|Overall Study|Physician Decision|1
5099191|NCT01945593|17609343|P2|Overall Study|Physician Decision|0
5099192|NCT01945593|17609344|P1|Overall Study|Physician Decision|0
5099193|NCT01945593|17609341|P4|Overall Study|Adverse Event|5
5099194|NCT01945593|17609342|P3|Overall Study|Adverse Event|0
5099195|NCT01945593|17609343|P2|Overall Study|Adverse Event|0
5099196|NCT01945593|17609344|P1|Overall Study|Adverse Event|0
5099197|NCT01945489|17609426|P2|Cycle 2|Lost to Follow-up|1
5099198|NCT01945489|17609427|P1|Cycle 2|Lost to Follow-up|0
5099199|NCT01945489|17609426|P2|Cycle 2|Adverse Event|0
5099200|NCT01945489|17609427|P1|Cycle 2|Adverse Event|1
5099201|NCT01945489|17609426|P2|Cycle 1|Other Miscellaneous Reasons|1
5099202|NCT01945489|17609427|P1|Cycle 1|Other Miscellaneous Reasons|3
5099203|NCT01945489|17609426|P2|Cycle 1|Protocol Violation|1
5099204|NCT01945489|17609427|P1|Cycle 1|Protocol Violation|0
5099205|NCT01945489|17609426|P2|Cycle 1|Personal Reasons|2
5099206|NCT01945489|17609427|P1|Cycle 1|Personal Reasons|4
5099207|NCT01945489|17609426|P2|Cycle 1|Lost to Follow-up|0
5099208|NCT01945489|17609427|P1|Cycle 1|Lost to Follow-up|4
5099209|NCT01945489|17609426|P2|Cycle 1|Adverse Event|0
5099210|NCT01945489|17609427|P1|Cycle 1|Adverse Event|2
5099211|NCT01945281|17609481|P2|Overall Study|Technical Problems|0
5099212|NCT01945281|17609482|P1|Overall Study|Technical Problems|1
5099213|NCT01945281|17609481|P2|Overall Study|Physician Decision|1
5099214|NCT01945281|17609482|P1|Overall Study|Physician Decision|1
5099215|NCT01945281|17609481|P2|Overall Study|Death|3
5099216|NCT01945281|17609482|P1|Overall Study|Death|3
5099217|NCT01945281|17609481|P2|Overall Study|Adverse Event|0
5099218|NCT01945281|17609482|P1|Overall Study|Adverse Event|1
5099219|NCT01945242|17609494|P2|Overall Study|Physician Decision|3
5099220|NCT01945242|17609495|P1|Overall Study|Physician Decision|3
5099221|NCT01945216|17609510|P1|Overall Study|CRF not assured by investigators|5
5099222|NCT01945216|17609510|P1|Overall Study|Protocol Violation|42
5099223|NCT01945216|17609510|P1|Overall Study|Case report forms (CRF) uncollected|52
5099224|NCT01945086|17609568|P3|Overall Study|Adverse Event|1
5099225|NCT01945086|17609569|P2|Overall Study|Adverse Event|0
5099226|NCT01945086|17609570|P1|Overall Study|Adverse Event|0
5099227|NCT01945086|17609568|P3|Overall Study|Withdrawal by Subject|1
5099228|NCT01945086|17609569|P2|Overall Study|Withdrawal by Subject|0
5099229|NCT01945086|17609570|P1|Overall Study|Withdrawal by Subject|1
5099230|NCT01945034|17609614|P3|Overall Study|Protocol Violation|1
5099231|NCT01945034|17609615|P2|Overall Study|Protocol Violation|0
5099232|NCT01945034|17609616|P1|Overall Study|Protocol Violation|1
5099233|NCT01945034|17609614|P3|Overall Study|Lost to Follow-up|2
5099234|NCT01945034|17609615|P2|Overall Study|Lost to Follow-up|0
5099235|NCT01945034|17609616|P1|Overall Study|Lost to Follow-up|0
5099236|NCT01945034|17609614|P3|Overall Study|Other|3
5099237|NCT01945034|17609615|P2|Overall Study|Other|1
5099238|NCT01945034|17609616|P1|Overall Study|Other|0
5099239|NCT01945034|17609614|P3|Overall Study|Withdrawal by Subject|1
5099240|NCT01945034|17609615|P2|Overall Study|Withdrawal by Subject|3
5099241|NCT01945034|17609616|P1|Overall Study|Withdrawal by Subject|0
5099242|NCT01945034|17609614|P3|Overall Study|Medication Error|0
5099243|NCT01945034|17609615|P2|Overall Study|Medication Error|1
5099244|NCT01945034|17609616|P1|Overall Study|Medication Error|0
5099245|NCT01945021|17609666|P1|Overall Study|Non-RECIST disease progression|1
5099246|NCT01945021|17609666|P1|Overall Study|Withdrawal of consent|3
5099247|NCT01945021|17609666|P1|Overall Study|Withdrawal by Subject|2
5099248|NCT01945021|17609666|P1|Overall Study|Global deterioration of health-related s|1
5099249|NCT01945021|17609666|P1|Overall Study|Disease progression by RECIST v1.1|30
5099250|NCT01945021|17609666|P1|Overall Study|Pregnancy|1
5099251|NCT01945021|17609666|P1|Overall Study|Death|1
5099252|NCT01945021|17609666|P1|Overall Study|Adverse Event|8
5099253|NCT01944969|17609680|P1|Overall Study|Administrative or other reasons|23
5099254|NCT01944969|17609680|P1|Overall Study|Non-compliance with IMP|1
5099255|NCT01944969|17609680|P1|Overall Study|Lack of Efficacy|1
5099256|NCT01944969|17609680|P1|Overall Study|Adverse Event|1
5099257|NCT01944839|17609704|P2|Overall Study|Subject non-compliance|3
5099258|NCT01944839|17609705|P1|Overall Study|Subject non-compliance|0
5099259|NCT01944839|17609704|P2|Overall Study|Lost to Follow-up|0
5099260|NCT01944839|17609705|P1|Overall Study|Lost to Follow-up|1
5099261|NCT01944839|17609704|P2|Overall Study|Withdrawal by Subject|17
5099262|NCT01944839|17609705|P1|Overall Study|Withdrawal by Subject|9
5099263|NCT01944839|17609704|P2|Overall Study|Adverse Event|5
5099264|NCT01944839|17609705|P1|Overall Study|Adverse Event|10
5099265|NCT01944839|17609704|P2|Overall Study|Protocol Violation|1
5099266|NCT01944839|17609705|P1|Overall Study|Protocol Violation|0
5099267|NCT01944839|17609704|P2|Overall Study|Physician Decision|2
5099268|NCT01944839|17609705|P1|Overall Study|Physician Decision|2
5099269|NCT01944774|17609714|P3|Overall Study|Lost to Follow-up|0
5099270|NCT01944774|17609715|P2|Overall Study|Lost to Follow-up|1
5099271|NCT01944774|17609716|P1|Overall Study|Lost to Follow-up|0
5099272|NCT01944774|17609714|P3|Overall Study|Lack of Efficacy|2
5099273|NCT01944774|17609715|P2|Overall Study|Lack of Efficacy|2
5099274|NCT01944774|17609716|P1|Overall Study|Lack of Efficacy|1
5099275|NCT01944774|17609714|P3|Overall Study|Adverse Event|3
5099276|NCT01944774|17609715|P2|Overall Study|Adverse Event|2
5099277|NCT01944774|17609716|P1|Overall Study|Adverse Event|3
5099278|NCT01944774|17609714|P3|Overall Study|Withdrawal by Subject|3
5099279|NCT01944774|17609715|P2|Overall Study|Withdrawal by Subject|3
5099280|NCT01944774|17609716|P1|Overall Study|Withdrawal by Subject|2
5099281|NCT01944722|17609759|P1|Overall Study|>ASCUS Cytology|1122
5099282|NCT01944722|17609759|P1|Overall Study|Unsatisfactory Cytology Result|63
5099283|NCT01944722|17609759|P1|Overall Study|NILM Subjects <30 years old|8106
5099284|NCT01944722|17609759|P1|Overall Study|Withdrawal by Subject|8
5099285|NCT01944722|17609759|P1|Overall Study|Specimens Mislabeled|2
5099286|NCT01944722|17609759|P1|Overall Study|Missing Specimens|3
5099287|NCT01944722|17609759|P1|Overall Study|Insufficient Volume for Test|1
5099288|NCT01944722|17609759|P1|Overall Study|Improper Storage/Transport|5
5099289|NCT01944722|17609759|P1|Overall Study|Specimen Shipping Issues|34
5099290|NCT01944722|17609759|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
5099291|NCT01944670|17609793|P1|Overall Study|Lost to Follow-up|2
5099292|NCT01944631|17609815|P2|Overall Study|Withdrawal by Subject|1
5099293|NCT01944631|17609816|P1|Overall Study|Withdrawal by Subject|0
5099294|NCT01944631|17609815|P2|Overall Study|Lost to Follow-up|1
5099295|NCT01944631|17609816|P1|Overall Study|Lost to Follow-up|3
5099296|NCT01944631|17609815|P2|Overall Study|Adverse Event|0
5099297|NCT01944631|17609816|P1|Overall Study|Adverse Event|1
5099298|NCT01944462|17609832|P1|PPPP Educational Program|Lost to Follow-up|60
5099299|NCT01944098|17609895|P2|Overall Study|Physician Decision|0
5099300|NCT01944098|17609896|P1|Overall Study|Physician Decision|1
5099301|NCT01944059|17609908|P1|Overall Study|Adverse Event|2
5099302|NCT01944059|17609908|P1|Overall Study|Withdrawal by Subject|1
5099303|NCT01944059|17609908|P1|Overall Study|Physician Decision|3
5099304|NCT01944059|17609908|P1|Overall Study|Lost to Follow-up|1
5099305|NCT01943825|17609949|P4|Overall Study|Other than specified above|1
5099306|NCT01943825|17609950|P3|Overall Study|Other than specified above|0
5099307|NCT01943825|17609951|P2|Overall Study|Other than specified above|1
5099308|NCT01943825|17609952|P1|Overall Study|Other than specified above|0
5099309|NCT01943825|17609949|P4|Overall Study|Withdrawal by Subject|2
5099310|NCT01943825|17609950|P3|Overall Study|Withdrawal by Subject|3
5099311|NCT01943825|17609951|P2|Overall Study|Withdrawal by Subject|0
5099312|NCT01943825|17609952|P1|Overall Study|Withdrawal by Subject|1
5099313|NCT01943825|17609949|P4|Overall Study|Lost to Follow-up|8
5099314|NCT01943825|17609950|P3|Overall Study|Lost to Follow-up|12
5099315|NCT01943825|17609951|P2|Overall Study|Lost to Follow-up|3
5099316|NCT01943825|17609952|P1|Overall Study|Lost to Follow-up|9
5099317|NCT01943799|17609994|P4|Overall Study|Withdrawal by Subject|0
5099318|NCT01943799|17609995|P3|Overall Study|Withdrawal by Subject|1
5099319|NCT01943799|17609996|P2|Overall Study|Withdrawal by Subject|2
5099320|NCT01943799|17609997|P1|Overall Study|Withdrawal by Subject|4
5099321|NCT01943799|17609994|P4|Overall Study|Protocol Violation|0
5099322|NCT01943799|17609995|P3|Overall Study|Protocol Violation|0
5099323|NCT01943799|17609996|P2|Overall Study|Protocol Violation|0
5099324|NCT01943799|17609997|P1|Overall Study|Protocol Violation|1
5099325|NCT01943799|17609994|P4|Overall Study|Lost to Follow-up|0
5099326|NCT01943799|17609995|P3|Overall Study|Lost to Follow-up|1
5099327|NCT01943799|17609996|P2|Overall Study|Lost to Follow-up|1
5099328|NCT01943799|17609997|P1|Overall Study|Lost to Follow-up|0
5099329|NCT01943591|17610037|P2|Overall Study|Death|7
5099330|NCT01943591|17610038|P1|Overall Study|Death|2
5099331|NCT01943591|17610037|P2|Overall Study|Lost to Follow-up|4
5099332|NCT01943591|17610038|P1|Overall Study|Lost to Follow-up|3
5099333|NCT01943552|17610096|P2|Overall Study|Other Reasons|17
5099334|NCT01943552|17610097|P1|Overall Study|Other Reasons|16
5099335|NCT01943552|17610096|P2|Overall Study|Withdrawal by Subject|6
5099336|NCT01943552|17610097|P1|Overall Study|Withdrawal by Subject|6
5099337|NCT01943552|17610096|P2|Overall Study|Adverse Event|2
5099338|NCT01943552|17610097|P1|Overall Study|Adverse Event|3
5099339|NCT01943539|17610113|P2|Overall Study|Non-compliance with at-home intervention|0
5099340|NCT01943539|17610114|P1|Overall Study|Non-compliance with at-home intervention|4
5099341|NCT01943435|17610211|P3|6 Month Follow up|Lost to Follow-up|15
5099342|NCT01943435|17610212|P2|6 Month Follow up|Lost to Follow-up|7
5099343|NCT01943435|17610213|P1|6 Month Follow up|Lost to Follow-up|12
5099344|NCT01943435|17610211|P3|2 Month Follow up|Lost to Follow-up|0
5099345|NCT01943435|17610212|P2|2 Month Follow up|Lost to Follow-up|3
5099346|NCT01943435|17610213|P1|2 Month Follow up|Lost to Follow-up|2
5099347|NCT01943435|17610211|P3|Intervention Period|Withdrawal by Subject|4
5099348|NCT01943435|17610212|P2|Intervention Period|Withdrawal by Subject|3
5099349|NCT01943435|17610213|P1|Intervention Period|Withdrawal by Subject|3
5099350|NCT01943435|17610211|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
5099351|NCT01943435|17610212|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
5099352|NCT01943435|17610213|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
5099353|NCT01943292|17610236|P3|Overall Study|Withdrawal by Subject|0
5099354|NCT01943292|17610237|P2|Overall Study|Withdrawal by Subject|0
5099355|NCT01943292|17610238|P1|Overall Study|Withdrawal by Subject|1
5099356|NCT01942993|17610274|P1|Overall Study|Physician Decision|1
5099357|NCT01942993|17610274|P1|Overall Study|Lost to Follow-up|1
5099358|NCT01942785|17610291|P1|Overall Study|Protocol Violation|1
5099359|NCT01942785|17610291|P1|Overall Study|Withdrawal by Subject|1
5099360|NCT01942785|17610291|P1|Overall Study|Adverse Event|2
5099361|NCT01942733|17610320|P1|Overall Study|Administrative|1
5099362|NCT01942733|17610320|P1|Overall Study|Non-compliance with IMP|1
5099363|NCT01942733|17610320|P1|Overall Study|Lost to Follow-up|1
5099364|NCT01942590|17611461|P2|Overall Study|Adverse Event|0
5099365|NCT01942590|17611462|P1|Overall Study|Adverse Event|1
5099366|NCT01942590|17611461|P2|Overall Study|Withdrawal by Subject|1
5099367|NCT01942590|17611462|P1|Overall Study|Withdrawal by Subject|0
5099368|NCT01942486|17611492|P1|Overall Study|Lost to Follow-up|27
5099369|NCT01942161|17611499|P3|Overall Study|Withdrawal by Subject|1
5099370|NCT01942161|17611500|P2|Overall Study|Withdrawal by Subject|3
5099371|NCT01942161|17611501|P1|Overall Study|Withdrawal by Subject|3
5099372|NCT01942161|17611499|P3|Overall Study|Protocol Violation|0
5099373|NCT01942161|17611500|P2|Overall Study|Protocol Violation|0
5099374|NCT01942161|17611501|P1|Overall Study|Protocol Violation|1
5099375|NCT01942161|17611499|P3|Overall Study|Physician Decision|0
5099376|NCT01942161|17611500|P2|Overall Study|Physician Decision|1
5099377|NCT01942161|17611501|P1|Overall Study|Physician Decision|3
5099378|NCT01942161|17611499|P3|Overall Study|Adverse Event|5
5099379|NCT01942161|17611500|P2|Overall Study|Adverse Event|2
5099380|NCT01942161|17611501|P1|Overall Study|Adverse Event|1
5099381|NCT01942148|17611521|P1|Overall Study|Use of the prohibition medicine|1
5099382|NCT01942148|17611521|P1|Overall Study|Withdrawal by Subject|8
5099383|NCT01942148|17611521|P1|Overall Study|Protocol Violation|1
5099384|NCT01942148|17611521|P1|Overall Study|Physician Decision|11
5099385|NCT01942148|17611521|P1|Overall Study|Lack of Efficacy|2
5099386|NCT01942148|17611521|P1|Overall Study|Adverse Event|4
5099387|NCT01942135|17611529|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
5099388|NCT01942135|17611530|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
5099389|NCT01942135|17611529|P2|Overall Study|Withdrawal by Subject|2
5099390|NCT01942135|17611530|P1|Overall Study|Withdrawal by Subject|4
5099391|NCT01942135|17611529|P2|Overall Study|Participant Refused toContinue Treatment|1
5099392|NCT01942135|17611530|P1|Overall Study|Participant Refused toContinue Treatment|1
5099393|NCT01942135|17611529|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
5099394|NCT01942135|17611530|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
5099395|NCT01942135|17611529|P2|Overall Study|Death|1
5099396|NCT01942135|17611530|P1|Overall Study|Death|0
5099397|NCT01942135|17611529|P2|Overall Study|Randomized Not Treated|2
5099398|NCT01942135|17611530|P1|Overall Study|Randomized Not Treated|2
5099399|NCT01942135|17611529|P2|Overall Study|Global deterioration of health status|3
5099400|NCT01942135|17611530|P1|Overall Study|Global deterioration of health status|8
5099401|NCT01942135|17611529|P2|Overall Study|Adverse Event|3
5099402|NCT01942135|17611530|P1|Overall Study|Adverse Event|9
5099403|NCT01941940|17611567|P1|Overall Study|Other|1
5099404|NCT01941940|17611567|P1|Overall Study|Other|1
5099405|NCT01941940|17611567|P1|Overall Study|Death|1
5099406|NCT01941940|17611567|P1|Overall Study|Withdrawal by Subject|15
5099407|NCT01941940|17611567|P1|Overall Study|Physician Decision|2
5099408|NCT01941940|17611567|P1|Overall Study|Lost to Follow-up|2
5099409|NCT01941940|17611567|P1|Overall Study|Adverse Event|11
5099410|NCT01941537|17611675|P2|Overall Study|Withdrawal by Subject|1
5099411|NCT01941537|17611676|P1|Overall Study|Withdrawal by Subject|0
5099412|NCT01941537|17611675|P2|Overall Study|Adverse Event|0
5099413|NCT01941537|17611676|P1|Overall Study|Adverse Event|1
5099414|NCT01941537|17611675|P2|Overall Study|Pregnancy|0
5099415|NCT01941537|17611676|P1|Overall Study|Pregnancy|1
5099416|NCT01941537|17611675|P2|Overall Study|Lost to Follow-up|0
5099417|NCT01941537|17611676|P1|Overall Study|Lost to Follow-up|1
5099418|NCT01941537|17611675|P2|Overall Study|Lack of Efficacy|2
5099419|NCT01941537|17611676|P1|Overall Study|Lack of Efficacy|1
5099420|NCT01941498|17611688|P1|Overall Study|Relocated out of state|1
5099421|NCT01941186|17611806|P2|Follow-up|Lost to Follow-up|0
5099422|NCT01941186|17611807|P1|Follow-up|Lost to Follow-up|1
5099423|NCT01941095|17611833|P1|Overall Study|Lost to Follow-up|10
5099424|NCT01941095|17611833|P1|Overall Study|Withdrawal by Subject|17
5099425|NCT01941095|17611833|P1|Overall Study|Physician Decision|3
5099426|NCT01941095|17611833|P1|Overall Study|Adverse Event|11
5099427|NCT01941095|17611833|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
5099428|NCT01941095|17611833|P1|Overall Study|Insufficient therapeutic response|13
5099429|NCT01941030|17611858|P2|Overall Study|Withdrawal by Subject|6
5099430|NCT01941030|17611859|P1|Overall Study|Withdrawal by Subject|4
5099431|NCT01941030|17611858|P2|Overall Study|Lost to Follow-up|5
5099432|NCT01941030|17611859|P1|Overall Study|Lost to Follow-up|6
5099433|NCT01941030|17611858|P2|Overall Study|Death|2
5099434|NCT01941030|17611859|P1|Overall Study|Death|3
5099435|NCT01940939|17611881|P2|Overall Study|Withdrawal by Subject|8
5099436|NCT01940939|17611882|P1|Overall Study|Withdrawal by Subject|2
5099437|NCT01940900|17611894|P2|Overall Study|other|0
5099438|NCT01940900|17611895|P1|Overall Study|other|1
5099439|NCT01940900|17611894|P2|Overall Study|subject non-compliance|1
5099440|NCT01940900|17611895|P1|Overall Study|subject non-compliance|1
5099441|NCT01940900|17611894|P2|Overall Study|Sponsor Decision|0
5099442|NCT01940900|17611895|P1|Overall Study|Sponsor Decision|1
5099443|NCT01940900|17611894|P2|Overall Study|Lost to Follow-up|0
5099444|NCT01940900|17611895|P1|Overall Study|Lost to Follow-up|1
5099445|NCT01940900|17611894|P2|Overall Study|Withdrawal by Subject|15
5099446|NCT01940900|17611895|P1|Overall Study|Withdrawal by Subject|11
5099447|NCT01940900|17611894|P2|Overall Study|Adverse Event|15
5099448|NCT01940900|17611895|P1|Overall Study|Adverse Event|10
5099449|NCT01940900|17611894|P2|Overall Study|Physician Decision|0
5099450|NCT01940900|17611895|P1|Overall Study|Physician Decision|4
5099451|NCT01940887|17611903|P2|Year 2|Lost to Follow-up|6
5099452|NCT01940887|17611904|P1|Year 2|Lost to Follow-up|1
5099453|NCT01940887|17611903|P2|Year 2|Withdrawal by Subject|8
5099454|NCT01940887|17611904|P1|Year 2|Withdrawal by Subject|8
5099455|NCT01940887|17611903|P2|Year 2|Adverse Event|2
5099456|NCT01940887|17611904|P1|Year 2|Adverse Event|8
5099457|NCT01940887|17611903|P2|Year 2|Sponsor Decision, early termination|203
5099458|NCT01940887|17611904|P1|Year 2|Sponsor Decision, early termination|192
5099459|NCT01940887|17611903|P2|Year 2|Death|2
5099460|NCT01940887|17611904|P1|Year 2|Death|0
5099461|NCT01940887|17611903|P2|Year 2|Physician Decision|1
5099462|NCT01940887|17611904|P1|Year 2|Physician Decision|8
5099463|NCT01940887|17611903|P2|Year 1|Lost to Follow-up|1
5099464|NCT01940887|17611904|P1|Year 1|Lost to Follow-up|2
5099465|NCT01940887|17611903|P2|Year 1|Withdrawal by Subject|9
5099466|NCT01940887|17611904|P1|Year 1|Withdrawal by Subject|18
5099467|NCT01940887|17611903|P2|Year 1|Adverse Event|6
5099468|NCT01940887|17611904|P1|Year 1|Adverse Event|7
5099469|NCT01940887|17611903|P2|Year 1|Death|3
5099470|NCT01940887|17611904|P1|Year 1|Death|5
5099471|NCT01940887|17611903|P2|Year 1|Physician Decision|3
5099472|NCT01940887|17611904|P1|Year 1|Physician Decision|7
5099473|NCT01940887|17611903|P2|Year 1|Protocol Violation|1
5099474|NCT01940887|17611904|P1|Year 1|Protocol Violation|0
5099475|NCT01940705|17611914|P4|Overall Study|Withdrawal by team - hearing aid change|0
5099476|NCT01940705|17611915|P3|Overall Study|Withdrawal by team - hearing aid change|0
5099477|NCT01940705|17611916|P2|Overall Study|Withdrawal by team - hearing aid change|0
5099478|NCT01940705|17611917|P1|Overall Study|Withdrawal by team - hearing aid change|1
5099479|NCT01940705|17611914|P4|Overall Study|Intervention not given|0
5099480|NCT01940705|17611915|P3|Overall Study|Intervention not given|3
5099481|NCT01940705|17611916|P2|Overall Study|Intervention not given|3
5099482|NCT01940705|17611917|P1|Overall Study|Intervention not given|0
5099483|NCT01940705|17611914|P4|Overall Study|Withdrawal by Subject|2
5099484|NCT01940705|17611915|P3|Overall Study|Withdrawal by Subject|3
5099485|NCT01940705|17611916|P2|Overall Study|Withdrawal by Subject|2
5099486|NCT01940705|17611917|P1|Overall Study|Withdrawal by Subject|2
5099487|NCT01940705|17611914|P4|Overall Study|Lost to Follow-up|2
5099488|NCT01940705|17611915|P3|Overall Study|Lost to Follow-up|2
5099489|NCT01940705|17611916|P2|Overall Study|Lost to Follow-up|3
5099490|NCT01940705|17611917|P1|Overall Study|Lost to Follow-up|1
5099491|NCT01940497|17611981|P2|Overall Study|Administrative/Other|1
5099492|NCT01940497|17611982|P1|Overall Study|Administrative/Other|1
5099493|NCT01940497|17611981|P2|Overall Study|Withdrew Consent|2
5099494|NCT01940497|17611982|P1|Overall Study|Withdrew Consent|6
5099495|NCT01940497|17611981|P2|Overall Study|Refused Treatment|3
5099496|NCT01940497|17611982|P1|Overall Study|Refused Treatment|1
5099497|NCT01940497|17611981|P2|Overall Study|Violation of Entry Criteria|1
5099498|NCT01940497|17611982|P1|Overall Study|Violation of Entry Criteria|1
5099499|NCT01940497|17611981|P2|Overall Study|Recurrence of Disease Postsurgery|3
5099500|NCT01940497|17611982|P1|Overall Study|Recurrence of Disease Postsurgery|1
5099501|NCT01940497|17611981|P2|Overall Study|Adverse Event/Intercurrent Illness|8
5099502|NCT01940497|17611982|P1|Overall Study|Adverse Event/Intercurrent Illness|11
5099503|NCT01940484|17612023|P1|Overall Study|Adverse Event|1
5099504|NCT01940484|17612023|P1|Overall Study|Death|2
5099505|NCT01940484|17612023|P1|Overall Study|Underwent transplantation|4
5099506|NCT01940484|17612023|P1|Overall Study|Withdrawal by Subject|3
5099507|NCT01940471|17612043|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
5099508|NCT01940471|17612044|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
5099509|NCT01940471|17612043|P2|Double-Blind Phase|Still in Double-Blind Phase|270
5099510|NCT01940471|17612044|P1|Double-Blind Phase|Still in Double-Blind Phase|539
5099511|NCT01940471|17612043|P2|Double-Blind Phase|Protocol Violation|1
5099512|NCT01940471|17612044|P1|Double-Blind Phase|Protocol Violation|0
5099513|NCT01940471|17612043|P2|Double-Blind Phase|Lack of Efficacy|0
5099514|NCT01940471|17612044|P1|Double-Blind Phase|Lack of Efficacy|1
5099515|NCT01940471|17612043|P2|Double-Blind Phase|Death|0
5099516|NCT01940471|17612044|P1|Double-Blind Phase|Death|1
5099517|NCT01940471|17612043|P2|Double-Blind Phase|Protocol-Specified Criteria|0
5099518|NCT01940471|17612044|P1|Double-Blind Phase|Protocol-Specified Criteria|1
5099519|NCT01940471|17612043|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5099520|NCT01940471|17612044|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5099521|NCT01940471|17612043|P2|Double-Blind Phase|Investigator's Discretion|0
5099522|NCT01940471|17612044|P1|Double-Blind Phase|Investigator's Discretion|5
5099523|NCT01940471|17612043|P2|Double-Blind Phase|Pregnancy|1
5099524|NCT01940471|17612044|P1|Double-Blind Phase|Pregnancy|2
5099525|NCT01940471|17612043|P2|Double-Blind Phase|Lost to Follow-up|2
5099526|NCT01940471|17612044|P1|Double-Blind Phase|Lost to Follow-up|3
5099527|NCT01940471|17612043|P2|Double-Blind Phase|Adverse Event|2
5099528|NCT01940471|17612044|P1|Double-Blind Phase|Adverse Event|1
5099529|NCT01940471|17612043|P2|Double-Blind Phase|Withdrew Consent|7
5099530|NCT01940471|17612044|P1|Double-Blind Phase|Withdrew Consent|13
5099531|NCT01940471|17612043|P2|Double-Blind Phase|Randomized but Never Treated|1
5099532|NCT01940471|17612044|P1|Double-Blind Phase|Randomized but Never Treated|1
5099533|NCT01940354|17612062|P2|Overall Study|Withdrawal by Subject|2
5099534|NCT01940354|17612063|P1|Overall Study|Withdrawal by Subject|4
5099535|NCT01940341|17612075|P2|Open-label Extension Phase|Still on Study|1
5099536|NCT01940341|17612076|P1|Open-label Extension Phase|Still on Study|4
5099537|NCT01940341|17612075|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
5099538|NCT01940341|17612076|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
5099539|NCT01940341|17612075|P2|Double-Blind Phase|Protocol Specified Criteria|0
5099540|NCT01940341|17612076|P1|Double-Blind Phase|Protocol Specified Criteria|1
5099541|NCT01940341|17612075|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5099542|NCT01940341|17612076|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
5099543|NCT01940341|17612075|P2|Double-Blind Phase|Investigator's Discretion|0
5099544|NCT01940341|17612076|P1|Double-Blind Phase|Investigator's Discretion|1
5099545|NCT01940341|17612075|P2|Double-Blind Phase|Pregnancy|1
5099546|NCT01940341|17612076|P1|Double-Blind Phase|Pregnancy|0
5099547|NCT01940341|17612075|P2|Double-Blind Phase|Lost to Follow-up|1
5099548|NCT01940341|17612076|P1|Double-Blind Phase|Lost to Follow-up|4
5099549|NCT01940341|17612075|P2|Double-Blind Phase|Withdrew Consent|2
5099550|NCT01940341|17612076|P1|Double-Blind Phase|Withdrew Consent|3
5099551|NCT01940341|17612075|P2|Double-Blind Phase|Adverse Event|2
5099552|NCT01940341|17612076|P1|Double-Blind Phase|Adverse Event|3
5099553|NCT01940341|17612075|P2|Double-Blind Phase|Randomized but Never Treated|1
5099554|NCT01940341|17612076|P1|Double-Blind Phase|Randomized but Never Treated|0
5099555|NCT01940120|17612107|P1|Overall Study|Withdrawal by Subject|8
5099556|NCT01940120|17612107|P1|Overall Study|Death|40
5099557|NCT01939977|17612263|P2|Overall Study|Did not receive study medication|1
5099558|NCT01939977|17612264|P1|Overall Study|Did not receive study medication|0
5099559|NCT01939977|17612263|P2|Overall Study|Did not meet inclusion criteria|0
5099560|NCT01939977|17612264|P1|Overall Study|Did not meet inclusion criteria|1
5099561|NCT01939977|17612263|P2|Overall Study|Withdrawal by Subject|2
5099562|NCT01939977|17612264|P1|Overall Study|Withdrawal by Subject|0
5099563|NCT01939977|17612263|P2|Overall Study|Physician Decision|1
5099564|NCT01939977|17612264|P1|Overall Study|Physician Decision|1
5099565|NCT01939977|17612263|P2|Overall Study|Lack of Efficacy|0
5099566|NCT01939977|17612264|P1|Overall Study|Lack of Efficacy|3
5099567|NCT01939977|17612263|P2|Overall Study|Adverse Event|3
5099568|NCT01939977|17612264|P1|Overall Study|Adverse Event|4
5099569|NCT01939899|17612311|P5|Phase 2|Disease Progression|1
5099570|NCT01939899|17612312|P4|Phase 2|Disease Progression|9
5099571|NCT01939899|17612313|P3|Phase 2|Disease Progression|0
5099572|NCT01939899|17612314|P2|Phase 2|Disease Progression|0
5099573|NCT01939899|17612315|P1|Phase 2|Disease Progression|0
5099574|NCT01939899|17612311|P5|Phase 2|Withdrawal by Subject|0
5099575|NCT01939899|17612312|P4|Phase 2|Withdrawal by Subject|2
5099576|NCT01939899|17612313|P3|Phase 2|Withdrawal by Subject|0
5099577|NCT01939899|17612314|P2|Phase 2|Withdrawal by Subject|0
5099578|NCT01939899|17612315|P1|Phase 2|Withdrawal by Subject|0
5099579|NCT01939899|17612311|P5|Lead-in Dose Finding Phase|Other|0
5099580|NCT01939899|17612312|P4|Lead-in Dose Finding Phase|Other|0
5099581|NCT01939899|17612313|P3|Lead-in Dose Finding Phase|Other|1
5099582|NCT01939899|17612314|P2|Lead-in Dose Finding Phase|Other|0
5099583|NCT01939899|17612315|P1|Lead-in Dose Finding Phase|Other|0
5099584|NCT01939899|17612311|P5|Lead-in Dose Finding Phase|Disease Progression|0
5099585|NCT01939899|17612312|P4|Lead-in Dose Finding Phase|Disease Progression|0
5099586|NCT01939899|17612313|P3|Lead-in Dose Finding Phase|Disease Progression|3
5099587|NCT01939899|17612314|P2|Lead-in Dose Finding Phase|Disease Progression|4
5099588|NCT01939899|17612315|P1|Lead-in Dose Finding Phase|Disease Progression|2
5099589|NCT01939899|17612311|P5|Lead-in Dose Finding Phase|Death|0
5099590|NCT01939899|17612312|P4|Lead-in Dose Finding Phase|Death|0
5099591|NCT01939899|17612313|P3|Lead-in Dose Finding Phase|Death|1
5099592|NCT01939899|17612314|P2|Lead-in Dose Finding Phase|Death|3
5099593|NCT01939899|17612315|P1|Lead-in Dose Finding Phase|Death|0
5099594|NCT01939548|17612362|P3|Overall Study|Did not complete follow-up|0
5099595|NCT01939548|17612363|P2|Overall Study|Did not complete follow-up|1
5099596|NCT01939548|17612364|P1|Overall Study|Did not complete follow-up|0
5099597|NCT01939548|17612362|P3|Overall Study|Participant withdrew consent|0
5099598|NCT01939548|17612363|P2|Overall Study|Participant withdrew consent|2
5099599|NCT01939548|17612364|P1|Overall Study|Participant withdrew consent|0
5099600|NCT01939548|17612362|P3|Overall Study|Participant unwilling to continue|0
5099601|NCT01939548|17612363|P2|Overall Study|Participant unwilling to continue|1
5099602|NCT01939548|17612364|P1|Overall Study|Participant unwilling to continue|0
5099603|NCT01939548|17612362|P3|Overall Study|Participant dropped|1
5099604|NCT01939548|17612363|P2|Overall Study|Participant dropped|0
5099605|NCT01939548|17612364|P1|Overall Study|Participant dropped|0
5099606|NCT01939548|17612362|P3|Overall Study|Death|1
5099607|NCT01939548|17612363|P2|Overall Study|Death|0
5099608|NCT01939548|17612364|P1|Overall Study|Death|0
5099609|NCT01939548|17612362|P3|Overall Study|Adverse Event|7
5099610|NCT01939548|17612363|P2|Overall Study|Adverse Event|9
5099611|NCT01939548|17612364|P1|Overall Study|Adverse Event|2
5099612|NCT01939548|17612362|P3|Overall Study|Lost to Follow-up|3
5099613|NCT01939548|17612363|P2|Overall Study|Lost to Follow-up|5
5099614|NCT01939548|17612364|P1|Overall Study|Lost to Follow-up|5
5099615|NCT01939548|17612362|P3|Overall Study|Protocol Violation|5
5099616|NCT01939548|17612363|P2|Overall Study|Protocol Violation|6
5099617|NCT01939548|17612364|P1|Overall Study|Protocol Violation|7
5099618|NCT01939548|17612362|P3|Overall Study|Withdrawal by Subject|1
5099619|NCT01939548|17612363|P2|Overall Study|Withdrawal by Subject|4
5099620|NCT01939548|17612364|P1|Overall Study|Withdrawal by Subject|4
5099621|NCT01939548|17612362|P3|Overall Study|Did Not Meet Entrance Criteria|0
5099622|NCT01939548|17612363|P2|Overall Study|Did Not Meet Entrance Criteria|0
5099623|NCT01939548|17612364|P1|Overall Study|Did Not Meet Entrance Criteria|1
5099624|NCT01939548|17612362|P3|Overall Study|Insufficient Clinical Response|0
5099625|NCT01939548|17612363|P2|Overall Study|Insufficient Clinical Response|0
5099626|NCT01939548|17612364|P1|Overall Study|Insufficient Clinical Response|1
5099627|NCT01939548|17612362|P3|Overall Study|Study Terminated by Sponsor|12
5099628|NCT01939548|17612363|P2|Overall Study|Study Terminated by Sponsor|19
5099629|NCT01939548|17612364|P1|Overall Study|Study Terminated by Sponsor|17
5099630|NCT01939548|17612362|P3|Overall Study|Non compliance|0
5099631|NCT01939548|17612363|P2|Overall Study|Non compliance|2
5099632|NCT01939548|17612364|P1|Overall Study|Non compliance|0
5099633|NCT01939496|17612438|P3|Overall Study|Other|1
5099634|NCT01939496|17612439|P2|Overall Study|Other|0
5099635|NCT01939496|17612440|P1|Overall Study|Other|2
5099636|NCT01939496|17612438|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
5099637|NCT01939496|17612439|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
5099638|NCT01939496|17612440|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
5099639|NCT01939496|17612438|P3|Overall Study|Withdrawal by Subject|1
5099640|NCT01939496|17612439|P2|Overall Study|Withdrawal by Subject|1
5099641|NCT01939496|17612440|P1|Overall Study|Withdrawal by Subject|0
5099642|NCT01939496|17612438|P3|Overall Study|Protocol Violation|0
5099643|NCT01939496|17612439|P2|Overall Study|Protocol Violation|0
5099644|NCT01939496|17612440|P1|Overall Study|Protocol Violation|3
5099645|NCT01939496|17612438|P3|Overall Study|Physician Decision|0
5099646|NCT01939496|17612439|P2|Overall Study|Physician Decision|0
5099647|NCT01939496|17612440|P1|Overall Study|Physician Decision|1
5099648|NCT01939496|17612438|P3|Overall Study|Lost to Follow-up|0
5099649|NCT01939496|17612439|P2|Overall Study|Lost to Follow-up|1
5099650|NCT01939496|17612440|P1|Overall Study|Lost to Follow-up|1
5099651|NCT01939496|17612438|P3|Overall Study|Adverse Event|0
5099652|NCT01939496|17612439|P2|Overall Study|Adverse Event|0
5099653|NCT01939496|17612440|P1|Overall Study|Adverse Event|2
5099654|NCT01939366|17612510|P5|Overall Study|GCP non-compliance at site|3
5099655|NCT01939366|17612511|P4|Overall Study|GCP non-compliance at site|3
5099656|NCT01939366|17612512|P3|Overall Study|GCP non-compliance at site|2
5099657|NCT01939366|17612513|P2|Overall Study|GCP non-compliance at site|3
5099658|NCT01939366|17612514|P1|Overall Study|GCP non-compliance at site|2
5099659|NCT01939366|17612510|P5|Overall Study|Sponsor decision|2
5099660|NCT01939366|17612511|P4|Overall Study|Sponsor decision|0
5099661|NCT01939366|17612512|P3|Overall Study|Sponsor decision|0
5099662|NCT01939366|17612513|P2|Overall Study|Sponsor decision|0
5099663|NCT01939366|17612514|P1|Overall Study|Sponsor decision|0
5099664|NCT01939366|17612510|P5|Overall Study|Protocol Violation|0
5099665|NCT01939366|17612511|P4|Overall Study|Protocol Violation|1
5099666|NCT01939366|17612512|P3|Overall Study|Protocol Violation|0
5099667|NCT01939366|17612513|P2|Overall Study|Protocol Violation|0
5099668|NCT01939366|17612514|P1|Overall Study|Protocol Violation|0
5099669|NCT01939366|17612510|P5|Overall Study|Other|1
5099670|NCT01939366|17612511|P4|Overall Study|Other|2
5099671|NCT01939366|17612512|P3|Overall Study|Other|2
5099672|NCT01939366|17612513|P2|Overall Study|Other|0
5099673|NCT01939366|17612514|P1|Overall Study|Other|0
5099674|NCT01939366|17612510|P5|Overall Study|Inclusion criteria not met|1
5099675|NCT01939366|17612511|P4|Overall Study|Inclusion criteria not met|0
5099676|NCT01939366|17612512|P3|Overall Study|Inclusion criteria not met|1
5099677|NCT01939366|17612513|P2|Overall Study|Inclusion criteria not met|1
5099678|NCT01939366|17612514|P1|Overall Study|Inclusion criteria not met|0
5099679|NCT01939366|17612510|P5|Overall Study|Withdrawal by Subject|3
5099680|NCT01939366|17612511|P4|Overall Study|Withdrawal by Subject|2
5099681|NCT01939366|17612512|P3|Overall Study|Withdrawal by Subject|2
5099682|NCT01939366|17612513|P2|Overall Study|Withdrawal by Subject|0
5099683|NCT01939366|17612514|P1|Overall Study|Withdrawal by Subject|1
5099684|NCT01939366|17612510|P5|Overall Study|Lost to Follow-up|0
5099685|NCT01939366|17612511|P4|Overall Study|Lost to Follow-up|0
5099686|NCT01939366|17612512|P3|Overall Study|Lost to Follow-up|0
5099687|NCT01939366|17612513|P2|Overall Study|Lost to Follow-up|1
5099688|NCT01939366|17612514|P1|Overall Study|Lost to Follow-up|1
5099689|NCT01939366|17612510|P5|Overall Study|Lack of Efficacy|3
5099690|NCT01939366|17612511|P4|Overall Study|Lack of Efficacy|1
5099691|NCT01939366|17612512|P3|Overall Study|Lack of Efficacy|1
5099692|NCT01939366|17612513|P2|Overall Study|Lack of Efficacy|1
5099693|NCT01939366|17612514|P1|Overall Study|Lack of Efficacy|2
5099694|NCT01939366|17612510|P5|Overall Study|Adverse Event|5
5099695|NCT01939366|17612511|P4|Overall Study|Adverse Event|8
5099696|NCT01939366|17612512|P3|Overall Study|Adverse Event|30
5099697|NCT01939366|17612513|P2|Overall Study|Adverse Event|17
5099698|NCT01939366|17612514|P1|Overall Study|Adverse Event|8
5099699|NCT01939314|17612528|P2|Overall Study|Lost to Follow-up|6
5099700|NCT01939314|17612529|P1|Overall Study|Lost to Follow-up|5
5099701|NCT01939314|17612528|P2|Overall Study|Pregnancy|1
5099702|NCT01939314|17612529|P1|Overall Study|Pregnancy|0
5099703|NCT01939314|17612528|P2|Overall Study|Protocol Violation|0
5099704|NCT01939314|17612529|P1|Overall Study|Protocol Violation|1
5099705|NCT01939314|17612528|P2|Overall Study|Withdrawal by Subject|1
5099706|NCT01939314|17612529|P1|Overall Study|Withdrawal by Subject|3
5099707|NCT01939223|17612563|P2|Overall Study|Withdrawal by Subject|0
5099708|NCT01939223|17612564|P1|Overall Study|Withdrawal by Subject|6
5099709|NCT01939223|17612563|P2|Overall Study|Study stopped by Sponsor|7
5099710|NCT01939223|17612564|P1|Overall Study|Study stopped by Sponsor|5
5099711|NCT01939223|17612563|P2|Overall Study|Disease recurrence (radiological)|3
5099712|NCT01939223|17612564|P1|Overall Study|Disease recurrence (radiological)|1
5099713|NCT01939223|17612563|P2|Overall Study|AE not assoc. with disease recurrence|1
5099714|NCT01939223|17612564|P1|Overall Study|AE not assoc. with disease recurrence|1
5099715|NCT01939197|17612579|P7|Overall Study|Lost to Follow-up|2
5099716|NCT01939197|17612580|P6|Overall Study|Lost to Follow-up|1
5099717|NCT01939197|17612581|P5|Overall Study|Lost to Follow-up|3
5099718|NCT01939197|17612582|P4|Overall Study|Lost to Follow-up|1
5099719|NCT01939197|17612583|P3|Overall Study|Lost to Follow-up|0
5099720|NCT01939197|17612584|P2|Overall Study|Lost to Follow-up|1
5099721|NCT01939197|17612585|P1|Overall Study|Lost to Follow-up|0
5099722|NCT01939197|17612579|P7|Overall Study|Withdrawal by Subject|0
5099723|NCT01939197|17612580|P6|Overall Study|Withdrawal by Subject|0
5099724|NCT01939197|17612581|P5|Overall Study|Withdrawal by Subject|1
5099725|NCT01939197|17612582|P4|Overall Study|Withdrawal by Subject|0
5099726|NCT01939197|17612583|P3|Overall Study|Withdrawal by Subject|0
5099727|NCT01939197|17612584|P2|Overall Study|Withdrawal by Subject|0
5099728|NCT01939197|17612585|P1|Overall Study|Withdrawal by Subject|1
5099729|NCT01939028|17612654|P1|Overall Study|Physician Decision|7
5099730|NCT01939028|17612654|P1|Overall Study|Withdrawal by Subject|5
5099731|NCT01939002|17612667|P2|Overall Study|Other|2
5099732|NCT01939002|17612668|P1|Overall Study|Other|1
5099733|NCT01939002|17612667|P2|Overall Study|Withdrawal by Subject|3
5099734|NCT01939002|17612668|P1|Overall Study|Withdrawal by Subject|5
5099735|NCT01939002|17612667|P2|Overall Study|Adverse Event|13
5099736|NCT01939002|17612668|P1|Overall Study|Adverse Event|13
5099737|NCT01938846|17612744|P3|Overall Study|Other than listed|4
5099738|NCT01938846|17612745|P2|Overall Study|Other than listed|1
5099739|NCT01938846|17612746|P1|Overall Study|Other than listed|5
5099740|NCT01938846|17612744|P3|Overall Study|Withdrawal by Subject|1
5099741|NCT01938846|17612745|P2|Overall Study|Withdrawal by Subject|2
5099742|NCT01938846|17612746|P1|Overall Study|Withdrawal by Subject|2
5099743|NCT01938846|17612744|P3|Overall Study|Adverse Event|3
5099744|NCT01938846|17612745|P2|Overall Study|Adverse Event|4
5099745|NCT01938846|17612746|P1|Overall Study|Adverse Event|8
5099746|NCT01938846|17612744|P3|Overall Study|Progressive disease|16
5099747|NCT01938846|17612745|P2|Overall Study|Progressive disease|18
5099748|NCT01938846|17612746|P1|Overall Study|Progressive disease|26
5099749|NCT01938716|17612946|P1|Overall Study|Withdrawal by Subject|2
5099750|NCT01938716|17612946|P1|Overall Study|Physician Decision|2
5099751|NCT01938625|17612969|P2|Overall Study|Adverse Event|1
5099752|NCT01938625|17612970|P1|Overall Study|Adverse Event|0
5099753|NCT01938625|17612969|P2|Overall Study|Withdrawal by Subject|1
5099754|NCT01938625|17612970|P1|Overall Study|Withdrawal by Subject|0
5099755|NCT01938573|17612990|P2|Overall Study|Operation at other hospital|0
5099756|NCT01938573|17612991|P1|Overall Study|Operation at other hospital|1
5099757|NCT01938573|17612990|P2|Overall Study|Lack of Efficacy|0
5099758|NCT01938573|17612991|P1|Overall Study|Lack of Efficacy|1
5099759|NCT01938430|17613011|P14|Overall Study|Withdrew Consent|0
5099760|NCT01938430|17613012|P13|Overall Study|Withdrew Consent|0
5099761|NCT01938430|17613013|P12|Overall Study|Withdrew Consent|0
5099762|NCT01938430|17613014|P11|Overall Study|Withdrew Consent|0
5099763|NCT01938430|17613015|P10|Overall Study|Withdrew Consent|0
5099764|NCT01938430|17613016|P9|Overall Study|Withdrew Consent|1
5099765|NCT01938430|17613017|P8|Overall Study|Withdrew Consent|0
5099766|NCT01938430|17613018|P7|Overall Study|Withdrew Consent|0
5099767|NCT01938430|17613019|P6|Overall Study|Withdrew Consent|0
5099768|NCT01938430|17613020|P5|Overall Study|Withdrew Consent|0
5099769|NCT01938430|17613021|P4|Overall Study|Withdrew Consent|0
5099770|NCT01938430|17613022|P3|Overall Study|Withdrew Consent|0
5099771|NCT01938430|17613023|P2|Overall Study|Withdrew Consent|0
5099772|NCT01938430|17613024|P1|Overall Study|Withdrew Consent|0
5099773|NCT01938430|17613011|P14|Overall Study|Lost to Follow-up|0
5099774|NCT01938430|17613012|P13|Overall Study|Lost to Follow-up|0
5099775|NCT01938430|17613013|P12|Overall Study|Lost to Follow-up|0
5099776|NCT01938430|17613014|P11|Overall Study|Lost to Follow-up|0
5099777|NCT01938430|17613015|P10|Overall Study|Lost to Follow-up|0
5099778|NCT01938430|17613016|P9|Overall Study|Lost to Follow-up|0
5099779|NCT01938430|17613017|P8|Overall Study|Lost to Follow-up|0
5099780|NCT01938430|17613018|P7|Overall Study|Lost to Follow-up|0
5099781|NCT01938430|17613019|P6|Overall Study|Lost to Follow-up|1
5099782|NCT01938430|17613020|P5|Overall Study|Lost to Follow-up|0
5099783|NCT01938430|17613021|P4|Overall Study|Lost to Follow-up|0
5099784|NCT01938430|17613022|P3|Overall Study|Lost to Follow-up|1
5099785|NCT01938430|17613023|P2|Overall Study|Lost to Follow-up|0
5099786|NCT01938430|17613024|P1|Overall Study|Lost to Follow-up|0
5099787|NCT01938430|17613011|P14|Overall Study|Lack of Efficacy|0
5099788|NCT01938430|17613012|P13|Overall Study|Lack of Efficacy|0
5099789|NCT01938430|17613013|P12|Overall Study|Lack of Efficacy|1
5099790|NCT01938430|17613014|P11|Overall Study|Lack of Efficacy|2
5099791|NCT01938430|17613015|P10|Overall Study|Lack of Efficacy|0
5099792|NCT01938430|17613016|P9|Overall Study|Lack of Efficacy|1
5099793|NCT01938430|17613017|P8|Overall Study|Lack of Efficacy|0
5099794|NCT01938430|17613018|P7|Overall Study|Lack of Efficacy|0
5099795|NCT01938430|17613019|P6|Overall Study|Lack of Efficacy|0
5099796|NCT01938430|17613020|P5|Overall Study|Lack of Efficacy|0
5099797|NCT01938430|17613021|P4|Overall Study|Lack of Efficacy|1
5099798|NCT01938430|17613022|P3|Overall Study|Lack of Efficacy|1
5099799|NCT01938430|17613023|P2|Overall Study|Lack of Efficacy|1
5099800|NCT01938430|17613024|P1|Overall Study|Lack of Efficacy|3
5099801|NCT01938430|17613011|P14|Overall Study|Investigator's Discretion|0
5099802|NCT01938430|17613012|P13|Overall Study|Investigator's Discretion|0
5099803|NCT01938430|17613013|P12|Overall Study|Investigator's Discretion|0
5099804|NCT01938430|17613014|P11|Overall Study|Investigator's Discretion|0
5099805|NCT01938430|17613015|P10|Overall Study|Investigator's Discretion|0
5099806|NCT01938430|17613016|P9|Overall Study|Investigator's Discretion|0
5099807|NCT01938430|17613017|P8|Overall Study|Investigator's Discretion|0
5099808|NCT01938430|17613018|P7|Overall Study|Investigator's Discretion|0
5099809|NCT01938430|17613019|P6|Overall Study|Investigator's Discretion|0
5099810|NCT01938430|17613020|P5|Overall Study|Investigator's Discretion|0
5099811|NCT01938430|17613021|P4|Overall Study|Investigator's Discretion|0
5099812|NCT01938430|17613022|P3|Overall Study|Investigator's Discretion|1
5099813|NCT01938430|17613023|P2|Overall Study|Investigator's Discretion|0
5099814|NCT01938430|17613024|P1|Overall Study|Investigator's Discretion|0
5099815|NCT01938430|17613011|P14|Overall Study|Death|0
5099816|NCT01938430|17613012|P13|Overall Study|Death|0
5099817|NCT01938430|17613013|P12|Overall Study|Death|0
5099818|NCT01938430|17613014|P11|Overall Study|Death|0
5099819|NCT01938430|17613015|P10|Overall Study|Death|3
5099820|NCT01938430|17613016|P9|Overall Study|Death|2
5099821|NCT01938430|17613017|P8|Overall Study|Death|1
5099822|NCT01938430|17613018|P7|Overall Study|Death|1
5099823|NCT01938430|17613019|P6|Overall Study|Death|0
5099824|NCT01938430|17613020|P5|Overall Study|Death|0
5099825|NCT01938430|17613021|P4|Overall Study|Death|1
5099826|NCT01938430|17613022|P3|Overall Study|Death|2
5099827|NCT01938430|17613023|P2|Overall Study|Death|2
5099828|NCT01938430|17613024|P1|Overall Study|Death|1
5099829|NCT01938430|17613011|P14|Overall Study|Adverse Event|0
5099830|NCT01938430|17613012|P13|Overall Study|Adverse Event|0
5099831|NCT01938430|17613013|P12|Overall Study|Adverse Event|0
5099832|NCT01938430|17613014|P11|Overall Study|Adverse Event|0
5099833|NCT01938430|17613015|P10|Overall Study|Adverse Event|0
5099834|NCT01938430|17613016|P9|Overall Study|Adverse Event|0
5099835|NCT01938430|17613017|P8|Overall Study|Adverse Event|0
5099836|NCT01938430|17613018|P7|Overall Study|Adverse Event|1
5099837|NCT01938430|17613019|P6|Overall Study|Adverse Event|0
5099838|NCT01938430|17613020|P5|Overall Study|Adverse Event|0
5099839|NCT01938430|17613021|P4|Overall Study|Adverse Event|0
5099840|NCT01938430|17613022|P3|Overall Study|Adverse Event|0
5099841|NCT01938430|17613023|P2|Overall Study|Adverse Event|0
5099842|NCT01938430|17613024|P1|Overall Study|Adverse Event|0
5099843|NCT01938430|17613011|P14|Overall Study|Randomized but Not Treated|1
5099844|NCT01938430|17613012|P13|Overall Study|Randomized but Not Treated|0
5099845|NCT01938430|17613013|P12|Overall Study|Randomized but Not Treated|0
5099846|NCT01938430|17613014|P11|Overall Study|Randomized but Not Treated|1
5099847|NCT01938430|17613015|P10|Overall Study|Randomized but Not Treated|0
5099848|NCT01938430|17613016|P9|Overall Study|Randomized but Not Treated|0
5099849|NCT01938430|17613017|P8|Overall Study|Randomized but Not Treated|0
5099850|NCT01938430|17613018|P7|Overall Study|Randomized but Not Treated|0
5099851|NCT01938430|17613019|P6|Overall Study|Randomized but Not Treated|0
5099852|NCT01938430|17613020|P5|Overall Study|Randomized but Not Treated|0
5099853|NCT01938430|17613021|P4|Overall Study|Randomized but Not Treated|0
5099854|NCT01938430|17613022|P3|Overall Study|Randomized but Not Treated|0
5099855|NCT01938430|17613023|P2|Overall Study|Randomized but Not Treated|0
5099856|NCT01938430|17613024|P1|Overall Study|Randomized but Not Treated|0
5099857|NCT01938391|17613349|P1|12 Month Follow up|Withdrawal by Subject|1
5099858|NCT01938391|17613349|P1|12 Month Follow up|Physician Decision|1
5099859|NCT01938391|17613349|P1|6 Month Follow up|Withdrawal by Subject|1
5099860|NCT01938001|17613483|P2|Overall Study|Death|26
5099861|NCT01938001|17613484|P1|Overall Study|Death|16
5099862|NCT01938001|17613483|P2|Overall Study|Lost to Follow-up|3
5099863|NCT01938001|17613484|P1|Overall Study|Lost to Follow-up|1
5099864|NCT01938001|17613483|P2|Overall Study|Participant Moved|1
5099865|NCT01938001|17613484|P1|Overall Study|Participant Moved|0
5099866|NCT01938001|17613483|P2|Overall Study|Non-compliant|0
5099867|NCT01938001|17613484|P1|Overall Study|Non-compliant|1
5099868|NCT01938001|17613483|P2|Overall Study|Withdrawal by Subject|17
5099869|NCT01938001|17613484|P1|Overall Study|Withdrawal by Subject|25
5099870|NCT01937871|17613563|P3|Overall Study|Entry Criteria Not Met|1
5099871|NCT01937871|17613564|P2|Overall Study|Entry Criteria Not Met|2
5099872|NCT01937871|17613565|P1|Overall Study|Entry Criteria Not Met|1
5099873|NCT01937871|17613563|P3|Overall Study|Physician Decision|0
5099874|NCT01937871|17613564|P2|Overall Study|Physician Decision|1
5099875|NCT01937871|17613565|P1|Overall Study|Physician Decision|0
5099876|NCT01937871|17613563|P3|Overall Study|Withdrawal by Subject|4
5099877|NCT01937871|17613564|P2|Overall Study|Withdrawal by Subject|6
5099878|NCT01937871|17613565|P1|Overall Study|Withdrawal by Subject|9
5099879|NCT01937871|17613563|P3|Overall Study|Lost to Follow-up|4
5099880|NCT01937871|17613564|P2|Overall Study|Lost to Follow-up|2
5099881|NCT01937871|17613565|P1|Overall Study|Lost to Follow-up|8
5099882|NCT01937871|17613563|P3|Overall Study|Adverse Event|2
5099883|NCT01937871|17613564|P2|Overall Study|Adverse Event|6
5099884|NCT01937871|17613565|P1|Overall Study|Adverse Event|6
5099885|NCT01937715|17613641|P5|Overall Study|Other|0
5099886|NCT01937715|17613642|P4|Overall Study|Other|3
5099887|NCT01937715|17613643|P3|Overall Study|Other|0
5099888|NCT01937715|17613644|P2|Overall Study|Other|0
5099889|NCT01937715|17613645|P1|Overall Study|Other|0
5099890|NCT01937715|17613641|P5|Overall Study|Withdrawal by Subject|2
5099891|NCT01937715|17613642|P4|Overall Study|Withdrawal by Subject|0
5099892|NCT01937715|17613643|P3|Overall Study|Withdrawal by Subject|0
5099893|NCT01937715|17613644|P2|Overall Study|Withdrawal by Subject|1
5099894|NCT01937715|17613645|P1|Overall Study|Withdrawal by Subject|0
5099895|NCT01937715|17613641|P5|Overall Study|Death|0
5099896|NCT01937715|17613642|P4|Overall Study|Death|1
5099897|NCT01937715|17613643|P3|Overall Study|Death|0
5099898|NCT01937715|17613644|P2|Overall Study|Death|0
5099899|NCT01937715|17613645|P1|Overall Study|Death|0
5099900|NCT01937559|17613797|P3|Overall Study|screen fail|0
5099901|NCT01937559|17613798|P2|Overall Study|screen fail|4
5099902|NCT01937559|17613799|P1|Overall Study|screen fail|2
5099903|NCT01937559|17613797|P3|Overall Study|Withdrawal by Subject|0
5099904|NCT01937559|17613798|P2|Overall Study|Withdrawal by Subject|4
5099905|NCT01937559|17613799|P1|Overall Study|Withdrawal by Subject|6
5099906|NCT01937559|17613797|P3|Overall Study|Physician Decision|0
5099907|NCT01937559|17613798|P2|Overall Study|Physician Decision|3
5099908|NCT01937559|17613799|P1|Overall Study|Physician Decision|3
5099909|NCT01937390|17613869|P1|Overall Study|Fail to return|21
5099910|NCT01937390|17613869|P1|Overall Study|Withdrawal by Subject|5
5099911|NCT01937390|17613869|P1|Overall Study|Lost to Follow-up|7
5099912|NCT01937390|17613869|P1|Overall Study|Death|2
5099913|NCT01937364|17613879|P2|Overall Study|Adverse Event|1
5099914|NCT01937364|17613880|P1|Overall Study|Adverse Event|2
5099915|NCT01937351|17613892|P2|Overall Study|Not treated w device, per protocol fail|0
5099916|NCT01937351|17613893|P1|Overall Study|Not treated w device, per protocol fail|4
5099917|NCT01937351|17613892|P2|Overall Study|Death|0
5099918|NCT01937351|17613893|P1|Overall Study|Death|1
5099919|NCT01937351|17613892|P2|Overall Study|Withdrawal by Subject|2
5099920|NCT01937351|17613893|P1|Overall Study|Withdrawal by Subject|4
5099921|NCT01937312|17613901|P2|Overall Study|Withdrawal of subject prior to treatment|1
5099922|NCT01937312|17613902|P1|Overall Study|Withdrawal of subject prior to treatment|1
5099923|NCT01937312|17613901|P2|Overall Study|Lack of Efficacy|1
5099924|NCT01937312|17613902|P1|Overall Study|Lack of Efficacy|0
5099925|NCT01937312|17613901|P2|Overall Study|Adverse Event|1
5099926|NCT01937312|17613902|P1|Overall Study|Adverse Event|10
5099927|NCT01937299|17613917|P2|Overall Study|Withdrawal by Subject|0
5099928|NCT01937299|17613918|P1|Overall Study|Withdrawal by Subject|1
5099929|NCT01937299|17613917|P2|Overall Study|Lack of Efficacy|4
5099930|NCT01937299|17613918|P1|Overall Study|Lack of Efficacy|0
5099931|NCT01937299|17613917|P2|Overall Study|Adverse Event|0
5099932|NCT01937299|17613918|P1|Overall Study|Adverse Event|13
5099933|NCT01937130|17613953|P4|Overall Study|Patient lost to FU due to death|0
5099934|NCT01937130|17613954|P3|Overall Study|Patient lost to FU due to death|0
5099935|NCT01937130|17613955|P2|Overall Study|Patient lost to FU due to death|0
5099936|NCT01937130|17613956|P1|Overall Study|Patient lost to FU due to death|2
5099937|NCT01937130|17613953|P4|Overall Study|Patients unable to swallow|0
5099938|NCT01937130|17613954|P3|Overall Study|Patients unable to swallow|0
5099939|NCT01937130|17613955|P2|Overall Study|Patients unable to swallow|1
5099940|NCT01937130|17613956|P1|Overall Study|Patients unable to swallow|0
5099941|NCT01937130|17613953|P4|Overall Study|Physician Decision|0
5099942|NCT01937130|17613954|P3|Overall Study|Physician Decision|0
5099943|NCT01937130|17613955|P2|Overall Study|Physician Decision|1
5099944|NCT01937130|17613956|P1|Overall Study|Physician Decision|0
5099945|NCT01937130|17613953|P4|Overall Study|Lost to Follow-up|0
5099946|NCT01937130|17613954|P3|Overall Study|Lost to Follow-up|2
5099947|NCT01937130|17613955|P2|Overall Study|Lost to Follow-up|0
5099948|NCT01937130|17613956|P1|Overall Study|Lost to Follow-up|2
5099949|NCT01937130|17613953|P4|Overall Study|Death|0
5099950|NCT01937130|17613954|P3|Overall Study|Death|1
5099951|NCT01937130|17613955|P2|Overall Study|Death|1
5099952|NCT01937130|17613956|P1|Overall Study|Death|1
5099953|NCT01937130|17613953|P4|Overall Study|Adverse Event|1
5099954|NCT01937130|17613954|P3|Overall Study|Adverse Event|0
5099955|NCT01937130|17613955|P2|Overall Study|Adverse Event|1
5099956|NCT01937130|17613956|P1|Overall Study|Adverse Event|0
5099957|NCT01937130|17613953|P4|Overall Study|Withdrawal by Subject|1
5099958|NCT01937130|17613954|P3|Overall Study|Withdrawal by Subject|0
5099959|NCT01937130|17613955|P2|Overall Study|Withdrawal by Subject|0
5099960|NCT01937130|17613956|P1|Overall Study|Withdrawal by Subject|0
5099961|NCT01937117|17613983|P1|Overall Study|Adverse Event|2
5099962|NCT01937117|17613983|P1|Overall Study|Physician Decision|4
5099963|NCT01937117|17613983|P1|Overall Study|Disease Progression|7
5099964|NCT01936974|17613998|P2|Overall Study|Physician Decision|5
5099965|NCT01936974|17613999|P1|Overall Study|Physician Decision|2
5099966|NCT01936870|17614029|P1|Overall Study|No Drug Administration|1
5099967|NCT01936870|17614029|P1|Overall Study|Protocol Violation|12
5099968|NCT01936870|17614029|P1|Overall Study|No Visit After Treatment|176
5099969|NCT01936857|17614044|P2|Overall Study|Other|2
5099970|NCT01936857|17614045|P1|Overall Study|Other|2
5099971|NCT01936857|17614044|P2|Overall Study|Side effect of medication|0
5099972|NCT01936857|17614045|P1|Overall Study|Side effect of medication|1
5099973|NCT01936857|17614044|P2|Overall Study|Withdrawal by Subject|0
5099974|NCT01936857|17614045|P1|Overall Study|Withdrawal by Subject|1
5099975|NCT01936857|17614044|P2|Overall Study|Moved|1
5099976|NCT01936857|17614045|P1|Overall Study|Moved|2
5099977|NCT01936857|17614044|P2|Overall Study|Death|3
5099978|NCT01936857|17614045|P1|Overall Study|Death|7
5099979|NCT01936857|17614044|P2|Overall Study|Lost to Follow-up|7
5099980|NCT01936857|17614045|P1|Overall Study|Lost to Follow-up|10
5099981|NCT01936857|17614044|P2|Overall Study|Sent to prison or 06 center|12
5099982|NCT01936857|17614045|P1|Overall Study|Sent to prison or 06 center|11
5099983|NCT01936649|17614075|P1|Overall Study|Other than specified above|5
5099984|NCT01936649|17614075|P1|Overall Study|Protocol Violation|2
5099985|NCT01936649|17614075|P1|Overall Study|Physician Decision|2
5099986|NCT01936649|17614075|P1|Overall Study|Withdrawal by Subject|4
5099987|NCT01936623|17614082|P2|Overall Study|Lost to Follow-up|5
5099988|NCT01936623|17614083|P1|Overall Study|Lost to Follow-up|0
5099989|NCT01936181|17614191|P4|Transition-extension|Withdrawal by Subject|1
5099990|NCT01936181|17614192|P3|Transition-extension|Withdrawal by Subject|2
5099991|NCT01936181|17614193|P2|Transition-extension|Withdrawal by Subject|0
5099992|NCT01936181|17614194|P1|Transition-extension|Withdrawal by Subject|7
5099993|NCT01936181|17614191|P4|Transition-extension|Physician Decision|1
5099994|NCT01936181|17614192|P3|Transition-extension|Physician Decision|0
5099995|NCT01936181|17614193|P2|Transition-extension|Physician Decision|0
5099996|NCT01936181|17614194|P1|Transition-extension|Physician Decision|2
5099997|NCT01936181|17614191|P4|Transition-extension|Lost to Follow-up|2
5099998|NCT01936181|17614192|P3|Transition-extension|Lost to Follow-up|1
5099999|NCT01936181|17614193|P2|Transition-extension|Lost to Follow-up|0
5100000|NCT01936181|17614194|P1|Transition-extension|Lost to Follow-up|3
5100001|NCT01936181|17614191|P4|Transition-extension|Adverse Event|1
5100002|NCT01936181|17614192|P3|Transition-extension|Adverse Event|3
5100003|NCT01936181|17614193|P2|Transition-extension|Adverse Event|0
5100004|NCT01936181|17614194|P1|Transition-extension|Adverse Event|3
5100005|NCT01936181|17614191|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
5100006|NCT01936181|17614192|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
5100007|NCT01936181|17614193|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
5100008|NCT01936181|17614194|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
5100009|NCT01936181|17614191|P4|Randomised, Double-blind|Withdrawal by Subject|0
5100010|NCT01936181|17614192|P3|Randomised, Double-blind|Withdrawal by Subject|0
5100011|NCT01936181|17614193|P2|Randomised, Double-blind|Withdrawal by Subject|26
5100012|NCT01936181|17614194|P1|Randomised, Double-blind|Withdrawal by Subject|23
5100013|NCT01936181|17614191|P4|Randomised, Double-blind|Physician Decision|0
5100014|NCT01936181|17614192|P3|Randomised, Double-blind|Physician Decision|0
5100015|NCT01936181|17614193|P2|Randomised, Double-blind|Physician Decision|4
5100016|NCT01936181|17614194|P1|Randomised, Double-blind|Physician Decision|4
5100017|NCT01936181|17614191|P4|Randomised, Double-blind|Pregnancy|0
5100018|NCT01936181|17614192|P3|Randomised, Double-blind|Pregnancy|0
5100019|NCT01936181|17614193|P2|Randomised, Double-blind|Pregnancy|1
5100020|NCT01936181|17614194|P1|Randomised, Double-blind|Pregnancy|0
5100021|NCT01936181|17614191|P4|Randomised, Double-blind|Lost to Follow-up|0
5100022|NCT01936181|17614192|P3|Randomised, Double-blind|Lost to Follow-up|0
5100023|NCT01936181|17614193|P2|Randomised, Double-blind|Lost to Follow-up|1
5100024|NCT01936181|17614194|P1|Randomised, Double-blind|Lost to Follow-up|0
5100025|NCT01936181|17614191|P4|Randomised, Double-blind|Lack of Efficacy|0
5100026|NCT01936181|17614192|P3|Randomised, Double-blind|Lack of Efficacy|0
5100027|NCT01936181|17614193|P2|Randomised, Double-blind|Lack of Efficacy|6
5100028|NCT01936181|17614194|P1|Randomised, Double-blind|Lack of Efficacy|5
5100029|NCT01936181|17614191|P4|Randomised, Double-blind|Protocol Violation|0
5100030|NCT01936181|17614192|P3|Randomised, Double-blind|Protocol Violation|0
5100031|NCT01936181|17614193|P2|Randomised, Double-blind|Protocol Violation|5
5100032|NCT01936181|17614194|P1|Randomised, Double-blind|Protocol Violation|1
5100033|NCT01936181|17614191|P4|Randomised, Double-blind|Adverse Event|0
5100034|NCT01936181|17614192|P3|Randomised, Double-blind|Adverse Event|0
5100035|NCT01936181|17614193|P2|Randomised, Double-blind|Adverse Event|21
5100036|NCT01936181|17614194|P1|Randomised, Double-blind|Adverse Event|27
5100037|NCT01935947|17614208|P3|Overall Study|Death|0
5100038|NCT01935947|17614209|P2|Overall Study|Death|0
5100039|NCT01935947|17614210|P1|Overall Study|Death|1
5100040|NCT01935947|17614208|P3|Overall Study|Diease Progression|2
5100041|NCT01935947|17614209|P2|Overall Study|Diease Progression|2
5100042|NCT01935947|17614210|P1|Overall Study|Diease Progression|2
5100043|NCT01935947|17614208|P3|Overall Study|Adverse Event|0
5100044|NCT01935947|17614209|P2|Overall Study|Adverse Event|2
5100045|NCT01935947|17614210|P1|Overall Study|Adverse Event|0
5100046|NCT01935700|17614245|P2|Overall Study|Physician Decision|0
5100047|NCT01935700|17614246|P1|Overall Study|Physician Decision|4
5100048|NCT01935700|17614245|P2|Overall Study|Withdrawal by Subject|0
5100049|NCT01935700|17614246|P1|Overall Study|Withdrawal by Subject|1
5100050|NCT01934972|17614290|P2|Overall Study|Withdrawal by Subject|6
5100051|NCT01934972|17614291|P1|Overall Study|Withdrawal by Subject|9
5100052|NCT01934894|17614321|P2|Overall Study|Progressive Disease|2
5100053|NCT01934894|17614322|P1|Overall Study|Progressive Disease|3
5100054|NCT01934894|17614321|P2|Overall Study|Withdrawal by Subject|1
5100055|NCT01934894|17614322|P1|Overall Study|Withdrawal by Subject|0
5100056|NCT01934894|17614321|P2|Overall Study|Death|0
5100057|NCT01934894|17614322|P1|Overall Study|Death|2
5100058|NCT01934894|17614321|P2|Overall Study|Adverse Event|2
5100059|NCT01934894|17614322|P1|Overall Study|Adverse Event|1
5100060|NCT01934790|17614337|P1|Active Follow up|Other reason|1
5100061|NCT01934790|17614337|P1|Active Follow up|Progressive disease|1
5100062|NCT01934790|17614337|P1|Active Follow up|Physician Decision|2
5100063|NCT01934790|17614337|P1|Active Follow up|Death|20
5100064|NCT01934790|17614337|P1|Treatment|Study drug never administered|1
5100065|NCT01934790|17614337|P1|Treatment|Withdrawal by Subject|2
5100066|NCT01934790|17614337|P1|Treatment|Radiological progression|4
5100067|NCT01934790|17614337|P1|Treatment|Clinical progression|6
5100068|NCT01934790|17614337|P1|Treatment|Adverse Event|3
5100069|NCT01934556|17614395|P3|Overall Study|Death|2
5100070|NCT01934556|17614396|P2|Overall Study|Death|5
5100071|NCT01934556|17614397|P1|Overall Study|Death|1
5100072|NCT01934556|17614395|P3|Overall Study|Lost to Follow-up|7
5100073|NCT01934556|17614396|P2|Overall Study|Lost to Follow-up|10
5100074|NCT01934556|17614397|P1|Overall Study|Lost to Follow-up|4
5100075|NCT01934556|17614395|P3|Overall Study|Withdrawal by Subject|1
5100076|NCT01934556|17614396|P2|Overall Study|Withdrawal by Subject|1
5100077|NCT01934556|17614397|P1|Overall Study|Withdrawal by Subject|0
5100078|NCT01934504|17614441|P4|Overall Study|Study Terminated by Sponsor|5
5100079|NCT01934504|17614442|P3|Overall Study|Study Terminated by Sponsor|5
5100080|NCT01934504|17614443|P2|Overall Study|Study Terminated by Sponsor|0
5100081|NCT01934504|17614444|P1|Overall Study|Study Terminated by Sponsor|1
5100082|NCT01934504|17614441|P4|Overall Study|Protocol Deviation|2
5100083|NCT01934504|17614442|P3|Overall Study|Protocol Deviation|0
5100084|NCT01934504|17614443|P2|Overall Study|Protocol Deviation|0
5100085|NCT01934504|17614444|P1|Overall Study|Protocol Deviation|0
5100086|NCT01934218|17614477|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
5100087|NCT01934218|17614478|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
5100088|NCT01934218|17614477|P2|Open-Label Phase|Noncompliance with Study Protocol|2
5100089|NCT01934218|17614478|P1|Open-Label Phase|Noncompliance with Study Protocol|4
5100090|NCT01934218|17614477|P2|Open-Label Phase|Withdrawal by Subject|11
5100091|NCT01934218|17614478|P1|Open-Label Phase|Withdrawal by Subject|13
5100092|NCT01934218|17614477|P2|Open-Label Phase|Protocol Violation|0
5100093|NCT01934218|17614478|P1|Open-Label Phase|Protocol Violation|1
5100094|NCT01934218|17614477|P2|Open-Label Phase|Physician Decision|0
5100095|NCT01934218|17614478|P1|Open-Label Phase|Physician Decision|1
5100096|NCT01934218|17614477|P2|Open-Label Phase|Lost to Follow-up|2
5100097|NCT01934218|17614478|P1|Open-Label Phase|Lost to Follow-up|4
5100098|NCT01934218|17614477|P2|Open-Label Phase|Lack of Efficacy|4
5100099|NCT01934218|17614478|P1|Open-Label Phase|Lack of Efficacy|1
5100100|NCT01934218|17614477|P2|Open-Label Phase|Adverse Event|4
5100101|NCT01934218|17614478|P1|Open-Label Phase|Adverse Event|2
5100102|NCT01934218|17614477|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
5100103|NCT01934218|17614478|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
5100104|NCT01934218|17614477|P2|Double-blind Phase|Noncompliance with Study Protocol|8
5100105|NCT01934218|17614478|P1|Double-blind Phase|Noncompliance with Study Protocol|5
5100106|NCT01934218|17614477|P2|Double-blind Phase|Withdrawal by Subject|13
5100107|NCT01934218|17614478|P1|Double-blind Phase|Withdrawal by Subject|16
5100108|NCT01934218|17614477|P2|Double-blind Phase|Protocol Violation|0
5100109|NCT01934218|17614478|P1|Double-blind Phase|Protocol Violation|4
5100110|NCT01934218|17614477|P2|Double-blind Phase|Physician Decision|2
5100111|NCT01934218|17614478|P1|Double-blind Phase|Physician Decision|1
5100112|NCT01934218|17614477|P2|Double-blind Phase|Lost to Follow-up|14
5100113|NCT01934218|17614478|P1|Double-blind Phase|Lost to Follow-up|7
5100114|NCT01934218|17614477|P2|Double-blind Phase|Lack of Efficacy|7
5100115|NCT01934218|17614478|P1|Double-blind Phase|Lack of Efficacy|6
5100116|NCT01934218|17614477|P2|Double-blind Phase|Adverse Event|8
5100117|NCT01934218|17614478|P1|Double-blind Phase|Adverse Event|8
5100118|NCT01934192|17614489|P4|Overall Study|Physician Decision|0
5100119|NCT01934192|17614490|P3|Overall Study|Physician Decision|0
5100120|NCT01934192|17614491|P2|Overall Study|Physician Decision|2
5100121|NCT01934192|17614492|P1|Overall Study|Physician Decision|3
5100122|NCT01934192|17614489|P4|Overall Study|Other: reached stopping criteria|0
5100123|NCT01934192|17614490|P3|Overall Study|Other: reached stopping criteria|1
5100124|NCT01934192|17614491|P2|Overall Study|Other: reached stopping criteria|5
5100125|NCT01934192|17614492|P1|Overall Study|Other: reached stopping criteria|6
5100126|NCT01934192|17614489|P4|Overall Study|Protocol Violation|1
5100127|NCT01934192|17614490|P3|Overall Study|Protocol Violation|0
5100128|NCT01934192|17614491|P2|Overall Study|Protocol Violation|0
5100129|NCT01934192|17614492|P1|Overall Study|Protocol Violation|0
5100130|NCT01934140|17614628|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
5100131|NCT01934140|17614629|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
5100132|NCT01934140|17614628|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
5100133|NCT01934140|17614629|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
5100134|NCT01934140|17614628|P2|Booster Phase (6 Months)|Lost to Follow-up|0
5100135|NCT01934140|17614629|P1|Booster Phase (6 Months)|Lost to Follow-up|1
5100136|NCT01934140|17614628|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
5100137|NCT01934140|17614629|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
5100138|NCT01934140|17614628|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
5100139|NCT01934140|17614629|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
5100140|NCT01934140|17614628|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
5100141|NCT01934140|17614629|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
5100142|NCT01934140|17614628|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
5100143|NCT01934140|17614629|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
5100144|NCT01934140|17614628|P2|Persistence Phase (Year 6-10)|Other|6
5100145|NCT01934140|17614629|P1|Persistence Phase (Year 6-10)|Other|24
5100146|NCT01934010|17614680|P3|Overall Study|Lost to Follow-up|0
5100147|NCT01934010|17614681|P2|Overall Study|Lost to Follow-up|4
5100148|NCT01934010|17614682|P1|Overall Study|Lost to Follow-up|7
5100149|NCT01934010|17614680|P3|Overall Study|Withdrawal by Subject|2
5100150|NCT01934010|17614681|P2|Overall Study|Withdrawal by Subject|6
5100151|NCT01934010|17614682|P1|Overall Study|Withdrawal by Subject|15
5100152|NCT01934010|17614680|P3|Overall Study|Adverse Event|0
5100153|NCT01934010|17614681|P2|Overall Study|Adverse Event|1
5100154|NCT01934010|17614682|P1|Overall Study|Adverse Event|1
5100155|NCT01933932|17614724|P2|Overall Study|Eligibility criteria not fulfilled|1
5100156|NCT01933932|17614725|P1|Overall Study|Eligibility criteria not fulfilled|0
5100157|NCT01933932|17614724|P2|Overall Study|Withdrawal by Subject|14
5100158|NCT01933932|17614725|P1|Overall Study|Withdrawal by Subject|11
5100159|NCT01933932|17614724|P2|Overall Study|Death|163
5100160|NCT01933932|17614725|P1|Overall Study|Death|173
5100161|NCT01933919|17614743|P2|Open-label Long-term Phase|Other|2
5100162|NCT01933919|17614744|P1|Open-label Long-term Phase|Other|1
5100163|NCT01933919|17614743|P2|Open-label Long-term Phase|Lost to Follow-up|0
5100164|NCT01933919|17614744|P1|Open-label Long-term Phase|Lost to Follow-up|1
5100165|NCT01933919|17614743|P2|Open-label Long-term Phase|Withdrawal by Subject|4
5100166|NCT01933919|17614744|P1|Open-label Long-term Phase|Withdrawal by Subject|3
5100167|NCT01933919|17614743|P2|Open-label Long-term Phase|Adverse Event|0
5100168|NCT01933919|17614744|P1|Open-label Long-term Phase|Adverse Event|2
5100169|NCT01933919|17614743|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
5100170|NCT01933919|17614744|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
5100171|NCT01933919|17614743|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
5100172|NCT01933919|17614744|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
5100173|NCT01933919|17614743|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
5100174|NCT01933919|17614744|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
5100175|NCT01933880|17614780|P2|Overall Study|Protocol Violation|0
5100176|NCT01933880|17614781|P1|Overall Study|Protocol Violation|1
5100177|NCT01933880|17614780|P2|Overall Study|Other|0
5100178|NCT01933880|17614781|P1|Overall Study|Other|4
5100179|NCT01933880|17614780|P2|Overall Study|Followup exceeded 4 days to visit window|0
5100180|NCT01933880|17614781|P1|Overall Study|Followup exceeded 4 days to visit window|19
5100181|NCT01933880|17614780|P2|Overall Study|Concomitant medication Interference|1
5100182|NCT01933880|17614781|P1|Overall Study|Concomitant medication Interference|0
5100183|NCT01933880|17614780|P2|Overall Study|Lack of Efficacy|0
5100184|NCT01933880|17614781|P1|Overall Study|Lack of Efficacy|1
5100185|NCT01933880|17614780|P2|Overall Study|Withdrawal by Subject|0
5100186|NCT01933880|17614781|P1|Overall Study|Withdrawal by Subject|5
5100187|NCT01933789|17614855|P9|Overall Study|Became Ineligible|0
5100188|NCT01933789|17614856|P8|Overall Study|Became Ineligible|6
5100189|NCT01933789|17614857|P7|Overall Study|Became Ineligible|13
5100190|NCT01933789|17614858|P6|Overall Study|Became Ineligible|10
5100191|NCT01933789|17614859|P5|Overall Study|Became Ineligible|13
5100192|NCT01933789|17614860|P4|Overall Study|Became Ineligible|0
5100193|NCT01933789|17614861|P3|Overall Study|Became Ineligible|0
5100194|NCT01933789|17614862|P2|Overall Study|Became Ineligible|0
5100195|NCT01933789|17614863|P1|Overall Study|Became Ineligible|4
5100196|NCT01933789|17614855|P9|Overall Study|Withdrawal by Subject|0
5100197|NCT01933789|17614856|P8|Overall Study|Withdrawal by Subject|4
5100198|NCT01933789|17614857|P7|Overall Study|Withdrawal by Subject|1
5100199|NCT01933789|17614858|P6|Overall Study|Withdrawal by Subject|16
5100200|NCT01933789|17614859|P5|Overall Study|Withdrawal by Subject|17
5100201|NCT01933789|17614860|P4|Overall Study|Withdrawal by Subject|0
5100202|NCT01933789|17614861|P3|Overall Study|Withdrawal by Subject|0
5100203|NCT01933789|17614862|P2|Overall Study|Withdrawal by Subject|1
5100204|NCT01933789|17614863|P1|Overall Study|Withdrawal by Subject|2
5100205|NCT01933789|17614855|P9|Overall Study|Lost to Follow-up|0
5100206|NCT01933789|17614856|P8|Overall Study|Lost to Follow-up|4
5100207|NCT01933789|17614857|P7|Overall Study|Lost to Follow-up|1
5100208|NCT01933789|17614858|P6|Overall Study|Lost to Follow-up|9
5100209|NCT01933789|17614859|P5|Overall Study|Lost to Follow-up|8
5100210|NCT01933789|17614860|P4|Overall Study|Lost to Follow-up|1
5100211|NCT01933789|17614861|P3|Overall Study|Lost to Follow-up|0
5100212|NCT01933789|17614862|P2|Overall Study|Lost to Follow-up|0
5100213|NCT01933789|17614863|P1|Overall Study|Lost to Follow-up|0
5100214|NCT01933789|17614855|P9|Overall Study|Death|0
5100215|NCT01933789|17614856|P8|Overall Study|Death|0
5100216|NCT01933789|17614857|P7|Overall Study|Death|0
5100217|NCT01933789|17614858|P6|Overall Study|Death|32
5100218|NCT01933789|17614859|P5|Overall Study|Death|21
5100219|NCT01933789|17614860|P4|Overall Study|Death|0
5100220|NCT01933789|17614861|P3|Overall Study|Death|0
5100221|NCT01933789|17614862|P2|Overall Study|Death|0
5100222|NCT01933789|17614863|P1|Overall Study|Death|0
5100223|NCT01933672|17615173|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5100224|NCT01933672|17615174|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5100225|NCT01933672|17615175|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5100226|NCT01933672|17615176|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5100227|NCT01933672|17615177|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5100228|NCT01933672|17615178|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
5100229|NCT01933672|17615179|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5100230|NCT01933672|17615173|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5100231|NCT01933672|17615174|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5100232|NCT01933672|17615175|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5100233|NCT01933672|17615176|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
5100234|NCT01933672|17615177|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5100235|NCT01933672|17615178|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5100236|NCT01933672|17615179|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5100237|NCT01933672|17615173|P7|Second Intervention Period (12-16 Days)|Other|0
5100238|NCT01933672|17615174|P6|Second Intervention Period (12-16 Days)|Other|0
5100239|NCT01933672|17615175|P5|Second Intervention Period (12-16 Days)|Other|0
5100240|NCT01933672|17615176|P4|Second Intervention Period (12-16 Days)|Other|0
5100241|NCT01933672|17615177|P3|Second Intervention Period (12-16 Days)|Other|1
5100242|NCT01933672|17615178|P2|Second Intervention Period (12-16 Days)|Other|1
5100243|NCT01933672|17615179|P1|Second Intervention Period (12-16 Days)|Other|0
5100244|NCT01933672|17615173|P7|First Intervention Period (12-16 Days)|Other|0
5100245|NCT01933672|17615174|P6|First Intervention Period (12-16 Days)|Other|1
5100246|NCT01933672|17615175|P5|First Intervention Period (12-16 Days)|Other|0
5100247|NCT01933672|17615176|P4|First Intervention Period (12-16 Days)|Other|0
5100248|NCT01933672|17615177|P3|First Intervention Period (12-16 Days)|Other|1
5100249|NCT01933672|17615178|P2|First Intervention Period (12-16 Days)|Other|0
5100250|NCT01933672|17615179|P1|First Intervention Period (12-16 Days)|Other|0
5100251|NCT01933672|17615173|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5100252|NCT01933672|17615174|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5100253|NCT01933672|17615175|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
5100254|NCT01933672|17615176|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5100255|NCT01933672|17615177|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5100256|NCT01933672|17615178|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5100257|NCT01933672|17615179|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5100258|NCT01933672|17615173|P7|Metformin Run-in Period|Other|0
5100259|NCT01933672|17615174|P6|Metformin Run-in Period|Other|0
5100260|NCT01933672|17615175|P5|Metformin Run-in Period|Other|0
5100261|NCT01933672|17615176|P4|Metformin Run-in Period|Other|0
5100262|NCT01933672|17615177|P3|Metformin Run-in Period|Other|0
5100263|NCT01933672|17615178|P2|Metformin Run-in Period|Other|0
5100264|NCT01933672|17615179|P1|Metformin Run-in Period|Other|5
5100265|NCT01933672|17615173|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
5100266|NCT01933672|17615174|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
5100267|NCT01933672|17615175|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
5100268|NCT01933672|17615176|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
5100269|NCT01933672|17615177|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
5100270|NCT01933672|17615178|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
5100271|NCT01933672|17615179|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
5100272|NCT01933672|17615173|P7|Metformin Run-in Period|Adverse Event|0
5100273|NCT01933672|17615174|P6|Metformin Run-in Period|Adverse Event|0
5100274|NCT01933672|17615175|P5|Metformin Run-in Period|Adverse Event|0
5100275|NCT01933672|17615176|P4|Metformin Run-in Period|Adverse Event|0
5100276|NCT01933672|17615177|P3|Metformin Run-in Period|Adverse Event|0
5100277|NCT01933672|17615178|P2|Metformin Run-in Period|Adverse Event|0
5100278|NCT01933672|17615179|P1|Metformin Run-in Period|Adverse Event|1
5100279|NCT01933594|17615231|P6|Overall Study|Ineligible for subsequent study step|0
5100280|NCT01933594|17615232|P5|Overall Study|Ineligible for subsequent study step|1
5100281|NCT01933594|17615233|P4|Overall Study|Ineligible for subsequent study step|0
5100282|NCT01933594|17615234|P3|Overall Study|Ineligible for subsequent study step|0
5100283|NCT01933594|17615235|P2|Overall Study|Ineligible for subsequent study step|0
5100284|NCT01933594|17615236|P1|Overall Study|Ineligible for subsequent study step|0
5100285|NCT01933594|17615231|P6|Overall Study|Lost to Follow-up|0
5100286|NCT01933594|17615232|P5|Overall Study|Lost to Follow-up|1
5100287|NCT01933594|17615233|P4|Overall Study|Lost to Follow-up|0
5100288|NCT01933594|17615234|P3|Overall Study|Lost to Follow-up|0
5100289|NCT01933594|17615235|P2|Overall Study|Lost to Follow-up|0
5100290|NCT01933594|17615236|P1|Overall Study|Lost to Follow-up|1
5100291|NCT01933334|17615370|P2|Overall Study|Withdrawal by Subject|1
5100292|NCT01933334|17615371|P1|Overall Study|Withdrawal by Subject|0
5100293|NCT01933334|17615370|P2|Overall Study|Adverse Event|1
5100294|NCT01933334|17615371|P1|Overall Study|Adverse Event|5
5100295|NCT01933217|17615400|P2|Randomization (4 Weeks)|Lost to Follow-up|1
5100296|NCT01933217|17615401|P1|Randomization (4 Weeks)|Lost to Follow-up|1
5100297|NCT01933217|17615400|P2|Randomization (4 Weeks)|Withdrawal by Subject|3
5100298|NCT01933217|17615401|P1|Randomization (4 Weeks)|Withdrawal by Subject|1
5100299|NCT01933113|17615413|P1|Overall Study|Fractured nonfunctioning lead.|1
5100300|NCT01933048|17615419|P2|Overall Study|unknown reasons|1
5100301|NCT01933048|17615420|P1|Overall Study|unknown reasons|1
5100302|NCT01933048|17615419|P2|Overall Study|Physician Decision|0
5100303|NCT01933048|17615420|P1|Overall Study|Physician Decision|1
5100304|NCT01933048|17615419|P2|Overall Study|Protocol Violation|8
5100305|NCT01933048|17615420|P1|Overall Study|Protocol Violation|7
5100306|NCT01933048|17615419|P2|Overall Study|personal reasons|1
5100307|NCT01933048|17615420|P1|Overall Study|personal reasons|1
5100308|NCT01933048|17615419|P2|Overall Study|Lost to Follow-up|18
5100309|NCT01933048|17615420|P1|Overall Study|Lost to Follow-up|15
5100310|NCT01932996|17615435|P2|Overall Study|Protocol Violation|0
5100311|NCT01932996|17615436|P1|Overall Study|Protocol Violation|2
5100312|NCT01932970|17615446|P1|Overall Study|Protocol Specified Criteria|10
5100313|NCT01932970|17615446|P1|Overall Study|Lost to Follow-up|2
5100314|NCT01932970|17615446|P1|Overall Study|Death|1
5100315|NCT01932970|17615446|P1|Overall Study|Withdrawal by Subject|5
5100316|NCT01932788|17615456|P2|Overall Study|Withdrawal by Subject|5
5100317|NCT01932788|17615457|P1|Overall Study|Withdrawal by Subject|0
5100318|NCT01932788|17615456|P2|Overall Study|Lack of Efficacy|0
5100319|NCT01932788|17615457|P1|Overall Study|Lack of Efficacy|2
5100320|NCT01932788|17615456|P2|Overall Study|Lost to Follow-up|46
5100321|NCT01932788|17615457|P1|Overall Study|Lost to Follow-up|18
5100322|NCT01932788|17615456|P2|Overall Study|Protocol Violation|0
5100323|NCT01932788|17615457|P1|Overall Study|Protocol Violation|18
5100324|NCT01932762|17615467|P4|Overall Study|Physician Decision|0
5100325|NCT01932762|17615468|P3|Overall Study|Physician Decision|0
5100326|NCT01932762|17615469|P2|Overall Study|Physician Decision|0
5100327|NCT01932762|17615470|P1|Overall Study|Physician Decision|1
5100328|NCT01932762|17615467|P4|Overall Study|Lost to Follow-up|1
5100329|NCT01932762|17615468|P3|Overall Study|Lost to Follow-up|0
5100330|NCT01932762|17615469|P2|Overall Study|Lost to Follow-up|0
5100331|NCT01932762|17615470|P1|Overall Study|Lost to Follow-up|4
5100332|NCT01932762|17615467|P4|Overall Study|Withdrawal by Subject|0
5100333|NCT01932762|17615468|P3|Overall Study|Withdrawal by Subject|0
5100334|NCT01932762|17615469|P2|Overall Study|Withdrawal by Subject|2
5100335|NCT01932762|17615470|P1|Overall Study|Withdrawal by Subject|1
5100336|NCT01932697|17615506|P2|Overall Study|Ineligible|0
5100337|NCT01932697|17615507|P1|Overall Study|Ineligible|1
5100338|NCT01932697|17615506|P2|Overall Study|Received a different amount of tx|0
5100339|NCT01932697|17615507|P1|Overall Study|Received a different amount of tx|1
5100340|NCT01932437|17615574|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
5100341|NCT01932437|17615575|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5100342|NCT01932437|17615576|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5100343|NCT01932437|17615577|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5100344|NCT01932437|17615578|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5100345|NCT01932437|17615579|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5100346|NCT01932294|17615629|P1|Overall Study|Transferred to other hospitals|12
5100347|NCT01932294|17615629|P1|Overall Study|Heart Transplantation|16
5100348|NCT01932294|17615629|P1|Overall Study|VAD Implantation|20
5100349|NCT01932294|17615629|P1|Overall Study|Lost to Follow-up|8
5100350|NCT01932294|17615629|P1|Overall Study|Death|43
5100351|NCT01931956|17615706|P4|Overall Study|Not due|0
5100352|NCT01931956|17615707|P3|Overall Study|Not due|21
5100353|NCT01931956|17615708|P2|Overall Study|Not due|0
5100354|NCT01931956|17615709|P1|Overall Study|Not due|0
5100355|NCT01931956|17615706|P4|Overall Study|Expected|0
5100356|NCT01931956|17615707|P3|Overall Study|Expected|6
5100357|NCT01931956|17615708|P2|Overall Study|Expected|0
5100358|NCT01931956|17615709|P1|Overall Study|Expected|2
5100359|NCT01931956|17615706|P4|Overall Study|Lost to Follow-up|7
5100360|NCT01931956|17615707|P3|Overall Study|Lost to Follow-up|11
5100361|NCT01931956|17615708|P2|Overall Study|Lost to Follow-up|0
5100362|NCT01931956|17615709|P1|Overall Study|Lost to Follow-up|2
5100363|NCT01931956|17615706|P4|Overall Study|Withdrawal by Subject|30
5100364|NCT01931956|17615707|P3|Overall Study|Withdrawal by Subject|70
5100365|NCT01931956|17615708|P2|Overall Study|Withdrawal by Subject|0
5100366|NCT01931956|17615709|P1|Overall Study|Withdrawal by Subject|5
5100367|NCT01931956|17615706|P4|Overall Study|Death|96
5100368|NCT01931956|17615707|P3|Overall Study|Death|379
5100369|NCT01931956|17615708|P2|Overall Study|Death|7
5100370|NCT01931956|17615709|P1|Overall Study|Death|42
5100371|NCT01931865|17616076|P1|Overall Study|Withdrawal by Subject|2
5100372|NCT01931865|17616076|P1|Overall Study|Lost to Follow-up|2
5100373|NCT01931839|17616089|P7|Overall Study|Other|0
5100374|NCT01931839|17616090|P6|Overall Study|Other|0
5100375|NCT01931839|17616091|P5|Overall Study|Other|0
5100376|NCT01931839|17616092|P4|Overall Study|Other|0
5100377|NCT01931839|17616093|P3|Overall Study|Other|6
5100378|NCT01931839|17616094|P2|Overall Study|Other|2
5100379|NCT01931839|17616095|P1|Overall Study|Other|4
5100380|NCT01931839|17616089|P7|Overall Study|Lost to Follow-up|0
5100381|NCT01931839|17616090|P6|Overall Study|Lost to Follow-up|0
5100382|NCT01931839|17616091|P5|Overall Study|Lost to Follow-up|0
5100383|NCT01931839|17616092|P4|Overall Study|Lost to Follow-up|5
5100384|NCT01931839|17616093|P3|Overall Study|Lost to Follow-up|4
5100385|NCT01931839|17616094|P2|Overall Study|Lost to Follow-up|2
5100386|NCT01931839|17616095|P1|Overall Study|Lost to Follow-up|1
5100387|NCT01931839|17616089|P7|Overall Study|Other non-compliance|0
5100388|NCT01931839|17616090|P6|Overall Study|Other non-compliance|3
5100389|NCT01931839|17616091|P5|Overall Study|Other non-compliance|0
5100390|NCT01931839|17616092|P4|Overall Study|Other non-compliance|3
5100391|NCT01931839|17616093|P3|Overall Study|Other non-compliance|12
5100392|NCT01931839|17616094|P2|Overall Study|Other non-compliance|9
5100393|NCT01931839|17616095|P1|Overall Study|Other non-compliance|15
5100394|NCT01931839|17616089|P7|Overall Study|Withdrawal of consent (not due to AE)|2
5100395|NCT01931839|17616090|P6|Overall Study|Withdrawal of consent (not due to AE)|2
5100396|NCT01931839|17616091|P5|Overall Study|Withdrawal of consent (not due to AE)|0
5100397|NCT01931839|17616092|P4|Overall Study|Withdrawal of consent (not due to AE)|3
5100398|NCT01931839|17616093|P3|Overall Study|Withdrawal of consent (not due to AE)|13
5100399|NCT01931839|17616094|P2|Overall Study|Withdrawal of consent (not due to AE)|8
5100400|NCT01931839|17616095|P1|Overall Study|Withdrawal of consent (not due to AE)|11
5100401|NCT01931839|17616089|P7|Overall Study|Adverse Event|1
5100402|NCT01931839|17616090|P6|Overall Study|Adverse Event|0
5100403|NCT01931839|17616091|P5|Overall Study|Adverse Event|0
5100404|NCT01931839|17616092|P4|Overall Study|Adverse Event|3
5100405|NCT01931839|17616093|P3|Overall Study|Adverse Event|1
5100406|NCT01931839|17616094|P2|Overall Study|Adverse Event|4
5100407|NCT01931839|17616095|P1|Overall Study|Adverse Event|9
5100408|NCT01931839|17616089|P7|Overall Study|Withdrawal of consent|0
5100409|NCT01931839|17616090|P6|Overall Study|Withdrawal of consent|0
5100410|NCT01931839|17616091|P5|Overall Study|Withdrawal of consent|1
5100411|NCT01931839|17616092|P4|Overall Study|Withdrawal of consent|0
5100412|NCT01931839|17616093|P3|Overall Study|Withdrawal of consent|0
5100413|NCT01931839|17616094|P2|Overall Study|Withdrawal of consent|0
5100414|NCT01931839|17616095|P1|Overall Study|Withdrawal of consent|0
5100415|NCT01931839|17616089|P7|Overall Study|Physician Decision|1
5100416|NCT01931839|17616090|P6|Overall Study|Physician Decision|0
5100417|NCT01931839|17616091|P5|Overall Study|Physician Decision|0
5100418|NCT01931839|17616092|P4|Overall Study|Physician Decision|0
5100419|NCT01931839|17616093|P3|Overall Study|Physician Decision|1
5100420|NCT01931839|17616094|P2|Overall Study|Physician Decision|0
5100421|NCT01931839|17616095|P1|Overall Study|Physician Decision|1
5100422|NCT01931839|17616089|P7|Overall Study|Death|0
5100423|NCT01931839|17616090|P6|Overall Study|Death|0
5100424|NCT01931839|17616091|P5|Overall Study|Death|0
5100425|NCT01931839|17616092|P4|Overall Study|Death|0
5100426|NCT01931839|17616093|P3|Overall Study|Death|2
5100427|NCT01931839|17616094|P2|Overall Study|Death|1
5100428|NCT01931839|17616095|P1|Overall Study|Death|0
5100429|NCT01931735|17616167|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
5100430|NCT01931735|17616168|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
5100431|NCT01931735|17616169|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
5100432|NCT01931735|17616170|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
5100433|NCT01931735|17616167|P4|Observational Non-Randomized Phase|Adverse Event|1
5100434|NCT01931735|17616168|P3|Observational Non-Randomized Phase|Adverse Event|0
5100435|NCT01931735|17616169|P2|Observational Non-Randomized Phase|Adverse Event|0
5100436|NCT01931735|17616170|P1|Observational Non-Randomized Phase|Adverse Event|0
5100437|NCT01931735|17616167|P4|Randomized Phase|Lost to Follow-up|0
5100438|NCT01931735|17616168|P3|Randomized Phase|Lost to Follow-up|5
5100439|NCT01931735|17616169|P2|Randomized Phase|Lost to Follow-up|2
5100440|NCT01931735|17616170|P1|Randomized Phase|Lost to Follow-up|2
5100441|NCT01931670|17616217|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
5100442|NCT01931670|17616218|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
5100443|NCT01931670|17616219|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
5100444|NCT01931670|17616217|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
5100445|NCT01931670|17616218|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
5100446|NCT01931670|17616219|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
5100447|NCT01931670|17616217|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
5100448|NCT01931670|17616218|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
5100449|NCT01931670|17616219|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
5100450|NCT01931670|17616217|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
5100451|NCT01931670|17616218|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
5100452|NCT01931670|17616219|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
5100453|NCT01931670|17616217|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
5100454|NCT01931670|17616218|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
5100455|NCT01931670|17616219|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
5100456|NCT01931670|17616217|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
5100457|NCT01931670|17616218|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
5100458|NCT01931670|17616219|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
5100459|NCT01931670|17616217|P3|Treatment Period|Lost to Follow-up|7
5100460|NCT01931670|17616218|P2|Treatment Period|Lost to Follow-up|5
5100461|NCT01931670|17616219|P1|Treatment Period|Lost to Follow-up|19
5100462|NCT01931670|17616217|P3|Treatment Period|Consent Withdrawn by Subject|7
5100463|NCT01931670|17616218|P2|Treatment Period|Consent Withdrawn by Subject|12
5100464|NCT01931670|17616219|P1|Treatment Period|Consent Withdrawn by Subject|17
5100465|NCT01931670|17616217|P3|Treatment Period|Other|2
5100466|NCT01931670|17616218|P2|Treatment Period|Other|7
5100467|NCT01931670|17616219|P1|Treatment Period|Other|8
5100468|NCT01931670|17616217|P3|Treatment Period|Pregnancy|0
5100469|NCT01931670|17616218|P2|Treatment Period|Pregnancy|2
5100470|NCT01931670|17616219|P1|Treatment Period|Pregnancy|7
5100471|NCT01931670|17616217|P3|Treatment Period|Lack of Efficacy|2
5100472|NCT01931670|17616218|P2|Treatment Period|Lack of Efficacy|2
5100473|NCT01931670|17616219|P1|Treatment Period|Lack of Efficacy|11
5100474|NCT01931670|17616217|P3|Treatment Period|Adverse Event|21
5100475|NCT01931670|17616218|P2|Treatment Period|Adverse Event|8
5100476|NCT01931670|17616219|P1|Treatment Period|Adverse Event|19
5100477|NCT01931670|17616217|P3|Treatment Period|Subject Noncompliant|5
5100478|NCT01931670|17616218|P2|Treatment Period|Subject Noncompliant|9
5100479|NCT01931670|17616219|P1|Treatment Period|Subject Noncompliant|4
5100480|NCT01931670|17616217|P3|Treatment Period|Surgery/Invasive Intervention|0
5100481|NCT01931670|17616218|P2|Treatment Period|Surgery/Invasive Intervention|2
5100482|NCT01931670|17616219|P1|Treatment Period|Surgery/Invasive Intervention|4
5100483|NCT01931670|17616217|P3|Treatment Period|Exclusionary Medication Received|1
5100484|NCT01931670|17616218|P2|Treatment Period|Exclusionary Medication Received|1
5100485|NCT01931670|17616219|P1|Treatment Period|Exclusionary Medication Received|1
5100486|NCT01931566|17616320|P3|Overall Study|Missing|1
5100487|NCT01931566|17616321|P2|Overall Study|Missing|0
5100488|NCT01931566|17616322|P1|Overall Study|Missing|0
5100489|NCT01931566|17616320|P3|Overall Study|Reason Not Specified|53
5100490|NCT01931566|17616321|P2|Overall Study|Reason Not Specified|47
5100491|NCT01931566|17616322|P1|Overall Study|Reason Not Specified|11
5100492|NCT01931566|17616320|P3|Overall Study|Study Termination|1037
5100493|NCT01931566|17616321|P2|Overall Study|Study Termination|968
5100494|NCT01931566|17616322|P1|Overall Study|Study Termination|289
5100495|NCT01931566|17616320|P3|Overall Study|Voluntary Withdrawal|225
5100496|NCT01931566|17616321|P2|Overall Study|Voluntary Withdrawal|245
5100497|NCT01931566|17616322|P1|Overall Study|Voluntary Withdrawal|78
5100498|NCT01931566|17616320|P3|Overall Study|Lost to Follow-up|23
5100499|NCT01931566|17616321|P2|Overall Study|Lost to Follow-up|26
5100500|NCT01931566|17616322|P1|Overall Study|Lost to Follow-up|3
5100501|NCT01931566|17616320|P3|Overall Study|Major Protocol Deviation|21
5100502|NCT01931566|17616321|P2|Overall Study|Major Protocol Deviation|14
5100503|NCT01931566|17616322|P1|Overall Study|Major Protocol Deviation|5
5100504|NCT01931566|17616320|P3|Overall Study|Adverse Event|132
5100505|NCT01931566|17616321|P2|Overall Study|Adverse Event|167
5100506|NCT01931566|17616322|P1|Overall Study|Adverse Event|37
5100507|NCT01931566|17616320|P3|Overall Study|Randomized But Not Treated|14
5100508|NCT01931566|17616321|P2|Overall Study|Randomized But Not Treated|9
5100509|NCT01931566|17616322|P1|Overall Study|Randomized But Not Treated|6
5100510|NCT01931475|17616360|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
5100511|NCT01931475|17616361|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
5100512|NCT01931475|17616360|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
5100513|NCT01931475|17616361|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
5100514|NCT01931475|17616360|P2|Period 2: Extension Treatment Phase|Physician Decision|1
5100515|NCT01931475|17616361|P1|Period 2: Extension Treatment Phase|Physician Decision|1
5100516|NCT01931475|17616360|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
5100517|NCT01931475|17616361|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
5100518|NCT01931475|17616360|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
5100519|NCT01931475|17616361|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
5100520|NCT01931475|17616360|P2|Period 2: Extension Treatment Phase|Adverse Event|8
5100521|NCT01931475|17616361|P1|Period 2: Extension Treatment Phase|Adverse Event|0
5100522|NCT01931475|17616360|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
5100523|NCT01931475|17616361|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
5100524|NCT01931475|17616360|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
5100525|NCT01931475|17616361|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
5100526|NCT01931475|17616360|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
5100527|NCT01931475|17616361|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
5100528|NCT01931475|17616360|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
5100529|NCT01931475|17616361|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
5100530|NCT01931475|17616360|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
5100531|NCT01931475|17616361|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
5100532|NCT01931462|17616388|P1|Overall Study|Withdrawal by Subject|1
5100533|NCT01931397|17616399|P1|Overall Study|moved out of state|1
5100534|NCT01931397|17616399|P1|Overall Study|Withdrawal by Subject|8
5100535|NCT01931397|17616399|P1|Overall Study|Physician Decision|2
5100536|NCT01931202|17616411|P3|Overall Study|Lost to Follow-up|2
5100537|NCT01931202|17616412|P2|Overall Study|Lost to Follow-up|5
5100538|NCT01931202|17616413|P1|Overall Study|Lost to Follow-up|0
5100539|NCT01931202|17616411|P3|Overall Study|Withdrawal by Subject|2
5100540|NCT01931202|17616412|P2|Overall Study|Withdrawal by Subject|0
5100541|NCT01931202|17616413|P1|Overall Study|Withdrawal by Subject|0
5100542|NCT01931150|17616459|P2|Overall Study|Withdrawal by Subject|2
5100543|NCT01931150|17616460|P1|Overall Study|Withdrawal by Subject|1
5100544|NCT01931098|17616468|P2|Overall Study|Refused further treatment|1
5100545|NCT01931098|17616469|P1|Overall Study|Refused further treatment|0
5100546|NCT01931098|17616468|P2|Overall Study|Unable to begin trmt:active infection|1
5100547|NCT01931098|17616469|P1|Overall Study|Unable to begin trmt:active infection|0
5100548|NCT01931098|17616468|P2|Overall Study|Enrolled in different protocol|1
5100549|NCT01931098|17616469|P1|Overall Study|Enrolled in different protocol|0
5100550|NCT01931098|17616468|P2|Overall Study|Withdrawal by Subject|1
5100551|NCT01931098|17616469|P1|Overall Study|Withdrawal by Subject|0
5100552|NCT01931059|17616485|P2|Day3|Lost to Follow-up|0
5100553|NCT01931059|17616486|P1|Day3|Lost to Follow-up|1
5100554|NCT01931059|17616485|P2|Day 1|Pregnancy|1
5100555|NCT01931059|17616486|P1|Day 1|Pregnancy|0
5100556|NCT01930890|17616502|P4|Overall Study|Adverse Event|0
5100557|NCT01930890|17616503|P3|Overall Study|Adverse Event|0
5100558|NCT01930890|17616504|P2|Overall Study|Adverse Event|1
5100559|NCT01930890|17616505|P1|Overall Study|Adverse Event|0
5100560|NCT01930890|17616502|P4|Overall Study|Consent Withdrawn|1
5100561|NCT01930890|17616503|P3|Overall Study|Consent Withdrawn|0
5100562|NCT01930890|17616504|P2|Overall Study|Consent Withdrawn|3
5100563|NCT01930890|17616505|P1|Overall Study|Consent Withdrawn|0
5100564|NCT01930890|17616502|P4|Overall Study|Investigator Decision|0
5100565|NCT01930890|17616503|P3|Overall Study|Investigator Decision|0
5100566|NCT01930890|17616504|P2|Overall Study|Investigator Decision|1
5100567|NCT01930890|17616505|P1|Overall Study|Investigator Decision|0
5100568|NCT01930890|17616502|P4|Overall Study|Death|1
5100569|NCT01930890|17616503|P3|Overall Study|Death|0
5100570|NCT01930890|17616504|P2|Overall Study|Death|0
5100571|NCT01930890|17616505|P1|Overall Study|Death|0
5100572|NCT01930890|17616502|P4|Overall Study|Study Termination|25
5100573|NCT01930890|17616503|P3|Overall Study|Study Termination|13
5100574|NCT01930890|17616504|P2|Overall Study|Study Termination|28
5100575|NCT01930890|17616505|P1|Overall Study|Study Termination|14
5100576|NCT01930799|17616519|P1|Overall Study|Lost to Follow-up|5
5100577|NCT01930799|17616519|P1|Overall Study|Withdrawal by Subject|3
5100578|NCT01930214|17616658|P3|Overall Study|Physician Decision|0
5100579|NCT01930214|17616659|P2|Overall Study|Physician Decision|0
5100580|NCT01930214|17616660|P1|Overall Study|Physician Decision|2
5100581|NCT01930214|17616658|P3|Overall Study|Voluntary withdrawal of infomed consent|2
5100582|NCT01930214|17616659|P2|Overall Study|Voluntary withdrawal of infomed consent|4
5100583|NCT01930214|17616660|P1|Overall Study|Voluntary withdrawal of infomed consent|2
5100584|NCT01930214|17616658|P3|Overall Study|Lost to Follow-up|12
5100585|NCT01930214|17616659|P2|Overall Study|Lost to Follow-up|13
5100586|NCT01930214|17616660|P1|Overall Study|Lost to Follow-up|12
5100587|NCT01930214|17616658|P3|Overall Study|Death|11
5100588|NCT01930214|17616659|P2|Overall Study|Death|4
5100589|NCT01930214|17616660|P1|Overall Study|Death|4
5100590|NCT01930188|17616680|P3|Overall Study|Withdrawal by Subject|8
5100591|NCT01930188|17616681|P2|Overall Study|Withdrawal by Subject|11
5100592|NCT01930188|17616682|P1|Overall Study|Withdrawal by Subject|9
5100593|NCT01930188|17616680|P3|Overall Study|Death|3
5100594|NCT01930188|17616681|P2|Overall Study|Death|1
5100595|NCT01930188|17616682|P1|Overall Study|Death|2
5100596|NCT01930188|17616680|P3|Overall Study|Lost to Follow-up|2
5100597|NCT01930188|17616681|P2|Overall Study|Lost to Follow-up|2
5100598|NCT01930188|17616682|P1|Overall Study|Lost to Follow-up|5
5100599|NCT01930188|17616680|P3|Overall Study|Missing follow-up information|3
5100600|NCT01930188|17616681|P2|Overall Study|Missing follow-up information|2
5100601|NCT01930188|17616682|P1|Overall Study|Missing follow-up information|2
5100602|NCT01930188|17616680|P3|Overall Study|unclassified|3
5100603|NCT01930188|17616681|P2|Overall Study|unclassified|5
5100604|NCT01930188|17616682|P1|Overall Study|unclassified|4
5100605|NCT01930175|17616709|P3|Core Study|Adverse Event|1
5100606|NCT01930175|17616710|P2|Core Study|Adverse Event|0
5100607|NCT01930175|17616711|P1|Core Study|Adverse Event|0
5100608|NCT01930175|17616709|P3|Core Study|Lost to Follow-up|0
5100609|NCT01930175|17616710|P2|Core Study|Lost to Follow-up|1
5100610|NCT01930175|17616711|P1|Core Study|Lost to Follow-up|0
5100611|NCT01930162|17616741|P1|Overall Study|Death|1
5100612|NCT01930162|17616741|P1|Overall Study|Abnormal test procedure result(s)|4
5100613|NCT01930045|17616777|P6|Pause (up to 37 Days)|Protocol Violation|1
5100614|NCT01930045|17616778|P5|Pause (up to 37 Days)|Protocol Violation|0
5100615|NCT01930045|17616779|P4|Pause (up to 37 Days)|Protocol Violation|0
5100616|NCT01930045|17616780|P3|Pause (up to 37 Days)|Protocol Violation|0
5100617|NCT01930045|17616781|P2|Pause (up to 37 Days)|Protocol Violation|0
5100618|NCT01930045|17616782|P1|Pause (up to 37 Days)|Protocol Violation|0
5100619|NCT01930045|17616777|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
5100620|NCT01930045|17616778|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
5100621|NCT01930045|17616779|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
5100622|NCT01930045|17616780|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
5100623|NCT01930045|17616781|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
5100624|NCT01930045|17616782|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
5100625|NCT01929993|17616809|P2|Overall Study|Absent CIN, invasion present or artifact|22
5100626|NCT01929993|17616810|P1|Overall Study|Absent CIN, invasion present or artifact|26
5100627|NCT01929993|17616809|P2|Overall Study|Protocol Violation|6
5100628|NCT01929993|17616810|P1|Overall Study|Protocol Violation|4
5100629|NCT01929980|17616816|P1|Overall Study|Physician Decision|1
5100630|NCT01929876|17616824|P1|Period 2|Non-Compliance|1
5100631|NCT01929863|17616837|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
5100632|NCT01929863|17616838|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
5100633|NCT01929863|17616837|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
5100634|NCT01929863|17616838|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
5100635|NCT01929863|17616837|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
5100636|NCT01929863|17616838|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
5100637|NCT01929707|17616893|P8|Intervention Period 2|Withdrawal by Subject|0
5100638|NCT01929707|17616894|P7|Intervention Period 2|Withdrawal by Subject|0
5100639|NCT01929707|17616895|P6|Intervention Period 2|Withdrawal by Subject|2
5100640|NCT01929707|17616896|P5|Intervention Period 2|Withdrawal by Subject|0
5100641|NCT01929707|17616897|P4|Intervention Period 2|Withdrawal by Subject|0
5100642|NCT01929707|17616898|P3|Intervention Period 2|Withdrawal by Subject|0
5100643|NCT01929707|17616899|P2|Intervention Period 2|Withdrawal by Subject|0
5100644|NCT01929707|17616900|P1|Intervention Period 2|Withdrawal by Subject|0
5100645|NCT01929707|17616893|P8|Intervention Period 1|Withdrawal by Subject|0
5100646|NCT01929707|17616894|P7|Intervention Period 1|Withdrawal by Subject|0
5100647|NCT01929707|17616895|P6|Intervention Period 1|Withdrawal by Subject|0
5100648|NCT01929707|17616896|P5|Intervention Period 1|Withdrawal by Subject|0
5100649|NCT01929707|17616897|P4|Intervention Period 1|Withdrawal by Subject|2
5100650|NCT01929707|17616898|P3|Intervention Period 1|Withdrawal by Subject|0
5100651|NCT01929707|17616899|P2|Intervention Period 1|Withdrawal by Subject|0
5100652|NCT01929707|17616900|P1|Intervention Period 1|Withdrawal by Subject|0
5100653|NCT01929707|17616893|P8|Intervention Period 1|Lost to Follow-up|0
5100654|NCT01929707|17616894|P7|Intervention Period 1|Lost to Follow-up|0
5100655|NCT01929707|17616895|P6|Intervention Period 1|Lost to Follow-up|0
5100656|NCT01929707|17616896|P5|Intervention Period 1|Lost to Follow-up|0
5100657|NCT01929707|17616897|P4|Intervention Period 1|Lost to Follow-up|1
5100658|NCT01929707|17616898|P3|Intervention Period 1|Lost to Follow-up|0
5100659|NCT01929707|17616899|P2|Intervention Period 1|Lost to Follow-up|0
5100660|NCT01929707|17616900|P1|Intervention Period 1|Lost to Follow-up|0
5100661|NCT01929681|17616932|P2|Overall Study|Physician Decision|1
5100662|NCT01929681|17616933|P1|Overall Study|Physician Decision|1
5100663|NCT01929681|17616932|P2|Overall Study|Withdrawal by Subject|0
5100664|NCT01929681|17616933|P1|Overall Study|Withdrawal by Subject|1
5100665|NCT01929408|17616976|P1|Overall Study|received HCT as initial treatment|8
5100666|NCT01929395|17616984|P3|Overall Study|Screen Fail|1
5100667|NCT01929395|17616985|P2|Overall Study|Screen Fail|0
5100668|NCT01929395|17616986|P1|Overall Study|Screen Fail|0
5100669|NCT01929395|17616984|P3|Overall Study|Withdrawal by Subject|0
5100670|NCT01929395|17616985|P2|Overall Study|Withdrawal by Subject|1
5100671|NCT01929395|17616986|P1|Overall Study|Withdrawal by Subject|0
5100672|NCT01929395|17616984|P3|Overall Study|Did not complete - non-related toxicity|0
5100673|NCT01929395|17616985|P2|Overall Study|Did not complete - non-related toxicity|0
5100674|NCT01929395|17616986|P1|Overall Study|Did not complete - non-related toxicity|1
5100675|NCT01929317|17616998|P2|Long-term Phase|Study Closed/Terminated|3
5100676|NCT01929317|17616999|P1|Long-term Phase|Study Closed/Terminated|5
5100677|NCT01929317|17616998|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
5100678|NCT01929317|17616999|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
5100679|NCT01929317|17616998|P2|Long-term Phase|Protocol Violation|0
5100680|NCT01929317|17616999|P1|Long-term Phase|Protocol Violation|1
5100681|NCT01929317|17616998|P2|Long-term Phase|Withdrawal by Subject|0
5100682|NCT01929317|17616999|P1|Long-term Phase|Withdrawal by Subject|4
5100683|NCT01929317|17616998|P2|Long-term Phase|Physician Decision|0
5100684|NCT01929317|17616999|P1|Long-term Phase|Physician Decision|3
5100685|NCT01929317|17616998|P2|Long-term Phase|Adverse Event|1
5100686|NCT01929317|17616999|P1|Long-term Phase|Adverse Event|5
5100687|NCT01929317|17616998|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
5100688|NCT01929317|17616999|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
5100689|NCT01929317|17616998|P2|Dose Increase Effect Verification Phase|Physician Decision|0
5100690|NCT01929317|17616999|P1|Dose Increase Effect Verification Phase|Physician Decision|1
5100691|NCT01929317|17616998|P2|Dose Increase Effect Verification Phase|Adverse Event|1
5100692|NCT01929317|17616999|P1|Dose Increase Effect Verification Phase|Adverse Event|5
5100693|NCT01929226|17617074|P2|Overall Study|Withdrawal by Subject|1
5100694|NCT01929226|17617075|P1|Overall Study|Withdrawal by Subject|1
5100695|NCT01929226|17617074|P2|Overall Study|Lost to Follow-up|0
5100696|NCT01929226|17617075|P1|Overall Study|Lost to Follow-up|4
5100697|NCT01929135|17617101|P2|Overall Study|Lost to Follow-up|1
5100698|NCT01929135|17617102|P1|Overall Study|Lost to Follow-up|1
5100699|NCT01929109|17617121|P5|Period 1 (All Groups)|Deviation from protocol|0
5100700|NCT01929109|17617122|P4|Period 1 (All Groups)|Deviation from protocol|0
5100701|NCT01929109|17617123|P3|Period 1 (All Groups)|Deviation from protocol|1
5100702|NCT01929109|17617124|P2|Period 1 (All Groups)|Deviation from protocol|0
5100703|NCT01929109|17617125|P1|Period 1 (All Groups)|Deviation from protocol|0
5100704|NCT01929083|17617144|P2|Intervention 2|Adverse Event|1
5100705|NCT01929083|17617145|P1|Intervention 2|Adverse Event|0
5100706|NCT01929083|17617144|P2|Intervention 1|Nonadherent to study medications|0
5100707|NCT01929083|17617145|P1|Intervention 1|Nonadherent to study medications|1
5100708|NCT01929083|17617144|P2|Intervention 1|Lost to Follow-up|0
5100709|NCT01929083|17617145|P1|Intervention 1|Lost to Follow-up|2
5100710|NCT01929044|17617182|P2|Overall Study|Not Treated|3
5100711|NCT01929044|17617183|P1|Overall Study|Not Treated|1
5100712|NCT01929044|17617182|P2|Overall Study|Protocol Violation|14
5100713|NCT01929044|17617183|P1|Overall Study|Protocol Violation|9
5100714|NCT01929044|17617182|P2|Overall Study|Adverse Event|0
5100715|NCT01929044|17617183|P1|Overall Study|Adverse Event|1
5100716|NCT01929031|17617205|P6|Overall Study|Reason other than specified above|0
5100717|NCT01929031|17617206|P5|Overall Study|Reason other than specified above|1
5100718|NCT01929031|17617207|P4|Overall Study|Reason other than specified above|0
5100719|NCT01929031|17617208|P3|Overall Study|Reason other than specified above|0
5100720|NCT01929031|17617209|P2|Overall Study|Reason other than specified above|1
5100721|NCT01929031|17617210|P1|Overall Study|Reason other than specified above|0
5100722|NCT01929031|17617205|P6|Overall Study|Protocol Violation|1
5100723|NCT01929031|17617206|P5|Overall Study|Protocol Violation|0
5100724|NCT01929031|17617207|P4|Overall Study|Protocol Violation|0
5100725|NCT01929031|17617208|P3|Overall Study|Protocol Violation|0
5100726|NCT01929031|17617209|P2|Overall Study|Protocol Violation|0
5100727|NCT01929031|17617210|P1|Overall Study|Protocol Violation|1
5100728|NCT01929031|17617205|P6|Overall Study|Adverse Event|0
5100729|NCT01929031|17617206|P5|Overall Study|Adverse Event|0
5100730|NCT01929031|17617207|P4|Overall Study|Adverse Event|0
5100731|NCT01929031|17617208|P3|Overall Study|Adverse Event|1
5100732|NCT01929031|17617209|P2|Overall Study|Adverse Event|1
5100733|NCT01929031|17617210|P1|Overall Study|Adverse Event|3
5100734|NCT01929018|17617234|P2|Overall Study|Hospitalization|1
5100735|NCT01929018|17617235|P1|Overall Study|Hospitalization|0
5100736|NCT01929018|17617234|P2|Overall Study|Lost to Follow-up|0
5100737|NCT01929018|17617235|P1|Overall Study|Lost to Follow-up|1
5100738|NCT01928940|17617259|P2|Overall Study|Adverse Event|1
5100739|NCT01928940|17617260|P1|Overall Study|Adverse Event|0
5100740|NCT01928927|17617303|P2|Overall Study|Withdrawal by Subject|1
5100741|NCT01928927|17617304|P1|Overall Study|Withdrawal by Subject|1
5100742|NCT01928927|17617303|P2|Overall Study|Lost to Follow-up|0
5100743|NCT01928927|17617304|P1|Overall Study|Lost to Follow-up|1
5100744|NCT01928862|17617445|P5|Overall Study|Lost to Follow-up|1
5100745|NCT01928862|17617446|P4|Overall Study|Lost to Follow-up|0
5100746|NCT01928862|17617447|P3|Overall Study|Lost to Follow-up|0
5100747|NCT01928862|17617448|P2|Overall Study|Lost to Follow-up|0
5100748|NCT01928862|17617449|P1|Overall Study|Lost to Follow-up|1
5100749|NCT01928771|17617523|P3|Overall Study|Severe Non-Compliance to Protocol|2
5100750|NCT01928771|17617524|P2|Overall Study|Severe Non-Compliance to Protocol|2
5100751|NCT01928771|17617525|P1|Overall Study|Severe Non-Compliance to Protocol|4
5100752|NCT01928771|17617523|P3|Overall Study|Other Reasons|14
5100753|NCT01928771|17617524|P2|Overall Study|Other Reasons|9
5100754|NCT01928771|17617525|P1|Overall Study|Other Reasons|9
5100755|NCT01928771|17617523|P3|Overall Study|Study-Specific Withdrawal Criteria|1
5100756|NCT01928771|17617524|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5100757|NCT01928771|17617525|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5100758|NCT01928771|17617523|P3|Overall Study|Withdrawal by Subject|17
5100759|NCT01928771|17617524|P2|Overall Study|Withdrawal by Subject|15
5100760|NCT01928771|17617525|P1|Overall Study|Withdrawal by Subject|20
5100761|NCT01928771|17617523|P3|Overall Study|Lost to Follow-up|3
5100762|NCT01928771|17617524|P2|Overall Study|Lost to Follow-up|6
5100763|NCT01928771|17617525|P1|Overall Study|Lost to Follow-up|5
5100764|NCT01928771|17617523|P3|Overall Study|Death|2
5100765|NCT01928771|17617524|P2|Overall Study|Death|2
5100766|NCT01928771|17617525|P1|Overall Study|Death|2
5100767|NCT01928771|17617523|P3|Overall Study|Adverse Event|1
5100768|NCT01928771|17617524|P2|Overall Study|Adverse Event|5
5100769|NCT01928771|17617525|P1|Overall Study|Adverse Event|6
5100770|NCT01928758|17617604|P2|Overall Study|Protocol Violation|4
5100771|NCT01928758|17617605|P1|Overall Study|Protocol Violation|3
5100772|NCT01928758|17617604|P2|Overall Study|Adverse Event|5
5100773|NCT01928758|17617605|P1|Overall Study|Adverse Event|3
5100774|NCT01928758|17617604|P2|Overall Study|Withdrawal by Subject|2
5100775|NCT01928758|17617605|P1|Overall Study|Withdrawal by Subject|5
5100776|NCT01928758|17617604|P2|Overall Study|Lost to Follow-up|9
5100777|NCT01928758|17617605|P1|Overall Study|Lost to Follow-up|14
5100778|NCT01928719|17617623|P2|Overall Study|Adverse Event|0
5100779|NCT01928719|17617624|P1|Overall Study|Adverse Event|1
5100780|NCT01928719|17617623|P2|Overall Study|Protocol Violation|1
5100781|NCT01928719|17617624|P1|Overall Study|Protocol Violation|3
5100782|NCT01928719|17617623|P2|Overall Study|Withdrawal by Subject|7
5100783|NCT01928719|17617624|P1|Overall Study|Withdrawal by Subject|22
5100784|NCT01928719|17617623|P2|Overall Study|Lost to Follow-up|11
5100785|NCT01928719|17617624|P1|Overall Study|Lost to Follow-up|26
5100786|NCT01928615|17617676|P1|Overall Study|Study Terminated by Sponsor|2
5100787|NCT01928485|17617693|P2|Overall Study|Physician Decision|1
5100788|NCT01928485|17617694|P1|Overall Study|Physician Decision|0
5100789|NCT01928472|17617746|P4|Overall Study|Unclassified|0
5100790|NCT01928472|17617747|P3|Overall Study|Unclassified|1
5100791|NCT01928472|17617748|P2|Overall Study|Unclassified|0
5100792|NCT01928472|17617749|P1|Overall Study|Unclassified|0
5100793|NCT01928472|17617746|P4|Overall Study|Administrative Reason|0
5100794|NCT01928472|17617747|P3|Overall Study|Administrative Reason|0
5100795|NCT01928472|17617748|P2|Overall Study|Administrative Reason|1
5100796|NCT01928472|17617749|P1|Overall Study|Administrative Reason|2
5100797|NCT01928472|17617746|P4|Overall Study|Lost to Follow-up|0
5100798|NCT01928472|17617747|P3|Overall Study|Lost to Follow-up|4
5100799|NCT01928472|17617748|P2|Overall Study|Lost to Follow-up|3
5100800|NCT01928472|17617749|P1|Overall Study|Lost to Follow-up|2
5100801|NCT01928472|17617746|P4|Overall Study|Withdrawal by Subject|2
5100802|NCT01928472|17617747|P3|Overall Study|Withdrawal by Subject|1
5100803|NCT01928472|17617748|P2|Overall Study|Withdrawal by Subject|4
5100804|NCT01928472|17617749|P1|Overall Study|Withdrawal by Subject|4
5100805|NCT01928472|17617746|P4|Overall Study|Death|0
5100806|NCT01928472|17617747|P3|Overall Study|Death|1
5100807|NCT01928472|17617748|P2|Overall Study|Death|0
5100808|NCT01928472|17617749|P1|Overall Study|Death|0
5100809|NCT01928433|17617819|P3|Overall Study|Other reasons|4
5100810|NCT01928433|17617820|P2|Overall Study|Other reasons|3
5100811|NCT01928433|17617821|P1|Overall Study|Other reasons|3
5100812|NCT01928433|17617819|P3|Overall Study|Lost to Follow-up|3
5100813|NCT01928433|17617820|P2|Overall Study|Lost to Follow-up|2
5100814|NCT01928433|17617821|P1|Overall Study|Lost to Follow-up|0
5100815|NCT01928433|17617819|P3|Overall Study|Negative screening urine culture|10
5100816|NCT01928433|17617820|P2|Overall Study|Negative screening urine culture|6
5100817|NCT01928433|17617821|P1|Overall Study|Negative screening urine culture|7
5100818|NCT01928433|17617819|P3|Overall Study|Withdrawal by Subject|0
5100819|NCT01928433|17617820|P2|Overall Study|Withdrawal by Subject|4
5100820|NCT01928433|17617821|P1|Overall Study|Withdrawal by Subject|0
5100821|NCT01928433|17617819|P3|Overall Study|Lack of Efficacy|4
5100822|NCT01928433|17617820|P2|Overall Study|Lack of Efficacy|4
5100823|NCT01928433|17617821|P1|Overall Study|Lack of Efficacy|5
5100824|NCT01928433|17617819|P3|Overall Study|Protocol Violation|2
5100825|NCT01928433|17617820|P2|Overall Study|Protocol Violation|0
5100826|NCT01928433|17617821|P1|Overall Study|Protocol Violation|0
5100827|NCT01928433|17617819|P3|Overall Study|Adverse Event|5
5100828|NCT01928433|17617820|P2|Overall Study|Adverse Event|2
5100829|NCT01928433|17617821|P1|Overall Study|Adverse Event|5
5100830|NCT01928394|17617867|P23|Follow-up Period|Lost to Follow-up|1
5100831|NCT01928394|17617868|P22|Follow-up Period|Lost to Follow-up|0
5100832|NCT01928394|17617869|P21|Follow-up Period|Lost to Follow-up|0
5100833|NCT01928394|17617870|P20|Follow-up Period|Lost to Follow-up|0
5100834|NCT01928394|17617871|P19|Follow-up Period|Lost to Follow-up|0
5100835|NCT01928394|17617872|P18|Follow-up Period|Lost to Follow-up|0
5100836|NCT01928394|17617873|P17|Follow-up Period|Lost to Follow-up|1
5100837|NCT01928394|17617874|P16|Follow-up Period|Lost to Follow-up|0
5100838|NCT01928394|17617875|P15|Follow-up Period|Lost to Follow-up|1
5100839|NCT01928394|17617876|P14|Follow-up Period|Lost to Follow-up|0
5100840|NCT01928394|17617877|P13|Follow-up Period|Lost to Follow-up|1
5100841|NCT01928394|17617878|P12|Follow-up Period|Lost to Follow-up|1
5100842|NCT01928394|17617879|P11|Follow-up Period|Lost to Follow-up|0
5100843|NCT01928394|17617880|P10|Follow-up Period|Lost to Follow-up|0
5100844|NCT01928394|17617881|P9|Follow-up Period|Lost to Follow-up|0
5100845|NCT01928394|17617882|P8|Follow-up Period|Lost to Follow-up|0
5100846|NCT01928394|17617883|P7|Follow-up Period|Lost to Follow-up|0
5100847|NCT01928394|17617884|P6|Follow-up Period|Lost to Follow-up|0
5100848|NCT01928394|17617885|P5|Follow-up Period|Lost to Follow-up|0
5100849|NCT01928394|17617886|P4|Follow-up Period|Lost to Follow-up|0
5100850|NCT01928394|17617887|P3|Follow-up Period|Lost to Follow-up|0
5100851|NCT01928394|17617888|P2|Follow-up Period|Lost to Follow-up|0
5100852|NCT01928394|17617889|P1|Follow-up Period|Lost to Follow-up|0
5100853|NCT01928394|17617867|P23|Follow-up Period|other reason|1
5100854|NCT01928394|17617868|P22|Follow-up Period|other reason|0
5100855|NCT01928394|17617869|P21|Follow-up Period|other reason|0
5100856|NCT01928394|17617870|P20|Follow-up Period|other reason|1
5100857|NCT01928394|17617871|P19|Follow-up Period|other reason|1
5100858|NCT01928394|17617872|P18|Follow-up Period|other reason|0
5100859|NCT01928394|17617873|P17|Follow-up Period|other reason|2
5100860|NCT01928394|17617874|P16|Follow-up Period|other reason|0
5100861|NCT01928394|17617875|P15|Follow-up Period|other reason|4
5100862|NCT01928394|17617876|P14|Follow-up Period|other reason|1
5100863|NCT01928394|17617877|P13|Follow-up Period|other reason|0
5100864|NCT01928394|17617878|P12|Follow-up Period|other reason|1
5100865|NCT01928394|17617879|P11|Follow-up Period|other reason|2
5100866|NCT01928394|17617880|P10|Follow-up Period|other reason|0
5100867|NCT01928394|17617881|P9|Follow-up Period|other reason|0
5100868|NCT01928394|17617882|P8|Follow-up Period|other reason|3
5100869|NCT01928394|17617883|P7|Follow-up Period|other reason|1
5100870|NCT01928394|17617884|P6|Follow-up Period|other reason|0
5100871|NCT01928394|17617885|P5|Follow-up Period|other reason|0
5100872|NCT01928394|17617886|P4|Follow-up Period|other reason|0
5100873|NCT01928394|17617887|P3|Follow-up Period|other reason|0
5100874|NCT01928394|17617888|P2|Follow-up Period|other reason|0
5100875|NCT01928394|17617889|P1|Follow-up Period|other reason|0
5100876|NCT01928394|17617867|P23|Follow-up Period|Death|2
5100877|NCT01928394|17617868|P22|Follow-up Period|Death|3
5100878|NCT01928394|17617869|P21|Follow-up Period|Death|5
5100879|NCT01928394|17617870|P20|Follow-up Period|Death|13
5100880|NCT01928394|17617871|P19|Follow-up Period|Death|13
5100881|NCT01928394|17617872|P18|Follow-up Period|Death|5
5100882|NCT01928394|17617873|P17|Follow-up Period|Death|6
5100883|NCT01928394|17617874|P16|Follow-up Period|Death|0
5100884|NCT01928394|17617875|P15|Follow-up Period|Death|18
5100885|NCT01928394|17617876|P14|Follow-up Period|Death|25
5100886|NCT01928394|17617877|P13|Follow-up Period|Death|11
5100887|NCT01928394|17617878|P12|Follow-up Period|Death|12
5100888|NCT01928394|17617879|P11|Follow-up Period|Death|4
5100889|NCT01928394|17617880|P10|Follow-up Period|Death|2
5100890|NCT01928394|17617881|P9|Follow-up Period|Death|1
5100891|NCT01928394|17617882|P8|Follow-up Period|Death|2
5100892|NCT01928394|17617883|P7|Follow-up Period|Death|6
5100893|NCT01928394|17617884|P6|Follow-up Period|Death|6
5100894|NCT01928394|17617885|P5|Follow-up Period|Death|0
5100895|NCT01928394|17617886|P4|Follow-up Period|Death|6
5100896|NCT01928394|17617887|P3|Follow-up Period|Death|2
5100897|NCT01928394|17617888|P2|Follow-up Period|Death|0
5100898|NCT01928394|17617889|P1|Follow-up Period|Death|0
5100899|NCT01928394|17617867|P23|Follow-up Period|Participant withdrew consent|2
5100900|NCT01928394|17617868|P22|Follow-up Period|Participant withdrew consent|6
5100901|NCT01928394|17617869|P21|Follow-up Period|Participant withdrew consent|4
5100902|NCT01928394|17617870|P20|Follow-up Period|Participant withdrew consent|7
5100903|NCT01928394|17617871|P19|Follow-up Period|Participant withdrew consent|2
5100904|NCT01928394|17617872|P18|Follow-up Period|Participant withdrew consent|3
5100905|NCT01928394|17617873|P17|Follow-up Period|Participant withdrew consent|5
5100906|NCT01928394|17617874|P16|Follow-up Period|Participant withdrew consent|0
5100907|NCT01928394|17617875|P15|Follow-up Period|Participant withdrew consent|7
5100908|NCT01928394|17617876|P14|Follow-up Period|Participant withdrew consent|12
5100909|NCT01928394|17617877|P13|Follow-up Period|Participant withdrew consent|2
5100910|NCT01928394|17617878|P12|Follow-up Period|Participant withdrew consent|8
5100911|NCT01928394|17617879|P11|Follow-up Period|Participant withdrew consent|5
5100912|NCT01928394|17617880|P10|Follow-up Period|Participant withdrew consent|0
5100913|NCT01928394|17617881|P9|Follow-up Period|Participant withdrew consent|0
5100914|NCT01928394|17617882|P8|Follow-up Period|Participant withdrew consent|1
5100915|NCT01928394|17617883|P7|Follow-up Period|Participant withdrew consent|5
5100916|NCT01928394|17617884|P6|Follow-up Period|Participant withdrew consent|2
5100917|NCT01928394|17617885|P5|Follow-up Period|Participant withdrew consent|0
5100918|NCT01928394|17617886|P4|Follow-up Period|Participant withdrew consent|4
5100919|NCT01928394|17617887|P3|Follow-up Period|Participant withdrew consent|1
5100920|NCT01928394|17617888|P2|Follow-up Period|Participant withdrew consent|0
5100921|NCT01928394|17617889|P1|Follow-up Period|Participant withdrew consent|3
5100922|NCT01928394|17617867|P23|Treatment Period|Death|0
5100923|NCT01928394|17617868|P22|Treatment Period|Death|0
5100924|NCT01928394|17617869|P21|Treatment Period|Death|0
5100925|NCT01928394|17617870|P20|Treatment Period|Death|0
5100926|NCT01928394|17617871|P19|Treatment Period|Death|0
5100927|NCT01928394|17617872|P18|Treatment Period|Death|0
5100928|NCT01928394|17617873|P17|Treatment Period|Death|0
5100929|NCT01928394|17617874|P16|Treatment Period|Death|0
5100930|NCT01928394|17617875|P15|Treatment Period|Death|2
5100931|NCT01928394|17617876|P14|Treatment Period|Death|1
5100932|NCT01928394|17617877|P13|Treatment Period|Death|0
5100933|NCT01928394|17617878|P12|Treatment Period|Death|0
5100934|NCT01928394|17617879|P11|Treatment Period|Death|0
5100935|NCT01928394|17617880|P10|Treatment Period|Death|0
5100936|NCT01928394|17617881|P9|Treatment Period|Death|0
5100937|NCT01928394|17617882|P8|Treatment Period|Death|0
5100938|NCT01928394|17617883|P7|Treatment Period|Death|0
5100939|NCT01928394|17617884|P6|Treatment Period|Death|0
5100940|NCT01928394|17617885|P5|Treatment Period|Death|0
5100941|NCT01928394|17617886|P4|Treatment Period|Death|0
5100942|NCT01928394|17617887|P3|Treatment Period|Death|0
5100943|NCT01928394|17617888|P2|Treatment Period|Death|0
5100944|NCT01928394|17617889|P1|Treatment Period|Death|0
5100945|NCT01928394|17617867|P23|Treatment Period|Lost to Follow-up|1
5100946|NCT01928394|17617868|P22|Treatment Period|Lost to Follow-up|0
5100947|NCT01928394|17617869|P21|Treatment Period|Lost to Follow-up|0
5100948|NCT01928394|17617870|P20|Treatment Period|Lost to Follow-up|0
5100949|NCT01928394|17617871|P19|Treatment Period|Lost to Follow-up|0
5100950|NCT01928394|17617872|P18|Treatment Period|Lost to Follow-up|0
5100951|NCT01928394|17617873|P17|Treatment Period|Lost to Follow-up|0
5100952|NCT01928394|17617874|P16|Treatment Period|Lost to Follow-up|0
5100953|NCT01928394|17617875|P15|Treatment Period|Lost to Follow-up|0
5100954|NCT01928394|17617876|P14|Treatment Period|Lost to Follow-up|0
5100955|NCT01928394|17617877|P13|Treatment Period|Lost to Follow-up|0
5100956|NCT01928394|17617878|P12|Treatment Period|Lost to Follow-up|0
5100957|NCT01928394|17617879|P11|Treatment Period|Lost to Follow-up|0
5100958|NCT01928394|17617880|P10|Treatment Period|Lost to Follow-up|0
5100959|NCT01928394|17617881|P9|Treatment Period|Lost to Follow-up|0
5100960|NCT01928394|17617882|P8|Treatment Period|Lost to Follow-up|0
5100961|NCT01928394|17617883|P7|Treatment Period|Lost to Follow-up|0
5100962|NCT01928394|17617884|P6|Treatment Period|Lost to Follow-up|0
5100963|NCT01928394|17617885|P5|Treatment Period|Lost to Follow-up|0
5100964|NCT01928394|17617886|P4|Treatment Period|Lost to Follow-up|0
5100965|NCT01928394|17617887|P3|Treatment Period|Lost to Follow-up|0
5100966|NCT01928394|17617888|P2|Treatment Period|Lost to Follow-up|0
5100967|NCT01928394|17617889|P1|Treatment Period|Lost to Follow-up|0
5100968|NCT01928394|17617867|P23|Treatment Period|Maximum clinical benefit|0
5100969|NCT01928394|17617868|P22|Treatment Period|Maximum clinical benefit|0
5100970|NCT01928394|17617869|P21|Treatment Period|Maximum clinical benefit|2
5100971|NCT01928394|17617870|P20|Treatment Period|Maximum clinical benefit|0
5100972|NCT01928394|17617871|P19|Treatment Period|Maximum clinical benefit|1
5100973|NCT01928394|17617872|P18|Treatment Period|Maximum clinical benefit|1
5100974|NCT01928394|17617873|P17|Treatment Period|Maximum clinical benefit|0
5100975|NCT01928394|17617874|P16|Treatment Period|Maximum clinical benefit|0
5100976|NCT01928394|17617875|P15|Treatment Period|Maximum clinical benefit|1
5100977|NCT01928394|17617876|P14|Treatment Period|Maximum clinical benefit|0
5100978|NCT01928394|17617877|P13|Treatment Period|Maximum clinical benefit|0
5100979|NCT01928394|17617878|P12|Treatment Period|Maximum clinical benefit|1
5100980|NCT01928394|17617879|P11|Treatment Period|Maximum clinical benefit|1
5100981|NCT01928394|17617880|P10|Treatment Period|Maximum clinical benefit|0
5100982|NCT01928394|17617881|P9|Treatment Period|Maximum clinical benefit|0
5100983|NCT01928394|17617882|P8|Treatment Period|Maximum clinical benefit|0
5100984|NCT01928394|17617883|P7|Treatment Period|Maximum clinical benefit|0
5100985|NCT01928394|17617884|P6|Treatment Period|Maximum clinical benefit|0
5100986|NCT01928394|17617885|P5|Treatment Period|Maximum clinical benefit|0
5100987|NCT01928394|17617886|P4|Treatment Period|Maximum clinical benefit|0
5100988|NCT01928394|17617887|P3|Treatment Period|Maximum clinical benefit|0
5100989|NCT01928394|17617888|P2|Treatment Period|Maximum clinical benefit|0
5100990|NCT01928394|17617889|P1|Treatment Period|Maximum clinical benefit|0
5100991|NCT01928394|17617867|P23|Treatment Period|other reason|0
5100992|NCT01928394|17617868|P22|Treatment Period|other reason|0
5100993|NCT01928394|17617869|P21|Treatment Period|other reason|0
5100994|NCT01928394|17617870|P20|Treatment Period|other reason|2
5100995|NCT01928394|17617871|P19|Treatment Period|other reason|2
5100996|NCT01928394|17617872|P18|Treatment Period|other reason|0
5100997|NCT01928394|17617873|P17|Treatment Period|other reason|0
5100998|NCT01928394|17617874|P16|Treatment Period|other reason|0
5100999|NCT01928394|17617875|P15|Treatment Period|other reason|1
5101000|NCT01928394|17617876|P14|Treatment Period|other reason|0
5101001|NCT01928394|17617877|P13|Treatment Period|other reason|1
5101002|NCT01928394|17617878|P12|Treatment Period|other reason|1
5101003|NCT01928394|17617879|P11|Treatment Period|other reason|1
5101004|NCT01928394|17617880|P10|Treatment Period|other reason|0
5101005|NCT01928394|17617881|P9|Treatment Period|other reason|0
5101006|NCT01928394|17617882|P8|Treatment Period|other reason|0
5101007|NCT01928394|17617883|P7|Treatment Period|other reason|0
5101008|NCT01928394|17617884|P6|Treatment Period|other reason|0
5101009|NCT01928394|17617885|P5|Treatment Period|other reason|0
5101010|NCT01928394|17617886|P4|Treatment Period|other reason|0
5101011|NCT01928394|17617887|P3|Treatment Period|other reason|0
5101012|NCT01928394|17617888|P2|Treatment Period|other reason|0
5101013|NCT01928394|17617889|P1|Treatment Period|other reason|0
5101014|NCT01928394|17617867|P23|Treatment Period|Poor/non-compliance|0
5101015|NCT01928394|17617868|P22|Treatment Period|Poor/non-compliance|0
5101016|NCT01928394|17617869|P21|Treatment Period|Poor/non-compliance|0
5101017|NCT01928394|17617870|P20|Treatment Period|Poor/non-compliance|1
5101018|NCT01928394|17617871|P19|Treatment Period|Poor/non-compliance|0
5101019|NCT01928394|17617872|P18|Treatment Period|Poor/non-compliance|1
5101020|NCT01928394|17617873|P17|Treatment Period|Poor/non-compliance|0
5101021|NCT01928394|17617874|P16|Treatment Period|Poor/non-compliance|0
5101022|NCT01928394|17617875|P15|Treatment Period|Poor/non-compliance|1
5101023|NCT01928394|17617876|P14|Treatment Period|Poor/non-compliance|0
5101024|NCT01928394|17617877|P13|Treatment Period|Poor/non-compliance|1
5101025|NCT01928394|17617878|P12|Treatment Period|Poor/non-compliance|0
5101026|NCT01928394|17617879|P11|Treatment Period|Poor/non-compliance|0
5101027|NCT01928394|17617880|P10|Treatment Period|Poor/non-compliance|0
5101028|NCT01928394|17617881|P9|Treatment Period|Poor/non-compliance|0
5101029|NCT01928394|17617882|P8|Treatment Period|Poor/non-compliance|0
5101030|NCT01928394|17617883|P7|Treatment Period|Poor/non-compliance|0
5101031|NCT01928394|17617884|P6|Treatment Period|Poor/non-compliance|0
5101032|NCT01928394|17617885|P5|Treatment Period|Poor/non-compliance|0
5101033|NCT01928394|17617886|P4|Treatment Period|Poor/non-compliance|1
5101034|NCT01928394|17617887|P3|Treatment Period|Poor/non-compliance|0
5101035|NCT01928394|17617888|P2|Treatment Period|Poor/non-compliance|0
5101036|NCT01928394|17617889|P1|Treatment Period|Poor/non-compliance|0
5101037|NCT01928394|17617867|P23|Treatment Period|Participant withdrew consent|0
5101038|NCT01928394|17617868|P22|Treatment Period|Participant withdrew consent|2
5101039|NCT01928394|17617869|P21|Treatment Period|Participant withdrew consent|0
5101040|NCT01928394|17617870|P20|Treatment Period|Participant withdrew consent|1
5101041|NCT01928394|17617871|P19|Treatment Period|Participant withdrew consent|1
5101042|NCT01928394|17617872|P18|Treatment Period|Participant withdrew consent|1
5101043|NCT01928394|17617873|P17|Treatment Period|Participant withdrew consent|2
5101044|NCT01928394|17617874|P16|Treatment Period|Participant withdrew consent|0
5101045|NCT01928394|17617875|P15|Treatment Period|Participant withdrew consent|2
5101046|NCT01928394|17617876|P14|Treatment Period|Participant withdrew consent|0
5101047|NCT01928394|17617877|P13|Treatment Period|Participant withdrew consent|1
5101048|NCT01928394|17617878|P12|Treatment Period|Participant withdrew consent|1
5101049|NCT01928394|17617879|P11|Treatment Period|Participant withdrew consent|1
5101050|NCT01928394|17617880|P10|Treatment Period|Participant withdrew consent|0
5101051|NCT01928394|17617881|P9|Treatment Period|Participant withdrew consent|0
5101052|NCT01928394|17617882|P8|Treatment Period|Participant withdrew consent|1
5101053|NCT01928394|17617883|P7|Treatment Period|Participant withdrew consent|0
5101054|NCT01928394|17617884|P6|Treatment Period|Participant withdrew consent|1
5101055|NCT01928394|17617885|P5|Treatment Period|Participant withdrew consent|0
5101056|NCT01928394|17617886|P4|Treatment Period|Participant withdrew consent|1
5101057|NCT01928394|17617887|P3|Treatment Period|Participant withdrew consent|1
5101058|NCT01928394|17617888|P2|Treatment Period|Participant withdrew consent|0
5101059|NCT01928394|17617889|P1|Treatment Period|Participant withdrew consent|0
5101060|NCT01928394|17617867|P23|Treatment Period|Participant request to stop therapy|3
5101061|NCT01928394|17617868|P22|Treatment Period|Participant request to stop therapy|1
5101062|NCT01928394|17617869|P21|Treatment Period|Participant request to stop therapy|3
5101063|NCT01928394|17617870|P20|Treatment Period|Participant request to stop therapy|1
5101064|NCT01928394|17617871|P19|Treatment Period|Participant request to stop therapy|1
5101065|NCT01928394|17617872|P18|Treatment Period|Participant request to stop therapy|3
5101066|NCT01928394|17617873|P17|Treatment Period|Participant request to stop therapy|1
5101067|NCT01928394|17617874|P16|Treatment Period|Participant request to stop therapy|0
5101068|NCT01928394|17617875|P15|Treatment Period|Participant request to stop therapy|4
5101069|NCT01928394|17617876|P14|Treatment Period|Participant request to stop therapy|2
5101070|NCT01928394|17617877|P13|Treatment Period|Participant request to stop therapy|1
5101071|NCT01928394|17617878|P12|Treatment Period|Participant request to stop therapy|2
5101072|NCT01928394|17617879|P11|Treatment Period|Participant request to stop therapy|3
5101073|NCT01928394|17617880|P10|Treatment Period|Participant request to stop therapy|0
5101074|NCT01928394|17617881|P9|Treatment Period|Participant request to stop therapy|0
5101075|NCT01928394|17617882|P8|Treatment Period|Participant request to stop therapy|0
5101076|NCT01928394|17617883|P7|Treatment Period|Participant request to stop therapy|3
5101077|NCT01928394|17617884|P6|Treatment Period|Participant request to stop therapy|3
5101078|NCT01928394|17617885|P5|Treatment Period|Participant request to stop therapy|0
5101079|NCT01928394|17617886|P4|Treatment Period|Participant request to stop therapy|0
5101080|NCT01928394|17617887|P3|Treatment Period|Participant request to stop therapy|0
5101081|NCT01928394|17617888|P2|Treatment Period|Participant request to stop therapy|0
5101082|NCT01928394|17617889|P1|Treatment Period|Participant request to stop therapy|0
5101083|NCT01928394|17617867|P23|Treatment Period|AE unrelated to study drug|0
5101084|NCT01928394|17617868|P22|Treatment Period|AE unrelated to study drug|1
5101085|NCT01928394|17617869|P21|Treatment Period|AE unrelated to study drug|1
5101086|NCT01928394|17617870|P20|Treatment Period|AE unrelated to study drug|5
5101087|NCT01928394|17617871|P19|Treatment Period|AE unrelated to study drug|3
5101088|NCT01928394|17617872|P18|Treatment Period|AE unrelated to study drug|6
5101089|NCT01928394|17617873|P17|Treatment Period|AE unrelated to study drug|1
5101090|NCT01928394|17617874|P16|Treatment Period|AE unrelated to study drug|1
5101091|NCT01928394|17617875|P15|Treatment Period|AE unrelated to study drug|6
5101092|NCT01928394|17617876|P14|Treatment Period|AE unrelated to study drug|13
5101093|NCT01928394|17617877|P13|Treatment Period|AE unrelated to study drug|6
5101094|NCT01928394|17617878|P12|Treatment Period|AE unrelated to study drug|12
5101095|NCT01928394|17617879|P11|Treatment Period|AE unrelated to study drug|0
5101096|NCT01928394|17617880|P10|Treatment Period|AE unrelated to study drug|2
5101097|NCT01928394|17617881|P9|Treatment Period|AE unrelated to study drug|0
5101098|NCT01928394|17617882|P8|Treatment Period|AE unrelated to study drug|0
5101099|NCT01928394|17617883|P7|Treatment Period|AE unrelated to study drug|1
5101100|NCT01928394|17617884|P6|Treatment Period|AE unrelated to study drug|5
5101101|NCT01928394|17617885|P5|Treatment Period|AE unrelated to study drug|0
5101102|NCT01928394|17617886|P4|Treatment Period|AE unrelated to study drug|3
5101103|NCT01928394|17617887|P3|Treatment Period|AE unrelated to study drug|2
5101104|NCT01928394|17617888|P2|Treatment Period|AE unrelated to study drug|0
5101105|NCT01928394|17617889|P1|Treatment Period|AE unrelated to study drug|0
5101106|NCT01928394|17617867|P23|Treatment Period|Study drug toxicity|4
5101107|NCT01928394|17617868|P22|Treatment Period|Study drug toxicity|7
5101108|NCT01928394|17617869|P21|Treatment Period|Study drug toxicity|4
5101109|NCT01928394|17617870|P20|Treatment Period|Study drug toxicity|15
5101110|NCT01928394|17617871|P19|Treatment Period|Study drug toxicity|12
5101111|NCT01928394|17617872|P18|Treatment Period|Study drug toxicity|3
5101112|NCT01928394|17617873|P17|Treatment Period|Study drug toxicity|3
5101113|NCT01928394|17617874|P16|Treatment Period|Study drug toxicity|0
5101114|NCT01928394|17617875|P15|Treatment Period|Study drug toxicity|12
5101115|NCT01928394|17617876|P14|Treatment Period|Study drug toxicity|5
5101116|NCT01928394|17617877|P13|Treatment Period|Study drug toxicity|7
5101117|NCT01928394|17617878|P12|Treatment Period|Study drug toxicity|3
5101118|NCT01928394|17617879|P11|Treatment Period|Study drug toxicity|2
5101119|NCT01928394|17617880|P10|Treatment Period|Study drug toxicity|5
5101120|NCT01928394|17617881|P9|Treatment Period|Study drug toxicity|0
5101121|NCT01928394|17617882|P8|Treatment Period|Study drug toxicity|1
5101122|NCT01928394|17617883|P7|Treatment Period|Study drug toxicity|7
5101123|NCT01928394|17617884|P6|Treatment Period|Study drug toxicity|9
5101124|NCT01928394|17617885|P5|Treatment Period|Study drug toxicity|0
5101125|NCT01928394|17617886|P4|Treatment Period|Study drug toxicity|3
5101126|NCT01928394|17617887|P3|Treatment Period|Study drug toxicity|3
5101127|NCT01928394|17617888|P2|Treatment Period|Study drug toxicity|1
5101128|NCT01928394|17617889|P1|Treatment Period|Study drug toxicity|1
5101129|NCT01928394|17617867|P23|Treatment Period|Disease progression|31
5101130|NCT01928394|17617868|P22|Treatment Period|Disease progression|31
5101131|NCT01928394|17617869|P21|Treatment Period|Disease progression|30
5101132|NCT01928394|17617870|P20|Treatment Period|Disease progression|71
5101133|NCT01928394|17617871|P19|Treatment Period|Disease progression|50
5101134|NCT01928394|17617872|P18|Treatment Period|Disease progression|56
5101135|NCT01928394|17617873|P17|Treatment Period|Disease progression|43
5101136|NCT01928394|17617874|P16|Treatment Period|Disease progression|1
5101137|NCT01928394|17617875|P15|Treatment Period|Disease progression|59
5101138|NCT01928394|17617876|P14|Treatment Period|Disease progression|118
5101139|NCT01928394|17617877|P13|Treatment Period|Disease progression|38
5101140|NCT01928394|17617878|P12|Treatment Period|Disease progression|73
5101141|NCT01928394|17617879|P11|Treatment Period|Disease progression|22
5101142|NCT01928394|17617880|P10|Treatment Period|Disease progression|11
5101143|NCT01928394|17617881|P9|Treatment Period|Disease progression|3
5101144|NCT01928394|17617882|P8|Treatment Period|Disease progression|16
5101145|NCT01928394|17617883|P7|Treatment Period|Disease progression|38
5101146|NCT01928394|17617884|P6|Treatment Period|Disease progression|25
5101147|NCT01928394|17617885|P5|Treatment Period|Disease progression|3
5101148|NCT01928394|17617886|P4|Treatment Period|Disease progression|48
5101149|NCT01928394|17617887|P3|Treatment Period|Disease progression|12
5101150|NCT01928394|17617888|P2|Treatment Period|Disease progression|2
5101151|NCT01928394|17617889|P1|Treatment Period|Disease progression|17
5101152|NCT01928381|17617937|P7|Part 2 - Post Third Intervention|Protocol Violation|0
5101153|NCT01928381|17617938|P6|Part 2 - Post Third Intervention|Protocol Violation|0
5101154|NCT01928381|17617939|P5|Part 2 - Post Third Intervention|Protocol Violation|0
5101155|NCT01928381|17617940|P4|Part 2 - Post Third Intervention|Protocol Violation|0
5101156|NCT01928381|17617941|P3|Part 2 - Post Third Intervention|Protocol Violation|1
5101157|NCT01928381|17617942|P2|Part 2 - Post Third Intervention|Protocol Violation|0
5101158|NCT01928381|17617943|P1|Part 2 - Post Third Intervention|Protocol Violation|0
5101159|NCT01928381|17617937|P7|Part 2 - Second Intervention|Lost to Follow-up|0
5101160|NCT01928381|17617938|P6|Part 2 - Second Intervention|Lost to Follow-up|0
5101161|NCT01928381|17617939|P5|Part 2 - Second Intervention|Lost to Follow-up|0
5101162|NCT01928381|17617940|P4|Part 2 - Second Intervention|Lost to Follow-up|1
5101163|NCT01928381|17617941|P3|Part 2 - Second Intervention|Lost to Follow-up|0
5101164|NCT01928381|17617942|P2|Part 2 - Second Intervention|Lost to Follow-up|1
5101165|NCT01928381|17617943|P1|Part 2 - Second Intervention|Lost to Follow-up|0
5101166|NCT01928381|17617937|P7|Washout First Intervention|Protocol Violation|0
5101167|NCT01928381|17617938|P6|Washout First Intervention|Protocol Violation|0
5101168|NCT01928381|17617939|P5|Washout First Intervention|Protocol Violation|1
5101169|NCT01928381|17617940|P4|Washout First Intervention|Protocol Violation|0
5101170|NCT01928381|17617941|P3|Washout First Intervention|Protocol Violation|0
5101171|NCT01928381|17617942|P2|Washout First Intervention|Protocol Violation|0
5101172|NCT01928381|17617943|P1|Washout First Intervention|Protocol Violation|0
5101173|NCT01928381|17617937|P7|Part 2 - First Intervention|Lost to Follow-up|0
5101174|NCT01928381|17617938|P6|Part 2 - First Intervention|Lost to Follow-up|0
5101175|NCT01928381|17617939|P5|Part 2 - First Intervention|Lost to Follow-up|0
5101176|NCT01928381|17617940|P4|Part 2 - First Intervention|Lost to Follow-up|1
5101177|NCT01928381|17617941|P3|Part 2 - First Intervention|Lost to Follow-up|0
5101178|NCT01928381|17617942|P2|Part 2 - First Intervention|Lost to Follow-up|0
5101179|NCT01928381|17617943|P1|Part 2 - First Intervention|Lost to Follow-up|0
5101180|NCT01928381|17617937|P7|Part 2 - First Intervention|Eligibility criterion not met|1
5101181|NCT01928381|17617938|P6|Part 2 - First Intervention|Eligibility criterion not met|1
5101182|NCT01928381|17617939|P5|Part 2 - First Intervention|Eligibility criterion not met|0
5101183|NCT01928381|17617940|P4|Part 2 - First Intervention|Eligibility criterion not met|0
5101184|NCT01928381|17617941|P3|Part 2 - First Intervention|Eligibility criterion not met|0
5101185|NCT01928381|17617942|P2|Part 2 - First Intervention|Eligibility criterion not met|0
5101186|NCT01928381|17617943|P1|Part 2 - First Intervention|Eligibility criterion not met|0
5101187|NCT01928381|17617937|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
5101188|NCT01928381|17617938|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
5101189|NCT01928381|17617939|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
5101190|NCT01928381|17617940|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
5101191|NCT01928381|17617941|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
5101192|NCT01928381|17617942|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
5101193|NCT01928381|17617943|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
5101194|NCT01928381|17617937|P7|Part 2 - First Intervention|Withdrawal by Subject|0
5101195|NCT01928381|17617938|P6|Part 2 - First Intervention|Withdrawal by Subject|0
5101196|NCT01928381|17617939|P5|Part 2 - First Intervention|Withdrawal by Subject|0
5101197|NCT01928381|17617940|P4|Part 2 - First Intervention|Withdrawal by Subject|0
5101198|NCT01928381|17617941|P3|Part 2 - First Intervention|Withdrawal by Subject|1
5101199|NCT01928381|17617942|P2|Part 2 - First Intervention|Withdrawal by Subject|0
5101200|NCT01928381|17617943|P1|Part 2 - First Intervention|Withdrawal by Subject|0
5101201|NCT01928381|17617937|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5101202|NCT01928381|17617938|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5101203|NCT01928381|17617939|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5101204|NCT01928381|17617940|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5101205|NCT01928381|17617941|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5101206|NCT01928381|17617942|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5101207|NCT01928381|17617943|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
5101208|NCT01928381|17617937|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5101209|NCT01928381|17617938|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5101210|NCT01928381|17617939|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5101211|NCT01928381|17617940|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5101212|NCT01928381|17617941|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5101213|NCT01928381|17617942|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5101214|NCT01928381|17617943|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
5101215|NCT01928381|17617937|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5101216|NCT01928381|17617938|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5101217|NCT01928381|17617939|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5101218|NCT01928381|17617940|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5101219|NCT01928381|17617941|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5101220|NCT01928381|17617942|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5101221|NCT01928381|17617943|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
5101222|NCT01928381|17617937|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5101223|NCT01928381|17617938|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5101224|NCT01928381|17617939|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5101225|NCT01928381|17617940|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5101226|NCT01928381|17617941|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5101227|NCT01928381|17617942|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5101228|NCT01928381|17617943|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
5101229|NCT01928381|17617937|P7|Part 1 - Pain Training|Protocol Violation|0
5101230|NCT01928381|17617938|P6|Part 1 - Pain Training|Protocol Violation|0
5101231|NCT01928381|17617939|P5|Part 1 - Pain Training|Protocol Violation|0
5101232|NCT01928381|17617940|P4|Part 1 - Pain Training|Protocol Violation|0
5101233|NCT01928381|17617941|P3|Part 1 - Pain Training|Protocol Violation|0
5101234|NCT01928381|17617942|P2|Part 1 - Pain Training|Protocol Violation|0
5101235|NCT01928381|17617943|P1|Part 1 - Pain Training|Protocol Violation|1
5101236|NCT01928381|17617937|P7|Part 1 - Pain Training|Lost to Follow-up|0
5101237|NCT01928381|17617938|P6|Part 1 - Pain Training|Lost to Follow-up|0
5101238|NCT01928381|17617939|P5|Part 1 - Pain Training|Lost to Follow-up|0
5101239|NCT01928381|17617940|P4|Part 1 - Pain Training|Lost to Follow-up|0
5101240|NCT01928381|17617941|P3|Part 1 - Pain Training|Lost to Follow-up|0
5101241|NCT01928381|17617942|P2|Part 1 - Pain Training|Lost to Follow-up|0
5101242|NCT01928381|17617943|P1|Part 1 - Pain Training|Lost to Follow-up|4
5101243|NCT01928381|17617937|P7|Part 1 - Pain Training|Withdrawal by Subject|0
5101244|NCT01928381|17617938|P6|Part 1 - Pain Training|Withdrawal by Subject|0
5101245|NCT01928381|17617939|P5|Part 1 - Pain Training|Withdrawal by Subject|0
5101246|NCT01928381|17617940|P4|Part 1 - Pain Training|Withdrawal by Subject|0
5101247|NCT01928381|17617941|P3|Part 1 - Pain Training|Withdrawal by Subject|0
5101248|NCT01928381|17617942|P2|Part 1 - Pain Training|Withdrawal by Subject|0
5101249|NCT01928381|17617943|P1|Part 1 - Pain Training|Withdrawal by Subject|1
5101250|NCT01928381|17617937|P7|Part 1 - Pain Training|Pain training criteria not met|0
5101251|NCT01928381|17617938|P6|Part 1 - Pain Training|Pain training criteria not met|0
5101252|NCT01928381|17617939|P5|Part 1 - Pain Training|Pain training criteria not met|0
5101253|NCT01928381|17617940|P4|Part 1 - Pain Training|Pain training criteria not met|0
5101254|NCT01928381|17617941|P3|Part 1 - Pain Training|Pain training criteria not met|0
5101255|NCT01928381|17617942|P2|Part 1 - Pain Training|Pain training criteria not met|0
5101256|NCT01928381|17617943|P1|Part 1 - Pain Training|Pain training criteria not met|29
5101257|NCT01928381|17617937|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5101258|NCT01928381|17617938|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5101259|NCT01928381|17617939|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5101260|NCT01928381|17617940|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5101261|NCT01928381|17617941|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5101262|NCT01928381|17617942|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5101263|NCT01928381|17617943|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
5101264|NCT01928329|17617958|P2|Overall Study|Physician Decision|1
5101265|NCT01928329|17617959|P1|Overall Study|Physician Decision|1
5101266|NCT01928329|17617958|P2|Overall Study|Withdrawal by Subject|5
5101267|NCT01928329|17617959|P1|Overall Study|Withdrawal by Subject|1
5101268|NCT01928329|17617958|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
5101269|NCT01928329|17617959|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
5101270|NCT01928329|17617958|P2|Overall Study|Adverse Event|3
5101271|NCT01928329|17617959|P1|Overall Study|Adverse Event|5
5101272|NCT01928329|17617958|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
5101273|NCT01928329|17617959|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
5101274|NCT01928329|17617958|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
5101275|NCT01928329|17617959|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
5101276|NCT01928225|17617994|P2|Overall Study|Lost to Follow-up|3
5101277|NCT01928225|17617995|P1|Overall Study|Lost to Follow-up|1
5101278|NCT01928225|17617994|P2|Overall Study|basaloid cervical cancer|0
5101279|NCT01928225|17617995|P1|Overall Study|basaloid cervical cancer|1
5101280|NCT01928225|17617994|P2|Overall Study|Pregnancy|0
5101281|NCT01928225|17617995|P1|Overall Study|Pregnancy|1
5101282|NCT01928082|17618017|P1|Overall Study|Study terminated.|1
5101283|NCT01927861|17618051|P2|Extension Phase (104 Weeks)|Unclassified|1
5101284|NCT01927861|17618052|P1|Extension Phase (104 Weeks)|Unclassified|0
5101285|NCT01927861|17618051|P2|Extension Phase (104 Weeks)|Adverse Event|2
5101286|NCT01927861|17618052|P1|Extension Phase (104 Weeks)|Adverse Event|0
5101287|NCT01927757|17618190|P1|Overall Study|Ethical Reasons|4
5101288|NCT01927757|17618190|P1|Overall Study|Other|1
5101289|NCT01927757|17618190|P1|Overall Study|Decision by Sponsor|2
5101290|NCT01927757|17618190|P1|Overall Study|Lost to Follow-up|2
5101291|NCT01927757|17618190|P1|Overall Study|Withdrawal by Subject|14
5101292|NCT01927627|17618212|P1|Overall Study|Financial Concerns|1
5101293|NCT01927627|17618212|P1|Overall Study|Lack of Efficacy|1
5101294|NCT01927627|17618212|P1|Overall Study|Adverse Event|3
5101295|NCT01927562|17618225|P1|Overall Study|Physician Decision|5
5101296|NCT01927562|17618225|P1|Overall Study|Withdrawal by Subject|3
5101297|NCT01927562|17618225|P1|Overall Study|Lost to Follow-up|30
5101298|NCT01927419|17618231|P2|Overall Study|Not reported|0
5101299|NCT01927419|17618232|P1|Overall Study|Not reported|1
5101300|NCT01927419|17618231|P2|Overall Study|Other|1
5101301|NCT01927419|17618232|P1|Overall Study|Other|2
5101302|NCT01927419|17618231|P2|Overall Study|Withdrawal by Subject|1
5101303|NCT01927419|17618232|P1|Overall Study|Withdrawal by Subject|3
5101304|NCT01927419|17618231|P2|Overall Study|Adverse event unrelated to study drug|1
5101305|NCT01927419|17618232|P1|Overall Study|Adverse event unrelated to study drug|6
5101306|NCT01927419|17618231|P2|Overall Study|Death|1
5101307|NCT01927419|17618232|P1|Overall Study|Death|0
5101308|NCT01927419|17618231|P2|Overall Study|Study drug toxicity|7
5101309|NCT01927419|17618232|P1|Overall Study|Study drug toxicity|43
5101310|NCT01927419|17618231|P2|Overall Study|Disease progression|17
5101311|NCT01927419|17618232|P1|Overall Study|Disease progression|15
5101312|NCT01927367|17618250|P2|Overall Study|No baseline data|1
5101313|NCT01927367|17618251|P1|Overall Study|No baseline data|0
5101314|NCT01927367|17618250|P2|Overall Study|Withdrawal by Subject|4
5101315|NCT01927367|17618251|P1|Overall Study|Withdrawal by Subject|7
5101316|NCT01927055|17618283|P3|Double-Blind|Extended Vacation|0
5101317|NCT01927055|17618284|P2|Double-Blind|Extended Vacation|1
5101318|NCT01927055|17618285|P1|Double-Blind|Extended Vacation|0
5101319|NCT01927055|17618283|P3|Double-Blind|Supine Hypertension|1
5101320|NCT01927055|17618284|P2|Double-Blind|Supine Hypertension|0
5101321|NCT01927055|17618285|P1|Double-Blind|Supine Hypertension|0
5101322|NCT01927055|17618283|P3|Double-Blind|Study Stopped|7
5101323|NCT01927055|17618284|P2|Double-Blind|Study Stopped|7
5101324|NCT01927055|17618285|P1|Double-Blind|Study Stopped|0
5101325|NCT01927055|17618283|P3|Double-Blind|Withdrawal by Subject|3
5101326|NCT01927055|17618284|P2|Double-Blind|Withdrawal by Subject|2
5101327|NCT01927055|17618285|P1|Double-Blind|Withdrawal by Subject|0
5101328|NCT01927055|17618283|P3|Double-Blind|Protocol Violation|1
5101329|NCT01927055|17618284|P2|Double-Blind|Protocol Violation|0
5101330|NCT01927055|17618285|P1|Double-Blind|Protocol Violation|0
5101331|NCT01927055|17618283|P3|Double-Blind|Adverse Event|1
5101332|NCT01927055|17618284|P2|Double-Blind|Adverse Event|1
5101333|NCT01927055|17618285|P1|Double-Blind|Adverse Event|0
5101334|NCT01927055|17618283|P3|Open-label|Difficulty attending study visits|0
5101335|NCT01927055|17618284|P2|Open-label|Difficulty attending study visits|0
5101336|NCT01927055|17618285|P1|Open-label|Difficulty attending study visits|1
5101337|NCT01927055|17618283|P3|Open-label|Supine Hypertension|0
5101338|NCT01927055|17618284|P2|Open-label|Supine Hypertension|0
5101339|NCT01927055|17618285|P1|Open-label|Supine Hypertension|4
5101340|NCT01927055|17618283|P3|Open-label|Study Stopped|0
5101341|NCT01927055|17618284|P2|Open-label|Study Stopped|0
5101342|NCT01927055|17618285|P1|Open-label|Study Stopped|4
5101343|NCT01927055|17618283|P3|Open-label|Withdrawal by Subject|0
5101344|NCT01927055|17618284|P2|Open-label|Withdrawal by Subject|0
5101345|NCT01927055|17618285|P1|Open-label|Withdrawal by Subject|1
5101346|NCT01927055|17618283|P3|Open-label|Adverse Event|0
5101347|NCT01927055|17618284|P2|Open-label|Adverse Event|0
5101348|NCT01927055|17618285|P1|Open-label|Adverse Event|6
5101349|NCT01926886|17618303|P2|Overall Study|Did not cooperate|0
5101350|NCT01926886|17618304|P1|Overall Study|Did not cooperate|1
5101351|NCT01926886|17618303|P2|Overall Study|Death|0
5101352|NCT01926886|17618304|P1|Overall Study|Death|1
5101353|NCT01926886|17618303|P2|Overall Study|Progression of disease|0
5101354|NCT01926886|17618304|P1|Overall Study|Progression of disease|2
5101355|NCT01926886|17618303|P2|Overall Study|Recurrence of disease|0
5101356|NCT01926886|17618304|P1|Overall Study|Recurrence of disease|1
5101357|NCT01926886|17618303|P2|Overall Study|Failure to return|0
5101358|NCT01926886|17618304|P1|Overall Study|Failure to return|3
5101359|NCT01926886|17618303|P2|Overall Study|Withdrawal by Subject|0
5101360|NCT01926886|17618304|P1|Overall Study|Withdrawal by Subject|15
5101361|NCT01926886|17618303|P2|Overall Study|Disease progression/recurrence|0
5101362|NCT01926886|17618304|P1|Overall Study|Disease progression/recurrence|4
5101363|NCT01926886|17618303|P2|Overall Study|Adverse event/intercurrent illness|0
5101364|NCT01926886|17618304|P1|Overall Study|Adverse event/intercurrent illness|4
5101365|NCT01926886|17618303|P2|Overall Study|Administrative/other|0
5101366|NCT01926886|17618304|P1|Overall Study|Administrative/other|1
5101367|NCT01926782|17618323|P6|Overall Study|Related to study drug administration|2
5101368|NCT01926782|17618324|P5|Overall Study|Related to study drug administration|0
5101369|NCT01926782|17618325|P4|Overall Study|Related to study drug administration|0
5101370|NCT01926782|17618326|P3|Overall Study|Related to study drug administration|0
5101371|NCT01926782|17618327|P2|Overall Study|Related to study drug administration|0
5101372|NCT01926782|17618328|P1|Overall Study|Related to study drug administration|0
5101373|NCT01926782|17618323|P6|Overall Study|Withdrawal by Subject|5
5101374|NCT01926782|17618324|P5|Overall Study|Withdrawal by Subject|0
5101375|NCT01926782|17618325|P4|Overall Study|Withdrawal by Subject|1
5101376|NCT01926782|17618326|P3|Overall Study|Withdrawal by Subject|8
5101377|NCT01926782|17618327|P2|Overall Study|Withdrawal by Subject|1
5101378|NCT01926782|17618328|P1|Overall Study|Withdrawal by Subject|6
5101379|NCT01926782|17618323|P6|Overall Study|Randomized and not treated|0
5101380|NCT01926782|17618324|P5|Overall Study|Randomized and not treated|0
5101381|NCT01926782|17618325|P4|Overall Study|Randomized and not treated|1
5101382|NCT01926782|17618326|P3|Overall Study|Randomized and not treated|0
5101383|NCT01926782|17618327|P2|Overall Study|Randomized and not treated|0
5101384|NCT01926782|17618328|P1|Overall Study|Randomized and not treated|0
5101385|NCT01926782|17618323|P6|Overall Study|Poor compliance to protocol|6
5101386|NCT01926782|17618324|P5|Overall Study|Poor compliance to protocol|1
5101387|NCT01926782|17618325|P4|Overall Study|Poor compliance to protocol|0
5101388|NCT01926782|17618326|P3|Overall Study|Poor compliance to protocol|8
5101389|NCT01926782|17618327|P2|Overall Study|Poor compliance to protocol|3
5101390|NCT01926782|17618328|P1|Overall Study|Poor compliance to protocol|5
5101391|NCT01926782|17618323|P6|Overall Study|Adverse Event|14
5101392|NCT01926782|17618324|P5|Overall Study|Adverse Event|3
5101393|NCT01926782|17618325|P4|Overall Study|Adverse Event|4
5101394|NCT01926782|17618326|P3|Overall Study|Adverse Event|17
5101395|NCT01926782|17618327|P2|Overall Study|Adverse Event|4
5101396|NCT01926782|17618328|P1|Overall Study|Adverse Event|13
5101397|NCT01926782|17618323|P6|Overall Study|Other than specified|11
5101398|NCT01926782|17618324|P5|Overall Study|Other than specified|4
5101399|NCT01926782|17618325|P4|Overall Study|Other than specified|12
5101400|NCT01926782|17618326|P3|Overall Study|Other than specified|5
5101401|NCT01926782|17618327|P2|Overall Study|Other than specified|3
5101402|NCT01926782|17618328|P1|Overall Study|Other than specified|2
5101403|NCT01926782|17618323|P6|Overall Study|Physician Decision|0
5101404|NCT01926782|17618324|P5|Overall Study|Physician Decision|0
5101405|NCT01926782|17618325|P4|Overall Study|Physician Decision|1
5101406|NCT01926782|17618326|P3|Overall Study|Physician Decision|1
5101407|NCT01926782|17618327|P2|Overall Study|Physician Decision|2
5101408|NCT01926782|17618328|P1|Overall Study|Physician Decision|0
5101409|NCT01926782|17618323|P6|Overall Study|Participant moved|3
5101410|NCT01926782|17618324|P5|Overall Study|Participant moved|0
5101411|NCT01926782|17618325|P4|Overall Study|Participant moved|1
5101412|NCT01926782|17618326|P3|Overall Study|Participant moved|1
5101413|NCT01926782|17618327|P2|Overall Study|Participant moved|0
5101414|NCT01926782|17618328|P1|Overall Study|Participant moved|2
5101415|NCT01926626|17618477|P1|Overall Study|Lost to Follow-up|7
5101416|NCT01926626|17618477|P1|Overall Study|Withdrawal by Subject|15
5101417|NCT01926509|17618491|P4|Overall Study|vital sign met discontinuation criteria|0
5101418|NCT01926509|17618492|P3|Overall Study|vital sign met discontinuation criteria|0
5101419|NCT01926509|17618493|P2|Overall Study|vital sign met discontinuation criteria|0
5101420|NCT01926509|17618494|P1|Overall Study|vital sign met discontinuation criteria|1
5101421|NCT01926444|17618534|P4|Overall Study|Colonoscopy not performed|2
5101422|NCT01926444|17618535|P3|Overall Study|Colonoscopy not performed|4
5101423|NCT01926444|17618536|P2|Overall Study|Colonoscopy not performed|0
5101424|NCT01926444|17618537|P1|Overall Study|Colonoscopy not performed|0
5101425|NCT01926119|17618579|P1|Overall Study|Withdrawal by Subject|1
5101426|NCT01926028|17618592|P3|Overall Study|Non compliance or other reasons|0
5101427|NCT01926028|17618593|P2|Overall Study|Non compliance or other reasons|2
5101428|NCT01926028|17618594|P1|Overall Study|Non compliance or other reasons|4
5101429|NCT01926028|17618592|P3|Overall Study|Withdrawal by Subject|2
5101430|NCT01926028|17618593|P2|Overall Study|Withdrawal by Subject|9
5101431|NCT01926028|17618594|P1|Overall Study|Withdrawal by Subject|9
5101432|NCT01926028|17618592|P3|Overall Study|Physician Decision|0
5101433|NCT01926028|17618593|P2|Overall Study|Physician Decision|5
5101434|NCT01926028|17618594|P1|Overall Study|Physician Decision|1
5101435|NCT01926028|17618592|P3|Overall Study|Lost to Follow-up|0
5101436|NCT01926028|17618593|P2|Overall Study|Lost to Follow-up|6
5101437|NCT01926028|17618594|P1|Overall Study|Lost to Follow-up|7
5101438|NCT01926015|17618630|P2|Overall Study|Randomized not treated|0
5101439|NCT01926015|17618631|P1|Overall Study|Randomized not treated|2
5101440|NCT01926015|17618630|P2|Overall Study|Withdrawal by parent/guardian|1
5101441|NCT01926015|17618631|P1|Overall Study|Withdrawal by parent/guardian|0
5101442|NCT01925989|17618663|P3|Period 1|Withdrawal by Subject|0
5101443|NCT01925989|17618664|P2|Period 1|Withdrawal by Subject|1
5101444|NCT01925989|17618665|P1|Period 1|Withdrawal by Subject|0
5101445|NCT01925989|17618663|P3|Period 1|Sponsor Decision|0
5101446|NCT01925989|17618664|P2|Period 1|Sponsor Decision|1
5101447|NCT01925989|17618665|P1|Period 1|Sponsor Decision|1
5101448|NCT01925950|17618685|P2|Part 2|Withdrawal by Subject|0
5101449|NCT01925950|17618686|P1|Part 2|Withdrawal by Subject|1
5101450|NCT01925768|17618705|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
5101451|NCT01925768|17618706|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
5101452|NCT01925768|17618705|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
5101453|NCT01925768|17618706|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
5101454|NCT01925768|17618705|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
5101455|NCT01925768|17618706|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
5101456|NCT01925768|17618705|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
5101457|NCT01925768|17618706|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
5101458|NCT01925768|17618705|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
5101459|NCT01925768|17618706|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
5101460|NCT01925768|17618705|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
5101461|NCT01925768|17618706|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
5101462|NCT01925768|17618705|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5101463|NCT01925768|17618706|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
5101464|NCT01925768|17618705|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
5101465|NCT01925768|17618706|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5101466|NCT01925768|17618705|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
5101467|NCT01925768|17618706|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
5101468|NCT01925768|17618705|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
5101469|NCT01925768|17618706|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5101470|NCT01925768|17618705|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5101471|NCT01925768|17618706|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5101472|NCT01925703|17618754|P1|Overall Study|Discharge prior to full iron repletion|1
5101473|NCT01925703|17618754|P1|Overall Study|Lost to Follow-up|2
5101474|NCT01925703|17618754|P1|Overall Study|Physician Decision|1
5101475|NCT01925612|17618772|P5|Overall Study|Adverse Event|2
5101476|NCT01925612|17618773|P4|Overall Study|Adverse Event|1
5101477|NCT01925612|17618774|P3|Overall Study|Adverse Event|0
5101478|NCT01925612|17618775|P2|Overall Study|Adverse Event|3
5101479|NCT01925612|17618776|P1|Overall Study|Adverse Event|3
5101480|NCT01925612|17618772|P5|Overall Study|Progressive Disease|0
5101481|NCT01925612|17618773|P4|Overall Study|Progressive Disease|0
5101482|NCT01925612|17618774|P3|Overall Study|Progressive Disease|1
5101483|NCT01925612|17618775|P2|Overall Study|Progressive Disease|1
5101484|NCT01925612|17618776|P1|Overall Study|Progressive Disease|1
5101485|NCT01925417|17618826|P1|Overall Study|Death|1
5101486|NCT01925417|17618826|P1|Overall Study|Withdrawal by Subject|2
5101487|NCT01925339|17618857|P2|Overall Study|Adverse Event|0
5101488|NCT01925339|17618858|P1|Overall Study|Adverse Event|2
5101489|NCT01925274|17618869|P3|Overall Study|Protocol amendment|6
5101490|NCT01925274|17618870|P2|Overall Study|Protocol amendment|3
5101491|NCT01925274|17618871|P1|Overall Study|Protocol amendment|1
5101492|NCT01925274|17618869|P3|Overall Study|Study terminated by sponsor|0
5101493|NCT01925274|17618870|P2|Overall Study|Study terminated by sponsor|0
5101494|NCT01925274|17618871|P1|Overall Study|Study terminated by sponsor|4
5101495|NCT01925274|17618869|P3|Overall Study|Withdrawal by Subject|0
5101496|NCT01925274|17618870|P2|Overall Study|Withdrawal by Subject|2
5101497|NCT01925274|17618871|P1|Overall Study|Withdrawal by Subject|1
5101498|NCT01925274|17618869|P3|Overall Study|Lost to Follow-up|0
5101499|NCT01925274|17618870|P2|Overall Study|Lost to Follow-up|1
5101500|NCT01925274|17618871|P1|Overall Study|Lost to Follow-up|0
5101501|NCT01925274|17618869|P3|Overall Study|Death|0
5101502|NCT01925274|17618870|P2|Overall Study|Death|0
5101503|NCT01925274|17618871|P1|Overall Study|Death|1
5101504|NCT01925209|17618952|P4|Follow-up|Withdrawal by Subject|2
5101505|NCT01925209|17618953|P3|Follow-up|Withdrawal by Subject|0
5101506|NCT01925209|17618954|P2|Follow-up|Withdrawal by Subject|2
5101507|NCT01925209|17618955|P1|Follow-up|Withdrawal by Subject|0
5101508|NCT01925209|17618952|P4|Follow-up|Non-compliance with study treatment|1
5101509|NCT01925209|17618953|P3|Follow-up|Non-compliance with study treatment|0
5101510|NCT01925209|17618954|P2|Follow-up|Non-compliance with study treatment|0
5101511|NCT01925209|17618955|P1|Follow-up|Non-compliance with study treatment|0
5101512|NCT01925209|17618952|P4|Follow-up|Physician Decision|0
5101513|NCT01925209|17618953|P3|Follow-up|Physician Decision|1
5101514|NCT01925209|17618954|P2|Follow-up|Physician Decision|0
5101515|NCT01925209|17618955|P1|Follow-up|Physician Decision|0
5101516|NCT01925209|17618952|P4|Follow-up|Adverse Event|1
5101517|NCT01925209|17618953|P3|Follow-up|Adverse Event|0
5101518|NCT01925209|17618954|P2|Follow-up|Adverse Event|4
5101519|NCT01925209|17618955|P1|Follow-up|Adverse Event|1
5101520|NCT01925209|17618952|P4|Maintenance Treatment Epoch|Adverse Event|0
5101521|NCT01925209|17618953|P3|Maintenance Treatment Epoch|Adverse Event|1
5101522|NCT01925209|17618954|P2|Maintenance Treatment Epoch|Adverse Event|0
5101523|NCT01925209|17618955|P1|Maintenance Treatment Epoch|Adverse Event|0
5101524|NCT01925209|17618952|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
5101525|NCT01925209|17618953|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
5101526|NCT01925209|17618954|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
5101527|NCT01925209|17618955|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
5101528|NCT01925209|17618952|P4|Treatment Epoch|Adverse Event|1
5101529|NCT01925209|17618953|P3|Treatment Epoch|Adverse Event|3
5101530|NCT01925209|17618954|P2|Treatment Epoch|Adverse Event|5
5101531|NCT01925209|17618955|P1|Treatment Epoch|Adverse Event|3
5101532|NCT01925209|17618952|P4|Treatment Epoch|Withdrawal by Subject|2
5101533|NCT01925209|17618953|P3|Treatment Epoch|Withdrawal by Subject|3
5101534|NCT01925209|17618954|P2|Treatment Epoch|Withdrawal by Subject|3
5101535|NCT01925209|17618955|P1|Treatment Epoch|Withdrawal by Subject|4
5101536|NCT01925209|17618952|P4|Treatment Epoch|Protocol deviation|1
5101537|NCT01925209|17618953|P3|Treatment Epoch|Protocol deviation|1
5101538|NCT01925209|17618954|P2|Treatment Epoch|Protocol deviation|0
5101539|NCT01925209|17618955|P1|Treatment Epoch|Protocol deviation|0
5101540|NCT01925209|17618952|P4|Treatment Epoch|Death|0
5101541|NCT01925209|17618953|P3|Treatment Epoch|Death|0
5101542|NCT01925209|17618954|P2|Treatment Epoch|Death|0
5101543|NCT01925209|17618955|P1|Treatment Epoch|Death|1
5101544|NCT01925209|17618952|P4|Treatment Epoch|Non-compliance with study treatment|1
5101545|NCT01925209|17618953|P3|Treatment Epoch|Non-compliance with study treatment|0
5101546|NCT01925209|17618954|P2|Treatment Epoch|Non-compliance with study treatment|0
5101547|NCT01925209|17618955|P1|Treatment Epoch|Non-compliance with study treatment|0
5101548|NCT01925209|17618952|P4|Treatment Epoch|Physician Decision|0
5101549|NCT01925209|17618953|P3|Treatment Epoch|Physician Decision|0
5101550|NCT01925209|17618954|P2|Treatment Epoch|Physician Decision|0
5101551|NCT01925209|17618955|P1|Treatment Epoch|Physician Decision|1
5101552|NCT01925183|17618987|P2|Overall Study|Adverse Event|0
5101553|NCT01925183|17618988|P1|Overall Study|Adverse Event|1
5101554|NCT01925170|17618996|P1|Overall Study|Unverified cancer status|53
5101555|NCT01925014|17619027|P2|Overall Study|Withdrawal by Subject|13
5101556|NCT01925014|17619028|P1|Overall Study|Withdrawal by Subject|5
5101557|NCT01925014|17619027|P2|Overall Study|Inappropriate enrollment|6
5101558|NCT01925014|17619028|P1|Overall Study|Inappropriate enrollment|4
5101559|NCT01924845|17619103|P1|Overall Study|Protocol Violation|1
5101560|NCT01924845|17619103|P1|Overall Study|Withdrawal by Subject|2
5101561|NCT01924845|17619103|P1|Overall Study|Adverse Event|3
5101562|NCT01924806|17619113|P2|Overall Study|Physician Decision|1
5101563|NCT01924806|17619114|P1|Overall Study|Physician Decision|2
5101564|NCT01924767|17619131|P5|Overall Study|Adverse Event|0
5101565|NCT01924767|17619132|P4|Overall Study|Adverse Event|0
5101566|NCT01924767|17619133|P3|Overall Study|Adverse Event|1
5101567|NCT01924767|17619134|P2|Overall Study|Adverse Event|0
5101568|NCT01924767|17619135|P1|Overall Study|Adverse Event|1
5101569|NCT01924689|17619241|P6|Overall Study|Other|0
5101570|NCT01924689|17619242|P5|Overall Study|Other|1
5101571|NCT01924689|17619243|P4|Overall Study|Other|0
5101572|NCT01924689|17619244|P3|Overall Study|Other|0
5101573|NCT01924689|17619245|P2|Overall Study|Other|0
5101574|NCT01924689|17619246|P1|Overall Study|Other|0
5101575|NCT01924689|17619241|P6|Overall Study|Withdrawal of consent|0
5101576|NCT01924689|17619242|P5|Overall Study|Withdrawal of consent|0
5101577|NCT01924689|17619243|P4|Overall Study|Withdrawal of consent|1
5101578|NCT01924689|17619244|P3|Overall Study|Withdrawal of consent|1
5101579|NCT01924689|17619245|P2|Overall Study|Withdrawal of consent|0
5101580|NCT01924689|17619246|P1|Overall Study|Withdrawal of consent|0
5101581|NCT01924689|17619241|P6|Overall Study|New therapy or study|0
5101582|NCT01924689|17619242|P5|Overall Study|New therapy or study|2
5101583|NCT01924689|17619243|P4|Overall Study|New therapy or study|4
5101584|NCT01924689|17619244|P3|Overall Study|New therapy or study|1
5101585|NCT01924689|17619245|P2|Overall Study|New therapy or study|2
5101586|NCT01924689|17619246|P1|Overall Study|New therapy or study|3
5101587|NCT01924689|17619241|P6|Overall Study|Disease progression|2
5101588|NCT01924689|17619242|P5|Overall Study|Disease progression|3
5101589|NCT01924689|17619243|P4|Overall Study|Disease progression|0
5101590|NCT01924689|17619244|P3|Overall Study|Disease progression|2
5101591|NCT01924689|17619245|P2|Overall Study|Disease progression|0
5101592|NCT01924689|17619246|P1|Overall Study|Disease progression|0
5101593|NCT01924689|17619241|P6|Overall Study|Death|0
5101594|NCT01924689|17619242|P5|Overall Study|Death|0
5101595|NCT01924689|17619243|P4|Overall Study|Death|1
5101596|NCT01924689|17619244|P3|Overall Study|Death|0
5101597|NCT01924689|17619245|P2|Overall Study|Death|1
5101598|NCT01924689|17619246|P1|Overall Study|Death|0
5101599|NCT01924533|17619320|P2|Overall Study|Other Eligibility criteria|1
5101600|NCT01924533|17619321|P1|Overall Study|Other Eligibility criteria|1
5101601|NCT01924533|17619320|P2|Overall Study|Withdrawal by Subject|3
5101602|NCT01924533|17619321|P1|Overall Study|Withdrawal by Subject|7
5101603|NCT01924533|17619320|P2|Overall Study|Lost to Follow-up|1
5101604|NCT01924533|17619321|P1|Overall Study|Lost to Follow-up|0
5101605|NCT01924533|17619320|P2|Overall Study|Death|200
5101606|NCT01924533|17619321|P1|Overall Study|Death|181
5101607|NCT01924429|17619362|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
5101608|NCT01924429|17619363|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
5101609|NCT01924364|17619406|P1|Overall Study|Physician Decision|3
5101610|NCT01924299|17619423|P2|Period 2|Adverse Event|1
5101611|NCT01924299|17619424|P1|Period 2|Adverse Event|0
5101612|NCT01924299|17619423|P2|Period 2|Withdrawal by Subject|0
5101613|NCT01924299|17619424|P1|Period 2|Withdrawal by Subject|1
5101614|NCT01924182|17619446|P2|Overall Study|Withdrawal by Subject|0
5101615|NCT01924182|17619447|P1|Overall Study|Withdrawal by Subject|1
5101616|NCT01923896|17619488|P2|Overall Study|Adverse Event|0
5101617|NCT01923896|17619489|P1|Overall Study|Adverse Event|1
5101618|NCT01923740|17619512|P2|Overall Study|Withdrawal by Subject|0
5101619|NCT01923740|17619513|P1|Overall Study|Withdrawal by Subject|2
5101620|NCT01923740|17619512|P2|Overall Study|Lost to Follow-up|9
5101621|NCT01923740|17619513|P1|Overall Study|Lost to Follow-up|4
5101622|NCT01923467|17619938|P1|Overall Study|Subject non-interest|479
5101623|NCT01923467|17619938|P1|Overall Study|Lost to Follow-up|62
5101624|NCT01923428|17619946|P4|Overall Study|Lack of Efficacy|1
5101625|NCT01923428|17619947|P3|Overall Study|Lack of Efficacy|1
5101626|NCT01923428|17619948|P2|Overall Study|Lack of Efficacy|0
5101627|NCT01923428|17619949|P1|Overall Study|Lack of Efficacy|0
5101628|NCT01923428|17619946|P4|Overall Study|Non Compliance to treatment|1
5101629|NCT01923428|17619947|P3|Overall Study|Non Compliance to treatment|0
5101630|NCT01923428|17619948|P2|Overall Study|Non Compliance to treatment|2
5101631|NCT01923428|17619949|P1|Overall Study|Non Compliance to treatment|1
5101632|NCT01923428|17619946|P4|Overall Study|Protocol Violation|1
5101633|NCT01923428|17619947|P3|Overall Study|Protocol Violation|2
5101634|NCT01923428|17619948|P2|Overall Study|Protocol Violation|0
5101635|NCT01923428|17619949|P1|Overall Study|Protocol Violation|3
5101636|NCT01923428|17619946|P4|Overall Study|Lost to Follow-up|0
5101637|NCT01923428|17619947|P3|Overall Study|Lost to Follow-up|5
5101638|NCT01923428|17619948|P2|Overall Study|Lost to Follow-up|1
5101639|NCT01923428|17619949|P1|Overall Study|Lost to Follow-up|2
5101640|NCT01923428|17619946|P4|Overall Study|Withdrawal by Subject|4
5101641|NCT01923428|17619947|P3|Overall Study|Withdrawal by Subject|0
5101642|NCT01923428|17619948|P2|Overall Study|Withdrawal by Subject|3
5101643|NCT01923428|17619949|P1|Overall Study|Withdrawal by Subject|5
5101644|NCT01923428|17619946|P4|Overall Study|Adverse Event|3
5101645|NCT01923428|17619947|P3|Overall Study|Adverse Event|3
5101646|NCT01923428|17619948|P2|Overall Study|Adverse Event|6
5101647|NCT01923428|17619949|P1|Overall Study|Adverse Event|8
5101648|NCT01923389|17619961|P2|Overall Study|Protocol Violation|0
5101649|NCT01923389|17619962|P1|Overall Study|Protocol Violation|1
5101650|NCT01923363|17619984|P1|Overall Study|Protocol Violation|1
5101651|NCT01923311|17619993|P2|Overall Study|Study Terminated by Sponsor|0
5101652|NCT01923311|17619994|P1|Overall Study|Study Terminated by Sponsor|12
5101653|NCT01923311|17619993|P2|Overall Study|Withdrew Consent|0
5101654|NCT01923311|17619994|P1|Overall Study|Withdrew Consent|1
5101655|NCT01923311|17619993|P2|Overall Study|Non-Compliance with Study Drug|1
5101656|NCT01923311|17619994|P1|Overall Study|Non-Compliance with Study Drug|2
5101657|NCT01923311|17619993|P2|Overall Study|Investigator's Discretion|0
5101658|NCT01923311|17619994|P1|Overall Study|Investigator's Discretion|1
5101659|NCT01923311|17619993|P2|Overall Study|Pregnancy|0
5101660|NCT01923311|17619994|P1|Overall Study|Pregnancy|1
5101661|NCT01923285|17620039|P2|Overall Study|Withdrawal by Subject|6
5101662|NCT01923285|17620040|P1|Overall Study|Withdrawal by Subject|7
5101663|NCT01923181|17620061|P9|Overall Study|Lost to Follow-up|1
5101664|NCT01923181|17620062|P8|Overall Study|Lost to Follow-up|3
5101665|NCT01923181|17620063|P7|Overall Study|Lost to Follow-up|3
5101666|NCT01923181|17620064|P6|Overall Study|Lost to Follow-up|1
5101667|NCT01923181|17620065|P5|Overall Study|Lost to Follow-up|2
5101668|NCT01923181|17620066|P4|Overall Study|Lost to Follow-up|1
5101669|NCT01923181|17620067|P3|Overall Study|Lost to Follow-up|2
5101670|NCT01923181|17620068|P2|Overall Study|Lost to Follow-up|3
5101671|NCT01923181|17620069|P1|Overall Study|Lost to Follow-up|0
5101672|NCT01923181|17620061|P9|Overall Study|Other|0
5101673|NCT01923181|17620062|P8|Overall Study|Other|0
5101674|NCT01923181|17620063|P7|Overall Study|Other|0
5101675|NCT01923181|17620064|P6|Overall Study|Other|0
5101676|NCT01923181|17620065|P5|Overall Study|Other|0
5101677|NCT01923181|17620066|P4|Overall Study|Other|1
5101678|NCT01923181|17620067|P3|Overall Study|Other|0
5101679|NCT01923181|17620068|P2|Overall Study|Other|0
5101680|NCT01923181|17620069|P1|Overall Study|Other|1
5101681|NCT01923181|17620061|P9|Overall Study|Withdrawal by Subject|1
5101682|NCT01923181|17620062|P8|Overall Study|Withdrawal by Subject|3
5101683|NCT01923181|17620063|P7|Overall Study|Withdrawal by Subject|4
5101684|NCT01923181|17620064|P6|Overall Study|Withdrawal by Subject|2
5101685|NCT01923181|17620065|P5|Overall Study|Withdrawal by Subject|4
5101686|NCT01923181|17620066|P4|Overall Study|Withdrawal by Subject|1
5101687|NCT01923181|17620067|P3|Overall Study|Withdrawal by Subject|0
5101688|NCT01923181|17620068|P2|Overall Study|Withdrawal by Subject|1
5101689|NCT01923181|17620069|P1|Overall Study|Withdrawal by Subject|0
5101690|NCT01923181|17620061|P9|Overall Study|Protocol Violation|1
5101691|NCT01923181|17620062|P8|Overall Study|Protocol Violation|2
5101692|NCT01923181|17620063|P7|Overall Study|Protocol Violation|1
5101693|NCT01923181|17620064|P6|Overall Study|Protocol Violation|1
5101694|NCT01923181|17620065|P5|Overall Study|Protocol Violation|2
5101695|NCT01923181|17620066|P4|Overall Study|Protocol Violation|2
5101696|NCT01923181|17620067|P3|Overall Study|Protocol Violation|0
5101697|NCT01923181|17620068|P2|Overall Study|Protocol Violation|2
5101698|NCT01923181|17620069|P1|Overall Study|Protocol Violation|2
5101699|NCT01923168|17620147|P3|Overall Study|Death|1
5101700|NCT01923168|17620148|P2|Overall Study|Death|0
5101701|NCT01923168|17620149|P1|Overall Study|Death|0
5101702|NCT01923168|17620147|P3|Overall Study|Progressive disease|7
5101703|NCT01923168|17620148|P2|Overall Study|Progressive disease|3
5101704|NCT01923168|17620149|P1|Overall Study|Progressive disease|4
5101705|NCT01923168|17620147|P3|Overall Study|Physician Decision|5
5101706|NCT01923168|17620148|P2|Overall Study|Physician Decision|9
5101707|NCT01923168|17620149|P1|Overall Study|Physician Decision|6
5101708|NCT01923168|17620147|P3|Overall Study|Adverse Event|0
5101709|NCT01923168|17620148|P2|Overall Study|Adverse Event|12
5101710|NCT01923168|17620149|P1|Overall Study|Adverse Event|12
5101711|NCT01923168|17620147|P3|Overall Study|Subject/guardian decision|4
5101712|NCT01923168|17620148|P2|Overall Study|Subject/guardian decision|14
5101713|NCT01923168|17620149|P1|Overall Study|Subject/guardian decision|14
5101714|NCT01923168|17620147|P3|Overall Study|Protocol Violation|0
5101715|NCT01923168|17620148|P2|Overall Study|Protocol Violation|1
5101716|NCT01923168|17620149|P1|Overall Study|Protocol Violation|1
5101717|NCT01922934|17620232|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
5101718|NCT01922934|17620233|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
5101719|NCT01922934|17620232|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
5101720|NCT01922934|17620233|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
5101721|NCT01922934|17620232|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
5101722|NCT01922934|17620233|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
5101723|NCT01922934|17620232|P2|Eligible Patients|Did not meet inclusion criteria|81
5101724|NCT01922934|17620233|P1|Eligible Patients|Did not meet inclusion criteria|36
5101725|NCT01922934|17620232|P2|Eligible Patients|Physician Decision|0
5101726|NCT01922934|17620233|P1|Eligible Patients|Physician Decision|17
5101727|NCT01922934|17620232|P2|Eligible Patients|Death|7
5101728|NCT01922934|17620233|P1|Eligible Patients|Death|0
5101729|NCT01922739|17620245|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
5101730|NCT01922739|17620245|P1|Open-label Treatment Period|Physician Decision|1
5101731|NCT01922739|17620245|P1|Open-label Treatment Period|Lost to Follow-up|2
5101732|NCT01922739|17620245|P1|Open-label Treatment Period|Noncompliance to study procedures|1
5101733|NCT01922739|17620245|P1|Open-label Treatment Period|Pregnancy|1
5101734|NCT01922739|17620245|P1|Open-label Treatment Period|Protocol Violation|5
5101735|NCT01922739|17620245|P1|Open-label Treatment Period|Noncompliance to study medication|3
5101736|NCT01922739|17620245|P1|Open-label Treatment Period|Withdrawal by Subject|14
5101737|NCT01922739|17620245|P1|Open-label Treatment Period|Adverse Event|6
5101738|NCT01922739|17620245|P1|Titration/Adjustment Period|Lack of Efficacy|3
5101739|NCT01922739|17620245|P1|Titration/Adjustment Period|Lost to Follow-up|1
5101740|NCT01922739|17620245|P1|Titration/Adjustment Period|Withdrawal by Subject|5
5101741|NCT01922739|17620245|P1|Titration/Adjustment Period|Adverse Event|3
5101742|NCT01922349|17620274|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
5101743|NCT01922349|17620275|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
5101744|NCT01922349|17620276|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
5101745|NCT01922349|17620277|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
5101746|NCT01922271|17620406|P2|WASHOUT Period|Withdrawal by Subject|0
5101747|NCT01922271|17620407|P1|WASHOUT Period|Withdrawal by Subject|1
5101748|NCT01922258|17620427|P2|Overall Study|Withdrawal by participant|5
5101749|NCT01922258|17620428|P1|Overall Study|Withdrawal by participant|5
5101750|NCT01922258|17620427|P2|Overall Study|Withdrawn by the Investigator|4
5101751|NCT01922258|17620428|P1|Overall Study|Withdrawn by the Investigator|1
5101752|NCT01922258|17620427|P2|Overall Study|Met Withdrawal Criteria|4
5101753|NCT01922258|17620428|P1|Overall Study|Met Withdrawal Criteria|0
5101754|NCT01922258|17620427|P2|Overall Study|Adverse Event|2
5101755|NCT01922258|17620428|P1|Overall Study|Adverse Event|9
5101756|NCT01922258|17620427|P2|Overall Study|Lost to Follow-up|1
5101757|NCT01922258|17620428|P1|Overall Study|Lost to Follow-up|1
5101758|NCT01922102|17620460|P3|Overall Study|Administrative problems|0
5101759|NCT01922102|17620461|P2|Overall Study|Administrative problems|2
5101760|NCT01922102|17620462|P1|Overall Study|Administrative problems|0
5101761|NCT01922102|17620460|P3|Overall Study|Lost to Follow-up|0
5101762|NCT01922102|17620461|P2|Overall Study|Lost to Follow-up|0
5101763|NCT01922102|17620462|P1|Overall Study|Lost to Follow-up|1
5101764|NCT01922102|17620460|P3|Overall Study|Adverse Event|0
5101765|NCT01922102|17620461|P2|Overall Study|Adverse Event|2
5101766|NCT01922102|17620462|P1|Overall Study|Adverse Event|1
5101767|NCT01922102|17620460|P3|Overall Study|Physician Decision|1
5101768|NCT01922102|17620461|P2|Overall Study|Physician Decision|2
5101769|NCT01922102|17620462|P1|Overall Study|Physician Decision|0
5101770|NCT01922102|17620460|P3|Overall Study|Withdrawal by Subject|7
5101771|NCT01922102|17620461|P2|Overall Study|Withdrawal by Subject|3
5101772|NCT01922102|17620462|P1|Overall Study|Withdrawal by Subject|7
5101773|NCT01922089|17620498|P2|Overall Study|Lost to Follow-up|1
5101774|NCT01922089|17620499|P1|Overall Study|Lost to Follow-up|0
5101775|NCT01922089|17620498|P2|Overall Study|Death|1
5101776|NCT01922089|17620499|P1|Overall Study|Death|2
5101777|NCT01922089|17620498|P2|Overall Study|Physician Decision|3
5101778|NCT01922089|17620499|P1|Overall Study|Physician Decision|2
5101779|NCT01922089|17620498|P2|Overall Study|administrative problems|1
5101780|NCT01922089|17620499|P1|Overall Study|administrative problems|4
5101781|NCT01922089|17620498|P2|Overall Study|Withdrawal by Subject|4
5101782|NCT01922089|17620499|P1|Overall Study|Withdrawal by Subject|3
5101783|NCT01922089|17620498|P2|Overall Study|Protocol Deviation|7
5101784|NCT01922089|17620499|P1|Overall Study|Protocol Deviation|10
5101785|NCT01922089|17620498|P2|Overall Study|Adverse Event|13
5101786|NCT01922089|17620499|P1|Overall Study|Adverse Event|18
5101787|NCT01922037|17620576|P2|Overall Study|Other unspecified|66
5101788|NCT01922037|17620577|P1|Overall Study|Other unspecified|2
5101789|NCT01922037|17620576|P2|Overall Study|Investigator/Sponsor decision|4
5101790|NCT01922037|17620577|P1|Overall Study|Investigator/Sponsor decision|1
5101791|NCT01922037|17620576|P2|Overall Study|Participant non-compliance|46
5101792|NCT01922037|17620577|P1|Overall Study|Participant non-compliance|4
5101793|NCT01922037|17620576|P2|Overall Study|Pregnancy|2
5101794|NCT01922037|17620577|P1|Overall Study|Pregnancy|0
5101795|NCT01922037|17620576|P2|Overall Study|Death|5
5101796|NCT01922037|17620577|P1|Overall Study|Death|0
5101797|NCT01922037|17620576|P2|Overall Study|Adverse Event|7
5101798|NCT01922037|17620577|P1|Overall Study|Adverse Event|1
5101799|NCT01922037|17620576|P2|Overall Study|Withdrawal by Subject|44
5101800|NCT01922037|17620577|P1|Overall Study|Withdrawal by Subject|2
5101801|NCT01922011|17620680|P2|Overall Study|Randomized in error|0
5101802|NCT01922011|17620681|P1|Overall Study|Randomized in error|1
5101803|NCT01922011|17620680|P2|Overall Study|Lack of willing home health agency|0
5101804|NCT01922011|17620681|P1|Overall Study|Lack of willing home health agency|1
5101805|NCT01922011|17620680|P2|Overall Study|Not Treated|0
5101806|NCT01922011|17620681|P1|Overall Study|Not Treated|1
5101807|NCT01922011|17620680|P2|Overall Study|Missed Test-of-Cure Visit|2
5101808|NCT01922011|17620681|P1|Overall Study|Missed Test-of-Cure Visit|0
5101809|NCT01922011|17620680|P2|Overall Study|Lost to Follow-up|1
5101810|NCT01922011|17620681|P1|Overall Study|Lost to Follow-up|0
5101811|NCT01922011|17620680|P2|Overall Study|Parent/Guardian Decision|0
5101812|NCT01922011|17620681|P1|Overall Study|Parent/Guardian Decision|3
5101813|NCT01922011|17620680|P2|Overall Study|Physician Decision|1
5101814|NCT01922011|17620681|P1|Overall Study|Physician Decision|0
5101815|NCT01922011|17620680|P2|Overall Study|Protocol Violation|1
5101816|NCT01922011|17620681|P1|Overall Study|Protocol Violation|0
5101817|NCT01921829|17620748|P2|Overall Study|Withdrawal by Subject|1
5101818|NCT01921829|17620749|P1|Overall Study|Withdrawal by Subject|0
5101819|NCT01921517|17620825|P2|Overall Study|Subject missed final imaging|4
5101820|NCT01921517|17620826|P1|Overall Study|Subject missed final imaging|1
5101821|NCT01921517|17620825|P2|Overall Study|Withdrawal by Subject|3
5101822|NCT01921517|17620826|P1|Overall Study|Withdrawal by Subject|7
5101823|NCT01921517|17620825|P2|Overall Study|Physician Decision|2
5101824|NCT01921517|17620826|P1|Overall Study|Physician Decision|0
5101825|NCT01921517|17620825|P2|Overall Study|Newly diagnosed health concern|0
5101826|NCT01921517|17620826|P1|Overall Study|Newly diagnosed health concern|2
5101827|NCT01921517|17620825|P2|Overall Study|Lost to Follow-up|0
5101828|NCT01921517|17620826|P1|Overall Study|Lost to Follow-up|5
5101829|NCT01921387|17620837|P1|Overall Study|Adverse Event|1
5101830|NCT01921348|17620846|P2|Overall Study|Lost to Follow-up|2
5101831|NCT01921348|17620847|P1|Overall Study|Lost to Follow-up|0
5101832|NCT01921348|17620846|P2|Overall Study|Withdrawal by Subject|0
5101833|NCT01921348|17620847|P1|Overall Study|Withdrawal by Subject|1
5101834|NCT01921270|17620876|P1|Overall Study|Withdrawal by Subject|1
5101835|NCT01921257|17620892|P1|Overall Study|Withdrawal by Subject|1
5101836|NCT01921257|17620892|P1|Overall Study|Protocol Violation|1
5101837|NCT01921257|17620892|P1|Overall Study|Adverse Event|1
5101838|NCT01921205|17620899|P2|Overall Study|Non Compliance Of Child|1
5101839|NCT01921205|17620900|P1|Overall Study|Non Compliance Of Child|0
5101840|NCT01921205|17620899|P2|Overall Study|Non Compliance Of The Parent|1
5101841|NCT01921205|17620900|P1|Overall Study|Non Compliance Of The Parent|0
5101842|NCT01921205|17620899|P2|Overall Study|The Excessive Use Of Rescue Medication|1
5101843|NCT01921205|17620900|P1|Overall Study|The Excessive Use Of Rescue Medication|0
5101844|NCT01921205|17620899|P2|Overall Study|Use Of Prohibited Medication|1
5101845|NCT01921205|17620900|P1|Overall Study|Use Of Prohibited Medication|0
5101846|NCT01921205|17620899|P2|Overall Study|Withdrawal by Subject|5
5101847|NCT01921205|17620900|P1|Overall Study|Withdrawal by Subject|6
5101848|NCT01921205|17620899|P2|Overall Study|Lost to Follow-up|1
5101849|NCT01921205|17620900|P1|Overall Study|Lost to Follow-up|1
5101850|NCT01921205|17620899|P2|Overall Study|Protocol Violation|3
5101851|NCT01921205|17620900|P1|Overall Study|Protocol Violation|1
5101852|NCT01921205|17620899|P2|Overall Study|Lack of Efficacy|0
5101853|NCT01921205|17620900|P1|Overall Study|Lack of Efficacy|1
5101854|NCT01921205|17620899|P2|Overall Study|Adverse Event|7
5101855|NCT01921205|17620900|P1|Overall Study|Adverse Event|12
5101856|NCT01921179|17620930|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
5101857|NCT01921179|17620931|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
5101858|NCT01921179|17620930|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
5101859|NCT01921179|17620931|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
5101860|NCT01921101|17620968|P2|Overall Study|Death|6
5101861|NCT01921101|17620969|P1|Overall Study|Death|16
5101862|NCT01920958|17620977|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
5101863|NCT01920893|17620995|P2|Overall Study|Lack of Efficacy|0
5101864|NCT01920893|17620996|P1|Overall Study|Lack of Efficacy|2
5101865|NCT01920893|17620995|P2|Overall Study|Adverse Event|2
5101866|NCT01920893|17620996|P1|Overall Study|Adverse Event|5
5101867|NCT01920854|17621029|P7|Overall Study|Withdrawal by Subject|1
5101868|NCT01920854|17621030|P6|Overall Study|Withdrawal by Subject|0
5101869|NCT01920854|17621031|P5|Overall Study|Withdrawal by Subject|1
5101870|NCT01920854|17621032|P4|Overall Study|Withdrawal by Subject|0
5101871|NCT01920854|17621033|P3|Overall Study|Withdrawal by Subject|0
5101872|NCT01920854|17621034|P2|Overall Study|Withdrawal by Subject|0
5101873|NCT01920854|17621035|P1|Overall Study|Withdrawal by Subject|1
5101874|NCT01920711|17621195|P2|Overall Study|Withdrawal by Subject|3
5101875|NCT01920711|17621196|P1|Overall Study|Withdrawal by Subject|4
5101876|NCT01920711|17621195|P2|Overall Study|Lost to Follow-up|14
5101877|NCT01920711|17621196|P1|Overall Study|Lost to Follow-up|13
5101878|NCT01920711|17621195|P2|Overall Study|Death|356
5101879|NCT01920711|17621196|P1|Overall Study|Death|347
5101880|NCT01920594|17621213|P2|Overall Study|Investigator discretion|1
5101881|NCT01920594|17621214|P1|Overall Study|Investigator discretion|0
5101882|NCT01920594|17621213|P2|Overall Study|Recovery|0
5101883|NCT01920594|17621214|P1|Overall Study|Recovery|2
5101884|NCT01920594|17621213|P2|Overall Study|Lost to Follow-up|0
5101885|NCT01920594|17621214|P1|Overall Study|Lost to Follow-up|1
5101886|NCT01920594|17621213|P2|Overall Study|Adverse Event|2
5101887|NCT01920594|17621214|P1|Overall Study|Adverse Event|4
5101888|NCT01920568|17621264|P2|Overall Study|Death due to disease progression|12
5101889|NCT01920568|17621265|P1|Overall Study|Death due to disease progression|25
5101890|NCT01920568|17621264|P2|Overall Study|Withdrawal by Subject|55
5101891|NCT01920568|17621265|P1|Overall Study|Withdrawal by Subject|79
5101892|NCT01920568|17621264|P2|Overall Study|Physician Decision|4
5101893|NCT01920568|17621265|P1|Overall Study|Physician Decision|13
5101894|NCT01920568|17621264|P2|Overall Study|Lost to Follow-up|2
5101895|NCT01920568|17621265|P1|Overall Study|Lost to Follow-up|2
5101896|NCT01920568|17621264|P2|Overall Study|Protocol Violation|3
5101897|NCT01920568|17621265|P1|Overall Study|Protocol Violation|5
5101898|NCT01920568|17621264|P2|Overall Study|Adverse Event|8
5101899|NCT01920568|17621265|P1|Overall Study|Adverse Event|27
5101900|NCT01920555|17621291|P5|Overall Study|Lost to Follow-up|0
5101901|NCT01920555|17621292|P4|Overall Study|Lost to Follow-up|1
5101902|NCT01920555|17621293|P3|Overall Study|Lost to Follow-up|0
5101903|NCT01920555|17621294|P2|Overall Study|Lost to Follow-up|1
5101904|NCT01920555|17621295|P1|Overall Study|Lost to Follow-up|0
5101905|NCT01920555|17621291|P5|Overall Study|Travel Difficulties|1
5101906|NCT01920555|17621292|P4|Overall Study|Travel Difficulties|0
5101907|NCT01920555|17621293|P3|Overall Study|Travel Difficulties|0
5101908|NCT01920555|17621294|P2|Overall Study|Travel Difficulties|1
5101909|NCT01920555|17621295|P1|Overall Study|Travel Difficulties|1
5101910|NCT01920555|17621291|P5|Overall Study|Lack of Efficacy|0
5101911|NCT01920555|17621292|P4|Overall Study|Lack of Efficacy|0
5101912|NCT01920555|17621293|P3|Overall Study|Lack of Efficacy|0
5101913|NCT01920555|17621294|P2|Overall Study|Lack of Efficacy|0
5101914|NCT01920555|17621295|P1|Overall Study|Lack of Efficacy|2
5101915|NCT01920555|17621291|P5|Overall Study|Physician Decision|0
5101916|NCT01920555|17621292|P4|Overall Study|Physician Decision|2
5101917|NCT01920555|17621293|P3|Overall Study|Physician Decision|1
5101918|NCT01920555|17621294|P2|Overall Study|Physician Decision|2
5101919|NCT01920555|17621295|P1|Overall Study|Physician Decision|1
5101920|NCT01920477|17621354|P2|Overall Study|Withdrawal by Subject|1
5101921|NCT01920477|17621355|P1|Overall Study|Withdrawal by Subject|0
5101922|NCT01920477|17621354|P2|Overall Study|Study closed/terminated|15
5101923|NCT01920477|17621355|P1|Overall Study|Study closed/terminated|14
5101924|NCT01920477|17621354|P2|Overall Study|Lack of Efficacy|0
5101925|NCT01920477|17621355|P1|Overall Study|Lack of Efficacy|1
5101926|NCT01920477|17621354|P2|Overall Study|Adverse Event|1
5101927|NCT01920477|17621355|P1|Overall Study|Adverse Event|0
5101928|NCT01920178|17621404|P2|Overall Study|Lost to Follow-up|1
5101929|NCT01920178|17621405|P1|Overall Study|Lost to Follow-up|2
5101930|NCT01919970|17621423|P2|Overall Study|Withdrawal by Subject|0
5101931|NCT01919970|17621424|P1|Overall Study|Withdrawal by Subject|3
5101932|NCT01919814|17621432|P2|Overall Study|Withdrawal by Subject|0
5101933|NCT01919814|17621433|P1|Overall Study|Withdrawal by Subject|1
5101934|NCT01919814|17621432|P2|Overall Study|Protocol Violation|0
5101935|NCT01919814|17621433|P1|Overall Study|Protocol Violation|1
5101936|NCT01919814|17621432|P2|Overall Study|Adverse Event|0
5101937|NCT01919814|17621433|P1|Overall Study|Adverse Event|1
5101938|NCT01919801|17621445|P2|Overall Study|Other|1
5101939|NCT01919801|17621446|P1|Overall Study|Other|0
5101940|NCT01919801|17621445|P2|Overall Study|Lost to Follow-up|1
5101941|NCT01919801|17621446|P1|Overall Study|Lost to Follow-up|0
5101942|NCT01919801|17621445|P2|Overall Study|Physician Decision|1
5101943|NCT01919801|17621446|P1|Overall Study|Physician Decision|0
5101944|NCT01919801|17621445|P2|Overall Study|Withdrawal by Subject|0
5101945|NCT01919801|17621446|P1|Overall Study|Withdrawal by Subject|1
5101946|NCT01919723|17621471|P2|Overall Study|Blood Samples Hemolyzed|2
5101947|NCT01919723|17621472|P1|Overall Study|Blood Samples Hemolyzed|2
5101948|NCT01919411|17621545|P2|Overall Study|Protocol Violation|1
5101949|NCT01919411|17621546|P1|Overall Study|Protocol Violation|2
5101950|NCT01919411|17621545|P2|Overall Study|Physician Decision|0
5101951|NCT01919411|17621546|P1|Overall Study|Physician Decision|1
5101952|NCT01919411|17621545|P2|Overall Study|Lost to Follow-up|4
5101953|NCT01919411|17621546|P1|Overall Study|Lost to Follow-up|2
5101954|NCT01919398|17621565|P3|Overall Study|Progressive Disease|4
5101955|NCT01919398|17621566|P2|Overall Study|Progressive Disease|0
5101956|NCT01919398|17621567|P1|Overall Study|Progressive Disease|0
5101957|NCT01919307|17621587|P1|Overall Study|Withdrawal by Subject|9
5101958|NCT01919229|17621597|P3|Overall Study|Subject/guardian decision|1
5101959|NCT01919229|17621598|P2|Overall Study|Subject/guardian decision|0
5101960|NCT01919229|17621599|P1|Overall Study|Subject/guardian decision|0
5101961|NCT01919164|17621646|P5|Overall Study|Other Un-specified|15
5101962|NCT01919164|17621647|P4|Overall Study|Other Un-specified|7
5101963|NCT01919164|17621648|P3|Overall Study|Other Un-specified|8
5101964|NCT01919164|17621649|P2|Overall Study|Other Un-specified|9
5101965|NCT01919164|17621650|P1|Overall Study|Other Un-specified|13
5101966|NCT01919164|17621646|P5|Overall Study|Withdrew consent|9
5101967|NCT01919164|17621647|P4|Overall Study|Withdrew consent|14
5101968|NCT01919164|17621648|P3|Overall Study|Withdrew consent|14
5101969|NCT01919164|17621649|P2|Overall Study|Withdrew consent|13
5101970|NCT01919164|17621650|P1|Overall Study|Withdrew consent|13
5101971|NCT01919164|17621646|P5|Overall Study|Disease progression|1
5101972|NCT01919164|17621647|P4|Overall Study|Disease progression|2
5101973|NCT01919164|17621648|P3|Overall Study|Disease progression|1
5101974|NCT01919164|17621649|P2|Overall Study|Disease progression|2
5101975|NCT01919164|17621650|P1|Overall Study|Disease progression|2
5101976|NCT01919164|17621646|P5|Overall Study|Protocol Violation|2
5101977|NCT01919164|17621647|P4|Overall Study|Protocol Violation|2
5101978|NCT01919164|17621648|P3|Overall Study|Protocol Violation|3
5101979|NCT01919164|17621649|P2|Overall Study|Protocol Violation|0
5101980|NCT01919164|17621650|P1|Overall Study|Protocol Violation|6
5101981|NCT01919164|17621646|P5|Overall Study|Death|0
5101982|NCT01919164|17621647|P4|Overall Study|Death|0
5101983|NCT01919164|17621648|P3|Overall Study|Death|0
5101984|NCT01919164|17621649|P2|Overall Study|Death|0
5101985|NCT01919164|17621650|P1|Overall Study|Death|1
5101986|NCT01919164|17621646|P5|Overall Study|Lost to Follow-up|4
5101987|NCT01919164|17621647|P4|Overall Study|Lost to Follow-up|0
5101988|NCT01919164|17621648|P3|Overall Study|Lost to Follow-up|2
5101989|NCT01919164|17621649|P2|Overall Study|Lost to Follow-up|2
5101990|NCT01919164|17621650|P1|Overall Study|Lost to Follow-up|2
5101991|NCT01919164|17621646|P5|Overall Study|Adverse Event|2
5101992|NCT01919164|17621647|P4|Overall Study|Adverse Event|3
5101993|NCT01919164|17621648|P3|Overall Study|Adverse Event|9
5101994|NCT01919164|17621649|P2|Overall Study|Adverse Event|4
5101995|NCT01919164|17621650|P1|Overall Study|Adverse Event|6
5101996|NCT01919112|17621705|P3|Secondary Analysis-day 30|Lost to Follow-up|0
5101997|NCT01919112|17621706|P2|Secondary Analysis-day 30|Lost to Follow-up|0
5101998|NCT01919112|17621707|P1|Secondary Analysis-day 30|Lost to Follow-up|1
5101999|NCT01919112|17621705|P3|Secondary Analysis-day 30|Death|1
5102000|NCT01919112|17621706|P2|Secondary Analysis-day 30|Death|1
5102001|NCT01919112|17621707|P1|Secondary Analysis-day 30|Death|1
5102002|NCT01918774|17621766|P1|Overall Study|Lost to Follow-up|1
5102003|NCT01918774|17621766|P1|Overall Study|Lost prior to first CBTw session|4
5102004|NCT01918371|17621790|P2|Overall Study|Missing Data|1
5102005|NCT01918371|17621791|P1|Overall Study|Missing Data|1
5102006|NCT01918332|17621869|P4|Overall Study|lipid result by central lab did not meet|0
5102007|NCT01918332|17621870|P3|Overall Study|lipid result by central lab did not meet|1
5102008|NCT01918332|17621871|P2|Overall Study|lipid result by central lab did not meet|0
5102009|NCT01918332|17621872|P1|Overall Study|lipid result by central lab did not meet|0
5102010|NCT01918332|17621869|P4|Overall Study|Protocol Violation|3
5102011|NCT01918332|17621870|P3|Overall Study|Protocol Violation|6
5102012|NCT01918332|17621871|P2|Overall Study|Protocol Violation|2
5102013|NCT01918332|17621872|P1|Overall Study|Protocol Violation|6
5102014|NCT01918332|17621869|P4|Overall Study|Withdrawal by Subject|3
5102015|NCT01918332|17621870|P3|Overall Study|Withdrawal by Subject|2
5102016|NCT01918332|17621871|P2|Overall Study|Withdrawal by Subject|3
5102017|NCT01918332|17621872|P1|Overall Study|Withdrawal by Subject|2
5102018|NCT01918332|17621869|P4|Overall Study|Adverse Event|1
5102019|NCT01918332|17621870|P3|Overall Study|Adverse Event|0
5102020|NCT01918332|17621871|P2|Overall Study|Adverse Event|0
5102021|NCT01918332|17621872|P1|Overall Study|Adverse Event|0
5102022|NCT01918306|17621884|P4|Overall Study|progress disease, crossover|0
5102023|NCT01918306|17621885|P3|Overall Study|progress disease, crossover|1
5102024|NCT01918306|17621886|P2|Overall Study|progress disease, crossover|0
5102025|NCT01918306|17621887|P1|Overall Study|progress disease, crossover|0
5102026|NCT01918306|17621884|P4|Overall Study|Lack of Efficacy|0
5102027|NCT01918306|17621885|P3|Overall Study|Lack of Efficacy|0
5102028|NCT01918306|17621886|P2|Overall Study|Lack of Efficacy|0
5102029|NCT01918306|17621887|P1|Overall Study|Lack of Efficacy|1
5102030|NCT01918306|17621884|P4|Overall Study|neutropenia|0
5102031|NCT01918306|17621885|P3|Overall Study|neutropenia|0
5102032|NCT01918306|17621886|P2|Overall Study|neutropenia|0
5102033|NCT01918306|17621887|P1|Overall Study|neutropenia|1
5102034|NCT01918306|17621884|P4|Overall Study|Withdrawal by Subject|2
5102035|NCT01918306|17621885|P3|Overall Study|Withdrawal by Subject|0
5102036|NCT01918306|17621886|P2|Overall Study|Withdrawal by Subject|0
5102037|NCT01918306|17621887|P1|Overall Study|Withdrawal by Subject|0
5102038|NCT01918306|17621884|P4|Overall Study|progresive disease|1
5102039|NCT01918306|17621885|P3|Overall Study|progresive disease|1
5102040|NCT01918306|17621886|P2|Overall Study|progresive disease|0
5102041|NCT01918306|17621887|P1|Overall Study|progresive disease|4
5102042|NCT01918085|17621918|P2|Test Period 1: Strata Strip|Adverse Event|1
5102043|NCT01918085|17621919|P1|Test Period 1: Strata Strip|Adverse Event|0
5102044|NCT01918033|17621943|P3|Overall Study|Withdrawal by Subject|0
5102045|NCT01918033|17621944|P2|Overall Study|Withdrawal by Subject|1
5102046|NCT01918033|17621945|P1|Overall Study|Withdrawal by Subject|2
5102047|NCT01918033|17621943|P3|Overall Study|Protocol Violation|1
5102048|NCT01918033|17621944|P2|Overall Study|Protocol Violation|0
5102049|NCT01918033|17621945|P1|Overall Study|Protocol Violation|2
5102050|NCT01918033|17621943|P3|Overall Study|Lost to Follow-up|0
5102051|NCT01918033|17621944|P2|Overall Study|Lost to Follow-up|1
5102052|NCT01918033|17621945|P1|Overall Study|Lost to Follow-up|0
5102053|NCT01918033|17621943|P3|Overall Study|Adverse Event|2
5102054|NCT01918033|17621944|P2|Overall Study|Adverse Event|0
5102055|NCT01918033|17621945|P1|Overall Study|Adverse Event|1
5102056|NCT01917747|17622016|P2|Overall Study|Lost to Follow-up|9
5102057|NCT01917747|17622017|P1|Overall Study|Lost to Follow-up|18
5102058|NCT01917747|17622016|P2|Overall Study|Withdrawal by Subject|2
5102059|NCT01917747|17622017|P1|Overall Study|Withdrawal by Subject|1
5102060|NCT01917656|17622031|P2|Overall Study|Lost to Follow-up|4
5102061|NCT01917656|17622032|P1|Overall Study|Lost to Follow-up|3
5102062|NCT01917656|17622031|P2|Overall Study|Withdrawal by Subject|3
5102063|NCT01917656|17622032|P1|Overall Study|Withdrawal by Subject|4
5102064|NCT01917656|17622031|P2|Overall Study|Unclassified|3
5102065|NCT01917656|17622032|P1|Overall Study|Unclassified|0
5102066|NCT01917656|17622031|P2|Overall Study|Withdrawal criteria|14
5102067|NCT01917656|17622032|P1|Overall Study|Withdrawal criteria|8
5102068|NCT01917656|17622031|P2|Overall Study|Adverse Event|0
5102069|NCT01917656|17622032|P1|Overall Study|Adverse Event|11
5102070|NCT01917526|17622058|P2|Overall Study|Protocol Violation|1
5102071|NCT01917526|17622059|P1|Overall Study|Protocol Violation|1
5102072|NCT01917344|17622076|P1|Overall Study|Withdrawal by Subject|1
5102073|NCT01917318|17622082|P2|First Treatment|Withdrawal by Subject|1
5102074|NCT01917318|17622083|P1|First Treatment|Withdrawal by Subject|0
5102075|NCT01917006|17622136|P8|Open-label Period|Lost to Follow-up|1
5102076|NCT01917006|17622137|P7|Open-label Period|Lost to Follow-up|0
5102077|NCT01917006|17622138|P6|Open-label Period|Lost to Follow-up|0
5102078|NCT01917006|17622139|P5|Open-label Period|Lost to Follow-up|0
5102079|NCT01917006|17622140|P4|Open-label Period|Lost to Follow-up|0
5102080|NCT01917006|17622141|P3|Open-label Period|Lost to Follow-up|0
5102081|NCT01917006|17622142|P2|Open-label Period|Lost to Follow-up|0
5102082|NCT01917006|17622143|P1|Open-label Period|Lost to Follow-up|0
5102083|NCT01917006|17622136|P8|Open-label Period|Adverse Event|1
5102084|NCT01917006|17622137|P7|Open-label Period|Adverse Event|0
5102085|NCT01917006|17622138|P6|Open-label Period|Adverse Event|0
5102086|NCT01917006|17622139|P5|Open-label Period|Adverse Event|0
5102087|NCT01917006|17622140|P4|Open-label Period|Adverse Event|0
5102088|NCT01917006|17622141|P3|Open-label Period|Adverse Event|0
5102089|NCT01917006|17622142|P2|Open-label Period|Adverse Event|0
5102090|NCT01917006|17622143|P1|Open-label Period|Adverse Event|0
5102091|NCT01917006|17622136|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102092|NCT01917006|17622137|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
5102093|NCT01917006|17622138|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102094|NCT01917006|17622139|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102095|NCT01917006|17622140|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102096|NCT01917006|17622141|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102097|NCT01917006|17622142|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102098|NCT01917006|17622143|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
5102099|NCT01917006|17622136|P8|Randomized-treatment Period|Protocol Violation|0
5102100|NCT01917006|17622137|P7|Randomized-treatment Period|Protocol Violation|0
5102101|NCT01917006|17622138|P6|Randomized-treatment Period|Protocol Violation|0
5102102|NCT01917006|17622139|P5|Randomized-treatment Period|Protocol Violation|0
5102103|NCT01917006|17622140|P4|Randomized-treatment Period|Protocol Violation|0
5102104|NCT01917006|17622141|P3|Randomized-treatment Period|Protocol Violation|0
5102105|NCT01917006|17622142|P2|Randomized-treatment Period|Protocol Violation|0
5102106|NCT01917006|17622143|P1|Randomized-treatment Period|Protocol Violation|1
5102107|NCT01917006|17622136|P8|Randomized-treatment Period|Personal Reasons|0
5102108|NCT01917006|17622137|P7|Randomized-treatment Period|Personal Reasons|0
5102109|NCT01917006|17622138|P6|Randomized-treatment Period|Personal Reasons|1
5102110|NCT01917006|17622139|P5|Randomized-treatment Period|Personal Reasons|0
5102111|NCT01917006|17622140|P4|Randomized-treatment Period|Personal Reasons|0
5102112|NCT01917006|17622141|P3|Randomized-treatment Period|Personal Reasons|0
5102113|NCT01917006|17622142|P2|Randomized-treatment Period|Personal Reasons|0
5102114|NCT01917006|17622143|P1|Randomized-treatment Period|Personal Reasons|0
5102115|NCT01917006|17622136|P8|Randomized-treatment Period|Lost to Follow-up|0
5102116|NCT01917006|17622137|P7|Randomized-treatment Period|Lost to Follow-up|0
5102117|NCT01917006|17622138|P6|Randomized-treatment Period|Lost to Follow-up|0
5102118|NCT01917006|17622139|P5|Randomized-treatment Period|Lost to Follow-up|0
5102119|NCT01917006|17622140|P4|Randomized-treatment Period|Lost to Follow-up|1
5102120|NCT01917006|17622141|P3|Randomized-treatment Period|Lost to Follow-up|0
5102121|NCT01917006|17622142|P2|Randomized-treatment Period|Lost to Follow-up|0
5102122|NCT01917006|17622143|P1|Randomized-treatment Period|Lost to Follow-up|1
5102123|NCT01916980|17622176|P2|Overall Study|Withdrawal by Subject|0
5102124|NCT01916980|17622177|P1|Overall Study|Withdrawal by Subject|1
5102125|NCT01916980|17622176|P2|Overall Study|Lack of Efficacy|2
5102126|NCT01916980|17622177|P1|Overall Study|Lack of Efficacy|2
5102127|NCT01916980|17622176|P2|Overall Study|Adverse Event|2
5102128|NCT01916980|17622177|P1|Overall Study|Adverse Event|4
5102129|NCT01916967|17622196|P3|Overall Study|Protocol Violation|0
5102130|NCT01916967|17622197|P2|Overall Study|Protocol Violation|1
5102131|NCT01916967|17622198|P1|Overall Study|Protocol Violation|0
5102132|NCT01916967|17622196|P3|Overall Study|Physician Decision|1
5102133|NCT01916967|17622197|P2|Overall Study|Physician Decision|0
5102134|NCT01916967|17622198|P1|Overall Study|Physician Decision|0
5102135|NCT01916967|17622196|P3|Overall Study|Lack of Efficacy|6
5102136|NCT01916967|17622197|P2|Overall Study|Lack of Efficacy|0
5102137|NCT01916967|17622198|P1|Overall Study|Lack of Efficacy|0
5102138|NCT01916967|17622196|P3|Overall Study|Adverse Event|2
5102139|NCT01916967|17622197|P2|Overall Study|Adverse Event|0
5102140|NCT01916967|17622198|P1|Overall Study|Adverse Event|0
5102141|NCT01916824|17622254|P2|Overall Study|Withdrawal by Subject|3
5102142|NCT01916824|17622255|P1|Overall Study|Withdrawal by Subject|2
5102143|NCT01916824|17622254|P2|Overall Study|Physician Decision|0
5102144|NCT01916824|17622255|P1|Overall Study|Physician Decision|2
5102145|NCT01916824|17622254|P2|Overall Study|Lost to Follow-up|6
5102146|NCT01916824|17622255|P1|Overall Study|Lost to Follow-up|3
5102147|NCT01916304|17622337|P1|Overall Study|Screening failure|17
5102148|NCT01916226|17622349|P4|Overall Study|Physician Decision|1
5102149|NCT01916226|17622350|P3|Overall Study|Physician Decision|0
5102150|NCT01916226|17622351|P2|Overall Study|Physician Decision|0
5102151|NCT01916226|17622352|P1|Overall Study|Physician Decision|0
5102152|NCT01916226|17622349|P4|Overall Study|Protocol Violation|1
5102153|NCT01916226|17622350|P3|Overall Study|Protocol Violation|0
5102154|NCT01916226|17622351|P2|Overall Study|Protocol Violation|1
5102155|NCT01916226|17622352|P1|Overall Study|Protocol Violation|0
5102156|NCT01916226|17622349|P4|Overall Study|Lack of Efficacy|1
5102157|NCT01916226|17622350|P3|Overall Study|Lack of Efficacy|2
5102158|NCT01916226|17622351|P2|Overall Study|Lack of Efficacy|0
5102159|NCT01916226|17622352|P1|Overall Study|Lack of Efficacy|0
5102160|NCT01916226|17622349|P4|Overall Study|Adverse Event|1
5102161|NCT01916226|17622350|P3|Overall Study|Adverse Event|1
5102162|NCT01916226|17622351|P2|Overall Study|Adverse Event|0
5102163|NCT01916226|17622352|P1|Overall Study|Adverse Event|1
5102164|NCT01916109|17622386|P1|Overall Study|Withdrawal by Subject|1
5102165|NCT01915940|17622392|P3|Treatment Period|Other Miscellaneous Reasons|0
5102166|NCT01915940|17622393|P2|Treatment Period|Other Miscellaneous Reasons|1
5102167|NCT01915940|17622394|P1|Treatment Period|Other Miscellaneous Reasons|0
5102168|NCT01915940|17622392|P3|Treatment Period|Adverse Event|1
5102169|NCT01915940|17622393|P2|Treatment Period|Adverse Event|9
5102170|NCT01915940|17622394|P1|Treatment Period|Adverse Event|0
5102171|NCT01915940|17622392|P3|Treatment Period|Decision of Participant|3
5102172|NCT01915940|17622393|P2|Treatment Period|Decision of Participant|1
5102173|NCT01915940|17622394|P1|Treatment Period|Decision of Participant|0
5102174|NCT01915940|17622392|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
5102175|NCT01915940|17622393|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
5102176|NCT01915940|17622394|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
5102177|NCT01915914|17622410|P4|Follow-up Phase|Physician Decision|1
5102178|NCT01915914|17622411|P3|Follow-up Phase|Physician Decision|0
5102179|NCT01915914|17622412|P2|Follow-up Phase|Physician Decision|0
5102180|NCT01915914|17622413|P1|Follow-up Phase|Physician Decision|0
5102181|NCT01915914|17622410|P4|Follow-up Phase|Withdrawal by Subject|1
5102182|NCT01915914|17622411|P3|Follow-up Phase|Withdrawal by Subject|0
5102183|NCT01915914|17622412|P2|Follow-up Phase|Withdrawal by Subject|0
5102184|NCT01915914|17622413|P1|Follow-up Phase|Withdrawal by Subject|0
5102185|NCT01915914|17622410|P4|Maintenance Phase|Missing|0
5102186|NCT01915914|17622411|P3|Maintenance Phase|Missing|0
5102187|NCT01915914|17622412|P2|Maintenance Phase|Missing|1
5102188|NCT01915914|17622413|P1|Maintenance Phase|Missing|0
5102189|NCT01915914|17622410|P4|Maintenance Phase|Lost to Follow-up|0
5102190|NCT01915914|17622411|P3|Maintenance Phase|Lost to Follow-up|1
5102191|NCT01915914|17622412|P2|Maintenance Phase|Lost to Follow-up|4
5102192|NCT01915914|17622413|P1|Maintenance Phase|Lost to Follow-up|0
5102193|NCT01915914|17622410|P4|Maintenance Phase|Withdrawal by Subject|0
5102194|NCT01915914|17622411|P3|Maintenance Phase|Withdrawal by Subject|1
5102195|NCT01915914|17622412|P2|Maintenance Phase|Withdrawal by Subject|1
5102196|NCT01915914|17622413|P1|Maintenance Phase|Withdrawal by Subject|0
5102197|NCT01915914|17622410|P4|Acute Phase|Missing|0
5102198|NCT01915914|17622411|P3|Acute Phase|Missing|0
5102199|NCT01915914|17622412|P2|Acute Phase|Missing|0
5102200|NCT01915914|17622413|P1|Acute Phase|Missing|1
5102201|NCT01915914|17622410|P4|Acute Phase|"Not Achieved treatment success"|0
5102202|NCT01915914|17622411|P3|Acute Phase|"Not Achieved treatment success"|0
5102203|NCT01915914|17622412|P2|Acute Phase|"Not Achieved treatment success"|0
5102204|NCT01915914|17622413|P1|Acute Phase|"Not Achieved treatment success"|1
5102205|NCT01915914|17622410|P4|Acute Phase|Accepted Other Topic Therapies|0
5102206|NCT01915914|17622411|P3|Acute Phase|Accepted Other Topic Therapies|0
5102207|NCT01915914|17622412|P2|Acute Phase|Accepted Other Topic Therapies|0
5102208|NCT01915914|17622413|P1|Acute Phase|Accepted Other Topic Therapies|1
5102209|NCT01915914|17622410|P4|Acute Phase|Physician Decision|0
5102210|NCT01915914|17622411|P3|Acute Phase|Physician Decision|0
5102211|NCT01915914|17622412|P2|Acute Phase|Physician Decision|0
5102212|NCT01915914|17622413|P1|Acute Phase|Physician Decision|1
5102213|NCT01915914|17622410|P4|Acute Phase|Lost to Follow-up|0
5102214|NCT01915914|17622411|P3|Acute Phase|Lost to Follow-up|0
5102215|NCT01915914|17622412|P2|Acute Phase|Lost to Follow-up|0
5102216|NCT01915914|17622413|P1|Acute Phase|Lost to Follow-up|4
5102217|NCT01915914|17622410|P4|Acute Phase|Withdrawal by Subject|0
5102218|NCT01915914|17622411|P3|Acute Phase|Withdrawal by Subject|0
5102219|NCT01915914|17622412|P2|Acute Phase|Withdrawal by Subject|0
5102220|NCT01915914|17622413|P1|Acute Phase|Withdrawal by Subject|4
5102221|NCT01915849|17622445|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5102222|NCT01915849|17622446|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5102223|NCT01915849|17622447|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5102224|NCT01915849|17622448|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5102225|NCT01915849|17622445|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
5102226|NCT01915849|17622446|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
5102227|NCT01915849|17622447|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
5102228|NCT01915849|17622448|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
5102229|NCT01915771|17622471|P1|Day 15|Withdrawal by Subject|1
5102230|NCT01915771|17622471|P1|Day 1|Withdrawal by Subject|1
5102231|NCT01915732|17622495|P2|Overall Study|Poor Conscious Effect|1
5102232|NCT01915732|17622496|P1|Overall Study|Poor Conscious Effect|0
5102233|NCT01915732|17622495|P2|Overall Study|Improper Facial Procedure|1
5102234|NCT01915732|17622496|P1|Overall Study|Improper Facial Procedure|0
5102235|NCT01915732|17622495|P2|Overall Study|Job Transfer|1
5102236|NCT01915732|17622496|P1|Overall Study|Job Transfer|0
5102237|NCT01915732|17622495|P2|Overall Study|Par. Refused to Hospital Visits|1
5102238|NCT01915732|17622496|P1|Overall Study|Par. Refused to Hospital Visits|0
5102239|NCT01915732|17622495|P2|Overall Study|Par. not Willing to Continue Treatment|1
5102240|NCT01915732|17622496|P1|Overall Study|Par. not Willing to Continue Treatment|0
5102241|NCT01915732|17622495|P2|Overall Study|Got Well|1
5102242|NCT01915732|17622496|P1|Overall Study|Got Well|0
5102243|NCT01915732|17622495|P2|Overall Study|Par. Unable to Come to the Hospital|1
5102244|NCT01915732|17622496|P1|Overall Study|Par. Unable to Come to the Hospital|0
5102245|NCT01915732|17622495|P2|Overall Study|Poor Perceived Efficacy|0
5102246|NCT01915732|17622496|P1|Overall Study|Poor Perceived Efficacy|1
5102247|NCT01915732|17622495|P2|Overall Study|Pregnancy|0
5102248|NCT01915732|17622496|P1|Overall Study|Pregnancy|1
5102249|NCT01915732|17622495|P2|Overall Study|Recovered|0
5102250|NCT01915732|17622496|P1|Overall Study|Recovered|1
5102251|NCT01915732|17622495|P2|Overall Study|Drug Release Error|0
5102252|NCT01915732|17622496|P1|Overall Study|Drug Release Error|1
5102253|NCT01915732|17622495|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
5102254|NCT01915732|17622496|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
5102255|NCT01915732|17622495|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
5102256|NCT01915732|17622496|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
5102257|NCT01915732|17622495|P2|Overall Study|Lost to Follow-up|26
5102258|NCT01915732|17622496|P1|Overall Study|Lost to Follow-up|22
5102259|NCT01915732|17622495|P2|Overall Study|Lack of Efficacy|11
5102260|NCT01915732|17622496|P1|Overall Study|Lack of Efficacy|6
5102261|NCT01915732|17622495|P2|Overall Study|Protocol Violation|5
5102262|NCT01915732|17622496|P1|Overall Study|Protocol Violation|5
5102263|NCT01915732|17622495|P2|Overall Study|Adverse Event|4
5102264|NCT01915732|17622496|P1|Overall Study|Adverse Event|12
5102265|NCT01915732|17622495|P2|Overall Study|Failure to Meet Randomization Criteria|0
5102266|NCT01915732|17622496|P1|Overall Study|Failure to Meet Randomization Criteria|1
5102267|NCT01915732|17622495|P2|Overall Study|Withdrawal by Subject|18
5102268|NCT01915732|17622496|P1|Overall Study|Withdrawal by Subject|18
5102269|NCT01915498|17622549|P19|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
5102270|NCT01915498|17622550|P18|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102271|NCT01915498|17622551|P17|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102272|NCT01915498|17622552|P16|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102273|NCT01915498|17622553|P15|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102274|NCT01915498|17622554|P14|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102275|NCT01915498|17622555|P13|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102276|NCT01915498|17622556|P12|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102277|NCT01915498|17622557|P11|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102278|NCT01915498|17622558|P10|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102279|NCT01915498|17622559|P9|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102280|NCT01915498|17622560|P8|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102281|NCT01915498|17622561|P7|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102282|NCT01915498|17622562|P6|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102283|NCT01915498|17622563|P5|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102284|NCT01915498|17622564|P4|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102285|NCT01915498|17622565|P3|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102286|NCT01915498|17622566|P2|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102287|NCT01915498|17622567|P1|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5102288|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102289|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5102290|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5102291|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5102292|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5102293|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5102294|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102295|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102296|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102297|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5102298|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102299|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102300|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102301|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5102302|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102303|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102304|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102305|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102306|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5102307|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102308|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
5102309|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102310|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102311|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5102312|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102313|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102314|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102315|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102316|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102317|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102318|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102319|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102320|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5102321|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102322|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102323|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102324|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5102325|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5102326|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102327|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5102328|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5102329|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102330|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102331|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5102332|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102333|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102334|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5102335|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102336|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102337|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102338|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102339|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102340|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102341|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102342|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102343|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102344|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5102345|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102346|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
5102347|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5102348|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5102349|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
5102350|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
5102351|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5102352|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102353|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5102354|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102355|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102356|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102357|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5102358|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102359|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102360|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5102361|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5102362|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5102363|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5102364|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102365|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
5102366|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
5102367|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102368|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102369|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102370|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102371|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102372|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102373|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102374|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102375|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102376|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102377|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102378|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102379|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102380|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
5102381|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5102382|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5102383|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102384|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102385|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102386|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102387|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102388|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102389|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102390|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102391|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102392|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
5102393|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102394|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102395|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102396|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102397|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
5102398|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102399|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102400|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102401|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5102402|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5102403|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Death|16
5102404|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Death|3
5102405|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Death|4
5102406|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5102407|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Death|4
5102408|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5102409|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5102410|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5102411|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5102412|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5102413|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5102414|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5102415|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5102416|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5102417|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5102418|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5102419|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5102420|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5102421|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102422|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102423|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102424|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102425|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102426|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102427|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102428|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102429|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
5102430|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102431|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102432|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102433|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102434|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102435|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102436|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102437|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102438|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102439|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5102440|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
5102441|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
5102442|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
5102443|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
5102444|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
5102445|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
5102446|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5102447|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
5102448|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5102449|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
5102450|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
5102451|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
5102452|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
5102453|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
5102454|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
5102455|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
5102456|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5102457|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5102458|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
5102459|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5102460|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
5102461|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5102462|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5102463|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102464|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5102465|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5102466|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102467|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102468|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5102469|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102470|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5102471|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102472|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5102473|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5102474|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102475|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5102476|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5102477|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5102478|NCT01915498|17622549|P19|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102479|NCT01915498|17622550|P18|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
5102480|NCT01915498|17622551|P17|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
5102481|NCT01915498|17622552|P16|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
5102482|NCT01915498|17622553|P15|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5102483|NCT01915498|17622554|P14|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
5102484|NCT01915498|17622555|P13|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5102485|NCT01915498|17622556|P12|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102486|NCT01915498|17622557|P11|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102487|NCT01915498|17622558|P10|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5102488|NCT01915498|17622559|P9|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102489|NCT01915498|17622560|P8|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102490|NCT01915498|17622561|P7|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102491|NCT01915498|17622562|P6|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102492|NCT01915498|17622563|P5|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5102493|NCT01915498|17622564|P4|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5102494|NCT01915498|17622565|P3|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102495|NCT01915498|17622566|P2|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102496|NCT01915498|17622567|P1|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5102497|NCT01915303|17623091|P1|Extension Phase|Protocol Violation|1
5102498|NCT01915303|17623091|P1|Extension Phase|Death|1
5102499|NCT01915303|17623091|P1|Extension Phase|Adverse Event|3
5102500|NCT01915303|17623091|P1|Extension Phase|Withdrawal by Subject|4
5102501|NCT01915303|17623091|P1|Extension Phase|Unsatisfactory therapeutic effect|8
5102502|NCT01915303|17623091|P1|Core Phase|Withdrawal by Subject|1
5102503|NCT01915303|17623091|P1|Core Phase|Abnormal lab value|1
5102504|NCT01915303|17623091|P1|Core Phase|Protocol Violation|2
5102505|NCT01915303|17623091|P1|Core Phase|Death|2
5102506|NCT01915303|17623091|P1|Core Phase|Unsatisfactory therapeutic effect|3
5102507|NCT01915303|17623091|P1|Core Phase|Adverse Event|7
5102508|NCT01915095|17623165|P5|Overall Study|Some subjects were unable to commit to the training study.|6
5102509|NCT01915095|17623166|P4|Overall Study|Some subjects were unable to commit to the training study.|4
5102510|NCT01915095|17623167|P3|Overall Study|Some subjects were unable to commit to the training study.|0
5102511|NCT01915095|17623168|P2|Overall Study|Some subjects were unable to commit to the training study.|0
5102512|NCT01915095|17623169|P1|Overall Study|Some subjects were unable to commit to the training study.|0
5102513|NCT01914926|17623192|P2|Overall Study|uncooperative, agitated and removed|1
5102514|NCT01914926|17623193|P1|Overall Study|uncooperative, agitated and removed|0
5102515|NCT01914926|17623192|P2|Overall Study|Adverse Event|0
5102516|NCT01914926|17623193|P1|Overall Study|Adverse Event|1
5102517|NCT01914757|17623202|P3|Overall Study|Other reasons|4
5102518|NCT01914757|17623203|P2|Overall Study|Other reasons|9
5102519|NCT01914757|17623204|P1|Overall Study|Other reasons|5
5102520|NCT01914757|17623202|P3|Overall Study|Eligibility criteria not fulfilled|2
5102521|NCT01914757|17623203|P2|Overall Study|Eligibility criteria not fulfilled|0
5102522|NCT01914757|17623204|P1|Overall Study|Eligibility criteria not fulfilled|2
5102523|NCT01914757|17623202|P3|Overall Study|Study specific withdrawal criteria|0
5102524|NCT01914757|17623203|P2|Overall Study|Study specific withdrawal criteria|1
5102525|NCT01914757|17623204|P1|Overall Study|Study specific withdrawal criteria|0
5102526|NCT01914757|17623202|P3|Overall Study|Adverse Event|4
5102527|NCT01914757|17623203|P2|Overall Study|Adverse Event|3
5102528|NCT01914757|17623204|P1|Overall Study|Adverse Event|4
5102529|NCT01914757|17623202|P3|Overall Study|Death|1
5102530|NCT01914757|17623203|P2|Overall Study|Death|2
5102531|NCT01914757|17623204|P1|Overall Study|Death|2
5102532|NCT01914757|17623202|P3|Overall Study|Withdrawal by Subject|19
5102533|NCT01914757|17623203|P2|Overall Study|Withdrawal by Subject|27
5102534|NCT01914757|17623204|P1|Overall Study|Withdrawal by Subject|15
5102535|NCT01914757|17623202|P3|Overall Study|Lost to Follow-up|6
5102536|NCT01914757|17623203|P2|Overall Study|Lost to Follow-up|8
5102537|NCT01914757|17623204|P1|Overall Study|Lost to Follow-up|5
5102538|NCT01914757|17623202|P3|Overall Study|Severe non-compliance to protocol|2
5102539|NCT01914757|17623203|P2|Overall Study|Severe non-compliance to protocol|1
5102540|NCT01914757|17623204|P1|Overall Study|Severe non-compliance to protocol|3
5102541|NCT01914679|17623278|P1|Overall Study|Sponsor terminated study|4
5102542|NCT01914679|17623278|P1|Overall Study|Lack of Efficacy|1
5102543|NCT01914666|17623285|P3|Treatment Period|Physician Decision|2
5102544|NCT01914666|17623286|P2|Treatment Period|Physician Decision|0
5102545|NCT01914666|17623287|P1|Treatment Period|Physician Decision|0
5102546|NCT01914666|17623285|P3|Treatment Period|Withdrawal by Subject|2
5102547|NCT01914666|17623286|P2|Treatment Period|Withdrawal by Subject|2
5102548|NCT01914666|17623287|P1|Treatment Period|Withdrawal by Subject|3
5102549|NCT01914666|17623285|P3|Treatment Period|Adverse Event|2
5102550|NCT01914666|17623286|P2|Treatment Period|Adverse Event|4
5102551|NCT01914666|17623287|P1|Treatment Period|Adverse Event|10
5102552|NCT01914666|17623285|P3|Treatment Period|Lack of Efficacy|2
5102553|NCT01914666|17623286|P2|Treatment Period|Lack of Efficacy|0
5102554|NCT01914666|17623287|P1|Treatment Period|Lack of Efficacy|0
5102555|NCT01914393|17623330|P3|Overall Study|subject never dosed|1
5102556|NCT01914393|17623331|P2|Overall Study|subject never dosed|0
5102557|NCT01914393|17623332|P1|Overall Study|subject never dosed|0
5102558|NCT01914393|17623330|P3|Overall Study|Lost to Follow-up|19
5102559|NCT01914393|17623331|P2|Overall Study|Lost to Follow-up|6
5102560|NCT01914393|17623332|P1|Overall Study|Lost to Follow-up|12
5102561|NCT01914393|17623330|P3|Overall Study|Withdrawal by Subject|47
5102562|NCT01914393|17623331|P2|Overall Study|Withdrawal by Subject|20
5102563|NCT01914393|17623332|P1|Overall Study|Withdrawal by Subject|38
5102564|NCT01914393|17623330|P3|Overall Study|Adverse Event|31
5102565|NCT01914393|17623331|P2|Overall Study|Adverse Event|18
5102566|NCT01914393|17623332|P1|Overall Study|Adverse Event|29
5102567|NCT01914393|17623330|P3|Overall Study|no reason given|16
5102568|NCT01914393|17623331|P2|Overall Study|no reason given|8
5102569|NCT01914393|17623332|P1|Overall Study|no reason given|14
5102570|NCT01914393|17623330|P3|Overall Study|Lack of Efficacy|5
5102571|NCT01914393|17623331|P2|Overall Study|Lack of Efficacy|16
5102572|NCT01914393|17623332|P1|Overall Study|Lack of Efficacy|11
5102573|NCT01914393|17623330|P3|Overall Study|Protocol Violation|19
5102574|NCT01914393|17623331|P2|Overall Study|Protocol Violation|3
5102575|NCT01914393|17623332|P1|Overall Study|Protocol Violation|11
5102576|NCT01913639|17623400|P1|Overall Study|Not Eligible|3
5102577|NCT01913483|17623466|P2|Overall Study|Death|17
5102578|NCT01913483|17623467|P1|Overall Study|Death|14
5102579|NCT01913483|17623466|P2|Overall Study|Lost to Follow-up|3
5102580|NCT01913483|17623467|P1|Overall Study|Lost to Follow-up|6
5102581|NCT01913483|17623466|P2|Overall Study|Withdrawal by Subject|2
5102582|NCT01913483|17623467|P1|Overall Study|Withdrawal by Subject|1
5102583|NCT01913470|17623479|P2|Overall Study|Withdrawal by Subject|1
5102584|NCT01913470|17623480|P1|Overall Study|Withdrawal by Subject|0
5102585|NCT01913470|17623479|P2|Overall Study|Physician Decision|1
5102586|NCT01913470|17623480|P1|Overall Study|Physician Decision|0
5102587|NCT01913470|17623479|P2|Overall Study|Lost to Follow-up|1
5102588|NCT01913470|17623480|P1|Overall Study|Lost to Follow-up|0
5102589|NCT01913405|17623498|P1|Overall Study|Adverse Event|1
5102590|NCT01913405|17623498|P1|Overall Study|Withdrawal by Subject|1
5102591|NCT01913353|17623554|P2|Overall Study|multiple reasons|7
5102592|NCT01913353|17623555|P1|Overall Study|multiple reasons|10
5102593|NCT01913353|17623554|P2|Overall Study|Withdrawal by Subject|6
5102594|NCT01913353|17623555|P1|Overall Study|Withdrawal by Subject|20
5102595|NCT01913353|17623554|P2|Overall Study|Physician Decision|2
5102596|NCT01913353|17623555|P1|Overall Study|Physician Decision|0
5102597|NCT01913353|17623554|P2|Overall Study|Adverse Event|0
5102598|NCT01913353|17623555|P1|Overall Study|Adverse Event|2
5102599|NCT01913340|17623625|P2|Overall Study|Lost to Follow-up|1
5102600|NCT01913340|17623626|P1|Overall Study|Lost to Follow-up|1
5102601|NCT01913340|17623625|P2|Overall Study|Death|5
5102602|NCT01913340|17623626|P1|Overall Study|Death|2
5102603|NCT01913327|17623650|P2|Overall Study|Withdrawal by Subject|1
5102604|NCT01913327|17623651|P1|Overall Study|Withdrawal by Subject|0
5102605|NCT01913041|17623676|P1|Overall Study|Physician Decision|1
5102606|NCT01913041|17623676|P1|Overall Study|Withdrawal by Subject|3
5102607|NCT01913041|17623676|P1|Overall Study|Protocol Violation|35
5102608|NCT01912963|17623683|P3|Overall Study|Sought treatment locally|0
5102609|NCT01912963|17623684|P2|Overall Study|Sought treatment locally|1
5102610|NCT01912963|17623685|P1|Overall Study|Sought treatment locally|0
5102611|NCT01912963|17623683|P3|Overall Study|Withdrawal by Subject|0
5102612|NCT01912963|17623684|P2|Overall Study|Withdrawal by Subject|1
5102613|NCT01912963|17623685|P1|Overall Study|Withdrawal by Subject|0
5102614|NCT01912963|17623683|P3|Overall Study|Adverse Event|1
5102615|NCT01912963|17623684|P2|Overall Study|Adverse Event|1
5102616|NCT01912963|17623685|P1|Overall Study|Adverse Event|0
5102617|NCT01912963|17623683|P3|Overall Study|Disease Progression (not RECIST1.1)|1
5102618|NCT01912963|17623684|P2|Overall Study|Disease Progression (not RECIST1.1)|7
5102619|NCT01912963|17623685|P1|Overall Study|Disease Progression (not RECIST1.1)|0
5102620|NCT01912963|17623683|P3|Overall Study|Disease Progression (RECIST1.1)|5
5102621|NCT01912963|17623684|P2|Overall Study|Disease Progression (RECIST1.1)|9
5102622|NCT01912963|17623685|P1|Overall Study|Disease Progression (RECIST1.1)|6
5102623|NCT01912872|17623708|P4|Overall Study|Missing|1
5102624|NCT01912872|17623709|P3|Overall Study|Missing|0
5102625|NCT01912872|17623710|P2|Overall Study|Missing|0
5102626|NCT01912872|17623711|P1|Overall Study|Missing|0
5102627|NCT01912872|17623708|P4|Overall Study|Withdrawal of study medication|2
5102628|NCT01912872|17623709|P3|Overall Study|Withdrawal of study medication|0
5102629|NCT01912872|17623710|P2|Overall Study|Withdrawal of study medication|0
5102630|NCT01912872|17623711|P1|Overall Study|Withdrawal of study medication|0
5102631|NCT01912872|17623708|P4|Overall Study|Unsatisfactory therapeutic effect|2
5102632|NCT01912872|17623709|P3|Overall Study|Unsatisfactory therapeutic effect|0
5102633|NCT01912872|17623710|P2|Overall Study|Unsatisfactory therapeutic effect|0
5102634|NCT01912872|17623711|P1|Overall Study|Unsatisfactory therapeutic effect|0
5102635|NCT01912872|17623708|P4|Overall Study|Protocol Violation|0
5102636|NCT01912872|17623709|P3|Overall Study|Protocol Violation|1
5102637|NCT01912872|17623710|P2|Overall Study|Protocol Violation|0
5102638|NCT01912872|17623711|P1|Overall Study|Protocol Violation|0
5102639|NCT01912872|17623708|P4|Overall Study|Non-compliance with lab inc/exclusion|1
5102640|NCT01912872|17623709|P3|Overall Study|Non-compliance with lab inc/exclusion|0
5102641|NCT01912872|17623710|P2|Overall Study|Non-compliance with lab inc/exclusion|0
5102642|NCT01912872|17623711|P1|Overall Study|Non-compliance with lab inc/exclusion|0
5102643|NCT01912872|17623708|P4|Overall Study|Informed consent withdrawn|1
5102644|NCT01912872|17623709|P3|Overall Study|Informed consent withdrawn|1
5102645|NCT01912872|17623710|P2|Overall Study|Informed consent withdrawn|0
5102646|NCT01912872|17623711|P1|Overall Study|Informed consent withdrawn|0
5102647|NCT01912872|17623708|P4|Overall Study|Other unspecified|0
5102648|NCT01912872|17623709|P3|Overall Study|Other unspecified|3
5102649|NCT01912872|17623710|P2|Overall Study|Other unspecified|1
5102650|NCT01912872|17623711|P1|Overall Study|Other unspecified|3
5102651|NCT01912872|17623708|P4|Overall Study|Lost to Follow-up|5
5102652|NCT01912872|17623709|P3|Overall Study|Lost to Follow-up|5
5102653|NCT01912872|17623710|P2|Overall Study|Lost to Follow-up|3
5102654|NCT01912872|17623711|P1|Overall Study|Lost to Follow-up|2
5102655|NCT01912781|17623755|P2|Overall Study|Withdrawal by Subject|0
5102656|NCT01912781|17623756|P1|Overall Study|Withdrawal by Subject|2
5102657|NCT01912768|17623787|P2|Overall Study|Randomized in error|0
5102658|NCT01912768|17623788|P1|Overall Study|Randomized in error|1
5102659|NCT01912768|17623787|P2|Overall Study|Withdrawal by Subject|3
5102660|NCT01912768|17623788|P1|Overall Study|Withdrawal by Subject|5
5102661|NCT01912768|17623787|P2|Overall Study|Lost to Follow-up|1
5102662|NCT01912768|17623788|P1|Overall Study|Lost to Follow-up|2
5102663|NCT01912768|17623787|P2|Overall Study|Adverse Event|0
5102664|NCT01912768|17623788|P1|Overall Study|Adverse Event|2
5102665|NCT01912729|17623819|P2|Overall Study|Withdrawal by Subject|1
5102666|NCT01912729|17623820|P1|Overall Study|Withdrawal by Subject|0
5102667|NCT01912612|17623843|P3|Overall Study|Study design change|3
5102668|NCT01912612|17623844|P2|Overall Study|Study design change|0
5102669|NCT01912612|17623845|P1|Overall Study|Study design change|0
5102670|NCT01912612|17623843|P3|Overall Study|Withdrew consent|0
5102671|NCT01912612|17623844|P2|Overall Study|Withdrew consent|0
5102672|NCT01912612|17623845|P1|Overall Study|Withdrew consent|1
5102673|NCT01912612|17623843|P3|Overall Study|Adverse Event|0
5102674|NCT01912612|17623844|P2|Overall Study|Adverse Event|0
5102675|NCT01912612|17623845|P1|Overall Study|Adverse Event|4
5102676|NCT01912599|17623889|P2|Overall Study|Withdrawal by Subject|1
5102677|NCT01912599|17623890|P1|Overall Study|Withdrawal by Subject|0
5102678|NCT01912404|17623915|P2|Overall Study|Due to personal reasons|0
5102679|NCT01912404|17623916|P1|Overall Study|Due to personal reasons|1
5102680|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
5102681|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
5102682|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
5102683|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
5102684|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
5102685|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
5102686|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
5102687|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
5102688|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
5102689|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
5102690|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
5102691|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
5102692|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
5102693|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
5102694|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
5102695|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
5102696|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
5102697|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
5102698|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
5102699|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
5102700|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
5102701|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
5102702|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
5102703|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
5102704|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
5102705|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
5102706|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
5102707|NCT01912339|17623929|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
5102708|NCT01912339|17623930|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
5102709|NCT01912339|17623931|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
5102710|NCT01912339|17623929|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
5102711|NCT01912339|17623930|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
5102712|NCT01912339|17623931|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
5102713|NCT01912339|17623929|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
5102714|NCT01912339|17623930|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
5102715|NCT01912339|17623931|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
5102716|NCT01912339|17623929|P3|Blinded (0 to 3 Months)|Declined to participate|0
5102717|NCT01912339|17623930|P2|Blinded (0 to 3 Months)|Declined to participate|0
5102718|NCT01912339|17623931|P1|Blinded (0 to 3 Months)|Declined to participate|1
5102719|NCT01912287|17623948|P3|Overall Study|Scheduling/change in availability|8
5102720|NCT01912287|17623949|P2|Overall Study|Scheduling/change in availability|10
5102721|NCT01912287|17623950|P1|Overall Study|Scheduling/change in availability|17
5102722|NCT01912287|17623948|P3|Overall Study|Missed Assesment|1
5102723|NCT01912287|17623949|P2|Overall Study|Missed Assesment|1
5102724|NCT01912287|17623950|P1|Overall Study|Missed Assesment|1
5102725|NCT01912287|17623948|P3|Overall Study|Uknown reason - subject drop out|3
5102726|NCT01912287|17623949|P2|Overall Study|Uknown reason - subject drop out|7
5102727|NCT01912287|17623950|P1|Overall Study|Uknown reason - subject drop out|5
5102728|NCT01912287|17623948|P3|Overall Study|Lost Interest|0
5102729|NCT01912287|17623949|P2|Overall Study|Lost Interest|0
5102730|NCT01912287|17623950|P1|Overall Study|Lost Interest|1
5102731|NCT01912287|17623948|P3|Overall Study|Life circumstances|0
5102732|NCT01912287|17623949|P2|Overall Study|Life circumstances|2
5102733|NCT01912287|17623950|P1|Overall Study|Life circumstances|4
5102734|NCT01912287|17623948|P3|Overall Study|Felt treatment no longer needed|0
5102735|NCT01912287|17623949|P2|Overall Study|Felt treatment no longer needed|1
5102736|NCT01912287|17623950|P1|Overall Study|Felt treatment no longer needed|0
5102737|NCT01912287|17623948|P3|Overall Study|Dissatisfaction with assigned treatment|1
5102738|NCT01912287|17623949|P2|Overall Study|Dissatisfaction with assigned treatment|2
5102739|NCT01912287|17623950|P1|Overall Study|Dissatisfaction with assigned treatment|4
5102740|NCT01912287|17623948|P3|Overall Study|No-show|1
5102741|NCT01912287|17623949|P2|Overall Study|No-show|0
5102742|NCT01912287|17623950|P1|Overall Study|No-show|0
5102743|NCT01912287|17623948|P3|Overall Study|Ineligible|1
5102744|NCT01912287|17623949|P2|Overall Study|Ineligible|0
5102745|NCT01912287|17623950|P1|Overall Study|Ineligible|1
5102746|NCT01912222|17623961|P3|Part B: Treatment Period|Withdrawal by Subject|2
5102747|NCT01912222|17623962|P2|Part B: Treatment Period|Withdrawal by Subject|1
5102748|NCT01912222|17623963|P1|Part B: Treatment Period|Withdrawal by Subject|2
5102749|NCT01912222|17623961|P3|Part B: Treatment Period|Adverse Event|3
5102750|NCT01912222|17623962|P2|Part B: Treatment Period|Adverse Event|2
5102751|NCT01912222|17623963|P1|Part B: Treatment Period|Adverse Event|1
5102752|NCT01912222|17623961|P3|Part B: Treatment Period|Progressive disease|15
5102753|NCT01912222|17623962|P2|Part B: Treatment Period|Progressive disease|12
5102754|NCT01912222|17623963|P1|Part B: Treatment Period|Progressive disease|10
5102755|NCT01912222|17623961|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
5102756|NCT01912222|17623962|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
5102757|NCT01912222|17623963|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
5102758|NCT01911845|17624021|P1|Overall Study|Other (not specified)|3
5102759|NCT01911845|17624021|P1|Overall Study|Lost to Follow-up|1
5102760|NCT01911845|17624021|P1|Overall Study|Adverse Event|2
5102761|NCT01911819|17624038|P3|Overall Study|Withdrawal by Subject|0
5102762|NCT01911819|17624039|P2|Overall Study|Withdrawal by Subject|1
5102763|NCT01911819|17624040|P1|Overall Study|Withdrawal by Subject|1
5102764|NCT01911819|17624038|P3|Overall Study|Adverse Event|0
5102765|NCT01911819|17624039|P2|Overall Study|Adverse Event|1
5102766|NCT01911819|17624040|P1|Overall Study|Adverse Event|0
5102767|NCT01911793|17624053|P2|Overall Study|Physician Decision|5
5102768|NCT01911793|17624054|P1|Overall Study|Physician Decision|1
5102769|NCT01911780|17624078|P2|Extension Period (52 Weeks)|Personal reason|1
5102770|NCT01911780|17624079|P1|Extension Period (52 Weeks)|Personal reason|1
5102771|NCT01911780|17624078|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
5102772|NCT01911780|17624079|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
5102773|NCT01911780|17624078|P2|Extension Period (52 Weeks)|Adverse Event|0
5102774|NCT01911780|17624079|P1|Extension Period (52 Weeks)|Adverse Event|3
5102775|NCT01911780|17624078|P2|Double-blind Period (8 Weeks)|Personal reason|0
5102776|NCT01911780|17624079|P1|Double-blind Period (8 Weeks)|Personal reason|1
5102777|NCT01911780|17624078|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
5102778|NCT01911780|17624079|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
5102779|NCT01911780|17624078|P2|Double-blind Period (8 Weeks)|Adverse Event|2
5102780|NCT01911780|17624079|P1|Double-blind Period (8 Weeks)|Adverse Event|1
5102781|NCT01911546|17624113|P1|Overall Study|Everolimus was discontinued|5
5102782|NCT01911546|17624113|P1|Overall Study|Lost to Follow-up|1
5102783|NCT01911442|17624123|P3|Overall Study|Mother's Work Schedule|0
5102784|NCT01911442|17624124|P2|Overall Study|Mother's Work Schedule|1
5102785|NCT01911442|17624125|P1|Overall Study|Mother's Work Schedule|0
5102786|NCT01911442|17624123|P3|Overall Study|Withdrawal by Subject|6
5102787|NCT01911442|17624124|P2|Overall Study|Withdrawal by Subject|0
5102788|NCT01911442|17624125|P1|Overall Study|Withdrawal by Subject|1
5102789|NCT01911442|17624123|P3|Overall Study|Lost to Follow-up|1
5102790|NCT01911442|17624124|P2|Overall Study|Lost to Follow-up|0
5102791|NCT01911442|17624125|P1|Overall Study|Lost to Follow-up|2
5102792|NCT01911442|17624123|P3|Overall Study|Lack of Efficacy|1
5102793|NCT01911442|17624124|P2|Overall Study|Lack of Efficacy|1
5102794|NCT01911442|17624125|P1|Overall Study|Lack of Efficacy|1
5102795|NCT01911442|17624123|P3|Overall Study|Adverse Event|4
5102796|NCT01911442|17624124|P2|Overall Study|Adverse Event|2
5102797|NCT01911442|17624125|P1|Overall Study|Adverse Event|2
5102798|NCT01911429|17624154|P3|Overall Study|subject left study|0
5102799|NCT01911429|17624155|P2|Overall Study|subject left study|0
5102800|NCT01911429|17624156|P1|Overall Study|subject left study|1
5102801|NCT01911429|17624154|P3|Overall Study|Accidental randomization|1
5102802|NCT01911429|17624155|P2|Overall Study|Accidental randomization|0
5102803|NCT01911429|17624156|P1|Overall Study|Accidental randomization|0
5102804|NCT01911429|17624154|P3|Overall Study|Withdrawal by Subject|4
5102805|NCT01911429|17624155|P2|Overall Study|Withdrawal by Subject|5
5102806|NCT01911429|17624156|P1|Overall Study|Withdrawal by Subject|5
5102807|NCT01911429|17624154|P3|Overall Study|Protocol Violation|1
5102808|NCT01911429|17624155|P2|Overall Study|Protocol Violation|0
5102809|NCT01911429|17624156|P1|Overall Study|Protocol Violation|0
5102810|NCT01911429|17624154|P3|Overall Study|Lost to Follow-up|1
5102811|NCT01911429|17624155|P2|Overall Study|Lost to Follow-up|0
5102812|NCT01911429|17624156|P1|Overall Study|Lost to Follow-up|0
5102813|NCT01911429|17624154|P3|Overall Study|Lack of Efficacy|4
5102814|NCT01911429|17624155|P2|Overall Study|Lack of Efficacy|2
5102815|NCT01911429|17624156|P1|Overall Study|Lack of Efficacy|1
5102816|NCT01911429|17624154|P3|Overall Study|Adverse Event|9
5102817|NCT01911429|17624155|P2|Overall Study|Adverse Event|3
5102818|NCT01911429|17624156|P1|Overall Study|Adverse Event|5
5102819|NCT01911273|17624248|P2|Overall Study|Withdrawal by Subject|2
5102820|NCT01911273|17624249|P1|Overall Study|Withdrawal by Subject|0
5102821|NCT01911273|17624248|P2|Overall Study|Progression of Disease|0
5102822|NCT01911273|17624249|P1|Overall Study|Progression of Disease|1
5102823|NCT01911260|17624283|P4|Follow-up Period|transference or evasion of school|12
5102824|NCT01911260|17624284|P3|Follow-up Period|transference or evasion of school|15
5102825|NCT01911260|17624285|P2|Follow-up Period|transference or evasion of school|20
5102826|NCT01911260|17624286|P1|Follow-up Period|transference or evasion of school|13
5102827|NCT01911260|17624283|P4|Supplementation Period|less than 12 weeks supplementation|2
5102828|NCT01911260|17624284|P3|Supplementation Period|less than 12 weeks supplementation|1
5102829|NCT01911260|17624285|P2|Supplementation Period|less than 12 weeks supplementation|3
5102830|NCT01911260|17624286|P1|Supplementation Period|less than 12 weeks supplementation|0
5102831|NCT01911260|17624283|P4|Supplementation Period|refused to receive supplement|0
5102832|NCT01911260|17624284|P3|Supplementation Period|refused to receive supplement|1
5102833|NCT01911260|17624285|P2|Supplementation Period|refused to receive supplement|0
5102834|NCT01911260|17624286|P1|Supplementation Period|refused to receive supplement|1
5102835|NCT01911260|17624283|P4|Supplementation Period|Adverse Event|0
5102836|NCT01911260|17624284|P3|Supplementation Period|Adverse Event|1
5102837|NCT01911260|17624285|P2|Supplementation Period|Adverse Event|0
5102838|NCT01911260|17624286|P1|Supplementation Period|Adverse Event|2
5102839|NCT01911260|17624283|P4|Supplementation Period|transference or evasion of school|6
5102840|NCT01911260|17624284|P3|Supplementation Period|transference or evasion of school|7
5102841|NCT01911260|17624285|P2|Supplementation Period|transference or evasion of school|9
5102842|NCT01911260|17624286|P1|Supplementation Period|transference or evasion of school|7
5102843|NCT01910519|17624372|P2|Overall Study|Adverse Event|0
5102844|NCT01910519|17624373|P1|Overall Study|Adverse Event|2
5102845|NCT01910519|17624372|P2|Overall Study|Withdrawal by Subject|0
5102846|NCT01910519|17624373|P1|Overall Study|Withdrawal by Subject|2
5102847|NCT01910441|17624399|P2|Overall Study|Physician Decision|1
5102848|NCT01910441|17624400|P1|Overall Study|Physician Decision|0
5102849|NCT01910441|17624399|P2|Overall Study|Adverse Event|0
5102850|NCT01910441|17624400|P1|Overall Study|Adverse Event|1
5102851|NCT01910441|17624399|P2|Overall Study|Non-compliance|1
5102852|NCT01910441|17624400|P1|Overall Study|Non-compliance|0
5102853|NCT01910441|17624399|P2|Overall Study|Withdrawal by Subject|1
5102854|NCT01910441|17624400|P1|Overall Study|Withdrawal by Subject|0
5102855|NCT01910441|17624399|P2|Overall Study|Lost to Follow-up|5
5102856|NCT01910441|17624400|P1|Overall Study|Lost to Follow-up|6
5102857|NCT01910441|17624399|P2|Overall Study|Sponsor decision|2
5102858|NCT01910441|17624400|P1|Overall Study|Sponsor decision|0
5102859|NCT01910402|17624408|P2|Continuation Phase|Withdrawal by Subject|0
5102860|NCT01910402|17624409|P1|Continuation Phase|Withdrawal by Subject|2
5102861|NCT01910402|17624408|P2|Continuation Phase|Protocol Violation|0
5102862|NCT01910402|17624409|P1|Continuation Phase|Protocol Violation|3
5102863|NCT01910402|17624408|P2|Continuation Phase|Adverse Event|0
5102864|NCT01910402|17624409|P1|Continuation Phase|Adverse Event|1
5102865|NCT01910402|17624408|P2|Continuation Phase|Ongoing|0
5102866|NCT01910402|17624409|P1|Continuation Phase|Ongoing|84
5102867|NCT01910402|17624408|P2|Randomized Phase|Withdrawal by Subject|7
5102868|NCT01910402|17624409|P1|Randomized Phase|Withdrawal by Subject|5
5102869|NCT01910402|17624408|P2|Randomized Phase|Protocol Violation|13
5102870|NCT01910402|17624409|P1|Randomized Phase|Protocol Violation|10
5102871|NCT01910402|17624408|P2|Randomized Phase|Lost to Follow-up|13
5102872|NCT01910402|17624409|P1|Randomized Phase|Lost to Follow-up|11
5102873|NCT01910402|17624408|P2|Randomized Phase|Lack of Efficacy|4
5102874|NCT01910402|17624409|P1|Randomized Phase|Lack of Efficacy|5
5102875|NCT01910402|17624408|P2|Randomized Phase|Physician Decision|0
5102876|NCT01910402|17624409|P1|Randomized Phase|Physician Decision|1
5102877|NCT01910402|17624408|P2|Randomized Phase|Adverse Event|18
5102878|NCT01910402|17624409|P1|Randomized Phase|Adverse Event|10
5102879|NCT01910389|17624479|P2|Overall Study|Study Closed|8
5102880|NCT01910389|17624480|P1|Overall Study|Study Closed|13
5102881|NCT01910389|17624479|P2|Overall Study|Withdrawal by Subject|0
5102882|NCT01910389|17624480|P1|Overall Study|Withdrawal by Subject|2
5102883|NCT01910298|17624523|P2|Overall Study|Other Miscellaneous Reasons|2
5102884|NCT01910298|17624524|P1|Overall Study|Other Miscellaneous Reasons|0
5102885|NCT01910298|17624523|P2|Overall Study|Study Terminated by Sponsor|17
5102886|NCT01910298|17624524|P1|Overall Study|Study Terminated by Sponsor|1
5102887|NCT01910298|17624523|P2|Overall Study|Lost to Follow-up|1
5102888|NCT01910298|17624524|P1|Overall Study|Lost to Follow-up|1
5102889|NCT01910298|17624523|P2|Overall Study|Protocol Deviation|5
5102890|NCT01910298|17624524|P1|Overall Study|Protocol Deviation|0
5102891|NCT01910298|17624523|P2|Overall Study|Withdrawal by Subject|7
5102892|NCT01910298|17624524|P1|Overall Study|Withdrawal by Subject|2
5102893|NCT01910298|17624523|P2|Overall Study|Adverse Event|0
5102894|NCT01910298|17624524|P1|Overall Study|Adverse Event|1
5102895|NCT01910181|17624542|P1|Overall Study|Study Terminated by Sponsor|6
5102896|NCT01910181|17624542|P1|Overall Study|Lost to Follow-up|3
5102897|NCT01910181|17624542|P1|Overall Study|Death|37
5102898|NCT01910129|17624569|P3|Randomized Phase 3|Withdrawal by Subject|0
5102899|NCT01910129|17624570|P2|Randomized Phase 3|Withdrawal by Subject|1
5102900|NCT01910129|17624571|P1|Randomized Phase 3|Withdrawal by Subject|0
5102901|NCT01910129|17624569|P3|Randomized Phase 2|Withdrawal by Subject|0
5102902|NCT01910129|17624570|P2|Randomized Phase 2|Withdrawal by Subject|1
5102903|NCT01910129|17624571|P1|Randomized Phase 2|Withdrawal by Subject|2
5102904|NCT01910116|17624595|P2|Overall Study|incomplete data|1
5102905|NCT01910116|17624596|P1|Overall Study|incomplete data|0
5102906|NCT01910116|17624595|P2|Overall Study|uncertain allocation|3
5102907|NCT01910116|17624596|P1|Overall Study|uncertain allocation|1
5102908|NCT01910116|17624595|P2|Overall Study|Withdrawal by Subject|3
5102909|NCT01910116|17624596|P1|Overall Study|Withdrawal by Subject|8
5102910|NCT01910116|17624595|P2|Overall Study|Protocol Violation|2
5102911|NCT01910116|17624596|P1|Overall Study|Protocol Violation|1
5102912|NCT01910116|17624595|P2|Overall Study|Lost to Follow-up|0
5102913|NCT01910116|17624596|P1|Overall Study|Lost to Follow-up|1
5102914|NCT01910116|17624595|P2|Overall Study|Lack of Efficacy|4
5102915|NCT01910116|17624596|P1|Overall Study|Lack of Efficacy|3
5102916|NCT01910116|17624595|P2|Overall Study|Adverse Event|3
5102917|NCT01910116|17624596|P1|Overall Study|Adverse Event|0
5102918|NCT01909973|17624683|P2|Overall Study|Lost to Follow-up|0
5102919|NCT01909973|17624684|P1|Overall Study|Lost to Follow-up|1
5102920|NCT01909804|17624704|P12|Overall Study|Protocol Violation|1
5102921|NCT01909804|17624705|P11|Overall Study|Protocol Violation|0
5102922|NCT01909804|17624706|P10|Overall Study|Protocol Violation|0
5102923|NCT01909804|17624707|P9|Overall Study|Protocol Violation|0
5102924|NCT01909804|17624708|P8|Overall Study|Protocol Violation|0
5102925|NCT01909804|17624709|P7|Overall Study|Protocol Violation|0
5102926|NCT01909804|17624710|P6|Overall Study|Protocol Violation|0
5102927|NCT01909804|17624711|P5|Overall Study|Protocol Violation|0
5102928|NCT01909804|17624712|P4|Overall Study|Protocol Violation|0
5102929|NCT01909804|17624713|P3|Overall Study|Protocol Violation|0
5102930|NCT01909804|17624714|P2|Overall Study|Protocol Violation|0
5102931|NCT01909804|17624715|P1|Overall Study|Protocol Violation|0
5102932|NCT01909804|17624704|P12|Overall Study|Withdrew Consent|0
5102933|NCT01909804|17624705|P11|Overall Study|Withdrew Consent|0
5102934|NCT01909804|17624706|P10|Overall Study|Withdrew Consent|0
5102935|NCT01909804|17624707|P9|Overall Study|Withdrew Consent|0
5102936|NCT01909804|17624708|P8|Overall Study|Withdrew Consent|0
5102937|NCT01909804|17624709|P7|Overall Study|Withdrew Consent|0
5102938|NCT01909804|17624710|P6|Overall Study|Withdrew Consent|1
5102939|NCT01909804|17624711|P5|Overall Study|Withdrew Consent|1
5102940|NCT01909804|17624712|P4|Overall Study|Withdrew Consent|0
5102941|NCT01909804|17624713|P3|Overall Study|Withdrew Consent|0
5102942|NCT01909804|17624714|P2|Overall Study|Withdrew Consent|0
5102943|NCT01909804|17624715|P1|Overall Study|Withdrew Consent|0
5102944|NCT01909804|17624704|P12|Overall Study|Lack of Efficacy|1
5102945|NCT01909804|17624705|P11|Overall Study|Lack of Efficacy|0
5102946|NCT01909804|17624706|P10|Overall Study|Lack of Efficacy|1
5102947|NCT01909804|17624707|P9|Overall Study|Lack of Efficacy|0
5102948|NCT01909804|17624708|P8|Overall Study|Lack of Efficacy|1
5102949|NCT01909804|17624709|P7|Overall Study|Lack of Efficacy|1
5102950|NCT01909804|17624710|P6|Overall Study|Lack of Efficacy|3
5102951|NCT01909804|17624711|P5|Overall Study|Lack of Efficacy|7
5102952|NCT01909804|17624712|P4|Overall Study|Lack of Efficacy|0
5102953|NCT01909804|17624713|P3|Overall Study|Lack of Efficacy|0
5102954|NCT01909804|17624714|P2|Overall Study|Lack of Efficacy|1
5102955|NCT01909804|17624715|P1|Overall Study|Lack of Efficacy|4
5102956|NCT01909804|17624704|P12|Overall Study|Death|0
5102957|NCT01909804|17624705|P11|Overall Study|Death|1
5102958|NCT01909804|17624706|P10|Overall Study|Death|0
5102959|NCT01909804|17624707|P9|Overall Study|Death|0
5102960|NCT01909804|17624708|P8|Overall Study|Death|0
5102961|NCT01909804|17624709|P7|Overall Study|Death|0
5102962|NCT01909804|17624710|P6|Overall Study|Death|0
5102963|NCT01909804|17624711|P5|Overall Study|Death|0
5102964|NCT01909804|17624712|P4|Overall Study|Death|0
5102965|NCT01909804|17624713|P3|Overall Study|Death|0
5102966|NCT01909804|17624714|P2|Overall Study|Death|0
5102967|NCT01909804|17624715|P1|Overall Study|Death|0
5102968|NCT01909804|17624704|P12|Overall Study|Randomized but Never Treated|1
5102969|NCT01909804|17624705|P11|Overall Study|Randomized but Never Treated|0
5102970|NCT01909804|17624706|P10|Overall Study|Randomized but Never Treated|0
5102971|NCT01909804|17624707|P9|Overall Study|Randomized but Never Treated|0
5102972|NCT01909804|17624708|P8|Overall Study|Randomized but Never Treated|0
5102973|NCT01909804|17624709|P7|Overall Study|Randomized but Never Treated|1
5102974|NCT01909804|17624710|P6|Overall Study|Randomized but Never Treated|0
5102975|NCT01909804|17624711|P5|Overall Study|Randomized but Never Treated|0
5102976|NCT01909804|17624712|P4|Overall Study|Randomized but Never Treated|0
5102977|NCT01909804|17624713|P3|Overall Study|Randomized but Never Treated|0
5102978|NCT01909804|17624714|P2|Overall Study|Randomized but Never Treated|0
5102979|NCT01909804|17624715|P1|Overall Study|Randomized but Never Treated|0
5102980|NCT01909791|17624764|P3|Overall Study|Missed Visit|1
5102981|NCT01909791|17624765|P2|Overall Study|Missed Visit|0
5102982|NCT01909791|17624766|P1|Overall Study|Missed Visit|2
5102983|NCT01909791|17624764|P3|Overall Study|Lost to Follow-up|10
5102984|NCT01909791|17624765|P2|Overall Study|Lost to Follow-up|11
5102985|NCT01909791|17624766|P1|Overall Study|Lost to Follow-up|5
5102986|NCT01909791|17624764|P3|Overall Study|Withdrawal by Subject|13
5102987|NCT01909791|17624765|P2|Overall Study|Withdrawal by Subject|9
5102988|NCT01909791|17624766|P1|Overall Study|Withdrawal by Subject|5
5102989|NCT01909791|17624764|P3|Overall Study|Death|4
5102990|NCT01909791|17624765|P2|Overall Study|Death|8
5102991|NCT01909791|17624766|P1|Overall Study|Death|9
5102992|NCT01909778|17624824|P1|Overall Study|failed screening|1
5102993|NCT01909674|17624903|P2|Overall Study|Withdrawal by Subject|2
5102994|NCT01909674|17624904|P1|Overall Study|Withdrawal by Subject|5
5102995|NCT01909466|17624923|P2|Overall Study|Lack of Efficacy|0
5102996|NCT01909466|17624924|P1|Overall Study|Lack of Efficacy|1
5102997|NCT01909466|17624923|P2|Overall Study|Withdrawal by Subject|9
5102998|NCT01909466|17624924|P1|Overall Study|Withdrawal by Subject|11
5102999|NCT01909466|17624923|P2|Overall Study|Physician Decision|0
5103000|NCT01909466|17624924|P1|Overall Study|Physician Decision|2
5103001|NCT01909466|17624923|P2|Overall Study|Met Withdrawal Criteria|3
5103002|NCT01909466|17624924|P1|Overall Study|Met Withdrawal Criteria|0
5103003|NCT01909466|17624923|P2|Overall Study|Adverse Event|4
5103004|NCT01909466|17624924|P1|Overall Study|Adverse Event|3
5103005|NCT01909466|17624923|P2|Overall Study|Lost to Follow-up|7
5103006|NCT01909466|17624924|P1|Overall Study|Lost to Follow-up|5
5103007|NCT01909336|17624947|P3|Overall Study|Physician Decision|1
5103008|NCT01909336|17624948|P2|Overall Study|Physician Decision|1
5103009|NCT01909336|17624949|P1|Overall Study|Physician Decision|0
5103010|NCT01909336|17624947|P3|Overall Study|Lost to Follow-up|2
5103011|NCT01909336|17624948|P2|Overall Study|Lost to Follow-up|2
5103012|NCT01909336|17624949|P1|Overall Study|Lost to Follow-up|4
5103013|NCT01908907|17625047|P2|Overall Study|Protocol Violation|0
5103014|NCT01908907|17625048|P1|Overall Study|Protocol Violation|1
5103015|NCT01908907|17625047|P2|Overall Study|Physician Decision|0
5103016|NCT01908907|17625048|P1|Overall Study|Physician Decision|1
5103017|NCT01908829|17625092|P3|Overall Study|Withdrawal by Subject|22
5103018|NCT01908829|17625093|P2|Overall Study|Withdrawal by Subject|29
5103019|NCT01908829|17625094|P1|Overall Study|Withdrawal by Subject|26
5103020|NCT01908829|17625092|P3|Overall Study|Lack of Efficacy|2
5103021|NCT01908829|17625093|P2|Overall Study|Lack of Efficacy|3
5103022|NCT01908829|17625094|P1|Overall Study|Lack of Efficacy|1
5103023|NCT01908829|17625092|P3|Overall Study|Protocol Violation|0
5103024|NCT01908829|17625093|P2|Overall Study|Protocol Violation|2
5103025|NCT01908829|17625094|P1|Overall Study|Protocol Violation|2
5103026|NCT01908829|17625092|P3|Overall Study|Miscellaneous|0
5103027|NCT01908829|17625093|P2|Overall Study|Miscellaneous|2
5103028|NCT01908829|17625094|P1|Overall Study|Miscellaneous|0
5103029|NCT01908829|17625092|P3|Overall Study|Discontinued (no EoT page)|0
5103030|NCT01908829|17625093|P2|Overall Study|Discontinued (no EoT page)|0
5103031|NCT01908829|17625094|P1|Overall Study|Discontinued (no EoT page)|2
5103032|NCT01908829|17625092|P3|Overall Study|Randomized no double-blind drug received|1
5103033|NCT01908829|17625093|P2|Overall Study|Randomized no double-blind drug received|0
5103034|NCT01908829|17625094|P1|Overall Study|Randomized no double-blind drug received|1
5103035|NCT01908829|17625092|P3|Overall Study|Lost to Follow-up|1
5103036|NCT01908829|17625093|P2|Overall Study|Lost to Follow-up|2
5103037|NCT01908829|17625094|P1|Overall Study|Lost to Follow-up|4
5103038|NCT01908829|17625092|P3|Overall Study|Adverse Event|13
5103039|NCT01908829|17625093|P2|Overall Study|Adverse Event|11
5103040|NCT01908829|17625094|P1|Overall Study|Adverse Event|13
5103041|NCT01908816|17625211|P4|Overall Study|Early termination|28
5103042|NCT01908816|17625212|P3|Overall Study|Early termination|43
5103043|NCT01908816|17625213|P2|Overall Study|Early termination|60
5103044|NCT01908816|17625214|P1|Overall Study|Early termination|87
5103045|NCT01908816|17625211|P4|Overall Study|Unsatisfactory therapeutic effect|0
5103046|NCT01908816|17625212|P3|Overall Study|Unsatisfactory therapeutic effect|1
5103047|NCT01908816|17625213|P2|Overall Study|Unsatisfactory therapeutic effect|13
5103048|NCT01908816|17625214|P1|Overall Study|Unsatisfactory therapeutic effect|1
5103049|NCT01908816|17625211|P4|Overall Study|Death|1
5103050|NCT01908816|17625212|P3|Overall Study|Death|7
5103051|NCT01908816|17625213|P2|Overall Study|Death|0
5103052|NCT01908816|17625214|P1|Overall Study|Death|1
5103053|NCT01908816|17625211|P4|Overall Study|Lost to Follow-up|2
5103054|NCT01908816|17625212|P3|Overall Study|Lost to Follow-up|4
5103055|NCT01908816|17625213|P2|Overall Study|Lost to Follow-up|5
5103056|NCT01908816|17625214|P1|Overall Study|Lost to Follow-up|3
5103057|NCT01908816|17625211|P4|Overall Study|Withdrawal by Subject|2
5103058|NCT01908816|17625212|P3|Overall Study|Withdrawal by Subject|2
5103059|NCT01908816|17625213|P2|Overall Study|Withdrawal by Subject|4
5103060|NCT01908816|17625214|P1|Overall Study|Withdrawal by Subject|0
5103061|NCT01908816|17625211|P4|Overall Study|Protocol deviation|1
5103062|NCT01908816|17625212|P3|Overall Study|Protocol deviation|1
5103063|NCT01908816|17625213|P2|Overall Study|Protocol deviation|2
5103064|NCT01908816|17625214|P1|Overall Study|Protocol deviation|1
5103065|NCT01908816|17625211|P4|Overall Study|Subject's no longer requires study drug|1
5103066|NCT01908816|17625212|P3|Overall Study|Subject's no longer requires study drug|0
5103067|NCT01908816|17625213|P2|Overall Study|Subject's no longer requires study drug|0
5103068|NCT01908816|17625214|P1|Overall Study|Subject's no longer requires study drug|0
5103069|NCT01908803|17625239|P2|Overall Study|Adverse Event (pre-treatment)|0
5103070|NCT01908803|17625240|P1|Overall Study|Adverse Event (pre-treatment)|1
5103071|NCT01908803|17625239|P2|Overall Study|Randomization Error|0
5103072|NCT01908803|17625240|P1|Overall Study|Randomization Error|1
5103073|NCT01908803|17625239|P2|Overall Study|Withdrawal by Subject|0
5103074|NCT01908803|17625240|P1|Overall Study|Withdrawal by Subject|1
5103075|NCT01908803|17625239|P2|Overall Study|Physician Decision|1
5103076|NCT01908803|17625240|P1|Overall Study|Physician Decision|0
5103077|NCT01908803|17625239|P2|Overall Study|Adverse Event|0
5103078|NCT01908803|17625240|P1|Overall Study|Adverse Event|1
5103079|NCT01908699|17625294|P2|Overall Study|Progressive Disease|29
5103080|NCT01908699|17625295|P1|Overall Study|Progressive Disease|30
5103081|NCT01908699|17625294|P2|Overall Study|Death|12
5103082|NCT01908699|17625295|P1|Overall Study|Death|9
5103083|NCT01908699|17625294|P2|Overall Study|Randomized in Error|0
5103084|NCT01908699|17625295|P1|Overall Study|Randomized in Error|1
5103085|NCT01908699|17625294|P2|Overall Study|Pregnancy|1
5103086|NCT01908699|17625295|P1|Overall Study|Pregnancy|0
5103087|NCT01908699|17625294|P2|Overall Study|Withdrawal by Subject|10
5103088|NCT01908699|17625295|P1|Overall Study|Withdrawal by Subject|15
5103089|NCT01908699|17625294|P2|Overall Study|Physician Decision|8
5103090|NCT01908699|17625295|P1|Overall Study|Physician Decision|8
5103091|NCT01908699|17625294|P2|Overall Study|Lost to Follow-up|4
5103092|NCT01908699|17625295|P1|Overall Study|Lost to Follow-up|2
5103093|NCT01908699|17625294|P2|Overall Study|Lack of Efficacy|2
5103094|NCT01908699|17625295|P1|Overall Study|Lack of Efficacy|2
5103095|NCT01908699|17625294|P2|Overall Study|Adverse Event|12
5103096|NCT01908699|17625295|P1|Overall Study|Adverse Event|8
5103097|NCT01908582|17625311|P1|Period 2|Withdrawal by Subject|1
5103098|NCT01908582|17625311|P1|Period 2|Physician Decision|1
5103099|NCT01908426|17625355|P2|Overall Study|No Study Treatment Given|0
5103100|NCT01908426|17625356|P1|Overall Study|No Study Treatment Given|3
5103101|NCT01908426|17625355|P2|Overall Study|Protocol Violation|0
5103102|NCT01908426|17625356|P1|Overall Study|Protocol Violation|1
5103103|NCT01908426|17625355|P2|Overall Study|Progressive Disease|152
5103104|NCT01908426|17625356|P1|Overall Study|Progressive Disease|206
5103105|NCT01908426|17625355|P2|Overall Study|Withdrawal by Subject|6
5103106|NCT01908426|17625356|P1|Overall Study|Withdrawal by Subject|11
5103107|NCT01908426|17625355|P2|Overall Study|Physician Decision|3
5103108|NCT01908426|17625356|P1|Overall Study|Physician Decision|3
5103109|NCT01908426|17625355|P2|Overall Study|Lost to Follow-up|1
5103110|NCT01908426|17625356|P1|Overall Study|Lost to Follow-up|0
5103111|NCT01908426|17625355|P2|Overall Study|Lack of Efficacy|0
5103112|NCT01908426|17625356|P1|Overall Study|Lack of Efficacy|3
5103113|NCT01908426|17625355|P2|Overall Study|Clinical Deterioration|38
5103114|NCT01908426|17625356|P1|Overall Study|Clinical Deterioration|72
5103115|NCT01908426|17625355|P2|Overall Study|Adverse Event|11
5103116|NCT01908426|17625356|P1|Overall Study|Adverse Event|98
5103117|NCT01908205|17625368|P2|Overall Study|Withdrawal by Subject|1
5103118|NCT01908205|17625369|P1|Overall Study|Withdrawal by Subject|3
5103119|NCT01908205|17625368|P2|Overall Study|Lost to Follow-up|0
5103120|NCT01908205|17625369|P1|Overall Study|Lost to Follow-up|2
5103121|NCT01908140|17625397|P2|Overall Study|Adverse Event|23
5103122|NCT01908140|17625398|P1|Overall Study|Adverse Event|22
5103123|NCT01908140|17625397|P2|Overall Study|Protocol Violation|9
5103124|NCT01908140|17625398|P1|Overall Study|Protocol Violation|8
5103125|NCT01908140|17625397|P2|Overall Study|Lost to Follow-up|6
5103126|NCT01908140|17625398|P1|Overall Study|Lost to Follow-up|1
5103127|NCT01908140|17625397|P2|Overall Study|Withdrawal by Subject|24
5103128|NCT01908140|17625398|P1|Overall Study|Withdrawal by Subject|23
5103129|NCT01908140|17625397|P2|Overall Study|Lack of Efficacy|5
5103130|NCT01908140|17625398|P1|Overall Study|Lack of Efficacy|7
5103131|NCT01908140|17625397|P2|Overall Study|Other or Progressive Disease|12
5103132|NCT01908140|17625398|P1|Overall Study|Other or Progressive Disease|5
5103133|NCT01908101|17625417|P1|Overall Study|Did not complete the first cycle|4
5103134|NCT01908101|17625417|P1|Overall Study|Incorrect Starting Dose|1
5103135|NCT01908101|17625417|P1|Overall Study|Incorrect Diagnosis|2
5103136|NCT01908101|17625417|P1|Overall Study|Withdrawal by Subject|1
5103137|NCT01908101|17625417|P1|Overall Study|Physician Decision|1
5103138|NCT01907906|17625451|P2|Overall Study|Physician Decision|1
5103139|NCT01907906|17625452|P1|Overall Study|Physician Decision|3
5103140|NCT01907906|17625451|P2|Overall Study|Withdrawal by Subject|0
5103141|NCT01907906|17625452|P1|Overall Study|Withdrawal by Subject|1
5103142|NCT01907854|17625532|P2|Overall Study|Unclassified|3
5103143|NCT01907854|17625533|P1|Overall Study|Unclassified|4
5103144|NCT01907854|17625532|P2|Overall Study|Lost to Follow-up|2
5103145|NCT01907854|17625533|P1|Overall Study|Lost to Follow-up|2
5103146|NCT01907854|17625532|P2|Overall Study|Withdrawal by Subject|7
5103147|NCT01907854|17625533|P1|Overall Study|Withdrawal by Subject|9
5103148|NCT01907854|17625532|P2|Overall Study|Protocol Violation|1
5103149|NCT01907854|17625533|P1|Overall Study|Protocol Violation|1
5103150|NCT01907828|17625553|P2|Overall Study|Participant met exclusion criteria|1
5103151|NCT01907828|17625554|P1|Overall Study|Participant met exclusion criteria|0
5103152|NCT01907828|17625553|P2|Overall Study|Participant refused 24-month follow-up|0
5103153|NCT01907828|17625554|P1|Overall Study|Participant refused 24-month follow-up|1
5103154|NCT01907828|17625553|P2|Overall Study|Lost to Follow-up|0
5103155|NCT01907828|17625554|P1|Overall Study|Lost to Follow-up|3
5103156|NCT01907828|17625553|P2|Overall Study|Withdrawal by Subject|4
5103157|NCT01907828|17625554|P1|Overall Study|Withdrawal by Subject|3
5103158|NCT01907828|17625553|P2|Overall Study|Exclusion criteria not met|1
5103159|NCT01907828|17625554|P1|Overall Study|Exclusion criteria not met|0
5103160|NCT01907815|17625582|P2|Overall Study|Withdrawal by Subject|0
5103161|NCT01907815|17625583|P1|Overall Study|Withdrawal by Subject|1
5103162|NCT01907737|17625597|P1|Overall Study|Withdrawal by Subject|1
5103163|NCT01907516|17625609|P2|First Intervention (3 Weeks)|Developed DKA during study|0
5103164|NCT01907516|17625610|P1|First Intervention (3 Weeks)|Developed DKA during study|1
5103165|NCT01907516|17625609|P2|First Intervention (3 Weeks)|Delivered before second arm|4
5103166|NCT01907516|17625610|P1|First Intervention (3 Weeks)|Delivered before second arm|3
5103167|NCT01907516|17625609|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
5103168|NCT01907516|17625610|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
5103169|NCT01907516|17625609|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
5103170|NCT01907516|17625610|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
5103171|NCT01907217|17625654|P2|Overall Study|Withdrawal by Subject|2
5103172|NCT01907217|17625655|P1|Overall Study|Withdrawal by Subject|0
5103173|NCT01907100|17625767|P4|Overall Study|Worsening/AE underlying cancer disease|8
5103174|NCT01907100|17625768|P3|Overall Study|Worsening/AE underlying cancer disease|8
5103175|NCT01907100|17625769|P2|Overall Study|Worsening/AE underlying cancer disease|0
5103176|NCT01907100|17625770|P1|Overall Study|Worsening/AE underlying cancer disease|0
5103177|NCT01907100|17625767|P4|Overall Study|Adverse event (AE)|23
5103178|NCT01907100|17625768|P3|Overall Study|Adverse event (AE)|22
5103179|NCT01907100|17625769|P2|Overall Study|Adverse event (AE)|3
5103180|NCT01907100|17625770|P1|Overall Study|Adverse event (AE)|6
5103181|NCT01907100|17625767|P4|Overall Study|Other than reasons specified|6
5103182|NCT01907100|17625768|P3|Overall Study|Other than reasons specified|10
5103183|NCT01907100|17625769|P2|Overall Study|Other than reasons specified|0
5103184|NCT01907100|17625770|P1|Overall Study|Other than reasons specified|1
5103185|NCT01907100|17625767|P4|Overall Study|Not treated|2
5103186|NCT01907100|17625768|P3|Overall Study|Not treated|1
5103187|NCT01907100|17625769|P2|Overall Study|Not treated|0
5103188|NCT01907100|17625770|P1|Overall Study|Not treated|2
5103189|NCT01907100|17625767|P4|Overall Study|Lost to Follow-up|1
5103190|NCT01907100|17625768|P3|Overall Study|Lost to Follow-up|0
5103191|NCT01907100|17625769|P2|Overall Study|Lost to Follow-up|0
5103192|NCT01907100|17625770|P1|Overall Study|Lost to Follow-up|0
5103193|NCT01907100|17625767|P4|Overall Study|Protocol Violation|1
5103194|NCT01907100|17625768|P3|Overall Study|Protocol Violation|1
5103195|NCT01907100|17625769|P2|Overall Study|Protocol Violation|0
5103196|NCT01907100|17625770|P1|Overall Study|Protocol Violation|0
5103197|NCT01907100|17625767|P4|Overall Study|Withdrawal by Subject|13
5103198|NCT01907100|17625768|P3|Overall Study|Withdrawal by Subject|10
5103199|NCT01907100|17625769|P2|Overall Study|Withdrawal by Subject|5
5103200|NCT01907100|17625770|P1|Overall Study|Withdrawal by Subject|2
5103201|NCT01907100|17625767|P4|Overall Study|PD based on modified RECIST criteria|92
5103202|NCT01907100|17625768|P3|Overall Study|PD based on modified RECIST criteria|95
5103203|NCT01907100|17625769|P2|Overall Study|PD based on modified RECIST criteria|32
5103204|NCT01907100|17625770|P1|Overall Study|PD based on modified RECIST criteria|31
5103205|NCT01907087|17625784|P1|Overall Study|Withdrawal by Subject|1
5103206|NCT01906476|17625847|P2|Overall Study|Lost to Follow-up|16
5103207|NCT01906476|17625848|P1|Overall Study|Lost to Follow-up|17
5103208|NCT01906372|17625856|P1|Overall Study|Withdrawal by Subject|2
5103209|NCT01906346|17625861|P1|Overall Study|AEs|1
5103210|NCT01906008|17625869|P2|Overall Study|Adverse Event|3
5103211|NCT01906008|17625870|P1|Overall Study|Adverse Event|0
5103212|NCT01906008|17625869|P2|Overall Study|Lack of compliance of study med|3
5103213|NCT01906008|17625870|P1|Overall Study|Lack of compliance of study med|5
5103214|NCT01906008|17625869|P2|Overall Study|Physician Decision|3
5103215|NCT01906008|17625870|P1|Overall Study|Physician Decision|3
5103216|NCT01906008|17625869|P2|Overall Study|Hospice|0
5103217|NCT01906008|17625870|P1|Overall Study|Hospice|1
5103218|NCT01906008|17625869|P2|Overall Study|Oxaliplatin stops|8
5103219|NCT01906008|17625870|P1|Overall Study|Oxaliplatin stops|10
5103220|NCT01906008|17625869|P2|Overall Study|Did not start study med|4
5103221|NCT01906008|17625870|P1|Overall Study|Did not start study med|3
5103222|NCT01906008|17625869|P2|Overall Study|Withdrawal by Subject|5
5103223|NCT01906008|17625870|P1|Overall Study|Withdrawal by Subject|1
5103224|NCT01906008|17625869|P2|Overall Study|Protocol Violation|1
5103225|NCT01906008|17625870|P1|Overall Study|Protocol Violation|0
5103226|NCT01906008|17625869|P2|Overall Study|Oxaliplatin toxicity|0
5103227|NCT01906008|17625870|P1|Overall Study|Oxaliplatin toxicity|2
5103228|NCT01906008|17625869|P2|Overall Study|Lost to Follow-up|0
5103229|NCT01906008|17625870|P1|Overall Study|Lost to Follow-up|2
5103230|NCT01905943|17625903|P1|Overall Study|Other|12
5103231|NCT01905943|17625903|P1|Overall Study|Adverse Event|3
5103232|NCT01905943|17625903|P1|Overall Study|Death|186
5103233|NCT01905943|17625903|P1|Overall Study|Investigator discretion|7
5103234|NCT01905943|17625903|P1|Overall Study|Lost to Follow-up|16
5103235|NCT01905943|17625903|P1|Overall Study|Withdrawal of consent|90
5103236|NCT01905683|17626020|P1|Overall Study|Lost to Follow-up|4
5103237|NCT01905683|17626020|P1|Overall Study|Adverse Event|4
5103238|NCT01905683|17626020|P1|Overall Study|Withdrawal by Subject|20
5103239|NCT01905683|17626020|P1|Overall Study|Lack of Efficacy|8
5103240|NCT01905683|17626020|P1|Overall Study|Physician Decision|1
5103241|NCT01905683|17626020|P1|Overall Study|Re-injection criteria not met; others|13
5103242|NCT01905683|17626020|P1|Overall Study|Protocol Violation|1
5103243|NCT01905657|17626036|P3|Overall Study|Excluded from Efficacy Analysis|0
5103244|NCT01905657|17626037|P2|Overall Study|Excluded from Efficacy Analysis|0
5103245|NCT01905657|17626038|P1|Overall Study|Excluded from Efficacy Analysis|1
5103246|NCT01905657|17626036|P3|Overall Study|Continuing in Study|11
5103247|NCT01905657|17626037|P2|Overall Study|Continuing in Study|74
5103248|NCT01905657|17626038|P1|Overall Study|Continuing in Study|74
5103249|NCT01905657|17626036|P3|Overall Study|Withdrawal by Subject|45
5103250|NCT01905657|17626037|P2|Overall Study|Withdrawal by Subject|10
5103251|NCT01905657|17626038|P1|Overall Study|Withdrawal by Subject|5
5103252|NCT01905657|17626036|P3|Overall Study|Protocol Violation|1
5103253|NCT01905657|17626037|P2|Overall Study|Protocol Violation|1
5103254|NCT01905657|17626038|P1|Overall Study|Protocol Violation|2
5103255|NCT01905657|17626036|P3|Overall Study|Progressive Disease|89
5103256|NCT01905657|17626037|P2|Overall Study|Progressive Disease|126
5103257|NCT01905657|17626038|P1|Overall Study|Progressive Disease|124
5103258|NCT01905657|17626036|P3|Overall Study|Physician Decision|113
5103259|NCT01905657|17626037|P2|Overall Study|Physician Decision|74
5103260|NCT01905657|17626038|P1|Overall Study|Physician Decision|82
5103261|NCT01905657|17626036|P3|Overall Study|Other|1
5103262|NCT01905657|17626037|P2|Overall Study|Other|7
5103263|NCT01905657|17626038|P1|Overall Study|Other|3
5103264|NCT01905657|17626036|P3|Overall Study|Death|21
5103265|NCT01905657|17626037|P2|Overall Study|Death|21
5103266|NCT01905657|17626038|P1|Overall Study|Death|21
5103267|NCT01905657|17626036|P3|Overall Study|Adverse Event|47
5103268|NCT01905657|17626037|P2|Overall Study|Adverse Event|32
5103269|NCT01905657|17626038|P1|Overall Study|Adverse Event|33
5103270|NCT01905657|17626036|P3|Overall Study|Not Treated|0
5103271|NCT01905657|17626037|P2|Overall Study|Not Treated|1
5103272|NCT01905657|17626038|P1|Overall Study|Not Treated|0
5103273|NCT01905592|17626063|P2|Overall Study|Withdrawal by Subject|2
5103274|NCT01905592|17626064|P1|Overall Study|Withdrawal by Subject|10
5103275|NCT01905592|17626063|P2|Overall Study|Ongoing in Study|7
5103276|NCT01905592|17626064|P1|Overall Study|Ongoing in Study|0
5103277|NCT01905592|17626063|P2|Overall Study|Not treated|3
5103278|NCT01905592|17626064|P1|Overall Study|Not treated|7
5103279|NCT01905592|17626063|P2|Overall Study|Sponsor's decision|0
5103280|NCT01905592|17626064|P1|Overall Study|Sponsor's decision|1
5103281|NCT01905592|17626063|P2|Overall Study|Protocol Violation|1
5103282|NCT01905592|17626064|P1|Overall Study|Protocol Violation|0
5103283|NCT01905592|17626063|P2|Overall Study|New anti-cancer|0
5103284|NCT01905592|17626064|P1|Overall Study|New anti-cancer|1
5103285|NCT01905592|17626063|P2|Overall Study|Physician Decision|2
5103286|NCT01905592|17626064|P1|Overall Study|Physician Decision|0
5103287|NCT01905592|17626063|P2|Overall Study|Toxicity|16
5103288|NCT01905592|17626064|P1|Overall Study|Toxicity|1
5103289|NCT01905592|17626063|P2|Overall Study|Disease Progression|104
5103290|NCT01905592|17626064|P1|Overall Study|Disease Progression|51
5103291|NCT01905553|17626078|P2|Period 2|Adverse Event|0
5103292|NCT01905553|17626079|P1|Period 2|Adverse Event|1
5103293|NCT01905540|17626093|P4|Period 3|Other|1
5103294|NCT01905540|17626094|P3|Period 3|Other|1
5103295|NCT01905540|17626095|P2|Period 3|Other|0
5103296|NCT01905540|17626096|P1|Period 3|Other|1
5103297|NCT01905267|17626162|P2|Overall Study|Physician Decision|2
5103298|NCT01905267|17626163|P1|Overall Study|Physician Decision|2
5103299|NCT01904773|17626184|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103300|NCT01904773|17626185|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103301|NCT01904773|17626186|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103302|NCT01904773|17626187|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103303|NCT01904773|17626188|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103304|NCT01904773|17626189|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103305|NCT01904773|17626190|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103306|NCT01904773|17626191|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
5103307|NCT01904773|17626192|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5103308|NCT01904773|17626184|P9|Fifth Intervention|Adverse Event|0
5103309|NCT01904773|17626185|P8|Fifth Intervention|Adverse Event|1
5103310|NCT01904773|17626186|P7|Fifth Intervention|Adverse Event|0
5103311|NCT01904773|17626187|P6|Fifth Intervention|Adverse Event|0
5103312|NCT01904773|17626188|P5|Fifth Intervention|Adverse Event|0
5103313|NCT01904773|17626189|P4|Fifth Intervention|Adverse Event|0
5103314|NCT01904773|17626190|P3|Fifth Intervention|Adverse Event|0
5103315|NCT01904773|17626191|P2|Fifth Intervention|Adverse Event|0
5103316|NCT01904773|17626192|P1|Fifth Intervention|Adverse Event|0
5103317|NCT01904773|17626184|P9|Placebo Washout First Intervention|Condition worsened|0
5103318|NCT01904773|17626185|P8|Placebo Washout First Intervention|Condition worsened|0
5103319|NCT01904773|17626186|P7|Placebo Washout First Intervention|Condition worsened|0
5103320|NCT01904773|17626187|P6|Placebo Washout First Intervention|Condition worsened|0
5103321|NCT01904773|17626188|P5|Placebo Washout First Intervention|Condition worsened|0
5103322|NCT01904773|17626189|P4|Placebo Washout First Intervention|Condition worsened|0
5103323|NCT01904773|17626190|P3|Placebo Washout First Intervention|Condition worsened|0
5103324|NCT01904773|17626191|P2|Placebo Washout First Intervention|Condition worsened|1
5103325|NCT01904773|17626192|P1|Placebo Washout First Intervention|Condition worsened|0
5103326|NCT01904773|17626184|P9|First Intervention|Adverse Event|0
5103327|NCT01904773|17626185|P8|First Intervention|Adverse Event|0
5103328|NCT01904773|17626186|P7|First Intervention|Adverse Event|1
5103329|NCT01904773|17626187|P6|First Intervention|Adverse Event|0
5103330|NCT01904773|17626188|P5|First Intervention|Adverse Event|0
5103331|NCT01904773|17626189|P4|First Intervention|Adverse Event|0
5103332|NCT01904773|17626190|P3|First Intervention|Adverse Event|0
5103333|NCT01904773|17626191|P2|First Intervention|Adverse Event|0
5103334|NCT01904773|17626192|P1|First Intervention|Adverse Event|0
5103335|NCT01904773|17626184|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103336|NCT01904773|17626185|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103337|NCT01904773|17626186|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103338|NCT01904773|17626187|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103339|NCT01904773|17626188|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103340|NCT01904773|17626189|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103341|NCT01904773|17626190|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103342|NCT01904773|17626191|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5103343|NCT01904773|17626192|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
5103344|NCT01904773|17626184|P9|Screen|Withdrawal by Subject|0
5103345|NCT01904773|17626185|P8|Screen|Withdrawal by Subject|0
5103346|NCT01904773|17626186|P7|Screen|Withdrawal by Subject|0
5103347|NCT01904773|17626187|P6|Screen|Withdrawal by Subject|0
5103348|NCT01904773|17626188|P5|Screen|Withdrawal by Subject|0
5103349|NCT01904773|17626189|P4|Screen|Withdrawal by Subject|0
5103350|NCT01904773|17626190|P3|Screen|Withdrawal by Subject|0
5103351|NCT01904773|17626191|P2|Screen|Withdrawal by Subject|0
5103352|NCT01904773|17626192|P1|Screen|Withdrawal by Subject|1
5103353|NCT01904773|17626184|P9|Screen|Screen failure|0
5103354|NCT01904773|17626185|P8|Screen|Screen failure|0
5103355|NCT01904773|17626186|P7|Screen|Screen failure|0
5103356|NCT01904773|17626187|P6|Screen|Screen failure|0
5103357|NCT01904773|17626188|P5|Screen|Screen failure|0
5103358|NCT01904773|17626189|P4|Screen|Screen failure|0
5103359|NCT01904773|17626190|P3|Screen|Screen failure|0
5103360|NCT01904773|17626191|P2|Screen|Screen failure|0
5103361|NCT01904773|17626192|P1|Screen|Screen failure|3
5103362|NCT01904760|17626209|P2|Overall Study|Protocol Violation|0
5103363|NCT01904760|17626210|P1|Overall Study|Protocol Violation|1
5103364|NCT01904721|17626225|P7|Overall Study|Adverse Event|0
5103365|NCT01904721|17626226|P6|Overall Study|Adverse Event|1
5103366|NCT01904721|17626227|P5|Overall Study|Adverse Event|3
5103367|NCT01904721|17626228|P4|Overall Study|Adverse Event|0
5103368|NCT01904721|17626229|P3|Overall Study|Adverse Event|0
5103369|NCT01904721|17626230|P2|Overall Study|Adverse Event|0
5103370|NCT01904721|17626231|P1|Overall Study|Adverse Event|0
5103371|NCT01904721|17626225|P7|Overall Study|Lack of Efficacy|1
5103372|NCT01904721|17626226|P6|Overall Study|Lack of Efficacy|0
5103373|NCT01904721|17626227|P5|Overall Study|Lack of Efficacy|0
5103374|NCT01904721|17626228|P4|Overall Study|Lack of Efficacy|0
5103375|NCT01904721|17626229|P3|Overall Study|Lack of Efficacy|0
5103376|NCT01904721|17626230|P2|Overall Study|Lack of Efficacy|0
5103377|NCT01904721|17626231|P1|Overall Study|Lack of Efficacy|0
5103378|NCT01904721|17626225|P7|Overall Study|Lost to Follow-up|1
5103379|NCT01904721|17626226|P6|Overall Study|Lost to Follow-up|3
5103380|NCT01904721|17626227|P5|Overall Study|Lost to Follow-up|1
5103381|NCT01904721|17626228|P4|Overall Study|Lost to Follow-up|0
5103382|NCT01904721|17626229|P3|Overall Study|Lost to Follow-up|0
5103383|NCT01904721|17626230|P2|Overall Study|Lost to Follow-up|0
5103384|NCT01904721|17626231|P1|Overall Study|Lost to Follow-up|0
5103385|NCT01904721|17626225|P7|Overall Study|Personal Reasons|3
5103386|NCT01904721|17626226|P6|Overall Study|Personal Reasons|3
5103387|NCT01904721|17626227|P5|Overall Study|Personal Reasons|2
5103388|NCT01904721|17626228|P4|Overall Study|Personal Reasons|0
5103389|NCT01904721|17626229|P3|Overall Study|Personal Reasons|0
5103390|NCT01904721|17626230|P2|Overall Study|Personal Reasons|0
5103391|NCT01904721|17626231|P1|Overall Study|Personal Reasons|0
5103392|NCT01904721|17626225|P7|Overall Study|Other Reasons|2
5103393|NCT01904721|17626226|P6|Overall Study|Other Reasons|2
5103394|NCT01904721|17626227|P5|Overall Study|Other Reasons|2
5103395|NCT01904721|17626228|P4|Overall Study|Other Reasons|1
5103396|NCT01904721|17626229|P3|Overall Study|Other Reasons|1
5103397|NCT01904721|17626230|P2|Overall Study|Other Reasons|0
5103398|NCT01904721|17626231|P1|Overall Study|Other Reasons|0
5103399|NCT01904604|17626261|P3|Overall Study|Lost to Follow-up|1
5103400|NCT01904604|17626262|P2|Overall Study|Lost to Follow-up|0
5103401|NCT01904604|17626263|P1|Overall Study|Lost to Follow-up|0
5103402|NCT01904604|17626261|P3|Overall Study|Participant Relocated|1
5103403|NCT01904604|17626262|P2|Overall Study|Participant Relocated|1
5103404|NCT01904604|17626263|P1|Overall Study|Participant Relocated|1
5103405|NCT01904604|17626261|P3|Overall Study|Withdrawal by Subject|0
5103406|NCT01904604|17626262|P2|Overall Study|Withdrawal by Subject|2
5103407|NCT01904604|17626263|P1|Overall Study|Withdrawal by Subject|1
5103408|NCT01904604|17626261|P3|Overall Study|Passed Week 52 OFC|0
5103409|NCT01904604|17626262|P2|Overall Study|Passed Week 52 OFC|0
5103410|NCT01904604|17626263|P1|Overall Study|Passed Week 52 OFC|1
5103411|NCT01904604|17626261|P3|Overall Study|Unrelated illness|0
5103412|NCT01904604|17626262|P2|Overall Study|Unrelated illness|1
5103413|NCT01904604|17626263|P1|Overall Study|Unrelated illness|0
5103414|NCT01904604|17626261|P3|Overall Study|Increased syncope|0
5103415|NCT01904604|17626262|P2|Overall Study|Increased syncope|1
5103416|NCT01904604|17626263|P1|Overall Study|Increased syncope|0
5103417|NCT01904604|17626261|P3|Overall Study|Patch site reactions|0
5103418|NCT01904604|17626262|P2|Overall Study|Patch site reactions|1
5103419|NCT01904604|17626263|P1|Overall Study|Patch site reactions|1
5103420|NCT01904604|17626261|P3|Overall Study|Anxiety about OFC/Refused OFC|0
5103421|NCT01904604|17626262|P2|Overall Study|Anxiety about OFC/Refused OFC|0
5103422|NCT01904604|17626263|P1|Overall Study|Anxiety about OFC/Refused OFC|2
5103423|NCT01904604|17626261|P3|Overall Study|Non-compliance|0
5103424|NCT01904604|17626262|P2|Overall Study|Non-compliance|0
5103425|NCT01904604|17626263|P1|Overall Study|Non-compliance|1
5103426|NCT01904604|17626261|P3|Overall Study|Withdrew before receiving dosing|0
5103427|NCT01904604|17626262|P2|Overall Study|Withdrew before receiving dosing|1
5103428|NCT01904604|17626263|P1|Overall Study|Withdrew before receiving dosing|0
5103429|NCT01904383|17626328|P1|Overall Study|No patient visit after entry|54
5103430|NCT01904383|17626328|P1|Overall Study|Adverse Event|271
5103431|NCT01904383|17626328|P1|Overall Study|Improvement|141
5103432|NCT01904383|17626328|P1|Overall Study|Lack of Efficacy|370
5103433|NCT01904383|17626328|P1|Overall Study|Lost to Follow-up|674
5103434|NCT01904383|17626328|P1|Overall Study|Reason not listed|147
5103435|NCT01904383|17626328|P1|Overall Study|CRF not collected|117
5103436|NCT01904279|17626335|P2|Overall Study|Withdrawal by Subject|0
5103437|NCT01904279|17626336|P1|Overall Study|Withdrawal by Subject|1
5103438|NCT01904279|17626335|P2|Overall Study|Lack of Efficacy|3
5103439|NCT01904279|17626336|P1|Overall Study|Lack of Efficacy|2
5103440|NCT01904149|17626362|P6|Overall Study|non compliance with study drug|0
5103441|NCT01904149|17626363|P5|Overall Study|non compliance with study drug|0
5103442|NCT01904149|17626364|P4|Overall Study|non compliance with study drug|0
5103443|NCT01904149|17626365|P3|Overall Study|non compliance with study drug|0
5103444|NCT01904149|17626366|P2|Overall Study|non compliance with study drug|0
5103445|NCT01904149|17626367|P1|Overall Study|non compliance with study drug|1
5103446|NCT01904149|17626362|P6|Overall Study|Protocol Violation|0
5103447|NCT01904149|17626363|P5|Overall Study|Protocol Violation|0
5103448|NCT01904149|17626364|P4|Overall Study|Protocol Violation|0
5103449|NCT01904149|17626365|P3|Overall Study|Protocol Violation|0
5103450|NCT01904149|17626366|P2|Overall Study|Protocol Violation|1
5103451|NCT01904149|17626367|P1|Overall Study|Protocol Violation|0
5103452|NCT01904149|17626362|P6|Overall Study|Withdrawal by Subject|0
5103453|NCT01904149|17626363|P5|Overall Study|Withdrawal by Subject|1
5103454|NCT01904149|17626364|P4|Overall Study|Withdrawal by Subject|0
5103455|NCT01904149|17626365|P3|Overall Study|Withdrawal by Subject|1
5103456|NCT01904149|17626366|P2|Overall Study|Withdrawal by Subject|3
5103457|NCT01904149|17626367|P1|Overall Study|Withdrawal by Subject|1
5103458|NCT01904149|17626362|P6|Overall Study|Lack of Efficacy|1
5103459|NCT01904149|17626363|P5|Overall Study|Lack of Efficacy|3
5103460|NCT01904149|17626364|P4|Overall Study|Lack of Efficacy|3
5103461|NCT01904149|17626365|P3|Overall Study|Lack of Efficacy|1
5103462|NCT01904149|17626366|P2|Overall Study|Lack of Efficacy|3
5103463|NCT01904149|17626367|P1|Overall Study|Lack of Efficacy|0
5103464|NCT01904149|17626362|P6|Overall Study|Adverse Event|2
5103465|NCT01904149|17626363|P5|Overall Study|Adverse Event|1
5103466|NCT01904149|17626364|P4|Overall Study|Adverse Event|1
5103467|NCT01904149|17626365|P3|Overall Study|Adverse Event|0
5103468|NCT01904149|17626366|P2|Overall Study|Adverse Event|4
5103469|NCT01904149|17626367|P1|Overall Study|Adverse Event|3
5103470|NCT01904058|17626418|P4|Overall Study|Pregnancy|1
5103471|NCT01904058|17626419|P3|Overall Study|Pregnancy|0
5103472|NCT01904058|17626420|P2|Overall Study|Pregnancy|0
5103473|NCT01904058|17626421|P1|Overall Study|Pregnancy|0
5103474|NCT01904058|17626418|P4|Overall Study|Withdrawal by Subject|0
5103475|NCT01904058|17626419|P3|Overall Study|Withdrawal by Subject|1
5103476|NCT01904058|17626420|P2|Overall Study|Withdrawal by Subject|0
5103477|NCT01904058|17626421|P1|Overall Study|Withdrawal by Subject|1
5103478|NCT01904058|17626418|P4|Overall Study|Adverse Event|0
5103479|NCT01904058|17626419|P3|Overall Study|Adverse Event|0
5103480|NCT01904058|17626420|P2|Overall Study|Adverse Event|0
5103481|NCT01904058|17626421|P1|Overall Study|Adverse Event|2
5103482|NCT01903993|17626461|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
5103483|NCT01903993|17626462|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
5103484|NCT01903993|17626461|P2|Overall Study|Study Terminated by Sponsor|14
5103485|NCT01903993|17626462|P1|Overall Study|Study Terminated by Sponsor|8
5103486|NCT01903993|17626461|P2|Overall Study|Lost to Follow-up|3
5103487|NCT01903993|17626462|P1|Overall Study|Lost to Follow-up|2
5103488|NCT01903993|17626461|P2|Overall Study|Withdrawal by Subject|4
5103489|NCT01903993|17626462|P1|Overall Study|Withdrawal by Subject|15
5103490|NCT01903993|17626461|P2|Overall Study|Death|121
5103491|NCT01903993|17626462|P1|Overall Study|Death|118
5103492|NCT01903876|17626479|P2|Six-Month Follow-up Period|Lost to Follow-up|145
5103493|NCT01903876|17626480|P1|Six-Month Follow-up Period|Lost to Follow-up|91
5103494|NCT01903876|17626479|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
5103495|NCT01903876|17626480|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
5103496|NCT01903863|17626490|P2|Overall Study|Physician Decision|0
5103497|NCT01903863|17626491|P1|Overall Study|Physician Decision|2
5103498|NCT01903811|17626513|P2|Overall Study|Withdrawal by Subject|1
5103499|NCT01903811|17626514|P1|Overall Study|Withdrawal by Subject|0
5103500|NCT01903811|17626513|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
5103501|NCT01903811|17626514|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
5103502|NCT01903811|17626513|P2|Overall Study|Incomplete/discontinued prior therapy|1
5103503|NCT01903811|17626514|P1|Overall Study|Incomplete/discontinued prior therapy|1
5103504|NCT01903811|17626513|P2|Overall Study|No measurable disease|1
5103505|NCT01903811|17626514|P1|Overall Study|No measurable disease|1
5103506|NCT01903720|17626548|P1|Overall Study|Treatment with alternative drug|1
5103507|NCT01903720|17626548|P1|Overall Study|Lost to Follow-up|2
5103508|NCT01903720|17626548|P1|Overall Study|Rescinding of informed consent|2
5103509|NCT01903720|17626548|P1|Overall Study|Adverse Event|1
5103510|NCT01903720|17626548|P1|Overall Study|Inclusion / exclusion criteria not met|6
5103511|NCT01903460|17626586|P4|Overall Study|Adverse Event|1
5103512|NCT01903460|17626587|P3|Overall Study|Adverse Event|0
5103513|NCT01903460|17626588|P2|Overall Study|Adverse Event|0
5103514|NCT01903460|17626589|P1|Overall Study|Adverse Event|0
5103515|NCT01903434|17626606|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
5103516|NCT01903434|17626607|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
5103517|NCT01903434|17626606|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
5103518|NCT01903434|17626607|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
5103519|NCT01903356|17626615|P1|Overall Study|Violated the dosage and administration|3
5103520|NCT01903356|17626615|P1|Overall Study|Violated inclusion/exclusion criteria|5
5103521|NCT01903356|17626615|P1|Overall Study|Lost to Follow-up|7
5103522|NCT01903252|17626642|P6|Maintenance, Open-Label|Other|2
5103523|NCT01903252|17626643|P5|Maintenance, Open-Label|Other|6
5103524|NCT01903252|17626644|P4|Maintenance, Open-Label|Other|2
5103525|NCT01903252|17626645|P3|Maintenance, Open-Label|Other|0
5103526|NCT01903252|17626646|P2|Maintenance, Open-Label|Other|0
5103527|NCT01903252|17626647|P1|Maintenance, Open-Label|Other|0
5103528|NCT01903252|17626642|P6|Maintenance, Open-Label|Withdrawal by Subject|2
5103529|NCT01903252|17626643|P5|Maintenance, Open-Label|Withdrawal by Subject|6
5103530|NCT01903252|17626644|P4|Maintenance, Open-Label|Withdrawal by Subject|1
5103531|NCT01903252|17626645|P3|Maintenance, Open-Label|Withdrawal by Subject|0
5103532|NCT01903252|17626646|P2|Maintenance, Open-Label|Withdrawal by Subject|0
5103533|NCT01903252|17626647|P1|Maintenance, Open-Label|Withdrawal by Subject|0
5103534|NCT01903252|17626642|P6|Maintenance, Open-Label|Adverse Event|14
5103535|NCT01903252|17626643|P5|Maintenance, Open-Label|Adverse Event|9
5103536|NCT01903252|17626644|P4|Maintenance, Open-Label|Adverse Event|3
5103537|NCT01903252|17626645|P3|Maintenance, Open-Label|Adverse Event|0
5103538|NCT01903252|17626646|P2|Maintenance, Open-Label|Adverse Event|0
5103539|NCT01903252|17626647|P1|Maintenance, Open-Label|Adverse Event|0
5103540|NCT01903252|17626642|P6|Extended Induction, Open-Label|Physician Decision|0
5103541|NCT01903252|17626643|P5|Extended Induction, Open-Label|Physician Decision|0
5103542|NCT01903252|17626644|P4|Extended Induction, Open-Label|Physician Decision|0
5103543|NCT01903252|17626645|P3|Extended Induction, Open-Label|Physician Decision|1
5103544|NCT01903252|17626646|P2|Extended Induction, Open-Label|Physician Decision|0
5103545|NCT01903252|17626647|P1|Extended Induction, Open-Label|Physician Decision|0
5103546|NCT01903252|17626642|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
5103547|NCT01903252|17626643|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
5103548|NCT01903252|17626644|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
5103549|NCT01903252|17626645|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
5103550|NCT01903252|17626646|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
5103551|NCT01903252|17626647|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
5103552|NCT01903252|17626642|P6|Extended Induction, Open-Label|Adverse Event|0
5103553|NCT01903252|17626643|P5|Extended Induction, Open-Label|Adverse Event|0
5103554|NCT01903252|17626644|P4|Extended Induction, Open-Label|Adverse Event|0
5103555|NCT01903252|17626645|P3|Extended Induction, Open-Label|Adverse Event|17
5103556|NCT01903252|17626646|P2|Extended Induction, Open-Label|Adverse Event|0
5103557|NCT01903252|17626647|P1|Extended Induction, Open-Label|Adverse Event|0
5103558|NCT01903252|17626642|P6|Double-Blind Induction|non-compliance,|0
5103559|NCT01903252|17626643|P5|Double-Blind Induction|non-compliance,|0
5103560|NCT01903252|17626644|P4|Double-Blind Induction|non-compliance,|0
5103561|NCT01903252|17626645|P3|Double-Blind Induction|non-compliance,|0
5103562|NCT01903252|17626646|P2|Double-Blind Induction|non-compliance,|7
5103563|NCT01903252|17626647|P1|Double-Blind Induction|non-compliance,|7
5103564|NCT01903252|17626642|P6|Double-Blind Induction|Physician Decision|0
5103565|NCT01903252|17626643|P5|Double-Blind Induction|Physician Decision|0
5103566|NCT01903252|17626644|P4|Double-Blind Induction|Physician Decision|0
5103567|NCT01903252|17626645|P3|Double-Blind Induction|Physician Decision|0
5103568|NCT01903252|17626646|P2|Double-Blind Induction|Physician Decision|3
5103569|NCT01903252|17626647|P1|Double-Blind Induction|Physician Decision|2
5103570|NCT01903252|17626642|P6|Double-Blind Induction|Withdrawal by Subject|0
5103571|NCT01903252|17626643|P5|Double-Blind Induction|Withdrawal by Subject|0
5103572|NCT01903252|17626644|P4|Double-Blind Induction|Withdrawal by Subject|0
5103573|NCT01903252|17626645|P3|Double-Blind Induction|Withdrawal by Subject|0
5103574|NCT01903252|17626646|P2|Double-Blind Induction|Withdrawal by Subject|13
5103575|NCT01903252|17626647|P1|Double-Blind Induction|Withdrawal by Subject|10
5103576|NCT01903252|17626642|P6|Double-Blind Induction|Adverse Event|0
5103577|NCT01903252|17626643|P5|Double-Blind Induction|Adverse Event|0
5103578|NCT01903252|17626644|P4|Double-Blind Induction|Adverse Event|0
5103579|NCT01903252|17626645|P3|Double-Blind Induction|Adverse Event|0
5103580|NCT01903252|17626646|P2|Double-Blind Induction|Adverse Event|18
5103581|NCT01903252|17626647|P1|Double-Blind Induction|Adverse Event|20
5103582|NCT01903031|17626760|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
5103583|NCT01903031|17626761|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
5103584|NCT01903031|17626762|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
5103585|NCT01903031|17626760|P3|Overall Study|Lost to Follow-up|1
5103586|NCT01903031|17626761|P2|Overall Study|Lost to Follow-up|0
5103587|NCT01903031|17626762|P1|Overall Study|Lost to Follow-up|0
5103588|NCT01903031|17626760|P3|Overall Study|Protocol Violation|2
5103589|NCT01903031|17626761|P2|Overall Study|Protocol Violation|0
5103590|NCT01903031|17626762|P1|Overall Study|Protocol Violation|0
5103591|NCT01903031|17626760|P3|Overall Study|Withdrawal by Subject|1
5103592|NCT01903031|17626761|P2|Overall Study|Withdrawal by Subject|1
5103593|NCT01903031|17626762|P1|Overall Study|Withdrawal by Subject|0
5103594|NCT01903031|17626760|P3|Overall Study|Adverse Event|0
5103595|NCT01903031|17626761|P2|Overall Study|Adverse Event|1
5103596|NCT01903031|17626762|P1|Overall Study|Adverse Event|0
5103597|NCT01903031|17626760|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
5103598|NCT01903031|17626761|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
5103599|NCT01903031|17626762|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
5103600|NCT01903031|17626760|P3|Overall Study|Not Able to Attend Clinic|0
5103601|NCT01903031|17626761|P2|Overall Study|Not Able to Attend Clinic|1
5103602|NCT01903031|17626762|P1|Overall Study|Not Able to Attend Clinic|1
5103603|NCT01902888|17626836|P1|Overall Study|Study Terminated|3
5103604|NCT01902628|17626850|P1|Overall Study|Lost to Follow-up|35
5103605|NCT01902628|17626850|P1|Overall Study|Adverse Event|41
5103606|NCT01902628|17626850|P1|Overall Study|Withdrawal of participant's consent|7
5103607|NCT01902303|17626878|P2|Overall Study|Did not develop a cold sore|19
5103608|NCT01902303|17626879|P1|Overall Study|Did not develop a cold sore|21
5103609|NCT01902303|17626878|P2|Overall Study|subject lost investigational product|1
5103610|NCT01902303|17626879|P1|Overall Study|subject lost investigational product|0
5103611|NCT01902303|17626878|P2|Overall Study|Protocol Violation|2
5103612|NCT01902303|17626879|P1|Overall Study|Protocol Violation|2
5103613|NCT01902303|17626878|P2|Overall Study|Lost to Follow-up|1
5103614|NCT01902303|17626879|P1|Overall Study|Lost to Follow-up|0
5103615|NCT01902303|17626878|P2|Overall Study|Adverse Event|1
5103616|NCT01902303|17626879|P1|Overall Study|Adverse Event|0
5103617|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 4|Death|1
5103618|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 4|Death|0
5103619|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 4|Death|0
5103620|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 4|Death|0
5103621|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 4|Death|0
5103622|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 4|Death|0
5103623|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
5103624|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5103625|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5103626|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5103627|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5103628|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5103629|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
5103630|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5103631|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5103632|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5103633|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5103634|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5103635|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5103636|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
5103637|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5103638|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5103639|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5103640|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5103641|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5103642|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
5103643|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5103644|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5103645|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5103646|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5103647|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5103648|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5103649|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
5103650|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5103651|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5103652|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5103653|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5103654|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5103655|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
5103656|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5103657|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5103658|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5103659|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5103660|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5103661|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5103662|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
5103663|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5103664|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5103665|NCT01902173|17626893|P6|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5103666|NCT01902173|17626894|P5|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5103667|NCT01902173|17626895|P4|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5103668|NCT01902173|17626896|P3|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
5103669|NCT01902173|17626897|P2|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5103670|NCT01902173|17626898|P1|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5103671|NCT01902173|17626893|P6|Phase 1 Doublet Regimen Cohort 2|No treated|0
5103672|NCT01902173|17626894|P5|Phase 1 Doublet Regimen Cohort 2|No treated|0
5103673|NCT01902173|17626895|P4|Phase 1 Doublet Regimen Cohort 2|No treated|0
5103674|NCT01902173|17626896|P3|Phase 1 Doublet Regimen Cohort 2|No treated|0
5103675|NCT01902173|17626897|P2|Phase 1 Doublet Regimen Cohort 2|No treated|3
5103676|NCT01902173|17626898|P1|Phase 1 Doublet Regimen Cohort 2|No treated|0
5103677|NCT01902173|17626893|P6|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5103678|NCT01902173|17626894|P5|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5103679|NCT01902173|17626895|P4|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5103680|NCT01902173|17626896|P3|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5103681|NCT01902173|17626897|P2|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
5103682|NCT01902173|17626898|P1|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5103683|NCT01902173|17626893|P6|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5103684|NCT01902173|17626894|P5|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5103685|NCT01902173|17626895|P4|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5103686|NCT01902173|17626896|P3|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5103687|NCT01902173|17626897|P2|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
5103688|NCT01902173|17626898|P1|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5103689|NCT01902173|17626893|P6|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5103690|NCT01902173|17626894|P5|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5103691|NCT01902173|17626895|P4|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5103692|NCT01902173|17626896|P3|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5103693|NCT01902173|17626897|P2|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5103694|NCT01902173|17626898|P1|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
5103695|NCT01902173|17626893|P6|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5103696|NCT01902173|17626894|P5|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5103697|NCT01902173|17626895|P4|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5103698|NCT01902173|17626896|P3|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5103699|NCT01902173|17626897|P2|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5103700|NCT01902173|17626898|P1|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
5103701|NCT01902134|17626921|P6|Overall Study|Other|0
5103702|NCT01902134|17626922|P5|Overall Study|Other|1
5103703|NCT01902134|17626923|P4|Overall Study|Other|0
5103704|NCT01902134|17626924|P3|Overall Study|Other|2
5103705|NCT01902134|17626925|P2|Overall Study|Other|1
5103706|NCT01902134|17626926|P1|Overall Study|Other|0
5103707|NCT01902134|17626921|P6|Overall Study|no compliance|0
5103708|NCT01902134|17626922|P5|Overall Study|no compliance|0
5103709|NCT01902134|17626923|P4|Overall Study|no compliance|0
5103710|NCT01902134|17626924|P3|Overall Study|no compliance|0
5103711|NCT01902134|17626925|P2|Overall Study|no compliance|0
5103712|NCT01902134|17626926|P1|Overall Study|no compliance|1
5103713|NCT01902134|17626921|P6|Overall Study|Withdrawal by Subject|4
5103714|NCT01902134|17626922|P5|Overall Study|Withdrawal by Subject|5
5103715|NCT01902134|17626923|P4|Overall Study|Withdrawal by Subject|1
5103716|NCT01902134|17626924|P3|Overall Study|Withdrawal by Subject|9
5103717|NCT01902134|17626925|P2|Overall Study|Withdrawal by Subject|8
5103718|NCT01902134|17626926|P1|Overall Study|Withdrawal by Subject|4
5103719|NCT01902134|17626921|P6|Overall Study|Protocol Violation|1
5103720|NCT01902134|17626922|P5|Overall Study|Protocol Violation|0
5103721|NCT01902134|17626923|P4|Overall Study|Protocol Violation|0
5103722|NCT01902134|17626924|P3|Overall Study|Protocol Violation|0
5103723|NCT01902134|17626925|P2|Overall Study|Protocol Violation|0
5103724|NCT01902134|17626926|P1|Overall Study|Protocol Violation|0
5103725|NCT01902134|17626921|P6|Overall Study|Physician Decision|0
5103726|NCT01902134|17626922|P5|Overall Study|Physician Decision|0
5103727|NCT01902134|17626923|P4|Overall Study|Physician Decision|0
5103728|NCT01902134|17626924|P3|Overall Study|Physician Decision|0
5103729|NCT01902134|17626925|P2|Overall Study|Physician Decision|1
5103730|NCT01902134|17626926|P1|Overall Study|Physician Decision|0
5103731|NCT01902134|17626921|P6|Overall Study|Lack of Efficacy|1
5103732|NCT01902134|17626922|P5|Overall Study|Lack of Efficacy|0
5103733|NCT01902134|17626923|P4|Overall Study|Lack of Efficacy|0
5103734|NCT01902134|17626924|P3|Overall Study|Lack of Efficacy|2
5103735|NCT01902134|17626925|P2|Overall Study|Lack of Efficacy|0
5103736|NCT01902134|17626926|P1|Overall Study|Lack of Efficacy|0
5103737|NCT01902134|17626921|P6|Overall Study|Adverse Event|3
5103738|NCT01902134|17626922|P5|Overall Study|Adverse Event|1
5103739|NCT01902134|17626923|P4|Overall Study|Adverse Event|1
5103740|NCT01902134|17626924|P3|Overall Study|Adverse Event|2
5103741|NCT01902134|17626925|P2|Overall Study|Adverse Event|1
5103742|NCT01902134|17626926|P1|Overall Study|Adverse Event|3
5103743|NCT01901874|17626963|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
5103744|NCT01901874|17626963|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
5103745|NCT01901874|17626963|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
5103746|NCT01901874|17626963|P1|1-Year (365-Day) MAE Evaluation|Death|7
5103747|NCT01901874|17626963|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
5103748|NCT01901874|17626963|P1|Screening Committee Retrospective Review|Protocol Violation|47
5103749|NCT01901848|17626978|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
5103750|NCT01901848|17626979|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
5103751|NCT01901848|17626978|P2|Randomized and Treated|Lost to Follow-up|6
5103752|NCT01901848|17626979|P1|Randomized and Treated|Lost to Follow-up|3
5103753|NCT01901653|17627021|P13|Overall Study|Alive at Study Termination by Sponsor|1
5103754|NCT01901653|17627022|P12|Overall Study|Alive at Study Termination by Sponsor|1
5103755|NCT01901653|17627023|P11|Overall Study|Alive at Study Termination by Sponsor|0
5103756|NCT01901653|17627024|P10|Overall Study|Alive at Study Termination by Sponsor|2
5103757|NCT01901653|17627025|P9|Overall Study|Alive at Study Termination by Sponsor|0
5103758|NCT01901653|17627026|P8|Overall Study|Alive at Study Termination by Sponsor|0
5103759|NCT01901653|17627027|P7|Overall Study|Alive at Study Termination by Sponsor|0
5103760|NCT01901653|17627028|P6|Overall Study|Alive at Study Termination by Sponsor|0
5103761|NCT01901653|17627029|P5|Overall Study|Alive at Study Termination by Sponsor|0
5103762|NCT01901653|17627030|P4|Overall Study|Alive at Study Termination by Sponsor|0
5103763|NCT01901653|17627031|P3|Overall Study|Alive at Study Termination by Sponsor|1
5103764|NCT01901653|17627032|P2|Overall Study|Alive at Study Termination by Sponsor|0
5103765|NCT01901653|17627033|P1|Overall Study|Alive at Study Termination by Sponsor|0
5103766|NCT01901653|17627021|P13|Overall Study|Withdrawal by Subject|0
5103767|NCT01901653|17627022|P12|Overall Study|Withdrawal by Subject|0
5103768|NCT01901653|17627023|P11|Overall Study|Withdrawal by Subject|0
5103769|NCT01901653|17627024|P10|Overall Study|Withdrawal by Subject|0
5103770|NCT01901653|17627025|P9|Overall Study|Withdrawal by Subject|0
5103771|NCT01901653|17627026|P8|Overall Study|Withdrawal by Subject|0
5103772|NCT01901653|17627027|P7|Overall Study|Withdrawal by Subject|1
5103773|NCT01901653|17627028|P6|Overall Study|Withdrawal by Subject|0
5103774|NCT01901653|17627029|P5|Overall Study|Withdrawal by Subject|0
5103775|NCT01901653|17627030|P4|Overall Study|Withdrawal by Subject|0
5103776|NCT01901653|17627031|P3|Overall Study|Withdrawal by Subject|0
5103777|NCT01901653|17627032|P2|Overall Study|Withdrawal by Subject|0
5103778|NCT01901653|17627033|P1|Overall Study|Withdrawal by Subject|0
5103779|NCT01901653|17627021|P13|Overall Study|Lost to Follow-up|0
5103780|NCT01901653|17627022|P12|Overall Study|Lost to Follow-up|0
5103781|NCT01901653|17627023|P11|Overall Study|Lost to Follow-up|0
5103782|NCT01901653|17627024|P10|Overall Study|Lost to Follow-up|0
5103783|NCT01901653|17627025|P9|Overall Study|Lost to Follow-up|0
5103784|NCT01901653|17627026|P8|Overall Study|Lost to Follow-up|1
5103785|NCT01901653|17627027|P7|Overall Study|Lost to Follow-up|0
5103786|NCT01901653|17627028|P6|Overall Study|Lost to Follow-up|1
5103787|NCT01901653|17627029|P5|Overall Study|Lost to Follow-up|0
5103788|NCT01901653|17627030|P4|Overall Study|Lost to Follow-up|0
5103789|NCT01901653|17627031|P3|Overall Study|Lost to Follow-up|2
5103790|NCT01901653|17627032|P2|Overall Study|Lost to Follow-up|0
5103791|NCT01901653|17627033|P1|Overall Study|Lost to Follow-up|1
5103792|NCT01901653|17627021|P13|Overall Study|Death|4
5103793|NCT01901653|17627022|P12|Overall Study|Death|15
5103794|NCT01901653|17627023|P11|Overall Study|Death|2
5103795|NCT01901653|17627024|P10|Overall Study|Death|16
5103796|NCT01901653|17627025|P9|Overall Study|Death|1
5103797|NCT01901653|17627026|P8|Overall Study|Death|9
5103798|NCT01901653|17627027|P7|Overall Study|Death|6
5103799|NCT01901653|17627028|P6|Overall Study|Death|2
5103800|NCT01901653|17627029|P5|Overall Study|Death|2
5103801|NCT01901653|17627030|P4|Overall Study|Death|3
5103802|NCT01901653|17627031|P3|Overall Study|Death|8
5103803|NCT01901653|17627032|P2|Overall Study|Death|1
5103804|NCT01901653|17627033|P1|Overall Study|Death|2
5103805|NCT01901614|17627077|P2|Overall Study|Screen Fail|0
5103806|NCT01901614|17627078|P1|Overall Study|Screen Fail|1
5103807|NCT01901614|17627077|P2|Overall Study|Lost to Follow-up|0
5103808|NCT01901614|17627078|P1|Overall Study|Lost to Follow-up|1
5103809|NCT01901614|17627077|P2|Overall Study|Adverse Event|1
5103810|NCT01901614|17627078|P1|Overall Study|Adverse Event|0
5103811|NCT01901432|17627113|P5|Overall Study|Patient decision to stop study drug|1
5103812|NCT01901432|17627114|P4|Overall Study|Patient decision to stop study drug|0
5103813|NCT01901432|17627115|P3|Overall Study|Patient decision to stop study drug|0
5103814|NCT01901432|17627116|P2|Overall Study|Patient decision to stop study drug|0
5103815|NCT01901432|17627117|P1|Overall Study|Patient decision to stop study drug|0
5103816|NCT01901432|17627113|P5|Overall Study|Physician Decision|2
5103817|NCT01901432|17627114|P4|Overall Study|Physician Decision|0
5103818|NCT01901432|17627115|P3|Overall Study|Physician Decision|0
5103819|NCT01901432|17627116|P2|Overall Study|Physician Decision|0
5103820|NCT01901432|17627117|P1|Overall Study|Physician Decision|0
5103821|NCT01901432|17627113|P5|Overall Study|Withdrawal by Subject|5
5103822|NCT01901432|17627114|P4|Overall Study|Withdrawal by Subject|0
5103823|NCT01901432|17627115|P3|Overall Study|Withdrawal by Subject|1
5103824|NCT01901432|17627116|P2|Overall Study|Withdrawal by Subject|0
5103825|NCT01901432|17627117|P1|Overall Study|Withdrawal by Subject|0
5103826|NCT01901432|17627113|P5|Overall Study|Adverse Event|1
5103827|NCT01901432|17627114|P4|Overall Study|Adverse Event|0
5103828|NCT01901432|17627115|P3|Overall Study|Adverse Event|1
5103829|NCT01901432|17627116|P2|Overall Study|Adverse Event|1
5103830|NCT01901432|17627117|P1|Overall Study|Adverse Event|0
5103831|NCT01901419|17627169|P2|Overall Study|unavailable researchers|3
5103832|NCT01901419|17627170|P1|Overall Study|unavailable researchers|6
5103833|NCT01901419|17627169|P2|Overall Study|Protocol Violation|6
5103834|NCT01901419|17627170|P1|Overall Study|Protocol Violation|2
5103835|NCT01901393|17627236|P2|Overall Study|Adverse Event|0
5103836|NCT01901393|17627237|P1|Overall Study|Adverse Event|1
5103837|NCT01901341|17627255|P2|Overall Study|Withdrawal by Subject|1
5103838|NCT01901341|17627256|P1|Overall Study|Withdrawal by Subject|1
5103839|NCT01901341|17627255|P2|Overall Study|Study Terminated by Sponsor|15
5103840|NCT01901341|17627256|P1|Overall Study|Study Terminated by Sponsor|13
5103841|NCT01901341|17627255|P2|Overall Study|Protocol Violation|0
5103842|NCT01901341|17627256|P1|Overall Study|Protocol Violation|2
5103843|NCT01901341|17627255|P2|Overall Study|Lost to Follow-up|1
5103844|NCT01901341|17627256|P1|Overall Study|Lost to Follow-up|0
5103845|NCT01901341|17627255|P2|Overall Study|Lack of Efficacy|2
5103846|NCT01901341|17627256|P1|Overall Study|Lack of Efficacy|0
5103847|NCT01901341|17627255|P2|Overall Study|Adverse Event|2
5103848|NCT01901341|17627256|P1|Overall Study|Adverse Event|4
5103849|NCT01901328|17627270|P2|Overall Study|Lack of Efficacy|1
5103850|NCT01901328|17627271|P1|Overall Study|Lack of Efficacy|0
5103851|NCT01901328|17627270|P2|Overall Study|Withdrawal by Subject|2
5103852|NCT01901328|17627271|P1|Overall Study|Withdrawal by Subject|1
5103853|NCT01901328|17627270|P2|Overall Study|Study Terminated by Sponsor|16
5103854|NCT01901328|17627271|P1|Overall Study|Study Terminated by Sponsor|19
5103855|NCT01901328|17627270|P2|Overall Study|Protocol Violation|1
5103856|NCT01901328|17627271|P1|Overall Study|Protocol Violation|1
5103857|NCT01901328|17627270|P2|Overall Study|Physician Decision|1
5103858|NCT01901328|17627271|P1|Overall Study|Physician Decision|0
5103859|NCT01901328|17627270|P2|Overall Study|Lost to Follow-up|0
5103860|NCT01901328|17627271|P1|Overall Study|Lost to Follow-up|1
5103861|NCT01901302|17627285|P2|Overall Study|Withdrawal by Subject|0
5103862|NCT01901302|17627286|P1|Overall Study|Withdrawal by Subject|2
5103863|NCT01901302|17627285|P2|Overall Study|Study Terminated by Sponsor|20
5103864|NCT01901302|17627286|P1|Overall Study|Study Terminated by Sponsor|23
5103865|NCT01901302|17627285|P2|Overall Study|Lack of Efficacy|2
5103866|NCT01901302|17627286|P1|Overall Study|Lack of Efficacy|0
5103867|NCT01901302|17627285|P2|Overall Study|Adverse Event|1
5103868|NCT01901302|17627286|P1|Overall Study|Adverse Event|2
5103869|NCT01901224|17627311|P1|Overall Study|study was not funded and terminated|2
5103870|NCT01901185|17627346|P1|Overall Study|Withdrawal by Subject|2
5103871|NCT01901146|17627355|P5|Adjuvant Phase|Withdrawal by Subject|4
5103872|NCT01901146|17627356|P4|Adjuvant Phase|Withdrawal by Subject|1
5103873|NCT01901146|17627357|P3|Adjuvant Phase|Withdrawal by Subject|4
5103874|NCT01901146|17627358|P2|Adjuvant Phase|Withdrawal by Subject|0
5103875|NCT01901146|17627359|P1|Adjuvant Phase|Withdrawal by Subject|0
5103876|NCT01901146|17627355|P5|Adjuvant Phase|Physician Decision|4
5103877|NCT01901146|17627356|P4|Adjuvant Phase|Physician Decision|2
5103878|NCT01901146|17627357|P3|Adjuvant Phase|Physician Decision|9
5103879|NCT01901146|17627358|P2|Adjuvant Phase|Physician Decision|0
5103880|NCT01901146|17627359|P1|Adjuvant Phase|Physician Decision|0
5103881|NCT01901146|17627355|P5|Adjuvant Phase|Disease Progression or Recurrence|3
5103882|NCT01901146|17627356|P4|Adjuvant Phase|Disease Progression or Recurrence|4
5103883|NCT01901146|17627357|P3|Adjuvant Phase|Disease Progression or Recurrence|12
5103884|NCT01901146|17627358|P2|Adjuvant Phase|Disease Progression or Recurrence|0
5103885|NCT01901146|17627359|P1|Adjuvant Phase|Disease Progression or Recurrence|0
5103886|NCT01901146|17627355|P5|Adjuvant Phase|Death|3
5103887|NCT01901146|17627356|P4|Adjuvant Phase|Death|0
5103888|NCT01901146|17627357|P3|Adjuvant Phase|Death|0
5103889|NCT01901146|17627358|P2|Adjuvant Phase|Death|0
5103890|NCT01901146|17627359|P1|Adjuvant Phase|Death|0
5103891|NCT01901146|17627355|P5|Adjuvant Phase|Other|0
5103892|NCT01901146|17627356|P4|Adjuvant Phase|Other|0
5103893|NCT01901146|17627357|P3|Adjuvant Phase|Other|1
5103894|NCT01901146|17627358|P2|Adjuvant Phase|Other|0
5103895|NCT01901146|17627359|P1|Adjuvant Phase|Other|0
5103896|NCT01901146|17627355|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5103897|NCT01901146|17627356|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5103898|NCT01901146|17627357|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5103899|NCT01901146|17627358|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
5103900|NCT01901146|17627359|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5103901|NCT01901146|17627355|P5|Neoadjuvant Phase|Withdrawal by Subject|0
5103902|NCT01901146|17627356|P4|Neoadjuvant Phase|Withdrawal by Subject|0
5103903|NCT01901146|17627357|P3|Neoadjuvant Phase|Withdrawal by Subject|0
5103904|NCT01901146|17627358|P2|Neoadjuvant Phase|Withdrawal by Subject|5
5103905|NCT01901146|17627359|P1|Neoadjuvant Phase|Withdrawal by Subject|2
5103906|NCT01901146|17627355|P5|Neoadjuvant Phase|Physician Decision|0
5103907|NCT01901146|17627356|P4|Neoadjuvant Phase|Physician Decision|0
5103908|NCT01901146|17627357|P3|Neoadjuvant Phase|Physician Decision|0
5103909|NCT01901146|17627358|P2|Neoadjuvant Phase|Physician Decision|2
5103910|NCT01901146|17627359|P1|Neoadjuvant Phase|Physician Decision|1
5103911|NCT01901146|17627355|P5|Neoadjuvant Phase|Lost to Follow-up|0
5103912|NCT01901146|17627356|P4|Neoadjuvant Phase|Lost to Follow-up|0
5103913|NCT01901146|17627357|P3|Neoadjuvant Phase|Lost to Follow-up|0
5103914|NCT01901146|17627358|P2|Neoadjuvant Phase|Lost to Follow-up|1
5103915|NCT01901146|17627359|P1|Neoadjuvant Phase|Lost to Follow-up|0
5103916|NCT01901146|17627355|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
5103917|NCT01901146|17627356|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
5103918|NCT01901146|17627357|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
5103919|NCT01901146|17627358|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
5103920|NCT01901146|17627359|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
5103921|NCT01901146|17627355|P5|Neoadjuvant Phase|Death|0
5103922|NCT01901146|17627356|P4|Neoadjuvant Phase|Death|0
5103923|NCT01901146|17627357|P3|Neoadjuvant Phase|Death|0
5103924|NCT01901146|17627358|P2|Neoadjuvant Phase|Death|2
5103925|NCT01901146|17627359|P1|Neoadjuvant Phase|Death|1
5103926|NCT01900899|17627374|P2|Overall Study|Migrated from study area|0
5103927|NCT01900899|17627375|P1|Overall Study|Migrated from study area|2
5103928|NCT01900899|17627374|P2|Overall Study|Withdrawal by Subject|1
5103929|NCT01900899|17627375|P1|Overall Study|Withdrawal by Subject|7
5103930|NCT01900730|17627401|P2|Overall Study|Screen Failure|0
5103931|NCT01900730|17627402|P1|Overall Study|Screen Failure|1
5103932|NCT01900730|17627401|P2|Overall Study|Withdrawal by Subject|0
5103933|NCT01900730|17627402|P1|Overall Study|Withdrawal by Subject|1
5103934|NCT01900665|17627426|P2|Open Label Period|Withdrawal by Subject|28
5103935|NCT01900665|17627427|P1|Open Label Period|Withdrawal by Subject|20
5103936|NCT01900665|17627426|P2|Open Label Period|Sponsor Decision|765
5103937|NCT01900665|17627427|P1|Open Label Period|Sponsor Decision|802
5103938|NCT01900665|17627426|P2|Open Label Period|Protocol Violation|1
5103939|NCT01900665|17627427|P1|Open Label Period|Protocol Violation|0
5103940|NCT01900665|17627426|P2|Open Label Period|Physician Decision|4
5103941|NCT01900665|17627427|P1|Open Label Period|Physician Decision|4
5103942|NCT01900665|17627426|P2|Open Label Period|Parent/Caregiver Decision|34
5103943|NCT01900665|17627427|P1|Open Label Period|Parent/Caregiver Decision|33
5103944|NCT01900665|17627426|P2|Open Label Period|Lost to Follow-up|1
5103945|NCT01900665|17627427|P1|Open Label Period|Lost to Follow-up|1
5103946|NCT01900665|17627426|P2|Open Label Period|Death|6
5103947|NCT01900665|17627427|P1|Open Label Period|Death|5
5103948|NCT01900665|17627426|P2|Open Label Period|Adverse Event|20
5103949|NCT01900665|17627427|P1|Open Label Period|Adverse Event|16
5103950|NCT01900665|17627426|P2|Placebo Controlled Period|Entry Criteria Not Met|9
5103951|NCT01900665|17627427|P1|Placebo Controlled Period|Entry Criteria Not Met|5
5103952|NCT01900665|17627426|P2|Placebo Controlled Period|Caregiver Decision|41
5103953|NCT01900665|17627427|P1|Placebo Controlled Period|Caregiver Decision|33
5103954|NCT01900665|17627426|P2|Placebo Controlled Period|Lost to Follow-up|0
5103955|NCT01900665|17627427|P1|Placebo Controlled Period|Lost to Follow-up|3
5103956|NCT01900665|17627426|P2|Placebo Controlled Period|Physician Decision|7
5103957|NCT01900665|17627427|P1|Placebo Controlled Period|Physician Decision|11
5103958|NCT01900665|17627426|P2|Placebo Controlled Period|Withdrawal by Subject|45
5103959|NCT01900665|17627427|P1|Placebo Controlled Period|Withdrawal by Subject|33
5103960|NCT01900665|17627426|P2|Placebo Controlled Period|Protocol Violation|7
5103961|NCT01900665|17627427|P1|Placebo Controlled Period|Protocol Violation|1
5103962|NCT01900665|17627426|P2|Placebo Controlled Period|Adverse Event|39
5103963|NCT01900665|17627427|P1|Placebo Controlled Period|Adverse Event|48
5103964|NCT01900665|17627426|P2|Placebo Controlled Period|Death|16
5103965|NCT01900665|17627427|P1|Placebo Controlled Period|Death|9
5103966|NCT01900652|17627470|P2|Overall Study|Physician Decision|1
5103967|NCT01900652|17627471|P1|Overall Study|Physician Decision|1
5103968|NCT01900652|17627470|P2|Overall Study|Adverse Event|1
5103969|NCT01900652|17627471|P1|Overall Study|Adverse Event|2
5103970|NCT01900652|17627470|P2|Overall Study|Death|0
5103971|NCT01900652|17627471|P1|Overall Study|Death|3
5103972|NCT01900652|17627470|P2|Overall Study|Consent withdrawn by subject|1
5103973|NCT01900652|17627471|P1|Overall Study|Consent withdrawn by subject|1
5103974|NCT01900652|17627470|P2|Overall Study|Progressive Disease|0
5103975|NCT01900652|17627471|P1|Overall Study|Progressive Disease|1
5103976|NCT01900626|17627507|P2|Overall Study|study was closed due to low enrollment|1
5103977|NCT01900626|17627508|P1|Overall Study|study was closed due to low enrollment|1
5103978|NCT01900444|17627587|P1|Overall Study|Lost to Follow-up|1
5103979|NCT01900444|17627587|P1|Overall Study|Protocol Violation|2
5103980|NCT01900431|17627600|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
5103981|NCT01900431|17627601|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
5103982|NCT01900431|17627602|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
5103983|NCT01900431|17627600|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
5103984|NCT01900431|17627601|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
5103985|NCT01900431|17627602|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
5103986|NCT01900431|17627600|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
5103987|NCT01900431|17627601|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
5103988|NCT01900431|17627602|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
5103989|NCT01900431|17627600|P3|Extended Treatment Period (Part B)|Other than specified above|0
5103990|NCT01900431|17627601|P2|Extended Treatment Period (Part B)|Other than specified above|1
5103991|NCT01900431|17627602|P1|Extended Treatment Period (Part B)|Other than specified above|0
5103992|NCT01900431|17627600|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
5103993|NCT01900431|17627601|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
5103994|NCT01900431|17627602|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
5103995|NCT01900431|17627600|P3|Extended Treatment Period (Part B)|Adverse Event|0
5103996|NCT01900431|17627601|P2|Extended Treatment Period (Part B)|Adverse Event|2
5103997|NCT01900431|17627602|P1|Extended Treatment Period (Part B)|Adverse Event|0
5103998|NCT01900431|17627600|P3|Principal Treatment Period (Part A)|Other than specified above|0
5103999|NCT01900431|17627601|P2|Principal Treatment Period (Part A)|Other than specified above|1
5104000|NCT01900431|17627602|P1|Principal Treatment Period (Part A)|Other than specified above|0
5104001|NCT01900431|17627600|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
5104002|NCT01900431|17627601|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
5104003|NCT01900431|17627602|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
5104004|NCT01900431|17627600|P3|Principal Treatment Period (Part A)|Adverse Event|0
5104005|NCT01900431|17627601|P2|Principal Treatment Period (Part A)|Adverse Event|3
5104006|NCT01900431|17627602|P1|Principal Treatment Period (Part A)|Adverse Event|1
5104007|NCT01900314|17627644|P2|Overall Study|Withdrawal by Subject|3
5104008|NCT01900314|17627645|P1|Overall Study|Withdrawal by Subject|3
5104009|NCT01900314|17627644|P2|Overall Study|Protocol Violation|1
5104010|NCT01900314|17627645|P1|Overall Study|Protocol Violation|0
5104011|NCT01900314|17627644|P2|Overall Study|Lost to Follow-up|0
5104012|NCT01900314|17627645|P1|Overall Study|Lost to Follow-up|1
5104013|NCT01900054|17627675|P1|Overall Study|Withdrawal by Subject|1
5104014|NCT01900054|17627675|P1|Overall Study|Physician Decision|1
5104015|NCT01899768|17627684|P1|Part B|Withdrawal by Subject|1
5104016|NCT01899768|17627684|P1|Part B|Adverse Event|1
5104017|NCT01899768|17627684|P1|Part A|Withdrawal by Subject|1
5104018|NCT01899768|17627684|P1|Part A|Adverse Event|2
5104019|NCT01899742|17627758|P2|Overall Study|Withdrawal by Subject|5
5104020|NCT01899742|17627759|P1|Overall Study|Withdrawal by Subject|9
5104021|NCT01899742|17627758|P2|Overall Study|Protocol Violation|2
5104022|NCT01899742|17627759|P1|Overall Study|Protocol Violation|2
5104023|NCT01899742|17627758|P2|Overall Study|Lack of Efficacy|5
5104024|NCT01899742|17627759|P1|Overall Study|Lack of Efficacy|1
5104025|NCT01899742|17627758|P2|Overall Study|Adverse Event|4
5104026|NCT01899742|17627759|P1|Overall Study|Adverse Event|5
5104027|NCT01899729|17627772|P5|Overall Study|Lack of Efficacy|1
5104028|NCT01899729|17627773|P4|Overall Study|Lack of Efficacy|0
5104029|NCT01899729|17627774|P3|Overall Study|Lack of Efficacy|2
5104030|NCT01899729|17627775|P2|Overall Study|Lack of Efficacy|0
5104031|NCT01899729|17627776|P1|Overall Study|Lack of Efficacy|0
5104032|NCT01899729|17627772|P5|Overall Study|Withdrawal by Subject|0
5104033|NCT01899729|17627773|P4|Overall Study|Withdrawal by Subject|0
5104034|NCT01899729|17627774|P3|Overall Study|Withdrawal by Subject|0
5104035|NCT01899729|17627775|P2|Overall Study|Withdrawal by Subject|2
5104036|NCT01899729|17627776|P1|Overall Study|Withdrawal by Subject|1
5104037|NCT01899729|17627772|P5|Overall Study|Adverse Event|1
5104038|NCT01899729|17627773|P4|Overall Study|Adverse Event|0
5104039|NCT01899729|17627774|P3|Overall Study|Adverse Event|0
5104040|NCT01899729|17627775|P2|Overall Study|Adverse Event|0
5104041|NCT01899729|17627776|P1|Overall Study|Adverse Event|1
5104042|NCT01899144|17627823|P1|Treatment Period 5|Other|1
5104043|NCT01899144|17627823|P1|Treatment Period 3|Other|2
5104044|NCT01899144|17627823|P1|Treatment Period 2|Other|1
5104045|NCT01899053|17627859|P14|Overall Study|Symptomatic Deterioration|0
5104046|NCT01899053|17627860|P13|Overall Study|Symptomatic Deterioration|2
5104047|NCT01899053|17627861|P12|Overall Study|Symptomatic Deterioration|1
5104048|NCT01899053|17627862|P11|Overall Study|Symptomatic Deterioration|0
5104049|NCT01899053|17627863|P10|Overall Study|Symptomatic Deterioration|0
5104050|NCT01899053|17627864|P9|Overall Study|Symptomatic Deterioration|0
5104051|NCT01899053|17627865|P8|Overall Study|Symptomatic Deterioration|1
5104052|NCT01899053|17627866|P7|Overall Study|Symptomatic Deterioration|0
5104053|NCT01899053|17627867|P6|Overall Study|Symptomatic Deterioration|1
5104054|NCT01899053|17627868|P5|Overall Study|Symptomatic Deterioration|0
5104055|NCT01899053|17627869|P4|Overall Study|Symptomatic Deterioration|0
5104056|NCT01899053|17627870|P3|Overall Study|Symptomatic Deterioration|0
5104057|NCT01899053|17627871|P2|Overall Study|Symptomatic Deterioration|0
5104058|NCT01899053|17627872|P1|Overall Study|Symptomatic Deterioration|0
5104059|NCT01899053|17627859|P14|Overall Study|Unsatisfactory Therapeutic Response|0
5104060|NCT01899053|17627860|P13|Overall Study|Unsatisfactory Therapeutic Response|0
5104061|NCT01899053|17627861|P12|Overall Study|Unsatisfactory Therapeutic Response|0
5104062|NCT01899053|17627862|P11|Overall Study|Unsatisfactory Therapeutic Response|1
5104063|NCT01899053|17627863|P10|Overall Study|Unsatisfactory Therapeutic Response|0
5104064|NCT01899053|17627864|P9|Overall Study|Unsatisfactory Therapeutic Response|0
5104065|NCT01899053|17627865|P8|Overall Study|Unsatisfactory Therapeutic Response|0
5104066|NCT01899053|17627866|P7|Overall Study|Unsatisfactory Therapeutic Response|0
5104067|NCT01899053|17627867|P6|Overall Study|Unsatisfactory Therapeutic Response|0
5104068|NCT01899053|17627868|P5|Overall Study|Unsatisfactory Therapeutic Response|0
5104069|NCT01899053|17627869|P4|Overall Study|Unsatisfactory Therapeutic Response|0
5104070|NCT01899053|17627870|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5104071|NCT01899053|17627871|P2|Overall Study|Unsatisfactory Therapeutic Response|1
5104072|NCT01899053|17627872|P1|Overall Study|Unsatisfactory Therapeutic Response|1
5104073|NCT01899053|17627859|P14|Overall Study|Protocol Violation|0
5104074|NCT01899053|17627860|P13|Overall Study|Protocol Violation|0
5104075|NCT01899053|17627861|P12|Overall Study|Protocol Violation|0
5104076|NCT01899053|17627862|P11|Overall Study|Protocol Violation|0
5104077|NCT01899053|17627863|P10|Overall Study|Protocol Violation|0
5104078|NCT01899053|17627864|P9|Overall Study|Protocol Violation|0
5104079|NCT01899053|17627865|P8|Overall Study|Protocol Violation|0
5104080|NCT01899053|17627866|P7|Overall Study|Protocol Violation|0
5104081|NCT01899053|17627867|P6|Overall Study|Protocol Violation|0
5104082|NCT01899053|17627868|P5|Overall Study|Protocol Violation|0
5104083|NCT01899053|17627869|P4|Overall Study|Protocol Violation|0
5104084|NCT01899053|17627870|P3|Overall Study|Protocol Violation|1
5104085|NCT01899053|17627871|P2|Overall Study|Protocol Violation|0
5104086|NCT01899053|17627872|P1|Overall Study|Protocol Violation|0
5104087|NCT01899053|17627859|P14|Overall Study|Withdrawal by Subject|1
5104088|NCT01899053|17627860|P13|Overall Study|Withdrawal by Subject|1
5104089|NCT01899053|17627861|P12|Overall Study|Withdrawal by Subject|0
5104090|NCT01899053|17627862|P11|Overall Study|Withdrawal by Subject|0
5104091|NCT01899053|17627863|P10|Overall Study|Withdrawal by Subject|0
5104092|NCT01899053|17627864|P9|Overall Study|Withdrawal by Subject|0
5104093|NCT01899053|17627865|P8|Overall Study|Withdrawal by Subject|1
5104094|NCT01899053|17627866|P7|Overall Study|Withdrawal by Subject|0
5104095|NCT01899053|17627867|P6|Overall Study|Withdrawal by Subject|0
5104096|NCT01899053|17627868|P5|Overall Study|Withdrawal by Subject|2
5104097|NCT01899053|17627869|P4|Overall Study|Withdrawal by Subject|0
5104098|NCT01899053|17627870|P3|Overall Study|Withdrawal by Subject|2
5104099|NCT01899053|17627871|P2|Overall Study|Withdrawal by Subject|1
5104100|NCT01899053|17627872|P1|Overall Study|Withdrawal by Subject|1
5104101|NCT01899053|17627859|P14|Overall Study|Reason Not Specified|0
5104102|NCT01899053|17627860|P13|Overall Study|Reason Not Specified|1
5104103|NCT01899053|17627861|P12|Overall Study|Reason Not Specified|0
5104104|NCT01899053|17627862|P11|Overall Study|Reason Not Specified|0
5104105|NCT01899053|17627863|P10|Overall Study|Reason Not Specified|0
5104106|NCT01899053|17627864|P9|Overall Study|Reason Not Specified|0
5104107|NCT01899053|17627865|P8|Overall Study|Reason Not Specified|0
5104108|NCT01899053|17627866|P7|Overall Study|Reason Not Specified|1
5104109|NCT01899053|17627867|P6|Overall Study|Reason Not Specified|0
5104110|NCT01899053|17627868|P5|Overall Study|Reason Not Specified|0
5104111|NCT01899053|17627869|P4|Overall Study|Reason Not Specified|0
5104112|NCT01899053|17627870|P3|Overall Study|Reason Not Specified|0
5104113|NCT01899053|17627871|P2|Overall Study|Reason Not Specified|0
5104114|NCT01899053|17627872|P1|Overall Study|Reason Not Specified|0
5104115|NCT01899053|17627859|P14|Overall Study|Adverse Event|2
5104116|NCT01899053|17627860|P13|Overall Study|Adverse Event|2
5104117|NCT01899053|17627861|P12|Overall Study|Adverse Event|1
5104118|NCT01899053|17627862|P11|Overall Study|Adverse Event|3
5104119|NCT01899053|17627863|P10|Overall Study|Adverse Event|0
5104120|NCT01899053|17627864|P9|Overall Study|Adverse Event|2
5104121|NCT01899053|17627865|P8|Overall Study|Adverse Event|0
5104122|NCT01899053|17627866|P7|Overall Study|Adverse Event|1
5104123|NCT01899053|17627867|P6|Overall Study|Adverse Event|1
5104124|NCT01899053|17627868|P5|Overall Study|Adverse Event|1
5104125|NCT01899053|17627869|P4|Overall Study|Adverse Event|3
5104126|NCT01899053|17627870|P3|Overall Study|Adverse Event|1
5104127|NCT01899053|17627871|P2|Overall Study|Adverse Event|1
5104128|NCT01899053|17627872|P1|Overall Study|Adverse Event|1
5104129|NCT01899053|17627859|P14|Overall Study|Progressive Disease|17
5104130|NCT01899053|17627860|P13|Overall Study|Progressive Disease|8
5104131|NCT01899053|17627861|P12|Overall Study|Progressive Disease|5
5104132|NCT01899053|17627862|P11|Overall Study|Progressive Disease|12
5104133|NCT01899053|17627863|P10|Overall Study|Progressive Disease|3
5104134|NCT01899053|17627864|P9|Overall Study|Progressive Disease|4
5104135|NCT01899053|17627865|P8|Overall Study|Progressive Disease|1
5104136|NCT01899053|17627866|P7|Overall Study|Progressive Disease|1
5104137|NCT01899053|17627867|P6|Overall Study|Progressive Disease|1
5104138|NCT01899053|17627868|P5|Overall Study|Progressive Disease|3
5104139|NCT01899053|17627869|P4|Overall Study|Progressive Disease|0
5104140|NCT01899053|17627870|P3|Overall Study|Progressive Disease|3
5104141|NCT01899053|17627871|P2|Overall Study|Progressive Disease|0
5104142|NCT01899053|17627872|P1|Overall Study|Progressive Disease|4
5104143|NCT01898884|17628129|P9|Multiple Dose Period|Randomized Not Treated|1
5104144|NCT01898884|17628130|P8|Multiple Dose Period|Randomized Not Treated|0
5104145|NCT01898884|17628131|P7|Multiple Dose Period|Randomized Not Treated|0
5104146|NCT01898884|17628132|P6|Multiple Dose Period|Randomized Not Treated|0
5104147|NCT01898884|17628133|P5|Multiple Dose Period|Randomized Not Treated|0
5104148|NCT01898884|17628134|P4|Multiple Dose Period|Randomized Not Treated|0
5104149|NCT01898884|17628135|P3|Multiple Dose Period|Randomized Not Treated|0
5104150|NCT01898884|17628136|P2|Multiple Dose Period|Randomized Not Treated|0
5104151|NCT01898884|17628137|P1|Multiple Dose Period|Randomized Not Treated|0
5104152|NCT01898884|17628129|P9|Multiple Dose Period|Adverse Event|0
5104153|NCT01898884|17628130|P8|Multiple Dose Period|Adverse Event|0
5104154|NCT01898884|17628131|P7|Multiple Dose Period|Adverse Event|1
5104155|NCT01898884|17628132|P6|Multiple Dose Period|Adverse Event|0
5104156|NCT01898884|17628133|P5|Multiple Dose Period|Adverse Event|0
5104157|NCT01898884|17628134|P4|Multiple Dose Period|Adverse Event|0
5104158|NCT01898884|17628135|P3|Multiple Dose Period|Adverse Event|0
5104159|NCT01898884|17628136|P2|Multiple Dose Period|Adverse Event|0
5104160|NCT01898884|17628137|P1|Multiple Dose Period|Adverse Event|0
5104161|NCT01898806|17628287|P1|Overall Study|Physician Decision|1
5104162|NCT01898806|17628287|P1|Overall Study|Withdrawal by Subject|2
5104163|NCT01898598|17628317|P2|Overall Study|Other|1
5104164|NCT01898598|17628318|P1|Overall Study|Other|0
5104165|NCT01898598|17628317|P2|Overall Study|Lost to Follow-up|1
5104166|NCT01898598|17628318|P1|Overall Study|Lost to Follow-up|0
5104167|NCT01898598|17628317|P2|Overall Study|Withdrawal by Subject|0
5104168|NCT01898598|17628318|P1|Overall Study|Withdrawal by Subject|3
5104169|NCT01898598|17628317|P2|Overall Study|Adverse Event|0
5104170|NCT01898598|17628318|P1|Overall Study|Adverse Event|1
5104171|NCT01898442|17628337|P3|Overall Study|Patient vomited pills|1
5104172|NCT01898442|17628338|P2|Overall Study|Patient vomited pills|0
5104173|NCT01898442|17628339|P1|Overall Study|Patient vomited pills|0
5104174|NCT01898442|17628337|P3|Overall Study|Hemolysis/technical problems|2
5104175|NCT01898442|17628338|P2|Overall Study|Hemolysis/technical problems|2
5104176|NCT01898442|17628339|P1|Overall Study|Hemolysis/technical problems|1
5104177|NCT01898299|17628376|P2|Post Treatment (One Month)|Lost to Follow-up|4
5104178|NCT01898299|17628377|P1|Post Treatment (One Month)|Lost to Follow-up|3
5104179|NCT01898286|17628383|P1|Overall Study|Lost to Follow-up|1
5104180|NCT01898286|17628383|P1|Overall Study|Protocol Violation|1
5104181|NCT01898286|17628383|P1|Overall Study|Withdrawal by Subject|1
5104182|NCT01898208|17628393|P3|Overall Study|Lost to Follow-up|1
5104183|NCT01898208|17628394|P2|Overall Study|Lost to Follow-up|1
5104184|NCT01898208|17628395|P1|Overall Study|Lost to Follow-up|3
5104185|NCT01898208|17628393|P3|Overall Study|System/Technical Error|3
5104186|NCT01898208|17628394|P2|Overall Study|System/Technical Error|2
5104187|NCT01898208|17628395|P1|Overall Study|System/Technical Error|1
5104188|NCT01898208|17628393|P3|Overall Study|Non-Blood Specimens in Bottles|4
5104189|NCT01898208|17628394|P2|Overall Study|Non-Blood Specimens in Bottles|5
5104190|NCT01898208|17628395|P1|Overall Study|Non-Blood Specimens in Bottles|3
5104191|NCT01898208|17628393|P3|Overall Study|Negative Gram Stain|6
5104192|NCT01898208|17628394|P2|Overall Study|Negative Gram Stain|9
5104193|NCT01898208|17628395|P1|Overall Study|Negative Gram Stain|6
5104194|NCT01898208|17628393|P3|Overall Study|Death/comfort care within 24 hours|8
5104195|NCT01898208|17628394|P2|Overall Study|Death/comfort care within 24 hours|9
5104196|NCT01898208|17628395|P1|Overall Study|Death/comfort care within 24 hours|10
5104197|NCT01898208|17628393|P3|Overall Study|Positive blood culture|15
5104198|NCT01898208|17628394|P2|Overall Study|Positive blood culture|23
5104199|NCT01898208|17628395|P1|Overall Study|Positive blood culture|17
5104200|NCT01898195|17628442|P3|Smoking Abstinence|Did not have good measurements|36
5104201|NCT01898195|17628443|P2|Smoking Abstinence|Did not have good measurements|38
5104202|NCT01898195|17628444|P1|Smoking Abstinence|Did not have good measurements|35
5104203|NCT01898130|17628455|P1|Follow up Until PD or Death|Lost to Follow-up|1
5104204|NCT01898130|17628455|P1|Treatment|Progressive Disease|4
5104205|NCT01898130|17628455|P1|Treatment|Withdrawal by Subject|2
5104206|NCT01898091|17628470|P2|Overall Study|Withdrawal by Subject|5
5104207|NCT01898091|17628471|P1|Overall Study|Withdrawal by Subject|1
5104208|NCT01898091|17628470|P2|Overall Study|Lost to Follow-up|1
5104209|NCT01898091|17628471|P1|Overall Study|Lost to Follow-up|1
5104210|NCT01898078|17628479|P2|Overall Study|Reason not Specified|1
5104211|NCT01898078|17628480|P1|Overall Study|Reason not Specified|0
5104212|NCT01898078|17628479|P2|Overall Study|Symptomatic Deterioration|0
5104213|NCT01898078|17628480|P1|Overall Study|Symptomatic Deterioration|2
5104214|NCT01898078|17628479|P2|Overall Study|Withdrawal by Subject|1
5104215|NCT01898078|17628480|P1|Overall Study|Withdrawal by Subject|1
5104216|NCT01898078|17628479|P2|Overall Study|Adverse Event|1
5104217|NCT01898078|17628480|P1|Overall Study|Adverse Event|2
5104218|NCT01898078|17628479|P2|Overall Study|Progressive Disease|5
5104219|NCT01898078|17628480|P1|Overall Study|Progressive Disease|1
5104220|NCT01897896|17628517|P2|Overall Study|Other than specified|1
5104221|NCT01897896|17628518|P1|Overall Study|Other than specified|2
5104222|NCT01897896|17628517|P2|Overall Study|Caregiver can no longer participate|2
5104223|NCT01897896|17628518|P1|Overall Study|Caregiver can no longer participate|0
5104224|NCT01897896|17628517|P2|Overall Study|Withdrawal per Investigator's judgement|1
5104225|NCT01897896|17628518|P1|Overall Study|Withdrawal per Investigator's judgement|1
5104226|NCT01897896|17628517|P2|Overall Study|Protocol Violation|1
5104227|NCT01897896|17628518|P1|Overall Study|Protocol Violation|1
5104228|NCT01897896|17628517|P2|Overall Study|Require drug that interfere with study|4
5104229|NCT01897896|17628518|P1|Overall Study|Require drug that interfere with study|1
5104230|NCT01897896|17628517|P2|Overall Study|Withdrawal by Subject|1
5104231|NCT01897896|17628518|P1|Overall Study|Withdrawal by Subject|7
5104232|NCT01897896|17628517|P2|Overall Study|Non-compliance with study drug dosing|1
5104233|NCT01897896|17628518|P1|Overall Study|Non-compliance with study drug dosing|1
5104234|NCT01897896|17628517|P2|Overall Study|Lost to Follow-up|0
5104235|NCT01897896|17628518|P1|Overall Study|Lost to Follow-up|1
5104236|NCT01897896|17628517|P2|Overall Study|Adverse Event|1
5104237|NCT01897896|17628518|P1|Overall Study|Adverse Event|11
5104238|NCT01897896|17628517|P2|Overall Study|Death|0
5104239|NCT01897896|17628518|P1|Overall Study|Death|1
5104240|NCT01897727|17628650|P2|Overall Study|Exclusion: central sleep apnea|1
5104241|NCT01897727|17628651|P1|Overall Study|Exclusion: central sleep apnea|0
5104242|NCT01897714|17628663|P6|Phase II (MTD)|Other|0
5104243|NCT01897714|17628664|P5|Phase II (MTD)|Other|3
5104244|NCT01897714|17628665|P4|Phase II (MTD)|Other|0
5104245|NCT01897714|17628666|P3|Phase II (MTD)|Other|0
5104246|NCT01897714|17628667|P2|Phase II (MTD)|Other|0
5104247|NCT01897714|17628668|P1|Phase II (MTD)|Other|0
5104248|NCT01897714|17628663|P6|Phase II (MTD)|Study terminated with patient alive|0
5104249|NCT01897714|17628664|P5|Phase II (MTD)|Study terminated with patient alive|1
5104250|NCT01897714|17628665|P4|Phase II (MTD)|Study terminated with patient alive|0
5104251|NCT01897714|17628666|P3|Phase II (MTD)|Study terminated with patient alive|0
5104252|NCT01897714|17628667|P2|Phase II (MTD)|Study terminated with patient alive|0
5104253|NCT01897714|17628668|P1|Phase II (MTD)|Study terminated with patient alive|0
5104254|NCT01897714|17628663|P6|Phase II (MTD)|Death|10
5104255|NCT01897714|17628664|P5|Phase II (MTD)|Death|25
5104256|NCT01897714|17628665|P4|Phase II (MTD)|Death|0
5104257|NCT01897714|17628666|P3|Phase II (MTD)|Death|0
5104258|NCT01897714|17628667|P2|Phase II (MTD)|Death|0
5104259|NCT01897714|17628668|P1|Phase II (MTD)|Death|0
5104260|NCT01897714|17628663|P6|Phase II (MTD)|Lost to Follow-up|0
5104261|NCT01897714|17628664|P5|Phase II (MTD)|Lost to Follow-up|1
5104262|NCT01897714|17628665|P4|Phase II (MTD)|Lost to Follow-up|0
5104263|NCT01897714|17628666|P3|Phase II (MTD)|Lost to Follow-up|0
5104264|NCT01897714|17628667|P2|Phase II (MTD)|Lost to Follow-up|0
5104265|NCT01897714|17628668|P1|Phase II (MTD)|Lost to Follow-up|0
5104266|NCT01897714|17628663|P6|Phase II (MTD)|Withdrawal by Subject|1
5104267|NCT01897714|17628664|P5|Phase II (MTD)|Withdrawal by Subject|0
5104268|NCT01897714|17628665|P4|Phase II (MTD)|Withdrawal by Subject|0
5104269|NCT01897714|17628666|P3|Phase II (MTD)|Withdrawal by Subject|0
5104270|NCT01897714|17628667|P2|Phase II (MTD)|Withdrawal by Subject|0
5104271|NCT01897714|17628668|P1|Phase II (MTD)|Withdrawal by Subject|0
5104272|NCT01897714|17628663|P6|Phase I (Dose Escalation)|Other|0
5104273|NCT01897714|17628664|P5|Phase I (Dose Escalation)|Other|0
5104274|NCT01897714|17628665|P4|Phase I (Dose Escalation)|Other|0
5104275|NCT01897714|17628666|P3|Phase I (Dose Escalation)|Other|0
5104276|NCT01897714|17628667|P2|Phase I (Dose Escalation)|Other|1
5104277|NCT01897714|17628668|P1|Phase I (Dose Escalation)|Other|0
5104278|NCT01897714|17628663|P6|Phase I (Dose Escalation)|Adverse Event|0
5104279|NCT01897714|17628664|P5|Phase I (Dose Escalation)|Adverse Event|0
5104280|NCT01897714|17628665|P4|Phase I (Dose Escalation)|Adverse Event|3
5104281|NCT01897714|17628666|P3|Phase I (Dose Escalation)|Adverse Event|4
5104282|NCT01897714|17628667|P2|Phase I (Dose Escalation)|Adverse Event|1
5104283|NCT01897714|17628668|P1|Phase I (Dose Escalation)|Adverse Event|0
5104284|NCT01897714|17628663|P6|Phase I (Dose Escalation)|Disease progression|0
5104285|NCT01897714|17628664|P5|Phase I (Dose Escalation)|Disease progression|0
5104286|NCT01897714|17628665|P4|Phase I (Dose Escalation)|Disease progression|3
5104287|NCT01897714|17628666|P3|Phase I (Dose Escalation)|Disease progression|1
5104288|NCT01897714|17628667|P2|Phase I (Dose Escalation)|Disease progression|5
5104289|NCT01897714|17628668|P1|Phase I (Dose Escalation)|Disease progression|3
5104290|NCT01897532|17628714|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
5104291|NCT01897532|17628715|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
5104292|NCT01897532|17628714|P2|Discontinuation From Trial|Not Treated|5
5104293|NCT01897532|17628715|P1|Discontinuation From Trial|Not Treated|7
5104294|NCT01897532|17628714|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
5104295|NCT01897532|17628715|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
5104296|NCT01897532|17628714|P2|Discontinuation From Treatment|Non compliance|15
5104297|NCT01897532|17628715|P1|Discontinuation From Treatment|Non compliance|24
5104298|NCT01897532|17628714|P2|Discontinuation From Treatment|Withdrawal by Subject|281
5104299|NCT01897532|17628715|P1|Discontinuation From Treatment|Withdrawal by Subject|333
5104300|NCT01897532|17628714|P2|Discontinuation From Treatment|Other reason than specified|176
5104301|NCT01897532|17628715|P1|Discontinuation From Treatment|Other reason than specified|196
5104302|NCT01897532|17628714|P2|Discontinuation From Treatment|Not Treated|5
5104303|NCT01897532|17628715|P1|Discontinuation From Treatment|Not Treated|7
5104304|NCT01897493|17628723|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
5104305|NCT01897233|17628759|P1|Part B (24 Weeks)|Physician Decision|1
5104306|NCT01897233|17628759|P1|Part B (24 Weeks)|Withdrawal by Subject|2
5104307|NCT01897233|17628759|P1|Part B (24 Weeks)|Adverse Event|1
5104308|NCT01896986|17628811|P2|Overall Study|samples lost|23
5104309|NCT01896986|17628812|P1|Overall Study|samples lost|14
5104310|NCT01896934|17628818|P1|Overall Study|Withdrawal by Subject|1
5104311|NCT01896934|17628818|P1|Overall Study|Adverse Event|1
5104312|NCT01896895|17628831|P4|Double-blind MP|Lost to Follow-up|0
5104313|NCT01896895|17628832|P3|Double-blind MP|Lost to Follow-up|1
5104314|NCT01896895|17628833|P2|Double-blind MP|Lost to Follow-up|0
5104315|NCT01896895|17628834|P1|Double-blind MP|Lost to Follow-up|1
5104316|NCT01896895|17628831|P4|Double-blind MP|Withdrawal by Subject|0
5104317|NCT01896895|17628832|P3|Double-blind MP|Withdrawal by Subject|1
5104318|NCT01896895|17628833|P2|Double-blind MP|Withdrawal by Subject|2
5104319|NCT01896895|17628834|P1|Double-blind MP|Withdrawal by Subject|0
5104320|NCT01896895|17628831|P4|Double-blind MP|Physician Decision|0
5104321|NCT01896895|17628832|P3|Double-blind MP|Physician Decision|1
5104322|NCT01896895|17628833|P2|Double-blind MP|Physician Decision|0
5104323|NCT01896895|17628834|P1|Double-blind MP|Physician Decision|0
5104324|NCT01896869|17628851|P2|Overall Study|Lost to Follow-up|0
5104325|NCT01896869|17628852|P1|Overall Study|Lost to Follow-up|1
5104326|NCT01896869|17628851|P2|Overall Study|Withdrawal by Subject|6
5104327|NCT01896869|17628852|P1|Overall Study|Withdrawal by Subject|0
5104328|NCT01896856|17628877|P6|Overall Study|Transportation issues / Non-compliance|0
5104329|NCT01896856|17628878|P5|Overall Study|Transportation issues / Non-compliance|0
5104330|NCT01896856|17628879|P4|Overall Study|Transportation issues / Non-compliance|0
5104331|NCT01896856|17628880|P3|Overall Study|Transportation issues / Non-compliance|1
5104332|NCT01896856|17628881|P2|Overall Study|Transportation issues / Non-compliance|0
5104333|NCT01896856|17628882|P1|Overall Study|Transportation issues / Non-compliance|0
5104334|NCT01896726|17628901|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
5104335|NCT01896726|17628901|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
5104336|NCT01896700|17628916|P2|Overall Study|Withdrawal by Subject|1
5104337|NCT01896700|17628917|P1|Overall Study|Withdrawal by Subject|0
5104338|NCT01896700|17628916|P2|Overall Study|Adverse Event|5
5104339|NCT01896700|17628917|P1|Overall Study|Adverse Event|4
5104340|NCT01896557|17628948|P2|Clopidogrel + GI Protector|Reading error|3
5104341|NCT01896557|17628949|P1|Clopidogrel + GI Protector|Reading error|1
5104342|NCT01896557|17628948|P2|Clopidogrel + GI Protector|low adherence|1
5104343|NCT01896557|17628949|P1|Clopidogrel + GI Protector|low adherence|1
5104344|NCT01896557|17628948|P2|Clopidogrel Alone|Adverse Event|0
5104345|NCT01896557|17628949|P1|Clopidogrel Alone|Adverse Event|1
5104346|NCT01896297|17628986|P1|Overall Study|Died in post treatment phase|1
5104347|NCT01896232|17628993|P2|Overall Study|Lost to Follow-up|12
5104348|NCT01896232|17628994|P1|Overall Study|Lost to Follow-up|9
5104349|NCT01896232|17628993|P2|Overall Study|Sponsor Decision|0
5104350|NCT01896232|17628994|P1|Overall Study|Sponsor Decision|2
5104351|NCT01896232|17628993|P2|Overall Study|Withdrawal by Subject|31
5104352|NCT01896232|17628994|P1|Overall Study|Withdrawal by Subject|32
5104353|NCT01896232|17628993|P2|Overall Study|Death|10
5104354|NCT01896232|17628994|P1|Overall Study|Death|6
5104355|NCT01896193|17629022|P2|Overall Study|Withdrew Consent|0
5104356|NCT01896193|17629023|P1|Overall Study|Withdrew Consent|1
5104357|NCT01896193|17629022|P2|Overall Study|Protocol Violation|1
5104358|NCT01896193|17629023|P1|Overall Study|Protocol Violation|0
5104359|NCT01896193|17629022|P2|Overall Study|Lack of Efficacy|11
5104360|NCT01896193|17629023|P1|Overall Study|Lack of Efficacy|20
5104361|NCT01896128|17629049|P2|Overall Study|Withdrawal by Subject|3
5104362|NCT01896128|17629050|P1|Overall Study|Withdrawal by Subject|3
5104363|NCT01896050|17629092|P2|Overall Study|Death|0
5104364|NCT01896050|17629093|P1|Overall Study|Death|1
5104365|NCT01896050|17629092|P2|Overall Study|Adverse Event|2
5104366|NCT01896050|17629093|P1|Overall Study|Adverse Event|37
5104367|NCT01895777|17629137|P2|Overall Study|Non-compliance with the CTP|1
5104368|NCT01895777|17629138|P1|Overall Study|Non-compliance with the CTP|2
5104369|NCT01895777|17629137|P2|Overall Study|Other reasons|2
5104370|NCT01895777|17629138|P1|Overall Study|Other reasons|3
5104371|NCT01895777|17629137|P2|Overall Study|Not treated|0
5104372|NCT01895777|17629138|P1|Overall Study|Not treated|1
5104373|NCT01895777|17629137|P2|Overall Study|Lost to Follow-up|0
5104374|NCT01895777|17629138|P1|Overall Study|Lost to Follow-up|2
5104375|NCT01895777|17629137|P2|Overall Study|Adverse Event|2
5104376|NCT01895777|17629138|P1|Overall Study|Adverse Event|1
5104377|NCT01895608|17629194|P4|Overall Study|Withdrawal by Subject|0
5104378|NCT01895608|17629195|P3|Overall Study|Withdrawal by Subject|2
5104379|NCT01895608|17629196|P2|Overall Study|Withdrawal by Subject|0
5104380|NCT01895608|17629197|P1|Overall Study|Withdrawal by Subject|0
5104381|NCT01895608|17629194|P4|Overall Study|change in health status|0
5104382|NCT01895608|17629195|P3|Overall Study|change in health status|1
5104383|NCT01895608|17629196|P2|Overall Study|change in health status|1
5104384|NCT01895608|17629197|P1|Overall Study|change in health status|0
5104385|NCT01895543|17629227|P1|Overall Study|Other (Not fulfilling above criteria)|24
5104386|NCT01895543|17629227|P1|Overall Study|Physician Decision|2
5104387|NCT01895543|17629227|P1|Overall Study|Protocol Violation|1
5104388|NCT01895543|17629227|P1|Overall Study|Subject's substantial non-compliance|6
5104389|NCT01895543|17629227|P1|Overall Study|Adverse Event|28
5104390|NCT01895543|17629227|P1|Overall Study|Lost to Follow-up|25
5104391|NCT01895543|17629227|P1|Overall Study|Withdrawal by Subject|43
5104392|NCT01895452|17629243|P2|Overall Study|Noncompliance with study drug|1
5104393|NCT01895452|17629244|P1|Overall Study|Noncompliance with study drug|0
5104394|NCT01895452|17629243|P2|Overall Study|Underlying disease|3
5104395|NCT01895452|17629244|P1|Overall Study|Underlying disease|0
5104396|NCT01895452|17629243|P2|Overall Study|Withdrawal by Subject|14
5104397|NCT01895452|17629244|P1|Overall Study|Withdrawal by Subject|2
5104398|NCT01895452|17629243|P2|Overall Study|Pregnancy|1
5104399|NCT01895452|17629244|P1|Overall Study|Pregnancy|0
5104400|NCT01895452|17629243|P2|Overall Study|Lost to Follow-up|5
5104401|NCT01895452|17629244|P1|Overall Study|Lost to Follow-up|1
5104402|NCT01895452|17629243|P2|Overall Study|Adverse Event|4
5104403|NCT01895452|17629244|P1|Overall Study|Adverse Event|1
5104404|NCT01895361|17629257|P3|Overall Study|Reasons different from categories above|4
5104405|NCT01895361|17629258|P2|Overall Study|Reasons different from categories above|3
5104406|NCT01895361|17629259|P1|Overall Study|Reasons different from categories above|7
5104407|NCT01895361|17629257|P3|Overall Study|Lack of Efficacy|0
5104408|NCT01895361|17629258|P2|Overall Study|Lack of Efficacy|1
5104409|NCT01895361|17629259|P1|Overall Study|Lack of Efficacy|0
5104410|NCT01895361|17629257|P3|Overall Study|Withdrawal by Subject|6
5104411|NCT01895361|17629258|P2|Overall Study|Withdrawal by Subject|6
5104412|NCT01895361|17629259|P1|Overall Study|Withdrawal by Subject|7
5104413|NCT01895361|17629257|P3|Overall Study|Physician Decision|2
5104414|NCT01895361|17629258|P2|Overall Study|Physician Decision|2
5104415|NCT01895361|17629259|P1|Overall Study|Physician Decision|2
5104416|NCT01895361|17629257|P3|Overall Study|Non-compliance with study|1
5104417|NCT01895361|17629258|P2|Overall Study|Non-compliance with study|3
5104418|NCT01895361|17629259|P1|Overall Study|Non-compliance with study|1
5104419|NCT01895361|17629257|P3|Overall Study|Lost to Follow-up|6
5104420|NCT01895361|17629258|P2|Overall Study|Lost to Follow-up|4
5104421|NCT01895361|17629259|P1|Overall Study|Lost to Follow-up|4
5104422|NCT01895361|17629257|P3|Overall Study|Death|2
5104423|NCT01895361|17629258|P2|Overall Study|Death|1
5104424|NCT01895361|17629259|P1|Overall Study|Death|2
5104425|NCT01895361|17629257|P3|Overall Study|Adverse Event|3
5104426|NCT01895361|17629258|P2|Overall Study|Adverse Event|1
5104427|NCT01895361|17629259|P1|Overall Study|Adverse Event|1
5104428|NCT01895335|17629288|P1|Overall Study|Other than Specified Above|44
5104429|NCT01895335|17629288|P1|Overall Study|Included But Not treated|1
5104430|NCT01895335|17629288|P1|Overall Study|Poor Compliance to Protocol|11
5104431|NCT01895335|17629288|P1|Overall Study|Lack of Efficacy|53
5104432|NCT01895335|17629288|P1|Overall Study|Adverse Event|106
5104433|NCT01895322|17629305|P1|Overall Study|Protocol Violation|10
5104434|NCT01895322|17629305|P1|Overall Study|Withdrawal by Subject|2
5104435|NCT01895322|17629305|P1|Overall Study|Adverse Event|1
5104436|NCT01895309|17629314|P2|Overall Study|Withdrawal by Subject|18
5104437|NCT01895309|17629315|P1|Overall Study|Withdrawal by Subject|9
5104438|NCT01895309|17629314|P2|Overall Study|Physician Decision|10
5104439|NCT01895309|17629315|P1|Overall Study|Physician Decision|15
5104440|NCT01895309|17629314|P2|Overall Study|Lost to Follow-up|3
5104441|NCT01895309|17629315|P1|Overall Study|Lost to Follow-up|1
5104442|NCT01895309|17629314|P2|Overall Study|Lack of Efficacy|3
5104443|NCT01895309|17629315|P1|Overall Study|Lack of Efficacy|1
5104444|NCT01895309|17629314|P2|Overall Study|Protocol Violation|0
5104445|NCT01895309|17629315|P1|Overall Study|Protocol Violation|1
5104446|NCT01895309|17629314|P2|Overall Study|Adverse Event|17
5104447|NCT01895309|17629315|P1|Overall Study|Adverse Event|13
5104448|NCT01895270|17629329|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
5104449|NCT01895270|17629330|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
5104450|NCT01895270|17629329|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
5104451|NCT01895270|17629330|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
5104452|NCT01895270|17629329|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
5104453|NCT01895270|17629330|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
5104454|NCT01895270|17629329|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
5104455|NCT01895270|17629330|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
5104456|NCT01895270|17629329|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
5104457|NCT01895270|17629330|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
5104458|NCT01895270|17629329|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
5104459|NCT01895270|17629330|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
5104460|NCT01895270|17629329|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
5104461|NCT01895270|17629330|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
5104462|NCT01895101|17629349|P3|Overall Study|coagulation disorder|0
5104463|NCT01895101|17629350|P2|Overall Study|coagulation disorder|1
5104464|NCT01895101|17629351|P1|Overall Study|coagulation disorder|0
5104465|NCT01895101|17629349|P3|Overall Study|Death|0
5104466|NCT01895101|17629350|P2|Overall Study|Death|1
5104467|NCT01895101|17629351|P1|Overall Study|Death|0
5104468|NCT01895101|17629349|P3|Overall Study|another study, enrolled in other study|0
5104469|NCT01895101|17629350|P2|Overall Study|another study, enrolled in other study|1
5104470|NCT01895101|17629351|P1|Overall Study|another study, enrolled in other study|0
5104471|NCT01895101|17629349|P3|Overall Study|Withdrawal by Subject|2
5104472|NCT01895101|17629350|P2|Overall Study|Withdrawal by Subject|1
5104473|NCT01895101|17629351|P1|Overall Study|Withdrawal by Subject|0
5104474|NCT01895101|17629349|P3|Overall Study|OPCAB procedure|3
5104475|NCT01895101|17629350|P2|Overall Study|OPCAB procedure|1
5104476|NCT01895101|17629351|P1|Overall Study|OPCAB procedure|1
5104477|NCT01894984|17629386|P2|Overall Study|Other|175
5104478|NCT01894984|17629387|P1|Overall Study|Other|314
5104479|NCT01894919|17629416|P13|Overall Study|Lost to Follow-up|0
5104480|NCT01894919|17629417|P12|Overall Study|Lost to Follow-up|0
5104481|NCT01894919|17629418|P11|Overall Study|Lost to Follow-up|0
5104482|NCT01894919|17629419|P10|Overall Study|Lost to Follow-up|0
5104483|NCT01894919|17629420|P9|Overall Study|Lost to Follow-up|0
5104484|NCT01894919|17629421|P8|Overall Study|Lost to Follow-up|0
5104485|NCT01894919|17629422|P7|Overall Study|Lost to Follow-up|0
5104486|NCT01894919|17629423|P6|Overall Study|Lost to Follow-up|0
5104487|NCT01894919|17629424|P5|Overall Study|Lost to Follow-up|2
5104488|NCT01894919|17629425|P4|Overall Study|Lost to Follow-up|0
5104489|NCT01894919|17629426|P3|Overall Study|Lost to Follow-up|0
5104490|NCT01894919|17629427|P2|Overall Study|Lost to Follow-up|0
5104491|NCT01894919|17629428|P1|Overall Study|Lost to Follow-up|0
5104492|NCT01894919|17629416|P13|Overall Study|Other-Unspecified|0
5104493|NCT01894919|17629417|P12|Overall Study|Other-Unspecified|0
5104494|NCT01894919|17629418|P11|Overall Study|Other-Unspecified|0
5104495|NCT01894919|17629419|P10|Overall Study|Other-Unspecified|0
5104496|NCT01894919|17629420|P9|Overall Study|Other-Unspecified|0
5104497|NCT01894919|17629421|P8|Overall Study|Other-Unspecified|0
5104498|NCT01894919|17629422|P7|Overall Study|Other-Unspecified|0
5104499|NCT01894919|17629423|P6|Overall Study|Other-Unspecified|0
5104500|NCT01894919|17629424|P5|Overall Study|Other-Unspecified|0
5104501|NCT01894919|17629425|P4|Overall Study|Other-Unspecified|0
5104502|NCT01894919|17629426|P3|Overall Study|Other-Unspecified|0
5104503|NCT01894919|17629427|P2|Overall Study|Other-Unspecified|0
5104504|NCT01894919|17629428|P1|Overall Study|Other-Unspecified|1
5104505|NCT01894919|17629416|P13|Overall Study|Adverse Event|0
5104506|NCT01894919|17629417|P12|Overall Study|Adverse Event|0
5104507|NCT01894919|17629418|P11|Overall Study|Adverse Event|1
5104508|NCT01894919|17629419|P10|Overall Study|Adverse Event|0
5104509|NCT01894919|17629420|P9|Overall Study|Adverse Event|0
5104510|NCT01894919|17629421|P8|Overall Study|Adverse Event|0
5104511|NCT01894919|17629422|P7|Overall Study|Adverse Event|0
5104512|NCT01894919|17629423|P6|Overall Study|Adverse Event|0
5104513|NCT01894919|17629424|P5|Overall Study|Adverse Event|0
5104514|NCT01894919|17629425|P4|Overall Study|Adverse Event|0
5104515|NCT01894919|17629426|P3|Overall Study|Adverse Event|0
5104516|NCT01894919|17629427|P2|Overall Study|Adverse Event|0
5104517|NCT01894919|17629428|P1|Overall Study|Adverse Event|0
5104518|NCT01894919|17629416|P13|Overall Study|Withdrawal by Subject|0
5104519|NCT01894919|17629417|P12|Overall Study|Withdrawal by Subject|0
5104520|NCT01894919|17629418|P11|Overall Study|Withdrawal by Subject|1
5104521|NCT01894919|17629419|P10|Overall Study|Withdrawal by Subject|1
5104522|NCT01894919|17629420|P9|Overall Study|Withdrawal by Subject|0
5104523|NCT01894919|17629421|P8|Overall Study|Withdrawal by Subject|0
5104524|NCT01894919|17629422|P7|Overall Study|Withdrawal by Subject|0
5104525|NCT01894919|17629423|P6|Overall Study|Withdrawal by Subject|0
5104526|NCT01894919|17629424|P5|Overall Study|Withdrawal by Subject|1
5104527|NCT01894919|17629425|P4|Overall Study|Withdrawal by Subject|0
5104528|NCT01894919|17629426|P3|Overall Study|Withdrawal by Subject|0
5104529|NCT01894919|17629427|P2|Overall Study|Withdrawal by Subject|0
5104530|NCT01894919|17629428|P1|Overall Study|Withdrawal by Subject|1
5104531|NCT01894841|17629583|P2|Overall Study|Lost to Follow-up|3
5104532|NCT01894841|17629584|P1|Overall Study|Lost to Follow-up|7
5104533|NCT01894841|17629583|P2|Overall Study|Withdrawn by investigator|2
5104534|NCT01894841|17629584|P1|Overall Study|Withdrawn by investigator|2
5104535|NCT01894841|17629583|P2|Overall Study|Withdrawal by Subject|4
5104536|NCT01894841|17629584|P1|Overall Study|Withdrawal by Subject|9
5104537|NCT01894776|17629600|P1|Overall Study|Withdrawal by Subject|1
5104538|NCT01894620|17629614|P2|Overall Study|Withdrawal by Subject|1
5104539|NCT01894620|17629615|P1|Overall Study|Withdrawal by Subject|0
5104540|NCT01894607|17629623|P1|Overall Study|Ineligible|1
5104541|NCT01894581|17629630|P2|Overall Study|Screen Failure|4
5104542|NCT01894581|17629631|P1|Overall Study|Screen Failure|3
5104543|NCT01894581|17629630|P2|Overall Study|Withdrawal by Subject|3
5104544|NCT01894581|17629631|P1|Overall Study|Withdrawal by Subject|2
5104545|NCT01894568|17629639|P2|Overall Study|Lost to Follow-up|1
5104546|NCT01894568|17629640|P1|Overall Study|Lost to Follow-up|0
5104547|NCT01894568|17629639|P2|Overall Study|Physician Decision|0
5104548|NCT01894568|17629640|P1|Overall Study|Physician Decision|1
5104549|NCT01894568|17629639|P2|Overall Study|Withdrawal by Subject|5
5104550|NCT01894568|17629640|P1|Overall Study|Withdrawal by Subject|5
5104551|NCT01894568|17629639|P2|Overall Study|Protocol required discontinuation|1
5104552|NCT01894568|17629640|P1|Overall Study|Protocol required discontinuation|2
5104553|NCT01894568|17629639|P2|Overall Study|Adverse Event|3
5104554|NCT01894568|17629640|P1|Overall Study|Adverse Event|2
5104555|NCT01894516|17629688|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5104556|NCT01894516|17629689|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
5104557|NCT01894516|17629690|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5104558|NCT01894516|17629691|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5104559|NCT01894516|17629688|P4|Period 2 (Week 13 to Week 24)|Adverse Event|1
5104560|NCT01894516|17629689|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
5104561|NCT01894516|17629690|P2|Period 2 (Week 13 to Week 24)|Adverse Event|2
5104562|NCT01894516|17629691|P1|Period 2 (Week 13 to Week 24)|Adverse Event|0
5104563|NCT01894516|17629688|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5104564|NCT01894516|17629689|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
5104565|NCT01894516|17629690|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5104566|NCT01894516|17629691|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5104567|NCT01894516|17629688|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
5104568|NCT01894516|17629689|P3|Period 1 (Baseline up to Week 12)|Adverse Event|0
5104569|NCT01894516|17629690|P2|Period 1 (Baseline up to Week 12)|Adverse Event|0
5104570|NCT01894516|17629691|P1|Period 1 (Baseline up to Week 12)|Adverse Event|2
5104571|NCT01894516|17629688|P4|Period 1 (Baseline up to Week 12)|Treatment failure|0
5104572|NCT01894516|17629689|P3|Period 1 (Baseline up to Week 12)|Treatment failure|1
5104573|NCT01894516|17629690|P2|Period 1 (Baseline up to Week 12)|Treatment failure|0
5104574|NCT01894516|17629691|P1|Period 1 (Baseline up to Week 12)|Treatment failure|0
5104575|NCT01894516|17629688|P4|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
5104576|NCT01894516|17629689|P3|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
5104577|NCT01894516|17629690|P2|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
5104578|NCT01894516|17629691|P1|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
5104579|NCT01894516|17629688|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5104580|NCT01894516|17629689|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5104581|NCT01894516|17629690|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5104582|NCT01894516|17629691|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
5104583|NCT01894516|17629688|P4|Period 1 (Baseline up to Week 12)|Other|0
5104584|NCT01894516|17629689|P3|Period 1 (Baseline up to Week 12)|Other|1
5104585|NCT01894516|17629690|P2|Period 1 (Baseline up to Week 12)|Other|1
5104586|NCT01894516|17629691|P1|Period 1 (Baseline up to Week 12)|Other|0
5104587|NCT01894477|17629747|P2|Overall Study|protocol changed due SC changed to cord|1
5104588|NCT01894477|17629748|P1|Overall Study|protocol changed due SC changed to cord|0
5104589|NCT01894477|17629747|P2|Overall Study|Protocol Violation|1
5104590|NCT01894477|17629748|P1|Overall Study|Protocol Violation|0
5104591|NCT01894256|17629759|P3|Part B|Lack of Efficacy|13
5104592|NCT01894256|17629760|P2|Part B|Lack of Efficacy|12
5104593|NCT01894256|17629761|P1|Part B|Lack of Efficacy|15
5104594|NCT01894256|17629759|P3|Part B|Withdrawal by Subject|0
5104595|NCT01894256|17629760|P2|Part B|Withdrawal by Subject|1
5104596|NCT01894256|17629761|P1|Part B|Withdrawal by Subject|0
5104597|NCT01894256|17629759|P3|Part B|Death|1
5104598|NCT01894256|17629760|P2|Part B|Death|1
5104599|NCT01894256|17629761|P1|Part B|Death|0
5104600|NCT01894256|17629759|P3|Part A|Adverse Event|0
5104601|NCT01894256|17629760|P2|Part A|Adverse Event|1
5104602|NCT01894256|17629761|P1|Part A|Adverse Event|0
5104603|NCT01894243|17629808|P3|Overall Study|Other|0
5104604|NCT01894243|17629809|P2|Overall Study|Other|0
5104605|NCT01894243|17629810|P1|Overall Study|Other|1
5104606|NCT01894243|17629808|P3|Overall Study|Subject decision|0
5104607|NCT01894243|17629809|P2|Overall Study|Subject decision|0
5104608|NCT01894243|17629810|P1|Overall Study|Subject decision|1
5104609|NCT01894243|17629808|P3|Overall Study|Condition under investigation worsened|2
5104610|NCT01894243|17629809|P2|Overall Study|Condition under investigation worsened|6
5104611|NCT01894243|17629810|P1|Overall Study|Condition under investigation worsened|8
5104612|NCT01894243|17629808|P3|Overall Study|Lack of Efficacy|1
5104613|NCT01894243|17629809|P2|Overall Study|Lack of Efficacy|3
5104614|NCT01894243|17629810|P1|Overall Study|Lack of Efficacy|3
5104615|NCT01894243|17629808|P3|Overall Study|Death|3
5104616|NCT01894243|17629809|P2|Overall Study|Death|0
5104617|NCT01894243|17629810|P1|Overall Study|Death|0
5104618|NCT01894243|17629808|P3|Overall Study|Adverse Event|2
5104619|NCT01894243|17629809|P2|Overall Study|Adverse Event|1
5104620|NCT01894243|17629810|P1|Overall Study|Adverse Event|0
5104621|NCT01894230|17629849|P2|Overall Study|Death|0
5104622|NCT01894230|17629850|P1|Overall Study|Death|1
5104623|NCT01894230|17629849|P2|Overall Study|Non-adherent|1
5104624|NCT01894230|17629850|P1|Overall Study|Non-adherent|0
5104625|NCT01894230|17629849|P2|Overall Study|Withdrawal by Subject|4
5104626|NCT01894230|17629850|P1|Overall Study|Withdrawal by Subject|4
5104627|NCT01894230|17629849|P2|Overall Study|Lost to Follow-up|2
5104628|NCT01894230|17629850|P1|Overall Study|Lost to Follow-up|2
5104629|NCT01894152|17629885|P1|Overall Study|No DMR and no Stent thrombosis|151
5104630|NCT01894100|17629928|P2|Overall Study|Withdrawal by Subject|0
5104631|NCT01894100|17629929|P1|Overall Study|Withdrawal by Subject|3
5104632|NCT01894100|17629928|P2|Overall Study|Lost to Follow-up|1
5104633|NCT01894100|17629929|P1|Overall Study|Lost to Follow-up|0
5104634|NCT01894022|17629954|P2|Overall Study|Study Closed/terminated|10
5104635|NCT01894022|17629955|P1|Overall Study|Study Closed/terminated|7
5104636|NCT01894022|17629954|P2|Overall Study|Adverse Event, non-fatal|0
5104637|NCT01894022|17629955|P1|Overall Study|Adverse Event, non-fatal|1
5104638|NCT01894022|17629954|P2|Overall Study|Death|0
5104639|NCT01894022|17629955|P1|Overall Study|Death|1
5104640|NCT01893905|17630024|P2|Overall Study|Other reason|3
5104641|NCT01893905|17630025|P1|Overall Study|Other reason|1
5104642|NCT01893905|17630024|P2|Overall Study|Lack of adherence to treatment|0
5104643|NCT01893905|17630025|P1|Overall Study|Lack of adherence to treatment|2
5104644|NCT01893905|17630024|P2|Overall Study|Protocol Violation|1
5104645|NCT01893905|17630025|P1|Overall Study|Protocol Violation|6
5104646|NCT01893905|17630024|P2|Overall Study|Lost to Follow-up|0
5104647|NCT01893905|17630025|P1|Overall Study|Lost to Follow-up|1
5104648|NCT01893905|17630024|P2|Overall Study|Lack of Efficacy|7
5104649|NCT01893905|17630025|P1|Overall Study|Lack of Efficacy|5
5104650|NCT01893905|17630024|P2|Overall Study|Adverse Event|3
5104651|NCT01893905|17630025|P1|Overall Study|Adverse Event|9
5104652|NCT01893905|17630024|P2|Overall Study|Withdrawal by Subject|0
5104653|NCT01893905|17630025|P1|Overall Study|Withdrawal by Subject|1
5104654|NCT01893827|17630042|P2|Overall Study|Lost to Follow-up|26
5104655|NCT01893827|17630043|P1|Overall Study|Lost to Follow-up|19
5104656|NCT01893411|17630073|P3|Overall Study|Lost to Follow-up|1
5104657|NCT01893411|17630074|P2|Overall Study|Lost to Follow-up|0
5104658|NCT01893411|17630075|P1|Overall Study|Lost to Follow-up|2
5104659|NCT01893411|17630073|P3|Overall Study|Withdrawal by Subject|3
5104660|NCT01893411|17630074|P2|Overall Study|Withdrawal by Subject|4
5104661|NCT01893411|17630075|P1|Overall Study|Withdrawal by Subject|7
5104662|NCT01893411|17630073|P3|Overall Study|Adverse Event|0
5104663|NCT01893411|17630074|P2|Overall Study|Adverse Event|0
5104664|NCT01893411|17630075|P1|Overall Study|Adverse Event|1
5104665|NCT01893411|17630073|P3|Overall Study|Other|3
5104666|NCT01893411|17630074|P2|Overall Study|Other|1
5104667|NCT01893411|17630075|P1|Overall Study|Other|3
5104668|NCT01893411|17630073|P3|Overall Study|Lack of Efficacy|0
5104669|NCT01893411|17630074|P2|Overall Study|Lack of Efficacy|1
5104670|NCT01893411|17630075|P1|Overall Study|Lack of Efficacy|2
5104671|NCT01893411|17630073|P3|Overall Study|Physician Decision|2
5104672|NCT01893411|17630074|P2|Overall Study|Physician Decision|1
5104673|NCT01893411|17630075|P1|Overall Study|Physician Decision|1
5104674|NCT01893411|17630073|P3|Overall Study|Protocol Violation|0
5104675|NCT01893411|17630074|P2|Overall Study|Protocol Violation|0
5104676|NCT01893411|17630075|P1|Overall Study|Protocol Violation|1
5104677|NCT01893346|17630172|P4|Overall Study|Withdrawal by Subject|0
5104678|NCT01893346|17630173|P3|Overall Study|Withdrawal by Subject|0
5104679|NCT01893346|17630174|P2|Overall Study|Withdrawal by Subject|0
5104680|NCT01893346|17630175|P1|Overall Study|Withdrawal by Subject|2
5104681|NCT01893346|17630172|P4|Overall Study|Protocol Violation|0
5104682|NCT01893346|17630173|P3|Overall Study|Protocol Violation|0
5104683|NCT01893346|17630174|P2|Overall Study|Protocol Violation|0
5104684|NCT01893346|17630175|P1|Overall Study|Protocol Violation|1
5104685|NCT01893346|17630172|P4|Overall Study|Lost to Follow-up|0
5104686|NCT01893346|17630173|P3|Overall Study|Lost to Follow-up|0
5104687|NCT01893346|17630174|P2|Overall Study|Lost to Follow-up|1
5104688|NCT01893346|17630175|P1|Overall Study|Lost to Follow-up|0
5104689|NCT01893281|17630189|P1|Overall Study|Withdrawal by Subject|1
5104690|NCT01893281|17630189|P1|Overall Study|Protocol Violation|1
5104691|NCT01893281|17630189|P1|Overall Study|Adverse Event|1
5104692|NCT01893203|17630196|P1|Overall Study|Withdrawal by Subject|1
5104693|NCT01892722|17630220|P2|Overall Study|Withdrawal by Subject|5
5104694|NCT01892722|17630221|P1|Overall Study|Withdrawal by Subject|3
5104695|NCT01892722|17630220|P2|Overall Study|Lack of Efficacy|7
5104696|NCT01892722|17630221|P1|Overall Study|Lack of Efficacy|0
5104697|NCT01892722|17630220|P2|Overall Study|Adverse Event|2
5104698|NCT01892722|17630221|P1|Overall Study|Adverse Event|3
5104699|NCT01892722|17630220|P2|Overall Study|Physician Decision|2
5104700|NCT01892722|17630221|P1|Overall Study|Physician Decision|1
5104701|NCT01892722|17630220|P2|Overall Study|Patient/guardian decision|2
5104702|NCT01892722|17630221|P1|Overall Study|Patient/guardian decision|0
5104703|NCT01892722|17630220|P2|Overall Study|Administrative problems|1
5104704|NCT01892722|17630221|P1|Overall Study|Administrative problems|0
5104705|NCT01892722|17630220|P2|Overall Study|Protocol deviation|1
5104706|NCT01892722|17630221|P1|Overall Study|Protocol deviation|0
5104707|NCT01892657|17630237|P1|Overall Study|Protocol Violation|12
5104708|NCT01892657|17630237|P1|Overall Study|Withdrawal by Subject|6
5104709|NCT01892540|17630256|P3|Overall Study|Did not fit in scanner|1
5104710|NCT01892540|17630257|P2|Overall Study|Did not fit in scanner|0
5104711|NCT01892540|17630258|P1|Overall Study|Did not fit in scanner|0
5104712|NCT01892540|17630256|P3|Overall Study|Did not complete PET/MRI|2
5104713|NCT01892540|17630257|P2|Overall Study|Did not complete PET/MRI|0
5104714|NCT01892540|17630258|P1|Overall Study|Did not complete PET/MRI|0
5104715|NCT01892436|17630279|P4|Overall Study|Adverse Event|3
5104716|NCT01892436|17630280|P3|Overall Study|Adverse Event|2
5104717|NCT01892436|17630281|P2|Overall Study|Adverse Event|6
5104718|NCT01892436|17630282|P1|Overall Study|Adverse Event|7
5104719|NCT01892436|17630279|P4|Overall Study|non-compliance with treatment|0
5104720|NCT01892436|17630280|P3|Overall Study|non-compliance with treatment|0
5104721|NCT01892436|17630281|P2|Overall Study|non-compliance with treatment|0
5104722|NCT01892436|17630282|P1|Overall Study|non-compliance with treatment|1
5104723|NCT01892436|17630279|P4|Overall Study|Lost to Follow-up|3
5104724|NCT01892436|17630280|P3|Overall Study|Lost to Follow-up|1
5104725|NCT01892436|17630281|P2|Overall Study|Lost to Follow-up|1
5104726|NCT01892436|17630282|P1|Overall Study|Lost to Follow-up|1
5104727|NCT01892436|17630279|P4|Overall Study|Lack of Efficacy|2
5104728|NCT01892436|17630280|P3|Overall Study|Lack of Efficacy|2
5104729|NCT01892436|17630281|P2|Overall Study|Lack of Efficacy|2
5104730|NCT01892436|17630282|P1|Overall Study|Lack of Efficacy|1
5104731|NCT01892436|17630279|P4|Overall Study|Technical problems|1
5104732|NCT01892436|17630280|P3|Overall Study|Technical problems|1
5104733|NCT01892436|17630281|P2|Overall Study|Technical problems|1
5104734|NCT01892436|17630282|P1|Overall Study|Technical problems|2
5104735|NCT01892436|17630279|P4|Overall Study|Pregnancy|0
5104736|NCT01892436|17630280|P3|Overall Study|Pregnancy|1
5104737|NCT01892436|17630281|P2|Overall Study|Pregnancy|2
5104738|NCT01892436|17630282|P1|Overall Study|Pregnancy|0
5104739|NCT01892436|17630279|P4|Overall Study|Physician Decision|1
5104740|NCT01892436|17630280|P3|Overall Study|Physician Decision|0
5104741|NCT01892436|17630281|P2|Overall Study|Physician Decision|1
5104742|NCT01892436|17630282|P1|Overall Study|Physician Decision|2
5104743|NCT01892436|17630279|P4|Overall Study|Death|0
5104744|NCT01892436|17630280|P3|Overall Study|Death|0
5104745|NCT01892436|17630281|P2|Overall Study|Death|1
5104746|NCT01892436|17630282|P1|Overall Study|Death|1
5104747|NCT01892436|17630279|P4|Overall Study|Withdrawal by Subject|4
5104748|NCT01892436|17630280|P3|Overall Study|Withdrawal by Subject|4
5104749|NCT01892436|17630281|P2|Overall Study|Withdrawal by Subject|15
5104750|NCT01892436|17630282|P1|Overall Study|Withdrawal by Subject|8
5104751|NCT01892345|17630322|P2|Overall Study|Withdrawal by Subject|1
5104752|NCT01892345|17630323|P1|Overall Study|Withdrawal by Subject|12
5104753|NCT01892345|17630322|P2|Overall Study|Lost to Follow-up|0
5104754|NCT01892345|17630323|P1|Overall Study|Lost to Follow-up|3
5104755|NCT01892345|17630322|P2|Overall Study|Death|0
5104756|NCT01892345|17630323|P1|Overall Study|Death|1
5104757|NCT01892345|17630322|P2|Overall Study|Adverse Event|2
5104758|NCT01892345|17630323|P1|Overall Study|Adverse Event|0
5104759|NCT01892293|17630364|P1|Overall Study|Apheresed but not treated|4
5104760|NCT01892189|17630408|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104761|NCT01892189|17630409|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104762|NCT01892189|17630410|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104763|NCT01892189|17630411|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
5104764|NCT01892189|17630412|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104765|NCT01892189|17630413|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104766|NCT01892189|17630414|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104767|NCT01892189|17630415|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104768|NCT01892189|17630416|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5104769|NCT01892189|17630408|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5104770|NCT01892189|17630409|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5104771|NCT01892189|17630410|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5104772|NCT01892189|17630411|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5104773|NCT01892189|17630412|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5104774|NCT01892189|17630413|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5104775|NCT01892189|17630414|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
5104776|NCT01892189|17630415|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5104777|NCT01892189|17630416|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5104778|NCT01892189|17630408|P9|Washout Period 1 (7 Days)|Adverse Event|1
5104779|NCT01892189|17630409|P8|Washout Period 1 (7 Days)|Adverse Event|0
5104780|NCT01892189|17630410|P7|Washout Period 1 (7 Days)|Adverse Event|0
5104781|NCT01892189|17630411|P6|Washout Period 1 (7 Days)|Adverse Event|0
5104782|NCT01892189|17630412|P5|Washout Period 1 (7 Days)|Adverse Event|0
5104783|NCT01892189|17630413|P4|Washout Period 1 (7 Days)|Adverse Event|0
5104784|NCT01892189|17630414|P3|Washout Period 1 (7 Days)|Adverse Event|0
5104785|NCT01892189|17630415|P2|Washout Period 1 (7 Days)|Adverse Event|0
5104786|NCT01892189|17630416|P1|Washout Period 1 (7 Days)|Adverse Event|0
5104787|NCT01892163|17630458|P2|Overall Study|Lost to Follow-up|0
5104788|NCT01892163|17630459|P1|Overall Study|Lost to Follow-up|1
5104789|NCT01892163|17630458|P2|Overall Study|Death|1
5104790|NCT01892163|17630459|P1|Overall Study|Death|1
5104791|NCT01892020|17630471|P2|Period 2|Protocol Violation|0
5104792|NCT01892020|17630472|P1|Period 2|Protocol Violation|1
5104793|NCT01892020|17630471|P2|Period 1|Unclassified|1
5104794|NCT01892020|17630472|P1|Period 1|Unclassified|0
5104795|NCT01892020|17630471|P2|Period 1|Protocol Violation|4
5104796|NCT01892020|17630472|P1|Period 1|Protocol Violation|2
5104797|NCT01892020|17630471|P2|Period 1|Adverse Event|1
5104798|NCT01892020|17630472|P1|Period 1|Adverse Event|1
5104799|NCT01891890|17630530|P3|Overall Study|Study ended before endpoint reached|6
5104800|NCT01891890|17630531|P2|Overall Study|Study ended before endpoint reached|3
5104801|NCT01891890|17630532|P1|Overall Study|Study ended before endpoint reached|7
5104802|NCT01891890|17630530|P3|Overall Study|Lost to Follow-up|1
5104803|NCT01891890|17630531|P2|Overall Study|Lost to Follow-up|0
5104804|NCT01891890|17630532|P1|Overall Study|Lost to Follow-up|0
5104805|NCT01891864|17630575|P6|Extension Period|Lost to Follow-up|0
5104806|NCT01891864|17630576|P5|Extension Period|Lost to Follow-up|0
5104807|NCT01891864|17630577|P4|Extension Period|Lost to Follow-up|0
5104808|NCT01891864|17630578|P3|Extension Period|Lost to Follow-up|2
5104809|NCT01891864|17630579|P2|Extension Period|Lost to Follow-up|0
5104810|NCT01891864|17630580|P1|Extension Period|Lost to Follow-up|0
5104811|NCT01891864|17630575|P6|Extension Period|Withdrawal by Subject|0
5104812|NCT01891864|17630576|P5|Extension Period|Withdrawal by Subject|4
5104813|NCT01891864|17630577|P4|Extension Period|Withdrawal by Subject|2
5104814|NCT01891864|17630578|P3|Extension Period|Withdrawal by Subject|1
5104815|NCT01891864|17630579|P2|Extension Period|Withdrawal by Subject|0
5104816|NCT01891864|17630580|P1|Extension Period|Withdrawal by Subject|0
5104817|NCT01891864|17630575|P6|Extension Period|Adverse Event|0
5104818|NCT01891864|17630576|P5|Extension Period|Adverse Event|2
5104819|NCT01891864|17630577|P4|Extension Period|Adverse Event|2
5104820|NCT01891864|17630578|P3|Extension Period|Adverse Event|4
5104821|NCT01891864|17630579|P2|Extension Period|Adverse Event|0
5104822|NCT01891864|17630580|P1|Extension Period|Adverse Event|0
5104823|NCT01891864|17630575|P6|Extension Period|Pregnancy|0
5104824|NCT01891864|17630576|P5|Extension Period|Pregnancy|0
5104825|NCT01891864|17630577|P4|Extension Period|Pregnancy|0
5104826|NCT01891864|17630578|P3|Extension Period|Pregnancy|1
5104827|NCT01891864|17630579|P2|Extension Period|Pregnancy|0
5104828|NCT01891864|17630580|P1|Extension Period|Pregnancy|0
5104829|NCT01891864|17630575|P6|Extension Period|Lack of Efficacy|0
5104830|NCT01891864|17630576|P5|Extension Period|Lack of Efficacy|1
5104831|NCT01891864|17630577|P4|Extension Period|Lack of Efficacy|1
5104832|NCT01891864|17630578|P3|Extension Period|Lack of Efficacy|0
5104833|NCT01891864|17630579|P2|Extension Period|Lack of Efficacy|0
5104834|NCT01891864|17630580|P1|Extension Period|Lack of Efficacy|0
5104835|NCT01891864|17630575|P6|Treatment Period 2|Withdrawal by Subject|1
5104836|NCT01891864|17630576|P5|Treatment Period 2|Withdrawal by Subject|1
5104837|NCT01891864|17630577|P4|Treatment Period 2|Withdrawal by Subject|4
5104838|NCT01891864|17630578|P3|Treatment Period 2|Withdrawal by Subject|3
5104839|NCT01891864|17630579|P2|Treatment Period 2|Withdrawal by Subject|0
5104840|NCT01891864|17630580|P1|Treatment Period 2|Withdrawal by Subject|0
5104841|NCT01891864|17630575|P6|Treatment Period 2|Termination of Site|0
5104842|NCT01891864|17630576|P5|Treatment Period 2|Termination of Site|2
5104843|NCT01891864|17630577|P4|Treatment Period 2|Termination of Site|0
5104844|NCT01891864|17630578|P3|Treatment Period 2|Termination of Site|0
5104845|NCT01891864|17630579|P2|Treatment Period 2|Termination of Site|0
5104846|NCT01891864|17630580|P1|Treatment Period 2|Termination of Site|0
5104847|NCT01891864|17630575|P6|Treatment Period 2|Adverse Event|4
5104848|NCT01891864|17630576|P5|Treatment Period 2|Adverse Event|0
5104849|NCT01891864|17630577|P4|Treatment Period 2|Adverse Event|2
5104850|NCT01891864|17630578|P3|Treatment Period 2|Adverse Event|1
5104851|NCT01891864|17630579|P2|Treatment Period 2|Adverse Event|0
5104852|NCT01891864|17630580|P1|Treatment Period 2|Adverse Event|0
5104853|NCT01891864|17630575|P6|Treatment Period 2|Lack of Efficacy|0
5104854|NCT01891864|17630576|P5|Treatment Period 2|Lack of Efficacy|1
5104855|NCT01891864|17630577|P4|Treatment Period 2|Lack of Efficacy|0
5104856|NCT01891864|17630578|P3|Treatment Period 2|Lack of Efficacy|1
5104857|NCT01891864|17630579|P2|Treatment Period 2|Lack of Efficacy|0
5104858|NCT01891864|17630580|P1|Treatment Period 2|Lack of Efficacy|0
5104859|NCT01891864|17630575|P6|Treatment Period 2|Site Termination|0
5104860|NCT01891864|17630576|P5|Treatment Period 2|Site Termination|0
5104861|NCT01891864|17630577|P4|Treatment Period 2|Site Termination|2
5104862|NCT01891864|17630578|P3|Treatment Period 2|Site Termination|1
5104863|NCT01891864|17630579|P2|Treatment Period 2|Site Termination|0
5104864|NCT01891864|17630580|P1|Treatment Period 2|Site Termination|0
5104865|NCT01891864|17630575|P6|Treatment Period 2|Physician Decision|0
5104866|NCT01891864|17630576|P5|Treatment Period 2|Physician Decision|0
5104867|NCT01891864|17630577|P4|Treatment Period 2|Physician Decision|0
5104868|NCT01891864|17630578|P3|Treatment Period 2|Physician Decision|1
5104869|NCT01891864|17630579|P2|Treatment Period 2|Physician Decision|0
5104870|NCT01891864|17630580|P1|Treatment Period 2|Physician Decision|0
5104871|NCT01891864|17630575|P6|Treatment Period 2|Protocol Violation|0
5104872|NCT01891864|17630576|P5|Treatment Period 2|Protocol Violation|0
5104873|NCT01891864|17630577|P4|Treatment Period 2|Protocol Violation|1
5104874|NCT01891864|17630578|P3|Treatment Period 2|Protocol Violation|0
5104875|NCT01891864|17630579|P2|Treatment Period 2|Protocol Violation|0
5104876|NCT01891864|17630580|P1|Treatment Period 2|Protocol Violation|0
5104877|NCT01891864|17630575|P6|Treatment Period 1|Lost to Follow-up|0
5104878|NCT01891864|17630576|P5|Treatment Period 1|Lost to Follow-up|0
5104879|NCT01891864|17630577|P4|Treatment Period 1|Lost to Follow-up|0
5104880|NCT01891864|17630578|P3|Treatment Period 1|Lost to Follow-up|0
5104881|NCT01891864|17630579|P2|Treatment Period 1|Lost to Follow-up|0
5104882|NCT01891864|17630580|P1|Treatment Period 1|Lost to Follow-up|1
5104883|NCT01891864|17630575|P6|Treatment Period 1|Withdrawal by Subject|0
5104884|NCT01891864|17630576|P5|Treatment Period 1|Withdrawal by Subject|0
5104885|NCT01891864|17630577|P4|Treatment Period 1|Withdrawal by Subject|0
5104886|NCT01891864|17630578|P3|Treatment Period 1|Withdrawal by Subject|0
5104887|NCT01891864|17630579|P2|Treatment Period 1|Withdrawal by Subject|5
5104888|NCT01891864|17630580|P1|Treatment Period 1|Withdrawal by Subject|2
5104889|NCT01891864|17630575|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5104890|NCT01891864|17630576|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5104891|NCT01891864|17630577|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5104892|NCT01891864|17630578|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5104893|NCT01891864|17630579|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
5104894|NCT01891864|17630580|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
5104895|NCT01891864|17630575|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
5104896|NCT01891864|17630576|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
5104897|NCT01891864|17630577|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
5104898|NCT01891864|17630578|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
5104899|NCT01891864|17630579|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
5104900|NCT01891864|17630580|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
5104901|NCT01891864|17630575|P6|Treatment Period 1|Physician Decision|0
5104902|NCT01891864|17630576|P5|Treatment Period 1|Physician Decision|0
5104903|NCT01891864|17630577|P4|Treatment Period 1|Physician Decision|0
5104904|NCT01891864|17630578|P3|Treatment Period 1|Physician Decision|0
5104905|NCT01891864|17630579|P2|Treatment Period 1|Physician Decision|1
5104906|NCT01891864|17630580|P1|Treatment Period 1|Physician Decision|0
5104907|NCT01891864|17630575|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5104908|NCT01891864|17630576|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5104909|NCT01891864|17630577|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5104910|NCT01891864|17630578|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5104911|NCT01891864|17630579|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
5104912|NCT01891864|17630580|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
5104913|NCT01891721|17630616|P3|Overall Study|Lost to Follow-up|1
5104914|NCT01891721|17630617|P2|Overall Study|Lost to Follow-up|5
5104915|NCT01891721|17630618|P1|Overall Study|Lost to Follow-up|10
5104916|NCT01891669|17630642|P10|Overall Study|Other|0
5104917|NCT01891669|17630643|P9|Overall Study|Other|0
5104918|NCT01891669|17630644|P8|Overall Study|Other|1
5104919|NCT01891669|17630645|P7|Overall Study|Other|0
5104920|NCT01891669|17630646|P6|Overall Study|Other|0
5104921|NCT01891669|17630647|P5|Overall Study|Other|0
5104922|NCT01891669|17630648|P4|Overall Study|Other|0
5104923|NCT01891669|17630649|P3|Overall Study|Other|0
5104924|NCT01891669|17630650|P2|Overall Study|Other|0
5104925|NCT01891669|17630651|P1|Overall Study|Other|1
5104926|NCT01891669|17630642|P10|Overall Study|Withdrawal by Subject|1
5104927|NCT01891669|17630643|P9|Overall Study|Withdrawal by Subject|1
5104928|NCT01891669|17630644|P8|Overall Study|Withdrawal by Subject|2
5104929|NCT01891669|17630645|P7|Overall Study|Withdrawal by Subject|1
5104930|NCT01891669|17630646|P6|Overall Study|Withdrawal by Subject|0
5104931|NCT01891669|17630647|P5|Overall Study|Withdrawal by Subject|0
5104932|NCT01891669|17630648|P4|Overall Study|Withdrawal by Subject|0
5104933|NCT01891669|17630649|P3|Overall Study|Withdrawal by Subject|0
5104934|NCT01891669|17630650|P2|Overall Study|Withdrawal by Subject|1
5104935|NCT01891669|17630651|P1|Overall Study|Withdrawal by Subject|1
5104936|NCT01891669|17630642|P10|Overall Study|Death|1
5104937|NCT01891669|17630643|P9|Overall Study|Death|0
5104938|NCT01891669|17630644|P8|Overall Study|Death|1
5104939|NCT01891669|17630645|P7|Overall Study|Death|0
5104940|NCT01891669|17630646|P6|Overall Study|Death|0
5104941|NCT01891669|17630647|P5|Overall Study|Death|0
5104942|NCT01891669|17630648|P4|Overall Study|Death|0
5104943|NCT01891669|17630649|P3|Overall Study|Death|0
5104944|NCT01891669|17630650|P2|Overall Study|Death|0
5104945|NCT01891669|17630651|P1|Overall Study|Death|0
5104946|NCT01891357|17630802|P1|Overall Study|Protocol Violation|3
5104947|NCT01890967|17630849|P6|Overall Study|Withdrawal by Subject|1
5104948|NCT01890967|17630850|P5|Overall Study|Withdrawal by Subject|3
5104949|NCT01890967|17630851|P4|Overall Study|Withdrawal by Subject|3
5104950|NCT01890967|17630852|P3|Overall Study|Withdrawal by Subject|2
5104951|NCT01890967|17630853|P2|Overall Study|Withdrawal by Subject|4
5104952|NCT01890967|17630854|P1|Overall Study|Withdrawal by Subject|3
5104953|NCT01890967|17630849|P6|Overall Study|Sponsor Decision|3
5104954|NCT01890967|17630850|P5|Overall Study|Sponsor Decision|2
5104955|NCT01890967|17630851|P4|Overall Study|Sponsor Decision|3
5104956|NCT01890967|17630852|P3|Overall Study|Sponsor Decision|1
5104957|NCT01890967|17630853|P2|Overall Study|Sponsor Decision|0
5104958|NCT01890967|17630854|P1|Overall Study|Sponsor Decision|2
5104959|NCT01890967|17630849|P6|Overall Study|Protocol Violation|1
5104960|NCT01890967|17630850|P5|Overall Study|Protocol Violation|4
5104961|NCT01890967|17630851|P4|Overall Study|Protocol Violation|2
5104962|NCT01890967|17630852|P3|Overall Study|Protocol Violation|3
5104963|NCT01890967|17630853|P2|Overall Study|Protocol Violation|3
5104964|NCT01890967|17630854|P1|Overall Study|Protocol Violation|0
5104965|NCT01890967|17630849|P6|Overall Study|Lost to Follow-up|1
5104966|NCT01890967|17630850|P5|Overall Study|Lost to Follow-up|0
5104967|NCT01890967|17630851|P4|Overall Study|Lost to Follow-up|1
5104968|NCT01890967|17630852|P3|Overall Study|Lost to Follow-up|1
5104969|NCT01890967|17630853|P2|Overall Study|Lost to Follow-up|1
5104970|NCT01890967|17630854|P1|Overall Study|Lost to Follow-up|1
5104971|NCT01890967|17630849|P6|Overall Study|Death|0
5104972|NCT01890967|17630850|P5|Overall Study|Death|0
5104973|NCT01890967|17630851|P4|Overall Study|Death|0
5104974|NCT01890967|17630852|P3|Overall Study|Death|0
5104975|NCT01890967|17630853|P2|Overall Study|Death|0
5104976|NCT01890967|17630854|P1|Overall Study|Death|1
5104977|NCT01890967|17630849|P6|Overall Study|Adverse Event|7
5104978|NCT01890967|17630850|P5|Overall Study|Adverse Event|1
5104979|NCT01890967|17630851|P4|Overall Study|Adverse Event|2
5104980|NCT01890967|17630852|P3|Overall Study|Adverse Event|3
5104981|NCT01890967|17630853|P2|Overall Study|Adverse Event|3
5104982|NCT01890967|17630854|P1|Overall Study|Adverse Event|3
5104983|NCT01890915|17630932|P2|Overall Study|Equipment Malfunction|1
5104984|NCT01890915|17630933|P1|Overall Study|Equipment Malfunction|0
5104985|NCT01890915|17630932|P2|Overall Study|Protocol Violation|0
5104986|NCT01890915|17630933|P1|Overall Study|Protocol Violation|2
5104987|NCT01890915|17630932|P2|Overall Study|Adverse Event|0
5104988|NCT01890915|17630933|P1|Overall Study|Adverse Event|1
5104989|NCT01890785|17630949|P6|Third Intervention|Withdrawal by Subject|0
5104990|NCT01890785|17630950|P5|Third Intervention|Withdrawal by Subject|0
5104991|NCT01890785|17630951|P4|Third Intervention|Withdrawal by Subject|0
5104992|NCT01890785|17630952|P3|Third Intervention|Withdrawal by Subject|0
5104993|NCT01890785|17630953|P2|Third Intervention|Withdrawal by Subject|1
5104994|NCT01890785|17630954|P1|Third Intervention|Withdrawal by Subject|0
5104995|NCT01890759|17630973|P2|Overall Study|Withdrawal by Subject|8
5104996|NCT01890759|17630974|P1|Overall Study|Withdrawal by Subject|2
5104997|NCT01890759|17630973|P2|Overall Study|Lost to Follow-up|2
5104998|NCT01890759|17630974|P1|Overall Study|Lost to Follow-up|0
5104999|NCT01890759|17630973|P2|Overall Study|Protocol Violation|2
5105000|NCT01890759|17630974|P1|Overall Study|Protocol Violation|0
5105001|NCT01890746|17631008|P2|Overall Study|Withdrawal by Subject|8
5105002|NCT01890746|17631009|P1|Overall Study|Withdrawal by Subject|5
5105003|NCT01890746|17631008|P2|Overall Study|Physician Decision|2
5105004|NCT01890746|17631009|P1|Overall Study|Physician Decision|3
5105005|NCT01890746|17631008|P2|Overall Study|Lost to Follow-up|1
5105006|NCT01890746|17631009|P1|Overall Study|Lost to Follow-up|4
5105007|NCT01890746|17631008|P2|Overall Study|Adverse Event|0
5105008|NCT01890746|17631009|P1|Overall Study|Adverse Event|1
5105009|NCT01890746|17631008|P2|Overall Study|Death|30
5105010|NCT01890746|17631009|P1|Overall Study|Death|39
5105011|NCT01890707|17631095|P2|Overall Study|Lost to Follow-up|1
5105012|NCT01890707|17631096|P1|Overall Study|Lost to Follow-up|1
5105013|NCT01890512|17631175|P1|Overall Study|Protocol Violation|1
5105014|NCT01890512|17631175|P1|Overall Study|Withdrawal by Subject|1
5105015|NCT01890512|17631175|P1|Overall Study|Physician Decision|1
5105016|NCT01890473|17631181|P2|Overall Study|Poor/non-compliance|0
5105017|NCT01890473|17631182|P1|Overall Study|Poor/non-compliance|1
5105018|NCT01890473|17631181|P2|Overall Study|Lost to Follow-up|0
5105019|NCT01890473|17631182|P1|Overall Study|Lost to Follow-up|1
5105020|NCT01890434|17631208|P1|Overall Study|Withdrawal by PI for ICA not performed|2
5105021|NCT01890434|17631208|P1|Overall Study|Unable to contact|1
5105022|NCT01890434|17631208|P1|Overall Study|Moved out of position|1
5105023|NCT01890434|17631208|P1|Overall Study|Uncontactable by phone|1
5105024|NCT01890434|17631208|P1|Overall Study|Participant didn't complete MRI|1
5105025|NCT01890434|17631208|P1|Overall Study|GSPECT at rest was not done|1
5105026|NCT01890434|17631208|P1|Overall Study|Decline to return for GSPECT|1
5105027|NCT01890434|17631208|P1|Overall Study|Could not get whole set of images|1
5105028|NCT01890434|17631208|P1|Overall Study|CRC didn't contact participant for FU|1
5105029|NCT01890434|17631208|P1|Overall Study|Assessment discrepancy|1
5105030|NCT01890434|17631208|P1|Overall Study|PCI at external hospital|1
5105031|NCT01890434|17631208|P1|Overall Study|Adverse Event|8
5105032|NCT01890421|17631238|P1|Overall Study|Other reason|10
5105033|NCT01890421|17631238|P1|Overall Study|Adverse Event|1
5105034|NCT01890265|17631283|P6|Overall Study|Withdrawal by Subject|0
5105035|NCT01890265|17631284|P5|Overall Study|Withdrawal by Subject|2
5105036|NCT01890265|17631285|P4|Overall Study|Withdrawal by Subject|0
5105037|NCT01890265|17631286|P3|Overall Study|Withdrawal by Subject|3
5105038|NCT01890265|17631287|P2|Overall Study|Withdrawal by Subject|2
5105039|NCT01890265|17631288|P1|Overall Study|Withdrawal by Subject|0
5105040|NCT01890265|17631283|P6|Overall Study|Death|0
5105041|NCT01890265|17631284|P5|Overall Study|Death|0
5105042|NCT01890265|17631285|P4|Overall Study|Death|0
5105043|NCT01890265|17631286|P3|Overall Study|Death|1
5105044|NCT01890265|17631287|P2|Overall Study|Death|3
5105045|NCT01890265|17631288|P1|Overall Study|Death|2
5105046|NCT01890265|17631283|P6|Overall Study|Adverse Event|0
5105047|NCT01890265|17631284|P5|Overall Study|Adverse Event|0
5105048|NCT01890265|17631285|P4|Overall Study|Adverse Event|0
5105049|NCT01890265|17631286|P3|Overall Study|Adverse Event|0
5105050|NCT01890265|17631287|P2|Overall Study|Adverse Event|1
5105051|NCT01890265|17631288|P1|Overall Study|Adverse Event|2
5105052|NCT01890265|17631283|P6|Overall Study|Progressive disease|0
5105053|NCT01890265|17631284|P5|Overall Study|Progressive disease|0
5105054|NCT01890265|17631285|P4|Overall Study|Progressive disease|0
5105055|NCT01890265|17631286|P3|Overall Study|Progressive disease|0
5105056|NCT01890265|17631287|P2|Overall Study|Progressive disease|6
5105057|NCT01890265|17631288|P1|Overall Study|Progressive disease|6
5105058|NCT01890265|17631283|P6|Overall Study|Other (Unspecified reason)|0
5105059|NCT01890265|17631284|P5|Overall Study|Other (Unspecified reason)|0
5105060|NCT01890265|17631285|P4|Overall Study|Other (Unspecified reason)|0
5105061|NCT01890265|17631286|P3|Overall Study|Other (Unspecified reason)|0
5105062|NCT01890265|17631287|P2|Overall Study|Other (Unspecified reason)|1
5105063|NCT01890265|17631288|P1|Overall Study|Other (Unspecified reason)|0
5105064|NCT01890148|17631325|P1|Overall Study|Adverse Event|1
5105065|NCT01890122|17631345|P4|Overall Study|Randomized but not Treated|0
5105066|NCT01890122|17631346|P3|Overall Study|Randomized but not Treated|0
5105067|NCT01890122|17631347|P2|Overall Study|Randomized but not Treated|1
5105068|NCT01890122|17631348|P1|Overall Study|Randomized but not Treated|1
5105069|NCT01890122|17631345|P4|Overall Study|Reason not Specified|2
5105070|NCT01890122|17631346|P3|Overall Study|Reason not Specified|1
5105071|NCT01890122|17631347|P2|Overall Study|Reason not Specified|1
5105072|NCT01890122|17631348|P1|Overall Study|Reason not Specified|0
5105073|NCT01890122|17631345|P4|Overall Study|Lack of Efficacy|41
5105074|NCT01890122|17631346|P3|Overall Study|Lack of Efficacy|7
5105075|NCT01890122|17631347|P2|Overall Study|Lack of Efficacy|24
5105076|NCT01890122|17631348|P1|Overall Study|Lack of Efficacy|14
5105077|NCT01890122|17631345|P4|Overall Study|Voluntary Withdrawal|11
5105078|NCT01890122|17631346|P3|Overall Study|Voluntary Withdrawal|2
5105079|NCT01890122|17631347|P2|Overall Study|Voluntary Withdrawal|8
5105080|NCT01890122|17631348|P1|Overall Study|Voluntary Withdrawal|8
5105081|NCT01890122|17631345|P4|Overall Study|Lost to Follow-up|2
5105082|NCT01890122|17631346|P3|Overall Study|Lost to Follow-up|2
5105083|NCT01890122|17631347|P2|Overall Study|Lost to Follow-up|1
5105084|NCT01890122|17631348|P1|Overall Study|Lost to Follow-up|0
5105085|NCT01890122|17631345|P4|Overall Study|Major Protocol Deviation|1
5105086|NCT01890122|17631346|P3|Overall Study|Major Protocol Deviation|0
5105087|NCT01890122|17631347|P2|Overall Study|Major Protocol Deviation|1
5105088|NCT01890122|17631348|P1|Overall Study|Major Protocol Deviation|3
5105089|NCT01890122|17631345|P4|Overall Study|Adverse Event|2
5105090|NCT01890122|17631346|P3|Overall Study|Adverse Event|1
5105091|NCT01890122|17631347|P2|Overall Study|Adverse Event|1
5105092|NCT01890122|17631348|P1|Overall Study|Adverse Event|1
5105093|NCT01890109|17631412|P2|Overall Study|Lost to Follow-up|2
5105094|NCT01890109|17631413|P1|Overall Study|Lost to Follow-up|1
5105095|NCT01890109|17631412|P2|Overall Study|Withdrawal by Subject|3
5105096|NCT01890109|17631413|P1|Overall Study|Withdrawal by Subject|0
5105097|NCT01889602|17631518|P3|Third Intervention|Withdrawal by Subject|0
5105098|NCT01889602|17631519|P2|Third Intervention|Withdrawal by Subject|2
5105099|NCT01889602|17631520|P1|Third Intervention|Withdrawal by Subject|2
5105100|NCT01889602|17631518|P3|Third Intervention|Protocol Violation|0
5105101|NCT01889602|17631519|P2|Third Intervention|Protocol Violation|0
5105102|NCT01889602|17631520|P1|Third Intervention|Protocol Violation|1
5105103|NCT01889602|17631518|P3|Second Intervention|Withdrawal by Subject|1
5105104|NCT01889602|17631519|P2|Second Intervention|Withdrawal by Subject|0
5105105|NCT01889602|17631520|P1|Second Intervention|Withdrawal by Subject|0
5105106|NCT01889602|17631518|P3|Second Intervention|Study ending|0
5105107|NCT01889602|17631519|P2|Second Intervention|Study ending|0
5105108|NCT01889602|17631520|P1|Second Intervention|Study ending|1
5105109|NCT01889602|17631518|P3|Second Intervention|Adverse Event|1
5105110|NCT01889602|17631519|P2|Second Intervention|Adverse Event|0
5105111|NCT01889602|17631520|P1|Second Intervention|Adverse Event|0
5105112|NCT01889602|17631518|P3|First Intervention|Study ending|0
5105113|NCT01889602|17631519|P2|First Intervention|Study ending|1
5105114|NCT01889602|17631520|P1|First Intervention|Study ending|0
5105115|NCT01889602|17631518|P3|First Intervention|Protocol Violation|1
5105116|NCT01889602|17631519|P2|First Intervention|Protocol Violation|1
5105117|NCT01889602|17631520|P1|First Intervention|Protocol Violation|0
5105118|NCT01889602|17631518|P3|First Intervention|Adverse Event|1
5105119|NCT01889602|17631519|P2|First Intervention|Adverse Event|1
5105120|NCT01889602|17631520|P1|First Intervention|Adverse Event|1
5105121|NCT01889251|17631568|P2|Overall Study|Adverse Event|0
5105122|NCT01889251|17631569|P1|Overall Study|Adverse Event|1
5105123|NCT01889238|17631575|P1|Overall Study|Treatment ongoing|9
5105124|NCT01889069|17631594|P1|Overall Study|Consent Withdrawal|3
5105125|NCT01889069|17631594|P1|Overall Study|Other|4
5105126|NCT01889069|17631594|P1|Overall Study|Lost to Follow-up|6
5105127|NCT01889069|17631594|P1|Overall Study|Progression of Disease|14
5105128|NCT01889069|17631594|P1|Overall Study|Death|18
5105129|NCT01888965|17631639|P1|Overall Study|Lack of Efficacy|4
5105130|NCT01888965|17631639|P1|Overall Study|Adverse Event|5
5105131|NCT01888900|17631651|P2|Overall Study|failed treatment|2
5105132|NCT01888900|17631652|P1|Overall Study|failed treatment|0
5105133|NCT01888874|17631679|P7|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5105134|NCT01888874|17631680|P6|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
5105135|NCT01888874|17631681|P5|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5105136|NCT01888874|17631682|P4|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5105137|NCT01888874|17631683|P3|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5105138|NCT01888874|17631684|P2|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
5105139|NCT01888874|17631685|P1|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5105140|NCT01888874|17631679|P7|Period 2 (Week 13 to Week 24)|Adverse Event|3
5105141|NCT01888874|17631680|P6|Period 2 (Week 13 to Week 24)|Adverse Event|1
5105142|NCT01888874|17631681|P5|Period 2 (Week 13 to Week 24)|Adverse Event|1
5105143|NCT01888874|17631682|P4|Period 2 (Week 13 to Week 24)|Adverse Event|2
5105144|NCT01888874|17631683|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
5105145|NCT01888874|17631684|P2|Period 2 (Week 13 to Week 24)|Adverse Event|0
5105146|NCT01888874|17631685|P1|Period 2 (Week 13 to Week 24)|Adverse Event|2
5105147|NCT01888874|17631679|P7|Period 2 (Week 13 to Week 24)|Treatment failure|0
5105148|NCT01888874|17631680|P6|Period 2 (Week 13 to Week 24)|Treatment failure|0
5105149|NCT01888874|17631681|P5|Period 2 (Week 13 to Week 24)|Treatment failure|0
5105150|NCT01888874|17631682|P4|Period 2 (Week 13 to Week 24)|Treatment failure|0
5105151|NCT01888874|17631683|P3|Period 2 (Week 13 to Week 24)|Treatment failure|1
5105152|NCT01888874|17631684|P2|Period 2 (Week 13 to Week 24)|Treatment failure|0
5105153|NCT01888874|17631685|P1|Period 2 (Week 13 to Week 24)|Treatment failure|0
5105154|NCT01888874|17631679|P7|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5105155|NCT01888874|17631680|P6|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
5105156|NCT01888874|17631681|P5|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5105157|NCT01888874|17631682|P4|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5105158|NCT01888874|17631683|P3|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
5105159|NCT01888874|17631684|P2|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5105160|NCT01888874|17631685|P1|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5105161|NCT01888874|17631679|P7|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5105162|NCT01888874|17631680|P6|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5105163|NCT01888874|17631681|P5|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
5105164|NCT01888874|17631682|P4|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5105165|NCT01888874|17631683|P3|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5105166|NCT01888874|17631684|P2|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5105167|NCT01888874|17631685|P1|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5105168|NCT01888874|17631679|P7|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5105169|NCT01888874|17631680|P6|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5105170|NCT01888874|17631681|P5|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5105171|NCT01888874|17631682|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5105172|NCT01888874|17631683|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
5105173|NCT01888874|17631684|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5105174|NCT01888874|17631685|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5105175|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5105176|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
5105177|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5105178|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5105179|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5105180|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
5105181|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5105182|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5105183|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5105184|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5105185|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5105186|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5105187|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
5105188|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5105189|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5105190|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5105191|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
5105192|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5105193|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5105194|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5105195|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5105196|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Adverse Event|0
5105197|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Adverse Event|1
5105198|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Adverse Event|2
5105199|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
5105200|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Adverse Event|3
5105201|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Adverse Event|2
5105202|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Adverse Event|0
5105203|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Physician Decision|1
5105204|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Physician Decision|0
5105205|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Physician Decision|0
5105206|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Physician Decision|0
5105207|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Physician Decision|0
5105208|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Physician Decision|0
5105209|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Physician Decision|0
5105210|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Other|0
5105211|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Other|3
5105212|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Other|3
5105213|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Other|1
5105214|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Other|1
5105215|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Other|0
5105216|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Other|1
5105217|NCT01888874|17631679|P7|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
5105218|NCT01888874|17631680|P6|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
5105219|NCT01888874|17631681|P5|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5105220|NCT01888874|17631682|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
5105221|NCT01888874|17631683|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5105222|NCT01888874|17631684|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5105223|NCT01888874|17631685|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5105224|NCT01888640|17631774|P3|Overall Study|Researcher Termination of Participant|1
5105225|NCT01888640|17631775|P2|Overall Study|Researcher Termination of Participant|1
5105226|NCT01888640|17631776|P1|Overall Study|Researcher Termination of Participant|0
5105227|NCT01888640|17631774|P3|Overall Study|Excluded for prior TENS|0
5105228|NCT01888640|17631775|P2|Overall Study|Excluded for prior TENS|1
5105229|NCT01888640|17631776|P1|Overall Study|Excluded for prior TENS|0
5105230|NCT01888640|17631774|P3|Overall Study|Given wrong unit (placebo)|0
5105231|NCT01888640|17631775|P2|Overall Study|Given wrong unit (placebo)|0
5105232|NCT01888640|17631776|P1|Overall Study|Given wrong unit (placebo)|1
5105233|NCT01888640|17631774|P3|Overall Study|Minimum dose not met|0
5105234|NCT01888640|17631775|P2|Overall Study|Minimum dose not met|16
5105235|NCT01888640|17631776|P1|Overall Study|Minimum dose not met|10
5105236|NCT01888640|17631774|P3|Overall Study|Withdrawal by Subject|4
5105237|NCT01888640|17631775|P2|Overall Study|Withdrawal by Subject|11
5105238|NCT01888640|17631776|P1|Overall Study|Withdrawal by Subject|15
5105239|NCT01888640|17631774|P3|Overall Study|Lost to Follow-up|0
5105240|NCT01888640|17631775|P2|Overall Study|Lost to Follow-up|2
5105241|NCT01888640|17631776|P1|Overall Study|Lost to Follow-up|1
5105242|NCT01888432|17631832|P2|36-month Analysis (Extension)|Death|0
5105243|NCT01888432|17631833|P1|36-month Analysis (Extension)|Death|1
5105244|NCT01888432|17631832|P2|24-month Analysis (FAS)|Death|4
5105245|NCT01888432|17631833|P1|24-month Analysis (FAS)|Death|8
5105246|NCT01888432|17631832|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
5105247|NCT01888432|17631833|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
5105248|NCT01888432|17631832|P2|24-month Analysis (FAS)|Physician Decision|4
5105249|NCT01888432|17631833|P1|24-month Analysis (FAS)|Physician Decision|2
5105250|NCT01888432|17631832|P2|24-month Analysis (FAS)|Lost to Follow-up|2
5105251|NCT01888432|17631833|P1|24-month Analysis (FAS)|Lost to Follow-up|0
5105252|NCT01888432|17631832|P2|24-month Analysis (FAS)|Graft loss|1
5105253|NCT01888432|17631833|P1|24-month Analysis (FAS)|Graft loss|0
5105254|NCT01888432|17631832|P2|12-month Analysis (FAS)|Death|3
5105255|NCT01888432|17631833|P1|12-month Analysis (FAS)|Death|4
5105256|NCT01888432|17631832|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
5105257|NCT01888432|17631833|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
5105258|NCT01888432|17631832|P2|12-month Analysis (FAS)|Physician Decision|1
5105259|NCT01888432|17631833|P1|12-month Analysis (FAS)|Physician Decision|1
5105260|NCT01888432|17631832|P2|12-month Analysis (FAS)|Lost to Follow-up|2
5105261|NCT01888432|17631833|P1|12-month Analysis (FAS)|Lost to Follow-up|0
5105262|NCT01888367|17631874|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
5105263|NCT01888367|17631875|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
5105264|NCT01888367|17631876|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
5105265|NCT01888367|17631874|P3|Overall Study|Protocol Violation|1
5105266|NCT01888367|17631875|P2|Overall Study|Protocol Violation|0
5105267|NCT01888367|17631876|P1|Overall Study|Protocol Violation|0
5105268|NCT01888367|17631874|P3|Overall Study|Lost to Follow-up|0
5105269|NCT01888367|17631875|P2|Overall Study|Lost to Follow-up|1
5105270|NCT01888367|17631876|P1|Overall Study|Lost to Follow-up|1
5105271|NCT01888367|17631874|P3|Overall Study|Withdrawal by Subject|1
5105272|NCT01888367|17631875|P2|Overall Study|Withdrawal by Subject|0
5105273|NCT01888367|17631876|P1|Overall Study|Withdrawal by Subject|1
5105274|NCT01888367|17631874|P3|Overall Study|Death|1
5105275|NCT01888367|17631875|P2|Overall Study|Death|0
5105276|NCT01888367|17631876|P1|Overall Study|Death|2
5105277|NCT01888367|17631874|P3|Overall Study|Physician Decision|2
5105278|NCT01888367|17631875|P2|Overall Study|Physician Decision|4
5105279|NCT01888367|17631876|P1|Overall Study|Physician Decision|3
5105280|NCT01888003|17631896|P3|Overall Study|Study Terminated|40
5105281|NCT01888003|17631897|P2|Overall Study|Study Terminated|6
5105282|NCT01888003|17631898|P1|Overall Study|Study Terminated|5
5105283|NCT01887912|17631938|P2|Overall Study|Other|58
5105284|NCT01887912|17631939|P1|Overall Study|Other|122
5105285|NCT01887912|17631938|P2|Overall Study|Withdrawal by Subject|349
5105286|NCT01887912|17631939|P1|Overall Study|Withdrawal by Subject|606
5105287|NCT01887912|17631938|P2|Overall Study|Lost to Follow-up|74
5105288|NCT01887912|17631939|P1|Overall Study|Lost to Follow-up|163
5105289|NCT01887912|17631938|P2|Overall Study|Protocol Violation|37
5105290|NCT01887912|17631939|P1|Overall Study|Protocol Violation|67
5105291|NCT01887912|17631938|P2|Overall Study|Other Adverse Event|15
5105292|NCT01887912|17631939|P1|Overall Study|Other Adverse Event|34
5105293|NCT01887912|17631938|P2|Overall Study|Serious adverse event|198
5105294|NCT01887912|17631939|P1|Overall Study|Serious adverse event|400
5105295|NCT01887717|17631967|P2|Overall Study|Administrative reasons|2
5105296|NCT01887717|17631968|P1|Overall Study|Administrative reasons|5
5105297|NCT01887717|17631967|P2|Overall Study|Physician Decision|2
5105298|NCT01887717|17631968|P1|Overall Study|Physician Decision|0
5105299|NCT01887717|17631967|P2|Overall Study|Withdrawal by Subject|7
5105300|NCT01887717|17631968|P1|Overall Study|Withdrawal by Subject|1
5105301|NCT01887678|17631990|P2|Overall Study|Specified|2
5105302|NCT01887678|17631991|P1|Overall Study|Specified|1
5105303|NCT01887678|17631990|P2|Overall Study|Non-compliance|3
5105304|NCT01887678|17631991|P1|Overall Study|Non-compliance|0
5105305|NCT01887678|17631990|P2|Overall Study|Lack of Efficacy|2
5105306|NCT01887678|17631991|P1|Overall Study|Lack of Efficacy|1
5105307|NCT01887678|17631990|P2|Overall Study|Deterioration of clinical condition|4
5105308|NCT01887678|17631991|P1|Overall Study|Deterioration of clinical condition|0
5105309|NCT01887678|17631990|P2|Overall Study|Lost to Follow-up|2
5105310|NCT01887678|17631991|P1|Overall Study|Lost to Follow-up|4
5105311|NCT01887678|17631990|P2|Overall Study|Withdrawal of consent|4
5105312|NCT01887678|17631991|P1|Overall Study|Withdrawal of consent|3
5105313|NCT01887678|17631990|P2|Overall Study|Exceeded rescue medication dosage|5
5105314|NCT01887678|17631991|P1|Overall Study|Exceeded rescue medication dosage|4
5105315|NCT01887678|17631990|P2|Overall Study|Adverse Event|6
5105316|NCT01887678|17631991|P1|Overall Study|Adverse Event|4
5105317|NCT01887418|17632064|P3|Overall Study|Travelling difficulties|1
5105318|NCT01887418|17632065|P2|Overall Study|Travelling difficulties|0
5105319|NCT01887418|17632066|P1|Overall Study|Travelling difficulties|0
5105320|NCT01887353|17632085|P2|Overall Study|Study stopped early|3
5105321|NCT01887353|17632086|P1|Overall Study|Study stopped early|4
5105322|NCT01887288|17632114|P1|Overall Study|The study was terminated and the PI has|16
5105323|NCT01887210|17632121|P2|Overall Study|Lost to Follow-up|1
5105324|NCT01887210|17632122|P1|Overall Study|Lost to Follow-up|0
5105325|NCT01887210|17632121|P2|Overall Study|Withdrawal by Subject|3
5105326|NCT01887210|17632122|P1|Overall Study|Withdrawal by Subject|1
5105327|NCT01886872|17632169|P3|Overall Study|Ineligible|12
5105328|NCT01886872|17632170|P2|Overall Study|Ineligible|4
5105329|NCT01886872|17632171|P1|Overall Study|Ineligible|7
5105330|NCT01886833|17632204|P1|Overall Study|IgA not available from both periods|204
5105331|NCT01886781|17632236|P2|Overall Study|Worsening of symptoms|1
5105332|NCT01886781|17632237|P1|Overall Study|Worsening of symptoms|1
5105333|NCT01886781|17632236|P2|Overall Study|Withdrawal by Subject|1
5105334|NCT01886781|17632237|P1|Overall Study|Withdrawal by Subject|2
5105335|NCT01886781|17632236|P2|Overall Study|Lost to Follow-up|0
5105336|NCT01886781|17632237|P1|Overall Study|Lost to Follow-up|5
5105337|NCT01886781|17632236|P2|Overall Study|Adverse Event|0
5105338|NCT01886781|17632237|P1|Overall Study|Adverse Event|1
5105339|NCT01886781|17632236|P2|Overall Study|Protocol Violation|0
5105340|NCT01886781|17632237|P1|Overall Study|Protocol Violation|5
5105341|NCT01886716|17632247|P4|Week 3|Lost to Follow-up|1
5105342|NCT01886716|17632248|P3|Week 3|Lost to Follow-up|0
5105343|NCT01886716|17632249|P2|Week 3|Lost to Follow-up|1
5105344|NCT01886716|17632250|P1|Week 3|Lost to Follow-up|1
5105345|NCT01886716|17632247|P4|Week 2|Lost to Follow-up|3
5105346|NCT01886716|17632248|P3|Week 2|Lost to Follow-up|1
5105347|NCT01886716|17632249|P2|Week 2|Lost to Follow-up|2
5105348|NCT01886716|17632250|P1|Week 2|Lost to Follow-up|3
5105349|NCT01886716|17632247|P4|Week 1|Lost to Follow-up|2
5105350|NCT01886716|17632248|P3|Week 1|Lost to Follow-up|2
5105351|NCT01886716|17632249|P2|Week 1|Lost to Follow-up|0
5105352|NCT01886716|17632250|P1|Week 1|Lost to Follow-up|0
5105353|NCT01886690|17632266|P2|Overall Study|Personal Reasons|1
5105354|NCT01886690|17632267|P1|Overall Study|Personal Reasons|0
5105355|NCT01886690|17632266|P2|Overall Study|Protocol Violation|1
5105356|NCT01886690|17632267|P1|Overall Study|Protocol Violation|0
5105357|NCT01886313|17632283|P2|Overall Study|Adverse Event|1
5105358|NCT01886313|17632284|P1|Overall Study|Adverse Event|1
5105359|NCT01886300|17632290|P1|Overall Study|Trial terminated by sponsor|16
5105360|NCT01886287|17632301|P1|Overall Study|Clinical progression due to disease|1
5105361|NCT01886287|17632301|P1|Overall Study|Radiographic disease progression|1
5105362|NCT01886105|17632317|P1|Overall Study|Lack of Efficacy|3
5105363|NCT01885936|17632324|P2|Overall Study|Withdrawal by Subject|0
5105364|NCT01885936|17632325|P1|Overall Study|Withdrawal by Subject|1
5105365|NCT01885559|17632408|P2|Overall Study|Protocol Violation|1
5105366|NCT01885559|17632409|P1|Overall Study|Protocol Violation|0
5105367|NCT01885559|17632408|P2|Overall Study|Less than full participation|19
5105368|NCT01885559|17632409|P1|Overall Study|Less than full participation|9
5105369|NCT01885559|17632408|P2|Overall Study|Lost to Follow-up|16
5105370|NCT01885559|17632409|P1|Overall Study|Lost to Follow-up|15
5105371|NCT01885208|17632431|P2|Overall Study|Unclassified|38
5105372|NCT01885208|17632432|P1|Overall Study|Unclassified|32
5105373|NCT01885182|17632450|P2|Overall Study|Lack of Efficacy|1
5105374|NCT01885182|17632451|P1|Overall Study|Lack of Efficacy|8
5105375|NCT01885182|17632450|P2|Overall Study|Lost to Follow-up|2
5105376|NCT01885182|17632451|P1|Overall Study|Lost to Follow-up|2
5105377|NCT01885182|17632450|P2|Overall Study|Withdrawal by Subject|6
5105378|NCT01885182|17632451|P1|Overall Study|Withdrawal by Subject|13
5105379|NCT01885182|17632450|P2|Overall Study|Adverse Event|13
5105380|NCT01885182|17632451|P1|Overall Study|Adverse Event|11
5105381|NCT01885104|17632498|P2|Overall Study|Physician Decision|0
5105382|NCT01885104|17632499|P1|Overall Study|Physician Decision|1
5105383|NCT01885104|17632498|P2|Overall Study|Lost to Follow-up|1
5105384|NCT01885104|17632499|P1|Overall Study|Lost to Follow-up|0
5105385|NCT01885104|17632498|P2|Overall Study|Withdrawal of Consent|0
5105386|NCT01885104|17632499|P1|Overall Study|Withdrawal of Consent|1
5105387|NCT01885000|17632509|P2|Overall Study|Protocol Violation|1
5105388|NCT01885000|17632510|P1|Overall Study|Protocol Violation|0
5105389|NCT01885000|17632509|P2|Overall Study|Withdrawal by Subject|1
5105390|NCT01885000|17632510|P1|Overall Study|Withdrawal by Subject|1
5105391|NCT01885000|17632509|P2|Overall Study|Adverse Event|0
5105392|NCT01885000|17632510|P1|Overall Study|Adverse Event|1
5105393|NCT01884688|17632531|P1|Overall Study|Screen Failure|2
5105394|NCT01884675|17632537|P2|Overall Study|Study closed/terminated|2
5105395|NCT01884675|17632538|P1|Overall Study|Study closed/terminated|3
5105396|NCT01884597|17632581|P3|Overall Study|Death|0
5105397|NCT01884597|17632582|P2|Overall Study|Death|1
5105398|NCT01884597|17632583|P1|Overall Study|Death|0
5105399|NCT01884597|17632581|P3|Overall Study|Lack of Efficacy|0
5105400|NCT01884597|17632582|P2|Overall Study|Lack of Efficacy|0
5105401|NCT01884597|17632583|P1|Overall Study|Lack of Efficacy|1
5105402|NCT01884597|17632581|P3|Overall Study|Adverse Event|1
5105403|NCT01884597|17632582|P2|Overall Study|Adverse Event|0
5105404|NCT01884597|17632583|P1|Overall Study|Adverse Event|0
5105405|NCT01884571|17632612|P1|Overall Study|Disease progression|3
5105406|NCT01884571|17632612|P1|Overall Study|Withdrawal by Subject|2
5105407|NCT01884571|17632612|P1|Overall Study|Death|2
5105408|NCT01884571|17632612|P1|Overall Study|Adverse Event|1
5105409|NCT01884545|17632627|P4|Overall Study|Non-adherence|0
5105410|NCT01884545|17632628|P3|Overall Study|Non-adherence|0
5105411|NCT01884545|17632629|P2|Overall Study|Non-adherence|2
5105412|NCT01884545|17632630|P1|Overall Study|Non-adherence|0
5105413|NCT01884545|17632627|P4|Overall Study|Patient withdrawn|5
5105414|NCT01884545|17632628|P3|Overall Study|Patient withdrawn|5
5105415|NCT01884545|17632629|P2|Overall Study|Patient withdrawn|12
5105416|NCT01884545|17632630|P1|Overall Study|Patient withdrawn|7
5105417|NCT01884545|17632627|P4|Overall Study|Lost to Follow-up|4
5105418|NCT01884545|17632628|P3|Overall Study|Lost to Follow-up|9
5105419|NCT01884545|17632629|P2|Overall Study|Lost to Follow-up|4
5105420|NCT01884545|17632630|P1|Overall Study|Lost to Follow-up|6
5105421|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
5105422|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
5105423|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
5105424|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
5105425|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
5105426|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
5105427|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
5105428|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
5105429|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
5105430|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
5105431|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
5105432|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
5105433|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
5105434|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
5105435|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
5105436|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
5105437|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
5105438|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
5105439|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
5105440|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
5105441|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
5105442|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
5105443|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
5105444|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
5105445|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
5105446|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
5105447|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
5105448|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
5105449|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
5105450|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
5105451|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
5105452|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
5105453|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
5105454|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
5105455|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
5105456|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
5105457|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
5105458|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
5105459|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
5105460|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
5105461|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
5105462|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
5105463|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
5105544|NCT01882647|17633118|P2|Overall Study|Withdrawal by Subject|4
5105464|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
5105465|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
5105466|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
5105467|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
5105468|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
5105469|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
5105470|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
5105471|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
5105472|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
5105473|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
5105474|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
5105475|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
5105476|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
5105477|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
5105478|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
5105479|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
5105480|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
5105481|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
5105482|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
5105483|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
5105484|NCT01884350|17632783|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
5105485|NCT01884350|17632784|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
5105486|NCT01884350|17632785|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
5105487|NCT01884337|17632808|P2|Follow-up Period|Lost to Follow-up|1
5105488|NCT01884337|17632809|P1|Follow-up Period|Lost to Follow-up|1
5105489|NCT01884337|17632808|P2|Treatment|Subj. request to discont. treatment|0
5105490|NCT01884337|17632809|P1|Treatment|Subj. request to discont. treatment|2
5105491|NCT01884337|17632808|P2|Treatment|Adverse Event|2
5105492|NCT01884337|17632809|P1|Treatment|Adverse Event|2
5105493|NCT01884311|17632817|P1|Overall Study|Precautionary measure|1
5105494|NCT01884311|17632817|P1|Overall Study|withdrew consent due to AEs|1
5105495|NCT01884311|17632817|P1|Overall Study|Withdrawal by Subject|3
5105496|NCT01884077|17632827|P2|Overall Study|study closed|4
5105497|NCT01884077|17632828|P1|Overall Study|study closed|6
5105498|NCT01884077|17632827|P2|Overall Study|Lost to Follow-up|4
5105499|NCT01884077|17632828|P1|Overall Study|Lost to Follow-up|0
5105500|NCT01884077|17632827|P2|Overall Study|canceled surgery|0
5105501|NCT01884077|17632828|P1|Overall Study|canceled surgery|2
5105502|NCT01884077|17632827|P2|Overall Study|screen fail|2
5105503|NCT01884077|17632828|P1|Overall Study|screen fail|0
5105504|NCT01884025|17632849|P2|Overall Study|Lost to Follow-up|4
5105505|NCT01884025|17632850|P1|Overall Study|Lost to Follow-up|3
5105506|NCT01883895|17632910|P1|Overall Study|Lost to Follow-up|2
5105507|NCT01883635|17632937|P2|Overall Study|Withdrawal by Subject|0
5105508|NCT01883635|17632938|P1|Overall Study|Withdrawal by Subject|4
5105509|NCT01883492|17632952|P2|Overall Study|bone anatomy did not meet study criteria|1
5105510|NCT01883492|17632953|P1|Overall Study|bone anatomy did not meet study criteria|1
5105511|NCT01883492|17632952|P2|Overall Study|inappropriate implant used|1
5105512|NCT01883492|17632953|P1|Overall Study|inappropriate implant used|1
5105513|NCT01883492|17632952|P2|Overall Study|Withdrawal by Subject|0
5105514|NCT01883492|17632953|P1|Overall Study|Withdrawal by Subject|1
5105515|NCT01883492|17632952|P2|Overall Study|Poor X-ray quality|4
5105516|NCT01883492|17632953|P1|Overall Study|Poor X-ray quality|7
5105517|NCT01883492|17632952|P2|Overall Study|Surgery on contra-lateral hip|1
5105518|NCT01883492|17632953|P1|Overall Study|Surgery on contra-lateral hip|0
5105519|NCT01883492|17632952|P2|Overall Study|Lost to Follow-up|4
5105520|NCT01883492|17632953|P1|Overall Study|Lost to Follow-up|3
5105521|NCT01883453|17632985|P2|Overall Study|No episode of common cold|23
5105522|NCT01883453|17632986|P1|Overall Study|No episode of common cold|25
5105523|NCT01882985|17633021|P1|Overall Study|Withdrawal by Subject|1
5105524|NCT01882985|17633021|P1|Overall Study|Lost to Follow-up|1
5105525|NCT01882907|17633030|P2|Overall Study|Withdrawal by Subject|6
5105526|NCT01882907|17633031|P1|Overall Study|Withdrawal by Subject|0
5105527|NCT01882907|17633030|P2|Overall Study|Protocol Violation|14
5105528|NCT01882907|17633031|P1|Overall Study|Protocol Violation|10
5105529|NCT01882907|17633030|P2|Overall Study|Lost to Follow-up|4
5105530|NCT01882907|17633031|P1|Overall Study|Lost to Follow-up|1
5105531|NCT01882907|17633030|P2|Overall Study|Lack of Efficacy|3
5105532|NCT01882907|17633031|P1|Overall Study|Lack of Efficacy|0
5105533|NCT01882907|17633030|P2|Overall Study|Adverse Event|1
5105534|NCT01882907|17633031|P1|Overall Study|Adverse Event|3
5105535|NCT01882829|17633077|P1|Overall Study|Withdrawal by Subject|1
5105536|NCT01882829|17633077|P1|Overall Study|Protocol Violation|1
5105537|NCT01882829|17633077|P1|Overall Study|Adverse Event|4
5105538|NCT01882803|17633091|P1|Overall Study|Withdrawal by Subject|4
5105539|NCT01882803|17633091|P1|Overall Study|Protocol Violation|1
5105540|NCT01882803|17633091|P1|Overall Study|Physician Decision|7
5105541|NCT01882803|17633091|P1|Overall Study|Death|7
5105542|NCT01882803|17633091|P1|Overall Study|Adverse Event|22
5105543|NCT01882803|17633091|P1|Overall Study|Disease Progression|53
5105545|NCT01882647|17633119|P1|Overall Study|Withdrawal by Subject|0
5105546|NCT01882647|17633118|P2|Overall Study|Lost to Follow-up|2
5105547|NCT01882647|17633119|P1|Overall Study|Lost to Follow-up|2
5105548|NCT01882465|17633159|P7|Period 2|Protocol Violation|0
5105549|NCT01882465|17633160|P6|Period 2|Protocol Violation|0
5105550|NCT01882465|17633161|P5|Period 2|Protocol Violation|1
5105551|NCT01882465|17633162|P4|Period 2|Protocol Violation|0
5105552|NCT01882465|17633163|P3|Period 2|Protocol Violation|0
5105553|NCT01882465|17633164|P2|Period 2|Protocol Violation|0
5105554|NCT01882465|17633165|P1|Period 2|Protocol Violation|0
5105555|NCT01882465|17633159|P7|Period 1|Withdrawal by Subject|1
5105556|NCT01882465|17633160|P6|Period 1|Withdrawal by Subject|0
5105557|NCT01882465|17633161|P5|Period 1|Withdrawal by Subject|0
5105558|NCT01882465|17633162|P4|Period 1|Withdrawal by Subject|0
5105559|NCT01882465|17633163|P3|Period 1|Withdrawal by Subject|0
5105560|NCT01882465|17633164|P2|Period 1|Withdrawal by Subject|0
5105561|NCT01882465|17633165|P1|Period 1|Withdrawal by Subject|0
5105562|NCT01882465|17633159|P7|Period 1|Lens Discomfort|0
5105563|NCT01882465|17633160|P6|Period 1|Lens Discomfort|0
5105564|NCT01882465|17633161|P5|Period 1|Lens Discomfort|0
5105565|NCT01882465|17633162|P4|Period 1|Lens Discomfort|1
5105566|NCT01882465|17633163|P3|Period 1|Lens Discomfort|0
5105567|NCT01882465|17633164|P2|Period 1|Lens Discomfort|0
5105568|NCT01882465|17633165|P1|Period 1|Lens Discomfort|0
5105569|NCT01882439|17633177|P4|Overall Study|Adverse event unrelated to study drug|1
5105570|NCT01882439|17633178|P3|Overall Study|Adverse event unrelated to study drug|1
5105571|NCT01882439|17633179|P2|Overall Study|Adverse event unrelated to study drug|2
5105572|NCT01882439|17633180|P1|Overall Study|Adverse event unrelated to study drug|2
5105573|NCT01882439|17633177|P4|Overall Study|Insufficient clinical response|2
5105574|NCT01882439|17633178|P3|Overall Study|Insufficient clinical response|4
5105575|NCT01882439|17633179|P2|Overall Study|Insufficient clinical response|4
5105576|NCT01882439|17633180|P1|Overall Study|Insufficient clinical response|1
5105577|NCT01882439|17633177|P4|Overall Study|Medication error with no associated AE|0
5105578|NCT01882439|17633178|P3|Overall Study|Medication error with no associated AE|2
5105579|NCT01882439|17633179|P2|Overall Study|Medication error with no associated AE|0
5105580|NCT01882439|17633180|P1|Overall Study|Medication error with no associated AE|0
5105581|NCT01882439|17633177|P4|Overall Study|No longer willing to participate|3
5105582|NCT01882439|17633178|P3|Overall Study|No longer willing to participate|2
5105583|NCT01882439|17633179|P2|Overall Study|No longer willing to participate|4
5105584|NCT01882439|17633180|P1|Overall Study|No longer willing to participate|1
5105585|NCT01882439|17633177|P4|Overall Study|Protocol Violation|1
5105586|NCT01882439|17633178|P3|Overall Study|Protocol Violation|0
5105587|NCT01882439|17633179|P2|Overall Study|Protocol Violation|2
5105588|NCT01882439|17633180|P1|Overall Study|Protocol Violation|2
5105589|NCT01882439|17633177|P4|Overall Study|Pregnancy|0
5105590|NCT01882439|17633178|P3|Overall Study|Pregnancy|0
5105591|NCT01882439|17633179|P2|Overall Study|Pregnancy|1
5105592|NCT01882439|17633180|P1|Overall Study|Pregnancy|0
5105593|NCT01882439|17633177|P4|Overall Study|Adverse event related to study drug|2
5105594|NCT01882439|17633178|P3|Overall Study|Adverse event related to study drug|1
5105595|NCT01882439|17633179|P2|Overall Study|Adverse event related to study drug|8
5105596|NCT01882439|17633180|P1|Overall Study|Adverse event related to study drug|3
5105597|NCT01882257|17633377|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
5105598|NCT01882257|17633378|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
5105599|NCT01882257|17633379|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
5105600|NCT01882257|17633377|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
5105601|NCT01882257|17633378|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
5105602|NCT01882257|17633379|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
5105603|NCT01882088|17633386|P1|Overall Study|inadequate pH-impedance tracings|2
5105604|NCT01882088|17633386|P1|Overall Study|Protocol Violation|1
5105605|NCT01882088|17633386|P1|Overall Study|no possibility to place the catheter|1
5105606|NCT01882088|17633386|P1|Overall Study|Intolerance of esophageal manometry|1
5105607|NCT01881776|17633468|P3|Overall Study|Protocol Violation|1
5105608|NCT01881776|17633469|P2|Overall Study|Protocol Violation|2
5105609|NCT01881776|17633470|P1|Overall Study|Protocol Violation|0
5105610|NCT01881776|17633468|P3|Overall Study|Lost to Follow-up|1
5105611|NCT01881776|17633469|P2|Overall Study|Lost to Follow-up|2
5105612|NCT01881776|17633470|P1|Overall Study|Lost to Follow-up|1
5105613|NCT01881750|17633498|P2|Overall Study|Lost to Follow-up|1
5105614|NCT01881750|17633499|P1|Overall Study|Lost to Follow-up|0
5105615|NCT01881750|17633498|P2|Overall Study|Changes in concomitant therapies|3
5105616|NCT01881750|17633499|P1|Overall Study|Changes in concomitant therapies|2
5105617|NCT01881737|17633517|P1|Overall Study|Worsening of baseline behavior|1
5105618|NCT01881737|17633517|P1|Overall Study|Withdrawal by Subject|1
5105619|NCT01881737|17633517|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
5105620|NCT01881620|17633526|P1|Overall Study|Protocol Violation|4
5105621|NCT01881230|17633606|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
5105622|NCT01881230|17633607|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
5105623|NCT01881230|17633608|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
5105624|NCT01881230|17633606|P3|Overall Study|Untreated: Death|1
5105625|NCT01881230|17633607|P2|Overall Study|Untreated: Death|0
5105626|NCT01881230|17633608|P1|Overall Study|Untreated: Death|0
5105627|NCT01881230|17633606|P3|Overall Study|Untreated: Other|1
5105628|NCT01881230|17633607|P2|Overall Study|Untreated: Other|0
5105629|NCT01881230|17633608|P1|Overall Study|Untreated: Other|0
5105630|NCT01881230|17633606|P3|Overall Study|Miscellaneous|0
5105631|NCT01881230|17633607|P2|Overall Study|Miscellaneous|3
5105632|NCT01881230|17633608|P1|Overall Study|Miscellaneous|3
5105633|NCT01881230|17633606|P3|Overall Study|Protocol Violation|0
5105634|NCT01881230|17633607|P2|Overall Study|Protocol Violation|1
5105635|NCT01881230|17633608|P1|Overall Study|Protocol Violation|1
5105636|NCT01881230|17633606|P3|Overall Study|Given Commercially Available Drug|2
5105637|NCT01881230|17633607|P2|Overall Study|Given Commercially Available Drug|0
5105638|NCT01881230|17633608|P1|Overall Study|Given Commercially Available Drug|0
5105639|NCT01881230|17633606|P3|Overall Study|Non-Compliance with Study Drug|0
5105640|NCT01881230|17633607|P2|Overall Study|Non-Compliance with Study Drug|2
5105641|NCT01881230|17633608|P1|Overall Study|Non-Compliance with Study Drug|1
5105642|NCT01881230|17633606|P3|Overall Study|Physician Decision|6
5105643|NCT01881230|17633607|P2|Overall Study|Physician Decision|3
5105644|NCT01881230|17633608|P1|Overall Study|Physician Decision|4
5105645|NCT01881230|17633606|P3|Overall Study|Withdrawal by Subject|6
5105646|NCT01881230|17633607|P2|Overall Study|Withdrawal by Subject|4
5105647|NCT01881230|17633608|P1|Overall Study|Withdrawal by Subject|6
5105648|NCT01881230|17633606|P3|Overall Study|Symptomatic Deterioration|1
5105649|NCT01881230|17633607|P2|Overall Study|Symptomatic Deterioration|3
5105650|NCT01881230|17633608|P1|Overall Study|Symptomatic Deterioration|3
5105651|NCT01881230|17633606|P3|Overall Study|Progressive Disease|36
5105652|NCT01881230|17633607|P2|Overall Study|Progressive Disease|35
5105653|NCT01881230|17633608|P1|Overall Study|Progressive Disease|31
5105654|NCT01881230|17633606|P3|Overall Study|Adverse Event|12
5105655|NCT01881230|17633607|P2|Overall Study|Adverse Event|13
5105656|NCT01881230|17633608|P1|Overall Study|Adverse Event|9
5105657|NCT01881230|17633606|P3|Overall Study|Death|1
5105658|NCT01881230|17633607|P2|Overall Study|Death|0
5105659|NCT01881230|17633608|P1|Overall Study|Death|2
5105660|NCT01881126|17633636|P2|Overall Study|Adverse Event|1
5105661|NCT01881126|17633637|P1|Overall Study|Adverse Event|0
5105662|NCT01881126|17633636|P2|Overall Study|Non-compliance|1
5105663|NCT01881126|17633637|P1|Overall Study|Non-compliance|1
5105664|NCT01881009|17633718|P2|Summer Camp Session (6 Days)|Unable to wear device|1
5105665|NCT01881009|17633719|P1|Summer Camp Session (6 Days)|Unable to wear device|0
5105666|NCT01880736|17633741|P4|Overall Study|Withdrawal Criteria|5
5105667|NCT01880736|17633742|P3|Overall Study|Withdrawal Criteria|1
5105668|NCT01880736|17633743|P2|Overall Study|Withdrawal Criteria|2
5105669|NCT01880736|17633744|P1|Overall Study|Withdrawal Criteria|1
5105670|NCT01880736|17633741|P4|Overall Study|Adverse Event|1
5105671|NCT01880736|17633742|P3|Overall Study|Adverse Event|0
5105672|NCT01880736|17633743|P2|Overall Study|Adverse Event|0
5105673|NCT01880736|17633744|P1|Overall Study|Adverse Event|0
5105674|NCT01880593|17633828|P2|Overall Study|Withdrawal by Subject|1
5105675|NCT01880593|17633829|P1|Overall Study|Withdrawal by Subject|6
5105676|NCT01880593|17633828|P2|Overall Study|Lack of Efficacy|5
5105677|NCT01880593|17633829|P1|Overall Study|Lack of Efficacy|1
5105678|NCT01880593|17633828|P2|Overall Study|Adverse Event|0
5105679|NCT01880593|17633829|P1|Overall Study|Adverse Event|1
5105680|NCT01880528|17633849|P2|Overall Study|Other|1
5105681|NCT01880528|17633850|P1|Overall Study|Other|1
5105682|NCT01880515|17633866|P2|Overall Study|Disease Progression|7
5105683|NCT01880515|17633867|P1|Overall Study|Disease Progression|5
5105684|NCT01880515|17633866|P2|Overall Study|Lost to Follow-up|2
5105685|NCT01880515|17633867|P1|Overall Study|Lost to Follow-up|3
5105686|NCT01880437|17633878|P3|Overall Study|Study terminated by Sponsor|2
5105687|NCT01880437|17633879|P2|Overall Study|Study terminated by Sponsor|0
5105688|NCT01880437|17633880|P1|Overall Study|Study terminated by Sponsor|3
5105689|NCT01880437|17633878|P3|Overall Study|Death|17
5105690|NCT01880437|17633879|P2|Overall Study|Death|4
5105691|NCT01880437|17633880|P1|Overall Study|Death|12
5105692|NCT01880424|17633906|P2|Overall Study|Other|0
5105693|NCT01880424|17633907|P1|Overall Study|Other|1
5105694|NCT01880424|17633906|P2|Overall Study|Withdrawal by Subject|30
5105695|NCT01880424|17633907|P1|Overall Study|Withdrawal by Subject|10
5105696|NCT01880424|17633906|P2|Overall Study|Protocol Violation|13
5105697|NCT01880424|17633907|P1|Overall Study|Protocol Violation|11
5105698|NCT01880424|17633906|P2|Overall Study|Lost to Follow-up|2
5105699|NCT01880424|17633907|P1|Overall Study|Lost to Follow-up|3
5105700|NCT01880424|17633906|P2|Overall Study|Lack of Efficacy|4
5105701|NCT01880424|17633907|P1|Overall Study|Lack of Efficacy|1
5105702|NCT01880424|17633906|P2|Overall Study|Adverse Event|6
5105703|NCT01880424|17633907|P1|Overall Study|Adverse Event|7
5105704|NCT01880086|17633963|P2|Overall Study|Lost to Follow-up|1
5105705|NCT01880086|17633964|P1|Overall Study|Lost to Follow-up|1
5105706|NCT01879852|17634019|P2|Overall Study|Withdrawal by Subject|0
5105707|NCT01879852|17634020|P1|Overall Study|Withdrawal by Subject|2
5105708|NCT01879722|17634075|P10|Overall Study|Voluntary Withdrawal|0
5105709|NCT01879722|17634076|P9|Overall Study|Voluntary Withdrawal|1
5105710|NCT01879722|17634077|P8|Overall Study|Voluntary Withdrawal|0
5105711|NCT01879722|17634078|P7|Overall Study|Voluntary Withdrawal|0
5105712|NCT01879722|17634079|P6|Overall Study|Voluntary Withdrawal|0
5105713|NCT01879722|17634080|P5|Overall Study|Voluntary Withdrawal|0
5105714|NCT01879722|17634081|P4|Overall Study|Voluntary Withdrawal|0
5105715|NCT01879722|17634082|P3|Overall Study|Voluntary Withdrawal|0
5105716|NCT01879722|17634083|P2|Overall Study|Voluntary Withdrawal|0
5105717|NCT01879722|17634084|P1|Overall Study|Voluntary Withdrawal|0
5105718|NCT01879722|17634075|P10|Overall Study|Pretreatment Event/Adverse Event|0
5105719|NCT01879722|17634076|P9|Overall Study|Pretreatment Event/Adverse Event|1
5105720|NCT01879722|17634077|P8|Overall Study|Pretreatment Event/Adverse Event|1
5105721|NCT01879722|17634078|P7|Overall Study|Pretreatment Event/Adverse Event|0
5105722|NCT01879722|17634079|P6|Overall Study|Pretreatment Event/Adverse Event|0
5105723|NCT01879722|17634080|P5|Overall Study|Pretreatment Event/Adverse Event|1
5105724|NCT01879722|17634081|P4|Overall Study|Pretreatment Event/Adverse Event|1
5105725|NCT01879722|17634082|P3|Overall Study|Pretreatment Event/Adverse Event|0
5105726|NCT01879722|17634083|P2|Overall Study|Pretreatment Event/Adverse Event|1
5105727|NCT01879722|17634084|P1|Overall Study|Pretreatment Event/Adverse Event|0
5105728|NCT01879683|17634232|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
5105729|NCT01879618|17634239|P1|Overall Study|Adverse Event|5
5105730|NCT01879618|17634239|P1|Overall Study|Protocol Violation|6
5105731|NCT01879618|17634239|P1|Overall Study|Surgery;changed schedule; not available|8
5105732|NCT01879618|17634239|P1|Overall Study|Withdrawal by Subject|1
5105733|NCT01879618|17634239|P1|Overall Study|Does not meet entrance criteria|1
5105734|NCT01879579|17634246|P2|Overall Study|Discontinued insulin - possible allergy|1
5105735|NCT01879579|17634247|P1|Overall Study|Discontinued insulin - possible allergy|0
5105736|NCT01879579|17634246|P2|Overall Study|Phenotypic type 1 diabetes|1
5105737|NCT01879579|17634247|P1|Overall Study|Phenotypic type 1 diabetes|0
5105738|NCT01879579|17634246|P2|Overall Study|Did not initiate insulin treatment|0
5105739|NCT01879579|17634247|P1|Overall Study|Did not initiate insulin treatment|1
5105740|NCT01879579|17634246|P2|Overall Study|Did not enroll in texting platform|0
5105741|NCT01879579|17634247|P1|Overall Study|Did not enroll in texting platform|1
5105742|NCT01879579|17634246|P2|Overall Study|Phone incompatible with texting platform|0
5105743|NCT01879579|17634247|P1|Overall Study|Phone incompatible with texting platform|3
5105744|NCT01879553|17634277|P2|Overall Study|Withdrawal by Subject|0
5105745|NCT01879553|17634278|P1|Overall Study|Withdrawal by Subject|1
5105746|NCT01879410|17634312|P2|Overall Study|Randomised in Error|2
5105747|NCT01879410|17634313|P1|Overall Study|Randomised in Error|1
5105748|NCT01879410|17634312|P2|Overall Study|Withdrawal by Subject|8
5105749|NCT01879410|17634313|P1|Overall Study|Withdrawal by Subject|7
5105750|NCT01879410|17634312|P2|Overall Study|Lost to Follow-up|1
5105751|NCT01879410|17634313|P1|Overall Study|Lost to Follow-up|2
5105752|NCT01879410|17634312|P2|Overall Study|Protocol Violation|7
5105753|NCT01879410|17634313|P1|Overall Study|Protocol Violation|1
5105754|NCT01879410|17634312|P2|Overall Study|Lack of Efficacy|6
5105755|NCT01879410|17634313|P1|Overall Study|Lack of Efficacy|4
5105756|NCT01879410|17634312|P2|Overall Study|Adverse Event|14
5105757|NCT01879410|17634313|P1|Overall Study|Adverse Event|9
5105758|NCT01879319|17634380|P2|Overall Study|Lost to Follow-up|5
5105759|NCT01879319|17634381|P1|Overall Study|Lost to Follow-up|1
5105760|NCT01879319|17634380|P2|Overall Study|Withdrawal by Subject|0
5105761|NCT01879319|17634381|P1|Overall Study|Withdrawal by Subject|1
5105762|NCT01879072|17634398|P1|Overall Study|Not Transplanted|30
5105763|NCT01879072|17634398|P1|Overall Study|Withdrawal by Subject|121
5105764|NCT01878383|17634542|P2|Overall Study|Lost to Follow-up|1499
5105765|NCT01878383|17634543|P1|Overall Study|Lost to Follow-up|0
5105766|NCT01878292|17634553|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
5105767|NCT01878292|17634554|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
5105768|NCT01878292|17634555|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
5105769|NCT01878292|17634553|P3|Double-blind Treatment Period|Adverse Event|8
5105770|NCT01878292|17634554|P2|Double-blind Treatment Period|Adverse Event|9
5105771|NCT01878292|17634555|P1|Double-blind Treatment Period|Adverse Event|4
5105772|NCT01878292|17634553|P3|Double-blind Treatment Period|Lack of Efficacy|0
5105773|NCT01878292|17634554|P2|Double-blind Treatment Period|Lack of Efficacy|3
5105774|NCT01878292|17634555|P1|Double-blind Treatment Period|Lack of Efficacy|5
5105775|NCT01878292|17634553|P3|Double-blind Treatment Period|Protocol Violation|2
5105776|NCT01878292|17634554|P2|Double-blind Treatment Period|Protocol Violation|4
5105777|NCT01878292|17634555|P1|Double-blind Treatment Period|Protocol Violation|3
5105778|NCT01878292|17634553|P3|Double-blind Treatment Period|Withdrawal by Subject|8
5105779|NCT01878292|17634554|P2|Double-blind Treatment Period|Withdrawal by Subject|7
5105780|NCT01878292|17634555|P1|Double-blind Treatment Period|Withdrawal by Subject|9
5105781|NCT01878292|17634553|P3|Double-blind Treatment Period|Lost to Follow-up|1
5105782|NCT01878292|17634554|P2|Double-blind Treatment Period|Lost to Follow-up|3
5105783|NCT01878292|17634555|P1|Double-blind Treatment Period|Lost to Follow-up|6
5105784|NCT01878292|17634553|P3|Double-blind Treatment Period|Other Reasons|0
5105785|NCT01878292|17634554|P2|Double-blind Treatment Period|Other Reasons|0
5105786|NCT01878292|17634555|P1|Double-blind Treatment Period|Other Reasons|2
5105787|NCT01878292|17634553|P3|Randomized|Adverse Event|0
5105788|NCT01878292|17634554|P2|Randomized|Adverse Event|0
5105789|NCT01878292|17634555|P1|Randomized|Adverse Event|1
5105790|NCT01878292|17634553|P3|Randomized|Lost to Follow-up|0
5105791|NCT01878292|17634554|P2|Randomized|Lost to Follow-up|0
5105792|NCT01878292|17634555|P1|Randomized|Lost to Follow-up|1
5105793|NCT01878292|17634553|P3|Randomized|Protocol Violation|0
5105794|NCT01878292|17634554|P2|Randomized|Protocol Violation|0
5105795|NCT01878292|17634555|P1|Randomized|Protocol Violation|1
5105796|NCT01878253|17634566|P1|Overall Study|Completed Study w/o Follow-up Data|2
5105797|NCT01878253|17634566|P1|Overall Study|Lost to Follow-up|2
5105798|NCT01878253|17634566|P1|Overall Study|Withdrawal by Subject|1
5105799|NCT01878253|17634566|P1|Overall Study|SIdus System Removal|3
5105800|NCT01878253|17634566|P1|Overall Study|Death|1
5105801|NCT01878214|17634577|P2|Overall Study|Lost to Follow-up|36
5105802|NCT01878214|17634578|P1|Overall Study|Lost to Follow-up|35
5105803|NCT01878214|17634577|P2|Overall Study|Death|1
5105804|NCT01878214|17634578|P1|Overall Study|Death|0
5105805|NCT01878214|17634577|P2|Overall Study|Withdrawal by Subject|7
5105806|NCT01878214|17634578|P1|Overall Study|Withdrawal by Subject|18
5105807|NCT01878175|17634592|P1|Overall Study|Developed contraindicated health problem|2
5105808|NCT01878149|17634611|P2|Overall Study|Did Not Meet Eligibility Criteria|2
5105809|NCT01878149|17634612|P1|Overall Study|Did Not Meet Eligibility Criteria|2
5105810|NCT01878097|17634620|P2|Implementation Year 4|Surveys not fully completed|3007
5105811|NCT01878097|17634621|P1|Implementation Year 4|Surveys not fully completed|3604
5105812|NCT01878097|17634620|P2|Implementation Year 3|Surveys not fully completed|2980
5105813|NCT01878097|17634621|P1|Implementation Year 3|Surveys not fully completed|3494
5105814|NCT01878097|17634620|P2|Implementation Year 2|Surveys not fully completed|2841
5105815|NCT01878097|17634621|P1|Implementation Year 2|Surveys not fully completed|3281
5105816|NCT01878097|17634620|P2|Implementation Year 1|Surveys not fully completed|2549
5105817|NCT01878097|17634621|P1|Implementation Year 1|Surveys not fully completed|3202
5105818|NCT01878097|17634620|P2|Baseline|Surveys not fully completed|1800
5105819|NCT01878097|17634621|P1|Baseline|Surveys not fully completed|2497
5105820|NCT01878084|17634629|P1|Overall Study|Physician Decision|2
5105821|NCT01877915|17634663|P2|Overall Study|Other|4
5105822|NCT01877915|17634664|P1|Overall Study|Other|2
5105823|NCT01877915|17634663|P2|Overall Study|Withdrawal by Subject|55
5105824|NCT01877915|17634664|P1|Overall Study|Withdrawal by Subject|42
5105825|NCT01877915|17634663|P2|Overall Study|Lost to Follow-up|9
5105826|NCT01877915|17634664|P1|Overall Study|Lost to Follow-up|10
5105827|NCT01877720|17634686|P2|Overall Study|Adverse Event|0
5105828|NCT01877720|17634687|P1|Overall Study|Adverse Event|1
5105829|NCT01877668|17634716|P5|Overall Study|Adverse event unrelated to study drug|1
5105830|NCT01877668|17634717|P4|Overall Study|Adverse event unrelated to study drug|0
5105831|NCT01877668|17634718|P3|Overall Study|Adverse event unrelated to study drug|2
5105832|NCT01877668|17634719|P2|Overall Study|Adverse event unrelated to study drug|1
5105833|NCT01877668|17634720|P1|Overall Study|Adverse event unrelated to study drug|4
5105834|NCT01877668|17634716|P5|Overall Study|Adverse event related to study drug|1
5105835|NCT01877668|17634717|P4|Overall Study|Adverse event related to study drug|2
5105836|NCT01877668|17634718|P3|Overall Study|Adverse event related to study drug|2
5105837|NCT01877668|17634719|P2|Overall Study|Adverse event related to study drug|2
5105838|NCT01877668|17634720|P1|Overall Study|Adverse event related to study drug|2
5105839|NCT01877668|17634716|P5|Overall Study|Protocol Violation|3
5105840|NCT01877668|17634717|P4|Overall Study|Protocol Violation|0
5105841|NCT01877668|17634718|P3|Overall Study|Protocol Violation|0
5105842|NCT01877668|17634719|P2|Overall Study|Protocol Violation|1
5105843|NCT01877668|17634720|P1|Overall Study|Protocol Violation|1
5105844|NCT01877668|17634716|P5|Overall Study|Other|3
5105845|NCT01877668|17634717|P4|Overall Study|Other|1
5105846|NCT01877668|17634718|P3|Overall Study|Other|1
5105847|NCT01877668|17634719|P2|Overall Study|Other|1
5105848|NCT01877668|17634720|P1|Overall Study|Other|1
5105849|NCT01877668|17634716|P5|Overall Study|Withdrawal by Subject|2
5105850|NCT01877668|17634717|P4|Overall Study|Withdrawal by Subject|2
5105851|NCT01877668|17634718|P3|Overall Study|Withdrawal by Subject|3
5105852|NCT01877668|17634719|P2|Overall Study|Withdrawal by Subject|0
5105853|NCT01877668|17634720|P1|Overall Study|Withdrawal by Subject|2
5105854|NCT01877668|17634716|P5|Overall Study|Lost to Follow-up|0
5105855|NCT01877668|17634717|P4|Overall Study|Lost to Follow-up|0
5105856|NCT01877668|17634718|P3|Overall Study|Lost to Follow-up|1
5105857|NCT01877668|17634719|P2|Overall Study|Lost to Follow-up|2
5105858|NCT01877668|17634720|P1|Overall Study|Lost to Follow-up|0
5105859|NCT01877668|17634716|P5|Overall Study|Insufficient clinical response|0
5105860|NCT01877668|17634717|P4|Overall Study|Insufficient clinical response|2
5105861|NCT01877668|17634718|P3|Overall Study|Insufficient clinical response|2
5105862|NCT01877668|17634719|P2|Overall Study|Insufficient clinical response|1
5105863|NCT01877668|17634720|P1|Overall Study|Insufficient clinical response|0
5105864|NCT01877668|17634716|P5|Overall Study|No longer met study criteria|0
5105865|NCT01877668|17634717|P4|Overall Study|No longer met study criteria|0
5105866|NCT01877668|17634718|P3|Overall Study|No longer met study criteria|1
5105867|NCT01877668|17634719|P2|Overall Study|No longer met study criteria|0
5105868|NCT01877668|17634720|P1|Overall Study|No longer met study criteria|1
5105869|NCT01877668|17634716|P5|Overall Study|Death|0
5105870|NCT01877668|17634717|P4|Overall Study|Death|1
5105871|NCT01877668|17634718|P3|Overall Study|Death|0
5105872|NCT01877668|17634719|P2|Overall Study|Death|0
5105873|NCT01877668|17634720|P1|Overall Study|Death|0
5105874|NCT01877655|17634951|P2|Overall Study|Randomized but Never Received Drug|5
5105875|NCT01877655|17634952|P1|Overall Study|Randomized but Never Received Drug|8
5105876|NCT01877655|17634951|P2|Overall Study|Miscellaneous|4
5105877|NCT01877655|17634952|P1|Overall Study|Miscellaneous|4
5105878|NCT01877655|17634951|P2|Overall Study|Physician Decision|10
5105879|NCT01877655|17634952|P1|Overall Study|Physician Decision|11
5105880|NCT01877655|17634951|P2|Overall Study|Withdrawal by Subject|26
5105881|NCT01877655|17634952|P1|Overall Study|Withdrawal by Subject|18
5105882|NCT01877655|17634951|P2|Overall Study|Death|52
5105883|NCT01877655|17634952|P1|Overall Study|Death|57
5105884|NCT01877551|17635008|P2|Overall Study|Physician Decision|1
5105885|NCT01877551|17635009|P1|Overall Study|Physician Decision|0
5105886|NCT01877421|17635058|P18|Phase 2|Protocol Violation|0
5105887|NCT01877421|17635059|P17|Phase 2|Protocol Violation|0
5105888|NCT01877421|17635060|P16|Phase 2|Protocol Violation|0
5105889|NCT01877421|17635061|P15|Phase 2|Protocol Violation|0
5105890|NCT01877421|17635062|P14|Phase 2|Protocol Violation|0
5105891|NCT01877421|17635063|P13|Phase 2|Protocol Violation|0
5105892|NCT01877421|17635064|P12|Phase 2|Protocol Violation|0
5105893|NCT01877421|17635065|P11|Phase 2|Protocol Violation|1
5105894|NCT01877421|17635066|P10|Phase 2|Protocol Violation|0
5105895|NCT01877421|17635067|P9|Phase 2|Protocol Violation|0
5105896|NCT01877421|17635068|P8|Phase 2|Protocol Violation|0
5105897|NCT01877421|17635069|P7|Phase 2|Protocol Violation|0
5105898|NCT01877421|17635070|P6|Phase 2|Protocol Violation|0
5105899|NCT01877421|17635071|P5|Phase 2|Protocol Violation|0
5105900|NCT01877421|17635072|P4|Phase 2|Protocol Violation|0
5105901|NCT01877421|17635073|P3|Phase 2|Protocol Violation|0
5105902|NCT01877421|17635074|P2|Phase 2|Protocol Violation|0
5105903|NCT01877421|17635075|P1|Phase 2|Protocol Violation|0
5105904|NCT01877421|17635058|P18|Phase 2|Withdrawal by Subject|0
5105905|NCT01877421|17635059|P17|Phase 2|Withdrawal by Subject|0
5105906|NCT01877421|17635060|P16|Phase 2|Withdrawal by Subject|1
5105907|NCT01877421|17635061|P15|Phase 2|Withdrawal by Subject|0
5105908|NCT01877421|17635062|P14|Phase 2|Withdrawal by Subject|0
5105909|NCT01877421|17635063|P13|Phase 2|Withdrawal by Subject|1
5105910|NCT01877421|17635064|P12|Phase 2|Withdrawal by Subject|0
5105911|NCT01877421|17635065|P11|Phase 2|Withdrawal by Subject|1
5105912|NCT01877421|17635066|P10|Phase 2|Withdrawal by Subject|0
5105913|NCT01877421|17635067|P9|Phase 2|Withdrawal by Subject|1
5105914|NCT01877421|17635068|P8|Phase 2|Withdrawal by Subject|0
5105915|NCT01877421|17635069|P7|Phase 2|Withdrawal by Subject|0
5105916|NCT01877421|17635070|P6|Phase 2|Withdrawal by Subject|0
5105917|NCT01877421|17635071|P5|Phase 2|Withdrawal by Subject|0
5105918|NCT01877421|17635072|P4|Phase 2|Withdrawal by Subject|0
5105919|NCT01877421|17635073|P3|Phase 2|Withdrawal by Subject|0
5105920|NCT01877421|17635074|P2|Phase 2|Withdrawal by Subject|0
5105921|NCT01877421|17635075|P1|Phase 2|Withdrawal by Subject|0
5105922|NCT01877421|17635058|P18|Phase 2|Lost to Follow-up|0
5105923|NCT01877421|17635059|P17|Phase 2|Lost to Follow-up|0
5105924|NCT01877421|17635060|P16|Phase 2|Lost to Follow-up|0
5105925|NCT01877421|17635061|P15|Phase 2|Lost to Follow-up|0
5105926|NCT01877421|17635062|P14|Phase 2|Lost to Follow-up|0
5105927|NCT01877421|17635063|P13|Phase 2|Lost to Follow-up|0
5105928|NCT01877421|17635064|P12|Phase 2|Lost to Follow-up|0
5105929|NCT01877421|17635065|P11|Phase 2|Lost to Follow-up|0
5105930|NCT01877421|17635066|P10|Phase 2|Lost to Follow-up|0
5105931|NCT01877421|17635067|P9|Phase 2|Lost to Follow-up|0
5105932|NCT01877421|17635068|P8|Phase 2|Lost to Follow-up|0
5105933|NCT01877421|17635069|P7|Phase 2|Lost to Follow-up|1
5105934|NCT01877421|17635070|P6|Phase 2|Lost to Follow-up|0
5105935|NCT01877421|17635071|P5|Phase 2|Lost to Follow-up|0
5105936|NCT01877421|17635072|P4|Phase 2|Lost to Follow-up|0
5105937|NCT01877421|17635073|P3|Phase 2|Lost to Follow-up|0
5105938|NCT01877421|17635074|P2|Phase 2|Lost to Follow-up|0
5105939|NCT01877421|17635075|P1|Phase 2|Lost to Follow-up|0
5105940|NCT01877408|17635185|P2|Overall Study|Lost to Follow-up|2
5105941|NCT01877408|17635186|P1|Overall Study|Lost to Follow-up|0
5105942|NCT01877278|17635219|P2|Overall Study|Lost to Follow-up|3
5105943|NCT01877278|17635220|P1|Overall Study|Lost to Follow-up|3
5105944|NCT01877265|17635228|P6|Treatment Period 3|Lost to Follow-up|0
5105945|NCT01877265|17635229|P5|Treatment Period 3|Lost to Follow-up|0
5105946|NCT01877265|17635230|P4|Treatment Period 3|Lost to Follow-up|0
5105947|NCT01877265|17635231|P3|Treatment Period 3|Lost to Follow-up|0
5105948|NCT01877265|17635232|P2|Treatment Period 3|Lost to Follow-up|0
5105949|NCT01877265|17635233|P1|Treatment Period 3|Lost to Follow-up|1
5105950|NCT01877265|17635228|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
5105951|NCT01877265|17635229|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5105952|NCT01877265|17635230|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5105953|NCT01877265|17635231|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5105954|NCT01877265|17635232|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5105955|NCT01877265|17635233|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5105956|NCT01877265|17635228|P6|Treatment Period 1|Sponsor Decision|0
5105957|NCT01877265|17635229|P5|Treatment Period 1|Sponsor Decision|0
5105958|NCT01877265|17635230|P4|Treatment Period 1|Sponsor Decision|0
5105959|NCT01877265|17635231|P3|Treatment Period 1|Sponsor Decision|1
5105960|NCT01877265|17635232|P2|Treatment Period 1|Sponsor Decision|0
5105961|NCT01877265|17635233|P1|Treatment Period 1|Sponsor Decision|0
5105962|NCT01877239|17635250|P1|Overall Study|Data not available|35
5105963|NCT01877239|17635250|P1|Overall Study|Lack of Efficacy|4
5105964|NCT01877239|17635250|P1|Overall Study|Other|2
5105965|NCT01877239|17635250|P1|Overall Study|Withdrawal by Subject|4
5105966|NCT01877239|17635250|P1|Overall Study|Disease Remission|1
5105967|NCT01877239|17635250|P1|Overall Study|Adverse Event|4
5105968|NCT01877187|17635256|P1|Overall Study|Liver transplant|2
5105969|NCT01877187|17635256|P1|Overall Study|Declining clinical status|11
5105970|NCT01877187|17635256|P1|Overall Study|Lost to Follow-up|3
5105971|NCT01877187|17635256|P1|Overall Study|Withdrawal by Subject|4
5105972|NCT01877187|17635256|P1|Overall Study|Death|2
5105973|NCT01877083|17635308|P1|Extension Phase|Adverse Event|2
5105974|NCT01877083|17635308|P1|Extension Phase|Disease Progression|3
5105975|NCT01877083|17635308|P1|Treatment Phase|Lost to Follow-up|1
5105976|NCT01877083|17635308|P1|Treatment Phase|Withdrawal by Subject|2
5105977|NCT01877083|17635308|P1|Treatment Phase|Adverse Event|6
5105978|NCT01877083|17635308|P1|Treatment Phase|Clinical Progression|1
5105979|NCT01877083|17635308|P1|Treatment Phase|Disease Progression|10
5105980|NCT01876979|17635332|P2|Overall Study|Physician Decision|3
5105981|NCT01876979|17635333|P1|Overall Study|Physician Decision|2
5105982|NCT01876823|17635339|P1|Overall Study|Patients moved|2
5105983|NCT01876823|17635339|P1|Overall Study|Physician Decision|2
5105984|NCT01876823|17635339|P1|Overall Study|Withdrawal by Subject|5
5105985|NCT01876810|17635352|P2|Overall Study|Physician Decision|1
5105986|NCT01876810|17635353|P1|Overall Study|Physician Decision|0
5105987|NCT01876784|17635365|P2|Overall Study|Ongoing|40
5105988|NCT01876784|17635366|P1|Overall Study|Ongoing|41
5105989|NCT01876784|17635365|P2|Overall Study|Other than specified above|6
5105990|NCT01876784|17635366|P1|Overall Study|Other than specified above|5
5105991|NCT01876784|17635365|P2|Overall Study|Randomized but not treated|1
5105992|NCT01876784|17635366|P1|Overall Study|Randomized but not treated|2
5105993|NCT01876784|17635365|P2|Overall Study|Death|0
5105994|NCT01876784|17635366|P1|Overall Study|Death|1
5105995|NCT01876784|17635365|P2|Overall Study|Lost to Follow-up|1
5105996|NCT01876784|17635366|P1|Overall Study|Lost to Follow-up|0
5105997|NCT01876784|17635365|P2|Overall Study|Disease progression|67
5105998|NCT01876784|17635366|P1|Overall Study|Disease progression|37
5105999|NCT01876784|17635365|P2|Overall Study|Protocol Violation|0
5106000|NCT01876784|17635366|P1|Overall Study|Protocol Violation|1
5106001|NCT01876784|17635365|P2|Overall Study|Adverse Event|2
5106002|NCT01876784|17635366|P1|Overall Study|Adverse Event|15
5106003|NCT01876784|17635365|P2|Overall Study|Withdrawal by Subject|2
5106004|NCT01876784|17635366|P1|Overall Study|Withdrawal by Subject|17
5106005|NCT01876732|17635372|P1|Overall Study|MMA was not over 800mg/dL|75
5106006|NCT01876706|17635377|P1|Overall Study|Death|3
5106007|NCT01876706|17635377|P1|Overall Study|Withdrawals|6
5106008|NCT01876706|17635377|P1|Overall Study|Lost to Follow-up|7
5106009|NCT01876706|17635377|P1|Overall Study|BPH Intervention|9
5106010|NCT01876511|17635397|P3|Overall Study|Physician Decision|1
5106011|NCT01876511|17635398|P2|Overall Study|Physician Decision|0
5106012|NCT01876511|17635399|P1|Overall Study|Physician Decision|1
5106013|NCT01876511|17635397|P3|Overall Study|Patient Decision|6
5106014|NCT01876511|17635398|P2|Overall Study|Patient Decision|0
5106015|NCT01876511|17635399|P1|Overall Study|Patient Decision|3
5106016|NCT01876511|17635397|P3|Overall Study|Drug-related Toxicity|6
5106017|NCT01876511|17635398|P2|Overall Study|Drug-related Toxicity|1
5106018|NCT01876511|17635399|P1|Overall Study|Drug-related Toxicity|5
5106019|NCT01876511|17635397|P3|Overall Study|Death (unrelated)|2
5106020|NCT01876511|17635398|P2|Overall Study|Death (unrelated)|0
5106021|NCT01876511|17635399|P1|Overall Study|Death (unrelated)|3
5106022|NCT01876511|17635397|P3|Overall Study|Disease Progression-clinical/radiologic|16
5106023|NCT01876511|17635398|P2|Overall Study|Disease Progression-clinical/radiologic|24
5106024|NCT01876511|17635399|P1|Overall Study|Disease Progression-clinical/radiologic|11
5106025|NCT01876446|17635447|P2|Overall Study|Physician Decision|3
5106026|NCT01876446|17635448|P1|Overall Study|Physician Decision|1
5106027|NCT01876446|17635447|P2|Overall Study|Withdrawal by Subject|2
5106028|NCT01876446|17635448|P1|Overall Study|Withdrawal by Subject|1
5106029|NCT01876446|17635447|P2|Overall Study|Death|1
5106030|NCT01876446|17635448|P1|Overall Study|Death|0
5106031|NCT01876420|17635464|P1|Overall Study|Missed 30 day visit|1
5106032|NCT01876381|17635476|P1|Overall Study|Withdrawal by Subject|1
5106033|NCT01876381|17635476|P1|Overall Study|Physician Decision|1
5106034|NCT01876381|17635476|P1|Overall Study|Lack of Efficacy|5
5106035|NCT01876368|17635483|P2|Overall Study|Subject/guardian decision|1
5106036|NCT01876368|17635484|P1|Overall Study|Subject/guardian decision|3
5106037|NCT01876368|17635483|P2|Overall Study|Protocol deviation|3
5106038|NCT01876368|17635484|P1|Overall Study|Protocol deviation|3
5106039|NCT01876368|17635483|P2|Overall Study|Physician Decision|2
5106040|NCT01876368|17635484|P1|Overall Study|Physician Decision|0
5106041|NCT01876368|17635483|P2|Overall Study|Non-compliance with study treatment|1
5106042|NCT01876368|17635484|P1|Overall Study|Non-compliance with study treatment|0
5106043|NCT01876368|17635483|P2|Overall Study|Lost to Follow-up|1
5106044|NCT01876368|17635484|P1|Overall Study|Lost to Follow-up|0
5106045|NCT01876368|17635483|P2|Overall Study|Lack of Efficacy|0
5106046|NCT01876368|17635484|P1|Overall Study|Lack of Efficacy|1
5106047|NCT01876368|17635483|P2|Overall Study|Adverse Event|5
5106048|NCT01876368|17635484|P1|Overall Study|Adverse Event|2
5106049|NCT01876251|17635529|P3|Overall Study|Objective progression or relapse|8
5106050|NCT01876251|17635530|P2|Overall Study|Objective progression or relapse|3
5106051|NCT01876251|17635531|P1|Overall Study|Objective progression or relapse|10
5106052|NCT01876251|17635529|P3|Overall Study|Study terminated|0
5106053|NCT01876251|17635530|P2|Overall Study|Study terminated|0
5106054|NCT01876251|17635531|P1|Overall Study|Study terminated|1
5106055|NCT01876251|17635529|P3|Overall Study|Participant refused further follow-up|1
5106056|NCT01876251|17635530|P2|Overall Study|Participant refused further follow-up|0
5106057|NCT01876251|17635531|P1|Overall Study|Participant refused further follow-up|0
5106058|NCT01876251|17635529|P3|Overall Study|Participant started new treatment|1
5106059|NCT01876251|17635530|P2|Overall Study|Participant started new treatment|0
5106060|NCT01876251|17635531|P1|Overall Study|Participant started new treatment|1
5106061|NCT01876251|17635529|P3|Overall Study|Death|1
5106062|NCT01876251|17635530|P2|Overall Study|Death|0
5106063|NCT01876251|17635531|P1|Overall Study|Death|2
5106064|NCT01876251|17635529|P3|Overall Study|Clinical progression|0
5106065|NCT01876251|17635530|P2|Overall Study|Clinical progression|0
5106066|NCT01876251|17635531|P1|Overall Study|Clinical progression|1
5106067|NCT01876043|17635635|P1|Overall Study|Withdrawal by Subject|1
5106068|NCT01876043|17635635|P1|Overall Study|Death|1
5106069|NCT01875991|17635647|P2|Overall Study|Sponsor Decision|0
5106070|NCT01875991|17635648|P1|Overall Study|Sponsor Decision|1
5106071|NCT01875991|17635647|P2|Overall Study|Withdrawal by Subject|6
5106072|NCT01875991|17635648|P1|Overall Study|Withdrawal by Subject|6
5106073|NCT01875874|17635684|P1|Overall Study|Death|3
5106074|NCT01875848|17635704|P2|Overall Study|Withdrawal by Subject|0
5106075|NCT01875848|17635705|P1|Overall Study|Withdrawal by Subject|2
5106076|NCT01875731|17635722|P2|Overall Study|Fail to obtain lab sample|0
5106077|NCT01875731|17635723|P1|Overall Study|Fail to obtain lab sample|1
5106078|NCT01875471|17635742|P2|Overall Study|Unsatisfactory Lens Fitting|0
5106079|NCT01875471|17635743|P1|Overall Study|Unsatisfactory Lens Fitting|1
5106080|NCT01875471|17635742|P2|Overall Study|Adverse Event|1
5106081|NCT01875471|17635743|P1|Overall Study|Adverse Event|0
5106082|NCT01875445|17635751|P2|Overall Study|Withdrawal by Subject|0
5106083|NCT01875445|17635752|P1|Overall Study|Withdrawal by Subject|2
5106084|NCT01875445|17635751|P2|Overall Study|Lost to Follow-up|0
5106085|NCT01875445|17635752|P1|Overall Study|Lost to Follow-up|5
5106086|NCT01875250|17635762|P2|Overall Study|Adverse Event|0
5106087|NCT01875250|17635763|P1|Overall Study|Adverse Event|2
5106088|NCT01875237|17635778|P2|Overall Study|DLI cells could not be produced|0
5106089|NCT01875237|17635779|P1|Overall Study|DLI cells could not be produced|1
5106090|NCT01875237|17635778|P2|Overall Study|GVDH before DLI|0
5106091|NCT01875237|17635779|P1|Overall Study|GVDH before DLI|1
5106092|NCT01875185|17635805|P2|Overall Study|study was terminated|48
5106093|NCT01875185|17635806|P1|Overall Study|study was terminated|52
5106094|NCT01874665|17635891|P2|Overall Study|Other|0
5106095|NCT01874665|17635892|P1|Overall Study|Other|2
5106096|NCT01874665|17635891|P2|Overall Study|Documented Progressive Disease|7
5106097|NCT01874665|17635892|P1|Overall Study|Documented Progressive Disease|11
5106098|NCT01874665|17635891|P2|Overall Study|Study Terminated by Sponsor|2
5106099|NCT01874665|17635892|P1|Overall Study|Study Terminated by Sponsor|0
5106100|NCT01874665|17635891|P2|Overall Study|Clinical Progressive Disease|3
5106101|NCT01874665|17635892|P1|Overall Study|Clinical Progressive Disease|4
5106102|NCT01874665|17635891|P2|Overall Study|Physician Decision|0
5106103|NCT01874665|17635892|P1|Overall Study|Physician Decision|3
5106104|NCT01874665|17635891|P2|Overall Study|Withdrawal by Subject|1
5106105|NCT01874665|17635892|P1|Overall Study|Withdrawal by Subject|4
5106106|NCT01874665|17635891|P2|Overall Study|Adverse Event|2
5106107|NCT01874665|17635892|P1|Overall Study|Adverse Event|6
5106108|NCT01874535|17635920|P2|Overall Study|incomplete symptom resolution|35
5106109|NCT01874535|17635921|P1|Overall Study|incomplete symptom resolution|45
5106110|NCT01874535|17635920|P2|Overall Study|Lost to Follow-up|9
5106111|NCT01874535|17635921|P1|Overall Study|Lost to Follow-up|10
5106112|NCT01874353|17635929|P2|Overall Study|Withdrawal by Subject|9
5106113|NCT01874353|17635930|P1|Overall Study|Withdrawal by Subject|7
5106114|NCT01874353|17635929|P2|Overall Study|Death|27
5106115|NCT01874353|17635930|P1|Overall Study|Death|45
5106116|NCT01874353|17635929|P2|Overall Study|Lost to Follow-up|1
5106117|NCT01874353|17635930|P1|Overall Study|Lost to Follow-up|1
5106118|NCT01874353|17635929|P2|Overall Study|Other|0
5106119|NCT01874353|17635930|P1|Overall Study|Other|2
5106120|NCT01874340|17635957|P4|Overall Study|Withdrawal by Subject|1
5106121|NCT01874340|17635958|P3|Overall Study|Withdrawal by Subject|0
5106122|NCT01874340|17635959|P2|Overall Study|Withdrawal by Subject|0
5106123|NCT01874340|17635960|P1|Overall Study|Withdrawal by Subject|0
5106124|NCT01874340|17635957|P4|Overall Study|Study terminated by Sponsor|4
5106125|NCT01874340|17635958|P3|Overall Study|Study terminated by Sponsor|8
5106126|NCT01874340|17635959|P2|Overall Study|Study terminated by Sponsor|8
5106127|NCT01874340|17635960|P1|Overall Study|Study terminated by Sponsor|6
5106128|NCT01874288|17635991|P5|Overall Study|Progressive disease|1
5106129|NCT01874288|17635992|P4|Overall Study|Progressive disease|5
5106130|NCT01874288|17635993|P3|Overall Study|Progressive disease|3
5106131|NCT01874288|17635994|P2|Overall Study|Progressive disease|0
5106132|NCT01874288|17635995|P1|Overall Study|Progressive disease|2
5106133|NCT01874288|17635991|P5|Overall Study|Physician Decision|0
5106134|NCT01874288|17635992|P4|Overall Study|Physician Decision|1
5106135|NCT01874288|17635993|P3|Overall Study|Physician Decision|0
5106136|NCT01874288|17635994|P2|Overall Study|Physician Decision|0
5106137|NCT01874288|17635995|P1|Overall Study|Physician Decision|0
5106138|NCT01874288|17635991|P5|Overall Study|Withdrawal by Subject|1
5106139|NCT01874288|17635992|P4|Overall Study|Withdrawal by Subject|1
5106140|NCT01874288|17635993|P3|Overall Study|Withdrawal by Subject|2
5106141|NCT01874288|17635994|P2|Overall Study|Withdrawal by Subject|0
5106142|NCT01874288|17635995|P1|Overall Study|Withdrawal by Subject|1
5106143|NCT01874275|17636030|P2|Overall Study|Lost to Follow-up|0
5106144|NCT01874275|17636031|P1|Overall Study|Lost to Follow-up|1
5106145|NCT01874145|17636054|P2|Extension Period|Lost to Follow-up|1
5106146|NCT01874145|17636055|P1|Extension Period|Lost to Follow-up|1
5106147|NCT01874145|17636054|P2|Extension Period|Withdrawal by Subject|1
5106148|NCT01874145|17636055|P1|Extension Period|Withdrawal by Subject|2
5106149|NCT01874145|17636054|P2|Extension Period|Adverse Event|2
5106150|NCT01874145|17636055|P1|Extension Period|Adverse Event|3
5106151|NCT01874145|17636054|P2|Core Period|Withdrawal by Subject|4
5106152|NCT01874145|17636055|P1|Core Period|Withdrawal by Subject|0
5106153|NCT01874145|17636054|P2|Core Period|Adverse Event|1
5106154|NCT01874145|17636055|P1|Core Period|Adverse Event|0
5106155|NCT01874145|17636054|P2|Core Period|Physician Decision|1
5106156|NCT01874145|17636055|P1|Core Period|Physician Decision|1
5106157|NCT01874145|17636054|P2|Core Period|Protocol Violation|1
5106158|NCT01874145|17636055|P1|Core Period|Protocol Violation|1
5106159|NCT01874145|17636054|P2|Core Period|Non-compliance|0
5106160|NCT01874145|17636055|P1|Core Period|Non-compliance|1
5106161|NCT01874054|17636114|P1|Overall Study|Death|5
5106162|NCT01874054|17636114|P1|Overall Study|Lost to Follow-up|5
5106163|NCT01874054|17636114|P1|Overall Study|Study Termination by Sponsor|42
5106164|NCT01874054|17636114|P1|Overall Study|Withdrawal by Subject|3
5106165|NCT01873950|17636136|P5|Period 5|Withdrawal by Subject|0
5106166|NCT01873950|17636137|P4|Period 5|Withdrawal by Subject|1
5106167|NCT01873950|17636138|P3|Period 5|Withdrawal by Subject|0
5106168|NCT01873950|17636139|P2|Period 5|Withdrawal by Subject|0
5106169|NCT01873950|17636140|P1|Period 5|Withdrawal by Subject|0
5106170|NCT01873859|17636177|P2|Overall Study|Withdrawal by Subject|4
5106171|NCT01873859|17636178|P1|Overall Study|Withdrawal by Subject|0
5106172|NCT01873742|17636196|P2|Overall Study|Lost to Follow-up|76
5106173|NCT01873742|17636197|P1|Overall Study|Lost to Follow-up|68
5106174|NCT01873729|17636203|P1|Overall Study|Withdrawal by Subject|1
5106175|NCT01873586|17636208|P1|Overall Study|Lost to Follow-up|3
5106176|NCT01873495|17636221|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
5106177|NCT01873495|17636221|P1|Overall Study|Removed for Transplantation|1
5106178|NCT01873495|17636221|P1|Overall Study|Adverse Event|1
5106179|NCT01873495|17636221|P1|Overall Study|Physician Decision|3
5106180|NCT01873495|17636221|P1|Overall Study|Withdrawal by Subject|1
5106181|NCT01873417|17636229|P1|Overall Study|Physician Decision|3
5106182|NCT01873417|17636229|P1|Overall Study|Withdrawal by Subject|2
5106183|NCT01873417|17636229|P1|Overall Study|Lost to Follow-up|2
5106184|NCT01873417|17636229|P1|Overall Study|Adverse Event|24
5106185|NCT01873417|17636229|P1|Overall Study|Did Not Receive Any Study Drug|4
5106186|NCT01872910|17636257|P6|Overall Study|Lost to Follow-up|0
5106187|NCT01872910|17636258|P5|Overall Study|Lost to Follow-up|0
5106188|NCT01872910|17636259|P4|Overall Study|Lost to Follow-up|0
5106189|NCT01872910|17636260|P3|Overall Study|Lost to Follow-up|2
5106190|NCT01872910|17636261|P2|Overall Study|Lost to Follow-up|0
5106191|NCT01872910|17636262|P1|Overall Study|Lost to Follow-up|2
5106192|NCT01872715|17636307|P1|Overall Study|Withdrawal by Subject|2
5106193|NCT01872715|17636307|P1|Overall Study|Protocol Violation|1
5106194|NCT01872715|17636307|P1|Overall Study|Adverse Event|1
5106195|NCT01872689|17636326|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
5106196|NCT01872689|17636327|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
5106197|NCT01872689|17636328|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
5106198|NCT01872689|17636329|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
5106199|NCT01872689|17636326|P4|Open-Label Period (Only For Monotherapy)|Death|0
5106200|NCT01872689|17636327|P3|Open-Label Period (Only For Monotherapy)|Death|0
5106201|NCT01872689|17636328|P2|Open-Label Period (Only For Monotherapy)|Death|3
5106202|NCT01872689|17636329|P1|Open-Label Period (Only For Monotherapy)|Death|5
5106203|NCT01872689|17636326|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
5106204|NCT01872689|17636327|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
5106205|NCT01872689|17636328|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
5106206|NCT01872689|17636329|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
5106207|NCT01872689|17636326|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5106208|NCT01872689|17636327|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5106209|NCT01872689|17636328|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
5106210|NCT01872689|17636329|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5106211|NCT01872689|17636326|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
5106212|NCT01872689|17636327|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
5106213|NCT01872689|17636328|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
5106214|NCT01872689|17636329|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
5106215|NCT01872689|17636326|P4|Open-Label Period (Only For Monotherapy)|Other|0
5106216|NCT01872689|17636327|P3|Open-Label Period (Only For Monotherapy)|Other|0
5106217|NCT01872689|17636328|P2|Open-Label Period (Only For Monotherapy)|Other|3
5106218|NCT01872689|17636329|P1|Open-Label Period (Only For Monotherapy)|Other|2
5106219|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
5106220|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
5106221|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
5106222|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
5106223|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Death|9
5106224|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Death|14
5106225|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Death|4
5106226|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Death|3
5106227|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
5106228|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
5106229|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
5106230|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
5106231|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
5106232|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
5106233|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
5106234|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
5106235|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
5106236|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
5106237|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
5106238|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
5106239|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
5106240|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
5106241|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
5106242|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
5106243|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Other|3
5106244|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Other|6
5106245|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Other|1
5106246|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Other|1
5106247|NCT01872689|17636326|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5106248|NCT01872689|17636327|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5106249|NCT01872689|17636328|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
5106250|NCT01872689|17636329|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5106251|NCT01872611|17636405|P2|Overall Study|Reason not provided|6
5106252|NCT01872611|17636406|P1|Overall Study|Reason not provided|6
5106253|NCT01872611|17636405|P2|Overall Study|Withdrawal by Subject|1
5106254|NCT01872611|17636406|P1|Overall Study|Withdrawal by Subject|6
5106255|NCT01872611|17636405|P2|Overall Study|Physician Decision|0
5106256|NCT01872611|17636406|P1|Overall Study|Physician Decision|1
5106257|NCT01872611|17636405|P2|Overall Study|Lost to Follow-up|1
5106258|NCT01872611|17636406|P1|Overall Study|Lost to Follow-up|8
5106259|NCT01872611|17636405|P2|Overall Study|Death, prior to treatment|1
5106260|NCT01872611|17636406|P1|Overall Study|Death, prior to treatment|0
5106261|NCT01872611|17636405|P2|Overall Study|Death|1
5106262|NCT01872611|17636406|P1|Overall Study|Death|0
5106263|NCT01872611|17636405|P2|Overall Study|Adverse Event, prior to treatment|1
5106264|NCT01872611|17636406|P1|Overall Study|Adverse Event, prior to treatment|0
5106265|NCT01872611|17636405|P2|Overall Study|Adverse Event|1
5106266|NCT01872611|17636406|P1|Overall Study|Adverse Event|3
5106267|NCT01872078|17636458|P4|Overall Study|Patient met exclusion criterion 16.|1
5106268|NCT01872078|17636459|P3|Overall Study|Patient met exclusion criterion 16.|0
5106269|NCT01872078|17636460|P2|Overall Study|Patient met exclusion criterion 16.|0
5106270|NCT01872078|17636461|P1|Overall Study|Patient met exclusion criterion 16.|0
5106271|NCT01872078|17636458|P4|Overall Study|Withdrawal by Subject|0
5106272|NCT01872078|17636459|P3|Overall Study|Withdrawal by Subject|1
5106273|NCT01872078|17636460|P2|Overall Study|Withdrawal by Subject|0
5106274|NCT01872078|17636461|P1|Overall Study|Withdrawal by Subject|0
5106275|NCT01872078|17636458|P4|Overall Study|Protocol Violation|0
5106276|NCT01872078|17636459|P3|Overall Study|Protocol Violation|1
5106277|NCT01872078|17636460|P2|Overall Study|Protocol Violation|0
5106278|NCT01872078|17636461|P1|Overall Study|Protocol Violation|0
5106279|NCT01872078|17636458|P4|Overall Study|Dose administration non-compliance|1
5106280|NCT01872078|17636459|P3|Overall Study|Dose administration non-compliance|0
5106281|NCT01872078|17636460|P2|Overall Study|Dose administration non-compliance|0
5106282|NCT01872078|17636461|P1|Overall Study|Dose administration non-compliance|0
5106283|NCT01872078|17636458|P4|Overall Study|Adverse Event|0
5106284|NCT01872078|17636459|P3|Overall Study|Adverse Event|1
5106285|NCT01872078|17636460|P2|Overall Study|Adverse Event|0
5106286|NCT01872078|17636461|P1|Overall Study|Adverse Event|0
5106287|NCT01871870|17636471|P1|Overall Study|hyperglycemia|2
5106288|NCT01871870|17636471|P1|Overall Study|Hardware issues|7
5106289|NCT01871805|17636482|P6|Phase II|Lost to Follow-up|13
5106290|NCT01871805|17636483|P5|Phase II|Lost to Follow-up|0
5106291|NCT01871805|17636484|P4|Phase II|Lost to Follow-up|0
5106292|NCT01871805|17636485|P3|Phase II|Lost to Follow-up|0
5106293|NCT01871805|17636486|P2|Phase II|Lost to Follow-up|0
5106294|NCT01871805|17636487|P1|Phase II|Lost to Follow-up|0
5106295|NCT01871805|17636482|P6|Phase II|Alive in Survival Follow-up|29
5106296|NCT01871805|17636483|P5|Phase II|Alive in Survival Follow-up|0
5106297|NCT01871805|17636484|P4|Phase II|Alive in Survival Follow-up|0
5106298|NCT01871805|17636485|P3|Phase II|Alive in Survival Follow-up|0
5106299|NCT01871805|17636486|P2|Phase II|Alive in Survival Follow-up|0
5106300|NCT01871805|17636487|P1|Phase II|Alive in Survival Follow-up|0
5106301|NCT01871805|17636482|P6|Phase II|Death|45
5106302|NCT01871805|17636483|P5|Phase II|Death|0
5106303|NCT01871805|17636484|P4|Phase II|Death|0
5106304|NCT01871805|17636485|P3|Phase II|Death|0
5106305|NCT01871805|17636486|P2|Phase II|Death|0
5106306|NCT01871805|17636487|P1|Phase II|Death|0
5106307|NCT01871805|17636482|P6|Phase I|Lost to Follow-up|0
5106308|NCT01871805|17636483|P5|Phase I|Lost to Follow-up|0
5106309|NCT01871805|17636484|P4|Phase I|Lost to Follow-up|0
5106310|NCT01871805|17636485|P3|Phase I|Lost to Follow-up|3
5106311|NCT01871805|17636486|P2|Phase I|Lost to Follow-up|1
5106312|NCT01871805|17636487|P1|Phase I|Lost to Follow-up|0
5106313|NCT01871805|17636482|P6|Phase I|Alive in Survival Follow-up|0
5106314|NCT01871805|17636483|P5|Phase I|Alive in Survival Follow-up|4
5106315|NCT01871805|17636484|P4|Phase I|Alive in Survival Follow-up|5
5106316|NCT01871805|17636485|P3|Phase I|Alive in Survival Follow-up|4
5106317|NCT01871805|17636486|P2|Phase I|Alive in Survival Follow-up|2
5106318|NCT01871805|17636487|P1|Phase I|Alive in Survival Follow-up|0
5106319|NCT01871805|17636482|P6|Phase I|Death|0
5106320|NCT01871805|17636483|P5|Phase I|Death|9
5106321|NCT01871805|17636484|P4|Phase I|Death|2
5106322|NCT01871805|17636485|P3|Phase I|Death|6
5106323|NCT01871805|17636486|P2|Phase I|Death|4
5106324|NCT01871805|17636487|P1|Phase I|Death|7
5106325|NCT01871558|17636559|P2|Overall Study|Withdrawal by Subject|0
5106326|NCT01871558|17636560|P1|Overall Study|Withdrawal by Subject|2
5106327|NCT01871558|17636559|P2|Overall Study|antidiabetic drug prematurely stopped|1
5106328|NCT01871558|17636560|P1|Overall Study|antidiabetic drug prematurely stopped|1
5106329|NCT01871558|17636559|P2|Overall Study|Other reason|1
5106330|NCT01871558|17636560|P1|Overall Study|Other reason|0
5106331|NCT01871545|17636580|P2|Overall Study|Withdrawal by Subject|1
5106332|NCT01871545|17636581|P1|Overall Study|Withdrawal by Subject|0
5106333|NCT01871545|17636580|P2|Overall Study|Physician Decision|0
5106334|NCT01871545|17636581|P1|Overall Study|Physician Decision|4
5106335|NCT01871545|17636580|P2|Overall Study|Lack of Efficacy|2
5106336|NCT01871545|17636581|P1|Overall Study|Lack of Efficacy|11
5106337|NCT01871545|17636580|P2|Overall Study|Death|0
5106338|NCT01871545|17636581|P1|Overall Study|Death|2
5106339|NCT01871532|17636622|P2|Overall Study|Withdrawal by Subject|2
5106340|NCT01871532|17636623|P1|Overall Study|Withdrawal by Subject|1
5106341|NCT01871519|17636657|P1|Overall Study|Withdrawal by Subject|49
5106342|NCT01871519|17636657|P1|Overall Study|Lost to Follow-up|15
5106343|NCT01871519|17636657|P1|Overall Study|Death|26
5106344|NCT01871402|17636714|P2|Overall Study|Non-compliance|1
5106345|NCT01871402|17636715|P1|Overall Study|Non-compliance|0
5106346|NCT01871402|17636714|P2|Overall Study|Withdrawal by Subject|2
5106347|NCT01871402|17636715|P1|Overall Study|Withdrawal by Subject|0
5106348|NCT01871402|17636714|P2|Overall Study|Lost to Follow-up|0
5106349|NCT01871402|17636715|P1|Overall Study|Lost to Follow-up|1
5106350|NCT01871285|17636733|P4|First Intervention (1 Day)|Lost to Follow-up|0
5106351|NCT01871285|17636734|P3|First Intervention (1 Day)|Lost to Follow-up|1
5106352|NCT01871285|17636735|P2|First Intervention (1 Day)|Lost to Follow-up|1
5106353|NCT01871285|17636736|P1|First Intervention (1 Day)|Lost to Follow-up|0
5106354|NCT01871285|17636733|P4|First Intervention (1 Day)|Adverse Event|0
5106355|NCT01871285|17636734|P3|First Intervention (1 Day)|Adverse Event|0
5106356|NCT01871285|17636735|P2|First Intervention (1 Day)|Adverse Event|0
5106357|NCT01871285|17636736|P1|First Intervention (1 Day)|Adverse Event|1
5106358|NCT01871142|17636762|P1|Overall Study|Adverse Event|1
5106359|NCT01871090|17636778|P2|Overall Study|Subject Non-Compliance|1
5106360|NCT01871090|17636779|P1|Overall Study|Subject Non-Compliance|0
5106361|NCT01871090|17636778|P2|Overall Study|Interrogation not completed correctly|0
5106362|NCT01871090|17636779|P1|Overall Study|Interrogation not completed correctly|1
5106363|NCT01871090|17636778|P2|Overall Study|Interrogation not done in Emergency Room|22
5106364|NCT01871090|17636779|P1|Overall Study|Interrogation not done in Emergency Room|1
5106365|NCT01870999|17636799|P3|Overall Study|Protocol Violation|1
5106366|NCT01870999|17636800|P2|Overall Study|Protocol Violation|0
5106367|NCT01870999|17636801|P1|Overall Study|Protocol Violation|0
5106368|NCT01870999|17636799|P3|Overall Study|Withdrawal by Subject|5
5106369|NCT01870999|17636800|P2|Overall Study|Withdrawal by Subject|2
5106370|NCT01870999|17636801|P1|Overall Study|Withdrawal by Subject|0
5106371|NCT01870999|17636799|P3|Overall Study|Subject withdrawn by Investigator|0
5106372|NCT01870999|17636800|P2|Overall Study|Subject withdrawn by Investigator|0
5106373|NCT01870999|17636801|P1|Overall Study|Subject withdrawn by Investigator|1
5106374|NCT01870999|17636799|P3|Overall Study|Subject met withdrawal criteria|0
5106375|NCT01870999|17636800|P2|Overall Study|Subject met withdrawal criteria|2
5106376|NCT01870999|17636801|P1|Overall Study|Subject met withdrawal criteria|3
5106377|NCT01870999|17636799|P3|Overall Study|Adverse Event|1
5106378|NCT01870999|17636800|P2|Overall Study|Adverse Event|4
5106379|NCT01870999|17636801|P1|Overall Study|Adverse Event|0
5106380|NCT01870973|17636859|P2|Overall Study|Lost to Follow-up|3
5106381|NCT01870973|17636860|P1|Overall Study|Lost to Follow-up|10
5106382|NCT01870921|17636866|P1|Overall Study|Other|1
5106383|NCT01870921|17636866|P1|Overall Study|Subject Lost to Follow up|2
5106384|NCT01870921|17636866|P1|Overall Study|Severe non-compliance to protocol|7
5106385|NCT01870921|17636866|P1|Overall Study|Subject decision|80
5106386|NCT01870869|17636876|P4|Overall Study|Not evaluable|10
5106387|NCT01870869|17636877|P3|Overall Study|Not evaluable|42
5106388|NCT01870869|17636878|P2|Overall Study|Not evaluable|5
5106389|NCT01870869|17636879|P1|Overall Study|Not evaluable|10
5106390|NCT01870869|17636876|P4|Overall Study|Reason not Specified|4
5106391|NCT01870869|17636877|P3|Overall Study|Reason not Specified|20
5106392|NCT01870869|17636878|P2|Overall Study|Reason not Specified|2
5106393|NCT01870869|17636879|P1|Overall Study|Reason not Specified|1
5106394|NCT01870869|17636876|P4|Overall Study|Lost to Follow-up|3
5106395|NCT01870869|17636877|P3|Overall Study|Lost to Follow-up|25
5106396|NCT01870869|17636878|P2|Overall Study|Lost to Follow-up|2
5106397|NCT01870869|17636879|P1|Overall Study|Lost to Follow-up|10
5106398|NCT01870869|17636876|P4|Overall Study|Subject choice|8
5106399|NCT01870869|17636877|P3|Overall Study|Subject choice|22
5106400|NCT01870869|17636878|P2|Overall Study|Subject choice|2
5106401|NCT01870869|17636879|P1|Overall Study|Subject choice|6
5106402|NCT01870869|17636876|P4|Overall Study|Death|1
5106403|NCT01870869|17636877|P3|Overall Study|Death|7
5106404|NCT01870869|17636878|P2|Overall Study|Death|0
5106405|NCT01870869|17636879|P1|Overall Study|Death|0
5106406|NCT01870869|17636876|P4|Overall Study|Implanted with nonstudy device|4
5106407|NCT01870869|17636877|P3|Overall Study|Implanted with nonstudy device|14
5106408|NCT01870869|17636878|P2|Overall Study|Implanted with nonstudy device|3
5106409|NCT01870869|17636879|P1|Overall Study|Implanted with nonstudy device|1
5106410|NCT01870843|17636918|P1|Overall Study|Withdrawal by Subject|18
5106411|NCT01870843|17636918|P1|Overall Study|Death|1
5106412|NCT01870843|17636918|P1|Overall Study|Lost to Follow-up|24
5106413|NCT01870843|17636918|P1|Overall Study|Adverse Event|10
5106414|NCT01870778|17636933|P2|Overall Study|Lost to Follow-up|2
5106415|NCT01870778|17636934|P1|Overall Study|Lost to Follow-up|0
5106416|NCT01870778|17636933|P2|Overall Study|Withdrawal by Subject|7
5106417|NCT01870778|17636934|P1|Overall Study|Withdrawal by Subject|8
5106418|NCT01870739|17636960|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
5106419|NCT01870739|17636961|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
5106420|NCT01870739|17636960|P2|Add-on Period (40 Weeks)|Protocol deviation|1
5106421|NCT01870739|17636961|P1|Add-on Period (40 Weeks)|Protocol deviation|1
5106422|NCT01870739|17636960|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
5106423|NCT01870739|17636961|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
5106424|NCT01870739|17636960|P2|Add-on Period (40 Weeks)|Adverse Event|1
5106425|NCT01870739|17636961|P1|Add-on Period (40 Weeks)|Adverse Event|0
5106426|NCT01870739|17636960|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
5106427|NCT01870739|17636961|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
5106428|NCT01870739|17636960|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
5106429|NCT01870739|17636961|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
5106430|NCT01870739|17636960|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
5106431|NCT01870739|17636961|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
5106432|NCT01870726|17637000|P7|Overall Study|Progressive disease|10
5106433|NCT01870726|17637001|P6|Overall Study|Progressive disease|4
5106434|NCT01870726|17637002|P5|Overall Study|Progressive disease|6
5106435|NCT01870726|17637003|P4|Overall Study|Progressive disease|5
5106436|NCT01870726|17637004|P3|Overall Study|Progressive disease|4
5106437|NCT01870726|17637005|P2|Overall Study|Progressive disease|5
5106438|NCT01870726|17637006|P1|Overall Study|Progressive disease|5
5106439|NCT01870726|17637000|P7|Overall Study|Adverse Event|0
5106440|NCT01870726|17637001|P6|Overall Study|Adverse Event|1
5106441|NCT01870726|17637002|P5|Overall Study|Adverse Event|1
5106442|NCT01870726|17637003|P4|Overall Study|Adverse Event|0
5106443|NCT01870726|17637004|P3|Overall Study|Adverse Event|0
5106444|NCT01870726|17637005|P2|Overall Study|Adverse Event|0
5106445|NCT01870726|17637006|P1|Overall Study|Adverse Event|0
5106446|NCT01870726|17637000|P7|Overall Study|Withdrawal by Subject|0
5106447|NCT01870726|17637001|P6|Overall Study|Withdrawal by Subject|0
5106448|NCT01870726|17637002|P5|Overall Study|Withdrawal by Subject|0
5106449|NCT01870726|17637003|P4|Overall Study|Withdrawal by Subject|0
5106450|NCT01870726|17637004|P3|Overall Study|Withdrawal by Subject|0
5106451|NCT01870726|17637005|P2|Overall Study|Withdrawal by Subject|1
5106452|NCT01870726|17637006|P1|Overall Study|Withdrawal by Subject|0
5106453|NCT01870726|17637000|P7|Overall Study|Withdrawal of informed consent|0
5106454|NCT01870726|17637001|P6|Overall Study|Withdrawal of informed consent|0
5106455|NCT01870726|17637002|P5|Overall Study|Withdrawal of informed consent|0
5106456|NCT01870726|17637003|P4|Overall Study|Withdrawal of informed consent|1
5106457|NCT01870726|17637004|P3|Overall Study|Withdrawal of informed consent|0
5106458|NCT01870726|17637005|P2|Overall Study|Withdrawal of informed consent|0
5106459|NCT01870726|17637006|P1|Overall Study|Withdrawal of informed consent|0
5106460|NCT01870583|17637101|P3|Overall Study|Lost to Follow-up|5
5106461|NCT01870583|17637102|P2|Overall Study|Lost to Follow-up|13
5106462|NCT01870583|17637103|P1|Overall Study|Lost to Follow-up|11
5106463|NCT01870583|17637101|P3|Overall Study|Protocol Violation|3
5106464|NCT01870583|17637102|P2|Overall Study|Protocol Violation|5
5106465|NCT01870583|17637103|P1|Overall Study|Protocol Violation|0
5106466|NCT01870401|17637113|P2|Overall Study|On-going in the Study|25
5106467|NCT01870401|17637114|P1|Overall Study|On-going in the Study|35
5106468|NCT01870401|17637113|P2|Overall Study|Other|7
5106469|NCT01870401|17637114|P1|Overall Study|Other|9
5106470|NCT01870401|17637113|P2|Overall Study|Lost to Follow-up|14
5106471|NCT01870401|17637114|P1|Overall Study|Lost to Follow-up|19
5106472|NCT01870401|17637113|P2|Overall Study|Withdrawal by Subject|26
5106473|NCT01870401|17637114|P1|Overall Study|Withdrawal by Subject|39
5106474|NCT01870401|17637113|P2|Overall Study|Death|24
5106475|NCT01870401|17637114|P1|Overall Study|Death|48
5106476|NCT01870297|17637190|P7|Overall Study|Sponsor Decision|1
5106477|NCT01870297|17637191|P6|Overall Study|Sponsor Decision|0
5106478|NCT01870297|17637192|P5|Overall Study|Sponsor Decision|0
5106479|NCT01870297|17637193|P4|Overall Study|Sponsor Decision|0
5106480|NCT01870297|17637194|P3|Overall Study|Sponsor Decision|0
5106481|NCT01870297|17637195|P2|Overall Study|Sponsor Decision|6
5106482|NCT01870297|17637196|P1|Overall Study|Sponsor Decision|0
5106483|NCT01870297|17637190|P7|Overall Study|Withdrawal by Subject|1
5106484|NCT01870297|17637191|P6|Overall Study|Withdrawal by Subject|1
5106485|NCT01870297|17637192|P5|Overall Study|Withdrawal by Subject|1
5106486|NCT01870297|17637193|P4|Overall Study|Withdrawal by Subject|0
5106487|NCT01870297|17637194|P3|Overall Study|Withdrawal by Subject|0
5106488|NCT01870297|17637195|P2|Overall Study|Withdrawal by Subject|0
5106489|NCT01870297|17637196|P1|Overall Study|Withdrawal by Subject|0
5106490|NCT01870297|17637190|P7|Overall Study|Lost to Follow-up|0
5106491|NCT01870297|17637191|P6|Overall Study|Lost to Follow-up|0
5106492|NCT01870297|17637192|P5|Overall Study|Lost to Follow-up|0
5106493|NCT01870297|17637193|P4|Overall Study|Lost to Follow-up|0
5106494|NCT01870297|17637194|P3|Overall Study|Lost to Follow-up|1
5106495|NCT01870297|17637195|P2|Overall Study|Lost to Follow-up|1
5106496|NCT01870297|17637196|P1|Overall Study|Lost to Follow-up|0
5106497|NCT01870297|17637190|P7|Overall Study|Adverse Event|0
5106498|NCT01870297|17637191|P6|Overall Study|Adverse Event|0
5106499|NCT01870297|17637192|P5|Overall Study|Adverse Event|2
5106500|NCT01870297|17637193|P4|Overall Study|Adverse Event|0
5106501|NCT01870297|17637194|P3|Overall Study|Adverse Event|0
5106502|NCT01870297|17637195|P2|Overall Study|Adverse Event|0
5106503|NCT01870297|17637196|P1|Overall Study|Adverse Event|0
5106504|NCT01870076|17637240|P4|Overall Study|Withdrawal by Subject|0
5106505|NCT01870076|17637241|P3|Overall Study|Withdrawal by Subject|1
5106506|NCT01870076|17637242|P2|Overall Study|Withdrawal by Subject|0
5106507|NCT01870076|17637243|P1|Overall Study|Withdrawal by Subject|1
5106508|NCT01869959|17637261|P5|Treatment Period|Withdrawal by Subject|0
5106509|NCT01869959|17637262|P4|Treatment Period|Withdrawal by Subject|0
5106510|NCT01869959|17637263|P3|Treatment Period|Withdrawal by Subject|0
5106511|NCT01869959|17637264|P2|Treatment Period|Withdrawal by Subject|1
5106512|NCT01869959|17637265|P1|Treatment Period|Withdrawal by Subject|0
5106513|NCT01869959|17637261|P5|Treatment Period|Sponsor decision|0
5106514|NCT01869959|17637262|P4|Treatment Period|Sponsor decision|1
5106515|NCT01869959|17637263|P3|Treatment Period|Sponsor decision|0
5106516|NCT01869959|17637264|P2|Treatment Period|Sponsor decision|1
5106517|NCT01869959|17637265|P1|Treatment Period|Sponsor decision|0
5106518|NCT01869959|17637261|P5|Treatment Period|Adverse Event|0
5106519|NCT01869959|17637262|P4|Treatment Period|Adverse Event|1
5106520|NCT01869959|17637263|P3|Treatment Period|Adverse Event|3
5106521|NCT01869959|17637264|P2|Treatment Period|Adverse Event|0
5106522|NCT01869959|17637265|P1|Treatment Period|Adverse Event|1
5106523|NCT01869959|17637261|P5|Randomization Period|Physician Decision|1
5106524|NCT01869959|17637262|P4|Randomization Period|Physician Decision|0
5106525|NCT01869959|17637263|P3|Randomization Period|Physician Decision|0
5106526|NCT01869959|17637264|P2|Randomization Period|Physician Decision|0
5106527|NCT01869959|17637265|P1|Randomization Period|Physician Decision|0
5106528|NCT01869777|17637333|P1|Overall Study|Excluded from the analysis, ineligible|1
5106529|NCT01869764|17637346|P2|Overall Study|Withdrawal by Subject|2
5106530|NCT01869764|17637347|P1|Overall Study|Withdrawal by Subject|0
5106531|NCT01869699|17637365|P2|Overall Study|Withdrawal by Subject|0
5106532|NCT01869699|17637366|P1|Overall Study|Withdrawal by Subject|1
5106533|NCT01869348|17637451|P2|Overall Study|Withdrawal by Subject|1
5106534|NCT01869348|17637452|P1|Overall Study|Withdrawal by Subject|1
5106535|NCT01869192|17637460|P2|Postoperative Chemotherapy|Physician Decision|2
5106536|NCT01869192|17637461|P1|Postoperative Chemotherapy|Physician Decision|0
5106537|NCT01869192|17637460|P2|Preoperative Chemotherapy to Surgery|patient choice|1
5106538|NCT01869192|17637461|P1|Preoperative Chemotherapy to Surgery|patient choice|2
5106539|NCT01868997|17637496|P2|Overall Study|Other|1
5106540|NCT01868997|17637497|P1|Overall Study|Other|3
5106541|NCT01868997|17637496|P2|Overall Study|Lack of Efficacy|0
5106542|NCT01868997|17637497|P1|Overall Study|Lack of Efficacy|2
5106543|NCT01868997|17637496|P2|Overall Study|Adverse Event|5
5106544|NCT01868997|17637497|P1|Overall Study|Adverse Event|2
5106545|NCT01868893|17637513|P1|Overall Study|Neutropenia|1
5106546|NCT01868893|17637513|P1|Overall Study|Commercial availability of study drug|17
5106547|NCT01868893|17637513|P1|Overall Study|Adverse Event|2
5106548|NCT01868646|17637544|P2|Overall Study|Do not meet inclusion criteria|5
5106549|NCT01868646|17637545|P1|Overall Study|Do not meet inclusion criteria|3
5106550|NCT01868594|17637590|P2|Overall Study|Do not meet inclusion criteria|3
5106551|NCT01868594|17637591|P1|Overall Study|Do not meet inclusion criteria|4
5106552|NCT01868542|17637611|P2|Overall Study|Unclassified|1
5106553|NCT01868542|17637612|P1|Overall Study|Unclassified|0
5106554|NCT01868542|17637611|P2|Overall Study|Protocol Violation|1
5106555|NCT01868542|17637612|P1|Overall Study|Protocol Violation|0
5106556|NCT01868503|17637630|P1|Overall Study|Protocol Violation|1
5106557|NCT01868503|17637630|P1|Overall Study|Withdrawal by Subject|1
5106558|NCT01868477|17637640|P2|Overall Study|Withdrawal by Subject|0
5106559|NCT01868477|17637641|P1|Overall Study|Withdrawal by Subject|1
5106560|NCT01868477|17637640|P2|Overall Study|Disease progression|1
5106561|NCT01868477|17637641|P1|Overall Study|Disease progression|1
5106562|NCT01868477|17637640|P2|Overall Study|Adverse Event|4
5106563|NCT01868477|17637641|P1|Overall Study|Adverse Event|2
5106564|NCT01868243|17637745|P2|Overall Study|Death|1
5106565|NCT01868243|17637746|P1|Overall Study|Death|0
5106566|NCT01868165|17637754|P1|Overall Study|Death|4
5106567|NCT01868165|17637754|P1|Overall Study|Lost to Follow-up|3
5106568|NCT01868165|17637754|P1|Overall Study|Physician Decision|2
5106569|NCT01868165|17637754|P1|Overall Study|Withdrawal by Subject|36
5106570|NCT01868074|17637770|P2|Overall Study|Withdrawal by Subject|2
5106571|NCT01868074|17637771|P1|Overall Study|Withdrawal by Subject|4
5106572|NCT01868074|17637770|P2|Overall Study|Lost to Follow-up|2
5106573|NCT01868074|17637771|P1|Overall Study|Lost to Follow-up|3
5106574|NCT01868035|17637781|P1|Overall Study|Non-compliance|1
5106575|NCT01868035|17637781|P1|Overall Study|Progressive Disease|2
5106576|NCT01868035|17637781|P1|Overall Study|Withdrawal by Subject|1
5106577|NCT01868035|17637781|P1|Overall Study|Lost to Follow-up|3
5106578|NCT01868022|17637806|P9|Overall Study|Ongoing|0
5106579|NCT01868022|17637807|P8|Overall Study|Ongoing|3
5106580|NCT01868022|17637808|P7|Overall Study|Ongoing|0
5106581|NCT01868022|17637809|P6|Overall Study|Ongoing|0
5106582|NCT01868022|17637810|P5|Overall Study|Ongoing|0
5106583|NCT01868022|17637811|P4|Overall Study|Ongoing|0
5106584|NCT01868022|17637812|P3|Overall Study|Ongoing|0
5106585|NCT01868022|17637813|P2|Overall Study|Ongoing|0
5106586|NCT01868022|17637814|P1|Overall Study|Ongoing|0
5106587|NCT01868022|17637806|P9|Overall Study|Study closed/terminated|0
5106588|NCT01868022|17637807|P8|Overall Study|Study closed/terminated|1
5106589|NCT01868022|17637808|P7|Overall Study|Study closed/terminated|0
5106590|NCT01868022|17637809|P6|Overall Study|Study closed/terminated|0
5106591|NCT01868022|17637810|P5|Overall Study|Study closed/terminated|0
5106592|NCT01868022|17637811|P4|Overall Study|Study closed/terminated|0
5106593|NCT01868022|17637812|P3|Overall Study|Study closed/terminated|0
5106594|NCT01868022|17637813|P2|Overall Study|Study closed/terminated|0
5106595|NCT01868022|17637814|P1|Overall Study|Study closed/terminated|0
5106596|NCT01868022|17637806|P9|Overall Study|Physician Decision|0
5106597|NCT01868022|17637807|P8|Overall Study|Physician Decision|2
5106598|NCT01868022|17637808|P7|Overall Study|Physician Decision|0
5106599|NCT01868022|17637809|P6|Overall Study|Physician Decision|1
5106600|NCT01868022|17637810|P5|Overall Study|Physician Decision|0
5106601|NCT01868022|17637811|P4|Overall Study|Physician Decision|0
5106602|NCT01868022|17637812|P3|Overall Study|Physician Decision|0
5106603|NCT01868022|17637813|P2|Overall Study|Physician Decision|0
5106604|NCT01868022|17637814|P1|Overall Study|Physician Decision|0
5106605|NCT01868022|17637806|P9|Overall Study|Adverse Event|2
5106606|NCT01868022|17637807|P8|Overall Study|Adverse Event|2
5106607|NCT01868022|17637808|P7|Overall Study|Adverse Event|0
5106608|NCT01868022|17637809|P6|Overall Study|Adverse Event|0
5106609|NCT01868022|17637810|P5|Overall Study|Adverse Event|2
5106610|NCT01868022|17637811|P4|Overall Study|Adverse Event|0
5106611|NCT01868022|17637812|P3|Overall Study|Adverse Event|0
5106612|NCT01868022|17637813|P2|Overall Study|Adverse Event|0
5106613|NCT01868022|17637814|P1|Overall Study|Adverse Event|0
5106614|NCT01868022|17637806|P9|Overall Study|Withdrawal by Subject|0
5106615|NCT01868022|17637807|P8|Overall Study|Withdrawal by Subject|1
5106616|NCT01868022|17637808|P7|Overall Study|Withdrawal by Subject|0
5106617|NCT01868022|17637809|P6|Overall Study|Withdrawal by Subject|0
5106618|NCT01868022|17637810|P5|Overall Study|Withdrawal by Subject|0
5106619|NCT01868022|17637811|P4|Overall Study|Withdrawal by Subject|1
5106620|NCT01868022|17637812|P3|Overall Study|Withdrawal by Subject|1
5106621|NCT01868022|17637813|P2|Overall Study|Withdrawal by Subject|0
5106622|NCT01868022|17637814|P1|Overall Study|Withdrawal by Subject|0
5106623|NCT01868009|17638020|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
5106624|NCT01868009|17638021|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
5106625|NCT01868009|17638020|P2|Period 2 (5-9 Days)|Adverse Event|0
5106626|NCT01868009|17638021|P1|Period 2 (5-9 Days)|Adverse Event|1
5106627|NCT01868009|17638020|P2|Period 1 (5-9 Days)|Adverse Event|2
5106628|NCT01868009|17638021|P1|Period 1 (5-9 Days)|Adverse Event|0
5106629|NCT01867710|17638035|P4|Overall Study|Study medication no longer effective|0
5106630|NCT01867710|17638036|P3|Overall Study|Study medication no longer effective|0
5106631|NCT01867710|17638037|P2|Overall Study|Study medication no longer effective|1
5106632|NCT01867710|17638038|P1|Overall Study|Study medication no longer effective|0
5106633|NCT01867710|17638035|P4|Overall Study|PSA-progression|0
5106634|NCT01867710|17638036|P3|Overall Study|PSA-progression|0
5106635|NCT01867710|17638037|P2|Overall Study|PSA-progression|1
5106636|NCT01867710|17638038|P1|Overall Study|PSA-progression|0
5106637|NCT01867710|17638035|P4|Overall Study|Protocol Violation|1
5106638|NCT01867710|17638036|P3|Overall Study|Protocol Violation|0
5106639|NCT01867710|17638037|P2|Overall Study|Protocol Violation|0
5106640|NCT01867710|17638038|P1|Overall Study|Protocol Violation|0
5106641|NCT01867710|17638035|P4|Overall Study|Progressive disease|0
5106642|NCT01867710|17638036|P3|Overall Study|Progressive disease|0
5106643|NCT01867710|17638037|P2|Overall Study|Progressive disease|0
5106644|NCT01867710|17638038|P1|Overall Study|Progressive disease|1
5106645|NCT01867710|17638035|P4|Overall Study|Patient to follow subsequent treatment|0
5106646|NCT01867710|17638036|P3|Overall Study|Patient to follow subsequent treatment|0
5106647|NCT01867710|17638037|P2|Overall Study|Patient to follow subsequent treatment|1
5106648|NCT01867710|17638038|P1|Overall Study|Patient to follow subsequent treatment|0
5106649|NCT01867710|17638035|P4|Overall Study|Patient decision|1
5106650|NCT01867710|17638036|P3|Overall Study|Patient decision|0
5106651|NCT01867710|17638037|P2|Overall Study|Patient decision|0
5106652|NCT01867710|17638038|P1|Overall Study|Patient decision|0
5106653|NCT01867710|17638035|P4|Overall Study|Disease progression|0
5106654|NCT01867710|17638036|P3|Overall Study|Disease progression|0
5106655|NCT01867710|17638037|P2|Overall Study|Disease progression|0
5106656|NCT01867710|17638038|P1|Overall Study|Disease progression|1
5106657|NCT01867710|17638035|P4|Overall Study|Clinical progression|0
5106658|NCT01867710|17638036|P3|Overall Study|Clinical progression|1
5106659|NCT01867710|17638037|P2|Overall Study|Clinical progression|0
5106660|NCT01867710|17638038|P1|Overall Study|Clinical progression|0
5106661|NCT01867710|17638035|P4|Overall Study|Biochemical progression|0
5106662|NCT01867710|17638036|P3|Overall Study|Biochemical progression|0
5106663|NCT01867710|17638037|P2|Overall Study|Biochemical progression|1
5106664|NCT01867710|17638038|P1|Overall Study|Biochemical progression|0
5106665|NCT01867710|17638035|P4|Overall Study|Study Terminated by Sponsor|16
5106666|NCT01867710|17638036|P3|Overall Study|Study Terminated by Sponsor|8
5106667|NCT01867710|17638037|P2|Overall Study|Study Terminated by Sponsor|13
5106668|NCT01867710|17638038|P1|Overall Study|Study Terminated by Sponsor|9
5106669|NCT01867710|17638035|P4|Overall Study|Withdrawal of consent|2
5106670|NCT01867710|17638036|P3|Overall Study|Withdrawal of consent|1
5106671|NCT01867710|17638037|P2|Overall Study|Withdrawal of consent|5
5106672|NCT01867710|17638038|P1|Overall Study|Withdrawal of consent|2
5106673|NCT01867710|17638035|P4|Overall Study|Lost to Follow-up|2
5106674|NCT01867710|17638036|P3|Overall Study|Lost to Follow-up|3
5106675|NCT01867710|17638037|P2|Overall Study|Lost to Follow-up|4
5106676|NCT01867710|17638038|P1|Overall Study|Lost to Follow-up|3
5106677|NCT01867710|17638035|P4|Overall Study|Death|20
5106678|NCT01867710|17638036|P3|Overall Study|Death|27
5106679|NCT01867710|17638037|P2|Overall Study|Death|15
5106680|NCT01867710|17638038|P1|Overall Study|Death|25
5106681|NCT01867671|17638106|P2|Overall Study|Withdrawal by Subject|21
5106682|NCT01867671|17638107|P1|Overall Study|Withdrawal by Subject|21
5106683|NCT01867671|17638106|P2|Overall Study|Non-compliance with Study Drug|2
5106684|NCT01867671|17638107|P1|Overall Study|Non-compliance with Study Drug|1
5106685|NCT01867671|17638106|P2|Overall Study|Lost to Follow-up|1
5106686|NCT01867671|17638107|P1|Overall Study|Lost to Follow-up|0
5106687|NCT01867671|17638106|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
5106688|NCT01867671|17638107|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
5106689|NCT01867671|17638106|P2|Overall Study|Anaphylaxis|1
5106690|NCT01867671|17638107|P1|Overall Study|Anaphylaxis|0
5106691|NCT01867671|17638106|P2|Overall Study|Adverse Event|3
5106692|NCT01867671|17638107|P1|Overall Study|Adverse Event|5
5106693|NCT01867658|17638120|P1|Overall Study|Subject could not be contacted|1
5106694|NCT01867658|17638120|P1|Overall Study|Death|2
5106695|NCT01867658|17638120|P1|Overall Study|Withdrawal by Subject|6
5106696|NCT01867606|17638144|P2|Overall Study|Protocol Violation|1
5106697|NCT01867606|17638145|P1|Overall Study|Protocol Violation|0
5106698|NCT01867606|17638144|P2|Overall Study|Withdrawal by Subject|14
5106699|NCT01867606|17638145|P1|Overall Study|Withdrawal by Subject|10
5106700|NCT01867580|17638163|P2|Overall Study|Wound recurrence|1
5106701|NCT01867580|17638164|P1|Overall Study|Wound recurrence|0
5106702|NCT01867580|17638163|P2|Overall Study|Continuation of therapy|1
5106703|NCT01867580|17638164|P1|Overall Study|Continuation of therapy|0
5106704|NCT01867580|17638163|P2|Overall Study|Osteomyelitis|1
5106705|NCT01867580|17638164|P1|Overall Study|Osteomyelitis|0
5106706|NCT01867580|17638163|P2|Overall Study|Interruption to therapy|0
5106707|NCT01867580|17638164|P1|Overall Study|Interruption to therapy|3
5106708|NCT01867580|17638163|P2|Overall Study|Missed follow-up assessment|1
5106709|NCT01867580|17638164|P1|Overall Study|Missed follow-up assessment|2
5106710|NCT01867580|17638163|P2|Overall Study|Sponsor terminated study|0
5106711|NCT01867580|17638164|P1|Overall Study|Sponsor terminated study|1
5106712|NCT01867580|17638163|P2|Overall Study|Lost to Follow-up|5
5106713|NCT01867580|17638164|P1|Overall Study|Lost to Follow-up|3
5106714|NCT01867580|17638163|P2|Overall Study|Physician Decision|12
5106715|NCT01867580|17638164|P1|Overall Study|Physician Decision|17
5106716|NCT01867580|17638163|P2|Overall Study|Withdrawal by Subject|3
5106717|NCT01867580|17638164|P1|Overall Study|Withdrawal by Subject|2
5106718|NCT01867424|17638189|P2|Overall Study|Patient noncompliance|1
5106719|NCT01867424|17638190|P1|Overall Study|Patient noncompliance|2
5106720|NCT01867307|17638204|P2|Overall Study|Other Adverse Event|3
5106721|NCT01867307|17638205|P1|Overall Study|Other Adverse Event|1
5106722|NCT01867307|17638204|P2|Overall Study|Protocol Violation|0
5106723|NCT01867307|17638205|P1|Overall Study|Protocol Violation|2
5106724|NCT01867294|17638215|P4|Overall Study|Withdrawal by Subject|0
5106725|NCT01867294|17638216|P3|Overall Study|Withdrawal by Subject|0
5106726|NCT01867294|17638217|P2|Overall Study|Withdrawal by Subject|1
5106727|NCT01867294|17638218|P1|Overall Study|Withdrawal by Subject|1
5106728|NCT01867216|17638265|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
5106729|NCT01867216|17638266|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
5106730|NCT01867216|17638267|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
5106731|NCT01867216|17638268|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
5106732|NCT01867216|17638269|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
5106733|NCT01867216|17638270|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
5106734|NCT01867216|17638271|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
5106735|NCT01867216|17638265|P7|Overall Study|Physician Decision|0
5106736|NCT01867216|17638266|P6|Overall Study|Physician Decision|0
5106737|NCT01867216|17638267|P5|Overall Study|Physician Decision|0
5106738|NCT01867216|17638268|P4|Overall Study|Physician Decision|0
5106739|NCT01867216|17638269|P3|Overall Study|Physician Decision|0
5106740|NCT01867216|17638270|P2|Overall Study|Physician Decision|0
5106741|NCT01867216|17638271|P1|Overall Study|Physician Decision|1
5106742|NCT01867216|17638265|P7|Overall Study|Withdrawal by Subject|1
5106743|NCT01867216|17638266|P6|Overall Study|Withdrawal by Subject|0
5106744|NCT01867216|17638267|P5|Overall Study|Withdrawal by Subject|1
5106745|NCT01867216|17638268|P4|Overall Study|Withdrawal by Subject|0
5106746|NCT01867216|17638269|P3|Overall Study|Withdrawal by Subject|0
5106747|NCT01867216|17638270|P2|Overall Study|Withdrawal by Subject|0
5106748|NCT01867216|17638271|P1|Overall Study|Withdrawal by Subject|2
5106749|NCT01867086|17638343|P1|Overall Study|Disease Progression|1
5106750|NCT01867047|17638352|P2|Overall Study|surgery not indicated in protocol|2
5106751|NCT01867047|17638353|P1|Overall Study|surgery not indicated in protocol|1
5106752|NCT01867047|17638352|P2|Overall Study|Physician Decision|0
5106753|NCT01867047|17638353|P1|Overall Study|Physician Decision|2
5106754|NCT01867047|17638352|P2|Overall Study|Withdrawal by Subject|0
5106755|NCT01867047|17638353|P1|Overall Study|Withdrawal by Subject|2
5106756|NCT01867047|17638352|P2|Overall Study|Lost to Follow-up|3
5106757|NCT01867047|17638353|P1|Overall Study|Lost to Follow-up|3
5106758|NCT01867021|17638373|P2|Overall Study|Withdrawal by Subject|6
5106759|NCT01867021|17638374|P1|Overall Study|Withdrawal by Subject|1
5106760|NCT01867021|17638373|P2|Overall Study|Lost to Follow-up|2
5106761|NCT01867021|17638374|P1|Overall Study|Lost to Follow-up|0
5106762|NCT01867021|17638373|P2|Overall Study|Death|0
5106763|NCT01867021|17638374|P1|Overall Study|Death|1
5106764|NCT01867021|17638373|P2|Overall Study|Not Eligible|1
5106765|NCT01867021|17638374|P1|Overall Study|Not Eligible|0
5106766|NCT01867021|17638373|P2|Overall Study|Adverse Event|1
5106767|NCT01867021|17638374|P1|Overall Study|Adverse Event|0
5106768|NCT01866917|17638405|P2|Overall Study|Pharmacist stopped dispensing treatment|6
5106769|NCT01866917|17638406|P1|Overall Study|Pharmacist stopped dispensing treatment|4
5106770|NCT01866826|17638430|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
5106771|NCT01866826|17638431|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
5106772|NCT01866826|17638430|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
5106773|NCT01866826|17638431|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
5106774|NCT01866826|17638430|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
5106775|NCT01866826|17638431|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
5106776|NCT01866709|17638447|P2|Overall Study|Adverse Event|0
5106777|NCT01866709|17638448|P1|Overall Study|Adverse Event|1
5106778|NCT01866423|17638489|P1|Overall Study|Sponsor Decision|1
5106779|NCT01866423|17638489|P1|Overall Study|Lack of Efficacy|3
5106780|NCT01866319|17638517|P3|Overall Study|Withdrawal by Subject|12
5106781|NCT01866319|17638518|P2|Overall Study|Withdrawal by Subject|14
5106782|NCT01866319|17638519|P1|Overall Study|Withdrawal by Subject|32
5106783|NCT01866319|17638517|P3|Overall Study|Protocol Violation|1
5106784|NCT01866319|17638518|P2|Overall Study|Protocol Violation|0
5106785|NCT01866319|17638519|P1|Overall Study|Protocol Violation|0
5106786|NCT01866319|17638517|P3|Overall Study|Physician Decision|1
5106787|NCT01866319|17638518|P2|Overall Study|Physician Decision|0
5106788|NCT01866319|17638519|P1|Overall Study|Physician Decision|1
5106789|NCT01866319|17638517|P3|Overall Study|Lost to Follow-up|8
5106790|NCT01866319|17638518|P2|Overall Study|Lost to Follow-up|3
5106791|NCT01866319|17638519|P1|Overall Study|Lost to Follow-up|6
5106792|NCT01866319|17638517|P3|Overall Study|Death|147
5106793|NCT01866319|17638518|P2|Overall Study|Death|154
5106794|NCT01866319|17638519|P1|Overall Study|Death|153
5106795|NCT01866319|17638517|P3|Overall Study|Clinical progression|2
5106796|NCT01866319|17638518|P2|Overall Study|Clinical progression|2
5106797|NCT01866319|17638519|P1|Overall Study|Clinical progression|3
5106798|NCT01866319|17638517|P3|Overall Study|Adverse Event|9
5106799|NCT01866319|17638518|P2|Overall Study|Adverse Event|5
5106800|NCT01866319|17638519|P1|Overall Study|Adverse Event|12
5106801|NCT01866293|17638618|P1|Overall Study|Adverse Event|2
5106802|NCT01866098|17638663|P3|Overall Study|Death|0
5106803|NCT01866098|17638664|P2|Overall Study|Death|1
5106804|NCT01866098|17638665|P1|Overall Study|Death|0
5106805|NCT01866098|17638663|P3|Overall Study|Pregnancy|0
5106806|NCT01866098|17638664|P2|Overall Study|Pregnancy|0
5106807|NCT01866098|17638665|P1|Overall Study|Pregnancy|2
5106808|NCT01866098|17638663|P3|Overall Study|Non-compliance|1
5106809|NCT01866098|17638664|P2|Overall Study|Non-compliance|0
5106810|NCT01866098|17638665|P1|Overall Study|Non-compliance|1
5106811|NCT01866098|17638663|P3|Overall Study|Unrelated Hospitalization|1
5106812|NCT01866098|17638664|P2|Overall Study|Unrelated Hospitalization|0
5106813|NCT01866098|17638665|P1|Overall Study|Unrelated Hospitalization|2
5106814|NCT01866098|17638663|P3|Overall Study|Withdrawal by Subject|0
5106815|NCT01866098|17638664|P2|Overall Study|Withdrawal by Subject|2
5106816|NCT01866098|17638665|P1|Overall Study|Withdrawal by Subject|1
5106817|NCT01866098|17638663|P3|Overall Study|Protocol Violation|0
5106818|NCT01866098|17638664|P2|Overall Study|Protocol Violation|0
5106819|NCT01866098|17638665|P1|Overall Study|Protocol Violation|1
5106820|NCT01866098|17638663|P3|Overall Study|Adverse Event|4
5106821|NCT01866098|17638664|P2|Overall Study|Adverse Event|5
5106822|NCT01866098|17638665|P1|Overall Study|Adverse Event|1
5106823|NCT01866098|17638663|P3|Overall Study|Physician Decision|2
5106824|NCT01866098|17638664|P2|Overall Study|Physician Decision|1
5106825|NCT01866098|17638665|P1|Overall Study|Physician Decision|0
5106826|NCT01866098|17638663|P3|Overall Study|Lost to Follow-up|13
5106827|NCT01866098|17638664|P2|Overall Study|Lost to Follow-up|18
5106828|NCT01866098|17638665|P1|Overall Study|Lost to Follow-up|11
5106829|NCT01865812|17638694|P1|Overall Study|Adverse Event|2
5106830|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Other|1
5106831|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Other|0
5106832|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
5106833|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
5106834|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
5106835|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
5106836|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Physician Decision|2
5106837|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Physician Decision|4
5106838|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
5106839|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
5106840|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
5106841|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
5106842|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
5106843|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
5106844|NCT01865747|17638702|P2|Primary Intent to Treat (PITT)|Adverse Event|20
5106845|NCT01865747|17638703|P1|Primary Intent to Treat (PITT)|Adverse Event|21
5106846|NCT01865747|17638702|P2|Overall Study (ITT)|Reason Not Provided|1
5106847|NCT01865747|17638703|P1|Overall Study (ITT)|Reason Not Provided|0
5106848|NCT01865747|17638702|P2|Overall Study (ITT)|Progressive Disease|158
5106849|NCT01865747|17638703|P1|Overall Study (ITT)|Progressive Disease|122
5106850|NCT01865747|17638702|P2|Overall Study (ITT)|Sponsor Decision|1
5106851|NCT01865747|17638703|P1|Overall Study (ITT)|Sponsor Decision|0
5106852|NCT01865747|17638702|P2|Overall Study (ITT)|Withdrawal by Subject|11
5106853|NCT01865747|17638703|P1|Overall Study (ITT)|Withdrawal by Subject|6
5106854|NCT01865747|17638702|P2|Overall Study (ITT)|Physician Decision|2
5106855|NCT01865747|17638703|P1|Overall Study (ITT)|Physician Decision|5
5106856|NCT01865747|17638702|P2|Overall Study (ITT)|Protocol Violation|1
5106857|NCT01865747|17638703|P1|Overall Study (ITT)|Protocol Violation|1
5106858|NCT01865747|17638702|P2|Overall Study (ITT)|Lack of Efficacy|0
5106859|NCT01865747|17638703|P1|Overall Study (ITT)|Lack of Efficacy|3
5106860|NCT01865747|17638702|P2|Overall Study (ITT)|Clinical Deterioration|50
5106861|NCT01865747|17638703|P1|Overall Study (ITT)|Clinical Deterioration|29
5106862|NCT01865747|17638702|P2|Overall Study (ITT)|Adverse Event|31
5106863|NCT01865747|17638703|P1|Overall Study (ITT)|Adverse Event|32
5106864|NCT01865552|17638724|P6|Period 1|Other|0
5106865|NCT01865552|17638725|P5|Period 1|Other|1
5106866|NCT01865552|17638726|P4|Period 1|Other|0
5106867|NCT01865552|17638727|P3|Period 1|Other|0
5106868|NCT01865552|17638728|P2|Period 1|Other|0
5106869|NCT01865552|17638729|P1|Period 1|Other|0
5106870|NCT01865552|17638724|P6|Period 1|Pathological lab|0
5106871|NCT01865552|17638725|P5|Period 1|Pathological lab|1
5106872|NCT01865552|17638726|P4|Period 1|Pathological lab|0
5106873|NCT01865552|17638727|P3|Period 1|Pathological lab|0
5106874|NCT01865552|17638728|P2|Period 1|Pathological lab|0
5106875|NCT01865552|17638729|P1|Period 1|Pathological lab|0
5106876|NCT01865552|17638724|P6|Period 1|Adverse Event|1
5106877|NCT01865552|17638725|P5|Period 1|Adverse Event|1
5106878|NCT01865552|17638726|P4|Period 1|Adverse Event|1
5106879|NCT01865552|17638727|P3|Period 1|Adverse Event|0
5106880|NCT01865552|17638728|P2|Period 1|Adverse Event|0
5106881|NCT01865552|17638729|P1|Period 1|Adverse Event|1
5106882|NCT01865487|17638767|P10|Overall Study|Withdrawal by Subject|0
5106883|NCT01865487|17638768|P9|Overall Study|Withdrawal by Subject|0
5106884|NCT01865487|17638769|P8|Overall Study|Withdrawal by Subject|0
5106885|NCT01865487|17638770|P7|Overall Study|Withdrawal by Subject|0
5106886|NCT01865487|17638771|P6|Overall Study|Withdrawal by Subject|0
5106887|NCT01865487|17638772|P5|Overall Study|Withdrawal by Subject|1
5106888|NCT01865487|17638773|P4|Overall Study|Withdrawal by Subject|0
5106889|NCT01865487|17638774|P3|Overall Study|Withdrawal by Subject|0
5106890|NCT01865487|17638775|P2|Overall Study|Withdrawal by Subject|0
5106891|NCT01865487|17638776|P1|Overall Study|Withdrawal by Subject|0
5106892|NCT01865487|17638767|P10|Overall Study|Lost to Follow-up|0
5106893|NCT01865487|17638768|P9|Overall Study|Lost to Follow-up|0
5106894|NCT01865487|17638769|P8|Overall Study|Lost to Follow-up|0
5106895|NCT01865487|17638770|P7|Overall Study|Lost to Follow-up|1
5106896|NCT01865487|17638771|P6|Overall Study|Lost to Follow-up|0
5106897|NCT01865487|17638772|P5|Overall Study|Lost to Follow-up|0
5106898|NCT01865487|17638773|P4|Overall Study|Lost to Follow-up|1
5106899|NCT01865487|17638774|P3|Overall Study|Lost to Follow-up|0
5106900|NCT01865487|17638775|P2|Overall Study|Lost to Follow-up|0
5106901|NCT01865487|17638776|P1|Overall Study|Lost to Follow-up|0
5106902|NCT01865448|17638815|P2|Overall Study|dropout unrelated to study|1
5106903|NCT01865448|17638816|P1|Overall Study|dropout unrelated to study|1
5106904|NCT01865448|17638815|P2|Overall Study|Pregnancy|1
5106905|NCT01865448|17638816|P1|Overall Study|Pregnancy|0
5106906|NCT01865448|17638815|P2|Overall Study|Adverse Event|1
5106907|NCT01865448|17638816|P1|Overall Study|Adverse Event|1
5106908|NCT01865084|17638927|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
5106909|NCT01865084|17638928|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
5106910|NCT01865084|17638929|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
5106911|NCT01865084|17638927|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
5106912|NCT01865084|17638928|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
5106913|NCT01865084|17638929|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
5106914|NCT01865084|17638927|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
5106915|NCT01865084|17638928|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
5106916|NCT01865084|17638929|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
5106917|NCT01865084|17638927|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
5106918|NCT01865084|17638928|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
5106919|NCT01865084|17638929|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
5106920|NCT01865084|17638927|P3|Open Label Extension (OLE) Period|Adverse Event|1
5106921|NCT01865084|17638928|P2|Open Label Extension (OLE) Period|Adverse Event|0
5106922|NCT01865084|17638929|P1|Open Label Extension (OLE) Period|Adverse Event|0
5106923|NCT01865084|17638927|P3|Double Blind Period (DB)|Withdrawal by Subject|0
5106924|NCT01865084|17638928|P2|Double Blind Period (DB)|Withdrawal by Subject|0
5106925|NCT01865084|17638929|P1|Double Blind Period (DB)|Withdrawal by Subject|1
5106926|NCT01865084|17638927|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
5106927|NCT01865084|17638928|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
5106928|NCT01865084|17638929|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
5106929|NCT01865084|17638927|P3|Double Blind Period (DB)|Protocol Violation|1
5106930|NCT01865084|17638928|P2|Double Blind Period (DB)|Protocol Violation|0
5106931|NCT01865084|17638929|P1|Double Blind Period (DB)|Protocol Violation|0
5106932|NCT01865084|17638927|P3|Double Blind Period (DB)|Adverse Event|1
5106933|NCT01865084|17638928|P2|Double Blind Period (DB)|Adverse Event|2
5106934|NCT01865084|17638929|P1|Double Blind Period (DB)|Adverse Event|2
5106935|NCT01864564|17638957|P2|Overall Study|not reported|34
5106936|NCT01864564|17638958|P1|Overall Study|not reported|0
5106937|NCT01864564|17638957|P2|Overall Study|Protocol Violation|27
5106938|NCT01864564|17638958|P1|Overall Study|Protocol Violation|0
5106939|NCT01864564|17638957|P2|Overall Study|Withdrawal by Subject|11
5106940|NCT01864564|17638958|P1|Overall Study|Withdrawal by Subject|20
5106941|NCT01864564|17638957|P2|Overall Study|Lost to Follow-up|23
5106942|NCT01864564|17638958|P1|Overall Study|Lost to Follow-up|17
5106943|NCT01864525|17638990|P2|Overall Study|Adverse Event|0
5106944|NCT01864525|17638991|P1|Overall Study|Adverse Event|1
5106945|NCT01864291|17639012|P1|Overall Study|need for revision surgery|2
5106946|NCT01864200|17639020|P2|Overall Study|Protocol Violation|0
5106947|NCT01864200|17639021|P1|Overall Study|Protocol Violation|1
5106948|NCT01864200|17639020|P2|Overall Study|Lost to Follow-up|3
5106949|NCT01864200|17639021|P1|Overall Study|Lost to Follow-up|1
5106950|NCT01864174|17639029|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
5106951|NCT01864174|17639030|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
5106952|NCT01864174|17639029|P2|Off Treatment Follow-Up|Other|0
5106953|NCT01864174|17639030|P1|Off Treatment Follow-Up|Other|2
5106954|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Other|10
5106955|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Other|6
5106956|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
5106957|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
5106958|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
5106959|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
5106960|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Death|0
5106961|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Death|1
5106962|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
5106963|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
5106964|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
5106965|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
5106966|NCT01864174|17639029|P2|Double Blind - Compliant Randomized|Adverse Event|1
5106967|NCT01864174|17639030|P1|Double Blind - Compliant Randomized|Adverse Event|6
5106968|NCT01864174|17639029|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
5106969|NCT01864174|17639030|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
5106970|NCT01864148|17639049|P5|Overall Study|Not Dosed|0
5106971|NCT01864148|17639050|P4|Overall Study|Not Dosed|1
5106972|NCT01864148|17639051|P3|Overall Study|Not Dosed|0
5106973|NCT01864148|17639052|P2|Overall Study|Not Dosed|0
5106974|NCT01864148|17639053|P1|Overall Study|Not Dosed|0
5106975|NCT01864148|17639049|P5|Overall Study|Adverse Event|7
5106976|NCT01864148|17639050|P4|Overall Study|Adverse Event|7
5106977|NCT01864148|17639051|P3|Overall Study|Adverse Event|4
5106978|NCT01864148|17639052|P2|Overall Study|Adverse Event|2
5106979|NCT01864148|17639053|P1|Overall Study|Adverse Event|4
5106980|NCT01864148|17639049|P5|Overall Study|Lost to Follow-up|1
5106981|NCT01864148|17639050|P4|Overall Study|Lost to Follow-up|2
5106982|NCT01864148|17639051|P3|Overall Study|Lost to Follow-up|0
5106983|NCT01864148|17639052|P2|Overall Study|Lost to Follow-up|0
5106984|NCT01864148|17639053|P1|Overall Study|Lost to Follow-up|0
5106985|NCT01864148|17639049|P5|Overall Study|Withdrawal by Subject|8
5106986|NCT01864148|17639050|P4|Overall Study|Withdrawal by Subject|8
5106987|NCT01864148|17639051|P3|Overall Study|Withdrawal by Subject|6
5106988|NCT01864148|17639052|P2|Overall Study|Withdrawal by Subject|2
5106989|NCT01864148|17639053|P1|Overall Study|Withdrawal by Subject|9
5106990|NCT01864148|17639049|P5|Overall Study|Investigator Decision|6
5106991|NCT01864148|17639050|P4|Overall Study|Investigator Decision|4
5106992|NCT01864148|17639051|P3|Overall Study|Investigator Decision|0
5106993|NCT01864148|17639052|P2|Overall Study|Investigator Decision|0
5106994|NCT01864148|17639053|P1|Overall Study|Investigator Decision|5
5106995|NCT01864148|17639049|P5|Overall Study|Death|0
5106996|NCT01864148|17639050|P4|Overall Study|Death|1
5106997|NCT01864148|17639051|P3|Overall Study|Death|0
5106998|NCT01864148|17639052|P2|Overall Study|Death|0
5106999|NCT01864148|17639053|P1|Overall Study|Death|0
5107000|NCT01864148|17639049|P5|Overall Study|Other|1
5107001|NCT01864148|17639050|P4|Overall Study|Other|3
5107002|NCT01864148|17639051|P3|Overall Study|Other|1
5107003|NCT01864148|17639052|P2|Overall Study|Other|1
5107004|NCT01864148|17639053|P1|Overall Study|Other|2
5107005|NCT01864005|17639082|P2|Overall Study|Need GP IIb/IIIa|3
5107006|NCT01864005|17639083|P1|Overall Study|Need GP IIb/IIIa|1
5107007|NCT01864005|17639082|P2|Overall Study|Disease need|1
5107008|NCT01864005|17639083|P1|Overall Study|Disease need|1
5107009|NCT01864005|17639082|P2|Overall Study|Incorrect enrolment|0
5107010|NCT01864005|17639083|P1|Overall Study|Incorrect enrolment|1
5107011|NCT01864005|17639082|P2|Overall Study|Withdrawal by Subject|1
5107012|NCT01864005|17639083|P1|Overall Study|Withdrawal by Subject|0
5107013|NCT01864005|17639082|P2|Overall Study|Protocol Violation|1
5107014|NCT01864005|17639083|P1|Overall Study|Protocol Violation|0
5107015|NCT01863953|17639100|P3|Overall Study|Adverse Event|1
5107016|NCT01863953|17639101|P2|Overall Study|Adverse Event|0
5107017|NCT01863953|17639102|P1|Overall Study|Adverse Event|0
5107018|NCT01863771|17639116|P4|Maintenance Phase|Withdrawal by Subject|3
5107019|NCT01863771|17639117|P3|Maintenance Phase|Withdrawal by Subject|2
5107020|NCT01863771|17639118|P2|Maintenance Phase|Withdrawal by Subject|1
5107021|NCT01863771|17639119|P1|Maintenance Phase|Withdrawal by Subject|0
5107022|NCT01863771|17639116|P4|Maintenance Phase|Pregnancy|0
5107023|NCT01863771|17639117|P3|Maintenance Phase|Pregnancy|0
5107024|NCT01863771|17639118|P2|Maintenance Phase|Pregnancy|1
5107025|NCT01863771|17639119|P1|Maintenance Phase|Pregnancy|0
5107026|NCT01863771|17639116|P4|Maintenance Phase|Physician Decision|1
5107027|NCT01863771|17639117|P3|Maintenance Phase|Physician Decision|2
5107028|NCT01863771|17639118|P2|Maintenance Phase|Physician Decision|0
5107029|NCT01863771|17639119|P1|Maintenance Phase|Physician Decision|0
5107030|NCT01863771|17639116|P4|Maintenance Phase|Lack of Efficacy|38
5107031|NCT01863771|17639117|P3|Maintenance Phase|Lack of Efficacy|7
5107032|NCT01863771|17639118|P2|Maintenance Phase|Lack of Efficacy|3
5107033|NCT01863771|17639119|P1|Maintenance Phase|Lack of Efficacy|0
5107034|NCT01863771|17639116|P4|Maintenance Phase|Adverse Event|1
5107035|NCT01863771|17639117|P3|Maintenance Phase|Adverse Event|1
5107036|NCT01863771|17639118|P2|Maintenance Phase|Adverse Event|0
5107037|NCT01863771|17639119|P1|Maintenance Phase|Adverse Event|0
5107038|NCT01863771|17639116|P4|Induction Phase|Withdrawal by Subject|0
5107039|NCT01863771|17639117|P3|Induction Phase|Withdrawal by Subject|0
5107040|NCT01863771|17639118|P2|Induction Phase|Withdrawal by Subject|0
5107041|NCT01863771|17639119|P1|Induction Phase|Withdrawal by Subject|2
5107042|NCT01863771|17639116|P4|Induction Phase|Lack of Efficacy|0
5107043|NCT01863771|17639117|P3|Induction Phase|Lack of Efficacy|0
5107044|NCT01863771|17639118|P2|Induction Phase|Lack of Efficacy|0
5107045|NCT01863771|17639119|P1|Induction Phase|Lack of Efficacy|10
5107046|NCT01863771|17639116|P4|Induction Phase|Adverse Event|0
5107047|NCT01863771|17639117|P3|Induction Phase|Adverse Event|0
5107048|NCT01863771|17639118|P2|Induction Phase|Adverse Event|0
5107049|NCT01863771|17639119|P1|Induction Phase|Adverse Event|9
5107050|NCT01863758|17639131|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
5107051|NCT01863758|17639131|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
5107052|NCT01863732|17639143|P4|Overall Study|Death|1
5107053|NCT01863732|17639144|P3|Overall Study|Death|0
5107054|NCT01863732|17639145|P2|Overall Study|Death|0
5107055|NCT01863732|17639146|P1|Overall Study|Death|1
5107056|NCT01863732|17639143|P4|Overall Study|Subject/guardian decision|1
5107057|NCT01863732|17639144|P3|Overall Study|Subject/guardian decision|3
5107058|NCT01863732|17639145|P2|Overall Study|Subject/guardian decision|9
5107059|NCT01863732|17639146|P1|Overall Study|Subject/guardian decision|6
5107060|NCT01863732|17639143|P4|Overall Study|Technical problems|0
5107061|NCT01863732|17639144|P3|Overall Study|Technical problems|1
5107062|NCT01863732|17639145|P2|Overall Study|Technical problems|1
5107063|NCT01863732|17639146|P1|Overall Study|Technical problems|0
5107064|NCT01863732|17639143|P4|Overall Study|Pregnancy|1
5107065|NCT01863732|17639144|P3|Overall Study|Pregnancy|0
5107066|NCT01863732|17639145|P2|Overall Study|Pregnancy|0
5107067|NCT01863732|17639146|P1|Overall Study|Pregnancy|0
5107068|NCT01863732|17639143|P4|Overall Study|Physician Decision|0
5107069|NCT01863732|17639144|P3|Overall Study|Physician Decision|1
5107070|NCT01863732|17639145|P2|Overall Study|Physician Decision|0
5107071|NCT01863732|17639146|P1|Overall Study|Physician Decision|1
5107072|NCT01863732|17639143|P4|Overall Study|Lost to Follow-up|1
5107073|NCT01863732|17639144|P3|Overall Study|Lost to Follow-up|1
5107074|NCT01863732|17639145|P2|Overall Study|Lost to Follow-up|2
5107075|NCT01863732|17639146|P1|Overall Study|Lost to Follow-up|2
5107076|NCT01863732|17639143|P4|Overall Study|Lack of Efficacy|1
5107077|NCT01863732|17639144|P3|Overall Study|Lack of Efficacy|2
5107078|NCT01863732|17639145|P2|Overall Study|Lack of Efficacy|0
5107079|NCT01863732|17639146|P1|Overall Study|Lack of Efficacy|1
5107080|NCT01863732|17639143|P4|Overall Study|Adverse Event|3
5107081|NCT01863732|17639144|P3|Overall Study|Adverse Event|3
5107082|NCT01863732|17639145|P2|Overall Study|Adverse Event|0
5107083|NCT01863732|17639146|P1|Overall Study|Adverse Event|2
5107084|NCT01863680|17639159|P1|Overall Study|Other|6
5107085|NCT01863680|17639159|P1|Overall Study|Did not undergo IVF/ET|14
5107086|NCT01863680|17639159|P1|Overall Study|Withdrawal by Subject|1
5107087|NCT01863680|17639159|P1|Overall Study|Spontaneous pregnancy|2
5107088|NCT01863680|17639159|P1|Overall Study|Risk of OHSS|17
5107089|NCT01863680|17639159|P1|Overall Study|Adverse Event|17
5107090|NCT01863667|17639167|P2|Overall Study|Withdrawal by Subject|2
5107091|NCT01863667|17639168|P1|Overall Study|Withdrawal by Subject|2
5107092|NCT01863667|17639167|P2|Overall Study|Study terminated by Sponsor|30
5107093|NCT01863667|17639168|P1|Overall Study|Study terminated by Sponsor|30
5107094|NCT01863667|17639167|P2|Overall Study|Adverse Event|0
5107095|NCT01863667|17639168|P1|Overall Study|Adverse Event|1
5107096|NCT01863433|17639205|P1|Overall Study|Protocol Violation|1
5107097|NCT01863368|17639215|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
5107098|NCT01863368|17639216|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
5107099|NCT01863368|17639215|P2|Phase II, Day 35 to Day 90|Adverse Event|0
5107100|NCT01863368|17639216|P1|Phase II, Day 35 to Day 90|Adverse Event|1
5107101|NCT01863368|17639215|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
5107102|NCT01863368|17639216|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
5107103|NCT01863368|17639215|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
5107104|NCT01863368|17639216|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
5107105|NCT01863368|17639215|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
5107106|NCT01863368|17639216|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
5107107|NCT01863368|17639215|P2|Phase I, Day 0 to Day 35|Adverse Event|4
5107108|NCT01863368|17639216|P1|Phase I, Day 0 to Day 35|Adverse Event|2
5107109|NCT01862991|17639270|P3|Overall Study|Protocol Violation|0
5107110|NCT01862991|17639271|P2|Overall Study|Protocol Violation|0
5107111|NCT01862991|17639272|P1|Overall Study|Protocol Violation|1
5107112|NCT01862991|17639270|P3|Overall Study|Lost to Follow-up|1
5107113|NCT01862991|17639271|P2|Overall Study|Lost to Follow-up|1
5107114|NCT01862991|17639272|P1|Overall Study|Lost to Follow-up|2
5107115|NCT01862874|17639285|P2|Overall Study|Death|1
5107116|NCT01862874|17639286|P1|Overall Study|Death|0
5107117|NCT01862874|17639285|P2|Overall Study|Withdrawal by Subject|40
5107118|NCT01862874|17639286|P1|Overall Study|Withdrawal by Subject|46
5107119|NCT01862874|17639285|P2|Overall Study|Withdrawn by parent/guardian|1
5107120|NCT01862874|17639286|P1|Overall Study|Withdrawn by parent/guardian|1
5107121|NCT01862874|17639285|P2|Overall Study|Physician Decision|3
5107122|NCT01862874|17639286|P1|Overall Study|Physician Decision|5
5107123|NCT01862874|17639285|P2|Overall Study|Lost to Follow-up|29
5107124|NCT01862874|17639286|P1|Overall Study|Lost to Follow-up|26
5107125|NCT01862874|17639285|P2|Overall Study|Adverse Event|3
5107126|NCT01862874|17639286|P1|Overall Study|Adverse Event|0
5107127|NCT01862874|17639285|P2|Overall Study|Randomized not treated|0
5107128|NCT01862874|17639286|P1|Overall Study|Randomized not treated|1
5107129|NCT01862796|17639305|P3|Overall Study|Prohibited medications|1
5107130|NCT01862796|17639306|P2|Overall Study|Prohibited medications|0
5107131|NCT01862796|17639307|P1|Overall Study|Prohibited medications|0
5107132|NCT01862640|17639322|P4|Overall Study|Protocol Deviation|0
5107133|NCT01862640|17639323|P3|Overall Study|Protocol Deviation|1
5107134|NCT01862640|17639324|P2|Overall Study|Protocol Deviation|0
5107135|NCT01862640|17639325|P1|Overall Study|Protocol Deviation|0
5107136|NCT01862640|17639322|P4|Overall Study|Withdrawal by Subject|5
5107137|NCT01862640|17639323|P3|Overall Study|Withdrawal by Subject|8
5107138|NCT01862640|17639324|P2|Overall Study|Withdrawal by Subject|4
5107139|NCT01862640|17639325|P1|Overall Study|Withdrawal by Subject|2
5107140|NCT01862640|17639322|P4|Overall Study|Participant Withdrawn by Investigator|1
5107141|NCT01862640|17639323|P3|Overall Study|Participant Withdrawn by Investigator|1
5107142|NCT01862640|17639324|P2|Overall Study|Participant Withdrawn by Investigator|1
5107143|NCT01862640|17639325|P1|Overall Study|Participant Withdrawn by Investigator|0
5107144|NCT01862640|17639322|P4|Overall Study|Participant Met Withdrawal Criteria|1
5107145|NCT01862640|17639323|P3|Overall Study|Participant Met Withdrawal Criteria|2
5107146|NCT01862640|17639324|P2|Overall Study|Participant Met Withdrawal Criteria|1
5107147|NCT01862640|17639325|P1|Overall Study|Participant Met Withdrawal Criteria|1
5107148|NCT01862640|17639322|P4|Overall Study|Adverse Event|8
5107149|NCT01862640|17639323|P3|Overall Study|Adverse Event|6
5107150|NCT01862640|17639324|P2|Overall Study|Adverse Event|10
5107151|NCT01862640|17639325|P1|Overall Study|Adverse Event|4
5107152|NCT01862484|17639339|P2|Overall Study|Withdrawal by Subject|3
5107153|NCT01862484|17639340|P1|Overall Study|Withdrawal by Subject|0
5107154|NCT01862484|17639339|P2|Overall Study|Protocol Violation|2
5107155|NCT01862484|17639340|P1|Overall Study|Protocol Violation|0
5107156|NCT01862484|17639339|P2|Overall Study|Lost to Follow-up|2
5107157|NCT01862484|17639340|P1|Overall Study|Lost to Follow-up|1
5107158|NCT01862484|17639339|P2|Overall Study|Lack of Efficacy|1
5107159|NCT01862484|17639340|P1|Overall Study|Lack of Efficacy|1
5107160|NCT01862328|17639366|P7|Overall Study|Symptomatic Deterioration|1
5107161|NCT01862328|17639367|P6|Overall Study|Symptomatic Deterioration|0
5107162|NCT01862328|17639368|P5|Overall Study|Symptomatic Deterioration|0
5107163|NCT01862328|17639369|P4|Overall Study|Symptomatic Deterioration|0
5107164|NCT01862328|17639370|P3|Overall Study|Symptomatic Deterioration|0
5107165|NCT01862328|17639371|P2|Overall Study|Symptomatic Deterioration|0
5107166|NCT01862328|17639372|P1|Overall Study|Symptomatic Deterioration|0
5107167|NCT01862328|17639366|P7|Overall Study|Withdrawal by Subject|1
5107168|NCT01862328|17639367|P6|Overall Study|Withdrawal by Subject|1
5107169|NCT01862328|17639368|P5|Overall Study|Withdrawal by Subject|1
5107170|NCT01862328|17639369|P4|Overall Study|Withdrawal by Subject|0
5107171|NCT01862328|17639370|P3|Overall Study|Withdrawal by Subject|0
5107172|NCT01862328|17639371|P2|Overall Study|Withdrawal by Subject|1
5107173|NCT01862328|17639372|P1|Overall Study|Withdrawal by Subject|1
5107174|NCT01862328|17639366|P7|Overall Study|Other|1
5107175|NCT01862328|17639367|P6|Overall Study|Other|0
5107176|NCT01862328|17639368|P5|Overall Study|Other|4
5107177|NCT01862328|17639369|P4|Overall Study|Other|0
5107178|NCT01862328|17639370|P3|Overall Study|Other|1
5107179|NCT01862328|17639371|P2|Overall Study|Other|2
5107180|NCT01862328|17639372|P1|Overall Study|Other|0
5107181|NCT01862328|17639366|P7|Overall Study|Adverse Event|4
5107182|NCT01862328|17639367|P6|Overall Study|Adverse Event|2
5107183|NCT01862328|17639368|P5|Overall Study|Adverse Event|0
5107184|NCT01862328|17639369|P4|Overall Study|Adverse Event|1
5107185|NCT01862328|17639370|P3|Overall Study|Adverse Event|0
5107186|NCT01862328|17639371|P2|Overall Study|Adverse Event|4
5107187|NCT01862328|17639372|P1|Overall Study|Adverse Event|0
5107188|NCT01862328|17639366|P7|Overall Study|Progressive Disease|3
5107189|NCT01862328|17639367|P6|Overall Study|Progressive Disease|4
5107190|NCT01862328|17639368|P5|Overall Study|Progressive Disease|7
5107191|NCT01862328|17639369|P4|Overall Study|Progressive Disease|6
5107192|NCT01862328|17639370|P3|Overall Study|Progressive Disease|5
5107193|NCT01862328|17639371|P2|Overall Study|Progressive Disease|11
5107194|NCT01862328|17639372|P1|Overall Study|Progressive Disease|3
5107195|NCT01862250|17639424|P1|Overall Study|Adverse Event|4
5107196|NCT01862029|17639445|P1|Overall Study|Physician Decision|1
5107197|NCT01861522|17639548|P2|Overall Study|Withdrawal by Subject|0
5107198|NCT01861522|17639549|P1|Overall Study|Withdrawal by Subject|2
5107199|NCT01861522|17639548|P2|Overall Study|Adverse Event|0
5107200|NCT01861522|17639549|P1|Overall Study|Adverse Event|1
5107201|NCT01860989|17639573|P1|Overall Study|Unsatisfactory therapeutic|5
5107202|NCT01860976|17639579|P2|Long Term Extension|Ongoing treatment at time of analysis|100
5107203|NCT01860976|17639580|P1|Long Term Extension|Ongoing treatment at time of analysis|106
5107204|NCT01860976|17639579|P2|Long Term Extension|Withdrawal by Subject|0
5107205|NCT01860976|17639580|P1|Long Term Extension|Withdrawal by Subject|1
5107206|NCT01860976|17639579|P2|Long Term Extension|Subject request to discontinue treatment|0
5107207|NCT01860976|17639580|P1|Long Term Extension|Subject request to discontinue treatment|2
5107208|NCT01860976|17639579|P2|Long Term Extension|Lack of Efficacy|7
5107209|NCT01860976|17639580|P1|Long Term Extension|Lack of Efficacy|3
5107210|NCT01860976|17639579|P2|Long Term Extension|Adverse Event|0
5107211|NCT01860976|17639580|P1|Long Term Extension|Adverse Event|1
5107212|NCT01860976|17639579|P2|Open-Label|Ongoing OL treatment at time of analysis|45
5107213|NCT01860976|17639580|P1|Open-Label|Ongoing OL treatment at time of analysis|46
5107214|NCT01860976|17639579|P2|Open-Label|Other Reasons|1
5107215|NCT01860976|17639580|P1|Open-Label|Other Reasons|1
5107216|NCT01860976|17639579|P2|Open-Label|Withdrawal by Subject|1
5107217|NCT01860976|17639580|P1|Open-Label|Withdrawal by Subject|4
5107218|NCT01860976|17639579|P2|Open-Label|Subject request discontinue treatment|3
5107219|NCT01860976|17639580|P1|Open-Label|Subject request discontinue treatment|4
5107220|NCT01860976|17639579|P2|Open-Label|Lost to Follow-up|2
5107221|NCT01860976|17639580|P1|Open-Label|Lost to Follow-up|1
5107222|NCT01860976|17639579|P2|Open-Label|Lack of Efficacy|8
5107223|NCT01860976|17639580|P1|Open-Label|Lack of Efficacy|16
5107224|NCT01860976|17639579|P2|Open-Label|Adverse Event|4
5107225|NCT01860976|17639580|P1|Open-Label|Adverse Event|2
5107226|NCT01860976|17639579|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
5107227|NCT01860976|17639580|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
5107228|NCT01860976|17639579|P2|Blinded Treatment|Entered Open-Label in error|1
5107229|NCT01860976|17639580|P1|Blinded Treatment|Entered Open-Label in error|0
5107230|NCT01860976|17639579|P2|Blinded Treatment|Subject no longer met criteria|0
5107231|NCT01860976|17639580|P1|Blinded Treatment|Subject no longer met criteria|1
5107232|NCT01860976|17639579|P2|Blinded Treatment|Withdrawal by Subject|5
5107233|NCT01860976|17639580|P1|Blinded Treatment|Withdrawal by Subject|3
5107234|NCT01860976|17639579|P2|Blinded Treatment|Subject request to discontinue treatment|3
5107235|NCT01860976|17639580|P1|Blinded Treatment|Subject request to discontinue treatment|2
5107236|NCT01860976|17639579|P2|Blinded Treatment|Lack of Efficacy|12
5107237|NCT01860976|17639580|P1|Blinded Treatment|Lack of Efficacy|5
5107238|NCT01860976|17639579|P2|Blinded Treatment|Adverse Event|3
5107239|NCT01860976|17639580|P1|Blinded Treatment|Adverse Event|1
5107240|NCT01860846|17639634|P1|Overall Study|Lost to Follow-up|33
5107241|NCT01860703|17639654|P4|Overall Study|Personal reason|0
5107242|NCT01860703|17639655|P3|Overall Study|Personal reason|1
5107243|NCT01860703|17639656|P2|Overall Study|Personal reason|0
5107244|NCT01860703|17639657|P1|Overall Study|Personal reason|1
5107245|NCT01860703|17639654|P4|Overall Study|Withdrawal by Subject|0
5107246|NCT01860703|17639655|P3|Overall Study|Withdrawal by Subject|0
5107247|NCT01860703|17639656|P2|Overall Study|Withdrawal by Subject|1
5107248|NCT01860703|17639657|P1|Overall Study|Withdrawal by Subject|0
5107249|NCT01860703|17639654|P4|Overall Study|Adverse Event|2
5107250|NCT01860703|17639655|P3|Overall Study|Adverse Event|0
5107251|NCT01860703|17639656|P2|Overall Study|Adverse Event|4
5107252|NCT01860703|17639657|P1|Overall Study|Adverse Event|1
5107253|NCT01860677|17639689|P2|Second Intervention (1 Day)|Lost to Follow-up|0
5107254|NCT01860677|17639690|P1|Second Intervention (1 Day)|Lost to Follow-up|7
5107255|NCT01860534|17639747|P2|ROP #2|discharged prior to ROP #2|0
5107256|NCT01860534|17639748|P1|ROP #2|discharged prior to ROP #2|1
5107257|NCT01860534|17639747|P2|ROP #1|Needed treatment for ROP|1
5107258|NCT01860534|17639748|P1|ROP #1|Needed treatment for ROP|0
5107259|NCT01860079|17639809|P2|Overall Study|Physician Decision|22
5107260|NCT01860079|17639810|P1|Overall Study|Physician Decision|14
5107261|NCT01860040|17639818|P2|Overall Study|Withdrawal by Subject|0
5107262|NCT01860040|17639819|P1|Overall Study|Withdrawal by Subject|1
5107263|NCT01859988|17639830|P6|Overall Study|Other than specified above|3
5107264|NCT01859988|17639831|P5|Overall Study|Other than specified above|5
5107265|NCT01859988|17639832|P4|Overall Study|Other than specified above|3
5107266|NCT01859988|17639833|P3|Overall Study|Other than specified above|11
5107267|NCT01859988|17639834|P2|Overall Study|Other than specified above|2
5107268|NCT01859988|17639835|P1|Overall Study|Other than specified above|0
5107269|NCT01859988|17639830|P6|Overall Study|Protocol Violation|0
5107270|NCT01859988|17639831|P5|Overall Study|Protocol Violation|0
5107271|NCT01859988|17639832|P4|Overall Study|Protocol Violation|0
5107272|NCT01859988|17639833|P3|Overall Study|Protocol Violation|1
5107273|NCT01859988|17639834|P2|Overall Study|Protocol Violation|0
5107274|NCT01859988|17639835|P1|Overall Study|Protocol Violation|0
5107275|NCT01859988|17639830|P6|Overall Study|Lost to Follow-up|2
5107276|NCT01859988|17639831|P5|Overall Study|Lost to Follow-up|3
5107277|NCT01859988|17639832|P4|Overall Study|Lost to Follow-up|0
5107278|NCT01859988|17639833|P3|Overall Study|Lost to Follow-up|3
5107279|NCT01859988|17639834|P2|Overall Study|Lost to Follow-up|2
5107280|NCT01859988|17639835|P1|Overall Study|Lost to Follow-up|1
5107281|NCT01859988|17639830|P6|Overall Study|Adverse Event|2
5107282|NCT01859988|17639831|P5|Overall Study|Adverse Event|2
5107283|NCT01859988|17639832|P4|Overall Study|Adverse Event|1
5107284|NCT01859988|17639833|P3|Overall Study|Adverse Event|3
5107285|NCT01859988|17639834|P2|Overall Study|Adverse Event|1
5107286|NCT01859988|17639835|P1|Overall Study|Adverse Event|2
5107287|NCT01859988|17639830|P6|Overall Study|Physician Decision|1
5107288|NCT01859988|17639831|P5|Overall Study|Physician Decision|4
5107289|NCT01859988|17639832|P4|Overall Study|Physician Decision|3
5107290|NCT01859988|17639833|P3|Overall Study|Physician Decision|1
5107291|NCT01859988|17639834|P2|Overall Study|Physician Decision|3
5107292|NCT01859988|17639835|P1|Overall Study|Physician Decision|1
5107293|NCT01859988|17639830|P6|Overall Study|Lack of Efficacy|9
5107294|NCT01859988|17639831|P5|Overall Study|Lack of Efficacy|7
5107295|NCT01859988|17639832|P4|Overall Study|Lack of Efficacy|0
5107296|NCT01859988|17639833|P3|Overall Study|Lack of Efficacy|5
5107297|NCT01859988|17639834|P2|Overall Study|Lack of Efficacy|1
5107298|NCT01859988|17639835|P1|Overall Study|Lack of Efficacy|1
5107299|NCT01859988|17639830|P6|Overall Study|Withdrawal by Subject|2
5107300|NCT01859988|17639831|P5|Overall Study|Withdrawal by Subject|2
5107301|NCT01859988|17639832|P4|Overall Study|Withdrawal by Subject|3
5107302|NCT01859988|17639833|P3|Overall Study|Withdrawal by Subject|4
5107303|NCT01859988|17639834|P2|Overall Study|Withdrawal by Subject|3
5107304|NCT01859988|17639835|P1|Overall Study|Withdrawal by Subject|6
5107305|NCT01859949|17639929|P2|Overall Study|Adverse Event|1
5107306|NCT01859949|17639930|P1|Overall Study|Adverse Event|0
5107307|NCT01859949|17639929|P2|Overall Study|Protocol Violation|1
5107308|NCT01859949|17639930|P1|Overall Study|Protocol Violation|1
5107309|NCT01859949|17639929|P2|Overall Study|Withdrawal by Subject|10
5107310|NCT01859949|17639930|P1|Overall Study|Withdrawal by Subject|11
5107311|NCT01859949|17639929|P2|Overall Study|Physician Decision|4
5107312|NCT01859949|17639930|P1|Overall Study|Physician Decision|2
5107313|NCT01859949|17639929|P2|Overall Study|Family Matters|1
5107314|NCT01859949|17639930|P1|Overall Study|Family Matters|0
5107315|NCT01859923|17639950|P4|Overall Study|Adverse Event|1
5107316|NCT01859923|17639951|P3|Overall Study|Adverse Event|1
5107317|NCT01859923|17639952|P2|Overall Study|Adverse Event|0
5107318|NCT01859923|17639953|P1|Overall Study|Adverse Event|0
5107319|NCT01859793|17640007|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
5107320|NCT01859793|17640008|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
5107321|NCT01859793|17640007|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
5107322|NCT01859793|17640008|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5107323|NCT01859793|17640007|P2|First Intervention (8 Weeks)|Adverse Event|0
5107324|NCT01859793|17640008|P1|First Intervention (8 Weeks)|Adverse Event|1
5107325|NCT01859793|17640007|P2|First Intervention (8 Weeks)|Protocol Violation|0
5107326|NCT01859793|17640008|P1|First Intervention (8 Weeks)|Protocol Violation|2
5107327|NCT01859741|17640026|P8|Overall Study|Other|0
5107328|NCT01859741|17640027|P7|Overall Study|Other|2
5107329|NCT01859741|17640028|P6|Overall Study|Other|0
5107330|NCT01859741|17640029|P5|Overall Study|Other|0
5107331|NCT01859741|17640030|P4|Overall Study|Other|0
5107332|NCT01859741|17640031|P3|Overall Study|Other|0
5107333|NCT01859741|17640032|P2|Overall Study|Other|0
5107334|NCT01859741|17640033|P1|Overall Study|Other|0
5107335|NCT01859741|17640026|P8|Overall Study|Study Terminated by Sponsor|14
5107336|NCT01859741|17640027|P7|Overall Study|Study Terminated by Sponsor|16
5107337|NCT01859741|17640028|P6|Overall Study|Study Terminated by Sponsor|0
5107338|NCT01859741|17640029|P5|Overall Study|Study Terminated by Sponsor|1
5107339|NCT01859741|17640030|P4|Overall Study|Study Terminated by Sponsor|0
5107340|NCT01859741|17640031|P3|Overall Study|Study Terminated by Sponsor|0
5107341|NCT01859741|17640032|P2|Overall Study|Study Terminated by Sponsor|0
5107342|NCT01859741|17640033|P1|Overall Study|Study Terminated by Sponsor|0
5107343|NCT01859741|17640026|P8|Overall Study|Withdrawal by Subject|1
5107344|NCT01859741|17640027|P7|Overall Study|Withdrawal by Subject|1
5107345|NCT01859741|17640028|P6|Overall Study|Withdrawal by Subject|1
5107346|NCT01859741|17640029|P5|Overall Study|Withdrawal by Subject|0
5107347|NCT01859741|17640030|P4|Overall Study|Withdrawal by Subject|0
5107348|NCT01859741|17640031|P3|Overall Study|Withdrawal by Subject|2
5107349|NCT01859741|17640032|P2|Overall Study|Withdrawal by Subject|1
5107350|NCT01859741|17640033|P1|Overall Study|Withdrawal by Subject|0
5107351|NCT01859741|17640026|P8|Overall Study|Lost to Follow-up|4
5107352|NCT01859741|17640027|P7|Overall Study|Lost to Follow-up|0
5107353|NCT01859741|17640028|P6|Overall Study|Lost to Follow-up|1
5107354|NCT01859741|17640029|P5|Overall Study|Lost to Follow-up|0
5107355|NCT01859741|17640030|P4|Overall Study|Lost to Follow-up|0
5107356|NCT01859741|17640031|P3|Overall Study|Lost to Follow-up|0
5107357|NCT01859741|17640032|P2|Overall Study|Lost to Follow-up|0
5107358|NCT01859741|17640033|P1|Overall Study|Lost to Follow-up|0
5107359|NCT01859741|17640026|P8|Overall Study|Death|51
5107360|NCT01859741|17640027|P7|Overall Study|Death|51
5107361|NCT01859741|17640028|P6|Overall Study|Death|4
5107362|NCT01859741|17640029|P5|Overall Study|Death|5
5107363|NCT01859741|17640030|P4|Overall Study|Death|3
5107364|NCT01859741|17640031|P3|Overall Study|Death|4
5107365|NCT01859741|17640032|P2|Overall Study|Death|2
5107366|NCT01859741|17640033|P1|Overall Study|Death|3
5107367|NCT01859715|17640062|P3|Overall Study|No 2nd VAS|23
5107368|NCT01859715|17640063|P2|Overall Study|No 2nd VAS|8
5107369|NCT01859715|17640064|P1|Overall Study|No 2nd VAS|16
5107370|NCT01859702|17640075|P1|Overall Study|Adverse Event|2
5107371|NCT01859702|17640075|P1|Overall Study|Protocol deviation|3
5107372|NCT01859598|17640089|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
5107373|NCT01859507|17640097|P1|Overall Study|left the country|4
5107374|NCT01859494|17640102|P1|Overall Study|Adverse Event|1
5107375|NCT01859390|17640113|P2|Overall Study|Shipment Error|1
5107376|NCT01859390|17640114|P1|Overall Study|Shipment Error|0
5107377|NCT01859390|17640113|P2|Overall Study|Tube Cracked|2
5107378|NCT01859390|17640114|P1|Overall Study|Tube Cracked|0
5107379|NCT01859390|17640113|P2|Overall Study|Sample Missing Collection Date|1
5107380|NCT01859390|17640114|P1|Overall Study|Sample Missing Collection Date|0
5107381|NCT01859390|17640113|P2|Overall Study|Insufficient Sputum Collected|3
5107382|NCT01859390|17640114|P1|Overall Study|Insufficient Sputum Collected|1
5107383|NCT01859143|17640248|P2|Overall Study|Lost to Follow-up|0
5107384|NCT01859143|17640249|P1|Overall Study|Lost to Follow-up|2
5107385|NCT01858766|17640305|P19|Overall Study|Withdrew Consent|0
5107386|NCT01858766|17640306|P18|Overall Study|Withdrew Consent|0
5107387|NCT01858766|17640307|P17|Overall Study|Withdrew Consent|0
5107388|NCT01858766|17640308|P16|Overall Study|Withdrew Consent|0
5107389|NCT01858766|17640309|P15|Overall Study|Withdrew Consent|0
5107390|NCT01858766|17640310|P14|Overall Study|Withdrew Consent|0
5107391|NCT01858766|17640311|P13|Overall Study|Withdrew Consent|0
5107392|NCT01858766|17640312|P12|Overall Study|Withdrew Consent|1
5107393|NCT01858766|17640313|P11|Overall Study|Withdrew Consent|0
5107394|NCT01858766|17640314|P10|Overall Study|Withdrew Consent|0
5107395|NCT01858766|17640315|P9|Overall Study|Withdrew Consent|0
5107396|NCT01858766|17640316|P8|Overall Study|Withdrew Consent|0
5107397|NCT01858766|17640317|P7|Overall Study|Withdrew Consent|0
5107398|NCT01858766|17640318|P6|Overall Study|Withdrew Consent|0
5107399|NCT01858766|17640319|P5|Overall Study|Withdrew Consent|0
5107400|NCT01858766|17640320|P4|Overall Study|Withdrew Consent|0
5107401|NCT01858766|17640321|P3|Overall Study|Withdrew Consent|0
5107402|NCT01858766|17640322|P2|Overall Study|Withdrew Consent|0
5107403|NCT01858766|17640323|P1|Overall Study|Withdrew Consent|0
5107404|NCT01858766|17640305|P19|Overall Study|Lost to Follow-up|1
5107405|NCT01858766|17640306|P18|Overall Study|Lost to Follow-up|0
5107406|NCT01858766|17640307|P17|Overall Study|Lost to Follow-up|1
5107407|NCT01858766|17640308|P16|Overall Study|Lost to Follow-up|1
5107408|NCT01858766|17640309|P15|Overall Study|Lost to Follow-up|3
5107409|NCT01858766|17640310|P14|Overall Study|Lost to Follow-up|0
5107410|NCT01858766|17640311|P13|Overall Study|Lost to Follow-up|0
5107411|NCT01858766|17640312|P12|Overall Study|Lost to Follow-up|1
5107412|NCT01858766|17640313|P11|Overall Study|Lost to Follow-up|0
5107413|NCT01858766|17640314|P10|Overall Study|Lost to Follow-up|0
5107414|NCT01858766|17640315|P9|Overall Study|Lost to Follow-up|0
5107415|NCT01858766|17640316|P8|Overall Study|Lost to Follow-up|2
5107416|NCT01858766|17640317|P7|Overall Study|Lost to Follow-up|0
5107417|NCT01858766|17640318|P6|Overall Study|Lost to Follow-up|1
5107418|NCT01858766|17640319|P5|Overall Study|Lost to Follow-up|0
5107419|NCT01858766|17640320|P4|Overall Study|Lost to Follow-up|0
5107420|NCT01858766|17640321|P3|Overall Study|Lost to Follow-up|0
5107421|NCT01858766|17640322|P2|Overall Study|Lost to Follow-up|0
5107422|NCT01858766|17640323|P1|Overall Study|Lost to Follow-up|0
5107423|NCT01858766|17640305|P19|Overall Study|Lack of Efficacy|3
5107424|NCT01858766|17640306|P18|Overall Study|Lack of Efficacy|3
5107425|NCT01858766|17640307|P17|Overall Study|Lack of Efficacy|2
5107426|NCT01858766|17640308|P16|Overall Study|Lack of Efficacy|5
5107427|NCT01858766|17640309|P15|Overall Study|Lack of Efficacy|5
5107428|NCT01858766|17640310|P14|Overall Study|Lack of Efficacy|3
5107429|NCT01858766|17640311|P13|Overall Study|Lack of Efficacy|5
5107430|NCT01858766|17640312|P12|Overall Study|Lack of Efficacy|3
5107431|NCT01858766|17640313|P11|Overall Study|Lack of Efficacy|0
5107432|NCT01858766|17640314|P10|Overall Study|Lack of Efficacy|0
5107433|NCT01858766|17640315|P9|Overall Study|Lack of Efficacy|0
5107434|NCT01858766|17640316|P8|Overall Study|Lack of Efficacy|0
5107435|NCT01858766|17640317|P7|Overall Study|Lack of Efficacy|0
5107436|NCT01858766|17640318|P6|Overall Study|Lack of Efficacy|2
5107437|NCT01858766|17640319|P5|Overall Study|Lack of Efficacy|1
5107438|NCT01858766|17640320|P4|Overall Study|Lack of Efficacy|0
5107439|NCT01858766|17640321|P3|Overall Study|Lack of Efficacy|0
5107440|NCT01858766|17640322|P2|Overall Study|Lack of Efficacy|0
5107441|NCT01858766|17640323|P1|Overall Study|Lack of Efficacy|1
5107442|NCT01858766|17640305|P19|Overall Study|Death|0
5107443|NCT01858766|17640306|P18|Overall Study|Death|0
5107444|NCT01858766|17640307|P17|Overall Study|Death|0
5107445|NCT01858766|17640308|P16|Overall Study|Death|0
5107446|NCT01858766|17640309|P15|Overall Study|Death|0
5107447|NCT01858766|17640310|P14|Overall Study|Death|0
5107448|NCT01858766|17640311|P13|Overall Study|Death|0
5107449|NCT01858766|17640312|P12|Overall Study|Death|0
5107450|NCT01858766|17640313|P11|Overall Study|Death|0
5107451|NCT01858766|17640314|P10|Overall Study|Death|0
5107452|NCT01858766|17640315|P9|Overall Study|Death|0
5107453|NCT01858766|17640316|P8|Overall Study|Death|0
5107454|NCT01858766|17640317|P7|Overall Study|Death|0
5107455|NCT01858766|17640318|P6|Overall Study|Death|0
5107456|NCT01858766|17640319|P5|Overall Study|Death|0
5107457|NCT01858766|17640320|P4|Overall Study|Death|0
5107458|NCT01858766|17640321|P3|Overall Study|Death|1
5107459|NCT01858766|17640322|P2|Overall Study|Death|0
5107460|NCT01858766|17640323|P1|Overall Study|Death|0
5107461|NCT01858766|17640305|P19|Overall Study|Randomized but Never Treated|0
5107462|NCT01858766|17640306|P18|Overall Study|Randomized but Never Treated|1
5107463|NCT01858766|17640307|P17|Overall Study|Randomized but Never Treated|0
5107464|NCT01858766|17640308|P16|Overall Study|Randomized but Never Treated|0
5107465|NCT01858766|17640309|P15|Overall Study|Randomized but Never Treated|0
5107466|NCT01858766|17640310|P14|Overall Study|Randomized but Never Treated|0
5107467|NCT01858766|17640311|P13|Overall Study|Randomized but Never Treated|0
5107468|NCT01858766|17640312|P12|Overall Study|Randomized but Never Treated|0
5107469|NCT01858766|17640313|P11|Overall Study|Randomized but Never Treated|0
5107470|NCT01858766|17640314|P10|Overall Study|Randomized but Never Treated|0
5107471|NCT01858766|17640315|P9|Overall Study|Randomized but Never Treated|0
5107472|NCT01858766|17640316|P8|Overall Study|Randomized but Never Treated|0
5107473|NCT01858766|17640317|P7|Overall Study|Randomized but Never Treated|0
5107474|NCT01858766|17640318|P6|Overall Study|Randomized but Never Treated|1
5107475|NCT01858766|17640319|P5|Overall Study|Randomized but Never Treated|0
5107476|NCT01858766|17640320|P4|Overall Study|Randomized but Never Treated|0
5107477|NCT01858766|17640321|P3|Overall Study|Randomized but Never Treated|0
5107478|NCT01858766|17640322|P2|Overall Study|Randomized but Never Treated|0
5107479|NCT01858766|17640323|P1|Overall Study|Randomized but Never Treated|0
5107480|NCT01858701|17640394|P2|Period 2, Second 30 Days of Wear|Comfort|1
5107481|NCT01858701|17640395|P1|Period 2, Second 30 Days of Wear|Comfort|0
5107482|NCT01858701|17640394|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
5107483|NCT01858701|17640395|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
5107484|NCT01858701|17640394|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
5107485|NCT01858701|17640395|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
5107486|NCT01858701|17640394|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5107487|NCT01858701|17640395|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5107488|NCT01858636|17640401|P1|Overall Study|Withdrawal by Subject|1
5107489|NCT01858636|17640401|P1|Overall Study|Lost to Follow-up|1
5107490|NCT01858636|17640401|P1|Overall Study|Death|1
5107491|NCT01858636|17640401|P1|Overall Study|Physician Decision|1
5107492|NCT01858636|17640401|P1|Overall Study|No Device Deployment Attempted|24
5107493|NCT01858558|17640408|P2|Overall Study|Failed expansion of cell product|0
5107494|NCT01858558|17640409|P1|Overall Study|Failed expansion of cell product|2
5107495|NCT01858558|17640408|P2|Overall Study|Product contamination|0
5107496|NCT01858558|17640409|P1|Overall Study|Product contamination|2
5107497|NCT01858558|17640408|P2|Overall Study|Disease progression|1
5107498|NCT01858558|17640409|P1|Overall Study|Disease progression|3
5107499|NCT01858558|17640408|P2|Overall Study|Lost to Follow-up|0
5107500|NCT01858558|17640409|P1|Overall Study|Lost to Follow-up|1
5107501|NCT01858558|17640408|P2|Overall Study|Death|1
5107502|NCT01858558|17640409|P1|Overall Study|Death|1
5107503|NCT01858532|17640431|P4|Overall Study|Other, not specified|11
5107504|NCT01858532|17640432|P3|Overall Study|Other, not specified|13
5107505|NCT01858532|17640433|P2|Overall Study|Other, not specified|15
5107506|NCT01858532|17640434|P1|Overall Study|Other, not specified|29
5107507|NCT01858532|17640431|P4|Overall Study|Investigator request|6
5107508|NCT01858532|17640432|P3|Overall Study|Investigator request|2
5107509|NCT01858532|17640433|P2|Overall Study|Investigator request|4
5107510|NCT01858532|17640434|P1|Overall Study|Investigator request|3
5107511|NCT01858532|17640431|P4|Overall Study|Deterioration of medical status|7
5107512|NCT01858532|17640432|P3|Overall Study|Deterioration of medical status|3
5107513|NCT01858532|17640433|P2|Overall Study|Deterioration of medical status|4
5107514|NCT01858532|17640434|P1|Overall Study|Deterioration of medical status|3
5107515|NCT01858532|17640431|P4|Overall Study|Lost to Follow-up|14
5107516|NCT01858532|17640432|P3|Overall Study|Lost to Follow-up|11
5107517|NCT01858532|17640433|P2|Overall Study|Lost to Follow-up|26
5107518|NCT01858532|17640434|P1|Overall Study|Lost to Follow-up|17
5107519|NCT01858532|17640431|P4|Overall Study|Withdrew consent|27
5107520|NCT01858532|17640432|P3|Overall Study|Withdrew consent|46
5107521|NCT01858532|17640433|P2|Overall Study|Withdrew consent|93
5107522|NCT01858532|17640434|P1|Overall Study|Withdrew consent|71
5107523|NCT01858532|17640431|P4|Overall Study|Adverse Event|28
5107524|NCT01858532|17640432|P3|Overall Study|Adverse Event|23
5107525|NCT01858532|17640433|P2|Overall Study|Adverse Event|50
5107526|NCT01858532|17640434|P1|Overall Study|Adverse Event|58
5107527|NCT01858389|17640488|P2|Overall Study|Did not receive treatment|3
5107528|NCT01858389|17640489|P1|Overall Study|Did not receive treatment|0
5107529|NCT01858389|17640488|P2|Overall Study|Adverse Event|1
5107530|NCT01858389|17640489|P1|Overall Study|Adverse Event|3
5107531|NCT01858389|17640488|P2|Overall Study|Other|4
5107532|NCT01858389|17640489|P1|Overall Study|Other|2
5107533|NCT01858389|17640488|P2|Overall Study|Progressive disease|11
5107534|NCT01858389|17640489|P1|Overall Study|Progressive disease|10
5107535|NCT01858389|17640488|P2|Overall Study|Withdrawal by Subject|1
5107536|NCT01858389|17640489|P1|Overall Study|Withdrawal by Subject|0
5107537|NCT01858389|17640488|P2|Overall Study|Study terminated by sponsor|2
5107538|NCT01858389|17640489|P1|Overall Study|Study terminated by sponsor|0
5107539|NCT01858389|17640488|P2|Overall Study|Death|3
5107540|NCT01858389|17640489|P1|Overall Study|Death|1
5107541|NCT01858376|17640504|P1|Overall Study|Dropped d/t lab work not fitting criter|4
5107542|NCT01858194|17640513|P2|Overall Study|Lost to Follow-up|1
5107543|NCT01858194|17640514|P1|Overall Study|Lost to Follow-up|0
5107544|NCT01858194|17640513|P2|Overall Study|Total Artificial Heart Implant|1
5107545|NCT01858194|17640514|P1|Overall Study|Total Artificial Heart Implant|0
5107546|NCT01857973|17640567|P1|Overall Study|Physician Decision|1
5107547|NCT01857973|17640567|P1|Overall Study|drop out after 3 failed attempts|1
5107548|NCT01857973|17640567|P1|Overall Study|Subject did not meet required BG range|3
5107549|NCT01857869|17640597|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107550|NCT01857869|17640598|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107551|NCT01857869|17640599|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107552|NCT01857869|17640600|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107553|NCT01857869|17640601|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107554|NCT01857869|17640602|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107555|NCT01857869|17640603|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
5107556|NCT01857869|17640604|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107557|NCT01857869|17640605|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107558|NCT01857869|17640606|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5107559|NCT01857869|17640597|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107560|NCT01857869|17640598|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107561|NCT01857869|17640599|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107562|NCT01857869|17640600|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107563|NCT01857869|17640601|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107564|NCT01857869|17640602|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107565|NCT01857869|17640603|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
5107566|NCT01857869|17640604|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107567|NCT01857869|17640605|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107568|NCT01857869|17640606|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
5107569|NCT01857869|17640597|P10|Primary/Challenge Phase|Other|0
5107570|NCT01857869|17640598|P9|Primary/Challenge Phase|Other|0
5107571|NCT01857869|17640599|P8|Primary/Challenge Phase|Other|0
5107572|NCT01857869|17640600|P7|Primary/Challenge Phase|Other|0
5107573|NCT01857869|17640601|P6|Primary/Challenge Phase|Other|0
5107574|NCT01857869|17640602|P5|Primary/Challenge Phase|Other|0
5107575|NCT01857869|17640603|P4|Primary/Challenge Phase|Other|0
5107576|NCT01857869|17640604|P3|Primary/Challenge Phase|Other|0
5107577|NCT01857869|17640605|P2|Primary/Challenge Phase|Other|1
5107578|NCT01857869|17640606|P1|Primary/Challenge Phase|Other|1
5107579|NCT01857869|17640597|P10|Primary/Challenge Phase|Protocol Violation|0
5107580|NCT01857869|17640598|P9|Primary/Challenge Phase|Protocol Violation|0
5107581|NCT01857869|17640599|P8|Primary/Challenge Phase|Protocol Violation|0
5107582|NCT01857869|17640600|P7|Primary/Challenge Phase|Protocol Violation|0
5107583|NCT01857869|17640601|P6|Primary/Challenge Phase|Protocol Violation|0
5107584|NCT01857869|17640602|P5|Primary/Challenge Phase|Protocol Violation|0
5107585|NCT01857869|17640603|P4|Primary/Challenge Phase|Protocol Violation|0
5107586|NCT01857869|17640604|P3|Primary/Challenge Phase|Protocol Violation|0
5107587|NCT01857869|17640605|P2|Primary/Challenge Phase|Protocol Violation|0
5107588|NCT01857869|17640606|P1|Primary/Challenge Phase|Protocol Violation|1
5107589|NCT01857869|17640597|P10|Primary/Challenge Phase|Pregnancy|0
5107590|NCT01857869|17640598|P9|Primary/Challenge Phase|Pregnancy|0
5107591|NCT01857869|17640599|P8|Primary/Challenge Phase|Pregnancy|0
5107592|NCT01857869|17640600|P7|Primary/Challenge Phase|Pregnancy|0
5107593|NCT01857869|17640601|P6|Primary/Challenge Phase|Pregnancy|0
5107594|NCT01857869|17640602|P5|Primary/Challenge Phase|Pregnancy|0
5107595|NCT01857869|17640603|P4|Primary/Challenge Phase|Pregnancy|0
5107596|NCT01857869|17640604|P3|Primary/Challenge Phase|Pregnancy|0
5107597|NCT01857869|17640605|P2|Primary/Challenge Phase|Pregnancy|0
5107598|NCT01857869|17640606|P1|Primary/Challenge Phase|Pregnancy|1
5107599|NCT01857869|17640597|P10|Primary/Challenge Phase|Lost to Follow-up|0
5107600|NCT01857869|17640598|P9|Primary/Challenge Phase|Lost to Follow-up|0
5107601|NCT01857869|17640599|P8|Primary/Challenge Phase|Lost to Follow-up|0
5107602|NCT01857869|17640600|P7|Primary/Challenge Phase|Lost to Follow-up|0
5107603|NCT01857869|17640601|P6|Primary/Challenge Phase|Lost to Follow-up|0
5107604|NCT01857869|17640602|P5|Primary/Challenge Phase|Lost to Follow-up|0
5107605|NCT01857869|17640603|P4|Primary/Challenge Phase|Lost to Follow-up|0
5107606|NCT01857869|17640604|P3|Primary/Challenge Phase|Lost to Follow-up|0
5107607|NCT01857869|17640605|P2|Primary/Challenge Phase|Lost to Follow-up|0
5107608|NCT01857869|17640606|P1|Primary/Challenge Phase|Lost to Follow-up|2
5107609|NCT01857622|17640696|P3|Overall Study|Withdrawal by Subject|0
5107610|NCT01857622|17640697|P2|Overall Study|Withdrawal by Subject|0
5107611|NCT01857622|17640698|P1|Overall Study|Withdrawal by Subject|1
5107612|NCT01857622|17640696|P3|Overall Study|Protocol Violation|0
5107613|NCT01857622|17640697|P2|Overall Study|Protocol Violation|1
5107614|NCT01857622|17640698|P1|Overall Study|Protocol Violation|4
5107615|NCT01857622|17640696|P3|Overall Study|Physician Decision|0
5107616|NCT01857622|17640697|P2|Overall Study|Physician Decision|0
5107617|NCT01857622|17640698|P1|Overall Study|Physician Decision|1
5107618|NCT01857622|17640696|P3|Overall Study|Adverse Event|2
5107619|NCT01857622|17640697|P2|Overall Study|Adverse Event|0
5107620|NCT01857622|17640698|P1|Overall Study|Adverse Event|5
5107621|NCT01857583|17640710|P4|Overall Study|Withdrawal by Subject|2
5107622|NCT01857583|17640711|P3|Overall Study|Withdrawal by Subject|1
5107623|NCT01857583|17640712|P2|Overall Study|Withdrawal by Subject|0
5107624|NCT01857583|17640713|P1|Overall Study|Withdrawal by Subject|1
5107625|NCT01857583|17640710|P4|Overall Study|Physician Decision|1
5107626|NCT01857583|17640711|P3|Overall Study|Physician Decision|0
5107627|NCT01857583|17640712|P2|Overall Study|Physician Decision|0
5107628|NCT01857583|17640713|P1|Overall Study|Physician Decision|0
5107629|NCT01857583|17640710|P4|Overall Study|Death|0
5107630|NCT01857583|17640711|P3|Overall Study|Death|1
5107631|NCT01857583|17640712|P2|Overall Study|Death|1
5107632|NCT01857583|17640713|P1|Overall Study|Death|0
5107633|NCT01857583|17640710|P4|Overall Study|Adverse Event|1
5107634|NCT01857583|17640711|P3|Overall Study|Adverse Event|1
5107635|NCT01857583|17640712|P2|Overall Study|Adverse Event|0
5107636|NCT01857583|17640713|P1|Overall Study|Adverse Event|0
5107637|NCT01857531|17640723|P1|Overall Study|Withdrawal by Subject|4
5107638|NCT01857323|17640741|P1|Overall Study|Did not complete 180 doses|48
5107639|NCT01857323|17640741|P1|Overall Study|Other|4
5107640|NCT01857323|17640741|P1|Overall Study|Lost to Follow-up|1
5107641|NCT01857323|17640741|P1|Overall Study|Protocol Violation|6
5107642|NCT01857323|17640741|P1|Overall Study|Non-compliance|1
5107643|NCT01857323|17640741|P1|Overall Study|Withdrawal by Subject|3
5107644|NCT01857323|17640741|P1|Overall Study|Adverse Event|1
5107645|NCT01857310|17640752|P2|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
5107646|NCT01857310|17640753|P1|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
5107647|NCT01857271|17640848|P1|Overall Study|Lost to Follow-up|1
5107648|NCT01857206|17640901|P2|Overall Study|Withdrawal by Subject|0
5107649|NCT01857206|17640902|P1|Overall Study|Withdrawal by Subject|1
5107650|NCT01857206|17640901|P2|Overall Study|Unclassified|3
5107651|NCT01857206|17640902|P1|Overall Study|Unclassified|3
5107652|NCT01857206|17640901|P2|Overall Study|Lost to Follow-up|6
5107653|NCT01857206|17640902|P1|Overall Study|Lost to Follow-up|9
5107654|NCT01857206|17640901|P2|Overall Study|ADMINISTRATIVE REASON|1
5107655|NCT01857206|17640902|P1|Overall Study|ADMINISTRATIVE REASON|0
5107656|NCT01857102|17640920|P2|Period 2|Unsatisfactory Lens Fit|0
5107657|NCT01857102|17640921|P1|Period 2|Unsatisfactory Lens Fit|1
5107658|NCT01857102|17640920|P2|Period 2|Lens Discomfort|0
5107659|NCT01857102|17640921|P1|Period 2|Lens Discomfort|1
5107660|NCT01857102|17640920|P2|Period 1|Physician Decision|0
5107661|NCT01857102|17640921|P1|Period 1|Physician Decision|1
5107662|NCT01857102|17640920|P2|Period 1|Unsatisfactory Visual Response|0
5107663|NCT01857102|17640921|P1|Period 1|Unsatisfactory Visual Response|1
5107664|NCT01857102|17640920|P2|Period 1|Unsatisfactory Lens Fit|0
5107665|NCT01857102|17640921|P1|Period 1|Unsatisfactory Lens Fit|1
5107666|NCT01857102|17640920|P2|Period 1|Lost to Follow-up|3
5107667|NCT01857102|17640921|P1|Period 1|Lost to Follow-up|0
5107668|NCT01857102|17640920|P2|Period 1|No longer meets Eligibility Criteria|2
5107669|NCT01857102|17640921|P1|Period 1|No longer meets Eligibility Criteria|0
5107670|NCT01857063|17640931|P2|Period 2 (7 Days)|Withdrawal by Subject|0
5107671|NCT01857063|17640932|P1|Period 2 (7 Days)|Withdrawal by Subject|1
5107672|NCT01857063|17640931|P2|Period 2 (7 Days)|Physician Decision|1
5107673|NCT01857063|17640932|P1|Period 2 (7 Days)|Physician Decision|1
5107674|NCT01857063|17640931|P2|Period 2 (7 Days)|Adverse Event|1
5107675|NCT01857063|17640932|P1|Period 2 (7 Days)|Adverse Event|2
5107676|NCT01857063|17640931|P2|Period 1 (7 Days)|Withdrawal by Subject|3
5107677|NCT01857063|17640932|P1|Period 1 (7 Days)|Withdrawal by Subject|1
5107678|NCT01857063|17640931|P2|Period 1 (7 Days)|Physician Decision|0
5107679|NCT01857063|17640932|P1|Period 1 (7 Days)|Physician Decision|1
5107680|NCT01857063|17640931|P2|Period 1 (7 Days)|Adverse Event|1
5107681|NCT01857063|17640932|P1|Period 1 (7 Days)|Adverse Event|0
5107682|NCT01856907|17640966|P3|Overall Study|Withdrawal by Subject|0
5107683|NCT01856907|17640967|P2|Overall Study|Withdrawal by Subject|1
5107684|NCT01856907|17640968|P1|Overall Study|Withdrawal by Subject|0
5107685|NCT01856907|17640966|P3|Overall Study|Pregnancy|0
5107686|NCT01856907|17640967|P2|Overall Study|Pregnancy|1
5107687|NCT01856907|17640968|P1|Overall Study|Pregnancy|0
5107688|NCT01856907|17640966|P3|Overall Study|Pregnancy|0
5107689|NCT01856907|17640967|P2|Overall Study|Pregnancy|1
5107690|NCT01856907|17640968|P1|Overall Study|Pregnancy|0
5107691|NCT01856790|17641006|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
5107692|NCT01856790|17641006|P1|Closed Loop Control|Withdrawal by Subject|2
5107693|NCT01856686|17641060|P2|Overall Study|Lost to Follow-up|11
5107694|NCT01856686|17641061|P1|Overall Study|Lost to Follow-up|5
5107695|NCT01856673|17641104|P3|Overall Study|Protocol Violation|1
5107696|NCT01856673|17641105|P2|Overall Study|Protocol Violation|0
5107697|NCT01856673|17641106|P1|Overall Study|Protocol Violation|1
5107698|NCT01856673|17641104|P3|Overall Study|Death|0
5107699|NCT01856673|17641105|P2|Overall Study|Death|1
5107700|NCT01856673|17641106|P1|Overall Study|Death|2
5107701|NCT01856673|17641104|P3|Overall Study|Paperwork errors|0
5107702|NCT01856673|17641105|P2|Overall Study|Paperwork errors|0
5107703|NCT01856673|17641106|P1|Overall Study|Paperwork errors|4
5107704|NCT01856673|17641104|P3|Overall Study|Psychologist decision|0
5107705|NCT01856673|17641105|P2|Overall Study|Psychologist decision|0
5107706|NCT01856673|17641106|P1|Overall Study|Psychologist decision|3
5107707|NCT01856673|17641104|P3|Overall Study|Unknown reasons|0
5107708|NCT01856673|17641105|P2|Overall Study|Unknown reasons|0
5107709|NCT01856673|17641106|P1|Overall Study|Unknown reasons|20
5107710|NCT01856673|17641104|P3|Overall Study|Lost to Follow-up|0
5107711|NCT01856673|17641105|P2|Overall Study|Lost to Follow-up|34
5107712|NCT01856673|17641106|P1|Overall Study|Lost to Follow-up|22
5107713|NCT01856673|17641104|P3|Overall Study|Withdrawal by Subject|33
5107714|NCT01856673|17641105|P2|Overall Study|Withdrawal by Subject|50
5107715|NCT01856673|17641106|P1|Overall Study|Withdrawal by Subject|46
5107716|NCT01856595|17641126|P9|Overall Study|Withdrawal by Subject|0
5107717|NCT01856595|17641127|P8|Overall Study|Withdrawal by Subject|0
5107718|NCT01856595|17641128|P7|Overall Study|Withdrawal by Subject|1
5107719|NCT01856595|17641129|P6|Overall Study|Withdrawal by Subject|0
5107720|NCT01856595|17641130|P5|Overall Study|Withdrawal by Subject|0
5107721|NCT01856595|17641131|P4|Overall Study|Withdrawal by Subject|0
5107722|NCT01856595|17641132|P3|Overall Study|Withdrawal by Subject|0
5107723|NCT01856595|17641133|P2|Overall Study|Withdrawal by Subject|1
5107724|NCT01856595|17641134|P1|Overall Study|Withdrawal by Subject|0
5107725|NCT01856582|17641367|P1|Overall Study|Died prior to Boost infusion|1
5107726|NCT01856569|17641371|P1|Overall Study|Did not met inclusion criteria|8
5107727|NCT01856569|17641371|P1|Overall Study|Lost to Follow-up|3
5107728|NCT01856569|17641371|P1|Overall Study|Changed Site/Structure|1
5107729|NCT01856569|17641371|P1|Overall Study|Other|1
5107730|NCT01856543|17641382|P2|Overall Study|Withdrawn before start|3
5107731|NCT01856543|17641383|P1|Overall Study|Withdrawn before start|7
5107732|NCT01856543|17641382|P2|Overall Study|Treatment discontinued|3
5107733|NCT01856543|17641383|P1|Overall Study|Treatment discontinued|6
5107734|NCT01856322|17641441|P3|Overall Study|off study due to lack of accrual|3
5107735|NCT01856322|17641442|P2|Overall Study|off study due to lack of accrual|0
5107736|NCT01856322|17641443|P1|Overall Study|off study due to lack of accrual|0
5107737|NCT01856309|17641454|P4|Overall Study|Noncompliance With Study Drug|1
5107738|NCT01856309|17641455|P3|Overall Study|Noncompliance With Study Drug|4
5107739|NCT01856309|17641456|P2|Overall Study|Noncompliance With Study Drug|1
5107740|NCT01856309|17641457|P1|Overall Study|Noncompliance With Study Drug|0
5107741|NCT01856309|17641454|P4|Overall Study|Physician Decision|8
5107742|NCT01856309|17641455|P3|Overall Study|Physician Decision|6
5107743|NCT01856309|17641456|P2|Overall Study|Physician Decision|1
5107744|NCT01856309|17641457|P1|Overall Study|Physician Decision|6
5107745|NCT01856309|17641454|P4|Overall Study|Pregnancy|1
5107746|NCT01856309|17641455|P3|Overall Study|Pregnancy|0
5107747|NCT01856309|17641456|P2|Overall Study|Pregnancy|0
5107748|NCT01856309|17641457|P1|Overall Study|Pregnancy|0
5107749|NCT01856309|17641454|P4|Overall Study|Adverse Event|65
5107750|NCT01856309|17641455|P3|Overall Study|Adverse Event|55
5107751|NCT01856309|17641456|P2|Overall Study|Adverse Event|31
5107752|NCT01856309|17641457|P1|Overall Study|Adverse Event|31
5107753|NCT01856309|17641454|P4|Overall Study|Lack of Efficacy|25
5107754|NCT01856309|17641455|P3|Overall Study|Lack of Efficacy|40
5107755|NCT01856309|17641456|P2|Overall Study|Lack of Efficacy|9
5107756|NCT01856309|17641457|P1|Overall Study|Lack of Efficacy|14
5107757|NCT01856309|17641454|P4|Overall Study|Other|469
5107758|NCT01856309|17641455|P3|Overall Study|Other|447
5107759|NCT01856309|17641456|P2|Overall Study|Other|225
5107760|NCT01856309|17641457|P1|Overall Study|Other|227
5107761|NCT01856309|17641454|P4|Overall Study|Withdrawal by Subject|26
5107762|NCT01856309|17641455|P3|Overall Study|Withdrawal by Subject|28
5107763|NCT01856309|17641456|P2|Overall Study|Withdrawal by Subject|13
5107764|NCT01856309|17641457|P1|Overall Study|Withdrawal by Subject|11
5107765|NCT01856309|17641454|P4|Overall Study|Lost to Follow-up|8
5107766|NCT01856309|17641455|P3|Overall Study|Lost to Follow-up|4
5107767|NCT01856309|17641456|P2|Overall Study|Lost to Follow-up|2
5107768|NCT01856309|17641457|P1|Overall Study|Lost to Follow-up|6
5107769|NCT01856309|17641454|P4|Overall Study|Death|6
5107770|NCT01856309|17641455|P3|Overall Study|Death|11
5107771|NCT01856309|17641456|P2|Overall Study|Death|6
5107772|NCT01856309|17641457|P1|Overall Study|Death|4
5107773|NCT01856257|17641581|P4|Overall Study|Donor complication|1
5107774|NCT01856257|17641582|P3|Overall Study|Donor complication|0
5107775|NCT01856257|17641583|P2|Overall Study|Donor complication|0
5107776|NCT01856257|17641584|P1|Overall Study|Donor complication|0
5107777|NCT01856257|17641581|P4|Overall Study|Withdrawal by Subject|0
5107778|NCT01856257|17641582|P3|Overall Study|Withdrawal by Subject|0
5107779|NCT01856257|17641583|P2|Overall Study|Withdrawal by Subject|1
5107780|NCT01856257|17641584|P1|Overall Study|Withdrawal by Subject|1
5107781|NCT01856257|17641581|P4|Overall Study|Physician Decision|1
5107782|NCT01856257|17641582|P3|Overall Study|Physician Decision|0
5107783|NCT01856257|17641583|P2|Overall Study|Physician Decision|0
5107784|NCT01856257|17641584|P1|Overall Study|Physician Decision|0
5107785|NCT01856257|17641581|P4|Overall Study|Death|0
5107786|NCT01856257|17641582|P3|Overall Study|Death|0
5107787|NCT01856257|17641583|P2|Overall Study|Death|0
5107788|NCT01856257|17641584|P1|Overall Study|Death|2
5107789|NCT01856114|17641699|P2|Overall Study|Adverse Event|0
5107790|NCT01856114|17641700|P1|Overall Study|Adverse Event|1
5107791|NCT01856114|17641699|P2|Overall Study|Withdrawal by Subject|0
5107792|NCT01856114|17641700|P1|Overall Study|Withdrawal by Subject|1
5107793|NCT01855958|17641765|P2|Overall Study|Withdrawal by Subject|0
5107794|NCT01855958|17641766|P1|Overall Study|Withdrawal by Subject|1
5107795|NCT01855945|17641796|P12|Overall Study|Withdrawal by Subject|1
5107796|NCT01855945|17641797|P11|Overall Study|Withdrawal by Subject|4
5107797|NCT01855945|17641798|P10|Overall Study|Withdrawal by Subject|2
5107798|NCT01855945|17641799|P9|Overall Study|Withdrawal by Subject|0
5107799|NCT01855945|17641800|P8|Overall Study|Withdrawal by Subject|0
5107800|NCT01855945|17641801|P7|Overall Study|Withdrawal by Subject|1
5107801|NCT01855945|17641802|P6|Overall Study|Withdrawal by Subject|0
5107802|NCT01855945|17641803|P5|Overall Study|Withdrawal by Subject|1
5107803|NCT01855945|17641804|P4|Overall Study|Withdrawal by Subject|1
5107804|NCT01855945|17641805|P3|Overall Study|Withdrawal by Subject|4
5107805|NCT01855945|17641806|P2|Overall Study|Withdrawal by Subject|0
5107806|NCT01855945|17641807|P1|Overall Study|Withdrawal by Subject|4
5107807|NCT01855945|17641796|P12|Overall Study|Other - Unclassified|0
5107808|NCT01855945|17641797|P11|Overall Study|Other - Unclassified|1
5107809|NCT01855945|17641798|P10|Overall Study|Other - Unclassified|0
5107810|NCT01855945|17641799|P9|Overall Study|Other - Unclassified|0
5107811|NCT01855945|17641800|P8|Overall Study|Other - Unclassified|1
5107812|NCT01855945|17641801|P7|Overall Study|Other - Unclassified|2
5107813|NCT01855945|17641802|P6|Overall Study|Other - Unclassified|0
5107814|NCT01855945|17641803|P5|Overall Study|Other - Unclassified|0
5107815|NCT01855945|17641804|P4|Overall Study|Other - Unclassified|0
5107816|NCT01855945|17641805|P3|Overall Study|Other - Unclassified|1
5107817|NCT01855945|17641806|P2|Overall Study|Other - Unclassified|1
5107818|NCT01855945|17641807|P1|Overall Study|Other - Unclassified|1
5107819|NCT01855945|17641796|P12|Overall Study|Lost to Follow-up|2
5107820|NCT01855945|17641797|P11|Overall Study|Lost to Follow-up|0
5107821|NCT01855945|17641798|P10|Overall Study|Lost to Follow-up|0
5107822|NCT01855945|17641799|P9|Overall Study|Lost to Follow-up|2
5107823|NCT01855945|17641800|P8|Overall Study|Lost to Follow-up|7
5107824|NCT01855945|17641801|P7|Overall Study|Lost to Follow-up|4
5107825|NCT01855945|17641802|P6|Overall Study|Lost to Follow-up|3
5107826|NCT01855945|17641803|P5|Overall Study|Lost to Follow-up|0
5107827|NCT01855945|17641804|P4|Overall Study|Lost to Follow-up|3
5107828|NCT01855945|17641805|P3|Overall Study|Lost to Follow-up|7
5107829|NCT01855945|17641806|P2|Overall Study|Lost to Follow-up|10
5107830|NCT01855945|17641807|P1|Overall Study|Lost to Follow-up|11
5107831|NCT01855945|17641796|P12|Overall Study|Death|0
5107832|NCT01855945|17641797|P11|Overall Study|Death|0
5107833|NCT01855945|17641798|P10|Overall Study|Death|0
5107834|NCT01855945|17641799|P9|Overall Study|Death|0
5107835|NCT01855945|17641800|P8|Overall Study|Death|0
5107836|NCT01855945|17641801|P7|Overall Study|Death|2
5107837|NCT01855945|17641802|P6|Overall Study|Death|0
5107838|NCT01855945|17641803|P5|Overall Study|Death|0
5107839|NCT01855945|17641804|P4|Overall Study|Death|0
5107840|NCT01855945|17641805|P3|Overall Study|Death|0
5107841|NCT01855945|17641806|P2|Overall Study|Death|0
5107842|NCT01855945|17641807|P1|Overall Study|Death|0
5107843|NCT01855945|17641796|P12|Overall Study|Adverse Event|0
5107844|NCT01855945|17641797|P11|Overall Study|Adverse Event|0
5107845|NCT01855945|17641798|P10|Overall Study|Adverse Event|0
5107846|NCT01855945|17641799|P9|Overall Study|Adverse Event|0
5107847|NCT01855945|17641800|P8|Overall Study|Adverse Event|0
5107848|NCT01855945|17641801|P7|Overall Study|Adverse Event|1
5107849|NCT01855945|17641802|P6|Overall Study|Adverse Event|0
5107850|NCT01855945|17641803|P5|Overall Study|Adverse Event|0
5107851|NCT01855945|17641804|P4|Overall Study|Adverse Event|0
5107852|NCT01855945|17641805|P3|Overall Study|Adverse Event|0
5107853|NCT01855945|17641806|P2|Overall Study|Adverse Event|0
5107854|NCT01855945|17641807|P1|Overall Study|Adverse Event|0
5107855|NCT01855919|17641943|P2|Overall Study|Protocol Violation|4
5107856|NCT01855919|17641944|P1|Overall Study|Protocol Violation|1
5107857|NCT01855919|17641943|P2|Overall Study|Entry Criteria Not Met|1
5107858|NCT01855919|17641944|P1|Overall Study|Entry Criteria Not Met|1
5107859|NCT01855919|17641943|P2|Overall Study|Withdrawal by Subject|10
5107860|NCT01855919|17641944|P1|Overall Study|Withdrawal by Subject|4
5107861|NCT01855919|17641943|P2|Overall Study|Lack of Efficacy|3
5107862|NCT01855919|17641944|P1|Overall Study|Lack of Efficacy|1
5107863|NCT01855919|17641943|P2|Overall Study|Adverse Event|8
5107864|NCT01855919|17641944|P1|Overall Study|Adverse Event|16
5107865|NCT01855828|17641976|P1|Overall Study|Withdrawal by Subject|1
5107866|NCT01855828|17641976|P1|Overall Study|Adverse Event|1
5107867|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Other|1
5107868|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Other|0
5107869|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Other|0
5107870|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Other|0
5107871|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Sponsor Decision|1
5107872|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Sponsor Decision|0
5107873|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Sponsor Decision|0
5107874|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Sponsor Decision|0
5107875|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
5107876|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
5107877|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
5107878|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
5107879|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Physician Decision|4
5107880|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Physician Decision|2
5107881|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Physician Decision|0
5107882|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Physician Decision|0
5107883|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
5107884|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
5107885|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
5107886|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
5107887|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Protocol Violation|1
5107888|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Protocol Violation|0
5107889|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Protocol Violation|0
5107890|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Protocol Violation|0
5107891|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
5107892|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
5107893|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
5107894|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
5107895|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
5107896|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
5107897|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
5107898|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
5107899|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
5107900|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5107901|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5107902|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5107903|NCT01855789|17641986|P4|2) Week 24 up to End of Study|Adverse Event|21
5107904|NCT01855789|17641987|P3|2) Week 24 up to End of Study|Adverse Event|5
5107905|NCT01855789|17641988|P2|2) Week 24 up to End of Study|Adverse Event|4
5107906|NCT01855789|17641989|P1|2) Week 24 up to End of Study|Adverse Event|0
5107907|NCT01855789|17641986|P4|1) Baseline up to Week 24|Other|0
5107908|NCT01855789|17641987|P3|1) Baseline up to Week 24|Other|0
5107909|NCT01855789|17641988|P2|1) Baseline up to Week 24|Other|0
5107910|NCT01855789|17641989|P1|1) Baseline up to Week 24|Other|4
5107911|NCT01855789|17641986|P4|1) Baseline up to Week 24|Sponsor Decision|0
5107912|NCT01855789|17641987|P3|1) Baseline up to Week 24|Sponsor Decision|0
5107913|NCT01855789|17641988|P2|1) Baseline up to Week 24|Sponsor Decision|0
5107914|NCT01855789|17641989|P1|1) Baseline up to Week 24|Sponsor Decision|3
5107915|NCT01855789|17641986|P4|1) Baseline up to Week 24|Participant Non-compliance|0
5107916|NCT01855789|17641987|P3|1) Baseline up to Week 24|Participant Non-compliance|0
5107917|NCT01855789|17641988|P2|1) Baseline up to Week 24|Participant Non-compliance|0
5107918|NCT01855789|17641989|P1|1) Baseline up to Week 24|Participant Non-compliance|3
5107919|NCT01855789|17641986|P4|1) Baseline up to Week 24|Pregnancy|0
5107920|NCT01855789|17641987|P3|1) Baseline up to Week 24|Pregnancy|0
5107921|NCT01855789|17641988|P2|1) Baseline up to Week 24|Pregnancy|0
5107922|NCT01855789|17641989|P1|1) Baseline up to Week 24|Pregnancy|1
5107923|NCT01855789|17641986|P4|1) Baseline up to Week 24|Physician Decision|0
5107924|NCT01855789|17641987|P3|1) Baseline up to Week 24|Physician Decision|0
5107925|NCT01855789|17641988|P2|1) Baseline up to Week 24|Physician Decision|0
5107926|NCT01855789|17641989|P1|1) Baseline up to Week 24|Physician Decision|4
5107927|NCT01855789|17641986|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
5107928|NCT01855789|17641987|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
5107929|NCT01855789|17641988|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
5107930|NCT01855789|17641989|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
5107931|NCT01855789|17641986|P4|1) Baseline up to Week 24|Protocol Violation|0
5107932|NCT01855789|17641987|P3|1) Baseline up to Week 24|Protocol Violation|0
5107933|NCT01855789|17641988|P2|1) Baseline up to Week 24|Protocol Violation|0
5107934|NCT01855789|17641989|P1|1) Baseline up to Week 24|Protocol Violation|4
5107935|NCT01855789|17641986|P4|1) Baseline up to Week 24|Lost to Follow-up|0
5107936|NCT01855789|17641987|P3|1) Baseline up to Week 24|Lost to Follow-up|0
5107937|NCT01855789|17641988|P2|1) Baseline up to Week 24|Lost to Follow-up|0
5107938|NCT01855789|17641989|P1|1) Baseline up to Week 24|Lost to Follow-up|11
5107939|NCT01855789|17641986|P4|1) Baseline up to Week 24|Lack of Efficacy|0
5107940|NCT01855789|17641987|P3|1) Baseline up to Week 24|Lack of Efficacy|0
5107941|NCT01855789|17641988|P2|1) Baseline up to Week 24|Lack of Efficacy|0
5107942|NCT01855789|17641989|P1|1) Baseline up to Week 24|Lack of Efficacy|16
5107943|NCT01855789|17641986|P4|1) Baseline up to Week 24|Death|0
5107944|NCT01855789|17641987|P3|1) Baseline up to Week 24|Death|0
5107945|NCT01855789|17641988|P2|1) Baseline up to Week 24|Death|0
5107946|NCT01855789|17641989|P1|1) Baseline up to Week 24|Death|2
5107947|NCT01855789|17641986|P4|1) Baseline up to Week 24|Adverse Event|0
5107948|NCT01855789|17641987|P3|1) Baseline up to Week 24|Adverse Event|0
5107949|NCT01855789|17641988|P2|1) Baseline up to Week 24|Adverse Event|0
5107950|NCT01855789|17641989|P1|1) Baseline up to Week 24|Adverse Event|37
5107951|NCT01855750|17642013|P2|Overall Study|Sponsor ends the study|290
5107952|NCT01855750|17642014|P1|Overall Study|Sponsor ends the study|297
5107953|NCT01855750|17642013|P2|Overall Study|Withdrawal by Subject|28
5107954|NCT01855750|17642014|P1|Overall Study|Withdrawal by Subject|35
5107955|NCT01855750|17642013|P2|Overall Study|Lost to Follow-up|23
5107956|NCT01855750|17642014|P1|Overall Study|Lost to Follow-up|9
5107957|NCT01855750|17642013|P2|Overall Study|Death|78
5107958|NCT01855750|17642014|P1|Overall Study|Death|78
5107959|NCT01855425|17642030|P1|Overall Study|Physician Decision|20
5107960|NCT01855399|17642036|P2|12 Month|Lost to Follow-up|11
5107961|NCT01855399|17642037|P1|12 Month|Lost to Follow-up|7
5107962|NCT01855399|17642036|P2|6 Month|Withdrawal by Subject|6
5107963|NCT01855399|17642037|P1|6 Month|Withdrawal by Subject|8
5107964|NCT01855399|17642036|P2|6 Month|Lost to Follow-up|9
5107965|NCT01855399|17642037|P1|6 Month|Lost to Follow-up|12
5107966|NCT01855243|17642046|P3|Overall Study|develpoed diabetic ketoacidosis|0
5107967|NCT01855243|17642047|P2|Overall Study|develpoed diabetic ketoacidosis|0
5107968|NCT01855243|17642048|P1|Overall Study|develpoed diabetic ketoacidosis|1
5107969|NCT01855126|17642070|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
5107970|NCT01855126|17642071|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
5107971|NCT01855126|17642070|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
5107972|NCT01855126|17642071|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
5107973|NCT01855074|17642083|P1|Overall Study|Started but not treated|1
5107974|NCT01855074|17642083|P1|Overall Study|Withdrawal by Subject|8
5107975|NCT01855074|17642083|P1|Overall Study|Lost to Follow-up|4
5107976|NCT01855074|17642083|P1|Overall Study|Adverse Event|1
5107977|NCT01854944|17642095|P3|Overall Study|Withdrawal by Subject|1
5107978|NCT01854944|17642096|P2|Overall Study|Withdrawal by Subject|0
5107979|NCT01854944|17642097|P1|Overall Study|Withdrawal by Subject|0
5107980|NCT01854918|17642149|P2|All-IP Period (Years 2 and 3)|Death|16
5107981|NCT01854918|17642150|P1|All-IP Period (Years 2 and 3)|Death|5
5107982|NCT01854918|17642149|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
5107983|NCT01854918|17642150|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
5107984|NCT01854918|17642149|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
5107985|NCT01854918|17642150|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
5107986|NCT01854918|17642149|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
5107987|NCT01854918|17642150|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
5107988|NCT01854918|17642149|P2|SOC-controlled Period (Year 1)|Death|5
5107989|NCT01854918|17642150|P1|SOC-controlled Period (Year 1)|Death|5
5107990|NCT01854918|17642149|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
5107991|NCT01854918|17642150|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
5107992|NCT01854918|17642149|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
5107993|NCT01854918|17642150|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
5107994|NCT01854918|17642149|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
5107995|NCT01854918|17642150|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
5107996|NCT01854879|17642169|P1|Overall Study|incomplete data set|1
5107997|NCT01854879|17642169|P1|Overall Study|screen fail|3
5107998|NCT01854879|17642169|P1|Overall Study|Could not complete testing within the scheduled time.|1
5107999|NCT01854827|17642173|P1|Overall Study|Death|1
5108000|NCT01854710|17642185|P6|Overall Study|CRI procedural error|2
5108001|NCT01854710|17642186|P5|Overall Study|CRI procedural error|2
5108002|NCT01854710|17642187|P4|Overall Study|CRI procedural error|2
5108003|NCT01854710|17642188|P3|Overall Study|CRI procedural error|2
5108004|NCT01854710|17642189|P2|Overall Study|CRI procedural error|2
5108005|NCT01854710|17642190|P1|Overall Study|CRI procedural error|2
5108006|NCT01854710|17642185|P6|Overall Study|Withdrawal by Subject|0
5108007|NCT01854710|17642186|P5|Overall Study|Withdrawal by Subject|0
5108008|NCT01854710|17642187|P4|Overall Study|Withdrawal by Subject|0
5108009|NCT01854710|17642188|P3|Overall Study|Withdrawal by Subject|0
5108010|NCT01854710|17642189|P2|Overall Study|Withdrawal by Subject|1
5108011|NCT01854710|17642190|P1|Overall Study|Withdrawal by Subject|2
5108012|NCT01854697|17642211|P5|Overall Study|Other|0
5108013|NCT01854697|17642212|P4|Overall Study|Other|0
5108014|NCT01854697|17642213|P3|Overall Study|Other|1
5108015|NCT01854697|17642214|P2|Overall Study|Other|1
5108016|NCT01854697|17642215|P1|Overall Study|Other|0
5108017|NCT01854697|17642211|P5|Overall Study|Withdrew Consent|0
5108018|NCT01854697|17642212|P4|Overall Study|Withdrew Consent|1
5108019|NCT01854697|17642213|P3|Overall Study|Withdrew Consent|0
5108020|NCT01854697|17642214|P2|Overall Study|Withdrew Consent|1
5108021|NCT01854697|17642215|P1|Overall Study|Withdrew Consent|0
5108022|NCT01854697|17642211|P5|Overall Study|To enter another AbbVie study|1
5108023|NCT01854697|17642212|P4|Overall Study|To enter another AbbVie study|0
5108024|NCT01854697|17642213|P3|Overall Study|To enter another AbbVie study|0
5108025|NCT01854697|17642214|P2|Overall Study|To enter another AbbVie study|0
5108026|NCT01854697|17642215|P1|Overall Study|To enter another AbbVie study|1
5108027|NCT01854697|17642211|P5|Overall Study|Lost to Follow-up|0
5108028|NCT01854697|17642212|P4|Overall Study|Lost to Follow-up|2
5108029|NCT01854697|17642213|P3|Overall Study|Lost to Follow-up|1
5108030|NCT01854697|17642214|P2|Overall Study|Lost to Follow-up|1
5108031|NCT01854697|17642215|P1|Overall Study|Lost to Follow-up|4
5108032|NCT01854697|17642211|P5|Overall Study|Adverse Event|1
5108033|NCT01854697|17642212|P4|Overall Study|Adverse Event|0
5108034|NCT01854697|17642213|P3|Overall Study|Adverse Event|0
5108035|NCT01854697|17642214|P2|Overall Study|Adverse Event|0
5108036|NCT01854697|17642215|P1|Overall Study|Adverse Event|1
5108037|NCT01854658|17642259|P4|Overall Study|Administrative reasons|2
5108038|NCT01854658|17642260|P3|Overall Study|Administrative reasons|2
5108039|NCT01854658|17642261|P2|Overall Study|Administrative reasons|1
5108040|NCT01854658|17642262|P1|Overall Study|Administrative reasons|5
5108041|NCT01854658|17642259|P4|Overall Study|Adverse Event|19
5108042|NCT01854658|17642260|P3|Overall Study|Adverse Event|23
5108043|NCT01854658|17642261|P2|Overall Study|Adverse Event|14
5108044|NCT01854658|17642262|P1|Overall Study|Adverse Event|21
5108045|NCT01854658|17642259|P4|Overall Study|Lack of Efficacy|7
5108046|NCT01854658|17642260|P3|Overall Study|Lack of Efficacy|4
5108047|NCT01854658|17642261|P2|Overall Study|Lack of Efficacy|8
5108048|NCT01854658|17642262|P1|Overall Study|Lack of Efficacy|3
5108049|NCT01854658|17642259|P4|Overall Study|Protocol-specified criteria|7
5108050|NCT01854658|17642260|P3|Overall Study|Protocol-specified criteria|10
5108051|NCT01854658|17642261|P2|Overall Study|Protocol-specified criteria|15
5108052|NCT01854658|17642262|P1|Overall Study|Protocol-specified criteria|15
5108053|NCT01854658|17642259|P4|Overall Study|Withdrawal by Subject|15
5108054|NCT01854658|17642260|P3|Overall Study|Withdrawal by Subject|29
5108055|NCT01854658|17642261|P2|Overall Study|Withdrawal by Subject|21
5108056|NCT01854658|17642262|P1|Overall Study|Withdrawal by Subject|28
5108057|NCT01854658|17642259|P4|Overall Study|Lost to Follow-up|4
5108058|NCT01854658|17642260|P3|Overall Study|Lost to Follow-up|8
5108059|NCT01854658|17642261|P2|Overall Study|Lost to Follow-up|9
5108060|NCT01854658|17642262|P1|Overall Study|Lost to Follow-up|8
5108061|NCT01854658|17642259|P4|Overall Study|Physician Decision|4
5108062|NCT01854658|17642260|P3|Overall Study|Physician Decision|2
5108063|NCT01854658|17642261|P2|Overall Study|Physician Decision|5
5108064|NCT01854658|17642262|P1|Overall Study|Physician Decision|7
5108065|NCT01854658|17642259|P4|Overall Study|Protocol Violation|1
5108066|NCT01854658|17642260|P3|Overall Study|Protocol Violation|2
5108067|NCT01854658|17642261|P2|Overall Study|Protocol Violation|2
5108068|NCT01854658|17642262|P1|Overall Study|Protocol Violation|6
5108069|NCT01854645|17642297|P5|Overall Study|Adverse Event|11
5108070|NCT01854645|17642298|P4|Overall Study|Adverse Event|20
5108071|NCT01854645|17642299|P3|Overall Study|Adverse Event|19
5108072|NCT01854645|17642300|P2|Overall Study|Adverse Event|31
5108073|NCT01854645|17642301|P1|Overall Study|Adverse Event|33
5108074|NCT01854645|17642297|P5|Overall Study|Lack of Efficacy|9
5108075|NCT01854645|17642298|P4|Overall Study|Lack of Efficacy|3
5108076|NCT01854645|17642299|P3|Overall Study|Lack of Efficacy|9
5108077|NCT01854645|17642300|P2|Overall Study|Lack of Efficacy|12
5108078|NCT01854645|17642301|P1|Overall Study|Lack of Efficacy|7
5108079|NCT01854645|17642297|P5|Overall Study|Withdrawal by Subject|24
5108080|NCT01854645|17642298|P4|Overall Study|Withdrawal by Subject|21
5108081|NCT01854645|17642299|P3|Overall Study|Withdrawal by Subject|30
5108082|NCT01854645|17642300|P2|Overall Study|Withdrawal by Subject|41
5108083|NCT01854645|17642301|P1|Overall Study|Withdrawal by Subject|31
5108084|NCT01854645|17642297|P5|Overall Study|Physician Decision|7
5108085|NCT01854645|17642298|P4|Overall Study|Physician Decision|3
5108086|NCT01854645|17642299|P3|Overall Study|Physician Decision|3
5108087|NCT01854645|17642300|P2|Overall Study|Physician Decision|5
5108088|NCT01854645|17642301|P1|Overall Study|Physician Decision|1
5108089|NCT01854645|17642297|P5|Overall Study|Lost to Follow-up|0
5108090|NCT01854645|17642298|P4|Overall Study|Lost to Follow-up|5
5108091|NCT01854645|17642299|P3|Overall Study|Lost to Follow-up|8
5108092|NCT01854645|17642300|P2|Overall Study|Lost to Follow-up|7
5108093|NCT01854645|17642301|P1|Overall Study|Lost to Follow-up|10
5108094|NCT01854645|17642297|P5|Overall Study|Protocol Violation|1
5108095|NCT01854645|17642298|P4|Overall Study|Protocol Violation|4
5108096|NCT01854645|17642299|P3|Overall Study|Protocol Violation|5
5108097|NCT01854645|17642300|P2|Overall Study|Protocol Violation|0
5108098|NCT01854645|17642301|P1|Overall Study|Protocol Violation|3
5108099|NCT01854645|17642297|P5|Overall Study|Administrative Reasons / Missing|1
5108100|NCT01854645|17642298|P4|Overall Study|Administrative Reasons / Missing|1
5108101|NCT01854645|17642299|P3|Overall Study|Administrative Reasons / Missing|0
5108102|NCT01854645|17642300|P2|Overall Study|Administrative Reasons / Missing|0
5108103|NCT01854645|17642301|P1|Overall Study|Administrative Reasons / Missing|0
5108104|NCT01854645|17642297|P5|Overall Study|Protocol-Specified Criteria|7
5108105|NCT01854645|17642298|P4|Overall Study|Protocol-Specified Criteria|5
5108106|NCT01854645|17642299|P3|Overall Study|Protocol-Specified Criteria|8
5108107|NCT01854645|17642300|P2|Overall Study|Protocol-Specified Criteria|10
5108108|NCT01854645|17642301|P1|Overall Study|Protocol-Specified Criteria|13
5108109|NCT01854528|17642382|P2|Overall Study|Virologic Failure|9
5108110|NCT01854528|17642383|P1|Overall Study|Virologic Failure|0
5108111|NCT01854528|17642382|P2|Overall Study|Withdrawal by Subject|2
5108112|NCT01854528|17642383|P1|Overall Study|Withdrawal by Subject|0
5108113|NCT01854528|17642382|P2|Overall Study|Adverse Event|4
5108114|NCT01854528|17642383|P1|Overall Study|Adverse Event|0
5108115|NCT01854047|17642454|P5|Overall Study|Other than specified above|8
5108116|NCT01854047|17642455|P4|Overall Study|Other than specified above|5
5108117|NCT01854047|17642456|P3|Overall Study|Other than specified above|3
5108118|NCT01854047|17642457|P2|Overall Study|Other than specified above|3
5108119|NCT01854047|17642458|P1|Overall Study|Other than specified above|3
5108120|NCT01854047|17642454|P5|Overall Study|Randomized but not treated|4
5108121|NCT01854047|17642455|P4|Overall Study|Randomized but not treated|0
5108122|NCT01854047|17642456|P3|Overall Study|Randomized but not treated|2
5108123|NCT01854047|17642457|P2|Overall Study|Randomized but not treated|1
5108124|NCT01854047|17642458|P1|Overall Study|Randomized but not treated|0
5108125|NCT01854047|17642454|P5|Overall Study|Adverse Event|7
5108126|NCT01854047|17642455|P4|Overall Study|Adverse Event|10
5108127|NCT01854047|17642456|P3|Overall Study|Adverse Event|6
5108128|NCT01854047|17642457|P2|Overall Study|Adverse Event|4
5108129|NCT01854047|17642458|P1|Overall Study|Adverse Event|5
5108130|NCT01854047|17642454|P5|Overall Study|Poor compliance to protocol|0
5108131|NCT01854047|17642455|P4|Overall Study|Poor compliance to protocol|0
5108132|NCT01854047|17642456|P3|Overall Study|Poor compliance to protocol|2
5108133|NCT01854047|17642457|P2|Overall Study|Poor compliance to protocol|0
5108134|NCT01854047|17642458|P1|Overall Study|Poor compliance to protocol|3
5108135|NCT01854047|17642454|P5|Overall Study|Lack of Efficacy|0
5108136|NCT01854047|17642455|P4|Overall Study|Lack of Efficacy|0
5108137|NCT01854047|17642456|P3|Overall Study|Lack of Efficacy|0
5108138|NCT01854047|17642457|P2|Overall Study|Lack of Efficacy|0
5108139|NCT01854047|17642458|P1|Overall Study|Lack of Efficacy|1
5108140|NCT01853982|17642589|P2|Overall Study|Lost to Follow-up|1
5108141|NCT01853982|17642590|P1|Overall Study|Lost to Follow-up|0
5108142|NCT01853982|17642589|P2|Overall Study|Death|0
5108143|NCT01853982|17642590|P1|Overall Study|Death|1
5108144|NCT01853982|17642589|P2|Overall Study|Withdrawal by Subject|0
5108145|NCT01853982|17642590|P1|Overall Study|Withdrawal by Subject|1
5108146|NCT01853878|17642607|P2|Overall Study|Other|43
5108147|NCT01853878|17642608|P1|Overall Study|Other|55
5108148|NCT01853878|17642607|P2|Overall Study|Migrated/moved from the study area|0
5108149|NCT01853878|17642608|P1|Overall Study|Migrated/moved from the study area|1
5108150|NCT01853878|17642607|P2|Overall Study|Withdrawal by Subject|1
5108151|NCT01853878|17642608|P1|Overall Study|Withdrawal by Subject|3
5108152|NCT01853878|17642607|P2|Overall Study|Adverse Event|0
5108153|NCT01853878|17642608|P1|Overall Study|Adverse Event|2
5108154|NCT01853878|17642607|P2|Overall Study|Recurrence|0
5108155|NCT01853878|17642608|P1|Overall Study|Recurrence|2
5108156|NCT01853839|17642632|P1|Overall Study|Lost to follow-up or no valid BP measure|336
5108157|NCT01853839|17642632|P1|Overall Study|End of treatment visit too early|33
5108158|NCT01853839|17642632|P1|Overall Study|Not meet ITT population definition|58
5108159|NCT01853839|17642632|P1|Overall Study|Violated inclusion criteria|2
5108160|NCT01853696|17642665|P2|Overall Study|Lost to Follow-up|4
5108161|NCT01853696|17642666|P1|Overall Study|Lost to Follow-up|5
5108162|NCT01853696|17642665|P2|Overall Study|Withdrawal by Subject|1
5108163|NCT01853696|17642666|P1|Overall Study|Withdrawal by Subject|1
5108164|NCT01853644|17642674|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
5108165|NCT01853644|17642674|P1|Continued Treatment After First Response|Progressive Diseaes|10
5108166|NCT01853644|17642674|P1|Continued Treatment After First Response|Adverse Event|2
5108167|NCT01853644|17642674|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
5108168|NCT01853644|17642674|P1|Reached First Response/Complete 2 Cycles|Other|1
5108169|NCT01853644|17642674|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
5108170|NCT01853644|17642674|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
5108171|NCT01853644|17642674|P1|Registration and Treatment Start|Did not start treatment|1
5108172|NCT01853618|17642688|P5|Overall Study|Refused further treatment|1
5108173|NCT01853618|17642689|P4|Overall Study|Refused further treatment|0
5108174|NCT01853618|17642690|P3|Overall Study|Refused further treatment|0
5108175|NCT01853618|17642691|P2|Overall Study|Refused further treatment|0
5108176|NCT01853618|17642692|P1|Overall Study|Refused further treatment|0
5108177|NCT01853618|17642688|P5|Overall Study|Physician Decision|0
5108178|NCT01853618|17642689|P4|Overall Study|Physician Decision|0
5108179|NCT01853618|17642690|P3|Overall Study|Physician Decision|1
5108180|NCT01853618|17642691|P2|Overall Study|Physician Decision|1
5108181|NCT01853618|17642692|P1|Overall Study|Physician Decision|0
5108182|NCT01853618|17642688|P5|Overall Study|Progressive disease|2
5108183|NCT01853618|17642689|P4|Overall Study|Progressive disease|1
5108184|NCT01853618|17642690|P3|Overall Study|Progressive disease|1
5108185|NCT01853618|17642691|P2|Overall Study|Progressive disease|1
5108186|NCT01853618|17642692|P1|Overall Study|Progressive disease|1
5108187|NCT01853618|17642688|P5|Overall Study|Bile duct stent blockage/progressive dis|0
5108188|NCT01853618|17642689|P4|Overall Study|Bile duct stent blockage/progressive dis|0
5108189|NCT01853618|17642690|P3|Overall Study|Bile duct stent blockage/progressive dis|0
5108190|NCT01853618|17642691|P2|Overall Study|Bile duct stent blockage/progressive dis|0
5108191|NCT01853618|17642692|P1|Overall Study|Bile duct stent blockage/progressive dis|1
5108192|NCT01853475|17642758|P3|Overall Study|Withdrawal by Subject|0
5108193|NCT01853475|17642759|P2|Overall Study|Withdrawal by Subject|1
5108194|NCT01853475|17642760|P1|Overall Study|Withdrawal by Subject|0
5108195|NCT01853462|17642779|P2|Overall Study|Withdrawal by Subject|1
5108196|NCT01853462|17642780|P1|Overall Study|Withdrawal by Subject|1
5108197|NCT01853397|17642850|P4|Overall Study|Subject Noncompliance|1
5108198|NCT01853397|17642851|P3|Overall Study|Subject Noncompliance|0
5108199|NCT01853397|17642852|P2|Overall Study|Subject Noncompliance|0
5108200|NCT01853397|17642853|P1|Overall Study|Subject Noncompliance|0
5108201|NCT01853397|17642850|P4|Overall Study|Withdrawal by Subject|1
5108202|NCT01853397|17642851|P3|Overall Study|Withdrawal by Subject|0
5108203|NCT01853397|17642852|P2|Overall Study|Withdrawal by Subject|0
5108204|NCT01853397|17642853|P1|Overall Study|Withdrawal by Subject|0
5108205|NCT01853384|17642881|P2|Completed Follow up Visit 2|Lost to Follow-up|1
5108206|NCT01853384|17642882|P1|Completed Follow up Visit 2|Lost to Follow-up|0
5108207|NCT01853384|17642881|P2|Completed Follow up Visit 2|Death|0
5108208|NCT01853384|17642882|P1|Completed Follow up Visit 2|Death|1
5108209|NCT01853384|17642881|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
5108210|NCT01853384|17642882|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
5108211|NCT01853384|17642881|P2|Completed Follow up Visit 2|Adverse Event|0
5108212|NCT01853384|17642882|P1|Completed Follow up Visit 2|Adverse Event|1
5108213|NCT01853384|17642881|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
5108214|NCT01853384|17642882|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
5108215|NCT01853384|17642881|P2|Completed Follow up Visit 1|Early Termination|9
5108216|NCT01853384|17642882|P1|Completed Follow up Visit 1|Early Termination|13
5108217|NCT01853384|17642881|P2|Randomized|Other|3
5108218|NCT01853384|17642882|P1|Randomized|Other|3
5108219|NCT01853384|17642881|P2|Randomized|Sponsor Decision|34
5108220|NCT01853384|17642882|P1|Randomized|Sponsor Decision|47
5108221|NCT01853384|17642881|P2|Randomized|Withdrawal by Subject|3
5108222|NCT01853384|17642882|P1|Randomized|Withdrawal by Subject|5
5108223|NCT01853384|17642881|P2|Randomized|Lost to Follow-up|1
5108224|NCT01853384|17642882|P1|Randomized|Lost to Follow-up|1
5108225|NCT01853384|17642881|P2|Randomized|Death|2
5108226|NCT01853384|17642882|P1|Randomized|Death|1
5108227|NCT01853384|17642881|P2|Randomized|Adverse Event|3
5108228|NCT01853384|17642882|P1|Randomized|Adverse Event|5
5108229|NCT01853280|17642922|P2|Overall Study|Ineligible|1
5108230|NCT01853280|17642923|P1|Overall Study|Ineligible|0
5108231|NCT01853280|17642922|P2|Overall Study|Withdrawal by Subject|1
5108232|NCT01853280|17642923|P1|Overall Study|Withdrawal by Subject|0
5108233|NCT01853280|17642922|P2|Overall Study|Physician Decision|1
5108234|NCT01853280|17642923|P1|Overall Study|Physician Decision|0
5108235|NCT01853280|17642922|P2|Overall Study|Lost to Follow-up|1
5108236|NCT01853280|17642923|P1|Overall Study|Lost to Follow-up|0
5108237|NCT01853280|17642922|P2|Overall Study|Lack of Efficacy|2
5108238|NCT01853280|17642923|P1|Overall Study|Lack of Efficacy|2
5108239|NCT01853254|17642929|P1|Overall Study|Administrative/Other|16
5108240|NCT01853254|17642929|P1|Overall Study|Withdrawal of Consent|16
5108241|NCT01853254|17642929|P1|Overall Study|Other Protocol Violation|1
5108242|NCT01853254|17642929|P1|Overall Study|Refusal of Treatment|1
5108243|NCT01853254|17642929|P1|Overall Study|Insufficient Therapeutic Response|22
5108244|NCT01853254|17642929|P1|Overall Study|Failure to Return|43
5108245|NCT01853254|17642929|P1|Overall Study|Death|1
5108246|NCT01853254|17642929|P1|Overall Study|Adverse Event/Intercurrent Illness|3
5108247|NCT01853254|17642929|P1|Overall Study|Abnormal Laboratory Test|1
5108248|NCT01853228|17642933|P2|Phase 2|Lack of Efficacy|4
5108249|NCT01853228|17642934|P1|Phase 2|Lack of Efficacy|0
5108250|NCT01853228|17642933|P2|Phase 2|Proceed To Transplant|3
5108251|NCT01853228|17642934|P1|Phase 2|Proceed To Transplant|0
5108252|NCT01853228|17642933|P2|Phase 2|Physician Decision|1
5108253|NCT01853228|17642934|P1|Phase 2|Physician Decision|0
5108254|NCT01853228|17642933|P2|Phase 1|Other|0
5108255|NCT01853228|17642934|P1|Phase 1|Other|1
5108256|NCT01853228|17642933|P2|Phase 1|Lack of Efficacy|0
5108257|NCT01853228|17642934|P1|Phase 1|Lack of Efficacy|8
5108258|NCT01853176|17642964|P2|Overall Study|Study terminated|0
5108259|NCT01853176|17642965|P1|Overall Study|Study terminated|4
5108260|NCT01853137|17642973|P2|Overall Study|Lost to Follow-up|1
5108261|NCT01853137|17642974|P1|Overall Study|Lost to Follow-up|4
5108262|NCT01853072|17642995|P2|Overall Study|Reason not specified|6
5108263|NCT01853072|17642996|P1|Overall Study|Reason not specified|9
5108264|NCT01853072|17642995|P2|Overall Study|Withdrawal by Subject|2
5108265|NCT01853072|17642996|P1|Overall Study|Withdrawal by Subject|1
5108266|NCT01853072|17642995|P2|Overall Study|Physician Decision|1
5108267|NCT01853072|17642996|P1|Overall Study|Physician Decision|1
5108268|NCT01853072|17642995|P2|Overall Study|Non-compliance with study drug|1
5108269|NCT01853072|17642996|P1|Overall Study|Non-compliance with study drug|0
5108270|NCT01853072|17642995|P2|Overall Study|Lost to Follow-up|3
5108271|NCT01853072|17642996|P1|Overall Study|Lost to Follow-up|0
5108272|NCT01853072|17642995|P2|Overall Study|Death|4
5108273|NCT01853072|17642996|P1|Overall Study|Death|1
5108274|NCT01853072|17642995|P2|Overall Study|Adverse Event|3
5108275|NCT01853072|17642996|P1|Overall Study|Adverse Event|0
5108276|NCT01853072|17642995|P2|Overall Study|Adverse event prior to treatment|1
5108277|NCT01853072|17642996|P1|Overall Study|Adverse event prior to treatment|0
5108278|NCT01853046|17643016|P2|Overall Study|Disease progression|3
5108279|NCT01853046|17643017|P1|Overall Study|Disease progression|13
5108280|NCT01853046|17643016|P2|Overall Study|Adverse Event|2
5108281|NCT01853046|17643017|P1|Overall Study|Adverse Event|4
5108282|NCT01853046|17643016|P2|Overall Study|Withdrawal by Subject|1
5108283|NCT01853046|17643017|P1|Overall Study|Withdrawal by Subject|1
5108284|NCT01852825|17643085|P3|Overall Study|Withdrawal by Subject|0
5108285|NCT01852825|17643086|P2|Overall Study|Withdrawal by Subject|0
5108286|NCT01852825|17643087|P1|Overall Study|Withdrawal by Subject|2
5108287|NCT01852812|17643113|P3|Overall Study|Non-compliance With Study Drug|0
5108288|NCT01852812|17643114|P2|Overall Study|Non-compliance With Study Drug|1
5108289|NCT01852812|17643115|P1|Overall Study|Non-compliance With Study Drug|0
5108290|NCT01852812|17643113|P3|Overall Study|Adverse Event|1
5108291|NCT01852812|17643114|P2|Overall Study|Adverse Event|0
5108292|NCT01852812|17643115|P1|Overall Study|Adverse Event|0
5108293|NCT01852591|17643153|P1|Overall Study|Not Evaluable at Time of Analysis|1
5108294|NCT01852591|17643153|P1|Overall Study|Withdrawal by Subject|2
5108295|NCT01852292|17643207|P2|Overall Study|Progressive disease|52
5108296|NCT01852292|17643208|P1|Overall Study|Progressive disease|42
5108297|NCT01852292|17643207|P2|Overall Study|Study terminated by Sponsor|1
5108298|NCT01852292|17643208|P1|Overall Study|Study terminated by Sponsor|0
5108299|NCT01852292|17643207|P2|Overall Study|Non-compliance with study treatment|0
5108300|NCT01852292|17643208|P1|Overall Study|Non-compliance with study treatment|1
5108301|NCT01852292|17643207|P2|Overall Study|Protocol Violation|0
5108302|NCT01852292|17643208|P1|Overall Study|Protocol Violation|2
5108303|NCT01852292|17643207|P2|Overall Study|Physician Decision|2
5108304|NCT01852292|17643208|P1|Overall Study|Physician Decision|6
5108305|NCT01852292|17643207|P2|Overall Study|Adverse Event|11
5108306|NCT01852292|17643208|P1|Overall Study|Adverse Event|8
5108307|NCT01852292|17643207|P2|Overall Study|Patient/guardian decision|4
5108308|NCT01852292|17643208|P1|Overall Study|Patient/guardian decision|8
5108309|NCT01852292|17643207|P2|Overall Study|Death|8
5108310|NCT01852292|17643208|P1|Overall Study|Death|9
5108311|NCT01852292|17643207|P2|Overall Study|Untreated - did not receive study drug|1
5108312|NCT01852292|17643208|P1|Overall Study|Untreated - did not receive study drug|3
5108313|NCT01852214|17643232|P2|Washout Period|Withdrawal by Subject|1
5108314|NCT01852214|17643233|P1|Washout Period|Withdrawal by Subject|0
5108315|NCT01852214|17643232|P2|Period 1|Withdrawal by Subject|1
5108316|NCT01852214|17643233|P1|Period 1|Withdrawal by Subject|0
5108317|NCT01852214|17643232|P2|Period 1|Adverse Event|2
5108318|NCT01852214|17643233|P1|Period 1|Adverse Event|1
5108319|NCT01852162|17643285|P2|Overall Study|Withdrawal by Subject|1
5108320|NCT01852162|17643286|P1|Overall Study|Withdrawal by Subject|3
5108321|NCT01852162|17643285|P2|Overall Study|Adverse Event|0
5108322|NCT01852162|17643286|P1|Overall Study|Adverse Event|1
5108323|NCT01852110|17643302|P6|Overall Study|Withdrawal by Subject|0
5108324|NCT01852110|17643303|P5|Overall Study|Withdrawal by Subject|0
5108325|NCT01852110|17643304|P4|Overall Study|Withdrawal by Subject|0
5108326|NCT01852110|17643305|P3|Overall Study|Withdrawal by Subject|0
5108327|NCT01852110|17643306|P2|Overall Study|Withdrawal by Subject|4
5108328|NCT01852110|17643307|P1|Overall Study|Withdrawal by Subject|4
5108329|NCT01852110|17643302|P6|Overall Study|Study Terminated by Sponsor|0
5108330|NCT01852110|17643303|P5|Overall Study|Study Terminated by Sponsor|0
5108331|NCT01852110|17643304|P4|Overall Study|Study Terminated by Sponsor|0
5108332|NCT01852110|17643305|P3|Overall Study|Study Terminated by Sponsor|0
5108333|NCT01852110|17643306|P2|Overall Study|Study Terminated by Sponsor|32
5108334|NCT01852110|17643307|P1|Overall Study|Study Terminated by Sponsor|30
5108335|NCT01852110|17643302|P6|Overall Study|Protocol Violation|0
5108336|NCT01852110|17643303|P5|Overall Study|Protocol Violation|0
5108337|NCT01852110|17643304|P4|Overall Study|Protocol Violation|0
5108338|NCT01852110|17643305|P3|Overall Study|Protocol Violation|0
5108339|NCT01852110|17643306|P2|Overall Study|Protocol Violation|1
5108340|NCT01852110|17643307|P1|Overall Study|Protocol Violation|0
5108341|NCT01852110|17643302|P6|Overall Study|Physician Decision|0
5108342|NCT01852110|17643303|P5|Overall Study|Physician Decision|0
5108343|NCT01852110|17643304|P4|Overall Study|Physician Decision|0
5108344|NCT01852110|17643305|P3|Overall Study|Physician Decision|0
5108345|NCT01852110|17643306|P2|Overall Study|Physician Decision|0
5108346|NCT01852110|17643307|P1|Overall Study|Physician Decision|1
5108347|NCT01852110|17643302|P6|Overall Study|Non-compliance with Study Drug|0
5108348|NCT01852110|17643303|P5|Overall Study|Non-compliance with Study Drug|0
5108349|NCT01852110|17643304|P4|Overall Study|Non-compliance with Study Drug|0
5108350|NCT01852110|17643305|P3|Overall Study|Non-compliance with Study Drug|0
5108351|NCT01852110|17643306|P2|Overall Study|Non-compliance with Study Drug|1
5108352|NCT01852110|17643307|P1|Overall Study|Non-compliance with Study Drug|2
5108353|NCT01852110|17643302|P6|Overall Study|Lost to Follow-up|0
5108354|NCT01852110|17643303|P5|Overall Study|Lost to Follow-up|0
5108355|NCT01852110|17643304|P4|Overall Study|Lost to Follow-up|0
5108356|NCT01852110|17643305|P3|Overall Study|Lost to Follow-up|0
5108357|NCT01852110|17643306|P2|Overall Study|Lost to Follow-up|3
5108358|NCT01852110|17643307|P1|Overall Study|Lost to Follow-up|1
5108359|NCT01852110|17643302|P6|Overall Study|Adverse Event|0
5108360|NCT01852110|17643303|P5|Overall Study|Adverse Event|0
5108361|NCT01852110|17643304|P4|Overall Study|Adverse Event|0
5108362|NCT01852110|17643305|P3|Overall Study|Adverse Event|0
5108363|NCT01852110|17643306|P2|Overall Study|Adverse Event|5
5108364|NCT01852110|17643307|P1|Overall Study|Adverse Event|12
5108365|NCT01852058|17643371|P12|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108366|NCT01852058|17643372|P11|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108367|NCT01852058|17643373|P10|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108368|NCT01852058|17643374|P9|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
5108369|NCT01852058|17643375|P8|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108370|NCT01852058|17643376|P7|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108371|NCT01852058|17643377|P6|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108372|NCT01852058|17643378|P5|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108373|NCT01852058|17643379|P4|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108374|NCT01852058|17643380|P3|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108375|NCT01852058|17643381|P2|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108376|NCT01852058|17643382|P1|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5108377|NCT01852058|17643371|P12|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108378|NCT01852058|17643372|P11|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108379|NCT01852058|17643373|P10|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108380|NCT01852058|17643374|P9|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108381|NCT01852058|17643375|P8|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
5108382|NCT01852058|17643376|P7|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108383|NCT01852058|17643377|P6|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108384|NCT01852058|17643378|P5|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108385|NCT01852058|17643379|P4|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108386|NCT01852058|17643380|P3|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108387|NCT01852058|17643381|P2|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108388|NCT01852058|17643382|P1|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5108389|NCT01852058|17643371|P12|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108390|NCT01852058|17643372|P11|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108391|NCT01852058|17643373|P10|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108392|NCT01852058|17643374|P9|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108393|NCT01852058|17643375|P8|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108394|NCT01852058|17643376|P7|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108549|NCT01850615|17643721|P1|Overall Study|Withdrawal by Subject|3
5108395|NCT01852058|17643377|P6|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
5108396|NCT01852058|17643378|P5|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
5108397|NCT01852058|17643379|P4|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108398|NCT01852058|17643380|P3|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108399|NCT01852058|17643381|P2|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108400|NCT01852058|17643382|P1|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5108401|NCT01852058|17643371|P12|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108402|NCT01852058|17643372|P11|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108403|NCT01852058|17643373|P10|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108404|NCT01852058|17643374|P9|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108405|NCT01852058|17643375|P8|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108406|NCT01852058|17643376|P7|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108407|NCT01852058|17643377|P6|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108408|NCT01852058|17643378|P5|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108409|NCT01852058|17643379|P4|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
5108410|NCT01852058|17643380|P3|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108411|NCT01852058|17643381|P2|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108412|NCT01852058|17643382|P1|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5108413|NCT01852058|17643371|P12|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108414|NCT01852058|17643372|P11|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108415|NCT01852058|17643373|P10|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108416|NCT01852058|17643374|P9|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108417|NCT01852058|17643375|P8|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108418|NCT01852058|17643376|P7|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108419|NCT01852058|17643377|P6|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
5108420|NCT01852058|17643378|P5|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
5108421|NCT01852058|17643379|P4|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108422|NCT01852058|17643380|P3|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108423|NCT01852058|17643381|P2|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108424|NCT01852058|17643382|P1|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5108425|NCT01852058|17643371|P12|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108426|NCT01852058|17643372|P11|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108427|NCT01852058|17643373|P10|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108428|NCT01852058|17643374|P9|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108429|NCT01852058|17643375|P8|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108430|NCT01852058|17643376|P7|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108431|NCT01852058|17643377|P6|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108432|NCT01852058|17643378|P5|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
5108433|NCT01852058|17643379|P4|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108434|NCT01852058|17643380|P3|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108435|NCT01852058|17643381|P2|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108436|NCT01852058|17643382|P1|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5108437|NCT01852058|17643371|P12|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108438|NCT01852058|17643372|P11|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108439|NCT01852058|17643373|P10|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108440|NCT01852058|17643374|P9|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108441|NCT01852058|17643375|P8|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108442|NCT01852058|17643376|P7|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108443|NCT01852058|17643377|P6|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
5108444|NCT01852058|17643378|P5|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
5108445|NCT01852058|17643379|P4|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108446|NCT01852058|17643380|P3|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108447|NCT01852058|17643381|P2|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108448|NCT01852058|17643382|P1|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5108449|NCT01852058|17643371|P12|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108450|NCT01852058|17643372|P11|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108451|NCT01852058|17643373|P10|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108452|NCT01852058|17643374|P9|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108453|NCT01852058|17643375|P8|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108454|NCT01852058|17643376|P7|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108455|NCT01852058|17643377|P6|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108456|NCT01852058|17643378|P5|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
5108457|NCT01852058|17643379|P4|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108458|NCT01852058|17643380|P3|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108459|NCT01852058|17643381|P2|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108460|NCT01852058|17643382|P1|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5108461|NCT01852058|17643371|P12|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108462|NCT01852058|17643372|P11|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108463|NCT01852058|17643373|P10|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108464|NCT01852058|17643374|P9|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108465|NCT01852058|17643375|P8|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108466|NCT01852058|17643376|P7|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108467|NCT01852058|17643377|P6|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108468|NCT01852058|17643378|P5|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108469|NCT01852058|17643379|P4|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108470|NCT01852058|17643380|P3|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108471|NCT01852058|17643381|P2|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5108472|NCT01852058|17643382|P1|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
5108473|NCT01852045|17643462|P3|Overall Study|Other Miscellaneous Reasons|2
5108474|NCT01852045|17643463|P2|Overall Study|Other Miscellaneous Reasons|3
5108475|NCT01852045|17643464|P1|Overall Study|Other Miscellaneous Reasons|1
5108476|NCT01852045|17643462|P3|Overall Study|Withdrawal by Subject|1
5108477|NCT01852045|17643463|P2|Overall Study|Withdrawal by Subject|0
5108478|NCT01852045|17643464|P1|Overall Study|Withdrawal by Subject|1
5108479|NCT01852045|17643462|P3|Overall Study|Lost to Follow-up|1
5108480|NCT01852045|17643463|P2|Overall Study|Lost to Follow-up|1
5108481|NCT01852045|17643464|P1|Overall Study|Lost to Follow-up|0
5108482|NCT01852045|17643462|P3|Overall Study|Lack of Efficacy|0
5108483|NCT01852045|17643463|P2|Overall Study|Lack of Efficacy|0
5108484|NCT01852045|17643464|P1|Overall Study|Lack of Efficacy|3
5108485|NCT01852045|17643462|P3|Overall Study|Adverse Event|0
5108486|NCT01852045|17643463|P2|Overall Study|Adverse Event|0
5108487|NCT01852045|17643464|P1|Overall Study|Adverse Event|1
5108488|NCT01851863|17643548|P4|Overall Study|Lost to Follow-up|3
5108489|NCT01851863|17643549|P3|Overall Study|Lost to Follow-up|2
5108490|NCT01851863|17643550|P2|Overall Study|Lost to Follow-up|4
5108491|NCT01851863|17643551|P1|Overall Study|Lost to Follow-up|3
5108492|NCT01851863|17643548|P4|Overall Study|Did not receive study medication|0
5108493|NCT01851863|17643549|P3|Overall Study|Did not receive study medication|3
5108494|NCT01851863|17643550|P2|Overall Study|Did not receive study medication|5
5108495|NCT01851863|17643551|P1|Overall Study|Did not receive study medication|2
5108496|NCT01851720|17643580|P2|Overall Study|Lost to Follow-up|1
5108497|NCT01851720|17643581|P1|Overall Study|Lost to Follow-up|0
5108498|NCT01851590|17643611|P3|Overall Study|Lack of Efficacy|0
5108499|NCT01851590|17643612|P2|Overall Study|Lack of Efficacy|1
5108500|NCT01851590|17643613|P1|Overall Study|Lack of Efficacy|0
5108501|NCT01851590|17643611|P3|Overall Study|Adverse Event|2
5108502|NCT01851590|17643612|P2|Overall Study|Adverse Event|0
5108503|NCT01851590|17643613|P1|Overall Study|Adverse Event|0
5108504|NCT01851590|17643611|P3|Overall Study|Withdrawal by Subject|1
5108505|NCT01851590|17643612|P2|Overall Study|Withdrawal by Subject|0
5108506|NCT01851590|17643613|P1|Overall Study|Withdrawal by Subject|0
5108507|NCT01851330|17643636|P3|Overall Study|Investigator's Discretion|1
5108508|NCT01851330|17643637|P2|Overall Study|Investigator's Discretion|0
5108509|NCT01851330|17643638|P1|Overall Study|Investigator's Discretion|0
5108510|NCT01851330|17643636|P3|Overall Study|Withdrew Consent|0
5108511|NCT01851330|17643637|P2|Overall Study|Withdrew Consent|1
5108512|NCT01851330|17643638|P1|Overall Study|Withdrew Consent|2
5108513|NCT01851330|17643636|P3|Overall Study|Lost to Follow-up|9
5108514|NCT01851330|17643637|P2|Overall Study|Lost to Follow-up|6
5108515|NCT01851330|17643638|P1|Overall Study|Lost to Follow-up|1
5108516|NCT01851330|17643636|P3|Overall Study|Lack of Efficacy|2
5108517|NCT01851330|17643637|P2|Overall Study|Lack of Efficacy|9
5108518|NCT01851330|17643638|P1|Overall Study|Lack of Efficacy|10
5108519|NCT01850823|17643681|P3|Overall Study|Withdrawal by Subject|1
5108520|NCT01850823|17643682|P2|Overall Study|Withdrawal by Subject|0
5108521|NCT01850823|17643683|P1|Overall Study|Withdrawal by Subject|2
5108522|NCT01850823|17643681|P3|Overall Study|Significant worstening of SAR|0
5108523|NCT01850823|17643682|P2|Overall Study|Significant worstening of SAR|1
5108524|NCT01850823|17643683|P1|Overall Study|Significant worstening of SAR|0
5108525|NCT01850823|17643681|P3|Overall Study|Restricted Medication|2
5108526|NCT01850823|17643682|P2|Overall Study|Restricted Medication|0
5108527|NCT01850823|17643683|P1|Overall Study|Restricted Medication|0
5108528|NCT01850823|17643681|P3|Overall Study|Lost to Follow-up|1
5108529|NCT01850823|17643682|P2|Overall Study|Lost to Follow-up|0
5108530|NCT01850823|17643683|P1|Overall Study|Lost to Follow-up|0
5108531|NCT01850823|17643681|P3|Overall Study|Lack of Efficacy|0
5108532|NCT01850823|17643682|P2|Overall Study|Lack of Efficacy|0
5108533|NCT01850823|17643683|P1|Overall Study|Lack of Efficacy|1
5108534|NCT01850823|17643681|P3|Overall Study|Enrolled in Error|2
5108535|NCT01850823|17643682|P2|Overall Study|Enrolled in Error|1
5108536|NCT01850823|17643683|P1|Overall Study|Enrolled in Error|0
5108537|NCT01850823|17643681|P3|Overall Study|Early Visit Window|4
5108538|NCT01850823|17643682|P2|Overall Study|Early Visit Window|1
5108539|NCT01850823|17643683|P1|Overall Study|Early Visit Window|0
5108540|NCT01850641|17643706|P1|Overall Study|Increase in serum ferritin|1
5108541|NCT01850641|17643706|P1|Overall Study|Decrease in serum calcium|2
5108542|NCT01850641|17643706|P1|Overall Study|Decrease in serum phosphorus|1
5108543|NCT01850641|17643706|P1|Overall Study|Physician Decision|1
5108544|NCT01850615|17643720|P2|Overall Study|Unclassified|1
5108545|NCT01850615|17643721|P1|Overall Study|Unclassified|0
5108546|NCT01850615|17643720|P2|Overall Study|Lost to Follow-up|1
5108547|NCT01850615|17643721|P1|Overall Study|Lost to Follow-up|0
5108548|NCT01850615|17643720|P2|Overall Study|Withdrawal by Subject|1
5108550|NCT01850615|17643720|P2|Overall Study|Adverse Event|1
5108551|NCT01850615|17643721|P1|Overall Study|Adverse Event|2
5108552|NCT01850615|17643720|P2|Overall Study|Protocol Violation|1
5108553|NCT01850615|17643721|P1|Overall Study|Protocol Violation|4
5108554|NCT01850602|17643739|P2|Overall Study|Increase in serum ferritin|0
5108555|NCT01850602|17643740|P1|Overall Study|Increase in serum ferritin|1
5108556|NCT01850602|17643739|P2|Overall Study|Decrease in serum calcium|3
5108557|NCT01850602|17643740|P1|Overall Study|Decrease in serum calcium|2
5108558|NCT01850602|17643739|P2|Overall Study|Withdrawal by Subject|4
5108559|NCT01850602|17643740|P1|Overall Study|Withdrawal by Subject|2
5108560|NCT01850602|17643739|P2|Overall Study|Physician Decision|1
5108561|NCT01850602|17643740|P1|Overall Study|Physician Decision|2
5108562|NCT01850602|17643739|P2|Overall Study|Adverse Event|10
5108563|NCT01850602|17643740|P1|Overall Study|Adverse Event|7
5108564|NCT01850589|17643754|P2|Overall Study|Withdrawal by Subject|0
5108565|NCT01850589|17643755|P1|Overall Study|Withdrawal by Subject|8
5108566|NCT01850446|17643795|P2|Overall Study|Protocol Violation|2
5108567|NCT01850446|17643796|P1|Overall Study|Protocol Violation|0
5108568|NCT01850446|17643795|P2|Overall Study|Withdrawal by Subject|0
5108569|NCT01850446|17643796|P1|Overall Study|Withdrawal by Subject|4
5108570|NCT01850446|17643795|P2|Overall Study|Lack of Efficacy|0
5108571|NCT01850446|17643796|P1|Overall Study|Lack of Efficacy|1
5108572|NCT01850030|17643855|P2|Overall Study|pregnancy not confirmed at visit 4|249
5108573|NCT01850030|17643856|P1|Overall Study|pregnancy not confirmed at visit 4|248
5108574|NCT01850030|17643855|P2|Overall Study|Protocol Violation|28
5108575|NCT01850030|17643856|P1|Overall Study|Protocol Violation|24
5108576|NCT01850030|17643855|P2|Overall Study|Withdrawal by Subject|4
5108577|NCT01850030|17643856|P1|Overall Study|Withdrawal by Subject|3
5108578|NCT01850030|17643855|P2|Overall Study|Lost to Follow-up|5
5108579|NCT01850030|17643856|P1|Overall Study|Lost to Follow-up|5
5108580|NCT01850030|17643855|P2|Overall Study|Lack of Efficacy|1
5108581|NCT01850030|17643856|P1|Overall Study|Lack of Efficacy|3
5108582|NCT01850030|17643855|P2|Overall Study|Adverse Event|82
5108583|NCT01850030|17643856|P1|Overall Study|Adverse Event|64
5108584|NCT01850004|17643868|P1|Overall Study|AE Unrelated to Study Drug|1
5108585|NCT01850004|17643868|P1|Overall Study|Subject Request to Discontinue Treatment|1
5108586|NCT01850004|17643868|P1|Overall Study|Subject Withdrew Consent|4
5108587|NCT01850004|17643868|P1|Overall Study|Poor/Non-compliance|1
5108588|NCT01850004|17643868|P1|Overall Study|Subject Moved|1
5108589|NCT01849848|17643875|P1|Overall Study|Progression of the primary disease|3
5108590|NCT01849848|17643875|P1|Overall Study|Physician Decision|1
5108591|NCT01849588|17643973|P1|Overall Study|Lack of Efficacy|3
5108592|NCT01849562|17643992|P3|Overall Study|Non-compliance with Study Drug|0
5108593|NCT01849562|17643993|P2|Overall Study|Non-compliance with Study Drug|0
5108594|NCT01849562|17643994|P1|Overall Study|Non-compliance with Study Drug|1
5108595|NCT01849562|17643992|P3|Overall Study|Lost to Follow-up|0
5108596|NCT01849562|17643993|P2|Overall Study|Lost to Follow-up|0
5108597|NCT01849562|17643994|P1|Overall Study|Lost to Follow-up|1
5108598|NCT01849497|17644007|P2|Overall Study|Lost to Follow-up|1
5108599|NCT01849497|17644008|P1|Overall Study|Lost to Follow-up|0
5108600|NCT01849497|17644007|P2|Overall Study|Sponsor Decision|1
5108601|NCT01849497|17644008|P1|Overall Study|Sponsor Decision|0
5108602|NCT01849497|17644007|P2|Overall Study|Withdrawal by Subject|2
5108603|NCT01849497|17644008|P1|Overall Study|Withdrawal by Subject|1
5108604|NCT01849458|17644016|P1|Overall Study|Lost to Follow-up|4
5108605|NCT01849289|17644055|P2|Overall Study|Unclassified|18
5108606|NCT01849289|17644056|P1|Overall Study|Unclassified|25
5108607|NCT01849289|17644055|P2|Overall Study|Withdrawal criteria|0
5108608|NCT01849289|17644056|P1|Overall Study|Withdrawal criteria|1
5108609|NCT01849289|17644055|P2|Overall Study|Protocol Violation|3
5108610|NCT01849289|17644056|P1|Overall Study|Protocol Violation|3
5108611|NCT01849289|17644055|P2|Overall Study|Adverse Event|3
5108612|NCT01849289|17644056|P1|Overall Study|Adverse Event|3
5108613|NCT01849276|17644072|P1|Followed for Survival for 5 Years|Early termination of the study|1
5108614|NCT01849276|17644072|P1|Followed for Survival for 5 Years|Death|1
5108615|NCT01849055|17644154|P6|Overall Study|Withdrawal by Subject|0
5108616|NCT01849055|17644155|P5|Overall Study|Withdrawal by Subject|0
5108617|NCT01849055|17644156|P4|Overall Study|Withdrawal by Subject|0
5108618|NCT01849055|17644157|P3|Overall Study|Withdrawal by Subject|1
5108619|NCT01849055|17644158|P2|Overall Study|Withdrawal by Subject|0
5108620|NCT01849055|17644159|P1|Overall Study|Withdrawal by Subject|0
5108621|NCT01848990|17644194|P3|Overall Study|Other|2
5108622|NCT01848990|17644195|P2|Overall Study|Other|4
5108623|NCT01848990|17644196|P1|Overall Study|Other|1
5108624|NCT01848990|17644194|P3|Overall Study|Death|1
5108625|NCT01848990|17644195|P2|Overall Study|Death|0
5108626|NCT01848990|17644196|P1|Overall Study|Death|1
5108627|NCT01848990|17644194|P3|Overall Study|Non Compliance|0
5108628|NCT01848990|17644195|P2|Overall Study|Non Compliance|0
5108629|NCT01848990|17644196|P1|Overall Study|Non Compliance|1
5108630|NCT01848990|17644194|P3|Overall Study|Physician Decision|0
5108631|NCT01848990|17644195|P2|Overall Study|Physician Decision|1
5108632|NCT01848990|17644196|P1|Overall Study|Physician Decision|1
5108633|NCT01848990|17644194|P3|Overall Study|Withdrawal by Subject|11
5108634|NCT01848990|17644195|P2|Overall Study|Withdrawal by Subject|10
5108635|NCT01848990|17644196|P1|Overall Study|Withdrawal by Subject|29
5108636|NCT01848990|17644194|P3|Overall Study|Protocol Violation|0
5108637|NCT01848990|17644195|P2|Overall Study|Protocol Violation|1
5108638|NCT01848990|17644196|P1|Overall Study|Protocol Violation|1
5108639|NCT01848990|17644194|P3|Overall Study|Lost to Follow-up|2
5108640|NCT01848990|17644195|P2|Overall Study|Lost to Follow-up|2
5108641|NCT01848990|17644196|P1|Overall Study|Lost to Follow-up|6
5108642|NCT01848990|17644194|P3|Overall Study|Adverse Event|0
5108643|NCT01848990|17644195|P2|Overall Study|Adverse Event|2
5108644|NCT01848990|17644196|P1|Overall Study|Adverse Event|6
5108645|NCT01848938|17644266|P2|Overall Study|Lost to Follow-up|1
5108646|NCT01848938|17644267|P1|Overall Study|Lost to Follow-up|1
5108647|NCT01848834|17644316|P5|Overall Study|Not Treated|0
5108648|NCT01848834|17644317|P4|Overall Study|Not Treated|0
5108649|NCT01848834|17644318|P3|Overall Study|Not Treated|0
5108650|NCT01848834|17644319|P2|Overall Study|Not Treated|1
5108651|NCT01848834|17644320|P1|Overall Study|Not Treated|0
5108652|NCT01848834|17644316|P5|Overall Study|Withdrawal by Subject|7
5108653|NCT01848834|17644317|P4|Overall Study|Withdrawal by Subject|0
5108654|NCT01848834|17644318|P3|Overall Study|Withdrawal by Subject|3
5108655|NCT01848834|17644319|P2|Overall Study|Withdrawal by Subject|2
5108656|NCT01848834|17644320|P1|Overall Study|Withdrawal by Subject|0
5108657|NCT01848834|17644316|P5|Overall Study|Protocol Violation|2
5108658|NCT01848834|17644317|P4|Overall Study|Protocol Violation|0
5108659|NCT01848834|17644318|P3|Overall Study|Protocol Violation|1
5108660|NCT01848834|17644319|P2|Overall Study|Protocol Violation|0
5108661|NCT01848834|17644320|P1|Overall Study|Protocol Violation|0
5108662|NCT01848834|17644316|P5|Overall Study|Progressive Disease|78
5108663|NCT01848834|17644317|P4|Overall Study|Progressive Disease|36
5108664|NCT01848834|17644318|P3|Overall Study|Progressive Disease|21
5108665|NCT01848834|17644319|P2|Overall Study|Progressive Disease|41
5108666|NCT01848834|17644320|P1|Overall Study|Progressive Disease|27
5108667|NCT01848834|17644316|P5|Overall Study|Death|3
5108668|NCT01848834|17644317|P4|Overall Study|Death|0
5108669|NCT01848834|17644318|P3|Overall Study|Death|0
5108670|NCT01848834|17644319|P2|Overall Study|Death|1
5108671|NCT01848834|17644320|P1|Overall Study|Death|0
5108672|NCT01848834|17644316|P5|Overall Study|Complete Response|0
5108673|NCT01848834|17644317|P4|Overall Study|Complete Response|0
5108674|NCT01848834|17644318|P3|Overall Study|Complete Response|0
5108675|NCT01848834|17644319|P2|Overall Study|Complete Response|1
5108676|NCT01848834|17644320|P1|Overall Study|Complete Response|0
5108677|NCT01848834|17644316|P5|Overall Study|Adverse Event|15
5108678|NCT01848834|17644317|P4|Overall Study|Adverse Event|1
5108679|NCT01848834|17644318|P3|Overall Study|Adverse Event|6
5108680|NCT01848834|17644319|P2|Overall Study|Adverse Event|8
5108681|NCT01848834|17644320|P1|Overall Study|Adverse Event|3
5108682|NCT01848834|17644316|P5|Overall Study|Physician Decision|1
5108683|NCT01848834|17644317|P4|Overall Study|Physician Decision|0
5108684|NCT01848834|17644318|P3|Overall Study|Physician Decision|0
5108685|NCT01848834|17644319|P2|Overall Study|Physician Decision|0
5108686|NCT01848834|17644320|P1|Overall Study|Physician Decision|0
5108687|NCT01848834|17644316|P5|Overall Study|Ongoing in Study|26
5108688|NCT01848834|17644317|P4|Overall Study|Ongoing in Study|0
5108689|NCT01848834|17644318|P3|Overall Study|Ongoing in Study|1
5108690|NCT01848834|17644319|P2|Overall Study|Ongoing in Study|6
5108691|NCT01848834|17644320|P1|Overall Study|Ongoing in Study|0
5108692|NCT01848756|17644368|P1|Overall Study|Enrolled in Error|1
5108693|NCT01848756|17644368|P1|Overall Study|Withdrawal by Subject|1
5108694|NCT01848756|17644368|P1|Overall Study|Adverse Event|1
5108695|NCT01848483|17644380|P2|Overall Study|Incarceration|2
5108696|NCT01848483|17644381|P1|Overall Study|Incarceration|2
5108697|NCT01848483|17644380|P2|Overall Study|Withdrawal by Subject|0
5108698|NCT01848483|17644381|P1|Overall Study|Withdrawal by Subject|1
5108699|NCT01848483|17644380|P2|Overall Study|Lost to Follow-up|8
5108700|NCT01848483|17644381|P1|Overall Study|Lost to Follow-up|6
5108701|NCT01848483|17644380|P2|Overall Study|Death|1
5108702|NCT01848483|17644381|P1|Overall Study|Death|2
5108703|NCT01848457|17644399|P4|Overall Study|Death|0
5108704|NCT01848457|17644400|P3|Overall Study|Death|0
5108705|NCT01848457|17644401|P2|Overall Study|Death|0
5108706|NCT01848457|17644402|P1|Overall Study|Death|1
5108707|NCT01848353|17644434|P4|Phase 3|Withdrawal by Subject|0
5108708|NCT01848353|17644435|P3|Phase 3|Withdrawal by Subject|0
5108709|NCT01848353|17644436|P2|Phase 3|Withdrawal by Subject|1
5108710|NCT01848353|17644437|P1|Phase 3|Withdrawal by Subject|1
5108711|NCT01848353|17644434|P4|Phase 2|Withdrawal by Subject|0
5108712|NCT01848353|17644435|P3|Phase 2|Withdrawal by Subject|0
5108713|NCT01848353|17644436|P2|Phase 2|Withdrawal by Subject|2
5108714|NCT01848353|17644437|P1|Phase 2|Withdrawal by Subject|3
5108715|NCT01848353|17644434|P4|Phase 1|Withdrawal by Subject|0
5108716|NCT01848353|17644435|P3|Phase 1|Withdrawal by Subject|0
5108717|NCT01848353|17644436|P2|Phase 1|Withdrawal by Subject|1
5108718|NCT01848353|17644437|P1|Phase 1|Withdrawal by Subject|3
5108719|NCT01848288|17644493|P1|Overall Study|Withdrawal by Subject|1
5108720|NCT01848288|17644493|P1|Overall Study|Protocol Violation|1
5108721|NCT01848288|17644493|P1|Overall Study|Death|1
5108722|NCT01848210|17644504|P2|Overall Study|Administrative|0
5108723|NCT01848210|17644505|P1|Overall Study|Administrative|1
5108724|NCT01848210|17644504|P2|Overall Study|Chronic Venous Insufficiency Course|2
5108725|NCT01848210|17644505|P1|Overall Study|Chronic Venous Insufficiency Course|1
5108726|NCT01848210|17644504|P2|Overall Study|Hepatic Function Alteration|0
5108727|NCT01848210|17644505|P1|Overall Study|Hepatic Function Alteration|4
5108728|NCT01848210|17644504|P2|Overall Study|Hypesensitivity|0
5108729|NCT01848210|17644505|P1|Overall Study|Hypesensitivity|1
5108730|NCT01848210|17644504|P2|Overall Study|Discontinuation Criterion|7
5108731|NCT01848210|17644505|P1|Overall Study|Discontinuation Criterion|5
5108732|NCT01848210|17644504|P2|Overall Study|Adverse Event|9
5108733|NCT01848210|17644505|P1|Overall Study|Adverse Event|7
5108734|NCT01848210|17644504|P2|Overall Study|Impedition Condition|9
5108735|NCT01848210|17644505|P1|Overall Study|Impedition Condition|5
5108736|NCT01848210|17644504|P2|Overall Study|Use of Forbidden Drugs|10
5108737|NCT01848210|17644505|P1|Overall Study|Use of Forbidden Drugs|9
5108738|NCT01848210|17644504|P2|Overall Study|Protocol Violation|5
5108739|NCT01848210|17644505|P1|Overall Study|Protocol Violation|3
5108740|NCT01848210|17644504|P2|Overall Study|Lost to Follow-up|12
5108741|NCT01848210|17644505|P1|Overall Study|Lost to Follow-up|24
5108742|NCT01848210|17644504|P2|Overall Study|Informed Consent Form Withdrawal|24
5108743|NCT01848210|17644505|P1|Overall Study|Informed Consent Form Withdrawal|28
5108744|NCT01848145|17644554|P1|Subsequent Infusions: Weeks 3-8|Death|1
5108745|NCT01848145|17644554|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
5108746|NCT01848145|17644554|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
5108747|NCT01848145|17644554|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
5108748|NCT01848145|17644554|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
5108749|NCT01848145|17644554|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
5108750|NCT01848145|17644554|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
5108751|NCT01847885|17644594|P3|Randomization|Screen Failure|0
5108752|NCT01847885|17644595|P2|Randomization|Screen Failure|3
5108753|NCT01847885|17644596|P1|Randomization|Screen Failure|0
5108754|NCT01847885|17644594|P3|Randomization|Withdrawal by Subject|2
5108755|NCT01847885|17644595|P2|Randomization|Withdrawal by Subject|0
5108756|NCT01847885|17644596|P1|Randomization|Withdrawal by Subject|0
5108757|NCT01847885|17644594|P3|Randomization|Protocol Violation|0
5108758|NCT01847885|17644595|P2|Randomization|Protocol Violation|1
5108759|NCT01847885|17644596|P1|Randomization|Protocol Violation|0
5108760|NCT01847885|17644594|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
5108761|NCT01847885|17644595|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
5108762|NCT01847885|17644596|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
5108763|NCT01847885|17644594|P3|Initial Enrollment (Consented)|Screen failure|0
5108764|NCT01847885|17644595|P2|Initial Enrollment (Consented)|Screen failure|0
5108765|NCT01847885|17644596|P1|Initial Enrollment (Consented)|Screen failure|39
5108766|NCT01847885|17644594|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
5108767|NCT01847885|17644595|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
5108768|NCT01847885|17644596|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
5108769|NCT01847885|17644594|P3|Initial Enrollment (Consented)|Protocol Violation|0
5108770|NCT01847885|17644595|P2|Initial Enrollment (Consented)|Protocol Violation|0
5108771|NCT01847885|17644596|P1|Initial Enrollment (Consented)|Protocol Violation|1
5108772|NCT01847443|17644760|P4|Washout Period Before Study Period 4|Positive alcohol test|0
5108773|NCT01847443|17644761|P3|Washout Period Before Study Period 4|Positive alcohol test|0
5108774|NCT01847443|17644762|P2|Washout Period Before Study Period 4|Positive alcohol test|0
5108775|NCT01847443|17644763|P1|Washout Period Before Study Period 4|Positive alcohol test|1
5108776|NCT01847443|17644760|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
5108777|NCT01847443|17644761|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
5108778|NCT01847443|17644762|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
5108779|NCT01847443|17644763|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
5108780|NCT01847443|17644760|P4|Washout Period Before Study Period 3|Other reason|0
5108781|NCT01847443|17644761|P3|Washout Period Before Study Period 3|Other reason|0
5108782|NCT01847443|17644762|P2|Washout Period Before Study Period 3|Other reason|0
5108783|NCT01847443|17644763|P1|Washout Period Before Study Period 3|Other reason|1
5108784|NCT01847443|17644760|P4|Washout Period Before Study Period 2|Other reason|0
5108785|NCT01847443|17644761|P3|Washout Period Before Study Period 2|Other reason|0
5108786|NCT01847443|17644762|P2|Washout Period Before Study Period 2|Other reason|0
5108787|NCT01847443|17644763|P1|Washout Period Before Study Period 2|Other reason|1
5108788|NCT01847443|17644760|P4|Washout Period Before Study Period 2|Adverse Event|0
5108789|NCT01847443|17644761|P3|Washout Period Before Study Period 2|Adverse Event|0
5108790|NCT01847443|17644762|P2|Washout Period Before Study Period 2|Adverse Event|1
5108791|NCT01847443|17644763|P1|Washout Period Before Study Period 2|Adverse Event|1
5108792|NCT01847443|17644760|P4|Study Period 1|Withdrawal by Subject|0
5108793|NCT01847443|17644761|P3|Study Period 1|Withdrawal by Subject|0
5108794|NCT01847443|17644762|P2|Study Period 1|Withdrawal by Subject|1
5108795|NCT01847443|17644763|P1|Study Period 1|Withdrawal by Subject|0
5108796|NCT01847313|17644806|P2|Overall Study|Withdrawal by Subject|1
5108797|NCT01847313|17644807|P1|Overall Study|Withdrawal by Subject|0
5108798|NCT01847313|17644806|P2|Overall Study|Death|1
5108799|NCT01847313|17644807|P1|Overall Study|Death|0
5108800|NCT01847274|17644823|P4|Overall Study|Non Compliance|0
5108801|NCT01847274|17644824|P3|Overall Study|Non Compliance|2
5108802|NCT01847274|17644825|P2|Overall Study|Non Compliance|0
5108803|NCT01847274|17644826|P1|Overall Study|Non Compliance|0
5108804|NCT01847274|17644823|P4|Overall Study|Other Reasons|3
5108805|NCT01847274|17644824|P3|Overall Study|Other Reasons|11
5108806|NCT01847274|17644825|P2|Overall Study|Other Reasons|1
5108807|NCT01847274|17644826|P1|Overall Study|Other Reasons|3
5108808|NCT01847274|17644823|P4|Overall Study|Treatment Associated Risk|0
5108809|NCT01847274|17644824|P3|Overall Study|Treatment Associated Risk|2
5108810|NCT01847274|17644825|P2|Overall Study|Treatment Associated Risk|2
5108811|NCT01847274|17644826|P1|Overall Study|Treatment Associated Risk|0
5108812|NCT01847274|17644823|P4|Overall Study|Disease Progression|98
5108813|NCT01847274|17644824|P3|Overall Study|Disease Progression|129
5108814|NCT01847274|17644825|P2|Overall Study|Disease Progression|49
5108815|NCT01847274|17644826|P1|Overall Study|Disease Progression|63
5108816|NCT01847274|17644823|P4|Overall Study|Withdrawal by Subject|1
5108817|NCT01847274|17644824|P3|Overall Study|Withdrawal by Subject|11
5108818|NCT01847274|17644825|P2|Overall Study|Withdrawal by Subject|8
5108819|NCT01847274|17644826|P1|Overall Study|Withdrawal by Subject|8
5108820|NCT01847274|17644823|P4|Overall Study|Adverse Event|2
5108821|NCT01847274|17644824|P3|Overall Study|Adverse Event|33
5108822|NCT01847274|17644825|P2|Overall Study|Adverse Event|1
5108823|NCT01847274|17644826|P1|Overall Study|Adverse Event|17
5108824|NCT01847209|17644880|P1|Overall Study|No lung nodule found on intraop CT scan|1
5108825|NCT01847209|17644880|P1|Overall Study|Withdrawal by Subject|1
5108826|NCT01847092|17644903|P2|Overall Study|Protocol Violation|2
5108827|NCT01847092|17644904|P1|Overall Study|Protocol Violation|0
5108828|NCT01847092|17644903|P2|Overall Study|Physician Decision|1
5108829|NCT01847092|17644904|P1|Overall Study|Physician Decision|1
5108830|NCT01847092|17644903|P2|Overall Study|Protocol Specified|0
5108831|NCT01847092|17644904|P1|Overall Study|Protocol Specified|8
5108832|NCT01847092|17644903|P2|Overall Study|Withdrawal by Subject|5
5108833|NCT01847092|17644904|P1|Overall Study|Withdrawal by Subject|5
5108834|NCT01847092|17644903|P2|Overall Study|Adverse Event|3
5108835|NCT01847092|17644904|P1|Overall Study|Adverse Event|12
5108836|NCT01846741|17644958|P1|Baseline Visit|Subject did not meet entry criteria|2
5108837|NCT01846624|17645114|P1|Overall Study|Died during induction, no midostaurin|1
5108838|NCT01846611|17645124|P2|Overall Study|Other|18
5108839|NCT01846611|17645125|P1|Overall Study|Other|19
5108840|NCT01846611|17645124|P2|Overall Study|Withdrawal by Subject|19
5108841|NCT01846611|17645125|P1|Overall Study|Withdrawal by Subject|15
5108842|NCT01846611|17645124|P2|Overall Study|Lost to Follow-up|6
5108843|NCT01846611|17645125|P1|Overall Study|Lost to Follow-up|4
5108844|NCT01846507|17645135|P1|Overall Study|Missing data|2
5108845|NCT01846507|17645135|P1|Overall Study|Protocol Violation|1
5108846|NCT01846507|17645135|P1|Overall Study|Lost to Follow-up|4
5108847|NCT01846442|17645233|P4|Overall Study|Left the city/Lost medication|1
5108848|NCT01846442|17645234|P3|Overall Study|Left the city/Lost medication|1
5108849|NCT01846442|17645235|P2|Overall Study|Left the city/Lost medication|0
5108850|NCT01846442|17645236|P1|Overall Study|Left the city/Lost medication|1
5108851|NCT01846442|17645233|P4|Overall Study|Withdrawal by Subject|1
5108852|NCT01846442|17645234|P3|Overall Study|Withdrawal by Subject|0
5108853|NCT01846442|17645235|P2|Overall Study|Withdrawal by Subject|2
5108854|NCT01846442|17645236|P1|Overall Study|Withdrawal by Subject|3
5108855|NCT01846442|17645233|P4|Overall Study|Lost to Follow-up|0
5108856|NCT01846442|17645234|P3|Overall Study|Lost to Follow-up|1
5108857|NCT01846442|17645235|P2|Overall Study|Lost to Follow-up|0
5108858|NCT01846442|17645236|P1|Overall Study|Lost to Follow-up|0
5108859|NCT01846442|17645233|P4|Overall Study|Adverse Event|1
5108860|NCT01846442|17645234|P3|Overall Study|Adverse Event|2
5108861|NCT01846442|17645235|P2|Overall Study|Adverse Event|4
5108862|NCT01846442|17645236|P1|Overall Study|Adverse Event|2
5108863|NCT01846416|17645277|P3|Survival Follow-up|Other|1
5108864|NCT01846416|17645278|P2|Survival Follow-up|Other|1
5108865|NCT01846416|17645279|P1|Survival Follow-up|Other|3
5108866|NCT01846416|17645277|P3|Survival Follow-up|Study Terminated by Sponsor|0
5108867|NCT01846416|17645278|P2|Survival Follow-up|Study Terminated by Sponsor|8
5108868|NCT01846416|17645279|P1|Survival Follow-up|Study Terminated by Sponsor|2
5108869|NCT01846416|17645277|P3|Survival Follow-up|Withdrawal by Subject|0
5108870|NCT01846416|17645278|P2|Survival Follow-up|Withdrawal by Subject|7
5108871|NCT01846416|17645279|P1|Survival Follow-up|Withdrawal by Subject|2
5108872|NCT01846416|17645277|P3|Survival Follow-up|Lost to Follow-up|2
5108873|NCT01846416|17645278|P2|Survival Follow-up|Lost to Follow-up|2
5108874|NCT01846416|17645279|P1|Survival Follow-up|Lost to Follow-up|0
5108875|NCT01846416|17645277|P3|Survival Follow-up|Death|9
5108876|NCT01846416|17645278|P2|Survival Follow-up|Death|62
5108877|NCT01846416|17645279|P1|Survival Follow-up|Death|21
5108878|NCT01846416|17645277|P3|Treatment Phase|Progressive Disease|9
5108879|NCT01846416|17645278|P2|Treatment Phase|Progressive Disease|63
5108880|NCT01846416|17645279|P1|Treatment Phase|Progressive Disease|21
5108881|NCT01846416|17645277|P3|Treatment Phase|Study Terminated by Sponsor|0
5108882|NCT01846416|17645278|P2|Treatment Phase|Study Terminated by Sponsor|4
5108883|NCT01846416|17645279|P1|Treatment Phase|Study Terminated by Sponsor|1
5108884|NCT01846416|17645277|P3|Treatment Phase|Non-compliance|0
5108885|NCT01846416|17645278|P2|Treatment Phase|Non-compliance|2
5108886|NCT01846416|17645279|P1|Treatment Phase|Non-compliance|0
5108887|NCT01846416|17645277|P3|Treatment Phase|Adverse Event|0
5108888|NCT01846416|17645278|P2|Treatment Phase|Adverse Event|4
5108889|NCT01846416|17645279|P1|Treatment Phase|Adverse Event|3
5108890|NCT01846416|17645277|P3|Treatment Phase|Physician Decision|0
5108891|NCT01846416|17645278|P2|Treatment Phase|Physician Decision|2
5108892|NCT01846416|17645279|P1|Treatment Phase|Physician Decision|1
5108893|NCT01846416|17645277|P3|Treatment Phase|Other|1
5108894|NCT01846416|17645278|P2|Treatment Phase|Other|5
5108895|NCT01846416|17645279|P1|Treatment Phase|Other|1
5108896|NCT01846416|17645277|P3|Treatment Phase|Withdrawal by Subject|2
5108897|NCT01846416|17645278|P2|Treatment Phase|Withdrawal by Subject|4
5108898|NCT01846416|17645279|P1|Treatment Phase|Withdrawal by Subject|2
5108899|NCT01846416|17645277|P3|Treatment Phase|Death|1
5108900|NCT01846416|17645278|P2|Treatment Phase|Death|9
5108901|NCT01846416|17645279|P1|Treatment Phase|Death|2
5108902|NCT01846299|17645324|P2|Overall Study|Adverse Event|0
5108903|NCT01846299|17645325|P1|Overall Study|Adverse Event|2
5108904|NCT01846299|17645324|P2|Overall Study|Withdrawal by Subject|6
5108905|NCT01846299|17645325|P1|Overall Study|Withdrawal by Subject|1
5108906|NCT01846299|17645324|P2|Overall Study|Lost to Follow-up|0
5108907|NCT01846299|17645325|P1|Overall Study|Lost to Follow-up|3
5108908|NCT01846299|17645324|P2|Overall Study|Death|2
5108909|NCT01846299|17645325|P1|Overall Study|Death|1
5108910|NCT01846299|17645324|P2|Overall Study|Protocol deviation|0
5108911|NCT01846299|17645325|P1|Overall Study|Protocol deviation|1
5108912|NCT01846299|17645324|P2|Overall Study|Physician Decision|2
5108913|NCT01846299|17645325|P1|Overall Study|Physician Decision|4
5108914|NCT01846273|17645364|P3|Overall Study|Physician Decision|0
5108915|NCT01846273|17645365|P2|Overall Study|Physician Decision|2
5108916|NCT01846273|17645366|P1|Overall Study|Physician Decision|1
5108917|NCT01846273|17645364|P3|Overall Study|Protocol Deviation|0
5108918|NCT01846273|17645365|P2|Overall Study|Protocol Deviation|3
5108919|NCT01846273|17645366|P1|Overall Study|Protocol Deviation|2
5108920|NCT01846273|17645364|P3|Overall Study|Disease Progression|0
5108921|NCT01846273|17645365|P2|Overall Study|Disease Progression|4
5108922|NCT01846273|17645366|P1|Overall Study|Disease Progression|0
5108923|NCT01846273|17645364|P3|Overall Study|Death|0
5108924|NCT01846273|17645365|P2|Overall Study|Death|1
5108925|NCT01846273|17645366|P1|Overall Study|Death|2
5108926|NCT01846273|17645364|P3|Overall Study|Administrative problems|0
5108927|NCT01846273|17645365|P2|Overall Study|Administrative problems|0
5108928|NCT01846273|17645366|P1|Overall Study|Administrative problems|1
5108929|NCT01846273|17645364|P3|Overall Study|Lost to Follow-up|0
5108930|NCT01846273|17645365|P2|Overall Study|Lost to Follow-up|1
5108931|NCT01846273|17645366|P1|Overall Study|Lost to Follow-up|2
5108932|NCT01846273|17645364|P3|Overall Study|Subject withdrew consent|0
5108933|NCT01846273|17645365|P2|Overall Study|Subject withdrew consent|8
5108934|NCT01846273|17645366|P1|Overall Study|Subject withdrew consent|5
5108935|NCT01846273|17645364|P3|Overall Study|Adverse Event|0
5108936|NCT01846273|17645365|P2|Overall Study|Adverse Event|7
5108937|NCT01846273|17645366|P1|Overall Study|Adverse Event|9
5108938|NCT01846221|17645422|P2|Overall Study|Age Exclusion|0
5108939|NCT01846221|17645423|P1|Overall Study|Age Exclusion|1
5108940|NCT01846221|17645422|P2|Overall Study|Catheter Failure|0
5108941|NCT01846221|17645423|P1|Overall Study|Catheter Failure|2
5108942|NCT01846208|17645440|P3|Overall Study|Refused SU OFC|1
5108943|NCT01846208|17645441|P2|Overall Study|Refused SU OFC|0
5108944|NCT01846208|17645442|P1|Overall Study|Refused SU OFC|0
5108945|NCT01846208|17645440|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
5108946|NCT01846208|17645441|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
5108947|NCT01846208|17645442|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
5108948|NCT01846208|17645440|P3|Overall Study|Non-compliance|0
5108949|NCT01846208|17645441|P2|Overall Study|Non-compliance|1
5108950|NCT01846208|17645442|P1|Overall Study|Non-compliance|1
5108951|NCT01846208|17645440|P3|Overall Study|Withdrawal by Subject|0
5108952|NCT01846208|17645441|P2|Overall Study|Withdrawal by Subject|0
5108953|NCT01846208|17645442|P1|Overall Study|Withdrawal by Subject|5
5108954|NCT01846208|17645440|P3|Overall Study|Dosing Symptoms|6
5108955|NCT01846208|17645441|P2|Overall Study|Dosing Symptoms|2
5108956|NCT01846208|17645442|P1|Overall Study|Dosing Symptoms|1
5108957|NCT01846208|17645440|P3|Overall Study|Withdrew prior to treatment|1
5108958|NCT01846208|17645441|P2|Overall Study|Withdrew prior to treatment|1
5108959|NCT01846208|17645442|P1|Overall Study|Withdrew prior to treatment|1
5108960|NCT01846104|17645462|P1|Overall Study|Withdrawal by Subject|1
5108961|NCT01846039|17645468|P1|Overall Study|Subject Withdrew Consent|1
5108962|NCT01846039|17645468|P1|Overall Study|Protocol Violation|1
5108963|NCT01845974|17645480|P2|Overall Study|screen failure|0
5108964|NCT01845974|17645481|P1|Overall Study|screen failure|1
5108965|NCT01845831|17645489|P5|Inpatient Phase|Withdrawal by Subject|0
5108966|NCT01845831|17645490|P4|Inpatient Phase|Withdrawal by Subject|0
5108967|NCT01845831|17645491|P3|Inpatient Phase|Withdrawal by Subject|0
5108968|NCT01845831|17645492|P2|Inpatient Phase|Withdrawal by Subject|1
5108969|NCT01845831|17645493|P1|Inpatient Phase|Withdrawal by Subject|1
5108970|NCT01845818|17645522|P2|Overall Study|No Follow-Up Data Available|1
5108971|NCT01845818|17645523|P1|Overall Study|No Follow-Up Data Available|4
5108972|NCT01845818|17645522|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
5108973|NCT01845818|17645523|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
5108974|NCT01845818|17645522|P2|Overall Study|Other|8
5108975|NCT01845818|17645523|P1|Overall Study|Other|25
5108976|NCT01845818|17645522|P2|Overall Study|Serious Adverse Event|1
5108977|NCT01845818|17645523|P1|Overall Study|Serious Adverse Event|1
5108978|NCT01845818|17645522|P2|Overall Study|Administrative Reasons|1
5108979|NCT01845818|17645523|P1|Overall Study|Administrative Reasons|3
5108980|NCT01845818|17645522|P2|Overall Study|Lost to Follow-up|5
5108981|NCT01845818|17645523|P1|Overall Study|Lost to Follow-up|7
5108982|NCT01845818|17645522|P2|Overall Study|Withdrawal by Subject|1
5108983|NCT01845818|17645523|P1|Overall Study|Withdrawal by Subject|0
5108984|NCT01845077|17645607|P6|Washout Period|Protocol Violation|0
5108985|NCT01845077|17645608|P5|Washout Period|Protocol Violation|1
5108986|NCT01845077|17645609|P4|Washout Period|Protocol Violation|1
5108987|NCT01845077|17645610|P3|Washout Period|Protocol Violation|0
5108988|NCT01845077|17645611|P2|Washout Period|Protocol Violation|0
5108989|NCT01845077|17645612|P1|Washout Period|Protocol Violation|0
5108990|NCT01845077|17645607|P6|Washout Period|elevated lab values (not clinic. sign.)|0
5108991|NCT01845077|17645608|P5|Washout Period|elevated lab values (not clinic. sign.)|0
5108992|NCT01845077|17645609|P4|Washout Period|elevated lab values (not clinic. sign.)|0
5108993|NCT01845077|17645610|P3|Washout Period|elevated lab values (not clinic. sign.)|1
5108994|NCT01845077|17645611|P2|Washout Period|elevated lab values (not clinic. sign.)|0
5108995|NCT01845077|17645612|P1|Washout Period|elevated lab values (not clinic. sign.)|0
5108996|NCT01845077|17645607|P6|Washout Period|Adverse Event|0
5108997|NCT01845077|17645608|P5|Washout Period|Adverse Event|0
5108998|NCT01845077|17645609|P4|Washout Period|Adverse Event|0
5108999|NCT01845077|17645610|P3|Washout Period|Adverse Event|0
5109000|NCT01845077|17645611|P2|Washout Period|Adverse Event|0
5109001|NCT01845077|17645612|P1|Washout Period|Adverse Event|1
5109002|NCT01845077|17645607|P6|Washout Period|Lost to Follow-up|1
5109003|NCT01845077|17645608|P5|Washout Period|Lost to Follow-up|0
5109004|NCT01845077|17645609|P4|Washout Period|Lost to Follow-up|1
5109005|NCT01845077|17645610|P3|Washout Period|Lost to Follow-up|0
5109006|NCT01845077|17645611|P2|Washout Period|Lost to Follow-up|1
5109007|NCT01845077|17645612|P1|Washout Period|Lost to Follow-up|0
5109008|NCT01845025|17645658|P2|Overall Study|Missing|1
5109009|NCT01845025|17645659|P1|Overall Study|Missing|1
5109010|NCT01845025|17645658|P2|Overall Study|Protocol deviation|6
5109011|NCT01845025|17645659|P1|Overall Study|Protocol deviation|3
5109012|NCT01845025|17645658|P2|Overall Study|Death|0
5109013|NCT01845025|17645659|P1|Overall Study|Death|2
5109014|NCT01845025|17645658|P2|Overall Study|Administrative problems|8
5109015|NCT01845025|17645659|P1|Overall Study|Administrative problems|8
5109016|NCT01845025|17645658|P2|Overall Study|Lost to Follow-up|13
5109017|NCT01845025|17645659|P1|Overall Study|Lost to Follow-up|13
5109018|NCT01845025|17645658|P2|Overall Study|Withdrawal by Subject|44
5109019|NCT01845025|17645659|P1|Overall Study|Withdrawal by Subject|48
5109020|NCT01845025|17645658|P2|Overall Study|Unsatisfactory therapeutic effect|2
5109021|NCT01845025|17645659|P1|Overall Study|Unsatisfactory therapeutic effect|4
5109022|NCT01845025|17645658|P2|Overall Study|Adverse Event|3
5109023|NCT01845025|17645659|P1|Overall Study|Adverse Event|6
5109024|NCT01844986|17645683|P2|Overall Study|Death|26
5109025|NCT01844986|17645684|P1|Overall Study|Death|55
5109026|NCT01844986|17645683|P2|Overall Study|Withdrawal by Subject|14
5109027|NCT01844986|17645684|P1|Overall Study|Withdrawal by Subject|21
5109028|NCT01844986|17645683|P2|Overall Study|Severe non-compliance to protocol|0
5109029|NCT01844986|17645684|P1|Overall Study|Severe non-compliance to protocol|1
5109030|NCT01844895|17645706|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
5109031|NCT01844895|17645706|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
5109032|NCT01844895|17645706|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
5109033|NCT01844895|17645706|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
5109034|NCT01844895|17645706|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
5109035|NCT01844895|17645706|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
5109036|NCT01844895|17645706|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
5109037|NCT01844856|17645724|P2|Overall Study|Randomized but was a Screen Failure|1
5109038|NCT01844856|17645725|P1|Overall Study|Randomized but was a Screen Failure|0
5109039|NCT01844856|17645724|P2|Overall Study|Inadvertently Not Scheduled|0
5109040|NCT01844856|17645725|P1|Overall Study|Inadvertently Not Scheduled|1
5109041|NCT01844856|17645724|P2|Overall Study|Enterococcus Resistant|1
5109042|NCT01844856|17645725|P1|Overall Study|Enterococcus Resistant|0
5109043|NCT01844856|17645724|P2|Overall Study|Noncompliance|3
5109044|NCT01844856|17645725|P1|Overall Study|Noncompliance|2
5109045|NCT01844856|17645724|P2|Overall Study|Withdrawal by Subject|2
5109046|NCT01844856|17645725|P1|Overall Study|Withdrawal by Subject|3
5109047|NCT01844856|17645724|P2|Overall Study|Adverse Event|6
5109048|NCT01844856|17645725|P1|Overall Study|Adverse Event|3
5109049|NCT01844856|17645724|P2|Overall Study|Lost to Follow-up|3
5109050|NCT01844856|17645725|P1|Overall Study|Lost to Follow-up|15
5109051|NCT01844830|17645737|P2|Overall Study|Withdrawal by Subject|0
5109052|NCT01844830|17645738|P1|Overall Study|Withdrawal by Subject|1
5109053|NCT01844817|17645768|P2|Treatment|Other|3
5109054|NCT01844817|17645769|P1|Treatment|Other|0
5109055|NCT01844817|17645768|P2|Treatment|Lost to Follow-up|1
5109056|NCT01844817|17645769|P1|Treatment|Lost to Follow-up|0
5109057|NCT01844817|17645768|P2|Treatment|Death|8
5109058|NCT01844817|17645769|P1|Treatment|Death|10
5109059|NCT01844817|17645768|P2|Treatment|Withdrawal by Subject|6
5109060|NCT01844817|17645769|P1|Treatment|Withdrawal by Subject|10
5109061|NCT01844817|17645768|P2|Treatment|Adverse Event|9
5109062|NCT01844817|17645769|P1|Treatment|Adverse Event|17
5109063|NCT01844817|17645768|P2|Treatment|Progressive Disease|36
5109064|NCT01844817|17645769|P1|Treatment|Progressive Disease|27
5109065|NCT01844817|17645768|P2|Enrolled and Randomized|Withdrawal by Subject|3
5109066|NCT01844817|17645769|P1|Enrolled and Randomized|Withdrawal by Subject|2
5109067|NCT01844778|17645782|P3|Overall Study|Adverse Event|2
5109068|NCT01844778|17645783|P2|Overall Study|Adverse Event|2
5109069|NCT01844778|17645784|P1|Overall Study|Adverse Event|0
5109070|NCT01844778|17645782|P3|Overall Study|Withdrawal by Subject|0
5109071|NCT01844778|17645783|P2|Overall Study|Withdrawal by Subject|0
5109072|NCT01844778|17645784|P1|Overall Study|Withdrawal by Subject|2
5109073|NCT01844778|17645782|P3|Overall Study|Protocol deviation|2
5109074|NCT01844778|17645783|P2|Overall Study|Protocol deviation|1
5109075|NCT01844778|17645784|P1|Overall Study|Protocol deviation|0
5109076|NCT01844765|17645810|P2|Overall Study|Untreated|0
5109077|NCT01844765|17645811|P1|Overall Study|Untreated|1
5109078|NCT01844765|17645810|P2|Overall Study|Protocol Violation|0
5109079|NCT01844765|17645811|P1|Overall Study|Protocol Violation|1
5109080|NCT01844765|17645810|P2|Overall Study|Disease progression|0
5109081|NCT01844765|17645811|P1|Overall Study|Disease progression|1
5109082|NCT01844765|17645810|P2|Overall Study|Administrative problems|1
5109083|NCT01844765|17645811|P1|Overall Study|Administrative problems|1
5109084|NCT01844765|17645810|P2|Overall Study|Withdrawal by Subject|1
5109085|NCT01844765|17645811|P1|Overall Study|Withdrawal by Subject|0
5109086|NCT01844765|17645810|P2|Overall Study|Adverse Event|4
5109087|NCT01844765|17645811|P1|Overall Study|Adverse Event|5
5109088|NCT01844700|17645831|P2|Overall Study|stopped taking meds|1
5109089|NCT01844700|17645832|P1|Overall Study|stopped taking meds|0
5109090|NCT01844700|17645831|P2|Overall Study|Withdrawal by Subject|0
5109091|NCT01844700|17645832|P1|Overall Study|Withdrawal by Subject|1
5109092|NCT01844700|17645831|P2|Overall Study|refused medication switch|0
5109093|NCT01844700|17645832|P1|Overall Study|refused medication switch|1
5109094|NCT01844700|17645831|P2|Overall Study|Lack of Efficacy|0
5109095|NCT01844700|17645832|P1|Overall Study|Lack of Efficacy|1
5109096|NCT01844687|17645844|P1|Visit 4|Withdrawal by Subject|2
5109097|NCT01844687|17645844|P1|Visit 4|Lost to Follow-up|1
5109098|NCT01844687|17645844|P1|Visit 4|Pregnancy|1
5109099|NCT01844687|17645844|P1|Visit 3|child care problems|1
5109100|NCT01844687|17645844|P1|Visit 3|Withdrawal by Subject|3
5109101|NCT01844687|17645844|P1|Visit 3|Lost to Follow-up|1
5109102|NCT01844687|17645844|P1|Visit 2|Protocol Violation|1
5109103|NCT01844687|17645844|P1|Visit 2|Withdrawal by Subject|1
5109104|NCT01844687|17645844|P1|Visit 1|Lost to Follow-up|5
5109105|NCT01844687|17645844|P1|Visit 1|Protocol Violation|3
5109106|NCT01844583|17645905|P2|Overall Study|Didn't complete dosing;PK/ECG assessment|10
5109107|NCT01844583|17645906|P1|Overall Study|Didn't complete dosing;PK/ECG assessment|8
5109108|NCT01844531|17645938|P4|Overall Study|Withdrawal by Subject|0
5109109|NCT01844531|17645939|P3|Overall Study|Withdrawal by Subject|0
5109110|NCT01844531|17645940|P2|Overall Study|Withdrawal by Subject|1
5109111|NCT01844531|17645941|P1|Overall Study|Withdrawal by Subject|0
5109112|NCT01844518|17645971|P1|Long-Term Extension|Still in On-Going Study|149
5109113|NCT01844518|17645971|P1|Long-Term Extension|No Longer Met Study Criteria|1
5109114|NCT01844518|17645971|P1|Long-Term Extension|Adverse Event|1
5109115|NCT01844518|17645971|P1|Long-Term Extension|Lack of Efficacy|6
5109116|NCT01844518|17645971|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
5109117|NCT01844518|17645971|P1|Short-Term (ST) Period|Withdrawal of Consent|2
5109118|NCT01844518|17645971|P1|Short-Term (ST) Period|Lack of Efficacy|3
5109119|NCT01844518|17645971|P1|Short-Term (ST) Period|Adverse Event|3
5109120|NCT01844505|17645988|P3|Overall Study|Not Reported|1
5109121|NCT01844505|17645989|P2|Overall Study|Not Reported|0
5109122|NCT01844505|17645990|P1|Overall Study|Not Reported|0
5109123|NCT01844505|17645988|P3|Overall Study|Other Reasons|2
5109124|NCT01844505|17645989|P2|Overall Study|Other Reasons|2
5109125|NCT01844505|17645990|P1|Overall Study|Other Reasons|4
5109126|NCT01844505|17645988|P3|Overall Study|Subject no longer meets criteria|0
5109127|NCT01844505|17645989|P2|Overall Study|Subject no longer meets criteria|1
5109128|NCT01844505|17645990|P1|Overall Study|Subject no longer meets criteria|0
5109129|NCT01844505|17645988|P3|Overall Study|Poor/non-compliance|1
5109130|NCT01844505|17645989|P2|Overall Study|Poor/non-compliance|1
5109131|NCT01844505|17645990|P1|Overall Study|Poor/non-compliance|1
5109132|NCT01844505|17645988|P3|Overall Study|Maximum clinical benefit|2
5109133|NCT01844505|17645989|P2|Overall Study|Maximum clinical benefit|11
5109134|NCT01844505|17645990|P1|Overall Study|Maximum clinical benefit|8
5109135|NCT01844505|17645988|P3|Overall Study|Lost to Follow-up|0
5109136|NCT01844505|17645989|P2|Overall Study|Lost to Follow-up|0
5109137|NCT01844505|17645990|P1|Overall Study|Lost to Follow-up|1
5109138|NCT01844505|17645988|P3|Overall Study|Withdrawal by Subject|0
5109139|NCT01844505|17645989|P2|Overall Study|Withdrawal by Subject|3
5109140|NCT01844505|17645990|P1|Overall Study|Withdrawal by Subject|0
5109141|NCT01844505|17645988|P3|Overall Study|Subject request discontinue treatment|8
5109142|NCT01844505|17645989|P2|Overall Study|Subject request discontinue treatment|14
5109143|NCT01844505|17645990|P1|Overall Study|Subject request discontinue treatment|17
5109144|NCT01844505|17645988|P3|Overall Study|Adverse event unrelated to study drug|6
5109145|NCT01844505|17645989|P2|Overall Study|Adverse event unrelated to study drug|15
5109146|NCT01844505|17645990|P1|Overall Study|Adverse event unrelated to study drug|7
5109147|NCT01844505|17645988|P3|Overall Study|Death|1
5109148|NCT01844505|17645989|P2|Overall Study|Death|3
5109149|NCT01844505|17645990|P1|Overall Study|Death|1
5109150|NCT01844505|17645988|P3|Overall Study|Study drug toxicity|50
5109151|NCT01844505|17645989|P2|Overall Study|Study drug toxicity|131
5109152|NCT01844505|17645990|P1|Overall Study|Study drug toxicity|40
5109153|NCT01844505|17645988|P3|Overall Study|Disease progression|224
5109154|NCT01844505|17645989|P2|Overall Study|Disease progression|88
5109155|NCT01844505|17645990|P1|Overall Study|Disease progression|170
5109156|NCT01844375|17646084|P2|Overall Study|Protocol Violation|1
5109157|NCT01844375|17646085|P1|Overall Study|Protocol Violation|1
5109158|NCT01844284|17646097|P2|Overall Study|Lost to Follow-up|7
5109159|NCT01844284|17646098|P1|Overall Study|Lost to Follow-up|12
5109160|NCT01844115|17646317|P2|Overall Study|Pregnancy|1
5109161|NCT01844115|17646318|P1|Overall Study|Pregnancy|0
5109162|NCT01844115|17646317|P2|Overall Study|Lost to Follow-up|10
5109163|NCT01844115|17646318|P1|Overall Study|Lost to Follow-up|11
5109164|NCT01844115|17646317|P2|Overall Study|Withdrawal by Subject|11
5109165|NCT01844115|17646318|P1|Overall Study|Withdrawal by Subject|11
5109166|NCT01844115|17646317|P2|Overall Study|Protocol Violation|10
5109167|NCT01844115|17646318|P1|Overall Study|Protocol Violation|12
5109168|NCT01844115|17646317|P2|Overall Study|Lack of Efficacy|4
5109169|NCT01844115|17646318|P1|Overall Study|Lack of Efficacy|1
5109170|NCT01844115|17646317|P2|Overall Study|Adverse Event|22
5109171|NCT01844115|17646318|P1|Overall Study|Adverse Event|4
5109172|NCT01843972|17646336|P10|Overall Study|Withdrawal by Subject|0
5109173|NCT01843972|17646337|P9|Overall Study|Withdrawal by Subject|0
5109174|NCT01843972|17646338|P8|Overall Study|Withdrawal by Subject|0
5109175|NCT01843972|17646339|P7|Overall Study|Withdrawal by Subject|0
5109176|NCT01843972|17646340|P6|Overall Study|Withdrawal by Subject|0
5109177|NCT01843972|17646341|P5|Overall Study|Withdrawal by Subject|1
5109178|NCT01843972|17646342|P4|Overall Study|Withdrawal by Subject|0
5109179|NCT01843972|17646343|P3|Overall Study|Withdrawal by Subject|0
5109180|NCT01843972|17646344|P2|Overall Study|Withdrawal by Subject|0
5109181|NCT01843972|17646345|P1|Overall Study|Withdrawal by Subject|0
5109182|NCT01843933|17646415|P2|Overall Study|Data lost|4
5109183|NCT01843933|17646416|P1|Overall Study|Data lost|6
5109184|NCT01843842|17646435|P2|Overall Study|Do not meet inclusion criteria|1
5109185|NCT01843842|17646436|P1|Overall Study|Do not meet inclusion criteria|1
5109186|NCT01843803|17646458|P2|Overall Study|not a Veteran, did not see provider|3
5109187|NCT01843803|17646459|P1|Overall Study|not a Veteran, did not see provider|1
5109188|NCT01843777|17646473|P2|Overall Study|Withdrawal by Subject|0
5109189|NCT01843777|17646474|P1|Overall Study|Withdrawal by Subject|1
5109190|NCT01843673|17646499|P1|Overall Study|Withdrawal by Subject|4
5109191|NCT01843673|17646499|P1|Overall Study|Lack of Efficacy|2
5109192|NCT01843660|17646511|P1|Overall Study|Other|30
5109193|NCT01843374|17646552|P2|Overall Study|Withdrawing due to Other reason|46
5109194|NCT01843374|17646553|P1|Overall Study|Withdrawing due to Other reason|20
5109195|NCT01843374|17646552|P2|Overall Study|Withdrawal by Subject|20
5109196|NCT01843374|17646553|P1|Overall Study|Withdrawal by Subject|14
5109197|NCT01843374|17646552|P2|Overall Study|Death|313
5109198|NCT01843374|17646553|P1|Overall Study|Death|155
5109199|NCT01843348|17646580|P3|Overall Study|Various reasons|6
5109200|NCT01843348|17646581|P2|Overall Study|Various reasons|9
5109201|NCT01843348|17646582|P1|Overall Study|Various reasons|4
5109202|NCT01843348|17646580|P3|Overall Study|Graft loss/retransplantation|11
5109203|NCT01843348|17646581|P2|Overall Study|Graft loss/retransplantation|8
5109204|NCT01843348|17646582|P1|Overall Study|Graft loss/retransplantation|5
5109205|NCT01843348|17646580|P3|Overall Study|Death|4
5109206|NCT01843348|17646581|P2|Overall Study|Death|3
5109207|NCT01843348|17646582|P1|Overall Study|Death|5
5109208|NCT01843348|17646580|P3|Overall Study|Lost to Follow-up|2
5109209|NCT01843348|17646581|P2|Overall Study|Lost to Follow-up|4
5109210|NCT01843348|17646582|P1|Overall Study|Lost to Follow-up|5
5109211|NCT01843348|17646580|P3|Overall Study|Withdrawal by Subject|18
5109212|NCT01843348|17646581|P2|Overall Study|Withdrawal by Subject|16
5109213|NCT01843348|17646582|P1|Overall Study|Withdrawal by Subject|4
5109214|NCT01843205|17646622|P2|First Treatment (11 Days)|Withdrawal by Subject|0
5109215|NCT01843205|17646623|P1|First Treatment (11 Days)|Withdrawal by Subject|1
5109216|NCT01843192|17646684|P3|Overall Study|Intra-operative exclusions per protocol|2
5109217|NCT01843192|17646685|P2|Overall Study|Intra-operative exclusions per protocol|6
5109218|NCT01843192|17646686|P1|Overall Study|Intra-operative exclusions per protocol|2
5109219|NCT01843062|17646717|P2|Overall Study|Lost to Follow-up|4
5109220|NCT01843062|17646718|P1|Overall Study|Lost to Follow-up|2
5109221|NCT01843062|17646717|P2|Overall Study|Death|2
5109222|NCT01843062|17646718|P1|Overall Study|Death|1
5109223|NCT01843062|17646717|P2|Overall Study|Withdrawal by Subject|3
5109224|NCT01843062|17646718|P1|Overall Study|Withdrawal by Subject|12
5109225|NCT01843062|17646717|P2|Overall Study|Incorrect randomisation|0
5109226|NCT01843062|17646718|P1|Overall Study|Incorrect randomisation|1
5109227|NCT01843062|17646717|P2|Overall Study|Adverse Event|0
5109228|NCT01843062|17646718|P1|Overall Study|Adverse Event|2
5109229|NCT01843062|17646717|P2|Overall Study|Pregnancy|0
5109230|NCT01843062|17646718|P1|Overall Study|Pregnancy|1
5109231|NCT01843062|17646717|P2|Overall Study|New treatment following progression|0
5109232|NCT01843062|17646718|P1|Overall Study|New treatment following progression|2
5109233|NCT01843062|17646717|P2|Overall Study|Protocol Violation|0
5109234|NCT01843062|17646718|P1|Overall Study|Protocol Violation|1
5109235|NCT01842958|17646732|P2|Overall Study|Lost to Follow-up|1
5109236|NCT01842958|17646733|P1|Overall Study|Lost to Follow-up|1
5109237|NCT01842633|17646808|P3|Overall Study|Technical issues|0
5109238|NCT01842633|17646809|P2|Overall Study|Technical issues|0
5109239|NCT01842633|17646810|P1|Overall Study|Technical issues|1
5109240|NCT01842633|17646808|P3|Overall Study|Withdrawal by Subject|0
5109241|NCT01842633|17646809|P2|Overall Study|Withdrawal by Subject|1
5109242|NCT01842633|17646810|P1|Overall Study|Withdrawal by Subject|0
5109243|NCT01842633|17646808|P3|Overall Study|Adverse Event|0
5109244|NCT01842633|17646809|P2|Overall Study|Adverse Event|1
5109245|NCT01842633|17646810|P1|Overall Study|Adverse Event|1
5109246|NCT01842633|17646808|P3|Overall Study|Screen Failure|0
5109247|NCT01842633|17646809|P2|Overall Study|Screen Failure|0
5109248|NCT01842633|17646810|P1|Overall Study|Screen Failure|1
5109249|NCT01842620|17646857|P2|Period 1|Withdrawal by Subject|0
5109250|NCT01842620|17646858|P1|Period 1|Withdrawal by Subject|1
5109251|NCT01842607|17646874|P1|Overall Study|Withdrawal by Subject|14
5109252|NCT01842607|17646874|P1|Overall Study|Physician Decision|9
5109253|NCT01842607|17646874|P1|Overall Study|Lost to Follow-up|3
5109254|NCT01842607|17646874|P1|Overall Study|Protocol defined stopping criteria|2
5109255|NCT01842607|17646874|P1|Overall Study|Protocol Violation|8
5109256|NCT01842607|17646874|P1|Overall Study|Lack of Efficacy|19
5109257|NCT01842607|17646874|P1|Overall Study|Adverse Event|11
5109258|NCT01842581|17646900|P2|Overall Study|Other than specified|1
5109259|NCT01842581|17646901|P1|Overall Study|Other than specified|3
5109260|NCT01842581|17646900|P2|Overall Study|Withdrawal by Subject|7
5109261|NCT01842581|17646901|P1|Overall Study|Withdrawal by Subject|5
5109262|NCT01842581|17646900|P2|Overall Study|Lost to Follow-up|5
5109263|NCT01842581|17646901|P1|Overall Study|Lost to Follow-up|2
5109264|NCT01842581|17646900|P2|Overall Study|Liver transplant|0
5109265|NCT01842581|17646901|P1|Overall Study|Liver transplant|2
5109266|NCT01842581|17646900|P2|Overall Study|HE breakthrough|13
5109267|NCT01842581|17646901|P1|Overall Study|HE breakthrough|26
5109268|NCT01842581|17646900|P2|Overall Study|Adverse Event|4
5109269|NCT01842581|17646901|P1|Overall Study|Adverse Event|6
5109270|NCT01842438|17646925|P2|T2: 6month Follow-up|Death|1
5109271|NCT01842438|17646926|P1|T2: 6month Follow-up|Death|0
5109272|NCT01842438|17646925|P2|T2: 6month Follow-up|Withdrawal by Subject|3
5109273|NCT01842438|17646926|P1|T2: 6month Follow-up|Withdrawal by Subject|4
5109274|NCT01842438|17646925|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
5109275|NCT01842438|17646926|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
5109276|NCT01842334|17646940|P2|Overall Study|Moved away mid-study|1
5109277|NCT01842334|17646941|P1|Overall Study|Moved away mid-study|0
5109278|NCT01842334|17646940|P2|Overall Study|Withdrawal by Subject|3
5109279|NCT01842334|17646941|P1|Overall Study|Withdrawal by Subject|3
5109280|NCT01842308|17646952|P5|Overall Study|Withdrawal by Subject|1
5109281|NCT01842308|17646953|P4|Overall Study|Withdrawal by Subject|0
5109282|NCT01842308|17646954|P3|Overall Study|Withdrawal by Subject|0
5109283|NCT01842308|17646955|P2|Overall Study|Withdrawal by Subject|0
5109284|NCT01842308|17646956|P1|Overall Study|Withdrawal by Subject|0
5109285|NCT01841970|17646975|P1|Overall Study|Lost to Follow-up|8
5109286|NCT01841970|17646975|P1|Overall Study|Physician Decision|2
5109287|NCT01841970|17646975|P1|Overall Study|Withdrawal by Subject|1
5109288|NCT01841762|17646999|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
5109289|NCT01841762|17646999|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
5109290|NCT01841762|17646999|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
5109291|NCT01841762|17646999|P1|Post-Treatment Safety Follow-Up Period|Death|1
5109292|NCT01841762|17646999|P1|Treatment Period|Other, including non-compliance|5
5109293|NCT01841762|17646999|P1|Treatment Period|Physician Decision|2
5109294|NCT01841762|17646999|P1|Treatment Period|Lost to Follow-up|1
5109295|NCT01841762|17646999|P1|Treatment Period|Withdrawal by Subject|7
5109296|NCT01841762|17646999|P1|Treatment Period|Death|1
5109297|NCT01841762|17646999|P1|Treatment Period|Adverse Event|16
5109298|NCT01841762|17646999|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
5109299|NCT01841697|17647023|P2|Overall Study|Withdrawal by Subject|16
5109300|NCT01841697|17647024|P1|Overall Study|Withdrawal by Subject|16
5109301|NCT01841697|17647023|P2|Overall Study|Lost to Follow-up|1
5109302|NCT01841697|17647024|P1|Overall Study|Lost to Follow-up|4
5109303|NCT01841697|17647023|P2|Overall Study|Death|1
5109304|NCT01841697|17647024|P1|Overall Study|Death|0
5109305|NCT01841593|17647064|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
5109306|NCT01841593|17647065|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
5109307|NCT01841593|17647064|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
5109308|NCT01841593|17647065|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
5109309|NCT01841567|17647081|P1|Overall Study|Adverse Event|3
5109310|NCT01841554|17647086|P1|Overall Study|Study exit due to secondary intervention|6
5109311|NCT01841554|17647086|P1|Overall Study|Discontinued Follow Up|5
5109312|NCT01841554|17647086|P1|Overall Study|No Implantation|1
5109313|NCT01841554|17647086|P1|Overall Study|Death|7
5109314|NCT01841073|17647135|P2|Overall Study|Lost to Follow-up|2
5109315|NCT01841073|17647136|P1|Overall Study|Lost to Follow-up|0
5109316|NCT01841073|17647135|P2|Overall Study|Physician Decision|0
5109317|NCT01841073|17647136|P1|Overall Study|Physician Decision|1
5109318|NCT01841073|17647135|P2|Overall Study|Adverse Event|1
5109319|NCT01841073|17647136|P1|Overall Study|Adverse Event|1
5109320|NCT01840943|17647158|P2|Overall Study|Lost to Follow-up|4
5109321|NCT01840943|17647159|P1|Overall Study|Lost to Follow-up|4
5109322|NCT01840943|17647158|P2|Overall Study|Physician Decision|2
5109323|NCT01840943|17647159|P1|Overall Study|Physician Decision|4
5109324|NCT01840943|17647158|P2|Overall Study|Withdrawal by Subject|6
5109325|NCT01840943|17647159|P1|Overall Study|Withdrawal by Subject|5
5109326|NCT01840605|17647208|P2|Overall Study|Physician Decision|1
5109327|NCT01840605|17647209|P1|Overall Study|Physician Decision|2
5109328|NCT01840605|17647208|P2|Overall Study|Adverse Event|1
5109329|NCT01840605|17647209|P1|Overall Study|Adverse Event|0
5109330|NCT01840410|17647223|P2|Overall Study|Adverse Event|1
5109331|NCT01840410|17647224|P1|Overall Study|Adverse Event|1
5109332|NCT01840410|17647223|P2|Overall Study|Withdrawal by Subject|1
5109333|NCT01840410|17647224|P1|Overall Study|Withdrawal by Subject|2
5109334|NCT01840410|17647223|P2|Overall Study|Lost to Follow-up|0
5109335|NCT01840410|17647224|P1|Overall Study|Lost to Follow-up|1
5109336|NCT01840410|17647223|P2|Overall Study|Protocol deviation|0
5109337|NCT01840410|17647224|P1|Overall Study|Protocol deviation|1
5109338|NCT01840410|17647223|P2|Overall Study|Pregnancy|0
5109339|NCT01840410|17647224|P1|Overall Study|Pregnancy|1
5109340|NCT01840410|17647223|P2|Overall Study|Physician Decision|2
5109341|NCT01840410|17647224|P1|Overall Study|Physician Decision|1
5109342|NCT01840228|17647273|P2|Overall Study|Lost to Follow-up|1
5109343|NCT01840228|17647274|P1|Overall Study|Lost to Follow-up|1
5109344|NCT01840163|17647302|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
5109345|NCT01840163|17647303|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
5109346|NCT01840163|17647302|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
5109347|NCT01840163|17647303|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
5109348|NCT01840163|17647302|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
5109349|NCT01840163|17647303|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
5109350|NCT01839916|17647348|P1|Overall Study|Graft Failure|1
5109351|NCT01839916|17647348|P1|Overall Study|GVHD|2
5109352|NCT01839916|17647348|P1|Overall Study|Relapse|12
5109353|NCT01839916|17647348|P1|Overall Study|Physician Decision|17
5109354|NCT01839916|17647348|P1|Overall Study|Death|9
5109355|NCT01839656|17647399|P2|Overall Study|Adverse Event|0
5109356|NCT01839656|17647400|P1|Overall Study|Adverse Event|1
5109357|NCT01839656|17647399|P2|Overall Study|Early study closure|11
5109358|NCT01839656|17647400|P1|Overall Study|Early study closure|0
5109359|NCT01839656|17647399|P2|Overall Study|Adverse event, serious fatal|4
5109360|NCT01839656|17647400|P1|Overall Study|Adverse event, serious fatal|1
5109361|NCT01839656|17647399|P2|Overall Study|Withdrawal by Subject|1
5109362|NCT01839656|17647400|P1|Overall Study|Withdrawal by Subject|1
5109363|NCT01839487|17647460|P6|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
5109364|NCT01839487|17647461|P5|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
5109365|NCT01839487|17647462|P4|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
5109366|NCT01839487|17647463|P3|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
5109367|NCT01839487|17647464|P2|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
5109368|NCT01839487|17647465|P1|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
5109369|NCT01839487|17647460|P6|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
5109370|NCT01839487|17647461|P5|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
5109371|NCT01839487|17647462|P4|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
5109372|NCT01839487|17647463|P3|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5109373|NCT01839487|17647464|P2|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5109374|NCT01839487|17647465|P1|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5109375|NCT01839487|17647460|P6|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5109376|NCT01839487|17647461|P5|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
5109377|NCT01839487|17647462|P4|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5109378|NCT01839487|17647463|P3|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
5109379|NCT01839487|17647464|P2|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5109380|NCT01839487|17647465|P1|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5109381|NCT01839487|17647460|P6|Phase 2 (Maximum Exposure:935 Days)|Death|32
5109382|NCT01839487|17647461|P5|Phase 2 (Maximum Exposure:935 Days)|Death|71
5109383|NCT01839487|17647462|P4|Phase 2 (Maximum Exposure:935 Days)|Death|49
5109384|NCT01839487|17647463|P3|Phase 2 (Maximum Exposure:935 Days)|Death|46
5109385|NCT01839487|17647464|P2|Phase 2 (Maximum Exposure:935 Days)|Death|0
5109386|NCT01839487|17647465|P1|Phase 2 (Maximum Exposure:935 Days)|Death|0
5109387|NCT01839487|17647460|P6|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
5109388|NCT01839487|17647461|P5|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
5109389|NCT01839487|17647462|P4|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
5109390|NCT01839487|17647463|P3|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
5109391|NCT01839487|17647464|P2|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
5109392|NCT01839487|17647465|P1|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
5109393|NCT01839487|17647460|P6|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5109394|NCT01839487|17647461|P5|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5109395|NCT01839487|17647462|P4|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5109396|NCT01839487|17647463|P3|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5109397|NCT01839487|17647464|P2|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5109398|NCT01839487|17647465|P1|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
5109399|NCT01839487|17647460|P6|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5109400|NCT01839487|17647461|P5|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5109401|NCT01839487|17647462|P4|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5109402|NCT01839487|17647463|P3|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5109403|NCT01839487|17647464|P2|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
5109404|NCT01839487|17647465|P1|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5109405|NCT01839487|17647460|P6|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5109406|NCT01839487|17647461|P5|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5109407|NCT01839487|17647462|P4|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5109408|NCT01839487|17647463|P3|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5109409|NCT01839487|17647464|P2|Run-in Phase (Maximum Exposure:295 Days)|Death|6
5109410|NCT01839487|17647465|P1|Run-in Phase (Maximum Exposure:295 Days)|Death|14
5109411|NCT01839487|17647460|P6|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5109412|NCT01839487|17647461|P5|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5109413|NCT01839487|17647462|P4|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5109414|NCT01839487|17647463|P3|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5109415|NCT01839487|17647464|P2|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5109416|NCT01839487|17647465|P1|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
5109417|NCT01839279|17647516|P3|Overall Study|Classified as 'Other'|0
5109418|NCT01839279|17647517|P2|Overall Study|Classified as 'Other'|0
5109419|NCT01839279|17647518|P1|Overall Study|Classified as 'Other'|5
5109420|NCT01839279|17647516|P3|Overall Study|Withdrawal by Subject|1
5109421|NCT01839279|17647517|P2|Overall Study|Withdrawal by Subject|1
5109422|NCT01839279|17647518|P1|Overall Study|Withdrawal by Subject|4
5109423|NCT01839279|17647516|P3|Overall Study|Adverse Event|1
5109424|NCT01839279|17647517|P2|Overall Study|Adverse Event|1
5109425|NCT01839279|17647518|P1|Overall Study|Adverse Event|4
5109426|NCT01839188|17647537|P1|Overall Study|Withdrawal by Subject|1
5109427|NCT01838941|17647609|P1|Overall Study|Withdrawal by Subject|1
5109428|NCT01838941|17647609|P1|Overall Study|Adverse Event|1
5109429|NCT01838876|17647614|P1|Overall Study|Did not meet eligibility criteria|78
5109430|NCT01838876|17647614|P1|Overall Study|Reason not Specified|7
5109431|NCT01838876|17647614|P1|Overall Study|Study or Site Terminated by Sponsor|1
5109432|NCT01838876|17647614|P1|Overall Study|Lost to Follow-up|21
5109433|NCT01838876|17647614|P1|Overall Study|Withdrawal of Consent|33
5109434|NCT01838876|17647614|P1|Overall Study|Protocol Violation|34
5109435|NCT01838876|17647614|P1|Overall Study|Insufficient Therapeutic Response|10
5109436|NCT01838876|17647614|P1|Overall Study|Adverse Event|49
5109437|NCT01838694|17647723|P2|Overall Study|Adverse Event|1
5109438|NCT01838694|17647724|P1|Overall Study|Adverse Event|0
5109439|NCT01838681|17647733|P4|Period B/A+|Administrative or other reasons|28
5109440|NCT01838681|17647734|P3|Period B/A+|Administrative or other reasons|10
5109441|NCT01838681|17647735|P2|Period B/A+|Administrative or other reasons|6
5109442|NCT01838681|17647736|P1|Period B/A+|Administrative or other reasons|0
5109443|NCT01838681|17647733|P4|Period B/A+|Withdrawal before treatment|0
5109444|NCT01838681|17647734|P3|Period B/A+|Withdrawal before treatment|0
5109445|NCT01838681|17647735|P2|Period B/A+|Withdrawal before treatment|1
5109446|NCT01838681|17647736|P1|Period B/A+|Withdrawal before treatment|0
5109447|NCT01838681|17647733|P4|Period B/A+|Lost to Follow-up|11
5109448|NCT01838681|17647734|P3|Period B/A+|Lost to Follow-up|5
5109449|NCT01838681|17647735|P2|Period B/A+|Lost to Follow-up|2
5109450|NCT01838681|17647736|P1|Period B/A+|Lost to Follow-up|0
5109451|NCT01838681|17647733|P4|Period B/A+|Non-compliance with IMP|3
5109452|NCT01838681|17647734|P3|Period B/A+|Non-compliance with IMP|3
5109453|NCT01838681|17647735|P2|Period B/A+|Non-compliance with IMP|2
5109454|NCT01838681|17647736|P1|Period B/A+|Non-compliance with IMP|0
5109455|NCT01838681|17647733|P4|Period B/A+|Protocol Violation|6
5109456|NCT01838681|17647734|P3|Period B/A+|Protocol Violation|4
5109457|NCT01838681|17647735|P2|Period B/A+|Protocol Violation|1
5109458|NCT01838681|17647736|P1|Period B/A+|Protocol Violation|0
5109459|NCT01838681|17647733|P4|Period B/A+|Withdrawal by Subject|47
5109460|NCT01838681|17647734|P3|Period B/A+|Withdrawal by Subject|35
5109461|NCT01838681|17647735|P2|Period B/A+|Withdrawal by Subject|28
5109462|NCT01838681|17647736|P1|Period B/A+|Withdrawal by Subject|0
5109463|NCT01838681|17647733|P4|Period B/A+|Lack of Efficacy|6
5109464|NCT01838681|17647734|P3|Period B/A+|Lack of Efficacy|11
5109465|NCT01838681|17647735|P2|Period B/A+|Lack of Efficacy|9
5109466|NCT01838681|17647736|P1|Period B/A+|Lack of Efficacy|0
5109467|NCT01838681|17647733|P4|Period B/A+|Adverse Event|16
5109468|NCT01838681|17647734|P3|Period B/A+|Adverse Event|27
5109469|NCT01838681|17647735|P2|Period B/A+|Adverse Event|13
5109470|NCT01838681|17647736|P1|Period B/A+|Adverse Event|0
5109471|NCT01838681|17647733|P4|Period A|Administrative or other reasons|0
5109472|NCT01838681|17647734|P3|Period A|Administrative or other reasons|0
5109473|NCT01838681|17647735|P2|Period A|Administrative or other reasons|0
5109474|NCT01838681|17647736|P1|Period A|Administrative or other reasons|17
5109475|NCT01838681|17647733|P4|Period A|Withdrawal before treatment|0
5109476|NCT01838681|17647734|P3|Period A|Withdrawal before treatment|0
5109477|NCT01838681|17647735|P2|Period A|Withdrawal before treatment|0
5109478|NCT01838681|17647736|P1|Period A|Withdrawal before treatment|4
5109479|NCT01838681|17647733|P4|Period A|Lost to Follow-up|0
5109480|NCT01838681|17647734|P3|Period A|Lost to Follow-up|0
5109481|NCT01838681|17647735|P2|Period A|Lost to Follow-up|0
5109482|NCT01838681|17647736|P1|Period A|Lost to Follow-up|4
5109483|NCT01838681|17647733|P4|Period A|Non-compliance with IMP|0
5109484|NCT01838681|17647734|P3|Period A|Non-compliance with IMP|0
5109485|NCT01838681|17647735|P2|Period A|Non-compliance with IMP|0
5109486|NCT01838681|17647736|P1|Period A|Non-compliance with IMP|6
5109487|NCT01838681|17647733|P4|Period A|Protocol Violation|0
5109488|NCT01838681|17647734|P3|Period A|Protocol Violation|0
5109489|NCT01838681|17647735|P2|Period A|Protocol Violation|0
5109490|NCT01838681|17647736|P1|Period A|Protocol Violation|16
5109491|NCT01838681|17647733|P4|Period A|Withdrawal by Subject|0
5109492|NCT01838681|17647734|P3|Period A|Withdrawal by Subject|0
5109493|NCT01838681|17647735|P2|Period A|Withdrawal by Subject|0
5109494|NCT01838681|17647736|P1|Period A|Withdrawal by Subject|70
5109495|NCT01838681|17647733|P4|Period A|Early response|0
5109496|NCT01838681|17647734|P3|Period A|Early response|0
5109497|NCT01838681|17647735|P2|Period A|Early response|0
5109498|NCT01838681|17647736|P1|Period A|Early response|148
5109499|NCT01838681|17647733|P4|Period A|Lack of Efficacy|0
5109500|NCT01838681|17647734|P3|Period A|Lack of Efficacy|0
5109501|NCT01838681|17647735|P2|Period A|Lack of Efficacy|0
5109502|NCT01838681|17647736|P1|Period A|Lack of Efficacy|21
5109503|NCT01838681|17647733|P4|Period A|Adverse Event|0
5109504|NCT01838681|17647734|P3|Period A|Adverse Event|0
5109505|NCT01838681|17647735|P2|Period A|Adverse Event|0
5109506|NCT01838681|17647736|P1|Period A|Adverse Event|39
5109507|NCT01838642|17647844|P1|Overall Study|Died on study|1
5109508|NCT01838616|17647857|P2|Pick-up Arm|Technical problems|0
5109509|NCT01838616|17647858|P1|Pick-up Arm|Technical problems|1
5109510|NCT01838616|17647857|P2|Pick-up Arm|Withdrawal by Subject|0
5109511|NCT01838616|17647858|P1|Pick-up Arm|Withdrawal by Subject|1
5109512|NCT01838616|17647857|P2|Pick-up Arm|Adverse Event|0
5109513|NCT01838616|17647858|P1|Pick-up Arm|Adverse Event|9
5109514|NCT01838616|17647857|P2|Pick-up Arm|Lack of Efficacy|0
5109515|NCT01838616|17647858|P1|Pick-up Arm|Lack of Efficacy|4
5109516|NCT01838616|17647857|P2|Continuation Period|Technical problems|1
5109517|NCT01838616|17647858|P1|Continuation Period|Technical problems|0
5109518|NCT01838616|17647857|P2|Continuation Period|Withdrawal by Subject|4
5109519|NCT01838616|17647858|P1|Continuation Period|Withdrawal by Subject|0
5109520|NCT01838616|17647857|P2|Continuation Period|Lost to Follow-up|0
5109521|NCT01838616|17647858|P1|Continuation Period|Lost to Follow-up|1
5109522|NCT01838616|17647857|P2|Continuation Period|Protocol Violation|0
5109523|NCT01838616|17647858|P1|Continuation Period|Protocol Violation|2
5109524|NCT01838616|17647857|P2|Continuation Period|Adverse Event|4
5109525|NCT01838616|17647858|P1|Continuation Period|Adverse Event|8
5109526|NCT01838616|17647857|P2|Continuation Period|Lack of Efficacy|5
5109527|NCT01838616|17647858|P1|Continuation Period|Lack of Efficacy|3
5109528|NCT01838616|17647857|P2|Titration Period|Protocol Violation|1
5109529|NCT01838616|17647858|P1|Titration Period|Protocol Violation|0
5109530|NCT01838616|17647857|P2|Titration Period|Other|0
5109531|NCT01838616|17647858|P1|Titration Period|Other|1
5109532|NCT01838616|17647857|P2|Titration Period|Technical problems|0
5109533|NCT01838616|17647858|P1|Titration Period|Technical problems|1
5109534|NCT01838616|17647857|P2|Titration Period|Withdrawal by Subject|5
5109535|NCT01838616|17647858|P1|Titration Period|Withdrawal by Subject|5
5109536|NCT01838616|17647857|P2|Titration Period|Lack of Efficacy|12
5109537|NCT01838616|17647858|P1|Titration Period|Lack of Efficacy|5
5109538|NCT01838616|17647857|P2|Titration Period|Adverse Event|48
5109539|NCT01838616|17647858|P1|Titration Period|Adverse Event|18
5109540|NCT01838590|17647929|P2|Overall Study|Lost to Follow-up|1
5109541|NCT01838590|17647930|P1|Overall Study|Lost to Follow-up|0
5109542|NCT01838590|17647929|P2|Overall Study|Lack of Efficacy|4
5109543|NCT01838590|17647930|P1|Overall Study|Lack of Efficacy|12
5109544|NCT01838499|17647954|P2|Overall Study|Withdrawal by Subject|9
5109545|NCT01838499|17647955|P1|Overall Study|Withdrawal by Subject|19
5109546|NCT01838499|17647954|P2|Overall Study|Adverse Event|1
5109547|NCT01838499|17647955|P1|Overall Study|Adverse Event|2
5109548|NCT01838499|17647954|P2|Overall Study|Lack of Efficacy|2
5109549|NCT01838499|17647955|P1|Overall Study|Lack of Efficacy|1
5109550|NCT01838499|17647954|P2|Overall Study|Lost to Follow-up|4
5109551|NCT01838499|17647955|P1|Overall Study|Lost to Follow-up|2
5109552|NCT01838499|17647954|P2|Overall Study|Protocol Violation|1
5109553|NCT01838499|17647955|P1|Overall Study|Protocol Violation|0
5109554|NCT01838447|17647967|P2|Overall Study|Withdrawal by Subject|1
5109555|NCT01838447|17647968|P1|Overall Study|Withdrawal by Subject|1
5109556|NCT01838447|17647967|P2|Overall Study|Change in surgical plan|2
5109557|NCT01838447|17647968|P1|Overall Study|Change in surgical plan|1
5109558|NCT01838213|17648016|P2|Overall Study|Ineligible|191
5109559|NCT01838213|17648017|P1|Overall Study|Ineligible|166
5109560|NCT01838200|17648025|P2|Overall Study|Progressive disease|0
5109561|NCT01838200|17648026|P1|Overall Study|Progressive disease|3
5109562|NCT01838200|17648025|P2|Overall Study|Adverse Event|2
5109563|NCT01838200|17648026|P1|Overall Study|Adverse Event|0
5109564|NCT01838044|17648038|P2|Overall Study|Lost to Follow-up|2
5109565|NCT01838044|17648039|P1|Overall Study|Lost to Follow-up|0
5109566|NCT01838044|17648038|P2|Overall Study|Medication error without associated AE|1
5109567|NCT01838044|17648039|P1|Overall Study|Medication error without associated AE|0
5109568|NCT01838044|17648038|P2|Overall Study|Insufficient clinical response|2
5109569|NCT01838044|17648039|P1|Overall Study|Insufficient clinical response|1
5109570|NCT01838044|17648038|P2|Overall Study|Withdrawal by Subject|2
5109571|NCT01838044|17648039|P1|Overall Study|Withdrawal by Subject|0
5109572|NCT01838044|17648038|P2|Overall Study|Protocol Violation|3
5109573|NCT01838044|17648039|P1|Overall Study|Protocol Violation|3
5109574|NCT01838044|17648038|P2|Overall Study|Adverse Event|6
5109575|NCT01838044|17648039|P1|Overall Study|Adverse Event|4
5109576|NCT01837966|17648072|P2|Overall Study|Withdrawal by Subject|1
5109577|NCT01837966|17648073|P1|Overall Study|Withdrawal by Subject|2
5109578|NCT01837823|17648079|P1|Overall Study|Lost to Follow-up|6
5109579|NCT01837797|17648110|P5|Period 3|Other|2
5109580|NCT01837797|17648111|P4|Period 3|Other|0
5109581|NCT01837797|17648112|P3|Period 3|Other|0
5109582|NCT01837797|17648113|P2|Period 3|Other|0
5109583|NCT01837797|17648114|P1|Period 3|Other|0
5109584|NCT01837797|17648110|P5|Period 3|Administrative reasons|20
5109585|NCT01837797|17648111|P4|Period 3|Administrative reasons|0
5109586|NCT01837797|17648112|P3|Period 3|Administrative reasons|0
5109587|NCT01837797|17648113|P2|Period 3|Administrative reasons|0
5109588|NCT01837797|17648114|P1|Period 3|Administrative reasons|0
5109589|NCT01837797|17648110|P5|Period 3|Adverse Event|1
5109590|NCT01837797|17648111|P4|Period 3|Adverse Event|0
5109591|NCT01837797|17648112|P3|Period 3|Adverse Event|0
5109592|NCT01837797|17648113|P2|Period 3|Adverse Event|0
5109593|NCT01837797|17648114|P1|Period 3|Adverse Event|0
5109594|NCT01837797|17648110|P5|Period 2|Adverse Event|0
5109595|NCT01837797|17648111|P4|Period 2|Adverse Event|1
5109596|NCT01837797|17648112|P3|Period 2|Adverse Event|0
5109597|NCT01837797|17648113|P2|Period 2|Adverse Event|0
5109598|NCT01837797|17648114|P1|Period 2|Adverse Event|0
5109599|NCT01837797|17648110|P5|Period 2|Administrative or other reasons|0
5109600|NCT01837797|17648111|P4|Period 2|Administrative or other reasons|4
5109601|NCT01837797|17648112|P3|Period 2|Administrative or other reasons|2
5109602|NCT01837797|17648113|P2|Period 2|Administrative or other reasons|5
5109603|NCT01837797|17648114|P1|Period 2|Administrative or other reasons|0
5109604|NCT01837797|17648110|P5|Period 1|Other|0
5109605|NCT01837797|17648111|P4|Period 1|Other|0
5109606|NCT01837797|17648112|P3|Period 1|Other|0
5109607|NCT01837797|17648113|P2|Period 1|Other|0
5109608|NCT01837797|17648114|P1|Period 1|Other|10
5109609|NCT01837797|17648110|P5|Period 1|Withdrawal of consent before treatment|0
5109610|NCT01837797|17648111|P4|Period 1|Withdrawal of consent before treatment|0
5109611|NCT01837797|17648112|P3|Period 1|Withdrawal of consent before treatment|0
5109612|NCT01837797|17648113|P2|Period 1|Withdrawal of consent before treatment|0
5109613|NCT01837797|17648114|P1|Period 1|Withdrawal of consent before treatment|1
5109614|NCT01837797|17648110|P5|Period 1|Administrative reasons|0
5109615|NCT01837797|17648111|P4|Period 1|Administrative reasons|0
5109616|NCT01837797|17648112|P3|Period 1|Administrative reasons|0
5109617|NCT01837797|17648113|P2|Period 1|Administrative reasons|0
5109618|NCT01837797|17648114|P1|Period 1|Administrative reasons|76
5109619|NCT01837797|17648110|P5|Period 1|Withdrawal by Subject|0
5109620|NCT01837797|17648111|P4|Period 1|Withdrawal by Subject|0
5109621|NCT01837797|17648112|P3|Period 1|Withdrawal by Subject|0
5109622|NCT01837797|17648113|P2|Period 1|Withdrawal by Subject|0
5109623|NCT01837797|17648114|P1|Period 1|Withdrawal by Subject|6
5109624|NCT01837797|17648110|P5|Period 1|Adverse Event|0
5109625|NCT01837797|17648111|P4|Period 1|Adverse Event|0
5109626|NCT01837797|17648112|P3|Period 1|Adverse Event|0
5109627|NCT01837797|17648113|P2|Period 1|Adverse Event|0
5109628|NCT01837797|17648114|P1|Period 1|Adverse Event|9
5109629|NCT01837719|17648149|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
5109630|NCT01837719|17648149|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
5109631|NCT01837680|17648218|P2|Overall Study|switched to oral hypoglycemic or diet|4
5109632|NCT01837680|17648219|P1|Overall Study|switched to oral hypoglycemic or diet|2
5109633|NCT01837680|17648218|P2|Overall Study|allergic reaction|0
5109634|NCT01837680|17648219|P1|Overall Study|allergic reaction|6
5109635|NCT01837680|17648218|P2|Overall Study|lack of insurance|2
5109636|NCT01837680|17648219|P1|Overall Study|lack of insurance|0
5109637|NCT01837680|17648218|P2|Overall Study|Lost to Follow-up|2
5109638|NCT01837680|17648219|P1|Overall Study|Lost to Follow-up|2
5109639|NCT01836549|17648353|P7|Overall Study|Patient inevaluable to start therapy|1
5109640|NCT01836549|17648354|P6|Overall Study|Patient inevaluable to start therapy|0
5109641|NCT01836549|17648355|P5|Overall Study|Patient inevaluable to start therapy|0
5109642|NCT01836549|17648356|P4|Overall Study|Patient inevaluable to start therapy|0
5109643|NCT01836549|17648357|P3|Overall Study|Patient inevaluable to start therapy|0
5109644|NCT01836549|17648358|P2|Overall Study|Patient inevaluable to start therapy|0
5109645|NCT01836549|17648359|P1|Overall Study|Patient inevaluable to start therapy|0
5109646|NCT01836549|17648353|P7|Overall Study|Patient declared ineligible|0
5109647|NCT01836549|17648354|P6|Overall Study|Patient declared ineligible|0
5109648|NCT01836549|17648355|P5|Overall Study|Patient declared ineligible|0
5109649|NCT01836549|17648356|P4|Overall Study|Patient declared ineligible|1
5109650|NCT01836549|17648357|P3|Overall Study|Patient declared ineligible|0
5109651|NCT01836549|17648358|P2|Overall Study|Patient declared ineligible|0
5109652|NCT01836549|17648359|P1|Overall Study|Patient declared ineligible|0
5109653|NCT01836549|17648353|P7|Overall Study|Did not receive study drug|0
5109654|NCT01836549|17648354|P6|Overall Study|Did not receive study drug|0
5109655|NCT01836549|17648355|P5|Overall Study|Did not receive study drug|0
5109656|NCT01836549|17648356|P4|Overall Study|Did not receive study drug|0
5109657|NCT01836549|17648357|P3|Overall Study|Did not receive study drug|1
5109658|NCT01836549|17648358|P2|Overall Study|Did not receive study drug|0
5109659|NCT01836549|17648359|P1|Overall Study|Did not receive study drug|0
5109660|NCT01836523|17648383|P4|Overall Study|Unclassified|29
5109661|NCT01836523|17648384|P3|Overall Study|Unclassified|19
5109662|NCT01836523|17648385|P2|Overall Study|Unclassified|28
5109663|NCT01836523|17648386|P1|Overall Study|Unclassified|17
5109664|NCT01836523|17648383|P4|Overall Study|Met Withdrawal Criteria|27
5109665|NCT01836523|17648384|P3|Overall Study|Met Withdrawal Criteria|21
5109666|NCT01836523|17648385|P2|Overall Study|Met Withdrawal Criteria|13
5109667|NCT01836523|17648386|P1|Overall Study|Met Withdrawal Criteria|13
5109668|NCT01836523|17648383|P4|Overall Study|Protocol Violation|4
5109669|NCT01836523|17648384|P3|Overall Study|Protocol Violation|2
5109670|NCT01836523|17648385|P2|Overall Study|Protocol Violation|3
5109671|NCT01836523|17648386|P1|Overall Study|Protocol Violation|6
5109672|NCT01836523|17648383|P4|Overall Study|Adverse Event|14
5109673|NCT01836523|17648384|P3|Overall Study|Adverse Event|49
5109674|NCT01836523|17648385|P2|Overall Study|Adverse Event|41
5109675|NCT01836523|17648386|P1|Overall Study|Adverse Event|15
5109676|NCT01836471|17648413|P5|Overall Study|Non compliance with tx|0
5109677|NCT01836471|17648414|P4|Overall Study|Non compliance with tx|0
5109678|NCT01836471|17648415|P3|Overall Study|Non compliance with tx|0
5109679|NCT01836471|17648416|P2|Overall Study|Non compliance with tx|1
5109680|NCT01836471|17648417|P1|Overall Study|Non compliance with tx|1
5109681|NCT01836471|17648413|P5|Overall Study|Adverse Event|2
5109682|NCT01836471|17648414|P4|Overall Study|Adverse Event|1
5109683|NCT01836471|17648415|P3|Overall Study|Adverse Event|1
5109684|NCT01836471|17648416|P2|Overall Study|Adverse Event|3
5109685|NCT01836471|17648417|P1|Overall Study|Adverse Event|6
5109686|NCT01836471|17648413|P5|Overall Study|Lost to Follow-up|1
5109687|NCT01836471|17648414|P4|Overall Study|Lost to Follow-up|1
5109688|NCT01836471|17648415|P3|Overall Study|Lost to Follow-up|0
5109689|NCT01836471|17648416|P2|Overall Study|Lost to Follow-up|0
5109690|NCT01836471|17648417|P1|Overall Study|Lost to Follow-up|0
5109691|NCT01836471|17648413|P5|Overall Study|Physician Decision|0
5109692|NCT01836471|17648414|P4|Overall Study|Physician Decision|0
5109693|NCT01836471|17648415|P3|Overall Study|Physician Decision|0
5109694|NCT01836471|17648416|P2|Overall Study|Physician Decision|1
5109695|NCT01836471|17648417|P1|Overall Study|Physician Decision|0
5109696|NCT01836471|17648413|P5|Overall Study|Withdrawal by Subject|2
5109697|NCT01836471|17648414|P4|Overall Study|Withdrawal by Subject|0
5109698|NCT01836471|17648415|P3|Overall Study|Withdrawal by Subject|1
5109699|NCT01836471|17648416|P2|Overall Study|Withdrawal by Subject|4
5109700|NCT01836471|17648417|P1|Overall Study|Withdrawal by Subject|3
5109701|NCT01836471|17648413|P5|Overall Study|Pregnancy|0
5109702|NCT01836471|17648414|P4|Overall Study|Pregnancy|0
5109703|NCT01836471|17648415|P3|Overall Study|Pregnancy|0
5109704|NCT01836471|17648416|P2|Overall Study|Pregnancy|0
5109705|NCT01836471|17648417|P1|Overall Study|Pregnancy|1
5109706|NCT01836458|17648446|P4|Overall Study|Unsatisfactory therapeutic effect|6
5109707|NCT01836458|17648447|P3|Overall Study|Unsatisfactory therapeutic effect|5
5109708|NCT01836458|17648448|P2|Overall Study|Unsatisfactory therapeutic effect|2
5109709|NCT01836458|17648449|P1|Overall Study|Unsatisfactory therapeutic effect|3
5109710|NCT01836276|17648534|P2|Overall Study|Lost to Follow-up|51
5109711|NCT01836276|17648535|P1|Overall Study|Lost to Follow-up|28
5109712|NCT01836198|17648543|P3|Part A, Period 2|Protocol Violation|0
5109713|NCT01836198|17648544|P2|Part A, Period 2|Protocol Violation|1
5109714|NCT01836198|17648545|P1|Part A, Period 2|Protocol Violation|0
5109715|NCT01835899|17648647|P3|Overall Study|Other than stated above|0
5109716|NCT01835899|17648648|P2|Overall Study|Other than stated above|1
5109717|NCT01835899|17648649|P1|Overall Study|Other than stated above|0
5109718|NCT01835899|17648647|P3|Overall Study|Adverse Event|1
5109719|NCT01835899|17648648|P2|Overall Study|Adverse Event|0
5109720|NCT01835899|17648649|P1|Overall Study|Adverse Event|0
5109721|NCT01835587|17648706|P4|Overall Study|Miscellaneous|0
5109722|NCT01835587|17648707|P3|Overall Study|Miscellaneous|0
5109723|NCT01835587|17648708|P2|Overall Study|Miscellaneous|1
5109724|NCT01835587|17648709|P1|Overall Study|Miscellaneous|0
5109725|NCT01835587|17648706|P4|Overall Study|Death|1
5109726|NCT01835587|17648707|P3|Overall Study|Death|0
5109727|NCT01835587|17648708|P2|Overall Study|Death|0
5109728|NCT01835587|17648709|P1|Overall Study|Death|0
5109729|NCT01835587|17648706|P4|Overall Study|Adverse Event|2
5109730|NCT01835587|17648707|P3|Overall Study|Adverse Event|2
5109731|NCT01835587|17648708|P2|Overall Study|Adverse Event|0
5109732|NCT01835587|17648709|P1|Overall Study|Adverse Event|0
5109733|NCT01835587|17648706|P4|Overall Study|Withdrawal by Subject|3
5109734|NCT01835587|17648707|P3|Overall Study|Withdrawal by Subject|0
5109735|NCT01835587|17648708|P2|Overall Study|Withdrawal by Subject|0
5109736|NCT01835587|17648709|P1|Overall Study|Withdrawal by Subject|2
5109737|NCT01835587|17648706|P4|Overall Study|Disease Recurrence or Relapse|3
5109738|NCT01835587|17648707|P3|Overall Study|Disease Recurrence or Relapse|0
5109739|NCT01835587|17648708|P2|Overall Study|Disease Recurrence or Relapse|3
5109740|NCT01835587|17648709|P1|Overall Study|Disease Recurrence or Relapse|0
5109741|NCT01835548|17648770|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
5109742|NCT01835548|17648771|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5109743|NCT01835548|17648772|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5109744|NCT01835548|17648770|P3|Double-Blind Treatment Period|Adverse Event|0
5109745|NCT01835548|17648771|P2|Double-Blind Treatment Period|Adverse Event|1
5109746|NCT01835548|17648772|P1|Double-Blind Treatment Period|Adverse Event|0
5109747|NCT01835548|17648770|P3|Dose Optimization Period|Withdrawal by Subject|1
5109748|NCT01835548|17648771|P2|Dose Optimization Period|Withdrawal by Subject|0
5109749|NCT01835548|17648772|P1|Dose Optimization Period|Withdrawal by Subject|0
5109750|NCT01835548|17648770|P3|Dose Optimization Period|Adverse Event|1
5109751|NCT01835548|17648771|P2|Dose Optimization Period|Adverse Event|0
5109752|NCT01835548|17648772|P1|Dose Optimization Period|Adverse Event|0
5109753|NCT01835470|17648801|P1|Long Term Treatment Period|Lack of Efficacy|3
5109754|NCT01835470|17648801|P1|Long Term Treatment Period|Subject Request to Discontinue|1
5109755|NCT01835431|17648813|P2|Overall Study|Protocol Violation|0
5109756|NCT01835431|17648814|P1|Overall Study|Protocol Violation|1
5109757|NCT01835431|17648813|P2|Overall Study|Withdrawal by Subject|10
5109758|NCT01835431|17648814|P1|Overall Study|Withdrawal by Subject|6
5109759|NCT01835431|17648813|P2|Overall Study|other|2
5109760|NCT01835431|17648814|P1|Overall Study|other|0
5109761|NCT01835431|17648813|P2|Overall Study|Adverse Event|0
5109762|NCT01835431|17648814|P1|Overall Study|Adverse Event|1
5109763|NCT01835223|17648854|P2|Overall Study|Became Inelligible|0
5109764|NCT01835223|17648855|P1|Overall Study|Became Inelligible|4
5109765|NCT01835223|17648854|P2|Overall Study|Disease progression|1
5109766|NCT01835223|17648855|P1|Overall Study|Disease progression|2
5109767|NCT01835223|17648854|P2|Overall Study|Withdrawal by Subject|0
5109768|NCT01835223|17648855|P1|Overall Study|Withdrawal by Subject|2
5109769|NCT01835223|17648854|P2|Overall Study|Adverse Event|0
5109770|NCT01835223|17648855|P1|Overall Study|Adverse Event|1
5109771|NCT01835158|17648875|P2|Overall Study|Withdrawal by Subject|6
5109772|NCT01835158|17648876|P1|Overall Study|Withdrawal by Subject|1
5109773|NCT01835145|17648888|P2|Overall Study|Ineligible prior to treatment|0
5109774|NCT01835145|17648889|P1|Overall Study|Ineligible prior to treatment|1
5109775|NCT01835132|17648904|P1|Initial Phase|Insufficient Therapeutic Response|2
5109776|NCT01835015|17648949|P5|Overall Study|Adverse Event|0
5109777|NCT01835015|17648950|P4|Overall Study|Adverse Event|0
5109778|NCT01835015|17648951|P3|Overall Study|Adverse Event|1
5109779|NCT01835015|17648952|P2|Overall Study|Adverse Event|0
5109780|NCT01835015|17648953|P1|Overall Study|Adverse Event|0
5109781|NCT01834729|17649030|P4|Overall Study|Adverse Event|2
5109782|NCT01834729|17649031|P3|Overall Study|Adverse Event|0
5109783|NCT01834729|17649032|P2|Overall Study|Adverse Event|0
5109784|NCT01834729|17649033|P1|Overall Study|Adverse Event|0
5109785|NCT01834729|17649030|P4|Overall Study|Withdrawal by Subject|0
5109786|NCT01834729|17649031|P3|Overall Study|Withdrawal by Subject|0
5109787|NCT01834729|17649032|P2|Overall Study|Withdrawal by Subject|1
5109788|NCT01834729|17649033|P1|Overall Study|Withdrawal by Subject|1
5109789|NCT01834729|17649030|P4|Overall Study|Did not return bowel diaries|0
5109790|NCT01834729|17649031|P3|Overall Study|Did not return bowel diaries|3
5109791|NCT01834729|17649032|P2|Overall Study|Did not return bowel diaries|0
5109792|NCT01834729|17649033|P1|Overall Study|Did not return bowel diaries|0
5109793|NCT01834586|17649066|P1|Overall Study|Adverse Event|1
5109794|NCT01834274|17649106|P2|Overall Study|Other|1
5109795|NCT01834274|17649107|P1|Overall Study|Other|2
5109796|NCT01834274|17649106|P2|Overall Study|Lost to Follow-up|1
5109797|NCT01834274|17649107|P1|Overall Study|Lost to Follow-up|3
5109798|NCT01834274|17649106|P2|Overall Study|Withdrawal by Subject|1
5109799|NCT01834274|17649107|P1|Overall Study|Withdrawal by Subject|1
5109800|NCT01834274|17649106|P2|Overall Study|Study Termination|38
5109801|NCT01834274|17649107|P1|Overall Study|Study Termination|41
5109802|NCT01834222|17649130|P1|Overall Study|Not meet inclusion/exclusion criteria|1
5109803|NCT01833897|17649225|P1|Overall Study|Lack of Efficacy|1
5109804|NCT01833832|17649237|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
5109805|NCT01833533|17649392|P2|Overall Study|Other|7
5109806|NCT01833533|17649393|P1|Overall Study|Other|2
5109807|NCT01833533|17649392|P2|Overall Study|To Enter an Extension Study|4
5109808|NCT01833533|17649393|P1|Overall Study|To Enter an Extension Study|0
5109809|NCT01833533|17649392|P2|Overall Study|Lost to Follow-up|9
5109810|NCT01833533|17649393|P1|Overall Study|Lost to Follow-up|4
5109811|NCT01833533|17649392|P2|Overall Study|Adverse Event|1
5109812|NCT01833533|17649393|P1|Overall Study|Adverse Event|0
5109813|NCT01833494|17649407|P1|Overall Study|Increase in serum ferritin|1
5109814|NCT01833494|17649407|P1|Overall Study|Decrease in serum calcium|4
5109815|NCT01833494|17649407|P1|Overall Study|Decrease in serum phosphorus|4
5109816|NCT01833494|17649407|P1|Overall Study|Withdrawal by Subject|6
5109817|NCT01833494|17649407|P1|Overall Study|Physician Decision|6
5109818|NCT01833494|17649407|P1|Overall Study|Adverse Event|24
5109819|NCT01833455|17649435|P2|Overall Study|Withdrawal by Subject|0
5109820|NCT01833455|17649436|P1|Overall Study|Withdrawal by Subject|1
5109821|NCT01833169|17649465|P1|Overall Study|Physician Decision|2
5109822|NCT01833169|17649465|P1|Overall Study|Death|3
5109823|NCT01833169|17649465|P1|Overall Study|Withdrawal by Subject|9
5109824|NCT01833169|17649465|P1|Overall Study|Adverse Event|33
5109825|NCT01833169|17649465|P1|Overall Study|Disease Progression|99
5109826|NCT01833143|17649476|P1|Overall Study|Not Treated|1
5109827|NCT01833065|17649541|P5|Overall Study|Others|4
5109828|NCT01833065|17649542|P4|Overall Study|Others|1
5109829|NCT01833065|17649543|P3|Overall Study|Others|1
5109830|NCT01833065|17649544|P2|Overall Study|Others|1
5109831|NCT01833065|17649545|P1|Overall Study|Others|2
5109832|NCT01833065|17649541|P5|Overall Study|Trial terminated by sponsor|13
5109833|NCT01833065|17649542|P4|Overall Study|Trial terminated by sponsor|3
5109834|NCT01833065|17649543|P3|Overall Study|Trial terminated by sponsor|7
5109835|NCT01833065|17649544|P2|Overall Study|Trial terminated by sponsor|8
5109836|NCT01833065|17649545|P1|Overall Study|Trial terminated by sponsor|8
5109837|NCT01833065|17649541|P5|Overall Study|Subject's substantial non-compliance|0
5109838|NCT01833065|17649542|P4|Overall Study|Subject's substantial non-compliance|0
5109839|NCT01833065|17649543|P3|Overall Study|Subject's substantial non-compliance|0
5109840|NCT01833065|17649544|P2|Overall Study|Subject's substantial non-compliance|1
5109841|NCT01833065|17649545|P1|Overall Study|Subject's substantial non-compliance|0
5109842|NCT01833065|17649541|P5|Overall Study|Withdrawal by Subject|11
5109843|NCT01833065|17649542|P4|Overall Study|Withdrawal by Subject|3
5109844|NCT01833065|17649543|P3|Overall Study|Withdrawal by Subject|4
5109845|NCT01833065|17649544|P2|Overall Study|Withdrawal by Subject|2
5109846|NCT01833065|17649545|P1|Overall Study|Withdrawal by Subject|6
5109847|NCT01833065|17649541|P5|Overall Study|Lost to Follow-up|3
5109848|NCT01833065|17649542|P4|Overall Study|Lost to Follow-up|0
5109849|NCT01833065|17649543|P3|Overall Study|Lost to Follow-up|0
5109850|NCT01833065|17649544|P2|Overall Study|Lost to Follow-up|0
5109851|NCT01833065|17649545|P1|Overall Study|Lost to Follow-up|1
5109852|NCT01833065|17649541|P5|Overall Study|Protocol Violation|2
5109853|NCT01833065|17649542|P4|Overall Study|Protocol Violation|0
5109854|NCT01833065|17649543|P3|Overall Study|Protocol Violation|0
5109855|NCT01833065|17649544|P2|Overall Study|Protocol Violation|0
5109856|NCT01833065|17649545|P1|Overall Study|Protocol Violation|1
5109857|NCT01833065|17649541|P5|Overall Study|Adverse Event|3
5109858|NCT01833065|17649542|P4|Overall Study|Adverse Event|2
5109859|NCT01833065|17649543|P3|Overall Study|Adverse Event|0
5109860|NCT01833065|17649544|P2|Overall Study|Adverse Event|1
5109861|NCT01833065|17649545|P1|Overall Study|Adverse Event|6
5109862|NCT01832818|17649614|P1|Overall Study|Lost to Follow-up|6
5109863|NCT01832766|17649623|P2|Washout|Lost to Follow-up|1
5109864|NCT01832766|17649624|P1|Washout|Lost to Follow-up|0
5109865|NCT01832727|17649660|P9|Overall Study|Study terminated by sponsor|1
5109866|NCT01832727|17649661|P8|Overall Study|Study terminated by sponsor|1
5109867|NCT01832727|17649662|P7|Overall Study|Study terminated by sponsor|0
5109868|NCT01832727|17649663|P6|Overall Study|Study terminated by sponsor|0
5109869|NCT01832727|17649664|P5|Overall Study|Study terminated by sponsor|0
5109870|NCT01832727|17649665|P4|Overall Study|Study terminated by sponsor|0
5109871|NCT01832727|17649666|P3|Overall Study|Study terminated by sponsor|0
5109872|NCT01832727|17649667|P2|Overall Study|Study terminated by sponsor|0
5109873|NCT01832727|17649668|P1|Overall Study|Study terminated by sponsor|0
5109874|NCT01832727|17649660|P9|Overall Study|Withdrawal by Subject|1
5109875|NCT01832727|17649661|P8|Overall Study|Withdrawal by Subject|2
5109876|NCT01832727|17649662|P7|Overall Study|Withdrawal by Subject|0
5109877|NCT01832727|17649663|P6|Overall Study|Withdrawal by Subject|1
5109878|NCT01832727|17649664|P5|Overall Study|Withdrawal by Subject|0
5109879|NCT01832727|17649665|P4|Overall Study|Withdrawal by Subject|1
5109880|NCT01832727|17649666|P3|Overall Study|Withdrawal by Subject|0
5109881|NCT01832727|17649667|P2|Overall Study|Withdrawal by Subject|1
5109882|NCT01832727|17649668|P1|Overall Study|Withdrawal by Subject|1
5109883|NCT01832727|17649660|P9|Overall Study|Physician Decision|0
5109884|NCT01832727|17649661|P8|Overall Study|Physician Decision|0
5109885|NCT01832727|17649662|P7|Overall Study|Physician Decision|0
5109886|NCT01832727|17649663|P6|Overall Study|Physician Decision|1
5109887|NCT01832727|17649664|P5|Overall Study|Physician Decision|0
5109888|NCT01832727|17649665|P4|Overall Study|Physician Decision|1
5109889|NCT01832727|17649666|P3|Overall Study|Physician Decision|0
5109890|NCT01832727|17649667|P2|Overall Study|Physician Decision|0
5109891|NCT01832727|17649668|P1|Overall Study|Physician Decision|1
5109892|NCT01832727|17649660|P9|Overall Study|Lost to Follow-up|0
5109893|NCT01832727|17649661|P8|Overall Study|Lost to Follow-up|0
5109894|NCT01832727|17649662|P7|Overall Study|Lost to Follow-up|0
5109895|NCT01832727|17649663|P6|Overall Study|Lost to Follow-up|0
5109896|NCT01832727|17649664|P5|Overall Study|Lost to Follow-up|0
5109897|NCT01832727|17649665|P4|Overall Study|Lost to Follow-up|1
5109898|NCT01832727|17649666|P3|Overall Study|Lost to Follow-up|0
5109899|NCT01832727|17649667|P2|Overall Study|Lost to Follow-up|0
5109900|NCT01832727|17649668|P1|Overall Study|Lost to Follow-up|0
5109901|NCT01832727|17649660|P9|Overall Study|Disease progression|7
5109902|NCT01832727|17649661|P8|Overall Study|Disease progression|2
5109903|NCT01832727|17649662|P7|Overall Study|Disease progression|6
5109904|NCT01832727|17649663|P6|Overall Study|Disease progression|3
5109905|NCT01832727|17649664|P5|Overall Study|Disease progression|3
5109906|NCT01832727|17649665|P4|Overall Study|Disease progression|1
5109907|NCT01832727|17649666|P3|Overall Study|Disease progression|2
5109908|NCT01832727|17649667|P2|Overall Study|Disease progression|0
5109909|NCT01832727|17649668|P1|Overall Study|Disease progression|3
5109910|NCT01832727|17649660|P9|Overall Study|Adverse Event|9
5109911|NCT01832727|17649661|P8|Overall Study|Adverse Event|1
5109912|NCT01832727|17649662|P7|Overall Study|Adverse Event|2
5109913|NCT01832727|17649663|P6|Overall Study|Adverse Event|1
5109914|NCT01832727|17649664|P5|Overall Study|Adverse Event|1
5109915|NCT01832727|17649665|P4|Overall Study|Adverse Event|0
5109916|NCT01832727|17649666|P3|Overall Study|Adverse Event|1
5109917|NCT01832727|17649667|P2|Overall Study|Adverse Event|6
5109918|NCT01832727|17649668|P1|Overall Study|Adverse Event|4
5109919|NCT01832532|17649781|P2|Overall Study|Withdrawal by Subject|2
5109920|NCT01832532|17649782|P1|Overall Study|Withdrawal by Subject|5
5109921|NCT01832493|17649844|P1|Overall Study|Unable to place LV lead|2
5109922|NCT01832493|17649844|P1|Overall Study|Protocol Violation|4
5109923|NCT01832493|17649844|P1|Overall Study|Physician Decision|2
5109924|NCT01832480|17649853|P2|Overall Study|post randomization ineligible|10
5109925|NCT01832480|17649854|P1|Overall Study|post randomization ineligible|8
5109926|NCT01832480|17649853|P2|Overall Study|Withdrawal by Subject|2
5109927|NCT01832480|17649854|P1|Overall Study|Withdrawal by Subject|0
5109928|NCT01832480|17649853|P2|Overall Study|Lost to Follow-up|30
5109929|NCT01832480|17649854|P1|Overall Study|Lost to Follow-up|33
5109930|NCT01832402|17649862|P2|Overall Study|Declining Performance status|1
5109931|NCT01832402|17649863|P1|Overall Study|Declining Performance status|2
5109932|NCT01832402|17649862|P2|Overall Study|Withdrawal by Subject|3
5109933|NCT01832402|17649863|P1|Overall Study|Withdrawal by Subject|3
5109934|NCT01832402|17649862|P2|Overall Study|Lost to Follow-up|0
5109935|NCT01832402|17649863|P1|Overall Study|Lost to Follow-up|2
5109936|NCT01832155|17649890|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
5109937|NCT01832155|17649891|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
5109938|NCT01832155|17649890|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
5109939|NCT01832155|17649891|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
5109940|NCT01832038|17649958|P1|Overall Study|Subject considered the efficacy was poor|1
5109941|NCT01832038|17649958|P1|Overall Study|Pregnancy and abortion in EP0008 study|1
5109942|NCT01832038|17649958|P1|Overall Study|Prohibited concomitant medication|1
5109943|NCT01832038|17649958|P1|Overall Study|Bad mood and has suicidal thought|1
5109944|NCT01832038|17649958|P1|Overall Study|Plan to pregnancy|7
5109945|NCT01832038|17649958|P1|Overall Study|Changes of implementation system|3
5109946|NCT01832038|17649958|P1|Overall Study|Not possible to visit the hospital|1
5109947|NCT01832038|17649958|P1|Overall Study|Prohibit procedure|2
5109948|NCT01832038|17649958|P1|Overall Study|Low compliance|3
5109949|NCT01832038|17649958|P1|Overall Study|Pregnancy|1
5109950|NCT01832038|17649958|P1|Overall Study|Back home|1
5109951|NCT01832038|17649958|P1|Overall Study|Participant was asked to quit|5
5109952|NCT01832038|17649958|P1|Overall Study|Not convenient to come back to site|2
5109953|NCT01832038|17649958|P1|Overall Study|Subject refused to return visit|2
5109954|NCT01832038|17649958|P1|Overall Study|Visit non-compliance|2
5109955|NCT01832038|17649958|P1|Overall Study|Withdrawal by Subject|49
5109956|NCT01832038|17649958|P1|Overall Study|Lost to Follow-up|10
5109957|NCT01832038|17649958|P1|Overall Study|Protocol Violation|7
5109958|NCT01832038|17649958|P1|Overall Study|Lack of Efficacy|81
5109959|NCT01832038|17649958|P1|Overall Study|Adverse Event|50
5109960|NCT01832038|17649958|P1|Overall Study|Death|5
5109961|NCT01831856|17650016|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
5109962|NCT01831856|17650017|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
5109963|NCT01831856|17650016|P2|Overall Study|Lack of Efficacy|11
5109964|NCT01831856|17650017|P1|Overall Study|Lack of Efficacy|13
5109965|NCT01831856|17650016|P2|Overall Study|Adverse Event|8
5109966|NCT01831856|17650017|P1|Overall Study|Adverse Event|5
5109967|NCT01831817|17650027|P4|Overall Study|Withdrawl of Consent|0
5109968|NCT01831817|17650028|P3|Overall Study|Withdrawl of Consent|0
5109969|NCT01831817|17650029|P2|Overall Study|Withdrawl of Consent|0
5109970|NCT01831817|17650030|P1|Overall Study|Withdrawl of Consent|3
5109971|NCT01831817|17650027|P4|Overall Study|Lost to Follow-up|0
5109972|NCT01831817|17650028|P3|Overall Study|Lost to Follow-up|0
5109973|NCT01831817|17650029|P2|Overall Study|Lost to Follow-up|0
5109974|NCT01831817|17650030|P1|Overall Study|Lost to Follow-up|1
5109975|NCT01831804|17650077|P9|Overall Study|Withdrew Consent|0
5109976|NCT01831804|17650078|P8|Overall Study|Withdrew Consent|2
5109977|NCT01831804|17650079|P7|Overall Study|Withdrew Consent|0
5109978|NCT01831804|17650080|P6|Overall Study|Withdrew Consent|0
5109979|NCT01831804|17650081|P5|Overall Study|Withdrew Consent|0
5109980|NCT01831804|17650082|P4|Overall Study|Withdrew Consent|0
5109981|NCT01831804|17650083|P3|Overall Study|Withdrew Consent|0
5109982|NCT01831804|17650084|P2|Overall Study|Withdrew Consent|1
5109983|NCT01831804|17650085|P1|Overall Study|Withdrew Consent|0
5109984|NCT01831804|17650077|P9|Overall Study|Investigator discretion|0
5109985|NCT01831804|17650078|P8|Overall Study|Investigator discretion|1
5109986|NCT01831804|17650079|P7|Overall Study|Investigator discretion|0
5109987|NCT01831804|17650080|P6|Overall Study|Investigator discretion|0
5109988|NCT01831804|17650081|P5|Overall Study|Investigator discretion|1
5109989|NCT01831804|17650082|P4|Overall Study|Investigator discretion|0
5109990|NCT01831804|17650083|P3|Overall Study|Investigator discretion|0
5109991|NCT01831804|17650084|P2|Overall Study|Investigator discretion|0
5109992|NCT01831804|17650085|P1|Overall Study|Investigator discretion|0
5109993|NCT01831804|17650077|P9|Overall Study|Lost to Follow-up|1
5109994|NCT01831804|17650078|P8|Overall Study|Lost to Follow-up|0
5109995|NCT01831804|17650079|P7|Overall Study|Lost to Follow-up|0
5109996|NCT01831804|17650080|P6|Overall Study|Lost to Follow-up|0
5109997|NCT01831804|17650081|P5|Overall Study|Lost to Follow-up|0
5109998|NCT01831804|17650082|P4|Overall Study|Lost to Follow-up|0
5109999|NCT01831804|17650083|P3|Overall Study|Lost to Follow-up|1
5110000|NCT01831804|17650084|P2|Overall Study|Lost to Follow-up|0
5110001|NCT01831804|17650085|P1|Overall Study|Lost to Follow-up|0
5110002|NCT01831804|17650077|P9|Overall Study|Protocol defined stopping criteria|0
5110003|NCT01831804|17650078|P8|Overall Study|Protocol defined stopping criteria|0
5110004|NCT01831804|17650079|P7|Overall Study|Protocol defined stopping criteria|0
5110005|NCT01831804|17650080|P6|Overall Study|Protocol defined stopping criteria|0
5110006|NCT01831804|17650081|P5|Overall Study|Protocol defined stopping criteria|1
5110007|NCT01831804|17650082|P4|Overall Study|Protocol defined stopping criteria|0
5110008|NCT01831804|17650083|P3|Overall Study|Protocol defined stopping criteria|3
5110009|NCT01831804|17650084|P2|Overall Study|Protocol defined stopping criteria|1
5110010|NCT01831804|17650085|P1|Overall Study|Protocol defined stopping criteria|1
5110011|NCT01831804|17650077|P9|Overall Study|Protocol Violation|0
5110012|NCT01831804|17650078|P8|Overall Study|Protocol Violation|0
5110013|NCT01831804|17650079|P7|Overall Study|Protocol Violation|0
5110014|NCT01831804|17650080|P6|Overall Study|Protocol Violation|0
5110015|NCT01831804|17650081|P5|Overall Study|Protocol Violation|0
5110016|NCT01831804|17650082|P4|Overall Study|Protocol Violation|0
5110017|NCT01831804|17650083|P3|Overall Study|Protocol Violation|2
5110018|NCT01831804|17650084|P2|Overall Study|Protocol Violation|0
5110019|NCT01831804|17650085|P1|Overall Study|Protocol Violation|0
5110020|NCT01831804|17650077|P9|Overall Study|Adverse Event|1
5110021|NCT01831804|17650078|P8|Overall Study|Adverse Event|0
5110022|NCT01831804|17650079|P7|Overall Study|Adverse Event|1
5110023|NCT01831804|17650080|P6|Overall Study|Adverse Event|0
5110024|NCT01831804|17650081|P5|Overall Study|Adverse Event|0
5110025|NCT01831804|17650082|P4|Overall Study|Adverse Event|0
5110026|NCT01831804|17650083|P3|Overall Study|Adverse Event|0
5110027|NCT01831804|17650084|P2|Overall Study|Adverse Event|0
5110028|NCT01831804|17650085|P1|Overall Study|Adverse Event|0
5110029|NCT01831791|17650180|P1|Overall Study|Withdrawal by Subject|10
5110030|NCT01831765|17650209|P3|Overall Study|Lost to Follow-up|3
5110031|NCT01831765|17650210|P2|Overall Study|Lost to Follow-up|3
5110032|NCT01831765|17650211|P1|Overall Study|Lost to Follow-up|2
5110033|NCT01831765|17650209|P3|Overall Study|Withdrawal criteria|16
5110034|NCT01831765|17650210|P2|Overall Study|Withdrawal criteria|10
5110035|NCT01831765|17650211|P1|Overall Study|Withdrawal criteria|12
5110036|NCT01831765|17650209|P3|Overall Study|Withdrawal by Subject|17
5110037|NCT01831765|17650210|P2|Overall Study|Withdrawal by Subject|7
5110038|NCT01831765|17650211|P1|Overall Study|Withdrawal by Subject|22
5110039|NCT01831765|17650209|P3|Overall Study|Adverse Event|3
5110040|NCT01831765|17650210|P2|Overall Study|Adverse Event|3
5110041|NCT01831765|17650211|P1|Overall Study|Adverse Event|5
5110042|NCT01831765|17650209|P3|Overall Study|Other, site closed|0
5110043|NCT01831765|17650210|P2|Overall Study|Other, site closed|1
5110044|NCT01831765|17650211|P1|Overall Study|Other, site closed|1
5110045|NCT01831765|17650209|P3|Overall Study|Death|1
5110046|NCT01831765|17650210|P2|Overall Study|Death|1
5110047|NCT01831765|17650211|P1|Overall Study|Death|0
5110048|NCT01831765|17650209|P3|Overall Study|Pregnancy|2
5110049|NCT01831765|17650210|P2|Overall Study|Pregnancy|1
5110050|NCT01831765|17650211|P1|Overall Study|Pregnancy|1
5110051|NCT01831765|17650209|P3|Overall Study|Other, sponsor withdrew subject|0
5110052|NCT01831765|17650210|P2|Overall Study|Other, sponsor withdrew subject|1
5110053|NCT01831765|17650211|P1|Overall Study|Other, sponsor withdrew subject|0
5110054|NCT01831765|17650209|P3|Overall Study|Lack of Efficacy|0
5110055|NCT01831765|17650210|P2|Overall Study|Lack of Efficacy|0
5110056|NCT01831765|17650211|P1|Overall Study|Lack of Efficacy|1
5110057|NCT01831726|17650237|P1|Overall Study|Subject/guardian decision|7
5110058|NCT01831726|17650237|P1|Overall Study|Physician Decision|1
5110059|NCT01831726|17650237|P1|Overall Study|Disease Progression|49
5110060|NCT01831726|17650237|P1|Overall Study|Death|7
5110061|NCT01831726|17650237|P1|Overall Study|Adverse Event|16
5110062|NCT01831596|17650244|P1|Overall Study|Other|8
5110063|NCT01831544|17650248|P1|Overall Study|Still on original MVAD device|2
5110064|NCT01831544|17650248|P1|Overall Study|Death|1
5110065|NCT01831466|17650277|P12|Overall Study|Adverse Event|2
5110066|NCT01831466|17650278|P11|Overall Study|Adverse Event|0
5110067|NCT01831466|17650279|P10|Overall Study|Adverse Event|1
5110068|NCT01831466|17650280|P9|Overall Study|Adverse Event|1
5110069|NCT01831466|17650281|P8|Overall Study|Adverse Event|1
5110070|NCT01831466|17650282|P7|Overall Study|Adverse Event|0
5110071|NCT01831466|17650283|P6|Overall Study|Adverse Event|7
5110072|NCT01831466|17650284|P5|Overall Study|Adverse Event|3
5110073|NCT01831466|17650285|P4|Overall Study|Adverse Event|6
5110074|NCT01831466|17650286|P3|Overall Study|Adverse Event|4
5110075|NCT01831466|17650287|P2|Overall Study|Adverse Event|0
5110076|NCT01831466|17650288|P1|Overall Study|Adverse Event|0
5110077|NCT01831466|17650277|P12|Overall Study|Lack of Efficacy|0
5110078|NCT01831466|17650278|P11|Overall Study|Lack of Efficacy|2
5110079|NCT01831466|17650279|P10|Overall Study|Lack of Efficacy|2
5110080|NCT01831466|17650280|P9|Overall Study|Lack of Efficacy|2
5110081|NCT01831466|17650281|P8|Overall Study|Lack of Efficacy|1
5110082|NCT01831466|17650282|P7|Overall Study|Lack of Efficacy|1
5110083|NCT01831466|17650283|P6|Overall Study|Lack of Efficacy|8
5110084|NCT01831466|17650284|P5|Overall Study|Lack of Efficacy|9
5110085|NCT01831466|17650285|P4|Overall Study|Lack of Efficacy|6
5110086|NCT01831466|17650286|P3|Overall Study|Lack of Efficacy|7
5110087|NCT01831466|17650287|P2|Overall Study|Lack of Efficacy|8
5110088|NCT01831466|17650288|P1|Overall Study|Lack of Efficacy|5
5110089|NCT01831466|17650277|P12|Overall Study|Lost to Follow-up|1
5110090|NCT01831466|17650278|P11|Overall Study|Lost to Follow-up|0
5110091|NCT01831466|17650279|P10|Overall Study|Lost to Follow-up|1
5110092|NCT01831466|17650280|P9|Overall Study|Lost to Follow-up|0
5110093|NCT01831466|17650281|P8|Overall Study|Lost to Follow-up|0
5110094|NCT01831466|17650282|P7|Overall Study|Lost to Follow-up|0
5110095|NCT01831466|17650283|P6|Overall Study|Lost to Follow-up|3
5110096|NCT01831466|17650284|P5|Overall Study|Lost to Follow-up|0
5110097|NCT01831466|17650285|P4|Overall Study|Lost to Follow-up|2
5110098|NCT01831466|17650286|P3|Overall Study|Lost to Follow-up|4
5110099|NCT01831466|17650287|P2|Overall Study|Lost to Follow-up|1
5110100|NCT01831466|17650288|P1|Overall Study|Lost to Follow-up|0
5110101|NCT01831466|17650277|P12|Overall Study|Withdrawal by Subject|1
5110102|NCT01831466|17650278|P11|Overall Study|Withdrawal by Subject|0
5110103|NCT01831466|17650279|P10|Overall Study|Withdrawal by Subject|1
5110104|NCT01831466|17650280|P9|Overall Study|Withdrawal by Subject|0
5110105|NCT01831466|17650281|P8|Overall Study|Withdrawal by Subject|0
5110106|NCT01831466|17650282|P7|Overall Study|Withdrawal by Subject|0
5110107|NCT01831466|17650283|P6|Overall Study|Withdrawal by Subject|5
5110108|NCT01831466|17650284|P5|Overall Study|Withdrawal by Subject|3
5110109|NCT01831466|17650285|P4|Overall Study|Withdrawal by Subject|3
5110110|NCT01831466|17650286|P3|Overall Study|Withdrawal by Subject|3
5110111|NCT01831466|17650287|P2|Overall Study|Withdrawal by Subject|3
5110112|NCT01831466|17650288|P1|Overall Study|Withdrawal by Subject|6
5110113|NCT01831466|17650277|P12|Overall Study|Death|0
5110114|NCT01831466|17650278|P11|Overall Study|Death|0
5110115|NCT01831466|17650279|P10|Overall Study|Death|0
5110116|NCT01831466|17650280|P9|Overall Study|Death|0
5110117|NCT01831466|17650281|P8|Overall Study|Death|0
5110118|NCT01831466|17650282|P7|Overall Study|Death|0
5110119|NCT01831466|17650283|P6|Overall Study|Death|0
5110120|NCT01831466|17650284|P5|Overall Study|Death|0
5110121|NCT01831466|17650285|P4|Overall Study|Death|0
5110122|NCT01831466|17650286|P3|Overall Study|Death|0
5110123|NCT01831466|17650287|P2|Overall Study|Death|1
5110124|NCT01831466|17650288|P1|Overall Study|Death|0
5110125|NCT01831466|17650277|P12|Overall Study|Non-compliance with study treatment|0
5110126|NCT01831466|17650278|P11|Overall Study|Non-compliance with study treatment|0
5110127|NCT01831466|17650279|P10|Overall Study|Non-compliance with study treatment|0
5110128|NCT01831466|17650280|P9|Overall Study|Non-compliance with study treatment|0
5110129|NCT01831466|17650281|P8|Overall Study|Non-compliance with study treatment|0
5110130|NCT01831466|17650282|P7|Overall Study|Non-compliance with study treatment|0
5110131|NCT01831466|17650283|P6|Overall Study|Non-compliance with study treatment|1
5110132|NCT01831466|17650284|P5|Overall Study|Non-compliance with study treatment|0
5110133|NCT01831466|17650285|P4|Overall Study|Non-compliance with study treatment|0
5110134|NCT01831466|17650286|P3|Overall Study|Non-compliance with study treatment|1
5110135|NCT01831466|17650287|P2|Overall Study|Non-compliance with study treatment|1
5110136|NCT01831466|17650288|P1|Overall Study|Non-compliance with study treatment|2
5110137|NCT01831466|17650277|P12|Overall Study|Other|0
5110138|NCT01831466|17650278|P11|Overall Study|Other|0
5110139|NCT01831466|17650279|P10|Overall Study|Other|0
5110140|NCT01831466|17650280|P9|Overall Study|Other|0
5110141|NCT01831466|17650281|P8|Overall Study|Other|0
5110142|NCT01831466|17650282|P7|Overall Study|Other|0
5110143|NCT01831466|17650283|P6|Overall Study|Other|1
5110144|NCT01831466|17650284|P5|Overall Study|Other|2
5110145|NCT01831466|17650285|P4|Overall Study|Other|2
5110146|NCT01831466|17650286|P3|Overall Study|Other|2
5110147|NCT01831466|17650287|P2|Overall Study|Other|3
5110148|NCT01831466|17650288|P1|Overall Study|Other|2
5110149|NCT01831466|17650277|P12|Overall Study|Protocol Violation|0
5110150|NCT01831466|17650278|P11|Overall Study|Protocol Violation|0
5110151|NCT01831466|17650279|P10|Overall Study|Protocol Violation|0
5110152|NCT01831466|17650280|P9|Overall Study|Protocol Violation|0
5110153|NCT01831466|17650281|P8|Overall Study|Protocol Violation|0
5110154|NCT01831466|17650282|P7|Overall Study|Protocol Violation|0
5110155|NCT01831466|17650283|P6|Overall Study|Protocol Violation|1
5110156|NCT01831466|17650284|P5|Overall Study|Protocol Violation|0
5110157|NCT01831466|17650285|P4|Overall Study|Protocol Violation|0
5110158|NCT01831466|17650286|P3|Overall Study|Protocol Violation|2
5110159|NCT01831466|17650287|P2|Overall Study|Protocol Violation|1
5110160|NCT01831466|17650288|P1|Overall Study|Protocol Violation|1
5110161|NCT01831258|17650410|P2|Overall Study|Lost to Follow-up|2
5110162|NCT01831258|17650411|P1|Overall Study|Lost to Follow-up|3
5110163|NCT01831258|17650410|P2|Overall Study|Withdrawal by Subject|1
5110164|NCT01831258|17650411|P1|Overall Study|Withdrawal by Subject|2
5110165|NCT01831089|17650501|P6|Cohort B: Arm B|Global end of study|1
5110166|NCT01831089|17650502|P5|Cohort B: Arm B|Global end of study|0
5110167|NCT01831089|17650503|P4|Cohort B: Arm B|Global end of study|0
5110168|NCT01831089|17650504|P3|Cohort B: Arm B|Global end of study|0
5110169|NCT01831089|17650505|P2|Cohort B: Arm B|Global end of study|0
5110170|NCT01831089|17650506|P1|Cohort B: Arm B|Global end of study|0
5110171|NCT01831089|17650501|P6|Cohort B: Arm B|Adverse Event|1
5110172|NCT01831089|17650502|P5|Cohort B: Arm B|Adverse Event|0
5110173|NCT01831089|17650503|P4|Cohort B: Arm B|Adverse Event|0
5110174|NCT01831089|17650504|P3|Cohort B: Arm B|Adverse Event|0
5110175|NCT01831089|17650505|P2|Cohort B: Arm B|Adverse Event|0
5110176|NCT01831089|17650506|P1|Cohort B: Arm B|Adverse Event|0
5110177|NCT01831089|17650501|P6|Cohort B: Arm B|Never treated|2
5110178|NCT01831089|17650502|P5|Cohort B: Arm B|Never treated|0
5110179|NCT01831089|17650503|P4|Cohort B: Arm B|Never treated|0
5110180|NCT01831089|17650504|P3|Cohort B: Arm B|Never treated|0
5110181|NCT01831089|17650505|P2|Cohort B: Arm B|Never treated|0
5110182|NCT01831089|17650506|P1|Cohort B: Arm B|Never treated|0
5110183|NCT01831089|17650501|P6|Cohort B: Arm B|Physician Decision|2
5110184|NCT01831089|17650502|P5|Cohort B: Arm B|Physician Decision|0
5110185|NCT01831089|17650503|P4|Cohort B: Arm B|Physician Decision|0
5110186|NCT01831089|17650504|P3|Cohort B: Arm B|Physician Decision|0
5110187|NCT01831089|17650505|P2|Cohort B: Arm B|Physician Decision|0
5110188|NCT01831089|17650506|P1|Cohort B: Arm B|Physician Decision|0
5110189|NCT01831089|17650501|P6|Cohort B: Arm B|Progressive disease|8
5110190|NCT01831089|17650502|P5|Cohort B: Arm B|Progressive disease|0
5110191|NCT01831089|17650503|P4|Cohort B: Arm B|Progressive disease|0
5110192|NCT01831089|17650504|P3|Cohort B: Arm B|Progressive disease|0
5110193|NCT01831089|17650505|P2|Cohort B: Arm B|Progressive disease|0
5110194|NCT01831089|17650506|P1|Cohort B: Arm B|Progressive disease|0
5110195|NCT01831089|17650501|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
5110196|NCT01831089|17650502|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
5110197|NCT01831089|17650503|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
5110198|NCT01831089|17650504|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
5110199|NCT01831089|17650505|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
5110200|NCT01831089|17650506|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
5110201|NCT01831089|17650501|P6|Cohort V: Dose Level 5|Global end of study|0
5110202|NCT01831089|17650502|P5|Cohort V: Dose Level 5|Global end of study|2
5110203|NCT01831089|17650503|P4|Cohort V: Dose Level 5|Global end of study|0
5110204|NCT01831089|17650504|P3|Cohort V: Dose Level 5|Global end of study|0
5110205|NCT01831089|17650505|P2|Cohort V: Dose Level 5|Global end of study|0
5110206|NCT01831089|17650506|P1|Cohort V: Dose Level 5|Global end of study|0
5110207|NCT01831089|17650501|P6|Cohort V: Dose Level 5|Death|0
5110208|NCT01831089|17650502|P5|Cohort V: Dose Level 5|Death|1
5110209|NCT01831089|17650503|P4|Cohort V: Dose Level 5|Death|0
5110210|NCT01831089|17650504|P3|Cohort V: Dose Level 5|Death|0
5110211|NCT01831089|17650505|P2|Cohort V: Dose Level 5|Death|0
5110212|NCT01831089|17650506|P1|Cohort V: Dose Level 5|Death|0
5110213|NCT01831089|17650501|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
5110214|NCT01831089|17650502|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
5110215|NCT01831089|17650503|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
5110216|NCT01831089|17650504|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
5110217|NCT01831089|17650505|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
5110218|NCT01831089|17650506|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
5110219|NCT01831089|17650501|P6|Cohort V: Dose Level 5|Progressive disease|0
5110220|NCT01831089|17650502|P5|Cohort V: Dose Level 5|Progressive disease|30
5110221|NCT01831089|17650503|P4|Cohort V: Dose Level 5|Progressive disease|0
5110222|NCT01831089|17650504|P3|Cohort V: Dose Level 5|Progressive disease|0
5110223|NCT01831089|17650505|P2|Cohort V: Dose Level 5|Progressive disease|0
5110224|NCT01831089|17650506|P1|Cohort V: Dose Level 5|Progressive disease|0
5110225|NCT01831089|17650501|P6|Cohort IV: Dose Level 4|Progressive disease|0
5110226|NCT01831089|17650502|P5|Cohort IV: Dose Level 4|Progressive disease|0
5110227|NCT01831089|17650503|P4|Cohort IV: Dose Level 4|Progressive disease|6
5110228|NCT01831089|17650504|P3|Cohort IV: Dose Level 4|Progressive disease|0
5110229|NCT01831089|17650505|P2|Cohort IV: Dose Level 4|Progressive disease|0
5110230|NCT01831089|17650506|P1|Cohort IV: Dose Level 4|Progressive disease|0
5110231|NCT01831089|17650501|P6|Cohort III: Dose Level 3|Global end of study|0
5110232|NCT01831089|17650502|P5|Cohort III: Dose Level 3|Global end of study|0
5110233|NCT01831089|17650503|P4|Cohort III: Dose Level 3|Global end of study|0
5110234|NCT01831089|17650504|P3|Cohort III: Dose Level 3|Global end of study|1
5110235|NCT01831089|17650505|P2|Cohort III: Dose Level 3|Global end of study|0
5110236|NCT01831089|17650506|P1|Cohort III: Dose Level 3|Global end of study|0
5110237|NCT01831089|17650501|P6|Cohort III: Dose Level 3|Adverse Event|0
5110238|NCT01831089|17650502|P5|Cohort III: Dose Level 3|Adverse Event|0
5110239|NCT01831089|17650503|P4|Cohort III: Dose Level 3|Adverse Event|0
5110240|NCT01831089|17650504|P3|Cohort III: Dose Level 3|Adverse Event|1
5110241|NCT01831089|17650505|P2|Cohort III: Dose Level 3|Adverse Event|0
5110242|NCT01831089|17650506|P1|Cohort III: Dose Level 3|Adverse Event|0
5110243|NCT01831089|17650501|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
5110244|NCT01831089|17650502|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
5110245|NCT01831089|17650503|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
5110246|NCT01831089|17650504|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
5110247|NCT01831089|17650505|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
5110248|NCT01831089|17650506|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
5110249|NCT01831089|17650501|P6|Cohort III: Dose Level 3|Progressive disease|0
5110250|NCT01831089|17650502|P5|Cohort III: Dose Level 3|Progressive disease|0
5110251|NCT01831089|17650503|P4|Cohort III: Dose Level 3|Progressive disease|0
5110252|NCT01831089|17650504|P3|Cohort III: Dose Level 3|Progressive disease|3
5110253|NCT01831089|17650505|P2|Cohort III: Dose Level 3|Progressive disease|0
5110254|NCT01831089|17650506|P1|Cohort III: Dose Level 3|Progressive disease|0
5110255|NCT01831089|17650501|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
5110256|NCT01831089|17650502|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
5110257|NCT01831089|17650503|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
5110258|NCT01831089|17650504|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
5110259|NCT01831089|17650505|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
5110260|NCT01831089|17650506|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
5110261|NCT01831089|17650501|P6|Cohort II: Dose Level 2|Progressive disease|0
5110262|NCT01831089|17650502|P5|Cohort II: Dose Level 2|Progressive disease|0
5110263|NCT01831089|17650503|P4|Cohort II: Dose Level 2|Progressive disease|0
5110264|NCT01831089|17650504|P3|Cohort II: Dose Level 2|Progressive disease|0
5110265|NCT01831089|17650505|P2|Cohort II: Dose Level 2|Progressive disease|2
5110266|NCT01831089|17650506|P1|Cohort II: Dose Level 2|Progressive disease|0
5110267|NCT01831089|17650501|P6|Cohort I: Dose Level 1|Progressive disease|0
5110268|NCT01831089|17650502|P5|Cohort I: Dose Level 1|Progressive disease|0
5110269|NCT01831089|17650503|P4|Cohort I: Dose Level 1|Progressive disease|0
5110270|NCT01831089|17650504|P3|Cohort I: Dose Level 1|Progressive disease|0
5110271|NCT01831089|17650505|P2|Cohort I: Dose Level 1|Progressive disease|0
5110272|NCT01831089|17650506|P1|Cohort I: Dose Level 1|Progressive disease|3
5110273|NCT01830972|17650557|P2|Part IV|Non-Compliance|0
5110274|NCT01830972|17650558|P1|Part IV|Non-Compliance|1
5110275|NCT01830972|17650557|P2|Part IV|Withdrawal by Subject|1
5110276|NCT01830972|17650558|P1|Part IV|Withdrawal by Subject|2
5110277|NCT01830972|17650557|P2|Part III|Noncompliance|0
5110278|NCT01830972|17650558|P1|Part III|Noncompliance|1
5110279|NCT01830972|17650557|P2|Part III|Withdrawal by Subject|0
5110280|NCT01830972|17650558|P1|Part III|Withdrawal by Subject|1
5110281|NCT01830972|17650557|P2|Part II|Withdrawal by Subject|2
5110282|NCT01830972|17650558|P1|Part II|Withdrawal by Subject|2
5110283|NCT01830920|17650602|P5|Overall Study|Other|3
5110284|NCT01830920|17650603|P4|Overall Study|Other|5
5110285|NCT01830920|17650604|P3|Overall Study|Other|1
5110286|NCT01830920|17650605|P2|Overall Study|Other|1
5110287|NCT01830920|17650606|P1|Overall Study|Other|15
5110288|NCT01830920|17650602|P5|Overall Study|Death|4
5110289|NCT01830920|17650603|P4|Overall Study|Death|4
5110290|NCT01830920|17650604|P3|Overall Study|Death|5
5110291|NCT01830920|17650605|P2|Overall Study|Death|3
5110292|NCT01830920|17650606|P1|Overall Study|Death|3
5110293|NCT01830920|17650602|P5|Overall Study|Withdrawal by Subject|1
5110294|NCT01830920|17650603|P4|Overall Study|Withdrawal by Subject|7
5110295|NCT01830920|17650604|P3|Overall Study|Withdrawal by Subject|1
5110296|NCT01830920|17650605|P2|Overall Study|Withdrawal by Subject|2
5110297|NCT01830920|17650606|P1|Overall Study|Withdrawal by Subject|2
5110298|NCT01830920|17650602|P5|Overall Study|Adverse Event|0
5110299|NCT01830920|17650603|P4|Overall Study|Adverse Event|0
5110300|NCT01830920|17650604|P3|Overall Study|Adverse Event|1
5110301|NCT01830920|17650605|P2|Overall Study|Adverse Event|0
5110302|NCT01830920|17650606|P1|Overall Study|Adverse Event|1
5110303|NCT01830881|17650645|P2|Overall Study|Changed decision to have an abortion|1
5110304|NCT01830881|17650646|P1|Overall Study|Changed decision to have an abortion|0
5110305|NCT01830855|17650694|P4|Overall Study|Lost to Follow-up|33
5110306|NCT01830855|17650695|P3|Overall Study|Lost to Follow-up|23
5110307|NCT01830855|17650696|P2|Overall Study|Lost to Follow-up|20
5110308|NCT01830855|17650697|P1|Overall Study|Lost to Follow-up|47
5110309|NCT01830855|17650694|P4|Overall Study|No longer willing to participate|17
5110310|NCT01830855|17650695|P3|Overall Study|No longer willing to participate|12
5110311|NCT01830855|17650696|P2|Overall Study|No longer willing to participate|13
5110312|NCT01830855|17650697|P1|Overall Study|No longer willing to participate|32
5110313|NCT01830855|17650694|P4|Overall Study|Withdrawal by Subject|12
5110314|NCT01830855|17650695|P3|Overall Study|Withdrawal by Subject|10
5110315|NCT01830855|17650696|P2|Overall Study|Withdrawal by Subject|14
5110316|NCT01830855|17650697|P1|Overall Study|Withdrawal by Subject|33
5110317|NCT01830855|17650694|P4|Overall Study|Protocol deviation|6
5110318|NCT01830855|17650695|P3|Overall Study|Protocol deviation|6
5110319|NCT01830855|17650696|P2|Overall Study|Protocol deviation|5
5110320|NCT01830855|17650697|P1|Overall Study|Protocol deviation|10
5110321|NCT01830855|17650694|P4|Overall Study|Adverse Event|3
5110322|NCT01830855|17650695|P3|Overall Study|Adverse Event|6
5110323|NCT01830855|17650696|P2|Overall Study|Adverse Event|5
5110324|NCT01830855|17650697|P1|Overall Study|Adverse Event|11
5110325|NCT01830855|17650694|P4|Overall Study|No longer meets eligibility criteria|5
5110326|NCT01830855|17650695|P3|Overall Study|No longer meets eligibility criteria|3
5110327|NCT01830855|17650696|P2|Overall Study|No longer meets eligibility criteria|2
5110328|NCT01830855|17650697|P1|Overall Study|No longer meets eligibility criteria|11
5110329|NCT01830855|17650694|P4|Overall Study|Pregnancy|1
5110330|NCT01830855|17650695|P3|Overall Study|Pregnancy|2
5110331|NCT01830855|17650696|P2|Overall Study|Pregnancy|1
5110332|NCT01830855|17650697|P1|Overall Study|Pregnancy|3
5110333|NCT01830855|17650694|P4|Overall Study|Medication error without associated AE|1
5110334|NCT01830855|17650695|P3|Overall Study|Medication error without associated AE|0
5110335|NCT01830855|17650696|P2|Overall Study|Medication error without associated AE|0
5110336|NCT01830855|17650697|P1|Overall Study|Medication error without associated AE|1
5110337|NCT01830855|17650694|P4|Overall Study|Other|4
5110338|NCT01830855|17650695|P3|Overall Study|Other|4
5110339|NCT01830855|17650696|P2|Overall Study|Other|1
5110340|NCT01830855|17650697|P1|Overall Study|Other|7
5110341|NCT01830816|17650813|P3|Overall Study|Reason not Specified|0
5110342|NCT01830816|17650814|P2|Overall Study|Reason not Specified|0
5110343|NCT01830816|17650815|P1|Overall Study|Reason not Specified|2
5110344|NCT01830816|17650813|P3|Overall Study|Symptomatic Deterioration|0
5110345|NCT01830816|17650814|P2|Overall Study|Symptomatic Deterioration|0
5110346|NCT01830816|17650815|P1|Overall Study|Symptomatic Deterioration|1
5110347|NCT01830816|17650813|P3|Overall Study|Lost to Follow-up|0
5110348|NCT01830816|17650814|P2|Overall Study|Lost to Follow-up|1
5110349|NCT01830816|17650815|P1|Overall Study|Lost to Follow-up|0
5110350|NCT01830816|17650813|P3|Overall Study|Withdrawal by Subject|0
5110351|NCT01830816|17650814|P2|Overall Study|Withdrawal by Subject|1
5110352|NCT01830816|17650815|P1|Overall Study|Withdrawal by Subject|1
5110353|NCT01830816|17650813|P3|Overall Study|Study Terminated by Sponsor|0
5110354|NCT01830816|17650814|P2|Overall Study|Study Terminated by Sponsor|1
5110355|NCT01830816|17650815|P1|Overall Study|Study Terminated by Sponsor|1
5110356|NCT01830816|17650813|P3|Overall Study|Adverse Event|0
5110357|NCT01830816|17650814|P2|Overall Study|Adverse Event|4
5110358|NCT01830816|17650815|P1|Overall Study|Adverse Event|3
5110359|NCT01830816|17650813|P3|Overall Study|Progressive Disease|7
5110360|NCT01830816|17650814|P2|Overall Study|Progressive Disease|7
5110361|NCT01830816|17650815|P1|Overall Study|Progressive Disease|12
5110362|NCT01830595|17650879|P2|Washout|Withdrawal by Subject|2
5110363|NCT01830595|17650880|P1|Washout|Withdrawal by Subject|2
5110364|NCT01830595|17650879|P2|First Period|Withdrawal by Subject|3
5110365|NCT01830595|17650880|P1|First Period|Withdrawal by Subject|1
5110366|NCT01830543|17650897|P3|Overall Study|Other|37
5110367|NCT01830543|17650898|P2|Overall Study|Other|17
5110368|NCT01830543|17650899|P1|Overall Study|Other|12
5110369|NCT01830543|17650897|P3|Overall Study|Withdrawal by consent|3
5110370|NCT01830543|17650898|P2|Overall Study|Withdrawal by consent|3
5110371|NCT01830543|17650899|P1|Overall Study|Withdrawal by consent|3
5110372|NCT01830543|17650897|P3|Overall Study|Physician Decision|12
5110373|NCT01830543|17650898|P2|Overall Study|Physician Decision|5
5110374|NCT01830543|17650899|P1|Overall Study|Physician Decision|11
5110375|NCT01830543|17650897|P3|Overall Study|Protocol Violation|7
5110376|NCT01830543|17650898|P2|Overall Study|Protocol Violation|7
5110377|NCT01830543|17650899|P1|Overall Study|Protocol Violation|3
5110378|NCT01830543|17650897|P3|Overall Study|Death|22
5110379|NCT01830543|17650898|P2|Overall Study|Death|22
5110380|NCT01830543|17650899|P1|Overall Study|Death|20
5110381|NCT01830543|17650897|P3|Overall Study|Adverse Event|76
5110382|NCT01830543|17650898|P2|Overall Study|Adverse Event|77
5110383|NCT01830543|17650899|P1|Overall Study|Adverse Event|91
5110384|NCT01830543|17650897|P3|Overall Study|Subject Decision|57
5110385|NCT01830543|17650898|P2|Overall Study|Subject Decision|21
5110386|NCT01830543|17650899|P1|Overall Study|Subject Decision|19
5110387|NCT01830127|17651031|P2|Overall Study|Other reason not defined above|2
5110388|NCT01830127|17651032|P1|Overall Study|Other reason not defined above|0
5110389|NCT01830127|17651031|P2|Overall Study|Withdrawal by Subject|1
5110390|NCT01830127|17651032|P1|Overall Study|Withdrawal by Subject|1
5110391|NCT01830127|17651031|P2|Overall Study|Lack of Efficacy|0
5110392|NCT01830127|17651032|P1|Overall Study|Lack of Efficacy|3
5110393|NCT01830127|17651031|P2|Overall Study|Adverse Event|6
5110394|NCT01830127|17651032|P1|Overall Study|Adverse Event|1
5110395|NCT01829711|17651065|P1|Overall Study|Due to lack of response|1
5110396|NCT01829711|17651065|P1|Overall Study|Due to progression of disease|13
5110397|NCT01829711|17651065|P1|Overall Study|Adverse Event|3
5110398|NCT01829711|17651065|P1|Overall Study|Started new therapies|17
5110399|NCT01829711|17651065|P1|Overall Study|Death|4
5110400|NCT01829711|17651065|P1|Overall Study|Withdrawal by Subject|3
5110401|NCT01829711|17651065|P1|Overall Study|Lost to Follow-up|2
5110402|NCT01829477|17651122|P2|Overall Study|Withdrawal by Subject|0
5110403|NCT01829477|17651123|P1|Overall Study|Withdrawal by Subject|1
5110404|NCT01829477|17651122|P2|Overall Study|Study Terminated by Sponsor|15
5110405|NCT01829477|17651123|P1|Overall Study|Study Terminated by Sponsor|15
5110406|NCT01829464|17651136|P3|Overall Study|Lack of Efficacy|0
5110407|NCT01829464|17651137|P2|Overall Study|Lack of Efficacy|1
5110408|NCT01829464|17651138|P1|Overall Study|Lack of Efficacy|0
5110409|NCT01829464|17651136|P3|Overall Study|Study terminated by sponsor|25
5110410|NCT01829464|17651137|P2|Overall Study|Study terminated by sponsor|28
5110411|NCT01829464|17651138|P1|Overall Study|Study terminated by sponsor|25
5110412|NCT01829464|17651136|P3|Overall Study|Withdrawal by Subject|0
5110413|NCT01829464|17651137|P2|Overall Study|Withdrawal by Subject|0
5110414|NCT01829464|17651138|P1|Overall Study|Withdrawal by Subject|2
5110415|NCT01829464|17651136|P3|Overall Study|Lost to Follow-up|1
5110416|NCT01829464|17651137|P2|Overall Study|Lost to Follow-up|0
5110417|NCT01829464|17651138|P1|Overall Study|Lost to Follow-up|0
5110418|NCT01829464|17651136|P3|Overall Study|Adverse Event|0
5110419|NCT01829464|17651137|P2|Overall Study|Adverse Event|0
5110420|NCT01829464|17651138|P1|Overall Study|Adverse Event|1
5110421|NCT01829425|17651154|P2|Overall Study|Lost to Follow-up|1
5110422|NCT01829425|17651155|P1|Overall Study|Lost to Follow-up|2
5110423|NCT01829425|17651154|P2|Overall Study|Withdrawal by Subject|3
5110424|NCT01829425|17651155|P1|Overall Study|Withdrawal by Subject|4
5110425|NCT01829360|17651198|P4|Overall Study|Protocol Violation|0
5110426|NCT01829360|17651199|P3|Overall Study|Protocol Violation|1
5110427|NCT01829360|17651200|P2|Overall Study|Protocol Violation|0
5110428|NCT01829360|17651201|P1|Overall Study|Protocol Violation|0
5110429|NCT01829347|17651221|P2|VTI-210E|Study terminated prematurely|5
5110430|NCT01829347|17651222|P1|VTI-210E|Study terminated prematurely|1
5110431|NCT01829347|17651221|P2|VTI-210E|Death|1
5110432|NCT01829347|17651222|P1|VTI-210E|Death|2
5110433|NCT01829347|17651221|P2|VTI-210|Withdrawal by Subject|0
5110434|NCT01829347|17651222|P1|VTI-210|Withdrawal by Subject|1
5110435|NCT01829347|17651221|P2|VTI-210|Death|3
5110436|NCT01829347|17651222|P1|VTI-210|Death|5
5110437|NCT01829295|17651232|P4|6-12 Months|Withdrawal by Subject|0
5110438|NCT01829295|17651233|P3|6-12 Months|Withdrawal by Subject|0
5110439|NCT01829295|17651234|P2|6-12 Months|Withdrawal by Subject|2
5110440|NCT01829295|17651235|P1|6-12 Months|Withdrawal by Subject|2
5110441|NCT01829295|17651232|P4|6-12 Months|Lost to Follow-up|0
5110442|NCT01829295|17651233|P3|6-12 Months|Lost to Follow-up|0
5110443|NCT01829295|17651234|P2|6-12 Months|Lost to Follow-up|0
5110444|NCT01829295|17651235|P1|6-12 Months|Lost to Follow-up|2
5110445|NCT01829295|17651232|P4|6-12 Months|Adverse Event|2
5110446|NCT01829295|17651233|P3|6-12 Months|Adverse Event|3
5110447|NCT01829295|17651234|P2|6-12 Months|Adverse Event|0
5110448|NCT01829295|17651235|P1|6-12 Months|Adverse Event|0
5110449|NCT01829295|17651232|P4|6-12 Months|Did not want to switch antimetabolites|11
5110450|NCT01829295|17651233|P3|6-12 Months|Did not want to switch antimetabolites|9
5110451|NCT01829295|17651234|P2|6-12 Months|Did not want to switch antimetabolites|0
5110452|NCT01829295|17651235|P1|6-12 Months|Did not want to switch antimetabolites|0
5110453|NCT01829243|17651245|P2|First Intervention|Screen Failure|2
5110454|NCT01829243|17651246|P1|First Intervention|Screen Failure|4
5110455|NCT01829230|17651260|P2|Overall Study|Lost to Follow-up|1
5110456|NCT01829230|17651261|P1|Overall Study|Lost to Follow-up|1
5110457|NCT01829230|17651260|P2|Overall Study|Withdrawal by Subject|1
5110458|NCT01829230|17651261|P1|Overall Study|Withdrawal by Subject|0
5110459|NCT01829230|17651260|P2|Overall Study|Protocol Violation|2
5110460|NCT01829230|17651261|P1|Overall Study|Protocol Violation|0
5110461|NCT01829191|17651275|P2|Overall Study|Subject was fit for ortho - k|1
5110462|NCT01829191|17651276|P1|Overall Study|Subject was fit for ortho - k|0
5110463|NCT01829191|17651275|P2|Overall Study|Lost to Follow-up|1
5110464|NCT01829191|17651276|P1|Overall Study|Lost to Follow-up|0
5110465|NCT01829191|17651275|P2|Overall Study|Withdrawal by Subject|3
5110466|NCT01829191|17651276|P1|Overall Study|Withdrawal by Subject|2
5110467|NCT01829191|17651275|P2|Overall Study|Protocol Violation|1
5110468|NCT01829191|17651276|P1|Overall Study|Protocol Violation|4
5110469|NCT01829191|17651275|P2|Overall Study|Lens handling difficulty|4
5110470|NCT01829191|17651276|P1|Overall Study|Lens handling difficulty|1
5110471|NCT01829191|17651275|P2|Overall Study|Lens discomfort|3
5110472|NCT01829191|17651276|P1|Overall Study|Lens discomfort|0
5110473|NCT01829191|17651275|P2|Overall Study|Relocation|1
5110474|NCT01829191|17651276|P1|Overall Study|Relocation|0
5110475|NCT01829165|17651285|P2|Overall Study|Did not complete intervention|0
5110476|NCT01829165|17651286|P1|Overall Study|Did not complete intervention|2
5110477|NCT01829113|17651294|P2|Overall Study|Physician Decision|1
5110478|NCT01829113|17651295|P1|Overall Study|Physician Decision|1
5110479|NCT01829113|17651294|P2|Overall Study|No Study Treatment Received|2
5110480|NCT01829113|17651295|P1|Overall Study|No Study Treatment Received|3
5110481|NCT01829113|17651294|P2|Overall Study|Sponsor Decision|1
5110482|NCT01829113|17651295|P1|Overall Study|Sponsor Decision|1
5110483|NCT01829113|17651294|P2|Overall Study|Death|6
5110484|NCT01829113|17651295|P1|Overall Study|Death|4
5110485|NCT01829113|17651294|P2|Overall Study|Withdrawal by Subject|10
5110486|NCT01829113|17651295|P1|Overall Study|Withdrawal by Subject|17
5110487|NCT01829113|17651294|P2|Overall Study|Adverse Event|10
5110488|NCT01829113|17651295|P1|Overall Study|Adverse Event|14
5110489|NCT01829113|17651294|P2|Overall Study|Disease Progression|48
5110490|NCT01829113|17651295|P1|Overall Study|Disease Progression|37
5110491|NCT01829048|17651312|P5|Overall Study|Withdrawal by Subject|0
5110492|NCT01829048|17651313|P4|Overall Study|Withdrawal by Subject|2
5110493|NCT01829048|17651314|P3|Overall Study|Withdrawal by Subject|0
5110494|NCT01829048|17651315|P2|Overall Study|Withdrawal by Subject|0
5110495|NCT01829048|17651316|P1|Overall Study|Withdrawal by Subject|0
5110496|NCT01828567|17651429|P2|Overall Study|Excluded - did not meet criteria|1
5110497|NCT01828567|17651430|P1|Overall Study|Excluded - did not meet criteria|4
5110498|NCT01828567|17651429|P2|Overall Study|Lost to Follow-up|9
5110499|NCT01828567|17651430|P1|Overall Study|Lost to Follow-up|27
5110500|NCT01828281|17651485|P2|Overall Study|Withdrawal by Subject|0
5110501|NCT01828281|17651486|P1|Overall Study|Withdrawal by Subject|1
5110502|NCT01828112|17651536|P2|Overall Study|Subject/guardian decision|8
5110503|NCT01828112|17651537|P1|Overall Study|Subject/guardian decision|6
5110504|NCT01828112|17651536|P2|Overall Study|Progressive disease|82
5110505|NCT01828112|17651537|P1|Overall Study|Progressive disease|56
5110506|NCT01828112|17651536|P2|Overall Study|Physician Decision|5
5110507|NCT01828112|17651537|P1|Overall Study|Physician Decision|5
5110508|NCT01828112|17651536|P2|Overall Study|Death|5
5110509|NCT01828112|17651537|P1|Overall Study|Death|9
5110510|NCT01828112|17651536|P2|Overall Study|Adverse Event|8
5110511|NCT01828112|17651537|P1|Overall Study|Adverse Event|6
5110512|NCT01828099|17651545|P2|Overall Study|Subject/guardian decision|23
5110513|NCT01828099|17651546|P1|Overall Study|Subject/guardian decision|7
5110514|NCT01828099|17651545|P2|Overall Study|Protocol Violation|0
5110515|NCT01828099|17651546|P1|Overall Study|Protocol Violation|1
5110516|NCT01828099|17651545|P2|Overall Study|Progressive disease|94
5110517|NCT01828099|17651546|P1|Overall Study|Progressive disease|51
5110518|NCT01828099|17651545|P2|Overall Study|Physician Decision|11
5110519|NCT01828099|17651546|P1|Overall Study|Physician Decision|7
5110520|NCT01828099|17651545|P2|Overall Study|Non-compliance with study treatment|0
5110521|NCT01828099|17651546|P1|Overall Study|Non-compliance with study treatment|2
5110522|NCT01828099|17651545|P2|Overall Study|Lost to Follow-up|0
5110523|NCT01828099|17651546|P1|Overall Study|Lost to Follow-up|2
5110524|NCT01828099|17651545|P2|Overall Study|Death|11
5110525|NCT01828099|17651546|P1|Overall Study|Death|9
5110526|NCT01828099|17651545|P2|Overall Study|Adverse Event|18
5110527|NCT01828099|17651546|P1|Overall Study|Adverse Event|15
5110528|NCT01828073|17651554|P2|Overall Study|Lost to Follow-up|2
5110529|NCT01828073|17651555|P1|Overall Study|Lost to Follow-up|1
5110530|NCT01828034|17651579|P4|Overall Study|Withdrawal by Subject|1
5110531|NCT01828034|17651580|P3|Overall Study|Withdrawal by Subject|0
5110532|NCT01828034|17651581|P2|Overall Study|Withdrawal by Subject|0
5110533|NCT01828034|17651582|P1|Overall Study|Withdrawal by Subject|0
5110534|NCT01828021|17651594|P1|Overall Study|Ileal obstruction, unrelated|1
5110535|NCT01828021|17651594|P1|Overall Study|Withdrawal by Subject|2
5110536|NCT01828021|17651594|P1|Overall Study|Lack of Efficacy|17
5110537|NCT01828021|17651594|P1|Overall Study|Adverse Event|5
5110538|NCT01827839|17651599|P1|Overall Study|Consent Withdrawal|2
5110539|NCT01827839|17651599|P1|Overall Study|Adverse Event|1
5110540|NCT01827670|17651644|P2|Overall Study|Lost to Follow-up|1
5110541|NCT01827670|17651645|P1|Overall Study|Lost to Follow-up|0
5110542|NCT01827670|17651644|P2|Overall Study|Withdrawal of Consent|2
5110543|NCT01827670|17651645|P1|Overall Study|Withdrawal of Consent|3
5110544|NCT01827592|17651664|P3|Overall Study|Others|3
5110545|NCT01827592|17651665|P2|Overall Study|Others|1
5110546|NCT01827592|17651666|P1|Overall Study|Others|0
5110547|NCT01827592|17651664|P3|Overall Study|Trial terminated by Sponsor|51
5110548|NCT01827592|17651665|P2|Overall Study|Trial terminated by Sponsor|53
5110549|NCT01827592|17651666|P1|Overall Study|Trial terminated by Sponsor|47
5110550|NCT01827592|17651664|P3|Overall Study|Patient's substantial non-compliance|6
5110551|NCT01827592|17651665|P2|Overall Study|Patient's substantial non-compliance|1
5110552|NCT01827592|17651666|P1|Overall Study|Patient's substantial non-compliance|1
5110553|NCT01827592|17651664|P3|Overall Study|Withdrawal by Subject|11
5110554|NCT01827592|17651665|P2|Overall Study|Withdrawal by Subject|11
5110555|NCT01827592|17651666|P1|Overall Study|Withdrawal by Subject|12
5110556|NCT01827592|17651664|P3|Overall Study|Lost to Follow-up|2
5110557|NCT01827592|17651665|P2|Overall Study|Lost to Follow-up|2
5110558|NCT01827592|17651666|P1|Overall Study|Lost to Follow-up|1
5110559|NCT01827592|17651664|P3|Overall Study|Protocol Violation|0
5110560|NCT01827592|17651665|P2|Overall Study|Protocol Violation|1
5110561|NCT01827592|17651666|P1|Overall Study|Protocol Violation|2
5110562|NCT01827592|17651664|P3|Overall Study|Physician Decision|1
5110563|NCT01827592|17651665|P2|Overall Study|Physician Decision|2
5110564|NCT01827592|17651666|P1|Overall Study|Physician Decision|0
5110565|NCT01827592|17651664|P3|Overall Study|Adverse Event|2
5110566|NCT01827592|17651665|P2|Overall Study|Adverse Event|9
5110567|NCT01827592|17651666|P1|Overall Study|Adverse Event|11
5110568|NCT01827371|17651731|P4|Overall Study|Temporary study halt to vaccinations|13
5110569|NCT01827371|17651732|P3|Overall Study|Temporary study halt to vaccinations|5
5110570|NCT01827371|17651733|P2|Overall Study|Temporary study halt to vaccinations|2
5110571|NCT01827371|17651734|P1|Overall Study|Temporary study halt to vaccinations|11
5110572|NCT01827371|17651731|P4|Overall Study|Physician Decision|1
5110573|NCT01827371|17651732|P3|Overall Study|Physician Decision|0
5110574|NCT01827371|17651733|P2|Overall Study|Physician Decision|1
5110575|NCT01827371|17651734|P1|Overall Study|Physician Decision|0
5110576|NCT01827371|17651731|P4|Overall Study|Withdrawal by Subject|3
5110577|NCT01827371|17651732|P3|Overall Study|Withdrawal by Subject|2
5110578|NCT01827371|17651733|P2|Overall Study|Withdrawal by Subject|2
5110579|NCT01827371|17651734|P1|Overall Study|Withdrawal by Subject|1
5110580|NCT01827371|17651731|P4|Overall Study|Protocol Violation|0
5110581|NCT01827371|17651732|P3|Overall Study|Protocol Violation|0
5110582|NCT01827371|17651733|P2|Overall Study|Protocol Violation|0
5110583|NCT01827371|17651734|P1|Overall Study|Protocol Violation|1
5110584|NCT01827371|17651731|P4|Overall Study|Lost to Follow-up|4
5110585|NCT01827371|17651732|P3|Overall Study|Lost to Follow-up|0
5110586|NCT01827371|17651733|P2|Overall Study|Lost to Follow-up|2
5110587|NCT01827371|17651734|P1|Overall Study|Lost to Follow-up|0
5110588|NCT01827371|17651731|P4|Overall Study|Adverse Event|2
5110589|NCT01827371|17651732|P3|Overall Study|Adverse Event|4
5110590|NCT01827371|17651733|P2|Overall Study|Adverse Event|0
5110591|NCT01827371|17651734|P1|Overall Study|Adverse Event|0
5110592|NCT01827332|17651793|P2|Overall Study|Lost to Follow-up|1
5110593|NCT01827332|17651794|P1|Overall Study|Lost to Follow-up|2
5110594|NCT01827319|17651802|P1|Overall Study|Lost to Follow-up|3
5110595|NCT01827267|17651825|P2|Overall Study|Still on study|2
5110596|NCT01827267|17651826|P1|Overall Study|Still on study|0
5110597|NCT01827267|17651825|P2|Overall Study|Sponsor Discontinued Study|8
5110598|NCT01827267|17651826|P1|Overall Study|Sponsor Discontinued Study|2
5110599|NCT01827267|17651825|P2|Overall Study|Disease Progression|1
5110600|NCT01827267|17651826|P1|Overall Study|Disease Progression|1
5110601|NCT01827267|17651825|P2|Overall Study|Physician Decision|0
5110602|NCT01827267|17651826|P1|Overall Study|Physician Decision|1
5110603|NCT01827267|17651825|P2|Overall Study|Did not receive study drug|1
5110604|NCT01827267|17651826|P1|Overall Study|Did not receive study drug|1
5110605|NCT01827254|17651841|P1|Overall Study|Intolerance to treatment|4
5110606|NCT01827254|17651841|P1|Overall Study|Disease progression|36
5110607|NCT01827254|17651841|P1|Overall Study|Did not complete re-challenge|1
5110608|NCT01827254|17651841|P1|Overall Study|Discontinued prior initiation: sunitinib|1
5110609|NCT01827254|17651841|P1|Overall Study|Invalidated centre|3
5110610|NCT01827254|17651841|P1|Overall Study|Case report form not completed|4
5110611|NCT01827254|17651841|P1|Overall Study|Death|10
5110612|NCT01827163|17651851|P1|Overall Study|Adverse Event|9
5110613|NCT01827163|17651851|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
5110614|NCT01827046|17651858|P2|Overall Study|Withdrawal by Subject|4
5110615|NCT01827046|17651859|P1|Overall Study|Withdrawal by Subject|0
5110616|NCT01827046|17651858|P2|Overall Study|Lost to Follow-up|5
5110617|NCT01827046|17651859|P1|Overall Study|Lost to Follow-up|1
5110618|NCT01826981|17651914|P15|Overall Study|Enrolled/Randomized but Not Treated|0
5110619|NCT01826981|17651915|P14|Overall Study|Enrolled/Randomized but Not Treated|0
5110620|NCT01826981|17651916|P13|Overall Study|Enrolled/Randomized but Not Treated|0
5110621|NCT01826981|17651917|P12|Overall Study|Enrolled/Randomized but Not Treated|0
5110622|NCT01826981|17651918|P11|Overall Study|Enrolled/Randomized but Not Treated|0
5110623|NCT01826981|17651919|P10|Overall Study|Enrolled/Randomized but Not Treated|0
5110624|NCT01826981|17651920|P9|Overall Study|Enrolled/Randomized but Not Treated|0
5110625|NCT01826981|17651921|P8|Overall Study|Enrolled/Randomized but Not Treated|1
5110626|NCT01826981|17651922|P7|Overall Study|Enrolled/Randomized but Not Treated|0
5110627|NCT01826981|17651923|P6|Overall Study|Enrolled/Randomized but Not Treated|0
5110628|NCT01826981|17651924|P5|Overall Study|Enrolled/Randomized but Not Treated|0
5110629|NCT01826981|17651925|P4|Overall Study|Enrolled/Randomized but Not Treated|0
5110630|NCT01826981|17651926|P3|Overall Study|Enrolled/Randomized but Not Treated|0
5110631|NCT01826981|17651927|P2|Overall Study|Enrolled/Randomized but Not Treated|0
5110632|NCT01826981|17651928|P1|Overall Study|Enrolled/Randomized but Not Treated|0
5110633|NCT01826981|17651914|P15|Overall Study|Upper G-I Haemorrhage|0
5110634|NCT01826981|17651915|P14|Overall Study|Upper G-I Haemorrhage|1
5110635|NCT01826981|17651916|P13|Overall Study|Upper G-I Haemorrhage|0
5110636|NCT01826981|17651917|P12|Overall Study|Upper G-I Haemorrhage|0
5110637|NCT01826981|17651918|P11|Overall Study|Upper G-I Haemorrhage|0
5110638|NCT01826981|17651919|P10|Overall Study|Upper G-I Haemorrhage|0
5110639|NCT01826981|17651920|P9|Overall Study|Upper G-I Haemorrhage|0
5110640|NCT01826981|17651921|P8|Overall Study|Upper G-I Haemorrhage|0
5110641|NCT01826981|17651922|P7|Overall Study|Upper G-I Haemorrhage|0
5110642|NCT01826981|17651923|P6|Overall Study|Upper G-I Haemorrhage|0
5110643|NCT01826981|17651924|P5|Overall Study|Upper G-I Haemorrhage|0
5110644|NCT01826981|17651925|P4|Overall Study|Upper G-I Haemorrhage|0
5110645|NCT01826981|17651926|P3|Overall Study|Upper G-I Haemorrhage|0
5110646|NCT01826981|17651927|P2|Overall Study|Upper G-I Haemorrhage|0
5110647|NCT01826981|17651928|P1|Overall Study|Upper G-I Haemorrhage|0
5110648|NCT01826981|17651914|P15|Overall Study|Adverse Event|0
5110649|NCT01826981|17651915|P14|Overall Study|Adverse Event|0
5110650|NCT01826981|17651916|P13|Overall Study|Adverse Event|0
5110651|NCT01826981|17651917|P12|Overall Study|Adverse Event|0
5110652|NCT01826981|17651918|P11|Overall Study|Adverse Event|0
5110653|NCT01826981|17651919|P10|Overall Study|Adverse Event|0
5110654|NCT01826981|17651920|P9|Overall Study|Adverse Event|0
5110655|NCT01826981|17651921|P8|Overall Study|Adverse Event|0
5110656|NCT01826981|17651922|P7|Overall Study|Adverse Event|0
5110657|NCT01826981|17651923|P6|Overall Study|Adverse Event|0
5110658|NCT01826981|17651924|P5|Overall Study|Adverse Event|1
5110659|NCT01826981|17651925|P4|Overall Study|Adverse Event|0
5110660|NCT01826981|17651926|P3|Overall Study|Adverse Event|0
5110661|NCT01826981|17651927|P2|Overall Study|Adverse Event|0
5110662|NCT01826981|17651928|P1|Overall Study|Adverse Event|0
5110663|NCT01826981|17651914|P15|Overall Study|Withdrew Consent|0
5110664|NCT01826981|17651915|P14|Overall Study|Withdrew Consent|1
5110665|NCT01826981|17651916|P13|Overall Study|Withdrew Consent|0
5110666|NCT01826981|17651917|P12|Overall Study|Withdrew Consent|1
5110667|NCT01826981|17651918|P11|Overall Study|Withdrew Consent|0
5110668|NCT01826981|17651919|P10|Overall Study|Withdrew Consent|0
5110669|NCT01826981|17651920|P9|Overall Study|Withdrew Consent|0
5110670|NCT01826981|17651921|P8|Overall Study|Withdrew Consent|1
5110671|NCT01826981|17651922|P7|Overall Study|Withdrew Consent|1
5110672|NCT01826981|17651923|P6|Overall Study|Withdrew Consent|0
5110673|NCT01826981|17651924|P5|Overall Study|Withdrew Consent|0
5110674|NCT01826981|17651925|P4|Overall Study|Withdrew Consent|0
5110675|NCT01826981|17651926|P3|Overall Study|Withdrew Consent|0
5110676|NCT01826981|17651927|P2|Overall Study|Withdrew Consent|0
5110677|NCT01826981|17651928|P1|Overall Study|Withdrew Consent|0
5110678|NCT01826981|17651914|P15|Overall Study|Lost to Follow-up|0
5110679|NCT01826981|17651915|P14|Overall Study|Lost to Follow-up|0
5110680|NCT01826981|17651916|P13|Overall Study|Lost to Follow-up|1
5110681|NCT01826981|17651917|P12|Overall Study|Lost to Follow-up|1
5110682|NCT01826981|17651918|P11|Overall Study|Lost to Follow-up|1
5110683|NCT01826981|17651919|P10|Overall Study|Lost to Follow-up|1
5110684|NCT01826981|17651920|P9|Overall Study|Lost to Follow-up|0
5110685|NCT01826981|17651921|P8|Overall Study|Lost to Follow-up|1
5110686|NCT01826981|17651922|P7|Overall Study|Lost to Follow-up|0
5110687|NCT01826981|17651923|P6|Overall Study|Lost to Follow-up|1
5110688|NCT01826981|17651924|P5|Overall Study|Lost to Follow-up|1
5110689|NCT01826981|17651925|P4|Overall Study|Lost to Follow-up|0
5110690|NCT01826981|17651926|P3|Overall Study|Lost to Follow-up|0
5110691|NCT01826981|17651927|P2|Overall Study|Lost to Follow-up|0
5110692|NCT01826981|17651928|P1|Overall Study|Lost to Follow-up|0
5110693|NCT01826981|17651914|P15|Overall Study|Lack of Efficacy|0
5110694|NCT01826981|17651915|P14|Overall Study|Lack of Efficacy|3
5110695|NCT01826981|17651916|P13|Overall Study|Lack of Efficacy|0
5110696|NCT01826981|17651917|P12|Overall Study|Lack of Efficacy|0
5110697|NCT01826981|17651918|P11|Overall Study|Lack of Efficacy|1
5110698|NCT01826981|17651919|P10|Overall Study|Lack of Efficacy|0
5110699|NCT01826981|17651920|P9|Overall Study|Lack of Efficacy|7
5110700|NCT01826981|17651921|P8|Overall Study|Lack of Efficacy|8
5110701|NCT01826981|17651922|P7|Overall Study|Lack of Efficacy|0
5110702|NCT01826981|17651923|P6|Overall Study|Lack of Efficacy|0
5110703|NCT01826981|17651924|P5|Overall Study|Lack of Efficacy|5
5110704|NCT01826981|17651925|P4|Overall Study|Lack of Efficacy|0
5110705|NCT01826981|17651926|P3|Overall Study|Lack of Efficacy|0
5110706|NCT01826981|17651927|P2|Overall Study|Lack of Efficacy|1
5110707|NCT01826981|17651928|P1|Overall Study|Lack of Efficacy|0
5110708|NCT01826604|17652114|P2|Overall Study|Lost to Follow-up|9
5110709|NCT01826604|17652115|P1|Overall Study|Lost to Follow-up|8
5110710|NCT01826487|17652159|P2|Overall Study|Protocol Violation|1
5110711|NCT01826487|17652160|P1|Overall Study|Protocol Violation|1
5110712|NCT01826487|17652159|P2|Overall Study|Withdrawal by Subject|3
5110713|NCT01826487|17652160|P1|Overall Study|Withdrawal by Subject|1
5110714|NCT01826487|17652159|P2|Overall Study|Lost to Follow-up|0
5110715|NCT01826487|17652160|P1|Overall Study|Lost to Follow-up|1
5110716|NCT01826487|17652159|P2|Overall Study|Adverse Event|1
5110717|NCT01826487|17652160|P1|Overall Study|Adverse Event|1
5110718|NCT01826448|17652187|P2|Overall Study|2 active cancers|1
5110719|NCT01826448|17652188|P1|Overall Study|2 active cancers|0
5110720|NCT01826448|17652187|P2|Overall Study|Physician Decision|1
5110721|NCT01826448|17652188|P1|Overall Study|Physician Decision|0
5110722|NCT01826448|17652187|P2|Overall Study|Withdrawal by Subject|0
5110723|NCT01826448|17652188|P1|Overall Study|Withdrawal by Subject|1
5110724|NCT01826448|17652187|P2|Overall Study|Disease progression|4
5110725|NCT01826448|17652188|P1|Overall Study|Disease progression|2
5110726|NCT01826448|17652187|P2|Overall Study|Adverse Event|3
5110727|NCT01826448|17652188|P1|Overall Study|Adverse Event|1
5110728|NCT01826422|17652196|P2|Overall Study|Withdrawal by Subject|3
5110729|NCT01826422|17652197|P1|Overall Study|Withdrawal by Subject|1
5110730|NCT01826370|17652241|P1|Overall Study|Other reason not defined above|2
5110731|NCT01826370|17652241|P1|Overall Study|Lost to Follow-up|12
5110732|NCT01826370|17652241|P1|Overall Study|Protocol Violation|6
5110733|NCT01826214|17652253|P2|Overall Study|Subject/guardian decision|3
5110734|NCT01826214|17652254|P1|Overall Study|Subject/guardian decision|2
5110735|NCT01826214|17652253|P2|Overall Study|Study terminated by Sponsor|1
5110736|NCT01826214|17652254|P1|Overall Study|Study terminated by Sponsor|0
5110737|NCT01826214|17652253|P2|Overall Study|Progressive disease|21
5110738|NCT01826214|17652254|P1|Overall Study|Progressive disease|22
5110739|NCT01826214|17652253|P2|Overall Study|Physician Decision|2
5110740|NCT01826214|17652254|P1|Overall Study|Physician Decision|0
5110741|NCT01826214|17652253|P2|Overall Study|Lost to Follow-up|0
5110742|NCT01826214|17652254|P1|Overall Study|Lost to Follow-up|1
5110743|NCT01826214|17652253|P2|Overall Study|Death|1
5110744|NCT01826214|17652254|P1|Overall Study|Death|3
5110745|NCT01826214|17652253|P2|Overall Study|Adverse Event|6
5110746|NCT01826214|17652254|P1|Overall Study|Adverse Event|7
5110747|NCT01826201|17652272|P1|Overall Study|Non compliance with protocol|4
5110748|NCT01825941|17652280|P2|Overall Study|Lost to Follow-up|1
5110749|NCT01825941|17652281|P1|Overall Study|Lost to Follow-up|4
5110750|NCT01825876|17652300|P2|Period 2|Withdrawal by Subject|1
5110751|NCT01825876|17652301|P1|Period 2|Withdrawal by Subject|0
5110752|NCT01825837|17652322|P4|PART II|reason unspecified|0
5110753|NCT01825837|17652323|P3|PART II|reason unspecified|2
5110754|NCT01825837|17652324|P2|PART II|reason unspecified|2
5110755|NCT01825837|17652325|P1|PART II|reason unspecified|2
5110756|NCT01825837|17652322|P4|PART II|Treatment failure|0
5110757|NCT01825837|17652323|P3|PART II|Treatment failure|5
5110758|NCT01825837|17652324|P2|PART II|Treatment failure|4
5110759|NCT01825837|17652325|P1|PART II|Treatment failure|6
5110760|NCT01825837|17652322|P4|PART II|Adverse Event|0
5110761|NCT01825837|17652323|P3|PART II|Adverse Event|1
5110762|NCT01825837|17652324|P2|PART II|Adverse Event|3
5110763|NCT01825837|17652325|P1|PART II|Adverse Event|3
5110764|NCT01825837|17652322|P4|PART II|Patient non-compliance|0
5110765|NCT01825837|17652323|P3|PART II|Patient non-compliance|4
5110766|NCT01825837|17652324|P2|PART II|Patient non-compliance|2
5110767|NCT01825837|17652325|P1|PART II|Patient non-compliance|5
5110768|NCT01825837|17652322|P4|PART II|Withdrawal by Subject|0
5110769|NCT01825837|17652323|P3|PART II|Withdrawal by Subject|7
5110770|NCT01825837|17652324|P2|PART II|Withdrawal by Subject|3
5110771|NCT01825837|17652325|P1|PART II|Withdrawal by Subject|3
5110772|NCT01825837|17652322|P4|PART I|reason unspecified|3
5110773|NCT01825837|17652323|P3|PART I|reason unspecified|0
5110774|NCT01825837|17652324|P2|PART I|reason unspecified|0
5110775|NCT01825837|17652325|P1|PART I|reason unspecified|0
5110776|NCT01825837|17652322|P4|PART I|Treatment failure|7
5110777|NCT01825837|17652323|P3|PART I|Treatment failure|0
5110778|NCT01825837|17652324|P2|PART I|Treatment failure|0
5110779|NCT01825837|17652325|P1|PART I|Treatment failure|0
5110780|NCT01825837|17652322|P4|PART I|Patient non-compliance|1
5110781|NCT01825837|17652323|P3|PART I|Patient non-compliance|0
5110782|NCT01825837|17652324|P2|PART I|Patient non-compliance|0
5110783|NCT01825837|17652325|P1|PART I|Patient non-compliance|0
5110784|NCT01825837|17652322|P4|PART I|Withdrawal by Subject|6
5110785|NCT01825837|17652323|P3|PART I|Withdrawal by Subject|0
5110786|NCT01825837|17652324|P2|PART I|Withdrawal by Subject|0
5110787|NCT01825837|17652325|P1|PART I|Withdrawal by Subject|0
5110788|NCT01825798|17652335|P2|Overall Study|Lost to Follow-up|0
5110789|NCT01825798|17652336|P1|Overall Study|Lost to Follow-up|1
5110790|NCT01825798|17652335|P2|Overall Study|Adverse Event|5
5110791|NCT01825798|17652336|P1|Overall Study|Adverse Event|1
5110792|NCT01825785|17652371|P7|Overall Study|Withdrawal by Subject|0
5110793|NCT01825785|17652372|P6|Overall Study|Withdrawal by Subject|1
5110794|NCT01825785|17652373|P5|Overall Study|Withdrawal by Subject|1
5110795|NCT01825785|17652374|P4|Overall Study|Withdrawal by Subject|0
5110796|NCT01825785|17652375|P3|Overall Study|Withdrawal by Subject|0
5110797|NCT01825785|17652376|P2|Overall Study|Withdrawal by Subject|0
5110798|NCT01825785|17652377|P1|Overall Study|Withdrawal by Subject|0
5110799|NCT01825785|17652371|P7|Overall Study|Adverse Event|0
5110800|NCT01825785|17652372|P6|Overall Study|Adverse Event|0
5110801|NCT01825785|17652373|P5|Overall Study|Adverse Event|1
5110802|NCT01825785|17652374|P4|Overall Study|Adverse Event|0
5110803|NCT01825785|17652375|P3|Overall Study|Adverse Event|0
5110804|NCT01825785|17652376|P2|Overall Study|Adverse Event|0
5110805|NCT01825785|17652377|P1|Overall Study|Adverse Event|0
5110806|NCT01825577|17652530|P1|Overall Study|Lack of Efficacy|3
5110807|NCT01825577|17652530|P1|Overall Study|Withdrawn by family members|2
5110808|NCT01825577|17652530|P1|Overall Study|Withdrawal by Subject|1
5110809|NCT01825577|17652530|P1|Overall Study|Physician Decision|2
5110810|NCT01825200|17652554|P2|Overall Study|Withdrawal by Subject|1
5110811|NCT01825200|17652555|P1|Overall Study|Withdrawal by Subject|0
5110812|NCT01825200|17652554|P2|Overall Study|Lost to Follow-up|6
5110813|NCT01825200|17652555|P1|Overall Study|Lost to Follow-up|5
5110814|NCT01824979|17652578|P2|Overall Study|Protocol Violation|13
5110815|NCT01824979|17652579|P1|Overall Study|Protocol Violation|6
5110816|NCT01824979|17652578|P2|Overall Study|Physician Decision|0
5110817|NCT01824979|17652579|P1|Overall Study|Physician Decision|2
5110818|NCT01824979|17652578|P2|Overall Study|Withdrawal by Subject|0
5110819|NCT01824979|17652579|P1|Overall Study|Withdrawal by Subject|5
5110820|NCT01824823|17652596|P2|Overall Study|Off-treatment reason not submitted|0
5110821|NCT01824823|17652597|P1|Overall Study|Off-treatment reason not submitted|1
5110822|NCT01824823|17652596|P2|Overall Study|Lack of Efficacy|1
5110823|NCT01824823|17652597|P1|Overall Study|Lack of Efficacy|1
5110824|NCT01824693|17652606|P3|Overall Study|No Transplant Planned|10
5110825|NCT01824693|17652607|P2|Overall Study|No Transplant Planned|0
5110826|NCT01824693|17652608|P1|Overall Study|No Transplant Planned|0
5110827|NCT01824693|17652606|P3|Overall Study|Ineligible|3
5110828|NCT01824693|17652607|P2|Overall Study|Ineligible|0
5110829|NCT01824693|17652608|P1|Overall Study|Ineligible|0
5110830|NCT01824693|17652606|P3|Overall Study|Progressive Disease|0
5110831|NCT01824693|17652607|P2|Overall Study|Progressive Disease|5
5110832|NCT01824693|17652608|P1|Overall Study|Progressive Disease|0
5110833|NCT01824693|17652606|P3|Overall Study|Withdrawal by Subject|1
5110834|NCT01824693|17652607|P2|Overall Study|Withdrawal by Subject|0
5110835|NCT01824693|17652608|P1|Overall Study|Withdrawal by Subject|0
5110836|NCT01824693|17652606|P3|Overall Study|Physician Decision|1
5110837|NCT01824693|17652607|P2|Overall Study|Physician Decision|1
5110838|NCT01824693|17652608|P1|Overall Study|Physician Decision|1
5110839|NCT01824693|17652606|P3|Overall Study|Death|0
5110840|NCT01824693|17652607|P2|Overall Study|Death|1
5110841|NCT01824693|17652608|P1|Overall Study|Death|0
5110842|NCT01824602|17652625|P4|Overall Study|Treatment failure|1
5110843|NCT01824602|17652626|P3|Overall Study|Treatment failure|0
5110844|NCT01824602|17652627|P2|Overall Study|Treatment failure|0
5110845|NCT01824602|17652628|P1|Overall Study|Treatment failure|0
5110846|NCT01824602|17652625|P4|Overall Study|Adverse Event|2
5110847|NCT01824602|17652626|P3|Overall Study|Adverse Event|2
5110848|NCT01824602|17652627|P2|Overall Study|Adverse Event|0
5110849|NCT01824602|17652628|P1|Overall Study|Adverse Event|1
5110850|NCT01824602|17652625|P4|Overall Study|Patient non-compliance|0
5110851|NCT01824602|17652626|P3|Overall Study|Patient non-compliance|1
5110852|NCT01824602|17652627|P2|Overall Study|Patient non-compliance|0
5110853|NCT01824602|17652628|P1|Overall Study|Patient non-compliance|0
5110854|NCT01824602|17652625|P4|Overall Study|Withdrawal by Subject|2
5110855|NCT01824602|17652626|P3|Overall Study|Withdrawal by Subject|1
5110856|NCT01824602|17652627|P2|Overall Study|Withdrawal by Subject|0
5110857|NCT01824602|17652628|P1|Overall Study|Withdrawal by Subject|0
5110858|NCT01824576|17652667|P1|Overall Study|Device deficiency|2
5110859|NCT01824498|17652685|P6|Washout (8 Weeks)|Withdrawal by Subject|0
5110860|NCT01824498|17652686|P5|Washout (8 Weeks)|Withdrawal by Subject|1
5110861|NCT01824498|17652687|P4|Washout (8 Weeks)|Withdrawal by Subject|1
5110862|NCT01824498|17652688|P3|Washout (8 Weeks)|Withdrawal by Subject|2
5110863|NCT01824498|17652689|P2|Washout (8 Weeks)|Withdrawal by Subject|0
5110864|NCT01824498|17652690|P1|Washout (8 Weeks)|Withdrawal by Subject|2
5110865|NCT01824472|17652701|P3|Overall Study|Ineligible post randomization&screening|0
5110866|NCT01824472|17652702|P2|Overall Study|Ineligible post randomization&screening|2
5110867|NCT01824472|17652703|P1|Overall Study|Ineligible post randomization&screening|0
5110868|NCT01824472|17652701|P3|Overall Study|Withdrawal by Subject|3
5110869|NCT01824472|17652702|P2|Overall Study|Withdrawal by Subject|5
5110870|NCT01824472|17652703|P1|Overall Study|Withdrawal by Subject|1
5110871|NCT01824472|17652701|P3|Overall Study|Lost to Follow-up|1
5110872|NCT01824472|17652702|P2|Overall Study|Lost to Follow-up|0
5110873|NCT01824472|17652703|P1|Overall Study|Lost to Follow-up|0
5110874|NCT01824394|17652737|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
5110875|NCT01824394|17652738|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
5110876|NCT01824394|17652739|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
5110877|NCT01824394|17652737|P3|Overall Study|Discontinued Subjects|2
5110878|NCT01824394|17652738|P2|Overall Study|Discontinued Subjects|1
5110879|NCT01824394|17652739|P1|Overall Study|Discontinued Subjects|1
5110880|NCT01824394|17652737|P3|Overall Study|Death|4
5110881|NCT01824394|17652738|P2|Overall Study|Death|2
5110882|NCT01824394|17652739|P1|Overall Study|Death|3
5110883|NCT01824394|17652737|P3|Overall Study|Lost to Follow-up|3
5110884|NCT01824394|17652738|P2|Overall Study|Lost to Follow-up|9
5110885|NCT01824394|17652739|P1|Overall Study|Lost to Follow-up|0
5110886|NCT01824394|17652737|P3|Overall Study|Withdrawn due to Study Termination|41
5110887|NCT01824394|17652738|P2|Overall Study|Withdrawn due to Study Termination|83
5110888|NCT01824394|17652739|P1|Overall Study|Withdrawn due to Study Termination|91
5110889|NCT01824394|17652737|P3|Overall Study|Early Termination|3
5110890|NCT01824394|17652738|P2|Overall Study|Early Termination|1
5110891|NCT01824394|17652739|P1|Overall Study|Early Termination|1
5110892|NCT01824355|17652749|P1|Overall Study|unevaluable reference method results per|1
5110893|NCT01824355|17652749|P1|Overall Study|Adverse Event|2
5110894|NCT01824342|17652760|P2|Overall Study|Death|0
5110895|NCT01824342|17652761|P1|Overall Study|Death|2
5110896|NCT01824342|17652760|P2|Overall Study|Physician Decision|0
5110897|NCT01824342|17652761|P1|Overall Study|Physician Decision|5
5110898|NCT01824342|17652760|P2|Overall Study|Disease Progression|1
5110899|NCT01824342|17652761|P1|Overall Study|Disease Progression|1
5110900|NCT01824342|17652760|P2|Overall Study|Adverse Event|1
5110901|NCT01824342|17652761|P1|Overall Study|Adverse Event|1
5110902|NCT01824342|17652760|P2|Overall Study|Withdrawal by Subject|3
5110903|NCT01824342|17652761|P1|Overall Study|Withdrawal by Subject|0
5110904|NCT01824303|17652775|P2|Randomized Study|Other Miscellaneous Reasons|0
5110905|NCT01824303|17652776|P1|Randomized Study|Other Miscellaneous Reasons|1
5110906|NCT01824303|17652775|P2|Randomized Study|Withdrawal by Subject|1
5110907|NCT01824303|17652776|P1|Randomized Study|Withdrawal by Subject|1
5110908|NCT01824290|17652802|P2|Overall Study|Investigator Reported Clinical Worsening|1
5110909|NCT01824290|17652803|P1|Overall Study|Investigator Reported Clinical Worsening|1
5110910|NCT01824290|17652802|P2|Overall Study|Parent/Caregiver Decision|1
5110911|NCT01824290|17652803|P1|Overall Study|Parent/Caregiver Decision|1
5110912|NCT01824290|17652802|P2|Overall Study|Entry Criteria Not Met|0
5110913|NCT01824290|17652803|P1|Overall Study|Entry Criteria Not Met|1
5110914|NCT01823991|17652821|P2|Overall Study|Withdrawal by Subject|5
5110915|NCT01823991|17652822|P1|Overall Study|Withdrawal by Subject|8
5110916|NCT01823679|17652863|P1|Overall Study|Death|1
5110917|NCT01823536|17652916|P6|Overall Study|Subject moved out of the state|0
5110918|NCT01823536|17652917|P5|Overall Study|Subject moved out of the state|1
5110919|NCT01823536|17652918|P4|Overall Study|Subject moved out of the state|0
5110920|NCT01823536|17652919|P3|Overall Study|Subject moved out of the state|0
5110921|NCT01823536|17652920|P2|Overall Study|Subject moved out of the state|0
5110922|NCT01823536|17652921|P1|Overall Study|Subject moved out of the state|0
5110923|NCT01823536|17652916|P6|Overall Study|Met exclusion criterion No 6|0
5110924|NCT01823536|17652917|P5|Overall Study|Met exclusion criterion No 6|0
5110925|NCT01823536|17652918|P4|Overall Study|Met exclusion criterion No 6|1
5110926|NCT01823536|17652919|P3|Overall Study|Met exclusion criterion No 6|0
5110927|NCT01823536|17652920|P2|Overall Study|Met exclusion criterion No 6|0
5110928|NCT01823536|17652921|P1|Overall Study|Met exclusion criterion No 6|0
5110929|NCT01823536|17652916|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
5110930|NCT01823536|17652917|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
5110931|NCT01823536|17652918|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
5110932|NCT01823536|17652919|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
5110933|NCT01823536|17652920|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
5110934|NCT01823536|17652921|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
5110935|NCT01823536|17652916|P6|Overall Study|Withdrawal by Subject|0
5110936|NCT01823536|17652917|P5|Overall Study|Withdrawal by Subject|0
5110937|NCT01823536|17652918|P4|Overall Study|Withdrawal by Subject|0
5110938|NCT01823536|17652919|P3|Overall Study|Withdrawal by Subject|0
5110939|NCT01823536|17652920|P2|Overall Study|Withdrawal by Subject|1
5110940|NCT01823536|17652921|P1|Overall Study|Withdrawal by Subject|1
5110941|NCT01823536|17652916|P6|Overall Study|Protocol Violation|0
5110942|NCT01823536|17652917|P5|Overall Study|Protocol Violation|0
5110943|NCT01823536|17652918|P4|Overall Study|Protocol Violation|0
5110944|NCT01823536|17652919|P3|Overall Study|Protocol Violation|0
5110945|NCT01823536|17652920|P2|Overall Study|Protocol Violation|1
5110946|NCT01823536|17652921|P1|Overall Study|Protocol Violation|0
5110947|NCT01823536|17652916|P6|Overall Study|Lost to Follow-up|0
5110948|NCT01823536|17652917|P5|Overall Study|Lost to Follow-up|1
5110949|NCT01823536|17652918|P4|Overall Study|Lost to Follow-up|1
5110950|NCT01823536|17652919|P3|Overall Study|Lost to Follow-up|0
5110951|NCT01823536|17652920|P2|Overall Study|Lost to Follow-up|0
5110952|NCT01823536|17652921|P1|Overall Study|Lost to Follow-up|1
5110953|NCT01823341|17652983|P1|Overall Study|Adverse Event|1
5110954|NCT01823341|17652983|P1|Overall Study|Withdrawal by Subject|7
5110955|NCT01823341|17652983|P1|Overall Study|Failed run-in|7
5110956|NCT01823328|17653028|P2|Overall Study|Withdrawal by Subject|6
5110957|NCT01823328|17653029|P1|Overall Study|Withdrawal by Subject|8
5110958|NCT01823289|17653049|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
5110959|NCT01823289|17653049|P1|Overall Study|Drug affected efficacy and safety|1
5110960|NCT01823289|17653049|P1|Overall Study|Transaminase increased more than 3 times|1
5110961|NCT01823289|17653049|P1|Overall Study|Administered contraindicated medicine|1
5110962|NCT01823289|17653049|P1|Overall Study|Physician Decision|9
5110963|NCT01823289|17653049|P1|Overall Study|Lack of Efficacy|1
5110964|NCT01823289|17653049|P1|Overall Study|Adverse Event|5
5110965|NCT01823289|17653049|P1|Overall Study|Lost to Follow-up|5
5110966|NCT01823224|17653057|P2|Overall Study|Withdrawal by Subject|1
5110967|NCT01823224|17653058|P1|Overall Study|Withdrawal by Subject|0
5110968|NCT01823224|17653057|P2|Overall Study|missed med dose|1
5110969|NCT01823224|17653058|P1|Overall Study|missed med dose|0
5110970|NCT01823224|17653057|P2|Overall Study|pharmacy error|1
5110971|NCT01823224|17653058|P1|Overall Study|pharmacy error|0
5110972|NCT01823224|17653057|P2|Overall Study|didn't qualify|2
5110973|NCT01823224|17653058|P1|Overall Study|didn't qualify|1
5110974|NCT01823224|17653057|P2|Overall Study|Lost to Follow-up|6
5110975|NCT01823224|17653058|P1|Overall Study|Lost to Follow-up|5
5110976|NCT01823146|17653068|P2|Overall Study|Lost to Follow-up|1
5110977|NCT01823146|17653069|P1|Overall Study|Lost to Follow-up|2
5110978|NCT01823146|17653068|P2|Overall Study|Withdrawal by Subject|1
5110979|NCT01823146|17653069|P1|Overall Study|Withdrawal by Subject|0
5110980|NCT01823107|17653079|P1|Overall Study|Withdrawal by Subject|1
5110981|NCT01822925|17653089|P4|Overall Study|Taking prohibited medication|1
5110982|NCT01822925|17653090|P3|Overall Study|Taking prohibited medication|0
5110983|NCT01822925|17653091|P2|Overall Study|Taking prohibited medication|0
5110984|NCT01822925|17653092|P1|Overall Study|Taking prohibited medication|2
5110985|NCT01822925|17653089|P4|Overall Study|Withdrawal by Subject|2
5110986|NCT01822925|17653090|P3|Overall Study|Withdrawal by Subject|2
5110987|NCT01822925|17653091|P2|Overall Study|Withdrawal by Subject|0
5110988|NCT01822925|17653092|P1|Overall Study|Withdrawal by Subject|2
5110989|NCT01822925|17653089|P4|Overall Study|Protocol Violation|1
5110990|NCT01822925|17653090|P3|Overall Study|Protocol Violation|0
5110991|NCT01822925|17653091|P2|Overall Study|Protocol Violation|0
5110992|NCT01822925|17653092|P1|Overall Study|Protocol Violation|1
5110993|NCT01822925|17653089|P4|Overall Study|Lost to Follow-up|0
5110994|NCT01822925|17653090|P3|Overall Study|Lost to Follow-up|0
5110995|NCT01822925|17653091|P2|Overall Study|Lost to Follow-up|1
5110996|NCT01822925|17653092|P1|Overall Study|Lost to Follow-up|0
5110997|NCT01822925|17653089|P4|Overall Study|Adverse Event|1
5110998|NCT01822925|17653090|P3|Overall Study|Adverse Event|1
5110999|NCT01822925|17653091|P2|Overall Study|Adverse Event|1
5111000|NCT01822925|17653092|P1|Overall Study|Adverse Event|1
5111001|NCT01822899|17653144|P2|Overall Study|Withdrawal by Subject|7
5111002|NCT01822899|17653145|P1|Overall Study|Withdrawal by Subject|5
5111003|NCT01822899|17653144|P2|Overall Study|Lost to Follow-up|0
5111004|NCT01822899|17653145|P1|Overall Study|Lost to Follow-up|1
5111005|NCT01822899|17653144|P2|Overall Study|Protocol Violation|3
5111006|NCT01822899|17653145|P1|Overall Study|Protocol Violation|6
5111007|NCT01822899|17653144|P2|Overall Study|Lack of Efficacy|3
5111008|NCT01822899|17653145|P1|Overall Study|Lack of Efficacy|6
5111009|NCT01822899|17653144|P2|Overall Study|Adverse Event|5
5111010|NCT01822899|17653145|P1|Overall Study|Adverse Event|6
5111011|NCT01822821|17653163|P2|Overall Study|Other reasons|0
5111012|NCT01822821|17653164|P1|Overall Study|Other reasons|1
5111013|NCT01822821|17653163|P2|Overall Study|Eligible surgery cancelled|1
5111014|NCT01822821|17653164|P1|Overall Study|Eligible surgery cancelled|1
5111015|NCT01822756|17653193|P5|Overall Study|disease progression & patient preference|0
5111016|NCT01822756|17653194|P4|Overall Study|disease progression & patient preference|0
5111017|NCT01822756|17653195|P3|Overall Study|disease progression & patient preference|1
5111018|NCT01822756|17653196|P2|Overall Study|disease progression & patient preference|0
5111019|NCT01822756|17653197|P1|Overall Study|disease progression & patient preference|2
5111020|NCT01822756|17653193|P5|Overall Study|Physician Decision|0
5111021|NCT01822756|17653194|P4|Overall Study|Physician Decision|0
5111022|NCT01822756|17653195|P3|Overall Study|Physician Decision|0
5111023|NCT01822756|17653196|P2|Overall Study|Physician Decision|1
5111024|NCT01822756|17653197|P1|Overall Study|Physician Decision|0
5111025|NCT01822756|17653193|P5|Overall Study|Lost to Follow-up|1
5111026|NCT01822756|17653194|P4|Overall Study|Lost to Follow-up|0
5111027|NCT01822756|17653195|P3|Overall Study|Lost to Follow-up|1
5111028|NCT01822756|17653196|P2|Overall Study|Lost to Follow-up|0
5111029|NCT01822756|17653197|P1|Overall Study|Lost to Follow-up|1
5111030|NCT01822756|17653193|P5|Overall Study|Death|0
5111031|NCT01822756|17653194|P4|Overall Study|Death|0
5111032|NCT01822756|17653195|P3|Overall Study|Death|1
5111033|NCT01822756|17653196|P2|Overall Study|Death|2
5111034|NCT01822756|17653197|P1|Overall Study|Death|2
5111035|NCT01822756|17653193|P5|Overall Study|Disease progression|6
5111036|NCT01822756|17653194|P4|Overall Study|Disease progression|2
5111037|NCT01822756|17653195|P3|Overall Study|Disease progression|7
5111038|NCT01822756|17653196|P2|Overall Study|Disease progression|1
5111039|NCT01822756|17653197|P1|Overall Study|Disease progression|11
5111040|NCT01822756|17653193|P5|Overall Study|Adverse Event|0
5111041|NCT01822756|17653194|P4|Overall Study|Adverse Event|2
5111042|NCT01822756|17653195|P3|Overall Study|Adverse Event|0
5111043|NCT01822756|17653196|P2|Overall Study|Adverse Event|0
5111044|NCT01822756|17653197|P1|Overall Study|Adverse Event|0
5111045|NCT01822691|17653239|P1|Overall Study|Withdrawal by Subject|2
5111046|NCT01822678|17653250|P3|Overall Study|Lost to Follow-up|1
5111047|NCT01822678|17653251|P2|Overall Study|Lost to Follow-up|2
5111048|NCT01822678|17653252|P1|Overall Study|Lost to Follow-up|0
5111049|NCT01822678|17653250|P3|Overall Study|Lack of Efficacy|5
5111050|NCT01822678|17653251|P2|Overall Study|Lack of Efficacy|6
5111051|NCT01822678|17653252|P1|Overall Study|Lack of Efficacy|3
5111052|NCT01822678|17653250|P3|Overall Study|Adverse Event|1
5111053|NCT01822678|17653251|P2|Overall Study|Adverse Event|3
5111054|NCT01822678|17653252|P1|Overall Study|Adverse Event|4
5111055|NCT01822678|17653250|P3|Overall Study|Withdrawal by Subject|4
5111056|NCT01822678|17653251|P2|Overall Study|Withdrawal by Subject|4
5111057|NCT01822678|17653252|P1|Overall Study|Withdrawal by Subject|5
5111058|NCT01822665|17653260|P1|Overall Study|Other Reason|5
5111059|NCT01822665|17653260|P1|Overall Study|Adverse Event|3
5111060|NCT01822587|17653287|P3|Overall Study|Physician Decision|6
5111061|NCT01822587|17653288|P2|Overall Study|Physician Decision|6
5111062|NCT01822587|17653289|P1|Overall Study|Physician Decision|9
5111063|NCT01822587|17653287|P3|Overall Study|Lost to Follow-up|12
5111064|NCT01822587|17653288|P2|Overall Study|Lost to Follow-up|9
5111065|NCT01822587|17653289|P1|Overall Study|Lost to Follow-up|7
5111066|NCT01822561|17653328|P1|Overall Study|Withdrawal by Subject|2
5111067|NCT01822535|17653349|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
5111068|NCT01822535|17653350|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
5111069|NCT01822535|17653349|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
5111070|NCT01822535|17653350|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
5111071|NCT01822535|17653349|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
5111072|NCT01822535|17653350|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
5111073|NCT01822496|17653366|P4|Overall Study|Withdrawal by Subject|3
5111074|NCT01822496|17653367|P3|Overall Study|Withdrawal by Subject|0
5111075|NCT01822496|17653368|P2|Overall Study|Withdrawal by Subject|0
5111076|NCT01822496|17653369|P1|Overall Study|Withdrawal by Subject|0
5111077|NCT01822496|17653366|P4|Overall Study|Protocol Violation|1
5111078|NCT01822496|17653367|P3|Overall Study|Protocol Violation|0
5111079|NCT01822496|17653368|P2|Overall Study|Protocol Violation|2
5111080|NCT01822496|17653369|P1|Overall Study|Protocol Violation|2
5111081|NCT01822366|17653422|P4|Overall Study|Partial Intervention Completion|15
5111082|NCT01822366|17653423|P3|Overall Study|Partial Intervention Completion|0
5111083|NCT01822366|17653424|P2|Overall Study|Partial Intervention Completion|15
5111084|NCT01822366|17653425|P1|Overall Study|Partial Intervention Completion|0
5111085|NCT01822366|17653422|P4|Overall Study|Withdrawal by Subject|6
5111086|NCT01822366|17653423|P3|Overall Study|Withdrawal by Subject|0
5111087|NCT01822366|17653424|P2|Overall Study|Withdrawal by Subject|6
5111088|NCT01822366|17653425|P1|Overall Study|Withdrawal by Subject|0
5111089|NCT01822366|17653422|P4|Overall Study|Lost to Follow-up|1
5111090|NCT01822366|17653423|P3|Overall Study|Lost to Follow-up|5
5111091|NCT01822366|17653424|P2|Overall Study|Lost to Follow-up|1
5111092|NCT01822366|17653425|P1|Overall Study|Lost to Follow-up|5
5111093|NCT01822353|17653456|P3|Overall Study|Withdrawal by Subject|0
5111094|NCT01822353|17653457|P2|Overall Study|Withdrawal by Subject|1
5111095|NCT01822353|17653458|P1|Overall Study|Withdrawal by Subject|3
5111096|NCT01822353|17653456|P3|Overall Study|Pregnancy|0
5111097|NCT01822353|17653457|P2|Overall Study|Pregnancy|1
5111098|NCT01822353|17653458|P1|Overall Study|Pregnancy|0
5111099|NCT01822353|17653456|P3|Overall Study|Adverse Event|1
5111100|NCT01822353|17653457|P2|Overall Study|Adverse Event|3
5111101|NCT01822353|17653458|P1|Overall Study|Adverse Event|1
5111102|NCT01822223|17653478|P2|Overall Study|Death|1
5111103|NCT01822223|17653479|P1|Overall Study|Death|0
5111104|NCT01822132|17653503|P2|Overall Study|Lost to Follow-up|2
5111105|NCT01822132|17653504|P1|Overall Study|Lost to Follow-up|4
5111106|NCT01821963|17653541|P1|Overall Study|Adverse Event|1
5111107|NCT01821937|17653547|P2|Overall Study|Adverse Event|3
5111108|NCT01821937|17653548|P1|Overall Study|Adverse Event|0
5111109|NCT01821807|17653572|P2|Overall Study|Lost to Follow-up|1
5111110|NCT01821807|17653573|P1|Overall Study|Lost to Follow-up|3
5111111|NCT01821729|17653581|P1|Overall Study|Withdrawal by Subject|1
5111112|NCT01821625|17653586|P1|Overall Study|Medical contraindication|1
5111113|NCT01821625|17653586|P1|Overall Study|Adverse Event|1
5111114|NCT01821625|17653586|P1|Overall Study|Lack of Efficacy|2
5111115|NCT01821625|17653586|P1|Overall Study|Withdrawal by Subject|2
5111116|NCT01821560|17653592|P2|Overall Study|Protocol Violation|1
5111117|NCT01821560|17653593|P1|Overall Study|Protocol Violation|0
5111118|NCT01821560|17653592|P2|Overall Study|Withdrawal by Subject|1
5111119|NCT01821560|17653593|P1|Overall Study|Withdrawal by Subject|1
5111120|NCT01821560|17653592|P2|Overall Study|Lost to Follow-up|5
5111121|NCT01821560|17653593|P1|Overall Study|Lost to Follow-up|5
5111122|NCT01821118|17653714|P2|Overall Study|Death|1
5111123|NCT01821118|17653715|P1|Overall Study|Death|0
5111124|NCT01820637|17653762|P1|Overall Study|Withdrawal by Subject|1
5111125|NCT01820637|17653762|P1|Overall Study|Death|2
5111126|NCT01820585|17653771|P4|Overall Study|Pregnancy|0
5111127|NCT01820585|17653772|P3|Overall Study|Pregnancy|0
5111128|NCT01820585|17653773|P2|Overall Study|Pregnancy|1
5111129|NCT01820585|17653774|P1|Overall Study|Pregnancy|0
5111130|NCT01820585|17653771|P4|Overall Study|at sponsor request|0
5111131|NCT01820585|17653772|P3|Overall Study|at sponsor request|1
5111132|NCT01820585|17653773|P2|Overall Study|at sponsor request|0
5111133|NCT01820585|17653774|P1|Overall Study|at sponsor request|0
5111134|NCT01820585|17653771|P4|Overall Study|Subject non-compliance|2
5111135|NCT01820585|17653772|P3|Overall Study|Subject non-compliance|1
5111136|NCT01820585|17653773|P2|Overall Study|Subject non-compliance|0
5111137|NCT01820585|17653774|P1|Overall Study|Subject non-compliance|0
5111138|NCT01820585|17653771|P4|Overall Study|Protocol Violation|1
5111139|NCT01820585|17653772|P3|Overall Study|Protocol Violation|1
5111140|NCT01820585|17653773|P2|Overall Study|Protocol Violation|1
5111141|NCT01820585|17653774|P1|Overall Study|Protocol Violation|3
5111142|NCT01820585|17653771|P4|Overall Study|Lost to Follow-up|3
5111143|NCT01820585|17653772|P3|Overall Study|Lost to Follow-up|0
5111144|NCT01820585|17653773|P2|Overall Study|Lost to Follow-up|3
5111145|NCT01820585|17653774|P1|Overall Study|Lost to Follow-up|3
5111146|NCT01820585|17653771|P4|Overall Study|Withdrawal by Subject|8
5111147|NCT01820585|17653772|P3|Overall Study|Withdrawal by Subject|3
5111148|NCT01820585|17653773|P2|Overall Study|Withdrawal by Subject|7
5111149|NCT01820585|17653774|P1|Overall Study|Withdrawal by Subject|3
5111150|NCT01820585|17653771|P4|Overall Study|Lack of Efficacy|1
5111151|NCT01820585|17653772|P3|Overall Study|Lack of Efficacy|5
5111152|NCT01820585|17653773|P2|Overall Study|Lack of Efficacy|7
5111153|NCT01820585|17653774|P1|Overall Study|Lack of Efficacy|9
5111154|NCT01820585|17653771|P4|Overall Study|Adverse Event|34
5111155|NCT01820585|17653772|P3|Overall Study|Adverse Event|23
5111156|NCT01820585|17653773|P2|Overall Study|Adverse Event|13
5111157|NCT01820585|17653774|P1|Overall Study|Adverse Event|9
5111158|NCT01820559|17653787|P3|Overall Study|Lack of Efficacy|3
5111159|NCT01820559|17653788|P2|Overall Study|Lack of Efficacy|2
5111160|NCT01820559|17653789|P1|Overall Study|Lack of Efficacy|3
5111161|NCT01820559|17653787|P3|Overall Study|At sponsor request|1
5111162|NCT01820559|17653788|P2|Overall Study|At sponsor request|0
5111163|NCT01820559|17653789|P1|Overall Study|At sponsor request|0
5111164|NCT01820559|17653787|P3|Overall Study|Lost to Follow-up|2
5111165|NCT01820559|17653788|P2|Overall Study|Lost to Follow-up|2
5111166|NCT01820559|17653789|P1|Overall Study|Lost to Follow-up|3
5111167|NCT01820559|17653787|P3|Overall Study|Subject's non-compliance|2
5111168|NCT01820559|17653788|P2|Overall Study|Subject's non-compliance|0
5111169|NCT01820559|17653789|P1|Overall Study|Subject's non-compliance|1
5111170|NCT01820559|17653787|P3|Overall Study|Protocol Violation|3
5111171|NCT01820559|17653788|P2|Overall Study|Protocol Violation|1
5111172|NCT01820559|17653789|P1|Overall Study|Protocol Violation|2
5111173|NCT01820559|17653787|P3|Overall Study|Withdrawal by Subject|5
5111174|NCT01820559|17653788|P2|Overall Study|Withdrawal by Subject|2
5111175|NCT01820559|17653789|P1|Overall Study|Withdrawal by Subject|1
5111176|NCT01820559|17653787|P3|Overall Study|Adverse Event|13
5111177|NCT01820559|17653788|P2|Overall Study|Adverse Event|6
5111178|NCT01820559|17653789|P1|Overall Study|Adverse Event|4
5111179|NCT01820364|17653810|P2|Part II: LGX818 + MEK162|Study Termination|1
5111180|NCT01820364|17653811|P1|Part II: LGX818 + MEK162|Study Termination|0
5111181|NCT01820364|17653810|P2|Part I: LGX818|Disease Progression|0
5111182|NCT01820364|17653811|P1|Part I: LGX818|Disease Progression|4
5111183|NCT01820364|17653810|P2|Part I: LGX818|Adverse Event|0
5111184|NCT01820364|17653811|P1|Part I: LGX818|Adverse Event|6
5111185|NCT01820364|17653810|P2|Part I: LGX818|Administrative Problems|0
5111186|NCT01820364|17653811|P1|Part I: LGX818|Administrative Problems|3
5111187|NCT01820364|17653810|P2|Part I: LGX818|Death|0
5111188|NCT01820364|17653811|P1|Part I: LGX818|Death|1
5111189|NCT01819727|17653955|P2|Overall Study|Quit due to lack of health benifits|1
5111190|NCT01819727|17653956|P1|Overall Study|Quit due to lack of health benifits|0
5111191|NCT01819727|17653955|P2|Overall Study|Unable to demostrate ability self-inject|1
5111192|NCT01819727|17653956|P1|Overall Study|Unable to demostrate ability self-inject|0
5111193|NCT01819727|17653955|P2|Overall Study|Withdrawal by Subject|11
5111194|NCT01819727|17653956|P1|Overall Study|Withdrawal by Subject|6
5111195|NCT01819727|17653955|P2|Overall Study|Study Terminated by Sponsor|1
5111196|NCT01819727|17653956|P1|Overall Study|Study Terminated by Sponsor|0
5111197|NCT01819727|17653955|P2|Overall Study|Protocol Violation|2
5111198|NCT01819727|17653956|P1|Overall Study|Protocol Violation|0
5111199|NCT01819727|17653955|P2|Overall Study|Pregnancy|0
5111200|NCT01819727|17653956|P1|Overall Study|Pregnancy|1
5111201|NCT01819727|17653955|P2|Overall Study|Physician Decision|2
5111202|NCT01819727|17653956|P1|Overall Study|Physician Decision|3
5111203|NCT01819727|17653955|P2|Overall Study|Lost to Follow-up|1
5111204|NCT01819727|17653956|P1|Overall Study|Lost to Follow-up|1
5111205|NCT01819727|17653955|P2|Overall Study|Death|0
5111206|NCT01819727|17653956|P1|Overall Study|Death|1
5111207|NCT01819727|17653955|P2|Overall Study|Adverse Event|9
5111208|NCT01819727|17653956|P1|Overall Study|Adverse Event|8
5111209|NCT01819506|17653978|P2|Overall Study|Withdrawal by Subject|3
5111210|NCT01819506|17653979|P1|Overall Study|Withdrawal by Subject|3
5111211|NCT01819506|17653978|P2|Overall Study|Physician Decision|2
5111212|NCT01819506|17653979|P1|Overall Study|Physician Decision|5
5111213|NCT01819272|17654031|P6|Overall Study|Loss of Glucose Control|0
5111214|NCT01819272|17654032|P5|Overall Study|Loss of Glucose Control|2
5111215|NCT01819272|17654033|P4|Overall Study|Loss of Glucose Control|1
5111216|NCT01819272|17654034|P3|Overall Study|Loss of Glucose Control|0
5111217|NCT01819272|17654035|P2|Overall Study|Loss of Glucose Control|1
5111218|NCT01819272|17654036|P1|Overall Study|Loss of Glucose Control|2
5111219|NCT01819272|17654031|P6|Overall Study|Withdrawal of Consent|1
5111220|NCT01819272|17654032|P5|Overall Study|Withdrawal of Consent|0
5111221|NCT01819272|17654033|P4|Overall Study|Withdrawal of Consent|1
5111222|NCT01819272|17654034|P3|Overall Study|Withdrawal of Consent|2
5111223|NCT01819272|17654035|P2|Overall Study|Withdrawal of Consent|1
5111224|NCT01819272|17654036|P1|Overall Study|Withdrawal of Consent|0
5111225|NCT01819272|17654031|P6|Overall Study|Physician Decision|0
5111226|NCT01819272|17654032|P5|Overall Study|Physician Decision|0
5111227|NCT01819272|17654033|P4|Overall Study|Physician Decision|0
5111228|NCT01819272|17654034|P3|Overall Study|Physician Decision|0
5111229|NCT01819272|17654035|P2|Overall Study|Physician Decision|1
5111230|NCT01819272|17654036|P1|Overall Study|Physician Decision|0
5111231|NCT01819272|17654031|P6|Overall Study|Protocol Violation|3
5111232|NCT01819272|17654032|P5|Overall Study|Protocol Violation|2
5111233|NCT01819272|17654033|P4|Overall Study|Protocol Violation|1
5111234|NCT01819272|17654034|P3|Overall Study|Protocol Violation|0
5111235|NCT01819272|17654035|P2|Overall Study|Protocol Violation|0
5111236|NCT01819272|17654036|P1|Overall Study|Protocol Violation|0
5111237|NCT01819272|17654031|P6|Overall Study|Lost to Follow-up|3
5111238|NCT01819272|17654032|P5|Overall Study|Lost to Follow-up|0
5111239|NCT01819272|17654033|P4|Overall Study|Lost to Follow-up|0
5111240|NCT01819272|17654034|P3|Overall Study|Lost to Follow-up|1
5111241|NCT01819272|17654035|P2|Overall Study|Lost to Follow-up|0
5111242|NCT01819272|17654036|P1|Overall Study|Lost to Follow-up|3
5111243|NCT01819272|17654031|P6|Overall Study|Adverse Event|0
5111244|NCT01819272|17654032|P5|Overall Study|Adverse Event|0
5111245|NCT01819272|17654033|P4|Overall Study|Adverse Event|2
5111246|NCT01819272|17654034|P3|Overall Study|Adverse Event|0
5111247|NCT01819272|17654035|P2|Overall Study|Adverse Event|0
5111248|NCT01819272|17654036|P1|Overall Study|Adverse Event|1
5111249|NCT01819194|17654074|P1|Overall Study|Loss of study articles|2
5111250|NCT01819129|17654081|P2|Overall Study|Withdrawal Criteria|15
5111251|NCT01819129|17654082|P1|Overall Study|Withdrawal Criteria|20
5111252|NCT01819129|17654081|P2|Overall Study|Death|1
5111253|NCT01819129|17654082|P1|Overall Study|Death|1
5111254|NCT01819129|17654081|P2|Overall Study|Adverse Event|4
5111255|NCT01819129|17654082|P1|Overall Study|Adverse Event|1
5111256|NCT01819129|17654081|P2|Overall Study|Lack of Efficacy|1
5111257|NCT01819129|17654082|P1|Overall Study|Lack of Efficacy|0
5111258|NCT01819129|17654081|P2|Overall Study|Lost to Follow-up|2
5111259|NCT01819129|17654082|P1|Overall Study|Lost to Follow-up|5
5111260|NCT01819129|17654081|P2|Overall Study|Withdrawal by Subject|15
5111261|NCT01819129|17654082|P1|Overall Study|Withdrawal by Subject|15
5111262|NCT01819129|17654081|P2|Overall Study|Other, Subject moved out of the country|1
5111263|NCT01819129|17654082|P1|Overall Study|Other, Subject moved out of the country|0
5111264|NCT01819129|17654081|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
5111265|NCT01819129|17654082|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
5111266|NCT01819129|17654081|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
5111267|NCT01819129|17654082|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
5111268|NCT01818765|17654107|P1|Overall Study|Death|2
5111269|NCT01818752|17654120|P2|Overall Study|Randomized but not Dosed|4
5111270|NCT01818752|17654121|P1|Overall Study|Randomized but not Dosed|7
5111271|NCT01818752|17654120|P2|Overall Study|Continuing Treatment|4
5111272|NCT01818752|17654121|P1|Overall Study|Continuing Treatment|1
5111273|NCT01818752|17654120|P2|Overall Study|Other|8
5111274|NCT01818752|17654121|P1|Overall Study|Other|7
5111275|NCT01818752|17654120|P2|Overall Study|Disease Progression|48
5111276|NCT01818752|17654121|P1|Overall Study|Disease Progression|54
5111277|NCT01818752|17654120|P2|Overall Study|Physician Decision|8
5111278|NCT01818752|17654121|P1|Overall Study|Physician Decision|9
5111279|NCT01818752|17654120|P2|Overall Study|Withdrawal by Subject|14
5111280|NCT01818752|17654121|P1|Overall Study|Withdrawal by Subject|15
5111281|NCT01818752|17654120|P2|Overall Study|Non-compliance|20
5111282|NCT01818752|17654121|P1|Overall Study|Non-compliance|16
5111283|NCT01818752|17654120|P2|Overall Study|Death|18
5111284|NCT01818752|17654121|P1|Overall Study|Death|14
5111285|NCT01818752|17654120|P2|Overall Study|Adverse Event|74
5111286|NCT01818752|17654121|P1|Overall Study|Adverse Event|64
5111287|NCT01818726|17654141|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
5111288|NCT01818726|17654142|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
5111289|NCT01818726|17654141|P2|Overall Study|Withdrawal by Subject|1
5111290|NCT01818726|17654142|P1|Overall Study|Withdrawal by Subject|0
5111291|NCT01818726|17654141|P2|Overall Study|Administrative reasons|1
5111292|NCT01818726|17654142|P1|Overall Study|Administrative reasons|5
5111293|NCT01818700|17654152|P1|Overall Study|Other|1
5111294|NCT01818700|17654152|P1|Overall Study|Protocol Violation|2
5111295|NCT01818700|17654152|P1|Overall Study|Withdrawal by Subject|27
5111296|NCT01818700|17654152|P1|Overall Study|Lost to Follow-up|5
5111297|NCT01818700|17654152|P1|Overall Study|Lack of Efficacy|2
5111298|NCT01818700|17654152|P1|Overall Study|Adverse Event|67
5111299|NCT01818596|17654163|P2|Overall Study|Lost to Follow-up|0
5111300|NCT01818596|17654164|P1|Overall Study|Lost to Follow-up|7
5111301|NCT01818596|17654163|P2|Overall Study|Withdrew Consent|0
5111302|NCT01818596|17654164|P1|Overall Study|Withdrew Consent|5
5111303|NCT01818596|17654163|P2|Overall Study|Protocol Violation|0
5111304|NCT01818596|17654164|P1|Overall Study|Protocol Violation|1
5111305|NCT01818596|17654163|P2|Overall Study|Investigator's Discretion|0
5111306|NCT01818596|17654164|P1|Overall Study|Investigator's Discretion|4
5111307|NCT01818596|17654163|P2|Overall Study|Death|0
5111308|NCT01818596|17654164|P1|Overall Study|Death|3
5111309|NCT01818596|17654163|P2|Overall Study|Adverse Event|0
5111310|NCT01818596|17654164|P1|Overall Study|Adverse Event|7
5111311|NCT01818596|17654163|P2|Overall Study|Enrolled but Not Treated|0
5111312|NCT01818596|17654164|P1|Overall Study|Enrolled but Not Treated|4
5111313|NCT01818531|17654203|P2|Overall Study|Withdrawn for failure to place block|1
5111314|NCT01818531|17654204|P1|Overall Study|Withdrawn for failure to place block|0
5111315|NCT01818531|17654203|P2|Overall Study|Withdrawn for long-acting opioid patch|1
5111316|NCT01818531|17654204|P1|Overall Study|Withdrawn for long-acting opioid patch|0
5111317|NCT01818531|17654203|P2|Overall Study|Withdrawn for case delay after block|0
5111318|NCT01818531|17654204|P1|Overall Study|Withdrawn for case delay after block|1
5111319|NCT01818492|17654243|P1|Overall Study|Additional therapy when not allowed PP|4
5111320|NCT01818492|17654243|P1|Overall Study|Withdrawal by Subject|1
5111321|NCT01818492|17654243|P1|Overall Study|Death|3
5111322|NCT01818492|17654243|P1|Overall Study|Adverse Event|2
5111323|NCT01818336|17654292|P2|Overall Study|Lost to Follow-up|1
5111324|NCT01818336|17654293|P1|Overall Study|Lost to Follow-up|0
5111325|NCT01818336|17654292|P2|Overall Study|Declined retest visit|11
5111326|NCT01818336|17654293|P1|Overall Study|Declined retest visit|0
5111327|NCT01818297|17654301|P2|Open Label Phase (3-12 Months)|Early study closure|10
5111328|NCT01818297|17654302|P1|Open Label Phase (3-12 Months)|Early study closure|17
5111329|NCT01818297|17654301|P2|Open Label Phase (3-12 Months)|Physician Decision|0
5111330|NCT01818297|17654302|P1|Open Label Phase (3-12 Months)|Physician Decision|1
5111331|NCT01818297|17654301|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
5111332|NCT01818297|17654302|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
5111333|NCT01818284|17654320|P2|Overall Study|Death|2
5111334|NCT01818284|17654321|P1|Overall Study|Death|0
5111335|NCT01818284|17654320|P2|Overall Study|Not eligible due to White Blood Counts|4
5111336|NCT01818284|17654321|P1|Overall Study|Not eligible due to White Blood Counts|4
5111337|NCT01818141|17654354|P2|Overall Study|Lost to Follow-up|2
5111338|NCT01818141|17654355|P1|Overall Study|Lost to Follow-up|0
5111339|NCT01818141|17654354|P2|Overall Study|No baseline C.diff colonies|1
5111340|NCT01818141|17654355|P1|Overall Study|No baseline C.diff colonies|1
5111341|NCT01818141|17654354|P2|Overall Study|Withdrawal by Subject|0
5111342|NCT01818141|17654355|P1|Overall Study|Withdrawal by Subject|2
5111343|NCT01817959|17654378|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
5111344|NCT01817959|17654379|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
5111345|NCT01817959|17654378|P2|Overall Study|Adverse Event|0
5111346|NCT01817959|17654379|P1|Overall Study|Adverse Event|1
5111347|NCT01817959|17654378|P2|Overall Study|forbidden medication|1
5111348|NCT01817959|17654379|P1|Overall Study|forbidden medication|1
5111349|NCT01817959|17654378|P2|Overall Study|Graft loss|1
5111350|NCT01817959|17654379|P1|Overall Study|Graft loss|1
5111351|NCT01817790|17654471|P2|Overall Study|Other: Could not attend appointment|1
5111352|NCT01817790|17654472|P1|Overall Study|Other: Could not attend appointment|1
5111353|NCT01817790|17654471|P2|Overall Study|Withdrawal by Subject|3
5111354|NCT01817790|17654472|P1|Overall Study|Withdrawal by Subject|1
5111355|NCT01817790|17654471|P2|Overall Study|Protocol Violation|1
5111356|NCT01817790|17654472|P1|Overall Study|Protocol Violation|2
5111357|NCT01817790|17654471|P2|Overall Study|Lost to Follow-up|1
5111358|NCT01817790|17654472|P1|Overall Study|Lost to Follow-up|0
5111359|NCT01817790|17654471|P2|Overall Study|Adverse Event|2
5111360|NCT01817790|17654472|P1|Overall Study|Adverse Event|0
5111361|NCT01817777|17654516|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
5111362|NCT01817777|17654517|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
5111363|NCT01817777|17654518|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
5111364|NCT01817777|17654516|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
5111365|NCT01817777|17654517|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
5111366|NCT01817777|17654518|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
5111367|NCT01817777|17654516|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
5111368|NCT01817777|17654517|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
5111369|NCT01817777|17654518|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
5111370|NCT01817777|17654516|P3|Observational Phase (8 Weeks)|Early Study Termination|0
5111371|NCT01817777|17654517|P2|Observational Phase (8 Weeks)|Early Study Termination|0
5111372|NCT01817777|17654518|P1|Observational Phase (8 Weeks)|Early Study Termination|2
5111373|NCT01817777|17654516|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
5111374|NCT01817777|17654517|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
5111375|NCT01817777|17654518|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
5111376|NCT01817764|17654542|P2|Overall Study|Withdrawal by Subject|12
5111377|NCT01817764|17654543|P1|Overall Study|Withdrawal by Subject|10
5111378|NCT01817764|17654542|P2|Overall Study|Lost to Follow-up|4
5111379|NCT01817764|17654543|P1|Overall Study|Lost to Follow-up|1
5111380|NCT01817764|17654542|P2|Overall Study|Protocol Violation|5
5111381|NCT01817764|17654543|P1|Overall Study|Protocol Violation|7
5111382|NCT01817764|17654542|P2|Overall Study|Lack of Efficacy|7
5111383|NCT01817764|17654543|P1|Overall Study|Lack of Efficacy|9
5111384|NCT01817764|17654542|P2|Overall Study|Adverse Event|10
5111385|NCT01817764|17654543|P1|Overall Study|Adverse Event|7
5111386|NCT01817725|17654551|P1|Overall Study|Withdrawal by Subject|1
5111387|NCT01817582|17654572|P3|Overall Study|Randomized but exclusion criteria met|0
5111388|NCT01817582|17654573|P2|Overall Study|Randomized but exclusion criteria met|0
5111389|NCT01817582|17654574|P1|Overall Study|Randomized but exclusion criteria met|1
5111390|NCT01817582|17654572|P3|Overall Study|Participant revealed masked treatment|0
5111391|NCT01817582|17654573|P2|Overall Study|Participant revealed masked treatment|0
5111392|NCT01817582|17654574|P1|Overall Study|Participant revealed masked treatment|1
5111393|NCT01817582|17654572|P3|Overall Study|Withdrawal by Subject|0
5111394|NCT01817582|17654573|P2|Overall Study|Withdrawal by Subject|1
5111395|NCT01817582|17654574|P1|Overall Study|Withdrawal by Subject|0
5111396|NCT01817530|17654644|P8|Overall Study|Lost to Follow-up|4
5111397|NCT01817530|17654645|P7|Overall Study|Lost to Follow-up|8
5111398|NCT01817530|17654646|P6|Overall Study|Lost to Follow-up|2
5111399|NCT01817530|17654647|P5|Overall Study|Lost to Follow-up|3
5111400|NCT01817530|17654648|P4|Overall Study|Lost to Follow-up|1
5111401|NCT01817530|17654649|P3|Overall Study|Lost to Follow-up|2
5111402|NCT01817530|17654650|P2|Overall Study|Lost to Follow-up|4
5111403|NCT01817530|17654651|P1|Overall Study|Lost to Follow-up|1
5111404|NCT01817530|17654644|P8|Overall Study|Consent Withdrawn by Subject|10
5111405|NCT01817530|17654645|P7|Overall Study|Consent Withdrawn by Subject|3
5111406|NCT01817530|17654646|P6|Overall Study|Consent Withdrawn by Subject|3
5111407|NCT01817530|17654647|P5|Overall Study|Consent Withdrawn by Subject|5
5111408|NCT01817530|17654648|P4|Overall Study|Consent Withdrawn by Subject|3
5111409|NCT01817530|17654649|P3|Overall Study|Consent Withdrawn by Subject|7
5111410|NCT01817530|17654650|P2|Overall Study|Consent Withdrawn by Subject|4
5111411|NCT01817530|17654651|P1|Overall Study|Consent Withdrawn by Subject|3
5111412|NCT01817530|17654644|P8|Overall Study|Surgery or Invasive Intervention|0
5111413|NCT01817530|17654645|P7|Overall Study|Surgery or Invasive Intervention|1
5111414|NCT01817530|17654646|P6|Overall Study|Surgery or Invasive Intervention|1
5111415|NCT01817530|17654647|P5|Overall Study|Surgery or Invasive Intervention|1
5111416|NCT01817530|17654648|P4|Overall Study|Surgery or Invasive Intervention|0
5111417|NCT01817530|17654649|P3|Overall Study|Surgery or Invasive Intervention|0
5111418|NCT01817530|17654650|P2|Overall Study|Surgery or Invasive Intervention|0
5111419|NCT01817530|17654651|P1|Overall Study|Surgery or Invasive Intervention|1
5111420|NCT01817530|17654644|P8|Overall Study|Other|0
5111421|NCT01817530|17654645|P7|Overall Study|Other|5
5111422|NCT01817530|17654646|P6|Overall Study|Other|0
5111423|NCT01817530|17654647|P5|Overall Study|Other|1
5111424|NCT01817530|17654648|P4|Overall Study|Other|0
5111425|NCT01817530|17654649|P3|Overall Study|Other|0
5111426|NCT01817530|17654650|P2|Overall Study|Other|1
5111427|NCT01817530|17654651|P1|Overall Study|Other|0
5111428|NCT01817530|17654644|P8|Overall Study|Pregnancy|0
5111429|NCT01817530|17654645|P7|Overall Study|Pregnancy|0
5111430|NCT01817530|17654646|P6|Overall Study|Pregnancy|1
5111431|NCT01817530|17654647|P5|Overall Study|Pregnancy|0
5111432|NCT01817530|17654648|P4|Overall Study|Pregnancy|0
5111433|NCT01817530|17654649|P3|Overall Study|Pregnancy|0
5111434|NCT01817530|17654650|P2|Overall Study|Pregnancy|0
5111435|NCT01817530|17654651|P1|Overall Study|Pregnancy|0
5111436|NCT01817530|17654644|P8|Overall Study|Lack of Efficacy|1
5111437|NCT01817530|17654645|P7|Overall Study|Lack of Efficacy|0
5111438|NCT01817530|17654646|P6|Overall Study|Lack of Efficacy|1
5111439|NCT01817530|17654647|P5|Overall Study|Lack of Efficacy|0
5111440|NCT01817530|17654648|P4|Overall Study|Lack of Efficacy|0
5111441|NCT01817530|17654649|P3|Overall Study|Lack of Efficacy|0
5111442|NCT01817530|17654650|P2|Overall Study|Lack of Efficacy|0
5111443|NCT01817530|17654651|P1|Overall Study|Lack of Efficacy|1
5111444|NCT01817530|17654644|P8|Overall Study|Subject Noncompliant|1
5111445|NCT01817530|17654645|P7|Overall Study|Subject Noncompliant|1
5111446|NCT01817530|17654646|P6|Overall Study|Subject Noncompliant|1
5111447|NCT01817530|17654647|P5|Overall Study|Subject Noncompliant|0
5111448|NCT01817530|17654648|P4|Overall Study|Subject Noncompliant|4
5111449|NCT01817530|17654649|P3|Overall Study|Subject Noncompliant|0
5111450|NCT01817530|17654650|P2|Overall Study|Subject Noncompliant|1
5111451|NCT01817530|17654651|P1|Overall Study|Subject Noncompliant|3
5111452|NCT01817530|17654644|P8|Overall Study|Adverse Event|8
5111453|NCT01817530|17654645|P7|Overall Study|Adverse Event|5
5111454|NCT01817530|17654646|P6|Overall Study|Adverse Event|10
5111455|NCT01817530|17654647|P5|Overall Study|Adverse Event|0
5111456|NCT01817530|17654648|P4|Overall Study|Adverse Event|5
5111457|NCT01817530|17654649|P3|Overall Study|Adverse Event|2
5111458|NCT01817530|17654650|P2|Overall Study|Adverse Event|3
5111459|NCT01817530|17654651|P1|Overall Study|Adverse Event|6
5111460|NCT01817530|17654644|P8|Overall Study|Exclusionary Medication Received|0
5111461|NCT01817530|17654645|P7|Overall Study|Exclusionary Medication Received|0
5111462|NCT01817530|17654646|P6|Overall Study|Exclusionary Medication Received|0
5111463|NCT01817530|17654647|P5|Overall Study|Exclusionary Medication Received|1
5111464|NCT01817530|17654648|P4|Overall Study|Exclusionary Medication Received|0
5111465|NCT01817530|17654649|P3|Overall Study|Exclusionary Medication Received|0
5111466|NCT01817530|17654650|P2|Overall Study|Exclusionary Medication Received|0
5111467|NCT01817530|17654651|P1|Overall Study|Exclusionary Medication Received|0
5111468|NCT01817075|17654876|P2|Overall Study|Ineligible|2
5111469|NCT01817075|17654877|P1|Overall Study|Ineligible|0
5111470|NCT01817075|17654876|P2|Overall Study|Received Sorafenib after enrollment|1
5111471|NCT01817075|17654877|P1|Overall Study|Received Sorafenib after enrollment|0
5111472|NCT01817075|17654876|P2|Overall Study|Withdrawal by Subject|15
5111473|NCT01817075|17654877|P1|Overall Study|Withdrawal by Subject|31
5111474|NCT01817075|17654876|P2|Overall Study|Physician Decision|12
5111475|NCT01817075|17654877|P1|Overall Study|Physician Decision|9
5111476|NCT01817075|17654876|P2|Overall Study|Adverse Event|5
5111477|NCT01817075|17654877|P1|Overall Study|Adverse Event|7
5111478|NCT01816984|17654889|P1|Overall Study|declining health status|1
5111479|NCT01816906|17654902|P2|12 Months|Lost to Follow-up|1
5111480|NCT01816906|17654903|P1|12 Months|Lost to Follow-up|2
5111481|NCT01816906|17654902|P2|12 Months|Death|2
5111482|NCT01816906|17654903|P1|12 Months|Death|0
5111483|NCT01816906|17654902|P2|12 Months|Adverse Event|2
5111484|NCT01816906|17654903|P1|12 Months|Adverse Event|2
5111485|NCT01816906|17654902|P2|Six Months|Lost to Follow-up|16
5111486|NCT01816906|17654903|P1|Six Months|Lost to Follow-up|14
5111487|NCT01816906|17654902|P2|Six Months|Did Not Show Up for Baseline Measurement|6
5111488|NCT01816906|17654903|P1|Six Months|Did Not Show Up for Baseline Measurement|7
5111489|NCT01816893|17654921|P2|Washout Period|Withdrawal by Subject|0
5111490|NCT01816893|17654922|P1|Washout Period|Withdrawal by Subject|2
5111491|NCT01816763|17654958|P3|Overall Study|The main reason for an incomplete survey|11
5111492|NCT01816763|17654959|P2|Overall Study|The main reason for an incomplete survey|15
5111493|NCT01816763|17654960|P1|Overall Study|The main reason for an incomplete survey|4
5111494|NCT01816685|17654976|P2|Overall Study|Surgery Cancelled|2
5111495|NCT01816685|17654977|P1|Overall Study|Surgery Cancelled|3
5111496|NCT01816685|17654976|P2|Overall Study|Lost to Follow-up|9
5111497|NCT01816685|17654977|P1|Overall Study|Lost to Follow-up|7
5111498|NCT01816594|17654987|P2|Overall Study|Physician Decision|0
5111499|NCT01816594|17654988|P1|Overall Study|Physician Decision|1
5111500|NCT01816594|17654987|P2|Overall Study|Withdrawal by Subject|0
5111501|NCT01816594|17654988|P1|Overall Study|Withdrawal by Subject|1
5111502|NCT01816594|17654987|P2|Overall Study|Adverse Event|0
5111503|NCT01816594|17654988|P1|Overall Study|Adverse Event|9
5111504|NCT01816594|17654987|P2|Overall Study|Local Progress|2
5111505|NCT01816594|17654988|P1|Overall Study|Local Progress|0
5111506|NCT01816477|17655026|P2|Overall Study|Unable to tolerate catheter placement|0
5111507|NCT01816477|17655027|P1|Overall Study|Unable to tolerate catheter placement|3
5111508|NCT01816477|17655026|P2|Overall Study|Withdrawal by Subject|1
5111509|NCT01816477|17655027|P1|Overall Study|Withdrawal by Subject|13
5111510|NCT01816295|17655081|P2|OLE Phase|Lack of Efficacy|7
5111511|NCT01816295|17655082|P1|OLE Phase|Lack of Efficacy|3
5111512|NCT01816295|17655081|P2|OLE Phase|Withdrawal by Subject|10
5111513|NCT01816295|17655082|P1|OLE Phase|Withdrawal by Subject|10
5111514|NCT01816295|17655081|P2|OLE Phase|Sponsor Decision|9
5111515|NCT01816295|17655082|P1|OLE Phase|Sponsor Decision|7
5111516|NCT01816295|17655081|P2|OLE Phase|Protocol Violation|4
5111517|NCT01816295|17655082|P1|OLE Phase|Protocol Violation|4
5111518|NCT01816295|17655081|P2|OLE Phase|Physician Decision|1
5111519|NCT01816295|17655082|P1|OLE Phase|Physician Decision|3
5111520|NCT01816295|17655081|P2|OLE Phase|Lost to Follow-up|5
5111521|NCT01816295|17655082|P1|OLE Phase|Lost to Follow-up|5
5111522|NCT01816295|17655081|P2|OLE Phase|Entry Criteria Not Met|5
5111523|NCT01816295|17655082|P1|OLE Phase|Entry Criteria Not Met|3
5111524|NCT01816295|17655081|P2|OLE Phase|Death|0
5111525|NCT01816295|17655082|P1|OLE Phase|Death|1
5111526|NCT01816295|17655081|P2|OLE Phase|Adverse Event|15
5111527|NCT01816295|17655082|P1|OLE Phase|Adverse Event|17
5111528|NCT01816295|17655081|P2|Double Blind Phase|Withdrawal by Subject|20
5111529|NCT01816295|17655082|P1|Double Blind Phase|Withdrawal by Subject|22
5111530|NCT01816295|17655081|P2|Double Blind Phase|Sponsor Decision|8
5111531|NCT01816295|17655082|P1|Double Blind Phase|Sponsor Decision|8
5111532|NCT01816295|17655081|P2|Double Blind Phase|Protocol Violation|11
5111533|NCT01816295|17655082|P1|Double Blind Phase|Protocol Violation|17
5111534|NCT01816295|17655081|P2|Double Blind Phase|Physician Decision|2
5111535|NCT01816295|17655082|P1|Double Blind Phase|Physician Decision|2
5111536|NCT01816295|17655081|P2|Double Blind Phase|Lost to Follow-up|5
5111537|NCT01816295|17655082|P1|Double Blind Phase|Lost to Follow-up|3
5111538|NCT01816295|17655081|P2|Double Blind Phase|Entry Criteria Not Met|2
5111539|NCT01816295|17655082|P1|Double Blind Phase|Entry Criteria Not Met|0
5111540|NCT01816295|17655081|P2|Double Blind Phase|Adverse Event|8
5111541|NCT01816295|17655082|P1|Double Blind Phase|Adverse Event|11
5111542|NCT01816243|17655097|P1|Overall Study|Amputation|3
5111543|NCT01816243|17655097|P1|Overall Study|Not eligible for the study|1
5111544|NCT01816243|17655097|P1|Overall Study|Lack of Efficacy|1
5111545|NCT01816243|17655097|P1|Overall Study|Lost to Follow-up|1
5111546|NCT01816243|17655097|P1|Overall Study|Adverse Event|6
5111547|NCT01816074|17655112|P4|Phase 2|Withdrawal by Subject|0
5111548|NCT01816074|17655113|P3|Phase 2|Withdrawal by Subject|0
5111549|NCT01816074|17655114|P2|Phase 2|Withdrawal by Subject|0
5111550|NCT01816074|17655115|P1|Phase 2|Withdrawal by Subject|1
5111551|NCT01816074|17655112|P4|Phase 2|Physician Decision|1
5111552|NCT01816074|17655113|P3|Phase 2|Physician Decision|0
5111553|NCT01816074|17655114|P2|Phase 2|Physician Decision|0
5111554|NCT01816074|17655115|P1|Phase 2|Physician Decision|0
5111555|NCT01816074|17655112|P4|Phase 2|Unsatisfied with Randomization assignmen|0
5111556|NCT01816074|17655113|P3|Phase 2|Unsatisfied with Randomization assignmen|0
5111557|NCT01816074|17655114|P2|Phase 2|Unsatisfied with Randomization assignmen|0
5111558|NCT01816074|17655115|P1|Phase 2|Unsatisfied with Randomization assignmen|1
5111559|NCT01816074|17655112|P4|Phase 2|Time commitment Issues|0
5111560|NCT01816074|17655113|P3|Phase 2|Time commitment Issues|0
5111561|NCT01816074|17655114|P2|Phase 2|Time commitment Issues|2
5111562|NCT01816074|17655115|P1|Phase 2|Time commitment Issues|0
5111563|NCT01816074|17655112|P4|Phase 1|Time commitment issues|0
5111564|NCT01816074|17655113|P3|Phase 1|Time commitment issues|1
5111565|NCT01816074|17655114|P2|Phase 1|Time commitment issues|0
5111566|NCT01816074|17655115|P1|Phase 1|Time commitment issues|0
5111567|NCT01816061|17655145|P2|Overall Study|Lost to Follow-up|24
5111568|NCT01816061|17655146|P1|Overall Study|Lost to Follow-up|13
5111569|NCT01816048|17655154|P1|Overall Study|Disease Progression|3
5111570|NCT01816048|17655154|P1|Overall Study|Withdrawal by Subject|1
5111571|NCT01816048|17655154|P1|Overall Study|Death|1
5111572|NCT01816048|17655154|P1|Overall Study|Adverse Event|1
5111573|NCT01815918|17655169|P2|Overall Study|Lack of Efficacy|15
5111574|NCT01815918|17655170|P1|Overall Study|Lack of Efficacy|15
5111575|NCT01815918|17655169|P2|Overall Study|Patient samples not analyzable|4
5111576|NCT01815918|17655170|P1|Overall Study|Patient samples not analyzable|3
5111577|NCT01815840|17655186|P2|Overall Study|Sponsor Termination Treatment|0
5111578|NCT01815840|17655187|P1|Overall Study|Sponsor Termination Treatment|1
5111579|NCT01815840|17655186|P2|Overall Study|Refused Treatment|1
5111580|NCT01815840|17655187|P1|Overall Study|Refused Treatment|5
5111581|NCT01815840|17655186|P2|Overall Study|Lost to Follow-up|6
5111582|NCT01815840|17655187|P1|Overall Study|Lost to Follow-up|3
5111583|NCT01815840|17655186|P2|Overall Study|Investigators Decision|3
5111584|NCT01815840|17655187|P1|Overall Study|Investigators Decision|2
5111585|NCT01815840|17655186|P2|Overall Study|Disease progression|2
5111586|NCT01815840|17655187|P1|Overall Study|Disease progression|3
5111587|NCT01815840|17655186|P2|Overall Study|Death|2
5111588|NCT01815840|17655187|P1|Overall Study|Death|2
5111589|NCT01815840|17655186|P2|Overall Study|Adverse Event|16
5111590|NCT01815840|17655187|P1|Overall Study|Adverse Event|10
5111591|NCT01815840|17655186|P2|Overall Study|Administrative/Other|3
5111592|NCT01815840|17655187|P1|Overall Study|Administrative/Other|1
5111593|NCT01815840|17655186|P2|Overall Study|Withdrew Consent|30
5111594|NCT01815840|17655187|P1|Overall Study|Withdrew Consent|31
5111595|NCT01815840|17655186|P2|Overall Study|Missing|0
5111596|NCT01815840|17655187|P1|Overall Study|Missing|1
5111597|NCT01815736|17655217|P2|Overall Study|Still on Study|449
5111598|NCT01815736|17655218|P1|Overall Study|Still on Study|929
5111599|NCT01815736|17655217|P2|Overall Study|Lost to Follow-up|7
5111600|NCT01815736|17655218|P1|Overall Study|Lost to Follow-up|6
5111601|NCT01815736|17655217|P2|Overall Study|Withdrew Consent|15
5111602|NCT01815736|17655218|P1|Overall Study|Withdrew Consent|7
5111603|NCT01815736|17655217|P2|Overall Study|Investigator's Discretion|0
5111604|NCT01815736|17655218|P1|Overall Study|Investigator's Discretion|4
5111605|NCT01815736|17655217|P2|Overall Study|Death|0
5111606|NCT01815736|17655218|P1|Overall Study|Death|4
5111607|NCT01815736|17655217|P2|Overall Study|Adverse Event|4
5111608|NCT01815736|17655218|P1|Overall Study|Adverse Event|7
5111609|NCT01815736|17655217|P2|Overall Study|Randomized but Not Treated|3
5111610|NCT01815736|17655218|P1|Overall Study|Randomized but Not Treated|4
5111611|NCT01815424|17655287|P5|Week 16 to 52|Withdrawal by Subject|0
5111612|NCT01815424|17655288|P4|Week 16 to 52|Withdrawal by Subject|0
5111613|NCT01815424|17655289|P3|Week 16 to 52|Withdrawal by Subject|0
5111614|NCT01815424|17655290|P2|Week 16 to 52|Withdrawal by Subject|2
5111615|NCT01815424|17655291|P1|Week 16 to 52|Withdrawal by Subject|1
5111616|NCT01815424|17655287|P5|Week 16 to 52|Lost to Follow-up|1
5111617|NCT01815424|17655288|P4|Week 16 to 52|Lost to Follow-up|2
5111618|NCT01815424|17655289|P3|Week 16 to 52|Lost to Follow-up|0
5111619|NCT01815424|17655290|P2|Week 16 to 52|Lost to Follow-up|2
5111620|NCT01815424|17655291|P1|Week 16 to 52|Lost to Follow-up|0
5111621|NCT01815424|17655287|P5|Week 16 to 52|Insufficient Clinical Response|1
5111622|NCT01815424|17655288|P4|Week 16 to 52|Insufficient Clinical Response|1
5111623|NCT01815424|17655289|P3|Week 16 to 52|Insufficient Clinical Response|0
5111624|NCT01815424|17655290|P2|Week 16 to 52|Insufficient Clinical Response|0
5111625|NCT01815424|17655291|P1|Week 16 to 52|Insufficient Clinical Response|1
5111626|NCT01815424|17655287|P5|Week 16 to 52|Adverse Event|1
5111627|NCT01815424|17655288|P4|Week 16 to 52|Adverse Event|0
5111628|NCT01815424|17655289|P3|Week 16 to 52|Adverse Event|0
5111629|NCT01815424|17655290|P2|Week 16 to 52|Adverse Event|0
5111630|NCT01815424|17655291|P1|Week 16 to 52|Adverse Event|0
5111631|NCT01815424|17655287|P5|Week 16 to 52|Other|0
5111632|NCT01815424|17655288|P4|Week 16 to 52|Other|0
5111633|NCT01815424|17655289|P3|Week 16 to 52|Other|0
5111634|NCT01815424|17655290|P2|Week 16 to 52|Other|1
5111635|NCT01815424|17655291|P1|Week 16 to 52|Other|0
5111636|NCT01815424|17655287|P5|Week 0 to 16|Insufficient Clinical Response|0
5111637|NCT01815424|17655288|P4|Week 0 to 16|Insufficient Clinical Response|0
5111638|NCT01815424|17655289|P3|Week 0 to 16|Insufficient Clinical Response|4
5111639|NCT01815424|17655290|P2|Week 0 to 16|Insufficient Clinical Response|0
5111640|NCT01815424|17655291|P1|Week 0 to 16|Insufficient Clinical Response|2
5111641|NCT01815424|17655287|P5|Week 0 to 16|Protocol Violation|0
5111642|NCT01815424|17655288|P4|Week 0 to 16|Protocol Violation|0
5111643|NCT01815424|17655289|P3|Week 0 to 16|Protocol Violation|0
5111644|NCT01815424|17655290|P2|Week 0 to 16|Protocol Violation|0
5111645|NCT01815424|17655291|P1|Week 0 to 16|Protocol Violation|1
5111646|NCT01815424|17655287|P5|Week 0 to 16|Other|0
5111647|NCT01815424|17655288|P4|Week 0 to 16|Other|0
5111648|NCT01815424|17655289|P3|Week 0 to 16|Other|3
5111649|NCT01815424|17655290|P2|Week 0 to 16|Other|0
5111650|NCT01815424|17655291|P1|Week 0 to 16|Other|1
5111651|NCT01815424|17655287|P5|Week 0 to 16|Withdrawal by Subject|0
5111652|NCT01815424|17655288|P4|Week 0 to 16|Withdrawal by Subject|0
5111653|NCT01815424|17655289|P3|Week 0 to 16|Withdrawal by Subject|1
5111654|NCT01815424|17655290|P2|Week 0 to 16|Withdrawal by Subject|0
5111655|NCT01815424|17655291|P1|Week 0 to 16|Withdrawal by Subject|0
5111656|NCT01815424|17655287|P5|Week 0 to 16|Lost to Follow-up|0
5111657|NCT01815424|17655288|P4|Week 0 to 16|Lost to Follow-up|0
5111658|NCT01815424|17655289|P3|Week 0 to 16|Lost to Follow-up|0
5111659|NCT01815424|17655290|P2|Week 0 to 16|Lost to Follow-up|1
5111660|NCT01815424|17655291|P1|Week 0 to 16|Lost to Follow-up|0
5111661|NCT01815424|17655287|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
5111662|NCT01815424|17655288|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
5111663|NCT01815424|17655289|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
5111664|NCT01815424|17655290|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
5111665|NCT01815424|17655291|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
5111666|NCT01815424|17655287|P5|Week 0 to 16|Adverse Event|0
5111667|NCT01815424|17655288|P4|Week 0 to 16|Adverse Event|0
5111668|NCT01815424|17655289|P3|Week 0 to 16|Adverse Event|3
5111669|NCT01815424|17655290|P2|Week 0 to 16|Adverse Event|3
5111670|NCT01815424|17655291|P1|Week 0 to 16|Adverse Event|1
5111671|NCT01815138|17655507|P2|Overall Study|Physician Decision|5
5111672|NCT01815138|17655508|P1|Overall Study|Physician Decision|8
5111673|NCT01815138|17655507|P2|Overall Study|Withdrawal by Subject|1
5111674|NCT01815138|17655508|P1|Overall Study|Withdrawal by Subject|0
5111675|NCT01815099|17655520|P1|Overall Study|unable to attend study visits|1
5111676|NCT01815099|17655520|P1|Overall Study|Lack of Efficacy|1
5111677|NCT01814878|17655534|P2|Overall Study|Other|0
5111678|NCT01814878|17655535|P1|Overall Study|Other|2
5111679|NCT01814878|17655534|P2|Overall Study|Screening failure (drop-out)|3
5111680|NCT01814878|17655535|P1|Overall Study|Screening failure (drop-out)|0
5111681|NCT01814878|17655534|P2|Overall Study|Physician Decision|1
5111682|NCT01814878|17655535|P1|Overall Study|Physician Decision|3
5111683|NCT01814878|17655534|P2|Overall Study|Protocol Violation|5
5111684|NCT01814878|17655535|P1|Overall Study|Protocol Violation|5
5111685|NCT01814878|17655534|P2|Overall Study|Withdrawal by Subject|16
5111686|NCT01814878|17655535|P1|Overall Study|Withdrawal by Subject|20
5111687|NCT01814878|17655534|P2|Overall Study|Adverse Event|5
5111688|NCT01814878|17655535|P1|Overall Study|Adverse Event|16
5111689|NCT01814826|17655558|P3|Overall Study|Death|3
5111690|NCT01814826|17655559|P2|Overall Study|Death|24
5111691|NCT01814826|17655560|P1|Overall Study|Death|29
5111692|NCT01814826|17655558|P3|Overall Study|Other|0
5111693|NCT01814826|17655559|P2|Overall Study|Other|5
5111694|NCT01814826|17655560|P1|Overall Study|Other|3
5111695|NCT01814800|17655652|P1|Overall Study|Subject relocation|1
5111696|NCT01814800|17655652|P1|Overall Study|Sponsor decision|1
5111697|NCT01814800|17655652|P1|Overall Study|Pregnancy|1
5111698|NCT01814800|17655652|P1|Overall Study|Adverse Event|2
5111699|NCT01814761|17655712|P2|Overall Study|Lost to Follow-up|5
5111700|NCT01814761|17655713|P1|Overall Study|Lost to Follow-up|1
5111701|NCT01814761|17655712|P2|Overall Study|Ocular Adverse Event|15
5111702|NCT01814761|17655713|P1|Overall Study|Ocular Adverse Event|6
5111703|NCT01814761|17655712|P2|Overall Study|Other Reasons|10
5111704|NCT01814761|17655713|P1|Overall Study|Other Reasons|1
5111705|NCT01814748|17655727|P2|Overall Study|Withdrawal by Subject|4
5111706|NCT01814748|17655728|P1|Overall Study|Withdrawal by Subject|6
5111707|NCT01814748|17655727|P2|Overall Study|Study site terminated by sponsor|1
5111708|NCT01814748|17655728|P1|Overall Study|Study site terminated by sponsor|1
5111709|NCT01814748|17655727|P2|Overall Study|Lost to Follow-up|2
5111710|NCT01814748|17655728|P1|Overall Study|Lost to Follow-up|1
5111711|NCT01814696|17655772|P2|Overall Study|Randomized to wrong group|0
5111712|NCT01814696|17655773|P1|Overall Study|Randomized to wrong group|1
5111713|NCT01814696|17655772|P2|Overall Study|Withdrawal by Subject|0
5111714|NCT01814696|17655773|P1|Overall Study|Withdrawal by Subject|1
5111715|NCT01814670|17655791|P1|Overall Study|Protocol Violation|12
5111716|NCT01814553|17655801|P2|Overall Study|Other than stated|8
5111717|NCT01814553|17655802|P1|Overall Study|Other than stated|7
5111718|NCT01814553|17655801|P2|Overall Study|Withdrawal by Subject|1
5111719|NCT01814553|17655802|P1|Overall Study|Withdrawal by Subject|1
5111720|NCT01814553|17655801|P2|Overall Study|Other Adverse Event|5
5111721|NCT01814553|17655802|P1|Overall Study|Other Adverse Event|4
5111722|NCT01814553|17655801|P2|Overall Study|PD per clinical progression|8
5111723|NCT01814553|17655802|P1|Overall Study|PD per clinical progression|6
5111724|NCT01814397|17655816|P1|Overall Study|Withdrawal by Subject|7
5111725|NCT01814397|17655816|P1|Overall Study|Adverse Event|7
5111726|NCT01814371|17655825|P2|Overall Study|Lost to Follow-up|27
5111727|NCT01814371|17655826|P1|Overall Study|Lost to Follow-up|30
5111728|NCT01814332|17655861|P2|Overall Study|Lost to Follow-up|1
5111729|NCT01814332|17655862|P1|Overall Study|Lost to Follow-up|5
5111730|NCT01814332|17655861|P2|Overall Study|Protocol Violation|4
5111731|NCT01814332|17655862|P1|Overall Study|Protocol Violation|0
5111732|NCT01814332|17655861|P2|Overall Study|Withdrawal by Subject|8
5111733|NCT01814332|17655862|P1|Overall Study|Withdrawal by Subject|3
5111734|NCT01814332|17655861|P2|Overall Study|Adverse Event|3
5111735|NCT01814332|17655862|P1|Overall Study|Adverse Event|8
5111736|NCT01814137|17655884|P2|Overall Study|Unclassified|1
5111737|NCT01814137|17655885|P1|Overall Study|Unclassified|2
5111738|NCT01814137|17655884|P2|Overall Study|Physician Decision|1
5111739|NCT01814137|17655885|P1|Overall Study|Physician Decision|1
5111740|NCT01814137|17655884|P2|Overall Study|Withdrawal by Subject|2
5111741|NCT01814137|17655885|P1|Overall Study|Withdrawal by Subject|2
5111742|NCT01814137|17655884|P2|Overall Study|Adverse Event|1
5111743|NCT01814137|17655885|P1|Overall Study|Adverse Event|0
5111744|NCT01814046|17655901|P3|Drug Administration|Death due to complications of RSV|0
5111745|NCT01814046|17655902|P2|Drug Administration|Death due to complications of RSV|0
5111746|NCT01814046|17655903|P1|Drug Administration|Death due to complications of RSV|1
5111747|NCT01813890|17655917|P3|Overall Study|Lack of Efficacy|2
5111748|NCT01813890|17655918|P2|Overall Study|Lack of Efficacy|1
5111749|NCT01813890|17655919|P1|Overall Study|Lack of Efficacy|9
5111750|NCT01813890|17655917|P3|Overall Study|Adverse Event|4
5111751|NCT01813890|17655918|P2|Overall Study|Adverse Event|3
5111752|NCT01813890|17655919|P1|Overall Study|Adverse Event|0
5111753|NCT01813721|17655956|P1|Overall Study|Withdrawal by Subject|1
5111754|NCT01813721|17655956|P1|Overall Study|Ineligibility determined|63
5111755|NCT01813474|17656011|P3|Overall Study|Death|1
5111756|NCT01813474|17656012|P2|Overall Study|Death|0
5111757|NCT01813474|17656013|P1|Overall Study|Death|0
5111758|NCT01813474|17656011|P3|Overall Study|Lack of Efficacy|9
5111759|NCT01813474|17656012|P2|Overall Study|Lack of Efficacy|6
5111760|NCT01813474|17656013|P1|Overall Study|Lack of Efficacy|2
5111761|NCT01813474|17656011|P3|Overall Study|Adverse Event|0
5111762|NCT01813474|17656012|P2|Overall Study|Adverse Event|1
5111763|NCT01813474|17656013|P1|Overall Study|Adverse Event|1
5111764|NCT01813474|17656011|P3|Overall Study|Withdrawal by Subject|1
5111765|NCT01813474|17656012|P2|Overall Study|Withdrawal by Subject|0
5111766|NCT01813474|17656013|P1|Overall Study|Withdrawal by Subject|0
5111767|NCT01813435|17656037|P2|Overall Study|Lost to Follow-up|237
5111768|NCT01813435|17656038|P1|Overall Study|Lost to Follow-up|268
5111769|NCT01813435|17656037|P2|Overall Study|did not finish experimental regimen|770
5111770|NCT01813435|17656038|P1|Overall Study|did not finish experimental regimen|1902
5111771|NCT01813422|17656062|P2|Overall Study|Lost to Follow-up|4
5111772|NCT01813422|17656063|P1|Overall Study|Lost to Follow-up|2
5111773|NCT01813422|17656062|P2|Overall Study|Sponsor Decision|1
5111774|NCT01813422|17656063|P1|Overall Study|Sponsor Decision|2
5111775|NCT01813422|17656062|P2|Overall Study|Death|3
5111776|NCT01813422|17656063|P1|Overall Study|Death|2
5111777|NCT01813422|17656062|P2|Overall Study|Withdrawal by Subject|8
5111778|NCT01813422|17656063|P1|Overall Study|Withdrawal by Subject|14
5111779|NCT01813357|17656077|P2|Overall Study|Lost to Follow-up|6
5111780|NCT01813357|17656078|P1|Overall Study|Lost to Follow-up|5
5111781|NCT01813071|17656119|P9|Overall Study|Met inc/exc criteria|1
5111782|NCT01813071|17656120|P8|Overall Study|Met inc/exc criteria|1
5111783|NCT01813071|17656121|P7|Overall Study|Met inc/exc criteria|0
5111784|NCT01813071|17656122|P6|Overall Study|Met inc/exc criteria|1
5111785|NCT01813071|17656123|P5|Overall Study|Met inc/exc criteria|0
5111786|NCT01813071|17656124|P4|Overall Study|Met inc/exc criteria|0
5111787|NCT01813071|17656125|P3|Overall Study|Met inc/exc criteria|0
5111788|NCT01813071|17656126|P2|Overall Study|Met inc/exc criteria|0
5111789|NCT01813071|17656127|P1|Overall Study|Met inc/exc criteria|0
5111790|NCT01813071|17656119|P9|Overall Study|Physician Decision|0
5111791|NCT01813071|17656120|P8|Overall Study|Physician Decision|0
5111792|NCT01813071|17656121|P7|Overall Study|Physician Decision|1
5111793|NCT01813071|17656122|P6|Overall Study|Physician Decision|0
5111794|NCT01813071|17656123|P5|Overall Study|Physician Decision|0
5111795|NCT01813071|17656124|P4|Overall Study|Physician Decision|0
5111796|NCT01813071|17656125|P3|Overall Study|Physician Decision|0
5111797|NCT01813071|17656126|P2|Overall Study|Physician Decision|0
5111798|NCT01813071|17656127|P1|Overall Study|Physician Decision|0
5111799|NCT01813071|17656119|P9|Overall Study|Adverse Event|0
5111800|NCT01813071|17656120|P8|Overall Study|Adverse Event|0
5111801|NCT01813071|17656121|P7|Overall Study|Adverse Event|0
5111802|NCT01813071|17656122|P6|Overall Study|Adverse Event|1
5111803|NCT01813071|17656123|P5|Overall Study|Adverse Event|0
5111804|NCT01813071|17656124|P4|Overall Study|Adverse Event|0
5111805|NCT01813071|17656125|P3|Overall Study|Adverse Event|0
5111806|NCT01813071|17656126|P2|Overall Study|Adverse Event|0
5111807|NCT01813071|17656127|P1|Overall Study|Adverse Event|0
5111808|NCT01813071|17656119|P9|Overall Study|Withdrawal by Subject|0
5111809|NCT01813071|17656120|P8|Overall Study|Withdrawal by Subject|0
5111810|NCT01813071|17656121|P7|Overall Study|Withdrawal by Subject|0
5111811|NCT01813071|17656122|P6|Overall Study|Withdrawal by Subject|1
5111812|NCT01813071|17656123|P5|Overall Study|Withdrawal by Subject|0
5111813|NCT01813071|17656124|P4|Overall Study|Withdrawal by Subject|0
5111814|NCT01813071|17656125|P3|Overall Study|Withdrawal by Subject|0
5111815|NCT01813071|17656126|P2|Overall Study|Withdrawal by Subject|0
5111816|NCT01813071|17656127|P1|Overall Study|Withdrawal by Subject|0
5111817|NCT01813071|17656119|P9|Overall Study|Protocol Violation|2
5111818|NCT01813071|17656120|P8|Overall Study|Protocol Violation|4
5111819|NCT01813071|17656121|P7|Overall Study|Protocol Violation|2
5111820|NCT01813071|17656122|P6|Overall Study|Protocol Violation|4
5111821|NCT01813071|17656123|P5|Overall Study|Protocol Violation|1
5111822|NCT01813071|17656124|P4|Overall Study|Protocol Violation|0
5111823|NCT01813071|17656125|P3|Overall Study|Protocol Violation|0
5111824|NCT01813071|17656126|P2|Overall Study|Protocol Violation|0
5111825|NCT01813071|17656127|P1|Overall Study|Protocol Violation|0
5111826|NCT01813058|17656594|P2|Overall Study|Withdrawal by Subject|4
5111827|NCT01813058|17656595|P1|Overall Study|Withdrawal by Subject|5
5111828|NCT01813019|17656603|P2|Overall Study|Protocol Deviation|1
5111829|NCT01813019|17656604|P1|Overall Study|Protocol Deviation|2
5111830|NCT01813019|17656603|P2|Overall Study|administrative problems|0
5111831|NCT01813019|17656604|P1|Overall Study|administrative problems|2
5111832|NCT01813019|17656603|P2|Overall Study|Withdrawal by Subject|2
5111833|NCT01813019|17656604|P1|Overall Study|Withdrawal by Subject|3
5111834|NCT01813019|17656603|P2|Overall Study|Adverse Event|3
5111835|NCT01813019|17656604|P1|Overall Study|Adverse Event|0
5111836|NCT01812837|17656615|P3|Overall Study|Protocol Violation|0
5111837|NCT01812837|17656616|P2|Overall Study|Protocol Violation|0
5111838|NCT01812837|17656617|P1|Overall Study|Protocol Violation|1
5111839|NCT01812837|17656615|P3|Overall Study|Lost to Follow-up|0
5111840|NCT01812837|17656616|P2|Overall Study|Lost to Follow-up|1
5111841|NCT01812837|17656617|P1|Overall Study|Lost to Follow-up|1
5111842|NCT01812759|17656628|P3|Overall Study|Physician Decision|1
5111843|NCT01812759|17656629|P2|Overall Study|Physician Decision|0
5111844|NCT01812759|17656630|P1|Overall Study|Physician Decision|0
5111845|NCT01812707|17656642|P4|Overall Study|Consent withdrawn by participant|0
5111846|NCT01812707|17656643|P3|Overall Study|Consent withdrawn by participant|0
5111847|NCT01812707|17656644|P2|Overall Study|Consent withdrawn by participant|0
5111848|NCT01812707|17656645|P1|Overall Study|Consent withdrawn by participant|1
5111849|NCT01812707|17656642|P4|Overall Study|Poor compliance to protocol|0
5111850|NCT01812707|17656643|P3|Overall Study|Poor compliance to protocol|0
5111851|NCT01812707|17656644|P2|Overall Study|Poor compliance to protocol|0
5111852|NCT01812707|17656645|P1|Overall Study|Poor compliance to protocol|1
5111853|NCT01812707|17656642|P4|Overall Study|Adverse Event|2
5111854|NCT01812707|17656643|P3|Overall Study|Adverse Event|0
5111855|NCT01812707|17656644|P2|Overall Study|Adverse Event|0
5111856|NCT01812707|17656645|P1|Overall Study|Adverse Event|0
5111857|NCT01812655|17656693|P3|Overall Study|Protocol Violation|0
5111858|NCT01812655|17656694|P2|Overall Study|Protocol Violation|1
5111859|NCT01812655|17656695|P1|Overall Study|Protocol Violation|1
5111860|NCT01812057|17656720|P2|Overall Study|Physician Decision|0
5111861|NCT01812057|17656721|P1|Overall Study|Physician Decision|1
5111862|NCT01812057|17656720|P2|Overall Study|Protocol Violation|0
5111863|NCT01812057|17656721|P1|Overall Study|Protocol Violation|1
5111864|NCT01811953|17656824|P6|Overall Study|Protocol Violation|0
5111865|NCT01811953|17656825|P5|Overall Study|Protocol Violation|1
5111866|NCT01811953|17656826|P4|Overall Study|Protocol Violation|0
5111867|NCT01811953|17656827|P3|Overall Study|Protocol Violation|0
5111868|NCT01811953|17656828|P2|Overall Study|Protocol Violation|0
5111869|NCT01811953|17656829|P1|Overall Study|Protocol Violation|0
5111870|NCT01811953|17656824|P6|Overall Study|Adverse Event|1
5111871|NCT01811953|17656825|P5|Overall Study|Adverse Event|0
5111872|NCT01811953|17656826|P4|Overall Study|Adverse Event|1
5111873|NCT01811953|17656827|P3|Overall Study|Adverse Event|0
5111874|NCT01811953|17656828|P2|Overall Study|Adverse Event|0
5111875|NCT01811953|17656829|P1|Overall Study|Adverse Event|0
5111876|NCT01811732|17656886|P2|Overall Study|Correct study drug not available on site|0
5111877|NCT01811732|17656887|P1|Overall Study|Correct study drug not available on site|1
5111878|NCT01811732|17656886|P2|Overall Study|Admitted to another facility|0
5111879|NCT01811732|17656887|P1|Overall Study|Admitted to another facility|1
5111880|NCT01811732|17656886|P2|Overall Study|Subject incarcerated|2
5111881|NCT01811732|17656887|P1|Overall Study|Subject incarcerated|1
5111882|NCT01811732|17656886|P2|Overall Study|Protocol Violation|1
5111883|NCT01811732|17656887|P1|Overall Study|Protocol Violation|0
5111884|NCT01811732|17656886|P2|Overall Study|Insufficient venous access|1
5111885|NCT01811732|17656887|P1|Overall Study|Insufficient venous access|0
5111886|NCT01811732|17656886|P2|Overall Study|Death|1
5111887|NCT01811732|17656887|P1|Overall Study|Death|1
5111888|NCT01811732|17656886|P2|Overall Study|Physician Decision|0
5111889|NCT01811732|17656887|P1|Overall Study|Physician Decision|2
5111890|NCT01811732|17656886|P2|Overall Study|Non-compliance with study drug/procedure|3
5111891|NCT01811732|17656887|P1|Overall Study|Non-compliance with study drug/procedure|3
5111892|NCT01811732|17656886|P2|Overall Study|Lack of Efficacy|1
5111893|NCT01811732|17656887|P1|Overall Study|Lack of Efficacy|3
5111894|NCT01811732|17656886|P2|Overall Study|Adverse Event|9
5111895|NCT01811732|17656887|P1|Overall Study|Adverse Event|3
5111896|NCT01811732|17656886|P2|Overall Study|Withdrawal by Subject|10
5111897|NCT01811732|17656887|P1|Overall Study|Withdrawal by Subject|16
5111898|NCT01811732|17656886|P2|Overall Study|Lost to Follow-up|30
5111899|NCT01811732|17656887|P1|Overall Study|Lost to Follow-up|24
5111900|NCT01811706|17656897|P2|First Intervention ( 4 Weeks)|Adverse Event|0
5111901|NCT01811706|17656898|P1|First Intervention ( 4 Weeks)|Adverse Event|1
5111902|NCT01811563|17656938|P2|Overall Study|Incorrect Randomization procedure|1
5111903|NCT01811563|17656939|P1|Overall Study|Incorrect Randomization procedure|0
5111904|NCT01811563|17656938|P2|Overall Study|Lost to Follow-up|2
5111905|NCT01811563|17656939|P1|Overall Study|Lost to Follow-up|5
5111906|NCT01811485|17656968|P3|Overall Study|Protocol Deviation|0
5111907|NCT01811485|17656969|P2|Overall Study|Protocol Deviation|1
5111908|NCT01811485|17656970|P1|Overall Study|Protocol Deviation|0
5111909|NCT01811485|17656968|P3|Overall Study|Administrative problems|0
5111910|NCT01811485|17656969|P2|Overall Study|Administrative problems|0
5111911|NCT01811485|17656970|P1|Overall Study|Administrative problems|1
5111912|NCT01811485|17656968|P3|Overall Study|Unsatisfactory therapeutic effect|3
5111913|NCT01811485|17656969|P2|Overall Study|Unsatisfactory therapeutic effect|0
5111914|NCT01811485|17656970|P1|Overall Study|Unsatisfactory therapeutic effect|0
5111915|NCT01811485|17656968|P3|Overall Study|Adverse Event|2
5111916|NCT01811485|17656969|P2|Overall Study|Adverse Event|3
5111917|NCT01811485|17656970|P1|Overall Study|Adverse Event|1
5111918|NCT01811472|17656990|P3|Overall Study|Subject/guardian decision|0
5111919|NCT01811472|17656991|P2|Overall Study|Subject/guardian decision|0
5111920|NCT01811472|17656992|P1|Overall Study|Subject/guardian decision|1
5111921|NCT01811472|17656990|P3|Overall Study|Lost to Follow-up|1
5111922|NCT01811472|17656991|P2|Overall Study|Lost to Follow-up|0
5111923|NCT01811472|17656992|P1|Overall Study|Lost to Follow-up|0
5111924|NCT01811472|17656990|P3|Overall Study|Adverse Event|4
5111925|NCT01811472|17656991|P2|Overall Study|Adverse Event|0
5111926|NCT01811472|17656992|P1|Overall Study|Adverse Event|1
5111927|NCT01811238|17657079|P1|Overall Study|subject refused study medication|6
5111928|NCT01811238|17657079|P1|Overall Study|Lack of Efficacy|4
5111929|NCT01811238|17657079|P1|Overall Study|Protocol Violation|4
5111930|NCT01811238|17657079|P1|Overall Study|Adverse Event|25
5111931|NCT01811238|17657079|P1|Overall Study|Withdrawal by Subject|42
5111932|NCT01811225|17657088|P2|Treatment Period 2|unable to remain smoke free overnight|4
5111933|NCT01811225|17657089|P1|Treatment Period 2|unable to remain smoke free overnight|3
5111934|NCT01811225|17657088|P2|Treatment Period 2|Lost to Follow-up|2
5111935|NCT01811225|17657089|P1|Treatment Period 2|Lost to Follow-up|1
5111936|NCT01811225|17657088|P2|Treatment Period 1|unable to remain smoke free overnight|6
5111937|NCT01811225|17657089|P1|Treatment Period 1|unable to remain smoke free overnight|10
5111938|NCT01811225|17657088|P2|Treatment Period 1|transporation|0
5111939|NCT01811225|17657089|P1|Treatment Period 1|transporation|1
5111940|NCT01811225|17657088|P2|Treatment Period 1|Lost to Follow-up|8
5111941|NCT01811225|17657089|P1|Treatment Period 1|Lost to Follow-up|12
5111942|NCT01811225|17657088|P2|Treatment Period 1|Adverse Event|3
5111943|NCT01811225|17657089|P1|Treatment Period 1|Adverse Event|2
5111944|NCT01811186|17657114|P2|Overall Study|Lost to Follow-up|2
5111945|NCT01811186|17657115|P1|Overall Study|Lost to Follow-up|4
5111946|NCT01811186|17657114|P2|Overall Study|Lack of Efficacy|6
5111947|NCT01811186|17657115|P1|Overall Study|Lack of Efficacy|3
5111948|NCT01811186|17657114|P2|Overall Study|Withdrawal by Subject|10
5111949|NCT01811186|17657115|P1|Overall Study|Withdrawal by Subject|5
5111950|NCT01811186|17657114|P2|Overall Study|Protocol Violation|6
5111951|NCT01811186|17657115|P1|Overall Study|Protocol Violation|5
5111952|NCT01811186|17657114|P2|Overall Study|Adverse Event|38
5111953|NCT01811186|17657115|P1|Overall Study|Adverse Event|54
5111954|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
5111955|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
5111956|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
5111957|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
5111958|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
5111959|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
5111960|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
5111961|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
5111962|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
5111963|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
5111964|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
5111965|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
5111966|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
5111967|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
5111968|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
5111969|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
5111970|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
5111971|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
5111972|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Death|1
5111973|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Death|0
5111974|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Death|0
5111975|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
5111976|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
5111977|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
5111978|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
5111979|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
5111980|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
5111981|NCT01810939|17657169|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
5111982|NCT01810939|17657170|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
5111983|NCT01810939|17657171|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
5111984|NCT01810939|17657169|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
5111985|NCT01810939|17657170|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
5111986|NCT01810939|17657171|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
5111987|NCT01810939|17657169|P3|Part A Treatment Period|Protocol-specified (High K+)|0
5111988|NCT01810939|17657170|P2|Part A Treatment Period|Protocol-specified (High K+)|0
5111989|NCT01810939|17657171|P1|Part A Treatment Period|Protocol-specified (High K+)|3
5111990|NCT01810939|17657169|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
5111991|NCT01810939|17657170|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
5111992|NCT01810939|17657171|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
5111993|NCT01810939|17657169|P3|Part A Treatment Period|Withdrawal by Subject|0
5111994|NCT01810939|17657170|P2|Part A Treatment Period|Withdrawal by Subject|0
5111995|NCT01810939|17657171|P1|Part A Treatment Period|Withdrawal by Subject|5
5111996|NCT01810939|17657169|P3|Part A Treatment Period|Adverse Event|0
5111997|NCT01810939|17657170|P2|Part A Treatment Period|Adverse Event|0
5111998|NCT01810939|17657171|P1|Part A Treatment Period|Adverse Event|10
5111999|NCT01810939|17657169|P3|Part A Treatment Period|Protocol Violation|0
5112000|NCT01810939|17657170|P2|Part A Treatment Period|Protocol Violation|0
5112001|NCT01810939|17657171|P1|Part A Treatment Period|Protocol Violation|2
5112002|NCT01810939|17657169|P3|Part A Treatment Period|Non-compliance with Study Drug|0
5112003|NCT01810939|17657170|P2|Part A Treatment Period|Non-compliance with Study Drug|0
5112004|NCT01810939|17657171|P1|Part A Treatment Period|Non-compliance with Study Drug|1
5112005|NCT01810783|17657184|P1|Overall Study|Enrolled, not treated|1
5112006|NCT01810783|17657184|P1|Overall Study|Adminstrative or other reason(s)|23
5112007|NCT01810783|17657184|P1|Overall Study|Non-compliance with IMP|4
5112008|NCT01810783|17657184|P1|Overall Study|Protocol Violation|5
5112009|NCT01810783|17657184|P1|Overall Study|Lost to Follow-up|10
5112010|NCT01810783|17657184|P1|Overall Study|Lack of Efficacy|12
5112011|NCT01810783|17657184|P1|Overall Study|Withdrawal by Subject|22
5112012|NCT01810783|17657184|P1|Overall Study|Adverse Event|32
5112013|NCT01810432|17657209|P2|Period 2|Lost to Follow-up|1
5112014|NCT01810432|17657210|P1|Period 2|Lost to Follow-up|1
5112015|NCT01810432|17657209|P2|Period 2|Physician Decision|0
5112016|NCT01810432|17657210|P1|Period 2|Physician Decision|1
5112017|NCT01810432|17657209|P2|Period 2|Withdrawal by Subject|1
5112018|NCT01810432|17657210|P1|Period 2|Withdrawal by Subject|2
5112019|NCT01810432|17657209|P2|Washout|Adverse Event|0
5112020|NCT01810432|17657210|P1|Washout|Adverse Event|1
5112021|NCT01810432|17657209|P2|Washout|Protocol Violation|1
5112022|NCT01810432|17657210|P1|Washout|Protocol Violation|0
5112023|NCT01810380|17657223|P3|Overall Study|Administrative or other reasons|9
5112024|NCT01810380|17657224|P2|Overall Study|Administrative or other reasons|13
5112025|NCT01810380|17657225|P1|Overall Study|Administrative or other reasons|11
5112026|NCT01810380|17657223|P3|Overall Study|Withdrawal by Subject|6
5112027|NCT01810380|17657224|P2|Overall Study|Withdrawal by Subject|0
5112028|NCT01810380|17657225|P1|Overall Study|Withdrawal by Subject|6
5112029|NCT01810380|17657223|P3|Overall Study|Protocol Violation|1
5112030|NCT01810380|17657224|P2|Overall Study|Protocol Violation|0
5112031|NCT01810380|17657225|P1|Overall Study|Protocol Violation|1
5112032|NCT01810380|17657223|P3|Overall Study|Lack of Efficacy|11
5112033|NCT01810380|17657224|P2|Overall Study|Lack of Efficacy|10
5112034|NCT01810380|17657225|P1|Overall Study|Lack of Efficacy|24
5112035|NCT01810380|17657223|P3|Overall Study|Adverse Event|4
5112036|NCT01810380|17657224|P2|Overall Study|Adverse Event|14
5112037|NCT01810380|17657225|P1|Overall Study|Adverse Event|11
5112038|NCT01810380|17657223|P3|Overall Study|Randomised not treated|1
5112039|NCT01810380|17657224|P2|Overall Study|Randomised not treated|1
5112040|NCT01810380|17657225|P1|Overall Study|Randomised not treated|2
5112041|NCT01810302|17657286|P2|Overall Study|Physician Decision|1
5112042|NCT01810302|17657287|P1|Overall Study|Physician Decision|0
5112043|NCT01810302|17657286|P2|Overall Study|Death|0
5112044|NCT01810302|17657287|P1|Overall Study|Death|1
5112045|NCT01810263|17657314|P2|Overall Study|Lost to Follow-up|7
5112046|NCT01810263|17657315|P1|Overall Study|Lost to Follow-up|8
5112047|NCT01810042|17657321|P1|Overall Study|Lost to Follow-up|10
5112048|NCT01810016|17657331|P3|Overall Study|Death|1
5112049|NCT01810016|17657332|P2|Overall Study|Death|0
5112050|NCT01810016|17657333|P1|Overall Study|Death|0
5112051|NCT01810016|17657331|P3|Overall Study|Progressive disease|0
5112052|NCT01810016|17657332|P2|Overall Study|Progressive disease|1
5112053|NCT01810016|17657333|P1|Overall Study|Progressive disease|1
5112054|NCT01809327|17657403|P5|Overall Study|Other|9
5112055|NCT01809327|17657404|P4|Overall Study|Other|4
5112056|NCT01809327|17657405|P3|Overall Study|Other|7
5112057|NCT01809327|17657406|P2|Overall Study|Other|15
5112058|NCT01809327|17657407|P1|Overall Study|Other|14
5112059|NCT01809327|17657403|P5|Overall Study|Pregnancy|0
5112060|NCT01809327|17657404|P4|Overall Study|Pregnancy|0
5112061|NCT01809327|17657405|P3|Overall Study|Pregnancy|0
5112062|NCT01809327|17657406|P2|Overall Study|Pregnancy|0
5112063|NCT01809327|17657407|P1|Overall Study|Pregnancy|1
5112064|NCT01809327|17657403|P5|Overall Study|Physician Decision|0
5112065|NCT01809327|17657404|P4|Overall Study|Physician Decision|0
5112066|NCT01809327|17657405|P3|Overall Study|Physician Decision|0
5112067|NCT01809327|17657406|P2|Overall Study|Physician Decision|1
5112068|NCT01809327|17657407|P1|Overall Study|Physician Decision|1
5112069|NCT01809327|17657403|P5|Overall Study|Protocol Violation|0
5112070|NCT01809327|17657404|P4|Overall Study|Protocol Violation|0
5112071|NCT01809327|17657405|P3|Overall Study|Protocol Violation|0
5112072|NCT01809327|17657406|P2|Overall Study|Protocol Violation|1
5112073|NCT01809327|17657407|P1|Overall Study|Protocol Violation|0
5112074|NCT01809327|17657403|P5|Overall Study|Death|0
5112075|NCT01809327|17657404|P4|Overall Study|Death|0
5112076|NCT01809327|17657405|P3|Overall Study|Death|0
5112077|NCT01809327|17657406|P2|Overall Study|Death|0
5112078|NCT01809327|17657407|P1|Overall Study|Death|1
5112079|NCT01809327|17657403|P5|Overall Study|Adverse Event|8
5112080|NCT01809327|17657404|P4|Overall Study|Adverse Event|4
5112081|NCT01809327|17657405|P3|Overall Study|Adverse Event|7
5112082|NCT01809327|17657406|P2|Overall Study|Adverse Event|3
5112083|NCT01809327|17657407|P1|Overall Study|Adverse Event|4
5112084|NCT01809327|17657403|P5|Overall Study|Withdrawal by Subject|5
5112085|NCT01809327|17657404|P4|Overall Study|Withdrawal by Subject|2
5112086|NCT01809327|17657405|P3|Overall Study|Withdrawal by Subject|4
5112087|NCT01809327|17657406|P2|Overall Study|Withdrawal by Subject|4
5112088|NCT01809327|17657407|P1|Overall Study|Withdrawal by Subject|6
5112089|NCT01809327|17657403|P5|Overall Study|Lost to Follow-up|3
5112090|NCT01809327|17657404|P4|Overall Study|Lost to Follow-up|2
5112091|NCT01809327|17657405|P3|Overall Study|Lost to Follow-up|4
5112092|NCT01809327|17657406|P2|Overall Study|Lost to Follow-up|2
5112093|NCT01809327|17657407|P1|Overall Study|Lost to Follow-up|5
5112094|NCT01809314|17657449|P1|Overall Study|Lost to Follow-up|724
5112095|NCT01809314|17657449|P1|Overall Study|Insufficient Therapeutic Response|14
5112096|NCT01809314|17657449|P1|Overall Study|Adverse Event|6
5112097|NCT01809314|17657449|P1|Overall Study|Withdrawal Prior to Treatment|1
5112098|NCT01809262|17657455|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
5112099|NCT01809262|17657456|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
5112100|NCT01809262|17657457|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
5112101|NCT01809262|17657458|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
5112102|NCT01809262|17657459|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
5112103|NCT01809262|17657460|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
5112104|NCT01809262|17657461|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
5112105|NCT01809262|17657462|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
5112106|NCT01809262|17657463|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
5112107|NCT01809262|17657464|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
5112108|NCT01809262|17657455|P10|Period 1 (First Dose + Washout)|Adverse Event|0
5112109|NCT01809262|17657456|P9|Period 1 (First Dose + Washout)|Adverse Event|0
5112110|NCT01809262|17657457|P8|Period 1 (First Dose + Washout)|Adverse Event|0
5112111|NCT01809262|17657458|P7|Period 1 (First Dose + Washout)|Adverse Event|0
5112112|NCT01809262|17657459|P6|Period 1 (First Dose + Washout)|Adverse Event|0
5112113|NCT01809262|17657460|P5|Period 1 (First Dose + Washout)|Adverse Event|1
5112114|NCT01809262|17657461|P4|Period 1 (First Dose + Washout)|Adverse Event|0
5112115|NCT01809262|17657462|P3|Period 1 (First Dose + Washout)|Adverse Event|0
5112116|NCT01809262|17657463|P2|Period 1 (First Dose + Washout)|Adverse Event|0
5112117|NCT01809262|17657464|P1|Period 1 (First Dose + Washout)|Adverse Event|0
5112118|NCT01809210|17657538|P7|Overall Study|Death|1
5112119|NCT01809210|17657539|P6|Overall Study|Death|3
5112120|NCT01809210|17657540|P5|Overall Study|Death|1
5112121|NCT01809210|17657541|P4|Overall Study|Death|0
5112122|NCT01809210|17657542|P3|Overall Study|Death|2
5112123|NCT01809210|17657543|P2|Overall Study|Death|1
5112124|NCT01809210|17657544|P1|Overall Study|Death|1
5112125|NCT01809210|17657538|P7|Overall Study|Withdrawal by Subject|4
5112126|NCT01809210|17657539|P6|Overall Study|Withdrawal by Subject|0
5112127|NCT01809210|17657540|P5|Overall Study|Withdrawal by Subject|1
5112128|NCT01809210|17657541|P4|Overall Study|Withdrawal by Subject|1
5112129|NCT01809210|17657542|P3|Overall Study|Withdrawal by Subject|1
5112130|NCT01809210|17657543|P2|Overall Study|Withdrawal by Subject|0
5112131|NCT01809210|17657544|P1|Overall Study|Withdrawal by Subject|0
5112132|NCT01809197|17657618|P2|Overall Study|Product not available|1
5112133|NCT01809197|17657619|P1|Overall Study|Product not available|0
5112134|NCT01809197|17657618|P2|Overall Study|Withdrawal by Subject|1
5112135|NCT01809197|17657619|P1|Overall Study|Withdrawal by Subject|1
5112136|NCT01809197|17657618|P2|Overall Study|Decision Unrelated to an Adverse Event|0
5112137|NCT01809197|17657619|P1|Overall Study|Decision Unrelated to an Adverse Event|1
5112138|NCT01809197|17657618|P2|Overall Study|Non-Compliance|1
5112139|NCT01809197|17657619|P1|Overall Study|Non-Compliance|1
5112140|NCT01809197|17657618|P2|Overall Study|Failed slit lamp exam|0
5112141|NCT01809197|17657619|P1|Overall Study|Failed slit lamp exam|1
5112142|NCT01809197|17657618|P2|Overall Study|Adverse Event|3
5112143|NCT01809197|17657619|P1|Overall Study|Adverse Event|2
5112144|NCT01809197|17657618|P2|Overall Study|Lost to Follow-up|2
5112145|NCT01809197|17657619|P1|Overall Study|Lost to Follow-up|4
5112146|NCT01808690|17657700|P2|Overall Study|Withdrawal by Subject|2
5112147|NCT01808690|17657701|P1|Overall Study|Withdrawal by Subject|1
5112148|NCT01808651|17657720|P3|Study Period 1|Participant Decision|3
5112149|NCT01808651|17657721|P2|Study Period 1|Participant Decision|7
5112150|NCT01808651|17657722|P1|Study Period 1|Participant Decision|9
5112151|NCT01808651|17657720|P3|Study Period 1|Adverse Event|1
5112152|NCT01808651|17657721|P2|Study Period 1|Adverse Event|4
5112153|NCT01808651|17657722|P1|Study Period 1|Adverse Event|10
5112154|NCT01808651|17657720|P3|Study Period 1|Lack of Efficacy|0
5112155|NCT01808651|17657721|P2|Study Period 1|Lack of Efficacy|1
5112156|NCT01808651|17657722|P1|Study Period 1|Lack of Efficacy|2
5112157|NCT01808651|17657720|P3|Study Period 1|Physician Decision|0
5112158|NCT01808651|17657721|P2|Study Period 1|Physician Decision|2
5112159|NCT01808651|17657722|P1|Study Period 1|Physician Decision|3
5112160|NCT01808651|17657720|P3|Study Period 1|Protocol Violation|1
5112161|NCT01808651|17657721|P2|Study Period 1|Protocol Violation|0
5112162|NCT01808651|17657722|P1|Study Period 1|Protocol Violation|1
5112163|NCT01808651|17657720|P3|Study Period 1|Lost to Follow-up|0
5112164|NCT01808651|17657721|P2|Study Period 1|Lost to Follow-up|3
5112165|NCT01808651|17657722|P1|Study Period 1|Lost to Follow-up|1
5112166|NCT01808612|17657757|P3|Discontinuation Period|Lost to Follow-up|0
5112167|NCT01808612|17657758|P2|Discontinuation Period|Lost to Follow-up|1
5112168|NCT01808612|17657759|P1|Discontinuation Period|Lost to Follow-up|0
5112169|NCT01808612|17657757|P3|Discontinuation Period|Physician Decision|0
5112170|NCT01808612|17657758|P2|Discontinuation Period|Physician Decision|0
5112171|NCT01808612|17657759|P1|Discontinuation Period|Physician Decision|1
5112172|NCT01808612|17657757|P3|Discontinuation Period|Adverse Event|0
5112173|NCT01808612|17657758|P2|Discontinuation Period|Adverse Event|0
5112174|NCT01808612|17657759|P1|Discontinuation Period|Adverse Event|1
5112175|NCT01808612|17657757|P3|Treatment Period|Lack of Efficacy|2
5112176|NCT01808612|17657758|P2|Treatment Period|Lack of Efficacy|1
5112177|NCT01808612|17657759|P1|Treatment Period|Lack of Efficacy|1
5112178|NCT01808612|17657757|P3|Treatment Period|Sponsor Decision|0
5112179|NCT01808612|17657758|P2|Treatment Period|Sponsor Decision|0
5112180|NCT01808612|17657759|P1|Treatment Period|Sponsor Decision|1
5112181|NCT01808612|17657757|P3|Treatment Period|Physician Decision|4
5112182|NCT01808612|17657758|P2|Treatment Period|Physician Decision|0
5112183|NCT01808612|17657759|P1|Treatment Period|Physician Decision|1
5112184|NCT01808612|17657757|P3|Treatment Period|Withdrawal by Subject|4
5112185|NCT01808612|17657758|P2|Treatment Period|Withdrawal by Subject|0
5112186|NCT01808612|17657759|P1|Treatment Period|Withdrawal by Subject|1
5112187|NCT01808612|17657757|P3|Treatment Period|Protocol Violation|0
5112188|NCT01808612|17657758|P2|Treatment Period|Protocol Violation|0
5112189|NCT01808612|17657759|P1|Treatment Period|Protocol Violation|1
5112190|NCT01808612|17657757|P3|Treatment Period|Lost to Follow-up|1
5112191|NCT01808612|17657758|P2|Treatment Period|Lost to Follow-up|2
5112192|NCT01808612|17657759|P1|Treatment Period|Lost to Follow-up|2
5112193|NCT01808612|17657757|P3|Treatment Period|Adverse Event|3
5112194|NCT01808612|17657758|P2|Treatment Period|Adverse Event|4
5112195|NCT01808612|17657759|P1|Treatment Period|Adverse Event|8
5112196|NCT01808573|17657790|P2|Overall Study|Randomized in Error|0
5112197|NCT01808573|17657791|P1|Overall Study|Randomized in Error|1
5112198|NCT01808573|17657790|P2|Overall Study|Discontinuation of study by sponsor|64
5112199|NCT01808573|17657791|P1|Overall Study|Discontinuation of study by sponsor|79
5112200|NCT01808573|17657790|P2|Overall Study|Lost to Follow-up|0
5112201|NCT01808573|17657791|P1|Overall Study|Lost to Follow-up|3
5112202|NCT01808573|17657790|P2|Overall Study|Withdrawal by Subject|10
5112203|NCT01808573|17657791|P1|Overall Study|Withdrawal by Subject|12
5112204|NCT01808573|17657790|P2|Overall Study|Death|240
5112205|NCT01808573|17657791|P1|Overall Study|Death|212
5112206|NCT01808534|17657846|P1|Overall Study|Physician Decision|1
5112207|NCT01808534|17657846|P1|Overall Study|Disease progression|3
5112208|NCT01808508|17657857|P3|Overall Study|Lost to Follow-up|0
5112209|NCT01808508|17657858|P2|Overall Study|Lost to Follow-up|0
5112210|NCT01808508|17657859|P1|Overall Study|Lost to Follow-up|1
5112211|NCT01808339|17657876|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112212|NCT01808339|17657877|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112213|NCT01808339|17657878|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112214|NCT01808339|17657879|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
5112215|NCT01808339|17657880|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112216|NCT01808339|17657881|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112217|NCT01808339|17657876|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5112218|NCT01808339|17657877|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5112219|NCT01808339|17657878|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5112220|NCT01808339|17657879|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5112221|NCT01808339|17657880|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5112222|NCT01808339|17657881|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5112223|NCT01808339|17657876|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
5112224|NCT01808339|17657877|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
5112225|NCT01808339|17657878|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
5112226|NCT01808339|17657879|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112227|NCT01808339|17657880|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112228|NCT01808339|17657881|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5112229|NCT01808313|17657925|P1|Overall Study|Physician Decision|1
5112230|NCT01808313|17657925|P1|Overall Study|Lost to Follow-up|1
5112231|NCT01808313|17657925|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5112232|NCT01808313|17657925|P1|Overall Study|Protocol Violation|2
5112233|NCT01808313|17657925|P1|Overall Study|Adverse Event|5
5112234|NCT01808261|17657955|P2|Overall Study|Lost to Follow-up|1
5112235|NCT01808261|17657956|P1|Overall Study|Lost to Follow-up|3
5112236|NCT01808261|17657955|P2|Overall Study|Consent withdrawn by subject|7
5112237|NCT01808261|17657956|P1|Overall Study|Consent withdrawn by subject|6
5112238|NCT01808261|17657955|P2|Overall Study|Adverse event, non-fatal|0
5112239|NCT01808261|17657956|P1|Overall Study|Adverse event, non-fatal|2
5112240|NCT01808261|17657955|P2|Overall Study|Study Closed/Terminated|23
5112241|NCT01808261|17657956|P1|Overall Study|Study Closed/Terminated|25
5112242|NCT01808261|17657955|P2|Overall Study|Physician Decision|2
5112243|NCT01808261|17657956|P1|Overall Study|Physician Decision|0
5112244|NCT01808248|17658012|P1|Overall Study|Lost to Follow-up|1
5112245|NCT01808248|17658012|P1|Overall Study|Withdrawal by Subject|1
5112246|NCT01808248|17658012|P1|Overall Study|Lack of Efficacy|3
5112247|NCT01808222|17658024|P1|Overall Study|mpMR scan was not performed|1
5112248|NCT01808209|17658031|P2|Overall Study|Lost to Follow-up|1
5112249|NCT01808209|17658032|P1|Overall Study|Lost to Follow-up|0
5112250|NCT01808196|17658074|P1|Overall Study|Lost to Follow-up|1
5112251|NCT01808144|17658082|P2|Overall Study|Adverse Event|15
5112252|NCT01808144|17658083|P1|Overall Study|Adverse Event|11
5112253|NCT01808144|17658082|P2|Overall Study|Gout flare|1
5112254|NCT01808144|17658083|P1|Overall Study|Gout flare|0
5112255|NCT01808144|17658082|P2|Overall Study|Protocol Violation|6
5112256|NCT01808144|17658083|P1|Overall Study|Protocol Violation|6
5112257|NCT01808144|17658082|P2|Overall Study|Lost to Follow-up|3
5112258|NCT01808144|17658083|P1|Overall Study|Lost to Follow-up|6
5112259|NCT01808144|17658082|P2|Overall Study|Withdrawal by Subject|23
5112260|NCT01808144|17658083|P1|Overall Study|Withdrawal by Subject|16
5112261|NCT01808144|17658082|P2|Overall Study|Death|0
5112262|NCT01808144|17658083|P1|Overall Study|Death|1
5112263|NCT01808118|17658091|P3|Period 2|Switched to other therapy|0
5112264|NCT01808118|17658092|P2|Period 2|Switched to other therapy|1
5112265|NCT01808118|17658093|P1|Period 2|Switched to other therapy|0
5112266|NCT01808118|17658091|P3|Period 2|Investigator no longer conducting trials|0
5112267|NCT01808118|17658092|P2|Period 2|Investigator no longer conducting trials|1
5112268|NCT01808118|17658093|P1|Period 2|Investigator no longer conducting trials|0
5112269|NCT01808118|17658091|P3|Period 2|Lost to Follow-up|2
5112270|NCT01808118|17658092|P2|Period 2|Lost to Follow-up|0
5112271|NCT01808118|17658093|P1|Period 2|Lost to Follow-up|0
5112272|NCT01808118|17658091|P3|Period 2|Withdrew consent|6
5112273|NCT01808118|17658092|P2|Period 2|Withdrew consent|7
5112274|NCT01808118|17658093|P1|Period 2|Withdrew consent|0
5112275|NCT01808118|17658091|P3|Period 2|Adverse Event|0
5112276|NCT01808118|17658092|P2|Period 2|Adverse Event|4
5112277|NCT01808118|17658093|P1|Period 2|Adverse Event|0
5112278|NCT01808118|17658091|P3|Period 1|Lack of Efficacy|0
5112279|NCT01808118|17658092|P2|Period 1|Lack of Efficacy|0
5112280|NCT01808118|17658093|P1|Period 1|Lack of Efficacy|1
5112281|NCT01808118|17658091|P3|Period 1|Non-compliance per sponsor|0
5112282|NCT01808118|17658092|P2|Period 1|Non-compliance per sponsor|0
5112283|NCT01808118|17658093|P1|Period 1|Non-compliance per sponsor|1
5112284|NCT01808118|17658091|P3|Period 1|Investigator decision: site closure|0
5112285|NCT01808118|17658092|P2|Period 1|Investigator decision: site closure|0
5112286|NCT01808118|17658093|P1|Period 1|Investigator decision: site closure|2
5112287|NCT01808118|17658091|P3|Period 1|Non-conformance with inclusion criteria|0
5112288|NCT01808118|17658092|P2|Period 1|Non-conformance with inclusion criteria|0
5112289|NCT01808118|17658093|P1|Period 1|Non-conformance with inclusion criteria|3
5112290|NCT01808118|17658091|P3|Period 1|Did not meet inclusion criteria|0
5112291|NCT01808118|17658092|P2|Period 1|Did not meet inclusion criteria|0
5112292|NCT01808118|17658093|P1|Period 1|Did not meet inclusion criteria|3
5112293|NCT01808118|17658091|P3|Period 1|Enrolled in error|0
5112294|NCT01808118|17658092|P2|Period 1|Enrolled in error|0
5112295|NCT01808118|17658093|P1|Period 1|Enrolled in error|7
5112296|NCT01808118|17658091|P3|Period 1|Did not meet criteria for remission|0
5112297|NCT01808118|17658092|P2|Period 1|Did not meet criteria for remission|0
5112298|NCT01808118|17658093|P1|Period 1|Did not meet criteria for remission|303
5112299|NCT01808118|17658091|P3|Period 1|Lost to Follow-up|0
5112300|NCT01808118|17658092|P2|Period 1|Lost to Follow-up|0
5112301|NCT01808118|17658093|P1|Period 1|Lost to Follow-up|9
5112302|NCT01808118|17658091|P3|Period 1|Withdrew consent|0
5112303|NCT01808118|17658092|P2|Period 1|Withdrew consent|0
5112304|NCT01808118|17658093|P1|Period 1|Withdrew consent|24
5112305|NCT01808118|17658091|P3|Period 1|Adverse Event|0
5112306|NCT01808118|17658092|P2|Period 1|Adverse Event|0
5112307|NCT01808118|17658093|P1|Period 1|Adverse Event|15
5112308|NCT01808092|17658156|P2|Overall Study|Other Eligibility criteria|5
5112309|NCT01808092|17658157|P1|Overall Study|Other Eligibility criteria|3
5112310|NCT01808092|17658156|P2|Overall Study|Withdrawal by Subject|4
5112311|NCT01808092|17658157|P1|Overall Study|Withdrawal by Subject|9
5112312|NCT01808092|17658156|P2|Overall Study|Lost to Follow-up|7
5112313|NCT01808092|17658157|P1|Overall Study|Lost to Follow-up|3
5112314|NCT01808092|17658156|P2|Overall Study|Death|29
5112315|NCT01808092|17658157|P1|Overall Study|Death|39
5112316|NCT01808066|17658259|P1|Overall Study|Withdrawal by Subject|15
5112317|NCT01807949|17658270|P3|Overall Study|Randomized But Not Treated|2
5112318|NCT01807949|17658271|P2|Overall Study|Randomized But Not Treated|2
5112319|NCT01807949|17658272|P1|Overall Study|Randomized But Not Treated|0
5112320|NCT01807949|17658270|P3|Overall Study|Undefined|2
5112321|NCT01807949|17658271|P2|Overall Study|Undefined|1
5112322|NCT01807949|17658272|P1|Overall Study|Undefined|0
5112323|NCT01807949|17658270|P3|Overall Study|Non-Compliance|1
5112324|NCT01807949|17658271|P2|Overall Study|Non-Compliance|0
5112325|NCT01807949|17658272|P1|Overall Study|Non-Compliance|0
5112326|NCT01807949|17658270|P3|Overall Study|Withdrawal by Subject|2
5112327|NCT01807949|17658271|P2|Overall Study|Withdrawal by Subject|2
5112328|NCT01807949|17658272|P1|Overall Study|Withdrawal by Subject|1
5112329|NCT01807949|17658270|P3|Overall Study|Adverse Event|2
5112330|NCT01807949|17658271|P2|Overall Study|Adverse Event|2
5112331|NCT01807949|17658272|P1|Overall Study|Adverse Event|1
5112332|NCT01807923|17658324|P3|Overall Study|Randomized But Not Treated|5
5112333|NCT01807923|17658325|P2|Overall Study|Randomized But Not Treated|2
5112334|NCT01807923|17658326|P1|Overall Study|Randomized But Not Treated|3
5112335|NCT01807923|17658324|P3|Overall Study|Not Eligible (Genotype)|1
5112336|NCT01807923|17658325|P2|Overall Study|Not Eligible (Genotype)|0
5112337|NCT01807923|17658326|P1|Overall Study|Not Eligible (Genotype)|0
5112338|NCT01807923|17658324|P3|Overall Study|Physician Decision|1
5112339|NCT01807923|17658325|P2|Overall Study|Physician Decision|0
5112340|NCT01807923|17658326|P1|Overall Study|Physician Decision|0
5112341|NCT01807923|17658324|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
5112342|NCT01807923|17658325|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
5112343|NCT01807923|17658326|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
5112344|NCT01807923|17658324|P3|Overall Study|Adverse Event|2
5112345|NCT01807923|17658325|P2|Overall Study|Adverse Event|1
5112346|NCT01807923|17658326|P1|Overall Study|Adverse Event|2
5112347|NCT01807650|17658388|P1|Overall Study|Other|2
5112348|NCT01807650|17658388|P1|Overall Study|Adverse Event|5
5112349|NCT01807650|17658388|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
5112350|NCT01807598|17658474|P1|Overall Study|Other Physician Decision|1
5112351|NCT01807598|17658474|P1|Overall Study|Adverse Event|1
5112352|NCT01807598|17658474|P1|Overall Study|Withdrawal by Subject|4
5112353|NCT01807520|17658506|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
5112354|NCT01807520|17658507|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
5112355|NCT01807520|17658508|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5112356|NCT01807520|17658509|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5112357|NCT01807520|17658510|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5112358|NCT01807520|17658511|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5112359|NCT01807520|17658512|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5112360|NCT01807520|17658506|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
5112361|NCT01807520|17658507|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
5112362|NCT01807520|17658508|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
5112363|NCT01807520|17658509|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
5112364|NCT01807520|17658510|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
5112365|NCT01807520|17658511|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
5112366|NCT01807520|17658512|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
5112367|NCT01807520|17658506|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5112368|NCT01807520|17658507|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
5112369|NCT01807520|17658508|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5112370|NCT01807520|17658509|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5112371|NCT01807520|17658510|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5112372|NCT01807520|17658511|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5112373|NCT01807520|17658512|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5112374|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5112375|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5112376|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
5112377|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
5112378|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5112379|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
5112380|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
5112381|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5112382|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5112383|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5112384|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5112385|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5112386|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5112387|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5112388|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5112389|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5112390|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
5112391|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5112392|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5112393|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
5112394|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
5112395|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5112396|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5112397|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5112398|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
5112399|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5112400|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5112401|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
5112402|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5112403|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5112404|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5112405|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5112406|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5112407|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
5112408|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5112409|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5112410|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5112411|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5112412|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5112413|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5112414|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5112415|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
5112416|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5112417|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5112418|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5112419|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
5112420|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5112421|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5112422|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5112423|NCT01807520|17658506|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5112424|NCT01807520|17658507|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5112425|NCT01807520|17658508|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
5112426|NCT01807520|17658509|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5112427|NCT01807520|17658510|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5112428|NCT01807520|17658511|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
5112429|NCT01807520|17658512|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
5112430|NCT01807520|17658506|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5112431|NCT01807520|17658507|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5112432|NCT01807520|17658508|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5112433|NCT01807520|17658509|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5112434|NCT01807520|17658510|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5112435|NCT01807520|17658511|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5112436|NCT01807520|17658512|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
5112437|NCT01807520|17658506|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5112438|NCT01807520|17658507|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5112439|NCT01807520|17658508|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5112440|NCT01807520|17658509|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5112441|NCT01807520|17658510|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
5112442|NCT01807520|17658511|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5112443|NCT01807520|17658512|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5112444|NCT01807520|17658506|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5112445|NCT01807520|17658507|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5112446|NCT01807520|17658508|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5112447|NCT01807520|17658509|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5112448|NCT01807520|17658510|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5112449|NCT01807520|17658511|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5112450|NCT01807520|17658512|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
5112451|NCT01807520|17658506|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5112452|NCT01807520|17658507|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5112453|NCT01807520|17658508|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5112454|NCT01807520|17658509|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5112455|NCT01807520|17658510|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
5112456|NCT01807520|17658511|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5112457|NCT01807520|17658512|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5112458|NCT01807520|17658506|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5112459|NCT01807520|17658507|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5112460|NCT01807520|17658508|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5112461|NCT01807520|17658509|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5112462|NCT01807520|17658510|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
5112463|NCT01807520|17658511|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5112464|NCT01807520|17658512|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
5112465|NCT01807520|17658506|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5112466|NCT01807520|17658507|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5112467|NCT01807520|17658508|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5112468|NCT01807520|17658509|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5112469|NCT01807520|17658510|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
5112470|NCT01807520|17658511|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
5112471|NCT01807520|17658512|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5112472|NCT01807299|17658543|P4|Overall Study|Protocol Violation|2
5112473|NCT01807299|17658544|P3|Overall Study|Protocol Violation|0
5112474|NCT01807299|17658545|P2|Overall Study|Protocol Violation|1
5112475|NCT01807299|17658546|P1|Overall Study|Protocol Violation|3
5112476|NCT01807234|17658562|P6|Overall Study|Lack of Efficacy|1
5112477|NCT01807234|17658563|P5|Overall Study|Lack of Efficacy|1
5112478|NCT01807234|17658564|P4|Overall Study|Lack of Efficacy|0
5112479|NCT01807234|17658565|P3|Overall Study|Lack of Efficacy|0
5112480|NCT01807234|17658566|P2|Overall Study|Lack of Efficacy|0
5112481|NCT01807234|17658567|P1|Overall Study|Lack of Efficacy|0
5112482|NCT01807234|17658562|P6|Overall Study|Withdrawal by Subject|1
5112483|NCT01807234|17658563|P5|Overall Study|Withdrawal by Subject|2
5112484|NCT01807234|17658564|P4|Overall Study|Withdrawal by Subject|1
5112485|NCT01807234|17658565|P3|Overall Study|Withdrawal by Subject|1
5112486|NCT01807234|17658566|P2|Overall Study|Withdrawal by Subject|1
5112487|NCT01807234|17658567|P1|Overall Study|Withdrawal by Subject|3
5112488|NCT01807234|17658562|P6|Overall Study|Lost to Follow-up|2
5112489|NCT01807234|17658563|P5|Overall Study|Lost to Follow-up|1
5112490|NCT01807234|17658564|P4|Overall Study|Lost to Follow-up|1
5112491|NCT01807234|17658565|P3|Overall Study|Lost to Follow-up|1
5112492|NCT01807234|17658566|P2|Overall Study|Lost to Follow-up|5
5112493|NCT01807234|17658567|P1|Overall Study|Lost to Follow-up|2
5112494|NCT01807156|17658602|P1|Overall Study|Physician Decision|1
5112495|NCT01807065|17658618|P2|Overall Study|Receive no sip-T due to IV access|1
5112496|NCT01807065|17658619|P1|Overall Study|Receive no sip-T due to IV access|1
5112497|NCT01806961|17658685|P1|Overall Study|sponsor decision|16
5112498|NCT01806896|17658691|P2|Overall Study|Other|0
5112499|NCT01806896|17658692|P1|Overall Study|Other|1
5112500|NCT01806896|17658691|P2|Overall Study|Adverse Event|0
5112501|NCT01806896|17658692|P1|Overall Study|Adverse Event|2
5112502|NCT01806779|17658759|P3|Overall Study|Withdrawal by Subject|22
5112503|NCT01806779|17658760|P2|Overall Study|Withdrawal by Subject|23
5112504|NCT01806779|17658761|P1|Overall Study|Withdrawal by Subject|20
5112505|NCT01806779|17658759|P3|Overall Study|Lost to Follow-up|0
5112506|NCT01806779|17658760|P2|Overall Study|Lost to Follow-up|20
5112507|NCT01806779|17658761|P1|Overall Study|Lost to Follow-up|19
5112508|NCT01806779|17658759|P3|Overall Study|Lack of Efficacy|0
5112509|NCT01806779|17658760|P2|Overall Study|Lack of Efficacy|1
5112510|NCT01806779|17658761|P1|Overall Study|Lack of Efficacy|1
5112511|NCT01806779|17658759|P3|Overall Study|Physician Decision|1
5112512|NCT01806779|17658760|P2|Overall Study|Physician Decision|0
5112513|NCT01806779|17658761|P1|Overall Study|Physician Decision|2
5112514|NCT01806740|17658774|P1|Overall Study|Patient's refusal of treatment|1
5112515|NCT01806740|17658774|P1|Overall Study|Physician Decision|1
5112516|NCT01806740|17658774|P1|Overall Study|Withdrawal by Subject|4
5112517|NCT01806714|17658785|P2|Overall Study|No functioning phone number|170
5112518|NCT01806714|17658786|P1|Overall Study|No functioning phone number|200
5112519|NCT01806662|17658821|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
5112520|NCT01806662|17658822|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
5112521|NCT01806662|17658821|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
5112522|NCT01806662|17658822|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
5112523|NCT01806662|17658821|P2|First Intervention (Weeks 0-16)|Adverse Event|1
5112524|NCT01806662|17658822|P1|First Intervention (Weeks 0-16)|Adverse Event|0
5112525|NCT01806662|17658821|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
5112526|NCT01806662|17658822|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
5112527|NCT01806623|17658828|P1|Overall Study|Did not meet the inclusion criteria|56
5112528|NCT01806623|17658828|P1|Overall Study|Adverse Event|1
5112529|NCT01806623|17658828|P1|Overall Study|Withdrawal by Subject|1
5112530|NCT01806597|17658848|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
5112531|NCT01806597|17658849|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5112532|NCT01806597|17658850|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5112533|NCT01806597|17658851|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5112534|NCT01806597|17658852|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5112535|NCT01806597|17658853|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5112536|NCT01806597|17658848|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
5112537|NCT01806597|17658849|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5112538|NCT01806597|17658850|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5112539|NCT01806597|17658851|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5112540|NCT01806597|17658852|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5112541|NCT01806597|17658853|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5112542|NCT01806597|17658848|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
5112543|NCT01806597|17658849|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5112544|NCT01806597|17658850|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5112545|NCT01806597|17658851|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5112546|NCT01806597|17658852|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5112547|NCT01806597|17658853|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5112548|NCT01806597|17658848|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
5112549|NCT01806597|17658849|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5112550|NCT01806597|17658850|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5112551|NCT01806597|17658851|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5112552|NCT01806597|17658852|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5112553|NCT01806597|17658853|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5112554|NCT01806597|17658848|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
5112555|NCT01806597|17658849|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5112556|NCT01806597|17658850|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5112557|NCT01806597|17658851|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5112558|NCT01806597|17658852|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5112559|NCT01806597|17658853|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5112560|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
5112561|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
5112562|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
5112563|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
5112564|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
5112565|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
5112566|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
5112567|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
5112568|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
5112569|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
5112570|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
5112571|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
5112572|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
5112573|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
5112574|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
5112575|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
5112576|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
5112577|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
5112578|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5112579|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5112580|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
5112581|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5112582|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
5112583|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5112584|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5112585|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5112586|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5112587|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5112588|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5112589|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
5112590|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5112591|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5112592|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5112593|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5112594|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
5112595|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
5112596|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5112597|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5112598|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5112599|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5112600|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5112601|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
5112602|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
5112603|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
5112604|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
5112605|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
5112606|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
5112607|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
5112608|NCT01806597|17658848|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
5112609|NCT01806597|17658849|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
5112610|NCT01806597|17658850|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
5112611|NCT01806597|17658851|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
5112612|NCT01806597|17658852|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
5112613|NCT01806597|17658853|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
5112614|NCT01806597|17658848|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
5112615|NCT01806597|17658849|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
5112616|NCT01806597|17658850|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
5112617|NCT01806597|17658851|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
5112618|NCT01806597|17658852|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
5112619|NCT01806597|17658853|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
5112620|NCT01806597|17658848|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5112621|NCT01806597|17658849|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
5112622|NCT01806597|17658850|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5112623|NCT01806597|17658851|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5112624|NCT01806597|17658852|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
5112625|NCT01806597|17658853|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
5112626|NCT01806597|17658848|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
5112627|NCT01806597|17658849|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
5112628|NCT01806597|17658850|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
5112629|NCT01806597|17658851|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
5112630|NCT01806597|17658852|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
5112631|NCT01806597|17658853|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
5112632|NCT01806597|17658848|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5112633|NCT01806597|17658849|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
5112634|NCT01806597|17658850|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5112635|NCT01806597|17658851|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5112636|NCT01806597|17658852|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5112637|NCT01806597|17658853|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
5112638|NCT01806597|17658848|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
5112639|NCT01806597|17658849|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
5112640|NCT01806597|17658850|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
5112641|NCT01806597|17658851|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
5112642|NCT01806597|17658852|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
5112643|NCT01806597|17658853|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
5112644|NCT01806584|17658889|P2|Overall Study|Other unspecified|0
5112645|NCT01806584|17658890|P1|Overall Study|Other unspecified|1
5112646|NCT01806584|17658889|P2|Overall Study|Withdrawal by Subject|1
5112647|NCT01806584|17658890|P1|Overall Study|Withdrawal by Subject|1
5112648|NCT01806584|17658889|P2|Overall Study|Study terminated by sponsor|14
5112649|NCT01806584|17658890|P1|Overall Study|Study terminated by sponsor|9
5112650|NCT01806584|17658889|P2|Overall Study|Lost to Follow-up|2
5112651|NCT01806584|17658890|P1|Overall Study|Lost to Follow-up|0
5112652|NCT01806584|17658889|P2|Overall Study|Death|0
5112653|NCT01806584|17658890|P1|Overall Study|Death|1
5112654|NCT01806584|17658889|P2|Overall Study|Adverse Event|1
5112655|NCT01806584|17658890|P1|Overall Study|Adverse Event|2
5112656|NCT01806545|17658912|P2|Overall Study|Withdrawal by Subject|2
5112657|NCT01806545|17658913|P1|Overall Study|Withdrawal by Subject|3
5112658|NCT01806545|17658912|P2|Overall Study|Lost to Follow-up|0
5112659|NCT01806545|17658913|P1|Overall Study|Lost to Follow-up|1
5112660|NCT01806545|17658912|P2|Overall Study|Adverse Event|3
5112661|NCT01806545|17658913|P1|Overall Study|Adverse Event|2
5112662|NCT01806506|17658937|P2|Overall Study|Lost to Follow-up|1
5112663|NCT01806506|17658938|P1|Overall Study|Lost to Follow-up|2
5112664|NCT01806389|17658944|P1|Overall Study|Withdrawal by Subject|4
5112665|NCT01806298|17658958|P1|Overall Study|Other|5
5112666|NCT01806298|17658958|P1|Overall Study|Withdrawal by Subject|1
5112667|NCT01806298|17658958|P1|Overall Study|Protocol Non-compliance|1
5112668|NCT01806298|17658958|P1|Overall Study|Adverse Event|3
5112669|NCT01806064|17658984|P5|Overall Study|Randomized Not Enrolled|2
5112670|NCT01806064|17658985|P4|Overall Study|Randomized Not Enrolled|1
5112671|NCT01806064|17658986|P3|Overall Study|Randomized Not Enrolled|0
5112672|NCT01806064|17658987|P2|Overall Study|Randomized Not Enrolled|0
5112673|NCT01806064|17658988|P1|Overall Study|Randomized Not Enrolled|0
5112674|NCT01806051|17659013|P1|Overall Study|Withdrawal by Subject|6
5112675|NCT01805180|17659130|P3|Lead-in Donor Phase|screen failure|0
5112676|NCT01805180|17659131|P2|Lead-in Donor Phase|screen failure|0
5112677|NCT01805180|17659132|P1|Lead-in Donor Phase|screen failure|1
5112678|NCT01804946|17659207|P2|Overall Study|Do not meet inclusion criteria|2
5112679|NCT01804946|17659208|P1|Overall Study|Do not meet inclusion criteria|1
5112680|NCT01804946|17659207|P2|Overall Study|Insufficient data available|1
5112681|NCT01804946|17659208|P1|Overall Study|Insufficient data available|0
5112682|NCT01804946|17659207|P2|Overall Study|Adverse Event|1
5112683|NCT01804946|17659208|P1|Overall Study|Adverse Event|0
5112684|NCT01804946|17659207|P2|Overall Study|Protocol Violation|0
5112685|NCT01804946|17659208|P1|Overall Study|Protocol Violation|1
5112686|NCT01804842|17659246|P3|Overall Study|Personal Reason|1
5112687|NCT01804842|17659247|P2|Overall Study|Personal Reason|0
5112688|NCT01804842|17659248|P1|Overall Study|Personal Reason|0
5112689|NCT01804842|17659246|P3|Overall Study|Non-Compliance|0
5112690|NCT01804842|17659247|P2|Overall Study|Non-Compliance|1
5112691|NCT01804842|17659248|P1|Overall Study|Non-Compliance|1
5112692|NCT01804842|17659246|P3|Overall Study|Lost to Follow-up|0
5112693|NCT01804842|17659247|P2|Overall Study|Lost to Follow-up|0
5112694|NCT01804842|17659248|P1|Overall Study|Lost to Follow-up|1
5112695|NCT01804842|17659246|P3|Overall Study|Adverse Event|0
5112696|NCT01804842|17659247|P2|Overall Study|Adverse Event|1
5112697|NCT01804842|17659248|P1|Overall Study|Adverse Event|1
5112698|NCT01804816|17659265|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
5112699|NCT01804816|17659265|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
5112700|NCT01804673|17659277|P1|Overall Study|Other|4
5112701|NCT01804673|17659277|P1|Overall Study|Use of Prohibited Medication|1
5112702|NCT01804673|17659277|P1|Overall Study|No Further Therapy Required|84
5112703|NCT01804673|17659277|P1|Overall Study|Change to Oral Therapy|37
5112704|NCT01804673|17659277|P1|Overall Study|Lack of Efficacy|9
5112705|NCT01804673|17659277|P1|Overall Study|Withdrawal by Subject|1
5112706|NCT01804673|17659277|P1|Overall Study|Adverse Event|4
5112707|NCT01804582|17659295|P2|Overall Study|Physician Decision|0
5112708|NCT01804582|17659296|P1|Overall Study|Physician Decision|2
5112709|NCT01804582|17659295|P2|Overall Study|Lost to Follow-up|56
5112710|NCT01804582|17659296|P1|Overall Study|Lost to Follow-up|47
5112711|NCT01804140|17659316|P1|Overall Study|No sampling or biopsy procedures done|114
5112712|NCT01804049|17659350|P2|Overall Study|Enrollment in dual studies|1
5112713|NCT01804049|17659351|P1|Overall Study|Enrollment in dual studies|0
5112714|NCT01804049|17659350|P2|Overall Study|other MD recommended|1
5112715|NCT01804049|17659351|P1|Overall Study|other MD recommended|1
5112716|NCT01804049|17659350|P2|Overall Study|Moved out of area|7
5112717|NCT01804049|17659351|P1|Overall Study|Moved out of area|0
5112718|NCT01804049|17659350|P2|Overall Study|Other health concerns|7
5112719|NCT01804049|17659351|P1|Overall Study|Other health concerns|2
5112720|NCT01804049|17659350|P2|Overall Study|Decreased interest/personal|5
5112721|NCT01804049|17659351|P1|Overall Study|Decreased interest/personal|4
5112722|NCT01804049|17659350|P2|Overall Study|Lost to Follow-up|1
5112723|NCT01804049|17659351|P1|Overall Study|Lost to Follow-up|2
5112724|NCT01804049|17659350|P2|Overall Study|Adverse Event|10
5112725|NCT01804049|17659351|P1|Overall Study|Adverse Event|2
5112726|NCT01803880|17659399|P3|Overall Study|Incomplete data entry by sites|0
5112727|NCT01803880|17659400|P2|Overall Study|Incomplete data entry by sites|0
5112728|NCT01803880|17659401|P1|Overall Study|Incomplete data entry by sites|2
5112729|NCT01803880|17659399|P3|Overall Study|Early study termination|5
5112730|NCT01803880|17659400|P2|Overall Study|Early study termination|6
5112731|NCT01803880|17659401|P1|Overall Study|Early study termination|0
5112732|NCT01803880|17659399|P3|Overall Study|Protocol Violation|0
5112733|NCT01803880|17659400|P2|Overall Study|Protocol Violation|0
5112734|NCT01803880|17659401|P1|Overall Study|Protocol Violation|1
5112735|NCT01803880|17659399|P3|Overall Study|Lost to Follow-up|3
5112736|NCT01803880|17659400|P2|Overall Study|Lost to Follow-up|2
5112737|NCT01803880|17659401|P1|Overall Study|Lost to Follow-up|1
5112738|NCT01803880|17659399|P3|Overall Study|Unable to return for follow-up visits|2
5112739|NCT01803880|17659400|P2|Overall Study|Unable to return for follow-up visits|1
5112740|NCT01803880|17659401|P1|Overall Study|Unable to return for follow-up visits|0
5112741|NCT01803880|17659399|P3|Overall Study|Physician Decision|1
5112742|NCT01803880|17659400|P2|Overall Study|Physician Decision|0
5112743|NCT01803880|17659401|P1|Overall Study|Physician Decision|0
5112744|NCT01803880|17659399|P3|Overall Study|Withdrawal by Subject|4
5112745|NCT01803880|17659400|P2|Overall Study|Withdrawal by Subject|1
5112746|NCT01803880|17659401|P1|Overall Study|Withdrawal by Subject|1
5112747|NCT01803880|17659399|P3|Overall Study|Adverse Event|0
5112748|NCT01803880|17659400|P2|Overall Study|Adverse Event|0
5112749|NCT01803880|17659401|P1|Overall Study|Adverse Event|1
5112750|NCT01803737|17659437|P2|Overall Study|Lost to Follow-up|2
5112751|NCT01803737|17659438|P1|Overall Study|Lost to Follow-up|0
5112752|NCT01803737|17659437|P2|Overall Study|Medical Reason|1
5112753|NCT01803737|17659438|P1|Overall Study|Medical Reason|0
5112754|NCT01803737|17659437|P2|Overall Study|Lack of Time|0
5112755|NCT01803737|17659438|P1|Overall Study|Lack of Time|1
5112756|NCT01803711|17659462|P2|Overall Study|Adverse Event|1
5112757|NCT01803711|17659463|P1|Overall Study|Adverse Event|1
5112758|NCT01803646|17659481|P2|Overall Study|Lost to Follow-up|1
5112759|NCT01803646|17659482|P1|Overall Study|Lost to Follow-up|5
5112760|NCT01803646|17659481|P2|Overall Study|Randomization error|2
5112761|NCT01803646|17659482|P1|Overall Study|Randomization error|1
5112762|NCT01803646|17659481|P2|Overall Study|Withdrawal by Subject|6
5112763|NCT01803646|17659482|P1|Overall Study|Withdrawal by Subject|9
5112764|NCT01803646|17659481|P2|Overall Study|Adverse Event|1
5112765|NCT01803646|17659482|P1|Overall Study|Adverse Event|1
5112766|NCT01803646|17659481|P2|Overall Study|Protocol Violation|0
5112767|NCT01803646|17659482|P1|Overall Study|Protocol Violation|1
5112768|NCT01803607|17659494|P2|Overall Study|Withdrawal by Subject|5
5112769|NCT01803607|17659495|P1|Overall Study|Withdrawal by Subject|6
5112770|NCT01803607|17659494|P2|Overall Study|Study terminated by sponsor|56
5112771|NCT01803607|17659495|P1|Overall Study|Study terminated by sponsor|54
5112772|NCT01803607|17659494|P2|Overall Study|Protocol Violation|2
5112773|NCT01803607|17659495|P1|Overall Study|Protocol Violation|3
5112774|NCT01803607|17659494|P2|Overall Study|Lack of Efficacy|1
5112775|NCT01803607|17659495|P1|Overall Study|Lack of Efficacy|0
5112776|NCT01803607|17659494|P2|Overall Study|Adverse Event|3
5112777|NCT01803607|17659495|P1|Overall Study|Adverse Event|5
5112778|NCT01803464|17659519|P4|Overall Study|Withdrawal by Subject|0
5112779|NCT01803464|17659520|P3|Overall Study|Withdrawal by Subject|0
5112780|NCT01803464|17659521|P2|Overall Study|Withdrawal by Subject|0
5112781|NCT01803464|17659522|P1|Overall Study|Withdrawal by Subject|1
5112782|NCT01803464|17659519|P4|Overall Study|Incomplete data|0
5112783|NCT01803464|17659520|P3|Overall Study|Incomplete data|4
5112784|NCT01803464|17659521|P2|Overall Study|Incomplete data|0
5112785|NCT01803464|17659522|P1|Overall Study|Incomplete data|0
5112786|NCT01803282|17659552|P12|Overall Study|Enrolled but Never Treated|0
5112787|NCT01803282|17659553|P11|Overall Study|Enrolled but Never Treated|0
5112788|NCT01803282|17659554|P10|Overall Study|Enrolled but Never Treated|1
5112789|NCT01803282|17659555|P9|Overall Study|Enrolled but Never Treated|0
5112790|NCT01803282|17659556|P8|Overall Study|Enrolled but Never Treated|1
5112791|NCT01803282|17659557|P7|Overall Study|Enrolled but Never Treated|1
5112792|NCT01803282|17659558|P6|Overall Study|Enrolled but Never Treated|0
5112793|NCT01803282|17659559|P5|Overall Study|Enrolled but Never Treated|1
5112794|NCT01803282|17659560|P4|Overall Study|Enrolled but Never Treated|0
5112795|NCT01803282|17659561|P3|Overall Study|Enrolled but Never Treated|0
5112796|NCT01803282|17659562|P2|Overall Study|Enrolled but Never Treated|0
5112797|NCT01803282|17659563|P1|Overall Study|Enrolled but Never Treated|0
5112798|NCT01803282|17659552|P12|Overall Study|Specified Criteria for Withdrawal|0
5112799|NCT01803282|17659553|P11|Overall Study|Specified Criteria for Withdrawal|1
5112800|NCT01803282|17659554|P10|Overall Study|Specified Criteria for Withdrawal|1
5112801|NCT01803282|17659555|P9|Overall Study|Specified Criteria for Withdrawal|0
5112802|NCT01803282|17659556|P8|Overall Study|Specified Criteria for Withdrawal|0
5112803|NCT01803282|17659557|P7|Overall Study|Specified Criteria for Withdrawal|0
5112804|NCT01803282|17659558|P6|Overall Study|Specified Criteria for Withdrawal|0
5112805|NCT01803282|17659559|P5|Overall Study|Specified Criteria for Withdrawal|0
5112806|NCT01803282|17659560|P4|Overall Study|Specified Criteria for Withdrawal|0
5112807|NCT01803282|17659561|P3|Overall Study|Specified Criteria for Withdrawal|0
5112808|NCT01803282|17659562|P2|Overall Study|Specified Criteria for Withdrawal|0
5112809|NCT01803282|17659563|P1|Overall Study|Specified Criteria for Withdrawal|0
5112810|NCT01803282|17659552|P12|Overall Study|Unknown Reason|0
5112811|NCT01803282|17659553|P11|Overall Study|Unknown Reason|0
5112812|NCT01803282|17659554|P10|Overall Study|Unknown Reason|0
5112813|NCT01803282|17659555|P9|Overall Study|Unknown Reason|0
5112814|NCT01803282|17659556|P8|Overall Study|Unknown Reason|1
5112815|NCT01803282|17659557|P7|Overall Study|Unknown Reason|0
5112816|NCT01803282|17659558|P6|Overall Study|Unknown Reason|0
5112817|NCT01803282|17659559|P5|Overall Study|Unknown Reason|0
5112818|NCT01803282|17659560|P4|Overall Study|Unknown Reason|0
5112819|NCT01803282|17659561|P3|Overall Study|Unknown Reason|0
5112820|NCT01803282|17659562|P2|Overall Study|Unknown Reason|0
5112821|NCT01803282|17659563|P1|Overall Study|Unknown Reason|0
5112822|NCT01803282|17659552|P12|Overall Study|Non-Compliance with Study Drug|0
5112823|NCT01803282|17659553|P11|Overall Study|Non-Compliance with Study Drug|0
5112824|NCT01803282|17659554|P10|Overall Study|Non-Compliance with Study Drug|0
5112825|NCT01803282|17659555|P9|Overall Study|Non-Compliance with Study Drug|0
5112826|NCT01803282|17659556|P8|Overall Study|Non-Compliance with Study Drug|0
5112827|NCT01803282|17659557|P7|Overall Study|Non-Compliance with Study Drug|0
5112828|NCT01803282|17659558|P6|Overall Study|Non-Compliance with Study Drug|0
5112829|NCT01803282|17659559|P5|Overall Study|Non-Compliance with Study Drug|0
5112830|NCT01803282|17659560|P4|Overall Study|Non-Compliance with Study Drug|1
5112831|NCT01803282|17659561|P3|Overall Study|Non-Compliance with Study Drug|0
5112832|NCT01803282|17659562|P2|Overall Study|Non-Compliance with Study Drug|0
5112833|NCT01803282|17659563|P1|Overall Study|Non-Compliance with Study Drug|0
5112834|NCT01803282|17659552|P12|Overall Study|Adverse Event|3
5112835|NCT01803282|17659553|P11|Overall Study|Adverse Event|0
5112836|NCT01803282|17659554|P10|Overall Study|Adverse Event|1
5112837|NCT01803282|17659555|P9|Overall Study|Adverse Event|0
5112838|NCT01803282|17659556|P8|Overall Study|Adverse Event|2
5112839|NCT01803282|17659557|P7|Overall Study|Adverse Event|1
5112840|NCT01803282|17659558|P6|Overall Study|Adverse Event|0
5112841|NCT01803282|17659559|P5|Overall Study|Adverse Event|0
5112842|NCT01803282|17659560|P4|Overall Study|Adverse Event|0
5112843|NCT01803282|17659561|P3|Overall Study|Adverse Event|0
5112844|NCT01803282|17659562|P2|Overall Study|Adverse Event|0
5112845|NCT01803282|17659563|P1|Overall Study|Adverse Event|0
5112846|NCT01803282|17659552|P12|Overall Study|Investigator's Discretion|0
5112847|NCT01803282|17659553|P11|Overall Study|Investigator's Discretion|1
5112848|NCT01803282|17659554|P10|Overall Study|Investigator's Discretion|7
5112849|NCT01803282|17659555|P9|Overall Study|Investigator's Discretion|6
5112850|NCT01803282|17659556|P8|Overall Study|Investigator's Discretion|10
5112851|NCT01803282|17659557|P7|Overall Study|Investigator's Discretion|7
5112852|NCT01803282|17659558|P6|Overall Study|Investigator's Discretion|1
5112853|NCT01803282|17659559|P5|Overall Study|Investigator's Discretion|2
5112854|NCT01803282|17659560|P4|Overall Study|Investigator's Discretion|7
5112855|NCT01803282|17659561|P3|Overall Study|Investigator's Discretion|0
5112856|NCT01803282|17659562|P2|Overall Study|Investigator's Discretion|0
5112857|NCT01803282|17659563|P1|Overall Study|Investigator's Discretion|0
5112858|NCT01803282|17659552|P12|Overall Study|Withdrew Consent|1
5112859|NCT01803282|17659553|P11|Overall Study|Withdrew Consent|0
5112860|NCT01803282|17659554|P10|Overall Study|Withdrew Consent|5
5112861|NCT01803282|17659555|P9|Overall Study|Withdrew Consent|1
5112862|NCT01803282|17659556|P8|Overall Study|Withdrew Consent|3
5112863|NCT01803282|17659557|P7|Overall Study|Withdrew Consent|8
5112864|NCT01803282|17659558|P6|Overall Study|Withdrew Consent|0
5112865|NCT01803282|17659559|P5|Overall Study|Withdrew Consent|1
5112866|NCT01803282|17659560|P4|Overall Study|Withdrew Consent|6
5112867|NCT01803282|17659561|P3|Overall Study|Withdrew Consent|0
5112868|NCT01803282|17659562|P2|Overall Study|Withdrew Consent|0
5112869|NCT01803282|17659563|P1|Overall Study|Withdrew Consent|0
5112870|NCT01803282|17659552|P12|Overall Study|Death|0
5112871|NCT01803282|17659553|P11|Overall Study|Death|0
5112872|NCT01803282|17659554|P10|Overall Study|Death|1
5112873|NCT01803282|17659555|P9|Overall Study|Death|1
5112874|NCT01803282|17659556|P8|Overall Study|Death|5
5112875|NCT01803282|17659557|P7|Overall Study|Death|1
5112876|NCT01803282|17659558|P6|Overall Study|Death|1
5112877|NCT01803282|17659559|P5|Overall Study|Death|2
5112878|NCT01803282|17659560|P4|Overall Study|Death|0
5112879|NCT01803282|17659561|P3|Overall Study|Death|0
5112880|NCT01803282|17659562|P2|Overall Study|Death|0
5112881|NCT01803282|17659563|P1|Overall Study|Death|0
5112882|NCT01803282|17659552|P12|Overall Study|Progressive Disease|11
5112883|NCT01803282|17659553|P11|Overall Study|Progressive Disease|6
5112884|NCT01803282|17659554|P10|Overall Study|Progressive Disease|29
5112885|NCT01803282|17659555|P9|Overall Study|Progressive Disease|3
5112886|NCT01803282|17659556|P8|Overall Study|Progressive Disease|24
5112887|NCT01803282|17659557|P7|Overall Study|Progressive Disease|23
5112888|NCT01803282|17659558|P6|Overall Study|Progressive Disease|8
5112889|NCT01803282|17659559|P5|Overall Study|Progressive Disease|5
5112890|NCT01803282|17659560|P4|Overall Study|Progressive Disease|22
5112891|NCT01803282|17659561|P3|Overall Study|Progressive Disease|6
5112892|NCT01803282|17659562|P2|Overall Study|Progressive Disease|3
5112893|NCT01803282|17659563|P1|Overall Study|Progressive Disease|4
5112894|NCT01803269|17659604|P3|Overall Study|Withdrawal by Subject|0
5112895|NCT01803269|17659605|P2|Overall Study|Withdrawal by Subject|0
5112896|NCT01803269|17659606|P1|Overall Study|Withdrawal by Subject|3
5112897|NCT01802879|17659920|P1|Overall Study|Disease progression|6
5112898|NCT01802879|17659920|P1|Overall Study|Administrative problems|2
5112899|NCT01802775|17659927|P2|Overall Study|Lost to Follow-up|2
5112900|NCT01802775|17659928|P1|Overall Study|Lost to Follow-up|1
5112901|NCT01802775|17659927|P2|Overall Study|Withdrawal by Subject|5
5112902|NCT01802775|17659928|P1|Overall Study|Withdrawal by Subject|3
5112903|NCT01802775|17659927|P2|Overall Study|Adverse Event|1
5112904|NCT01802775|17659928|P1|Overall Study|Adverse Event|1
5112905|NCT01802775|17659927|P2|Overall Study|Physician Decision|0
5112906|NCT01802775|17659928|P1|Overall Study|Physician Decision|1
5112907|NCT01802775|17659927|P2|Overall Study|Reason not provided|1
5112908|NCT01802775|17659928|P1|Overall Study|Reason not provided|0
5112909|NCT01802775|17659927|P2|Overall Study|Death|3
5112910|NCT01802775|17659928|P1|Overall Study|Death|0
5112911|NCT01802632|17659963|P6|Overall Study|Other (not specified)|1
5112912|NCT01802632|17659964|P5|Overall Study|Other (not specified)|0
5112913|NCT01802632|17659965|P4|Overall Study|Other (not specified)|1
5112914|NCT01802632|17659966|P3|Overall Study|Other (not specified)|7
5112915|NCT01802632|17659967|P2|Overall Study|Other (not specified)|0
5112916|NCT01802632|17659968|P1|Overall Study|Other (not specified)|0
5112917|NCT01802632|17659963|P6|Overall Study|Ongoing Study at Data Cut-off|22
5112918|NCT01802632|17659964|P5|Overall Study|Ongoing Study at Data Cut-off|6
5112919|NCT01802632|17659965|P4|Overall Study|Ongoing Study at Data Cut-off|50
5112920|NCT01802632|17659966|P3|Overall Study|Ongoing Study at Data Cut-off|115
5112921|NCT01802632|17659967|P2|Overall Study|Ongoing Study at Data Cut-off|16
5112922|NCT01802632|17659968|P1|Overall Study|Ongoing Study at Data Cut-off|168
5112923|NCT01802632|17659963|P6|Overall Study|Objective Disease Progression|4
5112924|NCT01802632|17659964|P5|Overall Study|Objective Disease Progression|4
5112925|NCT01802632|17659965|P4|Overall Study|Objective Disease Progression|6
5112926|NCT01802632|17659966|P3|Overall Study|Objective Disease Progression|104
5112927|NCT01802632|17659967|P2|Overall Study|Objective Disease Progression|12
5112928|NCT01802632|17659968|P1|Overall Study|Objective Disease Progression|1
5112929|NCT01802632|17659963|P6|Overall Study|Withdrawal by Subject|1
5112930|NCT01802632|17659964|P5|Overall Study|Withdrawal by Subject|0
5112931|NCT01802632|17659965|P4|Overall Study|Withdrawal by Subject|3
5112932|NCT01802632|17659966|P3|Overall Study|Withdrawal by Subject|7
5112933|NCT01802632|17659967|P2|Overall Study|Withdrawal by Subject|2
5112934|NCT01802632|17659968|P1|Overall Study|Withdrawal by Subject|4
5112935|NCT01802632|17659963|P6|Overall Study|Death|0
5112936|NCT01802632|17659964|P5|Overall Study|Death|2
5112937|NCT01802632|17659965|P4|Overall Study|Death|0
5112938|NCT01802632|17659966|P3|Overall Study|Death|38
5112939|NCT01802632|17659967|P2|Overall Study|Death|1
5112940|NCT01802632|17659968|P1|Overall Study|Death|28
5112941|NCT01802580|17659984|P2|Overall Study|Lack of Efficacy|2
5112942|NCT01802580|17659985|P1|Overall Study|Lack of Efficacy|0
5112943|NCT01802580|17659984|P2|Overall Study|Other|3
5112944|NCT01802580|17659985|P1|Overall Study|Other|1
5112945|NCT01802580|17659984|P2|Overall Study|Withdrawal by Subject|6
5112946|NCT01802580|17659985|P1|Overall Study|Withdrawal by Subject|5
5112947|NCT01802580|17659984|P2|Overall Study|Protocol Violation|0
5112948|NCT01802580|17659985|P1|Overall Study|Protocol Violation|2
5112949|NCT01802580|17659984|P2|Overall Study|Physician Decision|0
5112950|NCT01802580|17659985|P1|Overall Study|Physician Decision|1
5112951|NCT01802515|17660016|P3|Overall Study|Withdrawal by Subject|0
5112952|NCT01802515|17660017|P2|Overall Study|Withdrawal by Subject|0
5112953|NCT01802515|17660018|P1|Overall Study|Withdrawal by Subject|3
5112954|NCT01802437|17660031|P2|Overall Study|Withdrawal by Subject|4
5112955|NCT01802437|17660032|P1|Overall Study|Withdrawal by Subject|3
5112956|NCT01802437|17660031|P2|Overall Study|Lost to Follow-up|0
5112957|NCT01802437|17660032|P1|Overall Study|Lost to Follow-up|1
5112958|NCT01802385|17660044|P2|Overall Study|Death|120
5112959|NCT01802385|17660045|P1|Overall Study|Death|106
5112960|NCT01802333|17660068|P3|Overall Study|Did not start treatment|5
5112961|NCT01802333|17660069|P2|Overall Study|Did not start treatment|2
5112962|NCT01802333|17660070|P1|Overall Study|Did not start treatment|0
5112963|NCT01802333|17660068|P3|Overall Study|Other - not protocol specified|24
5112964|NCT01802333|17660069|P2|Overall Study|Other - not protocol specified|22
5112965|NCT01802333|17660070|P1|Overall Study|Other - not protocol specified|32
5112966|NCT01802333|17660068|P3|Overall Study|Death|13
5112967|NCT01802333|17660069|P2|Overall Study|Death|14
5112968|NCT01802333|17660070|P1|Overall Study|Death|7
5112969|NCT01802333|17660068|P3|Overall Study|Progression/relapse|0
5112970|NCT01802333|17660069|P2|Overall Study|Progression/relapse|3
5112971|NCT01802333|17660070|P1|Overall Study|Progression/relapse|1
5112972|NCT01802333|17660068|P3|Overall Study|Withdrawal by Subject|5
5112973|NCT01802333|17660069|P2|Overall Study|Withdrawal by Subject|6
5112974|NCT01802333|17660070|P1|Overall Study|Withdrawal by Subject|6
5112975|NCT01802333|17660068|P3|Overall Study|Adverse Event|8
5112976|NCT01802333|17660069|P2|Overall Study|Adverse Event|8
5112977|NCT01802333|17660070|P1|Overall Study|Adverse Event|1
5112978|NCT01802333|17660068|P3|Overall Study|Ineligible|8
5112979|NCT01802333|17660069|P2|Overall Study|Ineligible|6
5112980|NCT01802333|17660070|P1|Overall Study|Ineligible|2
5112981|NCT01802320|17660097|P1|Overall Study|Withdrawal by Subject|1
5112982|NCT01802320|17660097|P1|Overall Study|Death|1
5112983|NCT01802216|17660107|P2|12 Month Visit|Participant did not show to visit|4
5112984|NCT01802216|17660108|P1|12 Month Visit|Participant did not show to visit|3
5112985|NCT01802216|17660107|P2|8 Month Visit|Participant did not show to visit|5
5112986|NCT01802216|17660108|P1|8 Month Visit|Participant did not show to visit|3
5112987|NCT01802216|17660107|P2|4 Month Visit|Participant did not show to visit|4
5112988|NCT01802216|17660108|P1|4 Month Visit|Participant did not show to visit|3
5112989|NCT01802073|17660187|P2|Overall Study|Physician Decision|7
5112990|NCT01802073|17660188|P1|Overall Study|Physician Decision|0
5112991|NCT01802073|17660187|P2|Overall Study|Withdrawal by Subject|1
5112992|NCT01802073|17660188|P1|Overall Study|Withdrawal by Subject|1
5112993|NCT01802073|17660187|P2|Overall Study|Non-compliant|2
5112994|NCT01802073|17660188|P1|Overall Study|Non-compliant|4
5112995|NCT01802073|17660187|P2|Overall Study|Lost to Follow-up|1
5112996|NCT01802073|17660188|P1|Overall Study|Lost to Follow-up|0
5112997|NCT01801982|17660204|P1|Overall Study|Lost to Follow-up|1
5112998|NCT01801917|17660218|P4|Period 1 - Randomized|Adverse Event|0
5112999|NCT01801917|17660219|P3|Period 1 - Randomized|Adverse Event|1
5113000|NCT01801917|17660220|P2|Period 1 - Randomized|Adverse Event|0
5113001|NCT01801917|17660221|P1|Period 1 - Randomized|Adverse Event|1
5113002|NCT01801865|17660241|P1|Overall Study|Physician Decision|7
5113003|NCT01801865|17660241|P1|Overall Study|Patients scanned on another MRI scanner|35
5113004|NCT01801735|17660246|P1|Overall Study|Other, including site closure|19
5113005|NCT01801735|17660246|P1|Overall Study|Death|1
5113006|NCT01801735|17660246|P1|Overall Study|Physician Decision|3
5113007|NCT01801735|17660246|P1|Overall Study|Non-compliance with Trial Drug|13
5113008|NCT01801735|17660246|P1|Overall Study|Lost to Follow-up|15
5113009|NCT01801735|17660246|P1|Overall Study|Protocol Violation|25
5113010|NCT01801735|17660246|P1|Overall Study|Withdrawal by Subject|27
5113011|NCT01801735|17660246|P1|Overall Study|Lack of Efficacy|28
5113012|NCT01801735|17660246|P1|Overall Study|Adverse Event|79
5113013|NCT01801475|17660253|P5|Overall Study|Withdrawal by Subject|1
5113014|NCT01801475|17660254|P4|Overall Study|Withdrawal by Subject|0
5113015|NCT01801475|17660255|P3|Overall Study|Withdrawal by Subject|0
5113016|NCT01801475|17660256|P2|Overall Study|Withdrawal by Subject|0
5113017|NCT01801475|17660257|P1|Overall Study|Withdrawal by Subject|0
5113018|NCT01801436|17660282|P1|Overall Study|Progressive disease|4
5113019|NCT01801436|17660282|P1|Overall Study|Adverse Event|2
5113020|NCT01801436|17660282|P1|Overall Study|Withdrawal by Subject|3
5113021|NCT01801358|17660320|P6|Overall Study|Withdrawal by Subject|2
5113022|NCT01801358|17660321|P5|Overall Study|Withdrawal by Subject|0
5113023|NCT01801358|17660322|P4|Overall Study|Withdrawal by Subject|1
5113024|NCT01801358|17660323|P3|Overall Study|Withdrawal by Subject|0
5113025|NCT01801358|17660324|P2|Overall Study|Withdrawal by Subject|0
5113026|NCT01801358|17660325|P1|Overall Study|Withdrawal by Subject|0
5113027|NCT01801358|17660320|P6|Overall Study|Progressive Disease|5
5113028|NCT01801358|17660321|P5|Overall Study|Progressive Disease|6
5113029|NCT01801358|17660322|P4|Overall Study|Progressive Disease|5
5113030|NCT01801358|17660323|P3|Overall Study|Progressive Disease|4
5113031|NCT01801358|17660324|P2|Overall Study|Progressive Disease|4
5113032|NCT01801358|17660325|P1|Overall Study|Progressive Disease|6
5113033|NCT01801358|17660320|P6|Overall Study|Physician Decision|0
5113034|NCT01801358|17660321|P5|Overall Study|Physician Decision|0
5113035|NCT01801358|17660322|P4|Overall Study|Physician Decision|0
5113036|NCT01801358|17660323|P3|Overall Study|Physician Decision|1
5113037|NCT01801358|17660324|P2|Overall Study|Physician Decision|0
5113038|NCT01801358|17660325|P1|Overall Study|Physician Decision|0
5113039|NCT01801358|17660320|P6|Overall Study|Adverse Event|1
5113040|NCT01801358|17660321|P5|Overall Study|Adverse Event|0
5113041|NCT01801358|17660322|P4|Overall Study|Adverse Event|0
5113042|NCT01801358|17660323|P3|Overall Study|Adverse Event|1
5113043|NCT01801358|17660324|P2|Overall Study|Adverse Event|2
5113044|NCT01801358|17660325|P1|Overall Study|Adverse Event|0
5113045|NCT01801280|17660447|P4|Period 4|Protocol Violation|0
5113046|NCT01801280|17660448|P3|Period 4|Protocol Violation|1
5113047|NCT01801280|17660449|P2|Period 4|Protocol Violation|0
5113048|NCT01801280|17660450|P1|Period 4|Protocol Violation|0
5113049|NCT01801280|17660447|P4|Period 2|Withdrawal by Subject|0
5113050|NCT01801280|17660448|P3|Period 2|Withdrawal by Subject|0
5113051|NCT01801280|17660449|P2|Period 2|Withdrawal by Subject|0
5113052|NCT01801280|17660450|P1|Period 2|Withdrawal by Subject|1
5113053|NCT01801280|17660447|P4|Period 1|Withdrawal by Subject|0
5113054|NCT01801280|17660448|P3|Period 1|Withdrawal by Subject|0
5113055|NCT01801280|17660449|P2|Period 1|Withdrawal by Subject|1
5113056|NCT01801280|17660450|P1|Period 1|Withdrawal by Subject|0
5113057|NCT01801111|17660465|P1|Overall Study|Progressive Disease|81
5113058|NCT01801111|17660465|P1|Overall Study|Study Terminated by Sponsor|27
5113059|NCT01801111|17660465|P1|Overall Study|Withdrawal by Subject|4
5113060|NCT01801111|17660465|P1|Overall Study|Other|1
5113061|NCT01801111|17660465|P1|Overall Study|Physician Decision|5
5113062|NCT01801111|17660465|P1|Overall Study|Death|8
5113063|NCT01801111|17660465|P1|Overall Study|Adverse Event|12
5113064|NCT01801007|17660504|P1|Overall Study|Withdrawal by Subject|5
5113065|NCT01801007|17660504|P1|Overall Study|Lost to Follow-up|4
5113066|NCT01801007|17660504|P1|Overall Study|Adverse Event|2
5113067|NCT01800968|17660517|P2|Overall Study|Physician Decision|0
5113068|NCT01800968|17660518|P1|Overall Study|Physician Decision|1
5113069|NCT01800968|17660517|P2|Overall Study|Withdrawal by Subject|9
5113070|NCT01800968|17660518|P1|Overall Study|Withdrawal by Subject|7
5113071|NCT01800968|17660517|P2|Overall Study|Lost to Follow-up|7
5113072|NCT01800968|17660518|P1|Overall Study|Lost to Follow-up|5
5113073|NCT01800968|17660517|P2|Overall Study|Death|16
5113074|NCT01800968|17660518|P1|Overall Study|Death|23
5113075|NCT01800916|17660560|P9|Test Period 1 (1 Week)|Adverse Event|0
5113076|NCT01800916|17660561|P8|Test Period 1 (1 Week)|Adverse Event|0
5113077|NCT01800916|17660562|P7|Test Period 1 (1 Week)|Adverse Event|0
5113078|NCT01800916|17660563|P6|Test Period 1 (1 Week)|Adverse Event|0
5113079|NCT01800916|17660564|P5|Test Period 1 (1 Week)|Adverse Event|1
5113080|NCT01800916|17660565|P4|Test Period 1 (1 Week)|Adverse Event|0
5113081|NCT01800916|17660566|P3|Test Period 1 (1 Week)|Adverse Event|0
5113082|NCT01800916|17660567|P2|Test Period 1 (1 Week)|Adverse Event|0
5113083|NCT01800916|17660568|P1|Test Period 1 (1 Week)|Adverse Event|0
5113084|NCT01800916|17660560|P9|Test Period 1 (1 Week)|Convex product user|0
5113085|NCT01800916|17660561|P8|Test Period 1 (1 Week)|Convex product user|0
5113086|NCT01800916|17660562|P7|Test Period 1 (1 Week)|Convex product user|0
5113087|NCT01800916|17660563|P6|Test Period 1 (1 Week)|Convex product user|0
5113088|NCT01800916|17660564|P5|Test Period 1 (1 Week)|Convex product user|0
5113089|NCT01800916|17660565|P4|Test Period 1 (1 Week)|Convex product user|1
5113090|NCT01800916|17660566|P3|Test Period 1 (1 Week)|Convex product user|0
5113091|NCT01800916|17660567|P2|Test Period 1 (1 Week)|Convex product user|0
5113092|NCT01800916|17660568|P1|Test Period 1 (1 Week)|Convex product user|0
5113093|NCT01800903|17660578|P6|Second Test Period|unable to catheterise|0
5113094|NCT01800903|17660579|P5|Second Test Period|unable to catheterise|0
5113095|NCT01800903|17660580|P4|Second Test Period|unable to catheterise|0
5113096|NCT01800903|17660581|P3|Second Test Period|unable to catheterise|0
5113097|NCT01800903|17660582|P2|Second Test Period|unable to catheterise|0
5113098|NCT01800903|17660583|P1|Second Test Period|unable to catheterise|1
5113099|NCT01800201|17660672|P2|Overall Study|PI withdrawal, cognitive concerns|1
5113100|NCT01800201|17660673|P1|Overall Study|PI withdrawal, cognitive concerns|0
5113101|NCT01800201|17660672|P2|Overall Study|did not want to use device|1
5113102|NCT01800201|17660673|P1|Overall Study|did not want to use device|0
5113103|NCT01800201|17660672|P2|Overall Study|patient privacy concerns|1
5113104|NCT01800201|17660673|P1|Overall Study|patient privacy concerns|1
5113105|NCT01800201|17660672|P2|Overall Study|Withdrawal by Subject|0
5113106|NCT01800201|17660673|P1|Overall Study|Withdrawal by Subject|2
5113107|NCT01800058|17660714|P1|Overall Study|Lost to Follow-up|1
5113108|NCT01799993|17660727|P2|Overall Study|Subject didn't return for follow-up|1
5113109|NCT01799993|17660728|P1|Overall Study|Subject didn't return for follow-up|0
5113110|NCT01799993|17660727|P2|Overall Study|Other|0
5113111|NCT01799993|17660728|P1|Overall Study|Other|1
5113112|NCT01799993|17660727|P2|Overall Study|Withdrawal by parent/guardian|1
5113113|NCT01799993|17660728|P1|Overall Study|Withdrawal by parent/guardian|0
5113114|NCT01799993|17660727|P2|Overall Study|Non-compliance with medical device|0
5113115|NCT01799993|17660728|P1|Overall Study|Non-compliance with medical device|1
5113116|NCT01799993|17660727|P2|Overall Study|Protocol deviation|0
5113117|NCT01799993|17660728|P1|Overall Study|Protocol deviation|1
5113118|NCT01799993|17660727|P2|Overall Study|Logistical difficulties|0
5113119|NCT01799993|17660728|P1|Overall Study|Logistical difficulties|1
5113120|NCT01799993|17660727|P2|Overall Study|Recovery|1
5113121|NCT01799993|17660728|P1|Overall Study|Recovery|0
5113122|NCT01799993|17660727|P2|Overall Study|Lack of Efficacy|0
5113123|NCT01799993|17660728|P1|Overall Study|Lack of Efficacy|1
5113124|NCT01799993|17660727|P2|Overall Study|Adverse Event|0
5113125|NCT01799993|17660728|P1|Overall Study|Adverse Event|1
5113126|NCT01799993|17660727|P2|Overall Study|Screen failure|1
5113127|NCT01799993|17660728|P1|Overall Study|Screen failure|0
5113128|NCT01799993|17660727|P2|Overall Study|Deterioration of general conditions|0
5113129|NCT01799993|17660728|P1|Overall Study|Deterioration of general conditions|2
5113130|NCT01799993|17660727|P2|Overall Study|Protocol Violation|1
5113131|NCT01799993|17660728|P1|Overall Study|Protocol Violation|1
5113132|NCT01799993|17660727|P2|Overall Study|Protocol driven decision point|3
5113133|NCT01799993|17660728|P1|Overall Study|Protocol driven decision point|0
5113134|NCT01799993|17660727|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
5113135|NCT01799993|17660728|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
5113136|NCT01799993|17660727|P2|Overall Study|Lost to Follow-up|8
5113137|NCT01799993|17660728|P1|Overall Study|Lost to Follow-up|5
5113138|NCT01799993|17660727|P2|Overall Study|Withdrawal by Subject|24
5113139|NCT01799993|17660728|P1|Overall Study|Withdrawal by Subject|23
5113140|NCT01799993|17660727|P2|Overall Study|Death|45
5113141|NCT01799993|17660728|P1|Overall Study|Death|61
5113142|NCT01799993|17660727|P2|Overall Study|"Didn't complete CRF page End of FU"|40
5113143|NCT01799993|17660728|P1|Overall Study|"Didn't complete CRF page End of FU"|30
5113144|NCT01799941|17660760|P1|Overall Study|Other|15
5113145|NCT01799941|17660760|P1|Overall Study|Lost to Follow-up|17
5113146|NCT01799941|17660760|P1|Overall Study|Lack of Efficacy|3
5113147|NCT01799941|17660760|P1|Overall Study|Investigator Decision|4
5113148|NCT01799941|17660760|P1|Overall Study|Death|2
5113149|NCT01799941|17660760|P1|Overall Study|Withdrawal by Subject|21
5113150|NCT01799941|17660760|P1|Overall Study|Adverse Event|34
5113151|NCT01799889|17660826|P12|Overall Study|Non-Compliance With Study Drug|0
5113152|NCT01799889|17660827|P11|Overall Study|Non-Compliance With Study Drug|0
5113153|NCT01799889|17660828|P10|Overall Study|Non-Compliance With Study Drug|0
5113154|NCT01799889|17660829|P9|Overall Study|Non-Compliance With Study Drug|0
5113155|NCT01799889|17660830|P8|Overall Study|Non-Compliance With Study Drug|0
5113156|NCT01799889|17660831|P7|Overall Study|Non-Compliance With Study Drug|0
5113157|NCT01799889|17660832|P6|Overall Study|Non-Compliance With Study Drug|1
5113158|NCT01799889|17660833|P5|Overall Study|Non-Compliance With Study Drug|0
5113159|NCT01799889|17660834|P4|Overall Study|Non-Compliance With Study Drug|0
5113160|NCT01799889|17660835|P3|Overall Study|Non-Compliance With Study Drug|0
5113161|NCT01799889|17660836|P2|Overall Study|Non-Compliance With Study Drug|0
5113162|NCT01799889|17660837|P1|Overall Study|Non-Compliance With Study Drug|0
5113163|NCT01799889|17660826|P12|Overall Study|Withdrawal by Subject|1
5113164|NCT01799889|17660827|P11|Overall Study|Withdrawal by Subject|1
5113165|NCT01799889|17660828|P10|Overall Study|Withdrawal by Subject|1
5113166|NCT01799889|17660829|P9|Overall Study|Withdrawal by Subject|2
5113167|NCT01799889|17660830|P8|Overall Study|Withdrawal by Subject|1
5113168|NCT01799889|17660831|P7|Overall Study|Withdrawal by Subject|3
5113169|NCT01799889|17660832|P6|Overall Study|Withdrawal by Subject|1
5113170|NCT01799889|17660833|P5|Overall Study|Withdrawal by Subject|5
5113171|NCT01799889|17660834|P4|Overall Study|Withdrawal by Subject|0
5113172|NCT01799889|17660835|P3|Overall Study|Withdrawal by Subject|4
5113173|NCT01799889|17660836|P2|Overall Study|Withdrawal by Subject|6
5113174|NCT01799889|17660837|P1|Overall Study|Withdrawal by Subject|1
5113175|NCT01799889|17660826|P12|Overall Study|Study Terminated By Sponsor|0
5113176|NCT01799889|17660827|P11|Overall Study|Study Terminated By Sponsor|0
5113177|NCT01799889|17660828|P10|Overall Study|Study Terminated By Sponsor|1
5113178|NCT01799889|17660829|P9|Overall Study|Study Terminated By Sponsor|1
5113179|NCT01799889|17660830|P8|Overall Study|Study Terminated By Sponsor|2
5113180|NCT01799889|17660831|P7|Overall Study|Study Terminated By Sponsor|0
5113181|NCT01799889|17660832|P6|Overall Study|Study Terminated By Sponsor|1
5113182|NCT01799889|17660833|P5|Overall Study|Study Terminated By Sponsor|2
5113183|NCT01799889|17660834|P4|Overall Study|Study Terminated By Sponsor|0
5113184|NCT01799889|17660835|P3|Overall Study|Study Terminated By Sponsor|0
5113185|NCT01799889|17660836|P2|Overall Study|Study Terminated By Sponsor|0
5113186|NCT01799889|17660837|P1|Overall Study|Study Terminated By Sponsor|1
5113187|NCT01799889|17660826|P12|Overall Study|Specified Criteria for Withdrawal|0
5113188|NCT01799889|17660827|P11|Overall Study|Specified Criteria for Withdrawal|0
5113189|NCT01799889|17660828|P10|Overall Study|Specified Criteria for Withdrawal|0
5113190|NCT01799889|17660829|P9|Overall Study|Specified Criteria for Withdrawal|0
5113191|NCT01799889|17660830|P8|Overall Study|Specified Criteria for Withdrawal|0
5113192|NCT01799889|17660831|P7|Overall Study|Specified Criteria for Withdrawal|0
5113193|NCT01799889|17660832|P6|Overall Study|Specified Criteria for Withdrawal|0
5113194|NCT01799889|17660833|P5|Overall Study|Specified Criteria for Withdrawal|0
5113195|NCT01799889|17660834|P4|Overall Study|Specified Criteria for Withdrawal|0
5113196|NCT01799889|17660835|P3|Overall Study|Specified Criteria for Withdrawal|1
5113197|NCT01799889|17660836|P2|Overall Study|Specified Criteria for Withdrawal|1
5113198|NCT01799889|17660837|P1|Overall Study|Specified Criteria for Withdrawal|0
5113199|NCT01799889|17660826|P12|Overall Study|Progressive Disease|1
5113200|NCT01799889|17660827|P11|Overall Study|Progressive Disease|3
5113201|NCT01799889|17660828|P10|Overall Study|Progressive Disease|5
5113202|NCT01799889|17660829|P9|Overall Study|Progressive Disease|18
5113203|NCT01799889|17660830|P8|Overall Study|Progressive Disease|13
5113204|NCT01799889|17660831|P7|Overall Study|Progressive Disease|8
5113205|NCT01799889|17660832|P6|Overall Study|Progressive Disease|9
5113206|NCT01799889|17660833|P5|Overall Study|Progressive Disease|23
5113207|NCT01799889|17660834|P4|Overall Study|Progressive Disease|30
5113208|NCT01799889|17660835|P3|Overall Study|Progressive Disease|25
5113209|NCT01799889|17660836|P2|Overall Study|Progressive Disease|26
5113210|NCT01799889|17660837|P1|Overall Study|Progressive Disease|30
5113211|NCT01799889|17660826|P12|Overall Study|Physician Decision|1
5113212|NCT01799889|17660827|P11|Overall Study|Physician Decision|0
5113213|NCT01799889|17660828|P10|Overall Study|Physician Decision|0
5113214|NCT01799889|17660829|P9|Overall Study|Physician Decision|6
5113215|NCT01799889|17660830|P8|Overall Study|Physician Decision|2
5113216|NCT01799889|17660831|P7|Overall Study|Physician Decision|5
5113217|NCT01799889|17660832|P6|Overall Study|Physician Decision|5
5113218|NCT01799889|17660833|P5|Overall Study|Physician Decision|5
5113219|NCT01799889|17660834|P4|Overall Study|Physician Decision|4
5113220|NCT01799889|17660835|P3|Overall Study|Physician Decision|4
5113221|NCT01799889|17660836|P2|Overall Study|Physician Decision|2
5113222|NCT01799889|17660837|P1|Overall Study|Physician Decision|3
5113223|NCT01799889|17660826|P12|Overall Study|Lost to Follow-up|0
5113224|NCT01799889|17660827|P11|Overall Study|Lost to Follow-up|0
5113225|NCT01799889|17660828|P10|Overall Study|Lost to Follow-up|0
5113226|NCT01799889|17660829|P9|Overall Study|Lost to Follow-up|0
5113227|NCT01799889|17660830|P8|Overall Study|Lost to Follow-up|0
5113228|NCT01799889|17660831|P7|Overall Study|Lost to Follow-up|0
5113229|NCT01799889|17660832|P6|Overall Study|Lost to Follow-up|0
5113230|NCT01799889|17660833|P5|Overall Study|Lost to Follow-up|0
5113231|NCT01799889|17660834|P4|Overall Study|Lost to Follow-up|0
5113232|NCT01799889|17660835|P3|Overall Study|Lost to Follow-up|0
5113233|NCT01799889|17660836|P2|Overall Study|Lost to Follow-up|1
5113234|NCT01799889|17660837|P1|Overall Study|Lost to Follow-up|0
5113235|NCT01799889|17660826|P12|Overall Study|Lack of Efficacy|0
5113236|NCT01799889|17660827|P11|Overall Study|Lack of Efficacy|1
5113237|NCT01799889|17660828|P10|Overall Study|Lack of Efficacy|0
5113238|NCT01799889|17660829|P9|Overall Study|Lack of Efficacy|2
5113239|NCT01799889|17660830|P8|Overall Study|Lack of Efficacy|0
5113240|NCT01799889|17660831|P7|Overall Study|Lack of Efficacy|0
5113241|NCT01799889|17660832|P6|Overall Study|Lack of Efficacy|2
5113242|NCT01799889|17660833|P5|Overall Study|Lack of Efficacy|2
5113243|NCT01799889|17660834|P4|Overall Study|Lack of Efficacy|1
5113244|NCT01799889|17660835|P3|Overall Study|Lack of Efficacy|0
5113245|NCT01799889|17660836|P2|Overall Study|Lack of Efficacy|1
5113246|NCT01799889|17660837|P1|Overall Study|Lack of Efficacy|1
5113247|NCT01799889|17660826|P12|Overall Study|Death|0
5113248|NCT01799889|17660827|P11|Overall Study|Death|1
5113249|NCT01799889|17660828|P10|Overall Study|Death|0
5113250|NCT01799889|17660829|P9|Overall Study|Death|1
5113251|NCT01799889|17660830|P8|Overall Study|Death|0
5113252|NCT01799889|17660831|P7|Overall Study|Death|0
5113253|NCT01799889|17660832|P6|Overall Study|Death|0
5113254|NCT01799889|17660833|P5|Overall Study|Death|1
5113255|NCT01799889|17660834|P4|Overall Study|Death|3
5113256|NCT01799889|17660835|P3|Overall Study|Death|5
5113257|NCT01799889|17660836|P2|Overall Study|Death|0
5113258|NCT01799889|17660837|P1|Overall Study|Death|1
5113259|NCT01799889|17660826|P12|Overall Study|Adverse Event|0
5113260|NCT01799889|17660827|P11|Overall Study|Adverse Event|1
5113261|NCT01799889|17660828|P10|Overall Study|Adverse Event|1
5113262|NCT01799889|17660829|P9|Overall Study|Adverse Event|3
5113263|NCT01799889|17660830|P8|Overall Study|Adverse Event|2
5113264|NCT01799889|17660831|P7|Overall Study|Adverse Event|5
5113265|NCT01799889|17660832|P6|Overall Study|Adverse Event|1
5113266|NCT01799889|17660833|P5|Overall Study|Adverse Event|11
5113267|NCT01799889|17660834|P4|Overall Study|Adverse Event|1
5113268|NCT01799889|17660835|P3|Overall Study|Adverse Event|5
5113269|NCT01799889|17660836|P2|Overall Study|Adverse Event|4
5113270|NCT01799889|17660837|P1|Overall Study|Adverse Event|4
5113271|NCT01799720|17660938|P3|Overall Study|Pregnancy|1
5113272|NCT01799720|17660939|P2|Overall Study|Pregnancy|0
5113273|NCT01799720|17660940|P1|Overall Study|Pregnancy|0
5113274|NCT01799720|17660938|P3|Overall Study|Protocol Violation|0
5113275|NCT01799720|17660939|P2|Overall Study|Protocol Violation|1
5113276|NCT01799720|17660940|P1|Overall Study|Protocol Violation|0
5113277|NCT01799720|17660938|P3|Overall Study|Withdrawal by Subject|0
5113278|NCT01799720|17660939|P2|Overall Study|Withdrawal by Subject|0
5113279|NCT01799720|17660940|P1|Overall Study|Withdrawal by Subject|3
5113280|NCT01799590|17660978|P3|Overall Study|Other|1
5113281|NCT01799590|17660979|P2|Overall Study|Other|0
5113282|NCT01799590|17660980|P1|Overall Study|Other|3
5113283|NCT01799590|17660978|P3|Overall Study|Use of prohibited concomitant drugs|0
5113284|NCT01799590|17660979|P2|Overall Study|Use of prohibited concomitant drugs|0
5113285|NCT01799590|17660980|P1|Overall Study|Use of prohibited concomitant drugs|1
5113286|NCT01799590|17660978|P3|Overall Study|Using drugs with restricted days of use|2
5113287|NCT01799590|17660979|P2|Overall Study|Using drugs with restricted days of use|3
5113288|NCT01799590|17660980|P1|Overall Study|Using drugs with restricted days of use|0
5113289|NCT01799590|17660978|P3|Overall Study|Aggravation of complications|1
5113290|NCT01799590|17660979|P2|Overall Study|Aggravation of complications|1
5113291|NCT01799590|17660980|P1|Overall Study|Aggravation of complications|0
5113292|NCT01799590|17660978|P3|Overall Study|Participants convenience|2
5113293|NCT01799590|17660979|P2|Overall Study|Participants convenience|4
5113294|NCT01799590|17660980|P1|Overall Study|Participants convenience|4
5113295|NCT01799590|17660978|P3|Overall Study|Lack of Efficacy|3
5113296|NCT01799590|17660979|P2|Overall Study|Lack of Efficacy|1
5113297|NCT01799590|17660980|P1|Overall Study|Lack of Efficacy|3
5113298|NCT01799590|17660978|P3|Overall Study|Pregnancy|0
5113299|NCT01799590|17660979|P2|Overall Study|Pregnancy|0
5113300|NCT01799590|17660980|P1|Overall Study|Pregnancy|2
5113301|NCT01799590|17660978|P3|Overall Study|Adverse Event|5
5113302|NCT01799590|17660979|P2|Overall Study|Adverse Event|7
5113303|NCT01799590|17660980|P1|Overall Study|Adverse Event|13
5113304|NCT01799239|17661023|P2|Period 2 (7 Days)|Protocol Violation|0
5113305|NCT01799239|17661024|P1|Period 2 (7 Days)|Protocol Violation|1
5113306|NCT01799239|17661023|P2|Period 2 (7 Days)|Withdrawal by Subject|1
5113307|NCT01799239|17661024|P1|Period 2 (7 Days)|Withdrawal by Subject|1
5113308|NCT01799239|17661023|P2|Period 1 (7 Days)|Protocol Violation|1
5113309|NCT01799239|17661024|P1|Period 1 (7 Days)|Protocol Violation|0
5113310|NCT01799239|17661023|P2|Period 1 (7 Days)|Withdrawal by Subject|0
5113311|NCT01799239|17661024|P1|Period 1 (7 Days)|Withdrawal by Subject|2
5113312|NCT01799239|17661023|P2|Period 1 (7 Days)|Lack of Efficacy|0
5113313|NCT01799239|17661024|P1|Period 1 (7 Days)|Lack of Efficacy|1
5113314|NCT01799226|17661032|P2|Overall Study|Disqualified at Day 14|0
5113315|NCT01799226|17661033|P1|Overall Study|Disqualified at Day 14|1
5113316|NCT01799226|17661032|P2|Overall Study|Withdrawal by Subject|0
5113317|NCT01799226|17661033|P1|Overall Study|Withdrawal by Subject|1
5113318|NCT01798992|17661064|P4|Overall Study|Insufficient biopsy tissue|0
5113319|NCT01798992|17661065|P3|Overall Study|Insufficient biopsy tissue|1
5113320|NCT01798992|17661066|P2|Overall Study|Insufficient biopsy tissue|0
5113321|NCT01798992|17661067|P1|Overall Study|Insufficient biopsy tissue|0
5113322|NCT01798992|17661064|P4|Overall Study|Lost to Follow-up|0
5113323|NCT01798992|17661065|P3|Overall Study|Lost to Follow-up|1
5113324|NCT01798992|17661066|P2|Overall Study|Lost to Follow-up|1
5113325|NCT01798992|17661067|P1|Overall Study|Lost to Follow-up|0
5113326|NCT01798992|17661064|P4|Overall Study|Administrative withdrawal|1
5113327|NCT01798992|17661065|P3|Overall Study|Administrative withdrawal|0
5113328|NCT01798992|17661066|P2|Overall Study|Administrative withdrawal|1
5113329|NCT01798992|17661067|P1|Overall Study|Administrative withdrawal|0
5113330|NCT01798927|17661087|P1|Overall Study|Withdrawal by Subject|1
5113331|NCT01798849|17661096|P3|Overall Study|Physician Decision|1
5113332|NCT01798849|17661097|P2|Overall Study|Physician Decision|0
5113333|NCT01798849|17661098|P1|Overall Study|Physician Decision|0
5113334|NCT01798706|17661288|P2|Overall Study|Other than specified above|9
5113335|NCT01798706|17661289|P1|Overall Study|Other than specified above|5
5113336|NCT01798706|17661288|P2|Overall Study|Poor compliance to protocol|0
5113337|NCT01798706|17661289|P1|Overall Study|Poor compliance to protocol|1
5113338|NCT01798706|17661288|P2|Overall Study|Lack of Efficacy|2
5113339|NCT01798706|17661289|P1|Overall Study|Lack of Efficacy|0
5113340|NCT01798706|17661288|P2|Overall Study|Adverse Event|10
5113341|NCT01798706|17661289|P1|Overall Study|Adverse Event|15
5113342|NCT01798485|17661360|P2|Overall Study|Clinical Progression|24
5113343|NCT01798485|17661361|P1|Overall Study|Clinical Progression|35
5113344|NCT01798485|17661360|P2|Overall Study|Sponsor Decision|54
5113345|NCT01798485|17661361|P1|Overall Study|Sponsor Decision|61
5113346|NCT01798485|17661360|P2|Overall Study|Death|22
5113347|NCT01798485|17661361|P1|Overall Study|Death|25
5113348|NCT01798485|17661360|P2|Overall Study|Objective Disease Progression|106
5113349|NCT01798485|17661361|P1|Overall Study|Objective Disease Progression|152
5113350|NCT01798485|17661360|P2|Overall Study|Physician Decision|10
5113351|NCT01798485|17661361|P1|Overall Study|Physician Decision|14
5113352|NCT01798485|17661360|P2|Overall Study|Lost to Follow-up|3
5113353|NCT01798485|17661361|P1|Overall Study|Lost to Follow-up|0
5113354|NCT01798485|17661360|P2|Overall Study|Withdrawal by Subject|31
5113355|NCT01798485|17661361|P1|Overall Study|Withdrawal by Subject|27
5113356|NCT01798485|17661360|P2|Overall Study|Adverse Event|40
5113357|NCT01798485|17661361|P1|Overall Study|Adverse Event|32
5113358|NCT01798134|17661498|P1|Overall Study|Liver transplant/surgery|4
5113359|NCT01798134|17661498|P1|Overall Study|Physician Decision|3
5113360|NCT01798134|17661498|P1|Overall Study|Adverse Event|3
5113361|NCT01798134|17661498|P1|Overall Study|Death|2
5113362|NCT01798134|17661498|P1|Overall Study|Withdrawal by Subject|3
5113363|NCT01798134|17661498|P1|Overall Study|Lost to Follow-up|1
5113364|NCT01798056|17661507|P2|Overall Study|Other|2
5113365|NCT01798056|17661508|P1|Overall Study|Other|0
5113366|NCT01798056|17661507|P2|Overall Study|Lost to Follow-up|1
5113367|NCT01798056|17661508|P1|Overall Study|Lost to Follow-up|1
5113368|NCT01798056|17661507|P2|Overall Study|Migrated/moved from study area|1
5113369|NCT01798056|17661508|P1|Overall Study|Migrated/moved from study area|1
5113370|NCT01798056|17661507|P2|Overall Study|Withdrawal by Subject|9
5113371|NCT01798056|17661508|P1|Overall Study|Withdrawal by Subject|12
5113372|NCT01798056|17661507|P2|Overall Study|Serious Adverse Event|12
5113373|NCT01798056|17661508|P1|Overall Study|Serious Adverse Event|13
5113374|NCT01798004|17661542|P1|Overall Study|Enrollment another COG therapeutic trial|32
5113375|NCT01798004|17661542|P1|Overall Study|Initiation of other non-protocol therapy|5
5113376|NCT01798004|17661542|P1|Overall Study|Patient/parent refusal|7
5113377|NCT01798004|17661542|P1|Overall Study|Ineligible|4
5113378|NCT01798004|17661542|P1|Overall Study|Withdrawal by Subject|4
5113379|NCT01798004|17661542|P1|Overall Study|Physician Decision|25
5113380|NCT01798004|17661542|P1|Overall Study|Lack of Efficacy|8
5113381|NCT01798004|17661542|P1|Overall Study|Death|2
5113382|NCT01797965|17661550|P4|Overall Study|Reason Not Specified|15
5113383|NCT01797965|17661551|P3|Overall Study|Reason Not Specified|0
5113384|NCT01797965|17661552|P2|Overall Study|Reason Not Specified|295
5113385|NCT01797965|17661553|P1|Overall Study|Reason Not Specified|280
5113386|NCT01797965|17661550|P4|Overall Study|Disease progression, defined by protocol|0
5113475|NCT01797185|17662021|P2|Overall Study|Withdrawal by Subject|9
5113387|NCT01797965|17661551|P3|Overall Study|Disease progression, defined by protocol|0
5113388|NCT01797965|17661552|P2|Overall Study|Disease progression, defined by protocol|1
5113389|NCT01797965|17661553|P1|Overall Study|Disease progression, defined by protocol|3
5113390|NCT01797965|17661550|P4|Overall Study|Death|0
5113391|NCT01797965|17661551|P3|Overall Study|Death|0
5113392|NCT01797965|17661552|P2|Overall Study|Death|4
5113393|NCT01797965|17661553|P1|Overall Study|Death|2
5113394|NCT01797965|17661550|P4|Overall Study|Investigator decision|0
5113395|NCT01797965|17661551|P3|Overall Study|Investigator decision|0
5113396|NCT01797965|17661552|P2|Overall Study|Investigator decision|15
5113397|NCT01797965|17661553|P1|Overall Study|Investigator decision|21
5113398|NCT01797965|17661550|P4|Overall Study|Consent withdrawn|35
5113399|NCT01797965|17661551|P3|Overall Study|Consent withdrawn|3
5113400|NCT01797965|17661552|P2|Overall Study|Consent withdrawn|117
5113401|NCT01797965|17661553|P1|Overall Study|Consent withdrawn|130
5113402|NCT01797965|17661550|P4|Overall Study|Lost to Follow-up|2
5113403|NCT01797965|17661551|P3|Overall Study|Lost to Follow-up|1
5113404|NCT01797965|17661552|P2|Overall Study|Lost to Follow-up|8
5113405|NCT01797965|17661553|P1|Overall Study|Lost to Follow-up|9
5113406|NCT01797965|17661550|P4|Overall Study|Adverse Event|21
5113407|NCT01797965|17661551|P3|Overall Study|Adverse Event|4
5113408|NCT01797965|17661552|P2|Overall Study|Adverse Event|129
5113409|NCT01797965|17661553|P1|Overall Study|Adverse Event|104
5113410|NCT01797835|17661687|P2|Overall Study|Lost to Follow-up|27
5113411|NCT01797835|17661688|P1|Overall Study|Lost to Follow-up|31
5113412|NCT01797783|17661704|P2|Overall Study|Withdrawal by Subject|0
5113413|NCT01797783|17661705|P1|Overall Study|Withdrawal by Subject|1
5113414|NCT01797783|17661704|P2|Overall Study|Adverse Event|1
5113415|NCT01797783|17661705|P1|Overall Study|Adverse Event|1
5113416|NCT01797731|17661729|P2|Overall Study|Didn't have proper radiographs required|3
5113417|NCT01797731|17661730|P1|Overall Study|Didn't have proper radiographs required|3
5113418|NCT01797705|17661738|P1|Overall Study|Withdrawal by Subject|1
5113419|NCT01797705|17661738|P1|Overall Study|Equipment anomalies during sleep studies|4
5113420|NCT01797562|17661799|P1|Overall Study|Protocol Violation|5
5113421|NCT01797536|17661808|P4|Overall Study|Adverse Event|0
5113422|NCT01797536|17661809|P3|Overall Study|Adverse Event|0
5113423|NCT01797536|17661810|P2|Overall Study|Adverse Event|1
5113424|NCT01797536|17661811|P1|Overall Study|Adverse Event|0
5113425|NCT01797445|17661883|P2|Open-Label Extension Phase|Investigator's Discretion|0
5113426|NCT01797445|17661884|P1|Open-Label Extension Phase|Investigator's Discretion|1
5113427|NCT01797445|17661883|P2|Double-Blind Phase|Lost to Follow-up|26
5113428|NCT01797445|17661884|P1|Double-Blind Phase|Lost to Follow-up|34
5113429|NCT01797445|17661883|P2|Double-Blind Phase|Withdrew Consent|35
5113430|NCT01797445|17661884|P1|Double-Blind Phase|Withdrew Consent|20
5113431|NCT01797445|17661883|P2|Double-Blind Phase|Protocol Violation|1
5113432|NCT01797445|17661884|P1|Double-Blind Phase|Protocol Violation|0
5113433|NCT01797445|17661883|P2|Double-Blind Phase|Noncompliance with Study Drug|1
5113434|NCT01797445|17661884|P1|Double-Blind Phase|Noncompliance with Study Drug|5
5113435|NCT01797445|17661883|P2|Double-Blind Phase|Investigator's Discretion|17
5113436|NCT01797445|17661884|P1|Double-Blind Phase|Investigator's Discretion|15
5113437|NCT01797445|17661883|P2|Double-Blind Phase|Lack of Efficacy|2
5113438|NCT01797445|17661884|P1|Double-Blind Phase|Lack of Efficacy|1
5113439|NCT01797445|17661883|P2|Double-Blind Phase|Pregnancy|1
5113440|NCT01797445|17661884|P1|Double-Blind Phase|Pregnancy|0
5113441|NCT01797445|17661883|P2|Double-Blind Phase|Death|4
5113442|NCT01797445|17661884|P1|Double-Blind Phase|Death|5
5113443|NCT01797445|17661883|P2|Double-Blind Phase|Adverse Event|0
5113444|NCT01797445|17661884|P1|Double-Blind Phase|Adverse Event|3
5113445|NCT01797445|17661883|P2|Double-Blind Phase|Randomized but Not Treated|2
5113446|NCT01797445|17661884|P1|Double-Blind Phase|Randomized but Not Treated|4
5113447|NCT01797302|17661945|P3|Overall Study|Withdrawal by Subject|4
5113448|NCT01797302|17661946|P2|Overall Study|Withdrawal by Subject|3
5113449|NCT01797302|17661947|P1|Overall Study|Withdrawal by Subject|1
5113450|NCT01797302|17661945|P3|Overall Study|Lost to Follow-up|22
5113451|NCT01797302|17661946|P2|Overall Study|Lost to Follow-up|23
5113452|NCT01797302|17661947|P1|Overall Study|Lost to Follow-up|16
5113453|NCT01797263|17661984|P2|Overall Study|Lost to Follow-up|15
5113454|NCT01797263|17661985|P1|Overall Study|Lost to Follow-up|15
5113455|NCT01797263|17661984|P2|Overall Study|Death|0
5113456|NCT01797263|17661985|P1|Overall Study|Death|1
5113457|NCT01797263|17661984|P2|Overall Study|Withdrawal by Subject|25
5113458|NCT01797263|17661985|P1|Overall Study|Withdrawal by Subject|21
5113459|NCT01797185|17662020|P3|Overall Study|Protocol Violation|0
5113460|NCT01797185|17662021|P2|Overall Study|Protocol Violation|1
5113461|NCT01797185|17662022|P1|Overall Study|Protocol Violation|1
5113462|NCT01797185|17662020|P3|Overall Study|Physician Decision|0
5113463|NCT01797185|17662021|P2|Overall Study|Physician Decision|3
5113464|NCT01797185|17662022|P1|Overall Study|Physician Decision|1
5113465|NCT01797185|17662020|P3|Overall Study|Withdrawn per sponsor|0
5113466|NCT01797185|17662021|P2|Overall Study|Withdrawn per sponsor|0
5113467|NCT01797185|17662022|P1|Overall Study|Withdrawn per sponsor|5
5113468|NCT01797185|17662020|P3|Overall Study|Lost to Follow-up|1
5113469|NCT01797185|17662021|P2|Overall Study|Lost to Follow-up|6
5113470|NCT01797185|17662022|P1|Overall Study|Lost to Follow-up|2
5113471|NCT01797185|17662020|P3|Overall Study|Site terminated|0
5113472|NCT01797185|17662021|P2|Overall Study|Site terminated|4
5113473|NCT01797185|17662022|P1|Overall Study|Site terminated|8
5113474|NCT01797185|17662020|P3|Overall Study|Withdrawal by Subject|5
5113476|NCT01797185|17662022|P1|Overall Study|Withdrawal by Subject|6
5113477|NCT01797185|17662020|P3|Overall Study|Adverse Event|6
5113478|NCT01797185|17662021|P2|Overall Study|Adverse Event|15
5113479|NCT01797185|17662022|P1|Overall Study|Adverse Event|5
5113480|NCT01797120|17662046|P2|Overall Study|never start protocol therapy|0
5113481|NCT01797120|17662047|P1|Overall Study|never start protocol therapy|2
5113482|NCT01797120|17662046|P2|Overall Study|still on treatment|4
5113483|NCT01797120|17662047|P1|Overall Study|still on treatment|2
5113484|NCT01797120|17662046|P2|Overall Study|Physician Decision|0
5113485|NCT01797120|17662047|P1|Overall Study|Physician Decision|3
5113486|NCT01797120|17662046|P2|Overall Study|Non-compliance|0
5113487|NCT01797120|17662047|P1|Overall Study|Non-compliance|1
5113488|NCT01797120|17662046|P2|Overall Study|Symptomatic progression|1
5113489|NCT01797120|17662047|P1|Overall Study|Symptomatic progression|2
5113490|NCT01797120|17662046|P2|Overall Study|Withdrawal by Subject|6
5113491|NCT01797120|17662047|P1|Overall Study|Withdrawal by Subject|6
5113492|NCT01797120|17662046|P2|Overall Study|Adverse Event|5
5113493|NCT01797120|17662047|P1|Overall Study|Adverse Event|13
5113494|NCT01797120|17662046|P2|Overall Study|Disesae progression|49
5113495|NCT01797120|17662047|P1|Overall Study|Disesae progression|37
5113496|NCT01797094|17662061|P2|Overall Study|Other Miscellaneous Reasons|0
5113497|NCT01797094|17662062|P1|Overall Study|Other Miscellaneous Reasons|1
5113498|NCT01797094|17662061|P2|Overall Study|Protocol Violation|1
5113499|NCT01797094|17662062|P1|Overall Study|Protocol Violation|0
5113500|NCT01797094|17662061|P2|Overall Study|Personal Reasons|0
5113501|NCT01797094|17662062|P1|Overall Study|Personal Reasons|4
5113502|NCT01797094|17662061|P2|Overall Study|Adverse Event|1
5113503|NCT01797094|17662062|P1|Overall Study|Adverse Event|1
5113504|NCT01797081|17662084|P4|Overall Study|Protocol Violation|1
5113505|NCT01797081|17662085|P3|Overall Study|Protocol Violation|0
5113506|NCT01797081|17662086|P2|Overall Study|Protocol Violation|0
5113507|NCT01797081|17662087|P1|Overall Study|Protocol Violation|0
5113508|NCT01797081|17662084|P4|Overall Study|Personal Reasons|8
5113509|NCT01797081|17662085|P3|Overall Study|Personal Reasons|4
5113510|NCT01797081|17662086|P2|Overall Study|Personal Reasons|4
5113511|NCT01797081|17662087|P1|Overall Study|Personal Reasons|12
5113512|NCT01797081|17662084|P4|Overall Study|Pregnancy|0
5113513|NCT01797081|17662085|P3|Overall Study|Pregnancy|0
5113514|NCT01797081|17662086|P2|Overall Study|Pregnancy|0
5113515|NCT01797081|17662087|P1|Overall Study|Pregnancy|1
5113516|NCT01797081|17662084|P4|Overall Study|Adverse Event|0
5113517|NCT01797081|17662085|P3|Overall Study|Adverse Event|1
5113518|NCT01797081|17662086|P2|Overall Study|Adverse Event|0
5113519|NCT01797081|17662087|P1|Overall Study|Adverse Event|1
5113520|NCT01796964|17662128|P2|Overall Study|Withdrawal by Subject|1
5113521|NCT01796964|17662129|P1|Overall Study|Withdrawal by Subject|1
5113522|NCT01796964|17662128|P2|Overall Study|Protocol Violation|1
5113523|NCT01796964|17662129|P1|Overall Study|Protocol Violation|0
5113524|NCT01796964|17662128|P2|Overall Study|Death|0
5113525|NCT01796964|17662129|P1|Overall Study|Death|1
5113526|NCT01796964|17662128|P2|Overall Study|Adverse Event|1
5113527|NCT01796964|17662129|P1|Overall Study|Adverse Event|1
5113528|NCT01796860|17662170|P1|Overall Study|Withdrawal by Subject|3
5113529|NCT01796548|17662176|P1|Overall Study|Other|2
5113530|NCT01796548|17662176|P1|Overall Study|Lost to Follow-up|1
5113531|NCT01796470|17662193|P5|Overall Study|Withdrawal by Subject|1
5113532|NCT01796470|17662194|P4|Overall Study|Withdrawal by Subject|0
5113533|NCT01796470|17662195|P3|Overall Study|Withdrawal by Subject|0
5113534|NCT01796470|17662196|P2|Overall Study|Withdrawal by Subject|0
5113535|NCT01796470|17662197|P1|Overall Study|Withdrawal by Subject|7
5113536|NCT01796470|17662193|P5|Overall Study|Protocol Criteria for Withdrawal|0
5113537|NCT01796470|17662194|P4|Overall Study|Protocol Criteria for Withdrawal|0
5113538|NCT01796470|17662195|P3|Overall Study|Protocol Criteria for Withdrawal|0
5113539|NCT01796470|17662196|P2|Overall Study|Protocol Criteria for Withdrawal|0
5113540|NCT01796470|17662197|P1|Overall Study|Protocol Criteria for Withdrawal|1
5113541|NCT01796470|17662193|P5|Overall Study|Progressive Disease|0
5113542|NCT01796470|17662194|P4|Overall Study|Progressive Disease|2
5113543|NCT01796470|17662195|P3|Overall Study|Progressive Disease|3
5113544|NCT01796470|17662196|P2|Overall Study|Progressive Disease|7
5113545|NCT01796470|17662197|P1|Overall Study|Progressive Disease|7
5113546|NCT01796470|17662193|P5|Overall Study|Physician Decision|1
5113547|NCT01796470|17662194|P4|Overall Study|Physician Decision|0
5113548|NCT01796470|17662195|P3|Overall Study|Physician Decision|1
5113549|NCT01796470|17662196|P2|Overall Study|Physician Decision|4
5113550|NCT01796470|17662197|P1|Overall Study|Physician Decision|5
5113551|NCT01796470|17662193|P5|Overall Study|Lost to Follow-up|0
5113552|NCT01796470|17662194|P4|Overall Study|Lost to Follow-up|0
5113553|NCT01796470|17662195|P3|Overall Study|Lost to Follow-up|0
5113554|NCT01796470|17662196|P2|Overall Study|Lost to Follow-up|1
5113555|NCT01796470|17662197|P1|Overall Study|Lost to Follow-up|0
5113556|NCT01796470|17662193|P5|Overall Study|Initiated New Therapy|2
5113557|NCT01796470|17662194|P4|Overall Study|Initiated New Therapy|0
5113558|NCT01796470|17662195|P3|Overall Study|Initiated New Therapy|0
5113559|NCT01796470|17662196|P2|Overall Study|Initiated New Therapy|0
5113560|NCT01796470|17662197|P1|Overall Study|Initiated New Therapy|9
5113561|NCT01796470|17662193|P5|Overall Study|Death|1
5113562|NCT01796470|17662194|P4|Overall Study|Death|0
5113563|NCT01796470|17662195|P3|Overall Study|Death|0
5113564|NCT01796470|17662196|P2|Overall Study|Death|0
5113565|NCT01796470|17662197|P1|Overall Study|Death|2
5113566|NCT01796470|17662193|P5|Overall Study|Adverse Event|3
5113567|NCT01796470|17662194|P4|Overall Study|Adverse Event|1
5113568|NCT01796470|17662195|P3|Overall Study|Adverse Event|2
5113569|NCT01796470|17662196|P2|Overall Study|Adverse Event|2
5113570|NCT01796470|17662197|P1|Overall Study|Adverse Event|4
5113571|NCT01796392|17662241|P2|Overall Study|Lost to Follow-up|0
5113572|NCT01796392|17662242|P1|Overall Study|Lost to Follow-up|1
5113573|NCT01796392|17662241|P2|Overall Study|Excluded for medical reasons|2
5113574|NCT01796392|17662242|P1|Overall Study|Excluded for medical reasons|1
5113575|NCT01796392|17662241|P2|Overall Study|Death|1
5113576|NCT01796392|17662242|P1|Overall Study|Death|5
5113577|NCT01796392|17662241|P2|Overall Study|Withdrawal by Subject|0
5113578|NCT01796392|17662242|P1|Overall Study|Withdrawal by Subject|2
5113579|NCT01796301|17662256|P2|Overall Study|Decision by Sponsor|1
5113580|NCT01796301|17662257|P1|Overall Study|Decision by Sponsor|0
5113581|NCT01796301|17662256|P2|Overall Study|Death|1
5113582|NCT01796301|17662257|P1|Overall Study|Death|0
5113583|NCT01796301|17662256|P2|Overall Study|Lost to Follow-up|3
5113584|NCT01796301|17662257|P1|Overall Study|Lost to Follow-up|3
5113585|NCT01796301|17662256|P2|Overall Study|Withdrawal by Subject|15
5113586|NCT01796301|17662257|P1|Overall Study|Withdrawal by Subject|15
5113587|NCT01795937|17662343|P3|Overall Study|Physician Decision|0
5113588|NCT01795937|17662344|P2|Overall Study|Physician Decision|1
5113589|NCT01795937|17662345|P1|Overall Study|Physician Decision|0
5113590|NCT01795937|17662343|P3|Overall Study|Withdrawal by Subject|0
5113591|NCT01795937|17662344|P2|Overall Study|Withdrawal by Subject|0
5113592|NCT01795937|17662345|P1|Overall Study|Withdrawal by Subject|1
5113593|NCT01795898|17662374|P1|Overall Study|Physician Decision|1
5113594|NCT01795898|17662374|P1|Overall Study|Withdrew consent & had adverse events|3
5113595|NCT01795898|17662374|P1|Overall Study|Death|1
5113596|NCT01795898|17662374|P1|Overall Study|No pain|1
5113597|NCT01795898|17662374|P1|Overall Study|Diagnosed with metastasis|1
5113598|NCT01795898|17662374|P1|Overall Study|Withdrawal of consent|6
5113599|NCT01795898|17662374|P1|Overall Study|Lost to Follow-up|20
5113600|NCT01795898|17662374|P1|Overall Study|Adverse Event|27
5113601|NCT01795638|17662433|P2|Overall Study|Withdrawal by Subject|0
5113602|NCT01795638|17662434|P1|Overall Study|Withdrawal by Subject|1
5113603|NCT01795638|17662433|P2|Overall Study|discharged from hospital|5
5113604|NCT01795638|17662434|P1|Overall Study|discharged from hospital|7
5113605|NCT01795638|17662433|P2|Overall Study|Protocol Violation|0
5113606|NCT01795638|17662434|P1|Overall Study|Protocol Violation|3
5113607|NCT01795638|17662433|P2|Overall Study|transferred to quaternary hospital|3
5113608|NCT01795638|17662434|P1|Overall Study|transferred to quaternary hospital|2
5113609|NCT01795638|17662433|P2|Overall Study|Death|3
5113610|NCT01795638|17662434|P1|Overall Study|Death|0
5113611|NCT01795547|17662460|P2|Overall Study|Not stated|1
5113612|NCT01795547|17662461|P1|Overall Study|Not stated|0
5113613|NCT01795547|17662460|P2|Overall Study|Others|1
5113614|NCT01795547|17662461|P1|Overall Study|Others|4
5113615|NCT01795547|17662460|P2|Overall Study|Non-compliance with IMP|1
5113616|NCT01795547|17662461|P1|Overall Study|Non-compliance with IMP|1
5113617|NCT01795547|17662460|P2|Overall Study|Not Treated|10
5113618|NCT01795547|17662461|P1|Overall Study|Not Treated|4
5113619|NCT01795547|17662460|P2|Overall Study|Withdrawal of consent|12
5113620|NCT01795547|17662461|P1|Overall Study|Withdrawal of consent|7
5113621|NCT01795547|17662460|P2|Overall Study|Lost to Follow-up|5
5113622|NCT01795547|17662461|P1|Overall Study|Lost to Follow-up|2
5113623|NCT01795547|17662460|P2|Overall Study|Protocol Violation|4
5113624|NCT01795547|17662461|P1|Overall Study|Protocol Violation|6
5113625|NCT01795547|17662460|P2|Overall Study|Lack of Efficacy|3
5113626|NCT01795547|17662461|P1|Overall Study|Lack of Efficacy|8
5113627|NCT01795547|17662460|P2|Overall Study|Adverse Event|27
5113628|NCT01795547|17662461|P1|Overall Study|Adverse Event|16
5113629|NCT01795495|17662493|P3|Overall Study|Physician Decision|1
5113630|NCT01795495|17662494|P2|Overall Study|Physician Decision|0
5113631|NCT01795495|17662495|P1|Overall Study|Physician Decision|0
5113632|NCT01795495|17662493|P3|Overall Study|Protocol Violation|1
5113633|NCT01795495|17662494|P2|Overall Study|Protocol Violation|0
5113634|NCT01795495|17662495|P1|Overall Study|Protocol Violation|1
5113635|NCT01794949|17662515|P2|Overall Study|Lost to Follow-up|0
5113636|NCT01794949|17662516|P1|Overall Study|Lost to Follow-up|1
5113637|NCT01794845|17662527|P1|Overall Study|Withdrawal by Subject|1
5113638|NCT01794780|17662555|P8|Overall Study|Other|1
5113639|NCT01794780|17662556|P7|Overall Study|Other|4
5113640|NCT01794780|17662557|P6|Overall Study|Other|24
5113641|NCT01794780|17662558|P5|Overall Study|Other|1
5113642|NCT01794780|17662559|P4|Overall Study|Other|20
5113643|NCT01794780|17662560|P3|Overall Study|Other|25
5113644|NCT01794780|17662561|P2|Overall Study|Other|12
5113645|NCT01794780|17662562|P1|Overall Study|Other|0
5113646|NCT01794780|17662555|P8|Overall Study|Withdrew informed consent|3
5113647|NCT01794780|17662556|P7|Overall Study|Withdrew informed consent|4
5113648|NCT01794780|17662557|P6|Overall Study|Withdrew informed consent|48
5113649|NCT01794780|17662558|P5|Overall Study|Withdrew informed consent|0
5113650|NCT01794780|17662559|P4|Overall Study|Withdrew informed consent|9
5113651|NCT01794780|17662560|P3|Overall Study|Withdrew informed consent|36
5113652|NCT01794780|17662561|P2|Overall Study|Withdrew informed consent|17
5113653|NCT01794780|17662562|P1|Overall Study|Withdrew informed consent|7
5113654|NCT01794780|17662555|P8|Overall Study|Lost to Follow-up|5
5113655|NCT01794780|17662556|P7|Overall Study|Lost to Follow-up|30
5113656|NCT01794780|17662557|P6|Overall Study|Lost to Follow-up|99
5113657|NCT01794780|17662558|P5|Overall Study|Lost to Follow-up|2
5113658|NCT01794780|17662559|P4|Overall Study|Lost to Follow-up|53
5113659|NCT01794780|17662560|P3|Overall Study|Lost to Follow-up|165
5113660|NCT01794780|17662561|P2|Overall Study|Lost to Follow-up|64
5113661|NCT01794780|17662562|P1|Overall Study|Lost to Follow-up|10
5113662|NCT01794780|17662555|P8|Overall Study|Death|0
5113663|NCT01794780|17662556|P7|Overall Study|Death|4
5113664|NCT01794780|17662557|P6|Overall Study|Death|9
5113665|NCT01794780|17662558|P5|Overall Study|Death|0
5113666|NCT01794780|17662559|P4|Overall Study|Death|1
5113667|NCT01794780|17662560|P3|Overall Study|Death|14
5113668|NCT01794780|17662561|P2|Overall Study|Death|2
5113669|NCT01794780|17662562|P1|Overall Study|Death|0
5113670|NCT01794780|17662555|P8|Overall Study|Adverse Event|0
5113671|NCT01794780|17662556|P7|Overall Study|Adverse Event|0
5113672|NCT01794780|17662557|P6|Overall Study|Adverse Event|0
5113673|NCT01794780|17662558|P5|Overall Study|Adverse Event|0
5113674|NCT01794780|17662559|P4|Overall Study|Adverse Event|0
5113675|NCT01794780|17662560|P3|Overall Study|Adverse Event|2
5113676|NCT01794780|17662561|P2|Overall Study|Adverse Event|1
5113677|NCT01794780|17662562|P1|Overall Study|Adverse Event|0
5113678|NCT01794689|17662638|P4|Intervention 1 (2 Nights)|Adverse Event|0
5113679|NCT01794689|17662639|P3|Intervention 1 (2 Nights)|Adverse Event|0
5113680|NCT01794689|17662640|P2|Intervention 1 (2 Nights)|Adverse Event|1
5113681|NCT01794689|17662641|P1|Intervention 1 (2 Nights)|Adverse Event|0
5113682|NCT01794689|17662638|P4|Intervention 1 (2 Nights)|Physician Decision|0
5113683|NCT01794689|17662639|P3|Intervention 1 (2 Nights)|Physician Decision|0
5113684|NCT01794689|17662640|P2|Intervention 1 (2 Nights)|Physician Decision|1
5113685|NCT01794689|17662641|P1|Intervention 1 (2 Nights)|Physician Decision|1
5113686|NCT01794689|17662638|P4|Intervention 1 (2 Nights)|Protocol Violation|0
5113687|NCT01794689|17662639|P3|Intervention 1 (2 Nights)|Protocol Violation|1
5113688|NCT01794689|17662640|P2|Intervention 1 (2 Nights)|Protocol Violation|0
5113689|NCT01794689|17662641|P1|Intervention 1 (2 Nights)|Protocol Violation|1
5113690|NCT01794689|17662638|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
5113691|NCT01794689|17662639|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
5113692|NCT01794689|17662640|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
5113693|NCT01794689|17662641|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
5113694|NCT01794000|17662710|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5113695|NCT01794000|17662711|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
5113696|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
5113697|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
5113698|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
5113699|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
5113700|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Physician Decision|0
5113701|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Physician Decision|2
5113702|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
5113703|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
5113704|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
5113705|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
5113706|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Death|2
5113707|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Death|1
5113708|NCT01794000|17662710|P2|Double-Blind Phase (DBP)|Adverse Event|2
5113709|NCT01794000|17662711|P1|Double-Blind Phase (DBP)|Adverse Event|5
5113710|NCT01793935|17662744|P2|Overall Study|Lost to Follow-up|1
5113711|NCT01793935|17662745|P1|Overall Study|Lost to Follow-up|0
5113712|NCT01793935|17662744|P2|Overall Study|Patient did not take study medication|1
5113713|NCT01793935|17662745|P1|Overall Study|Patient did not take study medication|1
5113714|NCT01793935|17662744|P2|Overall Study|Adverse Event|0
5113715|NCT01793935|17662745|P1|Overall Study|Adverse Event|2
5113716|NCT01793935|17662744|P2|Overall Study|Protocol Violation|1
5113717|NCT01793935|17662745|P1|Overall Study|Protocol Violation|2
5113718|NCT01793935|17662744|P2|Overall Study|Pregnancy|0
5113719|NCT01793935|17662745|P1|Overall Study|Pregnancy|1
5113720|NCT01793883|17662791|P3|Overall Study|Respiratory distress during spirometry|1
5113721|NCT01793883|17662792|P2|Overall Study|Respiratory distress during spirometry|0
5113722|NCT01793883|17662793|P1|Overall Study|Respiratory distress during spirometry|0
5113723|NCT01793883|17662791|P3|Overall Study|Dosing error|0
5113724|NCT01793883|17662792|P2|Overall Study|Dosing error|1
5113725|NCT01793883|17662793|P1|Overall Study|Dosing error|0
5113726|NCT01793883|17662791|P3|Overall Study|Met exclusion criteria|0
5113727|NCT01793883|17662792|P2|Overall Study|Met exclusion criteria|0
5113728|NCT01793883|17662793|P1|Overall Study|Met exclusion criteria|1
5113729|NCT01793883|17662791|P3|Overall Study|Unable to complete measurements|0
5113730|NCT01793883|17662792|P2|Overall Study|Unable to complete measurements|0
5113731|NCT01793883|17662793|P1|Overall Study|Unable to complete measurements|1
5113732|NCT01793883|17662791|P3|Overall Study|Unable to complete spriometry|0
5113733|NCT01793883|17662792|P2|Overall Study|Unable to complete spriometry|0
5113734|NCT01793883|17662793|P1|Overall Study|Unable to complete spriometry|1
5113735|NCT01793883|17662791|P3|Overall Study|Randomized in error|0
5113736|NCT01793883|17662792|P2|Overall Study|Randomized in error|0
5113737|NCT01793883|17662793|P1|Overall Study|Randomized in error|1
5113738|NCT01793883|17662791|P3|Overall Study|Lost to Follow-up|3
5113739|NCT01793883|17662792|P2|Overall Study|Lost to Follow-up|1
5113740|NCT01793883|17662793|P1|Overall Study|Lost to Follow-up|5
5113741|NCT01793883|17662791|P3|Overall Study|Subject noncompliance|1
5113742|NCT01793883|17662792|P2|Overall Study|Subject noncompliance|1
5113743|NCT01793883|17662793|P1|Overall Study|Subject noncompliance|0
5113744|NCT01793883|17662791|P3|Overall Study|Withdrawal by Subject|3
5113745|NCT01793883|17662792|P2|Overall Study|Withdrawal by Subject|7
5113746|NCT01793883|17662793|P1|Overall Study|Withdrawal by Subject|3
5113747|NCT01793792|17662801|P1|Overall Study|Device Not Implanted|1
5113748|NCT01793792|17662801|P1|Overall Study|Withdrawal by Subject|1
5113749|NCT01793792|17662801|P1|Overall Study|Lost to Follow-up|5
5113750|NCT01793792|17662801|P1|Overall Study|Death|5
5113751|NCT01793688|17662806|P1|Overall Study|Protocol Violation|2
5113752|NCT01793610|17662816|P3|Overall Study|Withdrawal by Subject|1
5113753|NCT01793610|17662817|P2|Overall Study|Withdrawal by Subject|0
5113754|NCT01793610|17662818|P1|Overall Study|Withdrawal by Subject|1
5113755|NCT01793142|17662864|P1|Overall Study|Randomized not treated|7
5113756|NCT01792830|17662894|P11|Overall Study|Adverse Event|0
5113757|NCT01792830|17662895|P10|Overall Study|Adverse Event|0
5113758|NCT01792830|17662896|P9|Overall Study|Adverse Event|1
5113759|NCT01792830|17662897|P8|Overall Study|Adverse Event|0
5113760|NCT01792830|17662898|P7|Overall Study|Adverse Event|0
5113761|NCT01792830|17662899|P6|Overall Study|Adverse Event|0
5113762|NCT01792830|17662900|P5|Overall Study|Adverse Event|0
5113763|NCT01792830|17662901|P4|Overall Study|Adverse Event|0
5113764|NCT01792830|17662902|P3|Overall Study|Adverse Event|0
5113765|NCT01792830|17662903|P2|Overall Study|Adverse Event|0
5113766|NCT01792830|17662904|P1|Overall Study|Adverse Event|0
5113767|NCT01792830|17662894|P11|Overall Study|Death|1
5113768|NCT01792830|17662895|P10|Overall Study|Death|0
5113769|NCT01792830|17662896|P9|Overall Study|Death|1
5113770|NCT01792830|17662897|P8|Overall Study|Death|0
5113771|NCT01792830|17662898|P7|Overall Study|Death|1
5113772|NCT01792830|17662899|P6|Overall Study|Death|0
5113773|NCT01792830|17662900|P5|Overall Study|Death|0
5113774|NCT01792830|17662901|P4|Overall Study|Death|1
5113775|NCT01792830|17662902|P3|Overall Study|Death|0
5113776|NCT01792830|17662903|P2|Overall Study|Death|0
5113777|NCT01792830|17662904|P1|Overall Study|Death|3
5113778|NCT01792830|17662894|P11|Overall Study|Withdrawal by Subject|2
5113779|NCT01792830|17662895|P10|Overall Study|Withdrawal by Subject|0
5113780|NCT01792830|17662896|P9|Overall Study|Withdrawal by Subject|7
5113781|NCT01792830|17662897|P8|Overall Study|Withdrawal by Subject|1
5113782|NCT01792830|17662898|P7|Overall Study|Withdrawal by Subject|1
5113783|NCT01792830|17662899|P6|Overall Study|Withdrawal by Subject|1
5113784|NCT01792830|17662900|P5|Overall Study|Withdrawal by Subject|1
5113785|NCT01792830|17662901|P4|Overall Study|Withdrawal by Subject|2
5113786|NCT01792830|17662902|P3|Overall Study|Withdrawal by Subject|0
5113787|NCT01792830|17662903|P2|Overall Study|Withdrawal by Subject|0
5113788|NCT01792830|17662904|P1|Overall Study|Withdrawal by Subject|22
5113789|NCT01792635|17662991|P3|Part B|Study terminated|3
5113790|NCT01792635|17662992|P2|Part B|Study terminated|4
5113791|NCT01792635|17662993|P1|Part B|Study terminated|0
5113792|NCT01792635|17662991|P3|Part B|Adverse Event|1
5113793|NCT01792635|17662992|P2|Part B|Adverse Event|0
5113794|NCT01792635|17662993|P1|Part B|Adverse Event|0
5113795|NCT01792518|17663021|P2|Overall Study|Other Reason|1
5113796|NCT01792518|17663022|P1|Overall Study|Other Reason|0
5113797|NCT01792518|17663021|P2|Overall Study|Withdrawal by Subject|0
5113798|NCT01792518|17663022|P1|Overall Study|Withdrawal by Subject|2
5113799|NCT01792518|17663021|P2|Overall Study|Lost to Follow-up|1
5113800|NCT01792518|17663022|P1|Overall Study|Lost to Follow-up|3
5113801|NCT01792518|17663021|P2|Overall Study|Protocol Violation|1
5113802|NCT01792518|17663022|P1|Overall Study|Protocol Violation|0
5113803|NCT01792518|17663021|P2|Overall Study|Adverse Event|4
5113804|NCT01792518|17663022|P1|Overall Study|Adverse Event|3
5113805|NCT01792284|17663032|P3|Randomization Period 2|Withdrawal by Subject|0
5113806|NCT01792284|17663033|P2|Randomization Period 2|Withdrawal by Subject|2
5113807|NCT01792284|17663034|P1|Randomization Period 2|Withdrawal by Subject|0
5113808|NCT01792284|17663032|P3|Randomization Period 2|Protocol Violation|0
5113809|NCT01792284|17663033|P2|Randomization Period 2|Protocol Violation|1
5113810|NCT01792284|17663034|P1|Randomization Period 2|Protocol Violation|0
5113811|NCT01792284|17663032|P3|Randomization Period 1|Lost to Follow-up|1
5113812|NCT01792284|17663033|P2|Randomization Period 1|Lost to Follow-up|0
5113813|NCT01792284|17663034|P1|Randomization Period 1|Lost to Follow-up|0
5113814|NCT01792284|17663032|P3|Randomization Period 1|Adverse Event|2
5113815|NCT01792284|17663033|P2|Randomization Period 1|Adverse Event|0
5113816|NCT01792284|17663034|P1|Randomization Period 1|Adverse Event|0
5113817|NCT01792284|17663032|P3|Randomization Period 1|Physician Decision|1
5113818|NCT01792284|17663033|P2|Randomization Period 1|Physician Decision|1
5113819|NCT01792284|17663034|P1|Randomization Period 1|Physician Decision|0
5113820|NCT01792284|17663032|P3|Randomization Period 1|Withdrawal by Subject|1
5113821|NCT01792284|17663033|P2|Randomization Period 1|Withdrawal by Subject|1
5113822|NCT01792284|17663034|P1|Randomization Period 1|Withdrawal by Subject|0
5113823|NCT01792284|17663032|P3|Lead-in Period|Protocol Required Discontinuation|0
5113824|NCT01792284|17663033|P2|Lead-in Period|Protocol Required Discontinuation|0
5113825|NCT01792284|17663034|P1|Lead-in Period|Protocol Required Discontinuation|1
5113826|NCT01792284|17663032|P3|Lead-in Period|Physician Decision|0
5113827|NCT01792284|17663033|P2|Lead-in Period|Physician Decision|0
5113828|NCT01792284|17663034|P1|Lead-in Period|Physician Decision|1
5113829|NCT01792284|17663032|P3|Lead-in Period|Withdrawal by Subject|0
5113830|NCT01792284|17663033|P2|Lead-in Period|Withdrawal by Subject|0
5113831|NCT01792284|17663034|P1|Lead-in Period|Withdrawal by Subject|10
5113832|NCT01792284|17663032|P3|Lead-in Period|Protocol Violation|0
5113833|NCT01792284|17663033|P2|Lead-in Period|Protocol Violation|0
5113834|NCT01792284|17663034|P1|Lead-in Period|Protocol Violation|1
5113835|NCT01792284|17663032|P3|Lead-in Period|Lost to Follow-up|0
5113836|NCT01792284|17663033|P2|Lead-in Period|Lost to Follow-up|0
5113837|NCT01792284|17663034|P1|Lead-in Period|Lost to Follow-up|2
5113838|NCT01792284|17663032|P3|Lead-in Period|Adverse Event|0
5113839|NCT01792284|17663033|P2|Lead-in Period|Adverse Event|0
5113840|NCT01792284|17663034|P1|Lead-in Period|Adverse Event|15
5113841|NCT01792115|17663075|P3|Overall Study|Lost to Follow-up|0
5113842|NCT01792115|17663076|P2|Overall Study|Lost to Follow-up|1
5113843|NCT01792115|17663077|P1|Overall Study|Lost to Follow-up|0
5113844|NCT01791894|17663127|P1|Overall Study|Adverse Event|1
5113845|NCT01791803|17663138|P4|Overall Study|Death|2
5113846|NCT01791803|17663139|P3|Overall Study|Death|2
5113847|NCT01791803|17663140|P2|Overall Study|Death|0
5113848|NCT01791803|17663141|P1|Overall Study|Death|0
5113849|NCT01791803|17663138|P4|Overall Study|Physician Decision|1
5113850|NCT01791803|17663139|P3|Overall Study|Physician Decision|0
5113851|NCT01791803|17663140|P2|Overall Study|Physician Decision|2
5113852|NCT01791803|17663141|P1|Overall Study|Physician Decision|0
5113853|NCT01791803|17663138|P4|Overall Study|Withdrawal by Subject|2
5113854|NCT01791803|17663139|P3|Overall Study|Withdrawal by Subject|0
5113855|NCT01791803|17663140|P2|Overall Study|Withdrawal by Subject|0
5113856|NCT01791803|17663141|P1|Overall Study|Withdrawal by Subject|0
5113857|NCT01791725|17663159|P3|Overall Study|Withdrawal by Subject|0
5113858|NCT01791725|17663160|P2|Overall Study|Withdrawal by Subject|1
5113859|NCT01791725|17663161|P1|Overall Study|Withdrawal by Subject|0
5113860|NCT01791517|17663184|P12|Phase II|Pre-Existing Ocular Issue|1
5113861|NCT01791517|17663185|P11|Phase II|Pre-Existing Ocular Issue|0
5113862|NCT01791517|17663186|P10|Phase II|Pre-Existing Ocular Issue|0
5113863|NCT01791517|17663187|P9|Phase II|Pre-Existing Ocular Issue|0
5113864|NCT01791517|17663188|P8|Phase II|Pre-Existing Ocular Issue|0
5113865|NCT01791517|17663189|P7|Phase II|Pre-Existing Ocular Issue|0
5113866|NCT01791517|17663190|P6|Phase II|Pre-Existing Ocular Issue|0
5113867|NCT01791517|17663191|P5|Phase II|Pre-Existing Ocular Issue|0
5113868|NCT01791517|17663192|P4|Phase II|Pre-Existing Ocular Issue|0
5113869|NCT01791517|17663193|P3|Phase II|Pre-Existing Ocular Issue|0
5113870|NCT01791517|17663194|P2|Phase II|Pre-Existing Ocular Issue|0
5113871|NCT01791517|17663195|P1|Phase II|Pre-Existing Ocular Issue|0
5113872|NCT01791517|17663184|P12|Phase II|Unsatisfactory Lens Fitting|0
5113873|NCT01791517|17663185|P11|Phase II|Unsatisfactory Lens Fitting|0
5113874|NCT01791517|17663186|P10|Phase II|Unsatisfactory Lens Fitting|1
5113875|NCT01791517|17663187|P9|Phase II|Unsatisfactory Lens Fitting|0
5113876|NCT01791517|17663188|P8|Phase II|Unsatisfactory Lens Fitting|0
5113877|NCT01791517|17663189|P7|Phase II|Unsatisfactory Lens Fitting|0
5113878|NCT01791517|17663190|P6|Phase II|Unsatisfactory Lens Fitting|0
5113879|NCT01791517|17663191|P5|Phase II|Unsatisfactory Lens Fitting|0
5113880|NCT01791517|17663192|P4|Phase II|Unsatisfactory Lens Fitting|0
5113881|NCT01791517|17663193|P3|Phase II|Unsatisfactory Lens Fitting|0
5113882|NCT01791517|17663194|P2|Phase II|Unsatisfactory Lens Fitting|0
5113883|NCT01791517|17663195|P1|Phase II|Unsatisfactory Lens Fitting|0
5113884|NCT01791517|17663184|P12|Phase II|Lens Handling Difficulties|0
5113885|NCT01791517|17663185|P11|Phase II|Lens Handling Difficulties|0
5113886|NCT01791517|17663186|P10|Phase II|Lens Handling Difficulties|0
5113887|NCT01791517|17663187|P9|Phase II|Lens Handling Difficulties|1
5113888|NCT01791517|17663188|P8|Phase II|Lens Handling Difficulties|0
5113889|NCT01791517|17663189|P7|Phase II|Lens Handling Difficulties|0
5113890|NCT01791517|17663190|P6|Phase II|Lens Handling Difficulties|0
5113891|NCT01791517|17663191|P5|Phase II|Lens Handling Difficulties|0
5113892|NCT01791517|17663192|P4|Phase II|Lens Handling Difficulties|0
5113893|NCT01791517|17663193|P3|Phase II|Lens Handling Difficulties|0
5113894|NCT01791517|17663194|P2|Phase II|Lens Handling Difficulties|0
5113895|NCT01791517|17663195|P1|Phase II|Lens Handling Difficulties|0
5113896|NCT01791517|17663184|P12|Phase II|Adverse Event|0
5113897|NCT01791517|17663185|P11|Phase II|Adverse Event|0
5113898|NCT01791517|17663186|P10|Phase II|Adverse Event|1
5113899|NCT01791517|17663187|P9|Phase II|Adverse Event|0
5113900|NCT01791517|17663188|P8|Phase II|Adverse Event|1
5113901|NCT01791517|17663189|P7|Phase II|Adverse Event|2
5113902|NCT01791517|17663190|P6|Phase II|Adverse Event|0
5113903|NCT01791517|17663191|P5|Phase II|Adverse Event|0
5113904|NCT01791517|17663192|P4|Phase II|Adverse Event|0
5113905|NCT01791517|17663193|P3|Phase II|Adverse Event|0
5113906|NCT01791517|17663194|P2|Phase II|Adverse Event|0
5113907|NCT01791517|17663195|P1|Phase II|Adverse Event|0
5113908|NCT01791517|17663184|P12|Phase II|Lack of Efficacy|0
5113909|NCT01791517|17663185|P11|Phase II|Lack of Efficacy|0
5113910|NCT01791517|17663186|P10|Phase II|Lack of Efficacy|0
5113911|NCT01791517|17663187|P9|Phase II|Lack of Efficacy|0
5113912|NCT01791517|17663188|P8|Phase II|Lack of Efficacy|0
5113913|NCT01791517|17663189|P7|Phase II|Lack of Efficacy|0
5113914|NCT01791517|17663190|P6|Phase II|Lack of Efficacy|0
5113915|NCT01791517|17663191|P5|Phase II|Lack of Efficacy|1
5113916|NCT01791517|17663192|P4|Phase II|Lack of Efficacy|0
5113917|NCT01791517|17663193|P3|Phase II|Lack of Efficacy|0
5113918|NCT01791517|17663194|P2|Phase II|Lack of Efficacy|0
5113919|NCT01791517|17663195|P1|Phase II|Lack of Efficacy|0
5113920|NCT01791517|17663184|P12|Phase II|Withdrawal by Subject|0
5113921|NCT01791517|17663185|P11|Phase II|Withdrawal by Subject|1
5113922|NCT01791517|17663186|P10|Phase II|Withdrawal by Subject|0
5113923|NCT01791517|17663187|P9|Phase II|Withdrawal by Subject|0
5113924|NCT01791517|17663188|P8|Phase II|Withdrawal by Subject|1
5113925|NCT01791517|17663189|P7|Phase II|Withdrawal by Subject|0
5113926|NCT01791517|17663190|P6|Phase II|Withdrawal by Subject|2
5113927|NCT01791517|17663191|P5|Phase II|Withdrawal by Subject|0
5113928|NCT01791517|17663192|P4|Phase II|Withdrawal by Subject|0
5113929|NCT01791517|17663193|P3|Phase II|Withdrawal by Subject|0
5113930|NCT01791517|17663194|P2|Phase II|Withdrawal by Subject|0
5113931|NCT01791517|17663195|P1|Phase II|Withdrawal by Subject|1
5113932|NCT01791517|17663184|P12|Phase II|Lost to Follow-up|0
5113933|NCT01791517|17663185|P11|Phase II|Lost to Follow-up|0
5113934|NCT01791517|17663186|P10|Phase II|Lost to Follow-up|1
5113935|NCT01791517|17663187|P9|Phase II|Lost to Follow-up|1
5113936|NCT01791517|17663188|P8|Phase II|Lost to Follow-up|1
5113937|NCT01791517|17663189|P7|Phase II|Lost to Follow-up|0
5113938|NCT01791517|17663190|P6|Phase II|Lost to Follow-up|2
5113939|NCT01791517|17663191|P5|Phase II|Lost to Follow-up|1
5113940|NCT01791517|17663192|P4|Phase II|Lost to Follow-up|0
5113941|NCT01791517|17663193|P3|Phase II|Lost to Follow-up|1
5113942|NCT01791517|17663194|P2|Phase II|Lost to Follow-up|0
5113943|NCT01791517|17663195|P1|Phase II|Lost to Follow-up|1
5113944|NCT01791517|17663184|P12|Phase I: Period 3|Adverse Event|0
5113945|NCT01791517|17663185|P11|Phase I: Period 3|Adverse Event|0
5113946|NCT01791517|17663186|P10|Phase I: Period 3|Adverse Event|0
5113947|NCT01791517|17663187|P9|Phase I: Period 3|Adverse Event|0
5113948|NCT01791517|17663188|P8|Phase I: Period 3|Adverse Event|0
5113949|NCT01791517|17663189|P7|Phase I: Period 3|Adverse Event|0
5113950|NCT01791517|17663190|P6|Phase I: Period 3|Adverse Event|0
5113951|NCT01791517|17663191|P5|Phase I: Period 3|Adverse Event|0
5113952|NCT01791517|17663192|P4|Phase I: Period 3|Adverse Event|1
5113953|NCT01791517|17663193|P3|Phase I: Period 3|Adverse Event|0
5113954|NCT01791517|17663194|P2|Phase I: Period 3|Adverse Event|0
5113955|NCT01791517|17663195|P1|Phase I: Period 3|Adverse Event|0
5113956|NCT01791517|17663184|P12|Phase I: Period 3|Lost to Follow-up|0
5113957|NCT01791517|17663185|P11|Phase I: Period 3|Lost to Follow-up|0
5113958|NCT01791517|17663186|P10|Phase I: Period 3|Lost to Follow-up|0
5113959|NCT01791517|17663187|P9|Phase I: Period 3|Lost to Follow-up|0
5113960|NCT01791517|17663188|P8|Phase I: Period 3|Lost to Follow-up|0
5113961|NCT01791517|17663189|P7|Phase I: Period 3|Lost to Follow-up|0
5113962|NCT01791517|17663190|P6|Phase I: Period 3|Lost to Follow-up|0
5113963|NCT01791517|17663191|P5|Phase I: Period 3|Lost to Follow-up|1
5113964|NCT01791517|17663192|P4|Phase I: Period 3|Lost to Follow-up|0
5113965|NCT01791517|17663193|P3|Phase I: Period 3|Lost to Follow-up|0
5113966|NCT01791517|17663194|P2|Phase I: Period 3|Lost to Follow-up|1
5113967|NCT01791517|17663195|P1|Phase I: Period 3|Lost to Follow-up|0
5113968|NCT01791517|17663184|P12|Phase I: Period 3|Lens Discomfort|1
5113969|NCT01791517|17663185|P11|Phase I: Period 3|Lens Discomfort|0
5113970|NCT01791517|17663186|P10|Phase I: Period 3|Lens Discomfort|0
5113971|NCT01791517|17663187|P9|Phase I: Period 3|Lens Discomfort|0
5113972|NCT01791517|17663188|P8|Phase I: Period 3|Lens Discomfort|0
5113973|NCT01791517|17663189|P7|Phase I: Period 3|Lens Discomfort|0
5113974|NCT01791517|17663190|P6|Phase I: Period 3|Lens Discomfort|0
5113975|NCT01791517|17663191|P5|Phase I: Period 3|Lens Discomfort|0
5113976|NCT01791517|17663192|P4|Phase I: Period 3|Lens Discomfort|0
5113977|NCT01791517|17663193|P3|Phase I: Period 3|Lens Discomfort|0
5113978|NCT01791517|17663194|P2|Phase I: Period 3|Lens Discomfort|0
5113979|NCT01791517|17663195|P1|Phase I: Period 3|Lens Discomfort|0
5113980|NCT01791517|17663184|P12|Phase I: Period 2|Lost to Follow-up|0
5113981|NCT01791517|17663185|P11|Phase I: Period 2|Lost to Follow-up|0
5113982|NCT01791517|17663186|P10|Phase I: Period 2|Lost to Follow-up|0
5113983|NCT01791517|17663187|P9|Phase I: Period 2|Lost to Follow-up|0
5113984|NCT01791517|17663188|P8|Phase I: Period 2|Lost to Follow-up|0
5113985|NCT01791517|17663189|P7|Phase I: Period 2|Lost to Follow-up|0
5113986|NCT01791517|17663190|P6|Phase I: Period 2|Lost to Follow-up|0
5113987|NCT01791517|17663191|P5|Phase I: Period 2|Lost to Follow-up|0
5113988|NCT01791517|17663192|P4|Phase I: Period 2|Lost to Follow-up|0
5113989|NCT01791517|17663193|P3|Phase I: Period 2|Lost to Follow-up|2
5113990|NCT01791517|17663194|P2|Phase I: Period 2|Lost to Follow-up|3
5113991|NCT01791517|17663195|P1|Phase I: Period 2|Lost to Follow-up|0
5113992|NCT01791517|17663184|P12|Phase I: Period 2|Lens Discomfort|0
5113993|NCT01791517|17663185|P11|Phase I: Period 2|Lens Discomfort|0
5113994|NCT01791517|17663186|P10|Phase I: Period 2|Lens Discomfort|0
5113995|NCT01791517|17663187|P9|Phase I: Period 2|Lens Discomfort|0
5113996|NCT01791517|17663188|P8|Phase I: Period 2|Lens Discomfort|0
5113997|NCT01791517|17663189|P7|Phase I: Period 2|Lens Discomfort|0
5113998|NCT01791517|17663190|P6|Phase I: Period 2|Lens Discomfort|1
5113999|NCT01791517|17663191|P5|Phase I: Period 2|Lens Discomfort|0
5114000|NCT01791517|17663192|P4|Phase I: Period 2|Lens Discomfort|0
5114001|NCT01791517|17663193|P3|Phase I: Period 2|Lens Discomfort|0
5114002|NCT01791517|17663194|P2|Phase I: Period 2|Lens Discomfort|0
5114003|NCT01791517|17663195|P1|Phase I: Period 2|Lens Discomfort|0
5114004|NCT01791517|17663184|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
5114005|NCT01791517|17663185|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
5114006|NCT01791517|17663186|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
5114007|NCT01791517|17663187|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
5114008|NCT01791517|17663188|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
5114009|NCT01791517|17663189|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
5114010|NCT01791517|17663190|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
5114011|NCT01791517|17663191|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
5114012|NCT01791517|17663192|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
5114013|NCT01791517|17663193|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
5114014|NCT01791517|17663194|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
5114015|NCT01791517|17663195|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
5114016|NCT01791517|17663184|P12|Phase I: Period 2|Withdrawal by Subject|0
5114017|NCT01791517|17663185|P11|Phase I: Period 2|Withdrawal by Subject|1
5114018|NCT01791517|17663186|P10|Phase I: Period 2|Withdrawal by Subject|1
5114019|NCT01791517|17663187|P9|Phase I: Period 2|Withdrawal by Subject|0
5114020|NCT01791517|17663188|P8|Phase I: Period 2|Withdrawal by Subject|0
5114021|NCT01791517|17663189|P7|Phase I: Period 2|Withdrawal by Subject|0
5114022|NCT01791517|17663190|P6|Phase I: Period 2|Withdrawal by Subject|0
5114023|NCT01791517|17663191|P5|Phase I: Period 2|Withdrawal by Subject|0
5114024|NCT01791517|17663192|P4|Phase I: Period 2|Withdrawal by Subject|0
5114025|NCT01791517|17663193|P3|Phase I: Period 2|Withdrawal by Subject|0
5114026|NCT01791517|17663194|P2|Phase I: Period 2|Withdrawal by Subject|0
5114027|NCT01791517|17663195|P1|Phase I: Period 2|Withdrawal by Subject|0
5114028|NCT01791517|17663184|P12|Phase I: Period 2|Protocol Violation|0
5114029|NCT01791517|17663185|P11|Phase I: Period 2|Protocol Violation|0
5114030|NCT01791517|17663186|P10|Phase I: Period 2|Protocol Violation|0
5114031|NCT01791517|17663187|P9|Phase I: Period 2|Protocol Violation|0
5114032|NCT01791517|17663188|P8|Phase I: Period 2|Protocol Violation|0
5114033|NCT01791517|17663189|P7|Phase I: Period 2|Protocol Violation|0
5114034|NCT01791517|17663190|P6|Phase I: Period 2|Protocol Violation|0
5114035|NCT01791517|17663191|P5|Phase I: Period 2|Protocol Violation|0
5114036|NCT01791517|17663192|P4|Phase I: Period 2|Protocol Violation|1
5114037|NCT01791517|17663193|P3|Phase I: Period 2|Protocol Violation|0
5114038|NCT01791517|17663194|P2|Phase I: Period 2|Protocol Violation|0
5114039|NCT01791517|17663195|P1|Phase I: Period 2|Protocol Violation|0
5114040|NCT01791517|17663184|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114041|NCT01791517|17663185|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114042|NCT01791517|17663186|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114043|NCT01791517|17663187|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114044|NCT01791517|17663188|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114045|NCT01791517|17663189|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114046|NCT01791517|17663190|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114047|NCT01791517|17663191|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114048|NCT01791517|17663192|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114049|NCT01791517|17663193|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114050|NCT01791517|17663194|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
5114051|NCT01791517|17663195|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
5114052|NCT01791517|17663184|P12|Phase I: Period 1|Lens Handling DIfficulties|1
5114053|NCT01791517|17663185|P11|Phase I: Period 1|Lens Handling DIfficulties|0
5114054|NCT01791517|17663186|P10|Phase I: Period 1|Lens Handling DIfficulties|0
5114055|NCT01791517|17663187|P9|Phase I: Period 1|Lens Handling DIfficulties|0
5114056|NCT01791517|17663188|P8|Phase I: Period 1|Lens Handling DIfficulties|0
5114057|NCT01791517|17663189|P7|Phase I: Period 1|Lens Handling DIfficulties|0
5114058|NCT01791517|17663190|P6|Phase I: Period 1|Lens Handling DIfficulties|0
5114059|NCT01791517|17663191|P5|Phase I: Period 1|Lens Handling DIfficulties|0
5114060|NCT01791517|17663192|P4|Phase I: Period 1|Lens Handling DIfficulties|0
5114061|NCT01791517|17663193|P3|Phase I: Period 1|Lens Handling DIfficulties|0
5114062|NCT01791517|17663194|P2|Phase I: Period 1|Lens Handling DIfficulties|0
5114063|NCT01791517|17663195|P1|Phase I: Period 1|Lens Handling DIfficulties|0
5114064|NCT01791517|17663184|P12|Phase I: Period 1|Lost to Follow-up|0
5114065|NCT01791517|17663185|P11|Phase I: Period 1|Lost to Follow-up|0
5114066|NCT01791517|17663186|P10|Phase I: Period 1|Lost to Follow-up|1
5114067|NCT01791517|17663187|P9|Phase I: Period 1|Lost to Follow-up|1
5114068|NCT01791517|17663188|P8|Phase I: Period 1|Lost to Follow-up|0
5114069|NCT01791517|17663189|P7|Phase I: Period 1|Lost to Follow-up|1
5114070|NCT01791517|17663190|P6|Phase I: Period 1|Lost to Follow-up|0
5114071|NCT01791517|17663191|P5|Phase I: Period 1|Lost to Follow-up|0
5114072|NCT01791517|17663192|P4|Phase I: Period 1|Lost to Follow-up|1
5114073|NCT01791517|17663193|P3|Phase I: Period 1|Lost to Follow-up|0
5114074|NCT01791517|17663194|P2|Phase I: Period 1|Lost to Follow-up|0
5114075|NCT01791517|17663195|P1|Phase I: Period 1|Lost to Follow-up|0
5114076|NCT01791517|17663184|P12|Phase I: Period 1|Protocol Violation|0
5114077|NCT01791517|17663185|P11|Phase I: Period 1|Protocol Violation|0
5114078|NCT01791517|17663186|P10|Phase I: Period 1|Protocol Violation|0
5114079|NCT01791517|17663187|P9|Phase I: Period 1|Protocol Violation|0
5114080|NCT01791517|17663188|P8|Phase I: Period 1|Protocol Violation|0
5114081|NCT01791517|17663189|P7|Phase I: Period 1|Protocol Violation|0
5114082|NCT01791517|17663190|P6|Phase I: Period 1|Protocol Violation|0
5114083|NCT01791517|17663191|P5|Phase I: Period 1|Protocol Violation|0
5114084|NCT01791517|17663192|P4|Phase I: Period 1|Protocol Violation|0
5114085|NCT01791517|17663193|P3|Phase I: Period 1|Protocol Violation|0
5114086|NCT01791517|17663194|P2|Phase I: Period 1|Protocol Violation|1
5114087|NCT01791517|17663195|P1|Phase I: Period 1|Protocol Violation|0
5114088|NCT01791517|17663184|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114089|NCT01791517|17663185|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114090|NCT01791517|17663186|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114091|NCT01791517|17663187|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114092|NCT01791517|17663188|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114093|NCT01791517|17663189|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114094|NCT01791517|17663190|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114179|NCT01791153|17663394|P5|Part 2: Open-label Period|Death|0
5114095|NCT01791517|17663191|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114096|NCT01791517|17663192|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114097|NCT01791517|17663193|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114098|NCT01791517|17663194|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5114099|NCT01791517|17663195|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
5114100|NCT01791517|17663184|P12|Phase I: Period 1|Adverse Event|0
5114101|NCT01791517|17663185|P11|Phase I: Period 1|Adverse Event|0
5114102|NCT01791517|17663186|P10|Phase I: Period 1|Adverse Event|0
5114103|NCT01791517|17663187|P9|Phase I: Period 1|Adverse Event|0
5114104|NCT01791517|17663188|P8|Phase I: Period 1|Adverse Event|0
5114105|NCT01791517|17663189|P7|Phase I: Period 1|Adverse Event|0
5114106|NCT01791517|17663190|P6|Phase I: Period 1|Adverse Event|0
5114107|NCT01791517|17663191|P5|Phase I: Period 1|Adverse Event|0
5114108|NCT01791517|17663192|P4|Phase I: Period 1|Adverse Event|1
5114109|NCT01791517|17663193|P3|Phase I: Period 1|Adverse Event|1
5114110|NCT01791517|17663194|P2|Phase I: Period 1|Adverse Event|0
5114111|NCT01791517|17663195|P1|Phase I: Period 1|Adverse Event|0
5114112|NCT01791517|17663184|P12|Phase I: Period 1|Withdrawal by Subject|0
5114113|NCT01791517|17663185|P11|Phase I: Period 1|Withdrawal by Subject|0
5114114|NCT01791517|17663186|P10|Phase I: Period 1|Withdrawal by Subject|0
5114115|NCT01791517|17663187|P9|Phase I: Period 1|Withdrawal by Subject|0
5114116|NCT01791517|17663188|P8|Phase I: Period 1|Withdrawal by Subject|0
5114117|NCT01791517|17663189|P7|Phase I: Period 1|Withdrawal by Subject|0
5114118|NCT01791517|17663190|P6|Phase I: Period 1|Withdrawal by Subject|1
5114119|NCT01791517|17663191|P5|Phase I: Period 1|Withdrawal by Subject|1
5114120|NCT01791517|17663192|P4|Phase I: Period 1|Withdrawal by Subject|0
5114121|NCT01791517|17663193|P3|Phase I: Period 1|Withdrawal by Subject|1
5114122|NCT01791517|17663194|P2|Phase I: Period 1|Withdrawal by Subject|1
5114123|NCT01791517|17663195|P1|Phase I: Period 1|Withdrawal by Subject|0
5114124|NCT01791413|17663259|P2|Overall Study|Lost to Follow-up|1
5114125|NCT01791413|17663260|P1|Overall Study|Lost to Follow-up|5
5114126|NCT01791244|17663269|P2|Overall Study|Laboratory Abnormality|1
5114127|NCT01791244|17663270|P1|Overall Study|Laboratory Abnormality|0
5114128|NCT01791244|17663269|P2|Overall Study|Insufficient clinical response|10
5114129|NCT01791244|17663270|P1|Overall Study|Insufficient clinical response|10
5114130|NCT01791244|17663269|P2|Overall Study|Adverse Event|7
5114131|NCT01791244|17663270|P1|Overall Study|Adverse Event|5
5114132|NCT01791205|17663306|P2|Phase II|Physician's decision|0
5114133|NCT01791205|17663307|P1|Phase II|Physician's decision|1
5114134|NCT01791205|17663306|P2|Phase II|Remission of disease|0
5114135|NCT01791205|17663307|P1|Phase II|Remission of disease|1
5114136|NCT01791205|17663306|P2|Phase II|Lost to Follow-up|0
5114137|NCT01791205|17663307|P1|Phase II|Lost to Follow-up|1
5114138|NCT01791205|17663306|P2|Phase II|Safety|0
5114139|NCT01791205|17663307|P1|Phase II|Safety|1
5114140|NCT01791205|17663306|P2|Phase II|Adverse Event|0
5114141|NCT01791205|17663307|P1|Phase II|Adverse Event|2
5114142|NCT01791205|17663306|P2|Phase II|Lack of Efficacy|0
5114143|NCT01791205|17663307|P1|Phase II|Lack of Efficacy|6
5114144|NCT01791153|17663391|P8|Part 2: Open-label Period|Physician Decision|0
5114145|NCT01791153|17663392|P7|Part 2: Open-label Period|Physician Decision|0
5114146|NCT01791153|17663393|P6|Part 2: Open-label Period|Physician Decision|1
5114147|NCT01791153|17663394|P5|Part 2: Open-label Period|Physician Decision|1
5114148|NCT01791153|17663395|P4|Part 2: Open-label Period|Physician Decision|0
5114149|NCT01791153|17663396|P3|Part 2: Open-label Period|Physician Decision|0
5114150|NCT01791153|17663397|P2|Part 2: Open-label Period|Physician Decision|0
5114151|NCT01791153|17663398|P1|Part 2: Open-label Period|Physician Decision|0
5114152|NCT01791153|17663391|P8|Part 2: Open-label Period|Withdrawal by Subject|2
5114153|NCT01791153|17663392|P7|Part 2: Open-label Period|Withdrawal by Subject|3
5114154|NCT01791153|17663393|P6|Part 2: Open-label Period|Withdrawal by Subject|1
5114155|NCT01791153|17663394|P5|Part 2: Open-label Period|Withdrawal by Subject|1
5114156|NCT01791153|17663395|P4|Part 2: Open-label Period|Withdrawal by Subject|0
5114157|NCT01791153|17663396|P3|Part 2: Open-label Period|Withdrawal by Subject|0
5114158|NCT01791153|17663397|P2|Part 2: Open-label Period|Withdrawal by Subject|0
5114159|NCT01791153|17663398|P1|Part 2: Open-label Period|Withdrawal by Subject|0
5114160|NCT01791153|17663391|P8|Part 2: Open-label Period|Lack of Efficacy|1
5114161|NCT01791153|17663392|P7|Part 2: Open-label Period|Lack of Efficacy|0
5114162|NCT01791153|17663393|P6|Part 2: Open-label Period|Lack of Efficacy|0
5114163|NCT01791153|17663394|P5|Part 2: Open-label Period|Lack of Efficacy|0
5114164|NCT01791153|17663395|P4|Part 2: Open-label Period|Lack of Efficacy|0
5114165|NCT01791153|17663396|P3|Part 2: Open-label Period|Lack of Efficacy|0
5114166|NCT01791153|17663397|P2|Part 2: Open-label Period|Lack of Efficacy|0
5114167|NCT01791153|17663398|P1|Part 2: Open-label Period|Lack of Efficacy|0
5114168|NCT01791153|17663391|P8|Part 2: Open-label Period|Lost to Follow-up|0
5114169|NCT01791153|17663392|P7|Part 2: Open-label Period|Lost to Follow-up|1
5114170|NCT01791153|17663393|P6|Part 2: Open-label Period|Lost to Follow-up|0
5114171|NCT01791153|17663394|P5|Part 2: Open-label Period|Lost to Follow-up|0
5114172|NCT01791153|17663395|P4|Part 2: Open-label Period|Lost to Follow-up|0
5114173|NCT01791153|17663396|P3|Part 2: Open-label Period|Lost to Follow-up|0
5114174|NCT01791153|17663397|P2|Part 2: Open-label Period|Lost to Follow-up|0
5114175|NCT01791153|17663398|P1|Part 2: Open-label Period|Lost to Follow-up|0
5114176|NCT01791153|17663391|P8|Part 2: Open-label Period|Death|1
5114177|NCT01791153|17663392|P7|Part 2: Open-label Period|Death|1
5114178|NCT01791153|17663393|P6|Part 2: Open-label Period|Death|1
5114180|NCT01791153|17663395|P4|Part 2: Open-label Period|Death|0
5114181|NCT01791153|17663396|P3|Part 2: Open-label Period|Death|0
5114182|NCT01791153|17663397|P2|Part 2: Open-label Period|Death|0
5114183|NCT01791153|17663398|P1|Part 2: Open-label Period|Death|0
5114184|NCT01791153|17663391|P8|Part 2: Open-label Period|Adverse Event|2
5114185|NCT01791153|17663392|P7|Part 2: Open-label Period|Adverse Event|1
5114186|NCT01791153|17663393|P6|Part 2: Open-label Period|Adverse Event|1
5114187|NCT01791153|17663394|P5|Part 2: Open-label Period|Adverse Event|0
5114188|NCT01791153|17663395|P4|Part 2: Open-label Period|Adverse Event|0
5114189|NCT01791153|17663396|P3|Part 2: Open-label Period|Adverse Event|0
5114190|NCT01791153|17663397|P2|Part 2: Open-label Period|Adverse Event|0
5114191|NCT01791153|17663398|P1|Part 2: Open-label Period|Adverse Event|0
5114192|NCT01791153|17663391|P8|Part 1: Blinded Period|Withdrawal by Subject|0
5114193|NCT01791153|17663392|P7|Part 1: Blinded Period|Withdrawal by Subject|0
5114194|NCT01791153|17663393|P6|Part 1: Blinded Period|Withdrawal by Subject|0
5114195|NCT01791153|17663394|P5|Part 1: Blinded Period|Withdrawal by Subject|0
5114196|NCT01791153|17663395|P4|Part 1: Blinded Period|Withdrawal by Subject|1
5114197|NCT01791153|17663396|P3|Part 1: Blinded Period|Withdrawal by Subject|2
5114198|NCT01791153|17663397|P2|Part 1: Blinded Period|Withdrawal by Subject|2
5114199|NCT01791153|17663398|P1|Part 1: Blinded Period|Withdrawal by Subject|6
5114200|NCT01791153|17663391|P8|Part 1: Blinded Period|Protocol Violation|0
5114201|NCT01791153|17663392|P7|Part 1: Blinded Period|Protocol Violation|0
5114202|NCT01791153|17663393|P6|Part 1: Blinded Period|Protocol Violation|0
5114203|NCT01791153|17663394|P5|Part 1: Blinded Period|Protocol Violation|0
5114204|NCT01791153|17663395|P4|Part 1: Blinded Period|Protocol Violation|1
5114205|NCT01791153|17663396|P3|Part 1: Blinded Period|Protocol Violation|0
5114206|NCT01791153|17663397|P2|Part 1: Blinded Period|Protocol Violation|0
5114207|NCT01791153|17663398|P1|Part 1: Blinded Period|Protocol Violation|0
5114208|NCT01791153|17663391|P8|Part 1: Blinded Period|Physician Decision|0
5114209|NCT01791153|17663392|P7|Part 1: Blinded Period|Physician Decision|0
5114210|NCT01791153|17663393|P6|Part 1: Blinded Period|Physician Decision|0
5114211|NCT01791153|17663394|P5|Part 1: Blinded Period|Physician Decision|0
5114212|NCT01791153|17663395|P4|Part 1: Blinded Period|Physician Decision|1
5114213|NCT01791153|17663396|P3|Part 1: Blinded Period|Physician Decision|0
5114214|NCT01791153|17663397|P2|Part 1: Blinded Period|Physician Decision|0
5114215|NCT01791153|17663398|P1|Part 1: Blinded Period|Physician Decision|0
5114216|NCT01791153|17663391|P8|Part 1: Blinded Period|Non-Compliance|0
5114217|NCT01791153|17663392|P7|Part 1: Blinded Period|Non-Compliance|0
5114218|NCT01791153|17663393|P6|Part 1: Blinded Period|Non-Compliance|0
5114219|NCT01791153|17663394|P5|Part 1: Blinded Period|Non-Compliance|0
5114220|NCT01791153|17663395|P4|Part 1: Blinded Period|Non-Compliance|0
5114221|NCT01791153|17663396|P3|Part 1: Blinded Period|Non-Compliance|0
5114222|NCT01791153|17663397|P2|Part 1: Blinded Period|Non-Compliance|0
5114223|NCT01791153|17663398|P1|Part 1: Blinded Period|Non-Compliance|1
5114224|NCT01791153|17663391|P8|Part 1: Blinded Period|Lack of Efficacy|0
5114225|NCT01791153|17663392|P7|Part 1: Blinded Period|Lack of Efficacy|0
5114226|NCT01791153|17663393|P6|Part 1: Blinded Period|Lack of Efficacy|0
5114227|NCT01791153|17663394|P5|Part 1: Blinded Period|Lack of Efficacy|0
5114228|NCT01791153|17663395|P4|Part 1: Blinded Period|Lack of Efficacy|2
5114229|NCT01791153|17663396|P3|Part 1: Blinded Period|Lack of Efficacy|2
5114230|NCT01791153|17663397|P2|Part 1: Blinded Period|Lack of Efficacy|3
5114231|NCT01791153|17663398|P1|Part 1: Blinded Period|Lack of Efficacy|1
5114232|NCT01791153|17663391|P8|Part 1: Blinded Period|Adverse Event|0
5114233|NCT01791153|17663392|P7|Part 1: Blinded Period|Adverse Event|0
5114234|NCT01791153|17663393|P6|Part 1: Blinded Period|Adverse Event|0
5114235|NCT01791153|17663394|P5|Part 1: Blinded Period|Adverse Event|0
5114236|NCT01791153|17663395|P4|Part 1: Blinded Period|Adverse Event|0
5114237|NCT01791153|17663396|P3|Part 1: Blinded Period|Adverse Event|2
5114238|NCT01791153|17663397|P2|Part 1: Blinded Period|Adverse Event|3
5114239|NCT01791153|17663398|P1|Part 1: Blinded Period|Adverse Event|7
5114240|NCT01791127|17663458|P1|Overall Study|Study terminated for EP Passion|749
5114241|NCT01791127|17663458|P1|Overall Study|Completion of 30 day safety registry|1
5114242|NCT01791127|17663458|P1|Overall Study|All Siello leads are explanted|31
5114243|NCT01791127|17663458|P1|Overall Study|Lost to Follow-up|42
5114244|NCT01791127|17663458|P1|Overall Study|Patient has withdrawn from study|293
5114245|NCT01791127|17663458|P1|Overall Study|Death|356
5114246|NCT01790932|17663482|P1|Overall Study|Withdrawal by Subject|1
5114247|NCT01790932|17663482|P1|Overall Study|Physician Decision|1
5114248|NCT01790932|17663482|P1|Overall Study|Adverse Event|7
5114249|NCT01790932|17663482|P1|Overall Study|Disease Progression|41
5114250|NCT01790828|17663488|P1|Overall Study|Other|34
5114251|NCT01790633|17663546|P2|Overall Study|RT failure and no follow-up ELISA|3
5114252|NCT01790633|17663547|P1|Overall Study|RT failure and no follow-up ELISA|0
5114253|NCT01790633|17663546|P2|Overall Study|Did not have serology performed|0
5114254|NCT01790633|17663547|P1|Overall Study|Did not have serology performed|47
5114255|NCT01790633|17663546|P2|Overall Study|Protocol Violation|2
5114256|NCT01790633|17663547|P1|Overall Study|Protocol Violation|1
5114257|NCT01790594|17663560|P3|Overall Study|Terminated prior to week 76|0
5114258|NCT01790594|17663561|P2|Overall Study|Terminated prior to week 76|2
5114259|NCT01790594|17663562|P1|Overall Study|Terminated prior to week 76|0
5114260|NCT01790594|17663560|P3|Overall Study|Transplant was not done|3
5114261|NCT01790594|17663561|P2|Overall Study|Transplant was not done|0
5114262|NCT01790594|17663562|P1|Overall Study|Transplant was not done|0
5114263|NCT01790594|17663560|P3|Overall Study|Withdrawal by Subject|0
5114264|NCT01790594|17663561|P2|Overall Study|Withdrawal by Subject|0
5114265|NCT01790594|17663562|P1|Overall Study|Withdrawal by Subject|2
5114266|NCT01790594|17663560|P3|Overall Study|Physician Decision|0
5114267|NCT01790594|17663561|P2|Overall Study|Physician Decision|1
5114268|NCT01790594|17663562|P1|Overall Study|Physician Decision|2
5114269|NCT01790594|17663560|P3|Overall Study|Death|0
5114270|NCT01790594|17663561|P2|Overall Study|Death|0
5114271|NCT01790594|17663562|P1|Overall Study|Death|1
5114272|NCT01790568|17663639|P2|Overall Study|Progression prior to transplant|1
5114273|NCT01790568|17663640|P1|Overall Study|Progression prior to transplant|0
5114274|NCT01790516|17663648|P2|Overall Study|Physician Decision|0
5114275|NCT01790516|17663649|P1|Overall Study|Physician Decision|1
5114276|NCT01790503|17663666|P11|Overall Study|Other|0
5114277|NCT01790503|17663667|P10|Overall Study|Other|2
5114278|NCT01790503|17663668|P9|Overall Study|Other|1
5114279|NCT01790503|17663669|P8|Overall Study|Other|0
5114280|NCT01790503|17663670|P7|Overall Study|Other|0
5114281|NCT01790503|17663671|P6|Overall Study|Other|0
5114282|NCT01790503|17663672|P5|Overall Study|Other|1
5114283|NCT01790503|17663673|P4|Overall Study|Other|0
5114284|NCT01790503|17663674|P3|Overall Study|Other|0
5114285|NCT01790503|17663675|P2|Overall Study|Other|0
5114286|NCT01790503|17663676|P1|Overall Study|Other|0
5114287|NCT01790503|17663666|P11|Overall Study|Non Compliance|0
5114288|NCT01790503|17663667|P10|Overall Study|Non Compliance|0
5114289|NCT01790503|17663668|P9|Overall Study|Non Compliance|0
5114290|NCT01790503|17663669|P8|Overall Study|Non Compliance|0
5114291|NCT01790503|17663670|P7|Overall Study|Non Compliance|0
5114292|NCT01790503|17663671|P6|Overall Study|Non Compliance|0
5114293|NCT01790503|17663672|P5|Overall Study|Non Compliance|1
5114294|NCT01790503|17663673|P4|Overall Study|Non Compliance|0
5114295|NCT01790503|17663674|P3|Overall Study|Non Compliance|0
5114296|NCT01790503|17663675|P2|Overall Study|Non Compliance|0
5114297|NCT01790503|17663676|P1|Overall Study|Non Compliance|0
5114298|NCT01790503|17663666|P11|Overall Study|Death|0
5114299|NCT01790503|17663667|P10|Overall Study|Death|1
5114300|NCT01790503|17663668|P9|Overall Study|Death|0
5114301|NCT01790503|17663669|P8|Overall Study|Death|0
5114302|NCT01790503|17663670|P7|Overall Study|Death|0
5114303|NCT01790503|17663671|P6|Overall Study|Death|0
5114304|NCT01790503|17663672|P5|Overall Study|Death|0
5114305|NCT01790503|17663673|P4|Overall Study|Death|0
5114306|NCT01790503|17663674|P3|Overall Study|Death|0
5114307|NCT01790503|17663675|P2|Overall Study|Death|0
5114308|NCT01790503|17663676|P1|Overall Study|Death|0
5114309|NCT01790503|17663666|P11|Overall Study|Physician Decision|1
5114310|NCT01790503|17663667|P10|Overall Study|Physician Decision|1
5114311|NCT01790503|17663668|P9|Overall Study|Physician Decision|0
5114312|NCT01790503|17663669|P8|Overall Study|Physician Decision|0
5114313|NCT01790503|17663670|P7|Overall Study|Physician Decision|0
5114314|NCT01790503|17663671|P6|Overall Study|Physician Decision|0
5114315|NCT01790503|17663672|P5|Overall Study|Physician Decision|0
5114316|NCT01790503|17663673|P4|Overall Study|Physician Decision|0
5114317|NCT01790503|17663674|P3|Overall Study|Physician Decision|0
5114318|NCT01790503|17663675|P2|Overall Study|Physician Decision|0
5114319|NCT01790503|17663676|P1|Overall Study|Physician Decision|0
5114320|NCT01790503|17663666|P11|Overall Study|Protocol Violation|0
5114321|NCT01790503|17663667|P10|Overall Study|Protocol Violation|1
5114322|NCT01790503|17663668|P9|Overall Study|Protocol Violation|0
5114323|NCT01790503|17663669|P8|Overall Study|Protocol Violation|0
5114324|NCT01790503|17663670|P7|Overall Study|Protocol Violation|0
5114325|NCT01790503|17663671|P6|Overall Study|Protocol Violation|0
5114326|NCT01790503|17663672|P5|Overall Study|Protocol Violation|0
5114327|NCT01790503|17663673|P4|Overall Study|Protocol Violation|0
5114328|NCT01790503|17663674|P3|Overall Study|Protocol Violation|0
5114329|NCT01790503|17663675|P2|Overall Study|Protocol Violation|0
5114330|NCT01790503|17663676|P1|Overall Study|Protocol Violation|0
5114331|NCT01790503|17663666|P11|Overall Study|Disease progression|7
5114332|NCT01790503|17663667|P10|Overall Study|Disease progression|17
5114333|NCT01790503|17663668|P9|Overall Study|Disease progression|0
5114334|NCT01790503|17663669|P8|Overall Study|Disease progression|1
5114335|NCT01790503|17663670|P7|Overall Study|Disease progression|0
5114336|NCT01790503|17663671|P6|Overall Study|Disease progression|1
5114337|NCT01790503|17663672|P5|Overall Study|Disease progression|2
5114338|NCT01790503|17663673|P4|Overall Study|Disease progression|1
5114339|NCT01790503|17663674|P3|Overall Study|Disease progression|0
5114340|NCT01790503|17663675|P2|Overall Study|Disease progression|1
5114341|NCT01790503|17663676|P1|Overall Study|Disease progression|2
5114342|NCT01790503|17663666|P11|Overall Study|Withdrawal by Subject|1
5114343|NCT01790503|17663667|P10|Overall Study|Withdrawal by Subject|0
5114344|NCT01790503|17663668|P9|Overall Study|Withdrawal by Subject|0
5114345|NCT01790503|17663669|P8|Overall Study|Withdrawal by Subject|0
5114346|NCT01790503|17663670|P7|Overall Study|Withdrawal by Subject|1
5114347|NCT01790503|17663671|P6|Overall Study|Withdrawal by Subject|2
5114348|NCT01790503|17663672|P5|Overall Study|Withdrawal by Subject|1
5114349|NCT01790503|17663673|P4|Overall Study|Withdrawal by Subject|1
5114350|NCT01790503|17663674|P3|Overall Study|Withdrawal by Subject|1
5114351|NCT01790503|17663675|P2|Overall Study|Withdrawal by Subject|0
5114352|NCT01790503|17663676|P1|Overall Study|Withdrawal by Subject|0
5114353|NCT01790503|17663666|P11|Overall Study|Adverse Event|7
5114354|NCT01790503|17663667|P10|Overall Study|Adverse Event|4
5114355|NCT01790503|17663668|P9|Overall Study|Adverse Event|2
5114356|NCT01790503|17663669|P8|Overall Study|Adverse Event|0
5114357|NCT01790503|17663670|P7|Overall Study|Adverse Event|0
5114358|NCT01790503|17663671|P6|Overall Study|Adverse Event|2
5114359|NCT01790503|17663672|P5|Overall Study|Adverse Event|0
5114360|NCT01790503|17663673|P4|Overall Study|Adverse Event|0
5114361|NCT01790503|17663674|P3|Overall Study|Adverse Event|0
5114362|NCT01790503|17663675|P2|Overall Study|Adverse Event|0
5114363|NCT01790503|17663676|P1|Overall Study|Adverse Event|1
5114364|NCT01790438|17663746|P2|Overall Study|Protocol Required Discontinuation|1
5114365|NCT01790438|17663747|P1|Overall Study|Protocol Required Discontinuation|7
5114366|NCT01790438|17663746|P2|Overall Study|Sponsor Decision|3
5114367|NCT01790438|17663747|P1|Overall Study|Sponsor Decision|0
5114368|NCT01790438|17663746|P2|Overall Study|Physician Decision|1
5114369|NCT01790438|17663747|P1|Overall Study|Physician Decision|3
5114370|NCT01790438|17663746|P2|Overall Study|Withdrawal by Subject|2
5114371|NCT01790438|17663747|P1|Overall Study|Withdrawal by Subject|13
5114372|NCT01790438|17663746|P2|Overall Study|Lost to Follow-up|2
5114373|NCT01790438|17663747|P1|Overall Study|Lost to Follow-up|5
5114374|NCT01790438|17663746|P2|Overall Study|Death|0
5114375|NCT01790438|17663747|P1|Overall Study|Death|4
5114376|NCT01790438|17663746|P2|Overall Study|Adverse Event|2
5114377|NCT01790438|17663747|P1|Overall Study|Adverse Event|3
5114378|NCT01790295|17663797|P1|Overall Study|Study closure|4
5114379|NCT01790295|17663797|P1|Overall Study|Lack of Efficacy|2
5114380|NCT01790295|17663797|P1|Overall Study|Death|4
5114381|NCT01790295|17663797|P1|Overall Study|Adverse Event|1
5114382|NCT01790126|17663867|P3|Overall Study|Radiographic Progression|0
5114383|NCT01790126|17663868|P2|Overall Study|Radiographic Progression|1
5114384|NCT01790126|17663869|P1|Overall Study|Radiographic Progression|3
5114385|NCT01790126|17663867|P3|Overall Study|Death|0
5114386|NCT01790126|17663868|P2|Overall Study|Death|0
5114387|NCT01790126|17663869|P1|Overall Study|Death|2
5114388|NCT01790126|17663867|P3|Overall Study|Adverse Event|0
5114389|NCT01790126|17663868|P2|Overall Study|Adverse Event|2
5114390|NCT01790126|17663869|P1|Overall Study|Adverse Event|0
5114391|NCT01790126|17663867|P3|Overall Study|Lost to Follow-up|1
5114392|NCT01790126|17663868|P2|Overall Study|Lost to Follow-up|0
5114393|NCT01790126|17663869|P1|Overall Study|Lost to Follow-up|1
5114394|NCT01790126|17663867|P3|Overall Study|Withdrawal by Subject|2
5114395|NCT01790126|17663868|P2|Overall Study|Withdrawal by Subject|1
5114396|NCT01790126|17663869|P1|Overall Study|Withdrawal by Subject|3
5114397|NCT01790126|17663867|P3|Overall Study|Withdrawal by Physician|2
5114398|NCT01790126|17663868|P2|Overall Study|Withdrawal by Physician|1
5114399|NCT01790126|17663869|P1|Overall Study|Withdrawal by Physician|1
5114400|NCT01790126|17663867|P3|Overall Study|Initiation of Non-Protocol Therapy|2
5114401|NCT01790126|17663868|P2|Overall Study|Initiation of Non-Protocol Therapy|4
5114402|NCT01790126|17663869|P1|Overall Study|Initiation of Non-Protocol Therapy|3
5114403|NCT01790126|17663867|P3|Overall Study|Other|8
5114404|NCT01790126|17663868|P2|Overall Study|Other|4
5114405|NCT01790126|17663869|P1|Overall Study|Other|5
5114406|NCT01790126|17663867|P3|Overall Study|PSA Progression|16
5114407|NCT01790126|17663868|P2|Overall Study|PSA Progression|16
5114408|NCT01790126|17663869|P1|Overall Study|PSA Progression|12
5114409|NCT01790048|17663926|P2|Overall Study|Measurement error|0
5114410|NCT01790048|17663927|P1|Overall Study|Measurement error|1
5114411|NCT01790048|17663926|P2|Overall Study|SAM at Enrollment|0
5114412|NCT01790048|17663927|P1|Overall Study|SAM at Enrollment|2
5114413|NCT01790048|17663926|P2|Overall Study|Other|2
5114414|NCT01790048|17663927|P1|Overall Study|Other|0
5114415|NCT01790048|17663926|P2|Overall Study|data entry error|1
5114416|NCT01790048|17663927|P1|Overall Study|data entry error|0
5114417|NCT01790048|17663926|P2|Overall Study|Incorrect Age|14
5114418|NCT01790048|17663927|P1|Overall Study|Incorrect Age|9
5114419|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
5114420|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
5114421|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
5114422|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Other|3
5114423|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Other|1
5114424|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Other|0
5114425|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
5114426|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
5114427|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
5114428|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
5114429|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
5114430|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
5114431|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
5114432|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
5114433|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
5114434|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
5114435|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
5114436|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
5114437|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
5114438|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
5114439|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
5114440|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
5114441|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
5114442|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5114443|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
5114444|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
5114445|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5114446|NCT01789970|17663945|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
5114447|NCT01789970|17663946|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
5114448|NCT01789970|17663947|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
5114449|NCT01789970|17663945|P3|Open-label Titration Period|Dropped out prior to dosing|0
5114450|NCT01789970|17663946|P2|Open-label Titration Period|Dropped out prior to dosing|0
5114451|NCT01789970|17663947|P1|Open-label Titration Period|Dropped out prior to dosing|2
5114452|NCT01789970|17663945|P3|Open-label Titration Period|Other|0
5114453|NCT01789970|17663946|P2|Open-label Titration Period|Other|0
5114454|NCT01789970|17663947|P1|Open-label Titration Period|Other|76
5114455|NCT01789970|17663945|P3|Open-label Titration Period|Pregnancy|0
5114456|NCT01789970|17663946|P2|Open-label Titration Period|Pregnancy|0
5114457|NCT01789970|17663947|P1|Open-label Titration Period|Pregnancy|2
5114458|NCT01789970|17663945|P3|Open-label Titration Period|Noncompliance with study procedures|0
5114459|NCT01789970|17663946|P2|Open-label Titration Period|Noncompliance with study procedures|0
5114460|NCT01789970|17663947|P1|Open-label Titration Period|Noncompliance with study procedures|8
5114461|NCT01789970|17663945|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
5114462|NCT01789970|17663946|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
5114463|NCT01789970|17663947|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
5114464|NCT01789970|17663945|P3|Open-label Titration Period|Noncompliance to study drug admin|0
5114465|NCT01789970|17663946|P2|Open-label Titration Period|Noncompliance to study drug admin|0
5114466|NCT01789970|17663947|P1|Open-label Titration Period|Noncompliance to study drug admin|11
5114467|NCT01789970|17663945|P3|Open-label Titration Period|Lost to Follow-up|0
5114468|NCT01789970|17663946|P2|Open-label Titration Period|Lost to Follow-up|0
5114469|NCT01789970|17663947|P1|Open-label Titration Period|Lost to Follow-up|5
5114470|NCT01789970|17663945|P3|Open-label Titration Period|Protocol Violation|0
5114471|NCT01789970|17663946|P2|Open-label Titration Period|Protocol Violation|0
5114472|NCT01789970|17663947|P1|Open-label Titration Period|Protocol Violation|18
5114473|NCT01789970|17663945|P3|Open-label Titration Period|Withdrawal by Subject|0
5114474|NCT01789970|17663946|P2|Open-label Titration Period|Withdrawal by Subject|0
5114475|NCT01789970|17663947|P1|Open-label Titration Period|Withdrawal by Subject|31
5114476|NCT01789970|17663945|P3|Open-label Titration Period|Lack of Efficacy|0
5114477|NCT01789970|17663946|P2|Open-label Titration Period|Lack of Efficacy|0
5114478|NCT01789970|17663947|P1|Open-label Titration Period|Lack of Efficacy|31
5114479|NCT01789970|17663945|P3|Open-label Titration Period|Adverse Event|0
5114480|NCT01789970|17663946|P2|Open-label Titration Period|Adverse Event|0
5114481|NCT01789970|17663947|P1|Open-label Titration Period|Adverse Event|68
5114482|NCT01789606|17664005|P2|Overall Study|Ineligible or not Willing to Continue|348
5114483|NCT01789606|17664006|P1|Overall Study|Ineligible or not Willing to Continue|0
5114484|NCT01789606|17664005|P2|Overall Study|Lost to Follow-up|14
5114485|NCT01789606|17664006|P1|Overall Study|Lost to Follow-up|0
5114486|NCT01789606|17664005|P2|Overall Study|Adverse Event|3
5114487|NCT01789606|17664006|P1|Overall Study|Adverse Event|0
5114488|NCT01789606|17664005|P2|Overall Study|Protocol Violation|55
5114489|NCT01789606|17664006|P1|Overall Study|Protocol Violation|0
5114490|NCT01789606|17664005|P2|Overall Study|No Study Medication Taken|1
5114491|NCT01789606|17664006|P1|Overall Study|No Study Medication Taken|0
5114492|NCT01789606|17664005|P2|Overall Study|Administrative Reasons|6
5114493|NCT01789606|17664006|P1|Overall Study|Administrative Reasons|17
5114494|NCT01789606|17664005|P2|Overall Study|Ineligible|2
5114495|NCT01789606|17664006|P1|Overall Study|Ineligible|6
5114496|NCT01789606|17664005|P2|Overall Study|Withdrawal by Subject|1
5114497|NCT01789606|17664006|P1|Overall Study|Withdrawal by Subject|0
5114498|NCT01789606|17664005|P2|Overall Study|Participant not Purchased the Product|20
5114499|NCT01789606|17664006|P1|Overall Study|Participant not Purchased the Product|0
5114500|NCT01789567|17664024|P1|Overall Study|Death|6
5114501|NCT01789476|17664033|P2|Overall Study|Unable to get IV access|0
5114502|NCT01789476|17664034|P1|Overall Study|Unable to get IV access|1
5114503|NCT01789476|17664033|P2|Overall Study|Adverse Event|0
5114504|NCT01789476|17664034|P1|Overall Study|Adverse Event|1
5114505|NCT01789476|17664033|P2|Overall Study|Lack of Efficacy|2
5114506|NCT01789476|17664034|P1|Overall Study|Lack of Efficacy|6
5114507|NCT01789203|17664056|P2|Overall Study|patient non-adherent|0
5114508|NCT01789203|17664057|P1|Overall Study|patient non-adherent|2
5114509|NCT01789203|17664056|P2|Overall Study|Other|1
5114510|NCT01789203|17664057|P1|Overall Study|Other|1
5114511|NCT01789203|17664056|P2|Overall Study|Protocol Violation|1
5114512|NCT01789203|17664057|P1|Overall Study|Protocol Violation|2
5114513|NCT01789203|17664056|P2|Overall Study|Death|0
5114514|NCT01789203|17664057|P1|Overall Study|Death|1
5114515|NCT01789203|17664056|P2|Overall Study|Withdrawal by Subject|0
5114516|NCT01789203|17664057|P1|Overall Study|Withdrawal by Subject|1
5114517|NCT01789203|17664056|P2|Overall Study|Adverse Event|2
5114518|NCT01789203|17664057|P1|Overall Study|Adverse Event|2
5114519|NCT01789047|17664098|P2|Overall Study|Withdrawal by Subject|2
5114520|NCT01789047|17664099|P1|Overall Study|Withdrawal by Subject|1
5114521|NCT01789047|17664098|P2|Overall Study|Adverse Event|2
5114522|NCT01789047|17664099|P1|Overall Study|Adverse Event|3
5114523|NCT01788943|17664107|P2|Overall Study|Withdrawal by Subject|0
5114524|NCT01788943|17664108|P1|Overall Study|Withdrawal by Subject|1
5114525|NCT01788566|17664137|P1|Overall Study|Clinical Progressive Disease|3
5114526|NCT01788566|17664137|P1|Overall Study|Adverse Event|1
5114527|NCT01788566|17664137|P1|Overall Study|Death|4
5114528|NCT01788423|17664175|P3|Overall Study|See Comments in Completed (above)|5
5114529|NCT01788423|17664176|P2|Overall Study|See Comments in Completed (above)|4
5114530|NCT01788423|17664177|P1|Overall Study|See Comments in Completed (above)|0
5114531|NCT01788358|17664188|P1|Overall Study|Adverse Event|51
5114532|NCT01788358|17664188|P1|Overall Study|Lack of Efficacy|1
5114533|NCT01788358|17664188|P1|Overall Study|Withdrawal by Subject|26
5114534|NCT01788358|17664188|P1|Overall Study|Protocol Violation|3
5114535|NCT01788358|17664188|P1|Overall Study|Lost to Follow-up|5
5114536|NCT01788358|17664188|P1|Overall Study|Logistical difficulties|1
5114537|NCT01788358|17664188|P1|Overall Study|Other|11
5114538|NCT01788228|17664202|P2|Overall Study|Migrated/moved from study area|0
5114539|NCT01788228|17664203|P1|Overall Study|Migrated/moved from study area|1
5114540|NCT01788215|17664236|P2|Overall Study|Lost to Follow-up|0
5114541|NCT01788215|17664237|P1|Overall Study|Lost to Follow-up|2
5114542|NCT01788215|17664236|P2|Overall Study|Withdrawal by Subject|1
5114543|NCT01788215|17664237|P1|Overall Study|Withdrawal by Subject|0
5114544|NCT01788163|17664266|P9|Overall Study|Withdrawal by Subject|1
5114545|NCT01788163|17664267|P8|Overall Study|Withdrawal by Subject|0
5114546|NCT01788163|17664268|P7|Overall Study|Withdrawal by Subject|0
5114547|NCT01788163|17664269|P6|Overall Study|Withdrawal by Subject|0
5114548|NCT01788163|17664270|P5|Overall Study|Withdrawal by Subject|0
5114549|NCT01788163|17664271|P4|Overall Study|Withdrawal by Subject|0
5114550|NCT01788163|17664272|P3|Overall Study|Withdrawal by Subject|0
5114551|NCT01788163|17664273|P2|Overall Study|Withdrawal by Subject|0
5114552|NCT01788163|17664274|P1|Overall Study|Withdrawal by Subject|2
5114553|NCT01788163|17664266|P9|Overall Study|Other|15
5114554|NCT01788163|17664267|P8|Overall Study|Other|48
5114555|NCT01788163|17664268|P7|Overall Study|Other|1
5114556|NCT01788163|17664269|P6|Overall Study|Other|7
5114557|NCT01788163|17664270|P5|Overall Study|Other|0
5114558|NCT01788163|17664271|P4|Overall Study|Other|0
5114559|NCT01788163|17664272|P3|Overall Study|Other|0
5114560|NCT01788163|17664273|P2|Overall Study|Other|0
5114561|NCT01788163|17664274|P1|Overall Study|Other|53
5114562|NCT01788046|17664437|P2|Overall Study|Protocol Specified Criteria|1
5114563|NCT01788046|17664438|P1|Overall Study|Protocol Specified Criteria|25
5114564|NCT01788046|17664437|P2|Overall Study|Death|5
5114565|NCT01788046|17664438|P1|Overall Study|Death|7
5114566|NCT01788046|17664437|P2|Overall Study|Lost to Follow-up|19
5114567|NCT01788046|17664438|P1|Overall Study|Lost to Follow-up|12
5114568|NCT01788046|17664437|P2|Overall Study|Withdrawal by Subject|12
5114569|NCT01788046|17664438|P1|Overall Study|Withdrawal by Subject|12
5114570|NCT01787838|17664461|P1|Overall Study|refused|1413
5114571|NCT01787825|17664465|P2|Overall Study|Data Not Analyzable|1
5114572|NCT01787825|17664466|P1|Overall Study|Data Not Analyzable|5
5114573|NCT01787825|17664465|P2|Overall Study|Subject Did Not Ingest Capsules|0
5114574|NCT01787825|17664466|P1|Overall Study|Subject Did Not Ingest Capsules|1
5114575|NCT01787760|17664484|P3|Overall Study|Near vision blur|0
5114576|NCT01787760|17664485|P2|Overall Study|Near vision blur|0
5114577|NCT01787760|17664486|P1|Overall Study|Near vision blur|1
5114578|NCT01787760|17664484|P3|Overall Study|Unsatisfactory visual response|0
5114579|NCT01787760|17664485|P2|Overall Study|Unsatisfactory visual response|1
5114580|NCT01787760|17664486|P1|Overall Study|Unsatisfactory visual response|1
5114581|NCT01787760|17664484|P3|Overall Study|Unsatisfactory physiological response|0
5114582|NCT01787760|17664485|P2|Overall Study|Unsatisfactory physiological response|4
5114583|NCT01787760|17664486|P1|Overall Study|Unsatisfactory physiological response|2
5114584|NCT01787760|17664484|P3|Overall Study|Unsatisfactory lens fitting performance|0
5114585|NCT01787760|17664485|P2|Overall Study|Unsatisfactory lens fitting performance|6
5114586|NCT01787760|17664486|P1|Overall Study|Unsatisfactory lens fitting performance|3
5114587|NCT01787760|17664484|P3|Overall Study|Stroke|0
5114588|NCT01787760|17664485|P2|Overall Study|Stroke|0
5114589|NCT01787760|17664486|P1|Overall Study|Stroke|1
5114590|NCT01787760|17664484|P3|Overall Study|Lost to Follow-up|1
5114591|NCT01787760|17664485|P2|Overall Study|Lost to Follow-up|0
5114592|NCT01787760|17664486|P1|Overall Study|Lost to Follow-up|1
5114593|NCT01787760|17664484|P3|Overall Study|Withdrawal by Subject|2
5114594|NCT01787760|17664485|P2|Overall Study|Withdrawal by Subject|1
5114595|NCT01787760|17664486|P1|Overall Study|Withdrawal by Subject|5
5114596|NCT01787760|17664484|P3|Overall Study|Protocol Violation|1
5114597|NCT01787760|17664485|P2|Overall Study|Protocol Violation|0
5114598|NCT01787760|17664486|P1|Overall Study|Protocol Violation|6
5114599|NCT01787760|17664484|P3|Overall Study|Lens handling difficulty|0
5114600|NCT01787760|17664485|P2|Overall Study|Lens handling difficulty|2
5114601|NCT01787760|17664486|P1|Overall Study|Lens handling difficulty|1
5114602|NCT01787760|17664484|P3|Overall Study|Lens discomfort|0
5114603|NCT01787760|17664485|P2|Overall Study|Lens discomfort|0
5114604|NCT01787760|17664486|P1|Overall Study|Lens discomfort|3
5114605|NCT01787760|17664484|P3|Overall Study|Relocation|0
5114606|NCT01787760|17664485|P2|Overall Study|Relocation|1
5114607|NCT01787760|17664486|P1|Overall Study|Relocation|1
5114608|NCT01787760|17664484|P3|Overall Study|Dryness|0
5114609|NCT01787760|17664485|P2|Overall Study|Dryness|1
5114610|NCT01787760|17664486|P1|Overall Study|Dryness|0
5114611|NCT01787760|17664484|P3|Overall Study|Decompensated on left exotropia|1
5114612|NCT01787760|17664485|P2|Overall Study|Decompensated on left exotropia|0
5114613|NCT01787760|17664486|P1|Overall Study|Decompensated on left exotropia|0
5114614|NCT01787760|17664484|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
5114615|NCT01787760|17664485|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
5114616|NCT01787760|17664486|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
5114617|NCT01787591|17664511|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
5114618|NCT01787591|17664512|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5114619|NCT01787591|17664513|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5114620|NCT01787591|17664514|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5114621|NCT01787552|17664544|P4|Overall Study|Progressive Disease|1
5114622|NCT01787552|17664545|P3|Overall Study|Progressive Disease|1
5114623|NCT01787552|17664546|P2|Overall Study|Progressive Disease|2
5114624|NCT01787552|17664547|P1|Overall Study|Progressive Disease|2
5114625|NCT01787552|17664544|P4|Overall Study|Study terminated by Sponsor|3
5114626|NCT01787552|17664545|P3|Overall Study|Study terminated by Sponsor|1
5114627|NCT01787552|17664546|P2|Overall Study|Study terminated by Sponsor|0
5114628|NCT01787552|17664547|P1|Overall Study|Study terminated by Sponsor|0
5114629|NCT01787552|17664544|P4|Overall Study|Adverse Event|16
5114630|NCT01787552|17664545|P3|Overall Study|Adverse Event|2
5114631|NCT01787552|17664546|P2|Overall Study|Adverse Event|5
5114632|NCT01787552|17664547|P1|Overall Study|Adverse Event|2
5114633|NCT01787552|17664544|P4|Overall Study|Death|1
5114634|NCT01787552|17664545|P3|Overall Study|Death|0
5114635|NCT01787552|17664546|P2|Overall Study|Death|0
5114636|NCT01787552|17664547|P1|Overall Study|Death|0
5114637|NCT01787552|17664544|P4|Overall Study|Physician Decision|2
5114638|NCT01787552|17664545|P3|Overall Study|Physician Decision|1
5114639|NCT01787552|17664546|P2|Overall Study|Physician Decision|2
5114640|NCT01787552|17664547|P1|Overall Study|Physician Decision|2
5114641|NCT01787552|17664544|P4|Overall Study|Withdrawal by Subject|4
5114642|NCT01787552|17664545|P3|Overall Study|Withdrawal by Subject|0
5114643|NCT01787552|17664546|P2|Overall Study|Withdrawal by Subject|0
5114644|NCT01787552|17664547|P1|Overall Study|Withdrawal by Subject|2
5114645|NCT01787461|17664617|P2|Overall Study|Protocol Violation|0
5114646|NCT01787461|17664618|P1|Overall Study|Protocol Violation|3
5114647|NCT01787461|17664617|P2|Overall Study|Withdrawal by Subject|4
5114648|NCT01787461|17664618|P1|Overall Study|Withdrawal by Subject|3
5114649|NCT01787461|17664617|P2|Overall Study|No longer met eligibility criteria|0
5114650|NCT01787461|17664618|P1|Overall Study|No longer met eligibility criteria|1
5114651|NCT01787461|17664617|P2|Overall Study|Lost to Follow-up|2
5114652|NCT01787461|17664618|P1|Overall Study|Lost to Follow-up|3
5114653|NCT01787461|17664617|P2|Overall Study|Adverse Event|3
5114654|NCT01787461|17664618|P1|Overall Study|Adverse Event|4
5114655|NCT01787331|17664667|P1|Overall Study|Withdrawal by Subject|1
5114656|NCT01787331|17664667|P1|Overall Study|Physician Decision|1
5114657|NCT01787292|17664679|P2|Home Based Exercise Program|Withdrawal by Subject|1
5114658|NCT01787292|17664680|P1|Home Based Exercise Program|Withdrawal by Subject|3
5114659|NCT01787292|17664679|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
5114660|NCT01787292|17664680|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
5114661|NCT01787279|17664697|P1|Overall Study|Lack of Efficacy|1
5114662|NCT01787279|17664697|P1|Overall Study|Lost to Follow-up|2
5114663|NCT01787188|17664723|P3|Overall Study|Other, including patient moved|0
5114664|NCT01787188|17664724|P2|Overall Study|Other, including patient moved|3
5114665|NCT01787188|17664725|P1|Overall Study|Other, including patient moved|0
5114666|NCT01787188|17664723|P3|Overall Study|Lost to Follow-up|2
5114667|NCT01787188|17664724|P2|Overall Study|Lost to Follow-up|2
5114668|NCT01787188|17664725|P1|Overall Study|Lost to Follow-up|1
5114669|NCT01787188|17664723|P3|Overall Study|Protocol Violation|3
5114670|NCT01787188|17664724|P2|Overall Study|Protocol Violation|2
5114671|NCT01787188|17664725|P1|Overall Study|Protocol Violation|3
5114672|NCT01787188|17664723|P3|Overall Study|Withdrawal by Subject|2
5114673|NCT01787188|17664724|P2|Overall Study|Withdrawal by Subject|3
5114674|NCT01787188|17664725|P1|Overall Study|Withdrawal by Subject|4
5114675|NCT01787188|17664723|P3|Overall Study|Non-compliance with Study Drug|0
5114676|NCT01787188|17664724|P2|Overall Study|Non-compliance with Study Drug|1
5114677|NCT01787188|17664725|P1|Overall Study|Non-compliance with Study Drug|0
5114678|NCT01787188|17664723|P3|Overall Study|Lack of Efficacy|5
5114679|NCT01787188|17664724|P2|Overall Study|Lack of Efficacy|3
5114680|NCT01787188|17664725|P1|Overall Study|Lack of Efficacy|7
5114681|NCT01787188|17664723|P3|Overall Study|Adverse Event|6
5114682|NCT01787188|17664724|P2|Overall Study|Adverse Event|4
5114683|NCT01787188|17664725|P1|Overall Study|Adverse Event|2
5114684|NCT01787097|17664791|P4|Overall Study|Withdrawal by Subject|0
5114685|NCT01787097|17664792|P3|Overall Study|Withdrawal by Subject|0
5114686|NCT01787097|17664793|P2|Overall Study|Withdrawal by Subject|0
5114687|NCT01787097|17664794|P1|Overall Study|Withdrawal by Subject|1
5114688|NCT01787032|17664826|P6|Overall Study|Protocol Violation|1
5114689|NCT01787032|17664827|P5|Overall Study|Protocol Violation|1
5114690|NCT01787032|17664828|P4|Overall Study|Protocol Violation|0
5114691|NCT01787032|17664829|P3|Overall Study|Protocol Violation|0
5114692|NCT01787032|17664830|P2|Overall Study|Protocol Violation|0
5114693|NCT01787032|17664831|P1|Overall Study|Protocol Violation|0
5114694|NCT01786993|17664884|P2|Overall Study|Hospice Admission|0
5114695|NCT01786993|17664885|P1|Overall Study|Hospice Admission|1
5114696|NCT01786993|17664884|P2|Overall Study|System Explant|0
5114697|NCT01786993|17664885|P1|Overall Study|System Explant|1
5114698|NCT01786993|17664884|P2|Overall Study|Subject Non-Compliance|0
5114699|NCT01786993|17664885|P1|Overall Study|Subject Non-Compliance|1
5114700|NCT01786993|17664884|P2|Overall Study|Lost to Follow-up|1
5114701|NCT01786993|17664885|P1|Overall Study|Lost to Follow-up|0
5114702|NCT01786993|17664884|P2|Overall Study|Withdrawal by Subject|2
5114703|NCT01786993|17664885|P1|Overall Study|Withdrawal by Subject|3
5114704|NCT01786993|17664884|P2|Overall Study|Death|7
5114705|NCT01786993|17664885|P1|Overall Study|Death|6
5114706|NCT01786707|17664944|P2|Overall Study|Lost to Follow-up|1
5114707|NCT01786707|17664945|P1|Overall Study|Lost to Follow-up|1
5114708|NCT01786668|17664957|P4|Overall Study|Lost to Follow-up|0
5114709|NCT01786668|17664958|P3|Overall Study|Lost to Follow-up|1
5114710|NCT01786668|17664959|P2|Overall Study|Lost to Follow-up|0
5114711|NCT01786668|17664960|P1|Overall Study|Lost to Follow-up|1
5114712|NCT01786668|17664957|P4|Overall Study|Pregnancy|1
5114713|NCT01786668|17664958|P3|Overall Study|Pregnancy|0
5114714|NCT01786668|17664959|P2|Overall Study|Pregnancy|0
5114715|NCT01786668|17664960|P1|Overall Study|Pregnancy|0
5114716|NCT01786668|17664957|P4|Overall Study|Withdrawal by Subject|1
5114717|NCT01786668|17664958|P3|Overall Study|Withdrawal by Subject|3
5114718|NCT01786668|17664959|P2|Overall Study|Withdrawal by Subject|0
5114719|NCT01786668|17664960|P1|Overall Study|Withdrawal by Subject|0
5114720|NCT01786668|17664957|P4|Overall Study|Adverse Event|2
5114721|NCT01786668|17664958|P3|Overall Study|Adverse Event|1
5114722|NCT01786668|17664959|P2|Overall Study|Adverse Event|1
5114723|NCT01786668|17664960|P1|Overall Study|Adverse Event|0
5114724|NCT01786629|17665060|P2|Overall Study|Adverse Event|1
5114725|NCT01786629|17665061|P1|Overall Study|Adverse Event|0
5114726|NCT01786629|17665060|P2|Overall Study|Lack of Efficacy|4
5114727|NCT01786629|17665061|P1|Overall Study|Lack of Efficacy|0
5114728|NCT01786603|17665069|P2|Overall Study|Lost to Follow-up|2
5114729|NCT01786603|17665070|P1|Overall Study|Lost to Follow-up|1
5114730|NCT01786603|17665069|P2|Overall Study|Physician decision to withdraw|7
5114731|NCT01786603|17665070|P1|Overall Study|Physician decision to withdraw|6
5114732|NCT01786603|17665069|P2|Overall Study|Adverse Event|2
5114733|NCT01786603|17665070|P1|Overall Study|Adverse Event|6
5114734|NCT01786603|17665069|P2|Overall Study|Death|1
5114735|NCT01786603|17665070|P1|Overall Study|Death|5
5114736|NCT01786564|17665088|P1|Overall Study|Ineligible|17
5114737|NCT01786564|17665088|P1|Overall Study|Lost to Follow-up|47
5114738|NCT01786551|17665092|P1|Overall Study|Participant withdrew consent|2
5114739|NCT01786330|17665113|P2|Overall Study|Protocol Violation|0
5114740|NCT01786330|17665114|P1|Overall Study|Protocol Violation|1
5114741|NCT01786330|17665113|P2|Overall Study|Excluded intraoperatively|1
5114742|NCT01786330|17665114|P1|Overall Study|Excluded intraoperatively|0
5114743|NCT01786330|17665113|P2|Overall Study|Lost to Follow-up|1
5114744|NCT01786330|17665114|P1|Overall Study|Lost to Follow-up|0
5114745|NCT01786330|17665113|P2|Overall Study|Withdrawal by Subject|1
5114746|NCT01786330|17665114|P1|Overall Study|Withdrawal by Subject|0
5114747|NCT01786174|17665166|P2|Overall Study|Discontinued Study Drug|0
5114748|NCT01786174|17665167|P1|Overall Study|Discontinued Study Drug|2
5114749|NCT01786148|17665196|P2|Overall Study|Incarceration|1
5114750|NCT01786148|17665197|P1|Overall Study|Incarceration|1
5114751|NCT01786148|17665196|P2|Overall Study|Withdrawal by Subject|7
5114752|NCT01786148|17665197|P1|Overall Study|Withdrawal by Subject|0
5114753|NCT01786148|17665196|P2|Overall Study|Death|1
5114754|NCT01786148|17665197|P1|Overall Study|Death|0
5114755|NCT01786148|17665196|P2|Overall Study|Lost to Follow-up|13
5114756|NCT01786148|17665197|P1|Overall Study|Lost to Follow-up|21
5114757|NCT01786109|17665212|P3|Overall Study|adverse effects colon preparation|1
5114758|NCT01786109|17665213|P2|Overall Study|adverse effects colon preparation|0
5114759|NCT01786109|17665214|P1|Overall Study|adverse effects colon preparation|0
5114760|NCT01786109|17665212|P3|Overall Study|unrelated illness|1
5114761|NCT01786109|17665213|P2|Overall Study|unrelated illness|0
5114762|NCT01786109|17665214|P1|Overall Study|unrelated illness|0
5114763|NCT01786109|17665212|P3|Overall Study|fail manometry barostat tube placement|0
5114764|NCT01786109|17665213|P2|Overall Study|fail manometry barostat tube placement|0
5114765|NCT01786109|17665214|P1|Overall Study|fail manometry barostat tube placement|1
5114766|NCT01785875|17665243|P3|Overall Study|Missing|3
5114767|NCT01785875|17665244|P2|Overall Study|Missing|1
5114768|NCT01785875|17665245|P1|Overall Study|Missing|0
5114769|NCT01785875|17665243|P3|Overall Study|Protocol Specified Criteria|55
5114770|NCT01785875|17665244|P2|Overall Study|Protocol Specified Criteria|214
5114771|NCT01785875|17665245|P1|Overall Study|Protocol Specified Criteria|207
5114772|NCT01785875|17665243|P3|Overall Study|Sponsor Decision|0
5114773|NCT01785875|17665244|P2|Overall Study|Sponsor Decision|2
5114774|NCT01785875|17665245|P1|Overall Study|Sponsor Decision|0
5114775|NCT01785875|17665243|P3|Overall Study|Death|7
5114776|NCT01785875|17665244|P2|Overall Study|Death|16
5114777|NCT01785875|17665245|P1|Overall Study|Death|27
5114778|NCT01785875|17665243|P3|Overall Study|Lost to Follow-up|6
5114779|NCT01785875|17665244|P2|Overall Study|Lost to Follow-up|22
5114780|NCT01785875|17665245|P1|Overall Study|Lost to Follow-up|19
5114781|NCT01785875|17665243|P3|Overall Study|Withdrawal by Subject|36
5114782|NCT01785875|17665244|P2|Overall Study|Withdrawal by Subject|34
5114783|NCT01785875|17665245|P1|Overall Study|Withdrawal by Subject|41
5114784|NCT01785849|17665314|P2|Overall Study|Lost to Follow-up|11
5114785|NCT01785849|17665315|P1|Overall Study|Lost to Follow-up|10
5114786|NCT01785849|17665314|P2|Overall Study|Sponsor Decision|1
5114787|NCT01785849|17665315|P1|Overall Study|Sponsor Decision|0
5114788|NCT01785849|17665314|P2|Overall Study|Withdrawal by Subject|12
5114789|NCT01785849|17665315|P1|Overall Study|Withdrawal by Subject|15
5114790|NCT01785849|17665314|P2|Overall Study|Protocol Specified Criteria|1
5114791|NCT01785849|17665315|P1|Overall Study|Protocol Specified Criteria|29
5114792|NCT01785849|17665314|P2|Overall Study|Death|9
5114793|NCT01785849|17665315|P1|Overall Study|Death|7
5114794|NCT01785628|17665348|P2|Overall Study|Lost to Follow-up|3
5114795|NCT01785628|17665349|P1|Overall Study|Lost to Follow-up|2
5114796|NCT01785615|17665372|P4|Dietary Phase|Lost to Follow-up|24
5114797|NCT01785615|17665373|P3|Dietary Phase|Lost to Follow-up|0
5114798|NCT01785615|17665374|P2|Dietary Phase|Lost to Follow-up|0
5114799|NCT01785615|17665375|P1|Dietary Phase|Lost to Follow-up|0
5114800|NCT01785602|17665447|P2|Overall Study|Administrative problems|3
5114801|NCT01785602|17665448|P1|Overall Study|Administrative problems|7
5114802|NCT01785602|17665447|P2|Overall Study|Adverse Event|5
5114803|NCT01785602|17665448|P1|Overall Study|Adverse Event|3
5114804|NCT01785602|17665447|P2|Overall Study|Lost to Follow-up|1
5114805|NCT01785602|17665448|P1|Overall Study|Lost to Follow-up|1
5114806|NCT01785602|17665447|P2|Overall Study|Withdrawal by Subject|0
5114807|NCT01785602|17665448|P1|Overall Study|Withdrawal by Subject|2
5114808|NCT01785524|17665458|P2|Overall Study|Withdrawal by Subject|2
5114809|NCT01785524|17665459|P1|Overall Study|Withdrawal by Subject|2
5114810|NCT01785472|17665478|P3|Overall Study|Technical problems|1
5114811|NCT01785472|17665479|P2|Overall Study|Technical problems|0
5114812|NCT01785472|17665480|P1|Overall Study|Technical problems|0
5114813|NCT01785472|17665478|P3|Overall Study|Subject/guardian decision|11
5114814|NCT01785472|17665479|P2|Overall Study|Subject/guardian decision|10
5114815|NCT01785472|17665480|P1|Overall Study|Subject/guardian decision|15
5114816|NCT01785472|17665478|P3|Overall Study|Protocol deviation|2
5114817|NCT01785472|17665479|P2|Overall Study|Protocol deviation|2
5114818|NCT01785472|17665480|P1|Overall Study|Protocol deviation|0
5114819|NCT01785472|17665478|P3|Overall Study|Physician Decision|1
5114820|NCT01785472|17665479|P2|Overall Study|Physician Decision|1
5114821|NCT01785472|17665480|P1|Overall Study|Physician Decision|1
5114822|NCT01785472|17665478|P3|Overall Study|Lost to Follow-up|0
5114823|NCT01785472|17665479|P2|Overall Study|Lost to Follow-up|2
5114824|NCT01785472|17665480|P1|Overall Study|Lost to Follow-up|1
5114825|NCT01785472|17665478|P3|Overall Study|Lack of Efficacy|1
5114826|NCT01785472|17665479|P2|Overall Study|Lack of Efficacy|0
5114827|NCT01785472|17665480|P1|Overall Study|Lack of Efficacy|2
5114828|NCT01785472|17665478|P3|Overall Study|Adverse Event|6
5114829|NCT01785472|17665479|P2|Overall Study|Adverse Event|4
5114830|NCT01785472|17665480|P1|Overall Study|Adverse Event|5
5114831|NCT01785160|17665566|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
5114832|NCT01785160|17665566|P1|Treatment Period 1: Raltegravir|Not treated|1
5114833|NCT01785069|17665603|P4|Overall Study|Not evaluable|8
5114834|NCT01785069|17665604|P3|Overall Study|Not evaluable|5
5114835|NCT01785069|17665605|P2|Overall Study|Not evaluable|4
5114836|NCT01785069|17665606|P1|Overall Study|Not evaluable|7
5114837|NCT01785069|17665603|P4|Overall Study|Reason not Specified|4
5114838|NCT01785069|17665604|P3|Overall Study|Reason not Specified|1
5114839|NCT01785069|17665605|P2|Overall Study|Reason not Specified|2
5114840|NCT01785069|17665606|P1|Overall Study|Reason not Specified|1
5114841|NCT01785069|17665603|P4|Overall Study|Lost to Follow-up|1
5114842|NCT01785069|17665604|P3|Overall Study|Lost to Follow-up|4
5114843|NCT01785069|17665605|P2|Overall Study|Lost to Follow-up|2
5114844|NCT01785069|17665606|P1|Overall Study|Lost to Follow-up|1
5114845|NCT01785069|17665603|P4|Overall Study|Subject choice|1
5114846|NCT01785069|17665604|P3|Overall Study|Subject choice|0
5114847|NCT01785069|17665605|P2|Overall Study|Subject choice|2
5114848|NCT01785069|17665606|P1|Overall Study|Subject choice|2
5114849|NCT01785069|17665603|P4|Overall Study|Death|0
5114850|NCT01785069|17665604|P3|Overall Study|Death|2
5114851|NCT01785069|17665605|P2|Overall Study|Death|0
5114852|NCT01785069|17665606|P1|Overall Study|Death|0
5114853|NCT01785069|17665603|P4|Overall Study|Implanted with nonstudy device|0
5114854|NCT01785069|17665604|P3|Overall Study|Implanted with nonstudy device|1
5114855|NCT01785069|17665605|P2|Overall Study|Implanted with nonstudy device|2
5114856|NCT01785069|17665606|P1|Overall Study|Implanted with nonstudy device|1
5114857|NCT01784965|17665655|P2|Overall Study|Adverse Event|8
5114858|NCT01784965|17665656|P1|Overall Study|Adverse Event|0
5114859|NCT01784965|17665655|P2|Overall Study|Withdrawal by Subject|3
5114860|NCT01784965|17665656|P1|Overall Study|Withdrawal by Subject|6
5114861|NCT01784419|17665777|P1|Overall Study|Adverse Event|3
5114862|NCT01784211|17665785|P6|Part A (Days 1-15)|Withdrawal by Subject|0
5114863|NCT01784211|17665786|P5|Part A (Days 1-15)|Withdrawal by Subject|0
5114864|NCT01784211|17665787|P4|Part A (Days 1-15)|Withdrawal by Subject|0
5114865|NCT01784211|17665788|P3|Part A (Days 1-15)|Withdrawal by Subject|0
5114866|NCT01784211|17665789|P2|Part A (Days 1-15)|Withdrawal by Subject|1
5114867|NCT01784211|17665790|P1|Part A (Days 1-15)|Withdrawal by Subject|2
5114868|NCT01784211|17665785|P6|Part A (Days 1-15)|Adverse Event|0
5114869|NCT01784211|17665786|P5|Part A (Days 1-15)|Adverse Event|0
5114870|NCT01784211|17665787|P4|Part A (Days 1-15)|Adverse Event|0
5114871|NCT01784211|17665788|P3|Part A (Days 1-15)|Adverse Event|0
5114872|NCT01784211|17665789|P2|Part A (Days 1-15)|Adverse Event|1
5114873|NCT01784211|17665790|P1|Part A (Days 1-15)|Adverse Event|1
5114874|NCT01784029|17665815|P3|Overall Study|Lost to Follow-up|22
5114875|NCT01784029|17665816|P2|Overall Study|Lost to Follow-up|20
5114876|NCT01784029|17665817|P1|Overall Study|Lost to Follow-up|19
5114877|NCT01783938|17665846|P2|Overall Study|Other|0
5114878|NCT01783938|17665847|P1|Overall Study|Other|1
5114879|NCT01783938|17665846|P2|Overall Study|Withdrew Consent|0
5114880|NCT01783938|17665847|P1|Overall Study|Withdrew Consent|3
5114881|NCT01783938|17665846|P2|Overall Study|Request to Discontinue Study Treatment|2
5114882|NCT01783938|17665847|P1|Overall Study|Request to Discontinue Study Treatment|1
5114883|NCT01783938|17665846|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
5114884|NCT01783938|17665847|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
5114885|NCT01783938|17665846|P2|Overall Study|Study Drug Toxicity|10
5114886|NCT01783938|17665847|P1|Overall Study|Study Drug Toxicity|22
5114887|NCT01783938|17665846|P2|Overall Study|Disease Progression|39
5114888|NCT01783938|17665847|P1|Overall Study|Disease Progression|18
5114889|NCT01783886|17665875|P3|Overall Study|Adverse Event|4
5114890|NCT01783886|17665876|P2|Overall Study|Adverse Event|5
5114891|NCT01783886|17665877|P1|Overall Study|Adverse Event|4
5114892|NCT01783886|17665875|P3|Overall Study|Withdrawal of consent by participant|4
5114893|NCT01783886|17665876|P2|Overall Study|Withdrawal of consent by participant|3
5114894|NCT01783886|17665877|P1|Overall Study|Withdrawal of consent by participant|1
5114895|NCT01783886|17665875|P3|Overall Study|Protocol deviation|2
5114896|NCT01783886|17665876|P2|Overall Study|Protocol deviation|0
5114897|NCT01783886|17665877|P1|Overall Study|Protocol deviation|0
5114898|NCT01783886|17665875|P3|Overall Study|Lost to Follow-up|0
5114899|NCT01783886|17665876|P2|Overall Study|Lost to Follow-up|3
5114900|NCT01783886|17665877|P1|Overall Study|Lost to Follow-up|0
5114901|NCT01783821|17665940|P2|Overall Study|Screen Failure|1
5114902|NCT01783821|17665941|P1|Overall Study|Screen Failure|1
5114903|NCT01783743|17665959|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
5114904|NCT01783743|17665960|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
5114905|NCT01783743|17665959|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
5114906|NCT01783743|17665960|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
5114907|NCT01783743|17665959|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
5114908|NCT01783743|17665960|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
5114909|NCT01783730|17665974|P1|Overall Study|Failed to meet inclusion criteria|6
5114910|NCT01783678|17665999|P6|Overall Study|Withdrew Consent|0
5114911|NCT01783678|17666000|P5|Overall Study|Withdrew Consent|0
5114912|NCT01783678|17666001|P4|Overall Study|Withdrew Consent|2
5114913|NCT01783678|17666002|P3|Overall Study|Withdrew Consent|0
5114914|NCT01783678|17666003|P2|Overall Study|Withdrew Consent|1
5114915|NCT01783678|17666004|P1|Overall Study|Withdrew Consent|1
5114916|NCT01783678|17665999|P6|Overall Study|Lost to Follow-up|0
5114917|NCT01783678|17666000|P5|Overall Study|Lost to Follow-up|1
5114918|NCT01783678|17666001|P4|Overall Study|Lost to Follow-up|2
5114919|NCT01783678|17666002|P3|Overall Study|Lost to Follow-up|0
5114920|NCT01783678|17666003|P2|Overall Study|Lost to Follow-up|4
5114921|NCT01783678|17666004|P1|Overall Study|Lost to Follow-up|0
5114922|NCT01783678|17665999|P6|Overall Study|Lack of Efficacy|5
5114923|NCT01783678|17666000|P5|Overall Study|Lack of Efficacy|6
5114924|NCT01783678|17666001|P4|Overall Study|Lack of Efficacy|3
5114925|NCT01783678|17666002|P3|Overall Study|Lack of Efficacy|1
5114926|NCT01783678|17666003|P2|Overall Study|Lack of Efficacy|13
5114927|NCT01783678|17666004|P1|Overall Study|Lack of Efficacy|1
5114928|NCT01783678|17665999|P6|Overall Study|Randomized but Not Treated|0
5114929|NCT01783678|17666000|P5|Overall Study|Randomized but Not Treated|0
5114930|NCT01783678|17666001|P4|Overall Study|Randomized but Not Treated|1
5114931|NCT01783678|17666002|P3|Overall Study|Randomized but Not Treated|0
5114932|NCT01783678|17666003|P2|Overall Study|Randomized but Not Treated|0
5114933|NCT01783678|17666004|P1|Overall Study|Randomized but Not Treated|0
5114934|NCT01783548|17666108|P2|Overall Study|Lack of Efficacy|1
5114935|NCT01783548|17666109|P1|Overall Study|Lack of Efficacy|1
5114936|NCT01783548|17666108|P2|Overall Study|Lost to Follow-up|3
5114937|NCT01783548|17666109|P1|Overall Study|Lost to Follow-up|8
5114938|NCT01783548|17666108|P2|Overall Study|Protocol Violation|2
5114939|NCT01783548|17666109|P1|Overall Study|Protocol Violation|2
5114940|NCT01783548|17666108|P2|Overall Study|Non-compliance|0
5114941|NCT01783548|17666109|P1|Overall Study|Non-compliance|4
5114942|NCT01783548|17666108|P2|Overall Study|Withdrawal by Subject|8
5114943|NCT01783548|17666109|P1|Overall Study|Withdrawal by Subject|11
5114944|NCT01783548|17666108|P2|Overall Study|Adverse Event|4
5114945|NCT01783548|17666109|P1|Overall Study|Adverse Event|8
5114946|NCT01783496|17666142|P6|Overall Study|Withdrawal by Subject|0
5114947|NCT01783496|17666143|P5|Overall Study|Withdrawal by Subject|0
5114948|NCT01783496|17666144|P4|Overall Study|Withdrawal by Subject|0
5114949|NCT01783496|17666145|P3|Overall Study|Withdrawal by Subject|0
5114950|NCT01783496|17666146|P2|Overall Study|Withdrawal by Subject|0
5114951|NCT01783496|17666147|P1|Overall Study|Withdrawal by Subject|1
5114952|NCT01783496|17666142|P6|Overall Study|Lost to Follow-up|1
5114953|NCT01783496|17666143|P5|Overall Study|Lost to Follow-up|0
5114954|NCT01783496|17666144|P4|Overall Study|Lost to Follow-up|2
5114955|NCT01783496|17666145|P3|Overall Study|Lost to Follow-up|0
5114956|NCT01783496|17666146|P2|Overall Study|Lost to Follow-up|0
5114957|NCT01783496|17666147|P1|Overall Study|Lost to Follow-up|0
5114958|NCT01783483|17666175|P2|Overall Study|Physician Decision|1
5114959|NCT01783483|17666176|P1|Overall Study|Physician Decision|1
5114960|NCT01783483|17666175|P2|Overall Study|Withdrawal by Subject|1
5114961|NCT01783483|17666176|P1|Overall Study|Withdrawal by Subject|2
5114962|NCT01783483|17666175|P2|Overall Study|Lost to Follow-up|10
5114963|NCT01783483|17666176|P1|Overall Study|Lost to Follow-up|14
5114964|NCT01783483|17666175|P2|Overall Study|Death|3
5114965|NCT01783483|17666176|P1|Overall Study|Death|3
5114966|NCT01783418|17666214|P2|Overall Study|Withdrawal by Subject|0
5114967|NCT01783418|17666215|P1|Overall Study|Withdrawal by Subject|1
5114968|NCT01783015|17666268|P3|Open Label Treatment|Study Terminated by Sponsor|6
5114969|NCT01783015|17666269|P2|Open Label Treatment|Study Terminated by Sponsor|0
5114970|NCT01783015|17666270|P1|Open Label Treatment|Study Terminated by Sponsor|0
5114971|NCT01783015|17666268|P3|Blinded Treatment|Study Terminated by Sponsor|0
5114972|NCT01783015|17666269|P2|Blinded Treatment|Study Terminated by Sponsor|0
5114973|NCT01783015|17666270|P1|Blinded Treatment|Study Terminated by Sponsor|2
5114974|NCT01783015|17666268|P3|Blinded Treatment|Withdrawal by Subject|0
5114975|NCT01783015|17666269|P2|Blinded Treatment|Withdrawal by Subject|1
5114976|NCT01783015|17666270|P1|Blinded Treatment|Withdrawal by Subject|0
5114977|NCT01783015|17666268|P3|Blinded Treatment|Protocol Violation|0
5114978|NCT01783015|17666269|P2|Blinded Treatment|Protocol Violation|1
5114979|NCT01783015|17666270|P1|Blinded Treatment|Protocol Violation|0
5114980|NCT01783015|17666268|P3|Blinded Treatment|Adverse Event|0
5114981|NCT01783015|17666269|P2|Blinded Treatment|Adverse Event|1
5114982|NCT01783015|17666270|P1|Blinded Treatment|Adverse Event|0
5114983|NCT01782885|17666383|P2|Overall Study|Lost to Follow-up|6
5114984|NCT01782885|17666384|P1|Overall Study|Lost to Follow-up|4
5114985|NCT01782872|17666410|P4|Overall Study|Withdrawal by Subject|0
5114986|NCT01782872|17666411|P3|Overall Study|Withdrawal by Subject|0
5114987|NCT01782872|17666412|P2|Overall Study|Withdrawal by Subject|1
5114988|NCT01782872|17666413|P1|Overall Study|Withdrawal by Subject|0
5114989|NCT01782872|17666410|P4|Overall Study|Protocol Violation|1
5114990|NCT01782872|17666411|P3|Overall Study|Protocol Violation|0
5114991|NCT01782872|17666412|P2|Overall Study|Protocol Violation|0
5114992|NCT01782872|17666413|P1|Overall Study|Protocol Violation|0
5114993|NCT01782859|17666437|P2|Overall Study|Withdrawal by Subject|1
5114994|NCT01782859|17666438|P1|Overall Study|Withdrawal by Subject|0
5114995|NCT01782859|17666437|P2|Overall Study|Protocol Violation|6
5114996|NCT01782859|17666438|P1|Overall Study|Protocol Violation|6
5114997|NCT01782742|17666460|P2|Double-blind Treatment Phase|Adverse Event|0
5114998|NCT01782742|17666461|P1|Double-blind Treatment Phase|Adverse Event|1
5114999|NCT01782690|17666494|P1|Overall Study|Study completion unknown|7
5115000|NCT01782690|17666494|P1|Overall Study|Death|133
5115001|NCT01782690|17666494|P1|Overall Study|Tumor progression|74
5115002|NCT01782690|17666494|P1|Overall Study|Patient's wish|21
5115003|NCT01782690|17666494|P1|Overall Study|Physician Decision|13
5115004|NCT01782690|17666494|P1|Overall Study|Absent rash|9
5115005|NCT01782690|17666494|P1|Overall Study|Withdrawal of informed consent|2
5115006|NCT01782690|17666494|P1|Overall Study|Lost to Follow-up|31
5115007|NCT01782690|17666494|P1|Overall Study|Toxicity of erlotinib|1
5115008|NCT01782690|17666494|P1|Overall Study|Toxicity of gemcitabine|1
5115009|NCT01782690|17666494|P1|Overall Study|Not reported|7
5115010|NCT01782664|17666516|P6|Overall Study|Withdrawal by Subject|0
5115011|NCT01782664|17666517|P5|Overall Study|Withdrawal by Subject|0
5115012|NCT01782664|17666518|P4|Overall Study|Withdrawal by Subject|0
5115013|NCT01782664|17666519|P3|Overall Study|Withdrawal by Subject|0
5115014|NCT01782664|17666520|P2|Overall Study|Withdrawal by Subject|2
5115015|NCT01782664|17666521|P1|Overall Study|Withdrawal by Subject|2
5115016|NCT01782664|17666516|P6|Overall Study|Protocol Violation|0
5115017|NCT01782664|17666517|P5|Overall Study|Protocol Violation|0
5115018|NCT01782664|17666518|P4|Overall Study|Protocol Violation|1
5115019|NCT01782664|17666519|P3|Overall Study|Protocol Violation|0
5115020|NCT01782664|17666520|P2|Overall Study|Protocol Violation|1
5115021|NCT01782664|17666521|P1|Overall Study|Protocol Violation|0
5115022|NCT01782664|17666516|P6|Overall Study|Lack of Efficacy|0
5115023|NCT01782664|17666517|P5|Overall Study|Lack of Efficacy|0
5115024|NCT01782664|17666518|P4|Overall Study|Lack of Efficacy|2
5115025|NCT01782664|17666519|P3|Overall Study|Lack of Efficacy|2
5115026|NCT01782664|17666520|P2|Overall Study|Lack of Efficacy|0
5115027|NCT01782664|17666521|P1|Overall Study|Lack of Efficacy|2
5115028|NCT01782664|17666516|P6|Overall Study|Adverse Event|0
5115029|NCT01782664|17666517|P5|Overall Study|Adverse Event|0
5115030|NCT01782664|17666518|P4|Overall Study|Adverse Event|2
5115031|NCT01782664|17666519|P3|Overall Study|Adverse Event|2
5115032|NCT01782664|17666520|P2|Overall Study|Adverse Event|2
5115033|NCT01782664|17666521|P1|Overall Study|Adverse Event|2
5115034|NCT01782495|17666678|P11|Overall Study|Withdrew Consent|0
5115035|NCT01782495|17666679|P10|Overall Study|Withdrew Consent|0
5115036|NCT01782495|17666680|P9|Overall Study|Withdrew Consent|0
5115037|NCT01782495|17666681|P8|Overall Study|Withdrew Consent|1
5115038|NCT01782495|17666682|P7|Overall Study|Withdrew Consent|0
5115039|NCT01782495|17666683|P6|Overall Study|Withdrew Consent|0
5115040|NCT01782495|17666684|P5|Overall Study|Withdrew Consent|0
5115041|NCT01782495|17666685|P4|Overall Study|Withdrew Consent|0
5115042|NCT01782495|17666686|P3|Overall Study|Withdrew Consent|0
5115043|NCT01782495|17666687|P2|Overall Study|Withdrew Consent|1
5115044|NCT01782495|17666688|P1|Overall Study|Withdrew Consent|0
5115045|NCT01782495|17666678|P11|Overall Study|Adverse Event|0
5115046|NCT01782495|17666679|P10|Overall Study|Adverse Event|0
5115047|NCT01782495|17666680|P9|Overall Study|Adverse Event|0
5115048|NCT01782495|17666681|P8|Overall Study|Adverse Event|2
5115049|NCT01782495|17666682|P7|Overall Study|Adverse Event|0
5115050|NCT01782495|17666683|P6|Overall Study|Adverse Event|0
5115051|NCT01782495|17666684|P5|Overall Study|Adverse Event|0
5115052|NCT01782495|17666685|P4|Overall Study|Adverse Event|0
5115053|NCT01782495|17666686|P3|Overall Study|Adverse Event|0
5115054|NCT01782495|17666687|P2|Overall Study|Adverse Event|0
5115055|NCT01782495|17666688|P1|Overall Study|Adverse Event|0
5115056|NCT01782482|17666747|P2|Overall Study|Habitually wearing toric lens OS|1
5115057|NCT01782482|17666748|P1|Overall Study|Habitually wearing toric lens OS|0
5115058|NCT01782482|17666747|P2|Overall Study|Randomized in Error|2
5115059|NCT01782482|17666748|P1|Overall Study|Randomized in Error|2
5115060|NCT01782482|17666747|P2|Overall Study|Withdrawal by Subject|3
5115061|NCT01782482|17666748|P1|Overall Study|Withdrawal by Subject|2
5115062|NCT01782482|17666747|P2|Overall Study|Protocol Violation|0
5115063|NCT01782482|17666748|P1|Overall Study|Protocol Violation|1
5115064|NCT01782482|17666747|P2|Overall Study|Physician Decision|0
5115065|NCT01782482|17666748|P1|Overall Study|Physician Decision|1
5115066|NCT01782482|17666747|P2|Overall Study|Lost to Follow-up|3
5115067|NCT01782482|17666748|P1|Overall Study|Lost to Follow-up|2
5115068|NCT01782482|17666747|P2|Overall Study|Adverse Event|1
5115069|NCT01782482|17666748|P1|Overall Study|Adverse Event|2
5115070|NCT01782469|17666756|P1|Overall Study|Lost to Follow-up|1
5115071|NCT01782378|17666766|P2|Second Series|Did not choose to complete S2 Optional|0
5115072|NCT01782378|17666767|P1|Second Series|Did not choose to complete S2 Optional|18
5115073|NCT01782378|17666766|P2|Second Series|Lost to Follow-up|7
5115074|NCT01782378|17666767|P1|Second Series|Lost to Follow-up|8
5115075|NCT01782378|17666766|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
5115076|NCT01782378|17666767|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
5115077|NCT01782378|17666766|P2|First Series|Lost to Follow-up|8
5115078|NCT01782378|17666767|P1|First Series|Lost to Follow-up|7
5115079|NCT01782326|17666833|P2|Double-blind Treatment|Technical problems|5
5115080|NCT01782326|17666834|P1|Double-blind Treatment|Technical problems|0
5115081|NCT01782326|17666833|P2|Double-blind Treatment|Protocol deviation|7
5115082|NCT01782326|17666834|P1|Double-blind Treatment|Protocol deviation|8
5115083|NCT01782326|17666833|P2|Double-blind Treatment|Physician Decision|16
5115084|NCT01782326|17666834|P1|Double-blind Treatment|Physician Decision|13
5115085|NCT01782326|17666833|P2|Double-blind Treatment|Lack of Efficacy|22
5115086|NCT01782326|17666834|P1|Double-blind Treatment|Lack of Efficacy|17
5115087|NCT01782326|17666833|P2|Double-blind Treatment|Subject/guardian decision|125
5115088|NCT01782326|17666834|P1|Double-blind Treatment|Subject/guardian decision|111
5115089|NCT01782326|17666833|P2|Double-blind Treatment|Adverse Event|145
5115090|NCT01782326|17666834|P1|Double-blind Treatment|Adverse Event|129
5115091|NCT01782326|17666833|P2|Planned Treatment Epoch|Technical problems|4
5115092|NCT01782326|17666834|P1|Planned Treatment Epoch|Technical problems|0
5115093|NCT01782326|17666833|P2|Planned Treatment Epoch|Lost to Follow-up|4
5115094|NCT01782326|17666834|P1|Planned Treatment Epoch|Lost to Follow-up|4
5115095|NCT01782326|17666833|P2|Planned Treatment Epoch|Protocol deviation|3
5115096|NCT01782326|17666834|P1|Planned Treatment Epoch|Protocol deviation|2
5115097|NCT01782326|17666833|P2|Planned Treatment Epoch|Physician Decision|16
5115098|NCT01782326|17666834|P1|Planned Treatment Epoch|Physician Decision|18
5115099|NCT01782326|17666833|P2|Planned Treatment Epoch|Death|30
5115100|NCT01782326|17666834|P1|Planned Treatment Epoch|Death|29
5115101|NCT01782326|17666833|P2|Planned Treatment Epoch|Subject/guardian decision|151
5115102|NCT01782326|17666834|P1|Planned Treatment Epoch|Subject/guardian decision|149
5115103|NCT01782313|17666894|P1|Survival Follow up|Lost to Follow-up|1
5115104|NCT01782313|17666894|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
5115105|NCT01782313|17666894|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
5115106|NCT01782313|17666894|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
5115107|NCT01782313|17666894|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
5115108|NCT01782313|17666894|P1|Treated Cycle 3|Progressive Disease|21
5115109|NCT01782313|17666894|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
5115110|NCT01782313|17666894|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
5115111|NCT01782222|17666908|P3|Overall Study|Moved to other state|0
5115112|NCT01782222|17666909|P2|Overall Study|Moved to other state|1
5115113|NCT01782222|17666910|P1|Overall Study|Moved to other state|0
5115114|NCT01782222|17666908|P3|Overall Study|Withdrawal by Subject|1
5115115|NCT01782222|17666909|P2|Overall Study|Withdrawal by Subject|4
5115116|NCT01782222|17666910|P1|Overall Study|Withdrawal by Subject|1
5115117|NCT01782222|17666908|P3|Overall Study|Protocol Violation|0
5115118|NCT01782222|17666909|P2|Overall Study|Protocol Violation|0
5115119|NCT01782222|17666910|P1|Overall Study|Protocol Violation|1
5115120|NCT01782222|17666908|P3|Overall Study|Lack of Efficacy|0
5115121|NCT01782222|17666909|P2|Overall Study|Lack of Efficacy|1
5115122|NCT01782222|17666910|P1|Overall Study|Lack of Efficacy|2
5115123|NCT01782222|17666908|P3|Overall Study|Adverse Event|3
5115124|NCT01782222|17666909|P2|Overall Study|Adverse Event|5
5115125|NCT01782222|17666910|P1|Overall Study|Adverse Event|4
5115126|NCT01782131|17666948|P2|Overall Study|Reason not provided|1
5115127|NCT01782131|17666949|P1|Overall Study|Reason not provided|0
5115128|NCT01782131|17666948|P2|Overall Study|Randomized but not treated|5
5115129|NCT01782131|17666949|P1|Overall Study|Randomized but not treated|5
5115130|NCT01782131|17666948|P2|Overall Study|Withdrawal by Subject|10
5115131|NCT01782131|17666949|P1|Overall Study|Withdrawal by Subject|10
5115132|NCT01782131|17666948|P2|Overall Study|Lost to Follow-up|3
5115133|NCT01782131|17666949|P1|Overall Study|Lost to Follow-up|1
5115134|NCT01782131|17666948|P2|Overall Study|Death|96
5115135|NCT01782131|17666949|P1|Overall Study|Death|93
5115136|NCT01781975|17666986|P2|Overall Study|Withdrawal by Subject|1
5115137|NCT01781975|17666987|P1|Overall Study|Withdrawal by Subject|1
5115138|NCT01781975|17666986|P2|Overall Study|Death|0
5115139|NCT01781975|17666987|P1|Overall Study|Death|1
5115140|NCT01781962|17667003|P1|Overall Study|Other Miscellaneous Reasons|5
5115141|NCT01781832|17667009|P1|Overall Study|Withdrawal by Subject|1
5115142|NCT01781637|17667029|P2|Overall Study|Withdrawal by Subject|0
5115143|NCT01781637|17667030|P1|Overall Study|Withdrawal by Subject|1
5115144|NCT01781637|17667029|P2|Overall Study|Lack of Efficacy|6
5115145|NCT01781637|17667030|P1|Overall Study|Lack of Efficacy|2
5115146|NCT01781637|17667029|P2|Overall Study|Adverse Event|0
5115147|NCT01781637|17667030|P1|Overall Study|Adverse Event|1
5115148|NCT01781611|17667040|P2|Overall Study|Adverse Event|0
5115149|NCT01781611|17667041|P1|Overall Study|Adverse Event|4
5115150|NCT01781572|17667062|P3|MEK162 45mg LEE011 600mg|Progressive Disease|0
5115151|NCT01781572|17667063|P2|MEK162 45mg LEE011 600mg|Progressive Disease|5
5115152|NCT01781572|17667064|P1|MEK162 45mg LEE011 600mg|Progressive Disease|0
5115153|NCT01781572|17667062|P3|MEK162 45mg LEE011 600mg|Adverse Event|0
5115154|NCT01781572|17667063|P2|MEK162 45mg LEE011 600mg|Adverse Event|1
5115155|NCT01781572|17667064|P1|MEK162 45mg LEE011 600mg|Adverse Event|0
5115156|NCT01781572|17667062|P3|MEK162 45mg LEE011 450mg|Progressive Disease|0
5115157|NCT01781572|17667063|P2|MEK162 45mg LEE011 450mg|Progressive Disease|6
5115158|NCT01781572|17667064|P1|MEK162 45mg LEE011 450mg|Progressive Disease|0
5115159|NCT01781572|17667062|P3|MEK162 45mg LEE011 450mg|Physician Decision|0
5115160|NCT01781572|17667063|P2|MEK162 45mg LEE011 450mg|Physician Decision|2
5115161|NCT01781572|17667064|P1|MEK162 45mg LEE011 450mg|Physician Decision|0
5115162|NCT01781572|17667062|P3|MEK162 45mg LEE011 450mg|Adverse Event|0
5115163|NCT01781572|17667063|P2|MEK162 45mg LEE011 450mg|Adverse Event|1
5115164|NCT01781572|17667064|P1|MEK162 45mg LEE011 450mg|Adverse Event|0
5115165|NCT01781572|17667062|P3|MEK162 30mg LEE011 200mg|Progressive Disease|0
5115166|NCT01781572|17667063|P2|MEK162 30mg LEE011 200mg|Progressive Disease|5
5115167|NCT01781572|17667064|P1|MEK162 30mg LEE011 200mg|Progressive Disease|0
5115168|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 300mg|Death|0
5115169|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 300mg|Death|0
5115170|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 300mg|Death|1
5115171|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
5115172|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
5115173|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
5115174|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
5115175|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
5115176|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
5115177|NCT01781572|17667062|P3|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
5115178|NCT01781572|17667063|P2|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
5115179|NCT01781572|17667064|P1|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
5115180|NCT01781572|17667062|P3|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
5115181|NCT01781572|17667063|P2|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
5115182|NCT01781572|17667064|P1|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
5115183|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
5115184|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
5115185|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
5115186|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
5115187|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
5115188|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
5115189|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 200mg|Death|1
5115190|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 200mg|Death|0
5115191|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 200mg|Death|0
5115192|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
5115193|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
5115194|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
5115195|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
5115196|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
5115197|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
5115198|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
5115199|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
5115200|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
5115201|NCT01781572|17667062|P3|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
5115202|NCT01781572|17667063|P2|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
5115203|NCT01781572|17667064|P1|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
5115204|NCT01781429|17667405|P16|Overall Study|Enrolled, but not treated|0
5115205|NCT01781429|17667406|P15|Overall Study|Enrolled, but not treated|0
5115206|NCT01781429|17667407|P14|Overall Study|Enrolled, but not treated|0
5115207|NCT01781429|17667408|P13|Overall Study|Enrolled, but not treated|0
5115208|NCT01781429|17667409|P12|Overall Study|Enrolled, but not treated|0
5115209|NCT01781429|17667410|P11|Overall Study|Enrolled, but not treated|1
5115210|NCT01781429|17667411|P10|Overall Study|Enrolled, but not treated|0
5115211|NCT01781429|17667412|P9|Overall Study|Enrolled, but not treated|0
5115212|NCT01781429|17667413|P8|Overall Study|Enrolled, but not treated|0
5115213|NCT01781429|17667414|P7|Overall Study|Enrolled, but not treated|0
5115214|NCT01781429|17667415|P6|Overall Study|Enrolled, but not treated|0
5115215|NCT01781429|17667416|P5|Overall Study|Enrolled, but not treated|0
5115216|NCT01781429|17667417|P4|Overall Study|Enrolled, but not treated|0
5115217|NCT01781429|17667418|P3|Overall Study|Enrolled, but not treated|0
5115218|NCT01781429|17667419|P2|Overall Study|Enrolled, but not treated|0
5115219|NCT01781429|17667420|P1|Overall Study|Enrolled, but not treated|0
5115220|NCT01781429|17667405|P16|Overall Study|Other - as entered by PI in eCRF|0
5115221|NCT01781429|17667406|P15|Overall Study|Other - as entered by PI in eCRF|1
5115222|NCT01781429|17667407|P14|Overall Study|Other - as entered by PI in eCRF|1
5115223|NCT01781429|17667408|P13|Overall Study|Other - as entered by PI in eCRF|1
5115224|NCT01781429|17667409|P12|Overall Study|Other - as entered by PI in eCRF|2
5115225|NCT01781429|17667410|P11|Overall Study|Other - as entered by PI in eCRF|1
5115226|NCT01781429|17667411|P10|Overall Study|Other - as entered by PI in eCRF|1
5115227|NCT01781429|17667412|P9|Overall Study|Other - as entered by PI in eCRF|0
5115228|NCT01781429|17667413|P8|Overall Study|Other - as entered by PI in eCRF|0
5115229|NCT01781429|17667414|P7|Overall Study|Other - as entered by PI in eCRF|0
5115230|NCT01781429|17667415|P6|Overall Study|Other - as entered by PI in eCRF|0
5115231|NCT01781429|17667416|P5|Overall Study|Other - as entered by PI in eCRF|0
5115232|NCT01781429|17667417|P4|Overall Study|Other - as entered by PI in eCRF|0
5115233|NCT01781429|17667418|P3|Overall Study|Other - as entered by PI in eCRF|0
5115234|NCT01781429|17667419|P2|Overall Study|Other - as entered by PI in eCRF|1
5115235|NCT01781429|17667420|P1|Overall Study|Other - as entered by PI in eCRF|0
5115236|NCT01781429|17667405|P16|Overall Study|Patient Condition Changed|0
5115237|NCT01781429|17667406|P15|Overall Study|Patient Condition Changed|0
5115238|NCT01781429|17667407|P14|Overall Study|Patient Condition Changed|1
5115239|NCT01781429|17667408|P13|Overall Study|Patient Condition Changed|0
5115240|NCT01781429|17667409|P12|Overall Study|Patient Condition Changed|1
5115241|NCT01781429|17667410|P11|Overall Study|Patient Condition Changed|0
5115242|NCT01781429|17667411|P10|Overall Study|Patient Condition Changed|4
5115243|NCT01781429|17667412|P9|Overall Study|Patient Condition Changed|0
5115244|NCT01781429|17667413|P8|Overall Study|Patient Condition Changed|0
5115245|NCT01781429|17667414|P7|Overall Study|Patient Condition Changed|0
5115246|NCT01781429|17667415|P6|Overall Study|Patient Condition Changed|0
5115247|NCT01781429|17667416|P5|Overall Study|Patient Condition Changed|0
5115248|NCT01781429|17667417|P4|Overall Study|Patient Condition Changed|0
5115249|NCT01781429|17667418|P3|Overall Study|Patient Condition Changed|0
5115250|NCT01781429|17667419|P2|Overall Study|Patient Condition Changed|0
5115251|NCT01781429|17667420|P1|Overall Study|Patient Condition Changed|0
5115252|NCT01781429|17667405|P16|Overall Study|Unacceptable Toxicity|0
5115253|NCT01781429|17667406|P15|Overall Study|Unacceptable Toxicity|0
5115254|NCT01781429|17667407|P14|Overall Study|Unacceptable Toxicity|0
5115255|NCT01781429|17667408|P13|Overall Study|Unacceptable Toxicity|0
5115256|NCT01781429|17667409|P12|Overall Study|Unacceptable Toxicity|2
5115257|NCT01781429|17667410|P11|Overall Study|Unacceptable Toxicity|0
5115258|NCT01781429|17667411|P10|Overall Study|Unacceptable Toxicity|0
5115259|NCT01781429|17667412|P9|Overall Study|Unacceptable Toxicity|0
5115260|NCT01781429|17667413|P8|Overall Study|Unacceptable Toxicity|0
5115261|NCT01781429|17667414|P7|Overall Study|Unacceptable Toxicity|0
5115262|NCT01781429|17667415|P6|Overall Study|Unacceptable Toxicity|0
5115263|NCT01781429|17667416|P5|Overall Study|Unacceptable Toxicity|0
5115264|NCT01781429|17667417|P4|Overall Study|Unacceptable Toxicity|0
5115265|NCT01781429|17667418|P3|Overall Study|Unacceptable Toxicity|0
5115266|NCT01781429|17667419|P2|Overall Study|Unacceptable Toxicity|0
5115267|NCT01781429|17667420|P1|Overall Study|Unacceptable Toxicity|0
5115268|NCT01781429|17667405|P16|Overall Study|Disease Progression|0
5115269|NCT01781429|17667406|P15|Overall Study|Disease Progression|11
5115270|NCT01781429|17667407|P14|Overall Study|Disease Progression|4
5115271|NCT01781429|17667408|P13|Overall Study|Disease Progression|15
5115272|NCT01781429|17667409|P12|Overall Study|Disease Progression|15
5115273|NCT01781429|17667410|P11|Overall Study|Disease Progression|15
5115274|NCT01781429|17667411|P10|Overall Study|Disease Progression|15
5115275|NCT01781429|17667412|P9|Overall Study|Disease Progression|6
5115276|NCT01781429|17667413|P8|Overall Study|Disease Progression|4
5115277|NCT01781429|17667414|P7|Overall Study|Disease Progression|7
5115278|NCT01781429|17667415|P6|Overall Study|Disease Progression|4
5115279|NCT01781429|17667416|P5|Overall Study|Disease Progression|1
5115280|NCT01781429|17667417|P4|Overall Study|Disease Progression|1
5115281|NCT01781429|17667418|P3|Overall Study|Disease Progression|1
5115282|NCT01781429|17667419|P2|Overall Study|Disease Progression|0
5115283|NCT01781429|17667420|P1|Overall Study|Disease Progression|1
5115284|NCT01781429|17667405|P16|Overall Study|Withdrawal by Subject|0
5115285|NCT01781429|17667406|P15|Overall Study|Withdrawal by Subject|3
5115286|NCT01781429|17667407|P14|Overall Study|Withdrawal by Subject|2
5115287|NCT01781429|17667408|P13|Overall Study|Withdrawal by Subject|5
5115288|NCT01781429|17667409|P12|Overall Study|Withdrawal by Subject|1
5115289|NCT01781429|17667410|P11|Overall Study|Withdrawal by Subject|1
5115290|NCT01781429|17667411|P10|Overall Study|Withdrawal by Subject|3
5115291|NCT01781429|17667412|P9|Overall Study|Withdrawal by Subject|1
5115292|NCT01781429|17667413|P8|Overall Study|Withdrawal by Subject|0
5115293|NCT01781429|17667414|P7|Overall Study|Withdrawal by Subject|0
5115294|NCT01781429|17667415|P6|Overall Study|Withdrawal by Subject|0
5115295|NCT01781429|17667416|P5|Overall Study|Withdrawal by Subject|0
5115296|NCT01781429|17667417|P4|Overall Study|Withdrawal by Subject|0
5115297|NCT01781429|17667418|P3|Overall Study|Withdrawal by Subject|0
5115298|NCT01781429|17667419|P2|Overall Study|Withdrawal by Subject|0
5115299|NCT01781429|17667420|P1|Overall Study|Withdrawal by Subject|0
5115300|NCT01781429|17667405|P16|Overall Study|Death|0
5115301|NCT01781429|17667406|P15|Overall Study|Death|1
5115302|NCT01781429|17667407|P14|Overall Study|Death|0
5115303|NCT01781429|17667408|P13|Overall Study|Death|1
5115304|NCT01781429|17667409|P12|Overall Study|Death|0
5115305|NCT01781429|17667410|P11|Overall Study|Death|0
5115306|NCT01781429|17667411|P10|Overall Study|Death|1
5115307|NCT01781429|17667412|P9|Overall Study|Death|0
5115308|NCT01781429|17667413|P8|Overall Study|Death|0
5115309|NCT01781429|17667414|P7|Overall Study|Death|0
5115310|NCT01781429|17667415|P6|Overall Study|Death|0
5115311|NCT01781429|17667416|P5|Overall Study|Death|0
5115312|NCT01781429|17667417|P4|Overall Study|Death|0
5115313|NCT01781429|17667418|P3|Overall Study|Death|0
5115314|NCT01781429|17667419|P2|Overall Study|Death|0
5115315|NCT01781429|17667420|P1|Overall Study|Death|0
5115316|NCT01781299|17667497|P2|Overall Study|Withdrawal by Subject|1
5115317|NCT01781299|17667498|P1|Overall Study|Withdrawal by Subject|0
5115318|NCT01781286|17667506|P6|Overall Study|Noncompliance|0
5115319|NCT01781286|17667507|P5|Overall Study|Noncompliance|0
5115320|NCT01781286|17667508|P4|Overall Study|Noncompliance|1
5115321|NCT01781286|17667509|P3|Overall Study|Noncompliance|0
5115322|NCT01781286|17667510|P2|Overall Study|Noncompliance|0
5115323|NCT01781286|17667511|P1|Overall Study|Noncompliance|0
5115324|NCT01781286|17667506|P6|Overall Study|Time Constraints|0
5115325|NCT01781286|17667507|P5|Overall Study|Time Constraints|0
5115326|NCT01781286|17667508|P4|Overall Study|Time Constraints|0
5115327|NCT01781286|17667509|P3|Overall Study|Time Constraints|2
5115328|NCT01781286|17667510|P2|Overall Study|Time Constraints|0
5115329|NCT01781286|17667511|P1|Overall Study|Time Constraints|2
5115330|NCT01781286|17667506|P6|Overall Study|Lost to Follow-up|1
5115331|NCT01781286|17667507|P5|Overall Study|Lost to Follow-up|0
5115332|NCT01781286|17667508|P4|Overall Study|Lost to Follow-up|0
5115333|NCT01781286|17667509|P3|Overall Study|Lost to Follow-up|0
5115334|NCT01781286|17667510|P2|Overall Study|Lost to Follow-up|0
5115335|NCT01781286|17667511|P1|Overall Study|Lost to Follow-up|0
5115336|NCT01781234|17667536|P2|Overall Study|Withdrawal by Subject|3
5115337|NCT01781234|17667537|P1|Overall Study|Withdrawal by Subject|4
5115338|NCT01781234|17667536|P2|Overall Study|Protocol Violation|0
5115339|NCT01781234|17667537|P1|Overall Study|Protocol Violation|3
5115340|NCT01781234|17667536|P2|Overall Study|Adverse Event|0
5115341|NCT01781234|17667537|P1|Overall Study|Adverse Event|2
5115342|NCT01781026|17667575|P1|Overall Study|Lack of Efficacy|2
5115343|NCT01780987|17667581|P2|Overall Study|Not Receiving any Study Medication|1
5115344|NCT01780987|17667582|P1|Overall Study|Not Receiving any Study Medication|0
5115345|NCT01780987|17667581|P2|Overall Study|Changing Residence|0
5115346|NCT01780987|17667582|P1|Overall Study|Changing Residence|1
5115347|NCT01780987|17667581|P2|Overall Study|Request of Changing Hospital|1
5115348|NCT01780987|17667582|P1|Overall Study|Request of Changing Hospital|0
5115349|NCT01780987|17667581|P2|Overall Study|Withdrawal by Subject|0
5115350|NCT01780987|17667582|P1|Overall Study|Withdrawal by Subject|2
5115351|NCT01780987|17667581|P2|Overall Study|Adverse Event|4
5115352|NCT01780987|17667582|P1|Overall Study|Adverse Event|0
5115353|NCT01780974|17667600|P2|Overall Study|Adverse Event|3
5115354|NCT01780974|17667601|P1|Overall Study|Adverse Event|1
5115355|NCT01780974|17667600|P2|Overall Study|Death|0
5115356|NCT01780974|17667601|P1|Overall Study|Death|1
5115357|NCT01780935|17667611|P2|Overall Study|Patient withdrew consent|9
5115358|NCT01780935|17667612|P1|Overall Study|Patient withdrew consent|8
5115359|NCT01780935|17667611|P2|Overall Study|Protocol deviation|1
5115360|NCT01780935|17667612|P1|Overall Study|Protocol deviation|0
5115361|NCT01780935|17667611|P2|Overall Study|Physician Decision|1
5115362|NCT01780935|17667612|P1|Overall Study|Physician Decision|1
5115363|NCT01780935|17667611|P2|Overall Study|Lost to Follow-up|6
5115364|NCT01780935|17667612|P1|Overall Study|Lost to Follow-up|2
5115365|NCT01780935|17667611|P2|Overall Study|Death|6
5115366|NCT01780935|17667612|P1|Overall Study|Death|1
5115367|NCT01780935|17667611|P2|Overall Study|Adverse Event|4
5115368|NCT01780935|17667612|P1|Overall Study|Adverse Event|2
5115369|NCT01780935|17667611|P2|Overall Study|Admin problems due to early termination|309
5115370|NCT01780935|17667612|P1|Overall Study|Admin problems due to early termination|321
5115371|NCT01780831|17667717|P4|Overall Study|Lost to Follow-up|1
5115372|NCT01780831|17667718|P3|Overall Study|Lost to Follow-up|0
5115373|NCT01780831|17667719|P2|Overall Study|Lost to Follow-up|0
5115374|NCT01780831|17667720|P1|Overall Study|Lost to Follow-up|0
5115375|NCT01780831|17667717|P4|Overall Study|Withdrawal by Subject|0
5115376|NCT01780831|17667718|P3|Overall Study|Withdrawal by Subject|4
5115377|NCT01780831|17667719|P2|Overall Study|Withdrawal by Subject|0
5115378|NCT01780831|17667720|P1|Overall Study|Withdrawal by Subject|0
5115379|NCT01780662|17667788|P3|Overall Study|Ineligible|1
5115380|NCT01780662|17667789|P2|Overall Study|Ineligible|0
5115381|NCT01780662|17667790|P1|Overall Study|Ineligible|0
5115382|NCT01780662|17667788|P3|Overall Study|Protocol Violation|0
5115383|NCT01780662|17667789|P2|Overall Study|Protocol Violation|1
5115384|NCT01780662|17667790|P1|Overall Study|Protocol Violation|0
5115385|NCT01780662|17667788|P3|Overall Study|Physician Decision|7
5115386|NCT01780662|17667789|P2|Overall Study|Physician Decision|5
5115387|NCT01780662|17667790|P1|Overall Study|Physician Decision|0
5115388|NCT01780662|17667788|P3|Overall Study|Adverse Event|2
5115389|NCT01780662|17667789|P2|Overall Study|Adverse Event|0
5115390|NCT01780662|17667790|P1|Overall Study|Adverse Event|1
5115391|NCT01780584|17667807|P3|Overall Study|Protocol Violation|1
5115392|NCT01780584|17667808|P2|Overall Study|Protocol Violation|0
5115393|NCT01780584|17667809|P1|Overall Study|Protocol Violation|0
5115394|NCT01780584|17667807|P3|Overall Study|Adverse Event|0
5115395|NCT01780584|17667808|P2|Overall Study|Adverse Event|1
5115396|NCT01780584|17667809|P1|Overall Study|Adverse Event|0
5115397|NCT01780584|17667807|P3|Overall Study|Death|1
5115398|NCT01780584|17667808|P2|Overall Study|Death|0
5115399|NCT01780584|17667809|P1|Overall Study|Death|1
5115400|NCT01780545|17667831|P2|Overall Study|Lost to Follow-up|1
5115401|NCT01780545|17667832|P1|Overall Study|Lost to Follow-up|1
5115402|NCT01780545|17667831|P2|Overall Study|Withdrawal by Subject|1
5115403|NCT01780545|17667832|P1|Overall Study|Withdrawal by Subject|3
5115404|NCT01780506|17667850|P2|Open-Label Extension Phase|Enrolled but not Treated|1
5115405|NCT01780506|17667851|P1|Open-Label Extension Phase|Enrolled but not Treated|0
5115406|NCT01780506|17667850|P2|Double-Blind Phase|Lost to Follow-up|26
5115407|NCT01780506|17667851|P1|Double-Blind Phase|Lost to Follow-up|23
5115408|NCT01780506|17667850|P2|Double-Blind Phase|Withdrew Consent|24
5115409|NCT01780506|17667851|P1|Double-Blind Phase|Withdrew Consent|23
5115410|NCT01780506|17667850|P2|Double-Blind Phase|Protocol Violation|3
5115411|NCT01780506|17667851|P1|Double-Blind Phase|Protocol Violation|4
5115412|NCT01780506|17667850|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
5115413|NCT01780506|17667851|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
5115414|NCT01780506|17667850|P2|Double-Blind Phase|Investigator's Discretion|2
5115415|NCT01780506|17667851|P1|Double-Blind Phase|Investigator's Discretion|5
5115416|NCT01780506|17667850|P2|Double-Blind Phase|Lack of Efficacy|1
5115417|NCT01780506|17667851|P1|Double-Blind Phase|Lack of Efficacy|1
5115418|NCT01780506|17667850|P2|Double-Blind Phase|Pregnancy|1
5115419|NCT01780506|17667851|P1|Double-Blind Phase|Pregnancy|2
5115420|NCT01780506|17667850|P2|Double-Blind Phase|Death|2
5115421|NCT01780506|17667851|P1|Double-Blind Phase|Death|1
5115422|NCT01780506|17667850|P2|Double-Blind Phase|Adverse Event|14
5115423|NCT01780506|17667851|P1|Double-Blind Phase|Adverse Event|4
5115424|NCT01780506|17667850|P2|Double-Blind Phase|Randomized but not Treated|2
5115425|NCT01780506|17667851|P1|Double-Blind Phase|Randomized but not Treated|3
5115426|NCT01780389|17667909|P1|Overall Study|Adverse Event|1
5115427|NCT01779869|17667947|P1|Overall Study|Physician Decision|2
5115428|NCT01779700|17667953|P2|Overall Study|Withdrawal by Subject|2
5115429|NCT01779700|17667954|P1|Overall Study|Withdrawal by Subject|0
5115430|NCT01779700|17667953|P2|Overall Study|Adverse Event|3
5115431|NCT01779700|17667954|P1|Overall Study|Adverse Event|4
5115432|NCT01779648|17667994|P2|Overall Study|Protocol Violation|0
5115433|NCT01779648|17667995|P1|Overall Study|Protocol Violation|1
5115434|NCT01779440|17668025|P2|Overall Study|Withdrawal by Subject|5
5115435|NCT01779440|17668026|P1|Overall Study|Withdrawal by Subject|3
5115436|NCT01778985|17668091|P2|Overall Study|Protocol Violation|1
5115437|NCT01778985|17668092|P1|Overall Study|Protocol Violation|4
5115438|NCT01778985|17668091|P2|Overall Study|Physician Decision|2
5115439|NCT01778985|17668092|P1|Overall Study|Physician Decision|2
5115440|NCT01778985|17668091|P2|Overall Study|Lost to Follow-up|0
5115441|NCT01778985|17668092|P1|Overall Study|Lost to Follow-up|1
5115442|NCT01778855|17668138|P2|Overall Study|Death|1
5115443|NCT01778855|17668139|P1|Overall Study|Death|0
5115444|NCT01778751|17668147|P2|Overall Study|Transfered care|0
5115445|NCT01778751|17668148|P1|Overall Study|Transfered care|1
5115446|NCT01778751|17668147|P2|Overall Study|Withdrawal by Subject|2
5115447|NCT01778751|17668148|P1|Overall Study|Withdrawal by Subject|0
5115448|NCT01778751|17668147|P2|Overall Study|Lost to Follow-up|0
5115449|NCT01778751|17668148|P1|Overall Study|Lost to Follow-up|1
5115450|NCT01778556|17668205|P2|Long-term Follow-up|noncompliance with metreleptin|0
5115451|NCT01778556|17668206|P1|Long-term Follow-up|noncompliance with metreleptin|1
5115452|NCT01778556|17668205|P2|Intervention 2 (14 Days)|Protocol Violation|0
5115453|NCT01778556|17668206|P1|Intervention 2 (14 Days)|Protocol Violation|1
5115454|NCT01778556|17668205|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
5115455|NCT01778556|17668206|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
5115456|NCT01778556|17668205|P2|Intervention 1 (5 Days)|Protocol Violation|1
5115457|NCT01778556|17668206|P1|Intervention 1 (5 Days)|Protocol Violation|0
5115458|NCT01778530|17668219|P1|Overall Study|Adverse event/side effect|1
5115459|NCT01778530|17668219|P1|Overall Study|Progression on study|1
5115460|NCT01778127|17668261|P3|Overall Study|Withdrawal by Subject|4
5115461|NCT01778127|17668262|P2|Overall Study|Withdrawal by Subject|1
5115462|NCT01778127|17668263|P1|Overall Study|Withdrawal by Subject|3
5115463|NCT01778127|17668261|P3|Overall Study|Lost to Follow-up|2
5115464|NCT01778127|17668262|P2|Overall Study|Lost to Follow-up|1
5115465|NCT01778127|17668263|P1|Overall Study|Lost to Follow-up|5
5115466|NCT01778062|17668306|P2|Overall Study|major protocol deviation|3
5115467|NCT01778062|17668307|P1|Overall Study|major protocol deviation|4
5115468|NCT01778062|17668306|P2|Overall Study|Consent Withdrawal|5
5115469|NCT01778062|17668307|P1|Overall Study|Consent Withdrawal|1
5115470|NCT01778062|17668306|P2|Overall Study|Adverse Event|3
5115471|NCT01778062|17668307|P1|Overall Study|Adverse Event|1
5115472|NCT01778049|17668321|P6|Double Blind Treatment Period|Other reason not defined above|1
5115473|NCT01778049|17668322|P5|Double Blind Treatment Period|Other reason not defined above|2
5115474|NCT01778049|17668323|P4|Double Blind Treatment Period|Other reason not defined above|2
5115475|NCT01778049|17668324|P3|Double Blind Treatment Period|Other reason not defined above|4
5115476|NCT01778049|17668325|P2|Double Blind Treatment Period|Other reason not defined above|0
5115477|NCT01778049|17668326|P1|Double Blind Treatment Period|Other reason not defined above|0
5115478|NCT01778049|17668321|P6|Double Blind Treatment Period|Not treated|0
5115479|NCT01778049|17668322|P5|Double Blind Treatment Period|Not treated|2
5115480|NCT01778049|17668323|P4|Double Blind Treatment Period|Not treated|2
5115481|NCT01778049|17668324|P3|Double Blind Treatment Period|Not treated|0
5115482|NCT01778049|17668325|P2|Double Blind Treatment Period|Not treated|0
5115483|NCT01778049|17668326|P1|Double Blind Treatment Period|Not treated|0
5115484|NCT01778049|17668321|P6|Double Blind Treatment Period|Withdrawal by Subject|1
5115485|NCT01778049|17668322|P5|Double Blind Treatment Period|Withdrawal by Subject|0
5115486|NCT01778049|17668323|P4|Double Blind Treatment Period|Withdrawal by Subject|2
5115487|NCT01778049|17668324|P3|Double Blind Treatment Period|Withdrawal by Subject|1
5115488|NCT01778049|17668325|P2|Double Blind Treatment Period|Withdrawal by Subject|0
5115489|NCT01778049|17668326|P1|Double Blind Treatment Period|Withdrawal by Subject|0
5115490|NCT01778049|17668321|P6|Double Blind Treatment Period|Lost to Follow-up|2
5115491|NCT01778049|17668322|P5|Double Blind Treatment Period|Lost to Follow-up|5
5115492|NCT01778049|17668323|P4|Double Blind Treatment Period|Lost to Follow-up|1
5115493|NCT01778049|17668324|P3|Double Blind Treatment Period|Lost to Follow-up|4
5115494|NCT01778049|17668325|P2|Double Blind Treatment Period|Lost to Follow-up|0
5115495|NCT01778049|17668326|P1|Double Blind Treatment Period|Lost to Follow-up|0
5115496|NCT01778049|17668321|P6|Double Blind Treatment Period|Protocol Violation|0
5115497|NCT01778049|17668322|P5|Double Blind Treatment Period|Protocol Violation|0
5115498|NCT01778049|17668323|P4|Double Blind Treatment Period|Protocol Violation|0
5115499|NCT01778049|17668324|P3|Double Blind Treatment Period|Protocol Violation|2
5115500|NCT01778049|17668325|P2|Double Blind Treatment Period|Protocol Violation|0
5115501|NCT01778049|17668326|P1|Double Blind Treatment Period|Protocol Violation|0
5115502|NCT01778049|17668321|P6|Double Blind Treatment Period|Lack of Efficacy|1
5115503|NCT01778049|17668322|P5|Double Blind Treatment Period|Lack of Efficacy|0
5115504|NCT01778049|17668323|P4|Double Blind Treatment Period|Lack of Efficacy|0
5115505|NCT01778049|17668324|P3|Double Blind Treatment Period|Lack of Efficacy|0
5115506|NCT01778049|17668325|P2|Double Blind Treatment Period|Lack of Efficacy|0
5115507|NCT01778049|17668326|P1|Double Blind Treatment Period|Lack of Efficacy|0
5115508|NCT01778049|17668321|P6|Double Blind Treatment Period|Adverse Event|2
5115509|NCT01778049|17668322|P5|Double Blind Treatment Period|Adverse Event|3
5115510|NCT01778049|17668323|P4|Double Blind Treatment Period|Adverse Event|5
5115511|NCT01778049|17668324|P3|Double Blind Treatment Period|Adverse Event|4
5115512|NCT01778049|17668325|P2|Double Blind Treatment Period|Adverse Event|0
5115513|NCT01778049|17668326|P1|Double Blind Treatment Period|Adverse Event|0
5115514|NCT01778049|17668321|P6|Open Label Treatment Period|Other reason not defined above|0
5115515|NCT01778049|17668322|P5|Open Label Treatment Period|Other reason not defined above|0
5115516|NCT01778049|17668323|P4|Open Label Treatment Period|Other reason not defined above|0
5115517|NCT01778049|17668324|P3|Open Label Treatment Period|Other reason not defined above|0
5115518|NCT01778049|17668325|P2|Open Label Treatment Period|Other reason not defined above|94
5115519|NCT01778049|17668326|P1|Open Label Treatment Period|Other reason not defined above|77
5115520|NCT01778049|17668321|P6|Open Label Treatment Period|Not treated|0
5115521|NCT01778049|17668322|P5|Open Label Treatment Period|Not treated|0
5115522|NCT01778049|17668323|P4|Open Label Treatment Period|Not treated|0
5115523|NCT01778049|17668324|P3|Open Label Treatment Period|Not treated|0
5115524|NCT01778049|17668325|P2|Open Label Treatment Period|Not treated|1
5115525|NCT01778049|17668326|P1|Open Label Treatment Period|Not treated|2
5115526|NCT01778049|17668321|P6|Open Label Treatment Period|Withdrawal by Subject|0
5115527|NCT01778049|17668322|P5|Open Label Treatment Period|Withdrawal by Subject|0
5115528|NCT01778049|17668323|P4|Open Label Treatment Period|Withdrawal by Subject|0
5115529|NCT01778049|17668324|P3|Open Label Treatment Period|Withdrawal by Subject|0
5115530|NCT01778049|17668325|P2|Open Label Treatment Period|Withdrawal by Subject|10
5115531|NCT01778049|17668326|P1|Open Label Treatment Period|Withdrawal by Subject|4
5115532|NCT01778049|17668321|P6|Open Label Treatment Period|Lost to Follow-up|0
5115533|NCT01778049|17668322|P5|Open Label Treatment Period|Lost to Follow-up|0
5115534|NCT01778049|17668323|P4|Open Label Treatment Period|Lost to Follow-up|0
5115535|NCT01778049|17668324|P3|Open Label Treatment Period|Lost to Follow-up|0
5115536|NCT01778049|17668325|P2|Open Label Treatment Period|Lost to Follow-up|3
5115537|NCT01778049|17668326|P1|Open Label Treatment Period|Lost to Follow-up|4
5115538|NCT01778049|17668321|P6|Open Label Treatment Period|Protocol Violation|0
5115539|NCT01778049|17668322|P5|Open Label Treatment Period|Protocol Violation|0
5115540|NCT01778049|17668323|P4|Open Label Treatment Period|Protocol Violation|0
5115541|NCT01778049|17668324|P3|Open Label Treatment Period|Protocol Violation|0
5115542|NCT01778049|17668325|P2|Open Label Treatment Period|Protocol Violation|5
5115543|NCT01778049|17668326|P1|Open Label Treatment Period|Protocol Violation|5
5115544|NCT01778049|17668321|P6|Open Label Treatment Period|Lack of Efficacy|0
5115545|NCT01778049|17668322|P5|Open Label Treatment Period|Lack of Efficacy|0
5115546|NCT01778049|17668323|P4|Open Label Treatment Period|Lack of Efficacy|0
5115547|NCT01778049|17668324|P3|Open Label Treatment Period|Lack of Efficacy|0
5115548|NCT01778049|17668325|P2|Open Label Treatment Period|Lack of Efficacy|1
5115549|NCT01778049|17668326|P1|Open Label Treatment Period|Lack of Efficacy|1
5115550|NCT01778049|17668321|P6|Open Label Treatment Period|Adverse Event|0
5115551|NCT01778049|17668322|P5|Open Label Treatment Period|Adverse Event|0
5115552|NCT01778049|17668323|P4|Open Label Treatment Period|Adverse Event|0
5115553|NCT01778049|17668324|P3|Open Label Treatment Period|Adverse Event|0
5115554|NCT01778049|17668325|P2|Open Label Treatment Period|Adverse Event|15
5115555|NCT01778049|17668326|P1|Open Label Treatment Period|Adverse Event|5
5115556|NCT01778023|17668344|P2|Overall Study|Withdrawal by Subject|3
5115557|NCT01778023|17668345|P1|Overall Study|Withdrawal by Subject|0
5115558|NCT01778010|17668362|P1|Overall Study|rash while on placebo|1
5115559|NCT01778010|17668362|P1|Overall Study|Arrested|1
5115560|NCT01778010|17668362|P1|Overall Study|abnormal ECG before meds|1
5115561|NCT01778010|17668362|P1|Overall Study|Withdrawal by Subject|2
5115562|NCT01777997|17668403|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
5115563|NCT01777997|17668403|P1|Weeks 48 to 72/96 on ART|Death|1
5115564|NCT01777997|17668403|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
5115565|NCT01777997|17668403|P1|12 Week lead-in of no ART|Severe debilitation|2
5115566|NCT01777932|17668425|P1|Overall Study|Patient refused further treatment|10
5115567|NCT01777932|17668425|P1|Overall Study|Reimbursement limit|9
5115568|NCT01777932|17668425|P1|Overall Study|Investigator decision|10
5115569|NCT01777932|17668425|P1|Overall Study|Lost to Follow-up|3
5115570|NCT01777932|17668425|P1|Overall Study|Adverse Event|34
5115571|NCT01777932|17668425|P1|Overall Study|Death|3
5115572|NCT01777932|17668425|P1|Overall Study|Disease progression|136
5115573|NCT01777854|17668439|P2|Overall Study|Physician Decision|3
5115574|NCT01777854|17668440|P1|Overall Study|Physician Decision|3
5115575|NCT01777776|17668448|P4|Overall Study|Withdrawal by Subject|1
5115576|NCT01777776|17668449|P3|Overall Study|Withdrawal by Subject|0
5115577|NCT01777776|17668450|P2|Overall Study|Withdrawal by Subject|0
5115578|NCT01777776|17668451|P1|Overall Study|Withdrawal by Subject|0
5115579|NCT01777776|17668448|P4|Overall Study|Disease Progression|3
5115580|NCT01777776|17668449|P3|Overall Study|Disease Progression|6
5115581|NCT01777776|17668450|P2|Overall Study|Disease Progression|8
5115582|NCT01777776|17668451|P1|Overall Study|Disease Progression|4
5115583|NCT01777776|17668448|P4|Overall Study|Adverse Event|0
5115584|NCT01777776|17668449|P3|Overall Study|Adverse Event|0
5115585|NCT01777776|17668450|P2|Overall Study|Adverse Event|4
5115586|NCT01777776|17668451|P1|Overall Study|Adverse Event|2
5115587|NCT01777763|17668510|P2|Overall Study|Treatment Failure|6
5115588|NCT01777763|17668511|P1|Overall Study|Treatment Failure|1
5115589|NCT01777763|17668510|P2|Overall Study|Withdrawal by Subject|2
5115590|NCT01777763|17668511|P1|Overall Study|Withdrawal by Subject|0
5115591|NCT01777763|17668510|P2|Overall Study|Protocol Violation|7
5115592|NCT01777763|17668511|P1|Overall Study|Protocol Violation|1
5115593|NCT01777763|17668510|P2|Overall Study|Adverse Event|32
5115594|NCT01777763|17668511|P1|Overall Study|Adverse Event|2
5115595|NCT01777620|17668535|P2|Overall Study|Subject Withdrawal|0
5115596|NCT01777620|17668536|P1|Overall Study|Subject Withdrawal|1
5115597|NCT01777581|17668562|P2|Overall Study|Lack of Efficacy|1
5115598|NCT01777581|17668563|P1|Overall Study|Lack of Efficacy|0
5115599|NCT01777581|17668562|P2|Overall Study|Adverse Event|0
5115600|NCT01777581|17668563|P1|Overall Study|Adverse Event|2
5115601|NCT01777581|17668562|P2|Overall Study|Lost to Follow-up|1
5115602|NCT01777581|17668563|P1|Overall Study|Lost to Follow-up|1
5115603|NCT01777542|17668592|P2|Second Intervention (20 Weeks)|Adverse Event|1
5115604|NCT01777542|17668593|P1|Second Intervention (20 Weeks)|Adverse Event|0
5115605|NCT01777490|17668636|P4|Overall Study|Dyad withdrew with data use prohibition|1
5115606|NCT01777490|17668637|P3|Overall Study|Dyad withdrew with data use prohibition|1
5115607|NCT01777490|17668638|P2|Overall Study|Dyad withdrew with data use prohibition|0
5115608|NCT01777490|17668639|P1|Overall Study|Dyad withdrew with data use prohibition|0
5115609|NCT01777334|17668684|P2|Overall Study|Withdrawal by Subject|11
5115610|NCT01777334|17668685|P1|Overall Study|Withdrawal by Subject|14
5115611|NCT01777334|17668684|P2|Overall Study|Lost to Follow-up|2
5115612|NCT01777334|17668685|P1|Overall Study|Lost to Follow-up|3
5115613|NCT01777334|17668684|P2|Overall Study|Protocol Violation|7
5115614|NCT01777334|17668685|P1|Overall Study|Protocol Violation|3
5115615|NCT01777334|17668684|P2|Overall Study|Lack of Efficacy|29
5115616|NCT01777334|17668685|P1|Overall Study|Lack of Efficacy|15
5115617|NCT01777334|17668684|P2|Overall Study|Adverse Event|14
5115618|NCT01777334|17668685|P1|Overall Study|Adverse Event|18
5115619|NCT01777321|17668695|P2|Overall Study|Withdrawal by Subject|1
5115620|NCT01777321|17668696|P1|Overall Study|Withdrawal by Subject|0
5115621|NCT01777308|17668734|P2|Overall Study|Blood draw refusal at Visit 3|0
5115622|NCT01777308|17668735|P1|Overall Study|Blood draw refusal at Visit 3|1
5115623|NCT01777308|17668734|P2|Overall Study|Lost to Follow-up|2
5115624|NCT01777308|17668735|P1|Overall Study|Lost to Follow-up|7
5115625|NCT01777308|17668734|P2|Overall Study|Migrated/moved from study area|0
5115626|NCT01777308|17668735|P1|Overall Study|Migrated/moved from study area|1
5115627|NCT01777308|17668734|P2|Overall Study|Withdrawal by Subject|1
5115628|NCT01777308|17668735|P1|Overall Study|Withdrawal by Subject|5
5115629|NCT01777295|17668767|P2|Overall Study|Investigator call for AEs check|0
5115630|NCT01777295|17668768|P1|Overall Study|Investigator call for AEs check|1
5115631|NCT01777295|17668767|P2|Overall Study|Personal problem|0
5115632|NCT01777295|17668768|P1|Overall Study|Personal problem|1
5115633|NCT01777295|17668767|P2|Overall Study|Pregnancy|1
5115634|NCT01777295|17668768|P1|Overall Study|Pregnancy|0
5115635|NCT01777295|17668767|P2|Overall Study|Withdrawal by Subject|2
5115636|NCT01777295|17668768|P1|Overall Study|Withdrawal by Subject|2
5115637|NCT01777282|17668975|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
5115638|NCT01777282|17668976|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
5115639|NCT01777282|17668977|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
5115640|NCT01777282|17668978|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
5115641|NCT01777282|17668979|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
5115642|NCT01777282|17668975|P5|Overall Study|Protocol Violation|2
5115643|NCT01777282|17668976|P4|Overall Study|Protocol Violation|0
5115644|NCT01777282|17668977|P3|Overall Study|Protocol Violation|1
5115645|NCT01777282|17668978|P2|Overall Study|Protocol Violation|0
5115646|NCT01777282|17668979|P1|Overall Study|Protocol Violation|2
5115647|NCT01777282|17668975|P5|Overall Study|Withdrawal by Subject|2
5115648|NCT01777282|17668976|P4|Overall Study|Withdrawal by Subject|1
5115649|NCT01777282|17668977|P3|Overall Study|Withdrawal by Subject|0
5115650|NCT01777282|17668978|P2|Overall Study|Withdrawal by Subject|0
5115651|NCT01777282|17668979|P1|Overall Study|Withdrawal by Subject|4
5115652|NCT01777282|17668975|P5|Overall Study|Adverse Event|3
5115653|NCT01777282|17668976|P4|Overall Study|Adverse Event|1
5115654|NCT01777282|17668977|P3|Overall Study|Adverse Event|2
5115655|NCT01777282|17668978|P2|Overall Study|Adverse Event|4
5115656|NCT01777282|17668979|P1|Overall Study|Adverse Event|4
5115657|NCT01777282|17668975|P5|Overall Study|New Antidiabetic Medication|0
5115658|NCT01777282|17668976|P4|Overall Study|New Antidiabetic Medication|0
5115659|NCT01777282|17668977|P3|Overall Study|New Antidiabetic Medication|1
5115660|NCT01777282|17668978|P2|Overall Study|New Antidiabetic Medication|0
5115661|NCT01777282|17668979|P1|Overall Study|New Antidiabetic Medication|0
5115662|NCT01777282|17668975|P5|Overall Study|Persistent Hyperglycemia|0
5115663|NCT01777282|17668976|P4|Overall Study|Persistent Hyperglycemia|0
5115664|NCT01777282|17668977|P3|Overall Study|Persistent Hyperglycemia|1
5115665|NCT01777282|17668978|P2|Overall Study|Persistent Hyperglycemia|0
5115666|NCT01777282|17668979|P1|Overall Study|Persistent Hyperglycemia|0
5115667|NCT01777269|17669023|P2|Overall Study|Withdrawal by Subject|9
5115668|NCT01777269|17669024|P1|Overall Study|Withdrawal by Subject|9
5115669|NCT01777269|17669023|P2|Overall Study|Physician Decision|2
5115670|NCT01777269|17669024|P1|Overall Study|Physician Decision|5
5115671|NCT01777269|17669023|P2|Overall Study|Lost to Follow-up|0
5115672|NCT01777269|17669024|P1|Overall Study|Lost to Follow-up|4
5115673|NCT01777269|17669023|P2|Overall Study|Participants reached stopping criteria|1
5115674|NCT01777269|17669024|P1|Overall Study|Participants reached stopping criteria|1
5115675|NCT01777269|17669023|P2|Overall Study|Protocol Violation|4
5115676|NCT01777269|17669024|P1|Overall Study|Protocol Violation|4
5115677|NCT01777269|17669023|P2|Overall Study|Lack of Efficacy|10
5115678|NCT01777269|17669024|P1|Overall Study|Lack of Efficacy|8
5115679|NCT01777269|17669023|P2|Overall Study|Adverse Event|33
5115680|NCT01777269|17669024|P1|Overall Study|Adverse Event|24
5115681|NCT01777191|17669061|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
5115682|NCT01777191|17669062|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
5115683|NCT01777191|17669061|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
5115684|NCT01777191|17669062|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
5115685|NCT01777191|17669061|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
5115686|NCT01777191|17669062|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
5115687|NCT01777191|17669061|P2|Safety Extension Per (Week 12-Week 48)|Death|1
5115688|NCT01777191|17669062|P1|Safety Extension Per (Week 12-Week 48)|Death|0
5115689|NCT01777191|17669061|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
5115690|NCT01777191|17669062|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
5115691|NCT01777191|17669061|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
5115692|NCT01777191|17669062|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
5115693|NCT01777191|17669061|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
5115694|NCT01777191|17669062|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
5115695|NCT01777191|17669061|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
5115696|NCT01777191|17669062|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
5115697|NCT01777191|17669061|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
5115698|NCT01777191|17669062|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
5115699|NCT01777191|17669061|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
5115700|NCT01777191|17669062|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
5115701|NCT01777191|17669061|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
5115702|NCT01777191|17669062|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
5115703|NCT01777152|17669092|P2|Overall Study|Change of diagnosis|0
5115704|NCT01777152|17669093|P1|Overall Study|Change of diagnosis|1
5115705|NCT01777152|17669092|P2|Overall Study|Not eligible, no study drug received|0
5115706|NCT01777152|17669093|P1|Overall Study|Not eligible, no study drug received|1
5115707|NCT01777152|17669092|P2|Overall Study|Death|73
5115708|NCT01777152|17669093|P1|Overall Study|Death|51
5115709|NCT01777152|17669092|P2|Overall Study|Lost to Follow-up|4
5115710|NCT01777152|17669093|P1|Overall Study|Lost to Follow-up|0
5115711|NCT01777152|17669092|P2|Overall Study|Withdrawal by Subject|10
5115712|NCT01777152|17669093|P1|Overall Study|Withdrawal by Subject|16
5115713|NCT01777152|17669092|P2|Overall Study|In Follow Up|139
5115714|NCT01777152|17669093|P1|Overall Study|In Follow Up|157
5115715|NCT01777139|17669109|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
5115716|NCT01777139|17669110|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
5115717|NCT01777139|17669109|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
5115718|NCT01777139|17669110|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
5115885|NCT01774968|17669901|P2|Overall Study|Lost to Follow-up|3
5115719|NCT01777139|17669109|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
5115720|NCT01777139|17669110|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
5115721|NCT01777139|17669109|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
5115722|NCT01777139|17669110|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
5115723|NCT01777139|17669109|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
5115724|NCT01777139|17669110|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
5115725|NCT01777139|17669109|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
5115726|NCT01777139|17669110|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
5115727|NCT01777139|17669109|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
5115728|NCT01777139|17669110|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
5115729|NCT01777139|17669109|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
5115730|NCT01777139|17669110|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
5115731|NCT01776554|17669224|P2|Overall Study|Unclassified|1
5115732|NCT01776554|17669225|P1|Overall Study|Unclassified|4
5115733|NCT01776554|17669224|P2|Overall Study|Protocol Violation|0
5115734|NCT01776554|17669225|P1|Overall Study|Protocol Violation|1
5115735|NCT01776554|17669224|P2|Overall Study|Administrative Reason|5
5115736|NCT01776554|17669225|P1|Overall Study|Administrative Reason|2
5115737|NCT01776554|17669224|P2|Overall Study|Lost to Follow-up|9
5115738|NCT01776554|17669225|P1|Overall Study|Lost to Follow-up|6
5115739|NCT01776554|17669224|P2|Overall Study|Withdrawal by Subject|8
5115740|NCT01776554|17669225|P1|Overall Study|Withdrawal by Subject|3
5115741|NCT01776554|17669224|P2|Overall Study|Adverse Event|0
5115742|NCT01776554|17669225|P1|Overall Study|Adverse Event|1
5115743|NCT01776541|17669268|P2|Overall Study|Withdrawal by Subject|20
5115744|NCT01776541|17669269|P1|Overall Study|Withdrawal by Subject|12
5115745|NCT01776541|17669268|P2|Overall Study|Protocol Violation|1
5115746|NCT01776541|17669269|P1|Overall Study|Protocol Violation|2
5115747|NCT01776541|17669268|P2|Overall Study|Unclassified|4
5115748|NCT01776541|17669269|P1|Overall Study|Unclassified|5
5115749|NCT01776541|17669268|P2|Overall Study|Lost to Follow-up|48
5115750|NCT01776541|17669269|P1|Overall Study|Lost to Follow-up|27
5115751|NCT01776541|17669268|P2|Overall Study|Death|0
5115752|NCT01776541|17669269|P1|Overall Study|Death|4
5115753|NCT01776541|17669268|P2|Overall Study|Administrative Reason|2
5115754|NCT01776541|17669269|P1|Overall Study|Administrative Reason|6
5115755|NCT01776424|17669291|P3|Overall Study|Withdrawal by Subject|15
5115756|NCT01776424|17669292|P2|Overall Study|Withdrawal by Subject|11
5115757|NCT01776424|17669293|P1|Overall Study|Withdrawal by Subject|10
5115758|NCT01776424|17669291|P3|Overall Study|Lost to Follow-up|9
5115759|NCT01776424|17669292|P2|Overall Study|Lost to Follow-up|8
5115760|NCT01776424|17669293|P1|Overall Study|Lost to Follow-up|10
5115761|NCT01776008|17669324|P1|Overall Study|ineligible|2
5115762|NCT01775995|17669338|P2|Overall Study|Lost to Follow-up|1
5115763|NCT01775995|17669339|P1|Overall Study|Lost to Follow-up|1
5115764|NCT01775930|17669399|P1|Overall Study|Futility stopping boundary met|1
5115765|NCT01775904|17669407|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
5115766|NCT01775904|17669407|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
5115767|NCT01775787|17669473|P2|Second 7-10 Days|concerns with using IV|1
5115768|NCT01775787|17669474|P1|Second 7-10 Days|concerns with using IV|0
5115769|NCT01775787|17669473|P2|Second 7-10 Days|time commitment|1
5115770|NCT01775787|17669474|P1|Second 7-10 Days|time commitment|0
5115771|NCT01775787|17669473|P2|First 7-10 Days|concerns with using IV|2
5115772|NCT01775787|17669474|P1|First 7-10 Days|concerns with using IV|1
5115773|NCT01775787|17669473|P2|First 7-10 Days|time commitment|2
5115774|NCT01775787|17669474|P1|First 7-10 Days|time commitment|0
5115775|NCT01775787|17669473|P2|First 7-10 Days|family emergency|1
5115776|NCT01775787|17669474|P1|First 7-10 Days|family emergency|0
5115777|NCT01775787|17669473|P2|First 7-10 Days|Adverse Event|1
5115778|NCT01775787|17669474|P1|First 7-10 Days|Adverse Event|0
5115779|NCT01775670|17669530|P2|Overall Study|Lost to Follow-up|1
5115780|NCT01775670|17669531|P1|Overall Study|Lost to Follow-up|1
5115781|NCT01775553|17669557|P1|Overall Study|Disease Progression|12
5115782|NCT01775553|17669557|P1|Overall Study|Adverse Event|1
5115783|NCT01775501|17669565|P1|Overall Study|Discontinued prior to treatment|1
5115784|NCT01775189|17669574|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
5115785|NCT01775189|17669575|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
5115786|NCT01775189|17669576|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
5115787|NCT01775189|17669577|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
5115788|NCT01775189|17669578|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
5115789|NCT01775189|17669579|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
5115790|NCT01775189|17669580|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
5115791|NCT01775189|17669574|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
5115792|NCT01775189|17669575|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
5115793|NCT01775189|17669576|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
5115794|NCT01775189|17669577|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
5115795|NCT01775189|17669578|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
5115796|NCT01775189|17669579|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
5115797|NCT01775189|17669580|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
5115798|NCT01775189|17669574|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
5115799|NCT01775189|17669575|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
5115800|NCT01775189|17669576|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
5115801|NCT01775189|17669577|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
5115802|NCT01775189|17669578|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
5115803|NCT01775189|17669579|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
5115804|NCT01775189|17669580|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
5115805|NCT01775189|17669574|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5115806|NCT01775189|17669575|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5115807|NCT01775189|17669576|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5115808|NCT01775189|17669577|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5115809|NCT01775189|17669578|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
5115810|NCT01775189|17669579|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
5115811|NCT01775189|17669580|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5115812|NCT01775189|17669574|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
5115813|NCT01775189|17669575|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
5115814|NCT01775189|17669576|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
5115815|NCT01775189|17669577|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
5115816|NCT01775189|17669578|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
5115817|NCT01775189|17669579|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
5115818|NCT01775189|17669580|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
5115819|NCT01775189|17669574|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
5115820|NCT01775189|17669575|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
5115821|NCT01775189|17669576|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
5115822|NCT01775189|17669577|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
5115823|NCT01775189|17669578|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
5115824|NCT01775189|17669579|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
5115825|NCT01775189|17669580|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
5115826|NCT01775137|17669799|P1|Overall Study|Withdrawal by participants|5
5115827|NCT01775137|17669799|P1|Overall Study|Adverse Event|1
5115828|NCT01775137|17669799|P1|Overall Study|Unsatisfactory therapeutic effect|2
5115829|NCT01775137|17669799|P1|Overall Study|Protocol deviation|2
5115830|NCT01775137|17669799|P1|Overall Study|Death|1
5115831|NCT01775124|17669826|P2|Extension Period|Withdrawal by Subject|12
5115832|NCT01775124|17669827|P1|Extension Period|Withdrawal by Subject|9
5115833|NCT01775124|17669826|P2|Extension Period|Lost to Follow-up|1
5115834|NCT01775124|17669827|P1|Extension Period|Lost to Follow-up|0
5115835|NCT01775124|17669826|P2|Extension Period|Administrative problems|1
5115836|NCT01775124|17669827|P1|Extension Period|Administrative problems|0
5115837|NCT01775124|17669826|P2|Extension Period|Physician Decision|2
5115838|NCT01775124|17669827|P1|Extension Period|Physician Decision|0
5115839|NCT01775124|17669826|P2|Extension Period|Adverse Event|2
5115840|NCT01775124|17669827|P1|Extension Period|Adverse Event|3
5115841|NCT01775124|17669826|P2|Core Period|Adverse Event|5
5115842|NCT01775124|17669827|P1|Core Period|Adverse Event|5
5115843|NCT01775124|17669826|P2|Core Period|Withdrawal by Subject|2
5115844|NCT01775124|17669827|P1|Core Period|Withdrawal by Subject|4
5115845|NCT01775124|17669826|P2|Core Period|Administrative problems|0
5115846|NCT01775124|17669827|P1|Core Period|Administrative problems|1
5115847|NCT01775124|17669826|P2|Core Period|Death|1
5115848|NCT01775124|17669827|P1|Core Period|Death|0
5115849|NCT01775124|17669826|P2|Core Period|Physician Decision|1
5115850|NCT01775124|17669827|P1|Core Period|Physician Decision|1
5115851|NCT01775124|17669826|P2|Core Period|Disease Progression|1
5115852|NCT01775124|17669827|P1|Core Period|Disease Progression|0
5115853|NCT01774981|17669862|P8|Overall Study|Death|0
5115854|NCT01774981|17669863|P7|Overall Study|Death|0
5115855|NCT01774981|17669864|P6|Overall Study|Death|0
5115856|NCT01774981|17669865|P5|Overall Study|Death|1
5115857|NCT01774981|17669866|P4|Overall Study|Death|0
5115858|NCT01774981|17669867|P3|Overall Study|Death|0
5115859|NCT01774981|17669868|P2|Overall Study|Death|0
5115860|NCT01774981|17669869|P1|Overall Study|Death|0
5115861|NCT01774981|17669862|P8|Overall Study|Withdrawal by Subject|1
5115862|NCT01774981|17669863|P7|Overall Study|Withdrawal by Subject|0
5115863|NCT01774981|17669864|P6|Overall Study|Withdrawal by Subject|0
5115864|NCT01774981|17669865|P5|Overall Study|Withdrawal by Subject|0
5115865|NCT01774981|17669866|P4|Overall Study|Withdrawal by Subject|0
5115866|NCT01774981|17669867|P3|Overall Study|Withdrawal by Subject|0
5115867|NCT01774981|17669868|P2|Overall Study|Withdrawal by Subject|0
5115868|NCT01774981|17669869|P1|Overall Study|Withdrawal by Subject|0
5115869|NCT01774981|17669862|P8|Overall Study|Adverse Event|0
5115870|NCT01774981|17669863|P7|Overall Study|Adverse Event|0
5115871|NCT01774981|17669864|P6|Overall Study|Adverse Event|1
5115872|NCT01774981|17669865|P5|Overall Study|Adverse Event|0
5115873|NCT01774981|17669866|P4|Overall Study|Adverse Event|0
5115874|NCT01774981|17669867|P3|Overall Study|Adverse Event|0
5115875|NCT01774981|17669868|P2|Overall Study|Adverse Event|0
5115876|NCT01774981|17669869|P1|Overall Study|Adverse Event|0
5115877|NCT01774968|17669901|P2|Overall Study|Withdrawal by Subject|11
5115878|NCT01774968|17669902|P1|Overall Study|Withdrawal by Subject|6
5115879|NCT01774968|17669901|P2|Overall Study|Sponsor Decision|2
5115880|NCT01774968|17669902|P1|Overall Study|Sponsor Decision|0
5115881|NCT01774968|17669901|P2|Overall Study|Protocol Violation|13
5115882|NCT01774968|17669902|P1|Overall Study|Protocol Violation|14
5115883|NCT01774968|17669901|P2|Overall Study|Physician Decision|1
5115884|NCT01774968|17669902|P1|Overall Study|Physician Decision|5
5115886|NCT01774968|17669902|P1|Overall Study|Lost to Follow-up|1
5115887|NCT01774968|17669901|P2|Overall Study|Death|1
5115888|NCT01774968|17669902|P1|Overall Study|Death|0
5115889|NCT01774968|17669901|P2|Overall Study|Adverse Event|4
5115890|NCT01774968|17669902|P1|Overall Study|Adverse Event|4
5115891|NCT01774929|17669936|P1|Overall Study|Adverse Event|3
5115892|NCT01774903|17669942|P1|Overall Study|Ineligible to continue the trial|1
5115893|NCT01774903|17669942|P1|Overall Study|Lack of Efficacy|1
5115894|NCT01774903|17669942|P1|Overall Study|Withdrawal by Subject|2
5115895|NCT01774903|17669942|P1|Overall Study|Adverse Event|7
5115896|NCT01774799|17669962|P4|Overall Study|Lost to Follow-up|0
5115897|NCT01774799|17669963|P3|Overall Study|Lost to Follow-up|0
5115898|NCT01774799|17669964|P2|Overall Study|Lost to Follow-up|1
5115899|NCT01774799|17669965|P1|Overall Study|Lost to Follow-up|1
5115900|NCT01774786|17669981|P2|Overall Study|Ineligible for Study|3
5115901|NCT01774786|17669982|P1|Overall Study|Ineligible for Study|1
5115902|NCT01774786|17669981|P2|Overall Study|Physician Decision|0
5115903|NCT01774786|17669982|P1|Overall Study|Physician Decision|1
5115904|NCT01774786|17669981|P2|Overall Study|Withdrawal by Subject|12
5115905|NCT01774786|17669982|P1|Overall Study|Withdrawal by Subject|15
5115906|NCT01774786|17669981|P2|Overall Study|Lost to Follow-up|4
5115907|NCT01774786|17669982|P1|Overall Study|Lost to Follow-up|3
5115908|NCT01774786|17669981|P2|Overall Study|Death|262
5115909|NCT01774786|17669982|P1|Overall Study|Death|242
5115910|NCT01774786|17669981|P2|Overall Study|In Follow-up|62
5115911|NCT01774786|17669982|P1|Overall Study|In Follow-up|65
5115912|NCT01774786|17669981|P2|Overall Study|Between Treatment and Follow-up|2
5115913|NCT01774786|17669982|P1|Overall Study|Between Treatment and Follow-up|6
5115914|NCT01774786|17669981|P2|Overall Study|On Treatment|47
5115915|NCT01774786|17669982|P1|Overall Study|On Treatment|55
5115916|NCT01774721|17670016|P2|Overall Study|Ongoing in study|120
5115917|NCT01774721|17670017|P1|Overall Study|Ongoing in study|136
5115918|NCT01774721|17670016|P2|Overall Study|Did not meet eligibility criteria|3
5115919|NCT01774721|17670017|P1|Overall Study|Did not meet eligibility criteria|0
5115920|NCT01774721|17670016|P2|Overall Study|Lost to Follow-up|1
5115921|NCT01774721|17670017|P1|Overall Study|Lost to Follow-up|1
5115922|NCT01774721|17670016|P2|Overall Study|Withdrawal by Subject|10
5115923|NCT01774721|17670017|P1|Overall Study|Withdrawal by Subject|14
5115924|NCT01774721|17670016|P2|Overall Study|Death|91
5115925|NCT01774721|17670017|P1|Overall Study|Death|76
5115926|NCT01774591|17670082|P2|Overall Study|Adverse Event|2
5115927|NCT01774591|17670083|P1|Overall Study|Adverse Event|0
5115928|NCT01774591|17670082|P2|Overall Study|Withdrawal by Subject|1
5115929|NCT01774591|17670083|P1|Overall Study|Withdrawal by Subject|0
5115930|NCT01774591|17670082|P2|Overall Study|Physician Decision|1
5115931|NCT01774591|17670083|P1|Overall Study|Physician Decision|1
5115932|NCT01774370|17670093|P1|Overall Study|Follow-up failure|34
5115933|NCT01774370|17670093|P1|Overall Study|Violated inclusion/exclusion criteria|53
5115934|NCT01774370|17670093|P1|Overall Study|Subjects of contraindications|34
5115935|NCT01774370|17670093|P1|Overall Study|Administered prior to the contract date|4
5115936|NCT01774370|17670093|P1|Overall Study|Never taken the PRADAXA during the study|4
5115937|NCT01774344|17670101|P2|Overall Study|Did not enter Survival Follow up|83
5115938|NCT01774344|17670102|P1|Overall Study|Did not enter Survival Follow up|49
5115939|NCT01774344|17670101|P2|Overall Study|Other|1
5115940|NCT01774344|17670102|P1|Overall Study|Other|0
5115941|NCT01774344|17670101|P2|Overall Study|Data collection finished|14
5115942|NCT01774344|17670102|P1|Overall Study|Data collection finished|4
5115943|NCT01774344|17670101|P2|Overall Study|End of survival follow-up not available|2
5115944|NCT01774344|17670102|P1|Overall Study|End of survival follow-up not available|2
5115945|NCT01774344|17670101|P2|Overall Study|Lost to Follow-up|10
5115946|NCT01774344|17670102|P1|Overall Study|Lost to Follow-up|4
5115947|NCT01774344|17670101|P2|Overall Study|Protocol Violation|1
5115948|NCT01774344|17670102|P1|Overall Study|Protocol Violation|0
5115949|NCT01774344|17670101|P2|Overall Study|Withdrawal by Subject|10
5115950|NCT01774344|17670102|P1|Overall Study|Withdrawal by Subject|3
5115951|NCT01774305|17670120|P2|Overall Study|Physician Decision|0
5115952|NCT01774305|17670121|P1|Overall Study|Physician Decision|1
5115953|NCT01774253|17670129|P1|Overall Study|Death|1
5115954|NCT01774253|17670129|P1|Overall Study|Withdrawal by Subject|2
5115955|NCT01774253|17670129|P1|Overall Study|Physician Decision|2
5115956|NCT01774253|17670129|P1|Overall Study|Lack of Efficacy|4
5115957|NCT01774110|17670148|P1|Overall Study|Lost to Follow-up|7
5115958|NCT01774097|17670156|P2|Overall Study|Adverse Event|1
5115959|NCT01774097|17670157|P1|Overall Study|Adverse Event|1
5115960|NCT01774097|17670156|P2|Overall Study|Withdrawal by Subject|1
5115961|NCT01774097|17670157|P1|Overall Study|Withdrawal by Subject|1
5115962|NCT01774084|17670187|P2|Overall Study|Personal reasons|0
5115963|NCT01774084|17670188|P1|Overall Study|Personal reasons|1
5115964|NCT01773993|17670213|P1|Overall Study|No Visit After Treatment|35
5115965|NCT01773967|17670232|P2|Overall Study|Lost to Follow-up|13
5115966|NCT01773967|17670233|P1|Overall Study|Lost to Follow-up|15
5115967|NCT01773889|17670248|P1|Overall Study|lack of funding|2
5115968|NCT01773473|17670254|P2|Overall Study|Lost to Follow-up|0
5115969|NCT01773473|17670255|P1|Overall Study|Lost to Follow-up|2
5115970|NCT01773473|17670254|P2|Overall Study|Withdrawal by Subject|3
5115971|NCT01773473|17670255|P1|Overall Study|Withdrawal by Subject|5
5115972|NCT01773473|17670254|P2|Overall Study|Non-Compliance with study drug|4
5115973|NCT01773473|17670255|P1|Overall Study|Non-Compliance with study drug|1
5115974|NCT01773473|17670254|P2|Overall Study|Lack of Efficacy|1
5115975|NCT01773473|17670255|P1|Overall Study|Lack of Efficacy|0
5115976|NCT01773473|17670254|P2|Overall Study|Sponsor Decision|0
5115977|NCT01773473|17670255|P1|Overall Study|Sponsor Decision|2
5115978|NCT01773473|17670254|P2|Overall Study|Physician Decision|5
5115979|NCT01773473|17670255|P1|Overall Study|Physician Decision|3
5115980|NCT01773473|17670254|P2|Overall Study|Protocol Violation|4
5115981|NCT01773473|17670255|P1|Overall Study|Protocol Violation|0
5115982|NCT01773473|17670254|P2|Overall Study|Adverse Event|2
5115983|NCT01773473|17670255|P1|Overall Study|Adverse Event|3
5115984|NCT01773421|17670277|P7|Extension Phase|Adverse Event|0
5115985|NCT01773421|17670278|P6|Extension Phase|Adverse Event|0
5115986|NCT01773421|17670279|P5|Extension Phase|Adverse Event|2
5115987|NCT01773421|17670280|P4|Extension Phase|Adverse Event|0
5115988|NCT01773421|17670281|P3|Extension Phase|Adverse Event|0
5115989|NCT01773421|17670282|P2|Extension Phase|Adverse Event|0
5115990|NCT01773421|17670283|P1|Extension Phase|Adverse Event|0
5115991|NCT01773421|17670277|P7|Extension Phase|Other|0
5115992|NCT01773421|17670278|P6|Extension Phase|Other|2
5115993|NCT01773421|17670279|P5|Extension Phase|Other|1
5115994|NCT01773421|17670280|P4|Extension Phase|Other|0
5115995|NCT01773421|17670281|P3|Extension Phase|Other|0
5115996|NCT01773421|17670282|P2|Extension Phase|Other|0
5115997|NCT01773421|17670283|P1|Extension Phase|Other|0
5115998|NCT01773421|17670277|P7|Treatment Phase|Withdrawal by Subject|0
5115999|NCT01773421|17670278|P6|Treatment Phase|Withdrawal by Subject|0
5116000|NCT01773421|17670279|P5|Treatment Phase|Withdrawal by Subject|0
5116001|NCT01773421|17670280|P4|Treatment Phase|Withdrawal by Subject|1
5116002|NCT01773421|17670281|P3|Treatment Phase|Withdrawal by Subject|1
5116003|NCT01773421|17670282|P2|Treatment Phase|Withdrawal by Subject|0
5116004|NCT01773421|17670283|P1|Treatment Phase|Withdrawal by Subject|0
5116005|NCT01773421|17670277|P7|Treatment Phase|Adverse Event|0
5116006|NCT01773421|17670278|P6|Treatment Phase|Adverse Event|0
5116007|NCT01773421|17670279|P5|Treatment Phase|Adverse Event|0
5116008|NCT01773421|17670280|P4|Treatment Phase|Adverse Event|1
5116009|NCT01773421|17670281|P3|Treatment Phase|Adverse Event|3
5116010|NCT01773421|17670282|P2|Treatment Phase|Adverse Event|0
5116011|NCT01773421|17670283|P1|Treatment Phase|Adverse Event|0
5116012|NCT01773421|17670277|P7|Treatment Phase|Other|0
5116013|NCT01773421|17670278|P6|Treatment Phase|Other|0
5116014|NCT01773421|17670279|P5|Treatment Phase|Other|0
5116015|NCT01773421|17670280|P4|Treatment Phase|Other|0
5116016|NCT01773421|17670281|P3|Treatment Phase|Other|2
5116017|NCT01773421|17670282|P2|Treatment Phase|Other|0
5116018|NCT01773421|17670283|P1|Treatment Phase|Other|0
5116019|NCT01773291|17670314|P3|Overall Study|Withdrawal by Subject|1
5116020|NCT01773291|17670315|P2|Overall Study|Withdrawal by Subject|0
5116021|NCT01773291|17670316|P1|Overall Study|Withdrawal by Subject|0
5116022|NCT01773291|17670314|P3|Overall Study|Protocol Violation|0
5116023|NCT01773291|17670315|P2|Overall Study|Protocol Violation|0
5116024|NCT01773291|17670316|P1|Overall Study|Protocol Violation|1
5116025|NCT01773226|17670327|P1|Overall Study|Withdrawal by Subject|1
5116026|NCT01773122|17670357|P4|Overall Study|Due to amended age eligibility criteria|1
5116027|NCT01773122|17670358|P3|Overall Study|Due to amended age eligibility criteria|0
5116028|NCT01773122|17670359|P2|Overall Study|Due to amended age eligibility criteria|1
5116029|NCT01773122|17670360|P1|Overall Study|Due to amended age eligibility criteria|3
5116030|NCT01773109|17670374|P1|Overall Study|Death|1
5116031|NCT01773109|17670374|P1|Overall Study|Symptomatic Progression|2
5116032|NCT01773070|17670378|P1|Overall Study|Death (unrelated to study procedures)|3
5116033|NCT01773070|17670378|P1|Overall Study|Other|15
5116034|NCT01773070|17670378|P1|Overall Study|Lost to Follow-up|39
5116035|NCT01773070|17670378|P1|Overall Study|Withdrawal by Subject|24
5116036|NCT01772823|17670388|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
5116037|NCT01772823|17670389|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
5116038|NCT01772823|17670388|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
5116039|NCT01772823|17670389|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
5116040|NCT01772823|17670388|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
5116041|NCT01772823|17670389|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
5116042|NCT01772823|17670388|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
5116043|NCT01772823|17670389|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
5116044|NCT01772823|17670388|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
5116045|NCT01772823|17670389|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
5116046|NCT01772823|17670388|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
5116047|NCT01772823|17670389|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
5116048|NCT01772823|17670388|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
5116049|NCT01772823|17670389|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
5116050|NCT01772823|17670388|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
5116051|NCT01772823|17670389|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
5116052|NCT01772823|17670388|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
5116053|NCT01772823|17670389|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
5116054|NCT01772823|17670388|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
5116055|NCT01772823|17670389|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
5116056|NCT01772823|17670388|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
5116057|NCT01772823|17670389|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
5116058|NCT01772823|17670388|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
5116059|NCT01772823|17670389|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
5116060|NCT01772823|17670388|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
5116061|NCT01772823|17670389|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
5116062|NCT01772823|17670388|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
5116063|NCT01772823|17670389|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
5116064|NCT01772823|17670388|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
5116065|NCT01772823|17670389|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
5116066|NCT01772823|17670388|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
5116067|NCT01772823|17670389|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
5116068|NCT01772719|17670502|P1|Overall Study|Lost to Follow-up|1
5116069|NCT01772719|17670502|P1|Overall Study|Protocol Violation|1
5116070|NCT01772719|17670502|P1|Overall Study|Adverse Event|2
5116071|NCT01772719|17670502|P1|Overall Study|Withdrawal by Subject|3
5116072|NCT01772693|17670515|P2|Overall Study|Alternative Treatment|0
5116073|NCT01772693|17670516|P1|Overall Study|Alternative Treatment|2
5116074|NCT01772693|17670515|P2|Overall Study|Withdrawal by Subject|0
5116075|NCT01772693|17670516|P1|Overall Study|Withdrawal by Subject|2
5116076|NCT01772693|17670515|P2|Overall Study|Health Concerns Unrelated to Study|1
5116077|NCT01772693|17670516|P1|Overall Study|Health Concerns Unrelated to Study|2
5116078|NCT01772576|17670537|P1|Overall Study|Withdrawal by Subject|6
5116079|NCT01772576|17670537|P1|Overall Study|Adverse Event|6
5116080|NCT01772576|17670537|P1|Overall Study|Study device not used|3
5116081|NCT01772576|17670537|P1|Overall Study|Lost to Follow-up|3
5116082|NCT01772576|17670537|P1|Overall Study|Protocol Violation|1
5116083|NCT01772576|17670537|P1|Overall Study|Death|15
5116084|NCT01772550|17670549|P3|Overall Study|Adverse Event|1
5116085|NCT01772550|17670550|P2|Overall Study|Adverse Event|0
5116086|NCT01772550|17670551|P1|Overall Study|Adverse Event|0
5116087|NCT01772550|17670549|P3|Overall Study|Unable to insert IV in antecubital vein|5
5116088|NCT01772550|17670550|P2|Overall Study|Unable to insert IV in antecubital vein|1
5116089|NCT01772550|17670551|P1|Overall Study|Unable to insert IV in antecubital vein|1
5116090|NCT01772537|17670592|P3|Overall Study|unsuccessful lumbar drain placement|0
5116091|NCT01772537|17670593|P2|Overall Study|unsuccessful lumbar drain placement|0
5116092|NCT01772537|17670594|P1|Overall Study|unsuccessful lumbar drain placement|1
5116093|NCT01772472|17670610|P2|Overall Study|Ongoing|635
5116094|NCT01772472|17670611|P1|Overall Study|Ongoing|597
5116095|NCT01772472|17670610|P2|Overall Study|Withdrawal by Subject|50
5116096|NCT01772472|17670611|P1|Overall Study|Withdrawal by Subject|72
5116097|NCT01772472|17670610|P2|Overall Study|Lost to Follow-up|8
5116098|NCT01772472|17670611|P1|Overall Study|Lost to Follow-up|12
5116099|NCT01772472|17670610|P2|Overall Study|Other|5
5116100|NCT01772472|17670611|P1|Overall Study|Other|5
5116101|NCT01772472|17670610|P2|Overall Study|Physician Decision|3
5116102|NCT01772472|17670611|P1|Overall Study|Physician Decision|1
5116103|NCT01772472|17670610|P2|Overall Study|Death|42
5116104|NCT01772472|17670611|P1|Overall Study|Death|56
5116105|NCT01772368|17670623|P1|Overall Study|Other|1
5116106|NCT01772368|17670623|P1|Overall Study|Protocol Violation|2
5116107|NCT01772368|17670623|P1|Overall Study|Withdrawal by Subject|3
5116108|NCT01772368|17670623|P1|Overall Study|Adverse Event|1
5116109|NCT01772316|17670669|P1|Overall Study|Withdrawn by sponsor decision|5
5116110|NCT01772316|17670669|P1|Overall Study|Inform consent withdrawn|1
5116111|NCT01772316|17670669|P1|Overall Study|Serious adverse event|1
5116112|NCT01772160|17670687|P1|Overall Study|Other|5
5116113|NCT01772160|17670687|P1|Overall Study|Lost to Follow-up|30
5116114|NCT01772160|17670687|P1|Overall Study|Migrated / moved from the study area|4
5116115|NCT01772160|17670687|P1|Overall Study|Consent withdrawal|3
5116116|NCT01772160|17670687|P1|Overall Study|Eligibility criteria not fulfilled|3
5116117|NCT01772160|17670687|P1|Overall Study|Death|3
5116118|NCT01772147|17670710|P3|Overall Study|Lack of Efficacy|6
5116119|NCT01772147|17670711|P2|Overall Study|Lack of Efficacy|6
5116120|NCT01772147|17670712|P1|Overall Study|Lack of Efficacy|8
5116121|NCT01772147|17670710|P3|Overall Study|Protocol Deviation|1
5116122|NCT01772147|17670711|P2|Overall Study|Protocol Deviation|1
5116123|NCT01772147|17670712|P1|Overall Study|Protocol Deviation|2
5116124|NCT01772147|17670710|P3|Overall Study|Lost to Follow-up|1
5116125|NCT01772147|17670711|P2|Overall Study|Lost to Follow-up|0
5116126|NCT01772147|17670712|P1|Overall Study|Lost to Follow-up|1
5116127|NCT01772147|17670710|P3|Overall Study|Withdrew Consent|4
5116128|NCT01772147|17670711|P2|Overall Study|Withdrew Consent|8
5116129|NCT01772147|17670712|P1|Overall Study|Withdrew Consent|7
5116130|NCT01772147|17670710|P3|Overall Study|Adverse Event|6
5116131|NCT01772147|17670711|P2|Overall Study|Adverse Event|10
5116132|NCT01772147|17670712|P1|Overall Study|Adverse Event|13
5116133|NCT01772134|17670732|P3|Overall Study|Randomized Study Medication Not Received|1
5116134|NCT01772134|17670733|P2|Overall Study|Randomized Study Medication Not Received|0
5116135|NCT01772134|17670734|P1|Overall Study|Randomized Study Medication Not Received|2
5116136|NCT01772134|17670732|P3|Overall Study|Protocol-defined Stopping Criteria|0
5116137|NCT01772134|17670733|P2|Overall Study|Protocol-defined Stopping Criteria|0
5116138|NCT01772134|17670734|P1|Overall Study|Protocol-defined Stopping Criteria|1
5116139|NCT01772134|17670732|P3|Overall Study|Lack of Efficacy|3
5116140|NCT01772134|17670733|P2|Overall Study|Lack of Efficacy|5
5116141|NCT01772134|17670734|P1|Overall Study|Lack of Efficacy|11
5116142|NCT01772134|17670732|P3|Overall Study|Protocol Deviation|3
5116143|NCT01772134|17670733|P2|Overall Study|Protocol Deviation|3
5116144|NCT01772134|17670734|P1|Overall Study|Protocol Deviation|4
5116145|NCT01772134|17670732|P3|Overall Study|Lost to Follow-up|0
5116146|NCT01772134|17670733|P2|Overall Study|Lost to Follow-up|0
5116147|NCT01772134|17670734|P1|Overall Study|Lost to Follow-up|2
5116148|NCT01772134|17670732|P3|Overall Study|Withdrew Consent|5
5116149|NCT01772134|17670733|P2|Overall Study|Withdrew Consent|1
5116150|NCT01772134|17670734|P1|Overall Study|Withdrew Consent|3
5116151|NCT01772134|17670732|P3|Overall Study|Adverse Event|10
5116152|NCT01772134|17670733|P2|Overall Study|Adverse Event|5
5116153|NCT01772134|17670734|P1|Overall Study|Adverse Event|6
5116154|NCT01771913|17670790|P2|Overall Study|Withdrawal by Subject|0
5116155|NCT01771913|17670791|P1|Overall Study|Withdrawal by Subject|1
5116156|NCT01771809|17670803|P2|Overall Study|Other (other)|5
5116157|NCT01771809|17670804|P1|Overall Study|Other (other)|9
5116158|NCT01771809|17670803|P2|Overall Study|Death|0
5116159|NCT01771809|17670804|P1|Overall Study|Death|1
5116160|NCT01771809|17670803|P2|Overall Study|Other (Insufficient clinical response)|20
5116161|NCT01771809|17670804|P1|Overall Study|Other (Insufficient clinical response)|22
5116162|NCT01771809|17670803|P2|Overall Study|Lost to Follow-up|3
5116163|NCT01771809|17670804|P1|Overall Study|Lost to Follow-up|1
5116164|NCT01771809|17670803|P2|Overall Study|Withdrawal by Subject|42
5116165|NCT01771809|17670804|P1|Overall Study|Withdrawal by Subject|34
5116166|NCT01771809|17670803|P2|Overall Study|Protocol Violation|1
5116167|NCT01771809|17670804|P1|Overall Study|Protocol Violation|0
5116168|NCT01771809|17670803|P2|Overall Study|Adverse Event|12
5116169|NCT01771809|17670804|P1|Overall Study|Adverse Event|4
5116170|NCT01771731|17670820|P2|Overall Study|Adverse event: Pain Crisis|1
5116171|NCT01771731|17670821|P1|Overall Study|Adverse event: Pain Crisis|1
5116172|NCT01771731|17670820|P2|Overall Study|Protocol Violation|1
5116173|NCT01771731|17670821|P1|Overall Study|Protocol Violation|0
5116174|NCT01771731|17670820|P2|Overall Study|Physician Decision|0
5116175|NCT01771731|17670821|P1|Overall Study|Physician Decision|1
5116176|NCT01771250|17670841|P2|Period 1|Met exclusion criteria|0
5116177|NCT01771250|17670842|P1|Period 1|Met exclusion criteria|1
5116178|NCT01770912|17670860|P2|Overall Study|Lost to Follow-up|0
5116179|NCT01770912|17670861|P1|Overall Study|Lost to Follow-up|2
5116180|NCT01770860|17670895|P1|Overall Study|Administrative decision made by the PI|1
5116181|NCT01770860|17670895|P1|Overall Study|Lost to Follow-up|1
5116182|NCT01770860|17670895|P1|Overall Study|Withdrawal by Subject|4
5116183|NCT01770743|17670943|P5|Overall Study|Moving Out of State|0
5116184|NCT01770743|17670944|P4|Overall Study|Moving Out of State|0
5116185|NCT01770743|17670945|P3|Overall Study|Moving Out of State|0
5116186|NCT01770743|17670946|P2|Overall Study|Moving Out of State|1
5116187|NCT01770743|17670947|P1|Overall Study|Moving Out of State|0
5116188|NCT01770743|17670943|P5|Overall Study|Sponsor Terminated Subject|0
5116189|NCT01770743|17670944|P4|Overall Study|Sponsor Terminated Subject|1
5116190|NCT01770743|17670945|P3|Overall Study|Sponsor Terminated Subject|0
5116191|NCT01770743|17670946|P2|Overall Study|Sponsor Terminated Subject|0
5116192|NCT01770743|17670947|P1|Overall Study|Sponsor Terminated Subject|1
5116193|NCT01770743|17670943|P5|Overall Study|Lost to Follow-up|1
5116194|NCT01770743|17670944|P4|Overall Study|Lost to Follow-up|0
5116195|NCT01770743|17670945|P3|Overall Study|Lost to Follow-up|0
5116196|NCT01770743|17670946|P2|Overall Study|Lost to Follow-up|2
5116197|NCT01770743|17670947|P1|Overall Study|Lost to Follow-up|0
5116198|NCT01770743|17670943|P5|Overall Study|Withdrawal by Subject|1
5116199|NCT01770743|17670944|P4|Overall Study|Withdrawal by Subject|1
5116200|NCT01770743|17670945|P3|Overall Study|Withdrawal by Subject|1
5116201|NCT01770743|17670946|P2|Overall Study|Withdrawal by Subject|0
5116202|NCT01770743|17670947|P1|Overall Study|Withdrawal by Subject|0
5116203|NCT01770743|17670943|P5|Overall Study|Adverse Event|0
5116204|NCT01770743|17670944|P4|Overall Study|Adverse Event|0
5116205|NCT01770743|17670945|P3|Overall Study|Adverse Event|0
5116206|NCT01770743|17670946|P2|Overall Study|Adverse Event|0
5116207|NCT01770743|17670947|P1|Overall Study|Adverse Event|1
5116208|NCT01770509|17671049|P2|Overall Study|Lost to Follow-up|2
5116209|NCT01770509|17671050|P1|Overall Study|Lost to Follow-up|1
5116210|NCT01770509|17671049|P2|Overall Study|Injury|1
5116211|NCT01770509|17671050|P1|Overall Study|Injury|0
5116212|NCT01770392|17671086|P1|Washout Period of at Least 14 Days|Adverse Event|1
5116213|NCT01770379|17671101|P3|Overall Study|Adverse Event|2
5116214|NCT01770379|17671102|P2|Overall Study|Adverse Event|3
5116215|NCT01770379|17671103|P1|Overall Study|Adverse Event|1
5116216|NCT01770379|17671101|P3|Overall Study|Lack of Efficacy|6
5116217|NCT01770379|17671102|P2|Overall Study|Lack of Efficacy|6
5116218|NCT01770379|17671103|P1|Overall Study|Lack of Efficacy|8
5116219|NCT01770379|17671101|P3|Overall Study|Lost to Follow-up|2
5116220|NCT01770379|17671102|P2|Overall Study|Lost to Follow-up|0
5116221|NCT01770379|17671103|P1|Overall Study|Lost to Follow-up|0
5116222|NCT01770379|17671101|P3|Overall Study|Physician Decision|2
5116223|NCT01770379|17671102|P2|Overall Study|Physician Decision|1
5116224|NCT01770379|17671103|P1|Overall Study|Physician Decision|0
5116225|NCT01770379|17671101|P3|Overall Study|Protocol Violation|1
5116226|NCT01770379|17671102|P2|Overall Study|Protocol Violation|1
5116227|NCT01770379|17671103|P1|Overall Study|Protocol Violation|0
5116228|NCT01770379|17671101|P3|Overall Study|study terminated by sponsor|22
5116229|NCT01770379|17671102|P2|Overall Study|study terminated by sponsor|23
5116230|NCT01770379|17671103|P1|Overall Study|study terminated by sponsor|22
5116231|NCT01770379|17671101|P3|Overall Study|Withdrawal by Subject|7
5116232|NCT01770379|17671102|P2|Overall Study|Withdrawal by Subject|10
5116233|NCT01770379|17671103|P1|Overall Study|Withdrawal by Subject|7
5116234|NCT01770379|17671101|P3|Overall Study|Technical issues|0
5116235|NCT01770379|17671102|P2|Overall Study|Technical issues|0
5116236|NCT01770379|17671103|P1|Overall Study|Technical issues|1
5116237|NCT01770353|17671131|P2|Overall Study|Toxicity related diarrhoea + progression|1
5116238|NCT01770353|17671132|P1|Overall Study|Toxicity related diarrhoea + progression|0
5116239|NCT01770353|17671131|P2|Overall Study|Clinical deterioration|6
5116240|NCT01770353|17671132|P1|Overall Study|Clinical deterioration|3
5116241|NCT01770353|17671131|P2|Overall Study|Physician Decision|3
5116242|NCT01770353|17671132|P1|Overall Study|Physician Decision|0
5116243|NCT01770353|17671131|P2|Overall Study|Protocol Violation|0
5116244|NCT01770353|17671132|P1|Overall Study|Protocol Violation|1
5116245|NCT01770353|17671131|P2|Overall Study|Adverse Event|1
5116246|NCT01770353|17671132|P1|Overall Study|Adverse Event|0
5116247|NCT01770353|17671131|P2|Overall Study|Progressive disease|1
5116248|NCT01770353|17671132|P1|Overall Study|Progressive disease|2
5116249|NCT01770145|17671191|P1|Treatment|Withdrawal by Subject|1
5116250|NCT01770145|17671191|P1|Treatment|Adverse Event|3
5116251|NCT01770145|17671191|P1|Baseline|Unable to define optimal dose|4
5116252|NCT01770145|17671191|P1|Baseline|Lost to Follow-up|1
5116253|NCT01770145|17671191|P1|Baseline|Withdrawal by Subject|1
5116254|NCT01770145|17671191|P1|Baseline|Adverse Event|20
5116255|NCT01769508|17671247|P1|Overall Study|Lost to Follow-up|1
5116256|NCT01769508|17671247|P1|Overall Study|Adverse Event|1
5116257|NCT01769508|17671247|P1|Overall Study|Withdrawal by Subject|1
5116258|NCT01769508|17671247|P1|Overall Study|Death|3
5116259|NCT01769469|17671256|P1|Overall Study|Subject Confirmed HIV Positive|3
5116260|NCT01769469|17671256|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
5116261|NCT01769469|17671256|P1|Overall Study|Lost to Follow-up|17
5116262|NCT01769469|17671256|P1|Overall Study|Moved Out Of Area|3
5116263|NCT01769469|17671256|P1|Overall Study|Consent Withdrawn|5
5116264|NCT01769456|17671416|P1|Overall Study|Parental request to youth to withdraw|1
5116265|NCT01769456|17671416|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
5116266|NCT01769456|17671416|P1|Overall Study|Moved out of the area|3
5116267|NCT01769456|17671416|P1|Overall Study|Did not receive PCC intervention|6
5116268|NCT01769456|17671416|P1|Overall Study|Withdrawal by Subject|3
5116269|NCT01769456|17671416|P1|Overall Study|Lost to Follow-up|19
5116270|NCT01769443|17671437|P2|Overall Study|Study closure|0
5116271|NCT01769443|17671438|P1|Overall Study|Study closure|1
5116272|NCT01769404|17671480|P2|Treatment Period 2|Sponsor decision|0
5116273|NCT01769404|17671481|P1|Treatment Period 2|Sponsor decision|7
5116274|NCT01769404|17671480|P2|Treatment Period 1|Sponsor decision|0
5116275|NCT01769404|17671481|P1|Treatment Period 1|Sponsor decision|1
5116276|NCT01769404|17671480|P2|Treatment Period 1|Withdrawal by Subject|0
5116277|NCT01769404|17671481|P1|Treatment Period 1|Withdrawal by Subject|3
5116278|NCT01769404|17671480|P2|Treatment Period 1|Did not meet eligibility criteria|0
5116279|NCT01769404|17671481|P1|Treatment Period 1|Did not meet eligibility criteria|1
5116280|NCT01769391|17671503|P2|Overall Study|Investigator Decision|0
5116281|NCT01769391|17671504|P1|Overall Study|Investigator Decision|2
5116282|NCT01769391|17671503|P2|Overall Study|Withdrawal by Subject|3
5116283|NCT01769391|17671504|P1|Overall Study|Withdrawal by Subject|4
5116284|NCT01769391|17671503|P2|Overall Study|Progressive Disease|2
5116285|NCT01769391|17671504|P1|Overall Study|Progressive Disease|1
5116286|NCT01769391|17671503|P2|Overall Study|Adverse Event|3
5116287|NCT01769391|17671504|P1|Overall Study|Adverse Event|0
5116288|NCT01769391|17671503|P2|Overall Study|Death|1
5116289|NCT01769391|17671504|P1|Overall Study|Death|10
5116290|NCT01769378|17671523|P2|Overall Study|Lost to Follow-up|0
5116291|NCT01769378|17671524|P1|Overall Study|Lost to Follow-up|2
5116292|NCT01769378|17671523|P2|Overall Study|Sponsor Decision|0
5116293|NCT01769378|17671524|P1|Overall Study|Sponsor Decision|1
5116294|NCT01769378|17671523|P2|Overall Study|Withdrawal by Subject|3
5116295|NCT01769378|17671524|P1|Overall Study|Withdrawal by Subject|10
5116296|NCT01769378|17671523|P2|Overall Study|Protocol Violation|1
5116297|NCT01769378|17671524|P1|Overall Study|Protocol Violation|1
5116298|NCT01769378|17671523|P2|Overall Study|Entry criteria not met|0
5116299|NCT01769378|17671524|P1|Overall Study|Entry criteria not met|1
5116300|NCT01769378|17671523|P2|Overall Study|Adverse Event|0
5116301|NCT01769378|17671524|P1|Overall Study|Adverse Event|10
5116302|NCT01769339|17671604|P1|Overall Study|Adverse Event|1
5116303|NCT01769339|17671604|P1|Overall Study|Lost to Follow-up|42
5116304|NCT01769326|17671615|P4|Overall Study|Got sick and could not complete study|0
5116305|NCT01769326|17671616|P3|Overall Study|Got sick and could not complete study|1
5116306|NCT01769326|17671617|P2|Overall Study|Got sick and could not complete study|0
5116307|NCT01769326|17671618|P1|Overall Study|Got sick and could not complete study|0
5116308|NCT01769326|17671615|P4|Overall Study|got a job|0
5116309|NCT01769326|17671616|P3|Overall Study|got a job|0
5116310|NCT01769326|17671617|P2|Overall Study|got a job|1
5116311|NCT01769326|17671618|P1|Overall Study|got a job|0
5116312|NCT01769326|17671615|P4|Overall Study|unrelated injry|0
5116313|NCT01769326|17671616|P3|Overall Study|unrelated injry|0
5116314|NCT01769326|17671617|P2|Overall Study|unrelated injry|1
5116315|NCT01769326|17671618|P1|Overall Study|unrelated injry|1
5116316|NCT01769326|17671615|P4|Overall Study|Lost to Follow-up|0
5116317|NCT01769326|17671616|P3|Overall Study|Lost to Follow-up|0
5116318|NCT01769326|17671617|P2|Overall Study|Lost to Follow-up|2
5116319|NCT01769326|17671618|P1|Overall Study|Lost to Follow-up|1
5116320|NCT01769196|17671763|P2|Overall Study|Withdrew consent|40
5116321|NCT01769196|17671764|P1|Overall Study|Withdrew consent|36
5116322|NCT01769196|17671763|P2|Overall Study|Participant never dosed with study drug|0
5116323|NCT01769196|17671764|P1|Overall Study|Participant never dosed with study drug|1
5116324|NCT01769196|17671763|P2|Overall Study|Study terminated by sponsor|161
5116325|NCT01769196|17671764|P1|Overall Study|Study terminated by sponsor|160
5116326|NCT01769196|17671763|P2|Overall Study|Protocol Violation|3
5116327|NCT01769196|17671764|P1|Overall Study|Protocol Violation|0
5116328|NCT01769196|17671763|P2|Overall Study|Protocol defined criteria for withdrawal|11
5116329|NCT01769196|17671764|P1|Overall Study|Protocol defined criteria for withdrawal|9
5116330|NCT01769196|17671763|P2|Overall Study|Progressive disease|6
5116331|NCT01769196|17671764|P1|Overall Study|Progressive disease|11
5116332|NCT01769196|17671763|P2|Overall Study|Lack of Efficacy|2
5116333|NCT01769196|17671764|P1|Overall Study|Lack of Efficacy|3
5116334|NCT01769196|17671763|P2|Overall Study|Investigator Discretion|3
5116335|NCT01769196|17671764|P1|Overall Study|Investigator Discretion|7
5116336|NCT01769196|17671763|P2|Overall Study|Death|26
5116337|NCT01769196|17671764|P1|Overall Study|Death|21
5116338|NCT01769196|17671763|P2|Overall Study|Adverse Event|20
5116339|NCT01769196|17671764|P1|Overall Study|Adverse Event|24
5116340|NCT01769105|17671794|P2|Cross-over|Lost to Follow-up|0
5116341|NCT01769105|17671795|P1|Cross-over|Lost to Follow-up|5
5116342|NCT01769105|17671794|P2|First Intervention|Protocol Violation|2
5116343|NCT01769105|17671795|P1|First Intervention|Protocol Violation|2
5116344|NCT01768858|17671814|P1|Overall Study|Withdrawal by Subject|1
5116345|NCT01768858|17671814|P1|Overall Study|Exanthema|1
5116346|NCT01768858|17671814|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
5116347|NCT01768858|17671814|P1|Overall Study|Participant moved to Germany|1
5116348|NCT01768858|17671814|P1|Overall Study|Serious Adverse Event|1
5116349|NCT01768858|17671814|P1|Overall Study|Lack of Efficacy|8
5116350|NCT01768858|17671814|P1|Overall Study|Lost to Follow-up|9
5116351|NCT01768676|17671865|P2|Overall Study|Withdrawal by Subject|10
5116352|NCT01768676|17671866|P1|Overall Study|Withdrawal by Subject|3
5116353|NCT01768676|17671865|P2|Overall Study|Physician Decision|1
5116354|NCT01768676|17671866|P1|Overall Study|Physician Decision|4
5116355|NCT01768676|17671865|P2|Overall Study|Protocol Violation|1
5116356|NCT01768676|17671866|P1|Overall Study|Protocol Violation|1
5116357|NCT01768676|17671865|P2|Overall Study|Lost to Follow-up|16
5116358|NCT01768676|17671866|P1|Overall Study|Lost to Follow-up|13
5116359|NCT01768676|17671865|P2|Overall Study|Adverse Event|3
5116360|NCT01768676|17671866|P1|Overall Study|Adverse Event|3
5116361|NCT01768637|17671882|P2|Overall Study|Difficult blood draw|0
5116362|NCT01768637|17671883|P1|Overall Study|Difficult blood draw|1
5116363|NCT01768637|17671882|P2|Overall Study|Lost to Follow-up|7
5116364|NCT01768637|17671883|P1|Overall Study|Lost to Follow-up|2
5116365|NCT01768572|17671896|P3|Overall Study|Other, Not due to an adverse event|1
5116366|NCT01768572|17671897|P2|Overall Study|Other, Not due to an adverse event|1
5116367|NCT01768572|17671898|P1|Overall Study|Other, Not due to an adverse event|1
5116368|NCT01768572|17671896|P3|Overall Study|Lack of Efficacy|1
5116369|NCT01768572|17671897|P2|Overall Study|Lack of Efficacy|3
5116370|NCT01768572|17671898|P1|Overall Study|Lack of Efficacy|1
5116371|NCT01768572|17671896|P3|Overall Study|Adverse Event|4
5116372|NCT01768572|17671897|P2|Overall Study|Adverse Event|8
5116373|NCT01768572|17671898|P1|Overall Study|Adverse Event|7
5116374|NCT01768559|17671909|P3|Overall Study|Other than specified|5
5116375|NCT01768559|17671910|P2|Overall Study|Other than specified|8
5116376|NCT01768559|17671911|P1|Overall Study|Other than specified|9
5116377|NCT01768559|17671909|P3|Overall Study|Poor compliance to protocol|2
5116378|NCT01768559|17671910|P2|Overall Study|Poor compliance to protocol|3
5116379|NCT01768559|17671911|P1|Overall Study|Poor compliance to protocol|0
5116380|NCT01768559|17671909|P3|Overall Study|Lack of Efficacy|0
5116381|NCT01768559|17671910|P2|Overall Study|Lack of Efficacy|4
5116382|NCT01768559|17671911|P1|Overall Study|Lack of Efficacy|6
5116383|NCT01768559|17671909|P3|Overall Study|Adverse Event|5
5116384|NCT01768559|17671910|P2|Overall Study|Adverse Event|2
5116385|NCT01768559|17671911|P1|Overall Study|Adverse Event|15
5116386|NCT01768559|17671909|P3|Overall Study|Randomized but not treated|1
5116387|NCT01768559|17671910|P2|Overall Study|Randomized but not treated|0
5116388|NCT01768559|17671911|P1|Overall Study|Randomized but not treated|0
5116389|NCT01768286|17671992|P4|Overall Study|Withdrew Consent|0
5116390|NCT01768286|17671993|P3|Overall Study|Withdrew Consent|1
5116391|NCT01768286|17671994|P2|Overall Study|Withdrew Consent|0
5116392|NCT01768286|17671995|P1|Overall Study|Withdrew Consent|0
5116393|NCT01768286|17671992|P4|Overall Study|Lack of Efficacy|1
5116394|NCT01768286|17671993|P3|Overall Study|Lack of Efficacy|0
5116395|NCT01768286|17671994|P2|Overall Study|Lack of Efficacy|4
5116396|NCT01768286|17671995|P1|Overall Study|Lack of Efficacy|7
5116397|NCT01768286|17671992|P4|Overall Study|Randomized But Not Treated|0
5116398|NCT01768286|17671993|P3|Overall Study|Randomized But Not Treated|1
5116399|NCT01768286|17671994|P2|Overall Study|Randomized But Not Treated|0
5116400|NCT01768286|17671995|P1|Overall Study|Randomized But Not Treated|0
5116401|NCT01768117|17672057|P1|Overall Study|Protocol Violation|3
5116402|NCT01768117|17672057|P1|Overall Study|Withdrawal by Subject|2
5116403|NCT01768117|17672057|P1|Overall Study|Lost to Follow-up|1
5116404|NCT01767987|17672121|P2|Overall Study|Physician Decision|1
5116405|NCT01767987|17672122|P1|Overall Study|Physician Decision|4
5116406|NCT01767909|17672154|P2|Overall Study|LP uncessessful|1
5116407|NCT01767909|17672155|P1|Overall Study|LP uncessessful|0
5116408|NCT01767909|17672154|P2|Overall Study|Lost to Follow-up|1
5116409|NCT01767909|17672155|P1|Overall Study|Lost to Follow-up|0
5116410|NCT01767909|17672154|P2|Overall Study|Investigator Recommendation|1
5116411|NCT01767909|17672155|P1|Overall Study|Investigator Recommendation|0
5116412|NCT01767909|17672154|P2|Overall Study|Perceived Lack of Efficacy|0
5116413|NCT01767909|17672155|P1|Overall Study|Perceived Lack of Efficacy|1
5116414|NCT01767909|17672154|P2|Overall Study|Non-Compliance|0
5116415|NCT01767909|17672155|P1|Overall Study|Non-Compliance|2
5116416|NCT01767909|17672154|P2|Overall Study|Withdrawal by Study Partner|1
5116417|NCT01767909|17672155|P1|Overall Study|Withdrawal by Study Partner|3
5116418|NCT01767909|17672154|P2|Overall Study|Adverse Event|1
5116419|NCT01767909|17672155|P1|Overall Study|Adverse Event|3
5116420|NCT01767909|17672154|P2|Overall Study|Withdrawal by Subject|7
5116421|NCT01767909|17672155|P1|Overall Study|Withdrawal by Subject|4
5116422|NCT01767597|17672225|P2|Overall Study|Withdrawal by Subject|0
5116423|NCT01767597|17672226|P1|Overall Study|Withdrawal by Subject|1
5116424|NCT01767597|17672225|P2|Overall Study|Incomplete intervention|1
5116425|NCT01767597|17672226|P1|Overall Study|Incomplete intervention|3
5116426|NCT01767519|17672235|P3|Overall Study|Adverse Event|1
5116427|NCT01767519|17672236|P2|Overall Study|Adverse Event|5
5116428|NCT01767519|17672237|P1|Overall Study|Adverse Event|5
5116429|NCT01767519|17672235|P3|Overall Study|Lack of Efficacy|0
5116430|NCT01767519|17672236|P2|Overall Study|Lack of Efficacy|0
5116431|NCT01767519|17672237|P1|Overall Study|Lack of Efficacy|1
5116432|NCT01767519|17672235|P3|Overall Study|Lost to Follow-up|2
5116433|NCT01767519|17672236|P2|Overall Study|Lost to Follow-up|1
5116434|NCT01767519|17672237|P1|Overall Study|Lost to Follow-up|3
5116435|NCT01767519|17672235|P3|Overall Study|Personal Reasons|0
5116436|NCT01767519|17672236|P2|Overall Study|Personal Reasons|0
5116437|NCT01767519|17672237|P1|Overall Study|Personal Reasons|1
5116438|NCT01767519|17672235|P3|Overall Study|Protocol Violation|0
5116439|NCT01767519|17672236|P2|Overall Study|Protocol Violation|3
5116440|NCT01767519|17672237|P1|Overall Study|Protocol Violation|0
5116441|NCT01767519|17672235|P3|Overall Study|Other Reasons|2
5116442|NCT01767519|17672236|P2|Overall Study|Other Reasons|4
5116443|NCT01767519|17672237|P1|Overall Study|Other Reasons|4
5116444|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
5116445|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
5116446|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Physician Decision|0
5116447|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Physician Decision|1
5116448|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
5116449|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
5116450|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
5116451|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
5116452|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
5116453|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
5116454|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
5116455|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
5116456|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
5116457|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
5116458|NCT01767467|17672278|P2|End of Study Phase (up to Month 13)|Adverse Event|39
5116459|NCT01767467|17672279|P1|End of Study Phase (up to Month 13)|Adverse Event|29
5116460|NCT01767467|17672278|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
5116461|NCT01767467|17672279|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
5116462|NCT01767467|17672278|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
5116463|NCT01767467|17672279|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
5116464|NCT01767467|17672278|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
5116465|NCT01767467|17672279|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
5116466|NCT01767467|17672278|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
5116467|NCT01767467|17672279|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
5116468|NCT01767467|17672278|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
5116469|NCT01767467|17672279|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
5116470|NCT01767467|17672278|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
5116471|NCT01767467|17672279|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
5116472|NCT01767376|17672335|P3|Overall Study|Withdrawal by Subject|0
5116473|NCT01767376|17672336|P2|Overall Study|Withdrawal by Subject|1
5116474|NCT01767376|17672337|P1|Overall Study|Withdrawal by Subject|1
5116475|NCT01767376|17672335|P3|Overall Study|Lost to Follow-up|0
5116476|NCT01767376|17672336|P2|Overall Study|Lost to Follow-up|2
5116477|NCT01767376|17672337|P1|Overall Study|Lost to Follow-up|3
5116478|NCT01767194|17672403|P2|Overall Study|Criteria not met on time for next cycle|1
5116479|NCT01767194|17672404|P1|Overall Study|Criteria not met on time for next cycle|0
5116480|NCT01767194|17672403|P2|Overall Study|Refusal by patient/parent|4
5116481|NCT01767194|17672404|P1|Overall Study|Refusal by patient/parent|2
5116482|NCT01767194|17672403|P2|Overall Study|Ineligible|1
5116483|NCT01767194|17672404|P1|Overall Study|Ineligible|1
5116484|NCT01767194|17672403|P2|Overall Study|Withdrawal by Subject|1
5116485|NCT01767194|17672404|P1|Overall Study|Withdrawal by Subject|0
5116486|NCT01767194|17672403|P2|Overall Study|Physician Decision|23
5116487|NCT01767194|17672404|P1|Overall Study|Physician Decision|2
5116488|NCT01767194|17672403|P2|Overall Study|Lack of Efficacy|11
5116489|NCT01767194|17672404|P1|Overall Study|Lack of Efficacy|12
5116490|NCT01767194|17672403|P2|Overall Study|Death|1
5116491|NCT01767194|17672404|P1|Overall Study|Death|0
5116492|NCT01767194|17672403|P2|Overall Study|Adverse Event|1
5116493|NCT01767194|17672404|P1|Overall Study|Adverse Event|1
5116494|NCT01767142|17672426|P1|Overall Study|Lost to Follow-up|3
5116495|NCT01767116|17672435|P2|Overall Study|Lost to Follow-up|2
5116496|NCT01767116|17672436|P1|Overall Study|Lost to Follow-up|2
5116497|NCT01766921|17672494|P2|Overall Study|Withdrawal by Subject|5
5116498|NCT01766921|17672495|P1|Overall Study|Withdrawal by Subject|14
5116499|NCT01766921|17672494|P2|Overall Study|Protocol Violation|1
5116500|NCT01766921|17672495|P1|Overall Study|Protocol Violation|1
5116501|NCT01766921|17672494|P2|Overall Study|Unclassified|2
5116502|NCT01766921|17672495|P1|Overall Study|Unclassified|2
5116503|NCT01766921|17672494|P2|Overall Study|Lost to Follow-up|3
5116504|NCT01766921|17672495|P1|Overall Study|Lost to Follow-up|1
5116505|NCT01766921|17672494|P2|Overall Study|Death|1
5116506|NCT01766921|17672495|P1|Overall Study|Death|1
5116507|NCT01766921|17672494|P2|Overall Study|Administrative Reason|5
5116508|NCT01766921|17672495|P1|Overall Study|Administrative Reason|5
5116509|NCT01766817|17672517|P3|Overall Study|Other|0
5116510|NCT01766817|17672518|P2|Overall Study|Other|0
5116511|NCT01766817|17672519|P1|Overall Study|Other|1
5116512|NCT01766817|17672517|P3|Overall Study|Physician Decision|4
5116513|NCT01766817|17672518|P2|Overall Study|Physician Decision|3
5116514|NCT01766817|17672519|P1|Overall Study|Physician Decision|3
5116515|NCT01766817|17672517|P3|Overall Study|Subject non-compliance|2
5116516|NCT01766817|17672518|P2|Overall Study|Subject non-compliance|1
5116517|NCT01766817|17672519|P1|Overall Study|Subject non-compliance|0
5116518|NCT01766817|17672517|P3|Overall Study|Withdrawal by Subject|3
5116519|NCT01766817|17672518|P2|Overall Study|Withdrawal by Subject|0
5116520|NCT01766817|17672519|P1|Overall Study|Withdrawal by Subject|2
5116521|NCT01766817|17672517|P3|Overall Study|Unable to take study drug|0
5116522|NCT01766817|17672518|P2|Overall Study|Unable to take study drug|1
5116523|NCT01766817|17672519|P1|Overall Study|Unable to take study drug|0
5116524|NCT01766817|17672517|P3|Overall Study|Death|0
5116525|NCT01766817|17672518|P2|Overall Study|Death|1
5116526|NCT01766817|17672519|P1|Overall Study|Death|1
5116527|NCT01766817|17672517|P3|Overall Study|Drug-unrelated adverse event|3
5116528|NCT01766817|17672518|P2|Overall Study|Drug-unrelated adverse event|3
5116529|NCT01766817|17672519|P1|Overall Study|Drug-unrelated adverse event|3
5116530|NCT01766817|17672517|P3|Overall Study|Drug-related adverse event|1
5116531|NCT01766817|17672518|P2|Overall Study|Drug-related adverse event|2
5116532|NCT01766817|17672519|P1|Overall Study|Drug-related adverse event|1
5116533|NCT01766778|17672570|P2|Overall Study|Withdrawal by Subject|0
5116534|NCT01766778|17672571|P1|Overall Study|Withdrawal by Subject|1
5116535|NCT01766778|17672570|P2|Overall Study|Adverse Event|4
5116536|NCT01766778|17672571|P1|Overall Study|Adverse Event|4
5116537|NCT01766401|17672625|P2|Overall Study|Pregnancy|1
5116538|NCT01766401|17672626|P1|Overall Study|Pregnancy|1
5116539|NCT01766401|17672625|P2|Overall Study|Lost to Follow-up|11
5116540|NCT01766401|17672626|P1|Overall Study|Lost to Follow-up|10
5116541|NCT01766401|17672625|P2|Overall Study|Withdrawal by Subject|12
5116542|NCT01766401|17672626|P1|Overall Study|Withdrawal by Subject|15
5116543|NCT01766401|17672625|P2|Overall Study|Protocol Violation|8
5116544|NCT01766401|17672626|P1|Overall Study|Protocol Violation|3
5116545|NCT01766401|17672625|P2|Overall Study|Lack of Efficacy|2
5116546|NCT01766401|17672626|P1|Overall Study|Lack of Efficacy|1
5116547|NCT01766401|17672625|P2|Overall Study|Adverse Event|22
5116548|NCT01766401|17672626|P1|Overall Study|Adverse Event|7
5116549|NCT01766336|17672636|P2|Overall Study|Withdrawal by Subject|15
5116550|NCT01766336|17672637|P1|Overall Study|Withdrawal by Subject|18
5116551|NCT01766336|17672636|P2|Overall Study|Sponsor Decision|43
5116552|NCT01766336|17672637|P1|Overall Study|Sponsor Decision|52
5116553|NCT01766336|17672636|P2|Overall Study|Protocol Violation|1
5116554|NCT01766336|17672637|P1|Overall Study|Protocol Violation|0
5116555|NCT01766336|17672636|P2|Overall Study|Physician Decision|2
5116556|NCT01766336|17672637|P1|Overall Study|Physician Decision|4
5116557|NCT01766336|17672636|P2|Overall Study|Lost to Follow-up|3
5116558|NCT01766336|17672637|P1|Overall Study|Lost to Follow-up|1
5116559|NCT01766336|17672636|P2|Overall Study|Death|3
5116560|NCT01766336|17672637|P1|Overall Study|Death|4
5116561|NCT01766336|17672636|P2|Overall Study|Adverse Event|8
5116562|NCT01766336|17672637|P1|Overall Study|Adverse Event|11
5116563|NCT01766310|17672645|P2|Overall Study|Lost to Follow-up|3
5116564|NCT01766310|17672646|P1|Overall Study|Lost to Follow-up|1
5116565|NCT01766206|17672676|P1|Overall Study|Withdrawal and inappropriate enrollment|1
5116566|NCT01766206|17672676|P1|Overall Study|Inappropriate enrollment|18
5116567|NCT01766206|17672676|P1|Overall Study|Lost to Follow-up|10
5116568|NCT01766206|17672676|P1|Overall Study|Withdrawal by Subject|22
5116569|NCT01766050|17672703|P1|Overall Study|Withdrawal by Subject|2
5116570|NCT01766050|17672703|P1|Overall Study|Lost to Follow-up|1
5116571|NCT01766050|17672703|P1|Overall Study|Adverse Event|1
5116572|NCT01766037|17672838|P2|Overall Study|nausea / discomfort|0
5116573|NCT01766037|17672839|P1|Overall Study|nausea / discomfort|3
5116574|NCT01766037|17672838|P2|Overall Study|medical - unrelated|2
5116575|NCT01766037|17672839|P1|Overall Study|medical - unrelated|1
5116576|NCT01766037|17672838|P2|Overall Study|Moved from area|0
5116577|NCT01766037|17672839|P1|Overall Study|Moved from area|5
5116578|NCT01766037|17672838|P2|Overall Study|Withdrawal by Subject|16
5116579|NCT01766037|17672839|P1|Overall Study|Withdrawal by Subject|18
5116580|NCT01766037|17672838|P2|Overall Study|Physician Decision|1
5116581|NCT01766037|17672839|P1|Overall Study|Physician Decision|0
5116582|NCT01766037|17672838|P2|Overall Study|Lost to Follow-up|10
5116583|NCT01766037|17672839|P1|Overall Study|Lost to Follow-up|0
5116584|NCT01766037|17672838|P2|Overall Study|Lack of Efficacy|0
5116585|NCT01766037|17672839|P1|Overall Study|Lack of Efficacy|1
5116586|NCT01766037|17672838|P2|Overall Study|Adverse Event|0
5116587|NCT01766037|17672839|P1|Overall Study|Adverse Event|1
5116588|NCT01765764|17672908|P3|Treatment Period|Other Miscellaneous Reasons|2
5116589|NCT01765764|17672909|P2|Treatment Period|Other Miscellaneous Reasons|2
5116590|NCT01765764|17672910|P1|Treatment Period|Other Miscellaneous Reasons|1
5116591|NCT01765764|17672908|P3|Treatment Period|Personal Reasons|1
5116592|NCT01765764|17672909|P2|Treatment Period|Personal Reasons|2
5116593|NCT01765764|17672910|P1|Treatment Period|Personal Reasons|1
5116594|NCT01765764|17672908|P3|Treatment Period|Lost to Follow-up|2
5116595|NCT01765764|17672909|P2|Treatment Period|Lost to Follow-up|3
5116596|NCT01765764|17672910|P1|Treatment Period|Lost to Follow-up|0
5116597|NCT01765764|17672908|P3|Treatment Period|Adverse Event|1
5116598|NCT01765764|17672909|P2|Treatment Period|Adverse Event|2
5116599|NCT01765764|17672910|P1|Treatment Period|Adverse Event|1
5116600|NCT01765751|17672930|P3|Overall Study|Lost to Follow-up|1
5116601|NCT01765751|17672931|P2|Overall Study|Lost to Follow-up|2
5116602|NCT01765751|17672932|P1|Overall Study|Lost to Follow-up|0
5116603|NCT01765673|17672964|P1|Overall Study|No transportation for 2nd/3rd visits|1
5116604|NCT01765582|17672997|P3|Overall Study|Withdrawal of Consent|10
5116605|NCT01765582|17672998|P2|Overall Study|Withdrawal of Consent|6
5116606|NCT01765582|17672999|P1|Overall Study|Withdrawal of Consent|11
5116607|NCT01765582|17672997|P3|Overall Study|Sponsor Decision|42
5116608|NCT01765582|17672998|P2|Overall Study|Sponsor Decision|42
5116609|NCT01765582|17672999|P1|Overall Study|Sponsor Decision|46
5116610|NCT01765582|17672997|P3|Overall Study|Death|33
5116611|NCT01765582|17672998|P2|Overall Study|Death|36
5116612|NCT01765582|17672999|P1|Overall Study|Death|31
5116613|NCT01765582|17672997|P3|Overall Study|Lost to Follow-up|1
5116614|NCT01765582|17672998|P2|Overall Study|Lost to Follow-up|2
5116615|NCT01765582|17672999|P1|Overall Study|Lost to Follow-up|2
5116616|NCT01765582|17672997|P3|Overall Study|Other|9
5116617|NCT01765582|17672998|P2|Overall Study|Other|6
5116618|NCT01765582|17672999|P1|Overall Study|Other|3
5116619|NCT01765569|17673032|P1|Period C|Death|1
5116620|NCT01765569|17673032|P1|Period B|Withdrawal by Subject|1
5116621|NCT01765543|17673053|P1|Overall Study|Withdrawal by Subject|2
5116622|NCT01765543|17673053|P1|Overall Study|Death|1
5116623|NCT01765426|17673105|P4|Overall Study|Lost to Follow-up|0
5116624|NCT01765426|17673106|P3|Overall Study|Lost to Follow-up|0
5116625|NCT01765426|17673107|P2|Overall Study|Lost to Follow-up|1
5116626|NCT01765426|17673108|P1|Overall Study|Lost to Follow-up|0
5116627|NCT01765270|17673164|P2|Overall Study|Withdrawal by Subject|1
5116628|NCT01765270|17673165|P1|Overall Study|Withdrawal by Subject|0
5116629|NCT01765270|17673164|P2|Overall Study|Physician Decision|0
5116630|NCT01765270|17673165|P1|Overall Study|Physician Decision|1
5116631|NCT01765192|17673187|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
5116632|NCT01765192|17673188|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
5116633|NCT01765192|17673187|P2|Treatment Period 2|Reason not specified|2
5116634|NCT01765192|17673188|P1|Treatment Period 2|Reason not specified|0
5116635|NCT01765192|17673187|P2|Washout Period|Reason not specified|0
5116636|NCT01765192|17673188|P1|Washout Period|Reason not specified|1
5116637|NCT01765192|17673187|P2|Washout Period|Voluntary Withdrawal|1
5116638|NCT01765192|17673188|P1|Washout Period|Voluntary Withdrawal|1
5116639|NCT01765192|17673187|P2|Treatment Period 1|Adverse Event|1
5116640|NCT01765192|17673188|P1|Treatment Period 1|Adverse Event|0
5116641|NCT01765179|17673206|P1|Overall Study|Ca elevated 10.6|1
5116642|NCT01765179|17673206|P1|Overall Study|work conflict|1
5116643|NCT01765179|17673206|P1|Overall Study|lack of venous access|1
5116644|NCT01765179|17673206|P1|Overall Study|Out of country unable to finish study|1
5116645|NCT01765179|17673206|P1|Overall Study|prohibited med|1
5116646|NCT01765179|17673206|P1|Overall Study|Hematocrit >54%|3
5116647|NCT01765179|17673206|P1|Overall Study|Withdrawal by Subject|8
5116648|NCT01765179|17673206|P1|Overall Study|Protocol Violation|1
5116649|NCT01765179|17673206|P1|Overall Study|Non-compliance with study drug|2
5116650|NCT01765179|17673206|P1|Overall Study|Lost to Follow-up|5
5116651|NCT01765179|17673206|P1|Overall Study|Adverse Event|3
5116652|NCT01765153|17673213|P2|Rest Phase 2|Lost to Follow-up|1
5116653|NCT01765153|17673214|P1|Rest Phase 2|Lost to Follow-up|2
5116654|NCT01765153|17673213|P2|Training Phase 2|Withdrawal by Subject|1
5116655|NCT01765153|17673214|P1|Training Phase 2|Withdrawal by Subject|0
5116656|NCT01765153|17673213|P2|Rest Phase 1|Withdrawal by Subject|1
5116657|NCT01765153|17673214|P1|Rest Phase 1|Withdrawal by Subject|0
5116658|NCT01765153|17673213|P2|Training Phase 1|Poor participation in intervention|1
5116659|NCT01765153|17673214|P1|Training Phase 1|Poor participation in intervention|0
5116660|NCT01765153|17673213|P2|Training Phase 1|Format of intervention differed|0
5116661|NCT01765153|17673214|P1|Training Phase 1|Format of intervention differed|1
5116662|NCT01764997|17673321|P5|Study Drug Treatment Period|Other than specified above|10
5116663|NCT01764997|17673322|P4|Study Drug Treatment Period|Other than specified above|0
5116664|NCT01764997|17673323|P3|Study Drug Treatment Period|Other than specified above|0
5116665|NCT01764997|17673324|P2|Study Drug Treatment Period|Other than specified above|0
5116666|NCT01764997|17673325|P1|Study Drug Treatment Period|Other than specified above|0
5116667|NCT01764997|17673321|P5|Study Drug Treatment Period|Lack of Efficacy|2
5116668|NCT01764997|17673322|P4|Study Drug Treatment Period|Lack of Efficacy|0
5116669|NCT01764997|17673323|P3|Study Drug Treatment Period|Lack of Efficacy|0
5116670|NCT01764997|17673324|P2|Study Drug Treatment Period|Lack of Efficacy|0
5116671|NCT01764997|17673325|P1|Study Drug Treatment Period|Lack of Efficacy|0
5116672|NCT01764997|17673321|P5|Study Drug Treatment Period|Adverse Event|24
5116673|NCT01764997|17673322|P4|Study Drug Treatment Period|Adverse Event|0
5116674|NCT01764997|17673323|P3|Study Drug Treatment Period|Adverse Event|0
5116675|NCT01764997|17673324|P2|Study Drug Treatment Period|Adverse Event|1
5116676|NCT01764997|17673325|P1|Study Drug Treatment Period|Adverse Event|0
5116677|NCT01764997|17673321|P5|Run-in Period|Other than specified above|0
5116678|NCT01764997|17673322|P4|Run-in Period|Other than specified above|0
5116679|NCT01764997|17673323|P3|Run-in Period|Other than specified above|0
5116680|NCT01764997|17673324|P2|Run-in Period|Other than specified above|0
5116681|NCT01764997|17673325|P1|Run-in Period|Other than specified above|17
5116682|NCT01764997|17673321|P5|Run-in Period|Poor compliance to protocol|0
5116683|NCT01764997|17673322|P4|Run-in Period|Poor compliance to protocol|0
5116684|NCT01764997|17673323|P3|Run-in Period|Poor compliance to protocol|0
5116685|NCT01764997|17673324|P2|Run-in Period|Poor compliance to protocol|0
5116686|NCT01764997|17673325|P1|Run-in Period|Poor compliance to protocol|1
5116687|NCT01764997|17673321|P5|Run-in Period|Lack of Efficacy|0
5116688|NCT01764997|17673322|P4|Run-in Period|Lack of Efficacy|0
5116689|NCT01764997|17673323|P3|Run-in Period|Lack of Efficacy|0
5116690|NCT01764997|17673324|P2|Run-in Period|Lack of Efficacy|0
5116691|NCT01764997|17673325|P1|Run-in Period|Lack of Efficacy|5
5116692|NCT01764997|17673321|P5|Run-in Period|Adverse Event|0
5116693|NCT01764997|17673322|P4|Run-in Period|Adverse Event|0
5116694|NCT01764997|17673323|P3|Run-in Period|Adverse Event|0
5116695|NCT01764997|17673324|P2|Run-in Period|Adverse Event|0
5116696|NCT01764997|17673325|P1|Run-in Period|Adverse Event|15
5116697|NCT01764945|17673352|P8|Overall Study|Adverse Event|0
5116698|NCT01764945|17673353|P7|Overall Study|Adverse Event|1
5116699|NCT01764945|17673354|P6|Overall Study|Adverse Event|0
5116700|NCT01764945|17673355|P5|Overall Study|Adverse Event|0
5116701|NCT01764945|17673356|P4|Overall Study|Adverse Event|0
5116702|NCT01764945|17673357|P3|Overall Study|Adverse Event|0
5116703|NCT01764945|17673358|P2|Overall Study|Adverse Event|1
5116704|NCT01764945|17673359|P1|Overall Study|Adverse Event|0
5116705|NCT01764854|17673405|P4|Overall Study|Protocol Violation|2
5116706|NCT01764854|17673406|P3|Overall Study|Protocol Violation|1
5116707|NCT01764854|17673407|P2|Overall Study|Protocol Violation|0
5116708|NCT01764854|17673408|P1|Overall Study|Protocol Violation|0
5116709|NCT01764854|17673405|P4|Overall Study|relocation|0
5116710|NCT01764854|17673406|P3|Overall Study|relocation|2
5116711|NCT01764854|17673407|P2|Overall Study|relocation|0
5116712|NCT01764854|17673408|P1|Overall Study|relocation|0
5116713|NCT01764854|17673405|P4|Overall Study|Withdrawal by Subject|0
5116714|NCT01764854|17673406|P3|Overall Study|Withdrawal by Subject|1
5116715|NCT01764854|17673407|P2|Overall Study|Withdrawal by Subject|0
5116716|NCT01764854|17673408|P1|Overall Study|Withdrawal by Subject|0
5116717|NCT01764854|17673405|P4|Overall Study|Adverse Event|0
5116718|NCT01764854|17673406|P3|Overall Study|Adverse Event|2
5116719|NCT01764854|17673407|P2|Overall Study|Adverse Event|0
5116720|NCT01764854|17673408|P1|Overall Study|Adverse Event|0
5116721|NCT01764841|17673422|P4|Overall Study|Lost to Follow-up|0
5116722|NCT01764841|17673423|P3|Overall Study|Lost to Follow-up|1
5116723|NCT01764841|17673424|P2|Overall Study|Lost to Follow-up|0
5116724|NCT01764841|17673425|P1|Overall Study|Lost to Follow-up|3
5116725|NCT01764841|17673422|P4|Overall Study|Withdrawal by Subject|15
5116726|NCT01764841|17673423|P3|Overall Study|Withdrawal by Subject|11
5116727|NCT01764841|17673424|P2|Overall Study|Withdrawal by Subject|24
5116728|NCT01764841|17673425|P1|Overall Study|Withdrawal by Subject|16
5116729|NCT01764841|17673422|P4|Overall Study|Protocol Violation|0
5116730|NCT01764841|17673423|P3|Overall Study|Protocol Violation|0
5116731|NCT01764841|17673424|P2|Overall Study|Protocol Violation|1
5116732|NCT01764841|17673425|P1|Overall Study|Protocol Violation|0
5116733|NCT01764841|17673422|P4|Overall Study|No Follow Up|0
5116734|NCT01764841|17673423|P3|Overall Study|No Follow Up|1
5116735|NCT01764841|17673424|P2|Overall Study|No Follow Up|0
5116736|NCT01764841|17673425|P1|Overall Study|No Follow Up|1
5116737|NCT01764841|17673422|P4|Overall Study|Death|4
5116738|NCT01764841|17673423|P3|Overall Study|Death|1
5116739|NCT01764841|17673424|P2|Overall Study|Death|0
5116740|NCT01764841|17673425|P1|Overall Study|Death|3
5116741|NCT01764841|17673422|P4|Overall Study|Logistical Difficulties|0
5116742|NCT01764841|17673423|P3|Overall Study|Logistical Difficulties|0
5116743|NCT01764841|17673424|P2|Overall Study|Logistical Difficulties|1
5116744|NCT01764841|17673425|P1|Overall Study|Logistical Difficulties|0
5116745|NCT01764659|17673466|P1|Overall Study|Physician Decision|1
5116746|NCT01764659|17673466|P1|Overall Study|Death|1
5116747|NCT01764633|17673480|P2|Overall Study|Lost to Follow-up|5
5116748|NCT01764633|17673481|P1|Overall Study|Lost to Follow-up|13
5116749|NCT01764633|17673480|P2|Overall Study|Withdrawal by Subject|88
5116750|NCT01764633|17673481|P1|Overall Study|Withdrawal by Subject|105
5116751|NCT01764464|17673510|P2|Second Intervention (Cross-over)|Adverse Event|0
5116752|NCT01764464|17673511|P1|Second Intervention (Cross-over)|Adverse Event|2
5116753|NCT01764464|17673510|P2|First Intervention|did not receive study drug|1
5116754|NCT01764464|17673511|P1|First Intervention|did not receive study drug|0
5116755|NCT01764464|17673510|P2|First Intervention|Adverse Event|2
5116756|NCT01764464|17673511|P1|First Intervention|Adverse Event|0
5116757|NCT01764464|17673510|P2|First Intervention|Lost to Follow-up|0
5116758|NCT01764464|17673511|P1|First Intervention|Lost to Follow-up|1
5116759|NCT01764464|17673510|P2|First Intervention|Withdrawal by Subject|0
5116760|NCT01764464|17673511|P1|First Intervention|Withdrawal by Subject|1
5116761|NCT01764386|17673529|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
5116762|NCT01764386|17673530|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
5116763|NCT01764386|17673529|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
5116764|NCT01764386|17673530|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
5116765|NCT01764386|17673529|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
5116766|NCT01764386|17673530|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
5116767|NCT01764386|17673529|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
5116768|NCT01764386|17673530|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
5116769|NCT01764386|17673529|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
5116770|NCT01764386|17673530|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
5116771|NCT01764386|17673529|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
5116772|NCT01764386|17673530|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
5116773|NCT01764386|17673529|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
5116774|NCT01764386|17673530|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
5116775|NCT01764386|17673529|P2|Controlled Treatment Period (CTP)|Adverse Event|0
5116776|NCT01764386|17673530|P1|Controlled Treatment Period (CTP)|Adverse Event|35
5116777|NCT01764256|17673575|P4|Completed Study|Lost to Follow-up|1
5116778|NCT01764256|17673576|P3|Completed Study|Lost to Follow-up|0
5116779|NCT01764256|17673577|P2|Completed Study|Lost to Follow-up|0
5116780|NCT01764256|17673578|P1|Completed Study|Lost to Follow-up|0
5116781|NCT01764256|17673575|P4|Received All Vaccinations|Lost to Follow-up|0
5116782|NCT01764256|17673576|P3|Received All Vaccinations|Lost to Follow-up|0
5116783|NCT01764256|17673577|P2|Received All Vaccinations|Lost to Follow-up|0
5116784|NCT01764256|17673578|P1|Received All Vaccinations|Lost to Follow-up|1
5116785|NCT01764256|17673575|P4|Received All Vaccinations|Did not meet inclusion criteria|0
5116786|NCT01764256|17673576|P3|Received All Vaccinations|Did not meet inclusion criteria|1
5116787|NCT01764256|17673577|P2|Received All Vaccinations|Did not meet inclusion criteria|0
5116788|NCT01764256|17673578|P1|Received All Vaccinations|Did not meet inclusion criteria|0
5116789|NCT01764256|17673575|P4|Received All Vaccinations|Adverse Event|0
5116790|NCT01764256|17673576|P3|Received All Vaccinations|Adverse Event|0
5116791|NCT01764256|17673577|P2|Received All Vaccinations|Adverse Event|1
5116792|NCT01764256|17673578|P1|Received All Vaccinations|Adverse Event|1
5116793|NCT01764022|17673621|P2|Overall Study|Protocol Violation|0
5116794|NCT01764022|17673622|P1|Overall Study|Protocol Violation|1
5116795|NCT01764022|17673621|P2|Overall Study|Lost to Follow-up|0
5116796|NCT01764022|17673622|P1|Overall Study|Lost to Follow-up|2
5116797|NCT01764022|17673621|P2|Overall Study|Physician Decision|2
5116798|NCT01764022|17673622|P1|Overall Study|Physician Decision|0
5116799|NCT01764022|17673621|P2|Overall Study|Lack of Efficacy|1
5116800|NCT01764022|17673622|P1|Overall Study|Lack of Efficacy|0
5116801|NCT01764022|17673621|P2|Overall Study|Withdrawal by Subject|6
5116802|NCT01764022|17673622|P1|Overall Study|Withdrawal by Subject|2
5116803|NCT01764022|17673621|P2|Overall Study|Death|5
5116804|NCT01764022|17673622|P1|Overall Study|Death|3
5116805|NCT01763996|17673654|P2|Treatment Period 2|Adverse Event|1
5116806|NCT01763996|17673655|P1|Treatment Period 2|Adverse Event|0
5116807|NCT01763918|17673709|P4|Overall Study|Sponsor Decision|0
5116808|NCT01763918|17673710|P3|Overall Study|Sponsor Decision|9
5116809|NCT01763918|17673711|P2|Overall Study|Sponsor Decision|0
5116810|NCT01763918|17673712|P1|Overall Study|Sponsor Decision|4
5116811|NCT01763918|17673709|P4|Overall Study|Withdrawal by Subject|2
5116812|NCT01763918|17673710|P3|Overall Study|Withdrawal by Subject|1
5116813|NCT01763918|17673711|P2|Overall Study|Withdrawal by Subject|1
5116814|NCT01763918|17673712|P1|Overall Study|Withdrawal by Subject|2
5116815|NCT01763905|17673810|P4|Overall Study|Lost to Follow-up|0
5116816|NCT01763905|17673811|P3|Overall Study|Lost to Follow-up|1
5116817|NCT01763905|17673812|P2|Overall Study|Lost to Follow-up|0
5116818|NCT01763905|17673813|P1|Overall Study|Lost to Follow-up|0
5116819|NCT01763905|17673810|P4|Overall Study|Decision by sponsor|0
5116820|NCT01763905|17673811|P3|Overall Study|Decision by sponsor|8
5116821|NCT01763905|17673812|P2|Overall Study|Decision by sponsor|0
5116822|NCT01763905|17673813|P1|Overall Study|Decision by sponsor|5
5116823|NCT01763905|17673810|P4|Overall Study|Withdrawal by Subject|1
5116824|NCT01763905|17673811|P3|Overall Study|Withdrawal by Subject|0
5116825|NCT01763905|17673812|P2|Overall Study|Withdrawal by Subject|1
5116826|NCT01763905|17673813|P1|Overall Study|Withdrawal by Subject|1
5116827|NCT01763866|17673931|P24|Overall Study|Death|0
5116828|NCT01763866|17673932|P23|Overall Study|Death|0
5116829|NCT01763866|17673933|P22|Overall Study|Death|0
5116830|NCT01763866|17673934|P21|Overall Study|Death|0
5116831|NCT01763866|17673935|P20|Overall Study|Death|0
5116832|NCT01763866|17673936|P19|Overall Study|Death|0
5116833|NCT01763866|17673937|P18|Overall Study|Death|0
5116834|NCT01763866|17673938|P17|Overall Study|Death|1
5116835|NCT01763866|17673939|P16|Overall Study|Death|0
5116836|NCT01763866|17673940|P15|Overall Study|Death|0
5116837|NCT01763866|17673941|P14|Overall Study|Death|0
5116838|NCT01763866|17673942|P13|Overall Study|Death|0
5116839|NCT01763866|17673943|P12|Overall Study|Death|0
5116840|NCT01763866|17673944|P11|Overall Study|Death|0
5116841|NCT01763866|17673945|P10|Overall Study|Death|0
5116842|NCT01763866|17673946|P9|Overall Study|Death|0
5116843|NCT01763866|17673947|P8|Overall Study|Death|0
5116844|NCT01763866|17673948|P7|Overall Study|Death|0
5116845|NCT01763866|17673949|P6|Overall Study|Death|0
5116846|NCT01763866|17673950|P5|Overall Study|Death|0
5116847|NCT01763866|17673951|P4|Overall Study|Death|0
5116848|NCT01763866|17673952|P3|Overall Study|Death|0
5116849|NCT01763866|17673953|P2|Overall Study|Death|0
5116850|NCT01763866|17673954|P1|Overall Study|Death|0
5116851|NCT01763866|17673931|P24|Overall Study|Lost to Follow-up|1
5116852|NCT01763866|17673932|P23|Overall Study|Lost to Follow-up|0
5116853|NCT01763866|17673933|P22|Overall Study|Lost to Follow-up|0
5116854|NCT01763866|17673934|P21|Overall Study|Lost to Follow-up|0
5116855|NCT01763866|17673935|P20|Overall Study|Lost to Follow-up|1
5116856|NCT01763866|17673936|P19|Overall Study|Lost to Follow-up|1
5116857|NCT01763866|17673937|P18|Overall Study|Lost to Follow-up|0
5116858|NCT01763866|17673938|P17|Overall Study|Lost to Follow-up|0
5116859|NCT01763866|17673939|P16|Overall Study|Lost to Follow-up|0
5116860|NCT01763866|17673940|P15|Overall Study|Lost to Follow-up|1
5116861|NCT01763866|17673941|P14|Overall Study|Lost to Follow-up|0
5116862|NCT01763866|17673942|P13|Overall Study|Lost to Follow-up|1
5116863|NCT01763866|17673943|P12|Overall Study|Lost to Follow-up|0
5116864|NCT01763866|17673944|P11|Overall Study|Lost to Follow-up|0
5116865|NCT01763866|17673945|P10|Overall Study|Lost to Follow-up|0
5116866|NCT01763866|17673946|P9|Overall Study|Lost to Follow-up|0
5116867|NCT01763866|17673947|P8|Overall Study|Lost to Follow-up|0
5116868|NCT01763866|17673948|P7|Overall Study|Lost to Follow-up|1
5116869|NCT01763866|17673949|P6|Overall Study|Lost to Follow-up|0
5116870|NCT01763866|17673950|P5|Overall Study|Lost to Follow-up|0
5116871|NCT01763866|17673951|P4|Overall Study|Lost to Follow-up|0
5116872|NCT01763866|17673952|P3|Overall Study|Lost to Follow-up|0
5116873|NCT01763866|17673953|P2|Overall Study|Lost to Follow-up|0
5116874|NCT01763866|17673954|P1|Overall Study|Lost to Follow-up|0
5116875|NCT01763866|17673931|P24|Overall Study|Decision by sponsor|0
5116876|NCT01763866|17673932|P23|Overall Study|Decision by sponsor|1
5116877|NCT01763866|17673933|P22|Overall Study|Decision by sponsor|0
5116878|NCT01763866|17673934|P21|Overall Study|Decision by sponsor|2
5116879|NCT01763866|17673935|P20|Overall Study|Decision by sponsor|0
5116880|NCT01763866|17673936|P19|Overall Study|Decision by sponsor|4
5116881|NCT01763866|17673937|P18|Overall Study|Decision by sponsor|0
5116882|NCT01763866|17673938|P17|Overall Study|Decision by sponsor|0
5116883|NCT01763866|17673939|P16|Overall Study|Decision by sponsor|0
5116884|NCT01763866|17673940|P15|Overall Study|Decision by sponsor|5
5116885|NCT01763866|17673941|P14|Overall Study|Decision by sponsor|0
5116886|NCT01763866|17673942|P13|Overall Study|Decision by sponsor|1
5116887|NCT01763866|17673943|P12|Overall Study|Decision by sponsor|0
5116888|NCT01763866|17673944|P11|Overall Study|Decision by sponsor|6
5116889|NCT01763866|17673945|P10|Overall Study|Decision by sponsor|0
5116890|NCT01763866|17673946|P9|Overall Study|Decision by sponsor|2
5116891|NCT01763866|17673947|P8|Overall Study|Decision by sponsor|0
5116892|NCT01763866|17673948|P7|Overall Study|Decision by sponsor|2
5116893|NCT01763866|17673949|P6|Overall Study|Decision by sponsor|0
5116894|NCT01763866|17673950|P5|Overall Study|Decision by sponsor|2
5116895|NCT01763866|17673951|P4|Overall Study|Decision by sponsor|0
5116896|NCT01763866|17673952|P3|Overall Study|Decision by sponsor|1
5116897|NCT01763866|17673953|P2|Overall Study|Decision by sponsor|0
5116898|NCT01763866|17673954|P1|Overall Study|Decision by sponsor|0
5116899|NCT01763866|17673931|P24|Overall Study|Withdrawal by Subject|1
5116900|NCT01763866|17673932|P23|Overall Study|Withdrawal by Subject|2
5116901|NCT01763866|17673933|P22|Overall Study|Withdrawal by Subject|1
5116902|NCT01763866|17673934|P21|Overall Study|Withdrawal by Subject|2
5116903|NCT01763866|17673935|P20|Overall Study|Withdrawal by Subject|1
5116904|NCT01763866|17673936|P19|Overall Study|Withdrawal by Subject|1
5116905|NCT01763866|17673937|P18|Overall Study|Withdrawal by Subject|1
5116906|NCT01763866|17673938|P17|Overall Study|Withdrawal by Subject|0
5116907|NCT01763866|17673939|P16|Overall Study|Withdrawal by Subject|3
5116908|NCT01763866|17673940|P15|Overall Study|Withdrawal by Subject|6
5116909|NCT01763866|17673941|P14|Overall Study|Withdrawal by Subject|0
5116910|NCT01763866|17673942|P13|Overall Study|Withdrawal by Subject|2
5116911|NCT01763866|17673943|P12|Overall Study|Withdrawal by Subject|2
5116912|NCT01763866|17673944|P11|Overall Study|Withdrawal by Subject|2
5116913|NCT01763866|17673945|P10|Overall Study|Withdrawal by Subject|1
5116914|NCT01763866|17673946|P9|Overall Study|Withdrawal by Subject|1
5116915|NCT01763866|17673947|P8|Overall Study|Withdrawal by Subject|0
5116916|NCT01763866|17673948|P7|Overall Study|Withdrawal by Subject|4
5116917|NCT01763866|17673949|P6|Overall Study|Withdrawal by Subject|3
5116918|NCT01763866|17673950|P5|Overall Study|Withdrawal by Subject|0
5116919|NCT01763866|17673951|P4|Overall Study|Withdrawal by Subject|0
5116920|NCT01763866|17673952|P3|Overall Study|Withdrawal by Subject|4
5116921|NCT01763866|17673953|P2|Overall Study|Withdrawal by Subject|1
5116922|NCT01763866|17673954|P1|Overall Study|Withdrawal by Subject|2
5116923|NCT01763827|17674514|P6|Overall Study|Lost to Follow-up|1
5116924|NCT01763827|17674515|P5|Overall Study|Lost to Follow-up|2
5116925|NCT01763827|17674516|P4|Overall Study|Lost to Follow-up|1
5116926|NCT01763827|17674517|P3|Overall Study|Lost to Follow-up|1
5116927|NCT01763827|17674518|P2|Overall Study|Lost to Follow-up|1
5116928|NCT01763827|17674519|P1|Overall Study|Lost to Follow-up|0
5116929|NCT01763827|17674514|P6|Overall Study|Decision by sponsor|1
5116930|NCT01763827|17674515|P5|Overall Study|Decision by sponsor|2
5116931|NCT01763827|17674516|P4|Overall Study|Decision by sponsor|0
5116932|NCT01763827|17674517|P3|Overall Study|Decision by sponsor|3
5116933|NCT01763827|17674518|P2|Overall Study|Decision by sponsor|0
5116934|NCT01763827|17674519|P1|Overall Study|Decision by sponsor|2
5116935|NCT01763827|17674514|P6|Overall Study|Withdrawal by Subject|0
5116936|NCT01763827|17674515|P5|Overall Study|Withdrawal by Subject|2
5116937|NCT01763827|17674516|P4|Overall Study|Withdrawal by Subject|0
5116938|NCT01763827|17674517|P3|Overall Study|Withdrawal by Subject|0
5116939|NCT01763827|17674518|P2|Overall Study|Withdrawal by Subject|0
5116940|NCT01763827|17674519|P1|Overall Study|Withdrawal by Subject|1
5116941|NCT01763788|17674663|P4|Overall Study|Lost to Follow-up|0
5116942|NCT01763788|17674664|P3|Overall Study|Lost to Follow-up|1
5116943|NCT01763788|17674665|P2|Overall Study|Lost to Follow-up|0
5116944|NCT01763788|17674666|P1|Overall Study|Lost to Follow-up|0
5116945|NCT01763203|17674887|P2|Overall Study|Physician Decision|1
5116946|NCT01763203|17674888|P1|Overall Study|Physician Decision|2
5116947|NCT01763203|17674887|P2|Overall Study|Moved out of study region|10
5116948|NCT01763203|17674888|P1|Overall Study|Moved out of study region|7
5116949|NCT01763203|17674887|P2|Overall Study|Withdrawal by Subject|12
5116950|NCT01763203|17674888|P1|Overall Study|Withdrawal by Subject|8
5116951|NCT01763203|17674887|P2|Overall Study|Lost to Follow-up|12
5116952|NCT01763203|17674888|P1|Overall Study|Lost to Follow-up|12
5116953|NCT01763203|17674887|P2|Overall Study|Death|7
5116954|NCT01763203|17674888|P1|Overall Study|Death|4
5116955|NCT01763047|17674934|P2|Period 2|Unsatisfactory lens Fitting|1
5116956|NCT01763047|17674935|P1|Period 2|Unsatisfactory lens Fitting|0
5116957|NCT01763047|17674934|P2|Period 2|Protocol Violation|2
5116958|NCT01763047|17674935|P1|Period 2|Protocol Violation|0
5116959|NCT01763047|17674934|P2|Period 2|Unsatisfactory Visual Response|1
5116960|NCT01763047|17674935|P1|Period 2|Unsatisfactory Visual Response|1
5116961|NCT01763047|17674934|P2|Period 2|Study Site office Closed|1
5116962|NCT01763047|17674935|P1|Period 2|Study Site office Closed|1
5116963|NCT01763047|17674934|P2|Period 2|No longer meets Eligibility Criteria|0
5116964|NCT01763047|17674935|P1|Period 2|No longer meets Eligibility Criteria|1
5116965|NCT01763047|17674934|P2|Period 2|Lens Discomfort|0
5116966|NCT01763047|17674935|P1|Period 2|Lens Discomfort|1
5116967|NCT01763047|17674934|P2|Period 1|Study Site office Closed|1
5116968|NCT01763047|17674935|P1|Period 1|Study Site office Closed|0
5116969|NCT01763047|17674934|P2|Period 1|Lens Power Not Available|1
5116970|NCT01763047|17674935|P1|Period 1|Lens Power Not Available|0
5116971|NCT01763047|17674934|P2|Period 1|Unsatisfactory Visual Response|3
5116972|NCT01763047|17674935|P1|Period 1|Unsatisfactory Visual Response|0
5116973|NCT01763047|17674934|P2|Period 1|Adverse Event|1
5116974|NCT01763047|17674935|P1|Period 1|Adverse Event|0
5116975|NCT01763047|17674934|P2|Period 1|No Longer Meets Eligibility criteria|0
5116976|NCT01763047|17674935|P1|Period 1|No Longer Meets Eligibility criteria|1
5116977|NCT01763047|17674934|P2|Period 1|Protocol Violation|4
5116978|NCT01763047|17674935|P1|Period 1|Protocol Violation|4
5116979|NCT01763047|17674934|P2|Period 1|Test Article Not Available|1
5116980|NCT01763047|17674935|P1|Period 1|Test Article Not Available|4
5116981|NCT01762943|17674974|P2|Overall Study|Withdrawal by Subject|1
5116982|NCT01762943|17674975|P1|Overall Study|Withdrawal by Subject|2
5116983|NCT01762943|17674974|P2|Overall Study|Protocol Violation|0
5116984|NCT01762943|17674975|P1|Overall Study|Protocol Violation|1
5116985|NCT01762943|17674974|P2|Overall Study|Physician Decision|1
5116986|NCT01762943|17674975|P1|Overall Study|Physician Decision|1
5116987|NCT01762800|17674992|P2|Overall Study|Withdrawal by Subject|4
5116988|NCT01762800|17674993|P1|Overall Study|Withdrawal by Subject|7
5116989|NCT01762800|17674992|P2|Overall Study|Physician Decision|1
5116990|NCT01762800|17674993|P1|Overall Study|Physician Decision|1
5116991|NCT01762800|17674992|P2|Overall Study|Study Closed/Terminated|1
5116992|NCT01762800|17674993|P1|Overall Study|Study Closed/Terminated|0
5116993|NCT01762800|17674992|P2|Overall Study|Lack of Efficacy|2
5116994|NCT01762800|17674993|P1|Overall Study|Lack of Efficacy|3
5116995|NCT01762800|17674992|P2|Overall Study|Adverse Event|13
5116996|NCT01762800|17674993|P1|Overall Study|Adverse Event|8
5116997|NCT01762761|17675067|P2|Overall Study|Withdrawal by Subject|8
5116998|NCT01762761|17675068|P1|Overall Study|Withdrawal by Subject|7
5116999|NCT01762761|17675067|P2|Overall Study|Physician Decision|6
5117000|NCT01762761|17675068|P1|Overall Study|Physician Decision|4
5117001|NCT01762761|17675067|P2|Overall Study|Lost to Follow-up|6
5117002|NCT01762761|17675068|P1|Overall Study|Lost to Follow-up|3
5117003|NCT01762761|17675067|P2|Overall Study|Study closed/terminated|2
5117004|NCT01762761|17675068|P1|Overall Study|Study closed/terminated|0
5117005|NCT01762761|17675067|P2|Overall Study|Protocol Violation|1
5117006|NCT01762761|17675068|P1|Overall Study|Protocol Violation|1
5117007|NCT01762761|17675067|P2|Overall Study|Lack of Efficacy|25
5117008|NCT01762761|17675068|P1|Overall Study|Lack of Efficacy|9
5117009|NCT01762761|17675067|P2|Overall Study|Adverse Event|17
5117010|NCT01762761|17675068|P1|Overall Study|Adverse Event|15
5117011|NCT01762345|17675167|P1|Overall Study|Protocol Violation|2
5117012|NCT01762345|17675167|P1|Overall Study|Adverse Event|5
5117013|NCT01761565|17675228|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
5117014|NCT01761292|17675240|P1|Extension 1|Withdrawal by Subject|1
5117015|NCT01761292|17675240|P1|Part 1|not receiving treatment in Part 1|1
5117016|NCT01761292|17675240|P1|Part 1|Adverse Event|1
5117017|NCT01761266|17675274|P2|Overall Study|Ongoing as of data-cut off|107
5117018|NCT01761266|17675275|P1|Overall Study|Ongoing as of data-cut off|109
5117019|NCT01761266|17675274|P2|Overall Study|Withdrawal by Subject|8
5117020|NCT01761266|17675275|P1|Overall Study|Withdrawal by Subject|13
5117021|NCT01761266|17675274|P2|Overall Study|Lost to Follow-up|11
5117022|NCT01761266|17675275|P1|Overall Study|Lost to Follow-up|5
5117023|NCT01761266|17675274|P2|Overall Study|Death|350
5117024|NCT01761266|17675275|P1|Overall Study|Death|351
5117025|NCT01761162|17675332|P1|Overall Study|Withdrawal by Subject|3
5117026|NCT01760954|17675421|P4|Post-treatment Follow-up (12 Months)|Other|6
5117027|NCT01760954|17675422|P3|Post-treatment Follow-up (12 Months)|Other|9
5117028|NCT01760954|17675423|P2|Post-treatment Follow-up (12 Months)|Other|8
5117029|NCT01760954|17675424|P1|Post-treatment Follow-up (12 Months)|Other|13
5117030|NCT01760954|17675421|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5117031|NCT01760954|17675422|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
5117032|NCT01760954|17675423|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5117033|NCT01760954|17675424|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5117034|NCT01760954|17675421|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
5117035|NCT01760954|17675422|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
5117036|NCT01760954|17675423|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
5117037|NCT01760954|17675424|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
5117038|NCT01760954|17675421|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
5117039|NCT01760954|17675422|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
5117040|NCT01760954|17675423|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
5117041|NCT01760954|17675424|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
5117042|NCT01760954|17675421|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
5117043|NCT01760954|17675422|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
5117044|NCT01760954|17675423|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
5117045|NCT01760954|17675424|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
5117046|NCT01760954|17675421|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
5117047|NCT01760954|17675422|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
5117048|NCT01760954|17675423|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5117049|NCT01760954|17675424|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5117050|NCT01760954|17675421|P4|Treatment Period (6 Months)|Exclusionary Medication|0
5117051|NCT01760954|17675422|P3|Treatment Period (6 Months)|Exclusionary Medication|0
5117052|NCT01760954|17675423|P2|Treatment Period (6 Months)|Exclusionary Medication|0
5117053|NCT01760954|17675424|P1|Treatment Period (6 Months)|Exclusionary Medication|1
5117054|NCT01760954|17675421|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
5117055|NCT01760954|17675422|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
5117056|NCT01760954|17675423|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
5117057|NCT01760954|17675424|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
5117058|NCT01760954|17675421|P4|Treatment Period (6 Months)|Other|1
5117059|NCT01760954|17675422|P3|Treatment Period (6 Months)|Other|3
5117060|NCT01760954|17675423|P2|Treatment Period (6 Months)|Other|3
5117061|NCT01760954|17675424|P1|Treatment Period (6 Months)|Other|0
5117062|NCT01760954|17675421|P4|Treatment Period (6 Months)|Non-compliance|3
5117063|NCT01760954|17675422|P3|Treatment Period (6 Months)|Non-compliance|0
5117064|NCT01760954|17675423|P2|Treatment Period (6 Months)|Non-compliance|4
5117065|NCT01760954|17675424|P1|Treatment Period (6 Months)|Non-compliance|1
5117066|NCT01760954|17675421|P4|Treatment Period (6 Months)|Pregnancy|2
5117067|NCT01760954|17675422|P3|Treatment Period (6 Months)|Pregnancy|3
5117068|NCT01760954|17675423|P2|Treatment Period (6 Months)|Pregnancy|0
5117069|NCT01760954|17675424|P1|Treatment Period (6 Months)|Pregnancy|5
5117070|NCT01760954|17675421|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
5117071|NCT01760954|17675422|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5117072|NCT01760954|17675423|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5117073|NCT01760954|17675424|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5117074|NCT01760954|17675421|P4|Treatment Period (6 Months)|Lost to Follow-up|3
5117075|NCT01760954|17675422|P3|Treatment Period (6 Months)|Lost to Follow-up|4
5117076|NCT01760954|17675423|P2|Treatment Period (6 Months)|Lost to Follow-up|1
5117077|NCT01760954|17675424|P1|Treatment Period (6 Months)|Lost to Follow-up|9
5117078|NCT01760954|17675421|P4|Treatment Period (6 Months)|Adverse Event|10
5117079|NCT01760954|17675422|P3|Treatment Period (6 Months)|Adverse Event|4
5117080|NCT01760954|17675423|P2|Treatment Period (6 Months)|Adverse Event|3
5117081|NCT01760954|17675424|P1|Treatment Period (6 Months)|Adverse Event|5
5117082|NCT01760954|17675421|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
5117083|NCT01760954|17675422|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
5117084|NCT01760954|17675423|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
5117085|NCT01760954|17675424|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
5117086|NCT01760876|17675561|P1|Overall Study|Very poor baseline OCT quality|2
5117087|NCT01760876|17675561|P1|Overall Study|Major depression|1
5117088|NCT01760876|17675561|P1|Overall Study|Impaired renal function|1
5117089|NCT01760876|17675561|P1|Overall Study|Carcinoma of prostate|1
5117090|NCT01760876|17675561|P1|Overall Study|Non-cardiac death (head injury)|1
5117091|NCT01760733|17675576|P1|Transplanted|Graft loss|7
5117092|NCT01760733|17675576|P1|Transplanted|Death|26
5117093|NCT01760733|17675576|P1|Transplanted|Not reached 10 years post transplant|184
5117094|NCT01760733|17675576|P1|Waiting List|Not received a transplant yet|13
5117095|NCT01760733|17675576|P1|Waiting List|Removed from waiting list|41
5117096|NCT01760733|17675576|P1|Waiting List|Death|18
5117097|NCT01760447|17675606|P4|Weeks 20-54|Lost to Follow-up|2
5117098|NCT01760447|17675607|P3|Weeks 20-54|Lost to Follow-up|1
5117099|NCT01760447|17675608|P2|Weeks 20-54|Lost to Follow-up|0
5117100|NCT01760447|17675609|P1|Weeks 20-54|Lost to Follow-up|0
5117101|NCT01760447|17675606|P4|Weeks 20-54|Withdrawal by Subject|2
5117102|NCT01760447|17675607|P3|Weeks 20-54|Withdrawal by Subject|1
5117103|NCT01760447|17675608|P2|Weeks 20-54|Withdrawal by Subject|1
5117104|NCT01760447|17675609|P1|Weeks 20-54|Withdrawal by Subject|2
5117105|NCT01760447|17675606|P4|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
5117106|NCT01760447|17675607|P3|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5117107|NCT01760447|17675608|P2|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5117108|NCT01760447|17675609|P1|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5117109|NCT01760447|17675606|P4|Weeks 0-20|Randomized but not treated|0
5117110|NCT01760447|17675607|P3|Weeks 0-20|Randomized but not treated|2
5117111|NCT01760447|17675608|P2|Weeks 0-20|Randomized but not treated|0
5117112|NCT01760447|17675609|P1|Weeks 0-20|Randomized but not treated|0
5117113|NCT01760447|17675606|P4|Weeks 0-20|Lost to Follow-up|1
5117114|NCT01760447|17675607|P3|Weeks 0-20|Lost to Follow-up|1
5117115|NCT01760447|17675608|P2|Weeks 0-20|Lost to Follow-up|0
5117116|NCT01760447|17675609|P1|Weeks 0-20|Lost to Follow-up|1
5117117|NCT01760447|17675606|P4|Weeks 0-20|Withdrawal by Subject|0
5117118|NCT01760447|17675607|P3|Weeks 0-20|Withdrawal by Subject|1
5117119|NCT01760447|17675608|P2|Weeks 0-20|Withdrawal by Subject|0
5117120|NCT01760447|17675609|P1|Weeks 0-20|Withdrawal by Subject|2
5117121|NCT01760447|17675606|P4|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
5117122|NCT01760447|17675607|P3|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
5117123|NCT01760447|17675608|P2|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
5117124|NCT01760447|17675609|P1|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
5117125|NCT01759862|17675937|P2|Overall Study|Adverse Event|1
5117126|NCT01759862|17675938|P1|Overall Study|Adverse Event|0
5117127|NCT01759862|17675937|P2|Overall Study|Physician Decision|1
5117128|NCT01759862|17675938|P1|Overall Study|Physician Decision|3
5117129|NCT01759511|17675956|P1|Overall Study|Withdrawal by Subject|3
5117130|NCT01759511|17675956|P1|Overall Study|Study Terminated by Sponsor|13
5117131|NCT01759511|17675956|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
5117132|NCT01759511|17675956|P1|Overall Study|Progressive Disease|5
5117133|NCT01759511|17675956|P1|Overall Study|Physician Decision|1
5117134|NCT01759511|17675956|P1|Overall Study|Lack of Efficacy|2
5117135|NCT01759511|17675956|P1|Overall Study|Death|2
5117136|NCT01759511|17675956|P1|Overall Study|Adverse Event|4
5117137|NCT01759446|17675969|P5|Overall Study|Withdrawal by Subject|0
5117138|NCT01759446|17675970|P4|Overall Study|Withdrawal by Subject|1
5117139|NCT01759446|17675971|P3|Overall Study|Withdrawal by Subject|0
5117140|NCT01759446|17675972|P2|Overall Study|Withdrawal by Subject|1
5117141|NCT01759446|17675973|P1|Overall Study|Withdrawal by Subject|0
5117142|NCT01759446|17675969|P5|Overall Study|Protocol Violation|0
5117143|NCT01759446|17675970|P4|Overall Study|Protocol Violation|0
5117144|NCT01759446|17675971|P3|Overall Study|Protocol Violation|1
5117145|NCT01759446|17675972|P2|Overall Study|Protocol Violation|0
5117146|NCT01759446|17675973|P1|Overall Study|Protocol Violation|1
5117147|NCT01759420|17675985|P1|Overall Study|Inaccurate EKG machine readings|1
5117148|NCT01759420|17675985|P1|Overall Study|Screen failure|5
5117149|NCT01759407|17675992|P2|Overall Study|Protocol Violation|2
5117150|NCT01759407|17675993|P1|Overall Study|Protocol Violation|0
5117151|NCT01759381|17676005|P2|Overall Study|Death|0
5117152|NCT01759381|17676006|P1|Overall Study|Death|1
5117153|NCT01759368|17676014|P2|Overall Study|Lost to Follow-up|0
5117154|NCT01759368|17676015|P1|Overall Study|Lost to Follow-up|1
5117155|NCT01759290|17676033|P1|Overall Study|Unknown reason|4
5117156|NCT01759290|17676033|P1|Overall Study|Lost to Follow-up|53
5117157|NCT01759290|17676033|P1|Overall Study|Death|17
5117158|NCT01759290|17676033|P1|Overall Study|Physician Decision|2
5117159|NCT01759290|17676033|P1|Overall Study|Subjects withdrawn consent|5
5117160|NCT01759264|17676102|P1|Overall Study|Discontinued Humira Due to Business Trip|1
5117161|NCT01759264|17676102|P1|Overall Study|Withdrawal by Subject|3
5117162|NCT01759264|17676102|P1|Overall Study|Lost to Follow-up|2
5117163|NCT01759264|17676102|P1|Overall Study|Other|2
5117164|NCT01759264|17676102|P1|Overall Study|Adverse Event|1
5117165|NCT01759264|17676102|P1|Overall Study|Serious Adverse Events (SAEs)|1
5117166|NCT01758900|17676130|P2|Overall Study|difficulty for further intubation|8
5117167|NCT01758900|17676131|P1|Overall Study|difficulty for further intubation|7
5117168|NCT01758731|17676149|P1|Overall Study|Physician Decision|1
5117169|NCT01758523|17676168|P2|Overall Study|Withdrawal by Subject|7
5117170|NCT01758523|17676169|P1|Overall Study|Withdrawal by Subject|12
5117171|NCT01758523|17676168|P2|Overall Study|Lost to Follow-up|4
5117172|NCT01758523|17676169|P1|Overall Study|Lost to Follow-up|3
5117173|NCT01758523|17676168|P2|Overall Study|Lack of Efficacy|2
5117174|NCT01758523|17676169|P1|Overall Study|Lack of Efficacy|4
5117175|NCT01758523|17676168|P2|Overall Study|Adverse Event|1
5117176|NCT01758523|17676169|P1|Overall Study|Adverse Event|2
5117177|NCT01758289|17676272|P1|Overall Study|Adverse Event|9
5117178|NCT01758289|17676272|P1|Overall Study|Premature Study Termination|44
5117179|NCT01757847|17676298|P2|Overall Study|Withdrawal by Subject|4
5117180|NCT01757847|17676299|P1|Overall Study|Withdrawal by Subject|3
5117181|NCT01757821|17676307|P1|Overall Study|Adverse Event|1
5117182|NCT01757704|17676322|P2|Overall Study|Protocol Violation|3
5117183|NCT01757704|17676323|P1|Overall Study|Protocol Violation|1
5117184|NCT01757691|17676341|P2|Overall Study|Administrative problems|0
5117185|NCT01757691|17676342|P1|Overall Study|Administrative problems|2
5117186|NCT01757665|17676369|P2|Overall Study|Not Implanted with Device|1
5117187|NCT01757665|17676370|P1|Overall Study|Not Implanted with Device|5
5117188|NCT01757665|17676369|P2|Overall Study|Lost to Follow-up|1
5117189|NCT01757665|17676370|P1|Overall Study|Lost to Follow-up|1
5117190|NCT01757665|17676369|P2|Overall Study|Withdrawal by Subject|0
5117191|NCT01757665|17676370|P1|Overall Study|Withdrawal by Subject|10
5117192|NCT01757665|17676369|P2|Overall Study|Explant|2
5117193|NCT01757665|17676370|P1|Overall Study|Explant|1
5117194|NCT01757665|17676369|P2|Overall Study|Death|8
5117195|NCT01757665|17676370|P1|Overall Study|Death|25
5117196|NCT01757665|17676369|P2|Overall Study|Still on Study - Missed Visit|1
5117197|NCT01757665|17676370|P1|Overall Study|Still on Study - Missed Visit|14
5117198|NCT01757665|17676369|P2|Overall Study|Still on Study - Visit Pending|40
5117199|NCT01757665|17676370|P1|Overall Study|Still on Study - Visit Pending|398
5117200|NCT01757665|17676369|P2|Overall Study|Still on Study - Visit Completed|30
5117201|NCT01757665|17676370|P1|Overall Study|Still on Study - Visit Completed|240
5117202|NCT01757535|17676542|P2|Overall Study|Death|2
5117203|NCT01757535|17676543|P1|Overall Study|Death|1
5117204|NCT01757535|17676542|P2|Overall Study|Physician Decision|0
5117205|NCT01757535|17676543|P1|Overall Study|Physician Decision|6
5117206|NCT01757535|17676542|P2|Overall Study|Miscellaneous|2
5117207|NCT01757535|17676543|P1|Overall Study|Miscellaneous|5
5117208|NCT01757535|17676542|P2|Overall Study|Withdrawal by Subject|13
5117209|NCT01757535|17676543|P1|Overall Study|Withdrawal by Subject|9
5117210|NCT01757535|17676542|P2|Overall Study|Adverse Event|11
5117211|NCT01757535|17676543|P1|Overall Study|Adverse Event|29
5117212|NCT01757535|17676542|P2|Overall Study|Disease Relapse|180
5117213|NCT01757535|17676543|P1|Overall Study|Disease Relapse|143
5117214|NCT01757405|17676575|P2|Overall Study|Withdrawal by Subject|1
5117215|NCT01757405|17676576|P1|Overall Study|Withdrawal by Subject|0
5117216|NCT01757405|17676575|P2|Overall Study|Lost to Follow-up|1
5117217|NCT01757405|17676576|P1|Overall Study|Lost to Follow-up|1
5117218|NCT01757275|17676611|P2|Overall Study|Not treated|4
5117219|NCT01757275|17676612|P1|Overall Study|Not treated|3
5117220|NCT01757275|17676611|P2|Overall Study|Withdrawal by Subject|4
5117221|NCT01757275|17676612|P1|Overall Study|Withdrawal by Subject|2
5117222|NCT01757275|17676611|P2|Overall Study|Adverse Event|3
5117223|NCT01757275|17676612|P1|Overall Study|Adverse Event|3
5117224|NCT01757275|17676611|P2|Overall Study|Lost to Follow-up|2
5117225|NCT01757275|17676612|P1|Overall Study|Lost to Follow-up|1
5117226|NCT01757197|17676634|P1|Overall Study|Death|2
5117227|NCT01757184|17676643|P4|Open-label Period|Discontinued by Sponsor|2
5117228|NCT01757184|17676644|P3|Open-label Period|Discontinued by Sponsor|1
5117229|NCT01757184|17676645|P2|Open-label Period|Discontinued by Sponsor|0
5117230|NCT01757184|17676646|P1|Open-label Period|Discontinued by Sponsor|0
5117231|NCT01757184|17676643|P4|Open-label Period|Withdrawal by Subject|1
5117232|NCT01757184|17676644|P3|Open-label Period|Withdrawal by Subject|1
5117233|NCT01757184|17676645|P2|Open-label Period|Withdrawal by Subject|0
5117234|NCT01757184|17676646|P1|Open-label Period|Withdrawal by Subject|0
5117235|NCT01757184|17676643|P4|Open-label Period|Lost to Follow-up|0
5117236|NCT01757184|17676644|P3|Open-label Period|Lost to Follow-up|2
5117237|NCT01757184|17676645|P2|Open-label Period|Lost to Follow-up|0
5117238|NCT01757184|17676646|P1|Open-label Period|Lost to Follow-up|0
5117239|NCT01757184|17676643|P4|Double-blind Period|Adverse Event|0
5117240|NCT01757184|17676644|P3|Double-blind Period|Adverse Event|0
5117241|NCT01757184|17676645|P2|Double-blind Period|Adverse Event|0
5117242|NCT01757184|17676646|P1|Double-blind Period|Adverse Event|1
5117243|NCT01757171|17676690|P2|Overall Study|ECOG decline|0
5117244|NCT01757171|17676691|P1|Overall Study|ECOG decline|1
5117245|NCT01757171|17676690|P2|Overall Study|Hospitalization|0
5117246|NCT01757171|17676691|P1|Overall Study|Hospitalization|1
5117247|NCT01757171|17676690|P2|Overall Study|Disease Progression|0
5117248|NCT01757171|17676691|P1|Overall Study|Disease Progression|1
5117249|NCT01757171|17676690|P2|Overall Study|Adverse Event|1
5117250|NCT01757171|17676691|P1|Overall Study|Adverse Event|5
5117251|NCT01756846|17676727|P2|Overall Study|Withdrawal by Subject|2
5117252|NCT01756846|17676728|P1|Overall Study|Withdrawal by Subject|1
5117253|NCT01756846|17676727|P2|Overall Study|Lost to Follow-up|10
5117254|NCT01756846|17676728|P1|Overall Study|Lost to Follow-up|5
5117255|NCT01756456|17676773|P6|Follow Up Period Phase I/II|Other causes|5
5117256|NCT01756456|17676774|P5|Follow Up Period Phase I/II|Other causes|3
5117257|NCT01756456|17676775|P4|Follow Up Period Phase I/II|Other causes|1
5117258|NCT01756456|17676776|P3|Follow Up Period Phase I/II|Other causes|0
5117259|NCT01756456|17676777|P2|Follow Up Period Phase I/II|Other causes|0
5117260|NCT01756456|17676778|P1|Follow Up Period Phase I/II|Other causes|0
5117261|NCT01756456|17676773|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
5117262|NCT01756456|17676774|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
5117263|NCT01756456|17676775|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
5117264|NCT01756456|17676776|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
5117265|NCT01756456|17676777|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
5117266|NCT01756456|17676778|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
5117267|NCT01756456|17676773|P6|Follow Up Period Phase I/II|Adverse Event|1
5117268|NCT01756456|17676774|P5|Follow Up Period Phase I/II|Adverse Event|0
5117269|NCT01756456|17676775|P4|Follow Up Period Phase I/II|Adverse Event|5
5117270|NCT01756456|17676776|P3|Follow Up Period Phase I/II|Adverse Event|0
5117271|NCT01756456|17676777|P2|Follow Up Period Phase I/II|Adverse Event|0
5117272|NCT01756456|17676778|P1|Follow Up Period Phase I/II|Adverse Event|1
5117273|NCT01756456|17676773|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
5117274|NCT01756456|17676774|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
5117275|NCT01756456|17676775|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
5117276|NCT01756456|17676776|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
5117277|NCT01756456|17676777|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
5117278|NCT01756456|17676778|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
5117279|NCT01756456|17676773|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5117280|NCT01756456|17676774|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5117281|NCT01756456|17676775|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5117282|NCT01756456|17676776|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5117283|NCT01756456|17676777|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
5117284|NCT01756456|17676778|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5117285|NCT01756456|17676773|P6|Follow Up Period Phase I/II|still in study after week 20|25
5117286|NCT01756456|17676774|P5|Follow Up Period Phase I/II|still in study after week 20|23
5117287|NCT01756456|17676775|P4|Follow Up Period Phase I/II|still in study after week 20|25
5117288|NCT01756456|17676776|P3|Follow Up Period Phase I/II|still in study after week 20|0
5117289|NCT01756456|17676777|P2|Follow Up Period Phase I/II|still in study after week 20|0
5117290|NCT01756456|17676778|P1|Follow Up Period Phase I/II|still in study after week 20|0
5117291|NCT01756456|17676773|P6|Treatment Period: Phase I/II|Other causes|2
5117292|NCT01756456|17676774|P5|Treatment Period: Phase I/II|Other causes|2
5117293|NCT01756456|17676775|P4|Treatment Period: Phase I/II|Other causes|1
5117294|NCT01756456|17676776|P3|Treatment Period: Phase I/II|Other causes|0
5117295|NCT01756456|17676777|P2|Treatment Period: Phase I/II|Other causes|0
5117296|NCT01756456|17676778|P1|Treatment Period: Phase I/II|Other causes|0
5117297|NCT01756456|17676773|P6|Treatment Period: Phase I/II|Adverse Event|1
5117298|NCT01756456|17676774|P5|Treatment Period: Phase I/II|Adverse Event|9
5117299|NCT01756456|17676775|P4|Treatment Period: Phase I/II|Adverse Event|3
5117300|NCT01756456|17676776|P3|Treatment Period: Phase I/II|Adverse Event|2
5117301|NCT01756456|17676777|P2|Treatment Period: Phase I/II|Adverse Event|0
5117302|NCT01756456|17676778|P1|Treatment Period: Phase I/II|Adverse Event|1
5117303|NCT01756456|17676773|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
5117304|NCT01756456|17676774|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
5117305|NCT01756456|17676775|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
5117306|NCT01756456|17676776|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
5117307|NCT01756456|17676777|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
5117308|NCT01756456|17676778|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
5117309|NCT01756456|17676773|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
5117310|NCT01756456|17676774|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
5117311|NCT01756456|17676775|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
5117312|NCT01756456|17676776|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
5117313|NCT01756456|17676777|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
5117314|NCT01756456|17676778|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
5117315|NCT01756456|17676773|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5117316|NCT01756456|17676774|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5117317|NCT01756456|17676775|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5117318|NCT01756456|17676776|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5117319|NCT01756456|17676777|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5117320|NCT01756456|17676778|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5117321|NCT01756352|17676880|P1|Overall Study|moved away and lost to followup|1
5117322|NCT01756300|17676885|P1|Overall Study|Withdrawal by Subject|1
5117323|NCT01756300|17676885|P1|Overall Study|Death|1
5117324|NCT01756274|17676907|P1|Overall Study|Laboratory error|1
5117325|NCT01756274|17676907|P1|Overall Study|Protocol Violation|2
5117326|NCT01756235|17676914|P1|Overall Study|Adalimumab Treatment was not Documented|2
5117327|NCT01756157|17676952|P2|First Intervention Period|Lost to Follow-up|2
5117328|NCT01756157|17676953|P1|First Intervention Period|Lost to Follow-up|0
5117329|NCT01756157|17676952|P2|First Intervention Period|Withdrawal by Subject|0
5117330|NCT01756157|17676953|P1|First Intervention Period|Withdrawal by Subject|1
5117331|NCT01756079|17676967|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
5117332|NCT01756079|17676967|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
5117333|NCT01756079|17676967|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
5117334|NCT01756079|17676967|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
5117335|NCT01756079|17676967|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
5117336|NCT01756053|17676973|P2|Period 2 (10 Days)|Protocol Violation|2
5117337|NCT01756053|17676974|P1|Period 2 (10 Days)|Protocol Violation|0
5117338|NCT01756053|17676973|P2|Period 1 (10 Days)|Protocol Violation|1
5117339|NCT01756053|17676974|P1|Period 1 (10 Days)|Protocol Violation|1
5117340|NCT01755858|17677033|P2|Overall Study|Adverse Event|1
5117341|NCT01755858|17677034|P1|Overall Study|Adverse Event|1
5117342|NCT01755767|17677060|P4|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
5117343|NCT01755767|17677061|P3|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
5117344|NCT01755767|17677062|P2|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
5117345|NCT01755767|17677063|P1|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
5117346|NCT01755767|17677060|P4|Overall Study|Other|3
5117347|NCT01755767|17677061|P3|Overall Study|Other|2
5117348|NCT01755767|17677062|P2|Overall Study|Other|0
5117349|NCT01755767|17677063|P1|Overall Study|Other|0
5117350|NCT01755767|17677060|P4|Overall Study|Withdrawal by Subject|1
5117351|NCT01755767|17677061|P3|Overall Study|Withdrawal by Subject|2
5117352|NCT01755767|17677062|P2|Overall Study|Withdrawal by Subject|0
5117353|NCT01755767|17677063|P1|Overall Study|Withdrawal by Subject|0
5117354|NCT01755767|17677060|P4|Overall Study|Subject Decision|3
5117355|NCT01755767|17677061|P3|Overall Study|Subject Decision|10
5117356|NCT01755767|17677062|P2|Overall Study|Subject Decision|0
5117357|NCT01755767|17677063|P1|Overall Study|Subject Decision|0
5117358|NCT01755767|17677060|P4|Overall Study|Death|4
5117359|NCT01755767|17677061|P3|Overall Study|Death|15
5117360|NCT01755767|17677062|P2|Overall Study|Death|2
5117361|NCT01755767|17677063|P1|Overall Study|Death|1
5117362|NCT01755767|17677060|P4|Overall Study|Adverse Event|11
5117363|NCT01755767|17677061|P3|Overall Study|Adverse Event|28
5117364|NCT01755767|17677062|P2|Overall Study|Adverse Event|0
5117365|NCT01755767|17677063|P1|Overall Study|Adverse Event|6
5117366|NCT01755767|17677060|P4|Overall Study|Radiographic Disease Progression|27
5117367|NCT01755767|17677061|P3|Overall Study|Radiographic Disease Progression|44
5117368|NCT01755767|17677062|P2|Overall Study|Radiographic Disease Progression|4
5117369|NCT01755767|17677063|P1|Overall Study|Radiographic Disease Progression|9
5117370|NCT01755767|17677060|P4|Overall Study|Clinical Disease Progression|20
5117371|NCT01755767|17677061|P3|Overall Study|Clinical Disease Progression|29
5117372|NCT01755767|17677062|P2|Overall Study|Clinical Disease Progression|2
5117373|NCT01755767|17677063|P1|Overall Study|Clinical Disease Progression|4
5117374|NCT01755767|17677060|P4|Overall Study|Progressive Disease|43
5117375|NCT01755767|17677061|P3|Overall Study|Progressive Disease|91
5117376|NCT01755767|17677062|P2|Overall Study|Progressive Disease|7
5117377|NCT01755767|17677063|P1|Overall Study|Progressive Disease|8
5117378|NCT01755702|17677079|P1|Washout Period II|Other Reason|5
5117379|NCT01755702|17677079|P1|Wash Out Period I|Other Reason|3
5117380|NCT01755689|17677126|P5|Overall Study|Pregnancy|2
5117381|NCT01755689|17677127|P4|Overall Study|Pregnancy|4
5117382|NCT01755689|17677128|P3|Overall Study|Pregnancy|2
5117383|NCT01755689|17677129|P2|Overall Study|Pregnancy|1
5117384|NCT01755689|17677130|P1|Overall Study|Pregnancy|1
5117385|NCT01755689|17677126|P5|Overall Study|Lost to Follow-up|2
5117386|NCT01755689|17677127|P4|Overall Study|Lost to Follow-up|0
5117387|NCT01755689|17677128|P3|Overall Study|Lost to Follow-up|1
5117388|NCT01755689|17677129|P2|Overall Study|Lost to Follow-up|0
5117389|NCT01755689|17677130|P1|Overall Study|Lost to Follow-up|1
5117390|NCT01755689|17677126|P5|Overall Study|Migrated/moved from study area|1
5117391|NCT01755689|17677127|P4|Overall Study|Migrated/moved from study area|1
5117392|NCT01755689|17677128|P3|Overall Study|Migrated/moved from study area|1
5117393|NCT01755689|17677129|P2|Overall Study|Migrated/moved from study area|1
5117394|NCT01755689|17677130|P1|Overall Study|Migrated/moved from study area|0
5117395|NCT01755689|17677126|P5|Overall Study|Withdrawal by Subject|1
5117396|NCT01755689|17677127|P4|Overall Study|Withdrawal by Subject|1
5117397|NCT01755689|17677128|P3|Overall Study|Withdrawal by Subject|2
5117398|NCT01755689|17677129|P2|Overall Study|Withdrawal by Subject|3
5117399|NCT01755689|17677130|P1|Overall Study|Withdrawal by Subject|1
5117400|NCT01755637|17677205|P2|Period 1|Adverse Event|1
5117401|NCT01755637|17677206|P1|Period 1|Adverse Event|0
5117402|NCT01755598|17677226|P2|Overall Study|Adverse Event|28
5117403|NCT01755598|17677227|P1|Overall Study|Adverse Event|19
5117404|NCT01755598|17677226|P2|Overall Study|Protocol Violation|7
5117405|NCT01755598|17677227|P1|Overall Study|Protocol Violation|7
5117406|NCT01755598|17677226|P2|Overall Study|Withdrawal by Subject|31
5117407|NCT01755598|17677227|P1|Overall Study|Withdrawal by Subject|22
5117408|NCT01755598|17677226|P2|Overall Study|Migrated/moved from study area|65
5117409|NCT01755598|17677227|P1|Overall Study|Migrated/moved from study area|76
5117410|NCT01755598|17677226|P2|Overall Study|Lost to Follow-up|43
5117411|NCT01755598|17677227|P1|Overall Study|Lost to Follow-up|32
5117412|NCT01755598|17677226|P2|Overall Study|Other|109
5117413|NCT01755598|17677227|P1|Overall Study|Other|109
5117414|NCT01755546|17677261|P1|Long Term Treatment|other and ongoing|41
5117415|NCT01755546|17677261|P1|Long Term Treatment|Lost to Follow-up|17
5117416|NCT01755546|17677261|P1|Long Term Treatment|Withdrawal by Subject|35
5117417|NCT01755546|17677261|P1|Long Term Treatment|Protocol Violation|10
5117418|NCT01755546|17677261|P1|Long Term Treatment|Lack of Efficacy|6
5117419|NCT01755546|17677261|P1|Long Term Treatment|Adverse Event|12
5117420|NCT01755546|17677261|P1|Titration Phase|Withdrawal by Subject|8
5117421|NCT01755546|17677261|P1|Titration Phase|Other and Continuing|22
5117422|NCT01755546|17677261|P1|Titration Phase|Lost to Follow-up|2
5117423|NCT01755546|17677261|P1|Titration Phase|Protocol Violation|9
5117424|NCT01755546|17677261|P1|Titration Phase|Lack of Efficacy|18
5117425|NCT01755546|17677261|P1|Titration Phase|Adverse Event|11
5117426|NCT01755546|17677261|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
5117427|NCT01755546|17677261|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
5117428|NCT01755546|17677261|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
5117429|NCT01755546|17677261|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
5117430|NCT01755416|17677278|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
5117431|NCT01755416|17677279|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
5117432|NCT01755234|17677287|P2|Overall Study|unblinded|0
5117433|NCT01755234|17677288|P1|Overall Study|unblinded|1
5117434|NCT01755234|17677287|P2|Overall Study|Withdrawal by Subject|1
5117435|NCT01755234|17677288|P1|Overall Study|Withdrawal by Subject|0
5117436|NCT01755234|17677287|P2|Overall Study|case cancelled|0
5117437|NCT01755234|17677288|P1|Overall Study|case cancelled|1
5117438|NCT01755234|17677287|P2|Overall Study|Change in surgical case|1
5117439|NCT01755234|17677288|P1|Overall Study|Change in surgical case|2
5117440|NCT01755234|17677287|P2|Overall Study|Lost to Follow-up|6
5117441|NCT01755234|17677288|P1|Overall Study|Lost to Follow-up|11
5117442|NCT01755156|17677319|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
5117443|NCT01755156|17677320|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
5117444|NCT01755156|17677319|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
5117445|NCT01755156|17677320|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
5117446|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
5117447|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
5117448|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
5117449|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
5117450|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
5117451|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
5117452|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Protocol Violation|1
5117453|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Protocol Violation|1
5117454|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Physician Decision|1
5117455|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Physician Decision|0
5117456|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
5117457|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
5117458|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
5117459|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
5117460|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
5117461|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
5117462|NCT01755156|17677319|P2|Phase A (Weeks 0-24)|Adverse Event|3
5117463|NCT01755156|17677320|P1|Phase A (Weeks 0-24)|Adverse Event|2
5117464|NCT01755091|17677384|P3|Overall Study|Physician Decision|2
5117465|NCT01755091|17677385|P2|Overall Study|Physician Decision|1
5117466|NCT01755091|17677386|P1|Overall Study|Physician Decision|1
5117467|NCT01755091|17677384|P3|Overall Study|Lost to Follow-up|1
5117468|NCT01755091|17677385|P2|Overall Study|Lost to Follow-up|0
5117469|NCT01755091|17677386|P1|Overall Study|Lost to Follow-up|1
5117470|NCT01755091|17677384|P3|Overall Study|Adverse Event|1
5117471|NCT01755091|17677385|P2|Overall Study|Adverse Event|1
5117472|NCT01755091|17677386|P1|Overall Study|Adverse Event|1
5117473|NCT01755091|17677384|P3|Overall Study|Withdrawal by Subject|3
5117474|NCT01755091|17677385|P2|Overall Study|Withdrawal by Subject|1
5117475|NCT01755091|17677386|P1|Overall Study|Withdrawal by Subject|6
5117476|NCT01755026|17677411|P2|Overall Study|Withdrawal by Subject|1
5117477|NCT01755026|17677412|P1|Overall Study|Withdrawal by Subject|1
5117478|NCT01755026|17677411|P2|Overall Study|Adverse Event|0
5117479|NCT01755026|17677412|P1|Overall Study|Adverse Event|1
5117480|NCT01754922|17677435|P2|Overall Study|Adverse Event|1
5117481|NCT01754922|17677436|P1|Overall Study|Adverse Event|0
5117482|NCT01754766|17677462|P3|Overall Study|Personal reasons|0
5117483|NCT01754766|17677463|P2|Overall Study|Personal reasons|1
5117484|NCT01754766|17677464|P1|Overall Study|Personal reasons|1
5117485|NCT01754727|17677478|P1|Overall Study|Adalimumab Treatment was not Documented|2
5117486|NCT01754493|17677610|P1|Overall Study|Scheduling conflict|1
5117487|NCT01754493|17677610|P1|Overall Study|Moved out of town|1
5117488|NCT01754493|17677610|P1|Overall Study|Withdrawal by Subject|1
5117489|NCT01754493|17677610|P1|Overall Study|Lost to Follow-up|3
5117490|NCT01754493|17677610|P1|Overall Study|Adverse Event|1
5117491|NCT01754467|17677635|P1|Overall Study|Lost to Follow-up|1
5117492|NCT01754402|17677645|P3|Overall Study|Lack of Efficacy|1
5117493|NCT01754402|17677646|P2|Overall Study|Lack of Efficacy|0
5117494|NCT01754402|17677647|P1|Overall Study|Lack of Efficacy|0
5117495|NCT01754402|17677645|P3|Overall Study|Withdrawal by Subject|1
5117496|NCT01754402|17677646|P2|Overall Study|Withdrawal by Subject|0
5117497|NCT01754402|17677647|P1|Overall Study|Withdrawal by Subject|0
5117498|NCT01754402|17677645|P3|Overall Study|Adverse Event|1
5117499|NCT01754402|17677646|P2|Overall Study|Adverse Event|2
5117500|NCT01754402|17677647|P1|Overall Study|Adverse Event|2
5117501|NCT01754402|17677645|P3|Overall Study|Death|1
5117502|NCT01754402|17677646|P2|Overall Study|Death|0
5117503|NCT01754402|17677647|P1|Overall Study|Death|0
5117504|NCT01754376|17677681|P1|Overall Study|Lack of Efficacy|2
5117505|NCT01754376|17677681|P1|Overall Study|Adverse Event|1
5117506|NCT01754259|17677692|P2|Overall Study|Lost to Follow-up|1
5117507|NCT01754259|17677693|P1|Overall Study|Lost to Follow-up|0
5117508|NCT01754259|17677692|P2|Overall Study|Adverse Event|1
5117509|NCT01754259|17677693|P1|Overall Study|Adverse Event|3
5117510|NCT01754259|17677692|P2|Overall Study|Withdrawal by Subject|4
5117511|NCT01754259|17677693|P1|Overall Study|Withdrawal by Subject|2
5117512|NCT01754194|17677703|P2|Overall Study|Other|8
5117513|NCT01754194|17677704|P1|Overall Study|Other|9
5117514|NCT01754194|17677703|P2|Overall Study|Withdrawal by Subject|5
5117515|NCT01754194|17677704|P1|Overall Study|Withdrawal by Subject|4
5117516|NCT01754194|17677703|P2|Overall Study|Lost to Follow-up|14
5117517|NCT01754194|17677704|P1|Overall Study|Lost to Follow-up|39
5117518|NCT01754129|17677724|P1|Overall Study|Inclusion/exclusion criteria violation|3
5117519|NCT01754129|17677724|P1|Overall Study|Withdrew consent|1
5117520|NCT01754129|17677724|P1|Overall Study|Lost to Follow-up|7
5117521|NCT01754129|17677724|P1|Overall Study|Duodopa discontinuation|9
5117522|NCT01754129|17677724|P1|Overall Study|Death|13
5117523|NCT01753999|17677747|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
5117524|NCT01753999|17677748|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
5117525|NCT01753999|17677747|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
5117526|NCT01753999|17677748|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
5117527|NCT01753999|17677747|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
5117528|NCT01753999|17677748|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
5117529|NCT01753999|17677747|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
5117530|NCT01753999|17677748|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
5117531|NCT01753999|17677747|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
5117532|NCT01753999|17677748|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
5117533|NCT01753999|17677747|P2|Period 1 - Initial Assignment|Physician Decision|3
5117534|NCT01753999|17677748|P1|Period 1 - Initial Assignment|Physician Decision|2
5117535|NCT01753856|17677766|P2|Overall Study|Sponsor Decision|0
5117536|NCT01753856|17677767|P1|Overall Study|Sponsor Decision|2
5117537|NCT01753856|17677766|P2|Overall Study|Withdrawal by Subject|2
5117538|NCT01753856|17677767|P1|Overall Study|Withdrawal by Subject|0
5117539|NCT01753856|17677766|P2|Overall Study|Adverse Event|0
5117540|NCT01753856|17677767|P1|Overall Study|Adverse Event|1
5117541|NCT01753570|17677879|P3|Overall Study|Withdrawal by Subject|0
5117542|NCT01753570|17677880|P2|Overall Study|Withdrawal by Subject|4
5117543|NCT01753570|17677881|P1|Overall Study|Withdrawal by Subject|1
5117544|NCT01753570|17677879|P3|Overall Study|Physician Decision|0
5117545|NCT01753570|17677880|P2|Overall Study|Physician Decision|1
5117546|NCT01753570|17677881|P1|Overall Study|Physician Decision|0
5117547|NCT01753570|17677879|P3|Overall Study|Adverse Event|1
5117548|NCT01753570|17677880|P2|Overall Study|Adverse Event|0
5117549|NCT01753570|17677881|P1|Overall Study|Adverse Event|1
5117550|NCT01753518|17677924|P2|Postpartum Follow-up|Lost to Follow-up|15
5117551|NCT01753518|17677925|P1|Postpartum Follow-up|Lost to Follow-up|22
5117552|NCT01753518|17677924|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
5117553|NCT01753518|17677925|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
5117554|NCT01753518|17677924|P2|Intention-to-Treat Analysis|Multifetal gestation|3
5117555|NCT01753518|17677925|P1|Intention-to-Treat Analysis|Multifetal gestation|2
5117556|NCT01753518|17677924|P2|Intention-to-Treat Analysis|Missing consent form|3
5117557|NCT01753518|17677925|P1|Intention-to-Treat Analysis|Missing consent form|5
5117558|NCT01753401|17677949|P4|Open Label Period (44 Weeks)|Reason not provided|2
5117559|NCT01753401|17677950|P3|Open Label Period (44 Weeks)|Reason not provided|0
5117560|NCT01753401|17677951|P2|Open Label Period (44 Weeks)|Reason not provided|0
5117561|NCT01753401|17677952|P1|Open Label Period (44 Weeks)|Reason not provided|0
5117562|NCT01753401|17677949|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
5117563|NCT01753401|17677950|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
5117564|NCT01753401|17677951|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
5117565|NCT01753401|17677952|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
5117566|NCT01753401|17677949|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
5117567|NCT01753401|17677950|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5117568|NCT01753401|17677951|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5117569|NCT01753401|17677952|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5117570|NCT01753401|17677949|P4|Open Label Period (44 Weeks)|Adverse Event|4
5117571|NCT01753401|17677950|P3|Open Label Period (44 Weeks)|Adverse Event|3
5117572|NCT01753401|17677951|P2|Open Label Period (44 Weeks)|Adverse Event|0
5117573|NCT01753401|17677952|P1|Open Label Period (44 Weeks)|Adverse Event|0
5117574|NCT01753401|17677949|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
5117575|NCT01753401|17677950|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
5117576|NCT01753401|17677951|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
5117577|NCT01753401|17677952|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
5117578|NCT01753401|17677949|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
5117579|NCT01753401|17677950|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
5117580|NCT01753401|17677951|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
5117581|NCT01753401|17677952|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
5117582|NCT01753401|17677949|P4|Double-blind Period (8 Weeks)|Adverse Event|0
5117583|NCT01753401|17677950|P3|Double-blind Period (8 Weeks)|Adverse Event|0
5117584|NCT01753401|17677951|P2|Double-blind Period (8 Weeks)|Adverse Event|2
5117585|NCT01753401|17677952|P1|Double-blind Period (8 Weeks)|Adverse Event|0
5117586|NCT01753336|17678011|P1|Overall Study|Withdrawal by Subject|1
5117587|NCT01753336|17678011|P1|Overall Study|Sponsor's decision|2
5117588|NCT01753336|17678011|P1|Overall Study|Physician Decision|2
5117589|NCT01753336|17678011|P1|Overall Study|Lost to Follow-up|3
5117590|NCT01753336|17678011|P1|Overall Study|Patient decision|12
5117591|NCT01753323|17678023|P3|Overall Study|Adverse Event|1
5117592|NCT01753323|17678024|P2|Overall Study|Adverse Event|0
5117593|NCT01753323|17678025|P1|Overall Study|Adverse Event|0
5117594|NCT01753323|17678023|P3|Overall Study|Protocol deviation|0
5117595|NCT01753323|17678024|P2|Overall Study|Protocol deviation|0
5117596|NCT01753323|17678025|P1|Overall Study|Protocol deviation|1
5117597|NCT01753323|17678023|P3|Overall Study|Lack of Efficacy|8
5117598|NCT01753323|17678024|P2|Overall Study|Lack of Efficacy|0
5117599|NCT01753323|17678025|P1|Overall Study|Lack of Efficacy|0
5117600|NCT01753310|17678063|P2|Overall Study|Withdrawal by Subject|0
5117601|NCT01753310|17678064|P1|Overall Study|Withdrawal by Subject|1
5117602|NCT01753310|17678063|P2|Overall Study|Sponsor decision|0
5117603|NCT01753310|17678064|P1|Overall Study|Sponsor decision|1
5117604|NCT01753310|17678063|P2|Overall Study|Subject decision|2
5117605|NCT01753310|17678064|P1|Overall Study|Subject decision|2
5117606|NCT01753310|17678063|P2|Overall Study|Lost to Follow-up|0
5117607|NCT01753310|17678064|P1|Overall Study|Lost to Follow-up|2
5117608|NCT01753310|17678063|P2|Overall Study|Adverse Event|0
5117609|NCT01753310|17678064|P1|Overall Study|Adverse Event|1
5117610|NCT01753310|17678063|P2|Overall Study|Entered into open label extension study|22
5117611|NCT01753310|17678064|P1|Overall Study|Entered into open label extension study|25
5117612|NCT01753193|17678084|P1|Overall Study|Other|16
5117613|NCT01753193|17678084|P1|Overall Study|Death|1
5117614|NCT01753193|17678084|P1|Overall Study|Lost to Follow-up|6
5117615|NCT01753193|17678084|P1|Overall Study|Withdrawal by Subject|23
5117616|NCT01753115|17678099|P3|Overall Study|Used excluded drug|0
5117617|NCT01753115|17678100|P2|Overall Study|Used excluded drug|1
5117618|NCT01753115|17678101|P1|Overall Study|Used excluded drug|0
5117619|NCT01753115|17678099|P3|Overall Study|Subject non-compliant|0
5117620|NCT01753115|17678100|P2|Overall Study|Subject non-compliant|3
5117621|NCT01753115|17678101|P1|Overall Study|Subject non-compliant|3
5117622|NCT01753115|17678099|P3|Overall Study|Withdrawal by Subject|6
5117623|NCT01753115|17678100|P2|Overall Study|Withdrawal by Subject|5
5117624|NCT01753115|17678101|P1|Overall Study|Withdrawal by Subject|6
5117625|NCT01753115|17678099|P3|Overall Study|Lost to Follow-up|8
5117626|NCT01753115|17678100|P2|Overall Study|Lost to Follow-up|6
5117627|NCT01753115|17678101|P1|Overall Study|Lost to Follow-up|3
5117628|NCT01753076|17678111|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
5117629|NCT01753076|17678112|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
5117630|NCT01753076|17678111|P2|Overall Study|Withdrawal by Subject|24
5117631|NCT01753076|17678112|P1|Overall Study|Withdrawal by Subject|14
5117632|NCT01753076|17678111|P2|Overall Study|Physician Decision|2
5117633|NCT01753076|17678112|P1|Overall Study|Physician Decision|4
5117634|NCT01753076|17678111|P2|Overall Study|Lost to Follow-up|1
5117635|NCT01753076|17678112|P1|Overall Study|Lost to Follow-up|2
5117636|NCT01753076|17678111|P2|Overall Study|Lack of Efficacy|1
5117637|NCT01753076|17678112|P1|Overall Study|Lack of Efficacy|3
5117638|NCT01753076|17678111|P2|Overall Study|Adverse Event|18
5117639|NCT01753076|17678112|P1|Overall Study|Adverse Event|17
5117640|NCT01752985|17678139|P3|Treatment Period|Lost to Follow-up|1
5117641|NCT01752985|17678140|P2|Treatment Period|Lost to Follow-up|0
5117642|NCT01752985|17678141|P1|Treatment Period|Lost to Follow-up|0
5117643|NCT01752985|17678139|P3|Treatment Period|Withdrawal by Subject|0
5117644|NCT01752985|17678140|P2|Treatment Period|Withdrawal by Subject|1
5117645|NCT01752985|17678141|P1|Treatment Period|Withdrawal by Subject|1
5117646|NCT01752985|17678139|P3|Treatment Period|Adverse Event|2
5117647|NCT01752985|17678140|P2|Treatment Period|Adverse Event|1
5117648|NCT01752985|17678141|P1|Treatment Period|Adverse Event|2
5117649|NCT01752985|17678139|P3|Treatment Period|Subject no longer meets study criteria|1
5117650|NCT01752985|17678140|P2|Treatment Period|Subject no longer meets study criteria|1
5117651|NCT01752985|17678141|P1|Treatment Period|Subject no longer meets study criteria|0
5117652|NCT01752985|17678139|P3|Treatment Period|Subject request to discontinue treatment|1
5117653|NCT01752985|17678140|P2|Treatment Period|Subject request to discontinue treatment|0
5117654|NCT01752985|17678141|P1|Treatment Period|Subject request to discontinue treatment|1
5117655|NCT01752933|17678169|P2|Overall Study and Follow-up|Lost to Follow-up|2
5117656|NCT01752933|17678170|P1|Overall Study and Follow-up|Lost to Follow-up|0
5117657|NCT01752933|17678169|P2|Overall Study and Follow-up|Withdrawal by Subject|3
5117658|NCT01752933|17678170|P1|Overall Study and Follow-up|Withdrawal by Subject|0
5117659|NCT01752933|17678169|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
5117660|NCT01752933|17678170|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
5117661|NCT01752933|17678169|P2|Overall Study and Follow-up|Death|34
5117662|NCT01752933|17678170|P1|Overall Study and Follow-up|Death|4
5117663|NCT01752933|17678169|P2|Treatment|Patient unable to travel to appointments|1
5117664|NCT01752933|17678170|P1|Treatment|Patient unable to travel to appointments|0
5117665|NCT01752933|17678169|P2|Treatment|Patient noncompliant|1
5117666|NCT01752933|17678170|P1|Treatment|Patient noncompliant|0
5117667|NCT01752933|17678169|P2|Treatment|Hepatocellular carcinoma not confirmed|1
5117668|NCT01752933|17678170|P1|Treatment|Hepatocellular carcinoma not confirmed|0
5117669|NCT01752933|17678169|P2|Treatment|Death|2
5117670|NCT01752933|17678170|P1|Treatment|Death|0
5117671|NCT01752933|17678169|P2|Treatment|Physician Decision|3
5117672|NCT01752933|17678170|P1|Treatment|Physician Decision|0
5117673|NCT01752933|17678169|P2|Treatment|Adverse Event|4
5117674|NCT01752933|17678170|P1|Treatment|Adverse Event|1
5117675|NCT01752933|17678169|P2|Treatment|Withdrawal by Subject|5
5117676|NCT01752933|17678170|P1|Treatment|Withdrawal by Subject|0
5117677|NCT01752933|17678169|P2|Treatment|Disease Progression|29
5117678|NCT01752933|17678170|P1|Treatment|Disease Progression|3
5117679|NCT01752907|17678188|P2|Overall Study|Decision by Sponsor|9
5117680|NCT01752907|17678189|P1|Overall Study|Decision by Sponsor|6
5117681|NCT01752907|17678188|P2|Overall Study|Lost to Follow-up|1
5117682|NCT01752907|17678189|P1|Overall Study|Lost to Follow-up|2
5117683|NCT01752907|17678188|P2|Overall Study|Withdrawal by Subject|10
5117684|NCT01752907|17678189|P1|Overall Study|Withdrawal by Subject|4
5117685|NCT01752855|17678209|P2|Overall Study|Lack of Efficacy|2
5117686|NCT01752855|17678210|P1|Overall Study|Lack of Efficacy|0
5117687|NCT01752855|17678209|P2|Overall Study|Withdrew Consent|2
5117688|NCT01752855|17678210|P1|Overall Study|Withdrew Consent|0
5117689|NCT01752855|17678209|P2|Overall Study|Adverse Event|0
5117690|NCT01752855|17678210|P1|Overall Study|Adverse Event|1
5117691|NCT01752842|17678226|P2|Overall Study|Withdrawal by Subject|2
5117692|NCT01752842|17678227|P1|Overall Study|Withdrawal by Subject|0
5117693|NCT01752842|17678226|P2|Overall Study|Adverse Event|0
5117694|NCT01752842|17678227|P1|Overall Study|Adverse Event|3
5117695|NCT01752634|17678262|P6|Week 24 to Week 260|Adverse Event|0
5117696|NCT01752634|17678263|P5|Week 24 to Week 260|Adverse Event|2
5117697|NCT01752634|17678264|P4|Week 24 to Week 260|Adverse Event|4
5117698|NCT01752634|17678265|P3|Week 24 to Week 260|Adverse Event|8
5117699|NCT01752634|17678266|P2|Week 24 to Week 260|Adverse Event|8
5117700|NCT01752634|17678267|P1|Week 24 to Week 260|Adverse Event|4
5117701|NCT01752634|17678262|P6|Week 24 to Week 260|Lost to Follow-up|0
5117702|NCT01752634|17678263|P5|Week 24 to Week 260|Lost to Follow-up|2
5117703|NCT01752634|17678264|P4|Week 24 to Week 260|Lost to Follow-up|0
5117704|NCT01752634|17678265|P3|Week 24 to Week 260|Lost to Follow-up|3
5117705|NCT01752634|17678266|P2|Week 24 to Week 260|Lost to Follow-up|2
5117706|NCT01752634|17678267|P1|Week 24 to Week 260|Lost to Follow-up|2
5117707|NCT01752634|17678262|P6|Week 24 to Week 260|Noncompliance with study treatment|0
5117708|NCT01752634|17678263|P5|Week 24 to Week 260|Noncompliance with study treatment|0
5117709|NCT01752634|17678264|P4|Week 24 to Week 260|Noncompliance with study treatment|0
5117710|NCT01752634|17678265|P3|Week 24 to Week 260|Noncompliance with study treatment|1
5117711|NCT01752634|17678266|P2|Week 24 to Week 260|Noncompliance with study treatment|0
5117712|NCT01752634|17678267|P1|Week 24 to Week 260|Noncompliance with study treatment|0
5117713|NCT01752634|17678262|P6|Week 24 to Week 260|Pregnancy|0
5117714|NCT01752634|17678263|P5|Week 24 to Week 260|Pregnancy|0
5117715|NCT01752634|17678264|P4|Week 24 to Week 260|Pregnancy|0
5117716|NCT01752634|17678265|P3|Week 24 to Week 260|Pregnancy|1
5117717|NCT01752634|17678266|P2|Week 24 to Week 260|Pregnancy|0
5117718|NCT01752634|17678267|P1|Week 24 to Week 260|Pregnancy|0
5117719|NCT01752634|17678262|P6|Week 24 to Week 260|Death|0
5117720|NCT01752634|17678263|P5|Week 24 to Week 260|Death|0
5117721|NCT01752634|17678264|P4|Week 24 to Week 260|Death|0
5117722|NCT01752634|17678265|P3|Week 24 to Week 260|Death|0
5117723|NCT01752634|17678266|P2|Week 24 to Week 260|Death|1
5117724|NCT01752634|17678267|P1|Week 24 to Week 260|Death|0
5117725|NCT01752634|17678262|P6|Week 24 to Week 260|Physician Decision|0
5117726|NCT01752634|17678263|P5|Week 24 to Week 260|Physician Decision|1
5117727|NCT01752634|17678264|P4|Week 24 to Week 260|Physician Decision|2
5117728|NCT01752634|17678265|P3|Week 24 to Week 260|Physician Decision|4
5117729|NCT01752634|17678266|P2|Week 24 to Week 260|Physician Decision|2
5117730|NCT01752634|17678267|P1|Week 24 to Week 260|Physician Decision|1
5117731|NCT01752634|17678262|P6|Week 24 to Week 260|Subject/guardian decision|0
5117732|NCT01752634|17678263|P5|Week 24 to Week 260|Subject/guardian decision|5
5117733|NCT01752634|17678264|P4|Week 24 to Week 260|Subject/guardian decision|5
5117734|NCT01752634|17678265|P3|Week 24 to Week 260|Subject/guardian decision|9
5117735|NCT01752634|17678266|P2|Week 24 to Week 260|Subject/guardian decision|10
5117736|NCT01752634|17678267|P1|Week 24 to Week 260|Subject/guardian decision|12
5117737|NCT01752634|17678262|P6|Week 24 to Week 260|Lack of Efficacy|0
5117738|NCT01752634|17678263|P5|Week 24 to Week 260|Lack of Efficacy|4
5117739|NCT01752634|17678264|P4|Week 24 to Week 260|Lack of Efficacy|3
5117740|NCT01752634|17678265|P3|Week 24 to Week 260|Lack of Efficacy|7
5117741|NCT01752634|17678266|P2|Week 24 to Week 260|Lack of Efficacy|7
5117742|NCT01752634|17678267|P1|Week 24 to Week 260|Lack of Efficacy|15
5117743|NCT01752634|17678262|P6|Up to Week 24 (Primary Analysis)|Adverse Event|4
5117744|NCT01752634|17678263|P5|Up to Week 24 (Primary Analysis)|Adverse Event|0
5117745|NCT01752634|17678264|P4|Up to Week 24 (Primary Analysis)|Adverse Event|0
5117746|NCT01752634|17678265|P3|Up to Week 24 (Primary Analysis)|Adverse Event|2
5117747|NCT01752634|17678266|P2|Up to Week 24 (Primary Analysis)|Adverse Event|0
5117748|NCT01752634|17678267|P1|Up to Week 24 (Primary Analysis)|Adverse Event|3
5117749|NCT01752634|17678262|P6|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
5117750|NCT01752634|17678263|P5|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5117751|NCT01752634|17678264|P4|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5117752|NCT01752634|17678265|P3|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5117753|NCT01752634|17678266|P2|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
5117754|NCT01752634|17678267|P1|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
5117755|NCT01752634|17678262|P6|Up to Week 24 (Primary Analysis)|Physician Decision|0
5117756|NCT01752634|17678263|P5|Up to Week 24 (Primary Analysis)|Physician Decision|0
5117757|NCT01752634|17678264|P4|Up to Week 24 (Primary Analysis)|Physician Decision|0
5117758|NCT01752634|17678265|P3|Up to Week 24 (Primary Analysis)|Physician Decision|0
5117759|NCT01752634|17678266|P2|Up to Week 24 (Primary Analysis)|Physician Decision|1
5117760|NCT01752634|17678267|P1|Up to Week 24 (Primary Analysis)|Physician Decision|0
5117761|NCT01752634|17678262|P6|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
5117762|NCT01752634|17678263|P5|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
5117763|NCT01752634|17678264|P4|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
5117764|NCT01752634|17678265|P3|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5117765|NCT01752634|17678266|P2|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5117766|NCT01752634|17678267|P1|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5117767|NCT01752036|17678325|P1|Overall Study|Death|2
5117768|NCT01752023|17678338|P2|Overall Study|Physician Decision|1
5117769|NCT01752023|17678339|P1|Overall Study|Physician Decision|2
5117770|NCT01751906|17678375|P2|Overall Study|Other|0
5117771|NCT01751906|17678376|P1|Overall Study|Other|1
5117772|NCT01751906|17678375|P2|Overall Study|Death|22
5117773|NCT01751906|17678376|P1|Overall Study|Death|38
5117774|NCT01751906|17678375|P2|Overall Study|Physician Decision|1
5117775|NCT01751906|17678376|P1|Overall Study|Physician Decision|3
5117776|NCT01751906|17678375|P2|Overall Study|Withdrawal by Subject|6
5117777|NCT01751906|17678376|P1|Overall Study|Withdrawal by Subject|14
5117778|NCT01751906|17678375|P2|Overall Study|Lost to Follow-up|18
5117779|NCT01751906|17678376|P1|Overall Study|Lost to Follow-up|28
5117780|NCT01751867|17678580|P2|Overall Study|Randomized but not treated.|1
5117781|NCT01751867|17678581|P1|Overall Study|Randomized but not treated.|2
5117782|NCT01751867|17678580|P2|Overall Study|Other|37
5117783|NCT01751867|17678581|P1|Overall Study|Other|11
5117784|NCT01751867|17678580|P2|Overall Study|Death|5
5117785|NCT01751867|17678581|P1|Overall Study|Death|0
5117786|NCT01751867|17678580|P2|Overall Study|Protocol Violation|2
5117787|NCT01751867|17678581|P1|Overall Study|Protocol Violation|0
5117788|NCT01751867|17678580|P2|Overall Study|Physician Decision|7
5117789|NCT01751867|17678581|P1|Overall Study|Physician Decision|4
5117790|NCT01751867|17678580|P2|Overall Study|Withdrawal by Subject|1
5117791|NCT01751867|17678581|P1|Overall Study|Withdrawal by Subject|3
5117792|NCT01751867|17678580|P2|Overall Study|Poor Compliance|5
5117793|NCT01751867|17678581|P1|Overall Study|Poor Compliance|0
5117794|NCT01751867|17678580|P2|Overall Study|Adverse Event|15
5117795|NCT01751867|17678581|P1|Overall Study|Adverse Event|8
5117796|NCT01751867|17678580|P2|Overall Study|Diease Progression|18
5117797|NCT01751867|17678581|P1|Overall Study|Diease Progression|4
5117798|NCT01751867|17678580|P2|Overall Study|Completed treatment,dropped in follow-up|8
5117799|NCT01751867|17678581|P1|Overall Study|Completed treatment,dropped in follow-up|4
5117800|NCT01751802|17678601|P2|Overall Study|Adverse Event|2
5117801|NCT01751802|17678602|P1|Overall Study|Adverse Event|4
5117802|NCT01751724|17678616|P2|Overall Study|withdrawn by parent|2
5117803|NCT01751724|17678617|P1|Overall Study|withdrawn by parent|0
5117804|NCT01751724|17678616|P2|Overall Study|extubated bef.start assigned treatment|0
5117805|NCT01751724|17678617|P1|Overall Study|extubated bef.start assigned treatment|1
5117806|NCT01751646|17678645|P2|Overall Study|Childcare issues|1
5117807|NCT01751646|17678646|P1|Overall Study|Childcare issues|1
5117808|NCT01751646|17678645|P2|Overall Study|Fails to comply with study requirements|1
5117809|NCT01751646|17678646|P1|Overall Study|Fails to comply with study requirements|0
5117810|NCT01751646|17678645|P2|Overall Study|Off study due to multiple obligations|1
5117811|NCT01751646|17678646|P1|Overall Study|Off study due to multiple obligations|0
5117812|NCT01751646|17678645|P2|Overall Study|Inability to attend required visits|1
5117813|NCT01751646|17678646|P1|Overall Study|Inability to attend required visits|0
5117814|NCT01751646|17678645|P2|Overall Study|Moved out of the area|5
5117815|NCT01751646|17678646|P1|Overall Study|Moved out of the area|1
5117816|NCT01751646|17678645|P2|Overall Study|Inadvertent enrollment|1
5117817|NCT01751646|17678646|P1|Overall Study|Inadvertent enrollment|1
5117818|NCT01751646|17678645|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
5117819|NCT01751646|17678646|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
5117820|NCT01751646|17678645|P2|Overall Study|Starting hormone therapy|0
5117821|NCT01751646|17678646|P1|Overall Study|Starting hormone therapy|1
5117822|NCT01751646|17678645|P2|Overall Study|Withdrawal by Subject|4
5117823|NCT01751646|17678646|P1|Overall Study|Withdrawal by Subject|0
5117824|NCT01751646|17678645|P2|Overall Study|Lost to Follow-up|1
5117825|NCT01751646|17678646|P1|Overall Study|Lost to Follow-up|5
5117826|NCT01751412|17678794|P1|Overall Study|Disease Progression Before Treatment|1
5117827|NCT01751178|17678904|P3|Overall Study|Other Reason (unknown)|2
5117828|NCT01751178|17678905|P2|Overall Study|Other Reason (unknown)|0
5117829|NCT01751178|17678906|P1|Overall Study|Other Reason (unknown)|1
5117830|NCT01751178|17678904|P3|Overall Study|Adverse Event|0
5117831|NCT01751178|17678905|P2|Overall Study|Adverse Event|0
5117832|NCT01751178|17678906|P1|Overall Study|Adverse Event|2
5117833|NCT01751165|17678926|P3|Overall Study|Lost to Follow-up|1
5117834|NCT01751165|17678927|P2|Overall Study|Lost to Follow-up|1
5117835|NCT01751165|17678928|P1|Overall Study|Lost to Follow-up|1
5117836|NCT01751165|17678926|P3|Overall Study|Serious adverse event|0
5117837|NCT01751165|17678927|P2|Overall Study|Serious adverse event|2
5117838|NCT01751165|17678928|P1|Overall Study|Serious adverse event|0
5117839|NCT01751165|17678926|P3|Overall Study|Withdrawal by Subject|1
5117840|NCT01751165|17678927|P2|Overall Study|Withdrawal by Subject|0
5117841|NCT01751165|17678928|P1|Overall Study|Withdrawal by Subject|0
5117842|NCT01751165|17678926|P3|Overall Study|Adverse event, serious fatal|1
5117843|NCT01751165|17678927|P2|Overall Study|Adverse event, serious fatal|0
5117844|NCT01751165|17678928|P1|Overall Study|Adverse event, serious fatal|1
5117845|NCT01751139|17678968|P1|Overall Study|Death|31
5117846|NCT01751139|17678968|P1|Overall Study|Adverse Event|1
5117847|NCT01751139|17678968|P1|Overall Study|Withdrawal by Subject|251
5117848|NCT01751139|17678968|P1|Overall Study|Lost to Follow-up|240
5117849|NCT01751139|17678968|P1|Overall Study|Sponsor study termination|1609
5117850|NCT01751139|17678968|P1|Overall Study|Other|135
5117851|NCT01751113|17678986|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
5117852|NCT01751113|17678987|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
5117853|NCT01751113|17678988|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
5117854|NCT01751113|17678989|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
5117855|NCT01751113|17678990|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
5117856|NCT01751113|17678991|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
5117857|NCT01751113|17678986|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
5117858|NCT01751113|17678987|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
5117859|NCT01751113|17678988|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
5117860|NCT01751113|17678989|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
5117861|NCT01751113|17678990|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
5117862|NCT01751113|17678991|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
5117863|NCT01751087|17679032|P3|Overall Study|Physician Decision|1
5117864|NCT01751087|17679033|P2|Overall Study|Physician Decision|0
5117865|NCT01751087|17679034|P1|Overall Study|Physician Decision|0
5117866|NCT01751087|17679032|P3|Overall Study|Withdrawal by Subject|0
5117867|NCT01751087|17679033|P2|Overall Study|Withdrawal by Subject|0
5117868|NCT01751087|17679034|P1|Overall Study|Withdrawal by Subject|1
5117869|NCT01751061|17679068|P2|Overall Study|Physician Decision|0
5117870|NCT01751061|17679069|P1|Overall Study|Physician Decision|2
5117871|NCT01751061|17679068|P2|Overall Study|Withdrawal by Subject|1
5117872|NCT01751061|17679069|P1|Overall Study|Withdrawal by Subject|4
5117873|NCT01751061|17679068|P2|Overall Study|patient regained decisional capacity|8
5117874|NCT01751061|17679069|P1|Overall Study|patient regained decisional capacity|4
5117875|NCT01751061|17679068|P2|Overall Study|Lost to Follow-up|25
5117876|NCT01751061|17679069|P1|Overall Study|Lost to Follow-up|40
5117877|NCT01751061|17679068|P2|Overall Study|patient death|0
5117878|NCT01751061|17679069|P1|Overall Study|patient death|5
5117879|NCT01751061|17679068|P2|Overall Study|Death|0
5117880|NCT01751061|17679069|P1|Overall Study|Death|1
5117881|NCT01750840|17679143|P1|Overall Study|Lost to Follow-up|4
5117882|NCT01750697|17679148|P1|Overall Study|Withdrawal by Subject|1
5117883|NCT01750697|17679148|P1|Overall Study|Physician Decision|1
5117884|NCT01750697|17679148|P1|Overall Study|Transferred to Adult Services|5
5117885|NCT01750697|17679148|P1|Overall Study|Physician and Family Decision|1
5117886|NCT01750697|17679148|P1|Overall Study|Transferred Back to Local Hospital|1
5117887|NCT01750684|17679160|P2|Overall Study|Protocol Violation|0
5117888|NCT01750684|17679161|P1|Overall Study|Protocol Violation|1
5117889|NCT01750684|17679160|P2|Overall Study|Withdrawn by Sponsor|1
5117890|NCT01750684|17679161|P1|Overall Study|Withdrawn by Sponsor|0
5117891|NCT01750684|17679160|P2|Overall Study|Non-compliance with Study Drug|1
5117892|NCT01750684|17679161|P1|Overall Study|Non-compliance with Study Drug|0
5117893|NCT01750684|17679160|P2|Overall Study|Death|0
5117894|NCT01750684|17679161|P1|Overall Study|Death|1
5117895|NCT01750346|17679198|P3|Overall Study|Adverse Event|0
5117896|NCT01750346|17679199|P2|Overall Study|Adverse Event|0
5117897|NCT01750346|17679200|P1|Overall Study|Adverse Event|1
5117898|NCT01750294|17679226|P1|Overall Study|Safety Endpoint|1
5117899|NCT01750294|17679226|P1|Overall Study|Withdrawal by Subject|1
5117900|NCT01750281|17679233|P3|Overall Study|Did not receive treatment|0
5117901|NCT01750281|17679234|P2|Overall Study|Did not receive treatment|1
5117902|NCT01750281|17679235|P1|Overall Study|Did not receive treatment|0
5117903|NCT01750281|17679233|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
5117904|NCT01750281|17679234|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
5117905|NCT01750281|17679235|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
5117906|NCT01750281|17679233|P3|Overall Study|Discontinued Selumetinib/Placebo|75
5117907|NCT01750281|17679234|P2|Overall Study|Discontinued Selumetinib/Placebo|77
5117908|NCT01750281|17679235|P1|Overall Study|Discontinued Selumetinib/Placebo|37
5117909|NCT01750268|17679248|P2|Overall Study|Withdrawal by Subject|0
5117910|NCT01750268|17679249|P1|Overall Study|Withdrawal by Subject|2
5117911|NCT01750268|17679248|P2|Overall Study|Physician Decision|3
5117912|NCT01750268|17679249|P1|Overall Study|Physician Decision|0
5117913|NCT01750268|17679248|P2|Overall Study|Lost to Follow-up|2
5117914|NCT01750268|17679249|P1|Overall Study|Lost to Follow-up|0
5117915|NCT01750242|17679276|P1|Overall Study|Unreadable Images|3
5117916|NCT01750229|17679281|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
5117917|NCT01750229|17679281|P1|Long-term Follow-up Phase|Adverse Event|2
5117918|NCT01750229|17679281|P1|Randomized Crossover Phase|Withdrawal by Subject|1
5117919|NCT01750229|17679281|P1|Randomized Crossover Phase|Adverse Event|1
5117920|NCT01749982|17679308|P4|Overall Study|Withdrawal by Subject|1
5117921|NCT01749982|17679309|P3|Overall Study|Withdrawal by Subject|0
5117922|NCT01749982|17679310|P2|Overall Study|Withdrawal by Subject|0
5117923|NCT01749982|17679311|P1|Overall Study|Withdrawal by Subject|0
5117924|NCT01749982|17679308|P4|Overall Study|Lost to Follow-up|1
5117925|NCT01749982|17679309|P3|Overall Study|Lost to Follow-up|0
5117926|NCT01749982|17679310|P2|Overall Study|Lost to Follow-up|0
5117927|NCT01749982|17679311|P1|Overall Study|Lost to Follow-up|0
5117928|NCT01749982|17679308|P4|Overall Study|Physician Decision|1
5117929|NCT01749982|17679309|P3|Overall Study|Physician Decision|0
5117930|NCT01749982|17679310|P2|Overall Study|Physician Decision|0
5117931|NCT01749982|17679311|P1|Overall Study|Physician Decision|0
5117932|NCT01749826|17679375|P2|Overall Study|Study Terminated|0
5117933|NCT01749826|17679376|P1|Overall Study|Study Terminated|20
5117934|NCT01749800|17679391|P3|Overall Study|Withdrawal by Subject|0
5117935|NCT01749800|17679392|P2|Overall Study|Withdrawal by Subject|1
5117936|NCT01749800|17679393|P1|Overall Study|Withdrawal by Subject|0
5117937|NCT01749800|17679391|P3|Overall Study|not meeting inclusion criteria|0
5117938|NCT01749800|17679392|P2|Overall Study|not meeting inclusion criteria|0
5117939|NCT01749800|17679393|P1|Overall Study|not meeting inclusion criteria|3
5117940|NCT01749735|17679403|P2|Overall Study|Withdrawal by Subject|0
5117941|NCT01749735|17679404|P1|Overall Study|Withdrawal by Subject|1
5117942|NCT01749033|17679455|P3|Overall Study|Lost to Follow-up|1
5117943|NCT01749033|17679456|P2|Overall Study|Lost to Follow-up|2
5117944|NCT01749033|17679457|P1|Overall Study|Lost to Follow-up|0
5117945|NCT01749033|17679455|P3|Overall Study|Did not receive allocated intervention|0
5117946|NCT01749033|17679456|P2|Overall Study|Did not receive allocated intervention|3
5117947|NCT01749033|17679457|P1|Overall Study|Did not receive allocated intervention|3
5117948|NCT01748890|17679527|P1|Overall Study|Insufficient recruitment for analysis|4
5117949|NCT01748760|17679582|P2|Overall Study|Lost to Follow-up|1
5117950|NCT01748760|17679583|P1|Overall Study|Lost to Follow-up|5
5117951|NCT01748760|17679582|P2|Overall Study|Withdrawal by Subject|1
5117952|NCT01748760|17679583|P1|Overall Study|Withdrawal by Subject|1
5117953|NCT01748552|17679629|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
5117954|NCT01748552|17679630|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
5117955|NCT01748552|17679631|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
5117956|NCT01748552|17679632|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
5117957|NCT01748552|17679633|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
5117958|NCT01748552|17679634|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
5117959|NCT01748552|17679635|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
5117960|NCT01748552|17679636|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
5117961|NCT01748552|17679637|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
5117962|NCT01748552|17679638|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
5117963|NCT01748552|17679639|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
5117964|NCT01748552|17679640|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
5117965|NCT01748552|17679629|P12|Intervention Period 2 and Washout|Physician Decision|0
5117966|NCT01748552|17679630|P11|Intervention Period 2 and Washout|Physician Decision|0
5117967|NCT01748552|17679631|P10|Intervention Period 2 and Washout|Physician Decision|0
5117968|NCT01748552|17679632|P9|Intervention Period 2 and Washout|Physician Decision|0
5117969|NCT01748552|17679633|P8|Intervention Period 2 and Washout|Physician Decision|0
5117970|NCT01748552|17679634|P7|Intervention Period 2 and Washout|Physician Decision|0
5117971|NCT01748552|17679635|P6|Intervention Period 2 and Washout|Physician Decision|0
5117972|NCT01748552|17679636|P5|Intervention Period 2 and Washout|Physician Decision|0
5117973|NCT01748552|17679637|P4|Intervention Period 2 and Washout|Physician Decision|0
5117974|NCT01748552|17679638|P3|Intervention Period 2 and Washout|Physician Decision|1
5117975|NCT01748552|17679639|P2|Intervention Period 2 and Washout|Physician Decision|0
5117976|NCT01748552|17679640|P1|Intervention Period 2 and Washout|Physician Decision|0
5117977|NCT01748292|17679710|P2|Overall Study|Withdrawal by Subject|2
5117978|NCT01748292|17679711|P1|Overall Study|Withdrawal by Subject|0
5117979|NCT01748292|17679710|P2|Overall Study|Death|3
5117980|NCT01748292|17679711|P1|Overall Study|Death|0
5117981|NCT01748292|17679710|P2|Overall Study|Lost to Follow-up|3
5117982|NCT01748292|17679711|P1|Overall Study|Lost to Follow-up|0
5117983|NCT01748292|17679710|P2|Overall Study|Adverse Event|4
5117984|NCT01748292|17679711|P1|Overall Study|Adverse Event|2
5117985|NCT01748162|17679745|P2|Overall Study|reasons not available|2
5117986|NCT01748162|17679746|P1|Overall Study|reasons not available|3
5117987|NCT01748162|17679745|P2|Overall Study|participant consented but did not begin|1
5117988|NCT01748162|17679746|P1|Overall Study|participant consented but did not begin|0
5117989|NCT01748162|17679745|P2|Overall Study|no additional croup episodes to evaluate|2
5117990|NCT01748162|17679746|P1|Overall Study|no additional croup episodes to evaluate|2
5117991|NCT01748071|17679757|P3|Overall Study|Adverse Event|0
5117992|NCT01748071|17679758|P2|Overall Study|Adverse Event|2
5117993|NCT01748071|17679759|P1|Overall Study|Adverse Event|2
5117994|NCT01747915|17680022|P3|Overall Study|Pregnancy|1
5117995|NCT01747915|17680023|P2|Overall Study|Pregnancy|0
5117996|NCT01747915|17680024|P1|Overall Study|Pregnancy|0
5117997|NCT01747915|17680022|P3|Overall Study|Protocol Violation|0
5117998|NCT01747915|17680023|P2|Overall Study|Protocol Violation|0
5117999|NCT01747915|17680024|P1|Overall Study|Protocol Violation|1
5118000|NCT01747915|17680022|P3|Overall Study|Withdrawal by Subject|1
5118001|NCT01747915|17680023|P2|Overall Study|Withdrawal by Subject|4
5118002|NCT01747915|17680024|P1|Overall Study|Withdrawal by Subject|4
5118003|NCT01747915|17680022|P3|Overall Study|Lost to Follow-up|0
5118004|NCT01747915|17680023|P2|Overall Study|Lost to Follow-up|0
5118005|NCT01747915|17680024|P1|Overall Study|Lost to Follow-up|1
5118006|NCT01747915|17680022|P3|Overall Study|Lack of Efficacy|0
5118007|NCT01747915|17680023|P2|Overall Study|Lack of Efficacy|1
5118008|NCT01747915|17680024|P1|Overall Study|Lack of Efficacy|0
5118009|NCT01747915|17680022|P3|Overall Study|Death|1
5118010|NCT01747915|17680023|P2|Overall Study|Death|0
5118011|NCT01747915|17680024|P1|Overall Study|Death|0
5118012|NCT01747915|17680022|P3|Overall Study|Adverse Event|2
5118013|NCT01747915|17680023|P2|Overall Study|Adverse Event|5
5118014|NCT01747915|17680024|P1|Overall Study|Adverse Event|8
5118015|NCT01747915|17680022|P3|Overall Study|Other|1
5118016|NCT01747915|17680023|P2|Overall Study|Other|1
5118017|NCT01747915|17680024|P1|Overall Study|Other|1
5118018|NCT01747876|17680038|P3|Overall Study|Trtment duration compl. as per protocol|1
5118019|NCT01747876|17680039|P2|Overall Study|Trtment duration compl. as per protocol|1
5118020|NCT01747876|17680040|P1|Overall Study|Trtment duration compl. as per protocol|0
5118021|NCT01747876|17680038|P3|Overall Study|Disease progression|8
5118022|NCT01747876|17680039|P2|Overall Study|Disease progression|13
5118023|NCT01747876|17680040|P1|Overall Study|Disease progression|4
5118024|NCT01747876|17680038|P3|Overall Study|Withdrawal by Subject|1
5118025|NCT01747876|17680039|P2|Overall Study|Withdrawal by Subject|1
5118026|NCT01747876|17680040|P1|Overall Study|Withdrawal by Subject|0
5118027|NCT01747876|17680038|P3|Overall Study|Adverse Event|2
5118028|NCT01747876|17680039|P2|Overall Study|Adverse Event|0
5118029|NCT01747876|17680040|P1|Overall Study|Adverse Event|1
5118030|NCT01747837|17680093|P2|Overall Study|Death|4
5118031|NCT01747837|17680094|P1|Overall Study|Death|4
5118032|NCT01747837|17680093|P2|Overall Study|Lost to Follow-up|2
5118033|NCT01747837|17680094|P1|Overall Study|Lost to Follow-up|5
5118034|NCT01747811|17680124|P2|Overall Study|Lack of Efficacy|4
5118035|NCT01747811|17680125|P1|Overall Study|Lack of Efficacy|2
5118036|NCT01747772|17680141|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
5118037|NCT01747655|17680149|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
5118038|NCT01747655|17680150|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
5118039|NCT01747655|17680149|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
5118040|NCT01747655|17680150|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
5118041|NCT01747655|17680149|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
5118042|NCT01747655|17680150|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
5118043|NCT01747629|17680180|P2|Overall Study|Other|1
5118044|NCT01747629|17680181|P1|Overall Study|Other|2
5118045|NCT01747629|17680180|P2|Overall Study|Not treated|0
5118046|NCT01747629|17680181|P1|Overall Study|Not treated|1
5118047|NCT01747629|17680180|P2|Overall Study|Inclusion criteria not met|0
5118048|NCT01747629|17680181|P1|Overall Study|Inclusion criteria not met|1
5118049|NCT01747629|17680180|P2|Overall Study|Noncompliance|1
5118050|NCT01747629|17680181|P1|Overall Study|Noncompliance|1
5118051|NCT01747629|17680180|P2|Overall Study|Withdrawal by Subject|2
5118052|NCT01747629|17680181|P1|Overall Study|Withdrawal by Subject|2
5118053|NCT01747629|17680180|P2|Overall Study|Adverse Event|2
5118054|NCT01747629|17680181|P1|Overall Study|Adverse Event|1
5118055|NCT01747551|17680215|P2|Overall Study|Other|0
5118056|NCT01747551|17680216|P1|Overall Study|Other|2
5118057|NCT01747551|17680215|P2|Overall Study|Physician Decision|1
5118058|NCT01747551|17680216|P1|Overall Study|Physician Decision|2
5118059|NCT01747551|17680215|P2|Overall Study|Withdrawal by Subject|1
5118060|NCT01747551|17680216|P1|Overall Study|Withdrawal by Subject|3
5118061|NCT01747551|17680215|P2|Overall Study|Prolonged Treatment Delay|0
5118062|NCT01747551|17680216|P1|Overall Study|Prolonged Treatment Delay|2
5118063|NCT01747551|17680215|P2|Overall Study|Adverse Event|1
5118064|NCT01747551|17680216|P1|Overall Study|Adverse Event|7
5118065|NCT01747551|17680215|P2|Overall Study|Death|1
5118066|NCT01747551|17680216|P1|Overall Study|Death|3
5118067|NCT01747551|17680215|P2|Overall Study|Progressive Disease|17
5118068|NCT01747551|17680216|P1|Overall Study|Progressive Disease|24
5118069|NCT01747499|17680233|P5|Overall Study|Determined not to be eligible|1
5118070|NCT01747499|17680234|P4|Overall Study|Determined not to be eligible|0
5118071|NCT01747499|17680235|P3|Overall Study|Determined not to be eligible|0
5118072|NCT01747499|17680236|P2|Overall Study|Determined not to be eligible|0
5118073|NCT01747499|17680237|P1|Overall Study|Determined not to be eligible|0
5118074|NCT01747499|17680233|P5|Overall Study|Developed AML and death|1
5118075|NCT01747499|17680234|P4|Overall Study|Developed AML and death|0
5118076|NCT01747499|17680235|P3|Overall Study|Developed AML and death|0
5118077|NCT01747499|17680236|P2|Overall Study|Developed AML and death|0
5118078|NCT01747499|17680237|P1|Overall Study|Developed AML and death|0
5118079|NCT01747499|17680233|P5|Overall Study|Withdrawal by Subject|6
5118080|NCT01747499|17680234|P4|Overall Study|Withdrawal by Subject|0
5118081|NCT01747499|17680235|P3|Overall Study|Withdrawal by Subject|0
5118082|NCT01747499|17680236|P2|Overall Study|Withdrawal by Subject|0
5118083|NCT01747499|17680237|P1|Overall Study|Withdrawal by Subject|0
5118084|NCT01747499|17680233|P5|Overall Study|Death|1
5118085|NCT01747499|17680234|P4|Overall Study|Death|1
5118086|NCT01747499|17680235|P3|Overall Study|Death|0
5118087|NCT01747499|17680236|P2|Overall Study|Death|0
5118088|NCT01747499|17680237|P1|Overall Study|Death|0
5118089|NCT01747499|17680233|P5|Overall Study|Physician Decision|2
5118090|NCT01747499|17680234|P4|Overall Study|Physician Decision|0
5118091|NCT01747499|17680235|P3|Overall Study|Physician Decision|0
5118092|NCT01747499|17680236|P2|Overall Study|Physician Decision|1
5118093|NCT01747499|17680237|P1|Overall Study|Physician Decision|0
5118094|NCT01747499|17680233|P5|Overall Study|Steroid refractory aGvHD|4
5118095|NCT01747499|17680234|P4|Overall Study|Steroid refractory aGvHD|1
5118096|NCT01747499|17680235|P3|Overall Study|Steroid refractory aGvHD|0
5118097|NCT01747499|17680236|P2|Overall Study|Steroid refractory aGvHD|0
5118098|NCT01747499|17680237|P1|Overall Study|Steroid refractory aGvHD|1
5118099|NCT01747486|17680273|P2|Stage 2|Disease Progression|0
5118100|NCT01747486|17680274|P1|Stage 2|Disease Progression|3
5118101|NCT01747486|17680273|P2|Stage 2|New Cancer Therapy|0
5118102|NCT01747486|17680274|P1|Stage 2|New Cancer Therapy|3
5118103|NCT01747486|17680273|P2|Stage 2|Withdrawal by Subject|0
5118104|NCT01747486|17680274|P1|Stage 2|Withdrawal by Subject|1
5118105|NCT01747486|17680273|P2|Stage 2|Physician Decision|0
5118106|NCT01747486|17680274|P1|Stage 2|Physician Decision|2
5118107|NCT01747486|17680273|P2|Stage 1|Death|1
5118108|NCT01747486|17680274|P1|Stage 1|Death|1
5118109|NCT01747486|17680273|P2|Stage 1|Disease progression|9
5118110|NCT01747486|17680274|P1|Stage 1|Disease progression|4
5118111|NCT01747486|17680273|P2|Stage 1|Withdrawal by Subject|3
5118112|NCT01747486|17680274|P1|Stage 1|Withdrawal by Subject|4
5118113|NCT01747486|17680273|P2|Stage 1|Physician Decision|0
5118114|NCT01747486|17680274|P1|Stage 1|Physician Decision|3
5118115|NCT01746901|17680324|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
5118116|NCT01746901|17680325|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118117|NCT01746901|17680326|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
5118118|NCT01746901|17680327|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118119|NCT01746901|17680328|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118120|NCT01746901|17680329|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118121|NCT01746901|17680330|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118122|NCT01746901|17680331|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118123|NCT01746901|17680332|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
5118124|NCT01746901|17680324|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
5118125|NCT01746901|17680325|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
5118126|NCT01746901|17680326|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
5118127|NCT01746901|17680327|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
5118128|NCT01746901|17680328|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
5118129|NCT01746901|17680329|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
5118130|NCT01746901|17680330|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
5118131|NCT01746901|17680331|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
5118132|NCT01746901|17680332|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
5118133|NCT01746901|17680324|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118134|NCT01746901|17680325|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118135|NCT01746901|17680326|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118136|NCT01746901|17680327|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118137|NCT01746901|17680328|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118138|NCT01746901|17680329|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
5118139|NCT01746901|17680330|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118140|NCT01746901|17680331|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118141|NCT01746901|17680332|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5118142|NCT01746901|17680324|P9|Treatment Phase: Third Intervention|Protocol Violation|0
5118143|NCT01746901|17680325|P8|Treatment Phase: Third Intervention|Protocol Violation|0
5118144|NCT01746901|17680326|P7|Treatment Phase: Third Intervention|Protocol Violation|1
5118145|NCT01746901|17680327|P6|Treatment Phase: Third Intervention|Protocol Violation|1
5118146|NCT01746901|17680328|P5|Treatment Phase: Third Intervention|Protocol Violation|0
5118147|NCT01746901|17680329|P4|Treatment Phase: Third Intervention|Protocol Violation|0
5118148|NCT01746901|17680330|P3|Treatment Phase: Third Intervention|Protocol Violation|0
5118149|NCT01746901|17680331|P2|Treatment Phase: Third Intervention|Protocol Violation|0
5118150|NCT01746901|17680332|P1|Treatment Phase: Third Intervention|Protocol Violation|0
5118151|NCT01746901|17680324|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118152|NCT01746901|17680325|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
5118153|NCT01746901|17680326|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118154|NCT01746901|17680327|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118155|NCT01746901|17680328|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118156|NCT01746901|17680329|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118157|NCT01746901|17680330|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118158|NCT01746901|17680331|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118159|NCT01746901|17680332|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5118160|NCT01746901|17680324|P9|Treatment Phase: First Intervention|Protocol Violation|0
5118161|NCT01746901|17680325|P8|Treatment Phase: First Intervention|Protocol Violation|0
5118162|NCT01746901|17680326|P7|Treatment Phase: First Intervention|Protocol Violation|1
5118163|NCT01746901|17680327|P6|Treatment Phase: First Intervention|Protocol Violation|0
5118164|NCT01746901|17680328|P5|Treatment Phase: First Intervention|Protocol Violation|0
5118165|NCT01746901|17680329|P4|Treatment Phase: First Intervention|Protocol Violation|0
5118166|NCT01746901|17680330|P3|Treatment Phase: First Intervention|Protocol Violation|0
5118167|NCT01746901|17680331|P2|Treatment Phase: First Intervention|Protocol Violation|0
5118168|NCT01746901|17680332|P1|Treatment Phase: First Intervention|Protocol Violation|0
5118169|NCT01746901|17680324|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118170|NCT01746901|17680325|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118171|NCT01746901|17680326|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118172|NCT01746901|17680327|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118173|NCT01746901|17680328|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118174|NCT01746901|17680329|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118175|NCT01746901|17680330|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
5118176|NCT01746901|17680331|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
5118177|NCT01746901|17680332|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
5118178|NCT01746901|17680324|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118179|NCT01746901|17680325|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118180|NCT01746901|17680326|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118181|NCT01746901|17680327|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118182|NCT01746901|17680328|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118183|NCT01746901|17680329|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118184|NCT01746901|17680330|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
5118185|NCT01746901|17680331|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
5118186|NCT01746901|17680332|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5118187|NCT01746901|17680324|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
5118188|NCT01746901|17680325|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
5118189|NCT01746901|17680326|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
5118190|NCT01746901|17680327|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
5118191|NCT01746901|17680328|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
5118192|NCT01746901|17680329|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
5118193|NCT01746901|17680330|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
5118194|NCT01746901|17680331|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
5118195|NCT01746901|17680332|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
5118196|NCT01746901|17680324|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
5118197|NCT01746901|17680325|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
5118198|NCT01746901|17680326|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
5118199|NCT01746901|17680327|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
5118200|NCT01746901|17680328|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
5118201|NCT01746901|17680329|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
5118202|NCT01746901|17680330|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
5118203|NCT01746901|17680331|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
5118204|NCT01746901|17680332|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
5118205|NCT01746901|17680324|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118206|NCT01746901|17680325|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118207|NCT01746901|17680326|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118208|NCT01746901|17680327|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118209|NCT01746901|17680328|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118210|NCT01746901|17680329|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118211|NCT01746901|17680330|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118212|NCT01746901|17680331|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
5118213|NCT01746901|17680332|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
5118214|NCT01746901|17680324|P9|Naloxone Challenge Phase|Adverse Event|0
5118215|NCT01746901|17680325|P8|Naloxone Challenge Phase|Adverse Event|0
5118216|NCT01746901|17680326|P7|Naloxone Challenge Phase|Adverse Event|0
5118217|NCT01746901|17680327|P6|Naloxone Challenge Phase|Adverse Event|0
5118218|NCT01746901|17680328|P5|Naloxone Challenge Phase|Adverse Event|0
5118219|NCT01746901|17680329|P4|Naloxone Challenge Phase|Adverse Event|0
5118220|NCT01746901|17680330|P3|Naloxone Challenge Phase|Adverse Event|0
5118221|NCT01746901|17680331|P2|Naloxone Challenge Phase|Adverse Event|0
5118222|NCT01746901|17680332|P1|Naloxone Challenge Phase|Adverse Event|2
5118223|NCT01746862|17680655|P2|Overall Study|Entered puberty during the study|0
5118224|NCT01746862|17680656|P1|Overall Study|Entered puberty during the study|1
5118225|NCT01746862|17680655|P2|Overall Study|Consent withdrawal by parent's guardian|2
5118226|NCT01746862|17680656|P1|Overall Study|Consent withdrawal by parent's guardian|5
5118227|NCT01746862|17680655|P2|Overall Study|Protocol Violation|0
5118228|NCT01746862|17680656|P1|Overall Study|Protocol Violation|1
5118229|NCT01746862|17680655|P2|Overall Study|Withdrawal by Subject|1
5118230|NCT01746862|17680656|P1|Overall Study|Withdrawal by Subject|1
5118231|NCT01746732|17680720|P3|Period 2|Lost to Follow-up|1
5118232|NCT01746732|17680721|P2|Period 2|Lost to Follow-up|0
5118233|NCT01746732|17680722|P1|Period 2|Lost to Follow-up|0
5118234|NCT01746732|17680720|P3|Period 2|Adverse Event|1
5118235|NCT01746732|17680721|P2|Period 2|Adverse Event|0
5118236|NCT01746732|17680722|P1|Period 2|Adverse Event|0
5118237|NCT01746732|17680720|P3|Period 2|Withdrawal by Subject|2
5118238|NCT01746732|17680721|P2|Period 2|Withdrawal by Subject|0
5118239|NCT01746732|17680722|P1|Period 2|Withdrawal by Subject|0
5118240|NCT01746732|17680720|P3|Period 1|Physician Decision|0
5118241|NCT01746732|17680721|P2|Period 1|Physician Decision|1
5118242|NCT01746732|17680722|P1|Period 1|Physician Decision|0
5118243|NCT01746732|17680720|P3|Lead-In Period|Withdrawal by Subject|0
5118244|NCT01746732|17680721|P2|Lead-In Period|Withdrawal by Subject|0
5118245|NCT01746732|17680722|P1|Lead-In Period|Withdrawal by Subject|1
5118246|NCT01746368|17680803|P2|Overall Study|Withdrawal by Subject|1
5118247|NCT01746368|17680804|P1|Overall Study|Withdrawal by Subject|0
5118248|NCT01746368|17680803|P2|Overall Study|Lost to Follow-up|0
5118249|NCT01746368|17680804|P1|Overall Study|Lost to Follow-up|2
5118250|NCT01746225|17680834|P3|Overall Study|Continuing Treatment|3
5118251|NCT01746225|17680835|P2|Overall Study|Continuing Treatment|8
5118252|NCT01746225|17680836|P1|Overall Study|Continuing Treatment|5
5118253|NCT01746225|17680834|P3|Overall Study|Adverse Event|17
5118254|NCT01746225|17680835|P2|Overall Study|Adverse Event|12
5118255|NCT01746225|17680836|P1|Overall Study|Adverse Event|15
5118256|NCT01746225|17680834|P3|Overall Study|Physician Decision|3
5118257|NCT01746225|17680835|P2|Overall Study|Physician Decision|11
5118258|NCT01746225|17680836|P1|Overall Study|Physician Decision|14
5118259|NCT01746225|17680834|P3|Overall Study|Withdrawal by Subject|19
5118260|NCT01746225|17680835|P2|Overall Study|Withdrawal by Subject|15
5118261|NCT01746225|17680836|P1|Overall Study|Withdrawal by Subject|5
5118262|NCT01746225|17680834|P3|Overall Study|Death|1
5118263|NCT01746225|17680835|P2|Overall Study|Death|0
5118264|NCT01746225|17680836|P1|Overall Study|Death|1
5118265|NCT01746173|17680859|P1|Overall Study|Disease Progression|2
5118266|NCT01746108|17680867|P3|Overall Study|Lost to Follow-up|0
5118267|NCT01746108|17680868|P2|Overall Study|Lost to Follow-up|1
5118268|NCT01746108|17680869|P1|Overall Study|Lost to Follow-up|0
5118269|NCT01746108|17680867|P3|Overall Study|Withdrawal by Subject|0
5118270|NCT01746108|17680868|P2|Overall Study|Withdrawal by Subject|1
5118271|NCT01746108|17680869|P1|Overall Study|Withdrawal by Subject|0
5118272|NCT01746108|17680867|P3|Overall Study|Adverse event, non-fatal|0
5118273|NCT01746108|17680868|P2|Overall Study|Adverse event, non-fatal|1
5118274|NCT01746108|17680869|P1|Overall Study|Adverse event, non-fatal|0
5118275|NCT01746108|17680867|P3|Overall Study|Migrated /moved from study area|0
5118276|NCT01746108|17680868|P2|Overall Study|Migrated /moved from study area|1
5118277|NCT01746108|17680869|P1|Overall Study|Migrated /moved from study area|0
5118278|NCT01746017|17680986|P11|Period 3|Withdrawal by Subject|0
5118279|NCT01746017|17680987|P10|Period 3|Withdrawal by Subject|0
5118280|NCT01746017|17680988|P9|Period 3|Withdrawal by Subject|0
5118281|NCT01746017|17680989|P8|Period 3|Withdrawal by Subject|0
5118282|NCT01746017|17680990|P7|Period 3|Withdrawal by Subject|0
5118283|NCT01746017|17680991|P6|Period 3|Withdrawal by Subject|1
5118284|NCT01746017|17680992|P5|Period 3|Withdrawal by Subject|0
5118285|NCT01746017|17680993|P4|Period 3|Withdrawal by Subject|0
5118286|NCT01746017|17680994|P3|Period 3|Withdrawal by Subject|0
5118287|NCT01746017|17680995|P2|Period 3|Withdrawal by Subject|0
5118288|NCT01746017|17680996|P1|Period 3|Withdrawal by Subject|0
5118289|NCT01746017|17680986|P11|Period 1|Withdrawal by Subject|0
5118290|NCT01746017|17680987|P10|Period 1|Withdrawal by Subject|0
5118291|NCT01746017|17680988|P9|Period 1|Withdrawal by Subject|0
5118292|NCT01746017|17680989|P8|Period 1|Withdrawal by Subject|0
5118293|NCT01746017|17680990|P7|Period 1|Withdrawal by Subject|1
5118294|NCT01746017|17680991|P6|Period 1|Withdrawal by Subject|0
5118295|NCT01746017|17680992|P5|Period 1|Withdrawal by Subject|0
5118296|NCT01746017|17680993|P4|Period 1|Withdrawal by Subject|0
5118297|NCT01746017|17680994|P3|Period 1|Withdrawal by Subject|0
5118298|NCT01746017|17680995|P2|Period 1|Withdrawal by Subject|0
5118299|NCT01746017|17680996|P1|Period 1|Withdrawal by Subject|0
5118300|NCT01745848|17681117|P1|Overall Study|Adverse Event|6
5118301|NCT01745393|17681124|P2|12-month Follow-up|Lost to Follow-up|5
5118302|NCT01745393|17681125|P1|12-month Follow-up|Lost to Follow-up|6
5118303|NCT01745393|17681124|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
5118304|NCT01745393|17681125|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
5118305|NCT01745393|17681124|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
5118306|NCT01745393|17681125|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
5118307|NCT01745380|17681137|P2|Overall Study|Lack of Efficacy|1
5118308|NCT01745380|17681138|P1|Overall Study|Lack of Efficacy|0
5118309|NCT01745380|17681137|P2|Overall Study|Lost to Follow-up|0
5118310|NCT01745380|17681138|P1|Overall Study|Lost to Follow-up|1
5118311|NCT01745367|17681176|P2|Overall Study|Other Reasons Unspecified|2
5118312|NCT01745367|17681177|P1|Overall Study|Other Reasons Unspecified|0
5118313|NCT01745367|17681176|P2|Overall Study|Termination of The Study by The Sponsor|18
5118314|NCT01745367|17681177|P1|Overall Study|Termination of The Study by The Sponsor|6
5118315|NCT01745367|17681176|P2|Overall Study|Withdrawal by Subject|2
5118316|NCT01745367|17681177|P1|Overall Study|Withdrawal by Subject|1
5118317|NCT01745367|17681176|P2|Overall Study|Death|0
5118318|NCT01745367|17681177|P1|Overall Study|Death|1
5118319|NCT01745146|17681197|P2|Overall Study|Lost to Follow-up|0
5118320|NCT01745146|17681198|P1|Overall Study|Lost to Follow-up|2
5118321|NCT01745146|17681197|P2|Overall Study|Withdrawal by Subject|3
5118322|NCT01745146|17681198|P1|Overall Study|Withdrawal by Subject|1
5118323|NCT01745120|17681220|P2|Overall Study|Investigator decision|0
5118324|NCT01745120|17681221|P1|Overall Study|Investigator decision|1
5118325|NCT01745094|17681279|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
5118326|NCT01745094|17681280|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
5118327|NCT01745094|17681281|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
5118328|NCT01745094|17681282|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
5118329|NCT01745094|17681279|P4|Overall Study|Show no Stable Solifenacin Intake|0
5118330|NCT01745094|17681280|P3|Overall Study|Show no Stable Solifenacin Intake|1
5118331|NCT01745094|17681281|P2|Overall Study|Show no Stable Solifenacin Intake|0
5118332|NCT01745094|17681282|P1|Overall Study|Show no Stable Solifenacin Intake|0
5118333|NCT01745094|17681279|P4|Overall Study|Need Further Examinations Due to Biopsy|0
5118334|NCT01745094|17681280|P3|Overall Study|Need Further Examinations Due to Biopsy|1
5118335|NCT01745094|17681281|P2|Overall Study|Need Further Examinations Due to Biopsy|0
5118336|NCT01745094|17681282|P1|Overall Study|Need Further Examinations Due to Biopsy|0
5118337|NCT01745094|17681279|P4|Overall Study|Protocol Violation|1
5118338|NCT01745094|17681280|P3|Overall Study|Protocol Violation|3
5118339|NCT01745094|17681281|P2|Overall Study|Protocol Violation|0
5118340|NCT01745094|17681282|P1|Overall Study|Protocol Violation|1
5118341|NCT01745094|17681279|P4|Overall Study|Withdrawal by Subject|2
5118342|NCT01745094|17681280|P3|Overall Study|Withdrawal by Subject|1
5118343|NCT01745094|17681281|P2|Overall Study|Withdrawal by Subject|0
5118344|NCT01745094|17681282|P1|Overall Study|Withdrawal by Subject|2
5118345|NCT01745094|17681279|P4|Overall Study|Adverse Event|0
5118346|NCT01745094|17681280|P3|Overall Study|Adverse Event|3
5118347|NCT01745094|17681281|P2|Overall Study|Adverse Event|0
5118348|NCT01745094|17681282|P1|Overall Study|Adverse Event|0
5118349|NCT01745094|17681279|P4|Overall Study|Not Meeting the Eligibility Criteria|0
5118350|NCT01745094|17681280|P3|Overall Study|Not Meeting the Eligibility Criteria|3
5118351|NCT01745094|17681281|P2|Overall Study|Not Meeting the Eligibility Criteria|0
5118352|NCT01745094|17681282|P1|Overall Study|Not Meeting the Eligibility Criteria|1
5118353|NCT01744977|17681383|P2|Overall Study|No longer meets inclusion|0
5118354|NCT01744977|17681384|P1|Overall Study|No longer meets inclusion|6
5118355|NCT01744977|17681383|P2|Overall Study|Lost to Follow-up|0
5118356|NCT01744977|17681384|P1|Overall Study|Lost to Follow-up|2
5118357|NCT01744977|17681383|P2|Overall Study|Death|3
5118358|NCT01744977|17681384|P1|Overall Study|Death|2
5118359|NCT01744977|17681383|P2|Overall Study|Withdrawal by Subject|2
5118360|NCT01744977|17681384|P1|Overall Study|Withdrawal by Subject|1
5118361|NCT01744782|17681455|P1|Overall Study|Death|1
5118362|NCT01744691|17681616|P1|Overall Study|Physician Decision|4
5118363|NCT01744691|17681616|P1|Overall Study|Withdrawal of consent for treatment|3
5118364|NCT01744691|17681616|P1|Overall Study|Unacceptable toxicity, AE or death|18
5118365|NCT01744691|17681616|P1|Overall Study|Progressive Disease|18
5118366|NCT01744665|17681621|P1|Re-initiation Phase|Withdrawal by Subject|1
5118367|NCT01744665|17681621|P1|Re-initiation Phase|No longer required treatment|1
5118368|NCT01744665|17681621|P1|Re-initiation Phase|Adverse Event|1
5118369|NCT01744665|17681621|P1|Re-initiation Phase|Administrative problems|10
5118370|NCT01744665|17681621|P1|Consolidation Phase|Administrative problems|9
5118371|NCT01744665|17681621|P1|Consolidation Phase|Withdrawal by Subject|4
5118372|NCT01744665|17681621|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
5118373|NCT01744665|17681621|P1|Consolidation Phase|Adverse Event|2
5118374|NCT01744665|17681621|P1|Monitoring Phase|Did not achieve MR4.5|1
5118375|NCT01744665|17681621|P1|Monitoring Phase|Withdrawal by Subject|5
5118376|NCT01744665|17681621|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
5118377|NCT01744665|17681621|P1|Monitoring Phase|Abnormal laboratory value(s)|1
5118378|NCT01744665|17681621|P1|Monitoring Phase|Adverse Event|4
5118379|NCT01744496|17681691|P2|Maintenance Period|Subject left town|0
5118380|NCT01744496|17681692|P1|Maintenance Period|Subject left town|1
5118381|NCT01744496|17681691|P2|Maintenance Period|Withdrawal by Subject|1
5118382|NCT01744496|17681692|P1|Maintenance Period|Withdrawal by Subject|1
5118383|NCT01744496|17681691|P2|Maintenance Period|Protocol Violation|0
5118384|NCT01744496|17681692|P1|Maintenance Period|Protocol Violation|1
5118385|NCT01744496|17681691|P2|Maintenance Period|Adverse Event|3
5118386|NCT01744496|17681692|P1|Maintenance Period|Adverse Event|1
5118387|NCT01744496|17681691|P2|Titration Period|Personal reasons|1
5118388|NCT01744496|17681692|P1|Titration Period|Personal reasons|0
5118389|NCT01744496|17681691|P2|Titration Period|Adverse Event|1
5118390|NCT01744496|17681692|P1|Titration Period|Adverse Event|2
5118391|NCT01744483|17681713|P3|Overall Study|Routed to OSH|1
5118392|NCT01744483|17681714|P2|Overall Study|Routed to OSH|0
5118393|NCT01744483|17681715|P1|Overall Study|Routed to OSH|2
5118394|NCT01744483|17681713|P3|Overall Study|No ICU Admit|2
5118395|NCT01744483|17681714|P2|Overall Study|No ICU Admit|1
5118396|NCT01744483|17681715|P1|Overall Study|No ICU Admit|5
5118397|NCT01744483|17681713|P3|Overall Study|Withdrawal by Subject|2
5118398|NCT01744483|17681714|P2|Overall Study|Withdrawal by Subject|6
5118399|NCT01744483|17681715|P1|Overall Study|Withdrawal by Subject|4
5118400|NCT01744483|17681713|P3|Overall Study|Protocol Violation|1
5118401|NCT01744483|17681714|P2|Overall Study|Protocol Violation|2
5118402|NCT01744483|17681715|P1|Overall Study|Protocol Violation|1
5118403|NCT01744483|17681713|P3|Overall Study|Lost to Follow-up|11
5118404|NCT01744483|17681714|P2|Overall Study|Lost to Follow-up|9
5118405|NCT01744483|17681715|P1|Overall Study|Lost to Follow-up|8
5118406|NCT01744483|17681713|P3|Overall Study|Death|11
5118407|NCT01744483|17681714|P2|Overall Study|Death|4
5118408|NCT01744483|17681715|P1|Overall Study|Death|9
5118409|NCT01744392|17681723|P1|Overall Study|Physician Decision|1
5118410|NCT01744197|17681763|P2|Overall Study|No patch received|2
5118411|NCT01744197|17681764|P1|Overall Study|No patch received|2
5118412|NCT01744197|17681763|P2|Overall Study|Received 1 patch|1
5118413|NCT01744197|17681764|P1|Overall Study|Received 1 patch|2
5118414|NCT01743560|17681870|P1|Overall Study|>1 dose of study drug|3
5118415|NCT01743560|17681870|P1|Overall Study|Protocol Violation|1
5118416|NCT01743560|17681870|P1|Overall Study|Withdrawal by Subject|2
5118417|NCT01743560|17681870|P1|Overall Study|Death|3
5118418|NCT01743560|17681870|P1|Overall Study|Adverse Event|8
5118419|NCT01743560|17681870|P1|Overall Study|Disease progression|26
5118420|NCT01743469|17681954|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
5118421|NCT01743469|17681955|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
5118422|NCT01743469|17681956|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
5118423|NCT01743469|17681957|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
5118424|NCT01743469|17681954|P4|Follow-up Period - Post-Treatment|Death|16
5118425|NCT01743469|17681955|P3|Follow-up Period - Post-Treatment|Death|22
5118426|NCT01743469|17681956|P2|Follow-up Period - Post-Treatment|Death|47
5118427|NCT01743469|17681957|P1|Follow-up Period - Post-Treatment|Death|43
5118428|NCT01743469|17681954|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
5118429|NCT01743469|17681955|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
5118430|NCT01743469|17681956|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
5118431|NCT01743469|17681957|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
5118432|NCT01743469|17681954|P4|Active Treatment Phase|Missing|0
5118433|NCT01743469|17681955|P3|Active Treatment Phase|Missing|0
5118434|NCT01743469|17681956|P2|Active Treatment Phase|Missing|0
5118435|NCT01743469|17681957|P1|Active Treatment Phase|Missing|1
5118436|NCT01743469|17681954|P4|Active Treatment Phase|Withdrawal by Subject|0
5118437|NCT01743469|17681955|P3|Active Treatment Phase|Withdrawal by Subject|0
5118438|NCT01743469|17681956|P2|Active Treatment Phase|Withdrawal by Subject|3
5118439|NCT01743469|17681957|P1|Active Treatment Phase|Withdrawal by Subject|2
5118440|NCT01743469|17681954|P4|Active Treatment Phase|Disease Progression|20
5118441|NCT01743469|17681955|P3|Active Treatment Phase|Disease Progression|30
5118442|NCT01743469|17681956|P2|Active Treatment Phase|Disease Progression|47
5118443|NCT01743469|17681957|P1|Active Treatment Phase|Disease Progression|40
5118444|NCT01743469|17681954|P4|Active Treatment Phase|Adverse Event|1
5118445|NCT01743469|17681955|P3|Active Treatment Phase|Adverse Event|8
5118446|NCT01743469|17681956|P2|Active Treatment Phase|Adverse Event|5
5118447|NCT01743469|17681957|P1|Active Treatment Phase|Adverse Event|10
5118448|NCT01743092|17682022|P2|Overall Study|Lost to Follow-up|15
5118449|NCT01743092|17682023|P1|Overall Study|Lost to Follow-up|14
5118450|NCT01743040|17682031|P1|Overall Study|Withdrawal by Subject|121
5118451|NCT01743040|17682031|P1|Overall Study|Protocol Violation|1
5118452|NCT01743040|17682031|P1|Overall Study|Physician Decision|40
5118453|NCT01743040|17682031|P1|Overall Study|Lost to Follow-up|66
5118454|NCT01743040|17682031|P1|Overall Study|Death|1
5118455|NCT01743027|17682039|P4|Overall Study|Withdrawal by Subject|1
5118456|NCT01743027|17682040|P3|Overall Study|Withdrawal by Subject|3
5118457|NCT01743027|17682041|P2|Overall Study|Withdrawal by Subject|0
5118458|NCT01743027|17682042|P1|Overall Study|Withdrawal by Subject|1
5118459|NCT01743027|17682039|P4|Overall Study|Protocol Violation|0
5118460|NCT01743027|17682040|P3|Overall Study|Protocol Violation|1
5118461|NCT01743027|17682041|P2|Overall Study|Protocol Violation|1
5118462|NCT01743027|17682042|P1|Overall Study|Protocol Violation|1
5118463|NCT01743027|17682039|P4|Overall Study|Progressive Disease|0
5118464|NCT01743027|17682040|P3|Overall Study|Progressive Disease|3
5118465|NCT01743027|17682041|P2|Overall Study|Progressive Disease|4
5118466|NCT01743027|17682042|P1|Overall Study|Progressive Disease|1
5118467|NCT01743027|17682039|P4|Overall Study|Lost to Follow-up|0
5118468|NCT01743027|17682040|P3|Overall Study|Lost to Follow-up|2
5118469|NCT01743027|17682041|P2|Overall Study|Lost to Follow-up|0
5118470|NCT01743027|17682042|P1|Overall Study|Lost to Follow-up|0
5118471|NCT01743027|17682039|P4|Overall Study|Adverse Event|0
5118472|NCT01743027|17682040|P3|Overall Study|Adverse Event|0
5118473|NCT01743027|17682041|P2|Overall Study|Adverse Event|0
5118474|NCT01743027|17682042|P1|Overall Study|Adverse Event|2
5118475|NCT01743001|17682082|P2|Overall Study|Death|0
5118476|NCT01743001|17682083|P1|Overall Study|Death|1
5118477|NCT01743001|17682082|P2|Overall Study|Pregnancy|0
5118478|NCT01743001|17682083|P1|Overall Study|Pregnancy|1
5118479|NCT01743001|17682082|P2|Overall Study|Physician Decision|0
5118480|NCT01743001|17682083|P1|Overall Study|Physician Decision|1
5118481|NCT01742897|17682126|P1|Overall Study|Other|1
5118482|NCT01742897|17682126|P1|Overall Study|Withdrawal by Subject|1
5118483|NCT01742897|17682126|P1|Overall Study|Adverse Event|3
5118484|NCT01742286|17682179|P7|Expansion Phase|Withdrawal by Subject|1
5118485|NCT01742286|17682180|P6|Expansion Phase|Withdrawal by Subject|0
5118486|NCT01742286|17682181|P5|Expansion Phase|Withdrawal by Subject|0
5118487|NCT01742286|17682182|P4|Expansion Phase|Withdrawal by Subject|0
5118488|NCT01742286|17682183|P3|Expansion Phase|Withdrawal by Subject|0
5118489|NCT01742286|17682184|P2|Expansion Phase|Withdrawal by Subject|0
5118490|NCT01742286|17682185|P1|Expansion Phase|Withdrawal by Subject|0
5118491|NCT01742286|17682179|P7|Expansion Phase|Disease progression|15
5118492|NCT01742286|17682180|P6|Expansion Phase|Disease progression|0
5118493|NCT01742286|17682181|P5|Expansion Phase|Disease progression|0
5118494|NCT01742286|17682182|P4|Expansion Phase|Disease progression|0
5118495|NCT01742286|17682183|P3|Expansion Phase|Disease progression|3
5118496|NCT01742286|17682184|P2|Expansion Phase|Disease progression|0
5118497|NCT01742286|17682185|P1|Expansion Phase|Disease progression|0
5118498|NCT01742286|17682179|P7|Expansion Phase|Adverse Event|6
5118499|NCT01742286|17682180|P6|Expansion Phase|Adverse Event|0
5118500|NCT01742286|17682181|P5|Expansion Phase|Adverse Event|0
5118501|NCT01742286|17682182|P4|Expansion Phase|Adverse Event|0
5118502|NCT01742286|17682183|P3|Expansion Phase|Adverse Event|0
5118503|NCT01742286|17682184|P2|Expansion Phase|Adverse Event|0
5118504|NCT01742286|17682185|P1|Expansion Phase|Adverse Event|0
5118505|NCT01742286|17682179|P7|Expansion Phase|Physician Decision|9
5118506|NCT01742286|17682180|P6|Expansion Phase|Physician Decision|0
5118507|NCT01742286|17682181|P5|Expansion Phase|Physician Decision|0
5118508|NCT01742286|17682182|P4|Expansion Phase|Physician Decision|0
5118509|NCT01742286|17682183|P3|Expansion Phase|Physician Decision|4
5118510|NCT01742286|17682184|P2|Expansion Phase|Physician Decision|0
5118511|NCT01742286|17682185|P1|Expansion Phase|Physician Decision|0
5118512|NCT01742286|17682179|P7|Expansion Phase|Administrative problems|5
5118513|NCT01742286|17682180|P6|Expansion Phase|Administrative problems|0
5118514|NCT01742286|17682181|P5|Expansion Phase|Administrative problems|0
5118515|NCT01742286|17682182|P4|Expansion Phase|Administrative problems|0
5118516|NCT01742286|17682183|P3|Expansion Phase|Administrative problems|0
5118517|NCT01742286|17682184|P2|Expansion Phase|Administrative problems|0
5118518|NCT01742286|17682185|P1|Expansion Phase|Administrative problems|0
5118519|NCT01742286|17682179|P7|Escalation Phase|Subject/guardian decision|0
5118520|NCT01742286|17682180|P6|Escalation Phase|Subject/guardian decision|0
5118521|NCT01742286|17682181|P5|Escalation Phase|Subject/guardian decision|0
5118522|NCT01742286|17682182|P4|Escalation Phase|Subject/guardian decision|0
5118523|NCT01742286|17682183|P3|Escalation Phase|Subject/guardian decision|0
5118524|NCT01742286|17682184|P2|Escalation Phase|Subject/guardian decision|0
5118525|NCT01742286|17682185|P1|Escalation Phase|Subject/guardian decision|1
5118526|NCT01742286|17682179|P7|Escalation Phase|Physician Decision|2
5118527|NCT01742286|17682180|P6|Escalation Phase|Physician Decision|0
5118528|NCT01742286|17682181|P5|Escalation Phase|Physician Decision|0
5118529|NCT01742286|17682182|P4|Escalation Phase|Physician Decision|1
5118530|NCT01742286|17682183|P3|Escalation Phase|Physician Decision|0
5118531|NCT01742286|17682184|P2|Escalation Phase|Physician Decision|3
5118532|NCT01742286|17682185|P1|Escalation Phase|Physician Decision|0
5118533|NCT01742286|17682179|P7|Escalation Phase|Death|0
5118534|NCT01742286|17682180|P6|Escalation Phase|Death|1
5118535|NCT01742286|17682181|P5|Escalation Phase|Death|0
5118536|NCT01742286|17682182|P4|Escalation Phase|Death|0
5118537|NCT01742286|17682183|P3|Escalation Phase|Death|0
5118538|NCT01742286|17682184|P2|Escalation Phase|Death|0
5118539|NCT01742286|17682185|P1|Escalation Phase|Death|0
5118540|NCT01742286|17682179|P7|Escalation Phase|Disease progression|2
5118541|NCT01742286|17682180|P6|Escalation Phase|Disease progression|3
5118542|NCT01742286|17682181|P5|Escalation Phase|Disease progression|4
5118543|NCT01742286|17682182|P4|Escalation Phase|Disease progression|1
5118544|NCT01742286|17682183|P3|Escalation Phase|Disease progression|4
5118545|NCT01742286|17682184|P2|Escalation Phase|Disease progression|7
5118546|NCT01742286|17682185|P1|Escalation Phase|Disease progression|3
5118547|NCT01742286|17682179|P7|Escalation Phase|Adverse Event|0
5118548|NCT01742286|17682180|P6|Escalation Phase|Adverse Event|1
5118549|NCT01742286|17682181|P5|Escalation Phase|Adverse Event|0
5118550|NCT01742286|17682182|P4|Escalation Phase|Adverse Event|0
5118551|NCT01742286|17682183|P3|Escalation Phase|Adverse Event|2
5118552|NCT01742286|17682184|P2|Escalation Phase|Adverse Event|1
5118553|NCT01742286|17682185|P1|Escalation Phase|Adverse Event|0
5118554|NCT01742286|17682179|P7|Escalation Phase|Administrative problems|2
5118555|NCT01742286|17682180|P6|Escalation Phase|Administrative problems|0
5118556|NCT01742286|17682181|P5|Escalation Phase|Administrative problems|0
5118557|NCT01742286|17682182|P4|Escalation Phase|Administrative problems|0
5118558|NCT01742286|17682183|P3|Escalation Phase|Administrative problems|0
5118559|NCT01742286|17682184|P2|Escalation Phase|Administrative problems|1
5118560|NCT01742286|17682185|P1|Escalation Phase|Administrative problems|1
5118561|NCT01742091|17682318|P6|Overall Study|Lost to Follow-up|1
5118562|NCT01742091|17682319|P5|Overall Study|Lost to Follow-up|0
5118563|NCT01742091|17682320|P4|Overall Study|Lost to Follow-up|0
5118564|NCT01742091|17682321|P3|Overall Study|Lost to Follow-up|0
5118565|NCT01742091|17682322|P2|Overall Study|Lost to Follow-up|0
5118566|NCT01742091|17682323|P1|Overall Study|Lost to Follow-up|0
5118567|NCT01742091|17682318|P6|Overall Study|Withdrawal by Subject|0
5118568|NCT01742091|17682319|P5|Overall Study|Withdrawal by Subject|0
5118569|NCT01742091|17682320|P4|Overall Study|Withdrawal by Subject|1
5118570|NCT01742091|17682321|P3|Overall Study|Withdrawal by Subject|0
5118571|NCT01742091|17682322|P2|Overall Study|Withdrawal by Subject|0
5118572|NCT01742091|17682323|P1|Overall Study|Withdrawal by Subject|0
5118573|NCT01742091|17682318|P6|Overall Study|Physician Decision|1
5118574|NCT01742091|17682319|P5|Overall Study|Physician Decision|0
5118575|NCT01742091|17682320|P4|Overall Study|Physician Decision|0
5118576|NCT01742091|17682321|P3|Overall Study|Physician Decision|0
5118577|NCT01742091|17682322|P2|Overall Study|Physician Decision|0
5118578|NCT01742091|17682323|P1|Overall Study|Physician Decision|0
5118579|NCT01742091|17682318|P6|Overall Study|Adverse Event|0
5118580|NCT01742091|17682319|P5|Overall Study|Adverse Event|1
5118581|NCT01742091|17682320|P4|Overall Study|Adverse Event|0
5118582|NCT01742091|17682321|P3|Overall Study|Adverse Event|0
5118583|NCT01742091|17682322|P2|Overall Study|Adverse Event|0
5118584|NCT01742091|17682323|P1|Overall Study|Adverse Event|0
5118585|NCT01742078|17682369|P9|Overall Study|Withdrawal by Subject|0
5118586|NCT01742078|17682370|P8|Overall Study|Withdrawal by Subject|0
5118587|NCT01742078|17682371|P7|Overall Study|Withdrawal by Subject|0
5118588|NCT01742078|17682372|P6|Overall Study|Withdrawal by Subject|0
5118589|NCT01742078|17682373|P5|Overall Study|Withdrawal by Subject|0
5118590|NCT01742078|17682374|P4|Overall Study|Withdrawal by Subject|1
5118591|NCT01742078|17682375|P3|Overall Study|Withdrawal by Subject|0
5118592|NCT01742078|17682376|P2|Overall Study|Withdrawal by Subject|0
5118593|NCT01742078|17682377|P1|Overall Study|Withdrawal by Subject|0
5118594|NCT01741792|17682446|P3|Overall Study|Death|12
5118595|NCT01741792|17682447|P2|Overall Study|Death|1
5118596|NCT01741792|17682448|P1|Overall Study|Death|6
5118597|NCT01741701|17682515|P2|Overall Study|Withdrawal by Subject|1
5118598|NCT01741701|17682516|P1|Overall Study|Withdrawal by Subject|0
5118599|NCT01741701|17682515|P2|Overall Study|Adverse Event|1
5118600|NCT01741701|17682516|P1|Overall Study|Adverse Event|5
5118601|NCT01741688|17682532|P1|Overall Study|Withdrawal by Subject|1
5118602|NCT01741688|17682532|P1|Overall Study|Lack of insurance coverage|2
5118603|NCT01741545|17682551|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5118604|NCT01741545|17682552|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5118605|NCT01741545|17682551|P2|Follow-up Period (24 Weeks)|Other than specified|1
5118606|NCT01741545|17682552|P1|Follow-up Period (24 Weeks)|Other than specified|0
5118607|NCT01741545|17682551|P2|Treatment Period|Adverse event, non-fatal|3
5118608|NCT01741545|17682552|P1|Treatment Period|Adverse event, non-fatal|1
5118609|NCT01741545|17682551|P2|Treatment Period|Lack of Efficacy|1
5118610|NCT01741545|17682552|P1|Treatment Period|Lack of Efficacy|0
5118611|NCT01741532|17682576|P2|Overall Study|Medical event|0
5118612|NCT01741532|17682577|P1|Overall Study|Medical event|1
5118613|NCT01741532|17682576|P2|Overall Study|Sponsor decision|0
5118614|NCT01741532|17682577|P1|Overall Study|Sponsor decision|1
5118615|NCT01741532|17682576|P2|Overall Study|Worsening of the disease|1
5118616|NCT01741532|17682577|P1|Overall Study|Worsening of the disease|3
5118617|NCT01741532|17682576|P2|Overall Study|Protocol Violation|1
5118618|NCT01741532|17682577|P1|Overall Study|Protocol Violation|0
5118619|NCT01741532|17682576|P2|Overall Study|Withdrawal by Subject|1
5118620|NCT01741532|17682577|P1|Overall Study|Withdrawal by Subject|1
5118621|NCT01741532|17682576|P2|Overall Study|Adverse Event|0
5118622|NCT01741532|17682577|P1|Overall Study|Adverse Event|4
5118623|NCT01741259|17682791|P2|Overall Study|Withdrawal by Subject|2
5118624|NCT01741259|17682792|P1|Overall Study|Withdrawal by Subject|0
5118625|NCT01741259|17682791|P2|Overall Study|Protocol Violation|4
5118626|NCT01741259|17682792|P1|Overall Study|Protocol Violation|6
5118627|NCT01741012|17682846|P1|Overall Study|Withdrawal by Subject|2
5118628|NCT01741012|17682846|P1|Overall Study|Lost to Follow-up|1
5118629|NCT01740440|17682918|P1|Overall Study|Lost to Follow-up|3
5118630|NCT01740427|17682926|P2|Overall Study|Study terminated by Sponsor|0
5118631|NCT01740427|17682927|P1|Overall Study|Study terminated by Sponsor|1
5118632|NCT01740427|17682926|P2|Overall Study|Lost to Follow-up|0
5118633|NCT01740427|17682927|P1|Overall Study|Lost to Follow-up|1
5118634|NCT01740427|17682926|P2|Overall Study|Protocol Violation|3
5118635|NCT01740427|17682927|P1|Overall Study|Protocol Violation|5
5118636|NCT01740427|17682926|P2|Overall Study|Death|2
5118637|NCT01740427|17682927|P1|Overall Study|Death|6
5118638|NCT01740427|17682926|P2|Overall Study|Unspecified reasons|4
5118639|NCT01740427|17682927|P1|Overall Study|Unspecified reasons|6
5118640|NCT01740427|17682926|P2|Overall Study|Subject refused continued treatment|9
5118641|NCT01740427|17682927|P1|Overall Study|Subject refused continued treatment|12
5118642|NCT01740427|17682926|P2|Overall Study|Global deterioration of health status|9
5118643|NCT01740427|17682927|P1|Overall Study|Global deterioration of health status|16
5118644|NCT01740427|17682926|P2|Overall Study|Adverse Event|9
5118645|NCT01740427|17682927|P1|Overall Study|Adverse Event|20
5118646|NCT01740427|17682926|P2|Overall Study|Objective progression or relapse|125
5118647|NCT01740427|17682927|P1|Overall Study|Objective progression or relapse|172
5118648|NCT01740427|17682926|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
5118649|NCT01740427|17682927|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
5118650|NCT01740401|17682979|P1|Overall Study|Did not reach primary endpoint|2
5118651|NCT01740401|17682979|P1|Overall Study|Adverse Event|2
5118652|NCT01740401|17682979|P1|Overall Study|Progression of disease|6
5118653|NCT01740388|17682988|P2|Overall Study|Subjects missing data, completed|36
5118654|NCT01740388|17682989|P1|Overall Study|Subjects missing data, completed|41
5118655|NCT01740388|17682988|P2|Overall Study|Physician Decision|6
5118656|NCT01740388|17682989|P1|Overall Study|Physician Decision|2
5118657|NCT01740388|17682988|P2|Overall Study|Lost to Follow-up|0
5118658|NCT01740388|17682989|P1|Overall Study|Lost to Follow-up|2
5118659|NCT01740388|17682988|P2|Overall Study|Withdrawal by Subject|2
5118660|NCT01740388|17682989|P1|Overall Study|Withdrawal by Subject|1
5118661|NCT01740323|17683040|P2|Overall Study|Randomized but did not take study drug|0
5118662|NCT01740323|17683041|P1|Overall Study|Randomized but did not take study drug|1
5118663|NCT01740323|17683040|P2|Overall Study|Adverse Event|0
5118664|NCT01740323|17683041|P1|Overall Study|Adverse Event|1
5118665|NCT01740297|17683062|P3|Overall Study|Sponsor Decision|0
5118666|NCT01740297|17683063|P2|Overall Study|Sponsor Decision|1
5118667|NCT01740297|17683064|P1|Overall Study|Sponsor Decision|0
5118668|NCT01740297|17683062|P3|Overall Study|Death|19
5118669|NCT01740297|17683063|P2|Overall Study|Death|23
5118670|NCT01740297|17683064|P1|Overall Study|Death|8
5118671|NCT01740297|17683062|P3|Overall Study|Withdrawal by Subject|11
5118672|NCT01740297|17683063|P2|Overall Study|Withdrawal by Subject|9
5118673|NCT01740297|17683064|P1|Overall Study|Withdrawal by Subject|1
5118674|NCT01740297|17683062|P3|Overall Study|Continuing Study|68
5118675|NCT01740297|17683063|P2|Overall Study|Continuing Study|67
5118676|NCT01740297|17683064|P1|Overall Study|Continuing Study|10
5118677|NCT01740154|17683113|P1|Overall Study|Adverse Event|1
5118678|NCT01740128|17683121|P2|Overall Study|Insufficient protocol compliance|2
5118679|NCT01740128|17683122|P1|Overall Study|Insufficient protocol compliance|2
5118680|NCT01740128|17683121|P2|Overall Study|Withdrawal by Subject|0
5118681|NCT01740128|17683122|P1|Overall Study|Withdrawal by Subject|1
5118682|NCT01740128|17683121|P2|Overall Study|Lost to Follow-up|2
5118683|NCT01740128|17683122|P1|Overall Study|Lost to Follow-up|2
5118684|NCT01740128|17683121|P2|Overall Study|Protocol Violation|2
5118685|NCT01740128|17683122|P1|Overall Study|Protocol Violation|1
5118686|NCT01740128|17683121|P2|Overall Study|Pregnancy|1
5118687|NCT01740128|17683122|P1|Overall Study|Pregnancy|0
5118688|NCT01740089|17683151|P3|After 12 Weeks|Withdrawal by Subject|1
5118689|NCT01740089|17683152|P2|After 12 Weeks|Withdrawal by Subject|1
5118690|NCT01740089|17683153|P1|After 12 Weeks|Withdrawal by Subject|1
5118691|NCT01740089|17683151|P3|After 12 Weeks|Protocol Violation|1
5118692|NCT01740089|17683152|P2|After 12 Weeks|Protocol Violation|1
5118693|NCT01740089|17683153|P1|After 12 Weeks|Protocol Violation|1
5118694|NCT01740089|17683151|P3|After 12 Weeks|Adverse Event|5
5118695|NCT01740089|17683152|P2|After 12 Weeks|Adverse Event|0
5118696|NCT01740089|17683153|P1|After 12 Weeks|Adverse Event|2
5118697|NCT01740089|17683151|P3|After 12 Weeks|Lack of Efficacy|4
5118698|NCT01740089|17683152|P2|After 12 Weeks|Lack of Efficacy|1
5118699|NCT01740089|17683153|P1|After 12 Weeks|Lack of Efficacy|3
5118700|NCT01740089|17683151|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
5118701|NCT01740089|17683152|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
5118702|NCT01740089|17683153|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
5118703|NCT01740089|17683151|P3|First 12 Weeks of Treatment|Adverse Event|2
5118704|NCT01740089|17683152|P2|First 12 Weeks of Treatment|Adverse Event|1
5118705|NCT01740089|17683153|P1|First 12 Weeks of Treatment|Adverse Event|0
5118706|NCT01739803|17683171|P2|Overall Study|Lost to Follow-up|6
5118707|NCT01739803|17683172|P1|Overall Study|Lost to Follow-up|9
5118708|NCT01739790|17683184|P2|Overall Study|Early Trial Termination|4
5118709|NCT01739790|17683185|P1|Overall Study|Early Trial Termination|2
5118710|NCT01739764|17683194|P3|Overall Study|Withdrawal by Subject|27
5118711|NCT01739764|17683195|P2|Overall Study|Withdrawal by Subject|5
5118712|NCT01739764|17683196|P1|Overall Study|Withdrawal by Subject|6
5118713|NCT01739764|17683194|P3|Overall Study|Study Terminated by Sponsor|26
5118714|NCT01739764|17683195|P2|Overall Study|Study Terminated by Sponsor|13
5118715|NCT01739764|17683196|P1|Overall Study|Study Terminated by Sponsor|8
5118716|NCT01739764|17683194|P3|Overall Study|Protocol Violation|2
5118717|NCT01739764|17683195|P2|Overall Study|Protocol Violation|0
5118718|NCT01739764|17683196|P1|Overall Study|Protocol Violation|0
5118719|NCT01739764|17683194|P3|Overall Study|Progressive Disease|16
5118720|NCT01739764|17683195|P2|Overall Study|Progressive Disease|5
5118721|NCT01739764|17683196|P1|Overall Study|Progressive Disease|3
5118722|NCT01739764|17683194|P3|Overall Study|Physician Decision|4
5118723|NCT01739764|17683195|P2|Overall Study|Physician Decision|2
5118724|NCT01739764|17683196|P1|Overall Study|Physician Decision|2
5118725|NCT01739764|17683194|P3|Overall Study|Multiple Reasons|3
5118726|NCT01739764|17683195|P2|Overall Study|Multiple Reasons|2
5118727|NCT01739764|17683196|P1|Overall Study|Multiple Reasons|3
5118728|NCT01739764|17683194|P3|Overall Study|Non-Compliance|1
5118729|NCT01739764|17683195|P2|Overall Study|Non-Compliance|0
5118730|NCT01739764|17683196|P1|Overall Study|Non-Compliance|0
5118731|NCT01739764|17683194|P3|Overall Study|Lost to Follow-up|5
5118732|NCT01739764|17683195|P2|Overall Study|Lost to Follow-up|0
5118733|NCT01739764|17683196|P1|Overall Study|Lost to Follow-up|0
5118734|NCT01739764|17683194|P3|Overall Study|Death|38
5118735|NCT01739764|17683195|P2|Overall Study|Death|6
5118736|NCT01739764|17683196|P1|Overall Study|Death|4
5118737|NCT01739764|17683194|P3|Overall Study|Adverse Event|4
5118738|NCT01739764|17683195|P2|Overall Study|Adverse Event|3
5118739|NCT01739764|17683196|P1|Overall Study|Adverse Event|0
5118740|NCT01739595|17683210|P3|Overall Study|Drug discrepancy|0
5118741|NCT01739595|17683211|P2|Overall Study|Drug discrepancy|0
5118742|NCT01739595|17683212|P1|Overall Study|Drug discrepancy|1
5118743|NCT01739595|17683210|P3|Overall Study|Lab assessment|0
5118744|NCT01739595|17683211|P2|Overall Study|Lab assessment|0
5118745|NCT01739595|17683212|P1|Overall Study|Lab assessment|1
5118746|NCT01739595|17683210|P3|Overall Study|Protocol Violation|0
5118747|NCT01739595|17683211|P2|Overall Study|Protocol Violation|0
5118748|NCT01739595|17683212|P1|Overall Study|Protocol Violation|1
5118749|NCT01739595|17683210|P3|Overall Study|Eligibility issue|0
5118750|NCT01739595|17683211|P2|Overall Study|Eligibility issue|0
5118751|NCT01739595|17683212|P1|Overall Study|Eligibility issue|3
5118752|NCT01739595|17683210|P3|Overall Study|Withdrawal by Subject|2
5118753|NCT01739595|17683211|P2|Overall Study|Withdrawal by Subject|1
5118754|NCT01739595|17683212|P1|Overall Study|Withdrawal by Subject|2
5118755|NCT01739595|17683210|P3|Overall Study|Lost to Follow-up|0
5118756|NCT01739595|17683211|P2|Overall Study|Lost to Follow-up|0
5118757|NCT01739595|17683212|P1|Overall Study|Lost to Follow-up|2
5118758|NCT01739595|17683210|P3|Overall Study|Adverse Event|0
5118759|NCT01739595|17683211|P2|Overall Study|Adverse Event|0
5118760|NCT01739595|17683212|P1|Overall Study|Adverse Event|3
5118761|NCT01739400|17683222|P2|Overall Study|Withdrawal by Subject|7
5118762|NCT01739400|17683223|P1|Overall Study|Withdrawal by Subject|7
5118763|NCT01739400|17683222|P2|Overall Study|Death|2
5118764|NCT01739400|17683223|P1|Overall Study|Death|5
5118765|NCT01739400|17683222|P2|Overall Study|Lost to Follow-up|0
5118766|NCT01739400|17683223|P1|Overall Study|Lost to Follow-up|2
5118767|NCT01739400|17683222|P2|Overall Study|Physician Decision|0
5118768|NCT01739400|17683223|P1|Overall Study|Physician Decision|3
5118769|NCT01739348|17683251|P4|Part II (Extension Study)|Withdrawal by Subject|7
5118770|NCT01739348|17683252|P3|Part II (Extension Study)|Withdrawal by Subject|4
5118771|NCT01739348|17683253|P2|Part II (Extension Study)|Withdrawal by Subject|2
5118772|NCT01739348|17683254|P1|Part II (Extension Study)|Withdrawal by Subject|5
5118773|NCT01739348|17683251|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
5118774|NCT01739348|17683252|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
5118775|NCT01739348|17683253|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
5118776|NCT01739348|17683254|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
5118777|NCT01739348|17683251|P4|Part II (Extension Study)|Participant Moved|3
5118778|NCT01739348|17683252|P3|Part II (Extension Study)|Participant Moved|0
5118779|NCT01739348|17683253|P2|Part II (Extension Study)|Participant Moved|3
5118780|NCT01739348|17683254|P1|Part II (Extension Study)|Participant Moved|3
5118781|NCT01739348|17683251|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
5118782|NCT01739348|17683252|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
5118783|NCT01739348|17683253|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
5118784|NCT01739348|17683254|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
5118785|NCT01739348|17683251|P4|Part II (Extension Study)|Physician Decision|12
5118786|NCT01739348|17683252|P3|Part II (Extension Study)|Physician Decision|6
5118787|NCT01739348|17683253|P2|Part II (Extension Study)|Physician Decision|11
5118788|NCT01739348|17683254|P1|Part II (Extension Study)|Physician Decision|7
5118789|NCT01739348|17683251|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
5118790|NCT01739348|17683252|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
5118791|NCT01739348|17683253|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
5118792|NCT01739348|17683254|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
5118793|NCT01739348|17683251|P4|Part II (Extension Study)|Lost to Follow-up|1
5118794|NCT01739348|17683252|P3|Part II (Extension Study)|Lost to Follow-up|0
5118795|NCT01739348|17683253|P2|Part II (Extension Study)|Lost to Follow-up|4
5118796|NCT01739348|17683254|P1|Part II (Extension Study)|Lost to Follow-up|3
5118797|NCT01739348|17683251|P4|Part II (Extension Study)|Lack of Efficacy|1
5118798|NCT01739348|17683252|P3|Part II (Extension Study)|Lack of Efficacy|0
5118799|NCT01739348|17683253|P2|Part II (Extension Study)|Lack of Efficacy|5
5118800|NCT01739348|17683254|P1|Part II (Extension Study)|Lack of Efficacy|1
5118801|NCT01739348|17683251|P4|Part II (Extension Study)|Death|6
5118802|NCT01739348|17683252|P3|Part II (Extension Study)|Death|2
5118803|NCT01739348|17683253|P2|Part II (Extension Study)|Death|3
5118804|NCT01739348|17683254|P1|Part II (Extension Study)|Death|3
5118805|NCT01739348|17683251|P4|Part II (Extension Study)|Adverse Event|26
5118806|NCT01739348|17683252|P3|Part II (Extension Study)|Adverse Event|7
5118807|NCT01739348|17683253|P2|Part II (Extension Study)|Adverse Event|11
5118808|NCT01739348|17683254|P1|Part II (Extension Study)|Adverse Event|10
5118809|NCT01739348|17683251|P4|Part I (Base Study)|Withdrawal by Subject|20
5118810|NCT01739348|17683252|P3|Part I (Base Study)|Withdrawal by Subject|7
5118811|NCT01739348|17683253|P2|Part I (Base Study)|Withdrawal by Subject|21
5118812|NCT01739348|17683254|P1|Part I (Base Study)|Withdrawal by Subject|23
5118813|NCT01739348|17683251|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
5118814|NCT01739348|17683252|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
5118815|NCT01739348|17683253|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
5118816|NCT01739348|17683254|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
5118817|NCT01739348|17683251|P4|Part I (Base Study)|Participant Moved|7
5118818|NCT01739348|17683252|P3|Part I (Base Study)|Participant Moved|1
5118819|NCT01739348|17683253|P2|Part I (Base Study)|Participant Moved|3
5118820|NCT01739348|17683254|P1|Part I (Base Study)|Participant Moved|4
5118821|NCT01739348|17683251|P4|Part I (Base Study)|Study Terminated by Sponsor|86
5118822|NCT01739348|17683252|P3|Part I (Base Study)|Study Terminated by Sponsor|0
5118823|NCT01739348|17683253|P2|Part I (Base Study)|Study Terminated by Sponsor|73
5118824|NCT01739348|17683254|P1|Part I (Base Study)|Study Terminated by Sponsor|72
5118825|NCT01739348|17683251|P4|Part I (Base Study)|Site Discontinued Study Participation|0
5118826|NCT01739348|17683252|P3|Part I (Base Study)|Site Discontinued Study Participation|0
5118827|NCT01739348|17683253|P2|Part I (Base Study)|Site Discontinued Study Participation|3
5118828|NCT01739348|17683254|P1|Part I (Base Study)|Site Discontinued Study Participation|1
5118829|NCT01739348|17683251|P4|Part I (Base Study)|Screen Failure|0
5118830|NCT01739348|17683252|P3|Part I (Base Study)|Screen Failure|0
5118831|NCT01739348|17683253|P2|Part I (Base Study)|Screen Failure|0
5118832|NCT01739348|17683254|P1|Part I (Base Study)|Screen Failure|2
5118833|NCT01739348|17683251|P4|Part I (Base Study)|Protocol Violation|2
5118834|NCT01739348|17683252|P3|Part I (Base Study)|Protocol Violation|1
5118835|NCT01739348|17683253|P2|Part I (Base Study)|Protocol Violation|0
5118836|NCT01739348|17683254|P1|Part I (Base Study)|Protocol Violation|2
5118837|NCT01739348|17683251|P4|Part I (Base Study)|Physician Decision|4
5118838|NCT01739348|17683252|P3|Part I (Base Study)|Physician Decision|1
5118839|NCT01739348|17683253|P2|Part I (Base Study)|Physician Decision|7
5118840|NCT01739348|17683254|P1|Part I (Base Study)|Physician Decision|10
5118841|NCT01739348|17683251|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
5118842|NCT01739348|17683252|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
5118843|NCT01739348|17683253|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
5118844|NCT01739348|17683254|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
5118845|NCT01739348|17683251|P4|Part I (Base Study)|Lost to Follow-up|4
5118846|NCT01739348|17683252|P3|Part I (Base Study)|Lost to Follow-up|4
5118847|NCT01739348|17683253|P2|Part I (Base Study)|Lost to Follow-up|2
5118848|NCT01739348|17683254|P1|Part I (Base Study)|Lost to Follow-up|4
5118849|NCT01739348|17683251|P4|Part I (Base Study)|Lack of Efficacy|7
5118850|NCT01739348|17683252|P3|Part I (Base Study)|Lack of Efficacy|0
5118851|NCT01739348|17683253|P2|Part I (Base Study)|Lack of Efficacy|8
5118852|NCT01739348|17683254|P1|Part I (Base Study)|Lack of Efficacy|3
5118853|NCT01739348|17683251|P4|Part I (Base Study)|Death|8
5118854|NCT01739348|17683252|P3|Part I (Base Study)|Death|2
5118855|NCT01739348|17683253|P2|Part I (Base Study)|Death|7
5118856|NCT01739348|17683254|P1|Part I (Base Study)|Death|10
5118857|NCT01739348|17683251|P4|Part I (Base Study)|Adverse Event|33
5118858|NCT01739348|17683252|P3|Part I (Base Study)|Adverse Event|8
5118859|NCT01739348|17683253|P2|Part I (Base Study)|Adverse Event|52
5118860|NCT01739348|17683254|P1|Part I (Base Study)|Adverse Event|41
5118861|NCT01739335|17683326|P2|Overall Study|Ineligible patient randomized|1
5118862|NCT01739335|17683327|P1|Overall Study|Ineligible patient randomized|0
5118863|NCT01739335|17683326|P2|Overall Study|Lost to Follow-up|4
5118864|NCT01739335|17683327|P1|Overall Study|Lost to Follow-up|7
5118865|NCT01739309|17683359|P1|Overall Study|On study treatment|3
5118866|NCT01738984|17683554|P2|Overall Study|Lost to Follow-up|39
5118867|NCT01738984|17683555|P1|Overall Study|Lost to Follow-up|59
5118868|NCT01738984|17683554|P2|Overall Study|Withdrawal by Subject|0
5118869|NCT01738984|17683555|P1|Overall Study|Withdrawal by Subject|1
5118870|NCT01738984|17683554|P2|Overall Study|Pregnancy|0
5118871|NCT01738984|17683555|P1|Overall Study|Pregnancy|4
5118872|NCT01738971|17683568|P3|Overall Study|Lost to Follow-up|17
5118873|NCT01738971|17683569|P2|Overall Study|Lost to Follow-up|30
5118874|NCT01738971|17683570|P1|Overall Study|Lost to Follow-up|19
5118875|NCT01738919|17683586|P2|Overall Study|Not treated in accordance to guidelines|1
5118876|NCT01738919|17683587|P1|Overall Study|Not treated in accordance to guidelines|0
5118877|NCT01738919|17683586|P2|Overall Study|Withdrawal by Subject|1
5118878|NCT01738919|17683587|P1|Overall Study|Withdrawal by Subject|0
5118879|NCT01738919|17683586|P2|Overall Study|Immigrated|1
5118880|NCT01738919|17683587|P1|Overall Study|Immigrated|0
5118881|NCT01738919|17683586|P2|Overall Study|Lost to Follow-up|0
5118882|NCT01738919|17683587|P1|Overall Study|Lost to Follow-up|1
5118883|NCT01738646|17683737|P1|Overall Study|Still Receiving Treatment|2
5118884|NCT01738594|17683748|P8|Follow up for 1 Year|Other|0
5118885|NCT01738594|17683749|P7|Follow up for 1 Year|Other|0
5118886|NCT01738594|17683750|P6|Follow up for 1 Year|Other|2
5118887|NCT01738594|17683751|P5|Follow up for 1 Year|Other|0
5118888|NCT01738594|17683752|P4|Follow up for 1 Year|Other|0
5118889|NCT01738594|17683753|P3|Follow up for 1 Year|Other|0
5118890|NCT01738594|17683754|P2|Follow up for 1 Year|Other|0
5118891|NCT01738594|17683755|P1|Follow up for 1 Year|Other|0
5118892|NCT01738594|17683748|P8|Follow up for 1 Year|Death|0
5118893|NCT01738594|17683749|P7|Follow up for 1 Year|Death|0
5118894|NCT01738594|17683750|P6|Follow up for 1 Year|Death|1
5118895|NCT01738594|17683751|P5|Follow up for 1 Year|Death|0
5118896|NCT01738594|17683752|P4|Follow up for 1 Year|Death|0
5118897|NCT01738594|17683753|P3|Follow up for 1 Year|Death|0
5118898|NCT01738594|17683754|P2|Follow up for 1 Year|Death|0
5118899|NCT01738594|17683755|P1|Follow up for 1 Year|Death|0
5118900|NCT01738594|17683748|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118901|NCT01738594|17683749|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118902|NCT01738594|17683750|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118903|NCT01738594|17683751|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
5118904|NCT01738594|17683752|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118905|NCT01738594|17683753|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118906|NCT01738594|17683754|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118907|NCT01738594|17683755|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5118908|NCT01738594|17683748|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118909|NCT01738594|17683749|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118910|NCT01738594|17683750|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
5118911|NCT01738594|17683751|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118912|NCT01738594|17683752|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118913|NCT01738594|17683753|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118914|NCT01738594|17683754|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118915|NCT01738594|17683755|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5118916|NCT01738594|17683748|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118917|NCT01738594|17683749|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118918|NCT01738594|17683750|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
5118919|NCT01738594|17683751|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118920|NCT01738594|17683752|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118921|NCT01738594|17683753|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118922|NCT01738594|17683754|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118923|NCT01738594|17683755|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
5118924|NCT01738594|17683748|P8|Completed 4 Cycles of Treatment|Progressive disease|0
5118925|NCT01738594|17683749|P7|Completed 4 Cycles of Treatment|Progressive disease|0
5118926|NCT01738594|17683750|P6|Completed 4 Cycles of Treatment|Progressive disease|0
5118927|NCT01738594|17683751|P5|Completed 4 Cycles of Treatment|Progressive disease|0
5118928|NCT01738594|17683752|P4|Completed 4 Cycles of Treatment|Progressive disease|0
5118929|NCT01738594|17683753|P3|Completed 4 Cycles of Treatment|Progressive disease|0
5118930|NCT01738594|17683754|P2|Completed 4 Cycles of Treatment|Progressive disease|2
5118931|NCT01738594|17683755|P1|Completed 4 Cycles of Treatment|Progressive disease|0
5118932|NCT01738594|17683748|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118933|NCT01738594|17683749|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118934|NCT01738594|17683750|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
5118935|NCT01738594|17683751|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118936|NCT01738594|17683752|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118937|NCT01738594|17683753|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118938|NCT01738594|17683754|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118939|NCT01738594|17683755|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5118940|NCT01738594|17683748|P8|Registration and Treatment Start|Adverse Event|0
5118941|NCT01738594|17683749|P7|Registration and Treatment Start|Adverse Event|0
5118942|NCT01738594|17683750|P6|Registration and Treatment Start|Adverse Event|0
5118943|NCT01738594|17683751|P5|Registration and Treatment Start|Adverse Event|0
5118944|NCT01738594|17683752|P4|Registration and Treatment Start|Adverse Event|0
5118945|NCT01738594|17683753|P3|Registration and Treatment Start|Adverse Event|0
5118946|NCT01738594|17683754|P2|Registration and Treatment Start|Adverse Event|1
5118947|NCT01738594|17683755|P1|Registration and Treatment Start|Adverse Event|0
5118948|NCT01738581|17683773|P2|Overall Study|Lost to Follow-up|0
5118949|NCT01738581|17683774|P1|Overall Study|Lost to Follow-up|1
5118950|NCT01738503|17683798|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
5118951|NCT01738503|17683799|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
5118952|NCT01738503|17683800|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5118953|NCT01738503|17683801|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5118954|NCT01738503|17683802|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5118955|NCT01738503|17683803|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5118956|NCT01738503|17683804|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5118957|NCT01738503|17683798|P7|PET Imaging Sub-study|Adverse Event|0
5118958|NCT01738503|17683799|P6|PET Imaging Sub-study|Adverse Event|1
5118959|NCT01738503|17683800|P5|PET Imaging Sub-study|Adverse Event|0
5118960|NCT01738503|17683801|P4|PET Imaging Sub-study|Adverse Event|0
5118961|NCT01738503|17683802|P3|PET Imaging Sub-study|Adverse Event|0
5118962|NCT01738503|17683803|P2|PET Imaging Sub-study|Adverse Event|0
5118963|NCT01738503|17683804|P1|PET Imaging Sub-study|Adverse Event|0
5118964|NCT01738503|17683798|P7|Treatment Period|Other|0
5118965|NCT01738503|17683799|P6|Treatment Period|Other|0
5118966|NCT01738503|17683800|P5|Treatment Period|Other|0
5118967|NCT01738503|17683801|P4|Treatment Period|Other|0
5118968|NCT01738503|17683802|P3|Treatment Period|Other|1
5118969|NCT01738503|17683803|P2|Treatment Period|Other|0
5118970|NCT01738503|17683804|P1|Treatment Period|Other|0
5118971|NCT01738503|17683798|P7|Treatment Period|Protocol Violation|0
5118972|NCT01738503|17683799|P6|Treatment Period|Protocol Violation|2
5118973|NCT01738503|17683800|P5|Treatment Period|Protocol Violation|4
5118974|NCT01738503|17683801|P4|Treatment Period|Protocol Violation|0
5118975|NCT01738503|17683802|P3|Treatment Period|Protocol Violation|1
5118976|NCT01738503|17683803|P2|Treatment Period|Protocol Violation|3
5118977|NCT01738503|17683804|P1|Treatment Period|Protocol Violation|0
5118978|NCT01738503|17683798|P7|Treatment Period|Withdrawal by Subject|1
5118979|NCT01738503|17683799|P6|Treatment Period|Withdrawal by Subject|1
5118980|NCT01738503|17683800|P5|Treatment Period|Withdrawal by Subject|1
5118981|NCT01738503|17683801|P4|Treatment Period|Withdrawal by Subject|1
5118982|NCT01738503|17683802|P3|Treatment Period|Withdrawal by Subject|0
5118983|NCT01738503|17683803|P2|Treatment Period|Withdrawal by Subject|1
5118984|NCT01738503|17683804|P1|Treatment Period|Withdrawal by Subject|0
5118985|NCT01738503|17683798|P7|Treatment Period|Lost to Follow-up|5
5118986|NCT01738503|17683799|P6|Treatment Period|Lost to Follow-up|1
5118987|NCT01738503|17683800|P5|Treatment Period|Lost to Follow-up|1
5118988|NCT01738503|17683801|P4|Treatment Period|Lost to Follow-up|4
5118989|NCT01738503|17683802|P3|Treatment Period|Lost to Follow-up|3
5118990|NCT01738503|17683803|P2|Treatment Period|Lost to Follow-up|0
5118991|NCT01738503|17683804|P1|Treatment Period|Lost to Follow-up|0
5118992|NCT01738503|17683798|P7|Treatment Period|Adverse Event|2
5118993|NCT01738503|17683799|P6|Treatment Period|Adverse Event|2
5118994|NCT01738503|17683800|P5|Treatment Period|Adverse Event|2
5118995|NCT01738503|17683801|P4|Treatment Period|Adverse Event|1
5118996|NCT01738503|17683802|P3|Treatment Period|Adverse Event|0
5118997|NCT01738503|17683803|P2|Treatment Period|Adverse Event|1
5118998|NCT01738503|17683804|P1|Treatment Period|Adverse Event|0
5118999|NCT01738503|17683798|P7|Induction/Stabilization (Days -14 to -1)|Other|0
5119000|NCT01738503|17683799|P6|Induction/Stabilization (Days -14 to -1)|Other|0
5119001|NCT01738503|17683800|P5|Induction/Stabilization (Days -14 to -1)|Other|0
5119002|NCT01738503|17683801|P4|Induction/Stabilization (Days -14 to -1)|Other|0
5119003|NCT01738503|17683802|P3|Induction/Stabilization (Days -14 to -1)|Other|0
5119004|NCT01738503|17683803|P2|Induction/Stabilization (Days -14 to -1)|Other|0
5119005|NCT01738503|17683804|P1|Induction/Stabilization (Days -14 to -1)|Other|35
5119006|NCT01738477|17684002|P2|Overall Study|Lost to Follow-up|4
5119007|NCT01738477|17684003|P1|Overall Study|Lost to Follow-up|1
5119008|NCT01738438|17684031|P1|Overall Study|Adverse Event|3
5119009|NCT01738438|17684031|P1|Overall Study|Disease Progression|32
5119010|NCT01738191|17684048|P2|Overall Study|Withdrawal by Subject|1
5119011|NCT01738191|17684049|P1|Overall Study|Withdrawal by Subject|4
5119012|NCT01737996|17684072|P3|Overall Study|Withdrawal by Subject|1
5119013|NCT01737996|17684073|P2|Overall Study|Withdrawal by Subject|0
5119014|NCT01737996|17684074|P1|Overall Study|Withdrawal by Subject|0
5119015|NCT01737996|17684072|P3|Overall Study|Adverse Event|1
5119016|NCT01737996|17684073|P2|Overall Study|Adverse Event|1
5119017|NCT01737996|17684074|P1|Overall Study|Adverse Event|0
5119018|NCT01737931|17684136|P3|Overall Study|Physician Decision|0
5119019|NCT01737931|17684137|P2|Overall Study|Physician Decision|1
5119020|NCT01737931|17684138|P1|Overall Study|Physician Decision|0
5119021|NCT01737931|17684136|P3|Overall Study|Withdrawal by Subject|1
5119022|NCT01737931|17684137|P2|Overall Study|Withdrawal by Subject|1
5119023|NCT01737931|17684138|P1|Overall Study|Withdrawal by Subject|0
5119024|NCT01737879|17684153|P1|Overall Study|Sponsor decision|40
5119025|NCT01737879|17684153|P1|Overall Study|Death|1
5119026|NCT01737840|17684162|P2|Overall Study|Diagnosed with an other pathology|2
5119027|NCT01737840|17684163|P1|Overall Study|Diagnosed with an other pathology|2
5119028|NCT01737762|17684173|P2|Overall Study|Trial termination|9
5119029|NCT01737762|17684174|P1|Overall Study|Trial termination|11
5119030|NCT01737762|17684173|P2|Overall Study|Moved from area|1
5119031|NCT01737762|17684174|P1|Overall Study|Moved from area|2
5119032|NCT01737762|17684173|P2|Overall Study|Physician Decision|1
5119033|NCT01737762|17684174|P1|Overall Study|Physician Decision|1
5119034|NCT01737762|17684173|P2|Overall Study|Progressive disease|2
5119035|NCT01737762|17684174|P1|Overall Study|Progressive disease|1
5119036|NCT01737762|17684173|P2|Overall Study|Withdrawal by Subject|2
5119037|NCT01737762|17684174|P1|Overall Study|Withdrawal by Subject|2
5119038|NCT01737762|17684173|P2|Overall Study|Lost to Follow-up|0
5119039|NCT01737762|17684174|P1|Overall Study|Lost to Follow-up|1
5119040|NCT01737762|17684173|P2|Overall Study|Adverse Event|2
5119041|NCT01737762|17684174|P1|Overall Study|Adverse Event|2
5119042|NCT01737710|17684187|P5|Overall Study|Vaccinated in Error/Ineligible|0
5119043|NCT01737710|17684188|P4|Overall Study|Vaccinated in Error/Ineligible|0
5119044|NCT01737710|17684189|P3|Overall Study|Vaccinated in Error/Ineligible|0
5119045|NCT01737710|17684190|P2|Overall Study|Vaccinated in Error/Ineligible|1
5119046|NCT01737710|17684191|P1|Overall Study|Vaccinated in Error/Ineligible|1
5119047|NCT01737710|17684187|P5|Overall Study|Withdrawal by Subject|0
5119048|NCT01737710|17684188|P4|Overall Study|Withdrawal by Subject|0
5119049|NCT01737710|17684189|P3|Overall Study|Withdrawal by Subject|1
5119050|NCT01737710|17684190|P2|Overall Study|Withdrawal by Subject|1
5119051|NCT01737710|17684191|P1|Overall Study|Withdrawal by Subject|1
5119052|NCT01737710|17684187|P5|Overall Study|Lost to Follow-up|0
5119053|NCT01737710|17684188|P4|Overall Study|Lost to Follow-up|0
5119054|NCT01737710|17684189|P3|Overall Study|Lost to Follow-up|2
5119055|NCT01737710|17684190|P2|Overall Study|Lost to Follow-up|2
5119056|NCT01737710|17684191|P1|Overall Study|Lost to Follow-up|0
5119057|NCT01737697|17684233|P15|Subacute Phase|Death|0
5119058|NCT01737697|17684234|P14|Subacute Phase|Death|0
5119059|NCT01737697|17684235|P13|Subacute Phase|Death|0
5119060|NCT01737697|17684236|P12|Subacute Phase|Death|0
5119061|NCT01737697|17684237|P11|Subacute Phase|Death|1
5119062|NCT01737697|17684238|P10|Subacute Phase|Death|0
5119063|NCT01737697|17684239|P9|Subacute Phase|Death|0
5119064|NCT01737697|17684240|P8|Subacute Phase|Death|0
5119065|NCT01737697|17684241|P7|Subacute Phase|Death|0
5119066|NCT01737697|17684242|P6|Subacute Phase|Death|0
5119067|NCT01737697|17684243|P5|Subacute Phase|Death|0
5119068|NCT01737697|17684244|P4|Subacute Phase|Death|0
5119069|NCT01737697|17684245|P3|Subacute Phase|Death|0
5119070|NCT01737697|17684246|P2|Subacute Phase|Death|0
5119071|NCT01737697|17684247|P1|Subacute Phase|Death|0
5119072|NCT01737697|17684233|P15|Subacute Phase|Physician Decision|0
5119073|NCT01737697|17684234|P14|Subacute Phase|Physician Decision|0
5119074|NCT01737697|17684235|P13|Subacute Phase|Physician Decision|0
5119075|NCT01737697|17684236|P12|Subacute Phase|Physician Decision|0
5119076|NCT01737697|17684237|P11|Subacute Phase|Physician Decision|0
5119077|NCT01737697|17684238|P10|Subacute Phase|Physician Decision|0
5119078|NCT01737697|17684239|P9|Subacute Phase|Physician Decision|1
5119079|NCT01737697|17684240|P8|Subacute Phase|Physician Decision|0
5119080|NCT01737697|17684241|P7|Subacute Phase|Physician Decision|0
5119081|NCT01737697|17684242|P6|Subacute Phase|Physician Decision|0
5119082|NCT01737697|17684243|P5|Subacute Phase|Physician Decision|0
5119083|NCT01737697|17684244|P4|Subacute Phase|Physician Decision|0
5119084|NCT01737697|17684245|P3|Subacute Phase|Physician Decision|0
5119085|NCT01737697|17684246|P2|Subacute Phase|Physician Decision|0
5119086|NCT01737697|17684247|P1|Subacute Phase|Physician Decision|0
5119087|NCT01737697|17684233|P15|Subacute Phase|Protocol Violation|0
5119088|NCT01737697|17684234|P14|Subacute Phase|Protocol Violation|0
5119089|NCT01737697|17684235|P13|Subacute Phase|Protocol Violation|0
5119090|NCT01737697|17684236|P12|Subacute Phase|Protocol Violation|0
5119091|NCT01737697|17684237|P11|Subacute Phase|Protocol Violation|1
5119092|NCT01737697|17684238|P10|Subacute Phase|Protocol Violation|0
5119093|NCT01737697|17684239|P9|Subacute Phase|Protocol Violation|0
5119094|NCT01737697|17684240|P8|Subacute Phase|Protocol Violation|0
5119095|NCT01737697|17684241|P7|Subacute Phase|Protocol Violation|0
5119096|NCT01737697|17684242|P6|Subacute Phase|Protocol Violation|1
5119097|NCT01737697|17684243|P5|Subacute Phase|Protocol Violation|0
5119098|NCT01737697|17684244|P4|Subacute Phase|Protocol Violation|0
5119099|NCT01737697|17684245|P3|Subacute Phase|Protocol Violation|0
5119100|NCT01737697|17684246|P2|Subacute Phase|Protocol Violation|0
5119101|NCT01737697|17684247|P1|Subacute Phase|Protocol Violation|0
5119102|NCT01737697|17684233|P15|Subacute Phase|Hypo-or hyperkalemia|0
5119103|NCT01737697|17684234|P14|Subacute Phase|Hypo-or hyperkalemia|1
5119104|NCT01737697|17684235|P13|Subacute Phase|Hypo-or hyperkalemia|0
5119105|NCT01737697|17684236|P12|Subacute Phase|Hypo-or hyperkalemia|1
5119106|NCT01737697|17684237|P11|Subacute Phase|Hypo-or hyperkalemia|0
5119107|NCT01737697|17684238|P10|Subacute Phase|Hypo-or hyperkalemia|0
5119108|NCT01737697|17684239|P9|Subacute Phase|Hypo-or hyperkalemia|0
5119109|NCT01737697|17684240|P8|Subacute Phase|Hypo-or hyperkalemia|0
5119110|NCT01737697|17684241|P7|Subacute Phase|Hypo-or hyperkalemia|0
5119111|NCT01737697|17684242|P6|Subacute Phase|Hypo-or hyperkalemia|0
5119112|NCT01737697|17684243|P5|Subacute Phase|Hypo-or hyperkalemia|0
5119113|NCT01737697|17684244|P4|Subacute Phase|Hypo-or hyperkalemia|0
5119114|NCT01737697|17684245|P3|Subacute Phase|Hypo-or hyperkalemia|0
5119115|NCT01737697|17684246|P2|Subacute Phase|Hypo-or hyperkalemia|0
5119116|NCT01737697|17684247|P1|Subacute Phase|Hypo-or hyperkalemia|0
5119117|NCT01737697|17684233|P15|Subacute Phase|Lost to Follow-up|1
5119118|NCT01737697|17684234|P14|Subacute Phase|Lost to Follow-up|0
5119119|NCT01737697|17684235|P13|Subacute Phase|Lost to Follow-up|0
5119120|NCT01737697|17684236|P12|Subacute Phase|Lost to Follow-up|0
5119121|NCT01737697|17684237|P11|Subacute Phase|Lost to Follow-up|0
5119122|NCT01737697|17684238|P10|Subacute Phase|Lost to Follow-up|0
5119123|NCT01737697|17684239|P9|Subacute Phase|Lost to Follow-up|0
5119124|NCT01737697|17684240|P8|Subacute Phase|Lost to Follow-up|0
5119125|NCT01737697|17684241|P7|Subacute Phase|Lost to Follow-up|0
5119126|NCT01737697|17684242|P6|Subacute Phase|Lost to Follow-up|0
5119127|NCT01737697|17684243|P5|Subacute Phase|Lost to Follow-up|0
5119128|NCT01737697|17684244|P4|Subacute Phase|Lost to Follow-up|0
5119129|NCT01737697|17684245|P3|Subacute Phase|Lost to Follow-up|0
5119130|NCT01737697|17684246|P2|Subacute Phase|Lost to Follow-up|0
5119131|NCT01737697|17684247|P1|Subacute Phase|Lost to Follow-up|0
5119132|NCT01737697|17684233|P15|Subacute Phase|Withdrawal by Subject|0
5119133|NCT01737697|17684234|P14|Subacute Phase|Withdrawal by Subject|1
5119134|NCT01737697|17684235|P13|Subacute Phase|Withdrawal by Subject|1
5119135|NCT01737697|17684236|P12|Subacute Phase|Withdrawal by Subject|1
5119136|NCT01737697|17684237|P11|Subacute Phase|Withdrawal by Subject|0
5119137|NCT01737697|17684238|P10|Subacute Phase|Withdrawal by Subject|1
5119138|NCT01737697|17684239|P9|Subacute Phase|Withdrawal by Subject|0
5119139|NCT01737697|17684240|P8|Subacute Phase|Withdrawal by Subject|2
5119140|NCT01737697|17684241|P7|Subacute Phase|Withdrawal by Subject|0
5119141|NCT01737697|17684242|P6|Subacute Phase|Withdrawal by Subject|1
5119142|NCT01737697|17684243|P5|Subacute Phase|Withdrawal by Subject|0
5119143|NCT01737697|17684244|P4|Subacute Phase|Withdrawal by Subject|0
5119144|NCT01737697|17684245|P3|Subacute Phase|Withdrawal by Subject|0
5119145|NCT01737697|17684246|P2|Subacute Phase|Withdrawal by Subject|0
5119146|NCT01737697|17684247|P1|Subacute Phase|Withdrawal by Subject|0
5119147|NCT01737697|17684233|P15|Subacute Phase|Adverse Event|0
5119148|NCT01737697|17684234|P14|Subacute Phase|Adverse Event|0
5119149|NCT01737697|17684235|P13|Subacute Phase|Adverse Event|1
5119150|NCT01737697|17684236|P12|Subacute Phase|Adverse Event|1
5119151|NCT01737697|17684237|P11|Subacute Phase|Adverse Event|4
5119152|NCT01737697|17684238|P10|Subacute Phase|Adverse Event|1
5119153|NCT01737697|17684239|P9|Subacute Phase|Adverse Event|1
5119154|NCT01737697|17684240|P8|Subacute Phase|Adverse Event|1
5119155|NCT01737697|17684241|P7|Subacute Phase|Adverse Event|1
5119156|NCT01737697|17684242|P6|Subacute Phase|Adverse Event|1
5119157|NCT01737697|17684243|P5|Subacute Phase|Adverse Event|0
5119158|NCT01737697|17684244|P4|Subacute Phase|Adverse Event|0
5119159|NCT01737697|17684245|P3|Subacute Phase|Adverse Event|0
5119160|NCT01737697|17684246|P2|Subacute Phase|Adverse Event|0
5119161|NCT01737697|17684247|P1|Subacute Phase|Adverse Event|0
5119162|NCT01737697|17684233|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119163|NCT01737697|17684234|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119164|NCT01737697|17684235|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119165|NCT01737697|17684236|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119166|NCT01737697|17684237|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119167|NCT01737697|17684238|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119168|NCT01737697|17684239|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119169|NCT01737697|17684240|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119170|NCT01737697|17684241|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119171|NCT01737697|17684242|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119172|NCT01737697|17684243|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5119173|NCT01737697|17684244|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
5119174|NCT01737697|17684245|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5119175|NCT01737697|17684246|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5119176|NCT01737697|17684247|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5119177|NCT01737697|17684233|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119178|NCT01737697|17684234|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119179|NCT01737697|17684235|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119180|NCT01737697|17684236|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119181|NCT01737697|17684237|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119182|NCT01737697|17684238|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119183|NCT01737697|17684239|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119184|NCT01737697|17684240|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119185|NCT01737697|17684241|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119186|NCT01737697|17684242|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119187|NCT01737697|17684243|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
5119188|NCT01737697|17684244|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119189|NCT01737697|17684245|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119190|NCT01737697|17684246|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119191|NCT01737697|17684247|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5119192|NCT01737697|17684233|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119193|NCT01737697|17684234|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119194|NCT01737697|17684235|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119195|NCT01737697|17684236|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119196|NCT01737697|17684237|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119197|NCT01737697|17684238|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119198|NCT01737697|17684239|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119199|NCT01737697|17684240|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119200|NCT01737697|17684241|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119201|NCT01737697|17684242|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119202|NCT01737697|17684243|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119203|NCT01737697|17684244|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119204|NCT01737697|17684245|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119205|NCT01737697|17684246|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
5119206|NCT01737697|17684247|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5119207|NCT01737697|17684233|P15|Acute Phase-Initial 48 Hours|Family emergency|0
5119208|NCT01737697|17684234|P14|Acute Phase-Initial 48 Hours|Family emergency|0
5119209|NCT01737697|17684235|P13|Acute Phase-Initial 48 Hours|Family emergency|0
5119210|NCT01737697|17684236|P12|Acute Phase-Initial 48 Hours|Family emergency|0
5119211|NCT01737697|17684237|P11|Acute Phase-Initial 48 Hours|Family emergency|0
5119212|NCT01737697|17684238|P10|Acute Phase-Initial 48 Hours|Family emergency|0
5119213|NCT01737697|17684239|P9|Acute Phase-Initial 48 Hours|Family emergency|0
5119214|NCT01737697|17684240|P8|Acute Phase-Initial 48 Hours|Family emergency|0
5119215|NCT01737697|17684241|P7|Acute Phase-Initial 48 Hours|Family emergency|0
5119216|NCT01737697|17684242|P6|Acute Phase-Initial 48 Hours|Family emergency|0
5119217|NCT01737697|17684243|P5|Acute Phase-Initial 48 Hours|Family emergency|0
5119218|NCT01737697|17684244|P4|Acute Phase-Initial 48 Hours|Family emergency|1
5119219|NCT01737697|17684245|P3|Acute Phase-Initial 48 Hours|Family emergency|0
5119220|NCT01737697|17684246|P2|Acute Phase-Initial 48 Hours|Family emergency|0
5119221|NCT01737697|17684247|P1|Acute Phase-Initial 48 Hours|Family emergency|0
5119222|NCT01737697|17684233|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119223|NCT01737697|17684234|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119224|NCT01737697|17684235|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119225|NCT01737697|17684236|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119226|NCT01737697|17684237|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119227|NCT01737697|17684238|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119228|NCT01737697|17684239|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119229|NCT01737697|17684240|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119230|NCT01737697|17684241|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119231|NCT01737697|17684242|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119232|NCT01737697|17684243|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119233|NCT01737697|17684244|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5119234|NCT01737697|17684245|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
5119235|NCT01737697|17684246|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
5119236|NCT01737697|17684247|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
5119237|NCT01737697|17684233|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
5119238|NCT01737697|17684234|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
5119239|NCT01737697|17684235|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
5119240|NCT01737697|17684236|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
5119241|NCT01737697|17684237|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
5119242|NCT01737697|17684238|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
5119243|NCT01737697|17684239|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
5119244|NCT01737697|17684240|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
5119245|NCT01737697|17684241|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
5119246|NCT01737697|17684242|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
5119247|NCT01737697|17684243|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
5119248|NCT01737697|17684244|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
5119249|NCT01737697|17684245|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
5119250|NCT01737697|17684246|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
5119251|NCT01737697|17684247|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
5119252|NCT01737398|17684390|P2|Overall Study|Sponsor's decision|0
5119253|NCT01737398|17684391|P1|Overall Study|Sponsor's decision|2
5119254|NCT01737398|17684390|P2|Overall Study|Disease progression|3
5119255|NCT01737398|17684391|P1|Overall Study|Disease progression|2
5119256|NCT01737398|17684390|P2|Overall Study|Liver transplant|0
5119257|NCT01737398|17684391|P1|Overall Study|Liver transplant|1
5119258|NCT01737398|17684390|P2|Overall Study|Ineligibility|0
5119259|NCT01737398|17684391|P1|Overall Study|Ineligibility|1
5119260|NCT01737398|17684390|P2|Overall Study|Voluntary withdrawal|3
5119261|NCT01737398|17684391|P1|Overall Study|Voluntary withdrawal|2
5119262|NCT01737398|17684390|P2|Overall Study|Stopping rule met|1
5119263|NCT01737398|17684391|P1|Overall Study|Stopping rule met|2
5119264|NCT01737398|17684390|P2|Overall Study|Adverse event or SAE|1
5119265|NCT01737398|17684391|P1|Overall Study|Adverse event or SAE|16
5119266|NCT01737268|17684444|P1|Overall Study|In consideration of the patient's safety|1
5119267|NCT01737268|17684444|P1|Overall Study|Worsening of Target Disease|2
5119268|NCT01737268|17684444|P1|Overall Study|Adverse Event|6
5119269|NCT01737021|17684458|P2|Overall Study|Lost to Follow-up|3
5119270|NCT01737021|17684459|P1|Overall Study|Lost to Follow-up|5
5119271|NCT01736917|17684505|P1|Overall Study|Protocol Violation|10
5119272|NCT01736917|17684505|P1|Overall Study|Adverse Event|1
5119273|NCT01736696|17684545|P7|Overall Study|Withdrawal by Subject|0
5119274|NCT01736696|17684546|P6|Overall Study|Withdrawal by Subject|0
5119275|NCT01736696|17684547|P5|Overall Study|Withdrawal by Subject|0
5119276|NCT01736696|17684548|P4|Overall Study|Withdrawal by Subject|0
5119277|NCT01736696|17684549|P3|Overall Study|Withdrawal by Subject|1
5119278|NCT01736696|17684550|P2|Overall Study|Withdrawal by Subject|0
5119279|NCT01736696|17684551|P1|Overall Study|Withdrawal by Subject|0
5119280|NCT01736683|17684873|P5|Overall Study|Other|1
5119281|NCT01736683|17684874|P4|Overall Study|Other|9
5119282|NCT01736683|17684875|P3|Overall Study|Other|1
5119283|NCT01736683|17684876|P2|Overall Study|Other|0
5119284|NCT01736683|17684877|P1|Overall Study|Other|0
5119285|NCT01736683|17684873|P5|Overall Study|Progressive Disease|0
5119286|NCT01736683|17684874|P4|Overall Study|Progressive Disease|1
5119287|NCT01736683|17684875|P3|Overall Study|Progressive Disease|0
5119288|NCT01736683|17684876|P2|Overall Study|Progressive Disease|0
5119289|NCT01736683|17684877|P1|Overall Study|Progressive Disease|0
5119290|NCT01736683|17684873|P5|Overall Study|Lack of Therapeutic Effect|1
5119291|NCT01736683|17684874|P4|Overall Study|Lack of Therapeutic Effect|20
5119292|NCT01736683|17684875|P3|Overall Study|Lack of Therapeutic Effect|13
5119293|NCT01736683|17684876|P2|Overall Study|Lack of Therapeutic Effect|4
5119294|NCT01736683|17684877|P1|Overall Study|Lack of Therapeutic Effect|7
5119295|NCT01736683|17684873|P5|Overall Study|Withdrawal by Subject|1
5119296|NCT01736683|17684874|P4|Overall Study|Withdrawal by Subject|1
5119297|NCT01736683|17684875|P3|Overall Study|Withdrawal by Subject|3
5119298|NCT01736683|17684876|P2|Overall Study|Withdrawal by Subject|0
5119299|NCT01736683|17684877|P1|Overall Study|Withdrawal by Subject|0
5119300|NCT01736683|17684873|P5|Overall Study|Adverse Event|2
5119301|NCT01736683|17684874|P4|Overall Study|Adverse Event|3
5119302|NCT01736683|17684875|P3|Overall Study|Adverse Event|2
5119303|NCT01736683|17684876|P2|Overall Study|Adverse Event|2
5119304|NCT01736683|17684877|P1|Overall Study|Adverse Event|0
5119305|NCT01736683|17684873|P5|Overall Study|Disease Relapse|0
5119306|NCT01736683|17684874|P4|Overall Study|Disease Relapse|1
5119307|NCT01736683|17684875|P3|Overall Study|Disease Relapse|2
5119308|NCT01736683|17684876|P2|Overall Study|Disease Relapse|0
5119309|NCT01736683|17684877|P1|Overall Study|Disease Relapse|0
5119310|NCT01736657|17684939|P1|Overall Study|insufficient vascular access|1
5119311|NCT01736579|17684948|P2|Overall Study|Termination of Study by Sponsor|2
5119312|NCT01736579|17684949|P1|Overall Study|Termination of Study by Sponsor|2
5119313|NCT01736566|17684988|P5|Long Term Follow-up|Still collecting data|1
5119314|NCT01736566|17684989|P4|Long Term Follow-up|Still collecting data|0
5119315|NCT01736566|17684990|P3|Long Term Follow-up|Still collecting data|49
5119316|NCT01736566|17684991|P2|Long Term Follow-up|Still collecting data|0
5119317|NCT01736566|17684992|P1|Long Term Follow-up|Still collecting data|42
5119318|NCT01736553|17685077|P2|Overall Study|Lost to Follow-up|2
5119319|NCT01736553|17685078|P1|Overall Study|Lost to Follow-up|2
5119320|NCT01736553|17685077|P2|Overall Study|Withdrawal by Subject|2
5119321|NCT01736553|17685078|P1|Overall Study|Withdrawal by Subject|5
5119322|NCT01736553|17685077|P2|Overall Study|Death|0
5119323|NCT01736553|17685078|P1|Overall Study|Death|12
5119324|NCT01736540|17685129|P1|Overall Study|Unable to make MRI appointment|3
5119325|NCT01736540|17685129|P1|Overall Study|No show for MRI appointment|1
5119326|NCT01736540|17685129|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
5119327|NCT01736540|17685129|P1|Overall Study|Protocol Violation|1
5119328|NCT01736540|17685129|P1|Overall Study|Withdrawal by Subject|5
5119329|NCT01736540|17685129|P1|Overall Study|Abnormal test procedure|1
5119330|NCT01736540|17685129|P1|Overall Study|Death|1
5119331|NCT01736540|17685129|P1|Overall Study|Did not complete scan within 45 days|2
5119332|NCT01736475|17685195|P2|Overall Study|Other - Surgical procedure|0
5119333|NCT01736475|17685196|P1|Overall Study|Other - Surgical procedure|1
5119334|NCT01736475|17685195|P2|Overall Study|Other - Screen failure|0
5119335|NCT01736475|17685196|P1|Overall Study|Other - Screen failure|1
5119336|NCT01736475|17685195|P2|Overall Study|Protocol Violation|0
5119337|NCT01736475|17685196|P1|Overall Study|Protocol Violation|4
5119338|NCT01736475|17685195|P2|Overall Study|Withdrawal by Subject|0
5119339|NCT01736475|17685196|P1|Overall Study|Withdrawal by Subject|2
5119340|NCT01736475|17685195|P2|Overall Study|Adverse Event|0
5119341|NCT01736475|17685196|P1|Overall Study|Adverse Event|4
5119342|NCT01736397|17685251|P2|Overall Study|Not stated|4
5119343|NCT01736397|17685252|P1|Overall Study|Not stated|1
5119344|NCT01736397|17685251|P2|Overall Study|Adverse Event|3
5119345|NCT01736397|17685252|P1|Overall Study|Adverse Event|6
5119346|NCT01736397|17685251|P2|Overall Study|Lost to Follow-up|1
5119347|NCT01736397|17685252|P1|Overall Study|Lost to Follow-up|0
5119348|NCT01736397|17685251|P2|Overall Study|Withdrawal by Subject|5
5119349|NCT01736397|17685252|P1|Overall Study|Withdrawal by Subject|6
5119350|NCT01736397|17685251|P2|Overall Study|Lack of Efficacy|11
5119351|NCT01736397|17685252|P1|Overall Study|Lack of Efficacy|1
5119352|NCT01736254|17685285|P1|Period 3 (Days 13 to 23)|Adverse Event|1
5119353|NCT01736254|17685285|P1|Period 2 (Days 2 to 12)|Adverse Event|3
5119354|NCT01736215|17685350|P1|Overall Study|Insufficient data to perform analysis|8
5119355|NCT01736215|17685350|P1|Overall Study|Progressive disease stop chemotherapy|1
5119356|NCT01736215|17685350|P1|Overall Study|Adverse Event|4
5119357|NCT01736215|17685350|P1|Overall Study|Early termination of erythropoietin use|1
5119358|NCT01736189|17685362|P1|Overall Study|Criteria and protocol violations|1
5119359|NCT01736189|17685362|P1|Overall Study|Protocol Violation|4
5119360|NCT01736189|17685362|P1|Overall Study|Violation of registration criteria|41
5119361|NCT01736176|17685371|P1|Overall Study|Unable to Complete PEG Placement|1
5119362|NCT01736176|17685371|P1|Overall Study|Lack of Efficacy|3
5119363|NCT01736176|17685371|P1|Overall Study|Withdrawal by Subject|4
5119364|NCT01736176|17685371|P1|Overall Study|Adverse Event|3
5119365|NCT01735994|17685442|P2|Overall Study|Lost to Follow-up|62
5119366|NCT01735994|17685443|P1|Overall Study|Lost to Follow-up|50
5119367|NCT01735994|17685442|P2|Overall Study|Kicked off team|0
5119368|NCT01735994|17685443|P1|Overall Study|Kicked off team|5
5119369|NCT01735994|17685442|P2|Overall Study|Injury|0
5119370|NCT01735994|17685443|P1|Overall Study|Injury|2
5119371|NCT01735994|17685442|P2|Overall Study|Withdrawal by Subject|4
5119372|NCT01735994|17685443|P1|Overall Study|Withdrawal by Subject|6
5119373|NCT01735916|17685458|P3|Overall Study|Withdrawal by Subject|0
5119374|NCT01735916|17685459|P2|Overall Study|Withdrawal by Subject|0
5119375|NCT01735916|17685460|P1|Overall Study|Withdrawal by Subject|3
5119376|NCT01735916|17685458|P3|Overall Study|Early termination of study by sponsor|7
5119377|NCT01735916|17685459|P2|Overall Study|Early termination of study by sponsor|19
5119378|NCT01735916|17685460|P1|Overall Study|Early termination of study by sponsor|4
5119379|NCT01735916|17685458|P3|Overall Study|Subject not eligible to be randomized|0
5119380|NCT01735916|17685459|P2|Overall Study|Subject not eligible to be randomized|0
5119381|NCT01735916|17685460|P1|Overall Study|Subject not eligible to be randomized|11
5119382|NCT01735630|17685498|P2|Overall Study|Withdrawal by Subject|9
5119383|NCT01735630|17685499|P1|Overall Study|Withdrawal by Subject|7
5119384|NCT01735630|17685498|P2|Overall Study|Sponsor Decision|1
5119385|NCT01735630|17685499|P1|Overall Study|Sponsor Decision|2
5119386|NCT01735630|17685498|P2|Overall Study|Physician Decision|1
5119387|NCT01735630|17685499|P1|Overall Study|Physician Decision|0
5119388|NCT01735630|17685498|P2|Overall Study|Lost to Follow-up|0
5119389|NCT01735630|17685499|P1|Overall Study|Lost to Follow-up|1
5119390|NCT01735630|17685498|P2|Overall Study|Adverse Event|7
5119391|NCT01735630|17685499|P1|Overall Study|Adverse Event|8
5119392|NCT01735396|17685526|P1|Overall Study|not evaluable|1
5119393|NCT01735279|17685537|P2|Overall Study|Lost to Follow-up|8
5119394|NCT01735279|17685538|P1|Overall Study|Lost to Follow-up|11
5119395|NCT01735201|17685570|P8|Overall Study|Other Miscellaneous Reasons|1
5119396|NCT01735201|17685571|P7|Overall Study|Other Miscellaneous Reasons|1
5119397|NCT01735201|17685572|P6|Overall Study|Other Miscellaneous Reasons|2
5119398|NCT01735201|17685573|P5|Overall Study|Other Miscellaneous Reasons|0
5119399|NCT01735201|17685574|P4|Overall Study|Other Miscellaneous Reasons|1
5119400|NCT01735201|17685575|P3|Overall Study|Other Miscellaneous Reasons|0
5119401|NCT01735201|17685576|P2|Overall Study|Other Miscellaneous Reasons|0
5119402|NCT01735201|17685577|P1|Overall Study|Other Miscellaneous Reasons|0
5119403|NCT01735201|17685570|P8|Overall Study|Protocol Violation|0
5119404|NCT01735201|17685571|P7|Overall Study|Protocol Violation|0
5119405|NCT01735201|17685572|P6|Overall Study|Protocol Violation|0
5119406|NCT01735201|17685573|P5|Overall Study|Protocol Violation|0
5119407|NCT01735201|17685574|P4|Overall Study|Protocol Violation|0
5119408|NCT01735201|17685575|P3|Overall Study|Protocol Violation|0
5119409|NCT01735201|17685576|P2|Overall Study|Protocol Violation|0
5119410|NCT01735201|17685577|P1|Overall Study|Protocol Violation|1
5119411|NCT01735201|17685570|P8|Overall Study|Personal Reasons|0
5119412|NCT01735201|17685571|P7|Overall Study|Personal Reasons|0
5119413|NCT01735201|17685572|P6|Overall Study|Personal Reasons|0
5119414|NCT01735201|17685573|P5|Overall Study|Personal Reasons|0
5119415|NCT01735201|17685574|P4|Overall Study|Personal Reasons|0
5119416|NCT01735201|17685575|P3|Overall Study|Personal Reasons|0
5119417|NCT01735201|17685576|P2|Overall Study|Personal Reasons|0
5119418|NCT01735201|17685577|P1|Overall Study|Personal Reasons|1
5119419|NCT01735201|17685570|P8|Overall Study|Adverse Event|1
5119420|NCT01735201|17685571|P7|Overall Study|Adverse Event|2
5119421|NCT01735201|17685572|P6|Overall Study|Adverse Event|3
5119422|NCT01735201|17685573|P5|Overall Study|Adverse Event|1
5119423|NCT01735201|17685574|P4|Overall Study|Adverse Event|1
5119424|NCT01735201|17685575|P3|Overall Study|Adverse Event|0
5119425|NCT01735201|17685576|P2|Overall Study|Adverse Event|1
5119426|NCT01735201|17685577|P1|Overall Study|Adverse Event|1
5119427|NCT01735175|17685613|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
5119428|NCT01735175|17685614|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
5119429|NCT01735175|17685613|P2|Overall Study|Death|2
5119430|NCT01735175|17685614|P1|Overall Study|Death|3
5119431|NCT01735175|17685613|P2|Overall Study|Lost to Follow-up|2
5119432|NCT01735175|17685614|P1|Overall Study|Lost to Follow-up|4
5119433|NCT01735175|17685613|P2|Overall Study|Withdrawal by Subject|2
5119434|NCT01735175|17685614|P1|Overall Study|Withdrawal by Subject|9
5119435|NCT01734993|17685634|P1|Overall Study|Lack of Efficacy|1
5119436|NCT01734993|17685634|P1|Overall Study|Adverse Event|1
5119437|NCT01734902|17685662|P2|Overall Study|Other than listed|2
5119438|NCT01734902|17685663|P1|Overall Study|Other than listed|0
5119439|NCT01734850|17685684|P3|Overall Study|Not infused due to manufacturing failure|1
5119440|NCT01734850|17685685|P2|Overall Study|Not infused due to manufacturing failure|0
5119525|NCT01734434|17685847|P4|Overall Study|No Live Birth|6
5119441|NCT01734850|17685686|P1|Overall Study|Not infused due to manufacturing failure|0
5119442|NCT01734850|17685684|P3|Overall Study|Continued to Week 48 but recommenced ART|3
5119443|NCT01734850|17685685|P2|Overall Study|Continued to Week 48 but recommenced ART|2
5119444|NCT01734850|17685686|P1|Overall Study|Continued to Week 48 but recommenced ART|3
5119445|NCT01734811|17685743|P2|Overall Study|Withdrawal by Subject|0
5119446|NCT01734811|17685744|P1|Overall Study|Withdrawal by Subject|2
5119447|NCT01734811|17685743|P2|Overall Study|Lost to Follow-up|3
5119448|NCT01734811|17685744|P1|Overall Study|Lost to Follow-up|2
5119449|NCT01734785|17685771|P4|Double-Blind Period|Not treated|0
5119450|NCT01734785|17685772|P3|Double-Blind Period|Not treated|0
5119451|NCT01734785|17685773|P2|Double-Blind Period|Not treated|0
5119452|NCT01734785|17685774|P1|Double-Blind Period|Not treated|1
5119453|NCT01734785|17685771|P4|Double-Blind Period|Withdrawal by Subject|0
5119454|NCT01734785|17685772|P3|Double-Blind Period|Withdrawal by Subject|0
5119455|NCT01734785|17685773|P2|Double-Blind Period|Withdrawal by Subject|0
5119456|NCT01734785|17685774|P1|Double-Blind Period|Withdrawal by Subject|2
5119457|NCT01734785|17685771|P4|Double-Blind Period|Lost to Follow-up|0
5119458|NCT01734785|17685772|P3|Double-Blind Period|Lost to Follow-up|2
5119459|NCT01734785|17685773|P2|Double-Blind Period|Lost to Follow-up|4
5119460|NCT01734785|17685774|P1|Double-Blind Period|Lost to Follow-up|2
5119461|NCT01734785|17685771|P4|Double-Blind Period|Protocol Violation|0
5119462|NCT01734785|17685772|P3|Double-Blind Period|Protocol Violation|1
5119463|NCT01734785|17685773|P2|Double-Blind Period|Protocol Violation|1
5119464|NCT01734785|17685774|P1|Double-Blind Period|Protocol Violation|0
5119465|NCT01734785|17685771|P4|Double-Blind Period|Lack of Efficacy|0
5119466|NCT01734785|17685772|P3|Double-Blind Period|Lack of Efficacy|0
5119467|NCT01734785|17685773|P2|Double-Blind Period|Lack of Efficacy|1
5119468|NCT01734785|17685774|P1|Double-Blind Period|Lack of Efficacy|0
5119469|NCT01734785|17685771|P4|Double-Blind Period|Adverse Event|0
5119470|NCT01734785|17685772|P3|Double-Blind Period|Adverse Event|2
5119471|NCT01734785|17685773|P2|Double-Blind Period|Adverse Event|3
5119472|NCT01734785|17685774|P1|Double-Blind Period|Adverse Event|0
5119473|NCT01734785|17685771|P4|Open-Label Period|Other Reasons|224
5119474|NCT01734785|17685772|P3|Open-Label Period|Other Reasons|0
5119475|NCT01734785|17685773|P2|Open-Label Period|Other Reasons|0
5119476|NCT01734785|17685774|P1|Open-Label Period|Other Reasons|0
5119477|NCT01734785|17685771|P4|Open-Label Period|Withdrawal by Subject|12
5119478|NCT01734785|17685772|P3|Open-Label Period|Withdrawal by Subject|0
5119479|NCT01734785|17685773|P2|Open-Label Period|Withdrawal by Subject|0
5119480|NCT01734785|17685774|P1|Open-Label Period|Withdrawal by Subject|0
5119481|NCT01734785|17685771|P4|Open-Label Period|Lost to Follow-up|14
5119482|NCT01734785|17685772|P3|Open-Label Period|Lost to Follow-up|0
5119483|NCT01734785|17685773|P2|Open-Label Period|Lost to Follow-up|0
5119484|NCT01734785|17685774|P1|Open-Label Period|Lost to Follow-up|0
5119485|NCT01734785|17685771|P4|Open-Label Period|Protocol Violation|13
5119486|NCT01734785|17685772|P3|Open-Label Period|Protocol Violation|0
5119487|NCT01734785|17685773|P2|Open-Label Period|Protocol Violation|0
5119488|NCT01734785|17685774|P1|Open-Label Period|Protocol Violation|0
5119489|NCT01734785|17685771|P4|Open-Label Period|Lack of Efficacy|1
5119490|NCT01734785|17685772|P3|Open-Label Period|Lack of Efficacy|0
5119491|NCT01734785|17685773|P2|Open-Label Period|Lack of Efficacy|0
5119492|NCT01734785|17685774|P1|Open-Label Period|Lack of Efficacy|0
5119493|NCT01734785|17685771|P4|Open-Label Period|Adverse Event|9
5119494|NCT01734785|17685772|P3|Open-Label Period|Adverse Event|0
5119495|NCT01734785|17685773|P2|Open-Label Period|Adverse Event|0
5119496|NCT01734785|17685774|P1|Open-Label Period|Adverse Event|0
5119497|NCT01734772|17685791|P2|Overall Study|Withdrawal by Subject|1
5119498|NCT01734772|17685792|P1|Overall Study|Withdrawal by Subject|0
5119499|NCT01734772|17685791|P2|Overall Study|Adverse Event|2
5119500|NCT01734772|17685792|P1|Overall Study|Adverse Event|1
5119501|NCT01734434|17685847|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
5119502|NCT01734434|17685848|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
5119503|NCT01734434|17685849|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
5119504|NCT01734434|17685850|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
5119505|NCT01734434|17685847|P4|Overall Study|Wrong Version of Consent Form Signed|0
5119506|NCT01734434|17685848|P3|Overall Study|Wrong Version of Consent Form Signed|1
5119507|NCT01734434|17685849|P2|Overall Study|Wrong Version of Consent Form Signed|0
5119508|NCT01734434|17685850|P1|Overall Study|Wrong Version of Consent Form Signed|0
5119509|NCT01734434|17685847|P4|Overall Study|Treatment Defaulter|0
5119510|NCT01734434|17685848|P3|Overall Study|Treatment Defaulter|1
5119511|NCT01734434|17685849|P2|Overall Study|Treatment Defaulter|0
5119512|NCT01734434|17685850|P1|Overall Study|Treatment Defaulter|0
5119513|NCT01734434|17685847|P4|Overall Study|Subject Not Reachable|0
5119514|NCT01734434|17685848|P3|Overall Study|Subject Not Reachable|1
5119515|NCT01734434|17685849|P2|Overall Study|Subject Not Reachable|0
5119516|NCT01734434|17685850|P1|Overall Study|Subject Not Reachable|0
5119517|NCT01734434|17685847|P4|Overall Study|Signed Adult Version of Consent Form|0
5119518|NCT01734434|17685848|P3|Overall Study|Signed Adult Version of Consent Form|1
5119519|NCT01734434|17685849|P2|Overall Study|Signed Adult Version of Consent Form|0
5119520|NCT01734434|17685850|P1|Overall Study|Signed Adult Version of Consent Form|0
5119521|NCT01734434|17685847|P4|Overall Study|Withdrawal by Subject|1
5119522|NCT01734434|17685848|P3|Overall Study|Withdrawal by Subject|8
5119523|NCT01734434|17685849|P2|Overall Study|Withdrawal by Subject|0
5119524|NCT01734434|17685850|P1|Overall Study|Withdrawal by Subject|4
5119526|NCT01734434|17685848|P3|Overall Study|No Live Birth|32
5119527|NCT01734434|17685849|P2|Overall Study|No Live Birth|2
5119528|NCT01734434|17685850|P1|Overall Study|No Live Birth|1
5119529|NCT01734434|17685847|P4|Overall Study|Lost to Follow-up|11
5119530|NCT01734434|17685848|P3|Overall Study|Lost to Follow-up|67
5119531|NCT01734434|17685849|P2|Overall Study|Lost to Follow-up|9
5119532|NCT01734434|17685850|P1|Overall Study|Lost to Follow-up|2
5119533|NCT01734434|17685847|P4|Overall Study|Death Infant|5
5119534|NCT01734434|17685848|P3|Overall Study|Death Infant|17
5119535|NCT01734434|17685849|P2|Overall Study|Death Infant|1
5119536|NCT01734434|17685850|P1|Overall Study|Death Infant|3
5119537|NCT01734395|17685872|P1|Overall Study|Missing the reasons for not completed|3
5119538|NCT01734395|17685872|P1|Overall Study|Withdrawal by Subject|10
5119539|NCT01734395|17685872|P1|Overall Study|Adverse Event|40
5119540|NCT01734395|17685872|P1|Overall Study|Lack of Efficacy|5
5119541|NCT01734395|17685872|P1|Overall Study|Lost to Follow-up|287
5119542|NCT01734395|17685872|P1|Overall Study|Other|65
5119543|NCT01734382|17685881|P3|Part 2|Withdrawal by Subject|1
5119544|NCT01734382|17685882|P2|Part 2|Withdrawal by Subject|0
5119545|NCT01734382|17685883|P1|Part 2|Withdrawal by Subject|0
5119546|NCT01734382|17685881|P3|Part 2|Protocol Violation|0
5119547|NCT01734382|17685882|P2|Part 2|Protocol Violation|1
5119548|NCT01734382|17685883|P1|Part 2|Protocol Violation|0
5119549|NCT01734382|17685881|P3|Part 2|Physician Decision|3
5119550|NCT01734382|17685882|P2|Part 2|Physician Decision|0
5119551|NCT01734382|17685883|P1|Part 2|Physician Decision|0
5119552|NCT01734382|17685881|P3|Part 2|Other|1
5119553|NCT01734382|17685882|P2|Part 2|Other|0
5119554|NCT01734382|17685883|P1|Part 2|Other|0
5119555|NCT01734382|17685881|P3|Part 2|Lack of Efficacy|1
5119556|NCT01734382|17685882|P2|Part 2|Lack of Efficacy|1
5119557|NCT01734382|17685883|P1|Part 2|Lack of Efficacy|0
5119558|NCT01734382|17685881|P3|Part 2|Adverse Event|1
5119559|NCT01734382|17685882|P2|Part 2|Adverse Event|0
5119560|NCT01734382|17685883|P1|Part 2|Adverse Event|0
5119561|NCT01734382|17685881|P3|Part 1|Adverse Event|0
5119562|NCT01734382|17685882|P2|Part 1|Adverse Event|0
5119563|NCT01734382|17685883|P1|Part 1|Adverse Event|2
5119564|NCT01733758|17685996|P4|Overall Study|Inv Decision, HbA1c not controlled|1
5119565|NCT01733758|17685997|P3|Overall Study|Inv Decision, HbA1c not controlled|0
5119566|NCT01733758|17685998|P2|Overall Study|Inv Decision, HbA1c not controlled|1
5119567|NCT01733758|17685999|P1|Overall Study|Inv Decision, HbA1c not controlled|1
5119568|NCT01733758|17685996|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
5119569|NCT01733758|17685997|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
5119570|NCT01733758|17685998|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
5119571|NCT01733758|17685999|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
5119572|NCT01733758|17685996|P4|Overall Study|Non-compliance|0
5119573|NCT01733758|17685997|P3|Overall Study|Non-compliance|0
5119574|NCT01733758|17685998|P2|Overall Study|Non-compliance|0
5119575|NCT01733758|17685999|P1|Overall Study|Non-compliance|1
5119576|NCT01733758|17685996|P4|Overall Study|Protocol Violation|2
5119577|NCT01733758|17685997|P3|Overall Study|Protocol Violation|2
5119578|NCT01733758|17685998|P2|Overall Study|Protocol Violation|1
5119579|NCT01733758|17685999|P1|Overall Study|Protocol Violation|0
5119580|NCT01733758|17685996|P4|Overall Study|Persistent Hyperglycemia|0
5119581|NCT01733758|17685997|P3|Overall Study|Persistent Hyperglycemia|0
5119582|NCT01733758|17685998|P2|Overall Study|Persistent Hyperglycemia|2
5119583|NCT01733758|17685999|P1|Overall Study|Persistent Hyperglycemia|3
5119584|NCT01733758|17685996|P4|Overall Study|Withdrawal by Subject|3
5119585|NCT01733758|17685997|P3|Overall Study|Withdrawal by Subject|5
5119586|NCT01733758|17685998|P2|Overall Study|Withdrawal by Subject|1
5119587|NCT01733758|17685999|P1|Overall Study|Withdrawal by Subject|1
5119588|NCT01733758|17685996|P4|Overall Study|Adverse Event|1
5119589|NCT01733758|17685997|P3|Overall Study|Adverse Event|8
5119590|NCT01733758|17685998|P2|Overall Study|Adverse Event|7
5119591|NCT01733758|17685999|P1|Overall Study|Adverse Event|5
5119592|NCT01733732|17686065|P2|Overall Study|Did not attend all study visits|0
5119593|NCT01733732|17686066|P1|Overall Study|Did not attend all study visits|1
5119594|NCT01733732|17686065|P2|Overall Study|Adverse Event|0
5119595|NCT01733732|17686066|P1|Overall Study|Adverse Event|1
5119596|NCT01733680|17686102|P2|Overall Study|Withdrawal by Subject|1
5119597|NCT01733680|17686103|P1|Overall Study|Withdrawal by Subject|0
5119598|NCT01733329|17686162|P2|Overall Study|Uterine artery injury|0
5119599|NCT01733329|17686163|P1|Overall Study|Uterine artery injury|1
5119600|NCT01733329|17686162|P2|Overall Study|Protocol Violation|1
5119601|NCT01733329|17686163|P1|Overall Study|Protocol Violation|1
5119602|NCT01733316|17686175|P1|Long Term Extension Phase|Sponsor Decision|2
5119603|NCT01733316|17686175|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
5119604|NCT01733316|17686175|P1|Long Term Extension Phase|Adverse Event|1
5119605|NCT01733316|17686175|P1|RP103 Phase|Non-compliance|1
5119606|NCT01733121|17686218|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
5119607|NCT01733121|17686219|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5119608|NCT01733121|17686218|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
5119609|NCT01733121|17686219|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
5119610|NCT01733121|17686218|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
5119611|NCT01733121|17686219|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
5119612|NCT01733121|17686218|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
5119613|NCT01733121|17686219|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
5119614|NCT01732926|17686261|P2|Overall Study|Blind Broken by Subject or Study Site|1
5119615|NCT01732926|17686262|P1|Overall Study|Blind Broken by Subject or Study Site|1
5119616|NCT01732926|17686261|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
5119617|NCT01732926|17686262|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
5119618|NCT01732926|17686261|P2|Overall Study|Other Reason|4
5119619|NCT01732926|17686262|P1|Overall Study|Other Reason|21
5119620|NCT01732926|17686261|P2|Overall Study|Physician Decision|11
5119621|NCT01732926|17686262|P1|Overall Study|Physician Decision|24
5119622|NCT01732926|17686261|P2|Overall Study|Withdrawal by Subject|8
5119623|NCT01732926|17686262|P1|Overall Study|Withdrawal by Subject|46
5119624|NCT01732926|17686261|P2|Overall Study|Study Terminated by Sponsor|80
5119625|NCT01732926|17686262|P1|Overall Study|Study Terminated by Sponsor|168
5119626|NCT01732913|17686278|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
5119627|NCT01732913|17686279|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
5119628|NCT01732913|17686278|P2|Overall Study|Other|1
5119629|NCT01732913|17686279|P1|Overall Study|Other|7
5119630|NCT01732913|17686278|P2|Overall Study|Physician Decision|7
5119631|NCT01732913|17686279|P1|Overall Study|Physician Decision|14
5119632|NCT01732913|17686278|P2|Overall Study|Withdrawal by Subject|4
5119633|NCT01732913|17686279|P1|Overall Study|Withdrawal by Subject|27
5119634|NCT01732913|17686278|P2|Overall Study|Study Terminated by Sponsor|55
5119635|NCT01732913|17686279|P1|Overall Study|Study Terminated by Sponsor|105
5119636|NCT01732835|17686293|P1|2-year Extended Follow-up|Death|1
5119637|NCT01732835|17686293|P1|2-year Extended Follow-up|Adverse Event|3
5119638|NCT01732835|17686293|P1|2-year Extended Follow-up|Withdrawal by Subject|1
5119639|NCT01732835|17686293|P1|6-month Primary Endpoint|Adverse Event|3
5119640|NCT01732835|17686293|P1|6-month Primary Endpoint|Withdrawal by Subject|2
5119641|NCT01732835|17686293|P1|6-month Primary Endpoint|Did not receive device|19
5119642|NCT01732822|17686326|P2|Overall Study|Withdrawal by Subject|113
5119643|NCT01732822|17686327|P1|Overall Study|Withdrawal by Subject|123
5119644|NCT01732796|17686400|P3|Overall Study|Other reason not defined above|2
5119645|NCT01732796|17686401|P2|Overall Study|Other reason not defined above|0
5119646|NCT01732796|17686402|P1|Overall Study|Other reason not defined above|1
5119647|NCT01732796|17686400|P3|Overall Study|Withdrawal by Subject|2
5119648|NCT01732796|17686401|P2|Overall Study|Withdrawal by Subject|8
5119649|NCT01732796|17686402|P1|Overall Study|Withdrawal by Subject|6
5119650|NCT01732796|17686400|P3|Overall Study|Lost to Follow-up|0
5119651|NCT01732796|17686401|P2|Overall Study|Lost to Follow-up|0
5119652|NCT01732796|17686402|P1|Overall Study|Lost to Follow-up|2
5119653|NCT01732796|17686400|P3|Overall Study|Lack of Efficacy|5
5119654|NCT01732796|17686401|P2|Overall Study|Lack of Efficacy|18
5119655|NCT01732796|17686402|P1|Overall Study|Lack of Efficacy|21
5119656|NCT01732796|17686400|P3|Overall Study|Adverse Event|4
5119657|NCT01732796|17686401|P2|Overall Study|Adverse Event|16
5119658|NCT01732796|17686402|P1|Overall Study|Adverse Event|16
5119659|NCT01732783|17686421|P3|Overall Study|Withdrawal by Subject|0
5119660|NCT01732783|17686422|P2|Overall Study|Withdrawal by Subject|0
5119661|NCT01732783|17686423|P1|Overall Study|Withdrawal by Subject|1
5119662|NCT01732783|17686421|P3|Overall Study|Administrative Decision|1
5119663|NCT01732783|17686422|P2|Overall Study|Administrative Decision|2
5119664|NCT01732783|17686423|P1|Overall Study|Administrative Decision|8
5119665|NCT01732783|17686421|P3|Overall Study|Lost to Follow-up|1
5119666|NCT01732783|17686422|P2|Overall Study|Lost to Follow-up|1
5119667|NCT01732783|17686423|P1|Overall Study|Lost to Follow-up|7
5119668|NCT01732783|17686421|P3|Overall Study|Death|1
5119669|NCT01732783|17686422|P2|Overall Study|Death|4
5119670|NCT01732783|17686423|P1|Overall Study|Death|13
5119671|NCT01732783|17686421|P3|Overall Study|Discontinued Panitumumab Treatment|7
5119672|NCT01732783|17686422|P2|Overall Study|Discontinued Panitumumab Treatment|25
5119673|NCT01732783|17686423|P1|Overall Study|Discontinued Panitumumab Treatment|106
5119674|NCT01732770|17686487|P2|Overall Study|Death|0
5119675|NCT01732770|17686488|P1|Overall Study|Death|1
5119676|NCT01732770|17686487|P2|Overall Study|Decision by Sponsor|2
5119677|NCT01732770|17686488|P1|Overall Study|Decision by Sponsor|2
5119678|NCT01732770|17686487|P2|Overall Study|Withdrawal by Subject|3
5119679|NCT01732770|17686488|P1|Overall Study|Withdrawal by Subject|5
5119680|NCT01732770|17686487|P2|Overall Study|Lost to Follow-up|3
5119681|NCT01732770|17686488|P1|Overall Study|Lost to Follow-up|2
5119682|NCT01732757|17686503|P3|Overall Study|Lost to Follow-up|0
5119683|NCT01732757|17686504|P2|Overall Study|Lost to Follow-up|0
5119684|NCT01732757|17686505|P1|Overall Study|Lost to Follow-up|1
5119685|NCT01732692|17686582|P2|Overall Study|Adverse Event|1
5119686|NCT01732692|17686583|P1|Overall Study|Adverse Event|0
5119687|NCT01732640|17686597|P2|Overall Study|Death|1
5119688|NCT01732640|17686598|P1|Overall Study|Death|0
5119689|NCT01732640|17686597|P2|Overall Study|Adverse Event|1
5119690|NCT01732640|17686598|P1|Overall Study|Adverse Event|0
5119691|NCT01732627|17686615|P2|Overall Study|Withdrawal by Subject|0
5119692|NCT01732627|17686616|P1|Overall Study|Withdrawal by Subject|1
5119693|NCT01732588|17686649|P3|First Intervention (7 Days)|Adverse Event|0
5119694|NCT01732588|17686650|P2|First Intervention (7 Days)|Adverse Event|1
5119695|NCT01732588|17686651|P1|First Intervention (7 Days)|Adverse Event|0
5119696|NCT01732549|17686667|P2|Overall Study|Other|14
5119697|NCT01732549|17686668|P1|Overall Study|Other|8
5119698|NCT01732549|17686667|P2|Overall Study|Disease progression|50
5119699|NCT01732549|17686668|P1|Overall Study|Disease progression|37
5119700|NCT01732549|17686667|P2|Overall Study|Consent withdrawn|6
5119701|NCT01732549|17686668|P1|Overall Study|Consent withdrawn|13
5119702|NCT01732549|17686667|P2|Overall Study|Adverse Event|3
5119703|NCT01732549|17686668|P1|Overall Study|Adverse Event|13
5119704|NCT01732536|17686690|P2|Overall Study|Withdrawal by Subject|1
5119705|NCT01732536|17686691|P1|Overall Study|Withdrawal by Subject|1
5119706|NCT01732510|17686714|P7|Overall Study|Study Terminated By Sponsor|6
5119707|NCT01732510|17686715|P6|Overall Study|Study Terminated By Sponsor|12
5119708|NCT01732510|17686716|P5|Overall Study|Study Terminated By Sponsor|0
5119709|NCT01732510|17686717|P4|Overall Study|Study Terminated By Sponsor|1
5119710|NCT01732510|17686718|P3|Overall Study|Study Terminated By Sponsor|0
5119711|NCT01732510|17686719|P2|Overall Study|Study Terminated By Sponsor|0
5119712|NCT01732510|17686720|P1|Overall Study|Study Terminated By Sponsor|0
5119713|NCT01732510|17686714|P7|Overall Study|Pregnancy|0
5119714|NCT01732510|17686715|P6|Overall Study|Pregnancy|0
5119715|NCT01732510|17686716|P5|Overall Study|Pregnancy|0
5119716|NCT01732510|17686717|P4|Overall Study|Pregnancy|1
5119717|NCT01732510|17686718|P3|Overall Study|Pregnancy|0
5119718|NCT01732510|17686719|P2|Overall Study|Pregnancy|0
5119719|NCT01732510|17686720|P1|Overall Study|Pregnancy|0
5119720|NCT01732510|17686714|P7|Overall Study|Physician Decision|0
5119721|NCT01732510|17686715|P6|Overall Study|Physician Decision|0
5119722|NCT01732510|17686716|P5|Overall Study|Physician Decision|0
5119723|NCT01732510|17686717|P4|Overall Study|Physician Decision|0
5119724|NCT01732510|17686718|P3|Overall Study|Physician Decision|0
5119725|NCT01732510|17686719|P2|Overall Study|Physician Decision|1
5119726|NCT01732510|17686720|P1|Overall Study|Physician Decision|0
5119727|NCT01732510|17686714|P7|Overall Study|Lost to Follow-up|0
5119728|NCT01732510|17686715|P6|Overall Study|Lost to Follow-up|1
5119729|NCT01732510|17686716|P5|Overall Study|Lost to Follow-up|0
5119730|NCT01732510|17686717|P4|Overall Study|Lost to Follow-up|1
5119731|NCT01732510|17686718|P3|Overall Study|Lost to Follow-up|1
5119732|NCT01732510|17686719|P2|Overall Study|Lost to Follow-up|0
5119733|NCT01732510|17686720|P1|Overall Study|Lost to Follow-up|0
5119734|NCT01732510|17686714|P7|Overall Study|Withdrawal by Subject|1
5119735|NCT01732510|17686715|P6|Overall Study|Withdrawal by Subject|0
5119736|NCT01732510|17686716|P5|Overall Study|Withdrawal by Subject|5
5119737|NCT01732510|17686717|P4|Overall Study|Withdrawal by Subject|1
5119738|NCT01732510|17686718|P3|Overall Study|Withdrawal by Subject|2
5119739|NCT01732510|17686719|P2|Overall Study|Withdrawal by Subject|3
5119740|NCT01732510|17686720|P1|Overall Study|Withdrawal by Subject|1
5119741|NCT01732510|17686714|P7|Overall Study|Protocol Violation|0
5119742|NCT01732510|17686715|P6|Overall Study|Protocol Violation|0
5119743|NCT01732510|17686716|P5|Overall Study|Protocol Violation|0
5119744|NCT01732510|17686717|P4|Overall Study|Protocol Violation|1
5119745|NCT01732510|17686718|P3|Overall Study|Protocol Violation|0
5119746|NCT01732510|17686719|P2|Overall Study|Protocol Violation|0
5119747|NCT01732510|17686720|P1|Overall Study|Protocol Violation|0
5119748|NCT01732510|17686714|P7|Overall Study|Adverse Event|1
5119749|NCT01732510|17686715|P6|Overall Study|Adverse Event|0
5119750|NCT01732510|17686716|P5|Overall Study|Adverse Event|0
5119751|NCT01732510|17686717|P4|Overall Study|Adverse Event|0
5119752|NCT01732510|17686718|P3|Overall Study|Adverse Event|1
5119753|NCT01732510|17686719|P2|Overall Study|Adverse Event|1
5119754|NCT01732510|17686720|P1|Overall Study|Adverse Event|0
5119755|NCT01732484|17686799|P1|Overall Study|chronical illness|5
5119756|NCT01732484|17686799|P1|Overall Study|Lost to Follow-up|14
5119757|NCT01732484|17686799|P1|Overall Study|Death|7
5119758|NCT01732471|17686807|P1|Overall Study|Withdrawal by Subject|1
5119759|NCT01732458|17686818|P4|Overall Study|Screen Failure|0
5119760|NCT01732458|17686819|P3|Overall Study|Screen Failure|0
5119761|NCT01732458|17686820|P2|Overall Study|Screen Failure|1
5119762|NCT01732458|17686821|P1|Overall Study|Screen Failure|0
5119763|NCT01732458|17686818|P4|Overall Study|Protocol Violation|2
5119764|NCT01732458|17686819|P3|Overall Study|Protocol Violation|0
5119765|NCT01732458|17686820|P2|Overall Study|Protocol Violation|0
5119766|NCT01732458|17686821|P1|Overall Study|Protocol Violation|2
5119767|NCT01732458|17686818|P4|Overall Study|Physician Decision|0
5119768|NCT01732458|17686819|P3|Overall Study|Physician Decision|2
5119769|NCT01732458|17686820|P2|Overall Study|Physician Decision|2
5119770|NCT01732458|17686821|P1|Overall Study|Physician Decision|1
5119771|NCT01732458|17686818|P4|Overall Study|Non-Compliance With Study Drug|0
5119772|NCT01732458|17686819|P3|Overall Study|Non-Compliance With Study Drug|1
5119773|NCT01732458|17686820|P2|Overall Study|Non-Compliance With Study Drug|0
5119774|NCT01732458|17686821|P1|Overall Study|Non-Compliance With Study Drug|0
5119775|NCT01732458|17686818|P4|Overall Study|Lost to Follow-up|0
5119776|NCT01732458|17686819|P3|Overall Study|Lost to Follow-up|0
5119777|NCT01732458|17686820|P2|Overall Study|Lost to Follow-up|2
5119778|NCT01732458|17686821|P1|Overall Study|Lost to Follow-up|0
5119779|NCT01732107|17686983|P1|Overall Study|Withdrawal by Subject|2
5119780|NCT01732107|17686983|P1|Overall Study|Physician Decision|1
5119781|NCT01732107|17686983|P1|Overall Study|Disease Progression|8
5119782|NCT01732107|17686983|P1|Overall Study|Adverse Event|2
5119783|NCT01731990|17687000|P2|Overall Study|Death|0
5119784|NCT01731990|17687001|P1|Overall Study|Death|1
5119785|NCT01731990|17687000|P2|Overall Study|Protocol deviation|2
5119786|NCT01731990|17687001|P1|Overall Study|Protocol deviation|1
5119787|NCT01731990|17687000|P2|Overall Study|Withdrawal by Subject|1
5119788|NCT01731990|17687001|P1|Overall Study|Withdrawal by Subject|1
5119789|NCT01731990|17687000|P2|Overall Study|Adverse Event|5
5119790|NCT01731990|17687001|P1|Overall Study|Adverse Event|1
5119791|NCT01731938|17687017|P2|Primary Part II|Missed Week 6 visit|3
5119792|NCT01731938|17687018|P1|Primary Part II|Missed Week 6 visit|2
5119793|NCT01731938|17687017|P2|Primary Part II|Death|1
5119794|NCT01731938|17687018|P1|Primary Part II|Death|2
5119795|NCT01731938|17687017|P2|Primary Part II|Lost to Follow-up|5
5119796|NCT01731938|17687018|P1|Primary Part II|Lost to Follow-up|4
5119797|NCT01731938|17687017|P2|Primary Part II|Withdrawal by Subject|4
5119798|NCT01731938|17687018|P1|Primary Part II|Withdrawal by Subject|5
5119799|NCT01731938|17687017|P2|Preliminary Part I|Missed Week 6 visit|3
5119800|NCT01731938|17687018|P1|Preliminary Part I|Missed Week 6 visit|0
5119801|NCT01731938|17687017|P2|Preliminary Part I|Lost to Follow-up|3
5119802|NCT01731938|17687018|P1|Preliminary Part I|Lost to Follow-up|0
5119803|NCT01731938|17687017|P2|Preliminary Part I|Physician Decision|0
5119804|NCT01731938|17687018|P1|Preliminary Part I|Physician Decision|1
5119805|NCT01731938|17687017|P2|Preliminary Part I|Withdrawal by Subject|2
5119806|NCT01731938|17687018|P1|Preliminary Part I|Withdrawal by Subject|2
5119807|NCT01731912|17687030|P1|Overall Study|noncompliance|2
5119808|NCT01731886|17687037|P2|Overall Study|Non-compliant|0
5119809|NCT01731886|17687038|P1|Overall Study|Non-compliant|1
5119810|NCT01731886|17687037|P2|Overall Study|Never started treatment|1
5119811|NCT01731886|17687038|P1|Overall Study|Never started treatment|0
5119812|NCT01731886|17687037|P2|Overall Study|Death|0
5119813|NCT01731886|17687038|P1|Overall Study|Death|1
5119814|NCT01731678|17687083|P1|Overall Study|RMT too high, making TMS difficult|3
5119815|NCT01731678|17687083|P1|Overall Study|Did not meet inclusion criteria|1
5119816|NCT01731678|17687083|P1|Overall Study|Withdrawal by Subject|3
5119817|NCT01731600|17687089|P2|Overall Study|Other reasons|0
5119818|NCT01731600|17687090|P1|Overall Study|Other reasons|3
5119819|NCT01731600|17687089|P2|Overall Study|Withdrawal criteria|0
5119820|NCT01731600|17687090|P1|Overall Study|Withdrawal criteria|1
5119821|NCT01731600|17687089|P2|Overall Study|Adverse Event|0
5119822|NCT01731600|17687090|P1|Overall Study|Adverse Event|2
5119823|NCT01731470|17687144|P1|Overall Study|Did not meet study criteria|1
5119824|NCT01731470|17687144|P1|Overall Study|Withdrawal by Subject|1
5119825|NCT01731171|17687151|P2|Overall Study|Terminated for Safety Reasons|1
5119826|NCT01731171|17687152|P1|Overall Study|Terminated for Safety Reasons|0
5119827|NCT01731171|17687151|P2|Overall Study|Terminated for Lack of Adherence|1
5119828|NCT01731171|17687152|P1|Overall Study|Terminated for Lack of Adherence|0
5119829|NCT01731171|17687151|P2|Overall Study|Moved out of Area|2
5119830|NCT01731171|17687152|P1|Overall Study|Moved out of Area|0
5119831|NCT01731171|17687151|P2|Overall Study|Lost to Follow-up|2
5119832|NCT01731171|17687152|P1|Overall Study|Lost to Follow-up|3
5119833|NCT01731171|17687151|P2|Overall Study|Withdrawal by Subject|1
5119834|NCT01731171|17687152|P1|Overall Study|Withdrawal by Subject|4
5119835|NCT01731002|17687186|P3|Overall Study|Inappropriate use of study medications|1
5119836|NCT01731002|17687187|P2|Overall Study|Inappropriate use of study medications|0
5119837|NCT01731002|17687188|P1|Overall Study|Inappropriate use of study medications|0
5119838|NCT01731002|17687186|P3|Overall Study|Elevated IOP|0
5119839|NCT01731002|17687187|P2|Overall Study|Elevated IOP|0
5119840|NCT01731002|17687188|P1|Overall Study|Elevated IOP|1
5119841|NCT01731002|17687186|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
5119842|NCT01731002|17687187|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
5119843|NCT01731002|17687188|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
5119844|NCT01731002|17687186|P3|Overall Study|Test Agent Discontinuation|0
5119845|NCT01731002|17687187|P2|Overall Study|Test Agent Discontinuation|1
5119846|NCT01731002|17687188|P1|Overall Study|Test Agent Discontinuation|0
5119847|NCT01731002|17687186|P3|Overall Study|Lost to Follow-up|0
5119848|NCT01731002|17687187|P2|Overall Study|Lost to Follow-up|0
5119849|NCT01731002|17687188|P1|Overall Study|Lost to Follow-up|1
5119850|NCT01731002|17687186|P3|Overall Study|Non-Compliant|0
5119851|NCT01731002|17687187|P2|Overall Study|Non-Compliant|1
5119852|NCT01731002|17687188|P1|Overall Study|Non-Compliant|0
5119853|NCT01731002|17687186|P3|Overall Study|Adverse Event|2
5119854|NCT01731002|17687187|P2|Overall Study|Adverse Event|2
5119855|NCT01731002|17687188|P1|Overall Study|Adverse Event|0
5119856|NCT01730950|17687201|P2|Overall Study|Protocol Violation|6
5119857|NCT01730950|17687202|P1|Overall Study|Protocol Violation|6
5119858|NCT01730729|17687248|P1|Overall Study|Progressive Disease|12
5119859|NCT01730729|17687248|P1|Overall Study|Death|1
5119860|NCT01730729|17687248|P1|Overall Study|Adverse Event|1
5119861|NCT01730586|17687262|P1|Overall Study|Hospice|1
5119862|NCT01730586|17687262|P1|Overall Study|Adverse Event|2
5119863|NCT01730586|17687262|P1|Overall Study|Inadequate Trial|8
5119864|NCT01730586|17687262|P1|Overall Study|Progressive Disease|2
5119865|NCT01730534|17687271|P2|Overall Study|Lost to Follow-up|18
5119866|NCT01730534|17687272|P1|Overall Study|Lost to Follow-up|12
5119867|NCT01730534|17687271|P2|Overall Study|Withdrawal by Subject|127
5119868|NCT01730534|17687272|P1|Overall Study|Withdrawal by Subject|97
5119869|NCT01730378|17687286|P2|Overall Study|Lost to Follow-up|0
5119870|NCT01730378|17687287|P1|Overall Study|Lost to Follow-up|1
5119871|NCT01730339|17687318|P2|Overall Study|Un-specified|0
5119872|NCT01730339|17687319|P1|Overall Study|Un-specified|1
5119873|NCT01730339|17687318|P2|Overall Study|Lost to Follow-up|1
5119874|NCT01730339|17687319|P1|Overall Study|Lost to Follow-up|1
5119875|NCT01730339|17687318|P2|Overall Study|Withdrawal by Subject|2
5119876|NCT01730339|17687319|P1|Overall Study|Withdrawal by Subject|3
5119877|NCT01730053|17687359|P6|Overall Study|Other than specified|9
5119878|NCT01730053|17687360|P5|Overall Study|Other than specified|7
5119879|NCT01730053|17687361|P4|Overall Study|Other than specified|4
5119880|NCT01730053|17687362|P3|Overall Study|Other than specified|5
5119881|NCT01730053|17687363|P2|Overall Study|Other than specified|6
5119882|NCT01730053|17687364|P1|Overall Study|Other than specified|2
5119883|NCT01730053|17687359|P6|Overall Study|Poor compliance to protocol|2
5119884|NCT01730053|17687360|P5|Overall Study|Poor compliance to protocol|0
5119885|NCT01730053|17687361|P4|Overall Study|Poor compliance to protocol|0
5119886|NCT01730053|17687362|P3|Overall Study|Poor compliance to protocol|2
5119887|NCT01730053|17687363|P2|Overall Study|Poor compliance to protocol|2
5119888|NCT01730053|17687364|P1|Overall Study|Poor compliance to protocol|1
5119889|NCT01730053|17687359|P6|Overall Study|Adverse Event|2
5119890|NCT01730053|17687360|P5|Overall Study|Adverse Event|2
5119891|NCT01730053|17687361|P4|Overall Study|Adverse Event|3
5119892|NCT01730053|17687362|P3|Overall Study|Adverse Event|3
5119893|NCT01730053|17687363|P2|Overall Study|Adverse Event|6
5119894|NCT01730053|17687364|P1|Overall Study|Adverse Event|2
5119895|NCT01730053|17687359|P6|Overall Study|Physician Decision|0
5119896|NCT01730053|17687360|P5|Overall Study|Physician Decision|0
5119897|NCT01730053|17687361|P4|Overall Study|Physician Decision|1
5119898|NCT01730053|17687362|P3|Overall Study|Physician Decision|0
5119899|NCT01730053|17687363|P2|Overall Study|Physician Decision|0
5119900|NCT01730053|17687364|P1|Overall Study|Physician Decision|0
5119901|NCT01730053|17687359|P6|Overall Study|Participant moved|0
5119902|NCT01730053|17687360|P5|Overall Study|Participant moved|0
5119903|NCT01730053|17687361|P4|Overall Study|Participant moved|0
5119904|NCT01730053|17687362|P3|Overall Study|Participant moved|1
5119905|NCT01730053|17687363|P2|Overall Study|Participant moved|0
5119906|NCT01730053|17687364|P1|Overall Study|Participant moved|0
5119907|NCT01730040|17687523|P7|Overall Study|Poor compliance to protocol|1
5119908|NCT01730040|17687524|P6|Overall Study|Poor compliance to protocol|0
5119909|NCT01730040|17687525|P5|Overall Study|Poor compliance to protocol|0
5119910|NCT01730040|17687526|P4|Overall Study|Poor compliance to protocol|0
5119911|NCT01730040|17687527|P3|Overall Study|Poor compliance to protocol|0
5119912|NCT01730040|17687528|P2|Overall Study|Poor compliance to protocol|4
5119913|NCT01730040|17687529|P1|Overall Study|Poor compliance to protocol|2
5119914|NCT01730040|17687523|P7|Overall Study|Adverse Event|2
5119915|NCT01730040|17687524|P6|Overall Study|Adverse Event|1
5119916|NCT01730040|17687525|P5|Overall Study|Adverse Event|1
5119917|NCT01730040|17687526|P4|Overall Study|Adverse Event|3
5119918|NCT01730040|17687527|P3|Overall Study|Adverse Event|5
5119919|NCT01730040|17687528|P2|Overall Study|Adverse Event|3
5119920|NCT01730040|17687529|P1|Overall Study|Adverse Event|4
5119921|NCT01730040|17687523|P7|Overall Study|Other than specified|4
5119922|NCT01730040|17687524|P6|Overall Study|Other than specified|4
5119923|NCT01730040|17687525|P5|Overall Study|Other than specified|5
5119924|NCT01730040|17687526|P4|Overall Study|Other than specified|5
5119925|NCT01730040|17687527|P3|Overall Study|Other than specified|5
5119926|NCT01730040|17687528|P2|Overall Study|Other than specified|8
5119927|NCT01730040|17687529|P1|Overall Study|Other than specified|7
5119928|NCT01730040|17687523|P7|Overall Study|Physician Decision|1
5119929|NCT01730040|17687524|P6|Overall Study|Physician Decision|1
5119930|NCT01730040|17687525|P5|Overall Study|Physician Decision|0
5119931|NCT01730040|17687526|P4|Overall Study|Physician Decision|0
5119932|NCT01730040|17687527|P3|Overall Study|Physician Decision|0
5119933|NCT01730040|17687528|P2|Overall Study|Physician Decision|0
5119934|NCT01730040|17687529|P1|Overall Study|Physician Decision|0
5119935|NCT01730040|17687523|P7|Overall Study|Subject moved|1
5119936|NCT01730040|17687524|P6|Overall Study|Subject moved|0
5119937|NCT01730040|17687525|P5|Overall Study|Subject moved|0
5119938|NCT01730040|17687526|P4|Overall Study|Subject moved|0
5119939|NCT01730040|17687527|P3|Overall Study|Subject moved|1
5119940|NCT01730040|17687528|P2|Overall Study|Subject moved|0
5119941|NCT01730040|17687529|P1|Overall Study|Subject moved|0
5119942|NCT01730040|17687523|P7|Overall Study|Randomized but not treated|0
5119943|NCT01730040|17687524|P6|Overall Study|Randomized but not treated|1
5119944|NCT01730040|17687525|P5|Overall Study|Randomized but not treated|0
5119945|NCT01730040|17687526|P4|Overall Study|Randomized but not treated|0
5119946|NCT01730040|17687527|P3|Overall Study|Randomized but not treated|0
5119947|NCT01730040|17687528|P2|Overall Study|Randomized but not treated|0
5119948|NCT01730040|17687529|P1|Overall Study|Randomized but not treated|0
5119949|NCT01729871|17687718|P2|Overall Study|Other|9
5119950|NCT01729871|17687719|P1|Overall Study|Other|4
5119951|NCT01729871|17687718|P2|Overall Study|Withdrawal by Subject|3
5119952|NCT01729871|17687719|P1|Overall Study|Withdrawal by Subject|0
5119953|NCT01729871|17687718|P2|Overall Study|Protocol Violation|0
5119954|NCT01729871|17687719|P1|Overall Study|Protocol Violation|1
5119955|NCT01729871|17687718|P2|Overall Study|Physician Decision|2
5119956|NCT01729871|17687719|P1|Overall Study|Physician Decision|0
5119957|NCT01729871|17687718|P2|Overall Study|Lack of Efficacy|1
5119958|NCT01729871|17687719|P1|Overall Study|Lack of Efficacy|0
5119959|NCT01729871|17687718|P2|Overall Study|Death|1
5119960|NCT01729871|17687719|P1|Overall Study|Death|0
5119961|NCT01729871|17687718|P2|Overall Study|Adverse Event|7
5119962|NCT01729871|17687719|P1|Overall Study|Adverse Event|7
5119963|NCT01729819|17687753|P2|Overall Study|Withdrawal by Subject|2
5119964|NCT01729819|17687754|P1|Overall Study|Withdrawal by Subject|0
5119965|NCT01729819|17687753|P2|Overall Study|Protocol Violation|1
5119966|NCT01729819|17687754|P1|Overall Study|Protocol Violation|0
5119967|NCT01729819|17687753|P2|Overall Study|Other reason|0
5119968|NCT01729819|17687754|P1|Overall Study|Other reason|1
5119969|NCT01729819|17687753|P2|Overall Study|Lost to Follow-up|0
5119970|NCT01729819|17687754|P1|Overall Study|Lost to Follow-up|2
5119971|NCT01729819|17687753|P2|Overall Study|Lack of Efficacy|0
5119972|NCT01729819|17687754|P1|Overall Study|Lack of Efficacy|1
5119973|NCT01729819|17687753|P2|Overall Study|Adverse Event|4
5119974|NCT01729819|17687754|P1|Overall Study|Adverse Event|2
5119975|NCT01729754|17687773|P10|Part 3|Other Protocol Specified Criteria|0
5119976|NCT01729754|17687774|P9|Part 3|Other Protocol Specified Criteria|0
5119977|NCT01729754|17687775|P8|Part 3|Other Protocol Specified Criteria|1
5119978|NCT01729754|17687776|P7|Part 3|Other Protocol Specified Criteria|0
5119979|NCT01729754|17687777|P6|Part 3|Other Protocol Specified Criteria|2
5119980|NCT01729754|17687778|P5|Part 3|Other Protocol Specified Criteria|0
5119981|NCT01729754|17687779|P4|Part 3|Other Protocol Specified Criteria|0
5119982|NCT01729754|17687780|P3|Part 3|Other Protocol Specified Criteria|0
5119983|NCT01729754|17687781|P2|Part 3|Other Protocol Specified Criteria|0
5119984|NCT01729754|17687782|P1|Part 3|Other Protocol Specified Criteria|0
5119985|NCT01729754|17687773|P10|Part 3|Withdrawal by Subject|0
5119986|NCT01729754|17687774|P9|Part 3|Withdrawal by Subject|0
5119987|NCT01729754|17687775|P8|Part 3|Withdrawal by Subject|2
5119988|NCT01729754|17687776|P7|Part 3|Withdrawal by Subject|0
5119989|NCT01729754|17687777|P6|Part 3|Withdrawal by Subject|1
5119990|NCT01729754|17687778|P5|Part 3|Withdrawal by Subject|2
5119991|NCT01729754|17687779|P4|Part 3|Withdrawal by Subject|0
5119992|NCT01729754|17687780|P3|Part 3|Withdrawal by Subject|1
5119993|NCT01729754|17687781|P2|Part 3|Withdrawal by Subject|4
5119994|NCT01729754|17687782|P1|Part 3|Withdrawal by Subject|0
5119995|NCT01729754|17687773|P10|Part 3|Physician Decision|0
5119996|NCT01729754|17687774|P9|Part 3|Physician Decision|0
5119997|NCT01729754|17687775|P8|Part 3|Physician Decision|0
5119998|NCT01729754|17687776|P7|Part 3|Physician Decision|0
5119999|NCT01729754|17687777|P6|Part 3|Physician Decision|0
5120000|NCT01729754|17687778|P5|Part 3|Physician Decision|0
5120001|NCT01729754|17687779|P4|Part 3|Physician Decision|0
5120002|NCT01729754|17687780|P3|Part 3|Physician Decision|1
5120003|NCT01729754|17687781|P2|Part 3|Physician Decision|0
5120004|NCT01729754|17687782|P1|Part 3|Physician Decision|0
5120005|NCT01729754|17687773|P10|Part 3|Lost to Follow-up|0
5120006|NCT01729754|17687774|P9|Part 3|Lost to Follow-up|1
5120007|NCT01729754|17687775|P8|Part 3|Lost to Follow-up|0
5120008|NCT01729754|17687776|P7|Part 3|Lost to Follow-up|0
5120009|NCT01729754|17687777|P6|Part 3|Lost to Follow-up|3
5120010|NCT01729754|17687778|P5|Part 3|Lost to Follow-up|0
5120011|NCT01729754|17687779|P4|Part 3|Lost to Follow-up|0
5120012|NCT01729754|17687780|P3|Part 3|Lost to Follow-up|2
5120013|NCT01729754|17687781|P2|Part 3|Lost to Follow-up|1
5120014|NCT01729754|17687782|P1|Part 3|Lost to Follow-up|0
5120015|NCT01729754|17687773|P10|Part 3|Lack of Efficacy|4
5120016|NCT01729754|17687774|P9|Part 3|Lack of Efficacy|0
5120017|NCT01729754|17687775|P8|Part 3|Lack of Efficacy|0
5120018|NCT01729754|17687776|P7|Part 3|Lack of Efficacy|0
5120019|NCT01729754|17687777|P6|Part 3|Lack of Efficacy|0
5120020|NCT01729754|17687778|P5|Part 3|Lack of Efficacy|2
5120021|NCT01729754|17687779|P4|Part 3|Lack of Efficacy|0
5120022|NCT01729754|17687780|P3|Part 3|Lack of Efficacy|0
5120023|NCT01729754|17687781|P2|Part 3|Lack of Efficacy|0
5120024|NCT01729754|17687782|P1|Part 3|Lack of Efficacy|0
5120025|NCT01729754|17687773|P10|Part 3|Death|0
5120026|NCT01729754|17687774|P9|Part 3|Death|0
5120027|NCT01729754|17687775|P8|Part 3|Death|0
5120028|NCT01729754|17687776|P7|Part 3|Death|0
5120029|NCT01729754|17687777|P6|Part 3|Death|2
5120030|NCT01729754|17687778|P5|Part 3|Death|0
5120031|NCT01729754|17687779|P4|Part 3|Death|0
5120032|NCT01729754|17687780|P3|Part 3|Death|0
5120033|NCT01729754|17687781|P2|Part 3|Death|0
5120034|NCT01729754|17687782|P1|Part 3|Death|0
5120035|NCT01729754|17687773|P10|Part 3|Adverse Event|3
5120036|NCT01729754|17687774|P9|Part 3|Adverse Event|0
5120037|NCT01729754|17687775|P8|Part 3|Adverse Event|0
5120038|NCT01729754|17687776|P7|Part 3|Adverse Event|0
5120039|NCT01729754|17687777|P6|Part 3|Adverse Event|5
5120040|NCT01729754|17687778|P5|Part 3|Adverse Event|0
5120041|NCT01729754|17687779|P4|Part 3|Adverse Event|0
5120042|NCT01729754|17687780|P3|Part 3|Adverse Event|1
5120043|NCT01729754|17687781|P2|Part 3|Adverse Event|0
5120044|NCT01729754|17687782|P1|Part 3|Adverse Event|0
5120045|NCT01729754|17687773|P10|Part 2|Other Protocol Specified Criteria|0
5120046|NCT01729754|17687774|P9|Part 2|Other Protocol Specified Criteria|0
5120047|NCT01729754|17687775|P8|Part 2|Other Protocol Specified Criteria|1
5120048|NCT01729754|17687776|P7|Part 2|Other Protocol Specified Criteria|0
5120049|NCT01729754|17687777|P6|Part 2|Other Protocol Specified Criteria|0
5120050|NCT01729754|17687778|P5|Part 2|Other Protocol Specified Criteria|0
5120051|NCT01729754|17687779|P4|Part 2|Other Protocol Specified Criteria|0
5120052|NCT01729754|17687780|P3|Part 2|Other Protocol Specified Criteria|0
5120053|NCT01729754|17687781|P2|Part 2|Other Protocol Specified Criteria|0
5120054|NCT01729754|17687782|P1|Part 2|Other Protocol Specified Criteria|1
5120055|NCT01729754|17687773|P10|Part 2|Withdrawal by Subject|4
5120056|NCT01729754|17687774|P9|Part 2|Withdrawal by Subject|1
5120057|NCT01729754|17687775|P8|Part 2|Withdrawal by Subject|1
5120058|NCT01729754|17687776|P7|Part 2|Withdrawal by Subject|0
5120059|NCT01729754|17687777|P6|Part 2|Withdrawal by Subject|0
5120060|NCT01729754|17687778|P5|Part 2|Withdrawal by Subject|0
5120061|NCT01729754|17687779|P4|Part 2|Withdrawal by Subject|2
5120062|NCT01729754|17687780|P3|Part 2|Withdrawal by Subject|0
5120063|NCT01729754|17687781|P2|Part 2|Withdrawal by Subject|0
5120064|NCT01729754|17687782|P1|Part 2|Withdrawal by Subject|3
5120065|NCT01729754|17687773|P10|Part 2|Pregnancy|1
5120066|NCT01729754|17687774|P9|Part 2|Pregnancy|0
5120067|NCT01729754|17687775|P8|Part 2|Pregnancy|0
5120068|NCT01729754|17687776|P7|Part 2|Pregnancy|0
5120069|NCT01729754|17687777|P6|Part 2|Pregnancy|0
5120070|NCT01729754|17687778|P5|Part 2|Pregnancy|0
5120071|NCT01729754|17687779|P4|Part 2|Pregnancy|1
5120072|NCT01729754|17687780|P3|Part 2|Pregnancy|0
5120073|NCT01729754|17687781|P2|Part 2|Pregnancy|0
5120074|NCT01729754|17687782|P1|Part 2|Pregnancy|0
5120075|NCT01729754|17687773|P10|Part 2|Non-Compliance with Study Drug|1
5120076|NCT01729754|17687774|P9|Part 2|Non-Compliance with Study Drug|0
5120077|NCT01729754|17687775|P8|Part 2|Non-Compliance with Study Drug|0
5120078|NCT01729754|17687776|P7|Part 2|Non-Compliance with Study Drug|0
5120079|NCT01729754|17687777|P6|Part 2|Non-Compliance with Study Drug|0
5120080|NCT01729754|17687778|P5|Part 2|Non-Compliance with Study Drug|0
5120081|NCT01729754|17687779|P4|Part 2|Non-Compliance with Study Drug|0
5120082|NCT01729754|17687780|P3|Part 2|Non-Compliance with Study Drug|0
5120083|NCT01729754|17687781|P2|Part 2|Non-Compliance with Study Drug|0
5120084|NCT01729754|17687782|P1|Part 2|Non-Compliance with Study Drug|0
5120085|NCT01729754|17687773|P10|Part 2|Lost to Follow-up|2
5120086|NCT01729754|17687774|P9|Part 2|Lost to Follow-up|0
5120087|NCT01729754|17687775|P8|Part 2|Lost to Follow-up|1
5120088|NCT01729754|17687776|P7|Part 2|Lost to Follow-up|0
5120089|NCT01729754|17687777|P6|Part 2|Lost to Follow-up|0
5120090|NCT01729754|17687778|P5|Part 2|Lost to Follow-up|0
5120091|NCT01729754|17687779|P4|Part 2|Lost to Follow-up|2
5120092|NCT01729754|17687780|P3|Part 2|Lost to Follow-up|0
5120093|NCT01729754|17687781|P2|Part 2|Lost to Follow-up|0
5120094|NCT01729754|17687782|P1|Part 2|Lost to Follow-up|0
5120095|NCT01729754|17687773|P10|Part 2|Lack of Efficacy|2
5120096|NCT01729754|17687774|P9|Part 2|Lack of Efficacy|2
5120097|NCT01729754|17687775|P8|Part 2|Lack of Efficacy|0
5120098|NCT01729754|17687776|P7|Part 2|Lack of Efficacy|0
5120099|NCT01729754|17687777|P6|Part 2|Lack of Efficacy|0
5120100|NCT01729754|17687778|P5|Part 2|Lack of Efficacy|0
5120101|NCT01729754|17687779|P4|Part 2|Lack of Efficacy|0
5120102|NCT01729754|17687780|P3|Part 2|Lack of Efficacy|0
5120103|NCT01729754|17687781|P2|Part 2|Lack of Efficacy|0
5120104|NCT01729754|17687782|P1|Part 2|Lack of Efficacy|0
5120105|NCT01729754|17687773|P10|Part 2|Adverse Event|2
5120106|NCT01729754|17687774|P9|Part 2|Adverse Event|1
5120107|NCT01729754|17687775|P8|Part 2|Adverse Event|0
5120108|NCT01729754|17687776|P7|Part 2|Adverse Event|0
5120109|NCT01729754|17687777|P6|Part 2|Adverse Event|0
5120110|NCT01729754|17687778|P5|Part 2|Adverse Event|0
5120111|NCT01729754|17687779|P4|Part 2|Adverse Event|0
5120112|NCT01729754|17687780|P3|Part 2|Adverse Event|0
5120113|NCT01729754|17687781|P2|Part 2|Adverse Event|0
5120114|NCT01729754|17687782|P1|Part 2|Adverse Event|2
5120115|NCT01729754|17687773|P10|Part 1|Other Protocol Specified Criteria|4
5120116|NCT01729754|17687774|P9|Part 1|Other Protocol Specified Criteria|0
5120117|NCT01729754|17687775|P8|Part 1|Other Protocol Specified Criteria|0
5120118|NCT01729754|17687776|P7|Part 1|Other Protocol Specified Criteria|1
5120119|NCT01729754|17687777|P6|Part 1|Other Protocol Specified Criteria|0
5120120|NCT01729754|17687778|P5|Part 1|Other Protocol Specified Criteria|0
5120121|NCT01729754|17687779|P4|Part 1|Other Protocol Specified Criteria|0
5120122|NCT01729754|17687780|P3|Part 1|Other Protocol Specified Criteria|0
5120123|NCT01729754|17687781|P2|Part 1|Other Protocol Specified Criteria|0
5120124|NCT01729754|17687782|P1|Part 1|Other Protocol Specified Criteria|2
5120125|NCT01729754|17687773|P10|Part 1|Withdrawal by Subject|6
5120126|NCT01729754|17687774|P9|Part 1|Withdrawal by Subject|0
5120127|NCT01729754|17687775|P8|Part 1|Withdrawal by Subject|0
5120128|NCT01729754|17687776|P7|Part 1|Withdrawal by Subject|5
5120129|NCT01729754|17687777|P6|Part 1|Withdrawal by Subject|0
5120130|NCT01729754|17687778|P5|Part 1|Withdrawal by Subject|0
5120131|NCT01729754|17687779|P4|Part 1|Withdrawal by Subject|7
5120132|NCT01729754|17687780|P3|Part 1|Withdrawal by Subject|0
5120133|NCT01729754|17687781|P2|Part 1|Withdrawal by Subject|0
5120134|NCT01729754|17687782|P1|Part 1|Withdrawal by Subject|5
5120135|NCT01729754|17687773|P10|Part 1|Protocol Violation|0
5120136|NCT01729754|17687774|P9|Part 1|Protocol Violation|0
5120137|NCT01729754|17687775|P8|Part 1|Protocol Violation|0
5120138|NCT01729754|17687776|P7|Part 1|Protocol Violation|1
5120139|NCT01729754|17687777|P6|Part 1|Protocol Violation|0
5120140|NCT01729754|17687778|P5|Part 1|Protocol Violation|0
5120141|NCT01729754|17687779|P4|Part 1|Protocol Violation|1
5120142|NCT01729754|17687780|P3|Part 1|Protocol Violation|0
5120143|NCT01729754|17687781|P2|Part 1|Protocol Violation|0
5120144|NCT01729754|17687782|P1|Part 1|Protocol Violation|2
5120145|NCT01729754|17687773|P10|Part 1|Progressive Disease|1
5120146|NCT01729754|17687774|P9|Part 1|Progressive Disease|0
5120147|NCT01729754|17687775|P8|Part 1|Progressive Disease|0
5120148|NCT01729754|17687776|P7|Part 1|Progressive Disease|0
5120149|NCT01729754|17687777|P6|Part 1|Progressive Disease|0
5120150|NCT01729754|17687778|P5|Part 1|Progressive Disease|0
5120151|NCT01729754|17687779|P4|Part 1|Progressive Disease|0
5120152|NCT01729754|17687780|P3|Part 1|Progressive Disease|0
5120153|NCT01729754|17687781|P2|Part 1|Progressive Disease|0
5120154|NCT01729754|17687782|P1|Part 1|Progressive Disease|0
5120155|NCT01729754|17687773|P10|Part 1|Pregnancy|1
5120156|NCT01729754|17687774|P9|Part 1|Pregnancy|0
5120157|NCT01729754|17687775|P8|Part 1|Pregnancy|0
5120158|NCT01729754|17687776|P7|Part 1|Pregnancy|0
5120159|NCT01729754|17687777|P6|Part 1|Pregnancy|0
5120160|NCT01729754|17687778|P5|Part 1|Pregnancy|0
5120161|NCT01729754|17687779|P4|Part 1|Pregnancy|1
5120162|NCT01729754|17687780|P3|Part 1|Pregnancy|0
5120163|NCT01729754|17687781|P2|Part 1|Pregnancy|0
5120164|NCT01729754|17687782|P1|Part 1|Pregnancy|0
5120165|NCT01729754|17687773|P10|Part 1|Physician Decision|4
5120166|NCT01729754|17687774|P9|Part 1|Physician Decision|0
5120167|NCT01729754|17687775|P8|Part 1|Physician Decision|0
5120168|NCT01729754|17687776|P7|Part 1|Physician Decision|0
5120169|NCT01729754|17687777|P6|Part 1|Physician Decision|0
5120170|NCT01729754|17687778|P5|Part 1|Physician Decision|0
5120171|NCT01729754|17687779|P4|Part 1|Physician Decision|0
5120172|NCT01729754|17687780|P3|Part 1|Physician Decision|0
5120173|NCT01729754|17687781|P2|Part 1|Physician Decision|0
5120174|NCT01729754|17687782|P1|Part 1|Physician Decision|0
5120175|NCT01729754|17687773|P10|Part 1|Non-compliance with Study Drug|0
5120176|NCT01729754|17687774|P9|Part 1|Non-compliance with Study Drug|0
5120177|NCT01729754|17687775|P8|Part 1|Non-compliance with Study Drug|0
5120178|NCT01729754|17687776|P7|Part 1|Non-compliance with Study Drug|0
5120179|NCT01729754|17687777|P6|Part 1|Non-compliance with Study Drug|0
5120180|NCT01729754|17687778|P5|Part 1|Non-compliance with Study Drug|0
5120181|NCT01729754|17687779|P4|Part 1|Non-compliance with Study Drug|0
5120182|NCT01729754|17687780|P3|Part 1|Non-compliance with Study Drug|0
5120183|NCT01729754|17687781|P2|Part 1|Non-compliance with Study Drug|0
5120184|NCT01729754|17687782|P1|Part 1|Non-compliance with Study Drug|1
5120185|NCT01729754|17687773|P10|Part 1|Lost to Follow-up|3
5120186|NCT01729754|17687774|P9|Part 1|Lost to Follow-up|0
5120187|NCT01729754|17687775|P8|Part 1|Lost to Follow-up|0
5120188|NCT01729754|17687776|P7|Part 1|Lost to Follow-up|3
5120189|NCT01729754|17687777|P6|Part 1|Lost to Follow-up|0
5120190|NCT01729754|17687778|P5|Part 1|Lost to Follow-up|0
5120191|NCT01729754|17687779|P4|Part 1|Lost to Follow-up|2
5120192|NCT01729754|17687780|P3|Part 1|Lost to Follow-up|0
5120193|NCT01729754|17687781|P2|Part 1|Lost to Follow-up|0
5120194|NCT01729754|17687782|P1|Part 1|Lost to Follow-up|1
5120195|NCT01729754|17687773|P10|Part 1|Lack of Efficacy|0
5120196|NCT01729754|17687774|P9|Part 1|Lack of Efficacy|0
5120197|NCT01729754|17687775|P8|Part 1|Lack of Efficacy|0
5120198|NCT01729754|17687776|P7|Part 1|Lack of Efficacy|2
5120199|NCT01729754|17687777|P6|Part 1|Lack of Efficacy|0
5120200|NCT01729754|17687778|P5|Part 1|Lack of Efficacy|0
5120201|NCT01729754|17687779|P4|Part 1|Lack of Efficacy|0
5120202|NCT01729754|17687780|P3|Part 1|Lack of Efficacy|0
5120203|NCT01729754|17687781|P2|Part 1|Lack of Efficacy|0
5120204|NCT01729754|17687782|P1|Part 1|Lack of Efficacy|1
5120205|NCT01729754|17687773|P10|Part 1|Adverse Event|5
5120206|NCT01729754|17687774|P9|Part 1|Adverse Event|0
5120207|NCT01729754|17687775|P8|Part 1|Adverse Event|0
5120208|NCT01729754|17687776|P7|Part 1|Adverse Event|2
5120209|NCT01729754|17687777|P6|Part 1|Adverse Event|0
5120210|NCT01729754|17687778|P5|Part 1|Adverse Event|0
5120211|NCT01729754|17687779|P4|Part 1|Adverse Event|1
5120212|NCT01729754|17687780|P3|Part 1|Adverse Event|0
5120213|NCT01729754|17687781|P2|Part 1|Adverse Event|0
5120214|NCT01729754|17687782|P1|Part 1|Adverse Event|2
5120215|NCT01729728|17687989|P3|Overall Study|Protocol Violation|1
5120216|NCT01729728|17687990|P2|Overall Study|Protocol Violation|0
5120217|NCT01729728|17687991|P1|Overall Study|Protocol Violation|1
5120218|NCT01729728|17687989|P3|Overall Study|Adverse Event|0
5120219|NCT01729728|17687990|P2|Overall Study|Adverse Event|6
5120220|NCT01729728|17687991|P1|Overall Study|Adverse Event|0
5120221|NCT01729559|17688141|P2|Overall Study|Protocol Violation|28
5120222|NCT01729559|17688142|P1|Overall Study|Protocol Violation|31
5120223|NCT01729208|17688185|P2|36 Months Follow-up|Withdrawal by Subject|4
5120224|NCT01729208|17688186|P1|36 Months Follow-up|Withdrawal by Subject|2
5120225|NCT01729208|17688185|P2|36 Months Follow-up|Physician Decision|0
5120226|NCT01729208|17688186|P1|36 Months Follow-up|Physician Decision|1
5120227|NCT01729208|17688185|P2|24 Months Follow-up|Lost to Follow-up|0
5120228|NCT01729208|17688186|P1|24 Months Follow-up|Lost to Follow-up|3
5120229|NCT01729208|17688185|P2|12 Months Follow-up|Lost to Follow-up|3
5120230|NCT01729208|17688186|P1|12 Months Follow-up|Lost to Follow-up|3
5120231|NCT01729208|17688185|P2|12 Months Follow-up|Withdrawal by Subject|7
5120232|NCT01729208|17688186|P1|12 Months Follow-up|Withdrawal by Subject|4
5120233|NCT01729208|17688185|P2|Baseline|Physician Decision|4
5120234|NCT01729208|17688186|P1|Baseline|Physician Decision|5
5120235|NCT01729156|17688219|P3|Overall Study|Withdrawal by Subject|0
5120236|NCT01729156|17688220|P2|Overall Study|Withdrawal by Subject|0
5120237|NCT01729156|17688221|P1|Overall Study|Withdrawal by Subject|1
5120238|NCT01729039|17688249|P2|Overall Study|Withdrawal by Subject|7
5120239|NCT01729039|17688250|P1|Overall Study|Withdrawal by Subject|8
5120240|NCT01729039|17688249|P2|Overall Study|disqualified|5
5120241|NCT01729039|17688250|P1|Overall Study|disqualified|2
5120242|NCT01729026|17688266|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
5120243|NCT01729026|17688267|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
5120244|NCT01729026|17688266|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
5120245|NCT01729026|17688267|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
5120246|NCT01728792|17688370|P5|Overall Study|Lost to Follow-up|0
5120247|NCT01728792|17688371|P4|Overall Study|Lost to Follow-up|2
5120248|NCT01728792|17688372|P3|Overall Study|Lost to Follow-up|4
5120249|NCT01728792|17688373|P2|Overall Study|Lost to Follow-up|1
5120250|NCT01728792|17688374|P1|Overall Study|Lost to Follow-up|2
5120251|NCT01728792|17688370|P5|Overall Study|Withdrawal of Consent|0
5120252|NCT01728792|17688371|P4|Overall Study|Withdrawal of Consent|1
5120253|NCT01728792|17688372|P3|Overall Study|Withdrawal of Consent|0
5120254|NCT01728792|17688373|P2|Overall Study|Withdrawal of Consent|1
5120255|NCT01728792|17688374|P1|Overall Study|Withdrawal of Consent|1
5120256|NCT01728623|17688424|P1|Overall Study|Withdrawal by Subject|1
5120257|NCT01728623|17688424|P1|Overall Study|Adverse Event|1
5120258|NCT01728623|17688424|P1|Overall Study|Disease progression|26
5120259|NCT01728584|17688450|P4|Overall Study|Other reason (not specified)|1
5120260|NCT01728584|17688451|P3|Overall Study|Other reason (not specified)|0
5120261|NCT01728584|17688452|P2|Overall Study|Other reason (not specified)|0
5120262|NCT01728584|17688453|P1|Overall Study|Other reason (not specified)|1
5120263|NCT01728584|17688450|P4|Overall Study|Screen failure|0
5120264|NCT01728584|17688451|P3|Overall Study|Screen failure|0
5120265|NCT01728584|17688452|P2|Overall Study|Screen failure|0
5120266|NCT01728584|17688453|P1|Overall Study|Screen failure|1
5120267|NCT01728584|17688450|P4|Overall Study|Withdrawal by Subject|0
5120268|NCT01728584|17688451|P3|Overall Study|Withdrawal by Subject|0
5120269|NCT01728584|17688452|P2|Overall Study|Withdrawal by Subject|0
5120270|NCT01728584|17688453|P1|Overall Study|Withdrawal by Subject|1
5120271|NCT01728584|17688450|P4|Overall Study|Physician Decision|0
5120272|NCT01728584|17688451|P3|Overall Study|Physician Decision|1
5120273|NCT01728584|17688452|P2|Overall Study|Physician Decision|0
5120274|NCT01728584|17688453|P1|Overall Study|Physician Decision|4
5120275|NCT01728584|17688450|P4|Overall Study|Adverse Event|0
5120276|NCT01728584|17688451|P3|Overall Study|Adverse Event|0
5120277|NCT01728584|17688452|P2|Overall Study|Adverse Event|0
5120278|NCT01728584|17688453|P1|Overall Study|Adverse Event|1
5120279|NCT01728454|17688508|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
5120280|NCT01728454|17688509|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
5120281|NCT01728454|17688510|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
5120282|NCT01728454|17688508|P3|Stage 3|Lost to Follow-up|1
5120283|NCT01728454|17688509|P2|Stage 3|Lost to Follow-up|3
5120284|NCT01728454|17688510|P1|Stage 3|Lost to Follow-up|0
5120285|NCT01728454|17688508|P3|Stage 3|Non-compliance with Protocol|1
5120286|NCT01728454|17688509|P2|Stage 3|Non-compliance with Protocol|0
5120287|NCT01728454|17688510|P1|Stage 3|Non-compliance with Protocol|0
5120288|NCT01728454|17688508|P3|Stage 3|Withdrew Consent|1
5120289|NCT01728454|17688509|P2|Stage 3|Withdrew Consent|0
5120290|NCT01728454|17688510|P1|Stage 3|Withdrew Consent|1
5120291|NCT01728454|17688508|P3|Stage 3|Pregnancy|0
5120292|NCT01728454|17688509|P2|Stage 3|Pregnancy|0
5120293|NCT01728454|17688510|P1|Stage 3|Pregnancy|1
5120294|NCT01728454|17688508|P3|Stage 3|Subject Required Other Treatment|0
5120295|NCT01728454|17688509|P2|Stage 3|Subject Required Other Treatment|1
5120296|NCT01728454|17688510|P1|Stage 3|Subject Required Other Treatment|0
5120297|NCT01728454|17688508|P3|Stage 3|Reason Missing|1
5120298|NCT01728454|17688509|P2|Stage 3|Reason Missing|0
5120299|NCT01728454|17688510|P1|Stage 3|Reason Missing|0
5120300|NCT01728454|17688508|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
5120301|NCT01728454|17688509|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
5120302|NCT01728454|17688510|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
5120303|NCT01728454|17688508|P3|Stage 1 and 2|Lost to Follow-up|0
5120304|NCT01728454|17688509|P2|Stage 1 and 2|Lost to Follow-up|1
5120305|NCT01728454|17688510|P1|Stage 1 and 2|Lost to Follow-up|1
5120306|NCT01728454|17688508|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
5120307|NCT01728454|17688509|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
5120308|NCT01728454|17688510|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
5120309|NCT01728454|17688508|P3|Stage 1 and 2|Non-compliance with Protocol|1
5120310|NCT01728454|17688509|P2|Stage 1 and 2|Non-compliance with Protocol|0
5120311|NCT01728454|17688510|P1|Stage 1 and 2|Non-compliance with Protocol|0
5120312|NCT01728454|17688508|P3|Stage 1 and 2|Pregnancy|0
5120313|NCT01728454|17688509|P2|Stage 1 and 2|Pregnancy|0
5120314|NCT01728454|17688510|P1|Stage 1 and 2|Pregnancy|1
5120315|NCT01728376|17688560|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
5120316|NCT01728376|17688561|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
5120317|NCT01728376|17688562|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
5120318|NCT01728376|17688563|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
5120319|NCT01728376|17688564|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
5120320|NCT01728376|17688565|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
5120321|NCT01728376|17688560|P6|Overall Study|Did not receive treatment|0
5120322|NCT01728376|17688561|P5|Overall Study|Did not receive treatment|0
5120323|NCT01728376|17688562|P4|Overall Study|Did not receive treatment|0
5120324|NCT01728376|17688563|P3|Overall Study|Did not receive treatment|0
5120325|NCT01728376|17688564|P2|Overall Study|Did not receive treatment|1
5120326|NCT01728376|17688565|P1|Overall Study|Did not receive treatment|0
5120327|NCT01728376|17688560|P6|Overall Study|No relevant bacteria|1
5120328|NCT01728376|17688561|P5|Overall Study|No relevant bacteria|1
5120329|NCT01728376|17688562|P4|Overall Study|No relevant bacteria|0
5120330|NCT01728376|17688563|P3|Overall Study|No relevant bacteria|0
5120331|NCT01728376|17688564|P2|Overall Study|No relevant bacteria|0
5120332|NCT01728376|17688565|P1|Overall Study|No relevant bacteria|2
5120333|NCT01728376|17688560|P6|Overall Study|Persistent Positive Blood Cultures|0
5120334|NCT01728376|17688561|P5|Overall Study|Persistent Positive Blood Cultures|0
5120335|NCT01728376|17688562|P4|Overall Study|Persistent Positive Blood Cultures|0
5120336|NCT01728376|17688563|P3|Overall Study|Persistent Positive Blood Cultures|1
5120337|NCT01728376|17688564|P2|Overall Study|Persistent Positive Blood Cultures|0
5120338|NCT01728376|17688565|P1|Overall Study|Persistent Positive Blood Cultures|1
5120339|NCT01728376|17688560|P6|Overall Study|Adverse Event|0
5120340|NCT01728376|17688561|P5|Overall Study|Adverse Event|1
5120341|NCT01728376|17688562|P4|Overall Study|Adverse Event|1
5120342|NCT01728376|17688563|P3|Overall Study|Adverse Event|1
5120343|NCT01728376|17688564|P2|Overall Study|Adverse Event|1
5120344|NCT01728376|17688565|P1|Overall Study|Adverse Event|1
5120345|NCT01728324|17688638|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
5120346|NCT01728324|17688639|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
5120347|NCT01728324|17688640|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
5120348|NCT01728324|17688638|P3|Termination of RBV|Adverse Event (Placebo Period)|0
5120349|NCT01728324|17688639|P2|Termination of RBV|Adverse Event (Placebo Period)|1
5120350|NCT01728324|17688640|P1|Termination of RBV|Adverse Event (Placebo Period)|0
5120351|NCT01728324|17688638|P3|Termination of RBV|Other than stated|1
5120352|NCT01728324|17688639|P2|Termination of RBV|Other than stated|3
5120353|NCT01728324|17688640|P1|Termination of RBV|Other than stated|1
5120354|NCT01728324|17688638|P3|Termination of RBV|Withdrawal by Subject|2
5120355|NCT01728324|17688639|P2|Termination of RBV|Withdrawal by Subject|5
5120356|NCT01728324|17688640|P1|Termination of RBV|Withdrawal by Subject|9
5120357|NCT01728324|17688638|P3|Termination of RBV|Lack of Efficacy|7
5120358|NCT01728324|17688639|P2|Termination of RBV|Lack of Efficacy|11
5120359|NCT01728324|17688640|P1|Termination of RBV|Lack of Efficacy|14
5120360|NCT01728324|17688638|P3|Termination of RBV|Adverse Event|5
5120361|NCT01728324|17688639|P2|Termination of RBV|Adverse Event|16
5120362|NCT01728324|17688640|P1|Termination of RBV|Adverse Event|15
5120363|NCT01728324|17688638|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
5120364|NCT01728324|17688639|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
5120365|NCT01728324|17688640|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
5120366|NCT01728324|17688638|P3|Termination of FDV|Adverse Event (Placebo Period)|0
5120367|NCT01728324|17688639|P2|Termination of FDV|Adverse Event (Placebo Period)|1
5120368|NCT01728324|17688640|P1|Termination of FDV|Adverse Event (Placebo Period)|0
5120369|NCT01728324|17688638|P3|Termination of FDV|Other than stated|0
5120370|NCT01728324|17688639|P2|Termination of FDV|Other than stated|3
5120371|NCT01728324|17688640|P1|Termination of FDV|Other than stated|1
5120372|NCT01728324|17688638|P3|Termination of FDV|Withdrawal by Subject|2
5120373|NCT01728324|17688639|P2|Termination of FDV|Withdrawal by Subject|6
5120374|NCT01728324|17688640|P1|Termination of FDV|Withdrawal by Subject|9
5120375|NCT01728324|17688638|P3|Termination of FDV|Lack of Efficacy|8
5120376|NCT01728324|17688639|P2|Termination of FDV|Lack of Efficacy|12
5120377|NCT01728324|17688640|P1|Termination of FDV|Lack of Efficacy|14
5120378|NCT01728324|17688638|P3|Termination of FDV|Adverse Event|4
5120379|NCT01728324|17688639|P2|Termination of FDV|Adverse Event|13
5120380|NCT01728324|17688640|P1|Termination of FDV|Adverse Event|14
5120381|NCT01728324|17688638|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
5120382|NCT01728324|17688639|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
5120383|NCT01728324|17688640|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
5120384|NCT01728324|17688638|P3|Termination of DBV|Adverse Event (Placebo Period)|0
5120385|NCT01728324|17688639|P2|Termination of DBV|Adverse Event (Placebo Period)|1
5120386|NCT01728324|17688640|P1|Termination of DBV|Adverse Event (Placebo Period)|0
5120387|NCT01728324|17688638|P3|Termination of DBV|Other than stated|0
5120388|NCT01728324|17688639|P2|Termination of DBV|Other than stated|3
5120389|NCT01728324|17688640|P1|Termination of DBV|Other than stated|1
5120390|NCT01728324|17688638|P3|Termination of DBV|Withdrawal by Subject|2
5120391|NCT01728324|17688639|P2|Termination of DBV|Withdrawal by Subject|6
5120392|NCT01728324|17688640|P1|Termination of DBV|Withdrawal by Subject|9
5120393|NCT01728324|17688638|P3|Termination of DBV|Lack of Efficacy|8
5120394|NCT01728324|17688639|P2|Termination of DBV|Lack of Efficacy|12
5120395|NCT01728324|17688640|P1|Termination of DBV|Lack of Efficacy|14
5120396|NCT01728324|17688638|P3|Termination of DBV|Adverse Event|4
5120397|NCT01728324|17688639|P2|Termination of DBV|Adverse Event|13
5120398|NCT01728324|17688640|P1|Termination of DBV|Adverse Event|14
5120399|NCT01728246|17688661|P2|Overall Study|Adverse Event|5
5120400|NCT01728246|17688662|P1|Overall Study|Adverse Event|8
5120401|NCT01728246|17688661|P2|Overall Study|Lack of Efficacy|1
5120402|NCT01728246|17688662|P1|Overall Study|Lack of Efficacy|1
5120403|NCT01728246|17688661|P2|Overall Study|Lost to Follow-up|22
5120404|NCT01728246|17688662|P1|Overall Study|Lost to Follow-up|23
5120405|NCT01728246|17688661|P2|Overall Study|Withdrawal by Subject|3
5120406|NCT01728246|17688662|P1|Overall Study|Withdrawal by Subject|2
5120407|NCT01728246|17688661|P2|Overall Study|Protocol Violation|0
5120408|NCT01728246|17688662|P1|Overall Study|Protocol Violation|1
5120409|NCT01728246|17688661|P2|Overall Study|Participant needed rescue medication|5
5120410|NCT01728246|17688662|P1|Overall Study|Participant needed rescue medication|1
5120411|NCT01728194|17688680|P2|Overall Study|Family Member Request|0
5120412|NCT01728194|17688681|P1|Overall Study|Family Member Request|1
5120413|NCT01728194|17688680|P2|Overall Study|Perceived Medication Side Effects|0
5120414|NCT01728194|17688681|P1|Overall Study|Perceived Medication Side Effects|4
5120415|NCT01728194|17688680|P2|Overall Study|Withdrawal by Subject|3
5120416|NCT01728194|17688681|P1|Overall Study|Withdrawal by Subject|7
5120417|NCT01728194|17688680|P2|Overall Study|Physician Decision|0
5120418|NCT01728194|17688681|P1|Overall Study|Physician Decision|4
5120419|NCT01728194|17688680|P2|Overall Study|Lost to Follow-up|3
5120420|NCT01728194|17688681|P1|Overall Study|Lost to Follow-up|4
5120421|NCT01728116|17688691|P2|Overall Study|various not noted previously|0
5120422|NCT01728116|17688692|P1|Overall Study|various not noted previously|5
5120423|NCT01728116|17688691|P2|Overall Study|Incorrectly enrolled in Study|1
5120424|NCT01728116|17688692|P1|Overall Study|Incorrectly enrolled in Study|0
5120425|NCT01728116|17688691|P2|Overall Study|Inter-current finding at procedure|0
5120426|NCT01728116|17688692|P1|Overall Study|Inter-current finding at procedure|1
5120427|NCT01728116|17688691|P2|Overall Study|Subject Non-Compliance|0
5120428|NCT01728116|17688692|P1|Overall Study|Subject Non-Compliance|2
5120429|NCT01728116|17688691|P2|Overall Study|Physician Decision|0
5120430|NCT01728116|17688692|P1|Overall Study|Physician Decision|2
5120431|NCT01728116|17688691|P2|Overall Study|Lost to Follow-up|2
5120432|NCT01728116|17688692|P1|Overall Study|Lost to Follow-up|9
5120433|NCT01728116|17688691|P2|Overall Study|Procedure/device failure|0
5120434|NCT01728116|17688692|P1|Overall Study|Procedure/device failure|7
5120435|NCT01728116|17688691|P2|Overall Study|Adverse Event|0
5120436|NCT01728116|17688692|P1|Overall Study|Adverse Event|13
5120437|NCT01728116|17688691|P2|Overall Study|Withdrawal by Subject|9
5120438|NCT01728116|17688692|P1|Overall Study|Withdrawal by Subject|16
5120439|NCT01728116|17688691|P2|Overall Study|Sponsor Terminated Study|35
5120440|NCT01728116|17688692|P1|Overall Study|Sponsor Terminated Study|106
5120441|NCT01728077|17688717|P2|Overall Study|Non compliance|0
5120442|NCT01728077|17688718|P1|Overall Study|Non compliance|1
5120443|NCT01728077|17688717|P2|Overall Study|Patient moving|0
5120444|NCT01728077|17688718|P1|Overall Study|Patient moving|1
5120445|NCT01728077|17688717|P2|Overall Study|Death|1
5120446|NCT01728077|17688718|P1|Overall Study|Death|0
5120447|NCT01728077|17688717|P2|Overall Study|Subject choice|3
5120448|NCT01728077|17688718|P1|Overall Study|Subject choice|2
5120449|NCT01728077|17688717|P2|Overall Study|Lost to Follow-up|0
5120450|NCT01728077|17688718|P1|Overall Study|Lost to Follow-up|1
5120451|NCT01728077|17688717|P2|Overall Study|Lack of Efficacy|1
5120452|NCT01728077|17688718|P1|Overall Study|Lack of Efficacy|3
5120453|NCT01727713|17688816|P1|Overall Study|Protocol Deviation|2
5120454|NCT01727713|17688816|P1|Overall Study|Withdrawal by Subject|13
5120455|NCT01727713|17688816|P1|Overall Study|Participant Met Withdrawal Criteria|5
5120456|NCT01727713|17688816|P1|Overall Study|Adverse Event|10
5120457|NCT01727713|17688816|P1|Overall Study|Lost to Follow-up|5
5120458|NCT01727700|17688843|P3|Overall Study|Protocol Violation|0
5120459|NCT01727700|17688844|P2|Overall Study|Protocol Violation|0
5120460|NCT01727700|17688845|P1|Overall Study|Protocol Violation|2
5120461|NCT01727700|17688843|P3|Overall Study|Particpant withdrew consent|1
5120462|NCT01727700|17688844|P2|Overall Study|Particpant withdrew consent|3
5120463|NCT01727700|17688845|P1|Overall Study|Particpant withdrew consent|0
5120464|NCT01727700|17688843|P3|Overall Study|Adverse Event|1
5120465|NCT01727700|17688844|P2|Overall Study|Adverse Event|7
5120466|NCT01727700|17688845|P1|Overall Study|Adverse Event|0
5120467|NCT01727505|17688868|P2|Second 24 Hours|Missing data|1
5120468|NCT01727505|17688869|P1|Second 24 Hours|Missing data|0
5120469|NCT01727505|17688868|P2|First 24 Hours|Adverse Event|1
5120470|NCT01727505|17688869|P1|First 24 Hours|Adverse Event|0
5120471|NCT01727297|17688894|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
5120472|NCT01727297|17688895|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
5120473|NCT01727297|17688894|P2|Overall Study|Physician Decision|5
5120474|NCT01727297|17688895|P1|Overall Study|Physician Decision|19
5120475|NCT01727297|17688894|P2|Overall Study|Withdrawal by Subject|27
5120476|NCT01727297|17688895|P1|Overall Study|Withdrawal by Subject|26
5120477|NCT01727297|17688894|P2|Overall Study|Lost to Follow-up|0
5120478|NCT01727297|17688895|P1|Overall Study|Lost to Follow-up|11
5120479|NCT01727297|17688894|P2|Overall Study|Adverse Event|1
5120480|NCT01727297|17688895|P1|Overall Study|Adverse Event|3
5120481|NCT01727297|17688894|P2|Overall Study|Protocol Violation|10
5120482|NCT01727297|17688895|P1|Overall Study|Protocol Violation|1
5120483|NCT01727297|17688894|P2|Overall Study|Death|0
5120484|NCT01727297|17688895|P1|Overall Study|Death|13
5120485|NCT01727258|17688911|P3|Overall Study|Lost to Follow-up|0
5120486|NCT01727258|17688912|P2|Overall Study|Lost to Follow-up|0
5120487|NCT01727258|17688913|P1|Overall Study|Lost to Follow-up|1
5120488|NCT01727258|17688911|P3|Overall Study|Withdrawal by Subject|0
5120489|NCT01727258|17688912|P2|Overall Study|Withdrawal by Subject|1
5120490|NCT01727258|17688913|P1|Overall Study|Withdrawal by Subject|1
5120491|NCT01727258|17688911|P3|Overall Study|Noncompliance with Study Drug|1
5120492|NCT01727258|17688912|P2|Overall Study|Noncompliance with Study Drug|0
5120493|NCT01727258|17688913|P1|Overall Study|Noncompliance with Study Drug|0
5120494|NCT01727258|17688911|P3|Overall Study|Adverse Event|0
5120495|NCT01727258|17688912|P2|Overall Study|Adverse Event|2
5120496|NCT01727258|17688913|P1|Overall Study|Adverse Event|0
5120497|NCT01727154|17688951|P1|Overall Study|No Discontinuation Documentation|4
5120498|NCT01727154|17688951|P1|Overall Study|Study Terminated|6
5120499|NCT01727154|17688951|P1|Overall Study|Subject Withdrew Consent|18
5120500|NCT01727154|17688951|P1|Overall Study|Withdrawal by Subject|14
5120501|NCT01727154|17688951|P1|Overall Study|Death|17
5120502|NCT01727141|17688959|P4|Overall Study|Withdrawal by Subject|11
5120503|NCT01727141|17688960|P3|Overall Study|Withdrawal by Subject|2
5120504|NCT01727141|17688961|P2|Overall Study|Withdrawal by Subject|4
5120505|NCT01727141|17688962|P1|Overall Study|Withdrawal by Subject|4
5120506|NCT01727141|17688959|P4|Overall Study|Protocol deviation|1
5120507|NCT01727141|17688960|P3|Overall Study|Protocol deviation|0
5120508|NCT01727141|17688961|P2|Overall Study|Protocol deviation|1
5120509|NCT01727141|17688962|P1|Overall Study|Protocol deviation|1
5120510|NCT01727141|17688959|P4|Overall Study|Death|1
5120511|NCT01727141|17688960|P3|Overall Study|Death|1
5120512|NCT01727141|17688961|P2|Overall Study|Death|1
5120513|NCT01727141|17688962|P1|Overall Study|Death|0
5120514|NCT01727141|17688959|P4|Overall Study|Lost to Follow-up|0
5120515|NCT01727141|17688960|P3|Overall Study|Lost to Follow-up|0
5120516|NCT01727141|17688961|P2|Overall Study|Lost to Follow-up|2
5120517|NCT01727141|17688962|P1|Overall Study|Lost to Follow-up|0
5120518|NCT01727141|17688959|P4|Overall Study|Physician Decision|2
5120519|NCT01727141|17688960|P3|Overall Study|Physician Decision|0
5120520|NCT01727141|17688961|P2|Overall Study|Physician Decision|1
5120521|NCT01727141|17688962|P1|Overall Study|Physician Decision|0
5120522|NCT01727024|17689027|P2|Period 1|Withdrawal by Subject|3
5120523|NCT01727024|17689028|P1|Period 1|Withdrawal by Subject|2
5120524|NCT01727024|17689027|P2|Period 1|Lost to Follow-up|1
5120525|NCT01727024|17689028|P1|Period 1|Lost to Follow-up|1
5120526|NCT01726803|17689043|P2|Overall Study|Withdrawal by Subject|0
5120527|NCT01726803|17689044|P1|Overall Study|Withdrawal by Subject|1
5120528|NCT01726803|17689043|P2|Overall Study|Lost to Follow-up|1
5120529|NCT01726803|17689044|P1|Overall Study|Lost to Follow-up|6
5120530|NCT01726517|17689096|P5|Overall Study|Withdrawal by Subject|0
5120531|NCT01726517|17689097|P4|Overall Study|Withdrawal by Subject|0
5120532|NCT01726517|17689098|P3|Overall Study|Withdrawal by Subject|1
5120533|NCT01726517|17689099|P2|Overall Study|Withdrawal by Subject|0
5120534|NCT01726517|17689100|P1|Overall Study|Withdrawal by Subject|0
5120535|NCT01726335|17689156|P1|Overall Study|Exacerbation of psychotic symptoms|1
5120536|NCT01726335|17689156|P1|Overall Study|Lost to Follow-up|2
5120537|NCT01726335|17689156|P1|Overall Study|Adverse Event|4
5120538|NCT01726335|17689156|P1|Overall Study|Withdrawal by Subject|15
5120539|NCT01726335|17689156|P1|Overall Study|Lost to Follow-up|2
5120540|NCT01726270|17689172|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
5120541|NCT01726270|17689172|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
5120542|NCT01726270|17689172|P1|Part 2, Actual-Use Phase|Adverse Event|6
5120543|NCT01726270|17689172|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
5120544|NCT01726270|17689172|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
5120545|NCT01726270|17689172|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
5120546|NCT01726049|17689185|P2|Overall Study|refused second HC|2
5120547|NCT01726049|17689186|P1|Overall Study|refused second HC|0
5120548|NCT01726049|17689185|P2|Overall Study|Adverse Event|1
5120549|NCT01726049|17689186|P1|Overall Study|Adverse Event|4
5120550|NCT01726049|17689185|P2|Overall Study|Death|1
5120551|NCT01726049|17689186|P1|Overall Study|Death|1
5120552|NCT01726023|17689211|P2|Overall Study|Withdrawal by Subject|8
5120553|NCT01726023|17689212|P1|Overall Study|Withdrawal by Subject|16
5120554|NCT01726023|17689211|P2|Overall Study|Other Eligibility criteria|7
5120555|NCT01726023|17689212|P1|Overall Study|Other Eligibility criteria|7
5120556|NCT01726023|17689211|P2|Overall Study|Lost to Follow-up|10
5120557|NCT01726023|17689212|P1|Overall Study|Lost to Follow-up|5
5120558|NCT01726023|17689211|P2|Overall Study|Death|1
5120559|NCT01726023|17689212|P1|Overall Study|Death|1
5120560|NCT01725750|17689346|P2|Overall Study|Withdrawal by Subject|9
5120561|NCT01725750|17689347|P1|Overall Study|Withdrawal by Subject|0
5120562|NCT01725750|17689346|P2|Overall Study|Lost to Follow-up|1
5120563|NCT01725750|17689347|P1|Overall Study|Lost to Follow-up|1
5120564|NCT01725750|17689346|P2|Overall Study|Adverse Event|0
5120565|NCT01725750|17689347|P1|Overall Study|Adverse Event|1
5120566|NCT01725529|17689380|P3|Overall Study|Withdrawal by Subject|8
5120567|NCT01725529|17689381|P2|Overall Study|Withdrawal by Subject|14
5120568|NCT01725529|17689382|P1|Overall Study|Withdrawal by Subject|12
5120569|NCT01725529|17689380|P3|Overall Study|Protocol Violation|1
5120570|NCT01725529|17689381|P2|Overall Study|Protocol Violation|1
5120571|NCT01725529|17689382|P1|Overall Study|Protocol Violation|0
5120572|NCT01725529|17689380|P3|Overall Study|Lost to Follow-up|1
5120573|NCT01725529|17689381|P2|Overall Study|Lost to Follow-up|1
5120574|NCT01725529|17689382|P1|Overall Study|Lost to Follow-up|2
5120575|NCT01725529|17689380|P3|Overall Study|Adverse Event|0
5120576|NCT01725529|17689381|P2|Overall Study|Adverse Event|0
5120577|NCT01725529|17689382|P1|Overall Study|Adverse Event|1
5120578|NCT01725451|17689408|P4|Period 4|Adverse Event|0
5120579|NCT01725451|17689409|P3|Period 4|Adverse Event|1
5120580|NCT01725451|17689410|P2|Period 4|Adverse Event|0
5120581|NCT01725451|17689411|P1|Period 4|Adverse Event|0
5120582|NCT01725451|17689408|P4|Washout From Period 3|Adverse Event|0
5120583|NCT01725451|17689409|P3|Washout From Period 3|Adverse Event|0
5120584|NCT01725451|17689410|P2|Washout From Period 3|Adverse Event|1
5120585|NCT01725451|17689411|P1|Washout From Period 3|Adverse Event|0
5120586|NCT01725451|17689408|P4|Washout From Period 3|Protocol Violation|0
5120587|NCT01725451|17689409|P3|Washout From Period 3|Protocol Violation|1
5120588|NCT01725451|17689410|P2|Washout From Period 3|Protocol Violation|0
5120589|NCT01725451|17689411|P1|Washout From Period 3|Protocol Violation|0
5120590|NCT01725451|17689408|P4|Period 1|Withdrawal by Subject|0
5120591|NCT01725451|17689409|P3|Period 1|Withdrawal by Subject|0
5120592|NCT01725451|17689410|P2|Period 1|Withdrawal by Subject|0
5120593|NCT01725451|17689411|P1|Period 1|Withdrawal by Subject|1
5120594|NCT01725386|17689433|P2|Overall Study|Withdrawal by Subject|0
5120595|NCT01725386|17689434|P1|Overall Study|Withdrawal by Subject|10
5120596|NCT01725386|17689433|P2|Overall Study|Lost to Follow-up|6
5120597|NCT01725386|17689434|P1|Overall Study|Lost to Follow-up|81
5120598|NCT01725386|17689433|P2|Overall Study|Death|40
5120599|NCT01725386|17689434|P1|Overall Study|Death|84
5120600|NCT01725308|17689453|P3|Treatment Period II|Miscellaneous|7
5120601|NCT01725308|17689454|P2|Treatment Period II|Miscellaneous|3
5120602|NCT01725308|17689455|P1|Treatment Period II|Miscellaneous|5
5120603|NCT01725308|17689453|P3|Treatment Period II|Protocol Deviations|1
5120604|NCT01725308|17689454|P2|Treatment Period II|Protocol Deviations|0
5120605|NCT01725308|17689455|P1|Treatment Period II|Protocol Deviations|0
5120606|NCT01725308|17689453|P3|Treatment Period II|Lost to Follow-up|3
5120607|NCT01725308|17689454|P2|Treatment Period II|Lost to Follow-up|5
5120608|NCT01725308|17689455|P1|Treatment Period II|Lost to Follow-up|1
5120609|NCT01725308|17689453|P3|Treatment Period II|Withdrawal of Consent|16
5120610|NCT01725308|17689454|P2|Treatment Period II|Withdrawal of Consent|2
5120611|NCT01725308|17689455|P1|Treatment Period II|Withdrawal of Consent|28
5120612|NCT01725308|17689453|P3|Treatment Period II|Changes in the Episodes|5
5120613|NCT01725308|17689454|P2|Treatment Period II|Changes in the Episodes|0
5120614|NCT01725308|17689455|P1|Treatment Period II|Changes in the Episodes|1
5120615|NCT01725308|17689453|P3|Treatment Period II|Worsening of the Target Disease|2
5120616|NCT01725308|17689454|P2|Treatment Period II|Worsening of the Target Disease|4
5120617|NCT01725308|17689455|P1|Treatment Period II|Worsening of the Target Disease|1
5120618|NCT01725308|17689453|P3|Treatment Period II|Insufficient Response|6
5120619|NCT01725308|17689454|P2|Treatment Period II|Insufficient Response|4
5120620|NCT01725308|17689455|P1|Treatment Period II|Insufficient Response|2
5120621|NCT01725308|17689453|P3|Treatment Period II|Adverse Event|20
5120622|NCT01725308|17689454|P2|Treatment Period II|Adverse Event|8
5120623|NCT01725308|17689455|P1|Treatment Period II|Adverse Event|13
5120624|NCT01725308|17689453|P3|Treatment Period II|Did Not Receive Drug|0
5120625|NCT01725308|17689454|P2|Treatment Period II|Did Not Receive Drug|0
5120626|NCT01725308|17689455|P1|Treatment Period II|Did Not Receive Drug|4
5120627|NCT01725308|17689453|P3|Treatment Period II|Did Not Meet Transition Criteria|4
5120628|NCT01725308|17689454|P2|Treatment Period II|Did Not Meet Transition Criteria|3
5120629|NCT01725308|17689455|P1|Treatment Period II|Did Not Meet Transition Criteria|0
5120630|NCT01725308|17689453|P3|Treatment Period I|Miscellaneous|3
5120631|NCT01725308|17689454|P2|Treatment Period I|Miscellaneous|0
5120632|NCT01725308|17689455|P1|Treatment Period I|Miscellaneous|2
5120633|NCT01725308|17689453|P3|Treatment Period I|Protocol Deviations|1
5120634|NCT01725308|17689454|P2|Treatment Period I|Protocol Deviations|1
5120635|NCT01725308|17689455|P1|Treatment Period I|Protocol Deviations|3
5120636|NCT01725308|17689453|P3|Treatment Period I|Lost to Follow-up|2
5120637|NCT01725308|17689454|P2|Treatment Period I|Lost to Follow-up|2
5120638|NCT01725308|17689455|P1|Treatment Period I|Lost to Follow-up|3
5120639|NCT01725308|17689453|P3|Treatment Period I|Withdrawal of Consent|5
5120640|NCT01725308|17689454|P2|Treatment Period I|Withdrawal of Consent|7
5120641|NCT01725308|17689455|P1|Treatment Period I|Withdrawal of Consent|12
5120642|NCT01725308|17689453|P3|Treatment Period I|Changes in the Episodes|2
5120643|NCT01725308|17689454|P2|Treatment Period I|Changes in the Episodes|0
5120644|NCT01725308|17689455|P1|Treatment Period I|Changes in the Episodes|3
5120645|NCT01725308|17689453|P3|Treatment Period I|Worsening of the Target Disease|2
5120646|NCT01725308|17689454|P2|Treatment Period I|Worsening of the Target Disease|0
5120647|NCT01725308|17689455|P1|Treatment Period I|Worsening of the Target Disease|8
5120648|NCT01725308|17689453|P3|Treatment Period I|Insufficient Response|5
5120649|NCT01725308|17689454|P2|Treatment Period I|Insufficient Response|0
5120650|NCT01725308|17689455|P1|Treatment Period I|Insufficient Response|7
5120651|NCT01725308|17689453|P3|Treatment Period I|Adverse Event|21
5120652|NCT01725308|17689454|P2|Treatment Period I|Adverse Event|4
5120653|NCT01725308|17689455|P1|Treatment Period I|Adverse Event|5
5120654|NCT01725308|17689453|P3|Treatment Period I|Did Not Receive Drug|0
5120655|NCT01725308|17689454|P2|Treatment Period I|Did Not Receive Drug|0
5120656|NCT01725308|17689455|P1|Treatment Period I|Did Not Receive Drug|1
5120657|NCT01725282|17689602|P4|Overall Study|Lack of Efficacy|1
5120658|NCT01725282|17689603|P3|Overall Study|Lack of Efficacy|0
5120659|NCT01725282|17689604|P2|Overall Study|Lack of Efficacy|1
5120660|NCT01725282|17689605|P1|Overall Study|Lack of Efficacy|0
5120661|NCT01725282|17689602|P4|Overall Study|Withdrawal by Subject|1
5120662|NCT01725282|17689603|P3|Overall Study|Withdrawal by Subject|1
5120663|NCT01725282|17689604|P2|Overall Study|Withdrawal by Subject|0
5120664|NCT01725282|17689605|P1|Overall Study|Withdrawal by Subject|0
5120665|NCT01725282|17689602|P4|Overall Study|Study Site Withdrawal|0
5120666|NCT01725282|17689603|P3|Overall Study|Study Site Withdrawal|0
5120667|NCT01725282|17689604|P2|Overall Study|Study Site Withdrawal|1
5120668|NCT01725282|17689605|P1|Overall Study|Study Site Withdrawal|0
5120669|NCT01725282|17689602|P4|Overall Study|Met Exclusion Criteria|0
5120670|NCT01725282|17689603|P3|Overall Study|Met Exclusion Criteria|1
5120671|NCT01725282|17689604|P2|Overall Study|Met Exclusion Criteria|0
5120672|NCT01725282|17689605|P1|Overall Study|Met Exclusion Criteria|0
5120673|NCT01725282|17689602|P4|Overall Study|Exacerbation of Target Disease|1
5120674|NCT01725282|17689603|P3|Overall Study|Exacerbation of Target Disease|0
5120675|NCT01725282|17689604|P2|Overall Study|Exacerbation of Target Disease|0
5120676|NCT01725282|17689605|P1|Overall Study|Exacerbation of Target Disease|1
5120677|NCT01725282|17689602|P4|Overall Study|Adverse Event|4
5120678|NCT01725282|17689603|P3|Overall Study|Adverse Event|6
5120679|NCT01725282|17689604|P2|Overall Study|Adverse Event|3
5120680|NCT01725282|17689605|P1|Overall Study|Adverse Event|1
5120681|NCT01725217|17689638|P3|Overall Study|Withdrawal by Subject|0
5120682|NCT01725217|17689639|P2|Overall Study|Withdrawal by Subject|0
5120683|NCT01725217|17689640|P1|Overall Study|Withdrawal by Subject|1
5120684|NCT01725126|17689674|P6|Overall Study|Withdrawal by Subject|0
5120685|NCT01725126|17689675|P5|Overall Study|Withdrawal by Subject|0
5120686|NCT01725126|17689676|P4|Overall Study|Withdrawal by Subject|1
5120687|NCT01725126|17689677|P3|Overall Study|Withdrawal by Subject|0
5120688|NCT01725126|17689678|P2|Overall Study|Withdrawal by Subject|0
5120689|NCT01725126|17689679|P1|Overall Study|Withdrawal by Subject|0
5120690|NCT01725126|17689674|P6|Overall Study|Protocol Violation|0
5120691|NCT01725126|17689675|P5|Overall Study|Protocol Violation|0
5120692|NCT01725126|17689676|P4|Overall Study|Protocol Violation|0
5120693|NCT01725126|17689677|P3|Overall Study|Protocol Violation|0
5120694|NCT01725126|17689678|P2|Overall Study|Protocol Violation|1
5120695|NCT01725126|17689679|P1|Overall Study|Protocol Violation|0
5120696|NCT01724528|17689877|P2|Overall Study|Patient refused to attend last visit|0
5120697|NCT01724528|17689878|P1|Overall Study|Patient refused to attend last visit|1
5120698|NCT01724528|17689877|P2|Overall Study|Protocol Violation|1
5120699|NCT01724528|17689878|P1|Overall Study|Protocol Violation|0
5120700|NCT01724528|17689877|P2|Overall Study|Withdrawal by Subject|2
5120701|NCT01724528|17689878|P1|Overall Study|Withdrawal by Subject|0
5120702|NCT01724528|17689877|P2|Overall Study|Death|0
5120703|NCT01724528|17689878|P1|Overall Study|Death|3
5120704|NCT01724489|17689894|P2|Overall Study|Withdrawal by Subject|6
5120705|NCT01724489|17689895|P1|Overall Study|Withdrawal by Subject|6
5120706|NCT01724489|17689894|P2|Overall Study|Lost to Follow-up|2
5120707|NCT01724489|17689895|P1|Overall Study|Lost to Follow-up|1
5120708|NCT01724489|17689894|P2|Overall Study|Surgery, medication|1
5120709|NCT01724489|17689895|P1|Overall Study|Surgery, medication|1
5120710|NCT01724489|17689894|P2|Overall Study|Adverse Event|3
5120711|NCT01724489|17689895|P1|Overall Study|Adverse Event|8
5120712|NCT01724359|17689901|P1|Overall Study|Other|20
5120713|NCT01724359|17689901|P1|Overall Study|Death|1
5120714|NCT01724359|17689901|P1|Overall Study|Adverse Event|10
5120715|NCT01724216|17689914|P1|Overall Study|Scan was not completed|1
5120716|NCT01724177|17689918|P1|Overall Study|Serious Adverse Event Related|1
5120717|NCT01724177|17689918|P1|Overall Study|Nervous participant|1
5120718|NCT01724177|17689918|P1|Overall Study|Progressive disease or Relapsed Disease|16
5120719|NCT01724177|17689918|P1|Overall Study|Adverse Event|8
5120720|NCT01724021|17689964|P2|Overall Study|Missing|1
5120721|NCT01724021|17689965|P1|Overall Study|Missing|1
5120722|NCT01724021|17689964|P2|Overall Study|Reason Not Specified|39
5120723|NCT01724021|17689965|P1|Overall Study|Reason Not Specified|36
5120724|NCT01724021|17689964|P2|Overall Study|Lost to Follow-up|15
5120725|NCT01724021|17689965|P1|Overall Study|Lost to Follow-up|15
5120726|NCT01724021|17689964|P2|Overall Study|Participant request/ Withdrew consent|14
5120727|NCT01724021|17689965|P1|Overall Study|Participant request/ Withdrew consent|18
5120728|NCT01724021|17689964|P2|Overall Study|Death|58
5120729|NCT01724021|17689965|P1|Overall Study|Death|46
5120730|NCT01724021|17689964|P2|Overall Study|Adverse Event|6
5120731|NCT01724021|17689965|P1|Overall Study|Adverse Event|11
5120732|NCT01723904|17689997|P1|Overall Study|Unable to follow protocol/ judged by inv|3
5120733|NCT01723904|17689997|P1|Overall Study|Adverse Event|5
5120734|NCT01723904|17689997|P1|Overall Study|Noncompliant|3
5120735|NCT01723826|17690011|P4|Overall Study|Withdrawal by Subject|48
5120736|NCT01723826|17690012|P3|Overall Study|Withdrawal by Subject|27
5120737|NCT01723826|17690013|P2|Overall Study|Withdrawal by Subject|17
5120738|NCT01723826|17690014|P1|Overall Study|Withdrawal by Subject|10
5120739|NCT01723826|17690011|P4|Overall Study|Protocol Violation|1
5120740|NCT01723826|17690012|P3|Overall Study|Protocol Violation|3
5120741|NCT01723826|17690013|P2|Overall Study|Protocol Violation|1
5120742|NCT01723826|17690014|P1|Overall Study|Protocol Violation|1
5120743|NCT01723826|17690011|P4|Overall Study|Physician Decision|11
5120744|NCT01723826|17690012|P3|Overall Study|Physician Decision|4
5120745|NCT01723826|17690013|P2|Overall Study|Physician Decision|3
5120746|NCT01723826|17690014|P1|Overall Study|Physician Decision|1
5120747|NCT01723826|17690011|P4|Overall Study|Other Reason|14
5120748|NCT01723826|17690012|P3|Overall Study|Other Reason|12
5120749|NCT01723826|17690013|P2|Overall Study|Other Reason|6
5120750|NCT01723826|17690014|P1|Overall Study|Other Reason|8
5120751|NCT01723826|17690011|P4|Overall Study|Non-compliance With Study Drug|0
5120752|NCT01723826|17690012|P3|Overall Study|Non-compliance With Study Drug|0
5120753|NCT01723826|17690013|P2|Overall Study|Non-compliance With Study Drug|1
5120754|NCT01723826|17690014|P1|Overall Study|Non-compliance With Study Drug|0
5120755|NCT01723826|17690011|P4|Overall Study|Non-compliance|3
5120756|NCT01723826|17690012|P3|Overall Study|Non-compliance|3
5120757|NCT01723826|17690013|P2|Overall Study|Non-compliance|1
5120758|NCT01723826|17690014|P1|Overall Study|Non-compliance|0
5120759|NCT01723826|17690011|P4|Overall Study|Lost to Follow-up|1
5120760|NCT01723826|17690012|P3|Overall Study|Lost to Follow-up|1
5120761|NCT01723826|17690013|P2|Overall Study|Lost to Follow-up|3
5120762|NCT01723826|17690014|P1|Overall Study|Lost to Follow-up|1
5120763|NCT01723826|17690011|P4|Overall Study|Death according to AE eCRF|7
5120764|NCT01723826|17690012|P3|Overall Study|Death according to AE eCRF|3
5120765|NCT01723826|17690013|P2|Overall Study|Death according to AE eCRF|3
5120766|NCT01723826|17690014|P1|Overall Study|Death according to AE eCRF|2
5120767|NCT01723826|17690011|P4|Overall Study|Adverse Event|5
5120768|NCT01723826|17690012|P3|Overall Study|Adverse Event|4
5120769|NCT01723826|17690013|P2|Overall Study|Adverse Event|1
5120770|NCT01723826|17690014|P1|Overall Study|Adverse Event|4
5120771|NCT01723397|17690159|P2|Study Period 2|Protocol Violation|1
5120772|NCT01723397|17690160|P1|Study Period 2|Protocol Violation|0
5120773|NCT01723397|17690159|P2|Study Period 1|Protocol Violation|1
5120774|NCT01723397|17690160|P1|Study Period 1|Protocol Violation|0
5120775|NCT01723254|17690187|P8|Overall Study|Withdrawal by Subject|2
5120776|NCT01723254|17690188|P7|Overall Study|Withdrawal by Subject|1
5120777|NCT01723254|17690189|P6|Overall Study|Withdrawal by Subject|1
5120778|NCT01723254|17690190|P5|Overall Study|Withdrawal by Subject|1
5120779|NCT01723254|17690191|P4|Overall Study|Withdrawal by Subject|0
5120780|NCT01723254|17690192|P3|Overall Study|Withdrawal by Subject|1
5120781|NCT01723254|17690193|P2|Overall Study|Withdrawal by Subject|2
5120782|NCT01723254|17690194|P1|Overall Study|Withdrawal by Subject|1
5120783|NCT01723254|17690187|P8|Overall Study|Protocol Violation|0
5120784|NCT01723254|17690188|P7|Overall Study|Protocol Violation|0
5120785|NCT01723254|17690189|P6|Overall Study|Protocol Violation|0
5120786|NCT01723254|17690190|P5|Overall Study|Protocol Violation|0
5120787|NCT01723254|17690191|P4|Overall Study|Protocol Violation|0
5120788|NCT01723254|17690192|P3|Overall Study|Protocol Violation|0
5120789|NCT01723254|17690193|P2|Overall Study|Protocol Violation|1
5120790|NCT01723254|17690194|P1|Overall Study|Protocol Violation|0
5120791|NCT01723254|17690187|P8|Overall Study|Move/Left to another country/city|0
5120792|NCT01723254|17690188|P7|Overall Study|Move/Left to another country/city|0
5120793|NCT01723254|17690189|P6|Overall Study|Move/Left to another country/city|0
5120794|NCT01723254|17690190|P5|Overall Study|Move/Left to another country/city|1
5120795|NCT01723254|17690191|P4|Overall Study|Move/Left to another country/city|1
5120796|NCT01723254|17690192|P3|Overall Study|Move/Left to another country/city|2
5120797|NCT01723254|17690193|P2|Overall Study|Move/Left to another country/city|0
5120798|NCT01723254|17690194|P1|Overall Study|Move/Left to another country/city|0
5120799|NCT01723254|17690187|P8|Overall Study|No longer have time to participate|0
5120800|NCT01723254|17690188|P7|Overall Study|No longer have time to participate|0
5120801|NCT01723254|17690189|P6|Overall Study|No longer have time to participate|0
5120802|NCT01723254|17690190|P5|Overall Study|No longer have time to participate|0
5120803|NCT01723254|17690191|P4|Overall Study|No longer have time to participate|1
5120804|NCT01723254|17690192|P3|Overall Study|No longer have time to participate|0
5120805|NCT01723254|17690193|P2|Overall Study|No longer have time to participate|0
5120806|NCT01723254|17690194|P1|Overall Study|No longer have time to participate|0
5120807|NCT01723254|17690187|P8|Overall Study|Personal issues|0
5120808|NCT01723254|17690188|P7|Overall Study|Personal issues|0
5120809|NCT01723254|17690189|P6|Overall Study|Personal issues|1
5120810|NCT01723254|17690190|P5|Overall Study|Personal issues|0
5120811|NCT01723254|17690191|P4|Overall Study|Personal issues|0
5120812|NCT01723254|17690192|P3|Overall Study|Personal issues|0
5120813|NCT01723254|17690193|P2|Overall Study|Personal issues|0
5120814|NCT01723254|17690194|P1|Overall Study|Personal issues|0
5120815|NCT01723254|17690187|P8|Overall Study|Conflict with work schedule|1
5120816|NCT01723254|17690188|P7|Overall Study|Conflict with work schedule|0
5120817|NCT01723254|17690189|P6|Overall Study|Conflict with work schedule|0
5120818|NCT01723254|17690190|P5|Overall Study|Conflict with work schedule|0
5120819|NCT01723254|17690191|P4|Overall Study|Conflict with work schedule|0
5120820|NCT01723254|17690192|P3|Overall Study|Conflict with work schedule|0
5120821|NCT01723254|17690193|P2|Overall Study|Conflict with work schedule|0
5120822|NCT01723254|17690194|P1|Overall Study|Conflict with work schedule|0
5120823|NCT01723228|17690246|P2|Overall Study|Other|1
5120824|NCT01723228|17690247|P1|Overall Study|Other|2
5120825|NCT01723228|17690246|P2|Overall Study|Lost to Follow-up|1
5120826|NCT01723228|17690247|P1|Overall Study|Lost to Follow-up|2
5120827|NCT01723228|17690246|P2|Overall Study|Protocol Violation|2
5120828|NCT01723228|17690247|P1|Overall Study|Protocol Violation|0
5120829|NCT01723228|17690246|P2|Overall Study|Withdrawal by Subject|1
5120830|NCT01723228|17690247|P1|Overall Study|Withdrawal by Subject|2
5120831|NCT01723228|17690246|P2|Overall Study|Adverse Event|6
5120832|NCT01723228|17690247|P1|Overall Study|Adverse Event|2
5120833|NCT01723163|17690265|P2|12-Month Follow-up|Unable to Contact|28
5120834|NCT01723163|17690266|P1|12-Month Follow-up|Unable to Contact|23
5120835|NCT01723163|17690265|P2|12-Month Follow-up|Death|0
5120836|NCT01723163|17690266|P1|12-Month Follow-up|Death|1
5120837|NCT01723163|17690265|P2|6-Month Follow-up|Unable to Contact|15
5120838|NCT01723163|17690266|P1|6-Month Follow-up|Unable to Contact|17
5120839|NCT01723163|17690265|P2|6-Month Follow-up|Death|0
5120840|NCT01723163|17690266|P1|6-Month Follow-up|Death|1
5120841|NCT01723163|17690265|P2|3-Month Follow-up|Unable to Contact|19
5120842|NCT01723163|17690266|P1|3-Month Follow-up|Unable to Contact|12
5120843|NCT01723163|17690265|P2|3-Month Follow-up|Withdrawal by Subject|0
5120844|NCT01723163|17690266|P1|3-Month Follow-up|Withdrawal by Subject|1
5120845|NCT01723163|17690265|P2|Treatment Phase|Withdrawal by PI|1
5120846|NCT01723163|17690266|P1|Treatment Phase|Withdrawal by PI|5
5120847|NCT01723163|17690265|P2|Treatment Phase|Withdrawal by Subject|6
5120848|NCT01723163|17690266|P1|Treatment Phase|Withdrawal by Subject|14
5120849|NCT01723072|17690274|P2|Overall Study|Other|3
5120850|NCT01723072|17690275|P1|Overall Study|Other|4
5120851|NCT01723072|17690274|P2|Overall Study|Discon for rescue medication after wk 24|5
5120852|NCT01723072|17690275|P1|Overall Study|Discon for rescue medication after wk 24|0
5120853|NCT01723072|17690274|P2|Overall Study|Withdrawal by Subject|13
5120854|NCT01723072|17690275|P1|Overall Study|Withdrawal by Subject|7
5120855|NCT01722994|17690313|P2|Overall Study|Missing data|17
5120856|NCT01722994|17690314|P1|Overall Study|Missing data|25
5120857|NCT01722877|17690333|P1|Overall Study|Lost to Follow-up|1
5120858|NCT01722877|17690333|P1|Overall Study|Death|1
5120859|NCT01722669|17690359|P6|Overall Study|Withdrawal by Subject|2
5120860|NCT01722669|17690360|P5|Overall Study|Withdrawal by Subject|0
5120861|NCT01722669|17690361|P4|Overall Study|Withdrawal by Subject|0
5120862|NCT01722669|17690362|P3|Overall Study|Withdrawal by Subject|0
5120863|NCT01722669|17690363|P2|Overall Study|Withdrawal by Subject|0
5120864|NCT01722669|17690364|P1|Overall Study|Withdrawal by Subject|0
5120865|NCT01722331|17690435|P7|Part 3|Other Protocol Specified Criteria|0
5120866|NCT01722331|17690436|P6|Part 3|Other Protocol Specified Criteria|0
5120867|NCT01722331|17690437|P5|Part 3|Other Protocol Specified Criteria|0
5120868|NCT01722331|17690438|P4|Part 3|Other Protocol Specified Criteria|0
5120869|NCT01722331|17690439|P3|Part 3|Other Protocol Specified Criteria|0
5120870|NCT01722331|17690440|P2|Part 3|Other Protocol Specified Criteria|1
5120871|NCT01722331|17690441|P1|Part 3|Other Protocol Specified Criteria|1
5120872|NCT01722331|17690435|P7|Part 3|Withdrawal by Subject|1
5120873|NCT01722331|17690436|P6|Part 3|Withdrawal by Subject|2
5120874|NCT01722331|17690437|P5|Part 3|Withdrawal by Subject|0
5120875|NCT01722331|17690438|P4|Part 3|Withdrawal by Subject|0
5120876|NCT01722331|17690439|P3|Part 3|Withdrawal by Subject|0
5120877|NCT01722331|17690440|P2|Part 3|Withdrawal by Subject|7
5120878|NCT01722331|17690441|P1|Part 3|Withdrawal by Subject|4
5120879|NCT01722331|17690435|P7|Part 3|Protocol Violation|0
5120880|NCT01722331|17690436|P6|Part 3|Protocol Violation|0
5120881|NCT01722331|17690437|P5|Part 3|Protocol Violation|0
5120882|NCT01722331|17690438|P4|Part 3|Protocol Violation|0
5120883|NCT01722331|17690439|P3|Part 3|Protocol Violation|0
5120884|NCT01722331|17690440|P2|Part 3|Protocol Violation|1
5120885|NCT01722331|17690441|P1|Part 3|Protocol Violation|2
5120886|NCT01722331|17690435|P7|Part 3|Physician Decision|1
5120887|NCT01722331|17690436|P6|Part 3|Physician Decision|0
5120888|NCT01722331|17690437|P5|Part 3|Physician Decision|0
5120889|NCT01722331|17690438|P4|Part 3|Physician Decision|0
5120890|NCT01722331|17690439|P3|Part 3|Physician Decision|0
5120891|NCT01722331|17690440|P2|Part 3|Physician Decision|1
5120892|NCT01722331|17690441|P1|Part 3|Physician Decision|1
5120893|NCT01722331|17690435|P7|Part 3|Non-Compliance with Study Drug|0
5120894|NCT01722331|17690436|P6|Part 3|Non-Compliance with Study Drug|0
5120895|NCT01722331|17690437|P5|Part 3|Non-Compliance with Study Drug|0
5120896|NCT01722331|17690438|P4|Part 3|Non-Compliance with Study Drug|0
5120897|NCT01722331|17690439|P3|Part 3|Non-Compliance with Study Drug|0
5120898|NCT01722331|17690440|P2|Part 3|Non-Compliance with Study Drug|1
5120899|NCT01722331|17690441|P1|Part 3|Non-Compliance with Study Drug|0
5120900|NCT01722331|17690435|P7|Part 3|Lost to Follow-up|0
5120901|NCT01722331|17690436|P6|Part 3|Lost to Follow-up|1
5120902|NCT01722331|17690437|P5|Part 3|Lost to Follow-up|0
5120903|NCT01722331|17690438|P4|Part 3|Lost to Follow-up|0
5120904|NCT01722331|17690439|P3|Part 3|Lost to Follow-up|0
5120905|NCT01722331|17690440|P2|Part 3|Lost to Follow-up|4
5120906|NCT01722331|17690441|P1|Part 3|Lost to Follow-up|3
5120907|NCT01722331|17690435|P7|Part 3|Lack of Efficacy|0
5120908|NCT01722331|17690436|P6|Part 3|Lack of Efficacy|0
5120909|NCT01722331|17690437|P5|Part 3|Lack of Efficacy|0
5120910|NCT01722331|17690438|P4|Part 3|Lack of Efficacy|0
5120911|NCT01722331|17690439|P3|Part 3|Lack of Efficacy|0
5120912|NCT01722331|17690440|P2|Part 3|Lack of Efficacy|0
5120913|NCT01722331|17690441|P1|Part 3|Lack of Efficacy|1
5120914|NCT01722331|17690435|P7|Part 3|Death|0
5120915|NCT01722331|17690436|P6|Part 3|Death|0
5120916|NCT01722331|17690437|P5|Part 3|Death|0
5120917|NCT01722331|17690438|P4|Part 3|Death|0
5120918|NCT01722331|17690439|P3|Part 3|Death|0
5120919|NCT01722331|17690440|P2|Part 3|Death|0
5120920|NCT01722331|17690441|P1|Part 3|Death|1
5120921|NCT01722331|17690435|P7|Part 3|Adverse Event|0
5120922|NCT01722331|17690436|P6|Part 3|Adverse Event|0
5120923|NCT01722331|17690437|P5|Part 3|Adverse Event|0
5120924|NCT01722331|17690438|P4|Part 3|Adverse Event|1
5120925|NCT01722331|17690439|P3|Part 3|Adverse Event|0
5120926|NCT01722331|17690440|P2|Part 3|Adverse Event|2
5120927|NCT01722331|17690441|P1|Part 3|Adverse Event|2
5120928|NCT01722331|17690435|P7|Part 2|Other Protocol Specified Criteria|1
5120929|NCT01722331|17690436|P6|Part 2|Other Protocol Specified Criteria|2
5120930|NCT01722331|17690437|P5|Part 2|Other Protocol Specified Criteria|0
5120931|NCT01722331|17690438|P4|Part 2|Other Protocol Specified Criteria|0
5120932|NCT01722331|17690439|P3|Part 2|Other Protocol Specified Criteria|10
5120933|NCT01722331|17690440|P2|Part 2|Other Protocol Specified Criteria|0
5120934|NCT01722331|17690441|P1|Part 2|Other Protocol Specified Criteria|6
5120935|NCT01722331|17690435|P7|Part 2|Withdrawal by Subject|2
5120936|NCT01722331|17690436|P6|Part 2|Withdrawal by Subject|2
5120937|NCT01722331|17690437|P5|Part 2|Withdrawal by Subject|0
5120938|NCT01722331|17690438|P4|Part 2|Withdrawal by Subject|0
5120939|NCT01722331|17690439|P3|Part 2|Withdrawal by Subject|3
5120940|NCT01722331|17690440|P2|Part 2|Withdrawal by Subject|0
5120941|NCT01722331|17690441|P1|Part 2|Withdrawal by Subject|5
5120942|NCT01722331|17690435|P7|Part 2|Protocol Violation|0
5120943|NCT01722331|17690436|P6|Part 2|Protocol Violation|0
5120944|NCT01722331|17690437|P5|Part 2|Protocol Violation|0
5120945|NCT01722331|17690438|P4|Part 2|Protocol Violation|0
5120946|NCT01722331|17690439|P3|Part 2|Protocol Violation|0
5120947|NCT01722331|17690440|P2|Part 2|Protocol Violation|0
5120948|NCT01722331|17690441|P1|Part 2|Protocol Violation|1
5120949|NCT01722331|17690435|P7|Part 2|Progressive Disease|0
5120950|NCT01722331|17690436|P6|Part 2|Progressive Disease|0
5120951|NCT01722331|17690437|P5|Part 2|Progressive Disease|0
5120952|NCT01722331|17690438|P4|Part 2|Progressive Disease|0
5120953|NCT01722331|17690439|P3|Part 2|Progressive Disease|1
5120954|NCT01722331|17690440|P2|Part 2|Progressive Disease|0
5120955|NCT01722331|17690441|P1|Part 2|Progressive Disease|0
5120956|NCT01722331|17690435|P7|Part 2|Pregnancy|0
5120957|NCT01722331|17690436|P6|Part 2|Pregnancy|1
5120958|NCT01722331|17690437|P5|Part 2|Pregnancy|0
5120959|NCT01722331|17690438|P4|Part 2|Pregnancy|0
5120960|NCT01722331|17690439|P3|Part 2|Pregnancy|0
5120961|NCT01722331|17690440|P2|Part 2|Pregnancy|0
5120962|NCT01722331|17690441|P1|Part 2|Pregnancy|0
5120963|NCT01722331|17690435|P7|Part 2|Physician Decision|0
5120964|NCT01722331|17690436|P6|Part 2|Physician Decision|0
5120965|NCT01722331|17690437|P5|Part 2|Physician Decision|0
5120966|NCT01722331|17690438|P4|Part 2|Physician Decision|0
5120967|NCT01722331|17690439|P3|Part 2|Physician Decision|2
5120968|NCT01722331|17690440|P2|Part 2|Physician Decision|0
5120969|NCT01722331|17690441|P1|Part 2|Physician Decision|0
5120970|NCT01722331|17690435|P7|Part 2|Non-Compliance with Study Drug|0
5120971|NCT01722331|17690436|P6|Part 2|Non-Compliance with Study Drug|0
5120972|NCT01722331|17690437|P5|Part 2|Non-Compliance with Study Drug|0
5120973|NCT01722331|17690438|P4|Part 2|Non-Compliance with Study Drug|0
5120974|NCT01722331|17690439|P3|Part 2|Non-Compliance with Study Drug|1
5120975|NCT01722331|17690440|P2|Part 2|Non-Compliance with Study Drug|0
5120976|NCT01722331|17690441|P1|Part 2|Non-Compliance with Study Drug|1
5120977|NCT01722331|17690435|P7|Part 2|Lost to Follow-up|1
5120978|NCT01722331|17690436|P6|Part 2|Lost to Follow-up|1
5120979|NCT01722331|17690437|P5|Part 2|Lost to Follow-up|0
5120980|NCT01722331|17690438|P4|Part 2|Lost to Follow-up|0
5120981|NCT01722331|17690439|P3|Part 2|Lost to Follow-up|3
5120982|NCT01722331|17690440|P2|Part 2|Lost to Follow-up|0
5120983|NCT01722331|17690441|P1|Part 2|Lost to Follow-up|0
5120984|NCT01722331|17690435|P7|Part 2|Lack of Efficacy|3
5120985|NCT01722331|17690436|P6|Part 2|Lack of Efficacy|3
5120986|NCT01722331|17690437|P5|Part 2|Lack of Efficacy|0
5120987|NCT01722331|17690438|P4|Part 2|Lack of Efficacy|0
5120988|NCT01722331|17690439|P3|Part 2|Lack of Efficacy|11
5120989|NCT01722331|17690440|P2|Part 2|Lack of Efficacy|0
5120990|NCT01722331|17690441|P1|Part 2|Lack of Efficacy|3
5120991|NCT01722331|17690435|P7|Part 2|Adverse Event|0
5120992|NCT01722331|17690436|P6|Part 2|Adverse Event|1
5120993|NCT01722331|17690437|P5|Part 2|Adverse Event|0
5120994|NCT01722331|17690438|P4|Part 2|Adverse Event|0
5120995|NCT01722331|17690439|P3|Part 2|Adverse Event|0
5120996|NCT01722331|17690440|P2|Part 2|Adverse Event|0
5120997|NCT01722331|17690441|P1|Part 2|Adverse Event|3
5120998|NCT01722331|17690435|P7|Part 1|Withdrawal by Subject|0
5120999|NCT01722331|17690436|P6|Part 1|Withdrawal by Subject|0
5121000|NCT01722331|17690437|P5|Part 1|Withdrawal by Subject|3
5121001|NCT01722331|17690438|P4|Part 1|Withdrawal by Subject|0
5121002|NCT01722331|17690439|P3|Part 1|Withdrawal by Subject|3
5121003|NCT01722331|17690440|P2|Part 1|Withdrawal by Subject|0
5121004|NCT01722331|17690441|P1|Part 1|Withdrawal by Subject|2
5121005|NCT01722331|17690435|P7|Part 1|Protocol Violation|0
5121006|NCT01722331|17690436|P6|Part 1|Protocol Violation|0
5121007|NCT01722331|17690437|P5|Part 1|Protocol Violation|1
5121008|NCT01722331|17690438|P4|Part 1|Protocol Violation|0
5121009|NCT01722331|17690439|P3|Part 1|Protocol Violation|0
5121010|NCT01722331|17690440|P2|Part 1|Protocol Violation|0
5121011|NCT01722331|17690441|P1|Part 1|Protocol Violation|1
5121012|NCT01722331|17690435|P7|Part 1|Progressive Disease|0
5121013|NCT01722331|17690436|P6|Part 1|Progressive Disease|0
5121014|NCT01722331|17690437|P5|Part 1|Progressive Disease|1
5121015|NCT01722331|17690438|P4|Part 1|Progressive Disease|0
5121016|NCT01722331|17690439|P3|Part 1|Progressive Disease|0
5121017|NCT01722331|17690440|P2|Part 1|Progressive Disease|0
5121018|NCT01722331|17690441|P1|Part 1|Progressive Disease|0
5121019|NCT01722331|17690435|P7|Part 1|Pregnancy|0
5121020|NCT01722331|17690436|P6|Part 1|Pregnancy|0
5121021|NCT01722331|17690437|P5|Part 1|Pregnancy|0
5121022|NCT01722331|17690438|P4|Part 1|Pregnancy|0
5121023|NCT01722331|17690439|P3|Part 1|Pregnancy|0
5121024|NCT01722331|17690440|P2|Part 1|Pregnancy|0
5121025|NCT01722331|17690441|P1|Part 1|Pregnancy|1
5121026|NCT01722331|17690435|P7|Part 1|Physician Decision|0
5121027|NCT01722331|17690436|P6|Part 1|Physician Decision|0
5121028|NCT01722331|17690437|P5|Part 1|Physician Decision|1
5121029|NCT01722331|17690438|P4|Part 1|Physician Decision|0
5121030|NCT01722331|17690439|P3|Part 1|Physician Decision|3
5121031|NCT01722331|17690440|P2|Part 1|Physician Decision|0
5121032|NCT01722331|17690441|P1|Part 1|Physician Decision|0
5121033|NCT01722331|17690435|P7|Part 1|Lost to Follow-up|0
5121034|NCT01722331|17690436|P6|Part 1|Lost to Follow-up|0
5121035|NCT01722331|17690437|P5|Part 1|Lost to Follow-up|1
5121036|NCT01722331|17690438|P4|Part 1|Lost to Follow-up|0
5121037|NCT01722331|17690439|P3|Part 1|Lost to Follow-up|2
5121038|NCT01722331|17690440|P2|Part 1|Lost to Follow-up|0
5121039|NCT01722331|17690441|P1|Part 1|Lost to Follow-up|1
5121040|NCT01722331|17690435|P7|Part 1|Lack of Efficacy|0
5121041|NCT01722331|17690436|P6|Part 1|Lack of Efficacy|0
5121042|NCT01722331|17690437|P5|Part 1|Lack of Efficacy|2
5121043|NCT01722331|17690438|P4|Part 1|Lack of Efficacy|0
5121044|NCT01722331|17690439|P3|Part 1|Lack of Efficacy|1
5121045|NCT01722331|17690440|P2|Part 1|Lack of Efficacy|0
5121046|NCT01722331|17690441|P1|Part 1|Lack of Efficacy|0
5121047|NCT01722331|17690435|P7|Part 1|Adverse Event|0
5121048|NCT01722331|17690436|P6|Part 1|Adverse Event|0
5121049|NCT01722331|17690437|P5|Part 1|Adverse Event|0
5121050|NCT01722331|17690438|P4|Part 1|Adverse Event|0
5121051|NCT01722331|17690439|P3|Part 1|Adverse Event|0
5121052|NCT01722331|17690440|P2|Part 1|Adverse Event|0
5121053|NCT01722331|17690441|P1|Part 1|Adverse Event|5
5121054|NCT01722266|17690557|P4|Overall Study|Dropped out due to Nausea|0
5121055|NCT01722266|17690558|P3|Overall Study|Dropped out due to Nausea|2
5121056|NCT01722266|17690559|P2|Overall Study|Dropped out due to Nausea|0
5121057|NCT01722266|17690560|P1|Overall Study|Dropped out due to Nausea|0
5121058|NCT01722266|17690557|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
5121059|NCT01722266|17690558|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
5121060|NCT01722266|17690559|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
5121061|NCT01722266|17690560|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
5121062|NCT01722266|17690557|P4|Overall Study|Withdrawal by Subject|0
5121063|NCT01722266|17690558|P3|Overall Study|Withdrawal by Subject|0
5121064|NCT01722266|17690559|P2|Overall Study|Withdrawal by Subject|2
5121065|NCT01722266|17690560|P1|Overall Study|Withdrawal by Subject|1
5121066|NCT01722162|17690588|P2|Overall Study|Noncompliance|1
5121067|NCT01722162|17690589|P1|Overall Study|Noncompliance|0
5121068|NCT01722162|17690588|P2|Overall Study|Insurance denial post enrollment|1
5121069|NCT01722162|17690589|P1|Overall Study|Insurance denial post enrollment|0
5121070|NCT01722162|17690588|P2|Overall Study|Adverse Event|1
5121071|NCT01722162|17690589|P1|Overall Study|Adverse Event|1
5121072|NCT01722162|17690588|P2|Overall Study|Unrelated to study adverse event|2
5121073|NCT01722162|17690589|P1|Overall Study|Unrelated to study adverse event|2
5121074|NCT01722162|17690588|P2|Overall Study|Found ineligible|0
5121075|NCT01722162|17690589|P1|Overall Study|Found ineligible|1
5121076|NCT01722162|17690588|P2|Overall Study|Withdrawal by Subject|1
5121077|NCT01722162|17690589|P1|Overall Study|Withdrawal by Subject|1
5121078|NCT01722097|17690599|P2|Overall Study|Patient sheets not returned|5
5121079|NCT01722097|17690600|P1|Overall Study|Patient sheets not returned|6
5121080|NCT01722071|17690608|P2|Overall Study|Protocol Violation|0
5121081|NCT01722071|17690609|P1|Overall Study|Protocol Violation|1
5121082|NCT01722045|17690615|P1|Overall Study|Relocation (did not wish to transfer)|1
5121083|NCT01722045|17690615|P1|Overall Study|Physician Decision|3
5121084|NCT01722045|17690615|P1|Overall Study|Protocol Deviation|1
5121085|NCT01722045|17690615|P1|Overall Study|Lost to Follow-up|4
5121086|NCT01722045|17690615|P1|Overall Study|Withdrawal by Subject|8
5121087|NCT01722045|17690615|P1|Overall Study|Death|3
5121088|NCT01722045|17690615|P1|Overall Study|Adverse Event|8
5121089|NCT01721954|17690636|P2|Overall Study|Lost to Follow-up|1
5121090|NCT01721954|17690637|P1|Overall Study|Lost to Follow-up|2
5121091|NCT01721954|17690636|P2|Overall Study|Adverse Event|0
5121092|NCT01721954|17690637|P1|Overall Study|Adverse Event|2
5121093|NCT01721954|17690636|P2|Overall Study|Withdrawal by Subject|4
5121094|NCT01721954|17690637|P1|Overall Study|Withdrawal by Subject|8
5121095|NCT01721954|17690636|P2|Overall Study|Death|64
5121096|NCT01721954|17690637|P1|Overall Study|Death|58
5121097|NCT01721772|17690651|P2|Overall Study|Other|1
5121098|NCT01721772|17690652|P1|Overall Study|Other|0
5121099|NCT01721772|17690651|P2|Overall Study|Maximum clinical benefit|1
5121100|NCT01721772|17690652|P1|Overall Study|Maximum clinical benefit|1
5121101|NCT01721772|17690651|P2|Overall Study|Withdrawal by Subject|5
5121102|NCT01721772|17690652|P1|Overall Study|Withdrawal by Subject|7
5121103|NCT01721772|17690651|P2|Overall Study|Unrelated adverse event|3
5121104|NCT01721772|17690652|P1|Overall Study|Unrelated adverse event|2
5121105|NCT01721772|17690651|P2|Overall Study|Study drug toxicity|7
5121106|NCT01721772|17690652|P1|Overall Study|Study drug toxicity|5
5121107|NCT01721772|17690651|P2|Overall Study|Disease progression|175
5121108|NCT01721772|17690652|P1|Overall Study|Disease progression|96
5121109|NCT01721759|17690672|P1|Overall Study|Withdrawal by Subject|1
5121110|NCT01721759|17690672|P1|Overall Study|Adverse event unrelated to study drug|9
5121111|NCT01721759|17690672|P1|Overall Study|Study drug toxicity|14
5121112|NCT01721759|17690672|P1|Overall Study|Disease progression|78
5121113|NCT01721746|17690680|P3|Treatment Period|Other|1
5121114|NCT01721746|17690681|P2|Treatment Period|Other|1
5121115|NCT01721746|17690682|P1|Treatment Period|Other|2
5121116|NCT01721746|17690680|P3|Treatment Period|Subject No Longer Met Study Criteria|0
5121117|NCT01721746|17690681|P2|Treatment Period|Subject No Longer Met Study Criteria|0
5121118|NCT01721746|17690682|P1|Treatment Period|Subject No Longer Met Study Criteria|4
5121119|NCT01721746|17690680|P3|Treatment Period|Poor/Non-compliance|0
5121120|NCT01721746|17690681|P2|Treatment Period|Poor/Non-compliance|0
5121121|NCT01721746|17690682|P1|Treatment Period|Poor/Non-compliance|1
5121122|NCT01721746|17690680|P3|Treatment Period|Maximum Clinical Benefit|3
5121123|NCT01721746|17690681|P2|Treatment Period|Maximum Clinical Benefit|0
5121124|NCT01721746|17690682|P1|Treatment Period|Maximum Clinical Benefit|1
5121125|NCT01721746|17690680|P3|Treatment Period|Subject Withdrew Consent|2
5121126|NCT01721746|17690681|P2|Treatment Period|Subject Withdrew Consent|0
5121127|NCT01721746|17690682|P1|Treatment Period|Subject Withdrew Consent|3
5121128|NCT01721746|17690680|P3|Treatment Period|Subject Request to Discontinue Treatment|6
5121129|NCT01721746|17690681|P2|Treatment Period|Subject Request to Discontinue Treatment|1
5121130|NCT01721746|17690682|P1|Treatment Period|Subject Request to Discontinue Treatment|19
5121131|NCT01721746|17690680|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
5121132|NCT01721746|17690681|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
5121133|NCT01721746|17690682|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
5121134|NCT01721746|17690680|P3|Treatment Period|Study Drug Toxicity|9
5121135|NCT01721746|17690681|P2|Treatment Period|Study Drug Toxicity|2
5121136|NCT01721746|17690682|P1|Treatment Period|Study Drug Toxicity|15
5121137|NCT01721746|17690680|P3|Treatment Period|Disease Progression|34
5121138|NCT01721746|17690681|P2|Treatment Period|Disease Progression|40
5121139|NCT01721746|17690682|P1|Treatment Period|Disease Progression|182
5121140|NCT01721486|17690722|P2|Overall Study|Physician Decision|1
5121141|NCT01721486|17690723|P1|Overall Study|Physician Decision|0
5121142|NCT01721486|17690722|P2|Overall Study|Protocol Violation|0
5121143|NCT01721486|17690723|P1|Overall Study|Protocol Violation|1
5121144|NCT01721408|17690771|P2|Overall Study|Does not meet entrance criteria|0
5121145|NCT01721408|17690772|P1|Overall Study|Does not meet entrance criteria|1
5121146|NCT01721408|17690771|P2|Overall Study|Lost to Follow-up|2
5121147|NCT01721408|17690772|P1|Overall Study|Lost to Follow-up|1
5121148|NCT01721408|17690771|P2|Overall Study|Other|3
5121149|NCT01721408|17690772|P1|Overall Study|Other|3
5121150|NCT01721408|17690771|P2|Overall Study|Protocol Violation|2
5121151|NCT01721408|17690772|P1|Overall Study|Protocol Violation|0
5121152|NCT01721408|17690771|P2|Overall Study|No longer willing to participate study|10
5121153|NCT01721408|17690772|P1|Overall Study|No longer willing to participate study|9
5121154|NCT01721408|17690771|P2|Overall Study|Insufficient clinical response|6
5121155|NCT01721408|17690772|P1|Overall Study|Insufficient clinical response|15
5121156|NCT01721408|17690771|P2|Overall Study|Death|0
5121157|NCT01721408|17690772|P1|Overall Study|Death|1
5121158|NCT01721408|17690771|P2|Overall Study|Adverse Event|1
5121159|NCT01721408|17690772|P1|Overall Study|Adverse Event|6
5121160|NCT01721369|17690786|P1|Overall Study|Not initial etiological diagnosis|12
5121161|NCT01721330|17690792|P2|Overall Study|Withdrawal by Subject|1
5121162|NCT01721330|17690793|P1|Overall Study|Withdrawal by Subject|0
5121163|NCT01721317|17690801|P2|Overall Study|Withdrawal by Subject|1
5121164|NCT01721317|17690802|P1|Overall Study|Withdrawal by Subject|0
5121165|NCT01721317|17690801|P2|Overall Study|Physician Decision|1
5121166|NCT01721317|17690802|P1|Overall Study|Physician Decision|0
5121167|NCT01721317|17690801|P2|Overall Study|Study Closed / Terminated|2
5121168|NCT01721317|17690802|P1|Overall Study|Study Closed / Terminated|2
5121169|NCT01721200|17690881|P2|Overall Study|Lost to Follow-up|5
5121170|NCT01721200|17690882|P1|Overall Study|Lost to Follow-up|3
5121171|NCT01721161|17690907|P2|Overall Study|Other|1
5121172|NCT01721161|17690908|P1|Overall Study|Other|0
5121173|NCT01721161|17690907|P2|Overall Study|Withdrawal by Subject|1
5121174|NCT01721161|17690908|P1|Overall Study|Withdrawal by Subject|1
5121175|NCT01721161|17690907|P2|Overall Study|Lost to Follow-up|2
5121176|NCT01721161|17690908|P1|Overall Study|Lost to Follow-up|1
5121177|NCT01721161|17690907|P2|Overall Study|Adverse Event|3
5121178|NCT01721161|17690908|P1|Overall Study|Adverse Event|2
5121179|NCT01721109|17690931|P1|Overall Study|Lost to Follow-up|2
5121180|NCT01721109|17690931|P1|Overall Study|Withdrew Consent|1
5121181|NCT01721109|17690931|P1|Overall Study|Non- Compliance with Study Drug|3
5121182|NCT01721109|17690931|P1|Overall Study|Lack of Efficacy|1
5121183|NCT01721070|17691126|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
5121184|NCT01721057|17691137|P7|Rescue Period|Lack of Efficacy|0
5121185|NCT01721057|17691138|P6|Rescue Period|Lack of Efficacy|0
5121186|NCT01721057|17691139|P5|Rescue Period|Lack of Efficacy|0
5121187|NCT01721057|17691140|P4|Rescue Period|Lack of Efficacy|2
5121188|NCT01721057|17691141|P3|Rescue Period|Lack of Efficacy|0
5121189|NCT01721057|17691142|P2|Rescue Period|Lack of Efficacy|0
5121190|NCT01721057|17691143|P1|Rescue Period|Lack of Efficacy|0
5121191|NCT01721057|17691137|P7|Rescue Period|Adverse Event|0
5121192|NCT01721057|17691138|P6|Rescue Period|Adverse Event|0
5121193|NCT01721057|17691139|P5|Rescue Period|Adverse Event|0
5121194|NCT01721057|17691140|P4|Rescue Period|Adverse Event|1
5121195|NCT01721057|17691141|P3|Rescue Period|Adverse Event|0
5121196|NCT01721057|17691142|P2|Rescue Period|Adverse Event|0
5121197|NCT01721057|17691143|P1|Rescue Period|Adverse Event|0
5121198|NCT01721057|17691137|P7|Treatment Period|Death|0
5121199|NCT01721057|17691138|P6|Treatment Period|Death|0
5121200|NCT01721057|17691139|P5|Treatment Period|Death|0
5121201|NCT01721057|17691140|P4|Treatment Period|Death|0
5121202|NCT01721057|17691141|P3|Treatment Period|Death|0
5121203|NCT01721057|17691142|P2|Treatment Period|Death|0
5121204|NCT01721057|17691143|P1|Treatment Period|Death|2
5121205|NCT01721057|17691137|P7|Treatment Period|Physician Decision|0
5121206|NCT01721057|17691138|P6|Treatment Period|Physician Decision|0
5121207|NCT01721057|17691139|P5|Treatment Period|Physician Decision|0
5121208|NCT01721057|17691140|P4|Treatment Period|Physician Decision|0
5121209|NCT01721057|17691141|P3|Treatment Period|Physician Decision|3
5121210|NCT01721057|17691142|P2|Treatment Period|Physician Decision|1
5121211|NCT01721057|17691143|P1|Treatment Period|Physician Decision|0
5121212|NCT01721057|17691137|P7|Treatment Period|Lost to Follow-up|0
5121213|NCT01721057|17691138|P6|Treatment Period|Lost to Follow-up|0
5121214|NCT01721057|17691139|P5|Treatment Period|Lost to Follow-up|0
5121215|NCT01721057|17691140|P4|Treatment Period|Lost to Follow-up|0
5121216|NCT01721057|17691141|P3|Treatment Period|Lost to Follow-up|0
5121217|NCT01721057|17691142|P2|Treatment Period|Lost to Follow-up|0
5121218|NCT01721057|17691143|P1|Treatment Period|Lost to Follow-up|1
5121219|NCT01721057|17691137|P7|Treatment Period|Lack of Efficacy|0
5121220|NCT01721057|17691138|P6|Treatment Period|Lack of Efficacy|0
5121221|NCT01721057|17691139|P5|Treatment Period|Lack of Efficacy|0
5121222|NCT01721057|17691140|P4|Treatment Period|Lack of Efficacy|0
5121223|NCT01721057|17691141|P3|Treatment Period|Lack of Efficacy|0
5121224|NCT01721057|17691142|P2|Treatment Period|Lack of Efficacy|3
5121225|NCT01721057|17691143|P1|Treatment Period|Lack of Efficacy|7
5121226|NCT01721057|17691137|P7|Treatment Period|Adverse Event|0
5121227|NCT01721057|17691138|P6|Treatment Period|Adverse Event|0
5121228|NCT01721057|17691139|P5|Treatment Period|Adverse Event|0
5121229|NCT01721057|17691140|P4|Treatment Period|Adverse Event|0
5121230|NCT01721057|17691141|P3|Treatment Period|Adverse Event|12
5121231|NCT01721057|17691142|P2|Treatment Period|Adverse Event|10
5121232|NCT01721057|17691143|P1|Treatment Period|Adverse Event|7
5121233|NCT01721057|17691137|P7|Treatment Period|Withdrawal by Subject|0
5121234|NCT01721057|17691138|P6|Treatment Period|Withdrawal by Subject|0
5121235|NCT01721057|17691139|P5|Treatment Period|Withdrawal by Subject|0
5121236|NCT01721057|17691140|P4|Treatment Period|Withdrawal by Subject|0
5121237|NCT01721057|17691141|P3|Treatment Period|Withdrawal by Subject|8
5121238|NCT01721057|17691142|P2|Treatment Period|Withdrawal by Subject|5
5121239|NCT01721057|17691143|P1|Treatment Period|Withdrawal by Subject|11
5121240|NCT01721044|17691216|P3|Treatment Period|Withdrawal by Subject|1
5121241|NCT01721044|17691217|P2|Treatment Period|Withdrawal by Subject|6
5121242|NCT01721044|17691218|P1|Treatment Period|Withdrawal by Subject|7
5121243|NCT01721044|17691216|P3|Treatment Period|Protocol Violation|0
5121244|NCT01721044|17691217|P2|Treatment Period|Protocol Violation|0
5121245|NCT01721044|17691218|P1|Treatment Period|Protocol Violation|1
5121246|NCT01721044|17691216|P3|Treatment Period|Physician Decision|2
5121247|NCT01721044|17691217|P2|Treatment Period|Physician Decision|0
5121248|NCT01721044|17691218|P1|Treatment Period|Physician Decision|1
5121249|NCT01721044|17691216|P3|Treatment Period|Lost to Follow-up|1
5121250|NCT01721044|17691217|P2|Treatment Period|Lost to Follow-up|0
5121251|NCT01721044|17691218|P1|Treatment Period|Lost to Follow-up|0
5121252|NCT01721044|17691216|P3|Treatment Period|Lack of Efficacy|4
5121253|NCT01721044|17691217|P2|Treatment Period|Lack of Efficacy|4
5121254|NCT01721044|17691218|P1|Treatment Period|Lack of Efficacy|16
5121255|NCT01721044|17691216|P3|Treatment Period|Death|1
5121256|NCT01721044|17691217|P2|Treatment Period|Death|0
5121257|NCT01721044|17691218|P1|Treatment Period|Death|0
5121258|NCT01721044|17691216|P3|Treatment Period|Adverse Event|10
5121259|NCT01721044|17691217|P2|Treatment Period|Adverse Event|7
5121260|NCT01721044|17691218|P1|Treatment Period|Adverse Event|7
5121261|NCT01720797|17691291|P2|Overall Study|Withdrawal by Subject|0
5121262|NCT01720797|17691292|P1|Overall Study|Withdrawal by Subject|3
5121263|NCT01720667|17691300|P2|Overall Study|Withdrawal by Subject|0
5121264|NCT01720667|17691301|P1|Overall Study|Withdrawal by Subject|3
5121265|NCT01720667|17691300|P2|Overall Study|Adverse Event|1
5121266|NCT01720667|17691301|P1|Overall Study|Adverse Event|1
5121267|NCT01720602|17691315|P1|Overall Study|Progressive disease on therapy|2
5121268|NCT01720602|17691315|P1|Overall Study|Adverse Event|3
5121269|NCT01720524|17691325|P2|Part B|Death|2
5121270|NCT01720524|17691326|P1|Part B|Death|0
5121271|NCT01720524|17691325|P2|Part B|Lost to Follow-up|3
5121272|NCT01720524|17691326|P1|Part B|Lost to Follow-up|1
5121273|NCT01720524|17691325|P2|Part B|Other|0
5121274|NCT01720524|17691326|P1|Part B|Other|2
5121275|NCT01720524|17691325|P2|Part B|Withdrawal by Subject|4
5121276|NCT01720524|17691326|P1|Part B|Withdrawal by Subject|1
5121277|NCT01720524|17691325|P2|Part B|Ongoing|5
5121278|NCT01720524|17691326|P1|Part B|Ongoing|3
5121279|NCT01720524|17691325|P2|Part A|Lost to Follow-up|1
5121280|NCT01720524|17691326|P1|Part A|Lost to Follow-up|0
5121281|NCT01720524|17691325|P2|Part A|Other|1
5121282|NCT01720524|17691326|P1|Part A|Other|0
5121283|NCT01720524|17691325|P2|Part A|Withdrawal by Subject|1
5121284|NCT01720524|17691326|P1|Part A|Withdrawal by Subject|0
5121285|NCT01720524|17691325|P2|Part A|Missed 28 day follow-up visit|1
5121286|NCT01720524|17691326|P1|Part A|Missed 28 day follow-up visit|1
5121287|NCT01720524|17691325|P2|Part A|Lost to Follow-up|1
5121288|NCT01720524|17691326|P1|Part A|Lost to Follow-up|0
5121289|NCT01720524|17691325|P2|Part A|Death|1
5121290|NCT01720524|17691326|P1|Part A|Death|2
5121291|NCT01720524|17691325|P2|Part A|Adverse Event|2
5121292|NCT01720524|17691326|P1|Part A|Adverse Event|2
5121293|NCT01720524|17691325|P2|Part A|Insufficient Clinical Response|4
5121294|NCT01720524|17691326|P1|Part A|Insufficient Clinical Response|2
5121295|NCT01720446|17691359|P4|Overall Study|Withdrawal by Subject|4
5121296|NCT01720446|17691360|P3|Overall Study|Withdrawal by Subject|4
5121297|NCT01720446|17691361|P2|Overall Study|Withdrawal by Subject|5
5121298|NCT01720446|17691362|P1|Overall Study|Withdrawal by Subject|2
5121299|NCT01720446|17691359|P4|Overall Study|Lost to Follow-up|16
5121300|NCT01720446|17691360|P3|Overall Study|Lost to Follow-up|16
5121301|NCT01720446|17691361|P2|Overall Study|Lost to Follow-up|6
5121302|NCT01720446|17691362|P1|Overall Study|Lost to Follow-up|12
5121303|NCT01720264|17691483|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
5121304|NCT01720264|17691483|P1|Post-transplant (Day 16) to 1 Year|Death|8
5121305|NCT01720264|17691483|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
5121306|NCT01720069|17691514|P3|Overall Study|Lost to Follow-up|1
5121307|NCT01720069|17691515|P2|Overall Study|Lost to Follow-up|0
5121308|NCT01720069|17691516|P1|Overall Study|Lost to Follow-up|0
5121309|NCT01720069|17691514|P3|Overall Study|Non-compliance on using e-diary|1
5121310|NCT01720069|17691515|P2|Overall Study|Non-compliance on using e-diary|0
5121311|NCT01720069|17691516|P1|Overall Study|Non-compliance on using e-diary|0
5121312|NCT01720069|17691514|P3|Overall Study|OCS bursts occured, discontinued in line|0
5121313|NCT01720069|17691515|P2|Overall Study|OCS bursts occured, discontinued in line|0
5121314|NCT01720069|17691516|P1|Overall Study|OCS bursts occured, discontinued in line|1
5121315|NCT01720069|17691514|P3|Overall Study|Withdrawal by Subject|1
5121316|NCT01720069|17691515|P2|Overall Study|Withdrawal by Subject|2
5121317|NCT01720069|17691516|P1|Overall Study|Withdrawal by Subject|0
5121318|NCT01720069|17691514|P3|Overall Study|Treatment period withdrawal criteria met|9
5121319|NCT01720069|17691515|P2|Overall Study|Treatment period withdrawal criteria met|8
5121320|NCT01720069|17691516|P1|Overall Study|Treatment period withdrawal criteria met|4
5121321|NCT01720069|17691514|P3|Overall Study|Lack of Efficacy|0
5121322|NCT01720069|17691515|P2|Overall Study|Lack of Efficacy|4
5121323|NCT01720069|17691516|P1|Overall Study|Lack of Efficacy|0
5121324|NCT01720069|17691514|P3|Overall Study|Adverse Event|1
5121325|NCT01720069|17691515|P2|Overall Study|Adverse Event|0
5121326|NCT01720069|17691516|P1|Overall Study|Adverse Event|0
5121327|NCT01720069|17691514|P3|Overall Study|Randomised without baseline values|1
5121328|NCT01720069|17691515|P2|Overall Study|Randomised without baseline values|0
5121329|NCT01720069|17691516|P1|Overall Study|Randomised without baseline values|0
5121330|NCT01720069|17691514|P3|Overall Study|Could not use e-diary correctly|1
5121331|NCT01720069|17691515|P2|Overall Study|Could not use e-diary correctly|1
5121332|NCT01720069|17691516|P1|Overall Study|Could not use e-diary correctly|0
5121333|NCT01720043|17691542|P1|Overall Study|Withdrawal by Subject|1
5121334|NCT01719861|17691571|P1|Cycle 2|Death|1
5121335|NCT01719861|17691571|P1|Cycle 1|Death|4
5121336|NCT01719783|17691581|P2|Dose 2|Physician Decision|0
5121337|NCT01719783|17691582|P1|Dose 2|Physician Decision|1
5121338|NCT01719757|17691668|P1|Overall Study|well controlled pain|27
5121339|NCT01719757|17691668|P1|Overall Study|Protocol Violation|1
5121340|NCT01719757|17691668|P1|Overall Study|Lost to Follow-up|20
5121341|NCT01719757|17691668|P1|Overall Study|Withdrawal by Subject|15
5121342|NCT01719757|17691668|P1|Overall Study|Adverse Event|38
5121343|NCT01719224|17691722|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
5121344|NCT01719224|17691723|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
5121345|NCT01719172|17691732|P1|Overall Study|Death|1
5121346|NCT01719172|17691732|P1|Overall Study|Lost to Follow-up|1
5121347|NCT01719003|17691746|P9|Overall Study|Lack of Efficacy|0
5121348|NCT01719003|17691747|P8|Overall Study|Lack of Efficacy|0
5121349|NCT01719003|17691748|P7|Overall Study|Lack of Efficacy|1
5121350|NCT01719003|17691749|P6|Overall Study|Lack of Efficacy|0
5121351|NCT01719003|17691750|P5|Overall Study|Lack of Efficacy|0
5121352|NCT01719003|17691751|P4|Overall Study|Lack of Efficacy|0
5121353|NCT01719003|17691752|P3|Overall Study|Lack of Efficacy|0
5121354|NCT01719003|17691753|P2|Overall Study|Lack of Efficacy|0
5121355|NCT01719003|17691754|P1|Overall Study|Lack of Efficacy|0
5121356|NCT01719003|17691746|P9|Overall Study|Reason other than those specified|1
5121357|NCT01719003|17691747|P8|Overall Study|Reason other than those specified|3
5121358|NCT01719003|17691748|P7|Overall Study|Reason other than those specified|0
5121359|NCT01719003|17691749|P6|Overall Study|Reason other than those specified|1
5121360|NCT01719003|17691750|P5|Overall Study|Reason other than those specified|4
5121361|NCT01719003|17691751|P4|Overall Study|Reason other than those specified|3
5121362|NCT01719003|17691752|P3|Overall Study|Reason other than those specified|2
5121363|NCT01719003|17691753|P2|Overall Study|Reason other than those specified|0
5121364|NCT01719003|17691754|P1|Overall Study|Reason other than those specified|0
5121365|NCT01719003|17691746|P9|Overall Study|Refusal to continue, not due to AE|1
5121366|NCT01719003|17691747|P8|Overall Study|Refusal to continue, not due to AE|7
5121367|NCT01719003|17691748|P7|Overall Study|Refusal to continue, not due to AE|8
5121368|NCT01719003|17691749|P6|Overall Study|Refusal to continue, not due to AE|3
5121369|NCT01719003|17691750|P5|Overall Study|Refusal to continue, not due to AE|4
5121370|NCT01719003|17691751|P4|Overall Study|Refusal to continue, not due to AE|4
5121371|NCT01719003|17691752|P3|Overall Study|Refusal to continue, not due to AE|4
5121372|NCT01719003|17691753|P2|Overall Study|Refusal to continue, not due to AE|5
5121373|NCT01719003|17691754|P1|Overall Study|Refusal to continue, not due to AE|2
5121374|NCT01719003|17691746|P9|Overall Study|Lost to Follow-up|2
5121375|NCT01719003|17691747|P8|Overall Study|Lost to Follow-up|2
5121376|NCT01719003|17691748|P7|Overall Study|Lost to Follow-up|3
5121377|NCT01719003|17691749|P6|Overall Study|Lost to Follow-up|4
5121378|NCT01719003|17691750|P5|Overall Study|Lost to Follow-up|3
5121379|NCT01719003|17691751|P4|Overall Study|Lost to Follow-up|2
5121380|NCT01719003|17691752|P3|Overall Study|Lost to Follow-up|7
5121381|NCT01719003|17691753|P2|Overall Study|Lost to Follow-up|6
5121382|NCT01719003|17691754|P1|Overall Study|Lost to Follow-up|0
5121383|NCT01719003|17691746|P9|Overall Study|Adverse Event|0
5121384|NCT01719003|17691747|P8|Overall Study|Adverse Event|5
5121385|NCT01719003|17691748|P7|Overall Study|Adverse Event|6
5121386|NCT01719003|17691749|P6|Overall Study|Adverse Event|3
5121387|NCT01719003|17691750|P5|Overall Study|Adverse Event|4
5121388|NCT01719003|17691751|P4|Overall Study|Adverse Event|3
5121389|NCT01719003|17691752|P3|Overall Study|Adverse Event|4
5121390|NCT01719003|17691753|P2|Overall Study|Adverse Event|5
5121391|NCT01719003|17691754|P1|Overall Study|Adverse Event|6
5121392|NCT01719003|17691746|P9|Overall Study|Non compliant with protocol|0
5121393|NCT01719003|17691747|P8|Overall Study|Non compliant with protocol|3
5121394|NCT01719003|17691748|P7|Overall Study|Non compliant with protocol|2
5121395|NCT01719003|17691749|P6|Overall Study|Non compliant with protocol|1
5121396|NCT01719003|17691750|P5|Overall Study|Non compliant with protocol|2
5121397|NCT01719003|17691751|P4|Overall Study|Non compliant with protocol|1
5121398|NCT01719003|17691752|P3|Overall Study|Non compliant with protocol|0
5121399|NCT01719003|17691753|P2|Overall Study|Non compliant with protocol|1
5121400|NCT01719003|17691754|P1|Overall Study|Non compliant with protocol|1
5121401|NCT01718535|17691835|P10|Overall Study|Bidirectional Sequencing not possible|0
5121402|NCT01718535|17691836|P9|Overall Study|Bidirectional Sequencing not possible|0
5121403|NCT01718535|17691837|P8|Overall Study|Bidirectional Sequencing not possible|0
5121404|NCT01718535|17691838|P7|Overall Study|Bidirectional Sequencing not possible|0
5121405|NCT01718535|17691839|P6|Overall Study|Bidirectional Sequencing not possible|0
5121406|NCT01718535|17691840|P5|Overall Study|Bidirectional Sequencing not possible|0
5121407|NCT01718535|17691841|P4|Overall Study|Bidirectional Sequencing not possible|1
5121408|NCT01718535|17691842|P3|Overall Study|Bidirectional Sequencing not possible|0
5121409|NCT01718535|17691843|P2|Overall Study|Bidirectional Sequencing not possible|0
5121410|NCT01718535|17691844|P1|Overall Study|Bidirectional Sequencing not possible|1
5121411|NCT01718509|17691882|P2|Overall Study|Lack of Efficacy|0
5121412|NCT01718509|17691883|P1|Overall Study|Lack of Efficacy|1
5121413|NCT01718509|17691882|P2|Overall Study|Protocol Violation|2
5121414|NCT01718509|17691883|P1|Overall Study|Protocol Violation|4
5121415|NCT01718509|17691882|P2|Overall Study|Other|11
5121416|NCT01718509|17691883|P1|Overall Study|Other|13
5121417|NCT01718509|17691882|P2|Overall Study|Adverse Event|7
5121418|NCT01718509|17691883|P1|Overall Study|Adverse Event|5
5121419|NCT01718509|17691882|P2|Overall Study|Withdrawal by Subject|13
5121420|NCT01718509|17691883|P1|Overall Study|Withdrawal by Subject|7
5121421|NCT01718509|17691882|P2|Overall Study|Lost to Follow-up|15
5121422|NCT01718509|17691883|P1|Overall Study|Lost to Follow-up|18
5121423|NCT01718483|17691929|P2|Overall Study|Lack of Efficacy|0
5121424|NCT01718483|17691930|P1|Overall Study|Lack of Efficacy|1
5121425|NCT01718483|17691929|P2|Overall Study|Pregnancy|1
5121426|NCT01718483|17691930|P1|Overall Study|Pregnancy|1
5121427|NCT01718483|17691929|P2|Overall Study|Other|4
5121428|NCT01718483|17691930|P1|Overall Study|Other|1
5121429|NCT01718483|17691929|P2|Overall Study|Protocol Violation|2
5121430|NCT01718483|17691930|P1|Overall Study|Protocol Violation|4
5121431|NCT01718483|17691929|P2|Overall Study|Lost to Follow-up|3
5121432|NCT01718483|17691930|P1|Overall Study|Lost to Follow-up|8
5121433|NCT01718483|17691929|P2|Overall Study|Adverse Event|12
5121434|NCT01718483|17691930|P1|Overall Study|Adverse Event|5
5121435|NCT01718483|17691929|P2|Overall Study|Withdrawal by Subject|12
5121436|NCT01718483|17691930|P1|Overall Study|Withdrawal by Subject|14
5121437|NCT01718353|17691985|P2|Overall Study|Randomized but not treated|0
5121438|NCT01718353|17691986|P1|Overall Study|Randomized but not treated|2
5121439|NCT01718353|17691985|P2|Overall Study|Principal Investigator's Decision|4
5121440|NCT01718353|17691986|P1|Overall Study|Principal Investigator's Decision|10
5121441|NCT01718353|17691985|P2|Overall Study|Lost to Follow-up|1
5121442|NCT01718353|17691986|P1|Overall Study|Lost to Follow-up|0
5121443|NCT01717989|17692017|P1|Overall Study|Other|40
5121444|NCT01717989|17692017|P1|Overall Study|Protocol-specified criteria|551
5121445|NCT01717989|17692017|P1|Overall Study|Death|439
5121446|NCT01717989|17692017|P1|Overall Study|Lost to Follow-up|11
5121447|NCT01717989|17692017|P1|Overall Study|Physician Decision|2
5121448|NCT01717989|17692017|P1|Overall Study|Withdrawal by Subject|11
5121449|NCT01717989|17692017|P1|Overall Study|Protocol deviation|6
5121450|NCT01717989|17692017|P1|Overall Study|Ineligibility determined|6
5121451|NCT01717976|17692085|P2|Overall Study|Protocol Violation|1
5121452|NCT01717976|17692086|P1|Overall Study|Protocol Violation|0
5121453|NCT01717859|17692141|P1|Overall Study|Withdrawal by Subject|2
5121454|NCT01717859|17692141|P1|Overall Study|Lost to Follow-up|1
5121455|NCT01717859|17692141|P1|Overall Study|Patient concerned about mental health|1
5121456|NCT01717859|17692141|P1|Overall Study|Moved out of state|1
5121457|NCT01717859|17692141|P1|Overall Study|Adverse Event|5
5121458|NCT01717768|17692162|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121459|NCT01717768|17692163|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121460|NCT01717768|17692164|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
5121461|NCT01717768|17692165|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121462|NCT01717768|17692166|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121463|NCT01717768|17692167|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121464|NCT01717768|17692168|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121465|NCT01717768|17692169|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121466|NCT01717768|17692170|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121467|NCT01717768|17692171|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121468|NCT01717768|17692172|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121469|NCT01717768|17692173|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5121470|NCT01717768|17692162|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121471|NCT01717768|17692163|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121472|NCT01717768|17692164|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121473|NCT01717768|17692165|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121474|NCT01717768|17692166|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
5121475|NCT01717768|17692167|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121476|NCT01717768|17692168|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121477|NCT01717768|17692169|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121478|NCT01717768|17692170|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121479|NCT01717768|17692171|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121480|NCT01717768|17692172|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121481|NCT01717768|17692173|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5121482|NCT01717768|17692162|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
5121483|NCT01717768|17692163|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121484|NCT01717768|17692164|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121485|NCT01717768|17692165|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121486|NCT01717768|17692166|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121487|NCT01717768|17692167|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121488|NCT01717768|17692168|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121489|NCT01717768|17692169|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121490|NCT01717768|17692170|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121491|NCT01717768|17692171|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121492|NCT01717768|17692172|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121493|NCT01717768|17692173|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5121494|NCT01717768|17692162|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121495|NCT01717768|17692163|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121496|NCT01717768|17692164|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121497|NCT01717768|17692165|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121498|NCT01717768|17692166|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121499|NCT01717768|17692167|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121500|NCT01717768|17692168|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121501|NCT01717768|17692169|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121502|NCT01717768|17692170|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121503|NCT01717768|17692171|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121504|NCT01717768|17692172|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
5121505|NCT01717768|17692173|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5121506|NCT01717638|17692253|P13|Overall Study|Withdrawal by Subject|18
5121507|NCT01717638|17692254|P12|Overall Study|Withdrawal by Subject|0
5121508|NCT01717638|17692255|P11|Overall Study|Withdrawal by Subject|0
5121509|NCT01717638|17692256|P10|Overall Study|Withdrawal by Subject|1
5121510|NCT01717638|17692257|P9|Overall Study|Withdrawal by Subject|2
5121511|NCT01717638|17692258|P8|Overall Study|Withdrawal by Subject|1
5121512|NCT01717638|17692259|P7|Overall Study|Withdrawal by Subject|2
5121513|NCT01717638|17692260|P6|Overall Study|Withdrawal by Subject|0
5121514|NCT01717638|17692261|P5|Overall Study|Withdrawal by Subject|1
5121515|NCT01717638|17692262|P4|Overall Study|Withdrawal by Subject|0
5121516|NCT01717638|17692263|P3|Overall Study|Withdrawal by Subject|1
5121517|NCT01717638|17692264|P2|Overall Study|Withdrawal by Subject|1
5121518|NCT01717638|17692265|P1|Overall Study|Withdrawal by Subject|0
5121519|NCT01717638|17692253|P13|Overall Study|Father in hospital|1
5121520|NCT01717638|17692254|P12|Overall Study|Father in hospital|0
5121521|NCT01717638|17692255|P11|Overall Study|Father in hospital|0
5121522|NCT01717638|17692256|P10|Overall Study|Father in hospital|0
5121523|NCT01717638|17692257|P9|Overall Study|Father in hospital|0
5121524|NCT01717638|17692258|P8|Overall Study|Father in hospital|0
5121525|NCT01717638|17692259|P7|Overall Study|Father in hospital|0
5121526|NCT01717638|17692260|P6|Overall Study|Father in hospital|0
5121527|NCT01717638|17692261|P5|Overall Study|Father in hospital|0
5121528|NCT01717638|17692262|P4|Overall Study|Father in hospital|0
5121529|NCT01717638|17692263|P3|Overall Study|Father in hospital|0
5121530|NCT01717638|17692264|P2|Overall Study|Father in hospital|0
5121531|NCT01717638|17692265|P1|Overall Study|Father in hospital|0
5121532|NCT01717638|17692253|P13|Overall Study|Lost to Follow-up|0
5121533|NCT01717638|17692254|P12|Overall Study|Lost to Follow-up|0
5121534|NCT01717638|17692255|P11|Overall Study|Lost to Follow-up|0
5121535|NCT01717638|17692256|P10|Overall Study|Lost to Follow-up|0
5121536|NCT01717638|17692257|P9|Overall Study|Lost to Follow-up|0
5121537|NCT01717638|17692258|P8|Overall Study|Lost to Follow-up|0
5121538|NCT01717638|17692259|P7|Overall Study|Lost to Follow-up|0
5121539|NCT01717638|17692260|P6|Overall Study|Lost to Follow-up|1
5121540|NCT01717638|17692261|P5|Overall Study|Lost to Follow-up|0
5121541|NCT01717638|17692262|P4|Overall Study|Lost to Follow-up|0
5121542|NCT01717638|17692263|P3|Overall Study|Lost to Follow-up|0
5121543|NCT01717638|17692264|P2|Overall Study|Lost to Follow-up|0
5121544|NCT01717638|17692265|P1|Overall Study|Lost to Follow-up|0
5121545|NCT01717456|17692441|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
5121546|NCT01717456|17692442|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
5121547|NCT01717456|17692441|P2|End of Treatment|Lost to Follow-up|1
5121548|NCT01717456|17692442|P1|End of Treatment|Lost to Follow-up|0
5121549|NCT01717456|17692441|P2|End of Treatment|Physician Decision|1
5121550|NCT01717456|17692442|P1|End of Treatment|Physician Decision|0
5121551|NCT01717391|17692510|P1|Overall Study|FLT technical failure|3
5121552|NCT01717391|17692510|P1|Overall Study|Physician Decision|1
5121553|NCT01717391|17692510|P1|Overall Study|Withdrawal by Subject|5
5121554|NCT01717326|17692539|P20|Overall Study|Withdrawal by Subject|3
5121555|NCT01717326|17692540|P19|Overall Study|Withdrawal by Subject|2
5121556|NCT01717326|17692541|P18|Overall Study|Withdrawal by Subject|0
5121557|NCT01717326|17692542|P17|Overall Study|Withdrawal by Subject|0
5121558|NCT01717326|17692543|P16|Overall Study|Withdrawal by Subject|1
5121559|NCT01717326|17692544|P15|Overall Study|Withdrawal by Subject|0
5121560|NCT01717326|17692545|P14|Overall Study|Withdrawal by Subject|0
5121561|NCT01717326|17692546|P13|Overall Study|Withdrawal by Subject|1
5121562|NCT01717326|17692547|P12|Overall Study|Withdrawal by Subject|0
5121563|NCT01717326|17692548|P11|Overall Study|Withdrawal by Subject|0
5121564|NCT01717326|17692549|P10|Overall Study|Withdrawal by Subject|1
5121565|NCT01717326|17692550|P9|Overall Study|Withdrawal by Subject|0
5121566|NCT01717326|17692551|P8|Overall Study|Withdrawal by Subject|0
5121567|NCT01717326|17692552|P7|Overall Study|Withdrawal by Subject|0
5121568|NCT01717326|17692553|P6|Overall Study|Withdrawal by Subject|0
5121569|NCT01717326|17692554|P5|Overall Study|Withdrawal by Subject|0
5121570|NCT01717326|17692555|P4|Overall Study|Withdrawal by Subject|0
5121571|NCT01717326|17692556|P3|Overall Study|Withdrawal by Subject|0
5121572|NCT01717326|17692557|P2|Overall Study|Withdrawal by Subject|1
5121573|NCT01717326|17692558|P1|Overall Study|Withdrawal by Subject|0
5121574|NCT01717326|17692539|P20|Overall Study|Protocol Violation|0
5121575|NCT01717326|17692540|P19|Overall Study|Protocol Violation|0
5121576|NCT01717326|17692541|P18|Overall Study|Protocol Violation|0
5121577|NCT01717326|17692542|P17|Overall Study|Protocol Violation|0
5121578|NCT01717326|17692543|P16|Overall Study|Protocol Violation|0
5121579|NCT01717326|17692544|P15|Overall Study|Protocol Violation|0
5121580|NCT01717326|17692545|P14|Overall Study|Protocol Violation|0
5121581|NCT01717326|17692546|P13|Overall Study|Protocol Violation|0
5121582|NCT01717326|17692547|P12|Overall Study|Protocol Violation|0
5121583|NCT01717326|17692548|P11|Overall Study|Protocol Violation|0
5121584|NCT01717326|17692549|P10|Overall Study|Protocol Violation|0
5121585|NCT01717326|17692550|P9|Overall Study|Protocol Violation|0
5121586|NCT01717326|17692551|P8|Overall Study|Protocol Violation|0
5121587|NCT01717326|17692552|P7|Overall Study|Protocol Violation|0
5121588|NCT01717326|17692553|P6|Overall Study|Protocol Violation|0
5121589|NCT01717326|17692554|P5|Overall Study|Protocol Violation|1
5121590|NCT01717326|17692555|P4|Overall Study|Protocol Violation|0
5121591|NCT01717326|17692556|P3|Overall Study|Protocol Violation|0
5121592|NCT01717326|17692557|P2|Overall Study|Protocol Violation|0
5121593|NCT01717326|17692558|P1|Overall Study|Protocol Violation|0
5121594|NCT01717326|17692539|P20|Overall Study|Physician Decision|0
5121595|NCT01717326|17692540|P19|Overall Study|Physician Decision|0
5121596|NCT01717326|17692541|P18|Overall Study|Physician Decision|0
5121597|NCT01717326|17692542|P17|Overall Study|Physician Decision|0
5121598|NCT01717326|17692543|P16|Overall Study|Physician Decision|0
5121599|NCT01717326|17692544|P15|Overall Study|Physician Decision|0
5121600|NCT01717326|17692545|P14|Overall Study|Physician Decision|0
5121601|NCT01717326|17692546|P13|Overall Study|Physician Decision|0
5121602|NCT01717326|17692547|P12|Overall Study|Physician Decision|0
5121603|NCT01717326|17692548|P11|Overall Study|Physician Decision|0
5121604|NCT01717326|17692549|P10|Overall Study|Physician Decision|1
5121605|NCT01717326|17692550|P9|Overall Study|Physician Decision|0
5121606|NCT01717326|17692551|P8|Overall Study|Physician Decision|0
5121607|NCT01717326|17692552|P7|Overall Study|Physician Decision|0
5121608|NCT01717326|17692553|P6|Overall Study|Physician Decision|0
5121609|NCT01717326|17692554|P5|Overall Study|Physician Decision|0
5121610|NCT01717326|17692555|P4|Overall Study|Physician Decision|0
5121611|NCT01717326|17692556|P3|Overall Study|Physician Decision|0
5121612|NCT01717326|17692557|P2|Overall Study|Physician Decision|0
5121613|NCT01717326|17692558|P1|Overall Study|Physician Decision|0
5121614|NCT01717326|17692539|P20|Overall Study|Lost to Follow-up|3
5121615|NCT01717326|17692540|P19|Overall Study|Lost to Follow-up|2
5121616|NCT01717326|17692541|P18|Overall Study|Lost to Follow-up|0
5121617|NCT01717326|17692542|P17|Overall Study|Lost to Follow-up|1
5121618|NCT01717326|17692543|P16|Overall Study|Lost to Follow-up|2
5121619|NCT01717326|17692544|P15|Overall Study|Lost to Follow-up|0
5121620|NCT01717326|17692545|P14|Overall Study|Lost to Follow-up|0
5121621|NCT01717326|17692546|P13|Overall Study|Lost to Follow-up|0
5121622|NCT01717326|17692547|P12|Overall Study|Lost to Follow-up|0
5121623|NCT01717326|17692548|P11|Overall Study|Lost to Follow-up|1
5121624|NCT01717326|17692549|P10|Overall Study|Lost to Follow-up|0
5121625|NCT01717326|17692550|P9|Overall Study|Lost to Follow-up|0
5121626|NCT01717326|17692551|P8|Overall Study|Lost to Follow-up|0
5121627|NCT01717326|17692552|P7|Overall Study|Lost to Follow-up|1
5121628|NCT01717326|17692553|P6|Overall Study|Lost to Follow-up|0
5121629|NCT01717326|17692554|P5|Overall Study|Lost to Follow-up|1
5121630|NCT01717326|17692555|P4|Overall Study|Lost to Follow-up|2
5121631|NCT01717326|17692556|P3|Overall Study|Lost to Follow-up|0
5121632|NCT01717326|17692557|P2|Overall Study|Lost to Follow-up|0
5121633|NCT01717326|17692558|P1|Overall Study|Lost to Follow-up|3
5121634|NCT01717326|17692539|P20|Overall Study|Death|0
5121635|NCT01717326|17692540|P19|Overall Study|Death|0
5121636|NCT01717326|17692541|P18|Overall Study|Death|0
5121637|NCT01717326|17692542|P17|Overall Study|Death|0
5121638|NCT01717326|17692543|P16|Overall Study|Death|0
5121639|NCT01717326|17692544|P15|Overall Study|Death|0
5121640|NCT01717326|17692545|P14|Overall Study|Death|0
5121641|NCT01717326|17692546|P13|Overall Study|Death|0
5121642|NCT01717326|17692547|P12|Overall Study|Death|0
5121643|NCT01717326|17692548|P11|Overall Study|Death|1
5121644|NCT01717326|17692549|P10|Overall Study|Death|0
5121645|NCT01717326|17692550|P9|Overall Study|Death|0
5121646|NCT01717326|17692551|P8|Overall Study|Death|0
5121647|NCT01717326|17692552|P7|Overall Study|Death|0
5121648|NCT01717326|17692553|P6|Overall Study|Death|0
5121649|NCT01717326|17692554|P5|Overall Study|Death|0
5121650|NCT01717326|17692555|P4|Overall Study|Death|0
5121651|NCT01717326|17692556|P3|Overall Study|Death|0
5121652|NCT01717326|17692557|P2|Overall Study|Death|0
5121653|NCT01717326|17692558|P1|Overall Study|Death|0
5121654|NCT01717313|17692822|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
5121655|NCT01717313|17692823|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
5121656|NCT01717313|17692822|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
5121657|NCT01717313|17692823|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
5121658|NCT01717313|17692822|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
5121659|NCT01717313|17692823|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
5121660|NCT01717313|17692822|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
5121661|NCT01717313|17692823|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
5121662|NCT01717313|17692822|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
5121663|NCT01717313|17692823|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
5121664|NCT01717313|17692822|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
5121665|NCT01717313|17692823|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
5121666|NCT01717313|17692822|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
5121667|NCT01717313|17692823|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
5121668|NCT01717313|17692822|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
5121669|NCT01717313|17692823|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
5121670|NCT01717313|17692822|P2|Phase A (Weeks 0 to 24)|Death|1
5121671|NCT01717313|17692823|P1|Phase A (Weeks 0 to 24)|Death|0
5121672|NCT01717287|17692861|P2|Overall Study|Protocol Violation|1
5121673|NCT01717287|17692862|P1|Overall Study|Protocol Violation|0
5121674|NCT01717287|17692861|P2|Overall Study|Lost to Follow-up|2
5121675|NCT01717287|17692862|P1|Overall Study|Lost to Follow-up|0
5121676|NCT01717040|17692902|P2|Overall Study|New Substance Use Disorder|0
5121677|NCT01717040|17692903|P1|Overall Study|New Substance Use Disorder|1
5121678|NCT01717040|17692902|P2|Overall Study|Required Medication Change|1
5121679|NCT01717040|17692903|P1|Overall Study|Required Medication Change|0
5121680|NCT01717040|17692902|P2|Overall Study|Adverse Event|0
5121681|NCT01717040|17692903|P1|Overall Study|Adverse Event|1
5121682|NCT01717040|17692902|P2|Overall Study|Lack of Efficacy|1
5121683|NCT01717040|17692903|P1|Overall Study|Lack of Efficacy|1
5121684|NCT01717040|17692902|P2|Overall Study|Lost to Follow-up|3
5121685|NCT01717040|17692903|P1|Overall Study|Lost to Follow-up|2
5121686|NCT01716754|17692921|P4|Overall Study|Withdrawal by Subject|3
5121687|NCT01716754|17692922|P3|Overall Study|Withdrawal by Subject|4
5121688|NCT01716754|17692923|P2|Overall Study|Withdrawal by Subject|0
5121689|NCT01716754|17692924|P1|Overall Study|Withdrawal by Subject|5
5121690|NCT01716754|17692921|P4|Overall Study|Adverse Event|1
5121691|NCT01716754|17692922|P3|Overall Study|Adverse Event|2
5121692|NCT01716754|17692923|P2|Overall Study|Adverse Event|2
5121693|NCT01716754|17692924|P1|Overall Study|Adverse Event|4
5121694|NCT01716754|17692921|P4|Overall Study|Lost to Follow-up|1
5121695|NCT01716754|17692922|P3|Overall Study|Lost to Follow-up|0
5121696|NCT01716754|17692923|P2|Overall Study|Lost to Follow-up|0
5121697|NCT01716754|17692924|P1|Overall Study|Lost to Follow-up|1
5121698|NCT01716754|17692921|P4|Overall Study|Physician Decision|0
5121699|NCT01716754|17692922|P3|Overall Study|Physician Decision|0
5121700|NCT01716754|17692923|P2|Overall Study|Physician Decision|0
5121701|NCT01716754|17692924|P1|Overall Study|Physician Decision|1
5121702|NCT01716754|17692921|P4|Overall Study|Non-compliance with study treatment|0
5121703|NCT01716754|17692922|P3|Overall Study|Non-compliance with study treatment|1
5121704|NCT01716754|17692923|P2|Overall Study|Non-compliance with study treatment|0
5121705|NCT01716754|17692924|P1|Overall Study|Non-compliance with study treatment|0
5121706|NCT01716754|17692921|P4|Overall Study|Protocol deviation|2
5121707|NCT01716754|17692922|P3|Overall Study|Protocol deviation|7
5121708|NCT01716754|17692923|P2|Overall Study|Protocol deviation|2
5121709|NCT01716754|17692924|P1|Overall Study|Protocol deviation|0
5121710|NCT01716754|17692921|P4|Overall Study|Death|1
5121711|NCT01716754|17692922|P3|Overall Study|Death|0
5121712|NCT01716754|17692923|P2|Overall Study|Death|0
5121713|NCT01716754|17692924|P1|Overall Study|Death|0
5121714|NCT01716715|17692947|P2|Overall Study|Never Treated|4
5121715|NCT01716715|17692948|P1|Overall Study|Never Treated|2
5121716|NCT01716663|17692964|P1|Overall Study|Treated with non-study catheter|2
5121717|NCT01716663|17692964|P1|Overall Study|Withdrawn prior to procedure|4
5121718|NCT01716585|17692974|P2|Open-label Treatment|Withdrawal by Subject|3
5121719|NCT01716585|17692975|P1|Open-label Treatment|Withdrawal by Subject|0
5121720|NCT01716585|17692974|P2|Open-label Treatment|Virologic Failure|2
5121721|NCT01716585|17692975|P1|Open-label Treatment|Virologic Failure|0
5121722|NCT01716585|17692974|P2|Open-label Treatment|Adverse Event|2
5121723|NCT01716585|17692975|P1|Open-label Treatment|Adverse Event|0
5121724|NCT01716585|17692974|P2|Double-blind Treatment|Other|0
5121725|NCT01716585|17692975|P1|Double-blind Treatment|Other|1
5121726|NCT01716585|17692974|P2|Double-blind Treatment|Subject Noncompliant|0
5121727|NCT01716585|17692975|P1|Double-blind Treatment|Subject Noncompliant|1
5121728|NCT01716585|17692974|P2|Double-blind Treatment|Lost to Follow-up|0
5121729|NCT01716585|17692975|P1|Double-blind Treatment|Lost to Follow-up|2
5121730|NCT01716585|17692974|P2|Double-blind Treatment|Withdrawal by Subject|0
5121731|NCT01716585|17692975|P1|Double-blind Treatment|Withdrawal by Subject|3
5121732|NCT01716585|17692974|P2|Double-blind Treatment|Adverse Event|1
5121733|NCT01716585|17692975|P1|Double-blind Treatment|Adverse Event|2
5121734|NCT01716585|17692974|P2|Double-blind Treatment|Did Not Receive Study Drug|1
5121735|NCT01716585|17692975|P1|Double-blind Treatment|Did Not Receive Study Drug|4
5121736|NCT01716559|17692987|P1|Overall Study|Other withdrawal reason|75
5121737|NCT01716559|17692987|P1|Overall Study|Withdrawal by Subject|4
5121738|NCT01716559|17692987|P1|Overall Study|Death|21
5121739|NCT01716559|17692987|P1|Overall Study|Adverse Event|11
5121740|NCT01716533|17692999|P4|Overall Study|Immunosuppressants>14days past 6months|1
5121741|NCT01716533|17693000|P3|Overall Study|Immunosuppressants>14days past 6months|0
5121742|NCT01716533|17693001|P2|Overall Study|Immunosuppressants>14days past 6months|0
5121743|NCT01716533|17693002|P1|Overall Study|Immunosuppressants>14days past 6months|0
5121744|NCT01716533|17692999|P4|Overall Study|Death|2
5121745|NCT01716533|17693000|P3|Overall Study|Death|0
5121746|NCT01716533|17693001|P2|Overall Study|Death|0
5121747|NCT01716533|17693002|P1|Overall Study|Death|0
5121748|NCT01716533|17692999|P4|Overall Study|Withdrawal by Subject|5
5121749|NCT01716533|17693000|P3|Overall Study|Withdrawal by Subject|0
5121750|NCT01716533|17693001|P2|Overall Study|Withdrawal by Subject|0
5121751|NCT01716533|17693002|P1|Overall Study|Withdrawal by Subject|0
5121752|NCT01716533|17692999|P4|Overall Study|Failure of antibiotic treatment to treat|0
5121753|NCT01716533|17693000|P3|Overall Study|Failure of antibiotic treatment to treat|5
5121754|NCT01716533|17693001|P2|Overall Study|Failure of antibiotic treatment to treat|0
5121755|NCT01716533|17693002|P1|Overall Study|Failure of antibiotic treatment to treat|0
5121756|NCT01716520|17693056|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5121757|NCT01716520|17693057|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5121758|NCT01716520|17693058|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5121759|NCT01716520|17693059|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5121760|NCT01716520|17693060|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5121761|NCT01716520|17693061|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5121762|NCT01716520|17693056|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
5121763|NCT01716520|17693057|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5121764|NCT01716520|17693058|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5121765|NCT01716520|17693059|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5121766|NCT01716520|17693060|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5121767|NCT01716520|17693061|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5121768|NCT01716520|17693056|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5121769|NCT01716520|17693057|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5121770|NCT01716520|17693058|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5121771|NCT01716520|17693059|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5121772|NCT01716520|17693060|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
5121773|NCT01716520|17693061|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5121774|NCT01716520|17693056|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
5121775|NCT01716520|17693057|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5121776|NCT01716520|17693058|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5121777|NCT01716520|17693059|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5121778|NCT01716520|17693060|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5121779|NCT01716520|17693061|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5121780|NCT01716520|17693056|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5121781|NCT01716520|17693057|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5121782|NCT01716520|17693058|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5121783|NCT01716520|17693059|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5121784|NCT01716520|17693060|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5121785|NCT01716520|17693061|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
5121786|NCT01716520|17693056|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5121787|NCT01716520|17693057|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5121788|NCT01716520|17693058|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5121789|NCT01716520|17693059|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5121790|NCT01716520|17693060|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5121791|NCT01716520|17693061|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5121792|NCT01716520|17693056|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5121793|NCT01716520|17693057|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5121794|NCT01716520|17693058|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
5121795|NCT01716520|17693059|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5121796|NCT01716520|17693060|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5121797|NCT01716520|17693061|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5121798|NCT01716520|17693056|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5121799|NCT01716520|17693057|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
5121800|NCT01716520|17693058|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
5121801|NCT01716520|17693059|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
5121802|NCT01716520|17693060|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
5121803|NCT01716520|17693061|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
5121804|NCT01716520|17693056|P6|Treatment Period 2 (14 Days)|Adverse Event|0
5121805|NCT01716520|17693057|P5|Treatment Period 2 (14 Days)|Adverse Event|1
5121806|NCT01716520|17693058|P4|Treatment Period 2 (14 Days)|Adverse Event|0
5121807|NCT01716520|17693059|P3|Treatment Period 2 (14 Days)|Adverse Event|0
5121808|NCT01716520|17693060|P2|Treatment Period 2 (14 Days)|Adverse Event|0
5121809|NCT01716520|17693061|P1|Treatment Period 2 (14 Days)|Adverse Event|0
5121810|NCT01716520|17693056|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
5121892|NCT01716156|17693195|P2|Overall Study|Protocol Violation|0
5121811|NCT01716520|17693057|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5121812|NCT01716520|17693058|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5121813|NCT01716520|17693059|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
5121814|NCT01716520|17693060|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5121815|NCT01716520|17693061|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5121816|NCT01716520|17693056|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5121817|NCT01716520|17693057|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5121818|NCT01716520|17693058|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5121819|NCT01716520|17693059|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5121820|NCT01716520|17693060|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5121821|NCT01716520|17693061|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5121822|NCT01716520|17693056|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5121823|NCT01716520|17693057|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5121824|NCT01716520|17693058|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5121825|NCT01716520|17693059|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5121826|NCT01716520|17693060|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
5121827|NCT01716520|17693061|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5121828|NCT01716520|17693056|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5121829|NCT01716520|17693057|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5121830|NCT01716520|17693058|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5121831|NCT01716520|17693059|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5121832|NCT01716520|17693060|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5121833|NCT01716520|17693061|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5121834|NCT01716520|17693056|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5121835|NCT01716520|17693057|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
5121836|NCT01716520|17693058|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5121837|NCT01716520|17693059|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
5121838|NCT01716520|17693060|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
5121839|NCT01716520|17693061|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5121840|NCT01716520|17693056|P6|Treatment Period 1 (14 Days)|Adverse Event|0
5121841|NCT01716520|17693057|P5|Treatment Period 1 (14 Days)|Adverse Event|0
5121842|NCT01716520|17693058|P4|Treatment Period 1 (14 Days)|Adverse Event|0
5121843|NCT01716520|17693059|P3|Treatment Period 1 (14 Days)|Adverse Event|0
5121844|NCT01716520|17693060|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5121845|NCT01716520|17693061|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5121846|NCT01716234|17693116|P7|Overall Study|Withdrawal by Subject|0
5121847|NCT01716234|17693117|P6|Overall Study|Withdrawal by Subject|3
5121848|NCT01716234|17693118|P5|Overall Study|Withdrawal by Subject|1
5121849|NCT01716234|17693119|P4|Overall Study|Withdrawal by Subject|2
5121850|NCT01716234|17693120|P3|Overall Study|Withdrawal by Subject|2
5121851|NCT01716234|17693121|P2|Overall Study|Withdrawal by Subject|0
5121852|NCT01716234|17693122|P1|Overall Study|Withdrawal by Subject|3
5121853|NCT01716234|17693116|P7|Overall Study|Adverse Event|0
5121854|NCT01716234|17693117|P6|Overall Study|Adverse Event|6
5121855|NCT01716234|17693118|P5|Overall Study|Adverse Event|3
5121856|NCT01716234|17693119|P4|Overall Study|Adverse Event|8
5121857|NCT01716234|17693120|P3|Overall Study|Adverse Event|2
5121858|NCT01716234|17693121|P2|Overall Study|Adverse Event|10
5121859|NCT01716234|17693122|P1|Overall Study|Adverse Event|7
5121860|NCT01716234|17693116|P7|Overall Study|Did not meet protocol eligibility|0
5121861|NCT01716234|17693117|P6|Overall Study|Did not meet protocol eligibility|4
5121862|NCT01716234|17693118|P5|Overall Study|Did not meet protocol eligibility|0
5121863|NCT01716234|17693119|P4|Overall Study|Did not meet protocol eligibility|0
5121864|NCT01716234|17693120|P3|Overall Study|Did not meet protocol eligibility|1
5121865|NCT01716234|17693121|P2|Overall Study|Did not meet protocol eligibility|0
5121866|NCT01716234|17693122|P1|Overall Study|Did not meet protocol eligibility|0
5121867|NCT01716234|17693116|P7|Overall Study|Lack of Efficacy|0
5121868|NCT01716234|17693117|P6|Overall Study|Lack of Efficacy|0
5121869|NCT01716234|17693118|P5|Overall Study|Lack of Efficacy|0
5121870|NCT01716234|17693119|P4|Overall Study|Lack of Efficacy|1
5121871|NCT01716234|17693120|P3|Overall Study|Lack of Efficacy|0
5121872|NCT01716234|17693121|P2|Overall Study|Lack of Efficacy|0
5121873|NCT01716234|17693122|P1|Overall Study|Lack of Efficacy|0
5121874|NCT01716234|17693116|P7|Overall Study|Protocol Violation|0
5121875|NCT01716234|17693117|P6|Overall Study|Protocol Violation|1
5121876|NCT01716234|17693118|P5|Overall Study|Protocol Violation|1
5121877|NCT01716234|17693119|P4|Overall Study|Protocol Violation|1
5121878|NCT01716234|17693120|P3|Overall Study|Protocol Violation|0
5121879|NCT01716234|17693121|P2|Overall Study|Protocol Violation|0
5121880|NCT01716234|17693122|P1|Overall Study|Protocol Violation|0
5121881|NCT01716169|17693185|P1|Overall Study|inconsistent dressing application|1
5121882|NCT01716169|17693185|P1|Overall Study|Withdrawal by Subject|1
5121883|NCT01716169|17693185|P1|Overall Study|Lost to Follow-up|1
5121884|NCT01716169|17693185|P1|Overall Study|Adverse Event|1
5121885|NCT01716156|17693194|P3|Overall Study|Lost to Follow-up|0
5121886|NCT01716156|17693195|P2|Overall Study|Lost to Follow-up|0
5121887|NCT01716156|17693196|P1|Overall Study|Lost to Follow-up|1
5121888|NCT01716156|17693194|P3|Overall Study|Withdrawal by Subject|2
5121889|NCT01716156|17693195|P2|Overall Study|Withdrawal by Subject|1
5121890|NCT01716156|17693196|P1|Overall Study|Withdrawal by Subject|0
5121891|NCT01716156|17693194|P3|Overall Study|Protocol Violation|0
5121893|NCT01716156|17693196|P1|Overall Study|Protocol Violation|1
5121894|NCT01716117|17693222|P2|Overall Study|Withdrawal by Subject|0
5121895|NCT01716117|17693223|P1|Overall Study|Withdrawal by Subject|2
5121896|NCT01716117|17693222|P2|Overall Study|Death|2
5121897|NCT01716117|17693223|P1|Overall Study|Death|5
5121898|NCT01716104|17693242|P2|Overall Study|Do not meet inclusion criteria|7
5121899|NCT01716104|17693243|P1|Overall Study|Do not meet inclusion criteria|6
5121900|NCT01716052|17693269|P2|Overall Study|Withdrawal of funding|1
5121901|NCT01716052|17693270|P1|Overall Study|Withdrawal of funding|1
5121902|NCT01715896|17693312|P2|Overall Study|Other|5
5121903|NCT01715896|17693313|P1|Overall Study|Other|2
5121904|NCT01715896|17693312|P2|Overall Study|Withdrawal by Subject|4
5121905|NCT01715896|17693313|P1|Overall Study|Withdrawal by Subject|1
5121906|NCT01715896|17693312|P2|Overall Study|Lost to Follow-up|2
5121907|NCT01715896|17693313|P1|Overall Study|Lost to Follow-up|0
5121908|NCT01715857|17693386|P1|Overall Study|Did Not Meet Eligibility Criteria|96
5121909|NCT01715831|17693396|P1|Overall Study|Adverse Event|1
5121910|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5121911|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5121912|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
5121913|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5121914|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
5121915|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
5121916|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
5121917|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
5121918|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
5121919|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
5121920|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
5121921|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
5121922|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
5121923|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
5121924|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
5121925|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
5121926|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Protocol Violation|19
5121927|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Protocol Violation|12
5121928|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Protocol Violation|14
5121929|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Protocol Violation|0
5121930|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Adverse Event|2
5121931|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Adverse Event|23
5121932|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Adverse Event|3
5121933|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Adverse Event|0
5121934|NCT01715805|17693412|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
5121935|NCT01715805|17693413|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5121936|NCT01715805|17693414|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5121937|NCT01715805|17693415|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5121938|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5121939|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5121940|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5121941|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
5121942|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5121943|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5121944|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5121945|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
5121946|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5121947|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5121948|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5121949|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
5121950|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5121951|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5121952|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5121953|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
5121954|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
5121955|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
5121956|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
5121957|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
5121958|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5121959|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5121960|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5121961|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
5121962|NCT01715805|17693412|P4|Placebo + ADT Lead-in Period|Adverse Event|0
5121963|NCT01715805|17693413|P3|Placebo + ADT Lead-in Period|Adverse Event|0
5121964|NCT01715805|17693414|P2|Placebo + ADT Lead-in Period|Adverse Event|0
5121965|NCT01715805|17693415|P1|Placebo + ADT Lead-in Period|Adverse Event|41
5121966|NCT01715415|17693429|P2|Open-label Treatment|Subject Noncompliant|1
5121967|NCT01715415|17693430|P1|Open-label Treatment|Subject Noncompliant|0
5121968|NCT01715415|17693429|P2|Open-label Treatment|Adverse Event|1
5121969|NCT01715415|17693430|P1|Open-label Treatment|Adverse Event|0
5121970|NCT01715415|17693429|P2|Double-blind Treatment|Other|0
5121971|NCT01715415|17693430|P1|Double-blind Treatment|Other|1
5121972|NCT01715415|17693429|P2|Double-blind Treatment|Withdrawal by Subject|1
5121973|NCT01715415|17693430|P1|Double-blind Treatment|Withdrawal by Subject|1
5121974|NCT01715415|17693429|P2|Double-blind Treatment|Adverse Event|0
5121975|NCT01715415|17693430|P1|Double-blind Treatment|Adverse Event|3
5121976|NCT01715415|17693429|P2|Double-blind Treatment|Did Not Receive Study Drug|1
5121977|NCT01715415|17693430|P1|Double-blind Treatment|Did Not Receive Study Drug|0
5121978|NCT01715298|17693444|P2|Overall Study|Patient/guardian decision|9
5121979|NCT01715298|17693445|P1|Overall Study|Patient/guardian decision|7
5121980|NCT01715298|17693444|P2|Overall Study|Lost to Follow-up|2
5121981|NCT01715298|17693445|P1|Overall Study|Lost to Follow-up|0
5121982|NCT01715285|17693483|P3|Open-label (OL) Extension Phase|Ongoing|72
5121983|NCT01715285|17693484|P2|Open-label (OL) Extension Phase|Ongoing|0
5121984|NCT01715285|17693485|P1|Open-label (OL) Extension Phase|Ongoing|157
5121985|NCT01715285|17693483|P3|Treatment Period|Placebo Cross-over|0
5121986|NCT01715285|17693484|P2|Treatment Period|Placebo Cross-over|72
5121987|NCT01715285|17693485|P1|Treatment Period|Placebo Cross-over|0
5121988|NCT01715285|17693483|P3|Treatment Period|Other|0
5121989|NCT01715285|17693484|P2|Treatment Period|Other|12
5121990|NCT01715285|17693485|P1|Treatment Period|Other|10
5121991|NCT01715285|17693483|P3|Treatment Period|Ongoing|0
5121992|NCT01715285|17693484|P2|Treatment Period|Ongoing|0
5121993|NCT01715285|17693485|P1|Treatment Period|Ongoing|157
5121994|NCT01715285|17693483|P3|Treatment Period|Physician Decision|0
5121995|NCT01715285|17693484|P2|Treatment Period|Physician Decision|23
5121996|NCT01715285|17693485|P1|Treatment Period|Physician Decision|21
5121997|NCT01715285|17693483|P3|Treatment Period|Withdrawal Of Consent|0
5121998|NCT01715285|17693484|P2|Treatment Period|Withdrawal Of Consent|47
5121999|NCT01715285|17693485|P1|Treatment Period|Withdrawal Of Consent|52
5122000|NCT01715285|17693483|P3|Treatment Period|Progressive Disease|0
5122001|NCT01715285|17693484|P2|Treatment Period|Progressive Disease|388
5122002|NCT01715285|17693485|P1|Treatment Period|Progressive Disease|254
5122003|NCT01715285|17693483|P3|Treatment Period|Noncompliance With Study Drug|0
5122004|NCT01715285|17693484|P2|Treatment Period|Noncompliance With Study Drug|2
5122005|NCT01715285|17693485|P1|Treatment Period|Noncompliance With Study Drug|4
5122006|NCT01715285|17693483|P3|Treatment Period|Death|0
5122007|NCT01715285|17693484|P2|Treatment Period|Death|23
5122008|NCT01715285|17693485|P1|Treatment Period|Death|36
5122009|NCT01715285|17693483|P3|Treatment Period|Lost to Follow-up|0
5122010|NCT01715285|17693484|P2|Treatment Period|Lost to Follow-up|2
5122011|NCT01715285|17693485|P1|Treatment Period|Lost to Follow-up|3
5122012|NCT01715285|17693483|P3|Treatment Period|Adverse Event|0
5122013|NCT01715285|17693484|P2|Treatment Period|Adverse Event|33
5122014|NCT01715285|17693485|P1|Treatment Period|Adverse Event|60
5122015|NCT01715129|17693521|P1|Overall Study|Other|1
5122016|NCT01715129|17693521|P1|Overall Study|Lost to Follow-up|1
5122017|NCT01715129|17693521|P1|Overall Study|Consent Withdrawn|2
5122018|NCT01715129|17693521|P1|Overall Study|Protocol Violation|1
5122019|NCT01715129|17693521|P1|Overall Study|Lack of Efficacy|3
5122020|NCT01715129|17693521|P1|Overall Study|Adverse Event, fatal|1
5122021|NCT01714947|17693547|P1|Part B|Progressive Disease|3
5122022|NCT01714817|17693588|P2|Overall Study|Hypersensitivity to the medication|1
5122023|NCT01714817|17693589|P1|Overall Study|Hypersensitivity to the medication|0
5122024|NCT01714817|17693588|P2|Overall Study|Antiproteinuric changed/dose increased|1
5122025|NCT01714817|17693589|P1|Overall Study|Antiproteinuric changed/dose increased|0
5122026|NCT01714817|17693588|P2|Overall Study|Need of use of Prohibited Medications|0
5122027|NCT01714817|17693589|P1|Overall Study|Need of use of Prohibited Medications|1
5122028|NCT01714817|17693588|P2|Overall Study|Change in Concomitant Medication|1
5122029|NCT01714817|17693589|P1|Overall Study|Change in Concomitant Medication|0
5122030|NCT01714817|17693588|P2|Overall Study|Not treated- received ACE inhibition|0
5122031|NCT01714817|17693589|P1|Overall Study|Not treated- received ACE inhibition|1
5122032|NCT01714817|17693588|P2|Overall Study|Participant no longer meets criteria|2
5122033|NCT01714817|17693589|P1|Overall Study|Participant no longer meets criteria|6
5122034|NCT01714817|17693588|P2|Overall Study|Pregnancy|0
5122035|NCT01714817|17693589|P1|Overall Study|Pregnancy|2
5122036|NCT01714817|17693588|P2|Overall Study|Poor / non-compliance|1
5122037|NCT01714817|17693589|P1|Overall Study|Poor / non-compliance|0
5122038|NCT01714817|17693588|P2|Overall Study|Lost to Follow-up|2
5122039|NCT01714817|17693589|P1|Overall Study|Lost to Follow-up|0
5122040|NCT01714817|17693588|P2|Overall Study|Death|1
5122041|NCT01714817|17693589|P1|Overall Study|Death|1
5122042|NCT01714817|17693588|P2|Overall Study|Withdrawal by Subject|7
5122043|NCT01714817|17693589|P1|Overall Study|Withdrawal by Subject|6
5122044|NCT01714817|17693588|P2|Overall Study|Adverse Event|17
5122045|NCT01714817|17693589|P1|Overall Study|Adverse Event|20
5122046|NCT01714817|17693588|P2|Overall Study|Lack of Efficacy|9
5122047|NCT01714817|17693589|P1|Overall Study|Lack of Efficacy|11
5122048|NCT01714726|17693621|P4|Open-Label Period|Lost to Follow-up|4
5122049|NCT01714726|17693622|P3|Open-Label Period|Lost to Follow-up|3
5122050|NCT01714726|17693623|P2|Open-Label Period|Lost to Follow-up|0
5122051|NCT01714726|17693624|P1|Open-Label Period|Lost to Follow-up|0
5122052|NCT01714726|17693621|P4|Open-Label Period|Developed specific withdrawal criteria|2
5122053|NCT01714726|17693622|P3|Open-Label Period|Developed specific withdrawal criteria|5
5122054|NCT01714726|17693623|P2|Open-Label Period|Developed specific withdrawal criteria|0
5122055|NCT01714726|17693624|P1|Open-Label Period|Developed specific withdrawal criteria|0
5122056|NCT01714726|17693621|P4|Open-Label Period|Withdrawal by Subject|19
5122057|NCT01714726|17693622|P3|Open-Label Period|Withdrawal by Subject|9
5122058|NCT01714726|17693623|P2|Open-Label Period|Withdrawal by Subject|0
5122059|NCT01714726|17693624|P1|Open-Label Period|Withdrawal by Subject|0
5122060|NCT01714726|17693621|P4|Open-Label Period|Adverse Event|0
5122061|NCT01714726|17693622|P3|Open-Label Period|Adverse Event|1
5122062|NCT01714726|17693623|P2|Open-Label Period|Adverse Event|0
5122063|NCT01714726|17693624|P1|Open-Label Period|Adverse Event|0
5122064|NCT01714726|17693621|P4|Open-Label Period|Other|3
5122065|NCT01714726|17693622|P3|Open-Label Period|Other|1
5122066|NCT01714726|17693623|P2|Open-Label Period|Other|0
5122067|NCT01714726|17693624|P1|Open-Label Period|Other|0
5122068|NCT01714726|17693621|P4|Double-Blinded Induction Period|Lost to Follow-up|0
5122069|NCT01714726|17693622|P3|Double-Blinded Induction Period|Lost to Follow-up|0
5122070|NCT01714726|17693623|P2|Double-Blinded Induction Period|Lost to Follow-up|2
5122071|NCT01714726|17693624|P1|Double-Blinded Induction Period|Lost to Follow-up|0
5122072|NCT01714726|17693621|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
5122073|NCT01714726|17693622|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
5122074|NCT01714726|17693623|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
5122075|NCT01714726|17693624|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
5122076|NCT01714726|17693621|P4|Double-Blinded Induction Period|Adverse Event|0
5122077|NCT01714726|17693622|P3|Double-Blinded Induction Period|Adverse Event|0
5122078|NCT01714726|17693623|P2|Double-Blinded Induction Period|Adverse Event|1
5122079|NCT01714726|17693624|P1|Double-Blinded Induction Period|Adverse Event|0
5122080|NCT01714726|17693621|P4|Double-Blinded Induction Period|Subject not in open label period|0
5122081|NCT01714726|17693622|P3|Double-Blinded Induction Period|Subject not in open label period|0
5122082|NCT01714726|17693623|P2|Double-Blinded Induction Period|Subject not in open label period|1
5122083|NCT01714726|17693624|P1|Double-Blinded Induction Period|Subject not in open label period|3
5122084|NCT01714687|17693704|P2|Overall Study|Lost to Follow-up|4
5122085|NCT01714687|17693705|P1|Overall Study|Lost to Follow-up|2
5122086|NCT01714687|17693704|P2|Overall Study|Withdrawal by Subject|0
5122087|NCT01714687|17693705|P1|Overall Study|Withdrawal by Subject|1
5122088|NCT01714635|17693729|P3|Overall Study|Missed 6-month exam|0
5122089|NCT01714635|17693730|P2|Overall Study|Missed 6-month exam|0
5122090|NCT01714635|17693731|P1|Overall Study|Missed 6-month exam|1
5122091|NCT01714635|17693729|P3|Overall Study|Discontinued|2
5122092|NCT01714635|17693730|P2|Overall Study|Discontinued|0
5122093|NCT01714635|17693731|P1|Overall Study|Discontinued|1
5122094|NCT01714609|17693747|P2|Overall Study|Protocol Violation|0
5122095|NCT01714609|17693748|P1|Overall Study|Protocol Violation|1
5122096|NCT01714544|17693754|P1|Overall Study|Withdrawal by Subject|1
5122097|NCT01714544|17693754|P1|Overall Study|Physician Decision|1
5122098|NCT01714544|17693754|P1|Overall Study|Lost to Follow-up|1
5122099|NCT01714310|17693825|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
5122100|NCT01714310|17693826|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
5122101|NCT01714310|17693827|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
5122102|NCT01714310|17693825|P3|Double Blind Adjunctive Treatment|Adverse Event|0
5122103|NCT01714310|17693826|P2|Double Blind Adjunctive Treatment|Adverse Event|1
5122104|NCT01714310|17693827|P1|Double Blind Adjunctive Treatment|Adverse Event|1
5122105|NCT01714310|17693825|P3|Open Lisdexamfetamine Titration|Adverse Event|3
5122106|NCT01714310|17693826|P2|Open Lisdexamfetamine Titration|Adverse Event|0
5122107|NCT01714310|17693827|P1|Open Lisdexamfetamine Titration|Adverse Event|0
5122108|NCT01714310|17693825|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
5122109|NCT01714310|17693826|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
5122110|NCT01714310|17693827|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
5122111|NCT01714063|17693880|P1|Overall Study|Equipment malfunction|2
5122112|NCT01713998|17693917|P3|Overall Study|Withdrawal by Subject|0
5122113|NCT01713998|17693918|P2|Overall Study|Withdrawal by Subject|0
5122114|NCT01713998|17693919|P1|Overall Study|Withdrawal by Subject|1
5122115|NCT01713998|17693917|P3|Overall Study|Lost to Follow-up|2
5122116|NCT01713998|17693918|P2|Overall Study|Lost to Follow-up|0
5122117|NCT01713998|17693919|P1|Overall Study|Lost to Follow-up|2
5122118|NCT01713946|17693940|P3|Overall Study|Patients never switched to everolimus|5
5122119|NCT01713946|17693941|P2|Overall Study|Patients never switched to everolimus|0
5122120|NCT01713946|17693942|P1|Overall Study|Patients never switched to everolimus|0
5122121|NCT01713946|17693940|P3|Overall Study|Did not continue in Post-Ext. Phase|0
5122122|NCT01713946|17693941|P2|Overall Study|Did not continue in Post-Ext. Phase|2
5122123|NCT01713946|17693942|P1|Overall Study|Did not continue in Post-Ext. Phase|1
5122124|NCT01713946|17693940|P3|Overall Study|Did not continue in Ext|0
5122125|NCT01713946|17693941|P2|Overall Study|Did not continue in Ext|3
5122126|NCT01713946|17693942|P1|Overall Study|Did not continue in Ext|0
5122127|NCT01713946|17693940|P3|Overall Study|Administrative problems|0
5122128|NCT01713946|17693941|P2|Overall Study|Administrative problems|0
5122129|NCT01713946|17693942|P1|Overall Study|Administrative problems|1
5122130|NCT01713946|17693940|P3|Overall Study|Lost to Follow-up|1
5122131|NCT01713946|17693941|P2|Overall Study|Lost to Follow-up|0
5122132|NCT01713946|17693942|P1|Overall Study|Lost to Follow-up|0
5122133|NCT01713946|17693940|P3|Overall Study|Protocol Violation|1
5122134|NCT01713946|17693941|P2|Overall Study|Protocol Violation|4
5122135|NCT01713946|17693942|P1|Overall Study|Protocol Violation|2
5122136|NCT01713946|17693940|P3|Overall Study|Lack of Efficacy|14
5122137|NCT01713946|17693941|P2|Overall Study|Lack of Efficacy|8
5122138|NCT01713946|17693942|P1|Overall Study|Lack of Efficacy|8
5122139|NCT01713946|17693940|P3|Overall Study|Withdrawal by Subject|8
5122140|NCT01713946|17693941|P2|Overall Study|Withdrawal by Subject|12
5122141|NCT01713946|17693942|P1|Overall Study|Withdrawal by Subject|12
5122142|NCT01713946|17693940|P3|Overall Study|Adverse Event|13
5122143|NCT01713946|17693941|P2|Overall Study|Adverse Event|14
5122144|NCT01713946|17693942|P1|Overall Study|Adverse Event|19
5122145|NCT01713946|17693940|P3|Overall Study|Death|2
5122146|NCT01713946|17693941|P2|Overall Study|Death|2
5122147|NCT01713946|17693942|P1|Overall Study|Death|0
5122148|NCT01713933|17694033|P1|Overall Study|Excluded from analysis as a BMI outlier|1
5122149|NCT01713933|17694033|P1|Overall Study|Withdrawal by Subject|3
5122150|NCT01713933|17694033|P1|Overall Study|Lost to Follow-up|2
5122151|NCT01713686|17694082|P1|Overall Study|Withdrawal by Subject|6
5122152|NCT01713686|17694082|P1|Overall Study|Lost to Follow-up|9
5122153|NCT01713582|17694152|P21|Overall Study|Disease progression and adverse event|0
5122154|NCT01713582|17694153|P20|Overall Study|Disease progression and adverse event|0
5122155|NCT01713582|17694154|P19|Overall Study|Disease progression and adverse event|0
5122156|NCT01713582|17694155|P18|Overall Study|Disease progression and adverse event|0
5122157|NCT01713582|17694156|P17|Overall Study|Disease progression and adverse event|1
5122158|NCT01713582|17694157|P16|Overall Study|Disease progression and adverse event|0
5122159|NCT01713582|17694158|P15|Overall Study|Disease progression and adverse event|0
5122160|NCT01713582|17694159|P14|Overall Study|Disease progression and adverse event|0
5122161|NCT01713582|17694160|P13|Overall Study|Disease progression and adverse event|0
5122162|NCT01713582|17694161|P12|Overall Study|Disease progression and adverse event|0
5122163|NCT01713582|17694162|P11|Overall Study|Disease progression and adverse event|0
5122164|NCT01713582|17694163|P10|Overall Study|Disease progression and adverse event|0
5122165|NCT01713582|17694164|P9|Overall Study|Disease progression and adverse event|0
5122166|NCT01713582|17694165|P8|Overall Study|Disease progression and adverse event|0
5122167|NCT01713582|17694166|P7|Overall Study|Disease progression and adverse event|0
5122168|NCT01713582|17694167|P6|Overall Study|Disease progression and adverse event|0
5122169|NCT01713582|17694168|P5|Overall Study|Disease progression and adverse event|0
5122170|NCT01713582|17694169|P4|Overall Study|Disease progression and adverse event|0
5122171|NCT01713582|17694170|P3|Overall Study|Disease progression and adverse event|0
5122172|NCT01713582|17694171|P2|Overall Study|Disease progression and adverse event|0
5122173|NCT01713582|17694172|P1|Overall Study|Disease progression and adverse event|0
5122174|NCT01713582|17694152|P21|Overall Study|Stopped to receive bone marrow graft|0
5122175|NCT01713582|17694153|P20|Overall Study|Stopped to receive bone marrow graft|0
5122176|NCT01713582|17694154|P19|Overall Study|Stopped to receive bone marrow graft|0
5122177|NCT01713582|17694155|P18|Overall Study|Stopped to receive bone marrow graft|0
5122178|NCT01713582|17694156|P17|Overall Study|Stopped to receive bone marrow graft|1
5122179|NCT01713582|17694157|P16|Overall Study|Stopped to receive bone marrow graft|0
5122180|NCT01713582|17694158|P15|Overall Study|Stopped to receive bone marrow graft|0
5122181|NCT01713582|17694159|P14|Overall Study|Stopped to receive bone marrow graft|0
5122182|NCT01713582|17694160|P13|Overall Study|Stopped to receive bone marrow graft|0
5122183|NCT01713582|17694161|P12|Overall Study|Stopped to receive bone marrow graft|0
5122184|NCT01713582|17694162|P11|Overall Study|Stopped to receive bone marrow graft|0
5122185|NCT01713582|17694163|P10|Overall Study|Stopped to receive bone marrow graft|0
5122186|NCT01713582|17694164|P9|Overall Study|Stopped to receive bone marrow graft|0
5122187|NCT01713582|17694165|P8|Overall Study|Stopped to receive bone marrow graft|0
5122188|NCT01713582|17694166|P7|Overall Study|Stopped to receive bone marrow graft|0
5122189|NCT01713582|17694167|P6|Overall Study|Stopped to receive bone marrow graft|0
5122190|NCT01713582|17694168|P5|Overall Study|Stopped to receive bone marrow graft|0
5122191|NCT01713582|17694169|P4|Overall Study|Stopped to receive bone marrow graft|0
5122192|NCT01713582|17694170|P3|Overall Study|Stopped to receive bone marrow graft|0
5122193|NCT01713582|17694171|P2|Overall Study|Stopped to receive bone marrow graft|0
5122194|NCT01713582|17694172|P1|Overall Study|Stopped to receive bone marrow graft|0
5122195|NCT01713582|17694152|P21|Overall Study|Withdrawal by Subject|0
5122196|NCT01713582|17694153|P20|Overall Study|Withdrawal by Subject|0
5122197|NCT01713582|17694154|P19|Overall Study|Withdrawal by Subject|0
5122198|NCT01713582|17694155|P18|Overall Study|Withdrawal by Subject|1
5122199|NCT01713582|17694156|P17|Overall Study|Withdrawal by Subject|0
5122200|NCT01713582|17694157|P16|Overall Study|Withdrawal by Subject|0
5122201|NCT01713582|17694158|P15|Overall Study|Withdrawal by Subject|0
5122202|NCT01713582|17694159|P14|Overall Study|Withdrawal by Subject|0
5122203|NCT01713582|17694160|P13|Overall Study|Withdrawal by Subject|0
5122204|NCT01713582|17694161|P12|Overall Study|Withdrawal by Subject|0
5122205|NCT01713582|17694162|P11|Overall Study|Withdrawal by Subject|0
5122206|NCT01713582|17694163|P10|Overall Study|Withdrawal by Subject|0
5122207|NCT01713582|17694164|P9|Overall Study|Withdrawal by Subject|0
5122208|NCT01713582|17694165|P8|Overall Study|Withdrawal by Subject|0
5122209|NCT01713582|17694166|P7|Overall Study|Withdrawal by Subject|0
5122210|NCT01713582|17694167|P6|Overall Study|Withdrawal by Subject|0
5122211|NCT01713582|17694168|P5|Overall Study|Withdrawal by Subject|0
5122212|NCT01713582|17694169|P4|Overall Study|Withdrawal by Subject|0
5122213|NCT01713582|17694170|P3|Overall Study|Withdrawal by Subject|0
5122214|NCT01713582|17694171|P2|Overall Study|Withdrawal by Subject|0
5122215|NCT01713582|17694172|P1|Overall Study|Withdrawal by Subject|0
5122216|NCT01713582|17694152|P21|Overall Study|Lack of Efficacy|0
5122217|NCT01713582|17694153|P20|Overall Study|Lack of Efficacy|0
5122218|NCT01713582|17694154|P19|Overall Study|Lack of Efficacy|0
5122219|NCT01713582|17694155|P18|Overall Study|Lack of Efficacy|0
5122220|NCT01713582|17694156|P17|Overall Study|Lack of Efficacy|0
5122221|NCT01713582|17694157|P16|Overall Study|Lack of Efficacy|0
5122222|NCT01713582|17694158|P15|Overall Study|Lack of Efficacy|0
5122223|NCT01713582|17694159|P14|Overall Study|Lack of Efficacy|0
5122224|NCT01713582|17694160|P13|Overall Study|Lack of Efficacy|0
5122225|NCT01713582|17694161|P12|Overall Study|Lack of Efficacy|0
5122226|NCT01713582|17694162|P11|Overall Study|Lack of Efficacy|2
5122227|NCT01713582|17694163|P10|Overall Study|Lack of Efficacy|1
5122228|NCT01713582|17694164|P9|Overall Study|Lack of Efficacy|0
5122229|NCT01713582|17694165|P8|Overall Study|Lack of Efficacy|0
5122230|NCT01713582|17694166|P7|Overall Study|Lack of Efficacy|0
5122231|NCT01713582|17694167|P6|Overall Study|Lack of Efficacy|0
5122232|NCT01713582|17694168|P5|Overall Study|Lack of Efficacy|0
5122233|NCT01713582|17694169|P4|Overall Study|Lack of Efficacy|0
5122234|NCT01713582|17694170|P3|Overall Study|Lack of Efficacy|0
5122235|NCT01713582|17694171|P2|Overall Study|Lack of Efficacy|0
5122236|NCT01713582|17694172|P1|Overall Study|Lack of Efficacy|0
5122237|NCT01713582|17694152|P21|Overall Study|Withdrawal of consent|0
5122238|NCT01713582|17694153|P20|Overall Study|Withdrawal of consent|0
5122239|NCT01713582|17694154|P19|Overall Study|Withdrawal of consent|1
5122240|NCT01713582|17694155|P18|Overall Study|Withdrawal of consent|0
5122241|NCT01713582|17694156|P17|Overall Study|Withdrawal of consent|0
5122242|NCT01713582|17694157|P16|Overall Study|Withdrawal of consent|0
5122243|NCT01713582|17694158|P15|Overall Study|Withdrawal of consent|0
5122244|NCT01713582|17694159|P14|Overall Study|Withdrawal of consent|0
5122245|NCT01713582|17694160|P13|Overall Study|Withdrawal of consent|0
5122246|NCT01713582|17694161|P12|Overall Study|Withdrawal of consent|0
5122247|NCT01713582|17694162|P11|Overall Study|Withdrawal of consent|0
5122248|NCT01713582|17694163|P10|Overall Study|Withdrawal of consent|1
5122249|NCT01713582|17694164|P9|Overall Study|Withdrawal of consent|0
5122250|NCT01713582|17694165|P8|Overall Study|Withdrawal of consent|0
5122251|NCT01713582|17694166|P7|Overall Study|Withdrawal of consent|0
5122252|NCT01713582|17694167|P6|Overall Study|Withdrawal of consent|1
5122253|NCT01713582|17694168|P5|Overall Study|Withdrawal of consent|0
5122254|NCT01713582|17694169|P4|Overall Study|Withdrawal of consent|0
5122255|NCT01713582|17694170|P3|Overall Study|Withdrawal of consent|1
5122256|NCT01713582|17694171|P2|Overall Study|Withdrawal of consent|0
5122257|NCT01713582|17694172|P1|Overall Study|Withdrawal of consent|0
5122258|NCT01713582|17694152|P21|Overall Study|Adverse event-unrelated|0
5122259|NCT01713582|17694153|P20|Overall Study|Adverse event-unrelated|0
5122260|NCT01713582|17694154|P19|Overall Study|Adverse event-unrelated|0
5122261|NCT01713582|17694155|P18|Overall Study|Adverse event-unrelated|0
5122262|NCT01713582|17694156|P17|Overall Study|Adverse event-unrelated|0
5122263|NCT01713582|17694157|P16|Overall Study|Adverse event-unrelated|0
5122264|NCT01713582|17694158|P15|Overall Study|Adverse event-unrelated|1
5122265|NCT01713582|17694159|P14|Overall Study|Adverse event-unrelated|1
5122266|NCT01713582|17694160|P13|Overall Study|Adverse event-unrelated|0
5122267|NCT01713582|17694161|P12|Overall Study|Adverse event-unrelated|0
5122268|NCT01713582|17694162|P11|Overall Study|Adverse event-unrelated|0
5122269|NCT01713582|17694163|P10|Overall Study|Adverse event-unrelated|0
5122270|NCT01713582|17694164|P9|Overall Study|Adverse event-unrelated|0
5122271|NCT01713582|17694165|P8|Overall Study|Adverse event-unrelated|1
5122272|NCT01713582|17694166|P7|Overall Study|Adverse event-unrelated|1
5122273|NCT01713582|17694167|P6|Overall Study|Adverse event-unrelated|1
5122274|NCT01713582|17694168|P5|Overall Study|Adverse event-unrelated|0
5122275|NCT01713582|17694169|P4|Overall Study|Adverse event-unrelated|0
5122276|NCT01713582|17694170|P3|Overall Study|Adverse event-unrelated|0
5122277|NCT01713582|17694171|P2|Overall Study|Adverse event-unrelated|0
5122278|NCT01713582|17694172|P1|Overall Study|Adverse event-unrelated|0
5122279|NCT01713582|17694152|P21|Overall Study|Adverse event-related|0
5122280|NCT01713582|17694153|P20|Overall Study|Adverse event-related|0
5122281|NCT01713582|17694154|P19|Overall Study|Adverse event-related|1
5122282|NCT01713582|17694155|P18|Overall Study|Adverse event-related|0
5122283|NCT01713582|17694156|P17|Overall Study|Adverse event-related|0
5122284|NCT01713582|17694157|P16|Overall Study|Adverse event-related|0
5122285|NCT01713582|17694158|P15|Overall Study|Adverse event-related|0
5122286|NCT01713582|17694159|P14|Overall Study|Adverse event-related|0
5122287|NCT01713582|17694160|P13|Overall Study|Adverse event-related|0
5122288|NCT01713582|17694161|P12|Overall Study|Adverse event-related|0
5122289|NCT01713582|17694162|P11|Overall Study|Adverse event-related|1
5122290|NCT01713582|17694163|P10|Overall Study|Adverse event-related|1
5122291|NCT01713582|17694164|P9|Overall Study|Adverse event-related|0
5122292|NCT01713582|17694165|P8|Overall Study|Adverse event-related|0
5122293|NCT01713582|17694166|P7|Overall Study|Adverse event-related|0
5122294|NCT01713582|17694167|P6|Overall Study|Adverse event-related|0
5122295|NCT01713582|17694168|P5|Overall Study|Adverse event-related|0
5122296|NCT01713582|17694169|P4|Overall Study|Adverse event-related|0
5122297|NCT01713582|17694170|P3|Overall Study|Adverse event-related|0
5122298|NCT01713582|17694171|P2|Overall Study|Adverse event-related|0
5122299|NCT01713582|17694172|P1|Overall Study|Adverse event-related|0
5122300|NCT01713582|17694152|P21|Overall Study|Death|0
5122301|NCT01713582|17694153|P20|Overall Study|Death|0
5122302|NCT01713582|17694154|P19|Overall Study|Death|0
5122303|NCT01713582|17694155|P18|Overall Study|Death|0
5122304|NCT01713582|17694156|P17|Overall Study|Death|0
5122305|NCT01713582|17694157|P16|Overall Study|Death|0
5122306|NCT01713582|17694158|P15|Overall Study|Death|0
5122307|NCT01713582|17694159|P14|Overall Study|Death|0
5122308|NCT01713582|17694160|P13|Overall Study|Death|0
5122309|NCT01713582|17694161|P12|Overall Study|Death|0
5122310|NCT01713582|17694162|P11|Overall Study|Death|3
5122311|NCT01713582|17694163|P10|Overall Study|Death|4
5122312|NCT01713582|17694164|P9|Overall Study|Death|3
5122313|NCT01713582|17694165|P8|Overall Study|Death|2
5122314|NCT01713582|17694166|P7|Overall Study|Death|3
5122315|NCT01713582|17694167|P6|Overall Study|Death|3
5122316|NCT01713582|17694168|P5|Overall Study|Death|1
5122317|NCT01713582|17694169|P4|Overall Study|Death|1
5122318|NCT01713582|17694170|P3|Overall Study|Death|0
5122319|NCT01713582|17694171|P2|Overall Study|Death|0
5122320|NCT01713582|17694172|P1|Overall Study|Death|0
5122321|NCT01713582|17694152|P21|Overall Study|Disease progression|15
5122322|NCT01713582|17694153|P20|Overall Study|Disease progression|5
5122323|NCT01713582|17694154|P19|Overall Study|Disease progression|3
5122324|NCT01713582|17694155|P18|Overall Study|Disease progression|2
5122325|NCT01713582|17694156|P17|Overall Study|Disease progression|5
5122326|NCT01713582|17694157|P16|Overall Study|Disease progression|6
5122327|NCT01713582|17694158|P15|Overall Study|Disease progression|6
5122328|NCT01713582|17694159|P14|Overall Study|Disease progression|3
5122329|NCT01713582|17694160|P13|Overall Study|Disease progression|3
5122330|NCT01713582|17694161|P12|Overall Study|Disease progression|5
5122331|NCT01713582|17694162|P11|Overall Study|Disease progression|10
5122332|NCT01713582|17694163|P10|Overall Study|Disease progression|11
5122333|NCT01713582|17694164|P9|Overall Study|Disease progression|3
5122334|NCT01713582|17694165|P8|Overall Study|Disease progression|3
5122335|NCT01713582|17694166|P7|Overall Study|Disease progression|3
5122336|NCT01713582|17694167|P6|Overall Study|Disease progression|3
5122337|NCT01713582|17694168|P5|Overall Study|Disease progression|3
5122338|NCT01713582|17694169|P4|Overall Study|Disease progression|2
5122339|NCT01713582|17694170|P3|Overall Study|Disease progression|3
5122340|NCT01713582|17694171|P2|Overall Study|Disease progression|3
5122341|NCT01713582|17694172|P1|Overall Study|Disease progression|3
5122342|NCT01713530|17694335|P2|Overall Study|Unclassified|2
5122343|NCT01713530|17694336|P1|Overall Study|Unclassified|4
5122344|NCT01713530|17694335|P2|Overall Study|Withdrawal criteria|12
5122345|NCT01713530|17694336|P1|Overall Study|Withdrawal criteria|21
5122346|NCT01713530|17694335|P2|Overall Study|Adverse Event|5
5122347|NCT01713530|17694336|P1|Overall Study|Adverse Event|0
5122348|NCT01713348|17694367|P4|Overall Study|Lost to Follow-up|0
5122349|NCT01713348|17694368|P3|Overall Study|Lost to Follow-up|0
5122350|NCT01713348|17694369|P2|Overall Study|Lost to Follow-up|0
5122351|NCT01713348|17694370|P1|Overall Study|Lost to Follow-up|1
5122352|NCT01713348|17694367|P4|Overall Study|Withdrawal by Subject|0
5122353|NCT01713348|17694368|P3|Overall Study|Withdrawal by Subject|2
5122354|NCT01713348|17694369|P2|Overall Study|Withdrawal by Subject|2
5122355|NCT01713348|17694370|P1|Overall Study|Withdrawal by Subject|3
5122356|NCT01713283|17694400|P2|Overall Study|Lost to Follow-up|1
5122357|NCT01713283|17694401|P1|Overall Study|Lost to Follow-up|1
5122358|NCT01713283|17694400|P2|Overall Study|Lack of Efficacy|2
5122359|NCT01713283|17694401|P1|Overall Study|Lack of Efficacy|10
5122360|NCT01713036|17694423|P1|Overall Study|Death|1
5122361|NCT01712984|17694463|P3|Overall Study|Withdrawal by Subject|7
5122362|NCT01712984|17694464|P2|Overall Study|Withdrawal by Subject|6
5122363|NCT01712984|17694465|P1|Overall Study|Withdrawal by Subject|6
5122364|NCT01712984|17694463|P3|Overall Study|Lost to Follow-up|1
5122365|NCT01712984|17694464|P2|Overall Study|Lost to Follow-up|10
5122366|NCT01712984|17694465|P1|Overall Study|Lost to Follow-up|8
5122367|NCT01712984|17694463|P3|Overall Study|Protocol Violation|1
5122368|NCT01712984|17694464|P2|Overall Study|Protocol Violation|0
5122369|NCT01712984|17694465|P1|Overall Study|Protocol Violation|2
5122370|NCT01712984|17694463|P3|Overall Study|Adverse Event|1
5122371|NCT01712984|17694464|P2|Overall Study|Adverse Event|0
5122372|NCT01712984|17694465|P1|Overall Study|Adverse Event|0
5122373|NCT01712854|17694485|P1|Overall Study|Physician Decision|1
5122374|NCT01712685|17694508|P1|Overall Study|pt declined to participate before trmt|1
5122375|NCT01712516|17694524|P4|Overall Study|Withdrawal by Subject|9
5122376|NCT01712516|17694525|P3|Overall Study|Withdrawal by Subject|3
5122377|NCT01712516|17694526|P2|Overall Study|Withdrawal by Subject|9
5122378|NCT01712516|17694527|P1|Overall Study|Withdrawal by Subject|3
5122379|NCT01712516|17694524|P4|Overall Study|Physician Decision|1
5122380|NCT01712516|17694525|P3|Overall Study|Physician Decision|0
5122381|NCT01712516|17694526|P2|Overall Study|Physician Decision|0
5122382|NCT01712516|17694527|P1|Overall Study|Physician Decision|2
5122383|NCT01712516|17694524|P4|Overall Study|Protocol deviation|0
5122384|NCT01712516|17694525|P3|Overall Study|Protocol deviation|1
5122385|NCT01712516|17694526|P2|Overall Study|Protocol deviation|0
5122386|NCT01712516|17694527|P1|Overall Study|Protocol deviation|1
5122387|NCT01712516|17694524|P4|Overall Study|Death|0
5122388|NCT01712516|17694525|P3|Overall Study|Death|0
5122389|NCT01712516|17694526|P2|Overall Study|Death|1
5122390|NCT01712516|17694527|P1|Overall Study|Death|0
5122391|NCT01712516|17694524|P4|Overall Study|Lost to Follow-up|1
5122392|NCT01712516|17694525|P3|Overall Study|Lost to Follow-up|2
5122393|NCT01712516|17694526|P2|Overall Study|Lost to Follow-up|0
5122394|NCT01712516|17694527|P1|Overall Study|Lost to Follow-up|0
5122395|NCT01712516|17694524|P4|Overall Study|Technical problems|2
5122396|NCT01712516|17694525|P3|Overall Study|Technical problems|0
5122397|NCT01712516|17694526|P2|Overall Study|Technical problems|0
5122398|NCT01712516|17694527|P1|Overall Study|Technical problems|0
5122399|NCT01712490|17694579|P2|Overall Study|Lost to Follow-up|29
5122400|NCT01712490|17694580|P1|Overall Study|Lost to Follow-up|16
5122401|NCT01712490|17694579|P2|Overall Study|Withdrawal by Subject|44
5122402|NCT01712490|17694580|P1|Overall Study|Withdrawal by Subject|36
5122403|NCT01712490|17694579|P2|Overall Study|Other|11
5122404|NCT01712490|17694580|P1|Overall Study|Other|11
5122405|NCT01712490|17694579|P2|Overall Study|Ongoing|586
5122406|NCT01712490|17694580|P1|Overall Study|Ongoing|601
5122407|NCT01712438|17694617|P1|Overall Study|Prematurely Discontinued|25
5122408|NCT01712438|17694617|P1|Overall Study|Violated inclusion & exclusion criteria|4
5122409|NCT01712438|17694617|P1|Overall Study|Ongoing ITI treatment|6
5122410|NCT01712438|17694617|P1|Overall Study|Not treated with Human-cl rhFVIII|2
5122411|NCT01712399|17694627|P1|Overall Study|Study closure|345
5122412|NCT01712399|17694627|P1|Overall Study|Adverse Event|11
5122413|NCT01712399|17694627|P1|Overall Study|Death|1
5122414|NCT01712399|17694627|P1|Overall Study|Withdrawal by Subject|39
5122415|NCT01712399|17694627|P1|Overall Study|Lost to Follow-up|1
5122416|NCT01712334|17694673|P2|Treatment Period 1|Randomized in Error|2
5122417|NCT01712334|17694674|P1|Treatment Period 1|Randomized in Error|0
5122418|NCT01712256|17694682|P1|Overall Study|Lost to Follow-up|1
5122419|NCT01712204|17694712|P2|Overall Study|Protocol Violation|1
5122420|NCT01712204|17694713|P1|Overall Study|Protocol Violation|1
5122421|NCT01712204|17694712|P2|Overall Study|Lost to Follow-up|0
5122422|NCT01712204|17694713|P1|Overall Study|Lost to Follow-up|1
5122423|NCT01712204|17694712|P2|Overall Study|Withdrawal by Subject|3
5122424|NCT01712204|17694713|P1|Overall Study|Withdrawal by Subject|3
5122425|NCT01712204|17694712|P2|Overall Study|Adverse Event|1
5122426|NCT01712204|17694713|P1|Overall Study|Adverse Event|3
5122427|NCT01712178|17694721|P2|Overall Study|Lost to Follow-up|1
5122428|NCT01712178|17694722|P1|Overall Study|Lost to Follow-up|0
5122429|NCT01712178|17694721|P2|Overall Study|Serious adverse event/withdrew consent|1
5122430|NCT01712178|17694722|P1|Overall Study|Serious adverse event/withdrew consent|0
5122431|NCT01712178|17694721|P2|Overall Study|Withdrew consent due to an adverse event|1
5122432|NCT01712178|17694722|P1|Overall Study|Withdrew consent due to an adverse event|1
5122433|NCT01712074|17694747|P3|Double Blind Period|No longer met eligibility criteria|0
5122434|NCT01712074|17694748|P2|Double Blind Period|No longer met eligibility criteria|3
5122435|NCT01712074|17694749|P1|Double Blind Period|No longer met eligibility criteria|0
5122436|NCT01712074|17694747|P3|Double Blind Period|Protocol Violation|1
5122437|NCT01712074|17694748|P2|Double Blind Period|Protocol Violation|0
5122438|NCT01712074|17694749|P1|Double Blind Period|Protocol Violation|0
5122439|NCT01712074|17694747|P3|Double Blind Period|Other|1
5122440|NCT01712074|17694748|P2|Double Blind Period|Other|4
5122441|NCT01712074|17694749|P1|Double Blind Period|Other|0
5122442|NCT01712074|17694747|P3|Double Blind Period|Lost to Follow-up|1
5122443|NCT01712074|17694748|P2|Double Blind Period|Lost to Follow-up|2
5122444|NCT01712074|17694749|P1|Double Blind Period|Lost to Follow-up|0
5122445|NCT01712074|17694747|P3|Double Blind Period|Death|0
5122446|NCT01712074|17694748|P2|Double Blind Period|Death|1
5122447|NCT01712074|17694749|P1|Double Blind Period|Death|0
5122448|NCT01712074|17694747|P3|Double Blind Period|No longer willing to participate|4
5122449|NCT01712074|17694748|P2|Double Blind Period|No longer willing to participate|2
5122450|NCT01712074|17694749|P1|Double Blind Period|No longer willing to participate|0
5122451|NCT01712074|17694747|P3|Double Blind Period|Adverse Event|1
5122452|NCT01712074|17694748|P2|Double Blind Period|Adverse Event|2
5122453|NCT01712074|17694749|P1|Double Blind Period|Adverse Event|0
5122454|NCT01712074|17694747|P3|Placebo Run-in Period|No longer willing to participate|0
5122455|NCT01712074|17694748|P2|Placebo Run-in Period|No longer willing to participate|0
5122456|NCT01712074|17694749|P1|Placebo Run-in Period|No longer willing to participate|1
5122457|NCT01712074|17694747|P3|Placebo Run-in Period|Other|0
5122458|NCT01712074|17694748|P2|Placebo Run-in Period|Other|0
5122459|NCT01712074|17694749|P1|Placebo Run-in Period|Other|1
5122460|NCT01712074|17694747|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
5122461|NCT01712074|17694748|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
5122462|NCT01712074|17694749|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
5122463|NCT01712074|17694747|P3|Placebo Run-in Period|Lost to Follow-up|0
5122464|NCT01712074|17694748|P2|Placebo Run-in Period|Lost to Follow-up|0
5122465|NCT01712074|17694749|P1|Placebo Run-in Period|Lost to Follow-up|1
5122466|NCT01712074|17694747|P3|Placebo Run-in Period|Adverse Event|0
5122467|NCT01712074|17694748|P2|Placebo Run-in Period|Adverse Event|0
5122468|NCT01712074|17694749|P1|Placebo Run-in Period|Adverse Event|2
5122469|NCT01712061|17694805|P3|Overall Study|Other|0
5122470|NCT01712061|17694806|P2|Overall Study|Other|3
5122471|NCT01712061|17694807|P1|Overall Study|Other|0
5122472|NCT01712061|17694805|P3|Overall Study|Withdrawal by Subject|1
5122473|NCT01712061|17694806|P2|Overall Study|Withdrawal by Subject|7
5122474|NCT01712061|17694807|P1|Overall Study|Withdrawal by Subject|1
5122475|NCT01712061|17694805|P3|Overall Study|Medication Error Without Associated AE|0
5122476|NCT01712061|17694806|P2|Overall Study|Medication Error Without Associated AE|1
5122477|NCT01712061|17694807|P1|Overall Study|Medication Error Without Associated AE|0
5122478|NCT01712061|17694805|P3|Overall Study|Did Not Meet Entrance Criteria|3
5122479|NCT01712061|17694806|P2|Overall Study|Did Not Meet Entrance Criteria|6
5122480|NCT01712061|17694807|P1|Overall Study|Did Not Meet Entrance Criteria|4
5122481|NCT01712061|17694805|P3|Overall Study|Lost to Follow-up|1
5122482|NCT01712061|17694806|P2|Overall Study|Lost to Follow-up|0
5122483|NCT01712061|17694807|P1|Overall Study|Lost to Follow-up|1
5122484|NCT01712061|17694805|P3|Overall Study|Death|1
5122485|NCT01712061|17694806|P2|Overall Study|Death|0
5122486|NCT01712061|17694807|P1|Overall Study|Death|0
5122487|NCT01712061|17694805|P3|Overall Study|Adverse Event|5
5122488|NCT01712061|17694806|P2|Overall Study|Adverse Event|9
5122489|NCT01712061|17694807|P1|Overall Study|Adverse Event|4
5122490|NCT01712009|17694847|P3|Overall Study|Decision by Sponsor|12
5122491|NCT01712009|17694848|P2|Overall Study|Decision by Sponsor|14
5122492|NCT01712009|17694849|P1|Overall Study|Decision by Sponsor|12
5122493|NCT01712009|17694847|P3|Overall Study|Lost to Follow-up|1
5122494|NCT01712009|17694848|P2|Overall Study|Lost to Follow-up|0
5122495|NCT01712009|17694849|P1|Overall Study|Lost to Follow-up|2
5122496|NCT01712009|17694847|P3|Overall Study|Withdrawal by Subject|8
5122497|NCT01712009|17694848|P2|Overall Study|Withdrawal by Subject|15
5122498|NCT01712009|17694849|P1|Overall Study|Withdrawal by Subject|24
5122499|NCT01711983|17694875|P1|36-Month Closure Evaluation|Missed Echocardiograph|62
5122500|NCT01711983|17694875|P1|36-Month Closure Evaluation|Test Device Removal|2
5122501|NCT01711983|17694875|P1|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
5122502|NCT01711983|17694875|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
5122503|NCT01711866|17694893|P1|Overall Study|Adverse Event|2
5122504|NCT01711866|17694893|P1|Overall Study|Withdrawal by Subject|3
5122505|NCT01711866|17694893|P1|Overall Study|Noncompliant|3
5122506|NCT01711853|17694898|P1|Overall Study|Not treated|3
5122507|NCT01711736|17694905|P2|Overall Study|Migrated/moved from study area|1
5122508|NCT01711736|17694906|P1|Overall Study|Migrated/moved from study area|2
5122509|NCT01711736|17694905|P2|Overall Study|Withdrawal by Subject|6
5122510|NCT01711736|17694906|P1|Overall Study|Withdrawal by Subject|6
5122511|NCT01711736|17694905|P2|Overall Study|Lost to Follow-up|1
5122512|NCT01711736|17694906|P1|Overall Study|Lost to Follow-up|4
5122513|NCT01711645|17694934|P1|Overall Study|Physician Decision|5
5122514|NCT01711645|17694934|P1|Overall Study|Lost to Follow-up|6
5122515|NCT01711645|17694934|P1|Overall Study|Withdrawal by Subject|8
5122516|NCT01711619|17694971|P2|Overall Study|Lost to Follow-up|0
5122517|NCT01711619|17694972|P1|Overall Study|Lost to Follow-up|1
5122518|NCT01711619|17694971|P2|Overall Study|Adverse Event|0
5122519|NCT01711619|17694972|P1|Overall Study|Adverse Event|2
5122520|NCT01711619|17694971|P2|Overall Study|Protocol Violation|3
5122521|NCT01711619|17694972|P1|Overall Study|Protocol Violation|2
5122522|NCT01711619|17694971|P2|Overall Study|Withdrawal by Subject|7
5122523|NCT01711619|17694972|P1|Overall Study|Withdrawal by Subject|3
5122524|NCT01711619|17694971|P2|Overall Study|Early study termination|14
5122525|NCT01711619|17694972|P1|Overall Study|Early study termination|10
5122526|NCT01711541|17694989|P5|Overall Study|Ineligible|0
5122527|NCT01711541|17694990|P4|Overall Study|Ineligible|0
5122528|NCT01711541|17694991|P3|Overall Study|Ineligible|0
5122529|NCT01711541|17694992|P2|Overall Study|Ineligible|1
5122530|NCT01711541|17694993|P1|Overall Study|Ineligible|0
5122531|NCT01711541|17694989|P5|Overall Study|Cancel prior to treatment|0
5122532|NCT01711541|17694990|P4|Overall Study|Cancel prior to treatment|1
5122533|NCT01711541|17694991|P3|Overall Study|Cancel prior to treatment|0
5122534|NCT01711541|17694992|P2|Overall Study|Cancel prior to treatment|0
5122535|NCT01711541|17694993|P1|Overall Study|Cancel prior to treatment|0
5122536|NCT01711359|17695042|P3|Treatment Period|Randomized, Not Treated|0
5122537|NCT01711359|17695043|P2|Treatment Period|Randomized, Not Treated|1
5122538|NCT01711359|17695044|P1|Treatment Period|Randomized, Not Treated|3
5122539|NCT01711359|17695042|P3|Treatment Period|Lost to Follow-up|1
5122540|NCT01711359|17695043|P2|Treatment Period|Lost to Follow-up|1
5122541|NCT01711359|17695044|P1|Treatment Period|Lost to Follow-up|1
5122542|NCT01711359|17695042|P3|Treatment Period|Sponsor Decision|0
5122543|NCT01711359|17695043|P2|Treatment Period|Sponsor Decision|0
5122544|NCT01711359|17695044|P1|Treatment Period|Sponsor Decision|1
5122545|NCT01711359|17695042|P3|Treatment Period|Entry Criteria Not Met|0
5122546|NCT01711359|17695043|P2|Treatment Period|Entry Criteria Not Met|0
5122547|NCT01711359|17695044|P1|Treatment Period|Entry Criteria Not Met|1
5122548|NCT01711359|17695042|P3|Treatment Period|Death|0
5122549|NCT01711359|17695043|P2|Treatment Period|Death|0
5122550|NCT01711359|17695044|P1|Treatment Period|Death|3
5122551|NCT01711359|17695042|P3|Treatment Period|Physician Decision|2
5122552|NCT01711359|17695043|P2|Treatment Period|Physician Decision|3
5122553|NCT01711359|17695044|P1|Treatment Period|Physician Decision|4
5122554|NCT01711359|17695042|P3|Treatment Period|Adverse Event|24
5122555|NCT01711359|17695043|P2|Treatment Period|Adverse Event|10
5122556|NCT01711359|17695044|P1|Treatment Period|Adverse Event|8
5122557|NCT01711359|17695042|P3|Treatment Period|Lack of Efficacy|2
5122558|NCT01711359|17695043|P2|Treatment Period|Lack of Efficacy|2
5122559|NCT01711359|17695044|P1|Treatment Period|Lack of Efficacy|13
5122560|NCT01711359|17695042|P3|Treatment Period|Withdrawal by Subject|13
5122561|NCT01711359|17695043|P2|Treatment Period|Withdrawal by Subject|7
5122562|NCT01711359|17695044|P1|Treatment Period|Withdrawal by Subject|18
5122563|NCT01711216|17695128|P1|Overall Study|no reason specified|22
5122564|NCT01711216|17695128|P1|Overall Study|variety of other minor reasons|83
5122565|NCT01711216|17695128|P1|Overall Study|Lost to Follow-up|46
5122566|NCT01711216|17695128|P1|Overall Study|Withdrawal by Subject|6
5122567|NCT01711216|17695128|P1|Overall Study|Pregnancy|56
5122568|NCT01711216|17695128|P1|Overall Study|Adverse Event|4
5122569|NCT01710800|17695206|P1|Overall Study|Protocol Violation|1
5122570|NCT01710800|17695206|P1|Overall Study|Withdrawal by Subject|21
5122571|NCT01710709|17695270|P1|Overall Study|Lack of Efficacy|3
5122572|NCT01710709|17695270|P1|Overall Study|Protocol Violation|5
5122573|NCT01710709|17695270|P1|Overall Study|Withdrawal by Subject|53
5122574|NCT01710709|17695270|P1|Overall Study|Participant withdrawn by investigator|2
5122575|NCT01710709|17695270|P1|Overall Study|Participant met withdrawal criteria|33
5122576|NCT01710709|17695270|P1|Overall Study|Adverse Event|48
5122577|NCT01710709|17695270|P1|Overall Study|Lost to Follow-up|29
5122578|NCT01710657|17695285|P3|Overall Study|Lack of Efficacy|1
5122579|NCT01710657|17695286|P2|Overall Study|Lack of Efficacy|1
5122580|NCT01710657|17695287|P1|Overall Study|Lack of Efficacy|0
5122581|NCT01710657|17695285|P3|Overall Study|Withdrawal by Subject|2
5122582|NCT01710657|17695286|P2|Overall Study|Withdrawal by Subject|1
5122583|NCT01710657|17695287|P1|Overall Study|Withdrawal by Subject|0
5122584|NCT01710657|17695285|P3|Overall Study|Adverse Event|28
5122585|NCT01710657|17695286|P2|Overall Study|Adverse Event|8
5122586|NCT01710657|17695287|P1|Overall Study|Adverse Event|14
5122587|NCT01710657|17695285|P3|Overall Study|Protocol Violation|0
5122588|NCT01710657|17695286|P2|Overall Study|Protocol Violation|2
5122589|NCT01710657|17695287|P1|Overall Study|Protocol Violation|2
5122590|NCT01710657|17695285|P3|Overall Study|Lost to Follow-up|1
5122591|NCT01710657|17695286|P2|Overall Study|Lost to Follow-up|0
5122592|NCT01710657|17695287|P1|Overall Study|Lost to Follow-up|2
5122593|NCT01710527|17695304|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
5122594|NCT01710527|17695305|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
5122595|NCT01710514|17695331|P2|Overall Study|Withdrawal by Subject|0
5122596|NCT01710514|17695332|P1|Overall Study|Withdrawal by Subject|1
5122597|NCT01710514|17695331|P2|Overall Study|Adverse Event|7
5122598|NCT01710514|17695332|P1|Overall Study|Adverse Event|6
5122599|NCT01710501|17695353|P3|Overall Study|Lost to Follow-up|0
5122600|NCT01710501|17695354|P2|Overall Study|Lost to Follow-up|0
5122601|NCT01710501|17695355|P1|Overall Study|Lost to Follow-up|2
5122602|NCT01710358|17695387|P3|Rescue Period|Withdrawal by Subject|0
5122603|NCT01710358|17695388|P2|Rescue Period|Withdrawal by Subject|8
5122604|NCT01710358|17695389|P1|Rescue Period|Withdrawal by Subject|0
5122605|NCT01710358|17695387|P3|Rescue Period|Lack of Efficacy|0
5122606|NCT01710358|17695388|P2|Rescue Period|Lack of Efficacy|7
5122607|NCT01710358|17695389|P1|Rescue Period|Lack of Efficacy|0
5122608|NCT01710358|17695387|P3|Rescue Period|Death|0
5122609|NCT01710358|17695388|P2|Rescue Period|Death|1
5122610|NCT01710358|17695389|P1|Rescue Period|Death|0
5122611|NCT01710358|17695387|P3|Rescue Period|Adverse Event|0
5122612|NCT01710358|17695388|P2|Rescue Period|Adverse Event|15
5122613|NCT01710358|17695389|P1|Rescue Period|Adverse Event|0
5122614|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
5122615|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
5122616|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
5122617|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
5122618|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
5122619|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
5122620|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
5122621|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
5122622|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
5122623|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
5122624|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
5122625|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
5122626|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
5122627|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
5122628|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
5122629|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
5122630|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
5122631|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
5122632|NCT01710358|17695387|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
5122633|NCT01710358|17695388|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
5122634|NCT01710358|17695389|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
5122635|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
5122636|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
5122637|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
5122638|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
5122639|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
5122640|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
5122641|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
5122642|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
5122643|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
5122644|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
5122645|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
5122646|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
5122647|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
5122648|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
5122649|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
5122650|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
5122651|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
5122652|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
5122653|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
5122654|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
5122655|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
5122656|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
5122657|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
5122658|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
5122659|NCT01710358|17695387|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
5122660|NCT01710358|17695388|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
5122661|NCT01710358|17695389|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
5122662|NCT01710345|17695460|P3|Overall Study|Drug Dosing Error|0
5122663|NCT01710345|17695461|P2|Overall Study|Drug Dosing Error|0
5122664|NCT01710345|17695462|P1|Overall Study|Drug Dosing Error|1
5122665|NCT01710345|17695460|P3|Overall Study|Lack of Efficacy|1
5122666|NCT01710345|17695461|P2|Overall Study|Lack of Efficacy|3
5122667|NCT01710345|17695462|P1|Overall Study|Lack of Efficacy|2
5122668|NCT01710345|17695460|P3|Overall Study|Adverse Event|0
5122669|NCT01710345|17695461|P2|Overall Study|Adverse Event|2
5122670|NCT01710345|17695462|P1|Overall Study|Adverse Event|0
5122671|NCT01710046|17695521|P2|Overall Study|Lost to Follow-up|0
5122672|NCT01710046|17695522|P1|Overall Study|Lost to Follow-up|1
5122673|NCT01710033|17695562|P5|Stage 2|Adverse Event|1
5122674|NCT01710033|17695563|P4|Stage 2|Adverse Event|0
5122675|NCT01710033|17695564|P3|Stage 2|Adverse Event|0
5122676|NCT01710033|17695565|P2|Stage 2|Adverse Event|0
5122677|NCT01710033|17695566|P1|Stage 2|Adverse Event|0
5122678|NCT01710020|17695647|P1|Period 1|Protocol Violation|1
5122679|NCT01709903|17695683|P2|Overall Study|Adverse Event|18
5122680|NCT01709903|17695684|P1|Overall Study|Adverse Event|11
5122681|NCT01709903|17695683|P2|Overall Study|Withdrawal by Subject|6
5122682|NCT01709903|17695684|P1|Overall Study|Withdrawal by Subject|6
5122683|NCT01709903|17695683|P2|Overall Study|Lack of Efficacy|3
5122684|NCT01709903|17695684|P1|Overall Study|Lack of Efficacy|3
5122685|NCT01709903|17695683|P2|Overall Study|Protocol Violation|2
5122686|NCT01709903|17695684|P1|Overall Study|Protocol Violation|3
5122687|NCT01709903|17695683|P2|Overall Study|Death|0
5122688|NCT01709903|17695684|P1|Overall Study|Death|2
5122689|NCT01709903|17695683|P2|Overall Study|Lost to Follow-up|2
5122690|NCT01709903|17695684|P1|Overall Study|Lost to Follow-up|0
5122691|NCT01709903|17695683|P2|Overall Study|no longer needed study drug|1
5122692|NCT01709903|17695684|P1|Overall Study|no longer needed study drug|0
5122693|NCT01709903|17695683|P2|Overall Study|In ability to use device|1
5122694|NCT01709903|17695684|P1|Overall Study|In ability to use device|1
5122695|NCT01709903|17695683|P2|Overall Study|Abnormal test procedure results|0
5122696|NCT01709903|17695684|P1|Overall Study|Abnormal test procedure results|1
5122697|NCT01709903|17695683|P2|Overall Study|administrative problems|6
5122698|NCT01709903|17695684|P1|Overall Study|administrative problems|2
5122699|NCT01709864|17695708|P2|Overall Study|Death|1
5122700|NCT01709864|17695709|P1|Overall Study|Death|0
5122701|NCT01709864|17695708|P2|Overall Study|Adverse Event|2
5122702|NCT01709864|17695709|P1|Overall Study|Adverse Event|0
5122703|NCT01709864|17695708|P2|Overall Study|non-compliance with study treatment|1
5122704|NCT01709864|17695709|P1|Overall Study|non-compliance with study treatment|1
5122705|NCT01709864|17695708|P2|Overall Study|Lost to Follow-up|0
5122706|NCT01709864|17695709|P1|Overall Study|Lost to Follow-up|1
5122707|NCT01709864|17695708|P2|Overall Study|subject/guardian decision|6
5122708|NCT01709864|17695709|P1|Overall Study|subject/guardian decision|5
5122709|NCT01709864|17695708|P2|Overall Study|Physician Decision|1
5122710|NCT01709864|17695709|P1|Overall Study|Physician Decision|0
5122711|NCT01709838|17695743|P1|Overall Study|Protocol Violation|1
5122712|NCT01709838|17695743|P1|Overall Study|Death|3
5122713|NCT01709838|17695743|P1|Overall Study|Physician Decision|4
5122714|NCT01709838|17695743|P1|Overall Study|Adverse Event|4
5122715|NCT01709838|17695743|P1|Overall Study|Subject/guardian decision|8
5122716|NCT01709838|17695743|P1|Overall Study|Pregnancy|10
5122717|NCT01709838|17695743|P1|Overall Study|Lost to Follow-up|16
5122718|NCT01709838|17695743|P1|Overall Study|Withdrawal by Subject|21
5122719|NCT01709708|17695800|P2|Overall Study|Protocol Violation|2
5122720|NCT01709708|17695801|P1|Overall Study|Protocol Violation|1
5122721|NCT01709695|17695825|P2|Overall Study|Withdrawal by Subject|1
5122722|NCT01709695|17695826|P1|Overall Study|Withdrawal by Subject|1
5122723|NCT01709578|17695851|P3|Overall Study|Other, not related to safety or efficacy|5
5122724|NCT01709578|17695852|P2|Overall Study|Other, not related to safety or efficacy|7
5122725|NCT01709578|17695853|P1|Overall Study|Other, not related to safety or efficacy|2
5122726|NCT01709578|17695851|P3|Overall Study|Poor compliance to protocol|1
5122727|NCT01709578|17695852|P2|Overall Study|Poor compliance to protocol|2
5122728|NCT01709578|17695853|P1|Overall Study|Poor compliance to protocol|1
5122729|NCT01709578|17695851|P3|Overall Study|Lack of Efficacy|2
5122730|NCT01709578|17695852|P2|Overall Study|Lack of Efficacy|4
5122731|NCT01709578|17695853|P1|Overall Study|Lack of Efficacy|5
5122732|NCT01709578|17695851|P3|Overall Study|Adverse Event|17
5122733|NCT01709578|17695852|P2|Overall Study|Adverse Event|18
5122734|NCT01709578|17695853|P1|Overall Study|Adverse Event|9
5122735|NCT01709578|17695851|P3|Overall Study|Rescued and entered in long term safety|26
5122736|NCT01709578|17695852|P2|Overall Study|Rescued and entered in long term safety|25
5122737|NCT01709578|17695853|P1|Overall Study|Rescued and entered in long term safety|63
5122738|NCT01709513|17695984|P3|Overall Study|Other|7
5122739|NCT01709513|17695985|P2|Overall Study|Other|11
5122740|NCT01709513|17695986|P1|Overall Study|Other|3
5122741|NCT01709513|17695984|P3|Overall Study|Poor compliance to protocol|0
5122742|NCT01709513|17695985|P2|Overall Study|Poor compliance to protocol|0
5122743|NCT01709513|17695986|P1|Overall Study|Poor compliance to protocol|2
5122744|NCT01709513|17695984|P3|Overall Study|Adverse Event|23
5122745|NCT01709513|17695985|P2|Overall Study|Adverse Event|31
5122746|NCT01709513|17695986|P1|Overall Study|Adverse Event|16
5122747|NCT01709513|17695984|P3|Overall Study|Randomized but not treated|0
5122748|NCT01709513|17695985|P2|Overall Study|Randomized but not treated|1
5122749|NCT01709513|17695986|P1|Overall Study|Randomized but not treated|0
5122750|NCT01709500|17696047|P2|Overall Study|Treatment ongoing|78
5122751|NCT01709500|17696048|P1|Overall Study|Treatment ongoing|156
5122752|NCT01709500|17696047|P2|Overall Study|Related to IMP administration|0
5122753|NCT01709500|17696048|P1|Overall Study|Related to IMP administration|1
5122754|NCT01709500|17696047|P2|Overall Study|Other|1
5122755|NCT01709500|17696048|P1|Overall Study|Other|3
5122756|NCT01709500|17696047|P2|Overall Study|Poor compliance to protocol|1
5122757|NCT01709500|17696048|P1|Overall Study|Poor compliance to protocol|2
5122758|NCT01709500|17696047|P2|Overall Study|Adverse Event|1
5122759|NCT01709500|17696048|P1|Overall Study|Adverse Event|5
5122760|NCT01709500|17696047|P2|Overall Study|Randomized but not treated|1
5122761|NCT01709500|17696048|P1|Overall Study|Randomized but not treated|0
5122762|NCT01709409|17696126|P2|Overall Study|Protocol Violation|0
5122763|NCT01709409|17696127|P1|Overall Study|Protocol Violation|1
5122764|NCT01709383|17696135|P2|Overall Study|Lost to Follow-up|0
5122765|NCT01709383|17696136|P1|Overall Study|Lost to Follow-up|1
5122766|NCT01709331|17696154|P1|Overall Study|Adverse Event|1
5122767|NCT01709318|17696167|P7|Overall Study|Other Protocol Specified Criteria|0
5122768|NCT01709318|17696168|P6|Overall Study|Other Protocol Specified Criteria|0
5122769|NCT01709318|17696169|P5|Overall Study|Other Protocol Specified Criteria|0
5122770|NCT01709318|17696170|P4|Overall Study|Other Protocol Specified Criteria|0
5122771|NCT01709318|17696171|P3|Overall Study|Other Protocol Specified Criteria|0
5122772|NCT01709318|17696172|P2|Overall Study|Other Protocol Specified Criteria|1
5122773|NCT01709318|17696173|P1|Overall Study|Other Protocol Specified Criteria|0
5122774|NCT01709318|17696167|P7|Overall Study|Withdrawal by Subject|4
5122775|NCT01709318|17696168|P6|Overall Study|Withdrawal by Subject|2
5122776|NCT01709318|17696169|P5|Overall Study|Withdrawal by Subject|0
5122777|NCT01709318|17696170|P4|Overall Study|Withdrawal by Subject|3
5122778|NCT01709318|17696171|P3|Overall Study|Withdrawal by Subject|3
5122779|NCT01709318|17696172|P2|Overall Study|Withdrawal by Subject|0
5122780|NCT01709318|17696173|P1|Overall Study|Withdrawal by Subject|3
5122781|NCT01709318|17696167|P7|Overall Study|Technical Problems|0
5122782|NCT01709318|17696168|P6|Overall Study|Technical Problems|0
5122783|NCT01709318|17696169|P5|Overall Study|Technical Problems|0
5122784|NCT01709318|17696170|P4|Overall Study|Technical Problems|0
5122785|NCT01709318|17696171|P3|Overall Study|Technical Problems|0
5122786|NCT01709318|17696172|P2|Overall Study|Technical Problems|0
5122787|NCT01709318|17696173|P1|Overall Study|Technical Problems|1
5122788|NCT01709318|17696167|P7|Overall Study|Protocol Violation|1
5122789|NCT01709318|17696168|P6|Overall Study|Protocol Violation|0
5122790|NCT01709318|17696169|P5|Overall Study|Protocol Violation|2
5122791|NCT01709318|17696170|P4|Overall Study|Protocol Violation|0
5122792|NCT01709318|17696171|P3|Overall Study|Protocol Violation|0
5122793|NCT01709318|17696172|P2|Overall Study|Protocol Violation|0
5122794|NCT01709318|17696173|P1|Overall Study|Protocol Violation|0
5122795|NCT01709318|17696167|P7|Overall Study|Pregnancy|0
5122796|NCT01709318|17696168|P6|Overall Study|Pregnancy|0
5122797|NCT01709318|17696169|P5|Overall Study|Pregnancy|1
5122798|NCT01709318|17696170|P4|Overall Study|Pregnancy|0
5122799|NCT01709318|17696171|P3|Overall Study|Pregnancy|0
5122800|NCT01709318|17696172|P2|Overall Study|Pregnancy|0
5122801|NCT01709318|17696173|P1|Overall Study|Pregnancy|0
5122802|NCT01709318|17696167|P7|Overall Study|Physician Decision|1
5122803|NCT01709318|17696168|P6|Overall Study|Physician Decision|0
5122804|NCT01709318|17696169|P5|Overall Study|Physician Decision|0
5122805|NCT01709318|17696170|P4|Overall Study|Physician Decision|0
5122806|NCT01709318|17696171|P3|Overall Study|Physician Decision|0
5122807|NCT01709318|17696172|P2|Overall Study|Physician Decision|0
5122808|NCT01709318|17696173|P1|Overall Study|Physician Decision|0
5122809|NCT01709318|17696167|P7|Overall Study|Non-compliance with Study Drug|2
5122810|NCT01709318|17696168|P6|Overall Study|Non-compliance with Study Drug|0
5122811|NCT01709318|17696169|P5|Overall Study|Non-compliance with Study Drug|0
5122812|NCT01709318|17696170|P4|Overall Study|Non-compliance with Study Drug|1
5122813|NCT01709318|17696171|P3|Overall Study|Non-compliance with Study Drug|1
5122814|NCT01709318|17696172|P2|Overall Study|Non-compliance with Study Drug|2
5122815|NCT01709318|17696173|P1|Overall Study|Non-compliance with Study Drug|0
5122816|NCT01709318|17696167|P7|Overall Study|Lost to Follow-up|1
5122817|NCT01709318|17696168|P6|Overall Study|Lost to Follow-up|1
5122818|NCT01709318|17696169|P5|Overall Study|Lost to Follow-up|1
5122819|NCT01709318|17696170|P4|Overall Study|Lost to Follow-up|0
5122820|NCT01709318|17696171|P3|Overall Study|Lost to Follow-up|0
5122821|NCT01709318|17696172|P2|Overall Study|Lost to Follow-up|0
5122822|NCT01709318|17696173|P1|Overall Study|Lost to Follow-up|2
5122823|NCT01709318|17696167|P7|Overall Study|Adverse Event|2
5122824|NCT01709318|17696168|P6|Overall Study|Adverse Event|1
5122825|NCT01709318|17696169|P5|Overall Study|Adverse Event|0
5122826|NCT01709318|17696170|P4|Overall Study|Adverse Event|2
5122827|NCT01709318|17696171|P3|Overall Study|Adverse Event|2
5122828|NCT01709318|17696172|P2|Overall Study|Adverse Event|4
5122829|NCT01709318|17696173|P1|Overall Study|Adverse Event|3
5122830|NCT01709305|17696266|P5|Phase 2|Withdrawal by Subject|12
5122831|NCT01709305|17696267|P4|Phase 2|Withdrawal by Subject|15
5122832|NCT01709305|17696268|P3|Phase 2|Withdrawal by Subject|6
5122833|NCT01709305|17696269|P2|Phase 2|Withdrawal by Subject|8
5122834|NCT01709305|17696270|P1|Phase 2|Withdrawal by Subject|0
5122835|NCT01709305|17696266|P5|Phase 2|Protocol Violation|9
5122836|NCT01709305|17696267|P4|Phase 2|Protocol Violation|13
5122837|NCT01709305|17696268|P3|Phase 2|Protocol Violation|19
5122838|NCT01709305|17696269|P2|Phase 2|Protocol Violation|19
5122839|NCT01709305|17696270|P1|Phase 2|Protocol Violation|0
5122840|NCT01709305|17696266|P5|Phase 2|Physician Decision|2
5122841|NCT01709305|17696267|P4|Phase 2|Physician Decision|1
5122842|NCT01709305|17696268|P3|Phase 2|Physician Decision|0
5122843|NCT01709305|17696269|P2|Phase 2|Physician Decision|2
5122844|NCT01709305|17696270|P1|Phase 2|Physician Decision|0
5122845|NCT01709305|17696266|P5|Phase 2|Travel, moving, etc.|5
5122846|NCT01709305|17696267|P4|Phase 2|Travel, moving, etc.|3
5122847|NCT01709305|17696268|P3|Phase 2|Travel, moving, etc.|3
5122848|NCT01709305|17696269|P2|Phase 2|Travel, moving, etc.|2
5122849|NCT01709305|17696270|P1|Phase 2|Travel, moving, etc.|0
5122850|NCT01709305|17696266|P5|Phase 2|Lost to Follow-up|5
5122851|NCT01709305|17696267|P4|Phase 2|Lost to Follow-up|9
5122852|NCT01709305|17696268|P3|Phase 2|Lost to Follow-up|6
5122853|NCT01709305|17696269|P2|Phase 2|Lost to Follow-up|10
5122854|NCT01709305|17696270|P1|Phase 2|Lost to Follow-up|0
5122855|NCT01709305|17696266|P5|Phase 2|Laboratory Adverse Event|1
5122856|NCT01709305|17696267|P4|Phase 2|Laboratory Adverse Event|1
5122857|NCT01709305|17696268|P3|Phase 2|Laboratory Adverse Event|0
5122858|NCT01709305|17696269|P2|Phase 2|Laboratory Adverse Event|1
5122859|NCT01709305|17696270|P1|Phase 2|Laboratory Adverse Event|0
5122860|NCT01709305|17696266|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
5122861|NCT01709305|17696267|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
5122862|NCT01709305|17696268|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
5122863|NCT01709305|17696269|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
5122864|NCT01709305|17696270|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
5122865|NCT01709305|17696266|P5|Phase 2|Death|0
5122866|NCT01709305|17696267|P4|Phase 2|Death|0
5122867|NCT01709305|17696268|P3|Phase 2|Death|1
5122868|NCT01709305|17696269|P2|Phase 2|Death|0
5122869|NCT01709305|17696270|P1|Phase 2|Death|0
5122870|NCT01709305|17696266|P5|Phase 2|Clinical Adverse Event|11
5122871|NCT01709305|17696267|P4|Phase 2|Clinical Adverse Event|6
5122872|NCT01709305|17696268|P3|Phase 2|Clinical Adverse Event|10
5122873|NCT01709305|17696269|P2|Phase 2|Clinical Adverse Event|10
5122874|NCT01709305|17696270|P1|Phase 2|Clinical Adverse Event|0
5122875|NCT01709305|17696266|P5|Phase 1|Withdrawal by Subject|0
5122876|NCT01709305|17696267|P4|Phase 1|Withdrawal by Subject|0
5122877|NCT01709305|17696268|P3|Phase 1|Withdrawal by Subject|0
5122878|NCT01709305|17696269|P2|Phase 1|Withdrawal by Subject|0
5122879|NCT01709305|17696270|P1|Phase 1|Withdrawal by Subject|218
5122880|NCT01709305|17696266|P5|Phase 1|Protocol Violation|0
5122881|NCT01709305|17696267|P4|Phase 1|Protocol Violation|0
5122882|NCT01709305|17696268|P3|Phase 1|Protocol Violation|0
5122883|NCT01709305|17696269|P2|Phase 1|Protocol Violation|0
5122884|NCT01709305|17696270|P1|Phase 1|Protocol Violation|118
5122885|NCT01709305|17696266|P5|Phase 1|Physician Decision|0
5122886|NCT01709305|17696267|P4|Phase 1|Physician Decision|0
5122887|NCT01709305|17696268|P3|Phase 1|Physician Decision|0
5122888|NCT01709305|17696269|P2|Phase 1|Physician Decision|0
5122889|NCT01709305|17696270|P1|Phase 1|Physician Decision|13
5122890|NCT01709305|17696266|P5|Phase 1|Travel, moving, etc.|0
5122891|NCT01709305|17696267|P4|Phase 1|Travel, moving, etc.|0
5122892|NCT01709305|17696268|P3|Phase 1|Travel, moving, etc.|0
5122893|NCT01709305|17696269|P2|Phase 1|Travel, moving, etc.|0
5122894|NCT01709305|17696270|P1|Phase 1|Travel, moving, etc.|30
5122895|NCT01709305|17696266|P5|Phase 1|Lost to Follow-up|0
5122896|NCT01709305|17696267|P4|Phase 1|Lost to Follow-up|0
5122897|NCT01709305|17696268|P3|Phase 1|Lost to Follow-up|0
5122898|NCT01709305|17696269|P2|Phase 1|Lost to Follow-up|0
5122899|NCT01709305|17696270|P1|Phase 1|Lost to Follow-up|147
5122900|NCT01709305|17696266|P5|Phase 1|Laboratory Adverse Event|0
5122901|NCT01709305|17696267|P4|Phase 1|Laboratory Adverse Event|0
5122902|NCT01709305|17696268|P3|Phase 1|Laboratory Adverse Event|0
5122903|NCT01709305|17696269|P2|Phase 1|Laboratory Adverse Event|0
5122904|NCT01709305|17696270|P1|Phase 1|Laboratory Adverse Event|16
5122905|NCT01709305|17696266|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
5122906|NCT01709305|17696267|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
5122907|NCT01709305|17696268|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
5122908|NCT01709305|17696269|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
5122909|NCT01709305|17696270|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
5122910|NCT01709305|17696266|P5|Phase 1|Death|0
5122911|NCT01709305|17696267|P4|Phase 1|Death|0
5122912|NCT01709305|17696268|P3|Phase 1|Death|0
5122913|NCT01709305|17696269|P2|Phase 1|Death|0
5122914|NCT01709305|17696270|P1|Phase 1|Death|2
5122915|NCT01709305|17696266|P5|Phase 1|Clinical Adverse Event|0
5122916|NCT01709305|17696267|P4|Phase 1|Clinical Adverse Event|0
5122917|NCT01709305|17696268|P3|Phase 1|Clinical Adverse Event|0
5122918|NCT01709305|17696269|P2|Phase 1|Clinical Adverse Event|0
5122919|NCT01709305|17696270|P1|Phase 1|Clinical Adverse Event|80
5122920|NCT01709227|17696307|P2|Overall Study|Pleural Peritoneal communication|9
5122921|NCT01709227|17696308|P1|Overall Study|Pleural Peritoneal communication|0
5122922|NCT01709227|17696307|P2|Overall Study|Physician Decision|0
5122923|NCT01709227|17696308|P1|Overall Study|Physician Decision|1
5122924|NCT01709162|17696334|P2|Overall Study|Withdrawal by Subject|1
5122925|NCT01709162|17696335|P1|Overall Study|Withdrawal by Subject|0
5122926|NCT01709162|17696334|P2|Overall Study|Other|0
5122927|NCT01709162|17696335|P1|Overall Study|Other|1
5122928|NCT01709162|17696334|P2|Overall Study|Administrative reason by sponsor|1
5122929|NCT01709162|17696335|P1|Overall Study|Administrative reason by sponsor|0
5122930|NCT01709162|17696334|P2|Overall Study|Study drug toxicity|0
5122931|NCT01709162|17696335|P1|Overall Study|Study drug toxicity|2
5122932|NCT01709162|17696334|P2|Overall Study|Disease progression|3
5122933|NCT01709162|17696335|P1|Overall Study|Disease progression|3
5122934|NCT01709149|17696350|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5122935|NCT01709149|17696351|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5122936|NCT01709149|17696352|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5122937|NCT01709149|17696350|P3|Double-blind, Placebo-controlled Phase|not defined|2
5122938|NCT01709149|17696351|P2|Double-blind, Placebo-controlled Phase|not defined|1
5122939|NCT01709149|17696352|P1|Double-blind, Placebo-controlled Phase|not defined|0
5122940|NCT01709149|17696350|P3|Double-blind, Placebo-controlled Phase|Death|0
5122941|NCT01709149|17696351|P2|Double-blind, Placebo-controlled Phase|Death|2
5122942|NCT01709149|17696352|P1|Double-blind, Placebo-controlled Phase|Death|0
5122943|NCT01709149|17696350|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
5122944|NCT01709149|17696351|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
5122945|NCT01709149|17696352|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
5122946|NCT01709149|17696350|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
5122947|NCT01709149|17696351|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
5122948|NCT01709149|17696352|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5122949|NCT01709149|17696350|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
5122950|NCT01709149|17696351|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
5122951|NCT01709149|17696352|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
5122952|NCT01709149|17696350|P3|Open-label Lead-in Phase|Protocol Violation|0
5122953|NCT01709149|17696351|P2|Open-label Lead-in Phase|Protocol Violation|0
5122954|NCT01709149|17696352|P1|Open-label Lead-in Phase|Protocol Violation|3
5122955|NCT01709149|17696350|P3|Open-label Lead-in Phase|Death|0
5122956|NCT01709149|17696351|P2|Open-label Lead-in Phase|Death|0
5122957|NCT01709149|17696352|P1|Open-label Lead-in Phase|Death|1
5122958|NCT01709149|17696350|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
5122959|NCT01709149|17696351|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
5122960|NCT01709149|17696352|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
5122961|NCT01709149|17696350|P3|Open-label Lead-in Phase|Adverse Event|0
5122962|NCT01709149|17696351|P2|Open-label Lead-in Phase|Adverse Event|0
5122963|NCT01709149|17696352|P1|Open-label Lead-in Phase|Adverse Event|109
5122964|NCT01709110|17696380|P2|Overall Study|Caregiver Decision|1
5122965|NCT01709110|17696381|P1|Overall Study|Caregiver Decision|1
5122966|NCT01709110|17696380|P2|Overall Study|Lack of Efficacy|1
5122967|NCT01709110|17696381|P1|Overall Study|Lack of Efficacy|1
5122968|NCT01709110|17696380|P2|Overall Study|Sponsor Decision|2
5122969|NCT01709110|17696381|P1|Overall Study|Sponsor Decision|2
5122970|NCT01709110|17696380|P2|Overall Study|Physician Decision|10
5122971|NCT01709110|17696381|P1|Overall Study|Physician Decision|4
5122972|NCT01709110|17696380|P2|Overall Study|Withdrawal by Subject|89
5122973|NCT01709110|17696381|P1|Overall Study|Withdrawal by Subject|96
5122974|NCT01709110|17696380|P2|Overall Study|Protocol Violation|6
5122975|NCT01709110|17696381|P1|Overall Study|Protocol Violation|4
5122976|NCT01709110|17696380|P2|Overall Study|Lost to Follow-up|5
5122977|NCT01709110|17696381|P1|Overall Study|Lost to Follow-up|7
5122978|NCT01709110|17696380|P2|Overall Study|Death|6
5122979|NCT01709110|17696381|P1|Overall Study|Death|14
5122980|NCT01709110|17696380|P2|Overall Study|Adverse Event|48
5122981|NCT01709110|17696381|P1|Overall Study|Adverse Event|56
5122982|NCT01709084|17696411|P2|Overall Study|Not Treated|2
5122983|NCT01709084|17696412|P1|Overall Study|Not Treated|0
5122984|NCT01709084|17696411|P2|Overall Study|Participant Reached a Virologic Endpoint|1
5122985|NCT01709084|17696412|P1|Overall Study|Participant Reached a Virologic Endpoint|0
5122986|NCT01709084|17696411|P2|Overall Study|Other|3
5122987|NCT01709084|17696412|P1|Overall Study|Other|5
5122988|NCT01709084|17696411|P2|Overall Study|Adverse Event|0
5122989|NCT01709084|17696412|P1|Overall Study|Adverse Event|5
5122990|NCT01709084|17696411|P2|Overall Study|Withdrawal by Subject|2
5122991|NCT01709084|17696412|P1|Overall Study|Withdrawal by Subject|2
5122992|NCT01709084|17696411|P2|Overall Study|Lost to Follow-up|7
5122993|NCT01709084|17696412|P1|Overall Study|Lost to Follow-up|4
5122994|NCT01708954|17696445|P3|Step 2|Withdrawal by Subject|0
5122995|NCT01708954|17696446|P2|Step 2|Withdrawal by Subject|1
5122996|NCT01708954|17696447|P1|Step 2|Withdrawal by Subject|1
5122997|NCT01708954|17696445|P3|Step 2|Adverse Event|0
5122998|NCT01708954|17696446|P2|Step 2|Adverse Event|2
5122999|NCT01708954|17696447|P1|Step 2|Adverse Event|3
5123000|NCT01708954|17696445|P3|Step 2|Disease progression|0
5123001|NCT01708954|17696446|P2|Step 2|Disease progression|4
5123002|NCT01708954|17696447|P1|Step 2|Disease progression|9
5123003|NCT01708954|17696445|P3|Step 1|Ineligible or never received treatment|8
5123004|NCT01708954|17696446|P2|Step 1|Ineligible or never received treatment|2
5123005|NCT01708954|17696447|P1|Step 1|Ineligible or never received treatment|4
5123006|NCT01708954|17696445|P3|Step 1|Off-treatment reason not submitted|1
5123007|NCT01708954|17696446|P2|Step 1|Off-treatment reason not submitted|1
5123008|NCT01708954|17696447|P1|Step 1|Off-treatment reason not submitted|1
5123009|NCT01708954|17696445|P3|Step 1|Symptomatic deterioration|1
5123010|NCT01708954|17696446|P2|Step 1|Symptomatic deterioration|0
5123011|NCT01708954|17696447|P1|Step 1|Symptomatic deterioration|1
5123012|NCT01708954|17696445|P3|Step 1|Crossed over to Step 2|0
5123013|NCT01708954|17696446|P2|Step 1|Crossed over to Step 2|0
5123014|NCT01708954|17696447|P1|Step 1|Crossed over to Step 2|2
5123015|NCT01708954|17696445|P3|Step 1|Other complicating disease|0
5123016|NCT01708954|17696446|P2|Step 1|Other complicating disease|2
5123017|NCT01708954|17696447|P1|Step 1|Other complicating disease|0
5123018|NCT01708954|17696445|P3|Step 1|Withdrawal by Subject|3
5123019|NCT01708954|17696446|P2|Step 1|Withdrawal by Subject|5
5123020|NCT01708954|17696447|P1|Step 1|Withdrawal by Subject|2
5123021|NCT01708954|17696445|P3|Step 1|Death|3
5123022|NCT01708954|17696446|P2|Step 1|Death|2
5123023|NCT01708954|17696447|P1|Step 1|Death|3
5123024|NCT01708954|17696445|P3|Step 1|Adverse Event|13
5123025|NCT01708954|17696446|P2|Step 1|Adverse Event|11
5123026|NCT01708954|17696447|P1|Step 1|Adverse Event|3
5123027|NCT01708954|17696445|P3|Step 1|Disease progression|14
5123028|NCT01708954|17696446|P2|Step 1|Disease progression|17
5123029|NCT01708954|17696447|P1|Step 1|Disease progression|26
5123030|NCT01708941|17696472|P4|Overall Study|Ineligible|0
5123031|NCT01708941|17696473|P3|Overall Study|Ineligible|2
5123032|NCT01708941|17696474|P2|Overall Study|Ineligible|0
5123033|NCT01708941|17696475|P1|Overall Study|Ineligible|0
5123034|NCT01708941|17696472|P4|Overall Study|Never started treatment|0
5123035|NCT01708941|17696473|P3|Overall Study|Never started treatment|0
5123036|NCT01708941|17696474|P2|Overall Study|Never started treatment|1
5123037|NCT01708941|17696475|P1|Overall Study|Never started treatment|2
5123038|NCT01708941|17696472|P4|Overall Study|Ineligible and never started treatment|0
5123039|NCT01708941|17696473|P3|Overall Study|Ineligible and never started treatment|1
5123040|NCT01708941|17696474|P2|Overall Study|Ineligible and never started treatment|0
5123041|NCT01708941|17696475|P1|Overall Study|Ineligible and never started treatment|1
5123042|NCT01708941|17696472|P4|Overall Study|Alternative therapy|0
5123043|NCT01708941|17696473|P3|Overall Study|Alternative therapy|2
5123044|NCT01708941|17696474|P2|Overall Study|Alternative therapy|0
5123045|NCT01708941|17696475|P1|Overall Study|Alternative therapy|0
5123046|NCT01708941|17696472|P4|Overall Study|Disease progression|0
5123047|NCT01708941|17696473|P3|Overall Study|Disease progression|8
5123048|NCT01708941|17696474|P2|Overall Study|Disease progression|10
5123049|NCT01708941|17696475|P1|Overall Study|Disease progression|9
5123050|NCT01708941|17696472|P4|Overall Study|Withdrawal by Subject|4
5123051|NCT01708941|17696473|P3|Overall Study|Withdrawal by Subject|3
5123052|NCT01708941|17696474|P2|Overall Study|Withdrawal by Subject|0
5123053|NCT01708941|17696475|P1|Overall Study|Withdrawal by Subject|1
5123054|NCT01708941|17696472|P4|Overall Study|Death|14
5123055|NCT01708941|17696473|P3|Overall Study|Death|2
5123056|NCT01708941|17696474|P2|Overall Study|Death|1
5123057|NCT01708941|17696475|P1|Overall Study|Death|1
5123058|NCT01708941|17696472|P4|Overall Study|Adverse Event|0
5123059|NCT01708941|17696473|P3|Overall Study|Adverse Event|1
5123060|NCT01708941|17696474|P2|Overall Study|Adverse Event|6
5123061|NCT01708941|17696475|P1|Overall Study|Adverse Event|4
5123062|NCT01708915|17696493|P4|Overall Study|Other reasons than stated above|2
5123063|NCT01708915|17696494|P3|Overall Study|Other reasons than stated above|0
5123064|NCT01708915|17696495|P2|Overall Study|Other reasons than stated above|1
5123065|NCT01708915|17696496|P1|Overall Study|Other reasons than stated above|1
5123066|NCT01708915|17696493|P4|Overall Study|Withdrawal by Subject|2
5123067|NCT01708915|17696494|P3|Overall Study|Withdrawal by Subject|2
5123068|NCT01708915|17696495|P2|Overall Study|Withdrawal by Subject|1
5123069|NCT01708915|17696496|P1|Overall Study|Withdrawal by Subject|0
5123070|NCT01708915|17696493|P4|Overall Study|Protocol Violation|1
5123071|NCT01708915|17696494|P3|Overall Study|Protocol Violation|0
5123072|NCT01708915|17696495|P2|Overall Study|Protocol Violation|0
5123073|NCT01708915|17696496|P1|Overall Study|Protocol Violation|0
5123074|NCT01708915|17696493|P4|Overall Study|Lack of Efficacy|15
5123075|NCT01708915|17696494|P3|Overall Study|Lack of Efficacy|35
5123076|NCT01708915|17696495|P2|Overall Study|Lack of Efficacy|60
5123077|NCT01708915|17696496|P1|Overall Study|Lack of Efficacy|84
5123078|NCT01708915|17696493|P4|Overall Study|Adverse Event|13
5123079|NCT01708915|17696494|P3|Overall Study|Adverse Event|9
5123080|NCT01708915|17696495|P2|Overall Study|Adverse Event|0
5123081|NCT01708915|17696496|P1|Overall Study|Adverse Event|1
5123082|NCT01708902|17696525|P7|Overall Study|Other Reason|0
5123083|NCT01708902|17696526|P6|Overall Study|Other Reason|2
5123084|NCT01708902|17696527|P5|Overall Study|Other Reason|1
5123085|NCT01708902|17696528|P4|Overall Study|Other Reason|1
5123086|NCT01708902|17696529|P3|Overall Study|Other Reason|1
5123087|NCT01708902|17696530|P2|Overall Study|Other Reason|0
5123088|NCT01708902|17696531|P1|Overall Study|Other Reason|1
5123089|NCT01708902|17696525|P7|Overall Study|Refused to continue trial medication|1
5123090|NCT01708902|17696526|P6|Overall Study|Refused to continue trial medication|1
5123091|NCT01708902|17696527|P5|Overall Study|Refused to continue trial medication|8
5123092|NCT01708902|17696528|P4|Overall Study|Refused to continue trial medication|2
5123093|NCT01708902|17696529|P3|Overall Study|Refused to continue trial medication|4
5123094|NCT01708902|17696530|P2|Overall Study|Refused to continue trial medication|0
5123095|NCT01708902|17696531|P1|Overall Study|Refused to continue trial medication|8
5123096|NCT01708902|17696525|P7|Overall Study|Lost to Follow-up|1
5123097|NCT01708902|17696526|P6|Overall Study|Lost to Follow-up|0
5123098|NCT01708902|17696527|P5|Overall Study|Lost to Follow-up|0
5123099|NCT01708902|17696528|P4|Overall Study|Lost to Follow-up|2
5123100|NCT01708902|17696529|P3|Overall Study|Lost to Follow-up|2
5123101|NCT01708902|17696530|P2|Overall Study|Lost to Follow-up|1
5123102|NCT01708902|17696531|P1|Overall Study|Lost to Follow-up|2
5123103|NCT01708902|17696525|P7|Overall Study|Non compliance with protocol|0
5123104|NCT01708902|17696526|P6|Overall Study|Non compliance with protocol|0
5123105|NCT01708902|17696527|P5|Overall Study|Non compliance with protocol|0
5123106|NCT01708902|17696528|P4|Overall Study|Non compliance with protocol|3
5123107|NCT01708902|17696529|P3|Overall Study|Non compliance with protocol|1
5123108|NCT01708902|17696530|P2|Overall Study|Non compliance with protocol|2
5123109|NCT01708902|17696531|P1|Overall Study|Non compliance with protocol|0
5123110|NCT01708902|17696525|P7|Overall Study|Lack of Efficacy|0
5123111|NCT01708902|17696526|P6|Overall Study|Lack of Efficacy|1
5123112|NCT01708902|17696527|P5|Overall Study|Lack of Efficacy|0
5123113|NCT01708902|17696528|P4|Overall Study|Lack of Efficacy|0
5123114|NCT01708902|17696529|P3|Overall Study|Lack of Efficacy|0
5123115|NCT01708902|17696530|P2|Overall Study|Lack of Efficacy|1
5123116|NCT01708902|17696531|P1|Overall Study|Lack of Efficacy|3
5123117|NCT01708902|17696525|P7|Overall Study|Adverse Event|5
5123118|NCT01708902|17696526|P6|Overall Study|Adverse Event|3
5123119|NCT01708902|17696527|P5|Overall Study|Adverse Event|7
5123120|NCT01708902|17696528|P4|Overall Study|Adverse Event|2
5123121|NCT01708902|17696529|P3|Overall Study|Adverse Event|9
5123122|NCT01708902|17696530|P2|Overall Study|Adverse Event|4
5123123|NCT01708902|17696531|P1|Overall Study|Adverse Event|3
5123124|NCT01708291|17696673|P2|Overall Study|fighting|1
5123125|NCT01708291|17696674|P1|Overall Study|fighting|2
5123126|NCT01708187|17696713|P2|Overall Study|Lost to Follow-up|1
5123127|NCT01708187|17696714|P1|Overall Study|Lost to Follow-up|0
5123128|NCT01708174|17696723|P3|Treatment Period|Adverse Event|0
5123129|NCT01708174|17696724|P2|Treatment Period|Adverse Event|1
5123130|NCT01708174|17696725|P1|Treatment Period|Adverse Event|0
5123131|NCT01708174|17696723|P3|Treatment Period|Death|1
5123132|NCT01708174|17696724|P2|Treatment Period|Death|0
5123133|NCT01708174|17696725|P1|Treatment Period|Death|0
5123134|NCT01708174|17696723|P3|Treatment Period|Progressive disease|0
5123135|NCT01708174|17696724|P2|Treatment Period|Progressive disease|1
5123136|NCT01708174|17696725|P1|Treatment Period|Progressive disease|0
5123137|NCT01708174|17696723|P3|Treatment Period|Withdrawal by Subject|0
5123138|NCT01708174|17696724|P2|Treatment Period|Withdrawal by Subject|0
5123139|NCT01708174|17696725|P1|Treatment Period|Withdrawal by Subject|1
5123140|NCT01708161|17696757|P6|Overall Study|Disease progression|0
5123141|NCT01708161|17696758|P5|Overall Study|Disease progression|3
5123142|NCT01708161|17696759|P4|Overall Study|Disease progression|13
5123143|NCT01708161|17696760|P3|Overall Study|Disease progression|5
5123144|NCT01708161|17696761|P2|Overall Study|Disease progression|5
5123145|NCT01708161|17696762|P1|Overall Study|Disease progression|3
5123146|NCT01708161|17696757|P6|Overall Study|Administrative problems|0
5123147|NCT01708161|17696758|P5|Overall Study|Administrative problems|0
5123148|NCT01708161|17696759|P4|Overall Study|Administrative problems|0
5123149|NCT01708161|17696760|P3|Overall Study|Administrative problems|0
5123150|NCT01708161|17696761|P2|Overall Study|Administrative problems|1
5123151|NCT01708161|17696762|P1|Overall Study|Administrative problems|0
5123152|NCT01708161|17696757|P6|Overall Study|Withdrawal by Subject|0
5123153|NCT01708161|17696758|P5|Overall Study|Withdrawal by Subject|0
5123154|NCT01708161|17696759|P4|Overall Study|Withdrawal by Subject|0
5123155|NCT01708161|17696760|P3|Overall Study|Withdrawal by Subject|1
5123156|NCT01708161|17696761|P2|Overall Study|Withdrawal by Subject|1
5123157|NCT01708161|17696762|P1|Overall Study|Withdrawal by Subject|0
5123158|NCT01708161|17696757|P6|Overall Study|Death|1
5123159|NCT01708161|17696758|P5|Overall Study|Death|0
5123160|NCT01708161|17696759|P4|Overall Study|Death|1
5123161|NCT01708161|17696760|P3|Overall Study|Death|0
5123162|NCT01708161|17696761|P2|Overall Study|Death|0
5123163|NCT01708161|17696762|P1|Overall Study|Death|0
5123164|NCT01708161|17696757|P6|Overall Study|Adverse Event|0
5123165|NCT01708161|17696758|P5|Overall Study|Adverse Event|3
5123166|NCT01708161|17696759|P4|Overall Study|Adverse Event|2
5123167|NCT01708161|17696760|P3|Overall Study|Adverse Event|4
5123168|NCT01708161|17696761|P2|Overall Study|Adverse Event|3
5123169|NCT01708161|17696762|P1|Overall Study|Adverse Event|1
5123170|NCT01708057|17696813|P3|Overall Study|Withdrawal due to study termination.|1
5123171|NCT01708057|17696814|P2|Overall Study|Withdrawal due to study termination.|1
5123172|NCT01708057|17696815|P1|Overall Study|Withdrawal due to study termination.|1
5123173|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5123174|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
5123175|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5123176|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5123177|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5123178|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5123179|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
5123180|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
5123181|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
5123182|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5123183|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5123184|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5123185|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Noncompliance|2
5123186|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Noncompliance|4
5123187|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Noncompliance|0
5123188|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Noncompliance|0
5123189|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Noncompliance|0
5123190|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Noncompliance|0
5123191|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Other than specified|2
5123192|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Other than specified|5
5123193|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Other than specified|1
5123194|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Other than specified|0
5123195|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Other than specified|0
5123196|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Other than specified|0
5123197|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Death|0
5123198|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Death|0
5123199|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Death|2
5123200|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Death|0
5123201|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Death|0
5123202|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Death|0
5123203|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
5123204|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
5123205|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
5123206|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5123207|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5123208|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5123209|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Pregnancy|2
5123210|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Pregnancy|5
5123211|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Pregnancy|2
5123212|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Pregnancy|0
5123213|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Pregnancy|0
5123214|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Pregnancy|0
5123215|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
5123216|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
5123217|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
5123218|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5123219|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5123220|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5123221|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
5123222|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
5123223|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
5123224|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5123225|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5123226|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5123227|NCT01707992|17696874|P6|Active Treatment Phase (24 Months)|Adverse Event|0
5123228|NCT01707992|17696875|P5|Active Treatment Phase (24 Months)|Adverse Event|1
5123229|NCT01707992|17696876|P4|Active Treatment Phase (24 Months)|Adverse Event|4
5123230|NCT01707992|17696877|P3|Active Treatment Phase (24 Months)|Adverse Event|0
5123231|NCT01707992|17696878|P2|Active Treatment Phase (24 Months)|Adverse Event|0
5123232|NCT01707992|17696879|P1|Active Treatment Phase (24 Months)|Adverse Event|0
5123233|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
5123234|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
5123235|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
5123236|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
5123237|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
5123238|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
5123239|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5123240|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5123241|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5123242|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
5123243|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
5123244|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
5123245|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Death|0
5123246|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Death|0
5123247|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Death|0
5123248|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Death|1
5123249|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Death|1
5123250|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Death|2
5123251|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5123252|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5123253|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5123254|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
5123255|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
5123256|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
5123257|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5123258|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5123259|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5123260|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
5123261|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
5123262|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
5123263|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5123264|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5123265|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5123266|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5123267|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5123268|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
5123269|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5123270|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5123271|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5123272|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
5123273|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
5123274|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
5123275|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5123276|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5123277|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5123278|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
5123279|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
5123280|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
5123281|NCT01707992|17696874|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5123282|NCT01707992|17696875|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5123283|NCT01707992|17696876|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5123284|NCT01707992|17696877|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
5123285|NCT01707992|17696878|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
5123286|NCT01707992|17696879|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
5123287|NCT01707693|17696931|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
5123288|NCT01707693|17696932|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
5123289|NCT01707693|17696931|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
5123290|NCT01707693|17696932|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
5123291|NCT01707693|17696931|P2|Overall Study Allocation|Protocol Violation|3
5123292|NCT01707693|17696932|P1|Overall Study Allocation|Protocol Violation|4
5123293|NCT01707693|17696931|P2|Overall Study Allocation|Withdrawal by Subject|5
5123294|NCT01707693|17696932|P1|Overall Study Allocation|Withdrawal by Subject|9
5123295|NCT01707667|17696946|P2|Period 1|expulsion of colonic sensor catheter|0
5123296|NCT01707667|17696947|P1|Period 1|expulsion of colonic sensor catheter|1
5123297|NCT01707290|17697017|P2|Overall Study|Other unspecified|0
5123298|NCT01707290|17697018|P1|Overall Study|Other unspecified|17
5123299|NCT01707290|17697017|P2|Overall Study|Commercial drug available|1
5123300|NCT01707290|17697018|P1|Overall Study|Commercial drug available|60
5123301|NCT01707290|17697017|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
5123302|NCT01707290|17697018|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
5123303|NCT01707290|17697017|P2|Overall Study|Lost to Follow-up|0
5123304|NCT01707290|17697018|P1|Overall Study|Lost to Follow-up|3
5123305|NCT01707290|17697017|P2|Overall Study|Physician Decision|0
5123306|NCT01707290|17697018|P1|Overall Study|Physician Decision|1
5123307|NCT01707290|17697017|P2|Overall Study|Adverse event (AE)|0
5123308|NCT01707290|17697018|P1|Overall Study|Adverse event (AE)|1
5123309|NCT01707147|17697063|P1|Overall Study|Violated inclusion/exclusion criteria|77
5123310|NCT01707147|17697063|P1|Overall Study|Follow-up failure|17
5123311|NCT01707147|17697063|P1|Overall Study|Patients who have not taken Trajenta|1
5123312|NCT01707147|17697063|P1|Overall Study|Administered Trajenta prior to contract|5
5123313|NCT01707030|17697095|P2|Overall Study|Lost to Follow-up|13
5123314|NCT01707030|17697096|P1|Overall Study|Lost to Follow-up|8
5123315|NCT01707030|17697095|P2|Overall Study|Withdrawal by Subject|3
5123316|NCT01707030|17697096|P1|Overall Study|Withdrawal by Subject|2
5123317|NCT01707030|17697095|P2|Overall Study|Death|1
5123318|NCT01707030|17697096|P1|Overall Study|Death|1
5123319|NCT01707004|17697114|P1|Overall Study|Physician Decision|3
5123320|NCT01706926|17697168|P4|Overall Study|Other|3
5123321|NCT01706926|17697169|P3|Overall Study|Other|4
5123322|NCT01706926|17697170|P2|Overall Study|Other|4
5123323|NCT01706926|17697171|P1|Overall Study|Other|4
5123324|NCT01706926|17697168|P4|Overall Study|Withdrawal by Subject|2
5123325|NCT01706926|17697169|P3|Overall Study|Withdrawal by Subject|1
5123326|NCT01706926|17697170|P2|Overall Study|Withdrawal by Subject|0
5123327|NCT01706926|17697171|P1|Overall Study|Withdrawal by Subject|2
5123328|NCT01706926|17697168|P4|Overall Study|Lost to Follow-up|0
5123329|NCT01706926|17697169|P3|Overall Study|Lost to Follow-up|1
5123330|NCT01706926|17697170|P2|Overall Study|Lost to Follow-up|0
5123331|NCT01706926|17697171|P1|Overall Study|Lost to Follow-up|0
5123332|NCT01706770|17697290|P2|Overall Study|Physician Decision|0
5123333|NCT01706770|17697291|P1|Overall Study|Physician Decision|1
5123334|NCT01706770|17697290|P2|Overall Study|Lost to Follow-up|0
5123335|NCT01706770|17697291|P1|Overall Study|Lost to Follow-up|1
5123336|NCT01706575|17697339|P1|Overall Study|Started but not Treated|6
5123337|NCT01706575|17697339|P1|Overall Study|Lost to Follow-up|2
5123338|NCT01706575|17697339|P1|Overall Study|Participant Withdrew Consent|4
5123339|NCT01706536|17697360|P5|Overall Study|non compliance|0
5123340|NCT01706536|17697361|P4|Overall Study|non compliance|0
5123341|NCT01706536|17697362|P3|Overall Study|non compliance|0
5123342|NCT01706536|17697363|P2|Overall Study|non compliance|1
5123343|NCT01706536|17697364|P1|Overall Study|non compliance|0
5123344|NCT01706536|17697360|P5|Overall Study|Lack of Efficacy|0
5123345|NCT01706536|17697361|P4|Overall Study|Lack of Efficacy|1
5123346|NCT01706536|17697362|P3|Overall Study|Lack of Efficacy|0
5123347|NCT01706536|17697363|P2|Overall Study|Lack of Efficacy|0
5123348|NCT01706536|17697364|P1|Overall Study|Lack of Efficacy|1
5123349|NCT01706536|17697360|P5|Overall Study|Adverse Event|2
5123350|NCT01706536|17697361|P4|Overall Study|Adverse Event|3
5123351|NCT01706536|17697362|P3|Overall Study|Adverse Event|4
5123352|NCT01706536|17697363|P2|Overall Study|Adverse Event|3
5123353|NCT01706536|17697364|P1|Overall Study|Adverse Event|2
5123354|NCT01706536|17697360|P5|Overall Study|Withdrawal by Subject|0
5123355|NCT01706536|17697361|P4|Overall Study|Withdrawal by Subject|0
5123356|NCT01706536|17697362|P3|Overall Study|Withdrawal by Subject|1
5123357|NCT01706536|17697363|P2|Overall Study|Withdrawal by Subject|0
5123358|NCT01706536|17697364|P1|Overall Study|Withdrawal by Subject|1
5123359|NCT01706458|17697431|P2|Overall Study|Physician Decision|4
5123360|NCT01706458|17697432|P1|Overall Study|Physician Decision|3
5123361|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
5123362|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
5123363|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
5123364|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Physician Decision|2
5123365|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Physician Decision|2
5123366|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Physician Decision|0
5123367|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
5123368|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
5123369|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
5123370|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
5123371|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
5123372|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
5123373|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Protocol Violation|2
5123374|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Protocol Violation|4
5123375|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Protocol Violation|0
5123376|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
5123377|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
5123378|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
5123379|NCT01706328|17697456|P3|12-week Double-blind Treatment Period|Adverse Event|16
5123380|NCT01706328|17697457|P2|12-week Double-blind Treatment Period|Adverse Event|14
5123381|NCT01706328|17697458|P1|12-week Double-blind Treatment Period|Adverse Event|0
5123382|NCT01706328|17697456|P3|2-week Run-in Period|Lost to Follow-up|0
5123383|NCT01706328|17697457|P2|2-week Run-in Period|Lost to Follow-up|0
5123384|NCT01706328|17697458|P1|2-week Run-in Period|Lost to Follow-up|2
5123385|NCT01706328|17697456|P3|2-week Run-in Period|Adverse Event|0
5123386|NCT01706328|17697457|P2|2-week Run-in Period|Adverse Event|0
5123387|NCT01706328|17697458|P1|2-week Run-in Period|Adverse Event|4
5123388|NCT01706328|17697456|P3|2-week Run-in Period|Physician Decision|0
5123389|NCT01706328|17697457|P2|2-week Run-in Period|Physician Decision|0
5123390|NCT01706328|17697458|P1|2-week Run-in Period|Physician Decision|4
5123391|NCT01706328|17697456|P3|2-week Run-in Period|Withdrawal by Subject|0
5123392|NCT01706328|17697457|P2|2-week Run-in Period|Withdrawal by Subject|0
5123393|NCT01706328|17697458|P1|2-week Run-in Period|Withdrawal by Subject|15
5123394|NCT01706328|17697456|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5123395|NCT01706328|17697457|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5123396|NCT01706328|17697458|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
5123397|NCT01706250|17697477|P1|Overall Study|Lost to Follow-up|2
5123398|NCT01706198|17697508|P2|Overall Study|Withdrawal by Subject|31
5123399|NCT01706198|17697509|P1|Overall Study|Withdrawal by Subject|23
5123400|NCT01706198|17697508|P2|Overall Study|Physician Decision|37
5123401|NCT01706198|17697509|P1|Overall Study|Physician Decision|23
5123402|NCT01706198|17697508|P2|Overall Study|Lost to Follow-up|93
5123403|NCT01706198|17697509|P1|Overall Study|Lost to Follow-up|97
5123404|NCT01706198|17697508|P2|Overall Study|Other: Subject reached stopping criteria|13
5123405|NCT01706198|17697509|P1|Overall Study|Other: Subject reached stopping criteria|11
5123406|NCT01706198|17697508|P2|Overall Study|Protocol Violation|5
5123407|NCT01706198|17697509|P1|Overall Study|Protocol Violation|7
5123408|NCT01706198|17697508|P2|Overall Study|Adverse Event|15
5123409|NCT01706198|17697509|P1|Overall Study|Adverse Event|12
5123410|NCT01706159|17697561|P2|Overall Study|Unclassified|1
5123411|NCT01706159|17697562|P1|Overall Study|Unclassified|6
5123412|NCT01706159|17697561|P2|Overall Study|Withdrawal Criteria|1
5123413|NCT01706159|17697562|P1|Overall Study|Withdrawal Criteria|2
5123414|NCT01706146|17697576|P1|Overall Study|Developed AF and need for antiplatelets|2
5123415|NCT01706146|17697576|P1|Overall Study|Adverse Event|3
5123416|NCT01706146|17697576|P1|Overall Study|Withdrawal by Subject|1
5123417|NCT01706003|17697596|P2|Overall Study|Lost to Follow-up|4
5123418|NCT01706003|17697597|P1|Overall Study|Lost to Follow-up|6
5123419|NCT01706003|17697596|P2|Overall Study|Not scheduled|0
5123420|NCT01706003|17697597|P1|Overall Study|Not scheduled|3
5123421|NCT01706003|17697596|P2|Overall Study|Withdrawal by Subject|0
5123422|NCT01706003|17697597|P1|Overall Study|Withdrawal by Subject|2
5123423|NCT01705977|17697605|P2|Overall Study|Missing study conclusion form|2
5123424|NCT01705977|17697606|P1|Overall Study|Missing study conclusion form|2
5123425|NCT01705977|17697605|P2|Overall Study|Physician Decision|38
5123426|NCT01705977|17697606|P1|Overall Study|Physician Decision|48
5123427|NCT01705977|17697605|P2|Overall Study|Lost to Follow-up|37
5123428|NCT01705977|17697606|P1|Overall Study|Lost to Follow-up|33
5123429|NCT01705977|17697605|P2|Overall Study|Site closure|2
5123430|NCT01705977|17697606|P1|Overall Study|Site closure|3
5123431|NCT01705977|17697605|P2|Overall Study|Protocol Violation|4
5123432|NCT01705977|17697606|P1|Overall Study|Protocol Violation|2
5123433|NCT01705977|17697605|P2|Overall Study|Adverse Event|49
5123434|NCT01705977|17697606|P1|Overall Study|Adverse Event|57
5123435|NCT01705977|17697605|P2|Overall Study|Withdrawal by Subject|128
5123436|NCT01705977|17697606|P1|Overall Study|Withdrawal by Subject|128
5123437|NCT01705730|17697624|P1|Overall Study|Reason not Specified|4
5123438|NCT01705730|17697624|P1|Overall Study|Lost to Follow-up|1
5123439|NCT01705730|17697624|P1|Overall Study|Adverse Event|3
5123440|NCT01705730|17697624|P1|Overall Study|Lack of Efficacy|1
5123441|NCT01705717|17697664|P2|Overall Study|Other|2
5123442|NCT01705717|17697665|P1|Overall Study|Other|0
5123443|NCT01705717|17697664|P2|Overall Study|Lack of Efficacy|1
5123444|NCT01705717|17697665|P1|Overall Study|Lack of Efficacy|0
5123445|NCT01705717|17697664|P2|Overall Study|Adverse Event|2
5123446|NCT01705717|17697665|P1|Overall Study|Adverse Event|2
5123447|NCT01705691|17697682|P2|Overall Study|Other|1
5123448|NCT01705691|17697683|P1|Overall Study|Other|0
5123449|NCT01705691|17697682|P2|Overall Study|Lost to Follow-up|1
5123450|NCT01705691|17697683|P1|Overall Study|Lost to Follow-up|1
5123451|NCT01705691|17697682|P2|Overall Study|Withdrawal by Subject|2
5123452|NCT01705691|17697683|P1|Overall Study|Withdrawal by Subject|1
5123453|NCT01705691|17697682|P2|Overall Study|Death|2
5123454|NCT01705691|17697683|P1|Overall Study|Death|1
5123455|NCT01705652|17697703|P2|Overall Study|non-compliance|1
5123456|NCT01705652|17697704|P1|Overall Study|non-compliance|1
5123457|NCT01705652|17697703|P2|Overall Study|Withdrawal by Subject|2
5123458|NCT01705652|17697704|P1|Overall Study|Withdrawal by Subject|1
5123459|NCT01705652|17697703|P2|Overall Study|Adverse Event|0
5123460|NCT01705652|17697704|P1|Overall Study|Adverse Event|1
5123461|NCT01705587|17697712|P2|Overall Study|Withdrawal by Subject|1
5123462|NCT01705587|17697713|P1|Overall Study|Withdrawal by Subject|0
5123463|NCT01705574|17697731|P4|Open-Label Extension Phase|Pregnancy|1
5123464|NCT01705574|17697732|P3|Open-Label Extension Phase|Pregnancy|1
5123465|NCT01705574|17697733|P2|Open-Label Extension Phase|Pregnancy|0
5123466|NCT01705574|17697734|P1|Open-Label Extension Phase|Pregnancy|0
5123467|NCT01705574|17697731|P4|Open-Label Extension Phase|Physician Decision|0
5123468|NCT01705574|17697732|P3|Open-Label Extension Phase|Physician Decision|2
5123469|NCT01705574|17697733|P2|Open-Label Extension Phase|Physician Decision|0
5123470|NCT01705574|17697734|P1|Open-Label Extension Phase|Physician Decision|0
5123471|NCT01705574|17697731|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5123472|NCT01705574|17697732|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
5123473|NCT01705574|17697733|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5123474|NCT01705574|17697734|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5123475|NCT01705574|17697731|P4|Open-Label Extension Phase|Death|0
5123476|NCT01705574|17697732|P3|Open-Label Extension Phase|Death|1
5123477|NCT01705574|17697733|P2|Open-Label Extension Phase|Death|0
5123478|NCT01705574|17697734|P1|Open-Label Extension Phase|Death|2
5123479|NCT01705574|17697731|P4|Open-Label Extension Phase|Adverse Event|1
5123480|NCT01705574|17697732|P3|Open-Label Extension Phase|Adverse Event|0
5123481|NCT01705574|17697733|P2|Open-Label Extension Phase|Adverse Event|0
5123482|NCT01705574|17697734|P1|Open-Label Extension Phase|Adverse Event|3
5123483|NCT01705574|17697731|P4|Open-Label Extension Phase|Withdrew Consent|1
5123484|NCT01705574|17697732|P3|Open-Label Extension Phase|Withdrew Consent|4
5123485|NCT01705574|17697733|P2|Open-Label Extension Phase|Withdrew Consent|0
5123486|NCT01705574|17697734|P1|Open-Label Extension Phase|Withdrew Consent|4
5123487|NCT01705574|17697731|P4|Open-Label Extension Phase|Lost to Follow-up|2
5123488|NCT01705574|17697732|P3|Open-Label Extension Phase|Lost to Follow-up|2
5123489|NCT01705574|17697733|P2|Open-Label Extension Phase|Lost to Follow-up|0
5123490|NCT01705574|17697734|P1|Open-Label Extension Phase|Lost to Follow-up|6
5123491|NCT01705574|17697731|P4|Double-Blind Phase|Randomized but Not Treated|0
5123492|NCT01705574|17697732|P3|Double-Blind Phase|Randomized but Not Treated|0
5123493|NCT01705574|17697733|P2|Double-Blind Phase|Randomized but Not Treated|4
5123494|NCT01705574|17697734|P1|Double-Blind Phase|Randomized but Not Treated|4
5123495|NCT01705574|17697731|P4|Double-Blind Phase|Protocol Violation|0
5123496|NCT01705574|17697732|P3|Double-Blind Phase|Protocol Violation|0
5123497|NCT01705574|17697733|P2|Double-Blind Phase|Protocol Violation|0
5123498|NCT01705574|17697734|P1|Double-Blind Phase|Protocol Violation|1
5123499|NCT01705574|17697731|P4|Double-Blind Phase|Pregnancy|0
5123500|NCT01705574|17697732|P3|Double-Blind Phase|Pregnancy|0
5123501|NCT01705574|17697733|P2|Double-Blind Phase|Pregnancy|1
5123502|NCT01705574|17697734|P1|Double-Blind Phase|Pregnancy|1
5123503|NCT01705574|17697731|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
5123504|NCT01705574|17697732|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
5123505|NCT01705574|17697733|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
5123506|NCT01705574|17697734|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
5123507|NCT01705574|17697731|P4|Double-Blind Phase|Withdrew Consent|0
5123508|NCT01705574|17697732|P3|Double-Blind Phase|Withdrew Consent|0
5123509|NCT01705574|17697733|P2|Double-Blind Phase|Withdrew Consent|5
5123510|NCT01705574|17697734|P1|Double-Blind Phase|Withdrew Consent|8
5123511|NCT01705574|17697731|P4|Double-Blind Phase|Adverse Event|0
5123512|NCT01705574|17697732|P3|Double-Blind Phase|Adverse Event|0
5123513|NCT01705574|17697733|P2|Double-Blind Phase|Adverse Event|10
5123514|NCT01705574|17697734|P1|Double-Blind Phase|Adverse Event|3
5123515|NCT01705574|17697731|P4|Double-Blind Phase|Lost to Follow-up|0
5123516|NCT01705574|17697732|P3|Double-Blind Phase|Lost to Follow-up|0
5123517|NCT01705574|17697733|P2|Double-Blind Phase|Lost to Follow-up|16
5123518|NCT01705574|17697734|P1|Double-Blind Phase|Lost to Follow-up|12
5123519|NCT01705509|17697751|P1|CPET w/ Ranexa|Screen Failure|2
5123520|NCT01705509|17697751|P1|Inclusion CPET|Withdrawal by Subject|2
5123521|NCT01705509|17697751|P1|Inclusion CPET|Screen Failure|5
5123522|NCT01705236|17697778|P1|Overall Study|Adverse Event|5
5123523|NCT01705236|17697778|P1|Overall Study|Withdrawal by Subject|5
5123524|NCT01705236|17697778|P1|Overall Study|Abnormal laboratory value(s)|4
5123525|NCT01705236|17697778|P1|Overall Study|Abnormal test procedure result(s)|4
5123526|NCT01705236|17697778|P1|Overall Study|Protocol Violation|3
5123527|NCT01705236|17697778|P1|Overall Study|Unsatisfactory therapeutic effect|3
5123528|NCT01705236|17697778|P1|Overall Study|Administrative problems|2
5123529|NCT01705236|17697778|P1|Overall Study|Lost to Follow-up|1
5123530|NCT01705145|17697787|P1|Part B|Adverse Event|1
5123531|NCT01705080|17697827|P4|Overall Study|Missed 6 Month Visit|0
5123532|NCT01705080|17697828|P3|Overall Study|Missed 6 Month Visit|1
5123533|NCT01705080|17697829|P2|Overall Study|Missed 6 Month Visit|1
5123534|NCT01705080|17697830|P1|Overall Study|Missed 6 Month Visit|3
5123535|NCT01705080|17697827|P4|Overall Study|Protocol Violation|0
5123536|NCT01705080|17697828|P3|Overall Study|Protocol Violation|0
5123537|NCT01705080|17697829|P2|Overall Study|Protocol Violation|0
5123538|NCT01705080|17697830|P1|Overall Study|Protocol Violation|2
5123539|NCT01705080|17697827|P4|Overall Study|Lost to Follow-up|2
5123540|NCT01705080|17697828|P3|Overall Study|Lost to Follow-up|0
5123541|NCT01705080|17697829|P2|Overall Study|Lost to Follow-up|0
5123542|NCT01705080|17697830|P1|Overall Study|Lost to Follow-up|0
5123543|NCT01705080|17697827|P4|Overall Study|Physician Decision|8
5123544|NCT01705080|17697828|P3|Overall Study|Physician Decision|1
5123545|NCT01705080|17697829|P2|Overall Study|Physician Decision|2
5123546|NCT01705080|17697830|P1|Overall Study|Physician Decision|1
5123547|NCT01705080|17697827|P4|Overall Study|Withdrawal by Subject|12
5123548|NCT01705080|17697828|P3|Overall Study|Withdrawal by Subject|0
5123549|NCT01705080|17697829|P2|Overall Study|Withdrawal by Subject|1
5123550|NCT01705080|17697830|P1|Overall Study|Withdrawal by Subject|1
5123551|NCT01705080|17697827|P4|Overall Study|Death|0
5123552|NCT01705080|17697828|P3|Overall Study|Death|0
5123553|NCT01705080|17697829|P2|Overall Study|Death|1
5123554|NCT01705080|17697830|P1|Overall Study|Death|0
5123555|NCT01705080|17697827|P4|Overall Study|Failed Procedure|0
5123556|NCT01705080|17697828|P3|Overall Study|Failed Procedure|0
5123557|NCT01705080|17697829|P2|Overall Study|Failed Procedure|2
5123558|NCT01705080|17697830|P1|Overall Study|Failed Procedure|0
5123559|NCT01705080|17697827|P4|Overall Study|Screen Failure Post Consent|20
5123560|NCT01705080|17697828|P3|Overall Study|Screen Failure Post Consent|3
5123561|NCT01705080|17697829|P2|Overall Study|Screen Failure Post Consent|9
5123562|NCT01705080|17697830|P1|Overall Study|Screen Failure Post Consent|8
5123563|NCT01704846|17697959|P2|Treatment Period 2|Withdrawal by Subject|1
5123564|NCT01704846|17697960|P1|Treatment Period 2|Withdrawal by Subject|0
5123565|NCT01704755|17698015|P2|Overall Study|Withdrew consent and personal issues|0
5123566|NCT01704755|17698016|P1|Overall Study|Withdrew consent and personal issues|1
5123567|NCT01704755|17698015|P2|Overall Study|Other (not specified)|1
5123568|NCT01704755|17698016|P1|Overall Study|Other (not specified)|3
5123569|NCT01704755|17698015|P2|Overall Study|Withdrew consent|1
5123570|NCT01704755|17698016|P1|Overall Study|Withdrew consent|1
5123571|NCT01704755|17698015|P2|Overall Study|Lost to Follow-up|4
5123572|NCT01704755|17698016|P1|Overall Study|Lost to Follow-up|3
5123573|NCT01704755|17698015|P2|Overall Study|Adverse Event|1
5123574|NCT01704755|17698016|P1|Overall Study|Adverse Event|4
5123575|NCT01704651|17698030|P2|Overall Study|Post-op did not have laparotomy|1
5123576|NCT01704651|17698031|P1|Overall Study|Post-op did not have laparotomy|2
5123577|NCT01704651|17698030|P2|Overall Study|Nasogastric tube placement in surgery|1
5123578|NCT01704651|17698031|P1|Overall Study|Nasogastric tube placement in surgery|1
5123579|NCT01704651|17698030|P2|Overall Study|Pre-op change in treatment plan|4
5123580|NCT01704651|17698031|P1|Overall Study|Pre-op change in treatment plan|1
5123581|NCT01704651|17698030|P2|Overall Study|Pre-op withdrawal by subject|1
5123582|NCT01704651|17698031|P1|Overall Study|Pre-op withdrawal by subject|1
5123583|NCT01704599|17698039|P1|Overall Study|Adverse Event|1
5123584|NCT01704495|17698079|P4|Optional Safety Extension|Withdrawal by Subject|2
5123585|NCT01704495|17698080|P3|Optional Safety Extension|Withdrawal by Subject|1
5123586|NCT01704495|17698081|P2|Optional Safety Extension|Withdrawal by Subject|0
5123587|NCT01704495|17698082|P1|Optional Safety Extension|Withdrawal by Subject|2
5123588|NCT01704495|17698079|P4|Optional Safety Extension|Other reason|28
5123589|NCT01704495|17698080|P3|Optional Safety Extension|Other reason|30
5123590|NCT01704495|17698081|P2|Optional Safety Extension|Other reason|29
5123591|NCT01704495|17698082|P1|Optional Safety Extension|Other reason|27
5123592|NCT01704495|17698079|P4|Optional Safety Extension|Adverse Event|1
5123593|NCT01704495|17698080|P3|Optional Safety Extension|Adverse Event|0
5123594|NCT01704495|17698081|P2|Optional Safety Extension|Adverse Event|4
5123595|NCT01704495|17698082|P1|Optional Safety Extension|Adverse Event|0
5123596|NCT01704495|17698079|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
5123597|NCT01704495|17698080|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
5123598|NCT01704495|17698081|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
5123599|NCT01704495|17698082|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
5123600|NCT01704495|17698079|P4|Subjects Randomized|Protocol Violation|0
5123601|NCT01704495|17698080|P3|Subjects Randomized|Protocol Violation|2
5123602|NCT01704495|17698081|P2|Subjects Randomized|Protocol Violation|1
5123603|NCT01704495|17698082|P1|Subjects Randomized|Protocol Violation|1
5123604|NCT01704495|17698079|P4|Subjects Randomized|Withdrawal by Subject|5
5123605|NCT01704495|17698080|P3|Subjects Randomized|Withdrawal by Subject|5
5123606|NCT01704495|17698081|P2|Subjects Randomized|Withdrawal by Subject|5
5123607|NCT01704495|17698082|P1|Subjects Randomized|Withdrawal by Subject|5
5123608|NCT01704495|17698079|P4|Subjects Randomized|Adverse Event|7
5123609|NCT01704495|17698080|P3|Subjects Randomized|Adverse Event|0
5123610|NCT01704495|17698081|P2|Subjects Randomized|Adverse Event|2
5123611|NCT01704495|17698082|P1|Subjects Randomized|Adverse Event|8
5123612|NCT01704495|17698079|P4|Subjects Randomized|Discontinuation criteria met|0
5123613|NCT01704495|17698080|P3|Subjects Randomized|Discontinuation criteria met|2
5123614|NCT01704495|17698081|P2|Subjects Randomized|Discontinuation criteria met|2
5123615|NCT01704495|17698082|P1|Subjects Randomized|Discontinuation criteria met|4
5123616|NCT01704495|17698079|P4|Subjects Randomized|Other Reason|2
5123617|NCT01704495|17698080|P3|Subjects Randomized|Other Reason|3
5123618|NCT01704495|17698081|P2|Subjects Randomized|Other Reason|2
5123619|NCT01704495|17698082|P1|Subjects Randomized|Other Reason|3
5123620|NCT01704456|17698258|P2|Overall Study|Lost to Follow-up|14
5123621|NCT01704456|17698259|P1|Overall Study|Lost to Follow-up|8
5123622|NCT01704287|17698321|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5123623|NCT01704287|17698322|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
5123624|NCT01704287|17698323|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5123625|NCT01704287|17698324|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5123626|NCT01704287|17698325|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5123627|NCT01704287|17698321|P5|Switch to Pembrolizumab Treatment Period|Death|37
5123628|NCT01704287|17698322|P4|Switch to Pembrolizumab Treatment Period|Death|35
5123629|NCT01704287|17698323|P3|Switch to Pembrolizumab Treatment Period|Death|0
5123630|NCT01704287|17698324|P2|Switch to Pembrolizumab Treatment Period|Death|0
5123631|NCT01704287|17698325|P1|Switch to Pembrolizumab Treatment Period|Death|0
5123632|NCT01704287|17698321|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
5123633|NCT01704287|17698322|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
5123634|NCT01704287|17698323|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5123635|NCT01704287|17698324|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5123636|NCT01704287|17698325|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5123637|NCT01704287|17698321|P5|Initial Treatment Period|Switched to Pembrolizumab|0
5123638|NCT01704287|17698322|P4|Initial Treatment Period|Switched to Pembrolizumab|0
5123639|NCT01704287|17698323|P3|Initial Treatment Period|Switched to Pembrolizumab|98
5123640|NCT01704287|17698324|P2|Initial Treatment Period|Switched to Pembrolizumab|0
5123641|NCT01704287|17698325|P1|Initial Treatment Period|Switched to Pembrolizumab|0
5123642|NCT01704287|17698321|P5|Initial Treatment Period|Lost to Follow-up|0
5123643|NCT01704287|17698322|P4|Initial Treatment Period|Lost to Follow-up|0
5123644|NCT01704287|17698323|P3|Initial Treatment Period|Lost to Follow-up|0
5123645|NCT01704287|17698324|P2|Initial Treatment Period|Lost to Follow-up|3
5123646|NCT01704287|17698325|P1|Initial Treatment Period|Lost to Follow-up|5
5123647|NCT01704287|17698321|P5|Initial Treatment Period|Withdrawal by Subject|0
5123648|NCT01704287|17698322|P4|Initial Treatment Period|Withdrawal by Subject|0
5123649|NCT01704287|17698323|P3|Initial Treatment Period|Withdrawal by Subject|4
5123650|NCT01704287|17698324|P2|Initial Treatment Period|Withdrawal by Subject|2
5123651|NCT01704287|17698325|P1|Initial Treatment Period|Withdrawal by Subject|3
5123652|NCT01704287|17698321|P5|Initial Treatment Period|Death|0
5123653|NCT01704287|17698322|P4|Initial Treatment Period|Death|0
5123654|NCT01704287|17698323|P3|Initial Treatment Period|Death|71
5123655|NCT01704287|17698324|P2|Initial Treatment Period|Death|129
5123656|NCT01704287|17698325|P1|Initial Treatment Period|Death|139
5123657|NCT01704261|17698373|P2|Overall Study|Lost to Follow-up|0
5123658|NCT01704261|17698374|P1|Overall Study|Lost to Follow-up|1
5123659|NCT01704261|17698373|P2|Overall Study|Withdrawal by Subject|15
5123660|NCT01704261|17698374|P1|Overall Study|Withdrawal by Subject|12
5123661|NCT01704079|17698401|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
5123662|NCT01704079|17698402|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
5123663|NCT01704079|17698401|P2|Overall Study|Subject noncompliance|3
5123664|NCT01704079|17698402|P1|Overall Study|Subject noncompliance|2
5123665|NCT01704079|17698401|P2|Overall Study|Protocol Violation|0
5123666|NCT01704079|17698402|P1|Overall Study|Protocol Violation|1
5123667|NCT01704079|17698401|P2|Overall Study|Adverse Event|7
5123668|NCT01704079|17698402|P1|Overall Study|Adverse Event|4
5123669|NCT01704079|17698401|P2|Overall Study|Lost to Follow-up|5
5123670|NCT01704079|17698402|P1|Overall Study|Lost to Follow-up|2
5123671|NCT01704079|17698401|P2|Overall Study|Withdrawal by Subject|7
5123672|NCT01704079|17698402|P1|Overall Study|Withdrawal by Subject|5
5123673|NCT01703988|17698418|P4|Overall Study|Investigator Judgment|1
5123674|NCT01703988|17698419|P3|Overall Study|Investigator Judgment|0
5123675|NCT01703988|17698420|P2|Overall Study|Investigator Judgment|0
5123676|NCT01703988|17698421|P1|Overall Study|Investigator Judgment|0
5123677|NCT01703858|17698451|P3|Overall Study|Withdrawal by Subject|0
5123678|NCT01703858|17698452|P2|Overall Study|Withdrawal by Subject|1
5123679|NCT01703858|17698453|P1|Overall Study|Withdrawal by Subject|0
5123680|NCT01703845|17698478|P2|Overall Study|other than stated above|0
5123681|NCT01703845|17698479|P1|Overall Study|other than stated above|1
5123682|NCT01703845|17698478|P2|Overall Study|Protocol Violation|0
5123683|NCT01703845|17698479|P1|Overall Study|Protocol Violation|1
5123684|NCT01703845|17698478|P2|Overall Study|Adverse Event|0
5123685|NCT01703845|17698479|P1|Overall Study|Adverse Event|1
5123686|NCT01703832|17698516|P2|Overall Study|Withdrawal by Subject|0
5123687|NCT01703832|17698517|P1|Overall Study|Withdrawal by Subject|1
5123688|NCT01703819|17698549|P2|Overall Study|Withdrawal by Subject|1
5123689|NCT01703819|17698550|P1|Overall Study|Withdrawal by Subject|0
5123690|NCT01703819|17698549|P2|Overall Study|Adverse Event|1
5123691|NCT01703819|17698550|P1|Overall Study|Adverse Event|0
5123692|NCT01703741|17698580|P1|Overall Study|Subject started testosterone injections|1
5123693|NCT01703741|17698580|P1|Overall Study|Subject cannot comply with study visits|1
5123694|NCT01703741|17698580|P1|Overall Study|Subject did not want to continue|2
5123695|NCT01703741|17698580|P1|Overall Study|Lost to Follow-up|3
5123696|NCT01703741|17698580|P1|Overall Study|Protocol Violation|1
5123697|NCT01703741|17698580|P1|Overall Study|Physician Decision|2
5123698|NCT01703741|17698580|P1|Overall Study|Adverse Event|2
5123699|NCT01703741|17698580|P1|Overall Study|Withdrawal by Subject|6
5123700|NCT01703286|17698646|P6|Period 2 Including Washout|Adverse Event|0
5123701|NCT01703286|17698647|P5|Period 2 Including Washout|Adverse Event|0
5123702|NCT01703286|17698648|P4|Period 2 Including Washout|Adverse Event|1
5123703|NCT01703286|17698649|P3|Period 2 Including Washout|Adverse Event|0
5123704|NCT01703286|17698650|P2|Period 2 Including Washout|Adverse Event|0
5123705|NCT01703286|17698651|P1|Period 2 Including Washout|Adverse Event|0
5123706|NCT01703286|17698646|P6|Period 1 Including Washout|Withdrawal by Subject|1
5123707|NCT01703286|17698647|P5|Period 1 Including Washout|Withdrawal by Subject|0
5123708|NCT01703286|17698648|P4|Period 1 Including Washout|Withdrawal by Subject|1
5123709|NCT01703286|17698649|P3|Period 1 Including Washout|Withdrawal by Subject|0
5123710|NCT01703286|17698650|P2|Period 1 Including Washout|Withdrawal by Subject|0
5123711|NCT01703286|17698651|P1|Period 1 Including Washout|Withdrawal by Subject|0
5123712|NCT01703260|17698674|P3|Overall Study|Study Termination|0
5123713|NCT01703260|17698675|P2|Overall Study|Study Termination|2
5123714|NCT01703260|17698676|P1|Overall Study|Study Termination|1
5123715|NCT01703260|17698674|P3|Overall Study|Withdrawal by Subject|1
5123716|NCT01703260|17698675|P2|Overall Study|Withdrawal by Subject|0
5123717|NCT01703260|17698676|P1|Overall Study|Withdrawal by Subject|0
5123718|NCT01703260|17698674|P3|Overall Study|Lost to Follow-up|0
5123719|NCT01703260|17698675|P2|Overall Study|Lost to Follow-up|0
5123720|NCT01703260|17698676|P1|Overall Study|Lost to Follow-up|1
5123721|NCT01703260|17698674|P3|Overall Study|Adverse Event|2
5123722|NCT01703260|17698675|P2|Overall Study|Adverse Event|2
5123723|NCT01703260|17698676|P1|Overall Study|Adverse Event|1
5123724|NCT01703221|17698702|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
5123725|NCT01703221|17698703|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
5123726|NCT01703221|17698704|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
5123727|NCT01703221|17698702|P3|Phase B - (Week 25 to 52)|Adverse Event|2
5123728|NCT01703221|17698703|P2|Phase B - (Week 25 to 52)|Adverse Event|3
5123729|NCT01703221|17698704|P1|Phase B - (Week 25 to 52)|Adverse Event|2
5123730|NCT01703221|17698702|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
5123731|NCT01703221|17698703|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
5123732|NCT01703221|17698704|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
5123733|NCT01703221|17698702|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
5123734|NCT01703221|17698703|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
5123735|NCT01703221|17698704|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
5123736|NCT01703221|17698702|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5123737|NCT01703221|17698703|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5123738|NCT01703221|17698704|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
5123739|NCT01703221|17698702|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
5123740|NCT01703221|17698703|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
5123741|NCT01703221|17698704|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
5123742|NCT01703221|17698702|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
5123743|NCT01703221|17698703|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
5123744|NCT01703221|17698704|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
5123745|NCT01703221|17698702|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
5123746|NCT01703221|17698703|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
5123747|NCT01703221|17698704|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
5123748|NCT01703208|17698735|P2|Overall Study|Protocol Deviation|0
5123749|NCT01703208|17698736|P1|Overall Study|Protocol Deviation|2
5123750|NCT01703208|17698735|P2|Overall Study|Technical Problems|1
5123751|NCT01703208|17698736|P1|Overall Study|Technical Problems|0
5123752|NCT01703208|17698735|P2|Overall Study|Adverse Event|19
5123753|NCT01703208|17698736|P1|Overall Study|Adverse Event|14
5123754|NCT01703208|17698735|P2|Overall Study|Withdrawal by Subject|209
5123755|NCT01703208|17698736|P1|Overall Study|Withdrawal by Subject|205
5123756|NCT01703208|17698735|P2|Overall Study|Study Terminated by Sponsor|1716
5123757|NCT01703208|17698736|P1|Overall Study|Study Terminated by Sponsor|1710
5123758|NCT01703208|17698735|P2|Overall Study|Protocol Violation|1
5123759|NCT01703208|17698736|P1|Overall Study|Protocol Violation|1
5123760|NCT01703208|17698735|P2|Overall Study|Progressive disease|2
5123761|NCT01703208|17698736|P1|Overall Study|Progressive disease|2
5123762|NCT01703208|17698735|P2|Overall Study|Physician Decision|13
5123763|NCT01703208|17698736|P1|Overall Study|Physician Decision|11
5123764|NCT01703208|17698735|P2|Overall Study|Site Discontinued Study Participation|27
5123765|NCT01703208|17698736|P1|Overall Study|Site Discontinued Study Participation|23
5123766|NCT01703208|17698735|P2|Overall Study|Excluded Medication|2
5123767|NCT01703208|17698736|P1|Overall Study|Excluded Medication|1
5123768|NCT01703208|17698735|P2|Overall Study|Non-Compliance with Study Drug|0
5123769|NCT01703208|17698736|P1|Overall Study|Non-Compliance with Study Drug|1
5123770|NCT01703208|17698735|P2|Overall Study|Lost to Follow-up|62
5123771|NCT01703208|17698736|P1|Overall Study|Lost to Follow-up|68
5123772|NCT01703208|17698735|P2|Overall Study|Lack of Efficacy|2
5123773|NCT01703208|17698736|P1|Overall Study|Lack of Efficacy|1
5123774|NCT01703208|17698735|P2|Overall Study|Death|48
5123775|NCT01703208|17698736|P1|Overall Study|Death|61
5123776|NCT01703091|17698800|P2|Overall Study|Sponsor Decision|0
5123777|NCT01703091|17698801|P1|Overall Study|Sponsor Decision|1
5123778|NCT01703091|17698800|P2|Overall Study|Withdrawal by Subject|0
5123779|NCT01703091|17698801|P1|Overall Study|Withdrawal by Subject|1
5123780|NCT01703091|17698800|P2|Overall Study|Physician Decision|1
5123781|NCT01703091|17698801|P1|Overall Study|Physician Decision|2
5123782|NCT01703091|17698800|P2|Overall Study|Adverse Event|3
5123783|NCT01703091|17698801|P1|Overall Study|Adverse Event|5
5123784|NCT01703065|17698819|P2|Overall Study|Lack of Efficacy|0
5123785|NCT01703065|17698820|P1|Overall Study|Lack of Efficacy|1
5123786|NCT01703000|17698850|P1|Overall Study|Death|1
5123787|NCT01702987|17698883|P2|Overall Study|Withdrawal by Subject|0
5123788|NCT01702987|17698884|P1|Overall Study|Withdrawal by Subject|1
5123789|NCT01702961|17698890|P1|Overall Study|Ongoing|11
5123790|NCT01702961|17698890|P1|Overall Study|Lost to Follow-up|2
5123791|NCT01702961|17698890|P1|Overall Study|Death|6
5123792|NCT01702961|17698890|P1|Overall Study|Relapse|20
5123793|NCT01702961|17698890|P1|Overall Study|Progressive disease|5
5123794|NCT01702961|17698890|P1|Overall Study|Additional treatment|3
5123795|NCT01702844|17698908|P1|Overall Study|Physician Decision|6
5123796|NCT01702844|17698908|P1|Overall Study|Withdrawal by Subject|3
5123797|NCT01702844|17698908|P1|Overall Study|Death|1
5123798|NCT01702844|17698908|P1|Overall Study|Adverse Event|9
5123799|NCT01702558|17698920|P5|Overall Study|Other|17
5123800|NCT01702558|17698921|P4|Overall Study|Other|16
5123801|NCT01702558|17698922|P3|Overall Study|Other|0
5123802|NCT01702558|17698923|P2|Overall Study|Other|0
5123803|NCT01702558|17698924|P1|Overall Study|Other|0
5123804|NCT01702558|17698920|P5|Overall Study|Study Terminated by Sponsor|1
5123805|NCT01702558|17698921|P4|Overall Study|Study Terminated by Sponsor|0
5123806|NCT01702558|17698922|P3|Overall Study|Study Terminated by Sponsor|0
5123807|NCT01702558|17698923|P2|Overall Study|Study Terminated by Sponsor|1
5123808|NCT01702558|17698924|P1|Overall Study|Study Terminated by Sponsor|0
5123809|NCT01702558|17698920|P5|Overall Study|Safety Follow-Up less than 3 Months|0
5123810|NCT01702558|17698921|P4|Overall Study|Safety Follow-Up less than 3 Months|0
5123811|NCT01702558|17698922|P3|Overall Study|Safety Follow-Up less than 3 Months|2
5123812|NCT01702558|17698923|P2|Overall Study|Safety Follow-Up less than 3 Months|0
5123813|NCT01702558|17698924|P1|Overall Study|Safety Follow-Up less than 3 Months|0
5123814|NCT01702558|17698920|P5|Overall Study|Death|20
5123815|NCT01702558|17698921|P4|Overall Study|Death|16
5123816|NCT01702558|17698922|P3|Overall Study|Death|3
5123817|NCT01702558|17698923|P2|Overall Study|Death|3
5123818|NCT01702558|17698924|P1|Overall Study|Death|4
5123819|NCT01702558|17698920|P5|Overall Study|Lost to Follow-up|0
5123820|NCT01702558|17698921|P4|Overall Study|Lost to Follow-up|3
5123821|NCT01702558|17698922|P3|Overall Study|Lost to Follow-up|0
5123822|NCT01702558|17698923|P2|Overall Study|Lost to Follow-up|0
5123823|NCT01702558|17698924|P1|Overall Study|Lost to Follow-up|0
5123824|NCT01702558|17698920|P5|Overall Study|Withdrawal by Subject|4
5123825|NCT01702558|17698921|P4|Overall Study|Withdrawal by Subject|12
5123826|NCT01702558|17698922|P3|Overall Study|Withdrawal by Subject|0
5123827|NCT01702558|17698923|P2|Overall Study|Withdrawal by Subject|0
5123828|NCT01702558|17698924|P1|Overall Study|Withdrawal by Subject|0
5123829|NCT01702532|17698989|P2|Overall Study|Adverse Event|1
5123830|NCT01702532|17698990|P1|Overall Study|Adverse Event|0
5123831|NCT01702519|17699000|P2|Washout Period|Withdrawal by Subject|2
5123832|NCT01702519|17699001|P1|Washout Period|Withdrawal by Subject|0
5123833|NCT01702519|17699000|P2|Washout Period|Lost to Follow-up|0
5123834|NCT01702519|17699001|P1|Washout Period|Lost to Follow-up|1
5123835|NCT01702454|17699019|P2|Overall Study|Lost to Follow-up|6
5123836|NCT01702454|17699020|P1|Overall Study|Lost to Follow-up|3
5123837|NCT01702454|17699019|P2|Overall Study|Migrated/moved from study area|1
5123838|NCT01702454|17699020|P1|Overall Study|Migrated/moved from study area|0
5123839|NCT01702454|17699019|P2|Overall Study|Consent withdrawal|1
5123840|NCT01702454|17699020|P1|Overall Study|Consent withdrawal|0
5123841|NCT01702428|17699102|P4|Overall Study|Withdrawal by Subject|10
5123842|NCT01702428|17699103|P3|Overall Study|Withdrawal by Subject|14
5123843|NCT01702428|17699104|P2|Overall Study|Withdrawal by Subject|23
5123844|NCT01702428|17699105|P1|Overall Study|Withdrawal by Subject|21
5123845|NCT01702428|17699102|P4|Overall Study|Protocol Violation|0
5123846|NCT01702428|17699103|P3|Overall Study|Protocol Violation|1
5123847|NCT01702428|17699104|P2|Overall Study|Protocol Violation|0
5123848|NCT01702428|17699105|P1|Overall Study|Protocol Violation|3
5123849|NCT01702428|17699102|P4|Overall Study|Parents too busy|0
5123850|NCT01702428|17699103|P3|Overall Study|Parents too busy|0
5123851|NCT01702428|17699104|P2|Overall Study|Parents too busy|0
5123852|NCT01702428|17699105|P1|Overall Study|Parents too busy|1
5123853|NCT01702428|17699102|P4|Overall Study|Mother transferred care|0
5123854|NCT01702428|17699103|P3|Overall Study|Mother transferred care|0
5123855|NCT01702428|17699104|P2|Overall Study|Mother transferred care|1
5123856|NCT01702428|17699105|P1|Overall Study|Mother transferred care|0
5123857|NCT01702428|17699102|P4|Overall Study|Lost Health Plan|2
5123858|NCT01702428|17699103|P3|Overall Study|Lost Health Plan|0
5123859|NCT01702428|17699104|P2|Overall Study|Lost Health Plan|5
5123860|NCT01702428|17699105|P1|Overall Study|Lost Health Plan|3
5123861|NCT01702428|17699102|P4|Overall Study|Lost Coverage|1
5123862|NCT01702428|17699103|P3|Overall Study|Lost Coverage|0
5123863|NCT01702428|17699104|P2|Overall Study|Lost Coverage|0
5123864|NCT01702428|17699105|P1|Overall Study|Lost Coverage|0
5123865|NCT01702428|17699102|P4|Overall Study|Parents cannot assist to site|0
5123866|NCT01702428|17699103|P3|Overall Study|Parents cannot assist to site|1
5123867|NCT01702428|17699104|P2|Overall Study|Parents cannot assist to site|0
5123868|NCT01702428|17699105|P1|Overall Study|Parents cannot assist to site|1
5123869|NCT01702428|17699102|P4|Overall Study|Lost to Follow-up|44
5123870|NCT01702428|17699103|P3|Overall Study|Lost to Follow-up|37
5123871|NCT01702428|17699104|P2|Overall Study|Lost to Follow-up|41
5123872|NCT01702428|17699105|P1|Overall Study|Lost to Follow-up|33
5123873|NCT01702428|17699102|P4|Overall Study|Adverse Event|0
5123874|NCT01702428|17699103|P3|Overall Study|Adverse Event|0
5123875|NCT01702428|17699104|P2|Overall Study|Adverse Event|0
5123876|NCT01702428|17699105|P1|Overall Study|Adverse Event|2
5123877|NCT01702363|17699192|P1|Overall Study|Withdrawal by Subject|2
5123878|NCT01702363|17699192|P1|Overall Study|Lack of Efficacy|4
5123879|NCT01702363|17699192|P1|Overall Study|Adverse Event|14
5123880|NCT01702311|17699209|P2|Overall Study|Physician Decision|4
5123881|NCT01702311|17699210|P1|Overall Study|Physician Decision|3
5123882|NCT01702311|17699209|P2|Overall Study|Discharge less than 24 hours|7
5123883|NCT01702311|17699210|P1|Overall Study|Discharge less than 24 hours|10
5123884|NCT01702311|17699209|P2|Overall Study|Withdrawal by Subject|2
5123885|NCT01702311|17699210|P1|Overall Study|Withdrawal by Subject|3
5123886|NCT01702298|17699240|P1|Overall Study|Withdrawal by Subject|1
5123887|NCT01702246|17699268|P1|Overall Study|Physician Decision|1
5123888|NCT01702246|17699268|P1|Overall Study|Withdrawal by Subject|2
5123889|NCT01702246|17699268|P1|Overall Study|Lost to Follow-up|2
5123890|NCT01702025|17699322|P4|Overall Study|Adverse Event|0
5123891|NCT01702025|17699323|P3|Overall Study|Adverse Event|1
5123892|NCT01702025|17699324|P2|Overall Study|Adverse Event|1
5123893|NCT01702025|17699325|P1|Overall Study|Adverse Event|1
5123894|NCT01702025|17699322|P4|Overall Study|Equipment failure|0
5123895|NCT01702025|17699323|P3|Overall Study|Equipment failure|0
5123896|NCT01702025|17699324|P2|Overall Study|Equipment failure|0
5123897|NCT01702025|17699325|P1|Overall Study|Equipment failure|1
5123898|NCT01701973|17699354|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123899|NCT01701973|17699355|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123900|NCT01701973|17699356|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123901|NCT01701973|17699357|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123902|NCT01701973|17699358|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123903|NCT01701973|17699359|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123904|NCT01701973|17699360|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
5123905|NCT01701973|17699361|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
5123906|NCT01701674|17699408|P1|Overall Study|Unable to safely complete treatment|1
5123907|NCT01701401|17699494|P4|Overall Study|Protocol Violation|0
5123908|NCT01701401|17699495|P3|Overall Study|Protocol Violation|1
5123909|NCT01701401|17699496|P2|Overall Study|Protocol Violation|0
5123910|NCT01701401|17699497|P1|Overall Study|Protocol Violation|0
5123911|NCT01701401|17699494|P4|Overall Study|Adverse Event|0
5123912|NCT01701401|17699495|P3|Overall Study|Adverse Event|0
5123913|NCT01701401|17699496|P2|Overall Study|Adverse Event|0
5123914|NCT01701401|17699497|P1|Overall Study|Adverse Event|1
5123915|NCT01701401|17699494|P4|Overall Study|Lack of Efficacy|0
5123916|NCT01701401|17699495|P3|Overall Study|Lack of Efficacy|2
5123917|NCT01701401|17699496|P2|Overall Study|Lack of Efficacy|0
5123918|NCT01701401|17699497|P1|Overall Study|Lack of Efficacy|1
5123919|NCT01701401|17699494|P4|Overall Study|Withdrew Consent|2
5123920|NCT01701401|17699495|P3|Overall Study|Withdrew Consent|1
5123921|NCT01701401|17699496|P2|Overall Study|Withdrew Consent|3
5123922|NCT01701401|17699497|P1|Overall Study|Withdrew Consent|0
5123923|NCT01701401|17699494|P4|Overall Study|Lost to Follow-up|3
5123924|NCT01701401|17699495|P3|Overall Study|Lost to Follow-up|1
5123925|NCT01701401|17699496|P2|Overall Study|Lost to Follow-up|5
5123926|NCT01701401|17699497|P1|Overall Study|Lost to Follow-up|5
5123927|NCT01701401|17699494|P4|Overall Study|Randomized But Not Treated|1
5123928|NCT01701401|17699495|P3|Overall Study|Randomized But Not Treated|0
5123929|NCT01701401|17699496|P2|Overall Study|Randomized But Not Treated|1
5123930|NCT01701401|17699497|P1|Overall Study|Randomized But Not Treated|3
5123931|NCT01701362|17699549|P2|Overall Study|Reasons other than those mentioned above|5
5123932|NCT01701362|17699550|P1|Overall Study|Reasons other than those mentioned above|3
5123933|NCT01701362|17699549|P2|Overall Study|Randomized but not treated|2
5123934|NCT01701362|17699550|P1|Overall Study|Randomized but not treated|1
5123935|NCT01701362|17699549|P2|Overall Study|Death|1
5123936|NCT01701362|17699550|P1|Overall Study|Death|0
5123937|NCT01701362|17699549|P2|Overall Study|Insufficient clinical response|6
5123938|NCT01701362|17699550|P1|Overall Study|Insufficient clinical response|6
5123939|NCT01701362|17699549|P2|Overall Study|Lost to Follow-up|9
5123940|NCT01701362|17699550|P1|Overall Study|Lost to Follow-up|6
5123941|NCT01701362|17699549|P2|Overall Study|No longer willing to participate|14
5123942|NCT01701362|17699550|P1|Overall Study|No longer willing to participate|8
5123943|NCT01701362|17699549|P2|Overall Study|Protocol Violation|3
5123944|NCT01701362|17699550|P1|Overall Study|Protocol Violation|5
5123945|NCT01701362|17699549|P2|Overall Study|Adverse events related to study drug|10
5123946|NCT01701362|17699550|P1|Overall Study|Adverse events related to study drug|12
5123947|NCT01701362|17699549|P2|Overall Study|Adverse events not related to study drug|6
5123948|NCT01701362|17699550|P1|Overall Study|Adverse events not related to study drug|1
5123949|NCT01701258|17699588|P13|Assessment and Scheduling|Investigator Terminated|0
5123950|NCT01701258|17699589|P12|Assessment and Scheduling|Investigator Terminated|0
5123951|NCT01701258|17699590|P11|Assessment and Scheduling|Investigator Terminated|0
5123952|NCT01701258|17699591|P10|Assessment and Scheduling|Investigator Terminated|0
5123953|NCT01701258|17699592|P9|Assessment and Scheduling|Investigator Terminated|0
5123954|NCT01701258|17699593|P8|Assessment and Scheduling|Investigator Terminated|0
5123955|NCT01701258|17699594|P7|Assessment and Scheduling|Investigator Terminated|0
5123956|NCT01701258|17699595|P6|Assessment and Scheduling|Investigator Terminated|0
5123957|NCT01701258|17699596|P5|Assessment and Scheduling|Investigator Terminated|0
5123958|NCT01701258|17699597|P4|Assessment and Scheduling|Investigator Terminated|0
5123959|NCT01701258|17699598|P3|Assessment and Scheduling|Investigator Terminated|0
5123960|NCT01701258|17699599|P2|Assessment and Scheduling|Investigator Terminated|0
5123961|NCT01701258|17699600|P1|Assessment and Scheduling|Investigator Terminated|2
5123962|NCT01701258|17699588|P13|Assessment and Scheduling|Withdrawal by Subject|0
5123963|NCT01701258|17699589|P12|Assessment and Scheduling|Withdrawal by Subject|0
5123964|NCT01701258|17699590|P11|Assessment and Scheduling|Withdrawal by Subject|0
5123965|NCT01701258|17699591|P10|Assessment and Scheduling|Withdrawal by Subject|0
5123966|NCT01701258|17699592|P9|Assessment and Scheduling|Withdrawal by Subject|0
5123967|NCT01701258|17699593|P8|Assessment and Scheduling|Withdrawal by Subject|0
5123968|NCT01701258|17699594|P7|Assessment and Scheduling|Withdrawal by Subject|0
5123969|NCT01701258|17699595|P6|Assessment and Scheduling|Withdrawal by Subject|0
5123970|NCT01701258|17699596|P5|Assessment and Scheduling|Withdrawal by Subject|0
5123971|NCT01701258|17699597|P4|Assessment and Scheduling|Withdrawal by Subject|0
5123972|NCT01701258|17699598|P3|Assessment and Scheduling|Withdrawal by Subject|0
5123973|NCT01701258|17699599|P2|Assessment and Scheduling|Withdrawal by Subject|0
5123974|NCT01701258|17699600|P1|Assessment and Scheduling|Withdrawal by Subject|14
5123975|NCT01701258|17699588|P13|Assessment and Scheduling|Lost to Follow-up|0
5123976|NCT01701258|17699589|P12|Assessment and Scheduling|Lost to Follow-up|0
5123977|NCT01701258|17699590|P11|Assessment and Scheduling|Lost to Follow-up|0
5123978|NCT01701258|17699591|P10|Assessment and Scheduling|Lost to Follow-up|0
5123979|NCT01701258|17699592|P9|Assessment and Scheduling|Lost to Follow-up|0
5123980|NCT01701258|17699593|P8|Assessment and Scheduling|Lost to Follow-up|0
5123981|NCT01701258|17699594|P7|Assessment and Scheduling|Lost to Follow-up|0
5123982|NCT01701258|17699595|P6|Assessment and Scheduling|Lost to Follow-up|0
5123983|NCT01701258|17699596|P5|Assessment and Scheduling|Lost to Follow-up|0
5123984|NCT01701258|17699597|P4|Assessment and Scheduling|Lost to Follow-up|0
5123985|NCT01701258|17699598|P3|Assessment and Scheduling|Lost to Follow-up|0
5123986|NCT01701258|17699599|P2|Assessment and Scheduling|Lost to Follow-up|0
5123987|NCT01701258|17699600|P1|Assessment and Scheduling|Lost to Follow-up|10
5123988|NCT01701258|17699588|P13|Assessment and Scheduling|Found to be Ineligible|0
5123989|NCT01701258|17699589|P12|Assessment and Scheduling|Found to be Ineligible|0
5123990|NCT01701258|17699590|P11|Assessment and Scheduling|Found to be Ineligible|0
5123991|NCT01701258|17699591|P10|Assessment and Scheduling|Found to be Ineligible|0
5123992|NCT01701258|17699592|P9|Assessment and Scheduling|Found to be Ineligible|0
5123993|NCT01701258|17699593|P8|Assessment and Scheduling|Found to be Ineligible|0
5123994|NCT01701258|17699594|P7|Assessment and Scheduling|Found to be Ineligible|0
5123995|NCT01701258|17699595|P6|Assessment and Scheduling|Found to be Ineligible|0
5123996|NCT01701258|17699596|P5|Assessment and Scheduling|Found to be Ineligible|0
5123997|NCT01701258|17699597|P4|Assessment and Scheduling|Found to be Ineligible|0
5123998|NCT01701258|17699598|P3|Assessment and Scheduling|Found to be Ineligible|0
5123999|NCT01701258|17699599|P2|Assessment and Scheduling|Found to be Ineligible|0
5124000|NCT01701258|17699600|P1|Assessment and Scheduling|Found to be Ineligible|57
5124001|NCT01701245|17699654|P2|Overall Study|Did not complete the open label period|12
5124002|NCT01701245|17699655|P1|Overall Study|Did not complete the open label period|11
5124003|NCT01701245|17699654|P2|Overall Study|Protocol Violation|3
5124004|NCT01701245|17699655|P1|Overall Study|Protocol Violation|1
5124005|NCT01701063|17699702|P3|Overall Study|Other|1
5124006|NCT01701063|17699703|P2|Overall Study|Other|0
5124007|NCT01701063|17699704|P1|Overall Study|Other|0
5124008|NCT01701063|17699702|P3|Overall Study|Withdrawal by Subject|1
5124009|NCT01701063|17699703|P2|Overall Study|Withdrawal by Subject|0
5124010|NCT01701063|17699704|P1|Overall Study|Withdrawal by Subject|0
5124011|NCT01701063|17699702|P3|Overall Study|Lost to Follow-up|0
5124012|NCT01701063|17699703|P2|Overall Study|Lost to Follow-up|1
5124013|NCT01701063|17699704|P1|Overall Study|Lost to Follow-up|0
5124014|NCT01700985|17699788|P2|Overall Study|Incarcerated|1
5124015|NCT01700985|17699789|P1|Overall Study|Incarcerated|0
5124016|NCT01700959|17699811|P6|Overall Study|Side effects|1
5124017|NCT01700959|17699812|P5|Overall Study|Side effects|4
5124018|NCT01700959|17699813|P4|Overall Study|Side effects|4
5124019|NCT01700959|17699814|P3|Overall Study|Side effects|8
5124020|NCT01700959|17699815|P2|Overall Study|Side effects|4
5124021|NCT01700959|17699816|P1|Overall Study|Side effects|1
5124022|NCT01700959|17699811|P6|Overall Study|Noncompliant|9
5124023|NCT01700959|17699812|P5|Overall Study|Noncompliant|15
5124024|NCT01700959|17699813|P4|Overall Study|Noncompliant|18
5124025|NCT01700959|17699814|P3|Overall Study|Noncompliant|17
5124026|NCT01700959|17699815|P2|Overall Study|Noncompliant|9
5124027|NCT01700959|17699816|P1|Overall Study|Noncompliant|9
5124028|NCT01700959|17699811|P6|Overall Study|Ineligible|1
5124029|NCT01700959|17699812|P5|Overall Study|Ineligible|0
5124030|NCT01700959|17699813|P4|Overall Study|Ineligible|0
5124031|NCT01700959|17699814|P3|Overall Study|Ineligible|2
5124032|NCT01700959|17699815|P2|Overall Study|Ineligible|1
5124033|NCT01700959|17699816|P1|Overall Study|Ineligible|2
5124034|NCT01700959|17699811|P6|Overall Study|Withdrawal by Subject|12
5124035|NCT01700959|17699812|P5|Overall Study|Withdrawal by Subject|8
5124036|NCT01700959|17699813|P4|Overall Study|Withdrawal by Subject|11
5124037|NCT01700959|17699814|P3|Overall Study|Withdrawal by Subject|12
5124038|NCT01700959|17699815|P2|Overall Study|Withdrawal by Subject|9
5124039|NCT01700959|17699816|P1|Overall Study|Withdrawal by Subject|15
5124040|NCT01700959|17699811|P6|Overall Study|Adverse Event|2
5124041|NCT01700959|17699812|P5|Overall Study|Adverse Event|0
5124042|NCT01700959|17699813|P4|Overall Study|Adverse Event|2
5124043|NCT01700959|17699814|P3|Overall Study|Adverse Event|1
5124044|NCT01700959|17699815|P2|Overall Study|Adverse Event|1
5124045|NCT01700959|17699816|P1|Overall Study|Adverse Event|0
5124046|NCT01700829|17699857|P2|Overall Study|Withdrawal by Subject|1
5124047|NCT01700829|17699858|P1|Overall Study|Withdrawal by Subject|1
5124048|NCT01700621|17699918|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
5124049|NCT01700621|17699919|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
5124050|NCT01700621|17699918|P2|Analyzed for Immunogenicity|Protocol Violation|1
5124051|NCT01700621|17699919|P1|Analyzed for Immunogenicity|Protocol Violation|5
5124052|NCT01700621|17699918|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
5124053|NCT01700621|17699919|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
5124054|NCT01700530|17699957|P3|Overall Study|Withdrawal by Subject|1
5124055|NCT01700530|17699958|P2|Overall Study|Withdrawal by Subject|3
5124056|NCT01700530|17699959|P1|Overall Study|Withdrawal by Subject|0
5124057|NCT01700387|17700008|P2|Overall Study|Lost to Follow-up|1
5124058|NCT01700387|17700009|P1|Overall Study|Lost to Follow-up|2
5124059|NCT01700387|17700008|P2|Overall Study|Adverse Event|1
5124060|NCT01700387|17700009|P1|Overall Study|Adverse Event|1
5124061|NCT01700387|17700008|P2|Overall Study|Withdrawal by Subject|2
5124062|NCT01700387|17700009|P1|Overall Study|Withdrawal by Subject|1
5124063|NCT01700348|17700039|P1|Overall Study|Lost to Follow-up|1
5124064|NCT01700348|17700039|P1|Overall Study|Withdrawal by Subject|22
5124065|NCT01700205|17700062|P2|Overall Study|Protocol Violation|2
5124066|NCT01700205|17700063|P1|Overall Study|Protocol Violation|2
5124067|NCT01700205|17700062|P2|Overall Study|Withdrawal by Subject|13
5124068|NCT01700205|17700063|P1|Overall Study|Withdrawal by Subject|13
5124069|NCT01700192|17700085|P2|Overall Study|Never received study drug|0
5124070|NCT01700192|17700086|P1|Overall Study|Never received study drug|1
5124071|NCT01700192|17700085|P2|Overall Study|Withdrawal by Subject|64
5124072|NCT01700192|17700086|P1|Overall Study|Withdrawal by Subject|56
5124073|NCT01700192|17700085|P2|Overall Study|Technical problems|1
5124074|NCT01700192|17700086|P1|Overall Study|Technical problems|0
5124075|NCT01700192|17700085|P2|Overall Study|Protocol Violation|4
5124076|NCT01700192|17700086|P1|Overall Study|Protocol Violation|3
5124077|NCT01700192|17700085|P2|Overall Study|Progressive disease|0
5124078|NCT01700192|17700086|P1|Overall Study|Progressive disease|1
5124079|NCT01700192|17700085|P2|Overall Study|Pregnancy|4
5124080|NCT01700192|17700086|P1|Overall Study|Pregnancy|1
5124081|NCT01700192|17700085|P2|Overall Study|Physician Decision|3
5124082|NCT01700192|17700086|P1|Overall Study|Physician Decision|2
5124083|NCT01700192|17700085|P2|Overall Study|Noncompliance with study drug|5
5124084|NCT01700192|17700086|P1|Overall Study|Noncompliance with study drug|0
5124085|NCT01700192|17700085|P2|Overall Study|Lost to Follow-up|29
5124086|NCT01700192|17700086|P1|Overall Study|Lost to Follow-up|42
5124087|NCT01700192|17700085|P2|Overall Study|Lack of Efficacy|0
5124088|NCT01700192|17700086|P1|Overall Study|Lack of Efficacy|1
5124089|NCT01700192|17700085|P2|Overall Study|Adverse Event|18
5124090|NCT01700192|17700086|P1|Overall Study|Adverse Event|73
5124091|NCT01700179|17700104|P1|Overall Study|Physician Decision|2
5124092|NCT01700140|17700111|P3|Overall Study|Inclusion/exclusion criteria deviation|0
5124093|NCT01700140|17700112|P2|Overall Study|Inclusion/exclusion criteria deviation|4
5124094|NCT01700140|17700113|P1|Overall Study|Inclusion/exclusion criteria deviation|1
5124095|NCT01700140|17700111|P3|Overall Study|Adverse Event|0
5124096|NCT01700140|17700112|P2|Overall Study|Adverse Event|1
5124097|NCT01700140|17700113|P1|Overall Study|Adverse Event|0
5124098|NCT01700140|17700111|P3|Overall Study|Aggravation of symptoms|0
5124099|NCT01700140|17700112|P2|Overall Study|Aggravation of symptoms|0
5124100|NCT01700140|17700113|P1|Overall Study|Aggravation of symptoms|1
5124101|NCT01700140|17700111|P3|Overall Study|Use of chemotherapy or surgical therapy|0
5124102|NCT01700140|17700112|P2|Overall Study|Use of chemotherapy or surgical therapy|1
5124103|NCT01700140|17700113|P1|Overall Study|Use of chemotherapy or surgical therapy|0
5124104|NCT01700140|17700111|P3|Overall Study|Discontinuation of radiotherapy|0
5124105|NCT01700140|17700112|P2|Overall Study|Discontinuation of radiotherapy|0
5124106|NCT01700140|17700113|P1|Overall Study|Discontinuation of radiotherapy|1
5124107|NCT01700140|17700111|P3|Overall Study|Use of rescue drugs|1
5124108|NCT01700140|17700112|P2|Overall Study|Use of rescue drugs|3
5124109|NCT01700140|17700113|P1|Overall Study|Use of rescue drugs|3
5124110|NCT01700049|17700145|P1|Overall Study|Withdrawal by Subject|1
5124111|NCT01699867|17700160|P1|Overall Study|Screening Failure|3
5124112|NCT01699815|17700167|P2|Overall Study|Adverse Event|1
5124113|NCT01699815|17700168|P1|Overall Study|Adverse Event|0
5124114|NCT01699815|17700167|P2|Overall Study|record could not be located|0
5124115|NCT01699815|17700168|P1|Overall Study|record could not be located|1
5124116|NCT01699815|17700167|P2|Overall Study|Protocol Violation|7
5124117|NCT01699815|17700168|P1|Overall Study|Protocol Violation|4
5124118|NCT01699789|17700180|P2|Overall Study|Lost to Follow-up|101
5124119|NCT01699789|17700181|P1|Overall Study|Lost to Follow-up|83
5124120|NCT01699789|17700180|P2|Overall Study|Death|2
5124121|NCT01699789|17700181|P1|Overall Study|Death|1
5124122|NCT01699789|17700180|P2|Overall Study|Withdrawal by Subject|23
5124123|NCT01699789|17700181|P1|Overall Study|Withdrawal by Subject|18
5124124|NCT01699750|17700251|P2|Overall Study|Other|2
5124125|NCT01699750|17700252|P1|Overall Study|Other|0
5124126|NCT01699750|17700251|P2|Overall Study|Withdrew Consent|1
5124127|NCT01699750|17700252|P1|Overall Study|Withdrew Consent|0
5124128|NCT01699685|17700287|P2|Period 2|Lost to Follow-up|0
5124129|NCT01699685|17700288|P1|Period 2|Lost to Follow-up|1
5124130|NCT01699685|17700287|P2|Period 1|Patient request|1
5124131|NCT01699685|17700288|P1|Period 1|Patient request|0
5124132|NCT01699685|17700287|P2|Period 1|Other|1
5124133|NCT01699685|17700288|P1|Period 1|Other|0
5124134|NCT01699685|17700287|P2|Period 1|Medical or ethical, noncompliance|0
5124135|NCT01699685|17700288|P1|Period 1|Medical or ethical, noncompliance|2
5124136|NCT01699685|17700287|P2|Period 1|Adverse Event|1
5124137|NCT01699685|17700288|P1|Period 1|Adverse Event|1
5124138|NCT01699503|17700314|P2|Overall Study|Excluded due to quality|791
5124139|NCT01699503|17700315|P1|Overall Study|Excluded due to quality|783
5124140|NCT01699503|17700314|P2|Overall Study|Lost to Follow-up|117
5124141|NCT01699503|17700315|P1|Overall Study|Lost to Follow-up|121
5124142|NCT01699503|17700314|P2|Overall Study|Withdrawal by Subject|57
5124143|NCT01699503|17700315|P1|Overall Study|Withdrawal by Subject|65
5124144|NCT01699503|17700314|P2|Overall Study|Death|40
5124145|NCT01699503|17700315|P1|Overall Study|Death|31
5124146|NCT01699178|17700340|P2|Overall Study|ineligible/noncompliant/ subject reason|4
5124147|NCT01699178|17700341|P1|Overall Study|ineligible/noncompliant/ subject reason|4
5124148|NCT01699178|17700340|P2|Overall Study|PSA increase of >1.4 ng/mL|3
5124149|NCT01699178|17700341|P1|Overall Study|PSA increase of >1.4 ng/mL|4
5124150|NCT01699178|17700340|P2|Overall Study|Hematocrit >54%|1
5124151|NCT01699178|17700341|P1|Overall Study|Hematocrit >54%|1
5124152|NCT01699178|17700340|P2|Overall Study|Withdrawal by Subject|12
5124153|NCT01699178|17700341|P1|Overall Study|Withdrawal by Subject|4
5124154|NCT01699178|17700340|P2|Overall Study|Physician Decision|0
5124155|NCT01699178|17700341|P1|Overall Study|Physician Decision|1
5124156|NCT01699178|17700340|P2|Overall Study|Non-compliance with Study Drug|1
5124157|NCT01699178|17700341|P1|Overall Study|Non-compliance with Study Drug|3
5124158|NCT01699178|17700340|P2|Overall Study|Lost to Follow-up|6
5124159|NCT01699178|17700341|P1|Overall Study|Lost to Follow-up|1
5124160|NCT01699178|17700340|P2|Overall Study|Adverse Event|5
5124161|NCT01699178|17700341|P1|Overall Study|Adverse Event|1
5124162|NCT01699087|17700357|P1|Overall Study|Unable to make future visits|2
5124163|NCT01699087|17700357|P1|Overall Study|Screen failure (prior to treatment)|15
5124164|NCT01699087|17700357|P1|Overall Study|Lost to Follow-up|7
5124165|NCT01699022|17700371|P1|Overall Study|Early discontinuation from the study|3
5124166|NCT01698814|17700386|P2|Overall Study|Randomized in error|0
5124167|NCT01698814|17700387|P1|Overall Study|Randomized in error|1
5124168|NCT01698814|17700386|P2|Overall Study|Pregnancy|0
5124169|NCT01698814|17700387|P1|Overall Study|Pregnancy|1
5124170|NCT01698814|17700386|P2|Overall Study|Lost to Follow-up|1
5124171|NCT01698814|17700387|P1|Overall Study|Lost to Follow-up|0
5124172|NCT01698814|17700386|P2|Overall Study|Adverse Event|2
5124173|NCT01698814|17700387|P1|Overall Study|Adverse Event|0
5124174|NCT01698801|17700393|P1|Follow Up Phase|Death|4
5124175|NCT01698801|17700393|P1|Follow Up Phase|Withdrawal by Subject|1
5124176|NCT01698801|17700393|P1|Treatment Phase|Disease progression|1
5124177|NCT01698801|17700393|P1|Treatment Phase|Withdrawal by Subject|1
5124178|NCT01698801|17700393|P1|Treatment Phase|Other|4
5124179|NCT01698801|17700393|P1|Treatment Phase|Protocol Violation|1
5124180|NCT01698801|17700393|P1|Treatment Phase|Adverse Event|4
5124181|NCT01698775|17700404|P2|Phase B|Withdrawal by Subject|2
5124182|NCT01698775|17700405|P1|Phase B|Withdrawal by Subject|6
5124183|NCT01698775|17700404|P2|Phase B|Protocol Violation|1
5124184|NCT01698775|17700405|P1|Phase B|Protocol Violation|1
5124185|NCT01698775|17700404|P2|Phase B|Physician Decision|1
5124186|NCT01698775|17700405|P1|Phase B|Physician Decision|1
5124187|NCT01698775|17700404|P2|Phase B|Lost to Follow-up|1
5124188|NCT01698775|17700405|P1|Phase B|Lost to Follow-up|0
5124189|NCT01698775|17700404|P2|Phase B|Lack of Efficacy|1
5124190|NCT01698775|17700405|P1|Phase B|Lack of Efficacy|0
5124191|NCT01698775|17700404|P2|Phase B|Death|1
5124192|NCT01698775|17700405|P1|Phase B|Death|0
5124193|NCT01698775|17700404|P2|Phase B|Adverse Event|3
5124194|NCT01698775|17700405|P1|Phase B|Adverse Event|6
5124195|NCT01698775|17700404|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
5124196|NCT01698775|17700405|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
5124197|NCT01698775|17700404|P2|Phase A|Kidney [transplant]|1
5124198|NCT01698775|17700405|P1|Phase A|Kidney [transplant]|0
5124199|NCT01698775|17700404|P2|Phase A|Withdrawal by Subject|4
5124200|NCT01698775|17700405|P1|Phase A|Withdrawal by Subject|3
5124201|NCT01698775|17700404|P2|Phase A|Protocol Violation|0
5124202|NCT01698775|17700405|P1|Phase A|Protocol Violation|1
5124203|NCT01698775|17700404|P2|Phase A|Lost to Follow-up|2
5124204|NCT01698775|17700405|P1|Phase A|Lost to Follow-up|1
5124205|NCT01698775|17700404|P2|Phase A|Lack of Efficacy|0
5124206|NCT01698775|17700405|P1|Phase A|Lack of Efficacy|1
5124207|NCT01698775|17700404|P2|Phase A|Death|1
5124208|NCT01698775|17700405|P1|Phase A|Death|1
5124209|NCT01698775|17700404|P2|Phase A|Adverse Event|1
5124210|NCT01698775|17700405|P1|Phase A|Adverse Event|2
5124211|NCT01698554|17700454|P4|Overall Study|Other Miscellaneous Reasons|0
5124212|NCT01698554|17700455|P3|Overall Study|Other Miscellaneous Reasons|0
5124213|NCT01698554|17700456|P2|Overall Study|Other Miscellaneous Reasons|0
5124214|NCT01698554|17700457|P1|Overall Study|Other Miscellaneous Reasons|1
5124215|NCT01698554|17700454|P4|Overall Study|Protocol Violation|0
5124216|NCT01698554|17700455|P3|Overall Study|Protocol Violation|1
5124217|NCT01698554|17700456|P2|Overall Study|Protocol Violation|0
5124218|NCT01698554|17700457|P1|Overall Study|Protocol Violation|2
5124219|NCT01698554|17700454|P4|Overall Study|Personal Reasons|1
5124220|NCT01698554|17700455|P3|Overall Study|Personal Reasons|1
5124221|NCT01698554|17700456|P2|Overall Study|Personal Reasons|5
5124222|NCT01698554|17700457|P1|Overall Study|Personal Reasons|0
5124223|NCT01698554|17700454|P4|Overall Study|Lost to Follow-up|0
5124224|NCT01698554|17700455|P3|Overall Study|Lost to Follow-up|0
5124225|NCT01698554|17700456|P2|Overall Study|Lost to Follow-up|0
5124226|NCT01698554|17700457|P1|Overall Study|Lost to Follow-up|1
5124227|NCT01698554|17700454|P4|Overall Study|Adverse Event|1
5124228|NCT01698554|17700455|P3|Overall Study|Adverse Event|0
5124229|NCT01698554|17700456|P2|Overall Study|Adverse Event|5
5124230|NCT01698554|17700457|P1|Overall Study|Adverse Event|2
5124231|NCT01698320|17700527|P3|40-Week Open-Label Period|Lost to Follow-up|0
5124232|NCT01698320|17700528|P2|40-Week Open-Label Period|Lost to Follow-up|2
5124233|NCT01698320|17700529|P1|40-Week Open-Label Period|Lost to Follow-up|0
5124234|NCT01698320|17700527|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
5124235|NCT01698320|17700528|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
5124236|NCT01698320|17700529|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
5124237|NCT01698320|17700527|P3|40-Week Open-Label Period|Pregnancy|1
5124238|NCT01698320|17700528|P2|40-Week Open-Label Period|Pregnancy|2
5124239|NCT01698320|17700529|P1|40-Week Open-Label Period|Pregnancy|0
5124240|NCT01698320|17700527|P3|40-Week Open-Label Period|Withdrawal by Subject|7
5124241|NCT01698320|17700528|P2|40-Week Open-Label Period|Withdrawal by Subject|11
5124242|NCT01698320|17700529|P1|40-Week Open-Label Period|Withdrawal by Subject|0
5124243|NCT01698320|17700527|P3|40-Week Open-Label Period|Adverse Event|2
5124244|NCT01698320|17700528|P2|40-Week Open-Label Period|Adverse Event|3
5124245|NCT01698320|17700529|P1|40-Week Open-Label Period|Adverse Event|0
5124246|NCT01698320|17700527|P3|12-Week Double-Blind Period|Lost to Follow-up|4
5124247|NCT01698320|17700528|P2|12-Week Double-Blind Period|Lost to Follow-up|0
5124248|NCT01698320|17700529|P1|12-Week Double-Blind Period|Lost to Follow-up|0
5124249|NCT01698320|17700527|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
5124250|NCT01698320|17700528|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
5124251|NCT01698320|17700529|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
5124252|NCT01698320|17700527|P3|12-Week Double-Blind Period|Pregnancy|1
5124253|NCT01698320|17700528|P2|12-Week Double-Blind Period|Pregnancy|1
5124254|NCT01698320|17700529|P1|12-Week Double-Blind Period|Pregnancy|0
5124255|NCT01698320|17700527|P3|12-Week Double-Blind Period|Protocol Violation|2
5124256|NCT01698320|17700528|P2|12-Week Double-Blind Period|Protocol Violation|0
5124257|NCT01698320|17700529|P1|12-Week Double-Blind Period|Protocol Violation|0
5124258|NCT01698320|17700527|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
5124259|NCT01698320|17700528|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
5124260|NCT01698320|17700529|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
5124261|NCT01698320|17700527|P3|12-Week Double-Blind Period|Adverse Event|1
5124262|NCT01698320|17700528|P2|12-Week Double-Blind Period|Adverse Event|1
5124263|NCT01698320|17700529|P1|12-Week Double-Blind Period|Adverse Event|0
5124264|NCT01698320|17700527|P3|Run-In Period (Week -1 to Day 0)|Other|0
5124265|NCT01698320|17700528|P2|Run-In Period (Week -1 to Day 0)|Other|0
5124266|NCT01698320|17700529|P1|Run-In Period (Week -1 to Day 0)|Other|1
5124267|NCT01698320|17700527|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
5124268|NCT01698320|17700528|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
5124269|NCT01698320|17700529|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
5124270|NCT01698320|17700527|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
5124271|NCT01698320|17700528|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
5124272|NCT01698320|17700529|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
5124273|NCT01698320|17700527|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
5124274|NCT01698320|17700528|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
5124275|NCT01698320|17700529|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
5124276|NCT01698268|17700549|P2|Overall Study|Physician Decision|1
5124277|NCT01698268|17700550|P1|Overall Study|Physician Decision|2
5124278|NCT01698008|17700558|P2|Overall Study|Withdrawal by Subject|2
5124279|NCT01698008|17700559|P1|Overall Study|Withdrawal by Subject|1
5124280|NCT01697969|17700565|P1|Overall Study|Did not meet inc/exc criteria|3
5124281|NCT01697956|17700572|P2|Overall Study|Protocol Violation|1
5124282|NCT01697956|17700573|P1|Overall Study|Protocol Violation|1
5124283|NCT01697800|17700603|P2|Overall Study|Death|1
5124284|NCT01697800|17700604|P1|Overall Study|Death|0
5124285|NCT01697748|17700612|P2|Overall Study|Lost to Follow-up|65
5124286|NCT01697748|17700613|P1|Overall Study|Lost to Follow-up|53
5124287|NCT01697748|17700612|P2|Overall Study|ineligible uterine incision|1
5124288|NCT01697748|17700613|P1|Overall Study|ineligible uterine incision|4
5124289|NCT01697748|17700612|P2|Overall Study|ineligible skin incision|2
5124290|NCT01697748|17700613|P1|Overall Study|ineligible skin incision|1
5124291|NCT01697696|17700642|P2|Overall Study|Subject/guardian decision|35
5124292|NCT01697696|17700643|P1|Overall Study|Subject/guardian decision|31
5124293|NCT01697696|17700642|P2|Overall Study|Lost to Follow-up|7
5124294|NCT01697696|17700643|P1|Overall Study|Lost to Follow-up|10
5124295|NCT01697696|17700642|P2|Overall Study|Death|2
5124296|NCT01697696|17700643|P1|Overall Study|Death|4
5124297|NCT01697696|17700642|P2|Overall Study|Physician Decision|0
5124298|NCT01697696|17700643|P1|Overall Study|Physician Decision|1
5124299|NCT01697696|17700642|P2|Overall Study|Protocol deviation|0
5124300|NCT01697696|17700643|P1|Overall Study|Protocol deviation|1
5124301|NCT01697696|17700642|P2|Overall Study|Study terminated by sponsor|3
5124302|NCT01697696|17700643|P1|Overall Study|Study terminated by sponsor|0
5124303|NCT01697592|17700675|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
5124304|NCT01697592|17700676|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
5124305|NCT01697592|17700677|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
5124306|NCT01697592|17700678|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
5124307|NCT01697592|17700679|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
5124308|NCT01697592|17700680|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
5124309|NCT01697592|17700681|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
5124310|NCT01697592|17700682|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
5124311|NCT01697592|17700683|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
5124312|NCT01697592|17700684|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
5124313|NCT01697592|17700675|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124314|NCT01697592|17700676|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124315|NCT01697592|17700677|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
5124316|NCT01697592|17700678|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124317|NCT01697592|17700679|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
5124318|NCT01697592|17700680|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124319|NCT01697592|17700681|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124320|NCT01697592|17700682|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124321|NCT01697592|17700683|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5124322|NCT01697592|17700684|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
5124323|NCT01697592|17700675|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
5124324|NCT01697592|17700676|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
5124325|NCT01697592|17700677|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
5124326|NCT01697592|17700678|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
5124327|NCT01697592|17700679|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
5124328|NCT01697592|17700680|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
5124329|NCT01697592|17700681|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
5124330|NCT01697592|17700682|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
5124331|NCT01697592|17700683|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
5124332|NCT01697592|17700684|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
5124333|NCT01697592|17700675|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
5124334|NCT01697592|17700676|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
5124335|NCT01697592|17700677|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
5124336|NCT01697592|17700678|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
5124337|NCT01697592|17700679|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
5124338|NCT01697592|17700680|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
5124339|NCT01697592|17700681|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
5124340|NCT01697592|17700682|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
5124341|NCT01697592|17700683|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
5124342|NCT01697592|17700684|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
5124343|NCT01697592|17700675|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5124344|NCT01697592|17700676|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5124345|NCT01697592|17700677|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5124346|NCT01697592|17700678|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5124347|NCT01697592|17700679|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5124348|NCT01697592|17700680|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5124349|NCT01697592|17700681|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5124350|NCT01697592|17700682|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5124351|NCT01697592|17700683|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5124352|NCT01697592|17700684|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5124353|NCT01697592|17700675|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124354|NCT01697592|17700676|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124355|NCT01697592|17700677|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124356|NCT01697592|17700678|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124357|NCT01697592|17700679|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124358|NCT01697592|17700680|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124359|NCT01697592|17700681|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124360|NCT01697592|17700682|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124361|NCT01697592|17700683|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
5124362|NCT01697592|17700684|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
5124363|NCT01697592|17700675|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
5124364|NCT01697592|17700676|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
5124365|NCT01697592|17700677|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
5124366|NCT01697592|17700678|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
5124367|NCT01697592|17700679|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
5124368|NCT01697592|17700680|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
5124369|NCT01697592|17700681|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
5124370|NCT01697592|17700682|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
5124371|NCT01697592|17700683|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
5124372|NCT01697592|17700684|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
5124373|NCT01697592|17700675|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124374|NCT01697592|17700676|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124375|NCT01697592|17700677|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124376|NCT01697592|17700678|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124377|NCT01697592|17700679|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124378|NCT01697592|17700680|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124379|NCT01697592|17700681|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124380|NCT01697592|17700682|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124381|NCT01697592|17700683|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5124382|NCT01697592|17700684|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
5124383|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
5124384|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5124385|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5124386|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5124387|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5124388|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5124389|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5124390|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
5124391|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
5124392|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5124393|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5124394|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5124395|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5124396|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5124397|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Participant Moved|2
5124398|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Participant Moved|0
5124399|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Participant Moved|0
5124400|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Participant Moved|0
5124401|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Participant Moved|0
5124402|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Participant Moved|0
5124403|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Participant Moved|0
5124404|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Technical Problems|1
5124405|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Technical Problems|0
5124406|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Technical Problems|0
5124407|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Technical Problems|0
5124408|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Technical Problems|0
5124409|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Technical Problems|0
5124410|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Technical Problems|0
5124411|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
5124412|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5124413|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5124414|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5124415|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5124416|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5124417|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5124418|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
5124419|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
5124420|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5124421|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5124422|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5124423|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5124424|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5124425|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
5124426|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
5124427|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5124428|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5124429|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5124430|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5124431|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5124432|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5124433|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
5124434|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5124435|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5124436|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5124437|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5124438|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5124439|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
5124440|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
5124441|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
5124442|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
5124443|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
5124444|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
5124445|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
5124446|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
5124447|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
5124448|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
5124449|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
5124450|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
5124451|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
5124452|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
5124453|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Physician Decision|11
5124454|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Physician Decision|7
5124455|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Physician Decision|0
5124456|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Physician Decision|0
5124457|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Physician Decision|0
5124458|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Physician Decision|0
5124459|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Physician Decision|0
5124460|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
5124461|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
5124462|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5124463|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5124464|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5124465|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5124466|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5124467|NCT01697579|17700753|P7|Optional Extension-Cycles 2-6|Death|2
5124468|NCT01697579|17700754|P6|Optional Extension-Cycles 2-6|Death|0
5124469|NCT01697579|17700755|P5|Optional Extension-Cycles 2-6|Death|0
5124470|NCT01697579|17700756|P4|Optional Extension-Cycles 2-6|Death|0
5124471|NCT01697579|17700757|P3|Optional Extension-Cycles 2-6|Death|0
5124472|NCT01697579|17700758|P2|Optional Extension-Cycles 2-6|Death|0
5124473|NCT01697579|17700759|P1|Optional Extension-Cycles 2-6|Death|0
5124474|NCT01697579|17700753|P7|Base Study-Cycle 1|Technical Problems|0
5124475|NCT01697579|17700754|P6|Base Study-Cycle 1|Technical Problems|0
5124476|NCT01697579|17700755|P5|Base Study-Cycle 1|Technical Problems|0
5124477|NCT01697579|17700756|P4|Base Study-Cycle 1|Technical Problems|1
5124478|NCT01697579|17700757|P3|Base Study-Cycle 1|Technical Problems|1
5124479|NCT01697579|17700758|P2|Base Study-Cycle 1|Technical Problems|0
5124480|NCT01697579|17700759|P1|Base Study-Cycle 1|Technical Problems|0
5124481|NCT01697579|17700753|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5124482|NCT01697579|17700754|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5124483|NCT01697579|17700755|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5124484|NCT01697579|17700756|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5124485|NCT01697579|17700757|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5124486|NCT01697579|17700758|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
5124487|NCT01697579|17700759|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5124488|NCT01697579|17700753|P7|Base Study-Cycle 1|Protocol Violation|0
5124489|NCT01697579|17700754|P6|Base Study-Cycle 1|Protocol Violation|0
5124490|NCT01697579|17700755|P5|Base Study-Cycle 1|Protocol Violation|3
5124491|NCT01697579|17700756|P4|Base Study-Cycle 1|Protocol Violation|0
5124492|NCT01697579|17700757|P3|Base Study-Cycle 1|Protocol Violation|0
5124493|NCT01697579|17700758|P2|Base Study-Cycle 1|Protocol Violation|0
5124494|NCT01697579|17700759|P1|Base Study-Cycle 1|Protocol Violation|0
5124495|NCT01697579|17700753|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5124496|NCT01697579|17700754|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5124497|NCT01697579|17700755|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5124498|NCT01697579|17700756|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5124499|NCT01697579|17700757|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5124500|NCT01697579|17700758|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5124501|NCT01697579|17700759|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
5124502|NCT01697579|17700753|P7|Base Study-Cycle 1|Adverse Event|0
5124503|NCT01697579|17700754|P6|Base Study-Cycle 1|Adverse Event|0
5124504|NCT01697579|17700755|P5|Base Study-Cycle 1|Adverse Event|0
5124505|NCT01697579|17700756|P4|Base Study-Cycle 1|Adverse Event|0
5124506|NCT01697579|17700757|P3|Base Study-Cycle 1|Adverse Event|0
5124507|NCT01697579|17700758|P2|Base Study-Cycle 1|Adverse Event|0
5124508|NCT01697579|17700759|P1|Base Study-Cycle 1|Adverse Event|1
5124509|NCT01697501|17700871|P1|Overall Study|Protocol Violation|2
5124510|NCT01697462|17700914|P1|Overall Study|Missing|5
5124511|NCT01697462|17700914|P1|Overall Study|Other|10
5124512|NCT01697462|17700914|P1|Overall Study|Death|1
5124513|NCT01697462|17700914|P1|Overall Study|Investigator Decision|21
5124514|NCT01697462|17700914|P1|Overall Study|Withdrawal by Subject|12
5124515|NCT01697462|17700914|P1|Overall Study|Lost to Follow-up|21
5124516|NCT01697462|17700914|P1|Overall Study|Adverse Event|6
5124517|NCT01697462|17700914|P1|Overall Study|Disease Progression|1
5124518|NCT01697449|17700921|P1|Overall Study|Missing|25
5124519|NCT01697449|17700921|P1|Overall Study|Other|1
5124520|NCT01697449|17700921|P1|Overall Study|Death|2
5124521|NCT01697449|17700921|P1|Overall Study|Physician Decision|1
5124522|NCT01697449|17700921|P1|Overall Study|Withdrawal by Subject|2
5124523|NCT01697449|17700921|P1|Overall Study|Lost to Follow-up|5
5124524|NCT01697449|17700921|P1|Overall Study|Adverse Event|7
5124525|NCT01697449|17700921|P1|Overall Study|Disease progression|47
5124526|NCT01697358|17700932|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
5124527|NCT01697358|17700933|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
5124528|NCT01697358|17700932|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
5124529|NCT01697358|17700933|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
5124530|NCT01697358|17700932|P2|Period II: 6-24M Long-term Follow-up|Death|1
5124531|NCT01697358|17700933|P1|Period II: 6-24M Long-term Follow-up|Death|1
5124532|NCT01697358|17700932|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
5124533|NCT01697358|17700933|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
5124534|NCT01697358|17700932|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
5124535|NCT01697358|17700933|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
5124536|NCT01697358|17700932|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
5124537|NCT01697358|17700933|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
5124538|NCT01697358|17700932|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
5124539|NCT01697358|17700933|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
5124540|NCT01697358|17700932|P2|Period I: Randomization to 6 Months|Adverse Event|1
5124541|NCT01697358|17700933|P1|Period I: Randomization to 6 Months|Adverse Event|1
5124542|NCT01697358|17700932|P2|Period I: Randomization to 6 Months|Physician Decision|0
5124543|NCT01697358|17700933|P1|Period I: Randomization to 6 Months|Physician Decision|4
5124544|NCT01697358|17700932|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
5124545|NCT01697358|17700933|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
5124546|NCT01697345|17700949|P1|Overall Study|Withdrawal by Subject|1
5124547|NCT01697319|17700974|P1|Extension Phase|Terminated by Sponsor|15
5124548|NCT01697319|17700974|P1|Primary Phase|Withdrawal by Subject|1
5124549|NCT01696994|17700983|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
5124550|NCT01696994|17700984|P1|Overall Study|Refused Screen (Ovarian Screening)|0
5124551|NCT01696994|17700983|P2|Overall Study|Refused ASU (Control)|0
5124552|NCT01696994|17700984|P1|Overall Study|Refused ASU (Control)|311
5124553|NCT01696994|17700983|P2|Overall Study|No Ovaries at Baseline|4851
5124554|NCT01696994|17700984|P1|Overall Study|No Ovaries at Baseline|4807
5124555|NCT01696994|17700983|P2|Overall Study|Died Before ASU (Control)|0
5124556|NCT01696994|17700984|P1|Overall Study|Died Before ASU (Control)|73
5124557|NCT01696994|17700983|P2|Overall Study|Died Before Randomization|2
5124558|NCT01696994|17700984|P1|Overall Study|Died Before Randomization|1
5124559|NCT01696994|17700983|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
5124560|NCT01696994|17700984|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
5124561|NCT01696981|17701012|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
5124562|NCT01696981|17701013|P1|Overall Study|Refused Screen (Colorectal Screening)|0
5124563|NCT01696981|17701012|P2|Overall Study|Refused ASU (Control)|0
5124564|NCT01696981|17701013|P1|Overall Study|Refused ASU (Control)|920
5124565|NCT01696981|17701012|P2|Overall Study|Died Before ASU (Control)|0
5124566|NCT01696981|17701013|P1|Overall Study|Died Before ASU (Control)|278
5124567|NCT01696981|17701012|P2|Overall Study|Died Before Randomization|8
5124568|NCT01696981|17701013|P1|Overall Study|Died Before Randomization|3
5124569|NCT01696981|17701012|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
5124570|NCT01696981|17701013|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
5124571|NCT01696968|17701033|P2|Overall Study|Refused Screen (Lung Screening)|6796
5124572|NCT01696968|17701034|P1|Overall Study|Refused Screen (Lung Screening)|0
5124573|NCT01696968|17701033|P2|Overall Study|Refused ASU (Control)|0
5124574|NCT01696968|17701034|P1|Overall Study|Refused ASU (Control)|920
5124575|NCT01696968|17701033|P2|Overall Study|Died Before ASU (Control)|0
5124576|NCT01696968|17701034|P1|Overall Study|Died Before ASU (Control)|278
5124577|NCT01696968|17701033|P2|Overall Study|Died Before Randomization|8
5124578|NCT01696968|17701034|P1|Overall Study|Died Before Randomization|3
5124579|NCT01696968|17701033|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
5124580|NCT01696968|17701034|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
5124581|NCT01696955|17701056|P2|Main Study|Withdrawal by Subject|1
5124582|NCT01696955|17701057|P1|Main Study|Withdrawal by Subject|1
5124583|NCT01696955|17701056|P2|Main Study|Protocol Violation|0
5124584|NCT01696955|17701057|P1|Main Study|Protocol Violation|1
5124585|NCT01696942|17701082|P2|Overall Study|screen failure|1
5124586|NCT01696942|17701083|P1|Overall Study|screen failure|0
5124587|NCT01696942|17701082|P2|Overall Study|Protocol Violation|2
5124588|NCT01696942|17701083|P1|Overall Study|Protocol Violation|1
5124589|NCT01696942|17701082|P2|Overall Study|Withdrawal by Subject|0
5124590|NCT01696942|17701083|P1|Overall Study|Withdrawal by Subject|1
5124591|NCT01696929|17701091|P1|Overall Study|Physician Decision|1
5124592|NCT01696877|17701098|P2|Overall Study|Adverse Event|1
5124593|NCT01696877|17701099|P1|Overall Study|Adverse Event|0
5124594|NCT01696773|17701121|P2|Days 15-27, Washout|Adverse Event|0
5124595|NCT01696773|17701122|P1|Days 15-27, Washout|Adverse Event|1
5124596|NCT01696695|17701149|P1|Overall Study|Major Protocol Violation|192
5124597|NCT01696695|17701149|P1|Overall Study|Other|74
5124598|NCT01696695|17701149|P1|Overall Study|Lost to Follow-up|48
5124599|NCT01696695|17701149|P1|Overall Study|Withdrawal by Subject|92
5124600|NCT01696695|17701149|P1|Overall Study|Adverse Event|74
5124601|NCT01696695|17701149|P1|Overall Study|Death|29
5124602|NCT01696695|17701149|P1|Overall Study|Disease progression|373
5124603|NCT01696643|17701161|P2|Overall Study|Participant Did Not Receive Study Drug|2
5124604|NCT01696643|17701162|P1|Overall Study|Participant Did Not Receive Study Drug|2
5124605|NCT01696643|17701161|P2|Overall Study|Medical Monitor Decision|2
5124606|NCT01696643|17701162|P1|Overall Study|Medical Monitor Decision|0
5124607|NCT01696643|17701161|P2|Overall Study|Participant Incarcerated|1
5124608|NCT01696643|17701162|P1|Overall Study|Participant Incarcerated|0
5124609|NCT01696643|17701161|P2|Overall Study|Site Error|1
5124610|NCT01696643|17701162|P1|Overall Study|Site Error|2
5124611|NCT01696643|17701161|P2|Overall Study|Participant on Restricted Bed Rest|0
5124612|NCT01696643|17701162|P1|Overall Study|Participant on Restricted Bed Rest|1
5124613|NCT01696643|17701161|P2|Overall Study|Withdrawal by Subject|149
5124614|NCT01696643|17701162|P1|Overall Study|Withdrawal by Subject|142
5124615|NCT01696643|17701161|P2|Overall Study|Study Terminated by Sponsor|294
5124616|NCT01696643|17701162|P1|Overall Study|Study Terminated by Sponsor|286
5124617|NCT01696643|17701161|P2|Overall Study|Protocol Violation|7
5124618|NCT01696643|17701162|P1|Overall Study|Protocol Violation|7
5124619|NCT01696643|17701161|P2|Overall Study|Pregnancy|1
5124620|NCT01696643|17701162|P1|Overall Study|Pregnancy|0
5124621|NCT01696643|17701161|P2|Overall Study|Physician Decision|2
5124622|NCT01696643|17701162|P1|Overall Study|Physician Decision|3
5124623|NCT01696643|17701161|P2|Overall Study|Lost to Follow-up|67
5124624|NCT01696643|17701162|P1|Overall Study|Lost to Follow-up|67
5124625|NCT01696643|17701161|P2|Overall Study|Lack of Efficacy|0
5124626|NCT01696643|17701162|P1|Overall Study|Lack of Efficacy|3
5124627|NCT01696643|17701161|P2|Overall Study|Death|2
5124628|NCT01696643|17701162|P1|Overall Study|Death|1
5124629|NCT01696643|17701161|P2|Overall Study|Adverse Event|7
5124630|NCT01696643|17701162|P1|Overall Study|Adverse Event|15
5124631|NCT01696396|17701181|P4|Overall Study|Death|0
5124632|NCT01696396|17701182|P3|Overall Study|Death|1
5124633|NCT01696396|17701183|P2|Overall Study|Death|0
5124634|NCT01696396|17701184|P1|Overall Study|Death|0
5124635|NCT01696396|17701181|P4|Overall Study|Lost to Follow-up|1
5124636|NCT01696396|17701182|P3|Overall Study|Lost to Follow-up|4
5124637|NCT01696396|17701183|P2|Overall Study|Lost to Follow-up|1
5124638|NCT01696396|17701184|P1|Overall Study|Lost to Follow-up|9
5124639|NCT01696396|17701181|P4|Overall Study|Decision by Sponsor|2
5124640|NCT01696396|17701182|P3|Overall Study|Decision by Sponsor|2
5124641|NCT01696396|17701183|P2|Overall Study|Decision by Sponsor|1
5124642|NCT01696396|17701184|P1|Overall Study|Decision by Sponsor|3
5124643|NCT01696396|17701181|P4|Overall Study|Withdrawal by Subject|11
5124644|NCT01696396|17701182|P3|Overall Study|Withdrawal by Subject|19
5124645|NCT01696396|17701183|P2|Overall Study|Withdrawal by Subject|5
5124646|NCT01696396|17701184|P1|Overall Study|Withdrawal by Subject|19
5124647|NCT01696279|17701235|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
5124648|NCT01696279|17701236|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5124649|NCT01696279|17701237|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5124650|NCT01696279|17701238|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5124651|NCT01696279|17701235|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
5124652|NCT01696279|17701236|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5124653|NCT01696279|17701237|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5124654|NCT01696279|17701238|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5124655|NCT01696279|17701235|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
5124656|NCT01696279|17701236|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5124657|NCT01696279|17701237|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5124658|NCT01696279|17701238|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5124659|NCT01696279|17701235|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5124660|NCT01696279|17701236|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
5124661|NCT01696279|17701237|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5124662|NCT01696279|17701238|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5124663|NCT01696279|17701235|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5124664|NCT01696279|17701236|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5124665|NCT01696279|17701237|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
5124666|NCT01696279|17701238|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5124667|NCT01696279|17701235|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5124668|NCT01696279|17701236|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5124669|NCT01696279|17701237|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
5124670|NCT01696279|17701238|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5124671|NCT01696279|17701235|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5124672|NCT01696279|17701236|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5124673|NCT01696279|17701237|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
5124674|NCT01696279|17701238|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5124675|NCT01696279|17701235|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5124676|NCT01696279|17701236|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5124677|NCT01696279|17701237|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
5124678|NCT01696279|17701238|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5124679|NCT01696279|17701235|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5124680|NCT01696279|17701236|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5124681|NCT01696279|17701237|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
5124682|NCT01696279|17701238|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5124683|NCT01696279|17701235|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5124684|NCT01696279|17701236|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5124685|NCT01696279|17701237|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
5124686|NCT01696279|17701238|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5124687|NCT01696279|17701235|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5124688|NCT01696279|17701236|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5124689|NCT01696279|17701237|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5124690|NCT01696279|17701238|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
5124691|NCT01696214|17701276|P4|Overall Study|Lost to Follow-up|0
5124692|NCT01696214|17701277|P3|Overall Study|Lost to Follow-up|0
5124693|NCT01696214|17701278|P2|Overall Study|Lost to Follow-up|0
5124694|NCT01696214|17701279|P1|Overall Study|Lost to Follow-up|1
5124695|NCT01696188|17701299|P2|Overall Study|Protocol Violation|1
5124696|NCT01696188|17701300|P1|Overall Study|Protocol Violation|1
5124697|NCT01696071|17701331|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
5124698|NCT01696071|17701332|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
5124699|NCT01696058|17701360|P2|Overall Study|Other reason prematurely discontinued|3
5124700|NCT01696058|17701361|P1|Overall Study|Other reason prematurely discontinued|5
5124701|NCT01696058|17701360|P2|Overall Study|Withdrawal by Subject|6
5124702|NCT01696058|17701361|P1|Overall Study|Withdrawal by Subject|4
5124703|NCT01696058|17701360|P2|Overall Study|Lost to Follow-up|5
5124704|NCT01696058|17701361|P1|Overall Study|Lost to Follow-up|2
5124705|NCT01696058|17701360|P2|Overall Study|Protocol Violation|3
5124706|NCT01696058|17701361|P1|Overall Study|Protocol Violation|9
5124707|NCT01696058|17701360|P2|Overall Study|Lack of Efficacy|3
5124708|NCT01696058|17701361|P1|Overall Study|Lack of Efficacy|2
5124709|NCT01696058|17701360|P2|Overall Study|Adverse Event|11
5124710|NCT01696058|17701361|P1|Overall Study|Adverse Event|21
5124711|NCT01696045|17701389|P2|Overall Study|Disease progression|2
5124712|NCT01696045|17701390|P1|Overall Study|Disease progression|2
5124713|NCT01696045|17701389|P2|Overall Study|Study drug toxicity|5
5124714|NCT01696045|17701390|P1|Overall Study|Study drug toxicity|1
5124715|NCT01695993|17701409|P3|Overall Study|Changed Medical Facility|1
5124716|NCT01695993|17701410|P2|Overall Study|Changed Medical Facility|0
5124717|NCT01695993|17701411|P1|Overall Study|Changed Medical Facility|0
5124718|NCT01695993|17701409|P3|Overall Study|To ill to continue|0
5124719|NCT01695993|17701410|P2|Overall Study|To ill to continue|2
5124720|NCT01695993|17701411|P1|Overall Study|To ill to continue|1
5124721|NCT01695993|17701409|P3|Overall Study|Withdrawal by Subject|2
5124722|NCT01695993|17701410|P2|Overall Study|Withdrawal by Subject|2
5124723|NCT01695993|17701411|P1|Overall Study|Withdrawal by Subject|2
5124724|NCT01695993|17701409|P3|Overall Study|Lost to Follow-up|3
5124725|NCT01695993|17701410|P2|Overall Study|Lost to Follow-up|1
5124726|NCT01695993|17701411|P1|Overall Study|Lost to Follow-up|2
5124727|NCT01695954|17701421|P2|Overall Study|Adverse Event|2
5124728|NCT01695954|17701422|P1|Overall Study|Adverse Event|0
5124729|NCT01695954|17701421|P2|Overall Study|Withdrawal by Subject|0
5124730|NCT01695954|17701422|P1|Overall Study|Withdrawal by Subject|4
5124731|NCT01695772|17701432|P1|Overall Study|Unspecified Reason|1
5124732|NCT01695772|17701432|P1|Overall Study|Protocol Violation|2
5124733|NCT01695772|17701432|P1|Overall Study|Lost to Follow-up|4
5124734|NCT01695772|17701432|P1|Overall Study|Investigator Decision|5
5124735|NCT01695772|17701432|P1|Overall Study|Progressive Disease|8
5124736|NCT01695772|17701432|P1|Overall Study|Withdrawal by Subject|18
5124737|NCT01695746|17701444|P1|Overall Study|Participant not willing to participate|3
5124738|NCT01695746|17701444|P1|Overall Study|Protocol Violation|5
5124739|NCT01695746|17701444|P1|Overall Study|Non-compliance by the participant|3
5124740|NCT01695746|17701444|P1|Overall Study|Adverse Event|1
5124741|NCT01695239|17701504|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
5124742|NCT01695239|17701505|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
5124743|NCT01695239|17701506|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
5124744|NCT01695239|17701507|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
5124745|NCT01695239|17701508|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
5124746|NCT01695239|17701509|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
5124747|NCT01695239|17701510|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
5124748|NCT01695239|17701511|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
5124749|NCT01695239|17701512|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
5124750|NCT01695239|17701513|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
5124751|NCT01695239|17701514|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
5124752|NCT01695239|17701515|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
5124753|NCT01695239|17701516|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
5124754|NCT01695239|17701517|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
5124755|NCT01695239|17701504|P14|Post-Treatment Follow-Up Period|Physician Decision|0
5124756|NCT01695239|17701505|P13|Post-Treatment Follow-Up Period|Physician Decision|2
5124757|NCT01695239|17701506|P12|Post-Treatment Follow-Up Period|Physician Decision|0
5124758|NCT01695239|17701507|P11|Post-Treatment Follow-Up Period|Physician Decision|0
5124759|NCT01695239|17701508|P10|Post-Treatment Follow-Up Period|Physician Decision|0
5124760|NCT01695239|17701509|P9|Post-Treatment Follow-Up Period|Physician Decision|0
5124761|NCT01695239|17701510|P8|Post-Treatment Follow-Up Period|Physician Decision|0
5124762|NCT01695239|17701511|P7|Post-Treatment Follow-Up Period|Physician Decision|0
5124763|NCT01695239|17701512|P6|Post-Treatment Follow-Up Period|Physician Decision|0
5124764|NCT01695239|17701513|P5|Post-Treatment Follow-Up Period|Physician Decision|0
5124765|NCT01695239|17701514|P4|Post-Treatment Follow-Up Period|Physician Decision|0
5124766|NCT01695239|17701515|P3|Post-Treatment Follow-Up Period|Physician Decision|0
5124767|NCT01695239|17701516|P2|Post-Treatment Follow-Up Period|Physician Decision|0
5124768|NCT01695239|17701517|P1|Post-Treatment Follow-Up Period|Physician Decision|0
5124769|NCT01695239|17701504|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
5124770|NCT01695239|17701505|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
5124771|NCT01695239|17701506|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124772|NCT01695239|17701507|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124773|NCT01695239|17701508|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124774|NCT01695239|17701509|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124775|NCT01695239|17701510|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124776|NCT01695239|17701511|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124777|NCT01695239|17701512|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124778|NCT01695239|17701513|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124779|NCT01695239|17701514|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124780|NCT01695239|17701515|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124781|NCT01695239|17701516|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124782|NCT01695239|17701517|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5124783|NCT01695239|17701504|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5124784|NCT01695239|17701505|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
5124785|NCT01695239|17701506|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
5124786|NCT01695239|17701507|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124787|NCT01695239|17701508|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124788|NCT01695239|17701509|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124789|NCT01695239|17701510|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124790|NCT01695239|17701511|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124791|NCT01695239|17701512|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124792|NCT01695239|17701513|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124793|NCT01695239|17701514|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124794|NCT01695239|17701515|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124795|NCT01695239|17701516|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124796|NCT01695239|17701517|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5124797|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Death|0
5124798|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Death|0
5124799|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Death|0
5124800|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Death|0
5124801|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Death|0
5124802|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Death|1
5124803|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Death|0
5124804|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Death|0
5124805|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Death|0
5124806|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Death|0
5124807|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Death|0
5124808|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Death|0
5124809|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Death|0
5124810|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Death|0
5124811|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
5124812|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
5124813|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
5124814|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
5124815|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
5124816|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
5124817|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
5124818|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
5124819|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
5124820|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
5124821|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
5124822|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
5124823|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
5124824|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
5124825|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124826|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124827|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124828|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124829|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
5124830|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
5124831|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124832|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124833|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124834|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124835|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124836|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124837|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124838|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
5124839|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Physician Decision|0
5124840|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Physician Decision|0
5124841|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Physician Decision|0
5124842|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Physician Decision|0
5124843|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Physician Decision|0
5124844|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Physician Decision|3
5124845|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Physician Decision|0
5124846|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Physician Decision|0
5124847|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Physician Decision|0
5124848|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Physician Decision|0
5124849|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Physician Decision|0
5124850|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Physician Decision|0
5124851|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Physician Decision|0
5124852|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Physician Decision|0
5124853|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124854|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124855|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124856|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124857|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
5124858|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
5124859|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124860|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124861|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124862|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124863|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124864|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124865|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124866|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5124867|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Adverse Event|0
5124868|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Adverse Event|0
5124869|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Adverse Event|0
5124870|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Adverse Event|0
5124871|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Adverse Event|21
5124872|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Adverse Event|15
5124873|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Adverse Event|0
5124874|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Adverse Event|0
5124875|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Adverse Event|0
5124876|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Adverse Event|0
5124877|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Adverse Event|0
5124878|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Adverse Event|0
5124879|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Adverse Event|0
5124880|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Adverse Event|0
5124881|NCT01695239|17701504|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124882|NCT01695239|17701505|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124883|NCT01695239|17701506|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124884|NCT01695239|17701507|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124885|NCT01695239|17701508|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
5124886|NCT01695239|17701509|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
5124887|NCT01695239|17701510|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124888|NCT01695239|17701511|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124889|NCT01695239|17701512|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124890|NCT01695239|17701513|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124891|NCT01695239|17701514|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124892|NCT01695239|17701515|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124893|NCT01695239|17701516|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124894|NCT01695239|17701517|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
5124895|NCT01695239|17701504|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124896|NCT01695239|17701505|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124897|NCT01695239|17701506|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124898|NCT01695239|17701507|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124899|NCT01695239|17701508|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124900|NCT01695239|17701509|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124901|NCT01695239|17701510|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
5124902|NCT01695239|17701511|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124903|NCT01695239|17701512|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124904|NCT01695239|17701513|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124905|NCT01695239|17701514|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124906|NCT01695239|17701515|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124907|NCT01695239|17701516|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124908|NCT01695239|17701517|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5124909|NCT01695239|17701504|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124910|NCT01695239|17701505|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124911|NCT01695239|17701506|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124912|NCT01695239|17701507|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124913|NCT01695239|17701508|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124914|NCT01695239|17701509|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124915|NCT01695239|17701510|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
5124916|NCT01695239|17701511|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124917|NCT01695239|17701512|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124918|NCT01695239|17701513|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124919|NCT01695239|17701514|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124920|NCT01695239|17701515|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124921|NCT01695239|17701516|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124922|NCT01695239|17701517|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5124923|NCT01695239|17701504|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124924|NCT01695239|17701505|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124925|NCT01695239|17701506|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124926|NCT01695239|17701507|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124927|NCT01695239|17701508|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124928|NCT01695239|17701509|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124929|NCT01695239|17701510|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
5124930|NCT01695239|17701511|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124931|NCT01695239|17701512|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124932|NCT01695239|17701513|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124933|NCT01695239|17701514|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124934|NCT01695239|17701515|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124935|NCT01695239|17701516|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124936|NCT01695239|17701517|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5124937|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124938|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124939|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124940|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124941|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124942|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124943|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124944|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124945|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124946|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124947|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124948|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124949|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
5124950|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
5124951|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124952|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124953|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124954|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124955|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124956|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124957|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124958|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124959|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124960|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124961|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124962|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5124963|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5124964|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5124965|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124966|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124967|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124968|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124969|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124970|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124971|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124972|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124973|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124974|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124975|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124976|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
5124977|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5124978|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
5124979|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124980|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124981|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124982|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124983|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124984|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124985|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124986|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124987|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124988|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124989|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5124990|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
5124991|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
5124992|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
5124993|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5124994|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5124995|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5124996|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5124997|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5124998|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5124999|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5125000|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5125001|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5125002|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5125003|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5125004|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
5125005|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5125006|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
5125007|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
5125008|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
5125009|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
5125010|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
5125011|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
5125012|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
5125013|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
5125014|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
5125015|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
5125016|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
5125017|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
5125018|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
5125019|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
5125020|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
5125096|NCT01694771|17701711|P1|Overall Study|Lost to Follow-up|2
5125021|NCT01695239|17701504|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125022|NCT01695239|17701505|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125023|NCT01695239|17701506|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125024|NCT01695239|17701507|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125025|NCT01695239|17701508|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125026|NCT01695239|17701509|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125027|NCT01695239|17701510|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125028|NCT01695239|17701511|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125029|NCT01695239|17701512|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125030|NCT01695239|17701513|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5125031|NCT01695239|17701514|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
5125032|NCT01695239|17701515|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
5125033|NCT01695239|17701516|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
5125034|NCT01695239|17701517|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
5125035|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
5125036|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5125037|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5125038|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5125039|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Death|7
5125040|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Death|2
5125041|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Death|0
5125042|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Death|0
5125043|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Physician Decision|1
5125044|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Physician Decision|4
5125045|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Physician Decision|0
5125046|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Physician Decision|0
5125047|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Other|7
5125048|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Other|4
5125049|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Other|0
5125050|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Other|0
5125051|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Adverse Event|16
5125052|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Adverse Event|11
5125053|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Adverse Event|0
5125054|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Adverse Event|0
5125055|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
5125056|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
5125057|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
5125058|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
5125059|NCT01695135|17701658|P4|Open Label Extension Treatment Phase|Progressive disease|22
5125060|NCT01695135|17701659|P3|Open Label Extension Treatment Phase|Progressive disease|13
5125061|NCT01695135|17701660|P2|Open Label Extension Treatment Phase|Progressive disease|0
5125062|NCT01695135|17701661|P1|Open Label Extension Treatment Phase|Progressive disease|0
5125063|NCT01695135|17701658|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
5125064|NCT01695135|17701659|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
5125065|NCT01695135|17701660|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
5125066|NCT01695135|17701661|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
5125067|NCT01695135|17701658|P4|Double-blind Treatment Phase|Death|0
5125068|NCT01695135|17701659|P3|Double-blind Treatment Phase|Death|0
5125069|NCT01695135|17701660|P2|Double-blind Treatment Phase|Death|1
5125070|NCT01695135|17701661|P1|Double-blind Treatment Phase|Death|1
5125071|NCT01695135|17701658|P4|Double-blind Treatment Phase|Physician Decision|0
5125072|NCT01695135|17701659|P3|Double-blind Treatment Phase|Physician Decision|0
5125073|NCT01695135|17701660|P2|Double-blind Treatment Phase|Physician Decision|3
5125074|NCT01695135|17701661|P1|Double-blind Treatment Phase|Physician Decision|6
5125075|NCT01695135|17701658|P4|Double-blind Treatment Phase|Other|0
5125076|NCT01695135|17701659|P3|Double-blind Treatment Phase|Other|0
5125077|NCT01695135|17701660|P2|Double-blind Treatment Phase|Other|3
5125078|NCT01695135|17701661|P1|Double-blind Treatment Phase|Other|1
5125079|NCT01695135|17701658|P4|Double-blind Treatment Phase|Adverse Event|0
5125080|NCT01695135|17701659|P3|Double-blind Treatment Phase|Adverse Event|0
5125081|NCT01695135|17701660|P2|Double-blind Treatment Phase|Adverse Event|7
5125082|NCT01695135|17701661|P1|Double-blind Treatment Phase|Adverse Event|7
5125083|NCT01695135|17701658|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
5125084|NCT01695135|17701659|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
5125085|NCT01695135|17701660|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
5125086|NCT01695135|17701661|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
5125087|NCT01695135|17701658|P4|Double-blind Treatment Phase|Progressive disease|0
5125088|NCT01695135|17701659|P3|Double-blind Treatment Phase|Progressive disease|0
5125089|NCT01695135|17701660|P2|Double-blind Treatment Phase|Progressive disease|110
5125090|NCT01695135|17701661|P1|Double-blind Treatment Phase|Progressive disease|50
5125091|NCT01694771|17701710|P2|Overall Study|Other reasons|6
5125092|NCT01694771|17701711|P1|Overall Study|Other reasons|5
5125093|NCT01694771|17701710|P2|Overall Study|Consent withdrawn|9
5125094|NCT01694771|17701711|P1|Overall Study|Consent withdrawn|7
5125095|NCT01694771|17701710|P2|Overall Study|Lost to Follow-up|3
5125097|NCT01694771|17701710|P2|Overall Study|Non compliance protocol|6
5125098|NCT01694771|17701711|P1|Overall Study|Non compliance protocol|7
5125099|NCT01694771|17701710|P2|Overall Study|Lack of Efficacy|0
5125100|NCT01694771|17701711|P1|Overall Study|Lack of Efficacy|1
5125101|NCT01694771|17701710|P2|Overall Study|Adverse Event|16
5125102|NCT01694771|17701711|P1|Overall Study|Adverse Event|18
5125103|NCT01694706|17701735|P3|Overall Study|other reason not defined above|0
5125104|NCT01694706|17701736|P2|Overall Study|other reason not defined above|0
5125105|NCT01694706|17701737|P1|Overall Study|other reason not defined above|1
5125106|NCT01694706|17701735|P3|Overall Study|Adverse Event|0
5125107|NCT01694706|17701736|P2|Overall Study|Adverse Event|1
5125108|NCT01694706|17701737|P1|Overall Study|Adverse Event|0
5125109|NCT01694485|17701796|P5|Overall Study|Death|0
5125110|NCT01694485|17701797|P4|Overall Study|Death|1
5125111|NCT01694485|17701798|P3|Overall Study|Death|0
5125112|NCT01694485|17701799|P2|Overall Study|Death|0
5125113|NCT01694485|17701800|P1|Overall Study|Death|1
5125114|NCT01694485|17701796|P5|Overall Study|Lost to Follow-up|7
5125115|NCT01694485|17701797|P4|Overall Study|Lost to Follow-up|10
5125116|NCT01694485|17701798|P3|Overall Study|Lost to Follow-up|6
5125117|NCT01694485|17701799|P2|Overall Study|Lost to Follow-up|1
5125118|NCT01694485|17701800|P1|Overall Study|Lost to Follow-up|9
5125119|NCT01694485|17701796|P5|Overall Study|Sponsor Decision|0
5125120|NCT01694485|17701797|P4|Overall Study|Sponsor Decision|2
5125121|NCT01694485|17701798|P3|Overall Study|Sponsor Decision|0
5125122|NCT01694485|17701799|P2|Overall Study|Sponsor Decision|0
5125123|NCT01694485|17701800|P1|Overall Study|Sponsor Decision|3
5125124|NCT01694485|17701796|P5|Overall Study|Withdrawal by Subject|18
5125125|NCT01694485|17701797|P4|Overall Study|Withdrawal by Subject|25
5125126|NCT01694485|17701798|P3|Overall Study|Withdrawal by Subject|7
5125127|NCT01694485|17701799|P2|Overall Study|Withdrawal by Subject|6
5125128|NCT01694485|17701800|P1|Overall Study|Withdrawal by Subject|20
5125129|NCT01694433|17701834|P2|Overall Study|Withdrawal by Subject|4
5125130|NCT01694433|17701835|P1|Overall Study|Withdrawal by Subject|3
5125131|NCT01694433|17701834|P2|Overall Study|Physician Decision|0
5125132|NCT01694433|17701835|P1|Overall Study|Physician Decision|1
5125133|NCT01694433|17701834|P2|Overall Study|Adverse Event|0
5125134|NCT01694433|17701835|P1|Overall Study|Adverse Event|7
5125135|NCT01694420|17701843|P1|Overall Study|Lost to Follow-up|3
5125136|NCT01694121|17701880|P2|Overall Study|Participant used false ID, was withdrawn|0
5125137|NCT01694121|17701881|P1|Overall Study|Participant used false ID, was withdrawn|1
5125138|NCT01693614|17701995|P3|Overall Study|Withdrawal by Subject|5
5125139|NCT01693614|17701996|P2|Overall Study|Withdrawal by Subject|0
5125140|NCT01693614|17701997|P1|Overall Study|Withdrawal by Subject|1
5125141|NCT01693614|17701995|P3|Overall Study|Withdrawal by subject/guardian|2
5125142|NCT01693614|17701996|P2|Overall Study|Withdrawal by subject/guardian|0
5125143|NCT01693614|17701997|P1|Overall Study|Withdrawal by subject/guardian|0
5125144|NCT01693614|17701995|P3|Overall Study|Physician Decision|4
5125145|NCT01693614|17701996|P2|Overall Study|Physician Decision|1
5125146|NCT01693614|17701997|P1|Overall Study|Physician Decision|1
5125147|NCT01693614|17701995|P3|Overall Study|Death|0
5125148|NCT01693614|17701996|P2|Overall Study|Death|0
5125149|NCT01693614|17701997|P1|Overall Study|Death|1
5125150|NCT01693614|17701995|P3|Overall Study|Protocol Violation|1
5125151|NCT01693614|17701996|P2|Overall Study|Protocol Violation|2
5125152|NCT01693614|17701997|P1|Overall Study|Protocol Violation|5
5125153|NCT01693614|17701995|P3|Overall Study|Disease progression|7
5125154|NCT01693614|17701996|P2|Overall Study|Disease progression|8
5125155|NCT01693614|17701997|P1|Overall Study|Disease progression|11
5125156|NCT01693614|17701995|P3|Overall Study|Adverse Event|5
5125157|NCT01693614|17701996|P2|Overall Study|Adverse Event|11
5125158|NCT01693614|17701997|P1|Overall Study|Adverse Event|7
5125159|NCT01693523|17702022|P3|Overall Study|Chemotherapy was held|0
5125160|NCT01693523|17702023|P2|Overall Study|Chemotherapy was held|2
5125161|NCT01693523|17702024|P1|Overall Study|Chemotherapy was held|1
5125162|NCT01693523|17702022|P3|Overall Study|Lack of compliance study medication|0
5125163|NCT01693523|17702023|P2|Overall Study|Lack of compliance study medication|2
5125164|NCT01693523|17702024|P1|Overall Study|Lack of compliance study medication|1
5125165|NCT01693523|17702022|P3|Overall Study|Withdrawal by Subject|2
5125166|NCT01693523|17702023|P2|Overall Study|Withdrawal by Subject|2
5125167|NCT01693523|17702024|P1|Overall Study|Withdrawal by Subject|1
5125168|NCT01693523|17702022|P3|Overall Study|Physician Decision|1
5125169|NCT01693523|17702023|P2|Overall Study|Physician Decision|0
5125170|NCT01693523|17702024|P1|Overall Study|Physician Decision|0
5125171|NCT01693523|17702022|P3|Overall Study|Lost to Follow-up|4
5125172|NCT01693523|17702023|P2|Overall Study|Lost to Follow-up|0
5125173|NCT01693523|17702024|P1|Overall Study|Lost to Follow-up|0
5125174|NCT01693523|17702022|P3|Overall Study|Death|1
5125175|NCT01693523|17702023|P2|Overall Study|Death|1
5125176|NCT01693523|17702024|P1|Overall Study|Death|0
5125177|NCT01693523|17702022|P3|Overall Study|Adverse Event|0
5125178|NCT01693523|17702023|P2|Overall Study|Adverse Event|1
5125179|NCT01693523|17702024|P1|Overall Study|Adverse Event|2
5125180|NCT01693367|17702040|P2|Overall Study|Physician Decision|1
5125181|NCT01693367|17702041|P1|Overall Study|Physician Decision|0
5125182|NCT01693367|17702040|P2|Overall Study|Withdrawal by Subject|1
5125183|NCT01693367|17702041|P1|Overall Study|Withdrawal by Subject|1
5125184|NCT01693250|17702059|P2|Overall Study|Lost to Follow-up|2
5125185|NCT01693250|17702060|P1|Overall Study|Lost to Follow-up|2
5125272|NCT01692301|17702342|P1|Overall Study|Technical problems|0
5125186|NCT01693185|17702070|P2|Overall Study|diagnostic procedure after colonoscopy|6
5125187|NCT01693185|17702071|P1|Overall Study|diagnostic procedure after colonoscopy|0
5125188|NCT01693120|17702087|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
5125189|NCT01693120|17702087|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
5125190|NCT01693120|17702087|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
5125191|NCT01693120|17702087|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
5125192|NCT01693120|17702087|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
5125193|NCT01693120|17702087|P1|Enrollment|Other|1
5125194|NCT01693120|17702087|P1|Enrollment|Study closed|8
5125195|NCT01693120|17702087|P1|Enrollment|Adverse Event|1
5125196|NCT01693120|17702087|P1|Enrollment|Physician Decision|3
5125197|NCT01693120|17702087|P1|Enrollment|Protocol Violation|46
5125198|NCT01693120|17702087|P1|Enrollment|Withdrawal by Subject|10
5125199|NCT01693120|17702087|P1|Enrollment|Lost to Follow-up|1
5125200|NCT01693068|17702096|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
5125201|NCT01693068|17702097|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
5125202|NCT01693068|17702098|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
5125203|NCT01693068|17702096|P3|Randomization Period|On-study|0
5125204|NCT01693068|17702097|P2|Randomization Period|On-study|5
5125205|NCT01693068|17702098|P1|Randomization Period|On-study|2
5125206|NCT01693029|17702130|P2|Overall Study|Non-compliance|1
5125207|NCT01693029|17702131|P1|Overall Study|Non-compliance|2
5125208|NCT01693029|17702130|P2|Overall Study|Death|8
5125209|NCT01693029|17702131|P1|Overall Study|Death|5
5125210|NCT01693029|17702130|P2|Overall Study|Adverse Event|6
5125211|NCT01693029|17702131|P1|Overall Study|Adverse Event|1
5125212|NCT01693029|17702130|P2|Overall Study|Lost to Follow-up|1
5125213|NCT01693029|17702131|P1|Overall Study|Lost to Follow-up|0
5125214|NCT01693029|17702130|P2|Overall Study|Physician Decision|2
5125215|NCT01693029|17702131|P1|Overall Study|Physician Decision|0
5125216|NCT01693029|17702130|P2|Overall Study|Change in dialysis modality|1
5125217|NCT01693029|17702131|P1|Overall Study|Change in dialysis modality|2
5125218|NCT01693029|17702130|P2|Overall Study|Protocol Violation|7
5125219|NCT01693029|17702131|P1|Overall Study|Protocol Violation|6
5125220|NCT01693029|17702130|P2|Overall Study|Bindinging anti-EPO antibodies|2
5125221|NCT01693029|17702131|P1|Overall Study|Bindinging anti-EPO antibodies|6
5125222|NCT01693029|17702130|P2|Overall Study|Kidney transplantation|7
5125223|NCT01693029|17702131|P1|Overall Study|Kidney transplantation|7
5125224|NCT01693029|17702130|P2|Overall Study|Withdrawal by Subject|22
5125225|NCT01693029|17702131|P1|Overall Study|Withdrawal by Subject|15
5125226|NCT01692938|17702167|P2|Overall Study|Study completed prior to site completion|3
5125227|NCT01692938|17702168|P1|Overall Study|Study completed prior to site completion|3
5125228|NCT01692938|17702167|P2|Overall Study|Protocol Deviation|1
5125229|NCT01692938|17702168|P1|Overall Study|Protocol Deviation|1
5125230|NCT01692782|17702179|P3|Overall Study|Withdrawal by Subject|3
5125231|NCT01692782|17702180|P2|Overall Study|Withdrawal by Subject|10
5125232|NCT01692782|17702181|P1|Overall Study|Withdrawal by Subject|3
5125233|NCT01692782|17702179|P3|Overall Study|SAE not related to study drug|0
5125234|NCT01692782|17702180|P2|Overall Study|SAE not related to study drug|1
5125235|NCT01692782|17702181|P1|Overall Study|SAE not related to study drug|0
5125236|NCT01692782|17702179|P3|Overall Study|Non-compliant with study visits|1
5125237|NCT01692782|17702180|P2|Overall Study|Non-compliant with study visits|0
5125238|NCT01692782|17702181|P1|Overall Study|Non-compliant with study visits|0
5125239|NCT01692782|17702179|P3|Overall Study|Non-complance with study drug|1
5125240|NCT01692782|17702180|P2|Overall Study|Non-complance with study drug|4
5125241|NCT01692782|17702181|P1|Overall Study|Non-complance with study drug|0
5125242|NCT01692782|17702179|P3|Overall Study|Protocol Violation|2
5125243|NCT01692782|17702180|P2|Overall Study|Protocol Violation|0
5125244|NCT01692782|17702181|P1|Overall Study|Protocol Violation|1
5125245|NCT01692782|17702179|P3|Overall Study|Pregnancy|0
5125246|NCT01692782|17702180|P2|Overall Study|Pregnancy|0
5125247|NCT01692782|17702181|P1|Overall Study|Pregnancy|1
5125248|NCT01692782|17702179|P3|Overall Study|Lost to Follow-up|1
5125249|NCT01692782|17702180|P2|Overall Study|Lost to Follow-up|7
5125250|NCT01692782|17702181|P1|Overall Study|Lost to Follow-up|2
5125251|NCT01692782|17702179|P3|Overall Study|Lack of Efficacy|0
5125252|NCT01692782|17702180|P2|Overall Study|Lack of Efficacy|2
5125253|NCT01692782|17702181|P1|Overall Study|Lack of Efficacy|1
5125254|NCT01692782|17702179|P3|Overall Study|Adverse Event|2
5125255|NCT01692782|17702180|P2|Overall Study|Adverse Event|32
5125256|NCT01692782|17702181|P1|Overall Study|Adverse Event|12
5125257|NCT01692730|17702290|P2|Overall Study|Lost to Follow-up|227
5125258|NCT01692730|17702291|P1|Overall Study|Lost to Follow-up|225
5125259|NCT01692626|17702305|P2|Overall Study|Withdrawal by Subject|0
5125260|NCT01692626|17702306|P1|Overall Study|Withdrawal by Subject|1
5125261|NCT01692626|17702305|P2|Overall Study|Protocol Violation|2
5125262|NCT01692626|17702306|P1|Overall Study|Protocol Violation|1
5125263|NCT01692626|17702305|P2|Overall Study|Adverse Event|3
5125264|NCT01692626|17702306|P1|Overall Study|Adverse Event|2
5125265|NCT01692626|17702305|P2|Overall Study|Death|1
5125266|NCT01692626|17702306|P1|Overall Study|Death|0
5125267|NCT01692301|17702341|P2|Overall Study|Lost to Follow-up|1
5125268|NCT01692301|17702342|P1|Overall Study|Lost to Follow-up|1
5125269|NCT01692301|17702341|P2|Overall Study|Physician Decision|2
5125270|NCT01692301|17702342|P1|Overall Study|Physician Decision|2
5125271|NCT01692301|17702341|P2|Overall Study|Technical problems|1
5125273|NCT01692301|17702341|P2|Overall Study|Patient/guardian decision|15
5125274|NCT01692301|17702342|P1|Overall Study|Patient/guardian decision|16
5125275|NCT01692301|17702341|P2|Overall Study|Protocol deviation|2
5125276|NCT01692301|17702342|P1|Overall Study|Protocol deviation|9
5125277|NCT01692301|17702341|P2|Overall Study|Non-compliance with study treatment|2
5125278|NCT01692301|17702342|P1|Overall Study|Non-compliance with study treatment|1
5125279|NCT01692301|17702341|P2|Overall Study|Lack of Efficacy|5
5125280|NCT01692301|17702342|P1|Overall Study|Lack of Efficacy|0
5125281|NCT01692301|17702341|P2|Overall Study|Death|2
5125282|NCT01692301|17702342|P1|Overall Study|Death|1
5125283|NCT01692301|17702341|P2|Overall Study|Adverse Event|12
5125284|NCT01692301|17702342|P1|Overall Study|Adverse Event|15
5125285|NCT01692275|17702374|P2|Overall Study|Withdrawal by Subject|11
5125286|NCT01692275|17702375|P1|Overall Study|Withdrawal by Subject|9
5125287|NCT01692275|17702374|P2|Overall Study|Lost to Follow-up|48
5125288|NCT01692275|17702375|P1|Overall Study|Lost to Follow-up|57
5125289|NCT01692197|17702435|P1|Overall Study|Failed Screening|3
5125290|NCT01691898|17702457|P6|Overall Study|Non-Compliance|0
5125291|NCT01691898|17702458|P5|Overall Study|Non-Compliance|1
5125292|NCT01691898|17702459|P4|Overall Study|Non-Compliance|0
5125293|NCT01691898|17702460|P3|Overall Study|Non-Compliance|0
5125294|NCT01691898|17702461|P2|Overall Study|Non-Compliance|0
5125295|NCT01691898|17702462|P1|Overall Study|Non-Compliance|0
5125296|NCT01691898|17702457|P6|Overall Study|Withdrawal by Subject|3
5125297|NCT01691898|17702458|P5|Overall Study|Withdrawal by Subject|3
5125298|NCT01691898|17702459|P4|Overall Study|Withdrawal by Subject|1
5125299|NCT01691898|17702460|P3|Overall Study|Withdrawal by Subject|2
5125300|NCT01691898|17702461|P2|Overall Study|Withdrawal by Subject|8
5125301|NCT01691898|17702462|P1|Overall Study|Withdrawal by Subject|9
5125302|NCT01691898|17702457|P6|Overall Study|Lost to Follow-up|0
5125303|NCT01691898|17702458|P5|Overall Study|Lost to Follow-up|1
5125304|NCT01691898|17702459|P4|Overall Study|Lost to Follow-up|0
5125305|NCT01691898|17702460|P3|Overall Study|Lost to Follow-up|0
5125306|NCT01691898|17702461|P2|Overall Study|Lost to Follow-up|1
5125307|NCT01691898|17702462|P1|Overall Study|Lost to Follow-up|3
5125308|NCT01691898|17702457|P6|Overall Study|Progression of Disease|1
5125309|NCT01691898|17702458|P5|Overall Study|Progression of Disease|0
5125310|NCT01691898|17702459|P4|Overall Study|Progression of Disease|0
5125311|NCT01691898|17702460|P3|Overall Study|Progression of Disease|1
5125312|NCT01691898|17702461|P2|Overall Study|Progression of Disease|2
5125313|NCT01691898|17702462|P1|Overall Study|Progression of Disease|1
5125314|NCT01691898|17702457|P6|Overall Study|Adverse Event|0
5125315|NCT01691898|17702458|P5|Overall Study|Adverse Event|1
5125316|NCT01691898|17702459|P4|Overall Study|Adverse Event|1
5125317|NCT01691898|17702460|P3|Overall Study|Adverse Event|0
5125318|NCT01691898|17702461|P2|Overall Study|Adverse Event|1
5125319|NCT01691898|17702462|P1|Overall Study|Adverse Event|0
5125320|NCT01691898|17702457|P6|Overall Study|Death|31
5125321|NCT01691898|17702458|P5|Overall Study|Death|8
5125322|NCT01691898|17702459|P4|Overall Study|Death|3
5125323|NCT01691898|17702460|P3|Overall Study|Death|6
5125324|NCT01691898|17702461|P2|Overall Study|Death|32
5125325|NCT01691898|17702462|P1|Overall Study|Death|34
5125326|NCT01691885|17702616|P2|Washout Period (7-9 Days)|Adverse Event|1
5125327|NCT01691885|17702617|P1|Washout Period (7-9 Days)|Adverse Event|0
5125328|NCT01691885|17702616|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
5125329|NCT01691885|17702617|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
5125330|NCT01691859|17702623|P1|Overall Study|Withdrawal by Subject|31
5125331|NCT01691859|17702623|P1|Overall Study|Physician Decision|6
5125332|NCT01691859|17702623|P1|Overall Study|Lost to Follow-up|5
5125333|NCT01691859|17702623|P1|Overall Study|Study closed/terminated|50
5125334|NCT01691859|17702623|P1|Overall Study|Product commercially available|221
5125335|NCT01691859|17702623|P1|Overall Study|Protocol Violation|4
5125336|NCT01691859|17702623|P1|Overall Study|Lack of Efficacy|11
5125337|NCT01691859|17702623|P1|Overall Study|Adverse Event|19
5125338|NCT01691820|17702670|P3|Overall Study|Other (unspecified)|1
5125339|NCT01691820|17702671|P2|Overall Study|Other (unspecified)|0
5125340|NCT01691820|17702672|P1|Overall Study|Other (unspecified)|5
5125341|NCT01691820|17702670|P3|Overall Study|Lost to Follow-up|0
5125342|NCT01691820|17702671|P2|Overall Study|Lost to Follow-up|15
5125343|NCT01691820|17702672|P1|Overall Study|Lost to Follow-up|8
5125344|NCT01691820|17702670|P3|Overall Study|Migrated/moved from study area|0
5125345|NCT01691820|17702671|P2|Overall Study|Migrated/moved from study area|4
5125346|NCT01691820|17702672|P1|Overall Study|Migrated/moved from study area|7
5125347|NCT01691820|17702670|P3|Overall Study|Consent withdrawal (not due to an AE)|0
5125348|NCT01691820|17702671|P2|Overall Study|Consent withdrawal (not due to an AE)|15
5125349|NCT01691820|17702672|P1|Overall Study|Consent withdrawal (not due to an AE)|9
5125350|NCT01691794|17702710|P3|Overall Study|Did not complete first 24 weeks of study|3
5125351|NCT01691794|17702711|P2|Overall Study|Did not complete first 24 weeks of study|3
5125352|NCT01691794|17702712|P1|Overall Study|Did not complete first 24 weeks of study|0
5125353|NCT01691794|17702710|P3|Overall Study|Completed Only first 24 weeks of study|3
5125354|NCT01691794|17702711|P2|Overall Study|Completed Only first 24 weeks of study|2
5125355|NCT01691794|17702712|P1|Overall Study|Completed Only first 24 weeks of study|0
5125356|NCT01691794|17702710|P3|Overall Study|Adverse Event|1
5125357|NCT01691794|17702711|P2|Overall Study|Adverse Event|1
5125358|NCT01691794|17702712|P1|Overall Study|Adverse Event|0
5125359|NCT01691794|17702710|P3|Overall Study|Participant request to discontinue|0
5125360|NCT01691794|17702711|P2|Overall Study|Participant request to discontinue|1
5125361|NCT01691794|17702712|P1|Overall Study|Participant request to discontinue|0
5125362|NCT01691794|17702710|P3|Overall Study|Lack of Efficacy|1
5125363|NCT01691794|17702711|P2|Overall Study|Lack of Efficacy|7
5125364|NCT01691794|17702712|P1|Overall Study|Lack of Efficacy|0
5125365|NCT01691794|17702710|P3|Overall Study|Death|1
5125366|NCT01691794|17702711|P2|Overall Study|Death|0
5125367|NCT01691794|17702712|P1|Overall Study|Death|0
5125368|NCT01691794|17702710|P3|Overall Study|Poor/Non-Compliance|1
5125369|NCT01691794|17702711|P2|Overall Study|Poor/Non-Compliance|4
5125370|NCT01691794|17702712|P1|Overall Study|Poor/Non-Compliance|1
5125371|NCT01691781|17702728|P2|Overall Study|Adverse Event|1
5125372|NCT01691781|17702729|P1|Overall Study|Adverse Event|0
5125373|NCT01691781|17702728|P2|Overall Study|Protocol Violation|2
5125374|NCT01691781|17702729|P1|Overall Study|Protocol Violation|2
5125375|NCT01691781|17702728|P2|Overall Study|Physician Decision|1
5125376|NCT01691781|17702729|P1|Overall Study|Physician Decision|1
5125377|NCT01691781|17702728|P2|Overall Study|Withdrawal by Subject|3
5125378|NCT01691781|17702729|P1|Overall Study|Withdrawal by Subject|4
5125379|NCT01691768|17702741|P2|Overall Study|Investigator decision|1
5125380|NCT01691768|17702742|P1|Overall Study|Investigator decision|1
5125381|NCT01691768|17702741|P2|Overall Study|Relocated|1
5125382|NCT01691768|17702742|P1|Overall Study|Relocated|0
5125383|NCT01691768|17702741|P2|Overall Study|Withdrawal by Subject|9
5125384|NCT01691768|17702742|P1|Overall Study|Withdrawal by Subject|10
5125385|NCT01691768|17702741|P2|Overall Study|Lost to Follow-up|3
5125386|NCT01691768|17702742|P1|Overall Study|Lost to Follow-up|4
5125387|NCT01691768|17702741|P2|Overall Study|Death|2
5125388|NCT01691768|17702742|P1|Overall Study|Death|0
5125389|NCT01691612|17702777|P1|Overall Study|Adverse Event|1
5125390|NCT01691612|17702777|P1|Overall Study|deemed ineligible after 1st visit|6
5125391|NCT01691521|17702888|P3|Overall Study|Withdrawal by Subject|4
5125392|NCT01691521|17702889|P2|Overall Study|Withdrawal by Subject|9
5125393|NCT01691521|17702890|P1|Overall Study|Withdrawal by Subject|5
5125394|NCT01691521|17702888|P3|Overall Study|Physician Decision|0
5125395|NCT01691521|17702889|P2|Overall Study|Physician Decision|1
5125396|NCT01691521|17702890|P1|Overall Study|Physician Decision|2
5125397|NCT01691521|17702888|P3|Overall Study|Lost to Follow-up|2
5125398|NCT01691521|17702889|P2|Overall Study|Lost to Follow-up|2
5125399|NCT01691521|17702890|P1|Overall Study|Lost to Follow-up|0
5125400|NCT01691521|17702888|P3|Overall Study|Protocol Violation|0
5125401|NCT01691521|17702889|P2|Overall Study|Protocol Violation|3
5125402|NCT01691521|17702890|P1|Overall Study|Protocol Violation|0
5125403|NCT01691521|17702888|P3|Overall Study|Lack of Efficacy|2
5125404|NCT01691521|17702889|P2|Overall Study|Lack of Efficacy|1
5125405|NCT01691521|17702890|P1|Overall Study|Lack of Efficacy|1
5125406|NCT01691521|17702888|P3|Overall Study|Adverse Event|1
5125407|NCT01691521|17702889|P2|Overall Study|Adverse Event|0
5125408|NCT01691521|17702890|P1|Overall Study|Adverse Event|4
5125409|NCT01691508|17702912|P2|Overall Study|Withdrawal by Subject|0
5125410|NCT01691508|17702913|P1|Overall Study|Withdrawal by Subject|1
5125411|NCT01691508|17702912|P2|Overall Study|Adverse Event|3
5125412|NCT01691508|17702913|P1|Overall Study|Adverse Event|3
5125413|NCT01691482|17702927|P2|Treatment Period 2|Protocol Violation|1
5125414|NCT01691482|17702928|P1|Treatment Period 2|Protocol Violation|1
5125415|NCT01691482|17702927|P2|Treatment Period 2|Adverse Event|1
5125416|NCT01691482|17702928|P1|Treatment Period 2|Adverse Event|0
5125417|NCT01691430|17702946|P2|Overall Study|Lost to Follow-up|3
5125418|NCT01691430|17702947|P1|Overall Study|Lost to Follow-up|0
5125419|NCT01691430|17702946|P2|Overall Study|Withdrawal by Subject|1
5125420|NCT01691430|17702947|P1|Overall Study|Withdrawal by Subject|5
5125421|NCT01691430|17702946|P2|Overall Study|Death|16
5125422|NCT01691430|17702947|P1|Overall Study|Death|17
5125423|NCT01691378|17702973|P2|Overall Study|Lost to Follow-up|2
5125424|NCT01691378|17702974|P1|Overall Study|Lost to Follow-up|5
5125425|NCT01691378|17702973|P2|Overall Study|Withdrawal by Subject|0
5125426|NCT01691378|17702974|P1|Overall Study|Withdrawal by Subject|2
5125427|NCT01691248|17703057|P2|Overall Study|Not Treated|7
5125428|NCT01691248|17703058|P1|Overall Study|Not Treated|4
5125429|NCT01691248|17703057|P2|Overall Study|Reason not provided|4
5125430|NCT01691248|17703058|P1|Overall Study|Reason not provided|4
5125431|NCT01691248|17703057|P2|Overall Study|Lost to Follow-up|5
5125432|NCT01691248|17703058|P1|Overall Study|Lost to Follow-up|2
5125433|NCT01691248|17703057|P2|Overall Study|Confirmed CDAD|31
5125434|NCT01691248|17703058|P1|Overall Study|Confirmed CDAD|14
5125435|NCT01691248|17703057|P2|Overall Study|Withdrawal by Subject|18
5125436|NCT01691248|17703058|P1|Overall Study|Withdrawal by Subject|20
5125437|NCT01691248|17703057|P2|Overall Study|Adverse Event|22
5125438|NCT01691248|17703058|P1|Overall Study|Adverse Event|24
5125439|NCT01691248|17703057|P2|Overall Study|Protocol Violation|27
5125440|NCT01691248|17703058|P1|Overall Study|Protocol Violation|43
5125441|NCT01691105|17703070|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
5125442|NCT01691105|17703071|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
5125443|NCT01691105|17703070|P2|12 Month Biochemical Verification|Lost to Follow-up|71
5125444|NCT01691105|17703071|P1|12 Month Biochemical Verification|Lost to Follow-up|50
5125445|NCT01691105|17703070|P2|12 Month Biochemical Verification|Death|30
5125446|NCT01691105|17703071|P1|12 Month Biochemical Verification|Death|22
5125447|NCT01691105|17703070|P2|12 Month Follow-up|Death|30
5125448|NCT01691105|17703071|P1|12 Month Follow-up|Death|22
5125449|NCT01691105|17703070|P2|12 Month Follow-up|Lost to Follow-up|71
5125450|NCT01691105|17703071|P1|12 Month Follow-up|Lost to Follow-up|50
5125451|NCT01691105|17703070|P2|6 Month Follow-up|Death|13
5125452|NCT01691105|17703071|P1|6 Month Follow-up|Death|13
5125453|NCT01691105|17703070|P2|6 Month Follow-up|Lost to Follow-up|58
5125454|NCT01691105|17703071|P1|6 Month Follow-up|Lost to Follow-up|39
5125455|NCT01691105|17703070|P2|1 Month Follow-up|Death|3
5125456|NCT01691105|17703071|P1|1 Month Follow-up|Death|2
5125457|NCT01691105|17703070|P2|1 Month Follow-up|Lost to Follow-up|38
5125458|NCT01691105|17703071|P1|1 Month Follow-up|Lost to Follow-up|41
5125459|NCT01691092|17703091|P1|Overall Study|screen fail|19
5125460|NCT01691092|17703091|P1|Overall Study|used for different study|2
5125461|NCT01691092|17703091|P1|Overall Study|non-compliance|3
5125462|NCT01691092|17703091|P1|Overall Study|Withdrawal by Subject|3
5125463|NCT01691092|17703091|P1|Overall Study|Physician Decision|4
5125464|NCT01691092|17703091|P1|Overall Study|Lost to Follow-up|10
5125465|NCT01691014|17703115|P4|Overall Study|Lack of Efficacy|0
5125466|NCT01691014|17703116|P3|Overall Study|Lack of Efficacy|7
5125467|NCT01691014|17703117|P2|Overall Study|Lack of Efficacy|3
5125468|NCT01691014|17703118|P1|Overall Study|Lack of Efficacy|2
5125469|NCT01691014|17703115|P4|Overall Study|Adverse Event|1
5125470|NCT01691014|17703116|P3|Overall Study|Adverse Event|1
5125471|NCT01691014|17703117|P2|Overall Study|Adverse Event|5
5125472|NCT01691014|17703118|P1|Overall Study|Adverse Event|0
5125473|NCT01691014|17703115|P4|Overall Study|Withdrawal by Subject|1
5125474|NCT01691014|17703116|P3|Overall Study|Withdrawal by Subject|1
5125475|NCT01691014|17703117|P2|Overall Study|Withdrawal by Subject|1
5125476|NCT01691014|17703118|P1|Overall Study|Withdrawal by Subject|0
5125477|NCT01691014|17703115|P4|Overall Study|Other|0
5125478|NCT01691014|17703116|P3|Overall Study|Other|2
5125479|NCT01691014|17703117|P2|Overall Study|Other|0
5125480|NCT01691014|17703118|P1|Overall Study|Other|0
5125481|NCT01691014|17703115|P4|Overall Study|Premature Termination|3
5125482|NCT01691014|17703116|P3|Overall Study|Premature Termination|0
5125483|NCT01691014|17703117|P2|Overall Study|Premature Termination|6
5125484|NCT01691014|17703118|P1|Overall Study|Premature Termination|1
5125485|NCT01690988|17703163|P3|Overall Study|Sedated|2
5125486|NCT01690988|17703164|P2|Overall Study|Sedated|1
5125487|NCT01690988|17703165|P1|Overall Study|Sedated|1
5125488|NCT01690988|17703163|P3|Overall Study|Death|1
5125489|NCT01690988|17703164|P2|Overall Study|Death|1
5125490|NCT01690988|17703165|P1|Overall Study|Death|1
5125491|NCT01690988|17703163|P3|Overall Study|Determined ineligible|0
5125492|NCT01690988|17703164|P2|Overall Study|Determined ineligible|0
5125493|NCT01690988|17703165|P1|Overall Study|Determined ineligible|1
5125494|NCT01690988|17703163|P3|Overall Study|Operation Cancelled|0
5125495|NCT01690988|17703164|P2|Overall Study|Operation Cancelled|1
5125496|NCT01690988|17703165|P1|Overall Study|Operation Cancelled|1
5125497|NCT01690988|17703163|P3|Overall Study|Physician Decision|1
5125498|NCT01690988|17703164|P2|Overall Study|Physician Decision|0
5125499|NCT01690988|17703165|P1|Overall Study|Physician Decision|0
5125500|NCT01690988|17703163|P3|Overall Study|Withdrawal by Subject|3
5125501|NCT01690988|17703164|P2|Overall Study|Withdrawal by Subject|2
5125502|NCT01690988|17703165|P1|Overall Study|Withdrawal by Subject|2
5125503|NCT01690299|17703233|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
5125504|NCT01690299|17703234|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5125505|NCT01690299|17703235|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5125506|NCT01690299|17703236|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5125507|NCT01690299|17703237|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5125508|NCT01690299|17703238|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5125509|NCT01690299|17703233|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
5125510|NCT01690299|17703234|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
5125511|NCT01690299|17703235|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
5125512|NCT01690299|17703236|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5125513|NCT01690299|17703237|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5125514|NCT01690299|17703238|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5125515|NCT01690299|17703233|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
5125516|NCT01690299|17703234|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
5125517|NCT01690299|17703235|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
5125518|NCT01690299|17703236|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5125519|NCT01690299|17703237|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5125520|NCT01690299|17703238|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5125521|NCT01690299|17703233|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
5125522|NCT01690299|17703234|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
5125523|NCT01690299|17703235|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5125524|NCT01690299|17703236|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5125525|NCT01690299|17703237|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5125526|NCT01690299|17703238|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5125527|NCT01690299|17703233|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
5125528|NCT01690299|17703234|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
5125529|NCT01690299|17703235|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
5125530|NCT01690299|17703236|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5125612|NCT01689363|17703644|P4|Overall Study|Protocol Violation|0
5125531|NCT01690299|17703237|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5125532|NCT01690299|17703238|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5125533|NCT01690299|17703233|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
5125534|NCT01690299|17703234|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
5125535|NCT01690299|17703235|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
5125536|NCT01690299|17703236|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5125537|NCT01690299|17703237|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5125538|NCT01690299|17703238|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5125539|NCT01690299|17703233|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
5125540|NCT01690299|17703234|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
5125541|NCT01690299|17703235|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
5125542|NCT01690299|17703236|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
5125543|NCT01690299|17703237|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
5125544|NCT01690299|17703238|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
5125545|NCT01690299|17703233|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5125546|NCT01690299|17703234|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5125547|NCT01690299|17703235|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5125548|NCT01690299|17703236|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5125549|NCT01690299|17703237|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
5125550|NCT01690299|17703238|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
5125551|NCT01690299|17703233|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5125552|NCT01690299|17703234|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5125553|NCT01690299|17703235|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5125554|NCT01690299|17703236|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5125555|NCT01690299|17703237|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5125556|NCT01690299|17703238|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
5125557|NCT01690299|17703233|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5125558|NCT01690299|17703234|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5125559|NCT01690299|17703235|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5125560|NCT01690299|17703236|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
5125561|NCT01690299|17703237|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
5125562|NCT01690299|17703238|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
5125563|NCT01690143|17703335|P1|Overall Study|Withdrawal by Subject|1
5125564|NCT01690130|17703345|P2|Overall Study|Subject have cancelled visit.|0
5125565|NCT01690130|17703346|P1|Overall Study|Subject have cancelled visit.|1
5125566|NCT01690052|17703393|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
5125567|NCT01690052|17703394|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
5125568|NCT01689974|17703411|P2|Overall Study|Termination of Study|5
5125569|NCT01689974|17703412|P1|Overall Study|Termination of Study|5
5125570|NCT01689857|17703443|P2|Overall Study|Lost to Follow-up|2
5125571|NCT01689857|17703444|P1|Overall Study|Lost to Follow-up|5
5125572|NCT01689649|17703537|P1|Overall Study|Lost to Follow-up|5
5125573|NCT01689649|17703537|P1|Overall Study|Protocol Violation|3
5125574|NCT01689649|17703537|P1|Overall Study|Non-compliance|11
5125575|NCT01689649|17703537|P1|Overall Study|Lack of Efficacy|3
5125576|NCT01689532|17703549|P2|Overall Study|Physician Decision|0
5125577|NCT01689532|17703550|P1|Overall Study|Physician Decision|2
5125578|NCT01689532|17703549|P2|Overall Study|Withdrawal by Subject|2
5125579|NCT01689532|17703550|P1|Overall Study|Withdrawal by Subject|1
5125580|NCT01689532|17703549|P2|Overall Study|Lack of Efficacy|2
5125581|NCT01689532|17703550|P1|Overall Study|Lack of Efficacy|2
5125582|NCT01689532|17703549|P2|Overall Study|Adverse Event|5
5125583|NCT01689532|17703550|P1|Overall Study|Adverse Event|9
5125584|NCT01689519|17703614|P2|Safety Population|Withdrawal by Subject|20
5125585|NCT01689519|17703615|P1|Safety Population|Withdrawal by Subject|20
5125586|NCT01689519|17703614|P2|Safety Population|Study Terminated By Sponsor|47
5125587|NCT01689519|17703615|P1|Safety Population|Study Terminated By Sponsor|60
5125588|NCT01689519|17703614|P2|Safety Population|Physician Decision|1
5125589|NCT01689519|17703615|P1|Safety Population|Physician Decision|4
5125590|NCT01689519|17703614|P2|Safety Population|Other|4
5125591|NCT01689519|17703615|P1|Safety Population|Other|2
5125592|NCT01689519|17703614|P2|Safety Population|Lost to Follow-up|8
5125593|NCT01689519|17703615|P1|Safety Population|Lost to Follow-up|4
5125594|NCT01689519|17703614|P2|Safety Population|Death|165
5125595|NCT01689519|17703615|P1|Safety Population|Death|158
5125596|NCT01689519|17703614|P2|Intent to Treat|Withdrawal by Subject|20
5125597|NCT01689519|17703615|P1|Intent to Treat|Withdrawal by Subject|21
5125598|NCT01689519|17703614|P2|Intent to Treat|Study terminated by Spon6sor|48
5125599|NCT01689519|17703615|P1|Intent to Treat|Study terminated by Spon6sor|59
5125600|NCT01689519|17703614|P2|Intent to Treat|Physician Decision|1
5125601|NCT01689519|17703615|P1|Intent to Treat|Physician Decision|4
5125602|NCT01689519|17703614|P2|Intent to Treat|Other|4
5125603|NCT01689519|17703615|P1|Intent to Treat|Other|2
5125604|NCT01689519|17703614|P2|Intent to Treat|Lost to Follow-up|8
5125605|NCT01689519|17703615|P1|Intent to Treat|Lost to Follow-up|4
5125606|NCT01689519|17703614|P2|Intent to Treat|Death|167
5125607|NCT01689519|17703615|P1|Intent to Treat|Death|157
5125608|NCT01689363|17703640|P8|Overall Study|Protocol Violation|0
5125609|NCT01689363|17703641|P7|Overall Study|Protocol Violation|0
5125610|NCT01689363|17703642|P6|Overall Study|Protocol Violation|0
5125611|NCT01689363|17703643|P5|Overall Study|Protocol Violation|0
5125613|NCT01689363|17703645|P3|Overall Study|Protocol Violation|0
5125614|NCT01689363|17703646|P2|Overall Study|Protocol Violation|1
5125615|NCT01689363|17703647|P1|Overall Study|Protocol Violation|0
5125616|NCT01689337|17703702|P1|Overall Study|Study Discontinuation|1
5125617|NCT01689207|17703741|P11|Overall Study|Adverse Event|0
5125618|NCT01689207|17703742|P10|Overall Study|Adverse Event|0
5125619|NCT01689207|17703743|P9|Overall Study|Adverse Event|1
5125620|NCT01689207|17703744|P8|Overall Study|Adverse Event|0
5125621|NCT01689207|17703745|P7|Overall Study|Adverse Event|0
5125622|NCT01689207|17703746|P6|Overall Study|Adverse Event|1
5125623|NCT01689207|17703747|P5|Overall Study|Adverse Event|2
5125624|NCT01689207|17703748|P4|Overall Study|Adverse Event|0
5125625|NCT01689207|17703749|P3|Overall Study|Adverse Event|0
5125626|NCT01689207|17703750|P2|Overall Study|Adverse Event|1
5125627|NCT01689207|17703751|P1|Overall Study|Adverse Event|0
5125628|NCT01688999|17703859|P3|Overall Study|Ineligible/Not treated|0
5125629|NCT01688999|17703860|P2|Overall Study|Ineligible/Not treated|0
5125630|NCT01688999|17703861|P1|Overall Study|Ineligible/Not treated|1
5125631|NCT01688999|17703859|P3|Overall Study|Adverse Event|2
5125632|NCT01688999|17703860|P2|Overall Study|Adverse Event|0
5125633|NCT01688999|17703861|P1|Overall Study|Adverse Event|2
5125634|NCT01688999|17703859|P3|Overall Study|Withdrawal by Subject|1
5125635|NCT01688999|17703860|P2|Overall Study|Withdrawal by Subject|1
5125636|NCT01688999|17703861|P1|Overall Study|Withdrawal by Subject|5
5125637|NCT01688973|17703877|P2|Overall Study|Ineligible|3
5125638|NCT01688973|17703878|P1|Overall Study|Ineligible|2
5125639|NCT01688921|17703892|P2|Overall Study|informed consent|0
5125640|NCT01688921|17703893|P1|Overall Study|informed consent|3
5125641|NCT01688921|17703892|P2|Overall Study|Protocol Violation|1
5125642|NCT01688921|17703893|P1|Overall Study|Protocol Violation|0
5125643|NCT01688921|17703892|P2|Overall Study|Physician Decision|1
5125644|NCT01688921|17703893|P1|Overall Study|Physician Decision|6
5125645|NCT01688921|17703892|P2|Overall Study|Lost to Follow-up|13
5125646|NCT01688921|17703893|P1|Overall Study|Lost to Follow-up|7
5125647|NCT01688882|17703925|P2|Overall Study|Administrative problems|0
5125648|NCT01688882|17703926|P1|Overall Study|Administrative problems|1
5125649|NCT01688882|17703925|P2|Overall Study|Unsatisfactory therapeutic effect|1
5125650|NCT01688882|17703926|P1|Overall Study|Unsatisfactory therapeutic effect|1
5125651|NCT01688882|17703925|P2|Overall Study|Adverse Event|0
5125652|NCT01688882|17703926|P1|Overall Study|Adverse Event|1
5125653|NCT01688830|17703997|P21|Overall Study|Lost to Follow-up|0
5125654|NCT01688830|17703998|P20|Overall Study|Lost to Follow-up|0
5125655|NCT01688830|17703999|P19|Overall Study|Lost to Follow-up|0
5125656|NCT01688830|17704000|P18|Overall Study|Lost to Follow-up|0
5125657|NCT01688830|17704001|P17|Overall Study|Lost to Follow-up|0
5125658|NCT01688830|17704002|P16|Overall Study|Lost to Follow-up|0
5125659|NCT01688830|17704003|P15|Overall Study|Lost to Follow-up|0
5125660|NCT01688830|17704004|P14|Overall Study|Lost to Follow-up|0
5125661|NCT01688830|17704005|P13|Overall Study|Lost to Follow-up|0
5125662|NCT01688830|17704006|P12|Overall Study|Lost to Follow-up|0
5125663|NCT01688830|17704007|P11|Overall Study|Lost to Follow-up|1
5125664|NCT01688830|17704008|P10|Overall Study|Lost to Follow-up|0
5125665|NCT01688830|17704009|P9|Overall Study|Lost to Follow-up|0
5125666|NCT01688830|17704010|P8|Overall Study|Lost to Follow-up|0
5125667|NCT01688830|17704011|P7|Overall Study|Lost to Follow-up|0
5125668|NCT01688830|17704012|P6|Overall Study|Lost to Follow-up|0
5125669|NCT01688830|17704013|P5|Overall Study|Lost to Follow-up|0
5125670|NCT01688830|17704014|P4|Overall Study|Lost to Follow-up|0
5125671|NCT01688830|17704015|P3|Overall Study|Lost to Follow-up|0
5125672|NCT01688830|17704016|P2|Overall Study|Lost to Follow-up|0
5125673|NCT01688830|17704017|P1|Overall Study|Lost to Follow-up|0
5125674|NCT01688739|17704171|P10|Overall Study|Administrative Decision|0
5125675|NCT01688739|17704172|P9|Overall Study|Administrative Decision|0
5125676|NCT01688739|17704173|P8|Overall Study|Administrative Decision|0
5125677|NCT01688739|17704174|P7|Overall Study|Administrative Decision|0
5125678|NCT01688739|17704175|P6|Overall Study|Administrative Decision|0
5125679|NCT01688739|17704176|P5|Overall Study|Administrative Decision|0
5125680|NCT01688739|17704177|P4|Overall Study|Administrative Decision|0
5125681|NCT01688739|17704178|P3|Overall Study|Administrative Decision|0
5125682|NCT01688739|17704179|P2|Overall Study|Administrative Decision|0
5125683|NCT01688739|17704180|P1|Overall Study|Administrative Decision|1
5125684|NCT01688726|17704256|P2|Overall Study|Relocated abroad|1
5125685|NCT01688726|17704257|P1|Overall Study|Relocated abroad|0
5125686|NCT01688726|17704256|P2|Overall Study|Adverse Event|0
5125687|NCT01688726|17704257|P1|Overall Study|Adverse Event|1
5125688|NCT01688635|17704269|P2|Washout 3|Withdrawal by Subject|0
5125689|NCT01688635|17704270|P1|Washout 3|Withdrawal by Subject|1
5125690|NCT01688635|17704269|P2|Washout 2|Sponsor Decision|2
5125691|NCT01688635|17704270|P1|Washout 2|Sponsor Decision|1
5125692|NCT01688635|17704269|P2|Washout 2|Withdrawal by Subject|0
5125693|NCT01688635|17704270|P1|Washout 2|Withdrawal by Subject|1
5125694|NCT01688635|17704269|P2|Washout 2|Physician Decision|0
5125695|NCT01688635|17704270|P1|Washout 2|Physician Decision|1
5125696|NCT01688635|17704269|P2|Washout 1|Physician Decision|1
5125697|NCT01688635|17704270|P1|Washout 1|Physician Decision|0
5125698|NCT01688635|17704269|P2|Washout 1|Adverse Event|1
5125699|NCT01688635|17704270|P1|Washout 1|Adverse Event|0
5125700|NCT01688635|17704269|P2|Washout 1|Withdrawal by Subject|0
5125701|NCT01688635|17704270|P1|Washout 1|Withdrawal by Subject|1
5125702|NCT01688466|17704317|P2|Overall Study|Not evaluable|1
5125703|NCT01688466|17704318|P1|Overall Study|Not evaluable|0
5125704|NCT01688466|17704317|P2|Overall Study|Adverse Event|4
5125705|NCT01688466|17704318|P1|Overall Study|Adverse Event|0
5125706|NCT01688466|17704317|P2|Overall Study|Death|1
5125707|NCT01688466|17704318|P1|Overall Study|Death|0
5125708|NCT01688466|17704317|P2|Overall Study|Withdrawal by Subject|1
5125709|NCT01688466|17704318|P1|Overall Study|Withdrawal by Subject|2
5125710|NCT01688050|17704409|P1|Overall Study|Withdrawal by Subject|10
5125711|NCT01688050|17704409|P1|Overall Study|Lost to Follow-up|13
5125712|NCT01688050|17704409|P1|Overall Study|Conversion to open repair|1
5125713|NCT01688050|17704409|P1|Overall Study|Death|7
5125714|NCT01688037|17704418|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
5125715|NCT01688037|17704419|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
5125716|NCT01688037|17704420|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
5125717|NCT01688037|17704418|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
5125718|NCT01688037|17704419|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
5125719|NCT01688037|17704420|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
5125720|NCT01688037|17704418|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
5125721|NCT01688037|17704419|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
5125722|NCT01688037|17704420|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
5125723|NCT01688037|17704418|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
5125724|NCT01688037|17704419|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
5125725|NCT01688037|17704420|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
5125726|NCT01688037|17704418|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
5125727|NCT01688037|17704419|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
5125728|NCT01688037|17704420|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
5125729|NCT01688037|17704418|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
5125730|NCT01688037|17704419|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
5125731|NCT01688037|17704420|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
5125732|NCT01688037|17704418|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5125733|NCT01688037|17704419|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
5125734|NCT01688037|17704420|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5125735|NCT01688037|17704418|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
5125736|NCT01688037|17704419|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
5125737|NCT01688037|17704420|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
5125738|NCT01688037|17704418|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
5125739|NCT01688037|17704419|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
5125740|NCT01688037|17704420|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
5125741|NCT01688037|17704418|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
5125742|NCT01688037|17704419|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
5125743|NCT01688037|17704420|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
5125744|NCT01687998|17704436|P2|Overall Study|Lost to Follow-up|7
5125745|NCT01687998|17704437|P1|Overall Study|Lost to Follow-up|9
5125746|NCT01687998|17704436|P2|Overall Study|Known to be Alive at Study End|62
5125747|NCT01687998|17704437|P1|Overall Study|Known to be Alive at Study End|54
5125748|NCT01687998|17704436|P2|Overall Study|Withdrawal by Subject|51
5125749|NCT01687998|17704437|P1|Overall Study|Withdrawal by Subject|49
5125750|NCT01687712|17704473|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
5125751|NCT01687712|17704474|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
5125752|NCT01687712|17704473|P2|Cycle 3|Ectopic Pregnancy|0
5125753|NCT01687712|17704474|P1|Cycle 3|Ectopic Pregnancy|1
5125754|NCT01687712|17704473|P2|Cycle 3|Early Pregnancy Loss|2
5125755|NCT01687712|17704474|P1|Cycle 3|Early Pregnancy Loss|1
5125756|NCT01687712|17704473|P2|Cycle 3|Not Biochemically Pregnant|22
5125757|NCT01687712|17704474|P1|Cycle 3|Not Biochemically Pregnant|21
5125758|NCT01687712|17704473|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
5125759|NCT01687712|17704474|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
5125760|NCT01687712|17704473|P2|Cycle 2|Still Birth|0
5125761|NCT01687712|17704474|P1|Cycle 2|Still Birth|1
5125762|NCT01687712|17704473|P2|Cycle 2|Ectopic Pregnancy|1
5125763|NCT01687712|17704474|P1|Cycle 2|Ectopic Pregnancy|0
5125764|NCT01687712|17704473|P2|Cycle 2|Early Pregnancy Loss|16
5125765|NCT01687712|17704474|P1|Cycle 2|Early Pregnancy Loss|18
5125766|NCT01687712|17704473|P2|Cycle 2|Not Biochemically Pregnant|77
5125767|NCT01687712|17704474|P1|Cycle 2|Not Biochemically Pregnant|74
5125768|NCT01687712|17704473|P2|Cycle 1|Lost to Follow-up|1
5125769|NCT01687712|17704474|P1|Cycle 1|Lost to Follow-up|1
5125770|NCT01687712|17704473|P2|Cycle 1|Intrauterine Fetal Death|1
5125771|NCT01687712|17704474|P1|Cycle 1|Intrauterine Fetal Death|0
5125772|NCT01687712|17704473|P2|Cycle 1|Abortion|0
5125773|NCT01687712|17704474|P1|Cycle 1|Abortion|3
5125774|NCT01687712|17704473|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
5125775|NCT01687712|17704474|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
5125776|NCT01687712|17704473|P2|Cycle 1|Heterotropic Pregnancy|0
5125777|NCT01687712|17704474|P1|Cycle 1|Heterotropic Pregnancy|1
5125778|NCT01687712|17704473|P2|Cycle 1|Ectopic Pregnancy|5
5125779|NCT01687712|17704474|P1|Cycle 1|Ectopic Pregnancy|5
5125780|NCT01687712|17704473|P2|Cycle 1|Early Pregnancy Loss|60
5125781|NCT01687712|17704474|P1|Cycle 1|Early Pregnancy Loss|43
5125782|NCT01687712|17704473|P2|Cycle 1|Not Biochemically Pregnant|348
5125783|NCT01687712|17704474|P1|Cycle 1|Not Biochemically Pregnant|386
5125784|NCT01687478|17704514|P2|Overall Study|Entry Criteria Not Met|2
5125785|NCT01687478|17704515|P1|Overall Study|Entry Criteria Not Met|6
5125786|NCT01687478|17704514|P2|Overall Study|Physician Decision|3
5125787|NCT01687478|17704515|P1|Overall Study|Physician Decision|1
5125788|NCT01687478|17704514|P2|Overall Study|Withdrawal by Subject|19
5125789|NCT01687478|17704515|P1|Overall Study|Withdrawal by Subject|21
5125790|NCT01687478|17704514|P2|Overall Study|Protocol Violation|2
5125791|NCT01687478|17704515|P1|Overall Study|Protocol Violation|0
5125792|NCT01687478|17704514|P2|Overall Study|Lost to Follow-up|3
5125793|NCT01687478|17704515|P1|Overall Study|Lost to Follow-up|1
5125794|NCT01687478|17704514|P2|Overall Study|Adverse Event|10
5125795|NCT01687478|17704515|P1|Overall Study|Adverse Event|3
5125796|NCT01687413|17704539|P2|Overall Study|Patient withdrew before completing all radiotherapy|0
5125797|NCT01687413|17704540|P1|Overall Study|Patient withdrew before completing all radiotherapy|1
5125798|NCT01687413|17704539|P2|Overall Study|Not eligible|2
5125799|NCT01687413|17704540|P1|Overall Study|Not eligible|0
5125800|NCT01687413|17704539|P2|Overall Study|Withdrawal by Subject|2
5125801|NCT01687413|17704540|P1|Overall Study|Withdrawal by Subject|0
5125802|NCT01687296|17704645|P2|Overall Study|Withdrawal by Subject|3
5125803|NCT01687296|17704646|P1|Overall Study|Withdrawal by Subject|6
5125804|NCT01687296|17704645|P2|Overall Study|Protocol Violation|1
5125805|NCT01687296|17704646|P1|Overall Study|Protocol Violation|0
5125806|NCT01687296|17704645|P2|Overall Study|Lack of Efficacy|1
5125807|NCT01687296|17704646|P1|Overall Study|Lack of Efficacy|1
5125808|NCT01687283|17704668|P2|Overall Study|Withdrawal by Subject|8
5125809|NCT01687283|17704669|P1|Overall Study|Withdrawal by Subject|9
5125810|NCT01687283|17704668|P2|Overall Study|Investigator discretion|0
5125811|NCT01687283|17704669|P1|Overall Study|Investigator discretion|2
5125812|NCT01687283|17704668|P2|Overall Study|Lost to Follow-up|1
5125813|NCT01687283|17704669|P1|Overall Study|Lost to Follow-up|1
5125814|NCT01687283|17704668|P2|Overall Study|protocol defined stopping criteria|10
5125815|NCT01687283|17704669|P1|Overall Study|protocol defined stopping criteria|8
5125816|NCT01687283|17704668|P2|Overall Study|Protocol Violation|3
5125817|NCT01687283|17704669|P1|Overall Study|Protocol Violation|1
5125818|NCT01687283|17704668|P2|Overall Study|Lack of Efficacy|1
5125819|NCT01687283|17704669|P1|Overall Study|Lack of Efficacy|3
5125820|NCT01687283|17704668|P2|Overall Study|Adverse Event|4
5125821|NCT01687283|17704669|P1|Overall Study|Adverse Event|11
5125822|NCT01687270|17704692|P1|Overall Study|Lost to Follow-up|1
5125823|NCT01687270|17704692|P1|Overall Study|Lack of Efficacy|11
5125824|NCT01687257|17704703|P3|Overall Study|Investigator's Discretion|0
5125825|NCT01687257|17704704|P2|Overall Study|Investigator's Discretion|3
5125826|NCT01687257|17704705|P1|Overall Study|Investigator's Discretion|0
5125827|NCT01687257|17704703|P3|Overall Study|Adverse Event|0
5125828|NCT01687257|17704704|P2|Overall Study|Adverse Event|0
5125829|NCT01687257|17704705|P1|Overall Study|Adverse Event|1
5125830|NCT01687257|17704703|P3|Overall Study|Subject Withdrew Consent|1
5125831|NCT01687257|17704704|P2|Overall Study|Subject Withdrew Consent|1
5125832|NCT01687257|17704705|P1|Overall Study|Subject Withdrew Consent|1
5125833|NCT01687257|17704703|P3|Overall Study|Efficacy Failure|5
5125834|NCT01687257|17704704|P2|Overall Study|Efficacy Failure|0
5125835|NCT01687257|17704705|P1|Overall Study|Efficacy Failure|6
5125836|NCT01687218|17704770|P6|Overall Study|Relocated, no follow-up planned|0
5125837|NCT01687218|17704771|P5|Overall Study|Relocated, no follow-up planned|0
5125838|NCT01687218|17704772|P4|Overall Study|Relocated, no follow-up planned|1
5125839|NCT01687218|17704773|P3|Overall Study|Relocated, no follow-up planned|1
5125840|NCT01687218|17704774|P2|Overall Study|Relocated, no follow-up planned|0
5125841|NCT01687218|17704775|P1|Overall Study|Relocated, no follow-up planned|1
5125842|NCT01687218|17704770|P6|Overall Study|Withdrawal by Subject|0
5125843|NCT01687218|17704771|P5|Overall Study|Withdrawal by Subject|1
5125844|NCT01687218|17704772|P4|Overall Study|Withdrawal by Subject|1
5125845|NCT01687218|17704773|P3|Overall Study|Withdrawal by Subject|0
5125846|NCT01687218|17704774|P2|Overall Study|Withdrawal by Subject|3
5125847|NCT01687218|17704775|P1|Overall Study|Withdrawal by Subject|2
5125848|NCT01687166|17704827|P4|Overall Study|Insurance|1
5125849|NCT01687166|17704828|P3|Overall Study|Insurance|1
5125850|NCT01687166|17704829|P2|Overall Study|Insurance|0
5125851|NCT01687166|17704830|P1|Overall Study|Insurance|0
5125852|NCT01687166|17704827|P4|Overall Study|Physician choice to use different device|0
5125853|NCT01687166|17704828|P3|Overall Study|Physician choice to use different device|4
5125854|NCT01687166|17704829|P2|Overall Study|Physician choice to use different device|2
5125855|NCT01687166|17704830|P1|Overall Study|Physician choice to use different device|1
5125856|NCT01687166|17704827|P4|Overall Study|Patient unable to be compliant|0
5125857|NCT01687166|17704828|P3|Overall Study|Patient unable to be compliant|0
5125858|NCT01687166|17704829|P2|Overall Study|Patient unable to be compliant|0
5125859|NCT01687166|17704830|P1|Overall Study|Patient unable to be compliant|1
5125860|NCT01687166|17704827|P4|Overall Study|Subject moved out of state|0
5125861|NCT01687166|17704828|P3|Overall Study|Subject moved out of state|0
5125862|NCT01687166|17704829|P2|Overall Study|Subject moved out of state|1
5125863|NCT01687166|17704830|P1|Overall Study|Subject moved out of state|0
5125864|NCT01687166|17704827|P4|Overall Study|Protocol Violation|0
5125865|NCT01687166|17704828|P3|Overall Study|Protocol Violation|1
5125866|NCT01687166|17704829|P2|Overall Study|Protocol Violation|1
5125867|NCT01687166|17704830|P1|Overall Study|Protocol Violation|1
5125868|NCT01687166|17704827|P4|Overall Study|Death|0
5125869|NCT01687166|17704828|P3|Overall Study|Death|0
5125870|NCT01687166|17704829|P2|Overall Study|Death|1
5125871|NCT01687166|17704830|P1|Overall Study|Death|1
5125872|NCT01687166|17704827|P4|Overall Study|Equipment/Device Availability|0
5125873|NCT01687166|17704828|P3|Overall Study|Equipment/Device Availability|0
5125874|NCT01687166|17704829|P2|Overall Study|Equipment/Device Availability|1
5125875|NCT01687166|17704830|P1|Overall Study|Equipment/Device Availability|0
5125876|NCT01687166|17704827|P4|Overall Study|Lost to Follow-up|0
5125877|NCT01687166|17704828|P3|Overall Study|Lost to Follow-up|1
5125878|NCT01687166|17704829|P2|Overall Study|Lost to Follow-up|5
5125879|NCT01687166|17704830|P1|Overall Study|Lost to Follow-up|2
5125880|NCT01687166|17704827|P4|Overall Study|Withdrawal by Subject|0
5125881|NCT01687166|17704828|P3|Overall Study|Withdrawal by Subject|3
5125882|NCT01687166|17704829|P2|Overall Study|Withdrawal by Subject|4
5125883|NCT01687166|17704830|P1|Overall Study|Withdrawal by Subject|11
5125884|NCT01687166|17704827|P4|Overall Study|Physician Decision|0
5125885|NCT01687166|17704828|P3|Overall Study|Physician Decision|1
5125886|NCT01687166|17704829|P2|Overall Study|Physician Decision|2
5125887|NCT01687166|17704830|P1|Overall Study|Physician Decision|3
5125888|NCT01687166|17704827|P4|Overall Study|Adverse Event|0
5125889|NCT01687166|17704828|P3|Overall Study|Adverse Event|0
5125890|NCT01687166|17704829|P2|Overall Study|Adverse Event|1
5125891|NCT01687166|17704830|P1|Overall Study|Adverse Event|2
5125892|NCT01687166|17704827|P4|Overall Study|Did not meet eligibility criteria|1
5125893|NCT01687166|17704828|P3|Overall Study|Did not meet eligibility criteria|1
5125894|NCT01687166|17704829|P2|Overall Study|Did not meet eligibility criteria|6
5125895|NCT01687166|17704830|P1|Overall Study|Did not meet eligibility criteria|4
5125896|NCT01687166|17704827|P4|Overall Study|Attempt subject|0
5125897|NCT01687166|17704828|P3|Overall Study|Attempt subject|2
5125898|NCT01687166|17704829|P2|Overall Study|Attempt subject|3
5125899|NCT01687166|17704830|P1|Overall Study|Attempt subject|2
5125900|NCT01687101|17704846|P1|Overall Study|Lost to Follow-up|7
5125901|NCT01686958|17704871|P1|Overall Study|Withdrawal by Subject|1
5125902|NCT01686932|17704884|P2|Period 1|Adverse Event|1
5125903|NCT01686932|17704885|P1|Period 1|Adverse Event|1
5125904|NCT01686828|17704915|P4|Overall Study|Weight Loss|0
5125905|NCT01686828|17704916|P3|Overall Study|Weight Loss|1
5125906|NCT01686828|17704917|P2|Overall Study|Weight Loss|0
5125907|NCT01686828|17704918|P1|Overall Study|Weight Loss|0
5125908|NCT01686828|17704915|P4|Overall Study|New Job|0
5125909|NCT01686828|17704916|P3|Overall Study|New Job|0
5125910|NCT01686828|17704917|P2|Overall Study|New Job|1
5125911|NCT01686828|17704918|P1|Overall Study|New Job|0
5125912|NCT01686828|17704915|P4|Overall Study|Physician Decision|0
5125913|NCT01686828|17704916|P3|Overall Study|Physician Decision|0
5125914|NCT01686828|17704917|P2|Overall Study|Physician Decision|0
5125915|NCT01686828|17704918|P1|Overall Study|Physician Decision|1
5125916|NCT01686633|17705031|P3|Overall Study|Lost to Follow-up|1
5125917|NCT01686633|17705032|P2|Overall Study|Lost to Follow-up|1
5125918|NCT01686633|17705033|P1|Overall Study|Lost to Follow-up|0
5125919|NCT01686633|17705031|P3|Overall Study|Protocol-defined Stopping Criteria|1
5125920|NCT01686633|17705032|P2|Overall Study|Protocol-defined Stopping Criteria|0
5125921|NCT01686633|17705033|P1|Overall Study|Protocol-defined Stopping Criteria|1
5125922|NCT01686633|17705031|P3|Overall Study|Protocol Violation|0
5125923|NCT01686633|17705032|P2|Overall Study|Protocol Violation|3
5125924|NCT01686633|17705033|P1|Overall Study|Protocol Violation|2
5125925|NCT01686633|17705031|P3|Overall Study|Adverse Event|3
5125926|NCT01686633|17705032|P2|Overall Study|Adverse Event|3
5125927|NCT01686633|17705033|P1|Overall Study|Adverse Event|4
5125928|NCT01686633|17705031|P3|Overall Study|Physician Decision|4
5125929|NCT01686633|17705032|P2|Overall Study|Physician Decision|4
5125930|NCT01686633|17705033|P1|Overall Study|Physician Decision|3
5125931|NCT01686633|17705031|P3|Overall Study|Withdrawal by Subject|5
5125932|NCT01686633|17705032|P2|Overall Study|Withdrawal by Subject|8
5125933|NCT01686633|17705033|P1|Overall Study|Withdrawal by Subject|8
5125934|NCT01686633|17705031|P3|Overall Study|Lack of Efficacy|11
5125935|NCT01686633|17705032|P2|Overall Study|Lack of Efficacy|13
5125936|NCT01686633|17705033|P1|Overall Study|Lack of Efficacy|33
5125937|NCT01686581|17705056|P1|Overall Study|Reason Missing|1
5125938|NCT01686581|17705056|P1|Overall Study|Other Miscellaneous Reasons|36
5125939|NCT01686581|17705056|P1|Overall Study|Thinks it is Inconvenient|17
5125940|NCT01686581|17705056|P1|Overall Study|Trying to get Pregnant or Nursing|2
5125941|NCT01686581|17705056|P1|Overall Study|Thinks Injections Take Too Much Time|2
5125942|NCT01686581|17705056|P1|Overall Study|Thinks Injections Too Painful|8
5125943|NCT01686581|17705056|P1|Overall Study|Participant Concerned about Risks|6
5125944|NCT01686581|17705056|P1|Overall Study|Lack of Efficacy|90
5125945|NCT01686581|17705056|P1|Overall Study|Side-effects or Health Problems|15
5125946|NCT01686568|17705069|P2|Sub-Study|Not consented for sub-study|2
5125947|NCT01686568|17705070|P1|Sub-Study|Not consented for sub-study|2
5125948|NCT01686568|17705069|P2|Main Study|Liver enzymes above range of exclusion|0
5125949|NCT01686568|17705070|P1|Main Study|Liver enzymes above range of exclusion|1
5125950|NCT01686568|17705069|P2|Main Study|Noncompliance with protocol|1
5125951|NCT01686568|17705070|P1|Main Study|Noncompliance with protocol|0
5125952|NCT01686568|17705069|P2|Main Study|Withdrawal by Subject|3
5125953|NCT01686568|17705070|P1|Main Study|Withdrawal by Subject|1
5125954|NCT01686438|17705147|P3|Overall Study|Withdrawal by Subject|1
5125955|NCT01686438|17705148|P2|Overall Study|Withdrawal by Subject|0
5125956|NCT01686438|17705149|P1|Overall Study|Withdrawal by Subject|0
5125957|NCT01686438|17705147|P3|Overall Study|Protocol Violation|1
5125958|NCT01686438|17705148|P2|Overall Study|Protocol Violation|0
5125959|NCT01686438|17705149|P1|Overall Study|Protocol Violation|0
5125960|NCT01686438|17705147|P3|Overall Study|Adverse Event|1
5125961|NCT01686438|17705148|P2|Overall Study|Adverse Event|0
5125962|NCT01686438|17705149|P1|Overall Study|Adverse Event|0
5125963|NCT01686438|17705147|P3|Overall Study|Lost to Follow-up|10
5125964|NCT01686438|17705148|P2|Overall Study|Lost to Follow-up|9
5125965|NCT01686438|17705149|P1|Overall Study|Lost to Follow-up|8
5125966|NCT01686373|17705197|P2|Overall Study|Adverse Event|1
5125967|NCT01686373|17705198|P1|Overall Study|Adverse Event|0
5125968|NCT01686373|17705197|P2|Overall Study|Withdrawal by Subject|1
5125969|NCT01686373|17705198|P1|Overall Study|Withdrawal by Subject|0
5125970|NCT01686373|17705197|P2|Overall Study|Lost to Follow-up|0
5125971|NCT01686373|17705198|P1|Overall Study|Lost to Follow-up|3
5125972|NCT01686152|17705214|P3|Overall Study|Lost to Follow-up|5
5125973|NCT01686152|17705215|P2|Overall Study|Lost to Follow-up|6
5125974|NCT01686152|17705216|P1|Overall Study|Lost to Follow-up|7
5125975|NCT01686152|17705214|P3|Overall Study|IP Non-compliance|0
5125976|NCT01686152|17705215|P2|Overall Study|IP Non-compliance|5
5125977|NCT01686152|17705216|P1|Overall Study|IP Non-compliance|5
5125978|NCT01686152|17705214|P3|Overall Study|Lack of Efficacy|1
5125979|NCT01686152|17705215|P2|Overall Study|Lack of Efficacy|0
5125980|NCT01686152|17705216|P1|Overall Study|Lack of Efficacy|0
5125981|NCT01686152|17705214|P3|Overall Study|Adverse Event|0
5125982|NCT01686152|17705215|P2|Overall Study|Adverse Event|11
5125983|NCT01686152|17705216|P1|Overall Study|Adverse Event|12
5125984|NCT01686152|17705214|P3|Overall Study|Protocol Violation|0
5125985|NCT01686152|17705215|P2|Overall Study|Protocol Violation|1
5125986|NCT01686152|17705216|P1|Overall Study|Protocol Violation|6
5125987|NCT01686152|17705214|P3|Overall Study|Drug Code Unblinded|0
5125988|NCT01686152|17705215|P2|Overall Study|Drug Code Unblinded|1
5125989|NCT01686152|17705216|P1|Overall Study|Drug Code Unblinded|0
5125990|NCT01686152|17705214|P3|Overall Study|Withdrawal by Subject|3
5125991|NCT01686152|17705215|P2|Overall Study|Withdrawal by Subject|11
5125992|NCT01686152|17705216|P1|Overall Study|Withdrawal by Subject|11
5125993|NCT01685983|17705235|P1|Overall Study|Noncompliance with Study Drug|1
5125994|NCT01685983|17705235|P1|Overall Study|Progressive Disease|32
5125995|NCT01685983|17705235|P1|Overall Study|Other|7
5125996|NCT01685983|17705235|P1|Overall Study|Physician Decision|13
5125997|NCT01685983|17705235|P1|Overall Study|Protocol Violation|2
5125998|NCT01685983|17705235|P1|Overall Study|Withdrawal by Subject|19
5125999|NCT01685983|17705235|P1|Overall Study|Death|1
5126000|NCT01685983|17705235|P1|Overall Study|Adverse Event|7
5126001|NCT01685840|17705247|P2|Overall Study|Had VAD, Dialysis or Transplant|17
5126002|NCT01685840|17705248|P1|Overall Study|Had VAD, Dialysis or Transplant|11
5126003|NCT01685840|17705247|P2|Overall Study|Futility|200
5126004|NCT01685840|17705248|P1|Overall Study|Futility|197
5126005|NCT01685840|17705247|P2|Overall Study|Withdrawal by Subject|17
5126006|NCT01685840|17705248|P1|Overall Study|Withdrawal by Subject|14
5126007|NCT01685840|17705247|P2|Overall Study|Physician Decision|7
5126008|NCT01685840|17705248|P1|Overall Study|Physician Decision|3
5126009|NCT01685840|17705247|P2|Overall Study|Lost to Follow-up|25
5126010|NCT01685840|17705248|P1|Overall Study|Lost to Follow-up|27
5126011|NCT01685840|17705247|P2|Overall Study|Death|66
5126012|NCT01685840|17705248|P1|Overall Study|Death|77
5126013|NCT01685801|17705292|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
5126014|NCT01685801|17705293|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
5126015|NCT01685801|17705294|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
5126016|NCT01685801|17705295|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
5126017|NCT01685801|17705292|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
5126018|NCT01685801|17705293|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5126019|NCT01685801|17705294|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5126020|NCT01685801|17705295|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5126021|NCT01685697|17705317|P2|Overall Study|Protocol Violation|3
5126022|NCT01685697|17705318|P1|Overall Study|Protocol Violation|3
5126023|NCT01685606|17705352|P1|Overall Study|Withdrawal by Subject|1
5126024|NCT01685437|17705380|P1|Overall Study|Unable to make visits due to work|1
5126025|NCT01685437|17705380|P1|Overall Study|Protocol Violation|4
5126026|NCT01685437|17705380|P1|Overall Study|Adverse Event|1
5126027|NCT01685437|17705380|P1|Overall Study|Lost to Follow-up|3
5126028|NCT01685437|17705380|P1|Overall Study|Withdrawal by Subject|22
5126029|NCT01685372|17705394|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
5126030|NCT01685372|17705395|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
5126031|NCT01685229|17705485|P2|Overall Study|Death|0
5126032|NCT01685229|17705486|P1|Overall Study|Death|1
5126033|NCT01685229|17705485|P2|Overall Study|Withdrawal by Subject|5
5126034|NCT01685229|17705486|P1|Overall Study|Withdrawal by Subject|6
5126035|NCT01685229|17705485|P2|Overall Study|Lost to Follow-up|10
5126036|NCT01685229|17705486|P1|Overall Study|Lost to Follow-up|16
5126037|NCT01685229|17705485|P2|Overall Study|Subjects missing Study Exit form|1
5126038|NCT01685229|17705486|P1|Overall Study|Subjects missing Study Exit form|3
5126039|NCT01685216|17705512|P1|Overall Study|Did not receive study drug|1
5126040|NCT01685203|17705529|P7|Overall Study|Patient's decision|0
5126041|NCT01685203|17705530|P6|Overall Study|Patient's decision|1
5126042|NCT01685203|17705531|P5|Overall Study|Patient's decision|0
5126043|NCT01685203|17705532|P4|Overall Study|Patient's decision|0
5126044|NCT01685203|17705533|P3|Overall Study|Patient's decision|0
5126045|NCT01685203|17705534|P2|Overall Study|Patient's decision|0
5126046|NCT01685203|17705535|P1|Overall Study|Patient's decision|0
5126047|NCT01685203|17705529|P7|Overall Study|Adverse event and withdrew consent|0
5126048|NCT01685203|17705530|P6|Overall Study|Adverse event and withdrew consent|0
5126049|NCT01685203|17705531|P5|Overall Study|Adverse event and withdrew consent|0
5126050|NCT01685203|17705532|P4|Overall Study|Adverse event and withdrew consent|0
5126051|NCT01685203|17705533|P3|Overall Study|Adverse event and withdrew consent|0
5126052|NCT01685203|17705534|P2|Overall Study|Adverse event and withdrew consent|0
5126053|NCT01685203|17705535|P1|Overall Study|Adverse event and withdrew consent|1
5126054|NCT01685203|17705529|P7|Overall Study|Adverse Event|0
5126055|NCT01685203|17705530|P6|Overall Study|Adverse Event|2
5126056|NCT01685203|17705531|P5|Overall Study|Adverse Event|0
5126057|NCT01685203|17705532|P4|Overall Study|Adverse Event|0
5126058|NCT01685203|17705533|P3|Overall Study|Adverse Event|0
5126059|NCT01685203|17705534|P2|Overall Study|Adverse Event|0
5126060|NCT01685203|17705535|P1|Overall Study|Adverse Event|0
5126061|NCT01685203|17705529|P7|Overall Study|Lost to Follow-up|0
5126062|NCT01685203|17705530|P6|Overall Study|Lost to Follow-up|0
5126063|NCT01685203|17705531|P5|Overall Study|Lost to Follow-up|0
5126064|NCT01685203|17705532|P4|Overall Study|Lost to Follow-up|1
5126065|NCT01685203|17705533|P3|Overall Study|Lost to Follow-up|0
5126066|NCT01685203|17705534|P2|Overall Study|Lost to Follow-up|3
5126067|NCT01685203|17705535|P1|Overall Study|Lost to Follow-up|3
5126068|NCT01685138|17705579|P1|Overall Study|Progressive disease|53
5126069|NCT01685138|17705579|P1|Overall Study|Adverse Event|18
5126070|NCT01685138|17705579|P1|Overall Study|Death|10
5126071|NCT01685138|17705579|P1|Overall Study|Physician Decision|6
5126072|NCT01685138|17705579|P1|Overall Study|Subject/guardian decision|2
5126073|NCT01685138|17705579|P1|Overall Study|No longer requires treatment|1
5126074|NCT01685138|17705579|P1|Overall Study|Protocol Violation|1
5126075|NCT01685138|17705579|P1|Overall Study|Lost to Follow-up|1
5126076|NCT01685073|17705595|P2|Overall Study|Withdrawal by Subject|24
5126077|NCT01685073|17705596|P1|Overall Study|Withdrawal by Subject|24
5126078|NCT01685073|17705595|P2|Overall Study|Lost to Follow-up|8
5126079|NCT01685073|17705596|P1|Overall Study|Lost to Follow-up|6
5126080|NCT01685060|17705604|P1|Overall Study|Death|8
5126081|NCT01685060|17705604|P1|Overall Study|Lost to Follow-up|1
5126082|NCT01685060|17705604|P1|Overall Study|Subject/guardian decision|20
5126083|NCT01685060|17705604|P1|Overall Study|Physician Decision|14
5126084|NCT01685060|17705604|P1|Overall Study|Progressive disease|69
5126085|NCT01685060|17705604|P1|Overall Study|Adverse Event|12
5126086|NCT01685060|17705604|P1|Overall Study|Rollover patients|16
5126087|NCT01685047|17705619|P1|Overall Study|patient withdrawn by sponsor|1
5126088|NCT01685047|17705619|P1|Overall Study|Adverse Event|5
5126089|NCT01685047|17705619|P1|Overall Study|Physician Decision|25
5126090|NCT01685047|17705619|P1|Overall Study|Lost to Follow-up|8
5126091|NCT01685047|17705619|P1|Overall Study|Death|26
5126092|NCT01685047|17705619|P1|Overall Study|Withdrawal by Subject|20
5126093|NCT01684943|17705635|P3|Overall Study|Planning Pregnancy|0
5126094|NCT01684943|17705636|P2|Overall Study|Planning Pregnancy|0
5126095|NCT01684943|17705637|P1|Overall Study|Planning Pregnancy|1
5126096|NCT01684943|17705635|P3|Overall Study|Lost to Follow-up|0
5126097|NCT01684943|17705636|P2|Overall Study|Lost to Follow-up|0
5126098|NCT01684943|17705637|P1|Overall Study|Lost to Follow-up|3
5126099|NCT01684943|17705635|P3|Overall Study|Excluded from Analysis|1
5126100|NCT01684943|17705636|P2|Overall Study|Excluded from Analysis|1
5126101|NCT01684943|17705637|P1|Overall Study|Excluded from Analysis|1
5126102|NCT01684943|17705635|P3|Overall Study|Principal Investigator Determination|0
5126103|NCT01684943|17705636|P2|Overall Study|Principal Investigator Determination|0
5126104|NCT01684943|17705637|P1|Overall Study|Principal Investigator Determination|1
5126105|NCT01684943|17705635|P3|Overall Study|Inadequate Venous Access|0
5126106|NCT01684943|17705636|P2|Overall Study|Inadequate Venous Access|0
5126107|NCT01684943|17705637|P1|Overall Study|Inadequate Venous Access|3
5126108|NCT01684930|17705656|P2|Overall Study|Withdrawal by Subject|1
5126109|NCT01684930|17705657|P1|Overall Study|Withdrawal by Subject|3
5126110|NCT01684878|17705714|P4|Part 2: Randomized Phase|Participant noncompliance|1
5126111|NCT01684878|17705715|P3|Part 2: Randomized Phase|Participant noncompliance|0
5126112|NCT01684878|17705716|P2|Part 2: Randomized Phase|Participant noncompliance|0
5126113|NCT01684878|17705717|P1|Part 2: Randomized Phase|Participant noncompliance|0
5126114|NCT01684878|17705714|P4|Part 2: Randomized Phase|Alive at data-cut|7
5126115|NCT01684878|17705715|P3|Part 2: Randomized Phase|Alive at data-cut|13
5126116|NCT01684878|17705716|P2|Part 2: Randomized Phase|Alive at data-cut|0
5126117|NCT01684878|17705717|P1|Part 2: Randomized Phase|Alive at data-cut|0
5126118|NCT01684878|17705714|P4|Part 2: Randomized Phase|Death|68
5126119|NCT01684878|17705715|P3|Part 2: Randomized Phase|Death|62
5126120|NCT01684878|17705716|P2|Part 2: Randomized Phase|Death|0
5126121|NCT01684878|17705717|P1|Part 2: Randomized Phase|Death|0
5126122|NCT01684878|17705714|P4|Part 2: Randomized Phase|Lost to Follow-up|0
5126123|NCT01684878|17705715|P3|Part 2: Randomized Phase|Lost to Follow-up|2
5126124|NCT01684878|17705716|P2|Part 2: Randomized Phase|Lost to Follow-up|0
5126125|NCT01684878|17705717|P1|Part 2: Randomized Phase|Lost to Follow-up|0
5126126|NCT01684878|17705714|P4|Part 2: Randomized Phase|Participant withdrew consent|2
5126127|NCT01684878|17705715|P3|Part 2: Randomized Phase|Participant withdrew consent|1
5126128|NCT01684878|17705716|P2|Part 2: Randomized Phase|Participant withdrew consent|0
5126129|NCT01684878|17705717|P1|Part 2: Randomized Phase|Participant withdrew consent|0
5126130|NCT01684878|17705714|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
5126131|NCT01684878|17705715|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
5126132|NCT01684878|17705716|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
5126133|NCT01684878|17705717|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
5126134|NCT01684878|17705714|P4|Part 1: Safety Run in Phase|Death|0
5126135|NCT01684878|17705715|P3|Part 1: Safety Run in Phase|Death|0
5126136|NCT01684878|17705716|P2|Part 1: Safety Run in Phase|Death|20
5126137|NCT01684878|17705717|P1|Part 1: Safety Run in Phase|Death|15
5126138|NCT01684878|17705714|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
5126139|NCT01684878|17705715|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
5126140|NCT01684878|17705716|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
5126141|NCT01684878|17705717|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
5126142|NCT01684722|17705765|P4|Overall Study|Death|21
5126143|NCT01684722|17705766|P3|Overall Study|Death|19
5126144|NCT01684722|17705767|P2|Overall Study|Death|21
5126145|NCT01684722|17705768|P1|Overall Study|Death|19
5126146|NCT01684722|17705765|P4|Overall Study|Lost to Follow-up|89
5126147|NCT01684722|17705766|P3|Overall Study|Lost to Follow-up|75
5126148|NCT01684722|17705767|P2|Overall Study|Lost to Follow-up|56
5126149|NCT01684722|17705768|P1|Overall Study|Lost to Follow-up|78
5126150|NCT01684423|17705842|P5|Overall Study|Withdrawal by Subject|0
5126151|NCT01684423|17705843|P4|Overall Study|Withdrawal by Subject|0
5126152|NCT01684423|17705844|P3|Overall Study|Withdrawal by Subject|1
5126153|NCT01684423|17705845|P2|Overall Study|Withdrawal by Subject|0
5126154|NCT01684423|17705846|P1|Overall Study|Withdrawal by Subject|0
5126155|NCT01684215|17705903|P4|Phase 2|Lost to Follow-up|4
5126156|NCT01684215|17705904|P3|Phase 2|Lost to Follow-up|0
5126157|NCT01684215|17705905|P2|Phase 2|Lost to Follow-up|0
5126158|NCT01684215|17705906|P1|Phase 2|Lost to Follow-up|0
5126159|NCT01684215|17705903|P4|Phase 2|Enrolled but not treated|1
5126160|NCT01684215|17705904|P3|Phase 2|Enrolled but not treated|0
5126161|NCT01684215|17705905|P2|Phase 2|Enrolled but not treated|0
5126162|NCT01684215|17705906|P1|Phase 2|Enrolled but not treated|0
5126163|NCT01684215|17705903|P4|Phase 2|Study terminated by sponsor|30
5126164|NCT01684215|17705904|P3|Phase 2|Study terminated by sponsor|0
5126165|NCT01684215|17705905|P2|Phase 2|Study terminated by sponsor|0
5126166|NCT01684215|17705906|P1|Phase 2|Study terminated by sponsor|0
5126167|NCT01684215|17705903|P4|Phase 2|Death|8
5126168|NCT01684215|17705904|P3|Phase 2|Death|0
5126169|NCT01684215|17705905|P2|Phase 2|Death|0
5126170|NCT01684215|17705906|P1|Phase 2|Death|0
5126171|NCT01684215|17705903|P4|Phase 1, Part 2|Withdrawal by Subject|0
5126172|NCT01684215|17705904|P3|Phase 1, Part 2|Withdrawal by Subject|1
5126173|NCT01684215|17705905|P2|Phase 1, Part 2|Withdrawal by Subject|0
5126174|NCT01684215|17705906|P1|Phase 1, Part 2|Withdrawal by Subject|0
5126175|NCT01684215|17705903|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5126176|NCT01684215|17705904|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
5126177|NCT01684215|17705905|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5126178|NCT01684215|17705906|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5126179|NCT01684215|17705903|P4|Phase 1, Part 2|Adverse Event|0
5126180|NCT01684215|17705904|P3|Phase 1, Part 2|Adverse Event|1
5126181|NCT01684215|17705905|P2|Phase 1, Part 2|Adverse Event|0
5126182|NCT01684215|17705906|P1|Phase 1, Part 2|Adverse Event|0
5126183|NCT01684215|17705903|P4|Phase 1, Part 1|Objective progression or relapse|0
5126184|NCT01684215|17705904|P3|Phase 1, Part 1|Objective progression or relapse|0
5126185|NCT01684215|17705905|P2|Phase 1, Part 1|Objective progression or relapse|6
5126186|NCT01684215|17705906|P1|Phase 1, Part 1|Objective progression or relapse|5
5126187|NCT01684215|17705903|P4|Phase 1, Part 1|Adverse Event|0
5126188|NCT01684215|17705904|P3|Phase 1, Part 1|Adverse Event|0
5126189|NCT01684215|17705905|P2|Phase 1, Part 1|Adverse Event|0
5126190|NCT01684215|17705906|P1|Phase 1, Part 1|Adverse Event|1
5126191|NCT01684046|17705980|P2|Period 1, First 30 Days|Adverse Event|2
5126192|NCT01684046|17705981|P1|Period 1, First 30 Days|Adverse Event|0
5126193|NCT01684033|17705987|P2|Period 2, Second 30 Days|Adverse Event|0
5126194|NCT01684033|17705988|P1|Period 2, Second 30 Days|Adverse Event|1
5126195|NCT01684033|17705987|P2|Period 1, First 30 Days|Lost to Follow-up|0
5126196|NCT01684033|17705988|P1|Period 1, First 30 Days|Lost to Follow-up|1
5126197|NCT01684033|17705987|P2|Period 1, First 30 Days|Withdrawal by Subject|0
5126198|NCT01684033|17705988|P1|Period 1, First 30 Days|Withdrawal by Subject|1
5126199|NCT01684033|17705987|P2|Period 1, First 30 Days|Noncompliance|0
5126200|NCT01684033|17705988|P1|Period 1, First 30 Days|Noncompliance|1
5126201|NCT01684033|17705987|P2|Period 1, First 30 Days|Adverse Event|1
5126202|NCT01684033|17705988|P1|Period 1, First 30 Days|Adverse Event|1
5126203|NCT01683994|17706037|P5|Overall Study|Intercurrent illness|1
5126204|NCT01683994|17706038|P4|Overall Study|Intercurrent illness|2
5126205|NCT01683994|17706039|P3|Overall Study|Intercurrent illness|0
5126206|NCT01683994|17706040|P2|Overall Study|Intercurrent illness|0
5126207|NCT01683994|17706041|P1|Overall Study|Intercurrent illness|0
5126208|NCT01683994|17706037|P5|Overall Study|Withdrawal by Subject|0
5126209|NCT01683994|17706038|P4|Overall Study|Withdrawal by Subject|1
5126210|NCT01683994|17706039|P3|Overall Study|Withdrawal by Subject|0
5126211|NCT01683994|17706040|P2|Overall Study|Withdrawal by Subject|0
5126212|NCT01683994|17706041|P1|Overall Study|Withdrawal by Subject|1
5126213|NCT01683838|17706082|P2|Overall Study|Other|3
5126214|NCT01683838|17706083|P1|Overall Study|Other|4
5126215|NCT01683838|17706082|P2|Overall Study|Lost to Follow-up|1
5126216|NCT01683838|17706083|P1|Overall Study|Lost to Follow-up|1
5126217|NCT01683838|17706082|P2|Overall Study|Withdrawal by Subject|5
5126218|NCT01683838|17706083|P1|Overall Study|Withdrawal by Subject|6
5126219|NCT01683838|17706082|P2|Overall Study|Protocol Violation|1
5126220|NCT01683838|17706083|P1|Overall Study|Protocol Violation|3
5126221|NCT01683838|17706082|P2|Overall Study|Adverse Event|2
5126222|NCT01683838|17706083|P1|Overall Study|Adverse Event|12
5126223|NCT01683604|17706123|P1|Overall Study|Other|2
5126224|NCT01683604|17706123|P1|Overall Study|Lack of Efficacy|1
5126225|NCT01683604|17706123|P1|Overall Study|Adverse Event|2
5126226|NCT01683565|17706288|P2|Overall Study|Discontinued Intervention|1
5126227|NCT01683565|17706289|P1|Overall Study|Discontinued Intervention|1
5126228|NCT01683565|17706288|P2|Overall Study|Lost to Follow-up|0
5126229|NCT01683565|17706289|P1|Overall Study|Lost to Follow-up|2
5126230|NCT01683409|17706323|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5126231|NCT01683409|17706324|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5126232|NCT01683409|17706325|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
5126233|NCT01683409|17706326|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5126234|NCT01683409|17706327|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5126235|NCT01683409|17706323|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
5126236|NCT01683409|17706324|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5126237|NCT01683409|17706325|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5126238|NCT01683409|17706326|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5126239|NCT01683409|17706327|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5126240|NCT01683409|17706323|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
5126241|NCT01683409|17706324|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
5126242|NCT01683409|17706325|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
5126243|NCT01683409|17706326|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
5126244|NCT01683409|17706327|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
5126245|NCT01683409|17706323|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5126246|NCT01683409|17706324|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5126247|NCT01683409|17706325|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5126248|NCT01683409|17706326|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5126249|NCT01683409|17706327|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
5126250|NCT01683409|17706323|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
5126251|NCT01683409|17706324|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5126252|NCT01683409|17706325|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5126253|NCT01683409|17706326|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5126254|NCT01683409|17706327|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
5126255|NCT01683409|17706323|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5126256|NCT01683409|17706324|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
5126257|NCT01683409|17706325|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5126258|NCT01683409|17706326|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5126259|NCT01683409|17706327|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
5126260|NCT01683409|17706323|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5126261|NCT01683409|17706324|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5126262|NCT01683409|17706325|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
5126263|NCT01683409|17706326|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5126264|NCT01683409|17706327|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5126265|NCT01683409|17706323|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
5126266|NCT01683409|17706324|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
5126267|NCT01683409|17706325|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5126268|NCT01683409|17706326|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5126269|NCT01683409|17706327|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5126270|NCT01683409|17706323|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5126271|NCT01683409|17706324|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5126272|NCT01683409|17706325|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5126273|NCT01683409|17706326|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
5126274|NCT01683409|17706327|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5126275|NCT01683409|17706323|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
5126276|NCT01683409|17706324|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
5126277|NCT01683409|17706325|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
5126278|NCT01683409|17706326|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
5126279|NCT01683409|17706327|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
5126280|NCT01683409|17706323|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5126281|NCT01683409|17706324|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5126282|NCT01683409|17706325|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
5126283|NCT01683409|17706326|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5126284|NCT01683409|17706327|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5126285|NCT01683383|17706370|P2|Overall Study|Infant was not transported|0
5126286|NCT01683383|17706371|P1|Overall Study|Infant was not transported|1
5126287|NCT01683266|17706398|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
5126288|NCT01683266|17706399|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
5126289|NCT01683266|17706398|P2|Overall Study|Possibly Hypoglycemia|0
5126290|NCT01683266|17706399|P1|Overall Study|Possibly Hypoglycemia|1
5126291|NCT01683266|17706398|P2|Overall Study|Perceived Lack of Efficacy|1
5126292|NCT01683266|17706399|P1|Overall Study|Perceived Lack of Efficacy|1
5126293|NCT01683266|17706398|P2|Overall Study|Nonserious Hypoglycemia|3
5126294|NCT01683266|17706399|P1|Overall Study|Nonserious Hypoglycemia|0
5126295|NCT01683266|17706398|P2|Overall Study|Site Closure / Site Withdrawal|3
5126296|NCT01683266|17706399|P1|Overall Study|Site Closure / Site Withdrawal|1
5126297|NCT01683266|17706398|P2|Overall Study|Lost to Follow-up|0
5126298|NCT01683266|17706399|P1|Overall Study|Lost to Follow-up|5
5126299|NCT01683266|17706398|P2|Overall Study|Selection Criterion / Protocol Violation|5
5126300|NCT01683266|17706399|P1|Overall Study|Selection Criterion / Protocol Violation|7
5126301|NCT01683266|17706398|P2|Overall Study|Personal Reason|25
5126302|NCT01683266|17706399|P1|Overall Study|Personal Reason|17
5126303|NCT01683266|17706398|P2|Overall Study|Protocol Violation|6
5126304|NCT01683266|17706399|P1|Overall Study|Protocol Violation|13
5126305|NCT01683266|17706398|P2|Overall Study|Lack of Efficacy|2
5126306|NCT01683266|17706399|P1|Overall Study|Lack of Efficacy|5
5126307|NCT01683266|17706398|P2|Overall Study|Adverse Event|4
5126308|NCT01683266|17706399|P1|Overall Study|Adverse Event|5
5126309|NCT01683058|17706427|P1|Overall Study|Lack of Efficacy|2
5126310|NCT01683058|17706427|P1|Overall Study|Withdrawal by Subject|7
5126311|NCT01683058|17706427|P1|Overall Study|Subject Met Withdrawal Criteria|5
5126312|NCT01683058|17706427|P1|Overall Study|Adverse Event|6
5126313|NCT01683058|17706427|P1|Overall Study|Lost to Follow-up|9
5126314|NCT01683019|17706458|P3|Overall Study|Withdrawal by Subject|4
5126315|NCT01683019|17706459|P2|Overall Study|Withdrawal by Subject|1
5126316|NCT01683019|17706460|P1|Overall Study|Withdrawal by Subject|2
5126317|NCT01682876|17706494|P4|Overall Study|Other|1
5126318|NCT01682876|17706495|P3|Overall Study|Other|1
5126319|NCT01682876|17706496|P2|Overall Study|Other|0
5126320|NCT01682876|17706497|P1|Overall Study|Other|1
5126321|NCT01682876|17706494|P4|Overall Study|Withdrawal by Subject|2
5126322|NCT01682876|17706495|P3|Overall Study|Withdrawal by Subject|0
5126323|NCT01682876|17706496|P2|Overall Study|Withdrawal by Subject|0
5126324|NCT01682876|17706497|P1|Overall Study|Withdrawal by Subject|4
5126325|NCT01682876|17706494|P4|Overall Study|Protocol Violation|1
5126326|NCT01682876|17706495|P3|Overall Study|Protocol Violation|1
5126327|NCT01682876|17706496|P2|Overall Study|Protocol Violation|1
5126328|NCT01682876|17706497|P1|Overall Study|Protocol Violation|1
5126329|NCT01682876|17706494|P4|Overall Study|Lost to Follow-up|11
5126330|NCT01682876|17706495|P3|Overall Study|Lost to Follow-up|9
5126331|NCT01682876|17706496|P2|Overall Study|Lost to Follow-up|15
5126332|NCT01682876|17706497|P1|Overall Study|Lost to Follow-up|11
5126333|NCT01682876|17706494|P4|Overall Study|Adverse Event|1
5126334|NCT01682876|17706495|P3|Overall Study|Adverse Event|0
5126335|NCT01682876|17706496|P2|Overall Study|Adverse Event|0
5126336|NCT01682876|17706497|P1|Overall Study|Adverse Event|0
5126337|NCT01682876|17706494|P4|Overall Study|Administrative reason|3
5126338|NCT01682876|17706495|P3|Overall Study|Administrative reason|0
5126339|NCT01682876|17706496|P2|Overall Study|Administrative reason|4
5126340|NCT01682876|17706497|P1|Overall Study|Administrative reason|4
5126341|NCT01682863|17706543|P3|Overall Study|Physician Decision|1
5126342|NCT01682863|17706544|P2|Overall Study|Physician Decision|0
5126343|NCT01682863|17706545|P1|Overall Study|Physician Decision|0
5126344|NCT01682863|17706543|P3|Overall Study|Adverse Event|2
5126345|NCT01682863|17706544|P2|Overall Study|Adverse Event|1
5126346|NCT01682863|17706545|P1|Overall Study|Adverse Event|0
5126347|NCT01682863|17706543|P3|Overall Study|Technical problems|0
5126348|NCT01682863|17706544|P2|Overall Study|Technical problems|0
5126349|NCT01682863|17706545|P1|Overall Study|Technical problems|1
5126350|NCT01682863|17706543|P3|Overall Study|Protocol deviation|1
5126351|NCT01682863|17706544|P2|Overall Study|Protocol deviation|0
5126352|NCT01682863|17706545|P1|Overall Study|Protocol deviation|1
5126353|NCT01682863|17706543|P3|Overall Study|Death|4
5126354|NCT01682863|17706544|P2|Overall Study|Death|3
5126355|NCT01682863|17706545|P1|Overall Study|Death|1
5126356|NCT01682863|17706543|P3|Overall Study|Lost to Follow-up|6
5126357|NCT01682863|17706544|P2|Overall Study|Lost to Follow-up|1
5126358|NCT01682863|17706545|P1|Overall Study|Lost to Follow-up|5
5126359|NCT01682863|17706543|P3|Overall Study|Subject/guardian decision|10
5126360|NCT01682863|17706544|P2|Overall Study|Subject/guardian decision|12
5126361|NCT01682863|17706545|P1|Overall Study|Subject/guardian decision|19
5126362|NCT01682837|17706574|P1|Baseline|Withdrawal by Subject|5
5126363|NCT01682759|17706618|P2|Overall Study|Withdrawal by Subject|55
5126364|NCT01682759|17706619|P1|Overall Study|Withdrawal by Subject|56
5126365|NCT01682759|17706618|P2|Overall Study|Physician Decision|1
5126366|NCT01682759|17706619|P1|Overall Study|Physician Decision|1
5126367|NCT01682759|17706618|P2|Overall Study|Lost to Follow-up|13
5126368|NCT01682759|17706619|P1|Overall Study|Lost to Follow-up|10
5126369|NCT01682759|17706618|P2|Overall Study|Death|1
5126370|NCT01682759|17706619|P1|Overall Study|Death|2
5126371|NCT01682720|17706643|P4|Overall Study|Adverse Event|1
5126372|NCT01682720|17706644|P3|Overall Study|Adverse Event|1
5126373|NCT01682720|17706645|P2|Overall Study|Adverse Event|0
5126374|NCT01682720|17706646|P1|Overall Study|Adverse Event|1
5126375|NCT01682720|17706643|P4|Overall Study|Subject Withdrew Consent|2
5126376|NCT01682720|17706644|P3|Overall Study|Subject Withdrew Consent|2
5126377|NCT01682720|17706645|P2|Overall Study|Subject Withdrew Consent|0
5126378|NCT01682720|17706646|P1|Overall Study|Subject Withdrew Consent|0
5126379|NCT01682720|17706643|P4|Overall Study|Lost to Follow-up|6
5126380|NCT01682720|17706644|P3|Overall Study|Lost to Follow-up|0
5126381|NCT01682720|17706645|P2|Overall Study|Lost to Follow-up|1
5126382|NCT01682720|17706646|P1|Overall Study|Lost to Follow-up|1
5126383|NCT01682720|17706643|P4|Overall Study|Efficacy Failure|30
5126384|NCT01682720|17706644|P3|Overall Study|Efficacy Failure|3
5126385|NCT01682720|17706645|P2|Overall Study|Efficacy Failure|3
5126386|NCT01682720|17706646|P1|Overall Study|Efficacy Failure|0
5126387|NCT01682720|17706643|P4|Overall Study|Terminated by Sponsor|0
5126388|NCT01682720|17706644|P3|Overall Study|Terminated by Sponsor|0
5126389|NCT01682720|17706645|P2|Overall Study|Terminated by Sponsor|0
5126390|NCT01682720|17706646|P1|Overall Study|Terminated by Sponsor|83
5126391|NCT01682720|17706643|P4|Overall Study|Randomized but Not Treated|0
5126392|NCT01682720|17706644|P3|Overall Study|Randomized but Not Treated|1
5126393|NCT01682720|17706645|P2|Overall Study|Randomized but Not Treated|1
5126394|NCT01682720|17706646|P1|Overall Study|Randomized but Not Treated|0
5126395|NCT01682681|17706663|P1|Overall Study|Low compliance|13
5126396|NCT01682681|17706663|P1|Overall Study|Other|21
5126397|NCT01682681|17706663|P1|Overall Study|tapering of topiramate|5
5126398|NCT01682681|17706663|P1|Overall Study|Adverse Event|46
5126399|NCT01682681|17706663|P1|Overall Study|Lost to Follow-up|174
5126400|NCT01682681|17706663|P1|Overall Study|Moved to other hospital|10
5126401|NCT01682681|17706663|P1|Overall Study|Withdrawal by Subject|1
5126402|NCT01682681|17706663|P1|Overall Study|Lack of Efficacy|62
5126403|NCT01682603|17706692|P1|Overall Study|Lost to Follow-up|3
5126404|NCT01682512|17706737|P3|Overall Study|Other than stated above|2
5126405|NCT01682512|17706738|P2|Overall Study|Other than stated above|4
5126406|NCT01682512|17706739|P1|Overall Study|Other than stated above|2
5126407|NCT01682512|17706737|P3|Overall Study|Secondary lack of efficacy|0
5126408|NCT01682512|17706738|P2|Overall Study|Secondary lack of efficacy|1
5126409|NCT01682512|17706739|P1|Overall Study|Secondary lack of efficacy|1
5126410|NCT01682512|17706737|P3|Overall Study|Primary lack of efficacy|7
5126411|NCT01682512|17706738|P2|Overall Study|Primary lack of efficacy|7
5126412|NCT01682512|17706739|P1|Overall Study|Primary lack of efficacy|10
5126413|NCT01682512|17706737|P3|Overall Study|Protocol Violation|2
5126414|NCT01682512|17706738|P2|Overall Study|Protocol Violation|3
5126415|NCT01682512|17706739|P1|Overall Study|Protocol Violation|2
5126416|NCT01682512|17706737|P3|Overall Study|Lost to Follow-up|2
5126417|NCT01682512|17706738|P2|Overall Study|Lost to Follow-up|0
5126418|NCT01682512|17706739|P1|Overall Study|Lost to Follow-up|3
5126419|NCT01682512|17706737|P3|Overall Study|Study terminated by sponsor|0
5126420|NCT01682512|17706738|P2|Overall Study|Study terminated by sponsor|43
5126421|NCT01682512|17706739|P1|Overall Study|Study terminated by sponsor|46
5126422|NCT01682512|17706737|P3|Overall Study|Physician Decision|0
5126423|NCT01682512|17706738|P2|Overall Study|Physician Decision|2
5126424|NCT01682512|17706739|P1|Overall Study|Physician Decision|0
5126425|NCT01682512|17706737|P3|Overall Study|Withdrawal by Subject|3
5126426|NCT01682512|17706738|P2|Overall Study|Withdrawal by Subject|6
5126427|NCT01682512|17706739|P1|Overall Study|Withdrawal by Subject|2
5126428|NCT01682512|17706737|P3|Overall Study|Adverse Event|2
5126429|NCT01682512|17706738|P2|Overall Study|Adverse Event|5
5126430|NCT01682512|17706739|P1|Overall Study|Adverse Event|6
5126431|NCT01682460|17706764|P1|Overall Study|Did not meet inclusion criteria|2
5126432|NCT01682460|17706764|P1|Overall Study|Withdrawal by Subject|2
5126433|NCT01682213|17706779|P1|Overall Study|Withdrawal by Subject|2
5126434|NCT01682148|17706787|P2|Overall Study|Protocol Violation|1
5126435|NCT01682148|17706788|P1|Overall Study|Protocol Violation|1
5126436|NCT01682148|17706787|P2|Overall Study|Lost to Follow-up|2
5126437|NCT01682148|17706788|P1|Overall Study|Lost to Follow-up|1
5126438|NCT01682148|17706787|P2|Overall Study|Withdrawal by Subject|0
5126439|NCT01682148|17706788|P1|Overall Study|Withdrawal by Subject|2
5126440|NCT01682083|17706848|P2|Overall Study|Physician Decision|4
5126441|NCT01682083|17706849|P1|Overall Study|Physician Decision|5
5126442|NCT01682083|17706848|P2|Overall Study|Death|93
5126443|NCT01682083|17706849|P1|Overall Study|Death|60
5126444|NCT01682083|17706848|P2|Overall Study|Withdrawal by Subject|40
5126445|NCT01682083|17706849|P1|Overall Study|Withdrawal by Subject|31
5126446|NCT01682083|17706848|P2|Overall Study|Lost to Follow-up|18
5126447|NCT01682083|17706849|P1|Overall Study|Lost to Follow-up|11
5126448|NCT01682044|17706861|P1|Overall Study|Progression|3
5126449|NCT01682044|17706861|P1|Overall Study|Death|1
5126450|NCT01682031|17706873|P2|Overall Study|Patient stopped selenium on his own|1
5126451|NCT01682031|17706874|P1|Overall Study|Patient stopped selenium on his own|0
5126452|NCT01682031|17706873|P2|Overall Study|Patient could not swallow tablets|0
5126453|NCT01682031|17706874|P1|Overall Study|Patient could not swallow tablets|1
5126454|NCT01682031|17706873|P2|Overall Study|MRI results indicate increased nodul|1
5126455|NCT01682031|17706874|P1|Overall Study|MRI results indicate increased nodul|0
5126456|NCT01682031|17706873|P2|Overall Study|Adverse Event|2
5126457|NCT01682031|17706874|P1|Overall Study|Adverse Event|0
5126458|NCT01682031|17706873|P2|Overall Study|Withdrawal by Subject|1
5126459|NCT01682031|17706874|P1|Overall Study|Withdrawal by Subject|0
5126460|NCT01681992|17706897|P3|Overall Study|Withdrawal by Subject|25
5126461|NCT01681992|17706898|P2|Overall Study|Withdrawal by Subject|30
5126462|NCT01681992|17706899|P1|Overall Study|Withdrawal by Subject|27
5126463|NCT01681992|17706897|P3|Overall Study|Protocol Violation|1
5126464|NCT01681992|17706898|P2|Overall Study|Protocol Violation|0
5126465|NCT01681992|17706899|P1|Overall Study|Protocol Violation|0
5126466|NCT01681992|17706897|P3|Overall Study|As Per Sponsor Decision|1
5126467|NCT01681992|17706898|P2|Overall Study|As Per Sponsor Decision|0
5126468|NCT01681992|17706899|P1|Overall Study|As Per Sponsor Decision|0
5126469|NCT01681992|17706897|P3|Overall Study|Lost to Follow-up|53
5126470|NCT01681992|17706898|P2|Overall Study|Lost to Follow-up|38
5126471|NCT01681992|17706899|P1|Overall Study|Lost to Follow-up|36
5126472|NCT01681992|17706897|P3|Overall Study|Adverse Event|3
5126473|NCT01681992|17706898|P2|Overall Study|Adverse Event|2
5126474|NCT01681992|17706899|P1|Overall Study|Adverse Event|3
5126475|NCT01681849|17706988|P3|Overall Study|Lost to Follow-up|6
5126476|NCT01681849|17706989|P2|Overall Study|Lost to Follow-up|2
5126477|NCT01681849|17706990|P1|Overall Study|Lost to Follow-up|3
5126478|NCT01681849|17706988|P3|Overall Study|Withdrawal by Subject|33
5126479|NCT01681849|17706989|P2|Overall Study|Withdrawal by Subject|5
5126480|NCT01681849|17706990|P1|Overall Study|Withdrawal by Subject|3
5126481|NCT01681849|17706988|P3|Overall Study|Protocol Violation|0
5126482|NCT01681849|17706989|P2|Overall Study|Protocol Violation|0
5126483|NCT01681849|17706990|P1|Overall Study|Protocol Violation|2
5126484|NCT01681836|17706999|P2|Second Intervention|Withdrawal by Subject|1
5126485|NCT01681836|17707000|P1|Second Intervention|Withdrawal by Subject|0
5126486|NCT01681771|17707034|P2|Overall Study|Lost to Follow-up|2
5126487|NCT01681771|17707035|P1|Overall Study|Lost to Follow-up|4
5126488|NCT01681628|17707043|P2|19 Months Follow-up|Lost to Follow-up|43
5126489|NCT01681628|17707044|P1|19 Months Follow-up|Lost to Follow-up|61
5126490|NCT01681628|17707043|P2|19 Months Follow-up|Death|0
5126491|NCT01681628|17707044|P1|19 Months Follow-up|Death|1
5126492|NCT01681628|17707043|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
5126493|NCT01681628|17707044|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
5126494|NCT01681628|17707043|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
5126495|NCT01681628|17707044|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
5126496|NCT01681576|17707073|P2|Period 2|Non-compliance with study treatment|0
5126497|NCT01681576|17707074|P1|Period 2|Non-compliance with study treatment|1
5126498|NCT01681576|17707073|P2|Period 2|subject/guardian decision|1
5126499|NCT01681576|17707074|P1|Period 2|subject/guardian decision|3
5126500|NCT01681576|17707073|P2|Period 1|Protocol Deviation|0
5126501|NCT01681576|17707074|P1|Period 1|Protocol Deviation|1
5126502|NCT01681576|17707073|P2|Period 1|Adverse Event|0
5126503|NCT01681576|17707074|P1|Period 1|Adverse Event|1
5126504|NCT01681511|17707090|P2|Overall Study|No post-catheter sample collected|4
5126505|NCT01681511|17707091|P1|Overall Study|No post-catheter sample collected|11
5126506|NCT01681511|17707090|P2|Overall Study|No Daily Urine Sample Collected|1
5126507|NCT01681511|17707091|P1|Overall Study|No Daily Urine Sample Collected|0
5126508|NCT01681511|17707090|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
5126509|NCT01681511|17707091|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
5126510|NCT01681511|17707090|P2|Overall Study|Failed Inclusion/Exclusion|0
5126511|NCT01681511|17707091|P1|Overall Study|Failed Inclusion/Exclusion|3
5126512|NCT01681511|17707090|P2|Overall Study|No Treatment Received|3
5126513|NCT01681511|17707091|P1|Overall Study|No Treatment Received|1
5126514|NCT01681472|17707109|P4|Overall Study|Adverse Event|0
5126515|NCT01681472|17707110|P3|Overall Study|Adverse Event|0
5126516|NCT01681472|17707111|P2|Overall Study|Adverse Event|1
5126517|NCT01681472|17707112|P1|Overall Study|Adverse Event|0
5126518|NCT01681433|17707292|P2|Overall Study|Lost to Follow-up|1
5126519|NCT01681433|17707293|P1|Overall Study|Lost to Follow-up|0
5126520|NCT01681433|17707292|P2|Overall Study|Adverse Event|4
5126521|NCT01681433|17707293|P1|Overall Study|Adverse Event|2
5126522|NCT01681433|17707292|P2|Overall Study|Protocol Violation|0
5126523|NCT01681433|17707293|P1|Overall Study|Protocol Violation|2
5126524|NCT01681433|17707292|P2|Overall Study|Withdrawal by Subject|5
5126525|NCT01681433|17707293|P1|Overall Study|Withdrawal by Subject|5
5126526|NCT01681433|17707292|P2|Overall Study|Lack of Efficacy|23
5126527|NCT01681433|17707293|P1|Overall Study|Lack of Efficacy|23
5126528|NCT01681368|17707311|P1|Overall Study|Refused further follow up|1
5126529|NCT01681368|17707311|P1|Overall Study|Refused further treatment|1
5126530|NCT01681277|17707328|P5|Overall Study|Adverse Event|0
5126531|NCT01681277|17707329|P4|Overall Study|Adverse Event|0
5126532|NCT01681277|17707330|P3|Overall Study|Adverse Event|0
5126533|NCT01681277|17707331|P2|Overall Study|Adverse Event|0
5126534|NCT01681277|17707332|P1|Overall Study|Adverse Event|1
5126535|NCT01681212|17707373|P1|Overall Study|Administrative reason by sponsor|1
5126536|NCT01681212|17707373|P1|Overall Study|No longer met study criteria|5
5126537|NCT01681186|17707387|P8|Fourth Intervention|Protocol Violation|1
5126538|NCT01681186|17707388|P7|Fourth Intervention|Protocol Violation|0
5126539|NCT01681186|17707389|P6|Fourth Intervention|Protocol Violation|0
5126540|NCT01681186|17707390|P5|Fourth Intervention|Protocol Violation|0
5126541|NCT01681186|17707391|P4|Fourth Intervention|Protocol Violation|0
5126542|NCT01681186|17707392|P3|Fourth Intervention|Protocol Violation|0
5126543|NCT01681186|17707393|P2|Fourth Intervention|Protocol Violation|0
5126544|NCT01681186|17707394|P1|Fourth Intervention|Protocol Violation|0
5126545|NCT01681186|17707387|P8|Washout Period From Third Intervention|Lost to Follow-up|0
5126546|NCT01681186|17707388|P7|Washout Period From Third Intervention|Lost to Follow-up|1
5126547|NCT01681186|17707389|P6|Washout Period From Third Intervention|Lost to Follow-up|0
5126548|NCT01681186|17707390|P5|Washout Period From Third Intervention|Lost to Follow-up|0
5126549|NCT01681186|17707391|P4|Washout Period From Third Intervention|Lost to Follow-up|0
5126550|NCT01681186|17707392|P3|Washout Period From Third Intervention|Lost to Follow-up|0
5126551|NCT01681186|17707393|P2|Washout Period From Third Intervention|Lost to Follow-up|0
5126552|NCT01681186|17707394|P1|Washout Period From Third Intervention|Lost to Follow-up|0
5126553|NCT01681186|17707387|P8|Washout Period From Second Intervention|Protocol Violation|1
5126554|NCT01681186|17707388|P7|Washout Period From Second Intervention|Protocol Violation|0
5126555|NCT01681186|17707389|P6|Washout Period From Second Intervention|Protocol Violation|0
5126556|NCT01681186|17707390|P5|Washout Period From Second Intervention|Protocol Violation|0
5126557|NCT01681186|17707391|P4|Washout Period From Second Intervention|Protocol Violation|0
5126558|NCT01681186|17707392|P3|Washout Period From Second Intervention|Protocol Violation|0
5126559|NCT01681186|17707393|P2|Washout Period From Second Intervention|Protocol Violation|0
5126560|NCT01681186|17707394|P1|Washout Period From Second Intervention|Protocol Violation|0
5126561|NCT01681186|17707387|P8|Washout Period From Second Intervention|Adverse Event|0
5126562|NCT01681186|17707388|P7|Washout Period From Second Intervention|Adverse Event|1
5126563|NCT01681186|17707389|P6|Washout Period From Second Intervention|Adverse Event|0
5126564|NCT01681186|17707390|P5|Washout Period From Second Intervention|Adverse Event|0
5126565|NCT01681186|17707391|P4|Washout Period From Second Intervention|Adverse Event|0
5126566|NCT01681186|17707392|P3|Washout Period From Second Intervention|Adverse Event|0
5126567|NCT01681186|17707393|P2|Washout Period From Second Intervention|Adverse Event|0
5126568|NCT01681186|17707394|P1|Washout Period From Second Intervention|Adverse Event|0
5126569|NCT01681069|17707497|P2|Overall Study|Adverse Event|1
5126570|NCT01681069|17707498|P1|Overall Study|Adverse Event|0
5126571|NCT01681069|17707497|P2|Overall Study|Protocol Violation|1
5126572|NCT01681069|17707498|P1|Overall Study|Protocol Violation|1
5126573|NCT01681069|17707497|P2|Overall Study|Withdrawal by Subject|5
5126574|NCT01681069|17707498|P1|Overall Study|Withdrawal by Subject|4
5126575|NCT01681004|17707535|P2|Study Completion|Death|1
5126576|NCT01681004|17707536|P1|Study Completion|Death|1
5126577|NCT01681004|17707535|P2|Study Completion|Site Termination|1
5126578|NCT01681004|17707536|P1|Study Completion|Site Termination|2
5126579|NCT01681004|17707535|P2|Study Completion|Physician Decision|3
5126580|NCT01681004|17707536|P1|Study Completion|Physician Decision|1
5126581|NCT01681004|17707535|P2|Study Completion|Lost to Follow-up|3
5126582|NCT01681004|17707536|P1|Study Completion|Lost to Follow-up|8
5126583|NCT01681004|17707535|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
5126584|NCT01681004|17707536|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
5126585|NCT01680991|17707593|P3|Overall Study|PD confirmed in other hospital|0
5126586|NCT01680991|17707594|P2|Overall Study|PD confirmed in other hospital|0
5126587|NCT01680991|17707595|P1|Overall Study|PD confirmed in other hospital|1
5126588|NCT01680991|17707593|P3|Overall Study|Bad physical condition|1
5126589|NCT01680991|17707594|P2|Overall Study|Bad physical condition|0
5126590|NCT01680991|17707595|P1|Overall Study|Bad physical condition|0
5126591|NCT01680991|17707593|P3|Overall Study|Physician Decision|2
5126592|NCT01680991|17707594|P2|Overall Study|Physician Decision|7
5126593|NCT01680991|17707595|P1|Overall Study|Physician Decision|0
5126594|NCT01680991|17707593|P3|Overall Study|Progressive disease (PD)|0
5126595|NCT01680991|17707594|P2|Overall Study|Progressive disease (PD)|10
5126596|NCT01680991|17707595|P1|Overall Study|Progressive disease (PD)|0
5126597|NCT01680991|17707593|P3|Overall Study|Withdrawal by Subject|0
5126598|NCT01680991|17707594|P2|Overall Study|Withdrawal by Subject|1
5126599|NCT01680991|17707595|P1|Overall Study|Withdrawal by Subject|5
5126600|NCT01680991|17707593|P3|Overall Study|Protocol Violation|0
5126601|NCT01680991|17707594|P2|Overall Study|Protocol Violation|1
5126602|NCT01680991|17707595|P1|Overall Study|Protocol Violation|0
5126603|NCT01680991|17707593|P3|Overall Study|Death|1
5126604|NCT01680991|17707594|P2|Overall Study|Death|0
5126605|NCT01680991|17707595|P1|Overall Study|Death|1
5126606|NCT01680991|17707593|P3|Overall Study|Adverse Event|0
5126607|NCT01680991|17707594|P2|Overall Study|Adverse Event|0
5126608|NCT01680991|17707595|P1|Overall Study|Adverse Event|1
5126609|NCT01680965|17707658|P4|Overall Study|Death|6
5126610|NCT01680965|17707659|P3|Overall Study|Death|0
5126611|NCT01680965|17707660|P2|Overall Study|Death|0
5126612|NCT01680965|17707661|P1|Overall Study|Death|0
5126613|NCT01680861|17707702|P2|Early Post-transplant Period|Protocol Violation|1
5126614|NCT01680861|17707703|P1|Early Post-transplant Period|Protocol Violation|1
5126615|NCT01680497|17707800|P1|Overall Study|Lost to Follow-up|2
5126616|NCT01680458|17707810|P1|Overall Study|Protocol Violation|3
5126617|NCT01680341|17707821|P2|Overall Study|Unclassified|15
5126618|NCT01680341|17707822|P1|Overall Study|Unclassified|18
5126619|NCT01680341|17707821|P2|Overall Study|Adverse Event|2
5126620|NCT01680341|17707822|P1|Overall Study|Adverse Event|3
5126621|NCT01680159|17707893|P1|Increased Dose Period|Withdrawal by Subject|2
5126622|NCT01680159|17707893|P1|Increased Dose Period|Adverse Event|6
5126623|NCT01680159|17707893|P1|Screening Period|Not meet criteria for dose-up period|7
5126624|NCT01680016|17707920|P4|Overall Study|Withdrawal by Subject|1
5126625|NCT01680016|17707921|P3|Overall Study|Withdrawal by Subject|1
5126626|NCT01680016|17707922|P2|Overall Study|Withdrawal by Subject|7
5126627|NCT01680016|17707923|P1|Overall Study|Withdrawal by Subject|5
5126628|NCT01680016|17707920|P4|Overall Study|Protocol Violation|0
5126629|NCT01680016|17707921|P3|Overall Study|Protocol Violation|0
5126630|NCT01680016|17707922|P2|Overall Study|Protocol Violation|1
5126631|NCT01680016|17707923|P1|Overall Study|Protocol Violation|0
5126632|NCT01680016|17707920|P4|Overall Study|The Subject went out of The Trial|0
5126633|NCT01680016|17707921|P3|Overall Study|The Subject went out of The Trial|3
5126634|NCT01680016|17707922|P2|Overall Study|The Subject went out of The Trial|0
5126635|NCT01680016|17707923|P1|Overall Study|The Subject went out of The Trial|1
5126636|NCT01680016|17707920|P4|Overall Study|Adverse Event|4
5126637|NCT01680016|17707921|P3|Overall Study|Adverse Event|1
5126638|NCT01680016|17707922|P2|Overall Study|Adverse Event|0
5126639|NCT01680016|17707923|P1|Overall Study|Adverse Event|0
5126640|NCT01679613|17707985|P4|Overall Study|other than stated above|2
5126641|NCT01679613|17707986|P3|Overall Study|other than stated above|2
5126642|NCT01679613|17707987|P2|Overall Study|other than stated above|1
5126643|NCT01679613|17707988|P1|Overall Study|other than stated above|0
5126644|NCT01679405|17708010|P2|Overall Study|Death|5
5126645|NCT01679405|17708011|P1|Overall Study|Death|2
5126646|NCT01679301|17708046|P3|Screening Period|screen failure|0
5126647|NCT01679301|17708047|P2|Screening Period|screen failure|0
5126648|NCT01679301|17708048|P1|Screening Period|screen failure|3
5126649|NCT01679236|17708056|P2|Overall Study|Lost to Follow-up|15
5126650|NCT01679236|17708057|P1|Overall Study|Lost to Follow-up|15
5126651|NCT01679002|17708104|P3|Overall Study|Adverse Event|0
5126652|NCT01679002|17708105|P2|Overall Study|Adverse Event|1
5126653|NCT01679002|17708106|P1|Overall Study|Adverse Event|1
5126654|NCT01678924|17708137|P4|Overall Study|Unable to attend scheduled visits|1
5126655|NCT01678924|17708138|P3|Overall Study|Unable to attend scheduled visits|0
5126656|NCT01678924|17708139|P2|Overall Study|Unable to attend scheduled visits|0
5126657|NCT01678924|17708140|P1|Overall Study|Unable to attend scheduled visits|0
5126658|NCT01678924|17708137|P4|Overall Study|Withdrawal by Subject|2
5126659|NCT01678924|17708138|P3|Overall Study|Withdrawal by Subject|0
5126660|NCT01678924|17708139|P2|Overall Study|Withdrawal by Subject|3
5126661|NCT01678924|17708140|P1|Overall Study|Withdrawal by Subject|0
5126662|NCT01678924|17708137|P4|Overall Study|Personal Reasons|7
5126663|NCT01678924|17708138|P3|Overall Study|Personal Reasons|2
5126664|NCT01678924|17708139|P2|Overall Study|Personal Reasons|2
5126665|NCT01678924|17708140|P1|Overall Study|Personal Reasons|2
5126666|NCT01678924|17708137|P4|Overall Study|Lost to Follow-up|2
5126667|NCT01678924|17708138|P3|Overall Study|Lost to Follow-up|0
5126668|NCT01678924|17708139|P2|Overall Study|Lost to Follow-up|4
5126669|NCT01678924|17708140|P1|Overall Study|Lost to Follow-up|0
5126670|NCT01678924|17708137|P4|Overall Study|Lack of Efficacy|5
5126671|NCT01678924|17708138|P3|Overall Study|Lack of Efficacy|0
5126672|NCT01678924|17708139|P2|Overall Study|Lack of Efficacy|2
5126673|NCT01678924|17708140|P1|Overall Study|Lack of Efficacy|7
5126674|NCT01678924|17708137|P4|Overall Study|Adverse Event|1
5126675|NCT01678924|17708138|P3|Overall Study|Adverse Event|0
5126676|NCT01678924|17708139|P2|Overall Study|Adverse Event|1
5126677|NCT01678924|17708140|P1|Overall Study|Adverse Event|1
5126678|NCT01678911|17708271|P2|Second Intervention|Lost to Follow-up|0
5126679|NCT01678911|17708272|P1|Second Intervention|Lost to Follow-up|2
5126680|NCT01678898|17708289|P3|PB-102-F01|Physician Decision|0
5126681|NCT01678898|17708290|P2|PB-102-F01|Physician Decision|1
5126682|NCT01678898|17708291|P1|PB-102-F01|Physician Decision|0
5126683|NCT01678898|17708289|P3|PB-102-F01|Adverse Event|0
5126684|NCT01678898|17708290|P2|PB-102-F01|Adverse Event|1
5126685|NCT01678898|17708291|P1|PB-102-F01|Adverse Event|0
5126686|NCT01678820|17708401|P3|Overall Study|Not treated with double-blind study drug|2
5126687|NCT01678820|17708402|P2|Overall Study|Not treated with double-blind study drug|2
5126688|NCT01678820|17708403|P1|Overall Study|Not treated with double-blind study drug|0
5126689|NCT01678820|17708401|P3|Overall Study|Protocol Violation|4
5126690|NCT01678820|17708402|P2|Overall Study|Protocol Violation|5
5126691|NCT01678820|17708403|P1|Overall Study|Protocol Violation|4
5126692|NCT01678820|17708401|P3|Overall Study|Physician Decision|1
5126693|NCT01678820|17708402|P2|Overall Study|Physician Decision|0
5126694|NCT01678820|17708403|P1|Overall Study|Physician Decision|0
5126695|NCT01678820|17708401|P3|Overall Study|Non-compliance with study drug|0
5126696|NCT01678820|17708402|P2|Overall Study|Non-compliance with study drug|1
5126697|NCT01678820|17708403|P1|Overall Study|Non-compliance with study drug|0
5126698|NCT01678820|17708401|P3|Overall Study|Lost to Follow-up|2
5126699|NCT01678820|17708402|P2|Overall Study|Lost to Follow-up|2
5126700|NCT01678820|17708403|P1|Overall Study|Lost to Follow-up|7
5126701|NCT01678820|17708401|P3|Overall Study|Adverse Event|2
5126702|NCT01678820|17708402|P2|Overall Study|Adverse Event|2
5126703|NCT01678820|17708403|P1|Overall Study|Adverse Event|2
5126704|NCT01678820|17708401|P3|Overall Study|Protocol Specified Criteria|1
5126705|NCT01678820|17708402|P2|Overall Study|Protocol Specified Criteria|3
5126706|NCT01678820|17708403|P1|Overall Study|Protocol Specified Criteria|2
5126707|NCT01678820|17708401|P3|Overall Study|Withdrawal by Subject|2
5126708|NCT01678820|17708402|P2|Overall Study|Withdrawal by Subject|5
5126709|NCT01678820|17708403|P1|Overall Study|Withdrawal by Subject|2
5126710|NCT01678820|17708401|P3|Overall Study|Study Terminated by Sponsor|43
5126711|NCT01678820|17708402|P2|Overall Study|Study Terminated by Sponsor|43
5126712|NCT01678820|17708403|P1|Overall Study|Study Terminated by Sponsor|45
5126713|NCT01678807|17708448|P3|Overall Study|Withdrawn by Parent/Guardian|0
5126714|NCT01678807|17708449|P2|Overall Study|Withdrawn by Parent/Guardian|1
5126715|NCT01678807|17708450|P1|Overall Study|Withdrawn by Parent/Guardian|0
5126716|NCT01678807|17708448|P3|Overall Study|Adverse Event|0
5126717|NCT01678807|17708449|P2|Overall Study|Adverse Event|4
5126718|NCT01678807|17708450|P1|Overall Study|Adverse Event|4
5126719|NCT01678560|17708463|P2|Overall Study|Withdrawal by Subject|1
5126720|NCT01678560|17708464|P1|Overall Study|Withdrawal by Subject|0
5126721|NCT01678560|17708463|P2|Overall Study|Death|1
5126722|NCT01678560|17708464|P1|Overall Study|Death|0
5126723|NCT01678560|17708463|P2|Overall Study|Physician Decision|4
5126724|NCT01678560|17708464|P1|Overall Study|Physician Decision|4
5126725|NCT01678313|17708485|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
5126726|NCT01678313|17708486|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
5126727|NCT01678313|17708485|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
5126728|NCT01678313|17708486|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
5126729|NCT01678313|17708485|P2|Completed the 3-month Therapy|Physician Decision|4
5126730|NCT01678313|17708486|P1|Completed the 3-month Therapy|Physician Decision|3
5126731|NCT01678313|17708485|P2|Completed the 3-month Therapy|Lost to Follow-up|8
5126732|NCT01678313|17708486|P1|Completed the 3-month Therapy|Lost to Follow-up|3
5126733|NCT01678209|17708505|P3|Overall Study|screen fail|16
5126734|NCT01678209|17708506|P2|Overall Study|screen fail|17
5126735|NCT01678209|17708507|P1|Overall Study|screen fail|16
5126736|NCT01678209|17708505|P3|Overall Study|scheduling conflicts|1
5126737|NCT01678209|17708506|P2|Overall Study|scheduling conflicts|0
5126738|NCT01678209|17708507|P1|Overall Study|scheduling conflicts|0
5126739|NCT01678209|17708505|P3|Overall Study|could not scan twice|1
5126740|NCT01678209|17708506|P2|Overall Study|could not scan twice|1
5126741|NCT01678209|17708507|P1|Overall Study|could not scan twice|1
5126742|NCT01678144|17708548|P1|Stage 1: MAR Classic|Adverse Event|1
5126743|NCT01678131|17708567|P3|Overall Study|Withdrawal by Subject|2
5126744|NCT01678131|17708568|P2|Overall Study|Withdrawal by Subject|0
5126745|NCT01678131|17708569|P1|Overall Study|Withdrawal by Subject|0
5126746|NCT01678131|17708567|P3|Overall Study|Adverse Event|0
5126747|NCT01678131|17708568|P2|Overall Study|Adverse Event|1
5126748|NCT01678131|17708569|P1|Overall Study|Adverse Event|0
5126749|NCT01677988|17708577|P1|Overall Study|Lack of Efficacy|2
5126750|NCT01677936|17708590|P2|Overall Study|Protocol Violation|4
5126751|NCT01677936|17708591|P1|Overall Study|Protocol Violation|0
5126752|NCT01677936|17708590|P2|Overall Study|Lost to Follow-up|0
5126753|NCT01677936|17708591|P1|Overall Study|Lost to Follow-up|1
5126754|NCT01677936|17708590|P2|Overall Study|Adverse Event|0
5126755|NCT01677936|17708591|P1|Overall Study|Adverse Event|1
5126756|NCT01677936|17708590|P2|Overall Study|Protocol Violation|0
5126757|NCT01677936|17708591|P1|Overall Study|Protocol Violation|3
5126758|NCT01677936|17708590|P2|Overall Study|Lost to Follow-up|1
5126759|NCT01677936|17708591|P1|Overall Study|Lost to Follow-up|4
5126760|NCT01677910|17708602|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
5126761|NCT01677910|17708603|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5126762|NCT01677910|17708604|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5126763|NCT01677910|17708605|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5126764|NCT01677910|17708602|P4|Open-Label Extension Period (OLE)|Adverse Event|15
5126765|NCT01677910|17708603|P3|Open-Label Extension Period (OLE)|Adverse Event|0
5126766|NCT01677910|17708604|P2|Open-Label Extension Period (OLE)|Adverse Event|0
5126767|NCT01677910|17708605|P1|Open-Label Extension Period (OLE)|Adverse Event|0
5126768|NCT01677910|17708602|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
5126769|NCT01677910|17708603|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5126770|NCT01677910|17708604|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5126771|NCT01677910|17708605|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5126772|NCT01677910|17708602|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
5126773|NCT01677910|17708603|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5126774|NCT01677910|17708604|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5126775|NCT01677910|17708605|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5126776|NCT01677910|17708602|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
5126777|NCT01677910|17708603|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
5126778|NCT01677910|17708604|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
5126779|NCT01677910|17708605|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
5126780|NCT01677910|17708602|P4|Open-Label Extension Period (OLE)|Physician Decision|4
5126781|NCT01677910|17708603|P3|Open-Label Extension Period (OLE)|Physician Decision|0
5126782|NCT01677910|17708604|P2|Open-Label Extension Period (OLE)|Physician Decision|0
5126783|NCT01677910|17708605|P1|Open-Label Extension Period (OLE)|Physician Decision|0
5126784|NCT01677910|17708602|P4|Double-Blind Treatment Period|Reason Not Specified|0
5126785|NCT01677910|17708603|P3|Double-Blind Treatment Period|Reason Not Specified|0
5126786|NCT01677910|17708604|P2|Double-Blind Treatment Period|Reason Not Specified|1
5126787|NCT01677910|17708605|P1|Double-Blind Treatment Period|Reason Not Specified|0
5126788|NCT01677910|17708602|P4|Double-Blind Treatment Period|Withdrawal of consent|0
5126789|NCT01677910|17708603|P3|Double-Blind Treatment Period|Withdrawal of consent|3
5126790|NCT01677910|17708604|P2|Double-Blind Treatment Period|Withdrawal of consent|0
5126791|NCT01677910|17708605|P1|Double-Blind Treatment Period|Withdrawal of consent|1
5126792|NCT01677910|17708602|P4|Double-Blind Treatment Period|Physician Decision|0
5126793|NCT01677910|17708603|P3|Double-Blind Treatment Period|Physician Decision|1
5126794|NCT01677910|17708604|P2|Double-Blind Treatment Period|Physician Decision|0
5126795|NCT01677910|17708605|P1|Double-Blind Treatment Period|Physician Decision|0
5126796|NCT01677910|17708602|P4|Double-Blind Treatment Period|Adverse Event|0
5126797|NCT01677910|17708603|P3|Double-Blind Treatment Period|Adverse Event|3
5126798|NCT01677910|17708604|P2|Double-Blind Treatment Period|Adverse Event|2
5126799|NCT01677910|17708605|P1|Double-Blind Treatment Period|Adverse Event|6
5126800|NCT01677858|17708632|P5|Overall Study|Lost to Follow-up|1
5126801|NCT01677858|17708633|P4|Overall Study|Lost to Follow-up|0
5126802|NCT01677858|17708634|P3|Overall Study|Lost to Follow-up|0
5126803|NCT01677858|17708635|P2|Overall Study|Lost to Follow-up|0
5126804|NCT01677858|17708636|P1|Overall Study|Lost to Follow-up|0
5126805|NCT01677858|17708632|P5|Overall Study|Withdrawal by Subject|15
5126806|NCT01677858|17708633|P4|Overall Study|Withdrawal by Subject|0
5126807|NCT01677858|17708634|P3|Overall Study|Withdrawal by Subject|1
5126808|NCT01677858|17708635|P2|Overall Study|Withdrawal by Subject|1
5126809|NCT01677858|17708636|P1|Overall Study|Withdrawal by Subject|0
5126810|NCT01677858|17708632|P5|Overall Study|Progressive Disease|43
5126811|NCT01677858|17708633|P4|Overall Study|Progressive Disease|3
5126812|NCT01677858|17708634|P3|Overall Study|Progressive Disease|9
5126813|NCT01677858|17708635|P2|Overall Study|Progressive Disease|1
5126814|NCT01677858|17708636|P1|Overall Study|Progressive Disease|2
5126815|NCT01677858|17708632|P5|Overall Study|Physician Decision|12
5126816|NCT01677858|17708633|P4|Overall Study|Physician Decision|0
5126817|NCT01677858|17708634|P3|Overall Study|Physician Decision|2
5126818|NCT01677858|17708635|P2|Overall Study|Physician Decision|0
5126819|NCT01677858|17708636|P1|Overall Study|Physician Decision|1
5126820|NCT01677858|17708632|P5|Overall Study|Death|1
5126821|NCT01677858|17708633|P4|Overall Study|Death|0
5126822|NCT01677858|17708634|P3|Overall Study|Death|0
5126823|NCT01677858|17708635|P2|Overall Study|Death|0
5126824|NCT01677858|17708636|P1|Overall Study|Death|0
5126825|NCT01677858|17708632|P5|Overall Study|Adverse Event|13
5126826|NCT01677858|17708633|P4|Overall Study|Adverse Event|3
5126827|NCT01677858|17708634|P3|Overall Study|Adverse Event|2
5126828|NCT01677858|17708635|P2|Overall Study|Adverse Event|0
5126829|NCT01677858|17708636|P1|Overall Study|Adverse Event|0
5126830|NCT01677767|17708709|P1|Overall Study|Non-compliance by the participants|3
5126831|NCT01677767|17708709|P1|Overall Study|Withdrawal by Subject|10
5126832|NCT01677767|17708709|P1|Overall Study|Protocol Violation|4
5126833|NCT01677767|17708709|P1|Overall Study|Death|4
5126834|NCT01677767|17708709|P1|Overall Study|Adverse Event|1
5126835|NCT01677624|17708723|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
5126836|NCT01677507|17708728|P2|Second Assigment|Adverse Event|3
5126837|NCT01677507|17708729|P1|Second Assigment|Adverse Event|1
5126838|NCT01677507|17708728|P2|Second Assigment|Withdrawal by Subject|2
5126839|NCT01677507|17708729|P1|Second Assigment|Withdrawal by Subject|2
5126840|NCT01677507|17708728|P2|Initial Assignment|Protocol Violation|1
5126841|NCT01677507|17708729|P1|Initial Assignment|Protocol Violation|0
5126842|NCT01677507|17708728|P2|Initial Assignment|Adverse Event|1
5126843|NCT01677507|17708729|P1|Initial Assignment|Adverse Event|0
5126844|NCT01677377|17708742|P3|Overall Study|Pregnancy|1
5126845|NCT01677377|17708743|P2|Overall Study|Pregnancy|0
5126846|NCT01677377|17708744|P1|Overall Study|Pregnancy|0
5126847|NCT01677377|17708742|P3|Overall Study|Lack of Efficacy|1
5126848|NCT01677377|17708743|P2|Overall Study|Lack of Efficacy|0
5126849|NCT01677377|17708744|P1|Overall Study|Lack of Efficacy|0
5126850|NCT01677377|17708742|P3|Overall Study|Withdrawal by Subject|3
5126851|NCT01677377|17708743|P2|Overall Study|Withdrawal by Subject|0
5126852|NCT01677377|17708744|P1|Overall Study|Withdrawal by Subject|0
5126853|NCT01677377|17708742|P3|Overall Study|Lost to Follow-up|1
5126854|NCT01677377|17708743|P2|Overall Study|Lost to Follow-up|1
5126855|NCT01677377|17708744|P1|Overall Study|Lost to Follow-up|0
5126856|NCT01677377|17708742|P3|Overall Study|Protocol Violation|0
5126857|NCT01677377|17708743|P2|Overall Study|Protocol Violation|0
5126858|NCT01677377|17708744|P1|Overall Study|Protocol Violation|1
5126859|NCT01677299|17708960|P4|Overall Study|Withdrawal by Subject|1
5126860|NCT01677299|17708961|P3|Overall Study|Withdrawal by Subject|0
5126861|NCT01677299|17708962|P2|Overall Study|Withdrawal by Subject|1
5126862|NCT01677299|17708963|P1|Overall Study|Withdrawal by Subject|0
5126863|NCT01677299|17708960|P4|Overall Study|Adverse Event|0
5126864|NCT01677299|17708961|P3|Overall Study|Adverse Event|1
5126865|NCT01677299|17708962|P2|Overall Study|Adverse Event|2
5126866|NCT01677299|17708963|P1|Overall Study|Adverse Event|0
5126867|NCT01677195|17708995|P3|Overall Study|Protocol Violation|4
5126868|NCT01677195|17708996|P2|Overall Study|Protocol Violation|3
5126869|NCT01677195|17708997|P1|Overall Study|Protocol Violation|7
5126870|NCT01677195|17708995|P3|Overall Study|Pregnancy|0
5126871|NCT01677195|17708996|P2|Overall Study|Pregnancy|1
5126872|NCT01677195|17708997|P1|Overall Study|Pregnancy|0
5126873|NCT01677195|17708995|P3|Overall Study|Physician Decision|2
5126874|NCT01677195|17708996|P2|Overall Study|Physician Decision|2
5126875|NCT01677195|17708997|P1|Overall Study|Physician Decision|1
5126876|NCT01677195|17708995|P3|Overall Study|Adverse Event|1
5126877|NCT01677195|17708996|P2|Overall Study|Adverse Event|4
5126878|NCT01677195|17708997|P1|Overall Study|Adverse Event|6
5126879|NCT01677195|17708995|P3|Overall Study|Withdrawal by Subject|1
5126880|NCT01677195|17708996|P2|Overall Study|Withdrawal by Subject|0
5126881|NCT01677195|17708997|P1|Overall Study|Withdrawal by Subject|1
5126882|NCT01677195|17708995|P3|Overall Study|Lost to Follow-up|22
5126883|NCT01677195|17708996|P2|Overall Study|Lost to Follow-up|22
5126884|NCT01677195|17708997|P1|Overall Study|Lost to Follow-up|14
5126885|NCT01677182|17709008|P3|Overall Study|Other reasons|2
5126886|NCT01677182|17709009|P2|Overall Study|Other reasons|5
5126887|NCT01677182|17709010|P1|Overall Study|Other reasons|1
5126888|NCT01677182|17709008|P3|Overall Study|Lack of Efficacy|1
5126889|NCT01677182|17709009|P2|Overall Study|Lack of Efficacy|0
5126890|NCT01677182|17709010|P1|Overall Study|Lack of Efficacy|3
5126891|NCT01677182|17709008|P3|Overall Study|Study termination|11
5126892|NCT01677182|17709009|P2|Overall Study|Study termination|9
5126893|NCT01677182|17709010|P1|Overall Study|Study termination|12
5126894|NCT01677182|17709008|P3|Overall Study|Withdrawal by Subject|10
5126895|NCT01677182|17709009|P2|Overall Study|Withdrawal by Subject|12
5126896|NCT01677182|17709010|P1|Overall Study|Withdrawal by Subject|7
5126897|NCT01677182|17709008|P3|Overall Study|Lost to Follow-up|3
5126898|NCT01677182|17709009|P2|Overall Study|Lost to Follow-up|0
5126899|NCT01677182|17709010|P1|Overall Study|Lost to Follow-up|4
5126900|NCT01677182|17709008|P3|Overall Study|Protocol Violation|4
5126901|NCT01677182|17709009|P2|Overall Study|Protocol Violation|1
5126902|NCT01677182|17709010|P1|Overall Study|Protocol Violation|5
5126903|NCT01677182|17709008|P3|Overall Study|Adverse Event|8
5126904|NCT01677182|17709009|P2|Overall Study|Adverse Event|1
5126905|NCT01677182|17709010|P1|Overall Study|Adverse Event|2
5126906|NCT01676961|17709042|P1|Overall Study|Withdrawal by Subject|1
5126907|NCT01676961|17709042|P1|Overall Study|Lost to Follow-up|1
5126908|NCT01676961|17709042|P1|Overall Study|Death|3
5126909|NCT01676909|17709049|P2|Overall Study|Lost to Follow-up|9
5126910|NCT01676909|17709050|P1|Overall Study|Lost to Follow-up|15
5126911|NCT01676909|17709049|P2|Overall Study|Withdrawal by Subject|5
5126912|NCT01676909|17709050|P1|Overall Study|Withdrawal by Subject|3
5126913|NCT01676896|17709115|P3|Overall Study|Withdrawal by Subject|19
5126914|NCT01676896|17709116|P2|Overall Study|Withdrawal by Subject|7
5126915|NCT01676896|17709117|P1|Overall Study|Withdrawal by Subject|12
5126916|NCT01676727|17709225|P1|Overall Study|Valve explanted|1
5126917|NCT01676727|17709225|P1|Overall Study|Not willing to attend 1-year visit|2
5126918|NCT01676727|17709225|P1|Overall Study|Screening failure|5
5126919|NCT01676727|17709225|P1|Overall Study|Withdrawal by Subject|6
5126920|NCT01676727|17709225|P1|Overall Study|Death|18
5126921|NCT01676701|17709239|P2|Overall Study|Sponsor Decision|4
5126922|NCT01676701|17709240|P1|Overall Study|Sponsor Decision|3
5126923|NCT01676701|17709239|P2|Overall Study|Protocol Violation|0
5126924|NCT01676701|17709240|P1|Overall Study|Protocol Violation|1
5126925|NCT01676220|17709342|P2|Overall Study|No More Need of Insulin|0
5126926|NCT01676220|17709343|P1|Overall Study|No More Need of Insulin|1
5126927|NCT01676220|17709342|P2|Overall Study|Non Serious Hypoglycemia|0
5126928|NCT01676220|17709343|P1|Overall Study|Non Serious Hypoglycemia|2
5126929|NCT01676220|17709342|P2|Overall Study|Perceived Lack of Efficacy|1
5126930|NCT01676220|17709343|P1|Overall Study|Perceived Lack of Efficacy|3
5126931|NCT01676220|17709342|P2|Overall Study|Site Closure/Site Withdrawal|4
5126932|NCT01676220|17709343|P1|Overall Study|Site Closure/Site Withdrawal|1
5126933|NCT01676220|17709342|P2|Overall Study|Selection Criterion/Protocol Violation|9
5126934|NCT01676220|17709343|P1|Overall Study|Selection Criterion/Protocol Violation|9
5126935|NCT01676220|17709342|P2|Overall Study|Lost to Follow-up|18
5126936|NCT01676220|17709343|P1|Overall Study|Lost to Follow-up|11
5126937|NCT01676220|17709342|P2|Overall Study|Personal Reason|45
5126938|NCT01676220|17709343|P1|Overall Study|Personal Reason|34
5126939|NCT01676220|17709342|P2|Overall Study|Received Rescue Therapy|22
5126940|NCT01676220|17709343|P1|Overall Study|Received Rescue Therapy|14
5126941|NCT01676220|17709342|P2|Overall Study|Protocol Violation|12
5126942|NCT01676220|17709343|P1|Overall Study|Protocol Violation|11
5126943|NCT01676220|17709342|P2|Overall Study|Lack of Efficacy|5
5126944|NCT01676220|17709343|P1|Overall Study|Lack of Efficacy|2
5126945|NCT01676220|17709342|P2|Overall Study|Adverse Event|8
5126946|NCT01676220|17709343|P1|Overall Study|Adverse Event|10
5126947|NCT01676220|17709342|P2|Overall Study|Randomized But Not Treated|1
5126948|NCT01676220|17709343|P1|Overall Study|Randomized But Not Treated|4
5126949|NCT01676116|17709375|P2|Overall Study|Protocol Violation|3
5126950|NCT01676116|17709376|P1|Overall Study|Protocol Violation|9
5126951|NCT01676116|17709375|P2|Overall Study|Unclassified|10
5126952|NCT01676116|17709376|P1|Overall Study|Unclassified|4
5126953|NCT01676116|17709375|P2|Overall Study|Adverse Event|2
5126954|NCT01676116|17709376|P1|Overall Study|Adverse Event|1
5126955|NCT01676116|17709375|P2|Overall Study|Withdrawal criteria|14
5126956|NCT01676116|17709376|P1|Overall Study|Withdrawal criteria|2
5126957|NCT01676012|17709398|P1|Overall Study|incomplete set of videos|1
5126958|NCT01676012|17709398|P1|Overall Study|Adverse Event|2
5126959|NCT01675765|17709442|P2|Overall Study|Clinical progression|2
5126960|NCT01675765|17709443|P1|Overall Study|Clinical progression|3
5126961|NCT01675765|17709442|P2|Overall Study|Death|0
5126962|NCT01675765|17709443|P1|Overall Study|Death|1
5126963|NCT01675765|17709442|P2|Overall Study|Withdrawal by Subject|0
5126964|NCT01675765|17709443|P1|Overall Study|Withdrawal by Subject|2
5126965|NCT01675765|17709442|P2|Overall Study|Adverse Event|2
5126966|NCT01675765|17709443|P1|Overall Study|Adverse Event|1
5126967|NCT01675765|17709442|P2|Overall Study|Progressive disease|4
5126968|NCT01675765|17709443|P1|Overall Study|Progressive disease|4
5126969|NCT01675661|17709459|P2|Overall Study|Other reason|2
5126970|NCT01675661|17709460|P1|Overall Study|Other reason|1
5126971|NCT01675661|17709459|P2|Overall Study|Death|1
5126972|NCT01675661|17709460|P1|Overall Study|Death|0
5126973|NCT01675661|17709459|P2|Overall Study|Physician Decision|2
5126974|NCT01675661|17709460|P1|Overall Study|Physician Decision|0
5126975|NCT01675661|17709459|P2|Overall Study|Withdrawal by Subject|7
5126976|NCT01675661|17709460|P1|Overall Study|Withdrawal by Subject|3
5126977|NCT01675661|17709459|P2|Overall Study|Moved away|6
5126978|NCT01675661|17709460|P1|Overall Study|Moved away|5
5126979|NCT01675661|17709459|P2|Overall Study|Practical problems|5
5126980|NCT01675661|17709460|P1|Overall Study|Practical problems|9
5126981|NCT01675661|17709459|P2|Overall Study|Lost to Follow-up|23
5126982|NCT01675661|17709460|P1|Overall Study|Lost to Follow-up|22
5126983|NCT01675622|17709489|P2|Overall Study|Other|4
5126984|NCT01675622|17709490|P1|Overall Study|Other|5
5126985|NCT01675622|17709489|P2|Overall Study|Lost to Follow-up|3
5126986|NCT01675622|17709490|P1|Overall Study|Lost to Follow-up|1
5126987|NCT01675622|17709489|P2|Overall Study|Lack of Efficacy|4
5126988|NCT01675622|17709490|P1|Overall Study|Lack of Efficacy|2
5126989|NCT01675622|17709489|P2|Overall Study|Protocol Violation|1
5126990|NCT01675622|17709490|P1|Overall Study|Protocol Violation|4
5126991|NCT01675622|17709489|P2|Overall Study|Adverse Event|10
5126992|NCT01675622|17709490|P1|Overall Study|Adverse Event|12
5126993|NCT01675622|17709489|P2|Overall Study|Withdrawal by Subject|2
5126994|NCT01675622|17709490|P1|Overall Study|Withdrawal by Subject|2
5126995|NCT01675596|17709514|P1|Overall Study|Missed Visit|1
5126996|NCT01675596|17709514|P1|Overall Study|Exit with other reason|1
5126997|NCT01675596|17709514|P1|Overall Study|Death|6
5126998|NCT01675544|17709520|P1|Overall Study|Withdrawal by Subject|2
5126999|NCT01675531|17709525|P1|Overall Study|Protocol Violation|8
5127000|NCT01675531|17709525|P1|Overall Study|Lack of Efficacy|1
5127001|NCT01675531|17709525|P1|Overall Study|Withdrawal by Subject|7
5127002|NCT01675531|17709525|P1|Overall Study|Adverse Event|9
5127003|NCT01675492|17709532|P1|Overall Study|study completed early - product approval|42
5127004|NCT01675479|17709537|P1|Overall Study|Lost to Follow-up|11
5127005|NCT01675427|17709551|P1|Overall Study|Other|2
5127006|NCT01675427|17709551|P1|Overall Study|Lost to Follow-up|5
5127007|NCT01675427|17709551|P1|Overall Study|Sample not Collected by Mistake|2
5127008|NCT01675427|17709551|P1|Overall Study|Participant Refused Sample Collection|18
5127009|NCT01675427|17709551|P1|Overall Study|Withdrawal by Subject|7
5127010|NCT01675167|17709851|P3|Double-blind Treatment Phase|Other|5
5127011|NCT01675167|17709852|P2|Double-blind Treatment Phase|Other|7
5127012|NCT01675167|17709853|P1|Double-blind Treatment Phase|Other|0
5127013|NCT01675167|17709851|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
5127014|NCT01675167|17709852|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
5127015|NCT01675167|17709853|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
5127016|NCT01675167|17709851|P3|Double-blind Treatment Phase|Lost to Follow-up|5
5127017|NCT01675167|17709852|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5127018|NCT01675167|17709853|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5127019|NCT01675167|17709851|P3|Double-blind Treatment Phase|Protocol Violation|11
5127020|NCT01675167|17709852|P2|Double-blind Treatment Phase|Protocol Violation|4
5127021|NCT01675167|17709853|P1|Double-blind Treatment Phase|Protocol Violation|0
5127022|NCT01675167|17709851|P3|Double-blind Treatment Phase|Adverse Event|13
5127023|NCT01675167|17709852|P2|Double-blind Treatment Phase|Adverse Event|5
5127024|NCT01675167|17709853|P1|Double-blind Treatment Phase|Adverse Event|0
5127025|NCT01675167|17709851|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
5127026|NCT01675167|17709852|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
5127027|NCT01675167|17709853|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5127028|NCT01675167|17709851|P3|Double-blind Treatment Phase|Lack of Efficacy|61
5127029|NCT01675167|17709852|P2|Double-blind Treatment Phase|Lack of Efficacy|19
5127030|NCT01675167|17709853|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5127031|NCT01675167|17709851|P3|Open-label Titration Phase|Other|0
5127032|NCT01675167|17709852|P2|Open-label Titration Phase|Other|0
5127033|NCT01675167|17709853|P1|Open-label Titration Phase|Other|55
5127034|NCT01675167|17709851|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
5127035|NCT01675167|17709852|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
5127036|NCT01675167|17709853|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
5127037|NCT01675167|17709851|P3|Open-label Titration Phase|Lost to Follow-up|0
5127038|NCT01675167|17709852|P2|Open-label Titration Phase|Lost to Follow-up|0
5127039|NCT01675167|17709853|P1|Open-label Titration Phase|Lost to Follow-up|15
5127040|NCT01675167|17709851|P3|Open-label Titration Phase|Protocol Violation|0
5127041|NCT01675167|17709852|P2|Open-label Titration Phase|Protocol Violation|0
5127042|NCT01675167|17709853|P1|Open-label Titration Phase|Protocol Violation|43
5127043|NCT01675167|17709851|P3|Open-label Titration Phase|Withdrawal by Subject|0
5127044|NCT01675167|17709852|P2|Open-label Titration Phase|Withdrawal by Subject|0
5127045|NCT01675167|17709853|P1|Open-label Titration Phase|Withdrawal by Subject|46
5127046|NCT01675167|17709851|P3|Open-label Titration Phase|Lack of Efficacy|0
5127047|NCT01675167|17709852|P2|Open-label Titration Phase|Lack of Efficacy|0
5127048|NCT01675167|17709853|P1|Open-label Titration Phase|Lack of Efficacy|63
5127049|NCT01675167|17709851|P3|Open-label Titration Phase|Adverse Event|0
5127050|NCT01675167|17709852|P2|Open-label Titration Phase|Adverse Event|0
5127051|NCT01675167|17709853|P1|Open-label Titration Phase|Adverse Event|81
5127052|NCT01675141|17709875|P1|Overall Study|No treatment, per protocol|1
5127053|NCT01675141|17709875|P1|Overall Study|Physician Decision|4
5127054|NCT01675141|17709875|P1|Overall Study|Withdrawal by Subject|3
5127055|NCT01675141|17709875|P1|Overall Study|Lenalidomide outside NIH|3
5127056|NCT01675128|17709888|P3|Overall Study|Pulmonary complication; off study|0
5127057|NCT01675128|17709889|P2|Overall Study|Pulmonary complication; off study|1
5127058|NCT01675128|17709890|P1|Overall Study|Pulmonary complication; off study|0
5127059|NCT01675128|17709888|P3|Overall Study|Refused further treatment|0
5127060|NCT01675128|17709889|P2|Overall Study|Refused further treatment|0
5127061|NCT01675128|17709890|P1|Overall Study|Refused further treatment|1
5127062|NCT01675128|17709888|P3|Overall Study|Disease progression on study|1
5127063|NCT01675128|17709889|P2|Overall Study|Disease progression on study|1
5127064|NCT01675128|17709890|P1|Overall Study|Disease progression on study|1
5127065|NCT01675050|17709918|P2|Period One Treatment|Withdrawal by Subject|0
5127066|NCT01675050|17709919|P1|Period One Treatment|Withdrawal by Subject|1
5127067|NCT01675011|17709929|P2|Overall Study|Trial terminated by Sponsor|1
5127068|NCT01675011|17709930|P1|Overall Study|Trial terminated by Sponsor|3
5127069|NCT01674725|17709938|P2|Overall Study|Lost to Follow-up|1
5127070|NCT01674725|17709939|P1|Overall Study|Lost to Follow-up|0
5127071|NCT01674725|17709938|P2|Overall Study|Withdrawal by Subject|0
5127072|NCT01674725|17709939|P1|Overall Study|Withdrawal by Subject|1
5127073|NCT01674725|17709938|P2|Overall Study|Did not receive study drug|0
5127074|NCT01674725|17709939|P1|Overall Study|Did not receive study drug|1
5127075|NCT01674725|17709938|P2|Overall Study|Adverse Event|0
5127076|NCT01674725|17709939|P1|Overall Study|Adverse Event|1
5127077|NCT01674712|17709958|P5|Overall Study|Lack of Efficacy|1
5127078|NCT01674712|17709959|P4|Overall Study|Lack of Efficacy|0
5127079|NCT01674712|17709960|P3|Overall Study|Lack of Efficacy|1
5127080|NCT01674712|17709961|P2|Overall Study|Lack of Efficacy|0
5127081|NCT01674712|17709962|P1|Overall Study|Lack of Efficacy|0
5127082|NCT01674712|17709958|P5|Overall Study|Administrative|1
5127083|NCT01674712|17709959|P4|Overall Study|Administrative|0
5127084|NCT01674712|17709960|P3|Overall Study|Administrative|0
5127085|NCT01674712|17709961|P2|Overall Study|Administrative|1
5127086|NCT01674712|17709962|P1|Overall Study|Administrative|0
5127087|NCT01674712|17709958|P5|Overall Study|Withdrawal by Subject|3
5127088|NCT01674712|17709959|P4|Overall Study|Withdrawal by Subject|4
5127089|NCT01674712|17709960|P3|Overall Study|Withdrawal by Subject|5
5127090|NCT01674712|17709961|P2|Overall Study|Withdrawal by Subject|2
5127091|NCT01674712|17709962|P1|Overall Study|Withdrawal by Subject|2
5127092|NCT01674712|17709958|P5|Overall Study|Protocol Violation|0
5127093|NCT01674712|17709959|P4|Overall Study|Protocol Violation|0
5127094|NCT01674712|17709960|P3|Overall Study|Protocol Violation|0
5127095|NCT01674712|17709961|P2|Overall Study|Protocol Violation|0
5127096|NCT01674712|17709962|P1|Overall Study|Protocol Violation|2
5127097|NCT01674712|17709958|P5|Overall Study|Lost to Follow-up|0
5127098|NCT01674712|17709959|P4|Overall Study|Lost to Follow-up|0
5127099|NCT01674712|17709960|P3|Overall Study|Lost to Follow-up|0
5127100|NCT01674712|17709961|P2|Overall Study|Lost to Follow-up|0
5127101|NCT01674712|17709962|P1|Overall Study|Lost to Follow-up|1
5127102|NCT01674712|17709958|P5|Overall Study|Adverse Event|6
5127103|NCT01674712|17709959|P4|Overall Study|Adverse Event|4
5127104|NCT01674712|17709960|P3|Overall Study|Adverse Event|3
5127105|NCT01674712|17709961|P2|Overall Study|Adverse Event|6
5127106|NCT01674712|17709962|P1|Overall Study|Adverse Event|5
5127107|NCT01674647|17709986|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
5127108|NCT01674647|17709987|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
5127109|NCT01674647|17709986|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
5127110|NCT01674647|17709987|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
5127111|NCT01674647|17709986|P2|30-day Safety Follow-up Period|Logistical difficulties|3
5127112|NCT01674647|17709987|P1|30-day Safety Follow-up Period|Logistical difficulties|1
5127113|NCT01674647|17709986|P2|30-day Safety Follow-up Period|Protocol Violation|22
5127114|NCT01674647|17709987|P1|30-day Safety Follow-up Period|Protocol Violation|39
5127115|NCT01674647|17709986|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
5127116|NCT01674647|17709987|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
5127117|NCT01674647|17709986|P2|30-day Safety Follow-up Period|Death|2
5127118|NCT01674647|17709987|P1|30-day Safety Follow-up Period|Death|3
5127119|NCT01674647|17709986|P2|Treatment Period|Protocol Violation|36
5127120|NCT01674647|17709987|P1|Treatment Period|Protocol Violation|56
5127121|NCT01674647|17709986|P2|Treatment Period|Treatment failure|14
5127122|NCT01674647|17709987|P1|Treatment Period|Treatment failure|0
5127123|NCT01674647|17709986|P2|Treatment Period|Logistical difficulties|8
5127124|NCT01674647|17709987|P1|Treatment Period|Logistical difficulties|5
5127125|NCT01674647|17709986|P2|Treatment Period|Switching to other therapy|2
5127126|NCT01674647|17709987|P1|Treatment Period|Switching to other therapy|5
5127127|NCT01674647|17709986|P2|Treatment Period|Withdrawal by Subject|16
5127128|NCT01674647|17709987|P1|Treatment Period|Withdrawal by Subject|19
5127129|NCT01674647|17709986|P2|Treatment Period|Lost to Follow-up|1
5127130|NCT01674647|17709987|P1|Treatment Period|Lost to Follow-up|1
5127131|NCT01674647|17709986|P2|Treatment Period|Non-compliance with study drug|0
5127132|NCT01674647|17709987|P1|Treatment Period|Non-compliance with study drug|3
5127133|NCT01674647|17709986|P2|Treatment Period|Adverse Event|22
5127134|NCT01674647|17709987|P1|Treatment Period|Adverse Event|60
5127135|NCT01674647|17709986|P2|Treatment Period|Physician Decision|1
5127136|NCT01674647|17709987|P1|Treatment Period|Physician Decision|3
5127137|NCT01674647|17709986|P2|Treatment Period|Efficacy outcome reached|1
5127138|NCT01674647|17709987|P1|Treatment Period|Efficacy outcome reached|0
5127139|NCT01674647|17709986|P2|Treatment Period|Death|1
5127140|NCT01674647|17709987|P1|Treatment Period|Death|4
5127141|NCT01674634|17710013|P1|Overall Study|Lost to Follow-up|3
5127142|NCT01674634|17710013|P1|Overall Study|Withdrawal by Subject|3
5127143|NCT01674621|17710033|P5|Overall Study|Other than specified|2
5127144|NCT01674621|17710034|P4|Overall Study|Other than specified|0
5127145|NCT01674621|17710035|P3|Overall Study|Other than specified|0
5127146|NCT01674621|17710036|P2|Overall Study|Other than specified|1
5127147|NCT01674621|17710037|P1|Overall Study|Other than specified|0
5127148|NCT01674621|17710033|P5|Overall Study|Withdrawal by Subject|1
5127149|NCT01674621|17710034|P4|Overall Study|Withdrawal by Subject|0
5127150|NCT01674621|17710035|P3|Overall Study|Withdrawal by Subject|2
5127151|NCT01674621|17710036|P2|Overall Study|Withdrawal by Subject|5
5127152|NCT01674621|17710037|P1|Overall Study|Withdrawal by Subject|2
5127153|NCT01674621|17710033|P5|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5127154|NCT01674621|17710034|P4|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
5127155|NCT01674621|17710035|P3|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5127156|NCT01674621|17710036|P2|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5127157|NCT01674621|17710037|P1|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5127158|NCT01674621|17710033|P5|Overall Study|Inability to Complete Study Procedures|2
5127159|NCT01674621|17710034|P4|Overall Study|Inability to Complete Study Procedures|0
5127160|NCT01674621|17710035|P3|Overall Study|Inability to Complete Study Procedures|0
5127161|NCT01674621|17710036|P2|Overall Study|Inability to Complete Study Procedures|0
5127162|NCT01674621|17710037|P1|Overall Study|Inability to Complete Study Procedures|0
5127163|NCT01674621|17710033|P5|Overall Study|Adverse Event|1
5127164|NCT01674621|17710034|P4|Overall Study|Adverse Event|5
5127165|NCT01674621|17710035|P3|Overall Study|Adverse Event|5
5127166|NCT01674621|17710036|P2|Overall Study|Adverse Event|2
5127167|NCT01674621|17710037|P1|Overall Study|Adverse Event|3
5127168|NCT01674569|17710114|P6|Overall Study|Withdrawal by Subject|0
5127169|NCT01674569|17710115|P5|Overall Study|Withdrawal by Subject|0
5127170|NCT01674569|17710116|P4|Overall Study|Withdrawal by Subject|0
5127171|NCT01674569|17710117|P3|Overall Study|Withdrawal by Subject|1
5127172|NCT01674569|17710118|P2|Overall Study|Withdrawal by Subject|0
5127173|NCT01674569|17710119|P1|Overall Study|Withdrawal by Subject|0
5127174|NCT01674569|17710114|P6|Overall Study|Protocol Violation|0
5127175|NCT01674569|17710115|P5|Overall Study|Protocol Violation|0
5127176|NCT01674569|17710116|P4|Overall Study|Protocol Violation|0
5127177|NCT01674569|17710117|P3|Overall Study|Protocol Violation|1
5127178|NCT01674569|17710118|P2|Overall Study|Protocol Violation|1
5127179|NCT01674569|17710119|P1|Overall Study|Protocol Violation|0
5127180|NCT01674569|17710114|P6|Overall Study|Adverse Event|2
5127181|NCT01674569|17710115|P5|Overall Study|Adverse Event|2
5127182|NCT01674569|17710116|P4|Overall Study|Adverse Event|1
5127183|NCT01674569|17710117|P3|Overall Study|Adverse Event|0
5127184|NCT01674569|17710118|P2|Overall Study|Adverse Event|2
5127185|NCT01674569|17710119|P1|Overall Study|Adverse Event|0
5127186|NCT01674062|17710140|P2|Overall Study|Programming Error|0
5127187|NCT01674062|17710141|P1|Overall Study|Programming Error|1
5127188|NCT01674062|17710140|P2|Overall Study|Death|1
5127189|NCT01674062|17710141|P1|Overall Study|Death|0
5127190|NCT01674062|17710140|P2|Overall Study|Adverse Event|1
5127191|NCT01674062|17710141|P1|Overall Study|Adverse Event|1
5127192|NCT01674062|17710140|P2|Overall Study|Other|1
5127193|NCT01674062|17710141|P1|Overall Study|Other|8
5127194|NCT01674062|17710140|P2|Overall Study|Insufficient Therapeutic Response|26
5127195|NCT01674062|17710141|P1|Overall Study|Insufficient Therapeutic Response|56
5127196|NCT01674010|17710156|P3|Randomization Phase 2|Withdrawal by Subject|7
5127197|NCT01674010|17710157|P2|Randomization Phase 2|Withdrawal by Subject|8
5127198|NCT01674010|17710158|P1|Randomization Phase 2|Withdrawal by Subject|0
5127199|NCT01674010|17710156|P3|Randomization Phase 2|Sponsor Decision|45
5127200|NCT01674010|17710157|P2|Randomization Phase 2|Sponsor Decision|42
5127201|NCT01674010|17710158|P1|Randomization Phase 2|Sponsor Decision|0
5127202|NCT01674010|17710156|P3|Randomization Phase 2|Protocol Violation|1
5127203|NCT01674010|17710157|P2|Randomization Phase 2|Protocol Violation|1
5127204|NCT01674010|17710158|P1|Randomization Phase 2|Protocol Violation|0
5127205|NCT01674010|17710156|P3|Randomization Phase 2|Pregnancy|1
5127206|NCT01674010|17710157|P2|Randomization Phase 2|Pregnancy|1
5127207|NCT01674010|17710158|P1|Randomization Phase 2|Pregnancy|0
5127208|NCT01674010|17710156|P3|Randomization Phase 2|Physician Decision|2
5127209|NCT01674010|17710157|P2|Randomization Phase 2|Physician Decision|0
5127210|NCT01674010|17710158|P1|Randomization Phase 2|Physician Decision|0
5127211|NCT01674010|17710156|P3|Randomization Phase 2|Mood episode recurrence|2
5127212|NCT01674010|17710157|P2|Randomization Phase 2|Mood episode recurrence|8
5127213|NCT01674010|17710158|P1|Randomization Phase 2|Mood episode recurrence|0
5127214|NCT01674010|17710156|P3|Randomization Phase 2|Lost to Follow-up|2
5127215|NCT01674010|17710157|P2|Randomization Phase 2|Lost to Follow-up|1
5127216|NCT01674010|17710158|P1|Randomization Phase 2|Lost to Follow-up|0
5127217|NCT01674010|17710156|P3|Randomization Phase 2|Adverse Event|1
5127218|NCT01674010|17710157|P2|Randomization Phase 2|Adverse Event|1
5127219|NCT01674010|17710158|P1|Randomization Phase 2|Adverse Event|0
5127220|NCT01674010|17710156|P3|Open Treatment Phase 1|Withdrawal by Subject|0
5127221|NCT01674010|17710157|P2|Open Treatment Phase 1|Withdrawal by Subject|0
5127222|NCT01674010|17710158|P1|Open Treatment Phase 1|Withdrawal by Subject|25
5127223|NCT01674010|17710156|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
5127224|NCT01674010|17710157|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
5127225|NCT01674010|17710158|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
5127226|NCT01674010|17710156|P3|Open Treatment Phase 1|Sponsor Decision|0
5127227|NCT01674010|17710157|P2|Open Treatment Phase 1|Sponsor Decision|0
5127228|NCT01674010|17710158|P1|Open Treatment Phase 1|Sponsor Decision|79
5127229|NCT01674010|17710156|P3|Open Treatment Phase 1|Protocol Violation|0
5127230|NCT01674010|17710157|P2|Open Treatment Phase 1|Protocol Violation|0
5127231|NCT01674010|17710158|P1|Open Treatment Phase 1|Protocol Violation|7
5127232|NCT01674010|17710156|P3|Open Treatment Phase 1|Physician Decision|0
5127233|NCT01674010|17710157|P2|Open Treatment Phase 1|Physician Decision|0
5127234|NCT01674010|17710158|P1|Open Treatment Phase 1|Physician Decision|9
5127235|NCT01674010|17710156|P3|Open Treatment Phase 1|Lost to Follow-up|0
5127236|NCT01674010|17710157|P2|Open Treatment Phase 1|Lost to Follow-up|0
5127237|NCT01674010|17710158|P1|Open Treatment Phase 1|Lost to Follow-up|19
5127238|NCT01674010|17710156|P3|Open Treatment Phase 1|Death|0
5127239|NCT01674010|17710157|P2|Open Treatment Phase 1|Death|0
5127240|NCT01674010|17710158|P1|Open Treatment Phase 1|Death|1
5127241|NCT01674010|17710156|P3|Open Treatment Phase 1|Adverse Event|0
5127242|NCT01674010|17710157|P2|Open Treatment Phase 1|Adverse Event|0
5127243|NCT01674010|17710158|P1|Open Treatment Phase 1|Adverse Event|10
5127244|NCT01673984|17710177|P2|Overall Study|Study termination|6
5127245|NCT01673984|17710178|P1|Overall Study|Study termination|9
5127246|NCT01673984|17710177|P2|Overall Study|Adverse Event|0
5127247|NCT01673984|17710178|P1|Overall Study|Adverse Event|1
5127248|NCT01673867|17710228|P2|Treatment|Physician Decision|1
5127249|NCT01673867|17710229|P1|Treatment|Physician Decision|0
5127250|NCT01673867|17710228|P2|Treatment|Symptomatic deterioration|1
5127251|NCT01673867|17710229|P1|Treatment|Symptomatic deterioration|0
5127252|NCT01673867|17710228|P2|Treatment|Required prolonged hospitalization|1
5127253|NCT01673867|17710229|P1|Treatment|Required prolonged hospitalization|0
5127254|NCT01673867|17710228|P2|Treatment|Health status not improved|0
5127255|NCT01673867|17710229|P1|Treatment|Health status not improved|1
5127256|NCT01673867|17710228|P2|Treatment|Required steroid therapy|0
5127257|NCT01673867|17710229|P1|Treatment|Required steroid therapy|1
5127258|NCT01673867|17710228|P2|Treatment|No longer meets criteria|0
5127259|NCT01673867|17710229|P1|Treatment|No longer meets criteria|2
5127260|NCT01673867|17710228|P2|Treatment|Maximum clinical benefit|10
5127261|NCT01673867|17710229|P1|Treatment|Maximum clinical benefit|0
5127262|NCT01673867|17710228|P2|Treatment|Withdrawal by Subject|6
5127263|NCT01673867|17710229|P1|Treatment|Withdrawal by Subject|4
5127264|NCT01673867|17710228|P2|Treatment|Requested treatment discontinuation|16
5127265|NCT01673867|17710229|P1|Treatment|Requested treatment discontinuation|5
5127266|NCT01673867|17710228|P2|Treatment|AE unrelated to study drug|11
5127267|NCT01673867|17710229|P1|Treatment|AE unrelated to study drug|19
5127268|NCT01673867|17710228|P2|Treatment|Death|1
5127269|NCT01673867|17710229|P1|Treatment|Death|1
5127270|NCT01673867|17710228|P2|Treatment|Study Drug Toxicity|42
5127271|NCT01673867|17710229|P1|Treatment|Study Drug Toxicity|17
5127272|NCT01673867|17710228|P2|Treatment|Disease Progression|179
5127273|NCT01673867|17710229|P1|Treatment|Disease Progression|194
5127274|NCT01673867|17710228|P2|Randomization|No longer meets criteria|5
5127275|NCT01673867|17710229|P1|Randomization|No longer meets criteria|4
5127276|NCT01673867|17710228|P2|Randomization|Lost to Follow-up|1
5127277|NCT01673867|17710229|P1|Randomization|Lost to Follow-up|0
5127278|NCT01673867|17710228|P2|Randomization|Withdrawal by Subject|12
5127279|NCT01673867|17710229|P1|Randomization|Withdrawal by Subject|0
5127280|NCT01673867|17710228|P2|Randomization|Requested treatment discontinuation|4
5127281|NCT01673867|17710229|P1|Randomization|Requested treatment discontinuation|0
5127282|NCT01673867|17710228|P2|Randomization|AE unrelated to study drug|0
5127283|NCT01673867|17710229|P1|Randomization|AE unrelated to study drug|1
5127284|NCT01673854|17710255|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
5127285|NCT01673854|17710255|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
5127286|NCT01673854|17710255|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
5127287|NCT01673854|17710255|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
5127288|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
5127289|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
5127290|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
5127291|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
5127292|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
5127293|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
5127294|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
5127295|NCT01673854|17710255|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
5127296|NCT01673698|17710278|P2|Overall Study|Lost to Follow-up|13
5127297|NCT01673698|17710279|P1|Overall Study|Lost to Follow-up|51
5127298|NCT01673646|17710290|P3|Overall Study|Completed Core/did not enter Ext.|1
5127299|NCT01673646|17710291|P2|Overall Study|Completed Core/did not enter Ext.|1
5127300|NCT01673646|17710292|P1|Overall Study|Completed Core/did not enter Ext.|2
5127301|NCT01673646|17710290|P3|Overall Study|Withdrawal by Subject|2
5127302|NCT01673646|17710291|P2|Overall Study|Withdrawal by Subject|2
5127303|NCT01673646|17710292|P1|Overall Study|Withdrawal by Subject|0
5127304|NCT01673646|17710290|P3|Overall Study|Condition no longer requires study drug|0
5127305|NCT01673646|17710291|P2|Overall Study|Condition no longer requires study drug|1
5127306|NCT01673646|17710292|P1|Overall Study|Condition no longer requires study drug|0
5127307|NCT01673646|17710290|P3|Overall Study|Unsatisfactory therapeutic effect|0
5127308|NCT01673646|17710291|P2|Overall Study|Unsatisfactory therapeutic effect|2
5127309|NCT01673646|17710292|P1|Overall Study|Unsatisfactory therapeutic effect|0
5127310|NCT01673646|17710290|P3|Overall Study|Adverse Event|1
5127311|NCT01673646|17710291|P2|Overall Study|Adverse Event|1
5127312|NCT01673646|17710292|P1|Overall Study|Adverse Event|2
5127313|NCT01673620|17710331|P2|Overall Study|Adverse Event|0
5127314|NCT01673620|17710332|P1|Overall Study|Adverse Event|1
5127315|NCT01673594|17710342|P2|Overall Study|Withdrawal by Subject|1
5127316|NCT01673594|17710343|P1|Overall Study|Withdrawal by Subject|0
5127317|NCT01673594|17710342|P2|Overall Study|Physician Decision|4
5127318|NCT01673594|17710343|P1|Overall Study|Physician Decision|2
5127319|NCT01673594|17710342|P2|Overall Study|Lost to Follow-up|0
5127320|NCT01673594|17710343|P1|Overall Study|Lost to Follow-up|1
5127321|NCT01673594|17710342|P2|Overall Study|Adverse Event|1
5127322|NCT01673594|17710343|P1|Overall Study|Adverse Event|3
5127323|NCT01673490|17710362|P1|Overall Study|Withdrawal by Subject|3
5127324|NCT01673490|17710362|P1|Overall Study|Adverse Event|3
5127325|NCT01673490|17710362|P1|Overall Study|Lost to Follow-up|1
5127326|NCT01673386|17710379|P2|Overall Study|Withdrawal by Subject|2
5127327|NCT01673386|17710380|P1|Overall Study|Withdrawal by Subject|0
5127328|NCT01673386|17710379|P2|Overall Study|Progressive disease|1
5127329|NCT01673386|17710380|P1|Overall Study|Progressive disease|4
5127330|NCT01673386|17710379|P2|Overall Study|Adverse Event|2
5127331|NCT01673386|17710380|P1|Overall Study|Adverse Event|5
5127332|NCT01673386|17710379|P2|Overall Study|Study terminated by sponsor|22
5127333|NCT01673386|17710380|P1|Overall Study|Study terminated by sponsor|16
5127334|NCT01673373|17710410|P1|Overall Study|Death|2
5127335|NCT01673347|17710426|P1|Overall Study|failure of allograft|7
5127336|NCT01673282|17710435|P2|Overall Study|Other|6
5127337|NCT01673282|17710436|P1|Overall Study|Other|1
5127338|NCT01673282|17710435|P2|Overall Study|Withdrawal by Subject|3
5127339|NCT01673282|17710436|P1|Overall Study|Withdrawal by Subject|3
5127340|NCT01673282|17710435|P2|Overall Study|Lost to Follow-up|10
5127341|NCT01673282|17710436|P1|Overall Study|Lost to Follow-up|11
5127342|NCT01673282|17710435|P2|Overall Study|Lack of Efficacy|2
5127343|NCT01673282|17710436|P1|Overall Study|Lack of Efficacy|9
5127344|NCT01673282|17710435|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
5127345|NCT01673282|17710436|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
5127346|NCT01673178|17710472|P5|Overall Study|Other|0
5127347|NCT01673178|17710473|P4|Overall Study|Other|1
5127348|NCT01673178|17710474|P3|Overall Study|Other|2
5127349|NCT01673178|17710475|P2|Overall Study|Other|0
5127350|NCT01673178|17710476|P1|Overall Study|Other|1
5127351|NCT01673178|17710472|P5|Overall Study|Adverse Event|0
5127352|NCT01673178|17710473|P4|Overall Study|Adverse Event|2
5127353|NCT01673178|17710474|P3|Overall Study|Adverse Event|0
5127354|NCT01673178|17710475|P2|Overall Study|Adverse Event|0
5127355|NCT01673178|17710476|P1|Overall Study|Adverse Event|1
5127356|NCT01673178|17710472|P5|Overall Study|Protocol Violation|0
5127357|NCT01673178|17710473|P4|Overall Study|Protocol Violation|1
5127358|NCT01673178|17710474|P3|Overall Study|Protocol Violation|0
5127359|NCT01673178|17710475|P2|Overall Study|Protocol Violation|1
5127360|NCT01673178|17710476|P1|Overall Study|Protocol Violation|1
5127361|NCT01673178|17710472|P5|Overall Study|Withdrawal by Subject|2
5127362|NCT01673178|17710473|P4|Overall Study|Withdrawal by Subject|4
5127363|NCT01673178|17710474|P3|Overall Study|Withdrawal by Subject|1
5127364|NCT01673178|17710475|P2|Overall Study|Withdrawal by Subject|0
5127365|NCT01673178|17710476|P1|Overall Study|Withdrawal by Subject|0
5127366|NCT01673178|17710472|P5|Overall Study|Lost to Follow-up|0
5127367|NCT01673178|17710473|P4|Overall Study|Lost to Follow-up|0
5127368|NCT01673178|17710474|P3|Overall Study|Lost to Follow-up|0
5127369|NCT01673178|17710475|P2|Overall Study|Lost to Follow-up|1
5127370|NCT01673178|17710476|P1|Overall Study|Lost to Follow-up|0
5127371|NCT01673126|17710715|P2|Overall Study|change of diagnosis|3
5127372|NCT01673126|17710716|P1|Overall Study|change of diagnosis|4
5127373|NCT01673009|17710755|P1|Overall Study|Withdrawal by Subject|8
5127374|NCT01673009|17710755|P1|Overall Study|Physician Decision|5
5127375|NCT01672970|17710840|P1|Overall Study|Enrolled but not treated|1
5127376|NCT01672970|17710840|P1|Overall Study|Other|9
5127377|NCT01672970|17710840|P1|Overall Study|Lost to Follow-up|5
5127378|NCT01672970|17710840|P1|Overall Study|Withdrawal by Subject|2
5127379|NCT01672970|17710840|P1|Overall Study|Adverse Event|18
5127380|NCT01672970|17710840|P1|Overall Study|Lack of Efficacy|12
5127381|NCT01672957|17710876|P1|Overall Study|ICF Signed After Transplantation|5
5127382|NCT01672957|17710876|P1|Overall Study|Death|2
5127383|NCT01672957|17710876|P1|Overall Study|Protocol Violation|48
5127384|NCT01672892|17710891|P2|Overall Study|Protocol Violation|3
5127385|NCT01672892|17710892|P1|Overall Study|Protocol Violation|7
5127386|NCT01672879|17710921|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
5127387|NCT01672879|17710922|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
5127388|NCT01672879|17710923|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
5127389|NCT01672879|17710921|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
5127390|NCT01672879|17710922|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
5127391|NCT01672879|17710923|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
5127392|NCT01672879|17710921|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
5127393|NCT01672879|17710922|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
5127394|NCT01672879|17710923|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
5127395|NCT01672879|17710921|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
5127396|NCT01672879|17710922|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
5127397|NCT01672879|17710923|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
5127398|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
5127399|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
5127400|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
5127401|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
5127402|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
5127403|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
5127404|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
5127405|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
5127406|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
5127407|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Death|0
5127408|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Death|2
5127409|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Death|0
5127410|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
5127411|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
5127412|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
5127413|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
5127414|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
5127415|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
5127416|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
5127417|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
5127418|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
5127419|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
5127420|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
5127421|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
5127422|NCT01672879|17710921|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
5127423|NCT01672879|17710922|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
5127424|NCT01672879|17710923|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
5127425|NCT01672866|17710938|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
5127426|NCT01672866|17710939|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
5127427|NCT01672866|17710940|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
5127428|NCT01672866|17710938|P3|Open-Label Phase (up to 240 Weeks)|Death|0
5127429|NCT01672866|17710939|P2|Open-Label Phase (up to 240 Weeks)|Death|0
5127430|NCT01672866|17710940|P1|Open-Label Phase (up to 240 Weeks)|Death|1
5127431|NCT01672866|17710938|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
5127432|NCT01672866|17710939|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
5127433|NCT01672866|17710940|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
5127434|NCT01672866|17710938|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
5127435|NCT01672866|17710939|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
5127436|NCT01672866|17710940|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
5127437|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
5127438|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
5127439|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
5127440|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
5127441|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
5127442|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
5127443|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Death|1
5127444|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Death|0
5127445|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Death|0
5127446|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
5127447|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
5127448|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
5127449|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
5127450|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
5127451|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
5127452|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5127453|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5127454|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5127455|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
5127456|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
5127457|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
5127458|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
5127459|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
5127460|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
5127461|NCT01672866|17710938|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
5127462|NCT01672866|17710939|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
5127463|NCT01672866|17710940|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
5127464|NCT01672853|17710955|P3|Overall Study|Randomized but Never Treated|1
5127465|NCT01672853|17710956|P2|Overall Study|Randomized but Never Treated|0
5127466|NCT01672853|17710957|P1|Overall Study|Randomized but Never Treated|0
5127467|NCT01672853|17710955|P3|Overall Study|Lost to Follow-up|0
5127468|NCT01672853|17710956|P2|Overall Study|Lost to Follow-up|1
5127469|NCT01672853|17710957|P1|Overall Study|Lost to Follow-up|0
5127470|NCT01672853|17710955|P3|Overall Study|Adverse Event|8
5127471|NCT01672853|17710956|P2|Overall Study|Adverse Event|6
5127472|NCT01672853|17710957|P1|Overall Study|Adverse Event|4
5127473|NCT01672853|17710955|P3|Overall Study|Withdrew Consent|5
5127474|NCT01672853|17710956|P2|Overall Study|Withdrew Consent|5
5127475|NCT01672853|17710957|P1|Overall Study|Withdrew Consent|5
5127476|NCT01672853|17710955|P3|Overall Study|Investigator's Discretion|0
5127477|NCT01672853|17710956|P2|Overall Study|Investigator's Discretion|0
5127478|NCT01672853|17710957|P1|Overall Study|Investigator's Discretion|1
5127479|NCT01672853|17710955|P3|Overall Study|Pregnancy|0
5127480|NCT01672853|17710956|P2|Overall Study|Pregnancy|1
5127481|NCT01672853|17710957|P1|Overall Study|Pregnancy|0
5127482|NCT01672853|17710955|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
5127483|NCT01672853|17710956|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
5127484|NCT01672853|17710957|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
5127485|NCT01672801|17710982|P2|Overall Study|Screen Failure|1
5127486|NCT01672801|17710983|P1|Overall Study|Screen Failure|0
5127487|NCT01672788|17710991|P4|Washout Period 2 (7 Days)|Adverse Event|1
5127488|NCT01672788|17710992|P3|Washout Period 2 (7 Days)|Adverse Event|0
5127489|NCT01672788|17710993|P2|Washout Period 2 (7 Days)|Adverse Event|0
5127490|NCT01672788|17710994|P1|Washout Period 2 (7 Days)|Adverse Event|0
5127491|NCT01672736|17711024|P1|Overall Study|Available drug expired on 31 May 16|3
5127492|NCT01672723|17711028|P2|First Intervention|Adverse Event|0
5127493|NCT01672723|17711029|P1|First Intervention|Adverse Event|3
5127494|NCT01672710|17711041|P2|3 Month Follow up|follow up due after termination date|1
5127495|NCT01672710|17711042|P1|3 Month Follow up|follow up due after termination date|4
5127496|NCT01672710|17711041|P2|3 Month Follow up|Lost to Follow-up|3
5127497|NCT01672710|17711042|P1|3 Month Follow up|Lost to Follow-up|2
5127498|NCT01672710|17711041|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
5127499|NCT01672710|17711042|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
5127500|NCT01672294|17711077|P4|Overall Study|Lost to Follow-up|9
5127501|NCT01672294|17711078|P3|Overall Study|Lost to Follow-up|7
5127502|NCT01672294|17711079|P2|Overall Study|Lost to Follow-up|16
5127503|NCT01672294|17711080|P1|Overall Study|Lost to Follow-up|1
5127504|NCT01672294|17711077|P4|Overall Study|Excluded by study|0
5127505|NCT01672294|17711078|P3|Overall Study|Excluded by study|0
5127506|NCT01672294|17711079|P2|Overall Study|Excluded by study|1
5127507|NCT01672294|17711080|P1|Overall Study|Excluded by study|1
5127508|NCT01672294|17711077|P4|Overall Study|Withdrawal by Subject|4
5127509|NCT01672294|17711078|P3|Overall Study|Withdrawal by Subject|4
5127510|NCT01672294|17711079|P2|Overall Study|Withdrawal by Subject|4
5127511|NCT01672294|17711080|P1|Overall Study|Withdrawal by Subject|4
5127512|NCT01671748|17711125|P2|4 Week run-in Phase|Not eligible|0
5127513|NCT01671748|17711126|P1|4 Week run-in Phase|Not eligible|9
5127514|NCT01671748|17711125|P2|4 Week run-in Phase|Adverse Event|0
5127515|NCT01671748|17711126|P1|4 Week run-in Phase|Adverse Event|1
5127516|NCT01671748|17711125|P2|4 Week run-in Phase|Withdrawal by Subject|0
5127517|NCT01671748|17711126|P1|4 Week run-in Phase|Withdrawal by Subject|1
5127518|NCT01671488|17711153|P1|Overall Study|Withdrawal by Subject|1
5127519|NCT01671345|17711161|P2|Overall Study|visit with non-participating physician|3
5127520|NCT01671345|17711162|P1|Overall Study|visit with non-participating physician|3
5127521|NCT01671345|17711161|P2|Overall Study|Lost to Follow-up|6
5127522|NCT01671345|17711162|P1|Overall Study|Lost to Follow-up|10
5127523|NCT01671332|17711176|P2|Overall Study|Withdrawal by Subject|1
5127524|NCT01671332|17711177|P1|Overall Study|Withdrawal by Subject|1
5127525|NCT01671319|17711191|P1|Overall Study|Withdrawal by Subject|1
5127526|NCT01671280|17711206|P1|Overall Study|Withdrawal by Subject|2
5127527|NCT01671111|17711217|P1|Overall Study|Other|24
5127528|NCT01671111|17711217|P1|Overall Study|Physician Decision|1
5127529|NCT01671111|17711217|P1|Overall Study|Withdrawal by Subject|2
5127530|NCT01671111|17711217|P1|Overall Study|Lack of Efficacy|1
5127531|NCT01671111|17711217|P1|Overall Study|Adverse Event|2
5127532|NCT01671085|17711229|P2|Overall Study|Withdrawal by Subject|0
5127533|NCT01671085|17711230|P1|Overall Study|Withdrawal by Subject|1
5127534|NCT01671059|17711241|P1|Overall Study|Lack of Efficacy|1
5127535|NCT01671059|17711241|P1|Overall Study|Adverse Event|4
5127536|NCT01670721|17711337|P1|Overall Study|Other than specified above|38
5127537|NCT01670721|17711337|P1|Overall Study|Participant's decision|15
5127538|NCT01670656|17711349|P5|Overall Study|Subject moved|0
5127539|NCT01670656|17711350|P4|Overall Study|Subject moved|1
5127540|NCT01670656|17711351|P3|Overall Study|Subject moved|0
5127541|NCT01670656|17711352|P2|Overall Study|Subject moved|0
5127542|NCT01670656|17711353|P1|Overall Study|Subject moved|0
5127543|NCT01670656|17711349|P5|Overall Study|Lost to Follow-up|3
5127544|NCT01670656|17711350|P4|Overall Study|Lost to Follow-up|0
5127545|NCT01670656|17711351|P3|Overall Study|Lost to Follow-up|0
5127546|NCT01670656|17711352|P2|Overall Study|Lost to Follow-up|0
5127547|NCT01670656|17711353|P1|Overall Study|Lost to Follow-up|0
5127548|NCT01670656|17711349|P5|Overall Study|Subject withdrew consent|1
5127549|NCT01670656|17711350|P4|Overall Study|Subject withdrew consent|1
5127550|NCT01670656|17711351|P3|Overall Study|Subject withdrew consent|2
5127551|NCT01670656|17711352|P2|Overall Study|Subject withdrew consent|1
5127552|NCT01670656|17711353|P1|Overall Study|Subject withdrew consent|0
5127553|NCT01670656|17711349|P5|Overall Study|Adverse Event|3
5127554|NCT01670656|17711350|P4|Overall Study|Adverse Event|3
5127555|NCT01670656|17711351|P3|Overall Study|Adverse Event|2
5127556|NCT01670656|17711352|P2|Overall Study|Adverse Event|2
5127557|NCT01670656|17711353|P1|Overall Study|Adverse Event|2
5127558|NCT01670656|17711349|P5|Overall Study|Non-compliance with protocol|2
5127559|NCT01670656|17711350|P4|Overall Study|Non-compliance with protocol|1
5127560|NCT01670656|17711351|P3|Overall Study|Non-compliance with protocol|1
5127561|NCT01670656|17711352|P2|Overall Study|Non-compliance with protocol|3
5127562|NCT01670656|17711353|P1|Overall Study|Non-compliance with protocol|0
5127563|NCT01670656|17711349|P5|Overall Study|Withdrawal by Subject|0
5127564|NCT01670656|17711350|P4|Overall Study|Withdrawal by Subject|0
5127565|NCT01670656|17711351|P3|Overall Study|Withdrawal by Subject|0
5127566|NCT01670656|17711352|P2|Overall Study|Withdrawal by Subject|1
5127567|NCT01670656|17711353|P1|Overall Study|Withdrawal by Subject|1
5127568|NCT01670656|17711349|P5|Overall Study|Pregnancy|1
5127569|NCT01670656|17711350|P4|Overall Study|Pregnancy|0
5127570|NCT01670656|17711351|P3|Overall Study|Pregnancy|0
5127571|NCT01670656|17711352|P2|Overall Study|Pregnancy|0
5127572|NCT01670656|17711353|P1|Overall Study|Pregnancy|0
5127573|NCT01670656|17711349|P5|Overall Study|Non-compliance with study drug|1
5127574|NCT01670656|17711350|P4|Overall Study|Non-compliance with study drug|0
5127575|NCT01670656|17711351|P3|Overall Study|Non-compliance with study drug|3
5127576|NCT01670656|17711352|P2|Overall Study|Non-compliance with study drug|0
5127577|NCT01670656|17711353|P1|Overall Study|Non-compliance with study drug|0
5127578|NCT01670526|17711382|P2|Overall Study|Lost to Follow-up|5
5127579|NCT01670526|17711383|P1|Overall Study|Lost to Follow-up|9
5127580|NCT01670526|17711382|P2|Overall Study|Withdrawal by Subject|1
5127581|NCT01670526|17711383|P1|Overall Study|Withdrawal by Subject|3
5127582|NCT01670500|17711397|P2|Overall Study|Withdrawal by Subject|0
5127583|NCT01670500|17711398|P1|Overall Study|Withdrawal by Subject|1
5127584|NCT01670292|17711421|P1|Overall Study|Lost to Follow-up|14
5127585|NCT01670279|17711462|P4|Overall Study|Participant met withdrawal criteria|1
5127586|NCT01670279|17711463|P3|Overall Study|Participant met withdrawal criteria|0
5127587|NCT01670279|17711464|P2|Overall Study|Participant met withdrawal criteria|0
5127588|NCT01670279|17711465|P1|Overall Study|Participant met withdrawal criteria|0
5127589|NCT01670279|17711462|P4|Overall Study|Physician Decision|0
5127590|NCT01670279|17711463|P3|Overall Study|Physician Decision|0
5127591|NCT01670279|17711464|P2|Overall Study|Physician Decision|1
5127592|NCT01670279|17711465|P1|Overall Study|Physician Decision|0
5127593|NCT01670279|17711462|P4|Overall Study|Adverse Event|0
5127594|NCT01670279|17711463|P3|Overall Study|Adverse Event|0
5127595|NCT01670279|17711464|P2|Overall Study|Adverse Event|1
5127596|NCT01670279|17711465|P1|Overall Study|Adverse Event|0
5127597|NCT01670188|17711507|P2|Overall Study|Death|1
5127598|NCT01670188|17711508|P1|Overall Study|Death|0
5127599|NCT01670045|17711537|P1|Overall Study|Lost to Follow-up|11
5127600|NCT01670045|17711537|P1|Overall Study|Death|1
5127601|NCT01670045|17711537|P1|Overall Study|Adverse Event|1
5127602|NCT01670045|17711537|P1|Overall Study|Withdrawal by Subject|3
5127603|NCT01670019|17711555|P2|Overall Study|Withdrawal by Subject|0
5127604|NCT01670019|17711556|P1|Overall Study|Withdrawal by Subject|6
5127605|NCT01670019|17711555|P2|Overall Study|Adverse Event|0
5127606|NCT01670019|17711556|P1|Overall Study|Adverse Event|3
5127607|NCT01669902|17711570|P1|Overall Study|Other|8
5127608|NCT01669902|17711570|P1|Overall Study|Lack of Efficacy|10
5127609|NCT01669902|17711570|P1|Overall Study|Adverse Event|11
5127610|NCT01669811|17711605|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
5127611|NCT01669811|17711606|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5127612|NCT01669811|17711605|P2|Overall Study|Adverse Event|6
5127613|NCT01669811|17711606|P1|Overall Study|Adverse Event|2
5127614|NCT01669811|17711605|P2|Overall Study|Withdrawal by Subject|2
5127615|NCT01669811|17711606|P1|Overall Study|Withdrawal by Subject|1
5127616|NCT01669811|17711605|P2|Overall Study|Investigator decision|1
5127617|NCT01669811|17711606|P1|Overall Study|Investigator decision|0
5127618|NCT01669798|17711624|P1|Overall Study|Physician Decision|5
5127619|NCT01669629|17711730|P2|Period 1|protocol deviation|2
5127620|NCT01669629|17711731|P1|Period 1|protocol deviation|1
5127621|NCT01669577|17711754|P1|Overall Study|Physician Decision|34
5127622|NCT01669577|17711754|P1|Overall Study|Lost to Follow-up|78
5127623|NCT01669577|17711754|P1|Overall Study|Death|22
5127624|NCT01669421|17711792|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
5127625|NCT01669421|17711792|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
5127626|NCT01669174|17711811|P2|Overall Study|Administrative problems|2
5127627|NCT01669174|17711812|P1|Overall Study|Administrative problems|1
5127628|NCT01669174|17711811|P2|Overall Study|Adverse Event|2
5127629|NCT01669174|17711812|P1|Overall Study|Adverse Event|2
5127630|NCT01669174|17711811|P2|Overall Study|Lost to Follow-up|0
5127631|NCT01669174|17711812|P1|Overall Study|Lost to Follow-up|1
5127632|NCT01669174|17711811|P2|Overall Study|Subject withdrew consent|2
5127633|NCT01669174|17711812|P1|Overall Study|Subject withdrew consent|2
5127634|NCT01669122|17711828|P1|Washout Period II|Protocol Violation|2
5127635|NCT01669122|17711828|P1|Period I|Lost to Follow-up|1
5127636|NCT01668966|17711895|P1|Overall Study|Not treated|2
5127637|NCT01668966|17711895|P1|Overall Study|Death|1
5127638|NCT01668966|17711895|P1|Overall Study|Withdrawal by Subject|1
5127639|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
5127640|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
5127641|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
5127642|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
5127643|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
5127644|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
5127645|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
5127646|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
5127647|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
5127648|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
5127649|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
5127650|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
5127651|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
5127652|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
5127653|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
5127654|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
5127655|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5127656|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
5127657|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5127658|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5127659|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
5127660|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
5127661|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
5127662|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
5127663|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
5127664|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
5127665|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
5127666|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
5127667|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
5127668|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
5127669|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
5127670|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
5127671|NCT01668797|17711991|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
5127672|NCT01668797|17711992|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
5127673|NCT01668797|17711993|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
5127674|NCT01668797|17711994|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
5127675|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5127676|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5127677|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
5127678|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5127679|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5127680|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5127681|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
5127682|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5127683|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
5127684|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
5127685|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
5127686|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
5127687|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Protocol Violation|0
5127688|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Protocol Violation|0
5127689|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Protocol Violation|3
5127690|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Protocol Violation|0
5127691|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5127692|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5127693|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
5127694|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5127695|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Physician Decision|0
5127696|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Physician Decision|0
5127697|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Physician Decision|11
5127698|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Physician Decision|0
5127699|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5127700|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5127701|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
5127702|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5127703|NCT01668797|17711991|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
5127704|NCT01668797|17711992|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
5127705|NCT01668797|17711993|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
5127706|NCT01668797|17711994|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
5127707|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5127708|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5127709|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5127710|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
5127711|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5127712|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5127713|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5127714|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
5127715|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
5127716|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
5127717|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
5127718|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
5127719|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Protocol Violation|0
5127720|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Protocol Violation|0
5127721|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Protocol Violation|0
5127722|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Protocol Violation|2
5127723|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
5127724|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
5127725|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
5127726|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
5127727|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Physician Decision|0
5127728|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Physician Decision|0
5127729|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Physician Decision|0
5127730|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Physician Decision|2
5127731|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5127732|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5127733|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5127734|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
5127735|NCT01668797|17711991|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
5127736|NCT01668797|17711992|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
5127737|NCT01668797|17711993|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
5127738|NCT01668797|17711994|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
5127739|NCT01668784|17712059|P2|Treated (Overall)|Other|4
5127740|NCT01668784|17712060|P1|Treated (Overall)|Other|0
5127741|NCT01668784|17712059|P2|Treated (Overall)|Maximal Clinical Benefit|3
5127742|NCT01668784|17712060|P1|Treated (Overall)|Maximal Clinical Benefit|2
5127743|NCT01668784|17712059|P2|Treated (Overall)|Withdrawal by Subject|3
5127744|NCT01668784|17712060|P1|Treated (Overall)|Withdrawal by Subject|2
5127745|NCT01668784|17712059|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
5127746|NCT01668784|17712060|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
5127747|NCT01668784|17712059|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
5127748|NCT01668784|17712060|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
5127749|NCT01668784|17712059|P2|Treated (Overall)|Death|1
5127750|NCT01668784|17712060|P1|Treated (Overall)|Death|1
5127751|NCT01668784|17712059|P2|Treated (Overall)|Study Drug Toxicity|53
5127752|NCT01668784|17712060|P1|Treated (Overall)|Study Drug Toxicity|35
5127753|NCT01668784|17712059|P2|Treated (Overall)|Disease Progression|273
5127754|NCT01668784|17712060|P1|Treated (Overall)|Disease Progression|285
5127755|NCT01668784|17712059|P2|Randomized (Pre-treatment)|Other|1
5127756|NCT01668784|17712060|P1|Randomized (Pre-treatment)|Other|0
5127757|NCT01668784|17712059|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
5127758|NCT01668784|17712060|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
5127759|NCT01668784|17712059|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
5127760|NCT01668784|17712060|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
5127761|NCT01668784|17712059|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
5127762|NCT01668784|17712060|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
5127763|NCT01668784|17712059|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
5127764|NCT01668784|17712060|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
5127765|NCT01668784|17712059|P2|Randomized (Pre-treatment)|Disease Progression|1
5127766|NCT01668784|17712060|P1|Randomized (Pre-treatment)|Disease Progression|0
5127767|NCT01668667|17712088|P4|Overall Study|Withdrawal by Subject|5
5127768|NCT01668667|17712089|P3|Overall Study|Withdrawal by Subject|5
5127769|NCT01668667|17712090|P2|Overall Study|Withdrawal by Subject|4
5127770|NCT01668667|17712091|P1|Overall Study|Withdrawal by Subject|7
5127771|NCT01668667|17712088|P4|Overall Study|Physician Decision|0
5127772|NCT01668667|17712089|P3|Overall Study|Physician Decision|1
5127773|NCT01668667|17712090|P2|Overall Study|Physician Decision|0
5127774|NCT01668667|17712091|P1|Overall Study|Physician Decision|3
5127775|NCT01668667|17712088|P4|Overall Study|Lost to Follow-up|6
5127776|NCT01668667|17712089|P3|Overall Study|Lost to Follow-up|7
5127777|NCT01668667|17712090|P2|Overall Study|Lost to Follow-up|4
5127778|NCT01668667|17712091|P1|Overall Study|Lost to Follow-up|9
5127779|NCT01668667|17712088|P4|Overall Study|Protocol Violation|5
5127780|NCT01668667|17712089|P3|Overall Study|Protocol Violation|12
5127781|NCT01668667|17712090|P2|Overall Study|Protocol Violation|10
5127782|NCT01668667|17712091|P1|Overall Study|Protocol Violation|6
5127783|NCT01668667|17712088|P4|Overall Study|Lack of Efficacy|3
5127784|NCT01668667|17712089|P3|Overall Study|Lack of Efficacy|2
5127785|NCT01668667|17712090|P2|Overall Study|Lack of Efficacy|2
5127786|NCT01668667|17712091|P1|Overall Study|Lack of Efficacy|3
5127787|NCT01668667|17712088|P4|Overall Study|Adverse Event|4
5127788|NCT01668667|17712089|P3|Overall Study|Adverse Event|4
5127789|NCT01668667|17712090|P2|Overall Study|Adverse Event|6
5127790|NCT01668667|17712091|P1|Overall Study|Adverse Event|3
5127791|NCT01668654|17712113|P1|Overall Study|Withdrawal by Subject|1
5127792|NCT01668654|17712113|P1|Overall Study|Study Closed/Terminated|3
5127793|NCT01668589|17712174|P4|Overall Study|Other|15
5127794|NCT01668589|17712175|P3|Overall Study|Other|7
5127795|NCT01668589|17712176|P2|Overall Study|Other|10
5127796|NCT01668589|17712177|P1|Overall Study|Other|44
5127797|NCT01668589|17712174|P4|Overall Study|Death|11
5127798|NCT01668589|17712175|P3|Overall Study|Death|2
5127799|NCT01668589|17712176|P2|Overall Study|Death|3
5127800|NCT01668589|17712177|P1|Overall Study|Death|12
5127801|NCT01668589|17712174|P4|Overall Study|Full Consent/Agreement Withdrawn|4
5127802|NCT01668589|17712175|P3|Overall Study|Full Consent/Agreement Withdrawn|11
5127803|NCT01668589|17712176|P2|Overall Study|Full Consent/Agreement Withdrawn|8
5127804|NCT01668589|17712177|P1|Overall Study|Full Consent/Agreement Withdrawn|54
5127805|NCT01668589|17712174|P4|Overall Study|Lost to Follow-up|5
5127806|NCT01668589|17712175|P3|Overall Study|Lost to Follow-up|15
5127807|NCT01668589|17712176|P2|Overall Study|Lost to Follow-up|37
5127808|NCT01668589|17712177|P1|Overall Study|Lost to Follow-up|29
5127809|NCT01668537|17712217|P2|Overall Study|Other|3
5127810|NCT01668537|17712218|P1|Overall Study|Other|2
5127811|NCT01668537|17712217|P2|Overall Study|Lost to Follow-up|6
5127812|NCT01668537|17712218|P1|Overall Study|Lost to Follow-up|13
5127813|NCT01668537|17712217|P2|Overall Study|Reason Precludes Participation|0
5127814|NCT01668537|17712218|P1|Overall Study|Reason Precludes Participation|1
5127815|NCT01668537|17712217|P2|Overall Study|Subject unwilling/unable to comply|0
5127816|NCT01668537|17712218|P1|Overall Study|Subject unwilling/unable to comply|5
5127817|NCT01668537|17712217|P2|Overall Study|Request to Discontinue Prematurely|1
5127818|NCT01668537|17712218|P1|Overall Study|Request to Discontinue Prematurely|1
5127819|NCT01668355|17712260|P2|Overall Study|Withdrawal by Subject|1
5127820|NCT01668355|17712261|P1|Overall Study|Withdrawal by Subject|6
5127821|NCT01668355|17712260|P2|Overall Study|Death|1
5127822|NCT01668355|17712261|P1|Overall Study|Death|3
5127823|NCT01668173|17712281|P1|Overall Study|Trial suspension|4
5127824|NCT01668173|17712281|P1|Overall Study|Adverse Event|3
5127825|NCT01668147|17712285|P1|Overall Study|Withdrawal by Subject|6
5127826|NCT01668004|17712415|P1|Overall Study|Non-compliance with treatment|2
5127827|NCT01668004|17712415|P1|Overall Study|Lack of Efficacy|9
5127828|NCT01668004|17712415|P1|Overall Study|Lost to Follow-up|5
5127829|NCT01668004|17712415|P1|Overall Study|Withdrawal by Subject|2
5127830|NCT01668004|17712415|P1|Overall Study|Adverse Event|7
5127831|NCT01667926|17712437|P3|Overall Study|Side effects|0
5127832|NCT01667926|17712438|P2|Overall Study|Side effects|0
5127833|NCT01667926|17712439|P1|Overall Study|Side effects|3
5127834|NCT01667926|17712437|P3|Overall Study|Lost to Follow-up|1
5127835|NCT01667926|17712438|P2|Overall Study|Lost to Follow-up|2
5127836|NCT01667926|17712439|P1|Overall Study|Lost to Follow-up|1
5127837|NCT01667926|17712437|P3|Overall Study|Inclusion/Exclusion Criteria|5
5127838|NCT01667926|17712438|P2|Overall Study|Inclusion/Exclusion Criteria|0
5127839|NCT01667926|17712439|P1|Overall Study|Inclusion/Exclusion Criteria|0
5127840|NCT01667926|17712437|P3|Overall Study|Time committment|2
5127841|NCT01667926|17712438|P2|Overall Study|Time committment|0
5127842|NCT01667926|17712439|P1|Overall Study|Time committment|0
5127843|NCT01667926|17712437|P3|Overall Study|Physician Decision|1
5127844|NCT01667926|17712438|P2|Overall Study|Physician Decision|0
5127845|NCT01667926|17712439|P1|Overall Study|Physician Decision|0
5127846|NCT01667926|17712437|P3|Overall Study|Withdrawal by Subject|2
5127847|NCT01667926|17712438|P2|Overall Study|Withdrawal by Subject|2
5127848|NCT01667926|17712439|P1|Overall Study|Withdrawal by Subject|1
5127849|NCT01667900|17712452|P20|Part B|Death|0
5127850|NCT01667900|17712453|P19|Part B|Death|0
5127851|NCT01667900|17712454|P18|Part B|Death|0
5127852|NCT01667900|17712455|P17|Part B|Death|1
5127853|NCT01667900|17712456|P16|Part B|Death|0
5127854|NCT01667900|17712457|P15|Part B|Death|0
5127855|NCT01667900|17712458|P14|Part B|Death|0
5127856|NCT01667900|17712459|P13|Part B|Death|0
5127857|NCT01667900|17712460|P12|Part B|Death|0
5127858|NCT01667900|17712461|P11|Part B|Death|0
5127859|NCT01667900|17712462|P10|Part B|Death|0
5127860|NCT01667900|17712463|P9|Part B|Death|0
5127861|NCT01667900|17712464|P8|Part B|Death|0
5127862|NCT01667900|17712465|P7|Part B|Death|0
5127863|NCT01667900|17712466|P6|Part B|Death|0
5127864|NCT01667900|17712467|P5|Part B|Death|0
5127865|NCT01667900|17712468|P4|Part B|Death|0
5127866|NCT01667900|17712469|P3|Part B|Death|0
5127867|NCT01667900|17712470|P2|Part B|Death|0
5127868|NCT01667900|17712471|P1|Part B|Death|0
5127869|NCT01667731|17712541|P5|Overall Study|Death|0
5127870|NCT01667731|17712542|P4|Overall Study|Death|0
5127871|NCT01667731|17712543|P3|Overall Study|Death|0
5127872|NCT01667731|17712544|P2|Overall Study|Death|1
5127873|NCT01667731|17712545|P1|Overall Study|Death|0
5127874|NCT01667731|17712541|P5|Overall Study|Subject Withdrew Consent|1
5127875|NCT01667731|17712542|P4|Overall Study|Subject Withdrew Consent|0
5127876|NCT01667731|17712543|P3|Overall Study|Subject Withdrew Consent|1
5127877|NCT01667731|17712544|P2|Overall Study|Subject Withdrew Consent|0
5127878|NCT01667731|17712545|P1|Overall Study|Subject Withdrew Consent|2
5127879|NCT01667731|17712541|P5|Overall Study|Lost to Follow-up|2
5127880|NCT01667731|17712542|P4|Overall Study|Lost to Follow-up|1
5127881|NCT01667731|17712543|P3|Overall Study|Lost to Follow-up|1
5127882|NCT01667731|17712544|P2|Overall Study|Lost to Follow-up|3
5127883|NCT01667731|17712545|P1|Overall Study|Lost to Follow-up|2
5127884|NCT01667731|17712541|P5|Overall Study|Efficacy Failure|24
5127885|NCT01667731|17712542|P4|Overall Study|Efficacy Failure|1
5127886|NCT01667731|17712543|P3|Overall Study|Efficacy Failure|0
5127887|NCT01667731|17712544|P2|Overall Study|Efficacy Failure|12
5127888|NCT01667731|17712545|P1|Overall Study|Efficacy Failure|1
5127889|NCT01667731|17712541|P5|Overall Study|Enrolled but not treated|1
5127890|NCT01667731|17712542|P4|Overall Study|Enrolled but not treated|0
5127891|NCT01667731|17712543|P3|Overall Study|Enrolled but not treated|0
5127892|NCT01667731|17712544|P2|Overall Study|Enrolled but not treated|0
5127893|NCT01667731|17712545|P1|Overall Study|Enrolled but not treated|0
5127894|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
5127895|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
5127896|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
5127897|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
5127898|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
5127899|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
5127900|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
5127901|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
5127902|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
5127903|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
5127904|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
5127905|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
5127906|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
5127907|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
5127908|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
5127909|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
5127910|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
5127911|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
5127912|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
5127913|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
5127914|NCT01667679|17712600|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
5127915|NCT01667679|17712601|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
5127916|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
5127917|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
5127918|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
5127919|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
5127920|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
5127921|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
5127922|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
5127923|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
5127924|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
5127925|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
5127926|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
5127927|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
5127928|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
5127929|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
5127930|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
5127931|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
5127932|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
5127933|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
5127934|NCT01667679|17712600|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
5127935|NCT01667679|17712601|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
5127936|NCT01667562|17712659|P2|Erlotinib Phase|Switch to Commercial Drug|1
5127937|NCT01667562|17712660|P1|Erlotinib Phase|Switch to Commercial Drug|0
5127938|NCT01667562|17712659|P2|Erlotinib Phase|Adverse Event|1
5127939|NCT01667562|17712660|P1|Erlotinib Phase|Adverse Event|0
5127940|NCT01667562|17712659|P2|Erlotinib Phase|Lost to Follow-up|1
5127941|NCT01667562|17712660|P1|Erlotinib Phase|Lost to Follow-up|0
5127942|NCT01667562|17712659|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
5127943|NCT01667562|17712660|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
5127944|NCT01667549|17712674|P5|Overall Study|Withdrawal by Subject|1
5127945|NCT01667549|17712675|P4|Overall Study|Withdrawal by Subject|6
5127946|NCT01667549|17712676|P3|Overall Study|Withdrawal by Subject|7
5127947|NCT01667549|17712677|P2|Overall Study|Withdrawal by Subject|5
5127948|NCT01667549|17712678|P1|Overall Study|Withdrawal by Subject|3
5127949|NCT01667432|17712737|P1|Overall Study|Missing Information|4
5127950|NCT01667432|17712737|P1|Overall Study|Reason Not Specified|2
5127951|NCT01667432|17712737|P1|Overall Study|Principal Investigator Decision|1
5127952|NCT01667432|17712737|P1|Overall Study|Protocol Deviation|2
5127953|NCT01667432|17712737|P1|Overall Study|Adverse Event|1
5127954|NCT01667432|17712737|P1|Overall Study|Insufficient Therapeutic Response|4
5127955|NCT01667432|17712737|P1|Overall Study|Refused Treatment/Withdrew Consent|1
5127956|NCT01667432|17712737|P1|Overall Study|Lost to Follow-up|3
5127957|NCT01667432|17712737|P1|Overall Study|Moved to Another Center|3
5127958|NCT01667432|17712737|P1|Overall Study|Failure to Return|10
5127959|NCT01667432|17712737|P1|Overall Study|Premature Study Termination|26
5127960|NCT01667419|17712746|P4|Overall Study|Death|26
5127961|NCT01667419|17712747|P3|Overall Study|Death|25
5127962|NCT01667419|17712748|P2|Overall Study|Death|33
5127963|NCT01667419|17712749|P1|Overall Study|Death|18
5127964|NCT01667419|17712746|P4|Overall Study|Lost to Follow-up|4
5127965|NCT01667419|17712747|P3|Overall Study|Lost to Follow-up|2
5127966|NCT01667419|17712748|P2|Overall Study|Lost to Follow-up|6
5127967|NCT01667419|17712749|P1|Overall Study|Lost to Follow-up|7
5127968|NCT01667419|17712746|P4|Overall Study|Protocol Violation|0
5127969|NCT01667419|17712747|P3|Overall Study|Protocol Violation|0
5127970|NCT01667419|17712748|P2|Overall Study|Protocol Violation|0
5127971|NCT01667419|17712749|P1|Overall Study|Protocol Violation|1
5127972|NCT01667419|17712746|P4|Overall Study|Non-compliance|1
5127973|NCT01667419|17712747|P3|Overall Study|Non-compliance|0
5127974|NCT01667419|17712748|P2|Overall Study|Non-compliance|0
5127975|NCT01667419|17712749|P1|Overall Study|Non-compliance|0
5127976|NCT01667419|17712746|P4|Overall Study|Withdrawal by Subject|8
5127977|NCT01667419|17712747|P3|Overall Study|Withdrawal by Subject|9
5127978|NCT01667419|17712748|P2|Overall Study|Withdrawal by Subject|8
5127979|NCT01667419|17712749|P1|Overall Study|Withdrawal by Subject|16
5127980|NCT01667419|17712746|P4|Overall Study|Reason Not Specified|0
5127981|NCT01667419|17712747|P3|Overall Study|Reason Not Specified|0
5127982|NCT01667419|17712748|P2|Overall Study|Reason Not Specified|0
5127983|NCT01667419|17712749|P1|Overall Study|Reason Not Specified|1
5127984|NCT01667224|17712797|P2|Overall Study|Protocol Violation|1
5127985|NCT01667224|17712798|P1|Overall Study|Protocol Violation|1
5127986|NCT01667224|17712797|P2|Overall Study|Withdrawal by Subject|1
5127987|NCT01667224|17712798|P1|Overall Study|Withdrawal by Subject|3
5127988|NCT01667107|17712812|P2|Overall Study|Lack of Efficacy|1
5127989|NCT01667107|17712813|P1|Overall Study|Lack of Efficacy|0
5127990|NCT01667107|17712812|P2|Overall Study|Protocol Violation|1
5127991|NCT01667107|17712813|P1|Overall Study|Protocol Violation|0
5127992|NCT01667107|17712812|P2|Overall Study|Tolerability issues|2
5127993|NCT01667107|17712813|P1|Overall Study|Tolerability issues|0
5127994|NCT01667107|17712812|P2|Overall Study|Adverse Event|3
5127995|NCT01667107|17712813|P1|Overall Study|Adverse Event|4
5127996|NCT01666951|17712872|P2|Overall Study|Not dosed|1
5127997|NCT01666951|17712873|P1|Overall Study|Not dosed|1
5127998|NCT01666782|17712924|P2|Overall Study|Enrolled both years; year 1 data used|0
5127999|NCT01666782|17712925|P1|Overall Study|Enrolled both years; year 1 data used|4
5128000|NCT01666782|17712924|P2|Overall Study|Received 2 doses of vaccine|1
5128001|NCT01666782|17712925|P1|Overall Study|Received 2 doses of vaccine|0
5128002|NCT01666652|17712946|P5|Overall Study|Lost to Follow-up|0
5128003|NCT01666652|17712947|P4|Overall Study|Lost to Follow-up|1
5128004|NCT01666652|17712948|P3|Overall Study|Lost to Follow-up|1
5128005|NCT01666652|17712949|P2|Overall Study|Lost to Follow-up|1
5128006|NCT01666652|17712950|P1|Overall Study|Lost to Follow-up|1
5128007|NCT01666652|17712946|P5|Overall Study|Moved from study area|0
5128008|NCT01666652|17712947|P4|Overall Study|Moved from study area|2
5128009|NCT01666652|17712948|P3|Overall Study|Moved from study area|0
5128010|NCT01666652|17712949|P2|Overall Study|Moved from study area|0
5128011|NCT01666652|17712950|P1|Overall Study|Moved from study area|1
5128012|NCT01666652|17712946|P5|Overall Study|Withdrawal by Subject|1
5128013|NCT01666652|17712947|P4|Overall Study|Withdrawal by Subject|0
5128014|NCT01666652|17712948|P3|Overall Study|Withdrawal by Subject|0
5128015|NCT01666652|17712949|P2|Overall Study|Withdrawal by Subject|0
5128016|NCT01666652|17712950|P1|Overall Study|Withdrawal by Subject|0
5128017|NCT01666652|17712946|P5|Overall Study|Serious Adverse Event|0
5128018|NCT01666652|17712947|P4|Overall Study|Serious Adverse Event|1
5128019|NCT01666652|17712948|P3|Overall Study|Serious Adverse Event|0
5128020|NCT01666652|17712949|P2|Overall Study|Serious Adverse Event|0
5128021|NCT01666652|17712950|P1|Overall Study|Serious Adverse Event|0
5128022|NCT01666444|17712999|P2|Overall Study|Did not initiate treatment|1
5128023|NCT01666444|17713000|P1|Overall Study|Did not initiate treatment|2
5128024|NCT01666314|17713018|P4|Overall Study|Reason not Specified|5
5128025|NCT01666314|17713019|P3|Overall Study|Reason not Specified|5
5128026|NCT01666314|17713020|P2|Overall Study|Reason not Specified|7
5128027|NCT01666314|17713021|P1|Overall Study|Reason not Specified|10
5128028|NCT01666314|17713018|P4|Overall Study|Withdrawal by Subject|3
5128029|NCT01666314|17713019|P3|Overall Study|Withdrawal by Subject|2
5128030|NCT01666314|17713020|P2|Overall Study|Withdrawal by Subject|1
5128031|NCT01666314|17713021|P1|Overall Study|Withdrawal by Subject|1
5128032|NCT01666314|17713018|P4|Overall Study|Unsatisfactory Therapeutic Response|1
5128033|NCT01666314|17713019|P3|Overall Study|Unsatisfactory Therapeutic Response|1
5128034|NCT01666314|17713020|P2|Overall Study|Unsatisfactory Therapeutic Response|2
5128035|NCT01666314|17713021|P1|Overall Study|Unsatisfactory Therapeutic Response|7
5128036|NCT01666314|17713018|P4|Overall Study|Symptomatic Deterioration|0
5128037|NCT01666314|17713019|P3|Overall Study|Symptomatic Deterioration|2
5128038|NCT01666314|17713020|P2|Overall Study|Symptomatic Deterioration|0
5128039|NCT01666314|17713021|P1|Overall Study|Symptomatic Deterioration|1
5128040|NCT01666314|17713018|P4|Overall Study|Progressive Disease|20
5128041|NCT01666314|17713019|P3|Overall Study|Progressive Disease|19
5128042|NCT01666314|17713020|P2|Overall Study|Progressive Disease|9
5128043|NCT01666314|17713021|P1|Overall Study|Progressive Disease|11
5128044|NCT01666314|17713018|P4|Overall Study|Adverse Event|7
5128045|NCT01666314|17713019|P3|Overall Study|Adverse Event|7
5128046|NCT01666314|17713020|P2|Overall Study|Adverse Event|13
5128047|NCT01666314|17713021|P1|Overall Study|Adverse Event|3
5128048|NCT01666119|17713157|P1|Overall Study|Subject experiencing withdrawal symptoms|5
5128049|NCT01666119|17713157|P1|Overall Study|non compliance with study medication, pa|18
5128050|NCT01666119|17713157|P1|Overall Study|Lost to Follow-up|7
5128051|NCT01666119|17713157|P1|Overall Study|Withdrawal by Subject|16
5128052|NCT01666119|17713157|P1|Overall Study|Adverse Event|6
5128053|NCT01666002|17713164|P2|Overall Study|Lost to Follow-up|0
5128054|NCT01666002|17713165|P1|Overall Study|Lost to Follow-up|5
5128055|NCT01665911|17713186|P1|Overall Study|Adverse Event|1
5128056|NCT01665911|17713186|P1|Overall Study|Withdrawal by Subject|1
5128057|NCT01665911|17713186|P1|Overall Study|Protocol Violation|4
5128058|NCT01665807|17713212|P3|Overall Study|Withdrawal by Subject|1
5128059|NCT01665807|17713213|P2|Overall Study|Withdrawal by Subject|0
5128060|NCT01665807|17713214|P1|Overall Study|Withdrawal by Subject|2
5128061|NCT01665768|17713225|P1|Overall Study|Withdrawal by Subject|1
5128062|NCT01665768|17713225|P1|Overall Study|Lack of Efficacy|19
5128063|NCT01665768|17713225|P1|Overall Study|Adverse Event|3
5128064|NCT01665599|17713230|P1|Overall Study|Could Not Continue Due to Time Constrain|1
5128065|NCT01665599|17713230|P1|Overall Study|Participant Left for More Than 3 Months|1
5128066|NCT01665599|17713230|P1|Overall Study|Lost to Follow-up|2
5128067|NCT01665599|17713230|P1|Overall Study|Death|1
5128068|NCT01665599|17713230|P1|Overall Study|Investigator/Sponsor decision|1
5128069|NCT01665599|17713230|P1|Overall Study|Consent Withdrawn|1
5128070|NCT01665599|17713230|P1|Overall Study|Adverse Event|1
5128071|NCT01665430|17713266|P1|Overall Study|Other Unspecified|2
5128072|NCT01665430|17713266|P1|Overall Study|Withdrawal by Subject|6
5128073|NCT01665430|17713266|P1|Overall Study|Adverse Event|1
5128074|NCT01665144|17713364|P2|Overall Study|Withdrawal by Subject|77
5128075|NCT01665144|17713365|P1|Overall Study|Withdrawal by Subject|96
5128076|NCT01665144|17713364|P2|Overall Study|Adverse Event|18
5128077|NCT01665144|17713365|P1|Overall Study|Adverse Event|45
5128078|NCT01665144|17713364|P2|Overall Study|Lack of Efficacy|11
5128079|NCT01665144|17713365|P1|Overall Study|Lack of Efficacy|16
5128080|NCT01665144|17713364|P2|Overall Study|Physician Decision|1
5128081|NCT01665144|17713365|P1|Overall Study|Physician Decision|13
5128082|NCT01665144|17713364|P2|Overall Study|Lost to Follow-up|8
5128083|NCT01665144|17713365|P1|Overall Study|Lost to Follow-up|9
5128084|NCT01665144|17713364|P2|Overall Study|Progressive disease|4
5128085|NCT01665144|17713365|P1|Overall Study|Progressive disease|8
5128086|NCT01665144|17713364|P2|Overall Study|Non-compliance w/study treatment|0
5128087|NCT01665144|17713365|P1|Overall Study|Non-compliance w/study treatment|5
5128088|NCT01665144|17713364|P2|Overall Study|Protocol deviation|1
5128089|NCT01665144|17713365|P1|Overall Study|Protocol deviation|3
5128090|NCT01665144|17713364|P2|Overall Study|Death|1
5128091|NCT01665144|17713365|P1|Overall Study|Death|3
5128092|NCT01665144|17713364|P2|Overall Study|Technical problems|0
5128093|NCT01665144|17713365|P1|Overall Study|Technical problems|2
5128094|NCT01665144|17713364|P2|Overall Study|New therapy for study indication|1
5128095|NCT01665144|17713365|P1|Overall Study|New therapy for study indication|2
5128096|NCT01664949|17713445|P2|Overall Study|Other Miscellaneous Reasons|1
5128097|NCT01664949|17713446|P1|Overall Study|Other Miscellaneous Reasons|3
5128098|NCT01664949|17713445|P2|Overall Study|Protocol Violation|5
5128099|NCT01664949|17713446|P1|Overall Study|Protocol Violation|5
5128100|NCT01664949|17713445|P2|Overall Study|Personal Reasons|4
5128101|NCT01664949|17713446|P1|Overall Study|Personal Reasons|3
5128102|NCT01664949|17713445|P2|Overall Study|Lost to Follow-up|2
5128103|NCT01664949|17713446|P1|Overall Study|Lost to Follow-up|1
5128104|NCT01664949|17713445|P2|Overall Study|Lack of Efficacy|1
5128105|NCT01664949|17713446|P1|Overall Study|Lack of Efficacy|1
5128106|NCT01664949|17713445|P2|Overall Study|Adverse Event|12
5128107|NCT01664949|17713446|P1|Overall Study|Adverse Event|11
5128108|NCT01664923|17713462|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
5128109|NCT01664923|17713463|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
5128110|NCT01664923|17713462|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
5128111|NCT01664923|17713463|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
5128112|NCT01664923|17713462|P2|Period 2: Open-label Phase-36 Months|Other|1
5128113|NCT01664923|17713463|P1|Period 2: Open-label Phase-36 Months|Other|3
5128114|NCT01664923|17713462|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
5128115|NCT01664923|17713463|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
5128116|NCT01664923|17713462|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
5128117|NCT01664923|17713463|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
5128118|NCT01664923|17713462|P2|Period 2: Open-label Phase-36 Months|Death|1
5128119|NCT01664923|17713463|P1|Period 2: Open-label Phase-36 Months|Death|3
5128120|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
5128121|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
5128122|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Other|4
5128123|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Other|3
5128124|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
5128125|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
5128126|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
5128127|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
5128128|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
5128129|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
5128130|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
5128131|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
5128132|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
5128133|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
5128134|NCT01664923|17713462|P2|Period1:Double Blind Phase-29 Months|Death|6
5128135|NCT01664923|17713463|P1|Period1:Double Blind Phase-29 Months|Death|8
5128136|NCT01664624|17713554|P4|Overall Study|Adverse Event|0
5128137|NCT01664624|17713555|P3|Overall Study|Adverse Event|0
5128138|NCT01664624|17713556|P2|Overall Study|Adverse Event|1
5128139|NCT01664624|17713557|P1|Overall Study|Adverse Event|0
5128140|NCT01664533|17713604|P1|Overall Study|Protocol Violation|3
5128141|NCT01664533|17713604|P1|Overall Study|Study termination|9
5128142|NCT01664533|17713604|P1|Overall Study|Lost to Follow-up|3
5128143|NCT01664533|17713604|P1|Overall Study|Death|42
5128144|NCT01664494|17713612|P1|Overall Study|Lost to Follow-up|99
5128145|NCT01664494|17713612|P1|Overall Study|Other|49
5128146|NCT01664494|17713612|P1|Overall Study|Death|18
5128147|NCT01664494|17713612|P1|Overall Study|Withdrawal by Subject|27
5128148|NCT01664247|17713619|P2|Overall Study|Unclassified|29
5128149|NCT01664247|17713620|P1|Overall Study|Unclassified|5
5128150|NCT01664247|17713619|P2|Overall Study|Withdrawal Criteria|4
5128151|NCT01664247|17713620|P1|Overall Study|Withdrawal Criteria|1
5128152|NCT01664247|17713619|P2|Overall Study|Protocol Violation|5
5128153|NCT01664247|17713620|P1|Overall Study|Protocol Violation|3
5128154|NCT01664247|17713619|P2|Overall Study|Adverse Event|3
5128155|NCT01664247|17713620|P1|Overall Study|Adverse Event|5
5128156|NCT01664130|17713642|P1|Overall Study|competing secondary disease|2
5128157|NCT01664104|17713720|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
5128158|NCT01664104|17713720|P1|Overall Study|Other|1
5128159|NCT01664104|17713720|P1|Overall Study|Lost to Follow-up|4
5128160|NCT01664104|17713720|P1|Overall Study|Withdrawal by Subject|1
5128161|NCT01664104|17713720|P1|Overall Study|Lack of Efficacy|2
5128162|NCT01664104|17713720|P1|Overall Study|Adverse Event|6
5128163|NCT01664091|17713787|P1|Overall Study|Withdrawal by Subject|1
5128164|NCT01664091|17713787|P1|Overall Study|Lost to Follow-up|2
5128165|NCT01664091|17713787|P1|Overall Study|Disease Progression|2
5128166|NCT01664091|17713787|P1|Overall Study|Death|1
5128167|NCT01664078|17713795|P1|Overall Study|Other|53
5128168|NCT01664078|17713795|P1|Overall Study|missed 5 year visit|1
5128169|NCT01664078|17713795|P1|Overall Study|Lost to Follow-up|2
5128170|NCT01664078|17713795|P1|Overall Study|Withdrawal by Subject|4
5128171|NCT01664078|17713795|P1|Overall Study|Death|9
5128172|NCT01664052|17713848|P2|Phase 2|No device placement|4
5128173|NCT01664052|17713849|P1|Phase 2|No device placement|0
5128174|NCT01664052|17713848|P2|Phase 1|No HSG 1 hr post placement|0
5128175|NCT01664052|17713849|P1|Phase 1|No HSG 1 hr post placement|1
5128176|NCT01664052|17713848|P2|Phase 1|No device placement|0
5128177|NCT01664052|17713849|P1|Phase 1|No device placement|6
5128178|NCT01664039|17713867|P2|Overall Study|Noncompliance|1
5128179|NCT01664039|17713868|P1|Overall Study|Noncompliance|1
5128180|NCT01664039|17713867|P2|Overall Study|Withdrawal by Subject|3
5128181|NCT01664039|17713868|P1|Overall Study|Withdrawal by Subject|1
5128182|NCT01664039|17713867|P2|Overall Study|Lost to Follow-up|1
5128183|NCT01664039|17713868|P1|Overall Study|Lost to Follow-up|1
5128184|NCT01664039|17713867|P2|Overall Study|Adverse Event|4
5128185|NCT01664039|17713868|P1|Overall Study|Adverse Event|3
5128186|NCT01663987|17713890|P2|Overall Study|Other reason not defined above|0
5128187|NCT01663987|17713891|P1|Overall Study|Other reason not defined above|3
5128188|NCT01663987|17713890|P2|Overall Study|Withdrawal by Subject|3
5128189|NCT01663987|17713891|P1|Overall Study|Withdrawal by Subject|2
5128190|NCT01663987|17713890|P2|Overall Study|Lost to Follow-up|1
5128191|NCT01663987|17713891|P1|Overall Study|Lost to Follow-up|1
5128192|NCT01663987|17713890|P2|Overall Study|Adverse Event|2
5128193|NCT01663987|17713891|P1|Overall Study|Adverse Event|7
5128194|NCT01663896|17713930|P1|Overall Study|Various reasons|43
5128195|NCT01663857|17713941|P4|Overall Study|Lost to Follow-up|1
5128196|NCT01663857|17713942|P3|Overall Study|Lost to Follow-up|3
5128197|NCT01663857|17713943|P2|Overall Study|Lost to Follow-up|0
5128198|NCT01663857|17713944|P1|Overall Study|Lost to Follow-up|0
5128199|NCT01663857|17713941|P4|Overall Study|Withdrew Consent to Study Participation|3
5128200|NCT01663857|17713942|P3|Overall Study|Withdrew Consent to Study Participation|7
5128201|NCT01663857|17713943|P2|Overall Study|Withdrew Consent to Study Participation|1
5128202|NCT01663857|17713944|P1|Overall Study|Withdrew Consent to Study Participation|0
5128203|NCT01663740|17713972|P2|Overall Study|No end of study status|0
5128204|NCT01663740|17713973|P1|Overall Study|No end of study status|3
5128205|NCT01663740|17713972|P2|Overall Study|Withdrawal by Subject|1
5128206|NCT01663740|17713973|P1|Overall Study|Withdrawal by Subject|2
5128207|NCT01663740|17713972|P2|Overall Study|Death|1
5128208|NCT01663740|17713973|P1|Overall Study|Death|0
5128209|NCT01663740|17713972|P2|Overall Study|Inclusion/Exclusion not met|0
5128210|NCT01663740|17713973|P1|Overall Study|Inclusion/Exclusion not met|1
5128211|NCT01663740|17713972|P2|Overall Study|Other|2
5128212|NCT01663740|17713973|P1|Overall Study|Other|9
5128213|NCT01663740|17713972|P2|Overall Study|Lost to Follow-up|4
5128214|NCT01663740|17713973|P1|Overall Study|Lost to Follow-up|1
5128215|NCT01663727|17714033|P2|Overall Study|Withdrawal prior to dosing.|0
5128216|NCT01663727|17714034|P1|Overall Study|Withdrawal prior to dosing.|1
5128217|NCT01663727|17714033|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
5128218|NCT01663727|17714034|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
5128219|NCT01663727|17714033|P2|Overall Study|Study Terminated|50
5128220|NCT01663727|17714034|P1|Overall Study|Study Terminated|51
5128221|NCT01663727|17714033|P2|Overall Study|Withdrawal by Subject|25
5128222|NCT01663727|17714034|P1|Overall Study|Withdrawal by Subject|18
5128223|NCT01663727|17714033|P2|Overall Study|Lost to Follow-up|8
5128224|NCT01663727|17714034|P1|Overall Study|Lost to Follow-up|10
5128225|NCT01663727|17714033|P2|Overall Study|Death|155
5128226|NCT01663727|17714034|P1|Overall Study|Death|161
5128227|NCT01663714|17714066|P1|Long-Term Follow-Up|Non-compliance|1
5128228|NCT01663714|17714066|P1|Long-Term Follow-Up|Death|4
5128229|NCT01663714|17714066|P1|Long-Term Follow-Up|Lost to Follow-up|1
5128230|NCT01663714|17714066|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
5128231|NCT01663714|17714066|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
5128232|NCT01663714|17714066|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
5128233|NCT01663636|17714095|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
5128234|NCT01663636|17714096|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
5128235|NCT01663623|17714104|P2|Overall Study|Withdrawal by Subject|1
5128236|NCT01663623|17714105|P1|Overall Study|Withdrawal by Subject|2
5128237|NCT01663623|17714104|P2|Overall Study|Physician Decision|4
5128238|NCT01663623|17714105|P1|Overall Study|Physician Decision|1
5128239|NCT01663623|17714104|P2|Overall Study|Other-Study closed/terminated|1
5128240|NCT01663623|17714105|P1|Overall Study|Other-Study closed/terminated|1
5128241|NCT01663623|17714104|P2|Overall Study|Protocol Violation|1
5128242|NCT01663623|17714105|P1|Overall Study|Protocol Violation|0
5128243|NCT01663623|17714104|P2|Overall Study|Lack of Efficacy|6
5128244|NCT01663623|17714105|P1|Overall Study|Lack of Efficacy|5
5128245|NCT01663623|17714104|P2|Overall Study|Adverse Event|7
5128246|NCT01663623|17714105|P1|Overall Study|Adverse Event|3
5128247|NCT01663532|17714115|P2|Overall Study|Lack of Efficacy|60
5128248|NCT01663532|17714116|P1|Overall Study|Lack of Efficacy|15
5128249|NCT01663532|17714115|P2|Overall Study|Withdrawal by Subject|17
5128250|NCT01663532|17714116|P1|Overall Study|Withdrawal by Subject|35
5128251|NCT01663532|17714115|P2|Overall Study|Physician Decision|1
5128252|NCT01663532|17714116|P1|Overall Study|Physician Decision|1
5128253|NCT01663532|17714115|P2|Overall Study|Met Withdrawal Criteria|6
5128254|NCT01663532|17714116|P1|Overall Study|Met Withdrawal Criteria|7
5128255|NCT01663532|17714115|P2|Overall Study|Adverse Event|13
5128256|NCT01663532|17714116|P1|Overall Study|Adverse Event|7
5128257|NCT01663532|17714115|P2|Overall Study|Lost to Follow-up|10
5128258|NCT01663532|17714116|P1|Overall Study|Lost to Follow-up|9
5128259|NCT01663506|17714134|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
5128260|NCT01663506|17714134|P1|Overall Study|Adverse Event|1
5128261|NCT01663506|17714134|P1|Overall Study|Lost to Follow-up|1
5128262|NCT01663506|17714134|P1|Overall Study|Consent Withdrawal by Subject|1
5128263|NCT01663506|17714134|P1|Overall Study|Lack of Efficacy|3
5128264|NCT01663402|17714165|P2|Overall Study|Other than specified above|147
5128265|NCT01663402|17714166|P1|Overall Study|Other than specified above|172
5128266|NCT01663402|17714165|P2|Overall Study|Lost to Follow-up|15
5128267|NCT01663402|17714166|P1|Overall Study|Lost to Follow-up|17
5128268|NCT01663402|17714165|P2|Overall Study|Related to study drug administration|105
5128269|NCT01663402|17714166|P1|Overall Study|Related to study drug administration|96
5128270|NCT01663402|17714165|P2|Overall Study|Withdrawal by Subject|91
5128271|NCT01663402|17714166|P1|Overall Study|Withdrawal by Subject|118
5128272|NCT01663402|17714165|P2|Overall Study|Participant moved|104
5128273|NCT01663402|17714166|P1|Overall Study|Participant moved|139
5128274|NCT01663402|17714165|P2|Overall Study|Site terminated by sponsor|3
5128275|NCT01663402|17714166|P1|Overall Study|Site terminated by sponsor|1
5128276|NCT01663402|17714165|P2|Overall Study|Physician Decision|62
5128277|NCT01663402|17714166|P1|Overall Study|Physician Decision|77
5128278|NCT01663402|17714165|P2|Overall Study|Poor compliance to protocol|454
5128279|NCT01663402|17714166|P1|Overall Study|Poor compliance to protocol|529
5128280|NCT01663402|17714165|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
5128281|NCT01663402|17714166|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
5128282|NCT01663402|17714165|P2|Overall Study|Adverse Event|362
5128283|NCT01663402|17714166|P1|Overall Study|Adverse Event|347
5128284|NCT01663402|17714165|P2|Overall Study|Randomized but not treated|11
5128285|NCT01663402|17714166|P1|Overall Study|Randomized but not treated|19
5128286|NCT01663233|17714229|P2|Overall Study|Lost to Follow-up|1
5128287|NCT01663233|17714230|P1|Overall Study|Lost to Follow-up|0
5128288|NCT01663233|17714229|P2|Overall Study|Protocol Deviation|4
5128289|NCT01663233|17714230|P1|Overall Study|Protocol Deviation|1
5128290|NCT01663233|17714229|P2|Overall Study|Withdrawal by Subject|2
5128291|NCT01663233|17714230|P1|Overall Study|Withdrawal by Subject|3
5128292|NCT01663103|17714254|P2|Overall Study|dog bite|0
5128293|NCT01663103|17714255|P1|Overall Study|dog bite|1
5128294|NCT01663103|17714254|P2|Overall Study|Adverse Event|0
5128295|NCT01663103|17714255|P1|Overall Study|Adverse Event|1
5128296|NCT01663103|17714254|P2|Overall Study|Withdrawal by Subject|2
5128297|NCT01663103|17714255|P1|Overall Study|Withdrawal by Subject|1
5128298|NCT01662999|17714283|P6|Period 3|Withdrawal by Subject|0
5128299|NCT01662999|17714284|P5|Period 3|Withdrawal by Subject|0
5128300|NCT01662999|17714285|P4|Period 3|Withdrawal by Subject|0
5128301|NCT01662999|17714286|P3|Period 3|Withdrawal by Subject|0
5128302|NCT01662999|17714287|P2|Period 3|Withdrawal by Subject|1
5128303|NCT01662999|17714288|P1|Period 3|Withdrawal by Subject|0
5128304|NCT01662986|17714359|P2|Overall Study|Other than stated above|0
5128305|NCT01662986|17714360|P1|Overall Study|Other than stated above|3
5128306|NCT01662986|17714359|P2|Overall Study|Not Treated|0
5128307|NCT01662986|17714360|P1|Overall Study|Not Treated|1
5128308|NCT01662986|17714359|P2|Overall Study|Withdrawal by Subject|2
5128309|NCT01662986|17714360|P1|Overall Study|Withdrawal by Subject|2
5128310|NCT01662986|17714359|P2|Overall Study|Lost to Follow-up|4
5128311|NCT01662986|17714360|P1|Overall Study|Lost to Follow-up|5
5128312|NCT01662986|17714359|P2|Overall Study|Protocol Violation|3
5128313|NCT01662986|17714360|P1|Overall Study|Protocol Violation|2
5128314|NCT01662986|17714359|P2|Overall Study|Adverse Event|4
5128315|NCT01662986|17714360|P1|Overall Study|Adverse Event|5
5128316|NCT01662895|17714448|P2|Overall Study|Lost to Follow-up|1
5128317|NCT01662895|17714449|P1|Overall Study|Lost to Follow-up|0
5128318|NCT01662648|17714573|P2|Overall Study|LOE and Participant non-compliant|1
5128319|NCT01662648|17714574|P1|Overall Study|LOE and Participant non-compliant|0
5128320|NCT01662648|17714573|P2|Overall Study|LOE and other reason unspecified|0
5128321|NCT01662648|17714574|P1|Overall Study|LOE and other reason unspecified|1
5128322|NCT01662648|17714573|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
5128323|NCT01662648|17714574|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
5128324|NCT01662648|17714573|P2|Overall Study|Other|11
5128325|NCT01662648|17714574|P1|Overall Study|Other|8
5128326|NCT01662648|17714573|P2|Overall Study|Participant non-compliant|20
5128327|NCT01662648|17714574|P1|Overall Study|Participant non-compliant|16
5128328|NCT01662648|17714573|P2|Overall Study|Withdrawal by Subject|53
5128329|NCT01662648|17714574|P1|Overall Study|Withdrawal by Subject|36
5128330|NCT01662648|17714573|P2|Overall Study|Lost to Follow-up|36
5128331|NCT01662648|17714574|P1|Overall Study|Lost to Follow-up|24
5128332|NCT01662648|17714573|P2|Overall Study|Participant ineligible to continue trial|1
5128333|NCT01662648|17714574|P1|Overall Study|Participant ineligible to continue trial|1
5128334|NCT01662648|17714573|P2|Overall Study|Lack of Efficacy|16
5128335|NCT01662648|17714574|P1|Overall Study|Lack of Efficacy|17
5128336|NCT01662648|17714573|P2|Overall Study|Adverse Event|37
5128337|NCT01662648|17714574|P1|Overall Study|Adverse Event|40
5128338|NCT01662648|17714573|P2|Overall Study|Death|3
5128339|NCT01662648|17714574|P1|Overall Study|Death|1
5128340|NCT01662635|17714596|P1|Overall Study|scarce samples for evaluation|30
5128341|NCT01662505|17714647|P3|Overall Study|Not specified above|2
5128342|NCT01662505|17714648|P2|Overall Study|Not specified above|3
5128343|NCT01662505|17714649|P1|Overall Study|Not specified above|1
5128344|NCT01662505|17714647|P3|Overall Study|Refused cont. medication|1
5128345|NCT01662505|17714648|P2|Overall Study|Refused cont. medication|0
5128346|NCT01662505|17714649|P1|Overall Study|Refused cont. medication|0
5128347|NCT01662505|17714647|P3|Overall Study|Progressive disease|5
5128348|NCT01662505|17714648|P2|Overall Study|Progressive disease|1
5128349|NCT01662505|17714649|P1|Overall Study|Progressive disease|6
5128350|NCT01662492|17714673|P3|Overall Study|Lack of Efficacy|2
5128351|NCT01662492|17714674|P2|Overall Study|Lack of Efficacy|1
5128352|NCT01662492|17714675|P1|Overall Study|Lack of Efficacy|1
5128353|NCT01662492|17714673|P3|Overall Study|Lost to Follow-up|2
5128354|NCT01662492|17714674|P2|Overall Study|Lost to Follow-up|0
5128355|NCT01662492|17714675|P1|Overall Study|Lost to Follow-up|0
5128356|NCT01662492|17714673|P3|Overall Study|Protocol Violation|0
5128357|NCT01662492|17714674|P2|Overall Study|Protocol Violation|0
5128358|NCT01662492|17714675|P1|Overall Study|Protocol Violation|1
5128359|NCT01662492|17714673|P3|Overall Study|Withdrawal by Subject|1
5128360|NCT01662492|17714674|P2|Overall Study|Withdrawal by Subject|0
5128361|NCT01662492|17714675|P1|Overall Study|Withdrawal by Subject|0
5128362|NCT01662492|17714673|P3|Overall Study|Other miscellaneous reasons.|1
5128363|NCT01662492|17714674|P2|Overall Study|Other miscellaneous reasons.|0
5128364|NCT01662492|17714675|P1|Overall Study|Other miscellaneous reasons.|1
5128365|NCT01662440|17714699|P4|Overall Study|Withdrawal by Subject|2
5128366|NCT01662440|17714700|P3|Overall Study|Withdrawal by Subject|2
5128367|NCT01662440|17714701|P2|Overall Study|Withdrawal by Subject|2
5128368|NCT01662440|17714702|P1|Overall Study|Withdrawal by Subject|5
5128369|NCT01662440|17714699|P4|Overall Study|Protocol Violation|0
5128370|NCT01662440|17714700|P3|Overall Study|Protocol Violation|0
5128371|NCT01662440|17714701|P2|Overall Study|Protocol Violation|0
5128372|NCT01662440|17714702|P1|Overall Study|Protocol Violation|1
5128373|NCT01662440|17714699|P4|Overall Study|Subject moved to another country.|0
5128374|NCT01662440|17714700|P3|Overall Study|Subject moved to another country.|0
5128375|NCT01662440|17714701|P2|Overall Study|Subject moved to another country.|1
5128376|NCT01662440|17714702|P1|Overall Study|Subject moved to another country.|0
5128377|NCT01662440|17714699|P4|Overall Study|Lost to Follow-up|1
5128378|NCT01662440|17714700|P3|Overall Study|Lost to Follow-up|4
5128379|NCT01662440|17714701|P2|Overall Study|Lost to Follow-up|2
5128380|NCT01662440|17714702|P1|Overall Study|Lost to Follow-up|2
5128381|NCT01662440|17714699|P4|Overall Study|Death|0
5128382|NCT01662440|17714700|P3|Overall Study|Death|0
5128383|NCT01662440|17714701|P2|Overall Study|Death|1
5128384|NCT01662440|17714702|P1|Overall Study|Death|0
5128385|NCT01662440|17714699|P4|Overall Study|Adverse Event|1
5128386|NCT01662440|17714700|P3|Overall Study|Adverse Event|0
5128387|NCT01662440|17714701|P2|Overall Study|Adverse Event|0
5128388|NCT01662440|17714702|P1|Overall Study|Adverse Event|1
5128389|NCT01662362|17714750|P1|Overall Study|Lost to Follow-up|38
5128390|NCT01662336|17714755|P1|Overall Study|Withdrawal by Subject|6
5128391|NCT01662336|17714755|P1|Overall Study|Other|29
5128392|NCT01662336|17714755|P1|Overall Study|No longer on LPV/r|30
5128393|NCT01662336|17714755|P1|Overall Study|Adverse Event|1
5128394|NCT01662310|17714781|P5|Open-Label Extension Phase|Withdrawal by Subject|7
5128395|NCT01662310|17714782|P4|Open-Label Extension Phase|Withdrawal by Subject|2
5128396|NCT01662310|17714783|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5128397|NCT01662310|17714784|P2|Open-Label Extension Phase|Withdrawal by Subject|0
5128398|NCT01662310|17714785|P1|Open-Label Extension Phase|Withdrawal by Subject|0
5128399|NCT01662310|17714781|P5|Open-Label Extension Phase|Pregnancy|0
5128400|NCT01662310|17714782|P4|Open-Label Extension Phase|Pregnancy|1
5128401|NCT01662310|17714783|P3|Open-Label Extension Phase|Pregnancy|0
5128402|NCT01662310|17714784|P2|Open-Label Extension Phase|Pregnancy|0
5128403|NCT01662310|17714785|P1|Open-Label Extension Phase|Pregnancy|0
5128404|NCT01662310|17714781|P5|Open-Label Extension Phase|Lost to Follow-up|1
5128405|NCT01662310|17714782|P4|Open-Label Extension Phase|Lost to Follow-up|2
5128406|NCT01662310|17714783|P3|Open-Label Extension Phase|Lost to Follow-up|0
5128407|NCT01662310|17714784|P2|Open-Label Extension Phase|Lost to Follow-up|0
5128408|NCT01662310|17714785|P1|Open-Label Extension Phase|Lost to Follow-up|0
5128409|NCT01662310|17714781|P5|Open-Label Extension Phase|Lack of Efficacy|2
5128410|NCT01662310|17714782|P4|Open-Label Extension Phase|Lack of Efficacy|2
5128411|NCT01662310|17714783|P3|Open-Label Extension Phase|Lack of Efficacy|0
5128412|NCT01662310|17714784|P2|Open-Label Extension Phase|Lack of Efficacy|0
5128413|NCT01662310|17714785|P1|Open-Label Extension Phase|Lack of Efficacy|0
5128414|NCT01662310|17714781|P5|Open-Label Extension Phase|Death|0
5128415|NCT01662310|17714782|P4|Open-Label Extension Phase|Death|1
5128416|NCT01662310|17714783|P3|Open-Label Extension Phase|Death|0
5128417|NCT01662310|17714784|P2|Open-Label Extension Phase|Death|0
5128418|NCT01662310|17714785|P1|Open-Label Extension Phase|Death|0
5128419|NCT01662310|17714781|P5|Open-Label Extension Phase|Adverse Event|0
5128420|NCT01662310|17714782|P4|Open-Label Extension Phase|Adverse Event|3
5128421|NCT01662310|17714783|P3|Open-Label Extension Phase|Adverse Event|0
5128422|NCT01662310|17714784|P2|Open-Label Extension Phase|Adverse Event|0
5128423|NCT01662310|17714785|P1|Open-Label Extension Phase|Adverse Event|0
5128424|NCT01662310|17714781|P5|Double-Blind Phase|Randomized but not treated|0
5128425|NCT01662310|17714782|P4|Double-Blind Phase|Randomized but not treated|0
5128426|NCT01662310|17714783|P3|Double-Blind Phase|Randomized but not treated|0
5128427|NCT01662310|17714784|P2|Double-Blind Phase|Randomized but not treated|1
5128428|NCT01662310|17714785|P1|Double-Blind Phase|Randomized but not treated|0
5128429|NCT01662310|17714781|P5|Double-Blind Phase|Other|0
5128430|NCT01662310|17714782|P4|Double-Blind Phase|Other|0
5128431|NCT01662310|17714783|P3|Double-Blind Phase|Other|1
5128432|NCT01662310|17714784|P2|Double-Blind Phase|Other|0
5128433|NCT01662310|17714785|P1|Double-Blind Phase|Other|0
5128434|NCT01662310|17714781|P5|Double-Blind Phase|Withdrawal by Subject|0
5128435|NCT01662310|17714782|P4|Double-Blind Phase|Withdrawal by Subject|0
5128436|NCT01662310|17714783|P3|Double-Blind Phase|Withdrawal by Subject|3
5128437|NCT01662310|17714784|P2|Double-Blind Phase|Withdrawal by Subject|9
5128438|NCT01662310|17714785|P1|Double-Blind Phase|Withdrawal by Subject|0
5128439|NCT01662310|17714781|P5|Double-Blind Phase|Pregnancy|0
5128440|NCT01662310|17714782|P4|Double-Blind Phase|Pregnancy|0
5128441|NCT01662310|17714783|P3|Double-Blind Phase|Pregnancy|0
5128442|NCT01662310|17714784|P2|Double-Blind Phase|Pregnancy|2
5128443|NCT01662310|17714785|P1|Double-Blind Phase|Pregnancy|0
5128444|NCT01662310|17714781|P5|Double-Blind Phase|Lost to Follow-up|0
5128445|NCT01662310|17714782|P4|Double-Blind Phase|Lost to Follow-up|0
5128446|NCT01662310|17714783|P3|Double-Blind Phase|Lost to Follow-up|0
5128447|NCT01662310|17714784|P2|Double-Blind Phase|Lost to Follow-up|3
5128448|NCT01662310|17714785|P1|Double-Blind Phase|Lost to Follow-up|0
5128449|NCT01662310|17714781|P5|Double-Blind Phase|Adverse Event|0
5128450|NCT01662310|17714782|P4|Double-Blind Phase|Adverse Event|0
5128451|NCT01662310|17714783|P3|Double-Blind Phase|Adverse Event|1
5128452|NCT01662310|17714784|P2|Double-Blind Phase|Adverse Event|0
5128453|NCT01662310|17714785|P1|Double-Blind Phase|Adverse Event|0
5128454|NCT01662310|17714781|P5|Run-In or Stabilization Phase|Other|0
5128455|NCT01662310|17714782|P4|Run-In or Stabilization Phase|Other|0
5128456|NCT01662310|17714783|P3|Run-In or Stabilization Phase|Other|0
5128457|NCT01662310|17714784|P2|Run-In or Stabilization Phase|Other|0
5128458|NCT01662310|17714785|P1|Run-In or Stabilization Phase|Other|1
5128459|NCT01662310|17714781|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
5128460|NCT01662310|17714782|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
5128461|NCT01662310|17714783|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
5128462|NCT01662310|17714784|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
5128463|NCT01662310|17714785|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
5128464|NCT01662310|17714781|P5|Run-In or Stabilization Phase|Protocol Violation|0
5128465|NCT01662310|17714782|P4|Run-In or Stabilization Phase|Protocol Violation|0
5128466|NCT01662310|17714783|P3|Run-In or Stabilization Phase|Protocol Violation|0
5128467|NCT01662310|17714784|P2|Run-In or Stabilization Phase|Protocol Violation|0
5128468|NCT01662310|17714785|P1|Run-In or Stabilization Phase|Protocol Violation|15
5128469|NCT01662310|17714781|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
5128470|NCT01662310|17714782|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
5128471|NCT01662310|17714783|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
5128472|NCT01662310|17714784|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
5128473|NCT01662310|17714785|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
5128474|NCT01662310|17714781|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
5128475|NCT01662310|17714782|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
5128476|NCT01662310|17714783|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
5128477|NCT01662310|17714784|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
5128478|NCT01662310|17714785|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
5128479|NCT01662310|17714781|P5|Run-In or Stabilization Phase|Adverse Event|0
5128480|NCT01662310|17714782|P4|Run-In or Stabilization Phase|Adverse Event|0
5128481|NCT01662310|17714783|P3|Run-In or Stabilization Phase|Adverse Event|0
5128482|NCT01662310|17714784|P2|Run-In or Stabilization Phase|Adverse Event|0
5128483|NCT01662310|17714785|P1|Run-In or Stabilization Phase|Adverse Event|11
5128484|NCT01662102|17714866|P2|Overall Study|Sponsor's decision|0
5128485|NCT01662102|17714867|P1|Overall Study|Sponsor's decision|1
5128486|NCT01662063|17714875|P3|Overall Study|Other|0
5128487|NCT01662063|17714876|P2|Overall Study|Other|1
5128488|NCT01662063|17714877|P1|Overall Study|Other|0
5128489|NCT01662063|17714875|P3|Overall Study|Physician Decision|0
5128490|NCT01662063|17714876|P2|Overall Study|Physician Decision|2
5128491|NCT01662063|17714877|P1|Overall Study|Physician Decision|0
5128492|NCT01662063|17714875|P3|Overall Study|Withdrawal by Subject|1
5128493|NCT01662063|17714876|P2|Overall Study|Withdrawal by Subject|4
5128494|NCT01662063|17714877|P1|Overall Study|Withdrawal by Subject|2
5128495|NCT01662063|17714875|P3|Overall Study|Protocol Violation|0
5128496|NCT01662063|17714876|P2|Overall Study|Protocol Violation|0
5128497|NCT01662063|17714877|P1|Overall Study|Protocol Violation|1
5128498|NCT01662063|17714875|P3|Overall Study|Lost to Follow-up|0
5128499|NCT01662063|17714876|P2|Overall Study|Lost to Follow-up|4
5128500|NCT01662063|17714877|P1|Overall Study|Lost to Follow-up|0
5128501|NCT01662063|17714875|P3|Overall Study|Lack of Efficacy|0
5128502|NCT01662063|17714876|P2|Overall Study|Lack of Efficacy|6
5128503|NCT01662063|17714877|P1|Overall Study|Lack of Efficacy|1
5128504|NCT01662063|17714875|P3|Overall Study|Adverse Event or Intercurrent Illness|0
5128505|NCT01662063|17714876|P2|Overall Study|Adverse Event or Intercurrent Illness|12
5128506|NCT01662063|17714877|P1|Overall Study|Adverse Event or Intercurrent Illness|1
5128507|NCT01662024|17714956|P1|Overall Study|Withdrawal by Subject|3
5128508|NCT01662024|17714956|P1|Overall Study|Pregnancy|2
5128509|NCT01661972|17714968|P2|Overall Study|Withdrawal by Subject|1
5128510|NCT01661972|17714969|P1|Overall Study|Withdrawal by Subject|0
5128511|NCT01661972|17714968|P2|Overall Study|Death during Treatment period|1
5128512|NCT01661972|17714969|P1|Overall Study|Death during Treatment period|1
5128513|NCT01661972|17714968|P2|Overall Study|Adverse Event|2
5128514|NCT01661972|17714969|P1|Overall Study|Adverse Event|1
5128515|NCT01661933|17714988|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
5128516|NCT01661933|17714988|P1|Low-dose Gluten Challenge|Physician Decision|2
5128517|NCT01661881|17714995|P1|Overall Study|Disease Progression|1
5128518|NCT01661790|17715003|P2|Overall Study|Lost to Follow-up|2
5128519|NCT01661790|17715004|P1|Overall Study|Lost to Follow-up|0
5128520|NCT01661686|17715104|P2|Overall Study|did not receive allocated intervention|1
5128521|NCT01661686|17715105|P1|Overall Study|did not receive allocated intervention|0
5128522|NCT01661686|17715104|P2|Overall Study|Lost to Follow-up|1
5128523|NCT01661686|17715105|P1|Overall Study|Lost to Follow-up|2
5128524|NCT01661595|17715146|P4|Phase 2: Week 5-8.|Protocol Violation|0
5128525|NCT01661595|17715147|P3|Phase 2: Week 5-8.|Protocol Violation|1
5128526|NCT01661595|17715148|P2|Phase 2: Week 5-8.|Protocol Violation|0
5128527|NCT01661595|17715149|P1|Phase 2: Week 5-8.|Protocol Violation|0
5128528|NCT01661595|17715146|P4|Phase 1: Week 0-4|Adverse Event|0
5128529|NCT01661595|17715147|P3|Phase 1: Week 0-4|Adverse Event|0
5128530|NCT01661595|17715148|P2|Phase 1: Week 0-4|Adverse Event|0
5128531|NCT01661595|17715149|P1|Phase 1: Week 0-4|Adverse Event|1
5128532|NCT01661205|17715277|P1|Overall Study|Physician Decision|2
5128533|NCT01661179|17715288|P1|Overall Study|Other Eligibility criteria|4
5128534|NCT01661179|17715288|P1|Overall Study|Withdrawal by Subject|1
5128535|NCT01661179|17715288|P1|Overall Study|Death|1
5128536|NCT01661140|17715292|P3|Double-Blind Period|Administrative/Other|6
5128537|NCT01661140|17715293|P2|Double-Blind Period|Administrative/Other|7
5128538|NCT01661140|17715294|P1|Double-Blind Period|Administrative/Other|0
5128539|NCT01661140|17715292|P3|Double-Blind Period|Sponsor Termination|17
5128540|NCT01661140|17715293|P2|Double-Blind Period|Sponsor Termination|14
5128541|NCT01661140|17715294|P1|Double-Blind Period|Sponsor Termination|0
5128542|NCT01661140|17715292|P3|Double-Blind Period|Investigator's Decision|2
5128543|NCT01661140|17715293|P2|Double-Blind Period|Investigator's Decision|1
5128544|NCT01661140|17715294|P1|Double-Blind Period|Investigator's Decision|0
5128545|NCT01661140|17715292|P3|Double-Blind Period|Withdrawal by Subject|3
5128546|NCT01661140|17715293|P2|Double-Blind Period|Withdrawal by Subject|1
5128547|NCT01661140|17715294|P1|Double-Blind Period|Withdrawal by Subject|0
5128548|NCT01661140|17715292|P3|Double-Blind Period|Protocol Violation|3
5128549|NCT01661140|17715293|P2|Double-Blind Period|Protocol Violation|2
5128550|NCT01661140|17715294|P1|Double-Blind Period|Protocol Violation|0
5128551|NCT01661140|17715292|P3|Double-Blind Period|Adverse Event|18
5128552|NCT01661140|17715293|P2|Double-Blind Period|Adverse Event|16
5128553|NCT01661140|17715294|P1|Double-Blind Period|Adverse Event|0
5128554|NCT01661140|17715292|P3|Double-Blind Period|Refused Treatment|1
5128555|NCT01661140|17715293|P2|Double-Blind Period|Refused Treatment|0
5128556|NCT01661140|17715294|P1|Double-Blind Period|Refused Treatment|0
5128557|NCT01661140|17715292|P3|Open-Label Period|Lost to Follow-up|0
5128558|NCT01661140|17715293|P2|Open-Label Period|Lost to Follow-up|0
5128559|NCT01661140|17715294|P1|Open-Label Period|Lost to Follow-up|2
5128560|NCT01661140|17715292|P3|Open-Label Period|Did not meet EULAR criteria|0
5128561|NCT01661140|17715293|P2|Open-Label Period|Did not meet EULAR criteria|0
5128562|NCT01661140|17715294|P1|Open-Label Period|Did not meet EULAR criteria|1
5128563|NCT01661140|17715292|P3|Open-Label Period|Sponsor termination|0
5128564|NCT01661140|17715293|P2|Open-Label Period|Sponsor termination|0
5128565|NCT01661140|17715294|P1|Open-Label Period|Sponsor termination|16
5128566|NCT01661140|17715292|P3|Open-Label Period|Administrative/Other|0
5128567|NCT01661140|17715293|P2|Open-Label Period|Administrative/Other|0
5128568|NCT01661140|17715294|P1|Open-Label Period|Administrative/Other|1
5128569|NCT01661140|17715292|P3|Open-Label Period|Death|0
5128570|NCT01661140|17715293|P2|Open-Label Period|Death|0
5128571|NCT01661140|17715294|P1|Open-Label Period|Death|1
5128572|NCT01661140|17715292|P3|Open-Label Period|Investigator Decision|0
5128573|NCT01661140|17715293|P2|Open-Label Period|Investigator Decision|0
5128574|NCT01661140|17715294|P1|Open-Label Period|Investigator Decision|3
5128575|NCT01661140|17715292|P3|Open-Label Period|Withdrawal by Subject|0
5128576|NCT01661140|17715293|P2|Open-Label Period|Withdrawal by Subject|0
5128577|NCT01661140|17715294|P1|Open-Label Period|Withdrawal by Subject|5
5128578|NCT01661140|17715292|P3|Open-Label Period|Protocol Violation|0
5128579|NCT01661140|17715293|P2|Open-Label Period|Protocol Violation|0
5128580|NCT01661140|17715294|P1|Open-Label Period|Protocol Violation|3
5128581|NCT01661140|17715292|P3|Open-Label Period|Adverse Event|0
5128582|NCT01661140|17715293|P2|Open-Label Period|Adverse Event|0
5128583|NCT01661140|17715294|P1|Open-Label Period|Adverse Event|44
5128584|NCT01661062|17715346|P1|Overall Study|Withdrawal by Subject|2
5128585|NCT01661062|17715346|P1|Overall Study|Completed Treatment Off Study|3
5128586|NCT01660906|17715351|P1|Overall Study|Discontinued due to study drug toxicity|3
5128587|NCT01660763|17715434|P2|Overall Study|Patient ready for early discharge|4
5128588|NCT01660763|17715435|P1|Overall Study|Patient ready for early discharge|28
5128589|NCT01660763|17715434|P2|Overall Study|Withdrawal by Subject|0
5128590|NCT01660763|17715435|P1|Overall Study|Withdrawal by Subject|4
5128591|NCT01660763|17715434|P2|Overall Study|Protocol Violation|0
5128592|NCT01660763|17715435|P1|Overall Study|Protocol Violation|1
5128593|NCT01660763|17715434|P2|Overall Study|Adverse Event|7
5128594|NCT01660763|17715435|P1|Overall Study|Adverse Event|22
5128595|NCT01660763|17715434|P2|Overall Study|Lack of Efficacy|50
5128596|NCT01660763|17715435|P1|Overall Study|Lack of Efficacy|45
5128597|NCT01660451|17715483|P3|Overall Study|Ongoing with treatment|46
5128598|NCT01660451|17715484|P2|Overall Study|Ongoing with treatment|3
5128599|NCT01660451|17715485|P1|Overall Study|Ongoing with treatment|3
5128600|NCT01660451|17715483|P3|Overall Study|Withdrawal by Subject|16
5128601|NCT01660451|17715484|P2|Overall Study|Withdrawal by Subject|0
5128602|NCT01660451|17715485|P1|Overall Study|Withdrawal by Subject|1
5128603|NCT01660451|17715483|P3|Overall Study|Physician Decision|5
5128604|NCT01660451|17715484|P2|Overall Study|Physician Decision|2
5128605|NCT01660451|17715485|P1|Overall Study|Physician Decision|1
5128606|NCT01660451|17715483|P3|Overall Study|Protocol Deviation|1
5128607|NCT01660451|17715484|P2|Overall Study|Protocol Deviation|0
5128608|NCT01660451|17715485|P1|Overall Study|Protocol Deviation|0
5128609|NCT01660451|17715483|P3|Overall Study|Sponsor Decision|1
5128610|NCT01660451|17715484|P2|Overall Study|Sponsor Decision|0
5128611|NCT01660451|17715485|P1|Overall Study|Sponsor Decision|0
5128612|NCT01660451|17715483|P3|Overall Study|AE with Clinical PD|9
5128613|NCT01660451|17715484|P2|Overall Study|AE with Clinical PD|3
5128614|NCT01660451|17715485|P1|Overall Study|AE with Clinical PD|1
5128615|NCT01660451|17715483|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
5128616|NCT01660451|17715484|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
5128617|NCT01660451|17715485|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
5128618|NCT01660451|17715483|P3|Overall Study|Protocol Violation|1
5128619|NCT01660451|17715484|P2|Overall Study|Protocol Violation|1
5128620|NCT01660451|17715485|P1|Overall Study|Protocol Violation|0
5128621|NCT01660412|17715513|P2|Overall Study|Protocol Violation|3
5128622|NCT01660412|17715514|P1|Overall Study|Protocol Violation|0
5128623|NCT01660334|17715520|P1|Overall Study|Lost to Follow-up|1
5128624|NCT01660022|17715763|P6|First Sequence (7 Days)|Protocol Violation|1
5128625|NCT01660022|17715764|P5|First Sequence (7 Days)|Protocol Violation|0
5128626|NCT01660022|17715765|P4|First Sequence (7 Days)|Protocol Violation|0
5128627|NCT01660022|17715766|P3|First Sequence (7 Days)|Protocol Violation|0
5128628|NCT01660022|17715767|P2|First Sequence (7 Days)|Protocol Violation|0
5128629|NCT01660022|17715768|P1|First Sequence (7 Days)|Protocol Violation|0
5128630|NCT01660022|17715763|P6|First Sequence (7 Days)|Adverse Event|3
5128631|NCT01660022|17715764|P5|First Sequence (7 Days)|Adverse Event|1
5128632|NCT01660022|17715765|P4|First Sequence (7 Days)|Adverse Event|0
5128633|NCT01660022|17715766|P3|First Sequence (7 Days)|Adverse Event|0
5128634|NCT01660022|17715767|P2|First Sequence (7 Days)|Adverse Event|0
5128635|NCT01660022|17715768|P1|First Sequence (7 Days)|Adverse Event|0
5128636|NCT01660022|17715763|P6|First Sequence (7 Days)|Withdrawal by Subject|0
5128637|NCT01660022|17715764|P5|First Sequence (7 Days)|Withdrawal by Subject|0
5128638|NCT01660022|17715765|P4|First Sequence (7 Days)|Withdrawal by Subject|1
5128639|NCT01660022|17715766|P3|First Sequence (7 Days)|Withdrawal by Subject|0
5128640|NCT01660022|17715767|P2|First Sequence (7 Days)|Withdrawal by Subject|1
5128641|NCT01660022|17715768|P1|First Sequence (7 Days)|Withdrawal by Subject|0
5128642|NCT01659996|17715827|P3|Overall Study|Withdrawal by Subject|5
5128643|NCT01659996|17715828|P2|Overall Study|Withdrawal by Subject|1
5128644|NCT01659996|17715829|P1|Overall Study|Withdrawal by Subject|4
5128645|NCT01659996|17715827|P3|Overall Study|Adverse Event|1
5128646|NCT01659996|17715828|P2|Overall Study|Adverse Event|0
5128647|NCT01659996|17715829|P1|Overall Study|Adverse Event|0
5128648|NCT01659996|17715827|P3|Overall Study|Lost to Follow-up|2
5128649|NCT01659996|17715828|P2|Overall Study|Lost to Follow-up|3
5128650|NCT01659996|17715829|P1|Overall Study|Lost to Follow-up|1
5128651|NCT01659996|17715827|P3|Overall Study|Protocol Violation|3
5128652|NCT01659996|17715828|P2|Overall Study|Protocol Violation|3
5128653|NCT01659996|17715829|P1|Overall Study|Protocol Violation|3
5128654|NCT01659853|17715870|P2|Washout , 3 to 7 Days|Protocol Violation|0
5128655|NCT01659853|17715871|P1|Washout , 3 to 7 Days|Protocol Violation|1
5128656|NCT01659853|17715870|P2|Washout , 3 to 7 Days|Adverse Event|0
5128657|NCT01659853|17715871|P1|Washout , 3 to 7 Days|Adverse Event|1
5128658|NCT01659736|17715881|P2|3-month Follow-up|Lost to Follow-up|1
5128659|NCT01659736|17715882|P1|3-month Follow-up|Lost to Follow-up|0
5128660|NCT01659736|17715881|P2|Treatment Period|Withdrawal by Subject|0
5128661|NCT01659736|17715882|P1|Treatment Period|Withdrawal by Subject|1
5128662|NCT01659736|17715881|P2|Treatment Period|Protocol Violation|1
5128663|NCT01659736|17715882|P1|Treatment Period|Protocol Violation|3
5128664|NCT01659736|17715881|P2|Treatment Period|Adverse Event|1
5128665|NCT01659736|17715882|P1|Treatment Period|Adverse Event|1
5128666|NCT01659567|17715896|P1|Overall Study|Other|13
5128667|NCT01659567|17715896|P1|Overall Study|Progression of the main disease|1
5128668|NCT01659567|17715896|P1|Overall Study|Withdrawal by Subject|64
5128669|NCT01659567|17715896|P1|Overall Study|Good result at early stage of treatment|5
5128670|NCT01659567|17715896|P1|Overall Study|Adverse Event|12
5128671|NCT01659567|17715896|P1|Overall Study|Switched to Pegferon|6
5128672|NCT01659567|17715896|P1|Overall Study|Lack of Efficacy|22
5128673|NCT01659554|17715913|P1|Overall Study|Study Termination|4
5128674|NCT01659320|17715920|P1|Overall Study|Physician Decision|1
5128675|NCT01659320|17715920|P1|Overall Study|Withdrawal by Subject|2
5128676|NCT01659125|17715939|P1|Overall Study|Failed to Start Treatment|2
5128677|NCT01659125|17715939|P1|Overall Study|Time Constraints|2
5128678|NCT01659125|17715939|P1|Overall Study|Technical Problem|1
5128679|NCT01659125|17715939|P1|Overall Study|Lost to Follow-up|7
5128680|NCT01659125|17715939|P1|Overall Study|Withdrawal by Subject|2
5128681|NCT01659021|17715946|P2|Long-Term Follow Up|Withdrawal by Subject|1
5128682|NCT01659021|17715947|P1|Long-Term Follow Up|Withdrawal by Subject|2
5128683|NCT01659021|17715946|P2|Long-Term Follow Up|Lost to Follow-up|3
5128684|NCT01659021|17715947|P1|Long-Term Follow Up|Lost to Follow-up|3
5128685|NCT01659021|17715946|P2|Main Study|Study Terminated by Sponsor|1
5128686|NCT01659021|17715947|P1|Main Study|Study Terminated by Sponsor|16
5128687|NCT01659021|17715946|P2|Main Study|Withdrawal by Subject|16
5128688|NCT01659021|17715947|P1|Main Study|Withdrawal by Subject|19
5128689|NCT01659021|17715946|P2|Main Study|Physician Decision|16
5128690|NCT01659021|17715947|P1|Main Study|Physician Decision|34
5128691|NCT01659021|17715946|P2|Main Study|Unknown Reasons|1
5128692|NCT01659021|17715947|P1|Main Study|Unknown Reasons|2
5128693|NCT01659021|17715946|P2|Main Study|Lost to Follow-up|0
5128694|NCT01659021|17715947|P1|Main Study|Lost to Follow-up|1
5128695|NCT01659021|17715946|P2|Main Study|Adverse Event|3
5128696|NCT01659021|17715947|P1|Main Study|Adverse Event|2
5128697|NCT01658943|17715965|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
5128698|NCT01658943|17715966|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
5128699|NCT01658943|17715965|P2|Overall Study|Not eligible|9
5128700|NCT01658943|17715966|P1|Overall Study|Not eligible|7
5128701|NCT01658943|17715965|P2|Overall Study|not protocol specified|1
5128702|NCT01658943|17715966|P1|Overall Study|not protocol specified|4
5128703|NCT01658943|17715965|P2|Overall Study|Death|2
5128704|NCT01658943|17715966|P1|Overall Study|Death|4
5128705|NCT01658943|17715965|P2|Overall Study|Progression/Relapse|40
5128706|NCT01658943|17715966|P1|Overall Study|Progression/Relapse|39
5128707|NCT01658943|17715965|P2|Overall Study|Withdrawal by Subject|2
5128708|NCT01658943|17715966|P1|Overall Study|Withdrawal by Subject|9
5128709|NCT01658943|17715965|P2|Overall Study|Adverse Event|13
5128710|NCT01658943|17715966|P1|Overall Study|Adverse Event|6
5128711|NCT01658904|17715981|P3|Overall Study|Principal Investigator discretion|0
5128712|NCT01658904|17715982|P2|Overall Study|Principal Investigator discretion|0
5128713|NCT01658904|17715983|P1|Overall Study|Principal Investigator discretion|2
5128714|NCT01658813|17716009|P1|Overall Study|Disease progression|3
5128715|NCT01658735|17716020|P3|Overall Study|Withdrawal by Subject|3
5128716|NCT01658735|17716021|P2|Overall Study|Withdrawal by Subject|5
5128717|NCT01658735|17716022|P1|Overall Study|Withdrawal by Subject|3
5128718|NCT01658735|17716020|P3|Overall Study|Protocol Violation|0
5128719|NCT01658735|17716021|P2|Overall Study|Protocol Violation|1
5128720|NCT01658735|17716022|P1|Overall Study|Protocol Violation|0
5128721|NCT01658735|17716020|P3|Overall Study|Lost to Follow-up|0
5128722|NCT01658735|17716021|P2|Overall Study|Lost to Follow-up|1
5128723|NCT01658735|17716022|P1|Overall Study|Lost to Follow-up|1
5128724|NCT01658735|17716020|P3|Overall Study|Lack of Efficacy|1
5128725|NCT01658735|17716021|P2|Overall Study|Lack of Efficacy|0
5128726|NCT01658735|17716022|P1|Overall Study|Lack of Efficacy|1
5128727|NCT01658579|17716064|P4|Treatment Period B|Other|1
5128728|NCT01658579|17716065|P3|Treatment Period B|Other|0
5128729|NCT01658579|17716066|P2|Treatment Period B|Other|0
5128730|NCT01658579|17716067|P1|Treatment Period B|Other|0
5128731|NCT01658579|17716064|P4|Treatment Period A|Adverse Event|0
5128732|NCT01658579|17716065|P3|Treatment Period A|Adverse Event|0
5128733|NCT01658579|17716066|P2|Treatment Period A|Adverse Event|0
5128734|NCT01658579|17716067|P1|Treatment Period A|Adverse Event|1
5128735|NCT01658579|17716064|P4|Treatment Period A|Other|1
5128736|NCT01658579|17716065|P3|Treatment Period A|Other|1
5128737|NCT01658579|17716066|P2|Treatment Period A|Other|0
5128738|NCT01658579|17716067|P1|Treatment Period A|Other|0
5128739|NCT01658514|17716095|P3|Overall Study|Protocol Violation|2
5128740|NCT01658514|17716096|P2|Overall Study|Protocol Violation|0
5128741|NCT01658514|17716097|P1|Overall Study|Protocol Violation|1
5128742|NCT01658436|17716108|P2|Overall Study|Death|0
5128743|NCT01658436|17716109|P1|Overall Study|Death|1
5128744|NCT01658436|17716108|P2|Overall Study|Subject/guardian decision|1
5128745|NCT01658436|17716109|P1|Overall Study|Subject/guardian decision|0
5128746|NCT01658436|17716108|P2|Overall Study|Study terminated by sponsor|1
5128747|NCT01658436|17716109|P1|Overall Study|Study terminated by sponsor|0
5128748|NCT01658436|17716108|P2|Overall Study|Progressive disease|4
5128749|NCT01658436|17716109|P1|Overall Study|Progressive disease|12
5128750|NCT01658436|17716108|P2|Overall Study|Physician Decision|0
5128751|NCT01658436|17716109|P1|Overall Study|Physician Decision|1
5128752|NCT01658436|17716108|P2|Overall Study|Adverse Event|5
5128753|NCT01658436|17716109|P1|Overall Study|Adverse Event|6
5128754|NCT01658150|17716129|P1|Overall Study|Withdrawal by Subject|1
5128755|NCT01658072|17716151|P2|Overall Study|Protocol Violation|2
5128756|NCT01658072|17716152|P1|Overall Study|Protocol Violation|4
5128757|NCT01658020|17716167|P2|Overall Study|Protocol Violation|1
5128758|NCT01658020|17716168|P1|Overall Study|Protocol Violation|0
5128759|NCT01658020|17716167|P2|Overall Study|Withdrawal by Subject|5
5128760|NCT01658020|17716168|P1|Overall Study|Withdrawal by Subject|4
5128761|NCT01658020|17716167|P2|Overall Study|Lost to Follow-up|0
5128762|NCT01658020|17716168|P1|Overall Study|Lost to Follow-up|1
5128763|NCT01658020|17716167|P2|Overall Study|Adverse Event|3
5128764|NCT01658020|17716168|P1|Overall Study|Adverse Event|3
5128765|NCT01657903|17716184|P1|Overall Study|Withdrawal by Subject|1
5128766|NCT01657903|17716184|P1|Overall Study|Lost to Follow-up|1
5128767|NCT01657877|17716206|P1|Overall Study|Other Reason|2
5128768|NCT01657877|17716206|P1|Overall Study|Adverse Event|2
5128769|NCT01657877|17716206|P1|Overall Study|Protocol Violation|6
5128770|NCT01657877|17716206|P1|Overall Study|Withdrawal by Subject|4
5128771|NCT01657799|17716226|P3|Overall Study|Other|49
5128772|NCT01657799|17716227|P2|Overall Study|Other|62
5128773|NCT01657799|17716228|P1|Overall Study|Other|52
5128774|NCT01657799|17716226|P3|Overall Study|Radiographic & Clinical Progression|15
5128775|NCT01657799|17716227|P2|Overall Study|Radiographic & Clinical Progression|11
5128776|NCT01657799|17716228|P1|Overall Study|Radiographic & Clinical Progression|16
5128777|NCT01657799|17716226|P3|Overall Study|Progressive Disease Clinical|7
5128778|NCT01657799|17716227|P2|Overall Study|Progressive Disease Clinical|4
5128779|NCT01657799|17716228|P1|Overall Study|Progressive Disease Clinical|7
5128780|NCT01657799|17716226|P3|Overall Study|Disease Progression|4
5128781|NCT01657799|17716227|P2|Overall Study|Disease Progression|4
5128782|NCT01657799|17716228|P1|Overall Study|Disease Progression|2
5128783|NCT01657799|17716226|P3|Overall Study|Lost to Follow-up|1
5128784|NCT01657799|17716227|P2|Overall Study|Lost to Follow-up|0
5128785|NCT01657799|17716228|P1|Overall Study|Lost to Follow-up|1
5128786|NCT01657799|17716226|P3|Overall Study|Withdrawal by Subject|10
5128787|NCT01657799|17716227|P2|Overall Study|Withdrawal by Subject|10
5128788|NCT01657799|17716228|P1|Overall Study|Withdrawal by Subject|13
5128789|NCT01657799|17716226|P3|Overall Study|Adverse Event Not Related to Progression|4
5128790|NCT01657799|17716227|P2|Overall Study|Adverse Event Not Related to Progression|4
5128791|NCT01657799|17716228|P1|Overall Study|Adverse Event Not Related to Progression|5
5128792|NCT01657799|17716226|P3|Overall Study|Adverse Event Related to progression|12
5128793|NCT01657799|17716227|P2|Overall Study|Adverse Event Related to progression|8
5128794|NCT01657799|17716228|P1|Overall Study|Adverse Event Related to progression|6
5128795|NCT01657760|17716247|P4|Overall Study|Physician Decision|2
5128796|NCT01657760|17716248|P3|Overall Study|Physician Decision|1
5128797|NCT01657760|17716249|P2|Overall Study|Physician Decision|1
5128798|NCT01657760|17716250|P1|Overall Study|Physician Decision|1
5128799|NCT01657760|17716247|P4|Overall Study|Withdrawal by Subject|1
5128800|NCT01657760|17716248|P3|Overall Study|Withdrawal by Subject|0
5128801|NCT01657760|17716249|P2|Overall Study|Withdrawal by Subject|0
5128802|NCT01657760|17716250|P1|Overall Study|Withdrawal by Subject|0
5128803|NCT01657461|17716269|P2|Overall Study|Withdrawal by Subject|3
5128804|NCT01657461|17716270|P1|Overall Study|Withdrawal by Subject|1
5128805|NCT01657461|17716269|P2|Overall Study|Physician Decision|2
5128806|NCT01657461|17716270|P1|Overall Study|Physician Decision|0
5128807|NCT01657461|17716269|P2|Overall Study|Lost to Follow-up|3
5128808|NCT01657461|17716270|P1|Overall Study|Lost to Follow-up|0
5128809|NCT01657461|17716269|P2|Overall Study|Death|12
5128810|NCT01657461|17716270|P1|Overall Study|Death|9
5128811|NCT01657370|17716300|P6|Overall Study|Lost to Follow-up|1
5128812|NCT01657370|17716301|P5|Overall Study|Lost to Follow-up|0
5128813|NCT01657370|17716302|P4|Overall Study|Lost to Follow-up|0
5128814|NCT01657370|17716303|P3|Overall Study|Lost to Follow-up|1
5128815|NCT01657370|17716304|P2|Overall Study|Lost to Follow-up|0
5128816|NCT01657370|17716305|P1|Overall Study|Lost to Follow-up|2
5128817|NCT01657370|17716300|P6|Overall Study|Protocol Violation|0
5128818|NCT01657370|17716301|P5|Overall Study|Protocol Violation|0
5128819|NCT01657370|17716302|P4|Overall Study|Protocol Violation|1
5128820|NCT01657370|17716303|P3|Overall Study|Protocol Violation|1
5128821|NCT01657370|17716304|P2|Overall Study|Protocol Violation|1
5128822|NCT01657370|17716305|P1|Overall Study|Protocol Violation|1
5128823|NCT01657370|17716300|P6|Overall Study|Adverse Event|0
5128824|NCT01657370|17716301|P5|Overall Study|Adverse Event|1
5128825|NCT01657370|17716302|P4|Overall Study|Adverse Event|0
5128826|NCT01657370|17716303|P3|Overall Study|Adverse Event|0
5128827|NCT01657370|17716304|P2|Overall Study|Adverse Event|0
5128828|NCT01657370|17716305|P1|Overall Study|Adverse Event|0
5128829|NCT01657370|17716300|P6|Overall Study|Lack of Qualifying Event|2
5128830|NCT01657370|17716301|P5|Overall Study|Lack of Qualifying Event|1
5128831|NCT01657370|17716302|P4|Overall Study|Lack of Qualifying Event|2
5128832|NCT01657370|17716303|P3|Overall Study|Lack of Qualifying Event|3
5128833|NCT01657370|17716304|P2|Overall Study|Lack of Qualifying Event|0
5128834|NCT01657370|17716305|P1|Overall Study|Lack of Qualifying Event|1
5128835|NCT01657370|17716300|P6|Overall Study|Physician Decision|0
5128836|NCT01657370|17716301|P5|Overall Study|Physician Decision|5
5128837|NCT01657370|17716302|P4|Overall Study|Physician Decision|2
5128838|NCT01657370|17716303|P3|Overall Study|Physician Decision|1
5128839|NCT01657370|17716304|P2|Overall Study|Physician Decision|3
5128840|NCT01657370|17716305|P1|Overall Study|Physician Decision|2
5128841|NCT01657370|17716300|P6|Overall Study|Withdrawal by Subject|1
5128842|NCT01657370|17716301|P5|Overall Study|Withdrawal by Subject|0
5128843|NCT01657370|17716302|P4|Overall Study|Withdrawal by Subject|0
5128844|NCT01657370|17716303|P3|Overall Study|Withdrawal by Subject|1
5128845|NCT01657370|17716304|P2|Overall Study|Withdrawal by Subject|0
5128846|NCT01657370|17716305|P1|Overall Study|Withdrawal by Subject|0
5128847|NCT01657305|17716403|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
5128848|NCT01657305|17716403|P1|Overall Study|Lost to Follow-up|1
5128849|NCT01657305|17716403|P1|Overall Study|Adverse Event|1
5128850|NCT01657305|17716403|P1|Overall Study|Withdrawal by Subject|4
5128851|NCT01657305|17716403|P1|Overall Study|Lack of Wound Closure at Day 28|15
5128852|NCT01657292|17716453|P1|Overall Study|Change of therapy|1
5128853|NCT01657292|17716453|P1|Overall Study|Violation of eligibility criteria|1
5128854|NCT01657292|17716453|P1|Overall Study|Withdrawal by Subject|2
5128855|NCT01657292|17716453|P1|Overall Study|Adverse Event|6
5128856|NCT01657266|17716462|P2|Overall Study|Adverse Event|3
5128857|NCT01657266|17716463|P1|Overall Study|Adverse Event|2
5128858|NCT01657266|17716462|P2|Overall Study|Lost to Follow-up|2
5128859|NCT01657266|17716463|P1|Overall Study|Lost to Follow-up|2
5128860|NCT01657253|17716485|P2|Overall Study|Adverse Event|1
5128861|NCT01657253|17716486|P1|Overall Study|Adverse Event|0
5128862|NCT01657253|17716485|P2|Overall Study|Withdrawal by Subject|12
5128863|NCT01657253|17716486|P1|Overall Study|Withdrawal by Subject|11
5128864|NCT01657253|17716485|P2|Overall Study|Lost to Follow-up|5
5128865|NCT01657253|17716486|P1|Overall Study|Lost to Follow-up|6
5128866|NCT01657032|17716498|P2|Overall Study|Lost to Follow-up|7
5128867|NCT01657032|17716499|P1|Overall Study|Lost to Follow-up|0
5128868|NCT01657019|17716525|P1|Overall Study|Other|58
5128869|NCT01657019|17716525|P1|Overall Study|Lack of Efficacy|3
5128870|NCT01657019|17716525|P1|Overall Study|Protocol Violation|6
5128871|NCT01657019|17716525|P1|Overall Study|Lost to Follow-up|48
5128872|NCT01657019|17716525|P1|Overall Study|Adverse Event|55
5128873|NCT01657019|17716525|P1|Overall Study|Withdrawal by Subject|65
5128874|NCT01656967|17716539|P2|Overall Study|unsuccessful ETT insertion|2
5128875|NCT01656967|17716540|P1|Overall Study|unsuccessful ETT insertion|3
5128876|NCT01656967|17716539|P2|Overall Study|faulty monitor|0
5128877|NCT01656967|17716540|P1|Overall Study|faulty monitor|1
5128878|NCT01656889|17716566|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
5128879|NCT01656889|17716567|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
5128880|NCT01656889|17716566|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
5128881|NCT01656889|17716567|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
5128882|NCT01656889|17716566|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
5128883|NCT01656889|17716567|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
5128884|NCT01656889|17716566|P2|Post Treatment Follow-Up, 3 Months|Death|5
5128885|NCT01656889|17716567|P1|Post Treatment Follow-Up, 3 Months|Death|1
5128886|NCT01656889|17716566|P2|Treatment Period, 12 Weeks|Moved out of the area|2
5128887|NCT01656889|17716567|P1|Treatment Period, 12 Weeks|Moved out of the area|0
5128888|NCT01656889|17716566|P2|Treatment Period, 12 Weeks|Protocol Violation|1
5128889|NCT01656889|17716567|P1|Treatment Period, 12 Weeks|Protocol Violation|0
5128890|NCT01656889|17716566|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
5128891|NCT01656889|17716567|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
5128892|NCT01656889|17716566|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
5128893|NCT01656889|17716567|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
5128894|NCT01656889|17716566|P2|Treatment Period, 12 Weeks|Death|1
5128895|NCT01656889|17716567|P1|Treatment Period, 12 Weeks|Death|0
5128896|NCT01656889|17716566|P2|Treatment Period, 12 Weeks|Adverse Event|4
5128897|NCT01656889|17716567|P1|Treatment Period, 12 Weeks|Adverse Event|10
5128898|NCT01656850|17716587|P2|First Intervention (3 Months)|Withdrawal by Subject|4
5128899|NCT01656850|17716588|P1|First Intervention (3 Months)|Withdrawal by Subject|3
5128900|NCT01656759|17716679|P2|Overall Study|Protocol Violation|3
5128901|NCT01656759|17716680|P1|Overall Study|Protocol Violation|2
5128902|NCT01656733|17716694|P2|Overall Study|Spontaneous abortion|1
5128903|NCT01656733|17716695|P1|Overall Study|Spontaneous abortion|0
5128904|NCT01656733|17716694|P2|Overall Study|Delivery at another hospital|2
5128905|NCT01656733|17716695|P1|Overall Study|Delivery at another hospital|0
5128906|NCT01656733|17716694|P2|Overall Study|No permission to collect birth outcomes|1
5128907|NCT01656733|17716695|P1|Overall Study|No permission to collect birth outcomes|0
5128908|NCT01656434|17716745|P2|Overall Study|Withdrawal by Subject|7
5128909|NCT01656434|17716746|P1|Overall Study|Withdrawal by Subject|64
5128910|NCT01656434|17716745|P2|Overall Study|Participant withdrew consent|9
5128911|NCT01656434|17716746|P1|Overall Study|Participant withdrew consent|28
5128912|NCT01656434|17716745|P2|Overall Study|Participant moved|12
5128913|NCT01656434|17716746|P1|Overall Study|Participant moved|40
5128914|NCT01656434|17716745|P2|Overall Study|Non-compliance with protocol|15
5128915|NCT01656434|17716746|P1|Overall Study|Non-compliance with protocol|39
5128916|NCT01656434|17716745|P2|Overall Study|Part. discontinued; unrelated to drug|10
5128917|NCT01656434|17716746|P1|Overall Study|Part. discontinued; unrelated to drug|55
5128918|NCT01656434|17716745|P2|Overall Study|Participant discontinued; drug related|4
5128919|NCT01656434|17716746|P1|Overall Study|Participant discontinued; drug related|13
5128920|NCT01656434|17716745|P2|Overall Study|Study terminated by sponsor|348
5128921|NCT01656434|17716746|P1|Overall Study|Study terminated by sponsor|1501
5128922|NCT01656434|17716745|P2|Overall Study|Non-compliance with study drug|9
5128923|NCT01656434|17716746|P1|Overall Study|Non-compliance with study drug|48
5128924|NCT01656434|17716745|P2|Overall Study|Physician Decision|2
5128925|NCT01656434|17716746|P1|Overall Study|Physician Decision|7
5128926|NCT01656434|17716745|P2|Overall Study|Pregnancy|10
5128927|NCT01656434|17716746|P1|Overall Study|Pregnancy|45
5128928|NCT01656434|17716745|P2|Overall Study|Pregnancy wish|6
5128929|NCT01656434|17716746|P1|Overall Study|Pregnancy wish|18
5128930|NCT01656434|17716745|P2|Overall Study|Protocol Violation|0
5128931|NCT01656434|17716746|P1|Overall Study|Protocol Violation|7
5128932|NCT01656434|17716745|P2|Overall Study|Screen failure|0
5128933|NCT01656434|17716746|P1|Overall Study|Screen failure|2
5128934|NCT01656434|17716745|P2|Overall Study|Site discontinued study participation|9
5128935|NCT01656434|17716746|P1|Overall Study|Site discontinued study participation|24
5128936|NCT01656434|17716745|P2|Overall Study|Lost to Follow-up|76
5128937|NCT01656434|17716746|P1|Overall Study|Lost to Follow-up|309
5128938|NCT01656434|17716745|P2|Overall Study|Enrollment terminated at trial site|0
5128939|NCT01656434|17716746|P1|Overall Study|Enrollment terminated at trial site|2
5128940|NCT01656434|17716745|P2|Overall Study|Adverse Event|63
5128941|NCT01656434|17716746|P1|Overall Study|Adverse Event|199
5128942|NCT01656408|17716772|P10|Overall Study|Physician Decision|3
5128943|NCT01656408|17716773|P9|Overall Study|Physician Decision|1
5128944|NCT01656408|17716774|P8|Overall Study|Physician Decision|1
5128945|NCT01656408|17716775|P7|Overall Study|Physician Decision|0
5128946|NCT01656408|17716776|P6|Overall Study|Physician Decision|1
5128947|NCT01656408|17716777|P5|Overall Study|Physician Decision|1
5128948|NCT01656408|17716778|P4|Overall Study|Physician Decision|0
5128949|NCT01656408|17716779|P3|Overall Study|Physician Decision|1
5128950|NCT01656408|17716780|P2|Overall Study|Physician Decision|0
5128951|NCT01656408|17716781|P1|Overall Study|Physician Decision|1
5128952|NCT01656408|17716772|P10|Overall Study|Adverse Event|0
5128953|NCT01656408|17716773|P9|Overall Study|Adverse Event|1
5128954|NCT01656408|17716774|P8|Overall Study|Adverse Event|0
5128955|NCT01656408|17716775|P7|Overall Study|Adverse Event|1
5128956|NCT01656408|17716776|P6|Overall Study|Adverse Event|1
5128957|NCT01656408|17716777|P5|Overall Study|Adverse Event|0
5128958|NCT01656408|17716778|P4|Overall Study|Adverse Event|0
5128959|NCT01656408|17716779|P3|Overall Study|Adverse Event|1
5128960|NCT01656408|17716780|P2|Overall Study|Adverse Event|0
5128961|NCT01656408|17716781|P1|Overall Study|Adverse Event|0
5128962|NCT01656395|17716976|P8|Overall Study|Withdrawal by Subject|0
5128963|NCT01656395|17716977|P7|Overall Study|Withdrawal by Subject|0
5128964|NCT01656395|17716978|P6|Overall Study|Withdrawal by Subject|3
5128965|NCT01656395|17716979|P5|Overall Study|Withdrawal by Subject|0
5128966|NCT01656395|17716980|P4|Overall Study|Withdrawal by Subject|2
5128967|NCT01656395|17716981|P3|Overall Study|Withdrawal by Subject|4
5128968|NCT01656395|17716982|P2|Overall Study|Withdrawal by Subject|1
5128969|NCT01656395|17716983|P1|Overall Study|Withdrawal by Subject|3
5128970|NCT01656395|17716976|P8|Overall Study|Screen Failure|0
5128971|NCT01656395|17716977|P7|Overall Study|Screen Failure|0
5128972|NCT01656395|17716978|P6|Overall Study|Screen Failure|8
5128973|NCT01656395|17716979|P5|Overall Study|Screen Failure|0
5128974|NCT01656395|17716980|P4|Overall Study|Screen Failure|1
5128975|NCT01656395|17716981|P3|Overall Study|Screen Failure|7
5128976|NCT01656395|17716982|P2|Overall Study|Screen Failure|1
5128977|NCT01656395|17716983|P1|Overall Study|Screen Failure|2
5128978|NCT01656395|17716976|P8|Overall Study|Protocol Violation|0
5128979|NCT01656395|17716977|P7|Overall Study|Protocol Violation|0
5128980|NCT01656395|17716978|P6|Overall Study|Protocol Violation|10
5128981|NCT01656395|17716979|P5|Overall Study|Protocol Violation|4
5128982|NCT01656395|17716980|P4|Overall Study|Protocol Violation|2
5128983|NCT01656395|17716981|P3|Overall Study|Protocol Violation|9
5128984|NCT01656395|17716982|P2|Overall Study|Protocol Violation|6
5128985|NCT01656395|17716983|P1|Overall Study|Protocol Violation|6
5128986|NCT01656395|17716976|P8|Overall Study|Progressive Disease|0
5128987|NCT01656395|17716977|P7|Overall Study|Progressive Disease|0
5128988|NCT01656395|17716978|P6|Overall Study|Progressive Disease|1
5128989|NCT01656395|17716979|P5|Overall Study|Progressive Disease|0
5128990|NCT01656395|17716980|P4|Overall Study|Progressive Disease|0
5128991|NCT01656395|17716981|P3|Overall Study|Progressive Disease|0
5128992|NCT01656395|17716982|P2|Overall Study|Progressive Disease|0
5128993|NCT01656395|17716983|P1|Overall Study|Progressive Disease|0
5128994|NCT01656395|17716976|P8|Overall Study|Pregnancy|0
5128995|NCT01656395|17716977|P7|Overall Study|Pregnancy|0
5128996|NCT01656395|17716978|P6|Overall Study|Pregnancy|0
5128997|NCT01656395|17716979|P5|Overall Study|Pregnancy|0
5128998|NCT01656395|17716980|P4|Overall Study|Pregnancy|0
5128999|NCT01656395|17716981|P3|Overall Study|Pregnancy|1
5129000|NCT01656395|17716982|P2|Overall Study|Pregnancy|0
5129001|NCT01656395|17716983|P1|Overall Study|Pregnancy|0
5129002|NCT01656395|17716976|P8|Overall Study|Physician Decision|0
5129003|NCT01656395|17716977|P7|Overall Study|Physician Decision|0
5129004|NCT01656395|17716978|P6|Overall Study|Physician Decision|3
5129005|NCT01656395|17716979|P5|Overall Study|Physician Decision|3
5129006|NCT01656395|17716980|P4|Overall Study|Physician Decision|2
5129007|NCT01656395|17716981|P3|Overall Study|Physician Decision|3
5129008|NCT01656395|17716982|P2|Overall Study|Physician Decision|3
5129009|NCT01656395|17716983|P1|Overall Study|Physician Decision|2
5129010|NCT01656395|17716976|P8|Overall Study|Other|0
5129011|NCT01656395|17716977|P7|Overall Study|Other|0
5129012|NCT01656395|17716978|P6|Overall Study|Other|1
5129013|NCT01656395|17716979|P5|Overall Study|Other|0
5129014|NCT01656395|17716980|P4|Overall Study|Other|0
5129015|NCT01656395|17716981|P3|Overall Study|Other|1
5129016|NCT01656395|17716982|P2|Overall Study|Other|0
5129017|NCT01656395|17716983|P1|Overall Study|Other|0
5129018|NCT01656395|17716976|P8|Overall Study|Non-Compliance with Study Drug|0
5129019|NCT01656395|17716977|P7|Overall Study|Non-Compliance with Study Drug|0
5129020|NCT01656395|17716978|P6|Overall Study|Non-Compliance with Study Drug|1
5129021|NCT01656395|17716979|P5|Overall Study|Non-Compliance with Study Drug|1
5129022|NCT01656395|17716980|P4|Overall Study|Non-Compliance with Study Drug|0
5129023|NCT01656395|17716981|P3|Overall Study|Non-Compliance with Study Drug|0
5129024|NCT01656395|17716982|P2|Overall Study|Non-Compliance with Study Drug|1
5129025|NCT01656395|17716983|P1|Overall Study|Non-Compliance with Study Drug|1
5129026|NCT01656395|17716976|P8|Overall Study|Lost to Follow-up|0
5129027|NCT01656395|17716977|P7|Overall Study|Lost to Follow-up|0
5129028|NCT01656395|17716978|P6|Overall Study|Lost to Follow-up|0
5129029|NCT01656395|17716979|P5|Overall Study|Lost to Follow-up|0
5129030|NCT01656395|17716980|P4|Overall Study|Lost to Follow-up|0
5129031|NCT01656395|17716981|P3|Overall Study|Lost to Follow-up|0
5129032|NCT01656395|17716982|P2|Overall Study|Lost to Follow-up|0
5129033|NCT01656395|17716983|P1|Overall Study|Lost to Follow-up|1
5129034|NCT01656395|17716976|P8|Overall Study|Lack of Efficacy|0
5129035|NCT01656395|17716977|P7|Overall Study|Lack of Efficacy|0
5129036|NCT01656395|17716978|P6|Overall Study|Lack of Efficacy|6
5129037|NCT01656395|17716979|P5|Overall Study|Lack of Efficacy|1
5129038|NCT01656395|17716980|P4|Overall Study|Lack of Efficacy|1
5129039|NCT01656395|17716981|P3|Overall Study|Lack of Efficacy|6
5129040|NCT01656395|17716982|P2|Overall Study|Lack of Efficacy|8
5129041|NCT01656395|17716983|P1|Overall Study|Lack of Efficacy|1
5129042|NCT01656395|17716976|P8|Overall Study|Adverse Event|0
5129043|NCT01656395|17716977|P7|Overall Study|Adverse Event|0
5129044|NCT01656395|17716978|P6|Overall Study|Adverse Event|7
5129045|NCT01656395|17716979|P5|Overall Study|Adverse Event|5
5129046|NCT01656395|17716980|P4|Overall Study|Adverse Event|4
5129047|NCT01656395|17716981|P3|Overall Study|Adverse Event|5
5129048|NCT01656395|17716982|P2|Overall Study|Adverse Event|14
5129049|NCT01656395|17716983|P1|Overall Study|Adverse Event|1
5129050|NCT01656304|17717069|P1|Overall Study|Ineligible, uncontrolled hypertension|1
5129051|NCT01656200|17717110|P1|Overall Study|Withdrawal by Subject|1
5129052|NCT01656161|17717125|P1|Overall Study|Withdrawal by Subject|1
5129053|NCT01656161|17717125|P1|Overall Study|Protocol Violation|1
5129054|NCT01656161|17717125|P1|Overall Study|Adverse Event|2
5129055|NCT01656161|17717125|P1|Overall Study|Death|3
5129056|NCT01655901|17717143|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
5129057|NCT01655901|17717144|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
5129058|NCT01655901|17717145|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
5129059|NCT01655901|17717146|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
5129060|NCT01655901|17717147|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
5129061|NCT01655901|17717148|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
5129062|NCT01655823|17717162|P5|Overall Study|Withdrawal by Subject|0
5129063|NCT01655823|17717163|P4|Overall Study|Withdrawal by Subject|1
5129064|NCT01655823|17717164|P3|Overall Study|Withdrawal by Subject|0
5129065|NCT01655823|17717165|P2|Overall Study|Withdrawal by Subject|1
5129066|NCT01655823|17717166|P1|Overall Study|Withdrawal by Subject|0
5129067|NCT01655823|17717162|P5|Overall Study|Lost to Follow-up|1
5129068|NCT01655823|17717163|P4|Overall Study|Lost to Follow-up|0
5129069|NCT01655823|17717164|P3|Overall Study|Lost to Follow-up|0
5129070|NCT01655823|17717165|P2|Overall Study|Lost to Follow-up|1
5129071|NCT01655823|17717166|P1|Overall Study|Lost to Follow-up|0
5129072|NCT01655498|17717197|P1|Overall Study|Withdrawal by Subject|1
5129073|NCT01655498|17717197|P1|Overall Study|Protocol Violation|2
5129074|NCT01655498|17717197|P1|Overall Study|Unrelated health issue|2
5129075|NCT01655381|17717204|P1|Overall Study|Insufficient Treatment Response|1
5129076|NCT01655381|17717204|P1|Overall Study|Moved to Another City|1
5129077|NCT01655381|17717204|P1|Overall Study|Investigator Decision|1
5129078|NCT01655069|17717244|P4|Overall Study|Withdrawal by Subject|0
5129079|NCT01655069|17717245|P3|Overall Study|Withdrawal by Subject|0
5129080|NCT01655069|17717246|P2|Overall Study|Withdrawal by Subject|3
5129081|NCT01655069|17717247|P1|Overall Study|Withdrawal by Subject|2
5129082|NCT01655069|17717244|P4|Overall Study|No Treatment Needed|0
5129083|NCT01655069|17717245|P3|Overall Study|No Treatment Needed|0
5129084|NCT01655069|17717246|P2|Overall Study|No Treatment Needed|1
5129085|NCT01655069|17717247|P1|Overall Study|No Treatment Needed|0
5129086|NCT01655069|17717244|P4|Overall Study|Lack of Efficacy|0
5129087|NCT01655069|17717245|P3|Overall Study|Lack of Efficacy|0
5129088|NCT01655069|17717246|P2|Overall Study|Lack of Efficacy|1
5129089|NCT01655069|17717247|P1|Overall Study|Lack of Efficacy|0
5129090|NCT01655069|17717244|P4|Overall Study|Adverse Event|3
5129091|NCT01655069|17717245|P3|Overall Study|Adverse Event|2
5129092|NCT01655069|17717246|P2|Overall Study|Adverse Event|7
5129093|NCT01655069|17717247|P1|Overall Study|Adverse Event|6
5129094|NCT01655069|17717244|P4|Overall Study|Physician Decision|1
5129095|NCT01655069|17717245|P3|Overall Study|Physician Decision|0
5129096|NCT01655069|17717246|P2|Overall Study|Physician Decision|0
5129097|NCT01655069|17717247|P1|Overall Study|Physician Decision|0
5129098|NCT01654666|17717307|P3|Overall Study|Withdrawal by Subject|1
5129099|NCT01654666|17717308|P2|Overall Study|Withdrawal by Subject|4
5129100|NCT01654666|17717309|P1|Overall Study|Withdrawal by Subject|4
5129101|NCT01654666|17717307|P3|Overall Study|Lost to Follow-up|5
5129102|NCT01654666|17717308|P2|Overall Study|Lost to Follow-up|5
5129103|NCT01654666|17717309|P1|Overall Study|Lost to Follow-up|4
5129104|NCT01654666|17717307|P3|Overall Study|Protocol Violation|8
5129105|NCT01654666|17717308|P2|Overall Study|Protocol Violation|4
5129106|NCT01654666|17717309|P1|Overall Study|Protocol Violation|7
5129107|NCT01654601|17717334|P2|2nd Administration|Protocol Violation|1
5129108|NCT01654601|17717335|P1|2nd Administration|Protocol Violation|0
5129109|NCT01654601|17717334|P2|2nd Administration|Adverse Event|0
5129110|NCT01654601|17717335|P1|2nd Administration|Adverse Event|1
5129111|NCT01654601|17717334|P2|1st Administration|Protocol Violation|2
5129112|NCT01654601|17717335|P1|1st Administration|Protocol Violation|0
5129113|NCT01654601|17717334|P2|1st Administration|Withdrawal by Subject|0
5129114|NCT01654601|17717335|P1|1st Administration|Withdrawal by Subject|2
5129115|NCT01654549|17717349|P2|Overall Study|H.pylori eradication not successful|1
5129116|NCT01654549|17717350|P1|Overall Study|H.pylori eradication not successful|0
5129117|NCT01654536|17717362|P2|Overall Study|Withdrawal by Subject|25
5129118|NCT01654536|17717363|P1|Overall Study|Withdrawal by Subject|27
5129119|NCT01654536|17717362|P2|Overall Study|Physician Decision|8
5129120|NCT01654536|17717363|P1|Overall Study|Physician Decision|12
5129121|NCT01654536|17717362|P2|Overall Study|Lost to Follow-up|5
5129122|NCT01654536|17717363|P1|Overall Study|Lost to Follow-up|5
5129123|NCT01654523|17717399|P1|Overall Study|Withdrawal by Subject|1
5129124|NCT01654380|17717418|P4|Part B, Period 1|Physician Decision|0
5129125|NCT01654380|17717419|P3|Part B, Period 1|Physician Decision|1
5129126|NCT01654380|17717420|P2|Part B, Period 1|Physician Decision|0
5129127|NCT01654380|17717421|P1|Part B, Period 1|Physician Decision|0
5129128|NCT01654302|17717464|P2|Second Intervention (Day 7)|Lost to Follow-up|1
5129129|NCT01654302|17717465|P1|Second Intervention (Day 7)|Lost to Follow-up|1
5129130|NCT01654289|17717474|P3|Overall Study|Withdrew from intervention only|0
5129131|NCT01654289|17717475|P2|Overall Study|Withdrew from intervention only|20
5129132|NCT01654289|17717476|P1|Overall Study|Withdrew from intervention only|17
5129133|NCT01654289|17717474|P3|Overall Study|Withdrawal by Subject|5
5129134|NCT01654289|17717475|P2|Overall Study|Withdrawal by Subject|8
5129135|NCT01654289|17717476|P1|Overall Study|Withdrawal by Subject|10
5129136|NCT01654276|17717514|P1|Overall Study|Withdrawal by Subject|1
5129137|NCT01654276|17717514|P1|Overall Study|Lost to Follow-up|4
5129138|NCT01654276|17717514|P1|Overall Study|Lack of Efficacy|1
5129139|NCT01654250|17717568|P2|Overall Study|Lost to Follow-up|0
5129140|NCT01654250|17717569|P1|Overall Study|Lost to Follow-up|1
5129141|NCT01654224|17717586|P2|Overall Study|Insufficient blood sample|2
5129142|NCT01654224|17717587|P1|Overall Study|Insufficient blood sample|3
5129143|NCT01654224|17717586|P2|Overall Study|Did not receive allocation|8
5129144|NCT01654224|17717587|P1|Overall Study|Did not receive allocation|1
5129145|NCT01654224|17717586|P2|Overall Study|Lost to Follow-up|2
5129146|NCT01654224|17717587|P1|Overall Study|Lost to Follow-up|2
5129147|NCT01653912|17717618|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
5129148|NCT01653912|17717619|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5129149|NCT01653912|17717620|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5129150|NCT01653912|17717621|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5129151|NCT01653912|17717622|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5129152|NCT01653912|17717623|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5129153|NCT01653912|17717618|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
5129154|NCT01653912|17717619|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5129155|NCT01653912|17717620|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5129156|NCT01653912|17717621|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5129157|NCT01653912|17717622|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5129158|NCT01653912|17717623|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5129159|NCT01653912|17717618|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
5129160|NCT01653912|17717619|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
5129161|NCT01653912|17717620|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
5129162|NCT01653912|17717621|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
5129163|NCT01653912|17717622|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
5129164|NCT01653912|17717623|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
5129165|NCT01653912|17717618|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5129166|NCT01653912|17717619|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5129167|NCT01653912|17717620|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
5129168|NCT01653912|17717621|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5129169|NCT01653912|17717622|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5129170|NCT01653912|17717623|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5129171|NCT01653912|17717618|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5129172|NCT01653912|17717619|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5129173|NCT01653912|17717620|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
5129174|NCT01653912|17717621|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5129175|NCT01653912|17717622|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5129176|NCT01653912|17717623|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5129177|NCT01653912|17717618|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5129178|NCT01653912|17717619|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5129179|NCT01653912|17717620|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5129180|NCT01653912|17717621|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
5129181|NCT01653912|17717622|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5129182|NCT01653912|17717623|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5129183|NCT01653912|17717618|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5129184|NCT01653912|17717619|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5129185|NCT01653912|17717620|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5129186|NCT01653912|17717621|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5129187|NCT01653912|17717622|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
5129188|NCT01653912|17717623|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5129189|NCT01653782|17717641|P3|Overall Study|Lost to Follow-up|2
5129190|NCT01653782|17717642|P2|Overall Study|Lost to Follow-up|3
5129191|NCT01653782|17717643|P1|Overall Study|Lost to Follow-up|7
5129192|NCT01653782|17717641|P3|Overall Study|Withdrawal by Subject|4
5129193|NCT01653782|17717642|P2|Overall Study|Withdrawal by Subject|15
5129194|NCT01653782|17717643|P1|Overall Study|Withdrawal by Subject|9
5129195|NCT01653743|17717653|P2|Overall Study|Investigator discretion|0
5129196|NCT01653743|17717654|P1|Overall Study|Investigator discretion|3
5129197|NCT01653743|17717653|P2|Overall Study|Withdrawal by Subject|0
5129198|NCT01653743|17717654|P1|Overall Study|Withdrawal by Subject|1
5129199|NCT01653704|17717670|P2|Overall Study|Performance not reflective of training|0
5129200|NCT01653704|17717671|P1|Overall Study|Performance not reflective of training|1
5129201|NCT01653704|17717670|P2|Overall Study|Technical failure during recording|1
5129202|NCT01653704|17717671|P1|Overall Study|Technical failure during recording|1
5129203|NCT01653327|17717740|P1|Overall Study|Withdrawal by Subject|1
5129204|NCT01653262|17717765|P1|Overall Study|AE, non-serious non-fatal|1
5129205|NCT01653262|17717765|P1|Overall Study|SAE, non-fatal|1
5129206|NCT01653262|17717765|P1|Overall Study|Lack of Efficacy|1
5129207|NCT01653158|17717783|P8|Overall Study|Withdrawal by Subject|0
5129208|NCT01653158|17717784|P7|Overall Study|Withdrawal by Subject|0
5129209|NCT01653158|17717785|P6|Overall Study|Withdrawal by Subject|0
5129210|NCT01653158|17717786|P5|Overall Study|Withdrawal by Subject|0
5129211|NCT01653158|17717787|P4|Overall Study|Withdrawal by Subject|0
5129212|NCT01653158|17717788|P3|Overall Study|Withdrawal by Subject|0
5129213|NCT01653158|17717789|P2|Overall Study|Withdrawal by Subject|0
5129214|NCT01653158|17717790|P1|Overall Study|Withdrawal by Subject|1
5129215|NCT01653158|17717783|P8|Overall Study|Progressive disease|9
5129216|NCT01653158|17717784|P7|Overall Study|Progressive disease|2
5129217|NCT01653158|17717785|P6|Overall Study|Progressive disease|1
5129218|NCT01653158|17717786|P5|Overall Study|Progressive disease|1
5129219|NCT01653158|17717787|P4|Overall Study|Progressive disease|0
5129220|NCT01653158|17717788|P3|Overall Study|Progressive disease|0
5129221|NCT01653158|17717789|P2|Overall Study|Progressive disease|0
5129222|NCT01653158|17717790|P1|Overall Study|Progressive disease|0
5129223|NCT01653158|17717783|P8|Overall Study|Other|1
5129224|NCT01653158|17717784|P7|Overall Study|Other|0
5129225|NCT01653158|17717785|P6|Overall Study|Other|0
5129226|NCT01653158|17717786|P5|Overall Study|Other|0
5129227|NCT01653158|17717787|P4|Overall Study|Other|0
5129228|NCT01653158|17717788|P3|Overall Study|Other|0
5129229|NCT01653158|17717789|P2|Overall Study|Other|0
5129230|NCT01653158|17717790|P1|Overall Study|Other|0
5129231|NCT01653158|17717783|P8|Overall Study|Adverse Event|3
5129232|NCT01653158|17717784|P7|Overall Study|Adverse Event|0
5129233|NCT01653158|17717785|P6|Overall Study|Adverse Event|0
5129234|NCT01653158|17717786|P5|Overall Study|Adverse Event|0
5129235|NCT01653158|17717787|P4|Overall Study|Adverse Event|1
5129236|NCT01653158|17717788|P3|Overall Study|Adverse Event|0
5129237|NCT01653158|17717789|P2|Overall Study|Adverse Event|0
5129238|NCT01653158|17717790|P1|Overall Study|Adverse Event|0
5129239|NCT01653158|17717783|P8|Overall Study|Death|2
5129240|NCT01653158|17717784|P7|Overall Study|Death|0
5129241|NCT01653158|17717785|P6|Overall Study|Death|0
5129242|NCT01653158|17717786|P5|Overall Study|Death|0
5129243|NCT01653158|17717787|P4|Overall Study|Death|1
5129244|NCT01653158|17717788|P3|Overall Study|Death|0
5129245|NCT01653158|17717789|P2|Overall Study|Death|0
5129246|NCT01653158|17717790|P1|Overall Study|Death|0
5129247|NCT01653132|17718062|P2|First Intervention|Protocol Violation|0
5129248|NCT01653132|17718063|P1|First Intervention|Protocol Violation|1
5129249|NCT01652885|17718127|P1|Overall Study|Adverse Event|1
5129250|NCT01652872|17718154|P2|Overall Study|Withdrawal by Subject|84
5129251|NCT01652872|17718155|P1|Overall Study|Withdrawal by Subject|76
5129252|NCT01652872|17718154|P2|Overall Study|Decision by sponsor|7
5129253|NCT01652872|17718155|P1|Overall Study|Decision by sponsor|5
5129254|NCT01652872|17718154|P2|Overall Study|Lost to Follow-up|23
5129255|NCT01652872|17718155|P1|Overall Study|Lost to Follow-up|28
5129256|NCT01652872|17718154|P2|Overall Study|Death|39
5129257|NCT01652872|17718155|P1|Overall Study|Death|36
5129258|NCT01652729|17718172|P3|Overall Study|Administrative|0
5129259|NCT01652729|17718173|P2|Overall Study|Administrative|0
5129260|NCT01652729|17718174|P1|Overall Study|Administrative|1
5129261|NCT01652729|17718172|P3|Overall Study|Lost to Follow-up|3
5129262|NCT01652729|17718173|P2|Overall Study|Lost to Follow-up|6
5129263|NCT01652729|17718174|P1|Overall Study|Lost to Follow-up|6
5129264|NCT01652729|17718172|P3|Overall Study|Protocol Violation|0
5129265|NCT01652729|17718173|P2|Overall Study|Protocol Violation|0
5129266|NCT01652729|17718174|P1|Overall Study|Protocol Violation|1
5129267|NCT01652729|17718172|P3|Overall Study|Physician Decision|1
5129268|NCT01652729|17718173|P2|Overall Study|Physician Decision|0
5129269|NCT01652729|17718174|P1|Overall Study|Physician Decision|1
5129270|NCT01652729|17718172|P3|Overall Study|Adverse Event|3
5129271|NCT01652729|17718173|P2|Overall Study|Adverse Event|0
5129272|NCT01652729|17718174|P1|Overall Study|Adverse Event|4
5129273|NCT01652729|17718172|P3|Overall Study|Withdrawal by Subject|7
5129274|NCT01652729|17718173|P2|Overall Study|Withdrawal by Subject|7
5129275|NCT01652729|17718174|P1|Overall Study|Withdrawal by Subject|14
5129276|NCT01652716|17718196|P2|Overall Study|Withdrawal by Subject|18
5129277|NCT01652716|17718197|P1|Overall Study|Withdrawal by Subject|33
5129278|NCT01652716|17718196|P2|Overall Study|Adverse Event|10
5129279|NCT01652716|17718197|P1|Overall Study|Adverse Event|7
5129280|NCT01652716|17718196|P2|Overall Study|Protocol Violation|1
5129281|NCT01652716|17718197|P1|Overall Study|Protocol Violation|2
5129282|NCT01652716|17718196|P2|Overall Study|Lost to Follow-up|11
5129283|NCT01652716|17718197|P1|Overall Study|Lost to Follow-up|12
5129284|NCT01652716|17718196|P2|Overall Study|Investigator decision|4
5129285|NCT01652716|17718197|P1|Overall Study|Investigator decision|1
5129286|NCT01652716|17718196|P2|Overall Study|Administrative|2
5129287|NCT01652716|17718197|P1|Overall Study|Administrative|0
5129288|NCT01652716|17718196|P2|Overall Study|Loss of glucose control|0
5129289|NCT01652716|17718197|P1|Overall Study|Loss of glucose control|1
5129290|NCT01652703|17718217|P6|Overall Study|Other|1
5129291|NCT01652703|17718218|P5|Overall Study|Other|1
5129292|NCT01652703|17718219|P4|Overall Study|Other|1
5129293|NCT01652703|17718220|P3|Overall Study|Other|0
5129294|NCT01652703|17718221|P2|Overall Study|Other|0
5129295|NCT01652703|17718222|P1|Overall Study|Other|0
5129296|NCT01652703|17718217|P6|Overall Study|Withdrawal by Subject|1
5129297|NCT01652703|17718218|P5|Overall Study|Withdrawal by Subject|0
5129298|NCT01652703|17718219|P4|Overall Study|Withdrawal by Subject|1
5129299|NCT01652703|17718220|P3|Overall Study|Withdrawal by Subject|3
5129300|NCT01652703|17718221|P2|Overall Study|Withdrawal by Subject|1
5129301|NCT01652703|17718222|P1|Overall Study|Withdrawal by Subject|0
5129302|NCT01652690|17718280|P2|Overall Study|Death|2
5129303|NCT01652690|17718281|P1|Overall Study|Death|5
5129304|NCT01652690|17718280|P2|Overall Study|Lost to Follow-up|6
5129305|NCT01652690|17718281|P1|Overall Study|Lost to Follow-up|6
5129306|NCT01652690|17718280|P2|Overall Study|Other|9
5129307|NCT01652690|17718281|P1|Overall Study|Other|8
5129308|NCT01652690|17718280|P2|Overall Study|Withdrawal by Subject|4
5129309|NCT01652690|17718281|P1|Overall Study|Withdrawal by Subject|16
5129310|NCT01652664|17718315|P2|Overall Study|Inadequate IOP control|0
5129311|NCT01652664|17718316|P1|Overall Study|Inadequate IOP control|1
5129312|NCT01652664|17718315|P2|Overall Study|Treatment Failure|1
5129313|NCT01652664|17718316|P1|Overall Study|Treatment Failure|5
5129314|NCT01652573|17718325|P2|Overall Study|Adverse Event|1
5129315|NCT01652573|17718326|P1|Overall Study|Adverse Event|0
5129316|NCT01652534|17718368|P2|Overall Study|Lack of Efficacy|0
5129317|NCT01652534|17718369|P1|Overall Study|Lack of Efficacy|1
5129318|NCT01652469|17718410|P2|Overall Study|Lost to Follow-up|2
5129319|NCT01652469|17718411|P1|Overall Study|Lost to Follow-up|0
5129320|NCT01652469|17718410|P2|Overall Study|Withdrawal by Subject|4
5129321|NCT01652469|17718411|P1|Overall Study|Withdrawal by Subject|1
5129322|NCT01652287|17718427|P2|Overall Study|Withdrawal by Subject|0
5129323|NCT01652287|17718428|P1|Overall Study|Withdrawal by Subject|2
5129324|NCT01651949|17718459|P3|Overall Study|Withdrawal by Subject|9
5129325|NCT01651949|17718460|P2|Overall Study|Withdrawal by Subject|18
5129326|NCT01651949|17718461|P1|Overall Study|Withdrawal by Subject|17
5129327|NCT01651949|17718459|P3|Overall Study|Screen failure|0
5129328|NCT01651949|17718460|P2|Overall Study|Screen failure|2
5129329|NCT01651949|17718461|P1|Overall Study|Screen failure|2
5129330|NCT01651949|17718459|P3|Overall Study|Adverse Event|1
5129331|NCT01651949|17718460|P2|Overall Study|Adverse Event|2
5129332|NCT01651949|17718461|P1|Overall Study|Adverse Event|0
5129333|NCT01651949|17718459|P3|Overall Study|Physician Decision|0
5129334|NCT01651949|17718460|P2|Overall Study|Physician Decision|2
5129335|NCT01651949|17718461|P1|Overall Study|Physician Decision|0
5129336|NCT01651949|17718459|P3|Overall Study|Protocol Violation|1
5129337|NCT01651949|17718460|P2|Overall Study|Protocol Violation|2
5129338|NCT01651949|17718461|P1|Overall Study|Protocol Violation|0
5129339|NCT01651949|17718459|P3|Overall Study|Lost to Follow-up|20
5129340|NCT01651949|17718460|P2|Overall Study|Lost to Follow-up|56
5129341|NCT01651949|17718461|P1|Overall Study|Lost to Follow-up|30
5129342|NCT01651949|17718459|P3|Overall Study|Unknown status|0
5129343|NCT01651949|17718460|P2|Overall Study|Unknown status|4
5129344|NCT01651949|17718461|P1|Overall Study|Unknown status|4
5129345|NCT01651936|17718481|P3|Extension Study|Study terminated by sponsor|13
5129346|NCT01651936|17718482|P2|Extension Study|Study terminated by sponsor|0
5129347|NCT01651936|17718483|P1|Extension Study|Study terminated by sponsor|0
5129348|NCT01651936|17718481|P3|Extension Study|Lack of Efficacy|1
5129349|NCT01651936|17718482|P2|Extension Study|Lack of Efficacy|0
5129350|NCT01651936|17718483|P1|Extension Study|Lack of Efficacy|0
5129351|NCT01651936|17718481|P3|Base Study|Study terminated by sponsor|0
5129352|NCT01651936|17718482|P2|Base Study|Study terminated by sponsor|16
5129353|NCT01651936|17718483|P1|Base Study|Study terminated by sponsor|21
5129354|NCT01651936|17718481|P3|Base Study|Early Escape|0
5129355|NCT01651936|17718482|P2|Base Study|Early Escape|8
5129356|NCT01651936|17718483|P1|Base Study|Early Escape|2
5129357|NCT01651936|17718481|P3|Base Study|Withdrawal by Subject|0
5129358|NCT01651936|17718482|P2|Base Study|Withdrawal by Subject|1
5129359|NCT01651936|17718483|P1|Base Study|Withdrawal by Subject|1
5129360|NCT01651936|17718481|P3|Base Study|Adverse Event|0
5129361|NCT01651936|17718482|P2|Base Study|Adverse Event|0
5129362|NCT01651936|17718483|P1|Base Study|Adverse Event|3
5129363|NCT01651780|17718553|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
5129364|NCT01651780|17718554|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
5129365|NCT01651780|17718553|P2|Overall Study|Lost to Follow-up|2
5129366|NCT01651780|17718554|P1|Overall Study|Lost to Follow-up|1
5129367|NCT01651780|17718553|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5129368|NCT01651780|17718554|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
5129369|NCT01651780|17718553|P2|Overall Study|Withdrawal by Subject|0
5129370|NCT01651780|17718554|P1|Overall Study|Withdrawal by Subject|2
5129371|NCT01651780|17718553|P2|Overall Study|Reason Not Specified: No 30-day visit|2
5129372|NCT01651780|17718554|P1|Overall Study|Reason Not Specified: No 30-day visit|2
5129373|NCT01651780|17718553|P2|Overall Study|Physician decision: No 30-day visit|1
5129374|NCT01651780|17718554|P1|Overall Study|Physician decision: No 30-day visit|2
5129375|NCT01651403|17718605|P2|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|2
5129376|NCT01651403|17718606|P1|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|1
5129377|NCT01651403|17718605|P2|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
5129378|NCT01651403|17718606|P1|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
5129379|NCT01651403|17718605|P2|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|13
5129380|NCT01651403|17718606|P1|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|25
5129381|NCT01651403|17718605|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
5129382|NCT01651403|17718606|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
5129383|NCT01651403|17718605|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
5129384|NCT01651403|17718606|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
5129385|NCT01651403|17718605|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
5129386|NCT01651403|17718606|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
5129387|NCT01651260|17718656|P1|Overall Study|unable to apply product|3
5129388|NCT01651208|17718663|P2|Overall Study|Lost to Follow-up|16
5129389|NCT01651208|17718664|P1|Overall Study|Lost to Follow-up|14
5129390|NCT01651117|17718676|P4|Overall Study|Death|2
5129391|NCT01651117|17718677|P3|Overall Study|Death|2
5129392|NCT01651117|17718678|P2|Overall Study|Death|3
5129393|NCT01651117|17718679|P1|Overall Study|Death|2
5129394|NCT01651052|17718759|P1|Overall Study|Lost to Follow-up|3
5129395|NCT01651052|17718759|P1|Overall Study|Withdrawal by Subject|1
5129396|NCT01651052|17718759|P1|Overall Study|Explant|1
5129397|NCT01651052|17718759|P1|Overall Study|Death|21
5129398|NCT01651039|17718779|P1|Overall Study|Progressive Disease|22
5129399|NCT01651039|17718779|P1|Overall Study|Withdrawal by Subject|1
5129400|NCT01651039|17718779|P1|Overall Study|Physician Decision|2
5129401|NCT01651039|17718779|P1|Overall Study|Non-evaluables|5
5129402|NCT01651000|17718792|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
5129403|NCT01651000|17718793|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
5129404|NCT01651000|17718792|P2|Overall Study|Administrative reason|0
5129405|NCT01651000|17718793|P1|Overall Study|Administrative reason|1
5129406|NCT01651000|17718792|P2|Overall Study|Physician Decision|0
5129407|NCT01651000|17718793|P1|Overall Study|Physician Decision|1
5129408|NCT01651000|17718792|P2|Overall Study|Lack of Efficacy|1
5129409|NCT01651000|17718793|P1|Overall Study|Lack of Efficacy|1
5129410|NCT01651000|17718792|P2|Overall Study|Subject noncompliance|3
5129411|NCT01651000|17718793|P1|Overall Study|Subject noncompliance|0
5129412|NCT01651000|17718792|P2|Overall Study|Withdrawal by Subject|10
5129413|NCT01651000|17718793|P1|Overall Study|Withdrawal by Subject|2
5129414|NCT01651000|17718792|P2|Overall Study|Protocol Violation|3
5129415|NCT01651000|17718793|P1|Overall Study|Protocol Violation|0
5129416|NCT01651000|17718792|P2|Overall Study|Lost to Follow-up|2
5129417|NCT01651000|17718793|P1|Overall Study|Lost to Follow-up|3
5129418|NCT01651000|17718792|P2|Overall Study|Adverse Event|8
5129419|NCT01651000|17718793|P1|Overall Study|Adverse Event|2
5129420|NCT01650831|17718814|P1|Overall Study|Screen failure|1
5129421|NCT01650805|17718824|P2|Overall Study|Withdrawal by Subject|0
5129422|NCT01650805|17718825|P1|Overall Study|Withdrawal by Subject|1
5129423|NCT01650779|17718835|P1|Overall Study|Withdrawal by Subject|1
5129424|NCT01650636|17718844|P2|Washout up to 9 Months|Lost to Follow-up|1
5129425|NCT01650636|17718845|P1|Washout up to 9 Months|Lost to Follow-up|2
5129426|NCT01650636|17718844|P2|Washout up to 9 Months|Withdrawal by Subject|2
5129427|NCT01650636|17718845|P1|Washout up to 9 Months|Withdrawal by Subject|4
5129428|NCT01650636|17718844|P2|Washout up to 5 Months|Lost to Follow-up|8
5129429|NCT01650636|17718845|P1|Washout up to 5 Months|Lost to Follow-up|2
5129430|NCT01650636|17718844|P2|Washout up to 5 Months|Death|0
5129431|NCT01650636|17718845|P1|Washout up to 5 Months|Death|1
5129432|NCT01650636|17718844|P2|Washout up to 5 Months|Physician Decision|2
5129433|NCT01650636|17718845|P1|Washout up to 5 Months|Physician Decision|2
5129434|NCT01650636|17718844|P2|Washout up to 5 Months|Withdrawal by Subject|8
5129435|NCT01650636|17718845|P1|Washout up to 5 Months|Withdrawal by Subject|4
5129436|NCT01650519|17718885|P2|Overall Study|Withdrawal by Subject|0
5129437|NCT01650519|17718886|P1|Overall Study|Withdrawal by Subject|1
5129438|NCT01650285|17718968|P1|Overall Study|Adverse Event|1
5129439|NCT01650259|17718975|P2|Overall Study|Other than listed|146
5129440|NCT01650259|17718976|P1|Overall Study|Other than listed|64
5129441|NCT01650259|17718975|P2|Overall Study|Not treated|7
5129442|NCT01650259|17718976|P1|Overall Study|Not treated|1
5129443|NCT01650259|17718975|P2|Overall Study|CRF not collected|82
5129444|NCT01650259|17718976|P1|Overall Study|CRF not collected|98
5129445|NCT01650259|17718975|P2|Overall Study|Patients had no visit after entry|0
5129446|NCT01650259|17718976|P1|Overall Study|Patients had no visit after entry|70
5129447|NCT01650259|17718975|P2|Overall Study|Lost to Follow-up|0
5129448|NCT01650259|17718976|P1|Overall Study|Lost to Follow-up|435
5129449|NCT01650259|17718975|P2|Overall Study|Lack of Efficacy|0
5129450|NCT01650259|17718976|P1|Overall Study|Lack of Efficacy|143
5129451|NCT01650259|17718975|P2|Overall Study|Adverse Event|0
5129452|NCT01650259|17718976|P1|Overall Study|Adverse Event|127
5129453|NCT01650259|17718975|P2|Overall Study|Improvement|0
5129454|NCT01650259|17718976|P1|Overall Study|Improvement|105
5129455|NCT01650246|17718981|P1|Overall Study|Lack of Efficacy|30
5129456|NCT01650246|17718981|P1|Overall Study|Death|1
5129457|NCT01650246|17718981|P1|Overall Study|Withdrawal by Subject|26
5129458|NCT01650246|17718981|P1|Overall Study|Lost to Follow-up|5
5129459|NCT01650246|17718981|P1|Overall Study|Sponsor terminated study|53
5129460|NCT01650246|17718981|P1|Overall Study|Protocol Violation|5
5129461|NCT01650246|17718981|P1|Overall Study|Adverse Event|23
5129462|NCT01650194|17718986|P1|Overall Study|Miscellaneous|10
5129463|NCT01650194|17718986|P1|Overall Study|Withdrawal by Subject|2
5129464|NCT01650194|17718986|P1|Overall Study|Progressive Disease (PD)|35
5129465|NCT01649856|17719022|P2|Overall Study|Other|5
5129466|NCT01649856|17719023|P1|Overall Study|Other|20
5129467|NCT01649856|17719022|P2|Overall Study|Lack of Compliance|1
5129468|NCT01649856|17719023|P1|Overall Study|Lack of Compliance|6
5129469|NCT01649856|17719022|P2|Overall Study|Lost to Follow-up|16
5129470|NCT01649856|17719023|P1|Overall Study|Lost to Follow-up|20
5129471|NCT01649856|17719022|P2|Overall Study|Stable or Progressed Disease|3
5129472|NCT01649856|17719023|P1|Overall Study|Stable or Progressed Disease|5
5129473|NCT01649856|17719022|P2|Overall Study|Death|34
5129474|NCT01649856|17719023|P1|Overall Study|Death|69
5129475|NCT01649856|17719022|P2|Overall Study|Treatment Failure|1
5129476|NCT01649856|17719023|P1|Overall Study|Treatment Failure|1
5129477|NCT01649856|17719022|P2|Overall Study|Protocol Violation|4
5129478|NCT01649856|17719023|P1|Overall Study|Protocol Violation|4
5129479|NCT01649856|17719022|P2|Overall Study|Withdrawal by Subject|14
5129480|NCT01649856|17719023|P1|Overall Study|Withdrawal by Subject|14
5129481|NCT01649804|17719055|P1|Overall Study|Administrative/Other|8
5129482|NCT01649791|17719067|P1|Overall Study|Adverse Event|1
5129483|NCT01649791|17719067|P1|Overall Study|Disease Progression|2
5129484|NCT01649765|17719076|P2|Overall Study|Withdrawal by Subject|1
5129485|NCT01649765|17719077|P1|Overall Study|Withdrawal by Subject|2
5129486|NCT01649765|17719076|P2|Overall Study|Protocol Violation|0
5129487|NCT01649765|17719077|P1|Overall Study|Protocol Violation|1
5129488|NCT01649765|17719076|P2|Overall Study|Physician Decision|3
5129489|NCT01649765|17719077|P1|Overall Study|Physician Decision|0
5129490|NCT01649765|17719076|P2|Overall Study|Lack of Efficacy|1
5129491|NCT01649765|17719077|P1|Overall Study|Lack of Efficacy|1
5129492|NCT01649765|17719076|P2|Overall Study|Adverse Event|3
5129493|NCT01649765|17719077|P1|Overall Study|Adverse Event|5
5129494|NCT01649557|17719128|P3|Overall Study|Lack of Efficacy|0
5129495|NCT01649557|17719129|P2|Overall Study|Lack of Efficacy|0
5129496|NCT01649557|17719130|P1|Overall Study|Lack of Efficacy|5
5129497|NCT01649557|17719128|P3|Overall Study|Protocol deviation|0
5129498|NCT01649557|17719129|P2|Overall Study|Protocol deviation|2
5129499|NCT01649557|17719130|P1|Overall Study|Protocol deviation|0
5129500|NCT01649557|17719128|P3|Overall Study|Withdrawal by Subject|4
5129501|NCT01649557|17719129|P2|Overall Study|Withdrawal by Subject|5
5129502|NCT01649557|17719130|P1|Overall Study|Withdrawal by Subject|15
5129503|NCT01649557|17719128|P3|Overall Study|Physician Decision|1
5129504|NCT01649557|17719129|P2|Overall Study|Physician Decision|2
5129505|NCT01649557|17719130|P1|Overall Study|Physician Decision|8
5129506|NCT01649557|17719128|P3|Overall Study|Met withdrawal criteria|0
5129507|NCT01649557|17719129|P2|Overall Study|Met withdrawal criteria|0
5129508|NCT01649557|17719130|P1|Overall Study|Met withdrawal criteria|4
5129509|NCT01649557|17719128|P3|Overall Study|Adverse Event|1
5129510|NCT01649557|17719129|P2|Overall Study|Adverse Event|5
5129511|NCT01649557|17719130|P1|Overall Study|Adverse Event|7
5129512|NCT01649557|17719128|P3|Overall Study|Lost to Follow-up|3
5129513|NCT01649557|17719129|P2|Overall Study|Lost to Follow-up|0
5129514|NCT01649557|17719130|P1|Overall Study|Lost to Follow-up|5
5129515|NCT01649427|17719176|P2|Overall Study|Surgical problems during nephrectomy|2
5129516|NCT01649427|17719177|P1|Overall Study|Surgical problems during nephrectomy|2
5129517|NCT01649427|17719176|P2|Overall Study|Graft loss|1
5129518|NCT01649427|17719177|P1|Overall Study|Graft loss|0
5129519|NCT01649427|17719176|P2|Overall Study|Lost to Follow-up|1
5129520|NCT01649427|17719177|P1|Overall Study|Lost to Follow-up|0
5129521|NCT01649427|17719176|P2|Overall Study|Withdrawal by Subject|7
5129522|NCT01649427|17719177|P1|Overall Study|Withdrawal by Subject|8
5129523|NCT01649427|17719176|P2|Overall Study|Adverse Event|1
5129524|NCT01649427|17719177|P1|Overall Study|Adverse Event|1
5129525|NCT01649375|17719196|P5|Week 16 up to Week 260|Adverse Event|2
5129526|NCT01649375|17719197|P4|Week 16 up to Week 260|Adverse Event|3
5129527|NCT01649375|17719198|P3|Week 16 up to Week 260|Adverse Event|0
5129528|NCT01649375|17719199|P2|Week 16 up to Week 260|Adverse Event|2
5129529|NCT01649375|17719200|P1|Week 16 up to Week 260|Adverse Event|5
5129530|NCT01649375|17719196|P5|Week 16 up to Week 260|Death|0
5129531|NCT01649375|17719197|P4|Week 16 up to Week 260|Death|0
5129532|NCT01649375|17719198|P3|Week 16 up to Week 260|Death|0
5129533|NCT01649375|17719199|P2|Week 16 up to Week 260|Death|1
5129534|NCT01649375|17719200|P1|Week 16 up to Week 260|Death|1
5129535|NCT01649375|17719196|P5|Week 16 up to Week 260|Withdrawal by Subject|1
5129536|NCT01649375|17719197|P4|Week 16 up to Week 260|Withdrawal by Subject|3
5129537|NCT01649375|17719198|P3|Week 16 up to Week 260|Withdrawal by Subject|0
5129538|NCT01649375|17719199|P2|Week 16 up to Week 260|Withdrawal by Subject|2
5129539|NCT01649375|17719200|P1|Week 16 up to Week 260|Withdrawal by Subject|7
5129540|NCT01649375|17719196|P5|Week 16 up to Week 260|Technical issues|0
5129541|NCT01649375|17719197|P4|Week 16 up to Week 260|Technical issues|1
5129542|NCT01649375|17719198|P3|Week 16 up to Week 260|Technical issues|0
5129543|NCT01649375|17719199|P2|Week 16 up to Week 260|Technical issues|1
5129544|NCT01649375|17719200|P1|Week 16 up to Week 260|Technical issues|0
5129545|NCT01649375|17719196|P5|Week 16 up to Week 260|Physician Decision|0
5129546|NCT01649375|17719197|P4|Week 16 up to Week 260|Physician Decision|0
5129547|NCT01649375|17719198|P3|Week 16 up to Week 260|Physician Decision|0
5129548|NCT01649375|17719199|P2|Week 16 up to Week 260|Physician Decision|2
5129549|NCT01649375|17719200|P1|Week 16 up to Week 260|Physician Decision|0
5129550|NCT01649375|17719196|P5|Week 16 up to Week 260|Non-compliance|0
5129551|NCT01649375|17719197|P4|Week 16 up to Week 260|Non-compliance|1
5129552|NCT01649375|17719198|P3|Week 16 up to Week 260|Non-compliance|0
5129553|NCT01649375|17719199|P2|Week 16 up to Week 260|Non-compliance|1
5129554|NCT01649375|17719200|P1|Week 16 up to Week 260|Non-compliance|0
5129555|NCT01649375|17719196|P5|Week 16 up to Week 260|Lack of Efficacy|2
5129556|NCT01649375|17719197|P4|Week 16 up to Week 260|Lack of Efficacy|4
5129557|NCT01649375|17719198|P3|Week 16 up to Week 260|Lack of Efficacy|0
5129558|NCT01649375|17719199|P2|Week 16 up to Week 260|Lack of Efficacy|4
5129559|NCT01649375|17719200|P1|Week 16 up to Week 260|Lack of Efficacy|7
5129560|NCT01649375|17719196|P5|Up to Week 16|Death|0
5129561|NCT01649375|17719197|P4|Up to Week 16|Death|0
5129562|NCT01649375|17719198|P3|Up to Week 16|Death|0
5129563|NCT01649375|17719199|P2|Up to Week 16|Death|0
5129564|NCT01649375|17719200|P1|Up to Week 16|Death|1
5129565|NCT01649375|17719196|P5|Up to Week 16|Withdrawal by Subject|0
5129566|NCT01649375|17719197|P4|Up to Week 16|Withdrawal by Subject|0
5129567|NCT01649375|17719198|P3|Up to Week 16|Withdrawal by Subject|2
5129568|NCT01649375|17719199|P2|Up to Week 16|Withdrawal by Subject|1
5129569|NCT01649375|17719200|P1|Up to Week 16|Withdrawal by Subject|2
5129570|NCT01649375|17719196|P5|Up to Week 16|Physician Decision|0
5129571|NCT01649375|17719197|P4|Up to Week 16|Physician Decision|0
5129572|NCT01649375|17719198|P3|Up to Week 16|Physician Decision|1
5129573|NCT01649375|17719199|P2|Up to Week 16|Physician Decision|0
5129574|NCT01649375|17719200|P1|Up to Week 16|Physician Decision|0
5129575|NCT01649375|17719196|P5|Up to Week 16|Lack of Efficacy|0
5129576|NCT01649375|17719197|P4|Up to Week 16|Lack of Efficacy|0
5129577|NCT01649375|17719198|P3|Up to Week 16|Lack of Efficacy|1
5129578|NCT01649375|17719199|P2|Up to Week 16|Lack of Efficacy|0
5129579|NCT01649375|17719200|P1|Up to Week 16|Lack of Efficacy|0
5129580|NCT01649375|17719196|P5|Up to Week 16|Adverse Event|0
5129581|NCT01649375|17719197|P4|Up to Week 16|Adverse Event|0
5129582|NCT01649375|17719198|P3|Up to Week 16|Adverse Event|4
5129583|NCT01649375|17719199|P2|Up to Week 16|Adverse Event|5
5129584|NCT01649375|17719200|P1|Up to Week 16|Adverse Event|2
5129585|NCT01649297|17719247|P5|Overall Study|For other reason|0
5129586|NCT01649297|17719248|P4|Overall Study|For other reason|0
5129587|NCT01649297|17719249|P3|Overall Study|For other reason|2
5129588|NCT01649297|17719250|P2|Overall Study|For other reason|1
5129589|NCT01649297|17719251|P1|Overall Study|For other reason|4
5129590|NCT01649297|17719247|P5|Overall Study|Patient withdrawal (not due to AE)|1
5129591|NCT01649297|17719248|P4|Overall Study|Patient withdrawal (not due to AE)|1
5129592|NCT01649297|17719249|P3|Overall Study|Patient withdrawal (not due to AE)|4
5129593|NCT01649297|17719250|P2|Overall Study|Patient withdrawal (not due to AE)|6
5129594|NCT01649297|17719251|P1|Overall Study|Patient withdrawal (not due to AE)|3
5129595|NCT01649297|17719247|P5|Overall Study|Lost to Follow-up|0
5129596|NCT01649297|17719248|P4|Overall Study|Lost to Follow-up|3
5129597|NCT01649297|17719249|P3|Overall Study|Lost to Follow-up|4
5129598|NCT01649297|17719250|P2|Overall Study|Lost to Follow-up|1
5129599|NCT01649297|17719251|P1|Overall Study|Lost to Follow-up|1
5129600|NCT01649297|17719247|P5|Overall Study|Non compliant with Protocol|1
5129601|NCT01649297|17719248|P4|Overall Study|Non compliant with Protocol|2
5129602|NCT01649297|17719249|P3|Overall Study|Non compliant with Protocol|3
5129603|NCT01649297|17719250|P2|Overall Study|Non compliant with Protocol|0
5129604|NCT01649297|17719251|P1|Overall Study|Non compliant with Protocol|1
5129605|NCT01649297|17719247|P5|Overall Study|Lack of Efficacy|1
5129606|NCT01649297|17719248|P4|Overall Study|Lack of Efficacy|0
5129607|NCT01649297|17719249|P3|Overall Study|Lack of Efficacy|0
5129608|NCT01649297|17719250|P2|Overall Study|Lack of Efficacy|0
5129609|NCT01649297|17719251|P1|Overall Study|Lack of Efficacy|0
5129610|NCT01649297|17719247|P5|Overall Study|Adverse Event|1
5129611|NCT01649297|17719248|P4|Overall Study|Adverse Event|13
5129612|NCT01649297|17719249|P3|Overall Study|Adverse Event|4
5129613|NCT01649297|17719250|P2|Overall Study|Adverse Event|5
5129614|NCT01649297|17719251|P1|Overall Study|Adverse Event|5
5129615|NCT01649271|17719270|P2|Overall Study|Other than stated above|0
5129616|NCT01649271|17719271|P1|Overall Study|Other than stated above|1
5129617|NCT01649271|17719270|P2|Overall Study|Withdrawal by Subject|0
5129618|NCT01649271|17719271|P1|Overall Study|Withdrawal by Subject|1
5129619|NCT01649271|17719270|P2|Overall Study|Other Adverse Event|2
5129620|NCT01649271|17719271|P1|Overall Study|Other Adverse Event|0
5129621|NCT01649271|17719270|P2|Overall Study|Progressive disease|5
5129622|NCT01649271|17719271|P1|Overall Study|Progressive disease|4
5129623|NCT01649232|17719286|P2|Overall Study|Physician Decision|0
5129624|NCT01649232|17719287|P1|Overall Study|Physician Decision|2
5129625|NCT01648790|17719339|P5|Treatment 3|Withdrawal by Subject|0
5129626|NCT01648790|17719340|P4|Treatment 3|Withdrawal by Subject|1
5129627|NCT01648790|17719341|P3|Treatment 3|Withdrawal by Subject|0
5129628|NCT01648790|17719342|P2|Treatment 3|Withdrawal by Subject|0
5129629|NCT01648790|17719343|P1|Treatment 3|Withdrawal by Subject|0
5129630|NCT01648764|17719378|P14|Overall Study|Investigator Decision|0
5129631|NCT01648764|17719379|P13|Overall Study|Investigator Decision|0
5129632|NCT01648764|17719380|P12|Overall Study|Investigator Decision|1
5129633|NCT01648764|17719381|P11|Overall Study|Investigator Decision|0
5129634|NCT01648764|17719382|P10|Overall Study|Investigator Decision|0
5129635|NCT01648764|17719383|P9|Overall Study|Investigator Decision|0
5129636|NCT01648764|17719384|P8|Overall Study|Investigator Decision|0
5129637|NCT01648764|17719385|P7|Overall Study|Investigator Decision|1
5129638|NCT01648764|17719386|P6|Overall Study|Investigator Decision|0
5129639|NCT01648764|17719387|P5|Overall Study|Investigator Decision|0
5129640|NCT01648764|17719388|P4|Overall Study|Investigator Decision|0
5129641|NCT01648764|17719389|P3|Overall Study|Investigator Decision|0
5129642|NCT01648764|17719390|P2|Overall Study|Investigator Decision|0
5129643|NCT01648764|17719391|P1|Overall Study|Investigator Decision|0
5129644|NCT01648764|17719378|P14|Overall Study|Withdrawal by Subject|0
5129645|NCT01648764|17719379|P13|Overall Study|Withdrawal by Subject|1
5129646|NCT01648764|17719380|P12|Overall Study|Withdrawal by Subject|0
5129647|NCT01648764|17719381|P11|Overall Study|Withdrawal by Subject|0
5129648|NCT01648764|17719382|P10|Overall Study|Withdrawal by Subject|0
5129649|NCT01648764|17719383|P9|Overall Study|Withdrawal by Subject|0
5129650|NCT01648764|17719384|P8|Overall Study|Withdrawal by Subject|0
5129651|NCT01648764|17719385|P7|Overall Study|Withdrawal by Subject|2
5129652|NCT01648764|17719386|P6|Overall Study|Withdrawal by Subject|0
5129653|NCT01648764|17719387|P5|Overall Study|Withdrawal by Subject|0
5129654|NCT01648764|17719388|P4|Overall Study|Withdrawal by Subject|0
5129655|NCT01648764|17719389|P3|Overall Study|Withdrawal by Subject|0
5129656|NCT01648764|17719390|P2|Overall Study|Withdrawal by Subject|0
5129657|NCT01648764|17719391|P1|Overall Study|Withdrawal by Subject|0
5129658|NCT01648764|17719378|P14|Overall Study|Death|1
5129659|NCT01648764|17719379|P13|Overall Study|Death|0
5129660|NCT01648764|17719380|P12|Overall Study|Death|0
5129661|NCT01648764|17719381|P11|Overall Study|Death|0
5129662|NCT01648764|17719382|P10|Overall Study|Death|0
5129663|NCT01648764|17719383|P9|Overall Study|Death|0
5129664|NCT01648764|17719384|P8|Overall Study|Death|0
5129665|NCT01648764|17719385|P7|Overall Study|Death|1
5129666|NCT01648764|17719386|P6|Overall Study|Death|0
5129667|NCT01648764|17719387|P5|Overall Study|Death|0
5129668|NCT01648764|17719388|P4|Overall Study|Death|0
5129669|NCT01648764|17719389|P3|Overall Study|Death|0
5129670|NCT01648764|17719390|P2|Overall Study|Death|0
5129671|NCT01648764|17719391|P1|Overall Study|Death|0
5129672|NCT01648764|17719378|P14|Overall Study|Adverse Event|1
5129673|NCT01648764|17719379|P13|Overall Study|Adverse Event|1
5129674|NCT01648764|17719380|P12|Overall Study|Adverse Event|3
5129675|NCT01648764|17719381|P11|Overall Study|Adverse Event|0
5129676|NCT01648764|17719382|P10|Overall Study|Adverse Event|1
5129677|NCT01648764|17719383|P9|Overall Study|Adverse Event|0
5129678|NCT01648764|17719384|P8|Overall Study|Adverse Event|0
5129679|NCT01648764|17719385|P7|Overall Study|Adverse Event|0
5129680|NCT01648764|17719386|P6|Overall Study|Adverse Event|1
5129681|NCT01648764|17719387|P5|Overall Study|Adverse Event|0
5129682|NCT01648764|17719388|P4|Overall Study|Adverse Event|0
5129683|NCT01648764|17719389|P3|Overall Study|Adverse Event|0
5129684|NCT01648764|17719390|P2|Overall Study|Adverse Event|0
5129685|NCT01648764|17719391|P1|Overall Study|Adverse Event|0
5129686|NCT01648764|17719378|P14|Overall Study|Progressive Disease|1
5129687|NCT01648764|17719379|P13|Overall Study|Progressive Disease|2
5129688|NCT01648764|17719380|P12|Overall Study|Progressive Disease|1
5129689|NCT01648764|17719381|P11|Overall Study|Progressive Disease|0
5129690|NCT01648764|17719382|P10|Overall Study|Progressive Disease|2
5129691|NCT01648764|17719383|P9|Overall Study|Progressive Disease|0
5129692|NCT01648764|17719384|P8|Overall Study|Progressive Disease|0
5129693|NCT01648764|17719385|P7|Overall Study|Progressive Disease|1
5129694|NCT01648764|17719386|P6|Overall Study|Progressive Disease|1
5129695|NCT01648764|17719387|P5|Overall Study|Progressive Disease|0
5129696|NCT01648764|17719388|P4|Overall Study|Progressive Disease|0
5129697|NCT01648764|17719389|P3|Overall Study|Progressive Disease|0
5129698|NCT01648764|17719390|P2|Overall Study|Progressive Disease|1
5129699|NCT01648764|17719391|P1|Overall Study|Progressive Disease|0
5129700|NCT01648699|17719543|P1|Overall Study|Unspecified/unable to complete 4 visits|2
5129701|NCT01648699|17719543|P1|Overall Study|Lost to Follow-up|2
5129702|NCT01648699|17719543|P1|Overall Study|Death|1
5129703|NCT01648582|17719572|P3|Overall Study|Sponsor Decision|1
5129704|NCT01648582|17719573|P2|Overall Study|Sponsor Decision|1
5129705|NCT01648582|17719574|P1|Overall Study|Sponsor Decision|0
5129706|NCT01648582|17719572|P3|Overall Study|Death|0
5129707|NCT01648582|17719573|P2|Overall Study|Death|0
5129708|NCT01648582|17719574|P1|Overall Study|Death|1
5129709|NCT01648582|17719572|P3|Overall Study|Physician Decision|3
5129710|NCT01648582|17719573|P2|Overall Study|Physician Decision|1
5129711|NCT01648582|17719574|P1|Overall Study|Physician Decision|0
5129712|NCT01648582|17719572|P3|Overall Study|Withdrawal by Subject|17
5129713|NCT01648582|17719573|P2|Overall Study|Withdrawal by Subject|17
5129714|NCT01648582|17719574|P1|Overall Study|Withdrawal by Subject|15
5129715|NCT01648582|17719572|P3|Overall Study|Protocol Violation|1
5129716|NCT01648582|17719573|P2|Overall Study|Protocol Violation|2
5129717|NCT01648582|17719574|P1|Overall Study|Protocol Violation|1
5129718|NCT01648582|17719572|P3|Overall Study|Lost to Follow-up|8
5129719|NCT01648582|17719573|P2|Overall Study|Lost to Follow-up|6
5129720|NCT01648582|17719574|P1|Overall Study|Lost to Follow-up|9
5129721|NCT01648582|17719572|P3|Overall Study|Adverse Event|2
5129722|NCT01648582|17719573|P2|Overall Study|Adverse Event|11
5129723|NCT01648582|17719574|P1|Overall Study|Adverse Event|6
5129724|NCT01648348|17719677|P6|Overall Study|Replaced for MTD analysis|0
5129725|NCT01648348|17719678|P5|Overall Study|Replaced for MTD analysis|0
5129726|NCT01648348|17719679|P4|Overall Study|Replaced for MTD analysis|0
5129727|NCT01648348|17719680|P3|Overall Study|Replaced for MTD analysis|1
5129728|NCT01648348|17719681|P2|Overall Study|Replaced for MTD analysis|0
5129729|NCT01648348|17719682|P1|Overall Study|Replaced for MTD analysis|1
5129730|NCT01648348|17719677|P6|Overall Study|Cancel|6
5129731|NCT01648348|17719678|P5|Overall Study|Cancel|3
5129732|NCT01648348|17719679|P4|Overall Study|Cancel|0
5129733|NCT01648348|17719680|P3|Overall Study|Cancel|0
5129734|NCT01648348|17719681|P2|Overall Study|Cancel|0
5129735|NCT01648348|17719682|P1|Overall Study|Cancel|1
5129736|NCT01648283|17719769|P1|Overall Study|Withdrawal by Subject|14
5129737|NCT01648270|17719775|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
5129738|NCT01648166|17719787|P2|Overall Study|inadequate toenail samples|100
5129739|NCT01648166|17719788|P1|Overall Study|inadequate toenail samples|53
5129740|NCT01648140|17719798|P4|Overall Study|Lost to Follow-up|0
5129741|NCT01648140|17719799|P3|Overall Study|Lost to Follow-up|2
5129742|NCT01648140|17719800|P2|Overall Study|Lost to Follow-up|1
5129743|NCT01648140|17719801|P1|Overall Study|Lost to Follow-up|2
5129744|NCT01648140|17719798|P4|Overall Study|Withdrawal by Subject|2
5129745|NCT01648140|17719799|P3|Overall Study|Withdrawal by Subject|3
5129746|NCT01648140|17719800|P2|Overall Study|Withdrawal by Subject|3
5129747|NCT01648140|17719801|P1|Overall Study|Withdrawal by Subject|2
5129748|NCT01648140|17719798|P4|Overall Study|Adverse Event|0
5129749|NCT01648140|17719799|P3|Overall Study|Adverse Event|2
5129750|NCT01648140|17719800|P2|Overall Study|Adverse Event|1
5129751|NCT01648140|17719801|P1|Overall Study|Adverse Event|3
5129752|NCT01648140|17719798|P4|Overall Study|Lack of Efficacy|0
5129753|NCT01648140|17719799|P3|Overall Study|Lack of Efficacy|1
5129754|NCT01648140|17719800|P2|Overall Study|Lack of Efficacy|7
5129755|NCT01648140|17719801|P1|Overall Study|Lack of Efficacy|4
5129756|NCT01648140|17719798|P4|Overall Study|Physician Decision|0
5129757|NCT01648140|17719799|P3|Overall Study|Physician Decision|0
5129758|NCT01648140|17719800|P2|Overall Study|Physician Decision|0
5129759|NCT01648140|17719801|P1|Overall Study|Physician Decision|1
5129760|NCT01648101|17719966|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
5129761|NCT01648101|17719967|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
5129762|NCT01648101|17719968|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
5129763|NCT01648101|17719966|P3|Transition Phase (4 Weeks)|Study Terminated|0
5129764|NCT01648101|17719967|P2|Transition Phase (4 Weeks)|Study Terminated|0
5129765|NCT01648101|17719968|P1|Transition Phase (4 Weeks)|Study Terminated|1
5129766|NCT01648101|17719966|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
5129767|NCT01648101|17719967|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
5129768|NCT01648101|17719968|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
5129769|NCT01648101|17719966|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
5129770|NCT01648101|17719967|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
5129771|NCT01648101|17719968|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
5129772|NCT01648101|17719966|P3|Transition Phase (4 Weeks)|Adverse Event|2
5129773|NCT01648101|17719967|P2|Transition Phase (4 Weeks)|Adverse Event|3
5129774|NCT01648101|17719968|P1|Transition Phase (4 Weeks)|Adverse Event|4
5129775|NCT01648101|17719966|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
5129776|NCT01648101|17719967|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
5129777|NCT01648101|17719968|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
5129778|NCT01648101|17719966|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
5129779|NCT01648101|17719967|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
5129780|NCT01648101|17719968|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
5129781|NCT01648101|17719966|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
5129782|NCT01648101|17719967|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
5129783|NCT01648101|17719968|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
5129784|NCT01648101|17719966|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
5129785|NCT01648101|17719967|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
5129786|NCT01648101|17719968|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
5129787|NCT01648101|17719966|P3|Titration Phase (4 Weeks)|Adverse Event|3
5129788|NCT01648101|17719967|P2|Titration Phase (4 Weeks)|Adverse Event|2
5129789|NCT01648101|17719968|P1|Titration Phase (4 Weeks)|Adverse Event|0
5129790|NCT01648101|17719966|P3|Titration Phase (4 Weeks)|Protocol Violation|2
5129791|NCT01648101|17719967|P2|Titration Phase (4 Weeks)|Protocol Violation|1
5129792|NCT01648101|17719968|P1|Titration Phase (4 Weeks)|Protocol Violation|2
5129793|NCT01647958|17720018|P2|Extended Follow-up Phase|Lost to Follow-up|0
5129794|NCT01647958|17720019|P1|Extended Follow-up Phase|Lost to Follow-up|8
5129795|NCT01647958|17720018|P2|Continuation Phase|treatment received during Overall Study|0
5129796|NCT01647958|17720019|P1|Continuation Phase|treatment received during Overall Study|39
5129797|NCT01647958|17720018|P2|Initial Study|Lost to Follow-up|3
5129798|NCT01647958|17720019|P1|Initial Study|Lost to Follow-up|2
5129799|NCT01647711|17720106|P5|Overall Study|Other reason not defined|0
5129800|NCT01647711|17720107|P4|Overall Study|Other reason not defined|1
5129801|NCT01647711|17720108|P3|Overall Study|Other reason not defined|1
5129802|NCT01647711|17720109|P2|Overall Study|Other reason not defined|1
5129803|NCT01647711|17720110|P1|Overall Study|Other reason not defined|0
5129804|NCT01647711|17720106|P5|Overall Study|Refused to continue taking medication|1
5129805|NCT01647711|17720107|P4|Overall Study|Refused to continue taking medication|2
5129806|NCT01647711|17720108|P3|Overall Study|Refused to continue taking medication|0
5129807|NCT01647711|17720109|P2|Overall Study|Refused to continue taking medication|0
5129808|NCT01647711|17720110|P1|Overall Study|Refused to continue taking medication|0
5129809|NCT01647711|17720106|P5|Overall Study|Protocol Violation|1
5129810|NCT01647711|17720107|P4|Overall Study|Protocol Violation|0
5129811|NCT01647711|17720108|P3|Overall Study|Protocol Violation|0
5129812|NCT01647711|17720109|P2|Overall Study|Protocol Violation|0
5129813|NCT01647711|17720110|P1|Overall Study|Protocol Violation|0
5129814|NCT01647711|17720106|P5|Overall Study|Other adverse event|2
5129815|NCT01647711|17720107|P4|Overall Study|Other adverse event|0
5129816|NCT01647711|17720108|P3|Overall Study|Other adverse event|2
5129817|NCT01647711|17720109|P2|Overall Study|Other adverse event|0
5129818|NCT01647711|17720110|P1|Overall Study|Other adverse event|0
5129819|NCT01647711|17720106|P5|Overall Study|Progressive disease|2
5129820|NCT01647711|17720107|P4|Overall Study|Progressive disease|8
5129821|NCT01647711|17720108|P3|Overall Study|Progressive disease|6
5129822|NCT01647711|17720109|P2|Overall Study|Progressive disease|2
5129823|NCT01647711|17720110|P1|Overall Study|Progressive disease|6
5129824|NCT01647542|17720147|P3|Overall Study|Death|1
5129825|NCT01647542|17720148|P2|Overall Study|Death|0
5129826|NCT01647542|17720149|P1|Overall Study|Death|0
5129827|NCT01647542|17720147|P3|Overall Study|Lack of Efficacy|0
5129828|NCT01647542|17720148|P2|Overall Study|Lack of Efficacy|1
5129829|NCT01647542|17720149|P1|Overall Study|Lack of Efficacy|1
5129830|NCT01647542|17720147|P3|Overall Study|Study Termination|65
5129831|NCT01647542|17720148|P2|Overall Study|Study Termination|61
5129832|NCT01647542|17720149|P1|Overall Study|Study Termination|64
5129833|NCT01647542|17720147|P3|Overall Study|Withdrawal by Subject|0
5129834|NCT01647542|17720148|P2|Overall Study|Withdrawal by Subject|4
5129835|NCT01647542|17720149|P1|Overall Study|Withdrawal by Subject|6
5129836|NCT01647542|17720147|P3|Overall Study|Lost to Follow-up|2
5129837|NCT01647542|17720148|P2|Overall Study|Lost to Follow-up|2
5129838|NCT01647542|17720149|P1|Overall Study|Lost to Follow-up|0
5129839|NCT01647542|17720147|P3|Overall Study|Adverse Event|4
5129840|NCT01647542|17720148|P2|Overall Study|Adverse Event|5
5129841|NCT01647542|17720149|P1|Overall Study|Adverse Event|4
5129842|NCT01647542|17720147|P3|Overall Study|Major Protocol Deviation|0
5129843|NCT01647542|17720148|P2|Overall Study|Major Protocol Deviation|0
5129844|NCT01647542|17720149|P1|Overall Study|Major Protocol Deviation|1
5129845|NCT01647516|17720169|P6|Open-Label Period|No completion / discontinuation visit|1
5129846|NCT01647516|17720170|P5|Open-Label Period|No completion / discontinuation visit|2
5129847|NCT01647516|17720171|P4|Open-Label Period|No completion / discontinuation visit|0
5129848|NCT01647516|17720172|P3|Open-Label Period|No completion / discontinuation visit|0
5129849|NCT01647516|17720173|P2|Open-Label Period|No completion / discontinuation visit|0
5129850|NCT01647516|17720174|P1|Open-Label Period|No completion / discontinuation visit|0
5129851|NCT01647516|17720169|P6|Open-Label Period|Participant Choice to Stop Study Drug|10
5129852|NCT01647516|17720170|P5|Open-Label Period|Participant Choice to Stop Study Drug|9
5129853|NCT01647516|17720171|P4|Open-Label Period|Participant Choice to Stop Study Drug|7
5129854|NCT01647516|17720172|P3|Open-Label Period|Participant Choice to Stop Study Drug|0
5129855|NCT01647516|17720173|P2|Open-Label Period|Participant Choice to Stop Study Drug|0
5129856|NCT01647516|17720174|P1|Open-Label Period|Participant Choice to Stop Study Drug|0
5129857|NCT01647516|17720169|P6|Open-Label Period|Lack of Efficacy|10
5129858|NCT01647516|17720170|P5|Open-Label Period|Lack of Efficacy|9
5129859|NCT01647516|17720171|P4|Open-Label Period|Lack of Efficacy|7
5129860|NCT01647516|17720172|P3|Open-Label Period|Lack of Efficacy|0
5129861|NCT01647516|17720173|P2|Open-Label Period|Lack of Efficacy|0
5129862|NCT01647516|17720174|P1|Open-Label Period|Lack of Efficacy|0
5129863|NCT01647516|17720169|P6|Open-Label Period|Sponsor Termination; moved to 3102 study|23
5129864|NCT01647516|17720170|P5|Open-Label Period|Sponsor Termination; moved to 3102 study|13
5129865|NCT01647516|17720171|P4|Open-Label Period|Sponsor Termination; moved to 3102 study|18
5129866|NCT01647516|17720172|P3|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5129867|NCT01647516|17720173|P2|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5129868|NCT01647516|17720174|P1|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5129869|NCT01647516|17720169|P6|Open-Label Period|Lost to Follow-up|1
5129870|NCT01647516|17720170|P5|Open-Label Period|Lost to Follow-up|0
5129871|NCT01647516|17720171|P4|Open-Label Period|Lost to Follow-up|1
5129872|NCT01647516|17720172|P3|Open-Label Period|Lost to Follow-up|0
5129873|NCT01647516|17720173|P2|Open-Label Period|Lost to Follow-up|0
5129874|NCT01647516|17720174|P1|Open-Label Period|Lost to Follow-up|0
5129875|NCT01647516|17720169|P6|Open-Label Period|Withdrawal by Subject|6
5129876|NCT01647516|17720170|P5|Open-Label Period|Withdrawal by Subject|11
5129877|NCT01647516|17720171|P4|Open-Label Period|Withdrawal by Subject|9
5129878|NCT01647516|17720172|P3|Open-Label Period|Withdrawal by Subject|0
5129879|NCT01647516|17720173|P2|Open-Label Period|Withdrawal by Subject|0
5129880|NCT01647516|17720174|P1|Open-Label Period|Withdrawal by Subject|0
5129881|NCT01647516|17720169|P6|Open-Label Period|Physician Decision|0
5129882|NCT01647516|17720170|P5|Open-Label Period|Physician Decision|1
5129883|NCT01647516|17720171|P4|Open-Label Period|Physician Decision|1
5129884|NCT01647516|17720172|P3|Open-Label Period|Physician Decision|0
5129885|NCT01647516|17720173|P2|Open-Label Period|Physician Decision|0
5129886|NCT01647516|17720174|P1|Open-Label Period|Physician Decision|0
5129887|NCT01647516|17720169|P6|Open-Label Period|Non-compliance|1
5129888|NCT01647516|17720170|P5|Open-Label Period|Non-compliance|0
5129889|NCT01647516|17720171|P4|Open-Label Period|Non-compliance|1
5129890|NCT01647516|17720172|P3|Open-Label Period|Non-compliance|0
5129891|NCT01647516|17720173|P2|Open-Label Period|Non-compliance|0
5129892|NCT01647516|17720174|P1|Open-Label Period|Non-compliance|0
5129893|NCT01647516|17720169|P6|Open-Label Period|Pregnancy|1
5129894|NCT01647516|17720170|P5|Open-Label Period|Pregnancy|0
5129895|NCT01647516|17720171|P4|Open-Label Period|Pregnancy|0
5129896|NCT01647516|17720172|P3|Open-Label Period|Pregnancy|0
5129897|NCT01647516|17720173|P2|Open-Label Period|Pregnancy|0
5129898|NCT01647516|17720174|P1|Open-Label Period|Pregnancy|0
5129899|NCT01647516|17720169|P6|Open-Label Period|Adverse Event|3
5129900|NCT01647516|17720170|P5|Open-Label Period|Adverse Event|6
5129901|NCT01647516|17720171|P4|Open-Label Period|Adverse Event|5
5129902|NCT01647516|17720172|P3|Open-Label Period|Adverse Event|0
5129903|NCT01647516|17720173|P2|Open-Label Period|Adverse Event|0
5129904|NCT01647516|17720174|P1|Open-Label Period|Adverse Event|0
5129905|NCT01647516|17720169|P6|Maintenance Period (MP)|Lack of Efficacy|0
5129906|NCT01647516|17720170|P5|Maintenance Period (MP)|Lack of Efficacy|0
5129907|NCT01647516|17720171|P4|Maintenance Period (MP)|Lack of Efficacy|0
5129908|NCT01647516|17720172|P3|Maintenance Period (MP)|Lack of Efficacy|1
5129909|NCT01647516|17720173|P2|Maintenance Period (MP)|Lack of Efficacy|4
5129910|NCT01647516|17720174|P1|Maintenance Period (MP)|Lack of Efficacy|1
5129911|NCT01647516|17720169|P6|Maintenance Period (MP)|Withdrawal by Subject|0
5129912|NCT01647516|17720170|P5|Maintenance Period (MP)|Withdrawal by Subject|0
5129913|NCT01647516|17720171|P4|Maintenance Period (MP)|Withdrawal by Subject|0
5129914|NCT01647516|17720172|P3|Maintenance Period (MP)|Withdrawal by Subject|1
5129915|NCT01647516|17720173|P2|Maintenance Period (MP)|Withdrawal by Subject|1
5129916|NCT01647516|17720174|P1|Maintenance Period (MP)|Withdrawal by Subject|0
5129917|NCT01647516|17720169|P6|Maintenance Period (MP)|Non-compliance|0
5129918|NCT01647516|17720170|P5|Maintenance Period (MP)|Non-compliance|0
5129919|NCT01647516|17720171|P4|Maintenance Period (MP)|Non-compliance|0
5129920|NCT01647516|17720172|P3|Maintenance Period (MP)|Non-compliance|0
5129921|NCT01647516|17720173|P2|Maintenance Period (MP)|Non-compliance|0
5129922|NCT01647516|17720174|P1|Maintenance Period (MP)|Non-compliance|1
5129923|NCT01647516|17720169|P6|Maintenance Period (MP)|Adverse Event|0
5129924|NCT01647516|17720170|P5|Maintenance Period (MP)|Adverse Event|0
5129925|NCT01647516|17720171|P4|Maintenance Period (MP)|Adverse Event|0
5129926|NCT01647516|17720172|P3|Maintenance Period (MP)|Adverse Event|0
5129927|NCT01647516|17720173|P2|Maintenance Period (MP)|Adverse Event|1
5129928|NCT01647516|17720174|P1|Maintenance Period (MP)|Adverse Event|2
5129929|NCT01647516|17720169|P6|Induction Period (IP)|No study drug received|0
5129930|NCT01647516|17720170|P5|Induction Period (IP)|No study drug received|0
5129931|NCT01647516|17720171|P4|Induction Period (IP)|No study drug received|0
5129932|NCT01647516|17720172|P3|Induction Period (IP)|No study drug received|0
5129933|NCT01647516|17720173|P2|Induction Period (IP)|No study drug received|1
5129934|NCT01647516|17720174|P1|Induction Period (IP)|No study drug received|1
5129935|NCT01647516|17720169|P6|Induction Period (IP)|Lack of Efficacy|0
5129936|NCT01647516|17720170|P5|Induction Period (IP)|Lack of Efficacy|0
5129937|NCT01647516|17720171|P4|Induction Period (IP)|Lack of Efficacy|0
5129938|NCT01647516|17720172|P3|Induction Period (IP)|Lack of Efficacy|0
5129939|NCT01647516|17720173|P2|Induction Period (IP)|Lack of Efficacy|0
5129940|NCT01647516|17720174|P1|Induction Period (IP)|Lack of Efficacy|1
5129941|NCT01647516|17720169|P6|Induction Period (IP)|Participant Choice|0
5129942|NCT01647516|17720170|P5|Induction Period (IP)|Participant Choice|0
5129943|NCT01647516|17720171|P4|Induction Period (IP)|Participant Choice|0
5129944|NCT01647516|17720172|P3|Induction Period (IP)|Participant Choice|1
5129945|NCT01647516|17720173|P2|Induction Period (IP)|Participant Choice|0
5129946|NCT01647516|17720174|P1|Induction Period (IP)|Participant Choice|0
5129947|NCT01647516|17720169|P6|Induction Period (IP)|Withdrawal by Subject|0
5129948|NCT01647516|17720170|P5|Induction Period (IP)|Withdrawal by Subject|0
5129949|NCT01647516|17720171|P4|Induction Period (IP)|Withdrawal by Subject|0
5129950|NCT01647516|17720172|P3|Induction Period (IP)|Withdrawal by Subject|3
5129951|NCT01647516|17720173|P2|Induction Period (IP)|Withdrawal by Subject|0
5129952|NCT01647516|17720174|P1|Induction Period (IP)|Withdrawal by Subject|1
5129953|NCT01647516|17720169|P6|Induction Period (IP)|Adverse Event|0
5129954|NCT01647516|17720170|P5|Induction Period (IP)|Adverse Event|0
5129955|NCT01647516|17720171|P4|Induction Period (IP)|Adverse Event|0
5129956|NCT01647516|17720172|P3|Induction Period (IP)|Adverse Event|0
5129957|NCT01647516|17720173|P2|Induction Period (IP)|Adverse Event|2
5129958|NCT01647516|17720174|P1|Induction Period (IP)|Adverse Event|1
5129959|NCT01647516|17720169|P6|Induction Period (IP)|Physician Decision|0
5129960|NCT01647516|17720170|P5|Induction Period (IP)|Physician Decision|0
5129961|NCT01647516|17720171|P4|Induction Period (IP)|Physician Decision|0
5129962|NCT01647516|17720172|P3|Induction Period (IP)|Physician Decision|0
5129963|NCT01647516|17720173|P2|Induction Period (IP)|Physician Decision|0
5129964|NCT01647516|17720174|P1|Induction Period (IP)|Physician Decision|2
5129965|NCT01647282|17720230|P2|Overall Study|Physician Decision|5
5129966|NCT01647282|17720231|P1|Overall Study|Physician Decision|7
5129967|NCT01646827|17720252|P2|Overall Study|Withdrawal by Subject|0
5129968|NCT01646827|17720253|P1|Overall Study|Withdrawal by Subject|1
5129969|NCT01646827|17720252|P2|Overall Study|Physician Decision|2
5129970|NCT01646827|17720253|P1|Overall Study|Physician Decision|1
5129971|NCT01646827|17720252|P2|Overall Study|Lost to Follow-up|3
5129972|NCT01646827|17720253|P1|Overall Study|Lost to Follow-up|0
5129973|NCT01646398|17720340|P2|Overall Study|Withdrawal by Subject|0
5129974|NCT01646398|17720341|P1|Overall Study|Withdrawal by Subject|1
5129975|NCT01646385|17720357|P2|Overall Study|Switched to alternate biologic|649
5129976|NCT01646385|17720358|P1|Overall Study|Switched to alternate biologic|636
5129977|NCT01646385|17720357|P2|Overall Study|Death|222
5129978|NCT01646385|17720358|P1|Overall Study|Death|202
5129979|NCT01646320|17720401|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
5129980|NCT01646320|17720402|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
5129981|NCT01646320|17720401|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
5129982|NCT01646320|17720402|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
5129983|NCT01646320|17720401|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
5129984|NCT01646320|17720402|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
5129985|NCT01646320|17720401|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
5129986|NCT01646320|17720402|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
5129987|NCT01646320|17720401|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
5129988|NCT01646320|17720402|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
5129989|NCT01646320|17720401|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
5129990|NCT01646320|17720402|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
5129991|NCT01646320|17720401|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5129992|NCT01646320|17720402|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5129993|NCT01646320|17720401|P2|Short-term Period (Day 1 to Week 24)|Other|0
5129994|NCT01646320|17720402|P1|Short-term Period (Day 1 to Week 24)|Other|1
5129995|NCT01646320|17720401|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
5129996|NCT01646320|17720402|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
5129997|NCT01646320|17720401|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
5129998|NCT01646320|17720402|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
5129999|NCT01646320|17720401|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
5130000|NCT01646320|17720402|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
5130001|NCT01646268|17720418|P2|Overall Study|Other|0
5130002|NCT01646268|17720419|P1|Overall Study|Other|2
5130003|NCT01646268|17720418|P2|Overall Study|Withdrawal by Subject|5
5130004|NCT01646268|17720419|P1|Overall Study|Withdrawal by Subject|2
5130005|NCT01646268|17720418|P2|Overall Study|Protocol Violation|1
5130006|NCT01646268|17720419|P1|Overall Study|Protocol Violation|0
5130007|NCT01646268|17720418|P2|Overall Study|Lack of Efficacy|3
5130008|NCT01646268|17720419|P1|Overall Study|Lack of Efficacy|1
5130009|NCT01646268|17720418|P2|Overall Study|Adverse Event|7
5130010|NCT01646268|17720419|P1|Overall Study|Adverse Event|6
5130011|NCT01646255|17720433|P2|Overall Study|Inclusion Criteria Deviation|0
5130012|NCT01646255|17720434|P1|Overall Study|Inclusion Criteria Deviation|1
5130013|NCT01646255|17720433|P2|Overall Study|Compliance is not well|0
5130014|NCT01646255|17720434|P1|Overall Study|Compliance is not well|1
5130015|NCT01646255|17720433|P2|Overall Study|Withdrawal by Subject|6
5130016|NCT01646255|17720434|P1|Overall Study|Withdrawal by Subject|10
5130017|NCT01646255|17720433|P2|Overall Study|Lack of Efficacy|0
5130018|NCT01646255|17720434|P1|Overall Study|Lack of Efficacy|2
5130019|NCT01646255|17720433|P2|Overall Study|Adverse Event|8
5130020|NCT01646255|17720434|P1|Overall Study|Adverse Event|7
5130021|NCT01646216|17720466|P2|Overall Study|Investigator decision|1
5130022|NCT01646216|17720467|P1|Overall Study|Investigator decision|1
5130023|NCT01646216|17720466|P2|Overall Study|Did not complete training|2
5130024|NCT01646216|17720467|P1|Overall Study|Did not complete training|0
5130025|NCT01646216|17720466|P2|Overall Study|Baseline step length difference (<5cm)|10
5130026|NCT01646216|17720467|P1|Overall Study|Baseline step length difference (<5cm)|10
5130027|NCT01646203|17720489|P3|Overall Study|Physician's Decision|0
5130028|NCT01646203|17720490|P2|Overall Study|Physician's Decision|1
5130029|NCT01646203|17720491|P1|Overall Study|Physician's Decision|0
5130030|NCT01646203|17720489|P3|Overall Study|Withdrawal by Subject|0
5130031|NCT01646203|17720490|P2|Overall Study|Withdrawal by Subject|1
5130032|NCT01646203|17720491|P1|Overall Study|Withdrawal by Subject|0
5130033|NCT01646203|17720489|P3|Overall Study|Adverse Event|1
5130034|NCT01646203|17720490|P2|Overall Study|Adverse Event|0
5130035|NCT01646203|17720491|P1|Overall Study|Adverse Event|2
5130036|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
5130037|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
5130038|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130039|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130040|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130041|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130042|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130043|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130044|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130045|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130046|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130047|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5130048|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5130049|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5130050|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130051|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5130052|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130053|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130054|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130055|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130056|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130057|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130058|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130059|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5130060|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5130061|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5130062|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5130063|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130064|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130065|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130066|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130067|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130068|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130069|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130070|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130071|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5130072|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
5130073|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
5130074|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
5130075|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130076|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130077|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130078|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130079|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130080|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130081|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130082|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130083|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5130084|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
5130085|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
5130086|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
5130087|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
5130088|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130089|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130090|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130091|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130092|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130093|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130094|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130095|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5130096|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
5130097|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
5130098|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
5130099|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
5130100|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130101|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130102|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130103|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130104|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130105|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130106|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130107|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5130108|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
5130109|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
5130110|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
5130111|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
5130112|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130113|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130114|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130115|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130116|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130117|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130118|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130119|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5130120|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
5130121|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
5130122|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
5130123|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
5130124|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130125|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130126|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130127|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130128|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130129|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130130|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130131|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5130132|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
5130133|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
5130134|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
5130135|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
5130136|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130137|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130138|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130139|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130140|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130141|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130142|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130143|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5130144|NCT01646177|17720520|P12|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
5130145|NCT01646177|17720521|P11|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
5130146|NCT01646177|17720522|P10|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
5130147|NCT01646177|17720523|P9|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
5130148|NCT01646177|17720524|P8|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130149|NCT01646177|17720525|P7|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130150|NCT01646177|17720526|P6|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130151|NCT01646177|17720527|P5|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130152|NCT01646177|17720528|P4|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130153|NCT01646177|17720529|P3|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130154|NCT01646177|17720530|P2|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130155|NCT01646177|17720531|P1|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5130156|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130157|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130158|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130159|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130160|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
5130161|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
5130162|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
5130163|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130164|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130165|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130166|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130167|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5130168|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130169|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130170|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130171|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130172|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
5130173|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130174|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130175|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130176|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130177|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130178|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130179|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5130180|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130181|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130182|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130183|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130184|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
5130185|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5130186|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5130187|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5130188|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130189|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130190|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130191|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5130192|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Death|0
5130193|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Death|0
5130194|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Death|0
5130195|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Death|0
5130196|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Death|3
5130197|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Death|1
5130198|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Death|3
5130199|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Death|1
5130200|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Death|0
5130201|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Death|0
5130202|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Death|0
5130203|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Death|0
5130204|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130205|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130206|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130207|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130208|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5130209|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5130210|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5130211|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
5130212|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130213|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130214|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130215|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5130216|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130217|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130218|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130219|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130220|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
5130221|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130222|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
5130223|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
5130224|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130225|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130226|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130227|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5130228|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130229|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130230|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130231|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130232|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5130233|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5130234|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5130235|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Physician Decision|3
5130236|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130237|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130238|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130239|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5130240|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130241|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130242|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130243|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130244|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
5130245|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
5130246|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
5130247|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
5130248|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130249|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130250|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130251|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5130252|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130253|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130254|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130255|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130256|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
5130257|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
5130258|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
5130259|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
5130260|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130261|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130262|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130263|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5130264|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130265|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130266|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130267|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130268|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
5130269|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
5130270|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
5130271|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
5130272|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130273|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130274|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130275|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5130276|NCT01646177|17720520|P12|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130277|NCT01646177|17720521|P11|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130278|NCT01646177|17720522|P10|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130279|NCT01646177|17720523|P9|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130280|NCT01646177|17720524|P8|Long-Term Extension Period (Week 12-264)|Adverse Event|30
5130281|NCT01646177|17720525|P7|Long-Term Extension Period (Week 12-264)|Adverse Event|43
5130282|NCT01646177|17720526|P6|Long-Term Extension Period (Week 12-264)|Adverse Event|34
5130283|NCT01646177|17720527|P5|Long-Term Extension Period (Week 12-264)|Adverse Event|16
5130284|NCT01646177|17720528|P4|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130285|NCT01646177|17720529|P3|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130286|NCT01646177|17720530|P2|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130287|NCT01646177|17720531|P1|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5130288|NCT01646177|17720520|P12|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130289|NCT01646177|17720521|P11|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130290|NCT01646177|17720522|P10|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130291|NCT01646177|17720523|P9|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130292|NCT01646177|17720524|P8|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130293|NCT01646177|17720525|P7|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130294|NCT01646177|17720526|P6|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130295|NCT01646177|17720527|P5|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130296|NCT01646177|17720528|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5130297|NCT01646177|17720529|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
5130298|NCT01646177|17720530|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
5130299|NCT01646177|17720531|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
5130300|NCT01646177|17720520|P12|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130301|NCT01646177|17720521|P11|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130302|NCT01646177|17720522|P10|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130303|NCT01646177|17720523|P9|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130304|NCT01646177|17720524|P8|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130305|NCT01646177|17720525|P7|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130306|NCT01646177|17720526|P6|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130307|NCT01646177|17720527|P5|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130308|NCT01646177|17720528|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
5130309|NCT01646177|17720529|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
5130310|NCT01646177|17720530|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130311|NCT01646177|17720531|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5130312|NCT01646177|17720520|P12|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130313|NCT01646177|17720521|P11|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130314|NCT01646177|17720522|P10|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130315|NCT01646177|17720523|P9|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130316|NCT01646177|17720524|P8|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130317|NCT01646177|17720525|P7|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130318|NCT01646177|17720526|P6|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130319|NCT01646177|17720527|P5|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5130320|NCT01646177|17720528|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
5130321|NCT01646177|17720529|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
5130322|NCT01646177|17720530|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
5130323|NCT01646177|17720531|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
5130324|NCT01646177|17720520|P12|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130325|NCT01646177|17720521|P11|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130326|NCT01646177|17720522|P10|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130327|NCT01646177|17720523|P9|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130328|NCT01646177|17720524|P8|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130329|NCT01646177|17720525|P7|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130330|NCT01646177|17720526|P6|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130331|NCT01646177|17720527|P5|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5130332|NCT01646177|17720528|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
5130333|NCT01646177|17720529|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
5130334|NCT01646177|17720530|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
5130335|NCT01646177|17720531|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
5130336|NCT01646177|17720520|P12|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130337|NCT01646177|17720521|P11|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130338|NCT01646177|17720522|P10|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130339|NCT01646177|17720523|P9|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130340|NCT01646177|17720524|P8|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130341|NCT01646177|17720525|P7|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130342|NCT01646177|17720526|P6|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130343|NCT01646177|17720527|P5|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5130344|NCT01646177|17720528|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
5130345|NCT01646177|17720529|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
5130346|NCT01646177|17720530|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
5130347|NCT01646177|17720531|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
5130348|NCT01646177|17720520|P12|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130349|NCT01646177|17720521|P11|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130350|NCT01646177|17720522|P10|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130351|NCT01646177|17720523|P9|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130352|NCT01646177|17720524|P8|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130353|NCT01646177|17720525|P7|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130354|NCT01646177|17720526|P6|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130355|NCT01646177|17720527|P5|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5130356|NCT01646177|17720528|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
5130357|NCT01646177|17720529|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
5130358|NCT01646177|17720530|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
5130359|NCT01646177|17720531|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
5130360|NCT01646138|17720633|P5|Overall Study|Lost to Follow-up|2
5130361|NCT01646138|17720634|P4|Overall Study|Lost to Follow-up|0
5130362|NCT01646138|17720635|P3|Overall Study|Lost to Follow-up|0
5130363|NCT01646138|17720636|P2|Overall Study|Lost to Follow-up|0
5130364|NCT01646138|17720637|P1|Overall Study|Lost to Follow-up|0
5130365|NCT01646125|17720651|P2|Overall Study|Subject/Guardian decision|1
5130366|NCT01646125|17720652|P1|Overall Study|Subject/Guardian decision|1
5130367|NCT01646125|17720651|P2|Overall Study|Study terminated by sponsor|1
5130368|NCT01646125|17720652|P1|Overall Study|Study terminated by sponsor|2
5130369|NCT01646125|17720651|P2|Overall Study|Progressive disease|16
5130370|NCT01646125|17720652|P1|Overall Study|Progressive disease|22
5130371|NCT01646125|17720651|P2|Overall Study|Physician Decision|3
5130372|NCT01646125|17720652|P1|Overall Study|Physician Decision|1
5130373|NCT01646125|17720651|P2|Overall Study|Death|1
5130374|NCT01646125|17720652|P1|Overall Study|Death|1
5130375|NCT01646125|17720651|P2|Overall Study|Adverse Event|1
5130376|NCT01646125|17720652|P1|Overall Study|Adverse Event|2
5130377|NCT01646125|17720651|P2|Overall Study|Untreated|5
5130378|NCT01646125|17720652|P1|Overall Study|Untreated|2
5130379|NCT01646073|17720677|P2|Period B (12 Weeks)|Lost to Follow-up|1
5130380|NCT01646073|17720678|P1|Period B (12 Weeks)|Lost to Follow-up|0
5130381|NCT01646073|17720677|P2|Period B (12 Weeks)|Withdrawal by Subject|5
5130382|NCT01646073|17720678|P1|Period B (12 Weeks)|Withdrawal by Subject|1
5130383|NCT01646073|17720677|P2|Period B (12 Weeks)|Adverse Event|7
5130384|NCT01646073|17720678|P1|Period B (12 Weeks)|Adverse Event|0
5130385|NCT01646073|17720677|P2|Period A (12 Weeks)|Other|1
5130386|NCT01646073|17720678|P1|Period A (12 Weeks)|Other|0
5130387|NCT01646073|17720677|P2|Period A (12 Weeks)|Protocol Violation|1
5130388|NCT01646073|17720678|P1|Period A (12 Weeks)|Protocol Violation|0
5130389|NCT01646073|17720677|P2|Period A (12 Weeks)|Lack of Efficacy|0
5130390|NCT01646073|17720678|P1|Period A (12 Weeks)|Lack of Efficacy|1
5130391|NCT01646073|17720677|P2|Period A (12 Weeks)|Withdrawal by Subject|1
5130392|NCT01646073|17720678|P1|Period A (12 Weeks)|Withdrawal by Subject|1
5130393|NCT01646073|17720677|P2|Period A (12 Weeks)|Adverse Event|2
5130394|NCT01646073|17720678|P1|Period A (12 Weeks)|Adverse Event|0
5130395|NCT01646021|17720719|P2|Overall Study|Withdrawal by Subject|15
5130396|NCT01646021|17720720|P1|Overall Study|Withdrawal by Subject|10
5130397|NCT01646021|17720719|P2|Overall Study|Lost to Follow-up|2
5130398|NCT01646021|17720720|P1|Overall Study|Lost to Follow-up|2
5130399|NCT01646021|17720719|P2|Overall Study|Study Terminated by Sponsor|41
5130400|NCT01646021|17720720|P1|Overall Study|Study Terminated by Sponsor|50
5130401|NCT01646021|17720719|P2|Overall Study|Death|83
5130402|NCT01646021|17720720|P1|Overall Study|Death|77
5130403|NCT01645930|17720757|P1|Overall Study|Reason not Defined|1
5130404|NCT01645930|17720757|P1|Overall Study|Withdrawal by Participant|2
5130405|NCT01645930|17720757|P1|Overall Study|Unsatisfactory Therapeutic Response|2
5130406|NCT01645930|17720757|P1|Overall Study|Adverse Event|4
5130407|NCT01645930|17720757|P1|Overall Study|Progressive Disease|12
5130408|NCT01645930|17720757|P1|Overall Study|Participants Ongoing on Study Treatment|22
5130409|NCT01645735|17720774|P2|Overall Study|Adverse Event|1
5130410|NCT01645735|17720775|P1|Overall Study|Adverse Event|0
5130411|NCT01645735|17720774|P2|Overall Study|Protocol Violation|0
5130412|NCT01645735|17720775|P1|Overall Study|Protocol Violation|1
5130413|NCT01645735|17720774|P2|Overall Study|Withdrawal by Subject|0
5130414|NCT01645735|17720775|P1|Overall Study|Withdrawal by Subject|1
5130415|NCT01645735|17720774|P2|Overall Study|Physician Decision|0
5130416|NCT01645735|17720775|P1|Overall Study|Physician Decision|2
5130417|NCT01645280|17720817|P5|Overall Study|Treatment not completed/Completed f/u|2
5130418|NCT01645280|17720818|P4|Overall Study|Treatment not completed/Completed f/u|0
5130419|NCT01645280|17720819|P3|Overall Study|Treatment not completed/Completed f/u|2
5130420|NCT01645280|17720820|P2|Overall Study|Treatment not completed/Completed f/u|1
5130421|NCT01645280|17720821|P1|Overall Study|Treatment not completed/Completed f/u|1
5130422|NCT01645280|17720817|P5|Overall Study|Other|0
5130423|NCT01645280|17720818|P4|Overall Study|Other|0
5130424|NCT01645280|17720819|P3|Overall Study|Other|2
5130425|NCT01645280|17720820|P2|Overall Study|Other|1
5130426|NCT01645280|17720821|P1|Overall Study|Other|1
5130427|NCT01645280|17720817|P5|Overall Study|Lost to Follow-up|1
5130428|NCT01645280|17720818|P4|Overall Study|Lost to Follow-up|2
5130429|NCT01645280|17720819|P3|Overall Study|Lost to Follow-up|0
5130430|NCT01645280|17720820|P2|Overall Study|Lost to Follow-up|0
5130431|NCT01645280|17720821|P1|Overall Study|Lost to Follow-up|0
5130432|NCT01645280|17720817|P5|Overall Study|Withdrawal by Subject|5
5130433|NCT01645280|17720818|P4|Overall Study|Withdrawal by Subject|4
5130434|NCT01645280|17720819|P3|Overall Study|Withdrawal by Subject|2
5130435|NCT01645280|17720820|P2|Overall Study|Withdrawal by Subject|0
5130436|NCT01645280|17720821|P1|Overall Study|Withdrawal by Subject|4
5130437|NCT01645280|17720817|P5|Overall Study|Death|0
5130438|NCT01645280|17720818|P4|Overall Study|Death|0
5130439|NCT01645280|17720819|P3|Overall Study|Death|0
5130440|NCT01645280|17720820|P2|Overall Study|Death|1
5130441|NCT01645280|17720821|P1|Overall Study|Death|0
5130442|NCT01645176|17720849|P1|Overall Study|did not complete final MRI|1
5130443|NCT01645176|17720849|P1|Overall Study|Lack of Efficacy|4
5130444|NCT01645111|17720853|P1|Overall Study|Did not require Clevidipine|15
5130445|NCT01644890|17720894|P2|Overall Study|Other|9
5130446|NCT01644890|17720895|P1|Overall Study|Other|8
5130447|NCT01644890|17720894|P2|Overall Study|> 28 days since last dose of study drug|3
5130448|NCT01644890|17720895|P1|Overall Study|> 28 days since last dose of study drug|6
5130449|NCT01644890|17720894|P2|Overall Study|Clinical Progression|6
5130450|NCT01644890|17720895|P1|Overall Study|Clinical Progression|6
5130451|NCT01644890|17720894|P2|Overall Study|Progression Disease|131
5130452|NCT01644890|17720895|P1|Overall Study|Progression Disease|160
5130453|NCT01644890|17720894|P2|Overall Study|Withdrawal by Subject|27
5130454|NCT01644890|17720895|P1|Overall Study|Withdrawal by Subject|19
5130455|NCT01644890|17720894|P2|Overall Study|Protocol Violation|7
5130456|NCT01644890|17720895|P1|Overall Study|Protocol Violation|6
5130457|NCT01644890|17720894|P2|Overall Study|Physician Decision|9
5130458|NCT01644890|17720895|P1|Overall Study|Physician Decision|3
5130459|NCT01644890|17720894|P2|Overall Study|Death|3
5130460|NCT01644890|17720895|P1|Overall Study|Death|1
5130461|NCT01644890|17720894|P2|Overall Study|Adverse Event|20
5130462|NCT01644890|17720895|P1|Overall Study|Adverse Event|7
5130463|NCT01644734|17720905|P1|Overall Study|Missing documentation|238
5130464|NCT01644734|17720905|P1|Overall Study|Reasons other than stated above|7
5130465|NCT01644734|17720905|P1|Overall Study|Lost to Follow-up|17
5130466|NCT01644734|17720905|P1|Overall Study|Adverse Event|4
5130467|NCT01644643|17720919|P4|Overall Study|Other Eligibility criteria|2
5130468|NCT01644643|17720920|P3|Overall Study|Other Eligibility criteria|0
5130469|NCT01644643|17720921|P2|Overall Study|Other Eligibility criteria|0
5130470|NCT01644643|17720922|P1|Overall Study|Other Eligibility criteria|0
5130471|NCT01644643|17720919|P4|Overall Study|Withdrawal by Subject|1
5130472|NCT01644643|17720920|P3|Overall Study|Withdrawal by Subject|2
5130473|NCT01644643|17720921|P2|Overall Study|Withdrawal by Subject|0
5130474|NCT01644643|17720922|P1|Overall Study|Withdrawal by Subject|1
5130475|NCT01644643|17720919|P4|Overall Study|Lost to Follow-up|4
5130476|NCT01644643|17720920|P3|Overall Study|Lost to Follow-up|0
5130477|NCT01644643|17720921|P2|Overall Study|Lost to Follow-up|0
5130478|NCT01644643|17720922|P1|Overall Study|Lost to Follow-up|0
5130479|NCT01644643|17720919|P4|Overall Study|Death|3
5130480|NCT01644643|17720920|P3|Overall Study|Death|3
5130481|NCT01644643|17720921|P2|Overall Study|Death|0
5130482|NCT01644643|17720922|P1|Overall Study|Death|1
5130483|NCT01644617|17721087|P3|Overall Study|Adverse Event|6
5130484|NCT01644617|17721088|P2|Overall Study|Adverse Event|0
5130485|NCT01644617|17721089|P1|Overall Study|Adverse Event|3
5130486|NCT01644617|17721087|P3|Overall Study|Lost to Follow-up|0
5130487|NCT01644617|17721088|P2|Overall Study|Lost to Follow-up|1
5130488|NCT01644617|17721089|P1|Overall Study|Lost to Follow-up|0
5130489|NCT01644617|17721087|P3|Overall Study|Withdrawal by Subject|1
5130490|NCT01644617|17721088|P2|Overall Study|Withdrawal by Subject|4
5130491|NCT01644617|17721089|P1|Overall Study|Withdrawal by Subject|3
5130492|NCT01644565|17721139|P9|Overall Study|Relocation|1
5130493|NCT01644565|17721140|P8|Overall Study|Relocation|0
5130494|NCT01644565|17721141|P7|Overall Study|Relocation|0
5130495|NCT01644565|17721142|P6|Overall Study|Relocation|0
5130496|NCT01644565|17721143|P5|Overall Study|Relocation|0
5130497|NCT01644565|17721144|P4|Overall Study|Relocation|0
5130498|NCT01644565|17721145|P3|Overall Study|Relocation|0
5130499|NCT01644565|17721146|P2|Overall Study|Relocation|0
5130500|NCT01644565|17721147|P1|Overall Study|Relocation|0
5130501|NCT01644565|17721139|P9|Overall Study|Family emergency|0
5130502|NCT01644565|17721140|P8|Overall Study|Family emergency|0
5130503|NCT01644565|17721141|P7|Overall Study|Family emergency|0
5130504|NCT01644565|17721142|P6|Overall Study|Family emergency|0
5130505|NCT01644565|17721143|P5|Overall Study|Family emergency|1
5130506|NCT01644565|17721144|P4|Overall Study|Family emergency|0
5130507|NCT01644565|17721145|P3|Overall Study|Family emergency|0
5130508|NCT01644565|17721146|P2|Overall Study|Family emergency|0
5130509|NCT01644565|17721147|P1|Overall Study|Family emergency|0
5130510|NCT01644565|17721139|P9|Overall Study|Lost to Follow-up|0
5130511|NCT01644565|17721140|P8|Overall Study|Lost to Follow-up|2
5130512|NCT01644565|17721141|P7|Overall Study|Lost to Follow-up|0
5130513|NCT01644565|17721142|P6|Overall Study|Lost to Follow-up|0
5130514|NCT01644565|17721143|P5|Overall Study|Lost to Follow-up|0
5130515|NCT01644565|17721144|P4|Overall Study|Lost to Follow-up|1
5130516|NCT01644565|17721145|P3|Overall Study|Lost to Follow-up|0
5130517|NCT01644565|17721146|P2|Overall Study|Lost to Follow-up|0
5130518|NCT01644565|17721147|P1|Overall Study|Lost to Follow-up|0
5130519|NCT01644565|17721139|P9|Overall Study|Undisclosed Medical History|0
5130520|NCT01644565|17721140|P8|Overall Study|Undisclosed Medical History|0
5130521|NCT01644565|17721141|P7|Overall Study|Undisclosed Medical History|0
5130522|NCT01644565|17721142|P6|Overall Study|Undisclosed Medical History|0
5130523|NCT01644565|17721143|P5|Overall Study|Undisclosed Medical History|0
5130524|NCT01644565|17721144|P4|Overall Study|Undisclosed Medical History|0
5130525|NCT01644565|17721145|P3|Overall Study|Undisclosed Medical History|0
5130526|NCT01644565|17721146|P2|Overall Study|Undisclosed Medical History|0
5130527|NCT01644565|17721147|P1|Overall Study|Undisclosed Medical History|1
5130528|NCT01644500|17721188|P3|Overall Study|Physician Decision|1
5130529|NCT01644500|17721189|P2|Overall Study|Physician Decision|1
5130530|NCT01644500|17721190|P1|Overall Study|Physician Decision|1
5130531|NCT01644500|17721188|P3|Overall Study|Withdrawal by Subject|12
5130532|NCT01644500|17721189|P2|Overall Study|Withdrawal by Subject|12
5130533|NCT01644500|17721190|P1|Overall Study|Withdrawal by Subject|11
5130534|NCT01644500|17721188|P3|Overall Study|Protocol Violation|0
5130535|NCT01644500|17721189|P2|Overall Study|Protocol Violation|1
5130536|NCT01644500|17721190|P1|Overall Study|Protocol Violation|1
5130537|NCT01644500|17721188|P3|Overall Study|Lost to Follow-up|0
5130538|NCT01644500|17721189|P2|Overall Study|Lost to Follow-up|8
5130539|NCT01644500|17721190|P1|Overall Study|Lost to Follow-up|3
5130540|NCT01644500|17721188|P3|Overall Study|Death|0
5130541|NCT01644500|17721189|P2|Overall Study|Death|1
5130542|NCT01644500|17721190|P1|Overall Study|Death|0
5130543|NCT01644500|17721188|P3|Overall Study|Adverse Event|2
5130544|NCT01644500|17721189|P2|Overall Study|Adverse Event|1
5130545|NCT01644500|17721190|P1|Overall Study|Adverse Event|6
5130546|NCT01644474|17721260|P2|Overall Study|Protocol Violation|0
5130547|NCT01644474|17721261|P1|Overall Study|Protocol Violation|1
5130548|NCT01644474|17721260|P2|Overall Study|Site scheduling error|1
5130549|NCT01644474|17721261|P1|Overall Study|Site scheduling error|1
5130550|NCT01644474|17721260|P2|Overall Study|Adverse Event|5
5130551|NCT01644474|17721261|P1|Overall Study|Adverse Event|4
5130552|NCT01644474|17721260|P2|Overall Study|Participant moved|1
5130553|NCT01644474|17721261|P1|Overall Study|Participant moved|0
5130554|NCT01644474|17721260|P2|Overall Study|Consent withdrawn by participant|1
5130555|NCT01644474|17721261|P1|Overall Study|Consent withdrawn by participant|0
5130556|NCT01644474|17721260|P2|Overall Study|Poor compliance to protocol|0
5130557|NCT01644474|17721261|P1|Overall Study|Poor compliance to protocol|1
5130558|NCT01644188|17721445|P2|Overall Study|Other than specified above|7
5130559|NCT01644188|17721446|P1|Overall Study|Other than specified above|6
5130560|NCT01644188|17721445|P2|Overall Study|Site closure|1
5130561|NCT01644188|17721446|P1|Overall Study|Site closure|1
5130562|NCT01644188|17721445|P2|Overall Study|Last visit outside protocol visit window|16
5130563|NCT01644188|17721446|P1|Overall Study|Last visit outside protocol visit window|14
5130564|NCT01644188|17721445|P2|Overall Study|Death|3
5130565|NCT01644188|17721446|P1|Overall Study|Death|4
5130566|NCT01644188|17721445|P2|Overall Study|Lost to Follow-up|0
5130567|NCT01644188|17721446|P1|Overall Study|Lost to Follow-up|1
5130568|NCT01644188|17721445|P2|Overall Study|Selection criteria finally not met|0
5130569|NCT01644188|17721446|P1|Overall Study|Selection criteria finally not met|2
5130570|NCT01644188|17721445|P2|Overall Study|Consent withdrawn by participant|7
5130571|NCT01644188|17721446|P1|Overall Study|Consent withdrawn by participant|14
5130572|NCT01644188|17721445|P2|Overall Study|Related to auto-injector administration|2
5130573|NCT01644188|17721446|P1|Overall Study|Related to auto-injector administration|2
5130574|NCT01644188|17721445|P2|Overall Study|Participant moved|2
5130575|NCT01644188|17721446|P1|Overall Study|Participant moved|7
5130576|NCT01644188|17721445|P2|Overall Study|Physician Decision|3
5130577|NCT01644188|17721446|P1|Overall Study|Physician Decision|1
5130578|NCT01644188|17721445|P2|Overall Study|Poor compliance to protocol|14
5130579|NCT01644188|17721446|P1|Overall Study|Poor compliance to protocol|26
5130580|NCT01644188|17721445|P2|Overall Study|Adverse Event|20
5130581|NCT01644188|17721446|P1|Overall Study|Adverse Event|44
5130582|NCT01644175|17721504|P2|Overall Study|Other than specified above|3
5130583|NCT01644175|17721505|P1|Overall Study|Other than specified above|0
5130584|NCT01644175|17721504|P2|Overall Study|Lost to Follow-up|0
5130585|NCT01644175|17721505|P1|Overall Study|Lost to Follow-up|1
5130586|NCT01644175|17721504|P2|Overall Study|Site closure|2
5130587|NCT01644175|17721505|P1|Overall Study|Site closure|2
5130588|NCT01644175|17721504|P2|Overall Study|Selection criteria finally not met|1
5130589|NCT01644175|17721505|P1|Overall Study|Selection criteria finally not met|0
5130590|NCT01644175|17721504|P2|Overall Study|Last visit outside protocol visit window|11
5130591|NCT01644175|17721505|P1|Overall Study|Last visit outside protocol visit window|4
5130592|NCT01644175|17721504|P2|Overall Study|Related to Autoinjector Administration|1
5130593|NCT01644175|17721505|P1|Overall Study|Related to Autoinjector Administration|2
5130594|NCT01644175|17721504|P2|Overall Study|Consent withdrawn by participant|4
5130595|NCT01644175|17721505|P1|Overall Study|Consent withdrawn by participant|3
5130596|NCT01644175|17721504|P2|Overall Study|Participant Moved|2
5130597|NCT01644175|17721505|P1|Overall Study|Participant Moved|1
5130598|NCT01644175|17721504|P2|Overall Study|Physician Decision|2
5130599|NCT01644175|17721505|P1|Overall Study|Physician Decision|1
5130600|NCT01644175|17721504|P2|Overall Study|Poor compliance to protocol|10
5130601|NCT01644175|17721505|P1|Overall Study|Poor compliance to protocol|9
5130602|NCT01644175|17721504|P2|Overall Study|Death|2
5130603|NCT01644175|17721505|P1|Overall Study|Death|1
5130604|NCT01644175|17721504|P2|Overall Study|Adverse Event|13
5130605|NCT01644175|17721505|P1|Overall Study|Adverse Event|8
5130606|NCT01644175|17721504|P2|Overall Study|Randomized But Not Treated|2
5130607|NCT01644175|17721505|P1|Overall Study|Randomized But Not Treated|0
5130608|NCT01644149|17721557|P2|Overall Study|Lost to Follow-up|1
5130609|NCT01644149|17721558|P1|Overall Study|Lost to Follow-up|3
5130610|NCT01644149|17721557|P2|Overall Study|Withdrawal by Subject|0
5130611|NCT01644149|17721558|P1|Overall Study|Withdrawal by Subject|1
5130612|NCT01643928|17721578|P5|Overall Study|Adverse Event|2
5130613|NCT01643928|17721579|P4|Overall Study|Adverse Event|1
5130614|NCT01643928|17721580|P3|Overall Study|Adverse Event|0
5130615|NCT01643928|17721581|P2|Overall Study|Adverse Event|1
5130616|NCT01643928|17721582|P1|Overall Study|Adverse Event|2
5130617|NCT01643928|17721578|P5|Overall Study|Other|0
5130618|NCT01643928|17721579|P4|Overall Study|Other|0
5130619|NCT01643928|17721580|P3|Overall Study|Other|1
5130620|NCT01643928|17721581|P2|Overall Study|Other|1
5130621|NCT01643928|17721582|P1|Overall Study|Other|5
5130622|NCT01643928|17721578|P5|Overall Study|Pregnancy|0
5130623|NCT01643928|17721579|P4|Overall Study|Pregnancy|1
5130624|NCT01643928|17721580|P3|Overall Study|Pregnancy|0
5130625|NCT01643928|17721581|P2|Overall Study|Pregnancy|0
5130626|NCT01643928|17721582|P1|Overall Study|Pregnancy|0
5130627|NCT01643928|17721578|P5|Overall Study|Withdrawal by Subject|0
5130628|NCT01643928|17721579|P4|Overall Study|Withdrawal by Subject|1
5130629|NCT01643928|17721580|P3|Overall Study|Withdrawal by Subject|0
5130630|NCT01643928|17721581|P2|Overall Study|Withdrawal by Subject|0
5130631|NCT01643928|17721582|P1|Overall Study|Withdrawal by Subject|2
5130632|NCT01643928|17721578|P5|Overall Study|Lost to Follow-up|0
5130633|NCT01643928|17721579|P4|Overall Study|Lost to Follow-up|0
5130634|NCT01643928|17721580|P3|Overall Study|Lost to Follow-up|2
5130635|NCT01643928|17721581|P2|Overall Study|Lost to Follow-up|0
5130636|NCT01643928|17721582|P1|Overall Study|Lost to Follow-up|1
5130637|NCT01643850|17721886|P9|Overall Study|Administrative Problems|0
5130638|NCT01643850|17721887|P8|Overall Study|Administrative Problems|0
5130639|NCT01643850|17721888|P7|Overall Study|Administrative Problems|0
5130640|NCT01643850|17721889|P6|Overall Study|Administrative Problems|0
5130641|NCT01643850|17721890|P5|Overall Study|Administrative Problems|1
5130642|NCT01643850|17721891|P4|Overall Study|Administrative Problems|0
5130643|NCT01643850|17721892|P3|Overall Study|Administrative Problems|1
5130644|NCT01643850|17721893|P2|Overall Study|Administrative Problems|0
5130645|NCT01643850|17721894|P1|Overall Study|Administrative Problems|0
5130646|NCT01643850|17721886|P9|Overall Study|Adverse Event|0
5130647|NCT01643850|17721887|P8|Overall Study|Adverse Event|0
5130648|NCT01643850|17721888|P7|Overall Study|Adverse Event|0
5130649|NCT01643850|17721889|P6|Overall Study|Adverse Event|0
5130650|NCT01643850|17721890|P5|Overall Study|Adverse Event|1
5130651|NCT01643850|17721891|P4|Overall Study|Adverse Event|0
5130652|NCT01643850|17721892|P3|Overall Study|Adverse Event|0
5130653|NCT01643850|17721893|P2|Overall Study|Adverse Event|0
5130654|NCT01643850|17721894|P1|Overall Study|Adverse Event|0
5130655|NCT01643850|17721886|P9|Overall Study|Lost to Follow-up|1
5130656|NCT01643850|17721887|P8|Overall Study|Lost to Follow-up|0
5130657|NCT01643850|17721888|P7|Overall Study|Lost to Follow-up|1
5130658|NCT01643850|17721889|P6|Overall Study|Lost to Follow-up|0
5130659|NCT01643850|17721890|P5|Overall Study|Lost to Follow-up|0
5130660|NCT01643850|17721891|P4|Overall Study|Lost to Follow-up|0
5130661|NCT01643850|17721892|P3|Overall Study|Lost to Follow-up|0
5130662|NCT01643850|17721893|P2|Overall Study|Lost to Follow-up|0
5130663|NCT01643850|17721894|P1|Overall Study|Lost to Follow-up|0
5130664|NCT01643850|17721886|P9|Overall Study|Withdrawal by Subject|0
5130665|NCT01643850|17721887|P8|Overall Study|Withdrawal by Subject|0
5130666|NCT01643850|17721888|P7|Overall Study|Withdrawal by Subject|0
5130667|NCT01643850|17721889|P6|Overall Study|Withdrawal by Subject|0
5130668|NCT01643850|17721890|P5|Overall Study|Withdrawal by Subject|1
5130669|NCT01643850|17721891|P4|Overall Study|Withdrawal by Subject|0
5130670|NCT01643850|17721892|P3|Overall Study|Withdrawal by Subject|0
5130671|NCT01643850|17721893|P2|Overall Study|Withdrawal by Subject|0
5130672|NCT01643850|17721894|P1|Overall Study|Withdrawal by Subject|0
5130673|NCT01643798|17722033|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
5130674|NCT01643798|17722034|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
5130675|NCT01643772|17722049|P4|Overall Study|Adverse Event|1
5130676|NCT01643772|17722050|P3|Overall Study|Adverse Event|0
5130677|NCT01643772|17722051|P2|Overall Study|Adverse Event|0
5130678|NCT01643772|17722052|P1|Overall Study|Adverse Event|0
5130679|NCT01643772|17722049|P4|Overall Study|Protocol Violation|1
5130680|NCT01643772|17722050|P3|Overall Study|Protocol Violation|0
5130681|NCT01643772|17722051|P2|Overall Study|Protocol Violation|0
5130682|NCT01643772|17722052|P1|Overall Study|Protocol Violation|0
5130683|NCT01643668|17722092|P1|Overall Study|Death|1
5130684|NCT01643473|17722123|P2|Overall Study|Lost to Follow-up|0
5130685|NCT01643473|17722124|P1|Overall Study|Lost to Follow-up|1
5130686|NCT01643044|17722156|P2|Overall Study|Delivered outside of hospital|2
5130687|NCT01643044|17722157|P1|Overall Study|Delivered outside of hospital|1
5130688|NCT01643044|17722156|P2|Overall Study|Miscarried baby|2
5130689|NCT01643044|17722157|P1|Overall Study|Miscarried baby|2
5130690|NCT01643044|17722156|P2|Overall Study|Lost to Follow-up|1
5130691|NCT01643044|17722157|P1|Overall Study|Lost to Follow-up|1
5130692|NCT01642914|17722166|P3|Overall Study|Other Reason|0
5130693|NCT01642914|17722167|P2|Overall Study|Other Reason|0
5130694|NCT01642914|17722168|P1|Overall Study|Other Reason|1
5130695|NCT01642914|17722166|P3|Overall Study|Lost to Follow-up|7
5130696|NCT01642914|17722167|P2|Overall Study|Lost to Follow-up|3
5130697|NCT01642914|17722168|P1|Overall Study|Lost to Follow-up|5
5130698|NCT01642914|17722166|P3|Overall Study|Withdrawal by Subject|10
5130699|NCT01642914|17722167|P2|Overall Study|Withdrawal by Subject|5
5130700|NCT01642914|17722168|P1|Overall Study|Withdrawal by Subject|5
5130701|NCT01642914|17722166|P3|Overall Study|Protocol Violation|6
5130702|NCT01642914|17722167|P2|Overall Study|Protocol Violation|13
5130703|NCT01642914|17722168|P1|Overall Study|Protocol Violation|15
5130704|NCT01642914|17722166|P3|Overall Study|Lack of Efficacy|2
5130705|NCT01642914|17722167|P2|Overall Study|Lack of Efficacy|4
5130706|NCT01642914|17722168|P1|Overall Study|Lack of Efficacy|9
5130707|NCT01642914|17722166|P3|Overall Study|Adverse Event|15
5130708|NCT01642914|17722167|P2|Overall Study|Adverse Event|7
5130709|NCT01642914|17722168|P1|Overall Study|Adverse Event|11
5130710|NCT01642732|17722243|P1|Overall Study|Withdrawal by Subject|1
5130711|NCT01642615|17722248|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
5130712|NCT01642615|17722249|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
5130713|NCT01642615|17722250|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
5130714|NCT01642615|17722248|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
5130715|NCT01642615|17722249|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
5130716|NCT01642615|17722250|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
5130717|NCT01642615|17722248|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
5130718|NCT01642615|17722249|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
5130719|NCT01642615|17722250|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
5130720|NCT01642615|17722248|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
5130721|NCT01642615|17722249|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
5130722|NCT01642615|17722250|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
5130723|NCT01642615|17722248|P3|Open Label Maintenance Phase|Did not receive treatment|0
5130724|NCT01642615|17722249|P2|Open Label Maintenance Phase|Did not receive treatment|0
5130725|NCT01642615|17722250|P1|Open Label Maintenance Phase|Did not receive treatment|1
5130726|NCT01642615|17722248|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
5130727|NCT01642615|17722249|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
5130728|NCT01642615|17722250|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
5130729|NCT01642615|17722248|P3|Open Label Maintenance Phase|Lost to Follow-up|0
5130730|NCT01642615|17722249|P2|Open Label Maintenance Phase|Lost to Follow-up|0
5130731|NCT01642615|17722250|P1|Open Label Maintenance Phase|Lost to Follow-up|1
5130732|NCT01642615|17722248|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
5130733|NCT01642615|17722249|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
5130734|NCT01642615|17722250|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
5130735|NCT01642615|17722248|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
5130736|NCT01642615|17722249|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
5130737|NCT01642615|17722250|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
5130738|NCT01642602|17722264|P1|Overall Study|Adverse Event|2
5130739|NCT01642589|17722271|P2|Overall Study|Withdrawal by Subject|1
5130740|NCT01642589|17722272|P1|Overall Study|Withdrawal by Subject|1
5130741|NCT01642407|17722311|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
5130742|NCT01642407|17722311|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
5130743|NCT01642407|17722311|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
5130744|NCT01642277|17722358|P2|Overall Study|Withdrawal by Subject|0
5130745|NCT01642277|17722359|P1|Overall Study|Withdrawal by Subject|11
5130746|NCT01642277|17722358|P2|Overall Study|Protocol Violation|0
5130747|NCT01642277|17722359|P1|Overall Study|Protocol Violation|1
5130748|NCT01642277|17722358|P2|Overall Study|Physician Decision|0
5130749|NCT01642277|17722359|P1|Overall Study|Physician Decision|2
5130750|NCT01642277|17722358|P2|Overall Study|Adverse Event|0
5130751|NCT01642277|17722359|P1|Overall Study|Adverse Event|10
5130752|NCT01642251|17722371|P4|Overall Study|Ineligible/never start protocol therapy|8
5130753|NCT01642251|17722372|P3|Overall Study|Ineligible/never start protocol therapy|11
5130754|NCT01642251|17722373|P2|Overall Study|Ineligible/never start protocol therapy|0
5130755|NCT01642251|17722374|P1|Overall Study|Ineligible/never start protocol therapy|0
5130756|NCT01642251|17722371|P4|Overall Study|Other complicating disease|0
5130757|NCT01642251|17722372|P3|Overall Study|Other complicating disease|1
5130758|NCT01642251|17722373|P2|Overall Study|Other complicating disease|0
5130759|NCT01642251|17722374|P1|Overall Study|Other complicating disease|0
5130760|NCT01642251|17722371|P4|Overall Study|Alternative therapy|2
5130761|NCT01642251|17722372|P3|Overall Study|Alternative therapy|0
5130762|NCT01642251|17722373|P2|Overall Study|Alternative therapy|0
5130763|NCT01642251|17722374|P1|Overall Study|Alternative therapy|0
5130764|NCT01642251|17722371|P4|Overall Study|Withdrawal by Subject|3
5130765|NCT01642251|17722372|P3|Overall Study|Withdrawal by Subject|1
5130766|NCT01642251|17722373|P2|Overall Study|Withdrawal by Subject|0
5130767|NCT01642251|17722374|P1|Overall Study|Withdrawal by Subject|0
5130768|NCT01642251|17722371|P4|Overall Study|Death|3
5130769|NCT01642251|17722372|P3|Overall Study|Death|1
5130770|NCT01642251|17722373|P2|Overall Study|Death|0
5130771|NCT01642251|17722374|P1|Overall Study|Death|0
5130772|NCT01642251|17722371|P4|Overall Study|Adverse Event|4
5130773|NCT01642251|17722372|P3|Overall Study|Adverse Event|5
5130774|NCT01642251|17722373|P2|Overall Study|Adverse Event|0
5130775|NCT01642251|17722374|P1|Overall Study|Adverse Event|0
5130776|NCT01642251|17722371|P4|Overall Study|Progressive disease|3
5130777|NCT01642251|17722372|P3|Overall Study|Progressive disease|3
5130778|NCT01642251|17722373|P2|Overall Study|Progressive disease|0
5130779|NCT01642251|17722374|P1|Overall Study|Progressive disease|0
5130780|NCT01642212|17722412|P5|Open-label Extension|Other|1
5130781|NCT01642212|17722413|P4|Open-label Extension|Other|0
5130782|NCT01642212|17722414|P3|Open-label Extension|Other|0
5130783|NCT01642212|17722415|P2|Open-label Extension|Other|0
5130784|NCT01642212|17722416|P1|Open-label Extension|Other|0
5130785|NCT01642212|17722412|P5|Open-label Extension|Lost to Follow-up|1
5130786|NCT01642212|17722413|P4|Open-label Extension|Lost to Follow-up|0
5130787|NCT01642212|17722414|P3|Open-label Extension|Lost to Follow-up|0
5130788|NCT01642212|17722415|P2|Open-label Extension|Lost to Follow-up|0
5130789|NCT01642212|17722416|P1|Open-label Extension|Lost to Follow-up|0
5130790|NCT01642212|17722412|P5|Open-label Extension|Consent Withdrawn|2
5130791|NCT01642212|17722413|P4|Open-label Extension|Consent Withdrawn|0
5130792|NCT01642212|17722414|P3|Open-label Extension|Consent Withdrawn|0
5130793|NCT01642212|17722415|P2|Open-label Extension|Consent Withdrawn|0
5130794|NCT01642212|17722416|P1|Open-label Extension|Consent Withdrawn|0
5130795|NCT01642212|17722412|P5|Open-label Extension|Sponsor Decision|4
5130796|NCT01642212|17722413|P4|Open-label Extension|Sponsor Decision|7
5130797|NCT01642212|17722414|P3|Open-label Extension|Sponsor Decision|0
5130798|NCT01642212|17722415|P2|Open-label Extension|Sponsor Decision|0
5130799|NCT01642212|17722416|P1|Open-label Extension|Sponsor Decision|0
5130800|NCT01642212|17722412|P5|Open-label Extension|Adverse Event|0
5130801|NCT01642212|17722413|P4|Open-label Extension|Adverse Event|3
5130802|NCT01642212|17722414|P3|Open-label Extension|Adverse Event|0
5130803|NCT01642212|17722415|P2|Open-label Extension|Adverse Event|0
5130804|NCT01642212|17722416|P1|Open-label Extension|Adverse Event|0
5130805|NCT01642212|17722412|P5|Double-blind Treatment|Adverse Event|0
5130806|NCT01642212|17722413|P4|Double-blind Treatment|Adverse Event|0
5130807|NCT01642212|17722414|P3|Double-blind Treatment|Adverse Event|1
5130808|NCT01642212|17722415|P2|Double-blind Treatment|Adverse Event|0
5130809|NCT01642212|17722416|P1|Double-blind Treatment|Adverse Event|0
5130810|NCT01642212|17722412|P5|Double-blind Treatment|Non-compliance|0
5130811|NCT01642212|17722413|P4|Double-blind Treatment|Non-compliance|0
5130812|NCT01642212|17722414|P3|Double-blind Treatment|Non-compliance|0
5130813|NCT01642212|17722415|P2|Double-blind Treatment|Non-compliance|1
5130814|NCT01642212|17722416|P1|Double-blind Treatment|Non-compliance|0
5130815|NCT01642212|17722412|P5|Double-blind Treatment|Other|0
5130816|NCT01642212|17722413|P4|Double-blind Treatment|Other|0
5130817|NCT01642212|17722414|P3|Double-blind Treatment|Other|1
5130818|NCT01642212|17722415|P2|Double-blind Treatment|Other|2
5130819|NCT01642212|17722416|P1|Double-blind Treatment|Other|0
5130820|NCT01642212|17722412|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5130821|NCT01642212|17722413|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5130822|NCT01642212|17722414|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5130823|NCT01642212|17722415|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5130824|NCT01642212|17722416|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
5130825|NCT01642004|17722511|P2|Treatment|Missing from data|1
5130826|NCT01642004|17722512|P1|Treatment|Missing from data|0
5130827|NCT01642004|17722511|P2|Treatment|Other|2
5130828|NCT01642004|17722512|P1|Treatment|Other|1
5130829|NCT01642004|17722511|P2|Treatment|No longer meets study criteria|2
5130830|NCT01642004|17722512|P1|Treatment|No longer meets study criteria|1
5130831|NCT01642004|17722511|P2|Treatment|Poor/non-compliance|0
5130832|NCT01642004|17722512|P1|Treatment|Poor/non-compliance|1
5130833|NCT01642004|17722511|P2|Treatment|Maximum clinical benefit|7
5130834|NCT01642004|17722512|P1|Treatment|Maximum clinical benefit|2
5130835|NCT01642004|17722511|P2|Treatment|Withdrawal by Subject|9
5130836|NCT01642004|17722512|P1|Treatment|Withdrawal by Subject|5
5130837|NCT01642004|17722511|P2|Treatment|Adverse event unrelated to study drug|13
5130838|NCT01642004|17722512|P1|Treatment|Adverse event unrelated to study drug|6
5130839|NCT01642004|17722511|P2|Treatment|Death|0
5130840|NCT01642004|17722512|P1|Treatment|Death|1
5130841|NCT01642004|17722511|P2|Treatment|Study drug toxicity|13
5130842|NCT01642004|17722512|P1|Treatment|Study drug toxicity|5
5130843|NCT01642004|17722511|P2|Treatment|Disease progression|80
5130844|NCT01642004|17722512|P1|Treatment|Disease progression|88
5130845|NCT01642004|17722511|P2|Randomization|No longer meets study criteria|2
5130846|NCT01642004|17722512|P1|Randomization|No longer meets study criteria|2
5130847|NCT01642004|17722511|P2|Randomization|Withdrawal by Subject|6
5130848|NCT01642004|17722512|P1|Randomization|Withdrawal by Subject|1
5130849|NCT01642004|17722511|P2|Randomization|Adverse Event unrelated to study drug|0
5130850|NCT01642004|17722512|P1|Randomization|Adverse Event unrelated to study drug|1
5130851|NCT01641991|17722546|P4|Overall Study|no longer eligible|4
5130852|NCT01641991|17722547|P3|Overall Study|no longer eligible|0
5130853|NCT01641991|17722548|P2|Overall Study|no longer eligible|1
5130854|NCT01641991|17722549|P1|Overall Study|no longer eligible|2
5130855|NCT01641991|17722546|P4|Overall Study|Pregnancy|0
5130856|NCT01641991|17722547|P3|Overall Study|Pregnancy|1
5130857|NCT01641991|17722548|P2|Overall Study|Pregnancy|0
5130858|NCT01641991|17722549|P1|Overall Study|Pregnancy|0
5130859|NCT01641991|17722546|P4|Overall Study|Protocol Violation|0
5130860|NCT01641991|17722547|P3|Overall Study|Protocol Violation|3
5130861|NCT01641991|17722548|P2|Overall Study|Protocol Violation|1
5130862|NCT01641991|17722549|P1|Overall Study|Protocol Violation|1
5130863|NCT01641991|17722546|P4|Overall Study|Lost to Follow-up|1
5130864|NCT01641991|17722547|P3|Overall Study|Lost to Follow-up|3
5130865|NCT01641991|17722548|P2|Overall Study|Lost to Follow-up|2
5130866|NCT01641991|17722549|P1|Overall Study|Lost to Follow-up|0
5130867|NCT01641991|17722546|P4|Overall Study|Adverse Event|1
5130868|NCT01641991|17722547|P3|Overall Study|Adverse Event|2
5130869|NCT01641991|17722548|P2|Overall Study|Adverse Event|1
5130870|NCT01641991|17722549|P1|Overall Study|Adverse Event|2
5130871|NCT01641991|17722546|P4|Overall Study|Withdrawal by Subject|5
5130872|NCT01641991|17722547|P3|Overall Study|Withdrawal by Subject|1
5130873|NCT01641991|17722548|P2|Overall Study|Withdrawal by Subject|2
5130874|NCT01641991|17722549|P1|Overall Study|Withdrawal by Subject|4
5130875|NCT01641991|17722546|P4|Overall Study|Physician Decision|5
5130876|NCT01641991|17722547|P3|Overall Study|Physician Decision|7
5130877|NCT01641991|17722548|P2|Overall Study|Physician Decision|1
5130878|NCT01641991|17722549|P1|Overall Study|Physician Decision|0
5130879|NCT01641952|17722633|P1|Overall Study|Adverse Event|6
5130880|NCT01641952|17722633|P1|Overall Study|Lost to Follow-up|28
5130881|NCT01641939|17722649|P3|Overall Study|Study Terminated by Sponsor|3
5130882|NCT01641939|17722650|P2|Overall Study|Study Terminated by Sponsor|28
5130883|NCT01641939|17722651|P1|Overall Study|Study Terminated by Sponsor|10
5130884|NCT01641939|17722649|P3|Overall Study|Withdrawal by Subject|5
5130885|NCT01641939|17722650|P2|Overall Study|Withdrawal by Subject|11
5130886|NCT01641939|17722651|P1|Overall Study|Withdrawal by Subject|14
5130887|NCT01641939|17722649|P3|Overall Study|Lost to Follow-up|1
5130888|NCT01641939|17722650|P2|Overall Study|Lost to Follow-up|2
5130889|NCT01641939|17722651|P1|Overall Study|Lost to Follow-up|3
5130890|NCT01641939|17722649|P3|Overall Study|Death|61
5130891|NCT01641939|17722650|P2|Overall Study|Death|187
5130892|NCT01641939|17722651|P1|Overall Study|Death|90
5130893|NCT01641926|17722694|P4|Overall Study|Not Treated|0
5130894|NCT01641926|17722695|P3|Overall Study|Not Treated|1
5130895|NCT01641926|17722696|P2|Overall Study|Not Treated|1
5130896|NCT01641926|17722697|P1|Overall Study|Not Treated|1
5130897|NCT01641926|17722694|P4|Overall Study|Withdrawal by Subject|1
5130898|NCT01641926|17722695|P3|Overall Study|Withdrawal by Subject|6
5130899|NCT01641926|17722696|P2|Overall Study|Withdrawal by Subject|5
5130900|NCT01641926|17722697|P1|Overall Study|Withdrawal by Subject|13
5130901|NCT01641926|17722694|P4|Overall Study|Protocol Violation|1
5130902|NCT01641926|17722695|P3|Overall Study|Protocol Violation|0
5130903|NCT01641926|17722696|P2|Overall Study|Protocol Violation|0
5130904|NCT01641926|17722697|P1|Overall Study|Protocol Violation|1
5130905|NCT01641926|17722694|P4|Overall Study|Physician Decision|1
5130906|NCT01641926|17722695|P3|Overall Study|Physician Decision|0
5130907|NCT01641926|17722696|P2|Overall Study|Physician Decision|5
5130908|NCT01641926|17722697|P1|Overall Study|Physician Decision|6
5130909|NCT01641926|17722694|P4|Overall Study|Lost to Follow-up|0
5130910|NCT01641926|17722695|P3|Overall Study|Lost to Follow-up|1
5130911|NCT01641926|17722696|P2|Overall Study|Lost to Follow-up|2
5130912|NCT01641926|17722697|P1|Overall Study|Lost to Follow-up|2
5130913|NCT01641926|17722694|P4|Overall Study|Adverse Event|1
5130914|NCT01641926|17722695|P3|Overall Study|Adverse Event|3
5130915|NCT01641926|17722696|P2|Overall Study|Adverse Event|2
5130916|NCT01641926|17722697|P1|Overall Study|Adverse Event|5
5130917|NCT01641900|17722725|P2|Overall Study|Withdrawal by Subject|2
5130918|NCT01641900|17722726|P1|Overall Study|Withdrawal by Subject|2
5130919|NCT01641861|17722738|P2|Overall Study|Died due to drowning|1
5130920|NCT01641861|17722739|P1|Overall Study|Died due to drowning|0
5130921|NCT01641861|17722738|P2|Overall Study|Lost the tooth due to normal exfoliation|8
5130922|NCT01641861|17722739|P1|Overall Study|Lost the tooth due to normal exfoliation|14
5130923|NCT01641861|17722738|P2|Overall Study|Lost to Follow-up|16
5130924|NCT01641861|17722739|P1|Overall Study|Lost to Follow-up|21
5130925|NCT01641822|17722760|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
5130926|NCT01641822|17722761|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
5130927|NCT01641822|17722762|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
5130928|NCT01641822|17722760|P3|Comparative Phase|Withdrew consent|7
5130929|NCT01641822|17722761|P2|Comparative Phase|Withdrew consent|3
5130930|NCT01641822|17722762|P1|Comparative Phase|Withdrew consent|0
5130931|NCT01641822|17722760|P3|Comparative Phase|Adverse event, serious fatal|0
5130932|NCT01641822|17722761|P2|Comparative Phase|Adverse event, serious fatal|1
5130933|NCT01641822|17722762|P1|Comparative Phase|Adverse event, serious fatal|0
5130934|NCT01641822|17722760|P3|Comparative Phase|Pregnancy|1
5130935|NCT01641822|17722761|P2|Comparative Phase|Pregnancy|0
5130936|NCT01641822|17722762|P1|Comparative Phase|Pregnancy|0
5130937|NCT01641822|17722760|P3|Comparative Phase|Investigator's discretion|1
5130938|NCT01641822|17722761|P2|Comparative Phase|Investigator's discretion|0
5130939|NCT01641822|17722762|P1|Comparative Phase|Investigator's discretion|0
5130940|NCT01641822|17722760|P3|Comparative Phase|Noncompliance with study drug|0
5130941|NCT01641822|17722761|P2|Comparative Phase|Noncompliance with study drug|1
5130942|NCT01641822|17722762|P1|Comparative Phase|Noncompliance with study drug|0
5130943|NCT01641822|17722760|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
5130944|NCT01641822|17722761|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
5130945|NCT01641822|17722762|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
5130946|NCT01641822|17722760|P3|Run-in Phase|Withdrew consent|0
5130947|NCT01641822|17722761|P2|Run-in Phase|Withdrew consent|0
5130948|NCT01641822|17722762|P1|Run-in Phase|Withdrew consent|1
5130949|NCT01641822|17722760|P3|Run-in Phase|Adverse Event|0
5130950|NCT01641822|17722761|P2|Run-in Phase|Adverse Event|0
5130951|NCT01641822|17722762|P1|Run-in Phase|Adverse Event|3
5130952|NCT01641822|17722760|P3|Run-in Phase|Noncompliance with study drug|0
5130953|NCT01641822|17722761|P2|Run-in Phase|Noncompliance with study drug|0
5130954|NCT01641822|17722762|P1|Run-in Phase|Noncompliance with study drug|1
5130955|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
5130956|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
5130957|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
5130958|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
5130959|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
5130960|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
5130961|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
5130962|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
5130963|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
5130964|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
5130965|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
5130966|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
5130967|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Site closed|0
5130968|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Site closed|0
5130969|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Site closed|0
5130970|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Site closed|1
5130971|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
5130972|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
5130973|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
5130974|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
5130975|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
5130976|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
5130977|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
5130978|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
5130979|NCT01641809|17722783|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
5130980|NCT01641809|17722784|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
5130981|NCT01641809|17722785|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
5130982|NCT01641809|17722786|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
5130983|NCT01641809|17722783|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
5130984|NCT01641809|17722784|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
5130985|NCT01641809|17722785|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
5130986|NCT01641809|17722786|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
5130987|NCT01641809|17722783|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
5130988|NCT01641809|17722784|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
5130989|NCT01641809|17722785|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
5130990|NCT01641809|17722786|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
5130991|NCT01641809|17722783|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
5130992|NCT01641809|17722784|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
5130993|NCT01641809|17722785|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
5130994|NCT01641809|17722786|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
5130995|NCT01641809|17722783|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5130996|NCT01641809|17722784|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5130997|NCT01641809|17722785|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
5130998|NCT01641809|17722786|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5130999|NCT01641809|17722783|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
5131000|NCT01641809|17722784|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
5131001|NCT01641809|17722785|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
5131002|NCT01641809|17722786|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
5131003|NCT01641809|17722783|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
5131004|NCT01641809|17722784|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
5131005|NCT01641809|17722785|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
5131006|NCT01641809|17722786|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
5131007|NCT01641809|17722783|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
5131008|NCT01641809|17722784|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
5131009|NCT01641809|17722785|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
5131010|NCT01641809|17722786|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
5131011|NCT01641809|17722783|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
5131012|NCT01641809|17722784|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
5131013|NCT01641809|17722785|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
5131014|NCT01641809|17722786|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
5131015|NCT01641809|17722783|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
5131016|NCT01641809|17722784|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
5131017|NCT01641809|17722785|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
5131018|NCT01641809|17722786|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
5131019|NCT01641809|17722783|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
5131020|NCT01641809|17722784|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
5131021|NCT01641809|17722785|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
5131022|NCT01641809|17722786|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
5131023|NCT01641809|17722783|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5131024|NCT01641809|17722784|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
5131025|NCT01641809|17722785|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5131026|NCT01641809|17722786|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5131027|NCT01641692|17722970|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5131028|NCT01641692|17722971|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5131029|NCT01641692|17722972|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5131030|NCT01641692|17722973|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5131031|NCT01641692|17722974|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5131032|NCT01641692|17722975|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5131033|NCT01641692|17722976|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5131034|NCT01641692|17722977|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5131035|NCT01641692|17722970|P8|Washout Period 3 or Follow-up|Protocol Violation|0
5131036|NCT01641692|17722971|P7|Washout Period 3 or Follow-up|Protocol Violation|0
5131037|NCT01641692|17722972|P6|Washout Period 3 or Follow-up|Protocol Violation|1
5131038|NCT01641692|17722973|P5|Washout Period 3 or Follow-up|Protocol Violation|0
5131039|NCT01641692|17722974|P4|Washout Period 3 or Follow-up|Protocol Violation|0
5131040|NCT01641692|17722975|P3|Washout Period 3 or Follow-up|Protocol Violation|0
5131041|NCT01641692|17722976|P2|Washout Period 3 or Follow-up|Protocol Violation|0
5131042|NCT01641692|17722977|P1|Washout Period 3 or Follow-up|Protocol Violation|0
5131043|NCT01641692|17722970|P8|Treatment Period 3|Lost to Follow-up|0
5131044|NCT01641692|17722971|P7|Treatment Period 3|Lost to Follow-up|0
5131045|NCT01641692|17722972|P6|Treatment Period 3|Lost to Follow-up|0
5131046|NCT01641692|17722973|P5|Treatment Period 3|Lost to Follow-up|0
5131047|NCT01641692|17722974|P4|Treatment Period 3|Lost to Follow-up|0
5131048|NCT01641692|17722975|P3|Treatment Period 3|Lost to Follow-up|0
5131049|NCT01641692|17722976|P2|Treatment Period 3|Lost to Follow-up|1
5131050|NCT01641692|17722977|P1|Treatment Period 3|Lost to Follow-up|0
5131051|NCT01641692|17722970|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131052|NCT01641692|17722971|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
5131053|NCT01641692|17722972|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131054|NCT01641692|17722973|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131055|NCT01641692|17722974|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131056|NCT01641692|17722975|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131057|NCT01641692|17722976|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131058|NCT01641692|17722977|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
5131059|NCT01641692|17722970|P8|Treatment Period 3|Protocol Violation|0
5131060|NCT01641692|17722971|P7|Treatment Period 3|Protocol Violation|0
5131061|NCT01641692|17722972|P6|Treatment Period 3|Protocol Violation|0
5131062|NCT01641692|17722973|P5|Treatment Period 3|Protocol Violation|0
5131063|NCT01641692|17722974|P4|Treatment Period 3|Protocol Violation|0
5131064|NCT01641692|17722975|P3|Treatment Period 3|Protocol Violation|1
5131065|NCT01641692|17722976|P2|Treatment Period 3|Protocol Violation|0
5131066|NCT01641692|17722977|P1|Treatment Period 3|Protocol Violation|0
5131067|NCT01641692|17722970|P8|Treatment Period 3|Adverse Event|0
5131068|NCT01641692|17722971|P7|Treatment Period 3|Adverse Event|1
5131069|NCT01641692|17722972|P6|Treatment Period 3|Adverse Event|0
5131070|NCT01641692|17722973|P5|Treatment Period 3|Adverse Event|0
5131071|NCT01641692|17722974|P4|Treatment Period 3|Adverse Event|0
5131072|NCT01641692|17722975|P3|Treatment Period 3|Adverse Event|0
5131073|NCT01641692|17722976|P2|Treatment Period 3|Adverse Event|0
5131074|NCT01641692|17722977|P1|Treatment Period 3|Adverse Event|0
5131075|NCT01641692|17722970|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5131076|NCT01641692|17722971|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5131077|NCT01641692|17722972|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5131078|NCT01641692|17722973|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5131079|NCT01641692|17722974|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5131080|NCT01641692|17722975|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5131081|NCT01641692|17722976|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5131082|NCT01641692|17722977|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5131083|NCT01641692|17722970|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131084|NCT01641692|17722971|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
5131085|NCT01641692|17722972|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131086|NCT01641692|17722973|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
5131087|NCT01641692|17722974|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131088|NCT01641692|17722975|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131089|NCT01641692|17722976|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131090|NCT01641692|17722977|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131091|NCT01641692|17722970|P8|Treatment Period 2|Withdrawal by Subject|1
5131092|NCT01641692|17722971|P7|Treatment Period 2|Withdrawal by Subject|0
5131093|NCT01641692|17722972|P6|Treatment Period 2|Withdrawal by Subject|1
5131094|NCT01641692|17722973|P5|Treatment Period 2|Withdrawal by Subject|0
5131095|NCT01641692|17722974|P4|Treatment Period 2|Withdrawal by Subject|0
5131096|NCT01641692|17722975|P3|Treatment Period 2|Withdrawal by Subject|0
5131097|NCT01641692|17722976|P2|Treatment Period 2|Withdrawal by Subject|0
5131098|NCT01641692|17722977|P1|Treatment Period 2|Withdrawal by Subject|1
5131099|NCT01641692|17722970|P8|Treatment Period 2|Lost to Follow-up|0
5131100|NCT01641692|17722971|P7|Treatment Period 2|Lost to Follow-up|0
5131101|NCT01641692|17722972|P6|Treatment Period 2|Lost to Follow-up|1
5131102|NCT01641692|17722973|P5|Treatment Period 2|Lost to Follow-up|0
5131103|NCT01641692|17722974|P4|Treatment Period 2|Lost to Follow-up|0
5131104|NCT01641692|17722975|P3|Treatment Period 2|Lost to Follow-up|0
5131105|NCT01641692|17722976|P2|Treatment Period 2|Lost to Follow-up|0
5131106|NCT01641692|17722977|P1|Treatment Period 2|Lost to Follow-up|0
5131107|NCT01641692|17722970|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131108|NCT01641692|17722971|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131109|NCT01641692|17722972|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131110|NCT01641692|17722973|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131111|NCT01641692|17722974|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131112|NCT01641692|17722975|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131113|NCT01641692|17722976|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
5131114|NCT01641692|17722977|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
5131115|NCT01641692|17722970|P8|Treatment Period 2|Lack of Efficacy|0
5131116|NCT01641692|17722971|P7|Treatment Period 2|Lack of Efficacy|0
5131117|NCT01641692|17722972|P6|Treatment Period 2|Lack of Efficacy|0
5131118|NCT01641692|17722973|P5|Treatment Period 2|Lack of Efficacy|0
5131119|NCT01641692|17722974|P4|Treatment Period 2|Lack of Efficacy|0
5131120|NCT01641692|17722975|P3|Treatment Period 2|Lack of Efficacy|0
5131121|NCT01641692|17722976|P2|Treatment Period 2|Lack of Efficacy|0
5131122|NCT01641692|17722977|P1|Treatment Period 2|Lack of Efficacy|1
5131123|NCT01641692|17722970|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5131124|NCT01641692|17722971|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5131125|NCT01641692|17722972|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5131126|NCT01641692|17722973|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5131127|NCT01641692|17722974|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5131128|NCT01641692|17722975|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5131129|NCT01641692|17722976|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5131130|NCT01641692|17722977|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5131131|NCT01641692|17722970|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5131132|NCT01641692|17722971|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131133|NCT01641692|17722972|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131134|NCT01641692|17722973|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
5131135|NCT01641692|17722974|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5131136|NCT01641692|17722975|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
5131137|NCT01641692|17722976|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5131138|NCT01641692|17722977|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5131139|NCT01641692|17722970|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131140|NCT01641692|17722971|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
5131141|NCT01641692|17722972|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131142|NCT01641692|17722973|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131143|NCT01641692|17722974|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131144|NCT01641692|17722975|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131145|NCT01641692|17722976|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131146|NCT01641692|17722977|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
5131147|NCT01641692|17722970|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
5131148|NCT01641692|17722971|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
5131149|NCT01641692|17722972|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
5131150|NCT01641692|17722973|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
5131151|NCT01641692|17722974|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
5131152|NCT01641692|17722975|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
5131153|NCT01641692|17722976|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
5131154|NCT01641692|17722977|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
5131155|NCT01641692|17722970|P8|Treatment Period 1|Withdrawal by Subject|1
5131156|NCT01641692|17722971|P7|Treatment Period 1|Withdrawal by Subject|0
5131157|NCT01641692|17722972|P6|Treatment Period 1|Withdrawal by Subject|2
5131158|NCT01641692|17722973|P5|Treatment Period 1|Withdrawal by Subject|0
5131159|NCT01641692|17722974|P4|Treatment Period 1|Withdrawal by Subject|0
5131160|NCT01641692|17722975|P3|Treatment Period 1|Withdrawal by Subject|0
5131161|NCT01641692|17722976|P2|Treatment Period 1|Withdrawal by Subject|0
5131162|NCT01641692|17722977|P1|Treatment Period 1|Withdrawal by Subject|0
5131163|NCT01641692|17722970|P8|Treatment Period 1|Physician Decision|0
5131164|NCT01641692|17722971|P7|Treatment Period 1|Physician Decision|0
5131165|NCT01641692|17722972|P6|Treatment Period 1|Physician Decision|0
5131166|NCT01641692|17722973|P5|Treatment Period 1|Physician Decision|1
5131167|NCT01641692|17722974|P4|Treatment Period 1|Physician Decision|0
5131168|NCT01641692|17722975|P3|Treatment Period 1|Physician Decision|0
5131169|NCT01641692|17722976|P2|Treatment Period 1|Physician Decision|0
5131170|NCT01641692|17722977|P1|Treatment Period 1|Physician Decision|0
5131171|NCT01641692|17722970|P8|Treatment Period 1|Lost to Follow-up|0
5131172|NCT01641692|17722971|P7|Treatment Period 1|Lost to Follow-up|0
5131173|NCT01641692|17722972|P6|Treatment Period 1|Lost to Follow-up|0
5131174|NCT01641692|17722973|P5|Treatment Period 1|Lost to Follow-up|0
5131175|NCT01641692|17722974|P4|Treatment Period 1|Lost to Follow-up|0
5131176|NCT01641692|17722975|P3|Treatment Period 1|Lost to Follow-up|1
5131177|NCT01641692|17722976|P2|Treatment Period 1|Lost to Follow-up|0
5131178|NCT01641692|17722977|P1|Treatment Period 1|Lost to Follow-up|0
5131179|NCT01641692|17722970|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
5131180|NCT01641692|17722971|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
5131181|NCT01641692|17722972|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
5131182|NCT01641692|17722973|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
5131183|NCT01641692|17722974|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
5131184|NCT01641692|17722975|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
5131185|NCT01641692|17722976|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
5131186|NCT01641692|17722977|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
5131187|NCT01641692|17722970|P8|Treatment Period 1|Protocol Violation|0
5131188|NCT01641692|17722971|P7|Treatment Period 1|Protocol Violation|0
5131189|NCT01641692|17722972|P6|Treatment Period 1|Protocol Violation|0
5131190|NCT01641692|17722973|P5|Treatment Period 1|Protocol Violation|2
5131191|NCT01641692|17722974|P4|Treatment Period 1|Protocol Violation|0
5131192|NCT01641692|17722975|P3|Treatment Period 1|Protocol Violation|0
5131193|NCT01641692|17722976|P2|Treatment Period 1|Protocol Violation|0
5131194|NCT01641692|17722977|P1|Treatment Period 1|Protocol Violation|1
5131195|NCT01641692|17722970|P8|Treatment Period 1|Lack of Efficacy|1
5131196|NCT01641692|17722971|P7|Treatment Period 1|Lack of Efficacy|0
5131197|NCT01641692|17722972|P6|Treatment Period 1|Lack of Efficacy|0
5131198|NCT01641692|17722973|P5|Treatment Period 1|Lack of Efficacy|0
5131199|NCT01641692|17722974|P4|Treatment Period 1|Lack of Efficacy|0
5131200|NCT01641692|17722975|P3|Treatment Period 1|Lack of Efficacy|0
5131201|NCT01641692|17722976|P2|Treatment Period 1|Lack of Efficacy|0
5131202|NCT01641692|17722977|P1|Treatment Period 1|Lack of Efficacy|0
5131203|NCT01641692|17722970|P8|Treatment Period 1|Adverse Event|0
5131204|NCT01641692|17722971|P7|Treatment Period 1|Adverse Event|0
5131205|NCT01641692|17722972|P6|Treatment Period 1|Adverse Event|0
5131206|NCT01641692|17722973|P5|Treatment Period 1|Adverse Event|0
5131207|NCT01641692|17722974|P4|Treatment Period 1|Adverse Event|0
5131208|NCT01641692|17722975|P3|Treatment Period 1|Adverse Event|0
5131209|NCT01641692|17722976|P2|Treatment Period 1|Adverse Event|0
5131210|NCT01641692|17722977|P1|Treatment Period 1|Adverse Event|1
5131211|NCT01641640|17723177|P1|Overall Study|Adverse Event|1
5131212|NCT01641640|17723177|P1|Overall Study|Withdrawal by Subject|2
5131213|NCT01641640|17723177|P1|Overall Study|Lost to Follow-up|3
5131214|NCT01641640|17723177|P1|Overall Study|Efficacy failure|29
5131215|NCT01641640|17723177|P1|Overall Study|Enrolled but not treated|1
5131216|NCT01641601|17723188|P2|Overall Study|Study discontinued.|5
5131217|NCT01641601|17723189|P1|Overall Study|Study discontinued.|3
5131218|NCT01641471|17723199|P2|Overall Study|Protocol Violation|4
5131219|NCT01641471|17723200|P1|Overall Study|Protocol Violation|2
5131220|NCT01641471|17723199|P2|Overall Study|Lost to Follow-up|4
5131221|NCT01641471|17723200|P1|Overall Study|Lost to Follow-up|2
5131222|NCT01641471|17723199|P2|Overall Study|Withdrawal by Subject|19
5131223|NCT01641471|17723200|P1|Overall Study|Withdrawal by Subject|19
5131224|NCT01641367|17723247|P8|Randomized Adherence Intervention|Lost to Follow-up|12
5131225|NCT01641367|17723248|P7|Randomized Adherence Intervention|Lost to Follow-up|8
5131226|NCT01641367|17723249|P6|Randomized Adherence Intervention|Lost to Follow-up|0
5131227|NCT01641367|17723250|P5|Randomized Adherence Intervention|Lost to Follow-up|0
5131228|NCT01641367|17723251|P4|Randomized Adherence Intervention|Lost to Follow-up|0
5131229|NCT01641367|17723252|P3|Randomized Adherence Intervention|Lost to Follow-up|0
5131230|NCT01641367|17723253|P2|Randomized Adherence Intervention|Lost to Follow-up|0
5131231|NCT01641367|17723254|P1|Randomized Adherence Intervention|Lost to Follow-up|0
5131232|NCT01641367|17723247|P8|Randomized Adherence Intervention|Death|12
5131233|NCT01641367|17723248|P7|Randomized Adherence Intervention|Death|11
5131234|NCT01641367|17723249|P6|Randomized Adherence Intervention|Death|0
5131235|NCT01641367|17723250|P5|Randomized Adherence Intervention|Death|0
5131236|NCT01641367|17723251|P4|Randomized Adherence Intervention|Death|0
5131237|NCT01641367|17723252|P3|Randomized Adherence Intervention|Death|0
5131238|NCT01641367|17723253|P2|Randomized Adherence Intervention|Death|0
5131239|NCT01641367|17723254|P1|Randomized Adherence Intervention|Death|0
5131240|NCT01641367|17723247|P8|Cohorts|Lost to Follow-up|0
5131241|NCT01641367|17723248|P7|Cohorts|Lost to Follow-up|0
5131242|NCT01641367|17723249|P6|Cohorts|Lost to Follow-up|0
5131243|NCT01641367|17723250|P5|Cohorts|Lost to Follow-up|2
5131244|NCT01641367|17723251|P4|Cohorts|Lost to Follow-up|0
5131245|NCT01641367|17723252|P3|Cohorts|Lost to Follow-up|2
5131246|NCT01641367|17723253|P2|Cohorts|Lost to Follow-up|0
5131247|NCT01641367|17723254|P1|Cohorts|Lost to Follow-up|16
5131248|NCT01641367|17723247|P8|Cohorts|Death|0
5131249|NCT01641367|17723248|P7|Cohorts|Death|0
5131250|NCT01641367|17723249|P6|Cohorts|Death|1
5131251|NCT01641367|17723250|P5|Cohorts|Death|1
5131252|NCT01641367|17723251|P4|Cohorts|Death|0
5131253|NCT01641367|17723252|P3|Cohorts|Death|2
5131254|NCT01641367|17723253|P2|Cohorts|Death|1
5131255|NCT01641367|17723254|P1|Cohorts|Death|18
5131256|NCT01641237|17723505|P4|Period III|Lost to Follow-up|0
5131257|NCT01641237|17723506|P3|Period III|Lost to Follow-up|0
5131258|NCT01641237|17723507|P2|Period III|Lost to Follow-up|0
5131259|NCT01641237|17723508|P1|Period III|Lost to Follow-up|1
5131260|NCT01641237|17723505|P4|Period II|Withdrawal by Subject|0
5131261|NCT01641237|17723506|P3|Period II|Withdrawal by Subject|0
5131262|NCT01641237|17723507|P2|Period II|Withdrawal by Subject|0
5131263|NCT01641237|17723508|P1|Period II|Withdrawal by Subject|1
5131264|NCT01641198|17723533|P3|At 15-20 Years of Function|Death|1
5131265|NCT01641198|17723534|P2|At 15-20 Years of Function|Death|0
5131266|NCT01641198|17723535|P1|At 15-20 Years of Function|Death|1
5131267|NCT01641198|17723533|P3|At 15-20 Years of Function|Lost to Follow-up|1
5131268|NCT01641198|17723534|P2|At 15-20 Years of Function|Lost to Follow-up|1
5131269|NCT01641198|17723535|P1|At 15-20 Years of Function|Lost to Follow-up|5
5131270|NCT01641198|17723533|P3|After 24 Months of Function|Lost to Follow-up|6
5131271|NCT01641198|17723534|P2|After 24 Months of Function|Lost to Follow-up|9
5131272|NCT01641198|17723535|P1|After 24 Months of Function|Lost to Follow-up|4
5131273|NCT01641198|17723533|P3|After 12 Months of Function|Adverse Event|0
5131274|NCT01641198|17723534|P2|After 12 Months of Function|Adverse Event|1
5131275|NCT01641198|17723535|P1|After 12 Months of Function|Adverse Event|0
5131276|NCT01641198|17723533|P3|After 12 Months of Function|Protocol Violation|0
5131277|NCT01641198|17723534|P2|After 12 Months of Function|Protocol Violation|0
5131278|NCT01641198|17723535|P1|After 12 Months of Function|Protocol Violation|1
5131279|NCT01641198|17723533|P3|After 12 Months of Function|Lost to Follow-up|2
5131280|NCT01641198|17723534|P2|After 12 Months of Function|Lost to Follow-up|2
5131281|NCT01641198|17723535|P1|After 12 Months of Function|Lost to Follow-up|3
5131282|NCT01641159|17723551|P2|Overall Study|Withdrawal by Subject|1
5131283|NCT01641159|17723552|P1|Overall Study|Withdrawal by Subject|0
5131284|NCT01641159|17723551|P2|Overall Study|Lost to Follow-up|1
5131285|NCT01641159|17723552|P1|Overall Study|Lost to Follow-up|2
5131286|NCT01641133|17723563|P3|Overall Study|Lost to Follow-up|2
5131287|NCT01641133|17723564|P2|Overall Study|Lost to Follow-up|2
5131288|NCT01641133|17723565|P1|Overall Study|Lost to Follow-up|0
5131289|NCT01641133|17723563|P3|Overall Study|Withdrawal by Subject|3
5131290|NCT01641133|17723564|P2|Overall Study|Withdrawal by Subject|3
5131291|NCT01641133|17723565|P1|Overall Study|Withdrawal by Subject|5
5131292|NCT01641133|17723563|P3|Overall Study|Adverse Event|1
5131293|NCT01641133|17723564|P2|Overall Study|Adverse Event|0
5131294|NCT01641133|17723565|P1|Overall Study|Adverse Event|0
5131295|NCT01641133|17723563|P3|Overall Study|Migrated/moved from study area|1
5131296|NCT01641133|17723564|P2|Overall Study|Migrated/moved from study area|3
5131297|NCT01641133|17723565|P1|Overall Study|Migrated/moved from study area|5
5131298|NCT01641133|17723563|P3|Overall Study|Protocol Violation|1
5131299|NCT01641133|17723564|P2|Overall Study|Protocol Violation|1
5131300|NCT01641133|17723565|P1|Overall Study|Protocol Violation|0
5131301|NCT01641081|17723618|P10|Period 5|Adverse Event|0
5131302|NCT01641081|17723619|P9|Period 5|Adverse Event|0
5131303|NCT01641081|17723620|P8|Period 5|Adverse Event|0
5131304|NCT01641081|17723621|P7|Period 5|Adverse Event|0
5131305|NCT01641081|17723622|P6|Period 5|Adverse Event|0
5131306|NCT01641081|17723623|P5|Period 5|Adverse Event|0
5131307|NCT01641081|17723624|P4|Period 5|Adverse Event|0
5131308|NCT01641081|17723625|P3|Period 5|Adverse Event|2
5131309|NCT01641081|17723626|P2|Period 5|Adverse Event|0
5131310|NCT01641081|17723627|P1|Period 5|Adverse Event|0
5131311|NCT01641081|17723618|P10|Period 4|Adverse Event|0
5131312|NCT01641081|17723619|P9|Period 4|Adverse Event|0
5131313|NCT01641081|17723620|P8|Period 4|Adverse Event|0
5131314|NCT01641081|17723621|P7|Period 4|Adverse Event|0
5131315|NCT01641081|17723622|P6|Period 4|Adverse Event|0
5131316|NCT01641081|17723623|P5|Period 4|Adverse Event|0
5131317|NCT01641081|17723624|P4|Period 4|Adverse Event|1
5131318|NCT01641081|17723625|P3|Period 4|Adverse Event|0
5131319|NCT01641081|17723626|P2|Period 4|Adverse Event|1
5131320|NCT01641081|17723627|P1|Period 4|Adverse Event|0
5131321|NCT01641081|17723618|P10|Period 3|Withdrawal by Subject|0
5131322|NCT01641081|17723619|P9|Period 3|Withdrawal by Subject|1
5131323|NCT01641081|17723620|P8|Period 3|Withdrawal by Subject|0
5131324|NCT01641081|17723621|P7|Period 3|Withdrawal by Subject|0
5131325|NCT01641081|17723622|P6|Period 3|Withdrawal by Subject|0
5131326|NCT01641081|17723623|P5|Period 3|Withdrawal by Subject|0
5131327|NCT01641081|17723624|P4|Period 3|Withdrawal by Subject|0
5131328|NCT01641081|17723625|P3|Period 3|Withdrawal by Subject|0
5131329|NCT01641081|17723626|P2|Period 3|Withdrawal by Subject|0
5131330|NCT01641081|17723627|P1|Period 3|Withdrawal by Subject|0
5131331|NCT01641081|17723618|P10|Period 3|Adverse Event|0
5131332|NCT01641081|17723619|P9|Period 3|Adverse Event|0
5131333|NCT01641081|17723620|P8|Period 3|Adverse Event|0
5131334|NCT01641081|17723621|P7|Period 3|Adverse Event|0
5131335|NCT01641081|17723622|P6|Period 3|Adverse Event|0
5131336|NCT01641081|17723623|P5|Period 3|Adverse Event|0
5131337|NCT01641081|17723624|P4|Period 3|Adverse Event|0
5131338|NCT01641081|17723625|P3|Period 3|Adverse Event|1
5131339|NCT01641081|17723626|P2|Period 3|Adverse Event|0
5131340|NCT01641081|17723627|P1|Period 3|Adverse Event|0
5131341|NCT01641081|17723618|P10|Period 2|Protocol Violation|0
5131342|NCT01641081|17723619|P9|Period 2|Protocol Violation|0
5131343|NCT01641081|17723620|P8|Period 2|Protocol Violation|0
5131344|NCT01641081|17723621|P7|Period 2|Protocol Violation|0
5131345|NCT01641081|17723622|P6|Period 2|Protocol Violation|0
5131346|NCT01641081|17723623|P5|Period 2|Protocol Violation|0
5131347|NCT01641081|17723624|P4|Period 2|Protocol Violation|0
5131348|NCT01641081|17723625|P3|Period 2|Protocol Violation|0
5131349|NCT01641081|17723626|P2|Period 2|Protocol Violation|0
5131350|NCT01641081|17723627|P1|Period 2|Protocol Violation|1
5131351|NCT01641081|17723618|P10|Period 2|Withdrawal by Subject|0
5131352|NCT01641081|17723619|P9|Period 2|Withdrawal by Subject|0
5131353|NCT01641081|17723620|P8|Period 2|Withdrawal by Subject|0
5131354|NCT01641081|17723621|P7|Period 2|Withdrawal by Subject|2
5131355|NCT01641081|17723622|P6|Period 2|Withdrawal by Subject|0
5131356|NCT01641081|17723623|P5|Period 2|Withdrawal by Subject|0
5131357|NCT01641081|17723624|P4|Period 2|Withdrawal by Subject|1
5131358|NCT01641081|17723625|P3|Period 2|Withdrawal by Subject|0
5131359|NCT01641081|17723626|P2|Period 2|Withdrawal by Subject|0
5131360|NCT01641081|17723627|P1|Period 2|Withdrawal by Subject|0
5131361|NCT01641081|17723618|P10|Period 2|Adverse Event|0
5131362|NCT01641081|17723619|P9|Period 2|Adverse Event|0
5131363|NCT01641081|17723620|P8|Period 2|Adverse Event|0
5131364|NCT01641081|17723621|P7|Period 2|Adverse Event|0
5131365|NCT01641081|17723622|P6|Period 2|Adverse Event|1
5131366|NCT01641081|17723623|P5|Period 2|Adverse Event|0
5131367|NCT01641081|17723624|P4|Period 2|Adverse Event|0
5131368|NCT01641081|17723625|P3|Period 2|Adverse Event|0
5131369|NCT01641081|17723626|P2|Period 2|Adverse Event|0
5131370|NCT01641081|17723627|P1|Period 2|Adverse Event|0
5131371|NCT01641081|17723618|P10|Period 1|Adverse Event|0
5131372|NCT01641081|17723619|P9|Period 1|Adverse Event|0
5131373|NCT01641081|17723620|P8|Period 1|Adverse Event|2
5131374|NCT01641081|17723621|P7|Period 1|Adverse Event|0
5131375|NCT01641081|17723622|P6|Period 1|Adverse Event|0
5131376|NCT01641081|17723623|P5|Period 1|Adverse Event|0
5131377|NCT01641081|17723624|P4|Period 1|Adverse Event|0
5131378|NCT01641081|17723625|P3|Period 1|Adverse Event|0
5131379|NCT01641081|17723626|P2|Period 1|Adverse Event|0
5131380|NCT01641081|17723627|P1|Period 1|Adverse Event|1
5131381|NCT01641081|17723618|P10|Period 1|Protocol Violation|0
5131382|NCT01641081|17723619|P9|Period 1|Protocol Violation|0
5131383|NCT01641081|17723620|P8|Period 1|Protocol Violation|1
5131384|NCT01641081|17723621|P7|Period 1|Protocol Violation|0
5131385|NCT01641081|17723622|P6|Period 1|Protocol Violation|0
5131386|NCT01641081|17723623|P5|Period 1|Protocol Violation|1
5131387|NCT01641081|17723624|P4|Period 1|Protocol Violation|0
5131388|NCT01641081|17723625|P3|Period 1|Protocol Violation|0
5131389|NCT01641081|17723626|P2|Period 1|Protocol Violation|0
5131390|NCT01641081|17723627|P1|Period 1|Protocol Violation|0
5131391|NCT01641081|17723618|P10|Period 1|Sponsor request (potential unblinding)|0
5131392|NCT01641081|17723619|P9|Period 1|Sponsor request (potential unblinding)|0
5131393|NCT01641081|17723620|P8|Period 1|Sponsor request (potential unblinding)|0
5131394|NCT01641081|17723621|P7|Period 1|Sponsor request (potential unblinding)|1
5131395|NCT01641081|17723622|P6|Period 1|Sponsor request (potential unblinding)|0
5131396|NCT01641081|17723623|P5|Period 1|Sponsor request (potential unblinding)|0
5131397|NCT01641081|17723624|P4|Period 1|Sponsor request (potential unblinding)|0
5131398|NCT01641081|17723625|P3|Period 1|Sponsor request (potential unblinding)|0
5131399|NCT01641081|17723626|P2|Period 1|Sponsor request (potential unblinding)|0
5131400|NCT01641081|17723627|P1|Period 1|Sponsor request (potential unblinding)|0
5131401|NCT01640964|17723696|P3|Overall Study|Protocol Deviation|2
5131402|NCT01640964|17723697|P2|Overall Study|Protocol Deviation|1
5131403|NCT01640964|17723698|P1|Overall Study|Protocol Deviation|1
5131404|NCT01640964|17723696|P3|Overall Study|Lost to Follow-up|1
5131405|NCT01640964|17723697|P2|Overall Study|Lost to Follow-up|0
5131406|NCT01640964|17723698|P1|Overall Study|Lost to Follow-up|0
5131407|NCT01640951|17723721|P8|Overall Study|Death|2
5131408|NCT01640951|17723722|P7|Overall Study|Death|0
5131409|NCT01640951|17723723|P6|Overall Study|Death|0
5131410|NCT01640951|17723724|P5|Overall Study|Death|0
5131411|NCT01640951|17723725|P4|Overall Study|Death|0
5131412|NCT01640951|17723726|P3|Overall Study|Death|1
5131413|NCT01640951|17723727|P2|Overall Study|Death|1
5131414|NCT01640951|17723728|P1|Overall Study|Death|0
5131415|NCT01640951|17723721|P8|Overall Study|Subject/Guardian decision|4
5131416|NCT01640951|17723722|P7|Overall Study|Subject/Guardian decision|5
5131417|NCT01640951|17723723|P6|Overall Study|Subject/Guardian decision|19
5131418|NCT01640951|17723724|P5|Overall Study|Subject/Guardian decision|7
5131419|NCT01640951|17723725|P4|Overall Study|Subject/Guardian decision|15
5131420|NCT01640951|17723726|P3|Overall Study|Subject/Guardian decision|13
5131421|NCT01640951|17723727|P2|Overall Study|Subject/Guardian decision|4
5131422|NCT01640951|17723728|P1|Overall Study|Subject/Guardian decision|12
5131423|NCT01640951|17723721|P8|Overall Study|Protocol Deviation|0
5131424|NCT01640951|17723722|P7|Overall Study|Protocol Deviation|0
5131425|NCT01640951|17723723|P6|Overall Study|Protocol Deviation|1
5131426|NCT01640951|17723724|P5|Overall Study|Protocol Deviation|0
5131427|NCT01640951|17723725|P4|Overall Study|Protocol Deviation|1
5131428|NCT01640951|17723726|P3|Overall Study|Protocol Deviation|2
5131429|NCT01640951|17723727|P2|Overall Study|Protocol Deviation|1
5131430|NCT01640951|17723728|P1|Overall Study|Protocol Deviation|0
5131431|NCT01640951|17723721|P8|Overall Study|Pregnancy|0
5131432|NCT01640951|17723722|P7|Overall Study|Pregnancy|2
5131433|NCT01640951|17723723|P6|Overall Study|Pregnancy|0
5131434|NCT01640951|17723724|P5|Overall Study|Pregnancy|0
5131435|NCT01640951|17723725|P4|Overall Study|Pregnancy|4
5131436|NCT01640951|17723726|P3|Overall Study|Pregnancy|0
5131437|NCT01640951|17723727|P2|Overall Study|Pregnancy|0
5131438|NCT01640951|17723728|P1|Overall Study|Pregnancy|3
5131439|NCT01640951|17723721|P8|Overall Study|Physician Decision|0
5131440|NCT01640951|17723722|P7|Overall Study|Physician Decision|3
5131441|NCT01640951|17723723|P6|Overall Study|Physician Decision|3
5131442|NCT01640951|17723724|P5|Overall Study|Physician Decision|2
5131443|NCT01640951|17723725|P4|Overall Study|Physician Decision|2
5131444|NCT01640951|17723726|P3|Overall Study|Physician Decision|2
5131445|NCT01640951|17723727|P2|Overall Study|Physician Decision|5
5131446|NCT01640951|17723728|P1|Overall Study|Physician Decision|2
5131447|NCT01640951|17723721|P8|Overall Study|Non-compliance with study treatment|0
5131448|NCT01640951|17723722|P7|Overall Study|Non-compliance with study treatment|1
5131449|NCT01640951|17723723|P6|Overall Study|Non-compliance with study treatment|4
5131450|NCT01640951|17723724|P5|Overall Study|Non-compliance with study treatment|1
5131451|NCT01640951|17723725|P4|Overall Study|Non-compliance with study treatment|1
5131452|NCT01640951|17723726|P3|Overall Study|Non-compliance with study treatment|1
5131453|NCT01640951|17723727|P2|Overall Study|Non-compliance with study treatment|0
5131454|NCT01640951|17723728|P1|Overall Study|Non-compliance with study treatment|0
5131455|NCT01640951|17723721|P8|Overall Study|Lost to Follow-up|1
5131456|NCT01640951|17723722|P7|Overall Study|Lost to Follow-up|1
5131457|NCT01640951|17723723|P6|Overall Study|Lost to Follow-up|3
5131458|NCT01640951|17723724|P5|Overall Study|Lost to Follow-up|2
5131459|NCT01640951|17723725|P4|Overall Study|Lost to Follow-up|2
5131460|NCT01640951|17723726|P3|Overall Study|Lost to Follow-up|6
5131461|NCT01640951|17723727|P2|Overall Study|Lost to Follow-up|0
5131462|NCT01640951|17723728|P1|Overall Study|Lost to Follow-up|1
5131463|NCT01640951|17723721|P8|Overall Study|Lack of Efficacy|6
5131464|NCT01640951|17723722|P7|Overall Study|Lack of Efficacy|5
5131465|NCT01640951|17723723|P6|Overall Study|Lack of Efficacy|6
5131466|NCT01640951|17723724|P5|Overall Study|Lack of Efficacy|0
5131467|NCT01640951|17723725|P4|Overall Study|Lack of Efficacy|14
5131468|NCT01640951|17723726|P3|Overall Study|Lack of Efficacy|7
5131469|NCT01640951|17723727|P2|Overall Study|Lack of Efficacy|1
5131470|NCT01640951|17723728|P1|Overall Study|Lack of Efficacy|20
5131471|NCT01640951|17723721|P8|Overall Study|Adverse Event|3
5131472|NCT01640951|17723722|P7|Overall Study|Adverse Event|1
5131473|NCT01640951|17723723|P6|Overall Study|Adverse Event|11
5131474|NCT01640951|17723724|P5|Overall Study|Adverse Event|1
5131475|NCT01640951|17723725|P4|Overall Study|Adverse Event|6
5131476|NCT01640951|17723726|P3|Overall Study|Adverse Event|10
5131477|NCT01640951|17723727|P2|Overall Study|Adverse Event|3
5131478|NCT01640951|17723728|P1|Overall Study|Adverse Event|8
5131479|NCT01640925|17723830|P2|Overall Study|Previously enrolled in this trial|11
5131480|NCT01640925|17723831|P1|Overall Study|Previously enrolled in this trial|13
5131481|NCT01640925|17723830|P2|Overall Study|Withdrawal by Subject|0
5131482|NCT01640925|17723831|P1|Overall Study|Withdrawal by Subject|1
5131483|NCT01640873|17723845|P2|Overall Study|Protocol Violation|1
5131484|NCT01640873|17723846|P1|Overall Study|Protocol Violation|2
5131485|NCT01640366|17723919|P1|Overall Study|Lost to Follow-up|5
5131486|NCT01640366|17723919|P1|Overall Study|Protocol Violation|16
5131487|NCT01640366|17723919|P1|Overall Study|Withdrawal by Subject|1
5131488|NCT01640353|17723932|P1|Overall Study|Physician Decision|1
5131489|NCT01640353|17723932|P1|Overall Study|Lost to Follow-up|12
5131490|NCT01640353|17723932|P1|Overall Study|Early site termination|3
5131491|NCT01640353|17723932|P1|Overall Study|Death|2
5131492|NCT01640353|17723932|P1|Overall Study|Withdrawal by Subject|5
5131493|NCT01640353|17723932|P1|Overall Study|Withdrawn from analysis at term site|12
5131494|NCT01640353|17723932|P1|Overall Study|Withdrew prior to treatment|10
5131495|NCT01640314|17723980|P2|Overall Study|Protocol Violation|1
5131496|NCT01640314|17723981|P1|Overall Study|Protocol Violation|0
5131497|NCT01640288|17723997|P2|Overall Study|Withdrawal by Subject|0
5131498|NCT01640288|17723998|P1|Overall Study|Withdrawal by Subject|1
5131499|NCT01640288|17723997|P2|Overall Study|Withdrawn by PI|0
5131500|NCT01640288|17723998|P1|Overall Study|Withdrawn by PI|5
5131501|NCT01640288|17723997|P2|Overall Study|Screen Failure|18
5131502|NCT01640288|17723998|P1|Overall Study|Screen Failure|20
5131503|NCT01640288|17723997|P2|Overall Study|Equipment Failure or Poor Image Quality|5
5131504|NCT01640288|17723998|P1|Overall Study|Equipment Failure or Poor Image Quality|4
5131505|NCT01640249|17724015|P7|Period 1|Withdrawal by Subject|0
5131506|NCT01640249|17724016|P6|Period 1|Withdrawal by Subject|1
5131507|NCT01640249|17724017|P5|Period 1|Withdrawal by Subject|0
5131508|NCT01640249|17724018|P4|Period 1|Withdrawal by Subject|0
5131509|NCT01640249|17724019|P3|Period 1|Withdrawal by Subject|0
5131510|NCT01640249|17724020|P2|Period 1|Withdrawal by Subject|0
5131511|NCT01640249|17724021|P1|Period 1|Withdrawal by Subject|1
5131512|NCT01640184|17724069|P3|Overall Study|Protocol Violation|1
5131513|NCT01640184|17724070|P2|Overall Study|Protocol Violation|0
5131514|NCT01640184|17724071|P1|Overall Study|Protocol Violation|0
5131515|NCT01640184|17724069|P3|Overall Study|Withdrawal by Subject|1
5131516|NCT01640184|17724070|P2|Overall Study|Withdrawal by Subject|1
5131517|NCT01640184|17724071|P1|Overall Study|Withdrawal by Subject|0
5131518|NCT01640184|17724069|P3|Overall Study|Physician Decision|0
5131519|NCT01640184|17724070|P2|Overall Study|Physician Decision|0
5131520|NCT01640184|17724071|P1|Overall Study|Physician Decision|3
5131521|NCT01640184|17724069|P3|Overall Study|Lost to Follow-up|0
5131522|NCT01640184|17724070|P2|Overall Study|Lost to Follow-up|1
5131523|NCT01640184|17724071|P1|Overall Study|Lost to Follow-up|4
5131524|NCT01640184|17724069|P3|Overall Study|Death|0
5131525|NCT01640184|17724070|P2|Overall Study|Death|0
5131526|NCT01640184|17724071|P1|Overall Study|Death|1
5131527|NCT01640054|17724100|P1|Overall Study|Adverse Event|2
5131528|NCT01640054|17724100|P1|Overall Study|Lack of Efficacy|3
5131529|NCT01640054|17724100|P1|Overall Study|Study-specific disc criteria|1
5131530|NCT01639833|17724121|P2|Overall Study|Withdrawal by Subject|2
5131531|NCT01639833|17724122|P1|Overall Study|Withdrawal by Subject|2
5131532|NCT01639833|17724121|P2|Overall Study|Death|2
5131533|NCT01639833|17724122|P1|Overall Study|Death|4
5131534|NCT01639755|17724130|P1|Overall Study|Patient had device explantation|4
5131535|NCT01639755|17724130|P1|Overall Study|Study Ongoing|15
5131536|NCT01639742|17724138|P1|Overall Study|Lost to Follow-up|1
5131537|NCT01639742|17724138|P1|Overall Study|Study Ongoing|17
5131538|NCT01639729|17724146|P6|Overall Study|Withdrawal by Subject|0
5131539|NCT01639729|17724147|P5|Overall Study|Withdrawal by Subject|0
5131540|NCT01639729|17724148|P4|Overall Study|Withdrawal by Subject|1
5131541|NCT01639729|17724149|P3|Overall Study|Withdrawal by Subject|1
5131542|NCT01639729|17724150|P2|Overall Study|Withdrawal by Subject|0
5131543|NCT01639729|17724151|P1|Overall Study|Withdrawal by Subject|1
5131544|NCT01639703|17724173|P1|Overall Study|Other reason|7
5131545|NCT01639703|17724173|P1|Overall Study|Withdrawal by Subject|5
5131546|NCT01639560|17724238|P2|Overall Study|Adverse Event|2
5131547|NCT01639560|17724239|P1|Overall Study|Adverse Event|0
5131548|NCT01639560|17724238|P2|Overall Study|Lost to Follow-up|11
5131549|NCT01639560|17724239|P1|Overall Study|Lost to Follow-up|9
5131550|NCT01639560|17724238|P2|Overall Study|Lack of Efficacy|2
5131551|NCT01639560|17724239|P1|Overall Study|Lack of Efficacy|1
5131552|NCT01639560|17724238|P2|Overall Study|Withdrawal by Subject|14
5131553|NCT01639560|17724239|P1|Overall Study|Withdrawal by Subject|9
5131554|NCT01639495|17724251|P1|Overall Study|No radiofrequency energy applied|2
5131555|NCT01639495|17724251|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
5131556|NCT01639495|17724251|P1|Overall Study|Consented but didn't have study catheter|4
5131557|NCT01639495|17724251|P1|Overall Study|Lost to Follow-up|6
5131558|NCT01639469|17724261|P2|Overall Study|Lost to Follow-up|1
5131559|NCT01639469|17724262|P1|Overall Study|Lost to Follow-up|1
5131560|NCT01639469|17724261|P2|Overall Study|Death|2
5131561|NCT01639469|17724262|P1|Overall Study|Death|4
5131562|NCT01639339|17724298|P2|Overall Study|Adverse Event|7
5131563|NCT01639339|17724299|P1|Overall Study|Adverse Event|10
5131564|NCT01639339|17724298|P2|Overall Study|Lack of Efficacy|1
5131565|NCT01639339|17724299|P1|Overall Study|Lack of Efficacy|2
5131566|NCT01639339|17724298|P2|Overall Study|Protocol Violation|2
5131567|NCT01639339|17724299|P1|Overall Study|Protocol Violation|0
5131568|NCT01639339|17724298|P2|Overall Study|Lost to Follow-up|4
5131569|NCT01639339|17724299|P1|Overall Study|Lost to Follow-up|5
5131570|NCT01639339|17724298|P2|Overall Study|Physician Decision|5
5131571|NCT01639339|17724299|P1|Overall Study|Physician Decision|11
5131572|NCT01639339|17724298|P2|Overall Study|Withdrawal by Subject|19
5131573|NCT01639339|17724299|P1|Overall Study|Withdrawal by Subject|26
5131574|NCT01639144|17724388|P2|Overall Study|Met postoperative exclusion criteria|3
5131575|NCT01639144|17724389|P1|Overall Study|Met postoperative exclusion criteria|4
5131576|NCT01639144|17724388|P2|Overall Study|Physician Decision|0
5131577|NCT01639144|17724389|P1|Overall Study|Physician Decision|2
5131578|NCT01639144|17724388|P2|Overall Study|Withdrawal by Subject|2
5131579|NCT01639144|17724389|P1|Overall Study|Withdrawal by Subject|4
5131580|NCT01639040|17724397|P2|Overall Study|Adverse Event|0
5131581|NCT01639040|17724398|P1|Overall Study|Adverse Event|1
5131582|NCT01639001|17724416|P2|Overall Study|Death|35
5131583|NCT01639001|17724417|P1|Overall Study|Death|35
5131584|NCT01639001|17724416|P2|Overall Study|Lost to Follow-up|0
5131585|NCT01639001|17724417|P1|Overall Study|Lost to Follow-up|1
5131586|NCT01639001|17724416|P2|Overall Study|Refused further follow-up|6
5131587|NCT01639001|17724417|P1|Overall Study|Refused further follow-up|3
5131588|NCT01639001|17724416|P2|Overall Study|Ongoing at date of cutoff|60
5131589|NCT01639001|17724417|P1|Overall Study|Ongoing at date of cutoff|65
5131590|NCT01639001|17724416|P2|Overall Study|Randomized but not treated|2
5131591|NCT01639001|17724417|P1|Overall Study|Randomized but not treated|0
5131592|NCT01638819|17724463|P2|Overall Study|Lost to Follow-up|0
5131593|NCT01638819|17724464|P1|Overall Study|Lost to Follow-up|1
5131594|NCT01638559|17724473|P1|Overall Study|Subject declined to travel for biopsy|1
5131595|NCT01638559|17724473|P1|Overall Study|Withdrawal by Subject|1
5131596|NCT01638559|17724473|P1|Overall Study|Lost to Follow-up|1
5131597|NCT01638546|17724491|P2|Overall Study|Adverse Event|3
5131598|NCT01638546|17724492|P1|Overall Study|Adverse Event|1
5131599|NCT01638429|17724531|P1|Overall Study|Withdrawal by Subject|1
5131600|NCT01638390|17724582|P1|Overall Study|screening failures|21
5131601|NCT01638013|17724606|P3|Overall Study|Not met inclusion or exclusion criteria|1
5131602|NCT01638013|17724607|P2|Overall Study|Not met inclusion or exclusion criteria|0
5131603|NCT01638013|17724608|P1|Overall Study|Not met inclusion or exclusion criteria|0
5131604|NCT01638013|17724606|P3|Overall Study|Withdrawal of Consent|16
5131605|NCT01638013|17724607|P2|Overall Study|Withdrawal of Consent|12
5131606|NCT01638013|17724608|P1|Overall Study|Withdrawal of Consent|16
5131607|NCT01638013|17724606|P3|Overall Study|Miscellaneous|23
5131608|NCT01638013|17724607|P2|Overall Study|Miscellaneous|19
5131609|NCT01638013|17724608|P1|Overall Study|Miscellaneous|25
5131610|NCT01638013|17724606|P3|Overall Study|Subject Lost to Follow up|1
5131611|NCT01638013|17724607|P2|Overall Study|Subject Lost to Follow up|0
5131612|NCT01638013|17724608|P1|Overall Study|Subject Lost to Follow up|1
5131613|NCT01638013|17724606|P3|Overall Study|Met discontinuation criteria|7
5131614|NCT01638013|17724607|P2|Overall Study|Met discontinuation criteria|0
5131615|NCT01638013|17724608|P1|Overall Study|Met discontinuation criteria|4
5131616|NCT01638013|17724606|P3|Overall Study|Protocol Violation|11
5131617|NCT01638013|17724607|P2|Overall Study|Protocol Violation|7
5131618|NCT01638013|17724608|P1|Overall Study|Protocol Violation|10
5131619|NCT01638013|17724606|P3|Overall Study|Lack of Efficacy|14
5131620|NCT01638013|17724607|P2|Overall Study|Lack of Efficacy|11
5131621|NCT01638013|17724608|P1|Overall Study|Lack of Efficacy|39
5131622|NCT01638013|17724606|P3|Overall Study|Adverse Event|48
5131623|NCT01638013|17724607|P2|Overall Study|Adverse Event|29
5131624|NCT01638013|17724608|P1|Overall Study|Adverse Event|36
5131625|NCT01638000|17724741|P2|Overall Study|Miscellaneous|2
5131626|NCT01638000|17724742|P1|Overall Study|Miscellaneous|2
5131627|NCT01638000|17724741|P2|Overall Study|Withdrawal by Subject|24
5131628|NCT01638000|17724742|P1|Overall Study|Withdrawal by Subject|21
5131629|NCT01638000|17724741|P2|Overall Study|Protocol Violation|13
5131630|NCT01638000|17724742|P1|Overall Study|Protocol Violation|11
5131631|NCT01638000|17724741|P2|Overall Study|Lack of Efficacy|6
5131632|NCT01638000|17724742|P1|Overall Study|Lack of Efficacy|5
5131633|NCT01638000|17724741|P2|Overall Study|Adverse Event|16
5131634|NCT01638000|17724742|P1|Overall Study|Adverse Event|14
5131635|NCT01638000|17724741|P2|Overall Study|Randomized but Never Received Drug|10
5131636|NCT01638000|17724742|P1|Overall Study|Randomized but Never Received Drug|7
5131637|NCT01637961|17724840|P1|Overall Study|Ineligible: inadequate pathology|1
5131638|NCT01637961|17724840|P1|Overall Study|Ineligible: wrong primary|1
5131639|NCT01637922|17724872|P2|Overall Study|Lost to Follow-up|0
5131640|NCT01637922|17724873|P1|Overall Study|Lost to Follow-up|2
5131641|NCT01637922|17724872|P2|Overall Study|Withdrawal by Subject|3
5131642|NCT01637922|17724873|P1|Overall Study|Withdrawal by Subject|0
5131643|NCT01637922|17724872|P2|Overall Study|Protocol Violation|1
5131644|NCT01637922|17724873|P1|Overall Study|Protocol Violation|0
5131645|NCT01637922|17724872|P2|Overall Study|Adverse Event|1
5131646|NCT01637922|17724873|P1|Overall Study|Adverse Event|0
5131647|NCT01637623|17724903|P3|Overall Study|Physician Decision|1
5131648|NCT01637623|17724904|P2|Overall Study|Physician Decision|0
5131649|NCT01637623|17724905|P1|Overall Study|Physician Decision|1
5131650|NCT01637623|17724903|P3|Overall Study|Lost to Follow-up|2
5131651|NCT01637623|17724904|P2|Overall Study|Lost to Follow-up|0
5131652|NCT01637623|17724905|P1|Overall Study|Lost to Follow-up|0
5131653|NCT01637584|17724945|P2|Overall Study|Withdrawal by Subject|3
5131654|NCT01637584|17724946|P1|Overall Study|Withdrawal by Subject|1
5131655|NCT01637402|17724953|P2|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
5131656|NCT01637402|17724954|P1|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
5131657|NCT01637402|17724953|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
5131658|NCT01637402|17724954|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|4
5131659|NCT01637402|17724953|P2|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
5131660|NCT01637402|17724954|P1|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
5131661|NCT01637402|17724953|P2|Week 12 Evaluation|Lack of Efficacy|0
5131662|NCT01637402|17724954|P1|Week 12 Evaluation|Lack of Efficacy|6
5131663|NCT01637402|17724953|P2|Standard Dose Regimen|Adverse Event|0
5131664|NCT01637402|17724954|P1|Standard Dose Regimen|Adverse Event|1
5131665|NCT01637402|17724953|P2|Standard Dose Regimen|Lack of Efficacy|0
5131666|NCT01637402|17724954|P1|Standard Dose Regimen|Lack of Efficacy|2
5131667|NCT01637272|17724985|P1|Overall Study|Protocol Violation|2
5131668|NCT01637272|17724985|P1|Overall Study|Administrative problems|1
5131669|NCT01637272|17724985|P1|Overall Study|completed core, did not enter ext. phase|4
5131670|NCT01637272|17724985|P1|Overall Study|Lost to Follow-up|2
5131671|NCT01637272|17724985|P1|Overall Study|Withdrawal by Subject|3
5131672|NCT01637272|17724985|P1|Overall Study|Unsatisfactory therapeutic effect|2
5131673|NCT01637272|17724985|P1|Overall Study|Adverse Event|6
5131674|NCT01637077|17725065|P2|Overall Study|No cycle 1 questionnaire data|0
5131675|NCT01637077|17725066|P1|Overall Study|No cycle 1 questionnaire data|2
5131676|NCT01637077|17725065|P2|Overall Study|Withdrawal by Subject|0
5131677|NCT01637077|17725066|P1|Overall Study|Withdrawal by Subject|1
5131678|NCT01637077|17725065|P2|Overall Study|Cancel|1
5131679|NCT01637077|17725066|P1|Overall Study|Cancel|1
5131680|NCT01636986|17725094|P2|Overall Study|Corneal Staining|1
5131681|NCT01636986|17725095|P1|Overall Study|Corneal Staining|0
5131682|NCT01636986|17725094|P2|Overall Study|Withdrawal by Subject|1
5131683|NCT01636986|17725095|P1|Overall Study|Withdrawal by Subject|0
5131684|NCT01636960|17725101|P1|Maintenance Phase|Progressive disease|1
5131685|NCT01636960|17725101|P1|Maintenance Phase|Adverse Event|3
5131686|NCT01636960|17725101|P1|Maintenance Phase|Continued drug after regulatory approval|3
5131687|NCT01636960|17725101|P1|Induction Phase|Adverse Event|2
5131688|NCT01636947|17725109|P2|Overall Study|Did Not Meet Eligibility Criteria|4
5131689|NCT01636947|17725110|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5131690|NCT01636947|17725109|P2|Overall Study|Adverse Event|1
5131691|NCT01636947|17725110|P1|Overall Study|Adverse Event|1
5131692|NCT01636947|17725109|P2|Overall Study|Withdrawal by Subject|3
5131693|NCT01636947|17725110|P1|Overall Study|Withdrawal by Subject|3
5131694|NCT01636947|17725109|P2|Overall Study|Protocol Violation|1
5131695|NCT01636947|17725110|P1|Overall Study|Protocol Violation|1
5131696|NCT01636947|17725109|P2|Overall Study|Lost to Follow-up|0
5131697|NCT01636947|17725110|P1|Overall Study|Lost to Follow-up|4
5131698|NCT01636947|17725109|P2|Overall Study|Not Treated|2
5131699|NCT01636947|17725110|P1|Overall Study|Not Treated|2
5131700|NCT01636934|17725132|P2|Overall Study|Never started study medication|1
5131701|NCT01636934|17725133|P1|Overall Study|Never started study medication|1
5131702|NCT01636934|17725132|P2|Overall Study|Too ill to continue|0
5131703|NCT01636934|17725133|P1|Overall Study|Too ill to continue|1
5131704|NCT01636934|17725132|P2|Overall Study|Chemo cancel|0
5131705|NCT01636934|17725133|P1|Overall Study|Chemo cancel|1
5131706|NCT01636934|17725132|P2|Overall Study|Withdrawal by Subject|2
5131707|NCT01636934|17725133|P1|Overall Study|Withdrawal by Subject|3
5131708|NCT01636778|17725145|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
5131709|NCT01636778|17725146|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
5131710|NCT01636778|17725147|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
5131711|NCT01636778|17725145|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
5131712|NCT01636778|17725146|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
5131713|NCT01636778|17725147|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
5131714|NCT01636778|17725145|P3|Follow-up Period After Part 2|Other|1
5131715|NCT01636778|17725146|P2|Follow-up Period After Part 2|Other|0
5131716|NCT01636778|17725147|P1|Follow-up Period After Part 2|Other|0
5131717|NCT01636778|17725145|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
5131718|NCT01636778|17725146|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
5131719|NCT01636778|17725147|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
5131720|NCT01636778|17725145|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
5131721|NCT01636778|17725146|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
5131722|NCT01636778|17725147|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
5131723|NCT01636778|17725145|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
5131724|NCT01636778|17725146|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
5131725|NCT01636778|17725147|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
5131726|NCT01636778|17725145|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
5131727|NCT01636778|17725146|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
5131728|NCT01636778|17725147|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
5131729|NCT01636778|17725145|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
5131730|NCT01636778|17725146|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
5131731|NCT01636778|17725147|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
5131732|NCT01636713|17725218|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
5131733|NCT01636713|17725219|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
5131734|NCT01636713|17725220|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
5131735|NCT01636713|17725218|P3|Overall Study|Withdrawal by Subject|8
5131736|NCT01636713|17725219|P2|Overall Study|Withdrawal by Subject|4
5131737|NCT01636713|17725220|P1|Overall Study|Withdrawal by Subject|5
5131738|NCT01636713|17725218|P3|Overall Study|Lost to Follow-up|1
5131739|NCT01636713|17725219|P2|Overall Study|Lost to Follow-up|0
5131740|NCT01636713|17725220|P1|Overall Study|Lost to Follow-up|0
5131741|NCT01636713|17725218|P3|Overall Study|Protocol Violation|1
5131742|NCT01636713|17725219|P2|Overall Study|Protocol Violation|0
5131743|NCT01636713|17725220|P1|Overall Study|Protocol Violation|3
5131744|NCT01636713|17725218|P3|Overall Study|Lack of Efficacy|2
5131745|NCT01636713|17725219|P2|Overall Study|Lack of Efficacy|6
5131746|NCT01636713|17725220|P1|Overall Study|Lack of Efficacy|6
5131747|NCT01636713|17725218|P3|Overall Study|Adverse Event|7
5131748|NCT01636713|17725219|P2|Overall Study|Adverse Event|16
5131749|NCT01636713|17725220|P1|Overall Study|Adverse Event|16
5131750|NCT01636687|17725237|P5|Follow-up Period|Withdrawal by Subject|1
5131751|NCT01636687|17725238|P4|Follow-up Period|Withdrawal by Subject|0
5131752|NCT01636687|17725239|P3|Follow-up Period|Withdrawal by Subject|0
5131753|NCT01636687|17725240|P2|Follow-up Period|Withdrawal by Subject|0
5131754|NCT01636687|17725241|P1|Follow-up Period|Withdrawal by Subject|1
5131755|NCT01636687|17725237|P5|Extension Period|Withdrawal by Subject|0
5131756|NCT01636687|17725238|P4|Extension Period|Withdrawal by Subject|1
5131757|NCT01636687|17725239|P3|Extension Period|Withdrawal by Subject|1
5131758|NCT01636687|17725240|P2|Extension Period|Withdrawal by Subject|0
5131759|NCT01636687|17725241|P1|Extension Period|Withdrawal by Subject|1
5131760|NCT01636687|17725237|P5|Extension Period|study terminated by sponsor|0
5131761|NCT01636687|17725238|P4|Extension Period|study terminated by sponsor|23
5131762|NCT01636687|17725239|P3|Extension Period|study terminated by sponsor|17
5131763|NCT01636687|17725240|P2|Extension Period|study terminated by sponsor|50
5131764|NCT01636687|17725241|P1|Extension Period|study terminated by sponsor|33
5131765|NCT01636687|17725237|P5|Extension Period|Physician Decision|0
5131766|NCT01636687|17725238|P4|Extension Period|Physician Decision|1
5131767|NCT01636687|17725239|P3|Extension Period|Physician Decision|0
5131768|NCT01636687|17725240|P2|Extension Period|Physician Decision|0
5131769|NCT01636687|17725241|P1|Extension Period|Physician Decision|1
5131770|NCT01636687|17725237|P5|Extension Period|Lost to Follow-up|0
5131771|NCT01636687|17725238|P4|Extension Period|Lost to Follow-up|0
5131772|NCT01636687|17725239|P3|Extension Period|Lost to Follow-up|1
5131773|NCT01636687|17725240|P2|Extension Period|Lost to Follow-up|0
5131774|NCT01636687|17725241|P1|Extension Period|Lost to Follow-up|1
5131775|NCT01636687|17725237|P5|Extension Period|Lack of Efficacy|0
5131776|NCT01636687|17725238|P4|Extension Period|Lack of Efficacy|1
5131777|NCT01636687|17725239|P3|Extension Period|Lack of Efficacy|2
5131778|NCT01636687|17725240|P2|Extension Period|Lack of Efficacy|0
5131779|NCT01636687|17725241|P1|Extension Period|Lack of Efficacy|7
5131780|NCT01636687|17725237|P5|Extension Period|Adverse Event|0
5131781|NCT01636687|17725238|P4|Extension Period|Adverse Event|1
5131782|NCT01636687|17725239|P3|Extension Period|Adverse Event|2
5131783|NCT01636687|17725240|P2|Extension Period|Adverse Event|3
5131784|NCT01636687|17725241|P1|Extension Period|Adverse Event|4
5131785|NCT01636687|17725237|P5|Extension Period|technical problems|0
5131786|NCT01636687|17725238|P4|Extension Period|technical problems|1
5131787|NCT01636687|17725239|P3|Extension Period|technical problems|2
5131788|NCT01636687|17725240|P2|Extension Period|technical problems|1
5131789|NCT01636687|17725241|P1|Extension Period|technical problems|0
5131790|NCT01636687|17725237|P5|Maintenance Period|Physician Decision|1
5131791|NCT01636687|17725238|P4|Maintenance Period|Physician Decision|0
5131792|NCT01636687|17725239|P3|Maintenance Period|Physician Decision|0
5131793|NCT01636687|17725240|P2|Maintenance Period|Physician Decision|0
5131794|NCT01636687|17725241|P1|Maintenance Period|Physician Decision|0
5131795|NCT01636687|17725237|P5|Maintenance Period|Lost to Follow-up|1
5131796|NCT01636687|17725238|P4|Maintenance Period|Lost to Follow-up|0
5131797|NCT01636687|17725239|P3|Maintenance Period|Lost to Follow-up|0
5131798|NCT01636687|17725240|P2|Maintenance Period|Lost to Follow-up|1
5131799|NCT01636687|17725241|P1|Maintenance Period|Lost to Follow-up|1
5131800|NCT01636687|17725237|P5|Maintenance Period|Lack of Efficacy|0
5131801|NCT01636687|17725238|P4|Maintenance Period|Lack of Efficacy|0
5131802|NCT01636687|17725239|P3|Maintenance Period|Lack of Efficacy|0
5131803|NCT01636687|17725240|P2|Maintenance Period|Lack of Efficacy|1
5131804|NCT01636687|17725241|P1|Maintenance Period|Lack of Efficacy|4
5131805|NCT01636687|17725237|P5|Maintenance Period|Adverse Event|0
5131806|NCT01636687|17725238|P4|Maintenance Period|Adverse Event|0
5131807|NCT01636687|17725239|P3|Maintenance Period|Adverse Event|0
5131808|NCT01636687|17725240|P2|Maintenance Period|Adverse Event|0
5131809|NCT01636687|17725241|P1|Maintenance Period|Adverse Event|1
5131810|NCT01636687|17725237|P5|Maintenance Period|Withdrawal by Subject|0
5131811|NCT01636687|17725238|P4|Maintenance Period|Withdrawal by Subject|0
5131812|NCT01636687|17725239|P3|Maintenance Period|Withdrawal by Subject|2
5131813|NCT01636687|17725240|P2|Maintenance Period|Withdrawal by Subject|0
5131814|NCT01636687|17725241|P1|Maintenance Period|Withdrawal by Subject|2
5131815|NCT01636687|17725237|P5|Induction Period|Physician Decision|0
5131816|NCT01636687|17725238|P4|Induction Period|Physician Decision|0
5131817|NCT01636687|17725239|P3|Induction Period|Physician Decision|0
5131818|NCT01636687|17725240|P2|Induction Period|Physician Decision|0
5131819|NCT01636687|17725241|P1|Induction Period|Physician Decision|1
5131820|NCT01636687|17725237|P5|Induction Period|Lack of Efficacy|1
5131821|NCT01636687|17725238|P4|Induction Period|Lack of Efficacy|0
5131822|NCT01636687|17725239|P3|Induction Period|Lack of Efficacy|0
5131823|NCT01636687|17725240|P2|Induction Period|Lack of Efficacy|0
5131824|NCT01636687|17725241|P1|Induction Period|Lack of Efficacy|0
5131825|NCT01636687|17725237|P5|Induction Period|Adverse Event|1
5131826|NCT01636687|17725238|P4|Induction Period|Adverse Event|0
5131827|NCT01636687|17725239|P3|Induction Period|Adverse Event|0
5131828|NCT01636687|17725240|P2|Induction Period|Adverse Event|0
5131829|NCT01636687|17725241|P1|Induction Period|Adverse Event|1
5131830|NCT01636687|17725237|P5|Induction Period|Withdrawal by Subject|0
5131831|NCT01636687|17725238|P4|Induction Period|Withdrawal by Subject|0
5131832|NCT01636687|17725239|P3|Induction Period|Withdrawal by Subject|0
5131833|NCT01636687|17725240|P2|Induction Period|Withdrawal by Subject|0
5131834|NCT01636687|17725241|P1|Induction Period|Withdrawal by Subject|1
5131835|NCT01636362|17725382|P1|Overall Study|Withdrawal by Subject|1
5131836|NCT01636362|17725382|P1|Overall Study|Subject healed, not returning|1
5131837|NCT01636362|17725382|P1|Overall Study|Physician Decision|6
5131838|NCT01636258|17725413|P2|Overall Study|Lost to Follow-up|0
5131839|NCT01636258|17725414|P1|Overall Study|Lost to Follow-up|1
5131840|NCT01636076|17725454|P2|Overall Study|Withdrawal by Subject|10
5131841|NCT01636076|17725455|P1|Overall Study|Withdrawal by Subject|7
5131842|NCT01636076|17725454|P2|Overall Study|Adverse Event|11
5131843|NCT01636076|17725455|P1|Overall Study|Adverse Event|6
5131844|NCT01636076|17725454|P2|Overall Study|Non-compliance with study treatment|1
5131845|NCT01636076|17725455|P1|Overall Study|Non-compliance with study treatment|1
5131846|NCT01636076|17725454|P2|Overall Study|Physician Decision|1
5131847|NCT01636076|17725455|P1|Overall Study|Physician Decision|1
5131848|NCT01636076|17725454|P2|Overall Study|Lost to Follow-up|0
5131849|NCT01636076|17725455|P1|Overall Study|Lost to Follow-up|1
5131850|NCT01636076|17725454|P2|Overall Study|Lack of Efficacy|1
5131851|NCT01636076|17725455|P1|Overall Study|Lack of Efficacy|0
5131852|NCT01636076|17725454|P2|Overall Study|Terminated by sponsor|1
5131853|NCT01636076|17725455|P1|Overall Study|Terminated by sponsor|1
5131854|NCT01635998|17725526|P2|Overall Study|Withdrawal by Subject|5
5131855|NCT01635998|17725527|P1|Overall Study|Withdrawal by Subject|1
5131856|NCT01635998|17725526|P2|Overall Study|Lost to Follow-up|1
5131857|NCT01635998|17725527|P1|Overall Study|Lost to Follow-up|2
5131858|NCT01635998|17725526|P2|Overall Study|Death|1
5131859|NCT01635998|17725527|P1|Overall Study|Death|1
5131860|NCT01635933|17725555|P2|Overall Study|No longer had transportation|1
5131861|NCT01635933|17725556|P1|Overall Study|No longer had transportation|0
5131862|NCT01635933|17725555|P2|Overall Study|Noncompliance|1
5131863|NCT01635933|17725556|P1|Overall Study|Noncompliance|0
5131864|NCT01635933|17725555|P2|Overall Study|Subject decision|1
5131865|NCT01635933|17725556|P1|Overall Study|Subject decision|1
5131866|NCT01635933|17725555|P2|Overall Study|Lost to Follow-up|5
5131867|NCT01635933|17725556|P1|Overall Study|Lost to Follow-up|0
5131868|NCT01635933|17725555|P2|Overall Study|Adverse Event|0
5131869|NCT01635933|17725556|P1|Overall Study|Adverse Event|1
5131870|NCT01635920|17725568|P2|Overall Study|Subject decision|0
5131871|NCT01635920|17725569|P1|Overall Study|Subject decision|2
5131872|NCT01635920|17725568|P2|Overall Study|Lost to Follow-up|1
5131873|NCT01635920|17725569|P1|Overall Study|Lost to Follow-up|0
5131874|NCT01635920|17725568|P2|Overall Study|Adverse Event|0
5131875|NCT01635920|17725569|P1|Overall Study|Adverse Event|1
5131876|NCT01635855|17725582|P1|Overall Study|Withdrawal by Subject|4
5131877|NCT01635764|17725591|P1|Overall Study|Other|28
5131878|NCT01635764|17725591|P1|Overall Study|Lost to Follow-up|53
5131879|NCT01635764|17725591|P1|Overall Study|Withdrew Consent|67
5131880|NCT01635764|17725591|P1|Overall Study|Protocol Deviation|1
5131881|NCT01635764|17725591|P1|Overall Study|Exceed Protocol-specified Interventions|2
5131882|NCT01635764|17725591|P1|Overall Study|Lack of Efficacy|76
5131883|NCT01635764|17725591|P1|Overall Study|Adverse Event|46
5131884|NCT01635283|17725641|P1|Overall Study|Lost to Follow-up|1
5131885|NCT01635283|17725641|P1|Overall Study|Tumor Progression|3
5131886|NCT01635218|17725665|P3|Overall Study|Lost to Follow-up|6
5131887|NCT01635218|17725666|P2|Overall Study|Lost to Follow-up|7
5131888|NCT01635218|17725667|P1|Overall Study|Lost to Follow-up|3
5131889|NCT01635153|17725689|P2|Overall Study|Lost to Follow-up|43
5131890|NCT01635153|17725690|P1|Overall Study|Lost to Follow-up|40
5131891|NCT01634854|17725743|P2|Overall Study|Cesarean delivery|7
5131892|NCT01634854|17725744|P1|Overall Study|Cesarean delivery|2
5131893|NCT01634659|17725764|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
5131894|NCT01634659|17725765|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
5131895|NCT01634659|17725764|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
5131896|NCT01634659|17725765|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
5131897|NCT01634555|17725795|P1|Overall Study|Physician Decision|1
5131898|NCT01634555|17725795|P1|Overall Study|Adverse Event|3
5131899|NCT01634360|17725806|P2|Overall Study|Study termination by sponsor|44
5131900|NCT01634360|17725807|P1|Overall Study|Study termination by sponsor|18
5131901|NCT01634360|17725806|P2|Overall Study|Other|20
5131902|NCT01634360|17725807|P1|Overall Study|Other|3
5131903|NCT01634360|17725806|P2|Overall Study|Lack of Efficacy|14
5131904|NCT01634360|17725807|P1|Overall Study|Lack of Efficacy|4
5131905|NCT01634360|17725806|P2|Overall Study|Protocol Violation|1
5131906|NCT01634360|17725807|P1|Overall Study|Protocol Violation|1
5131907|NCT01634360|17725806|P2|Overall Study|subject withdrew consent|23
5131908|NCT01634360|17725807|P1|Overall Study|subject withdrew consent|13
5131909|NCT01634360|17725806|P2|Overall Study|Adverse Event|34
5131910|NCT01634360|17725807|P1|Overall Study|Adverse Event|10
5131911|NCT01634243|17725881|P2|Overall Study|Lack of Efficacy|0
5131912|NCT01634243|17725882|P1|Overall Study|Lack of Efficacy|1
5131913|NCT01634243|17725881|P2|Overall Study|Adverse Event|5
5131914|NCT01634243|17725882|P1|Overall Study|Adverse Event|5
5131915|NCT01634165|17725908|P4|Period 2|Adverse Event|0
5131916|NCT01634165|17725909|P3|Period 2|Adverse Event|0
5131917|NCT01634165|17725910|P2|Period 2|Adverse Event|1
5131918|NCT01634165|17725911|P1|Period 2|Adverse Event|0
5131919|NCT01634152|17725944|P3|Overall Study|Other reason not defined above|1
5131920|NCT01634152|17725945|P2|Overall Study|Other reason not defined above|0
5131921|NCT01634152|17725946|P1|Overall Study|Other reason not defined above|1
5131922|NCT01634152|17725944|P3|Overall Study|Not treated|0
5131923|NCT01634152|17725945|P2|Overall Study|Not treated|1
5131924|NCT01634152|17725946|P1|Overall Study|Not treated|0
5131925|NCT01634152|17725944|P3|Overall Study|Consent withdrawn not due to AE|1
5131926|NCT01634152|17725945|P2|Overall Study|Consent withdrawn not due to AE|0
5131927|NCT01634152|17725946|P1|Overall Study|Consent withdrawn not due to AE|1
5131928|NCT01634152|17725944|P3|Overall Study|Adverse Event|2
5131929|NCT01634152|17725945|P2|Overall Study|Adverse Event|0
5131930|NCT01634152|17725946|P1|Overall Study|Adverse Event|2
5131931|NCT01634139|17726029|P3|Overall Study|Not treated|0
5131932|NCT01634139|17726030|P2|Overall Study|Not treated|1
5131933|NCT01634139|17726031|P1|Overall Study|Not treated|1
5131934|NCT01634139|17726029|P3|Overall Study|Lost to Follow-up|0
5131935|NCT01634139|17726030|P2|Overall Study|Lost to Follow-up|2
5131936|NCT01634139|17726031|P1|Overall Study|Lost to Follow-up|0
5131937|NCT01634139|17726029|P3|Overall Study|Other|3
5131938|NCT01634139|17726030|P2|Overall Study|Other|0
5131939|NCT01634139|17726031|P1|Overall Study|Other|4
5131940|NCT01634139|17726029|P3|Overall Study|Consent withdrawn not due to AE|2
5131941|NCT01634139|17726030|P2|Overall Study|Consent withdrawn not due to AE|3
5131942|NCT01634139|17726031|P1|Overall Study|Consent withdrawn not due to AE|4
5131943|NCT01634139|17726029|P3|Overall Study|Non compliant with protocol|0
5131944|NCT01634139|17726030|P2|Overall Study|Non compliant with protocol|0
5131945|NCT01634139|17726031|P1|Overall Study|Non compliant with protocol|1
5131946|NCT01634113|17726132|P3|Overall Study|Not treated|1
5131947|NCT01634113|17726133|P2|Overall Study|Not treated|0
5131948|NCT01634113|17726134|P1|Overall Study|Not treated|0
5131949|NCT01634100|17726178|P6|Overall Study|Withdrawal by Subject|0
5131950|NCT01634100|17726179|P5|Overall Study|Withdrawal by Subject|0
5131951|NCT01634100|17726180|P4|Overall Study|Withdrawal by Subject|0
5131952|NCT01634100|17726181|P3|Overall Study|Withdrawal by Subject|1
5131953|NCT01634100|17726182|P2|Overall Study|Withdrawal by Subject|0
5131954|NCT01634100|17726183|P1|Overall Study|Withdrawal by Subject|1
5131955|NCT01633944|17726199|P3|Double-blind Treatment Phase|Other|0
5131956|NCT01633944|17726200|P2|Double-blind Treatment Phase|Other|7
5131957|NCT01633944|17726201|P1|Double-blind Treatment Phase|Other|0
5131958|NCT01633944|17726199|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
5131959|NCT01633944|17726200|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
5131960|NCT01633944|17726201|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
5131961|NCT01633944|17726199|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
5131962|NCT01633944|17726200|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
5131963|NCT01633944|17726201|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
5131964|NCT01633944|17726199|P3|Double-blind Treatment Phase|Lost to Follow-up|9
5131965|NCT01633944|17726200|P2|Double-blind Treatment Phase|Lost to Follow-up|4
5131966|NCT01633944|17726201|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5131967|NCT01633944|17726199|P3|Double-blind Treatment Phase|Protocol Violation|10
5131968|NCT01633944|17726200|P2|Double-blind Treatment Phase|Protocol Violation|7
5131969|NCT01633944|17726201|P1|Double-blind Treatment Phase|Protocol Violation|0
5131970|NCT01633944|17726199|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
5131971|NCT01633944|17726200|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
5131972|NCT01633944|17726201|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5131973|NCT01633944|17726199|P3|Double-blind Treatment Phase|Lack of Efficacy|23
5131974|NCT01633944|17726200|P2|Double-blind Treatment Phase|Lack of Efficacy|8
5131975|NCT01633944|17726201|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5131976|NCT01633944|17726199|P3|Double-blind Treatment Phase|Adverse Event|7
5131977|NCT01633944|17726200|P2|Double-blind Treatment Phase|Adverse Event|13
5131978|NCT01633944|17726201|P1|Double-blind Treatment Phase|Adverse Event|0
5131979|NCT01633944|17726199|P3|Open-label Titration Phase|Other|0
5131980|NCT01633944|17726200|P2|Open-label Titration Phase|Other|0
5131981|NCT01633944|17726201|P1|Open-label Titration Phase|Other|68
5131982|NCT01633944|17726199|P3|Open-label Titration Phase|Lost to Follow-up|0
5131983|NCT01633944|17726200|P2|Open-label Titration Phase|Lost to Follow-up|0
5131984|NCT01633944|17726201|P1|Open-label Titration Phase|Lost to Follow-up|22
5131985|NCT01633944|17726199|P3|Open-label Titration Phase|Protocol Violation|0
5131986|NCT01633944|17726200|P2|Open-label Titration Phase|Protocol Violation|0
5131987|NCT01633944|17726201|P1|Open-label Titration Phase|Protocol Violation|24
5131988|NCT01633944|17726199|P3|Open-label Titration Phase|Withdrawal by Subject|0
5131989|NCT01633944|17726200|P2|Open-label Titration Phase|Withdrawal by Subject|0
5131990|NCT01633944|17726201|P1|Open-label Titration Phase|Withdrawal by Subject|34
5131991|NCT01633944|17726199|P3|Open-label Titration Phase|Lack of Efficacy|0
5131992|NCT01633944|17726200|P2|Open-label Titration Phase|Lack of Efficacy|0
5131993|NCT01633944|17726201|P1|Open-label Titration Phase|Lack of Efficacy|33
5131994|NCT01633944|17726199|P3|Open-label Titration Phase|Adverse Event|0
5131995|NCT01633944|17726200|P2|Open-label Titration Phase|Adverse Event|0
5131996|NCT01633944|17726201|P1|Open-label Titration Phase|Adverse Event|109
5131997|NCT01633788|17726269|P4|Overall Study|Other Reasons|7
5131998|NCT01633788|17726270|P3|Overall Study|Other Reasons|3
5131999|NCT01633788|17726271|P2|Overall Study|Other Reasons|2
5132000|NCT01633788|17726272|P1|Overall Study|Other Reasons|0
5132001|NCT01633788|17726269|P4|Overall Study|Protocol Violation|0
5132002|NCT01633788|17726270|P3|Overall Study|Protocol Violation|1
5132003|NCT01633788|17726271|P2|Overall Study|Protocol Violation|0
5132004|NCT01633788|17726272|P1|Overall Study|Protocol Violation|1
5132005|NCT01633788|17726269|P4|Overall Study|Personal Reasons|3
5132006|NCT01633788|17726270|P3|Overall Study|Personal Reasons|1
5132007|NCT01633788|17726271|P2|Overall Study|Personal Reasons|1
5132008|NCT01633788|17726272|P1|Overall Study|Personal Reasons|3
5132009|NCT01633788|17726269|P4|Overall Study|Lost to Follow-up|0
5132010|NCT01633788|17726270|P3|Overall Study|Lost to Follow-up|2
5132011|NCT01633788|17726271|P2|Overall Study|Lost to Follow-up|2
5132012|NCT01633788|17726272|P1|Overall Study|Lost to Follow-up|2
5132013|NCT01633788|17726269|P4|Overall Study|Adverse Event|3
5132014|NCT01633788|17726270|P3|Overall Study|Adverse Event|3
5132015|NCT01633788|17726271|P2|Overall Study|Adverse Event|3
5132016|NCT01633788|17726272|P1|Overall Study|Adverse Event|1
5132017|NCT01633112|17726304|P3|Overall Study|missing Study Completion CRF|4
5132018|NCT01633112|17726305|P2|Overall Study|missing Study Completion CRF|1
5132019|NCT01633112|17726306|P1|Overall Study|missing Study Completion CRF|1
5132020|NCT01633112|17726304|P3|Overall Study|Withdrawal by Subject|41
5132021|NCT01633112|17726305|P2|Overall Study|Withdrawal by Subject|12
5132022|NCT01633112|17726306|P1|Overall Study|Withdrawal by Subject|20
5132023|NCT01633112|17726304|P3|Overall Study|Subject no longer requires study drug|1
5132024|NCT01633112|17726305|P2|Overall Study|Subject no longer requires study drug|0
5132025|NCT01633112|17726306|P1|Overall Study|Subject no longer requires study drug|0
5132026|NCT01633112|17726304|P3|Overall Study|Protocol Violation|2
5132027|NCT01633112|17726305|P2|Overall Study|Protocol Violation|0
5132028|NCT01633112|17726306|P1|Overall Study|Protocol Violation|4
5132029|NCT01633112|17726304|P3|Overall Study|Lost to Follow-up|6
5132030|NCT01633112|17726305|P2|Overall Study|Lost to Follow-up|19
5132031|NCT01633112|17726306|P1|Overall Study|Lost to Follow-up|7
5132032|NCT01633112|17726304|P3|Overall Study|Adverse Event|20
5132033|NCT01633112|17726305|P2|Overall Study|Adverse Event|18
5132034|NCT01633112|17726306|P1|Overall Study|Adverse Event|16
5132035|NCT01633112|17726304|P3|Overall Study|Administrative problems|5
5132036|NCT01633112|17726305|P2|Overall Study|Administrative problems|2
5132037|NCT01633112|17726306|P1|Overall Study|Administrative problems|1
5132038|NCT01633112|17726304|P3|Overall Study|Abnormal test procedure result(s)|0
5132039|NCT01633112|17726305|P2|Overall Study|Abnormal test procedure result(s)|1
5132040|NCT01633112|17726306|P1|Overall Study|Abnormal test procedure result(s)|0
5132041|NCT01633112|17726304|P3|Overall Study|Abnormal laboratory value(s)|0
5132042|NCT01633112|17726305|P2|Overall Study|Abnormal laboratory value(s)|1
5132043|NCT01633112|17726306|P1|Overall Study|Abnormal laboratory value(s)|3
5132044|NCT01633112|17726304|P3|Overall Study|Lack of Efficacy|13
5132045|NCT01633112|17726305|P2|Overall Study|Lack of Efficacy|6
5132046|NCT01633112|17726306|P1|Overall Study|Lack of Efficacy|1
5132047|NCT01633060|17726341|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
5132048|NCT01633060|17726342|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
5132049|NCT01633060|17726341|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5132050|NCT01633060|17726342|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5132051|NCT01633060|17726341|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
5132052|NCT01633060|17726342|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
5132053|NCT01633060|17726341|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
5132054|NCT01633060|17726342|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
5132055|NCT01633060|17726341|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
5132056|NCT01633060|17726342|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
5132057|NCT01633060|17726341|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5132058|NCT01633060|17726342|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
5132059|NCT01633060|17726341|P2|Treatment Phase|Death|3
5132060|NCT01633060|17726342|P1|Treatment Phase|Death|4
5132061|NCT01633060|17726341|P2|Treatment Phase|Subject/guardian decision|4
5132062|NCT01633060|17726342|P1|Treatment Phase|Subject/guardian decision|25
5132063|NCT01633060|17726341|P2|Treatment Phase|Study Terminated by sponsor|3
5132064|NCT01633060|17726342|P1|Treatment Phase|Study Terminated by sponsor|7
5132065|NCT01633060|17726341|P2|Treatment Phase|Protocol Deviation|0
5132066|NCT01633060|17726342|P1|Treatment Phase|Protocol Deviation|1
5132067|NCT01633060|17726341|P2|Treatment Phase|Progressive Disease|120
5132068|NCT01633060|17726342|P1|Treatment Phase|Progressive Disease|210
5132069|NCT01633060|17726341|P2|Treatment Phase|Physician Decision|7
5132070|NCT01633060|17726342|P1|Treatment Phase|Physician Decision|16
5132071|NCT01633060|17726341|P2|Treatment Phase|Lost to Follow-up|0
5132072|NCT01633060|17726342|P1|Treatment Phase|Lost to Follow-up|1
5132073|NCT01633060|17726341|P2|Treatment Phase|Adverse Event|3
5132074|NCT01633060|17726342|P1|Treatment Phase|Adverse Event|24
5132075|NCT01633060|17726341|P2|Randomization Phase|Technical problem|1
5132076|NCT01633060|17726342|P1|Randomization Phase|Technical problem|0
5132077|NCT01633060|17726341|P2|Randomization Phase|Protocol deviation|2
5132078|NCT01633060|17726342|P1|Randomization Phase|Protocol deviation|1
5132079|NCT01632904|17726382|P2|Overall Study|Reason for discontinuation not available|1
5132080|NCT01632904|17726383|P1|Overall Study|Reason for discontinuation not available|0
5132081|NCT01632904|17726382|P2|Overall Study|Disease Progression|1
5132082|NCT01632904|17726383|P1|Overall Study|Disease Progression|0
5132083|NCT01632904|17726382|P2|Overall Study|Subject decision|2
5132084|NCT01632904|17726383|P1|Overall Study|Subject decision|3
5132085|NCT01632904|17726382|P2|Overall Study|Physician Decision|1
5132086|NCT01632904|17726383|P1|Overall Study|Physician Decision|0
5132087|NCT01632904|17726382|P2|Overall Study|Adverse Event|1
5132088|NCT01632904|17726383|P1|Overall Study|Adverse Event|4
5132089|NCT01632891|17726394|P2|Overall Study|Withdrawal by Subject|0
5132090|NCT01632891|17726395|P1|Overall Study|Withdrawal by Subject|1
5132091|NCT01632891|17726394|P2|Overall Study|Lost to Follow-up|1
5132092|NCT01632891|17726395|P1|Overall Study|Lost to Follow-up|0
5132093|NCT01632878|17726419|P1|Treatment|no information on study completion|43
5132094|NCT01632878|17726419|P1|Treatment|missing information|4
5132095|NCT01632878|17726419|P1|Treatment|Physician Decision|34
5132096|NCT01632878|17726419|P1|Treatment|Withdrawal by Subject|36
5132097|NCT01632878|17726419|P1|Treatment|Lost to Follow-up|41
5132098|NCT01632878|17726419|P1|Screening|Physician Decision|268
5132099|NCT01632800|17726423|P1|Overall Study|Subject did not fit in apparatus|1
5132100|NCT01632579|17726490|P9|Period 2 (Second Intervention)|Adverse Event|0
5132101|NCT01632579|17726491|P8|Period 2 (Second Intervention)|Adverse Event|0
5132102|NCT01632579|17726492|P7|Period 2 (Second Intervention)|Adverse Event|0
5132103|NCT01632579|17726493|P6|Period 2 (Second Intervention)|Adverse Event|0
5132104|NCT01632579|17726494|P5|Period 2 (Second Intervention)|Adverse Event|0
5132105|NCT01632579|17726495|P4|Period 2 (Second Intervention)|Adverse Event|0
5132106|NCT01632579|17726496|P3|Period 2 (Second Intervention)|Adverse Event|0
5132107|NCT01632579|17726497|P2|Period 2 (Second Intervention)|Adverse Event|0
5132108|NCT01632579|17726498|P1|Period 2 (Second Intervention)|Adverse Event|1
5132109|NCT01632579|17726490|P9|Washout Period|Adverse Event|0
5132110|NCT01632579|17726491|P8|Washout Period|Adverse Event|0
5132111|NCT01632579|17726492|P7|Washout Period|Adverse Event|0
5132112|NCT01632579|17726493|P6|Washout Period|Adverse Event|0
5132113|NCT01632579|17726494|P5|Washout Period|Adverse Event|0
5132114|NCT01632579|17726495|P4|Washout Period|Adverse Event|0
5132115|NCT01632579|17726496|P3|Washout Period|Adverse Event|0
5132116|NCT01632579|17726497|P2|Washout Period|Adverse Event|0
5132117|NCT01632579|17726498|P1|Washout Period|Adverse Event|1
5132118|NCT01632566|17726565|P5|Overall Study|Sponsor Decision|2
5132119|NCT01632566|17726566|P4|Overall Study|Sponsor Decision|2
5132120|NCT01632566|17726567|P3|Overall Study|Sponsor Decision|9
5132121|NCT01632566|17726568|P2|Overall Study|Sponsor Decision|2
5132122|NCT01632566|17726569|P1|Overall Study|Sponsor Decision|0
5132123|NCT01632566|17726565|P5|Overall Study|Withdrawal by Subject|0
5132124|NCT01632566|17726566|P4|Overall Study|Withdrawal by Subject|0
5132125|NCT01632566|17726567|P3|Overall Study|Withdrawal by Subject|0
5132126|NCT01632566|17726568|P2|Overall Study|Withdrawal by Subject|1
5132127|NCT01632566|17726569|P1|Overall Study|Withdrawal by Subject|0
5132128|NCT01632345|17726620|P7|Treatment: Part II|Withdrawal by Subject|2
5132129|NCT01632345|17726621|P6|Treatment: Part II|Withdrawal by Subject|2
5132130|NCT01632345|17726622|P5|Treatment: Part II|Withdrawal by Subject|0
5132131|NCT01632345|17726623|P4|Treatment: Part II|Withdrawal by Subject|0
5132132|NCT01632345|17726624|P3|Treatment: Part II|Withdrawal by Subject|0
5132133|NCT01632345|17726625|P2|Treatment: Part II|Withdrawal by Subject|0
5132134|NCT01632345|17726626|P1|Treatment: Part II|Withdrawal by Subject|0
5132135|NCT01632345|17726620|P7|Treatment: Part II|Non-Compliance with Study Drug|0
5132136|NCT01632345|17726621|P6|Treatment: Part II|Non-Compliance with Study Drug|3
5132137|NCT01632345|17726622|P5|Treatment: Part II|Non-Compliance with Study Drug|0
5132138|NCT01632345|17726623|P4|Treatment: Part II|Non-Compliance with Study Drug|0
5132139|NCT01632345|17726624|P3|Treatment: Part II|Non-Compliance with Study Drug|0
5132140|NCT01632345|17726625|P2|Treatment: Part II|Non-Compliance with Study Drug|0
5132141|NCT01632345|17726626|P1|Treatment: Part II|Non-Compliance with Study Drug|0
5132142|NCT01632345|17726620|P7|Treatment: Part II|Lost to Follow-up|1
5132143|NCT01632345|17726621|P6|Treatment: Part II|Lost to Follow-up|3
5132144|NCT01632345|17726622|P5|Treatment: Part II|Lost to Follow-up|0
5132145|NCT01632345|17726623|P4|Treatment: Part II|Lost to Follow-up|0
5132146|NCT01632345|17726624|P3|Treatment: Part II|Lost to Follow-up|0
5132147|NCT01632345|17726625|P2|Treatment: Part II|Lost to Follow-up|0
5132148|NCT01632345|17726626|P1|Treatment: Part II|Lost to Follow-up|0
5132149|NCT01632345|17726620|P7|Treatment: Part II|Adverse Event|8
5132150|NCT01632345|17726621|P6|Treatment: Part II|Adverse Event|3
5132151|NCT01632345|17726622|P5|Treatment: Part II|Adverse Event|0
5132152|NCT01632345|17726623|P4|Treatment: Part II|Adverse Event|0
5132153|NCT01632345|17726624|P3|Treatment: Part II|Adverse Event|0
5132154|NCT01632345|17726625|P2|Treatment: Part II|Adverse Event|0
5132155|NCT01632345|17726626|P1|Treatment: Part II|Adverse Event|0
5132156|NCT01632345|17726620|P7|Treatment: Part I|Withdrawal by Subject|0
5132157|NCT01632345|17726621|P6|Treatment: Part I|Withdrawal by Subject|0
5132158|NCT01632345|17726622|P5|Treatment: Part I|Withdrawal by Subject|4
5132159|NCT01632345|17726623|P4|Treatment: Part I|Withdrawal by Subject|1
5132160|NCT01632345|17726624|P3|Treatment: Part I|Withdrawal by Subject|4
5132161|NCT01632345|17726625|P2|Treatment: Part I|Withdrawal by Subject|4
5132162|NCT01632345|17726626|P1|Treatment: Part I|Withdrawal by Subject|3
5132163|NCT01632345|17726620|P7|Treatment: Part I|Protocol Deviation|0
5132164|NCT01632345|17726621|P6|Treatment: Part I|Protocol Deviation|0
5132165|NCT01632345|17726622|P5|Treatment: Part I|Protocol Deviation|0
5132166|NCT01632345|17726623|P4|Treatment: Part I|Protocol Deviation|1
5132167|NCT01632345|17726624|P3|Treatment: Part I|Protocol Deviation|1
5132168|NCT01632345|17726625|P2|Treatment: Part I|Protocol Deviation|0
5132169|NCT01632345|17726626|P1|Treatment: Part I|Protocol Deviation|0
5132170|NCT01632345|17726620|P7|Treatment: Part I|Pregnancy|0
5132171|NCT01632345|17726621|P6|Treatment: Part I|Pregnancy|0
5132172|NCT01632345|17726622|P5|Treatment: Part I|Pregnancy|0
5132173|NCT01632345|17726623|P4|Treatment: Part I|Pregnancy|0
5132174|NCT01632345|17726624|P3|Treatment: Part I|Pregnancy|0
5132175|NCT01632345|17726625|P2|Treatment: Part I|Pregnancy|1
5132176|NCT01632345|17726626|P1|Treatment: Part I|Pregnancy|0
5132177|NCT01632345|17726620|P7|Treatment: Part I|Physician Decision|0
5132178|NCT01632345|17726621|P6|Treatment: Part I|Physician Decision|0
5132179|NCT01632345|17726622|P5|Treatment: Part I|Physician Decision|1
5132180|NCT01632345|17726623|P4|Treatment: Part I|Physician Decision|0
5132181|NCT01632345|17726624|P3|Treatment: Part I|Physician Decision|0
5132182|NCT01632345|17726625|P2|Treatment: Part I|Physician Decision|1
5132183|NCT01632345|17726626|P1|Treatment: Part I|Physician Decision|2
5132184|NCT01632345|17726620|P7|Treatment: Part I|Non-Compliance with Study Drug|0
5132185|NCT01632345|17726621|P6|Treatment: Part I|Non-Compliance with Study Drug|0
5132186|NCT01632345|17726622|P5|Treatment: Part I|Non-Compliance with Study Drug|0
5132187|NCT01632345|17726623|P4|Treatment: Part I|Non-Compliance with Study Drug|1
5132188|NCT01632345|17726624|P3|Treatment: Part I|Non-Compliance with Study Drug|2
5132189|NCT01632345|17726625|P2|Treatment: Part I|Non-Compliance with Study Drug|2
5132190|NCT01632345|17726626|P1|Treatment: Part I|Non-Compliance with Study Drug|3
5132191|NCT01632345|17726620|P7|Treatment: Part I|Lost to Follow-up|0
5132192|NCT01632345|17726621|P6|Treatment: Part I|Lost to Follow-up|0
5132193|NCT01632345|17726622|P5|Treatment: Part I|Lost to Follow-up|4
5132194|NCT01632345|17726623|P4|Treatment: Part I|Lost to Follow-up|3
5132195|NCT01632345|17726624|P3|Treatment: Part I|Lost to Follow-up|1
5132196|NCT01632345|17726625|P2|Treatment: Part I|Lost to Follow-up|2
5132197|NCT01632345|17726626|P1|Treatment: Part I|Lost to Follow-up|3
5132198|NCT01632345|17726620|P7|Treatment: Part I|Lack of Efficacy|0
5132199|NCT01632345|17726621|P6|Treatment: Part I|Lack of Efficacy|0
5132200|NCT01632345|17726622|P5|Treatment: Part I|Lack of Efficacy|1
5132201|NCT01632345|17726623|P4|Treatment: Part I|Lack of Efficacy|1
5132202|NCT01632345|17726624|P3|Treatment: Part I|Lack of Efficacy|0
5132203|NCT01632345|17726625|P2|Treatment: Part I|Lack of Efficacy|1
5132204|NCT01632345|17726626|P1|Treatment: Part I|Lack of Efficacy|0
5132205|NCT01632345|17726620|P7|Treatment: Part I|Adverse Event|0
5132206|NCT01632345|17726621|P6|Treatment: Part I|Adverse Event|0
5132207|NCT01632345|17726622|P5|Treatment: Part I|Adverse Event|3
5132208|NCT01632345|17726623|P4|Treatment: Part I|Adverse Event|1
5132209|NCT01632345|17726624|P3|Treatment: Part I|Adverse Event|2
5132210|NCT01632345|17726625|P2|Treatment: Part I|Adverse Event|4
5132211|NCT01632345|17726626|P1|Treatment: Part I|Adverse Event|1
5132212|NCT01632306|17726688|P3|Overall Study|Protocol Violation|0
5132213|NCT01632306|17726689|P2|Overall Study|Protocol Violation|0
5132214|NCT01632306|17726690|P1|Overall Study|Protocol Violation|1
5132215|NCT01632280|17726706|P2|Overall Study|Withdrawal by Subject|0
5132216|NCT01632280|17726707|P1|Overall Study|Withdrawal by Subject|1
5132217|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
5132218|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
5132219|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
5132220|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
5132221|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
5132222|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
5132223|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Site Closed|8
5132224|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Site Closed|2
5132225|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
5132226|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
5132227|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
5132228|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
5132229|NCT01632241|17726723|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
5132230|NCT01632241|17726724|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
5132231|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Adverse Event|19
5132232|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Adverse Event|10
5132233|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
5132234|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
5132235|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
5132236|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
5132237|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Physician Decision|12
5132238|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Physician Decision|9
5132239|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
5132240|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
5132241|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
5132242|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
5132243|NCT01632241|17726723|P2|Double-blinded (Up to Week 52)|Site Closed|5
5132244|NCT01632241|17726724|P1|Double-blinded (Up to Week 52)|Site Closed|3
5132245|NCT01632150|17726783|P1|Overall Study|Moved to compassionate program|2
5132246|NCT01632150|17726783|P1|Overall Study|Patient underwent autologous transplant|1
5132247|NCT01632150|17726783|P1|Overall Study|Withdrawal by Subject|2
5132248|NCT01632150|17726783|P1|Overall Study|Unrelated adverse event|7
5132249|NCT01632150|17726783|P1|Overall Study|Study drug toxicity|1
5132250|NCT01632150|17726783|P1|Overall Study|Disease progression|27
5132251|NCT01632020|17726792|P2|Overall Study|Adverse Event|0
5132252|NCT01632020|17726793|P1|Overall Study|Adverse Event|1
5132253|NCT01632020|17726792|P2|Overall Study|Withdrawal by Subject|0
5132254|NCT01632020|17726793|P1|Overall Study|Withdrawal by Subject|1
5132255|NCT01631864|17726812|P2|Overall Study|Adverse Event|3
5132256|NCT01631864|17726813|P1|Overall Study|Adverse Event|2
5132257|NCT01631864|17726812|P2|Overall Study|Withdrawal by Subject|1
5132258|NCT01631864|17726813|P1|Overall Study|Withdrawal by Subject|0
5132259|NCT01631825|17726825|P1|Overall Study|Physician Decision|2
5132260|NCT01631825|17726825|P1|Overall Study|Discontinuation criteria|1
5132261|NCT01631825|17726825|P1|Overall Study|Protocol Violation|4
5132262|NCT01631825|17726825|P1|Overall Study|Withdrawal by Subject|9
5132263|NCT01631825|17726825|P1|Overall Study|Lack of Efficacy|7
5132264|NCT01631825|17726825|P1|Overall Study|Adverse Event|42
5132265|NCT01631812|17726845|P1|Overall Study|Physician Decision|3
5132266|NCT01631812|17726845|P1|Overall Study|Withdrawal by Subject|4
5132267|NCT01631812|17726845|P1|Overall Study|Lack of Efficacy|5
5132268|NCT01631812|17726845|P1|Overall Study|Adverse Event|25
5132269|NCT01631747|17726855|P2|One Year Infant Outcomes|Patient Refused|9
5132270|NCT01631747|17726856|P1|One Year Infant Outcomes|Patient Refused|13
5132271|NCT01631747|17726855|P2|Live Birth|Stillbirth|1
5132272|NCT01631747|17726856|P1|Live Birth|Stillbirth|1
5132273|NCT01631747|17726855|P2|Live Birth|MIscarriage|0
5132274|NCT01631747|17726856|P1|Live Birth|MIscarriage|2
5132275|NCT01631747|17726855|P2|Live Birth|Pregnancy Termination|0
5132276|NCT01631747|17726856|P1|Live Birth|Pregnancy Termination|1
5132277|NCT01631747|17726855|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
5132278|NCT01631747|17726856|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
5132279|NCT01631474|17727038|P5|Overall Study|Adverse Event|0
5132280|NCT01631474|17727039|P4|Overall Study|Adverse Event|0
5132281|NCT01631474|17727040|P3|Overall Study|Adverse Event|0
5132282|NCT01631474|17727041|P2|Overall Study|Adverse Event|1
5132283|NCT01631474|17727042|P1|Overall Study|Adverse Event|0
5132284|NCT01631474|17727038|P5|Overall Study|Noncompliance with Study Drug|1
5132285|NCT01631474|17727039|P4|Overall Study|Noncompliance with Study Drug|0
5132286|NCT01631474|17727040|P3|Overall Study|Noncompliance with Study Drug|0
5132287|NCT01631474|17727041|P2|Overall Study|Noncompliance with Study Drug|0
5132288|NCT01631474|17727042|P1|Overall Study|Noncompliance with Study Drug|0
5132289|NCT01631474|17727038|P5|Overall Study|Lack of Efficacy|2
5132290|NCT01631474|17727039|P4|Overall Study|Lack of Efficacy|0
5132291|NCT01631474|17727040|P3|Overall Study|Lack of Efficacy|0
5132292|NCT01631474|17727041|P2|Overall Study|Lack of Efficacy|2
5132293|NCT01631474|17727042|P1|Overall Study|Lack of Efficacy|2
5132294|NCT01631474|17727038|P5|Overall Study|Withdrawal by Subject|5
5132295|NCT01631474|17727039|P4|Overall Study|Withdrawal by Subject|6
5132296|NCT01631474|17727040|P3|Overall Study|Withdrawal by Subject|2
5132297|NCT01631474|17727041|P2|Overall Study|Withdrawal by Subject|4
5132298|NCT01631474|17727042|P1|Overall Study|Withdrawal by Subject|4
5132299|NCT01631474|17727038|P5|Overall Study|Lost to Follow-up|5
5132300|NCT01631474|17727039|P4|Overall Study|Lost to Follow-up|5
5132301|NCT01631474|17727040|P3|Overall Study|Lost to Follow-up|7
5132302|NCT01631474|17727041|P2|Overall Study|Lost to Follow-up|5
5132303|NCT01631474|17727042|P1|Overall Study|Lost to Follow-up|8
5132304|NCT01631435|17727079|P1|Overall Study|incomplete study procedure|5
5132305|NCT01631435|17727079|P1|Overall Study|Withdrawal by Subject|2
5132306|NCT01631435|17727079|P1|Overall Study|Adverse Event|2
5132307|NCT01631227|17727093|P2|Overall Study|administrative|1
5132308|NCT01631227|17727094|P1|Overall Study|administrative|2
5132309|NCT01631227|17727093|P2|Overall Study|Adverse Event|0
5132310|NCT01631227|17727094|P1|Overall Study|Adverse Event|1
5132311|NCT01631227|17727093|P2|Overall Study|withdrawn consent|21
5132312|NCT01631227|17727094|P1|Overall Study|withdrawn consent|27
5132313|NCT01631214|17727102|P2|Overall Study|Administrative Decision|0
5132314|NCT01631214|17727103|P1|Overall Study|Administrative Decision|1
5132315|NCT01631214|17727102|P2|Overall Study|Ineligibility determined|2
5132316|NCT01631214|17727103|P1|Overall Study|Ineligibility determined|5
5132317|NCT01631214|17727102|P2|Overall Study|Protocol Deviation|3
5132318|NCT01631214|17727103|P1|Overall Study|Protocol Deviation|4
5132319|NCT01631214|17727102|P2|Overall Study|Requirement for Alternative Therapy|3
5132320|NCT01631214|17727103|P1|Overall Study|Requirement for Alternative Therapy|8
5132321|NCT01631214|17727102|P2|Overall Study|Noncompliance|15
5132322|NCT01631214|17727103|P1|Overall Study|Noncompliance|16
5132323|NCT01631214|17727102|P2|Overall Study|Other|19
5132324|NCT01631214|17727103|P1|Overall Study|Other|22
5132325|NCT01631214|17727102|P2|Overall Study|Adverse Event|45
5132326|NCT01631214|17727103|P1|Overall Study|Adverse Event|45
5132327|NCT01631214|17727102|P2|Overall Study|Lost to Follow-up|40
5132328|NCT01631214|17727103|P1|Overall Study|Lost to Follow-up|54
5132329|NCT01631214|17727102|P2|Overall Study|Death|106
5132330|NCT01631214|17727103|P1|Overall Study|Death|113
5132331|NCT01631214|17727102|P2|Overall Study|Withdrawal by Subject|290
5132332|NCT01631214|17727103|P1|Overall Study|Withdrawal by Subject|276
5132333|NCT01630811|17727212|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
5132334|NCT01630811|17727213|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
5132335|NCT01630616|17727240|P6|Overall Study|Withdrawal by Subject|0
5132336|NCT01630616|17727241|P5|Overall Study|Withdrawal by Subject|0
5132337|NCT01630616|17727242|P4|Overall Study|Withdrawal by Subject|2
5132338|NCT01630616|17727243|P3|Overall Study|Withdrawal by Subject|0
5132339|NCT01630616|17727244|P2|Overall Study|Withdrawal by Subject|0
5132340|NCT01630616|17727245|P1|Overall Study|Withdrawal by Subject|0
5132341|NCT01630616|17727240|P6|Overall Study|Adverse Event|0
5132342|NCT01630616|17727241|P5|Overall Study|Adverse Event|0
5132343|NCT01630616|17727242|P4|Overall Study|Adverse Event|1
5132344|NCT01630616|17727243|P3|Overall Study|Adverse Event|0
5132345|NCT01630616|17727244|P2|Overall Study|Adverse Event|0
5132346|NCT01630616|17727245|P1|Overall Study|Adverse Event|0
5132347|NCT01630135|17727345|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
5132348|NCT01630135|17727346|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
5132349|NCT01629966|17727410|P3|Overall Study|Adverse Event|30
5132350|NCT01629966|17727411|P2|Overall Study|Adverse Event|18
5132351|NCT01629966|17727412|P1|Overall Study|Adverse Event|11
5132352|NCT01629966|17727410|P3|Overall Study|Lack of Efficacy|4
5132353|NCT01629966|17727411|P2|Overall Study|Lack of Efficacy|2
5132354|NCT01629966|17727412|P1|Overall Study|Lack of Efficacy|5
5132355|NCT01629966|17727410|P3|Overall Study|Protocol Violation|7
5132356|NCT01629966|17727411|P2|Overall Study|Protocol Violation|9
5132357|NCT01629966|17727412|P1|Overall Study|Protocol Violation|7
5132358|NCT01629966|17727410|P3|Overall Study|Withdrawal by Subject|16
5132359|NCT01629966|17727411|P2|Overall Study|Withdrawal by Subject|9
5132360|NCT01629966|17727412|P1|Overall Study|Withdrawal by Subject|8
5132361|NCT01629966|17727410|P3|Overall Study|Lost to Follow-up|9
5132362|NCT01629966|17727411|P2|Overall Study|Lost to Follow-up|13
5132363|NCT01629966|17727412|P1|Overall Study|Lost to Follow-up|10
5132364|NCT01629966|17727410|P3|Overall Study|Pregnancy|0
5132365|NCT01629966|17727411|P2|Overall Study|Pregnancy|1
5132366|NCT01629966|17727412|P1|Overall Study|Pregnancy|0
5132367|NCT01629953|17727425|P2|Overall Study|Lost to Follow-up|14
5132368|NCT01629953|17727426|P1|Overall Study|Lost to Follow-up|10
5132369|NCT01629953|17727425|P2|Overall Study|Death|1
5132370|NCT01629953|17727426|P1|Overall Study|Death|3
5132371|NCT01629823|17727446|P3|Washout Period|Protocol Violation|0
5132372|NCT01629823|17727447|P2|Washout Period|Protocol Violation|1
5132373|NCT01629823|17727448|P1|Washout Period|Protocol Violation|0
5132374|NCT01629823|17727446|P3|Washout Period|Pregnancy|0
5132375|NCT01629823|17727447|P2|Washout Period|Pregnancy|0
5132376|NCT01629823|17727448|P1|Washout Period|Pregnancy|1
5132377|NCT01629823|17727446|P3|Washout Period|Safety|0
5132378|NCT01629823|17727447|P2|Washout Period|Safety|5
5132379|NCT01629823|17727448|P1|Washout Period|Safety|2
5132380|NCT01629823|17727446|P3|Trial Period|Failed to hold medication|1
5132381|NCT01629823|17727447|P2|Trial Period|Failed to hold medication|0
5132382|NCT01629823|17727448|P1|Trial Period|Failed to hold medication|0
5132383|NCT01629823|17727446|P3|Trial Period|Out-of-window visit|0
5132384|NCT01629823|17727447|P2|Trial Period|Out-of-window visit|2
5132385|NCT01629823|17727448|P1|Trial Period|Out-of-window visit|0
5132386|NCT01629823|17727446|P3|Trial Period|Adverse Event|0
5132387|NCT01629823|17727447|P2|Trial Period|Adverse Event|1
5132388|NCT01629823|17727448|P1|Trial Period|Adverse Event|0
5132389|NCT01629823|17727446|P3|Trial Period|Pregnancy|0
5132390|NCT01629823|17727447|P2|Trial Period|Pregnancy|0
5132391|NCT01629823|17727448|P1|Trial Period|Pregnancy|1
5132392|NCT01629823|17727446|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5132393|NCT01629823|17727447|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5132394|NCT01629823|17727448|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5132395|NCT01629823|17727446|P3|Trial Period|Missed visit|8
5132396|NCT01629823|17727447|P2|Trial Period|Missed visit|9
5132397|NCT01629823|17727448|P1|Trial Period|Missed visit|11
5132398|NCT01629706|17727483|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
5132399|NCT01629706|17727483|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
5132400|NCT01629706|17727483|P1|Phase 2 Habitual|Relocation prior to Dispense|1
5132401|NCT01629706|17727483|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
5132402|NCT01629706|17727483|P1|Phase 2 Habitual|Screen Failure|6
5132403|NCT01629706|17727483|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
5132404|NCT01629706|17727483|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
5132405|NCT01629706|17727483|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
5132406|NCT01629706|17727483|P1|Phase 1 PureVision|Screen Failure|4
5132407|NCT01629693|17727511|P2|Overall Study|Subject decision unrelated to AE|1
5132408|NCT01629693|17727512|P1|Overall Study|Subject decision unrelated to AE|0
5132409|NCT01629693|17727511|P2|Overall Study|Poor comfort of study lenses|2
5132410|NCT01629693|17727512|P1|Overall Study|Poor comfort of study lenses|0
5132411|NCT01629693|17727511|P2|Overall Study|Investigator decision|1
5132412|NCT01629693|17727512|P1|Overall Study|Investigator decision|0
5132413|NCT01629693|17727511|P2|Overall Study|Adverse Event|0
5132414|NCT01629693|17727512|P1|Overall Study|Adverse Event|1
5132415|NCT01629693|17727511|P2|Overall Study|Withdrawal by Subject|2
5132416|NCT01629693|17727512|P1|Overall Study|Withdrawal by Subject|2
5132417|NCT01629693|17727511|P2|Overall Study|Lost to Follow-up|4
5132418|NCT01629693|17727512|P1|Overall Study|Lost to Follow-up|2
5132419|NCT01629667|17727521|P3|Overall Study|Code break|0
5132420|NCT01629667|17727522|P2|Overall Study|Code break|0
5132421|NCT01629667|17727523|P1|Overall Study|Code break|1
5132422|NCT01629667|17727521|P3|Overall Study|Enrolled in another clinical study|0
5132423|NCT01629667|17727522|P2|Overall Study|Enrolled in another clinical study|1
5132424|NCT01629667|17727523|P1|Overall Study|Enrolled in another clinical study|0
5132425|NCT01629667|17727521|P3|Overall Study|Site error in safety follow-up|1
5132426|NCT01629667|17727522|P2|Overall Study|Site error in safety follow-up|0
5132427|NCT01629667|17727523|P1|Overall Study|Site error in safety follow-up|0
5132428|NCT01629667|17727521|P3|Overall Study|Started other medicine|1
5132429|NCT01629667|17727522|P2|Overall Study|Started other medicine|0
5132430|NCT01629667|17727523|P1|Overall Study|Started other medicine|1
5132431|NCT01629667|17727521|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
5132432|NCT01629667|17727522|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
5132433|NCT01629667|17727523|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
5132434|NCT01629667|17727521|P3|Overall Study|Requiring lung transplant|3
5132435|NCT01629667|17727522|P2|Overall Study|Requiring lung transplant|1
5132436|NCT01629667|17727523|P1|Overall Study|Requiring lung transplant|2
5132437|NCT01629667|17727521|P3|Overall Study|Ongoing AE worsening right heart failure|0
5132438|NCT01629667|17727522|P2|Overall Study|Ongoing AE worsening right heart failure|1
5132439|NCT01629667|17727523|P1|Overall Study|Ongoing AE worsening right heart failure|0
5132440|NCT01629667|17727521|P3|Overall Study|Randomized, not treated|0
5132441|NCT01629667|17727522|P2|Overall Study|Randomized, not treated|1
5132442|NCT01629667|17727523|P1|Overall Study|Randomized, not treated|2
5132443|NCT01629667|17727521|P3|Overall Study|Death|3
5132444|NCT01629667|17727522|P2|Overall Study|Death|5
5132445|NCT01629667|17727523|P1|Overall Study|Death|1
5132446|NCT01629667|17727521|P3|Overall Study|Withdrawal by Subject|28
5132447|NCT01629667|17727522|P2|Overall Study|Withdrawal by Subject|20
5132448|NCT01629667|17727523|P1|Overall Study|Withdrawal by Subject|31
5132449|NCT01629667|17727521|P3|Overall Study|Lost to Follow-up|1
5132450|NCT01629667|17727522|P2|Overall Study|Lost to Follow-up|1
5132451|NCT01629667|17727523|P1|Overall Study|Lost to Follow-up|0
5132452|NCT01629589|17727614|P2|Overall Study|Did not receive study vaccine|1
5132453|NCT01629589|17727615|P1|Overall Study|Did not receive study vaccine|0
5132454|NCT01629589|17727614|P2|Overall Study|Withdrawal by Subject|3
5132455|NCT01629589|17727615|P1|Overall Study|Withdrawal by Subject|2
5132456|NCT01629589|17727614|P2|Overall Study|Lost to Follow-up|1
5132457|NCT01629589|17727615|P1|Overall Study|Lost to Follow-up|2
5132458|NCT01629589|17727614|P2|Overall Study|Protocol Violation|2
5132459|NCT01629589|17727615|P1|Overall Study|Protocol Violation|4
5132460|NCT01629563|17727633|P2|Overall Study|Protocol Violation|1
5132461|NCT01629563|17727634|P1|Overall Study|Protocol Violation|0
5132462|NCT01629563|17727633|P2|Overall Study|Lack of return of menses|7
5132463|NCT01629563|17727634|P1|Overall Study|Lack of return of menses|12
5132464|NCT01629563|17727633|P2|Overall Study|surgery|3
5132465|NCT01629563|17727634|P1|Overall Study|surgery|0
5132466|NCT01629563|17727633|P2|Overall Study|Withdrawal by Subject|20
5132467|NCT01629563|17727634|P1|Overall Study|Withdrawal by Subject|27
5132468|NCT01629563|17727633|P2|Overall Study|Protocol Violation|1
5132469|NCT01629563|17727634|P1|Overall Study|Protocol Violation|0
5132470|NCT01629563|17727633|P2|Overall Study|Pregnancy|2
5132471|NCT01629563|17727634|P1|Overall Study|Pregnancy|1
5132472|NCT01629563|17727633|P2|Overall Study|Lost to Follow-up|0
5132473|NCT01629563|17727634|P1|Overall Study|Lost to Follow-up|1
5132474|NCT01629563|17727633|P2|Overall Study|Lack of Efficacy|3
5132475|NCT01629563|17727634|P1|Overall Study|Lack of Efficacy|2
5132476|NCT01629563|17727633|P2|Overall Study|Death|0
5132477|NCT01629563|17727634|P1|Overall Study|Death|2
5132478|NCT01629563|17727633|P2|Overall Study|Adverse Event|16
5132479|NCT01629563|17727634|P1|Overall Study|Adverse Event|16
5132480|NCT01628965|17727723|P1|Overall Study|Discontinuation criteria|8
5132481|NCT01628965|17727723|P1|Overall Study|Lost to Follow-up|1
5132482|NCT01628965|17727723|P1|Overall Study|Withdrawal by Subject|3
5132483|NCT01628965|17727723|P1|Overall Study|Lack of Efficacy|7
5132484|NCT01628965|17727723|P1|Overall Study|Adverse Event|30
5132485|NCT01628926|17727732|P3|Overall Study|Physician Decision|1
5132486|NCT01628926|17727733|P2|Overall Study|Physician Decision|2
5132487|NCT01628926|17727734|P1|Overall Study|Physician Decision|2
5132488|NCT01628926|17727732|P3|Overall Study|Discontinuation criteria|0
5132489|NCT01628926|17727733|P2|Overall Study|Discontinuation criteria|4
5132490|NCT01628926|17727734|P1|Overall Study|Discontinuation criteria|3
5132491|NCT01628926|17727732|P3|Overall Study|Protocol Violation|0
5132492|NCT01628926|17727733|P2|Overall Study|Protocol Violation|1
5132493|NCT01628926|17727734|P1|Overall Study|Protocol Violation|0
5132494|NCT01628926|17727732|P3|Overall Study|Withdrawal by Subject|2
5132495|NCT01628926|17727733|P2|Overall Study|Withdrawal by Subject|4
5132496|NCT01628926|17727734|P1|Overall Study|Withdrawal by Subject|6
5132497|NCT01628926|17727732|P3|Overall Study|Lack of Efficacy|5
5132498|NCT01628926|17727733|P2|Overall Study|Lack of Efficacy|1
5132499|NCT01628926|17727734|P1|Overall Study|Lack of Efficacy|2
5132500|NCT01628926|17727732|P3|Overall Study|Adverse Event|9
5132501|NCT01628926|17727733|P2|Overall Study|Adverse Event|11
5132502|NCT01628926|17727734|P1|Overall Study|Adverse Event|13
5132503|NCT01628913|17727783|P2|Overall Study|Physician Decision|3
5132504|NCT01628913|17727784|P1|Overall Study|Physician Decision|1
5132505|NCT01628913|17727783|P2|Overall Study|Withdrawal by Subject|0
5132506|NCT01628913|17727784|P1|Overall Study|Withdrawal by Subject|1
5132507|NCT01628913|17727783|P2|Overall Study|study terminated by Sponsor|9
5132508|NCT01628913|17727784|P1|Overall Study|study terminated by Sponsor|4
5132509|NCT01628913|17727783|P2|Overall Study|Death|0
5132510|NCT01628913|17727784|P1|Overall Study|Death|1
5132511|NCT01628913|17727783|P2|Overall Study|Protocol Violation|0
5132512|NCT01628913|17727784|P1|Overall Study|Protocol Violation|1
5132513|NCT01628913|17727783|P2|Overall Study|Disease Progression|14
5132514|NCT01628913|17727784|P1|Overall Study|Disease Progression|11
5132515|NCT01628913|17727783|P2|Overall Study|Adverse Event|5
5132516|NCT01628913|17727784|P1|Overall Study|Adverse Event|12
5132517|NCT01628874|17727798|P2|Overall Study|Age >4 months|2
5132518|NCT01628874|17727799|P1|Overall Study|Age >4 months|4
5132519|NCT01628874|17727798|P2|Overall Study|Physician Decision|1
5132520|NCT01628874|17727799|P1|Overall Study|Physician Decision|1
5132521|NCT01628848|17727815|P2|Overall Study|Physician Decision|1
5132522|NCT01628848|17727816|P1|Overall Study|Physician Decision|3
5132523|NCT01628848|17727815|P2|Overall Study|Withdrawal by Subject|2
5132524|NCT01628848|17727816|P1|Overall Study|Withdrawal by Subject|0
5132525|NCT01628848|17727815|P2|Overall Study|Lack of Efficacy|4
5132526|NCT01628848|17727816|P1|Overall Study|Lack of Efficacy|0
5132527|NCT01628848|17727815|P2|Overall Study|Adverse Event|7
5132528|NCT01628848|17727816|P1|Overall Study|Adverse Event|9
5132529|NCT01628692|17727859|P6|Overall Study|Completed 12 Week only|1
5132530|NCT01628692|17727860|P5|Overall Study|Completed 12 Week only|0
5132531|NCT01628692|17727861|P4|Overall Study|Completed 12 Week only|0
5132532|NCT01628692|17727862|P3|Overall Study|Completed 12 Week only|0
5132533|NCT01628692|17727863|P2|Overall Study|Completed 12 Week only|0
5132534|NCT01628692|17727864|P1|Overall Study|Completed 12 Week only|0
5132535|NCT01628692|17727859|P6|Overall Study|Administrative reason by sponsor|1
5132536|NCT01628692|17727860|P5|Overall Study|Administrative reason by sponsor|0
5132537|NCT01628692|17727861|P4|Overall Study|Administrative reason by sponsor|0
5132538|NCT01628692|17727862|P3|Overall Study|Administrative reason by sponsor|0
5132539|NCT01628692|17727863|P2|Overall Study|Administrative reason by sponsor|0
5132540|NCT01628692|17727864|P1|Overall Study|Administrative reason by sponsor|0
5132541|NCT01628692|17727859|P6|Overall Study|Poor compliance/noncompliance|0
5132542|NCT01628692|17727860|P5|Overall Study|Poor compliance/noncompliance|0
5132543|NCT01628692|17727861|P4|Overall Study|Poor compliance/noncompliance|0
5132544|NCT01628692|17727862|P3|Overall Study|Poor compliance/noncompliance|0
5132545|NCT01628692|17727863|P2|Overall Study|Poor compliance/noncompliance|0
5132546|NCT01628692|17727864|P1|Overall Study|Poor compliance/noncompliance|1
5132547|NCT01628692|17727859|P6|Overall Study|Death|0
5132548|NCT01628692|17727860|P5|Overall Study|Death|0
5132549|NCT01628692|17727861|P4|Overall Study|Death|0
5132550|NCT01628692|17727862|P3|Overall Study|Death|0
5132551|NCT01628692|17727863|P2|Overall Study|Death|1
5132552|NCT01628692|17727864|P1|Overall Study|Death|0
5132553|NCT01628692|17727859|P6|Overall Study|Withdrawal by Subject|0
5132554|NCT01628692|17727860|P5|Overall Study|Withdrawal by Subject|0
5132555|NCT01628692|17727861|P4|Overall Study|Withdrawal by Subject|0
5132556|NCT01628692|17727862|P3|Overall Study|Withdrawal by Subject|1
5132557|NCT01628692|17727863|P2|Overall Study|Withdrawal by Subject|1
5132558|NCT01628692|17727864|P1|Overall Study|Withdrawal by Subject|0
5132559|NCT01628692|17727859|P6|Overall Study|Adverse Event|0
5132560|NCT01628692|17727860|P5|Overall Study|Adverse Event|0
5132561|NCT01628692|17727861|P4|Overall Study|Adverse Event|0
5132562|NCT01628692|17727862|P3|Overall Study|Adverse Event|2
5132563|NCT01628692|17727863|P2|Overall Study|Adverse Event|0
5132564|NCT01628692|17727864|P1|Overall Study|Adverse Event|2
5132565|NCT01628692|17727859|P6|Overall Study|Lack of Efficacy|7
5132566|NCT01628692|17727860|P5|Overall Study|Lack of Efficacy|4
5132567|NCT01628692|17727861|P4|Overall Study|Lack of Efficacy|1
5132568|NCT01628692|17727862|P3|Overall Study|Lack of Efficacy|5
5132569|NCT01628692|17727863|P2|Overall Study|Lack of Efficacy|4
5132570|NCT01628692|17727864|P1|Overall Study|Lack of Efficacy|4
5132571|NCT01628549|17727934|P4|Overall Study|positive pregnancy test|1
5132572|NCT01628549|17727935|P3|Overall Study|positive pregnancy test|0
5132573|NCT01628549|17727936|P2|Overall Study|positive pregnancy test|0
5132574|NCT01628549|17727937|P1|Overall Study|positive pregnancy test|0
5132575|NCT01628549|17727934|P4|Overall Study|abnormal laboratory test results|0
5132576|NCT01628549|17727935|P3|Overall Study|abnormal laboratory test results|1
5132577|NCT01628549|17727936|P2|Overall Study|abnormal laboratory test results|0
5132578|NCT01628549|17727937|P1|Overall Study|abnormal laboratory test results|0
5132579|NCT01628549|17727934|P4|Overall Study|withdrawn for noncompliance|0
5132580|NCT01628549|17727935|P3|Overall Study|withdrawn for noncompliance|1
5132581|NCT01628549|17727936|P2|Overall Study|withdrawn for noncompliance|2
5132582|NCT01628549|17727937|P1|Overall Study|withdrawn for noncompliance|0
5132583|NCT01628549|17727934|P4|Overall Study|Protocol Violation|0
5132584|NCT01628549|17727935|P3|Overall Study|Protocol Violation|1
5132585|NCT01628549|17727936|P2|Overall Study|Protocol Violation|1
5132586|NCT01628549|17727937|P1|Overall Study|Protocol Violation|2
5132587|NCT01628549|17727934|P4|Overall Study|Withdrawal by Subject|1
5132588|NCT01628549|17727935|P3|Overall Study|Withdrawal by Subject|4
5132589|NCT01628549|17727936|P2|Overall Study|Withdrawal by Subject|4
5132590|NCT01628549|17727937|P1|Overall Study|Withdrawal by Subject|3
5132591|NCT01628549|17727934|P4|Overall Study|Lost to Follow-up|3
5132592|NCT01628549|17727935|P3|Overall Study|Lost to Follow-up|3
5132593|NCT01628549|17727936|P2|Overall Study|Lost to Follow-up|4
5132594|NCT01628549|17727937|P1|Overall Study|Lost to Follow-up|3
5132595|NCT01628549|17727934|P4|Overall Study|Adverse Event|4
5132596|NCT01628549|17727935|P3|Overall Study|Adverse Event|0
5132597|NCT01628549|17727936|P2|Overall Study|Adverse Event|1
5132598|NCT01628549|17727937|P1|Overall Study|Adverse Event|1
5132599|NCT01628510|17727978|P2|Overall Study|Death|1
5132600|NCT01628510|17727979|P1|Overall Study|Death|3
5132601|NCT01628510|17727978|P2|Overall Study|Withdrawal by Subject|4
5132602|NCT01628510|17727979|P1|Overall Study|Withdrawal by Subject|0
5132603|NCT01628367|17727989|P2|Overall Study|Adverse Event|0
5132604|NCT01628367|17727990|P1|Overall Study|Adverse Event|1
5132605|NCT01628198|17728009|P1|Overall Study|Screen failure|1
5132606|NCT01628198|17728009|P1|Overall Study|Withdrawal by Subject|10
5132607|NCT01628198|17728009|P1|Overall Study|Lost to Follow-up|7
5132608|NCT01628120|17728036|P1|Overall Study|Use of Standard of Care|1
5132609|NCT01628120|17728036|P1|Overall Study|Kidney Transplant|2
5132610|NCT01628120|17728036|P1|Overall Study|Moved or Relocated|5
5132611|NCT01628120|17728036|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
5132612|NCT01628120|17728036|P1|Overall Study|Switched Dialysis Method|2
5132613|NCT01628120|17728036|P1|Overall Study|Sponsor Decision|5
5132614|NCT01628120|17728036|P1|Overall Study|Not Treated|3
5132615|NCT01628120|17728036|P1|Overall Study|Non-compliant with Study Procedures|1
5132616|NCT01628120|17728036|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
5132617|NCT01628120|17728036|P1|Overall Study|Lost to Follow-up|1
5132618|NCT01628120|17728036|P1|Overall Study|Adverse Event|12
5132619|NCT01628120|17728036|P1|Overall Study|Withdrawal by Subject|7
5132620|NCT01628107|17728061|P1|Overall Study|Use of Standard of Care|9
5132621|NCT01628107|17728061|P1|Overall Study|Kidney Transplant|9
5132622|NCT01628107|17728061|P1|Overall Study|Relocated|8
5132623|NCT01628107|17728061|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
5132624|NCT01628107|17728061|P1|Overall Study|Sponsor Decision|11
5132625|NCT01628107|17728061|P1|Overall Study|Not Treated|8
5132626|NCT01628107|17728061|P1|Overall Study|Non-compliant with Study Procedures|10
5132627|NCT01628107|17728061|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
5132628|NCT01628107|17728061|P1|Overall Study|Physician Decision|2
5132629|NCT01628107|17728061|P1|Overall Study|Adverse Event|33
5132630|NCT01628107|17728061|P1|Overall Study|Lost to Follow-up|4
5132631|NCT01628107|17728061|P1|Overall Study|Withdrawal by Subject|17
5132632|NCT01627899|17728127|P1|Overall Study|Study terminated early by sponsor.|5
5132633|NCT01627860|17728137|P2|Overall Study|Protocol Violation|0
5132634|NCT01627860|17728138|P1|Overall Study|Protocol Violation|1
5132635|NCT01627860|17728137|P2|Overall Study|Seizure frequency doubled|1
5132636|NCT01627860|17728138|P1|Overall Study|Seizure frequency doubled|0
5132637|NCT01627860|17728137|P2|Overall Study|Withdrawal by Subject|1
5132638|NCT01627860|17728138|P1|Overall Study|Withdrawal by Subject|2
5132639|NCT01627860|17728137|P2|Overall Study|Adverse Event|4
5132640|NCT01627860|17728138|P1|Overall Study|Adverse Event|9
5132641|NCT01627782|17728152|P4|Overall Study|Randomized But Not Treated|0
5132642|NCT01627782|17728153|P3|Overall Study|Randomized But Not Treated|0
5132643|NCT01627782|17728154|P2|Overall Study|Randomized But Not Treated|0
5132644|NCT01627782|17728155|P1|Overall Study|Randomized But Not Treated|1
5132645|NCT01627782|17728152|P4|Overall Study|Other|3
5132646|NCT01627782|17728153|P3|Overall Study|Other|0
5132647|NCT01627782|17728154|P2|Overall Study|Other|2
5132648|NCT01627782|17728155|P1|Overall Study|Other|0
5132649|NCT01627782|17728152|P4|Overall Study|Withdrawal by Subject|0
5132650|NCT01627782|17728153|P3|Overall Study|Withdrawal by Subject|0
5132651|NCT01627782|17728154|P2|Overall Study|Withdrawal by Subject|1
5132652|NCT01627782|17728155|P1|Overall Study|Withdrawal by Subject|2
5132653|NCT01627782|17728152|P4|Overall Study|Protocol Violation|0
5132654|NCT01627782|17728153|P3|Overall Study|Protocol Violation|0
5132655|NCT01627782|17728154|P2|Overall Study|Protocol Violation|0
5132656|NCT01627782|17728155|P1|Overall Study|Protocol Violation|1
5132657|NCT01627782|17728152|P4|Overall Study|Lack of Efficacy|2
5132658|NCT01627782|17728153|P3|Overall Study|Lack of Efficacy|15
5132659|NCT01627782|17728154|P2|Overall Study|Lack of Efficacy|1
5132660|NCT01627782|17728155|P1|Overall Study|Lack of Efficacy|11
5132661|NCT01627782|17728152|P4|Overall Study|Adverse Event|1
5132662|NCT01627782|17728153|P3|Overall Study|Adverse Event|0
5132663|NCT01627782|17728154|P2|Overall Study|Adverse Event|2
5132664|NCT01627782|17728155|P1|Overall Study|Adverse Event|1
5132665|NCT01627691|17728211|P1|Overall Study|Missed the visit|3
5132666|NCT01627691|17728211|P1|Overall Study|Withdrawal by Subject|1
5132667|NCT01627691|17728211|P1|Overall Study|Lost to Follow-up|3
5132668|NCT01627691|17728211|P1|Overall Study|Death|11
5132669|NCT01627561|17728224|P2|Overall Study|Migrated/moved from study area|2
5132670|NCT01627561|17728225|P1|Overall Study|Migrated/moved from study area|0
5132671|NCT01627561|17728224|P2|Overall Study|Withdrawal by Subject|1
5132672|NCT01627561|17728225|P1|Overall Study|Withdrawal by Subject|0
5132673|NCT01627561|17728224|P2|Overall Study|Lost to Follow-up|0
5132674|NCT01627561|17728225|P1|Overall Study|Lost to Follow-up|1
5132675|NCT01627340|17728291|P2|Overall Study|Withdrawal by Subject|0
5132676|NCT01627340|17728292|P1|Overall Study|Withdrawal by Subject|2
5132677|NCT01627340|17728291|P2|Overall Study|Pregnancy|0
5132678|NCT01627340|17728292|P1|Overall Study|Pregnancy|1
5132679|NCT01627340|17728291|P2|Overall Study|Lost to Follow-up|4
5132680|NCT01627340|17728292|P1|Overall Study|Lost to Follow-up|8
5132681|NCT01627340|17728291|P2|Overall Study|Adverse Event|0
5132682|NCT01627340|17728292|P1|Overall Study|Adverse Event|1
5132683|NCT01627327|17728310|P2|Overall Study|Withdrawal by Subject|3
5132684|NCT01627327|17728311|P1|Overall Study|Withdrawal by Subject|3
5132685|NCT01627327|17728310|P2|Overall Study|Physician Decision|0
5132686|NCT01627327|17728311|P1|Overall Study|Physician Decision|1
5132687|NCT01627327|17728310|P2|Overall Study|Lost to Follow-up|3
5132688|NCT01627327|17728311|P1|Overall Study|Lost to Follow-up|1
5132689|NCT01627327|17728310|P2|Overall Study|Protocol Violation|10
5132690|NCT01627327|17728311|P1|Overall Study|Protocol Violation|4
5132691|NCT01627327|17728310|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
5132692|NCT01627327|17728311|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
5132693|NCT01627327|17728310|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
5132694|NCT01627327|17728311|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
5132695|NCT01627327|17728310|P2|Overall Study|Adverse Event|12
5132696|NCT01627327|17728311|P1|Overall Study|Adverse Event|6
5132697|NCT01627249|17728361|P3|Overall Study|Missed Visit|0
5132698|NCT01627249|17728362|P2|Overall Study|Missed Visit|1
5132699|NCT01627249|17728363|P1|Overall Study|Missed Visit|1
5132700|NCT01627249|17728361|P3|Overall Study|Withdrawal by Subject|9
5132701|NCT01627249|17728362|P2|Overall Study|Withdrawal by Subject|6
5132702|NCT01627249|17728363|P1|Overall Study|Withdrawal by Subject|12
5132703|NCT01627249|17728361|P3|Overall Study|Death|3
5132704|NCT01627249|17728362|P2|Overall Study|Death|5
5132705|NCT01627249|17728363|P1|Overall Study|Death|3
5132706|NCT01627067|17728398|P1|Overall Study|Screen Failure|1
5132707|NCT01626989|17728467|P3|Screening Period|Withdrawal by Subject|0
5132708|NCT01626989|17728468|P2|Screening Period|Withdrawal by Subject|0
5132709|NCT01626989|17728469|P1|Screening Period|Withdrawal by Subject|2
5132710|NCT01626989|17728467|P3|Screening Period|Screen Failure|0
5132711|NCT01626989|17728468|P2|Screening Period|Screen Failure|0
5132712|NCT01626989|17728469|P1|Screening Period|Screen Failure|15
5132713|NCT01626690|17728541|P2|Overall Study|Adverse Event|0
5132714|NCT01626690|17728542|P1|Overall Study|Adverse Event|1
5132715|NCT01626690|17728541|P2|Overall Study|Protocol Violation|0
5132716|NCT01626690|17728542|P1|Overall Study|Protocol Violation|1
5132717|NCT01626495|17728579|P1|Overall Study|Manufacturing failure|1
5132718|NCT01626495|17728579|P1|Overall Study|New cancer therapy|16
5132719|NCT01626495|17728579|P1|Overall Study|Physician Decision|1
5132720|NCT01626495|17728579|P1|Overall Study|Death|2
5132721|NCT01626495|17728579|P1|Overall Study|Administrative problem|1
5132722|NCT01626495|17728579|P1|Overall Study|Withdrawal by Subject|1
5132723|NCT01626495|17728579|P1|Overall Study|Disease progression|27
5132724|NCT01626495|17728579|P1|Overall Study|Adverse Event|3
5132725|NCT01626456|17728588|P2|Overall Study|Incarceration|2
5132726|NCT01626456|17728589|P1|Overall Study|Incarceration|0
5132727|NCT01626456|17728588|P2|Overall Study|Site Closure|3
5132728|NCT01626456|17728589|P1|Overall Study|Site Closure|2
5132729|NCT01626456|17728588|P2|Overall Study|Protocol Violation|1
5132730|NCT01626456|17728589|P1|Overall Study|Protocol Violation|1
5132731|NCT01626456|17728588|P2|Overall Study|Physician Decision|4
5132732|NCT01626456|17728589|P1|Overall Study|Physician Decision|1
5132733|NCT01626456|17728588|P2|Overall Study|Lack of Efficacy|7
5132734|NCT01626456|17728589|P1|Overall Study|Lack of Efficacy|6
5132735|NCT01626456|17728588|P2|Overall Study|Lost to Follow-up|27
5132736|NCT01626456|17728589|P1|Overall Study|Lost to Follow-up|2
5132737|NCT01626456|17728588|P2|Overall Study|Adverse Event|27
5132738|NCT01626456|17728589|P1|Overall Study|Adverse Event|2
5132739|NCT01626456|17728588|P2|Overall Study|Withdrawal by Subject|46
5132740|NCT01626456|17728589|P1|Overall Study|Withdrawal by Subject|21
5132741|NCT01626391|17728619|P2|Overall Study|Withdrawal by Subject|0
5132742|NCT01626391|17728620|P1|Overall Study|Withdrawal by Subject|1
5132743|NCT01626391|17728619|P2|Overall Study|Physician Decision|0
5132744|NCT01626391|17728620|P1|Overall Study|Physician Decision|1
5132745|NCT01626352|17728626|P1|Overall Study|Never Treated|1
5132746|NCT01626352|17728626|P1|Overall Study|Non-Compliance|1
5132747|NCT01626352|17728626|P1|Overall Study|Withdrawal by Subject|1
5132748|NCT01626352|17728626|P1|Overall Study|Death|2
5132749|NCT01626352|17728626|P1|Overall Study|Intercurrent Illness|2
5132750|NCT01626352|17728626|P1|Overall Study|Disease Progression|3
5132751|NCT01626118|17728640|P4|Overall Study|Investigator Decision|0
5132752|NCT01626118|17728641|P3|Overall Study|Investigator Decision|0
5132753|NCT01626118|17728642|P2|Overall Study|Investigator Decision|1
5132754|NCT01626118|17728643|P1|Overall Study|Investigator Decision|0
5132755|NCT01626118|17728640|P4|Overall Study|Adverse Event|0
5132756|NCT01626118|17728641|P3|Overall Study|Adverse Event|1
5132757|NCT01626118|17728642|P2|Overall Study|Adverse Event|1
5132758|NCT01626118|17728643|P1|Overall Study|Adverse Event|0
5132759|NCT01626118|17728640|P4|Overall Study|Lost to Follow-up|0
5132760|NCT01626118|17728641|P3|Overall Study|Lost to Follow-up|0
5132761|NCT01626118|17728642|P2|Overall Study|Lost to Follow-up|0
5132762|NCT01626118|17728643|P1|Overall Study|Lost to Follow-up|1
5132763|NCT01626118|17728640|P4|Overall Study|Lack of Efficacy|3
5132764|NCT01626118|17728641|P3|Overall Study|Lack of Efficacy|1
5132765|NCT01626118|17728642|P2|Overall Study|Lack of Efficacy|0
5132766|NCT01626118|17728643|P1|Overall Study|Lack of Efficacy|1
5132767|NCT01626079|17728689|P2|Overall Study|Visits Expected or Not Due|69
5132768|NCT01626079|17728690|P1|Overall Study|Visits Expected or Not Due|74
5132769|NCT01626079|17728689|P2|Overall Study|Lost to Follow-up|3
5132770|NCT01626079|17728690|P1|Overall Study|Lost to Follow-up|3
5132771|NCT01626079|17728689|P2|Overall Study|Withdrawal by Subject|29
5132772|NCT01626079|17728690|P1|Overall Study|Withdrawal by Subject|12
5132773|NCT01626079|17728689|P2|Overall Study|Death|115
5132774|NCT01626079|17728690|P1|Overall Study|Death|78
5132775|NCT01625988|17729063|P2|Overall Study|Protocol Violation|2
5132776|NCT01625988|17729064|P1|Overall Study|Protocol Violation|0
5132777|NCT01625988|17729063|P2|Overall Study|Randomized Inappropriately|0
5132778|NCT01625988|17729064|P1|Overall Study|Randomized Inappropriately|1
5132779|NCT01625988|17729063|P2|Overall Study|Lack of Efficacy|1
5132780|NCT01625988|17729064|P1|Overall Study|Lack of Efficacy|0
5132781|NCT01625988|17729063|P2|Overall Study|Adverse Event|1
5132782|NCT01625988|17729064|P1|Overall Study|Adverse Event|0
5132783|NCT01625988|17729063|P2|Overall Study|Withdrawal by Subject|3
5132784|NCT01625988|17729064|P1|Overall Study|Withdrawal by Subject|8
5132785|NCT01625988|17729063|P2|Overall Study|Lost to Follow-up|6
5132786|NCT01625988|17729064|P1|Overall Study|Lost to Follow-up|5
5132787|NCT01625910|17729088|P2|Overall Study|Lost to Follow-up|4
5132788|NCT01625910|17729089|P1|Overall Study|Lost to Follow-up|3
5132789|NCT01625845|17729099|P2|Overall Study|Withdrawal by Subject|0
5132790|NCT01625845|17729100|P1|Overall Study|Withdrawal by Subject|2
5132791|NCT01625845|17729099|P2|Overall Study|Lost to Follow-up|1
5132792|NCT01625845|17729100|P1|Overall Study|Lost to Follow-up|2
5132793|NCT01625845|17729099|P2|Overall Study|Adverse Event|2
5132794|NCT01625845|17729100|P1|Overall Study|Adverse Event|1
5132795|NCT01625689|17729120|P2|Overall Study|Migration|1
5132796|NCT01625689|17729121|P1|Overall Study|Migration|2
5132797|NCT01625377|17729176|P2|Overall Study|Abnormal laboratory values|0
5132798|NCT01625377|17729177|P1|Overall Study|Abnormal laboratory values|1
5132799|NCT01625377|17729176|P2|Overall Study|Unsatisfactory therapeutic effect|1
5132800|NCT01625377|17729177|P1|Overall Study|Unsatisfactory therapeutic effect|0
5132801|NCT01625377|17729176|P2|Overall Study|Graft loss|0
5132802|NCT01625377|17729177|P1|Overall Study|Graft loss|1
5132803|NCT01625377|17729176|P2|Overall Study|Adverse Event|16
5132804|NCT01625377|17729177|P1|Overall Study|Adverse Event|3
5132805|NCT01625377|17729176|P2|Overall Study|Protocol Violation|3
5132806|NCT01625377|17729177|P1|Overall Study|Protocol Violation|0
5132807|NCT01625377|17729176|P2|Overall Study|Administrative Problem|1
5132808|NCT01625377|17729177|P1|Overall Study|Administrative Problem|1
5132809|NCT01625377|17729176|P2|Overall Study|Death|1
5132810|NCT01625377|17729177|P1|Overall Study|Death|1
5132811|NCT01625338|17729210|P3|Overall Study|Study Discontinued by Sponsor|1
5132812|NCT01625338|17729211|P2|Overall Study|Study Discontinued by Sponsor|0
5132813|NCT01625338|17729212|P1|Overall Study|Study Discontinued by Sponsor|0
5132814|NCT01625338|17729210|P3|Overall Study|Adverse Event|1
5132815|NCT01625338|17729211|P2|Overall Study|Adverse Event|0
5132816|NCT01625338|17729212|P1|Overall Study|Adverse Event|1
5132817|NCT01625338|17729210|P3|Overall Study|Subject Withdrew Consent|2
5132818|NCT01625338|17729211|P2|Overall Study|Subject Withdrew Consent|0
5132819|NCT01625338|17729212|P1|Overall Study|Subject Withdrew Consent|1
5132820|NCT01625338|17729210|P3|Overall Study|Investigator Decision|1
5132821|NCT01625338|17729211|P2|Overall Study|Investigator Decision|2
5132822|NCT01625338|17729212|P1|Overall Study|Investigator Decision|0
5132823|NCT01625338|17729210|P3|Overall Study|Lost to Follow-up|2
5132824|NCT01625338|17729211|P2|Overall Study|Lost to Follow-up|3
5132825|NCT01625338|17729212|P1|Overall Study|Lost to Follow-up|3
5132826|NCT01625338|17729210|P3|Overall Study|Efficacy Failure|31
5132827|NCT01625338|17729211|P2|Overall Study|Efficacy Failure|39
5132828|NCT01625338|17729212|P1|Overall Study|Efficacy Failure|27
5132829|NCT01625338|17729210|P3|Overall Study|Enrolled but not Treated|1
5132830|NCT01625338|17729211|P2|Overall Study|Enrolled but not Treated|0
5132831|NCT01625338|17729212|P1|Overall Study|Enrolled but not Treated|0
5132832|NCT01625286|17729239|P7|Overall Study|Ongoing on-treatment at DCO|6
5132833|NCT01625286|17729240|P6|Overall Study|Ongoing on-treatment at DCO|8
5132834|NCT01625286|17729241|P5|Overall Study|Ongoing on-treatment at DCO|0
5132835|NCT01625286|17729242|P4|Overall Study|Ongoing on-treatment at DCO|0
5132836|NCT01625286|17729243|P3|Overall Study|Ongoing on-treatment at DCO|0
5132837|NCT01625286|17729244|P2|Overall Study|Ongoing on-treatment at DCO|4
5132838|NCT01625286|17729245|P1|Overall Study|Ongoing on-treatment at DCO|6
5132839|NCT01625286|17729239|P7|Overall Study|Ongoing off-treatment at DCO|31
5132840|NCT01625286|17729240|P6|Overall Study|Ongoing off-treatment at DCO|32
5132841|NCT01625286|17729241|P5|Overall Study|Ongoing off-treatment at DCO|0
5132842|NCT01625286|17729242|P4|Overall Study|Ongoing off-treatment at DCO|0
5132843|NCT01625286|17729243|P3|Overall Study|Ongoing off-treatment at DCO|0
5132844|NCT01625286|17729244|P2|Overall Study|Ongoing off-treatment at DCO|0
5132845|NCT01625286|17729245|P1|Overall Study|Ongoing off-treatment at DCO|0
5132846|NCT01625286|17729239|P7|Overall Study|Lost to Follow-up|1
5132847|NCT01625286|17729240|P6|Overall Study|Lost to Follow-up|0
5132848|NCT01625286|17729241|P5|Overall Study|Lost to Follow-up|0
5132849|NCT01625286|17729242|P4|Overall Study|Lost to Follow-up|0
5132850|NCT01625286|17729243|P3|Overall Study|Lost to Follow-up|0
5132851|NCT01625286|17729244|P2|Overall Study|Lost to Follow-up|0
5132852|NCT01625286|17729245|P1|Overall Study|Lost to Follow-up|0
5132853|NCT01625286|17729239|P7|Overall Study|Progressive disease|0
5132854|NCT01625286|17729240|P6|Overall Study|Progressive disease|0
5132855|NCT01625286|17729241|P5|Overall Study|Progressive disease|5
5132856|NCT01625286|17729242|P4|Overall Study|Progressive disease|5
5132857|NCT01625286|17729243|P3|Overall Study|Progressive disease|4
5132858|NCT01625286|17729244|P2|Overall Study|Progressive disease|3
5132859|NCT01625286|17729245|P1|Overall Study|Progressive disease|6
5132860|NCT01625286|17729239|P7|Overall Study|Any reason not specifically recorded|0
5132861|NCT01625286|17729240|P6|Overall Study|Any reason not specifically recorded|1
5132862|NCT01625286|17729241|P5|Overall Study|Any reason not specifically recorded|0
5132863|NCT01625286|17729242|P4|Overall Study|Any reason not specifically recorded|0
5132864|NCT01625286|17729243|P3|Overall Study|Any reason not specifically recorded|0
5132865|NCT01625286|17729244|P2|Overall Study|Any reason not specifically recorded|0
5132866|NCT01625286|17729245|P1|Overall Study|Any reason not specifically recorded|0
5132867|NCT01625286|17729239|P7|Overall Study|Withdrawal by Subject|1
5132868|NCT01625286|17729240|P6|Overall Study|Withdrawal by Subject|0
5132869|NCT01625286|17729241|P5|Overall Study|Withdrawal by Subject|0
5132870|NCT01625286|17729242|P4|Overall Study|Withdrawal by Subject|1
5132871|NCT01625286|17729243|P3|Overall Study|Withdrawal by Subject|0
5132872|NCT01625286|17729244|P2|Overall Study|Withdrawal by Subject|1
5132873|NCT01625286|17729245|P1|Overall Study|Withdrawal by Subject|0
5132874|NCT01625286|17729239|P7|Overall Study|Death|16
5132875|NCT01625286|17729240|P6|Overall Study|Death|11
5132876|NCT01625286|17729241|P5|Overall Study|Death|0
5132877|NCT01625286|17729242|P4|Overall Study|Death|1
5132878|NCT01625286|17729243|P3|Overall Study|Death|1
5132879|NCT01625286|17729244|P2|Overall Study|Death|0
5132880|NCT01625286|17729245|P1|Overall Study|Death|0
5132881|NCT01625286|17729239|P7|Overall Study|Adverse Event|1
5132882|NCT01625286|17729240|P6|Overall Study|Adverse Event|2
5132883|NCT01625286|17729241|P5|Overall Study|Adverse Event|1
5132884|NCT01625286|17729242|P4|Overall Study|Adverse Event|0
5132885|NCT01625286|17729243|P3|Overall Study|Adverse Event|0
5132886|NCT01625286|17729244|P2|Overall Study|Adverse Event|0
5132887|NCT01625286|17729245|P1|Overall Study|Adverse Event|0
5132888|NCT01625182|17729331|P2|Overall Study|Lack of Efficacy|8
5132889|NCT01625182|17729332|P1|Overall Study|Lack of Efficacy|12
5132890|NCT01625182|17729331|P2|Overall Study|Withdrawal by Subject|1
5132891|NCT01625182|17729332|P1|Overall Study|Withdrawal by Subject|5
5132892|NCT01625182|17729331|P2|Overall Study|Adverse Event|0
5132893|NCT01625182|17729332|P1|Overall Study|Adverse Event|2
5132894|NCT01625182|17729331|P2|Overall Study|Protocol deviation|2
5132895|NCT01625182|17729332|P1|Overall Study|Protocol deviation|0
5132896|NCT01625182|17729331|P2|Overall Study|Administrative problems|0
5132897|NCT01625182|17729332|P1|Overall Study|Administrative problems|1
5132898|NCT01625091|17729369|P2|Post-intervention|Study termination|1
5132899|NCT01625091|17729370|P1|Post-intervention|Study termination|2
5132900|NCT01625091|17729369|P2|Post-intervention|Lost to Follow-up|0
5132901|NCT01625091|17729370|P1|Post-intervention|Lost to Follow-up|2
5132902|NCT01625091|17729369|P2|Post-intervention|Death|1
5132903|NCT01625091|17729370|P1|Post-intervention|Death|0
5132904|NCT01625091|17729369|P2|Intervention|Study termination|3
5132905|NCT01625091|17729370|P1|Intervention|Study termination|2
5132906|NCT01625091|17729369|P2|Intervention|Lost to Follow-up|4
5132907|NCT01625091|17729370|P1|Intervention|Lost to Follow-up|4
5132908|NCT01625091|17729369|P2|Intervention|Adverse Event|2
5132909|NCT01625091|17729370|P1|Intervention|Adverse Event|0
5132910|NCT01625091|17729369|P2|Intervention|Withdrawal by Subject|1
5132911|NCT01625091|17729370|P1|Intervention|Withdrawal by Subject|4
5132912|NCT01625091|17729369|P2|Intervention|Death|1
5132913|NCT01625091|17729370|P1|Intervention|Death|1
5132914|NCT01624974|17729388|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
5132915|NCT01624974|17729389|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
5132916|NCT01624974|17729388|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
5132917|NCT01624974|17729389|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
5132918|NCT01624974|17729388|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
5132919|NCT01624974|17729389|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
5132920|NCT01624974|17729388|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
5132921|NCT01624974|17729389|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
5132922|NCT01624974|17729388|P2|Period IV Washout (4 Weeks)|Adverse Event|0
5132923|NCT01624974|17729389|P1|Period IV Washout (4 Weeks)|Adverse Event|2
5132924|NCT01624974|17729388|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
5132925|NCT01624974|17729389|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
5132926|NCT01624974|17729388|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
5132927|NCT01624974|17729389|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
5132928|NCT01624974|17729388|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
5132929|NCT01624974|17729389|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
5132930|NCT01624974|17729388|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
5132931|NCT01624974|17729389|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
5132932|NCT01624974|17729388|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
5132933|NCT01624974|17729389|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
5132934|NCT01624974|17729388|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
5132935|NCT01624974|17729389|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
5132936|NCT01624974|17729388|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
5132937|NCT01624974|17729389|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
5132938|NCT01624870|17729430|P1|Overall Study|Lost to follow up|1
5132939|NCT01624870|17729430|P1|Overall Study|CoreValve not implanted|6
5132940|NCT01624870|17729430|P1|Overall Study|Withdrawal by Subject|1
5132941|NCT01624870|17729430|P1|Overall Study|Death|19
5132942|NCT01624662|17729450|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5132943|NCT01624662|17729451|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5132944|NCT01624662|17729452|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5132945|NCT01624662|17729453|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5132946|NCT01624662|17729450|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5132947|NCT01624662|17729451|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5132948|NCT01624662|17729452|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
5132949|NCT01624662|17729453|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5132950|NCT01624662|17729450|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5132951|NCT01624662|17729451|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5132952|NCT01624662|17729452|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5132953|NCT01624662|17729453|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5132954|NCT01624662|17729450|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5132955|NCT01624662|17729451|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
5132956|NCT01624662|17729452|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5132957|NCT01624662|17729453|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
5132958|NCT01624662|17729450|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5132959|NCT01624662|17729451|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5132960|NCT01624662|17729452|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
5132961|NCT01624662|17729453|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5132962|NCT01624662|17729450|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5132963|NCT01624662|17729451|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5132964|NCT01624662|17729452|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
5132965|NCT01624662|17729453|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
5132966|NCT01624662|17729450|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
5132967|NCT01624662|17729451|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5132968|NCT01624662|17729452|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5132969|NCT01624662|17729453|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
5132970|NCT01624467|17729524|P1|Overall Study|Subject Withdrew from Treatment|1
5132971|NCT01624467|17729524|P1|Overall Study|Per Sponsor Requirement|1
5132972|NCT01624467|17729524|P1|Overall Study|Progressive Disease|19
5132973|NCT01624467|17729524|P1|Overall Study|Adverse Event|7
5132974|NCT01624467|17729524|P1|Overall Study|Lost to Follow-up|1
5132975|NCT01624467|17729524|P1|Overall Study|Withdrawal by Subject|2
5132976|NCT01624259|17729563|P2|Overall Study|Abnormal laboratory measure|0
5132977|NCT01624259|17729564|P1|Overall Study|Abnormal laboratory measure|3
5132978|NCT01624259|17729563|P2|Overall Study|Lost to Follow-up|3
5132979|NCT01624259|17729564|P1|Overall Study|Lost to Follow-up|2
5132980|NCT01624259|17729563|P2|Overall Study|Physician Decision|1
5132981|NCT01624259|17729564|P1|Overall Study|Physician Decision|1
5132982|NCT01624259|17729563|P2|Overall Study|Withdrawal by Subject|7
5132983|NCT01624259|17729564|P1|Overall Study|Withdrawal by Subject|5
5132984|NCT01624259|17729563|P2|Overall Study|Protocol Violation|2
5132985|NCT01624259|17729564|P1|Overall Study|Protocol Violation|1
5132986|NCT01624259|17729563|P2|Overall Study|Adverse Event|18
5132987|NCT01624259|17729564|P1|Overall Study|Adverse Event|18
5132988|NCT01624233|17729613|P1|Period 6: Follow-up|Withdrawal by Subject|3
5132989|NCT01624233|17729613|P1|Period 6: Follow-up|Physician Decision|1
5132990|NCT01624233|17729613|P1|Period 6: Follow-up|Lack of Efficacy|2
5132991|NCT01624233|17729613|P1|Period 6: Follow-up|Adverse Event|3
5132992|NCT01624233|17729613|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
5132993|NCT01624233|17729613|P1|Period 5 - Retreatment Period|Physician Decision|1
5132994|NCT01624233|17729613|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
5132995|NCT01624233|17729613|P1|Period 5 - Retreatment Period|Adverse Event|5
5132996|NCT01624233|17729613|P1|Period 4 - Drug Free Period|Relapsed|61
5132997|NCT01624233|17729613|P1|Period 3 - Maintenance|Withdrawal by Subject|2
5132998|NCT01624233|17729613|P1|Period 3 - Maintenance|Physician Decision|2
5132999|NCT01624233|17729613|P1|Period 3 - Maintenance|Lack of Efficacy|1
5133000|NCT01624233|17729613|P1|Period 3 - Maintenance|Adverse Event|2
5133001|NCT01624233|17729613|P1|Period 2 - Induction|Adverse Event|1
5133002|NCT01624194|17729645|P2|Overall Study|Withdrawal by Subject|0
5133003|NCT01624194|17729646|P1|Overall Study|Withdrawal by Subject|1
5133004|NCT01624194|17729645|P2|Overall Study|Lost to Follow-up|0
5133005|NCT01624194|17729646|P1|Overall Study|Lost to Follow-up|1
5133006|NCT01624142|17729714|P2|Overall Study|Other|0
5133007|NCT01624142|17729715|P1|Overall Study|Other|1
5133008|NCT01624142|17729714|P2|Overall Study|Lost to Follow-up|0
5133009|NCT01624142|17729715|P1|Overall Study|Lost to Follow-up|2
5133010|NCT01624142|17729714|P2|Overall Study|Study Closure|6
5133011|NCT01624142|17729715|P1|Overall Study|Study Closure|12
5133012|NCT01624142|17729714|P2|Overall Study|Death|6
5133013|NCT01624142|17729715|P1|Overall Study|Death|3
5133014|NCT01624142|17729714|P2|Overall Study|Withdrawal by Subject|4
5133015|NCT01624142|17729715|P1|Overall Study|Withdrawal by Subject|14
5133016|NCT01624090|17729740|P4|Overall Study|Dose escalated|0
5133017|NCT01624090|17729741|P3|Overall Study|Dose escalated|3
5133018|NCT01624090|17729742|P2|Overall Study|Dose escalated|0
5133019|NCT01624090|17729743|P1|Overall Study|Dose escalated|0
5133020|NCT01624090|17729740|P4|Overall Study|Did not complete 1 crse of therapy|0
5133021|NCT01624090|17729741|P3|Overall Study|Did not complete 1 crse of therapy|2
5133022|NCT01624090|17729742|P2|Overall Study|Did not complete 1 crse of therapy|0
5133023|NCT01624090|17729743|P1|Overall Study|Did not complete 1 crse of therapy|0
5133024|NCT01624090|17729740|P4|Overall Study|Died on study|0
5133025|NCT01624090|17729741|P3|Overall Study|Died on study|2
5133026|NCT01624090|17729742|P2|Overall Study|Died on study|0
5133027|NCT01624090|17729743|P1|Overall Study|Died on study|0
5133028|NCT01624090|17729740|P4|Overall Study|Withdrew prior to treatment|0
5133029|NCT01624090|17729741|P3|Overall Study|Withdrew prior to treatment|0
5133030|NCT01624090|17729742|P2|Overall Study|Withdrew prior to treatment|1
5133031|NCT01624090|17729743|P1|Overall Study|Withdrew prior to treatment|0
5133032|NCT01624090|17729740|P4|Overall Study|DLT, taken off therapy|0
5133033|NCT01624090|17729741|P3|Overall Study|DLT, taken off therapy|0
5133034|NCT01624090|17729742|P2|Overall Study|DLT, taken off therapy|1
5133035|NCT01624090|17729743|P1|Overall Study|DLT, taken off therapy|0
5133036|NCT01623830|17729765|P2|Overall Study|Exclusion from Study|2
5133037|NCT01623830|17729766|P1|Overall Study|Exclusion from Study|1
5133038|NCT01623830|17729765|P2|Overall Study|Withdrawal by Subject|7
5133039|NCT01623830|17729766|P1|Overall Study|Withdrawal by Subject|6
5133040|NCT01623752|17729783|P3|Phase 2 (78 Weeks)|Adverse Event|0
5133041|NCT01623752|17729784|P2|Phase 2 (78 Weeks)|Adverse Event|4
5133042|NCT01623752|17729785|P1|Phase 2 (78 Weeks)|Adverse Event|4
5133043|NCT01623752|17729783|P3|Phase 2 (78 Weeks)|No Data|0
5133044|NCT01623752|17729784|P2|Phase 2 (78 Weeks)|No Data|11
5133045|NCT01623752|17729785|P1|Phase 2 (78 Weeks)|No Data|43
5133046|NCT01623752|17729783|P3|Phase 2 (78 Weeks)|Other|0
5133047|NCT01623752|17729784|P2|Phase 2 (78 Weeks)|Other|1
5133048|NCT01623752|17729785|P1|Phase 2 (78 Weeks)|Other|5
5133049|NCT01623752|17729783|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
5133050|NCT01623752|17729784|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
5133051|NCT01623752|17729785|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
5133052|NCT01623752|17729783|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
5133053|NCT01623752|17729784|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
5133054|NCT01623752|17729785|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
5133055|NCT01623752|17729783|P3|Phase 1 (78 Weeks)|Adverse Event|0
5133056|NCT01623752|17729784|P2|Phase 1 (78 Weeks)|Adverse Event|39
5133057|NCT01623752|17729785|P1|Phase 1 (78 Weeks)|Adverse Event|122
5133058|NCT01623752|17729783|P3|Phase 1 (78 Weeks)|Other|0
5133059|NCT01623752|17729784|P2|Phase 1 (78 Weeks)|Other|20
5133060|NCT01623752|17729785|P1|Phase 1 (78 Weeks)|Other|33
5133061|NCT01623752|17729783|P3|Phase 1 (78 Weeks)|No Data|2
5133062|NCT01623752|17729784|P2|Phase 1 (78 Weeks)|No Data|66
5133063|NCT01623752|17729785|P1|Phase 1 (78 Weeks)|No Data|249
5133064|NCT01623596|17729888|P2|Overall Study|Lack of Efficacy|3
5133065|NCT01623596|17729889|P1|Overall Study|Lack of Efficacy|5
5133066|NCT01623596|17729888|P2|Overall Study|Protocol Violation|6
5133067|NCT01623596|17729889|P1|Overall Study|Protocol Violation|0
5133068|NCT01623596|17729888|P2|Overall Study|Patient no longer requires study drug|0
5133069|NCT01623596|17729889|P1|Overall Study|Patient no longer requires study drug|1
5133070|NCT01623596|17729888|P2|Overall Study|Withdrawal by Subject|31
5133071|NCT01623596|17729889|P1|Overall Study|Withdrawal by Subject|13
5133072|NCT01623596|17729888|P2|Overall Study|Lost to Follow-up|16
5133073|NCT01623596|17729889|P1|Overall Study|Lost to Follow-up|12
5133074|NCT01623596|17729888|P2|Overall Study|Death|2
5133075|NCT01623596|17729889|P1|Overall Study|Death|0
5133076|NCT01623596|17729888|P2|Overall Study|Adverse Event|29
5133077|NCT01623596|17729889|P1|Overall Study|Adverse Event|20
5133078|NCT01623596|17729888|P2|Overall Study|Administrative problems|13
5133079|NCT01623596|17729889|P1|Overall Study|Administrative problems|9
5133080|NCT01623596|17729888|P2|Overall Study|Abnormal laboratory values|0
5133081|NCT01623596|17729889|P1|Overall Study|Abnormal laboratory values|2
5133082|NCT01623531|17729907|P2|Overall Study|Missing data at primary outcome time poi|1
5133083|NCT01623531|17729908|P1|Overall Study|Missing data at primary outcome time poi|1
5133084|NCT01623531|17729907|P2|Overall Study|Protocol Violation|1
5133085|NCT01623531|17729908|P1|Overall Study|Protocol Violation|2
5133086|NCT01623531|17729907|P2|Overall Study|Death|0
5133087|NCT01623531|17729908|P1|Overall Study|Death|1
5133088|NCT01623310|17729975|P1|Overall Study|Investigators Discretion-Noncompliant|1
5133089|NCT01623310|17729975|P1|Overall Study|Diagnoses of bilateral cateracts|1
5133090|NCT01623310|17729975|P1|Overall Study|Became potentially child-bearing|1
5133091|NCT01623310|17729975|P1|Overall Study|Withdrawal by Subject|25
5133092|NCT01623310|17729975|P1|Overall Study|Protocol Violation|6
5133093|NCT01623310|17729975|P1|Overall Study|Lack of Efficacy|6
5133094|NCT01623310|17729975|P1|Overall Study|Lost to Follow-up|18
5133095|NCT01623310|17729975|P1|Overall Study|Adverse Event|21
5133096|NCT01623271|17729984|P1|Overall Study|Withdrawal by Subject|2
5133097|NCT01623154|17730001|P1|Overall Study|Did not drink Pranactin Citric|4
5133098|NCT01623115|17730009|P2|Overall Study|Other than specified above|3
5133099|NCT01623115|17730010|P1|Overall Study|Other than specified above|0
5133100|NCT01623115|17730009|P2|Overall Study|Death|4
5133101|NCT01623115|17730010|P1|Overall Study|Death|0
5133102|NCT01623115|17730009|P2|Overall Study|Site closure|7
5133103|NCT01623115|17730010|P1|Overall Study|Site closure|1
5133104|NCT01623115|17730009|P2|Overall Study|Last visit outside protocol visit window|26
5133105|NCT01623115|17730010|P1|Overall Study|Last visit outside protocol visit window|14
5133106|NCT01623115|17730009|P2|Overall Study|Related to study drug administration|2
5133107|NCT01623115|17730010|P1|Overall Study|Related to study drug administration|0
5133108|NCT01623115|17730009|P2|Overall Study|Consent withdrawn by participant|6
5133109|NCT01623115|17730010|P1|Overall Study|Consent withdrawn by participant|2
5133110|NCT01623115|17730009|P2|Overall Study|Poor compliance to protocol|10
5133111|NCT01623115|17730010|P1|Overall Study|Poor compliance to protocol|4
5133112|NCT01623115|17730009|P2|Overall Study|Adverse Event|13
5133113|NCT01623115|17730010|P1|Overall Study|Adverse Event|10
5133114|NCT01623115|17730009|P2|Overall Study|Participants moved|5
5133115|NCT01623115|17730010|P1|Overall Study|Participants moved|1
5133116|NCT01623115|17730009|P2|Overall Study|Physician Decision|0
5133117|NCT01623115|17730010|P1|Overall Study|Physician Decision|1
5133118|NCT01623115|17730009|P2|Overall Study|Randomized but not treated|1
5133119|NCT01623115|17730010|P1|Overall Study|Randomized but not treated|0
5133120|NCT01623050|17730070|P1|Overall Study|Lost to Follow-up|9
5133121|NCT01622673|17730108|P6|Treatment Period 3|Protocol Violation|0
5133122|NCT01622673|17730109|P5|Treatment Period 3|Protocol Violation|0
5133123|NCT01622673|17730110|P4|Treatment Period 3|Protocol Violation|0
5133124|NCT01622673|17730111|P3|Treatment Period 3|Protocol Violation|0
5133125|NCT01622673|17730112|P2|Treatment Period 3|Protocol Violation|1
5133126|NCT01622673|17730113|P1|Treatment Period 3|Protocol Violation|0
5133127|NCT01622673|17730108|P6|Treatment Period 2|Withdrawal by Subject|0
5133128|NCT01622673|17730109|P5|Treatment Period 2|Withdrawal by Subject|0
5133129|NCT01622673|17730110|P4|Treatment Period 2|Withdrawal by Subject|1
5133130|NCT01622673|17730111|P3|Treatment Period 2|Withdrawal by Subject|0
5133131|NCT01622673|17730112|P2|Treatment Period 2|Withdrawal by Subject|0
5133132|NCT01622673|17730113|P1|Treatment Period 2|Withdrawal by Subject|0
5133133|NCT01622673|17730108|P6|Treatment Period 1|Protocol Violation|0
5133134|NCT01622673|17730109|P5|Treatment Period 1|Protocol Violation|0
5133135|NCT01622673|17730110|P4|Treatment Period 1|Protocol Violation|0
5133136|NCT01622673|17730111|P3|Treatment Period 1|Protocol Violation|0
5133137|NCT01622673|17730112|P2|Treatment Period 1|Protocol Violation|1
5133138|NCT01622673|17730113|P1|Treatment Period 1|Protocol Violation|0
5133139|NCT01622673|17730108|P6|Treatment Period 1|Withdrawal by Subject|0
5133140|NCT01622673|17730109|P5|Treatment Period 1|Withdrawal by Subject|0
5133141|NCT01622673|17730110|P4|Treatment Period 1|Withdrawal by Subject|1
5133142|NCT01622673|17730111|P3|Treatment Period 1|Withdrawal by Subject|0
5133143|NCT01622673|17730112|P2|Treatment Period 1|Withdrawal by Subject|0
5133144|NCT01622673|17730113|P1|Treatment Period 1|Withdrawal by Subject|0
5133145|NCT01622660|17730148|P1|Overall Study|Adverse Event|1
5133146|NCT01622569|17730156|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
5133147|NCT01622569|17730157|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5133148|NCT01622569|17730158|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5133149|NCT01622569|17730159|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5133150|NCT01622569|17730156|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5133151|NCT01622569|17730157|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
5133152|NCT01622569|17730158|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5133153|NCT01622569|17730159|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5133154|NCT01622569|17730156|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5133155|NCT01622569|17730157|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5133156|NCT01622569|17730158|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
5133157|NCT01622569|17730159|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5133158|NCT01622569|17730156|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5133159|NCT01622569|17730157|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5133160|NCT01622569|17730158|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5133161|NCT01622569|17730159|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5133162|NCT01622569|17730156|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
5133163|NCT01622569|17730157|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5133164|NCT01622569|17730158|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
5133165|NCT01622569|17730159|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5133166|NCT01622569|17730156|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
5133167|NCT01622569|17730157|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
5133168|NCT01622569|17730158|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5133169|NCT01622569|17730159|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
5133170|NCT01622569|17730156|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5133171|NCT01622569|17730157|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
5133172|NCT01622569|17730158|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5133173|NCT01622569|17730159|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5133174|NCT01622569|17730156|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5133175|NCT01622569|17730157|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
5133176|NCT01622569|17730158|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
5133177|NCT01622569|17730159|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
5133178|NCT01622348|17730244|P3|Overall Study|Withdrawal by Subject|1
5133179|NCT01622348|17730245|P2|Overall Study|Withdrawal by Subject|0
5133180|NCT01622348|17730246|P1|Overall Study|Withdrawal by Subject|1
5133181|NCT01622231|17730285|P1|Overall Study|Withdrawal by Subject|1
5133182|NCT01622231|17730285|P1|Overall Study|Physician Decision|1
5133183|NCT01621880|17730315|P2|Overall Study|Withdrawal by Subject|4
5133184|NCT01621880|17730316|P1|Overall Study|Withdrawal by Subject|5
5133185|NCT01621880|17730315|P2|Overall Study|Adverse Event|1
5133186|NCT01621880|17730316|P1|Overall Study|Adverse Event|5
5133187|NCT01621802|17730330|P6|Overall Study|Lost to Follow-up|11
5133188|NCT01621802|17730331|P5|Overall Study|Lost to Follow-up|31
5133189|NCT01621802|17730332|P4|Overall Study|Lost to Follow-up|7
5133190|NCT01621802|17730333|P3|Overall Study|Lost to Follow-up|24
5133191|NCT01621802|17730334|P2|Overall Study|Lost to Follow-up|16
5133192|NCT01621802|17730335|P1|Overall Study|Lost to Follow-up|36
5133193|NCT01621802|17730330|P6|Overall Study|Others|0
5133194|NCT01621802|17730331|P5|Overall Study|Others|1
5133195|NCT01621802|17730332|P4|Overall Study|Others|2
5133196|NCT01621802|17730333|P3|Overall Study|Others|3
5133197|NCT01621802|17730334|P2|Overall Study|Others|3
5133198|NCT01621802|17730335|P1|Overall Study|Others|3
5133199|NCT01621802|17730330|P6|Overall Study|Migrated/moved from study area|0
5133200|NCT01621802|17730331|P5|Overall Study|Migrated/moved from study area|1
5133201|NCT01621802|17730332|P4|Overall Study|Migrated/moved from study area|0
5133202|NCT01621802|17730333|P3|Overall Study|Migrated/moved from study area|2
5133203|NCT01621802|17730334|P2|Overall Study|Migrated/moved from study area|0
5133204|NCT01621802|17730335|P1|Overall Study|Migrated/moved from study area|0
5133205|NCT01621802|17730330|P6|Overall Study|Withdrawal by Subject|0
5133206|NCT01621802|17730331|P5|Overall Study|Withdrawal by Subject|2
5133207|NCT01621802|17730332|P4|Overall Study|Withdrawal by Subject|2
5133208|NCT01621802|17730333|P3|Overall Study|Withdrawal by Subject|4
5133209|NCT01621802|17730334|P2|Overall Study|Withdrawal by Subject|4
5133210|NCT01621802|17730335|P1|Overall Study|Withdrawal by Subject|8
5133211|NCT01621802|17730330|P6|Overall Study|Protocol Violation|1
5133212|NCT01621802|17730331|P5|Overall Study|Protocol Violation|0
5133213|NCT01621802|17730332|P4|Overall Study|Protocol Violation|0
5133214|NCT01621802|17730333|P3|Overall Study|Protocol Violation|0
5133215|NCT01621802|17730334|P2|Overall Study|Protocol Violation|0
5133216|NCT01621802|17730335|P1|Overall Study|Protocol Violation|0
5133217|NCT01621542|17730520|P6|Overall Study|study stopped by sponsor|0
5133218|NCT01621542|17730521|P5|Overall Study|study stopped by sponsor|0
5133219|NCT01621542|17730522|P4|Overall Study|study stopped by sponsor|1
5133220|NCT01621542|17730523|P3|Overall Study|study stopped by sponsor|0
5133221|NCT01621542|17730524|P2|Overall Study|study stopped by sponsor|0
5133222|NCT01621542|17730525|P1|Overall Study|study stopped by sponsor|0
5133223|NCT01621542|17730520|P6|Overall Study|Protocol Violation|0
5133224|NCT01621542|17730521|P5|Overall Study|Protocol Violation|0
5133225|NCT01621542|17730522|P4|Overall Study|Protocol Violation|1
5133226|NCT01621542|17730523|P3|Overall Study|Protocol Violation|0
5133227|NCT01621542|17730524|P2|Overall Study|Protocol Violation|0
5133228|NCT01621542|17730525|P1|Overall Study|Protocol Violation|0
5133229|NCT01621542|17730520|P6|Overall Study|progression/treatment failure|5
5133230|NCT01621542|17730521|P5|Overall Study|progression/treatment failure|3
5133231|NCT01621542|17730522|P4|Overall Study|progression/treatment failure|7
5133232|NCT01621542|17730523|P3|Overall Study|progression/treatment failure|3
5133233|NCT01621542|17730524|P2|Overall Study|progression/treatment failure|4
5133234|NCT01621542|17730525|P1|Overall Study|progression/treatment failure|2
5133235|NCT01621542|17730520|P6|Overall Study|Withdrawal by Subject|3
5133236|NCT01621542|17730521|P5|Overall Study|Withdrawal by Subject|3
5133237|NCT01621542|17730522|P4|Overall Study|Withdrawal by Subject|3
5133238|NCT01621542|17730523|P3|Overall Study|Withdrawal by Subject|1
5133239|NCT01621542|17730524|P2|Overall Study|Withdrawal by Subject|0
5133240|NCT01621542|17730525|P1|Overall Study|Withdrawal by Subject|2
5133241|NCT01621542|17730520|P6|Overall Study|Physician Decision|1
5133242|NCT01621542|17730521|P5|Overall Study|Physician Decision|3
5133243|NCT01621542|17730522|P4|Overall Study|Physician Decision|13
5133244|NCT01621542|17730523|P3|Overall Study|Physician Decision|1
5133245|NCT01621542|17730524|P2|Overall Study|Physician Decision|0
5133246|NCT01621542|17730525|P1|Overall Study|Physician Decision|1
5133247|NCT01621542|17730520|P6|Overall Study|Death|0
5133248|NCT01621542|17730521|P5|Overall Study|Death|0
5133249|NCT01621542|17730522|P4|Overall Study|Death|0
5133250|NCT01621542|17730523|P3|Overall Study|Death|0
5133251|NCT01621542|17730524|P2|Overall Study|Death|1
5133252|NCT01621542|17730525|P1|Overall Study|Death|0
5133253|NCT01621542|17730520|P6|Overall Study|Adverse Event|0
5133254|NCT01621542|17730521|P5|Overall Study|Adverse Event|0
5133255|NCT01621542|17730522|P4|Overall Study|Adverse Event|3
5133256|NCT01621542|17730523|P3|Overall Study|Adverse Event|1
5133257|NCT01621542|17730524|P2|Overall Study|Adverse Event|0
5133258|NCT01621542|17730525|P1|Overall Study|Adverse Event|0
5133259|NCT01621490|17730566|P9|Overall Study|Patient delayed due to toxicity|0
5133260|NCT01621490|17730567|P8|Overall Study|Patient delayed due to toxicity|0
5133261|NCT01621490|17730568|P7|Overall Study|Patient delayed due to toxicity|0
5133262|NCT01621490|17730569|P6|Overall Study|Patient delayed due to toxicity|1
5133263|NCT01621490|17730570|P5|Overall Study|Patient delayed due to toxicity|0
5133264|NCT01621490|17730571|P4|Overall Study|Patient delayed due to toxicity|0
5133265|NCT01621490|17730572|P3|Overall Study|Patient delayed due to toxicity|0
5133266|NCT01621490|17730573|P2|Overall Study|Patient delayed due to toxicity|0
5133267|NCT01621490|17730574|P1|Overall Study|Patient delayed due to toxicity|0
5133268|NCT01621490|17730566|P9|Overall Study|Complete response|1
5133269|NCT01621490|17730567|P8|Overall Study|Complete response|0
5133270|NCT01621490|17730568|P7|Overall Study|Complete response|0
5133271|NCT01621490|17730569|P6|Overall Study|Complete response|0
5133272|NCT01621490|17730570|P5|Overall Study|Complete response|0
5133273|NCT01621490|17730571|P4|Overall Study|Complete response|0
5133274|NCT01621490|17730572|P3|Overall Study|Complete response|0
5133275|NCT01621490|17730573|P2|Overall Study|Complete response|0
5133276|NCT01621490|17730574|P1|Overall Study|Complete response|0
5133277|NCT01621490|17730566|P9|Overall Study|Clinical deterioration|0
5133278|NCT01621490|17730567|P8|Overall Study|Clinical deterioration|0
5133279|NCT01621490|17730568|P7|Overall Study|Clinical deterioration|0
5133280|NCT01621490|17730569|P6|Overall Study|Clinical deterioration|0
5133281|NCT01621490|17730570|P5|Overall Study|Clinical deterioration|0
5133282|NCT01621490|17730571|P4|Overall Study|Clinical deterioration|0
5133283|NCT01621490|17730572|P3|Overall Study|Clinical deterioration|0
5133284|NCT01621490|17730573|P2|Overall Study|Clinical deterioration|1
5133285|NCT01621490|17730574|P1|Overall Study|Clinical deterioration|0
5133286|NCT01621490|17730566|P9|Overall Study|Patient reached treatment 2 yr limit|0
5133287|NCT01621490|17730567|P8|Overall Study|Patient reached treatment 2 yr limit|0
5133288|NCT01621490|17730568|P7|Overall Study|Patient reached treatment 2 yr limit|0
5133289|NCT01621490|17730569|P6|Overall Study|Patient reached treatment 2 yr limit|0
5133290|NCT01621490|17730570|P5|Overall Study|Patient reached treatment 2 yr limit|0
5133291|NCT01621490|17730571|P4|Overall Study|Patient reached treatment 2 yr limit|0
5133292|NCT01621490|17730572|P3|Overall Study|Patient reached treatment 2 yr limit|0
5133293|NCT01621490|17730573|P2|Overall Study|Patient reached treatment 2 yr limit|1
5133294|NCT01621490|17730574|P1|Overall Study|Patient reached treatment 2 yr limit|0
5133295|NCT01621490|17730566|P9|Overall Study|Documented disease progression|0
5133296|NCT01621490|17730567|P8|Overall Study|Documented disease progression|0
5133297|NCT01621490|17730568|P7|Overall Study|Documented disease progression|0
5133298|NCT01621490|17730569|P6|Overall Study|Documented disease progression|0
5133299|NCT01621490|17730570|P5|Overall Study|Documented disease progression|0
5133300|NCT01621490|17730571|P4|Overall Study|Documented disease progression|0
5133301|NCT01621490|17730572|P3|Overall Study|Documented disease progression|1
5133302|NCT01621490|17730573|P2|Overall Study|Documented disease progression|0
5133303|NCT01621490|17730574|P1|Overall Study|Documented disease progression|0
5133304|NCT01621490|17730566|P9|Overall Study|Investigator decision|0
5133305|NCT01621490|17730567|P8|Overall Study|Investigator decision|0
5133306|NCT01621490|17730568|P7|Overall Study|Investigator decision|1
5133307|NCT01621490|17730569|P6|Overall Study|Investigator decision|0
5133308|NCT01621490|17730570|P5|Overall Study|Investigator decision|1
5133309|NCT01621490|17730571|P4|Overall Study|Investigator decision|0
5133310|NCT01621490|17730572|P3|Overall Study|Investigator decision|1
5133311|NCT01621490|17730573|P2|Overall Study|Investigator decision|0
5133312|NCT01621490|17730574|P1|Overall Study|Investigator decision|0
5133313|NCT01621490|17730566|P9|Overall Study|BMS informed of patient status|0
5133314|NCT01621490|17730567|P8|Overall Study|BMS informed of patient status|0
5133315|NCT01621490|17730568|P7|Overall Study|BMS informed of patient status|0
5133316|NCT01621490|17730569|P6|Overall Study|BMS informed of patient status|0
5133317|NCT01621490|17730570|P5|Overall Study|BMS informed of patient status|0
5133318|NCT01621490|17730571|P4|Overall Study|BMS informed of patient status|0
5133319|NCT01621490|17730572|P3|Overall Study|BMS informed of patient status|1
5133320|NCT01621490|17730573|P2|Overall Study|BMS informed of patient status|0
5133321|NCT01621490|17730574|P1|Overall Study|BMS informed of patient status|0
5133322|NCT01621490|17730566|P9|Overall Study|Grade 4 Lipase elevation|0
5133323|NCT01621490|17730567|P8|Overall Study|Grade 4 Lipase elevation|0
5133324|NCT01621490|17730568|P7|Overall Study|Grade 4 Lipase elevation|0
5133325|NCT01621490|17730569|P6|Overall Study|Grade 4 Lipase elevation|0
5133326|NCT01621490|17730570|P5|Overall Study|Grade 4 Lipase elevation|0
5133327|NCT01621490|17730571|P4|Overall Study|Grade 4 Lipase elevation|0
5133328|NCT01621490|17730572|P3|Overall Study|Grade 4 Lipase elevation|0
5133329|NCT01621490|17730573|P2|Overall Study|Grade 4 Lipase elevation|0
5133330|NCT01621490|17730574|P1|Overall Study|Grade 4 Lipase elevation|1
5133331|NCT01621490|17730566|P9|Overall Study|Death|0
5133332|NCT01621490|17730567|P8|Overall Study|Death|1
5133333|NCT01621490|17730568|P7|Overall Study|Death|0
5133334|NCT01621490|17730569|P6|Overall Study|Death|0
5133335|NCT01621490|17730570|P5|Overall Study|Death|0
5133336|NCT01621490|17730571|P4|Overall Study|Death|0
5133337|NCT01621490|17730572|P3|Overall Study|Death|0
5133338|NCT01621490|17730573|P2|Overall Study|Death|0
5133339|NCT01621490|17730574|P1|Overall Study|Death|0
5133340|NCT01621490|17730566|P9|Overall Study|Study drug toxicity|1
5133341|NCT01621490|17730567|P8|Overall Study|Study drug toxicity|4
5133342|NCT01621490|17730568|P7|Overall Study|Study drug toxicity|1
5133343|NCT01621490|17730569|P6|Overall Study|Study drug toxicity|10
5133344|NCT01621490|17730570|P5|Overall Study|Study drug toxicity|1
5133345|NCT01621490|17730571|P4|Overall Study|Study drug toxicity|3
5133346|NCT01621490|17730572|P3|Overall Study|Study drug toxicity|5
5133347|NCT01621490|17730573|P2|Overall Study|Study drug toxicity|4
5133348|NCT01621490|17730574|P1|Overall Study|Study drug toxicity|1
5133349|NCT01621490|17730566|P9|Overall Study|Disease progression|4
5133350|NCT01621490|17730567|P8|Overall Study|Disease progression|0
5133351|NCT01621490|17730568|P7|Overall Study|Disease progression|7
5133352|NCT01621490|17730569|P6|Overall Study|Disease progression|8
5133353|NCT01621490|17730570|P5|Overall Study|Disease progression|3
5133354|NCT01621490|17730571|P4|Overall Study|Disease progression|5
5133355|NCT01621490|17730572|P3|Overall Study|Disease progression|1
5133356|NCT01621490|17730573|P2|Overall Study|Disease progression|28
5133357|NCT01621490|17730574|P1|Overall Study|Disease progression|27
5133358|NCT01621490|17730566|P9|Overall Study|Adverse event unrelated to study drug|1
5133359|NCT01621490|17730567|P8|Overall Study|Adverse event unrelated to study drug|2
5133360|NCT01621490|17730568|P7|Overall Study|Adverse event unrelated to study drug|0
5133361|NCT01621490|17730569|P6|Overall Study|Adverse event unrelated to study drug|0
5133362|NCT01621490|17730570|P5|Overall Study|Adverse event unrelated to study drug|0
5133363|NCT01621490|17730571|P4|Overall Study|Adverse event unrelated to study drug|0
5133364|NCT01621490|17730572|P3|Overall Study|Adverse event unrelated to study drug|0
5133365|NCT01621490|17730573|P2|Overall Study|Adverse event unrelated to study drug|1
5133366|NCT01621490|17730574|P1|Overall Study|Adverse event unrelated to study drug|2
5133367|NCT01621490|17730566|P9|Overall Study|Subject request to discontinue study|1
5133368|NCT01621490|17730567|P8|Overall Study|Subject request to discontinue study|0
5133369|NCT01621490|17730568|P7|Overall Study|Subject request to discontinue study|1
5133370|NCT01621490|17730569|P6|Overall Study|Subject request to discontinue study|2
5133371|NCT01621490|17730570|P5|Overall Study|Subject request to discontinue study|0
5133372|NCT01621490|17730571|P4|Overall Study|Subject request to discontinue study|1
5133373|NCT01621490|17730572|P3|Overall Study|Subject request to discontinue study|1
5133374|NCT01621490|17730573|P2|Overall Study|Subject request to discontinue study|3
5133375|NCT01621490|17730574|P1|Overall Study|Subject request to discontinue study|1
5133376|NCT01621490|17730566|P9|Overall Study|Withdrawal by Subject|0
5133377|NCT01621490|17730567|P8|Overall Study|Withdrawal by Subject|0
5133378|NCT01621490|17730568|P7|Overall Study|Withdrawal by Subject|0
5133379|NCT01621490|17730569|P6|Overall Study|Withdrawal by Subject|3
5133380|NCT01621490|17730570|P5|Overall Study|Withdrawal by Subject|0
5133381|NCT01621490|17730571|P4|Overall Study|Withdrawal by Subject|0
5133382|NCT01621490|17730572|P3|Overall Study|Withdrawal by Subject|0
5133383|NCT01621490|17730573|P2|Overall Study|Withdrawal by Subject|0
5133384|NCT01621490|17730574|P1|Overall Study|Withdrawal by Subject|1
5133385|NCT01621490|17730566|P9|Overall Study|Maximum clinical benefit|0
5133386|NCT01621490|17730567|P8|Overall Study|Maximum clinical benefit|2
5133387|NCT01621490|17730568|P7|Overall Study|Maximum clinical benefit|1
5133388|NCT01621490|17730569|P6|Overall Study|Maximum clinical benefit|0
5133389|NCT01621490|17730570|P5|Overall Study|Maximum clinical benefit|0
5133390|NCT01621490|17730571|P4|Overall Study|Maximum clinical benefit|0
5133391|NCT01621490|17730572|P3|Overall Study|Maximum clinical benefit|0
5133392|NCT01621490|17730573|P2|Overall Study|Maximum clinical benefit|2
5133393|NCT01621490|17730574|P1|Overall Study|Maximum clinical benefit|3
5133394|NCT01621490|17730566|P9|Overall Study|Subject no longer meets study criteria|0
5133395|NCT01621490|17730567|P8|Overall Study|Subject no longer meets study criteria|0
5133396|NCT01621490|17730568|P7|Overall Study|Subject no longer meets study criteria|0
5133397|NCT01621490|17730569|P6|Overall Study|Subject no longer meets study criteria|0
5133398|NCT01621490|17730570|P5|Overall Study|Subject no longer meets study criteria|1
5133399|NCT01621490|17730571|P4|Overall Study|Subject no longer meets study criteria|0
5133400|NCT01621490|17730572|P3|Overall Study|Subject no longer meets study criteria|0
5133401|NCT01621490|17730573|P2|Overall Study|Subject no longer meets study criteria|0
5133402|NCT01621490|17730574|P1|Overall Study|Subject no longer meets study criteria|0
5133403|NCT01621490|17730566|P9|Overall Study|Patient could not travel|0
5133404|NCT01621490|17730567|P8|Overall Study|Patient could not travel|0
5133405|NCT01621490|17730568|P7|Overall Study|Patient could not travel|0
5133406|NCT01621490|17730569|P6|Overall Study|Patient could not travel|0
5133407|NCT01621490|17730570|P5|Overall Study|Patient could not travel|0
5133408|NCT01621490|17730571|P4|Overall Study|Patient could not travel|0
5133409|NCT01621490|17730572|P3|Overall Study|Patient could not travel|0
5133410|NCT01621490|17730573|P2|Overall Study|Patient could not travel|0
5133411|NCT01621490|17730574|P1|Overall Study|Patient could not travel|1
5133412|NCT01621490|17730566|P9|Overall Study|Participant completed treatment|0
5133413|NCT01621490|17730567|P8|Overall Study|Participant completed treatment|1
5133414|NCT01621490|17730568|P7|Overall Study|Participant completed treatment|0
5133415|NCT01621490|17730569|P6|Overall Study|Participant completed treatment|0
5133416|NCT01621490|17730570|P5|Overall Study|Participant completed treatment|0
5133417|NCT01621490|17730571|P4|Overall Study|Participant completed treatment|0
5133418|NCT01621490|17730572|P3|Overall Study|Participant completed treatment|1
5133419|NCT01621490|17730573|P2|Overall Study|Participant completed treatment|4
5133420|NCT01621490|17730574|P1|Overall Study|Participant completed treatment|4
5133421|NCT01621191|17730826|P1|Overall Study|Site Removed From Study|1
5133422|NCT01621191|17730826|P1|Overall Study|Lost to Follow-up|1
5133423|NCT01621191|17730826|P1|Overall Study|Lack of Efficacy|6
5133424|NCT01621191|17730826|P1|Overall Study|Withdrawal by Subject|8
5133425|NCT01621191|17730826|P1|Overall Study|Adverse Event|9
5133426|NCT01621178|17730840|P3|Overall Study|Physician Decision|7
5133427|NCT01621178|17730841|P2|Overall Study|Physician Decision|2
5133428|NCT01621178|17730842|P1|Overall Study|Physician Decision|5
5133429|NCT01621178|17730840|P3|Overall Study|Withdrawal by Subject|18
5133430|NCT01621178|17730841|P2|Overall Study|Withdrawal by Subject|17
5133431|NCT01621178|17730842|P1|Overall Study|Withdrawal by Subject|14
5133432|NCT01621178|17730840|P3|Overall Study|Lost to Follow-up|1
5133433|NCT01621178|17730841|P2|Overall Study|Lost to Follow-up|2
5133434|NCT01621178|17730842|P1|Overall Study|Lost to Follow-up|1
5133435|NCT01621178|17730840|P3|Overall Study|Death|2
5133436|NCT01621178|17730841|P2|Overall Study|Death|7
5133437|NCT01621178|17730842|P1|Overall Study|Death|6
5133438|NCT01621178|17730840|P3|Overall Study|Adverse Event|8
5133439|NCT01621178|17730841|P2|Overall Study|Adverse Event|2
5133440|NCT01621178|17730842|P1|Overall Study|Adverse Event|5
5133441|NCT01621126|17730934|P1|Overall Study|Physician Decision|6
5133442|NCT01620983|17730956|P3|Overall Study|Physician Decision|5
5133443|NCT01620983|17730957|P2|Overall Study|Physician Decision|10
5133444|NCT01620983|17730958|P1|Overall Study|Physician Decision|3
5133445|NCT01620983|17730956|P3|Overall Study|Death|0
5133446|NCT01620983|17730957|P2|Overall Study|Death|0
5133447|NCT01620983|17730958|P1|Overall Study|Death|2
5133448|NCT01620983|17730956|P3|Overall Study|Withdrawal by Subject|1
5133449|NCT01620983|17730957|P2|Overall Study|Withdrawal by Subject|8
5133450|NCT01620983|17730958|P1|Overall Study|Withdrawal by Subject|6
5133451|NCT01620983|17730956|P3|Overall Study|Lost to Follow-up|9
5133452|NCT01620983|17730957|P2|Overall Study|Lost to Follow-up|4
5133453|NCT01620983|17730958|P1|Overall Study|Lost to Follow-up|8
5133454|NCT01620762|17730987|P3|Overall Study|Use of prohibted therapies|1
5133455|NCT01620762|17730988|P2|Overall Study|Use of prohibted therapies|1
5133456|NCT01620762|17730989|P1|Overall Study|Use of prohibted therapies|0
5133457|NCT01620762|17730987|P3|Overall Study|Non-specified|5
5133458|NCT01620762|17730988|P2|Overall Study|Non-specified|6
5133459|NCT01620762|17730989|P1|Overall Study|Non-specified|3
5133460|NCT01620762|17730987|P3|Overall Study|Subject deterioration|1
5133461|NCT01620762|17730988|P2|Overall Study|Subject deterioration|1
5133462|NCT01620762|17730989|P1|Overall Study|Subject deterioration|0
5133463|NCT01620762|17730987|P3|Overall Study|Protocol deviation|6
5133464|NCT01620762|17730988|P2|Overall Study|Protocol deviation|1
5133465|NCT01620762|17730989|P1|Overall Study|Protocol deviation|1
5133466|NCT01620762|17730987|P3|Overall Study|Lost to Follow-up|10
5133467|NCT01620762|17730988|P2|Overall Study|Lost to Follow-up|17
5133468|NCT01620762|17730989|P1|Overall Study|Lost to Follow-up|11
5133469|NCT01620762|17730987|P3|Overall Study|Withdrawal by Subject|27
5133470|NCT01620762|17730988|P2|Overall Study|Withdrawal by Subject|26
5133471|NCT01620762|17730989|P1|Overall Study|Withdrawal by Subject|23
5133472|NCT01620762|17730987|P3|Overall Study|Adverse Event|2
5133473|NCT01620762|17730988|P2|Overall Study|Adverse Event|5
5133474|NCT01620762|17730989|P1|Overall Study|Adverse Event|9
5133475|NCT01620762|17730987|P3|Overall Study|Protocol Violation|1
5133476|NCT01620762|17730988|P2|Overall Study|Protocol Violation|1
5133477|NCT01620762|17730989|P1|Overall Study|Protocol Violation|1
5133478|NCT01620528|17731050|P3|Post-Treatment Follow-Up Period|Other|2
5133479|NCT01620528|17731051|P2|Post-Treatment Follow-Up Period|Other|4
5133480|NCT01620528|17731052|P1|Post-Treatment Follow-Up Period|Other|6
5133481|NCT01620528|17731050|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
5133482|NCT01620528|17731051|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
5133483|NCT01620528|17731052|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
5133484|NCT01620528|17731050|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
5133485|NCT01620528|17731051|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
5133486|NCT01620528|17731052|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
5133487|NCT01620528|17731050|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5133488|NCT01620528|17731051|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5133489|NCT01620528|17731052|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5133490|NCT01620528|17731050|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5133491|NCT01620528|17731051|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
5133492|NCT01620528|17731052|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5133493|NCT01620528|17731050|P3|Treatment Period|Exclusionary Medication Received|0
5133494|NCT01620528|17731051|P2|Treatment Period|Exclusionary Medication Received|1
5133495|NCT01620528|17731052|P1|Treatment Period|Exclusionary Medication Received|0
5133496|NCT01620528|17731050|P3|Treatment Period|Surgery/Invasive Intervention|3
5133497|NCT01620528|17731051|P2|Treatment Period|Surgery/Invasive Intervention|1
5133498|NCT01620528|17731052|P1|Treatment Period|Surgery/Invasive Intervention|5
5133499|NCT01620528|17731050|P3|Treatment Period|Pregnancy|2
5133500|NCT01620528|17731051|P2|Treatment Period|Pregnancy|2
5133501|NCT01620528|17731052|P1|Treatment Period|Pregnancy|7
5133502|NCT01620528|17731050|P3|Treatment Period|Subject Noncompliant|2
5133503|NCT01620528|17731051|P2|Treatment Period|Subject Noncompliant|2
5133504|NCT01620528|17731052|P1|Treatment Period|Subject Noncompliant|11
5133505|NCT01620528|17731050|P3|Treatment Period|Other|7
5133506|NCT01620528|17731051|P2|Treatment Period|Other|5
5133507|NCT01620528|17731052|P1|Treatment Period|Other|9
5133508|NCT01620528|17731050|P3|Treatment Period|Lost to Follow-up|14
5133509|NCT01620528|17731051|P2|Treatment Period|Lost to Follow-up|8
5133510|NCT01620528|17731052|P1|Treatment Period|Lost to Follow-up|16
5133511|NCT01620528|17731050|P3|Treatment Period|Adverse Event|21
5133512|NCT01620528|17731051|P2|Treatment Period|Adverse Event|13
5133513|NCT01620528|17731052|P1|Treatment Period|Adverse Event|17
5133514|NCT01620528|17731050|P3|Treatment Period|Withdrawal by Subject|16
5133515|NCT01620528|17731051|P2|Treatment Period|Withdrawal by Subject|21
5133516|NCT01620528|17731052|P1|Treatment Period|Withdrawal by Subject|35
5133517|NCT01620528|17731050|P3|Treatment Period|Did Not Receive Study Drug|1
5133518|NCT01620528|17731051|P2|Treatment Period|Did Not Receive Study Drug|0
5133519|NCT01620528|17731052|P1|Treatment Period|Did Not Receive Study Drug|0
5133520|NCT01620489|17731392|P2|Overall Study|Unclassified|2
5133521|NCT01620489|17731393|P1|Overall Study|Unclassified|1
5133522|NCT01620489|17731392|P2|Overall Study|Withdrawal Criteria|25
5133523|NCT01620489|17731393|P1|Overall Study|Withdrawal Criteria|17
5133524|NCT01620489|17731392|P2|Overall Study|Protocol Violation|3
5133525|NCT01620489|17731393|P1|Overall Study|Protocol Violation|0
5133526|NCT01620489|17731392|P2|Overall Study|Adverse Event|4
5133527|NCT01620489|17731393|P1|Overall Study|Adverse Event|17
5133528|NCT01620255|17731414|P5|Overall Study|Withdrawn at discretion of investigator|1
5133529|NCT01620255|17731415|P4|Overall Study|Withdrawn at discretion of investigator|0
5133530|NCT01620255|17731416|P3|Overall Study|Withdrawn at discretion of investigator|0
5133531|NCT01620255|17731417|P2|Overall Study|Withdrawn at discretion of investigator|0
5133532|NCT01620255|17731418|P1|Overall Study|Withdrawn at discretion of investigator|0
5133533|NCT01620255|17731414|P5|Overall Study|Adverse Event|1
5133534|NCT01620255|17731415|P4|Overall Study|Adverse Event|1
5133535|NCT01620255|17731416|P3|Overall Study|Adverse Event|0
5133536|NCT01620255|17731417|P2|Overall Study|Adverse Event|4
5133537|NCT01620255|17731418|P1|Overall Study|Adverse Event|0
5133538|NCT01620255|17731414|P5|Overall Study|Non-compliance|0
5133539|NCT01620255|17731415|P4|Overall Study|Non-compliance|0
5133540|NCT01620255|17731416|P3|Overall Study|Non-compliance|0
5133541|NCT01620255|17731417|P2|Overall Study|Non-compliance|1
5133542|NCT01620255|17731418|P1|Overall Study|Non-compliance|0
5133543|NCT01620255|17731414|P5|Overall Study|Participant underwent fecal transplant|0
5133544|NCT01620255|17731415|P4|Overall Study|Participant underwent fecal transplant|0
5133545|NCT01620255|17731416|P3|Overall Study|Participant underwent fecal transplant|1
5133546|NCT01620255|17731417|P2|Overall Study|Participant underwent fecal transplant|0
5133547|NCT01620255|17731418|P1|Overall Study|Participant underwent fecal transplant|0
5133548|NCT01620255|17731414|P5|Overall Study|Withdrawal by Subject|4
5133549|NCT01620255|17731415|P4|Overall Study|Withdrawal by Subject|2
5133550|NCT01620255|17731416|P3|Overall Study|Withdrawal by Subject|1
5133551|NCT01620255|17731417|P2|Overall Study|Withdrawal by Subject|1
5133552|NCT01620255|17731418|P1|Overall Study|Withdrawal by Subject|4
5133553|NCT01620177|17731495|P1|Overall Study|Randomized, Not Active due to Scheduling|1
5133554|NCT01620177|17731495|P1|Overall Study|Physician Decision|2
5133555|NCT01620177|17731495|P1|Overall Study|Lost to Follow-up|7
5133556|NCT01620177|17731495|P1|Overall Study|Withdrawal by Subject|26
5133557|NCT01620177|17731495|P1|Overall Study|Failure at Screening Visit|43
5133558|NCT01620138|17731520|P2|Overall Study|Adverse Event|0
5133559|NCT01620138|17731521|P1|Overall Study|Adverse Event|2
5133560|NCT01620138|17731520|P2|Overall Study|Lack of Efficacy|0
5133561|NCT01620138|17731521|P1|Overall Study|Lack of Efficacy|1
5133562|NCT01620138|17731520|P2|Overall Study|Withdrawal by Subject|0
5133563|NCT01620138|17731521|P1|Overall Study|Withdrawal by Subject|3
5133564|NCT01620086|17731529|P3|Overall Study|Physician Decision|0
5133565|NCT01620086|17731530|P2|Overall Study|Physician Decision|0
5133566|NCT01620086|17731531|P1|Overall Study|Physician Decision|1
5133567|NCT01620086|17731529|P3|Overall Study|failed study criteria|0
5133568|NCT01620086|17731530|P2|Overall Study|failed study criteria|4
5133569|NCT01620086|17731531|P1|Overall Study|failed study criteria|1
5133570|NCT01620086|17731529|P3|Overall Study|Withdrawal by Subject|0
5133571|NCT01620086|17731530|P2|Overall Study|Withdrawal by Subject|3
5133572|NCT01620086|17731531|P1|Overall Study|Withdrawal by Subject|3
5133573|NCT01620060|17731550|P1|Overall Study|Per Sponsor Decision|2
5133574|NCT01620060|17731550|P1|Overall Study|Family emergency|1
5133575|NCT01620060|17731550|P1|Overall Study|Did not comply with Study Produre|1
5133576|NCT01620060|17731550|P1|Overall Study|Withdrawal by Subject|1
5133577|NCT01620060|17731550|P1|Overall Study|Protocol Violation|1
5133578|NCT01620060|17731550|P1|Overall Study|Adverse Event|9
5133579|NCT01619878|17731588|P1|Follow-up at 12 Months of Age|Death|2
5133580|NCT01619878|17731588|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
5133581|NCT01619878|17731588|P1|6 Week Follow-up Phase|Adverse Event|1
5133582|NCT01619852|17731602|P2|3 Month Follow up|Lost to Follow-up|34
5133583|NCT01619852|17731603|P1|3 Month Follow up|Lost to Follow-up|31
5133584|NCT01619852|17731602|P2|24 Hour Assessment|Withdrawal by Subject|1
5133585|NCT01619852|17731603|P1|24 Hour Assessment|Withdrawal by Subject|1
5133586|NCT01619800|17731619|P2|Overall Study|study terminated|0
5133587|NCT01619800|17731620|P1|Overall Study|study terminated|2
5133588|NCT01619787|17731628|P1|Overall Study|Lost to Follow-up|5
5133589|NCT01619579|17731645|P2|Overall Study|Withdrawal by Subject|3
5133590|NCT01619579|17731646|P1|Overall Study|Withdrawal by Subject|0
5133591|NCT01619423|17731660|P4|Part 1 (Dose Escalation)|High basal Mn|0
5133592|NCT01619423|17731661|P3|Part 1 (Dose Escalation)|High basal Mn|0
5133593|NCT01619423|17731662|P2|Part 1 (Dose Escalation)|High basal Mn|2
5133594|NCT01619423|17731663|P1|Part 1 (Dose Escalation)|High basal Mn|0
5133595|NCT01619410|17731676|P2|Overall Study|Lost to Follow-up|4
5133596|NCT01619410|17731677|P1|Overall Study|Lost to Follow-up|7
5133597|NCT01619085|17731689|P1|Overall Study|Ongoing on trial|27
5133598|NCT01619085|17731689|P1|Overall Study|Not treated|1
5133599|NCT01619085|17731689|P1|Overall Study|Other than specified|94
5133600|NCT01619085|17731689|P1|Overall Study|Withdrawal by Subject|15
5133601|NCT01619085|17731689|P1|Overall Study|Lost to Follow-up|10
5133602|NCT01619085|17731689|P1|Overall Study|Protocol Violation|10
5133603|NCT01619085|17731689|P1|Overall Study|Adverse Event|212
5133604|NCT01619059|17731695|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
5133605|NCT01619059|17731696|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
5133606|NCT01619059|17731695|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
5133607|NCT01619059|17731696|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
5133608|NCT01619059|17731695|P2|Long-Term (LT) Treatment Period|Death|0
5133609|NCT01619059|17731696|P1|Long-Term (LT) Treatment Period|Death|1
5133610|NCT01619059|17731695|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
5133611|NCT01619059|17731696|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
5133612|NCT01619059|17731695|P2|Long-Term (LT) Treatment Period|Adverse Event|3
5133613|NCT01619059|17731696|P1|Long-Term (LT) Treatment Period|Adverse Event|2
5133614|NCT01619059|17731695|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
5133615|NCT01619059|17731696|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
5133616|NCT01619059|17731695|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
5133617|NCT01619059|17731696|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
5133618|NCT01619059|17731695|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
5133619|NCT01619059|17731696|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
5133620|NCT01619059|17731695|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
5133621|NCT01619059|17731696|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
5133622|NCT01619059|17731695|P2|Short-Term (ST) Treatment Period|Adverse Event|0
5133623|NCT01619059|17731696|P1|Short-Term (ST) Treatment Period|Adverse Event|1
5133624|NCT01618968|17731712|P4|Overall Study|Death|1
5133625|NCT01618968|17731713|P3|Overall Study|Death|0
5133626|NCT01618968|17731714|P2|Overall Study|Death|0
5133627|NCT01618968|17731715|P1|Overall Study|Death|0
5133628|NCT01618968|17731712|P4|Overall Study|Adverse Event|0
5133629|NCT01618968|17731713|P3|Overall Study|Adverse Event|0
5133630|NCT01618968|17731714|P2|Overall Study|Adverse Event|0
5133631|NCT01618968|17731715|P1|Overall Study|Adverse Event|1
5133632|NCT01618916|17731788|P6|Overall Study|Lost to Follow-up|0
5133633|NCT01618916|17731789|P5|Overall Study|Lost to Follow-up|0
5133634|NCT01618916|17731790|P4|Overall Study|Lost to Follow-up|2
5133635|NCT01618916|17731791|P3|Overall Study|Lost to Follow-up|0
5133636|NCT01618916|17731792|P2|Overall Study|Lost to Follow-up|0
5133637|NCT01618916|17731793|P1|Overall Study|Lost to Follow-up|1
5133638|NCT01618916|17731788|P6|Overall Study|Withdrawal by Subject|0
5133639|NCT01618916|17731789|P5|Overall Study|Withdrawal by Subject|1
5133640|NCT01618916|17731790|P4|Overall Study|Withdrawal by Subject|0
5133641|NCT01618916|17731791|P3|Overall Study|Withdrawal by Subject|1
5133642|NCT01618916|17731792|P2|Overall Study|Withdrawal by Subject|1
5133643|NCT01618916|17731793|P1|Overall Study|Withdrawal by Subject|0
5133644|NCT01618916|17731788|P6|Overall Study|Adverse Event|0
5133645|NCT01618916|17731789|P5|Overall Study|Adverse Event|0
5133646|NCT01618916|17731790|P4|Overall Study|Adverse Event|0
5133647|NCT01618916|17731791|P3|Overall Study|Adverse Event|0
5133648|NCT01618916|17731792|P2|Overall Study|Adverse Event|0
5133649|NCT01618916|17731793|P1|Overall Study|Adverse Event|1
5133650|NCT01618864|17731823|P1|Overall Study|Lost to Follow-up|2
5133651|NCT01618864|17731823|P1|Overall Study|Withdrawal by Subject|2
5133652|NCT01618838|17731832|P1|Overall Study|slow accrual, trial closed prematurely.|4
5133653|NCT01618708|17731840|P2|Overall Study|Randomized but not treated|2
5133654|NCT01618708|17731841|P1|Overall Study|Randomized but not treated|3
5133655|NCT01618708|17731840|P2|Overall Study|Other than specified above|1
5133656|NCT01618708|17731841|P1|Overall Study|Other than specified above|1
5133657|NCT01618708|17731840|P2|Overall Study|Technical problems|0
5133658|NCT01618708|17731841|P1|Overall Study|Technical problems|2
5133659|NCT01618708|17731840|P2|Overall Study|Lack of Efficacy|8
5133660|NCT01618708|17731841|P1|Overall Study|Lack of Efficacy|8
5133661|NCT01618708|17731840|P2|Overall Study|Withdrawal by Subject|22
5133662|NCT01618708|17731841|P1|Overall Study|Withdrawal by Subject|17
5133663|NCT01618708|17731840|P2|Overall Study|Lost to Follow-up|3
5133664|NCT01618708|17731841|P1|Overall Study|Lost to Follow-up|3
5133665|NCT01618708|17731840|P2|Overall Study|Adverse Event|10
5133666|NCT01618708|17731841|P1|Overall Study|Adverse Event|10
5133667|NCT01618695|17731857|P4|Overall Study|Not treated|0
5133668|NCT01618695|17731858|P3|Overall Study|Not treated|2
5133669|NCT01618695|17731859|P2|Overall Study|Not treated|0
5133670|NCT01618695|17731860|P1|Overall Study|Not treated|1
5133671|NCT01618695|17731857|P4|Overall Study|Other than specified|2
5133672|NCT01618695|17731858|P3|Overall Study|Other than specified|2
5133673|NCT01618695|17731859|P2|Overall Study|Other than specified|2
5133674|NCT01618695|17731860|P1|Overall Study|Other than specified|1
5133675|NCT01618695|17731857|P4|Overall Study|Lack of Efficacy|1
5133676|NCT01618695|17731858|P3|Overall Study|Lack of Efficacy|1
5133677|NCT01618695|17731859|P2|Overall Study|Lack of Efficacy|2
5133678|NCT01618695|17731860|P1|Overall Study|Lack of Efficacy|1
5133679|NCT01618695|17731857|P4|Overall Study|Pregnancy|0
5133680|NCT01618695|17731858|P3|Overall Study|Pregnancy|0
5133681|NCT01618695|17731859|P2|Overall Study|Pregnancy|0
5133682|NCT01618695|17731860|P1|Overall Study|Pregnancy|2
5133683|NCT01618695|17731857|P4|Overall Study|Withdrawal by Subject|13
5133684|NCT01618695|17731858|P3|Overall Study|Withdrawal by Subject|9
5133685|NCT01618695|17731859|P2|Overall Study|Withdrawal by Subject|11
5133686|NCT01618695|17731860|P1|Overall Study|Withdrawal by Subject|16
5133687|NCT01618695|17731857|P4|Overall Study|Lost to Follow-up|0
5133688|NCT01618695|17731858|P3|Overall Study|Lost to Follow-up|1
5133689|NCT01618695|17731859|P2|Overall Study|Lost to Follow-up|0
5133690|NCT01618695|17731860|P1|Overall Study|Lost to Follow-up|0
5133691|NCT01618695|17731857|P4|Overall Study|Adverse Event|20
5133692|NCT01618695|17731858|P3|Overall Study|Adverse Event|15
5133693|NCT01618695|17731859|P2|Overall Study|Adverse Event|5
5133694|NCT01618695|17731860|P1|Overall Study|Adverse Event|4
5133695|NCT01618669|17731884|P2|Overall Study|Miscellaneous Reason|1
5133696|NCT01618669|17731885|P1|Overall Study|Miscellaneous Reason|0
5133697|NCT01618669|17731884|P2|Overall Study|Withdrawal by Subject|9
5133698|NCT01618669|17731885|P1|Overall Study|Withdrawal by Subject|9
5133699|NCT01618669|17731884|P2|Overall Study|Protocol Violation|3
5133700|NCT01618669|17731885|P1|Overall Study|Protocol Violation|5
5133701|NCT01618669|17731884|P2|Overall Study|Adverse Event|7
5133702|NCT01618669|17731885|P1|Overall Study|Adverse Event|16
5133703|NCT01618669|17731884|P2|Overall Study|Randomized but Never Received Study Drug|2
5133704|NCT01618669|17731885|P1|Overall Study|Randomized but Never Received Study Drug|3
5133705|NCT01618669|17731884|P2|Overall Study|Lost to Follow-up|1
5133706|NCT01618669|17731885|P1|Overall Study|Lost to Follow-up|1
5133707|NCT01618305|17731944|P2|Overall Study|Withdrawal by Subject|2
5133708|NCT01618305|17731945|P1|Overall Study|Withdrawal by Subject|3
5133709|NCT01618305|17731944|P2|Overall Study|Protocol Violation|0
5133710|NCT01618305|17731945|P1|Overall Study|Protocol Violation|1
5133711|NCT01618305|17731944|P2|Overall Study|Lost to Follow-up|7
5133712|NCT01618305|17731945|P1|Overall Study|Lost to Follow-up|11
5133713|NCT01618305|17731944|P2|Overall Study|Death|1
5133714|NCT01618305|17731945|P1|Overall Study|Death|0
5133715|NCT01618266|17731987|P1|Overall Study|Protocol Violation|43
5133716|NCT01618266|17731987|P1|Overall Study|Lack of Efficacy|23
5133717|NCT01618266|17731987|P1|Overall Study|Other reasons|11
5133718|NCT01618266|17731987|P1|Overall Study|Treatment satisfaction|10
5133719|NCT01618266|17731987|P1|Overall Study|Lost to Follow-up|9
5133720|NCT01618214|17732024|P2|Overall Study|Unclassified|5
5133721|NCT01618214|17732025|P1|Overall Study|Unclassified|4
5133722|NCT01618214|17732024|P2|Overall Study|Withdrawal Criteria|2
5133723|NCT01618214|17732025|P1|Overall Study|Withdrawal Criteria|1
5133724|NCT01618214|17732024|P2|Overall Study|Protocol Violation|4
5133725|NCT01618214|17732025|P1|Overall Study|Protocol Violation|1
5133726|NCT01618214|17732024|P2|Overall Study|Lack of Efficacy|1
5133727|NCT01618214|17732025|P1|Overall Study|Lack of Efficacy|1
5133728|NCT01618214|17732024|P2|Overall Study|Adverse Event|1
5133729|NCT01618214|17732025|P1|Overall Study|Adverse Event|3
5133730|NCT01618162|17732041|P2|Overall Study|Unclassified|13
5133731|NCT01618162|17732042|P1|Overall Study|Unclassified|14
5133732|NCT01618162|17732041|P2|Overall Study|Withdrawal Criteria|10
5133733|NCT01618162|17732042|P1|Overall Study|Withdrawal Criteria|2
5133734|NCT01618162|17732041|P2|Overall Study|Adverse Event|2
5133735|NCT01618162|17732042|P1|Overall Study|Adverse Event|9
5133736|NCT01618162|17732041|P2|Overall Study|Protocol Violation|10
5133737|NCT01618162|17732042|P1|Overall Study|Protocol Violation|13
5133738|NCT01618019|17732062|P2|Overall Study|Withdrawal by Subject|14
5133739|NCT01618019|17732063|P1|Overall Study|Withdrawal by Subject|14
5133740|NCT01617967|17732089|P6|Overall Study|Dosing Suspended by Sponsor|0
5133741|NCT01617967|17732090|P5|Overall Study|Dosing Suspended by Sponsor|0
5133742|NCT01617967|17732091|P4|Overall Study|Dosing Suspended by Sponsor|0
5133743|NCT01617967|17732092|P3|Overall Study|Dosing Suspended by Sponsor|0
5133744|NCT01617967|17732093|P2|Overall Study|Dosing Suspended by Sponsor|0
5133745|NCT01617967|17732094|P1|Overall Study|Dosing Suspended by Sponsor|1
5133746|NCT01617967|17732089|P6|Overall Study|Withdrawal by Subject|1
5133747|NCT01617967|17732090|P5|Overall Study|Withdrawal by Subject|0
5133748|NCT01617967|17732091|P4|Overall Study|Withdrawal by Subject|0
5133749|NCT01617967|17732092|P3|Overall Study|Withdrawal by Subject|0
5133750|NCT01617967|17732093|P2|Overall Study|Withdrawal by Subject|0
5133751|NCT01617967|17732094|P1|Overall Study|Withdrawal by Subject|0
5133752|NCT01617967|17732089|P6|Overall Study|Protocol Violation|0
5133753|NCT01617967|17732090|P5|Overall Study|Protocol Violation|0
5133754|NCT01617967|17732091|P4|Overall Study|Protocol Violation|1
5133755|NCT01617967|17732092|P3|Overall Study|Protocol Violation|0
5133756|NCT01617967|17732093|P2|Overall Study|Protocol Violation|0
5133757|NCT01617967|17732094|P1|Overall Study|Protocol Violation|0
5133758|NCT01617681|17732148|P5|Period 2 Open Label|Withdrawal by Subject|3
5133759|NCT01617681|17732149|P4|Period 2 Open Label|Withdrawal by Subject|0
5133760|NCT01617681|17732150|P3|Period 2 Open Label|Withdrawal by Subject|0
5133761|NCT01617681|17732151|P2|Period 2 Open Label|Withdrawal by Subject|0
5133762|NCT01617681|17732152|P1|Period 2 Open Label|Withdrawal by Subject|0
5133763|NCT01617681|17732148|P5|Period 2 Open Label|Adverse Event|3
5133764|NCT01617681|17732149|P4|Period 2 Open Label|Adverse Event|0
5133765|NCT01617681|17732150|P3|Period 2 Open Label|Adverse Event|0
5133766|NCT01617681|17732151|P2|Period 2 Open Label|Adverse Event|0
5133767|NCT01617681|17732152|P1|Period 2 Open Label|Adverse Event|0
5133768|NCT01617681|17732148|P5|Period 1 Double Blind|Withdrawal by Subject|0
5133769|NCT01617681|17732149|P4|Period 1 Double Blind|Withdrawal by Subject|0
5133770|NCT01617681|17732150|P3|Period 1 Double Blind|Withdrawal by Subject|1
5133771|NCT01617681|17732151|P2|Period 1 Double Blind|Withdrawal by Subject|1
5133772|NCT01617681|17732152|P1|Period 1 Double Blind|Withdrawal by Subject|1
5133773|NCT01617681|17732148|P5|Period 1 Double Blind|Adverse Event|0
5133774|NCT01617681|17732149|P4|Period 1 Double Blind|Adverse Event|2
5133775|NCT01617681|17732150|P3|Period 1 Double Blind|Adverse Event|0
5133776|NCT01617681|17732151|P2|Period 1 Double Blind|Adverse Event|0
5133777|NCT01617681|17732152|P1|Period 1 Double Blind|Adverse Event|2
5133778|NCT01617668|17732173|P4|Overall Study|Subject/guardian decision|1
5133779|NCT01617668|17732174|P3|Overall Study|Subject/guardian decision|2
5133780|NCT01617668|17732175|P2|Overall Study|Subject/guardian decision|3
5133781|NCT01617668|17732176|P1|Overall Study|Subject/guardian decision|1
5133782|NCT01617668|17732173|P4|Overall Study|Progressive Disease|9
5133783|NCT01617668|17732174|P3|Overall Study|Progressive Disease|6
5133784|NCT01617668|17732175|P2|Overall Study|Progressive Disease|4
5133785|NCT01617668|17732176|P1|Overall Study|Progressive Disease|4
5133786|NCT01617668|17732173|P4|Overall Study|Physician Decision|0
5133787|NCT01617668|17732174|P3|Overall Study|Physician Decision|3
5133788|NCT01617668|17732175|P2|Overall Study|Physician Decision|2
5133789|NCT01617668|17732176|P1|Overall Study|Physician Decision|1
5133790|NCT01617668|17732173|P4|Overall Study|Adverse Event|5
5133791|NCT01617668|17732174|P3|Overall Study|Adverse Event|12
5133792|NCT01617668|17732175|P2|Overall Study|Adverse Event|0
5133793|NCT01617668|17732176|P1|Overall Study|Adverse Event|7
5133794|NCT01617655|17732217|P2|Overall Study|Other than specified above|2
5133795|NCT01617655|17732218|P1|Overall Study|Other than specified above|1
5133796|NCT01617655|17732217|P2|Overall Study|Site closure|5
5133797|NCT01617655|17732218|P1|Overall Study|Site closure|3
5133798|NCT01617655|17732217|P2|Overall Study|Last visit outside protocol visit window|10
5133799|NCT01617655|17732218|P1|Overall Study|Last visit outside protocol visit window|1
5133800|NCT01617655|17732217|P2|Overall Study|Consent withdrawn by participant|1
5133801|NCT01617655|17732218|P1|Overall Study|Consent withdrawn by participant|1
5133802|NCT01617655|17732217|P2|Overall Study|Participants moved|4
5133803|NCT01617655|17732218|P1|Overall Study|Participants moved|0
5133804|NCT01617655|17732217|P2|Overall Study|Poor compliance to protocol|4
5133805|NCT01617655|17732218|P1|Overall Study|Poor compliance to protocol|1
5133806|NCT01617655|17732217|P2|Overall Study|Adverse Event|3
5133807|NCT01617655|17732218|P1|Overall Study|Adverse Event|2
5133808|NCT01617629|17732278|P1|Overall Study|Participant Withdrew Consent|2
5133809|NCT01617629|17732278|P1|Overall Study|Reason Not Specified|1
5133810|NCT01617629|17732278|P1|Overall Study|Investigator's Clinical Judgement|1
5133811|NCT01617629|17732278|P1|Overall Study|Death|2
5133812|NCT01617460|17732306|P1|Overall Study|Withdrawal by Subject|9
5133813|NCT01617460|17732306|P1|Overall Study|Protocol Violation|5
5133814|NCT01617460|17732306|P1|Overall Study|Physician Decision|16
5133815|NCT01617460|17732306|P1|Overall Study|Adverse Event|10
5133816|NCT01617447|17732312|P2|Overall Study|Physician Decision|2
5133817|NCT01617447|17732313|P1|Overall Study|Physician Decision|0
5133818|NCT01617447|17732312|P2|Overall Study|Adverse Event|1
5133819|NCT01617447|17732313|P1|Overall Study|Adverse Event|0
5133820|NCT01617434|17732321|P2|Overall Study|Unclassified|4
5133821|NCT01617434|17732322|P1|Overall Study|Unclassified|3
5133822|NCT01617434|17732321|P2|Overall Study|Withdrawal Criteria|37
5133823|NCT01617434|17732322|P1|Overall Study|Withdrawal Criteria|12
5133824|NCT01617434|17732321|P2|Overall Study|Protocol Violation|7
5133825|NCT01617434|17732322|P1|Overall Study|Protocol Violation|8
5133826|NCT01617434|17732321|P2|Overall Study|Adverse Event|3
5133827|NCT01617434|17732322|P1|Overall Study|Adverse Event|12
5133828|NCT01617187|17732361|P4|Treatment Through Study Completion|Protocol Violation|1
5133829|NCT01617187|17732362|P3|Treatment Through Study Completion|Protocol Violation|0
5133830|NCT01617187|17732363|P2|Treatment Through Study Completion|Protocol Violation|0
5133831|NCT01617187|17732364|P1|Treatment Through Study Completion|Protocol Violation|1
5133832|NCT01617187|17732361|P4|Treatment Through Study Completion|Withdrawal by Subject|6
5133833|NCT01617187|17732362|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5133834|NCT01617187|17732363|P2|Treatment Through Study Completion|Withdrawal by Subject|8
5133835|NCT01617187|17732364|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5133836|NCT01617187|17732361|P4|Treatment Through Study Completion|Lost to Follow-up|2
5133837|NCT01617187|17732362|P3|Treatment Through Study Completion|Lost to Follow-up|2
5133838|NCT01617187|17732363|P2|Treatment Through Study Completion|Lost to Follow-up|2
5133839|NCT01617187|17732364|P1|Treatment Through Study Completion|Lost to Follow-up|4
5133840|NCT01617187|17732361|P4|Treatment Through Study Completion|Adverse Event|1
5133841|NCT01617187|17732362|P3|Treatment Through Study Completion|Adverse Event|0
5133842|NCT01617187|17732363|P2|Treatment Through Study Completion|Adverse Event|1
5133843|NCT01617187|17732364|P1|Treatment Through Study Completion|Adverse Event|1
5133844|NCT01617187|17732361|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5133845|NCT01617187|17732362|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5133846|NCT01617187|17732363|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5133847|NCT01617187|17732364|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
5133848|NCT01617187|17732361|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
5133849|NCT01617187|17732362|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5133850|NCT01617187|17732363|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5133851|NCT01617187|17732364|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5133852|NCT01617187|17732361|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
5133853|NCT01617187|17732362|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5133854|NCT01617187|17732363|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5133855|NCT01617187|17732364|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5133856|NCT01617070|17732461|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
5133857|NCT01617005|17732479|P1|Overall Study|Lack of motivation for treatment|1
5133858|NCT01617005|17732479|P1|Overall Study|Pregnancy|1
5133859|NCT01616953|17732488|P2|Overall Study|lack of bone and soft tissue|0
5133860|NCT01616953|17732489|P1|Overall Study|lack of bone and soft tissue|1
5133861|NCT01616953|17732488|P2|Overall Study|Lost to Follow-up|0
5133862|NCT01616953|17732489|P1|Overall Study|Lost to Follow-up|1
5133863|NCT01616771|17732497|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
5133864|NCT01616693|17732510|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
5133865|NCT01616693|17732511|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
5133866|NCT01616693|17732512|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
5133867|NCT01616693|17732513|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
5133868|NCT01616693|17732510|P4|Received Both Vaccines|Lost to Follow-up|4
5133869|NCT01616693|17732511|P3|Received Both Vaccines|Lost to Follow-up|4
5133870|NCT01616693|17732512|P2|Received Both Vaccines|Lost to Follow-up|3
5133871|NCT01616693|17732513|P1|Received Both Vaccines|Lost to Follow-up|4
5133872|NCT01616693|17732510|P4|Received Both Vaccines|Withdrawal by Subject|15
5133873|NCT01616693|17732511|P3|Received Both Vaccines|Withdrawal by Subject|8
5133874|NCT01616693|17732512|P2|Received Both Vaccines|Withdrawal by Subject|7
5133875|NCT01616693|17732513|P1|Received Both Vaccines|Withdrawal by Subject|7
5133876|NCT01616693|17732510|P4|Received Both Vaccines|Adverse Event|0
5133877|NCT01616693|17732511|P3|Received Both Vaccines|Adverse Event|0
5133878|NCT01616693|17732512|P2|Received Both Vaccines|Adverse Event|0
5133879|NCT01616693|17732513|P1|Received Both Vaccines|Adverse Event|2
5133880|NCT01616693|17732510|P4|Evaluated for Safety|Physician Decision|0
5133881|NCT01616693|17732511|P3|Evaluated for Safety|Physician Decision|1
5133882|NCT01616693|17732512|P2|Evaluated for Safety|Physician Decision|0
5133883|NCT01616693|17732513|P1|Evaluated for Safety|Physician Decision|1
5133884|NCT01616459|17732579|P4|Overall Study|Other reason|0
5133885|NCT01616459|17732580|P3|Overall Study|Other reason|1
5133886|NCT01616459|17732581|P2|Overall Study|Other reason|1
5133887|NCT01616459|17732582|P1|Overall Study|Other reason|0
5133888|NCT01616459|17732579|P4|Overall Study|Withdrawal by Subject|4
5133889|NCT01616459|17732580|P3|Overall Study|Withdrawal by Subject|4
5133890|NCT01616459|17732581|P2|Overall Study|Withdrawal by Subject|4
5133891|NCT01616459|17732582|P1|Overall Study|Withdrawal by Subject|2
5133892|NCT01616459|17732579|P4|Overall Study|Protocol Violation|2
5133893|NCT01616459|17732580|P3|Overall Study|Protocol Violation|0
5133894|NCT01616459|17732581|P2|Overall Study|Protocol Violation|0
5133895|NCT01616459|17732582|P1|Overall Study|Protocol Violation|0
5133896|NCT01616459|17732579|P4|Overall Study|Lost to Follow-up|2
5133897|NCT01616459|17732580|P3|Overall Study|Lost to Follow-up|3
5133898|NCT01616459|17732581|P2|Overall Study|Lost to Follow-up|11
5133899|NCT01616459|17732582|P1|Overall Study|Lost to Follow-up|1
5133900|NCT01616459|17732579|P4|Overall Study|Adverse Event|0
5133901|NCT01616459|17732580|P3|Overall Study|Adverse Event|2
5133902|NCT01616459|17732581|P2|Overall Study|Adverse Event|1
5133903|NCT01616459|17732582|P1|Overall Study|Adverse Event|1
5133904|NCT01616173|17732683|P3|Overall Study|Lost to Follow-up|0
5133905|NCT01616173|17732684|P2|Overall Study|Lost to Follow-up|2
5133906|NCT01616173|17732685|P1|Overall Study|Lost to Follow-up|0
5133907|NCT01615939|17732731|P2|Overall Study|Lost to Follow-up|0
5133908|NCT01615939|17732732|P1|Overall Study|Lost to Follow-up|5
5133909|NCT01615822|17732745|P3|Period 2|Lost to Follow-up|2
5133910|NCT01615822|17732746|P2|Period 2|Lost to Follow-up|1
5133911|NCT01615822|17732747|P1|Period 2|Lost to Follow-up|0
5133912|NCT01615822|17732745|P3|Period 1|Adverse Event|0
5133913|NCT01615822|17732746|P2|Period 1|Adverse Event|1
5133914|NCT01615822|17732747|P1|Period 1|Adverse Event|1
5133915|NCT01615822|17732745|P3|Period 1|Withdrawal by Subject|0
5133916|NCT01615822|17732746|P2|Period 1|Withdrawal by Subject|1
5133917|NCT01615822|17732747|P1|Period 1|Withdrawal by Subject|0
5133918|NCT01615328|17732835|P2|Overall Study|Lost to Follow-up|5
5133919|NCT01615328|17732836|P1|Overall Study|Lost to Follow-up|3
5133920|NCT01615263|17732848|P2|Overall Study|Post-randomization exclusion|2
5133921|NCT01615263|17732849|P1|Overall Study|Post-randomization exclusion|0
5133922|NCT01615198|17732863|P2|Overall Study|Adverse Event|5
5133923|NCT01615198|17732864|P1|Overall Study|Adverse Event|11
5133924|NCT01615198|17732863|P2|Overall Study|Lack of Efficacy|6
5133925|NCT01615198|17732864|P1|Overall Study|Lack of Efficacy|1
5133926|NCT01615198|17732863|P2|Overall Study|Lost to Follow-up|1
5133927|NCT01615198|17732864|P1|Overall Study|Lost to Follow-up|1
5133928|NCT01615198|17732863|P2|Overall Study|Physician Decision|1
5133929|NCT01615198|17732864|P1|Overall Study|Physician Decision|5
5133930|NCT01615198|17732863|P2|Overall Study|Protocol deviation|1
5133931|NCT01615198|17732864|P1|Overall Study|Protocol deviation|1
5133932|NCT01615198|17732863|P2|Overall Study|Withdrawal by Subject|5
5133933|NCT01615198|17732864|P1|Overall Study|Withdrawal by Subject|5
5133934|NCT01615029|17732897|P5|Overall Study|Ongoing|23
5133935|NCT01615029|17732898|P4|Overall Study|Ongoing|2
5133936|NCT01615029|17732899|P3|Overall Study|Ongoing|3
5133937|NCT01615029|17732900|P2|Overall Study|Ongoing|2
5133938|NCT01615029|17732901|P1|Overall Study|Ongoing|1
5133939|NCT01615029|17732897|P5|Overall Study|Physician Decision|1
5133940|NCT01615029|17732898|P4|Overall Study|Physician Decision|0
5133941|NCT01615029|17732899|P3|Overall Study|Physician Decision|0
5133942|NCT01615029|17732900|P2|Overall Study|Physician Decision|0
5133943|NCT01615029|17732901|P1|Overall Study|Physician Decision|0
5133944|NCT01615029|17732897|P5|Overall Study|Progressive disease|5
5133945|NCT01615029|17732898|P4|Overall Study|Progressive disease|1
5133946|NCT01615029|17732899|P3|Overall Study|Progressive disease|1
5133947|NCT01615029|17732900|P2|Overall Study|Progressive disease|1
5133948|NCT01615029|17732901|P1|Overall Study|Progressive disease|2
5133949|NCT01615029|17732897|P5|Overall Study|Lost to Follow-up|1
5133950|NCT01615029|17732898|P4|Overall Study|Lost to Follow-up|0
5133951|NCT01615029|17732899|P3|Overall Study|Lost to Follow-up|0
5133952|NCT01615029|17732900|P2|Overall Study|Lost to Follow-up|0
5133953|NCT01615029|17732901|P1|Overall Study|Lost to Follow-up|0
5133954|NCT01615029|17732897|P5|Overall Study|Death|1
5133955|NCT01615029|17732898|P4|Overall Study|Death|0
5133956|NCT01615029|17732899|P3|Overall Study|Death|0
5133957|NCT01615029|17732900|P2|Overall Study|Death|0
5133958|NCT01615029|17732901|P1|Overall Study|Death|0
5133959|NCT01615029|17732897|P5|Overall Study|Adverse Event|1
5133960|NCT01615029|17732898|P4|Overall Study|Adverse Event|0
5133961|NCT01615029|17732899|P3|Overall Study|Adverse Event|0
5133962|NCT01615029|17732900|P2|Overall Study|Adverse Event|0
5133963|NCT01615029|17732901|P1|Overall Study|Adverse Event|0
5133964|NCT01614886|17732969|P2|Overall Study|Protocol deviation|2
5133965|NCT01614886|17732970|P1|Overall Study|Protocol deviation|0
5133966|NCT01614886|17732969|P2|Overall Study|Death|0
5133967|NCT01614886|17732970|P1|Overall Study|Death|1
5133968|NCT01614886|17732969|P2|Overall Study|Withdrawal by Subject|4
5133969|NCT01614886|17732970|P1|Overall Study|Withdrawal by Subject|4
5133970|NCT01614886|17732969|P2|Overall Study|Adverse Event|20
5133971|NCT01614886|17732970|P1|Overall Study|Adverse Event|15
5133972|NCT01614795|17733011|P4|Overall Study|Ineligible|0
5133973|NCT01614795|17733012|P3|Overall Study|Ineligible|0
5133974|NCT01614795|17733013|P2|Overall Study|Ineligible|1
5133975|NCT01614795|17733014|P1|Overall Study|Ineligible|0
5133976|NCT01614795|17733011|P4|Overall Study|Withdrawal by Subject|2
5133977|NCT01614795|17733012|P3|Overall Study|Withdrawal by Subject|0
5133978|NCT01614795|17733013|P2|Overall Study|Withdrawal by Subject|1
5133979|NCT01614795|17733014|P1|Overall Study|Withdrawal by Subject|0
5133980|NCT01614795|17733011|P4|Overall Study|Physician Decision|1
5133981|NCT01614795|17733012|P3|Overall Study|Physician Decision|1
5133982|NCT01614795|17733013|P2|Overall Study|Physician Decision|0
5133983|NCT01614795|17733014|P1|Overall Study|Physician Decision|1
5133984|NCT01614795|17733011|P4|Overall Study|Lack of Efficacy|8
5133985|NCT01614795|17733012|P3|Overall Study|Lack of Efficacy|9
5133986|NCT01614795|17733013|P2|Overall Study|Lack of Efficacy|10
5133987|NCT01614795|17733014|P1|Overall Study|Lack of Efficacy|10
5133988|NCT01614795|17733011|P4|Overall Study|Adverse Event|1
5133989|NCT01614795|17733012|P3|Overall Study|Adverse Event|1
5133990|NCT01614795|17733013|P2|Overall Study|Adverse Event|0
5133991|NCT01614795|17733014|P1|Overall Study|Adverse Event|0
5133992|NCT01614769|17733034|P6|Period 3|Withdrawal by Subject|0
5133993|NCT01614769|17733035|P5|Period 3|Withdrawal by Subject|0
5133994|NCT01614769|17733036|P4|Period 3|Withdrawal by Subject|0
5133995|NCT01614769|17733037|P3|Period 3|Withdrawal by Subject|1
5133996|NCT01614769|17733038|P2|Period 3|Withdrawal by Subject|0
5133997|NCT01614769|17733039|P1|Period 3|Withdrawal by Subject|0
5133998|NCT01614769|17733034|P6|Period 1|Withdrawal by Subject|0
5133999|NCT01614769|17733035|P5|Period 1|Withdrawal by Subject|0
5134000|NCT01614769|17733036|P4|Period 1|Withdrawal by Subject|0
5134001|NCT01614769|17733037|P3|Period 1|Withdrawal by Subject|0
5134002|NCT01614769|17733038|P2|Period 1|Withdrawal by Subject|0
5134003|NCT01614769|17733039|P1|Period 1|Withdrawal by Subject|1
5134004|NCT01614769|17733034|P6|Period 1|Protocol Violation|0
5134005|NCT01614769|17733035|P5|Period 1|Protocol Violation|0
5134006|NCT01614769|17733036|P4|Period 1|Protocol Violation|1
5134007|NCT01614769|17733037|P3|Period 1|Protocol Violation|0
5134008|NCT01614769|17733038|P2|Period 1|Protocol Violation|0
5134009|NCT01614769|17733039|P1|Period 1|Protocol Violation|0
5134010|NCT01614769|17733034|P6|Period 1|Discontinued due to Hypoglycemia|1
5134011|NCT01614769|17733035|P5|Period 1|Discontinued due to Hypoglycemia|0
5134012|NCT01614769|17733036|P4|Period 1|Discontinued due to Hypoglycemia|1
5134013|NCT01614769|17733037|P3|Period 1|Discontinued due to Hypoglycemia|0
5134014|NCT01614769|17733038|P2|Period 1|Discontinued due to Hypoglycemia|0
5134015|NCT01614769|17733039|P1|Period 1|Discontinued due to Hypoglycemia|0
5134016|NCT01614600|17733076|P1|Overall Study|Protocol deviation|1
5134017|NCT01614600|17733076|P1|Overall Study|Unable to remove lens at the end of day|1
5134018|NCT01614600|17733076|P1|Overall Study|Discomfort|1
5134019|NCT01614600|17733076|P1|Overall Study|Unacceptable fit|1
5134020|NCT01614470|17733107|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
5134021|NCT01614470|17733108|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
5134022|NCT01614470|17733109|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
5134023|NCT01614470|17733107|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5134024|NCT01614470|17733108|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5134025|NCT01614470|17733109|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
5134026|NCT01614457|17733131|P2|Overall Study|Pregnancy (Self or Partner)|0
5134027|NCT01614457|17733132|P1|Overall Study|Pregnancy (Self or Partner)|1
5134028|NCT01614457|17733131|P2|Overall Study|Non-Compliance|0
5134029|NCT01614457|17733132|P1|Overall Study|Non-Compliance|1
5134030|NCT01614249|17733159|P2|Overall Study|Lost to Follow-up|23
5134031|NCT01614249|17733160|P1|Overall Study|Lost to Follow-up|11
5134032|NCT01614093|17733174|P1|Overall Study|Withdrawal by Subject|1
5134033|NCT01613716|17733187|P1|Overall Study|Lost to Follow-up|4
5134034|NCT01613716|17733187|P1|Overall Study|screen failures|3
5134035|NCT01613599|17733192|P1|Overall Study|Reason not specified|3
5134036|NCT01613599|17733192|P1|Overall Study|Withdrawal by Subject|8
5134037|NCT01613599|17733192|P1|Overall Study|Lost to Follow-up|5
5134038|NCT01613599|17733192|P1|Overall Study|Death|9
5134039|NCT01613417|17733207|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
5134040|NCT01613417|17733208|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
5134041|NCT01613378|17733245|P1|Overall Study|Other Reason|4
5134042|NCT01613378|17733245|P1|Overall Study|Lost to Follow-up|1
5134043|NCT01613378|17733245|P1|Overall Study|Death|2
5134044|NCT01613378|17733245|P1|Overall Study|Withdrawal by Subject|8
5134045|NCT01613378|17733245|P1|Overall Study|Adverse Event|11
5134046|NCT01613378|17733245|P1|Overall Study|Lack of Efficacy|13
5134047|NCT01613326|17733275|P2|Overall Study|Protocol Violation|1
5134048|NCT01613326|17733276|P1|Overall Study|Protocol Violation|0
5134049|NCT01613326|17733275|P2|Overall Study|Administrative|2
5134050|NCT01613326|17733276|P1|Overall Study|Administrative|0
5134051|NCT01613326|17733275|P2|Overall Study|Lost to Follow-up|1
5134052|NCT01613326|17733276|P1|Overall Study|Lost to Follow-up|0
5134053|NCT01613326|17733275|P2|Overall Study|Lack of Efficacy|1
5134054|NCT01613326|17733276|P1|Overall Study|Lack of Efficacy|0
5134055|NCT01613326|17733275|P2|Overall Study|inability to use device|0
5134056|NCT01613326|17733276|P1|Overall Study|inability to use device|1
5134057|NCT01613326|17733275|P2|Overall Study|Abnormal test procedure result(s)|0
5134058|NCT01613326|17733276|P1|Overall Study|Abnormal test procedure result(s)|2
5134059|NCT01613326|17733275|P2|Overall Study|Withdrawal by Subject|4
5134060|NCT01613326|17733276|P1|Overall Study|Withdrawal by Subject|3
5134061|NCT01613326|17733275|P2|Overall Study|Adverse Event|5
5134062|NCT01613326|17733276|P1|Overall Study|Adverse Event|7
5134063|NCT01613248|17733333|P6|Overall Study|Pregnancy|0
5134064|NCT01613248|17733334|P5|Overall Study|Pregnancy|0
5134065|NCT01613248|17733335|P4|Overall Study|Pregnancy|1
5134066|NCT01613248|17733336|P3|Overall Study|Pregnancy|0
5134067|NCT01613248|17733337|P2|Overall Study|Pregnancy|0
5134068|NCT01613248|17733338|P1|Overall Study|Pregnancy|0
5134069|NCT01613248|17733333|P6|Overall Study|Lack of Qualifying Event|18
5134070|NCT01613248|17733334|P5|Overall Study|Lack of Qualifying Event|15
5134071|NCT01613248|17733335|P4|Overall Study|Lack of Qualifying Event|11
5134072|NCT01613248|17733336|P3|Overall Study|Lack of Qualifying Event|10
5134073|NCT01613248|17733337|P2|Overall Study|Lack of Qualifying Event|11
5134074|NCT01613248|17733338|P1|Overall Study|Lack of Qualifying Event|9
5134075|NCT01613248|17733333|P6|Overall Study|Physician Decision|6
5134076|NCT01613248|17733334|P5|Overall Study|Physician Decision|7
5134077|NCT01613248|17733335|P4|Overall Study|Physician Decision|4
5134078|NCT01613248|17733336|P3|Overall Study|Physician Decision|9
5134079|NCT01613248|17733337|P2|Overall Study|Physician Decision|8
5134080|NCT01613248|17733338|P1|Overall Study|Physician Decision|8
5134081|NCT01613248|17733333|P6|Overall Study|Study Terminated by Sponsor|11
5134082|NCT01613248|17733334|P5|Overall Study|Study Terminated by Sponsor|9
5134083|NCT01613248|17733335|P4|Overall Study|Study Terminated by Sponsor|8
5134084|NCT01613248|17733336|P3|Overall Study|Study Terminated by Sponsor|8
5134085|NCT01613248|17733337|P2|Overall Study|Study Terminated by Sponsor|6
5134086|NCT01613248|17733338|P1|Overall Study|Study Terminated by Sponsor|4
5134087|NCT01613248|17733333|P6|Overall Study|Lost to Follow-up|2
5134088|NCT01613248|17733334|P5|Overall Study|Lost to Follow-up|4
5134089|NCT01613248|17733335|P4|Overall Study|Lost to Follow-up|8
5134090|NCT01613248|17733336|P3|Overall Study|Lost to Follow-up|4
5134091|NCT01613248|17733337|P2|Overall Study|Lost to Follow-up|7
5134092|NCT01613248|17733338|P1|Overall Study|Lost to Follow-up|5
5134093|NCT01613248|17733333|P6|Overall Study|Withdrawal by Subject|1
5134094|NCT01613248|17733334|P5|Overall Study|Withdrawal by Subject|0
5134095|NCT01613248|17733335|P4|Overall Study|Withdrawal by Subject|5
5134096|NCT01613248|17733336|P3|Overall Study|Withdrawal by Subject|2
5134097|NCT01613248|17733337|P2|Overall Study|Withdrawal by Subject|2
5134098|NCT01613248|17733338|P1|Overall Study|Withdrawal by Subject|3
5134099|NCT01613248|17733333|P6|Overall Study|Adverse Event|0
5134100|NCT01613248|17733334|P5|Overall Study|Adverse Event|0
5134101|NCT01613248|17733335|P4|Overall Study|Adverse Event|1
5134102|NCT01613248|17733336|P3|Overall Study|Adverse Event|0
5134103|NCT01613248|17733337|P2|Overall Study|Adverse Event|0
5134104|NCT01613248|17733338|P1|Overall Study|Adverse Event|0
5134105|NCT01613222|17733436|P1|Overall Study|Reused disposable sensors|10
5134106|NCT01613222|17733436|P1|Overall Study|Unable to place arterial line|1
5134107|NCT01613222|17733436|P1|Overall Study|Physician Decision|1
5134108|NCT01613131|17733451|P2|Overall Study|Withdrawal by Subject|5
5134109|NCT01613131|17733452|P1|Overall Study|Withdrawal by Subject|3
5134110|NCT01613027|17733480|P1|Overall Study|Patient's Decision Due to Adverse Event|1
5134111|NCT01613027|17733480|P1|Overall Study|Lack of Efficacy|1
5134112|NCT01613027|17733480|P1|Overall Study|Switched Physician|1
5134113|NCT01613027|17733480|P1|Overall Study|Lost to Follow-up|5
5134114|NCT01612858|17733523|P2|Overall Study|Withdrawal by Subject|1
5134115|NCT01612858|17733524|P1|Overall Study|Withdrawal by Subject|5
5134116|NCT01612780|17733541|P1|Overall Study|Withdrawal by Subject|5
5134117|NCT01612780|17733541|P1|Overall Study|Treatment not completed|1
5134118|NCT01612702|17733603|P2|Overall Study|Protocol Violation|11
5134119|NCT01612702|17733604|P1|Overall Study|Protocol Violation|11
5134120|NCT01612676|17733618|P4|Overall Study|Protocol Violation|0
5134121|NCT01612676|17733619|P3|Overall Study|Protocol Violation|0
5134122|NCT01612676|17733620|P2|Overall Study|Protocol Violation|1
5134123|NCT01612676|17733621|P1|Overall Study|Protocol Violation|0
5134124|NCT01612676|17733618|P4|Overall Study|Adverse Event|3
5134125|NCT01612676|17733619|P3|Overall Study|Adverse Event|1
5134126|NCT01612676|17733620|P2|Overall Study|Adverse Event|3
5134127|NCT01612676|17733621|P1|Overall Study|Adverse Event|2
5134128|NCT01612156|17733719|P2|Overall Study|Protocol Violation|0
5134129|NCT01612156|17733720|P1|Overall Study|Protocol Violation|2
5134130|NCT01612000|17733732|P4|Overall Study|Withdrawal by Subject|2
5134131|NCT01612000|17733733|P3|Overall Study|Withdrawal by Subject|2
5134132|NCT01612000|17733734|P2|Overall Study|Withdrawal by Subject|1
5134133|NCT01612000|17733735|P1|Overall Study|Withdrawal by Subject|3
5134134|NCT01612000|17733732|P4|Overall Study|Physician Decision|0
5134135|NCT01612000|17733733|P3|Overall Study|Physician Decision|1
5134136|NCT01612000|17733734|P2|Overall Study|Physician Decision|0
5134137|NCT01612000|17733735|P1|Overall Study|Physician Decision|0
5134138|NCT01612000|17733732|P4|Overall Study|Lost to Follow-up|8
5134139|NCT01612000|17733733|P3|Overall Study|Lost to Follow-up|4
5134140|NCT01612000|17733734|P2|Overall Study|Lost to Follow-up|4
5134141|NCT01612000|17733735|P1|Overall Study|Lost to Follow-up|6
5134142|NCT01611974|17733760|P3|Overall Study|Withdrawal by Subject|4
5134143|NCT01611974|17733761|P2|Overall Study|Withdrawal by Subject|1
5134144|NCT01611974|17733762|P1|Overall Study|Withdrawal by Subject|0
5134145|NCT01611974|17733760|P3|Overall Study|Physician Decision|2
5134146|NCT01611974|17733761|P2|Overall Study|Physician Decision|1
5134147|NCT01611974|17733762|P1|Overall Study|Physician Decision|5
5134148|NCT01611974|17733760|P3|Overall Study|Lost to Follow-up|0
5134149|NCT01611974|17733761|P2|Overall Study|Lost to Follow-up|1
5134150|NCT01611974|17733762|P1|Overall Study|Lost to Follow-up|0
5134151|NCT01611974|17733760|P3|Overall Study|Death|10
5134152|NCT01611974|17733761|P2|Overall Study|Death|12
5134153|NCT01611974|17733762|P1|Overall Study|Death|10
5134154|NCT01611935|17733808|P2|Overall Study|Family Declined Participation|0
5134155|NCT01611935|17733809|P1|Overall Study|Family Declined Participation|1
5134156|NCT01611883|17733821|P2|Overall Study|Adverse Event|1
5134157|NCT01611883|17733822|P1|Overall Study|Adverse Event|1
5134158|NCT01611857|17733848|P2|Overall Study|Withdrawal by Subject|2
5134159|NCT01611857|17733849|P1|Overall Study|Withdrawal by Subject|0
5134160|NCT01611792|17733861|P2|Followup: at 6 Months|Lost to Follow-up|13
5134161|NCT01611792|17733862|P1|Followup: at 6 Months|Lost to Follow-up|6
5134162|NCT01611792|17733861|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
5134163|NCT01611792|17733862|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
5134164|NCT01611558|17733916|P1|Maintenance Phase|Elevated Uric acid|1
5134165|NCT01611558|17733916|P1|Maintenance Phase|Withdrawal by Subject|1
5134166|NCT01611558|17733916|P1|Induction Phase|Death|1
5134167|NCT01611558|17733916|P1|Induction Phase|Adverse event unrelated to study drug|3
5134168|NCT01611558|17733916|P1|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
5134169|NCT01611558|17733916|P1|Induction Phase|Disease progression|18
5134170|NCT01611558|17733916|P1|Induction Phase|Study drug toxicity|15
5134171|NCT01611298|17733922|P1|Overall Study|Relapsed|2
5134172|NCT01611259|17733927|P1|Overall Study|Withdrawal by Subject|7
5134173|NCT01611259|17733927|P1|Overall Study|Adverse Event|4
5134174|NCT01611259|17733927|P1|Overall Study|Lack of Efficacy|2
5134175|NCT01611259|17733927|P1|Overall Study|Physician Decision|1
5134176|NCT01611194|17733933|P2|Overall Study|drug use|1
5134177|NCT01611194|17733934|P1|Overall Study|drug use|0
5134178|NCT01611194|17733933|P2|Overall Study|Withdrawal by Subject|1
5134179|NCT01611194|17733934|P1|Overall Study|Withdrawal by Subject|0
5134180|NCT01611194|17733933|P2|Overall Study|Lost to Follow-up|1
5134181|NCT01611194|17733934|P1|Overall Study|Lost to Follow-up|0
5134182|NCT01611155|17733972|P2|Overall Study|Ineligible patient|1
5134183|NCT01611155|17733973|P1|Overall Study|Ineligible patient|0
5134184|NCT01611155|17733972|P2|Overall Study|Alternative treatment|1
5134185|NCT01611155|17733973|P1|Overall Study|Alternative treatment|0
5134186|NCT01611155|17733972|P2|Overall Study|Withdrawal by Subject|0
5134187|NCT01611155|17733973|P1|Overall Study|Withdrawal by Subject|1
5134188|NCT01611155|17733972|P2|Overall Study|Disease progression|0
5134189|NCT01611155|17733973|P1|Overall Study|Disease progression|1
5134190|NCT01611155|17733972|P2|Overall Study|Refused further treatment|4
5134191|NCT01611155|17733973|P1|Overall Study|Refused further treatment|6
5134192|NCT01611155|17733972|P2|Overall Study|Adverse Event|1
5134193|NCT01611155|17733973|P1|Overall Study|Adverse Event|1
5134194|NCT01611090|17733983|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
5134195|NCT01611090|17733984|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
5134196|NCT01611090|17733985|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
5134197|NCT01611090|17733983|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
5134198|NCT01611090|17733984|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
5134199|NCT01611090|17733985|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
5134200|NCT01611090|17733983|P3|Randomized Period|Withdrawal by Subject|0
5134201|NCT01611090|17733984|P2|Randomized Period|Withdrawal by Subject|26
5134202|NCT01611090|17733985|P1|Randomized Period|Withdrawal by Subject|22
5134203|NCT01611090|17733983|P3|Randomized Period|Lost to Follow-up|0
5134204|NCT01611090|17733984|P2|Randomized Period|Lost to Follow-up|3
5134205|NCT01611090|17733985|P1|Randomized Period|Lost to Follow-up|8
5134206|NCT01610791|17734018|P1|Overall Study|Not determined|5
5134207|NCT01610791|17734018|P1|Overall Study|Death|1
5134208|NCT01610791|17734018|P1|Overall Study|Adverse event and Investigator decision|1
5134209|NCT01610791|17734018|P1|Overall Study|Physician Decision|1
5134210|NCT01610791|17734018|P1|Overall Study|Adverse Event|6
5134211|NCT01610791|17734018|P1|Overall Study|Lost to Follow-up|7
5134212|NCT01610752|17734042|P3|Overall Study|Miscarriage/Pregnancy loss|4
5134213|NCT01610752|17734043|P2|Overall Study|Miscarriage/Pregnancy loss|0
5134214|NCT01610752|17734044|P1|Overall Study|Miscarriage/Pregnancy loss|0
5134215|NCT01610713|17734066|P2|Overall Study|Lost to Follow-up|1
5134216|NCT01610713|17734067|P1|Overall Study|Lost to Follow-up|0
5134217|NCT01610713|17734066|P2|Overall Study|adv. to use original dose/amitriptyline|0
5134218|NCT01610713|17734067|P1|Overall Study|adv. to use original dose/amitriptyline|1
5134219|NCT01610713|17734066|P2|Overall Study|low mood and poor motivation|0
5134220|NCT01610713|17734067|P1|Overall Study|low mood and poor motivation|1
5134221|NCT01610713|17734066|P2|Overall Study|Lack of Efficacy|0
5134222|NCT01610713|17734067|P1|Overall Study|Lack of Efficacy|1
5134223|NCT01610713|17734066|P2|Overall Study|Adverse Event|0
5134224|NCT01610713|17734067|P1|Overall Study|Adverse Event|3
5134225|NCT01610700|17734125|P2|Overall Study|subject took one dose of street cannabis|1
5134226|NCT01610700|17734126|P1|Overall Study|subject took one dose of street cannabis|0
5134227|NCT01610700|17734125|P2|Overall Study|Withdrawal by Subject|1
5134228|NCT01610700|17734126|P1|Overall Study|Withdrawal by Subject|0
5134229|NCT01610700|17734125|P2|Overall Study|Adverse Event|1
5134230|NCT01610700|17734126|P1|Overall Study|Adverse Event|3
5134231|NCT01610687|17734180|P1|Overall Study|Felt more alter without study medication|1
5134232|NCT01610687|17734180|P1|Overall Study|Cannabis affecting job|1
5134233|NCT01610687|17734180|P1|Overall Study|Death|1
5134234|NCT01610687|17734180|P1|Overall Study|Unable to make journey|1
5134235|NCT01610687|17734180|P1|Overall Study|Symptom control without study medication|2
5134236|NCT01610687|17734180|P1|Overall Study|Lost to Follow-up|4
5134237|NCT01610687|17734180|P1|Overall Study|Withdrawal by Subject|7
5134238|NCT01610687|17734180|P1|Overall Study|Moved out of area|6
5134239|NCT01610687|17734180|P1|Overall Study|Adverse Event|18
5134240|NCT01610687|17734180|P1|Overall Study|Lack of Efficacy|26
5134241|NCT01610596|17734193|P2|Overall Study|Lost to Follow-up|1
5134242|NCT01610596|17734194|P1|Overall Study|Lost to Follow-up|0
5134243|NCT01610557|17734252|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
5134244|NCT01610557|17734253|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
5134245|NCT01610557|17734254|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
5134246|NCT01610557|17734255|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
5134247|NCT01610557|17734256|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
5134248|NCT01610557|17734252|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5134249|NCT01610557|17734253|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5134250|NCT01610557|17734254|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5134251|NCT01610557|17734255|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
5134252|NCT01610557|17734256|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5134253|NCT01610492|17734269|P1|Overall Study|Other:Treatment stopped due to remission|1
5134254|NCT01610492|17734269|P1|Overall Study|Other: Reached stopping criteria|1
5134255|NCT01610492|17734269|P1|Overall Study|Lack of Efficacy|3
5134256|NCT01610492|17734269|P1|Overall Study|Adverse Event|1
5134257|NCT01610414|17734335|P2|After Month 25|Study end not reached|53
5134258|NCT01610414|17734336|P1|After Month 25|Study end not reached|48
5134259|NCT01610414|17734335|P2|Month 13 - Month 25|Other reasons for withdrawal|7
5134260|NCT01610414|17734336|P1|Month 13 - Month 25|Other reasons for withdrawal|6
5134261|NCT01610414|17734335|P2|Month 13 - Month 25|Lost to Follow-up|9
5134262|NCT01610414|17734336|P1|Month 13 - Month 25|Lost to Follow-up|5
5134263|NCT01610414|17734335|P2|Month 13 - Month 25|Protocol Violation|2
5134264|NCT01610414|17734336|P1|Month 13 - Month 25|Protocol Violation|0
5134265|NCT01610414|17734335|P2|Month 13 - Month 25|Migrated/moved from study area|2
5134266|NCT01610414|17734336|P1|Month 13 - Month 25|Migrated/moved from study area|4
5134267|NCT01610414|17734335|P2|Month 13 - Month 25|Withdrawal by Subject|8
5134268|NCT01610414|17734336|P1|Month 13 - Month 25|Withdrawal by Subject|7
5134269|NCT01610414|17734335|P2|Month 13 - Month 25|Adverse Event|4
5134270|NCT01610414|17734336|P1|Month 13 - Month 25|Adverse Event|8
5134271|NCT01610414|17734335|P2|Month 13 - Month 25|Serious Adverse Event|38
5134272|NCT01610414|17734336|P1|Month 13 - Month 25|Serious Adverse Event|35
5134273|NCT01610414|17734335|P2|Study Start - Month 13|Other reasons for withdrawal|4
5134274|NCT01610414|17734336|P1|Study Start - Month 13|Other reasons for withdrawal|3
5134275|NCT01610414|17734335|P2|Study Start - Month 13|Suspected HZ episode|3
5134276|NCT01610414|17734336|P1|Study Start - Month 13|Suspected HZ episode|1
5134277|NCT01610414|17734335|P2|Study Start - Month 13|Lost to Follow-up|6
5134278|NCT01610414|17734336|P1|Study Start - Month 13|Lost to Follow-up|4
5134279|NCT01610414|17734335|P2|Study Start - Month 13|Migrated/moved from study area|4
5134280|NCT01610414|17734336|P1|Study Start - Month 13|Migrated/moved from study area|2
5134281|NCT01610414|17734335|P2|Study Start - Month 13|Withdrawal by Subject|30
5134282|NCT01610414|17734336|P1|Study Start - Month 13|Withdrawal by Subject|23
5134283|NCT01610414|17734335|P2|Study Start - Month 13|Protocol Violation|1
5134284|NCT01610414|17734336|P1|Study Start - Month 13|Protocol Violation|3
5134285|NCT01610414|17734335|P2|Study Start - Month 13|Adverse Event|14
5134286|NCT01610414|17734336|P1|Study Start - Month 13|Adverse Event|14
5134287|NCT01610414|17734335|P2|Study Start - Month 13|Serious Adverse Event|67
5134288|NCT01610414|17734336|P1|Study Start - Month 13|Serious Adverse Event|65
5134289|NCT01610297|17734365|P1|Overall Study|Lost to Follow-up|1
5134290|NCT01610284|17734375|P2|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
5134291|NCT01610284|17734376|P1|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
5134292|NCT01610284|17734375|P2|Post-Treatment Efficacy Follow-Up Phase|Death|4
5134293|NCT01610284|17734376|P1|Post-Treatment Efficacy Follow-Up Phase|Death|4
5134294|NCT01610284|17734375|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5134295|NCT01610284|17734376|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
5134296|NCT01610284|17734375|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
5134297|NCT01610284|17734376|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
5134298|NCT01610284|17734375|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
5134299|NCT01610284|17734376|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
5134300|NCT01610284|17734375|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5134301|NCT01610284|17734376|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
5134302|NCT01610284|17734375|P2|Treatment Phase|Death|5
5134303|NCT01610284|17734376|P1|Treatment Phase|Death|6
5134304|NCT01610284|17734375|P2|Treatment Phase|Subject/Guardian Decision|23
5134305|NCT01610284|17734376|P1|Treatment Phase|Subject/Guardian Decision|55
5134306|NCT01610284|17734375|P2|Treatment Phase|Study terminated by Sponsor|15
5134307|NCT01610284|17734376|P1|Treatment Phase|Study terminated by Sponsor|18
5134308|NCT01610284|17734375|P2|Treatment Phase|Protocol Deviation|3
5134309|NCT01610284|17734376|P1|Treatment Phase|Protocol Deviation|2
5134310|NCT01610284|17734375|P2|Treatment Phase|Progressive Disease|486
5134311|NCT01610284|17734376|P1|Treatment Phase|Progressive Disease|377
5134312|NCT01610284|17734375|P2|Treatment Phase|Physician Decision|24
5134313|NCT01610284|17734376|P1|Treatment Phase|Physician Decision|27
5134314|NCT01610284|17734375|P2|Treatment Phase|Non-compliance with Study Treatment|1
5134315|NCT01610284|17734376|P1|Treatment Phase|Non-compliance with Study Treatment|8
5134316|NCT01610284|17734375|P2|Treatment Phase|Lost to Follow-up|0
5134317|NCT01610284|17734376|P1|Treatment Phase|Lost to Follow-up|1
5134318|NCT01610284|17734375|P2|Treatment Phase|Adverse Event|12
5134319|NCT01610284|17734376|P1|Treatment Phase|Adverse Event|80
5134320|NCT01610284|17734375|P2|Randomization Phase|Death|1
5134321|NCT01610284|17734376|P1|Randomization Phase|Death|0
5134322|NCT01610284|17734375|P2|Randomization Phase|Physician Decision|1
5134323|NCT01610284|17734376|P1|Randomization Phase|Physician Decision|1
5134324|NCT01610284|17734375|P2|Randomization Phase|Adverse Event|0
5134325|NCT01610284|17734376|P1|Randomization Phase|Adverse Event|1
5134326|NCT01610271|17734398|P2|Overall Study|Prosthesis not implanted|3
5134327|NCT01610271|17734399|P1|Overall Study|Prosthesis not implanted|2
5134328|NCT01610271|17734398|P2|Overall Study|Surgery not complete|1
5134329|NCT01610271|17734399|P1|Overall Study|Surgery not complete|0
5134330|NCT01610167|17734414|P3|Overall Study|Scheduling conflict.|2
5134331|NCT01610167|17734415|P2|Overall Study|Scheduling conflict.|0
5134332|NCT01610167|17734416|P1|Overall Study|Scheduling conflict.|0
5134333|NCT01610076|17734453|P2|Overall Study|Lost to Follow-up|4
5134334|NCT01610076|17734454|P1|Overall Study|Lost to Follow-up|3
5134335|NCT01610076|17734453|P2|Overall Study|Technical issue with video|1
5134336|NCT01610076|17734454|P1|Overall Study|Technical issue with video|0
5134337|NCT01610063|17734465|P2|Overall Study|Lost to Follow-up|20
5134338|NCT01610063|17734466|P1|Overall Study|Lost to Follow-up|42
5134339|NCT01610037|17734489|P3|Treatment and Follow up Period|Lost to Follow-up|4
5134340|NCT01610037|17734490|P2|Treatment and Follow up Period|Lost to Follow-up|6
5134341|NCT01610037|17734491|P1|Treatment and Follow up Period|Lost to Follow-up|1
5134342|NCT01610037|17734489|P3|Treatment and Follow up Period|Administrative problems|2
5134343|NCT01610037|17734490|P2|Treatment and Follow up Period|Administrative problems|3
5134344|NCT01610037|17734491|P1|Treatment and Follow up Period|Administrative problems|1
5134345|NCT01610037|17734489|P3|Treatment and Follow up Period|Death|4
5134346|NCT01610037|17734490|P2|Treatment and Follow up Period|Death|5
5134347|NCT01610037|17734491|P1|Treatment and Follow up Period|Death|10
5134348|NCT01610037|17734489|P3|Treatment and Follow up Period|Subject withdrew consent|16
5134349|NCT01610037|17734490|P2|Treatment and Follow up Period|Subject withdrew consent|14
5134350|NCT01610037|17734491|P1|Treatment and Follow up Period|Subject withdrew consent|13
5134351|NCT01610037|17734489|P3|All Patients|Abnormal test procedure result(s)|3
5134352|NCT01610037|17734490|P2|All Patients|Abnormal test procedure result(s)|1
5134353|NCT01610037|17734491|P1|All Patients|Abnormal test procedure result(s)|0
5134354|NCT01610037|17734489|P3|All Patients|Lost to Follow-up|0
5134355|NCT01610037|17734490|P2|All Patients|Lost to Follow-up|0
5134356|NCT01610037|17734491|P1|All Patients|Lost to Follow-up|1
5134357|NCT01610037|17734489|P3|All Patients|Administrative problems|4
5134358|NCT01610037|17734490|P2|All Patients|Administrative problems|4
5134359|NCT01610037|17734491|P1|All Patients|Administrative problems|1
5134360|NCT01610037|17734489|P3|All Patients|Abnormal laboratory value|0
5134361|NCT01610037|17734490|P2|All Patients|Abnormal laboratory value|1
5134362|NCT01610037|17734491|P1|All Patients|Abnormal laboratory value|1
5134363|NCT01610037|17734489|P3|All Patients|Protocol deviation|3
5134364|NCT01610037|17734490|P2|All Patients|Protocol deviation|3
5134365|NCT01610037|17734491|P1|All Patients|Protocol deviation|4
5134366|NCT01610037|17734489|P3|All Patients|Death|1
5134367|NCT01610037|17734490|P2|All Patients|Death|2
5134368|NCT01610037|17734491|P1|All Patients|Death|4
5134369|NCT01610037|17734489|P3|All Patients|Unsatisfactory therapeutic effect|27
5134370|NCT01610037|17734490|P2|All Patients|Unsatisfactory therapeutic effect|8
5134371|NCT01610037|17734491|P1|All Patients|Unsatisfactory therapeutic effect|9
5134372|NCT01610037|17734489|P3|All Patients|Withdrawal by Subject|20
5134373|NCT01610037|17734490|P2|All Patients|Withdrawal by Subject|10
5134374|NCT01610037|17734491|P1|All Patients|Withdrawal by Subject|12
5134375|NCT01610037|17734489|P3|All Patients|Adverse Event|26
5134376|NCT01610037|17734490|P2|All Patients|Adverse Event|22
5134377|NCT01610037|17734491|P1|All Patients|Adverse Event|27
5134378|NCT01609933|17734541|P1|Overall Study|Withdrawal by Subject|3
5134379|NCT01609933|17734541|P1|Overall Study|Adverse Event|1
5134380|NCT01609842|17734552|P2|Concurrent Intervention Control|pharmacy data not available|0
5134381|NCT01609842|17734553|P1|Concurrent Intervention Control|pharmacy data not available|2
5134382|NCT01609790|17734580|P3|Overall Study|Protocol Violation|8
5134383|NCT01609790|17734581|P2|Overall Study|Protocol Violation|7
5134384|NCT01609790|17734582|P1|Overall Study|Protocol Violation|1
5134385|NCT01609582|17734601|P2|Overall Study|Randomized, but not treated|3
5134386|NCT01609582|17734602|P1|Overall Study|Randomized, but not treated|0
5134387|NCT01609582|17734601|P2|Overall Study|Other|10
5134388|NCT01609582|17734602|P1|Overall Study|Other|9
5134389|NCT01609582|17734601|P2|Overall Study|Study Terminated by Sponsor|1548
5134390|NCT01609582|17734602|P1|Overall Study|Study Terminated by Sponsor|1543
5134391|NCT01609582|17734601|P2|Overall Study|Withdrawal by Subject|15
5134392|NCT01609582|17734602|P1|Overall Study|Withdrawal by Subject|21
5134393|NCT01609582|17734601|P2|Overall Study|Lost to Follow-up|10
5134394|NCT01609582|17734602|P1|Overall Study|Lost to Follow-up|10
5134395|NCT01609582|17734601|P2|Overall Study|Adverse Event|18
5134396|NCT01609582|17734602|P1|Overall Study|Adverse Event|20
5134397|NCT01609543|17734610|P1|Overall Study|Death|7
5134398|NCT01609543|17734610|P1|Overall Study|Protocol Violation|1
5134399|NCT01609543|17734610|P1|Overall Study|Withdrawal by Subject|1
5134400|NCT01609543|17734610|P1|Overall Study|Adverse Event|5
5134401|NCT01609543|17734610|P1|Overall Study|Disease Progression|28
5134402|NCT01609478|17734619|P3|Overall Study|Withdrawal by Subject|2
5134403|NCT01609478|17734620|P2|Overall Study|Withdrawal by Subject|0
5134404|NCT01609478|17734621|P1|Overall Study|Withdrawal by Subject|2
5134405|NCT01609478|17734619|P3|Overall Study|Physician Decision|1
5134406|NCT01609478|17734620|P2|Overall Study|Physician Decision|0
5134407|NCT01609478|17734621|P1|Overall Study|Physician Decision|1
5134408|NCT01609478|17734619|P3|Overall Study|Non-Compliance with study treatment|0
5134409|NCT01609478|17734620|P2|Overall Study|Non-Compliance with study treatment|0
5134410|NCT01609478|17734621|P1|Overall Study|Non-Compliance with study treatment|1
5134411|NCT01609478|17734619|P3|Overall Study|Protocol Deviation|1
5134412|NCT01609478|17734620|P2|Overall Study|Protocol Deviation|1
5134413|NCT01609478|17734621|P1|Overall Study|Protocol Deviation|0
5134414|NCT01609478|17734619|P3|Overall Study|Adverse Event|5
5134415|NCT01609478|17734620|P2|Overall Study|Adverse Event|1
5134416|NCT01609478|17734621|P1|Overall Study|Adverse Event|3
5134417|NCT01609296|17734694|P1|Overall Study|Withdrawal by Subject|71
5134418|NCT01609296|17734694|P1|Overall Study|Death|49
5134419|NCT01609257|17734707|P2|Overall Study|Non-compliance/Protocol deviation|6
5134420|NCT01609257|17734708|P1|Overall Study|Non-compliance/Protocol deviation|4
5134421|NCT01609257|17734707|P2|Overall Study|Voluntary Withdrawal by Subject|1
5134422|NCT01609257|17734708|P1|Overall Study|Voluntary Withdrawal by Subject|0
5134423|NCT01609257|17734707|P2|Overall Study|Lost to Follow-up|1
5134424|NCT01609257|17734708|P1|Overall Study|Lost to Follow-up|2
5134425|NCT01609231|17734780|P2|Overall Study|Withdrawal by Subject|0
5134426|NCT01609231|17734781|P1|Overall Study|Withdrawal by Subject|1
5134427|NCT01609231|17734780|P2|Overall Study|Physician Decision|0
5134428|NCT01609231|17734781|P1|Overall Study|Physician Decision|1
5134429|NCT01609231|17734780|P2|Overall Study|Adverse Event|3
5134430|NCT01609231|17734781|P1|Overall Study|Adverse Event|1
5134431|NCT01609062|17734791|P2|Extension Phase|Anticipated surgery & transition to EAP|1
5134432|NCT01609062|17734792|P1|Extension Phase|Anticipated surgery & transition to EAP|0
5134433|NCT01609062|17734791|P2|Extension Phase|Discontinued drug and then was pregnant|0
5134434|NCT01609062|17734792|P1|Extension Phase|Discontinued drug and then was pregnant|1
5134435|NCT01609062|17734791|P2|Extension Phase|Terminated by Sponsor|9
5134436|NCT01609062|17734792|P1|Extension Phase|Terminated by Sponsor|14
5134437|NCT01609023|17734835|P1|Overall Study|Personal reasons|1
5134438|NCT01609023|17734835|P1|Overall Study|Death|2
5134439|NCT01609023|17734835|P1|Overall Study|Physician Decision|2
5134440|NCT01609023|17734835|P1|Overall Study|Disease progression|10
5134441|NCT01609023|17734835|P1|Overall Study|Toxicity|3
5134442|NCT01609023|17734835|P1|Overall Study|Lost to Follow-up|8
5134443|NCT01609023|17734835|P1|Overall Study|Withdrawal by Subject|4
5134444|NCT01609023|17734835|P1|Overall Study|Lack of Efficacy|3
5134445|NCT01609010|17734847|P2|Overall Study|Lost to Follow-up|1
5134446|NCT01609010|17734848|P1|Overall Study|Lost to Follow-up|1
5134447|NCT01609010|17734847|P2|Overall Study|New cancer|0
5134448|NCT01609010|17734848|P1|Overall Study|New cancer|1
5134449|NCT01609010|17734847|P2|Overall Study|Protocol Violation|1
5134450|NCT01609010|17734848|P1|Overall Study|Protocol Violation|1
5134451|NCT01609010|17734847|P2|Overall Study|Pathology review|1
5134452|NCT01609010|17734848|P1|Overall Study|Pathology review|2
5134453|NCT01609010|17734847|P2|Overall Study|Other malignancy|0
5134454|NCT01609010|17734848|P1|Overall Study|Other malignancy|1
5134455|NCT01609010|17734847|P2|Overall Study|Other|0
5134456|NCT01609010|17734848|P1|Overall Study|Other|2
5134457|NCT01609010|17734847|P2|Overall Study|Withdrawal by Subject|2
5134458|NCT01609010|17734848|P1|Overall Study|Withdrawal by Subject|2
5134459|NCT01609010|17734847|P2|Overall Study|Adverse Event|6
5134460|NCT01609010|17734848|P1|Overall Study|Adverse Event|3
5134461|NCT01609010|17734847|P2|Overall Study|Progressive disease (PD)|10
5134462|NCT01609010|17734848|P1|Overall Study|Progressive disease (PD)|8
5134463|NCT01609010|17734847|P2|Overall Study|Stable disease (SD)|16
5134464|NCT01609010|17734848|P1|Overall Study|Stable disease (SD)|22
5134465|NCT01608724|17734909|P1|Overall Study|Safety reasons|1
5134466|NCT01608724|17734909|P1|Overall Study|bood sugar too high, etc.|3
5134467|NCT01608724|17734909|P1|Overall Study|Protocol Violation|6
5134468|NCT01608724|17734909|P1|Overall Study|Adverse Event|29
5134469|NCT01608724|17734909|P1|Overall Study|Study-specific discontinuation criteria|32
5134470|NCT01608724|17734909|P1|Overall Study|Lost to Follow-up|41
5134471|NCT01608724|17734909|P1|Overall Study|Withdrawal by Subject|131
5134472|NCT01608321|17734941|P2|Overall Study|Withdrawal by Subject|0
5134473|NCT01608321|17734942|P1|Overall Study|Withdrawal by Subject|1
5134474|NCT01608308|17734950|P2|Overall Study|pretreatment medical and billing reasons|2
5134475|NCT01608308|17734951|P1|Overall Study|pretreatment medical and billing reasons|0
5134476|NCT01608087|17735014|P3|Overall Study|Other Reason|0
5134477|NCT01608087|17735015|P2|Overall Study|Other Reason|1
5134478|NCT01608087|17735016|P1|Overall Study|Other Reason|0
5134479|NCT01608087|17735014|P3|Overall Study|Lost to Follow-up|0
5134480|NCT01608087|17735015|P2|Overall Study|Lost to Follow-up|1
5134481|NCT01608087|17735016|P1|Overall Study|Lost to Follow-up|0
5134482|NCT01607957|17735046|P2|Overall Study|Participant refusal|0
5134483|NCT01607957|17735047|P1|Overall Study|Participant refusal|1
5134484|NCT01607957|17735046|P2|Overall Study|Lost to Follow-up|3
5134485|NCT01607957|17735047|P1|Overall Study|Lost to Follow-up|3
5134486|NCT01607957|17735046|P2|Overall Study|Death|211
5134487|NCT01607957|17735047|P1|Overall Study|Death|367
5134488|NCT01607957|17735046|P2|Overall Study|Not treated|1
5134489|NCT01607957|17735047|P1|Overall Study|Not treated|1
5134490|NCT01607593|17735226|P1|Overall Study|Other|4
5134491|NCT01607593|17735226|P1|Overall Study|Continuation|33
5134492|NCT01607593|17735226|P1|Overall Study|Lost to Follow-up|25
5134493|NCT01607593|17735226|P1|Overall Study|Lack of Efficacy|16
5134494|NCT01607593|17735226|P1|Overall Study|Adverse Event|15
5134495|NCT01607554|17735232|P1|Overall Study|Disease progression|2
5134496|NCT01607476|17735245|P3|Overall Study|Lost to Follow-up|2
5134497|NCT01607476|17735246|P2|Overall Study|Lost to Follow-up|0
5134498|NCT01607476|17735247|P1|Overall Study|Lost to Follow-up|0
5134499|NCT01607476|17735245|P3|Overall Study|Withdrawal by Subject|1
5134500|NCT01607476|17735246|P2|Overall Study|Withdrawal by Subject|0
5134501|NCT01607476|17735247|P1|Overall Study|Withdrawal by Subject|1
5134502|NCT01607398|17735341|P2|Overall Study|Severe COPD|0
5134503|NCT01607398|17735342|P1|Overall Study|Severe COPD|2
5134504|NCT01607398|17735341|P2|Overall Study|Adverse Event|2
5134505|NCT01607398|17735342|P1|Overall Study|Adverse Event|0
5134506|NCT01607346|17735386|P1|Overall Study|Adverse Event|3
5134507|NCT01606800|17735484|P2|Overall Study|Missing completion status|0
5134508|NCT01606800|17735485|P1|Overall Study|Missing completion status|2
5134509|NCT01606800|17735484|P2|Overall Study|Participant withdrew consent|1
5134510|NCT01606800|17735485|P1|Overall Study|Participant withdrew consent|0
5134511|NCT01606800|17735484|P2|Overall Study|Adverse Event|1
5134512|NCT01606800|17735485|P1|Overall Study|Adverse Event|3
5134513|NCT01606787|17735493|P2|Overall Study|Surgery canceled|2
5134514|NCT01606787|17735494|P1|Overall Study|Surgery canceled|0
5134515|NCT01606787|17735493|P2|Overall Study|Withdrawal by Subject|5
5134516|NCT01606787|17735494|P1|Overall Study|Withdrawal by Subject|4
5134517|NCT01606761|17735505|P5|Safety Follow-up Period (Week 52-68)|Other|3
5134518|NCT01606761|17735506|P4|Safety Follow-up Period (Week 52-68)|Other|1
5134519|NCT01606761|17735507|P3|Safety Follow-up Period (Week 52-68)|Other|9
5134520|NCT01606761|17735508|P2|Safety Follow-up Period (Week 52-68)|Other|3
5134521|NCT01606761|17735509|P1|Safety Follow-up Period (Week 52-68)|Other|0
5134522|NCT01606761|17735505|P5|Safety Follow-up Period (Week 52-68)|Death|1
5134523|NCT01606761|17735506|P4|Safety Follow-up Period (Week 52-68)|Death|0
5134524|NCT01606761|17735507|P3|Safety Follow-up Period (Week 52-68)|Death|0
5134525|NCT01606761|17735508|P2|Safety Follow-up Period (Week 52-68)|Death|0
5134526|NCT01606761|17735509|P1|Safety Follow-up Period (Week 52-68)|Death|0
5134527|NCT01606761|17735505|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
5134528|NCT01606761|17735506|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
5134529|NCT01606761|17735507|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
5134530|NCT01606761|17735508|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
5134531|NCT01606761|17735509|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
5134532|NCT01606761|17735505|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
5134533|NCT01606761|17735506|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
5134534|NCT01606761|17735507|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
5134535|NCT01606761|17735508|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
5134536|NCT01606761|17735509|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
5134537|NCT01606761|17735505|P5|Week 24 to Week 52|Other|2
5134538|NCT01606761|17735506|P4|Week 24 to Week 52|Other|2
5134539|NCT01606761|17735507|P3|Week 24 to Week 52|Other|5
5134540|NCT01606761|17735508|P2|Week 24 to Week 52|Other|1
5134541|NCT01606761|17735509|P1|Week 24 to Week 52|Other|0
5134542|NCT01606761|17735505|P5|Week 24 to Week 52|Physician Decision|0
5134543|NCT01606761|17735506|P4|Week 24 to Week 52|Physician Decision|0
5134544|NCT01606761|17735507|P3|Week 24 to Week 52|Physician Decision|1
5134545|NCT01606761|17735508|P2|Week 24 to Week 52|Physician Decision|1
5134546|NCT01606761|17735509|P1|Week 24 to Week 52|Physician Decision|0
5134547|NCT01606761|17735505|P5|Week 24 to Week 52|Lack of Efficacy|3
5134548|NCT01606761|17735506|P4|Week 24 to Week 52|Lack of Efficacy|10
5134549|NCT01606761|17735507|P3|Week 24 to Week 52|Lack of Efficacy|7
5134550|NCT01606761|17735508|P2|Week 24 to Week 52|Lack of Efficacy|13
5134551|NCT01606761|17735509|P1|Week 24 to Week 52|Lack of Efficacy|0
5134552|NCT01606761|17735505|P5|Week 24 to Week 52|Death|0
5134553|NCT01606761|17735506|P4|Week 24 to Week 52|Death|1
5134554|NCT01606761|17735507|P3|Week 24 to Week 52|Death|2
5134555|NCT01606761|17735508|P2|Week 24 to Week 52|Death|0
5134556|NCT01606761|17735509|P1|Week 24 to Week 52|Death|0
5134557|NCT01606761|17735505|P5|Week 24 to Week 52|Adverse Event|15
5134558|NCT01606761|17735506|P4|Week 24 to Week 52|Adverse Event|3
5134559|NCT01606761|17735507|P3|Week 24 to Week 52|Adverse Event|14
5134560|NCT01606761|17735508|P2|Week 24 to Week 52|Adverse Event|11
5134561|NCT01606761|17735509|P1|Week 24 to Week 52|Adverse Event|0
5134562|NCT01606761|17735505|P5|Week 24 to Week 52|Withdrawal by Subject|0
5134563|NCT01606761|17735506|P4|Week 24 to Week 52|Withdrawal by Subject|0
5134564|NCT01606761|17735507|P3|Week 24 to Week 52|Withdrawal by Subject|3
5134565|NCT01606761|17735508|P2|Week 24 to Week 52|Withdrawal by Subject|6
5134566|NCT01606761|17735509|P1|Week 24 to Week 52|Withdrawal by Subject|0
5134567|NCT01606761|17735505|P5|Week 24 to Week 52|Lost to Follow-up|0
5134568|NCT01606761|17735506|P4|Week 24 to Week 52|Lost to Follow-up|1
5134569|NCT01606761|17735507|P3|Week 24 to Week 52|Lost to Follow-up|1
5134570|NCT01606761|17735508|P2|Week 24 to Week 52|Lost to Follow-up|1
5134571|NCT01606761|17735509|P1|Week 24 to Week 52|Lost to Follow-up|0
5134572|NCT01606761|17735505|P5|Prior to Week 24|Other|0
5134573|NCT01606761|17735506|P4|Prior to Week 24|Other|0
5134574|NCT01606761|17735507|P3|Prior to Week 24|Other|5
5134575|NCT01606761|17735508|P2|Prior to Week 24|Other|7
5134576|NCT01606761|17735509|P1|Prior to Week 24|Other|4
5134577|NCT01606761|17735505|P5|Prior to Week 24|Physician Decision|0
5134578|NCT01606761|17735506|P4|Prior to Week 24|Physician Decision|0
5134579|NCT01606761|17735507|P3|Prior to Week 24|Physician Decision|1
5134580|NCT01606761|17735508|P2|Prior to Week 24|Physician Decision|3
5134581|NCT01606761|17735509|P1|Prior to Week 24|Physician Decision|0
5134582|NCT01606761|17735505|P5|Prior to Week 24|Lack of Efficacy|0
5134583|NCT01606761|17735506|P4|Prior to Week 24|Lack of Efficacy|0
5134584|NCT01606761|17735507|P3|Prior to Week 24|Lack of Efficacy|8
5134585|NCT01606761|17735508|P2|Prior to Week 24|Lack of Efficacy|14
5134586|NCT01606761|17735509|P1|Prior to Week 24|Lack of Efficacy|15
5134587|NCT01606761|17735505|P5|Prior to Week 24|Adverse Event|0
5134588|NCT01606761|17735506|P4|Prior to Week 24|Adverse Event|0
5134589|NCT01606761|17735507|P3|Prior to Week 24|Adverse Event|22
5134590|NCT01606761|17735508|P2|Prior to Week 24|Adverse Event|18
5134591|NCT01606761|17735509|P1|Prior to Week 24|Adverse Event|11
5134592|NCT01606761|17735505|P5|Prior to Week 24|Withdrawal by Subject|0
5134593|NCT01606761|17735506|P4|Prior to Week 24|Withdrawal by Subject|0
5134594|NCT01606761|17735507|P3|Prior to Week 24|Withdrawal by Subject|9
5134595|NCT01606761|17735508|P2|Prior to Week 24|Withdrawal by Subject|10
5134596|NCT01606761|17735509|P1|Prior to Week 24|Withdrawal by Subject|12
5134597|NCT01606761|17735505|P5|Prior to Week 24|Lost to Follow-up|0
5134598|NCT01606761|17735506|P4|Prior to Week 24|Lost to Follow-up|0
5134599|NCT01606761|17735507|P3|Prior to Week 24|Lost to Follow-up|2
5134600|NCT01606761|17735508|P2|Prior to Week 24|Lost to Follow-up|3
5134601|NCT01606761|17735509|P1|Prior to Week 24|Lost to Follow-up|0
5134602|NCT01606748|17735535|P2|Overall Study|Withdrawal by Subject|0
5134603|NCT01606748|17735536|P1|Overall Study|Withdrawal by Subject|1
5134604|NCT01606748|17735535|P2|Overall Study|Progressive Disease|0
5134605|NCT01606748|17735536|P1|Overall Study|Progressive Disease|1
5134606|NCT01606748|17735535|P2|Overall Study|Adverse Event|0
5134607|NCT01606748|17735536|P1|Overall Study|Adverse Event|1
5134608|NCT01606670|17735588|P1|Overall Study|Other Reason|2
5134609|NCT01606670|17735588|P1|Overall Study|Withdrawal by Subject|3
5134610|NCT01606670|17735588|P1|Overall Study|Lost to Follow-up|3
5134611|NCT01606670|17735588|P1|Overall Study|Lack of Efficacy|2
5134612|NCT01606670|17735588|P1|Overall Study|Adverse Event|6
5134613|NCT01606319|17735598|P2|Overall Study|Adverse Event|4
5134614|NCT01606319|17735599|P1|Overall Study|Adverse Event|1
5134615|NCT01606319|17735598|P2|Overall Study|Lack of Efficacy|8
5134616|NCT01606319|17735599|P1|Overall Study|Lack of Efficacy|6
5134617|NCT01606319|17735598|P2|Overall Study|Physician Decision|2
5134618|NCT01606319|17735599|P1|Overall Study|Physician Decision|1
5134619|NCT01606319|17735598|P2|Overall Study|Withdrawal by Subject|12
5134620|NCT01606319|17735599|P1|Overall Study|Withdrawal by Subject|9
5134621|NCT01606319|17735598|P2|Overall Study|Lost to Follow-up|14
5134622|NCT01606319|17735599|P1|Overall Study|Lost to Follow-up|17
5134623|NCT01606306|17735617|P6|Overall Study|Physician Decision|0
5134624|NCT01606306|17735618|P5|Overall Study|Physician Decision|0
5134625|NCT01606306|17735619|P4|Overall Study|Physician Decision|0
5134626|NCT01606306|17735620|P3|Overall Study|Physician Decision|0
5134627|NCT01606306|17735621|P2|Overall Study|Physician Decision|2
5134628|NCT01606306|17735622|P1|Overall Study|Physician Decision|1
5134629|NCT01606306|17735617|P6|Overall Study|Withdrawal by Subject|4
5134630|NCT01606306|17735618|P5|Overall Study|Withdrawal by Subject|5
5134631|NCT01606306|17735619|P4|Overall Study|Withdrawal by Subject|4
5134632|NCT01606306|17735620|P3|Overall Study|Withdrawal by Subject|4
5134633|NCT01606306|17735621|P2|Overall Study|Withdrawal by Subject|3
5134634|NCT01606306|17735622|P1|Overall Study|Withdrawal by Subject|4
5134635|NCT01606306|17735617|P6|Overall Study|Lost to Follow-up|5
5134636|NCT01606306|17735618|P5|Overall Study|Lost to Follow-up|3
5134637|NCT01606306|17735619|P4|Overall Study|Lost to Follow-up|4
5134638|NCT01606306|17735620|P3|Overall Study|Lost to Follow-up|5
5134639|NCT01606306|17735621|P2|Overall Study|Lost to Follow-up|4
5134640|NCT01606306|17735622|P1|Overall Study|Lost to Follow-up|7
5134641|NCT01606306|17735617|P6|Overall Study|Adverse Event|0
5134642|NCT01606306|17735618|P5|Overall Study|Adverse Event|2
5134643|NCT01606306|17735619|P4|Overall Study|Adverse Event|1
5134644|NCT01606306|17735620|P3|Overall Study|Adverse Event|1
5134645|NCT01606306|17735621|P2|Overall Study|Adverse Event|0
5134646|NCT01606306|17735622|P1|Overall Study|Adverse Event|1
5134647|NCT01606306|17735617|P6|Overall Study|Lack of Efficacy|2
5134648|NCT01606306|17735618|P5|Overall Study|Lack of Efficacy|1
5134649|NCT01606306|17735619|P4|Overall Study|Lack of Efficacy|4
5134650|NCT01606306|17735620|P3|Overall Study|Lack of Efficacy|4
5134651|NCT01606306|17735621|P2|Overall Study|Lack of Efficacy|1
5134652|NCT01606306|17735622|P1|Overall Study|Lack of Efficacy|2
5134653|NCT01606254|17735632|P4|Overall Study|Adverse Event|1
5134654|NCT01606254|17735633|P3|Overall Study|Adverse Event|0
5134655|NCT01606254|17735634|P2|Overall Study|Adverse Event|1
5134656|NCT01606254|17735635|P1|Overall Study|Adverse Event|1
5134657|NCT01606254|17735632|P4|Overall Study|Withdrawal by Subject|2
5134658|NCT01606254|17735633|P3|Overall Study|Withdrawal by Subject|0
5134659|NCT01606254|17735634|P2|Overall Study|Withdrawal by Subject|3
5134660|NCT01606254|17735635|P1|Overall Study|Withdrawal by Subject|1
5134661|NCT01606228|17735717|P1|Overall Study|Adverse Event|1
5134662|NCT01606228|17735717|P1|Overall Study|Lack of Efficacy|2
5134663|NCT01606228|17735717|P1|Overall Study|Non-compliant|3
5134664|NCT01606228|17735717|P1|Overall Study|Withdrawal by Subject|3
5134665|NCT01606228|17735717|P1|Overall Study|Lost to Follow-up|20
5134666|NCT01606202|17735734|P2|Overall Study|Problems with administration|1
5134667|NCT01606202|17735735|P1|Overall Study|Problems with administration|0
5134668|NCT01606202|17735734|P2|Overall Study|Personal problems|1
5134669|NCT01606202|17735735|P1|Overall Study|Personal problems|0
5134670|NCT01606202|17735734|P2|Overall Study|Withdrawal by Subject|1
5134671|NCT01606202|17735735|P1|Overall Study|Withdrawal by Subject|2
5134672|NCT01606202|17735734|P2|Overall Study|Adverse Event|0
5134673|NCT01606202|17735735|P1|Overall Study|Adverse Event|5
5134674|NCT01606189|17735767|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
5134675|NCT01606189|17735768|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5134676|NCT01606189|17735769|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5134677|NCT01606189|17735770|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5134678|NCT01606189|17735771|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5134679|NCT01606189|17735772|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5134680|NCT01606189|17735767|P6|Second Intenvention (14-20 Days)|Adverse Event|1
5134681|NCT01606189|17735768|P5|Second Intenvention (14-20 Days)|Adverse Event|0
5134682|NCT01606189|17735769|P4|Second Intenvention (14-20 Days)|Adverse Event|0
5134683|NCT01606189|17735770|P3|Second Intenvention (14-20 Days)|Adverse Event|0
5134684|NCT01606189|17735771|P2|Second Intenvention (14-20 Days)|Adverse Event|0
5134685|NCT01606189|17735772|P1|Second Intenvention (14-20 Days)|Adverse Event|0
5134686|NCT01606176|17735806|P2|Overall Study|Withdrawal by Subject|0
5134687|NCT01606176|17735807|P1|Overall Study|Withdrawal by Subject|1
5134688|NCT01606176|17735806|P2|Overall Study|Disease progression|0
5134689|NCT01606176|17735807|P1|Overall Study|Disease progression|1
5134690|NCT01606176|17735806|P2|Overall Study|Adverse Event|3
5134691|NCT01606176|17735807|P1|Overall Study|Adverse Event|2
5134692|NCT01606137|17735852|P1|Overall Study|Unable to collect consistent data|1
5134693|NCT01606137|17735852|P1|Overall Study|Patient moving|1
5134694|NCT01606137|17735852|P1|Overall Study|Unable to tolerate study med. taste|1
5134695|NCT01606137|17735852|P1|Overall Study|Personal reasons|1
5134696|NCT01606137|17735852|P1|Overall Study|Patient leaving country|1
5134697|NCT01606137|17735852|P1|Overall Study|Wanted to try another treatment|1
5134698|NCT01606137|17735852|P1|Overall Study|Not enough improvement|4
5134699|NCT01606137|17735852|P1|Overall Study|Spray causes nausea|1
5134700|NCT01606137|17735852|P1|Overall Study|Increased bilirubin|1
5134701|NCT01606137|17735852|P1|Overall Study|multiple sclerosis less stable|1
5134702|NCT01606137|17735852|P1|Overall Study|Issues with driving|4
5134703|NCT01606137|17735852|P1|Overall Study|Decreased/no pain|4
5134704|NCT01606137|17735852|P1|Overall Study|Death|1
5134705|NCT01606137|17735852|P1|Overall Study|Patient non-compliance|9
5134706|NCT01606137|17735852|P1|Overall Study|Protocol Violation|1
5134707|NCT01606137|17735852|P1|Overall Study|Lost to Follow-up|15
5134708|NCT01606137|17735852|P1|Overall Study|Lack of Efficacy|56
5134709|NCT01606137|17735852|P1|Overall Study|Withdrawal by Subject|74
5134710|NCT01606137|17735852|P1|Overall Study|Adverse Event|85
5134711|NCT01606007|17735886|P3|Overall Study|Poor/Non-compliance|0
5134712|NCT01606007|17735887|P2|Overall Study|Poor/Non-compliance|0
5134713|NCT01606007|17735888|P1|Overall Study|Poor/Non-compliance|1
5134714|NCT01606007|17735886|P3|Overall Study|Lost to Follow-up|5
5134715|NCT01606007|17735887|P2|Overall Study|Lost to Follow-up|8
5134716|NCT01606007|17735888|P1|Overall Study|Lost to Follow-up|6
5134717|NCT01606007|17735886|P3|Overall Study|discontinue study treatment|1
5134718|NCT01606007|17735887|P2|Overall Study|discontinue study treatment|2
5134719|NCT01606007|17735888|P1|Overall Study|discontinue study treatment|0
5134720|NCT01606007|17735886|P3|Overall Study|Adverse Event|1
5134721|NCT01606007|17735887|P2|Overall Study|Adverse Event|1
5134722|NCT01606007|17735888|P1|Overall Study|Adverse Event|0
5134723|NCT01606007|17735886|P3|Overall Study|Withdrawal by Subject|1
5134724|NCT01606007|17735887|P2|Overall Study|Withdrawal by Subject|6
5134725|NCT01606007|17735888|P1|Overall Study|Withdrawal by Subject|8
5134726|NCT01606007|17735886|P3|Overall Study|Pregnancy|1
5134727|NCT01606007|17735887|P2|Overall Study|Pregnancy|1
5134728|NCT01606007|17735888|P1|Overall Study|Pregnancy|0
5134729|NCT01606007|17735886|P3|Overall Study|Reason 'Other' in the protocol|1
5134730|NCT01606007|17735887|P2|Overall Study|Reason 'Other' in the protocol|1
5134731|NCT01606007|17735888|P1|Overall Study|Reason 'Other' in the protocol|0
5134732|NCT01605916|17735923|P5|Overall Study|Withdrawal by Subject|2
5134733|NCT01605916|17735924|P4|Overall Study|Withdrawal by Subject|0
5134734|NCT01605916|17735925|P3|Overall Study|Withdrawal by Subject|0
5134735|NCT01605916|17735926|P2|Overall Study|Withdrawal by Subject|1
5134736|NCT01605916|17735927|P1|Overall Study|Withdrawal by Subject|1
5134737|NCT01605916|17735923|P5|Overall Study|Lack of Efficacy|4
5134738|NCT01605916|17735924|P4|Overall Study|Lack of Efficacy|5
5134739|NCT01605916|17735925|P3|Overall Study|Lack of Efficacy|3
5134740|NCT01605916|17735926|P2|Overall Study|Lack of Efficacy|3
5134741|NCT01605916|17735927|P1|Overall Study|Lack of Efficacy|2
5134742|NCT01605916|17735923|P5|Overall Study|Adverse Event|0
5134743|NCT01605916|17735924|P4|Overall Study|Adverse Event|1
5134744|NCT01605916|17735925|P3|Overall Study|Adverse Event|0
5134745|NCT01605916|17735926|P2|Overall Study|Adverse Event|0
5134746|NCT01605916|17735927|P1|Overall Study|Adverse Event|1
5134747|NCT01605877|17736024|P1|Overall Study|Withdrawal by Subject|1
5134748|NCT01605825|17736088|P2|Overall Study|Non-Compliance with Protocol|0
5134749|NCT01605825|17736089|P1|Overall Study|Non-Compliance with Protocol|3
5134750|NCT01605825|17736088|P2|Overall Study|Non-Compliance -Investigational Drug|0
5134751|NCT01605825|17736089|P1|Overall Study|Non-Compliance -Investigational Drug|3
5134752|NCT01605825|17736088|P2|Overall Study|Withdrawal by Subject|1
5134753|NCT01605825|17736089|P1|Overall Study|Withdrawal by Subject|0
5134754|NCT01605825|17736088|P2|Overall Study|Adverse Event|2
5134755|NCT01605825|17736089|P1|Overall Study|Adverse Event|4
5134756|NCT01605799|17736097|P2|Overall Study|Withdrawal by Subject|1
5134757|NCT01605799|17736098|P1|Overall Study|Withdrawal by Subject|2
5134758|NCT01605617|17736113|P2|Washout Period of 4 Weeks|Study Terminated|1
5134759|NCT01605617|17736114|P1|Washout Period of 4 Weeks|Study Terminated|2
5134760|NCT01605617|17736113|P2|First Intervention|Adverse Event|1
5134761|NCT01605617|17736114|P1|First Intervention|Adverse Event|0
5134762|NCT01605461|17736173|P1|Overall Study|Withdrawal by Subject|1
5134763|NCT01605461|17736173|P1|Overall Study|Lost to Follow-up|3
5134764|NCT01605396|17736232|P2|Overall Study|Transfer Off Study|5
5134765|NCT01605396|17736233|P1|Overall Study|Transfer Off Study|4
5134766|NCT01605396|17736232|P2|Overall Study|Withdrawal by Subject|2
5134767|NCT01605396|17736233|P1|Overall Study|Withdrawal by Subject|4
5134768|NCT01605396|17736232|P2|Overall Study|Progressive Disease|27
5134769|NCT01605396|17736233|P1|Overall Study|Progressive Disease|23
5134770|NCT01605396|17736232|P2|Overall Study|Physician Decision|2
5134771|NCT01605396|17736233|P1|Overall Study|Physician Decision|2
5134772|NCT01605396|17736232|P2|Overall Study|Non-Compliance With Study Drug|1
5134773|NCT01605396|17736233|P1|Overall Study|Non-Compliance With Study Drug|1
5134774|NCT01605396|17736232|P2|Overall Study|Lost to Follow-up|0
5134775|NCT01605396|17736233|P1|Overall Study|Lost to Follow-up|1
5134776|NCT01605396|17736232|P2|Overall Study|Adverse Event|3
5134777|NCT01605396|17736233|P1|Overall Study|Adverse Event|5
5134778|NCT01605370|17736247|P2|Overall Study|Adverse Event|0
5134779|NCT01605370|17736248|P1|Overall Study|Adverse Event|1
5134780|NCT01605227|17736283|P2|Overall Study|Dose Held >6 weeks|1
5134781|NCT01605227|17736284|P1|Overall Study|Dose Held >6 weeks|0
5134782|NCT01605227|17736283|P2|Overall Study|Subject Decision|1
5134783|NCT01605227|17736284|P1|Overall Study|Subject Decision|0
5134784|NCT01605227|17736283|P2|Overall Study|Started New Therapy|0
5134785|NCT01605227|17736284|P1|Overall Study|Started New Therapy|1
5134786|NCT01605227|17736283|P2|Overall Study|Sponsor Decision|0
5134787|NCT01605227|17736284|P1|Overall Study|Sponsor Decision|2
5134788|NCT01605227|17736283|P2|Overall Study|Withdrawal by Subject|14
5134789|NCT01605227|17736284|P1|Overall Study|Withdrawal by Subject|18
5134790|NCT01605227|17736283|P2|Overall Study|Physician Decision|7
5134791|NCT01605227|17736284|P1|Overall Study|Physician Decision|9
5134792|NCT01605227|17736283|P2|Overall Study|Protocol Violation|0
5134793|NCT01605227|17736284|P1|Overall Study|Protocol Violation|1
5134794|NCT01605227|17736283|P2|Overall Study|Lost to Follow-up|0
5134795|NCT01605227|17736284|P1|Overall Study|Lost to Follow-up|1
5134796|NCT01605227|17736283|P2|Overall Study|Clinical Deterioration|133
5134797|NCT01605227|17736284|P1|Overall Study|Clinical Deterioration|227
5134798|NCT01605227|17736283|P2|Overall Study|Progressive Disease|128
5134799|NCT01605227|17736284|P1|Overall Study|Progressive Disease|132
5134800|NCT01605227|17736283|P2|Overall Study|Adverse Event|42
5134801|NCT01605227|17736284|P1|Overall Study|Adverse Event|228
5134802|NCT01605227|17736283|P2|Overall Study|Did not receive study treatment|3
5134803|NCT01605227|17736284|P1|Overall Study|Did not receive study treatment|2
5134804|NCT01605136|17736296|P2|Safety Follow-Up Period|Withdrawal by Subject|2
5134805|NCT01605136|17736297|P1|Safety Follow-Up Period|Withdrawal by Subject|1
5134806|NCT01605136|17736296|P2|Study Period|Lost to Follow-up|2
5134807|NCT01605136|17736297|P1|Study Period|Lost to Follow-up|0
5134808|NCT01605136|17736296|P2|Study Period|Physician Decision|1
5134809|NCT01605136|17736297|P1|Study Period|Physician Decision|1
5134810|NCT01605136|17736296|P2|Study Period|Withdrawal by Subject|0
5134811|NCT01605136|17736297|P1|Study Period|Withdrawal by Subject|2
5134812|NCT01605019|17736326|P2|Overall Study|pt did not meet transplant endpoint|0
5134813|NCT01605019|17736327|P1|Overall Study|pt did not meet transplant endpoint|3
5134814|NCT01604941|17736337|P6|Overall Study|Early Study Termination|0
5134815|NCT01604941|17736338|P5|Overall Study|Early Study Termination|0
5134816|NCT01604941|17736339|P4|Overall Study|Early Study Termination|3
5134817|NCT01604941|17736340|P3|Overall Study|Early Study Termination|3
5134818|NCT01604941|17736341|P2|Overall Study|Early Study Termination|2
5134819|NCT01604941|17736342|P1|Overall Study|Early Study Termination|9
5134820|NCT01604941|17736337|P6|Overall Study|Participant Decision|2
5134821|NCT01604941|17736338|P5|Overall Study|Participant Decision|0
5134822|NCT01604941|17736339|P4|Overall Study|Participant Decision|0
5134823|NCT01604941|17736340|P3|Overall Study|Participant Decision|0
5134824|NCT01604941|17736341|P2|Overall Study|Participant Decision|0
5134825|NCT01604941|17736342|P1|Overall Study|Participant Decision|0
5134826|NCT01604941|17736337|P6|Overall Study|Non-compliance|0
5134827|NCT01604941|17736338|P5|Overall Study|Non-compliance|0
5134828|NCT01604941|17736339|P4|Overall Study|Non-compliance|0
5134829|NCT01604941|17736340|P3|Overall Study|Non-compliance|0
5134830|NCT01604941|17736341|P2|Overall Study|Non-compliance|0
5134831|NCT01604941|17736342|P1|Overall Study|Non-compliance|1
5134832|NCT01604941|17736337|P6|Overall Study|Adverse Event|5
5134833|NCT01604941|17736338|P5|Overall Study|Adverse Event|1
5134834|NCT01604941|17736339|P4|Overall Study|Adverse Event|0
5134835|NCT01604941|17736340|P3|Overall Study|Adverse Event|0
5134836|NCT01604941|17736341|P2|Overall Study|Adverse Event|2
5134837|NCT01604941|17736342|P1|Overall Study|Adverse Event|1
5134838|NCT01604850|17736370|P2|Overall Study|Subject withdrew consent|0
5134839|NCT01604850|17736371|P1|Overall Study|Subject withdrew consent|1
5134840|NCT01604850|17736370|P2|Overall Study|Lost to Follow-up|0
5134841|NCT01604850|17736371|P1|Overall Study|Lost to Follow-up|1
5134842|NCT01604850|17736370|P2|Overall Study|Efficacy Failure|29
5134843|NCT01604850|17736371|P1|Overall Study|Efficacy Failure|50
5134844|NCT01604850|17736370|P2|Overall Study|Enrolled but never treated|1
5134845|NCT01604850|17736371|P1|Overall Study|Enrolled but never treated|0
5134846|NCT01604824|17736391|P6|Open-label Extension (OLE) Period|Refused to come into office|0
5134847|NCT01604824|17736392|P5|Open-label Extension (OLE) Period|Refused to come into office|1
5134848|NCT01604824|17736393|P4|Open-label Extension (OLE) Period|Refused to come into office|0
5134849|NCT01604824|17736394|P3|Open-label Extension (OLE) Period|Refused to come into office|0
5134850|NCT01604824|17736395|P2|Open-label Extension (OLE) Period|Refused to come into office|0
5134851|NCT01604824|17736396|P1|Open-label Extension (OLE) Period|Refused to come into office|0
5134852|NCT01604824|17736391|P6|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5134853|NCT01604824|17736392|P5|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
5134854|NCT01604824|17736393|P4|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5134855|NCT01604824|17736394|P3|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5134856|NCT01604824|17736395|P2|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5134857|NCT01604824|17736396|P1|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5134858|NCT01604785|17736426|P2|Overall Study|Repeat Visits Not Included in Analysis|1
5134859|NCT01604785|17736427|P1|Overall Study|Repeat Visits Not Included in Analysis|7
5134860|NCT01604408|17736446|P2|Observation Period|Withdrawal by Subject|2
5134861|NCT01604408|17736447|P1|Observation Period|Withdrawal by Subject|0
5134862|NCT01604408|17736446|P2|Observation Period|Adverse Event|1
5134863|NCT01604408|17736447|P1|Observation Period|Adverse Event|1
5134864|NCT01604408|17736446|P2|Treatment Period 6|Sponsor decision|1
5134865|NCT01604408|17736447|P1|Treatment Period 6|Sponsor decision|0
5134866|NCT01604408|17736446|P2|Treatment Period 6|Adverse Event|0
5134867|NCT01604408|17736447|P1|Treatment Period 6|Adverse Event|2
5134868|NCT01604408|17736446|P2|Treatment Period 6|Lost to Follow-up|1
5134869|NCT01604408|17736447|P1|Treatment Period 6|Lost to Follow-up|0
5134870|NCT01604408|17736446|P2|Treatment Period 5|Adverse Event|0
5134871|NCT01604408|17736447|P1|Treatment Period 5|Adverse Event|4
5134872|NCT01604408|17736446|P2|Treatment Period 4|Adverse Event|1
5134873|NCT01604408|17736447|P1|Treatment Period 4|Adverse Event|0
5134874|NCT01604408|17736446|P2|Treatment Period 4|Withdrawal by Subject|1
5134875|NCT01604408|17736447|P1|Treatment Period 4|Withdrawal by Subject|2
5134876|NCT01604408|17736446|P2|Treatment Period 4|Death|0
5134877|NCT01604408|17736447|P1|Treatment Period 4|Death|1
5134878|NCT01604408|17736446|P2|Treatment Period 3|Sponsor Decision|0
5134879|NCT01604408|17736447|P1|Treatment Period 3|Sponsor Decision|1
5134880|NCT01604408|17736446|P2|Treatment Period 3|Withdrawal by Subject|1
5134881|NCT01604408|17736447|P1|Treatment Period 3|Withdrawal by Subject|3
5134882|NCT01604408|17736446|P2|Treatment Period 3|Adverse Event|3
5134883|NCT01604408|17736447|P1|Treatment Period 3|Adverse Event|0
5134884|NCT01604408|17736446|P2|Treatment Period 3|Protocol Violation|1
5134885|NCT01604408|17736447|P1|Treatment Period 3|Protocol Violation|1
5134886|NCT01604408|17736446|P2|Treatment Period 2|Adverse Event|1
5134887|NCT01604408|17736447|P1|Treatment Period 2|Adverse Event|0
5134888|NCT01604408|17736446|P2|Treatment Period 2|Protocol Violation|0
5134889|NCT01604408|17736447|P1|Treatment Period 2|Protocol Violation|1
5134890|NCT01604408|17736446|P2|Treatment Period 2|Withdrawal by Subject|1
5134891|NCT01604408|17736447|P1|Treatment Period 2|Withdrawal by Subject|1
5134892|NCT01604408|17736446|P2|Treatment Period 1|Protocol Violation|1
5134893|NCT01604408|17736447|P1|Treatment Period 1|Protocol Violation|0
5134894|NCT01604343|17736462|P5|Safety Follow-up Period (Week 104-120)|Other|14
5134895|NCT01604343|17736463|P4|Safety Follow-up Period (Week 104-120)|Other|6
5134896|NCT01604343|17736464|P3|Safety Follow-up Period (Week 104-120)|Other|20
5134897|NCT01604343|17736465|P2|Safety Follow-up Period (Week 104-120)|Other|2
5134898|NCT01604343|17736466|P1|Safety Follow-up Period (Week 104-120)|Other|15
5134899|NCT01604343|17736462|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
5134900|NCT01604343|17736463|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
5134901|NCT01604343|17736464|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
5134902|NCT01604343|17736465|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
5134903|NCT01604343|17736466|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
5134904|NCT01604343|17736462|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5134905|NCT01604343|17736463|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5134906|NCT01604343|17736464|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
5134907|NCT01604343|17736465|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5134908|NCT01604343|17736466|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
5134909|NCT01604343|17736462|P5|Week 52 to Week 104|Other|3
5134910|NCT01604343|17736463|P4|Week 52 to Week 104|Other|6
5134911|NCT01604343|17736464|P3|Week 52 to Week 104|Other|11
5134912|NCT01604343|17736465|P2|Week 52 to Week 104|Other|11
5134913|NCT01604343|17736466|P1|Week 52 to Week 104|Other|0
5134914|NCT01604343|17736462|P5|Week 52 to Week 104|Pregnancy|1
5134915|NCT01604343|17736463|P4|Week 52 to Week 104|Pregnancy|2
5134916|NCT01604343|17736464|P3|Week 52 to Week 104|Pregnancy|1
5134917|NCT01604343|17736465|P2|Week 52 to Week 104|Pregnancy|0
5134918|NCT01604343|17736466|P1|Week 52 to Week 104|Pregnancy|0
5134919|NCT01604343|17736462|P5|Week 52 to Week 104|Physician Decision|2
5134920|NCT01604343|17736463|P4|Week 52 to Week 104|Physician Decision|0
5134921|NCT01604343|17736464|P3|Week 52 to Week 104|Physician Decision|0
5134922|NCT01604343|17736465|P2|Week 52 to Week 104|Physician Decision|1
5134923|NCT01604343|17736466|P1|Week 52 to Week 104|Physician Decision|0
5134924|NCT01604343|17736462|P5|Week 52 to Week 104|Lack of Efficacy|3
5134925|NCT01604343|17736463|P4|Week 52 to Week 104|Lack of Efficacy|2
5134926|NCT01604343|17736464|P3|Week 52 to Week 104|Lack of Efficacy|11
5134927|NCT01604343|17736465|P2|Week 52 to Week 104|Lack of Efficacy|6
5134928|NCT01604343|17736466|P1|Week 52 to Week 104|Lack of Efficacy|0
5134929|NCT01604343|17736462|P5|Week 52 to Week 104|Death|0
5134930|NCT01604343|17736463|P4|Week 52 to Week 104|Death|5
5134931|NCT01604343|17736464|P3|Week 52 to Week 104|Death|2
5134932|NCT01604343|17736465|P2|Week 52 to Week 104|Death|4
5134933|NCT01604343|17736466|P1|Week 52 to Week 104|Death|0
5134934|NCT01604343|17736462|P5|Week 52 to Week 104|Adverse Event|27
5134935|NCT01604343|17736463|P4|Week 52 to Week 104|Adverse Event|21
5134936|NCT01604343|17736464|P3|Week 52 to Week 104|Adverse Event|26
5134937|NCT01604343|17736465|P2|Week 52 to Week 104|Adverse Event|12
5134938|NCT01604343|17736466|P1|Week 52 to Week 104|Adverse Event|0
5134939|NCT01604343|17736462|P5|Week 52 to Week 104|Withdrawal by Subject|4
5134940|NCT01604343|17736463|P4|Week 52 to Week 104|Withdrawal by Subject|8
5134941|NCT01604343|17736464|P3|Week 52 to Week 104|Withdrawal by Subject|12
5134942|NCT01604343|17736465|P2|Week 52 to Week 104|Withdrawal by Subject|7
5134943|NCT01604343|17736466|P1|Week 52 to Week 104|Withdrawal by Subject|0
5134944|NCT01604343|17736462|P5|Week 52 to Week 104|Lost to Follow-up|1
5134945|NCT01604343|17736463|P4|Week 52 to Week 104|Lost to Follow-up|2
5134946|NCT01604343|17736464|P3|Week 52 to Week 104|Lost to Follow-up|4
5134947|NCT01604343|17736465|P2|Week 52 to Week 104|Lost to Follow-up|2
5134948|NCT01604343|17736466|P1|Week 52 to Week 104|Lost to Follow-up|0
5134949|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Other|6
5134950|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Other|0
5134951|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Other|10
5134952|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Other|0
5134953|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Other|15
5134954|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
5134955|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
5134956|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
5134957|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
5134958|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
5134959|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
5134960|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
5134961|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
5134962|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
5134963|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
5134964|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
5134965|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
5134966|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
5134967|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
5134968|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
5134969|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Death|4
5134970|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Death|0
5134971|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Death|2
5134972|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Death|0
5134973|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Death|5
5134974|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
5134975|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
5134976|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
5134977|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
5134978|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
5134979|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
5134980|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
5134981|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
5134982|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
5134983|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
5134984|NCT01604343|17736462|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
5134985|NCT01604343|17736463|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
5134986|NCT01604343|17736464|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
5134987|NCT01604343|17736465|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
5134988|NCT01604343|17736466|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
5134989|NCT01604278|17736631|P2|Overall Study|Protocol Deviation|3
5134990|NCT01604278|17736632|P1|Overall Study|Protocol Deviation|5
5134991|NCT01604278|17736631|P2|Overall Study|Adverse Event|5
5134992|NCT01604278|17736632|P1|Overall Study|Adverse Event|3
5134993|NCT01604278|17736631|P2|Overall Study|Withdrawal by Subject|3
5134994|NCT01604278|17736632|P1|Overall Study|Withdrawal by Subject|3
5134995|NCT01604278|17736631|P2|Overall Study|Administrative problems|1
5134996|NCT01604278|17736632|P1|Overall Study|Administrative problems|2
5134997|NCT01604278|17736631|P2|Overall Study|Lost to Follow-up|0
5134998|NCT01604278|17736632|P1|Overall Study|Lost to Follow-up|1
5134999|NCT01604278|17736631|P2|Overall Study|Lack of Efficacy|1
5135000|NCT01604278|17736632|P1|Overall Study|Lack of Efficacy|0
5135001|NCT01604265|17736658|P2|Overall Study|Withdrawal by Subject|0
5135002|NCT01604265|17736659|P1|Overall Study|Withdrawal by Subject|1
5135003|NCT01604265|17736658|P2|Overall Study|Adverse Event|0
5135004|NCT01604265|17736659|P1|Overall Study|Adverse Event|1
5135005|NCT01603875|17736770|P3|Overall Study|Protocol Violation|0
5135006|NCT01603875|17736771|P2|Overall Study|Protocol Violation|1
5135007|NCT01603875|17736772|P1|Overall Study|Protocol Violation|0
5135008|NCT01603875|17736770|P3|Overall Study|Lost to Follow-up|6
5135009|NCT01603875|17736771|P2|Overall Study|Lost to Follow-up|3
5135010|NCT01603875|17736772|P1|Overall Study|Lost to Follow-up|4
5135011|NCT01603875|17736770|P3|Overall Study|Preexisting rabies antibody|3
5135012|NCT01603875|17736771|P2|Overall Study|Preexisting rabies antibody|4
5135013|NCT01603875|17736772|P1|Overall Study|Preexisting rabies antibody|3
5135014|NCT01603641|17736792|P1|Overall Study|Other Miscellaneous Reasons|6
5135015|NCT01603641|17736792|P1|Overall Study|Personal Reasons|18
5135016|NCT01603641|17736792|P1|Overall Study|Lost to Follow-up|6
5135017|NCT01603641|17736792|P1|Overall Study|Lack of Efficacy|1
5135018|NCT01603641|17736792|P1|Overall Study|Adverse Event|1
5135019|NCT01603641|17736792|P1|Overall Study|Did not Receive Treatment|3
5135020|NCT01603628|17736799|P3|Overall Study|Other Miscellaneous Reason|0
5135021|NCT01603628|17736800|P2|Overall Study|Other Miscellaneous Reason|0
5135022|NCT01603628|17736801|P1|Overall Study|Other Miscellaneous Reason|1
5135023|NCT01603628|17736799|P3|Overall Study|Lost to Follow-up|0
5135024|NCT01603628|17736800|P2|Overall Study|Lost to Follow-up|1
5135025|NCT01603628|17736801|P1|Overall Study|Lost to Follow-up|0
5135026|NCT01603628|17736799|P3|Overall Study|Protocol Violation|0
5135027|NCT01603628|17736800|P2|Overall Study|Protocol Violation|1
5135028|NCT01603628|17736801|P1|Overall Study|Protocol Violation|1
5135029|NCT01603628|17736799|P3|Overall Study|Personal Reasons|2
5135030|NCT01603628|17736800|P2|Overall Study|Personal Reasons|1
5135031|NCT01603628|17736801|P1|Overall Study|Personal Reasons|1
5135032|NCT01603615|17736818|P1|Overall Study|Other Miscellaneous|1
5135033|NCT01603615|17736818|P1|Overall Study|Personal Reasons|17
5135034|NCT01603615|17736818|P1|Overall Study|Lost to Follow-up|9
5135035|NCT01603615|17736818|P1|Overall Study|Did not Receive Treatment|7
5135036|NCT01603602|17736825|P3|Overall Study|Personal Reasons|1
5135037|NCT01603602|17736826|P2|Overall Study|Personal Reasons|0
5135038|NCT01603602|17736827|P1|Overall Study|Personal Reasons|1
5135039|NCT01603602|17736825|P3|Overall Study|Adverse Event|0
5135040|NCT01603602|17736826|P2|Overall Study|Adverse Event|0
5135041|NCT01603602|17736827|P1|Overall Study|Adverse Event|1
5135042|NCT01603459|17736847|P1|Overall Study|Administrative reason|1
5135043|NCT01603459|17736847|P1|Overall Study|Non-compliance|1
5135044|NCT01603459|17736847|P1|Overall Study|Predefined discontinuation criteria|3
5135045|NCT01603459|17736847|P1|Overall Study|Lost to Follow-up|3
5135046|NCT01603459|17736847|P1|Overall Study|Withdrawal by Subject|5
5135047|NCT01603459|17736847|P1|Overall Study|Adverse Event|5
5135048|NCT01603394|17736998|P1|Overall Study|Adverse Event|1
5135049|NCT01603355|17737052|P1|Overall Study|Lack of Efficacy|2
5135050|NCT01603277|17737058|P2|Overall Study|Non-Compliance|1
5135051|NCT01603277|17737059|P1|Overall Study|Non-Compliance|2
5135052|NCT01603277|17737058|P2|Overall Study|Withdrawal by Subject|4
5135053|NCT01603277|17737059|P1|Overall Study|Withdrawal by Subject|5
5135054|NCT01603277|17737058|P2|Overall Study|Protocol Violation|10
5135055|NCT01603277|17737059|P1|Overall Study|Protocol Violation|6
5135056|NCT01603277|17737058|P2|Overall Study|Physician Decision|1
5135057|NCT01603277|17737059|P1|Overall Study|Physician Decision|0
5135058|NCT01603277|17737058|P2|Overall Study|Adverse Event|2
5135059|NCT01603277|17737059|P1|Overall Study|Adverse Event|1
5135060|NCT01603121|17737065|P2|Second Intervention, 10 Hours|Adverse Event|0
5135061|NCT01603121|17737066|P1|Second Intervention, 10 Hours|Adverse Event|1
5135062|NCT01603082|17737078|P2|Overall Study|Failed inclusion criterion after dosed|0
5135063|NCT01603082|17737079|P1|Overall Study|Failed inclusion criterion after dosed|1
5135064|NCT01603082|17737078|P2|Overall Study|Withdrawal by Subject|0
5135065|NCT01603082|17737079|P1|Overall Study|Withdrawal by Subject|1
5135066|NCT01603082|17737078|P2|Overall Study|Adverse Event|1
5135067|NCT01603082|17737079|P1|Overall Study|Adverse Event|0
5135068|NCT01603043|17737120|P2|Overall Study|Study Futility|3
5135069|NCT01603043|17737121|P1|Overall Study|Study Futility|7
5135070|NCT01602965|17737133|P2|Overall Study|Lost to Follow-up|2
5135071|NCT01602965|17737134|P1|Overall Study|Lost to Follow-up|4
5135072|NCT01602744|17737142|P2|Overall Study|Lost to Follow-up|8
5135073|NCT01602744|17737143|P1|Overall Study|Lost to Follow-up|13
5135074|NCT01602744|17737142|P2|Overall Study|Death|15
5135075|NCT01602744|17737143|P1|Overall Study|Death|17
5135076|NCT01602562|17737274|P2|Overall Study|Withdrawal by Subject|1
5135077|NCT01602562|17737275|P1|Overall Study|Withdrawal by Subject|1
5135078|NCT01602562|17737274|P2|Overall Study|Physician Decision|1
5135079|NCT01602562|17737275|P1|Overall Study|Physician Decision|1
5135080|NCT01602562|17737274|P2|Overall Study|Adverse Event|1
5135081|NCT01602562|17737275|P1|Overall Study|Adverse Event|3
5135082|NCT01602549|17737311|P2|Overall Study|Withdrawal by Subject|0
5135083|NCT01602549|17737312|P1|Overall Study|Withdrawal by Subject|1
5135084|NCT01602549|17737311|P2|Overall Study|Protocol Violation|1
5135085|NCT01602549|17737312|P1|Overall Study|Protocol Violation|0
5135086|NCT01602510|17737391|P3|Randomized Phase|Withdrawal by Subject|7
5135087|NCT01602510|17737392|P2|Randomized Phase|Withdrawal by Subject|6
5135088|NCT01602510|17737393|P1|Randomized Phase|Withdrawal by Subject|0
5135089|NCT01602510|17737391|P3|Randomized Phase|Physician Decision|2
5135090|NCT01602510|17737392|P2|Randomized Phase|Physician Decision|0
5135091|NCT01602510|17737393|P1|Randomized Phase|Physician Decision|0
5135092|NCT01602510|17737391|P3|Randomized Phase|Lost to Follow-up|3
5135093|NCT01602510|17737392|P2|Randomized Phase|Lost to Follow-up|1
5135094|NCT01602510|17737393|P1|Randomized Phase|Lost to Follow-up|0
5135095|NCT01602510|17737391|P3|Randomized Phase|Met protocol-defined stopping criteria|48
5135096|NCT01602510|17737392|P2|Randomized Phase|Met protocol-defined stopping criteria|58
5135097|NCT01602510|17737393|P1|Randomized Phase|Met protocol-defined stopping criteria|0
5135098|NCT01602510|17737391|P3|Randomized Phase|Protocol Violation|3
5135099|NCT01602510|17737392|P2|Randomized Phase|Protocol Violation|3
5135100|NCT01602510|17737393|P1|Randomized Phase|Protocol Violation|0
5135101|NCT01602510|17737391|P3|Randomized Phase|Lack of Efficacy|4
5135102|NCT01602510|17737392|P2|Randomized Phase|Lack of Efficacy|4
5135103|NCT01602510|17737393|P1|Randomized Phase|Lack of Efficacy|0
5135104|NCT01602510|17737391|P3|Randomized Phase|Adverse Event|6
5135105|NCT01602510|17737392|P2|Randomized Phase|Adverse Event|2
5135106|NCT01602510|17737393|P1|Randomized Phase|Adverse Event|0
5135107|NCT01602510|17737391|P3|Open Label Phase|Withdrawal by Subject|0
5135108|NCT01602510|17737392|P2|Open Label Phase|Withdrawal by Subject|0
5135109|NCT01602510|17737393|P1|Open Label Phase|Withdrawal by Subject|57
5135110|NCT01602510|17737391|P3|Open Label Phase|Physician Decision|0
5135111|NCT01602510|17737392|P2|Open Label Phase|Physician Decision|0
5135112|NCT01602510|17737393|P1|Open Label Phase|Physician Decision|19
5135113|NCT01602510|17737391|P3|Open Label Phase|Lost to Follow-up|0
5135114|NCT01602510|17737392|P2|Open Label Phase|Lost to Follow-up|0
5135115|NCT01602510|17737393|P1|Open Label Phase|Lost to Follow-up|22
5135116|NCT01602510|17737391|P3|Open Label Phase|Met protocol-defined stopping criteria|0
5135117|NCT01602510|17737392|P2|Open Label Phase|Met protocol-defined stopping criteria|0
5135118|NCT01602510|17737393|P1|Open Label Phase|Met protocol-defined stopping criteria|122
5135119|NCT01602510|17737391|P3|Open Label Phase|Protocol Violation|0
5135120|NCT01602510|17737392|P2|Open Label Phase|Protocol Violation|0
5135121|NCT01602510|17737393|P1|Open Label Phase|Protocol Violation|15
5135122|NCT01602510|17737391|P3|Open Label Phase|Lack of Efficacy|0
5135123|NCT01602510|17737392|P2|Open Label Phase|Lack of Efficacy|0
5135124|NCT01602510|17737393|P1|Open Label Phase|Lack of Efficacy|22
5135125|NCT01602510|17737391|P3|Open Label Phase|Adverse Event|0
5135126|NCT01602510|17737392|P2|Open Label Phase|Adverse Event|0
5135127|NCT01602510|17737393|P1|Open Label Phase|Adverse Event|46
5135128|NCT01602484|17737419|P2|Overall Study|Airway issues unrelated to study|1
5135129|NCT01602484|17737420|P1|Overall Study|Airway issues unrelated to study|0
5135130|NCT01602419|17737436|P1|Overall Study|Lost to Follow-up|6
5135131|NCT01602419|17737436|P1|Overall Study|Withdrawal by Subject|5
5135132|NCT01602419|17737436|P1|Overall Study|Treatment centre closed|1
5135133|NCT01602419|17737436|P1|Overall Study|Changed treatment centre|1
5135134|NCT01602419|17737436|P1|Overall Study|Insurance issues|3
5135135|NCT01602419|17737436|P1|Overall Study|Adverse Drug Reaction|4
5135136|NCT01602419|17737436|P1|Overall Study|Not treated with Wilate|9
5135137|NCT01602380|17737491|P2|Overall Study|Eligibility criteria not fulfilled|3
5135138|NCT01602380|17737492|P1|Overall Study|Eligibility criteria not fulfilled|2
5135139|NCT01602380|17737491|P2|Overall Study|Lost to Follow-up|1
5135140|NCT01602380|17737492|P1|Overall Study|Lost to Follow-up|6
5135141|NCT01602380|17737491|P2|Overall Study|Withdrawal by Subject|29
5135142|NCT01602380|17737492|P1|Overall Study|Withdrawal by Subject|22
5135143|NCT01602380|17737491|P2|Overall Study|Death|68
5135144|NCT01602380|17737492|P1|Overall Study|Death|63
5135145|NCT01602341|17737516|P2|Overall Study|Adverse Event|1
5135146|NCT01602341|17737517|P1|Overall Study|Adverse Event|0
5135147|NCT01602315|17737558|P7|Overall Study|Cross-over patients to combo treatment|0
5135148|NCT01602315|17737559|P6|Overall Study|Cross-over patients to combo treatment|16
5135149|NCT01602315|17737560|P5|Overall Study|Cross-over patients to combo treatment|0
5135150|NCT01602315|17737561|P4|Overall Study|Cross-over patients to combo treatment|0
5135151|NCT01602315|17737562|P3|Overall Study|Cross-over patients to combo treatment|0
5135152|NCT01602315|17737563|P2|Overall Study|Cross-over patients to combo treatment|0
5135153|NCT01602315|17737564|P1|Overall Study|Cross-over patients to combo treatment|0
5135154|NCT01602315|17737558|P7|Overall Study|Subject/guardian decision|1
5135155|NCT01602315|17737559|P6|Overall Study|Subject/guardian decision|0
5135156|NCT01602315|17737560|P5|Overall Study|Subject/guardian decision|0
5135157|NCT01602315|17737561|P4|Overall Study|Subject/guardian decision|0
5135158|NCT01602315|17737562|P3|Overall Study|Subject/guardian decision|0
5135159|NCT01602315|17737563|P2|Overall Study|Subject/guardian decision|0
5135160|NCT01602315|17737564|P1|Overall Study|Subject/guardian decision|0
5135161|NCT01602315|17737558|P7|Overall Study|Adverse Event|9
5135162|NCT01602315|17737559|P6|Overall Study|Adverse Event|3
5135163|NCT01602315|17737560|P5|Overall Study|Adverse Event|15
5135164|NCT01602315|17737561|P4|Overall Study|Adverse Event|4
5135165|NCT01602315|17737562|P3|Overall Study|Adverse Event|5
5135166|NCT01602315|17737563|P2|Overall Study|Adverse Event|1
5135167|NCT01602315|17737564|P1|Overall Study|Adverse Event|5
5135168|NCT01602315|17737558|P7|Overall Study|Withdrawal by Subject|1
5135169|NCT01602315|17737559|P6|Overall Study|Withdrawal by Subject|0
5135170|NCT01602315|17737560|P5|Overall Study|Withdrawal by Subject|6
5135171|NCT01602315|17737561|P4|Overall Study|Withdrawal by Subject|0
5135172|NCT01602315|17737562|P3|Overall Study|Withdrawal by Subject|2
5135173|NCT01602315|17737563|P2|Overall Study|Withdrawal by Subject|0
5135174|NCT01602315|17737564|P1|Overall Study|Withdrawal by Subject|2
5135175|NCT01602315|17737558|P7|Overall Study|Death|2
5135176|NCT01602315|17737559|P6|Overall Study|Death|2
5135177|NCT01602315|17737560|P5|Overall Study|Death|7
5135178|NCT01602315|17737561|P4|Overall Study|Death|1
5135179|NCT01602315|17737562|P3|Overall Study|Death|1
5135180|NCT01602315|17737563|P2|Overall Study|Death|1
5135181|NCT01602315|17737564|P1|Overall Study|Death|1
5135182|NCT01602315|17737558|P7|Overall Study|Disease progression|15
5135183|NCT01602315|17737559|P6|Overall Study|Disease progression|12
5135184|NCT01602315|17737560|P5|Overall Study|Disease progression|41
5135185|NCT01602315|17737561|P4|Overall Study|Disease progression|1
5135186|NCT01602315|17737562|P3|Overall Study|Disease progression|10
5135187|NCT01602315|17737563|P2|Overall Study|Disease progression|3
5135188|NCT01602315|17737564|P1|Overall Study|Disease progression|6
5135189|NCT01602315|17737558|P7|Overall Study|Physician Decision|1
5135190|NCT01602315|17737559|P6|Overall Study|Physician Decision|1
5135191|NCT01602315|17737560|P5|Overall Study|Physician Decision|2
5135192|NCT01602315|17737561|P4|Overall Study|Physician Decision|0
5135193|NCT01602315|17737562|P3|Overall Study|Physician Decision|0
5135194|NCT01602315|17737563|P2|Overall Study|Physician Decision|0
5135195|NCT01602315|17737564|P1|Overall Study|Physician Decision|2
5135196|NCT01602315|17737558|P7|Overall Study|Protocol Violation|0
5135197|NCT01602315|17737559|P6|Overall Study|Protocol Violation|1
5135198|NCT01602315|17737560|P5|Overall Study|Protocol Violation|0
5135199|NCT01602315|17737561|P4|Overall Study|Protocol Violation|0
5135200|NCT01602315|17737562|P3|Overall Study|Protocol Violation|0
5135201|NCT01602315|17737563|P2|Overall Study|Protocol Violation|0
5135202|NCT01602315|17737564|P1|Overall Study|Protocol Violation|0
5135203|NCT01602224|17737653|P3|Overall Study|Withdrawal by Subject|3
5135204|NCT01602224|17737654|P2|Overall Study|Withdrawal by Subject|3
5135205|NCT01602224|17737655|P1|Overall Study|Withdrawal by Subject|5
5135206|NCT01602224|17737653|P3|Overall Study|Sponsor Decision|2
5135207|NCT01602224|17737654|P2|Overall Study|Sponsor Decision|3
5135208|NCT01602224|17737655|P1|Overall Study|Sponsor Decision|2
5135209|NCT01602224|17737653|P3|Overall Study|Protocol Violation|0
5135210|NCT01602224|17737654|P2|Overall Study|Protocol Violation|1
5135211|NCT01602224|17737655|P1|Overall Study|Protocol Violation|0
5135212|NCT01602224|17737653|P3|Overall Study|Lost to Follow-up|1
5135213|NCT01602224|17737654|P2|Overall Study|Lost to Follow-up|0
5135214|NCT01602224|17737655|P1|Overall Study|Lost to Follow-up|0
5135215|NCT01602224|17737653|P3|Overall Study|Investigator Decison|0
5135216|NCT01602224|17737654|P2|Overall Study|Investigator Decison|0
5135217|NCT01602224|17737655|P1|Overall Study|Investigator Decison|1
5135218|NCT01602224|17737653|P3|Overall Study|Adverse Event|0
5135219|NCT01602224|17737654|P2|Overall Study|Adverse Event|1
5135220|NCT01602224|17737655|P1|Overall Study|Adverse Event|0
5135221|NCT01602120|17737740|P4|Overall Study|Unspecified Reason|2
5135222|NCT01602120|17737741|P3|Overall Study|Unspecified Reason|0
5135223|NCT01602120|17737742|P2|Overall Study|Unspecified Reason|1
5135224|NCT01602120|17737743|P1|Overall Study|Unspecified Reason|3
5135225|NCT01602120|17737740|P4|Overall Study|Physician Decision|0
5135226|NCT01602120|17737741|P3|Overall Study|Physician Decision|0
5135227|NCT01602120|17737742|P2|Overall Study|Physician Decision|3
5135228|NCT01602120|17737743|P1|Overall Study|Physician Decision|2
5135229|NCT01602120|17737740|P4|Overall Study|Study Terminated by Sponsor|44
5135230|NCT01602120|17737741|P3|Overall Study|Study Terminated by Sponsor|17
5135231|NCT01602120|17737742|P2|Overall Study|Study Terminated by Sponsor|24
5135232|NCT01602120|17737743|P1|Overall Study|Study Terminated by Sponsor|12
5135233|NCT01602120|17737740|P4|Overall Study|Withdrawal by Subject|3
5135234|NCT01602120|17737741|P3|Overall Study|Withdrawal by Subject|0
5135235|NCT01602120|17737742|P2|Overall Study|Withdrawal by Subject|17
5135236|NCT01602120|17737743|P1|Overall Study|Withdrawal by Subject|8
5135237|NCT01602120|17737740|P4|Overall Study|Non-compliance|1
5135238|NCT01602120|17737741|P3|Overall Study|Non-compliance|0
5135239|NCT01602120|17737742|P2|Overall Study|Non-compliance|3
5135240|NCT01602120|17737743|P1|Overall Study|Non-compliance|0
5135241|NCT01602120|17737740|P4|Overall Study|Protocol Violation|0
5135242|NCT01602120|17737741|P3|Overall Study|Protocol Violation|0
5135243|NCT01602120|17737742|P2|Overall Study|Protocol Violation|1
5135244|NCT01602120|17737743|P1|Overall Study|Protocol Violation|1
5135245|NCT01602120|17737740|P4|Overall Study|Lost to Follow-up|1
5135246|NCT01602120|17737741|P3|Overall Study|Lost to Follow-up|0
5135247|NCT01602120|17737742|P2|Overall Study|Lost to Follow-up|1
5135248|NCT01602120|17737743|P1|Overall Study|Lost to Follow-up|0
5135249|NCT01602120|17737740|P4|Overall Study|Death|0
5135250|NCT01602120|17737741|P3|Overall Study|Death|0
5135251|NCT01602120|17737742|P2|Overall Study|Death|4
5135252|NCT01602120|17737743|P1|Overall Study|Death|0
5135253|NCT01602120|17737740|P4|Overall Study|Adverse Event|2
5135254|NCT01602120|17737741|P3|Overall Study|Adverse Event|0
5135255|NCT01602120|17737742|P2|Overall Study|Adverse Event|6
5135256|NCT01602120|17737743|P1|Overall Study|Adverse Event|3
5135257|NCT01601873|17737791|P2|Overall Study|Lost to Follow-up|3
5135258|NCT01601873|17737792|P1|Overall Study|Lost to Follow-up|2
5135259|NCT01601847|17737818|P2|Overall Study|Lost to Follow-up|3
5135260|NCT01601847|17737819|P1|Overall Study|Lost to Follow-up|1
5135261|NCT01601847|17737818|P2|Overall Study|Withdrawal by Subject|7
5135262|NCT01601847|17737819|P1|Overall Study|Withdrawal by Subject|11
5135263|NCT01601847|17737818|P2|Overall Study|Death|0
5135264|NCT01601847|17737819|P1|Overall Study|Death|1
5135265|NCT01601821|17737831|P2|Overall Study|Other|1
5135266|NCT01601821|17737832|P1|Overall Study|Other|5
5135267|NCT01601821|17737831|P2|Overall Study|Study Events|1
5135268|NCT01601821|17737832|P1|Overall Study|Study Events|7
5135269|NCT01601821|17737831|P2|Overall Study|Graft Loss|6
5135270|NCT01601821|17737832|P1|Overall Study|Graft Loss|6
5135271|NCT01601821|17737831|P2|Overall Study|Withdrawal by Subject|0
5135272|NCT01601821|17737832|P1|Overall Study|Withdrawal by Subject|1
5135273|NCT01601821|17737831|P2|Overall Study|Lost to Follow-up|14
5135274|NCT01601821|17737832|P1|Overall Study|Lost to Follow-up|6
5135275|NCT01601821|17737831|P2|Overall Study|Protocol Violation|2
5135276|NCT01601821|17737832|P1|Overall Study|Protocol Violation|2
5135277|NCT01601821|17737831|P2|Overall Study|Death|5
5135278|NCT01601821|17737832|P1|Overall Study|Death|2
5135279|NCT01601704|17737868|P2|Overall Study|Randomized but not dispensed study med|4
5135280|NCT01601704|17737869|P1|Overall Study|Randomized but not dispensed study med|1
5135281|NCT01601626|17737890|P3|Overall Study|Not Willing to Adhere to Requirements|0
5135282|NCT01601626|17737891|P2|Overall Study|Not Willing to Adhere to Requirements|0
5135283|NCT01601626|17737892|P1|Overall Study|Not Willing to Adhere to Requirements|1
5135284|NCT01601626|17737890|P3|Overall Study|Withdrawal by Subject|1
5135285|NCT01601626|17737891|P2|Overall Study|Withdrawal by Subject|1
5135286|NCT01601626|17737892|P1|Overall Study|Withdrawal by Subject|0
5135287|NCT01601626|17737890|P3|Overall Study|Unable to Get to Clinic|0
5135288|NCT01601626|17737891|P2|Overall Study|Unable to Get to Clinic|1
5135289|NCT01601626|17737892|P1|Overall Study|Unable to Get to Clinic|0
5135290|NCT01601626|17737890|P3|Overall Study|Lost to Follow-up|0
5135291|NCT01601626|17737891|P2|Overall Study|Lost to Follow-up|2
5135292|NCT01601626|17737892|P1|Overall Study|Lost to Follow-up|1
5135293|NCT01601626|17737890|P3|Overall Study|Death|1
5135294|NCT01601626|17737891|P2|Overall Study|Death|1
5135295|NCT01601626|17737892|P1|Overall Study|Death|1
5135296|NCT01601535|17737981|P6|Phase 2|Started Another Treatment|2
5135297|NCT01601535|17737982|P5|Phase 2|Started Another Treatment|1
5135298|NCT01601535|17737983|P4|Phase 2|Started Another Treatment|0
5135299|NCT01601535|17737984|P3|Phase 2|Started Another Treatment|0
5135300|NCT01601535|17737985|P2|Phase 2|Started Another Treatment|0
5135301|NCT01601535|17737986|P1|Phase 2|Started Another Treatment|0
5135302|NCT01601535|17737981|P6|Phase 2|Progressive Disease|7
5135303|NCT01601535|17737982|P5|Phase 2|Progressive Disease|5
5135304|NCT01601535|17737983|P4|Phase 2|Progressive Disease|0
5135305|NCT01601535|17737984|P3|Phase 2|Progressive Disease|0
5135306|NCT01601535|17737985|P2|Phase 2|Progressive Disease|0
5135307|NCT01601535|17737986|P1|Phase 2|Progressive Disease|0
5135308|NCT01601535|17737981|P6|Phase 2|Withdrawal by Subject|2
5135309|NCT01601535|17737982|P5|Phase 2|Withdrawal by Subject|8
5135310|NCT01601535|17737983|P4|Phase 2|Withdrawal by Subject|0
5135311|NCT01601535|17737984|P3|Phase 2|Withdrawal by Subject|0
5135312|NCT01601535|17737985|P2|Phase 2|Withdrawal by Subject|0
5135313|NCT01601535|17737986|P1|Phase 2|Withdrawal by Subject|0
5135314|NCT01601535|17737981|P6|Phase 2|Adverse Event|1
5135315|NCT01601535|17737982|P5|Phase 2|Adverse Event|5
5135316|NCT01601535|17737983|P4|Phase 2|Adverse Event|0
5135317|NCT01601535|17737984|P3|Phase 2|Adverse Event|0
5135318|NCT01601535|17737985|P2|Phase 2|Adverse Event|0
5135319|NCT01601535|17737986|P1|Phase 2|Adverse Event|0
5135320|NCT01601535|17737981|P6|Phase 1|Started Another Treatment|0
5135321|NCT01601535|17737982|P5|Phase 1|Started Another Treatment|0
5135322|NCT01601535|17737983|P4|Phase 1|Started Another Treatment|0
5135323|NCT01601535|17737984|P3|Phase 1|Started Another Treatment|0
5135324|NCT01601535|17737985|P2|Phase 1|Started Another Treatment|2
5135325|NCT01601535|17737986|P1|Phase 1|Started Another Treatment|1
5135326|NCT01601535|17737981|P6|Phase 1|Progressive Disease|0
5135327|NCT01601535|17737982|P5|Phase 1|Progressive Disease|0
5135328|NCT01601535|17737983|P4|Phase 1|Progressive Disease|1
5135329|NCT01601535|17737984|P3|Phase 1|Progressive Disease|2
5135330|NCT01601535|17737985|P2|Phase 1|Progressive Disease|3
5135331|NCT01601535|17737986|P1|Phase 1|Progressive Disease|2
5135332|NCT01601535|17737981|P6|Phase 1|Withdrawal by Subject|0
5135333|NCT01601535|17737982|P5|Phase 1|Withdrawal by Subject|0
5135334|NCT01601535|17737983|P4|Phase 1|Withdrawal by Subject|2
5135335|NCT01601535|17737984|P3|Phase 1|Withdrawal by Subject|1
5135336|NCT01601535|17737985|P2|Phase 1|Withdrawal by Subject|1
5135337|NCT01601535|17737986|P1|Phase 1|Withdrawal by Subject|2
5135338|NCT01601535|17737981|P6|Phase 1|Adverse Event|0
5135339|NCT01601535|17737982|P5|Phase 1|Adverse Event|0
5135340|NCT01601535|17737983|P4|Phase 1|Adverse Event|1
5135341|NCT01601535|17737984|P3|Phase 1|Adverse Event|2
5135342|NCT01601535|17737985|P2|Phase 1|Adverse Event|0
5135343|NCT01601535|17737986|P1|Phase 1|Adverse Event|1
5135344|NCT01601496|17738042|P1|Overall Study|Other: patient refusal to continue|3
5135345|NCT01601496|17738042|P1|Overall Study|Death|4
5135346|NCT01601496|17738042|P1|Overall Study|Lost to Follow-up|6
5135347|NCT01601496|17738042|P1|Overall Study|Withdrawal by Subject|1
5135348|NCT01601496|17738042|P1|Overall Study|Physician Decision|1
5135349|NCT01601470|17738050|P1|Period 2 - LCZ696|Physician Decision|1
5135350|NCT01601132|17738121|P1|Overall Study|Protocol deviation|1
5135351|NCT01601132|17738121|P1|Overall Study|Patient withdrew consent|1
5135352|NCT01600885|17738166|P2|First Period|moved out of area|0
5135353|NCT01600885|17738167|P1|First Period|moved out of area|1
5135354|NCT01600885|17738166|P2|First Period|Adverse Event|1
5135355|NCT01600885|17738167|P1|First Period|Adverse Event|1
5135356|NCT01600716|17738184|P2|Overall Study|Adverse Event|1
5135357|NCT01600716|17738185|P1|Overall Study|Adverse Event|1
5135358|NCT01600716|17738184|P2|Overall Study|Lack of Efficacy|1
5135359|NCT01600716|17738185|P1|Overall Study|Lack of Efficacy|2
5135360|NCT01600716|17738184|P2|Overall Study|Pregnancy|0
5135361|NCT01600716|17738185|P1|Overall Study|Pregnancy|1
5135362|NCT01600716|17738184|P2|Overall Study|Lost to Follow-up|2
5135363|NCT01600716|17738185|P1|Overall Study|Lost to Follow-up|0
5135364|NCT01600716|17738184|P2|Overall Study|Personal Reasons|2
5135365|NCT01600716|17738185|P1|Overall Study|Personal Reasons|0
5135366|NCT01600716|17738184|P2|Overall Study|Other Reasons|1
5135367|NCT01600716|17738185|P1|Overall Study|Other Reasons|3
5135368|NCT01600586|17738233|P2|Overall Study|Physician Decision|3
5135369|NCT01600586|17738234|P1|Overall Study|Physician Decision|3
5135370|NCT01600326|17738286|P2|Overall Study|Lost to Follow-up|1
5135371|NCT01600326|17738287|P1|Overall Study|Lost to Follow-up|1
5135372|NCT01600105|17738388|P2|Sub Study V|Poor Image Quality|0
5135373|NCT01600105|17738389|P1|Sub Study V|Poor Image Quality|2
5135374|NCT01600105|17738388|P2|Sub Study III|Insufficient image quality|0
5135375|NCT01600105|17738389|P1|Sub Study III|Insufficient image quality|5
5135376|NCT01600105|17738388|P2|Sub Study II|Insufficient image quality|0
5135377|NCT01600105|17738389|P1|Sub Study II|Insufficient image quality|3
5135378|NCT01600105|17738388|P2|Sub Study II|No images in PACS|0
5135379|NCT01600105|17738389|P1|Sub Study II|No images in PACS|1
5135380|NCT01600105|17738388|P2|Sub Study II|Withdrawal by Subject|0
5135381|NCT01600105|17738389|P1|Sub Study II|Withdrawal by Subject|1
5135382|NCT01600105|17738388|P2|Sub Study I|Insufficient image quality|10
5135383|NCT01600105|17738389|P1|Sub Study I|Insufficient image quality|0
5135384|NCT01600105|17738388|P2|Total Participants|Insufficient image quality|10
5135385|NCT01600105|17738389|P1|Total Participants|Insufficient image quality|30
5135386|NCT01600105|17738388|P2|Total Participants|No images in PACS|0
5135387|NCT01600105|17738389|P1|Total Participants|No images in PACS|10
5135388|NCT01600105|17738388|P2|Total Participants|Withdrawal by Subject|0
5135389|NCT01600105|17738389|P1|Total Participants|Withdrawal by Subject|1
5135390|NCT01600092|17738417|P2|Overall Study|Randomized but not vaccinated|3
5135391|NCT01600092|17738418|P1|Overall Study|Randomized but not vaccinated|3
5135392|NCT01600092|17738417|P2|Overall Study|Physician Decision|1
5135393|NCT01600092|17738418|P1|Overall Study|Physician Decision|1
5135394|NCT01600092|17738417|P2|Overall Study|Withdrawal by parent/guardian|6
5135395|NCT01600092|17738418|P1|Overall Study|Withdrawal by parent/guardian|8
5135396|NCT01600092|17738417|P2|Overall Study|Lost to Follow-up|6
5135397|NCT01600092|17738418|P1|Overall Study|Lost to Follow-up|4
5135398|NCT01600092|17738417|P2|Overall Study|Adverse Event|0
5135399|NCT01600092|17738418|P1|Overall Study|Adverse Event|2
5135400|NCT01600053|17738432|P1|Overall Study|trial will not meet the interim endpoint|9
5135401|NCT01600053|17738432|P1|Overall Study|Adverse Event|2
5135402|NCT01600014|17738437|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
5135403|NCT01600014|17738438|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
5135404|NCT01600014|17738437|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
5135405|NCT01600014|17738438|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
5135406|NCT01600014|17738437|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
5135407|NCT01600014|17738438|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
5135408|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
5135409|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
5135410|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
5135411|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
5135412|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
5135413|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
5135414|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
5135415|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
5135416|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
5135417|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
5135418|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
5135419|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
5135420|NCT01600014|17738437|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
5135421|NCT01600014|17738438|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
5135422|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
5135423|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
5135424|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
5135425|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
5135426|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
5135427|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
5135428|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Other|0
5135429|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Other|27
5135430|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
5135431|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
5135432|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
5135433|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
5135434|NCT01600014|17738437|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
5135435|NCT01600014|17738438|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
5135436|NCT01599806|17738466|P2|Overall Study|Other Eligibility criteria|9
5135437|NCT01599806|17738467|P1|Overall Study|Other Eligibility criteria|11
5135438|NCT01599806|17738466|P2|Overall Study|Withdrawal by Subject|12
5135439|NCT01599806|17738467|P1|Overall Study|Withdrawal by Subject|12
5135440|NCT01599806|17738466|P2|Overall Study|Lost to Follow-up|20
5135441|NCT01599806|17738467|P1|Overall Study|Lost to Follow-up|20
5135442|NCT01599793|17738591|P1|Overall Study|Adverse Event|2
5135443|NCT01599754|17738603|P2|Overall Study|Study terminated by sponsor|285
5135444|NCT01599754|17738604|P1|Overall Study|Study terminated by sponsor|282
5135445|NCT01599754|17738603|P2|Overall Study|Withdrawal by Subject|25
5135446|NCT01599754|17738604|P1|Overall Study|Withdrawal by Subject|24
5135447|NCT01599754|17738603|P2|Overall Study|Investigator decision|3
5135448|NCT01599754|17738604|P1|Overall Study|Investigator decision|1
5135449|NCT01599754|17738603|P2|Overall Study|Adverse Event|2
5135450|NCT01599754|17738604|P1|Overall Study|Adverse Event|3
5135451|NCT01599754|17738603|P2|Overall Study|Death|33
5135452|NCT01599754|17738604|P1|Overall Study|Death|31
5135453|NCT01599754|17738603|P2|Overall Study|Lost to Follow-up|6
5135454|NCT01599754|17738604|P1|Overall Study|Lost to Follow-up|13
5135455|NCT01599754|17738603|P2|Overall Study|Participant noncompliance|4
5135456|NCT01599754|17738604|P1|Overall Study|Participant noncompliance|4
5135457|NCT01599754|17738603|P2|Overall Study|Anticancer therapy need not in protocol|2
5135458|NCT01599754|17738604|P1|Overall Study|Anticancer therapy need not in protocol|5
5135459|NCT01599650|17738635|P3|Overall Study|Adverse Event|4
5135460|NCT01599650|17738636|P2|Overall Study|Adverse Event|8
5135461|NCT01599650|17738637|P1|Overall Study|Adverse Event|3
5135462|NCT01599650|17738635|P3|Overall Study|Withdrawal by Subject|10
5135463|NCT01599650|17738636|P2|Overall Study|Withdrawal by Subject|11
5135464|NCT01599650|17738637|P1|Overall Study|Withdrawal by Subject|11
5135465|NCT01599650|17738635|P3|Overall Study|Lost to Follow-up|3
5135466|NCT01599650|17738636|P2|Overall Study|Lost to Follow-up|3
5135467|NCT01599650|17738637|P1|Overall Study|Lost to Follow-up|3
5135468|NCT01599650|17738635|P3|Overall Study|Death|2
5135469|NCT01599650|17738636|P2|Overall Study|Death|1
5135470|NCT01599650|17738637|P1|Overall Study|Death|2
5135471|NCT01599650|17738635|P3|Overall Study|Protocol Violation|0
5135472|NCT01599650|17738636|P2|Overall Study|Protocol Violation|3
5135473|NCT01599650|17738637|P1|Overall Study|Protocol Violation|0
5135474|NCT01599650|17738635|P3|Overall Study|Physician Decision|7
5135475|NCT01599650|17738636|P2|Overall Study|Physician Decision|0
5135476|NCT01599650|17738637|P1|Overall Study|Physician Decision|2
5135477|NCT01599650|17738635|P3|Overall Study|Administrative issue|1
5135478|NCT01599650|17738636|P2|Overall Study|Administrative issue|0
5135479|NCT01599650|17738637|P1|Overall Study|Administrative issue|1
5135480|NCT01599637|17738676|P3|Overall Study|Adverse Event|0
5135481|NCT01599637|17738677|P2|Overall Study|Adverse Event|0
5135482|NCT01599637|17738678|P1|Overall Study|Adverse Event|1
5135483|NCT01599637|17738676|P3|Overall Study|administrative problems|0
5135484|NCT01599637|17738677|P2|Overall Study|administrative problems|2
5135485|NCT01599637|17738678|P1|Overall Study|administrative problems|0
5135486|NCT01599585|17738725|P2|Overall Study|randomized did not start treatment|3
5135487|NCT01599585|17738726|P1|Overall Study|randomized did not start treatment|3
5135488|NCT01599585|17738725|P2|Overall Study|Lost to Follow-up|5
5135489|NCT01599585|17738726|P1|Overall Study|Lost to Follow-up|3
5135490|NCT01599585|17738725|P2|Overall Study|Withdrawal by Subject|9
5135491|NCT01599585|17738726|P1|Overall Study|Withdrawal by Subject|16
5135492|NCT01599325|17738764|P1|Extension Phase|Withdrawal by Subject|8
5135493|NCT01599325|17738764|P1|Extension Phase|Disease Progression|1
5135494|NCT01599325|17738764|P1|Extension Phase|Lack of Therapeutic Effect|4
5135495|NCT01599325|17738764|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
5135496|NCT01599325|17738764|P1|Extension Phase|Study Closure|1
5135497|NCT01599325|17738764|P1|Primary Parent Phase|Other|2
5135498|NCT01599325|17738764|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
5135499|NCT01599325|17738764|P1|Primary Parent Phase|Protocol Violation|1
5135500|NCT01599325|17738764|P1|Primary Parent Phase|Death|13
5135501|NCT01599325|17738764|P1|Primary Parent Phase|Withdrawal by Subject|20
5135502|NCT01599325|17738764|P1|Primary Parent Phase|Disease Progression|7
5135503|NCT01599325|17738764|P1|Primary Parent Phase|Adverse Event|5
5135504|NCT01599234|17738788|P2|Overall Study|Pregnancy|1
5135505|NCT01599234|17738789|P1|Overall Study|Pregnancy|0
5135506|NCT01599234|17738788|P2|Overall Study|Contra-indication discovered|1
5135507|NCT01599234|17738789|P1|Overall Study|Contra-indication discovered|0
5135508|NCT01599234|17738788|P2|Overall Study|Patient would not stop driving|0
5135509|NCT01599234|17738789|P1|Overall Study|Patient would not stop driving|1
5135510|NCT01599234|17738788|P2|Overall Study|Death|0
5135511|NCT01599234|17738789|P1|Overall Study|Death|1
5135512|NCT01599234|17738788|P2|Overall Study|Sponsor request as creatinine levels <50|1
5135513|NCT01599234|17738789|P1|Overall Study|Sponsor request as creatinine levels <50|0
5135514|NCT01599234|17738788|P2|Overall Study|Unable to operate spray|0
5135515|NCT01599234|17738789|P1|Overall Study|Unable to operate spray|1
5135516|NCT01599234|17738788|P2|Overall Study|Lack of Efficacy|4
5135517|NCT01599234|17738789|P1|Overall Study|Lack of Efficacy|2
5135518|NCT01599234|17738788|P2|Overall Study|Lost to Follow-up|2
5135519|NCT01599234|17738789|P1|Overall Study|Lost to Follow-up|1
5135520|NCT01599234|17738788|P2|Overall Study|Withdrawal by Subject|1
5135521|NCT01599234|17738789|P1|Overall Study|Withdrawal by Subject|2
5135522|NCT01599234|17738788|P2|Overall Study|Adverse Event|5
5135523|NCT01599234|17738789|P1|Overall Study|Adverse Event|9
5135524|NCT01599104|17738814|P3|Overall Study|Adverse Event|12
5135525|NCT01599104|17738815|P2|Overall Study|Adverse Event|6
5135526|NCT01599104|17738816|P1|Overall Study|Adverse Event|7
5135527|NCT01599104|17738814|P3|Overall Study|Lack of Efficacy|10
5135528|NCT01599104|17738815|P2|Overall Study|Lack of Efficacy|4
5135529|NCT01599104|17738816|P1|Overall Study|Lack of Efficacy|4
5135530|NCT01599104|17738814|P3|Overall Study|Non-compliance with study treatment|0
5135531|NCT01599104|17738815|P2|Overall Study|Non-compliance with study treatment|1
5135532|NCT01599104|17738816|P1|Overall Study|Non-compliance with study treatment|0
5135533|NCT01599104|17738814|P3|Overall Study|Physician Decision|2
5135534|NCT01599104|17738815|P2|Overall Study|Physician Decision|2
5135535|NCT01599104|17738816|P1|Overall Study|Physician Decision|3
5135536|NCT01599104|17738814|P3|Overall Study|Technical Problems|0
5135537|NCT01599104|17738815|P2|Overall Study|Technical Problems|0
5135538|NCT01599104|17738816|P1|Overall Study|Technical Problems|1
5135539|NCT01599104|17738814|P3|Overall Study|Withdrawal by Subject|2
5135540|NCT01599104|17738815|P2|Overall Study|Withdrawal by Subject|1
5135541|NCT01599104|17738816|P1|Overall Study|Withdrawal by Subject|1
5135542|NCT01598987|17738854|P1|Baseline to 24 Month|Lost to Follow-up|1
5135543|NCT01598987|17738854|P1|Baseline to 24 Month|Administrative problems|2
5135544|NCT01598987|17738854|P1|Baseline to 24 Month|Withdrawal by Subject|5
5135545|NCT01598987|17738854|P1|Baseline to Month 12|Withdrawal by Subject|4
5135546|NCT01598987|17738854|P1|Baseline to Month 12|Administrative problems|2
5135547|NCT01598896|17738890|P2|Overall Study|Lack of Efficacy|1
5135548|NCT01598896|17738891|P1|Overall Study|Lack of Efficacy|0
5135549|NCT01598896|17738890|P2|Overall Study|Withdrawal by Subject|1
5135550|NCT01598896|17738891|P1|Overall Study|Withdrawal by Subject|0
5135551|NCT01598753|17738930|P4|Overall Study|Withdrawal by Subject|1
5135552|NCT01598753|17738931|P3|Overall Study|Withdrawal by Subject|0
5135553|NCT01598753|17738932|P2|Overall Study|Withdrawal by Subject|2
5135554|NCT01598753|17738933|P1|Overall Study|Withdrawal by Subject|7
5135555|NCT01598753|17738930|P4|Overall Study|Physician Decision|2
5135556|NCT01598753|17738931|P3|Overall Study|Physician Decision|0
5135557|NCT01598753|17738932|P2|Overall Study|Physician Decision|1
5135558|NCT01598753|17738933|P1|Overall Study|Physician Decision|0
5135559|NCT01598753|17738930|P4|Overall Study|Lost to Follow-up|5
5135560|NCT01598753|17738931|P3|Overall Study|Lost to Follow-up|7
5135561|NCT01598753|17738932|P2|Overall Study|Lost to Follow-up|3
5135562|NCT01598753|17738933|P1|Overall Study|Lost to Follow-up|4
5135563|NCT01598753|17738930|P4|Overall Study|Adverse Event|7
5135564|NCT01598753|17738931|P3|Overall Study|Adverse Event|1
5135565|NCT01598753|17738932|P2|Overall Study|Adverse Event|9
5135566|NCT01598753|17738933|P1|Overall Study|Adverse Event|1
5135567|NCT01598662|17738973|P2|Overall Study|IUD expelled before month 6|2
5135568|NCT01598662|17738974|P1|Overall Study|IUD expelled before month 6|0
5135569|NCT01598662|17738973|P2|Overall Study|Physician Decision|2
5135570|NCT01598662|17738974|P1|Overall Study|Physician Decision|1
5135571|NCT01598662|17738973|P2|Overall Study|Lost to Follow-up|17
5135572|NCT01598662|17738974|P1|Overall Study|Lost to Follow-up|10
5135573|NCT01598610|17738980|P1|Overall Study|Adverse Event|1
5135574|NCT01598532|17738997|P1|Overall Study|Did not meet inclusion criteria|8
5135575|NCT01598532|17738997|P1|Overall Study|Lost to Follow-up|3
5135576|NCT01598506|17739006|P1|Overall Study|Withdrawal by Subject|2
5135577|NCT01598311|17739026|P2|Overall Study|Assigned to CB but received vancomycin|0
5135578|NCT01598311|17739027|P1|Overall Study|Assigned to CB but received vancomycin|1
5135579|NCT01598311|17739026|P2|Overall Study|Treated but no confirmed CDAD|8
5135580|NCT01598311|17739027|P1|Overall Study|Treated but no confirmed CDAD|9
5135581|NCT01598311|17739026|P2|Overall Study|Randomized but never treated|5
5135582|NCT01598311|17739027|P1|Overall Study|Randomized but never treated|8
5135583|NCT01598311|17739026|P2|Overall Study|No reason provided.|5
5135584|NCT01598311|17739027|P1|Overall Study|No reason provided.|0
5135585|NCT01598311|17739026|P2|Overall Study|Withdrawal by Subject|13
5135586|NCT01598311|17739027|P1|Overall Study|Withdrawal by Subject|9
5135587|NCT01598311|17739026|P2|Overall Study|Lost to Follow-up|12
5135588|NCT01598311|17739027|P1|Overall Study|Lost to Follow-up|7
5135589|NCT01598311|17739026|P2|Overall Study|Adverse Event|13
5135590|NCT01598311|17739027|P1|Overall Study|Adverse Event|9
5135591|NCT01598311|17739026|P2|Overall Study|Physician Decision|5
5135592|NCT01598311|17739027|P1|Overall Study|Physician Decision|4
5135593|NCT01598298|17739043|P2|Overall Study|Other reason (not protocol specified)|0
5135594|NCT01598298|17739044|P1|Overall Study|Other reason (not protocol specified)|4
5135595|NCT01598298|17739043|P2|Overall Study|Withdrawal by Subject|15
5135596|NCT01598298|17739044|P1|Overall Study|Withdrawal by Subject|10
5135597|NCT01598298|17739043|P2|Overall Study|Progression/relapse|2
5135598|NCT01598298|17739044|P1|Overall Study|Progression/relapse|0
5135599|NCT01598298|17739043|P2|Overall Study|Adverse Event|19
5135600|NCT01598298|17739044|P1|Overall Study|Adverse Event|21
5135601|NCT01598298|17739043|P2|Overall Study|Not eligible|5
5135602|NCT01598298|17739044|P1|Overall Study|Not eligible|5
5135603|NCT01598129|17739088|P1|Overall Study|Withdrawal by Subject|1
5135604|NCT01598129|17739088|P1|Overall Study|Deterioration of WHO status to WHO 4|2
5135605|NCT01598129|17739088|P1|Overall Study|Disease progression|6
5135606|NCT01598090|17739100|P3|Follow-up Period|Lost to Follow-up|12
5135607|NCT01598090|17739101|P2|Follow-up Period|Lost to Follow-up|10
5135608|NCT01598090|17739102|P1|Follow-up Period|Lost to Follow-up|2
5135609|NCT01598090|17739100|P3|Follow-up Period|Other reasons|8
5135610|NCT01598090|17739101|P2|Follow-up Period|Other reasons|8
5135611|NCT01598090|17739102|P1|Follow-up Period|Other reasons|2
5135612|NCT01598090|17739100|P3|Follow-up Period|Withdrawal by Subject|2
5135613|NCT01598090|17739101|P2|Follow-up Period|Withdrawal by Subject|3
5135614|NCT01598090|17739102|P1|Follow-up Period|Withdrawal by Subject|0
5135615|NCT01598090|17739100|P3|Follow-up Period|Not reported|4
5135616|NCT01598090|17739101|P2|Follow-up Period|Not reported|10
5135617|NCT01598090|17739102|P1|Follow-up Period|Not reported|0
5135618|NCT01598090|17739100|P3|Follow-up Period|No longer required per protocol|2
5135619|NCT01598090|17739101|P2|Follow-up Period|No longer required per protocol|3
5135620|NCT01598090|17739102|P1|Follow-up Period|No longer required per protocol|1
5135621|NCT01598090|17739100|P3|Follow-up Period|Death|0
5135622|NCT01598090|17739101|P2|Follow-up Period|Death|1
5135623|NCT01598090|17739102|P1|Follow-up Period|Death|0
5135624|NCT01598090|17739100|P3|Treatment Period|Lost to Follow-up|1
5135625|NCT01598090|17739101|P2|Treatment Period|Lost to Follow-up|5
5135626|NCT01598090|17739102|P1|Treatment Period|Lost to Follow-up|1
5135627|NCT01598090|17739100|P3|Treatment Period|Withdrawal by Subject|10
5135628|NCT01598090|17739101|P2|Treatment Period|Withdrawal by Subject|13
5135629|NCT01598090|17739102|P1|Treatment Period|Withdrawal by Subject|3
5135630|NCT01598090|17739100|P3|Treatment Period|Other reasons|1
5135631|NCT01598090|17739101|P2|Treatment Period|Other reasons|4
5135632|NCT01598090|17739102|P1|Treatment Period|Other reasons|0
5135633|NCT01598090|17739100|P3|Treatment Period|Adverse Event|17
5135634|NCT01598090|17739101|P2|Treatment Period|Adverse Event|33
5135635|NCT01598090|17739102|P1|Treatment Period|Adverse Event|2
5135636|NCT01598090|17739100|P3|Treatment Period|Lack of Efficacy|6
5135637|NCT01598090|17739101|P2|Treatment Period|Lack of Efficacy|14
5135638|NCT01598090|17739102|P1|Treatment Period|Lack of Efficacy|5
5135639|NCT01598090|17739100|P3|Treatment Period|No longer meet study criteria|0
5135640|NCT01598090|17739101|P2|Treatment Period|No longer meet study criteria|1
5135641|NCT01598090|17739102|P1|Treatment Period|No longer meet study criteria|0
5135642|NCT01598090|17739100|P3|Treatment Period|Poor/non-compliance|0
5135643|NCT01598090|17739101|P2|Treatment Period|Poor/non-compliance|2
5135644|NCT01598090|17739102|P1|Treatment Period|Poor/non-compliance|0
5135645|NCT01597908|17739149|P2|Overall Study|Ongoing|202
5135646|NCT01597908|17739150|P1|Overall Study|Ongoing|236
5135647|NCT01597908|17739149|P2|Overall Study|Withdrawal by Subject|18
5135648|NCT01597908|17739150|P1|Overall Study|Withdrawal by Subject|10
5135649|NCT01597908|17739149|P2|Overall Study|Physician Decision|1
5135650|NCT01597908|17739150|P1|Overall Study|Physician Decision|2
5135651|NCT01597908|17739149|P2|Overall Study|Lost to Follow-up|9
5135652|NCT01597908|17739150|P1|Overall Study|Lost to Follow-up|4
5135653|NCT01597908|17739149|P2|Overall Study|Death|122
5135654|NCT01597908|17739150|P1|Overall Study|Death|100
5135655|NCT01597791|17739196|P2|Overall Study|Protocol Violation|1
5135656|NCT01597791|17739197|P1|Overall Study|Protocol Violation|0
5135657|NCT01597791|17739196|P2|Overall Study|Subject withdrawal|1
5135658|NCT01597791|17739197|P1|Overall Study|Subject withdrawal|0
5135659|NCT01597791|17739196|P2|Overall Study|Cesarean Section|7
5135660|NCT01597791|17739197|P1|Overall Study|Cesarean Section|6
5135661|NCT01597791|17739196|P2|Overall Study|Physician Decision|1
5135662|NCT01597791|17739197|P1|Overall Study|Physician Decision|2
5135663|NCT01597635|17739284|P3|Part B|Withdrawal by Subject|0
5135664|NCT01597635|17739285|P2|Part B|Withdrawal by Subject|1
5135665|NCT01597635|17739286|P1|Part B|Withdrawal by Subject|0
5135666|NCT01597635|17739284|P3|Part B|Protocol-defined stopping criteria|3
5135667|NCT01597635|17739285|P2|Part B|Protocol-defined stopping criteria|4
5135668|NCT01597635|17739286|P1|Part B|Protocol-defined stopping criteria|0
5135669|NCT01597635|17739284|P3|Part B|Protocol Violation|0
5135670|NCT01597635|17739285|P2|Part B|Protocol Violation|1
5135671|NCT01597635|17739286|P1|Part B|Protocol Violation|0
5135672|NCT01597635|17739284|P3|Part B|Adverse Event|1
5135673|NCT01597635|17739285|P2|Part B|Adverse Event|0
5135674|NCT01597635|17739286|P1|Part B|Adverse Event|0
5135675|NCT01597635|17739284|P3|Part A|Adverse Event|0
5135676|NCT01597635|17739285|P2|Part A|Adverse Event|0
5135677|NCT01597635|17739286|P1|Part A|Adverse Event|3
5135678|NCT01597622|17739349|P1|Overall Study|Death|1
5135679|NCT01597622|17739349|P1|Overall Study|Withdrawal by Subject|20
5135680|NCT01597622|17739349|P1|Overall Study|Investigator Discretion|5
5135681|NCT01597622|17739349|P1|Overall Study|Lost to Follow-up|1
5135682|NCT01597622|17739349|P1|Overall Study|Protocol Violation|1
5135683|NCT01597622|17739349|P1|Overall Study|Lack of Efficacy|3
5135684|NCT01597622|17739349|P1|Overall Study|Adverse Event|7
5135685|NCT01597596|17739356|P2|Overall Study|Physician Decision|1
5135686|NCT01597596|17739357|P1|Overall Study|Physician Decision|0
5135687|NCT01597596|17739356|P2|Overall Study|Study terminated by sponsor|0
5135688|NCT01597596|17739357|P1|Overall Study|Study terminated by sponsor|1
5135689|NCT01597557|17739371|P2|Overall Study|Did not undergo cardioversion procedure|3
5135690|NCT01597557|17739372|P1|Overall Study|Did not undergo cardioversion procedure|4
5135691|NCT01597505|17739384|P2|Overall Study|Missing|0
5135692|NCT01597505|17739385|P1|Overall Study|Missing|1
5135693|NCT01597505|17739384|P2|Overall Study|Other|6
5135694|NCT01597505|17739385|P1|Overall Study|Other|5
5135695|NCT01597505|17739384|P2|Overall Study|Withdrawal by Subject|18
5135696|NCT01597505|17739385|P1|Overall Study|Withdrawal by Subject|10
5135697|NCT01597505|17739384|P2|Overall Study|Lost to Follow-up|2
5135698|NCT01597505|17739385|P1|Overall Study|Lost to Follow-up|4
5135699|NCT01597505|17739384|P2|Overall Study|Adverse Event|7
5135700|NCT01597505|17739385|P1|Overall Study|Adverse Event|19
5135701|NCT01597505|17739384|P2|Overall Study|Physician Decision|0
5135702|NCT01597505|17739385|P1|Overall Study|Physician Decision|5
5135703|NCT01597492|17739419|P2|Overall Study|Other Reason|0
5135704|NCT01597492|17739420|P1|Overall Study|Other Reason|2
5135705|NCT01597492|17739419|P2|Overall Study|Lost to Follow-up|2
5135706|NCT01597492|17739420|P1|Overall Study|Lost to Follow-up|0
5135707|NCT01597492|17739419|P2|Overall Study|Adverse Event|0
5135708|NCT01597492|17739420|P1|Overall Study|Adverse Event|3
5135709|NCT01597492|17739419|P2|Overall Study|Withdrawal by Subject|2
5135710|NCT01597492|17739420|P1|Overall Study|Withdrawal by Subject|1
5135711|NCT01597479|17739428|P2|Overall Study|Lost to Follow-up|0
5135712|NCT01597479|17739429|P1|Overall Study|Lost to Follow-up|1
5135713|NCT01597479|17739428|P2|Overall Study|Protocol Violation|0
5135714|NCT01597479|17739429|P1|Overall Study|Protocol Violation|1
5135715|NCT01597375|17739715|P2|Second Intervention|Failed to react at both Aspirin|1
5135716|NCT01597375|17739716|P1|Second Intervention|Failed to react at both Aspirin|1
5135717|NCT01597375|17739715|P2|Washout (2 Weeks)|Adverse Event|0
5135718|NCT01597375|17739716|P1|Washout (2 Weeks)|Adverse Event|1
5135719|NCT01597375|17739715|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
5135720|NCT01597375|17739716|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
5135721|NCT01597375|17739715|P2|First Intervention (4 Weeks)|Needed surgery|0
5135722|NCT01597375|17739716|P1|First Intervention (4 Weeks)|Needed surgery|1
5135723|NCT01597375|17739715|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
5135724|NCT01597375|17739716|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
5135725|NCT01597258|17739733|P1|Overall Study|No Drug Administration|1
5135726|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135727|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
5135728|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135729|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135730|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135731|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135732|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135733|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135734|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135735|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135736|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135737|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135738|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135739|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135740|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135741|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135742|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135743|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135744|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135745|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135746|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5135747|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135748|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
5135749|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135750|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135751|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
5135752|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135753|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135754|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135755|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135756|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135757|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135758|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135759|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135760|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135761|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135762|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135763|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135764|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135765|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135766|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135767|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5135768|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135769|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
5135770|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135771|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135772|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
5135773|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135774|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135775|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135776|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135777|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135778|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135779|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135780|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135781|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135782|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135783|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135784|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135785|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135786|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135787|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135788|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5135789|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
5135790|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
5135791|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135792|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135793|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
5135794|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135795|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135796|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135797|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135798|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135799|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135800|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135801|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135802|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135803|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135804|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135805|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135806|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135807|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135808|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135809|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5135810|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
5135811|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
5135812|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135813|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135814|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
5135815|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135816|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135817|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135818|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135819|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135820|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135821|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135822|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135823|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135824|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135825|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135826|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135827|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135828|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135829|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135830|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5135831|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
5135832|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
5135833|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
5135834|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135835|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135836|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135837|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135838|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135839|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135840|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135841|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135842|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135843|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135844|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135845|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135846|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135847|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135848|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135849|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135850|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135851|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5135852|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
5135853|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
5135854|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135855|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135856|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
5135857|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135858|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135859|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135860|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135861|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135862|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135863|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135864|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135865|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135866|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135867|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135868|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135869|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135870|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135871|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135872|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5135873|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
5135874|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
5135875|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
5135876|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
5135877|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135878|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135879|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135880|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135881|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135882|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135883|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135884|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135885|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135886|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135887|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135888|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135889|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135890|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135891|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135892|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135893|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5135894|NCT01597245|17739742|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
5135895|NCT01597245|17739743|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
5135896|NCT01597245|17739744|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
5135897|NCT01597245|17739745|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
5135898|NCT01597245|17739746|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
5135899|NCT01597245|17739747|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135900|NCT01597245|17739748|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135901|NCT01597245|17739749|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135902|NCT01597245|17739750|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135903|NCT01597245|17739751|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135904|NCT01597245|17739752|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135905|NCT01597245|17739753|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135906|NCT01597245|17739754|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135907|NCT01597245|17739755|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135908|NCT01597245|17739756|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135909|NCT01597245|17739757|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5136556|NCT01595009|17740529|P2|Core|Lost to Follow-up|2
5135910|NCT01597245|17739758|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135911|NCT01597245|17739759|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135912|NCT01597245|17739760|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135913|NCT01597245|17739761|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135914|NCT01597245|17739762|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5135915|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135916|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135917|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135918|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135919|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135920|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135921|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135922|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
5135923|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135924|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135925|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135926|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135927|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135928|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135929|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135930|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135931|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135932|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135933|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135934|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135935|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5135936|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135937|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135938|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135939|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135940|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135941|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
5135942|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
5135943|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135944|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135945|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135946|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135947|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135948|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135949|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135950|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135951|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135952|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135953|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135954|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135955|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135956|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5135957|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135958|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135959|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135960|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135961|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135962|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
5135963|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
5135964|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135965|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135966|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135967|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135968|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135969|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135970|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135971|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135972|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135973|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135974|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135975|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135976|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5135977|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5136557|NCT01595009|17740530|P1|Core|Lost to Follow-up|1
5135978|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135979|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135980|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135981|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135982|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135983|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
5135984|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
5135985|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135986|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135987|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135988|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135989|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135990|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135991|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135992|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135993|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135994|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135995|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135996|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135997|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135998|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5135999|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Death|0
5136000|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Death|0
5136001|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Death|0
5136002|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Death|0
5136003|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Death|0
5136004|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Death|8
5136005|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Death|8
5136006|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Death|0
5136007|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Death|0
5136008|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Death|0
5136009|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Death|0
5136010|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Death|0
5136011|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Death|0
5136012|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Death|0
5136013|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Death|0
5136014|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Death|0
5136015|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Death|0
5136016|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Death|0
5136017|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Death|0
5136018|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Death|0
5136019|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Death|0
5136020|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136021|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136022|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136023|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136024|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136025|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
5136026|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
5136027|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
5136028|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136029|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136030|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136031|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136032|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136033|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136034|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136035|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136036|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136037|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136038|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136039|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136040|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5136041|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136042|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136043|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136044|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136045|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136046|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
5136047|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
5136048|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136558|NCT01595009|17740527|P4|Core|Death|0
5136049|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136050|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136051|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136052|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136053|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136054|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136055|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136056|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136057|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136058|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136059|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136060|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136061|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5136062|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136063|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136064|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136065|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136066|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136067|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
5136068|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
5136069|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136070|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136071|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136072|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136073|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136074|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136075|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136076|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136077|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136078|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136079|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136080|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136081|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136082|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5136083|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136084|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136085|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136086|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136087|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136088|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
5136089|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
5136090|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
5136091|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136092|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136093|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136094|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136095|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136096|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136097|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136098|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136099|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136100|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136101|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136102|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136103|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5136104|NCT01597245|17739742|P21|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136105|NCT01597245|17739743|P20|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136106|NCT01597245|17739744|P19|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136107|NCT01597245|17739745|P18|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136108|NCT01597245|17739746|P17|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136109|NCT01597245|17739747|P16|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
5136110|NCT01597245|17739748|P15|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
5136111|NCT01597245|17739749|P14|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
5136112|NCT01597245|17739750|P13|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136113|NCT01597245|17739751|P12|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136114|NCT01597245|17739752|P11|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136115|NCT01597245|17739753|P10|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136116|NCT01597245|17739754|P9|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136559|NCT01595009|17740528|P3|Core|Death|0
5136117|NCT01597245|17739755|P8|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136118|NCT01597245|17739756|P7|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136119|NCT01597245|17739757|P6|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136120|NCT01597245|17739758|P5|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136121|NCT01597245|17739759|P4|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136122|NCT01597245|17739760|P3|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136123|NCT01597245|17739761|P2|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136124|NCT01597245|17739762|P1|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5136125|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136126|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136127|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136128|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136129|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136130|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136131|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136132|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136133|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136134|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136135|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
5136136|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136137|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136138|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136139|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136140|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136141|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136142|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136143|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136144|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136145|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5136146|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136147|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136148|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136149|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136150|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136151|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136152|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136153|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136154|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136155|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5136156|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5136157|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5136158|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5136159|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136160|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136161|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5136162|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136163|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136164|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136165|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136166|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5136167|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136168|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136169|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136170|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136171|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136172|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136173|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136174|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136175|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5136176|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5136177|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5136178|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5136179|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5136180|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136181|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5136182|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
5136183|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
5136184|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136185|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136186|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136187|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5136188|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136189|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136190|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136191|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136192|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136193|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136194|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136195|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136196|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5136197|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136198|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
5136199|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5136200|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
5136201|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136202|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136203|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136204|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5136205|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136206|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136207|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136208|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5136209|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136210|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136211|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136212|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136213|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136214|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136215|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136216|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136217|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
5136218|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
5136219|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
5136220|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
5136221|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
5136222|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136223|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
5136224|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
5136225|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
5136226|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136227|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136228|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136229|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5136230|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136231|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136232|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136233|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136234|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136235|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136236|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136237|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136238|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
5136239|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
5136240|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
5136241|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
5136242|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
5136243|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
5136244|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
5136245|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
5136246|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
5136247|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136248|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136249|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136250|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5136251|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136252|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136253|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136254|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136560|NCT01595009|17740529|P2|Core|Death|6
5136255|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136256|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136257|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136258|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136259|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
5136260|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
5136261|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
5136262|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136263|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
5136264|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136265|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136266|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
5136267|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136268|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136269|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136270|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136271|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5136272|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136273|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136274|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136275|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136276|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136277|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136278|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136279|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136280|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136281|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136282|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136283|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|114
5136284|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136285|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
5136286|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|80
5136287|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|22
5136288|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|150
5136289|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136290|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136291|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136292|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5136293|NCT01597245|17739742|P21|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136294|NCT01597245|17739743|P20|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136295|NCT01597245|17739744|P19|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136296|NCT01597245|17739745|P18|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136297|NCT01597245|17739746|P17|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136298|NCT01597245|17739747|P16|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136299|NCT01597245|17739748|P15|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136300|NCT01597245|17739749|P14|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136301|NCT01597245|17739750|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136302|NCT01597245|17739751|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136303|NCT01597245|17739752|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136304|NCT01597245|17739753|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136305|NCT01597245|17739754|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136306|NCT01597245|17739755|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136307|NCT01597245|17739756|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
5136308|NCT01597245|17739757|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
5136309|NCT01597245|17739758|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136310|NCT01597245|17739759|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136311|NCT01597245|17739760|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136312|NCT01597245|17739761|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136313|NCT01597245|17739762|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5136314|NCT01597245|17739742|P21|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136315|NCT01597245|17739743|P20|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136316|NCT01597245|17739744|P19|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136317|NCT01597245|17739745|P18|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136318|NCT01597245|17739746|P17|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136319|NCT01597245|17739747|P16|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136320|NCT01597245|17739748|P15|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136321|NCT01597245|17739749|P14|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136322|NCT01597245|17739750|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136323|NCT01597245|17739751|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136324|NCT01597245|17739752|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136325|NCT01597245|17739753|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136561|NCT01595009|17740530|P1|Core|Death|3
5136326|NCT01597245|17739754|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136327|NCT01597245|17739755|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136328|NCT01597245|17739756|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136329|NCT01597245|17739757|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136330|NCT01597245|17739758|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136331|NCT01597245|17739759|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5136332|NCT01597245|17739760|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
5136333|NCT01597245|17739761|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
5136334|NCT01597245|17739762|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
5136335|NCT01597245|17739742|P21|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136336|NCT01597245|17739743|P20|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136337|NCT01597245|17739744|P19|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136338|NCT01597245|17739745|P18|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136339|NCT01597245|17739746|P17|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136340|NCT01597245|17739747|P16|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136341|NCT01597245|17739748|P15|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136342|NCT01597245|17739749|P14|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136343|NCT01597245|17739750|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136344|NCT01597245|17739751|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136345|NCT01597245|17739752|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136346|NCT01597245|17739753|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136347|NCT01597245|17739754|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136348|NCT01597245|17739755|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136349|NCT01597245|17739756|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136350|NCT01597245|17739757|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136351|NCT01597245|17739758|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136352|NCT01597245|17739759|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
5136353|NCT01597245|17739760|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136354|NCT01597245|17739761|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
5136355|NCT01597245|17739762|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
5136356|NCT01597245|17739742|P21|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136357|NCT01597245|17739743|P20|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136358|NCT01597245|17739744|P19|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136359|NCT01597245|17739745|P18|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136360|NCT01597245|17739746|P17|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136361|NCT01597245|17739747|P16|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136362|NCT01597245|17739748|P15|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136363|NCT01597245|17739749|P14|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136364|NCT01597245|17739750|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136365|NCT01597245|17739751|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136366|NCT01597245|17739752|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136367|NCT01597245|17739753|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136368|NCT01597245|17739754|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136369|NCT01597245|17739755|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136370|NCT01597245|17739756|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136371|NCT01597245|17739757|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136372|NCT01597245|17739758|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136373|NCT01597245|17739759|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5136374|NCT01597245|17739760|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
5136375|NCT01597245|17739761|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
5136376|NCT01597245|17739762|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
5136377|NCT01597245|17739742|P21|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136378|NCT01597245|17739743|P20|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136379|NCT01597245|17739744|P19|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136380|NCT01597245|17739745|P18|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136381|NCT01597245|17739746|P17|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136382|NCT01597245|17739747|P16|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136383|NCT01597245|17739748|P15|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136384|NCT01597245|17739749|P14|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136385|NCT01597245|17739750|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136386|NCT01597245|17739751|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136387|NCT01597245|17739752|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136388|NCT01597245|17739753|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136389|NCT01597245|17739754|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136390|NCT01597245|17739755|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136391|NCT01597245|17739756|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136392|NCT01597245|17739757|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136393|NCT01597245|17739758|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5136394|NCT01597245|17739759|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
5136395|NCT01597245|17739760|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
5136396|NCT01597245|17739761|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
5136397|NCT01597245|17739762|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
5136398|NCT01597245|17739742|P21|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136399|NCT01597245|17739743|P20|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136400|NCT01597245|17739744|P19|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136401|NCT01597245|17739745|P18|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136402|NCT01597245|17739746|P17|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136403|NCT01597245|17739747|P16|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136404|NCT01597245|17739748|P15|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136405|NCT01597245|17739749|P14|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136406|NCT01597245|17739750|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136407|NCT01597245|17739751|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136408|NCT01597245|17739752|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136409|NCT01597245|17739753|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136410|NCT01597245|17739754|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136411|NCT01597245|17739755|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136412|NCT01597245|17739756|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136413|NCT01597245|17739757|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136414|NCT01597245|17739758|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5136415|NCT01597245|17739759|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
5136416|NCT01597245|17739760|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
5136417|NCT01597245|17739761|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
5136418|NCT01597245|17739762|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
5136419|NCT01597245|17739742|P21|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136420|NCT01597245|17739743|P20|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136421|NCT01597245|17739744|P19|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136422|NCT01597245|17739745|P18|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136423|NCT01597245|17739746|P17|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136424|NCT01597245|17739747|P16|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136425|NCT01597245|17739748|P15|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136426|NCT01597245|17739749|P14|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136427|NCT01597245|17739750|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136428|NCT01597245|17739751|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136429|NCT01597245|17739752|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136430|NCT01597245|17739753|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136431|NCT01597245|17739754|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136432|NCT01597245|17739755|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136433|NCT01597245|17739756|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136434|NCT01597245|17739757|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136435|NCT01597245|17739758|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
5136436|NCT01597245|17739759|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
5136437|NCT01597245|17739760|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
5136438|NCT01597245|17739761|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
5136439|NCT01597245|17739762|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
5136440|NCT01597193|17739860|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5136441|NCT01597193|17739861|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
5136442|NCT01597193|17739862|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5136443|NCT01597193|17739863|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
5136444|NCT01597193|17739864|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5136445|NCT01597193|17739865|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5136446|NCT01597193|17739866|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5136447|NCT01597193|17739860|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
5136448|NCT01597193|17739861|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
5136449|NCT01597193|17739862|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
5136450|NCT01597193|17739863|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
5136451|NCT01597193|17739864|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
5136452|NCT01597193|17739865|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
5136453|NCT01597193|17739866|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
5136454|NCT01597193|17739860|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
5136455|NCT01597193|17739861|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
5136456|NCT01597193|17739862|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
5136457|NCT01597193|17739863|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
5136458|NCT01597193|17739864|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
5136459|NCT01597193|17739865|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
5136460|NCT01597193|17739866|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
5136461|NCT01597193|17739860|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5136462|NCT01597193|17739861|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
5136463|NCT01597193|17739862|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
5136464|NCT01597193|17739863|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
5136465|NCT01597193|17739864|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5136466|NCT01597193|17739865|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5136467|NCT01597193|17739866|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5136468|NCT01597193|17739860|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5136469|NCT01597193|17739861|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5136470|NCT01597193|17739862|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5136471|NCT01597193|17739863|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5136472|NCT01597193|17739864|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5136473|NCT01597193|17739865|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
5136474|NCT01597193|17739866|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
5136475|NCT01597050|17739985|P2|Overall Study|Withdrawal by Subject|0
5136476|NCT01597050|17739986|P1|Overall Study|Withdrawal by Subject|1
5136477|NCT01596972|17739994|P2|Overall Study|Withdrawal by Subject|1
5136478|NCT01596972|17739995|P1|Overall Study|Withdrawal by Subject|0
5136479|NCT01596972|17739994|P2|Overall Study|Lost to Follow-up|4
5136480|NCT01596972|17739995|P1|Overall Study|Lost to Follow-up|0
5136481|NCT01596972|17739994|P2|Overall Study|Physician Decision|9
5136482|NCT01596972|17739995|P1|Overall Study|Physician Decision|1
5136483|NCT01596582|17740067|P2|Overall Study|Missing all outcome data|1
5136484|NCT01596582|17740068|P1|Overall Study|Missing all outcome data|1
5136485|NCT01596582|17740067|P2|Overall Study|Deemed ineligible after study visit|6
5136486|NCT01596582|17740068|P1|Overall Study|Deemed ineligible after study visit|3
5136487|NCT01596504|17740095|P3|Overall Study|Withdrawal by Subject|0
5136488|NCT01596504|17740096|P2|Overall Study|Withdrawal by Subject|0
5136489|NCT01596504|17740097|P1|Overall Study|Withdrawal by Subject|1
5136490|NCT01596504|17740095|P3|Overall Study|Adverse Event|1
5136491|NCT01596504|17740096|P2|Overall Study|Adverse Event|2
5136492|NCT01596504|17740097|P1|Overall Study|Adverse Event|1
5136493|NCT01596504|17740095|P3|Overall Study|Participant's Private Reason|0
5136494|NCT01596504|17740096|P2|Overall Study|Participant's Private Reason|1
5136495|NCT01596504|17740097|P1|Overall Study|Participant's Private Reason|0
5136496|NCT01596335|17740155|P2|Overall Study|exacerbation of primary disease|9
5136497|NCT01596335|17740156|P1|Overall Study|exacerbation of primary disease|5
5136498|NCT01596127|17740192|P1|Overall Study|Patient Ineligible|1
5136499|NCT01596062|17740204|P3|Overall Study|Lack of Efficacy|1
5136500|NCT01596062|17740205|P2|Overall Study|Lack of Efficacy|0
5136501|NCT01596062|17740206|P1|Overall Study|Lack of Efficacy|0
5136502|NCT01596062|17740204|P3|Overall Study|Adverse Event|2
5136503|NCT01596062|17740205|P2|Overall Study|Adverse Event|0
5136504|NCT01596062|17740206|P1|Overall Study|Adverse Event|1
5136505|NCT01595646|17740270|P3|Overall Study|Withdrawal by Subject|0
5136506|NCT01595646|17740271|P2|Overall Study|Withdrawal by Subject|0
5136507|NCT01595646|17740272|P1|Overall Study|Withdrawal by Subject|1
5136508|NCT01595529|17740294|P2|Overall Study|Entry Failure/Screening Failure|1
5136509|NCT01595529|17740295|P1|Overall Study|Entry Failure/Screening Failure|6
5136510|NCT01595529|17740294|P2|Overall Study|Administrative Decision|0
5136511|NCT01595529|17740295|P1|Overall Study|Administrative Decision|1
5136512|NCT01595529|17740294|P2|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
5136513|NCT01595529|17740295|P1|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
5136514|NCT01595529|17740294|P2|Overall Study|Physician Decision|0
5136515|NCT01595529|17740295|P1|Overall Study|Physician Decision|1
5136516|NCT01595529|17740294|P2|Overall Study|Protocol Violation|2
5136517|NCT01595529|17740295|P1|Overall Study|Protocol Violation|1
5136518|NCT01595529|17740294|P2|Overall Study|Lost to Follow-up|14
5136519|NCT01595529|17740295|P1|Overall Study|Lost to Follow-up|8
5136520|NCT01595529|17740294|P2|Overall Study|Subject Non-Compliant|0
5136521|NCT01595529|17740295|P1|Overall Study|Subject Non-Compliant|2
5136522|NCT01595529|17740294|P2|Overall Study|Adverse Event|0
5136523|NCT01595529|17740295|P1|Overall Study|Adverse Event|2
5136524|NCT01595438|17740358|P2|Overall Study|Other Eligibility criteria|9
5136525|NCT01595438|17740359|P1|Overall Study|Other Eligibility criteria|11
5136526|NCT01595438|17740358|P2|Overall Study|Withdrawal by Subject|12
5136527|NCT01595438|17740359|P1|Overall Study|Withdrawal by Subject|12
5136528|NCT01595438|17740358|P2|Overall Study|Lost to Follow-up|20
5136529|NCT01595438|17740359|P1|Overall Study|Lost to Follow-up|20
5136530|NCT01595009|17740527|P4|Extension|Adverse Event|1
5136531|NCT01595009|17740528|P3|Extension|Adverse Event|0
5136532|NCT01595009|17740529|P2|Extension|Adverse Event|0
5136533|NCT01595009|17740530|P1|Extension|Adverse Event|0
5136534|NCT01595009|17740527|P4|Extension|Disease progression|7
5136535|NCT01595009|17740528|P3|Extension|Disease progression|4
5136536|NCT01595009|17740529|P2|Extension|Disease progression|0
5136537|NCT01595009|17740530|P1|Extension|Disease progression|0
5136538|NCT01595009|17740527|P4|Extension|Patients completed per protocol|2
5136539|NCT01595009|17740528|P3|Extension|Patients completed per protocol|0
5136540|NCT01595009|17740529|P2|Extension|Patients completed per protocol|0
5136541|NCT01595009|17740530|P1|Extension|Patients completed per protocol|0
5136542|NCT01595009|17740527|P4|Extension|Administrative problems|1
5136543|NCT01595009|17740528|P3|Extension|Administrative problems|0
5136544|NCT01595009|17740529|P2|Extension|Administrative problems|0
5136545|NCT01595009|17740530|P1|Extension|Administrative problems|0
5136546|NCT01595009|17740527|P4|Core|Administrative problems|0
5136547|NCT01595009|17740528|P3|Core|Administrative problems|0
5136548|NCT01595009|17740529|P2|Core|Administrative problems|1
5136549|NCT01595009|17740530|P1|Core|Administrative problems|0
5136550|NCT01595009|17740527|P4|Core|Protocol deviation|0
5136551|NCT01595009|17740528|P3|Core|Protocol deviation|0
5136552|NCT01595009|17740529|P2|Core|Protocol deviation|1
5136553|NCT01595009|17740530|P1|Core|Protocol deviation|0
5136554|NCT01595009|17740527|P4|Core|Lost to Follow-up|0
5136555|NCT01595009|17740528|P3|Core|Lost to Follow-up|0
5136562|NCT01595009|17740527|P4|Core|Withdrawal by Subject|0
5136563|NCT01595009|17740528|P3|Core|Withdrawal by Subject|0
5136564|NCT01595009|17740529|P2|Core|Withdrawal by Subject|17
5136565|NCT01595009|17740530|P1|Core|Withdrawal by Subject|4
5136566|NCT01595009|17740527|P4|Core|Disease progression|0
5136567|NCT01595009|17740528|P3|Core|Disease progression|0
5136568|NCT01595009|17740529|P2|Core|Disease progression|26
5136569|NCT01595009|17740530|P1|Core|Disease progression|14
5136570|NCT01595009|17740527|P4|Core|Adverse Event|0
5136571|NCT01595009|17740528|P3|Core|Adverse Event|0
5136572|NCT01595009|17740529|P2|Core|Adverse Event|23
5136573|NCT01595009|17740530|P1|Core|Adverse Event|19
5136574|NCT01595009|17740527|P4|Core|Patients completed per protocol|0
5136575|NCT01595009|17740528|P3|Core|Patients completed per protocol|0
5136576|NCT01595009|17740529|P2|Core|Patients completed per protocol|44
5136577|NCT01595009|17740530|P1|Core|Patients completed per protocol|85
5136578|NCT01594970|17740565|P3|Overall Study|Lost to Follow-up|37
5136579|NCT01594970|17740566|P2|Overall Study|Lost to Follow-up|54
5136580|NCT01594970|17740567|P1|Overall Study|Lost to Follow-up|54
5136581|NCT01594970|17740565|P3|Overall Study|Adverse Event|23
5136582|NCT01594970|17740566|P2|Overall Study|Adverse Event|23
5136583|NCT01594970|17740567|P1|Overall Study|Adverse Event|17
5136584|NCT01594970|17740565|P3|Overall Study|Non-Adverse Event Related|6
5136585|NCT01594970|17740566|P2|Overall Study|Non-Adverse Event Related|5
5136586|NCT01594970|17740567|P1|Overall Study|Non-Adverse Event Related|4
5136587|NCT01594853|17740586|P2|Overall Study|noncompliance with exercise|1
5136588|NCT01594853|17740587|P1|Overall Study|noncompliance with exercise|0
5136589|NCT01594853|17740586|P2|Overall Study|Lost to Follow-up|1
5136590|NCT01594853|17740587|P1|Overall Study|Lost to Follow-up|1
5136591|NCT01594853|17740586|P2|Overall Study|Withdrawal by Subject|1
5136592|NCT01594853|17740587|P1|Overall Study|Withdrawal by Subject|1
5136593|NCT01594827|17740595|P2|Overall Study|Physician Decision|0
5136594|NCT01594827|17740596|P1|Overall Study|Physician Decision|3
5136595|NCT01594827|17740595|P2|Overall Study|Adverse Event|0
5136596|NCT01594827|17740596|P1|Overall Study|Adverse Event|1
5136597|NCT01594762|17740620|P2|Overall Study|Lost to Follow-up|10
5136598|NCT01594762|17740621|P1|Overall Study|Lost to Follow-up|10
5136599|NCT01594762|17740620|P2|Overall Study|Withdrawal by Subject|0
5136600|NCT01594762|17740621|P1|Overall Study|Withdrawal by Subject|1
5136601|NCT01594749|17740633|P2|Overall Study|Lost Source Documentation|0
5136602|NCT01594749|17740634|P1|Overall Study|Lost Source Documentation|1
5136603|NCT01594749|17740633|P2|Overall Study|Not Treated|10
5136604|NCT01594749|17740634|P1|Overall Study|Not Treated|4
5136605|NCT01594749|17740633|P2|Overall Study|Death|3
5136606|NCT01594749|17740634|P1|Overall Study|Death|9
5136607|NCT01594749|17740633|P2|Overall Study|Lost to Follow-up|0
5136608|NCT01594749|17740634|P1|Overall Study|Lost to Follow-up|1
5136609|NCT01594749|17740633|P2|Overall Study|Non-compliance with Protocol|1
5136610|NCT01594749|17740634|P1|Overall Study|Non-compliance with Protocol|0
5136611|NCT01594749|17740633|P2|Overall Study|Physician Decision|1
5136612|NCT01594749|17740634|P1|Overall Study|Physician Decision|1
5136613|NCT01594749|17740633|P2|Overall Study|Protocol Violation|0
5136614|NCT01594749|17740634|P1|Overall Study|Protocol Violation|2
5136615|NCT01594749|17740633|P2|Overall Study|Withdrawal by Subject|2
5136616|NCT01594749|17740634|P1|Overall Study|Withdrawal by Subject|2
5136617|NCT01594749|17740633|P2|Overall Study|Adverse Event|1
5136618|NCT01594749|17740634|P1|Overall Study|Adverse Event|2
5136619|NCT01594476|17740772|P2|Overall Study|Protocol Violation|3
5136620|NCT01594476|17740773|P1|Overall Study|Protocol Violation|1
5136621|NCT01594411|17740795|P1|Overall Study|Lost to Follow-up|2
5136622|NCT01594333|17740829|P2|Overall Study|Withdrawal by Subject|63
5136623|NCT01594333|17740830|P1|Overall Study|Withdrawal by Subject|60
5136624|NCT01594333|17740829|P2|Overall Study|Lost to Follow-up|5
5136625|NCT01594333|17740830|P1|Overall Study|Lost to Follow-up|5
5136626|NCT01594333|17740829|P2|Overall Study|Death|83
5136627|NCT01594333|17740830|P1|Overall Study|Death|96
5136628|NCT01594281|17740876|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
5136629|NCT01594281|17740877|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
5136630|NCT01594281|17740878|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
5136631|NCT01594281|17740876|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
5136632|NCT01594281|17740877|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
5136633|NCT01594281|17740878|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
5136634|NCT01594281|17740876|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
5136635|NCT01594281|17740877|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
5136636|NCT01594281|17740878|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
5136637|NCT01594281|17740876|P3|Interventional Core Phase|Adverse Event|4
5136638|NCT01594281|17740877|P2|Interventional Core Phase|Adverse Event|4
5136639|NCT01594281|17740878|P1|Interventional Core Phase|Adverse Event|4
5136640|NCT01594281|17740876|P3|Interventional Core Phase|Lost to Follow-up|1
5136641|NCT01594281|17740877|P2|Interventional Core Phase|Lost to Follow-up|4
5136642|NCT01594281|17740878|P1|Interventional Core Phase|Lost to Follow-up|1
5136643|NCT01594281|17740876|P3|Interventional Core Phase|Death|2
5136644|NCT01594281|17740877|P2|Interventional Core Phase|Death|1
5136645|NCT01594281|17740878|P1|Interventional Core Phase|Death|1
5136646|NCT01594281|17740876|P3|Interventional Core Phase|Subject Withdrew Consent|1
5136647|NCT01594281|17740877|P2|Interventional Core Phase|Subject Withdrew Consent|1
5136648|NCT01594281|17740878|P1|Interventional Core Phase|Subject Withdrew Consent|0
5136649|NCT01594281|17740876|P3|Interventional Core Phase|Protocol Deviation|0
5136650|NCT01594281|17740877|P2|Interventional Core Phase|Protocol Deviation|0
5136651|NCT01594281|17740878|P1|Interventional Core Phase|Protocol Deviation|1
5136652|NCT01594125|17740918|P5|Overall Study|Progressive Disease|7
5136653|NCT01594125|17740919|P4|Overall Study|Progressive Disease|3
5136654|NCT01594125|17740920|P3|Overall Study|Progressive Disease|3
5136655|NCT01594125|17740921|P2|Overall Study|Progressive Disease|12
5136656|NCT01594125|17740922|P1|Overall Study|Progressive Disease|3
5136657|NCT01594125|17740918|P5|Overall Study|Withdrawal by Subject|0
5136658|NCT01594125|17740919|P4|Overall Study|Withdrawal by Subject|1
5136659|NCT01594125|17740920|P3|Overall Study|Withdrawal by Subject|0
5136660|NCT01594125|17740921|P2|Overall Study|Withdrawal by Subject|0
5136661|NCT01594125|17740922|P1|Overall Study|Withdrawal by Subject|1
5136662|NCT01593787|17740982|P3|Overall Study|Adverse Event|0
5136663|NCT01593787|17740983|P2|Overall Study|Adverse Event|0
5136664|NCT01593787|17740984|P1|Overall Study|Adverse Event|1
5136665|NCT01593696|17741060|P4|Dose Expansion|Fungal infection|0
5136666|NCT01593696|17741061|P3|Dose Expansion|Fungal infection|1
5136667|NCT01593696|17741062|P2|Dose Expansion|Fungal infection|0
5136668|NCT01593696|17741063|P1|Dose Expansion|Fungal infection|0
5136669|NCT01593696|17741060|P4|Dose Escalation|Progressive Disease|0
5136670|NCT01593696|17741061|P3|Dose Escalation|Progressive Disease|0
5136671|NCT01593696|17741062|P2|Dose Escalation|Progressive Disease|0
5136672|NCT01593696|17741063|P1|Dose Escalation|Progressive Disease|2
5136673|NCT01593254|17741120|P2|Follow-Up Period|Study Drug Side Effects|1
5136674|NCT01593254|17741121|P1|Follow-Up Period|Study Drug Side Effects|0
5136675|NCT01593254|17741120|P2|Follow-Up Period|Disease Progression|1
5136676|NCT01593254|17741121|P1|Follow-Up Period|Disease Progression|0
5136677|NCT01593254|17741120|P2|Follow-Up Period|Fundus Hemorrhage|1
5136678|NCT01593254|17741121|P1|Follow-Up Period|Fundus Hemorrhage|0
5136679|NCT01593254|17741120|P2|Follow-Up Period|Patient refused to return|1
5136680|NCT01593254|17741121|P1|Follow-Up Period|Patient refused to return|0
5136681|NCT01593254|17741120|P2|Follow-Up Period|Study Drug Toxicity|1
5136682|NCT01593254|17741121|P1|Follow-Up Period|Study Drug Toxicity|0
5136683|NCT01593254|17741120|P2|Follow-Up Period|Pregnancy|1
5136684|NCT01593254|17741121|P1|Follow-Up Period|Pregnancy|0
5136685|NCT01593254|17741120|P2|Follow-Up Period|Subject request to Discontinue|1
5136686|NCT01593254|17741121|P1|Follow-Up Period|Subject request to Discontinue|0
5136687|NCT01593254|17741120|P2|Follow-Up Period|Death|2
5136688|NCT01593254|17741121|P1|Follow-Up Period|Death|2
5136689|NCT01593254|17741120|P2|Follow-Up Period|Non-Compliance|0
5136690|NCT01593254|17741121|P1|Follow-Up Period|Non-Compliance|1
5136691|NCT01593254|17741120|P2|Follow-Up Period|Withdrawal by Subject|2
5136692|NCT01593254|17741121|P1|Follow-Up Period|Withdrawal by Subject|0
5136693|NCT01593254|17741120|P2|Treatment Period|Investigator Decision|1
5136694|NCT01593254|17741121|P1|Treatment Period|Investigator Decision|2
5136695|NCT01593254|17741120|P2|Treatment Period|T315I MUTATION|1
5136696|NCT01593254|17741121|P1|Treatment Period|T315I MUTATION|0
5136697|NCT01593254|17741120|P2|Treatment Period|No Response|0
5136698|NCT01593254|17741121|P1|Treatment Period|No Response|1
5136699|NCT01593254|17741120|P2|Treatment Period|Patient Refused to Return|1
5136700|NCT01593254|17741121|P1|Treatment Period|Patient Refused to Return|0
5136701|NCT01593254|17741120|P2|Treatment Period|Did Not Achieve RCC|1
5136702|NCT01593254|17741121|P1|Treatment Period|Did Not Achieve RCC|0
5136703|NCT01593254|17741120|P2|Treatment Period|Disease Progression|6
5136704|NCT01593254|17741121|P1|Treatment Period|Disease Progression|1
5136705|NCT01593254|17741120|P2|Treatment Period|Study Drug Toxicity|9
5136706|NCT01593254|17741121|P1|Treatment Period|Study Drug Toxicity|3
5136707|NCT01593254|17741120|P2|Treatment Period|Death|1
5136708|NCT01593254|17741121|P1|Treatment Period|Death|2
5136709|NCT01593254|17741120|P2|Treatment Period|AE unrelated to Study Drug|1
5136710|NCT01593254|17741121|P1|Treatment Period|AE unrelated to Study Drug|0
5136711|NCT01593254|17741120|P2|Treatment Period|Subject Request to Discontinue|1
5136712|NCT01593254|17741121|P1|Treatment Period|Subject Request to Discontinue|1
5136713|NCT01593254|17741120|P2|Treatment Period|Subject withdrew consent|5
5136714|NCT01593254|17741121|P1|Treatment Period|Subject withdrew consent|0
5136715|NCT01593254|17741120|P2|Treatment Period|Maximum clinical benefit|0
5136716|NCT01593254|17741121|P1|Treatment Period|Maximum clinical benefit|1
5136717|NCT01593254|17741120|P2|Treatment Period|Poor/Non-Compliance|1
5136718|NCT01593254|17741121|P1|Treatment Period|Poor/Non-Compliance|2
5136719|NCT01593254|17741120|P2|Treatment Period|Pregnancy|1
5136720|NCT01593254|17741121|P1|Treatment Period|Pregnancy|0
5136721|NCT01593254|17741120|P2|Treatment Period|Treatment Failure|2
5136722|NCT01593254|17741121|P1|Treatment Period|Treatment Failure|1
5136723|NCT01592864|17741139|P2|Overall Study|Withdrawal by Subject|1
5136724|NCT01592864|17741140|P1|Overall Study|Withdrawal by Subject|0
5136725|NCT01592786|17741201|P1|Overall Study|Other|3
5136726|NCT01592786|17741201|P1|Overall Study|Lost to Follow-up|19
5136727|NCT01592786|17741201|P1|Overall Study|Withdrawal by Subject|23
5136728|NCT01592786|17741201|P1|Overall Study|Protocol Violation|14
5136729|NCT01592786|17741201|P1|Overall Study|Lack of Efficacy|19
5136730|NCT01592786|17741201|P1|Overall Study|Adverse Event|60
5136731|NCT01592773|17741205|P1|Overall Study|Other Reason|1
5136732|NCT01592773|17741205|P1|Overall Study|Inclusion/exclusion not meet|1
5136733|NCT01592773|17741205|P1|Overall Study|Protocol Violation|2
5136734|NCT01592773|17741205|P1|Overall Study|Lack of Efficacy|9
5136735|NCT01592773|17741205|P1|Overall Study|Adverse Event|17
5136736|NCT01592773|17741205|P1|Overall Study|Lost to Follow-up|19
5136737|NCT01592773|17741205|P1|Overall Study|Withdrawal by Subject|35
5136738|NCT01592773|17741205|P1|Overall Study|Study Terminated by Sponsor|582
5136739|NCT01592760|17741212|P3|24-hour Follow-Up|Lost to Follow-up|2
5136740|NCT01592760|17741213|P2|24-hour Follow-Up|Lost to Follow-up|3
5136741|NCT01592760|17741214|P1|24-hour Follow-Up|Lost to Follow-up|4
5136742|NCT01592747|17741258|P3|Overall Study|Other Reasons|0
5136743|NCT01592747|17741259|P2|Overall Study|Other Reasons|1
5136744|NCT01592747|17741260|P1|Overall Study|Other Reasons|1
5136745|NCT01592747|17741258|P3|Overall Study|Lost to Follow-up|1
5136746|NCT01592747|17741259|P2|Overall Study|Lost to Follow-up|0
5136747|NCT01592747|17741260|P1|Overall Study|Lost to Follow-up|1
5136748|NCT01592747|17741258|P3|Overall Study|Withdrawal by Subject|2
5136749|NCT01592747|17741259|P2|Overall Study|Withdrawal by Subject|0
5136750|NCT01592747|17741260|P1|Overall Study|Withdrawal by Subject|2
5136751|NCT01592747|17741258|P3|Overall Study|Lack of Efficacy|0
5136752|NCT01592747|17741259|P2|Overall Study|Lack of Efficacy|1
5136753|NCT01592747|17741260|P1|Overall Study|Lack of Efficacy|0
5136754|NCT01592747|17741258|P3|Overall Study|Protocol Violation|4
5136755|NCT01592747|17741259|P2|Overall Study|Protocol Violation|0
5136756|NCT01592747|17741260|P1|Overall Study|Protocol Violation|4
5136757|NCT01592747|17741258|P3|Overall Study|Adverse Event|0
5136758|NCT01592747|17741259|P2|Overall Study|Adverse Event|0
5136759|NCT01592747|17741260|P1|Overall Study|Adverse Event|1
5136760|NCT01592747|17741258|P3|Overall Study|Inclusion/Exclusion criteria not met|1
5136761|NCT01592747|17741259|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5136762|NCT01592747|17741260|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5136763|NCT01592747|17741258|P3|Overall Study|Loss of Therapeutic Response|100
5136764|NCT01592747|17741259|P2|Overall Study|Loss of Therapeutic Response|108
5136765|NCT01592747|17741260|P1|Overall Study|Loss of Therapeutic Response|107
5136766|NCT01592708|17741303|P2|Overall Study|Protocol Violation|0
5136767|NCT01592708|17741304|P1|Overall Study|Protocol Violation|3
5136768|NCT01592695|17741320|P2|Overall Study|Lost to Follow-up|4
5136769|NCT01592695|17741321|P1|Overall Study|Lost to Follow-up|8
5136770|NCT01592409|17741376|P2|Overall Study|Withdrawal by Subject|1
5136771|NCT01592409|17741377|P1|Overall Study|Withdrawal by Subject|0
5136772|NCT01592383|17741401|P1|Overall Study|Adverse Event|1
5136773|NCT01592344|17741412|P2|Overall Study|not available at primary outcome visit|4
5136774|NCT01592344|17741413|P1|Overall Study|not available at primary outcome visit|2
5136775|NCT01592344|17741412|P2|Overall Study|Lack of Efficacy|0
5136776|NCT01592344|17741413|P1|Overall Study|Lack of Efficacy|1
5136777|NCT01592344|17741412|P2|Overall Study|Adverse Event|1
5136778|NCT01592344|17741413|P1|Overall Study|Adverse Event|1
5136779|NCT01592292|17741427|P4|Overall Study|Other|1
5136780|NCT01592292|17741428|P3|Overall Study|Other|2
5136781|NCT01592292|17741429|P2|Overall Study|Other|1
5136782|NCT01592292|17741430|P1|Overall Study|Other|1
5136783|NCT01592292|17741427|P4|Overall Study|Withdrew consent|0
5136784|NCT01592292|17741428|P3|Overall Study|Withdrew consent|0
5136785|NCT01592292|17741429|P2|Overall Study|Withdrew consent|1
5136786|NCT01592292|17741430|P1|Overall Study|Withdrew consent|2
5136787|NCT01592292|17741427|P4|Overall Study|Follow-up loss|0
5136788|NCT01592292|17741428|P3|Overall Study|Follow-up loss|1
5136789|NCT01592292|17741429|P2|Overall Study|Follow-up loss|3
5136790|NCT01592292|17741430|P1|Overall Study|Follow-up loss|3
5136791|NCT01592240|17741469|P7|Overall Study|Did Not Meet Entrance Criteria|0
5136792|NCT01592240|17741470|P6|Overall Study|Did Not Meet Entrance Criteria|0
5136793|NCT01592240|17741471|P5|Overall Study|Did Not Meet Entrance Criteria|0
5136794|NCT01592240|17741472|P4|Overall Study|Did Not Meet Entrance Criteria|0
5136795|NCT01592240|17741473|P3|Overall Study|Did Not Meet Entrance Criteria|1
5136796|NCT01592240|17741474|P2|Overall Study|Did Not Meet Entrance Criteria|0
5136797|NCT01592240|17741475|P1|Overall Study|Did Not Meet Entrance Criteria|1
5136798|NCT01592240|17741469|P7|Overall Study|Other|1
5136799|NCT01592240|17741470|P6|Overall Study|Other|0
5136800|NCT01592240|17741471|P5|Overall Study|Other|0
5136801|NCT01592240|17741472|P4|Overall Study|Other|1
5136802|NCT01592240|17741473|P3|Overall Study|Other|1
5136803|NCT01592240|17741474|P2|Overall Study|Other|3
5136804|NCT01592240|17741475|P1|Overall Study|Other|0
5136805|NCT01592240|17741469|P7|Overall Study|Withdrawal by Subject|2
5136806|NCT01592240|17741470|P6|Overall Study|Withdrawal by Subject|0
5136807|NCT01592240|17741471|P5|Overall Study|Withdrawal by Subject|3
5136808|NCT01592240|17741472|P4|Overall Study|Withdrawal by Subject|1
5136809|NCT01592240|17741473|P3|Overall Study|Withdrawal by Subject|4
5136810|NCT01592240|17741474|P2|Overall Study|Withdrawal by Subject|4
5136811|NCT01592240|17741475|P1|Overall Study|Withdrawal by Subject|0
5136812|NCT01592240|17741469|P7|Overall Study|Protocol Violation|0
5136813|NCT01592240|17741470|P6|Overall Study|Protocol Violation|1
5136814|NCT01592240|17741471|P5|Overall Study|Protocol Violation|0
5136815|NCT01592240|17741472|P4|Overall Study|Protocol Violation|0
5136816|NCT01592240|17741473|P3|Overall Study|Protocol Violation|0
5136817|NCT01592240|17741474|P2|Overall Study|Protocol Violation|0
5136818|NCT01592240|17741475|P1|Overall Study|Protocol Violation|0
5136819|NCT01592240|17741469|P7|Overall Study|Lost to Follow-up|0
5136820|NCT01592240|17741470|P6|Overall Study|Lost to Follow-up|2
5136821|NCT01592240|17741471|P5|Overall Study|Lost to Follow-up|3
5136822|NCT01592240|17741472|P4|Overall Study|Lost to Follow-up|0
5136823|NCT01592240|17741473|P3|Overall Study|Lost to Follow-up|1
5136824|NCT01592240|17741474|P2|Overall Study|Lost to Follow-up|3
5136825|NCT01592240|17741475|P1|Overall Study|Lost to Follow-up|1
5136826|NCT01592240|17741469|P7|Overall Study|Death|0
5136827|NCT01592240|17741470|P6|Overall Study|Death|0
5136828|NCT01592240|17741471|P5|Overall Study|Death|0
5136829|NCT01592240|17741472|P4|Overall Study|Death|0
5136830|NCT01592240|17741473|P3|Overall Study|Death|0
5136831|NCT01592240|17741474|P2|Overall Study|Death|1
5136832|NCT01592240|17741475|P1|Overall Study|Death|0
5136833|NCT01592240|17741469|P7|Overall Study|Adverse Event|0
5136834|NCT01592240|17741470|P6|Overall Study|Adverse Event|0
5136835|NCT01592240|17741471|P5|Overall Study|Adverse Event|1
5136836|NCT01592240|17741472|P4|Overall Study|Adverse Event|1
5136837|NCT01592240|17741473|P3|Overall Study|Adverse Event|0
5136838|NCT01592240|17741474|P2|Overall Study|Adverse Event|0
5136839|NCT01592240|17741475|P1|Overall Study|Adverse Event|1
5136840|NCT01592045|17741668|P2|Overall Study|Moved out of country|0
5136841|NCT01592045|17741669|P1|Overall Study|Moved out of country|2
5136842|NCT01592045|17741668|P2|Overall Study|Withdrawal by Subject|0
5136843|NCT01592045|17741669|P1|Overall Study|Withdrawal by Subject|1
5136844|NCT01592045|17741668|P2|Overall Study|Adverse Event|1
5136845|NCT01592045|17741669|P1|Overall Study|Adverse Event|1
5136846|NCT01592045|17741668|P2|Overall Study|Disease Progression|1
5136847|NCT01592045|17741669|P1|Overall Study|Disease Progression|1
5136848|NCT01591863|17741687|P1|Overall Study|Lack of Efficacy|1
5136849|NCT01591863|17741687|P1|Overall Study|recurrence|9
5136850|NCT01591863|17741687|P1|Overall Study|Withdrawal by Subject|1
5136851|NCT01591863|17741687|P1|Overall Study|Adverse Event|3
5136852|NCT01591681|17741744|P1|Overall Study|Failed to use system during run-in|1
5136853|NCT01591681|17741744|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
5136854|NCT01591616|17741791|P1|Overall Study|Withdrawal by Subject|1
5136855|NCT01591499|17741932|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
5136856|NCT01591499|17741933|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
5136857|NCT01591499|17741934|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
5136858|NCT01591499|17741935|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
5136859|NCT01591499|17741932|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
5136860|NCT01591499|17741933|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
5136861|NCT01591499|17741934|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
5136862|NCT01591499|17741935|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
5136863|NCT01591499|17741932|P4|Baseline Visit|Withdrawal by Subject|2
5136864|NCT01591499|17741933|P3|Baseline Visit|Withdrawal by Subject|0
5136865|NCT01591499|17741934|P2|Baseline Visit|Withdrawal by Subject|2
5136866|NCT01591499|17741935|P1|Baseline Visit|Withdrawal by Subject|0
5136867|NCT01591460|17742001|P1|Overall Study|Protocol Violation|1
5136868|NCT01591460|17742001|P1|Overall Study|Withdrawal by Subject|1
5136869|NCT01591460|17742001|P1|Overall Study|Participant Refusal|3
5136870|NCT01591460|17742001|P1|Overall Study|Noncompliance|1
5136871|NCT01591460|17742001|P1|Overall Study|Lost to Follow-up|1
5136872|NCT01591460|17742001|P1|Overall Study|Treatment Discontinued by Error|1
5136873|NCT01591460|17742001|P1|Overall Study|Rebound or Breakthrough|3
5136874|NCT01591460|17742001|P1|Overall Study|Futility Rule (Week 24)|3
5136875|NCT01591460|17742001|P1|Overall Study|Futility Rule (Week 12)|7
5136876|NCT01591460|17742001|P1|Overall Study|Adverse Event or Intercurrent Illness|5
5136877|NCT01591382|17742092|P2|Overall Study|Participant Opted for Morphine PCA|1
5136878|NCT01591382|17742093|P1|Overall Study|Participant Opted for Morphine PCA|1
5136879|NCT01591382|17742092|P2|Overall Study|Discharged Prior to Study Completion|1
5136880|NCT01591382|17742093|P1|Overall Study|Discharged Prior to Study Completion|2
5136881|NCT01591096|17742161|P1|Overall Study|Adverse Event|1
5136882|NCT01590888|17742246|P3|Overall Study|Lost to Follow-up|0
5136883|NCT01590888|17742247|P2|Overall Study|Lost to Follow-up|0
5136884|NCT01590888|17742248|P1|Overall Study|Lost to Follow-up|1
5136885|NCT01590888|17742246|P3|Overall Study|Adverse Event|1
5136886|NCT01590888|17742247|P2|Overall Study|Adverse Event|0
5136887|NCT01590888|17742248|P1|Overall Study|Adverse Event|3
5136888|NCT01590810|17742308|P5|Overall Study|Physician Decision|0
5136889|NCT01590810|17742309|P4|Overall Study|Physician Decision|0
5136890|NCT01590810|17742310|P3|Overall Study|Physician Decision|1
5136891|NCT01590810|17742311|P2|Overall Study|Physician Decision|1
5136892|NCT01590810|17742312|P1|Overall Study|Physician Decision|0
5136893|NCT01590797|17742457|P2|Overall Study|Other Protocol Specified Criteria|4
5136894|NCT01590797|17742458|P1|Overall Study|Other Protocol Specified Criteria|2
5136895|NCT01590797|17742457|P2|Overall Study|Withdrawal by Subject|5
5136896|NCT01590797|17742458|P1|Overall Study|Withdrawal by Subject|7
5136897|NCT01590797|17742457|P2|Overall Study|Protocol Violation|1
5136898|NCT01590797|17742458|P1|Overall Study|Protocol Violation|4
5136899|NCT01590797|17742457|P2|Overall Study|Lost to Follow-up|1
5136900|NCT01590797|17742458|P1|Overall Study|Lost to Follow-up|0
5136901|NCT01590797|17742457|P2|Overall Study|Lack of Efficacy|2
5136902|NCT01590797|17742458|P1|Overall Study|Lack of Efficacy|0
5136903|NCT01590797|17742457|P2|Overall Study|Adverse Event|3
5136904|NCT01590797|17742458|P1|Overall Study|Adverse Event|4
5136905|NCT01590771|17742474|P2|Overall Study|Adverse Event|7
5136906|NCT01590771|17742475|P1|Overall Study|Adverse Event|3
5136907|NCT01590771|17742474|P2|Overall Study|Lack of Efficacy|0
5136908|NCT01590771|17742475|P1|Overall Study|Lack of Efficacy|1
5136909|NCT01590771|17742474|P2|Overall Study|Lost to Follow-up|1
5136910|NCT01590771|17742475|P1|Overall Study|Lost to Follow-up|1
5136911|NCT01590771|17742474|P2|Overall Study|Protocol Violation|2
5136912|NCT01590771|17742475|P1|Overall Study|Protocol Violation|1
5136913|NCT01590771|17742474|P2|Overall Study|Withdrawal by Subject|15
5136914|NCT01590771|17742475|P1|Overall Study|Withdrawal by Subject|8
5136915|NCT01590771|17742474|P2|Overall Study|Other Protocol Specified Criteria|14
5136916|NCT01590771|17742475|P1|Overall Study|Other Protocol Specified Criteria|5
5136917|NCT01590758|17742503|P2|Overall Study|Lost to Follow-up|2
5136918|NCT01590758|17742504|P1|Overall Study|Lost to Follow-up|4
5136919|NCT01590758|17742503|P2|Overall Study|Physician Decision|2
5136920|NCT01590758|17742504|P1|Overall Study|Physician Decision|1
5136921|NCT01590758|17742503|P2|Overall Study|Withdrawal by Subject|3
5136922|NCT01590758|17742504|P1|Overall Study|Withdrawal by Subject|0
5136923|NCT01590563|17742514|P1|Overall Study|simple uterine hyperplasia - not related|1
5136924|NCT01590433|17742528|P2|Overall Study|Adverse Event|3
5136925|NCT01590433|17742529|P1|Overall Study|Adverse Event|11
5136926|NCT01590433|17742528|P2|Overall Study|Withdrawal by Subject|11
5136927|NCT01590433|17742529|P1|Overall Study|Withdrawal by Subject|21
5136928|NCT01590433|17742528|P2|Overall Study|Lost to Follow-up|8
5136929|NCT01590433|17742529|P1|Overall Study|Lost to Follow-up|20
5136930|NCT01590212|17742551|P3|Overall Study|Lost to Follow-up|3
5136931|NCT01590212|17742552|P2|Overall Study|Lost to Follow-up|2
5136932|NCT01590212|17742553|P1|Overall Study|Lost to Follow-up|1
5136933|NCT01590212|17742551|P3|Overall Study|Withdrawal by Subject|2
5136934|NCT01590212|17742552|P2|Overall Study|Withdrawal by Subject|2
5136935|NCT01590212|17742553|P1|Overall Study|Withdrawal by Subject|2
5136936|NCT01590082|17742572|P2|Overall Study|Ineligible|0
5136937|NCT01590082|17742573|P1|Overall Study|Ineligible|1
5136938|NCT01590082|17742572|P2|Overall Study|Withdrawal by Subject|0
5136939|NCT01590082|17742573|P1|Overall Study|Withdrawal by Subject|1
5136940|NCT01590017|17742579|P1|Overall Study|Physician Decision|1
5136941|NCT01590017|17742579|P1|Overall Study|Lack of Efficacy|1
5136942|NCT01590017|17742579|P1|Overall Study|Withdrawal by Subject|1
5136943|NCT01590017|17742579|P1|Overall Study|Adverse Event|1
5136944|NCT01589822|17742632|P3|Overall Study|Missed 90 day visit|1
5136945|NCT01589822|17742633|P2|Overall Study|Missed 90 day visit|1
5136946|NCT01589822|17742634|P1|Overall Study|Missed 90 day visit|2
5136947|NCT01589822|17742632|P3|Overall Study|Death|0
5136948|NCT01589822|17742633|P2|Overall Study|Death|0
5136949|NCT01589822|17742634|P1|Overall Study|Death|1
5136950|NCT01589822|17742632|P3|Overall Study|Withdrawal by Subject|0
5136951|NCT01589822|17742633|P2|Overall Study|Withdrawal by Subject|2
5136952|NCT01589822|17742634|P1|Overall Study|Withdrawal by Subject|1
5136953|NCT01589770|17742653|P2|Overall Study|claustrophobic when entering cardiac MRI|1
5136954|NCT01589770|17742654|P1|Overall Study|claustrophobic when entering cardiac MRI|2
5136955|NCT01589770|17742653|P2|Overall Study|EGFR <60ml/min|4
5136956|NCT01589770|17742654|P1|Overall Study|EGFR <60ml/min|6
5136957|NCT01589653|17742664|P2|Overall Study|Unclassified|3
5136958|NCT01589653|17742665|P1|Overall Study|Unclassified|0
5136959|NCT01589653|17742664|P2|Overall Study|Withdrawal criteria|7
5136960|NCT01589653|17742665|P1|Overall Study|Withdrawal criteria|4
5136961|NCT01589653|17742664|P2|Overall Study|Protocol Violation|1
5136962|NCT01589653|17742665|P1|Overall Study|Protocol Violation|3
5136963|NCT01589497|17742715|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
5136964|NCT01589497|17742716|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
5136965|NCT01589497|17742717|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
5136966|NCT01589497|17742718|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
5136967|NCT01589497|17742715|P4|Overall Study|Death|0
5136968|NCT01589497|17742716|P3|Overall Study|Death|0
5136969|NCT01589497|17742717|P2|Overall Study|Death|0
5136970|NCT01589497|17742718|P1|Overall Study|Death|1
5136971|NCT01589497|17742715|P4|Overall Study|Withdrawal by Subject|1
5136972|NCT01589497|17742716|P3|Overall Study|Withdrawal by Subject|0
5136973|NCT01589497|17742717|P2|Overall Study|Withdrawal by Subject|1
5136974|NCT01589497|17742718|P1|Overall Study|Withdrawal by Subject|0
5136975|NCT01589445|17742824|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
5136976|NCT01589445|17742824|P1|002 (Metformin)-3 Months|Adverse Event|2
5136977|NCT01589445|17742824|P1|002 (Metformin)-3 Months|Protocol Violation|2
5136978|NCT01589445|17742824|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
5136979|NCT01589445|17742824|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
5136980|NCT01589445|17742824|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
5136981|NCT01589445|17742824|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
5136982|NCT01589445|17742824|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
5136983|NCT01589445|17742824|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
5136984|NCT01589445|17742824|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
5136985|NCT01589237|17742867|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
5136986|NCT01589237|17742868|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5136987|NCT01589237|17742869|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5136988|NCT01589237|17742870|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5136989|NCT01589237|17742867|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
5136990|NCT01589237|17742868|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
5136991|NCT01589237|17742869|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
5136992|NCT01589237|17742870|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
5136993|NCT01589237|17742867|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5136994|NCT01589237|17742868|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5136995|NCT01589237|17742869|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
5136996|NCT01589237|17742870|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5136997|NCT01589237|17742867|P4|Part A (52 Weeks)|Subject/guardian decision|0
5136998|NCT01589237|17742868|P3|Part A (52 Weeks)|Subject/guardian decision|2
5136999|NCT01589237|17742869|P2|Part A (52 Weeks)|Subject/guardian decision|3
5137000|NCT01589237|17742870|P1|Part A (52 Weeks)|Subject/guardian decision|2
5137001|NCT01589185|17742921|P5|Overall Study|Lost to Follow-up|0
5137002|NCT01589185|17742922|P4|Overall Study|Lost to Follow-up|3
5137003|NCT01589185|17742923|P3|Overall Study|Lost to Follow-up|2
5137004|NCT01589185|17742924|P2|Overall Study|Lost to Follow-up|0
5137005|NCT01589185|17742925|P1|Overall Study|Lost to Follow-up|1
5137006|NCT01589185|17742921|P5|Overall Study|Death|1
5137007|NCT01589185|17742922|P4|Overall Study|Death|0
5137008|NCT01589185|17742923|P3|Overall Study|Death|2
5137009|NCT01589185|17742924|P2|Overall Study|Death|2
5137010|NCT01589185|17742925|P1|Overall Study|Death|1
5137011|NCT01589094|17742958|P1|Overall Study|Did not receive treatment|2
5137012|NCT01588990|17742965|P1|Phase B|Other|2
5137013|NCT01588990|17742965|P1|Phase B|Physician Decision|4
5137014|NCT01588990|17742965|P1|Phase B|Withdrawal by Subject|3
5137015|NCT01588990|17742965|P1|Phase B|Still on therapy at end of study|5
5137016|NCT01588990|17742965|P1|Phase B|Adverse Event|2
5137017|NCT01588990|17742965|P1|Phase A|Still on therapy at end of study|6
5137018|NCT01588990|17742965|P1|Phase A|Adverse Event|28
5137019|NCT01588990|17742965|P1|Phase A|Death|5
5137020|NCT01588990|17742965|P1|Phase A|Lost to Follow-up|1
5137021|NCT01588990|17742965|P1|Phase A|Other|14
5137022|NCT01588990|17742965|P1|Phase A|Physician Decision|11
5137023|NCT01588990|17742965|P1|Phase A|Withdrawal by Subject|5
5137024|NCT01588951|17742993|P3|Overall Study|Ineligible in retrospect|1
5137025|NCT01588951|17742994|P2|Overall Study|Ineligible in retrospect|0
5137026|NCT01588951|17742995|P1|Overall Study|Ineligible in retrospect|0
5137027|NCT01588548|17743031|P6|Overall Study|Condition Under Investigation Worsened|3
5137028|NCT01588548|17743032|P5|Overall Study|Condition Under Investigation Worsened|3
5137029|NCT01588548|17743033|P4|Overall Study|Condition Under Investigation Worsened|4
5137030|NCT01588548|17743034|P3|Overall Study|Condition Under Investigation Worsened|4
5137031|NCT01588548|17743035|P2|Overall Study|Condition Under Investigation Worsened|6
5137032|NCT01588548|17743036|P1|Overall Study|Condition Under Investigation Worsened|3
5137033|NCT01588548|17743031|P6|Overall Study|Adverse Event|0
5137034|NCT01588548|17743032|P5|Overall Study|Adverse Event|1
5137035|NCT01588548|17743033|P4|Overall Study|Adverse Event|2
5137036|NCT01588548|17743034|P3|Overall Study|Adverse Event|1
5137037|NCT01588548|17743035|P2|Overall Study|Adverse Event|0
5137038|NCT01588548|17743036|P1|Overall Study|Adverse Event|0
5137039|NCT01588548|17743031|P6|Overall Study|Withdrawal by Subject|3
5137040|NCT01588548|17743032|P5|Overall Study|Withdrawal by Subject|2
5137041|NCT01588548|17743033|P4|Overall Study|Withdrawal by Subject|1
5137042|NCT01588548|17743034|P3|Overall Study|Withdrawal by Subject|1
5137043|NCT01588548|17743035|P2|Overall Study|Withdrawal by Subject|1
5137044|NCT01588548|17743036|P1|Overall Study|Withdrawal by Subject|0
5137045|NCT01588509|17743052|P2|Overall Study|Lost to Follow-up|0
5137046|NCT01588509|17743053|P1|Overall Study|Lost to Follow-up|1
5137047|NCT01588496|17743076|P3|Overall Study|Withdrawal by Subject|0
5137048|NCT01588496|17743077|P2|Overall Study|Withdrawal by Subject|1
5137049|NCT01588496|17743078|P1|Overall Study|Withdrawal by Subject|0
5137050|NCT01588405|17743153|P1|Overall Study|Clinical Worsening|1
5137051|NCT01588405|17743153|P1|Overall Study|Adverse Event|1
5137052|NCT01588366|17743182|P6|Overall Study|Adverse Event|2
5137053|NCT01588366|17743183|P5|Overall Study|Adverse Event|0
5137054|NCT01588366|17743184|P4|Overall Study|Adverse Event|1
5137055|NCT01588366|17743185|P3|Overall Study|Adverse Event|0
5137056|NCT01588366|17743186|P2|Overall Study|Adverse Event|1
5137057|NCT01588366|17743187|P1|Overall Study|Adverse Event|0
5137058|NCT01588353|17743215|P3|Step3|Adverse Event|2
5137059|NCT01588353|17743216|P2|Step3|Adverse Event|0
5137060|NCT01588353|17743217|P1|Step3|Adverse Event|0
5137061|NCT01588353|17743215|P3|Step2|Withdrawal by Subject|0
5137062|NCT01588353|17743216|P2|Step2|Withdrawal by Subject|1
5137063|NCT01588353|17743217|P1|Step2|Withdrawal by Subject|0
5137064|NCT01588197|17743266|P2|Overall Study|No MRI|0
5137065|NCT01588197|17743267|P1|Overall Study|No MRI|1
5137066|NCT01588197|17743266|P2|Overall Study|Lack of Efficacy|1
5137067|NCT01588197|17743267|P1|Overall Study|Lack of Efficacy|0
5137068|NCT01588184|17743283|P6|Overall Study|multiple reasons|0
5137069|NCT01588184|17743284|P5|Overall Study|multiple reasons|0
5137070|NCT01588184|17743285|P4|Overall Study|multiple reasons|1
5137071|NCT01588184|17743286|P3|Overall Study|multiple reasons|0
5137072|NCT01588184|17743287|P2|Overall Study|multiple reasons|3
5137073|NCT01588184|17743288|P1|Overall Study|multiple reasons|0
5137074|NCT01588184|17743283|P6|Overall Study|Bevacizumab treatment provision changed|3
5137075|NCT01588184|17743284|P5|Overall Study|Bevacizumab treatment provision changed|1
5137076|NCT01588184|17743285|P4|Overall Study|Bevacizumab treatment provision changed|0
5137077|NCT01588184|17743286|P3|Overall Study|Bevacizumab treatment provision changed|2
5137078|NCT01588184|17743287|P2|Overall Study|Bevacizumab treatment provision changed|6
5137079|NCT01588184|17743288|P1|Overall Study|Bevacizumab treatment provision changed|0
5137080|NCT01588184|17743283|P6|Overall Study|Withdrawal by Subject|0
5137081|NCT01588184|17743284|P5|Overall Study|Withdrawal by Subject|0
5137082|NCT01588184|17743285|P4|Overall Study|Withdrawal by Subject|1
5137083|NCT01588184|17743286|P3|Overall Study|Withdrawal by Subject|0
5137084|NCT01588184|17743287|P2|Overall Study|Withdrawal by Subject|4
5137085|NCT01588184|17743288|P1|Overall Study|Withdrawal by Subject|2
5137086|NCT01588184|17743283|P6|Overall Study|Death|1
5137087|NCT01588184|17743284|P5|Overall Study|Death|1
5137088|NCT01588184|17743285|P4|Overall Study|Death|1
5137089|NCT01588184|17743286|P3|Overall Study|Death|0
5137090|NCT01588184|17743287|P2|Overall Study|Death|0
5137091|NCT01588184|17743288|P1|Overall Study|Death|1
5137092|NCT01588106|17743341|P2|Overall Study|Withdrawal by Subject|4
5137093|NCT01588106|17743342|P1|Overall Study|Withdrawal by Subject|5
5137094|NCT01587989|17743350|P3|Randomized Study Treatment|Physician Decision|1
5137095|NCT01587989|17743351|P2|Randomized Study Treatment|Physician Decision|0
5137096|NCT01587989|17743352|P1|Randomized Study Treatment|Physician Decision|0
5137097|NCT01587989|17743350|P3|Randomized Study Treatment|Screening failure|0
5137098|NCT01587989|17743351|P2|Randomized Study Treatment|Screening failure|1
5137099|NCT01587989|17743352|P1|Randomized Study Treatment|Screening failure|0
5137100|NCT01587989|17743350|P3|Randomized Study Treatment|Withdrawal by Subject|0
5137101|NCT01587989|17743351|P2|Randomized Study Treatment|Withdrawal by Subject|1
5137102|NCT01587989|17743352|P1|Randomized Study Treatment|Withdrawal by Subject|0
5137103|NCT01587989|17743350|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
5137104|NCT01587989|17743351|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
5137105|NCT01587989|17743352|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
5137106|NCT01587989|17743350|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
5137107|NCT01587989|17743351|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
5137108|NCT01587989|17743352|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
5137109|NCT01587989|17743350|P3|12-Week Open-Label Run-In Period|Physician Decision|0
5137110|NCT01587989|17743351|P2|12-Week Open-Label Run-In Period|Physician Decision|0
5137111|NCT01587989|17743352|P1|12-Week Open-Label Run-In Period|Physician Decision|7
5137112|NCT01587924|17743417|P4|Overall Study|Withdrawal by Subject|0
5137113|NCT01587924|17743418|P3|Overall Study|Withdrawal by Subject|1
5137114|NCT01587924|17743419|P2|Overall Study|Withdrawal by Subject|1
5137115|NCT01587924|17743420|P1|Overall Study|Withdrawal by Subject|0
5137116|NCT01587924|17743417|P4|Overall Study|Met Hemoglobin stopping criteria|0
5137117|NCT01587924|17743418|P3|Overall Study|Met Hemoglobin stopping criteria|1
5137118|NCT01587924|17743419|P2|Overall Study|Met Hemoglobin stopping criteria|0
5137119|NCT01587924|17743420|P1|Overall Study|Met Hemoglobin stopping criteria|2
5137120|NCT01587924|17743417|P4|Overall Study|Protocol Violation|1
5137121|NCT01587924|17743418|P3|Overall Study|Protocol Violation|2
5137122|NCT01587924|17743419|P2|Overall Study|Protocol Violation|1
5137123|NCT01587924|17743420|P1|Overall Study|Protocol Violation|2
5137124|NCT01587924|17743417|P4|Overall Study|Adverse Event|0
5137125|NCT01587924|17743418|P3|Overall Study|Adverse Event|0
5137126|NCT01587924|17743419|P2|Overall Study|Adverse Event|2
5137127|NCT01587924|17743420|P1|Overall Study|Adverse Event|0
5137128|NCT01587898|17743521|P4|Overall Study|Met haemoglobin stopping criteria|0
5137129|NCT01587898|17743522|P3|Overall Study|Met haemoglobin stopping criteria|1
5137130|NCT01587898|17743523|P2|Overall Study|Met haemoglobin stopping criteria|1
5137131|NCT01587898|17743524|P1|Overall Study|Met haemoglobin stopping criteria|1
5137132|NCT01587898|17743521|P4|Overall Study|Withdrawal by Subject|0
5137133|NCT01587898|17743522|P3|Overall Study|Withdrawal by Subject|0
5137134|NCT01587898|17743523|P2|Overall Study|Withdrawal by Subject|1
5137135|NCT01587898|17743524|P1|Overall Study|Withdrawal by Subject|2
5137136|NCT01587898|17743521|P4|Overall Study|Lost to Follow-up|1
5137137|NCT01587898|17743522|P3|Overall Study|Lost to Follow-up|0
5137138|NCT01587898|17743523|P2|Overall Study|Lost to Follow-up|0
5137139|NCT01587898|17743524|P1|Overall Study|Lost to Follow-up|0
5137140|NCT01587898|17743521|P4|Overall Study|Protocol Violation|1
5137141|NCT01587898|17743522|P3|Overall Study|Protocol Violation|1
5137142|NCT01587898|17743523|P2|Overall Study|Protocol Violation|2
5137143|NCT01587898|17743524|P1|Overall Study|Protocol Violation|0
5137144|NCT01587898|17743521|P4|Overall Study|Adverse Event|0
5137145|NCT01587898|17743522|P3|Overall Study|Adverse Event|0
5137146|NCT01587898|17743523|P2|Overall Study|Adverse Event|1
5137147|NCT01587898|17743524|P1|Overall Study|Adverse Event|1
5137148|NCT01587885|17743700|P2|Treatment Period 1|Protocol Violation|2
5137149|NCT01587885|17743701|P1|Treatment Period 1|Protocol Violation|0
5137150|NCT01587885|17743700|P2|Treatment Period 1|Failure to Return|1
5137151|NCT01587885|17743701|P1|Treatment Period 1|Failure to Return|0
5137152|NCT01587703|17743732|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137153|NCT01587703|17743733|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137154|NCT01587703|17743734|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137155|NCT01587703|17743735|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137156|NCT01587703|17743736|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137157|NCT01587703|17743737|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137158|NCT01587703|17743738|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137159|NCT01587703|17743739|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
5137160|NCT01587703|17743740|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137161|NCT01587703|17743741|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137162|NCT01587703|17743742|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137163|NCT01587703|17743743|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137164|NCT01587703|17743744|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137165|NCT01587703|17743745|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137458|NCT01587079|17744223|P1|Overall Study|Protocol-specified criteria|9
5137166|NCT01587703|17743746|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137167|NCT01587703|17743747|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137168|NCT01587703|17743748|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137169|NCT01587703|17743749|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137170|NCT01587703|17743750|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5137171|NCT01587703|17743732|P19|Part2(Median Exposure of 1.41 Months)|Death|0
5137172|NCT01587703|17743733|P18|Part2(Median Exposure of 1.41 Months)|Death|0
5137173|NCT01587703|17743734|P17|Part2(Median Exposure of 1.41 Months)|Death|5
5137174|NCT01587703|17743735|P16|Part2(Median Exposure of 1.41 Months)|Death|17
5137175|NCT01587703|17743736|P15|Part2(Median Exposure of 1.41 Months)|Death|16
5137176|NCT01587703|17743737|P14|Part2(Median Exposure of 1.41 Months)|Death|21
5137177|NCT01587703|17743738|P13|Part2(Median Exposure of 1.41 Months)|Death|12
5137178|NCT01587703|17743739|P12|Part2(Median Exposure of 1.41 Months)|Death|8
5137179|NCT01587703|17743740|P11|Part2(Median Exposure of 1.41 Months)|Death|0
5137180|NCT01587703|17743741|P10|Part2(Median Exposure of 1.41 Months)|Death|0
5137181|NCT01587703|17743742|P9|Part2(Median Exposure of 1.41 Months)|Death|0
5137182|NCT01587703|17743743|P8|Part2(Median Exposure of 1.41 Months)|Death|0
5137183|NCT01587703|17743744|P7|Part2(Median Exposure of 1.41 Months)|Death|0
5137184|NCT01587703|17743745|P6|Part2(Median Exposure of 1.41 Months)|Death|0
5137185|NCT01587703|17743746|P5|Part2(Median Exposure of 1.41 Months)|Death|0
5137186|NCT01587703|17743747|P4|Part2(Median Exposure of 1.41 Months)|Death|0
5137187|NCT01587703|17743748|P3|Part2(Median Exposure of 1.41 Months)|Death|0
5137188|NCT01587703|17743749|P2|Part2(Median Exposure of 1.41 Months)|Death|0
5137189|NCT01587703|17743750|P1|Part2(Median Exposure of 1.41 Months)|Death|0
5137190|NCT01587703|17743732|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137191|NCT01587703|17743733|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137192|NCT01587703|17743734|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
5137193|NCT01587703|17743735|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
5137194|NCT01587703|17743736|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
5137195|NCT01587703|17743737|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
5137196|NCT01587703|17743738|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
5137197|NCT01587703|17743739|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
5137198|NCT01587703|17743740|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137199|NCT01587703|17743741|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137200|NCT01587703|17743742|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137201|NCT01587703|17743743|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137202|NCT01587703|17743744|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137203|NCT01587703|17743745|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137204|NCT01587703|17743746|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137205|NCT01587703|17743747|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137206|NCT01587703|17743748|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137207|NCT01587703|17743749|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137208|NCT01587703|17743750|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
5137209|NCT01587703|17743732|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137210|NCT01587703|17743733|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137211|NCT01587703|17743734|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137212|NCT01587703|17743735|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137213|NCT01587703|17743736|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
5137214|NCT01587703|17743737|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137215|NCT01587703|17743738|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137216|NCT01587703|17743739|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
5137217|NCT01587703|17743740|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137218|NCT01587703|17743741|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137219|NCT01587703|17743742|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137220|NCT01587703|17743743|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137221|NCT01587703|17743744|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137222|NCT01587703|17743745|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137223|NCT01587703|17743746|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137224|NCT01587703|17743747|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137225|NCT01587703|17743748|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137226|NCT01587703|17743749|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137227|NCT01587703|17743750|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5137228|NCT01587703|17743732|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137229|NCT01587703|17743733|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137230|NCT01587703|17743734|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137231|NCT01587703|17743735|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
5137232|NCT01587703|17743736|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137233|NCT01587703|17743737|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137234|NCT01587703|17743738|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137235|NCT01587703|17743739|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137236|NCT01587703|17743740|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137237|NCT01587703|17743741|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137238|NCT01587703|17743742|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137239|NCT01587703|17743743|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137240|NCT01587703|17743744|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137241|NCT01587703|17743745|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137242|NCT01587703|17743746|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137243|NCT01587703|17743747|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137244|NCT01587703|17743748|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137245|NCT01587703|17743749|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137246|NCT01587703|17743750|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5137247|NCT01587703|17743732|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
5137248|NCT01587703|17743733|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
5137249|NCT01587703|17743734|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137250|NCT01587703|17743735|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137251|NCT01587703|17743736|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137252|NCT01587703|17743737|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137253|NCT01587703|17743738|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137254|NCT01587703|17743739|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137255|NCT01587703|17743740|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137256|NCT01587703|17743741|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137257|NCT01587703|17743742|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137258|NCT01587703|17743743|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137259|NCT01587703|17743744|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137260|NCT01587703|17743745|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137261|NCT01587703|17743746|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137262|NCT01587703|17743747|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137263|NCT01587703|17743748|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137264|NCT01587703|17743749|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137265|NCT01587703|17743750|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5137266|NCT01587703|17743732|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
5137267|NCT01587703|17743733|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137268|NCT01587703|17743734|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137269|NCT01587703|17743735|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137270|NCT01587703|17743736|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137271|NCT01587703|17743737|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137272|NCT01587703|17743738|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137273|NCT01587703|17743739|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137274|NCT01587703|17743740|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137275|NCT01587703|17743741|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137276|NCT01587703|17743742|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137277|NCT01587703|17743743|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137278|NCT01587703|17743744|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137279|NCT01587703|17743745|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137280|NCT01587703|17743746|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137281|NCT01587703|17743747|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137282|NCT01587703|17743748|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137283|NCT01587703|17743749|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137284|NCT01587703|17743750|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5137285|NCT01587703|17743732|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137286|NCT01587703|17743733|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137287|NCT01587703|17743734|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137288|NCT01587703|17743735|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137289|NCT01587703|17743736|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137290|NCT01587703|17743737|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137291|NCT01587703|17743738|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137292|NCT01587703|17743739|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137293|NCT01587703|17743740|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137294|NCT01587703|17743741|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137295|NCT01587703|17743742|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
5137296|NCT01587703|17743743|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137297|NCT01587703|17743744|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137298|NCT01587703|17743745|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137299|NCT01587703|17743746|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137300|NCT01587703|17743747|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137301|NCT01587703|17743748|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137302|NCT01587703|17743749|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137303|NCT01587703|17743750|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5137304|NCT01587703|17743732|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137305|NCT01587703|17743733|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137306|NCT01587703|17743734|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137307|NCT01587703|17743735|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137308|NCT01587703|17743736|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137309|NCT01587703|17743737|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137310|NCT01587703|17743738|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137311|NCT01587703|17743739|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137312|NCT01587703|17743740|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
5137313|NCT01587703|17743741|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
5137314|NCT01587703|17743742|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137315|NCT01587703|17743743|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137316|NCT01587703|17743744|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137317|NCT01587703|17743745|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137318|NCT01587703|17743746|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137319|NCT01587703|17743747|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137320|NCT01587703|17743748|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137321|NCT01587703|17743749|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137322|NCT01587703|17743750|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5137323|NCT01587703|17743732|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137324|NCT01587703|17743733|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137325|NCT01587703|17743734|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137326|NCT01587703|17743735|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137327|NCT01587703|17743736|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137328|NCT01587703|17743737|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137329|NCT01587703|17743738|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137330|NCT01587703|17743739|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137331|NCT01587703|17743740|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
5137332|NCT01587703|17743741|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137333|NCT01587703|17743742|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
5137334|NCT01587703|17743743|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137335|NCT01587703|17743744|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137336|NCT01587703|17743745|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137337|NCT01587703|17743746|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137338|NCT01587703|17743747|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137339|NCT01587703|17743748|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137340|NCT01587703|17743749|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137341|NCT01587703|17743750|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5137342|NCT01587703|17743732|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
5137343|NCT01587703|17743733|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
5137344|NCT01587703|17743734|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
5137345|NCT01587703|17743735|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
5137346|NCT01587703|17743736|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
5137347|NCT01587703|17743737|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
5137348|NCT01587703|17743738|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
5137349|NCT01587703|17743739|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
5137350|NCT01587703|17743740|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
5137351|NCT01587703|17743741|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
5137352|NCT01587703|17743742|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
5137353|NCT01587703|17743743|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
5137354|NCT01587703|17743744|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
5137355|NCT01587703|17743745|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
5137356|NCT01587703|17743746|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
5137357|NCT01587703|17743747|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
5137358|NCT01587703|17743748|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
5137359|NCT01587703|17743749|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
5137360|NCT01587703|17743750|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
5137361|NCT01587703|17743732|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
5137362|NCT01587703|17743733|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
5137363|NCT01587703|17743734|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
5137364|NCT01587703|17743735|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
5137365|NCT01587703|17743736|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
5137366|NCT01587703|17743737|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
5137367|NCT01587703|17743738|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
5137368|NCT01587703|17743739|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
5137369|NCT01587703|17743740|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
5137370|NCT01587703|17743741|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
5137371|NCT01587703|17743742|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
5137372|NCT01587703|17743743|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
5137373|NCT01587703|17743744|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
5137374|NCT01587703|17743745|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
5137375|NCT01587703|17743746|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
5137376|NCT01587703|17743747|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
5137377|NCT01587703|17743748|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
5137378|NCT01587703|17743749|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
5137379|NCT01587703|17743750|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
5137380|NCT01587703|17743732|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137381|NCT01587703|17743733|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137382|NCT01587703|17743734|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137383|NCT01587703|17743735|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137384|NCT01587703|17743736|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137385|NCT01587703|17743737|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137386|NCT01587703|17743738|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137387|NCT01587703|17743739|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137388|NCT01587703|17743740|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137389|NCT01587703|17743741|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137390|NCT01587703|17743742|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137391|NCT01587703|17743743|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137392|NCT01587703|17743744|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
5137393|NCT01587703|17743745|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137394|NCT01587703|17743746|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137395|NCT01587703|17743747|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137396|NCT01587703|17743748|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137397|NCT01587703|17743749|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137398|NCT01587703|17743750|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5137399|NCT01587703|17743732|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137400|NCT01587703|17743733|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137401|NCT01587703|17743734|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137402|NCT01587703|17743735|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137403|NCT01587703|17743736|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137404|NCT01587703|17743737|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137405|NCT01587703|17743738|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137406|NCT01587703|17743739|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137407|NCT01587703|17743740|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137408|NCT01587703|17743741|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137409|NCT01587703|17743742|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137410|NCT01587703|17743743|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
5137411|NCT01587703|17743744|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137412|NCT01587703|17743745|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
5137413|NCT01587703|17743746|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137414|NCT01587703|17743747|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137415|NCT01587703|17743748|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137416|NCT01587703|17743749|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137417|NCT01587703|17743750|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5137418|NCT01587703|17743732|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137419|NCT01587703|17743733|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137420|NCT01587703|17743734|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137421|NCT01587703|17743735|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137422|NCT01587703|17743736|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137423|NCT01587703|17743737|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137424|NCT01587703|17743738|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137425|NCT01587703|17743739|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137426|NCT01587703|17743740|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137427|NCT01587703|17743741|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137428|NCT01587703|17743742|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137429|NCT01587703|17743743|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137430|NCT01587703|17743744|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137431|NCT01587703|17743745|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137432|NCT01587703|17743746|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137433|NCT01587703|17743747|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137434|NCT01587703|17743748|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137435|NCT01587703|17743749|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5137436|NCT01587703|17743750|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
5137437|NCT01587651|17744157|P3|Overall Study|Withdrawal by Subject|0
5137438|NCT01587651|17744158|P2|Overall Study|Withdrawal by Subject|1
5137439|NCT01587651|17744159|P1|Overall Study|Withdrawal by Subject|0
5137440|NCT01587651|17744157|P3|Overall Study|Protocol Violation|1
5137441|NCT01587651|17744158|P2|Overall Study|Protocol Violation|1
5137442|NCT01587651|17744159|P1|Overall Study|Protocol Violation|0
5137443|NCT01587651|17744157|P3|Overall Study|Adverse Event|0
5137444|NCT01587651|17744158|P2|Overall Study|Adverse Event|1
5137445|NCT01587651|17744159|P1|Overall Study|Adverse Event|0
5137446|NCT01587274|17744189|P3|Overall Study|Lost to Follow-up|3
5137447|NCT01587274|17744190|P2|Overall Study|Lost to Follow-up|5
5137448|NCT01587274|17744191|P1|Overall Study|Lost to Follow-up|4
5137449|NCT01587118|17744199|P1|Overall Study|nonresponse|1
5137450|NCT01587118|17744199|P1|Overall Study|Relocation|1
5137451|NCT01587118|17744199|P1|Overall Study|Lost to Follow-up|2
5137452|NCT01587118|17744199|P1|Overall Study|Adverse Event|3
5137453|NCT01587079|17744223|P1|Overall Study|Adverse Event|14
5137454|NCT01587079|17744223|P1|Overall Study|Withdrawal by Subject|7
5137455|NCT01587079|17744223|P1|Overall Study|Physician Decision|2
5137456|NCT01587079|17744223|P1|Overall Study|Lost to Follow-up|2
5137457|NCT01587079|17744223|P1|Overall Study|Protocol Violation|5
5137459|NCT01587040|17744349|P4|Overall Study|Other than specified|1
5137460|NCT01587040|17744350|P3|Overall Study|Other than specified|11
5137461|NCT01587040|17744351|P2|Overall Study|Other than specified|1
5137462|NCT01587040|17744352|P1|Overall Study|Other than specified|5
5137463|NCT01587040|17744349|P4|Overall Study|Disease progression|3
5137464|NCT01587040|17744350|P3|Overall Study|Disease progression|15
5137465|NCT01587040|17744351|P2|Overall Study|Disease progression|1
5137466|NCT01587040|17744352|P1|Overall Study|Disease progression|12
5137467|NCT01587040|17744349|P4|Overall Study|Adverse Event|0
5137468|NCT01587040|17744350|P3|Overall Study|Adverse Event|10
5137469|NCT01587040|17744351|P2|Overall Study|Adverse Event|1
5137470|NCT01587040|17744352|P1|Overall Study|Adverse Event|0
5137471|NCT01587040|17744349|P4|Overall Study|Protocol Violation|0
5137472|NCT01587040|17744350|P3|Overall Study|Protocol Violation|1
5137473|NCT01587040|17744351|P2|Overall Study|Protocol Violation|0
5137474|NCT01587040|17744352|P1|Overall Study|Protocol Violation|0
5137475|NCT01587014|17744379|P1|Overall Study|Death|2
5137476|NCT01587001|17744386|P2|Overall Study|Insufficient samples to complete testing|1
5137477|NCT01587001|17744387|P1|Overall Study|Insufficient samples to complete testing|4
5137478|NCT01587001|17744386|P2|Overall Study|Lost to Follow-up|0
5137479|NCT01587001|17744387|P1|Overall Study|Lost to Follow-up|2
5137480|NCT01586910|17744416|P2|Overall Study|Physician withdrew Subject|24
5137481|NCT01586910|17744417|P1|Overall Study|Physician withdrew Subject|5
5137482|NCT01586910|17744416|P2|Overall Study|Withdrawal by Subject|43
5137483|NCT01586910|17744417|P1|Overall Study|Withdrawal by Subject|6
5137484|NCT01586910|17744416|P2|Overall Study|Death|4
5137485|NCT01586910|17744417|P1|Overall Study|Death|4
5137486|NCT01586819|17744491|P2|Overall Study|Withdrawal by Subject|0
5137487|NCT01586819|17744492|P1|Overall Study|Withdrawal by Subject|1
5137488|NCT01586806|17744503|P3|Overall Study|Lost to Follow-up|2
5137489|NCT01586806|17744504|P2|Overall Study|Lost to Follow-up|3
5137490|NCT01586806|17744505|P1|Overall Study|Lost to Follow-up|2
5137491|NCT01586806|17744503|P3|Overall Study|Withdrawal by Subject|0
5137492|NCT01586806|17744504|P2|Overall Study|Withdrawal by Subject|0
5137493|NCT01586806|17744505|P1|Overall Study|Withdrawal by Subject|1
5137494|NCT01586806|17744503|P3|Overall Study|Protocol Violation|0
5137495|NCT01586806|17744504|P2|Overall Study|Protocol Violation|1
5137496|NCT01586806|17744505|P1|Overall Study|Protocol Violation|0
5137497|NCT01586364|17744525|P1|Overall Study|Other-Not specified|1
5137498|NCT01586364|17744525|P1|Overall Study|Other-PI discretion, site closing|2
5137499|NCT01586364|17744525|P1|Overall Study|Other-Site closure due to PI illness|1
5137500|NCT01586364|17744525|P1|Overall Study|Other-Subject wasn't getting much relief|1
5137501|NCT01586364|17744525|P1|Overall Study|Other-Did not feel better post-treatment|1
5137502|NCT01586364|17744525|P1|Overall Study|Lack of Efficacy|1
5137503|NCT01586364|17744525|P1|Overall Study|Protocol Violation|16
5137504|NCT01586364|17744525|P1|Overall Study|Lost to Follow-up|17
5137505|NCT01586364|17744525|P1|Overall Study|Adverse Event|37
5137506|NCT01586364|17744525|P1|Overall Study|Withdrawal by Subject|40
5137507|NCT01586338|17744578|P1|Overall Study|Other|1
5137508|NCT01586338|17744578|P1|Overall Study|Withdrawal by participant|3
5137509|NCT01586338|17744578|P1|Overall Study|Lost to Follow-up|1
5137510|NCT01586338|17744578|P1|Overall Study|Adverse Event|3
5137511|NCT01586195|17744601|P1|Overall Study|Reason not specified|9
5137512|NCT01586195|17744601|P1|Overall Study|Started new anti-melanoma therapy|1
5137513|NCT01586195|17744601|P1|Overall Study|Withdrawal of Consent|5
5137514|NCT01586195|17744601|P1|Overall Study|Death|11
5137515|NCT01586156|17744615|P3|Overall Study|Pregnancy|0
5137516|NCT01586156|17744616|P2|Overall Study|Pregnancy|1
5137517|NCT01586156|17744617|P1|Overall Study|Pregnancy|0
5137518|NCT01585987|17744674|P2|Treated|Poor/Non-Compliance|1
5137519|NCT01585987|17744675|P1|Treated|Poor/Non-Compliance|0
5137520|NCT01585987|17744674|P2|Treated|Subject Request|1
5137521|NCT01585987|17744675|P1|Treated|Subject Request|0
5137522|NCT01585987|17744674|P2|Treated|Non-Specified|2
5137523|NCT01585987|17744675|P1|Treated|Non-Specified|1
5137524|NCT01585987|17744674|P2|Treated|Maximum Clinical Benefit|1
5137525|NCT01585987|17744675|P1|Treated|Maximum Clinical Benefit|0
5137526|NCT01585987|17744674|P2|Treated|Lost to Follow-up|1
5137527|NCT01585987|17744675|P1|Treated|Lost to Follow-up|0
5137528|NCT01585987|17744674|P2|Treated|Death|0
5137529|NCT01585987|17744675|P1|Treated|Death|1
5137530|NCT01585987|17744674|P2|Treated|Withdrawal by Subject|2
5137531|NCT01585987|17744675|P1|Treated|Withdrawal by Subject|1
5137532|NCT01585987|17744674|P2|Treated|Adverse Event|0
5137533|NCT01585987|17744675|P1|Treated|Adverse Event|3
5137534|NCT01585987|17744674|P2|Treated|Study Drug Toxicity|5
5137535|NCT01585987|17744675|P1|Treated|Study Drug Toxicity|9
5137536|NCT01585987|17744674|P2|Treated|Disease Progression|36
5137537|NCT01585987|17744675|P1|Treated|Disease Progression|39
5137538|NCT01585987|17744674|P2|Randomized|No longer met criteria|2
5137539|NCT01585987|17744675|P1|Randomized|No longer met criteria|0
5137540|NCT01585987|17744674|P2|Randomized|Withdrawal by Subject|4
5137541|NCT01585987|17744675|P1|Randomized|Withdrawal by Subject|0
5137542|NCT01585961|17744690|P1|Overall Study|Ablation cancelled for slow-heal wound|1
5137543|NCT01585961|17744690|P1|Overall Study|Lost to Follow-up|23
5137544|NCT01585961|17744690|P1|Overall Study|Withdrawal by Subject|1
5137545|NCT01585961|17744690|P1|Overall Study|Decision to use non-study catheter|1
5137546|NCT01585961|17744690|P1|Overall Study|Physician Decision|1
5137547|NCT01585961|17744690|P1|Overall Study|Death|6
5137548|NCT01585766|17744768|P6|Overall Study|Physician Decision|0
5137549|NCT01585766|17744769|P5|Overall Study|Physician Decision|0
5137550|NCT01585766|17744770|P4|Overall Study|Physician Decision|0
5137551|NCT01585766|17744771|P3|Overall Study|Physician Decision|1
5137552|NCT01585766|17744772|P2|Overall Study|Physician Decision|0
5137553|NCT01585766|17744773|P1|Overall Study|Physician Decision|0
5137554|NCT01585766|17744768|P6|Overall Study|Death|0
5137555|NCT01585766|17744769|P5|Overall Study|Death|0
5137556|NCT01585766|17744770|P4|Overall Study|Death|0
5137557|NCT01585766|17744771|P3|Overall Study|Death|0
5137558|NCT01585766|17744772|P2|Overall Study|Death|1
5137559|NCT01585766|17744773|P1|Overall Study|Death|0
5137560|NCT01585766|17744768|P6|Overall Study|Withdrawal by Subject|0
5137561|NCT01585766|17744769|P5|Overall Study|Withdrawal by Subject|0
5137562|NCT01585766|17744770|P4|Overall Study|Withdrawal by Subject|0
5137563|NCT01585766|17744771|P3|Overall Study|Withdrawal by Subject|1
5137564|NCT01585766|17744772|P2|Overall Study|Withdrawal by Subject|1
5137565|NCT01585766|17744773|P1|Overall Study|Withdrawal by Subject|0
5137566|NCT01585584|17744877|P1|Overall Study|Physician Decision|2
5137567|NCT01585584|17744877|P1|Overall Study|Withdrawal by Subject|1
5137568|NCT01585584|17744877|P1|Overall Study|Lack of Efficacy|1
5137569|NCT01585558|17744884|P3|Overall Study|Lack of Efficacy|1
5137570|NCT01585558|17744885|P2|Overall Study|Lack of Efficacy|0
5137571|NCT01585558|17744886|P1|Overall Study|Lack of Efficacy|0
5137572|NCT01585558|17744884|P3|Overall Study|Protocol Violation|2
5137573|NCT01585558|17744885|P2|Overall Study|Protocol Violation|3
5137574|NCT01585558|17744886|P1|Overall Study|Protocol Violation|4
5137575|NCT01585558|17744884|P3|Overall Study|Adverse Event|1
5137576|NCT01585558|17744885|P2|Overall Study|Adverse Event|4
5137577|NCT01585558|17744886|P1|Overall Study|Adverse Event|3
5137578|NCT01585558|17744884|P3|Overall Study|Lost to Follow-up|3
5137579|NCT01585558|17744885|P2|Overall Study|Lost to Follow-up|0
5137580|NCT01585558|17744886|P1|Overall Study|Lost to Follow-up|2
5137581|NCT01585558|17744884|P3|Overall Study|Withdrawal by Subject|8
5137582|NCT01585558|17744885|P2|Overall Study|Withdrawal by Subject|5
5137583|NCT01585558|17744886|P1|Overall Study|Withdrawal by Subject|4
5137584|NCT01585428|17745120|P2|Overall Study|Death during treatment|0
5137585|NCT01585428|17745121|P1|Overall Study|Death during treatment|1
5137586|NCT01585298|17745145|P1|Overall Study|Adverse Event|24
5137587|NCT01585298|17745145|P1|Overall Study|Abnormal test procedure results|1
5137588|NCT01585298|17745145|P1|Overall Study|Withdrawal by Subject|4
5137589|NCT01585298|17745145|P1|Overall Study|Lost to Follow-up|2
5137590|NCT01585298|17745145|P1|Overall Study|Administrative problems|4
5137591|NCT01585298|17745145|P1|Overall Study|Protocol deviation|1
5137592|NCT01585298|17745145|P1|Overall Study|Study completion was not documented.|1
5137593|NCT01585272|17745153|P1|Overall Study|Withdrawal by Subject|10
5137594|NCT01585272|17745153|P1|Overall Study|Protocol Violation|7
5137595|NCT01585272|17745153|P1|Overall Study|Adverse Event|22
5137596|NCT01585246|17745166|P5|Overall Study|Other|0
5137597|NCT01585246|17745167|P4|Overall Study|Other|1
5137598|NCT01585246|17745168|P3|Overall Study|Other|1
5137599|NCT01585246|17745169|P2|Overall Study|Other|1
5137600|NCT01585246|17745170|P1|Overall Study|Other|0
5137601|NCT01585246|17745166|P5|Overall Study|Withdrawal by Subject|1
5137602|NCT01585246|17745167|P4|Overall Study|Withdrawal by Subject|2
5137603|NCT01585246|17745168|P3|Overall Study|Withdrawal by Subject|1
5137604|NCT01585246|17745169|P2|Overall Study|Withdrawal by Subject|0
5137605|NCT01585246|17745170|P1|Overall Study|Withdrawal by Subject|0
5137606|NCT01585246|17745166|P5|Overall Study|Protocol Violation|1
5137607|NCT01585246|17745167|P4|Overall Study|Protocol Violation|0
5137608|NCT01585246|17745168|P3|Overall Study|Protocol Violation|0
5137609|NCT01585246|17745169|P2|Overall Study|Protocol Violation|0
5137610|NCT01585246|17745170|P1|Overall Study|Protocol Violation|0
5137611|NCT01585246|17745166|P5|Overall Study|Lost to Follow-up|0
5137612|NCT01585246|17745167|P4|Overall Study|Lost to Follow-up|1
5137613|NCT01585246|17745168|P3|Overall Study|Lost to Follow-up|2
5137614|NCT01585246|17745169|P2|Overall Study|Lost to Follow-up|0
5137615|NCT01585246|17745170|P1|Overall Study|Lost to Follow-up|0
5137616|NCT01585168|17745191|P4|Overall Study|Lost to Follow-up|1
5137617|NCT01585168|17745192|P3|Overall Study|Lost to Follow-up|1
5137618|NCT01585168|17745193|P2|Overall Study|Lost to Follow-up|1
5137619|NCT01585168|17745194|P1|Overall Study|Lost to Follow-up|3
5137620|NCT01585155|17745214|P1|Overall Study|Worsening ulcerative colitis|2
5137621|NCT01585155|17745214|P1|Overall Study|Lack of Efficacy|2
5137622|NCT01585155|17745214|P1|Overall Study|Adverse Event|1
5137623|NCT01585038|17745236|P2|Overall Study|Adverse Event|2
5137624|NCT01585038|17745237|P1|Overall Study|Adverse Event|2
5137625|NCT01585025|17745252|P3|Overall Study|Withdrawal by Subject|4
5137626|NCT01585025|17745253|P2|Overall Study|Withdrawal by Subject|3
5137627|NCT01585025|17745254|P1|Overall Study|Withdrawal by Subject|0
5137628|NCT01584843|17745284|P6|Second Treatment Period|Withdrawal by Subject|1
5137629|NCT01584843|17745285|P5|Second Treatment Period|Withdrawal by Subject|0
5137630|NCT01584843|17745286|P4|Second Treatment Period|Withdrawal by Subject|0
5137631|NCT01584843|17745287|P3|Second Treatment Period|Withdrawal by Subject|0
5137632|NCT01584843|17745288|P2|Second Treatment Period|Withdrawal by Subject|0
5137633|NCT01584843|17745289|P1|Second Treatment Period|Withdrawal by Subject|0
5137634|NCT01584843|17745284|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
5137635|NCT01584843|17745285|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5137636|NCT01584843|17745286|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5137637|NCT01584843|17745287|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5137638|NCT01584843|17745288|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5137639|NCT01584843|17745289|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5137640|NCT01584843|17745284|P6|First Treatment Period|Protocol Violation|1
5137641|NCT01584843|17745285|P5|First Treatment Period|Protocol Violation|0
5137642|NCT01584843|17745286|P4|First Treatment Period|Protocol Violation|0
5137643|NCT01584843|17745287|P3|First Treatment Period|Protocol Violation|0
5137644|NCT01584843|17745288|P2|First Treatment Period|Protocol Violation|0
5137645|NCT01584843|17745289|P1|First Treatment Period|Protocol Violation|0
5137646|NCT01584843|17745284|P6|First Treatment Period|Adverse Event|0
5137647|NCT01584843|17745285|P5|First Treatment Period|Adverse Event|0
5137648|NCT01584843|17745286|P4|First Treatment Period|Adverse Event|0
5137649|NCT01584843|17745287|P3|First Treatment Period|Adverse Event|1
5137650|NCT01584843|17745288|P2|First Treatment Period|Adverse Event|0
5137651|NCT01584843|17745289|P1|First Treatment Period|Adverse Event|0
5137652|NCT01584648|17745400|P2|Overall Study|Ongoing|147
5137653|NCT01584648|17745401|P1|Overall Study|Ongoing|154
5137654|NCT01584648|17745400|P2|Overall Study|Death|55
5137655|NCT01584648|17745401|P1|Overall Study|Death|40
5137656|NCT01584648|17745400|P2|Overall Study|Withdrawal by Subject|5
5137657|NCT01584648|17745401|P1|Overall Study|Withdrawal by Subject|11
5137658|NCT01584648|17745400|P2|Overall Study|Physician Decision|2
5137659|NCT01584648|17745401|P1|Overall Study|Physician Decision|2
5137660|NCT01584648|17745400|P2|Overall Study|Lost to Follow-up|3
5137661|NCT01584648|17745401|P1|Overall Study|Lost to Follow-up|4
5137662|NCT01584232|17745529|P2|Overall Study|Lost to Follow-up|0
5137663|NCT01584232|17745530|P1|Overall Study|Lost to Follow-up|1
5137664|NCT01584232|17745529|P2|Overall Study|Physician Decision|1
5137665|NCT01584232|17745530|P1|Overall Study|Physician Decision|2
5137666|NCT01584232|17745529|P2|Overall Study|Withdrawal by Subject|1
5137667|NCT01584232|17745530|P1|Overall Study|Withdrawal by Subject|2
5137668|NCT01584232|17745529|P2|Overall Study|Adverse Event|1
5137669|NCT01584232|17745530|P1|Overall Study|Adverse Event|3
5137670|NCT01584024|17745546|P1|Overall Study|Withdrawal by Subject|3
5137671|NCT01584024|17745546|P1|Overall Study|Lost to Follow-up|10
5137672|NCT01583530|17745643|P6|Overall Study|Lack of compliance|0
5137673|NCT01583530|17745644|P5|Overall Study|Lack of compliance|1
5137674|NCT01583530|17745645|P4|Overall Study|Lack of compliance|0
5137675|NCT01583530|17745646|P3|Overall Study|Lack of compliance|0
5137676|NCT01583530|17745647|P2|Overall Study|Lack of compliance|0
5137677|NCT01583530|17745648|P1|Overall Study|Lack of compliance|0
5137678|NCT01583530|17745643|P6|Overall Study|Lost to Follow-up|0
5137679|NCT01583530|17745644|P5|Overall Study|Lost to Follow-up|3
5137680|NCT01583530|17745645|P4|Overall Study|Lost to Follow-up|0
5137681|NCT01583530|17745646|P3|Overall Study|Lost to Follow-up|0
5137682|NCT01583530|17745647|P2|Overall Study|Lost to Follow-up|0
5137683|NCT01583530|17745648|P1|Overall Study|Lost to Follow-up|0
5137684|NCT01583530|17745643|P6|Overall Study|Withdrawal by Subject|2
5137685|NCT01583530|17745644|P5|Overall Study|Withdrawal by Subject|1
5137686|NCT01583530|17745645|P4|Overall Study|Withdrawal by Subject|1
5137687|NCT01583530|17745646|P3|Overall Study|Withdrawal by Subject|0
5137688|NCT01583530|17745647|P2|Overall Study|Withdrawal by Subject|3
5137689|NCT01583530|17745648|P1|Overall Study|Withdrawal by Subject|0
5137690|NCT01583530|17745643|P6|Overall Study|Adverse Event|1
5137691|NCT01583530|17745644|P5|Overall Study|Adverse Event|0
5137692|NCT01583530|17745645|P4|Overall Study|Adverse Event|0
5137693|NCT01583530|17745646|P3|Overall Study|Adverse Event|0
5137694|NCT01583530|17745647|P2|Overall Study|Adverse Event|0
5137695|NCT01583530|17745648|P1|Overall Study|Adverse Event|0
5137696|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5137697|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5137698|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
5137699|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5137700|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5137701|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
5137702|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5137703|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
5137704|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5137705|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5137706|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5137707|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5137708|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5137709|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5137710|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5137711|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5137712|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5137713|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5137714|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Death|0
5137715|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Death|0
5137716|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Death|1
5137717|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Death|0
5137718|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Death|1
5137719|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Death|0
5137720|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Death|0
5137721|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Death|0
5137722|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Death|0
5137723|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
5137724|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
5137725|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
5137726|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
5137727|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
5137728|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
5137729|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
5137730|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
5137731|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
5137732|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5137733|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5137734|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5137735|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5137736|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5137737|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5137738|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5137739|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5137740|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5137741|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5137742|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
5137743|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5137744|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
5137745|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
5137746|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
5137747|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
5137748|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5137749|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
5137750|NCT01583374|17745710|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
5137751|NCT01583374|17745711|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
5137752|NCT01583374|17745712|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5137753|NCT01583374|17745713|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5137754|NCT01583374|17745714|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
5137755|NCT01583374|17745715|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5137756|NCT01583374|17745716|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5137757|NCT01583374|17745717|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
5137758|NCT01583374|17745718|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
5137759|NCT01583374|17745710|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5137760|NCT01583374|17745711|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5137761|NCT01583374|17745712|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5137762|NCT01583374|17745713|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
5137763|NCT01583374|17745714|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5137764|NCT01583374|17745715|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5137765|NCT01583374|17745716|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5137766|NCT01583374|17745717|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5137767|NCT01583374|17745718|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5137768|NCT01583374|17745710|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5137769|NCT01583374|17745711|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5137770|NCT01583374|17745712|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5137771|NCT01583374|17745713|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5137772|NCT01583374|17745714|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
5137773|NCT01583374|17745715|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5137774|NCT01583374|17745716|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
5137775|NCT01583374|17745717|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
5137776|NCT01583374|17745718|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5137777|NCT01583374|17745710|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5137778|NCT01583374|17745711|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
5137779|NCT01583374|17745712|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
5137780|NCT01583374|17745713|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5137781|NCT01583374|17745714|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
5137782|NCT01583374|17745715|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
5137783|NCT01583374|17745716|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5137784|NCT01583374|17745717|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5137785|NCT01583374|17745718|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5137786|NCT01583374|17745710|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5137787|NCT01583374|17745711|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5137788|NCT01583374|17745712|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5137789|NCT01583374|17745713|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5137790|NCT01583374|17745714|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5137791|NCT01583374|17745715|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5137792|NCT01583374|17745716|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
5137793|NCT01583374|17745717|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5137794|NCT01583374|17745718|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5137795|NCT01583374|17745710|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137796|NCT01583374|17745711|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
5137797|NCT01583374|17745712|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137798|NCT01583374|17745713|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137799|NCT01583374|17745714|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137800|NCT01583374|17745715|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137801|NCT01583374|17745716|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137802|NCT01583374|17745717|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137803|NCT01583374|17745718|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5137804|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Other|0
5137805|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Other|0
5137806|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Other|0
5137807|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Other|0
5137808|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Other|0
5137809|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Other|0
5137810|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Other|0
5137811|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Other|1
5137812|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Other|0
5137813|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137814|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137815|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137816|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137817|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137818|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137819|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
5137820|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137821|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5137822|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137823|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137824|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137825|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137826|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137827|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137828|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5137829|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
5137830|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
5137831|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5137832|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5137833|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5137834|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5137835|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5137836|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5137837|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
5137838|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
5137839|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
5137840|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137841|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137842|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137843|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137844|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137845|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137846|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5137847|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5137848|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5137849|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5137850|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5137851|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5137852|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5137853|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5137854|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5137855|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
5137856|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
5137857|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
5137858|NCT01583374|17745710|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5137859|NCT01583374|17745711|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5137860|NCT01583374|17745712|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5137861|NCT01583374|17745713|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5137862|NCT01583374|17745714|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5137863|NCT01583374|17745715|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5137864|NCT01583374|17745716|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
5137865|NCT01583374|17745717|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
5137866|NCT01583374|17745718|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
5137867|NCT01583218|17745760|P2|Overall Study|Withdraw of consent on day of random|0
5137868|NCT01583218|17745761|P1|Overall Study|Withdraw of consent on day of random|1
5137869|NCT01583218|17745760|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
5137870|NCT01583218|17745761|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
5137871|NCT01583218|17745760|P2|Overall Study|Patient was randomized due to mistake|0
5137872|NCT01583218|17745761|P1|Overall Study|Patient was randomized due to mistake|1
5137873|NCT01583218|17745760|P2|Overall Study|Patient was early terminated from study|1
5137874|NCT01583218|17745761|P1|Overall Study|Patient was early terminated from study|0
5137875|NCT01583218|17745760|P2|Overall Study|Patient deemed ineligible after random|0
5137876|NCT01583218|17745761|P1|Overall Study|Patient deemed ineligible after random|2
5137877|NCT01583218|17745760|P2|Overall Study|Patient was assessed via phone in person|0
5137878|NCT01583218|17745761|P1|Overall Study|Patient was assessed via phone in person|1
5137879|NCT01583218|17745760|P2|Overall Study|Patient randomized but not dosed|16
5137880|NCT01583218|17745761|P1|Overall Study|Patient randomized but not dosed|17
5137881|NCT01583218|17745760|P2|Overall Study|Patient did not wish to attend visits|1
5137882|NCT01583218|17745761|P1|Overall Study|Patient did not wish to attend visits|0
5137883|NCT01583218|17745760|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
5137884|NCT01583218|17745761|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
5137885|NCT01583218|17745760|P2|Overall Study|Cannot contact patient directly|2
5137886|NCT01583218|17745761|P1|Overall Study|Cannot contact patient directly|1
5137887|NCT01583218|17745760|P2|Overall Study|Patient /Family decision|0
5137888|NCT01583218|17745761|P1|Overall Study|Patient /Family decision|3
5137889|NCT01583218|17745760|P2|Overall Study|Adverse event or serious adverse event|3
5137890|NCT01583218|17745761|P1|Overall Study|Adverse event or serious adverse event|3
5137891|NCT01583218|17745760|P2|Overall Study|Lost to Follow-up|17
5137892|NCT01583218|17745761|P1|Overall Study|Lost to Follow-up|11
5137893|NCT01583218|17745760|P2|Overall Study|Death|211
5137894|NCT01583218|17745761|P1|Overall Study|Death|206
5137895|NCT01583218|17745760|P2|Overall Study|Withdrawal by Subject|29
5137896|NCT01583218|17745761|P1|Overall Study|Withdrawal by Subject|43
5137897|NCT01583179|17745781|P2|Overall Study|Screen failure|2
5137898|NCT01583179|17745782|P1|Overall Study|Screen failure|1
5137899|NCT01583166|17745792|P2|Overall Study|Withdrawal by Subject|6
5137900|NCT01583166|17745793|P1|Overall Study|Withdrawal by Subject|4
5137901|NCT01582971|17745816|P2|Overall Study|Other|13
5137902|NCT01582971|17745817|P1|Overall Study|Other|15
5137903|NCT01582971|17745816|P2|Overall Study|Withdrawal by Subject|2
5137904|NCT01582971|17745817|P1|Overall Study|Withdrawal by Subject|4
5137905|NCT01582971|17745816|P2|Overall Study|Lost to Follow-up|21
5137906|NCT01582971|17745817|P1|Overall Study|Lost to Follow-up|18
5137907|NCT01582971|17745816|P2|Overall Study|Death|1
5137908|NCT01582971|17745817|P1|Overall Study|Death|2
5137909|NCT01582945|17745835|P1|Overall Study|Scheduling conflicts|1
5137910|NCT01582945|17745835|P1|Overall Study|Intolerable side-effects|1
5137911|NCT01582854|17745849|P2|Overall Study|Other Miscellaneous Reason|0
5137912|NCT01582854|17745850|P1|Overall Study|Other Miscellaneous Reason|1
5137913|NCT01582854|17745849|P2|Overall Study|General Anaesthesia|1
5137914|NCT01582854|17745850|P1|Overall Study|General Anaesthesia|0
5137915|NCT01582854|17745849|P2|Overall Study|Carotid or Neurosurgery|1
5137916|NCT01582854|17745850|P1|Overall Study|Carotid or Neurosurgery|0
5137917|NCT01582854|17745849|P2|Overall Study|Disallowed Concomitant Medication|2
5137918|NCT01582854|17745850|P1|Overall Study|Disallowed Concomitant Medication|3
5137919|NCT01582854|17745849|P2|Overall Study|Recurrent Stroke|8
5137920|NCT01582854|17745850|P1|Overall Study|Recurrent Stroke|13
5137921|NCT01582854|17745849|P2|Overall Study|Physician Decision|1
5137922|NCT01582854|17745850|P1|Overall Study|Physician Decision|0
5137923|NCT01582854|17745849|P2|Overall Study|Lost to Follow-up|2
5137924|NCT01582854|17745850|P1|Overall Study|Lost to Follow-up|1
5137925|NCT01582854|17745849|P2|Overall Study|Withdrawal by Participant|11
5137926|NCT01582854|17745850|P1|Overall Study|Withdrawal by Participant|8
5137927|NCT01582854|17745849|P2|Overall Study|Adverse Event|3
5137928|NCT01582854|17745850|P1|Overall Study|Adverse Event|2
5137929|NCT01582854|17745849|P2|Overall Study|Death|5
5137930|NCT01582854|17745850|P1|Overall Study|Death|8
5137931|NCT01582789|17745878|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
5137932|NCT01582789|17745879|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
5137933|NCT01582451|17745939|P2|Overall Study|Sponsor Decision|0
5137934|NCT01582451|17745940|P1|Overall Study|Sponsor Decision|1
5137935|NCT01582451|17745939|P2|Overall Study|Physician Decision|0
5137936|NCT01582451|17745940|P1|Overall Study|Physician Decision|3
5137937|NCT01582451|17745939|P2|Overall Study|Withdrawal by Subject|9
5137938|NCT01582451|17745940|P1|Overall Study|Withdrawal by Subject|13
5137939|NCT01582451|17745939|P2|Overall Study|Protocol Violation|3
5137940|NCT01582451|17745940|P1|Overall Study|Protocol Violation|11
5137941|NCT01582451|17745939|P2|Overall Study|Lost to Follow-up|2
5137942|NCT01582451|17745940|P1|Overall Study|Lost to Follow-up|0
5137943|NCT01582451|17745939|P2|Overall Study|Death|3
5137944|NCT01582451|17745940|P1|Overall Study|Death|3
5137945|NCT01582451|17745939|P2|Overall Study|Adverse Event|3
5137946|NCT01582451|17745940|P1|Overall Study|Adverse Event|1
5137947|NCT01582308|17745982|P10|Period 4|Physician Decision|1
5137948|NCT01582308|17745983|P9|Period 4|Physician Decision|0
5137949|NCT01582308|17745984|P8|Period 4|Physician Decision|0
5137950|NCT01582308|17745985|P7|Period 4|Physician Decision|0
5137951|NCT01582308|17745986|P6|Period 4|Physician Decision|1
5137952|NCT01582308|17745987|P5|Period 4|Physician Decision|0
5137953|NCT01582308|17745988|P4|Period 4|Physician Decision|0
5137954|NCT01582308|17745989|P3|Period 4|Physician Decision|0
5137955|NCT01582308|17745990|P2|Period 4|Physician Decision|0
5137956|NCT01582308|17745991|P1|Period 4|Physician Decision|1
5137957|NCT01582308|17745982|P10|10-day Washout Following Period 1|Physician Decision|0
5137958|NCT01582308|17745983|P9|10-day Washout Following Period 1|Physician Decision|0
5137959|NCT01582308|17745984|P8|10-day Washout Following Period 1|Physician Decision|0
5137960|NCT01582308|17745985|P7|10-day Washout Following Period 1|Physician Decision|0
5137961|NCT01582308|17745986|P6|10-day Washout Following Period 1|Physician Decision|0
5137962|NCT01582308|17745987|P5|10-day Washout Following Period 1|Physician Decision|1
5137963|NCT01582308|17745988|P4|10-day Washout Following Period 1|Physician Decision|0
5137964|NCT01582308|17745989|P3|10-day Washout Following Period 1|Physician Decision|0
5137965|NCT01582308|17745990|P2|10-day Washout Following Period 1|Physician Decision|0
5137966|NCT01582308|17745991|P1|10-day Washout Following Period 1|Physician Decision|0
5137967|NCT01582308|17745982|P10|Period 1|Withdrawal by Subject|0
5137968|NCT01582308|17745983|P9|Period 1|Withdrawal by Subject|0
5137969|NCT01582308|17745984|P8|Period 1|Withdrawal by Subject|0
5137970|NCT01582308|17745985|P7|Period 1|Withdrawal by Subject|1
5137971|NCT01582308|17745986|P6|Period 1|Withdrawal by Subject|0
5137972|NCT01582308|17745987|P5|Period 1|Withdrawal by Subject|0
5137973|NCT01582308|17745988|P4|Period 1|Withdrawal by Subject|0
5137974|NCT01582308|17745989|P3|Period 1|Withdrawal by Subject|0
5137975|NCT01582308|17745990|P2|Period 1|Withdrawal by Subject|0
5137976|NCT01582308|17745991|P1|Period 1|Withdrawal by Subject|0
5137977|NCT01582282|17746019|P3|Overall Study|fasting blood glucose outside Protocol|0
5137978|NCT01582282|17746020|P2|Overall Study|fasting blood glucose outside Protocol|1
5137979|NCT01582282|17746021|P1|Overall Study|fasting blood glucose outside Protocol|0
5137980|NCT01582282|17746019|P3|Overall Study|Lost to Follow-up|0
5137981|NCT01582282|17746020|P2|Overall Study|Lost to Follow-up|0
5137982|NCT01582282|17746021|P1|Overall Study|Lost to Follow-up|1
5137983|NCT01582282|17746019|P3|Overall Study|Adverse Event|0
5137984|NCT01582282|17746020|P2|Overall Study|Adverse Event|1
5137985|NCT01582282|17746021|P1|Overall Study|Adverse Event|1
5137986|NCT01582243|17746044|P1|Overall Study|Lost to Follow-up|1
5137987|NCT01582243|17746044|P1|Overall Study|Adverse Event|1
5137988|NCT01582243|17746044|P1|Overall Study|Withdrawal by Subject|1
5137989|NCT01582178|17746055|P2|Overall Study|Physician Decision|5
5137990|NCT01582178|17746056|P1|Overall Study|Physician Decision|6
5137991|NCT01582152|17746064|P2|Overall Study|Adverse Event|1
5137992|NCT01582152|17746065|P1|Overall Study|Adverse Event|2
5137993|NCT01582152|17746064|P2|Overall Study|Disease Progression|5
5137994|NCT01582152|17746065|P1|Overall Study|Disease Progression|4
5137995|NCT01582100|17746088|P1|Overall Study|Withdrawal by Subject|1
5137996|NCT01582100|17746088|P1|Overall Study|Adverse Event|1
5137997|NCT01582061|17746094|P2|Overall Study|Lost to Follow-up|0
5137998|NCT01582061|17746095|P1|Overall Study|Lost to Follow-up|1
5137999|NCT01582061|17746094|P2|Overall Study|condition no longer requires study drug|0
5138000|NCT01582061|17746095|P1|Overall Study|condition no longer requires study drug|1
5138001|NCT01582061|17746094|P2|Overall Study|Death|1
5138002|NCT01582061|17746095|P1|Overall Study|Death|0
5138003|NCT01582061|17746094|P2|Overall Study|Abnormal laboratory value(s)|0
5138004|NCT01582061|17746095|P1|Overall Study|Abnormal laboratory value(s)|1
5138005|NCT01582061|17746094|P2|Overall Study|Withdrawal by Subject|4
5138006|NCT01582061|17746095|P1|Overall Study|Withdrawal by Subject|10
5138007|NCT01582061|17746094|P2|Overall Study|Adverse Event|8
5138008|NCT01582061|17746095|P1|Overall Study|Adverse Event|12
5138009|NCT01582061|17746094|P2|Overall Study|Lack of Efficacy|23
5138010|NCT01582061|17746095|P1|Overall Study|Lack of Efficacy|3
5138011|NCT01582009|17746145|P1|Overall Study|Physician Decision|1
5138012|NCT01582009|17746145|P1|Overall Study|Withdrawal by Subject|1
5138013|NCT01581931|17746162|P2|Washout|Adverse Event|1
5138014|NCT01581931|17746163|P1|Washout|Adverse Event|0
5138015|NCT01581684|17746216|P10|Overall Study|Other reason not defined|0
5138016|NCT01581684|17746217|P9|Overall Study|Other reason not defined|1
5138017|NCT01581684|17746218|P8|Overall Study|Other reason not defined|0
5138018|NCT01581684|17746219|P7|Overall Study|Other reason not defined|0
5138019|NCT01581684|17746220|P6|Overall Study|Other reason not defined|0
5138020|NCT01581684|17746221|P5|Overall Study|Other reason not defined|0
5138021|NCT01581684|17746222|P4|Overall Study|Other reason not defined|0
5138022|NCT01581684|17746223|P3|Overall Study|Other reason not defined|0
5138023|NCT01581684|17746224|P2|Overall Study|Other reason not defined|0
5138024|NCT01581684|17746225|P1|Overall Study|Other reason not defined|0
5138025|NCT01581619|17746321|P1|Overall Study|Lost to Follow-up|1
5138026|NCT01581619|17746321|P1|Overall Study|Withdrawal by Subject|1
5138027|NCT01581307|17746474|P1|Overall Study|Withdrawal by Subject|1
5138028|NCT01581281|17746483|P3|Overall Study|Early Study Closure|12
5138029|NCT01581281|17746484|P2|Overall Study|Early Study Closure|6
5138030|NCT01581281|17746485|P1|Overall Study|Early Study Closure|15
5138031|NCT01581021|17746507|P2|Overall Study|Lack of Efficacy|1
5138032|NCT01581021|17746508|P1|Overall Study|Lack of Efficacy|0
5138033|NCT01581021|17746507|P2|Overall Study|Lenke 6 Classification|1
5138034|NCT01581021|17746508|P1|Overall Study|Lenke 6 Classification|0
5138035|NCT01581021|17746507|P2|Overall Study|Not Randomized|2
5138036|NCT01581021|17746508|P1|Overall Study|Not Randomized|1
5138037|NCT01581021|17746507|P2|Overall Study|Neuromuscular|1
5138038|NCT01581021|17746508|P1|Overall Study|Neuromuscular|2
5138039|NCT01581021|17746507|P2|Overall Study|More than 2 hooks in thoracic|0
5138040|NCT01581021|17746508|P1|Overall Study|More than 2 hooks in thoracic|3
5138041|NCT01581021|17746507|P2|Overall Study|Lost to Follow-up|6
5138042|NCT01581021|17746508|P1|Overall Study|Lost to Follow-up|4
5138043|NCT01580995|17746535|P2|Overall Study|Lost to Follow-up|2
5138044|NCT01580995|17746536|P1|Overall Study|Lost to Follow-up|2
5138045|NCT01580969|17746545|P3|Overall Study|Physician Decision|0
5138046|NCT01580969|17746546|P2|Overall Study|Physician Decision|0
5138047|NCT01580969|17746547|P1|Overall Study|Physician Decision|3
5138048|NCT01580670|17746594|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
5138049|NCT01580670|17746594|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
5138050|NCT01580488|17746635|P1|Overall Study|Withdrawal by Subject|1
5138051|NCT01580293|17746741|P3|Part B|Part B ongoing|1
5138052|NCT01580293|17746742|P2|Part B|Part B ongoing|0
5138053|NCT01580293|17746743|P1|Part B|Part B ongoing|0
5138054|NCT01580293|17746741|P3|Part B|Other reason|1
5138055|NCT01580293|17746742|P2|Part B|Other reason|0
5138056|NCT01580293|17746743|P1|Part B|Other reason|0
5138057|NCT01580293|17746741|P3|Part B|Withdrawal by Subject|1
5138058|NCT01580293|17746742|P2|Part B|Withdrawal by Subject|0
5138059|NCT01580293|17746743|P1|Part B|Withdrawal by Subject|0
5138060|NCT01580293|17746741|P3|Part A_Extension|Extension ongoing|0
5138061|NCT01580293|17746742|P2|Part A_Extension|Extension ongoing|69
5138062|NCT01580293|17746743|P1|Part A_Extension|Extension ongoing|9
5138063|NCT01580293|17746741|P3|Part A_Extension|Other Reason|0
5138064|NCT01580293|17746742|P2|Part A_Extension|Other Reason|1
5138065|NCT01580293|17746743|P1|Part A_Extension|Other Reason|0
5138066|NCT01580293|17746741|P3|Part A_Extension|Lost to Follow-up|0
5138067|NCT01580293|17746742|P2|Part A_Extension|Lost to Follow-up|1
5138068|NCT01580293|17746743|P1|Part A_Extension|Lost to Follow-up|0
5138069|NCT01580293|17746741|P3|Part A_Extension|Withdrawal by Subject|0
5138070|NCT01580293|17746742|P2|Part A_Extension|Withdrawal by Subject|2
5138071|NCT01580293|17746743|P1|Part A_Extension|Withdrawal by Subject|0
5138072|NCT01580293|17746741|P3|Part A_Extension|Adverse Event|0
5138073|NCT01580293|17746742|P2|Part A_Extension|Adverse Event|2
5138074|NCT01580293|17746743|P1|Part A_Extension|Adverse Event|0
5138075|NCT01580293|17746741|P3|Part A_Main Trial|Non-adherence to the protocol|0
5138076|NCT01580293|17746742|P2|Part A_Main Trial|Non-adherence to the protocol|0
5138077|NCT01580293|17746743|P1|Part A_Main Trial|Non-adherence to the protocol|1
5138078|NCT01580293|17746741|P3|Part A_Main Trial|Withdrawal by Subject|0
5138079|NCT01580293|17746742|P2|Part A_Main Trial|Withdrawal by Subject|4
5138080|NCT01580293|17746743|P1|Part A_Main Trial|Withdrawal by Subject|1
5138081|NCT01580293|17746741|P3|Part A_Main Trial|Adverse Event|0
5138082|NCT01580293|17746742|P2|Part A_Main Trial|Adverse Event|2
5138083|NCT01580293|17746743|P1|Part A_Main Trial|Adverse Event|0
5138084|NCT01580020|17746883|P4|Overall Study|Lost to Follow-up|0
5138085|NCT01580020|17746884|P3|Overall Study|Lost to Follow-up|1
5138086|NCT01580020|17746885|P2|Overall Study|Lost to Follow-up|0
5138087|NCT01580020|17746886|P1|Overall Study|Lost to Follow-up|0
5138088|NCT01580020|17746883|P4|Overall Study|Administrative Problems|0
5138089|NCT01580020|17746884|P3|Overall Study|Administrative Problems|1
5138090|NCT01580020|17746885|P2|Overall Study|Administrative Problems|0
5138091|NCT01580020|17746886|P1|Overall Study|Administrative Problems|0
5138092|NCT01580020|17746883|P4|Overall Study|Adverse Event|1
5138093|NCT01580020|17746884|P3|Overall Study|Adverse Event|1
5138094|NCT01580020|17746885|P2|Overall Study|Adverse Event|1
5138095|NCT01580020|17746886|P1|Overall Study|Adverse Event|1
5138096|NCT01580020|17746883|P4|Overall Study|Withdrawal by Subject|0
5138097|NCT01580020|17746884|P3|Overall Study|Withdrawal by Subject|1
5138098|NCT01580020|17746885|P2|Overall Study|Withdrawal by Subject|1
5138099|NCT01580020|17746886|P1|Overall Study|Withdrawal by Subject|0
5138100|NCT01580020|17746883|P4|Overall Study|Lack of Efficacy|1
5138101|NCT01580020|17746884|P3|Overall Study|Lack of Efficacy|0
5138102|NCT01580020|17746885|P2|Overall Study|Lack of Efficacy|5
5138103|NCT01580020|17746886|P1|Overall Study|Lack of Efficacy|0
5138104|NCT01579916|17746930|P2|Overall Study|Death|0
5138105|NCT01579916|17746931|P1|Overall Study|Death|1
5138106|NCT01579916|17746930|P2|Overall Study|Withdrawal by Subject|1
5138107|NCT01579916|17746931|P1|Overall Study|Withdrawal by Subject|1
5138108|NCT01579916|17746930|P2|Overall Study|Lost to Follow-up|1
5138109|NCT01579916|17746931|P1|Overall Study|Lost to Follow-up|6
5138110|NCT01579812|17746957|P1|Overall Study|Withdrawal by Subject|6
5138111|NCT01579812|17746957|P1|Overall Study|Noncompliance|3
5138112|NCT01579812|17746957|P1|Overall Study|Patient choice|3
5138113|NCT01579812|17746957|P1|Overall Study|Ineligible after treatment start|40
5138114|NCT01579578|17746991|P2|Overall Study|Ongoing|0
5138115|NCT01579578|17746992|P1|Overall Study|Ongoing|3
5138116|NCT01579578|17746991|P2|Overall Study|Eligibility criteria|9
5138117|NCT01579578|17746992|P1|Overall Study|Eligibility criteria|3
5138118|NCT01579578|17746991|P2|Overall Study|Withdrawal by Subject|1
5138119|NCT01579578|17746992|P1|Overall Study|Withdrawal by Subject|2
5138120|NCT01579578|17746991|P2|Overall Study|Lost to Follow-up|1
5138121|NCT01579578|17746992|P1|Overall Study|Lost to Follow-up|1
5138122|NCT01579578|17746991|P2|Overall Study|Death|1
5138123|NCT01579578|17746992|P1|Overall Study|Death|4
5138124|NCT01579565|17747004|P2|Treated|declined to return for final visit|1
5138125|NCT01579565|17747005|P1|Treated|declined to return for final visit|0
5138126|NCT01579565|17747004|P2|Treated|Lost to Follow-up|1
5138127|NCT01579565|17747005|P1|Treated|Lost to Follow-up|2
5138128|NCT01579565|17747004|P2|Treated|Physician Decision|1
5138129|NCT01579565|17747005|P1|Treated|Physician Decision|0
5138130|NCT01579565|17747004|P2|Randomized|prohibited preoperative medication|1
5138131|NCT01579565|17747005|P1|Randomized|prohibited preoperative medication|0
5138132|NCT01579565|17747004|P2|Randomized|prohibited preoperative eating|0
5138133|NCT01579565|17747005|P1|Randomized|prohibited preoperative eating|1
5138134|NCT01579565|17747004|P2|Randomized|inadequate preoperative pupil dilation|1
5138135|NCT01579565|17747005|P1|Randomized|inadequate preoperative pupil dilation|0
5138136|NCT01579565|17747004|P2|Randomized|Withdrawal by Subject|0
5138137|NCT01579565|17747005|P1|Randomized|Withdrawal by Subject|3
5138138|NCT01579565|17747004|P2|Randomized|Adverse Event|3
5138139|NCT01579565|17747005|P1|Randomized|Adverse Event|1
5138140|NCT01579474|17747056|P6|Overall Study|Withdrawal by Subject|0
5138141|NCT01579474|17747057|P5|Overall Study|Withdrawal by Subject|0
5138142|NCT01579474|17747058|P4|Overall Study|Withdrawal by Subject|0
5138143|NCT01579474|17747059|P3|Overall Study|Withdrawal by Subject|0
5138144|NCT01579474|17747060|P2|Overall Study|Withdrawal by Subject|0
5138145|NCT01579474|17747061|P1|Overall Study|Withdrawal by Subject|1
5138146|NCT01579474|17747056|P6|Overall Study|Lack of Efficacy|0
5138147|NCT01579474|17747057|P5|Overall Study|Lack of Efficacy|1
5138148|NCT01579474|17747058|P4|Overall Study|Lack of Efficacy|0
5138149|NCT01579474|17747059|P3|Overall Study|Lack of Efficacy|0
5138150|NCT01579474|17747060|P2|Overall Study|Lack of Efficacy|0
5138151|NCT01579474|17747061|P1|Overall Study|Lack of Efficacy|1
5138152|NCT01579474|17747056|P6|Overall Study|Adverse Event|1
5138153|NCT01579474|17747057|P5|Overall Study|Adverse Event|0
5138154|NCT01579474|17747058|P4|Overall Study|Adverse Event|0
5138155|NCT01579474|17747059|P3|Overall Study|Adverse Event|2
5138156|NCT01579474|17747060|P2|Overall Study|Adverse Event|13
5138157|NCT01579474|17747061|P1|Overall Study|Adverse Event|1
5138158|NCT01579318|17747135|P1|Overall Study|Disease Progression|1
5138159|NCT01579006|17747230|P1|Overall Study|Scheduled surgery|1
5138160|NCT01579006|17747230|P1|Overall Study|Due to participant's health fund|1
5138161|NCT01579006|17747230|P1|Overall Study|Non-compliance|3
5138162|NCT01579006|17747230|P1|Overall Study|Withdrawal by Subject|5
5138163|NCT01579006|17747230|P1|Overall Study|Adverse Event|13
5138164|NCT01579006|17747230|P1|Overall Study|Lack of Efficacy|10
5138165|NCT01578850|17747289|P3|Period 2|Unspecified Reasons|0
5138166|NCT01578850|17747290|P2|Period 2|Unspecified Reasons|1
5138167|NCT01578850|17747291|P1|Period 2|Unspecified Reasons|0
5138168|NCT01578850|17747289|P3|Period 2|Study Terminated by Sponsor|4
5138169|NCT01578850|17747290|P2|Period 2|Study Terminated by Sponsor|5
5138170|NCT01578850|17747291|P1|Period 2|Study Terminated by Sponsor|0
5138171|NCT01578850|17747289|P3|Period 2|Withdrawal by Subject|2
5138172|NCT01578850|17747290|P2|Period 2|Withdrawal by Subject|2
5138173|NCT01578850|17747291|P1|Period 2|Withdrawal by Subject|0
5138174|NCT01578850|17747289|P3|Period 2|Lost to Follow-up|2
5138175|NCT01578850|17747290|P2|Period 2|Lost to Follow-up|1
5138176|NCT01578850|17747291|P1|Period 2|Lost to Follow-up|0
5138177|NCT01578850|17747289|P3|Period 2|Adverse Event|6
5138178|NCT01578850|17747290|P2|Period 2|Adverse Event|3
5138179|NCT01578850|17747291|P1|Period 2|Adverse Event|0
5138180|NCT01578850|17747289|P3|Period 2|Insufficient Clinical Response|0
5138181|NCT01578850|17747290|P2|Period 2|Insufficient Clinical Response|1
5138182|NCT01578850|17747291|P1|Period 2|Insufficient Clinical Response|0
5138183|NCT01578850|17747289|P3|Period 1|Study Terminated by Sponsor|0
5138184|NCT01578850|17747290|P2|Period 1|Study Terminated by Sponsor|0
5138185|NCT01578850|17747291|P1|Period 1|Study Terminated by Sponsor|3
5138186|NCT01578850|17747289|P3|Period 1|Withdrawal by Subject|0
5138187|NCT01578850|17747290|P2|Period 1|Withdrawal by Subject|0
5138188|NCT01578850|17747291|P1|Period 1|Withdrawal by Subject|9
5138189|NCT01578850|17747289|P3|Period 1|Does Not Meet Entrance Criteria|0
5138190|NCT01578850|17747290|P2|Period 1|Does Not Meet Entrance Criteria|0
5138191|NCT01578850|17747291|P1|Period 1|Does Not Meet Entrance Criteria|12
5138192|NCT01578850|17747289|P3|Period 1|Death|0
5138193|NCT01578850|17747290|P2|Period 1|Death|0
5138194|NCT01578850|17747291|P1|Period 1|Death|1
5138195|NCT01578850|17747289|P3|Period 1|Adverse Event|0
5138196|NCT01578850|17747290|P2|Period 1|Adverse Event|0
5138197|NCT01578850|17747291|P1|Period 1|Adverse Event|11
5138198|NCT01578850|17747289|P3|Period 1|Insufficient Clinical Response|0
5138199|NCT01578850|17747290|P2|Period 1|Insufficient Clinical Response|0
5138200|NCT01578850|17747291|P1|Period 1|Insufficient Clinical Response|1
5138201|NCT01578785|17747343|P2|Overall Study|Study terminated by sponsor|118
5138202|NCT01578785|17747344|P1|Overall Study|Study terminated by sponsor|59
5138203|NCT01578785|17747343|P2|Overall Study|Withdrawal by Subject|1
5138204|NCT01578785|17747344|P1|Overall Study|Withdrawal by Subject|0
5138205|NCT01578551|17747409|P2|Overall Study|Adverse Event|0
5138206|NCT01578551|17747410|P1|Overall Study|Adverse Event|1
5138207|NCT01578499|17747422|P2|Overall Study|Died and End of Study Page not Completed|0
5138208|NCT01578499|17747423|P1|Overall Study|Died and End of Study Page not Completed|2
5138209|NCT01578499|17747422|P2|Overall Study|Death|25
5138210|NCT01578499|17747423|P1|Overall Study|Death|20
5138211|NCT01578499|17747422|P2|Overall Study|Withdrawal by Subject|16
5138212|NCT01578499|17747423|P1|Overall Study|Withdrawal by Subject|10
5138213|NCT01578499|17747422|P2|Overall Study|Lost to Follow-up|1
5138214|NCT01578499|17747423|P1|Overall Study|Lost to Follow-up|2
5138215|NCT01578499|17747422|P2|Overall Study|Reason not Specified|1
5138216|NCT01578499|17747423|P1|Overall Study|Reason not Specified|0
5138217|NCT01578486|17747457|P1|Overall Study|Withdrawal by Subject|2
5138218|NCT01578486|17747457|P1|Overall Study|Physician Decision|3
5138219|NCT01578330|17747468|P1|Overall Study|Protocol Violation|5
5138220|NCT01578330|17747468|P1|Overall Study|Adverse Event|2
5138221|NCT01578187|17747510|P1|Usability Phase|Withdrawal by Subject|1
5138222|NCT01577758|17747552|P8|mCRC Expansion Phase|Progression Disease|19
5138223|NCT01577758|17747553|P7|mCRC Expansion Phase|Progression Disease|0
5138224|NCT01577758|17747554|P6|mCRC Expansion Phase|Progression Disease|0
5138225|NCT01577758|17747555|P5|mCRC Expansion Phase|Progression Disease|0
5138226|NCT01577758|17747556|P4|mCRC Expansion Phase|Progression Disease|0
5138227|NCT01577758|17747557|P3|mCRC Expansion Phase|Progression Disease|0
5138228|NCT01577758|17747558|P2|mCRC Expansion Phase|Progression Disease|0
5138229|NCT01577758|17747559|P1|mCRC Expansion Phase|Progression Disease|0
5138230|NCT01577758|17747552|P8|mCRC Expansion Phase|Withdrawal by Subject|2
5138231|NCT01577758|17747553|P7|mCRC Expansion Phase|Withdrawal by Subject|0
5138232|NCT01577758|17747554|P6|mCRC Expansion Phase|Withdrawal by Subject|0
5138233|NCT01577758|17747555|P5|mCRC Expansion Phase|Withdrawal by Subject|0
5138234|NCT01577758|17747556|P4|mCRC Expansion Phase|Withdrawal by Subject|0
5138235|NCT01577758|17747557|P3|mCRC Expansion Phase|Withdrawal by Subject|0
5138236|NCT01577758|17747558|P2|mCRC Expansion Phase|Withdrawal by Subject|0
5138237|NCT01577758|17747559|P1|mCRC Expansion Phase|Withdrawal by Subject|0
5138238|NCT01577758|17747552|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
5138239|NCT01577758|17747553|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
5138240|NCT01577758|17747554|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
5138241|NCT01577758|17747555|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
5138242|NCT01577758|17747556|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
5138243|NCT01577758|17747557|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
5138244|NCT01577758|17747558|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
5138245|NCT01577758|17747559|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
5138246|NCT01577758|17747552|P8|Dose Escalation Phase|Progression Disease|0
5138247|NCT01577758|17747553|P7|Dose Escalation Phase|Progression Disease|0
5138248|NCT01577758|17747554|P6|Dose Escalation Phase|Progression Disease|0
5138249|NCT01577758|17747555|P5|Dose Escalation Phase|Progression Disease|5
5138250|NCT01577758|17747556|P4|Dose Escalation Phase|Progression Disease|2
5138251|NCT01577758|17747557|P3|Dose Escalation Phase|Progression Disease|1
5138252|NCT01577758|17747558|P2|Dose Escalation Phase|Progression Disease|2
5138253|NCT01577758|17747559|P1|Dose Escalation Phase|Progression Disease|2
5138254|NCT01577758|17747552|P8|Dose Escalation Phase|Withdrawal by Subject|0
5138255|NCT01577758|17747553|P7|Dose Escalation Phase|Withdrawal by Subject|0
5138256|NCT01577758|17747554|P6|Dose Escalation Phase|Withdrawal by Subject|1
5138257|NCT01577758|17747555|P5|Dose Escalation Phase|Withdrawal by Subject|0
5138258|NCT01577758|17747556|P4|Dose Escalation Phase|Withdrawal by Subject|0
5138259|NCT01577758|17747557|P3|Dose Escalation Phase|Withdrawal by Subject|0
5138260|NCT01577758|17747558|P2|Dose Escalation Phase|Withdrawal by Subject|0
5138261|NCT01577758|17747559|P1|Dose Escalation Phase|Withdrawal by Subject|0
5138262|NCT01577758|17747552|P8|Dose Escalation Phase|Symptomatic Deterioration|0
5138263|NCT01577758|17747553|P7|Dose Escalation Phase|Symptomatic Deterioration|0
5138264|NCT01577758|17747554|P6|Dose Escalation Phase|Symptomatic Deterioration|1
5138265|NCT01577758|17747555|P5|Dose Escalation Phase|Symptomatic Deterioration|1
5138266|NCT01577758|17747556|P4|Dose Escalation Phase|Symptomatic Deterioration|0
5138267|NCT01577758|17747557|P3|Dose Escalation Phase|Symptomatic Deterioration|1
5138268|NCT01577758|17747558|P2|Dose Escalation Phase|Symptomatic Deterioration|0
5138269|NCT01577758|17747559|P1|Dose Escalation Phase|Symptomatic Deterioration|0
5138270|NCT01577758|17747552|P8|Dose Escalation Phase|Adverse Event|0
5138271|NCT01577758|17747553|P7|Dose Escalation Phase|Adverse Event|1
5138272|NCT01577758|17747554|P6|Dose Escalation Phase|Adverse Event|2
5138273|NCT01577758|17747555|P5|Dose Escalation Phase|Adverse Event|0
5138274|NCT01577758|17747556|P4|Dose Escalation Phase|Adverse Event|0
5138275|NCT01577758|17747557|P3|Dose Escalation Phase|Adverse Event|0
5138276|NCT01577758|17747558|P2|Dose Escalation Phase|Adverse Event|0
5138277|NCT01577758|17747559|P1|Dose Escalation Phase|Adverse Event|0
5138278|NCT01577745|17747598|P6|Overall Study|Alternative Therapy|0
5138279|NCT01577745|17747599|P5|Overall Study|Alternative Therapy|1
5138280|NCT01577745|17747600|P4|Overall Study|Alternative Therapy|1
5138281|NCT01577745|17747601|P3|Overall Study|Alternative Therapy|0
5138282|NCT01577745|17747602|P2|Overall Study|Alternative Therapy|0
5138283|NCT01577745|17747603|P1|Overall Study|Alternative Therapy|0
5138284|NCT01577745|17747598|P6|Overall Study|Lost to Follow-up|1
5138285|NCT01577745|17747599|P5|Overall Study|Lost to Follow-up|0
5138286|NCT01577745|17747600|P4|Overall Study|Lost to Follow-up|0
5138287|NCT01577745|17747601|P3|Overall Study|Lost to Follow-up|0
5138288|NCT01577745|17747602|P2|Overall Study|Lost to Follow-up|0
5138289|NCT01577745|17747603|P1|Overall Study|Lost to Follow-up|0
5138290|NCT01577745|17747598|P6|Overall Study|Physician Decision|0
5138291|NCT01577745|17747599|P5|Overall Study|Physician Decision|1
5138292|NCT01577745|17747600|P4|Overall Study|Physician Decision|1
5138293|NCT01577745|17747601|P3|Overall Study|Physician Decision|0
5138294|NCT01577745|17747602|P2|Overall Study|Physician Decision|0
5138295|NCT01577745|17747603|P1|Overall Study|Physician Decision|0
5138296|NCT01577745|17747598|P6|Overall Study|Death|3
5138297|NCT01577745|17747599|P5|Overall Study|Death|1
5138298|NCT01577745|17747600|P4|Overall Study|Death|1
5138299|NCT01577745|17747601|P3|Overall Study|Death|2
5138300|NCT01577745|17747602|P2|Overall Study|Death|2
5138301|NCT01577745|17747603|P1|Overall Study|Death|3
5138302|NCT01577745|17747598|P6|Overall Study|Withdrawal by Subject|0
5138303|NCT01577745|17747599|P5|Overall Study|Withdrawal by Subject|2
5138304|NCT01577745|17747600|P4|Overall Study|Withdrawal by Subject|3
5138305|NCT01577745|17747601|P3|Overall Study|Withdrawal by Subject|0
5138306|NCT01577745|17747602|P2|Overall Study|Withdrawal by Subject|1
5138307|NCT01577745|17747603|P1|Overall Study|Withdrawal by Subject|0
5138308|NCT01577381|17747804|P4|Overall Study|Ongoing at Date of Cut-Off|0
5138309|NCT01577381|17747805|P3|Overall Study|Ongoing at Date of Cut-Off|1
5138310|NCT01577381|17747806|P2|Overall Study|Ongoing at Date of Cut-Off|2
5138311|NCT01577381|17747807|P1|Overall Study|Ongoing at Date of Cut-Off|0
5138312|NCT01577381|17747804|P4|Overall Study|Discontinued|2
5138313|NCT01577381|17747805|P3|Overall Study|Discontinued|2
5138314|NCT01577381|17747806|P2|Overall Study|Discontinued|1
5138315|NCT01577381|17747807|P1|Overall Study|Discontinued|2
5138316|NCT01577186|17747962|P1|Overall Study|Other|2
5138317|NCT01577186|17747962|P1|Overall Study|Non-Compliant|8
5138318|NCT01577186|17747962|P1|Overall Study|Ineligible to Continue|15
5138319|NCT01577186|17747962|P1|Overall Study|Insufficient Response|18
5138320|NCT01577186|17747962|P1|Overall Study|Withdrawal by Subject|35
5138321|NCT01577186|17747962|P1|Overall Study|Lost to Follow-up|28
5138322|NCT01577186|17747962|P1|Overall Study|Death|1
5138323|NCT01577186|17747962|P1|Overall Study|Adverse Event|23
5138324|NCT01577160|17747970|P1|Overall Study|Other|9
5138325|NCT01577160|17747970|P1|Overall Study|Subject Uncooperative|7
5138326|NCT01577160|17747970|P1|Overall Study|Withdrawal by Subject|18
5138327|NCT01577160|17747970|P1|Overall Study|Lost to Follow-up|40
5138328|NCT01577160|17747970|P1|Overall Study|Lack of Efficacy|15
5138329|NCT01577160|17747970|P1|Overall Study|Adverse Event|9
5138330|NCT01576783|17748025|P2|Overall Study|Withdrawal by Subject|1
5138331|NCT01576783|17748026|P1|Overall Study|Withdrawal by Subject|5
5138332|NCT01576783|17748025|P2|Overall Study|Lost to Follow-up|16
5138333|NCT01576783|17748026|P1|Overall Study|Lost to Follow-up|14
5138334|NCT01576783|17748025|P2|Overall Study|Change in Medical Care|0
5138335|NCT01576783|17748026|P1|Overall Study|Change in Medical Care|1
5138336|NCT01576718|17748052|P7|Treatment Period|Noncompliance to study medication|1
5138337|NCT01576718|17748053|P6|Treatment Period|Noncompliance to study medication|1
5138338|NCT01576718|17748054|P5|Treatment Period|Noncompliance to study medication|0
5138339|NCT01576718|17748055|P4|Treatment Period|Noncompliance to study medication|0
5138340|NCT01576718|17748056|P3|Treatment Period|Noncompliance to study medication|0
5138341|NCT01576718|17748057|P2|Treatment Period|Noncompliance to study medication|0
5138342|NCT01576718|17748058|P1|Treatment Period|Noncompliance to study medication|0
5138343|NCT01576718|17748052|P7|Treatment Period|Lost to Follow-up|0
5138344|NCT01576718|17748053|P6|Treatment Period|Lost to Follow-up|0
5138345|NCT01576718|17748054|P5|Treatment Period|Lost to Follow-up|1
5138346|NCT01576718|17748055|P4|Treatment Period|Lost to Follow-up|0
5138347|NCT01576718|17748056|P3|Treatment Period|Lost to Follow-up|0
5138348|NCT01576718|17748057|P2|Treatment Period|Lost to Follow-up|0
5138349|NCT01576718|17748058|P1|Treatment Period|Lost to Follow-up|0
5138350|NCT01576718|17748052|P7|Treatment Period|Met stopping criteria|15
5138351|NCT01576718|17748053|P6|Treatment Period|Met stopping criteria|33
5138352|NCT01576718|17748054|P5|Treatment Period|Met stopping criteria|16
5138353|NCT01576718|17748055|P4|Treatment Period|Met stopping criteria|19
5138354|NCT01576718|17748056|P3|Treatment Period|Met stopping criteria|13
5138355|NCT01576718|17748057|P2|Treatment Period|Met stopping criteria|16
5138356|NCT01576718|17748058|P1|Treatment Period|Met stopping criteria|0
5138357|NCT01576718|17748052|P7|Treatment Period|Sponsor request|0
5138358|NCT01576718|17748053|P6|Treatment Period|Sponsor request|1
5138359|NCT01576718|17748054|P5|Treatment Period|Sponsor request|0
5138360|NCT01576718|17748055|P4|Treatment Period|Sponsor request|0
5138361|NCT01576718|17748056|P3|Treatment Period|Sponsor request|0
5138362|NCT01576718|17748057|P2|Treatment Period|Sponsor request|1
5138363|NCT01576718|17748058|P1|Treatment Period|Sponsor request|0
5138364|NCT01576718|17748052|P7|Treatment Period|Protocol Violation|12
5138365|NCT01576718|17748053|P6|Treatment Period|Protocol Violation|8
5138366|NCT01576718|17748054|P5|Treatment Period|Protocol Violation|6
5138367|NCT01576718|17748055|P4|Treatment Period|Protocol Violation|10
5138368|NCT01576718|17748056|P3|Treatment Period|Protocol Violation|4
5138369|NCT01576718|17748057|P2|Treatment Period|Protocol Violation|5
5138370|NCT01576718|17748058|P1|Treatment Period|Protocol Violation|0
5138371|NCT01576718|17748052|P7|Treatment Period|Physician Decision|0
5138372|NCT01576718|17748053|P6|Treatment Period|Physician Decision|0
5138373|NCT01576718|17748054|P5|Treatment Period|Physician Decision|1
5138374|NCT01576718|17748055|P4|Treatment Period|Physician Decision|1
5138375|NCT01576718|17748056|P3|Treatment Period|Physician Decision|1
5138376|NCT01576718|17748057|P2|Treatment Period|Physician Decision|1
5138377|NCT01576718|17748058|P1|Treatment Period|Physician Decision|0
5138378|NCT01576718|17748052|P7|Treatment Period|Withdrawal by Subject|2
5138379|NCT01576718|17748053|P6|Treatment Period|Withdrawal by Subject|4
5138380|NCT01576718|17748054|P5|Treatment Period|Withdrawal by Subject|2
5138381|NCT01576718|17748055|P4|Treatment Period|Withdrawal by Subject|0
5138382|NCT01576718|17748056|P3|Treatment Period|Withdrawal by Subject|1
5138383|NCT01576718|17748057|P2|Treatment Period|Withdrawal by Subject|1
5138384|NCT01576718|17748058|P1|Treatment Period|Withdrawal by Subject|0
5138385|NCT01576718|17748052|P7|Treatment Period|Adverse Event|0
5138386|NCT01576718|17748053|P6|Treatment Period|Adverse Event|1
5138387|NCT01576718|17748054|P5|Treatment Period|Adverse Event|1
5138388|NCT01576718|17748055|P4|Treatment Period|Adverse Event|1
5138389|NCT01576718|17748056|P3|Treatment Period|Adverse Event|1
5138390|NCT01576718|17748057|P2|Treatment Period|Adverse Event|1
5138391|NCT01576718|17748058|P1|Treatment Period|Adverse Event|0
5138392|NCT01576718|17748052|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
5138393|NCT01576718|17748053|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
5138394|NCT01576718|17748054|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
5138395|NCT01576718|17748055|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
5138396|NCT01576718|17748056|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
5138397|NCT01576718|17748057|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
5138398|NCT01576718|17748058|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
5138399|NCT01576718|17748052|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5138400|NCT01576718|17748053|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5138401|NCT01576718|17748054|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5138402|NCT01576718|17748055|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5138403|NCT01576718|17748056|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5138404|NCT01576718|17748057|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5138405|NCT01576718|17748058|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
5138406|NCT01576718|17748052|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5138407|NCT01576718|17748053|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5138408|NCT01576718|17748054|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5138409|NCT01576718|17748055|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5138410|NCT01576718|17748056|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5138411|NCT01576718|17748057|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5138412|NCT01576718|17748058|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
5138413|NCT01576718|17748052|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5138414|NCT01576718|17748053|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5138415|NCT01576718|17748054|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5138416|NCT01576718|17748055|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5138417|NCT01576718|17748056|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5138418|NCT01576718|17748057|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5138419|NCT01576718|17748058|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
5138420|NCT01576718|17748052|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5138421|NCT01576718|17748053|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5138422|NCT01576718|17748054|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5138423|NCT01576718|17748055|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5138424|NCT01576718|17748056|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5138425|NCT01576718|17748057|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5138426|NCT01576718|17748058|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
5138427|NCT01576705|17748154|P4|Overall Study|invalid ICF|0
5138428|NCT01576705|17748155|P3|Overall Study|invalid ICF|0
5138429|NCT01576705|17748156|P2|Overall Study|invalid ICF|1
5138430|NCT01576705|17748157|P1|Overall Study|invalid ICF|0
5138431|NCT01576705|17748154|P4|Overall Study|TSH > 7 mIU/L at baseline|3
5138432|NCT01576705|17748155|P3|Overall Study|TSH > 7 mIU/L at baseline|5
5138433|NCT01576705|17748156|P2|Overall Study|TSH > 7 mIU/L at baseline|7
5138434|NCT01576705|17748157|P1|Overall Study|TSH > 7 mIU/L at baseline|3
5138435|NCT01576575|17748178|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
5138436|NCT01576575|17748178|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
5138437|NCT01576575|17748178|P1|Buprenorphine Control|Withdrawal by Subject|3
5138438|NCT01576549|17748188|P1|Overall Study|Sponsor Decision|2
5138439|NCT01576484|17748204|P2|Overall Study|Other|5
5138440|NCT01576484|17748205|P1|Overall Study|Other|2
5138441|NCT01576484|17748204|P2|Overall Study|Withdrawal by Subject|3
5138442|NCT01576484|17748205|P1|Overall Study|Withdrawal by Subject|0
5138443|NCT01576484|17748204|P2|Overall Study|Sponsor Decision|8
5138444|NCT01576484|17748205|P1|Overall Study|Sponsor Decision|2
5138445|NCT01576484|17748204|P2|Overall Study|Protocol Violation|2
5138446|NCT01576484|17748205|P1|Overall Study|Protocol Violation|0
5138447|NCT01576484|17748204|P2|Overall Study|Adverse Event|1
5138448|NCT01576484|17748205|P1|Overall Study|Adverse Event|1
5138449|NCT01576406|17748284|P6|Overall Study|Other|0
5138450|NCT01576406|17748285|P5|Overall Study|Other|0
5138451|NCT01576406|17748286|P4|Overall Study|Other|2
5138452|NCT01576406|17748287|P3|Overall Study|Other|2
5138453|NCT01576406|17748288|P2|Overall Study|Other|0
5138454|NCT01576406|17748289|P1|Overall Study|Other|0
5138455|NCT01576406|17748284|P6|Overall Study|Withdrawal the consent|3
5138456|NCT01576406|17748285|P5|Overall Study|Withdrawal the consent|1
5138457|NCT01576406|17748286|P4|Overall Study|Withdrawal the consent|1
5138458|NCT01576406|17748287|P3|Overall Study|Withdrawal the consent|5
5138459|NCT01576406|17748288|P2|Overall Study|Withdrawal the consent|2
5138460|NCT01576406|17748289|P1|Overall Study|Withdrawal the consent|2
5138461|NCT01576406|17748284|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
5138462|NCT01576406|17748285|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
5138463|NCT01576406|17748286|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
5138464|NCT01576406|17748287|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
5138465|NCT01576406|17748288|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
5138466|NCT01576406|17748289|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
5138467|NCT01576406|17748284|P6|Overall Study|Death|9
5138468|NCT01576406|17748285|P5|Overall Study|Death|7
5138469|NCT01576406|17748286|P4|Overall Study|Death|5
5138470|NCT01576406|17748287|P3|Overall Study|Death|8
5138471|NCT01576406|17748288|P2|Overall Study|Death|4
5138472|NCT01576406|17748289|P1|Overall Study|Death|3
5138473|NCT01576406|17748284|P6|Overall Study|Lost to Follow-up|0
5138474|NCT01576406|17748285|P5|Overall Study|Lost to Follow-up|0
5138475|NCT01576406|17748286|P4|Overall Study|Lost to Follow-up|0
5138476|NCT01576406|17748287|P3|Overall Study|Lost to Follow-up|0
5138477|NCT01576406|17748288|P2|Overall Study|Lost to Follow-up|2
5138478|NCT01576406|17748289|P1|Overall Study|Lost to Follow-up|1
5138479|NCT01576367|17748537|P1|Overall Study|Moved to commercial use after 6 months|1
5138480|NCT01576367|17748537|P1|Overall Study|Unsatisfactory therapeutic effect|2
5138481|NCT01576341|17748545|P1|Overall Study|Other|12
5138482|NCT01576341|17748545|P1|Overall Study|Protocol Violation|12
5138483|NCT01576341|17748545|P1|Overall Study|Kidney transplantation|10
5138484|NCT01576341|17748545|P1|Overall Study|Lost to Follow-up|2
5138485|NCT01576341|17748545|P1|Overall Study|Physician Decision|2
5138486|NCT01576341|17748545|P1|Overall Study|Death|21
5138487|NCT01576341|17748545|P1|Overall Study|Adverse Event|10
5138488|NCT01576341|17748545|P1|Overall Study|Withdrawal by Subject|24
5138489|NCT01576172|17748564|P2|Overall Study|Insurance issue|0
5138490|NCT01576172|17748565|P1|Overall Study|Insurance issue|1
5138491|NCT01576172|17748564|P2|Overall Study|Withdrawal by Subject|0
5138492|NCT01576172|17748565|P1|Overall Study|Withdrawal by Subject|2
5138493|NCT01576172|17748564|P2|Overall Study|Ineligible|1
5138494|NCT01576172|17748565|P1|Overall Study|Ineligible|2
5138495|NCT01576159|17748583|P4|Overall Study|Protocol Violation|0
5138496|NCT01576159|17748584|P3|Overall Study|Protocol Violation|0
5138497|NCT01576159|17748585|P2|Overall Study|Protocol Violation|0
5138498|NCT01576159|17748586|P1|Overall Study|Protocol Violation|1
5138499|NCT01576159|17748583|P4|Overall Study|Lost to Follow-up|1
5138500|NCT01576159|17748584|P3|Overall Study|Lost to Follow-up|0
5138501|NCT01576159|17748585|P2|Overall Study|Lost to Follow-up|0
5138502|NCT01576159|17748586|P1|Overall Study|Lost to Follow-up|0
5138503|NCT01576159|17748583|P4|Overall Study|Physician Decision|0
5138504|NCT01576159|17748584|P3|Overall Study|Physician Decision|1
5138505|NCT01576159|17748585|P2|Overall Study|Physician Decision|0
5138506|NCT01576159|17748586|P1|Overall Study|Physician Decision|0
5138507|NCT01576159|17748583|P4|Overall Study|Withdrawal by Subject|0
5138508|NCT01576159|17748584|P3|Overall Study|Withdrawal by Subject|0
5138509|NCT01576159|17748585|P2|Overall Study|Withdrawal by Subject|1
5138510|NCT01576159|17748586|P1|Overall Study|Withdrawal by Subject|0
5138511|NCT01576146|17748604|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
5138512|NCT01576146|17748604|P1|Extension Period 2|Renal Transplant|1
5138513|NCT01576146|17748604|P1|Extension Period 2|Adverse Event|1
5138514|NCT01576146|17748604|P1|Extension Period 2|Death|1
5138515|NCT01576146|17748604|P1|Extension Period 2|Sponsor Decision|13
5138516|NCT01576146|17748604|P1|Extension Period 1|Renal Transplant|1
5138517|NCT01576146|17748604|P1|Extension Period 1|Parathyroidectomy|1
5138518|NCT01576146|17748604|P1|Extension Period 1|Lost to Follow-up|1
5138519|NCT01576146|17748604|P1|Extension Period 1|Withdrawal by Subject|1
5138520|NCT01576146|17748604|P1|Extension Period 1|Physician Decision|2
5138521|NCT01576146|17748604|P1|Extension Period 1|Death|2
5138522|NCT01576146|17748604|P1|Extension Period 1|Adverse Event|2
5138523|NCT01576042|17748637|P2|Overall Study|Physician Decision|0
5138524|NCT01576042|17748638|P1|Overall Study|Physician Decision|2
5138525|NCT01576016|17748660|P2|MRI Safety|MRI scan not performed at MRI visit|3
5138526|NCT01576016|17748661|P1|MRI Safety|MRI scan not performed at MRI visit|0
5138527|NCT01576016|17748660|P2|MRI Safety|Has not yet completed MRI scan|56
5138528|NCT01576016|17748661|P1|MRI Safety|Has not yet completed MRI scan|0
5138529|NCT01576016|17748660|P2|MRI Safety|Non-MRI Compatible Device or Material|5
5138530|NCT01576016|17748661|P1|MRI Safety|Non-MRI Compatible Device or Material|0
5138531|NCT01576016|17748660|P2|MRI Safety|Withdrawal by Subject|10
5138532|NCT01576016|17748661|P1|MRI Safety|Withdrawal by Subject|0
5138533|NCT01576016|17748660|P2|Lead Safety|Patient no longer followed by study PI|0
5138534|NCT01576016|17748661|P1|Lead Safety|Patient no longer followed by study PI|1
5138535|NCT01576016|17748660|P2|Lead Safety|System deactivated|0
5138536|NCT01576016|17748661|P1|Lead Safety|System deactivated|1
5138537|NCT01576016|17748660|P2|Lead Safety|Too far from study site|0
5138538|NCT01576016|17748661|P1|Lead Safety|Too far from study site|1
5138539|NCT01576016|17748660|P2|Lead Safety|Patient noncompliance|0
5138540|NCT01576016|17748661|P1|Lead Safety|Patient noncompliance|1
5138541|NCT01576016|17748660|P2|Lead Safety|Patient on Palliative Care|0
5138542|NCT01576016|17748661|P1|Lead Safety|Patient on Palliative Care|1
5138543|NCT01576016|17748660|P2|Lead Safety|Device replaced with CRT-D|0
5138544|NCT01576016|17748661|P1|Lead Safety|Device replaced with CRT-D|1
5138545|NCT01576016|17748660|P2|Lead Safety|Sponsor request|0
5138546|NCT01576016|17748661|P1|Lead Safety|Sponsor request|1
5138547|NCT01576016|17748660|P2|Lead Safety|Unsuccessful implant|0
5138548|NCT01576016|17748661|P1|Lead Safety|Unsuccessful implant|2
5138549|NCT01576016|17748660|P2|Lead Safety|Lost to Follow-up|0
5138550|NCT01576016|17748661|P1|Lead Safety|Lost to Follow-up|13
5138551|NCT01576016|17748660|P2|Lead Safety|Physician Decision|0
5138552|NCT01576016|17748661|P1|Lead Safety|Physician Decision|14
5138553|NCT01576016|17748660|P2|Lead Safety|System Explanted without Replacement|0
5138554|NCT01576016|17748661|P1|Lead Safety|System Explanted without Replacement|24
5138555|NCT01576016|17748660|P2|Lead Safety|Withdrawal by Subject|0
5138556|NCT01576016|17748661|P1|Lead Safety|Withdrawal by Subject|81
5138557|NCT01576016|17748660|P2|Lead Safety|Death|0
5138558|NCT01576016|17748661|P1|Lead Safety|Death|132
5138559|NCT01575899|17748713|P3|Overall Study|Protocol Violation|0
5138560|NCT01575899|17748714|P2|Overall Study|Protocol Violation|1
5138561|NCT01575899|17748715|P1|Overall Study|Protocol Violation|2
5138562|NCT01575899|17748713|P3|Overall Study|Lost to Follow-up|2
5138563|NCT01575899|17748714|P2|Overall Study|Lost to Follow-up|4
5138564|NCT01575899|17748715|P1|Overall Study|Lost to Follow-up|3
5138565|NCT01575873|17748729|P4|Overall Study|Other|2
5138566|NCT01575873|17748730|P3|Overall Study|Other|4
5138567|NCT01575873|17748731|P2|Overall Study|Other|0
5138568|NCT01575873|17748732|P1|Overall Study|Other|0
5138569|NCT01575873|17748729|P4|Overall Study|Requirement for Alternative Therapy|1
5138570|NCT01575873|17748730|P3|Overall Study|Requirement for Alternative Therapy|1
5138571|NCT01575873|17748731|P2|Overall Study|Requirement for Alternative Therapy|0
5138572|NCT01575873|17748732|P1|Overall Study|Requirement for Alternative Therapy|0
5138573|NCT01575873|17748729|P4|Overall Study|Protocol deviation|1
5138574|NCT01575873|17748730|P3|Overall Study|Protocol deviation|0
5138575|NCT01575873|17748731|P2|Overall Study|Protocol deviation|1
5138576|NCT01575873|17748732|P1|Overall Study|Protocol deviation|0
5138577|NCT01575873|17748729|P4|Overall Study|Administrative decision|0
5138578|NCT01575873|17748730|P3|Overall Study|Administrative decision|1
5138579|NCT01575873|17748731|P2|Overall Study|Administrative decision|1
5138580|NCT01575873|17748732|P1|Overall Study|Administrative decision|1
5138581|NCT01575873|17748729|P4|Overall Study|Noncompliance|3
5138582|NCT01575873|17748730|P3|Overall Study|Noncompliance|4
5138583|NCT01575873|17748731|P2|Overall Study|Noncompliance|2
5138584|NCT01575873|17748732|P1|Overall Study|Noncompliance|1
5138585|NCT01575873|17748729|P4|Overall Study|Death|9
5138586|NCT01575873|17748730|P3|Overall Study|Death|8
5138587|NCT01575873|17748731|P2|Overall Study|Death|2
5138588|NCT01575873|17748732|P1|Overall Study|Death|3
5138589|NCT01575873|17748729|P4|Overall Study|Lost to Follow-up|5
5138590|NCT01575873|17748730|P3|Overall Study|Lost to Follow-up|13
5138591|NCT01575873|17748731|P2|Overall Study|Lost to Follow-up|3
5138592|NCT01575873|17748732|P1|Overall Study|Lost to Follow-up|1
5138593|NCT01575873|17748729|P4|Overall Study|Adverse Event|12
5138594|NCT01575873|17748730|P3|Overall Study|Adverse Event|9
5138595|NCT01575873|17748731|P2|Overall Study|Adverse Event|7
5138596|NCT01575873|17748732|P1|Overall Study|Adverse Event|7
5138597|NCT01575873|17748729|P4|Overall Study|Withdrawal by Subject|34
5138598|NCT01575873|17748730|P3|Overall Study|Withdrawal by Subject|34
5138599|NCT01575873|17748731|P2|Overall Study|Withdrawal by Subject|20
5138600|NCT01575873|17748732|P1|Overall Study|Withdrawal by Subject|15
5138601|NCT01575860|17748756|P1|Overall Study|Progression Prior to Lenalidomide Maint.|1
5138602|NCT01575860|17748756|P1|Overall Study|Withdrawal by Subject|1
5138603|NCT01575834|17748764|P2|Overall Study|Requirement for Alternative Therapy|4
5138604|NCT01575834|17748765|P1|Overall Study|Requirement for Alternative Therapy|2
5138605|NCT01575834|17748764|P2|Overall Study|Protocol Deviation|3
5138606|NCT01575834|17748765|P1|Overall Study|Protocol Deviation|4
5138607|NCT01575834|17748764|P2|Overall Study|Ineligibility Determined|8
5138608|NCT01575834|17748765|P1|Overall Study|Ineligibility Determined|5
5138609|NCT01575834|17748764|P2|Overall Study|Administrative decision|33
5138610|NCT01575834|17748765|P1|Overall Study|Administrative decision|15
5138611|NCT01575834|17748764|P2|Overall Study|Noncompliance|27
5138612|NCT01575834|17748765|P1|Overall Study|Noncompliance|52
5138613|NCT01575834|17748764|P2|Overall Study|Lost to Follow-up|68
5138614|NCT01575834|17748765|P1|Overall Study|Lost to Follow-up|55
5138615|NCT01575834|17748764|P2|Overall Study|Adverse Event|61
5138616|NCT01575834|17748765|P1|Overall Study|Adverse Event|63
5138617|NCT01575834|17748764|P2|Overall Study|Other|70
5138618|NCT01575834|17748765|P1|Overall Study|Other|70
5138619|NCT01575834|17748764|P2|Overall Study|Death|74
5138620|NCT01575834|17748765|P1|Overall Study|Death|81
5138621|NCT01575834|17748764|P2|Overall Study|Withdrawal by Subject|390
5138622|NCT01575834|17748765|P1|Overall Study|Withdrawal by Subject|352
5138623|NCT01575808|17748817|P2|Overall Study|Withdrawal by Subject|0
5138624|NCT01575808|17748818|P1|Overall Study|Withdrawal by Subject|1
5138625|NCT01575808|17748817|P2|Overall Study|Death|0
5138626|NCT01575808|17748818|P1|Overall Study|Death|2
5138627|NCT01575769|17748865|P1|Overall Study|Study terminated by sponsor|40
5138628|NCT01575769|17748865|P1|Overall Study|Adverse Event|1
5138629|NCT01575561|17748923|P1|Overall Study|administration|1
5138630|NCT01575561|17748923|P1|Overall Study|Withdrawal by Subject|11
5138631|NCT01575561|17748923|P1|Overall Study|Protocol Violation|4
5138632|NCT01575561|17748923|P1|Overall Study|Lost to Follow-up|6
5138633|NCT01575561|17748923|P1|Overall Study|Lack of Efficacy|8
5138634|NCT01575561|17748923|P1|Overall Study|Adverse Event|9
5138635|NCT01575197|17748953|P3|Overall Study|Protocol Violation|1
5138636|NCT01575197|17748954|P2|Overall Study|Protocol Violation|1
5138637|NCT01575197|17748955|P1|Overall Study|Protocol Violation|2
5138638|NCT01575197|17748953|P3|Overall Study|Withdrawal by Subject|1
5138639|NCT01575197|17748954|P2|Overall Study|Withdrawal by Subject|1
5138640|NCT01575197|17748955|P1|Overall Study|Withdrawal by Subject|0
5138641|NCT01575197|17748953|P3|Overall Study|Lost to Follow-up|0
5138642|NCT01575197|17748954|P2|Overall Study|Lost to Follow-up|1
5138643|NCT01575197|17748955|P1|Overall Study|Lost to Follow-up|0
5138644|NCT01575197|17748953|P3|Overall Study|SAE|0
5138645|NCT01575197|17748954|P2|Overall Study|SAE|1
5138646|NCT01575197|17748955|P1|Overall Study|SAE|0
5138647|NCT01575197|17748953|P3|Overall Study|Migration out of study area|4
5138648|NCT01575197|17748954|P2|Overall Study|Migration out of study area|5
5138649|NCT01575197|17748955|P1|Overall Study|Migration out of study area|1
5138650|NCT01575054|17748983|P2|Overall Study|Adverse Event|8
5138651|NCT01575054|17748984|P1|Overall Study|Adverse Event|9
5138652|NCT01575054|17748983|P2|Overall Study|Lost to Follow-up|3
5138653|NCT01575054|17748984|P1|Overall Study|Lost to Follow-up|3
5138654|NCT01575054|17748983|P2|Overall Study|Personal Reasons|11
5138655|NCT01575054|17748984|P1|Overall Study|Personal Reasons|10
5138656|NCT01575054|17748983|P2|Overall Study|Protocol Violation|1
5138657|NCT01575054|17748984|P1|Overall Study|Protocol Violation|2
5138658|NCT01575054|17748983|P2|Overall Study|Other Reasons|3
5138659|NCT01575054|17748984|P1|Overall Study|Other Reasons|5
5138660|NCT01575028|17749000|P2|Overall Study|Physician Decision|1
5138661|NCT01575028|17749001|P1|Overall Study|Physician Decision|0
5138662|NCT01574716|17749018|P5|Part 2|Lost to Follow-up|0
5138663|NCT01574716|17749019|P4|Part 2|Lost to Follow-up|3
5138664|NCT01574716|17749020|P3|Part 2|Lost to Follow-up|0
5138665|NCT01574716|17749021|P2|Part 2|Lost to Follow-up|0
5138666|NCT01574716|17749022|P1|Part 2|Lost to Follow-up|0
5138667|NCT01574716|17749018|P5|Part 2|Brain metastases|0
5138668|NCT01574716|17749019|P4|Part 2|Brain metastases|1
5138669|NCT01574716|17749020|P3|Part 2|Brain metastases|0
5138670|NCT01574716|17749021|P2|Part 2|Brain metastases|0
5138671|NCT01574716|17749022|P1|Part 2|Brain metastases|0
5138672|NCT01574716|17749018|P5|Part 2|Withdrawal by Subject|4
5138673|NCT01574716|17749019|P4|Part 2|Withdrawal by Subject|5
5138674|NCT01574716|17749020|P3|Part 2|Withdrawal by Subject|0
5138675|NCT01574716|17749021|P2|Part 2|Withdrawal by Subject|0
5138676|NCT01574716|17749022|P1|Part 2|Withdrawal by Subject|0
5138677|NCT01574716|17749018|P5|Part 2|Discontinuation of study by sponsor|31
5138678|NCT01574716|17749019|P4|Part 2|Discontinuation of study by sponsor|51
5138679|NCT01574716|17749020|P3|Part 2|Discontinuation of study by sponsor|0
5138680|NCT01574716|17749021|P2|Part 2|Discontinuation of study by sponsor|0
5138681|NCT01574716|17749022|P1|Part 2|Discontinuation of study by sponsor|0
5138682|NCT01574716|17749018|P5|Part 2|Death|35
5138683|NCT01574716|17749019|P4|Part 2|Death|76
5138684|NCT01574716|17749020|P3|Part 2|Death|0
5138685|NCT01574716|17749021|P2|Part 2|Death|0
5138686|NCT01574716|17749022|P1|Part 2|Death|0
5138687|NCT01574716|17749018|P5|Part 2|Progressive disease|0
5138688|NCT01574716|17749019|P4|Part 2|Progressive disease|1
5138689|NCT01574716|17749020|P3|Part 2|Progressive disease|0
5138690|NCT01574716|17749021|P2|Part 2|Progressive disease|0
5138691|NCT01574716|17749022|P1|Part 2|Progressive disease|0
5138692|NCT01574716|17749018|P5|Part 1|Lost to Follow-up|0
5138693|NCT01574716|17749019|P4|Part 1|Lost to Follow-up|0
5138694|NCT01574716|17749020|P3|Part 1|Lost to Follow-up|0
5138695|NCT01574716|17749021|P2|Part 1|Lost to Follow-up|1
5138696|NCT01574716|17749022|P1|Part 1|Lost to Follow-up|0
5138697|NCT01574716|17749018|P5|Part 1|Withdrawal by Subject|0
5138698|NCT01574716|17749019|P4|Part 1|Withdrawal by Subject|0
5138699|NCT01574716|17749020|P3|Part 1|Withdrawal by Subject|0
5138700|NCT01574716|17749021|P2|Part 1|Withdrawal by Subject|2
5138701|NCT01574716|17749022|P1|Part 1|Withdrawal by Subject|0
5138702|NCT01574716|17749018|P5|Part 1|Discontinuation of study by sponsor|0
5138703|NCT01574716|17749019|P4|Part 1|Discontinuation of study by sponsor|0
5138704|NCT01574716|17749020|P3|Part 1|Discontinuation of study by sponsor|1
5138705|NCT01574716|17749021|P2|Part 1|Discontinuation of study by sponsor|0
5138706|NCT01574716|17749022|P1|Part 1|Discontinuation of study by sponsor|0
5138707|NCT01574716|17749018|P5|Part 1|Death|0
5138708|NCT01574716|17749019|P4|Part 1|Death|0
5138709|NCT01574716|17749020|P3|Part 1|Death|8
5138710|NCT01574716|17749021|P2|Part 1|Death|1
5138711|NCT01574716|17749022|P1|Part 1|Death|3
5138712|NCT01574703|17749045|P4|Overall Study|Death|0
5138713|NCT01574703|17749046|P3|Overall Study|Death|1
5138714|NCT01574703|17749047|P2|Overall Study|Death|1
5138715|NCT01574703|17749048|P1|Overall Study|Death|2
5138716|NCT01574703|17749045|P4|Overall Study|Lost to Follow-up|35
5138717|NCT01574703|17749046|P3|Overall Study|Lost to Follow-up|46
5138718|NCT01574703|17749047|P2|Overall Study|Lost to Follow-up|41
5138719|NCT01574703|17749048|P1|Overall Study|Lost to Follow-up|43
5138720|NCT01574703|17749045|P4|Overall Study|Met Withdrawal Criteria|0
5138721|NCT01574703|17749046|P3|Overall Study|Met Withdrawal Criteria|1
5138722|NCT01574703|17749047|P2|Overall Study|Met Withdrawal Criteria|1
5138723|NCT01574703|17749048|P1|Overall Study|Met Withdrawal Criteria|0
5138724|NCT01574703|17749045|P4|Overall Study|Withdrawal by Subject|61
5138725|NCT01574703|17749046|P3|Overall Study|Withdrawal by Subject|36
5138726|NCT01574703|17749047|P2|Overall Study|Withdrawal by Subject|52
5138727|NCT01574703|17749048|P1|Overall Study|Withdrawal by Subject|53
5138728|NCT01574703|17749045|P4|Overall Study|Unspecified Reason|16
5138729|NCT01574703|17749046|P3|Overall Study|Unspecified Reason|20
5138730|NCT01574703|17749047|P2|Overall Study|Unspecified Reason|15
5138731|NCT01574703|17749048|P1|Overall Study|Unspecified Reason|27
5138732|NCT01574703|17749045|P4|Overall Study|Protocol Violation|1
5138733|NCT01574703|17749046|P3|Overall Study|Protocol Violation|0
5138734|NCT01574703|17749047|P2|Overall Study|Protocol Violation|0
5138735|NCT01574703|17749048|P1|Overall Study|Protocol Violation|0
5138736|NCT01574703|17749045|P4|Overall Study|Adverse Event|1
5138737|NCT01574703|17749046|P3|Overall Study|Adverse Event|1
5138738|NCT01574703|17749047|P2|Overall Study|Adverse Event|2
5138739|NCT01574703|17749048|P1|Overall Study|Adverse Event|0
5138740|NCT01574651|17749092|P2|Overall Study|Withdrawal by Subject|10
5138741|NCT01574651|17749093|P1|Overall Study|Withdrawal by Subject|9
5138742|NCT01574651|17749092|P2|Overall Study|Protocol Violation|5
5138743|NCT01574651|17749093|P1|Overall Study|Protocol Violation|3
5138744|NCT01574651|17749092|P2|Overall Study|Unsatisfactory therapeutic effect|0
5138745|NCT01574651|17749093|P1|Overall Study|Unsatisfactory therapeutic effect|6
5138746|NCT01574651|17749092|P2|Overall Study|Abnormal test procedure result(s)|1
5138747|NCT01574651|17749093|P1|Overall Study|Abnormal test procedure result(s)|1
5138748|NCT01574651|17749092|P2|Overall Study|Abnormal laboratory value(s)|0
5138749|NCT01574651|17749093|P1|Overall Study|Abnormal laboratory value(s)|1
5138750|NCT01574651|17749092|P2|Overall Study|Adverse Event|27
5138751|NCT01574651|17749093|P1|Overall Study|Adverse Event|36
5138752|NCT01574651|17749092|P2|Overall Study|Patient's inability to use the device|1
5138753|NCT01574651|17749093|P1|Overall Study|Patient's inability to use the device|0
5138754|NCT01574651|17749092|P2|Overall Study|Death|3
5138755|NCT01574651|17749093|P1|Overall Study|Death|3
5138756|NCT01574651|17749092|P2|Overall Study|Administrative problems|1
5138757|NCT01574651|17749093|P1|Overall Study|Administrative problems|0
5138758|NCT01574651|17749092|P2|Overall Study|Lost to Follow-up|4
5138759|NCT01574651|17749093|P1|Overall Study|Lost to Follow-up|2
5138760|NCT01574612|17749115|P1|Overall Study|Lost to Follow-up|2
5138761|NCT01574612|17749115|P1|Overall Study|Withdrawal by Subject|1
5138762|NCT01574612|17749115|P1|Overall Study|non compliant with drug|2
5138763|NCT01574612|17749115|P1|Overall Study|Adverse Event|3
5138764|NCT01574352|17749121|P2|Overall Study|Injury in non-camp related sport|0
5138765|NCT01574352|17749122|P1|Overall Study|Injury in non-camp related sport|1
5138766|NCT01574352|17749121|P2|Overall Study|Withdrawal by Subject|13
5138767|NCT01574352|17749122|P1|Overall Study|Withdrawal by Subject|6
5138768|NCT01574326|17749134|P2|Overall Study|Other: Mainly kidney transplant|8
5138769|NCT01574326|17749135|P1|Overall Study|Other: Mainly kidney transplant|8
5138770|NCT01574326|17749134|P2|Overall Study|Adverse Event|3
5138771|NCT01574326|17749135|P1|Overall Study|Adverse Event|1
5138772|NCT01574326|17749134|P2|Overall Study|Physician Decision|3
5138773|NCT01574326|17749135|P1|Overall Study|Physician Decision|5
5138774|NCT01574326|17749134|P2|Overall Study|Withdrawal by Participant|4
5138775|NCT01574326|17749135|P1|Overall Study|Withdrawal by Participant|2
5138776|NCT01574326|17749134|P2|Overall Study|Randomized but not treated|1
5138777|NCT01574326|17749135|P1|Overall Study|Randomized but not treated|0
5138778|NCT01574248|17749153|P2|Overall Study|Missing primary endpoint data|0
5138779|NCT01574248|17749154|P1|Overall Study|Missing primary endpoint data|1
5138780|NCT01574248|17749153|P2|Overall Study|Withdrawal by Subject|0
5138781|NCT01574248|17749154|P1|Overall Study|Withdrawal by Subject|2
5138782|NCT01574157|17749187|P2|Overall Study|Lost to Follow-up|3
5138783|NCT01574157|17749188|P1|Overall Study|Lost to Follow-up|0
5138784|NCT01574157|17749187|P2|Overall Study|Withdrawal by Subject|5
5138785|NCT01574157|17749188|P1|Overall Study|Withdrawal by Subject|4
5138786|NCT01574079|17749222|P2|Overall Study|Lost to Follow-up|0
5138787|NCT01574079|17749223|P1|Overall Study|Lost to Follow-up|1
5138788|NCT01574079|17749222|P2|Overall Study|Physician Decision|2
5138789|NCT01574079|17749223|P1|Overall Study|Physician Decision|0
5138790|NCT01573910|17749242|P2|Overall Study|Patient decision unrelated to Advs Event|11
5138791|NCT01573910|17749243|P1|Overall Study|Patient decision unrelated to Advs Event|11
5138792|NCT01573910|17749242|P2|Overall Study|Protocol Violation|0
5138793|NCT01573910|17749243|P1|Overall Study|Protocol Violation|3
5138794|NCT01573910|17749242|P2|Overall Study|Withdrawal by Subject|1
5138795|NCT01573910|17749243|P1|Overall Study|Withdrawal by Subject|0
5138796|NCT01573910|17749242|P2|Overall Study|Lost to Follow-up|1
5138797|NCT01573910|17749243|P1|Overall Study|Lost to Follow-up|2
5138798|NCT01573910|17749242|P2|Overall Study|Adverse Event|4
5138799|NCT01573910|17749243|P1|Overall Study|Adverse Event|4
5138800|NCT01573767|17749255|P4|Overall Study|Withdrawal by Subject|0
5138801|NCT01573767|17749256|P3|Overall Study|Withdrawal by Subject|0
5138802|NCT01573767|17749257|P2|Overall Study|Withdrawal by Subject|1
5138803|NCT01573767|17749258|P1|Overall Study|Withdrawal by Subject|0
5138804|NCT01573767|17749255|P4|Overall Study|Physician Decision|2
5138805|NCT01573767|17749256|P3|Overall Study|Physician Decision|0
5138806|NCT01573767|17749257|P2|Overall Study|Physician Decision|2
5138807|NCT01573767|17749258|P1|Overall Study|Physician Decision|1
5138808|NCT01573767|17749255|P4|Overall Study|Lost to Follow-up|1
5138809|NCT01573767|17749256|P3|Overall Study|Lost to Follow-up|1
5138810|NCT01573767|17749257|P2|Overall Study|Lost to Follow-up|1
5138811|NCT01573767|17749258|P1|Overall Study|Lost to Follow-up|0
5138812|NCT01573767|17749255|P4|Overall Study|Protocol Violation|3
5138813|NCT01573767|17749256|P3|Overall Study|Protocol Violation|1
5138814|NCT01573767|17749257|P2|Overall Study|Protocol Violation|1
5138815|NCT01573767|17749258|P1|Overall Study|Protocol Violation|3
5138816|NCT01573767|17749255|P4|Overall Study|Lack of Efficacy|17
5138817|NCT01573767|17749256|P3|Overall Study|Lack of Efficacy|12
5138818|NCT01573767|17749257|P2|Overall Study|Lack of Efficacy|15
5138819|NCT01573767|17749258|P1|Overall Study|Lack of Efficacy|18
5138820|NCT01573767|17749255|P4|Overall Study|Adverse Event|1
5138821|NCT01573767|17749256|P3|Overall Study|Adverse Event|0
5138822|NCT01573767|17749257|P2|Overall Study|Adverse Event|1
5138823|NCT01573767|17749258|P1|Overall Study|Adverse Event|0
5138824|NCT01573624|17749292|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5138825|NCT01573624|17749293|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5138826|NCT01573624|17749294|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5138827|NCT01573624|17749295|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5138828|NCT01573624|17749296|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5138829|NCT01573624|17749297|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5138830|NCT01573624|17749298|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
5138831|NCT01573624|17749292|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5138832|NCT01573624|17749293|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
5138833|NCT01573624|17749294|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
5138834|NCT01573624|17749295|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5138835|NCT01573624|17749296|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5138836|NCT01573624|17749297|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5138837|NCT01573624|17749298|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5138838|NCT01573624|17749292|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5138839|NCT01573624|17749293|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5138840|NCT01573624|17749294|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5138841|NCT01573624|17749295|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5138842|NCT01573624|17749296|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5138843|NCT01573624|17749297|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5138844|NCT01573624|17749298|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
5138845|NCT01573624|17749292|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5138846|NCT01573624|17749293|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
5138847|NCT01573624|17749294|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5138848|NCT01573624|17749295|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5138849|NCT01573624|17749296|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5138850|NCT01573624|17749297|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
5138851|NCT01573624|17749298|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5138852|NCT01573624|17749292|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
5138853|NCT01573624|17749293|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
5138854|NCT01573624|17749294|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
5138855|NCT01573624|17749295|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5138856|NCT01573624|17749296|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5138857|NCT01573624|17749297|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5138858|NCT01573624|17749298|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
5138859|NCT01573624|17749292|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5138860|NCT01573624|17749293|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5138861|NCT01573624|17749294|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5138862|NCT01573624|17749295|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5138863|NCT01573624|17749296|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5138864|NCT01573624|17749297|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5138865|NCT01573624|17749298|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5138866|NCT01573624|17749292|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5138867|NCT01573624|17749293|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5138868|NCT01573624|17749294|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5138869|NCT01573624|17749295|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5138870|NCT01573624|17749296|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5138871|NCT01573624|17749297|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5138872|NCT01573624|17749298|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5138873|NCT01573624|17749292|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5138874|NCT01573624|17749293|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5138875|NCT01573624|17749294|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5138876|NCT01573624|17749295|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5138877|NCT01573624|17749296|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5138878|NCT01573624|17749297|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
5138879|NCT01573624|17749298|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5138880|NCT01573624|17749292|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5138881|NCT01573624|17749293|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5138882|NCT01573624|17749294|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5138883|NCT01573624|17749295|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5138884|NCT01573624|17749296|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5138885|NCT01573624|17749297|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
5138886|NCT01573624|17749298|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5138887|NCT01573624|17749292|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5138888|NCT01573624|17749293|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
5138889|NCT01573624|17749294|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5138890|NCT01573624|17749295|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5138891|NCT01573624|17749296|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5138892|NCT01573624|17749297|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5138893|NCT01573624|17749298|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
5138894|NCT01573624|17749292|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
5138895|NCT01573624|17749293|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5138896|NCT01573624|17749294|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5138897|NCT01573624|17749295|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5138898|NCT01573624|17749296|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5138899|NCT01573624|17749297|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5138900|NCT01573624|17749298|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
5138901|NCT01573624|17749292|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5138902|NCT01573624|17749293|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5138903|NCT01573624|17749294|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5138904|NCT01573624|17749295|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5138905|NCT01573624|17749296|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5138906|NCT01573624|17749297|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5138907|NCT01573624|17749298|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
5138908|NCT01573624|17749292|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5138909|NCT01573624|17749293|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5138910|NCT01573624|17749294|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5138911|NCT01573624|17749295|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5138912|NCT01573624|17749296|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5138913|NCT01573624|17749297|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5138914|NCT01573624|17749298|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5138915|NCT01573624|17749292|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5138916|NCT01573624|17749293|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5138917|NCT01573624|17749294|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5138918|NCT01573624|17749295|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5138919|NCT01573624|17749296|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5138920|NCT01573624|17749297|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5138921|NCT01573624|17749298|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
5138922|NCT01573624|17749292|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5138923|NCT01573624|17749293|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
5138924|NCT01573624|17749294|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5138925|NCT01573624|17749295|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5138926|NCT01573624|17749296|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5138927|NCT01573624|17749297|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
5138928|NCT01573624|17749298|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5138929|NCT01573624|17749292|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
5138930|NCT01573624|17749293|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
5138931|NCT01573624|17749294|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
5138932|NCT01573624|17749295|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
5138933|NCT01573624|17749296|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
5138934|NCT01573624|17749297|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
5138935|NCT01573624|17749298|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
5138936|NCT01573624|17749292|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5138937|NCT01573624|17749293|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5138938|NCT01573624|17749294|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5138939|NCT01573624|17749295|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5138940|NCT01573624|17749296|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5138941|NCT01573624|17749297|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5138942|NCT01573624|17749298|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5138943|NCT01573624|17749292|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5138944|NCT01573624|17749293|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5138945|NCT01573624|17749294|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5138946|NCT01573624|17749295|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
5138947|NCT01573624|17749296|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5138948|NCT01573624|17749297|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5138949|NCT01573624|17749298|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5138950|NCT01573624|17749292|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5138951|NCT01573624|17749293|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
5138952|NCT01573624|17749294|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5138953|NCT01573624|17749295|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5138954|NCT01573624|17749296|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5138955|NCT01573624|17749297|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5138956|NCT01573624|17749298|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5138957|NCT01573624|17749292|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5138958|NCT01573624|17749293|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5138959|NCT01573624|17749294|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5138960|NCT01573624|17749295|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
5138961|NCT01573624|17749296|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
5138962|NCT01573624|17749297|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5138963|NCT01573624|17749298|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
5138964|NCT01573624|17749292|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5138965|NCT01573624|17749293|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5138966|NCT01573624|17749294|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5138967|NCT01573624|17749295|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5138968|NCT01573624|17749296|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5138969|NCT01573624|17749297|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5138970|NCT01573624|17749298|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5138971|NCT01573624|17749292|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5138972|NCT01573624|17749293|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
5138973|NCT01573624|17749294|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5138974|NCT01573624|17749295|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5138975|NCT01573624|17749296|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5138976|NCT01573624|17749297|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5138977|NCT01573624|17749298|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5138978|NCT01573624|17749292|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5138979|NCT01573624|17749293|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5138980|NCT01573624|17749294|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5138981|NCT01573624|17749295|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5138982|NCT01573624|17749296|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5138983|NCT01573624|17749297|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5138984|NCT01573624|17749298|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5138985|NCT01573624|17749292|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5138986|NCT01573624|17749293|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5138987|NCT01573624|17749294|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5138988|NCT01573624|17749295|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5138989|NCT01573624|17749296|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5138990|NCT01573624|17749297|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5138991|NCT01573624|17749298|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5138992|NCT01573624|17749292|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5138993|NCT01573624|17749293|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5138994|NCT01573624|17749294|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5138995|NCT01573624|17749295|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5138996|NCT01573624|17749296|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5138997|NCT01573624|17749297|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5138998|NCT01573624|17749298|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
5138999|NCT01573624|17749292|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
5139000|NCT01573624|17749293|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
5139001|NCT01573624|17749294|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
5139002|NCT01573624|17749295|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
5139003|NCT01573624|17749296|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
5139004|NCT01573624|17749297|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
5139005|NCT01573624|17749298|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
5139006|NCT01573624|17749292|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5139007|NCT01573624|17749293|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
5139008|NCT01573624|17749294|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5139009|NCT01573624|17749295|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5139010|NCT01573624|17749296|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
5139011|NCT01573624|17749297|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5139012|NCT01573624|17749298|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5139013|NCT01573442|17749358|P2|Overall Study|Cancels|10
5139014|NCT01573442|17749359|P1|Overall Study|Cancels|9
5139015|NCT01573000|17749503|P2|Long-Term Follow-Up|Lost to Follow-up|1
5139016|NCT01573000|17749504|P1|Long-Term Follow-Up|Lost to Follow-up|0
5139017|NCT01573000|17749503|P2|Long-Term Follow-Up|Death|0
5139018|NCT01573000|17749504|P1|Long-Term Follow-Up|Death|3
5139019|NCT01573000|17749503|P2|Crossover Phase|Death|3
5139020|NCT01573000|17749504|P1|Crossover Phase|Death|0
5139021|NCT01573000|17749503|P2|Crossover Phase|Lost to Follow-up|2
5139022|NCT01573000|17749504|P1|Crossover Phase|Lost to Follow-up|0
5139023|NCT01573000|17749503|P2|Crossover Phase|Lack of Efficacy|13
5139024|NCT01573000|17749504|P1|Crossover Phase|Lack of Efficacy|0
5139025|NCT01573000|17749503|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
5139026|NCT01573000|17749504|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
5139027|NCT01573000|17749503|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
5139028|NCT01573000|17749504|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
5139029|NCT01573000|17749503|P2|Dosimetric and Therapeutic Treatment|Death|1
5139030|NCT01573000|17749504|P1|Dosimetric and Therapeutic Treatment|Death|0
5139031|NCT01573000|17749503|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
5139032|NCT01573000|17749504|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
5139033|NCT01573000|17749503|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
5139034|NCT01573000|17749504|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
5139035|NCT01572948|17749600|P2|Overall Study|unable to contact|1
5139036|NCT01572948|17749601|P1|Overall Study|unable to contact|0
5139037|NCT01572948|17749600|P2|Overall Study|Lost to Follow-up|0
5139038|NCT01572948|17749601|P1|Overall Study|Lost to Follow-up|1
5139039|NCT01572922|17749617|P1|Overall Study|Death|1
5139040|NCT01572922|17749617|P1|Overall Study|Protocol Violation|1
5139041|NCT01572922|17749617|P1|Overall Study|Adverse Event|1
5139042|NCT01572909|17749629|P2|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
5139043|NCT01572909|17749630|P1|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
5139044|NCT01572909|17749629|P2|Overall Study|Withdrawal by Subject|11
5139045|NCT01572909|17749630|P1|Overall Study|Withdrawal by Subject|12
5139046|NCT01572909|17749629|P2|Overall Study|Technical Issues|0
5139047|NCT01572909|17749630|P1|Overall Study|Technical Issues|1
5139048|NCT01572909|17749629|P2|Overall Study|Physician Decision|1
5139049|NCT01572909|17749630|P1|Overall Study|Physician Decision|1
5139050|NCT01572909|17749629|P2|Overall Study|Lost to Follow-up|7
5139051|NCT01572909|17749630|P1|Overall Study|Lost to Follow-up|8
5139052|NCT01572909|17749629|P2|Overall Study|Death|1
5139053|NCT01572909|17749630|P1|Overall Study|Death|3
5139054|NCT01572909|17749629|P2|Overall Study|Adverse Event|2
5139055|NCT01572909|17749630|P1|Overall Study|Adverse Event|7
5139056|NCT01572844|17749674|P2|Overall Study|Physician Decision|1
5139057|NCT01572844|17749675|P1|Overall Study|Physician Decision|1
5139058|NCT01572792|17749693|P5|Extension Study|Site termination/COPD exacerbation/other|6
5139059|NCT01572792|17749694|P4|Extension Study|Site termination/COPD exacerbation/other|6
5139060|NCT01572792|17749695|P3|Extension Study|Site termination/COPD exacerbation/other|4
5139061|NCT01572792|17749696|P2|Extension Study|Site termination/COPD exacerbation/other|8
5139062|NCT01572792|17749697|P1|Extension Study|Site termination/COPD exacerbation/other|3
5139063|NCT01572792|17749693|P5|Extension Study|Adverse Event|4
5139064|NCT01572792|17749694|P4|Extension Study|Adverse Event|6
5139065|NCT01572792|17749695|P3|Extension Study|Adverse Event|5
5139066|NCT01572792|17749696|P2|Extension Study|Adverse Event|6
5139067|NCT01572792|17749697|P1|Extension Study|Adverse Event|7
5139068|NCT01572792|17749693|P5|Extension Study|Lack of Efficacy|2
5139069|NCT01572792|17749694|P4|Extension Study|Lack of Efficacy|2
5139070|NCT01572792|17749695|P3|Extension Study|Lack of Efficacy|3
5139071|NCT01572792|17749696|P2|Extension Study|Lack of Efficacy|3
5139072|NCT01572792|17749697|P1|Extension Study|Lack of Efficacy|2
5139073|NCT01572792|17749693|P5|Extension Study|Protocol Violation|3
5139074|NCT01572792|17749694|P4|Extension Study|Protocol Violation|4
5139075|NCT01572792|17749695|P3|Extension Study|Protocol Violation|3
5139076|NCT01572792|17749696|P2|Extension Study|Protocol Violation|4
5139077|NCT01572792|17749697|P1|Extension Study|Protocol Violation|0
5139078|NCT01572792|17749693|P5|Extension Study|Withdrawal by Subject|14
5139079|NCT01572792|17749694|P4|Extension Study|Withdrawal by Subject|8
5139080|NCT01572792|17749695|P3|Extension Study|Withdrawal by Subject|11
5139081|NCT01572792|17749696|P2|Extension Study|Withdrawal by Subject|6
5139082|NCT01572792|17749697|P1|Extension Study|Withdrawal by Subject|7
5139083|NCT01572792|17749693|P5|Extension Study|Lost to Follow-up|3
5139084|NCT01572792|17749694|P4|Extension Study|Lost to Follow-up|3
5139085|NCT01572792|17749695|P3|Extension Study|Lost to Follow-up|0
5139086|NCT01572792|17749696|P2|Extension Study|Lost to Follow-up|2
5139087|NCT01572792|17749697|P1|Extension Study|Lost to Follow-up|6
5139088|NCT01572792|17749693|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
5139089|NCT01572792|17749694|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
5139090|NCT01572792|17749695|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
5139091|NCT01572792|17749696|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
5139092|NCT01572792|17749697|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
5139093|NCT01572792|17749693|P5|Lead-in Study|Adverse Event|14
5139094|NCT01572792|17749694|P4|Lead-in Study|Adverse Event|16
5139095|NCT01572792|17749695|P3|Lead-in Study|Adverse Event|22
5139096|NCT01572792|17749696|P2|Lead-in Study|Adverse Event|21
5139097|NCT01572792|17749697|P1|Lead-in Study|Adverse Event|21
5139098|NCT01572792|17749693|P5|Lead-in Study|Lack of Efficacy|10
5139099|NCT01572792|17749694|P4|Lead-in Study|Lack of Efficacy|8
5139100|NCT01572792|17749695|P3|Lead-in Study|Lack of Efficacy|4
5139101|NCT01572792|17749696|P2|Lead-in Study|Lack of Efficacy|5
5139102|NCT01572792|17749697|P1|Lead-in Study|Lack of Efficacy|20
5139103|NCT01572792|17749693|P5|Lead-in Study|Protocol Violation|21
5139104|NCT01572792|17749694|P4|Lead-in Study|Protocol Violation|13
5139105|NCT01572792|17749695|P3|Lead-in Study|Protocol Violation|12
5139106|NCT01572792|17749696|P2|Lead-in Study|Protocol Violation|10
5139107|NCT01572792|17749697|P1|Lead-in Study|Protocol Violation|19
5139108|NCT01572792|17749693|P5|Lead-in Study|Withdrawal by Subject|11
5139109|NCT01572792|17749694|P4|Lead-in Study|Withdrawal by Subject|24
5139110|NCT01572792|17749695|P3|Lead-in Study|Withdrawal by Subject|12
5139111|NCT01572792|17749696|P2|Lead-in Study|Withdrawal by Subject|11
5139112|NCT01572792|17749697|P1|Lead-in Study|Withdrawal by Subject|22
5139113|NCT01572792|17749693|P5|Lead-in Study|Lost to Follow-up|4
5139114|NCT01572792|17749694|P4|Lead-in Study|Lost to Follow-up|2
5139115|NCT01572792|17749695|P3|Lead-in Study|Lost to Follow-up|4
5139116|NCT01572792|17749696|P2|Lead-in Study|Lost to Follow-up|9
5139117|NCT01572792|17749697|P1|Lead-in Study|Lost to Follow-up|5
5139118|NCT01572740|17749746|P2|Overall Study|unclassified|3
5139119|NCT01572740|17749747|P1|Overall Study|unclassified|4
5139120|NCT01572740|17749746|P2|Overall Study|Withdrawal by Subject|1
5139121|NCT01572740|17749747|P1|Overall Study|Withdrawal by Subject|1
5139122|NCT01572740|17749746|P2|Overall Study|Adverse Event|1
5139123|NCT01572740|17749747|P1|Overall Study|Adverse Event|1
5139124|NCT01572727|17749777|P2|Overall Study|Untreated|7
5139125|NCT01572727|17749778|P1|Overall Study|Untreated|4
5139126|NCT01572727|17749777|P2|Overall Study|Death|2
5139127|NCT01572727|17749778|P1|Overall Study|Death|2
5139128|NCT01572727|17749777|P2|Overall Study|Parent/guardian decision|9
5139129|NCT01572727|17749778|P1|Overall Study|Parent/guardian decision|14
5139130|NCT01572727|17749777|P2|Overall Study|Study terminated by sponsor|83
5139131|NCT01572727|17749778|P1|Overall Study|Study terminated by sponsor|61
5139132|NCT01572727|17749777|P2|Overall Study|Protocol Violation|1
5139133|NCT01572727|17749778|P1|Overall Study|Protocol Violation|0
5139134|NCT01572727|17749777|P2|Overall Study|Progressive disease|82
5139135|NCT01572727|17749778|P1|Overall Study|Progressive disease|59
5139136|NCT01572727|17749777|P2|Overall Study|Physician Decision|9
5139137|NCT01572727|17749778|P1|Overall Study|Physician Decision|23
5139138|NCT01572727|17749777|P2|Overall Study|Lost to Follow-up|1
5139139|NCT01572727|17749778|P1|Overall Study|Lost to Follow-up|1
5139140|NCT01572727|17749777|P2|Overall Study|Adverse Event|15
5139141|NCT01572727|17749778|P1|Overall Study|Adverse Event|43
5139142|NCT01572675|17749800|P2|Overall Study|Lost to Follow-up|27
5139143|NCT01572675|17749801|P1|Overall Study|Lost to Follow-up|22
5139144|NCT01572675|17749800|P2|Overall Study|Missing data|4
5139145|NCT01572675|17749801|P1|Overall Study|Missing data|1
5139146|NCT01572675|17749800|P2|Overall Study|Rheumatologist new evaluation|1
5139147|NCT01572675|17749801|P1|Overall Study|Rheumatologist new evaluation|0
5139148|NCT01572675|17749800|P2|Overall Study|Unknown reason|1
5139149|NCT01572675|17749801|P1|Overall Study|Unknown reason|1
5139150|NCT01572675|17749800|P2|Overall Study|Other disease detected|1
5139151|NCT01572675|17749801|P1|Overall Study|Other disease detected|1
5139152|NCT01572675|17749800|P2|Overall Study|Death unrelated to coxibs|1
5139153|NCT01572675|17749801|P1|Overall Study|Death unrelated to coxibs|1
5139154|NCT01572675|17749800|P2|Overall Study|Physician Decision|2
5139155|NCT01572675|17749801|P1|Overall Study|Physician Decision|2
5139156|NCT01572675|17749800|P2|Overall Study|Withdrawal by Subject|1
5139157|NCT01572675|17749801|P1|Overall Study|Withdrawal by Subject|5
5139158|NCT01572675|17749800|P2|Overall Study|Surgical intervention|6
5139159|NCT01572675|17749801|P1|Overall Study|Surgical intervention|3
5139160|NCT01572675|17749800|P2|Overall Study|Improved symptoms|2
5139161|NCT01572675|17749801|P1|Overall Study|Improved symptoms|8
5139162|NCT01572675|17749800|P2|Overall Study|Intolerance|5
5139163|NCT01572675|17749801|P1|Overall Study|Intolerance|6
5139164|NCT01572675|17749800|P2|Overall Study|Lack of Efficacy|31
5139165|NCT01572675|17749801|P1|Overall Study|Lack of Efficacy|31
5139166|NCT01572675|17749800|P2|Overall Study|Recovery|23
5139167|NCT01572675|17749801|P1|Overall Study|Recovery|16
5139168|NCT01572675|17749800|P2|Overall Study|End of prescribed treatment|118
5139169|NCT01572675|17749801|P1|Overall Study|End of prescribed treatment|140
5139170|NCT01572389|17749919|P2|Overall Study|Only A1C or Assessment was Collected|2
5139171|NCT01572389|17749920|P1|Overall Study|Only A1C or Assessment was Collected|6
5139172|NCT01572389|17749919|P2|Overall Study|Lost to Follow-up|14
5139173|NCT01572389|17749920|P1|Overall Study|Lost to Follow-up|25
5139174|NCT01572389|17749919|P2|Overall Study|Withdrawal by Subject|2
5139175|NCT01572389|17749920|P1|Overall Study|Withdrawal by Subject|14
5139176|NCT01572389|17749919|P2|Overall Study|Death|3
5139177|NCT01572389|17749920|P1|Overall Study|Death|1
5139178|NCT01572038|17749952|P1|Overall Study|Sponsor Decision|1
5139179|NCT01572038|17749952|P1|Overall Study|Patient Deterioration|1
5139180|NCT01572038|17749952|P1|Overall Study|Termination by Sponsor|2
5139181|NCT01572038|17749952|P1|Overall Study|Participated in Another Trial|3
5139182|NCT01572038|17749952|P1|Overall Study|Enrolled into Another Trial|3
5139183|NCT01572038|17749952|P1|Overall Study|Site Closed Before Completing Form|6
5139184|NCT01572038|17749952|P1|Overall Study|Progressive Disease|8
5139185|NCT01572038|17749952|P1|Overall Study|Patient Decision|14
5139186|NCT01572038|17749952|P1|Overall Study|Physician Decision|20
5139187|NCT01572038|17749952|P1|Overall Study|Lost to Follow-up|81
5139188|NCT01572038|17749952|P1|Overall Study|Withdrawal by Subject|204
5139189|NCT01572038|17749952|P1|Overall Study|Death|648
5139190|NCT01571453|17750067|P2|Overall Study|Administrative or other reason(s)|3
5139191|NCT01571453|17750068|P1|Overall Study|Administrative or other reason(s)|4
5139192|NCT01571453|17750067|P2|Overall Study|Lost to Follow-up|2
5139193|NCT01571453|17750068|P1|Overall Study|Lost to Follow-up|4
5139194|NCT01571453|17750067|P2|Overall Study|Withdrawal of consent|13
5139195|NCT01571453|17750068|P1|Overall Study|Withdrawal of consent|5
5139196|NCT01571453|17750067|P2|Overall Study|Protocol Violation|5
5139197|NCT01571453|17750068|P1|Overall Study|Protocol Violation|1
5139198|NCT01571453|17750067|P2|Overall Study|Non-compliance|4
5139199|NCT01571453|17750068|P1|Overall Study|Non-compliance|2
5139200|NCT01571453|17750067|P2|Overall Study|Lack of Efficacy|3
5139201|NCT01571453|17750068|P1|Overall Study|Lack of Efficacy|8
5139202|NCT01571453|17750067|P2|Overall Study|Adverse Event|32
5139203|NCT01571453|17750068|P1|Overall Study|Adverse Event|14
5139204|NCT01571362|17750115|P3|Double-Blind Treatment Period|Other - unspecified|1
5139205|NCT01571362|17750116|P2|Double-Blind Treatment Period|Other - unspecified|6
5139206|NCT01571362|17750117|P1|Double-Blind Treatment Period|Other - unspecified|0
5139207|NCT01571362|17750115|P3|Double-Blind Treatment Period|Insufficient clinical response|4
5139208|NCT01571362|17750116|P2|Double-Blind Treatment Period|Insufficient clinical response|16
5139209|NCT01571362|17750117|P1|Double-Blind Treatment Period|Insufficient clinical response|0
5139210|NCT01571362|17750115|P3|Double-Blind Treatment Period|Lost to Follow-up|6
5139211|NCT01571362|17750116|P2|Double-Blind Treatment Period|Lost to Follow-up|3
5139212|NCT01571362|17750117|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5139213|NCT01571362|17750115|P3|Double-Blind Treatment Period|Adverse Event|14
5139214|NCT01571362|17750116|P2|Double-Blind Treatment Period|Adverse Event|9
5139215|NCT01571362|17750117|P1|Double-Blind Treatment Period|Adverse Event|0
5139216|NCT01571362|17750115|P3|Double-Blind Treatment Period|Protocol Violation|9
5139217|NCT01571362|17750116|P2|Double-Blind Treatment Period|Protocol Violation|8
5139218|NCT01571362|17750117|P1|Double-Blind Treatment Period|Protocol Violation|0
5139219|NCT01571362|17750115|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
5139220|NCT01571362|17750116|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
5139221|NCT01571362|17750117|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5139222|NCT01571362|17750115|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
5139223|NCT01571362|17750116|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
5139224|NCT01571362|17750117|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
5139225|NCT01571362|17750115|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
5139226|NCT01571362|17750116|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
5139227|NCT01571362|17750117|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
5139228|NCT01571362|17750115|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
5139229|NCT01571362|17750116|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
5139230|NCT01571362|17750117|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
5139231|NCT01571362|17750115|P3|Open-Label Conversion + Titration Period|Adverse Event|0
5139232|NCT01571362|17750116|P2|Open-Label Conversion + Titration Period|Adverse Event|0
5139233|NCT01571362|17750117|P1|Open-Label Conversion + Titration Period|Adverse Event|57
5139234|NCT01571362|17750115|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
5139235|NCT01571362|17750116|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
5139236|NCT01571362|17750117|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
5139237|NCT01571362|17750115|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
5139238|NCT01571362|17750116|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
5139239|NCT01571362|17750117|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
5139240|NCT01571284|17750287|P1|Overall Study|Other than specified above|80
5139241|NCT01571284|17750287|P1|Overall Study|Enrolled but not treated|2
5139242|NCT01571284|17750287|P1|Overall Study|Lost to Follow-up|3
5139243|NCT01571284|17750287|P1|Overall Study|Participant's decision|84
5139244|NCT01571232|17750310|P2|Overall Study|Withdrawal by Subject|0
5139245|NCT01571232|17750311|P1|Overall Study|Withdrawal by Subject|1
5139246|NCT01571232|17750310|P2|Overall Study|Lost to Follow-up|1
5139247|NCT01571232|17750311|P1|Overall Study|Lost to Follow-up|0
5139248|NCT01570868|17750323|P2|Overall Study|Withdrawal by Subject|0
5139249|NCT01570868|17750324|P1|Overall Study|Withdrawal by Subject|1
5139250|NCT01570868|17750323|P2|Overall Study|Lost to Follow-up|0
5139251|NCT01570868|17750324|P1|Overall Study|Lost to Follow-up|1
5139252|NCT01570868|17750323|P2|Overall Study|Physician Decision|4
5139253|NCT01570868|17750324|P1|Overall Study|Physician Decision|10
5139254|NCT01570868|17750323|P2|Overall Study|FDA Recommendation|3
5139255|NCT01570868|17750324|P1|Overall Study|FDA Recommendation|23
5139256|NCT01570868|17750323|P2|Overall Study|Adverse Event|1
5139257|NCT01570868|17750324|P1|Overall Study|Adverse Event|8
5139258|NCT01570751|17750336|P2|Period B (16 Weeks)|Protocol Violation|1
5139259|NCT01570751|17750337|P1|Period B (16 Weeks)|Protocol Violation|0
5139260|NCT01570751|17750336|P2|Period B (16 Weeks)|Adverse Event|0
5139261|NCT01570751|17750337|P1|Period B (16 Weeks)|Adverse Event|1
5139262|NCT01570751|17750336|P2|Period A (16 Weeks)|Unclassified|3
5139263|NCT01570751|17750337|P1|Period A (16 Weeks)|Unclassified|2
5139264|NCT01570751|17750336|P2|Period A (16 Weeks)|Withdrawal criteria|1
5139265|NCT01570751|17750337|P1|Period A (16 Weeks)|Withdrawal criteria|0
5139266|NCT01570751|17750336|P2|Period A (16 Weeks)|Protocol Violation|1
5139267|NCT01570751|17750337|P1|Period A (16 Weeks)|Protocol Violation|1
5139268|NCT01570686|17750355|P2|Overall Study|Unsatisfactory therapeutic effect|1
5139269|NCT01570686|17750356|P1|Overall Study|Unsatisfactory therapeutic effect|2
5139270|NCT01570686|17750355|P2|Overall Study|Withdrawal by Subject|4
5139271|NCT01570686|17750356|P1|Overall Study|Withdrawal by Subject|4
5139272|NCT01570686|17750355|P2|Overall Study|Protocol Deviation|0
5139273|NCT01570686|17750356|P1|Overall Study|Protocol Deviation|3
5139274|NCT01570686|17750355|P2|Overall Study|Lost to Follow-up|3
5139275|NCT01570686|17750356|P1|Overall Study|Lost to Follow-up|4
5139276|NCT01570686|17750355|P2|Overall Study|Adverse Event|6
5139277|NCT01570686|17750356|P1|Overall Study|Adverse Event|8
5139278|NCT01570686|17750355|P2|Overall Study|Administrative problems|1
5139279|NCT01570686|17750356|P1|Overall Study|Administrative problems|0
5139280|NCT01570686|17750355|P2|Overall Study|Abnormal test procedure result(s)|1
5139281|NCT01570686|17750356|P1|Overall Study|Abnormal test procedure result(s)|1
5139282|NCT01570491|17750392|P2|Overall Study|treatment: not given or discontinued|0
5139283|NCT01570491|17750393|P1|Overall Study|treatment: not given or discontinued|2
5139284|NCT01570491|17750392|P2|Overall Study|Lost to Follow-up|1
5139285|NCT01570491|17750393|P1|Overall Study|Lost to Follow-up|3
5139286|NCT01570387|17750409|P4|Overall Study|Withdrawal by Subject|1
5139287|NCT01570387|17750410|P3|Overall Study|Withdrawal by Subject|0
5139288|NCT01570387|17750411|P2|Overall Study|Withdrawal by Subject|0
5139289|NCT01570387|17750412|P1|Overall Study|Withdrawal by Subject|0
5139290|NCT01570387|17750409|P4|Overall Study|Death|1
5139291|NCT01570387|17750410|P3|Overall Study|Death|0
5139292|NCT01570387|17750411|P2|Overall Study|Death|0
5139293|NCT01570387|17750412|P1|Overall Study|Death|0
5139294|NCT01570387|17750409|P4|Overall Study|Adverse Event|0
5139295|NCT01570387|17750410|P3|Overall Study|Adverse Event|0
5139296|NCT01570387|17750411|P2|Overall Study|Adverse Event|0
5139297|NCT01570387|17750412|P1|Overall Study|Adverse Event|1
5139298|NCT01570361|17750424|P2|Overall Study|Other|2
5139299|NCT01570361|17750425|P1|Overall Study|Other|0
5139300|NCT01570361|17750424|P2|Overall Study|Death|4
5139301|NCT01570361|17750425|P1|Overall Study|Death|5
5139302|NCT01570361|17750424|P2|Overall Study|Lost to Follow-up|4
5139303|NCT01570361|17750425|P1|Overall Study|Lost to Follow-up|4
5139304|NCT01570361|17750424|P2|Overall Study|Adverse Event|1
5139305|NCT01570361|17750425|P1|Overall Study|Adverse Event|2
5139306|NCT01570361|17750424|P2|Overall Study|Subject withdrew consent|9
5139307|NCT01570361|17750425|P1|Overall Study|Subject withdrew consent|14
5139308|NCT01570361|17750424|P2|Overall Study|Subject excluded|3
5139309|NCT01570361|17750425|P1|Overall Study|Subject excluded|5
5139310|NCT01570361|17750424|P2|Overall Study|Sponsor closing the study|50
5139311|NCT01570361|17750425|P1|Overall Study|Sponsor closing the study|51
5139312|NCT01570361|17750424|P2|Overall Study|Subject discontinued|2
5139313|NCT01570361|17750425|P1|Overall Study|Subject discontinued|1
5139314|NCT01570309|17750468|P2|Overall Study|Withdrawal by Subject|3
5139315|NCT01570309|17750469|P1|Overall Study|Withdrawal by Subject|3
5139316|NCT01570283|17750486|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
5139317|NCT01570283|17750487|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5139318|NCT01570283|17750488|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5139319|NCT01570283|17750489|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5139320|NCT01570283|17750490|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5139321|NCT01570283|17750491|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5139322|NCT01570283|17750486|P6|Cohort 3: Dose Level 3|Death|1
5139323|NCT01570283|17750487|P5|Cohort 3: Dose Level 3|Death|0
5139324|NCT01570283|17750488|P4|Cohort 3: Dose Level 3|Death|0
5139325|NCT01570283|17750489|P3|Cohort 3: Dose Level 3|Death|0
5139326|NCT01570283|17750490|P2|Cohort 3: Dose Level 3|Death|0
5139327|NCT01570283|17750491|P1|Cohort 3: Dose Level 3|Death|0
5139328|NCT01570283|17750486|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5139329|NCT01570283|17750487|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5139330|NCT01570283|17750488|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
5139331|NCT01570283|17750489|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5139332|NCT01570283|17750490|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5139333|NCT01570283|17750491|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5139334|NCT01570283|17750486|P6|Cohort 2: Dose Level 2|Death|0
5139335|NCT01570283|17750487|P5|Cohort 2: Dose Level 2|Death|0
5139336|NCT01570283|17750488|P4|Cohort 2: Dose Level 2|Death|0
5139337|NCT01570283|17750489|P3|Cohort 2: Dose Level 2|Death|1
5139338|NCT01570283|17750490|P2|Cohort 2: Dose Level 2|Death|0
5139339|NCT01570283|17750491|P1|Cohort 2: Dose Level 2|Death|0
5139340|NCT01570283|17750486|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5139341|NCT01570283|17750487|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5139342|NCT01570283|17750488|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5139343|NCT01570283|17750489|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5139344|NCT01570283|17750490|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
5139345|NCT01570283|17750491|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5139346|NCT01570283|17750486|P6|Cohort 1: Dose Level 1|Death|0
5139347|NCT01570283|17750487|P5|Cohort 1: Dose Level 1|Death|0
5139348|NCT01570283|17750488|P4|Cohort 1: Dose Level 1|Death|0
5139349|NCT01570283|17750489|P3|Cohort 1: Dose Level 1|Death|0
5139350|NCT01570283|17750490|P2|Cohort 1: Dose Level 1|Death|1
5139351|NCT01570283|17750491|P1|Cohort 1: Dose Level 1|Death|0
5139352|NCT01570244|17750508|P1|Microgynon+Faldaprevir|Adverse Event|1
5139353|NCT01570192|17750530|P2|Overall Study|Physician Decision|1
5139354|NCT01570192|17750531|P1|Overall Study|Physician Decision|0
5139355|NCT01570192|17750530|P2|Overall Study|changed to palliative care|0
5139356|NCT01570192|17750531|P1|Overall Study|changed to palliative care|1
5139357|NCT01570192|17750530|P2|Overall Study|no qualifying organism|12
5139358|NCT01570192|17750531|P1|Overall Study|no qualifying organism|6
5139359|NCT01569841|17750569|P2|Period A (6 Weeks)|Withdrawal by Subject|1
5139360|NCT01569841|17750570|P1|Period A (6 Weeks)|Withdrawal by Subject|0
5139361|NCT01569763|17750659|P2|Overall Study|Adverse Event|0
5139362|NCT01569763|17750660|P1|Overall Study|Adverse Event|1
5139363|NCT01569763|17750659|P2|Overall Study|Lack of Efficacy|7
5139364|NCT01569763|17750660|P1|Overall Study|Lack of Efficacy|2
5139365|NCT01569594|17750699|P1|Overall Study|No ECM used|9
5139366|NCT01569594|17750699|P1|Overall Study|Other|4
5139367|NCT01569594|17750699|P1|Overall Study|Withdrawal by Subject|13
5139368|NCT01569594|17750699|P1|Overall Study|Adverse Event|2
5139369|NCT01569594|17750699|P1|Overall Study|Lost to Follow-up|22
5139370|NCT01569594|17750699|P1|Overall Study|Death|13
5139371|NCT01569594|17750699|P1|Overall Study|Physician Decision|4
5139372|NCT01569568|17750705|P2|Overall Study|Physician Decision|2
5139373|NCT01569568|17750706|P1|Overall Study|Physician Decision|0
5139374|NCT01569464|17750729|P2|Overall Study|Other|1
5139375|NCT01569464|17750730|P1|Overall Study|Other|1
5139376|NCT01569464|17750729|P2|Overall Study|Withdrawal by Subject|1
5139377|NCT01569464|17750730|P1|Overall Study|Withdrawal by Subject|1
5139378|NCT01569464|17750729|P2|Overall Study|Lost to Follow-up|3
5139379|NCT01569464|17750730|P1|Overall Study|Lost to Follow-up|2
5139380|NCT01569464|17750729|P2|Overall Study|Protocol Violation|0
5139381|NCT01569464|17750730|P1|Overall Study|Protocol Violation|1
5139382|NCT01569464|17750729|P2|Overall Study|Lack of Efficacy|0
5139383|NCT01569464|17750730|P1|Overall Study|Lack of Efficacy|1
5139384|NCT01569464|17750729|P2|Overall Study|Adverse Event|0
5139385|NCT01569464|17750730|P1|Overall Study|Adverse Event|4
5139386|NCT01569438|17750797|P2|Overall Study|Unable to adhere to study schedule|1
5139387|NCT01569438|17750798|P1|Overall Study|Unable to adhere to study schedule|0
5139388|NCT01569438|17750797|P2|Overall Study|Sponsor/Physician decision|1
5139389|NCT01569438|17750798|P1|Overall Study|Sponsor/Physician decision|1
5139390|NCT01569438|17750797|P2|Overall Study|Decrease of GFR greater than 30 ml/min|0
5139391|NCT01569438|17750798|P1|Overall Study|Decrease of GFR greater than 30 ml/min|1
5139392|NCT01569438|17750797|P2|Overall Study|Protocol Violation|0
5139393|NCT01569438|17750798|P1|Overall Study|Protocol Violation|2
5139394|NCT01569438|17750797|P2|Overall Study|Adverse Event|15
5139395|NCT01569438|17750798|P1|Overall Study|Adverse Event|2
5139396|NCT01569438|17750797|P2|Overall Study|Withdrawal by Subject|3
5139397|NCT01569438|17750798|P1|Overall Study|Withdrawal by Subject|0
5139398|NCT01569438|17750797|P2|Overall Study|Lack of Efficacy|2
5139399|NCT01569438|17750798|P1|Overall Study|Lack of Efficacy|1
5139400|NCT01569295|17750812|P2|Overall Study|Lost to Follow-up|1
5139401|NCT01569295|17750813|P1|Overall Study|Lost to Follow-up|1
5139402|NCT01569295|17750812|P2|Overall Study|Other Anticancer/Experimental Therapy|2
5139403|NCT01569295|17750813|P1|Overall Study|Other Anticancer/Experimental Therapy|2
5139404|NCT01569295|17750812|P2|Overall Study|Non-Compliance with Study Drug|1
5139405|NCT01569295|17750813|P1|Overall Study|Non-Compliance with Study Drug|6
5139406|NCT01569295|17750812|P2|Overall Study|Other Reason not Specified|5
5139407|NCT01569295|17750813|P1|Overall Study|Other Reason not Specified|3
5139408|NCT01569295|17750812|P2|Overall Study|Study Terminated by Sponsor|2
5139409|NCT01569295|17750813|P1|Overall Study|Study Terminated by Sponsor|24
5139410|NCT01569295|17750812|P2|Overall Study|Physician Decision|18
5139411|NCT01569295|17750813|P1|Overall Study|Physician Decision|13
5139412|NCT01569295|17750812|P2|Overall Study|Death|15
5139413|NCT01569295|17750813|P1|Overall Study|Death|19
5139414|NCT01569295|17750812|P2|Overall Study|Withdrawal by Subject|12
5139415|NCT01569295|17750813|P1|Overall Study|Withdrawal by Subject|25
5139416|NCT01569295|17750812|P2|Overall Study|Adverse Event|14
5139417|NCT01569295|17750813|P1|Overall Study|Adverse Event|39
5139418|NCT01569295|17750812|P2|Overall Study|Progressive Disease|139
5139419|NCT01569295|17750813|P1|Overall Study|Progressive Disease|75
5139420|NCT01569152|17750850|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
5139421|NCT01569152|17750851|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
5139422|NCT01569152|17750852|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
5139423|NCT01569152|17750850|P3|Safety Extension, Period 3|Physician Decision|2
5139424|NCT01569152|17750851|P2|Safety Extension, Period 3|Physician Decision|0
5139425|NCT01569152|17750852|P1|Safety Extension, Period 3|Physician Decision|0
5139426|NCT01569152|17750850|P3|Safety Extension, Period 3|Withdrawal by Subject|2
5139427|NCT01569152|17750851|P2|Safety Extension, Period 3|Withdrawal by Subject|0
5139428|NCT01569152|17750852|P1|Safety Extension, Period 3|Withdrawal by Subject|0
5139429|NCT01569152|17750850|P3|Safety Extension, Period 3|Adverse Event|4
5139430|NCT01569152|17750851|P2|Safety Extension, Period 3|Adverse Event|0
5139431|NCT01569152|17750852|P1|Safety Extension, Period 3|Adverse Event|0
5139432|NCT01569152|17750850|P3|Phase IIa, Period 1|Withdrawal by Subject|0
5139433|NCT01569152|17750851|P2|Phase IIa, Period 1|Withdrawal by Subject|1
5139434|NCT01569152|17750852|P1|Phase IIa, Period 1|Withdrawal by Subject|2
5139435|NCT01569152|17750850|P3|Phase IIa, Period 1|Protocol Violation|0
5139436|NCT01569152|17750851|P2|Phase IIa, Period 1|Protocol Violation|1
5139437|NCT01569152|17750852|P1|Phase IIa, Period 1|Protocol Violation|0
5139438|NCT01569152|17750850|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
5139439|NCT01569152|17750851|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
5139440|NCT01569152|17750852|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
5139441|NCT01569152|17750850|P3|Phase IIa, Period 1|Lost to Follow-up|0
5139442|NCT01569152|17750851|P2|Phase IIa, Period 1|Lost to Follow-up|0
5139443|NCT01569152|17750852|P1|Phase IIa, Period 1|Lost to Follow-up|1
5139444|NCT01569152|17750850|P3|Phase IIa, Period 1|Adverse Event|0
5139445|NCT01569152|17750851|P2|Phase IIa, Period 1|Adverse Event|0
5139446|NCT01569152|17750852|P1|Phase IIa, Period 1|Adverse Event|4
5139447|NCT01569152|17750850|P3|Phase IIa, Period 1|Early Escape|0
5139448|NCT01569152|17750851|P2|Phase IIa, Period 1|Early Escape|22
5139449|NCT01569152|17750852|P1|Phase IIa, Period 1|Early Escape|5
5139450|NCT01569074|17750988|P5|Overall Study|Adverse Event|0
5139451|NCT01569074|17750989|P4|Overall Study|Adverse Event|0
5139452|NCT01569074|17750990|P3|Overall Study|Adverse Event|3
5139453|NCT01569074|17750991|P2|Overall Study|Adverse Event|0
5139454|NCT01569074|17750992|P1|Overall Study|Adverse Event|1
5139455|NCT01569074|17750988|P5|Overall Study|eg change in circumstances|1
5139456|NCT01569074|17750989|P4|Overall Study|eg change in circumstances|1
5139457|NCT01569074|17750990|P3|Overall Study|eg change in circumstances|0
5139458|NCT01569074|17750991|P2|Overall Study|eg change in circumstances|2
5139459|NCT01569074|17750992|P1|Overall Study|eg change in circumstances|0
5139460|NCT01569074|17750988|P5|Overall Study|Severe non-compliance to protocol|0
5139461|NCT01569074|17750989|P4|Overall Study|Severe non-compliance to protocol|0
5139462|NCT01569074|17750990|P3|Overall Study|Severe non-compliance to protocol|1
5139463|NCT01569074|17750991|P2|Overall Study|Severe non-compliance to protocol|0
5139464|NCT01569074|17750992|P1|Overall Study|Severe non-compliance to protocol|0
5139465|NCT01569074|17750988|P5|Overall Study|Study-specific discontinuation criteria|0
5139466|NCT01569074|17750989|P4|Overall Study|Study-specific discontinuation criteria|0
5139467|NCT01569074|17750990|P3|Overall Study|Study-specific discontinuation criteria|0
5139468|NCT01569074|17750991|P2|Overall Study|Study-specific discontinuation criteria|1
5139469|NCT01569074|17750992|P1|Overall Study|Study-specific discontinuation criteria|0
5139470|NCT01569074|17750988|P5|Overall Study|Study stopped|7
5139471|NCT01569074|17750989|P4|Overall Study|Study stopped|7
5139472|NCT01569074|17750990|P3|Overall Study|Study stopped|8
5139473|NCT01569074|17750991|P2|Overall Study|Study stopped|6
5139474|NCT01569074|17750992|P1|Overall Study|Study stopped|6
5139475|NCT01569022|17751048|P2|Second Intervention|Lost to Follow-up|2
5139476|NCT01569022|17751049|P1|Second Intervention|Lost to Follow-up|2
5139477|NCT01569022|17751048|P2|First Intervention|Lost to Follow-up|1
5139478|NCT01569022|17751049|P1|First Intervention|Lost to Follow-up|2
5139479|NCT01568892|17751104|P2|Open-label Phase|Lost to Follow-up|1
5139480|NCT01568892|17751105|P1|Open-label Phase|Lost to Follow-up|0
5139481|NCT01568892|17751104|P2|Open-label Phase|Lack of Efficacy|2
5139482|NCT01568892|17751105|P1|Open-label Phase|Lack of Efficacy|4
5139483|NCT01568892|17751104|P2|Open-label Phase|Adverse Event|0
5139484|NCT01568892|17751105|P1|Open-label Phase|Adverse Event|2
5139485|NCT01568866|17751175|P2|Overall Study|Randomized but Not Dosed|1
5139486|NCT01568866|17751176|P1|Overall Study|Randomized but Not Dosed|9
5139487|NCT01568866|17751175|P2|Overall Study|Lost to Follow-up|0
5139488|NCT01568866|17751176|P1|Overall Study|Lost to Follow-up|1
5139489|NCT01568866|17751175|P2|Overall Study|Protocol Non-compliance|4
5139490|NCT01568866|17751176|P1|Overall Study|Protocol Non-compliance|2
5139491|NCT01568866|17751175|P2|Overall Study|Death|18
5139492|NCT01568866|17751176|P1|Overall Study|Death|10
5139493|NCT01568866|17751175|P2|Overall Study|Withdrawal by Subject|11
5139494|NCT01568866|17751176|P1|Overall Study|Withdrawal by Subject|19
5139495|NCT01568866|17751175|P2|Overall Study|Physician Decision|32
5139496|NCT01568866|17751176|P1|Overall Study|Physician Decision|40
5139497|NCT01568866|17751175|P2|Overall Study|Patient Request|71
5139498|NCT01568866|17751176|P1|Overall Study|Patient Request|55
5139499|NCT01568866|17751175|P2|Overall Study|Adverse Event|96
5139500|NCT01568866|17751176|P1|Overall Study|Adverse Event|94
5139501|NCT01568866|17751175|P2|Overall Study|Disease Progression|183
5139502|NCT01568866|17751176|P1|Overall Study|Disease Progression|208
5139503|NCT01568593|17751211|P2|Overall Study|Adverse Event|2
5139504|NCT01568593|17751212|P1|Overall Study|Adverse Event|3
5139505|NCT01568593|17751211|P2|Overall Study|Lack of Efficacy|1
5139506|NCT01568593|17751212|P1|Overall Study|Lack of Efficacy|4
5139507|NCT01568112|17751257|P4|Overall Study|Withdrawal by Physician|1
5139508|NCT01568112|17751258|P3|Overall Study|Withdrawal by Physician|1
5139509|NCT01568112|17751259|P2|Overall Study|Withdrawal by Physician|0
5139510|NCT01568112|17751260|P1|Overall Study|Withdrawal by Physician|1
5139511|NCT01568112|17751257|P4|Overall Study|Withdrawal by Subject|7
5139512|NCT01568112|17751258|P3|Overall Study|Withdrawal by Subject|0
5139513|NCT01568112|17751259|P2|Overall Study|Withdrawal by Subject|3
5139514|NCT01568112|17751260|P1|Overall Study|Withdrawal by Subject|2
5139515|NCT01568112|17751257|P4|Overall Study|Lost to Follow-up|1
5139516|NCT01568112|17751258|P3|Overall Study|Lost to Follow-up|0
5139517|NCT01568112|17751259|P2|Overall Study|Lost to Follow-up|0
5139518|NCT01568112|17751260|P1|Overall Study|Lost to Follow-up|0
5139519|NCT01568112|17751257|P4|Overall Study|Withdrew due to Adverse Event|3
5139520|NCT01568112|17751258|P3|Overall Study|Withdrew due to Adverse Event|6
5139521|NCT01568112|17751259|P2|Overall Study|Withdrew due to Adverse Event|4
5139522|NCT01568112|17751260|P1|Overall Study|Withdrew due to Adverse Event|2
5139523|NCT01568112|17751257|P4|Overall Study|Randomized But Not Treated|0
5139524|NCT01568112|17751258|P3|Overall Study|Randomized But Not Treated|0
5139525|NCT01568112|17751259|P2|Overall Study|Randomized But Not Treated|1
5139526|NCT01568112|17751260|P1|Overall Study|Randomized But Not Treated|0
5139527|NCT01568047|17751418|P4|Overall Study|Adverse Event|1
5139528|NCT01568047|17751419|P3|Overall Study|Adverse Event|1
5139529|NCT01568047|17751420|P2|Overall Study|Adverse Event|0
5139530|NCT01568047|17751421|P1|Overall Study|Adverse Event|0
5139531|NCT01568047|17751418|P4|Overall Study|Withdrawal by Subject|0
5139532|NCT01568047|17751419|P3|Overall Study|Withdrawal by Subject|0
5139533|NCT01568047|17751420|P2|Overall Study|Withdrawal by Subject|1
5139534|NCT01568047|17751421|P1|Overall Study|Withdrawal by Subject|0
5139535|NCT01568047|17751418|P4|Overall Study|Ineligibility|0
5139536|NCT01568047|17751419|P3|Overall Study|Ineligibility|0
5139537|NCT01568047|17751420|P2|Overall Study|Ineligibility|0
5139538|NCT01568047|17751421|P1|Overall Study|Ineligibility|1
5139539|NCT01568034|17751439|P4|Overall Study|Withdrawal by Subject|0
5139540|NCT01568034|17751440|P3|Overall Study|Withdrawal by Subject|0
5139541|NCT01568034|17751441|P2|Overall Study|Withdrawal by Subject|0
5139542|NCT01568034|17751442|P1|Overall Study|Withdrawal by Subject|1
5139543|NCT01567865|17751505|P4|Evaluated for Immunogenicity|Missing blood sample|28
5139544|NCT01567865|17751506|P3|Evaluated for Immunogenicity|Missing blood sample|16
5139545|NCT01567865|17751507|P2|Evaluated for Immunogenicity|Missing blood sample|24
5139546|NCT01567865|17751508|P1|Evaluated for Immunogenicity|Missing blood sample|17
5139547|NCT01567865|17751505|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
5139548|NCT01567865|17751506|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
5139549|NCT01567865|17751507|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
5139550|NCT01567865|17751508|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
5139551|NCT01567852|17751538|P2|Overall Study|ECT discontinued|1
5139552|NCT01567852|17751539|P1|Overall Study|ECT discontinued|1
5139553|NCT01567852|17751538|P2|Overall Study|Withdrawal by Subject|6
5139554|NCT01567852|17751539|P1|Overall Study|Withdrawal by Subject|3
5139555|NCT01567826|17751557|P2|Overall Study|Lost to Follow-up|2
5139556|NCT01567826|17751558|P1|Overall Study|Lost to Follow-up|3
5139557|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
5139558|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
5139559|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5139560|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5139561|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5139562|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
5139563|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
5139564|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5139565|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5139566|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5139567|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
5139568|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
5139569|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5139570|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5139571|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5139572|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
5139573|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
5139574|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5139575|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5139576|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5139577|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
5139578|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
5139579|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5139580|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5139581|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5139582|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
5139583|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
5139584|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5139585|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5139586|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5139587|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
5139588|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
5139589|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5139590|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5139591|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5139592|NCT01567527|17751584|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
5139593|NCT01567527|17751585|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
5139594|NCT01567527|17751586|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5139595|NCT01567527|17751587|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5139596|NCT01567527|17751588|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5139597|NCT01567527|17751584|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
5139598|NCT01567527|17751585|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
5139599|NCT01567527|17751586|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
5139600|NCT01567527|17751587|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
5139601|NCT01567527|17751588|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
5139602|NCT01567527|17751584|P5|IM Depot Stabilization.|Adverse Event|0
5139603|NCT01567527|17751585|P4|IM Depot Stabilization.|Adverse Event|0
5139604|NCT01567527|17751586|P3|IM Depot Stabilization.|Adverse Event|37
5139605|NCT01567527|17751587|P2|IM Depot Stabilization.|Adverse Event|0
5139606|NCT01567527|17751588|P1|IM Depot Stabilization.|Adverse Event|0
5139607|NCT01567527|17751584|P5|IM Depot Stabilization.|Lack of Efficacy|0
5139608|NCT01567527|17751585|P4|IM Depot Stabilization.|Lack of Efficacy|0
5139609|NCT01567527|17751586|P3|IM Depot Stabilization.|Lack of Efficacy|7
5139610|NCT01567527|17751587|P2|IM Depot Stabilization.|Lack of Efficacy|0
5139611|NCT01567527|17751588|P1|IM Depot Stabilization.|Lack of Efficacy|0
5139612|NCT01567527|17751584|P5|IM Depot Stabilization.|Lost to Follow-up|0
5139613|NCT01567527|17751585|P4|IM Depot Stabilization.|Lost to Follow-up|0
5139614|NCT01567527|17751586|P3|IM Depot Stabilization.|Lost to Follow-up|21
5139615|NCT01567527|17751587|P2|IM Depot Stabilization.|Lost to Follow-up|0
5139616|NCT01567527|17751588|P1|IM Depot Stabilization.|Lost to Follow-up|0
5139617|NCT01567527|17751584|P5|IM Depot Stabilization.|Sponsor discontinued study|0
5139618|NCT01567527|17751585|P4|IM Depot Stabilization.|Sponsor discontinued study|0
5139619|NCT01567527|17751586|P3|IM Depot Stabilization.|Sponsor discontinued study|1
5139620|NCT01567527|17751587|P2|IM Depot Stabilization.|Sponsor discontinued study|0
5139621|NCT01567527|17751588|P1|IM Depot Stabilization.|Sponsor discontinued study|0
5139622|NCT01567527|17751584|P5|IM Depot Stabilization.|Withdrawal by Subject|0
5139623|NCT01567527|17751585|P4|IM Depot Stabilization.|Withdrawal by Subject|0
5139624|NCT01567527|17751586|P3|IM Depot Stabilization.|Withdrawal by Subject|56
5139625|NCT01567527|17751587|P2|IM Depot Stabilization.|Withdrawal by Subject|0
5139626|NCT01567527|17751588|P1|IM Depot Stabilization.|Withdrawal by Subject|0
5139627|NCT01567527|17751584|P5|IM Depot Stabilization.|Met withdrawal criteria|0
5139628|NCT01567527|17751585|P4|IM Depot Stabilization.|Met withdrawal criteria|0
5139629|NCT01567527|17751586|P3|IM Depot Stabilization.|Met withdrawal criteria|26
5139630|NCT01567527|17751587|P2|IM Depot Stabilization.|Met withdrawal criteria|0
5139631|NCT01567527|17751588|P1|IM Depot Stabilization.|Met withdrawal criteria|0
5139632|NCT01567527|17751584|P5|IM Depot Stabilization.|Protocol deviation|0
5139633|NCT01567527|17751585|P4|IM Depot Stabilization.|Protocol deviation|0
5139634|NCT01567527|17751586|P3|IM Depot Stabilization.|Protocol deviation|5
5139635|NCT01567527|17751587|P2|IM Depot Stabilization.|Protocol deviation|0
5139636|NCT01567527|17751588|P1|IM Depot Stabilization.|Protocol deviation|0
5139637|NCT01567527|17751584|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5139638|NCT01567527|17751585|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5139639|NCT01567527|17751586|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5139640|NCT01567527|17751587|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
5139641|NCT01567527|17751588|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5139642|NCT01567527|17751584|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5139643|NCT01567527|17751585|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5139644|NCT01567527|17751586|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5139645|NCT01567527|17751587|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
5139646|NCT01567527|17751588|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5139647|NCT01567527|17751584|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5139648|NCT01567527|17751585|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5139649|NCT01567527|17751586|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5139650|NCT01567527|17751587|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
5139651|NCT01567527|17751588|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5139652|NCT01567527|17751584|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5139653|NCT01567527|17751585|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5139654|NCT01567527|17751586|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5139655|NCT01567527|17751587|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
5139656|NCT01567527|17751588|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5139657|NCT01567527|17751584|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5139658|NCT01567527|17751585|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5139659|NCT01567527|17751586|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5139660|NCT01567527|17751587|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
5139661|NCT01567527|17751588|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5139662|NCT01567527|17751584|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5139663|NCT01567527|17751585|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5139664|NCT01567527|17751586|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5139665|NCT01567527|17751587|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
5139666|NCT01567527|17751588|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5139667|NCT01567527|17751584|P5|Conversion Phase.|Withdrawn by the investigator|0
5139668|NCT01567527|17751585|P4|Conversion Phase.|Withdrawn by the investigator|0
5139669|NCT01567527|17751586|P3|Conversion Phase.|Withdrawn by the investigator|0
5139670|NCT01567527|17751587|P2|Conversion Phase.|Withdrawn by the investigator|0
5139671|NCT01567527|17751588|P1|Conversion Phase.|Withdrawn by the investigator|3
5139672|NCT01567527|17751584|P5|Conversion Phase.|Adverse Event|0
5139673|NCT01567527|17751585|P4|Conversion Phase.|Adverse Event|0
5139674|NCT01567527|17751586|P3|Conversion Phase.|Adverse Event|0
5139675|NCT01567527|17751587|P2|Conversion Phase.|Adverse Event|0
5139676|NCT01567527|17751588|P1|Conversion Phase.|Adverse Event|33
5139677|NCT01567527|17751584|P5|Conversion Phase.|Lack of Efficacy|0
5139678|NCT01567527|17751585|P4|Conversion Phase.|Lack of Efficacy|0
5139679|NCT01567527|17751586|P3|Conversion Phase.|Lack of Efficacy|0
5139680|NCT01567527|17751587|P2|Conversion Phase.|Lack of Efficacy|0
5139681|NCT01567527|17751588|P1|Conversion Phase.|Lack of Efficacy|2
5139682|NCT01567527|17751584|P5|Conversion Phase.|Lost to Follow-up|0
5139683|NCT01567527|17751585|P4|Conversion Phase.|Lost to Follow-up|0
5139684|NCT01567527|17751586|P3|Conversion Phase.|Lost to Follow-up|0
5139685|NCT01567527|17751587|P2|Conversion Phase.|Lost to Follow-up|0
5139686|NCT01567527|17751588|P1|Conversion Phase.|Lost to Follow-up|16
5139687|NCT01567527|17751584|P5|Conversion Phase.|Withdrawal by Subject|0
5139688|NCT01567527|17751585|P4|Conversion Phase.|Withdrawal by Subject|0
5139689|NCT01567527|17751586|P3|Conversion Phase.|Withdrawal by Subject|0
5139690|NCT01567527|17751587|P2|Conversion Phase.|Withdrawal by Subject|0
5139691|NCT01567527|17751588|P1|Conversion Phase.|Withdrawal by Subject|32
5139692|NCT01567527|17751584|P5|Conversion Phase.|Met withdrawal criteria|0
5139693|NCT01567527|17751585|P4|Conversion Phase.|Met withdrawal criteria|0
5139694|NCT01567527|17751586|P3|Conversion Phase.|Met withdrawal criteria|0
5139695|NCT01567527|17751587|P2|Conversion Phase.|Met withdrawal criteria|0
5139696|NCT01567527|17751588|P1|Conversion Phase.|Met withdrawal criteria|10
5139697|NCT01567527|17751584|P5|Conversion Phase.|Protocol deviation|0
5139698|NCT01567527|17751585|P4|Conversion Phase.|Protocol deviation|0
5139699|NCT01567527|17751586|P3|Conversion Phase.|Protocol deviation|0
5139700|NCT01567527|17751587|P2|Conversion Phase.|Protocol deviation|0
5139701|NCT01567527|17751588|P1|Conversion Phase.|Protocol deviation|3
5139702|NCT01567462|17751605|P2|Overall Study|Withdrawal by Subject|7
5139703|NCT01567462|17751606|P1|Overall Study|Withdrawal by Subject|4
5139704|NCT01567306|17751629|P6|Overall Study|Withdrawal by Subject|1
5139705|NCT01567306|17751630|P5|Overall Study|Withdrawal by Subject|0
5139706|NCT01567306|17751631|P4|Overall Study|Withdrawal by Subject|0
5139707|NCT01567306|17751632|P3|Overall Study|Withdrawal by Subject|0
5139708|NCT01567306|17751633|P2|Overall Study|Withdrawal by Subject|0
5139709|NCT01567306|17751634|P1|Overall Study|Withdrawal by Subject|0
5139710|NCT01567306|17751629|P6|Overall Study|Lost to Follow-up|0
5139711|NCT01567306|17751630|P5|Overall Study|Lost to Follow-up|2
5139712|NCT01567306|17751631|P4|Overall Study|Lost to Follow-up|0
5139713|NCT01567306|17751632|P3|Overall Study|Lost to Follow-up|0
5139714|NCT01567306|17751633|P2|Overall Study|Lost to Follow-up|0
5139715|NCT01567306|17751634|P1|Overall Study|Lost to Follow-up|0
5139716|NCT01567306|17751629|P6|Overall Study|Adverse Event|1
5139717|NCT01567306|17751630|P5|Overall Study|Adverse Event|4
5139718|NCT01567306|17751631|P4|Overall Study|Adverse Event|2
5139719|NCT01567306|17751632|P3|Overall Study|Adverse Event|0
5139720|NCT01567306|17751633|P2|Overall Study|Adverse Event|0
5139721|NCT01567306|17751634|P1|Overall Study|Adverse Event|0
5139722|NCT01567306|17751629|P6|Overall Study|Change site living|0
5139723|NCT01567306|17751630|P5|Overall Study|Change site living|0
5139724|NCT01567306|17751631|P4|Overall Study|Change site living|0
5139725|NCT01567306|17751632|P3|Overall Study|Change site living|0
5139726|NCT01567306|17751633|P2|Overall Study|Change site living|0
5139727|NCT01567306|17751634|P1|Overall Study|Change site living|1
5139728|NCT01567306|17751629|P6|Overall Study|Protocol Violation|1
5139729|NCT01567306|17751630|P5|Overall Study|Protocol Violation|1
5139730|NCT01567306|17751631|P4|Overall Study|Protocol Violation|3
5139731|NCT01567306|17751632|P3|Overall Study|Protocol Violation|0
5139732|NCT01567306|17751633|P2|Overall Study|Protocol Violation|2
5139733|NCT01567306|17751634|P1|Overall Study|Protocol Violation|2
5139734|NCT01567163|17751648|P1|Overall Study|Lost to Follow-up|2
5139735|NCT01567163|17751648|P1|Overall Study|Progressive Disease|2
5139736|NCT01567085|17751669|P1|Overall Study|Terminal chronic kidney dysfunction|1
5139737|NCT01567085|17751669|P1|Overall Study|Returned to chronic dialysis|1
5139738|NCT01567085|17751669|P1|Overall Study|Renal transplantectomy|1
5139739|NCT01567085|17751669|P1|Overall Study|Graft loss|2
5139740|NCT01567085|17751669|P1|Overall Study|Lost to Follow-up|3
5139741|NCT01567085|17751669|P1|Overall Study|Adverse Event|6
5139742|NCT01567085|17751669|P1|Overall Study|Death|6
5139743|NCT01566981|17751706|P2|Overall Study|Lost to Follow-up|8
5139744|NCT01566981|17751707|P1|Overall Study|Lost to Follow-up|5
5139745|NCT01566773|17751736|P1|Overall Study|Physician Decision|2
5139746|NCT01566773|17751736|P1|Overall Study|Adverse Event|10
5139747|NCT01566773|17751736|P1|Overall Study|Administrative reason|1
5139748|NCT01566773|17751736|P1|Overall Study|Withdrawal by Subject|9
5139749|NCT01566773|17751736|P1|Overall Study|Protocol Violation|4
5139750|NCT01566773|17751736|P1|Overall Study|Protocol specified criteria|4
5139751|NCT01566721|17751945|P2|Overall Study|Withdrew Prior to Treatment|1
5139752|NCT01566721|17751946|P1|Overall Study|Withdrew Prior to Treatment|3
5139753|NCT01566721|17751945|P2|Overall Study|Other|4
5139754|NCT01566721|17751946|P1|Overall Study|Other|10
5139755|NCT01566721|17751945|P2|Overall Study|Death|3
5139756|NCT01566721|17751946|P1|Overall Study|Death|6
5139757|NCT01566721|17751945|P2|Overall Study|Lost to Follow-up|0
5139758|NCT01566721|17751946|P1|Overall Study|Lost to Follow-up|18
5139759|NCT01566721|17751945|P2|Overall Study|Disease Progression/Recurrence|28
5139760|NCT01566721|17751946|P1|Overall Study|Disease Progression/Recurrence|123
5139761|NCT01566721|17751945|P2|Overall Study|Withdrawal by Subject|15
5139762|NCT01566721|17751946|P1|Overall Study|Withdrawal by Subject|58
5139763|NCT01566721|17751945|P2|Overall Study|Ongoing Study|659
5139764|NCT01566721|17751946|P1|Overall Study|Ongoing Study|1649
5139765|NCT01566695|17751971|P2|Overall Study|Miscellaneous|6
5139766|NCT01566695|17751972|P1|Overall Study|Miscellaneous|4
5139767|NCT01566695|17751971|P2|Overall Study|Progressive Disease|6
5139768|NCT01566695|17751972|P1|Overall Study|Progressive Disease|11
5139769|NCT01566695|17751971|P2|Overall Study|Withdrawal by Subject|7
5139770|NCT01566695|17751972|P1|Overall Study|Withdrawal by Subject|14
5139771|NCT01566695|17751971|P2|Overall Study|Death|8
5139772|NCT01566695|17751972|P1|Overall Study|Death|20
5139773|NCT01566695|17751971|P2|Overall Study|Adverse Event|27
5139774|NCT01566695|17751972|P1|Overall Study|Adverse Event|28
5139775|NCT01566695|17751971|P2|Overall Study|Lack of Efficacy|45
5139776|NCT01566695|17751972|P1|Overall Study|Lack of Efficacy|18
5139777|NCT01566604|17752137|P2|Overall Study|Withdrawal by Subject|6
5139778|NCT01566604|17752138|P1|Overall Study|Withdrawal by Subject|9
5139779|NCT01566604|17752137|P2|Overall Study|Adverse Event|2
5139780|NCT01566604|17752138|P1|Overall Study|Adverse Event|4
5139781|NCT01566604|17752137|P2|Overall Study|Death|1
5139782|NCT01566604|17752138|P1|Overall Study|Death|4
5139783|NCT01566604|17752137|P2|Overall Study|Abnormal laboratory value|0
5139784|NCT01566604|17752138|P1|Overall Study|Abnormal laboratory value|2
5139785|NCT01566604|17752137|P2|Overall Study|Protocol deviation|0
5139786|NCT01566604|17752138|P1|Overall Study|Protocol deviation|2
5139787|NCT01566604|17752137|P2|Overall Study|Lack of Efficacy|2
5139788|NCT01566604|17752138|P1|Overall Study|Lack of Efficacy|1
5139789|NCT01566604|17752137|P2|Overall Study|Administrative problems|0
5139790|NCT01566604|17752138|P1|Overall Study|Administrative problems|1
5139791|NCT01566604|17752137|P2|Overall Study|Patient's inability to use the device|0
5139792|NCT01566604|17752138|P1|Overall Study|Patient's inability to use the device|1
5139793|NCT01566435|17752294|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
5139794|NCT01566214|17752360|P2|Overall Study|Lost to Follow-up|0
5139795|NCT01566214|17752361|P1|Overall Study|Lost to Follow-up|3
5139796|NCT01566149|17752405|P2|Overall Study|Withdrawal by Subject|0
5139797|NCT01566149|17752406|P1|Overall Study|Withdrawal by Subject|1
5139798|NCT01566149|17752405|P2|Overall Study|Protocol Violation|1
5139799|NCT01566149|17752406|P1|Overall Study|Protocol Violation|0
5139800|NCT01566149|17752405|P2|Overall Study|Non-compliance with study medication|0
5139801|NCT01566149|17752406|P1|Overall Study|Non-compliance with study medication|2
5139802|NCT01566149|17752405|P2|Overall Study|Adverse Event|1
5139803|NCT01566149|17752406|P1|Overall Study|Adverse Event|0
5139804|NCT01565993|17752439|P2|Overall Study|Physician Decision|3
5139805|NCT01565993|17752440|P1|Overall Study|Physician Decision|0
5139806|NCT01565980|17752448|P2|Overall Study|Withdrawal by Subject|3
5139807|NCT01565980|17752449|P1|Overall Study|Withdrawal by Subject|0
5139808|NCT01565980|17752448|P2|Overall Study|stopped medical treatment|0
5139809|NCT01565980|17752449|P1|Overall Study|stopped medical treatment|1
5139810|NCT01565980|17752448|P2|Overall Study|health complications|1
5139811|NCT01565980|17752449|P1|Overall Study|health complications|1
5139812|NCT01565980|17752448|P2|Overall Study|Lost to Follow-up|0
5139813|NCT01565980|17752449|P1|Overall Study|Lost to Follow-up|1
5139814|NCT01565980|17752448|P2|Overall Study|Death|0
5139815|NCT01565980|17752449|P1|Overall Study|Death|1
5139816|NCT01565941|17752469|P2|Overall Study|Randomized; did not receive intevention|2
5139817|NCT01565941|17752470|P1|Overall Study|Randomized; did not receive intevention|8
5139818|NCT01565941|17752469|P2|Overall Study|Withdrawn by parent/guardian|2
5139819|NCT01565941|17752470|P1|Overall Study|Withdrawn by parent/guardian|3
5139820|NCT01565928|17752512|P1|Overall Study|Death|2
5139821|NCT01565928|17752512|P1|Overall Study|Withdrawal by Subject|1
5139822|NCT01565928|17752512|P1|Overall Study|Progressive Disease|13
5139823|NCT01565928|17752512|P1|Overall Study|Other|3
5139824|NCT01565928|17752512|P1|Overall Study|Adverse Event|3
5139825|NCT01565889|17752566|P6|Part B|Lost to Follow-up|1
5139826|NCT01565889|17752567|P5|Part B|Lost to Follow-up|0
5139827|NCT01565889|17752568|P4|Part B|Lost to Follow-up|0
5139828|NCT01565889|17752569|P3|Part B|Lost to Follow-up|0
5139829|NCT01565889|17752570|P2|Part B|Lost to Follow-up|0
5139830|NCT01565889|17752571|P1|Part B|Lost to Follow-up|0
5139831|NCT01565889|17752566|P6|Part B|Lack of Efficacy|2
5139832|NCT01565889|17752567|P5|Part B|Lack of Efficacy|0
5139833|NCT01565889|17752568|P4|Part B|Lack of Efficacy|0
5139834|NCT01565889|17752569|P3|Part B|Lack of Efficacy|0
5139835|NCT01565889|17752570|P2|Part B|Lack of Efficacy|0
5139836|NCT01565889|17752571|P1|Part B|Lack of Efficacy|0
5139837|NCT01565889|17752566|P6|Part B|Withdrawal by Subject|1
5139838|NCT01565889|17752567|P5|Part B|Withdrawal by Subject|0
5139839|NCT01565889|17752568|P4|Part B|Withdrawal by Subject|0
5139840|NCT01565889|17752569|P3|Part B|Withdrawal by Subject|0
5139841|NCT01565889|17752570|P2|Part B|Withdrawal by Subject|0
5139842|NCT01565889|17752571|P1|Part B|Withdrawal by Subject|0
5139843|NCT01565889|17752566|P6|Part A|Withdrawal by Subject|0
5139844|NCT01565889|17752567|P5|Part A|Withdrawal by Subject|0
5139845|NCT01565889|17752568|P4|Part A|Withdrawal by Subject|0
5139846|NCT01565889|17752569|P3|Part A|Withdrawal by Subject|0
5139847|NCT01565889|17752570|P2|Part A|Withdrawal by Subject|0
5139848|NCT01565889|17752571|P1|Part A|Withdrawal by Subject|1
5139849|NCT01565850|17752602|P2|Overall Study|Withdrew Consent|2
5139850|NCT01565850|17752603|P1|Overall Study|Withdrew Consent|4
5139851|NCT01565850|17752602|P2|Overall Study|Participant noncompliance|0
5139852|NCT01565850|17752603|P1|Overall Study|Participant noncompliance|2
5139853|NCT01565850|17752602|P2|Overall Study|Investigator's Discretion|1
5139854|NCT01565850|17752603|P1|Overall Study|Investigator's Discretion|2
5139855|NCT01565850|17752602|P2|Overall Study|Lost to Follow-up|4
5139856|NCT01565850|17752603|P1|Overall Study|Lost to Follow-up|12
5139857|NCT01565850|17752602|P2|Overall Study|Adverse Event|1
5139858|NCT01565850|17752603|P1|Overall Study|Adverse Event|0
5139859|NCT01565707|17752623|P4|Overall Study|Miscellaneous|2
5139860|NCT01565707|17752624|P3|Overall Study|Miscellaneous|0
5139861|NCT01565707|17752625|P2|Overall Study|Miscellaneous|1
5139862|NCT01565707|17752626|P1|Overall Study|Miscellaneous|1
5139863|NCT01565707|17752623|P4|Overall Study|Randomized but not evaluable|0
5139864|NCT01565707|17752624|P3|Overall Study|Randomized but not evaluable|0
5139865|NCT01565707|17752625|P2|Overall Study|Randomized but not evaluable|0
5139866|NCT01565707|17752626|P1|Overall Study|Randomized but not evaluable|2
5139867|NCT01565707|17752623|P4|Overall Study|Withdrawal by Subject|1
5139868|NCT01565707|17752624|P3|Overall Study|Withdrawal by Subject|1
5139869|NCT01565707|17752625|P2|Overall Study|Withdrawal by Subject|1
5139870|NCT01565707|17752626|P1|Overall Study|Withdrawal by Subject|3
5139871|NCT01565707|17752623|P4|Overall Study|Protocol Violation|1
5139872|NCT01565707|17752624|P3|Overall Study|Protocol Violation|0
5139873|NCT01565707|17752625|P2|Overall Study|Protocol Violation|0
5139874|NCT01565707|17752626|P1|Overall Study|Protocol Violation|1
5139875|NCT01565707|17752623|P4|Overall Study|Lost to Follow-up|0
5139876|NCT01565707|17752624|P3|Overall Study|Lost to Follow-up|0
5139877|NCT01565707|17752625|P2|Overall Study|Lost to Follow-up|0
5139878|NCT01565707|17752626|P1|Overall Study|Lost to Follow-up|1
5139879|NCT01565707|17752623|P4|Overall Study|Adverse Event|1
5139880|NCT01565707|17752624|P3|Overall Study|Adverse Event|2
5139881|NCT01565707|17752625|P2|Overall Study|Adverse Event|6
5139882|NCT01565707|17752626|P1|Overall Study|Adverse Event|1
5139883|NCT01565694|17752717|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
5139884|NCT01565694|17752717|P1|Dose-Titration Period|Protocol Violation|10
5139885|NCT01565694|17752717|P1|Dose-Titration Period|Adverse Event|4
5139886|NCT01565668|17752738|P2|Overall Study|HSCT Transplant|15
5139887|NCT01565668|17752739|P1|Overall Study|HSCT Transplant|11
5139888|NCT01565668|17752738|P2|Overall Study|Withdrawal by Subject|3
5139889|NCT01565668|17752739|P1|Overall Study|Withdrawal by Subject|1
5139890|NCT01565668|17752738|P2|Overall Study|Progressive disease|14
5139891|NCT01565668|17752739|P1|Overall Study|Progressive disease|13
5139892|NCT01565668|17752738|P2|Overall Study|Randomized, but never received drug|2
5139893|NCT01565668|17752739|P1|Overall Study|Randomized, but never received drug|0
5139894|NCT01565668|17752738|P2|Overall Study|Adverse Event|1
5139895|NCT01565668|17752739|P1|Overall Study|Adverse Event|6
5139896|NCT01565668|17752738|P2|Overall Study|Participant went on Hospice Care|0
5139897|NCT01565668|17752739|P1|Overall Study|Participant went on Hospice Care|1
5139898|NCT01565668|17752738|P2|Overall Study|Lack of Efficacy|2
5139899|NCT01565668|17752739|P1|Overall Study|Lack of Efficacy|4
5139900|NCT01565668|17752738|P2|Overall Study|Death|1
5139901|NCT01565668|17752739|P1|Overall Study|Death|2
5139902|NCT01565642|17752763|P2|Overall Study|Withdrawal by Subject|1
5139903|NCT01565642|17752764|P1|Overall Study|Withdrawal by Subject|2
5139904|NCT01565564|17752799|P2|Overall Study|Lost to Follow-up|1
5139905|NCT01565564|17752800|P1|Overall Study|Lost to Follow-up|5
5139906|NCT01565499|17752830|P1|Overall Study|Withdrawal by Subject|2
5139907|NCT01565499|17752830|P1|Overall Study|Adverse Event|5
5139908|NCT01565499|17752830|P1|Overall Study|Physician Decision|1
5139909|NCT01565343|17752864|P3|Overall Study|Administrative decision/technical issues|0
5139910|NCT01565343|17752865|P2|Overall Study|Administrative decision/technical issues|0
5139911|NCT01565343|17752866|P1|Overall Study|Administrative decision/technical issues|1
5139912|NCT01565291|17752896|P2|Overall Study|Withdrawal by Subject|0
5139913|NCT01565291|17752897|P1|Overall Study|Withdrawal by Subject|1
5139914|NCT01565148|17752909|P4|Overall Study|Physician Decision|0
5139915|NCT01565148|17752910|P3|Overall Study|Physician Decision|0
5139916|NCT01565148|17752911|P2|Overall Study|Physician Decision|5
5139917|NCT01565148|17752912|P1|Overall Study|Physician Decision|2
5139918|NCT01565148|17752909|P4|Overall Study|Death|0
5139919|NCT01565148|17752910|P3|Overall Study|Death|1
5139920|NCT01565148|17752911|P2|Overall Study|Death|0
5139921|NCT01565148|17752912|P1|Overall Study|Death|0
5139922|NCT01565148|17752909|P4|Overall Study|Rescue Therapy|8
5139923|NCT01565148|17752910|P3|Overall Study|Rescue Therapy|5
5139924|NCT01565148|17752911|P2|Overall Study|Rescue Therapy|5
5139925|NCT01565148|17752912|P1|Overall Study|Rescue Therapy|8
5139926|NCT01565148|17752909|P4|Overall Study|Lost to Follow-up|3
5139927|NCT01565148|17752910|P3|Overall Study|Lost to Follow-up|0
5139928|NCT01565148|17752911|P2|Overall Study|Lost to Follow-up|4
5139929|NCT01565148|17752912|P1|Overall Study|Lost to Follow-up|4
5139930|NCT01565148|17752909|P4|Overall Study|Withdrawal by Subject|2
5139931|NCT01565148|17752910|P3|Overall Study|Withdrawal by Subject|1
5139932|NCT01565148|17752911|P2|Overall Study|Withdrawal by Subject|1
5139933|NCT01565148|17752912|P1|Overall Study|Withdrawal by Subject|1
5139934|NCT01565083|17752948|P2|Overall Study|Other|5
5139935|NCT01565083|17752949|P1|Overall Study|Other|3
5139936|NCT01565083|17752948|P2|Overall Study|Death|23
5139937|NCT01565083|17752949|P1|Overall Study|Death|22
5139938|NCT01565083|17752948|P2|Overall Study|Lost to Follow-up|7
5139939|NCT01565083|17752949|P1|Overall Study|Lost to Follow-up|2
5139940|NCT01565083|17752948|P2|Overall Study|Withdrawal by Subject|4
5139941|NCT01565083|17752949|P1|Overall Study|Withdrawal by Subject|6
5139942|NCT01564862|17753000|P3|Overall Study|Other reason(s)|0
5139943|NCT01564862|17753001|P2|Overall Study|Other reason(s)|0
5139944|NCT01564862|17753002|P1|Overall Study|Other reason(s)|1
5139945|NCT01564862|17753000|P3|Overall Study|Lack of Efficacy|6
5139946|NCT01564862|17753001|P2|Overall Study|Lack of Efficacy|5
5139947|NCT01564862|17753002|P1|Overall Study|Lack of Efficacy|1
5139948|NCT01564862|17753000|P3|Overall Study|Voluntary Withdrawal|8
5139949|NCT01564862|17753001|P2|Overall Study|Voluntary Withdrawal|6
5139950|NCT01564862|17753002|P1|Overall Study|Voluntary Withdrawal|9
5139951|NCT01564862|17753000|P3|Overall Study|Lost to Follow-up|6
5139952|NCT01564862|17753001|P2|Overall Study|Lost to Follow-up|8
5139953|NCT01564862|17753002|P1|Overall Study|Lost to Follow-up|10
5139954|NCT01564862|17753000|P3|Overall Study|Major Protocol Deviation|4
5139955|NCT01564862|17753001|P2|Overall Study|Major Protocol Deviation|3
5139956|NCT01564862|17753002|P1|Overall Study|Major Protocol Deviation|3
5139957|NCT01564862|17753000|P3|Overall Study|Pretreatment Event or Adverse Event|6
5139958|NCT01564862|17753001|P2|Overall Study|Pretreatment Event or Adverse Event|12
5139959|NCT01564862|17753002|P1|Overall Study|Pretreatment Event or Adverse Event|6
5139960|NCT01564784|17753053|P2|Overall Study|Death|126
5139961|NCT01564784|17753054|P1|Overall Study|Death|131
5139962|NCT01564784|17753053|P2|Overall Study|Lost to Follow-up|1
5139963|NCT01564784|17753054|P1|Overall Study|Lost to Follow-up|1
5139964|NCT01564784|17753053|P2|Overall Study|Subject refused further follow-up|6
5139965|NCT01564784|17753054|P1|Overall Study|Subject refused further follow-up|1
5139966|NCT01564784|17753053|P2|Overall Study|Other|0
5139967|NCT01564784|17753054|P1|Overall Study|Other|1
5139968|NCT01564758|17753081|P1|Overall Study|Other|3
5139969|NCT01564758|17753081|P1|Overall Study|Adverse Event|3
5139970|NCT01564758|17753081|P1|Overall Study|Death|8
5139971|NCT01564732|17753088|P2|Overall Study|Early termination by the study sponsor|5
5139972|NCT01564732|17753089|P1|Overall Study|Early termination by the study sponsor|6
5139973|NCT01564537|17753130|P2|Overall Study|Other Miscellaneous Reasons|2
5139974|NCT01564537|17753131|P1|Overall Study|Other Miscellaneous Reasons|1
5139975|NCT01564537|17753130|P2|Overall Study|Lost to Follow-up|0
5139976|NCT01564537|17753131|P1|Overall Study|Lost to Follow-up|1
5139977|NCT01564537|17753130|P2|Overall Study|Withdrawal by Participant|4
5139978|NCT01564537|17753131|P1|Overall Study|Withdrawal by Participant|4
5139979|NCT01564459|17753154|P3|Double-blind Treatment|Adverse Event|1
5139980|NCT01564459|17753155|P2|Double-blind Treatment|Adverse Event|0
5139981|NCT01564459|17753156|P1|Double-blind Treatment|Adverse Event|0
5139982|NCT01564459|17753154|P3|Run-In|Withdrawal by Subject|0
5139983|NCT01564459|17753155|P2|Run-In|Withdrawal by Subject|0
5139984|NCT01564459|17753156|P1|Run-In|Withdrawal by Subject|1
5139985|NCT01564459|17753154|P3|Run-In|Protocol Violation|0
5139986|NCT01564459|17753155|P2|Run-In|Protocol Violation|0
5139987|NCT01564459|17753156|P1|Run-In|Protocol Violation|1
5139988|NCT01564459|17753154|P3|Run-In|Non-compliance with study drug|0
5139989|NCT01564459|17753155|P2|Run-In|Non-compliance with study drug|0
5139990|NCT01564459|17753156|P1|Run-In|Non-compliance with study drug|2
5139991|NCT01564459|17753154|P3|Run-In|Lost to Follow-up|0
5139992|NCT01564459|17753155|P2|Run-In|Lost to Follow-up|0
5139993|NCT01564459|17753156|P1|Run-In|Lost to Follow-up|1
5139994|NCT01564459|17753154|P3|Run-In|Adverse Event|0
5139995|NCT01564459|17753155|P2|Run-In|Adverse Event|0
5139996|NCT01564459|17753156|P1|Run-In|Adverse Event|7
5139997|NCT01564407|17753180|P5|Overall Study|funding lost, study ended|0
5139998|NCT01564407|17753181|P4|Overall Study|funding lost, study ended|1
5139999|NCT01564407|17753182|P3|Overall Study|funding lost, study ended|0
5140000|NCT01564407|17753183|P2|Overall Study|funding lost, study ended|0
5140001|NCT01564407|17753184|P1|Overall Study|funding lost, study ended|0
5140002|NCT01564407|17753180|P5|Overall Study|Withdrawal by Subject|0
5140003|NCT01564407|17753181|P4|Overall Study|Withdrawal by Subject|0
5140004|NCT01564407|17753182|P3|Overall Study|Withdrawal by Subject|0
5140005|NCT01564407|17753183|P2|Overall Study|Withdrawal by Subject|1
5140006|NCT01564407|17753184|P1|Overall Study|Withdrawal by Subject|0
5140007|NCT01564407|17753180|P5|Overall Study|Lost to Follow-up|0
5140008|NCT01564407|17753181|P4|Overall Study|Lost to Follow-up|0
5140009|NCT01564407|17753182|P3|Overall Study|Lost to Follow-up|0
5140010|NCT01564407|17753183|P2|Overall Study|Lost to Follow-up|1
5140011|NCT01564407|17753184|P1|Overall Study|Lost to Follow-up|0
5140012|NCT01564394|17753225|P2|Overall Study|Withdrawal by Subject|10
5140013|NCT01564394|17753226|P1|Overall Study|Withdrawal by Subject|6
5140014|NCT01564277|17753240|P2|Overall Study|Physician Decision|0
5140015|NCT01564277|17753241|P1|Overall Study|Physician Decision|1
5140016|NCT01564277|17753240|P2|Overall Study|Protocol Violation|1
5140017|NCT01564277|17753241|P1|Overall Study|Protocol Violation|0
5140018|NCT01563978|17753259|P2|Overall Study|Adverse Event|2
5140019|NCT01563978|17753260|P1|Overall Study|Adverse Event|1
5140020|NCT01563978|17753259|P2|Overall Study|Dev. of study specific discont. criteria|0
5140021|NCT01563978|17753260|P1|Overall Study|Dev. of study specific discont. criteria|1
5140022|NCT01563978|17753259|P2|Overall Study|Lost to Follow-up|0
5140023|NCT01563978|17753260|P1|Overall Study|Lost to Follow-up|1
5140024|NCT01563978|17753259|P2|Overall Study|Physician Decision|0
5140025|NCT01563978|17753260|P1|Overall Study|Physician Decision|1
5140026|NCT01563913|17753286|P2|Overall Study|Spouse Passed Away|0
5140027|NCT01563913|17753287|P1|Overall Study|Spouse Passed Away|1
5140028|NCT01563913|17753286|P2|Overall Study|Physician Decision|0
5140029|NCT01563913|17753287|P1|Overall Study|Physician Decision|1
5140030|NCT01563536|17753299|P2|Overall Study|Lost to Follow-up|0
5140031|NCT01563536|17753300|P1|Overall Study|Lost to Follow-up|1
5140032|NCT01563536|17753299|P2|Overall Study|Withdrawal by Subject|2
5140033|NCT01563536|17753300|P1|Overall Study|Withdrawal by Subject|0
5140034|NCT01563185|17753359|P1|Overall Study|Non-Compliance with study drug|1
5140035|NCT01563185|17753359|P1|Overall Study|Withdrawal by Subject|1
5140036|NCT01563172|17753373|P1|Overall Study|Other (Not specified)|1
5140037|NCT01563172|17753373|P1|Overall Study|Other (Protocol deviation)|5
5140038|NCT01563172|17753373|P1|Overall Study|Lost to Follow-up|2
5140039|NCT01563172|17753373|P1|Overall Study|Adverse Event|5
5140040|NCT01563029|17753479|P5|Overall Study|Withdrawal by Subject|3
5140041|NCT01563029|17753480|P4|Overall Study|Withdrawal by Subject|4
5140042|NCT01563029|17753481|P3|Overall Study|Withdrawal by Subject|3
5140043|NCT01563029|17753482|P2|Overall Study|Withdrawal by Subject|1
5140044|NCT01563029|17753483|P1|Overall Study|Withdrawal by Subject|4
5140045|NCT01563029|17753479|P5|Overall Study|Physician Decision|2
5140046|NCT01563029|17753480|P4|Overall Study|Physician Decision|4
5140047|NCT01563029|17753481|P3|Overall Study|Physician Decision|2
5140048|NCT01563029|17753482|P2|Overall Study|Physician Decision|5
5140049|NCT01563029|17753483|P1|Overall Study|Physician Decision|3
5140050|NCT01563029|17753479|P5|Overall Study|Lost to Follow-up|1
5140051|NCT01563029|17753480|P4|Overall Study|Lost to Follow-up|1
5140052|NCT01563029|17753481|P3|Overall Study|Lost to Follow-up|1
5140053|NCT01563029|17753482|P2|Overall Study|Lost to Follow-up|0
5140054|NCT01563029|17753483|P1|Overall Study|Lost to Follow-up|1
5140055|NCT01563029|17753479|P5|Overall Study|Protocol defined stopping criteria|0
5140056|NCT01563029|17753480|P4|Overall Study|Protocol defined stopping criteria|0
5140057|NCT01563029|17753481|P3|Overall Study|Protocol defined stopping criteria|0
5140058|NCT01563029|17753482|P2|Overall Study|Protocol defined stopping criteria|0
5140059|NCT01563029|17753483|P1|Overall Study|Protocol defined stopping criteria|1
5140060|NCT01563029|17753479|P5|Overall Study|Protocol Violation|3
5140061|NCT01563029|17753480|P4|Overall Study|Protocol Violation|1
5140062|NCT01563029|17753481|P3|Overall Study|Protocol Violation|3
5140063|NCT01563029|17753482|P2|Overall Study|Protocol Violation|2
5140064|NCT01563029|17753483|P1|Overall Study|Protocol Violation|1
5140065|NCT01563029|17753479|P5|Overall Study|Lack of Efficacy|19
5140066|NCT01563029|17753480|P4|Overall Study|Lack of Efficacy|21
5140067|NCT01563029|17753481|P3|Overall Study|Lack of Efficacy|23
5140068|NCT01563029|17753482|P2|Overall Study|Lack of Efficacy|16
5140069|NCT01563029|17753483|P1|Overall Study|Lack of Efficacy|42
5140070|NCT01563029|17753479|P5|Overall Study|Adverse Event|1
5140071|NCT01563029|17753480|P4|Overall Study|Adverse Event|2
5140072|NCT01563029|17753481|P3|Overall Study|Adverse Event|1
5140073|NCT01563029|17753482|P2|Overall Study|Adverse Event|0
5140074|NCT01563029|17753483|P1|Overall Study|Adverse Event|1
5140075|NCT01562873|17753549|P2|Overall Study|Clinical PD and adverse event|0
5140076|NCT01562873|17753550|P1|Overall Study|Clinical PD and adverse event|1
5140077|NCT01562873|17753549|P2|Overall Study|Clinical Disease Progression|0
5140078|NCT01562873|17753550|P1|Overall Study|Clinical Disease Progression|9
5140079|NCT01562873|17753549|P2|Overall Study|Adverse Event|0
5140080|NCT01562873|17753550|P1|Overall Study|Adverse Event|1
5140081|NCT01562873|17753549|P2|Overall Study|Disease Progression per RECIST|0
5140082|NCT01562873|17753550|P1|Overall Study|Disease Progression per RECIST|10
5140083|NCT01562782|17753559|P2|Overall Study|screen failure|2
5140084|NCT01562782|17753560|P1|Overall Study|screen failure|1
5140085|NCT01562782|17753559|P2|Overall Study|Withdrawal by Subject|3
5140086|NCT01562782|17753560|P1|Overall Study|Withdrawal by Subject|3
5140087|NCT01562743|17753589|P1|Overall Study|Physician Decision|2
5140088|NCT01562743|17753589|P1|Overall Study|Lost to Follow-up|2
5140089|NCT01562743|17753589|P1|Overall Study|Discontinuation criteria|2
5140090|NCT01562743|17753589|P1|Overall Study|Protocol Violation|1
5140091|NCT01562743|17753589|P1|Overall Study|Withdrawal by Subject|13
5140092|NCT01562743|17753589|P1|Overall Study|Lack of Efficacy|3
5140093|NCT01562743|17753589|P1|Overall Study|Adverse Event|29
5140094|NCT01562613|17753608|P1|Overall Study|Withdrawal by Subject|2
5140095|NCT01562613|17753608|P1|Overall Study|Lost to Follow-up|2
5140096|NCT01562548|17753618|P4|Overall Study|Lost to Follow-up|0
5140097|NCT01562548|17753619|P3|Overall Study|Lost to Follow-up|1
5140098|NCT01562548|17753620|P2|Overall Study|Lost to Follow-up|0
5140099|NCT01562548|17753621|P1|Overall Study|Lost to Follow-up|0
5140100|NCT01562444|17753674|P3|Overall Study|Protocol forbidden medication|0
5140101|NCT01562444|17753675|P2|Overall Study|Protocol forbidden medication|0
5140102|NCT01562444|17753676|P1|Overall Study|Protocol forbidden medication|1
5140103|NCT01562444|17753674|P3|Overall Study|Protocol forbidden concomitant vaccine|1
5140104|NCT01562444|17753675|P2|Overall Study|Protocol forbidden concomitant vaccine|0
5140105|NCT01562444|17753676|P1|Overall Study|Protocol forbidden concomitant vaccine|1
5140106|NCT01562444|17753674|P3|Overall Study|Unavailable serological results|2
5140107|NCT01562444|17753675|P2|Overall Study|Unavailable serological results|2
5140108|NCT01562444|17753676|P1|Overall Study|Unavailable serological results|0
5140109|NCT01562444|17753674|P3|Overall Study|Did not comply with blood draw schedule|1
5140110|NCT01562444|17753675|P2|Overall Study|Did not comply with blood draw schedule|0
5140111|NCT01562444|17753676|P1|Overall Study|Did not comply with blood draw schedule|1
5140112|NCT01562444|17753674|P3|Overall Study|Did not meet entry criteria|3
5140113|NCT01562444|17753675|P2|Overall Study|Did not meet entry criteria|0
5140114|NCT01562444|17753676|P1|Overall Study|Did not meet entry criteria|2
5140115|NCT01562327|17753942|P1|Overall Study|Infusion not received at 6 month window|4
5140116|NCT01562327|17753942|P1|Overall Study|Participant drop-out|1
5140117|NCT01562327|17753942|P1|Overall Study|Lack of Efficacy|1
5140118|NCT01562327|17753942|P1|Overall Study|Adverse Event|2
5140119|NCT01562314|17753972|P2|Overall Study|Withdrawal by Subject|1
5140120|NCT01562314|17753973|P1|Overall Study|Withdrawal by Subject|0
5140121|NCT01562314|17753972|P2|Overall Study|Met Withdrawal Criteria|2
5140122|NCT01562314|17753973|P1|Overall Study|Met Withdrawal Criteria|3
5140123|NCT01562314|17753972|P2|Overall Study|Adverse Event|5
5140124|NCT01562314|17753973|P1|Overall Study|Adverse Event|10
5140125|NCT01562275|17754030|P13|Stage 2|Progression of Disease|4
5140126|NCT01562275|17754031|P12|Stage 2|Progression of Disease|12
5140127|NCT01562275|17754032|P11|Stage 2|Progression of Disease|0
5140128|NCT01562275|17754033|P10|Stage 2|Progression of Disease|0
5140129|NCT01562275|17754034|P9|Stage 2|Progression of Disease|0
5140130|NCT01562275|17754035|P8|Stage 2|Progression of Disease|0
5140131|NCT01562275|17754036|P7|Stage 2|Progression of Disease|0
5140132|NCT01562275|17754037|P6|Stage 2|Progression of Disease|0
5140133|NCT01562275|17754038|P5|Stage 2|Progression of Disease|0
5140134|NCT01562275|17754039|P4|Stage 2|Progression of Disease|0
5140135|NCT01562275|17754040|P3|Stage 2|Progression of Disease|0
5140136|NCT01562275|17754041|P2|Stage 2|Progression of Disease|0
5140137|NCT01562275|17754042|P1|Stage 2|Progression of Disease|0
5140138|NCT01562275|17754030|P13|Stage 2|Death|1
5140139|NCT01562275|17754031|P12|Stage 2|Death|2
5140140|NCT01562275|17754032|P11|Stage 2|Death|0
5140141|NCT01562275|17754033|P10|Stage 2|Death|0
5140142|NCT01562275|17754034|P9|Stage 2|Death|0
5140143|NCT01562275|17754035|P8|Stage 2|Death|0
5140144|NCT01562275|17754036|P7|Stage 2|Death|0
5140145|NCT01562275|17754037|P6|Stage 2|Death|0
5140146|NCT01562275|17754038|P5|Stage 2|Death|0
5140147|NCT01562275|17754039|P4|Stage 2|Death|0
5140148|NCT01562275|17754040|P3|Stage 2|Death|0
5140149|NCT01562275|17754041|P2|Stage 2|Death|0
5140150|NCT01562275|17754042|P1|Stage 2|Death|0
5140151|NCT01562275|17754030|P13|Stage 1|Withdrawal by Subject|0
5140152|NCT01562275|17754031|P12|Stage 1|Withdrawal by Subject|0
5140153|NCT01562275|17754032|P11|Stage 1|Withdrawal by Subject|0
5140154|NCT01562275|17754033|P10|Stage 1|Withdrawal by Subject|1
5140155|NCT01562275|17754034|P9|Stage 1|Withdrawal by Subject|0
5140156|NCT01562275|17754035|P8|Stage 1|Withdrawal by Subject|0
5140157|NCT01562275|17754036|P7|Stage 1|Withdrawal by Subject|1
5140158|NCT01562275|17754037|P6|Stage 1|Withdrawal by Subject|0
5140159|NCT01562275|17754038|P5|Stage 1|Withdrawal by Subject|0
5140160|NCT01562275|17754039|P4|Stage 1|Withdrawal by Subject|2
5140161|NCT01562275|17754040|P3|Stage 1|Withdrawal by Subject|0
5140162|NCT01562275|17754041|P2|Stage 1|Withdrawal by Subject|1
5140163|NCT01562275|17754042|P1|Stage 1|Withdrawal by Subject|0
5140164|NCT01562275|17754030|P13|Stage 1|Progression of Disease|0
5140165|NCT01562275|17754031|P12|Stage 1|Progression of Disease|0
5140166|NCT01562275|17754032|P11|Stage 1|Progression of Disease|3
5140167|NCT01562275|17754033|P10|Stage 1|Progression of Disease|5
5140168|NCT01562275|17754034|P9|Stage 1|Progression of Disease|2
5140169|NCT01562275|17754035|P8|Stage 1|Progression of Disease|7
5140170|NCT01562275|17754036|P7|Stage 1|Progression of Disease|1
5140171|NCT01562275|17754037|P6|Stage 1|Progression of Disease|4
5140172|NCT01562275|17754038|P5|Stage 1|Progression of Disease|2
5140173|NCT01562275|17754039|P4|Stage 1|Progression of Disease|1
5140174|NCT01562275|17754040|P3|Stage 1|Progression of Disease|2
5140175|NCT01562275|17754041|P2|Stage 1|Progression of Disease|6
5140176|NCT01562275|17754042|P1|Stage 1|Progression of Disease|2
5140177|NCT01562275|17754030|P13|Stage 1|Physician Decision|0
5140178|NCT01562275|17754031|P12|Stage 1|Physician Decision|0
5140179|NCT01562275|17754032|P11|Stage 1|Physician Decision|0
5140180|NCT01562275|17754033|P10|Stage 1|Physician Decision|0
5140181|NCT01562275|17754034|P9|Stage 1|Physician Decision|1
5140182|NCT01562275|17754035|P8|Stage 1|Physician Decision|0
5140183|NCT01562275|17754036|P7|Stage 1|Physician Decision|1
5140184|NCT01562275|17754037|P6|Stage 1|Physician Decision|0
5140185|NCT01562275|17754038|P5|Stage 1|Physician Decision|1
5140186|NCT01562275|17754039|P4|Stage 1|Physician Decision|0
5140187|NCT01562275|17754040|P3|Stage 1|Physician Decision|0
5140188|NCT01562275|17754041|P2|Stage 1|Physician Decision|0
5140189|NCT01562275|17754042|P1|Stage 1|Physician Decision|0
5140190|NCT01562275|17754030|P13|Stage 1|Non Compliance|0
5140191|NCT01562275|17754031|P12|Stage 1|Non Compliance|0
5140192|NCT01562275|17754032|P11|Stage 1|Non Compliance|0
5140193|NCT01562275|17754033|P10|Stage 1|Non Compliance|0
5140194|NCT01562275|17754034|P9|Stage 1|Non Compliance|0
5140195|NCT01562275|17754035|P8|Stage 1|Non Compliance|0
5140196|NCT01562275|17754036|P7|Stage 1|Non Compliance|0
5140197|NCT01562275|17754037|P6|Stage 1|Non Compliance|0
5140198|NCT01562275|17754038|P5|Stage 1|Non Compliance|0
5140199|NCT01562275|17754039|P4|Stage 1|Non Compliance|0
5140200|NCT01562275|17754040|P3|Stage 1|Non Compliance|1
5140201|NCT01562275|17754041|P2|Stage 1|Non Compliance|0
5140202|NCT01562275|17754042|P1|Stage 1|Non Compliance|0
5140203|NCT01562275|17754030|P13|Stage 1|Death|0
5140204|NCT01562275|17754031|P12|Stage 1|Death|0
5140205|NCT01562275|17754032|P11|Stage 1|Death|0
5140206|NCT01562275|17754033|P10|Stage 1|Death|0
5140207|NCT01562275|17754034|P9|Stage 1|Death|0
5140208|NCT01562275|17754035|P8|Stage 1|Death|0
5140209|NCT01562275|17754036|P7|Stage 1|Death|0
5140210|NCT01562275|17754037|P6|Stage 1|Death|0
5140211|NCT01562275|17754038|P5|Stage 1|Death|0
5140212|NCT01562275|17754039|P4|Stage 1|Death|0
5140213|NCT01562275|17754040|P3|Stage 1|Death|0
5140214|NCT01562275|17754041|P2|Stage 1|Death|0
5140215|NCT01562275|17754042|P1|Stage 1|Death|1
5140216|NCT01562275|17754030|P13|Stage 1|Adverse Event|0
5140217|NCT01562275|17754031|P12|Stage 1|Adverse Event|0
5140218|NCT01562275|17754032|P11|Stage 1|Adverse Event|0
5140219|NCT01562275|17754033|P10|Stage 1|Adverse Event|1
5140220|NCT01562275|17754034|P9|Stage 1|Adverse Event|0
5140221|NCT01562275|17754035|P8|Stage 1|Adverse Event|0
5140222|NCT01562275|17754036|P7|Stage 1|Adverse Event|0
5140223|NCT01562275|17754037|P6|Stage 1|Adverse Event|0
5140224|NCT01562275|17754038|P5|Stage 1|Adverse Event|1
5140225|NCT01562275|17754039|P4|Stage 1|Adverse Event|1
5140226|NCT01562275|17754040|P3|Stage 1|Adverse Event|0
5140227|NCT01562275|17754041|P2|Stage 1|Adverse Event|0
5140228|NCT01562275|17754042|P1|Stage 1|Adverse Event|0
5140229|NCT01562028|17754183|P2|Overall Study|Lost to Follow-up|1
5140230|NCT01562028|17754184|P1|Overall Study|Lost to Follow-up|2
5140231|NCT01562028|17754183|P2|Overall Study|Withdrawal by Subject|1
5140232|NCT01562028|17754184|P1|Overall Study|Withdrawal by Subject|1
5140233|NCT01561989|17754204|P2|Overall Study|accural target not met.|6
5140234|NCT01561989|17754205|P1|Overall Study|accural target not met.|5
5140235|NCT01561976|17754227|P6|Washout Period 2 (7 Days)|Non-compliance|0
5140236|NCT01561976|17754228|P5|Washout Period 2 (7 Days)|Non-compliance|0
5140237|NCT01561976|17754229|P4|Washout Period 2 (7 Days)|Non-compliance|0
5140238|NCT01561976|17754230|P3|Washout Period 2 (7 Days)|Non-compliance|1
5140239|NCT01561976|17754231|P2|Washout Period 2 (7 Days)|Non-compliance|0
5140240|NCT01561976|17754232|P1|Washout Period 2 (7 Days)|Non-compliance|1
5140241|NCT01561976|17754227|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5140242|NCT01561976|17754228|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5140243|NCT01561976|17754229|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5140244|NCT01561976|17754230|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5140245|NCT01561976|17754231|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5140246|NCT01561976|17754232|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5140247|NCT01561976|17754227|P6|Washout Period 1 (7 Days)|Adverse Event|0
5140248|NCT01561976|17754228|P5|Washout Period 1 (7 Days)|Adverse Event|0
5140249|NCT01561976|17754229|P4|Washout Period 1 (7 Days)|Adverse Event|1
5140250|NCT01561976|17754230|P3|Washout Period 1 (7 Days)|Adverse Event|0
5140251|NCT01561976|17754231|P2|Washout Period 1 (7 Days)|Adverse Event|0
5140252|NCT01561976|17754232|P1|Washout Period 1 (7 Days)|Adverse Event|0
5140253|NCT01561976|17754227|P6|Period 1|Adverse Event|0
5140254|NCT01561976|17754228|P5|Period 1|Adverse Event|0
5140255|NCT01561976|17754229|P4|Period 1|Adverse Event|0
5140256|NCT01561976|17754230|P3|Period 1|Adverse Event|1
5140257|NCT01561976|17754231|P2|Period 1|Adverse Event|0
5140258|NCT01561976|17754232|P1|Period 1|Adverse Event|0
5140259|NCT01561898|17754265|P4|Overall Study|Physician Decision|1
5140260|NCT01561898|17754266|P3|Overall Study|Physician Decision|7
5140261|NCT01561898|17754267|P2|Overall Study|Physician Decision|5
5140262|NCT01561898|17754268|P1|Overall Study|Physician Decision|1
5140263|NCT01561898|17754265|P4|Overall Study|Adverse Event|9
5140264|NCT01561898|17754266|P3|Overall Study|Adverse Event|14
5140265|NCT01561898|17754267|P2|Overall Study|Adverse Event|19
5140266|NCT01561898|17754268|P1|Overall Study|Adverse Event|1
5140267|NCT01561898|17754265|P4|Overall Study|Lost to Follow-up|0
5140268|NCT01561898|17754266|P3|Overall Study|Lost to Follow-up|1
5140269|NCT01561898|17754267|P2|Overall Study|Lost to Follow-up|0
5140270|NCT01561898|17754268|P1|Overall Study|Lost to Follow-up|0
5140271|NCT01561898|17754265|P4|Overall Study|Worsening of complications|0
5140272|NCT01561898|17754266|P3|Overall Study|Worsening of complications|0
5140273|NCT01561898|17754267|P2|Overall Study|Worsening of complications|1
5140274|NCT01561898|17754268|P1|Overall Study|Worsening of complications|0
5140275|NCT01561898|17754265|P4|Overall Study|Lack of Efficacy|5
5140276|NCT01561898|17754266|P3|Overall Study|Lack of Efficacy|10
5140277|NCT01561898|17754267|P2|Overall Study|Lack of Efficacy|8
5140278|NCT01561898|17754268|P1|Overall Study|Lack of Efficacy|0
5140279|NCT01561898|17754265|P4|Overall Study|Withdrawal by Subject|5
5140280|NCT01561898|17754266|P3|Overall Study|Withdrawal by Subject|12
5140281|NCT01561898|17754267|P2|Overall Study|Withdrawal by Subject|8
5140282|NCT01561898|17754268|P1|Overall Study|Withdrawal by Subject|0
5140283|NCT01561755|17754286|P2|Overall Study|Lost to Follow-up|1
5140284|NCT01561755|17754287|P1|Overall Study|Lost to Follow-up|0
5140285|NCT01561560|17754339|P2|Second Two Weeks of Wear|Adverse Event|1
5140286|NCT01561560|17754340|P1|Second Two Weeks of Wear|Adverse Event|0
5140287|NCT01561560|17754339|P2|First Two Weeks of Wear|Adverse Event|1
5140288|NCT01561560|17754340|P1|First Two Weeks of Wear|Adverse Event|0
5140289|NCT01561560|17754339|P2|First Two Weeks of Wear|Time/job conflict|1
5140290|NCT01561560|17754340|P1|First Two Weeks of Wear|Time/job conflict|0
5140291|NCT01561430|17754375|P4|Overall Study|Sponsor Decision|12
5140292|NCT01561430|17754376|P3|Overall Study|Sponsor Decision|13
5140293|NCT01561430|17754377|P2|Overall Study|Sponsor Decision|14
5140294|NCT01561430|17754378|P1|Overall Study|Sponsor Decision|1
5140295|NCT01561430|17754375|P4|Overall Study|Physician Decision|0
5140296|NCT01561430|17754376|P3|Overall Study|Physician Decision|0
5140297|NCT01561430|17754377|P2|Overall Study|Physician Decision|1
5140298|NCT01561430|17754378|P1|Overall Study|Physician Decision|0
5140299|NCT01561430|17754375|P4|Overall Study|Withdrawal by Subject|0
5140300|NCT01561430|17754376|P3|Overall Study|Withdrawal by Subject|1
5140301|NCT01561430|17754377|P2|Overall Study|Withdrawal by Subject|0
5140302|NCT01561430|17754378|P1|Overall Study|Withdrawal by Subject|0
5140303|NCT01561430|17754375|P4|Overall Study|Adverse Event|1
5140304|NCT01561430|17754376|P3|Overall Study|Adverse Event|3
5140305|NCT01561430|17754377|P2|Overall Study|Adverse Event|0
5140306|NCT01561430|17754378|P1|Overall Study|Adverse Event|0
5140307|NCT01561313|17754441|P2|Overall Study|Adverse event and withdrawal by subject|0
5140308|NCT01561313|17754442|P1|Overall Study|Adverse event and withdrawal by subject|1
5140309|NCT01561313|17754441|P2|Overall Study|Withdrawal by Subject|0
5140310|NCT01561313|17754442|P1|Overall Study|Withdrawal by Subject|1
5140311|NCT01561300|17754460|P2|Run in on Placebo|Adverse Event|0
5140312|NCT01561300|17754461|P1|Run in on Placebo|Adverse Event|1
5140313|NCT01561079|17754472|P1|Overall Study|Protocol Violation|2
5140314|NCT01561079|17754472|P1|Overall Study|Withdrawal by Subject|59
5140315|NCT01561079|17754472|P1|Overall Study|Physician Decision|17
5140316|NCT01560988|17754558|P2|Washout (Six Weeks)|Lost to Follow-up|2
5140317|NCT01560988|17754559|P1|Washout (Six Weeks)|Lost to Follow-up|2
5140318|NCT01560988|17754558|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
5140319|NCT01560988|17754559|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
5140320|NCT01560988|17754558|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
5140321|NCT01560988|17754559|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
5140322|NCT01560949|17754595|P1|Surgery Phase|Physician Decision|3
5140323|NCT01560949|17754595|P1|Systemic Phase: mFOLFIRINOX|Adverse Event|6
5140324|NCT01560871|17754629|P2|Overall Study|Lost to Follow-up|0
5140325|NCT01560871|17754630|P1|Overall Study|Lost to Follow-up|1
5140326|NCT01560871|17754629|P2|Overall Study|readmission to a hospital|1
5140327|NCT01560871|17754630|P1|Overall Study|readmission to a hospital|2
5140328|NCT01560871|17754629|P2|Overall Study|relocation|0
5140329|NCT01560871|17754630|P1|Overall Study|relocation|1
5140330|NCT01560871|17754629|P2|Overall Study|transportation issues|1
5140331|NCT01560871|17754630|P1|Overall Study|transportation issues|2
5140332|NCT01560819|17754646|P2|Overall Study|Physician Decision|0
5140333|NCT01560819|17754647|P1|Overall Study|Physician Decision|1
5140334|NCT01560780|17754653|P2|Overall Study|Patient Preference|11
5140335|NCT01560780|17754654|P1|Overall Study|Patient Preference|11
5140336|NCT01560780|17754653|P2|Overall Study|Death|1
5140337|NCT01560780|17754654|P1|Overall Study|Death|2
5140338|NCT01560507|17754690|P3|Overall Study|Withdrawal by Subject|0
5140339|NCT01560507|17754691|P2|Overall Study|Withdrawal by Subject|1
5140340|NCT01560507|17754692|P1|Overall Study|Withdrawal by Subject|1
5140341|NCT01560507|17754690|P3|Overall Study|Lost to Follow-up|2
5140342|NCT01560507|17754691|P2|Overall Study|Lost to Follow-up|1
5140343|NCT01560507|17754692|P1|Overall Study|Lost to Follow-up|3
5140344|NCT01560429|17754705|P2|Overall Study|Protocol Violation|6
5140345|NCT01560429|17754706|P1|Overall Study|Protocol Violation|3
5140346|NCT01560416|17754716|P2|Randomized Phase|Crossover Participants|0
5140347|NCT01560416|17754717|P1|Randomized Phase|Crossover Participants|7
5140348|NCT01560403|17754735|P2|Overall Study|Lost to Follow-up|1
5140349|NCT01560403|17754736|P1|Overall Study|Lost to Follow-up|0
5140350|NCT01560234|17754784|P8|Overall Study|Lost to Follow-up|2
5140351|NCT01560234|17754785|P7|Overall Study|Lost to Follow-up|0
5140352|NCT01560234|17754786|P6|Overall Study|Lost to Follow-up|2
5140353|NCT01560234|17754787|P5|Overall Study|Lost to Follow-up|0
5140354|NCT01560234|17754788|P4|Overall Study|Lost to Follow-up|0
5140355|NCT01560234|17754789|P3|Overall Study|Lost to Follow-up|1
5140356|NCT01560234|17754790|P2|Overall Study|Lost to Follow-up|0
5140357|NCT01560234|17754791|P1|Overall Study|Lost to Follow-up|3
5140358|NCT01559935|17754886|P1|Maintenance Phase|Non-compliance|2
5140359|NCT01559935|17754886|P1|Maintenance Phase|Withdrawal by Subject|5
5140360|NCT01559935|17754886|P1|Maintenance Phase|Lack of Efficacy|18
5140361|NCT01559935|17754886|P1|Maintenance Phase|Toxicity|1
5140362|NCT01559935|17754886|P1|Maintenance Phase|Remains on study|28
5140363|NCT01559935|17754886|P1|BiRD Phase|Withdrawal by Subject|2
5140364|NCT01559935|17754886|P1|BiRD Phase|Lack of Efficacy|1
5140365|NCT01559935|17754886|P1|BiRD Phase|Toxicity|1
5140366|NCT01559935|17754886|P1|Car Phase|non-compliance|1
5140367|NCT01559935|17754886|P1|Car Phase|Insurance|1
5140368|NCT01559935|17754886|P1|Car Phase|Per protocol|1
5140369|NCT01559935|17754886|P1|Car Phase|Withdrawal by Subject|2
5140370|NCT01559935|17754886|P1|Car Phase|Physician Decision|1
5140371|NCT01559935|17754886|P1|Car Phase|Lost to Follow-up|1
5140372|NCT01559935|17754886|P1|Car Phase|Lack of Efficacy|2
5140373|NCT01559935|17754886|P1|Car Phase|Death|1
5140374|NCT01559935|17754886|P1|Car Phase|Toxicity|4
5140375|NCT01559844|17754922|P1|Overall Study|No Longer A Transplant Candidate|3
5140376|NCT01559844|17754922|P1|Overall Study|Efficacy Failure|10
5140377|NCT01559844|17754922|P1|Overall Study|Death|5
5140378|NCT01559844|17754922|P1|Overall Study|Consent Withdrawn|7
5140379|NCT01559675|17754935|P2|Overall Study|2nd operation on same patient excluded|12
5140380|NCT01559675|17754936|P1|Overall Study|2nd operation on same patient excluded|14
5140381|NCT01559675|17754935|P2|Overall Study|Protocol Violation|2
5140382|NCT01559675|17754936|P1|Overall Study|Protocol Violation|1
5140383|NCT01559454|17754967|P2|Overall Study|Lack of Efficacy|1
5140384|NCT01559454|17754968|P1|Overall Study|Lack of Efficacy|0
5140385|NCT01559454|17754967|P2|Overall Study|Protocol Violation|1
5140386|NCT01559454|17754968|P1|Overall Study|Protocol Violation|0
5140387|NCT01559454|17754967|P2|Overall Study|Physician Decision|1
5140388|NCT01559454|17754968|P1|Overall Study|Physician Decision|0
5140389|NCT01559454|17754967|P2|Overall Study|Withdrawal by Subject|1
5140390|NCT01559454|17754968|P1|Overall Study|Withdrawal by Subject|0
5140391|NCT01559454|17754967|P2|Overall Study|Lost to Follow-up|2
5140392|NCT01559454|17754968|P1|Overall Study|Lost to Follow-up|3
5140393|NCT01559389|17754986|P2|Overall Study|Withdrawal by Subject|20
5140394|NCT01559389|17754987|P1|Overall Study|Withdrawal by Subject|20
5140395|NCT01559311|17755000|P3|Overall Study|Adverse Event|1
5140396|NCT01559311|17755001|P2|Overall Study|Adverse Event|0
5140397|NCT01559311|17755002|P1|Overall Study|Adverse Event|0
5140398|NCT01559311|17755000|P3|Overall Study|Lost to Follow-up|2
5140399|NCT01559311|17755001|P2|Overall Study|Lost to Follow-up|3
5140400|NCT01559311|17755002|P1|Overall Study|Lost to Follow-up|0
5140401|NCT01559311|17755000|P3|Overall Study|Death|3
5140402|NCT01559311|17755001|P2|Overall Study|Death|2
5140403|NCT01559311|17755002|P1|Overall Study|Death|0
5140404|NCT01559311|17755000|P3|Overall Study|Withdrawal by Subject|0
5140405|NCT01559311|17755001|P2|Overall Study|Withdrawal by Subject|1
5140406|NCT01559311|17755002|P1|Overall Study|Withdrawal by Subject|2
5140407|NCT01559311|17755000|P3|Overall Study|Difficulty in cannulating the lateral ve|0
5140408|NCT01559311|17755001|P2|Overall Study|Difficulty in cannulating the lateral ve|0
5140409|NCT01559311|17755002|P1|Overall Study|Difficulty in cannulating the lateral ve|1
5140410|NCT01559311|17755000|P3|Overall Study|Protocol Violation|2
5140411|NCT01559311|17755001|P2|Overall Study|Protocol Violation|0
5140412|NCT01559311|17755002|P1|Overall Study|Protocol Violation|0
5140413|NCT01559259|17755018|P5|Overall Study|Adverse Event|0
5140414|NCT01559259|17755019|P4|Overall Study|Adverse Event|0
5140415|NCT01559259|17755020|P3|Overall Study|Adverse Event|1
5140416|NCT01559259|17755021|P2|Overall Study|Adverse Event|1
5140417|NCT01559259|17755022|P1|Overall Study|Adverse Event|0
5140418|NCT01559259|17755018|P5|Overall Study|Withdrawal by Subject|0
5140419|NCT01559259|17755019|P4|Overall Study|Withdrawal by Subject|1
5140420|NCT01559259|17755020|P3|Overall Study|Withdrawal by Subject|0
5140421|NCT01559259|17755021|P2|Overall Study|Withdrawal by Subject|0
5140422|NCT01559259|17755022|P1|Overall Study|Withdrawal by Subject|0
5140423|NCT01559129|17755111|P2|Open-label Extension Period|Study Terminated by Sponsor|2
5140424|NCT01559129|17755112|P1|Open-label Extension Period|Study Terminated by Sponsor|5
5140425|NCT01559129|17755111|P2|Open-label Extension Period|Adverse Event|0
5140426|NCT01559129|17755112|P1|Open-label Extension Period|Adverse Event|1
5140427|NCT01559129|17755111|P2|Treatment Phase|Did Not Receive Study Drug|1
5140428|NCT01559129|17755112|P1|Treatment Phase|Did Not Receive Study Drug|0
5140429|NCT01559129|17755111|P2|Treatment Phase|Protocol Exclusion Criteria|0
5140430|NCT01559129|17755112|P1|Treatment Phase|Protocol Exclusion Criteria|1
5140431|NCT01559129|17755111|P2|Treatment Phase|Study Terminated by Sponsor|2
5140432|NCT01559129|17755112|P1|Treatment Phase|Study Terminated by Sponsor|3
5140433|NCT01559129|17755111|P2|Treatment Phase|Lack of Efficacy|1
5140434|NCT01559129|17755112|P1|Treatment Phase|Lack of Efficacy|0
5140435|NCT01559129|17755111|P2|Treatment Phase|Progressive Disease|1
5140436|NCT01559129|17755112|P1|Treatment Phase|Progressive Disease|1
5140437|NCT01559129|17755111|P2|Treatment Phase|Adverse Event|2
5140438|NCT01559129|17755112|P1|Treatment Phase|Adverse Event|0
5140439|NCT01559116|17755188|P1|Overall Study|other than stated above|9
5140440|NCT01559116|17755188|P1|Overall Study|Withdrawal by Subject|4
5140441|NCT01559116|17755188|P1|Overall Study|Protocol Violation|1
5140442|NCT01559116|17755188|P1|Overall Study|Lost to Follow-up|1
5140443|NCT01559116|17755188|P1|Overall Study|Lack of Efficacy|1
5140444|NCT01559116|17755188|P1|Overall Study|Adverse Event|10
5140445|NCT01559090|17755259|P3|Stage II|Withdrawal by Subject|0
5140446|NCT01559090|17755260|P2|Stage II|Withdrawal by Subject|0
5140447|NCT01559090|17755261|P1|Stage II|Withdrawal by Subject|1
5140448|NCT01559090|17755259|P3|Stage I|Withdrawal by Subject|3
5140449|NCT01559090|17755260|P2|Stage I|Withdrawal by Subject|2
5140450|NCT01559090|17755261|P1|Stage I|Withdrawal by Subject|2
5140451|NCT01559012|17755293|P2|Overall Study|Withdrawal by Subject|1
5140452|NCT01559012|17755294|P1|Overall Study|Withdrawal by Subject|0
5140453|NCT01558739|17755332|P1|Overall Study|Protocol Violation|1
5140454|NCT01558739|17755332|P1|Overall Study|Disease Progression|4
5140455|NCT01558739|17755332|P1|Overall Study|Death|3
5140456|NCT01558739|17755332|P1|Overall Study|Withdrawal by Subject|2
5140457|NCT01558739|17755332|P1|Overall Study|Adverse Event|7
5140458|NCT01558674|17755357|P2|Part 1|Withdrawal by Subject|0
5140459|NCT01558674|17755358|P1|Part 1|Withdrawal by Subject|1
5140460|NCT01558674|17755357|P2|Part 1|Study Terminated by Sponsor|0
5140461|NCT01558674|17755358|P1|Part 1|Study Terminated by Sponsor|10
5140462|NCT01558635|17755409|P1|Overall Study|Reveal XT was explanted|1
5140463|NCT01558635|17755409|P1|Overall Study|Subject received other treatment|1
5140464|NCT01558635|17755409|P1|Overall Study|Physician Decision|1
5140465|NCT01558635|17755409|P1|Overall Study|Withdrawal by Subject|2
5140466|NCT01558635|17755409|P1|Overall Study|Death|1
5140467|NCT01558596|17755426|P2|Overall Study|Protocol Violation|0
5140468|NCT01558596|17755427|P1|Overall Study|Protocol Violation|1
5140469|NCT01558596|17755426|P2|Overall Study|surgery elsewhere or cancelled|1
5140470|NCT01558596|17755427|P1|Overall Study|surgery elsewhere or cancelled|1
5140471|NCT01558596|17755426|P2|Overall Study|Withdrawal by Subject|0
5140472|NCT01558596|17755427|P1|Overall Study|Withdrawal by Subject|1
5140473|NCT01558297|17755442|P3|Overall Study|Withdrawal by Subject|1
5140474|NCT01558297|17755443|P2|Overall Study|Withdrawal by Subject|2
5140475|NCT01558297|17755444|P1|Overall Study|Withdrawal by Subject|2
5140476|NCT01558271|17755461|P3|Overall Study|Physician Decision|1
5140477|NCT01558271|17755462|P2|Overall Study|Physician Decision|2
5140478|NCT01558271|17755463|P1|Overall Study|Physician Decision|0
5140479|NCT01558271|17755461|P3|Overall Study|Withdrawal by Subject|12
5140480|NCT01558271|17755462|P2|Overall Study|Withdrawal by Subject|6
5140481|NCT01558271|17755463|P1|Overall Study|Withdrawal by Subject|10
5140482|NCT01558271|17755461|P3|Overall Study|Protocol Violation|0
5140483|NCT01558271|17755462|P2|Overall Study|Protocol Violation|0
5140484|NCT01558271|17755463|P1|Overall Study|Protocol Violation|1
5140485|NCT01558271|17755461|P3|Overall Study|Lost to Follow-up|0
5140486|NCT01558271|17755462|P2|Overall Study|Lost to Follow-up|0
5140487|NCT01558271|17755463|P1|Overall Study|Lost to Follow-up|1
5140488|NCT01558271|17755461|P3|Overall Study|Adverse Event|4
5140489|NCT01558271|17755462|P2|Overall Study|Adverse Event|3
5140490|NCT01558271|17755463|P1|Overall Study|Adverse Event|6
5140491|NCT01558089|17755529|P1|Overall Study|Withdrawal by Subject|6
5140492|NCT01558089|17755529|P1|Overall Study|Lost to Follow-up|5
5140493|NCT01558089|17755529|P1|Overall Study|Lack of Efficacy|1
5140494|NCT01558089|17755529|P1|Overall Study|Adverse Event|1
5140495|NCT01557946|17755582|P2|Overall Study|Adverse Event|0
5140496|NCT01557946|17755583|P1|Overall Study|Adverse Event|3
5140497|NCT01557920|17755589|P2|Overall Study|Lack of Efficacy|0
5140498|NCT01557920|17755590|P1|Overall Study|Lack of Efficacy|1
5140499|NCT01557920|17755589|P2|Overall Study|Withdrawal by Subject|3
5140500|NCT01557920|17755590|P1|Overall Study|Withdrawal by Subject|2
5140501|NCT01557842|17755659|P2|Overall Study|Not Ablated|0
5140502|NCT01557842|17755660|P1|Overall Study|Not Ablated|2
5140503|NCT01557842|17755659|P2|Overall Study|Study Terminated by Sponsor|4
5140504|NCT01557842|17755660|P1|Overall Study|Study Terminated by Sponsor|3
5140505|NCT01557842|17755659|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
5140506|NCT01557842|17755660|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
5140507|NCT01557842|17755659|P2|Overall Study|Lack of Efficacy|1
5140508|NCT01557842|17755660|P1|Overall Study|Lack of Efficacy|0
5140509|NCT01557842|17755659|P2|Overall Study|Death|0
5140510|NCT01557842|17755660|P1|Overall Study|Death|1
5140511|NCT01557842|17755659|P2|Overall Study|Lost to Follow-up|1
5140512|NCT01557842|17755660|P1|Overall Study|Lost to Follow-up|0
5140513|NCT01557751|17755672|P1|Overall Study|Physician Decision|3
5140514|NCT01557582|17755717|P1|Overall Study|Operator error|2
5140515|NCT01557582|17755717|P1|Overall Study|Protocol Violation|4
5140516|NCT01557569|17755725|P2|Overall Study|noncompliance with rules of residential|1
5140517|NCT01557569|17755726|P1|Overall Study|noncompliance with rules of residential|0
5140518|NCT01557569|17755725|P2|Overall Study|Withdrawal by Subject|5
5140519|NCT01557569|17755726|P1|Overall Study|Withdrawal by Subject|3
5140520|NCT01557569|17755725|P2|Overall Study|high blood pressure|1
5140521|NCT01557569|17755726|P1|Overall Study|high blood pressure|0
5140522|NCT01557569|17755725|P2|Overall Study|Adverse Event|0
5140523|NCT01557569|17755726|P1|Overall Study|Adverse Event|2
5140524|NCT01557517|17755734|P2|Overall Study|Pt declined before treatment started|0
5140525|NCT01557517|17755735|P1|Overall Study|Pt declined before treatment started|1
5140526|NCT01557517|17755734|P2|Overall Study|Adverse Event|2
5140527|NCT01557517|17755735|P1|Overall Study|Adverse Event|0
5140528|NCT01557517|17755734|P2|Overall Study|Refused further treatment|2
5140529|NCT01557517|17755735|P1|Overall Study|Refused further treatment|0
5140530|NCT01557517|17755734|P2|Overall Study|Death|0
5140531|NCT01557517|17755735|P1|Overall Study|Death|1
5140532|NCT01557504|17755761|P2|Overall Study|Physician Decision|0
5140533|NCT01557504|17755762|P1|Overall Study|Physician Decision|1
5140534|NCT01557400|17755785|P1|Overall Study|Withdrawal by Subject|9
5140535|NCT01557400|17755785|P1|Overall Study|Lost to Follow-up|5
5140536|NCT01557400|17755785|P1|Overall Study|Adverse Event|3
5140537|NCT01557400|17755785|P1|Overall Study|Transitioned to Commercial Drug Product|40
5140538|NCT01557348|17755797|P2|Overall Study|Administrative|11
5140539|NCT01557348|17755798|P1|Overall Study|Administrative|18
5140540|NCT01557348|17755797|P2|Overall Study|Lost to Follow-up|22
5140541|NCT01557348|17755798|P1|Overall Study|Lost to Follow-up|26
5140542|NCT01557348|17755797|P2|Overall Study|Withdrawal by Subject|4
5140543|NCT01557348|17755798|P1|Overall Study|Withdrawal by Subject|5
5140544|NCT01557348|17755797|P2|Overall Study|Insufficient Therapeutic Response|28
5140545|NCT01557348|17755798|P1|Overall Study|Insufficient Therapeutic Response|13
5140546|NCT01557348|17755797|P2|Overall Study|Death|4
5140547|NCT01557348|17755798|P1|Overall Study|Death|7
5140548|NCT01557348|17755797|P2|Overall Study|Infusion reaction event|5
5140549|NCT01557348|17755798|P1|Overall Study|Infusion reaction event|5
5140550|NCT01557348|17755797|P2|Overall Study|Adverse Event|16
5140551|NCT01557348|17755798|P1|Overall Study|Adverse Event|6
5140552|NCT01557283|17755915|P1|Overall Study|Other|6
5140553|NCT01557283|17755915|P1|Overall Study|Worsening of psoriasis|1
5140554|NCT01557283|17755915|P1|Overall Study|Participant's weight too high for dose|1
5140555|NCT01557283|17755915|P1|Overall Study|Withdrawal by Subject|1
5140556|NCT01557283|17755915|P1|Overall Study|Non-compliance|1
5140557|NCT01557283|17755915|P1|Overall Study|Lack of Efficacy|1
5140558|NCT01557283|17755915|P1|Overall Study|Adverse Event|7
5140559|NCT01557283|17755915|P1|Overall Study|Non-responder|19
5140560|NCT01557283|17755915|P1|Overall Study|Lost to Follow-up|7
5140561|NCT01557166|17755927|P2|Overall Study|Unclassified|5
5140562|NCT01557166|17755928|P1|Overall Study|Unclassified|2
5140563|NCT01557166|17755927|P2|Overall Study|Psychiatric disorder|0
5140564|NCT01557166|17755928|P1|Overall Study|Psychiatric disorder|1
5140565|NCT01557166|17755927|P2|Overall Study|Target dose not tolerated|0
5140566|NCT01557166|17755928|P1|Overall Study|Target dose not tolerated|1
5140567|NCT01557166|17755927|P2|Overall Study|Withdrawn consent|20
5140568|NCT01557166|17755928|P1|Overall Study|Withdrawn consent|12
5140569|NCT01557166|17755927|P2|Overall Study|Protocol Violation|5
5140570|NCT01557166|17755928|P1|Overall Study|Protocol Violation|8
5140571|NCT01557166|17755927|P2|Overall Study|Lack of Efficacy|1
5140572|NCT01557166|17755928|P1|Overall Study|Lack of Efficacy|2
5140573|NCT01557166|17755927|P2|Overall Study|Adverse Event|6
5140574|NCT01557166|17755928|P1|Overall Study|Adverse Event|20
5140575|NCT01556997|17755943|P3|Overall Study|Other|7
5140576|NCT01556997|17755944|P2|Overall Study|Other|3
5140577|NCT01556997|17755945|P1|Overall Study|Other|2
5140578|NCT01556997|17755943|P3|Overall Study|Withdrawal by Subject|8
5140579|NCT01556997|17755944|P2|Overall Study|Withdrawal by Subject|6
5140580|NCT01556997|17755945|P1|Overall Study|Withdrawal by Subject|7
5140581|NCT01556997|17755943|P3|Overall Study|Physician Decision|1
5140582|NCT01556997|17755944|P2|Overall Study|Physician Decision|1
5140583|NCT01556997|17755945|P1|Overall Study|Physician Decision|1
5140584|NCT01556997|17755943|P3|Overall Study|Lost to Follow-up|4
5140585|NCT01556997|17755944|P2|Overall Study|Lost to Follow-up|6
5140586|NCT01556997|17755945|P1|Overall Study|Lost to Follow-up|6
5140587|NCT01556997|17755943|P3|Overall Study|Adverse Event|12
5140588|NCT01556997|17755944|P2|Overall Study|Adverse Event|12
5140589|NCT01556997|17755945|P1|Overall Study|Adverse Event|10
5140590|NCT01556932|17755956|P2|Time Point 60 Minutes|Withdrawal by Subject|1
5140591|NCT01556932|17755957|P1|Time Point 60 Minutes|Withdrawal by Subject|1
5140592|NCT01556763|17755983|P3|Overall Study|Withdrawal by Subject|0
5140593|NCT01556763|17755984|P2|Overall Study|Withdrawal by Subject|1
5140594|NCT01556763|17755985|P1|Overall Study|Withdrawal by Subject|0
5140595|NCT01556438|17756124|P2|Overall Study|Death|1
5140596|NCT01556438|17756125|P1|Overall Study|Death|0
5140597|NCT01556438|17756124|P2|Overall Study|Progressive Disease|6
5140598|NCT01556438|17756125|P1|Overall Study|Progressive Disease|0
5140599|NCT01556438|17756124|P2|Overall Study|Sponsor Decision|2
5140600|NCT01556438|17756125|P1|Overall Study|Sponsor Decision|0
5140601|NCT01556438|17756124|P2|Overall Study|Adverse Event|2
5140602|NCT01556438|17756125|P1|Overall Study|Adverse Event|4
5140603|NCT01556165|17756212|P2|Overall Study|Withdrawal of Consent|1
5140604|NCT01556165|17756213|P1|Overall Study|Withdrawal of Consent|7
5140605|NCT01556165|17756212|P2|Overall Study|Protocol Violation|3
5140606|NCT01556165|17756213|P1|Overall Study|Protocol Violation|0
5140607|NCT01556165|17756212|P2|Overall Study|Adverse Event|3
5140608|NCT01556165|17756213|P1|Overall Study|Adverse Event|5
5140609|NCT01555983|17756254|P6|Overall Study|Withdrawal by Subject|1
5140610|NCT01555983|17756255|P5|Overall Study|Withdrawal by Subject|1
5140611|NCT01555983|17756256|P4|Overall Study|Withdrawal by Subject|0
5140612|NCT01555983|17756257|P3|Overall Study|Withdrawal by Subject|0
5140613|NCT01555983|17756258|P2|Overall Study|Withdrawal by Subject|0
5140614|NCT01555983|17756259|P1|Overall Study|Withdrawal by Subject|1
5140615|NCT01555931|17756269|P2|Overall Study|Lost to Follow-up|5
5140616|NCT01555931|17756270|P1|Overall Study|Lost to Follow-up|2
5140617|NCT01555762|17756278|P1|Overall Study|Death linked to an adverse event|14
5140618|NCT01555762|17756278|P1|Overall Study|Missing data|1
5140619|NCT01555762|17756278|P1|Overall Study|Participant not wishing to continue|5
5140620|NCT01555762|17756278|P1|Overall Study|Investigator's decision|10
5140621|NCT01555762|17756278|P1|Overall Study|Lost follow-up/moved house/changed team|35
5140622|NCT01555762|17756278|P1|Overall Study|Death linked to progression of disease|165
5140623|NCT01555762|17756278|P1|Overall Study|Treatment with Bevacizumab ticked No|24
5140624|NCT01555762|17756278|P1|Overall Study|75 years old or more ticked No|1
5140625|NCT01555762|17756278|P1|Overall Study|Missing start date of infusion|8
5140626|NCT01555762|17756278|P1|Overall Study|No information on Bevacizumab intake|11
5140627|NCT01555463|17756358|P2|Follow up|Other reason|3
5140628|NCT01555463|17756359|P1|Follow up|Other reason|3
5140629|NCT01555463|17756358|P2|Follow up|Protocol Violation|4
5140630|NCT01555463|17756359|P1|Follow up|Protocol Violation|2
5140631|NCT01555463|17756358|P2|Follow up|Lost to Follow-up|10
5140632|NCT01555463|17756359|P1|Follow up|Lost to Follow-up|9
5140633|NCT01555463|17756358|P2|Follow up|Withdrawal by Subject|22
5140634|NCT01555463|17756359|P1|Follow up|Withdrawal by Subject|22
5140635|NCT01555463|17756358|P2|Follow up|Death|1
5140636|NCT01555463|17756359|P1|Follow up|Death|0
5140637|NCT01555463|17756358|P2|Follow up|Adverse Event|5
5140638|NCT01555463|17756359|P1|Follow up|Adverse Event|2
5140639|NCT01555463|17756358|P2|Treatment|Other reason|3
5140640|NCT01555463|17756359|P1|Treatment|Other reason|2
5140641|NCT01555463|17756358|P2|Treatment|Protocol Violation|5
5140642|NCT01555463|17756359|P1|Treatment|Protocol Violation|4
5140643|NCT01555463|17756358|P2|Treatment|Lost to Follow-up|23
5140644|NCT01555463|17756359|P1|Treatment|Lost to Follow-up|28
5140645|NCT01555463|17756358|P2|Treatment|Withdrawal by Subject|36
5140646|NCT01555463|17756359|P1|Treatment|Withdrawal by Subject|24
5140647|NCT01555463|17756358|P2|Treatment|Adverse Event|12
5140648|NCT01555463|17756359|P1|Treatment|Adverse Event|6
5140649|NCT01555164|17756401|P2|Overall Study|Subject Withdrew Consent|11
5140650|NCT01555164|17756402|P1|Overall Study|Subject Withdrew Consent|6
5140651|NCT01555164|17756401|P2|Overall Study|Subject Non-compliance|6
5140652|NCT01555164|17756402|P1|Overall Study|Subject Non-compliance|14
5140653|NCT01555164|17756401|P2|Overall Study|Protocol Violation|5
5140654|NCT01555164|17756402|P1|Overall Study|Protocol Violation|9
5140655|NCT01555164|17756401|P2|Overall Study|Lost to Follow-up|3
5140656|NCT01555164|17756402|P1|Overall Study|Lost to Follow-up|4
5140657|NCT01555164|17756401|P2|Overall Study|Investigator's Discretion|2
5140658|NCT01555164|17756402|P1|Overall Study|Investigator's Discretion|2
5140659|NCT01555164|17756401|P2|Overall Study|Hyperglycemia|1
5140660|NCT01555164|17756402|P1|Overall Study|Hyperglycemia|0
5140661|NCT01555164|17756401|P2|Overall Study|Adverse Event|7
5140662|NCT01555164|17756402|P1|Overall Study|Adverse Event|5
5140663|NCT01555151|17756416|P4|Overall Study|Lost to Follow-up|1
5140664|NCT01555151|17756417|P3|Overall Study|Lost to Follow-up|0
5140665|NCT01555151|17756418|P2|Overall Study|Lost to Follow-up|0
5140666|NCT01555151|17756419|P1|Overall Study|Lost to Follow-up|0
5140667|NCT01555151|17756416|P4|Overall Study|Adverse Event|2
5140668|NCT01555151|17756417|P3|Overall Study|Adverse Event|1
5140669|NCT01555151|17756418|P2|Overall Study|Adverse Event|2
5140670|NCT01555151|17756419|P1|Overall Study|Adverse Event|1
5140671|NCT01555151|17756416|P4|Overall Study|Protocol Violation|5
5140672|NCT01555151|17756417|P3|Overall Study|Protocol Violation|3
5140673|NCT01555151|17756418|P2|Overall Study|Protocol Violation|3
5140674|NCT01555151|17756419|P1|Overall Study|Protocol Violation|3
5140675|NCT01555151|17756416|P4|Overall Study|Administrative|0
5140676|NCT01555151|17756417|P3|Overall Study|Administrative|2
5140677|NCT01555151|17756418|P2|Overall Study|Administrative|1
5140678|NCT01555151|17756419|P1|Overall Study|Administrative|3
5140679|NCT01555151|17756416|P4|Overall Study|Withdrawal by Subject|2
5140680|NCT01555151|17756417|P3|Overall Study|Withdrawal by Subject|0
5140681|NCT01555151|17756418|P2|Overall Study|Withdrawal by Subject|2
5140682|NCT01555151|17756419|P1|Overall Study|Withdrawal by Subject|6
5140683|NCT01555138|17756472|P2|Overall Study|Adverse Event|14
5140684|NCT01555138|17756473|P1|Overall Study|Adverse Event|14
5140685|NCT01555138|17756472|P2|Overall Study|Withdrawal by Subject|15
5140686|NCT01555138|17756473|P1|Overall Study|Withdrawal by Subject|16
5140687|NCT01555138|17756472|P2|Overall Study|Administrative problems|0
5140688|NCT01555138|17756473|P1|Overall Study|Administrative problems|8
5140689|NCT01555138|17756472|P2|Overall Study|Protocol Violation|3
5140690|NCT01555138|17756473|P1|Overall Study|Protocol Violation|5
5140691|NCT01555138|17756472|P2|Overall Study|Lack of Efficacy|2
5140692|NCT01555138|17756473|P1|Overall Study|Lack of Efficacy|2
5140693|NCT01555138|17756472|P2|Overall Study|Abnormal Lab reults|3
5140694|NCT01555138|17756473|P1|Overall Study|Abnormal Lab reults|1
5140695|NCT01555138|17756472|P2|Overall Study|Lost to Follow-up|0
5140696|NCT01555138|17756473|P1|Overall Study|Lost to Follow-up|1
5140697|NCT01555138|17756472|P2|Overall Study|Death|1
5140698|NCT01555138|17756473|P1|Overall Study|Death|0
5140699|NCT01555125|17756502|P5|Follow-Up Period|Subject / guardian decision|0
5140700|NCT01555125|17756503|P4|Follow-Up Period|Subject / guardian decision|1
5140701|NCT01555125|17756504|P3|Follow-Up Period|Subject / guardian decision|1
5140702|NCT01555125|17756505|P2|Follow-Up Period|Subject / guardian decision|1
5140703|NCT01555125|17756506|P1|Follow-Up Period|Subject / guardian decision|3
5140704|NCT01555125|17756502|P5|Follow-Up Period|Lost to Follow-up|0
5140705|NCT01555125|17756503|P4|Follow-Up Period|Lost to Follow-up|0
5140706|NCT01555125|17756504|P3|Follow-Up Period|Lost to Follow-up|0
5140707|NCT01555125|17756505|P2|Follow-Up Period|Lost to Follow-up|0
5140708|NCT01555125|17756506|P1|Follow-Up Period|Lost to Follow-up|1
5140709|NCT01555125|17756502|P5|Extension|Technical Problems|0
5140710|NCT01555125|17756503|P4|Extension|Technical Problems|1
5140711|NCT01555125|17756504|P3|Extension|Technical Problems|0
5140712|NCT01555125|17756505|P2|Extension|Technical Problems|0
5140713|NCT01555125|17756506|P1|Extension|Technical Problems|1
5140714|NCT01555125|17756502|P5|Extension|Subject/guardian decision|0
5140715|NCT01555125|17756503|P4|Extension|Subject/guardian decision|0
5140716|NCT01555125|17756504|P3|Extension|Subject/guardian decision|1
5140717|NCT01555125|17756505|P2|Extension|Subject/guardian decision|9
5140718|NCT01555125|17756506|P1|Extension|Subject/guardian decision|1
5140719|NCT01555125|17756502|P5|Extension|Study terminated by sponsor|0
5140720|NCT01555125|17756503|P4|Extension|Study terminated by sponsor|20
5140721|NCT01555125|17756504|P3|Extension|Study terminated by sponsor|16
5140722|NCT01555125|17756505|P2|Extension|Study terminated by sponsor|33
5140723|NCT01555125|17756506|P1|Extension|Study terminated by sponsor|32
5140724|NCT01555125|17756502|P5|Extension|Lost to Follow-up|0
5140725|NCT01555125|17756503|P4|Extension|Lost to Follow-up|0
5140726|NCT01555125|17756504|P3|Extension|Lost to Follow-up|2
5140727|NCT01555125|17756505|P2|Extension|Lost to Follow-up|1
5140728|NCT01555125|17756506|P1|Extension|Lost to Follow-up|2
5140729|NCT01555125|17756502|P5|Extension|Lack of Efficacy|0
5140730|NCT01555125|17756503|P4|Extension|Lack of Efficacy|0
5140731|NCT01555125|17756504|P3|Extension|Lack of Efficacy|3
5140732|NCT01555125|17756505|P2|Extension|Lack of Efficacy|6
5140733|NCT01555125|17756506|P1|Extension|Lack of Efficacy|7
5140734|NCT01555125|17756502|P5|Extension|Protocol deviation|0
5140735|NCT01555125|17756503|P4|Extension|Protocol deviation|0
5140736|NCT01555125|17756504|P3|Extension|Protocol deviation|0
5140737|NCT01555125|17756505|P2|Extension|Protocol deviation|0
5140738|NCT01555125|17756506|P1|Extension|Protocol deviation|1
5140739|NCT01555125|17756502|P5|Extension|Adverse Event|0
5140740|NCT01555125|17756503|P4|Extension|Adverse Event|1
5140741|NCT01555125|17756504|P3|Extension|Adverse Event|1
5140742|NCT01555125|17756505|P2|Extension|Adverse Event|2
5140743|NCT01555125|17756506|P1|Extension|Adverse Event|1
5140744|NCT01555125|17756502|P5|Maintenance Period|Death|0
5140745|NCT01555125|17756503|P4|Maintenance Period|Death|1
5140746|NCT01555125|17756504|P3|Maintenance Period|Death|0
5140747|NCT01555125|17756505|P2|Maintenance Period|Death|0
5140748|NCT01555125|17756506|P1|Maintenance Period|Death|0
5140749|NCT01555125|17756502|P5|Maintenance Period|Physician Decision|0
5140750|NCT01555125|17756503|P4|Maintenance Period|Physician Decision|0
5140751|NCT01555125|17756504|P3|Maintenance Period|Physician Decision|1
5140752|NCT01555125|17756505|P2|Maintenance Period|Physician Decision|0
5140753|NCT01555125|17756506|P1|Maintenance Period|Physician Decision|0
5140754|NCT01555125|17756502|P5|Maintenance Period|Lack of Efficacy|0
5140755|NCT01555125|17756503|P4|Maintenance Period|Lack of Efficacy|0
5140756|NCT01555125|17756504|P3|Maintenance Period|Lack of Efficacy|3
5140757|NCT01555125|17756505|P2|Maintenance Period|Lack of Efficacy|1
5140758|NCT01555125|17756506|P1|Maintenance Period|Lack of Efficacy|6
5140759|NCT01555125|17756502|P5|Maintenance Period|Lost to Follow-up|0
5140760|NCT01555125|17756503|P4|Maintenance Period|Lost to Follow-up|1
5140761|NCT01555125|17756504|P3|Maintenance Period|Lost to Follow-up|0
5140762|NCT01555125|17756505|P2|Maintenance Period|Lost to Follow-up|0
5140763|NCT01555125|17756506|P1|Maintenance Period|Lost to Follow-up|2
5140764|NCT01555125|17756502|P5|Maintenance Period|Subject / guardian decision|0
5140765|NCT01555125|17756503|P4|Maintenance Period|Subject / guardian decision|0
5140766|NCT01555125|17756504|P3|Maintenance Period|Subject / guardian decision|0
5140767|NCT01555125|17756505|P2|Maintenance Period|Subject / guardian decision|2
5140768|NCT01555125|17756506|P1|Maintenance Period|Subject / guardian decision|1
5140769|NCT01555125|17756502|P5|Maintenance Period|Adverse Event|0
5140770|NCT01555125|17756503|P4|Maintenance Period|Adverse Event|0
5140771|NCT01555125|17756504|P3|Maintenance Period|Adverse Event|0
5140772|NCT01555125|17756505|P2|Maintenance Period|Adverse Event|1
5140773|NCT01555125|17756506|P1|Maintenance Period|Adverse Event|1
5140774|NCT01555125|17756502|P5|Induction Period|Death|0
5140775|NCT01555125|17756503|P4|Induction Period|Death|0
5140776|NCT01555125|17756504|P3|Induction Period|Death|0
5140777|NCT01555125|17756505|P2|Induction Period|Death|0
5140778|NCT01555125|17756506|P1|Induction Period|Death|1
5140779|NCT01555125|17756502|P5|Induction Period|Subject / guardian decision|2
5140780|NCT01555125|17756503|P4|Induction Period|Subject / guardian decision|0
5140781|NCT01555125|17756504|P3|Induction Period|Subject / guardian decision|0
5140782|NCT01555125|17756505|P2|Induction Period|Subject / guardian decision|0
5140783|NCT01555125|17756506|P1|Induction Period|Subject / guardian decision|0
5140784|NCT01555125|17756502|P5|Induction Period|Adverse Event|1
5140785|NCT01555125|17756503|P4|Induction Period|Adverse Event|0
5140786|NCT01555125|17756504|P3|Induction Period|Adverse Event|0
5140787|NCT01555125|17756505|P2|Induction Period|Adverse Event|1
5140788|NCT01555125|17756506|P1|Induction Period|Adverse Event|0
5140789|NCT01555125|17756502|P5|Induction Period|Lost to Follow-up|0
5140790|NCT01555125|17756503|P4|Induction Period|Lost to Follow-up|0
5140791|NCT01555125|17756504|P3|Induction Period|Lost to Follow-up|0
5140792|NCT01555125|17756505|P2|Induction Period|Lost to Follow-up|2
5140793|NCT01555125|17756506|P1|Induction Period|Lost to Follow-up|0
5140794|NCT01555073|17756599|P4|Overall Study|Lost to Follow-up|5
5140795|NCT01555073|17756600|P3|Overall Study|Lost to Follow-up|0
5140796|NCT01555073|17756601|P2|Overall Study|Lost to Follow-up|2
5140797|NCT01555073|17756602|P1|Overall Study|Lost to Follow-up|1
5140798|NCT01555021|17756618|P2|Overall Study|Lost to Follow-up|2
5140799|NCT01555021|17756619|P1|Overall Study|Lost to Follow-up|1
5140800|NCT01554904|17756644|P1|Overall Study|Had sleep apnea on Home Study 1|1
5140801|NCT01554904|17756644|P1|Overall Study|Withdrawal by Subject|3
5140802|NCT01554579|17756689|P2|Overall Study|Withdrawal by Subject|1
5140803|NCT01554579|17756690|P1|Overall Study|Withdrawal by Subject|2
5140804|NCT01554579|17756689|P2|Overall Study|Lack of Efficacy|1
5140805|NCT01554579|17756690|P1|Overall Study|Lack of Efficacy|2
5140806|NCT01554579|17756689|P2|Overall Study|Adverse Event|25
5140807|NCT01554579|17756690|P1|Overall Study|Adverse Event|6
5140808|NCT01554527|17756703|P3|Overall Study|Physician Decision|1
5140809|NCT01554527|17756704|P2|Overall Study|Physician Decision|0
5140810|NCT01554527|17756705|P1|Overall Study|Physician Decision|0
5140811|NCT01554527|17756703|P3|Overall Study|Lost to Follow-up|4
5140812|NCT01554527|17756704|P2|Overall Study|Lost to Follow-up|0
5140813|NCT01554527|17756705|P1|Overall Study|Lost to Follow-up|0
5140814|NCT01554527|17756703|P3|Overall Study|Withdrawal by Subject|3
5140815|NCT01554527|17756704|P2|Overall Study|Withdrawal by Subject|0
5140816|NCT01554527|17756705|P1|Overall Study|Withdrawal by Subject|1
5140817|NCT01554241|17756761|P4|Overall Study|Withdrawal by Subject|0
5140818|NCT01554241|17756762|P3|Overall Study|Withdrawal by Subject|2
5140819|NCT01554241|17756763|P2|Overall Study|Withdrawal by Subject|0
5140820|NCT01554241|17756764|P1|Overall Study|Withdrawal by Subject|0
5140821|NCT01554241|17756761|P4|Overall Study|protocol specified change in eGFR|0
5140822|NCT01554241|17756762|P3|Overall Study|protocol specified change in eGFR|1
5140823|NCT01554241|17756763|P2|Overall Study|protocol specified change in eGFR|0
5140824|NCT01554241|17756764|P1|Overall Study|protocol specified change in eGFR|0
5140825|NCT01554241|17756761|P4|Overall Study|protocol specified renal stone|1
5140826|NCT01554241|17756762|P3|Overall Study|protocol specified renal stone|0
5140827|NCT01554241|17756763|P2|Overall Study|protocol specified renal stone|0
5140828|NCT01554241|17756764|P1|Overall Study|protocol specified renal stone|0
5140829|NCT01554241|17756761|P4|Overall Study|Death|0
5140830|NCT01554241|17756762|P3|Overall Study|Death|1
5140831|NCT01554241|17756763|P2|Overall Study|Death|1
5140832|NCT01554241|17756764|P1|Overall Study|Death|3
5140833|NCT01554176|17756780|P5|Run-out Phase|Protocol Violation|0
5140834|NCT01554176|17756781|P4|Run-out Phase|Protocol Violation|1
5140835|NCT01554176|17756782|P3|Run-out Phase|Protocol Violation|0
5140836|NCT01554176|17756783|P2|Run-out Phase|Protocol Violation|0
5140837|NCT01554176|17756784|P1|Run-out Phase|Protocol Violation|0
5140838|NCT01554176|17756780|P5|Treatment Phase|Lost to Follow-up|0
5140839|NCT01554176|17756781|P4|Treatment Phase|Lost to Follow-up|0
5140840|NCT01554176|17756782|P3|Treatment Phase|Lost to Follow-up|0
5140841|NCT01554176|17756783|P2|Treatment Phase|Lost to Follow-up|0
5140842|NCT01554176|17756784|P1|Treatment Phase|Lost to Follow-up|3
5140843|NCT01554176|17756780|P5|Treatment Phase|Withdrawal by Subject|0
5140844|NCT01554176|17756781|P4|Treatment Phase|Withdrawal by Subject|0
5140845|NCT01554176|17756782|P3|Treatment Phase|Withdrawal by Subject|0
5140846|NCT01554176|17756783|P2|Treatment Phase|Withdrawal by Subject|0
5140847|NCT01554176|17756784|P1|Treatment Phase|Withdrawal by Subject|1
5140848|NCT01554176|17756780|P5|Treatment Phase|Non-compliance with study drug|0
5140849|NCT01554176|17756781|P4|Treatment Phase|Non-compliance with study drug|0
5140850|NCT01554176|17756782|P3|Treatment Phase|Non-compliance with study drug|0
5140851|NCT01554176|17756783|P2|Treatment Phase|Non-compliance with study drug|0
5140852|NCT01554176|17756784|P1|Treatment Phase|Non-compliance with study drug|1
5140853|NCT01554176|17756780|P5|Treatment Phase|Adverse event, non-fatal|0
5140854|NCT01554176|17756781|P4|Treatment Phase|Adverse event, non-fatal|0
5140855|NCT01554176|17756782|P3|Treatment Phase|Adverse event, non-fatal|0
5140856|NCT01554176|17756783|P2|Treatment Phase|Adverse event, non-fatal|1
5140857|NCT01554176|17756784|P1|Treatment Phase|Adverse event, non-fatal|1
5140858|NCT01554176|17756780|P5|Treatment Phase|Lack of Efficacy|0
5140859|NCT01554176|17756781|P4|Treatment Phase|Lack of Efficacy|0
5140860|NCT01554176|17756782|P3|Treatment Phase|Lack of Efficacy|0
5140861|NCT01554176|17756783|P2|Treatment Phase|Lack of Efficacy|1
5140862|NCT01554176|17756784|P1|Treatment Phase|Lack of Efficacy|0
5140863|NCT01554176|17756780|P5|Treatment Phase|Physician Decision|0
5140864|NCT01554176|17756781|P4|Treatment Phase|Physician Decision|0
5140865|NCT01554176|17756782|P3|Treatment Phase|Physician Decision|0
5140866|NCT01554176|17756783|P2|Treatment Phase|Physician Decision|1
5140867|NCT01554176|17756784|P1|Treatment Phase|Physician Decision|1
5140868|NCT01554176|17756780|P5|Treatment Phase|Protocol Violation|0
5140869|NCT01554176|17756781|P4|Treatment Phase|Protocol Violation|0
5140870|NCT01554176|17756782|P3|Treatment Phase|Protocol Violation|0
5140871|NCT01554176|17756783|P2|Treatment Phase|Protocol Violation|2
5140872|NCT01554176|17756784|P1|Treatment Phase|Protocol Violation|1
5140873|NCT01554163|17756811|P2|Overall Study|Not Treated|0
5140874|NCT01554163|17756812|P1|Overall Study|Not Treated|1
5140875|NCT01554163|17756811|P2|Overall Study|Withdrawal by Subject|5
5140876|NCT01554163|17756812|P1|Overall Study|Withdrawal by Subject|1
5140877|NCT01554163|17756811|P2|Overall Study|Protocol Violation|4
5140878|NCT01554163|17756812|P1|Overall Study|Protocol Violation|0
5140879|NCT01554163|17756811|P2|Overall Study|Non-Compliance With Study Drug|1
5140880|NCT01554163|17756812|P1|Overall Study|Non-Compliance With Study Drug|1
5140881|NCT01554163|17756811|P2|Overall Study|Lost to Follow-up|0
5140882|NCT01554163|17756812|P1|Overall Study|Lost to Follow-up|1
5140883|NCT01554163|17756811|P2|Overall Study|Lack of Efficacy|0
5140884|NCT01554163|17756812|P1|Overall Study|Lack of Efficacy|1
5140885|NCT01554163|17756811|P2|Overall Study|Adverse Event|0
5140886|NCT01554163|17756812|P1|Overall Study|Adverse Event|3
5140887|NCT01553916|17756830|P1|Overall Study|Pre-treatment MRI metastatic disease|1
5140888|NCT01553916|17756830|P1|Overall Study|Withdrawal by Subject|2
5140889|NCT01553851|17756847|P1|Overall Study|constipation|1
5140890|NCT01553851|17756847|P1|Overall Study|Adverse Event|2
5140891|NCT01553747|17756862|P3|Overall Study|Physician decision: lack of efficacy|3
5140892|NCT01553747|17756863|P2|Overall Study|Physician decision: lack of efficacy|5
5140893|NCT01553747|17756864|P1|Overall Study|Physician decision: lack of efficacy|1
5140894|NCT01553747|17756862|P3|Overall Study|Sponsor decision, specify|0
5140895|NCT01553747|17756863|P2|Overall Study|Sponsor decision, specify|5
5140896|NCT01553747|17756864|P1|Overall Study|Sponsor decision, specify|7
5140897|NCT01553747|17756862|P3|Overall Study|Lost to Follow-up|6
5140898|NCT01553747|17756863|P2|Overall Study|Lost to Follow-up|5
5140899|NCT01553747|17756864|P1|Overall Study|Lost to Follow-up|11
5140900|NCT01553747|17756862|P3|Overall Study|Physician decision: other|7
5140901|NCT01553747|17756863|P2|Overall Study|Physician decision: other|8
5140902|NCT01553747|17756864|P1|Overall Study|Physician decision: other|10
5140903|NCT01553747|17756862|P3|Overall Study|Adverse event or SAE|19
5140904|NCT01553747|17756863|P2|Overall Study|Adverse event or SAE|28
5140905|NCT01553747|17756864|P1|Overall Study|Adverse event or SAE|32
5140906|NCT01553747|17756862|P3|Overall Study|Voluntarily withdrew|74
5140907|NCT01553747|17756863|P2|Overall Study|Voluntarily withdrew|66
5140908|NCT01553747|17756864|P1|Overall Study|Voluntarily withdrew|70
5140909|NCT01553747|17756862|P3|Overall Study|Protocol Violation|0
5140910|NCT01553747|17756863|P2|Overall Study|Protocol Violation|2
5140911|NCT01553747|17756864|P1|Overall Study|Protocol Violation|0
5140912|NCT01553591|17756926|P3|Overall Study|Randomized and never dispensed drug|0
5140913|NCT01553591|17756927|P2|Overall Study|Randomized and never dispensed drug|1
5140914|NCT01553591|17756928|P1|Overall Study|Randomized and never dispensed drug|0
5140915|NCT01553591|17756926|P3|Overall Study|Sponsor decision|3
5140916|NCT01553591|17756927|P2|Overall Study|Sponsor decision|0
5140917|NCT01553591|17756928|P1|Overall Study|Sponsor decision|1
5140918|NCT01553591|17756926|P3|Overall Study|Protocol Violation|4
5140919|NCT01553591|17756927|P2|Overall Study|Protocol Violation|4
5140920|NCT01553591|17756928|P1|Overall Study|Protocol Violation|3
5140921|NCT01553591|17756926|P3|Overall Study|Physician decision: lack of efficacy|7
5140922|NCT01553591|17756927|P2|Overall Study|Physician decision: lack of efficacy|3
5140923|NCT01553591|17756928|P1|Overall Study|Physician decision: lack of efficacy|2
5140924|NCT01553591|17756926|P3|Overall Study|Physician decision: other|16
5140925|NCT01553591|17756927|P2|Overall Study|Physician decision: other|14
5140926|NCT01553591|17756928|P1|Overall Study|Physician decision: other|11
5140927|NCT01553591|17756926|P3|Overall Study|Lost to Follow-up|16
5140928|NCT01553591|17756927|P2|Overall Study|Lost to Follow-up|23
5140929|NCT01553591|17756928|P1|Overall Study|Lost to Follow-up|25
5140930|NCT01553591|17756926|P3|Overall Study|Adverse Event|16
5140931|NCT01553591|17756927|P2|Overall Study|Adverse Event|45
5140932|NCT01553591|17756928|P1|Overall Study|Adverse Event|36
5140933|NCT01553591|17756926|P3|Overall Study|Voluntarily withdrew|96
5140934|NCT01553591|17756927|P2|Overall Study|Voluntarily withdrew|79
5140935|NCT01553591|17756928|P1|Overall Study|Voluntarily withdrew|94
5140936|NCT01553318|17756988|P2|Overall Study|Protocol Violation|2
5140937|NCT01553318|17756989|P1|Overall Study|Protocol Violation|3
5140938|NCT01553279|17757019|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
5140939|NCT01553279|17757020|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
5140940|NCT01553279|17757019|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
5140941|NCT01553279|17757020|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
5140942|NCT01553279|17757019|P2|Interim Period|Lost to Follow-up|0
5140943|NCT01553279|17757020|P1|Interim Period|Lost to Follow-up|1
5140944|NCT01553279|17757019|P2|Interim Period|Withdrawal by Subject|2
5140945|NCT01553279|17757020|P1|Interim Period|Withdrawal by Subject|2
5140946|NCT01553279|17757019|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
5140947|NCT01553279|17757020|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
5140948|NCT01553279|17757019|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
5140949|NCT01553279|17757020|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
5140950|NCT01553188|17757095|P4|Overall Study|Intercurrent illness and adverse event|0
5140951|NCT01553188|17757096|P3|Overall Study|Intercurrent illness and adverse event|2
5140952|NCT01553188|17757097|P2|Overall Study|Intercurrent illness and adverse event|1
5140953|NCT01553188|17757098|P1|Overall Study|Intercurrent illness and adverse event|0
5140954|NCT01553188|17757095|P4|Overall Study|Patient choice|0
5140955|NCT01553188|17757096|P3|Overall Study|Patient choice|0
5140956|NCT01553188|17757097|P2|Overall Study|Patient choice|0
5140957|NCT01553188|17757098|P1|Overall Study|Patient choice|1
5140958|NCT01553136|17757125|P2|Overall Study|Scheduling Difficulties|4
5140959|NCT01553136|17757126|P1|Overall Study|Scheduling Difficulties|5
5140960|NCT01553136|17757125|P2|Overall Study|Physician Decision|3
5140961|NCT01553136|17757126|P1|Overall Study|Physician Decision|2
5140962|NCT01553136|17757125|P2|Overall Study|Lost to Follow-up|10
5140963|NCT01553136|17757126|P1|Overall Study|Lost to Follow-up|4
5140964|NCT01553136|17757125|P2|Overall Study|Withdrawal by Subject|3
5140965|NCT01553136|17757126|P1|Overall Study|Withdrawal by Subject|2
5140966|NCT01553136|17757125|P2|Overall Study|Adverse Event|2
5140967|NCT01553136|17757126|P1|Overall Study|Adverse Event|3
5140968|NCT01553084|17757143|P3|Overall Study|Withdrawal by Subject|35
5140969|NCT01553084|17757144|P2|Overall Study|Withdrawal by Subject|13
5140970|NCT01553084|17757145|P1|Overall Study|Withdrawal by Subject|15
5140971|NCT01552954|17757227|P2|Overall Study|diagnosed DM|0
5140972|NCT01552954|17757228|P1|Overall Study|diagnosed DM|1
5140973|NCT01552954|17757227|P2|Overall Study|Protocol Violation|2
5140974|NCT01552954|17757228|P1|Overall Study|Protocol Violation|1
5140975|NCT01552954|17757227|P2|Overall Study|Withdrawal by Subject|1
5140976|NCT01552954|17757228|P1|Overall Study|Withdrawal by Subject|1
5140977|NCT01552954|17757227|P2|Overall Study|Lost to Follow-up|1
5140978|NCT01552954|17757228|P1|Overall Study|Lost to Follow-up|1
5140979|NCT01552954|17757227|P2|Overall Study|Adverse Event|2
5140980|NCT01552954|17757228|P1|Overall Study|Adverse Event|1
5140981|NCT01552928|17757244|P4|Period 3|Adverse Event|0
5140982|NCT01552928|17757245|P3|Period 3|Adverse Event|1
5140983|NCT01552928|17757246|P2|Period 3|Adverse Event|0
5140984|NCT01552928|17757247|P1|Period 3|Adverse Event|0
5140985|NCT01552915|17757294|P3|Overall Study|Other|6
5140986|NCT01552915|17757295|P2|Overall Study|Other|0
5140987|NCT01552915|17757296|P1|Overall Study|Other|2
5140988|NCT01552915|17757294|P3|Overall Study|Lack of Efficacy|4
5140989|NCT01552915|17757295|P2|Overall Study|Lack of Efficacy|1
5140990|NCT01552915|17757296|P1|Overall Study|Lack of Efficacy|8
5140991|NCT01552915|17757294|P3|Overall Study|Protocol Violation|4
5140992|NCT01552915|17757295|P2|Overall Study|Protocol Violation|4
5140993|NCT01552915|17757296|P1|Overall Study|Protocol Violation|0
5140994|NCT01552915|17757294|P3|Overall Study|Withdrawal by Subject|5
5140995|NCT01552915|17757295|P2|Overall Study|Withdrawal by Subject|4
5140996|NCT01552915|17757296|P1|Overall Study|Withdrawal by Subject|6
5140997|NCT01552915|17757294|P3|Overall Study|Lost to Follow-up|5
5140998|NCT01552915|17757295|P2|Overall Study|Lost to Follow-up|6
5140999|NCT01552915|17757296|P1|Overall Study|Lost to Follow-up|4
5141000|NCT01552915|17757294|P3|Overall Study|Adverse Event|3
5141001|NCT01552915|17757295|P2|Overall Study|Adverse Event|14
5141002|NCT01552915|17757296|P1|Overall Study|Adverse Event|3
5141003|NCT01552902|17757319|P3|Overall Study|Other|3
5141004|NCT01552902|17757320|P2|Overall Study|Other|4
5141005|NCT01552902|17757321|P1|Overall Study|Other|3
5141006|NCT01552902|17757319|P3|Overall Study|Lost to Follow-up|6
5141007|NCT01552902|17757320|P2|Overall Study|Lost to Follow-up|3
5141008|NCT01552902|17757321|P1|Overall Study|Lost to Follow-up|1
5141009|NCT01552902|17757319|P3|Overall Study|Withdrawal by Subject|6
5141010|NCT01552902|17757320|P2|Overall Study|Withdrawal by Subject|9
5141011|NCT01552902|17757321|P1|Overall Study|Withdrawal by Subject|1
5141012|NCT01552902|17757319|P3|Overall Study|Lack of Efficacy|1
5141013|NCT01552902|17757320|P2|Overall Study|Lack of Efficacy|3
5141014|NCT01552902|17757321|P1|Overall Study|Lack of Efficacy|4
5141015|NCT01552902|17757319|P3|Overall Study|Protocol Violation|3
5141016|NCT01552902|17757320|P2|Overall Study|Protocol Violation|3
5141017|NCT01552902|17757321|P1|Overall Study|Protocol Violation|3
5141018|NCT01552902|17757319|P3|Overall Study|Adverse Event|14
5141019|NCT01552902|17757320|P2|Overall Study|Adverse Event|15
5141020|NCT01552902|17757321|P1|Overall Study|Adverse Event|1
5141021|NCT01552772|17757371|P1|Overall Study|Protocol Deviation|1
5141022|NCT01552772|17757371|P1|Overall Study|Adverse Event|1
5141023|NCT01552772|17757371|P1|Overall Study|Lost to Follow-up|2
5141024|NCT01552694|17757387|P2|Overall Study|Protocol Violation|1
5141025|NCT01552694|17757388|P1|Overall Study|Protocol Violation|0
5141026|NCT01552694|17757387|P2|Overall Study|Lost to Follow-up|1
5141027|NCT01552694|17757388|P1|Overall Study|Lost to Follow-up|0
5141028|NCT01552681|17757404|P2|Overall Study|Subject moved away|1
5141029|NCT01552681|17757405|P1|Overall Study|Subject moved away|0
5141030|NCT01552681|17757404|P2|Overall Study|Physician Decision|0
5141031|NCT01552681|17757405|P1|Overall Study|Physician Decision|1
5141032|NCT01552681|17757404|P2|Overall Study|Withdrawal by Subject|0
5141033|NCT01552681|17757405|P1|Overall Study|Withdrawal by Subject|4
5141034|NCT01552603|17757453|P1|Overall Study|Physician Decision|1
5141035|NCT01552408|17757460|P2|Overall Study|Withdrawal by Subject|1
5141036|NCT01552408|17757461|P1|Overall Study|Withdrawal by Subject|2
5141037|NCT01552408|17757460|P2|Overall Study|Relocation|1
5141038|NCT01552408|17757461|P1|Overall Study|Relocation|0
5141039|NCT01552408|17757460|P2|Overall Study|Lost to Follow-up|0
5141040|NCT01552408|17757461|P1|Overall Study|Lost to Follow-up|2
5141041|NCT01552369|17757483|P2|Overall Study|Did not consent to extended follow up|9
5141042|NCT01552369|17757484|P1|Overall Study|Did not consent to extended follow up|8
5141043|NCT01552057|17757573|P2|Overall Study|Physician Decision|0
5141044|NCT01552057|17757574|P1|Overall Study|Physician Decision|1
5141045|NCT01552057|17757573|P2|Overall Study|Entry Criteria Not Met|2
5141046|NCT01552057|17757574|P1|Overall Study|Entry Criteria Not Met|2
5141047|NCT01552057|17757573|P2|Overall Study|Withdrawal by Subject|8
5141048|NCT01552057|17757574|P1|Overall Study|Withdrawal by Subject|5
5141049|NCT01552057|17757573|P2|Overall Study|Lack of Efficacy|23
5141050|NCT01552057|17757574|P1|Overall Study|Lack of Efficacy|8
5141051|NCT01552057|17757573|P2|Overall Study|Adverse Event|15
5141052|NCT01552057|17757574|P1|Overall Study|Adverse Event|14
5141053|NCT01551758|17757640|P2|Overall Study|Withdrawal by Subject|17
5141054|NCT01551758|17757641|P1|Overall Study|Withdrawal by Subject|14
5141055|NCT01551758|17757640|P2|Overall Study|Physician Decision|3
5141056|NCT01551758|17757641|P1|Overall Study|Physician Decision|9
5141057|NCT01551758|17757640|P2|Overall Study|Lost to Follow-up|25
5141058|NCT01551758|17757641|P1|Overall Study|Lost to Follow-up|29
5141059|NCT01551758|17757640|P2|Overall Study|Met Protocol-defined stopping criteria|10
5141060|NCT01551758|17757641|P1|Overall Study|Met Protocol-defined stopping criteria|8
5141061|NCT01551758|17757640|P2|Overall Study|Protocol Violation|6
5141062|NCT01551758|17757641|P1|Overall Study|Protocol Violation|5
5141063|NCT01551758|17757640|P2|Overall Study|Lack of Efficacy|1
5141064|NCT01551758|17757641|P1|Overall Study|Lack of Efficacy|0
5141065|NCT01551758|17757640|P2|Overall Study|Adverse Event|43
5141066|NCT01551758|17757641|P1|Overall Study|Adverse Event|29
5141067|NCT01551745|17757679|P1|Overall Study|Disease Progression|2
5141068|NCT01551745|17757679|P1|Overall Study|Withdrawal by Subject|1
5141069|NCT01551693|17757688|P2|Overall Study|Withdrawal by Subject|1
5141070|NCT01551693|17757689|P1|Overall Study|Withdrawal by Subject|0
5141071|NCT01551693|17757688|P2|Overall Study|Adverse Event|1
5141072|NCT01551693|17757689|P1|Overall Study|Adverse Event|0
5141073|NCT01551693|17757688|P2|Overall Study|Disease Progression|0
5141074|NCT01551693|17757689|P1|Overall Study|Disease Progression|1
5141075|NCT01551420|17757710|P2|Home Use (Part B)|Withdrawal by staff|1
5141076|NCT01551420|17757711|P1|Home Use (Part B)|Withdrawal by staff|0
5141077|NCT01551420|17757710|P2|Home Use (Part B)|Withdrawal by Subject|0
5141078|NCT01551420|17757711|P1|Home Use (Part B)|Withdrawal by Subject|6
5141079|NCT01551420|17757710|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
5141080|NCT01551420|17757711|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
5141081|NCT01551420|17757710|P2|Screened for Part B Eligibility|Declined participation|1
5141082|NCT01551420|17757711|P1|Screened for Part B Eligibility|Declined participation|8
5141083|NCT01551420|17757710|P2|In-laboratory (Part A)|Scheduling conflict|1
5141084|NCT01551420|17757711|P1|In-laboratory (Part A)|Scheduling conflict|2
5141085|NCT01551420|17757710|P2|In-laboratory (Part A)|Withdrawal by Subject|0
5141086|NCT01551420|17757711|P1|In-laboratory (Part A)|Withdrawal by Subject|2
5141087|NCT01551420|17757710|P2|In-laboratory (Part A)|Lost to Follow-up|1
5141088|NCT01551420|17757711|P1|In-laboratory (Part A)|Lost to Follow-up|2
5141089|NCT01551355|17757741|P6|Overall Study|Lost to Follow-up|6
5141090|NCT01551355|17757742|P5|Overall Study|Lost to Follow-up|9
5141091|NCT01551355|17757743|P4|Overall Study|Lost to Follow-up|24
5141092|NCT01551355|17757744|P3|Overall Study|Lost to Follow-up|34
5141093|NCT01551355|17757745|P2|Overall Study|Lost to Follow-up|49
5141094|NCT01551355|17757746|P1|Overall Study|Lost to Follow-up|51
5141095|NCT01551303|17757760|P2|Overall Study|failed awareness check on vision test|7
5141096|NCT01551303|17757761|P1|Overall Study|failed awareness check on vision test|4
5141097|NCT01551212|17757769|P2|Overall Study|Never Received Study Treatment|4
5141098|NCT01551212|17757770|P1|Overall Study|Never Received Study Treatment|2
5141099|NCT01551212|17757769|P2|Overall Study|Death|4
5141100|NCT01551212|17757770|P1|Overall Study|Death|2
5141101|NCT01551212|17757769|P2|Overall Study|Withdrawal by Subject|7
5141102|NCT01551212|17757770|P1|Overall Study|Withdrawal by Subject|0
5141103|NCT01551212|17757769|P2|Overall Study|Protocol Violation|1
5141104|NCT01551212|17757770|P1|Overall Study|Protocol Violation|0
5141105|NCT01551212|17757769|P2|Overall Study|Lost to Follow-up|1
5141106|NCT01551212|17757770|P1|Overall Study|Lost to Follow-up|0
5141107|NCT01551212|17757769|P2|Overall Study|Administrative problems|2
5141108|NCT01551212|17757770|P1|Overall Study|Administrative problems|1
5141109|NCT01551212|17757769|P2|Overall Study|Graft loss/Retransplantation|1
5141110|NCT01551212|17757770|P1|Overall Study|Graft loss/Retransplantation|0
5141111|NCT01551173|17757805|P2|Overall Study|Other|3
5141112|NCT01551173|17757806|P1|Overall Study|Other|5
5141113|NCT01551173|17757805|P2|Overall Study|Lost to Follow-up|7
5141114|NCT01551173|17757806|P1|Overall Study|Lost to Follow-up|5
5141115|NCT01551173|17757805|P2|Overall Study|Adverse Event|6
5141116|NCT01551173|17757806|P1|Overall Study|Adverse Event|7
5141117|NCT01551173|17757805|P2|Overall Study|Withdrawal by Subject|16
5141118|NCT01551173|17757806|P1|Overall Study|Withdrawal by Subject|11
5141119|NCT01550965|17757883|P1|Overall Study|Other|13
5141120|NCT01550965|17757883|P1|Overall Study|Lack of Efficacy|59
5141121|NCT01550965|17757883|P1|Overall Study|Lost to Follow-up|2
5141122|NCT01550965|17757883|P1|Overall Study|Withdrawal by Subject|10
5141123|NCT01550965|17757883|P1|Overall Study|Adverse Event|26
5141124|NCT01550757|17757927|P4|Overall Study|Withdrawal by Subject|1
5141125|NCT01550757|17757928|P3|Overall Study|Withdrawal by Subject|3
5141126|NCT01550757|17757929|P2|Overall Study|Withdrawal by Subject|0
5141127|NCT01550757|17757930|P1|Overall Study|Withdrawal by Subject|2
5141128|NCT01550757|17757927|P4|Overall Study|Lost to Follow-up|53
5141129|NCT01550757|17757928|P3|Overall Study|Lost to Follow-up|42
5141130|NCT01550757|17757929|P2|Overall Study|Lost to Follow-up|14
5141131|NCT01550757|17757930|P1|Overall Study|Lost to Follow-up|21
5141132|NCT01550744|17757940|P3|Double-Blind|Other|10
5141133|NCT01550744|17757941|P2|Double-Blind|Other|2
5141134|NCT01550744|17757942|P1|Double-Blind|Other|0
5141135|NCT01550744|17757940|P3|Double-Blind|Pregnancy|3
5141136|NCT01550744|17757941|P2|Double-Blind|Pregnancy|0
5141137|NCT01550744|17757942|P1|Double-Blind|Pregnancy|0
5141138|NCT01550744|17757940|P3|Double-Blind|Protocol Violation|4
5141139|NCT01550744|17757941|P2|Double-Blind|Protocol Violation|0
5141140|NCT01550744|17757942|P1|Double-Blind|Protocol Violation|0
5141141|NCT01550744|17757940|P3|Double-Blind|Lack of Efficacy|8
5141142|NCT01550744|17757941|P2|Double-Blind|Lack of Efficacy|2
5141143|NCT01550744|17757942|P1|Double-Blind|Lack of Efficacy|0
5141144|NCT01550744|17757940|P3|Double-Blind|Death|0
5141145|NCT01550744|17757941|P2|Double-Blind|Death|1
5141146|NCT01550744|17757942|P1|Double-Blind|Death|0
5141147|NCT01550744|17757940|P3|Double-Blind|Adverse Event|15
5141148|NCT01550744|17757941|P2|Double-Blind|Adverse Event|4
5141149|NCT01550744|17757942|P1|Double-Blind|Adverse Event|0
5141150|NCT01550744|17757940|P3|Double-Blind|Withdrawal by Subject|15
5141151|NCT01550744|17757941|P2|Double-Blind|Withdrawal by Subject|2
5141152|NCT01550744|17757942|P1|Double-Blind|Withdrawal by Subject|0
5141153|NCT01550744|17757940|P3|Double-Blind|Lost to Follow-up|12
5141154|NCT01550744|17757941|P2|Double-Blind|Lost to Follow-up|6
5141155|NCT01550744|17757942|P1|Double-Blind|Lost to Follow-up|0
5141156|NCT01550744|17757940|P3|Open-Label|Other|0
5141157|NCT01550744|17757941|P2|Open-Label|Other|0
5141158|NCT01550744|17757942|P1|Open-Label|Other|1
5141159|NCT01550744|17757940|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
5141160|NCT01550744|17757941|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
5141161|NCT01550744|17757942|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
5141162|NCT01550744|17757940|P3|Open-Label|Not all 3 study drug injections received|0
5141163|NCT01550744|17757941|P2|Open-Label|Not all 3 study drug injections received|0
5141164|NCT01550744|17757942|P1|Open-Label|Not all 3 study drug injections received|2
5141165|NCT01550744|17757940|P3|Open-Label|Protocol Violation|0
5141166|NCT01550744|17757941|P2|Open-Label|Protocol Violation|0
5141167|NCT01550744|17757942|P1|Open-Label|Protocol Violation|4
5141168|NCT01550744|17757940|P3|Open-Label|Lack of Efficacy|0
5141169|NCT01550744|17757941|P2|Open-Label|Lack of Efficacy|0
5141170|NCT01550744|17757942|P1|Open-Label|Lack of Efficacy|4
5141171|NCT01550744|17757940|P3|Open-Label|Adverse Event|0
5141172|NCT01550744|17757941|P2|Open-Label|Adverse Event|0
5141173|NCT01550744|17757942|P1|Open-Label|Adverse Event|11
5141174|NCT01550744|17757940|P3|Open-Label|Withdrawal by Subject|0
5141175|NCT01550744|17757941|P2|Open-Label|Withdrawal by Subject|0
5141176|NCT01550744|17757942|P1|Open-Label|Withdrawal by Subject|13
5141177|NCT01550744|17757940|P3|Open-Label|Lost to Follow-up|0
5141178|NCT01550744|17757941|P2|Open-Label|Lost to Follow-up|0
5141179|NCT01550744|17757942|P1|Open-Label|Lost to Follow-up|7
5141180|NCT01550289|17758091|P2|Overall Study|Withdrawal by Subject|3
5141181|NCT01550289|17758092|P1|Overall Study|Withdrawal by Subject|11
5141182|NCT01550289|17758091|P2|Overall Study|Lost to Follow-up|1
5141183|NCT01550289|17758092|P1|Overall Study|Lost to Follow-up|1
5141184|NCT01550289|17758091|P2|Overall Study|Protocol Violation|0
5141185|NCT01550289|17758092|P1|Overall Study|Protocol Violation|1
5141186|NCT01549964|17758168|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
5141187|NCT01549964|17758169|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
5141188|NCT01549964|17758170|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
5141189|NCT01549964|17758171|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
5141190|NCT01549964|17758168|P4|80-Week Extension Period|Lost to Follow-up|1
5141191|NCT01549964|17758169|P3|80-Week Extension Period|Lost to Follow-up|2
5141192|NCT01549964|17758170|P2|80-Week Extension Period|Lost to Follow-up|0
5141193|NCT01549964|17758171|P1|80-Week Extension Period|Lost to Follow-up|1
5141194|NCT01549964|17758168|P4|80-Week Extension Period|Voluntary Withdrawal|2
5141195|NCT01549964|17758169|P3|80-Week Extension Period|Voluntary Withdrawal|4
5141196|NCT01549964|17758170|P2|80-Week Extension Period|Voluntary Withdrawal|1
5141197|NCT01549964|17758171|P1|80-Week Extension Period|Voluntary Withdrawal|0
5141198|NCT01549964|17758168|P4|80-Week Extension Period|Study Terminated by Sponsor|132
5141199|NCT01549964|17758169|P3|80-Week Extension Period|Study Terminated by Sponsor|132
5141200|NCT01549964|17758170|P2|80-Week Extension Period|Study Terminated by Sponsor|137
5141201|NCT01549964|17758171|P1|80-Week Extension Period|Study Terminated by Sponsor|65
5141202|NCT01549964|17758168|P4|80-Week Extension Period|Pregnancy|0
5141203|NCT01549964|17758169|P3|80-Week Extension Period|Pregnancy|1
5141204|NCT01549964|17758170|P2|80-Week Extension Period|Pregnancy|0
5141205|NCT01549964|17758171|P1|80-Week Extension Period|Pregnancy|0
5141206|NCT01549964|17758168|P4|24-Week Treatment Period|Completion Status Unknown|0
5141207|NCT01549964|17758169|P3|24-Week Treatment Period|Completion Status Unknown|1
5141208|NCT01549964|17758170|P2|24-Week Treatment Period|Completion Status Unknown|0
5141209|NCT01549964|17758171|P1|24-Week Treatment Period|Completion Status Unknown|1
5141210|NCT01549964|17758168|P4|24-Week Treatment Period|Randomized but Not Treated|1
5141211|NCT01549964|17758169|P3|24-Week Treatment Period|Randomized but Not Treated|0
5141212|NCT01549964|17758170|P2|24-Week Treatment Period|Randomized but Not Treated|0
5141213|NCT01549964|17758171|P1|24-Week Treatment Period|Randomized but Not Treated|0
5141214|NCT01549964|17758168|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5141215|NCT01549964|17758169|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
5141216|NCT01549964|17758170|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5141217|NCT01549964|17758171|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5141218|NCT01549964|17758168|P4|24-Week Treatment Period|Other|0
5141219|NCT01549964|17758169|P3|24-Week Treatment Period|Other|1
5141220|NCT01549964|17758170|P2|24-Week Treatment Period|Other|0
5141221|NCT01549964|17758171|P1|24-Week Treatment Period|Other|1
5141222|NCT01549964|17758168|P4|24-Week Treatment Period|Lack of Efficacy|1
5141223|NCT01549964|17758169|P3|24-Week Treatment Period|Lack of Efficacy|1
5141224|NCT01549964|17758170|P2|24-Week Treatment Period|Lack of Efficacy|0
5141225|NCT01549964|17758171|P1|24-Week Treatment Period|Lack of Efficacy|1
5141226|NCT01549964|17758168|P4|24-Week Treatment Period|Lost to Follow-up|2
5141227|NCT01549964|17758169|P3|24-Week Treatment Period|Lost to Follow-up|1
5141228|NCT01549964|17758170|P2|24-Week Treatment Period|Lost to Follow-up|0
5141229|NCT01549964|17758171|P1|24-Week Treatment Period|Lost to Follow-up|1
5141230|NCT01549964|17758168|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5141231|NCT01549964|17758169|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5141232|NCT01549964|17758170|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5141233|NCT01549964|17758171|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
5141234|NCT01549964|17758168|P4|24-Week Treatment Period|Voluntary Withdrawal|8
5141235|NCT01549964|17758169|P3|24-Week Treatment Period|Voluntary Withdrawal|3
5141236|NCT01549964|17758170|P2|24-Week Treatment Period|Voluntary Withdrawal|3
5141237|NCT01549964|17758171|P1|24-Week Treatment Period|Voluntary Withdrawal|6
5141238|NCT01549964|17758168|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
5141239|NCT01549964|17758169|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
5141240|NCT01549964|17758170|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
5141241|NCT01549964|17758171|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
5141242|NCT01549951|17758189|P1|Overall Study|Other|2
5141243|NCT01549951|17758189|P1|Overall Study|Symptomatic deterioration|1
5141244|NCT01549951|17758189|P1|Overall Study|Progressive disease|29
5141245|NCT01549951|17758189|P1|Overall Study|Unsatisfactory therapeutic response|1
5141246|NCT01549951|17758189|P1|Overall Study|Withdrawal by Subject|2
5141247|NCT01549951|17758189|P1|Overall Study|Adverse Event|15
5141248|NCT01549873|17758216|P2|Overall Study|Physician Decision|1
5141249|NCT01549873|17758217|P1|Overall Study|Physician Decision|0
5141250|NCT01549860|17758229|P2|Overall Study|Physician Decision|1
5141251|NCT01549860|17758230|P1|Overall Study|Physician Decision|1
5141252|NCT01549860|17758229|P2|Overall Study|Withdrawal by Subject|0
5141253|NCT01549860|17758230|P1|Overall Study|Withdrawal by Subject|1
5141254|NCT01549652|17758243|P4|Overall Study|Withdrawal by Subject|3
5141255|NCT01549652|17758244|P3|Overall Study|Withdrawal by Subject|5
5141256|NCT01549652|17758245|P2|Overall Study|Withdrawal by Subject|0
5141257|NCT01549652|17758246|P1|Overall Study|Withdrawal by Subject|0
5141258|NCT01549652|17758243|P4|Overall Study|Titration Side Effects|3
5141259|NCT01549652|17758244|P3|Overall Study|Titration Side Effects|6
5141260|NCT01549652|17758245|P2|Overall Study|Titration Side Effects|0
5141261|NCT01549652|17758246|P1|Overall Study|Titration Side Effects|0
5141262|NCT01549652|17758243|P4|Overall Study|Titration Non-Compliance|5
5141263|NCT01549652|17758244|P3|Overall Study|Titration Non-Compliance|4
5141264|NCT01549652|17758245|P2|Overall Study|Titration Non-Compliance|3
5141265|NCT01549652|17758246|P1|Overall Study|Titration Non-Compliance|1
5141266|NCT01549652|17758243|P4|Overall Study|Problem with Infusion|0
5141267|NCT01549652|17758244|P3|Overall Study|Problem with Infusion|0
5141268|NCT01549652|17758245|P2|Overall Study|Problem with Infusion|0
5141269|NCT01549652|17758246|P1|Overall Study|Problem with Infusion|1
5141270|NCT01549652|17758243|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
5141271|NCT01549652|17758244|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
5141272|NCT01549652|17758245|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
5141273|NCT01549652|17758246|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
5141274|NCT01549652|17758243|P4|Overall Study|Withdrawal Effect|0
5141275|NCT01549652|17758244|P3|Overall Study|Withdrawal Effect|0
5141276|NCT01549652|17758245|P2|Overall Study|Withdrawal Effect|2
5141277|NCT01549652|17758246|P1|Overall Study|Withdrawal Effect|0
5141278|NCT01549652|17758243|P4|Overall Study|Study Drug Titration Failure|0
5141279|NCT01549652|17758244|P3|Overall Study|Study Drug Titration Failure|0
5141280|NCT01549652|17758245|P2|Overall Study|Study Drug Titration Failure|6
5141281|NCT01549652|17758246|P1|Overall Study|Study Drug Titration Failure|5
5141282|NCT01549652|17758243|P4|Overall Study|Did Not Receive Allocated Intervention|0
5141283|NCT01549652|17758244|P3|Overall Study|Did Not Receive Allocated Intervention|2
5141284|NCT01549652|17758245|P2|Overall Study|Did Not Receive Allocated Intervention|0
5141285|NCT01549652|17758246|P1|Overall Study|Did Not Receive Allocated Intervention|0
5141286|NCT01549613|17758264|P2|Overall Study|Lost to Follow-up|11
5141287|NCT01549613|17758265|P1|Overall Study|Lost to Follow-up|11
5141288|NCT01549392|17758303|P2|Overall Study|Withdrawal by Subject|0
5141289|NCT01549392|17758304|P1|Overall Study|Withdrawal by Subject|1
5141290|NCT01549275|17758342|P2|Overall Study|Lost to Follow-up|0
5141291|NCT01549275|17758343|P1|Overall Study|Lost to Follow-up|1
5141292|NCT01549041|17758366|P2|Overall Study|Adverse Event|4
5141293|NCT01549041|17758367|P1|Overall Study|Adverse Event|0
5141294|NCT01549041|17758366|P2|Overall Study|Lack of Efficacy|4
5141295|NCT01549041|17758367|P1|Overall Study|Lack of Efficacy|2
5141296|NCT01549002|17758377|P2|Overall Study|Moderate sedation required|2
5141297|NCT01549002|17758378|P1|Overall Study|Moderate sedation required|0
5141298|NCT01549002|17758377|P2|Overall Study|Excessive pain|2
5141299|NCT01549002|17758378|P1|Overall Study|Excessive pain|0
5141300|NCT01548768|17758405|P4|Overall Study|Non-Compliance|3
5141301|NCT01548768|17758406|P3|Overall Study|Non-Compliance|0
5141302|NCT01548768|17758407|P2|Overall Study|Non-Compliance|0
5141303|NCT01548768|17758408|P1|Overall Study|Non-Compliance|0
5141304|NCT01548768|17758405|P4|Overall Study|Adverse Event|1
5141305|NCT01548768|17758406|P3|Overall Study|Adverse Event|0
5141306|NCT01548768|17758407|P2|Overall Study|Adverse Event|0
5141307|NCT01548768|17758408|P1|Overall Study|Adverse Event|0
5141308|NCT01548768|17758405|P4|Overall Study|Physician Decision|0
5141309|NCT01548768|17758406|P3|Overall Study|Physician Decision|0
5141310|NCT01548768|17758407|P2|Overall Study|Physician Decision|0
5141311|NCT01548768|17758408|P1|Overall Study|Physician Decision|1
5141312|NCT01548768|17758405|P4|Overall Study|Withdrawal by Subject|0
5141313|NCT01548768|17758406|P3|Overall Study|Withdrawal by Subject|1
5141314|NCT01548768|17758407|P2|Overall Study|Withdrawal by Subject|2
5141315|NCT01548768|17758408|P1|Overall Study|Withdrawal by Subject|0
5141316|NCT01548638|17758486|P1|Overall Study|Withdrawal by Subject|1
5141317|NCT01548638|17758486|P1|Overall Study|Protocol Violation|3
5141318|NCT01548599|17758498|P2|Overall Study|Death|1
5141319|NCT01548599|17758499|P1|Overall Study|Death|2
5141320|NCT01548599|17758498|P2|Overall Study|Withdrawal by Subject|0
5141321|NCT01548599|17758499|P1|Overall Study|Withdrawal by Subject|4
5141322|NCT01548599|17758498|P2|Overall Study|Lost to Follow-up|1
5141323|NCT01548599|17758499|P1|Overall Study|Lost to Follow-up|0
5141324|NCT01548573|17758515|P1|Overall Study|Withdrawal by Subject|2
5141325|NCT01548573|17758515|P1|Overall Study|Death|3
5141326|NCT01548417|17758524|P2|Overall Study|Withdrawal by Subject|2
5141327|NCT01548417|17758525|P1|Overall Study|Withdrawal by Subject|0
5141328|NCT01548404|17758535|P2|Overall Study|Other than specified above|2
5141329|NCT01548404|17758536|P1|Overall Study|Other than specified above|0
5141330|NCT01548404|17758535|P2|Overall Study|Withdrawal by Subject|3
5141331|NCT01548404|17758536|P1|Overall Study|Withdrawal by Subject|0
5141332|NCT01548404|17758535|P2|Overall Study|Lost to Follow-up|0
5141333|NCT01548404|17758536|P1|Overall Study|Lost to Follow-up|2
5141334|NCT01548404|17758535|P2|Overall Study|Inadequate response to study treatment|7
5141335|NCT01548404|17758536|P1|Overall Study|Inadequate response to study treatment|23
5141336|NCT01548404|17758535|P2|Overall Study|Physician Decision|1
5141337|NCT01548404|17758536|P1|Overall Study|Physician Decision|2
5141338|NCT01548404|17758535|P2|Overall Study|Adverse Event|1
5141339|NCT01548404|17758536|P1|Overall Study|Adverse Event|3
5141340|NCT01548287|17758575|P5|Randomized Period|Adverse Event|0
5141341|NCT01548287|17758576|P4|Randomized Period|Adverse Event|0
5141342|NCT01548287|17758577|P3|Randomized Period|Adverse Event|5
5141343|NCT01548287|17758578|P2|Randomized Period|Adverse Event|2
5141344|NCT01548287|17758579|P1|Randomized Period|Adverse Event|0
5141345|NCT01548287|17758575|P5|Randomized Period|Did not meet inclusion criteria|0
5141346|NCT01548287|17758576|P4|Randomized Period|Did not meet inclusion criteria|0
5141347|NCT01548287|17758577|P3|Randomized Period|Did not meet inclusion criteria|2
5141348|NCT01548287|17758578|P2|Randomized Period|Did not meet inclusion criteria|0
5141349|NCT01548287|17758579|P1|Randomized Period|Did not meet inclusion criteria|0
5141350|NCT01548287|17758575|P5|Screening|Did not meet eligibility criteria|74
5141351|NCT01548287|17758576|P4|Screening|Did not meet eligibility criteria|0
5141352|NCT01548287|17758577|P3|Screening|Did not meet eligibility criteria|0
5141353|NCT01548287|17758578|P2|Screening|Did not meet eligibility criteria|0
5141354|NCT01548287|17758579|P1|Screening|Did not meet eligibility criteria|0
5141355|NCT01548287|17758575|P5|Screening|No reason provided|9
5141356|NCT01548287|17758576|P4|Screening|No reason provided|0
5141357|NCT01548287|17758577|P3|Screening|No reason provided|0
5141358|NCT01548287|17758578|P2|Screening|No reason provided|0
5141359|NCT01548287|17758579|P1|Screening|No reason provided|0
5141360|NCT01547728|17758636|P1|Overall Study|Screen failure|39
5141361|NCT01547728|17758636|P1|Overall Study|Drug not ready for subject|1
5141362|NCT01547728|17758636|P1|Overall Study|Change in procedure and equipment|1
5141363|NCT01547598|17758745|P2|Overall Study|Other Miscellaneous Reasons|1
5141364|NCT01547598|17758746|P1|Overall Study|Other Miscellaneous Reasons|2
5141365|NCT01547598|17758745|P2|Overall Study|Protocol Violation|1
5141366|NCT01547598|17758746|P1|Overall Study|Protocol Violation|1
5141367|NCT01547598|17758745|P2|Overall Study|Adverse Event|1
5141368|NCT01547598|17758746|P1|Overall Study|Adverse Event|1
5141369|NCT01547598|17758745|P2|Overall Study|Lost to Follow-up|1
5141370|NCT01547598|17758746|P1|Overall Study|Lost to Follow-up|1
5141371|NCT01547598|17758745|P2|Overall Study|Withdrew consent|1
5141372|NCT01547598|17758746|P1|Overall Study|Withdrew consent|1
5141373|NCT01547390|17758763|P2|Overall Study|Adverse Event|0
5141374|NCT01547390|17758764|P1|Overall Study|Adverse Event|3
5141375|NCT01547390|17758763|P2|Overall Study|Lost to Follow-up|2
5141376|NCT01547390|17758764|P1|Overall Study|Lost to Follow-up|0
5141377|NCT01547390|17758763|P2|Overall Study|termination of pregnancy|1
5141378|NCT01547390|17758764|P1|Overall Study|termination of pregnancy|0
5141379|NCT01547390|17758763|P2|Overall Study|Withdrawal by Subject|7
5141380|NCT01547390|17758764|P1|Overall Study|Withdrawal by Subject|10
5141381|NCT01547299|17758774|P2|Overall Study|Withdrawal by Subject|2
5141382|NCT01547299|17758775|P1|Overall Study|Withdrawal by Subject|2
5141383|NCT01547286|17758841|P1|Overall Study|Physician Decision|1
5141384|NCT01547286|17758841|P1|Overall Study|Did not meet all eligibility criteria|1
5141385|NCT01547130|17758861|P2|Overall Study|Lost to Follow-up|5
5141386|NCT01547130|17758862|P1|Overall Study|Lost to Follow-up|9
5141387|NCT01546922|17758885|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
5141388|NCT01546922|17758886|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
5141389|NCT01546922|17758885|P2|Second Period of 10 Weeks|Protocol Violation|1
5141390|NCT01546922|17758886|P1|Second Period of 10 Weeks|Protocol Violation|3
5141391|NCT01546922|17758885|P2|First Period of 10 Weeks|Investigator's judgment|0
5141392|NCT01546922|17758886|P1|First Period of 10 Weeks|Investigator's judgment|1
5141393|NCT01546922|17758885|P2|First Period of 10 Weeks|Withdrawal by Subject|1
5141394|NCT01546922|17758886|P1|First Period of 10 Weeks|Withdrawal by Subject|1
5141395|NCT01546922|17758885|P2|First Period of 10 Weeks|Protocol Violation|1
5141396|NCT01546922|17758886|P1|First Period of 10 Weeks|Protocol Violation|3
5141397|NCT01546883|17758892|P1|Overall Study|other unrelated illness|1
5141398|NCT01546883|17758892|P1|Overall Study|early closure of study|2
5141399|NCT01546883|17758892|P1|Overall Study|Lost to Follow-up|2
5141400|NCT01546883|17758892|P1|Overall Study|Adverse Event|4
5141401|NCT01546883|17758892|P1|Overall Study|Withdrawal by Subject|3
5141402|NCT01546688|17758898|P2|Overall Study|Lack of Efficacy|0
5141403|NCT01546688|17758899|P1|Overall Study|Lack of Efficacy|1
5141404|NCT01546688|17758898|P2|Overall Study|Withdrawal by Subject|1
5141405|NCT01546688|17758899|P1|Overall Study|Withdrawal by Subject|2
5141406|NCT01546688|17758898|P2|Overall Study|Adverse Event|4
5141407|NCT01546688|17758899|P1|Overall Study|Adverse Event|0
5141408|NCT01546649|17758931|P2|Overall Study|Withdrawal by Subject|2
5141409|NCT01546649|17758932|P1|Overall Study|Withdrawal by Subject|1
5141410|NCT01546649|17758931|P2|Overall Study|Discovery of secondary cancer|1
5141411|NCT01546649|17758932|P1|Overall Study|Discovery of secondary cancer|0
5141412|NCT01546649|17758931|P2|Overall Study|Recurrence|1
5141413|NCT01546649|17758932|P1|Overall Study|Recurrence|1
5141414|NCT01546649|17758931|P2|Overall Study|Lack of Efficacy|0
5141415|NCT01546649|17758932|P1|Overall Study|Lack of Efficacy|1
5141416|NCT01546649|17758931|P2|Overall Study|Protocol Violation|0
5141417|NCT01546649|17758932|P1|Overall Study|Protocol Violation|1
5141418|NCT01546649|17758931|P2|Overall Study|Adverse Event|5
5141419|NCT01546649|17758932|P1|Overall Study|Adverse Event|4
5141420|NCT01546623|17758967|P2|Overall Study|Did Not Receive Study Drug|1
5141421|NCT01546623|17758968|P1|Overall Study|Did Not Receive Study Drug|1
5141422|NCT01546623|17758967|P2|Overall Study|High Prostate specific antigen|1
5141423|NCT01546623|17758968|P1|Overall Study|High Prostate specific antigen|2
5141424|NCT01546623|17758967|P2|Overall Study|Major Protocol Deviation|1
5141425|NCT01546623|17758968|P1|Overall Study|Major Protocol Deviation|1
5141426|NCT01546623|17758967|P2|Overall Study|Adverse Event|3
5141427|NCT01546623|17758968|P1|Overall Study|Adverse Event|2
5141428|NCT01546519|17758998|P4|Overall Study|Withdrawal by Subject|0
5141429|NCT01546519|17758999|P3|Overall Study|Withdrawal by Subject|0
5141430|NCT01546519|17759000|P2|Overall Study|Withdrawal by Subject|0
5141431|NCT01546519|17759001|P1|Overall Study|Withdrawal by Subject|1
5141432|NCT01546519|17758998|P4|Overall Study|Physician Decision|3
5141433|NCT01546519|17758999|P3|Overall Study|Physician Decision|2
5141434|NCT01546519|17759000|P2|Overall Study|Physician Decision|5
5141435|NCT01546519|17759001|P1|Overall Study|Physician Decision|6
5141436|NCT01546519|17758998|P4|Overall Study|related to disease progression|1
5141437|NCT01546519|17758999|P3|Overall Study|related to disease progression|2
5141438|NCT01546519|17759000|P2|Overall Study|related to disease progression|2
5141439|NCT01546519|17759001|P1|Overall Study|related to disease progression|2
5141440|NCT01546519|17758998|P4|Overall Study|Death|1
5141441|NCT01546519|17758999|P3|Overall Study|Death|3
5141442|NCT01546519|17759000|P2|Overall Study|Death|1
5141443|NCT01546519|17759001|P1|Overall Study|Death|0
5141444|NCT01546519|17758998|P4|Overall Study|Adverse Event|1
5141445|NCT01546519|17758999|P3|Overall Study|Adverse Event|1
5141446|NCT01546519|17759000|P2|Overall Study|Adverse Event|0
5141447|NCT01546519|17759001|P1|Overall Study|Adverse Event|0
5141448|NCT01546207|17759066|P1|Overall Study|Death|1
5141449|NCT01546168|17759081|P2|Overall Study|ineligible after signing consent|0
5141450|NCT01546168|17759082|P1|Overall Study|ineligible after signing consent|2
5141451|NCT01546168|17759081|P2|Overall Study|Withdrawal by Subject|0
5141452|NCT01546168|17759082|P1|Overall Study|Withdrawal by Subject|1
5141453|NCT01546168|17759081|P2|Overall Study|Lost to Follow-up|0
5141454|NCT01546168|17759082|P1|Overall Study|Lost to Follow-up|1
5141455|NCT01546155|17759094|P1|Overall Study|could not tolerate long scan duration|3
5141456|NCT01546142|17759100|P2|Overall Study|Subject Randomized but Not Treated|0
5141457|NCT01546142|17759101|P1|Overall Study|Subject Randomized but Not Treated|1
5141458|NCT01546142|17759100|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
5141459|NCT01546142|17759101|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
5141460|NCT01546142|17759100|P2|Overall Study|Lost to Follow-up|15
5141461|NCT01546142|17759101|P1|Overall Study|Lost to Follow-up|20
5141462|NCT01546142|17759100|P2|Overall Study|Adverse Event|3
5141463|NCT01546142|17759101|P1|Overall Study|Adverse Event|6
5141464|NCT01546142|17759100|P2|Overall Study|Subject Noncompliance|1
5141465|NCT01546142|17759101|P1|Overall Study|Subject Noncompliance|1
5141466|NCT01546142|17759100|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
5141467|NCT01546142|17759101|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
5141468|NCT01546038|17759119|P9|Overall Study|: Randomized, not treated|3
5141469|NCT01546038|17759120|P8|Overall Study|: Randomized, not treated|4
5141470|NCT01546038|17759121|P7|Overall Study|: Randomized, not treated|2
5141471|NCT01546038|17759122|P6|Overall Study|: Randomized, not treated|0
5141472|NCT01546038|17759123|P5|Overall Study|: Randomized, not treated|0
5141473|NCT01546038|17759124|P4|Overall Study|: Randomized, not treated|0
5141474|NCT01546038|17759125|P3|Overall Study|: Randomized, not treated|0
5141475|NCT01546038|17759126|P2|Overall Study|: Randomized, not treated|0
5141476|NCT01546038|17759127|P1|Overall Study|: Randomized, not treated|0
5141477|NCT01546038|17759119|P9|Overall Study|Withdrawal by Subject|1
5141478|NCT01546038|17759120|P8|Overall Study|Withdrawal by Subject|3
5141479|NCT01546038|17759121|P7|Overall Study|Withdrawal by Subject|3
5141480|NCT01546038|17759122|P6|Overall Study|Withdrawal by Subject|1
5141481|NCT01546038|17759123|P5|Overall Study|Withdrawal by Subject|0
5141482|NCT01546038|17759124|P4|Overall Study|Withdrawal by Subject|1
5141483|NCT01546038|17759125|P3|Overall Study|Withdrawal by Subject|0
5141484|NCT01546038|17759126|P2|Overall Study|Withdrawal by Subject|0
5141485|NCT01546038|17759127|P1|Overall Study|Withdrawal by Subject|1
5141486|NCT01546038|17759119|P9|Overall Study|Lost to Follow-up|0
5141487|NCT01546038|17759120|P8|Overall Study|Lost to Follow-up|1
5141488|NCT01546038|17759121|P7|Overall Study|Lost to Follow-up|2
5141489|NCT01546038|17759122|P6|Overall Study|Lost to Follow-up|0
5141490|NCT01546038|17759123|P5|Overall Study|Lost to Follow-up|1
5141491|NCT01546038|17759124|P4|Overall Study|Lost to Follow-up|0
5141492|NCT01546038|17759125|P3|Overall Study|Lost to Follow-up|0
5141493|NCT01546038|17759126|P2|Overall Study|Lost to Follow-up|0
5141494|NCT01546038|17759127|P1|Overall Study|Lost to Follow-up|0
5141495|NCT01546038|17759119|P9|Overall Study|Death|39
5141496|NCT01546038|17759120|P8|Overall Study|Death|76
5141497|NCT01546038|17759121|P7|Overall Study|Death|46
5141498|NCT01546038|17759122|P6|Overall Study|Death|3
5141499|NCT01546038|17759123|P5|Overall Study|Death|9
5141500|NCT01546038|17759124|P4|Overall Study|Death|2
5141501|NCT01546038|17759125|P3|Overall Study|Death|4
5141502|NCT01546038|17759126|P2|Overall Study|Death|6
5141503|NCT01546038|17759127|P1|Overall Study|Death|15
5141504|NCT01545817|17759321|P2|Everolimus|Adverse Event|6
5141505|NCT01545817|17759322|P1|Everolimus|Adverse Event|0
5141506|NCT01545817|17759321|P2|Everolimus|Disease progression|25
5141507|NCT01545817|17759322|P1|Everolimus|Disease progression|0
5141508|NCT01545817|17759321|P2|Everolimus|Other reason|7
5141509|NCT01545817|17759322|P1|Everolimus|Other reason|0
5141510|NCT01545817|17759321|P2|Pazopanib|Other reason|0
5141511|NCT01545817|17759322|P1|Pazopanib|Other reason|4
5141512|NCT01545817|17759321|P2|Pazopanib|Adverse Event|0
5141513|NCT01545817|17759322|P1|Pazopanib|Adverse Event|19
5141514|NCT01545817|17759321|P2|Pazopanib|Disease progression|0
5141515|NCT01545817|17759322|P1|Pazopanib|Disease progression|51
5141516|NCT01545388|17759471|P3|Overall Study|Other|0
5141517|NCT01545388|17759472|P2|Overall Study|Other|1
5141518|NCT01545388|17759473|P1|Overall Study|Other|1
5141519|NCT01545388|17759471|P3|Overall Study|Withdrawal by Subject|2
5141520|NCT01545388|17759472|P2|Overall Study|Withdrawal by Subject|4
5141521|NCT01545388|17759473|P1|Overall Study|Withdrawal by Subject|1
5141522|NCT01545388|17759471|P3|Overall Study|Participant moved or relocated|0
5141523|NCT01545388|17759472|P2|Overall Study|Participant moved or relocated|0
5141524|NCT01545388|17759473|P1|Overall Study|Participant moved or relocated|1
5141525|NCT01545388|17759471|P3|Overall Study|Lack of Efficacy|5
5141526|NCT01545388|17759472|P2|Overall Study|Lack of Efficacy|2
5141527|NCT01545388|17759473|P1|Overall Study|Lack of Efficacy|3
5141528|NCT01545388|17759471|P3|Overall Study|Adverse Event|1
5141529|NCT01545388|17759472|P2|Overall Study|Adverse Event|4
5141530|NCT01545388|17759473|P1|Overall Study|Adverse Event|2
5141531|NCT01545375|17759492|P2|Overall Study|Withdrawal by Subject|55
5141532|NCT01545375|17759493|P1|Overall Study|Withdrawal by Subject|58
5141533|NCT01545375|17759492|P2|Overall Study|Protocol Violation|3
5141534|NCT01545375|17759493|P1|Overall Study|Protocol Violation|3
5141535|NCT01545375|17759492|P2|Overall Study|Lost to Follow-up|31
5141536|NCT01545375|17759493|P1|Overall Study|Lost to Follow-up|34
5141537|NCT01545375|17759492|P2|Overall Study|Adverse Event|1
5141538|NCT01545375|17759493|P1|Overall Study|Adverse Event|2
5141539|NCT01545076|17759625|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
5141540|NCT01545076|17759626|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
5141541|NCT01545076|17759627|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
5141542|NCT01545076|17759628|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
5141543|NCT01545076|17759629|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
5141544|NCT01545076|17759625|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5141545|NCT01545076|17759626|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5141546|NCT01545076|17759627|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
5141547|NCT01545076|17759628|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
5141548|NCT01545076|17759629|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5141549|NCT01545076|17759625|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
5141550|NCT01545076|17759626|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
5141551|NCT01545076|17759627|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
5141552|NCT01545076|17759628|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
5141553|NCT01545076|17759629|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
5141554|NCT01545076|17759625|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5141555|NCT01545076|17759626|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
5141556|NCT01545076|17759627|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5141557|NCT01545076|17759628|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5141558|NCT01545076|17759629|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5141559|NCT01545076|17759625|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
5141560|NCT01545076|17759626|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
5141561|NCT01545076|17759627|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
5141562|NCT01545076|17759628|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
5141563|NCT01545076|17759629|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
5141564|NCT01545076|17759625|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5141565|NCT01545076|17759626|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5141566|NCT01545076|17759627|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5141567|NCT01545076|17759628|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5141568|NCT01545076|17759629|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
5141569|NCT01545076|17759625|P5|IgPro10 Restabilization Period|Protocol Violation|0
5141570|NCT01545076|17759626|P4|IgPro10 Restabilization Period|Protocol Violation|0
5141571|NCT01545076|17759627|P3|IgPro10 Restabilization Period|Protocol Violation|0
5141572|NCT01545076|17759628|P2|IgPro10 Restabilization Period|Protocol Violation|0
5141573|NCT01545076|17759629|P1|IgPro10 Restabilization Period|Protocol Violation|1
5141574|NCT01545076|17759625|P5|IgPro10 Restabilization Period|Physician Decision|0
5141575|NCT01545076|17759626|P4|IgPro10 Restabilization Period|Physician Decision|0
5141576|NCT01545076|17759627|P3|IgPro10 Restabilization Period|Physician Decision|0
5141577|NCT01545076|17759628|P2|IgPro10 Restabilization Period|Physician Decision|0
5141578|NCT01545076|17759629|P1|IgPro10 Restabilization Period|Physician Decision|2
5141579|NCT01545076|17759625|P5|IgPro10 Restabilization Period|Adverse Event|0
5141580|NCT01545076|17759626|P4|IgPro10 Restabilization Period|Adverse Event|0
5141581|NCT01545076|17759627|P3|IgPro10 Restabilization Period|Adverse Event|0
5141582|NCT01545076|17759628|P2|IgPro10 Restabilization Period|Adverse Event|0
5141583|NCT01545076|17759629|P1|IgPro10 Restabilization Period|Adverse Event|4
5141584|NCT01544920|17759700|P2|Overall Study|Withdrawal by Subject|4
5141585|NCT01544920|17759701|P1|Overall Study|Withdrawal by Subject|4
5141586|NCT01544920|17759700|P2|Overall Study|Physician Decision|1
5141587|NCT01544920|17759701|P1|Overall Study|Physician Decision|4
5141588|NCT01544920|17759700|P2|Overall Study|Protocol Violation|2
5141589|NCT01544920|17759701|P1|Overall Study|Protocol Violation|0
5141590|NCT01544920|17759700|P2|Overall Study|Lost to Follow-up|12
5141591|NCT01544920|17759701|P1|Overall Study|Lost to Follow-up|11
5141592|NCT01544920|17759700|P2|Overall Study|Death|1
5141593|NCT01544920|17759701|P1|Overall Study|Death|0
5141594|NCT01544920|17759700|P2|Overall Study|Adverse Event|3
5141595|NCT01544920|17759701|P1|Overall Study|Adverse Event|0
5141596|NCT01544595|17759715|P6|Status at Week 156|Lack of Efficacy|5
5141597|NCT01544595|17759716|P5|Status at Week 156|Lack of Efficacy|10
5141598|NCT01544595|17759717|P4|Status at Week 156|Lack of Efficacy|4
5141599|NCT01544595|17759718|P3|Status at Week 156|Lack of Efficacy|1
5141600|NCT01544595|17759719|P2|Status at Week 156|Lack of Efficacy|0
5141601|NCT01544595|17759720|P1|Status at Week 156|Lack of Efficacy|1
5141602|NCT01544595|17759715|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
5141603|NCT01544595|17759716|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
5141854|NCT01544127|17760131|P3|Overall Study|Withdrawal by Subject|1
5141604|NCT01544595|17759717|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
5141605|NCT01544595|17759718|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
5141606|NCT01544595|17759719|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
5141607|NCT01544595|17759720|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
5141608|NCT01544595|17759715|P6|Status at Week 156|Technical problems|0
5141609|NCT01544595|17759716|P5|Status at Week 156|Technical problems|0
5141610|NCT01544595|17759717|P4|Status at Week 156|Technical problems|1
5141611|NCT01544595|17759718|P3|Status at Week 156|Technical problems|0
5141612|NCT01544595|17759719|P2|Status at Week 156|Technical problems|1
5141613|NCT01544595|17759720|P1|Status at Week 156|Technical problems|3
5141614|NCT01544595|17759715|P6|Status at Week 156|Protocol Violation|0
5141615|NCT01544595|17759716|P5|Status at Week 156|Protocol Violation|0
5141616|NCT01544595|17759717|P4|Status at Week 156|Protocol Violation|2
5141617|NCT01544595|17759718|P3|Status at Week 156|Protocol Violation|2
5141618|NCT01544595|17759719|P2|Status at Week 156|Protocol Violation|1
5141619|NCT01544595|17759720|P1|Status at Week 156|Protocol Violation|3
5141620|NCT01544595|17759715|P6|Status at Week 156|Pregnancy|0
5141621|NCT01544595|17759716|P5|Status at Week 156|Pregnancy|0
5141622|NCT01544595|17759717|P4|Status at Week 156|Pregnancy|0
5141623|NCT01544595|17759718|P3|Status at Week 156|Pregnancy|0
5141624|NCT01544595|17759719|P2|Status at Week 156|Pregnancy|3
5141625|NCT01544595|17759720|P1|Status at Week 156|Pregnancy|2
5141626|NCT01544595|17759715|P6|Status at Week 156|Physician Decision|0
5141627|NCT01544595|17759716|P5|Status at Week 156|Physician Decision|0
5141628|NCT01544595|17759717|P4|Status at Week 156|Physician Decision|0
5141629|NCT01544595|17759718|P3|Status at Week 156|Physician Decision|1
5141630|NCT01544595|17759719|P2|Status at Week 156|Physician Decision|3
5141631|NCT01544595|17759720|P1|Status at Week 156|Physician Decision|0
5141632|NCT01544595|17759715|P6|Status at Week 156|Non-compliance with study treatement|1
5141633|NCT01544595|17759716|P5|Status at Week 156|Non-compliance with study treatement|0
5141634|NCT01544595|17759717|P4|Status at Week 156|Non-compliance with study treatement|1
5141635|NCT01544595|17759718|P3|Status at Week 156|Non-compliance with study treatement|0
5141636|NCT01544595|17759719|P2|Status at Week 156|Non-compliance with study treatement|1
5141637|NCT01544595|17759720|P1|Status at Week 156|Non-compliance with study treatement|0
5141638|NCT01544595|17759715|P6|Status at Week 156|Lost to Follow-up|1
5141639|NCT01544595|17759716|P5|Status at Week 156|Lost to Follow-up|4
5141640|NCT01544595|17759717|P4|Status at Week 156|Lost to Follow-up|1
5141641|NCT01544595|17759718|P3|Status at Week 156|Lost to Follow-up|0
5141642|NCT01544595|17759719|P2|Status at Week 156|Lost to Follow-up|4
5141643|NCT01544595|17759720|P1|Status at Week 156|Lost to Follow-up|4
5141644|NCT01544595|17759715|P6|Status at Week 156|Adverse Event|2
5141645|NCT01544595|17759716|P5|Status at Week 156|Adverse Event|4
5141646|NCT01544595|17759717|P4|Status at Week 156|Adverse Event|3
5141647|NCT01544595|17759718|P3|Status at Week 156|Adverse Event|1
5141648|NCT01544595|17759719|P2|Status at Week 156|Adverse Event|11
5141649|NCT01544595|17759720|P1|Status at Week 156|Adverse Event|9
5141650|NCT01544595|17759715|P6|Status at Week 156|Withdrawal by Subject|6
5141651|NCT01544595|17759716|P5|Status at Week 156|Withdrawal by Subject|20
5141652|NCT01544595|17759717|P4|Status at Week 156|Withdrawal by Subject|9
5141653|NCT01544595|17759718|P3|Status at Week 156|Withdrawal by Subject|4
5141654|NCT01544595|17759719|P2|Status at Week 156|Withdrawal by Subject|10
5141655|NCT01544595|17759720|P1|Status at Week 156|Withdrawal by Subject|9
5141656|NCT01544595|17759715|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
5141657|NCT01544595|17759716|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
5141658|NCT01544595|17759717|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
5141659|NCT01544595|17759718|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
5141660|NCT01544595|17759719|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
5141661|NCT01544595|17759720|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
5141662|NCT01544595|17759715|P6|Status at Week 68|Withdrawal by Subject|0
5141663|NCT01544595|17759716|P5|Status at Week 68|Withdrawal by Subject|0
5141664|NCT01544595|17759717|P4|Status at Week 68|Withdrawal by Subject|2
5141665|NCT01544595|17759718|P3|Status at Week 68|Withdrawal by Subject|1
5141666|NCT01544595|17759719|P2|Status at Week 68|Withdrawal by Subject|1
5141667|NCT01544595|17759720|P1|Status at Week 68|Withdrawal by Subject|0
5141668|NCT01544595|17759715|P6|Status at Week 68|Technical problems|0
5141669|NCT01544595|17759716|P5|Status at Week 68|Technical problems|0
5141670|NCT01544595|17759717|P4|Status at Week 68|Technical problems|1
5141671|NCT01544595|17759718|P3|Status at Week 68|Technical problems|0
5141672|NCT01544595|17759719|P2|Status at Week 68|Technical problems|0
5141673|NCT01544595|17759720|P1|Status at Week 68|Technical problems|1
5141674|NCT01544595|17759715|P6|Status at Week 68|Protocol Violation|0
5141675|NCT01544595|17759716|P5|Status at Week 68|Protocol Violation|0
5141676|NCT01544595|17759717|P4|Status at Week 68|Protocol Violation|1
5141677|NCT01544595|17759718|P3|Status at Week 68|Protocol Violation|1
5141678|NCT01544595|17759719|P2|Status at Week 68|Protocol Violation|0
5141679|NCT01544595|17759720|P1|Status at Week 68|Protocol Violation|2
5141680|NCT01544595|17759715|P6|Status at Week 68|Non-compliance with study treatment|0
5141681|NCT01544595|17759716|P5|Status at Week 68|Non-compliance with study treatment|0
5141682|NCT01544595|17759717|P4|Status at Week 68|Non-compliance with study treatment|1
5141683|NCT01544595|17759718|P3|Status at Week 68|Non-compliance with study treatment|0
5141684|NCT01544595|17759719|P2|Status at Week 68|Non-compliance with study treatment|0
5141685|NCT01544595|17759720|P1|Status at Week 68|Non-compliance with study treatment|1
5141686|NCT01544595|17759715|P6|Status at Week 68|Lost to Follow-up|0
5141687|NCT01544595|17759716|P5|Status at Week 68|Lost to Follow-up|0
5141688|NCT01544595|17759717|P4|Status at Week 68|Lost to Follow-up|0
5141689|NCT01544595|17759718|P3|Status at Week 68|Lost to Follow-up|0
5141690|NCT01544595|17759719|P2|Status at Week 68|Lost to Follow-up|1
5141691|NCT01544595|17759720|P1|Status at Week 68|Lost to Follow-up|1
5141692|NCT01544595|17759715|P6|Status at Week 68|Lack of Efficacy|0
5141693|NCT01544595|17759716|P5|Status at Week 68|Lack of Efficacy|0
5141694|NCT01544595|17759717|P4|Status at Week 68|Lack of Efficacy|0
5141695|NCT01544595|17759718|P3|Status at Week 68|Lack of Efficacy|0
5141696|NCT01544595|17759719|P2|Status at Week 68|Lack of Efficacy|0
5141697|NCT01544595|17759720|P1|Status at Week 68|Lack of Efficacy|1
5141698|NCT01544595|17759715|P6|Status at Week 68|Adverse Event|0
5141699|NCT01544595|17759716|P5|Status at Week 68|Adverse Event|0
5141700|NCT01544595|17759717|P4|Status at Week 68|Adverse Event|0
5141701|NCT01544595|17759718|P3|Status at Week 68|Adverse Event|1
5141702|NCT01544595|17759719|P2|Status at Week 68|Adverse Event|2
5141703|NCT01544595|17759720|P1|Status at Week 68|Adverse Event|3
5141704|NCT01544582|17759796|P4|Analysis Population|Participant in Jail|0
5141705|NCT01544582|17759797|P3|Analysis Population|Participant in Jail|1
5141706|NCT01544582|17759798|P2|Analysis Population|Participant in Jail|0
5141707|NCT01544582|17759799|P1|Analysis Population|Participant in Jail|0
5141708|NCT01544582|17759796|P4|Analysis Population|Programmed Surgery|0
5141709|NCT01544582|17759797|P3|Analysis Population|Programmed Surgery|0
5141710|NCT01544582|17759798|P2|Analysis Population|Programmed Surgery|1
5141711|NCT01544582|17759799|P1|Analysis Population|Programmed Surgery|0
5141712|NCT01544582|17759796|P4|Analysis Population|Poor Participant Compliance|0
5141713|NCT01544582|17759797|P3|Analysis Population|Poor Participant Compliance|0
5141714|NCT01544582|17759798|P2|Analysis Population|Poor Participant Compliance|1
5141715|NCT01544582|17759799|P1|Analysis Population|Poor Participant Compliance|0
5141716|NCT01544582|17759796|P4|Analysis Population|Poor Adherence|0
5141717|NCT01544582|17759797|P3|Analysis Population|Poor Adherence|1
5141718|NCT01544582|17759798|P2|Analysis Population|Poor Adherence|0
5141719|NCT01544582|17759799|P1|Analysis Population|Poor Adherence|0
5141720|NCT01544582|17759796|P4|Analysis Population|No Social Insurance|0
5141721|NCT01544582|17759797|P3|Analysis Population|No Social Insurance|1
5141722|NCT01544582|17759798|P2|Analysis Population|No Social Insurance|0
5141723|NCT01544582|17759799|P1|Analysis Population|No Social Insurance|0
5141724|NCT01544582|17759796|P4|Analysis Population|Liver Transplantation|0
5141725|NCT01544582|17759797|P3|Analysis Population|Liver Transplantation|1
5141726|NCT01544582|17759798|P2|Analysis Population|Liver Transplantation|0
5141727|NCT01544582|17759799|P1|Analysis Population|Liver Transplantation|0
5141728|NCT01544582|17759796|P4|Analysis Population|Intolerance|0
5141729|NCT01544582|17759797|P3|Analysis Population|Intolerance|0
5141730|NCT01544582|17759798|P2|Analysis Population|Intolerance|1
5141731|NCT01544582|17759799|P1|Analysis Population|Intolerance|0
5141732|NCT01544582|17759796|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
5141733|NCT01544582|17759797|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
5141734|NCT01544582|17759798|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
5141735|NCT01544582|17759799|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
5141736|NCT01544582|17759796|P4|Analysis Population|Bad Tolerance to Treatment|0
5141737|NCT01544582|17759797|P3|Analysis Population|Bad Tolerance to Treatment|2
5141738|NCT01544582|17759798|P2|Analysis Population|Bad Tolerance to Treatment|0
5141739|NCT01544582|17759799|P1|Analysis Population|Bad Tolerance to Treatment|0
5141740|NCT01544582|17759796|P4|Analysis Population|Lost to Follow-up|5
5141741|NCT01544582|17759797|P3|Analysis Population|Lost to Follow-up|6
5141742|NCT01544582|17759798|P2|Analysis Population|Lost to Follow-up|6
5141743|NCT01544582|17759799|P1|Analysis Population|Lost to Follow-up|0
5141744|NCT01544582|17759796|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
5141745|NCT01544582|17759797|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
5141746|NCT01544582|17759798|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
5141747|NCT01544582|17759799|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
5141748|NCT01544582|17759796|P4|Analysis Population|Effectiveness Reason|12
5141749|NCT01544582|17759797|P3|Analysis Population|Effectiveness Reason|29
5141750|NCT01544582|17759798|P2|Analysis Population|Effectiveness Reason|48
5141751|NCT01544582|17759799|P1|Analysis Population|Effectiveness Reason|0
5141752|NCT01544582|17759796|P4|Analysis Population|Safety Reason|8
5141753|NCT01544582|17759797|P3|Analysis Population|Safety Reason|31
5141754|NCT01544582|17759798|P2|Analysis Population|Safety Reason|33
5141755|NCT01544582|17759799|P1|Analysis Population|Safety Reason|0
5141756|NCT01544582|17759796|P4|Analysis Population|Physician Decision|9
5141757|NCT01544582|17759797|P3|Analysis Population|Physician Decision|10
5141758|NCT01544582|17759798|P2|Analysis Population|Physician Decision|13
5141759|NCT01544582|17759799|P1|Analysis Population|Physician Decision|0
5141760|NCT01544582|17759796|P4|Analysis Population|Participant Refuses to Continue Study|4
5141761|NCT01544582|17759797|P3|Analysis Population|Participant Refuses to Continue Study|17
5141762|NCT01544582|17759798|P2|Analysis Population|Participant Refuses to Continue Study|15
5141763|NCT01544582|17759799|P1|Analysis Population|Participant Refuses to Continue Study|0
5141764|NCT01544582|17759796|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
5141765|NCT01544582|17759797|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
5141766|NCT01544582|17759798|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
5141767|NCT01544582|17759799|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
5141768|NCT01544582|17759796|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
5141769|NCT01544582|17759797|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
5141770|NCT01544582|17759798|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
5141771|NCT01544582|17759799|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
5141772|NCT01544491|17759859|P2|Overall Study|administrative problems|0
5141773|NCT01544491|17759860|P1|Overall Study|administrative problems|2
5141774|NCT01544491|17759859|P2|Overall Study|Lost to Follow-up|1
5141775|NCT01544491|17759860|P1|Overall Study|Lost to Follow-up|0
5141776|NCT01544491|17759859|P2|Overall Study|Withdrawal by Subject|2
5141777|NCT01544491|17759860|P1|Overall Study|Withdrawal by Subject|3
5141778|NCT01544478|17759886|P1|Overall Study|Withdrawal by Subject|52
5141779|NCT01544478|17759886|P1|Overall Study|Pregnancy|1
5141780|NCT01544478|17759886|P1|Overall Study|Physician Decision|15
5141781|NCT01544478|17759886|P1|Overall Study|Lost to Follow-up|48
5141782|NCT01544478|17759886|P1|Overall Study|Death|1
5141783|NCT01544478|17759886|P1|Overall Study|Adverse Event|1
5141784|NCT01544348|17759929|P8|Overall Study|Physician Decision|0
5141785|NCT01544348|17759930|P7|Overall Study|Physician Decision|0
5141786|NCT01544348|17759931|P6|Overall Study|Physician Decision|1
5141787|NCT01544348|17759932|P5|Overall Study|Physician Decision|0
5141788|NCT01544348|17759933|P4|Overall Study|Physician Decision|0
5141789|NCT01544348|17759934|P3|Overall Study|Physician Decision|0
5141790|NCT01544348|17759935|P2|Overall Study|Physician Decision|0
5141791|NCT01544348|17759936|P1|Overall Study|Physician Decision|0
5141792|NCT01544348|17759929|P8|Overall Study|Withdrawal by Subject|0
5141793|NCT01544348|17759930|P7|Overall Study|Withdrawal by Subject|1
5141794|NCT01544348|17759931|P6|Overall Study|Withdrawal by Subject|2
5141795|NCT01544348|17759932|P5|Overall Study|Withdrawal by Subject|1
5141796|NCT01544348|17759933|P4|Overall Study|Withdrawal by Subject|0
5141797|NCT01544348|17759934|P3|Overall Study|Withdrawal by Subject|0
5141798|NCT01544348|17759935|P2|Overall Study|Withdrawal by Subject|0
5141799|NCT01544348|17759936|P1|Overall Study|Withdrawal by Subject|1
5141800|NCT01544348|17759929|P8|Overall Study|Lost to Follow-up|0
5141801|NCT01544348|17759930|P7|Overall Study|Lost to Follow-up|1
5141802|NCT01544348|17759931|P6|Overall Study|Lost to Follow-up|0
5141803|NCT01544348|17759932|P5|Overall Study|Lost to Follow-up|0
5141804|NCT01544348|17759933|P4|Overall Study|Lost to Follow-up|0
5141805|NCT01544348|17759934|P3|Overall Study|Lost to Follow-up|0
5141806|NCT01544348|17759935|P2|Overall Study|Lost to Follow-up|0
5141807|NCT01544348|17759936|P1|Overall Study|Lost to Follow-up|1
5141808|NCT01544309|17759978|P2|Overall Study|Administered prohibit prior medication|0
5141809|NCT01544309|17759979|P1|Overall Study|Administered prohibit prior medication|1
5141810|NCT01544309|17759978|P2|Overall Study|Not performed pre-dose examination|2
5141811|NCT01544309|17759979|P1|Overall Study|Not performed pre-dose examination|1
5141812|NCT01544309|17759978|P2|Overall Study|Physician Decision|1
5141813|NCT01544309|17759979|P1|Overall Study|Physician Decision|4
5141814|NCT01544309|17759978|P2|Overall Study|Protocol Violation|1
5141815|NCT01544309|17759979|P1|Overall Study|Protocol Violation|2
5141816|NCT01544309|17759978|P2|Overall Study|Withdrawal by Subject|7
5141817|NCT01544309|17759979|P1|Overall Study|Withdrawal by Subject|12
5141818|NCT01544179|17760017|P2|Overall Study|Eligibility criteria not fulfilled|0
5141819|NCT01544179|17760018|P1|Overall Study|Eligibility criteria not fulfilled|1
5141820|NCT01544179|17760017|P2|Overall Study|Withdrawal by Subject|7
5141821|NCT01544179|17760018|P1|Overall Study|Withdrawal by Subject|12
5141822|NCT01544179|17760017|P2|Overall Study|Adverse Event|1
5141823|NCT01544179|17760018|P1|Overall Study|Adverse Event|0
5141824|NCT01544179|17760017|P2|Overall Study|Lost to Follow-up|1
5141825|NCT01544179|17760018|P1|Overall Study|Lost to Follow-up|0
5141826|NCT01544179|17760017|P2|Overall Study|Death|37
5141827|NCT01544179|17760018|P1|Overall Study|Death|50
5141828|NCT01544153|17760111|P4|Overall Study|Non-smoker|0
5141829|NCT01544153|17760112|P3|Overall Study|Non-smoker|1
5141830|NCT01544153|17760113|P2|Overall Study|Non-smoker|0
5141831|NCT01544153|17760114|P1|Overall Study|Non-smoker|0
5141832|NCT01544153|17760111|P4|Overall Study|Under 18|0
5141833|NCT01544153|17760112|P3|Overall Study|Under 18|0
5141834|NCT01544153|17760113|P2|Overall Study|Under 18|1
5141835|NCT01544153|17760114|P1|Overall Study|Under 18|0
5141836|NCT01544127|17760131|P3|Overall Study|Went active duty|1
5141837|NCT01544127|17760132|P2|Overall Study|Went active duty|0
5141838|NCT01544127|17760133|P1|Overall Study|Went active duty|0
5141839|NCT01544127|17760131|P3|Overall Study|Researcher withdrew|0
5141840|NCT01544127|17760132|P2|Overall Study|Researcher withdrew|0
5141841|NCT01544127|17760133|P1|Overall Study|Researcher withdrew|1
5141842|NCT01544127|17760131|P3|Overall Study|Became Psychotic|0
5141843|NCT01544127|17760132|P2|Overall Study|Became Psychotic|0
5141844|NCT01544127|17760133|P1|Overall Study|Became Psychotic|1
5141845|NCT01544127|17760131|P3|Overall Study|Jail or Prison|2
5141846|NCT01544127|17760132|P2|Overall Study|Jail or Prison|1
5141847|NCT01544127|17760133|P1|Overall Study|Jail or Prison|1
5141848|NCT01544127|17760131|P3|Overall Study|Death|0
5141849|NCT01544127|17760132|P2|Overall Study|Death|0
5141850|NCT01544127|17760133|P1|Overall Study|Death|1
5141851|NCT01544127|17760131|P3|Overall Study|Discharged out of catchment area|1
5141852|NCT01544127|17760132|P2|Overall Study|Discharged out of catchment area|1
5141853|NCT01544127|17760133|P1|Overall Study|Discharged out of catchment area|1
5141855|NCT01544127|17760132|P2|Overall Study|Withdrawal by Subject|2
5141856|NCT01544127|17760133|P1|Overall Study|Withdrawal by Subject|2
5141857|NCT01544127|17760131|P3|Overall Study|Lost to Follow-up|9
5141858|NCT01544127|17760132|P2|Overall Study|Lost to Follow-up|2
5141859|NCT01544127|17760133|P1|Overall Study|Lost to Follow-up|4
5141860|NCT01544114|17760153|P3|Overall Study|Protocol Violation|0
5141861|NCT01544114|17760154|P2|Overall Study|Protocol Violation|1
5141862|NCT01544114|17760155|P1|Overall Study|Protocol Violation|0
5141863|NCT01544114|17760153|P3|Overall Study|Adverse Event|2
5141864|NCT01544114|17760154|P2|Overall Study|Adverse Event|1
5141865|NCT01544114|17760155|P1|Overall Study|Adverse Event|1
5141866|NCT01544114|17760153|P3|Overall Study|Lost to Follow-up|0
5141867|NCT01544114|17760154|P2|Overall Study|Lost to Follow-up|2
5141868|NCT01544114|17760155|P1|Overall Study|Lost to Follow-up|0
5141869|NCT01544114|17760153|P3|Overall Study|Withdrawal by Subject|3
5141870|NCT01544114|17760154|P2|Overall Study|Withdrawal by Subject|0
5141871|NCT01544114|17760155|P1|Overall Study|Withdrawal by Subject|0
5141872|NCT01543958|17760253|P1|Overall Study|ART initiation|1
5141873|NCT01543958|17760253|P1|Overall Study|Loss to follow-up|3
5141874|NCT01543828|17760308|P2|Treatment 2|Lost to Follow-up|0
5141875|NCT01543828|17760309|P1|Treatment 2|Lost to Follow-up|1
5141876|NCT01543776|17760319|P2|Overall Study|Withdrawal by Subject|2
5141877|NCT01543776|17760320|P1|Overall Study|Withdrawal by Subject|2
5141878|NCT01543685|17760339|P5|Overall Study|Adverse Event|2
5141879|NCT01543685|17760340|P4|Overall Study|Adverse Event|0
5141880|NCT01543685|17760341|P3|Overall Study|Adverse Event|0
5141881|NCT01543685|17760342|P2|Overall Study|Adverse Event|1
5141882|NCT01543685|17760343|P1|Overall Study|Adverse Event|2
5141883|NCT01543685|17760339|P5|Overall Study|Lack of Efficacy|2
5141884|NCT01543685|17760340|P4|Overall Study|Lack of Efficacy|0
5141885|NCT01543685|17760341|P3|Overall Study|Lack of Efficacy|2
5141886|NCT01543685|17760342|P2|Overall Study|Lack of Efficacy|2
5141887|NCT01543685|17760343|P1|Overall Study|Lack of Efficacy|1
5141888|NCT01543503|17760415|P2|Overall Study|Screen failure|0
5141889|NCT01543503|17760416|P1|Overall Study|Screen failure|1
5141890|NCT01543503|17760415|P2|Overall Study|Participant went to United States|0
5141891|NCT01543503|17760416|P1|Overall Study|Participant went to United States|1
5141892|NCT01543503|17760415|P2|Overall Study|Participant consented to another study|2
5141893|NCT01543503|17760416|P1|Overall Study|Participant consented to another study|0
5141894|NCT01543503|17760415|P2|Overall Study|Moved to other rheumatologic site|1
5141895|NCT01543503|17760416|P1|Overall Study|Moved to other rheumatologic site|0
5141896|NCT01543503|17760415|P2|Overall Study|Participant did not attend a visit|0
5141897|NCT01543503|17760416|P1|Overall Study|Participant did not attend a visit|1
5141898|NCT01543503|17760415|P2|Overall Study|Site stopped participation|1
5141899|NCT01543503|17760416|P1|Overall Study|Site stopped participation|5
5141900|NCT01543503|17760415|P2|Overall Study|Participant recruited after closing date|1
5141901|NCT01543503|17760416|P1|Overall Study|Participant recruited after closing date|0
5141902|NCT01543503|17760415|P2|Overall Study|Investigator did not wish to participate|1
5141903|NCT01543503|17760416|P1|Overall Study|Investigator did not wish to participate|1
5141904|NCT01543503|17760415|P2|Overall Study|Participant decision to stop treatment|0
5141905|NCT01543503|17760416|P1|Overall Study|Participant decision to stop treatment|1
5141906|NCT01543503|17760415|P2|Overall Study|Participant moved to Scotland|0
5141907|NCT01543503|17760416|P1|Overall Study|Participant moved to Scotland|1
5141908|NCT01543503|17760415|P2|Overall Study|Participant transferred to another city|0
5141909|NCT01543503|17760416|P1|Overall Study|Participant transferred to another city|1
5141910|NCT01543503|17760415|P2|Overall Study|Participant will not return for visits|2
5141911|NCT01543503|17760416|P1|Overall Study|Participant will not return for visits|0
5141912|NCT01543503|17760415|P2|Overall Study|Participant moved to another city|0
5141913|NCT01543503|17760416|P1|Overall Study|Participant moved to another city|2
5141914|NCT01543503|17760415|P2|Overall Study|Incorrect medication received|0
5141915|NCT01543503|17760416|P1|Overall Study|Incorrect medication received|1
5141916|NCT01543503|17760415|P2|Overall Study|Refused to continue treatment|0
5141917|NCT01543503|17760416|P1|Overall Study|Refused to continue treatment|7
5141918|NCT01543503|17760415|P2|Overall Study|Participant did not complete last visit|2
5141919|NCT01543503|17760416|P1|Overall Study|Participant did not complete last visit|0
5141920|NCT01543503|17760415|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
5141921|NCT01543503|17760416|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
5141922|NCT01543503|17760415|P2|Overall Study|Intolerance to the biologic treatment|1
5141923|NCT01543503|17760416|P1|Overall Study|Intolerance to the biologic treatment|0
5141924|NCT01543503|17760415|P2|Overall Study|Change of jobs|1
5141925|NCT01543503|17760416|P1|Overall Study|Change of jobs|0
5141926|NCT01543503|17760415|P2|Overall Study|Participant withdrew informed consent|10
5141927|NCT01543503|17760416|P1|Overall Study|Participant withdrew informed consent|8
5141928|NCT01543503|17760415|P2|Overall Study|Lack of Efficacy|16
5141929|NCT01543503|17760416|P1|Overall Study|Lack of Efficacy|4
5141930|NCT01543503|17760415|P2|Overall Study|Adverse Event|13
5141931|NCT01543503|17760416|P1|Overall Study|Adverse Event|9
5141932|NCT01543503|17760415|P2|Overall Study|Lost to Follow-up|36
5141933|NCT01543503|17760416|P1|Overall Study|Lost to Follow-up|32
5141934|NCT01543204|17760460|P1|Overall Study|Lost to Follow-up|1
5141935|NCT01543204|17760460|P1|Overall Study|Requirement for Alternative Therapy|1
5141936|NCT01543204|17760460|P1|Overall Study|Withdrawal by Subject|4
5141937|NCT01543204|17760460|P1|Overall Study|Adverse Event|1
5141938|NCT01543204|17760460|P1|Overall Study|Non-compliance|1
5141939|NCT01543087|17760522|P6|Booster Stage (26 Months)|Lost to Follow-up|0
5141940|NCT01543087|17760523|P5|Booster Stage (26 Months)|Lost to Follow-up|0
5141941|NCT01543087|17760524|P4|Booster Stage (26 Months)|Lost to Follow-up|0
5141942|NCT01543087|17760525|P3|Booster Stage (26 Months)|Lost to Follow-up|1
5141943|NCT01543087|17760526|P2|Booster Stage (26 Months)|Lost to Follow-up|0
5141944|NCT01543087|17760527|P1|Booster Stage (26 Months)|Lost to Follow-up|0
5141945|NCT01543087|17760522|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5141946|NCT01543087|17760523|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
5141947|NCT01543087|17760524|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5141948|NCT01543087|17760525|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5141949|NCT01543087|17760526|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
5141950|NCT01543087|17760527|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5141951|NCT01543087|17760522|P6|Stage 1 (48 Months)|Protocol Violation|0
5141952|NCT01543087|17760523|P5|Stage 1 (48 Months)|Protocol Violation|0
5141953|NCT01543087|17760524|P4|Stage 1 (48 Months)|Protocol Violation|0
5141954|NCT01543087|17760525|P3|Stage 1 (48 Months)|Protocol Violation|0
5141955|NCT01543087|17760526|P2|Stage 1 (48 Months)|Protocol Violation|3
5141956|NCT01543087|17760527|P1|Stage 1 (48 Months)|Protocol Violation|0
5141957|NCT01543087|17760522|P6|Stage 1 (48 Months)|Other than specified|0
5141958|NCT01543087|17760523|P5|Stage 1 (48 Months)|Other than specified|0
5141959|NCT01543087|17760524|P4|Stage 1 (48 Months)|Other than specified|0
5141960|NCT01543087|17760525|P3|Stage 1 (48 Months)|Other than specified|9
5141961|NCT01543087|17760526|P2|Stage 1 (48 Months)|Other than specified|0
5141962|NCT01543087|17760527|P1|Stage 1 (48 Months)|Other than specified|5
5141963|NCT01543087|17760522|P6|Stage 1 (48 Months)|No longer willing to participate|0
5141964|NCT01543087|17760523|P5|Stage 1 (48 Months)|No longer willing to participate|3
5141965|NCT01543087|17760524|P4|Stage 1 (48 Months)|No longer willing to participate|6
5141966|NCT01543087|17760525|P3|Stage 1 (48 Months)|No longer willing to participate|18
5141967|NCT01543087|17760526|P2|Stage 1 (48 Months)|No longer willing to participate|3
5141968|NCT01543087|17760527|P1|Stage 1 (48 Months)|No longer willing to participate|5
5141969|NCT01543087|17760522|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
5141970|NCT01543087|17760523|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
5141971|NCT01543087|17760524|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
5141972|NCT01543087|17760525|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
5141973|NCT01543087|17760526|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
5141974|NCT01543087|17760527|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
5141975|NCT01543087|17760522|P6|Stage 1 (48 Months)|Lost to Follow-up|0
5141976|NCT01543087|17760523|P5|Stage 1 (48 Months)|Lost to Follow-up|0
5141977|NCT01543087|17760524|P4|Stage 1 (48 Months)|Lost to Follow-up|0
5141978|NCT01543087|17760525|P3|Stage 1 (48 Months)|Lost to Follow-up|12
5141979|NCT01543087|17760526|P2|Stage 1 (48 Months)|Lost to Follow-up|4
5141980|NCT01543087|17760527|P1|Stage 1 (48 Months)|Lost to Follow-up|3
5141981|NCT01542788|17760704|P2|Overall Study|Withdrawal by Subject|0
5141982|NCT01542788|17760705|P1|Overall Study|Withdrawal by Subject|1
5141983|NCT01542788|17760704|P2|Overall Study|Physician Decision|0
5141984|NCT01542788|17760705|P1|Overall Study|Physician Decision|1
5141985|NCT01542788|17760704|P2|Overall Study|Protocol Violation|0
5141986|NCT01542788|17760705|P1|Overall Study|Protocol Violation|2
5141987|NCT01542788|17760704|P2|Overall Study|Death|0
5141988|NCT01542788|17760705|P1|Overall Study|Death|3
5141989|NCT01542788|17760704|P2|Overall Study|Lost to Follow-up|0
5141990|NCT01542788|17760705|P1|Overall Study|Lost to Follow-up|5
5141991|NCT01542788|17760704|P2|Overall Study|Lack of Efficacy|71
5141992|NCT01542788|17760705|P1|Overall Study|Lack of Efficacy|41
5141993|NCT01542788|17760704|P2|Overall Study|Randomized but Not Treated|0
5141994|NCT01542788|17760705|P1|Overall Study|Randomized but Not Treated|2
5141995|NCT01542632|17760752|P6|Overall Study|Sponsor/Investigator Decision|0
5141996|NCT01542632|17760753|P5|Overall Study|Sponsor/Investigator Decision|1
5141997|NCT01542632|17760754|P4|Overall Study|Sponsor/Investigator Decision|0
5141998|NCT01542632|17760755|P3|Overall Study|Sponsor/Investigator Decision|0
5141999|NCT01542632|17760756|P2|Overall Study|Sponsor/Investigator Decision|0
5142000|NCT01542632|17760757|P1|Overall Study|Sponsor/Investigator Decision|0
5142001|NCT01542632|17760752|P6|Overall Study|Lost to Follow-up|0
5142002|NCT01542632|17760753|P5|Overall Study|Lost to Follow-up|0
5142003|NCT01542632|17760754|P4|Overall Study|Lost to Follow-up|0
5142004|NCT01542632|17760755|P3|Overall Study|Lost to Follow-up|0
5142005|NCT01542632|17760756|P2|Overall Study|Lost to Follow-up|1
5142006|NCT01542632|17760757|P1|Overall Study|Lost to Follow-up|0
5142007|NCT01542632|17760752|P6|Overall Study|Adverse Event|0
5142008|NCT01542632|17760753|P5|Overall Study|Adverse Event|0
5142009|NCT01542632|17760754|P4|Overall Study|Adverse Event|0
5142010|NCT01542632|17760755|P3|Overall Study|Adverse Event|1
5142011|NCT01542632|17760756|P2|Overall Study|Adverse Event|0
5142012|NCT01542632|17760757|P1|Overall Study|Adverse Event|0
5142013|NCT01542632|17760752|P6|Overall Study|Withdrawal of Consent|0
5142014|NCT01542632|17760753|P5|Overall Study|Withdrawal of Consent|3
5142015|NCT01542632|17760754|P4|Overall Study|Withdrawal of Consent|2
5142016|NCT01542632|17760755|P3|Overall Study|Withdrawal of Consent|0
5142017|NCT01542632|17760756|P2|Overall Study|Withdrawal of Consent|0
5142018|NCT01542632|17760757|P1|Overall Study|Withdrawal of Consent|0
5142019|NCT01542528|17760814|P2|Overall Study|Withdrawal by Subject|6
5142020|NCT01542528|17760815|P1|Overall Study|Withdrawal by Subject|9
5142021|NCT01542528|17760814|P2|Overall Study|Physician Decision|0
5142022|NCT01542528|17760815|P1|Overall Study|Physician Decision|1
5142023|NCT01542528|17760814|P2|Overall Study|Lost to Follow-up|1
5142024|NCT01542528|17760815|P1|Overall Study|Lost to Follow-up|2
5142025|NCT01542034|17760923|P2|Overall Study|Lost to Follow-up|6
5142026|NCT01542034|17760924|P1|Overall Study|Lost to Follow-up|7
5142027|NCT01542034|17760923|P2|Overall Study|Adverse Event|2
5142028|NCT01542034|17760924|P1|Overall Study|Adverse Event|2
5142029|NCT01542034|17760923|P2|Overall Study|Subject Noncompliance|0
5142030|NCT01542034|17760924|P1|Overall Study|Subject Noncompliance|1
5142031|NCT01542034|17760923|P2|Overall Study|Administrative decision|3
5142032|NCT01542034|17760924|P1|Overall Study|Administrative decision|0
5142033|NCT01542034|17760923|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
5142034|NCT01542034|17760924|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
5142035|NCT01541969|17760938|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
5142036|NCT01541969|17760939|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
5142037|NCT01541969|17760938|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
5142038|NCT01541969|17760939|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
5142039|NCT01541969|17760938|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
5142040|NCT01541969|17760939|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
5142041|NCT01541969|17760938|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
5142042|NCT01541969|17760939|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
5142043|NCT01541969|17760938|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
5142044|NCT01541969|17760939|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
5142045|NCT01541969|17760938|P2|Double-blind (0-12 Weeks)|Adverse Event|0
5142046|NCT01541969|17760939|P1|Double-blind (0-12 Weeks)|Adverse Event|2
5142047|NCT01541969|17760938|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
5142048|NCT01541969|17760939|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
5142049|NCT01541969|17760938|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
5142050|NCT01541969|17760939|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
5142051|NCT01541969|17760938|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
5142052|NCT01541969|17760939|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
5142053|NCT01541969|17760938|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
5142054|NCT01541969|17760939|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
5142055|NCT01541930|17760955|P1|Overall Study|Withdrawal by Subject|1
5142056|NCT01541917|17760977|P2|Overall Study|Withdrawal by Subject|7
5142057|NCT01541917|17760978|P1|Overall Study|Withdrawal by Subject|13
5142058|NCT01541917|17760977|P2|Overall Study|Lost to Follow-up|2
5142059|NCT01541917|17760978|P1|Overall Study|Lost to Follow-up|2
5142060|NCT01541865|17761007|P1|Overall Study|Protocol Violation|1
5142061|NCT01541865|17761007|P1|Overall Study|Adverse Event|1
5142062|NCT01541865|17761007|P1|Overall Study|Withdrawal by Subject|9
5142063|NCT01541865|17761007|P1|Overall Study|Lost to Follow-up|11
5142064|NCT01541826|17761025|P3|Overall Study|Withdrawal by Subject|0
5142065|NCT01541826|17761026|P2|Overall Study|Withdrawal by Subject|0
5142066|NCT01541826|17761027|P1|Overall Study|Withdrawal by Subject|2
5142067|NCT01541826|17761025|P3|Overall Study|Lost to Follow-up|0
5142068|NCT01541826|17761026|P2|Overall Study|Lost to Follow-up|3
5142069|NCT01541826|17761027|P1|Overall Study|Lost to Follow-up|2
5142070|NCT01541748|17761094|P1|Overall Study|Did not receive study device|1
5142071|NCT01541748|17761094|P1|Overall Study|Screen failure|5
5142072|NCT01541748|17761094|P1|Overall Study|Withdrawal by Subject|7
5142073|NCT01541748|17761094|P1|Overall Study|Moved out of state|1
5142074|NCT01541748|17761094|P1|Overall Study|Lost to Follow-up|17
5142075|NCT01541644|17761130|P1|Overall Study|Withdrawal by Subject|3
5142076|NCT01541397|17761149|P2|Overall Study|Study ended prior to data collection|2
5142077|NCT01541397|17761150|P1|Overall Study|Study ended prior to data collection|4
5142078|NCT01541371|17761175|P1|Overall Study|Other|6
5142079|NCT01541371|17761175|P1|Overall Study|Study medication non-compliance|3
5142080|NCT01541371|17761175|P1|Overall Study|Protocol Violation|6
5142081|NCT01541371|17761175|P1|Overall Study|Lack of Efficacy|12
5142082|NCT01541371|17761175|P1|Overall Study|Adverse Event|15
5142083|NCT01541371|17761175|P1|Overall Study|Lost to Follow-up|21
5142084|NCT01541371|17761175|P1|Overall Study|Withdrawal by Subject|14
5142085|NCT01541254|17761204|P1|Overall Study|alternate stent used|1
5142086|NCT01541254|17761204|P1|Overall Study|stent not required|1
5142087|NCT01541254|17761204|P1|Overall Study|GI bleed prior to procedure|1
5142088|NCT01541254|17761204|P1|Overall Study|enrolled after study closed|1
5142089|NCT01541254|17761204|P1|Overall Study|excluded - metal allergy|1
5142090|NCT01541254|17761204|P1|Overall Study|Withdrawal by Subject|1
5142091|NCT01541215|17761211|P2|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
5142092|NCT01541215|17761212|P1|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
5142093|NCT01541215|17761211|P2|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
5142094|NCT01541215|17761212|P1|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
5142095|NCT01541215|17761211|P2|Treatment Period (52 Weeks)|Unclassified|3
5142096|NCT01541215|17761212|P1|Treatment Period (52 Weeks)|Unclassified|0
5142097|NCT01541215|17761211|P2|Treatment Period (52 Weeks)|Adverse Event|1
5142098|NCT01541215|17761212|P1|Treatment Period (52 Weeks)|Adverse Event|0
5142099|NCT01541215|17761211|P2|Treatment Period (52 Weeks)|Non-compliance|4
5142100|NCT01541215|17761212|P1|Treatment Period (52 Weeks)|Non-compliance|4
5142186|NCT01539291|17761824|P3|Study GS-US-312-0116|Other|0
5142101|NCT01541215|17761211|P2|Treatment Period (52 Weeks)|Withdrawal criteria|8
5142102|NCT01541215|17761212|P1|Treatment Period (52 Weeks)|Withdrawal criteria|6
5142103|NCT01540981|17761358|P2|Overall Study|Withdrawal by Subject|0
5142104|NCT01540981|17761359|P1|Overall Study|Withdrawal by Subject|1
5142105|NCT01540851|17761369|P2|Overall Study|Withdrawal by Subject|3
5142106|NCT01540851|17761370|P1|Overall Study|Withdrawal by Subject|7
5142107|NCT01540851|17761369|P2|Overall Study|Lost to Follow-up|15
5142108|NCT01540851|17761370|P1|Overall Study|Lost to Follow-up|14
5142109|NCT01540838|17761382|P2|Overall Study|Not BM. Other treatment|1
5142110|NCT01540838|17761383|P1|Overall Study|Not BM. Other treatment|3
5142111|NCT01540838|17761382|P2|Overall Study|Died before treatment initiation|1
5142112|NCT01540838|17761383|P1|Overall Study|Died before treatment initiation|1
5142113|NCT01540838|17761382|P2|Overall Study|Additional antibiotic treatment|2
5142114|NCT01540838|17761383|P1|Overall Study|Additional antibiotic treatment|1
5142115|NCT01540838|17761382|P2|Overall Study|Treatment doses missing|12
5142116|NCT01540838|17761383|P1|Overall Study|Treatment doses missing|8
5142117|NCT01540838|17761382|P2|Overall Study|Open nasogastric tube|7
5142118|NCT01540838|17761383|P1|Overall Study|Open nasogastric tube|9
5142119|NCT01540565|17761533|P1|Overall Study|Ineligible|2
5142120|NCT01540487|17761552|P2|Overall Study|Protocol Violation|0
5142121|NCT01540487|17761553|P1|Overall Study|Protocol Violation|1
5142122|NCT01539837|17761692|P3|Overall Study|bad compliance|1
5142123|NCT01539837|17761693|P2|Overall Study|bad compliance|0
5142124|NCT01539837|17761694|P1|Overall Study|bad compliance|0
5142125|NCT01539837|17761692|P3|Overall Study|reduce neutrophil level|1
5142126|NCT01539837|17761693|P2|Overall Study|reduce neutrophil level|1
5142127|NCT01539837|17761694|P1|Overall Study|reduce neutrophil level|0
5142128|NCT01539759|17761716|P2|Overall Study|Lost to Follow-up|8
5142129|NCT01539759|17761717|P1|Overall Study|Lost to Follow-up|6
5142130|NCT01539642|17761738|P2|Overall Study|Withdrawal by Subject|2
5142131|NCT01539642|17761739|P1|Overall Study|Withdrawal by Subject|2
5142132|NCT01539642|17761738|P2|Overall Study|Adverse Event|4
5142133|NCT01539642|17761739|P1|Overall Study|Adverse Event|6
5142134|NCT01539642|17761738|P2|Overall Study|Patient ready for early discharge|7
5142135|NCT01539642|17761739|P1|Overall Study|Patient ready for early discharge|8
5142136|NCT01539642|17761738|P2|Overall Study|Lack of Efficacy|18
5142137|NCT01539642|17761739|P1|Overall Study|Lack of Efficacy|20
5142138|NCT01539538|17761756|P2|Overall Study|PCA no longer required or PCA problem|7
5142139|NCT01539538|17761757|P1|Overall Study|PCA no longer required or PCA problem|3
5142140|NCT01539538|17761756|P2|Overall Study|Withdrawal by Subject|3
5142141|NCT01539538|17761757|P1|Overall Study|Withdrawal by Subject|2
5142142|NCT01539538|17761756|P2|Overall Study|Lack of Efficacy|16
5142143|NCT01539538|17761757|P1|Overall Study|Lack of Efficacy|13
5142144|NCT01539538|17761756|P2|Overall Study|Adverse Event|18
5142145|NCT01539538|17761757|P1|Overall Study|Adverse Event|13
5142146|NCT01539525|17761766|P3|Overall Study|Protocol Violation|4
5142147|NCT01539525|17761767|P2|Overall Study|Protocol Violation|1
5142148|NCT01539525|17761768|P1|Overall Study|Protocol Violation|1
5142149|NCT01539525|17761766|P3|Overall Study|Withdrawal by Subject|2
5142150|NCT01539525|17761767|P2|Overall Study|Withdrawal by Subject|3
5142151|NCT01539525|17761768|P1|Overall Study|Withdrawal by Subject|0
5142152|NCT01539525|17761766|P3|Overall Study|Lost to Follow-up|11
5142153|NCT01539525|17761767|P2|Overall Study|Lost to Follow-up|12
5142154|NCT01539525|17761768|P1|Overall Study|Lost to Follow-up|19
5142155|NCT01539512|17761787|P2|Overall Study|Richter's Transformation|0
5142156|NCT01539512|17761788|P1|Overall Study|Richter's Transformation|1
5142157|NCT01539512|17761787|P2|Overall Study|Withdrawal by Subject|5
5142158|NCT01539512|17761788|P1|Overall Study|Withdrawal by Subject|12
5142159|NCT01539512|17761787|P2|Overall Study|Physician Decision|1
5142160|NCT01539512|17761788|P1|Overall Study|Physician Decision|1
5142161|NCT01539512|17761787|P2|Overall Study|Adverse Event|7
5142162|NCT01539512|17761788|P1|Overall Study|Adverse Event|9
5142163|NCT01539317|17761804|P2|Overall Study|Screening Error. Deleted from analysis.|0
5142164|NCT01539317|17761805|P1|Overall Study|Screening Error. Deleted from analysis.|1
5142165|NCT01539291|17761823|P4|Study GS-US-312-0117|Other|1
5142166|NCT01539291|17761824|P3|Study GS-US-312-0117|Other|1
5142167|NCT01539291|17761825|P2|Study GS-US-312-0117|Other|1
5142168|NCT01539291|17761826|P1|Study GS-US-312-0117|Other|2
5142169|NCT01539291|17761823|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
5142170|NCT01539291|17761824|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
5142171|NCT01539291|17761825|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
5142172|NCT01539291|17761826|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
5142173|NCT01539291|17761823|P4|Study GS-US-312-0117|Withdrawal by Subject|4
5142174|NCT01539291|17761824|P3|Study GS-US-312-0117|Withdrawal by Subject|6
5142175|NCT01539291|17761825|P2|Study GS-US-312-0117|Withdrawal by Subject|0
5142176|NCT01539291|17761826|P1|Study GS-US-312-0117|Withdrawal by Subject|5
5142177|NCT01539291|17761823|P4|Study GS-US-312-0117|Physician Decision|4
5142178|NCT01539291|17761824|P3|Study GS-US-312-0117|Physician Decision|6
5142179|NCT01539291|17761825|P2|Study GS-US-312-0117|Physician Decision|0
5142180|NCT01539291|17761826|P1|Study GS-US-312-0117|Physician Decision|9
5142181|NCT01539291|17761823|P4|Study GS-US-312-0117|Adverse Event|12
5142182|NCT01539291|17761824|P3|Study GS-US-312-0117|Adverse Event|9
5142183|NCT01539291|17761825|P2|Study GS-US-312-0117|Adverse Event|1
5142184|NCT01539291|17761826|P1|Study GS-US-312-0117|Adverse Event|22
5142185|NCT01539291|17761823|P4|Study GS-US-312-0116|Other|0
5142187|NCT01539291|17761825|P2|Study GS-US-312-0116|Other|0
5142188|NCT01539291|17761826|P1|Study GS-US-312-0116|Other|1
5142189|NCT01539291|17761823|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
5142190|NCT01539291|17761824|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
5142191|NCT01539291|17761825|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
5142192|NCT01539291|17761826|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
5142193|NCT01539291|17761823|P4|Study GS-US-312-0116|Withdrawal by Subject|0
5142194|NCT01539291|17761824|P3|Study GS-US-312-0116|Withdrawal by Subject|0
5142195|NCT01539291|17761825|P2|Study GS-US-312-0116|Withdrawal by Subject|0
5142196|NCT01539291|17761826|P1|Study GS-US-312-0116|Withdrawal by Subject|12
5142197|NCT01539291|17761823|P4|Study GS-US-312-0116|Physician Decision|0
5142198|NCT01539291|17761824|P3|Study GS-US-312-0116|Physician Decision|0
5142199|NCT01539291|17761825|P2|Study GS-US-312-0116|Physician Decision|0
5142200|NCT01539291|17761826|P1|Study GS-US-312-0116|Physician Decision|1
5142201|NCT01539291|17761823|P4|Study GS-US-312-0116|Adverse Event|0
5142202|NCT01539291|17761824|P3|Study GS-US-312-0116|Adverse Event|0
5142203|NCT01539291|17761825|P2|Study GS-US-312-0116|Adverse Event|0
5142204|NCT01539291|17761826|P1|Study GS-US-312-0116|Adverse Event|9
5142205|NCT01539239|17761898|P2|Overall Study|Lost to Follow-up|12
5142206|NCT01539239|17761899|P1|Overall Study|Lost to Follow-up|7
5142207|NCT01539239|17761898|P2|Overall Study|Death|5
5142208|NCT01539239|17761899|P1|Overall Study|Death|5
5142209|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Death|11
5142210|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Death|6
5142211|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Death|0
5142212|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Progressive Disease|3
5142213|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Progressive Disease|6
5142214|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Progressive Disease|0
5142215|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
5142216|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
5142217|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
5142218|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
5142219|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
5142220|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
5142221|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Adverse Event|1
5142222|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Adverse Event|1
5142223|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Adverse Event|0
5142224|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Other|1
5142225|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Other|1
5142226|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Other|0
5142227|NCT01539083|17761922|P3|After Randomization (TP and VTP)|Physician Decision|1
5142228|NCT01539083|17761923|P2|After Randomization (TP and VTP)|Physician Decision|0
5142229|NCT01539083|17761924|P1|After Randomization (TP and VTP)|Physician Decision|0
5142230|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Other|0
5142231|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Other|0
5142232|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Other|5
5142233|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Progressive Disease|0
5142234|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Progressive Disease|0
5142235|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Progressive Disease|8
5142236|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Physician Decision|0
5142237|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Physician Decision|0
5142238|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Physician Decision|14
5142239|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Protocol Violation|0
5142240|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Protocol Violation|0
5142241|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Protocol Violation|2
5142242|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Death|0
5142243|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Death|0
5142244|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Death|6
5142245|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Adverse Event|0
5142246|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Adverse Event|0
5142247|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Adverse Event|14
5142248|NCT01539083|17761922|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
5142249|NCT01539083|17761923|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
5142250|NCT01539083|17761924|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
5142251|NCT01538719|17761968|P2|Overall Study|Lost to Follow-up|0
5142252|NCT01538719|17761969|P1|Overall Study|Lost to Follow-up|2
5142253|NCT01538472|17761992|P1|Overall Study|Death|1
5142254|NCT01538472|17761992|P1|Overall Study|Disease Progression|3
5142255|NCT01538199|17762003|P4|Overall Study|Lack of Efficacy|0
5142256|NCT01538199|17762004|P3|Overall Study|Lack of Efficacy|0
5142257|NCT01538199|17762005|P2|Overall Study|Lack of Efficacy|1
5142258|NCT01538199|17762006|P1|Overall Study|Lack of Efficacy|0
5142259|NCT01538199|17762003|P4|Overall Study|participant did not have time|2
5142260|NCT01538199|17762004|P3|Overall Study|participant did not have time|0
5142261|NCT01538199|17762005|P2|Overall Study|participant did not have time|0
5142262|NCT01538199|17762006|P1|Overall Study|participant did not have time|1
5142263|NCT01538199|17762003|P4|Overall Study|Lost to Follow-up|0
5142264|NCT01538199|17762004|P3|Overall Study|Lost to Follow-up|1
5142265|NCT01538199|17762005|P2|Overall Study|Lost to Follow-up|2
5142266|NCT01538199|17762006|P1|Overall Study|Lost to Follow-up|1
5142267|NCT01537887|17762040|P6|Period 3|Withdrawal by Subject|0
5142268|NCT01537887|17762041|P5|Period 3|Withdrawal by Subject|0
5142269|NCT01537887|17762042|P4|Period 3|Withdrawal by Subject|0
5142270|NCT01537887|17762043|P3|Period 3|Withdrawal by Subject|0
5142271|NCT01537887|17762044|P2|Period 3|Withdrawal by Subject|1
5142272|NCT01537887|17762045|P1|Period 3|Withdrawal by Subject|0
5142273|NCT01537887|17762040|P6|Period 3|Adverse Event|0
5142274|NCT01537887|17762041|P5|Period 3|Adverse Event|0
5142275|NCT01537887|17762042|P4|Period 3|Adverse Event|0
5142276|NCT01537887|17762043|P3|Period 3|Adverse Event|1
5142277|NCT01537887|17762044|P2|Period 3|Adverse Event|0
5142278|NCT01537887|17762045|P1|Period 3|Adverse Event|0
5142279|NCT01537887|17762040|P6|Period 2|Withdrawal by Subject|0
5142280|NCT01537887|17762041|P5|Period 2|Withdrawal by Subject|0
5142281|NCT01537887|17762042|P4|Period 2|Withdrawal by Subject|0
5142282|NCT01537887|17762043|P3|Period 2|Withdrawal by Subject|0
5142283|NCT01537887|17762044|P2|Period 2|Withdrawal by Subject|1
5142284|NCT01537887|17762045|P1|Period 2|Withdrawal by Subject|0
5142285|NCT01537887|17762040|P6|Period 1|Did not receive treatment|0
5142286|NCT01537887|17762041|P5|Period 1|Did not receive treatment|0
5142287|NCT01537887|17762042|P4|Period 1|Did not receive treatment|0
5142288|NCT01537887|17762043|P3|Period 1|Did not receive treatment|1
5142289|NCT01537887|17762044|P2|Period 1|Did not receive treatment|0
5142290|NCT01537887|17762045|P1|Period 1|Did not receive treatment|0
5142291|NCT01537887|17762040|P6|Period 1|Physician Decision|1
5142292|NCT01537887|17762041|P5|Period 1|Physician Decision|1
5142293|NCT01537887|17762042|P4|Period 1|Physician Decision|0
5142294|NCT01537887|17762043|P3|Period 1|Physician Decision|0
5142295|NCT01537887|17762044|P2|Period 1|Physician Decision|0
5142296|NCT01537887|17762045|P1|Period 1|Physician Decision|0
5142297|NCT01537783|17762074|P2|Overall Study|Lost to Follow-up|2
5142298|NCT01537783|17762075|P1|Overall Study|Lost to Follow-up|11
5142299|NCT01537549|17762126|P1|Overall Study|Withdrawal by Subject|2
5142300|NCT01537549|17762126|P1|Overall Study|Lost to Follow-up|1
5142301|NCT01537432|17762134|P2|Overall Study|Unsatisfactory therapeutic effect|0
5142302|NCT01537432|17762135|P1|Overall Study|Unsatisfactory therapeutic effect|1
5142303|NCT01537432|17762134|P2|Overall Study|Adverse Event|0
5142304|NCT01537432|17762135|P1|Overall Study|Adverse Event|1
5142305|NCT01537432|17762134|P2|Overall Study|Administrative problems|0
5142306|NCT01537432|17762135|P1|Overall Study|Administrative problems|1
5142307|NCT01537432|17762134|P2|Overall Study|Withdrawal by Subject|1
5142308|NCT01537432|17762135|P1|Overall Study|Withdrawal by Subject|0
5142309|NCT01537432|17762134|P2|Overall Study|Lost to Follow-up|1
5142310|NCT01537432|17762135|P1|Overall Study|Lost to Follow-up|3
5142311|NCT01537393|17762158|P2|Overall Study|Censored (severe event unrelated to PT)|1
5142312|NCT01537393|17762159|P1|Overall Study|Censored (severe event unrelated to PT)|1
5142313|NCT01537393|17762158|P2|Overall Study|Failure - Not regrafted|6
5142314|NCT01537393|17762159|P1|Overall Study|Failure - Not regrafted|2
5142315|NCT01537393|17762158|P2|Overall Study|Failure - Regrafted|43
5142316|NCT01537393|17762159|P1|Overall Study|Failure - Regrafted|28
5142317|NCT01537393|17762158|P2|Overall Study|Lost to Follow-up|48
5142318|NCT01537393|17762159|P1|Overall Study|Lost to Follow-up|53
5142319|NCT01537393|17762158|P2|Overall Study|Withdrawal by Subject|17
5142320|NCT01537393|17762159|P1|Overall Study|Withdrawal by Subject|18
5142321|NCT01537393|17762158|P2|Overall Study|Death|32
5142322|NCT01537393|17762159|P1|Overall Study|Death|20
5142323|NCT01537393|17762158|P2|Overall Study|Exclude prior to study|44
5142324|NCT01537393|17762159|P1|Overall Study|Exclude prior to study|32
5142325|NCT01537302|17762195|P1|Overall Study|Withdrawal by Subject|1
5142326|NCT01537302|17762195|P1|Overall Study|Lost to Follow-up|1
5142327|NCT01537211|17762204|P2|Overall Study|Lost to Follow-up|1
5142328|NCT01537211|17762205|P1|Overall Study|Lost to Follow-up|0
5142329|NCT01537198|17762239|P1|Overall Study|Other|111
5142330|NCT01537198|17762239|P1|Overall Study|No Further Visits to the Clinic|37
5142331|NCT01537198|17762239|P1|Overall Study|Adverse Event|4
5142332|NCT01537198|17762239|P1|Overall Study|RSV infection|2
5142333|NCT01537133|17762268|P4|Overall Study|Lost to Follow-up|0
5142334|NCT01537133|17762269|P3|Overall Study|Lost to Follow-up|0
5142335|NCT01537133|17762270|P2|Overall Study|Lost to Follow-up|0
5142336|NCT01537133|17762271|P1|Overall Study|Lost to Follow-up|1
5142337|NCT01537133|17762268|P4|Overall Study|Withdrawal by Subject|0
5142338|NCT01537133|17762269|P3|Overall Study|Withdrawal by Subject|0
5142339|NCT01537133|17762270|P2|Overall Study|Withdrawal by Subject|0
5142340|NCT01537133|17762271|P1|Overall Study|Withdrawal by Subject|2
5142341|NCT01537120|17762287|P1|3 Weeks Placebo|Withdrawal by Subject|1
5142342|NCT01537120|17762287|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
5142343|NCT01537081|17762300|P3|Overall Study|Assigned but never dosed|0
5142344|NCT01537081|17762301|P2|Overall Study|Assigned but never dosed|0
5142345|NCT01537081|17762302|P1|Overall Study|Assigned but never dosed|1
5142346|NCT01537081|17762300|P3|Overall Study|Sponsor decision|0
5142347|NCT01537081|17762301|P2|Overall Study|Sponsor decision|1
5142348|NCT01537081|17762302|P1|Overall Study|Sponsor decision|0
5142349|NCT01537081|17762300|P3|Overall Study|Physician Decision|0
5142350|NCT01537081|17762301|P2|Overall Study|Physician Decision|6
5142351|NCT01537081|17762302|P1|Overall Study|Physician Decision|5
5142352|NCT01537081|17762300|P3|Overall Study|Withdrawal by Subject|3
5142353|NCT01537081|17762301|P2|Overall Study|Withdrawal by Subject|11
5142354|NCT01537081|17762302|P1|Overall Study|Withdrawal by Subject|6
5142355|NCT01537081|17762300|P3|Overall Study|Protocol Violation|2
5142356|NCT01537081|17762301|P2|Overall Study|Protocol Violation|2
5142357|NCT01537081|17762302|P1|Overall Study|Protocol Violation|3
5142358|NCT01537081|17762300|P3|Overall Study|Lost to Follow-up|9
5142359|NCT01537081|17762301|P2|Overall Study|Lost to Follow-up|15
5142360|NCT01537081|17762302|P1|Overall Study|Lost to Follow-up|17
5142361|NCT01537081|17762300|P3|Overall Study|Lack of Efficacy|0
5142362|NCT01537081|17762301|P2|Overall Study|Lack of Efficacy|1
5142363|NCT01537081|17762302|P1|Overall Study|Lack of Efficacy|2
5142364|NCT01537081|17762300|P3|Overall Study|Adverse Event|2
5142365|NCT01537081|17762301|P2|Overall Study|Adverse Event|2
5142366|NCT01537081|17762302|P1|Overall Study|Adverse Event|5
5142367|NCT01537068|17762315|P2|Overall Study|Lack of Efficacy|0
5142368|NCT01537068|17762316|P1|Overall Study|Lack of Efficacy|1
5142369|NCT01537068|17762315|P2|Overall Study|Withdrawal by Subject|1
5142370|NCT01537068|17762316|P1|Overall Study|Withdrawal by Subject|1
5142371|NCT01537068|17762315|P2|Overall Study|Adverse Event|1
5142372|NCT01537068|17762316|P1|Overall Study|Adverse Event|0
5142373|NCT01537068|17762315|P2|Overall Study|Lost to Follow-up|1
5142374|NCT01537068|17762316|P1|Overall Study|Lost to Follow-up|2
5142375|NCT01537042|17762328|P2|Overall Study|Other|1
5142376|NCT01537042|17762329|P1|Overall Study|Other|0
5142377|NCT01537042|17762328|P2|Overall Study|Protocol Violation|1
5142378|NCT01537042|17762329|P1|Overall Study|Protocol Violation|0
5142379|NCT01537042|17762328|P2|Overall Study|Lack of Efficacy|1
5142380|NCT01537042|17762329|P1|Overall Study|Lack of Efficacy|0
5142381|NCT01537042|17762328|P2|Overall Study|Adverse Event|2
5142382|NCT01537042|17762329|P1|Overall Study|Adverse Event|0
5142383|NCT01536951|17762371|P9|Second Intervention and Washout Period 2|Adverse Event|0
5142384|NCT01536951|17762372|P8|Second Intervention and Washout Period 2|Adverse Event|1
5142385|NCT01536951|17762373|P7|Second Intervention and Washout Period 2|Adverse Event|0
5142386|NCT01536951|17762374|P6|Second Intervention and Washout Period 2|Adverse Event|0
5142387|NCT01536951|17762375|P5|Second Intervention and Washout Period 2|Adverse Event|0
5142388|NCT01536951|17762376|P4|Second Intervention and Washout Period 2|Adverse Event|0
5142389|NCT01536951|17762377|P3|Second Intervention and Washout Period 2|Adverse Event|0
5142390|NCT01536951|17762378|P2|Second Intervention and Washout Period 2|Adverse Event|0
5142391|NCT01536951|17762379|P1|Second Intervention and Washout Period 2|Adverse Event|0
5142392|NCT01536951|17762371|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142393|NCT01536951|17762372|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142394|NCT01536951|17762373|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142395|NCT01536951|17762374|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142396|NCT01536951|17762375|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142397|NCT01536951|17762376|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142398|NCT01536951|17762377|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
5142399|NCT01536951|17762378|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142400|NCT01536951|17762379|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
5142401|NCT01536860|17762436|P3|Washout Period (3 Days)|Lost to Follow-up|0
5142402|NCT01536860|17762437|P2|Washout Period (3 Days)|Lost to Follow-up|0
5142403|NCT01536860|17762438|P1|Washout Period (3 Days)|Lost to Follow-up|1
5142404|NCT01536704|17762446|P4|Washout Period 3|Adverse Event|0
5142405|NCT01536704|17762447|P3|Washout Period 3|Adverse Event|1
5142406|NCT01536704|17762448|P2|Washout Period 3|Adverse Event|0
5142407|NCT01536704|17762449|P1|Washout Period 3|Adverse Event|0
5142408|NCT01536704|17762446|P4|Period 3|Adverse Event|1
5142409|NCT01536704|17762447|P3|Period 3|Adverse Event|0
5142410|NCT01536704|17762448|P2|Period 3|Adverse Event|0
5142411|NCT01536704|17762449|P1|Period 3|Adverse Event|0
5142412|NCT01536704|17762446|P4|Washout Period 2|Withdrawal by Subject|1
5142413|NCT01536704|17762447|P3|Washout Period 2|Withdrawal by Subject|0
5142414|NCT01536704|17762448|P2|Washout Period 2|Withdrawal by Subject|0
5142415|NCT01536704|17762449|P1|Washout Period 2|Withdrawal by Subject|0
5142416|NCT01536704|17762446|P4|Washout Period 2|Adverse Event|0
5142417|NCT01536704|17762447|P3|Washout Period 2|Adverse Event|0
5142418|NCT01536704|17762448|P2|Washout Period 2|Adverse Event|0
5142419|NCT01536704|17762449|P1|Washout Period 2|Adverse Event|1
5142420|NCT01536704|17762446|P4|Washout Period 1|Withdrawal by Subject|0
5142421|NCT01536704|17762447|P3|Washout Period 1|Withdrawal by Subject|0
5142422|NCT01536704|17762448|P2|Washout Period 1|Withdrawal by Subject|2
5142423|NCT01536704|17762449|P1|Washout Period 1|Withdrawal by Subject|1
5142424|NCT01536587|17762479|P1|Overall Study|Adverse Event|2
5142425|NCT01536574|17762518|P2|Overall Study|Lack of Efficacy|0
5142426|NCT01536574|17762519|P1|Overall Study|Lack of Efficacy|1
5142427|NCT01536574|17762518|P2|Overall Study|Withdrawal by Subject|2
5142428|NCT01536574|17762519|P1|Overall Study|Withdrawal by Subject|1
5142429|NCT01536574|17762518|P2|Overall Study|Adverse Event|5
5142430|NCT01536574|17762519|P1|Overall Study|Adverse Event|4
5142431|NCT01536561|17762537|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
5142432|NCT01536561|17762537|P1|Dosimetric and Therapeutic Treatment|Death|2
5142433|NCT01536561|17762537|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
5142434|NCT01536561|17762537|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
5142435|NCT01536561|17762537|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
5142436|NCT01536561|17762537|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
5142437|NCT01536535|17762577|P2|Overall Study|Participant moved|1
5142438|NCT01536535|17762578|P1|Overall Study|Participant moved|0
5142439|NCT01536535|17762577|P2|Overall Study|Physician Decision|1
5142440|NCT01536535|17762578|P1|Overall Study|Physician Decision|1
5142441|NCT01536535|17762577|P2|Overall Study|Lost to Follow-up|6
5142442|NCT01536535|17762578|P1|Overall Study|Lost to Follow-up|4
5142443|NCT01536535|17762577|P2|Overall Study|Withdrawal by Subject|5
5142444|NCT01536535|17762578|P1|Overall Study|Withdrawal by Subject|10
5142445|NCT01536418|17762627|P2|Overall Study|Withdrawal by Subject|3
5142446|NCT01536418|17762628|P1|Overall Study|Withdrawal by Subject|5
5142447|NCT01536418|17762627|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
5142448|NCT01536418|17762628|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
5142449|NCT01536418|17762627|P2|Overall Study|Adverse Event|4
5142450|NCT01536418|17762628|P1|Overall Study|Adverse Event|9
5142451|NCT01536418|17762627|P2|Overall Study|Lack of Efficacy|16
5142452|NCT01536418|17762628|P1|Overall Study|Lack of Efficacy|10
5142453|NCT01536418|17762627|P2|Overall Study|Study closed/terminated|37
5142454|NCT01536418|17762628|P1|Overall Study|Study closed/terminated|41
5142455|NCT01536418|17762627|P2|Overall Study|Physician Decision|3
5142456|NCT01536418|17762628|P1|Overall Study|Physician Decision|1
5142457|NCT01536418|17762627|P2|Overall Study|Protocol Violation|3
5142458|NCT01536418|17762628|P1|Overall Study|Protocol Violation|2
5142459|NCT01536405|17762648|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
5142460|NCT01536405|17762649|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
5142461|NCT01536405|17762648|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
5142462|NCT01536405|17762649|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
5142463|NCT01536405|17762648|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
5142464|NCT01536405|17762649|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
5142465|NCT01536405|17762648|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
5142466|NCT01536405|17762649|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
5142467|NCT01536405|17762648|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
5142468|NCT01536405|17762649|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
5142469|NCT01536405|17762648|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
5142470|NCT01536405|17762649|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
5142471|NCT01536405|17762648|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
5142472|NCT01536405|17762649|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
5142473|NCT01536405|17762648|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
5142474|NCT01536405|17762649|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
5142475|NCT01536405|17762648|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
5142476|NCT01536405|17762649|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
5142477|NCT01536405|17762648|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
5142478|NCT01536405|17762649|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
5142479|NCT01536405|17762648|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
5142480|NCT01536405|17762649|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
5142481|NCT01536405|17762648|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
5142482|NCT01536405|17762649|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
5142483|NCT01536405|17762648|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
5142484|NCT01536405|17762649|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
5142485|NCT01536379|17762687|P2|Overall Study|Withdrawal by Subject|1
5142486|NCT01536379|17762688|P1|Overall Study|Withdrawal by Subject|1
5142487|NCT01536379|17762687|P2|Overall Study|Adverse Event|2
5142488|NCT01536379|17762688|P1|Overall Study|Adverse Event|1
5142489|NCT01536262|17762780|P3|Overall Study|Other than stated above|0
5142490|NCT01536262|17762781|P2|Overall Study|Other than stated above|0
5142491|NCT01536262|17762782|P1|Overall Study|Other than stated above|1
5142492|NCT01536262|17762780|P3|Overall Study|Withdrawal by Subject|0
5142493|NCT01536262|17762781|P2|Overall Study|Withdrawal by Subject|1
5142494|NCT01536262|17762782|P1|Overall Study|Withdrawal by Subject|1
5142495|NCT01536262|17762780|P3|Overall Study|Adverse Event|2
5142496|NCT01536262|17762781|P2|Overall Study|Adverse Event|1
5142497|NCT01536262|17762782|P1|Overall Study|Adverse Event|6
5142498|NCT01536171|17762824|P1|Overall Study|Withdrawal by Subject|1
5142499|NCT01536145|17762829|P11|Overall Study|Adverse Event|3
5142500|NCT01536145|17762830|P10|Overall Study|Adverse Event|0
5142501|NCT01536145|17762831|P9|Overall Study|Adverse Event|0
5142502|NCT01536145|17762832|P8|Overall Study|Adverse Event|2
5142503|NCT01536145|17762833|P7|Overall Study|Adverse Event|0
5142504|NCT01536145|17762834|P6|Overall Study|Adverse Event|0
5142505|NCT01536145|17762835|P5|Overall Study|Adverse Event|0
5142506|NCT01536145|17762836|P4|Overall Study|Adverse Event|0
5142507|NCT01536145|17762837|P3|Overall Study|Adverse Event|0
5142508|NCT01536145|17762838|P2|Overall Study|Adverse Event|0
5142509|NCT01536145|17762839|P1|Overall Study|Adverse Event|0
5142510|NCT01536145|17762829|P11|Overall Study|Death|0
5142511|NCT01536145|17762830|P10|Overall Study|Death|0
5142512|NCT01536145|17762831|P9|Overall Study|Death|0
5142513|NCT01536145|17762832|P8|Overall Study|Death|0
5142514|NCT01536145|17762833|P7|Overall Study|Death|1
5142515|NCT01536145|17762834|P6|Overall Study|Death|0
5142516|NCT01536145|17762835|P5|Overall Study|Death|0
5142517|NCT01536145|17762836|P4|Overall Study|Death|0
5142518|NCT01536145|17762837|P3|Overall Study|Death|0
5142519|NCT01536145|17762838|P2|Overall Study|Death|0
5142520|NCT01536145|17762839|P1|Overall Study|Death|0
5142521|NCT01536145|17762829|P11|Overall Study|Other|2
5142522|NCT01536145|17762830|P10|Overall Study|Other|3
5142523|NCT01536145|17762831|P9|Overall Study|Other|0
5142524|NCT01536145|17762832|P8|Overall Study|Other|0
5142525|NCT01536145|17762833|P7|Overall Study|Other|0
5142526|NCT01536145|17762834|P6|Overall Study|Other|0
5142527|NCT01536145|17762835|P5|Overall Study|Other|1
5142528|NCT01536145|17762836|P4|Overall Study|Other|0
5142529|NCT01536145|17762837|P3|Overall Study|Other|0
5142530|NCT01536145|17762838|P2|Overall Study|Other|0
5142531|NCT01536145|17762839|P1|Overall Study|Other|0
5142532|NCT01536145|17762829|P11|Overall Study|Withdrawal by Subject|2
5142533|NCT01536145|17762830|P10|Overall Study|Withdrawal by Subject|0
5142534|NCT01536145|17762831|P9|Overall Study|Withdrawal by Subject|2
5142535|NCT01536145|17762832|P8|Overall Study|Withdrawal by Subject|0
5142536|NCT01536145|17762833|P7|Overall Study|Withdrawal by Subject|0
5142537|NCT01536145|17762834|P6|Overall Study|Withdrawal by Subject|1
5142538|NCT01536145|17762835|P5|Overall Study|Withdrawal by Subject|0
5142539|NCT01536145|17762836|P4|Overall Study|Withdrawal by Subject|0
5142540|NCT01536145|17762837|P3|Overall Study|Withdrawal by Subject|1
5142541|NCT01536145|17762838|P2|Overall Study|Withdrawal by Subject|0
5142542|NCT01536145|17762839|P1|Overall Study|Withdrawal by Subject|0
5142543|NCT01536145|17762829|P11|Overall Study|Progressive disease|3
5142544|NCT01536145|17762830|P10|Overall Study|Progressive disease|3
5142545|NCT01536145|17762831|P9|Overall Study|Progressive disease|1
5142546|NCT01536145|17762832|P8|Overall Study|Progressive disease|2
5142547|NCT01536145|17762833|P7|Overall Study|Progressive disease|1
5142548|NCT01536145|17762834|P6|Overall Study|Progressive disease|2
5142549|NCT01536145|17762835|P5|Overall Study|Progressive disease|1
5142550|NCT01536145|17762836|P4|Overall Study|Progressive disease|2
5142551|NCT01536145|17762837|P3|Overall Study|Progressive disease|1
5142552|NCT01536145|17762838|P2|Overall Study|Progressive disease|4
5142553|NCT01536145|17762839|P1|Overall Study|Progressive disease|3
5142554|NCT01536119|17762946|P2|Overall Study|Lost to Follow-up|14
5142555|NCT01536119|17762947|P1|Overall Study|Lost to Follow-up|17
5142556|NCT01536093|17762973|P2|Overall Study|Withdrawal by Subject|1
5142557|NCT01536093|17762974|P1|Overall Study|Withdrawal by Subject|0
5142558|NCT01536093|17762973|P2|Overall Study|absence of maternal colostrum|0
5142559|NCT01536093|17762974|P1|Overall Study|absence of maternal colostrum|2
5142560|NCT01536093|17762973|P2|Overall Study|Death|2
5142561|NCT01536093|17762974|P1|Overall Study|Death|1
5142562|NCT01536067|17762990|P1|Overall Study|Disease Progression|1
5142563|NCT01536015|17763003|P2|Overall Study|Study closure|5
5142564|NCT01536015|17763004|P1|Overall Study|Study closure|5
5142565|NCT01536015|17763003|P2|Overall Study|Inclusion Criterion not met|0
5142566|NCT01536015|17763004|P1|Overall Study|Inclusion Criterion not met|2
5142567|NCT01536015|17763003|P2|Overall Study|Lost to Follow-up|1
5142568|NCT01536015|17763004|P1|Overall Study|Lost to Follow-up|0
5142569|NCT01536015|17763003|P2|Overall Study|Adverse Event|4
5142570|NCT01536015|17763004|P1|Overall Study|Adverse Event|1
5142571|NCT01535807|17763042|P2|Overall Study|Data collection error|1
5142572|NCT01535807|17763043|P1|Overall Study|Data collection error|1
5142573|NCT01535807|17763042|P2|Overall Study|Withdrawal by Subject|1
5142574|NCT01535807|17763043|P1|Overall Study|Withdrawal by Subject|1
5142575|NCT01535729|17763049|P1|Overall Study|No participant record available|5
5142576|NCT01535729|17763049|P1|Overall Study|Not treated|9
5142577|NCT01535729|17763049|P1|Overall Study|Screening failure|1
5142578|NCT01535729|17763049|P1|Overall Study|Protocol Violation|11
5142579|NCT01535729|17763049|P1|Overall Study|NSCLC grade IV histology not confirmed|20
5142580|NCT01535729|17763049|P1|Overall Study|No previous chemotherapy|33
5142581|NCT01535729|17763049|P1|Overall Study|Did not sign informed consent|1
5142582|NCT01535729|17763049|P1|Overall Study|Other|19
5142583|NCT01535729|17763049|P1|Overall Study|Death|52
5142584|NCT01535729|17763049|P1|Overall Study|Lost to Follow-up|8
5142585|NCT01535729|17763049|P1|Overall Study|Discontinued treatment|25
5142586|NCT01535729|17763049|P1|Overall Study|Disease progression|230
5142587|NCT01535729|17763049|P1|Overall Study|Withdrawal by Subject|2
5142588|NCT01535638|17763090|P6|Treatment 3 (Single Dose)|Protocol Violation|0
5142589|NCT01535638|17763091|P5|Treatment 3 (Single Dose)|Protocol Violation|0
5142590|NCT01535638|17763092|P4|Treatment 3 (Single Dose)|Protocol Violation|1
5142591|NCT01535638|17763093|P3|Treatment 3 (Single Dose)|Protocol Violation|0
5142592|NCT01535638|17763094|P2|Treatment 3 (Single Dose)|Protocol Violation|0
5142593|NCT01535638|17763095|P1|Treatment 3 (Single Dose)|Protocol Violation|0
5142594|NCT01535638|17763090|P6|Treatment 1 (Single Dose)|Protocol Violation|1
5142595|NCT01535638|17763091|P5|Treatment 1 (Single Dose)|Protocol Violation|0
5142596|NCT01535638|17763092|P4|Treatment 1 (Single Dose)|Protocol Violation|0
5142597|NCT01535638|17763093|P3|Treatment 1 (Single Dose)|Protocol Violation|0
5142598|NCT01535638|17763094|P2|Treatment 1 (Single Dose)|Protocol Violation|0
5142599|NCT01535638|17763095|P1|Treatment 1 (Single Dose)|Protocol Violation|0
5142600|NCT01535599|17763109|P2|Overall Study|Noncompliance|1
5142601|NCT01535599|17763110|P1|Overall Study|Noncompliance|0
5142602|NCT01535599|17763109|P2|Overall Study|Stopped medication|1
5142603|NCT01535599|17763110|P1|Overall Study|Stopped medication|0
5142604|NCT01535599|17763109|P2|Overall Study|Other|0
5142605|NCT01535599|17763110|P1|Overall Study|Other|1
5142606|NCT01535599|17763109|P2|Overall Study|Did not use product|0
5142607|NCT01535599|17763110|P1|Overall Study|Did not use product|1
5142608|NCT01535599|17763109|P2|Overall Study|Randomized in Error|4
5142609|NCT01535599|17763110|P1|Overall Study|Randomized in Error|2
5142610|NCT01535599|17763109|P2|Overall Study|BL Culture + for Yeast//Fungi|1
5142611|NCT01535599|17763110|P1|Overall Study|BL Culture + for Yeast//Fungi|0
5142612|NCT01535599|17763109|P2|Overall Study|BL Culture + for Group A Strep|1
5142613|NCT01535599|17763110|P1|Overall Study|BL Culture + for Group A Strep|0
5142614|NCT01535599|17763109|P2|Overall Study|Treatment Failure|66
5142615|NCT01535599|17763110|P1|Overall Study|Treatment Failure|33
5142616|NCT01535599|17763109|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
5142617|NCT01535599|17763110|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
5142618|NCT01535599|17763109|P2|Overall Study|Lost to Follow-up|4
5142619|NCT01535599|17763110|P1|Overall Study|Lost to Follow-up|3
5142620|NCT01535599|17763109|P2|Overall Study|Adverse Event|15
5142621|NCT01535599|17763110|P1|Overall Study|Adverse Event|6
5142622|NCT01535560|17763144|P2|Overall Study|Randomized in Error|1
5142623|NCT01535560|17763145|P1|Overall Study|Randomized in Error|0
5142624|NCT01535560|17763144|P2|Overall Study|Other|1
5142625|NCT01535560|17763145|P1|Overall Study|Other|0
5142626|NCT01535560|17763144|P2|Overall Study|Treatment Failure|83
5142627|NCT01535560|17763145|P1|Overall Study|Treatment Failure|21
5142628|NCT01535560|17763144|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
5142629|NCT01535560|17763145|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
5142630|NCT01535560|17763144|P2|Overall Study|Lost to Follow-up|3
5142631|NCT01535560|17763145|P1|Overall Study|Lost to Follow-up|1
5142632|NCT01535560|17763144|P2|Overall Study|Adverse Event|7
5142633|NCT01535560|17763145|P1|Overall Study|Adverse Event|12
5142634|NCT01535443|17763155|P1|Overall Study|Physician Decision|3
5142635|NCT01535287|17763205|P2|Overall Study|drug not prepared in time|6
5142636|NCT01535287|17763206|P1|Overall Study|drug not prepared in time|5
5142637|NCT01535261|17763222|P1|Overall Study|Adverse Event|12
5142638|NCT01535261|17763222|P1|Overall Study|Withdrawal by Subject|14
5142639|NCT01535261|17763222|P1|Overall Study|Lost to Follow-up|8
5142640|NCT01535261|17763222|P1|Overall Study|Death|5
5142641|NCT01535261|17763222|P1|Overall Study|Protocol Violation|3
5142642|NCT01535261|17763222|P1|Overall Study|Physician Decision|8
5142643|NCT01535235|17763235|P2|Overall Study|Adverse Event|0
5142644|NCT01535235|17763236|P1|Overall Study|Adverse Event|1
5142645|NCT01535222|17763250|P6|Overall Study|Inclusion/exclusion|0
5142646|NCT01535222|17763251|P5|Overall Study|Inclusion/exclusion|0
5142647|NCT01535222|17763252|P4|Overall Study|Inclusion/exclusion|0
5142648|NCT01535222|17763253|P3|Overall Study|Inclusion/exclusion|1
5142649|NCT01535222|17763254|P2|Overall Study|Inclusion/exclusion|0
5142650|NCT01535222|17763255|P1|Overall Study|Inclusion/exclusion|0
5142651|NCT01535053|17763286|P2|Overall Study|Ineligible|2
5142652|NCT01535053|17763287|P1|Overall Study|Ineligible|1
5142653|NCT01535040|17763305|P2|Overall Study|Multiple Reasons|1
5142654|NCT01535040|17763306|P1|Overall Study|Multiple Reasons|1
5142655|NCT01535040|17763305|P2|Overall Study|Toxicity|5
5142656|NCT01535040|17763306|P1|Overall Study|Toxicity|7
5142657|NCT01535040|17763305|P2|Overall Study|Never Started|4
5142658|NCT01535040|17763306|P1|Overall Study|Never Started|9
5142659|NCT01535040|17763305|P2|Overall Study|Withdrawal by Subject|10
5142660|NCT01535040|17763306|P1|Overall Study|Withdrawal by Subject|13
5142661|NCT01535040|17763305|P2|Overall Study|Physician Decision|1
5142662|NCT01535040|17763306|P1|Overall Study|Physician Decision|0
5142663|NCT01534962|17763403|P4|Overall Study|Discontinued at AF recurrence|31
5142664|NCT01534962|17763404|P3|Overall Study|Discontinued at AF recurrence|24
5142665|NCT01534962|17763405|P2|Overall Study|Discontinued at AF recurrence|26
5142666|NCT01534962|17763406|P1|Overall Study|Discontinued at AF recurrence|35
5142667|NCT01534962|17763403|P4|Overall Study|Randomized but did not start treatment|1
5142668|NCT01534962|17763404|P3|Overall Study|Randomized but did not start treatment|0
5142669|NCT01534962|17763405|P2|Overall Study|Randomized but did not start treatment|0
5142670|NCT01534962|17763406|P1|Overall Study|Randomized but did not start treatment|2
5142671|NCT01534676|17763463|P2|Overall Study|Study closed due to poor enrollment|1
5142672|NCT01534676|17763464|P1|Overall Study|Study closed due to poor enrollment|2
5142673|NCT01534637|17763470|P1|Overall Study|Liver Mets before treatment|1
5142674|NCT01534637|17763470|P1|Overall Study|Adverse Event|1
5142675|NCT01534637|17763470|P1|Overall Study|Withdrawal by Subject|1
5142676|NCT01534637|17763470|P1|Overall Study|Lack of Efficacy|3
5142677|NCT01534637|17763470|P1|Overall Study|Physician Decision|3
5142678|NCT01534533|17763480|P4|Overall Study|Withdrawal by Subject|1
5142679|NCT01534533|17763481|P3|Overall Study|Withdrawal by Subject|4
5142680|NCT01534533|17763482|P2|Overall Study|Withdrawal by Subject|3
5142681|NCT01534533|17763483|P1|Overall Study|Withdrawal by Subject|5
5142682|NCT01534533|17763480|P4|Overall Study|Lost to Follow-up|3
5142683|NCT01534533|17763481|P3|Overall Study|Lost to Follow-up|4
5142684|NCT01534533|17763482|P2|Overall Study|Lost to Follow-up|0
5142685|NCT01534533|17763483|P1|Overall Study|Lost to Follow-up|3
5142686|NCT01534520|17763511|P2|Overall Study|Adverse Event|1
5142687|NCT01534520|17763512|P1|Overall Study|Adverse Event|0
5142688|NCT01534351|17763546|P3|Overall Study|Study Terminated Early|0
5142689|NCT01534351|17763547|P2|Overall Study|Study Terminated Early|0
5142690|NCT01534351|17763548|P1|Overall Study|Study Terminated Early|1
5142691|NCT01534273|17763569|P7|Period 1|Physician Decision|0
5142692|NCT01534273|17763570|P6|Period 1|Physician Decision|0
5142693|NCT01534273|17763571|P5|Period 1|Physician Decision|0
5142694|NCT01534273|17763572|P4|Period 1|Physician Decision|1
5142695|NCT01534273|17763573|P3|Period 1|Physician Decision|0
5142696|NCT01534273|17763574|P2|Period 1|Physician Decision|0
5142697|NCT01534273|17763575|P1|Period 1|Physician Decision|0
5142698|NCT01534260|17763602|P2|Overall Study|No treatment, per protocol|1
5142699|NCT01534260|17763603|P1|Overall Study|No treatment, per protocol|0
5142700|NCT01534260|17763602|P2|Overall Study|Physician Decision|1
5142701|NCT01534260|17763603|P1|Overall Study|Physician Decision|3
5142702|NCT01534260|17763602|P2|Overall Study|Disease Progression|6
5142703|NCT01534260|17763603|P1|Overall Study|Disease Progression|8
5142704|NCT01534260|17763602|P2|Overall Study|Withdrawal by Subject|3
5142705|NCT01534260|17763603|P1|Overall Study|Withdrawal by Subject|1
5142706|NCT01534260|17763602|P2|Overall Study|Lack of Efficacy|1
5142707|NCT01534260|17763603|P1|Overall Study|Lack of Efficacy|1
5142708|NCT01534260|17763602|P2|Overall Study|Death|0
5142709|NCT01534260|17763603|P1|Overall Study|Death|2
5142710|NCT01534260|17763602|P2|Overall Study|Adverse Event|8
5142711|NCT01534260|17763603|P1|Overall Study|Adverse Event|1
5142712|NCT01534208|17763613|P2|Overall Study|Needed prohibited meds|0
5142713|NCT01534208|17763614|P1|Overall Study|Needed prohibited meds|1
5142714|NCT01534208|17763613|P2|Overall Study|PCP decision|0
5142715|NCT01534208|17763614|P1|Overall Study|PCP decision|1
5142716|NCT01534208|17763613|P2|Overall Study|Eligibility error|0
5142717|NCT01534208|17763614|P1|Overall Study|Eligibility error|3
5142718|NCT01534208|17763613|P2|Overall Study|Lab assessment|1
5142719|NCT01534208|17763614|P1|Overall Study|Lab assessment|2
5142720|NCT01534208|17763613|P2|Overall Study|Subject relocation|0
5142721|NCT01534208|17763614|P1|Overall Study|Subject relocation|2
5142722|NCT01534208|17763613|P2|Overall Study|Sponsor decision|1
5142723|NCT01534208|17763614|P1|Overall Study|Sponsor decision|4
5142724|NCT01534208|17763613|P2|Overall Study|Protocol Violation|2
5142725|NCT01534208|17763614|P1|Overall Study|Protocol Violation|2
5142726|NCT01534208|17763613|P2|Overall Study|Lack of Efficacy|3
5142727|NCT01534208|17763614|P1|Overall Study|Lack of Efficacy|0
5142728|NCT01534208|17763613|P2|Overall Study|Physician Decision|0
5142729|NCT01534208|17763614|P1|Overall Study|Physician Decision|2
5142730|NCT01534208|17763613|P2|Overall Study|Adverse Event|8
5142731|NCT01534208|17763614|P1|Overall Study|Adverse Event|15
5142732|NCT01534208|17763613|P2|Overall Study|Withdrawal by Subject|20
5142733|NCT01534208|17763614|P1|Overall Study|Withdrawal by Subject|6
5142734|NCT01534208|17763613|P2|Overall Study|Lost to Follow-up|14
5142735|NCT01534208|17763614|P1|Overall Study|Lost to Follow-up|19
5142736|NCT01534195|17763632|P2|Overall Study|Withdrawal by Subject|1
5142737|NCT01534195|17763633|P1|Overall Study|Withdrawal by Subject|1
5142738|NCT01534182|17763647|P2|Overall Study|Adverse Event|3
5142739|NCT01534182|17763648|P1|Overall Study|Adverse Event|7
5142740|NCT01534182|17763647|P2|Overall Study|Withdrawal by Subject|7
5142741|NCT01534182|17763648|P1|Overall Study|Withdrawal by Subject|4
5142742|NCT01534182|17763647|P2|Overall Study|Administrative problems|0
5142743|NCT01534182|17763648|P1|Overall Study|Administrative problems|1
5142744|NCT01534078|17763679|P1|Overall Study|Withdrawal by Subject|1
5142745|NCT01534078|17763679|P1|Overall Study|Death|1
5142746|NCT01533935|17763716|P5|Overall Study|Other reason not defined above|1
5142747|NCT01533935|17763717|P4|Overall Study|Other reason not defined above|0
5142748|NCT01533935|17763718|P3|Overall Study|Other reason not defined above|1
5142749|NCT01533935|17763719|P2|Overall Study|Other reason not defined above|0
5142750|NCT01533935|17763720|P1|Overall Study|Other reason not defined above|1
5142751|NCT01533935|17763716|P5|Overall Study|Withdrawal by Subject|4
5142752|NCT01533935|17763717|P4|Overall Study|Withdrawal by Subject|2
5142753|NCT01533935|17763718|P3|Overall Study|Withdrawal by Subject|5
5142754|NCT01533935|17763719|P2|Overall Study|Withdrawal by Subject|4
5142755|NCT01533935|17763720|P1|Overall Study|Withdrawal by Subject|0
5142756|NCT01533935|17763716|P5|Overall Study|Lost to Follow-up|0
5142757|NCT01533935|17763717|P4|Overall Study|Lost to Follow-up|0
5142758|NCT01533935|17763718|P3|Overall Study|Lost to Follow-up|1
5142759|NCT01533935|17763719|P2|Overall Study|Lost to Follow-up|0
5142760|NCT01533935|17763720|P1|Overall Study|Lost to Follow-up|0
5142761|NCT01533935|17763716|P5|Overall Study|Protocol Violation|0
5142762|NCT01533935|17763717|P4|Overall Study|Protocol Violation|0
5142763|NCT01533935|17763718|P3|Overall Study|Protocol Violation|0
5142764|NCT01533935|17763719|P2|Overall Study|Protocol Violation|2
5142765|NCT01533935|17763720|P1|Overall Study|Protocol Violation|0
5142766|NCT01533935|17763716|P5|Overall Study|Adverse Event|3
5142767|NCT01533935|17763717|P4|Overall Study|Adverse Event|5
5142768|NCT01533935|17763718|P3|Overall Study|Adverse Event|1
5142769|NCT01533935|17763719|P2|Overall Study|Adverse Event|7
5142770|NCT01533935|17763720|P1|Overall Study|Adverse Event|5
5142771|NCT01533922|17763747|P5|Overall Study|Other reason not defined above|0
5142772|NCT01533922|17763748|P4|Overall Study|Other reason not defined above|0
5142773|NCT01533922|17763749|P3|Overall Study|Other reason not defined above|1
5142774|NCT01533922|17763750|P2|Overall Study|Other reason not defined above|0
5142775|NCT01533922|17763751|P1|Overall Study|Other reason not defined above|2
5142776|NCT01533922|17763747|P5|Overall Study|Withdrawal by Subject|1
5142777|NCT01533922|17763748|P4|Overall Study|Withdrawal by Subject|2
5142778|NCT01533922|17763749|P3|Overall Study|Withdrawal by Subject|2
5142779|NCT01533922|17763750|P2|Overall Study|Withdrawal by Subject|1
5142780|NCT01533922|17763751|P1|Overall Study|Withdrawal by Subject|3
5142781|NCT01533922|17763747|P5|Overall Study|Protocol Violation|1
5142782|NCT01533922|17763748|P4|Overall Study|Protocol Violation|0
5142783|NCT01533922|17763749|P3|Overall Study|Protocol Violation|0
5142784|NCT01533922|17763750|P2|Overall Study|Protocol Violation|3
5142785|NCT01533922|17763751|P1|Overall Study|Protocol Violation|0
5142786|NCT01533922|17763747|P5|Overall Study|Lack of Efficacy|0
5142787|NCT01533922|17763748|P4|Overall Study|Lack of Efficacy|0
5142788|NCT01533922|17763749|P3|Overall Study|Lack of Efficacy|1
5142789|NCT01533922|17763750|P2|Overall Study|Lack of Efficacy|0
5142790|NCT01533922|17763751|P1|Overall Study|Lack of Efficacy|0
5142791|NCT01533922|17763747|P5|Overall Study|Adverse Event|4
5142792|NCT01533922|17763748|P4|Overall Study|Adverse Event|3
5142793|NCT01533922|17763749|P3|Overall Study|Adverse Event|6
5142794|NCT01533922|17763750|P2|Overall Study|Adverse Event|8
5142795|NCT01533922|17763751|P1|Overall Study|Adverse Event|5
5142796|NCT01533688|17763796|P3|Overall Study|Had colonoscopy at outside hospital|2
5142797|NCT01533688|17763797|P2|Overall Study|Had colonoscopy at outside hospital|3
5142798|NCT01533688|17763798|P1|Overall Study|Had colonoscopy at outside hospital|2
5142799|NCT01533688|17763796|P3|Overall Study|Medically unstable|3
5142800|NCT01533688|17763797|P2|Overall Study|Medically unstable|3
5142801|NCT01533688|17763798|P1|Overall Study|Medically unstable|1
5142802|NCT01533688|17763796|P3|Overall Study|Withdrawal by Subject|3
5142803|NCT01533688|17763797|P2|Overall Study|Withdrawal by Subject|4
5142804|NCT01533688|17763798|P1|Overall Study|Withdrawal by Subject|5
5142805|NCT01533493|17763830|P2|Overall Study|Lost to Follow-up|0
5142806|NCT01533493|17763831|P1|Overall Study|Lost to Follow-up|2
5142807|NCT01533493|17763830|P2|Overall Study|Withdrawal by Subject|2
5142808|NCT01533493|17763831|P1|Overall Study|Withdrawal by Subject|1
5142809|NCT01533493|17763830|P2|Overall Study|Adverse Event|1
5142810|NCT01533493|17763831|P1|Overall Study|Adverse Event|2
5142811|NCT01533428|17763839|P2|Overall Study|Withdrawal by Subject|6
5142812|NCT01533428|17763840|P1|Overall Study|Withdrawal by Subject|7
5142813|NCT01533428|17763839|P2|Overall Study|Lost to Follow-up|1
5142814|NCT01533428|17763840|P1|Overall Study|Lost to Follow-up|2
5142815|NCT01533428|17763839|P2|Overall Study|Adverse Event|1
5142816|NCT01533428|17763840|P1|Overall Study|Adverse Event|0
5142817|NCT01533246|17763886|P1|Overall Study|Withdrawal by Subject|1
5142818|NCT01533246|17763886|P1|Overall Study|Adverse Event|1
5142819|NCT01533181|17763910|P2|Overall Study|Patient withdrawal pre-active treatment|0
5142820|NCT01533181|17763911|P1|Overall Study|Patient withdrawal pre-active treatment|1
5142821|NCT01533181|17763910|P2|Overall Study|Disease progression pre-active treatment|1
5142822|NCT01533181|17763911|P1|Overall Study|Disease progression pre-active treatment|0
5142823|NCT01532999|17764028|P2|Overall Study|New job|2
5142824|NCT01532999|17764029|P1|Overall Study|New job|0
5142825|NCT01532999|17764028|P2|Overall Study|incarcerated|1
5142826|NCT01532999|17764029|P1|Overall Study|incarcerated|0
5142827|NCT01532999|17764028|P2|Overall Study|Adverse Event|1
5142828|NCT01532999|17764029|P1|Overall Study|Adverse Event|0
5142829|NCT01532999|17764028|P2|Overall Study|no show for week 9 assessments|4
5142830|NCT01532999|17764029|P1|Overall Study|no show for week 9 assessments|6
5142831|NCT01532999|17764028|P2|Overall Study|substantial noncompliance|0
5142832|NCT01532999|17764029|P1|Overall Study|substantial noncompliance|2
5142833|NCT01532999|17764028|P2|Overall Study|should not have been randomized|0
5142834|NCT01532999|17764029|P1|Overall Study|should not have been randomized|1
5142835|NCT01532999|17764028|P2|Overall Study|Relocated|0
5142836|NCT01532999|17764029|P1|Overall Study|Relocated|2
5142837|NCT01532999|17764028|P2|Overall Study|Withdrawal by Subject|0
5142838|NCT01532999|17764029|P1|Overall Study|Withdrawal by Subject|5
5142839|NCT01532999|17764028|P2|Overall Study|Physician Decision|2
5142840|NCT01532999|17764029|P1|Overall Study|Physician Decision|1
5142841|NCT01532999|17764028|P2|Overall Study|Lost to Follow-up|8
5142842|NCT01532999|17764029|P1|Overall Study|Lost to Follow-up|14
5142843|NCT01532986|17764053|P2|Overall Study|Physician Decision|5
5142844|NCT01532986|17764054|P1|Overall Study|Physician Decision|7
5142845|NCT01532986|17764053|P2|Overall Study|Withdrawal by Subject|10
5142846|NCT01532986|17764054|P1|Overall Study|Withdrawal by Subject|7
5142847|NCT01532986|17764053|P2|Overall Study|Death|9
5142848|NCT01532986|17764054|P1|Overall Study|Death|9
5142849|NCT01532934|17764138|P2|Overall Study|In controlled environment|2
5142850|NCT01532934|17764139|P1|Overall Study|In controlled environment|3
5142851|NCT01532934|17764138|P2|Overall Study|Lost to Follow-up|11
5142852|NCT01532934|17764139|P1|Overall Study|Lost to Follow-up|11
5142853|NCT01532921|17764149|P1|Overall Study|Device was explanted during procedure|1
5142854|NCT01532921|17764149|P1|Overall Study|Physician Decision|7
5142855|NCT01532921|17764149|P1|Overall Study|Lost to Follow-up|3
5142856|NCT01532921|17764149|P1|Overall Study|Withdrawal by Subject|2
5142857|NCT01532921|17764149|P1|Overall Study|Death|3
5142858|NCT01532869|17764171|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
5142859|NCT01532869|17764172|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
5142860|NCT01532869|17764171|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
5142861|NCT01532869|17764172|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
5142862|NCT01532869|17764171|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
5142863|NCT01532869|17764172|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
5142864|NCT01532869|17764171|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
5142865|NCT01532869|17764172|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
5142866|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
5142867|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
5142868|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
5142869|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
5142870|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
5142871|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
5142872|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
5142873|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
5142874|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
5142875|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
5142876|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
5142877|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
5142878|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
5142879|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
5142880|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
5142881|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
5142882|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
5142883|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
5142884|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
5142885|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
5142886|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
5142887|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
5142888|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
5142889|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
5142890|NCT01532869|17764171|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
5142891|NCT01532869|17764172|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
5142892|NCT01532648|17764231|P2|Overall Study|Withdrawal by Subject|2
5142893|NCT01532648|17764232|P1|Overall Study|Withdrawal by Subject|16
5142894|NCT01532648|17764231|P2|Overall Study|Adverse Event|9
5142895|NCT01532648|17764232|P1|Overall Study|Adverse Event|12
5142896|NCT01532648|17764231|P2|Overall Study|Protocol Violation|1
5142897|NCT01532648|17764232|P1|Overall Study|Protocol Violation|1
5142898|NCT01532648|17764231|P2|Overall Study|Lack of Efficacy|1
5142899|NCT01532648|17764232|P1|Overall Study|Lack of Efficacy|4
5142900|NCT01532648|17764231|P2|Overall Study|Lost to Follow-up|4
5142901|NCT01532648|17764232|P1|Overall Study|Lost to Follow-up|3
5142902|NCT01532570|17764266|P4|Overall Study|Withdrawal by Subject|0
5142903|NCT01532570|17764267|P3|Overall Study|Withdrawal by Subject|0
5142904|NCT01532570|17764268|P2|Overall Study|Withdrawal by Subject|1
5142905|NCT01532570|17764269|P1|Overall Study|Withdrawal by Subject|0
5142906|NCT01532570|17764266|P4|Overall Study|Lack of Efficacy|0
5142907|NCT01532570|17764267|P3|Overall Study|Lack of Efficacy|0
5142908|NCT01532570|17764268|P2|Overall Study|Lack of Efficacy|0
5142909|NCT01532570|17764269|P1|Overall Study|Lack of Efficacy|1
5142910|NCT01532414|17764314|P3|Overall Study|Withdrawn by sponsor|0
5142911|NCT01532414|17764315|P2|Overall Study|Withdrawn by sponsor|0
5142912|NCT01532414|17764316|P1|Overall Study|Withdrawn by sponsor|1
5142913|NCT01532414|17764314|P3|Overall Study|Unable to complete 24 hour PK|1
5142914|NCT01532414|17764315|P2|Overall Study|Unable to complete 24 hour PK|0
5142915|NCT01532414|17764316|P1|Overall Study|Unable to complete 24 hour PK|0
5142916|NCT01532414|17764314|P3|Overall Study|Adverse Event|1
5142917|NCT01532414|17764315|P2|Overall Study|Adverse Event|1
5142918|NCT01532414|17764316|P1|Overall Study|Adverse Event|0
5142919|NCT01532414|17764314|P3|Overall Study|No V6 semen sample|0
5142920|NCT01532414|17764315|P2|Overall Study|No V6 semen sample|1
5142921|NCT01532414|17764316|P1|Overall Study|No V6 semen sample|0
5142922|NCT01532414|17764314|P3|Overall Study|Withdrawal by Subject|0
5142923|NCT01532414|17764315|P2|Overall Study|Withdrawal by Subject|0
5142924|NCT01532414|17764316|P1|Overall Study|Withdrawal by Subject|3
5142925|NCT01532414|17764314|P3|Overall Study|Lost to Follow-up|1
5142926|NCT01532414|17764315|P2|Overall Study|Lost to Follow-up|0
5142927|NCT01532414|17764316|P1|Overall Study|Lost to Follow-up|3
5142928|NCT01532388|17764326|P2|12-month Follow-up|Lost to Follow-up|67
5142929|NCT01532388|17764327|P1|12-month Follow-up|Lost to Follow-up|69
5142930|NCT01532388|17764326|P2|6-month Follow-up|Lost to Follow-up|66
5142931|NCT01532388|17764327|P1|6-month Follow-up|Lost to Follow-up|74
5142932|NCT01532388|17764326|P2|3-month Follow-up|Lost to Follow-up|68
5142933|NCT01532388|17764327|P1|3-month Follow-up|Lost to Follow-up|68
5142934|NCT01531998|17764432|P1|Overall Study|Withdrawal by Subject|3
5142935|NCT01531894|17764454|P1|Overall Study|Death|1
5142936|NCT01531894|17764454|P1|Overall Study|Physician Decision|8
5142937|NCT01531725|17764471|P1|Overall Study|Protocol Violation|5
5142938|NCT01531673|17764489|P13|Overall Study|Other|0
5142939|NCT01531673|17764490|P12|Overall Study|Other|0
5142940|NCT01531673|17764491|P11|Overall Study|Other|0
5142941|NCT01531673|17764492|P10|Overall Study|Other|1
5142942|NCT01531673|17764493|P9|Overall Study|Other|0
5142943|NCT01531673|17764494|P8|Overall Study|Other|0
5142944|NCT01531673|17764495|P7|Overall Study|Other|0
5142945|NCT01531673|17764496|P6|Overall Study|Other|0
5142946|NCT01531673|17764497|P5|Overall Study|Other|0
5142947|NCT01531673|17764498|P4|Overall Study|Other|1
5142948|NCT01531673|17764499|P3|Overall Study|Other|0
5142949|NCT01531673|17764500|P2|Overall Study|Other|0
5142950|NCT01531673|17764501|P1|Overall Study|Other|0
5142951|NCT01531673|17764489|P13|Overall Study|Lost to Follow-up|0
5142952|NCT01531673|17764490|P12|Overall Study|Lost to Follow-up|0
5142953|NCT01531673|17764491|P11|Overall Study|Lost to Follow-up|0
5142954|NCT01531673|17764492|P10|Overall Study|Lost to Follow-up|0
5142955|NCT01531673|17764493|P9|Overall Study|Lost to Follow-up|0
5142956|NCT01531673|17764494|P8|Overall Study|Lost to Follow-up|0
5142957|NCT01531673|17764495|P7|Overall Study|Lost to Follow-up|0
5142958|NCT01531673|17764496|P6|Overall Study|Lost to Follow-up|0
5142959|NCT01531673|17764497|P5|Overall Study|Lost to Follow-up|1
5142960|NCT01531673|17764498|P4|Overall Study|Lost to Follow-up|0
5142961|NCT01531673|17764499|P3|Overall Study|Lost to Follow-up|0
5142962|NCT01531673|17764500|P2|Overall Study|Lost to Follow-up|0
5142963|NCT01531673|17764501|P1|Overall Study|Lost to Follow-up|0
5142964|NCT01531673|17764489|P13|Overall Study|Adverse Event|0
5142965|NCT01531673|17764490|P12|Overall Study|Adverse Event|0
5142966|NCT01531673|17764491|P11|Overall Study|Adverse Event|0
5142967|NCT01531673|17764492|P10|Overall Study|Adverse Event|0
5142968|NCT01531673|17764493|P9|Overall Study|Adverse Event|0
5142969|NCT01531673|17764494|P8|Overall Study|Adverse Event|0
5142970|NCT01531673|17764495|P7|Overall Study|Adverse Event|0
5142971|NCT01531673|17764496|P6|Overall Study|Adverse Event|0
5142972|NCT01531673|17764497|P5|Overall Study|Adverse Event|0
5142973|NCT01531673|17764498|P4|Overall Study|Adverse Event|0
5142974|NCT01531673|17764499|P3|Overall Study|Adverse Event|0
5142975|NCT01531673|17764500|P2|Overall Study|Adverse Event|1
5142976|NCT01531673|17764501|P1|Overall Study|Adverse Event|0
5142977|NCT01531673|17764489|P13|Overall Study|Non-Compliance|0
5142978|NCT01531673|17764490|P12|Overall Study|Non-Compliance|0
5142979|NCT01531673|17764491|P11|Overall Study|Non-Compliance|0
5142980|NCT01531673|17764492|P10|Overall Study|Non-Compliance|0
5142981|NCT01531673|17764493|P9|Overall Study|Non-Compliance|0
5142982|NCT01531673|17764494|P8|Overall Study|Non-Compliance|0
5142983|NCT01531673|17764495|P7|Overall Study|Non-Compliance|0
5142984|NCT01531673|17764496|P6|Overall Study|Non-Compliance|1
5142985|NCT01531673|17764497|P5|Overall Study|Non-Compliance|0
5142986|NCT01531673|17764498|P4|Overall Study|Non-Compliance|0
5142987|NCT01531673|17764499|P3|Overall Study|Non-Compliance|0
5142988|NCT01531673|17764500|P2|Overall Study|Non-Compliance|0
5142989|NCT01531673|17764501|P1|Overall Study|Non-Compliance|0
5142990|NCT01531387|17764627|P2|Overall Study|Early termination of study|11
5142991|NCT01531387|17764628|P1|Overall Study|Early termination of study|11
5142992|NCT01531205|17764720|P1|Overall Study|Did not proceed to surgery|1
5142993|NCT01531153|17764732|P3|Overall Study|Withdrawal by Subject|15
5142994|NCT01531153|17764733|P2|Overall Study|Withdrawal by Subject|9
5142995|NCT01531153|17764734|P1|Overall Study|Withdrawal by Subject|10
5142996|NCT01530997|17764790|P1|Overall Study|Withdrawal by Subject|1
5142997|NCT01530997|17764790|P1|Overall Study|Physician Decision|1
5142998|NCT01530464|17764834|P2|Washout (24h)|Withdrawal by Subject|1
5142999|NCT01530464|17764835|P1|Washout (24h)|Withdrawal by Subject|0
5143000|NCT01530464|17764834|P2|Washout (24h)|Withdrawal by Subject|0
5143001|NCT01530464|17764835|P1|Washout (24h)|Withdrawal by Subject|1
5143002|NCT01530334|17764887|P1|Overall Study|Progressive disease|47
5143003|NCT01530334|17764887|P1|Overall Study|unknown reason|1
5143004|NCT01530334|17764887|P1|Overall Study|Adverse Event|3
5143005|NCT01530087|17764934|P1|Overall Study|Physician Decision|2
5143006|NCT01529749|17764950|P4|Overall Study|Protocol Violation|1
5143007|NCT01529749|17764951|P3|Overall Study|Protocol Violation|0
5143008|NCT01529749|17764952|P2|Overall Study|Protocol Violation|0
5143009|NCT01529749|17764953|P1|Overall Study|Protocol Violation|0
5143010|NCT01529749|17764950|P4|Overall Study|Withdrawal by Subject|0
5143011|NCT01529749|17764951|P3|Overall Study|Withdrawal by Subject|1
5143012|NCT01529749|17764952|P2|Overall Study|Withdrawal by Subject|1
5143013|NCT01529749|17764953|P1|Overall Study|Withdrawal by Subject|0
5143014|NCT01529749|17764950|P4|Overall Study|Physician Decision|1
5143015|NCT01529749|17764951|P3|Overall Study|Physician Decision|0
5143016|NCT01529749|17764952|P2|Overall Study|Physician Decision|0
5143017|NCT01529749|17764953|P1|Overall Study|Physician Decision|0
5143018|NCT01529749|17764950|P4|Overall Study|Lost to Follow-up|0
5143019|NCT01529749|17764951|P3|Overall Study|Lost to Follow-up|1
5143020|NCT01529749|17764952|P2|Overall Study|Lost to Follow-up|1
5143021|NCT01529749|17764953|P1|Overall Study|Lost to Follow-up|0
5143022|NCT01529645|17765037|P10|Overall Study|Withdrawal by Subject|0
5143023|NCT01529645|17765038|P9|Overall Study|Withdrawal by Subject|0
5143024|NCT01529645|17765039|P8|Overall Study|Withdrawal by Subject|0
5143025|NCT01529645|17765040|P7|Overall Study|Withdrawal by Subject|0
5143026|NCT01529645|17765041|P6|Overall Study|Withdrawal by Subject|1
5143027|NCT01529645|17765042|P5|Overall Study|Withdrawal by Subject|1
5143028|NCT01529645|17765043|P4|Overall Study|Withdrawal by Subject|1
5143029|NCT01529645|17765044|P3|Overall Study|Withdrawal by Subject|0
5143030|NCT01529645|17765045|P2|Overall Study|Withdrawal by Subject|0
5143031|NCT01529645|17765046|P1|Overall Study|Withdrawal by Subject|2
5143032|NCT01529645|17765037|P10|Overall Study|SAE - Premature contractions|0
5143033|NCT01529645|17765038|P9|Overall Study|SAE - Premature contractions|0
5143034|NCT01529645|17765039|P8|Overall Study|SAE - Premature contractions|0
5143035|NCT01529645|17765040|P7|Overall Study|SAE - Premature contractions|0
5143036|NCT01529645|17765041|P6|Overall Study|SAE - Premature contractions|0
5143037|NCT01529645|17765042|P5|Overall Study|SAE - Premature contractions|0
5143038|NCT01529645|17765043|P4|Overall Study|SAE - Premature contractions|0
5143039|NCT01529645|17765044|P3|Overall Study|SAE - Premature contractions|1
5143040|NCT01529645|17765045|P2|Overall Study|SAE - Premature contractions|0
5143041|NCT01529645|17765046|P1|Overall Study|SAE - Premature contractions|0
5143042|NCT01529645|17765037|P10|Overall Study|Lost to Follow-up|0
5143043|NCT01529645|17765038|P9|Overall Study|Lost to Follow-up|1
5143044|NCT01529645|17765039|P8|Overall Study|Lost to Follow-up|0
5143045|NCT01529645|17765040|P7|Overall Study|Lost to Follow-up|2
5143046|NCT01529645|17765041|P6|Overall Study|Lost to Follow-up|0
5143047|NCT01529645|17765042|P5|Overall Study|Lost to Follow-up|1
5143048|NCT01529645|17765043|P4|Overall Study|Lost to Follow-up|1
5143049|NCT01529645|17765044|P3|Overall Study|Lost to Follow-up|1
5143050|NCT01529645|17765045|P2|Overall Study|Lost to Follow-up|1
5143051|NCT01529645|17765046|P1|Overall Study|Lost to Follow-up|0
5143052|NCT01529632|17765144|P2|Overall Study|Adverse Event|1
5143053|NCT01529632|17765145|P1|Overall Study|Adverse Event|1
5143054|NCT01529632|17765144|P2|Overall Study|Protocol Violation|1
5143055|NCT01529632|17765145|P1|Overall Study|Protocol Violation|0
5143056|NCT01529632|17765144|P2|Overall Study|Administrative problem|1
5143057|NCT01529632|17765145|P1|Overall Study|Administrative problem|2
5143058|NCT01529606|17765165|P2|Overall Study|Lost to Follow-up|18
5143059|NCT01529606|17765166|P1|Overall Study|Lost to Follow-up|21
5143060|NCT01529515|17765178|P4|DOUBLE BLIND PHASE|Other|2
5143061|NCT01529515|17765179|P3|DOUBLE BLIND PHASE|Other|9
5143062|NCT01529515|17765180|P2|DOUBLE BLIND PHASE|Other|0
5143063|NCT01529515|17765181|P1|DOUBLE BLIND PHASE|Other|0
5143064|NCT01529515|17765178|P4|DOUBLE BLIND PHASE|Protocol Violation|0
5143065|NCT01529515|17765179|P3|DOUBLE BLIND PHASE|Protocol Violation|1
5143066|NCT01529515|17765180|P2|DOUBLE BLIND PHASE|Protocol Violation|0
5143067|NCT01529515|17765181|P1|DOUBLE BLIND PHASE|Protocol Violation|0
5143068|NCT01529515|17765178|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
5143069|NCT01529515|17765179|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
5143070|NCT01529515|17765180|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
5143071|NCT01529515|17765181|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
5143072|NCT01529515|17765178|P4|DOUBLE BLIND PHASE|Pregnancy|0
5143073|NCT01529515|17765179|P3|DOUBLE BLIND PHASE|Pregnancy|1
5143074|NCT01529515|17765180|P2|DOUBLE BLIND PHASE|Pregnancy|0
5143075|NCT01529515|17765181|P1|DOUBLE BLIND PHASE|Pregnancy|0
5143076|NCT01529515|17765178|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
5143077|NCT01529515|17765179|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
5143078|NCT01529515|17765180|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
5143079|NCT01529515|17765181|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
5143080|NCT01529515|17765178|P4|DOUBLE BLIND PHASE|Adverse Event|0
5143081|NCT01529515|17765179|P3|DOUBLE BLIND PHASE|Adverse Event|1
5143082|NCT01529515|17765180|P2|DOUBLE BLIND PHASE|Adverse Event|0
5143083|NCT01529515|17765181|P1|DOUBLE BLIND PHASE|Adverse Event|0
5143084|NCT01529515|17765178|P4|MAINTENANCE PHASE|Other|0
5143085|NCT01529515|17765179|P3|MAINTENANCE PHASE|Other|0
5143086|NCT01529515|17765180|P2|MAINTENANCE PHASE|Other|10
5143087|NCT01529515|17765181|P1|MAINTENANCE PHASE|Other|0
5143088|NCT01529515|17765178|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
5143089|NCT01529515|17765179|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
5143090|NCT01529515|17765180|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
5143091|NCT01529515|17765181|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
5143092|NCT01529515|17765178|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
5143093|NCT01529515|17765179|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
5143094|NCT01529515|17765180|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
5143095|NCT01529515|17765181|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
5143096|NCT01529515|17765178|P4|MAINTENANCE PHASE|Protocol Violation|0
5143097|NCT01529515|17765179|P3|MAINTENANCE PHASE|Protocol Violation|0
5143098|NCT01529515|17765180|P2|MAINTENANCE PHASE|Protocol Violation|12
5143099|NCT01529515|17765181|P1|MAINTENANCE PHASE|Protocol Violation|0
5143100|NCT01529515|17765178|P4|MAINTENANCE PHASE|Lost to Follow-up|0
5143101|NCT01529515|17765179|P3|MAINTENANCE PHASE|Lost to Follow-up|0
5143102|NCT01529515|17765180|P2|MAINTENANCE PHASE|Lost to Follow-up|5
5143103|NCT01529515|17765181|P1|MAINTENANCE PHASE|Lost to Follow-up|0
5143104|NCT01529515|17765178|P4|MAINTENANCE PHASE|Lack of Efficacy|0
5143105|NCT01529515|17765179|P3|MAINTENANCE PHASE|Lack of Efficacy|0
5143106|NCT01529515|17765180|P2|MAINTENANCE PHASE|Lack of Efficacy|9
5143107|NCT01529515|17765181|P1|MAINTENANCE PHASE|Lack of Efficacy|0
5143108|NCT01529515|17765178|P4|MAINTENANCE PHASE|Adverse Event|0
5143109|NCT01529515|17765179|P3|MAINTENANCE PHASE|Adverse Event|0
5143110|NCT01529515|17765180|P2|MAINTENANCE PHASE|Adverse Event|10
5143111|NCT01529515|17765181|P1|MAINTENANCE PHASE|Adverse Event|0
5143112|NCT01529515|17765178|P4|TRANSITION PHASE|Other|0
5143113|NCT01529515|17765179|P3|TRANSITION PHASE|Other|0
5143114|NCT01529515|17765180|P2|TRANSITION PHASE|Other|0
5143115|NCT01529515|17765181|P1|TRANSITION PHASE|Other|9
5143116|NCT01529515|17765178|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5143117|NCT01529515|17765179|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5143118|NCT01529515|17765180|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5143119|NCT01529515|17765181|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
5143120|NCT01529515|17765178|P4|TRANSITION PHASE|Withdrawal by Subject|0
5143121|NCT01529515|17765179|P3|TRANSITION PHASE|Withdrawal by Subject|0
5143122|NCT01529515|17765180|P2|TRANSITION PHASE|Withdrawal by Subject|0
5143123|NCT01529515|17765181|P1|TRANSITION PHASE|Withdrawal by Subject|51
5143124|NCT01529515|17765178|P4|TRANSITION PHASE|Protocol Violation|0
5143125|NCT01529515|17765179|P3|TRANSITION PHASE|Protocol Violation|0
5143126|NCT01529515|17765180|P2|TRANSITION PHASE|Protocol Violation|0
5143127|NCT01529515|17765181|P1|TRANSITION PHASE|Protocol Violation|4
5143128|NCT01529515|17765178|P4|TRANSITION PHASE|Lost to Follow-up|0
5143129|NCT01529515|17765179|P3|TRANSITION PHASE|Lost to Follow-up|0
5143130|NCT01529515|17765180|P2|TRANSITION PHASE|Lost to Follow-up|0
5143131|NCT01529515|17765181|P1|TRANSITION PHASE|Lost to Follow-up|19
5143132|NCT01529515|17765178|P4|TRANSITION PHASE|Lack of Efficacy|0
5143133|NCT01529515|17765179|P3|TRANSITION PHASE|Lack of Efficacy|0
5143134|NCT01529515|17765180|P2|TRANSITION PHASE|Lack of Efficacy|0
5143135|NCT01529515|17765181|P1|TRANSITION PHASE|Lack of Efficacy|19
5143136|NCT01529515|17765178|P4|TRANSITION PHASE|Death|0
5143137|NCT01529515|17765179|P3|TRANSITION PHASE|Death|0
5143138|NCT01529515|17765180|P2|TRANSITION PHASE|Death|0
5143139|NCT01529515|17765181|P1|TRANSITION PHASE|Death|1
5143140|NCT01529515|17765178|P4|TRANSITION PHASE|Adverse Event|0
5143141|NCT01529515|17765179|P3|TRANSITION PHASE|Adverse Event|0
5143142|NCT01529515|17765180|P2|TRANSITION PHASE|Adverse Event|0
5143143|NCT01529515|17765181|P1|TRANSITION PHASE|Adverse Event|16
5143144|NCT01529385|17765228|P2|Overall Study|Lost to Follow-up|1
5143145|NCT01529385|17765229|P1|Overall Study|Lost to Follow-up|2
5143146|NCT01529346|17765258|P5|Overall Study|Other|0
5143147|NCT01529346|17765259|P4|Overall Study|Other|0
5143148|NCT01529346|17765260|P3|Overall Study|Other|1
5143149|NCT01529346|17765261|P2|Overall Study|Other|1
5143150|NCT01529346|17765262|P1|Overall Study|Other|0
5143151|NCT01529346|17765258|P5|Overall Study|Lost to Follow-up|0
5143152|NCT01529346|17765259|P4|Overall Study|Lost to Follow-up|0
5143153|NCT01529346|17765260|P3|Overall Study|Lost to Follow-up|1
5143154|NCT01529346|17765261|P2|Overall Study|Lost to Follow-up|0
5143155|NCT01529346|17765262|P1|Overall Study|Lost to Follow-up|2
5143156|NCT01529268|17765350|P2|Overall Study|Moved|0
5143157|NCT01529268|17765351|P1|Overall Study|Moved|3
5143158|NCT01529268|17765350|P2|Overall Study|Lost to Follow-up|3
5143159|NCT01529268|17765351|P1|Overall Study|Lost to Follow-up|9
5143160|NCT01529112|17765413|P2|Overall Study|Withdrawal by Subject|3
5143161|NCT01529112|17765414|P1|Overall Study|Withdrawal by Subject|7
5143162|NCT01529112|17765413|P2|Overall Study|Protocol Violation|0
5143163|NCT01529112|17765414|P1|Overall Study|Protocol Violation|1
5143164|NCT01529112|17765413|P2|Overall Study|Death|38
5143165|NCT01529112|17765414|P1|Overall Study|Death|59
5143166|NCT01529112|17765413|P2|Overall Study|Adverse Event|0
5143167|NCT01529112|17765414|P1|Overall Study|Adverse Event|2
5143168|NCT01529034|17765450|P1|Overall Study|Study drug not available|2
5143169|NCT01529034|17765450|P1|Overall Study|Investigator no longer available|2
5143170|NCT01529034|17765450|P1|Overall Study|Lack of Efficacy|4
5143171|NCT01529034|17765450|P1|Overall Study|Protocol Violation|4
5143172|NCT01529034|17765450|P1|Overall Study|Adverse Event|4
5143173|NCT01529034|17765450|P1|Overall Study|Caregiver no longer available|7
5143174|NCT01529034|17765450|P1|Overall Study|Noncompliance|8
5143175|NCT01529034|17765450|P1|Overall Study|No treated SCs within protocol window|13
5143176|NCT01529034|17765450|P1|Overall Study|Withdrawal by Subject|25
5143177|NCT01529034|17765450|P1|Overall Study|Study termination|29
5143178|NCT01529034|17765450|P1|Overall Study|Site closure|62
5143179|NCT01529034|17765450|P1|Overall Study|Discontinued prior to study treatment|14
5143180|NCT01528969|17765465|P2|Overall Study|absent from the school at baseline|0
5143181|NCT01528969|17765466|P1|Overall Study|absent from the school at baseline|2
5143182|NCT01528787|17765499|P4|Overall Study|Family Emergency|0
5143183|NCT01528787|17765500|P3|Overall Study|Family Emergency|1
5143184|NCT01528787|17765501|P2|Overall Study|Family Emergency|0
5143185|NCT01528787|17765502|P1|Overall Study|Family Emergency|0
5143186|NCT01528787|17765499|P4|Overall Study|Withdrawal by Subject|1
5143187|NCT01528787|17765500|P3|Overall Study|Withdrawal by Subject|0
5143188|NCT01528787|17765501|P2|Overall Study|Withdrawal by Subject|0
5143189|NCT01528787|17765502|P1|Overall Study|Withdrawal by Subject|0
5143190|NCT01528735|17765514|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
5143191|NCT01528735|17765515|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
5143192|NCT01528735|17765514|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
5143193|NCT01528735|17765515|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
5143194|NCT01528709|17765617|P2|Overall Study|allergy|0
5143195|NCT01528709|17765618|P1|Overall Study|allergy|1
5143196|NCT01528709|17765617|P2|Overall Study|Withdrawal by Subject|15
5143197|NCT01528709|17765618|P1|Overall Study|Withdrawal by Subject|10
5143198|NCT01528709|17765617|P2|Overall Study|Death|0
5143199|NCT01528709|17765618|P1|Overall Study|Death|2
5143200|NCT01528696|17765628|P2|Overall Study|See detailed description|19
5143201|NCT01528696|17765629|P1|Overall Study|See detailed description|18
5143202|NCT01528605|17765645|P6|Overall Study|Death|0
5143203|NCT01528605|17765646|P5|Overall Study|Death|0
5143204|NCT01528605|17765647|P4|Overall Study|Death|0
5143205|NCT01528605|17765648|P3|Overall Study|Death|0
5143206|NCT01528605|17765649|P2|Overall Study|Death|0
5143207|NCT01528605|17765650|P1|Overall Study|Death|1
5143208|NCT01528605|17765645|P6|Overall Study|Lost to Follow-up|0
5143209|NCT01528605|17765646|P5|Overall Study|Lost to Follow-up|0
5143210|NCT01528605|17765647|P4|Overall Study|Lost to Follow-up|1
5143211|NCT01528605|17765648|P3|Overall Study|Lost to Follow-up|1
5143212|NCT01528605|17765649|P2|Overall Study|Lost to Follow-up|0
5143213|NCT01528605|17765650|P1|Overall Study|Lost to Follow-up|1
5143214|NCT01528345|17765680|P2|Overall Study|Subject/Guardian Decision|0
5143215|NCT01528345|17765681|P1|Overall Study|Subject/Guardian Decision|5
5143216|NCT01528345|17765680|P2|Overall Study|Study Terminated by Sponsor|8
5143217|NCT01528345|17765681|P1|Overall Study|Study Terminated by Sponsor|4
5143218|NCT01528345|17765680|P2|Overall Study|Progressive Disease|40
5143219|NCT01528345|17765681|P1|Overall Study|Progressive Disease|26
5143220|NCT01528345|17765680|P2|Overall Study|Non-compliance with study treatment|0
5143221|NCT01528345|17765681|P1|Overall Study|Non-compliance with study treatment|1
5143222|NCT01528345|17765680|P2|Overall Study|Death|1
5143223|NCT01528345|17765681|P1|Overall Study|Death|1
5143224|NCT01528345|17765680|P2|Overall Study|Adverse Event|1
5143225|NCT01528345|17765681|P1|Overall Study|Adverse Event|10
5143226|NCT01528254|17765732|P2|Overall Study|No longer requires study drug|1
5143227|NCT01528254|17765733|P1|Overall Study|No longer requires study drug|1
5143228|NCT01528254|17765732|P2|Overall Study|Abnormal test procedure result(s)|0
5143229|NCT01528254|17765733|P1|Overall Study|Abnormal test procedure result(s)|1
5143230|NCT01528254|17765732|P2|Overall Study|Abnormal laboratory value(s)|7
5143231|NCT01528254|17765733|P1|Overall Study|Abnormal laboratory value(s)|3
5143232|NCT01528254|17765732|P2|Overall Study|Withdrawal by Subject|4
5143233|NCT01528254|17765733|P1|Overall Study|Withdrawal by Subject|5
5143234|NCT01528254|17765732|P2|Overall Study|Unsatisfactory therapeutic effect|8
5143235|NCT01528254|17765733|P1|Overall Study|Unsatisfactory therapeutic effect|6
5143236|NCT01528254|17765732|P2|Overall Study|New therapy for study indication|6
5143237|NCT01528254|17765733|P1|Overall Study|New therapy for study indication|8
5143238|NCT01528254|17765732|P2|Overall Study|Protocol deviation|19
5143239|NCT01528254|17765733|P1|Overall Study|Protocol deviation|9
5143240|NCT01528254|17765732|P2|Overall Study|Death|9
5143241|NCT01528254|17765733|P1|Overall Study|Death|13
5143242|NCT01528254|17765732|P2|Overall Study|Lost to Follow-up|24
5143243|NCT01528254|17765733|P1|Overall Study|Lost to Follow-up|17
5143244|NCT01528254|17765732|P2|Overall Study|Adverse Event|44
5143245|NCT01528254|17765733|P1|Overall Study|Adverse Event|28
5143246|NCT01528254|17765732|P2|Overall Study|Administrative problems|94
5143247|NCT01528254|17765733|P1|Overall Study|Administrative problems|96
5143248|NCT01528215|17765765|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
5143249|NCT01528215|17765766|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
5143250|NCT01528215|17765765|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
5143251|NCT01528215|17765766|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
5143252|NCT01528215|17765765|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
5143253|NCT01528215|17765766|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
5143254|NCT01528215|17765765|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
5143255|NCT01528215|17765766|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
5143256|NCT01528072|17765825|P1|Overall Study|Early Termination of Study|52
5143257|NCT01528072|17765825|P1|Overall Study|Death|2
5143258|NCT01528072|17765825|P1|Overall Study|Site Closure|4
5143259|NCT01528072|17765825|P1|Overall Study|Explanted|2
5143260|NCT01528072|17765825|P1|Overall Study|Lost to Follow-up|5
5143261|NCT01528072|17765825|P1|Overall Study|Missed Visit|2
5143262|NCT01528072|17765825|P1|Overall Study|Determined not eligible by AEAC|1
5143263|NCT01528072|17765825|P1|Overall Study|Physician Decision|1
5143264|NCT01528072|17765825|P1|Overall Study|Withdrawal by Subject|5
5143265|NCT01528033|17765831|P2|Follow Up|No data available|44
5143266|NCT01528033|17765832|P1|Follow Up|No data available|46
5143267|NCT01528033|17765831|P2|Primary Endpoint Assessment ITT|No post baseline documentation|2
5143268|NCT01528033|17765832|P1|Primary Endpoint Assessment ITT|No post baseline documentation|2
5143269|NCT01528033|17765831|P2|Primary Endpoint Assessment ITT|Physician Decision|1
5143270|NCT01528033|17765832|P1|Primary Endpoint Assessment ITT|Physician Decision|2
5143271|NCT01528033|17765831|P2|Primary Endpoint Assessment ITT|Death|2
5143272|NCT01528033|17765832|P1|Primary Endpoint Assessment ITT|Death|2
5143273|NCT01528033|17765831|P2|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
5143274|NCT01528033|17765832|P1|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
5143275|NCT01528033|17765831|P2|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
5143276|NCT01528033|17765832|P1|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
5143277|NCT01527682|17765855|P1|Overall Study|Protocol Violation|8
5143278|NCT01527500|17765878|P2|Part B|Adverse Event|0
5143279|NCT01527500|17765879|P1|Part B|Adverse Event|1
5143280|NCT01527500|17765878|P2|Part A|Withdrawal by Subject|0
5143281|NCT01527500|17765879|P1|Part A|Withdrawal by Subject|2
5143282|NCT01527500|17765878|P2|Part A|Protocol Deviation|2
5143283|NCT01527500|17765879|P1|Part A|Protocol Deviation|9
5143284|NCT01527500|17765878|P2|Part A|Lost to Follow-up|1
5143285|NCT01527500|17765879|P1|Part A|Lost to Follow-up|0
5143286|NCT01527500|17765878|P2|Part A|Death|1
5143287|NCT01527500|17765879|P1|Part A|Death|4
5143288|NCT01527500|17765878|P2|Part A|Adverse Event|2
5143289|NCT01527500|17765879|P1|Part A|Adverse Event|4
5143290|NCT01527500|17765878|P2|Part A|Administrative|7
5143291|NCT01527500|17765879|P1|Part A|Administrative|11
5143292|NCT01527487|17765909|P2|Overall Study|Death|1
5143293|NCT01527487|17765910|P1|Overall Study|Death|0
5143294|NCT01527487|17765909|P2|Overall Study|Adverse Event|1
5143295|NCT01527487|17765910|P1|Overall Study|Adverse Event|1
5143296|NCT01527487|17765909|P2|Overall Study|Disease Progression|1
5143297|NCT01527487|17765910|P1|Overall Study|Disease Progression|4
5143298|NCT01527487|17765909|P2|Overall Study|MD Discretion/Lack of Efficacy|4
5143299|NCT01527487|17765910|P1|Overall Study|MD Discretion/Lack of Efficacy|3
5143300|NCT01527383|17765924|P2|Overall Study|Withdrawal by Subject|3
5143301|NCT01527383|17765925|P1|Overall Study|Withdrawal by Subject|2
5143302|NCT01527383|17765924|P2|Overall Study|Participant moved|1
5143303|NCT01527383|17765925|P1|Overall Study|Participant moved|0
5143304|NCT01527383|17765924|P2|Overall Study|Screen failure|0
5143305|NCT01527383|17765925|P1|Overall Study|Screen failure|1
5143306|NCT01527383|17765924|P2|Overall Study|Protocol Violation|0
5143307|NCT01527383|17765925|P1|Overall Study|Protocol Violation|1
5143308|NCT01527383|17765924|P2|Overall Study|Pregnancy|0
5143309|NCT01527383|17765925|P1|Overall Study|Pregnancy|1
5143310|NCT01527383|17765924|P2|Overall Study|Physician Decision|0
5143311|NCT01527383|17765925|P1|Overall Study|Physician Decision|2
5143312|NCT01527383|17765924|P2|Overall Study|Lost to Follow-up|0
5143313|NCT01527383|17765925|P1|Overall Study|Lost to Follow-up|3
5143314|NCT01527383|17765924|P2|Overall Study|Adverse Event|0
5143315|NCT01527383|17765925|P1|Overall Study|Adverse Event|5
5143316|NCT01527370|17765939|P1|Overall Study|Death|1
5143317|NCT01527370|17765939|P1|Overall Study|Physician Decision|1
5143318|NCT01527370|17765939|P1|Overall Study|Withdrawal by Subject|4
5143319|NCT01527357|17765947|P2|Overall Study|Did Not Receive Treatment|0
5143320|NCT01527357|17765948|P1|Overall Study|Did Not Receive Treatment|2
5143321|NCT01527357|17765947|P2|Overall Study|No Day 29 Visit|1
5143322|NCT01527357|17765948|P1|Overall Study|No Day 29 Visit|0
5143323|NCT01527357|17765947|P2|Overall Study|Non-compliance|1
5143324|NCT01527357|17765948|P1|Overall Study|Non-compliance|0
5143325|NCT01527357|17765947|P2|Overall Study|Withdrew Consent|1
5143326|NCT01527357|17765948|P1|Overall Study|Withdrew Consent|1
5143327|NCT01527357|17765947|P2|Overall Study|Lost to Follow-up|4
5143328|NCT01527357|17765948|P1|Overall Study|Lost to Follow-up|6
5143329|NCT01527357|17765947|P2|Overall Study|Death|2
5143330|NCT01527357|17765948|P1|Overall Study|Death|8
5143331|NCT01527292|17765970|P2|Overall Study|Physician Decision|3
5143332|NCT01527292|17765971|P1|Overall Study|Physician Decision|0
5143333|NCT01527149|17765998|P1|Overall Study|Death|2
5143334|NCT01527110|17766013|P1|Overall Study|Adverse Event|1
5143335|NCT01527006|17766094|P2|Extension Phase|Other|3
5143336|NCT01527006|17766095|P1|Extension Phase|Other|0
5143337|NCT01527006|17766094|P2|Extension Phase|Inadequate therapeutic effect|1
5143338|NCT01527006|17766095|P1|Extension Phase|Inadequate therapeutic effect|1
5143339|NCT01527006|17766094|P2|Extension Phase|Subject Choice|1
5143340|NCT01527006|17766095|P1|Extension Phase|Subject Choice|1
5143341|NCT01527006|17766094|P2|Extension Phase|Lost to Follow-up|1
5143342|NCT01527006|17766095|P1|Extension Phase|Lost to Follow-up|0
5143343|NCT01527006|17766094|P2|Extension Phase|Adverse Event|2
5143344|NCT01527006|17766095|P1|Extension Phase|Adverse Event|4
5143345|NCT01527006|17766094|P2|Core Study|Other|2
5143346|NCT01527006|17766095|P1|Core Study|Other|0
5143347|NCT01527006|17766094|P2|Core Study|Withdrawal by Subject|1
5143348|NCT01527006|17766095|P1|Core Study|Withdrawal by Subject|0
5143349|NCT01527006|17766094|P2|Core Study|Inadequate Therapeutic Effect|0
5143350|NCT01527006|17766095|P1|Core Study|Inadequate Therapeutic Effect|1
5143351|NCT01527006|17766094|P2|Core Study|Subject Choice|0
5143352|NCT01527006|17766095|P1|Core Study|Subject Choice|1
5143353|NCT01527006|17766094|P2|Core Study|Lost to Follow-up|1
5143354|NCT01527006|17766095|P1|Core Study|Lost to Follow-up|0
5143355|NCT01527006|17766094|P2|Core Study|Adverse Event|2
5143356|NCT01527006|17766095|P1|Core Study|Adverse Event|0
5143357|NCT01526928|17766151|P6|Overall Study|Missing|0
5143358|NCT01526928|17766152|P5|Overall Study|Missing|2
5143359|NCT01526928|17766153|P4|Overall Study|Missing|0
5143360|NCT01526928|17766154|P3|Overall Study|Missing|1
5143361|NCT01526928|17766155|P2|Overall Study|Missing|0
5143362|NCT01526928|17766156|P1|Overall Study|Missing|0
5143363|NCT01526928|17766151|P6|Overall Study|Protocol Deviation|0
5143364|NCT01526928|17766152|P5|Overall Study|Protocol Deviation|0
5143365|NCT01526928|17766153|P4|Overall Study|Protocol Deviation|2
5143366|NCT01526928|17766154|P3|Overall Study|Protocol Deviation|0
5143367|NCT01526928|17766155|P2|Overall Study|Protocol Deviation|0
5143368|NCT01526928|17766156|P1|Overall Study|Protocol Deviation|0
5143369|NCT01526928|17766151|P6|Overall Study|Lost to Follow-up|0
5143370|NCT01526928|17766152|P5|Overall Study|Lost to Follow-up|0
5143371|NCT01526928|17766153|P4|Overall Study|Lost to Follow-up|1
5143372|NCT01526928|17766154|P3|Overall Study|Lost to Follow-up|0
5143373|NCT01526928|17766155|P2|Overall Study|Lost to Follow-up|0
5143374|NCT01526928|17766156|P1|Overall Study|Lost to Follow-up|0
5143375|NCT01526928|17766151|P6|Overall Study|Other Reason|0
5143376|NCT01526928|17766152|P5|Overall Study|Other Reason|1
5143377|NCT01526928|17766153|P4|Overall Study|Other Reason|4
5143378|NCT01526928|17766154|P3|Overall Study|Other Reason|11
5143379|NCT01526928|17766155|P2|Overall Study|Other Reason|1
5143380|NCT01526928|17766156|P1|Overall Study|Other Reason|0
5143381|NCT01526928|17766151|P6|Overall Study|Physician Decision|0
5143382|NCT01526928|17766152|P5|Overall Study|Physician Decision|0
5143383|NCT01526928|17766153|P4|Overall Study|Physician Decision|5
5143384|NCT01526928|17766154|P3|Overall Study|Physician Decision|2
5143385|NCT01526928|17766155|P2|Overall Study|Physician Decision|0
5143386|NCT01526928|17766156|P1|Overall Study|Physician Decision|0
5143387|NCT01526928|17766151|P6|Overall Study|Withdrawal by Subject|0
5143388|NCT01526928|17766152|P5|Overall Study|Withdrawal by Subject|3
5143389|NCT01526928|17766153|P4|Overall Study|Withdrawal by Subject|11
5143390|NCT01526928|17766154|P3|Overall Study|Withdrawal by Subject|13
5143391|NCT01526928|17766155|P2|Overall Study|Withdrawal by Subject|0
5143392|NCT01526928|17766156|P1|Overall Study|Withdrawal by Subject|1
5143393|NCT01526928|17766151|P6|Overall Study|Death|0
5143394|NCT01526928|17766152|P5|Overall Study|Death|0
5143395|NCT01526928|17766153|P4|Overall Study|Death|0
5143396|NCT01526928|17766154|P3|Overall Study|Death|3
5143397|NCT01526928|17766155|P2|Overall Study|Death|0
5143398|NCT01526928|17766156|P1|Overall Study|Death|0
5143399|NCT01526928|17766151|P6|Overall Study|Adverse Event|2
5143400|NCT01526928|17766152|P5|Overall Study|Adverse Event|13
5143401|NCT01526928|17766153|P4|Overall Study|Adverse Event|40
5143402|NCT01526928|17766154|P3|Overall Study|Adverse Event|29
5143403|NCT01526928|17766155|P2|Overall Study|Adverse Event|1
5143404|NCT01526928|17766156|P1|Overall Study|Adverse Event|2
5143405|NCT01526928|17766151|P6|Overall Study|Progressive Disease|4
5143406|NCT01526928|17766152|P5|Overall Study|Progressive Disease|76
5143407|NCT01526928|17766153|P4|Overall Study|Progressive Disease|182
5143408|NCT01526928|17766154|P3|Overall Study|Progressive Disease|150
5143409|NCT01526928|17766155|P2|Overall Study|Progressive Disease|17
5143410|NCT01526928|17766156|P1|Overall Study|Progressive Disease|35
5143411|NCT01526889|17766294|P2|Treatment Extension Period|Administrative problems|0
5143412|NCT01526889|17766295|P1|Treatment Extension Period|Administrative problems|1
5143413|NCT01526889|17766294|P2|Treatment Period|Adverse Event|0
5143414|NCT01526889|17766295|P1|Treatment Period|Adverse Event|2
5143415|NCT01526785|17766316|P1|Overall Study|Withdrawal by Subject|2
5143416|NCT01526785|17766316|P1|Overall Study|Physician Decision|1
5143417|NCT01526785|17766316|P1|Overall Study|Death|2
5143418|NCT01526785|17766316|P1|Overall Study|Study Terminated by Sponsor|8
5143419|NCT01526733|17766326|P2|Phase 1|Withdrawal by Subject|1
5143420|NCT01526733|17766327|P1|Phase 1|Withdrawal by Subject|1
5143421|NCT01526733|17766326|P2|Phase 1|Protocol Violation|0
5143422|NCT01526733|17766327|P1|Phase 1|Protocol Violation|1
5143423|NCT01526551|17766366|P1|Overall Study|Lack of returned parental consent form|424
5143424|NCT01526148|17766444|P2|Overall Study|Incarcerated|2
5143425|NCT01526148|17766445|P1|Overall Study|Incarcerated|0
5143426|NCT01526148|17766444|P2|Overall Study|Moved out of state|0
5143427|NCT01526148|17766445|P1|Overall Study|Moved out of state|1
5143428|NCT01526148|17766444|P2|Overall Study|Unable to discontinue concomitant med|0
5143429|NCT01526148|17766445|P1|Overall Study|Unable to discontinue concomitant med|1
5143430|NCT01526148|17766444|P2|Overall Study|Unstable Medical Condition|0
5143431|NCT01526148|17766445|P1|Overall Study|Unstable Medical Condition|1
5143432|NCT01526148|17766444|P2|Overall Study|Withdrawal by Subject|0
5143433|NCT01526148|17766445|P1|Overall Study|Withdrawal by Subject|2
5143434|NCT01526148|17766444|P2|Overall Study|Lost to Follow-up|6
5143435|NCT01526148|17766445|P1|Overall Study|Lost to Follow-up|3
5143436|NCT01526148|17766444|P2|Overall Study|Adverse Event|5
5143437|NCT01526148|17766445|P1|Overall Study|Adverse Event|6
5143438|NCT01526057|17766456|P3|Overall Study|Protocol Violation|1
5143439|NCT01526057|17766457|P2|Overall Study|Protocol Violation|0
5143440|NCT01526057|17766458|P1|Overall Study|Protocol Violation|0
5143441|NCT01526057|17766456|P3|Overall Study|Other|1
5143442|NCT01526057|17766457|P2|Overall Study|Other|0
5143443|NCT01526057|17766458|P1|Overall Study|Other|1
5143444|NCT01526057|17766456|P3|Overall Study|Lost to Follow-up|1
5143445|NCT01526057|17766457|P2|Overall Study|Lost to Follow-up|0
5143446|NCT01526057|17766458|P1|Overall Study|Lost to Follow-up|1
5143447|NCT01526057|17766456|P3|Overall Study|Death|0
5143448|NCT01526057|17766457|P2|Overall Study|Death|0
5143449|NCT01526057|17766458|P1|Overall Study|Death|1
5143450|NCT01526057|17766456|P3|Overall Study|Adverse Event|1
5143451|NCT01526057|17766457|P2|Overall Study|Adverse Event|1
5143452|NCT01526057|17766458|P1|Overall Study|Adverse Event|3
5143453|NCT01526057|17766456|P3|Overall Study|Withdrawal by Subject|2
5143454|NCT01526057|17766457|P2|Overall Study|Withdrawal by Subject|2
5143455|NCT01526057|17766458|P1|Overall Study|Withdrawal by Subject|3
5143456|NCT01525875|17766557|P2|Open-label Period|Lost to Follow-up|2
5143457|NCT01525875|17766558|P1|Open-label Period|Lost to Follow-up|0
5143458|NCT01525875|17766557|P2|Placebo-controlled Period|Withdrawal by Subject|2
5143459|NCT01525875|17766558|P1|Placebo-controlled Period|Withdrawal by Subject|1
5143460|NCT01525849|17766581|P2|Overall Study|Anatomic exclusion criteria identified|3
5143461|NCT01525849|17766582|P1|Overall Study|Anatomic exclusion criteria identified|0
5143462|NCT01525849|17766581|P2|Overall Study|Unrelated medical issue (not treated)|2
5143463|NCT01525849|17766582|P1|Overall Study|Unrelated medical issue (not treated)|1
5143464|NCT01525849|17766581|P2|Overall Study|Withdrawal by Subject|9
5143465|NCT01525849|17766582|P1|Overall Study|Withdrawal by Subject|1
5143466|NCT01525849|17766581|P2|Overall Study|Lost to Follow-up|2
5143467|NCT01525849|17766582|P1|Overall Study|Lost to Follow-up|3
5143468|NCT01525641|17766638|P1|Overall Study|Other than stated above|7
5143469|NCT01525641|17766638|P1|Overall Study|Lost to follow-up (Changing hospital)|19
5143470|NCT01525641|17766638|P1|Overall Study|Lost to follow-up (Unknown reason)|10
5143471|NCT01525641|17766638|P1|Overall Study|Lost to follow-up (relocation)|1
5143472|NCT01525641|17766638|P1|Overall Study|Improvement|5
5143473|NCT01525641|17766638|P1|Overall Study|Lack of Efficacy|24
5143474|NCT01525641|17766638|P1|Overall Study|Adverse Event|73
5143475|NCT01525641|17766638|P1|Overall Study|No visit since the first visit|16
5143476|NCT01525641|17766638|P1|Overall Study|Case report form not collected|25
5143477|NCT01525628|17766652|P5|Overall Study|Other reason not defined above|0
5143478|NCT01525628|17766653|P4|Overall Study|Other reason not defined above|3
5143479|NCT01525628|17766654|P3|Overall Study|Other reason not defined above|0
5143480|NCT01525628|17766655|P2|Overall Study|Other reason not defined above|0
5143481|NCT01525628|17766656|P1|Overall Study|Other reason not defined above|0
5143482|NCT01525628|17766652|P5|Overall Study|Withdrawal by Subject|0
5143483|NCT01525628|17766653|P4|Overall Study|Withdrawal by Subject|0
5143484|NCT01525628|17766654|P3|Overall Study|Withdrawal by Subject|0
5143485|NCT01525628|17766655|P2|Overall Study|Withdrawal by Subject|1
5143486|NCT01525628|17766656|P1|Overall Study|Withdrawal by Subject|0
5143487|NCT01525628|17766652|P5|Overall Study|Lost to Follow-up|0
5143488|NCT01525628|17766653|P4|Overall Study|Lost to Follow-up|0
5143489|NCT01525628|17766654|P3|Overall Study|Lost to Follow-up|0
5143490|NCT01525628|17766655|P2|Overall Study|Lost to Follow-up|1
5143491|NCT01525628|17766656|P1|Overall Study|Lost to Follow-up|1
5143492|NCT01525628|17766652|P5|Overall Study|Protocol Violation|0
5143493|NCT01525628|17766653|P4|Overall Study|Protocol Violation|0
5143494|NCT01525628|17766654|P3|Overall Study|Protocol Violation|1
5143495|NCT01525628|17766655|P2|Overall Study|Protocol Violation|0
5143496|NCT01525628|17766656|P1|Overall Study|Protocol Violation|0
5143497|NCT01525628|17766652|P5|Overall Study|Lack of Efficacy|2
5143498|NCT01525628|17766653|P4|Overall Study|Lack of Efficacy|1
5143499|NCT01525628|17766654|P3|Overall Study|Lack of Efficacy|2
5143500|NCT01525628|17766655|P2|Overall Study|Lack of Efficacy|2
5143501|NCT01525628|17766656|P1|Overall Study|Lack of Efficacy|0
5143502|NCT01525628|17766652|P5|Overall Study|Adverse Event|1
5143503|NCT01525628|17766653|P4|Overall Study|Adverse Event|0
5143504|NCT01525628|17766654|P3|Overall Study|Adverse Event|2
5143505|NCT01525628|17766655|P2|Overall Study|Adverse Event|1
5143506|NCT01525628|17766656|P1|Overall Study|Adverse Event|1
5143507|NCT01525615|17766723|P3|Overall Study|Other reason not described above|1
5143508|NCT01525615|17766724|P2|Overall Study|Other reason not described above|0
5143509|NCT01525615|17766725|P1|Overall Study|Other reason not described above|1
5143510|NCT01525615|17766723|P3|Overall Study|Withdrawal by Subject|0
5143511|NCT01525615|17766724|P2|Overall Study|Withdrawal by Subject|0
5143512|NCT01525615|17766725|P1|Overall Study|Withdrawal by Subject|1
5143513|NCT01525615|17766723|P3|Overall Study|Lost to Follow-up|0
5143514|NCT01525615|17766724|P2|Overall Study|Lost to Follow-up|0
5143515|NCT01525615|17766725|P1|Overall Study|Lost to Follow-up|1
5143516|NCT01525615|17766723|P3|Overall Study|Adverse Event|5
5143517|NCT01525615|17766724|P2|Overall Study|Adverse Event|7
5143518|NCT01525615|17766725|P1|Overall Study|Adverse Event|11
5143519|NCT01525602|17766777|P8|Overall Study|Unqualified based on biopsy; not dosed|1
5143520|NCT01525602|17766778|P7|Overall Study|Unqualified based on biopsy; not dosed|1
5143521|NCT01525602|17766779|P6|Overall Study|Unqualified based on biopsy; not dosed|0
5143522|NCT01525602|17766780|P5|Overall Study|Unqualified based on biopsy; not dosed|0
5143523|NCT01525602|17766781|P4|Overall Study|Unqualified based on biopsy; not dosed|0
5143524|NCT01525602|17766782|P3|Overall Study|Unqualified based on biopsy; not dosed|0
5143525|NCT01525602|17766783|P2|Overall Study|Unqualified based on biopsy; not dosed|0
5143526|NCT01525602|17766784|P1|Overall Study|Unqualified based on biopsy; not dosed|0
5143527|NCT01525602|17766777|P8|Overall Study|Death|0
5143528|NCT01525602|17766778|P7|Overall Study|Death|0
5143529|NCT01525602|17766779|P6|Overall Study|Death|1
5143530|NCT01525602|17766780|P5|Overall Study|Death|1
5143531|NCT01525602|17766781|P4|Overall Study|Death|0
5143532|NCT01525602|17766782|P3|Overall Study|Death|0
5143533|NCT01525602|17766783|P2|Overall Study|Death|0
5143534|NCT01525602|17766784|P1|Overall Study|Death|0
5143535|NCT01525602|17766777|P8|Overall Study|Physician Decision|0
5143536|NCT01525602|17766778|P7|Overall Study|Physician Decision|1
5143537|NCT01525602|17766779|P6|Overall Study|Physician Decision|0
5143538|NCT01525602|17766780|P5|Overall Study|Physician Decision|3
5143539|NCT01525602|17766781|P4|Overall Study|Physician Decision|0
5143540|NCT01525602|17766782|P3|Overall Study|Physician Decision|0
5143541|NCT01525602|17766783|P2|Overall Study|Physician Decision|0
5143542|NCT01525602|17766784|P1|Overall Study|Physician Decision|0
5143543|NCT01525602|17766777|P8|Overall Study|Withdrawal by Subject|1
5143544|NCT01525602|17766778|P7|Overall Study|Withdrawal by Subject|0
5143545|NCT01525602|17766779|P6|Overall Study|Withdrawal by Subject|1
5143546|NCT01525602|17766780|P5|Overall Study|Withdrawal by Subject|3
5143547|NCT01525602|17766781|P4|Overall Study|Withdrawal by Subject|0
5143548|NCT01525602|17766782|P3|Overall Study|Withdrawal by Subject|0
5143549|NCT01525602|17766783|P2|Overall Study|Withdrawal by Subject|0
5143550|NCT01525602|17766784|P1|Overall Study|Withdrawal by Subject|0
5143551|NCT01525602|17766777|P8|Overall Study|Non-compliance|0
5143552|NCT01525602|17766778|P7|Overall Study|Non-compliance|0
5143553|NCT01525602|17766779|P6|Overall Study|Non-compliance|0
5143554|NCT01525602|17766780|P5|Overall Study|Non-compliance|1
5143555|NCT01525602|17766781|P4|Overall Study|Non-compliance|0
5143556|NCT01525602|17766782|P3|Overall Study|Non-compliance|0
5143557|NCT01525602|17766783|P2|Overall Study|Non-compliance|0
5143558|NCT01525602|17766784|P1|Overall Study|Non-compliance|0
5143559|NCT01525602|17766777|P8|Overall Study|Clinical progression|1
5143560|NCT01525602|17766778|P7|Overall Study|Clinical progression|1
5143561|NCT01525602|17766779|P6|Overall Study|Clinical progression|0
5143562|NCT01525602|17766780|P5|Overall Study|Clinical progression|0
5143563|NCT01525602|17766781|P4|Overall Study|Clinical progression|0
5143564|NCT01525602|17766782|P3|Overall Study|Clinical progression|0
5143565|NCT01525602|17766783|P2|Overall Study|Clinical progression|0
5143566|NCT01525602|17766784|P1|Overall Study|Clinical progression|2
5143567|NCT01525602|17766777|P8|Overall Study|Disease progression|3
5143568|NCT01525602|17766778|P7|Overall Study|Disease progression|3
5143569|NCT01525602|17766779|P6|Overall Study|Disease progression|2
5143570|NCT01525602|17766780|P5|Overall Study|Disease progression|22
5143571|NCT01525602|17766781|P4|Overall Study|Disease progression|5
5143572|NCT01525602|17766782|P3|Overall Study|Disease progression|2
5143573|NCT01525602|17766783|P2|Overall Study|Disease progression|3
5143574|NCT01525602|17766784|P1|Overall Study|Disease progression|6
5143575|NCT01525602|17766777|P8|Overall Study|Adverse Event|1
5143576|NCT01525602|17766778|P7|Overall Study|Adverse Event|0
5143577|NCT01525602|17766779|P6|Overall Study|Adverse Event|3
5143578|NCT01525602|17766780|P5|Overall Study|Adverse Event|3
5143579|NCT01525602|17766781|P4|Overall Study|Adverse Event|1
5143580|NCT01525602|17766782|P3|Overall Study|Adverse Event|1
5143581|NCT01525602|17766783|P2|Overall Study|Adverse Event|0
5143582|NCT01525602|17766784|P1|Overall Study|Adverse Event|1
5143583|NCT01525589|17766855|P3|Overall Study|Withdrawal by Subject|0
5143584|NCT01525589|17766856|P2|Overall Study|Withdrawal by Subject|1
5143585|NCT01525589|17766857|P1|Overall Study|Withdrawal by Subject|0
5143586|NCT01525589|17766855|P3|Overall Study|Other reasons|0
5143587|NCT01525589|17766856|P2|Overall Study|Other reasons|1
5143588|NCT01525589|17766857|P1|Overall Study|Other reasons|0
5143589|NCT01525589|17766855|P3|Overall Study|Treatment-related AE|2
5143590|NCT01525589|17766856|P2|Overall Study|Treatment-related AE|1
5143591|NCT01525589|17766857|P1|Overall Study|Treatment-related AE|1
5143592|NCT01525589|17766855|P3|Overall Study|Death|2
5143593|NCT01525589|17766856|P2|Overall Study|Death|0
5143594|NCT01525589|17766857|P1|Overall Study|Death|0
5143595|NCT01525589|17766855|P3|Overall Study|Physician Decision|2
5143596|NCT01525589|17766856|P2|Overall Study|Physician Decision|2
5143597|NCT01525589|17766857|P1|Overall Study|Physician Decision|4
5143598|NCT01525589|17766855|P3|Overall Study|Never treated|0
5143599|NCT01525589|17766856|P2|Overall Study|Never treated|0
5143600|NCT01525589|17766857|P1|Overall Study|Never treated|2
5143601|NCT01525589|17766855|P3|Overall Study|Progressive disease|29
5143602|NCT01525589|17766856|P2|Overall Study|Progressive disease|15
5143603|NCT01525589|17766857|P1|Overall Study|Progressive disease|48
5143604|NCT01525589|17766855|P3|Overall Study|Non-treatment-related AE|0
5143605|NCT01525589|17766856|P2|Overall Study|Non-treatment-related AE|0
5143606|NCT01525589|17766857|P1|Overall Study|Non-treatment-related AE|1
5143607|NCT01525550|17766913|P2|Overall Study|Withdrawal by Subject|0
5143608|NCT01525550|17766914|P1|Overall Study|Withdrawal by Subject|4
5143609|NCT01525550|17766913|P2|Overall Study|Sponsor's Decision|11
5143610|NCT01525550|17766914|P1|Overall Study|Sponsor's Decision|30
5143611|NCT01525550|17766913|P2|Overall Study|Other|4
5143612|NCT01525550|17766914|P1|Overall Study|Other|0
5143613|NCT01525550|17766913|P2|Overall Study|Death|28
5143614|NCT01525550|17766914|P1|Overall Study|Death|19
5143615|NCT01525550|17766913|P2|Overall Study|Lost to Follow-up|2
5143616|NCT01525550|17766914|P1|Overall Study|Lost to Follow-up|8
5143617|NCT01525407|17766985|P2|Overall Study|Delay in Transplant|0
5143618|NCT01525407|17766986|P1|Overall Study|Delay in Transplant|1
5143619|NCT01525407|17766985|P2|Overall Study|Transplant was delayed|1
5143620|NCT01525407|17766986|P1|Overall Study|Transplant was delayed|0
5143621|NCT01525407|17766985|P2|Overall Study|Withdrawal by Subject|1
5143622|NCT01525407|17766986|P1|Overall Study|Withdrawal by Subject|0
5143623|NCT01525407|17766985|P2|Overall Study|Change in recipient treatment plan|2
5143624|NCT01525407|17766986|P1|Overall Study|Change in recipient treatment plan|2
5143625|NCT01525238|17767020|P3|Overall Study|Withdrawal by Subject|0
5143626|NCT01525238|17767021|P2|Overall Study|Withdrawal by Subject|0
5143627|NCT01525238|17767022|P1|Overall Study|Withdrawal by Subject|1
5143628|NCT01525225|17767087|P1|Enrollment|Other|1
5143629|NCT01525225|17767087|P1|Enrollment|No longer met study criteria|1
5143630|NCT01524991|17767101|P1|Overall Study|Symptomatic Deterioration|1
5143631|NCT01524991|17767101|P1|Overall Study|Withdrawal by Subject|2
5143632|NCT01524991|17767101|P1|Overall Study|Other complicating disease|1
5143633|NCT01524991|17767101|P1|Overall Study|Disease ProgressionDu|17
5143634|NCT01524991|17767101|P1|Overall Study|Death|1
5143635|NCT01524991|17767101|P1|Overall Study|Adverse Event|12
5143636|NCT01524978|17767119|P11|Overall Study|Death|17
5143637|NCT01524978|17767120|P10|Overall Study|Death|6
5143638|NCT01524978|17767121|P9|Overall Study|Death|5
5143639|NCT01524978|17767122|P8|Overall Study|Death|9
5143640|NCT01524978|17767123|P7|Overall Study|Death|1
5143641|NCT01524978|17767124|P6|Overall Study|Death|4
5143642|NCT01524978|17767125|P5|Overall Study|Death|4
5143643|NCT01524978|17767126|P4|Overall Study|Death|24
5143644|NCT01524978|17767127|P3|Overall Study|Death|5
5143645|NCT01524978|17767128|P2|Overall Study|Death|2
5143646|NCT01524978|17767129|P1|Overall Study|Death|34
5143647|NCT01524978|17767119|P11|Overall Study|Lost to Follow-up|1
5143648|NCT01524978|17767120|P10|Overall Study|Lost to Follow-up|1
5143649|NCT01524978|17767121|P9|Overall Study|Lost to Follow-up|1
5143650|NCT01524978|17767122|P8|Overall Study|Lost to Follow-up|0
5143651|NCT01524978|17767123|P7|Overall Study|Lost to Follow-up|2
5143652|NCT01524978|17767124|P6|Overall Study|Lost to Follow-up|1
5143653|NCT01524978|17767125|P5|Overall Study|Lost to Follow-up|1
5143654|NCT01524978|17767126|P4|Overall Study|Lost to Follow-up|0
5143655|NCT01524978|17767127|P3|Overall Study|Lost to Follow-up|3
5143656|NCT01524978|17767128|P2|Overall Study|Lost to Follow-up|0
5143657|NCT01524978|17767129|P1|Overall Study|Lost to Follow-up|0
5143658|NCT01524978|17767119|P11|Overall Study|Withdrawal by Subject|5
5143659|NCT01524978|17767120|P10|Overall Study|Withdrawal by Subject|0
5143660|NCT01524978|17767121|P9|Overall Study|Withdrawal by Subject|4
5143661|NCT01524978|17767122|P8|Overall Study|Withdrawal by Subject|2
5143662|NCT01524978|17767123|P7|Overall Study|Withdrawal by Subject|6
5143663|NCT01524978|17767124|P6|Overall Study|Withdrawal by Subject|1
5143664|NCT01524978|17767125|P5|Overall Study|Withdrawal by Subject|3
5143665|NCT01524978|17767126|P4|Overall Study|Withdrawal by Subject|1
5143666|NCT01524978|17767127|P3|Overall Study|Withdrawal by Subject|1
5143667|NCT01524978|17767128|P2|Overall Study|Withdrawal by Subject|0
5143668|NCT01524978|17767129|P1|Overall Study|Withdrawal by Subject|12
5143669|NCT01524978|17767119|P11|Overall Study|Other|5
5143670|NCT01524978|17767120|P10|Overall Study|Other|2
5143671|NCT01524978|17767121|P9|Overall Study|Other|2
5143672|NCT01524978|17767122|P8|Overall Study|Other|1
5143673|NCT01524978|17767123|P7|Overall Study|Other|17
5143674|NCT01524978|17767124|P6|Overall Study|Other|3
5143675|NCT01524978|17767125|P5|Overall Study|Other|1
5143676|NCT01524978|17767126|P4|Overall Study|Other|2
5143677|NCT01524978|17767127|P3|Overall Study|Other|1
5143678|NCT01524978|17767128|P2|Overall Study|Other|2
5143679|NCT01524978|17767129|P1|Overall Study|Other|16
5143680|NCT01524913|17767257|P3|Overall Study|Lost to Follow-up|0
5143681|NCT01524913|17767258|P2|Overall Study|Lost to Follow-up|0
5143682|NCT01524913|17767259|P1|Overall Study|Lost to Follow-up|4
5143683|NCT01524900|17767281|P5|Overall Study|No reason documented|0
5143684|NCT01524900|17767282|P4|Overall Study|No reason documented|1
5143685|NCT01524900|17767283|P3|Overall Study|No reason documented|0
5143686|NCT01524900|17767284|P2|Overall Study|No reason documented|1
5143687|NCT01524900|17767285|P1|Overall Study|No reason documented|2
5143688|NCT01524900|17767281|P5|Overall Study|Other reason than stated above|0
5143689|NCT01524900|17767282|P4|Overall Study|Other reason than stated above|0
5143690|NCT01524900|17767283|P3|Overall Study|Other reason than stated above|0
5143691|NCT01524900|17767284|P2|Overall Study|Other reason than stated above|1
5143692|NCT01524900|17767285|P1|Overall Study|Other reason than stated above|1
5143693|NCT01524900|17767281|P5|Overall Study|Lost to Follow-up|0
5143694|NCT01524900|17767282|P4|Overall Study|Lost to Follow-up|0
5143695|NCT01524900|17767283|P3|Overall Study|Lost to Follow-up|1
5143696|NCT01524900|17767284|P2|Overall Study|Lost to Follow-up|12
5143697|NCT01524900|17767285|P1|Overall Study|Lost to Follow-up|3
5143698|NCT01524887|17767330|P3|Overall Study|Use of prohibited medication|0
5143699|NCT01524887|17767331|P2|Overall Study|Use of prohibited medication|0
5143700|NCT01524887|17767332|P1|Overall Study|Use of prohibited medication|1
5143701|NCT01524887|17767330|P3|Overall Study|Withdrawal by Caregiver|2
5143702|NCT01524887|17767331|P2|Overall Study|Withdrawal by Caregiver|0
5143703|NCT01524887|17767332|P1|Overall Study|Withdrawal by Caregiver|0
5143704|NCT01524887|17767330|P3|Overall Study|Study termination|79
5143705|NCT01524887|17767331|P2|Overall Study|Study termination|87
5143706|NCT01524887|17767332|P1|Overall Study|Study termination|73
5143707|NCT01524887|17767330|P3|Overall Study|Protocol Violation|1
5143708|NCT01524887|17767331|P2|Overall Study|Protocol Violation|0
5143709|NCT01524887|17767332|P1|Overall Study|Protocol Violation|0
5143710|NCT01524887|17767330|P3|Overall Study|Adverse Event|1
5143711|NCT01524887|17767331|P2|Overall Study|Adverse Event|1
5143712|NCT01524887|17767332|P1|Overall Study|Adverse Event|5
5143713|NCT01524887|17767330|P3|Overall Study|Withdrawal by Subject|3
5143714|NCT01524887|17767331|P2|Overall Study|Withdrawal by Subject|2
5143715|NCT01524887|17767332|P1|Overall Study|Withdrawal by Subject|6
5143716|NCT01524796|17767376|P1|Overall Study|Adverse Event and Lack of Efficacy|1
5143717|NCT01524796|17767376|P1|Overall Study|Switch to carbamazapine|1
5143718|NCT01524796|17767376|P1|Overall Study|Nervous about confidentiality|1
5143719|NCT01524796|17767376|P1|Overall Study|Gall stone surgery|1
5143720|NCT01524796|17767376|P1|Overall Study|Deterioration of pains|1
5143721|NCT01524796|17767376|P1|Overall Study|Move|1
5143722|NCT01524796|17767376|P1|Overall Study|Withdrawal by Subject|4
5143723|NCT01524796|17767376|P1|Overall Study|The price|1
5143724|NCT01524796|17767376|P1|Overall Study|Lost to Follow-up|1
5143725|NCT01524796|17767376|P1|Overall Study|Lack of Efficacy|3
5143726|NCT01524796|17767376|P1|Overall Study|Adverse Event|13
5143727|NCT01524783|17767391|P2|Randomized and Treated|Death|1
5143728|NCT01524783|17767392|P1|Randomized and Treated|Death|4
5143729|NCT01524783|17767391|P2|Randomized and Treated|Protocol Violation|1
5143730|NCT01524783|17767392|P1|Randomized and Treated|Protocol Violation|1
5143731|NCT01524783|17767391|P2|Randomized and Treated|Withdrawal by Subject|5
5143732|NCT01524783|17767392|P1|Randomized and Treated|Withdrawal by Subject|15
5143733|NCT01524783|17767391|P2|Randomized and Treated|Disease Progression|70
5143734|NCT01524783|17767392|P1|Randomized and Treated|Disease Progression|76
5143735|NCT01524783|17767391|P2|Randomized and Treated|Adverse Event|7
5143736|NCT01524783|17767392|P1|Randomized and Treated|Adverse Event|59
5143737|NCT01524783|17767391|P2|Randomized But Not Treated|Randomized, did not receive drug|0
5143738|NCT01524783|17767392|P1|Randomized But Not Treated|Randomized, did not receive drug|2
5143739|NCT01524770|17767400|P2|First Intervention|Protocol Violation|0
5143740|NCT01524770|17767401|P1|First Intervention|Protocol Violation|1
5143741|NCT01524770|17767400|P2|First Intervention|Adverse Event|1
5143742|NCT01524770|17767401|P1|First Intervention|Adverse Event|1
5143743|NCT01524770|17767400|P2|First Intervention|Withdrawal by Subject|0
5143744|NCT01524770|17767401|P1|First Intervention|Withdrawal by Subject|1
5143745|NCT01524692|17767411|P1|Overall Study|Withdrawal by Subject|3
5143746|NCT01524679|17767421|P2|Overall Study|e.g.wish for children, relocation|1
5143747|NCT01524679|17767422|P1|Overall Study|e.g.wish for children, relocation|6
5143748|NCT01524679|17767421|P2|Overall Study|Lack of Efficacy|0
5143749|NCT01524679|17767422|P1|Overall Study|Lack of Efficacy|2
5143750|NCT01524679|17767421|P2|Overall Study|Protocol Violation|0
5143751|NCT01524679|17767422|P1|Overall Study|Protocol Violation|1
5143752|NCT01524679|17767421|P2|Overall Study|Adverse Event|0
5143753|NCT01524679|17767422|P1|Overall Study|Adverse Event|9
5143754|NCT01524679|17767421|P2|Overall Study|Withdrawal by Subject|4
5143755|NCT01524679|17767422|P1|Overall Study|Withdrawal by Subject|4
5143756|NCT01524679|17767421|P2|Overall Study|Lost to Follow-up|4
5143757|NCT01524679|17767422|P1|Overall Study|Lost to Follow-up|1
5143758|NCT01524627|17767434|P2|Overall Study|Lost to Follow-up|1
5143759|NCT01524627|17767435|P1|Overall Study|Lost to Follow-up|1
5143760|NCT01524627|17767434|P2|Overall Study|Physician Decision|1
5143761|NCT01524627|17767435|P1|Overall Study|Physician Decision|0
5143762|NCT01524289|17767462|P2|Overall Study|Did not take study medication|0
5143763|NCT01524289|17767463|P1|Overall Study|Did not take study medication|1
5143764|NCT01524289|17767462|P2|Overall Study|Adverse Event|5
5143765|NCT01524289|17767463|P1|Overall Study|Adverse Event|12
5143766|NCT01524289|17767462|P2|Overall Study|Withdrawal by Subject|7
5143767|NCT01524289|17767463|P1|Overall Study|Withdrawal by Subject|11
5143768|NCT01524289|17767462|P2|Overall Study|Protocol Violation|1
5143769|NCT01524289|17767463|P1|Overall Study|Protocol Violation|5
5143770|NCT01524289|17767462|P2|Overall Study|Physician Decision|0
5143771|NCT01524289|17767463|P1|Overall Study|Physician Decision|1
5143772|NCT01524289|17767462|P2|Overall Study|Lost to Follow-up|1
5143773|NCT01524289|17767463|P1|Overall Study|Lost to Follow-up|0
5143774|NCT01524224|17767521|P8|Overall Study|Sponsor Decision|0
5143775|NCT01524224|17767522|P7|Overall Study|Sponsor Decision|0
5143776|NCT01524224|17767523|P6|Overall Study|Sponsor Decision|0
5143777|NCT01524224|17767524|P5|Overall Study|Sponsor Decision|1
5143778|NCT01524224|17767525|P4|Overall Study|Sponsor Decision|0
5143779|NCT01524224|17767526|P3|Overall Study|Sponsor Decision|0
5143780|NCT01524224|17767527|P2|Overall Study|Sponsor Decision|0
5143781|NCT01524224|17767528|P1|Overall Study|Sponsor Decision|0
5143782|NCT01524224|17767521|P8|Overall Study|Physician Decision|1
5143783|NCT01524224|17767522|P7|Overall Study|Physician Decision|0
5143784|NCT01524224|17767523|P6|Overall Study|Physician Decision|0
5143785|NCT01524224|17767524|P5|Overall Study|Physician Decision|1
5143786|NCT01524224|17767525|P4|Overall Study|Physician Decision|1
5143787|NCT01524224|17767526|P3|Overall Study|Physician Decision|0
5143788|NCT01524224|17767527|P2|Overall Study|Physician Decision|0
5143789|NCT01524224|17767528|P1|Overall Study|Physician Decision|0
5143790|NCT01524224|17767521|P8|Overall Study|Adverse Event|0
5143791|NCT01524224|17767522|P7|Overall Study|Adverse Event|0
5143792|NCT01524224|17767523|P6|Overall Study|Adverse Event|1
5143793|NCT01524224|17767524|P5|Overall Study|Adverse Event|0
5143794|NCT01524224|17767525|P4|Overall Study|Adverse Event|0
5143795|NCT01524224|17767526|P3|Overall Study|Adverse Event|0
5143796|NCT01524224|17767527|P2|Overall Study|Adverse Event|1
5143797|NCT01524224|17767528|P1|Overall Study|Adverse Event|0
5143798|NCT01524224|17767521|P8|Overall Study|Withdrawal by Subject|0
5143799|NCT01524224|17767522|P7|Overall Study|Withdrawal by Subject|2
5143800|NCT01524224|17767523|P6|Overall Study|Withdrawal by Subject|0
5143801|NCT01524224|17767524|P5|Overall Study|Withdrawal by Subject|0
5143802|NCT01524224|17767525|P4|Overall Study|Withdrawal by Subject|0
5143803|NCT01524224|17767526|P3|Overall Study|Withdrawal by Subject|0
5143804|NCT01524224|17767527|P2|Overall Study|Withdrawal by Subject|0
5143805|NCT01524224|17767528|P1|Overall Study|Withdrawal by Subject|2
5143806|NCT01524224|17767521|P8|Overall Study|Progressive Disease|5
5143807|NCT01524224|17767522|P7|Overall Study|Progressive Disease|1
5143808|NCT01524224|17767523|P6|Overall Study|Progressive Disease|1
5143809|NCT01524224|17767524|P5|Overall Study|Progressive Disease|2
5143810|NCT01524224|17767525|P4|Overall Study|Progressive Disease|1
5143811|NCT01524224|17767526|P3|Overall Study|Progressive Disease|2
5143812|NCT01524224|17767527|P2|Overall Study|Progressive Disease|0
5143813|NCT01524224|17767528|P1|Overall Study|Progressive Disease|1
5143814|NCT01524198|17767564|P2|Overall Study|Withdrawal by Subject|10
5143815|NCT01524198|17767565|P1|Overall Study|Withdrawal by Subject|15
5143816|NCT01524198|17767564|P2|Overall Study|Protocol Violation|6
5143817|NCT01524198|17767565|P1|Overall Study|Protocol Violation|8
5143818|NCT01524133|17767576|P3|Overall Study 52 Weeks|Lost to Follow-up|15
5143819|NCT01524133|17767577|P2|Overall Study 52 Weeks|Lost to Follow-up|15
5143820|NCT01524133|17767578|P1|Overall Study 52 Weeks|Lost to Follow-up|16
5143821|NCT01524133|17767576|P3|Overall Study 52 Weeks|Physician Decision|2
5143822|NCT01524133|17767577|P2|Overall Study 52 Weeks|Physician Decision|0
5143823|NCT01524133|17767578|P1|Overall Study 52 Weeks|Physician Decision|1
5143824|NCT01524133|17767576|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
5143825|NCT01524133|17767577|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
5143826|NCT01524133|17767578|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
5143827|NCT01524133|17767576|P3|Treatment Phase|Lost to Follow-up|2
5143828|NCT01524133|17767577|P2|Treatment Phase|Lost to Follow-up|1
5143829|NCT01524133|17767578|P1|Treatment Phase|Lost to Follow-up|0
5143830|NCT01524133|17767576|P3|Treatment Phase|Physician Decision|3
5143831|NCT01524133|17767577|P2|Treatment Phase|Physician Decision|3
5143832|NCT01524133|17767578|P1|Treatment Phase|Physician Decision|6
5143833|NCT01524133|17767576|P3|Treatment Phase|Withdrawal by Subject|31
5143834|NCT01524133|17767577|P2|Treatment Phase|Withdrawal by Subject|28
5143835|NCT01524133|17767578|P1|Treatment Phase|Withdrawal by Subject|13
5143836|NCT01523886|17767621|P2|Overall Study|surgery cancelled|1
5143837|NCT01523886|17767622|P1|Overall Study|surgery cancelled|0
5143838|NCT01523873|17767628|P1|Overall Study|Protocol Violation|422
5143839|NCT01523756|17767723|P2|Test Period 2|Withdrawal by Subject|1
5143840|NCT01523756|17767724|P1|Test Period 2|Withdrawal by Subject|0
5143841|NCT01523756|17767723|P2|Test Period 1|Adverse Event|0
5143842|NCT01523756|17767724|P1|Test Period 1|Adverse Event|1
5143843|NCT01523756|17767723|P2|Baseline Period|Adverse Event|1
5143844|NCT01523756|17767724|P1|Baseline Period|Adverse Event|0
5143845|NCT01523743|17767732|P2|Period 2|Adverse Event|0
5143846|NCT01523743|17767733|P1|Period 2|Adverse Event|1
5143847|NCT01523743|17767732|P2|Period 2|Withdrawal by Subject|2
5143848|NCT01523743|17767733|P1|Period 2|Withdrawal by Subject|0
5143849|NCT01523743|17767732|P2|Period 1|Felt unable to empty bladder|0
5143850|NCT01523743|17767733|P1|Period 1|Felt unable to empty bladder|1
5143851|NCT01523743|17767732|P2|Period 1|Lack of Efficacy|0
5143852|NCT01523743|17767733|P1|Period 1|Lack of Efficacy|1
5143853|NCT01523743|17767732|P2|Period 1|Lost to Follow-up|0
5143854|NCT01523743|17767733|P1|Period 1|Lost to Follow-up|1
5143855|NCT01523743|17767732|P2|Period 1|Withdrawal by Subject|2
5143856|NCT01523743|17767733|P1|Period 1|Withdrawal by Subject|6
5143857|NCT01523743|17767732|P2|Period 1|Adverse Event|0
5143858|NCT01523743|17767733|P1|Period 1|Adverse Event|1
5143859|NCT01523587|17767756|P2|Overall Study|Randomised but bot treated|2
5143860|NCT01523587|17767757|P1|Overall Study|Randomised but bot treated|6
5143861|NCT01523587|17767756|P2|Overall Study|Withdrew due to Progressive disease|279
5143862|NCT01523587|17767757|P1|Overall Study|Withdrew due to Progressive disease|265
5143863|NCT01523587|17767756|P2|Overall Study|Withdrawal by Subject|20
5143864|NCT01523587|17767757|P1|Overall Study|Withdrawal by Subject|28
5143865|NCT01523587|17767756|P2|Overall Study|Lost to Follow-up|2
5143866|NCT01523587|17767757|P1|Overall Study|Lost to Follow-up|2
5143867|NCT01523587|17767756|P2|Overall Study|Protocol Violation|3
5143868|NCT01523587|17767757|P1|Overall Study|Protocol Violation|5
5143869|NCT01523587|17767756|P2|Overall Study|Adverse Event|52
5143870|NCT01523587|17767757|P1|Overall Study|Adverse Event|68
5143871|NCT01523587|17767756|P2|Overall Study|Worsening of underlying cancer disease|34
5143872|NCT01523587|17767757|P1|Overall Study|Worsening of underlying cancer disease|19
5143873|NCT01523587|17767756|P2|Overall Study|Other than listed|5
5143874|NCT01523587|17767757|P1|Overall Study|Other than listed|5
5143875|NCT01523457|17767800|P2|Overall Study|Withdrawal by Subject|2
5143876|NCT01523457|17767801|P1|Overall Study|Withdrawal by Subject|7
5143877|NCT01523392|17767819|P2|Washout Period - 10 to 14 Days|Adverse Event|0
5143878|NCT01523392|17767820|P1|Washout Period - 10 to 14 Days|Adverse Event|1
5143879|NCT01523392|17767819|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
5143880|NCT01523392|17767820|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
5143881|NCT01523392|17767819|P2|Treatment Period 1|Withdrawal by Subject|0
5143882|NCT01523392|17767820|P1|Treatment Period 1|Withdrawal by Subject|2
5143883|NCT01523366|17767836|P2|Treatment Period 2|Not completed at least 7 days treatment|0
5143884|NCT01523366|17767837|P1|Treatment Period 2|Not completed at least 7 days treatment|1
5143885|NCT01523366|17767836|P2|Treatment Period 1|Withdrawal by Subject|0
5143886|NCT01523366|17767837|P1|Treatment Period 1|Withdrawal by Subject|1
5143887|NCT01523301|17767853|P2|Overall Study|Other Reason|2
5143888|NCT01523301|17767854|P1|Overall Study|Other Reason|0
5143889|NCT01523301|17767853|P2|Overall Study|Withdrawal by Subject|8
5143890|NCT01523301|17767854|P1|Overall Study|Withdrawal by Subject|6
5143891|NCT01523301|17767853|P2|Overall Study|Lost to Follow-up|0
5143892|NCT01523301|17767854|P1|Overall Study|Lost to Follow-up|1
5143893|NCT01523301|17767853|P2|Overall Study|Protocol Violation|4
5143894|NCT01523301|17767854|P1|Overall Study|Protocol Violation|3
5143895|NCT01523301|17767853|P2|Overall Study|Lack of Efficacy|2
5143896|NCT01523301|17767854|P1|Overall Study|Lack of Efficacy|0
5143897|NCT01523301|17767853|P2|Overall Study|Adverse Event|16
5143898|NCT01523301|17767854|P1|Overall Study|Adverse Event|25
5143899|NCT01523275|17767874|P2|Overall Study|Withdrawal by Subject|0
5143900|NCT01523275|17767875|P1|Overall Study|Withdrawal by Subject|1
5143901|NCT01523275|17767874|P2|Overall Study|Lost to Follow-up|2
5143902|NCT01523275|17767875|P1|Overall Study|Lost to Follow-up|1
5143903|NCT01522976|17767888|P3|Overall Study|Not protocol specified|27
5143904|NCT01522976|17767889|P2|Overall Study|Not protocol specified|27
5143905|NCT01522976|17767890|P1|Overall Study|Not protocol specified|22
5143906|NCT01522976|17767888|P3|Overall Study|Refusal unrelated to adverse event|14
5143907|NCT01522976|17767889|P2|Overall Study|Refusal unrelated to adverse event|13
5143908|NCT01522976|17767890|P1|Overall Study|Refusal unrelated to adverse event|10
5143909|NCT01522976|17767888|P3|Overall Study|Adverse Event|18
5143910|NCT01522976|17767889|P2|Overall Study|Adverse Event|7
5143911|NCT01522976|17767890|P1|Overall Study|Adverse Event|17
5143912|NCT01522976|17767888|P3|Overall Study|Disease progression|25
5143913|NCT01522976|17767889|P2|Overall Study|Disease progression|30
5143914|NCT01522976|17767890|P1|Overall Study|Disease progression|28
5143915|NCT01522976|17767888|P3|Overall Study|Still on treatment|6
5143916|NCT01522976|17767889|P2|Overall Study|Still on treatment|9
5143917|NCT01522976|17767890|P1|Overall Study|Still on treatment|9
5143918|NCT01522976|17767888|P3|Overall Study|Death|2
5143919|NCT01522976|17767889|P2|Overall Study|Death|6
5143920|NCT01522976|17767890|P1|Overall Study|Death|7
5143921|NCT01522976|17767888|P3|Overall Study|Ineligible|1
5143922|NCT01522976|17767889|P2|Overall Study|Ineligible|0
5143923|NCT01522976|17767890|P1|Overall Study|Ineligible|4
5143924|NCT01522950|17767935|P3|Overall Study|Study Medication Sensitivity|0
5143925|NCT01522950|17767936|P2|Overall Study|Study Medication Sensitivity|1
5143926|NCT01522950|17767937|P1|Overall Study|Study Medication Sensitivity|0
5143927|NCT01522950|17767935|P3|Overall Study|Death|1
5143928|NCT01522950|17767936|P2|Overall Study|Death|1
5143929|NCT01522950|17767937|P1|Overall Study|Death|0
5143930|NCT01522950|17767935|P3|Overall Study|Protocol Violation|2
5143931|NCT01522950|17767936|P2|Overall Study|Protocol Violation|0
5143932|NCT01522950|17767937|P1|Overall Study|Protocol Violation|0
5143933|NCT01522950|17767935|P3|Overall Study|Adverse Event|1
5143934|NCT01522950|17767936|P2|Overall Study|Adverse Event|1
5143935|NCT01522950|17767937|P1|Overall Study|Adverse Event|3
5143936|NCT01522950|17767935|P3|Overall Study|Withdrawal by Subject|1
5143937|NCT01522950|17767936|P2|Overall Study|Withdrawal by Subject|2
5143938|NCT01522950|17767937|P1|Overall Study|Withdrawal by Subject|3
5143939|NCT01522651|17768005|P5|Overall Study|Randomized but Never Treated|1
5143940|NCT01522651|17768006|P4|Overall Study|Randomized but Never Treated|1
5143941|NCT01522651|17768007|P3|Overall Study|Randomized but Never Treated|0
5143942|NCT01522651|17768008|P2|Overall Study|Randomized but Never Treated|1
5143943|NCT01522651|17768009|P1|Overall Study|Randomized but Never Treated|0
5143944|NCT01522651|17768005|P5|Overall Study|Withdrew Consent|1
5143945|NCT01522651|17768006|P4|Overall Study|Withdrew Consent|1
5143946|NCT01522651|17768007|P3|Overall Study|Withdrew Consent|0
5143947|NCT01522651|17768008|P2|Overall Study|Withdrew Consent|1
5143948|NCT01522651|17768009|P1|Overall Study|Withdrew Consent|1
5143949|NCT01522651|17768005|P5|Overall Study|Participant Non-Compliance|0
5143950|NCT01522651|17768006|P4|Overall Study|Participant Non-Compliance|0
5143951|NCT01522651|17768007|P3|Overall Study|Participant Non-Compliance|0
5143952|NCT01522651|17768008|P2|Overall Study|Participant Non-Compliance|0
5143953|NCT01522651|17768009|P1|Overall Study|Participant Non-Compliance|1
5143954|NCT01522651|17768005|P5|Overall Study|Reason Not Specified|0
5143955|NCT01522651|17768006|P4|Overall Study|Reason Not Specified|1
5143956|NCT01522651|17768007|P3|Overall Study|Reason Not Specified|0
5143957|NCT01522651|17768008|P2|Overall Study|Reason Not Specified|0
5143958|NCT01522651|17768009|P1|Overall Study|Reason Not Specified|0
5143959|NCT01522651|17768005|P5|Overall Study|Protocol Violation|0
5143960|NCT01522651|17768006|P4|Overall Study|Protocol Violation|0
5143961|NCT01522651|17768007|P3|Overall Study|Protocol Violation|0
5143962|NCT01522651|17768008|P2|Overall Study|Protocol Violation|0
5143963|NCT01522651|17768009|P1|Overall Study|Protocol Violation|3
5143964|NCT01522651|17768005|P5|Overall Study|Investigator's Discretion|0
5143965|NCT01522651|17768006|P4|Overall Study|Investigator's Discretion|0
5143966|NCT01522651|17768007|P3|Overall Study|Investigator's Discretion|0
5143967|NCT01522651|17768008|P2|Overall Study|Investigator's Discretion|1
5143968|NCT01522651|17768009|P1|Overall Study|Investigator's Discretion|0
5143969|NCT01522651|17768005|P5|Overall Study|Device Malfunction|0
5143970|NCT01522651|17768006|P4|Overall Study|Device Malfunction|0
5143971|NCT01522651|17768007|P3|Overall Study|Device Malfunction|0
5143972|NCT01522651|17768008|P2|Overall Study|Device Malfunction|1
5143973|NCT01522651|17768009|P1|Overall Study|Device Malfunction|0
5143974|NCT01522651|17768005|P5|Overall Study|Cardioversion|0
5143975|NCT01522651|17768006|P4|Overall Study|Cardioversion|0
5143976|NCT01522651|17768007|P3|Overall Study|Cardioversion|0
5143977|NCT01522651|17768008|P2|Overall Study|Cardioversion|0
5143978|NCT01522651|17768009|P1|Overall Study|Cardioversion|1
5143979|NCT01522651|17768005|P5|Overall Study|Adverse Event|4
5143980|NCT01522651|17768006|P4|Overall Study|Adverse Event|5
5143981|NCT01522651|17768007|P3|Overall Study|Adverse Event|4
5143982|NCT01522651|17768008|P2|Overall Study|Adverse Event|4
5143983|NCT01522651|17768009|P1|Overall Study|Adverse Event|3
5143984|NCT01522456|17768036|P1|Overall Study|Tolerability Assessment|1
5143985|NCT01522456|17768036|P1|Overall Study|Pregnancy|1
5143986|NCT01522456|17768036|P1|Overall Study|Withdrawal by Subject|2
5143987|NCT01522456|17768036|P1|Overall Study|Lost to Follow-up|2
5143988|NCT01522456|17768036|P1|Overall Study|Adverse Event|2
5143989|NCT01522443|17768099|P2|Overall Study|Other|3
5143990|NCT01522443|17768100|P1|Overall Study|Other|1
5143991|NCT01522443|17768099|P2|Overall Study|No study treatment given|1
5143992|NCT01522443|17768100|P1|Overall Study|No study treatment given|1
5143993|NCT01522443|17768099|P2|Overall Study|Withdrawal by Subject|8
5143994|NCT01522443|17768100|P1|Overall Study|Withdrawal by Subject|5
5143995|NCT01522443|17768099|P2|Overall Study|Adverse Event|15
5143996|NCT01522443|17768100|P1|Overall Study|Adverse Event|10
5143997|NCT01522443|17768099|P2|Overall Study|No longer receiving clinical benefit|28
5143998|NCT01522443|17768100|P1|Overall Study|No longer receiving clinical benefit|36
5143999|NCT01522404|17768112|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
5144000|NCT01522404|17768113|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
5144001|NCT01522404|17768112|P2|First Intervention (up to Week 29)|Adverse Event|0
5144002|NCT01522404|17768113|P1|First Intervention (up to Week 29)|Adverse Event|1
5144003|NCT01522404|17768112|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
5144004|NCT01522404|17768113|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
5144005|NCT01522248|17768199|P2|Overall Study|Lost to Follow-up|0
5144006|NCT01522248|17768200|P1|Overall Study|Lost to Follow-up|1
5144007|NCT01522235|17768215|P2|Overall Study|Physician Decision|1
5144008|NCT01522235|17768216|P1|Overall Study|Physician Decision|1
5144009|NCT01521923|17768252|P4|Overall Study|AE, captured in Period 1|1
5144010|NCT01521923|17768253|P3|Overall Study|AE, captured in Period 1|0
5144011|NCT01521923|17768254|P2|Overall Study|AE, captured in Period 1|1
5144012|NCT01521923|17768255|P1|Overall Study|AE, captured in Period 1|0
5144013|NCT01521923|17768252|P4|Overall Study|Other|6
5144014|NCT01521923|17768253|P3|Overall Study|Other|3
5144015|NCT01521923|17768254|P2|Overall Study|Other|1
5144016|NCT01521923|17768255|P1|Overall Study|Other|2
5144017|NCT01521923|17768252|P4|Overall Study|Withdrawal by Subject|2
5144018|NCT01521923|17768253|P3|Overall Study|Withdrawal by Subject|1
5144019|NCT01521923|17768254|P2|Overall Study|Withdrawal by Subject|1
5144020|NCT01521923|17768255|P1|Overall Study|Withdrawal by Subject|1
5144021|NCT01521923|17768252|P4|Overall Study|Lost to Follow-up|1
5144022|NCT01521923|17768253|P3|Overall Study|Lost to Follow-up|2
5144023|NCT01521923|17768254|P2|Overall Study|Lost to Follow-up|0
5144024|NCT01521923|17768255|P1|Overall Study|Lost to Follow-up|1
5144025|NCT01521923|17768252|P4|Overall Study|Protocol Violation|0
5144026|NCT01521923|17768253|P3|Overall Study|Protocol Violation|1
5144027|NCT01521923|17768254|P2|Overall Study|Protocol Violation|0
5144028|NCT01521923|17768255|P1|Overall Study|Protocol Violation|0
5144029|NCT01521923|17768252|P4|Overall Study|Lack of Efficacy|0
5144030|NCT01521923|17768253|P3|Overall Study|Lack of Efficacy|0
5144031|NCT01521923|17768254|P2|Overall Study|Lack of Efficacy|1
5144032|NCT01521923|17768255|P1|Overall Study|Lack of Efficacy|1
5144033|NCT01521923|17768252|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
5144034|NCT01521923|17768253|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5144035|NCT01521923|17768254|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5144036|NCT01521923|17768255|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5144037|NCT01521923|17768252|P4|Overall Study|AE, non-serious, non-fatal|2
5144038|NCT01521923|17768253|P3|Overall Study|AE, non-serious, non-fatal|6
5144039|NCT01521923|17768254|P2|Overall Study|AE, non-serious, non-fatal|3
5144040|NCT01521923|17768255|P1|Overall Study|AE, non-serious, non-fatal|1
5144041|NCT01521923|17768252|P4|Overall Study|SAE, non-fatal|0
5144042|NCT01521923|17768253|P3|Overall Study|SAE, non-fatal|2
5144043|NCT01521923|17768254|P2|Overall Study|SAE, non-fatal|2
5144044|NCT01521923|17768255|P1|Overall Study|SAE, non-fatal|0
5144045|NCT01521923|17768252|P4|Overall Study|AE, serious fatal|0
5144046|NCT01521923|17768253|P3|Overall Study|AE, serious fatal|0
5144047|NCT01521923|17768254|P2|Overall Study|AE, serious fatal|0
5144048|NCT01521923|17768255|P1|Overall Study|AE, serious fatal|1
5144049|NCT01521897|17768375|P1|Overall Study|Lost to Follow-up|5
5144050|NCT01521897|17768375|P1|Overall Study|Protocol Violation|18
5144051|NCT01521884|17768387|P1|Overall Study|Lost to Follow-up|4
5144052|NCT01521884|17768387|P1|Overall Study|Participant non-eligible|1
5144053|NCT01521884|17768387|P1|Overall Study|Protocol Violation|3
5144054|NCT01521884|17768387|P1|Overall Study|Physician Decision|2
5144055|NCT01521884|17768387|P1|Overall Study|Withdrawal by Subject|1
5144056|NCT01521884|17768387|P1|Overall Study|Pregnancy|1
5144057|NCT01521884|17768387|P1|Overall Study|Adverse Event|5
5144058|NCT01521884|17768387|P1|Overall Study|Non Responders|10
5144059|NCT01521559|17768484|P2|Overall Study|Other|2
5144060|NCT01521559|17768485|P1|Overall Study|Other|1
5144061|NCT01521559|17768484|P2|Overall Study|Protocol Violation|0
5144062|NCT01521559|17768485|P1|Overall Study|Protocol Violation|1
5144063|NCT01521559|17768484|P2|Overall Study|Lost to Follow-up|1
5144064|NCT01521559|17768485|P1|Overall Study|Lost to Follow-up|3
5144065|NCT01521559|17768484|P2|Overall Study|Withdrawal by Subject|11
5144066|NCT01521559|17768485|P1|Overall Study|Withdrawal by Subject|9
5144067|NCT01521559|17768484|P2|Overall Study|Death|0
5144068|NCT01521559|17768485|P1|Overall Study|Death|1
5144069|NCT01521559|17768484|P2|Overall Study|Adverse Event|4
5144070|NCT01521559|17768485|P1|Overall Study|Adverse Event|0
5144071|NCT01521507|17768508|P2|Stage 2: Observational Design|Physician Decision|0
5144072|NCT01521507|17768509|P1|Stage 2: Observational Design|Physician Decision|1
5144073|NCT01521507|17768508|P2|Stage 2: Observational Design|Withdrawal by Subject|1
5144074|NCT01521507|17768509|P1|Stage 2: Observational Design|Withdrawal by Subject|3
5144075|NCT01521507|17768508|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
5144076|NCT01521507|17768509|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
5144077|NCT01521507|17768508|P2|Stage 1: Randomized Design|Lost to Follow-up|2
5144078|NCT01521507|17768509|P1|Stage 1: Randomized Design|Lost to Follow-up|0
5144079|NCT01521507|17768508|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
5144080|NCT01521507|17768509|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
5144081|NCT01521507|17768508|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
5144082|NCT01521507|17768509|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
5144083|NCT01521494|17768531|P5|Overall Study|Physician Decision|2
5144084|NCT01521494|17768532|P4|Overall Study|Physician Decision|0
5144085|NCT01521494|17768533|P3|Overall Study|Physician Decision|0
5144086|NCT01521494|17768534|P2|Overall Study|Physician Decision|0
5144087|NCT01521494|17768535|P1|Overall Study|Physician Decision|0
5144088|NCT01521494|17768531|P5|Overall Study|Decrease in serum calcium|1
5144089|NCT01521494|17768532|P4|Overall Study|Decrease in serum calcium|1
5144090|NCT01521494|17768533|P3|Overall Study|Decrease in serum calcium|0
5144091|NCT01521494|17768534|P2|Overall Study|Decrease in serum calcium|0
5144092|NCT01521494|17768535|P1|Overall Study|Decrease in serum calcium|0
5144093|NCT01521494|17768531|P5|Overall Study|Decrease in serum phosphate|0
5144094|NCT01521494|17768532|P4|Overall Study|Decrease in serum phosphate|12
5144095|NCT01521494|17768533|P3|Overall Study|Decrease in serum phosphate|3
5144096|NCT01521494|17768534|P2|Overall Study|Decrease in serum phosphate|2
5144097|NCT01521494|17768535|P1|Overall Study|Decrease in serum phosphate|0
5144098|NCT01521494|17768531|P5|Overall Study|Withdrawal by Subject|0
5144099|NCT01521494|17768532|P4|Overall Study|Withdrawal by Subject|2
5144100|NCT01521494|17768533|P3|Overall Study|Withdrawal by Subject|0
5144101|NCT01521494|17768534|P2|Overall Study|Withdrawal by Subject|1
5144102|NCT01521494|17768535|P1|Overall Study|Withdrawal by Subject|1
5144103|NCT01521494|17768531|P5|Overall Study|Lack of Efficacy|2
5144104|NCT01521494|17768532|P4|Overall Study|Lack of Efficacy|0
5144105|NCT01521494|17768533|P3|Overall Study|Lack of Efficacy|0
5144106|NCT01521494|17768534|P2|Overall Study|Lack of Efficacy|0
5144107|NCT01521494|17768535|P1|Overall Study|Lack of Efficacy|0
5144108|NCT01521494|17768531|P5|Overall Study|Adverse Event|2
5144109|NCT01521494|17768532|P4|Overall Study|Adverse Event|6
5144110|NCT01521494|17768533|P3|Overall Study|Adverse Event|9
5144111|NCT01521494|17768534|P2|Overall Study|Adverse Event|2
5144112|NCT01521494|17768535|P1|Overall Study|Adverse Event|1
5144113|NCT01521364|17768557|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
5144114|NCT01521364|17768557|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
5144115|NCT01520987|17768633|P8|Overall Study|Withdrawal by Subject|0
5144116|NCT01520987|17768634|P7|Overall Study|Withdrawal by Subject|0
5144117|NCT01520987|17768635|P6|Overall Study|Withdrawal by Subject|1
5144118|NCT01520987|17768636|P5|Overall Study|Withdrawal by Subject|0
5144119|NCT01520987|17768637|P4|Overall Study|Withdrawal by Subject|0
5144120|NCT01520987|17768638|P3|Overall Study|Withdrawal by Subject|0
5144121|NCT01520987|17768639|P2|Overall Study|Withdrawal by Subject|0
5144122|NCT01520987|17768640|P1|Overall Study|Withdrawal by Subject|1
5144123|NCT01520922|17768700|P2|Survival Follow-up|Withdrawal by Subject|0
5144124|NCT01520922|17768701|P1|Survival Follow-up|Withdrawal by Subject|1
5144125|NCT01520922|17768700|P2|Follow up|Lost to Follow-up|1
5144126|NCT01520922|17768701|P1|Follow up|Lost to Follow-up|0
5144127|NCT01520922|17768700|P2|Treatment Phase|Adverse Event|5
5144128|NCT01520922|17768701|P1|Treatment Phase|Adverse Event|3
5144129|NCT01520922|17768700|P2|Treatment Phase|Progression|2
5144130|NCT01520922|17768701|P1|Treatment Phase|Progression|0
5144131|NCT01520922|17768700|P2|Treatment Phase|Physician Decision|1
5144132|NCT01520922|17768701|P1|Treatment Phase|Physician Decision|2
5144133|NCT01520909|17768763|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
5144134|NCT01520909|17768764|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
5144135|NCT01520909|17768765|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
5144136|NCT01520909|17768763|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
5144137|NCT01520909|17768764|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
5144138|NCT01520909|17768765|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
5144139|NCT01520909|17768763|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
5144140|NCT01520909|17768764|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
5144141|NCT01520909|17768765|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
5144142|NCT01520909|17768763|P3|Part 1 (Randomized Period)|Adverse Event|0
5144143|NCT01520909|17768764|P2|Part 1 (Randomized Period)|Adverse Event|2
5144144|NCT01520909|17768765|P1|Part 1 (Randomized Period)|Adverse Event|1
5144145|NCT01520714|17768882|P2|Overall Study|Lack of Efficacy|1
5144146|NCT01520714|17768883|P1|Overall Study|Lack of Efficacy|0
5144147|NCT01520714|17768882|P2|Overall Study|Adverse Event|2
5144148|NCT01520714|17768883|P1|Overall Study|Adverse Event|0
5144149|NCT01520714|17768882|P2|Overall Study|Protocol Violation|3
5144150|NCT01520714|17768883|P1|Overall Study|Protocol Violation|0
5144151|NCT01520506|17768928|P1|Overall Study|Withdrawal by Subject|1
5144152|NCT01520506|17768928|P1|Overall Study|Lost to Follow-up|1
5144153|NCT01520506|17768928|P1|Overall Study|Missed Visit|4
5144154|NCT01520402|17768983|P1|Overall Study|Physician Decision|3
5144155|NCT01520402|17768983|P1|Overall Study|Withdrawal by Subject|2
5144156|NCT01520363|17768996|P2|Overall Study|Withdrawal by Subject|0
5144157|NCT01520363|17768997|P1|Overall Study|Withdrawal by Subject|2
5144158|NCT01520324|17769071|P1|Overall Study|Subject discontinued (moderate illness)|1
5144159|NCT01519960|17769100|P3|Overall Study|Lost to Follow-up|0
5144160|NCT01519960|17769101|P2|Overall Study|Lost to Follow-up|1
5144161|NCT01519960|17769102|P1|Overall Study|Lost to Follow-up|0
5144162|NCT01519960|17769100|P3|Overall Study|Withdrawal by Subject|0
5144163|NCT01519960|17769101|P2|Overall Study|Withdrawal by Subject|4
5144164|NCT01519960|17769102|P1|Overall Study|Withdrawal by Subject|0
5144165|NCT01519960|17769100|P3|Overall Study|Adverse Event|0
5144166|NCT01519960|17769101|P2|Overall Study|Adverse Event|1
5144167|NCT01519960|17769102|P1|Overall Study|Adverse Event|0
5144168|NCT01519960|17769100|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
5144169|NCT01519960|17769101|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
5144170|NCT01519960|17769102|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
5144171|NCT01519960|17769100|P3|Overall Study|Ongoing in Follow-Up|10
5144172|NCT01519960|17769101|P2|Overall Study|Ongoing in Follow-Up|11
5144173|NCT01519960|17769102|P1|Overall Study|Ongoing in Follow-Up|101
5144174|NCT01519947|17769212|P4|Overall Study|Adverse Event|1
5144175|NCT01519947|17769213|P3|Overall Study|Adverse Event|1
5144176|NCT01519947|17769214|P2|Overall Study|Adverse Event|0
5144177|NCT01519947|17769215|P1|Overall Study|Adverse Event|1
5144178|NCT01519947|17769212|P4|Overall Study|Poor Response|1
5144179|NCT01519947|17769213|P3|Overall Study|Poor Response|0
5144180|NCT01519947|17769214|P2|Overall Study|Poor Response|0
5144181|NCT01519947|17769215|P1|Overall Study|Poor Response|1
5144182|NCT01519947|17769212|P4|Overall Study|Lost to Follow-up|2
5144183|NCT01519947|17769213|P3|Overall Study|Lost to Follow-up|3
5144184|NCT01519947|17769214|P2|Overall Study|Lost to Follow-up|0
5144185|NCT01519947|17769215|P1|Overall Study|Lost to Follow-up|0
5144186|NCT01519947|17769212|P4|Overall Study|Withdrawal by Subject|1
5144187|NCT01519947|17769213|P3|Overall Study|Withdrawal by Subject|0
5144188|NCT01519947|17769214|P2|Overall Study|Withdrawal by Subject|1
5144189|NCT01519947|17769215|P1|Overall Study|Withdrawal by Subject|0
5144190|NCT01519947|17769212|P4|Overall Study|Blood Transfusion|0
5144191|NCT01519947|17769213|P3|Overall Study|Blood Transfusion|1
5144192|NCT01519947|17769214|P2|Overall Study|Blood Transfusion|1
5144193|NCT01519947|17769215|P1|Overall Study|Blood Transfusion|0
5144194|NCT01519947|17769212|P4|Overall Study|Development of Anemia|1
5144195|NCT01519947|17769213|P3|Overall Study|Development of Anemia|0
5144196|NCT01519947|17769214|P2|Overall Study|Development of Anemia|1
5144197|NCT01519947|17769215|P1|Overall Study|Development of Anemia|0
5144198|NCT01519947|17769212|P4|Overall Study|Peritoneal Dialysis Needed|0
5144199|NCT01519947|17769213|P3|Overall Study|Peritoneal Dialysis Needed|0
5144200|NCT01519947|17769214|P2|Overall Study|Peritoneal Dialysis Needed|1
5144201|NCT01519947|17769215|P1|Overall Study|Peritoneal Dialysis Needed|0
5144202|NCT01519947|17769212|P4|Overall Study|Protocol Violation|1
5144203|NCT01519947|17769213|P3|Overall Study|Protocol Violation|2
5144204|NCT01519947|17769214|P2|Overall Study|Protocol Violation|0
5144205|NCT01519947|17769215|P1|Overall Study|Protocol Violation|0
5144206|NCT01519947|17769212|P4|Overall Study|Death|1
5144207|NCT01519947|17769213|P3|Overall Study|Death|0
5144208|NCT01519947|17769214|P2|Overall Study|Death|0
5144209|NCT01519947|17769215|P1|Overall Study|Death|0
5144210|NCT01519934|17769245|P1|Overall Study|Lost to Follow-up|3
5144211|NCT01519921|17769254|P2|Overall Study|High alanine aminotransferase (ALT)|1
5144212|NCT01519921|17769255|P1|Overall Study|High alanine aminotransferase (ALT)|0
5144213|NCT01519921|17769254|P2|Overall Study|Treatment refusal|1
5144214|NCT01519921|17769255|P1|Overall Study|Treatment refusal|2
5144215|NCT01519921|17769254|P2|Overall Study|Lost to Follow-up|1
5144216|NCT01519921|17769255|P1|Overall Study|Lost to Follow-up|2
5144217|NCT01519921|17769254|P2|Overall Study|Withdrawal by Subject|0
5144218|NCT01519921|17769255|P1|Overall Study|Withdrawal by Subject|3
5144219|NCT01519921|17769254|P2|Overall Study|Lack of Efficacy|3
5144220|NCT01519921|17769255|P1|Overall Study|Lack of Efficacy|4
5144221|NCT01519921|17769254|P2|Overall Study|Adverse Event|9
5144222|NCT01519921|17769255|P1|Overall Study|Adverse Event|10
5144223|NCT01519817|17769304|P4|Overall Study|Off study due to infection|1
5144224|NCT01519817|17769305|P3|Overall Study|Off study due to infection|0
5144225|NCT01519817|17769306|P2|Overall Study|Off study due to infection|0
5144226|NCT01519817|17769307|P1|Overall Study|Off study due to infection|0
5144227|NCT01519817|17769304|P4|Overall Study|Withdrawal by Subject|0
5144228|NCT01519817|17769305|P3|Overall Study|Withdrawal by Subject|0
5144229|NCT01519817|17769306|P2|Overall Study|Withdrawal by Subject|0
5144230|NCT01519817|17769307|P1|Overall Study|Withdrawal by Subject|1
5144231|NCT01519791|17769347|P2|Overall Study|Lost to Follow-up|14
5144232|NCT01519791|17769348|P1|Overall Study|Lost to Follow-up|6
5144233|NCT01519791|17769347|P2|Overall Study|Withdrawal by Subject|37
5144234|NCT01519791|17769348|P1|Overall Study|Withdrawal by Subject|15
5144235|NCT01519791|17769347|P2|Overall Study|AE, non-serious non-fatal|31
5144236|NCT01519791|17769348|P1|Overall Study|AE, non-serious non-fatal|12
5144237|NCT01519791|17769347|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
5144238|NCT01519791|17769348|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
5144239|NCT01519791|17769347|P2|Overall Study|AE, serious fatal|1
5144240|NCT01519791|17769348|P1|Overall Study|AE, serious fatal|0
5144241|NCT01519791|17769347|P2|Overall Study|SAE, non-fatal|22
5144242|NCT01519791|17769348|P1|Overall Study|SAE, non-fatal|6
5144243|NCT01519791|17769347|P2|Overall Study|Lack of Efficacy|20
5144244|NCT01519791|17769348|P1|Overall Study|Lack of Efficacy|16
5144245|NCT01519791|17769347|P2|Overall Study|subjects randomized in error|0
5144246|NCT01519791|17769348|P1|Overall Study|subjects randomized in error|2
5144247|NCT01519791|17769347|P2|Overall Study|Other Reason|222
5144248|NCT01519791|17769348|P1|Overall Study|Other Reason|87
5144249|NCT01519791|17769347|P2|Overall Study|Protocol Violation|19
5144250|NCT01519791|17769348|P1|Overall Study|Protocol Violation|6
5144251|NCT01519791|17769347|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
5144252|NCT01519791|17769348|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
5144253|NCT01519778|17769412|P1|Overall Study|Physician Decision|1
5144254|NCT01519778|17769412|P1|Overall Study|Lost to Follow-up|10
5144255|NCT01519778|17769412|P1|Overall Study|Withdrawal by Subject|3
5144256|NCT01519765|17769418|P2|Overall Study|Withdrawal by Subject|1
5144257|NCT01519765|17769419|P1|Overall Study|Withdrawal by Subject|0
5144258|NCT01519765|17769418|P2|Overall Study|Protocol Violation|0
5144259|NCT01519765|17769419|P1|Overall Study|Protocol Violation|1
5144260|NCT01519765|17769418|P2|Overall Study|Lack of Efficacy|0
5144261|NCT01519765|17769419|P1|Overall Study|Lack of Efficacy|2
5144262|NCT01519765|17769418|P2|Overall Study|Adverse Event|1
5144263|NCT01519765|17769419|P1|Overall Study|Adverse Event|0
5144264|NCT01519700|17769497|P4|Overall Study|Other Reason|4
5144265|NCT01519700|17769498|P3|Overall Study|Other Reason|0
5144266|NCT01519700|17769499|P2|Overall Study|Other Reason|2
5144267|NCT01519700|17769500|P1|Overall Study|Other Reason|2
5144268|NCT01519700|17769497|P4|Overall Study|Withdrawal by Subject|2
5144269|NCT01519700|17769498|P3|Overall Study|Withdrawal by Subject|3
5144270|NCT01519700|17769499|P2|Overall Study|Withdrawal by Subject|3
5144271|NCT01519700|17769500|P1|Overall Study|Withdrawal by Subject|5
5144272|NCT01519700|17769497|P4|Overall Study|Physician Decision|0
5144273|NCT01519700|17769498|P3|Overall Study|Physician Decision|3
5144274|NCT01519700|17769499|P2|Overall Study|Physician Decision|1
5144275|NCT01519700|17769500|P1|Overall Study|Physician Decision|1
5144276|NCT01519700|17769497|P4|Overall Study|Lost to Follow-up|1
5144277|NCT01519700|17769498|P3|Overall Study|Lost to Follow-up|1
5144278|NCT01519700|17769499|P2|Overall Study|Lost to Follow-up|0
5144279|NCT01519700|17769500|P1|Overall Study|Lost to Follow-up|0
5144280|NCT01519700|17769497|P4|Overall Study|Death|0
5144281|NCT01519700|17769498|P3|Overall Study|Death|0
5144282|NCT01519700|17769499|P2|Overall Study|Death|0
5144283|NCT01519700|17769500|P1|Overall Study|Death|1
5144284|NCT01519674|17769535|P3|Overall Study|Unsclassified|3
5144285|NCT01519674|17769536|P2|Overall Study|Unsclassified|4
5144286|NCT01519674|17769537|P1|Overall Study|Unsclassified|10
5144287|NCT01519674|17769535|P3|Overall Study|Withdrawal Criteria|7
5144288|NCT01519674|17769536|P2|Overall Study|Withdrawal Criteria|2
5144289|NCT01519674|17769537|P1|Overall Study|Withdrawal Criteria|7
5144290|NCT01519674|17769535|P3|Overall Study|Protocol Violation|1
5144291|NCT01519674|17769536|P2|Overall Study|Protocol Violation|3
5144292|NCT01519674|17769537|P1|Overall Study|Protocol Violation|0
5144293|NCT01519674|17769535|P3|Overall Study|Lack of Efficacy|1
5144294|NCT01519674|17769536|P2|Overall Study|Lack of Efficacy|1
5144295|NCT01519674|17769537|P1|Overall Study|Lack of Efficacy|1
5144296|NCT01519674|17769535|P3|Overall Study|Adverse Event|0
5144297|NCT01519674|17769536|P2|Overall Study|Adverse Event|3
5144298|NCT01519674|17769537|P1|Overall Study|Adverse Event|3
5144299|NCT01519661|17769575|P1|Overall Study|Adverse Event|29
5144300|NCT01519661|17769575|P1|Overall Study|Lack of Efficacy|6
5144301|NCT01519661|17769575|P1|Overall Study|Withdrawal by Subject|17
5144302|NCT01519661|17769575|P1|Overall Study|Lost to Follow-up|3
5144303|NCT01519661|17769575|P1|Overall Study|Protocol deviation|6
5144304|NCT01519635|17769601|P2|Overall Study|No possibility to put a catheter|2
5144305|NCT01519635|17769602|P1|Overall Study|No possibility to put a catheter|1
5144306|NCT01519635|17769601|P2|Overall Study|Withdrawal by Subject|1
5144307|NCT01519635|17769602|P1|Overall Study|Withdrawal by Subject|0
5144308|NCT01519518|17769619|P2|Overall Study|Consent not available|10
5144309|NCT01519518|17769620|P1|Overall Study|Consent not available|7
5144310|NCT01519427|17769645|P1|Overall Study|disease progression|2
5144311|NCT01519323|17769677|P2|Overall Study|Study terminated by sponsor|1
5144312|NCT01519323|17769678|P1|Overall Study|Study terminated by sponsor|0
5144313|NCT01519323|17769677|P2|Overall Study|Death|2
5144314|NCT01519323|17769678|P1|Overall Study|Death|3
5144315|NCT01519245|17769738|P2|Overall Study|Met exclusion criteria, not analysed|2
5144316|NCT01519245|17769739|P1|Overall Study|Met exclusion criteria, not analysed|1
5144317|NCT01519206|17769751|P1|Overall Study|Missed Visit|2
5144318|NCT01519206|17769751|P1|Overall Study|Lost to Follow-up|3
5144319|NCT01519167|17769765|P2|Overall Study|Physician Decision|1
5144320|NCT01519167|17769766|P1|Overall Study|Physician Decision|0
5144321|NCT01519167|17769765|P2|Overall Study|Medical condition changes&deep sedation|2
5144322|NCT01519167|17769766|P1|Overall Study|Medical condition changes&deep sedation|0
5144323|NCT01519167|17769765|P2|Overall Study|Lack of Efficacy|1
5144324|NCT01519167|17769766|P1|Overall Study|Lack of Efficacy|0
5144325|NCT01519167|17769765|P2|Overall Study|Adverse Event|1
5144326|NCT01519167|17769766|P1|Overall Study|Adverse Event|0
5144327|NCT01519167|17769765|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
5144328|NCT01519167|17769766|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
5144329|NCT01519089|17769792|P2|Overall Study|Not received study drug|1
5144330|NCT01519089|17769793|P1|Overall Study|Not received study drug|0
5144331|NCT01519089|17769792|P2|Overall Study|Other|6
5144332|NCT01519089|17769793|P1|Overall Study|Other|2
5144333|NCT01519089|17769792|P2|Overall Study|Withdrawal by Subject|2
5144334|NCT01519089|17769793|P1|Overall Study|Withdrawal by Subject|0
5144335|NCT01519089|17769792|P2|Overall Study|Lost to Follow-up|0
5144336|NCT01519089|17769793|P1|Overall Study|Lost to Follow-up|1
5144337|NCT01519089|17769792|P2|Overall Study|Lack of Efficacy|2
5144338|NCT01519089|17769793|P1|Overall Study|Lack of Efficacy|0
5144339|NCT01519089|17769792|P2|Overall Study|Adverse Event|4
5144340|NCT01519089|17769793|P1|Overall Study|Adverse Event|4
5144341|NCT01518972|17769935|P2|Overall Study|Declined medication starting on day 12|1
5144342|NCT01518972|17769936|P1|Overall Study|Declined medication starting on day 12|0
5144343|NCT01518972|17769935|P2|Overall Study|Exclusionary medication|1
5144344|NCT01518972|17769936|P1|Overall Study|Exclusionary medication|0
5144345|NCT01518972|17769935|P2|Overall Study|Missed safety visits|1
5144346|NCT01518972|17769936|P1|Overall Study|Missed safety visits|0
5144347|NCT01518972|17769935|P2|Overall Study|Exclusionary medical condition|0
5144348|NCT01518972|17769936|P1|Overall Study|Exclusionary medical condition|1
5144349|NCT01518972|17769935|P2|Overall Study|Transportation problems|0
5144350|NCT01518972|17769936|P1|Overall Study|Transportation problems|1
5144351|NCT01518972|17769935|P2|Overall Study|Moved from area|0
5144352|NCT01518972|17769936|P1|Overall Study|Moved from area|1
5144353|NCT01518972|17769935|P2|Overall Study|Withdrawal by Subject|0
5144354|NCT01518972|17769936|P1|Overall Study|Withdrawal by Subject|1
5144355|NCT01518972|17769935|P2|Overall Study|Lost to Follow-up|1
5144356|NCT01518972|17769936|P1|Overall Study|Lost to Follow-up|2
5144357|NCT01518946|17769950|P3|Randomized Phase (First Intervention)|Other|0
5144358|NCT01518946|17769951|P2|Randomized Phase (First Intervention)|Other|1
5144359|NCT01518946|17769952|P1|Randomized Phase (First Intervention)|Other|0
5144360|NCT01518946|17769950|P3|Open-label Phase|Other|0
5144361|NCT01518946|17769951|P2|Open-label Phase|Other|0
5144362|NCT01518946|17769952|P1|Open-label Phase|Other|4
5144363|NCT01518374|17769972|P1|Overall Study|Lost to Follow-up|2
5144364|NCT01518374|17769972|P1|Overall Study|Protocol Violation|3
5144365|NCT01518374|17769972|P1|Overall Study|Withdrawal by Subject|2
5144366|NCT01518322|17769976|P1|Overall Study|FeNO measurement was missing|13
5144367|NCT01518309|17769989|P1|Overall Study|Not in Predefined Categories|9
5144368|NCT01518309|17769989|P1|Overall Study|Sponsor Decision|2
5144369|NCT01518309|17769989|P1|Overall Study|Physician Decision|3
5144370|NCT01518309|17769989|P1|Overall Study|Withdrawal by Subject|6
5144371|NCT01518309|17769989|P1|Overall Study|Lack of Efficacy|7
5144372|NCT01518309|17769989|P1|Overall Study|Death|6
5144373|NCT01518309|17769989|P1|Overall Study|Adverse Event|6
5144374|NCT01518257|17770001|P2|Overall Study|Other Miscellaneous Reason|0
5144375|NCT01518257|17770002|P1|Overall Study|Other Miscellaneous Reason|1
5144376|NCT01518257|17770001|P2|Overall Study|Lost to Follow-up|0
5144377|NCT01518257|17770002|P1|Overall Study|Lost to Follow-up|1
5144378|NCT01518244|17770024|P1|Overall Study|Adverse Event|3
5144379|NCT01518192|17770032|P3|Overall Study|Lost to Follow-up|35
5144380|NCT01518192|17770033|P2|Overall Study|Lost to Follow-up|26
5144381|NCT01518192|17770034|P1|Overall Study|Lost to Follow-up|29
5144382|NCT01518153|17770055|P3|Donor Lymphocyte Infusion|Death|1
5144383|NCT01518153|17770056|P2|Donor Lymphocyte Infusion|Death|2
5144384|NCT01518153|17770057|P1|Donor Lymphocyte Infusion|Death|0
5144385|NCT01518153|17770055|P3|Stem Cell Transplant|Adverse Event|0
5144386|NCT01518153|17770056|P2|Stem Cell Transplant|Adverse Event|0
5144387|NCT01518153|17770057|P1|Stem Cell Transplant|Adverse Event|1
5144388|NCT01518153|17770055|P3|Stem Cell Transplant|Secondary graft failure|0
5144389|NCT01518153|17770056|P2|Stem Cell Transplant|Secondary graft failure|0
5144390|NCT01518153|17770057|P1|Stem Cell Transplant|Secondary graft failure|1
5144391|NCT01518153|17770055|P3|Stem Cell Transplant|Death|0
5144392|NCT01518153|17770056|P2|Stem Cell Transplant|Death|0
5144393|NCT01518153|17770057|P1|Stem Cell Transplant|Death|2
5144394|NCT01518153|17770055|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
5144395|NCT01518153|17770056|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
5144396|NCT01518153|17770057|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
5144397|NCT01517984|17770068|P4|Overall Study|Ineligible for randomization|0
5144398|NCT01517984|17770069|P3|Overall Study|Ineligible for randomization|0
5144399|NCT01517984|17770070|P2|Overall Study|Ineligible for randomization|14
5144400|NCT01517984|17770071|P1|Overall Study|Ineligible for randomization|0
5144401|NCT01517984|17770068|P4|Overall Study|Screen Failure|0
5144402|NCT01517984|17770069|P3|Overall Study|Screen Failure|0
5144403|NCT01517984|17770070|P2|Overall Study|Screen Failure|0
5144404|NCT01517984|17770071|P1|Overall Study|Screen Failure|4
5144405|NCT01517984|17770068|P4|Overall Study|Withdrawal by Subject|1
5144406|NCT01517984|17770069|P3|Overall Study|Withdrawal by Subject|4
5144407|NCT01517984|17770070|P2|Overall Study|Withdrawal by Subject|8
5144408|NCT01517984|17770071|P1|Overall Study|Withdrawal by Subject|1
5144409|NCT01517984|17770068|P4|Overall Study|Lost to Follow-up|0
5144410|NCT01517984|17770069|P3|Overall Study|Lost to Follow-up|0
5144411|NCT01517984|17770070|P2|Overall Study|Lost to Follow-up|1
5144412|NCT01517984|17770071|P1|Overall Study|Lost to Follow-up|0
5144413|NCT01517893|17770097|P2|Overall Study|Withdrawal by Subject|0
5144414|NCT01517893|17770098|P1|Overall Study|Withdrawal by Subject|3
5144415|NCT01517867|17770120|P2|Overall Study|Still in treatment at study end|3
5144416|NCT01517867|17770121|P1|Overall Study|Still in treatment at study end|0
5144417|NCT01517867|17770120|P2|Overall Study|Withdrawal by Subject|30
5144418|NCT01517867|17770121|P1|Overall Study|Withdrawal by Subject|34
5144419|NCT01517867|17770120|P2|Overall Study|never started treatment|32
5144420|NCT01517867|17770121|P1|Overall Study|never started treatment|29
5144421|NCT01517750|17770149|P4|Overall Study|Lost to Follow-up|1
5144422|NCT01517750|17770150|P3|Overall Study|Lost to Follow-up|4
5144423|NCT01517750|17770151|P2|Overall Study|Lost to Follow-up|2
5144424|NCT01517750|17770152|P1|Overall Study|Lost to Follow-up|1
5144425|NCT01517412|17770196|P2|Overall Study|Other than specified above|5
5144426|NCT01517412|17770197|P1|Overall Study|Other than specified above|8
5144427|NCT01517412|17770196|P2|Overall Study|Poor compliance to protocol|3
5144428|NCT01517412|17770197|P1|Overall Study|Poor compliance to protocol|8
5144429|NCT01517412|17770196|P2|Overall Study|Lack of Efficacy|5
5144430|NCT01517412|17770197|P1|Overall Study|Lack of Efficacy|10
5144431|NCT01517412|17770196|P2|Overall Study|Adverse Event|11
5144432|NCT01517412|17770197|P1|Overall Study|Adverse Event|10
5144433|NCT01517373|17770226|P6|Treatment Period|Medication error without AEs|2
5144434|NCT01517373|17770227|P5|Treatment Period|Medication error without AEs|0
5144435|NCT01517373|17770228|P4|Treatment Period|Medication error without AEs|1
5144436|NCT01517373|17770229|P3|Treatment Period|Medication error without AEs|2
5144437|NCT01517373|17770230|P2|Treatment Period|Medication error without AEs|0
5144438|NCT01517373|17770231|P1|Treatment Period|Medication error without AEs|0
5144439|NCT01517373|17770226|P6|Treatment Period|Lack of Efficacy|0
5144440|NCT01517373|17770227|P5|Treatment Period|Lack of Efficacy|2
5144441|NCT01517373|17770228|P4|Treatment Period|Lack of Efficacy|3
5144442|NCT01517373|17770229|P3|Treatment Period|Lack of Efficacy|1
5144443|NCT01517373|17770230|P2|Treatment Period|Lack of Efficacy|1
5144444|NCT01517373|17770231|P1|Treatment Period|Lack of Efficacy|0
5144445|NCT01517373|17770226|P6|Treatment Period|Protocol Violation|0
5144446|NCT01517373|17770227|P5|Treatment Period|Protocol Violation|1
5144447|NCT01517373|17770228|P4|Treatment Period|Protocol Violation|0
5144448|NCT01517373|17770229|P3|Treatment Period|Protocol Violation|0
5144449|NCT01517373|17770230|P2|Treatment Period|Protocol Violation|0
5144450|NCT01517373|17770231|P1|Treatment Period|Protocol Violation|0
5144451|NCT01517373|17770226|P6|Treatment Period|Other|0
5144452|NCT01517373|17770227|P5|Treatment Period|Other|1
5144453|NCT01517373|17770228|P4|Treatment Period|Other|0
5144454|NCT01517373|17770229|P3|Treatment Period|Other|0
5144455|NCT01517373|17770230|P2|Treatment Period|Other|0
5144456|NCT01517373|17770231|P1|Treatment Period|Other|0
5144457|NCT01517373|17770226|P6|Treatment Period|Withdrawal by Subject|3
5144458|NCT01517373|17770227|P5|Treatment Period|Withdrawal by Subject|2
5144459|NCT01517373|17770228|P4|Treatment Period|Withdrawal by Subject|2
5144460|NCT01517373|17770229|P3|Treatment Period|Withdrawal by Subject|2
5144461|NCT01517373|17770230|P2|Treatment Period|Withdrawal by Subject|3
5144462|NCT01517373|17770231|P1|Treatment Period|Withdrawal by Subject|0
5144463|NCT01517373|17770226|P6|Treatment Period|Lost to Follow-up|0
5144464|NCT01517373|17770227|P5|Treatment Period|Lost to Follow-up|0
5144465|NCT01517373|17770228|P4|Treatment Period|Lost to Follow-up|1
5144466|NCT01517373|17770229|P3|Treatment Period|Lost to Follow-up|1
5144467|NCT01517373|17770230|P2|Treatment Period|Lost to Follow-up|0
5144468|NCT01517373|17770231|P1|Treatment Period|Lost to Follow-up|0
5144469|NCT01517373|17770226|P6|Treatment Period|Adverse Event|2
5144470|NCT01517373|17770227|P5|Treatment Period|Adverse Event|0
5144471|NCT01517373|17770228|P4|Treatment Period|Adverse Event|0
5144472|NCT01517373|17770229|P3|Treatment Period|Adverse Event|0
5144473|NCT01517373|17770230|P2|Treatment Period|Adverse Event|0
5144474|NCT01517373|17770231|P1|Treatment Period|Adverse Event|0
5144475|NCT01517373|17770226|P6|Run-in Period|Other|0
5144476|NCT01517373|17770227|P5|Run-in Period|Other|0
5144477|NCT01517373|17770228|P4|Run-in Period|Other|0
5144478|NCT01517373|17770229|P3|Run-in Period|Other|0
5144479|NCT01517373|17770230|P2|Run-in Period|Other|0
5144480|NCT01517373|17770231|P1|Run-in Period|Other|1
5144481|NCT01517373|17770226|P6|Run-in Period|Sponsor Decision|0
5144482|NCT01517373|17770227|P5|Run-in Period|Sponsor Decision|0
5144483|NCT01517373|17770228|P4|Run-in Period|Sponsor Decision|0
5144484|NCT01517373|17770229|P3|Run-in Period|Sponsor Decision|0
5144485|NCT01517373|17770230|P2|Run-in Period|Sponsor Decision|0
5144486|NCT01517373|17770231|P1|Run-in Period|Sponsor Decision|3
5144487|NCT01517373|17770226|P6|Run-in Period|Withdrawal by Subject|0
5144488|NCT01517373|17770227|P5|Run-in Period|Withdrawal by Subject|0
5144489|NCT01517373|17770228|P4|Run-in Period|Withdrawal by Subject|0
5144490|NCT01517373|17770229|P3|Run-in Period|Withdrawal by Subject|0
5144491|NCT01517373|17770230|P2|Run-in Period|Withdrawal by Subject|0
5144492|NCT01517373|17770231|P1|Run-in Period|Withdrawal by Subject|12
5144493|NCT01517373|17770226|P6|Run-in Period|Lost to Follow-up|0
5144494|NCT01517373|17770227|P5|Run-in Period|Lost to Follow-up|0
5144495|NCT01517373|17770228|P4|Run-in Period|Lost to Follow-up|0
5144496|NCT01517373|17770229|P3|Run-in Period|Lost to Follow-up|0
5144497|NCT01517373|17770230|P2|Run-in Period|Lost to Follow-up|0
5144498|NCT01517373|17770231|P1|Run-in Period|Lost to Follow-up|1
5144499|NCT01517373|17770226|P6|Run-in Period|Did not meet eligibility criteria|0
5144500|NCT01517373|17770227|P5|Run-in Period|Did not meet eligibility criteria|0
5144501|NCT01517373|17770228|P4|Run-in Period|Did not meet eligibility criteria|0
5144502|NCT01517373|17770229|P3|Run-in Period|Did not meet eligibility criteria|0
5144503|NCT01517373|17770230|P2|Run-in Period|Did not meet eligibility criteria|0
5144504|NCT01517373|17770231|P1|Run-in Period|Did not meet eligibility criteria|34
5144505|NCT01517373|17770226|P6|Run-in Period|Adverse Event|0
5144506|NCT01517373|17770227|P5|Run-in Period|Adverse Event|0
5144507|NCT01517373|17770228|P4|Run-in Period|Adverse Event|0
5144508|NCT01517373|17770229|P3|Run-in Period|Adverse Event|0
5144509|NCT01517373|17770230|P2|Run-in Period|Adverse Event|0
5144510|NCT01517373|17770231|P1|Run-in Period|Adverse Event|5
5144511|NCT01517373|17770226|P6|Run-in Period|Death|0
5144512|NCT01517373|17770227|P5|Run-in Period|Death|0
5144513|NCT01517373|17770228|P4|Run-in Period|Death|0
5144514|NCT01517373|17770229|P3|Run-in Period|Death|0
5144515|NCT01517373|17770230|P2|Run-in Period|Death|0
5144516|NCT01517373|17770231|P1|Run-in Period|Death|1
5144517|NCT01517295|17770301|P2|Overall Study|Physician Decision|0
5144518|NCT01517295|17770302|P1|Overall Study|Physician Decision|1
5144519|NCT01517282|17770316|P4|Overall Study|Physician Decision|0
5144520|NCT01517282|17770317|P3|Overall Study|Physician Decision|0
5144521|NCT01517282|17770318|P2|Overall Study|Physician Decision|0
5144522|NCT01517282|17770319|P1|Overall Study|Physician Decision|1
5144523|NCT01517282|17770316|P4|Overall Study|Consent withdrawn|1
5144524|NCT01517282|17770317|P3|Overall Study|Consent withdrawn|1
5144525|NCT01517282|17770318|P2|Overall Study|Consent withdrawn|1
5144526|NCT01517282|17770319|P1|Overall Study|Consent withdrawn|0
5144527|NCT01517178|17770353|P2|Period 2|E.g. study termination|2
5144528|NCT01517178|17770354|P1|Period 2|E.g. study termination|2
5144529|NCT01517178|17770353|P2|Period 2|Withdrawal by Subject|0
5144530|NCT01517178|17770354|P1|Period 2|Withdrawal by Subject|3
5144531|NCT01517178|17770353|P2|Period 2|Adverse Event|0
5144532|NCT01517178|17770354|P1|Period 2|Adverse Event|1
5144533|NCT01517178|17770353|P2|Period 1|Withdrawal by Subject|1
5144534|NCT01517178|17770354|P1|Period 1|Withdrawal by Subject|0
5144535|NCT01517178|17770353|P2|Period 1|E.g. study termination|1
5144536|NCT01517178|17770354|P1|Period 1|E.g. study termination|3
5144537|NCT01517178|17770353|P2|Period 1|Lack of Efficacy|1
5144538|NCT01517178|17770354|P1|Period 1|Lack of Efficacy|0
5144539|NCT01517178|17770353|P2|Period 1|Adverse Event|2
5144540|NCT01517178|17770354|P1|Period 1|Adverse Event|1
5144541|NCT01516970|17770382|P2|Overall Study|Other|7
5144542|NCT01516970|17770383|P1|Overall Study|Other|9
5144543|NCT01516970|17770382|P2|Overall Study|Withdrawal by Subject|1
5144544|NCT01516970|17770383|P1|Overall Study|Withdrawal by Subject|1
5144545|NCT01516970|17770382|P2|Overall Study|Adverse Event|5
5144546|NCT01516970|17770383|P1|Overall Study|Adverse Event|1
5144547|NCT01516970|17770382|P2|Overall Study|Lost to Follow-up|8
5144548|NCT01516970|17770383|P1|Overall Study|Lost to Follow-up|7
5144549|NCT01516892|17770422|P1|Overall Study|Missing|1
5144550|NCT01516892|17770422|P1|Overall Study|Other Miscellaneous Reasons|43
5144551|NCT01516892|17770422|P1|Overall Study|Protocol Violation|60
5144552|NCT01516892|17770422|P1|Overall Study|Subject Withdrew Consent|92
5144553|NCT01516892|17770422|P1|Overall Study|Lost to Follow-up|82
5144554|NCT01516892|17770422|P1|Overall Study|Pregnancy|5
5144555|NCT01516892|17770422|P1|Overall Study|Lack of Efficacy|35
5144556|NCT01516892|17770422|P1|Overall Study|Adverse Event|25
5144557|NCT01516879|17770430|P2|Overall Study|Other|10
5144558|NCT01516879|17770431|P1|Overall Study|Other|5
5144559|NCT01516879|17770430|P2|Overall Study|Lost to Follow-up|11
5144560|NCT01516879|17770431|P1|Overall Study|Lost to Follow-up|2
5144561|NCT01516879|17770430|P2|Overall Study|Death|2
5144562|NCT01516879|17770431|P1|Overall Study|Death|0
5144563|NCT01516879|17770430|P2|Overall Study|Withdrawal by Subject|11
5144564|NCT01516879|17770431|P1|Overall Study|Withdrawal by Subject|9
5144565|NCT01516749|17770465|P1|Follow-up Off Therapy|Lost to Follow-up|1
5144566|NCT01516749|17770465|P1|Active Therapy|Lost to Follow-up|1
5144567|NCT01516736|17770474|P2|Overall Study|Other (not specified)|1
5144568|NCT01516736|17770475|P1|Overall Study|Other (not specified)|0
5144569|NCT01516736|17770474|P2|Overall Study|Protocol Violation|1
5144570|NCT01516736|17770475|P1|Overall Study|Protocol Violation|0
5144571|NCT01516736|17770474|P2|Overall Study|Lack of Efficacy|0
5144572|NCT01516736|17770475|P1|Overall Study|Lack of Efficacy|1
5144573|NCT01516736|17770474|P2|Overall Study|Physician Decision|1
5144574|NCT01516736|17770475|P1|Overall Study|Physician Decision|2
5144575|NCT01516736|17770474|P2|Overall Study|Death|1
5144576|NCT01516736|17770475|P1|Overall Study|Death|3
5144577|NCT01516736|17770474|P2|Overall Study|Adverse Event|5
5144578|NCT01516736|17770475|P1|Overall Study|Adverse Event|4
5144579|NCT01516736|17770474|P2|Overall Study|Withdrawal by Subject|4
5144580|NCT01516736|17770475|P1|Overall Study|Withdrawal by Subject|10
5144581|NCT01516437|17770529|P4|Overall Study|Reason not specified|1
5144582|NCT01516437|17770530|P3|Overall Study|Reason not specified|1
5144583|NCT01516437|17770531|P2|Overall Study|Reason not specified|0
5144584|NCT01516437|17770532|P1|Overall Study|Reason not specified|0
5144585|NCT01516034|17770604|P1|Overall Study|Lack of Efficacy|7
5144586|NCT01516034|17770604|P1|Overall Study|Physician Decision|1
5144587|NCT01516008|17770611|P3|Overall Study|Reason not specified|1
5144588|NCT01516008|17770612|P2|Overall Study|Reason not specified|0
5144589|NCT01516008|17770613|P1|Overall Study|Reason not specified|0
5144590|NCT01516008|17770611|P3|Overall Study|Protocol Violation|0
5144591|NCT01516008|17770612|P2|Overall Study|Protocol Violation|0
5144592|NCT01516008|17770613|P1|Overall Study|Protocol Violation|1
5144593|NCT01516008|17770611|P3|Overall Study|Lack of Efficacy|10
5144594|NCT01516008|17770612|P2|Overall Study|Lack of Efficacy|14
5144595|NCT01516008|17770613|P1|Overall Study|Lack of Efficacy|44
5144596|NCT01516008|17770611|P3|Overall Study|Adverse Event|7
5144597|NCT01516008|17770612|P2|Overall Study|Adverse Event|2
5144598|NCT01516008|17770613|P1|Overall Study|Adverse Event|0
5144599|NCT01515865|17770718|P3|Part B (Open-label)|Other|0
5144600|NCT01515865|17770719|P2|Part B (Open-label)|Other|0
5144601|NCT01515865|17770720|P1|Part B (Open-label)|Other|1
5144602|NCT01515865|17770718|P3|Part B (Open-label)|Withdrawal by Subject|0
5144603|NCT01515865|17770719|P2|Part B (Open-label)|Withdrawal by Subject|0
5144604|NCT01515865|17770720|P1|Part B (Open-label)|Withdrawal by Subject|1
5144605|NCT01515865|17770718|P3|Part A (Open-label)|Other|0
5144606|NCT01515865|17770719|P2|Part A (Open-label)|Other|0
5144607|NCT01515865|17770720|P1|Part A (Open-label)|Other|3
5144608|NCT01515748|17770730|P2|Overall Study|Ongoing|90
5144609|NCT01515748|17770731|P1|Overall Study|Ongoing|86
5144610|NCT01515748|17770730|P2|Overall Study|Lost to Follow-up|4
5144611|NCT01515748|17770731|P1|Overall Study|Lost to Follow-up|2
5144612|NCT01515748|17770730|P2|Overall Study|Withdrawal by Subject|41
5144613|NCT01515748|17770731|P1|Overall Study|Withdrawal by Subject|32
5144614|NCT01515475|17770814|P4|Overall Study|Lost to Follow-up|12
5144615|NCT01515475|17770815|P3|Overall Study|Lost to Follow-up|12
5144616|NCT01515475|17770816|P2|Overall Study|Lost to Follow-up|15
5144617|NCT01515475|17770817|P1|Overall Study|Lost to Follow-up|20
5144618|NCT01515423|17770891|P3|DOUBLE BLIND|Blind broken by investigator|0
5144619|NCT01515423|17770892|P2|DOUBLE BLIND|Blind broken by investigator|1
5144620|NCT01515423|17770893|P1|DOUBLE BLIND|Blind broken by investigator|0
5144621|NCT01515423|17770891|P3|DOUBLE BLIND|Other|12
5144622|NCT01515423|17770892|P2|DOUBLE BLIND|Other|6
5144623|NCT01515423|17770893|P1|DOUBLE BLIND|Other|0
5144624|NCT01515423|17770891|P3|DOUBLE BLIND|Withdrawal by Subject|53
5144625|NCT01515423|17770892|P2|DOUBLE BLIND|Withdrawal by Subject|50
5144626|NCT01515423|17770893|P1|DOUBLE BLIND|Withdrawal by Subject|0
5144627|NCT01515423|17770891|P3|DOUBLE BLIND|Pregnancy|0
5144628|NCT01515423|17770892|P2|DOUBLE BLIND|Pregnancy|2
5144629|NCT01515423|17770893|P1|DOUBLE BLIND|Pregnancy|0
5144630|NCT01515423|17770891|P3|DOUBLE BLIND|Lost to Follow-up|12
5144631|NCT01515423|17770892|P2|DOUBLE BLIND|Lost to Follow-up|7
5144632|NCT01515423|17770893|P1|DOUBLE BLIND|Lost to Follow-up|0
5144633|NCT01515423|17770891|P3|DOUBLE BLIND|Death|2
5144634|NCT01515423|17770892|P2|DOUBLE BLIND|Death|1
5144635|NCT01515423|17770893|P1|DOUBLE BLIND|Death|0
5144636|NCT01515423|17770891|P3|DOUBLE BLIND|Adverse Event|13
5144637|NCT01515423|17770892|P2|DOUBLE BLIND|Adverse Event|15
5144638|NCT01515423|17770893|P1|DOUBLE BLIND|Adverse Event|0
5144639|NCT01515423|17770891|P3|Open Label Phase|Other|0
5144640|NCT01515423|17770892|P2|Open Label Phase|Other|0
5144641|NCT01515423|17770893|P1|Open Label Phase|Other|28
5144642|NCT01515423|17770891|P3|Open Label Phase|excluded from DB Phase|0
5144643|NCT01515423|17770892|P2|Open Label Phase|excluded from DB Phase|0
5144644|NCT01515423|17770893|P1|Open Label Phase|excluded from DB Phase|70
5144645|NCT01515423|17770891|P3|Open Label Phase|Withdrawal by Subject|0
5144646|NCT01515423|17770892|P2|Open Label Phase|Withdrawal by Subject|0
5144647|NCT01515423|17770893|P1|Open Label Phase|Withdrawal by Subject|118
5144648|NCT01515423|17770891|P3|Open Label Phase|Lost to Follow-up|0
5144649|NCT01515423|17770892|P2|Open Label Phase|Lost to Follow-up|0
5144650|NCT01515423|17770893|P1|Open Label Phase|Lost to Follow-up|21
5144651|NCT01515423|17770891|P3|Open Label Phase|Lack of Efficacy|0
5144652|NCT01515423|17770892|P2|Open Label Phase|Lack of Efficacy|0
5144653|NCT01515423|17770893|P1|Open Label Phase|Lack of Efficacy|117
5144654|NCT01515423|17770891|P3|Open Label Phase|Death|0
5144655|NCT01515423|17770892|P2|Open Label Phase|Death|0
5144656|NCT01515423|17770893|P1|Open Label Phase|Death|2
5144657|NCT01515423|17770891|P3|Open Label Phase|Adverse Event|0
5144658|NCT01515423|17770892|P2|Open Label Phase|Adverse Event|0
5144659|NCT01515423|17770893|P1|Open Label Phase|Adverse Event|57
5144660|NCT01515306|17770934|P2|Overall Study|Ongoing receiving treatment|14
5144661|NCT01515306|17770935|P1|Overall Study|Ongoing receiving treatment|9
5144662|NCT01515306|17770934|P2|Overall Study|Progressive Disease|0
5144663|NCT01515306|17770935|P1|Overall Study|Progressive Disease|1
5144664|NCT01515306|17770934|P2|Overall Study|Adverse Event|0
5144665|NCT01515306|17770935|P1|Overall Study|Adverse Event|2
5144666|NCT01515189|17770948|P2|First Re-Induction Phase|Other|0
5144667|NCT01515189|17770949|P1|First Re-Induction Phase|Other|1
5144668|NCT01515189|17770948|P2|First Re-Induction Phase|No longer meets study criteria|0
5144669|NCT01515189|17770949|P1|First Re-Induction Phase|No longer meets study criteria|1
5144670|NCT01515189|17770948|P2|First Re-Induction Phase|Withdrawal by Subject|1
5144671|NCT01515189|17770949|P1|First Re-Induction Phase|Withdrawal by Subject|1
5144672|NCT01515189|17770948|P2|First Re-Induction Phase|Study drug toxicity|0
5144673|NCT01515189|17770949|P1|First Re-Induction Phase|Study drug toxicity|5
5144674|NCT01515189|17770948|P2|First Re-Induction Phase|Disease progression|14
5144675|NCT01515189|17770949|P1|First Re-Induction Phase|Disease progression|6
5144676|NCT01515189|17770948|P2|Induction|Other|4
5144677|NCT01515189|17770949|P1|Induction|Other|0
5144678|NCT01515189|17770948|P2|Induction|Lost to Follow-up|0
5144679|NCT01515189|17770949|P1|Induction|Lost to Follow-up|1
5144680|NCT01515189|17770948|P2|Induction|No longer meets study criteria|2
5144681|NCT01515189|17770949|P1|Induction|No longer meets study criteria|0
5144682|NCT01515189|17770948|P2|Induction|Withdrawal by Subject|9
5144683|NCT01515189|17770949|P1|Induction|Withdrawal by Subject|3
5144684|NCT01515189|17770948|P2|Induction|Adverse Event|9
5144685|NCT01515189|17770949|P1|Induction|Adverse Event|14
5144686|NCT01515189|17770948|P2|Induction|Death|17
5144687|NCT01515189|17770949|P1|Induction|Death|24
5144688|NCT01515189|17770948|P2|Induction|Study drug toxicity|36
5144689|NCT01515189|17770949|P1|Induction|Study drug toxicity|86
5144690|NCT01515189|17770948|P2|Induction|Disease Progression|155
5144691|NCT01515189|17770949|P1|Induction|Disease Progression|109
5144692|NCT01514864|17771037|P2|Overall Study|Study drug toxicity|0
5144693|NCT01514864|17771038|P1|Overall Study|Study drug toxicity|2
5144694|NCT01514864|17771037|P2|Overall Study|Disease progression|5
5144695|NCT01514864|17771038|P1|Overall Study|Disease progression|7
5144696|NCT01514760|17771063|P1|Overall Study|Lost to Follow-up|2
5144697|NCT01514682|17771076|P2|Overall Study|Physician Decision|3
5144698|NCT01514682|17771077|P1|Overall Study|Physician Decision|4
5144699|NCT01514682|17771076|P2|Overall Study|Withdrawal by Subject|3
5144700|NCT01514682|17771077|P1|Overall Study|Withdrawal by Subject|2
5144701|NCT01514461|17771111|P3|Overall Study|Death|0
5144702|NCT01514461|17771112|P2|Overall Study|Death|0
5144703|NCT01514461|17771113|P1|Overall Study|Death|1
5144704|NCT01514461|17771111|P3|Overall Study|Patient/guardian decision|1
5144705|NCT01514461|17771112|P2|Overall Study|Patient/guardian decision|1
5144706|NCT01514461|17771113|P1|Overall Study|Patient/guardian decision|1
5144707|NCT01514461|17771111|P3|Overall Study|Physician Decision|0
5144708|NCT01514461|17771112|P2|Overall Study|Physician Decision|1
5144709|NCT01514461|17771113|P1|Overall Study|Physician Decision|1
5144710|NCT01514461|17771111|P3|Overall Study|Adverse Event|3
5144711|NCT01514461|17771112|P2|Overall Study|Adverse Event|1
5144712|NCT01514461|17771113|P1|Overall Study|Adverse Event|2
5144713|NCT01514448|17771152|P2|Overall Study|New Cancer Therapy|0
5144714|NCT01514448|17771153|P1|Overall Study|New Cancer Therapy|1
5144715|NCT01514448|17771152|P2|Overall Study|Lost to Follow-up|0
5144716|NCT01514448|17771153|P1|Overall Study|Lost to Follow-up|2
5144717|NCT01514448|17771152|P2|Overall Study|Withdrawal by Subject|0
5144718|NCT01514448|17771153|P1|Overall Study|Withdrawal by Subject|2
5144719|NCT01514448|17771152|P2|Overall Study|Death|8
5144720|NCT01514448|17771153|P1|Overall Study|Death|7
5144721|NCT01514422|17771168|P1|Overall Study|Lost to Follow-up|1
5144722|NCT01514370|17771186|P2|Overall Study|Other|7
5144723|NCT01514370|17771187|P1|Overall Study|Other|6
5144724|NCT01514370|17771186|P2|Overall Study|Adverse Event|3
5144725|NCT01514370|17771187|P1|Overall Study|Adverse Event|1
5144726|NCT01514370|17771186|P2|Overall Study|Withdrawal by Subject|1
5144727|NCT01514370|17771187|P1|Overall Study|Withdrawal by Subject|2
5144728|NCT01514370|17771186|P2|Overall Study|Lost to Follow-up|2
5144729|NCT01514370|17771187|P1|Overall Study|Lost to Follow-up|0
5144730|NCT01514370|17771186|P2|Overall Study|Protocol Violation|3
5144731|NCT01514370|17771187|P1|Overall Study|Protocol Violation|2
5144732|NCT01514357|17771233|P2|Overall Study|Withdrawal by Subject|0
5144733|NCT01514357|17771234|P1|Overall Study|Withdrawal by Subject|2
5144734|NCT01514357|17771233|P2|Overall Study|Screen failure|0
5144735|NCT01514357|17771234|P1|Overall Study|Screen failure|2
5144736|NCT01514240|17771319|P2|Overall Study|Subject Decision|7
5144737|NCT01514240|17771320|P1|Overall Study|Subject Decision|2
5144738|NCT01514240|17771319|P2|Overall Study|Adverse Event|4
5144739|NCT01514240|17771320|P1|Overall Study|Adverse Event|4
5144740|NCT01514201|17771398|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
5144741|NCT01514201|17771399|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5144742|NCT01514201|17771400|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5144743|NCT01514201|17771401|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5144744|NCT01514201|17771398|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
5144745|NCT01514201|17771399|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5144746|NCT01514201|17771400|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5144747|NCT01514201|17771401|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5144748|NCT01514201|17771398|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
5144749|NCT01514201|17771399|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5144750|NCT01514201|17771400|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5144751|NCT01514201|17771401|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5144752|NCT01514201|17771398|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
5144753|NCT01514201|17771399|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5144754|NCT01514201|17771400|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5144755|NCT01514201|17771401|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5144756|NCT01514201|17771398|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
5144757|NCT01514201|17771399|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5144758|NCT01514201|17771400|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5144759|NCT01514201|17771401|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5144760|NCT01514201|17771398|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
5144761|NCT01514201|17771399|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
5144762|NCT01514201|17771400|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
5144763|NCT01514201|17771401|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
5144764|NCT01514201|17771398|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
5144765|NCT01514201|17771399|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5144766|NCT01514201|17771400|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5144767|NCT01514201|17771401|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5144768|NCT01514201|17771398|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
5144769|NCT01514201|17771399|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5144770|NCT01514201|17771400|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5144771|NCT01514201|17771401|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5144772|NCT01514201|17771398|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5144773|NCT01514201|17771399|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5144774|NCT01514201|17771400|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
5144775|NCT01514201|17771401|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
5144776|NCT01514201|17771398|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5144777|NCT01514201|17771399|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
5144778|NCT01514201|17771400|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
5144779|NCT01514201|17771401|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
5144780|NCT01514201|17771398|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
5144781|NCT01514201|17771399|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
5144782|NCT01514201|17771400|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
5144783|NCT01514201|17771401|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
5144784|NCT01514201|17771398|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5144785|NCT01514201|17771399|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5144786|NCT01514201|17771400|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5144787|NCT01514201|17771401|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
5144788|NCT01514136|17771499|P8|Test Period 2; Test C*|Protocol Violation|0
5144789|NCT01514136|17771500|P7|Test Period 2; Test C*|Protocol Violation|1
5144790|NCT01514136|17771501|P6|Test Period 2; Test C*|Protocol Violation|0
5144791|NCT01514136|17771502|P5|Test Period 2; Test C*|Protocol Violation|0
5144792|NCT01514136|17771503|P4|Test Period 2; Test C*|Protocol Violation|0
5144793|NCT01514136|17771504|P3|Test Period 2; Test C*|Protocol Violation|0
5144794|NCT01514136|17771505|P2|Test Period 2; Test C*|Protocol Violation|0
5144795|NCT01514136|17771506|P1|Test Period 2; Test C*|Protocol Violation|0
5144796|NCT01514136|17771499|P8|Test Period 2; Test C*|holiday|0
5144797|NCT01514136|17771500|P7|Test Period 2; Test C*|holiday|1
5144798|NCT01514136|17771501|P6|Test Period 2; Test C*|holiday|0
5144799|NCT01514136|17771502|P5|Test Period 2; Test C*|holiday|0
5144800|NCT01514136|17771503|P4|Test Period 2; Test C*|holiday|0
5144801|NCT01514136|17771504|P3|Test Period 2; Test C*|holiday|0
5144802|NCT01514136|17771505|P2|Test Period 2; Test C*|holiday|0
5144803|NCT01514136|17771506|P1|Test Period 2; Test C*|holiday|0
5144804|NCT01514136|17771499|P8|Test Period 2; Test C*|Withdrawal by Subject|0
5144805|NCT01514136|17771500|P7|Test Period 2; Test C*|Withdrawal by Subject|1
5144806|NCT01514136|17771501|P6|Test Period 2; Test C*|Withdrawal by Subject|0
5144807|NCT01514136|17771502|P5|Test Period 2; Test C*|Withdrawal by Subject|0
5144808|NCT01514136|17771503|P4|Test Period 2; Test C*|Withdrawal by Subject|0
5144809|NCT01514136|17771504|P3|Test Period 2; Test C*|Withdrawal by Subject|0
5144810|NCT01514136|17771505|P2|Test Period 2; Test C*|Withdrawal by Subject|0
5144811|NCT01514136|17771506|P1|Test Period 2; Test C*|Withdrawal by Subject|0
5144812|NCT01514136|17771499|P8|Test Period 2; Test B*|Withdrawal by Subject|0
5144813|NCT01514136|17771500|P7|Test Period 2; Test B*|Withdrawal by Subject|0
5144814|NCT01514136|17771501|P6|Test Period 2; Test B*|Withdrawal by Subject|2
5144815|NCT01514136|17771502|P5|Test Period 2; Test B*|Withdrawal by Subject|0
5144816|NCT01514136|17771503|P4|Test Period 2; Test B*|Withdrawal by Subject|0
5144817|NCT01514136|17771504|P3|Test Period 2; Test B*|Withdrawal by Subject|0
5144818|NCT01514136|17771505|P2|Test Period 2; Test B*|Withdrawal by Subject|0
5144819|NCT01514136|17771506|P1|Test Period 2; Test B*|Withdrawal by Subject|0
5144820|NCT01514136|17771499|P8|Test Period 2; Test A*|Holiday|0
5144821|NCT01514136|17771500|P7|Test Period 2; Test A*|Holiday|0
5144822|NCT01514136|17771501|P6|Test Period 2; Test A*|Holiday|0
5144823|NCT01514136|17771502|P5|Test Period 2; Test A*|Holiday|1
5144824|NCT01514136|17771503|P4|Test Period 2; Test A*|Holiday|0
5144825|NCT01514136|17771504|P3|Test Period 2; Test A*|Holiday|0
5144826|NCT01514136|17771505|P2|Test Period 2; Test A*|Holiday|0
5144827|NCT01514136|17771506|P1|Test Period 2; Test A*|Holiday|0
5144828|NCT01514136|17771499|P8|Test Period 2; Test A*|Adverse Event|0
5144829|NCT01514136|17771500|P7|Test Period 2; Test A*|Adverse Event|0
5144830|NCT01514136|17771501|P6|Test Period 2; Test A*|Adverse Event|0
5144831|NCT01514136|17771502|P5|Test Period 2; Test A*|Adverse Event|1
5144832|NCT01514136|17771503|P4|Test Period 2; Test A*|Adverse Event|0
5144833|NCT01514136|17771504|P3|Test Period 2; Test A*|Adverse Event|0
5144834|NCT01514136|17771505|P2|Test Period 2; Test A*|Adverse Event|0
5144835|NCT01514136|17771506|P1|Test Period 2; Test A*|Adverse Event|0
5144836|NCT01514136|17771499|P8|Test Period 1; Test D|Subject took a break due to holiday|0
5144837|NCT01514136|17771500|P7|Test Period 1; Test D|Subject took a break due to holiday|0
5144838|NCT01514136|17771501|P6|Test Period 1; Test D|Subject took a break due to holiday|0
5144839|NCT01514136|17771502|P5|Test Period 1; Test D|Subject took a break due to holiday|0
5144840|NCT01514136|17771503|P4|Test Period 1; Test D|Subject took a break due to holiday|2
5144841|NCT01514136|17771504|P3|Test Period 1; Test D|Subject took a break due to holiday|0
5144842|NCT01514136|17771505|P2|Test Period 1; Test D|Subject took a break due to holiday|0
5144843|NCT01514136|17771506|P1|Test Period 1; Test D|Subject took a break due to holiday|0
5144844|NCT01514136|17771499|P8|Test Period 1; Test B|Withdrawal by Subject|0
5144845|NCT01514136|17771500|P7|Test Period 1; Test B|Withdrawal by Subject|0
5144846|NCT01514136|17771501|P6|Test Period 1; Test B|Withdrawal by Subject|0
5144847|NCT01514136|17771502|P5|Test Period 1; Test B|Withdrawal by Subject|0
5144848|NCT01514136|17771503|P4|Test Period 1; Test B|Withdrawal by Subject|0
5144849|NCT01514136|17771504|P3|Test Period 1; Test B|Withdrawal by Subject|0
5144850|NCT01514136|17771505|P2|Test Period 1; Test B|Withdrawal by Subject|1
5144851|NCT01514136|17771506|P1|Test Period 1; Test B|Withdrawal by Subject|0
5144852|NCT01514136|17771499|P8|Test Period 1; Test A|Break from study holiday|0
5144853|NCT01514136|17771500|P7|Test Period 1; Test A|Break from study holiday|0
5144854|NCT01514136|17771501|P6|Test Period 1; Test A|Break from study holiday|0
5144855|NCT01514136|17771502|P5|Test Period 1; Test A|Break from study holiday|0
5144856|NCT01514136|17771503|P4|Test Period 1; Test A|Break from study holiday|0
5144857|NCT01514136|17771504|P3|Test Period 1; Test A|Break from study holiday|0
5144858|NCT01514136|17771505|P2|Test Period 1; Test A|Break from study holiday|0
5144859|NCT01514136|17771506|P1|Test Period 1; Test A|Break from study holiday|2
5144860|NCT01514136|17771499|P8|Test Period 1; Test A|Protocol Violation|0
5144861|NCT01514136|17771500|P7|Test Period 1; Test A|Protocol Violation|0
5144862|NCT01514136|17771501|P6|Test Period 1; Test A|Protocol Violation|0
5144863|NCT01514136|17771502|P5|Test Period 1; Test A|Protocol Violation|0
5144864|NCT01514136|17771503|P4|Test Period 1; Test A|Protocol Violation|0
5144865|NCT01514136|17771504|P3|Test Period 1; Test A|Protocol Violation|0
5144866|NCT01514136|17771505|P2|Test Period 1; Test A|Protocol Violation|0
5144867|NCT01514136|17771506|P1|Test Period 1; Test A|Protocol Violation|1
5144868|NCT01513967|17771540|P8|Overall Study|Physician Decision|0
5144869|NCT01513967|17771541|P7|Overall Study|Physician Decision|0
5144870|NCT01513967|17771542|P6|Overall Study|Physician Decision|1
5144871|NCT01513967|17771543|P5|Overall Study|Physician Decision|0
5144872|NCT01513967|17771544|P4|Overall Study|Physician Decision|0
5144873|NCT01513967|17771545|P3|Overall Study|Physician Decision|0
5144874|NCT01513967|17771546|P2|Overall Study|Physician Decision|0
5144875|NCT01513967|17771547|P1|Overall Study|Physician Decision|0
5144876|NCT01513967|17771540|P8|Overall Study|excluded due to positive drug screen|2
5144877|NCT01513967|17771541|P7|Overall Study|excluded due to positive drug screen|0
5144878|NCT01513967|17771542|P6|Overall Study|excluded due to positive drug screen|0
5144879|NCT01513967|17771543|P5|Overall Study|excluded due to positive drug screen|0
5144880|NCT01513967|17771544|P4|Overall Study|excluded due to positive drug screen|0
5144881|NCT01513967|17771545|P3|Overall Study|excluded due to positive drug screen|0
5144882|NCT01513967|17771546|P2|Overall Study|excluded due to positive drug screen|0
5144883|NCT01513967|17771547|P1|Overall Study|excluded due to positive drug screen|0
5144884|NCT01513967|17771540|P8|Overall Study|missed a study visit|0
5144885|NCT01513967|17771541|P7|Overall Study|missed a study visit|1
5144886|NCT01513967|17771542|P6|Overall Study|missed a study visit|0
5144887|NCT01513967|17771543|P5|Overall Study|missed a study visit|0
5144888|NCT01513967|17771544|P4|Overall Study|missed a study visit|0
5144889|NCT01513967|17771545|P3|Overall Study|missed a study visit|0
5144890|NCT01513967|17771546|P2|Overall Study|missed a study visit|0
5144891|NCT01513967|17771547|P1|Overall Study|missed a study visit|0
5144892|NCT01513967|17771540|P8|Overall Study|Pregnancy|0
5144893|NCT01513967|17771541|P7|Overall Study|Pregnancy|1
5144894|NCT01513967|17771542|P6|Overall Study|Pregnancy|0
5144895|NCT01513967|17771543|P5|Overall Study|Pregnancy|0
5144896|NCT01513967|17771544|P4|Overall Study|Pregnancy|0
5144897|NCT01513967|17771545|P3|Overall Study|Pregnancy|0
5144898|NCT01513967|17771546|P2|Overall Study|Pregnancy|0
5144899|NCT01513967|17771547|P1|Overall Study|Pregnancy|0
5144900|NCT01513759|17771605|P1|Overall Study|Death during catheter placement|1
5144901|NCT01513759|17771605|P1|Overall Study|Protocol Violation|4
5144902|NCT01513590|17771616|P2|Overall Study|Unclassified|10
5144903|NCT01513590|17771617|P1|Overall Study|Unclassified|5
5144904|NCT01513590|17771616|P2|Overall Study|Withdrawal Criteria|0
5144905|NCT01513590|17771617|P1|Overall Study|Withdrawal Criteria|3
5144906|NCT01513590|17771616|P2|Overall Study|Adverse Event|3
5144907|NCT01513590|17771617|P1|Overall Study|Adverse Event|2
5144908|NCT01513551|17771638|P3|Overall Study|Randomized but not vaccinated|1
5144909|NCT01513551|17771639|P2|Overall Study|Randomized but not vaccinated|0
5144910|NCT01513551|17771640|P1|Overall Study|Randomized but not vaccinated|0
5144911|NCT01513551|17771638|P3|Overall Study|Withdrawal by Subject|2
5144912|NCT01513551|17771639|P2|Overall Study|Withdrawal by Subject|0
5144913|NCT01513551|17771640|P1|Overall Study|Withdrawal by Subject|1
5144914|NCT01513551|17771638|P3|Overall Study|Lost to Follow-up|2
5144915|NCT01513551|17771639|P2|Overall Study|Lost to Follow-up|5
5144916|NCT01513551|17771640|P1|Overall Study|Lost to Follow-up|3
5144917|NCT01513551|17771638|P3|Overall Study|Death|0
5144918|NCT01513551|17771639|P2|Overall Study|Death|1
5144919|NCT01513551|17771640|P1|Overall Study|Death|0
5144920|NCT01513473|17771672|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
5144921|NCT01513473|17771673|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
5144922|NCT01513473|17771672|P2|Extension Trial (26 Weeks)|Adverse Event|1
5144923|NCT01513473|17771673|P1|Extension Trial (26 Weeks)|Adverse Event|0
5144924|NCT01513473|17771672|P2|Main Trial (26 Weeks)|Unclassified|2
5144925|NCT01513473|17771673|P1|Main Trial (26 Weeks)|Unclassified|0
5144926|NCT01513473|17771672|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
5144927|NCT01513473|17771673|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
5144928|NCT01513473|17771672|P2|Main Trial (26 Weeks)|Adverse Event|2
5144929|NCT01513473|17771673|P1|Main Trial (26 Weeks)|Adverse Event|0
5144930|NCT01513460|17771700|P3|Overall Study|Abnormal test procedure|0
5144931|NCT01513460|17771701|P2|Overall Study|Abnormal test procedure|0
5144932|NCT01513460|17771702|P1|Overall Study|Abnormal test procedure|1
5144933|NCT01513460|17771700|P3|Overall Study|Adverse Event|23
5144934|NCT01513460|17771701|P2|Overall Study|Adverse Event|18
5144935|NCT01513460|17771702|P1|Overall Study|Adverse Event|16
5144936|NCT01513460|17771700|P3|Overall Study|Withdrawal by Subject|21
5144937|NCT01513460|17771701|P2|Overall Study|Withdrawal by Subject|8
5144938|NCT01513460|17771702|P1|Overall Study|Withdrawal by Subject|7
5144939|NCT01513460|17771700|P3|Overall Study|Protocol deviations|3
5144940|NCT01513460|17771701|P2|Overall Study|Protocol deviations|4
5144941|NCT01513460|17771702|P1|Overall Study|Protocol deviations|3
5144942|NCT01513460|17771700|P3|Overall Study|Lack of Efficacy|5
5144943|NCT01513460|17771701|P2|Overall Study|Lack of Efficacy|2
5144944|NCT01513460|17771702|P1|Overall Study|Lack of Efficacy|1
5144945|NCT01513460|17771700|P3|Overall Study|Abnormal laboratory value|1
5144946|NCT01513460|17771701|P2|Overall Study|Abnormal laboratory value|0
5144947|NCT01513460|17771702|P1|Overall Study|Abnormal laboratory value|1
5144948|NCT01513460|17771700|P3|Overall Study|Lost to Follow-up|2
5144949|NCT01513460|17771701|P2|Overall Study|Lost to Follow-up|0
5144950|NCT01513460|17771702|P1|Overall Study|Lost to Follow-up|0
5144951|NCT01513460|17771700|P3|Overall Study|Death|1
5144952|NCT01513460|17771701|P2|Overall Study|Death|0
5144953|NCT01513460|17771702|P1|Overall Study|Death|0
5144954|NCT01513330|17771737|P2|Standard Care First,|Other|0
5144955|NCT01513330|17771738|P1|Standard Care First,|Other|1
5144956|NCT01513330|17771737|P2|Standard Care First,|Withdrawal by Subject|2
5144957|NCT01513330|17771738|P1|Standard Care First,|Withdrawal by Subject|1
5144958|NCT01513330|17771737|P2|Standard Care First,|Lack of Efficacy|2
5144959|NCT01513330|17771738|P1|Standard Care First,|Lack of Efficacy|2
5144960|NCT01513330|17771737|P2|SenSura Mio First,|Other|0
5144961|NCT01513330|17771738|P1|SenSura Mio First,|Other|1
5144962|NCT01513330|17771737|P2|SenSura Mio First,|Withdrawal by Subject|1
5144963|NCT01513330|17771738|P1|SenSura Mio First,|Withdrawal by Subject|1
5144964|NCT01513330|17771737|P2|SenSura Mio First,|Lack of Efficacy|1
5144965|NCT01513330|17771738|P1|SenSura Mio First,|Lack of Efficacy|0
5144966|NCT01513330|17771737|P2|SenSura Mio First,|Adverse Event|0
5144967|NCT01513330|17771738|P1|SenSura Mio First,|Adverse Event|2
5144968|NCT01513317|17771746|P2|Overall Study|Other|1
5144969|NCT01513317|17771747|P1|Overall Study|Other|0
5144970|NCT01513317|17771746|P2|Overall Study|Study terminated by sponsor|18
5144971|NCT01513317|17771747|P1|Overall Study|Study terminated by sponsor|18
5144972|NCT01513317|17771746|P2|Overall Study|Death|1
5144973|NCT01513317|17771747|P1|Overall Study|Death|1
5144974|NCT01513317|17771746|P2|Overall Study|Withdrawal by Subject|4
5144975|NCT01513317|17771747|P1|Overall Study|Withdrawal by Subject|15
5144976|NCT01513291|17771765|P5|Run-out Period|Withdrawal by Subject|0
5144977|NCT01513291|17771766|P4|Run-out Period|Withdrawal by Subject|1
5144978|NCT01513291|17771767|P3|Run-out Period|Withdrawal by Subject|0
5144979|NCT01513291|17771768|P2|Run-out Period|Withdrawal by Subject|0
5144980|NCT01513291|17771769|P1|Run-out Period|Withdrawal by Subject|0
5144981|NCT01513291|17771765|P5|Run-out Period|Lost to Follow-up|0
5144982|NCT01513291|17771766|P4|Run-out Period|Lost to Follow-up|1
5144983|NCT01513291|17771767|P3|Run-out Period|Lost to Follow-up|0
5144984|NCT01513291|17771768|P2|Run-out Period|Lost to Follow-up|0
5144985|NCT01513291|17771769|P1|Run-out Period|Lost to Follow-up|0
5144986|NCT01513291|17771765|P5|Treatment Period|Randomized not treated|0
5144987|NCT01513291|17771766|P4|Treatment Period|Randomized not treated|0
5144988|NCT01513291|17771767|P3|Treatment Period|Randomized not treated|0
5144989|NCT01513291|17771768|P2|Treatment Period|Randomized not treated|2
5144990|NCT01513291|17771769|P1|Treatment Period|Randomized not treated|0
5144991|NCT01513291|17771765|P5|Treatment Period|Withdrawal by Subject|0
5144992|NCT01513291|17771766|P4|Treatment Period|Withdrawal by Subject|0
5144993|NCT01513291|17771767|P3|Treatment Period|Withdrawal by Subject|0
5144994|NCT01513291|17771768|P2|Treatment Period|Withdrawal by Subject|5
5144995|NCT01513291|17771769|P1|Treatment Period|Withdrawal by Subject|8
5144996|NCT01513291|17771765|P5|Treatment Period|Protocol Violation|0
5144997|NCT01513291|17771766|P4|Treatment Period|Protocol Violation|0
5144998|NCT01513291|17771767|P3|Treatment Period|Protocol Violation|0
5144999|NCT01513291|17771768|P2|Treatment Period|Protocol Violation|2
5145000|NCT01513291|17771769|P1|Treatment Period|Protocol Violation|1
5145001|NCT01513291|17771765|P5|Treatment Period|Physician Decision|0
5145002|NCT01513291|17771766|P4|Treatment Period|Physician Decision|0
5145003|NCT01513291|17771767|P3|Treatment Period|Physician Decision|0
5145004|NCT01513291|17771768|P2|Treatment Period|Physician Decision|0
5145005|NCT01513291|17771769|P1|Treatment Period|Physician Decision|1
5145006|NCT01513291|17771765|P5|Treatment Period|Lost to Follow-up|0
5145007|NCT01513291|17771766|P4|Treatment Period|Lost to Follow-up|0
5145008|NCT01513291|17771767|P3|Treatment Period|Lost to Follow-up|0
5145009|NCT01513291|17771768|P2|Treatment Period|Lost to Follow-up|3
5145010|NCT01513291|17771769|P1|Treatment Period|Lost to Follow-up|2
5145011|NCT01513291|17771765|P5|Treatment Period|Lack of Efficacy|0
5145012|NCT01513291|17771766|P4|Treatment Period|Lack of Efficacy|0
5145013|NCT01513291|17771767|P3|Treatment Period|Lack of Efficacy|0
5145014|NCT01513291|17771768|P2|Treatment Period|Lack of Efficacy|0
5145015|NCT01513291|17771769|P1|Treatment Period|Lack of Efficacy|3
5145016|NCT01513291|17771765|P5|Treatment Period|Adverse Event|0
5145017|NCT01513291|17771766|P4|Treatment Period|Adverse Event|0
5145018|NCT01513291|17771767|P3|Treatment Period|Adverse Event|0
5145019|NCT01513291|17771768|P2|Treatment Period|Adverse Event|4
5145020|NCT01513291|17771769|P1|Treatment Period|Adverse Event|8
5145021|NCT01513239|17771797|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
5145022|NCT01513239|17771798|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
5145023|NCT01513239|17771799|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
5145024|NCT01513239|17771800|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
5145025|NCT01513239|17771801|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
5145026|NCT01513239|17771802|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
5145027|NCT01513239|17771797|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
5145028|NCT01513239|17771798|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
5145029|NCT01513239|17771799|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
5145030|NCT01513239|17771800|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
5145031|NCT01513239|17771801|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
5145032|NCT01513239|17771802|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
5145033|NCT01513239|17771797|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5145034|NCT01513239|17771798|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
5145035|NCT01513239|17771799|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
5145036|NCT01513239|17771800|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5145037|NCT01513239|17771801|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5145038|NCT01513239|17771802|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5145039|NCT01513239|17771797|P6|Period 2: 9 Month Extension Phase|Death|2
5145040|NCT01513239|17771798|P5|Period 2: 9 Month Extension Phase|Death|5
5145041|NCT01513239|17771799|P4|Period 2: 9 Month Extension Phase|Death|2
5145042|NCT01513239|17771800|P3|Period 2: 9 Month Extension Phase|Death|0
5145043|NCT01513239|17771801|P2|Period 2: 9 Month Extension Phase|Death|0
5145044|NCT01513239|17771802|P1|Period 2: 9 Month Extension Phase|Death|0
5145045|NCT01513239|17771797|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
5145046|NCT01513239|17771798|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
5145047|NCT01513239|17771799|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
5145048|NCT01513239|17771800|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5145049|NCT01513239|17771801|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5145050|NCT01513239|17771802|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5145051|NCT01513239|17771797|P6|Period 1: Main Phase|Withdrawal by Subject|0
5145052|NCT01513239|17771798|P5|Period 1: Main Phase|Withdrawal by Subject|0
5145053|NCT01513239|17771799|P4|Period 1: Main Phase|Withdrawal by Subject|0
5145054|NCT01513239|17771800|P3|Period 1: Main Phase|Withdrawal by Subject|42
5145055|NCT01513239|17771801|P2|Period 1: Main Phase|Withdrawal by Subject|29
5145056|NCT01513239|17771802|P1|Period 1: Main Phase|Withdrawal by Subject|27
5145057|NCT01513239|17771797|P6|Period 1: Main Phase|Technical Problems|0
5145058|NCT01513239|17771798|P5|Period 1: Main Phase|Technical Problems|0
5145059|NCT01513239|17771799|P4|Period 1: Main Phase|Technical Problems|0
5145060|NCT01513239|17771800|P3|Period 1: Main Phase|Technical Problems|0
5145061|NCT01513239|17771801|P2|Period 1: Main Phase|Technical Problems|2
5145062|NCT01513239|17771802|P1|Period 1: Main Phase|Technical Problems|1
5145063|NCT01513239|17771797|P6|Period 1: Main Phase|Protocol Violation|0
5145064|NCT01513239|17771798|P5|Period 1: Main Phase|Protocol Violation|0
5145065|NCT01513239|17771799|P4|Period 1: Main Phase|Protocol Violation|0
5145066|NCT01513239|17771800|P3|Period 1: Main Phase|Protocol Violation|2
5145067|NCT01513239|17771801|P2|Period 1: Main Phase|Protocol Violation|2
5145068|NCT01513239|17771802|P1|Period 1: Main Phase|Protocol Violation|2
5145069|NCT01513239|17771797|P6|Period 1: Main Phase|Physician Decision|0
5145070|NCT01513239|17771798|P5|Period 1: Main Phase|Physician Decision|0
5145071|NCT01513239|17771799|P4|Period 1: Main Phase|Physician Decision|0
5145072|NCT01513239|17771800|P3|Period 1: Main Phase|Physician Decision|4
5145073|NCT01513239|17771801|P2|Period 1: Main Phase|Physician Decision|4
5145074|NCT01513239|17771802|P1|Period 1: Main Phase|Physician Decision|4
5145075|NCT01513239|17771797|P6|Period 1: Main Phase|Lost to Follow-up|0
5145076|NCT01513239|17771798|P5|Period 1: Main Phase|Lost to Follow-up|0
5145077|NCT01513239|17771799|P4|Period 1: Main Phase|Lost to Follow-up|0
5145078|NCT01513239|17771800|P3|Period 1: Main Phase|Lost to Follow-up|6
5145079|NCT01513239|17771801|P2|Period 1: Main Phase|Lost to Follow-up|10
5145080|NCT01513239|17771802|P1|Period 1: Main Phase|Lost to Follow-up|11
5145081|NCT01513239|17771797|P6|Period 1: Main Phase|Death|0
5145082|NCT01513239|17771798|P5|Period 1: Main Phase|Death|0
5145083|NCT01513239|17771799|P4|Period 1: Main Phase|Death|0
5145084|NCT01513239|17771800|P3|Period 1: Main Phase|Death|32
5145085|NCT01513239|17771801|P2|Period 1: Main Phase|Death|22
5145086|NCT01513239|17771802|P1|Period 1: Main Phase|Death|29
5145087|NCT01513239|17771797|P6|Period 1: Main Phase|Adverse Event|0
5145088|NCT01513239|17771798|P5|Period 1: Main Phase|Adverse Event|0
5145089|NCT01513239|17771799|P4|Period 1: Main Phase|Adverse Event|0
5145090|NCT01513239|17771800|P3|Period 1: Main Phase|Adverse Event|2
5145091|NCT01513239|17771801|P2|Period 1: Main Phase|Adverse Event|1
5145092|NCT01513239|17771802|P1|Period 1: Main Phase|Adverse Event|1
5145093|NCT01513148|17771855|P2|Overall Study|Protocol Violation|2
5145094|NCT01513148|17771856|P1|Overall Study|Protocol Violation|2
5145095|NCT01512979|17771923|P2|Overall Study|Reason other than stated above|9
5145096|NCT01512979|17771924|P1|Overall Study|Reason other than stated above|13
5145097|NCT01512979|17771923|P2|Overall Study|Withdrawal by Subject|2
5145098|NCT01512979|17771924|P1|Overall Study|Withdrawal by Subject|1
5145099|NCT01512979|17771923|P2|Overall Study|Lost to Follow-up|5
5145100|NCT01512979|17771924|P1|Overall Study|Lost to Follow-up|2
5145101|NCT01512979|17771923|P2|Overall Study|Protocol Violation|4
5145102|NCT01512979|17771924|P1|Overall Study|Protocol Violation|1
5145103|NCT01512979|17771923|P2|Overall Study|Adverse Event|2
5145104|NCT01512979|17771924|P1|Overall Study|Adverse Event|2
5145105|NCT01512745|17772024|P2|Overall Study|Protocol Violation|0
5145106|NCT01512745|17772025|P1|Overall Study|Protocol Violation|1
5145107|NCT01512745|17772024|P2|Overall Study|Lack of Efficacy|2
5145108|NCT01512745|17772025|P1|Overall Study|Lack of Efficacy|2
5145109|NCT01512745|17772024|P2|Overall Study|Lost to Follow-up|0
5145110|NCT01512745|17772025|P1|Overall Study|Lost to Follow-up|4
5145111|NCT01512745|17772024|P2|Overall Study|Withdrawal by Subject|2
5145112|NCT01512745|17772025|P1|Overall Study|Withdrawal by Subject|2
5145113|NCT01512745|17772024|P2|Overall Study|Death|13
5145114|NCT01512745|17772025|P1|Overall Study|Death|9
5145115|NCT01512745|17772024|P2|Overall Study|Adverse Event|3
5145116|NCT01512745|17772025|P1|Overall Study|Adverse Event|22
5145117|NCT01512693|17772041|P2|Overall Study|Withdrawal by Subject|1
5145118|NCT01512693|17772042|P1|Overall Study|Withdrawal by Subject|0
5145119|NCT01512368|17772082|P1|Overall Study|Protocol Violation|3
5145120|NCT01512264|17772095|P4|Overall Study|Lost to Follow-up|1
5145121|NCT01512264|17772096|P3|Overall Study|Lost to Follow-up|0
5145122|NCT01512264|17772097|P2|Overall Study|Lost to Follow-up|0
5145123|NCT01512264|17772098|P1|Overall Study|Lost to Follow-up|0
5145124|NCT01512160|17772237|P4|Overall Study|Withdrawal by Subject|1
5145125|NCT01512160|17772238|P3|Overall Study|Withdrawal by Subject|0
5145126|NCT01512160|17772239|P2|Overall Study|Withdrawal by Subject|0
5145127|NCT01512160|17772240|P1|Overall Study|Withdrawal by Subject|1
5145128|NCT01512160|17772237|P4|Overall Study|Lost to Follow-up|0
5145129|NCT01512160|17772238|P3|Overall Study|Lost to Follow-up|0
5145130|NCT01512160|17772239|P2|Overall Study|Lost to Follow-up|0
5145131|NCT01512160|17772240|P1|Overall Study|Lost to Follow-up|1
5145132|NCT01512108|17772332|P2|Overall Study|Unclassified|3
5145133|NCT01512108|17772333|P1|Overall Study|Unclassified|11
5145134|NCT01512108|17772332|P2|Overall Study|Withdrawal Criteria|0
5145135|NCT01512108|17772333|P1|Overall Study|Withdrawal Criteria|1
5145136|NCT01512108|17772332|P2|Overall Study|Protocol Violation|2
5145137|NCT01512108|17772333|P1|Overall Study|Protocol Violation|1
5145138|NCT01512108|17772332|P2|Overall Study|Adverse Event|4
5145139|NCT01512108|17772333|P1|Overall Study|Adverse Event|9
5145140|NCT01511939|17772359|P3|Overall Study|Withdrawal by Subject|0
5145141|NCT01511939|17772360|P2|Overall Study|Withdrawal by Subject|1
5145142|NCT01511939|17772361|P1|Overall Study|Withdrawal by Subject|2
5145143|NCT01511536|17772390|P3|Phase 2|Other|9
5145144|NCT01511536|17772391|P2|Phase 2|Other|0
5145145|NCT01511536|17772392|P1|Phase 2|Other|0
5145146|NCT01511536|17772390|P3|Phase 1|Other|0
5145147|NCT01511536|17772391|P2|Phase 1|Other|1
5145148|NCT01511536|17772392|P1|Phase 1|Other|0
5145149|NCT01511445|17772414|P2|Overall Study|Protocol Violation|0
5145150|NCT01511445|17772415|P1|Overall Study|Protocol Violation|1
5145151|NCT01511445|17772414|P2|Overall Study|Protocol Violation|3
5145152|NCT01511445|17772415|P1|Overall Study|Protocol Violation|1
5145153|NCT01511445|17772414|P2|Overall Study|Lost to Follow-up|1
5145154|NCT01511445|17772415|P1|Overall Study|Lost to Follow-up|3
5145155|NCT01511419|17772425|P2|Dose 2|Physician Decision|0
5145156|NCT01511419|17772426|P1|Dose 2|Physician Decision|1
5145157|NCT01511250|17772538|P10|Overall Study|Protocol Violation|0
5145158|NCT01511250|17772539|P9|Overall Study|Protocol Violation|0
5145159|NCT01511250|17772540|P8|Overall Study|Protocol Violation|0
5145160|NCT01511250|17772541|P7|Overall Study|Protocol Violation|0
5145161|NCT01511250|17772542|P6|Overall Study|Protocol Violation|0
5145162|NCT01511250|17772543|P5|Overall Study|Protocol Violation|0
5145163|NCT01511250|17772544|P4|Overall Study|Protocol Violation|0
5145164|NCT01511250|17772545|P3|Overall Study|Protocol Violation|1
5145165|NCT01511250|17772546|P2|Overall Study|Protocol Violation|2
5145166|NCT01511250|17772547|P1|Overall Study|Protocol Violation|0
5145167|NCT01511250|17772538|P10|Overall Study|Lost to Follow-up|5
5145168|NCT01511250|17772539|P9|Overall Study|Lost to Follow-up|13
5145169|NCT01511250|17772540|P8|Overall Study|Lost to Follow-up|3
5145170|NCT01511250|17772541|P7|Overall Study|Lost to Follow-up|2
5145171|NCT01511250|17772542|P6|Overall Study|Lost to Follow-up|0
5145172|NCT01511250|17772543|P5|Overall Study|Lost to Follow-up|0
5145173|NCT01511250|17772544|P4|Overall Study|Lost to Follow-up|3
5145174|NCT01511250|17772545|P3|Overall Study|Lost to Follow-up|3
5145175|NCT01511250|17772546|P2|Overall Study|Lost to Follow-up|3
5145176|NCT01511250|17772547|P1|Overall Study|Lost to Follow-up|7
5145177|NCT01511250|17772538|P10|Overall Study|Sponsor/Investigator Decision|0
5145178|NCT01511250|17772539|P9|Overall Study|Sponsor/Investigator Decision|0
5145179|NCT01511250|17772540|P8|Overall Study|Sponsor/Investigator Decision|0
5145180|NCT01511250|17772541|P7|Overall Study|Sponsor/Investigator Decision|0
5145181|NCT01511250|17772542|P6|Overall Study|Sponsor/Investigator Decision|0
5145182|NCT01511250|17772543|P5|Overall Study|Sponsor/Investigator Decision|0
5145183|NCT01511250|17772544|P4|Overall Study|Sponsor/Investigator Decision|0
5145184|NCT01511250|17772545|P3|Overall Study|Sponsor/Investigator Decision|0
5145185|NCT01511250|17772546|P2|Overall Study|Sponsor/Investigator Decision|0
5145186|NCT01511250|17772547|P1|Overall Study|Sponsor/Investigator Decision|1
5145187|NCT01511250|17772538|P10|Overall Study|Withdrawal of Consent|0
5145188|NCT01511250|17772539|P9|Overall Study|Withdrawal of Consent|1
5145189|NCT01511250|17772540|P8|Overall Study|Withdrawal of Consent|1
5145190|NCT01511250|17772541|P7|Overall Study|Withdrawal of Consent|0
5145191|NCT01511250|17772542|P6|Overall Study|Withdrawal of Consent|0
5145192|NCT01511250|17772543|P5|Overall Study|Withdrawal of Consent|0
5145193|NCT01511250|17772544|P4|Overall Study|Withdrawal of Consent|0
5145194|NCT01511250|17772545|P3|Overall Study|Withdrawal of Consent|0
5145195|NCT01511250|17772546|P2|Overall Study|Withdrawal of Consent|0
5145196|NCT01511250|17772547|P1|Overall Study|Withdrawal of Consent|1
5145197|NCT01511107|17772695|P2|Overall Study|Withdrawal by Subject|20
5145198|NCT01511107|17772696|P1|Overall Study|Withdrawal by Subject|9
5145199|NCT01511107|17772695|P2|Overall Study|Lost to Follow-up|19
5145200|NCT01511107|17772696|P1|Overall Study|Lost to Follow-up|10
5145201|NCT01511107|17772695|P2|Overall Study|Ineligible|2
5145202|NCT01511107|17772696|P1|Overall Study|Ineligible|3
5145203|NCT01511055|17772768|P1|Overall Study|Withdrawal by Subject|6
5145204|NCT01510912|17772792|P1|Overall Study|Other, including joint replacement|5
5145205|NCT01510912|17772792|P1|Overall Study|Lost to Follow-up|26
5145206|NCT01510912|17772792|P1|Overall Study|Protocol Violation|27
5145207|NCT01510912|17772792|P1|Overall Study|Physician Decision|1
5145208|NCT01510912|17772792|P1|Overall Study|Withdrawal by Subject|49
5145209|NCT01510912|17772792|P1|Overall Study|Non-compliance with trial drug|23
5145210|NCT01510912|17772792|P1|Overall Study|Lack of Efficacy|12
5145211|NCT01510912|17772792|P1|Overall Study|Adverse Event|99
5145212|NCT01510769|17772808|P3|Overall Study|Death|0
5145213|NCT01510769|17772809|P2|Overall Study|Death|1
5145214|NCT01510769|17772810|P1|Overall Study|Death|1
5145215|NCT01510769|17772808|P3|Overall Study|Withdrawal by Subject|3
5145216|NCT01510769|17772809|P2|Overall Study|Withdrawal by Subject|4
5145217|NCT01510769|17772810|P1|Overall Study|Withdrawal by Subject|3
5145218|NCT01510769|17772808|P3|Overall Study|Lost to Follow-up|5
5145219|NCT01510769|17772809|P2|Overall Study|Lost to Follow-up|1
5145220|NCT01510769|17772810|P1|Overall Study|Lost to Follow-up|5
5145221|NCT01510769|17772808|P3|Overall Study|Protocol Violation|9
5145222|NCT01510769|17772809|P2|Overall Study|Protocol Violation|10
5145223|NCT01510769|17772810|P1|Overall Study|Protocol Violation|11
5145224|NCT01510769|17772808|P3|Overall Study|Gout Flare|1
5145225|NCT01510769|17772809|P2|Overall Study|Gout Flare|3
5145226|NCT01510769|17772810|P1|Overall Study|Gout Flare|0
5145227|NCT01510769|17772808|P3|Overall Study|Adverse Event|4
5145228|NCT01510769|17772809|P2|Overall Study|Adverse Event|6
5145229|NCT01510769|17772810|P1|Overall Study|Adverse Event|7
5145230|NCT01510756|17772827|P1|Overall Study|Physician Decision|1
5145231|NCT01510756|17772827|P1|Overall Study|Lack of Efficacy|2
5145232|NCT01510756|17772827|P1|Overall Study|Death|1
5145233|NCT01510717|17772835|P2|Overall Study|Withdrawal by Subject|2
5145234|NCT01510717|17772836|P1|Overall Study|Withdrawal by Subject|0
5145235|NCT01510717|17772835|P2|Overall Study|Lost to Follow-up|1
5145236|NCT01510717|17772836|P1|Overall Study|Lost to Follow-up|0
5145237|NCT01510717|17772835|P2|Overall Study|Death|0
5145238|NCT01510717|17772836|P1|Overall Study|Death|1
5145239|NCT01510717|17772835|P2|Overall Study|Adverse Event|2
5145240|NCT01510717|17772836|P1|Overall Study|Adverse Event|1
5145241|NCT01510158|17772956|P3|Overall Study|Death|0
5145242|NCT01510158|17772957|P2|Overall Study|Death|0
5145243|NCT01510158|17772958|P1|Overall Study|Death|1
5145244|NCT01510158|17772956|P3|Overall Study|Withdrawal by Subject|10
5145245|NCT01510158|17772957|P2|Overall Study|Withdrawal by Subject|13
5145246|NCT01510158|17772958|P1|Overall Study|Withdrawal by Subject|10
5145247|NCT01510158|17772956|P3|Overall Study|Lost to Follow-up|9
5145248|NCT01510158|17772957|P2|Overall Study|Lost to Follow-up|16
5145249|NCT01510158|17772958|P1|Overall Study|Lost to Follow-up|13
5145250|NCT01510158|17772956|P3|Overall Study|Sponsor terminated study.|2
5145251|NCT01510158|17772957|P2|Overall Study|Sponsor terminated study.|0
5145252|NCT01510158|17772958|P1|Overall Study|Sponsor terminated study.|2
5145253|NCT01510158|17772956|P3|Overall Study|Protocol Violation|24
5145254|NCT01510158|17772957|P2|Overall Study|Protocol Violation|16
5145255|NCT01510158|17772958|P1|Overall Study|Protocol Violation|17
5145256|NCT01510158|17772956|P3|Overall Study|Gout flare|0
5145257|NCT01510158|17772957|P2|Overall Study|Gout flare|0
5145258|NCT01510158|17772958|P1|Overall Study|Gout flare|1
5145259|NCT01510158|17772956|P3|Overall Study|Adverse Event|5
5145260|NCT01510158|17772957|P2|Overall Study|Adverse Event|8
5145261|NCT01510158|17772958|P1|Overall Study|Adverse Event|7
5145262|NCT01510145|17772972|P1|Overall Study|Relative reported subject withdrew|1
5145263|NCT01510145|17772972|P1|Overall Study|Withdrawal by Subject|6
5145264|NCT01510145|17772972|P1|Overall Study|Lost to Follow-up|5
5145265|NCT01510145|17772972|P1|Overall Study|Adverse Event|6
5145266|NCT01510028|17772981|P4|Overall Study|Lack of Efficacy|0
5145267|NCT01510028|17772982|P3|Overall Study|Lack of Efficacy|0
5145268|NCT01510028|17772983|P2|Overall Study|Lack of Efficacy|0
5145269|NCT01510028|17772984|P1|Overall Study|Lack of Efficacy|1
5145270|NCT01509664|17773245|P2|Overall Study|Lost to Follow-up|21
5145271|NCT01509664|17773246|P1|Overall Study|Lost to Follow-up|15
5145272|NCT01509547|17773322|P2|Overall Study|Physician Decision|1
5145273|NCT01509547|17773323|P1|Overall Study|Physician Decision|0
5145274|NCT01509547|17773322|P2|Overall Study|Withdrawal by Subject|24
5145275|NCT01509547|17773323|P1|Overall Study|Withdrawal by Subject|11
5145276|NCT01509547|17773322|P2|Overall Study|Lost to Follow-up|14
5145277|NCT01509547|17773323|P1|Overall Study|Lost to Follow-up|24
5145278|NCT01509079|17773390|P2|Overall Study|started an excluded medication|1
5145279|NCT01509079|17773391|P1|Overall Study|started an excluded medication|0
5145280|NCT01509079|17773390|P2|Overall Study|Lack of Efficacy|2
5145281|NCT01509079|17773391|P1|Overall Study|Lack of Efficacy|0
5145282|NCT01509053|17773411|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
5145283|NCT01509053|17773411|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
5145284|NCT01509053|17773411|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
5145285|NCT01509053|17773411|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
5145286|NCT01509053|17773411|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
5145287|NCT01509053|17773411|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
5145288|NCT01508936|17773473|P2|Overall Study|Data from 2 sites deemed invalid|11
5145289|NCT01508936|17773474|P1|Overall Study|Data from 2 sites deemed invalid|4
5145290|NCT01508936|17773473|P2|Overall Study|Other|5
5145291|NCT01508936|17773474|P1|Overall Study|Other|0
5145292|NCT01508936|17773473|P2|Overall Study|Lost to Follow-up|9
5145293|NCT01508936|17773474|P1|Overall Study|Lost to Follow-up|2
5145294|NCT01508936|17773473|P2|Overall Study|Protocol Violation|3
5145295|NCT01508936|17773474|P1|Overall Study|Protocol Violation|2
5145296|NCT01508936|17773473|P2|Overall Study|Withdrawal by Subject|18
5145297|NCT01508936|17773474|P1|Overall Study|Withdrawal by Subject|4
5145298|NCT01508936|17773473|P2|Overall Study|Lack of Efficacy|1
5145299|NCT01508936|17773474|P1|Overall Study|Lack of Efficacy|0
5145300|NCT01508936|17773473|P2|Overall Study|Adverse Event|32
5145301|NCT01508936|17773474|P1|Overall Study|Adverse Event|11
5145302|NCT01508910|17773513|P4|Treatment|Sponsor Decision|1
5145303|NCT01508910|17773514|P3|Treatment|Sponsor Decision|0
5145304|NCT01508910|17773515|P2|Treatment|Sponsor Decision|0
5145305|NCT01508910|17773516|P1|Treatment|Sponsor Decision|0
5145306|NCT01508910|17773513|P4|Treatment|Withdrawal by Subject|1
5145307|NCT01508910|17773514|P3|Treatment|Withdrawal by Subject|6
5145308|NCT01508910|17773515|P2|Treatment|Withdrawal by Subject|1
5145309|NCT01508910|17773516|P1|Treatment|Withdrawal by Subject|0
5145310|NCT01508910|17773513|P4|Treatment|Lost to Follow-up|1
5145311|NCT01508910|17773514|P3|Treatment|Lost to Follow-up|2
5145312|NCT01508910|17773515|P2|Treatment|Lost to Follow-up|0
5145313|NCT01508910|17773516|P1|Treatment|Lost to Follow-up|0
5145314|NCT01508910|17773513|P4|Treatment|Death|0
5145315|NCT01508910|17773514|P3|Treatment|Death|2
5145316|NCT01508910|17773515|P2|Treatment|Death|3
5145317|NCT01508910|17773516|P1|Treatment|Death|2
5145318|NCT01508702|17773549|P2|Overall Study|Withdrawal by Subject|7
5145319|NCT01508702|17773550|P1|Overall Study|Withdrawal by Subject|11
5145320|NCT01508702|17773549|P2|Overall Study|Lost to Follow-up|2
5145321|NCT01508702|17773550|P1|Overall Study|Lost to Follow-up|1
5145322|NCT01508702|17773549|P2|Overall Study|Protocol Violation|1
5145323|NCT01508702|17773550|P1|Overall Study|Protocol Violation|2
5145324|NCT01508702|17773549|P2|Overall Study|Gout flare|0
5145325|NCT01508702|17773550|P1|Overall Study|Gout flare|2
5145326|NCT01508702|17773549|P2|Overall Study|Adverse Event|3
5145327|NCT01508702|17773550|P1|Overall Study|Adverse Event|7
5145328|NCT01508676|17773558|P2|Phase II (2 Weeks)|Medication Exclusion|0
5145329|NCT01508676|17773559|P1|Phase II (2 Weeks)|Medication Exclusion|1
5145330|NCT01508676|17773558|P2|Phase II (2 Weeks)|Skin Sensitivity|1
5145331|NCT01508676|17773559|P1|Phase II (2 Weeks)|Skin Sensitivity|0
5145332|NCT01508676|17773558|P2|Phase I (2 Weeks)|Positive Drug Screen|2
5145333|NCT01508676|17773559|P1|Phase I (2 Weeks)|Positive Drug Screen|0
5145334|NCT01508676|17773558|P2|Phase I (2 Weeks)|Wrong Pain Type|0
5145335|NCT01508676|17773559|P1|Phase I (2 Weeks)|Wrong Pain Type|1
5145336|NCT01508676|17773558|P2|Phase I (2 Weeks)|Medication Exclusion|1
5145337|NCT01508676|17773559|P1|Phase I (2 Weeks)|Medication Exclusion|1
5145338|NCT01508650|17773571|P2|Overall Study|Lost to Follow-up|3
5145339|NCT01508650|17773572|P1|Overall Study|Lost to Follow-up|0
5145340|NCT01508325|17773591|P2|Overall Study|Other|2
5145341|NCT01508325|17773592|P1|Overall Study|Other|2
5145342|NCT01508325|17773591|P2|Overall Study|Lost to Follow-up|6
5145343|NCT01508325|17773592|P1|Overall Study|Lost to Follow-up|5
5145344|NCT01508325|17773591|P2|Overall Study|Adverse Event|0
5145345|NCT01508325|17773592|P1|Overall Study|Adverse Event|1
5145346|NCT01508325|17773591|P2|Overall Study|Physician Decision|1
5145347|NCT01508325|17773592|P1|Overall Study|Physician Decision|2
5145348|NCT01508325|17773591|P2|Overall Study|Protocol Violation|3
5145349|NCT01508325|17773592|P1|Overall Study|Protocol Violation|0
5145350|NCT01508325|17773591|P2|Overall Study|Withdrawal by Subject|9
5145351|NCT01508325|17773592|P1|Overall Study|Withdrawal by Subject|8
5145352|NCT01508169|17773622|P2|Overall Study|Lost to Follow-up|2
5145353|NCT01508169|17773623|P1|Overall Study|Lost to Follow-up|1
5145354|NCT01508169|17773622|P2|Overall Study|Withdrawal by Subject|0
5145355|NCT01508169|17773623|P1|Overall Study|Withdrawal by Subject|1
5145356|NCT01508169|17773622|P2|Overall Study|Adverse Event|0
5145357|NCT01508169|17773623|P1|Overall Study|Adverse Event|1
5145358|NCT01508130|17773637|P2|Overall Study|Administrative|3
5145359|NCT01508130|17773638|P1|Overall Study|Administrative|14
5145360|NCT01508130|17773637|P2|Overall Study|Insufficient therapeutic response|23
5145361|NCT01508130|17773638|P1|Overall Study|Insufficient therapeutic response|74
5145362|NCT01508130|17773637|P2|Overall Study|Subject's substantial non-compliance|9
5145363|NCT01508130|17773638|P1|Overall Study|Subject's substantial non-compliance|25
5145364|NCT01508130|17773637|P2|Overall Study|Withdrawal by Subject|3
5145365|NCT01508130|17773638|P1|Overall Study|Withdrawal by Subject|3
5145366|NCT01508130|17773637|P2|Overall Study|Lost to Follow-up|2
5145367|NCT01508130|17773638|P1|Overall Study|Lost to Follow-up|25
5145368|NCT01508130|17773637|P2|Overall Study|Protocol Violation|0
5145369|NCT01508130|17773638|P1|Overall Study|Protocol Violation|2
5145370|NCT01508130|17773637|P2|Overall Study|Death|1
5145371|NCT01508130|17773638|P1|Overall Study|Death|3
5145372|NCT01508130|17773637|P2|Overall Study|Adverse Event|28
5145373|NCT01508130|17773638|P1|Overall Study|Adverse Event|81
5145374|NCT01507896|17773706|P1|Overall Study|The surgery was denied by the sponsor.|1
5145375|NCT01507896|17773706|P1|Overall Study|Withdrawal by Subject|1
5145376|NCT01507831|17773749|P2|Overall Study|Other|6
5145377|NCT01507831|17773750|P1|Overall Study|Other|3
5145378|NCT01507831|17773749|P2|Overall Study|Potential lost to follow-up|0
5145379|NCT01507831|17773750|P1|Overall Study|Potential lost to follow-up|3
5145380|NCT01507831|17773749|P2|Overall Study|Site closure|3
5145381|NCT01507831|17773750|P1|Overall Study|Site closure|0
5145382|NCT01507831|17773749|P2|Overall Study|Selection criteria finally not met|1
5145383|NCT01507831|17773750|P1|Overall Study|Selection criteria finally not met|0
5145384|NCT01507831|17773749|P2|Overall Study|Last visit outside protocol visit window|143
5145385|NCT01507831|17773750|P1|Overall Study|Last visit outside protocol visit window|51
5145386|NCT01507831|17773749|P2|Overall Study|Related to study drug administration|14
5145387|NCT01507831|17773750|P1|Overall Study|Related to study drug administration|5
5145388|NCT01507831|17773749|P2|Overall Study|Consent withdrawn by participant|72
5145389|NCT01507831|17773750|P1|Overall Study|Consent withdrawn by participant|34
5145390|NCT01507831|17773749|P2|Overall Study|Participant moved|19
5145391|NCT01507831|17773750|P1|Overall Study|Participant moved|5
5145392|NCT01507831|17773749|P2|Overall Study|Physician Decision|4
5145393|NCT01507831|17773750|P1|Overall Study|Physician Decision|0
5145394|NCT01507831|17773749|P2|Overall Study|Poor compliance to protocol|60
5145395|NCT01507831|17773750|P1|Overall Study|Poor compliance to protocol|38
5145396|NCT01507831|17773749|P2|Overall Study|Death|2
5145397|NCT01507831|17773750|P1|Overall Study|Death|6
5145398|NCT01507831|17773749|P2|Overall Study|Adverse Event|113
5145399|NCT01507831|17773750|P1|Overall Study|Adverse Event|48
5145400|NCT01507831|17773749|P2|Overall Study|Randomized but not treated|3
5145401|NCT01507831|17773750|P1|Overall Study|Randomized but not treated|0
5145402|NCT01507662|17773870|P2|Overall Study|Proxy interview done|3
5145403|NCT01507662|17773871|P1|Overall Study|Proxy interview done|2
5145404|NCT01507662|17773870|P2|Overall Study|Lost to Follow-up|523
5145405|NCT01507662|17773871|P1|Overall Study|Lost to Follow-up|498
5145406|NCT01507662|17773870|P2|Overall Study|Withdrawal by Subject|287
5145407|NCT01507662|17773871|P1|Overall Study|Withdrawal by Subject|290
5145408|NCT01507662|17773870|P2|Overall Study|Death|18
5145409|NCT01507662|17773871|P1|Overall Study|Death|26
5145410|NCT01507298|17773906|P2|Overall Study|Protocol Violation|6
5145411|NCT01507298|17773907|P1|Overall Study|Protocol Violation|0
5145412|NCT01507246|17773917|P2|Overall Study|Required different surgical procedures|1
5145413|NCT01507246|17773918|P1|Overall Study|Required different surgical procedures|2
5145414|NCT01507090|17774016|P1|Overall Study|incomplete dataset|18
5145415|NCT01507051|17774055|P4|Overall Study|Adverse Event|0
5145416|NCT01507051|17774056|P3|Overall Study|Adverse Event|0
5145417|NCT01507051|17774057|P2|Overall Study|Adverse Event|0
5145418|NCT01507051|17774058|P1|Overall Study|Adverse Event|1
5145419|NCT01507051|17774055|P4|Overall Study|Physician Decision|1
5145420|NCT01507051|17774056|P3|Overall Study|Physician Decision|0
5145421|NCT01507051|17774057|P2|Overall Study|Physician Decision|0
5145422|NCT01507051|17774058|P1|Overall Study|Physician Decision|0
5145423|NCT01507051|17774055|P4|Overall Study|Withdrawal by Subject|6
5145424|NCT01507051|17774056|P3|Overall Study|Withdrawal by Subject|1
5145425|NCT01507051|17774057|P2|Overall Study|Withdrawal by Subject|3
5145426|NCT01507051|17774058|P1|Overall Study|Withdrawal by Subject|1
5145427|NCT01506960|17774176|P1|Overall Study|Did not meet angiographic criteria|47
5145428|NCT01506947|17774182|P1|Overall Study|Did Not Meet Eligibility Criteria|3
5145429|NCT01506947|17774182|P1|Overall Study|Death|1
5145430|NCT01506947|17774182|P1|Overall Study|Adverse Event|5
5145431|NCT01506947|17774182|P1|Overall Study|Lost to Follow-up|7
5145432|NCT01506908|17774200|P2|Overall Study|Adverse Event|0
5145433|NCT01506908|17774201|P1|Overall Study|Adverse Event|1
5145434|NCT01506882|17774219|P2|Overall Study|Other Reason|0
5145435|NCT01506882|17774220|P1|Overall Study|Other Reason|2
5145436|NCT01506882|17774219|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5145437|NCT01506882|17774220|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5145438|NCT01506882|17774219|P2|Overall Study|AE, non-serious non-fatal|1
5145439|NCT01506882|17774220|P1|Overall Study|AE, non-serious non-fatal|3
5145440|NCT01506882|17774219|P2|Overall Study|SAE, non-fatal|0
5145441|NCT01506882|17774220|P1|Overall Study|SAE, non-fatal|2
5145442|NCT01506882|17774219|P2|Overall Study|Withdrawal by Subject|3
5145443|NCT01506882|17774220|P1|Overall Study|Withdrawal by Subject|9
5145444|NCT01506882|17774219|P2|Overall Study|Lost to Follow-up|0
5145445|NCT01506882|17774220|P1|Overall Study|Lost to Follow-up|1
5145446|NCT01506882|17774219|P2|Overall Study|Lack of Efficacy|3
5145447|NCT01506882|17774220|P1|Overall Study|Lack of Efficacy|4
5145448|NCT01506726|17774234|P2|Overall Study|Adverse Event|2
5145449|NCT01506726|17774235|P1|Overall Study|Adverse Event|1
5145450|NCT01506596|17774275|P1|Overall Study|ineligible pathology|1
5145451|NCT01506479|17774286|P3|Overall Study|Adverse Event|0
5145452|NCT01506479|17774287|P2|Overall Study|Adverse Event|1
5145453|NCT01506479|17774288|P1|Overall Study|Adverse Event|0
5145454|NCT01506479|17774286|P3|Overall Study|Missing assessment|0
5145455|NCT01506479|17774287|P2|Overall Study|Missing assessment|0
5145456|NCT01506479|17774288|P1|Overall Study|Missing assessment|1
5145457|NCT01506479|17774286|P3|Overall Study|Withdrawal by Subject|1
5145458|NCT01506479|17774287|P2|Overall Study|Withdrawal by Subject|2
5145459|NCT01506479|17774288|P1|Overall Study|Withdrawal by Subject|1
5145460|NCT01506479|17774286|P3|Overall Study|Lost to Follow-up|2
5145461|NCT01506479|17774287|P2|Overall Study|Lost to Follow-up|2
5145462|NCT01506479|17774288|P1|Overall Study|Lost to Follow-up|1
5145463|NCT01506453|17774302|P2|Overall Study|Withdrawal prior to treatment|2
5145464|NCT01506453|17774303|P1|Overall Study|Withdrawal prior to treatment|0
5145465|NCT01506323|17774319|P2|Overall Study|Started another treatment|0
5145466|NCT01506323|17774320|P1|Overall Study|Started another treatment|1
5145467|NCT01506323|17774319|P2|Overall Study|Schedule or Transportation conflict|0
5145468|NCT01506323|17774320|P1|Overall Study|Schedule or Transportation conflict|8
5145469|NCT01506323|17774319|P2|Overall Study|Moved out of area|2
5145470|NCT01506323|17774320|P1|Overall Study|Moved out of area|5
5145471|NCT01506323|17774319|P2|Overall Study|Lack of Efficacy|3
5145472|NCT01506323|17774320|P1|Overall Study|Lack of Efficacy|1
5145473|NCT01506323|17774319|P2|Overall Study|Withdrawal by Subject|4
5145474|NCT01506323|17774320|P1|Overall Study|Withdrawal by Subject|4
5145475|NCT01506323|17774319|P2|Overall Study|Lost to Follow-up|4
5145476|NCT01506323|17774320|P1|Overall Study|Lost to Follow-up|5
5145477|NCT01506271|17774349|P3|Overall Study|Lost to Follow-up|2
5145478|NCT01506271|17774350|P2|Overall Study|Lost to Follow-up|1
5145479|NCT01506271|17774351|P1|Overall Study|Lost to Follow-up|0
5145480|NCT01506271|17774349|P3|Overall Study|Withdrawal by Subject|1
5145481|NCT01506271|17774350|P2|Overall Study|Withdrawal by Subject|1
5145482|NCT01506271|17774351|P1|Overall Study|Withdrawal by Subject|0
5145483|NCT01506271|17774349|P3|Overall Study|Insufficient supply of study drug|0
5145484|NCT01506271|17774350|P2|Overall Study|Insufficient supply of study drug|0
5145485|NCT01506271|17774351|P1|Overall Study|Insufficient supply of study drug|1
5145486|NCT01506271|17774349|P3|Overall Study|Adverse Event|0
5145487|NCT01506271|17774350|P2|Overall Study|Adverse Event|2
5145488|NCT01506271|17774351|P1|Overall Study|Adverse Event|0
5145489|NCT01506271|17774349|P3|Overall Study|Death|0
5145490|NCT01506271|17774350|P2|Overall Study|Death|1
5145491|NCT01506271|17774351|P1|Overall Study|Death|0
5145492|NCT01506271|17774349|P3|Overall Study|Protocol Violation|0
5145493|NCT01506271|17774350|P2|Overall Study|Protocol Violation|1
5145494|NCT01506271|17774351|P1|Overall Study|Protocol Violation|3
5145495|NCT01506271|17774349|P3|Overall Study|Progressive disease|0
5145496|NCT01506271|17774350|P2|Overall Study|Progressive disease|1
5145497|NCT01506271|17774351|P1|Overall Study|Progressive disease|0
5145498|NCT01506193|17774413|P3|Overall Study|Lost to Follow-up|3
5145499|NCT01506193|17774414|P2|Overall Study|Lost to Follow-up|3
5145500|NCT01506193|17774415|P1|Overall Study|Lost to Follow-up|8
5145501|NCT01506193|17774413|P3|Overall Study|Withdrawal by Subject|8
5145502|NCT01506193|17774414|P2|Overall Study|Withdrawal by Subject|1
5145503|NCT01506193|17774415|P1|Overall Study|Withdrawal by Subject|5
5145504|NCT01506193|17774413|P3|Overall Study|Adverse event, non-fatal|1
5145505|NCT01506193|17774414|P2|Overall Study|Adverse event, non-fatal|0
5145506|NCT01506193|17774415|P1|Overall Study|Adverse event, non-fatal|0
5145507|NCT01506193|17774413|P3|Overall Study|Migrated/moved from study area|1
5145508|NCT01506193|17774414|P2|Overall Study|Migrated/moved from study area|0
5145509|NCT01506193|17774415|P1|Overall Study|Migrated/moved from study area|0
5145510|NCT01506193|17774413|P3|Overall Study|Protocol Violation|1
5145511|NCT01506193|17774414|P2|Overall Study|Protocol Violation|0
5145512|NCT01506193|17774415|P1|Overall Study|Protocol Violation|1
5145513|NCT01505881|17774461|P2|Overall Study|Withdrawal by Subject|0
5145514|NCT01505881|17774462|P1|Overall Study|Withdrawal by Subject|2
5145515|NCT01505881|17774461|P2|Overall Study|Lost to Follow-up|0
5145516|NCT01505881|17774462|P1|Overall Study|Lost to Follow-up|2
5145517|NCT01505881|17774461|P2|Overall Study|Adverse Event|1
5145518|NCT01505881|17774462|P1|Overall Study|Adverse Event|0
5145519|NCT01505647|17774568|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
5145520|NCT01505647|17774569|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
5145521|NCT01505647|17774568|P2|Day 43 Through Day 182 Follow-up|Death|1
5145522|NCT01505647|17774569|P1|Day 43 Through Day 182 Follow-up|Death|0
5145523|NCT01505647|17774568|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
5145524|NCT01505647|17774569|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
5145525|NCT01505647|17774568|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
5145526|NCT01505647|17774569|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
5145527|NCT01505647|17774568|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
5145528|NCT01505647|17774569|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
5145529|NCT01505634|17774586|P3|Overall Study|In a conflict zone|1
5145530|NCT01505634|17774587|P2|Overall Study|In a conflict zone|0
5145531|NCT01505634|17774588|P1|Overall Study|In a conflict zone|0
5145532|NCT01505634|17774586|P3|Overall Study|Death|0
5145533|NCT01505634|17774587|P2|Overall Study|Death|0
5145534|NCT01505634|17774588|P1|Overall Study|Death|1
5145535|NCT01505634|17774586|P3|Overall Study|Lost to Follow-up|4
5145536|NCT01505634|17774587|P2|Overall Study|Lost to Follow-up|4
5145537|NCT01505634|17774588|P1|Overall Study|Lost to Follow-up|1
5145538|NCT01505634|17774586|P3|Overall Study|Protocol Violation|0
5145539|NCT01505634|17774587|P2|Overall Study|Protocol Violation|0
5145540|NCT01505634|17774588|P1|Overall Study|Protocol Violation|2
5145541|NCT01505634|17774586|P3|Overall Study|Insufficient supply of drug at site|0
5145542|NCT01505634|17774587|P2|Overall Study|Insufficient supply of drug at site|0
5145543|NCT01505634|17774588|P1|Overall Study|Insufficient supply of drug at site|1
5145544|NCT01505634|17774586|P3|Overall Study|Adverse Event|0
5145545|NCT01505634|17774587|P2|Overall Study|Adverse Event|0
5145546|NCT01505634|17774588|P1|Overall Study|Adverse Event|1
5145547|NCT01505634|17774586|P3|Overall Study|Physician Decision|0
5145548|NCT01505634|17774587|P2|Overall Study|Physician Decision|1
5145549|NCT01505634|17774588|P1|Overall Study|Physician Decision|1
5145550|NCT01505634|17774586|P3|Overall Study|Withdrawal by Subject|1
5145551|NCT01505634|17774587|P2|Overall Study|Withdrawal by Subject|5
5145552|NCT01505634|17774588|P1|Overall Study|Withdrawal by Subject|2
5145553|NCT01505608|17774643|P2|Phase II|Protocol Violation|1
5145554|NCT01505608|17774644|P1|Phase II|Protocol Violation|0
5145555|NCT01505608|17774643|P2|Phase II|Lack of Efficacy|1
5145556|NCT01505608|17774644|P1|Phase II|Lack of Efficacy|2
5145557|NCT01505608|17774643|P2|Phase I|Withdrawal by Subject|1
5145558|NCT01505608|17774644|P1|Phase I|Withdrawal by Subject|0
5145559|NCT01505608|17774643|P2|Phase I|Adverse Event|1
5145560|NCT01505608|17774644|P1|Phase I|Adverse Event|0
5145561|NCT01505608|17774643|P2|Phase I|Lack of Efficacy|4
5145562|NCT01505608|17774644|P1|Phase I|Lack of Efficacy|0
5145563|NCT01505530|17774663|P3|Overall Study|entry criteria not met|0
5145564|NCT01505530|17774664|P2|Overall Study|entry criteria not met|1
5145565|NCT01505530|17774665|P1|Overall Study|entry criteria not met|0
5145566|NCT01505530|17774663|P3|Overall Study|Death|5
5145567|NCT01505530|17774664|P2|Overall Study|Death|6
5145568|NCT01505530|17774665|P1|Overall Study|Death|7
5145569|NCT01505530|17774663|P3|Overall Study|Sponsor Decision|7
5145570|NCT01505530|17774664|P2|Overall Study|Sponsor Decision|8
5145571|NCT01505530|17774665|P1|Overall Study|Sponsor Decision|1
5145572|NCT01505530|17774663|P3|Overall Study|Physician Decision|5
5145573|NCT01505530|17774664|P2|Overall Study|Physician Decision|2
5145574|NCT01505530|17774665|P1|Overall Study|Physician Decision|6
5145575|NCT01505530|17774663|P3|Overall Study|Withdrawal by Subject|6
5145576|NCT01505530|17774664|P2|Overall Study|Withdrawal by Subject|8
5145577|NCT01505530|17774665|P1|Overall Study|Withdrawal by Subject|7
5145578|NCT01505530|17774663|P3|Overall Study|Adverse Event|0
5145579|NCT01505530|17774664|P2|Overall Study|Adverse Event|1
5145580|NCT01505530|17774665|P1|Overall Study|Adverse Event|1
5145581|NCT01505530|17774663|P3|Overall Study|Progressive Disease|18
5145582|NCT01505530|17774664|P2|Overall Study|Progressive Disease|17
5145583|NCT01505530|17774665|P1|Overall Study|Progressive Disease|19
5145584|NCT01505491|17774709|P3|Overall Study|Lost to Follow-up|1
5145585|NCT01505491|17774710|P2|Overall Study|Lost to Follow-up|0
5145586|NCT01505491|17774711|P1|Overall Study|Lost to Follow-up|0
5145587|NCT01505491|17774709|P3|Overall Study|Withdrawal by Subject|4
5145588|NCT01505491|17774710|P2|Overall Study|Withdrawal by Subject|1
5145589|NCT01505491|17774711|P1|Overall Study|Withdrawal by Subject|1
5145590|NCT01505491|17774709|P3|Overall Study|Other reason not listed|0
5145591|NCT01505491|17774710|P2|Overall Study|Other reason not listed|0
5145592|NCT01505491|17774711|P1|Overall Study|Other reason not listed|1
5145593|NCT01505387|17774750|P2|Overall Study|Withdrawal by Subject|1
5145594|NCT01505387|17774751|P1|Overall Study|Withdrawal by Subject|1
5145595|NCT01505387|17774750|P2|Overall Study|Protocol Violation|0
5145596|NCT01505387|17774751|P1|Overall Study|Protocol Violation|1
5145597|NCT01505374|17774757|P2|Overall Study|Lost to Follow-up|0
5145598|NCT01505374|17774758|P1|Overall Study|Lost to Follow-up|1
5145599|NCT01505114|17774808|P4|Overall Study|investigator decision|0
5145600|NCT01505114|17774809|P3|Overall Study|investigator decision|1
5145601|NCT01505114|17774810|P2|Overall Study|investigator decision|0
5145602|NCT01505114|17774811|P1|Overall Study|investigator decision|1
5145603|NCT01505114|17774808|P4|Overall Study|staff safety concerns|1
5145604|NCT01505114|17774809|P3|Overall Study|staff safety concerns|0
5145605|NCT01505114|17774810|P2|Overall Study|staff safety concerns|0
5145606|NCT01505114|17774811|P1|Overall Study|staff safety concerns|0
5145607|NCT01505114|17774808|P4|Overall Study|inadvertent enrollment due to peanut all|1
5145608|NCT01505114|17774809|P3|Overall Study|inadvertent enrollment due to peanut all|0
5145609|NCT01505114|17774810|P2|Overall Study|inadvertent enrollment due to peanut all|0
5145610|NCT01505114|17774811|P1|Overall Study|inadvertent enrollment due to peanut all|0
5145611|NCT01505114|17774808|P4|Overall Study|relocated|3
5145612|NCT01505114|17774809|P3|Overall Study|relocated|2
5145613|NCT01505114|17774810|P2|Overall Study|relocated|2
5145614|NCT01505114|17774811|P1|Overall Study|relocated|4
5145615|NCT01505114|17774808|P4|Overall Study|Lost to Follow-up|7
5145616|NCT01505114|17774809|P3|Overall Study|Lost to Follow-up|8
5145617|NCT01505114|17774810|P2|Overall Study|Lost to Follow-up|5
5145618|NCT01505114|17774811|P1|Overall Study|Lost to Follow-up|11
5145619|NCT01505114|17774808|P4|Overall Study|unable to adhere to visit schedule|3
5145620|NCT01505114|17774809|P3|Overall Study|unable to adhere to visit schedule|3
5145621|NCT01505114|17774810|P2|Overall Study|unable to adhere to visit schedule|2
5145622|NCT01505114|17774811|P1|Overall Study|unable to adhere to visit schedule|3
5145623|NCT01505114|17774808|P4|Overall Study|Death|1
5145624|NCT01505114|17774809|P3|Overall Study|Death|0
5145625|NCT01505114|17774810|P2|Overall Study|Death|0
5145626|NCT01505114|17774811|P1|Overall Study|Death|1
5145627|NCT01505114|17774808|P4|Overall Study|Withdrawal by Subject|7
5145628|NCT01505114|17774809|P3|Overall Study|Withdrawal by Subject|4
5145629|NCT01505114|17774810|P2|Overall Study|Withdrawal by Subject|4
5145630|NCT01505114|17774811|P1|Overall Study|Withdrawal by Subject|5
5145631|NCT01505010|17774839|P2|Overall Study|Lost to Follow-up|1
5145632|NCT01505010|17774840|P1|Overall Study|Lost to Follow-up|0
5145633|NCT01505010|17774839|P2|Overall Study|Protocol Violation|1
5145634|NCT01505010|17774840|P1|Overall Study|Protocol Violation|0
5145635|NCT01504971|17774854|P1|Overall Study|Physician Decision|13
5145636|NCT01504867|17774883|P2|Overall Study|Consent revoked|1
5145637|NCT01504867|17774884|P1|Overall Study|Consent revoked|5
5145638|NCT01504867|17774883|P2|Overall Study|Inclusion criteria not met|2
5145639|NCT01504867|17774884|P1|Overall Study|Inclusion criteria not met|2
5145640|NCT01504841|17774922|P3|Overall Study|On study due to Long-term Follow-up|0
5145641|NCT01504841|17774923|P2|Overall Study|On study due to Long-term Follow-up|3
5145642|NCT01504841|17774924|P1|Overall Study|On study due to Long-term Follow-up|15
5145643|NCT01504841|17774922|P3|Overall Study|Withdrawal by Subject|0
5145644|NCT01504841|17774923|P2|Overall Study|Withdrawal by Subject|1
5145645|NCT01504841|17774924|P1|Overall Study|Withdrawal by Subject|1
5145646|NCT01504412|17774977|P5|Overall Study|Death|0
5145647|NCT01504412|17774978|P4|Overall Study|Death|1
5145648|NCT01504412|17774979|P3|Overall Study|Death|0
5145649|NCT01504412|17774980|P2|Overall Study|Death|0
5145650|NCT01504412|17774981|P1|Overall Study|Death|0
5145651|NCT01504412|17774977|P5|Overall Study|Lack of Efficacy|1
5145652|NCT01504412|17774978|P4|Overall Study|Lack of Efficacy|0
5145653|NCT01504412|17774979|P3|Overall Study|Lack of Efficacy|1
5145654|NCT01504412|17774980|P2|Overall Study|Lack of Efficacy|0
5145655|NCT01504412|17774981|P1|Overall Study|Lack of Efficacy|0
5145656|NCT01504412|17774977|P5|Overall Study|Lost to Follow-up|0
5145657|NCT01504412|17774978|P4|Overall Study|Lost to Follow-up|0
5145658|NCT01504412|17774979|P3|Overall Study|Lost to Follow-up|0
5145659|NCT01504412|17774980|P2|Overall Study|Lost to Follow-up|2
5145660|NCT01504412|17774981|P1|Overall Study|Lost to Follow-up|0
5145661|NCT01504412|17774977|P5|Overall Study|Other|1
5145662|NCT01504412|17774978|P4|Overall Study|Other|6
5145663|NCT01504412|17774979|P3|Overall Study|Other|1
5145664|NCT01504412|17774980|P2|Overall Study|Other|1
5145665|NCT01504412|17774981|P1|Overall Study|Other|2
5145666|NCT01504412|17774977|P5|Overall Study|Withdrawal by Subject|1
5145667|NCT01504412|17774978|P4|Overall Study|Withdrawal by Subject|5
5145668|NCT01504412|17774979|P3|Overall Study|Withdrawal by Subject|1
5145669|NCT01504412|17774980|P2|Overall Study|Withdrawal by Subject|1
5145670|NCT01504412|17774981|P1|Overall Study|Withdrawal by Subject|2
5145671|NCT01504412|17774977|P5|Overall Study|Adverse Event|10
5145672|NCT01504412|17774978|P4|Overall Study|Adverse Event|7
5145673|NCT01504412|17774979|P3|Overall Study|Adverse Event|1
5145674|NCT01504412|17774980|P2|Overall Study|Adverse Event|8
5145675|NCT01504412|17774981|P1|Overall Study|Adverse Event|1
5145676|NCT01504204|17775000|P2|Overall Study|Lost to Follow-up|1
5145677|NCT01504204|17775001|P1|Overall Study|Lost to Follow-up|1
5145678|NCT01503164|17775058|P2|Overall Study|Withdrawal by Subject|1
5145679|NCT01503164|17775059|P1|Overall Study|Withdrawal by Subject|2
5145680|NCT01503021|17775089|P2|Overall Study|Moved, received transplant, etc.|7
5145681|NCT01503021|17775090|P1|Overall Study|Moved, received transplant, etc.|5
5145682|NCT01503021|17775089|P2|Overall Study|Withdrawal by Subject|8
5145683|NCT01503021|17775090|P1|Overall Study|Withdrawal by Subject|9
5145684|NCT01503021|17775089|P2|Overall Study|Protocol Violation|3
5145685|NCT01503021|17775090|P1|Overall Study|Protocol Violation|1
5145686|NCT01503021|17775089|P2|Overall Study|Physician Decision|0
5145687|NCT01503021|17775090|P1|Overall Study|Physician Decision|3
5145688|NCT01503021|17775089|P2|Overall Study|Lost to Follow-up|0
5145689|NCT01503021|17775090|P1|Overall Study|Lost to Follow-up|2
5145690|NCT01503021|17775089|P2|Overall Study|Death|2
5145691|NCT01503021|17775090|P1|Overall Study|Death|0
5145692|NCT01503021|17775089|P2|Overall Study|Adverse Event|6
5145693|NCT01503021|17775090|P1|Overall Study|Adverse Event|7
5145694|NCT01502956|17775139|P2|Overall Study|Withdrawal by Subject|10
5145695|NCT01502956|17775140|P1|Overall Study|Withdrawal by Subject|8
5145696|NCT01502956|17775139|P2|Overall Study|Physician Decision|3
5145697|NCT01502956|17775140|P1|Overall Study|Physician Decision|2
5145698|NCT01502956|17775139|P2|Overall Study|Lost to Follow-up|11
5145699|NCT01502956|17775140|P1|Overall Study|Lost to Follow-up|14
5145700|NCT01502956|17775139|P2|Overall Study|Death|2
5145701|NCT01502956|17775140|P1|Overall Study|Death|0
5145702|NCT01502709|17775198|P2|Overall Study|Lost to Follow-up|0
5145703|NCT01502709|17775199|P1|Overall Study|Lost to Follow-up|4
5145704|NCT01502644|17775212|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
5145705|NCT01502644|17775213|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
5145706|NCT01502644|17775214|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
5145707|NCT01502644|17775215|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
5145708|NCT01502644|17775212|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
5145709|NCT01502644|17775213|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
5145710|NCT01502644|17775214|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
5145711|NCT01502644|17775215|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
5145712|NCT01502644|17775212|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5145713|NCT01502644|17775213|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5145714|NCT01502644|17775214|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5145715|NCT01502644|17775215|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
5145716|NCT01502644|17775212|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5145717|NCT01502644|17775213|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5145718|NCT01502644|17775214|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5145719|NCT01502644|17775215|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
5145720|NCT01502644|17775212|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5145721|NCT01502644|17775213|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5145722|NCT01502644|17775214|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5145723|NCT01502644|17775215|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
5145724|NCT01502423|17775225|P2|Overall Study|Withdrawal by Subject|1
5145725|NCT01502423|17775226|P1|Overall Study|Withdrawal by Subject|0
5145726|NCT01502410|17775248|P4|Overall Study|Withdrawal by Subject|0
5145727|NCT01502410|17775249|P3|Overall Study|Withdrawal by Subject|0
5145728|NCT01502410|17775250|P2|Overall Study|Withdrawal by Subject|0
5145729|NCT01502410|17775251|P1|Overall Study|Withdrawal by Subject|2
5145730|NCT01502410|17775248|P4|Overall Study|Physician Decision|0
5145731|NCT01502410|17775249|P3|Overall Study|Physician Decision|0
5145732|NCT01502410|17775250|P2|Overall Study|Physician Decision|1
5145733|NCT01502410|17775251|P1|Overall Study|Physician Decision|0
5145734|NCT01502410|17775248|P4|Overall Study|Lack of Efficacy|0
5145735|NCT01502410|17775249|P3|Overall Study|Lack of Efficacy|0
5145736|NCT01502410|17775250|P2|Overall Study|Lack of Efficacy|7
5145737|NCT01502410|17775251|P1|Overall Study|Lack of Efficacy|7
5145738|NCT01502410|17775248|P4|Overall Study|Adverse Event|0
5145739|NCT01502410|17775249|P3|Overall Study|Adverse Event|0
5145740|NCT01502410|17775250|P2|Overall Study|Adverse Event|2
5145741|NCT01502410|17775251|P1|Overall Study|Adverse Event|1
5145742|NCT01502371|17775269|P5|Overall Study|Excluded Medication|1
5145743|NCT01502371|17775270|P4|Overall Study|Excluded Medication|0
5145744|NCT01502371|17775271|P3|Overall Study|Excluded Medication|1
5145745|NCT01502371|17775272|P2|Overall Study|Excluded Medication|1
5145746|NCT01502371|17775273|P1|Overall Study|Excluded Medication|0
5145747|NCT01502371|17775269|P5|Overall Study|Protocol Violation|10
5145748|NCT01502371|17775270|P4|Overall Study|Protocol Violation|5
5145749|NCT01502371|17775271|P3|Overall Study|Protocol Violation|6
5145750|NCT01502371|17775272|P2|Overall Study|Protocol Violation|5
5145751|NCT01502371|17775273|P1|Overall Study|Protocol Violation|9
5145752|NCT01502371|17775269|P5|Overall Study|Technical Problems|1
5145753|NCT01502371|17775270|P4|Overall Study|Technical Problems|4
5145754|NCT01502371|17775271|P3|Overall Study|Technical Problems|2
5145755|NCT01502371|17775272|P2|Overall Study|Technical Problems|0
5145756|NCT01502371|17775273|P1|Overall Study|Technical Problems|1
5145757|NCT01502371|17775269|P5|Overall Study|Noncompliance with Study Drug|1
5145758|NCT01502371|17775270|P4|Overall Study|Noncompliance with Study Drug|2
5145759|NCT01502371|17775271|P3|Overall Study|Noncompliance with Study Drug|1
5145760|NCT01502371|17775272|P2|Overall Study|Noncompliance with Study Drug|0
5145761|NCT01502371|17775273|P1|Overall Study|Noncompliance with Study Drug|0
5145762|NCT01502371|17775269|P5|Overall Study|Physician Decision|1
5145763|NCT01502371|17775270|P4|Overall Study|Physician Decision|0
5145764|NCT01502371|17775271|P3|Overall Study|Physician Decision|0
5145765|NCT01502371|17775272|P2|Overall Study|Physician Decision|0
5145766|NCT01502371|17775273|P1|Overall Study|Physician Decision|3
5145767|NCT01502371|17775269|P5|Overall Study|Lack of Efficacy|4
5145768|NCT01502371|17775270|P4|Overall Study|Lack of Efficacy|2
5145769|NCT01502371|17775271|P3|Overall Study|Lack of Efficacy|2
5145770|NCT01502371|17775272|P2|Overall Study|Lack of Efficacy|3
5145771|NCT01502371|17775273|P1|Overall Study|Lack of Efficacy|3
5145772|NCT01502371|17775269|P5|Overall Study|Treatment Failure|30
5145773|NCT01502371|17775270|P4|Overall Study|Treatment Failure|19
5145774|NCT01502371|17775271|P3|Overall Study|Treatment Failure|12
5145775|NCT01502371|17775272|P2|Overall Study|Treatment Failure|20
5145776|NCT01502371|17775273|P1|Overall Study|Treatment Failure|22
5145777|NCT01502371|17775269|P5|Overall Study|Adverse Event|3
5145778|NCT01502371|17775270|P4|Overall Study|Adverse Event|4
5145779|NCT01502371|17775271|P3|Overall Study|Adverse Event|0
5145780|NCT01502371|17775272|P2|Overall Study|Adverse Event|1
5145781|NCT01502371|17775273|P1|Overall Study|Adverse Event|2
5145782|NCT01502371|17775269|P5|Overall Study|Withdrawal by Subject|1
5145783|NCT01502371|17775270|P4|Overall Study|Withdrawal by Subject|1
5145784|NCT01502371|17775271|P3|Overall Study|Withdrawal by Subject|1
5145785|NCT01502371|17775272|P2|Overall Study|Withdrawal by Subject|2
5145786|NCT01502371|17775273|P1|Overall Study|Withdrawal by Subject|1
5145787|NCT01502293|17775338|P3|Overall Study|Physician Decision|1
5145788|NCT01502293|17775339|P2|Overall Study|Physician Decision|0
5145789|NCT01502293|17775340|P1|Overall Study|Physician Decision|0
5145790|NCT01502293|17775338|P3|Overall Study|Reason Not Specified|0
5145791|NCT01502293|17775339|P2|Overall Study|Reason Not Specified|0
5145792|NCT01502293|17775340|P1|Overall Study|Reason Not Specified|2
5145793|NCT01502293|17775338|P3|Overall Study|Adverse Event|0
5145794|NCT01502293|17775339|P2|Overall Study|Adverse Event|2
5145795|NCT01502293|17775340|P1|Overall Study|Adverse Event|0
5145796|NCT01502293|17775338|P3|Overall Study|Withdrawal by Subject|1
5145797|NCT01502293|17775339|P2|Overall Study|Withdrawal by Subject|3
5145798|NCT01502293|17775340|P1|Overall Study|Withdrawal by Subject|3
5145799|NCT01502293|17775338|P3|Overall Study|Progressive Disease|2
5145800|NCT01502293|17775339|P2|Overall Study|Progressive Disease|12
5145801|NCT01502293|17775340|P1|Overall Study|Progressive Disease|20
5145802|NCT01502228|17775369|P1|Overall Study|Death|1
5145803|NCT01502033|17775374|P1|Overall Study|1 participant went back to school|1
5145804|NCT01502033|17775374|P1|Overall Study|1 participant had worsening depression|1
5145805|NCT01502033|17775374|P1|Overall Study|1 participant had scalp discomfort|1
5145806|NCT01501955|17775382|P2|Overall Study|Adverse Event|3
5145807|NCT01501955|17775383|P1|Overall Study|Adverse Event|1
5145808|NCT01501955|17775382|P2|Overall Study|Withdrawal by Subject|0
5145809|NCT01501955|17775383|P1|Overall Study|Withdrawal by Subject|1
5145810|NCT01501110|17775447|P2|Overall Study|Death|1
5145811|NCT01501110|17775448|P1|Overall Study|Death|0
5145812|NCT01500720|17775533|P2|Overall Study|Other|8
5145813|NCT01500720|17775534|P1|Overall Study|Other|4
5145814|NCT01500720|17775533|P2|Overall Study|Randomized But Not Treated|1
5145815|NCT01500720|17775534|P1|Overall Study|Randomized But Not Treated|1
5145816|NCT01500694|17775548|P2|Overall Study|Other|3
5145817|NCT01500694|17775549|P1|Overall Study|Other|9
5145818|NCT01500694|17775548|P2|Overall Study|Lack of Efficacy|5
5145819|NCT01500694|17775549|P1|Overall Study|Lack of Efficacy|14
5145820|NCT01500694|17775548|P2|Overall Study|Lost to Follow-up|3
5145821|NCT01500694|17775549|P1|Overall Study|Lost to Follow-up|2
5145822|NCT01500694|17775548|P2|Overall Study|Withdrawal by Subject|14
5145823|NCT01500694|17775549|P1|Overall Study|Withdrawal by Subject|23
5145824|NCT01500694|17775548|P2|Overall Study|Protocol Violation|1
5145825|NCT01500694|17775549|P1|Overall Study|Protocol Violation|0
5145826|NCT01500694|17775548|P2|Overall Study|Adverse Event|3
5145827|NCT01500694|17775549|P1|Overall Study|Adverse Event|4
5145828|NCT01500629|17775575|P2|Washout Period of 14 to 30 Days|Pregnancy|0
5145829|NCT01500629|17775576|P1|Washout Period of 14 to 30 Days|Pregnancy|1
5145830|NCT01500434|17775660|P1|Overall Study|Missed 12-month follow-up|5
5145831|NCT01500434|17775660|P1|Overall Study|Withdrawal by Subject|1
5145832|NCT01500434|17775660|P1|Overall Study|Death|1
5145833|NCT01500382|17775693|P4|Washout Period|Study site went out of business|0
5145834|NCT01500382|17775694|P3|Washout Period|Study site went out of business|1
5145835|NCT01500382|17775695|P2|Washout Period|Study site went out of business|0
5145836|NCT01500382|17775696|P1|Washout Period|Study site went out of business|0
5145837|NCT01500317|17775721|P3|Overall Study|Withdrawal by Subject|0
5145838|NCT01500317|17775722|P2|Overall Study|Withdrawal by Subject|2
5145839|NCT01500317|17775723|P1|Overall Study|Withdrawal by Subject|3
5145840|NCT01500278|17775745|P2|Week 13 - Week 104|Adverse Event|54
5145841|NCT01500278|17775746|P1|Week 13 - Week 104|Adverse Event|54
5145842|NCT01500278|17775745|P2|Week 13 - Week 104|Death|4
5145843|NCT01500278|17775746|P1|Week 13 - Week 104|Death|2
5145844|NCT01500278|17775745|P2|Week 13 - Week 104|Not completed|1
5145845|NCT01500278|17775746|P1|Week 13 - Week 104|Not completed|0
5145846|NCT01500278|17775745|P2|Week 13 - Week 104|Personal reason|1
5145847|NCT01500278|17775746|P1|Week 13 - Week 104|Personal reason|0
5145848|NCT01500278|17775745|P2|Week 13 - Week 104|Medical monitor decision|2
5145849|NCT01500278|17775746|P1|Week 13 - Week 104|Medical monitor decision|0
5145850|NCT01500278|17775745|P2|Week 13 - Week 104|Sponsor decision|2
5145851|NCT01500278|17775746|P1|Week 13 - Week 104|Sponsor decision|0
5145852|NCT01500278|17775745|P2|Week 13 - Week 104|Relocation|1
5145853|NCT01500278|17775746|P1|Week 13 - Week 104|Relocation|0
5145854|NCT01500278|17775745|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
5145855|NCT01500278|17775746|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
5145856|NCT01500278|17775745|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
5145857|NCT01500278|17775746|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
5145858|NCT01500278|17775745|P2|Week 13 - Week 104|Principal investigator retiring|0
5145859|NCT01500278|17775746|P1|Week 13 - Week 104|Principal investigator retiring|1
5145860|NCT01500278|17775745|P2|Week 13 - Week 104|Protocol deviation|0
5145861|NCT01500278|17775746|P1|Week 13 - Week 104|Protocol deviation|1
5145862|NCT01500278|17775745|P2|Week 13 - Week 104|Exclusion criteria not met|0
5145863|NCT01500278|17775746|P1|Week 13 - Week 104|Exclusion criteria not met|1
5145864|NCT01500278|17775745|P2|Week 13 - Week 104|Withdrawn in error|0
5145865|NCT01500278|17775746|P1|Week 13 - Week 104|Withdrawn in error|1
5145866|NCT01500278|17775745|P2|Week 13 - Week 104|Sponsor request|0
5145867|NCT01500278|17775746|P1|Week 13 - Week 104|Sponsor request|4
5145868|NCT01500278|17775745|P2|Week 13 - Week 104|False positive test|2
5145869|NCT01500278|17775746|P1|Week 13 - Week 104|False positive test|1
5145870|NCT01500278|17775745|P2|Week 13 - Week 104|Recurrent infections|0
5145871|NCT01500278|17775746|P1|Week 13 - Week 104|Recurrent infections|1
5145872|NCT01500278|17775745|P2|Week 13 - Week 104|Non/bad compliance|5
5145873|NCT01500278|17775746|P1|Week 13 - Week 104|Non/bad compliance|7
5145874|NCT01500278|17775745|P2|Week 13 - Week 104|Week 24 Non-Responder|16
5145875|NCT01500278|17775746|P1|Week 13 - Week 104|Week 24 Non-Responder|20
5145876|NCT01500278|17775745|P2|Week 13 - Week 104|Withdrawal by Subject|13
5145877|NCT01500278|17775746|P1|Week 13 - Week 104|Withdrawal by Subject|22
5145878|NCT01500278|17775745|P2|Week 13 - Week 104|Lost to Follow-up|5
5145879|NCT01500278|17775746|P1|Week 13 - Week 104|Lost to Follow-up|6
5145880|NCT01500278|17775745|P2|Week 13 - Week 104|Protocol Violation|6
5145881|NCT01500278|17775746|P1|Week 13 - Week 104|Protocol Violation|6
5145882|NCT01500278|17775745|P2|Week 13 - Week 104|Lack of Efficacy|12
5145883|NCT01500278|17775746|P1|Week 13 - Week 104|Lack of Efficacy|11
5145884|NCT01500278|17775745|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
5145885|NCT01500278|17775746|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
5145886|NCT01500278|17775745|P2|Week 0 - Week 12|Other serious disease|1
5145887|NCT01500278|17775746|P1|Week 0 - Week 12|Other serious disease|0
5145888|NCT01500278|17775745|P2|Week 0 - Week 12|Personal reason|1
5145889|NCT01500278|17775746|P1|Week 0 - Week 12|Personal reason|0
5145890|NCT01500278|17775745|P2|Week 0 - Week 12|Sponsor decision|0
5145891|NCT01500278|17775746|P1|Week 0 - Week 12|Sponsor decision|1
5145892|NCT01500278|17775745|P2|Week 0 - Week 12|Prior history of serious disease|0
5145893|NCT01500278|17775746|P1|Week 0 - Week 12|Prior history of serious disease|1
5145894|NCT01500278|17775745|P2|Week 0 - Week 12|Investigator decision|0
5145895|NCT01500278|17775746|P1|Week 0 - Week 12|Investigator decision|1
5145896|NCT01500278|17775745|P2|Week 0 - Week 12|Exclusion criteria not met|0
5145897|NCT01500278|17775746|P1|Week 0 - Week 12|Exclusion criteria not met|1
5145898|NCT01500278|17775745|P2|Week 0 - Week 12|Patient decision|0
5145899|NCT01500278|17775746|P1|Week 0 - Week 12|Patient decision|1
5145900|NCT01500278|17775745|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
5145901|NCT01500278|17775746|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
5145902|NCT01500278|17775745|P2|Week 0 - Week 12|Withdrawal by Subject|2
5145903|NCT01500278|17775746|P1|Week 0 - Week 12|Withdrawal by Subject|7
5145904|NCT01500278|17775745|P2|Week 0 - Week 12|Lost to Follow-up|1
5145905|NCT01500278|17775746|P1|Week 0 - Week 12|Lost to Follow-up|1
5145906|NCT01500278|17775745|P2|Week 0 - Week 12|Protocol Violation|16
5145907|NCT01500278|17775746|P1|Week 0 - Week 12|Protocol Violation|10
5145908|NCT01500278|17775745|P2|Week 0 - Week 12|Lack of Efficacy|1
5145909|NCT01500278|17775746|P1|Week 0 - Week 12|Lack of Efficacy|0
5145910|NCT01500252|17775770|P2|Overall Study|Lost to Follow-up|4
5145911|NCT01500252|17775771|P1|Overall Study|Lost to Follow-up|5
5145912|NCT01500252|17775770|P2|Overall Study|Death|2
5145913|NCT01500252|17775771|P1|Overall Study|Death|4
5145914|NCT01500226|17775797|P2|Overall Study|Other Reasons|16
5145915|NCT01500226|17775798|P1|Overall Study|Other Reasons|19
5145916|NCT01500226|17775797|P2|Overall Study|Lost to Follow-up|5
5145917|NCT01500226|17775798|P1|Overall Study|Lost to Follow-up|9
5145918|NCT01500226|17775797|P2|Overall Study|Lack of Efficacy|30
5145919|NCT01500226|17775798|P1|Overall Study|Lack of Efficacy|14
5145920|NCT01500226|17775797|P2|Overall Study|Physician Decision|15
5145921|NCT01500226|17775798|P1|Overall Study|Physician Decision|17
5145922|NCT01500226|17775797|P2|Overall Study|Protocol Violation|39
5145923|NCT01500226|17775798|P1|Overall Study|Protocol Violation|53
5145924|NCT01500226|17775797|P2|Overall Study|Disease Progression|14
5145925|NCT01500226|17775798|P1|Overall Study|Disease Progression|16
5145926|NCT01500226|17775797|P2|Overall Study|Death|4
5145927|NCT01500226|17775798|P1|Overall Study|Death|12
5145928|NCT01500226|17775797|P2|Overall Study|Withdrawal by Subject|96
5145929|NCT01500226|17775798|P1|Overall Study|Withdrawal by Subject|93
5145930|NCT01500226|17775797|P2|Overall Study|Chemo Completed or Change in Therapy|237
5145931|NCT01500226|17775798|P1|Overall Study|Chemo Completed or Change in Therapy|235
5145932|NCT01500226|17775797|P2|Overall Study|Adverse Event|38
5145933|NCT01500226|17775798|P1|Overall Study|Adverse Event|31
5145934|NCT01500213|17775810|P2|Overall Study|Other Reasons|5
5145935|NCT01500213|17775811|P1|Overall Study|Other Reasons|7
5145936|NCT01500213|17775810|P2|Overall Study|Lost to Follow-up|6
5145937|NCT01500213|17775811|P1|Overall Study|Lost to Follow-up|3
5145938|NCT01500213|17775810|P2|Overall Study|Lack of Efficacy|7
5145939|NCT01500213|17775811|P1|Overall Study|Lack of Efficacy|9
5145940|NCT01500213|17775810|P2|Overall Study|Physician Decision|10
5145941|NCT01500213|17775811|P1|Overall Study|Physician Decision|12
5145942|NCT01500213|17775810|P2|Overall Study|Protocol Violation|19
5145943|NCT01500213|17775811|P1|Overall Study|Protocol Violation|19
5145944|NCT01500213|17775810|P2|Overall Study|Disease Progression|21
5145945|NCT01500213|17775811|P1|Overall Study|Disease Progression|13
5145946|NCT01500213|17775810|P2|Overall Study|Death|3
5145947|NCT01500213|17775811|P1|Overall Study|Death|7
5145948|NCT01500213|17775810|P2|Overall Study|Withdrawal by Subject|37
5145949|NCT01500213|17775811|P1|Overall Study|Withdrawal by Subject|28
5145950|NCT01500213|17775810|P2|Overall Study|Chemo Completed or Change in Therapy|81
5145951|NCT01500213|17775811|P1|Overall Study|Chemo Completed or Change in Therapy|84
5145952|NCT01500213|17775810|P2|Overall Study|Adverse Event|35
5145953|NCT01500213|17775811|P1|Overall Study|Adverse Event|35
5145954|NCT01500200|17775824|P6|Stage 2|Adverse Event|4
5145955|NCT01500200|17775825|P5|Stage 2|Adverse Event|5
5145956|NCT01500200|17775826|P4|Stage 2|Adverse Event|0
5145957|NCT01500200|17775827|P3|Stage 2|Adverse Event|0
5145958|NCT01500200|17775828|P2|Stage 2|Adverse Event|0
5145959|NCT01500200|17775829|P1|Stage 2|Adverse Event|0
5145960|NCT01500200|17775824|P6|Stage 1|Physician Decision|0
5145961|NCT01500200|17775825|P5|Stage 1|Physician Decision|0
5145962|NCT01500200|17775826|P4|Stage 1|Physician Decision|0
5145963|NCT01500200|17775827|P3|Stage 1|Physician Decision|0
5145964|NCT01500200|17775828|P2|Stage 1|Physician Decision|0
5145965|NCT01500200|17775829|P1|Stage 1|Physician Decision|1
5145966|NCT01500200|17775824|P6|Stage 1|Noncompliance with Study Drug|0
5145967|NCT01500200|17775825|P5|Stage 1|Noncompliance with Study Drug|0
5145968|NCT01500200|17775826|P4|Stage 1|Noncompliance with Study Drug|0
5145969|NCT01500200|17775827|P3|Stage 1|Noncompliance with Study Drug|0
5145970|NCT01500200|17775828|P2|Stage 1|Noncompliance with Study Drug|0
5145971|NCT01500200|17775829|P1|Stage 1|Noncompliance with Study Drug|1
5145972|NCT01500200|17775824|P6|Stage 1|Withdrawal by Subject|0
5145973|NCT01500200|17775825|P5|Stage 1|Withdrawal by Subject|0
5145974|NCT01500200|17775826|P4|Stage 1|Withdrawal by Subject|0
5145975|NCT01500200|17775827|P3|Stage 1|Withdrawal by Subject|0
5145976|NCT01500200|17775828|P2|Stage 1|Withdrawal by Subject|0
5145977|NCT01500200|17775829|P1|Stage 1|Withdrawal by Subject|3
5145978|NCT01500200|17775824|P6|Stage 1|Lost to Follow-up|0
5145979|NCT01500200|17775825|P5|Stage 1|Lost to Follow-up|0
5145980|NCT01500200|17775826|P4|Stage 1|Lost to Follow-up|0
5145981|NCT01500200|17775827|P3|Stage 1|Lost to Follow-up|1
5145982|NCT01500200|17775828|P2|Stage 1|Lost to Follow-up|2
5145983|NCT01500200|17775829|P1|Stage 1|Lost to Follow-up|2
5145984|NCT01500200|17775824|P6|Stage 1|Adverse Event|0
5145985|NCT01500200|17775825|P5|Stage 1|Adverse Event|0
5145986|NCT01500200|17775826|P4|Stage 1|Adverse Event|0
5145987|NCT01500200|17775827|P3|Stage 1|Adverse Event|5
5145988|NCT01500200|17775828|P2|Stage 1|Adverse Event|4
5145989|NCT01500200|17775829|P1|Stage 1|Adverse Event|1
5145990|NCT01500187|17775863|P2|Overall Study|Lost to Follow-up|0
5145991|NCT01500187|17775864|P1|Overall Study|Lost to Follow-up|6
5145992|NCT01500135|17775872|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
5145993|NCT01500135|17775873|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
5145994|NCT01500135|17775872|P2|Overall Study|Participant was a Safety Concern|0
5145995|NCT01500135|17775873|P1|Overall Study|Participant was a Safety Concern|1
5145996|NCT01500135|17775872|P2|Overall Study|Patient Missed Scheduled Appointments|1
5145997|NCT01500135|17775873|P1|Overall Study|Patient Missed Scheduled Appointments|0
5145998|NCT01500135|17775872|P2|Overall Study|Principal Investigator (PI) Discretion|0
5145999|NCT01500135|17775873|P1|Overall Study|Principal Investigator (PI) Discretion|1
5146000|NCT01500135|17775872|P2|Overall Study|Fatal Adverse Event (AE)|5
5146001|NCT01500135|17775873|P1|Overall Study|Fatal Adverse Event (AE)|5
5146002|NCT01500135|17775872|P2|Overall Study|Lost to Follow-up|4
5146003|NCT01500135|17775873|P1|Overall Study|Lost to Follow-up|6
5146004|NCT01500135|17775872|P2|Overall Study|Withdrawal of Consent|0
5146005|NCT01500135|17775873|P1|Overall Study|Withdrawal of Consent|4
5146006|NCT01500096|17775900|P4|Overall Study|Lost to Follow-up|2
5146007|NCT01500096|17775901|P3|Overall Study|Lost to Follow-up|0
5146008|NCT01500096|17775902|P2|Overall Study|Lost to Follow-up|0
5146009|NCT01500096|17775903|P1|Overall Study|Lost to Follow-up|1
5146010|NCT01500083|17775959|P2|Overall Study|Other Reasons|5
5146011|NCT01500083|17775960|P1|Overall Study|Other Reasons|2
5146012|NCT01500083|17775959|P2|Overall Study|Investigator Discretion|8
5146013|NCT01500083|17775960|P1|Overall Study|Investigator Discretion|3
5146014|NCT01500083|17775959|P2|Overall Study|Disease Progression|10
5146015|NCT01500083|17775960|P1|Overall Study|Disease Progression|2
5146016|NCT01500083|17775959|P2|Overall Study|Withdrawal of Consent|1
5146017|NCT01500083|17775960|P1|Overall Study|Withdrawal of Consent|0
5146018|NCT01500083|17775959|P2|Overall Study|Lost to Follow-up|0
5146019|NCT01500083|17775960|P1|Overall Study|Lost to Follow-up|1
5146020|NCT01500083|17775959|P2|Overall Study|Death|2
5146021|NCT01500083|17775960|P1|Overall Study|Death|0
5146022|NCT01500083|17775959|P2|Overall Study|Adverse Event|17
5146023|NCT01500083|17775960|P1|Overall Study|Adverse Event|4
5146024|NCT01500057|17775968|P2|Overall Study|Lost to Follow-up|4
5146025|NCT01500057|17775969|P1|Overall Study|Lost to Follow-up|6
5146026|NCT01500031|17775979|P1|Overall Study|Withdrawal by Subject|4
5146027|NCT01500031|17775979|P1|Overall Study|Death|1
5146028|NCT01499849|17776014|P2|Overall Study|Other Reasons|30
5146029|NCT01499849|17776015|P1|Overall Study|Other Reasons|27
5146030|NCT01499849|17776014|P2|Overall Study|Lost to Follow-up|3
5146031|NCT01499849|17776015|P1|Overall Study|Lost to Follow-up|6
5146032|NCT01499849|17776014|P2|Overall Study|Lack of Efficacy|4
5146033|NCT01499849|17776015|P1|Overall Study|Lack of Efficacy|3
5146034|NCT01499849|17776014|P2|Overall Study|Physician Decision|19
5146035|NCT01499849|17776015|P1|Overall Study|Physician Decision|20
5146036|NCT01499849|17776014|P2|Overall Study|Protocol Violation|11
5146037|NCT01499849|17776015|P1|Overall Study|Protocol Violation|11
5146038|NCT01499849|17776014|P2|Overall Study|Disease Progression|10
5146039|NCT01499849|17776015|P1|Overall Study|Disease Progression|11
5146040|NCT01499849|17776014|P2|Overall Study|Death|7
5146041|NCT01499849|17776015|P1|Overall Study|Death|5
5146042|NCT01499849|17776014|P2|Overall Study|Withdrawal by Subject|43
5146043|NCT01499849|17776015|P1|Overall Study|Withdrawal by Subject|43
5146044|NCT01499849|17776014|P2|Overall Study|Chemo completed or Change in Therapy|67
5146045|NCT01499849|17776015|P1|Overall Study|Chemo completed or Change in Therapy|70
5146046|NCT01499849|17776014|P2|Overall Study|Adverse Event|32
5146047|NCT01499849|17776015|P1|Overall Study|Adverse Event|28
5146048|NCT01499810|17776025|P1|Overall Study|Withdrawal by Subject|1
5146049|NCT01499810|17776025|P1|Overall Study|Protocol Violation|1
5146050|NCT01499810|17776025|P1|Overall Study|Lost to Follow-up|10
5146051|NCT01499667|17776075|P3|Overall Study|Lack of Efficacy|0
5146052|NCT01499667|17776076|P2|Overall Study|Lack of Efficacy|0
5146053|NCT01499667|17776077|P1|Overall Study|Lack of Efficacy|2
5146054|NCT01499667|17776075|P3|Overall Study|Withdrawal by Subject|1
5146055|NCT01499667|17776076|P2|Overall Study|Withdrawal by Subject|1
5146056|NCT01499667|17776077|P1|Overall Study|Withdrawal by Subject|2
5146057|NCT01499667|17776075|P3|Overall Study|Adverse Event|2
5146058|NCT01499667|17776076|P2|Overall Study|Adverse Event|2
5146059|NCT01499667|17776077|P1|Overall Study|Adverse Event|0
5146060|NCT01499667|17776075|P3|Overall Study|Protocol Violation|2
5146061|NCT01499667|17776076|P2|Overall Study|Protocol Violation|3
5146062|NCT01499667|17776077|P1|Overall Study|Protocol Violation|1
5146063|NCT01499667|17776075|P3|Overall Study|administrative problems|5
5146064|NCT01499667|17776076|P2|Overall Study|administrative problems|5
5146065|NCT01499667|17776077|P1|Overall Study|administrative problems|4
5146066|NCT01499576|17776125|P1|Overall Study|Withdrawal by Subject|9
5146067|NCT01499576|17776125|P1|Overall Study|Physician Decision|12
5146068|NCT01499511|17776133|P2|Overall Study|Death|0
5146069|NCT01499511|17776134|P1|Overall Study|Death|1
5146070|NCT01499368|17776162|P3|Overall Study|Error of Prescriptions|1
5146071|NCT01499368|17776163|P2|Overall Study|Error of Prescriptions|0
5146072|NCT01499368|17776164|P1|Overall Study|Error of Prescriptions|0
5146073|NCT01499368|17776162|P3|Overall Study|Deviation from visit window|1
5146074|NCT01499368|17776163|P2|Overall Study|Deviation from visit window|0
5146075|NCT01499368|17776164|P1|Overall Study|Deviation from visit window|0
5146076|NCT01499368|17776162|P3|Overall Study|Physician Decision|0
5146077|NCT01499368|17776163|P2|Overall Study|Physician Decision|1
5146078|NCT01499368|17776164|P1|Overall Study|Physician Decision|0
5146079|NCT01499368|17776162|P3|Overall Study|Adverse Event|2
5146080|NCT01499368|17776163|P2|Overall Study|Adverse Event|0
5146081|NCT01499368|17776164|P1|Overall Study|Adverse Event|4
5146082|NCT01499368|17776162|P3|Overall Study|Lost to Follow-up|5
5146083|NCT01499368|17776163|P2|Overall Study|Lost to Follow-up|2
5146084|NCT01499368|17776164|P1|Overall Study|Lost to Follow-up|3
5146085|NCT01499368|17776162|P3|Overall Study|Withdrawal by Subject|8
5146086|NCT01499368|17776163|P2|Overall Study|Withdrawal by Subject|10
5146087|NCT01499368|17776164|P1|Overall Study|Withdrawal by Subject|11
5146088|NCT01499368|17776162|P3|Overall Study|Prohibited Concomitant medication|0
5146089|NCT01499368|17776163|P2|Overall Study|Prohibited Concomitant medication|1
5146090|NCT01499368|17776164|P1|Overall Study|Prohibited Concomitant medication|1
5146091|NCT01499368|17776162|P3|Overall Study|Did not meet I/E criteria|4
5146092|NCT01499368|17776163|P2|Overall Study|Did not meet I/E criteria|4
5146093|NCT01499368|17776164|P1|Overall Study|Did not meet I/E criteria|8
5146094|NCT01499355|17776181|P4|Double-Blind Period|Lost to Follow-up|0
5146095|NCT01499355|17776182|P3|Double-Blind Period|Lost to Follow-up|0
5146096|NCT01499355|17776183|P2|Double-Blind Period|Lost to Follow-up|1
5146097|NCT01499355|17776184|P1|Double-Blind Period|Lost to Follow-up|0
5146098|NCT01499355|17776181|P4|Double-Blind Period|Consent Withdrawn|2
5146099|NCT01499355|17776182|P3|Double-Blind Period|Consent Withdrawn|1
5146100|NCT01499355|17776183|P2|Double-Blind Period|Consent Withdrawn|0
5146101|NCT01499355|17776184|P1|Double-Blind Period|Consent Withdrawn|0
5146102|NCT01499355|17776181|P4|Double-Blind Period|Investigator Decision|3
5146103|NCT01499355|17776182|P3|Double-Blind Period|Investigator Decision|3
5146104|NCT01499355|17776183|P2|Double-Blind Period|Investigator Decision|0
5146105|NCT01499355|17776184|P1|Double-Blind Period|Investigator Decision|0
5146106|NCT01499355|17776181|P4|Double-Blind Period|Death|0
5146107|NCT01499355|17776182|P3|Double-Blind Period|Death|0
5146108|NCT01499355|17776183|P2|Double-Blind Period|Death|1
5146109|NCT01499355|17776184|P1|Double-Blind Period|Death|0
5146110|NCT01499355|17776181|P4|Double-Blind Period|Other|2
5146111|NCT01499355|17776182|P3|Double-Blind Period|Other|2
5146112|NCT01499355|17776183|P2|Double-Blind Period|Other|1
5146113|NCT01499355|17776184|P1|Double-Blind Period|Other|0
5146114|NCT01499355|17776181|P4|Double-Blind Period|Study Termination|14
5146115|NCT01499355|17776182|P3|Double-Blind Period|Study Termination|16
5146116|NCT01499355|17776183|P2|Double-Blind Period|Study Termination|18
5146117|NCT01499355|17776184|P1|Double-Blind Period|Study Termination|0
5146118|NCT01499355|17776181|P4|Double-Blind Period|Adverse Event|2
5146119|NCT01499355|17776182|P3|Double-Blind Period|Adverse Event|3
5146120|NCT01499355|17776183|P2|Double-Blind Period|Adverse Event|2
5146121|NCT01499355|17776184|P1|Double-Blind Period|Adverse Event|0
5146122|NCT01499355|17776181|P4|Run-In Period|Adverse Event|0
5146123|NCT01499355|17776182|P3|Run-In Period|Adverse Event|0
5146124|NCT01499355|17776183|P2|Run-In Period|Adverse Event|0
5146125|NCT01499355|17776184|P1|Run-In Period|Adverse Event|8
5146126|NCT01499355|17776181|P4|Run-In Period|Consent Withdrawn|0
5146127|NCT01499355|17776182|P3|Run-In Period|Consent Withdrawn|0
5146128|NCT01499355|17776183|P2|Run-In Period|Consent Withdrawn|0
5146129|NCT01499355|17776184|P1|Run-In Period|Consent Withdrawn|1
5146130|NCT01499355|17776181|P4|Run-In Period|Investigator Decision|0
5146131|NCT01499355|17776182|P3|Run-In Period|Investigator Decision|0
5146132|NCT01499355|17776183|P2|Run-In Period|Investigator Decision|0
5146133|NCT01499355|17776184|P1|Run-In Period|Investigator Decision|2
5146134|NCT01499355|17776181|P4|Run-In Period|Death|0
5146135|NCT01499355|17776182|P3|Run-In Period|Death|0
5146136|NCT01499355|17776183|P2|Run-In Period|Death|0
5146137|NCT01499355|17776184|P1|Run-In Period|Death|2
5146138|NCT01499355|17776181|P4|Run-In Period|Other|0
5146139|NCT01499355|17776182|P3|Run-In Period|Other|0
5146140|NCT01499355|17776183|P2|Run-In Period|Other|0
5146141|NCT01499355|17776184|P1|Run-In Period|Other|3
5146142|NCT01499355|17776181|P4|Run-In Period|Study Termination|0
5146143|NCT01499355|17776182|P3|Run-In Period|Study Termination|0
5146144|NCT01499355|17776183|P2|Run-In Period|Study Termination|0
5146145|NCT01499355|17776184|P1|Run-In Period|Study Termination|15
5146146|NCT01499303|17776217|P2|Overall Study|Other|1
5146147|NCT01499303|17776218|P1|Overall Study|Other|0
5146148|NCT01499303|17776217|P2|Overall Study|Adverse Event|4
5146149|NCT01499303|17776218|P1|Overall Study|Adverse Event|1
5146150|NCT01499303|17776217|P2|Overall Study|Withdrawal by Subject|1
5146151|NCT01499303|17776218|P1|Overall Study|Withdrawal by Subject|0
5146152|NCT01499303|17776217|P2|Overall Study|Ongoing|1
5146153|NCT01499303|17776218|P1|Overall Study|Ongoing|2
5146154|NCT01499290|17776226|P2|Overall Study|Adverse Event|7
5146155|NCT01499290|17776227|P1|Overall Study|Adverse Event|14
5146156|NCT01499290|17776226|P2|Overall Study|Lack of Efficacy|8
5146157|NCT01499290|17776227|P1|Overall Study|Lack of Efficacy|7
5146158|NCT01499290|17776226|P2|Overall Study|Condition improved/subject recovered|0
5146159|NCT01499290|17776227|P1|Overall Study|Condition improved/subject recovered|1
5146160|NCT01499290|17776226|P2|Overall Study|Not specified in study report|5
5146161|NCT01499290|17776227|P1|Overall Study|Not specified in study report|11
5146162|NCT01499290|17776226|P2|Overall Study|Withdrawal by Subject|15
5146163|NCT01499290|17776227|P1|Overall Study|Withdrawal by Subject|22
5146164|NCT01499277|17776277|P2|Overall Study|Lack of therapeutic response and other|7
5146165|NCT01499277|17776278|P1|Overall Study|Lack of therapeutic response and other|8
5146166|NCT01499277|17776277|P2|Overall Study|Withdrawal by Subject|6
5146167|NCT01499277|17776278|P1|Overall Study|Withdrawal by Subject|16
5146168|NCT01499277|17776277|P2|Overall Study|Protocol Violation|3
5146169|NCT01499277|17776278|P1|Overall Study|Protocol Violation|2
5146170|NCT01499277|17776277|P2|Overall Study|Lost to Follow-up|8
5146171|NCT01499277|17776278|P1|Overall Study|Lost to Follow-up|15
5146172|NCT01499277|17776277|P2|Overall Study|Death|2
5146173|NCT01499277|17776278|P1|Overall Study|Death|3
5146174|NCT01499277|17776277|P2|Overall Study|Adverse Event|6
5146175|NCT01499277|17776278|P1|Overall Study|Adverse Event|3
5146176|NCT01499199|17776300|P1|Overall Study|Lack of Efficacy|1
5146177|NCT01499199|17776300|P1|Overall Study|Adverse Event|1
5146178|NCT01499160|17776329|P1|Overall Study|Withdrawal by Subject|1
5146179|NCT01499160|17776329|P1|Overall Study|Adverse Event|1
5146180|NCT01499134|17776352|P2|Overall Study|Withdrawal by Subject|1
5146181|NCT01499134|17776353|P1|Overall Study|Withdrawal by Subject|0
5146182|NCT01499095|17776375|P2|Overall Study|Perceived Lack of Efficacy|1
5146183|NCT01499095|17776376|P1|Overall Study|Perceived Lack of Efficacy|1
5146184|NCT01499095|17776375|P2|Overall Study|Change in Injection Schedule|0
5146185|NCT01499095|17776376|P1|Overall Study|Change in Injection Schedule|2
5146186|NCT01499095|17776375|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
5146187|NCT01499095|17776376|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
5146188|NCT01499095|17776375|P2|Overall Study|Hypoglycemia|1
5146189|NCT01499095|17776376|P1|Overall Study|Hypoglycemia|3
5146190|NCT01499095|17776375|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
5146191|NCT01499095|17776376|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
5146192|NCT01499095|17776375|P2|Overall Study|Lost to Follow-up|4
5146193|NCT01499095|17776376|P1|Overall Study|Lost to Follow-up|6
5146194|NCT01499095|17776375|P2|Overall Study|Diverse Reasons|25
5146195|NCT01499095|17776376|P1|Overall Study|Diverse Reasons|22
5146196|NCT01499095|17776375|P2|Overall Study|Received Rescue Therapy|40
5146197|NCT01499095|17776376|P1|Overall Study|Received Rescue Therapy|32
5146198|NCT01499095|17776375|P2|Overall Study|Protocol Violation|7
5146199|NCT01499095|17776376|P1|Overall Study|Protocol Violation|6
5146200|NCT01499095|17776375|P2|Overall Study|Lack of Efficacy|1
5146201|NCT01499095|17776376|P1|Overall Study|Lack of Efficacy|2
5146202|NCT01499095|17776375|P2|Overall Study|Adverse Event|7
5146203|NCT01499095|17776376|P1|Overall Study|Adverse Event|12
5146204|NCT01499095|17776375|P2|Overall Study|Randomized But Not Treated|1
5146205|NCT01499095|17776376|P1|Overall Study|Randomized But Not Treated|1
5146206|NCT01499082|17776406|P2|Overall Study|Lost to Follow-up|3
5146207|NCT01499082|17776407|P1|Overall Study|Lost to Follow-up|1
5146208|NCT01499082|17776406|P2|Overall Study|Hypoglycemia|3
5146209|NCT01499082|17776407|P1|Overall Study|Hypoglycemia|2
5146210|NCT01499082|17776406|P2|Overall Study|Site Closure for Noncompliance|2
5146211|NCT01499082|17776407|P1|Overall Study|Site Closure for Noncompliance|5
5146212|NCT01499082|17776406|P2|Overall Study|Diverse Reasons|14
5146213|NCT01499082|17776407|P1|Overall Study|Diverse Reasons|18
5146214|NCT01499082|17776406|P2|Overall Study|Protocol Violation|8
5146215|NCT01499082|17776407|P1|Overall Study|Protocol Violation|6
5146216|NCT01499082|17776406|P2|Overall Study|Lack of Efficacy|1
5146217|NCT01499082|17776407|P1|Overall Study|Lack of Efficacy|1
5146218|NCT01499082|17776406|P2|Overall Study|Adverse Event|16
5146219|NCT01499082|17776407|P1|Overall Study|Adverse Event|12
5146220|NCT01499082|17776406|P2|Overall Study|Randomized but not Treated|1
5146221|NCT01499082|17776407|P1|Overall Study|Randomized but not Treated|0
5146222|NCT01499043|17776435|P1|Overall Study|Adverse Event|1
5146223|NCT01499043|17776435|P1|Overall Study|Withdrawal by Subject|2
5146224|NCT01499043|17776435|P1|Overall Study|Progressive disease (clinical)|1
5146225|NCT01499043|17776435|P1|Overall Study|Progressive disease (radiographic)|2
5146226|NCT01498952|17776478|P5|Overall Study|Death|0
5146227|NCT01498952|17776479|P4|Overall Study|Death|0
5146228|NCT01498952|17776480|P3|Overall Study|Death|0
5146229|NCT01498952|17776481|P2|Overall Study|Death|2
5146230|NCT01498952|17776482|P1|Overall Study|Death|2
5146231|NCT01498887|17776524|P2|Overall Study|Adverse Event|1
5146232|NCT01498887|17776525|P1|Overall Study|Adverse Event|4
5146233|NCT01498887|17776524|P2|Overall Study|Abnormal laboratory value|2
5146234|NCT01498887|17776525|P1|Overall Study|Abnormal laboratory value|2
5146235|NCT01498887|17776524|P2|Overall Study|Abnormal result from test procedure|1
5146236|NCT01498887|17776525|P1|Overall Study|Abnormal result from test procedure|1
5146237|NCT01498887|17776524|P2|Overall Study|Lack of Efficacy|3
5146238|NCT01498887|17776525|P1|Overall Study|Lack of Efficacy|5
5146239|NCT01498887|17776524|P2|Overall Study|Protocol Violation|3
5146240|NCT01498887|17776525|P1|Overall Study|Protocol Violation|1
5146241|NCT01498887|17776524|P2|Overall Study|Withdrawal by Subject|0
5146242|NCT01498887|17776525|P1|Overall Study|Withdrawal by Subject|1
5146243|NCT01498887|17776524|P2|Overall Study|Lost to Follow-up|1
5146244|NCT01498887|17776525|P1|Overall Study|Lost to Follow-up|1
5146245|NCT01498887|17776524|P2|Overall Study|Administrative problems|0
5146246|NCT01498887|17776525|P1|Overall Study|Administrative problems|1
5146247|NCT01498822|17776546|P2|Overall Study|Lost to Follow-up|3
5146248|NCT01498822|17776547|P1|Overall Study|Lost to Follow-up|8
5146249|NCT01498822|17776546|P2|Overall Study|Withdrawal by Subject|25
5146250|NCT01498822|17776547|P1|Overall Study|Withdrawal by Subject|15
5146251|NCT01498822|17776546|P2|Overall Study|Adverse Event, serious fatal|1
5146252|NCT01498822|17776547|P1|Overall Study|Adverse Event, serious fatal|1
5146253|NCT01498822|17776546|P2|Overall Study|SAE, non-fatal|2
5146254|NCT01498822|17776547|P1|Overall Study|SAE, non-fatal|2
5146255|NCT01498822|17776546|P2|Overall Study|AE, non-serious non-fatal|17
5146256|NCT01498822|17776547|P1|Overall Study|AE, non-serious non-fatal|8
5146257|NCT01498822|17776546|P2|Overall Study|Lack of Efficacy|2
5146258|NCT01498822|17776547|P1|Overall Study|Lack of Efficacy|7
5146259|NCT01498822|17776546|P2|Overall Study|Other Reason|2
5146260|NCT01498822|17776547|P1|Overall Study|Other Reason|5
5146261|NCT01498822|17776546|P2|Overall Study|Protocol Violation|4
5146262|NCT01498822|17776547|P1|Overall Study|Protocol Violation|8
5146263|NCT01498692|17776574|P1|Overall Study|Missed 12-month visit|3
5146264|NCT01498692|17776574|P1|Overall Study|Withdrawal by Subject|1
5146265|NCT01498692|17776574|P1|Overall Study|Death|4
5146266|NCT01498679|17776605|P2|Overall Study|Withdrawal by Subject|4
5146267|NCT01498679|17776606|P1|Overall Study|Withdrawal by Subject|12
5146268|NCT01498679|17776605|P2|Overall Study|Physician Decision|2
5146269|NCT01498679|17776606|P1|Overall Study|Physician Decision|0
5146270|NCT01498679|17776605|P2|Overall Study|Protocol Violation|0
5146271|NCT01498679|17776606|P1|Overall Study|Protocol Violation|4
5146272|NCT01498679|17776605|P2|Overall Study|Lack of Efficacy|12
5146273|NCT01498679|17776606|P1|Overall Study|Lack of Efficacy|72
5146274|NCT01498679|17776605|P2|Overall Study|Adverse Event|4
5146275|NCT01498679|17776606|P1|Overall Study|Adverse Event|1
5146276|NCT01498653|17776622|P2|Overall Study|Withdrawal by Subject|3
5146277|NCT01498653|17776623|P1|Overall Study|Withdrawal by Subject|2
5146278|NCT01498653|17776622|P2|Overall Study|Physician Decision|0
5146279|NCT01498653|17776623|P1|Overall Study|Physician Decision|2
5146280|NCT01498653|17776622|P2|Overall Study|Lost to Follow-up|0
5146281|NCT01498653|17776623|P1|Overall Study|Lost to Follow-up|1
5146282|NCT01498653|17776622|P2|Overall Study|Protocol Violation|4
5146283|NCT01498653|17776623|P1|Overall Study|Protocol Violation|0
5146284|NCT01498653|17776622|P2|Overall Study|Lack of Efficacy|26
5146285|NCT01498653|17776623|P1|Overall Study|Lack of Efficacy|12
5146286|NCT01498653|17776622|P2|Overall Study|Adverse Event|2
5146287|NCT01498653|17776623|P1|Overall Study|Adverse Event|2
5146288|NCT01498640|17776637|P1|Overall Study|Other|3
5146289|NCT01498640|17776637|P1|Overall Study|Death|1
5146290|NCT01498640|17776637|P1|Overall Study|Lost to Follow-up|1
5146291|NCT01498575|17776667|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
5146292|NCT01498575|17776668|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
5146293|NCT01498575|17776667|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
5146294|NCT01498575|17776668|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
5146295|NCT01498575|17776667|P2|Overall Sample|Withdrawal by Subject|14
5146296|NCT01498575|17776668|P1|Overall Sample|Withdrawal by Subject|60
5146297|NCT01498458|17776685|P1|Overall Study|Physician Decision|3
5146298|NCT01498458|17776685|P1|Overall Study|Adverse Event|4
5146299|NCT01498445|17776700|P6|Overall Study|Screen Failure|1
5146300|NCT01498445|17776701|P5|Overall Study|Screen Failure|1
5146301|NCT01498445|17776702|P4|Overall Study|Screen Failure|0
5146302|NCT01498445|17776703|P3|Overall Study|Screen Failure|0
5146303|NCT01498445|17776704|P2|Overall Study|Screen Failure|0
5146304|NCT01498445|17776705|P1|Overall Study|Screen Failure|0
5146305|NCT01498445|17776700|P6|Overall Study|Lack of Efficacy|0
5146306|NCT01498445|17776701|P5|Overall Study|Lack of Efficacy|0
5146307|NCT01498445|17776702|P4|Overall Study|Lack of Efficacy|2
5146308|NCT01498445|17776703|P3|Overall Study|Lack of Efficacy|1
5146309|NCT01498445|17776704|P2|Overall Study|Lack of Efficacy|0
5146310|NCT01498445|17776705|P1|Overall Study|Lack of Efficacy|0
5146311|NCT01498289|17776780|P2|Overall Study|Reason under review|1
5146312|NCT01498289|17776781|P1|Overall Study|Reason under review|0
5146313|NCT01498289|17776780|P2|Overall Study|Not protocol specified|2
5146314|NCT01498289|17776781|P1|Overall Study|Not protocol specified|7
5146315|NCT01498289|17776780|P2|Overall Study|Progression/relapse|59
5146316|NCT01498289|17776781|P1|Overall Study|Progression/relapse|53
5146317|NCT01498289|17776780|P2|Overall Study|Withdrawal unrelated to AE|16
5146318|NCT01498289|17776781|P1|Overall Study|Withdrawal unrelated to AE|16
5146319|NCT01498289|17776780|P2|Overall Study|Death|8
5146320|NCT01498289|17776781|P1|Overall Study|Death|6
5146321|NCT01498289|17776780|P2|Overall Study|Adverse Event|18
5146322|NCT01498289|17776781|P1|Overall Study|Adverse Event|16
5146323|NCT01498185|17776802|P5|Overall Study|No longer met criteria, etc|2
5146324|NCT01498185|17776803|P4|Overall Study|No longer met criteria, etc|0
5146325|NCT01498185|17776804|P3|Overall Study|No longer met criteria, etc|0
5146326|NCT01498185|17776805|P2|Overall Study|No longer met criteria, etc|0
5146327|NCT01498185|17776806|P1|Overall Study|No longer met criteria, etc|0
5146328|NCT01498185|17776802|P5|Overall Study|Withdrawal by Subject|1
5146329|NCT01498185|17776803|P4|Overall Study|Withdrawal by Subject|2
5146330|NCT01498185|17776804|P3|Overall Study|Withdrawal by Subject|0
5146331|NCT01498185|17776805|P2|Overall Study|Withdrawal by Subject|1
5146332|NCT01498185|17776806|P1|Overall Study|Withdrawal by Subject|1
5146333|NCT01498185|17776802|P5|Overall Study|Adverse Event|0
5146334|NCT01498185|17776803|P4|Overall Study|Adverse Event|1
5146335|NCT01498185|17776804|P3|Overall Study|Adverse Event|0
5146336|NCT01498185|17776805|P2|Overall Study|Adverse Event|0
5146337|NCT01498185|17776806|P1|Overall Study|Adverse Event|0
5146338|NCT01498120|17776846|P1|Overall Study|Other|4
5146339|NCT01498120|17776846|P1|Overall Study|AE, non-serious non-fatal|3
5146340|NCT01498120|17776846|P1|Overall Study|Withdrawal by Subject|5
5146341|NCT01498120|17776846|P1|Overall Study|Lost to Follow-up|1
5146342|NCT01498068|17776853|P2|Overall Study|Withdrawal by Subject|1
5146343|NCT01498068|17776854|P1|Overall Study|Withdrawal by Subject|1
5146344|NCT01497938|17776872|P2|Overall Study|Device Violation|0
5146345|NCT01497938|17776873|P1|Overall Study|Device Violation|1
5146346|NCT01497938|17776872|P2|Overall Study|Withdrawal by Subject|0
5146347|NCT01497938|17776873|P1|Overall Study|Withdrawal by Subject|4
5146348|NCT01497938|17776872|P2|Overall Study|Physician Decision|1
5146349|NCT01497938|17776873|P1|Overall Study|Physician Decision|0
5146350|NCT01497938|17776872|P2|Overall Study|Adverse Event|1
5146351|NCT01497938|17776873|P1|Overall Study|Adverse Event|0
5146352|NCT01497899|17776885|P4|Open-Label Extension Phase|Lost to Follow-up|5
5146353|NCT01497899|17776886|P3|Open-Label Extension Phase|Lost to Follow-up|5
5146354|NCT01497899|17776887|P2|Open-Label Extension Phase|Lost to Follow-up|3
5146355|NCT01497899|17776888|P1|Open-Label Extension Phase|Lost to Follow-up|9
5146356|NCT01497899|17776885|P4|Open-Label Extension Phase|Protocol Violation|0
5146357|NCT01497899|17776886|P3|Open-Label Extension Phase|Protocol Violation|1
5146358|NCT01497899|17776887|P2|Open-Label Extension Phase|Protocol Violation|0
5146359|NCT01497899|17776888|P1|Open-Label Extension Phase|Protocol Violation|0
5146360|NCT01497899|17776885|P4|Open-Label Extension Phase|Pregnancy|0
5146361|NCT01497899|17776886|P3|Open-Label Extension Phase|Pregnancy|1
5146362|NCT01497899|17776887|P2|Open-Label Extension Phase|Pregnancy|1
5146363|NCT01497899|17776888|P1|Open-Label Extension Phase|Pregnancy|0
5146364|NCT01497899|17776885|P4|Open-Label Extension Phase|Withdrew Consent|0
5146365|NCT01497899|17776886|P3|Open-Label Extension Phase|Withdrew Consent|2
5146366|NCT01497899|17776887|P2|Open-Label Extension Phase|Withdrew Consent|3
5146367|NCT01497899|17776888|P1|Open-Label Extension Phase|Withdrew Consent|8
5146368|NCT01497899|17776885|P4|Open-Label Extension Phase|Death|0
5146369|NCT01497899|17776886|P3|Open-Label Extension Phase|Death|0
5146370|NCT01497899|17776887|P2|Open-Label Extension Phase|Death|0
5146371|NCT01497899|17776888|P1|Open-Label Extension Phase|Death|1
5146372|NCT01497899|17776885|P4|Open-Label Extension Phase|Adverse Event|0
5146373|NCT01497899|17776886|P3|Open-Label Extension Phase|Adverse Event|0
5146374|NCT01497899|17776887|P2|Open-Label Extension Phase|Adverse Event|0
5146375|NCT01497899|17776888|P1|Open-Label Extension Phase|Adverse Event|1
5146376|NCT01497899|17776885|P4|Double-Blind Phase|Subject Non-Compliance|0
5146377|NCT01497899|17776886|P3|Double-Blind Phase|Subject Non-Compliance|0
5146378|NCT01497899|17776887|P2|Double-Blind Phase|Subject Non-Compliance|1
5146379|NCT01497899|17776888|P1|Double-Blind Phase|Subject Non-Compliance|0
5146380|NCT01497899|17776885|P4|Double-Blind Phase|Lost to Follow-up|0
5146381|NCT01497899|17776886|P3|Double-Blind Phase|Lost to Follow-up|0
5146382|NCT01497899|17776887|P2|Double-Blind Phase|Lost to Follow-up|2
5146383|NCT01497899|17776888|P1|Double-Blind Phase|Lost to Follow-up|3
5146384|NCT01497899|17776885|P4|Double-Blind Phase|Withdrew Consent|0
5146385|NCT01497899|17776886|P3|Double-Blind Phase|Withdrew Consent|0
5146386|NCT01497899|17776887|P2|Double-Blind Phase|Withdrew Consent|1
5146387|NCT01497899|17776888|P1|Double-Blind Phase|Withdrew Consent|0
5146388|NCT01497899|17776885|P4|Double-Blind Phase|Investigator's Discretion|0
5146389|NCT01497899|17776886|P3|Double-Blind Phase|Investigator's Discretion|0
5146390|NCT01497899|17776887|P2|Double-Blind Phase|Investigator's Discretion|0
5146391|NCT01497899|17776888|P1|Double-Blind Phase|Investigator's Discretion|1
5146392|NCT01497899|17776885|P4|Double-Blind Phase|Lack of Efficacy|0
5146393|NCT01497899|17776886|P3|Double-Blind Phase|Lack of Efficacy|0
5146394|NCT01497899|17776887|P2|Double-Blind Phase|Lack of Efficacy|1
5146395|NCT01497899|17776888|P1|Double-Blind Phase|Lack of Efficacy|0
5146396|NCT01497899|17776885|P4|Double-Blind Phase|Adverse Event|0
5146397|NCT01497899|17776886|P3|Double-Blind Phase|Adverse Event|0
5146398|NCT01497899|17776887|P2|Double-Blind Phase|Adverse Event|0
5146399|NCT01497899|17776888|P1|Double-Blind Phase|Adverse Event|1
5146400|NCT01497899|17776885|P4|Double-Blind Phase|Randomized but not Treated|0
5146401|NCT01497899|17776886|P3|Double-Blind Phase|Randomized but not Treated|0
5146402|NCT01497899|17776887|P2|Double-Blind Phase|Randomized but not Treated|0
5146403|NCT01497899|17776888|P1|Double-Blind Phase|Randomized but not Treated|1
5146404|NCT01497366|17776965|P2|Overall Study|Randomized but not treated|21
5146405|NCT01497366|17776966|P1|Overall Study|Randomized but not treated|7
5146406|NCT01497366|17776965|P2|Overall Study|Death|1
5146407|NCT01497366|17776966|P1|Overall Study|Death|1
5146408|NCT01497366|17776965|P2|Overall Study|Other|0
5146409|NCT01497366|17776966|P1|Overall Study|Other|5
5146410|NCT01497366|17776965|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
5146411|NCT01497366|17776966|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
5146412|NCT01497366|17776965|P2|Overall Study|Withdrawal by Subject|6
5146413|NCT01497366|17776966|P1|Overall Study|Withdrawal by Subject|6
5146414|NCT01497366|17776965|P2|Overall Study|Lost to Follow-up|10
5146415|NCT01497366|17776966|P1|Overall Study|Lost to Follow-up|11
5146416|NCT01497366|17776965|P2|Overall Study|Virologic failure|50
5146417|NCT01497366|17776966|P1|Overall Study|Virologic failure|2
5146418|NCT01497275|17776984|P1|Overall Study|Adverse Event|1
5146419|NCT01497275|17776984|P1|Overall Study|Death|1
5146420|NCT01497262|17776991|P1|Overall Study|Protocol Violation|1
5146421|NCT01497262|17776991|P1|Overall Study|Adverse Event|2
5146422|NCT01497262|17776991|P1|Overall Study|Withdrawal by Subject|2
5146423|NCT01497262|17776991|P1|Overall Study|Physician Decision|1
5146424|NCT01497262|17776991|P1|Overall Study|Abnormal Test Procedure Result|1
5146425|NCT01497262|17776991|P1|Overall Study|Abnormal Lab Values|4
5146426|NCT01497197|17776998|P2|Overall Study|Other|1
5146427|NCT01497197|17776999|P1|Overall Study|Other|3
5146428|NCT01497197|17776998|P2|Overall Study|All embryos discarded|3
5146429|NCT01497197|17776999|P1|Overall Study|All embryos discarded|0
5146430|NCT01497197|17776998|P2|Overall Study|Intention to freeze all embryos|1
5146431|NCT01497197|17776999|P1|Overall Study|Intention to freeze all embryos|0
5146432|NCT01497197|17776998|P2|Overall Study|No fertilisation|5
5146433|NCT01497197|17776999|P1|Overall Study|No fertilisation|6
5146434|NCT01497197|17776998|P2|Overall Study|No oocytes retrieved|2
5146435|NCT01497197|17776999|P1|Overall Study|No oocytes retrieved|3
5146436|NCT01497197|17776998|P2|Overall Study|Risk of OHSS|0
5146437|NCT01497197|17776999|P1|Overall Study|Risk of OHSS|1
5146438|NCT01497197|17776998|P2|Overall Study|Excessive/lack of response to treatment|0
5146439|NCT01497197|17776999|P1|Overall Study|Excessive/lack of response to treatment|1
5146440|NCT01497197|17776998|P2|Overall Study|Withdrawal by Subject|1
5146441|NCT01497197|17776999|P1|Overall Study|Withdrawal by Subject|2
5146442|NCT01497197|17776998|P2|Overall Study|Protocol Violation|2
5146443|NCT01497197|17776999|P1|Overall Study|Protocol Violation|0
5146444|NCT01497197|17776998|P2|Overall Study|Lost to Follow-up|0
5146445|NCT01497197|17776999|P1|Overall Study|Lost to Follow-up|1
5146446|NCT01497067|17777034|P1|Overall Study|Other|13
5146447|NCT01497067|17777034|P1|Overall Study|Patient decision unrel to Adverse Event|10
5146448|NCT01497067|17777034|P1|Overall Study|Adverse Event|3
5146449|NCT01497067|17777034|P1|Overall Study|Lost to Follow-up|56
5146450|NCT01496846|17777045|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5146451|NCT01496846|17777046|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5146452|NCT01496846|17777047|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5146453|NCT01496846|17777048|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5146454|NCT01496846|17777049|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
5146455|NCT01496846|17777050|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
5146456|NCT01496807|17777061|P1|Overall Study|Change in diagnosis|1
5146457|NCT01496807|17777061|P1|Overall Study|Participant preference/toxicity|8
5146458|NCT01496807|17777061|P1|Overall Study|Progressive Disease|21
5146459|NCT01496469|17777073|P2|Overall Study|Other|1
5146460|NCT01496469|17777074|P1|Overall Study|Other|1
5146461|NCT01496469|17777073|P2|Overall Study|BP exceeds protocol limits|2
5146462|NCT01496469|17777074|P1|Overall Study|BP exceeds protocol limits|1
5146463|NCT01496469|17777073|P2|Overall Study|Withdrawal by Subject|4
5146464|NCT01496469|17777074|P1|Overall Study|Withdrawal by Subject|4
5146465|NCT01496469|17777073|P2|Overall Study|Lost to Follow-up|1
5146466|NCT01496469|17777074|P1|Overall Study|Lost to Follow-up|1
5146467|NCT01496469|17777073|P2|Overall Study|Protocol Violation|0
5146468|NCT01496469|17777074|P1|Overall Study|Protocol Violation|2
5146469|NCT01496469|17777073|P2|Overall Study|Adverse Event|0
5146470|NCT01496469|17777074|P1|Overall Study|Adverse Event|1
5146471|NCT01496456|17777084|P1|Overall Study|Lost to Follow-up|7
5146472|NCT01496456|17777084|P1|Overall Study|Protocol Violation|1
5146473|NCT01496430|17777097|P3|Overall Study|Other|0
5146474|NCT01496430|17777098|P2|Overall Study|Other|0
5146475|NCT01496430|17777099|P1|Overall Study|Other|2
5146476|NCT01496430|17777097|P3|Overall Study|Principal Investigator Discretion|1
5146477|NCT01496430|17777098|P2|Overall Study|Principal Investigator Discretion|1
5146478|NCT01496430|17777099|P1|Overall Study|Principal Investigator Discretion|0
5146479|NCT01496430|17777097|P3|Overall Study|Voluntary Withdrawal|6
5146480|NCT01496430|17777098|P2|Overall Study|Voluntary Withdrawal|1
5146481|NCT01496430|17777099|P1|Overall Study|Voluntary Withdrawal|2
5146482|NCT01496430|17777097|P3|Overall Study|Lost to Follow-up|1
5146483|NCT01496430|17777098|P2|Overall Study|Lost to Follow-up|3
5146484|NCT01496430|17777099|P1|Overall Study|Lost to Follow-up|2
5146485|NCT01496430|17777097|P3|Overall Study|Major Protocol Deviation|1
5146486|NCT01496430|17777098|P2|Overall Study|Major Protocol Deviation|0
5146487|NCT01496430|17777099|P1|Overall Study|Major Protocol Deviation|0
5146488|NCT01496430|17777097|P3|Overall Study|Adverse Event|1
5146489|NCT01496430|17777098|P2|Overall Study|Adverse Event|0
5146490|NCT01496430|17777099|P1|Overall Study|Adverse Event|0
5146491|NCT01496287|17777211|P1|Overall Study|Incomplete anesthesia|5
5146492|NCT01496287|17777211|P1|Overall Study|Lost to Follow-up|1
5146493|NCT01496274|17777221|P2|Overall Study|Lost to Follow-up|3
5146494|NCT01496274|17777222|P1|Overall Study|Lost to Follow-up|0
5146495|NCT01496274|17777221|P2|Overall Study|Withdrawal by Subject|0
5146496|NCT01496274|17777222|P1|Overall Study|Withdrawal by Subject|2
5146497|NCT01496274|17777221|P2|Overall Study|Adverse Event|1
5146498|NCT01496274|17777222|P1|Overall Study|Adverse Event|1
5146499|NCT01496274|17777221|P2|Overall Study|Protocol Violation|1
5146500|NCT01496274|17777222|P1|Overall Study|Protocol Violation|0
5146501|NCT01496183|17777267|P2|Overall Study|Withdrawal by Subject|1
5146502|NCT01496183|17777268|P1|Overall Study|Withdrawal by Subject|0
5146503|NCT01496183|17777267|P2|Overall Study|Physician Decision|1
5146504|NCT01496183|17777268|P1|Overall Study|Physician Decision|3
5146505|NCT01496066|17777320|P2|Overall Study|Death|4
5146506|NCT01496066|17777321|P1|Overall Study|Death|1
5146507|NCT01496066|17777320|P2|Overall Study|Explant|0
5146508|NCT01496066|17777321|P1|Overall Study|Explant|3
5146509|NCT01496066|17777320|P2|Overall Study|Lost to Follow-up|5
5146510|NCT01496066|17777321|P1|Overall Study|Lost to Follow-up|8
5146511|NCT01495975|17777383|P2|Overall Study|Lost to Follow-up|0
5146512|NCT01495975|17777384|P1|Overall Study|Lost to Follow-up|1
5146513|NCT01495793|17777508|P1|Overall Study|Violation of inclusion criteria|1
5146514|NCT01495793|17777508|P1|Overall Study|Lost to Follow-up|1
5146515|NCT01495702|17777521|P2|Randomized Phase|Protocol Violation|1
5146516|NCT01495702|17777522|P1|Randomized Phase|Protocol Violation|3
5146517|NCT01495702|17777521|P2|Randomized Phase|Participant Noncompliance|0
5146518|NCT01495702|17777522|P1|Randomized Phase|Participant Noncompliance|1
5146519|NCT01495702|17777521|P2|Randomized Phase|Lost to Follow-up|3
5146520|NCT01495702|17777522|P1|Randomized Phase|Lost to Follow-up|4
5146521|NCT01495702|17777521|P2|Randomized Phase|Withdrew Consent|18
5146522|NCT01495702|17777522|P1|Randomized Phase|Withdrew Consent|10
5146523|NCT01495702|17777521|P2|Randomized Phase|Investigators Discretion|0
5146524|NCT01495702|17777522|P1|Randomized Phase|Investigators Discretion|2
5146525|NCT01495702|17777521|P2|Randomized Phase|Lack of Efficacy|0
5146526|NCT01495702|17777522|P1|Randomized Phase|Lack of Efficacy|2
5146527|NCT01495702|17777521|P2|Randomized Phase|Death|0
5146528|NCT01495702|17777522|P1|Randomized Phase|Death|1
5146529|NCT01495702|17777521|P2|Randomized Phase|Adverse Event|2
5146530|NCT01495702|17777522|P1|Randomized Phase|Adverse Event|2
5146531|NCT01495702|17777521|P2|Randomized Phase|Randomized But Not Treated|4
5146532|NCT01495702|17777522|P1|Randomized Phase|Randomized But Not Treated|1
5146533|NCT01495000|17777600|P2|Overall Study|Withdrawal by Subject|10
5146534|NCT01495000|17777601|P1|Overall Study|Withdrawal by Subject|10
5146535|NCT01495000|17777600|P2|Overall Study|Protocol Violation|0
5146536|NCT01495000|17777601|P1|Overall Study|Protocol Violation|1
5146537|NCT01495000|17777600|P2|Overall Study|Lost to Follow-up|2
5146538|NCT01495000|17777601|P1|Overall Study|Lost to Follow-up|2
5146539|NCT01494987|17777643|P2|Overall Study|Subject Withdrew Consent|3
5146540|NCT01494987|17777644|P1|Overall Study|Subject Withdrew Consent|2
5146541|NCT01494987|17777643|P2|Overall Study|Subject Non-Compliance|10
5146542|NCT01494987|17777644|P1|Overall Study|Subject Non-Compliance|9
5146543|NCT01494987|17777643|P2|Overall Study|Protocol Violation|3
5146544|NCT01494987|17777644|P1|Overall Study|Protocol Violation|3
5146545|NCT01494987|17777643|P2|Overall Study|Lost to Follow-up|1
5146546|NCT01494987|17777644|P1|Overall Study|Lost to Follow-up|1
5146547|NCT01494987|17777643|P2|Overall Study|Investigator's Discretion|2
5146548|NCT01494987|17777644|P1|Overall Study|Investigator's Discretion|1
5146549|NCT01494987|17777643|P2|Overall Study|Hyperglycemia|4
5146550|NCT01494987|17777644|P1|Overall Study|Hyperglycemia|6
5146551|NCT01494987|17777643|P2|Overall Study|Adverse Event|5
5146552|NCT01494987|17777644|P1|Overall Study|Adverse Event|6
5146553|NCT01494818|17777658|P2|Overall Study|Lost to Follow-up|0
5146554|NCT01494818|17777659|P1|Overall Study|Lost to Follow-up|1
5146555|NCT01494818|17777658|P2|Overall Study|Relocation|2
5146556|NCT01494818|17777659|P1|Overall Study|Relocation|1
5146557|NCT01494649|17777690|P2|Overall Study|Lost to Follow-up|1
5146558|NCT01494649|17777691|P1|Overall Study|Lost to Follow-up|0
5146559|NCT01494610|17777707|P2|Period 4|Protocol Violation|0
5146560|NCT01494610|17777708|P1|Period 4|Protocol Violation|1
5146561|NCT01494610|17777707|P2|Period 3|Withdrawal by Subject|0
5146562|NCT01494610|17777708|P1|Period 3|Withdrawal by Subject|1
5146563|NCT01494610|17777707|P2|Period 3|Adverse Event|0
5146564|NCT01494610|17777708|P1|Period 3|Adverse Event|1
5146565|NCT01494610|17777707|P2|Period 1|Withdrawal by Subject|1
5146566|NCT01494610|17777708|P1|Period 1|Withdrawal by Subject|1
5146567|NCT01494584|17777776|P1|Overall Study|Study Closed/Terminated|1
5146568|NCT01494532|17777908|P6|Overall Study|Withdrawal by Subject|0
5146569|NCT01494532|17777909|P5|Overall Study|Withdrawal by Subject|2
5146570|NCT01494532|17777910|P4|Overall Study|Withdrawal by Subject|3
5146571|NCT01494532|17777911|P3|Overall Study|Withdrawal by Subject|4
5146572|NCT01494532|17777912|P2|Overall Study|Withdrawal by Subject|1
5146573|NCT01494532|17777913|P1|Overall Study|Withdrawal by Subject|3
5146574|NCT01494532|17777908|P6|Overall Study|Physician Decision|0
5146575|NCT01494532|17777909|P5|Overall Study|Physician Decision|0
5146576|NCT01494532|17777910|P4|Overall Study|Physician Decision|2
5146577|NCT01494532|17777911|P3|Overall Study|Physician Decision|1
5146578|NCT01494532|17777912|P2|Overall Study|Physician Decision|1
5146579|NCT01494532|17777913|P1|Overall Study|Physician Decision|0
5146580|NCT01494532|17777908|P6|Overall Study|Lost to Follow-up|0
5146581|NCT01494532|17777909|P5|Overall Study|Lost to Follow-up|0
5146582|NCT01494532|17777910|P4|Overall Study|Lost to Follow-up|2
5146583|NCT01494532|17777911|P3|Overall Study|Lost to Follow-up|0
5146584|NCT01494532|17777912|P2|Overall Study|Lost to Follow-up|0
5146585|NCT01494532|17777913|P1|Overall Study|Lost to Follow-up|1
5146586|NCT01494532|17777908|P6|Overall Study|Protocol-defined stopping criteria|0
5146587|NCT01494532|17777909|P5|Overall Study|Protocol-defined stopping criteria|0
5146588|NCT01494532|17777910|P4|Overall Study|Protocol-defined stopping criteria|0
5146589|NCT01494532|17777911|P3|Overall Study|Protocol-defined stopping criteria|1
5146590|NCT01494532|17777912|P2|Overall Study|Protocol-defined stopping criteria|0
5146591|NCT01494532|17777913|P1|Overall Study|Protocol-defined stopping criteria|0
5146592|NCT01494532|17777908|P6|Overall Study|Protocol deviation|0
5146593|NCT01494532|17777909|P5|Overall Study|Protocol deviation|3
5146594|NCT01494532|17777910|P4|Overall Study|Protocol deviation|2
5146595|NCT01494532|17777911|P3|Overall Study|Protocol deviation|3
5146596|NCT01494532|17777912|P2|Overall Study|Protocol deviation|1
5146597|NCT01494532|17777913|P1|Overall Study|Protocol deviation|2
5146598|NCT01494532|17777908|P6|Overall Study|Lack of Efficacy|0
5146599|NCT01494532|17777909|P5|Overall Study|Lack of Efficacy|2
5146600|NCT01494532|17777910|P4|Overall Study|Lack of Efficacy|0
5146601|NCT01494532|17777911|P3|Overall Study|Lack of Efficacy|0
5146602|NCT01494532|17777912|P2|Overall Study|Lack of Efficacy|0
5146603|NCT01494532|17777913|P1|Overall Study|Lack of Efficacy|0
5146604|NCT01494532|17777908|P6|Overall Study|Adverse Event|0
5146605|NCT01494532|17777909|P5|Overall Study|Adverse Event|5
5146606|NCT01494532|17777910|P4|Overall Study|Adverse Event|6
5146607|NCT01494532|17777911|P3|Overall Study|Adverse Event|8
5146608|NCT01494532|17777912|P2|Overall Study|Adverse Event|1
5146609|NCT01494532|17777913|P1|Overall Study|Adverse Event|4
5146610|NCT01494506|17778068|P3|Overall Study|Other|1
5146611|NCT01494506|17778069|P2|Overall Study|Other|3
5146612|NCT01494506|17778070|P1|Overall Study|Other|0
5146613|NCT01494506|17778068|P3|Overall Study|Sponsor Decision|1
5146614|NCT01494506|17778069|P2|Overall Study|Sponsor Decision|0
5146615|NCT01494506|17778070|P1|Overall Study|Sponsor Decision|0
5146616|NCT01494506|17778068|P3|Overall Study|Clinical Deterioration|13
5146617|NCT01494506|17778069|P2|Overall Study|Clinical Deterioration|17
5146618|NCT01494506|17778070|P1|Overall Study|Clinical Deterioration|21
5146619|NCT01494506|17778068|P3|Overall Study|Withdrawal by Subject|14
5146620|NCT01494506|17778069|P2|Overall Study|Withdrawal by Subject|20
5146621|NCT01494506|17778070|P1|Overall Study|Withdrawal by Subject|17
5146622|NCT01494506|17778068|P3|Overall Study|Physician Decision|4
5146623|NCT01494506|17778069|P2|Overall Study|Physician Decision|5
5146624|NCT01494506|17778070|P1|Overall Study|Physician Decision|7
5146625|NCT01494506|17778068|P3|Overall Study|Death|2
5146626|NCT01494506|17778069|P2|Overall Study|Death|5
5146627|NCT01494506|17778070|P1|Overall Study|Death|9
5146628|NCT01494506|17778068|P3|Overall Study|Adverse Event|11
5146629|NCT01494506|17778069|P2|Overall Study|Adverse Event|10
5146630|NCT01494506|17778070|P1|Overall Study|Adverse Event|17
5146631|NCT01494506|17778068|P3|Overall Study|Lack of Efficacy|57
5146632|NCT01494506|17778069|P2|Overall Study|Lack of Efficacy|83
5146633|NCT01494506|17778070|P1|Overall Study|Lack of Efficacy|77
5146634|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
5146635|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
5146636|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
5146637|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
5146638|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
5146639|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
5146640|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
5146641|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
5146642|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
5146643|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
5146644|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
5146645|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
5146646|NCT01494467|17778107|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
5146647|NCT01494467|17778108|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
5146648|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
5146649|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
5146650|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Other|1
5146651|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Other|1
5146652|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
5146653|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
5146654|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
5146655|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
5146656|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
5146657|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
5146658|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
5146659|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
5146660|NCT01494467|17778107|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
5146661|NCT01494467|17778108|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
5146662|NCT01494350|17778124|P1|Overall Study|Worsening of lesion|1
5146663|NCT01494298|17778134|P2|Overall Study|Protocol Violation|8
5146664|NCT01494298|17778135|P1|Overall Study|Protocol Violation|2
5146665|NCT01494038|17778158|P2|Overall Study|Death|4
5146666|NCT01494038|17778159|P1|Overall Study|Death|2
5146667|NCT01494038|17778158|P2|Overall Study|Not willing to adhere to reqs|9
5146668|NCT01494038|17778159|P1|Overall Study|Not willing to adhere to reqs|2
5146669|NCT01494038|17778158|P2|Overall Study|Not able to get to clinic|15
5146670|NCT01494038|17778159|P1|Overall Study|Not able to get to clinic|21
5146671|NCT01494038|17778158|P2|Overall Study|Withdrawal by Subject|34
5146672|NCT01494038|17778159|P1|Overall Study|Withdrawal by Subject|44
5146673|NCT01494038|17778158|P2|Overall Study|Lost to Follow-up|20
5146674|NCT01494038|17778159|P1|Overall Study|Lost to Follow-up|18
5146675|NCT01494038|17778158|P2|Overall Study|Protocol Violation|1
5146676|NCT01494038|17778159|P1|Overall Study|Protocol Violation|1
5146677|NCT01493960|17778247|P2|Overall Study|Non-specified|4
5146678|NCT01493960|17778248|P1|Overall Study|Non-specified|4
5146679|NCT01493960|17778247|P2|Overall Study|Withdrawal by Subject|4
5146680|NCT01493960|17778248|P1|Overall Study|Withdrawal by Subject|10
5146681|NCT01493960|17778247|P2|Overall Study|Protocol Violation|0
5146682|NCT01493960|17778248|P1|Overall Study|Protocol Violation|3
5146683|NCT01493960|17778247|P2|Overall Study|Lack of Efficacy|9
5146684|NCT01493960|17778248|P1|Overall Study|Lack of Efficacy|15
5146685|NCT01493960|17778247|P2|Overall Study|Adverse Event|1
5146686|NCT01493960|17778248|P1|Overall Study|Adverse Event|0
5146687|NCT01493778|17778279|P1|Overall Study|Withdrawal by Subject|8
5146688|NCT01493687|17778341|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
5146689|NCT01493687|17778342|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
5146690|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
5146691|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
5146692|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
5146693|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
5146694|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
5146695|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
5146696|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
5146697|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
5146698|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
5146699|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
5146700|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
5146701|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
5146702|NCT01493687|17778341|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
5146703|NCT01493687|17778342|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
5146704|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
5146705|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
5146706|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
5146707|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
5146708|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
5146709|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
5146710|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
5146711|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
5146712|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
5146713|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
5146714|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
5146715|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
5146716|NCT01493687|17778341|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
5146717|NCT01493687|17778342|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
5146718|NCT01493557|17778361|P3|Adding the Second Strategy|Withdrawal by Subject|0
5146719|NCT01493557|17778362|P2|Adding the Second Strategy|Withdrawal by Subject|1
5146720|NCT01493557|17778363|P1|Adding the Second Strategy|Withdrawal by Subject|0
5146721|NCT01493557|17778361|P3|Adding the Second Strategy|Other adverse event|0
5146722|NCT01493557|17778362|P2|Adding the Second Strategy|Other adverse event|2
5146723|NCT01493557|17778363|P1|Adding the Second Strategy|Other adverse event|1
5146724|NCT01493557|17778361|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
5146725|NCT01493557|17778362|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
5146726|NCT01493557|17778363|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
5146727|NCT01493557|17778361|P3|Randomized to Management Strategies|Other than stated above|0
5146728|NCT01493557|17778362|P2|Randomized to Management Strategies|Other than stated above|3
5146729|NCT01493557|17778363|P1|Randomized to Management Strategies|Other than stated above|1
5146730|NCT01493557|17778361|P3|Randomized to Management Strategies|Withdrawal by Subject|0
5146731|NCT01493557|17778362|P2|Randomized to Management Strategies|Withdrawal by Subject|1
5146732|NCT01493557|17778363|P1|Randomized to Management Strategies|Withdrawal by Subject|0
5146733|NCT01493557|17778361|P3|Randomized to Management Strategies|Protocol Violation|0
5146734|NCT01493557|17778362|P2|Randomized to Management Strategies|Protocol Violation|0
5146735|NCT01493557|17778363|P1|Randomized to Management Strategies|Protocol Violation|3
5146736|NCT01493557|17778361|P3|Randomized to Management Strategies|Other adverse event|0
5146737|NCT01493557|17778362|P2|Randomized to Management Strategies|Other adverse event|5
5146738|NCT01493557|17778363|P1|Randomized to Management Strategies|Other adverse event|8
5146739|NCT01493557|17778361|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
5146740|NCT01493557|17778362|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
5146741|NCT01493557|17778363|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
5146742|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Other than stated above|21
5146743|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Other than stated above|0
5146744|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Other than stated above|0
5146745|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Early termination|34
5146746|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Early termination|0
5146747|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Early termination|0
5146748|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
5146749|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
5146750|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
5146751|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
5146752|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
5146753|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
5146754|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Protocol Violation|1
5146755|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Protocol Violation|0
5146756|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Protocol Violation|0
5146757|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Other adverse event|54
5146758|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Other adverse event|0
5146759|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Other adverse event|0
5146760|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
5146761|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
5146762|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
5146763|NCT01493557|17778361|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
5146764|NCT01493557|17778362|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
5146765|NCT01493557|17778363|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
5146766|NCT01493531|17778391|P3|Overall Study|Death|0
5146767|NCT01493531|17778392|P2|Overall Study|Death|1
5146768|NCT01493531|17778393|P1|Overall Study|Death|0
5146769|NCT01493531|17778391|P3|Overall Study|Withdrawal by Subject|11
5146770|NCT01493531|17778392|P2|Overall Study|Withdrawal by Subject|13
5146771|NCT01493531|17778393|P1|Overall Study|Withdrawal by Subject|16
5146772|NCT01493531|17778391|P3|Overall Study|Lost to Follow-up|11
5146773|NCT01493531|17778392|P2|Overall Study|Lost to Follow-up|7
5146774|NCT01493531|17778393|P1|Overall Study|Lost to Follow-up|5
5146775|NCT01493531|17778391|P3|Overall Study|Sponsor terminated study|3
5146776|NCT01493531|17778392|P2|Overall Study|Sponsor terminated study|2
5146777|NCT01493531|17778393|P1|Overall Study|Sponsor terminated study|5
5146778|NCT01493531|17778391|P3|Overall Study|Protocol Violation|12
5146779|NCT01493531|17778392|P2|Overall Study|Protocol Violation|15
5146780|NCT01493531|17778393|P1|Overall Study|Protocol Violation|8
5146781|NCT01493531|17778391|P3|Overall Study|Gout flare|2
5146782|NCT01493531|17778392|P2|Overall Study|Gout flare|0
5146783|NCT01493531|17778393|P1|Overall Study|Gout flare|3
5146784|NCT01493531|17778391|P3|Overall Study|Adverse Event|9
5146785|NCT01493531|17778392|P2|Overall Study|Adverse Event|12
5146786|NCT01493531|17778393|P1|Overall Study|Adverse Event|4
5146787|NCT01493427|17778407|P1|Overall Study|Other|2
5146788|NCT01493427|17778407|P1|Overall Study|Inability to Follow Instructions|2
5146789|NCT01493427|17778407|P1|Overall Study|Lost to Follow-up|2
5146790|NCT01493427|17778407|P1|Overall Study|Personal Reasons|4
5146791|NCT01493427|17778407|P1|Overall Study|Adverse Event|10
5146792|NCT01493414|17778412|P1|Overall Study|Lost to Follow-up|16
5146793|NCT01493414|17778412|P1|Overall Study|Administrative problems|25
5146794|NCT01493414|17778412|P1|Overall Study|Protocol deviation|27
5146795|NCT01493414|17778412|P1|Overall Study|Withdrawal by Subject|79
5146796|NCT01493414|17778412|P1|Overall Study|Physician Decision|93
5146797|NCT01493414|17778412|P1|Overall Study|Death|101
5146798|NCT01493414|17778412|P1|Overall Study|Disease progression|204
5146799|NCT01493414|17778412|P1|Overall Study|Adverse Event|405
5146800|NCT01493284|17778425|P1|Overall Study|Withdrawal by Subject|32
5146801|NCT01493284|17778425|P1|Overall Study|Death|29
5146802|NCT01493089|17778447|P2|Overall Study|Physician Decision|1
5146803|NCT01493089|17778448|P1|Overall Study|Physician Decision|0
5146804|NCT01493089|17778447|P2|Overall Study|Withdrawal by Subject|0
5146805|NCT01493089|17778448|P1|Overall Study|Withdrawal by Subject|1
5146806|NCT01493089|17778447|P2|Overall Study|Protocol Violation|2
5146807|NCT01493089|17778448|P1|Overall Study|Protocol Violation|2
5146808|NCT01492686|17778547|P2|Open-label Phase|Due to a discontinuation criterion|9
5146809|NCT01492686|17778548|P1|Open-label Phase|Due to a discontinuation criterion|4
5146810|NCT01492686|17778547|P2|Open-label Phase|Withdrawal by Subject|7
5146811|NCT01492686|17778548|P1|Open-label Phase|Withdrawal by Subject|6
5146812|NCT01492686|17778547|P2|Open-label Phase|Physician Decision|0
5146813|NCT01492686|17778548|P1|Open-label Phase|Physician Decision|1
5146814|NCT01492686|17778547|P2|Open-label Phase|Adverse Event|2
5146815|NCT01492686|17778548|P1|Open-label Phase|Adverse Event|1
5146816|NCT01492686|17778547|P2|Double-blind Phase|Due to a discontinuation criterion|3
5146817|NCT01492686|17778548|P1|Double-blind Phase|Due to a discontinuation criterion|2
5146818|NCT01492686|17778547|P2|Double-blind Phase|Withdrawal by Subject|2
5146819|NCT01492686|17778548|P1|Double-blind Phase|Withdrawal by Subject|0
5146820|NCT01492686|17778547|P2|Double-blind Phase|Physician Decision|1
5146821|NCT01492686|17778548|P1|Double-blind Phase|Physician Decision|0
5146822|NCT01492686|17778547|P2|Double-blind Phase|Adverse Event|2
5146823|NCT01492686|17778548|P1|Double-blind Phase|Adverse Event|0
5146824|NCT01492439|17778605|P2|Overall Study|Withdrew from RTE|9
5146825|NCT01492439|17778606|P1|Overall Study|Withdrew from RTE|4
5146826|NCT01492426|17778654|P2|Follow-Up|Lost to Follow-up|6
5146827|NCT01492426|17778655|P1|Follow-Up|Lost to Follow-up|12
5146828|NCT01492426|17778654|P2|Follow-Up|Participant Withdrew Consent|1
5146829|NCT01492426|17778655|P1|Follow-Up|Participant Withdrew Consent|6
5146830|NCT01492426|17778654|P2|Follow-Up|Other|2
5146831|NCT01492426|17778655|P1|Follow-Up|Other|4
5146832|NCT01492426|17778654|P2|Follow-Up|Death|0
5146833|NCT01492426|17778655|P1|Follow-Up|Death|1
5146834|NCT01492426|17778654|P2|Follow-Up|Protocol Requires no Follow-Up|1
5146835|NCT01492426|17778655|P1|Follow-Up|Protocol Requires no Follow-Up|2
5146836|NCT01492426|17778654|P2|Treatment|Participant does not meet study criteria|0
5146837|NCT01492426|17778655|P1|Treatment|Participant does not meet study criteria|1
5146838|NCT01492426|17778654|P2|Treatment|Lost to Follow-up|4
5146839|NCT01492426|17778655|P1|Treatment|Lost to Follow-up|9
5146840|NCT01492426|17778654|P2|Treatment|Subject requested discontinue study drug|3
5146841|NCT01492426|17778655|P1|Treatment|Subject requested discontinue study drug|7
5146842|NCT01492426|17778654|P2|Treatment|Poor compliance/noncompliance|0
5146843|NCT01492426|17778655|P1|Treatment|Poor compliance/noncompliance|1
5146844|NCT01492426|17778654|P2|Treatment|Participant withdrew consent|2
5146845|NCT01492426|17778655|P1|Treatment|Participant withdrew consent|1
5146846|NCT01492426|17778654|P2|Treatment|Lack of Efficacy|5
5146847|NCT01492426|17778655|P1|Treatment|Lack of Efficacy|38
5146848|NCT01492426|17778654|P2|Treatment|Adverse Event|25
5146849|NCT01492426|17778655|P1|Treatment|Adverse Event|25
5146850|NCT01492426|17778654|P2|Treatment|Other|0
5146851|NCT01492426|17778655|P1|Treatment|Other|1
5146852|NCT01492426|17778654|P2|Treatment|Death|1
5146853|NCT01492426|17778655|P1|Treatment|Death|0
5146854|NCT01492400|17778673|P2|Overall Study|Adverse Event|5
5146855|NCT01492400|17778674|P1|Overall Study|Adverse Event|10
5146856|NCT01492400|17778673|P2|Overall Study|Lack of Efficacy|1
5146857|NCT01492400|17778674|P1|Overall Study|Lack of Efficacy|1
5146858|NCT01492400|17778673|P2|Overall Study|Pregnancy|1
5146859|NCT01492400|17778674|P1|Overall Study|Pregnancy|0
5146860|NCT01492400|17778673|P2|Overall Study|Lost to Follow-up|1
5146861|NCT01492400|17778674|P1|Overall Study|Lost to Follow-up|3
5146862|NCT01492400|17778673|P2|Overall Study|Personal Reasons|5
5146863|NCT01492400|17778674|P1|Overall Study|Personal Reasons|0
5146864|NCT01492400|17778673|P2|Overall Study|Miscellaneous Reasons|3
5146865|NCT01492400|17778674|P1|Overall Study|Miscellaneous Reasons|2
5146866|NCT01492088|17778698|P3|Overall Study|Alive at Last Follow-up|11
5146867|NCT01492088|17778699|P2|Overall Study|Alive at Last Follow-up|6
5146868|NCT01492088|17778700|P1|Overall Study|Alive at Last Follow-up|0
5146869|NCT01492088|17778698|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
5146870|NCT01492088|17778699|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
5146871|NCT01492088|17778700|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
5146872|NCT01492088|17778698|P3|Overall Study|Death|2
5146873|NCT01492088|17778699|P2|Overall Study|Death|6
5146874|NCT01492088|17778700|P1|Overall Study|Death|1
5146875|NCT01492088|17778698|P3|Overall Study|Withdrawal by Patient|0
5146876|NCT01492088|17778699|P2|Overall Study|Withdrawal by Patient|2
5146877|NCT01492088|17778700|P1|Overall Study|Withdrawal by Patient|0
5146878|NCT01491919|17778781|P3|Overall Study|Insufficient PK sampling|1
5146879|NCT01491919|17778782|P2|Overall Study|Insufficient PK sampling|2
5146880|NCT01491919|17778783|P1|Overall Study|Insufficient PK sampling|1
5146881|NCT01491854|17778854|P1|Overall Study|Lost to Follow-up|33
5146882|NCT01491854|17778854|P1|Overall Study|Withdrawal by Subject|3
5146883|NCT01491854|17778854|P1|Overall Study|Death|1
5146884|NCT01491854|17778854|P1|Overall Study|mainly due to premature termination|93
5146885|NCT01491841|17778865|P1|Overall Study|Withdrawal by Subject|1
5146886|NCT01491841|17778865|P1|Overall Study|Screen Failure|10
5146887|NCT01491802|17778879|P2|Overall Study|Withdrawal by Subject|1
5146888|NCT01491802|17778880|P1|Overall Study|Withdrawal by Subject|0
5146889|NCT01491802|17778879|P2|Overall Study|Adverse Event|1
5146890|NCT01491802|17778880|P1|Overall Study|Adverse Event|1
5146891|NCT01491737|17778907|P2|Overall Study|Reason Not Specified|9
5146892|NCT01491737|17778908|P1|Overall Study|Reason Not Specified|8
5146893|NCT01491737|17778907|P2|Overall Study|Study Termination by Sponsor|36
5146894|NCT01491737|17778908|P1|Overall Study|Study Termination by Sponsor|36
5146895|NCT01491737|17778907|P2|Overall Study|Death|57
5146896|NCT01491737|17778908|P1|Overall Study|Death|63
5146897|NCT01491737|17778907|P2|Overall Study|Lost to Follow-up|10
5146898|NCT01491737|17778908|P1|Overall Study|Lost to Follow-up|2
5146899|NCT01491737|17778907|P2|Overall Study|Withdrawal by Subject|17
5146900|NCT01491737|17778908|P1|Overall Study|Withdrawal by Subject|20
5146901|NCT01491672|17778935|P3|Overall Study|Death|0
5146902|NCT01491672|17778936|P2|Overall Study|Death|4
5146903|NCT01491672|17778937|P1|Overall Study|Death|0
5146904|NCT01491672|17778935|P3|Overall Study|Protocol deviation|0
5146905|NCT01491672|17778936|P2|Overall Study|Protocol deviation|1
5146906|NCT01491672|17778937|P1|Overall Study|Protocol deviation|0
5146907|NCT01491672|17778935|P3|Overall Study|Disease progression|6
5146908|NCT01491672|17778936|P2|Overall Study|Disease progression|34
5146909|NCT01491672|17778937|P1|Overall Study|Disease progression|42
5146910|NCT01491672|17778935|P3|Overall Study|Adverse Event|4
5146911|NCT01491672|17778936|P2|Overall Study|Adverse Event|10
5146912|NCT01491672|17778937|P1|Overall Study|Adverse Event|8
5146913|NCT01491672|17778935|P3|Overall Study|Withdrawal by Subject|0
5146914|NCT01491672|17778936|P2|Overall Study|Withdrawal by Subject|7
5146915|NCT01491672|17778937|P1|Overall Study|Withdrawal by Subject|6
5146916|NCT01491672|17778935|P3|Overall Study|Lost to Follow-up|1
5146917|NCT01491672|17778936|P2|Overall Study|Lost to Follow-up|4
5146918|NCT01491672|17778937|P1|Overall Study|Lost to Follow-up|0
5146919|NCT01491607|17778974|P1|Overall Study|Withdrawal by Subject|3
5146920|NCT01491607|17778974|P1|Overall Study|Lost to Follow-up|7
5146921|NCT01491178|17779079|P1|Overall Study|Other than specified above|657
5146922|NCT01491178|17779079|P1|Overall Study|To take a contraindication|20
5146923|NCT01491178|17779079|P1|Overall Study|Lost to follow-up (changing hospital)|545
5146924|NCT01491178|17779079|P1|Overall Study|Lost to follow-up (unknown reason)|287
5146925|NCT01491178|17779079|P1|Overall Study|To conduct invasive treatment|59
5146926|NCT01491178|17779079|P1|Overall Study|Improvement of NVAF|210
5146927|NCT01491178|17779079|P1|Overall Study|Adverse Event|1016
5146928|NCT01491035|17779188|P8|Overall Study|Lost to Follow-up|0
5146929|NCT01491035|17779189|P7|Overall Study|Lost to Follow-up|0
5146930|NCT01491035|17779190|P6|Overall Study|Lost to Follow-up|0
5146931|NCT01491035|17779191|P5|Overall Study|Lost to Follow-up|1
5146932|NCT01491035|17779192|P4|Overall Study|Lost to Follow-up|0
5146933|NCT01491035|17779193|P3|Overall Study|Lost to Follow-up|0
5146934|NCT01491035|17779194|P2|Overall Study|Lost to Follow-up|0
5146935|NCT01491035|17779195|P1|Overall Study|Lost to Follow-up|0
5146936|NCT01490918|17779299|P3|Overall Study|other cause|8
5146937|NCT01490918|17779300|P2|Overall Study|other cause|5
5146938|NCT01490918|17779301|P1|Overall Study|other cause|4
5146939|NCT01490918|17779299|P3|Overall Study|Adverse Event|1
5146940|NCT01490918|17779300|P2|Overall Study|Adverse Event|0
5146941|NCT01490918|17779301|P1|Overall Study|Adverse Event|0
5146942|NCT01490918|17779299|P3|Overall Study|Withdrawal by Subject|3
5146943|NCT01490918|17779300|P2|Overall Study|Withdrawal by Subject|8
5146944|NCT01490918|17779301|P1|Overall Study|Withdrawal by Subject|7
5146945|NCT01490918|17779299|P3|Overall Study|Lost to Follow-up|0
5146946|NCT01490918|17779300|P2|Overall Study|Lost to Follow-up|1
5146947|NCT01490918|17779301|P1|Overall Study|Lost to Follow-up|2
5146948|NCT01490866|17779339|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
5146949|NCT01490866|17779339|P1|Axitinib Maintenance Therapy|Protocol Violation|2
5146950|NCT01490866|17779339|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
5146951|NCT01490866|17779339|P1|Axitinib Maintenance Therapy|Adverse Event|12
5146952|NCT01490866|17779339|P1|Axitinib Maintenance Therapy|Disease Progression|30
5146953|NCT01490866|17779339|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
5146954|NCT01490866|17779339|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
5146955|NCT01490866|17779339|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
5146956|NCT01490866|17779339|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
5146957|NCT01490866|17779339|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
5146958|NCT01490866|17779339|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
5146959|NCT01490840|17779350|P2|Phase 2|Adverse Event|1
5146960|NCT01490840|17779351|P1|Phase 2|Adverse Event|1
5146961|NCT01490840|17779350|P2|Phase 2|Lost to Follow-up|1
5146962|NCT01490840|17779351|P1|Phase 2|Lost to Follow-up|1
5146963|NCT01490840|17779350|P2|Phase 2|Permanent interruption of fingolimod|1
5146964|NCT01490840|17779351|P1|Phase 2|Permanent interruption of fingolimod|0
5146965|NCT01490840|17779350|P2|Phase 2|Withdrawal by Subject|3
5146966|NCT01490840|17779351|P1|Phase 2|Withdrawal by Subject|4
5146967|NCT01490840|17779350|P2|Phase 1|Visit 6a omitted|0
5146968|NCT01490840|17779351|P1|Phase 1|Visit 6a omitted|1
5146969|NCT01490840|17779350|P2|Phase 1|Withdrawal by Subject|5
5146970|NCT01490840|17779351|P1|Phase 1|Withdrawal by Subject|6
5146971|NCT01490840|17779350|P2|Phase 1|Adverse Event|1
5146972|NCT01490840|17779351|P1|Phase 1|Adverse Event|2
5146973|NCT01490840|17779350|P2|Phase 1|Lost to Follow-up|0
5146974|NCT01490840|17779351|P1|Phase 1|Lost to Follow-up|1
5146975|NCT01490814|17779375|P2|Overall Study|Withdrawal by Subject|5
5146976|NCT01490814|17779376|P1|Overall Study|Withdrawal by Subject|0
5146977|NCT01490814|17779375|P2|Overall Study|Physician Decision|0
5146978|NCT01490814|17779376|P1|Overall Study|Physician Decision|1
5146979|NCT01490814|17779375|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
5146980|NCT01490814|17779376|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
5146981|NCT01490697|17779419|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
5146982|NCT01490697|17779420|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
5146983|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
5146984|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
5146985|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
5146986|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146987|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146988|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146989|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146990|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146991|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146992|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146993|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146994|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146995|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146996|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146997|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146998|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
5146999|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
5147000|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
5147001|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
5147002|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
5147003|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Protocol Violation|0
5147004|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Protocol Violation|1
5147005|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Protocol Violation|0
5147006|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Protocol Violation|0
5147007|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Protocol Violation|0
5147008|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Protocol Violation|0
5147009|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Protocol Violation|0
5147010|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Protocol Violation|0
5147011|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Protocol Violation|0
5147012|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Protocol Violation|0
5147013|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Protocol Violation|0
5147014|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Protocol Violation|0
5147015|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Protocol Violation|0
5147016|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Protocol Violation|0
5147017|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Protocol Violation|0
5147018|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Protocol Violation|0
5147019|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Protocol Violation|0
5147020|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Protocol Violation|0
5147021|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Protocol Violation|0
5147022|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Protocol Violation|0
5147023|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Physician Decision|1
5147024|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Physician Decision|1
5147025|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Physician Decision|0
5147026|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Physician Decision|0
5147027|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Physician Decision|0
5147028|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Physician Decision|0
5147029|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Physician Decision|0
5147030|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Physician Decision|0
5147031|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Physician Decision|0
5147032|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Physician Decision|0
5147033|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Physician Decision|0
5147034|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Physician Decision|0
5147035|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Physician Decision|0
5147036|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Physician Decision|0
5147037|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Physician Decision|0
5147118|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Adverse Event|0
5147038|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Physician Decision|0
5147039|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Physician Decision|0
5147040|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Physician Decision|0
5147041|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Physician Decision|0
5147042|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Physician Decision|0
5147043|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
5147044|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
5147045|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
5147046|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
5147047|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
5147048|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
5147049|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
5147050|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
5147051|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
5147052|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
5147053|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
5147054|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
5147055|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
5147056|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
5147057|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
5147058|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
5147059|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
5147060|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
5147061|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
5147062|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
5147063|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
5147064|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
5147065|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
5147066|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
5147067|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
5147068|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
5147069|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
5147070|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
5147071|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
5147072|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
5147073|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
5147074|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
5147075|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
5147076|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
5147077|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
5147078|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
5147079|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
5147080|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
5147081|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
5147082|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
5147083|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Death|0
5147084|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Death|1
5147085|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Death|0
5147086|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Death|0
5147087|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Death|0
5147088|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Death|0
5147089|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Death|0
5147090|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Death|0
5147091|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Death|0
5147092|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Death|0
5147093|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Death|0
5147094|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Death|0
5147095|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Death|0
5147096|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Death|0
5147097|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Death|0
5147098|NCT01490632|17779455|P5|Part D: Re-Treatment Period|Death|0
5147099|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Death|0
5147100|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Death|0
5147101|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Death|0
5147102|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Death|0
5147103|NCT01490632|17779440|P20|Part D: Re-Treatment Period|Adverse Event|3
5147104|NCT01490632|17779441|P19|Part D: Re-Treatment Period|Adverse Event|1
5147105|NCT01490632|17779442|P18|Part D: Re-Treatment Period|Adverse Event|1
5147106|NCT01490632|17779443|P17|Part D: Re-Treatment Period|Adverse Event|0
5147107|NCT01490632|17779444|P16|Part D: Re-Treatment Period|Adverse Event|0
5147108|NCT01490632|17779445|P15|Part D: Re-Treatment Period|Adverse Event|0
5147109|NCT01490632|17779446|P14|Part D: Re-Treatment Period|Adverse Event|0
5147110|NCT01490632|17779447|P13|Part D: Re-Treatment Period|Adverse Event|0
5147111|NCT01490632|17779448|P12|Part D: Re-Treatment Period|Adverse Event|0
5147112|NCT01490632|17779449|P11|Part D: Re-Treatment Period|Adverse Event|0
5147113|NCT01490632|17779450|P10|Part D: Re-Treatment Period|Adverse Event|0
5147114|NCT01490632|17779451|P9|Part D: Re-Treatment Period|Adverse Event|0
5147115|NCT01490632|17779452|P8|Part D: Re-Treatment Period|Adverse Event|0
5147116|NCT01490632|17779453|P7|Part D: Re-Treatment Period|Adverse Event|0
5147117|NCT01490632|17779454|P6|Part D: Re-Treatment Period|Adverse Event|0
5147119|NCT01490632|17779456|P4|Part D: Re-Treatment Period|Adverse Event|0
5147120|NCT01490632|17779457|P3|Part D: Re-Treatment Period|Adverse Event|0
5147121|NCT01490632|17779458|P2|Part D: Re-Treatment Period|Adverse Event|0
5147122|NCT01490632|17779459|P1|Part D: Re-Treatment Period|Adverse Event|0
5147123|NCT01490632|17779440|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147124|NCT01490632|17779441|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147125|NCT01490632|17779442|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147126|NCT01490632|17779443|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147127|NCT01490632|17779444|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
5147128|NCT01490632|17779445|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
5147129|NCT01490632|17779446|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
5147130|NCT01490632|17779447|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
5147131|NCT01490632|17779448|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147132|NCT01490632|17779449|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147133|NCT01490632|17779450|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147134|NCT01490632|17779451|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147135|NCT01490632|17779452|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147136|NCT01490632|17779453|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147137|NCT01490632|17779454|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147138|NCT01490632|17779455|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147139|NCT01490632|17779456|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147140|NCT01490632|17779457|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147141|NCT01490632|17779458|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147142|NCT01490632|17779459|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5147143|NCT01490632|17779440|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147144|NCT01490632|17779441|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147145|NCT01490632|17779442|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147146|NCT01490632|17779443|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147147|NCT01490632|17779444|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
5147148|NCT01490632|17779445|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
5147149|NCT01490632|17779446|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147150|NCT01490632|17779447|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147151|NCT01490632|17779448|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147152|NCT01490632|17779449|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147153|NCT01490632|17779450|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147154|NCT01490632|17779451|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147155|NCT01490632|17779452|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147156|NCT01490632|17779453|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147157|NCT01490632|17779454|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147158|NCT01490632|17779455|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147159|NCT01490632|17779456|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147160|NCT01490632|17779457|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147161|NCT01490632|17779458|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147162|NCT01490632|17779459|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5147163|NCT01490632|17779440|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147164|NCT01490632|17779441|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147165|NCT01490632|17779442|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147166|NCT01490632|17779443|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147167|NCT01490632|17779444|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147168|NCT01490632|17779445|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147169|NCT01490632|17779446|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
5147170|NCT01490632|17779447|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147171|NCT01490632|17779448|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147172|NCT01490632|17779449|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147173|NCT01490632|17779450|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147174|NCT01490632|17779451|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147175|NCT01490632|17779452|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147176|NCT01490632|17779453|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147177|NCT01490632|17779454|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147178|NCT01490632|17779455|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147179|NCT01490632|17779456|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147180|NCT01490632|17779457|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147181|NCT01490632|17779458|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147182|NCT01490632|17779459|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5147183|NCT01490632|17779440|P20|Part C: Washout or Step-Down Period|Adverse Event|0
5147184|NCT01490632|17779441|P19|Part C: Washout or Step-Down Period|Adverse Event|0
5147185|NCT01490632|17779442|P18|Part C: Washout or Step-Down Period|Adverse Event|0
5147186|NCT01490632|17779443|P17|Part C: Washout or Step-Down Period|Adverse Event|0
5147187|NCT01490632|17779444|P16|Part C: Washout or Step-Down Period|Adverse Event|2
5147188|NCT01490632|17779445|P15|Part C: Washout or Step-Down Period|Adverse Event|2
5147189|NCT01490632|17779446|P14|Part C: Washout or Step-Down Period|Adverse Event|0
5147190|NCT01490632|17779447|P13|Part C: Washout or Step-Down Period|Adverse Event|0
5147191|NCT01490632|17779448|P12|Part C: Washout or Step-Down Period|Adverse Event|0
5147192|NCT01490632|17779449|P11|Part C: Washout or Step-Down Period|Adverse Event|0
5147193|NCT01490632|17779450|P10|Part C: Washout or Step-Down Period|Adverse Event|0
5147194|NCT01490632|17779451|P9|Part C: Washout or Step-Down Period|Adverse Event|0
5147195|NCT01490632|17779452|P8|Part C: Washout or Step-Down Period|Adverse Event|0
5147196|NCT01490632|17779453|P7|Part C: Washout or Step-Down Period|Adverse Event|0
5147197|NCT01490632|17779454|P6|Part C: Washout or Step-Down Period|Adverse Event|0
5147198|NCT01490632|17779455|P5|Part C: Washout or Step-Down Period|Adverse Event|0
5147199|NCT01490632|17779456|P4|Part C: Washout or Step-Down Period|Adverse Event|0
5147200|NCT01490632|17779457|P3|Part C: Washout or Step-Down Period|Adverse Event|0
5147201|NCT01490632|17779458|P2|Part C: Washout or Step-Down Period|Adverse Event|0
5147202|NCT01490632|17779459|P1|Part C: Washout or Step-Down Period|Adverse Event|0
5147203|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147204|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147205|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147206|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147207|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147208|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147209|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147210|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147211|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
5147212|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
5147213|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
5147214|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
5147215|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
5147216|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
5147217|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
5147218|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147219|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147220|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147221|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147222|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5147223|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147224|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147225|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147226|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147227|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147228|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147229|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147230|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147231|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
5147232|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5147233|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147234|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5147235|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147236|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5147237|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147238|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147239|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147240|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147241|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147242|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5147243|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147244|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147245|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147246|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147247|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147248|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147249|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147250|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147251|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147252|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147253|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147254|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147255|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147256|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147257|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
5147258|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147259|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147260|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147261|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147262|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
5147263|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Physician Decision|0
5147264|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Physician Decision|0
5147265|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Physician Decision|0
5147266|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Physician Decision|0
5147267|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Physician Decision|0
5147268|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Physician Decision|0
5147269|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Physician Decision|0
5147270|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Physician Decision|0
5147271|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Physician Decision|0
5147272|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Physician Decision|0
5147273|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Physician Decision|0
5147274|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Physician Decision|0
5147275|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Physician Decision|0
5147276|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Physician Decision|1
5147277|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Physician Decision|0
5147278|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Physician Decision|0
5147279|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Physician Decision|0
5147280|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Physician Decision|0
5147281|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Physician Decision|0
5147282|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Physician Decision|0
5147283|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147284|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147285|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147286|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147287|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147288|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147289|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147290|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147291|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147292|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147293|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
5147294|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147295|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147296|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
5147297|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147298|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147299|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147300|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147301|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147302|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5147303|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147304|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147305|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147306|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147307|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147308|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147309|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147310|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147311|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147312|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5147313|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
5147314|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5147315|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147316|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5147317|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147318|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147319|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147320|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147321|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147322|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5147323|NCT01490632|17779440|P20|Part B: Extension or Step-Up Period|Adverse Event|0
5147324|NCT01490632|17779441|P19|Part B: Extension or Step-Up Period|Adverse Event|0
5147325|NCT01490632|17779442|P18|Part B: Extension or Step-Up Period|Adverse Event|0
5147326|NCT01490632|17779443|P17|Part B: Extension or Step-Up Period|Adverse Event|0
5147327|NCT01490632|17779444|P16|Part B: Extension or Step-Up Period|Adverse Event|0
5147328|NCT01490632|17779445|P15|Part B: Extension or Step-Up Period|Adverse Event|0
5147329|NCT01490632|17779446|P14|Part B: Extension or Step-Up Period|Adverse Event|0
5147330|NCT01490632|17779447|P13|Part B: Extension or Step-Up Period|Adverse Event|0
5147331|NCT01490632|17779448|P12|Part B: Extension or Step-Up Period|Adverse Event|1
5147332|NCT01490632|17779449|P11|Part B: Extension or Step-Up Period|Adverse Event|3
5147333|NCT01490632|17779450|P10|Part B: Extension or Step-Up Period|Adverse Event|2
5147334|NCT01490632|17779451|P9|Part B: Extension or Step-Up Period|Adverse Event|0
5147335|NCT01490632|17779452|P8|Part B: Extension or Step-Up Period|Adverse Event|0
5147336|NCT01490632|17779453|P7|Part B: Extension or Step-Up Period|Adverse Event|2
5147337|NCT01490632|17779454|P6|Part B: Extension or Step-Up Period|Adverse Event|2
5147338|NCT01490632|17779455|P5|Part B: Extension or Step-Up Period|Adverse Event|0
5147339|NCT01490632|17779456|P4|Part B: Extension or Step-Up Period|Adverse Event|0
5147340|NCT01490632|17779457|P3|Part B: Extension or Step-Up Period|Adverse Event|0
5147341|NCT01490632|17779458|P2|Part B: Extension or Step-Up Period|Adverse Event|0
5147342|NCT01490632|17779459|P1|Part B: Extension or Step-Up Period|Adverse Event|0
5147343|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147344|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147345|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147346|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147347|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147348|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147349|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147350|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147351|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147352|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147353|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147354|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147355|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147356|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147357|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147358|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
5147359|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147360|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147361|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147362|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5147363|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147364|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147365|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147366|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147367|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147368|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147369|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147370|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147371|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147372|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147373|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147374|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147375|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147376|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147377|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147378|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
5147379|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
5147380|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
5147381|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
5147382|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
5147383|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Sponsor Decision|0
5147384|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Sponsor Decision|0
5147385|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Sponsor Decision|0
5147386|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Sponsor Decision|0
5147387|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Sponsor Decision|0
5147388|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Sponsor Decision|0
5147389|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Sponsor Decision|0
5147390|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Sponsor Decision|0
5147391|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Sponsor Decision|0
5147392|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Sponsor Decision|0
5147393|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Sponsor Decision|0
5147394|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Sponsor Decision|0
5147395|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Sponsor Decision|0
5147396|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Sponsor Decision|0
5147397|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Sponsor Decision|0
5147398|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Sponsor Decision|0
5147399|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Sponsor Decision|0
5147400|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Sponsor Decision|0
5147401|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Sponsor Decision|0
5147402|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Sponsor Decision|2
5147403|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Physician Decision|0
5147404|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Physician Decision|0
5147405|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Physician Decision|0
5147406|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Physician Decision|0
5147407|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Physician Decision|0
5147408|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Physician Decision|0
5147409|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Physician Decision|0
5147410|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Physician Decision|0
5147411|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Physician Decision|0
5147412|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Physician Decision|0
5147413|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Physician Decision|0
5147414|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Physician Decision|0
5147415|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Physician Decision|0
5147416|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Physician Decision|0
5147417|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Physician Decision|0
5147418|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Physician Decision|0
5147419|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Physician Decision|1
5147420|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Physician Decision|0
5147421|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Physician Decision|1
5147422|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Physician Decision|0
5147423|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
5147424|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
5147425|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
5147426|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
5147427|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
5147428|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
5147429|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
5147430|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
5147431|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
5147432|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
5147433|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
5147434|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
5147435|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
5147436|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
5147437|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
5147438|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
5147439|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
5147440|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
5147441|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
5147442|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
5147443|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
5147444|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
5147445|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
5147446|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
5147447|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
5147448|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
5147449|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
5147450|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
5147451|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
5147452|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
5147453|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
5147454|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
5147455|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
5147456|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
5147457|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
5147458|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
5147459|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
5147460|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
5147461|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
5147462|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
5147463|NCT01490632|17779440|P20|Part A: Initial Treatment Period|Adverse Event|0
5147464|NCT01490632|17779441|P19|Part A: Initial Treatment Period|Adverse Event|0
5147465|NCT01490632|17779442|P18|Part A: Initial Treatment Period|Adverse Event|0
5147466|NCT01490632|17779443|P17|Part A: Initial Treatment Period|Adverse Event|0
5147467|NCT01490632|17779444|P16|Part A: Initial Treatment Period|Adverse Event|0
5147468|NCT01490632|17779445|P15|Part A: Initial Treatment Period|Adverse Event|0
5147469|NCT01490632|17779446|P14|Part A: Initial Treatment Period|Adverse Event|0
5147470|NCT01490632|17779447|P13|Part A: Initial Treatment Period|Adverse Event|0
5147471|NCT01490632|17779448|P12|Part A: Initial Treatment Period|Adverse Event|0
5147472|NCT01490632|17779449|P11|Part A: Initial Treatment Period|Adverse Event|0
5147473|NCT01490632|17779450|P10|Part A: Initial Treatment Period|Adverse Event|0
5147474|NCT01490632|17779451|P9|Part A: Initial Treatment Period|Adverse Event|0
5147475|NCT01490632|17779452|P8|Part A: Initial Treatment Period|Adverse Event|0
5147476|NCT01490632|17779453|P7|Part A: Initial Treatment Period|Adverse Event|0
5147477|NCT01490632|17779454|P6|Part A: Initial Treatment Period|Adverse Event|0
5147478|NCT01490632|17779455|P5|Part A: Initial Treatment Period|Adverse Event|4
5147479|NCT01490632|17779456|P4|Part A: Initial Treatment Period|Adverse Event|4
5147480|NCT01490632|17779457|P3|Part A: Initial Treatment Period|Adverse Event|2
5147481|NCT01490632|17779458|P2|Part A: Initial Treatment Period|Adverse Event|0
5147482|NCT01490632|17779459|P1|Part A: Initial Treatment Period|Adverse Event|0
5147483|NCT01490580|17779589|P2|Overall Study|Parents withdrew consent|2
5147484|NCT01490580|17779590|P1|Overall Study|Parents withdrew consent|0
5147485|NCT01490294|17779637|P4|Overall Study|Adverse Event|0
5147486|NCT01490294|17779638|P3|Overall Study|Adverse Event|0
5147487|NCT01490294|17779639|P2|Overall Study|Adverse Event|0
5147488|NCT01490294|17779640|P1|Overall Study|Adverse Event|1
5147489|NCT01490294|17779637|P4|Overall Study|Prematurely discontinuation|1
5147490|NCT01490294|17779638|P3|Overall Study|Prematurely discontinuation|1
5147491|NCT01490294|17779639|P2|Overall Study|Prematurely discontinuation|0
5147492|NCT01490294|17779640|P1|Overall Study|Prematurely discontinuation|4
5147493|NCT01490190|17779874|P1|Overall Study|Ring expulsion|2
5147494|NCT01490190|17779874|P1|Overall Study|Inconvenience|1
5147495|NCT01490190|17779874|P1|Overall Study|Relocation|1
5147496|NCT01490190|17779874|P1|Overall Study|Lost to Follow-up|13
5147497|NCT01490190|17779874|P1|Overall Study|Protocol Violation|5
5147498|NCT01490190|17779874|P1|Overall Study|Adverse Event|17
5147499|NCT01490190|17779874|P1|Overall Study|Withdrawal by Subject|9
5147500|NCT01490125|17779901|P6|Period III|Lack of Efficacy|0
5147501|NCT01490125|17779902|P5|Period III|Lack of Efficacy|1
5147502|NCT01490125|17779903|P4|Period III|Lack of Efficacy|0
5147503|NCT01490125|17779904|P3|Period III|Lack of Efficacy|0
5147504|NCT01490125|17779905|P2|Period III|Lack of Efficacy|0
5147505|NCT01490125|17779906|P1|Period III|Lack of Efficacy|0
5147506|NCT01490125|17779901|P6|Period III|Death|0
5147507|NCT01490125|17779902|P5|Period III|Death|0
5147508|NCT01490125|17779903|P4|Period III|Death|1
5147509|NCT01490125|17779904|P3|Period III|Death|0
5147510|NCT01490125|17779905|P2|Period III|Death|0
5147511|NCT01490125|17779906|P1|Period III|Death|0
5147512|NCT01490125|17779901|P6|Period III|Adverse Event|0
5147513|NCT01490125|17779902|P5|Period III|Adverse Event|0
5147514|NCT01490125|17779903|P4|Period III|Adverse Event|1
5147515|NCT01490125|17779904|P3|Period III|Adverse Event|0
5147516|NCT01490125|17779905|P2|Period III|Adverse Event|1
5147517|NCT01490125|17779906|P1|Period III|Adverse Event|3
5147518|NCT01490125|17779901|P6|Period II|Withdrawal by Subject|0
5147519|NCT01490125|17779902|P5|Period II|Withdrawal by Subject|0
5147520|NCT01490125|17779903|P4|Period II|Withdrawal by Subject|0
5147521|NCT01490125|17779904|P3|Period II|Withdrawal by Subject|0
5147522|NCT01490125|17779905|P2|Period II|Withdrawal by Subject|0
5147523|NCT01490125|17779906|P1|Period II|Withdrawal by Subject|1
5147524|NCT01490125|17779901|P6|Period II|Lost to Follow-up|0
5147525|NCT01490125|17779902|P5|Period II|Lost to Follow-up|0
5147526|NCT01490125|17779903|P4|Period II|Lost to Follow-up|0
5147527|NCT01490125|17779904|P3|Period II|Lost to Follow-up|0
5147528|NCT01490125|17779905|P2|Period II|Lost to Follow-up|1
5147529|NCT01490125|17779906|P1|Period II|Lost to Follow-up|0
5147530|NCT01490125|17779901|P6|Period II|Protocol Violation|0
5147531|NCT01490125|17779902|P5|Period II|Protocol Violation|0
5147532|NCT01490125|17779903|P4|Period II|Protocol Violation|1
5147533|NCT01490125|17779904|P3|Period II|Protocol Violation|1
5147534|NCT01490125|17779905|P2|Period II|Protocol Violation|0
5147535|NCT01490125|17779906|P1|Period II|Protocol Violation|0
5147536|NCT01490125|17779901|P6|Period II|Adverse Event|2
5147537|NCT01490125|17779902|P5|Period II|Adverse Event|4
5147538|NCT01490125|17779903|P4|Period II|Adverse Event|2
5147539|NCT01490125|17779904|P3|Period II|Adverse Event|2
5147540|NCT01490125|17779905|P2|Period II|Adverse Event|3
5147541|NCT01490125|17779906|P1|Period II|Adverse Event|2
5147542|NCT01490125|17779901|P6|Period I|Withdrawal by Subject|1
5147543|NCT01490125|17779902|P5|Period I|Withdrawal by Subject|2
5147544|NCT01490125|17779903|P4|Period I|Withdrawal by Subject|1
5147545|NCT01490125|17779904|P3|Period I|Withdrawal by Subject|2
5147546|NCT01490125|17779905|P2|Period I|Withdrawal by Subject|3
5147547|NCT01490125|17779906|P1|Period I|Withdrawal by Subject|1
5147548|NCT01490125|17779901|P6|Period I|Protocol Violation|0
5147549|NCT01490125|17779902|P5|Period I|Protocol Violation|0
5147550|NCT01490125|17779903|P4|Period I|Protocol Violation|1
5147551|NCT01490125|17779904|P3|Period I|Protocol Violation|1
5147552|NCT01490125|17779905|P2|Period I|Protocol Violation|1
5147553|NCT01490125|17779906|P1|Period I|Protocol Violation|1
5147554|NCT01490125|17779901|P6|Period I|Adverse Event|4
5147555|NCT01490125|17779902|P5|Period I|Adverse Event|2
5147556|NCT01490125|17779903|P4|Period I|Adverse Event|3
5147557|NCT01490125|17779904|P3|Period I|Adverse Event|1
5147558|NCT01490125|17779905|P2|Period I|Adverse Event|1
5147559|NCT01490125|17779906|P1|Period I|Adverse Event|4
5147560|NCT01490086|17779934|P5|Overall Study|Subject left hospital|0
5147561|NCT01490086|17779935|P4|Overall Study|Subject left hospital|1
5147562|NCT01490086|17779936|P3|Overall Study|Subject left hospital|0
5147563|NCT01490086|17779937|P2|Overall Study|Subject left hospital|1
5147564|NCT01490086|17779938|P1|Overall Study|Subject left hospital|0
5147565|NCT01490086|17779934|P5|Overall Study|Subject uncontrollable and abusive|0
5147566|NCT01490086|17779935|P4|Overall Study|Subject uncontrollable and abusive|0
5147567|NCT01490086|17779936|P3|Overall Study|Subject uncontrollable and abusive|0
5147568|NCT01490086|17779937|P2|Overall Study|Subject uncontrollable and abusive|1
5147569|NCT01490086|17779938|P1|Overall Study|Subject uncontrollable and abusive|0
5147570|NCT01490086|17779934|P5|Overall Study|Worsening of symptoms|0
5147571|NCT01490086|17779935|P4|Overall Study|Worsening of symptoms|1
5147572|NCT01490086|17779936|P3|Overall Study|Worsening of symptoms|0
5147573|NCT01490086|17779937|P2|Overall Study|Worsening of symptoms|1
5147574|NCT01490086|17779938|P1|Overall Study|Worsening of symptoms|0
5147575|NCT01490086|17779934|P5|Overall Study|Lack of Efficacy|8
5147576|NCT01490086|17779935|P4|Overall Study|Lack of Efficacy|0
5147577|NCT01490086|17779936|P3|Overall Study|Lack of Efficacy|1
5147578|NCT01490086|17779937|P2|Overall Study|Lack of Efficacy|3
5147579|NCT01490086|17779938|P1|Overall Study|Lack of Efficacy|0
5147580|NCT01490086|17779934|P5|Overall Study|Adverse Event|0
5147581|NCT01490086|17779935|P4|Overall Study|Adverse Event|2
5147582|NCT01490086|17779936|P3|Overall Study|Adverse Event|1
5147583|NCT01490086|17779937|P2|Overall Study|Adverse Event|0
5147584|NCT01490086|17779938|P1|Overall Study|Adverse Event|0
5147585|NCT01490086|17779934|P5|Overall Study|Physician Decision|1
5147586|NCT01490086|17779935|P4|Overall Study|Physician Decision|3
5147587|NCT01490086|17779936|P3|Overall Study|Physician Decision|2
5147588|NCT01490086|17779937|P2|Overall Study|Physician Decision|4
5147589|NCT01490086|17779938|P1|Overall Study|Physician Decision|3
5147590|NCT01490086|17779934|P5|Overall Study|Lost to Follow-up|1
5147591|NCT01490086|17779935|P4|Overall Study|Lost to Follow-up|0
5147592|NCT01490086|17779936|P3|Overall Study|Lost to Follow-up|0
5147593|NCT01490086|17779937|P2|Overall Study|Lost to Follow-up|0
5147594|NCT01490086|17779938|P1|Overall Study|Lost to Follow-up|0
5147595|NCT01490086|17779934|P5|Overall Study|Abnormal laboratory findings|0
5147596|NCT01490086|17779935|P4|Overall Study|Abnormal laboratory findings|0
5147597|NCT01490086|17779936|P3|Overall Study|Abnormal laboratory findings|0
5147598|NCT01490086|17779937|P2|Overall Study|Abnormal laboratory findings|0
5147599|NCT01490086|17779938|P1|Overall Study|Abnormal laboratory findings|1
5147600|NCT01490086|17779934|P5|Overall Study|Non-compliance|0
5147601|NCT01490086|17779935|P4|Overall Study|Non-compliance|0
5147602|NCT01490086|17779936|P3|Overall Study|Non-compliance|0
5147603|NCT01490086|17779937|P2|Overall Study|Non-compliance|1
5147604|NCT01490086|17779938|P1|Overall Study|Non-compliance|0
5147605|NCT01490086|17779934|P5|Overall Study|Consent withdrawn|1
5147606|NCT01490086|17779935|P4|Overall Study|Consent withdrawn|0
5147607|NCT01490086|17779936|P3|Overall Study|Consent withdrawn|3
5147608|NCT01490086|17779937|P2|Overall Study|Consent withdrawn|4
5147609|NCT01490086|17779938|P1|Overall Study|Consent withdrawn|4
5147610|NCT01490060|17779983|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
5147611|NCT01490060|17779984|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
5147612|NCT01490060|17779985|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
5147613|NCT01490060|17779986|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
5147614|NCT01490060|17779983|P4|Cycle 2|Non-Compliance|0
5147615|NCT01490060|17779984|P3|Cycle 2|Non-Compliance|1
5147616|NCT01490060|17779985|P2|Cycle 2|Non-Compliance|0
5147617|NCT01490060|17779986|P1|Cycle 2|Non-Compliance|0
5147618|NCT01490060|17779983|P4|Cycle 2|Change of Treatment|0
5147619|NCT01490060|17779984|P3|Cycle 2|Change of Treatment|0
5147620|NCT01490060|17779985|P2|Cycle 2|Change of Treatment|1
5147621|NCT01490060|17779986|P1|Cycle 2|Change of Treatment|1
5147622|NCT01490060|17779983|P4|Cycle 1|Treatment at Another Facility|1
5147623|NCT01490060|17779984|P3|Cycle 1|Treatment at Another Facility|0
5147624|NCT01490060|17779985|P2|Cycle 1|Treatment at Another Facility|0
5147625|NCT01490060|17779986|P1|Cycle 1|Treatment at Another Facility|0
5147626|NCT01490060|17779983|P4|Cycle 1|Withdrawal by Subject|1
5147627|NCT01490060|17779984|P3|Cycle 1|Withdrawal by Subject|0
5147628|NCT01490060|17779985|P2|Cycle 1|Withdrawal by Subject|0
5147629|NCT01490060|17779986|P1|Cycle 1|Withdrawal by Subject|0
5147630|NCT01490060|17779983|P4|Cycle 1|Insurance Denied|0
5147631|NCT01490060|17779984|P3|Cycle 1|Insurance Denied|2
5147632|NCT01490060|17779985|P2|Cycle 1|Insurance Denied|0
5147633|NCT01490060|17779986|P1|Cycle 1|Insurance Denied|0
5147634|NCT01490060|17779983|P4|Cycle 1|Change of Treatment|1
5147635|NCT01490060|17779984|P3|Cycle 1|Change of Treatment|1
5147636|NCT01490060|17779985|P2|Cycle 1|Change of Treatment|1
5147637|NCT01490060|17779986|P1|Cycle 1|Change of Treatment|0
5147638|NCT01489956|17780015|P3|Overall Study|Withdrawal by Subject|1
5147639|NCT01489956|17780016|P2|Overall Study|Withdrawal by Subject|0
5147640|NCT01489956|17780017|P1|Overall Study|Withdrawal by Subject|0
5147641|NCT01489956|17780015|P3|Overall Study|Lost to Follow-up|0
5147642|NCT01489956|17780016|P2|Overall Study|Lost to Follow-up|0
5147643|NCT01489956|17780017|P1|Overall Study|Lost to Follow-up|1
5147644|NCT01489891|17780054|P2|Overall Study|Endoscopy failure|0
5147645|NCT01489891|17780055|P1|Overall Study|Endoscopy failure|1
5147646|NCT01489527|17780210|P2|Overall Study|Not compliant|0
5147647|NCT01489527|17780211|P1|Overall Study|Not compliant|1
5147648|NCT01489527|17780210|P2|Overall Study|Procedures|0
5147649|NCT01489527|17780211|P1|Overall Study|Procedures|1
5147650|NCT01489527|17780210|P2|Overall Study|Lost to Follow-up|1
5147651|NCT01489527|17780211|P1|Overall Study|Lost to Follow-up|5
5147652|NCT01489527|17780210|P2|Overall Study|Withdrawal by Subject|4
5147653|NCT01489527|17780211|P1|Overall Study|Withdrawal by Subject|0
5147654|NCT01489527|17780210|P2|Overall Study|Participant moved|7
5147655|NCT01489527|17780211|P1|Overall Study|Participant moved|6
5147656|NCT01489527|17780210|P2|Overall Study|Pregnancy|14
5147657|NCT01489527|17780211|P1|Overall Study|Pregnancy|9
5147658|NCT01489358|17780228|P3|Overall Study|Lost to Follow-up|2
5147659|NCT01489358|17780229|P2|Overall Study|Lost to Follow-up|0
5147660|NCT01489358|17780230|P1|Overall Study|Lost to Follow-up|0
5147661|NCT01489254|17780280|P4|Open-label Extension Part|Other reasons for not completing study|5
5147662|NCT01489254|17780281|P3|Open-label Extension Part|Other reasons for not completing study|0
5147663|NCT01489254|17780282|P2|Open-label Extension Part|Other reasons for not completing study|0
5147664|NCT01489254|17780283|P1|Open-label Extension Part|Other reasons for not completing study|0
5147665|NCT01489254|17780280|P4|Open-label Extension Part|Lost to Follow-up|9
5147666|NCT01489254|17780281|P3|Open-label Extension Part|Lost to Follow-up|0
5147667|NCT01489254|17780282|P2|Open-label Extension Part|Lost to Follow-up|0
5147668|NCT01489254|17780283|P1|Open-label Extension Part|Lost to Follow-up|0
5147669|NCT01489254|17780280|P4|Open-label Extension Part|Protocol Violation|1
5147670|NCT01489254|17780281|P3|Open-label Extension Part|Protocol Violation|0
5147671|NCT01489254|17780282|P2|Open-label Extension Part|Protocol Violation|0
5147672|NCT01489254|17780283|P1|Open-label Extension Part|Protocol Violation|0
5147673|NCT01489254|17780280|P4|Open-label Extension Part|Withdrawal by Subject|30
5147674|NCT01489254|17780281|P3|Open-label Extension Part|Withdrawal by Subject|0
5147675|NCT01489254|17780282|P2|Open-label Extension Part|Withdrawal by Subject|0
5147676|NCT01489254|17780283|P1|Open-label Extension Part|Withdrawal by Subject|0
5147677|NCT01489254|17780280|P4|Open-label Extension Part|Pregnancy|3
5147678|NCT01489254|17780281|P3|Open-label Extension Part|Pregnancy|0
5147679|NCT01489254|17780282|P2|Open-label Extension Part|Pregnancy|0
5147680|NCT01489254|17780283|P1|Open-label Extension Part|Pregnancy|0
5147681|NCT01489254|17780280|P4|Open-label Extension Part|Adverse Event|10
5147682|NCT01489254|17780281|P3|Open-label Extension Part|Adverse Event|0
5147683|NCT01489254|17780282|P2|Open-label Extension Part|Adverse Event|0
5147684|NCT01489254|17780283|P1|Open-label Extension Part|Adverse Event|0
5147685|NCT01489254|17780280|P4|Double-blind Part|Other reasons for not completing study|0
5147686|NCT01489254|17780281|P3|Double-blind Part|Other reasons for not completing study|0
5147687|NCT01489254|17780282|P2|Double-blind Part|Other reasons for not completing study|6
5147688|NCT01489254|17780283|P1|Double-blind Part|Other reasons for not completing study|4
5147689|NCT01489254|17780280|P4|Double-blind Part|Lost to Follow-up|0
5147690|NCT01489254|17780281|P3|Double-blind Part|Lost to Follow-up|0
5147691|NCT01489254|17780282|P2|Double-blind Part|Lost to Follow-up|2
5147692|NCT01489254|17780283|P1|Double-blind Part|Lost to Follow-up|1
5147693|NCT01489254|17780280|P4|Double-blind Part|Withdrawal by Subject|0
5147694|NCT01489254|17780281|P3|Double-blind Part|Withdrawal by Subject|1
5147695|NCT01489254|17780282|P2|Double-blind Part|Withdrawal by Subject|20
5147696|NCT01489254|17780283|P1|Double-blind Part|Withdrawal by Subject|12
5147697|NCT01489254|17780280|P4|Double-blind Part|Pregnancy|0
5147698|NCT01489254|17780281|P3|Double-blind Part|Pregnancy|0
5147699|NCT01489254|17780282|P2|Double-blind Part|Pregnancy|3
5147700|NCT01489254|17780283|P1|Double-blind Part|Pregnancy|1
5147701|NCT01489254|17780280|P4|Double-blind Part|Adverse Event|0
5147702|NCT01489254|17780281|P3|Double-blind Part|Adverse Event|2
5147703|NCT01489254|17780282|P2|Double-blind Part|Adverse Event|2
5147704|NCT01489254|17780283|P1|Double-blind Part|Adverse Event|7
5147705|NCT01489189|17780294|P2|Overall Study|Missed Visit|4
5147706|NCT01489189|17780295|P1|Overall Study|Missed Visit|1
5147707|NCT01489189|17780294|P2|Overall Study|Death|8
5147708|NCT01489189|17780295|P1|Overall Study|Death|10
5147709|NCT01489189|17780294|P2|Overall Study|Withdrawal by Subject|23
5147710|NCT01489189|17780295|P1|Overall Study|Withdrawal by Subject|20
5147711|NCT01489111|17780320|P1|Overall Study|Withdrawal criterion|1
5147712|NCT01489020|17780341|P6|Overall Study|Concomitant disease|0
5147713|NCT01489020|17780342|P5|Overall Study|Concomitant disease|3
5147714|NCT01489020|17780343|P4|Overall Study|Concomitant disease|0
5147715|NCT01489020|17780344|P3|Overall Study|Concomitant disease|0
5147716|NCT01489020|17780345|P2|Overall Study|Concomitant disease|0
5147717|NCT01489020|17780346|P1|Overall Study|Concomitant disease|0
5147718|NCT01489020|17780341|P6|Overall Study|Adverse Event|0
5147719|NCT01489020|17780342|P5|Overall Study|Adverse Event|3
5147720|NCT01489020|17780343|P4|Overall Study|Adverse Event|0
5147721|NCT01489020|17780344|P3|Overall Study|Adverse Event|3
5147722|NCT01489020|17780345|P2|Overall Study|Adverse Event|0
5147723|NCT01489020|17780346|P1|Overall Study|Adverse Event|0
5147724|NCT01489020|17780341|P6|Overall Study|Withdrawal by Subject|0
5147725|NCT01489020|17780342|P5|Overall Study|Withdrawal by Subject|0
5147726|NCT01489020|17780343|P4|Overall Study|Withdrawal by Subject|0
5147727|NCT01489020|17780344|P3|Overall Study|Withdrawal by Subject|0
5147728|NCT01489020|17780345|P2|Overall Study|Withdrawal by Subject|0
5147729|NCT01489020|17780346|P1|Overall Study|Withdrawal by Subject|1
5147730|NCT01488994|17780380|P2|Overall Study|Withdrawal by Subject|1
5147731|NCT01488994|17780381|P1|Overall Study|Withdrawal by Subject|0
5147732|NCT01488890|17780472|P4|Overall Study|Withdrawal by Subject|2
5147733|NCT01488890|17780473|P3|Overall Study|Withdrawal by Subject|11
5147734|NCT01488890|17780474|P2|Overall Study|Withdrawal by Subject|10
5147735|NCT01488890|17780475|P1|Overall Study|Withdrawal by Subject|14
5147736|NCT01488890|17780472|P4|Overall Study|Lost to Follow-up|3
5147737|NCT01488890|17780473|P3|Overall Study|Lost to Follow-up|20
5147738|NCT01488890|17780474|P2|Overall Study|Lost to Follow-up|10
5147739|NCT01488890|17780475|P1|Overall Study|Lost to Follow-up|13
5147740|NCT01488890|17780472|P4|Overall Study|Protocol Violation|0
5147741|NCT01488890|17780473|P3|Overall Study|Protocol Violation|4
5147742|NCT01488890|17780474|P2|Overall Study|Protocol Violation|0
5147743|NCT01488890|17780475|P1|Overall Study|Protocol Violation|3
5147744|NCT01488890|17780472|P4|Overall Study|Serious adverse event|0
5147745|NCT01488890|17780473|P3|Overall Study|Serious adverse event|0
5147746|NCT01488890|17780474|P2|Overall Study|Serious adverse event|0
5147747|NCT01488890|17780475|P1|Overall Study|Serious adverse event|2
5147748|NCT01488578|17780553|P1|Overall Study|Protocol Violation|1836
5147749|NCT01488487|17780587|P1|Overall Study|Withdrawal by Subject|2
5147750|NCT01488487|17780587|P1|Overall Study|Death|1
5147751|NCT01488487|17780587|P1|Overall Study|Adverse Event|6
5147752|NCT01488448|17780596|P2|Overall Study|Protocol Violation|3
5147753|NCT01488448|17780597|P1|Overall Study|Protocol Violation|4
5147754|NCT01488448|17780596|P2|Overall Study|Physician Decision|9
5147755|NCT01488448|17780597|P1|Overall Study|Physician Decision|4
5147756|NCT01488448|17780596|P2|Overall Study|Adverse Event|4
5147757|NCT01488448|17780597|P1|Overall Study|Adverse Event|9
5147758|NCT01488448|17780596|P2|Overall Study|Withdrawal by Subject|1
5147759|NCT01488448|17780597|P1|Overall Study|Withdrawal by Subject|3
5147760|NCT01488370|17780639|P3|Overall Study|Protocol Violation|1
5147761|NCT01488370|17780640|P2|Overall Study|Protocol Violation|1
5147762|NCT01488370|17780641|P1|Overall Study|Protocol Violation|0
5147763|NCT01488097|17780700|P1|Overall Study|Lost to Follow-up|1
5147764|NCT01488071|17780713|P2|Overall Study|Administrative or Other Reason(s)|4
5147765|NCT01488071|17780714|P1|Overall Study|Administrative or Other Reason(s)|5
5147766|NCT01488071|17780713|P2|Overall Study|Lost to Follow-up|0
5147767|NCT01488071|17780714|P1|Overall Study|Lost to Follow-up|1
5147768|NCT01488071|17780713|P2|Overall Study|Withdrawal of Consent|12
5147769|NCT01488071|17780714|P1|Overall Study|Withdrawal of Consent|14
5147770|NCT01488071|17780713|P2|Overall Study|Protocol Violation|7
5147771|NCT01488071|17780714|P1|Overall Study|Protocol Violation|5
5147772|NCT01488071|17780713|P2|Overall Study|Non-compliance with study drug|0
5147773|NCT01488071|17780714|P1|Overall Study|Non-compliance with study drug|2
5147774|NCT01488071|17780713|P2|Overall Study|Lack of Efficacy|17
5147775|NCT01488071|17780714|P1|Overall Study|Lack of Efficacy|11
5147776|NCT01488071|17780713|P2|Overall Study|Adverse Event|23
5147777|NCT01488071|17780714|P1|Overall Study|Adverse Event|15
5147778|NCT01487863|17780794|P2|Overall Study|Death|19
5147779|NCT01487863|17780795|P1|Overall Study|Death|19
5147780|NCT01487577|17780812|P1|Overall Study|Became ineligible after signing consent|1
5147781|NCT01487525|17780826|P2|Overall Study|Withdrawal by Subject|1
5147782|NCT01487525|17780827|P1|Overall Study|Withdrawal by Subject|0
5147783|NCT01487265|17780843|P1|Overall Study|Still on Treatment|1
5147784|NCT01487265|17780843|P1|Overall Study|Death|2
5147785|NCT01487265|17780843|P1|Overall Study|Disease Progression|21
5147786|NCT01487265|17780843|P1|Overall Study|Withdrawal by Subject|5
5147787|NCT01487265|17780843|P1|Overall Study|Adverse Event|8
5147788|NCT01487200|17780855|P4|Overall Study|Withdrawal by Subject|0
5147789|NCT01487200|17780856|P3|Overall Study|Withdrawal by Subject|0
5147790|NCT01487200|17780857|P2|Overall Study|Withdrawal by Subject|1
5147791|NCT01487200|17780858|P1|Overall Study|Withdrawal by Subject|0
5147792|NCT01487161|17780888|P4|Overall Study|missing data|0
5147793|NCT01487161|17780889|P3|Overall Study|missing data|0
5147794|NCT01487161|17780890|P2|Overall Study|missing data|1
5147795|NCT01487161|17780891|P1|Overall Study|missing data|0
5147796|NCT01487161|17780888|P4|Overall Study|Withdrawal by Subject|2
5147797|NCT01487161|17780889|P3|Overall Study|Withdrawal by Subject|1
5147798|NCT01487161|17780890|P2|Overall Study|Withdrawal by Subject|1
5147799|NCT01487161|17780891|P1|Overall Study|Withdrawal by Subject|1
5147800|NCT01487161|17780888|P4|Overall Study|Adverse Event|0
5147801|NCT01487161|17780889|P3|Overall Study|Adverse Event|0
5147802|NCT01487161|17780890|P2|Overall Study|Adverse Event|0
5147803|NCT01487161|17780891|P1|Overall Study|Adverse Event|1
5147804|NCT01486966|17780956|P2|Overall Study|Withdrawal by Subject|1
5147805|NCT01486966|17780957|P1|Overall Study|Withdrawal by Subject|0
5147806|NCT01486966|17780956|P2|Overall Study|Adverse Event|1
5147807|NCT01486966|17780957|P1|Overall Study|Adverse Event|0
5147808|NCT01486927|17780981|P1|Overall Study|Subject did not reach 6 mo of treatment|1
5147809|NCT01486927|17780981|P1|Overall Study|Withdrawal by Subject|8
5147810|NCT01486927|17780981|P1|Overall Study|50 Exposure days not reached|2
5147811|NCT01486927|17780981|P1|Overall Study|Physician Decision|1
5147812|NCT01486927|17780981|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
5147813|NCT01486758|17781019|P2|Overall Study|Lost to Follow-up|1
5147814|NCT01486758|17781020|P1|Overall Study|Lost to Follow-up|0
5147815|NCT01486446|17781087|P2|Overall Study|Adverse Event|0
5147816|NCT01486446|17781088|P1|Overall Study|Adverse Event|1
5147817|NCT01486316|17781111|P4|Overall Study|Death|0
5147818|NCT01486316|17781112|P3|Overall Study|Death|0
5147819|NCT01486316|17781113|P2|Overall Study|Death|1
5147820|NCT01486316|17781114|P1|Overall Study|Death|0
5147821|NCT01486316|17781111|P4|Overall Study|Physician Decision|0
5147822|NCT01486316|17781112|P3|Overall Study|Physician Decision|1
5147823|NCT01486316|17781113|P2|Overall Study|Physician Decision|0
5147824|NCT01486316|17781114|P1|Overall Study|Physician Decision|0
5147825|NCT01486316|17781111|P4|Overall Study|Withdrawal by Subject|0
5147826|NCT01486316|17781112|P3|Overall Study|Withdrawal by Subject|3
5147827|NCT01486316|17781113|P2|Overall Study|Withdrawal by Subject|0
5147828|NCT01486316|17781114|P1|Overall Study|Withdrawal by Subject|1
5147829|NCT01486316|17781111|P4|Overall Study|Not meeting eligibility criteria|0
5147830|NCT01486316|17781112|P3|Overall Study|Not meeting eligibility criteria|1
5147831|NCT01486316|17781113|P2|Overall Study|Not meeting eligibility criteria|0
5147832|NCT01486316|17781114|P1|Overall Study|Not meeting eligibility criteria|0
5147833|NCT01486316|17781111|P4|Overall Study|Device explanted with/without re-implant|2
5147834|NCT01486316|17781112|P3|Overall Study|Device explanted with/without re-implant|0
5147835|NCT01486316|17781113|P2|Overall Study|Device explanted with/without re-implant|2
5147836|NCT01486316|17781114|P1|Overall Study|Device explanted with/without re-implant|3
5147837|NCT01486264|17781126|P2|Overall Study|Not treated|1
5147838|NCT01486264|17781127|P1|Overall Study|Not treated|0
5147839|NCT01486264|17781126|P2|Overall Study|Other|11
5147840|NCT01486264|17781127|P1|Overall Study|Other|5
5147841|NCT01486264|17781126|P2|Overall Study|Lost to Follow-up|2
5147842|NCT01486264|17781127|P1|Overall Study|Lost to Follow-up|3
5147843|NCT01486264|17781126|P2|Overall Study|Protocol Violation|0
5147844|NCT01486264|17781127|P1|Overall Study|Protocol Violation|3
5147845|NCT01486264|17781126|P2|Overall Study|Physician Decision|1
5147846|NCT01486264|17781127|P1|Overall Study|Physician Decision|1
5147847|NCT01486264|17781126|P2|Overall Study|Withdrawal by Subject|18
5147848|NCT01486264|17781127|P1|Overall Study|Withdrawal by Subject|7
5147849|NCT01486264|17781126|P2|Overall Study|Lack of Efficacy|10
5147850|NCT01486264|17781127|P1|Overall Study|Lack of Efficacy|6
5147851|NCT01486264|17781126|P2|Overall Study|Adverse Event|3
5147852|NCT01486264|17781127|P1|Overall Study|Adverse Event|3
5147853|NCT01486264|17781126|P2|Overall Study|Death|1
5147854|NCT01486264|17781127|P1|Overall Study|Death|1
5147855|NCT01486238|17781159|P2|Overall Study|Lost to Follow-up|3
5147856|NCT01486238|17781160|P1|Overall Study|Lost to Follow-up|0
5147857|NCT01486238|17781159|P2|Overall Study|Withdrawal by Subject|1
5147858|NCT01486238|17781160|P1|Overall Study|Withdrawal by Subject|2
5147859|NCT01486238|17781159|P2|Overall Study|Death|2
5147860|NCT01486238|17781160|P1|Overall Study|Death|0
5147861|NCT01486199|17781168|P2|Two Year Period Between Study Days|Physician Decision|0
5147862|NCT01486199|17781169|P1|Two Year Period Between Study Days|Physician Decision|1
5147863|NCT01485991|17781189|P2|Overall Study|randomized but not treated|2
5147864|NCT01485991|17781190|P1|Overall Study|randomized but not treated|6
5147865|NCT01485991|17781189|P2|Overall Study|Withdrawal by Subject|20
5147866|NCT01485991|17781190|P1|Overall Study|Withdrawal by Subject|13
5147867|NCT01485991|17781189|P2|Overall Study|Lost to Follow-up|10
5147868|NCT01485991|17781190|P1|Overall Study|Lost to Follow-up|13
5147869|NCT01485991|17781189|P2|Overall Study|Adverse Event|4
5147870|NCT01485991|17781190|P1|Overall Study|Adverse Event|0
5147871|NCT01485887|17781200|P1|Overall Study|Primary disease markedly improved|1
5147872|NCT01485887|17781200|P1|Overall Study|Deterioration of primary disease|1
5147873|NCT01485887|17781200|P1|Overall Study|Adverse Event|8
5147874|NCT01485887|17781200|P1|Overall Study|Withdrawal by Subject|2
5147875|NCT01485796|17781212|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
5147876|NCT01485796|17781212|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
5147877|NCT01485796|17781212|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
5147878|NCT01485796|17781212|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
5147879|NCT01485796|17781212|P1|Period 2: Epoch 2|Switch to safety follow-up|26
5147880|NCT01485796|17781212|P1|Period 2: Epoch 2|Adverse Event|3
5147881|NCT01485796|17781212|P1|Period 2: Epoch 2|Withdrawal by Subject|6
5147882|NCT01485796|17781212|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
5147883|NCT01485640|17781234|P1|Overall Study|Terminated by Sponsor|95
5147884|NCT01485640|17781234|P1|Overall Study|Withdrawal by Subject|14
5147885|NCT01485640|17781234|P1|Overall Study|Protocol Violation|1
5147886|NCT01485640|17781234|P1|Overall Study|Lack of Efficacy|2
5147887|NCT01485640|17781234|P1|Overall Study|Adverse Event|10
5147888|NCT01485627|17781241|P2|Overall Study|caregiver was not bereaved|35
5147889|NCT01485627|17781242|P1|Overall Study|caregiver was not bereaved|42
5147890|NCT01485627|17781241|P2|Overall Study|Caregiver died|0
5147891|NCT01485627|17781242|P1|Overall Study|Caregiver died|1
5147892|NCT01485627|17781241|P2|Overall Study|Caregiver lost to follow up|12
5147893|NCT01485627|17781242|P1|Overall Study|Caregiver lost to follow up|11
5147894|NCT01485627|17781241|P2|Overall Study|Caregiver withdrew|3
5147895|NCT01485627|17781242|P1|Overall Study|Caregiver withdrew|3
5147896|NCT01485627|17781241|P2|Overall Study|Patient lost to followup|1
5147897|NCT01485627|17781242|P1|Overall Study|Patient lost to followup|0
5147898|NCT01485627|17781241|P2|Overall Study|Patient died|1
5147899|NCT01485627|17781242|P1|Overall Study|Patient died|3
5147900|NCT01485627|17781241|P2|Overall Study|Patient withdrew|5
5147901|NCT01485627|17781242|P1|Overall Study|Patient withdrew|6
5147902|NCT01485536|17781276|P1|Overall Study|Adverse Event|1
5147903|NCT01485536|17781276|P1|Overall Study|Withdrawal by Subject|3
5147904|NCT01485354|17781294|P1|Overall Study|Withdrawal by Subject|5
5147905|NCT01485172|17781308|P6|Overall Study|Withdrawal by Subject|1
5147906|NCT01485172|17781309|P5|Overall Study|Withdrawal by Subject|1
5147907|NCT01485172|17781310|P4|Overall Study|Withdrawal by Subject|1
5147908|NCT01485172|17781311|P3|Overall Study|Withdrawal by Subject|0
5147909|NCT01485172|17781312|P2|Overall Study|Withdrawal by Subject|0
5147910|NCT01485172|17781313|P1|Overall Study|Withdrawal by Subject|2
5147911|NCT01485172|17781308|P6|Overall Study|Physician Decision|0
5147912|NCT01485172|17781309|P5|Overall Study|Physician Decision|1
5147913|NCT01485172|17781310|P4|Overall Study|Physician Decision|0
5147914|NCT01485172|17781311|P3|Overall Study|Physician Decision|0
5147915|NCT01485172|17781312|P2|Overall Study|Physician Decision|0
5147916|NCT01485172|17781313|P1|Overall Study|Physician Decision|0
5147917|NCT01485172|17781308|P6|Overall Study|Lost to Follow-up|1
5147918|NCT01485172|17781309|P5|Overall Study|Lost to Follow-up|0
5147919|NCT01485172|17781310|P4|Overall Study|Lost to Follow-up|0
5147920|NCT01485172|17781311|P3|Overall Study|Lost to Follow-up|1
5147921|NCT01485172|17781312|P2|Overall Study|Lost to Follow-up|0
5147922|NCT01485172|17781313|P1|Overall Study|Lost to Follow-up|0
5147923|NCT01485172|17781308|P6|Overall Study|Protocol defined stopping criteria|0
5147924|NCT01485172|17781309|P5|Overall Study|Protocol defined stopping criteria|1
5147925|NCT01485172|17781310|P4|Overall Study|Protocol defined stopping criteria|0
5147926|NCT01485172|17781311|P3|Overall Study|Protocol defined stopping criteria|0
5147927|NCT01485172|17781312|P2|Overall Study|Protocol defined stopping criteria|0
5147928|NCT01485172|17781313|P1|Overall Study|Protocol defined stopping criteria|1
5147929|NCT01485172|17781308|P6|Overall Study|Protocol Violation|0
5147930|NCT01485172|17781309|P5|Overall Study|Protocol Violation|1
5147931|NCT01485172|17781310|P4|Overall Study|Protocol Violation|5
5147932|NCT01485172|17781311|P3|Overall Study|Protocol Violation|4
5147933|NCT01485172|17781312|P2|Overall Study|Protocol Violation|0
5147934|NCT01485172|17781313|P1|Overall Study|Protocol Violation|0
5147935|NCT01485172|17781308|P6|Overall Study|Lack of Efficacy|0
5147936|NCT01485172|17781309|P5|Overall Study|Lack of Efficacy|0
5147937|NCT01485172|17781310|P4|Overall Study|Lack of Efficacy|0
5147938|NCT01485172|17781311|P3|Overall Study|Lack of Efficacy|0
5147939|NCT01485172|17781312|P2|Overall Study|Lack of Efficacy|0
5147940|NCT01485172|17781313|P1|Overall Study|Lack of Efficacy|2
5147941|NCT01485172|17781308|P6|Overall Study|Adverse Event|2
5147942|NCT01485172|17781309|P5|Overall Study|Adverse Event|1
5147943|NCT01485172|17781310|P4|Overall Study|Adverse Event|2
5147944|NCT01485172|17781311|P3|Overall Study|Adverse Event|2
5147945|NCT01485172|17781312|P2|Overall Study|Adverse Event|1
5147946|NCT01485172|17781313|P1|Overall Study|Adverse Event|2
5147947|NCT01485120|17781387|P1|Overall Study|Withdrawal by Subject|2
5147948|NCT01485094|17781395|P3|Overall Study|Withdrawal by Subject|0
5147949|NCT01485094|17781396|P2|Overall Study|Withdrawal by Subject|1
5147950|NCT01485094|17781397|P1|Overall Study|Withdrawal by Subject|1
5147951|NCT01485094|17781395|P3|Overall Study|Lost to Follow-up|0
5147952|NCT01485094|17781396|P2|Overall Study|Lost to Follow-up|0
5147953|NCT01485094|17781397|P1|Overall Study|Lost to Follow-up|1
5147954|NCT01485094|17781395|P3|Overall Study|Adverse Event|1
5147955|NCT01485094|17781396|P2|Overall Study|Adverse Event|1
5147956|NCT01485094|17781397|P1|Overall Study|Adverse Event|1
5147957|NCT01484977|17781442|P1|Overall Study|Lack of Compliance|1
5147958|NCT01484977|17781442|P1|Overall Study|Low White Blood Cell Count|1
5147959|NCT01484977|17781442|P1|Overall Study|Moving Overseas|1
5147960|NCT01484977|17781442|P1|Overall Study|Subject Protocol Non-compliant|1
5147961|NCT01484977|17781442|P1|Overall Study|Withdrawal by Subject|4
5147962|NCT01484977|17781442|P1|Overall Study|Lost to Follow-up|1
5147963|NCT01484977|17781442|P1|Overall Study|Protocol Violation|6
5147964|NCT01484977|17781442|P1|Overall Study|Lack of Efficacy|4
5147965|NCT01484977|17781442|P1|Overall Study|Adverse Event|8
5147966|NCT01484951|17781446|P1|Overall Study|Non-Compliance|1
5147967|NCT01484951|17781446|P1|Overall Study|Personal Reasons|1
5147968|NCT01484951|17781446|P1|Overall Study|Adverse Event|3
5147969|NCT01484938|17781451|P1|Overall Study|Noncompliance|1
5147970|NCT01484938|17781451|P1|Overall Study|Lost to Follow-up|1
5147971|NCT01484938|17781451|P1|Overall Study|Adverse Event|2
5147972|NCT01484912|17781458|P2|Overall Study|Physician Decision|1
5147973|NCT01484912|17781459|P1|Overall Study|Physician Decision|0
5147974|NCT01484912|17781458|P2|Overall Study|Withdrawal by Subject|0
5147975|NCT01484912|17781459|P1|Overall Study|Withdrawal by Subject|1
5147976|NCT01484873|17781469|P1|Overall Study|Withdrawal by Subject|2
5147977|NCT01484834|17781481|P4|Overall Study|Lost to Follow-up|4
5147978|NCT01484834|17781482|P3|Overall Study|Lost to Follow-up|1
5147979|NCT01484834|17781483|P2|Overall Study|Lost to Follow-up|8
5147980|NCT01484834|17781484|P1|Overall Study|Lost to Follow-up|5
5147981|NCT01484561|17781525|P2|Overall Study|Adverse Event|4
5147982|NCT01484561|17781526|P1|Overall Study|Adverse Event|1
5147983|NCT01484561|17781525|P2|Overall Study|Other|1
5147984|NCT01484561|17781526|P1|Overall Study|Other|1
5147985|NCT01484561|17781525|P2|Overall Study|Withdrawal by Subject|0
5147986|NCT01484561|17781526|P1|Overall Study|Withdrawal by Subject|3
5147987|NCT01484561|17781525|P2|Overall Study|Lost to Follow-up|0
5147988|NCT01484561|17781526|P1|Overall Study|Lost to Follow-up|1
5147989|NCT01484561|17781525|P2|Overall Study|Lack of Efficacy|1
5147990|NCT01484561|17781526|P1|Overall Study|Lack of Efficacy|3
5147991|NCT01484496|17781616|P4|Period 2|Other|6
5147992|NCT01484496|17781617|P3|Period 2|Other|9
5147993|NCT01484496|17781618|P2|Period 2|Other|0
5147994|NCT01484496|17781619|P1|Period 2|Other|0
5147995|NCT01484496|17781616|P4|Period 2|Adverse Event|13
5147996|NCT01484496|17781617|P3|Period 2|Adverse Event|5
5147997|NCT01484496|17781618|P2|Period 2|Adverse Event|0
5147998|NCT01484496|17781619|P1|Period 2|Adverse Event|0
5147999|NCT01484496|17781616|P4|Period 2|Lack of Efficacy|3
5148000|NCT01484496|17781617|P3|Period 2|Lack of Efficacy|1
5148001|NCT01484496|17781618|P2|Period 2|Lack of Efficacy|0
5148002|NCT01484496|17781619|P1|Period 2|Lack of Efficacy|0
5148003|NCT01484496|17781616|P4|Period 1|Unable to Visit Site|0
5148004|NCT01484496|17781617|P3|Period 1|Unable to Visit Site|0
5148005|NCT01484496|17781618|P2|Period 1|Unable to Visit Site|2
5148006|NCT01484496|17781619|P1|Period 1|Unable to Visit Site|0
5148007|NCT01484496|17781616|P4|Period 1|Lack of Compliance|0
5148008|NCT01484496|17781617|P3|Period 1|Lack of Compliance|0
5148009|NCT01484496|17781618|P2|Period 1|Lack of Compliance|1
5148010|NCT01484496|17781619|P1|Period 1|Lack of Compliance|2
5148011|NCT01484496|17781616|P4|Period 1|Treatment Failure|0
5148012|NCT01484496|17781617|P3|Period 1|Treatment Failure|0
5148013|NCT01484496|17781618|P2|Period 1|Treatment Failure|6
5148014|NCT01484496|17781619|P1|Period 1|Treatment Failure|3
5148015|NCT01484496|17781616|P4|Period 1|Positive Pregnancy|0
5148016|NCT01484496|17781617|P3|Period 1|Positive Pregnancy|0
5148017|NCT01484496|17781618|P2|Period 1|Positive Pregnancy|6
5148018|NCT01484496|17781619|P1|Period 1|Positive Pregnancy|1
5148019|NCT01484496|17781616|P4|Period 1|Lost to Follow-up|0
5148020|NCT01484496|17781617|P3|Period 1|Lost to Follow-up|0
5148021|NCT01484496|17781618|P2|Period 1|Lost to Follow-up|6
5148022|NCT01484496|17781619|P1|Period 1|Lost to Follow-up|2
5148023|NCT01484496|17781616|P4|Period 1|Withdrawal by Subject|0
5148024|NCT01484496|17781617|P3|Period 1|Withdrawal by Subject|0
5148025|NCT01484496|17781618|P2|Period 1|Withdrawal by Subject|12
5148026|NCT01484496|17781619|P1|Period 1|Withdrawal by Subject|15
5148027|NCT01484496|17781616|P4|Period 1|Adverse Event|0
5148028|NCT01484496|17781617|P3|Period 1|Adverse Event|0
5148029|NCT01484496|17781618|P2|Period 1|Adverse Event|40
5148030|NCT01484496|17781619|P1|Period 1|Adverse Event|25
5148031|NCT01484496|17781616|P4|Period 1|Lack of Efficacy|0
5148032|NCT01484496|17781617|P3|Period 1|Lack of Efficacy|0
5148033|NCT01484496|17781618|P2|Period 1|Lack of Efficacy|15
5148034|NCT01484496|17781619|P1|Period 1|Lack of Efficacy|10
5148035|NCT01484496|17781616|P4|Period 1|Physician Decision|0
5148036|NCT01484496|17781617|P3|Period 1|Physician Decision|0
5148037|NCT01484496|17781618|P2|Period 1|Physician Decision|1
5148038|NCT01484496|17781619|P1|Period 1|Physician Decision|5
5148039|NCT01484496|17781616|P4|Period 1|Protocol Violation|0
5148040|NCT01484496|17781617|P3|Period 1|Protocol Violation|0
5148041|NCT01484496|17781618|P2|Period 1|Protocol Violation|4
5148042|NCT01484496|17781619|P1|Period 1|Protocol Violation|3
5148043|NCT01484431|17781634|P3|Period 2|Non-Compliance with Study Drug|0
5148044|NCT01484431|17781635|P2|Period 2|Non-Compliance with Study Drug|0
5148045|NCT01484431|17781636|P1|Period 2|Non-Compliance with Study Drug|1
5148046|NCT01484431|17781634|P3|Period 2|Physician Decision|1
5148047|NCT01484431|17781635|P2|Period 2|Physician Decision|0
5148048|NCT01484431|17781636|P1|Period 2|Physician Decision|0
5148049|NCT01484431|17781634|P3|Period 2|Death|1
5148050|NCT01484431|17781635|P2|Period 2|Death|1
5148051|NCT01484431|17781636|P1|Period 2|Death|0
5148052|NCT01484431|17781634|P3|Period 1: High Dose|Physician Decision|0
5148053|NCT01484431|17781635|P2|Period 1: High Dose|Physician Decision|1
5148054|NCT01484431|17781636|P1|Period 1: High Dose|Physician Decision|0
5148055|NCT01484275|17781674|P2|Overall Study|Lost to Follow-up|1
5148056|NCT01484275|17781675|P1|Overall Study|Lost to Follow-up|1
5148057|NCT01484275|17781674|P2|Overall Study|Withdrawal by Subject|5
5148058|NCT01484275|17781675|P1|Overall Study|Withdrawal by Subject|1
5148059|NCT01484275|17781674|P2|Overall Study|Death|4
5148060|NCT01484275|17781675|P1|Overall Study|Death|3
5148061|NCT01484275|17781674|P2|Overall Study|Other|0
5148062|NCT01484275|17781675|P1|Overall Study|Other|10
5148063|NCT01484275|17781674|P2|Overall Study|Study terminated by sponsor|32
5148064|NCT01484275|17781675|P1|Overall Study|Study terminated by sponsor|28
5148065|NCT01484197|17781697|P4|Treatment Period 2|Subject withdrew consent|1
5148066|NCT01484197|17781698|P3|Treatment Period 2|Subject withdrew consent|0
5148067|NCT01484197|17781699|P2|Treatment Period 2|Subject withdrew consent|0
5148068|NCT01484197|17781700|P1|Treatment Period 2|Subject withdrew consent|0
5148069|NCT01484197|17781697|P4|Treatment Period 1|Adverse Event|0
5148070|NCT01484197|17781698|P3|Treatment Period 1|Adverse Event|0
5148071|NCT01484197|17781699|P2|Treatment Period 1|Adverse Event|0
5148072|NCT01484197|17781700|P1|Treatment Period 1|Adverse Event|1
5148073|NCT01484132|17781783|P1|Overall Study|No post-treatment urine sample collected|10
5148074|NCT01484132|17781783|P1|Overall Study|No pre-treatment urine sample collected|1
5148075|NCT01484132|17781783|P1|Overall Study|Ineligible|1
5148076|NCT01484132|17781783|P1|Overall Study|Difficulty with time commitment|2
5148077|NCT01484132|17781783|P1|Overall Study|Lost to Follow-up|8
5148078|NCT01484054|17781791|P2|Period 1|Withdrawal by Subject|1
5148079|NCT01484054|17781792|P1|Period 1|Withdrawal by Subject|0
5148080|NCT01484028|17781810|P4|Period 1|Lens Discomfort|0
5148081|NCT01484028|17781811|P3|Period 1|Lens Discomfort|0
5148082|NCT01484028|17781812|P2|Period 1|Lens Discomfort|1
5148083|NCT01484028|17781813|P1|Period 1|Lens Discomfort|0
5148084|NCT01484028|17781810|P4|Period 1|Non-Compliance to Protocol|1
5148085|NCT01484028|17781811|P3|Period 1|Non-Compliance to Protocol|0
5148086|NCT01484028|17781812|P2|Period 1|Non-Compliance to Protocol|1
5148087|NCT01484028|17781813|P1|Period 1|Non-Compliance to Protocol|0
5148088|NCT01484028|17781810|P4|Period 1|Lost to Follow-up|0
5148089|NCT01484028|17781811|P3|Period 1|Lost to Follow-up|0
5148090|NCT01484028|17781812|P2|Period 1|Lost to Follow-up|1
5148091|NCT01484028|17781813|P1|Period 1|Lost to Follow-up|0
5148092|NCT01483937|17781906|P2|Overall Study|Withdrawal by Subject|3
5148093|NCT01483937|17781907|P1|Overall Study|Withdrawal by Subject|4
5148094|NCT01483924|17781934|P5|Overall Study|Sponsor concern over ECG result|0
5148095|NCT01483924|17781935|P4|Overall Study|Sponsor concern over ECG result|1
5148096|NCT01483924|17781936|P3|Overall Study|Sponsor concern over ECG result|0
5148097|NCT01483924|17781937|P2|Overall Study|Sponsor concern over ECG result|0
5148098|NCT01483924|17781938|P1|Overall Study|Sponsor concern over ECG result|0
5148099|NCT01483924|17781934|P5|Overall Study|Non-compliance|1
5148100|NCT01483924|17781935|P4|Overall Study|Non-compliance|1
5148101|NCT01483924|17781936|P3|Overall Study|Non-compliance|0
5148102|NCT01483924|17781937|P2|Overall Study|Non-compliance|0
5148103|NCT01483924|17781938|P1|Overall Study|Non-compliance|0
5148104|NCT01483924|17781934|P5|Overall Study|Adverse Event|0
5148105|NCT01483924|17781935|P4|Overall Study|Adverse Event|1
5148106|NCT01483924|17781936|P3|Overall Study|Adverse Event|1
5148107|NCT01483924|17781937|P2|Overall Study|Adverse Event|0
5148108|NCT01483924|17781938|P1|Overall Study|Adverse Event|0
5148109|NCT01483924|17781934|P5|Overall Study|Withdrawal by Subject|1
5148110|NCT01483924|17781935|P4|Overall Study|Withdrawal by Subject|1
5148111|NCT01483924|17781936|P3|Overall Study|Withdrawal by Subject|0
5148112|NCT01483924|17781937|P2|Overall Study|Withdrawal by Subject|0
5148113|NCT01483924|17781938|P1|Overall Study|Withdrawal by Subject|2
5148114|NCT01483820|17781991|P1|Overall Study|Death|1
5148115|NCT01483820|17781991|P1|Overall Study|Adverse Event|1
5148116|NCT01483820|17781991|P1|Overall Study|Lack of Efficacy|6
5148117|NCT01483690|17782014|P2|Overall Study|exclusionary procedure|1
5148118|NCT01483690|17782015|P1|Overall Study|exclusionary procedure|0
5148119|NCT01483690|17782014|P2|Overall Study|Physician Decision|2
5148120|NCT01483690|17782015|P1|Overall Study|Physician Decision|0
5148121|NCT01483690|17782014|P2|Overall Study|clinical deterioration|0
5148122|NCT01483690|17782015|P1|Overall Study|clinical deterioration|1
5148123|NCT01483690|17782014|P2|Overall Study|Adverse Event|2
5148124|NCT01483690|17782015|P1|Overall Study|Adverse Event|1
5148125|NCT01483651|17782023|P6|Overall Study|Withdrawal by Subject|1
5148126|NCT01483651|17782024|P5|Overall Study|Withdrawal by Subject|0
5148127|NCT01483651|17782025|P4|Overall Study|Withdrawal by Subject|0
5148128|NCT01483651|17782026|P3|Overall Study|Withdrawal by Subject|1
5148129|NCT01483651|17782027|P2|Overall Study|Withdrawal by Subject|1
5148130|NCT01483651|17782028|P1|Overall Study|Withdrawal by Subject|0
5148131|NCT01483625|17782038|P2|Overall Study|Due to other reason|0
5148132|NCT01483625|17782039|P1|Overall Study|Due to other reason|1
5148133|NCT01483625|17782038|P2|Overall Study|Refused to continue medication|1
5148134|NCT01483625|17782039|P1|Overall Study|Refused to continue medication|2
5148135|NCT01483625|17782038|P2|Overall Study|Adverse Event|1
5148136|NCT01483625|17782039|P1|Overall Study|Adverse Event|1
5148137|NCT01483599|17782062|P14|After Controlled Period(Week 16-Week 40)|Other|0
5148138|NCT01483599|17782063|P13|After Controlled Period(Week 16-Week 40)|Other|1
5148139|NCT01483599|17782064|P12|After Controlled Period(Week 16-Week 40)|Other|0
5148140|NCT01483599|17782065|P11|After Controlled Period(Week 16-Week 40)|Other|0
5148141|NCT01483599|17782066|P10|After Controlled Period(Week 16-Week 40)|Other|4
5148142|NCT01483599|17782067|P9|After Controlled Period(Week 16-Week 40)|Other|0
5148143|NCT01483599|17782068|P8|After Controlled Period(Week 16-Week 40)|Other|1
5148144|NCT01483599|17782069|P7|After Controlled Period(Week 16-Week 40)|Other|0
5148145|NCT01483599|17782070|P6|After Controlled Period(Week 16-Week 40)|Other|0
5148146|NCT01483599|17782071|P5|After Controlled Period(Week 16-Week 40)|Other|0
5148147|NCT01483599|17782072|P4|After Controlled Period(Week 16-Week 40)|Other|0
5148148|NCT01483599|17782073|P3|After Controlled Period(Week 16-Week 40)|Other|0
5148149|NCT01483599|17782074|P2|After Controlled Period(Week 16-Week 40)|Other|0
5148150|NCT01483599|17782075|P1|After Controlled Period(Week 16-Week 40)|Other|0
5148151|NCT01483599|17782062|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
5148152|NCT01483599|17782063|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
5148153|NCT01483599|17782064|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148154|NCT01483599|17782065|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148155|NCT01483599|17782066|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148156|NCT01483599|17782067|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
5148157|NCT01483599|17782068|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148158|NCT01483599|17782069|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148159|NCT01483599|17782070|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148160|NCT01483599|17782071|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148161|NCT01483599|17782072|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148162|NCT01483599|17782073|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148163|NCT01483599|17782074|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148164|NCT01483599|17782075|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5148165|NCT01483599|17782062|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
5148166|NCT01483599|17782063|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148167|NCT01483599|17782064|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148168|NCT01483599|17782065|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
5148169|NCT01483599|17782066|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148170|NCT01483599|17782067|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
5148171|NCT01483599|17782068|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148172|NCT01483599|17782069|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148173|NCT01483599|17782070|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148174|NCT01483599|17782071|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148175|NCT01483599|17782072|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148176|NCT01483599|17782073|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148177|NCT01483599|17782074|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148178|NCT01483599|17782075|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5148179|NCT01483599|17782062|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5148180|NCT01483599|17782063|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148181|NCT01483599|17782064|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5148182|NCT01483599|17782065|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148183|NCT01483599|17782066|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148184|NCT01483599|17782067|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5148185|NCT01483599|17782068|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148186|NCT01483599|17782069|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148187|NCT01483599|17782070|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148188|NCT01483599|17782071|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148189|NCT01483599|17782072|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148190|NCT01483599|17782073|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148191|NCT01483599|17782074|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148192|NCT01483599|17782075|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5148193|NCT01483599|17782062|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5148194|NCT01483599|17782063|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5148195|NCT01483599|17782064|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148196|NCT01483599|17782065|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148197|NCT01483599|17782066|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148198|NCT01483599|17782067|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5148199|NCT01483599|17782068|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5148200|NCT01483599|17782069|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148201|NCT01483599|17782070|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148202|NCT01483599|17782071|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148203|NCT01483599|17782072|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148204|NCT01483599|17782073|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148205|NCT01483599|17782074|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148206|NCT01483599|17782075|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5148207|NCT01483599|17782062|P14|After Controlled Period(Week 16-Week 40)|Death|0
5148208|NCT01483599|17782063|P13|After Controlled Period(Week 16-Week 40)|Death|0
5148209|NCT01483599|17782064|P12|After Controlled Period(Week 16-Week 40)|Death|0
5148210|NCT01483599|17782065|P11|After Controlled Period(Week 16-Week 40)|Death|0
5148211|NCT01483599|17782066|P10|After Controlled Period(Week 16-Week 40)|Death|0
5148212|NCT01483599|17782067|P9|After Controlled Period(Week 16-Week 40)|Death|1
5148213|NCT01483599|17782068|P8|After Controlled Period(Week 16-Week 40)|Death|0
5148214|NCT01483599|17782069|P7|After Controlled Period(Week 16-Week 40)|Death|0
5148215|NCT01483599|17782070|P6|After Controlled Period(Week 16-Week 40)|Death|0
5148216|NCT01483599|17782071|P5|After Controlled Period(Week 16-Week 40)|Death|0
5148217|NCT01483599|17782072|P4|After Controlled Period(Week 16-Week 40)|Death|0
5148218|NCT01483599|17782073|P3|After Controlled Period(Week 16-Week 40)|Death|0
5148219|NCT01483599|17782074|P2|After Controlled Period(Week 16-Week 40)|Death|0
5148220|NCT01483599|17782075|P1|After Controlled Period(Week 16-Week 40)|Death|0
5148221|NCT01483599|17782062|P14|Controlled Period (CP) (up to Week 16)|Other|0
5148222|NCT01483599|17782063|P13|Controlled Period (CP) (up to Week 16)|Other|0
5148223|NCT01483599|17782064|P12|Controlled Period (CP) (up to Week 16)|Other|0
5148224|NCT01483599|17782065|P11|Controlled Period (CP) (up to Week 16)|Other|0
5148225|NCT01483599|17782066|P10|Controlled Period (CP) (up to Week 16)|Other|0
5148226|NCT01483599|17782067|P9|Controlled Period (CP) (up to Week 16)|Other|0
5148227|NCT01483599|17782068|P8|Controlled Period (CP) (up to Week 16)|Other|0
5148228|NCT01483599|17782069|P7|Controlled Period (CP) (up to Week 16)|Other|0
5148229|NCT01483599|17782070|P6|Controlled Period (CP) (up to Week 16)|Other|0
5148230|NCT01483599|17782071|P5|Controlled Period (CP) (up to Week 16)|Other|1
5148231|NCT01483599|17782072|P4|Controlled Period (CP) (up to Week 16)|Other|1
5148232|NCT01483599|17782073|P3|Controlled Period (CP) (up to Week 16)|Other|0
5148233|NCT01483599|17782074|P2|Controlled Period (CP) (up to Week 16)|Other|2
5148234|NCT01483599|17782075|P1|Controlled Period (CP) (up to Week 16)|Other|0
5148235|NCT01483599|17782062|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148236|NCT01483599|17782063|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148237|NCT01483599|17782064|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148238|NCT01483599|17782065|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148239|NCT01483599|17782066|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148240|NCT01483599|17782067|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148241|NCT01483599|17782068|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148242|NCT01483599|17782069|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148243|NCT01483599|17782070|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148244|NCT01483599|17782071|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148245|NCT01483599|17782072|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148246|NCT01483599|17782073|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148247|NCT01483599|17782074|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5148248|NCT01483599|17782075|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
5148249|NCT01483599|17782062|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148250|NCT01483599|17782063|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148251|NCT01483599|17782064|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148252|NCT01483599|17782065|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148253|NCT01483599|17782066|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148254|NCT01483599|17782067|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148255|NCT01483599|17782068|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148256|NCT01483599|17782069|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5148257|NCT01483599|17782070|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148258|NCT01483599|17782071|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148259|NCT01483599|17782072|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5148260|NCT01483599|17782073|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148261|NCT01483599|17782074|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5148262|NCT01483599|17782075|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5148263|NCT01483599|17782062|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148264|NCT01483599|17782063|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148265|NCT01483599|17782064|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148266|NCT01483599|17782065|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148267|NCT01483599|17782066|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148268|NCT01483599|17782067|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148269|NCT01483599|17782068|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148270|NCT01483599|17782069|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
5148271|NCT01483599|17782070|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
5148272|NCT01483599|17782071|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
5148273|NCT01483599|17782072|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
5148274|NCT01483599|17782073|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148275|NCT01483599|17782074|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5148276|NCT01483599|17782075|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
5148277|NCT01483183|17782188|P10|Overall Study|Withdrawal by Subject|1
5148278|NCT01483183|17782189|P9|Overall Study|Withdrawal by Subject|0
5148279|NCT01483183|17782190|P8|Overall Study|Withdrawal by Subject|0
5148280|NCT01483183|17782191|P7|Overall Study|Withdrawal by Subject|0
5148281|NCT01483183|17782192|P6|Overall Study|Withdrawal by Subject|0
5148282|NCT01483183|17782193|P5|Overall Study|Withdrawal by Subject|0
5148283|NCT01483183|17782194|P4|Overall Study|Withdrawal by Subject|0
5148284|NCT01483183|17782195|P3|Overall Study|Withdrawal by Subject|0
5148285|NCT01483183|17782196|P2|Overall Study|Withdrawal by Subject|0
5148286|NCT01483183|17782197|P1|Overall Study|Withdrawal by Subject|0
5148287|NCT01483183|17782188|P10|Overall Study|Physician Decision|0
5148288|NCT01483183|17782189|P9|Overall Study|Physician Decision|0
5148289|NCT01483183|17782190|P8|Overall Study|Physician Decision|0
5148290|NCT01483183|17782191|P7|Overall Study|Physician Decision|2
5148291|NCT01483183|17782192|P6|Overall Study|Physician Decision|0
5148292|NCT01483183|17782193|P5|Overall Study|Physician Decision|0
5148293|NCT01483183|17782194|P4|Overall Study|Physician Decision|0
5148294|NCT01483183|17782195|P3|Overall Study|Physician Decision|0
5148295|NCT01483183|17782196|P2|Overall Study|Physician Decision|0
5148296|NCT01483183|17782197|P1|Overall Study|Physician Decision|0
5148297|NCT01483118|17782267|P2|Overall Study|Lost to Follow-up|16
5148298|NCT01483118|17782268|P1|Overall Study|Lost to Follow-up|12
5148299|NCT01482962|17782280|P2|Overall Study|Did not Receive Study Drug|6
5148300|NCT01482962|17782281|P1|Overall Study|Did not Receive Study Drug|1
5148301|NCT01482962|17782280|P2|Overall Study|Study Terminated by Sponsor|2
5148302|NCT01482962|17782281|P1|Overall Study|Study Terminated by Sponsor|5
5148303|NCT01482962|17782280|P2|Overall Study|Other Reason|5
5148304|NCT01482962|17782281|P1|Overall Study|Other Reason|1
5148305|NCT01482962|17782280|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
5148306|NCT01482962|17782281|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
5148307|NCT01482962|17782280|P2|Overall Study|Withdrawal by Participant|13
5148308|NCT01482962|17782281|P1|Overall Study|Withdrawal by Participant|8
5148309|NCT01482962|17782280|P2|Overall Study|Adverse Event|22
5148310|NCT01482962|17782281|P1|Overall Study|Adverse Event|18
5148311|NCT01482962|17782280|P2|Overall Study|Unsatisfactory Therapeutic Response|23
5148312|NCT01482962|17782281|P1|Overall Study|Unsatisfactory Therapeutic Response|37
5148313|NCT01482962|17782280|P2|Overall Study|Progressive Disease|53
5148314|NCT01482962|17782281|P1|Overall Study|Progressive Disease|65
5148315|NCT01482910|17782314|P2|Overall Study|Death|0
5148316|NCT01482910|17782315|P1|Overall Study|Death|1
5148317|NCT01482910|17782314|P2|Overall Study|Withdrawal by Subject|2
5148318|NCT01482910|17782315|P1|Overall Study|Withdrawal by Subject|7
5148319|NCT01482910|17782314|P2|Overall Study|Protocol Violation|1
5148320|NCT01482910|17782315|P1|Overall Study|Protocol Violation|1
5148321|NCT01482910|17782314|P2|Overall Study|Lost to Follow-up|1
5148322|NCT01482910|17782315|P1|Overall Study|Lost to Follow-up|0
5148323|NCT01482910|17782314|P2|Overall Study|Adverse Event|5
5148324|NCT01482910|17782315|P1|Overall Study|Adverse Event|6
5148325|NCT01482884|17782327|P2|Overall Study|Withdrawal by Subject|13
5148326|NCT01482884|17782328|P1|Overall Study|Withdrawal by Subject|8
5148327|NCT01482884|17782327|P2|Overall Study|Adverse Event|1
5148328|NCT01482884|17782328|P1|Overall Study|Adverse Event|2
5148329|NCT01482884|17782327|P2|Overall Study|Lack of Efficacy|1
5148330|NCT01482884|17782328|P1|Overall Study|Lack of Efficacy|0
5148331|NCT01482884|17782327|P2|Overall Study|Lost to Follow-up|2
5148332|NCT01482884|17782328|P1|Overall Study|Lost to Follow-up|2
5148333|NCT01482884|17782327|P2|Overall Study|Protocol Violation|0
5148334|NCT01482884|17782328|P1|Overall Study|Protocol Violation|1
5148335|NCT01482884|17782327|P2|Overall Study|Medical decision due to lack of efficacy|1
5148336|NCT01482884|17782328|P1|Overall Study|Medical decision due to lack of efficacy|0
5148337|NCT01482819|17782354|P1|Overall Study|Lost to Follow-up|2
5148338|NCT01482767|17782374|P2|Overall Study|Nurse error|0
5148339|NCT01482767|17782375|P1|Overall Study|Nurse error|1
5148340|NCT01482767|17782374|P2|Overall Study|Ineligible|5
5148341|NCT01482767|17782375|P1|Overall Study|Ineligible|0
5148342|NCT01482767|17782374|P2|Overall Study|Alternate HCV treatment|8
5148343|NCT01482767|17782375|P1|Overall Study|Alternate HCV treatment|7
5148344|NCT01482767|17782374|P2|Overall Study|Non-adherence to study requirements|7
5148345|NCT01482767|17782375|P1|Overall Study|Non-adherence to study requirements|4
5148346|NCT01482767|17782374|P2|Overall Study|Site closure|14
5148347|NCT01482767|17782375|P1|Overall Study|Site closure|22
5148348|NCT01482767|17782374|P2|Overall Study|Adverse Event|3
5148349|NCT01482767|17782375|P1|Overall Study|Adverse Event|0
5148350|NCT01482767|17782374|P2|Overall Study|Lost to Follow-up|6
5148351|NCT01482767|17782375|P1|Overall Study|Lost to Follow-up|12
5148352|NCT01482767|17782374|P2|Overall Study|Withdrawal by Subject|5
5148353|NCT01482767|17782375|P1|Overall Study|Withdrawal by Subject|7
5148354|NCT01482767|17782374|P2|Overall Study|Death|1
5148355|NCT01482767|17782375|P1|Overall Study|Death|1
5148356|NCT01482598|17782397|P2|Overall Study|Lost to Follow-up|4
5148357|NCT01482598|17782398|P1|Overall Study|Lost to Follow-up|5
5148358|NCT01482598|17782397|P2|Overall Study|Withdrawal by Subject|5
5148359|NCT01482598|17782398|P1|Overall Study|Withdrawal by Subject|4
5148360|NCT01482598|17782397|P2|Overall Study|Physician Decision|3
5148361|NCT01482598|17782398|P1|Overall Study|Physician Decision|0
5148362|NCT01482598|17782397|P2|Overall Study|Death|10
5148363|NCT01482598|17782398|P1|Overall Study|Death|7
5148364|NCT01482429|17782406|P2|Protocol|Protocol Violation|0
5148365|NCT01482429|17782407|P1|Protocol|Protocol Violation|275
5148366|NCT01482429|17782406|P2|Care Usual|Lost to Follow-up|1
5148367|NCT01482429|17782407|P1|Care Usual|Lost to Follow-up|0
5148368|NCT01482429|17782406|P2|Care Usual|Protocol Violation|172
5148369|NCT01482429|17782407|P1|Care Usual|Protocol Violation|0
5148370|NCT01482312|17782443|P3|Period 2, 90 Minutes of Wear|Other|0
5148371|NCT01482312|17782444|P2|Period 2, 90 Minutes of Wear|Other|0
5148372|NCT01482312|17782445|P1|Period 2, 90 Minutes of Wear|Other|1
5148373|NCT01482312|17782443|P3|Period 1, 90 Minutes of Wear|Other|0
5148374|NCT01482312|17782444|P2|Period 1, 90 Minutes of Wear|Other|0
5148375|NCT01482312|17782445|P1|Period 1, 90 Minutes of Wear|Other|1
5148376|NCT01482221|17782459|P3|Overall Study|Physician Decision|0
5148377|NCT01482221|17782460|P2|Overall Study|Physician Decision|1
5148378|NCT01482221|17782461|P1|Overall Study|Physician Decision|0
5148379|NCT01482221|17782459|P3|Overall Study|Incorrect randomization|0
5148380|NCT01482221|17782460|P2|Overall Study|Incorrect randomization|1
5148381|NCT01482221|17782461|P1|Overall Study|Incorrect randomization|0
5148382|NCT01482221|17782459|P3|Overall Study|Withdrawal by Subject|12
5148383|NCT01482221|17782460|P2|Overall Study|Withdrawal by Subject|7
5148384|NCT01482221|17782461|P1|Overall Study|Withdrawal by Subject|10
5148385|NCT01482221|17782459|P3|Overall Study|Adverse Event|3
5148386|NCT01482221|17782460|P2|Overall Study|Adverse Event|7
5148387|NCT01482221|17782461|P1|Overall Study|Adverse Event|1
5148388|NCT01482221|17782459|P3|Overall Study|Severe Non-Compliance to Protocol|1
5148389|NCT01482221|17782460|P2|Overall Study|Severe Non-Compliance to Protocol|0
5148390|NCT01482221|17782461|P1|Overall Study|Severe Non-Compliance to Protocol|1
5148391|NCT01482221|17782459|P3|Overall Study|Condition under Investigation Worsened|4
5148392|NCT01482221|17782460|P2|Overall Study|Condition under Investigation Worsened|2
5148393|NCT01482221|17782461|P1|Overall Study|Condition under Investigation Worsened|3
5148394|NCT01482221|17782459|P3|Overall Study|Study-Specific Withdrawal Criteria|1
5148395|NCT01482221|17782460|P2|Overall Study|Study-Specific Withdrawal Criteria|0
5148396|NCT01482221|17782461|P1|Overall Study|Study-Specific Withdrawal Criteria|2
5148397|NCT01482221|17782459|P3|Overall Study|Lost to Follow-up|1
5148398|NCT01482221|17782460|P2|Overall Study|Lost to Follow-up|2
5148399|NCT01482221|17782461|P1|Overall Study|Lost to Follow-up|3
5148400|NCT01482221|17782459|P3|Overall Study|Lack of Efficacy|1
5148401|NCT01482221|17782460|P2|Overall Study|Lack of Efficacy|0
5148402|NCT01482221|17782461|P1|Overall Study|Lack of Efficacy|1
5148403|NCT01482169|17782502|P1|Overall Study|Physician Decision|2
5148404|NCT01482065|17782544|P2|Overall Study|Withdrawal by Subject|1
5148405|NCT01482065|17782545|P1|Overall Study|Withdrawal by Subject|0
5148406|NCT01481896|17782566|P1|Overall Study|Lost to Follow-up|12
5148407|NCT01481779|17782582|P2|Overall Study|Sponsor Decision|1
5148408|NCT01481779|17782583|P1|Overall Study|Sponsor Decision|3
5148409|NCT01481779|17782582|P2|Overall Study|Physician Decision|4
5148410|NCT01481779|17782583|P1|Overall Study|Physician Decision|13
5148411|NCT01481779|17782582|P2|Overall Study|Withdrawal by Subject|13
5148412|NCT01481779|17782583|P1|Overall Study|Withdrawal by Subject|26
5148413|NCT01481779|17782582|P2|Overall Study|Protocol Violation|3
5148414|NCT01481779|17782583|P1|Overall Study|Protocol Violation|2
5148415|NCT01481779|17782582|P2|Overall Study|Lost to Follow-up|2
5148416|NCT01481779|17782583|P1|Overall Study|Lost to Follow-up|3
5148417|NCT01481779|17782582|P2|Overall Study|Adverse Event|5
5148418|NCT01481779|17782583|P1|Overall Study|Adverse Event|23
5148419|NCT01481324|17782668|P3|Overall Study|Missing Data|2
5148420|NCT01481324|17782669|P2|Overall Study|Missing Data|2
5148421|NCT01481324|17782670|P1|Overall Study|Missing Data|0
5148422|NCT01481116|17782689|P3|Overall Study|Hypoglycemic Event|0
5148423|NCT01481116|17782690|P2|Overall Study|Hypoglycemic Event|0
5148424|NCT01481116|17782691|P1|Overall Study|Hypoglycemic Event|4
5148425|NCT01481116|17782689|P3|Overall Study|Death|0
5148426|NCT01481116|17782690|P2|Overall Study|Death|1
5148427|NCT01481116|17782691|P1|Overall Study|Death|2
5148428|NCT01481116|17782689|P3|Overall Study|Investigator's Discretion|0
5148429|NCT01481116|17782690|P2|Overall Study|Investigator's Discretion|0
5148430|NCT01481116|17782691|P1|Overall Study|Investigator's Discretion|2
5148431|NCT01481116|17782689|P3|Overall Study|Non-Compliant With Study Drug|1
5148432|NCT01481116|17782690|P2|Overall Study|Non-Compliant With Study Drug|1
5148433|NCT01481116|17782691|P1|Overall Study|Non-Compliant With Study Drug|0
5148434|NCT01481116|17782689|P3|Overall Study|Sponsor Decision|3
5148435|NCT01481116|17782690|P2|Overall Study|Sponsor Decision|1
5148436|NCT01481116|17782691|P1|Overall Study|Sponsor Decision|0
5148437|NCT01481116|17782689|P3|Overall Study|Investigator Decision|1
5148438|NCT01481116|17782690|P2|Overall Study|Investigator Decision|2
5148439|NCT01481116|17782691|P1|Overall Study|Investigator Decision|3
5148440|NCT01481116|17782689|P3|Overall Study|Participant Moved Out of Country|1
5148441|NCT01481116|17782690|P2|Overall Study|Participant Moved Out of Country|0
5148442|NCT01481116|17782691|P1|Overall Study|Participant Moved Out of Country|1
5148443|NCT01481116|17782689|P3|Overall Study|Participant Moved Out of Area|1
5148444|NCT01481116|17782690|P2|Overall Study|Participant Moved Out of Area|0
5148445|NCT01481116|17782691|P1|Overall Study|Participant Moved Out of Area|2
5148446|NCT01481116|17782689|P3|Overall Study|Participant Started Taking Glipizide|0
5148447|NCT01481116|17782690|P2|Overall Study|Participant Started Taking Glipizide|0
5148448|NCT01481116|17782691|P1|Overall Study|Participant Started Taking Glipizide|1
5148449|NCT01481116|17782689|P3|Overall Study|Other|0
5148450|NCT01481116|17782690|P2|Overall Study|Other|1
5148451|NCT01481116|17782691|P1|Overall Study|Other|1
5148452|NCT01481116|17782689|P3|Overall Study|Contraindications|0
5148453|NCT01481116|17782690|P2|Overall Study|Contraindications|1
5148454|NCT01481116|17782691|P1|Overall Study|Contraindications|1
5148455|NCT01481116|17782689|P3|Overall Study|Lack of Efficacy|1
5148456|NCT01481116|17782690|P2|Overall Study|Lack of Efficacy|3
5148457|NCT01481116|17782691|P1|Overall Study|Lack of Efficacy|3
5148458|NCT01481116|17782689|P3|Overall Study|Pregnancy|1
5148459|NCT01481116|17782690|P2|Overall Study|Pregnancy|0
5148460|NCT01481116|17782691|P1|Overall Study|Pregnancy|0
5148461|NCT01481116|17782689|P3|Overall Study|Study Termination|713
5148462|NCT01481116|17782690|P2|Overall Study|Study Termination|729
5148463|NCT01481116|17782691|P1|Overall Study|Study Termination|730
5148464|NCT01481116|17782689|P3|Overall Study|Withdrawal by Subject|37
5148465|NCT01481116|17782690|P2|Overall Study|Withdrawal by Subject|33
5148466|NCT01481116|17782691|P1|Overall Study|Withdrawal by Subject|37
5148467|NCT01481116|17782689|P3|Overall Study|Lost to Follow-up|11
5148468|NCT01481116|17782690|P2|Overall Study|Lost to Follow-up|12
5148469|NCT01481116|17782691|P1|Overall Study|Lost to Follow-up|8
5148470|NCT01481116|17782689|P3|Overall Study|Major Protocol Deviation|1
5148471|NCT01481116|17782690|P2|Overall Study|Major Protocol Deviation|7
5148472|NCT01481116|17782691|P1|Overall Study|Major Protocol Deviation|3
5148473|NCT01481116|17782689|P3|Overall Study|Adverse Event|42
5148474|NCT01481116|17782690|P2|Overall Study|Adverse Event|26
5148475|NCT01481116|17782691|P1|Overall Study|Adverse Event|26
5148476|NCT01480674|17782722|P1|Overall Study|visit not done|10
5148477|NCT01480674|17782722|P1|Overall Study|Lost to Follow-up|2
5148478|NCT01480674|17782722|P1|Overall Study|Death|23
5148479|NCT01480596|17782736|P2|Overall Study|MG exacerbation or change in medication|2
5148480|NCT01480596|17782737|P1|Overall Study|MG exacerbation or change in medication|2
5148481|NCT01480596|17782736|P2|Overall Study|Adverse Event|0
5148482|NCT01480596|17782737|P1|Overall Study|Adverse Event|3
5148483|NCT01480284|17782785|P2|Overall Study|Physician Decision|0
5148484|NCT01480284|17782786|P1|Overall Study|Physician Decision|1
5148485|NCT01480284|17782785|P2|Overall Study|Lost to Follow-up|0
5148486|NCT01480284|17782786|P1|Overall Study|Lost to Follow-up|1
5148487|NCT01480284|17782785|P2|Overall Study|Study closed/terminated|0
5148488|NCT01480284|17782786|P1|Overall Study|Study closed/terminated|3
5148489|NCT01480284|17782785|P2|Overall Study|Adverse Event|0
5148490|NCT01480284|17782786|P1|Overall Study|Adverse Event|1
5148491|NCT01480284|17782785|P2|Overall Study|Withdrawal by Subject|0
5148492|NCT01480284|17782786|P1|Overall Study|Withdrawal by Subject|2
5148493|NCT01480258|17782816|P2|Interim Period|Withdrawal by Subject|6
5148494|NCT01480258|17782817|P1|Interim Period|Withdrawal by Subject|9
5148495|NCT01480258|17782816|P2|Interim Period|Protocol Violation|1
5148496|NCT01480258|17782817|P1|Interim Period|Protocol Violation|0
5148497|NCT01480258|17782816|P2|Interim Period|Physician Decision|0
5148498|NCT01480258|17782817|P1|Interim Period|Physician Decision|1
5148499|NCT01480258|17782816|P2|Interim Period|Lost to Follow-up|2
5148500|NCT01480258|17782817|P1|Interim Period|Lost to Follow-up|0
5148501|NCT01480258|17782816|P2|Infant Series|Withdrawal by Subject|6
5148502|NCT01480258|17782817|P1|Infant Series|Withdrawal by Subject|1
5148503|NCT01480258|17782816|P2|Infant Series|Adverse Event|1
5148504|NCT01480258|17782817|P1|Infant Series|Adverse Event|1
5148505|NCT01480258|17782816|P2|Infant Series|Not Vaccinated|0
5148506|NCT01480258|17782817|P1|Infant Series|Not Vaccinated|3
5148507|NCT01480258|17782816|P2|Infant Series|Physician Decision|1
5148508|NCT01480258|17782817|P1|Infant Series|Physician Decision|0
5148509|NCT01480258|17782816|P2|Infant Series|Protocol Violation|0
5148510|NCT01480258|17782817|P1|Infant Series|Protocol Violation|2
5148511|NCT01480180|17782883|P6|Extension Phase, Part 2|Unclassified|0
5148512|NCT01480180|17782884|P5|Extension Phase, Part 2|Unclassified|1
5148513|NCT01480180|17782885|P4|Extension Phase, Part 2|Unclassified|1
5148514|NCT01480180|17782886|P3|Extension Phase, Part 2|Unclassified|3
5148515|NCT01480180|17782887|P2|Extension Phase, Part 2|Unclassified|0
5148516|NCT01480180|17782888|P1|Extension Phase, Part 2|Unclassified|0
5148517|NCT01480180|17782883|P6|Extension Phase, Part 2|Lack of Efficacy|0
5148518|NCT01480180|17782884|P5|Extension Phase, Part 2|Lack of Efficacy|0
5148519|NCT01480180|17782885|P4|Extension Phase, Part 2|Lack of Efficacy|0
5148520|NCT01480180|17782886|P3|Extension Phase, Part 2|Lack of Efficacy|4
5148521|NCT01480180|17782887|P2|Extension Phase, Part 2|Lack of Efficacy|0
5148522|NCT01480180|17782888|P1|Extension Phase, Part 2|Lack of Efficacy|0
5148523|NCT01480180|17782883|P6|Extension Phase, Part 2|Withdrawal criteria|0
5148524|NCT01480180|17782884|P5|Extension Phase, Part 2|Withdrawal criteria|1
5148525|NCT01480180|17782885|P4|Extension Phase, Part 2|Withdrawal criteria|6
5148526|NCT01480180|17782886|P3|Extension Phase, Part 2|Withdrawal criteria|10
5148527|NCT01480180|17782887|P2|Extension Phase, Part 2|Withdrawal criteria|0
5148528|NCT01480180|17782888|P1|Extension Phase, Part 2|Withdrawal criteria|0
5148529|NCT01480180|17782883|P6|Extension Phase, Part 1|Change of treatment|0
5148530|NCT01480180|17782884|P5|Extension Phase, Part 1|Change of treatment|0
5148531|NCT01480180|17782885|P4|Extension Phase, Part 1|Change of treatment|9
5148532|NCT01480180|17782886|P3|Extension Phase, Part 1|Change of treatment|0
5148533|NCT01480180|17782887|P2|Extension Phase, Part 1|Change of treatment|0
5148534|NCT01480180|17782888|P1|Extension Phase, Part 1|Change of treatment|0
5148535|NCT01480180|17782883|P6|Extension Phase, Part 1|Adverse Event|0
5148536|NCT01480180|17782884|P5|Extension Phase, Part 1|Adverse Event|0
5148537|NCT01480180|17782885|P4|Extension Phase, Part 1|Adverse Event|1
5148538|NCT01480180|17782886|P3|Extension Phase, Part 1|Adverse Event|4
5148539|NCT01480180|17782887|P2|Extension Phase, Part 1|Adverse Event|0
5148540|NCT01480180|17782888|P1|Extension Phase, Part 1|Adverse Event|0
5148541|NCT01480180|17782883|P6|Extension Phase, Part 1|Unclassified|0
5148542|NCT01480180|17782884|P5|Extension Phase, Part 1|Unclassified|0
5148543|NCT01480180|17782885|P4|Extension Phase, Part 1|Unclassified|0
5148544|NCT01480180|17782886|P3|Extension Phase, Part 1|Unclassified|1
5148545|NCT01480180|17782887|P2|Extension Phase, Part 1|Unclassified|0
5148546|NCT01480180|17782888|P1|Extension Phase, Part 1|Unclassified|0
5148547|NCT01480180|17782883|P6|Extension Phase, Part 1|Withdrawal criteria|0
5148548|NCT01480180|17782884|P5|Extension Phase, Part 1|Withdrawal criteria|0
5148549|NCT01480180|17782885|P4|Extension Phase, Part 1|Withdrawal criteria|0
5148550|NCT01480180|17782886|P3|Extension Phase, Part 1|Withdrawal criteria|5
5148551|NCT01480180|17782887|P2|Extension Phase, Part 1|Withdrawal criteria|0
5148552|NCT01480180|17782888|P1|Extension Phase, Part 1|Withdrawal criteria|0
5148553|NCT01480180|17782883|P6|Main Phase|Unclassified|0
5148554|NCT01480180|17782884|P5|Main Phase|Unclassified|0
5148555|NCT01480180|17782885|P4|Main Phase|Unclassified|0
5148556|NCT01480180|17782886|P3|Main Phase|Unclassified|0
5148557|NCT01480180|17782887|P2|Main Phase|Unclassified|0
5148558|NCT01480180|17782888|P1|Main Phase|Unclassified|3
5148559|NCT01480180|17782883|P6|Main Phase|Non-compliance|0
5148560|NCT01480180|17782884|P5|Main Phase|Non-compliance|0
5148561|NCT01480180|17782885|P4|Main Phase|Non-compliance|0
5148562|NCT01480180|17782886|P3|Main Phase|Non-compliance|0
5148563|NCT01480180|17782887|P2|Main Phase|Non-compliance|0
5148564|NCT01480180|17782888|P1|Main Phase|Non-compliance|3
5148565|NCT01480180|17782883|P6|Main Phase|Lack of Efficacy|0
5148566|NCT01480180|17782884|P5|Main Phase|Lack of Efficacy|0
5148567|NCT01480180|17782885|P4|Main Phase|Lack of Efficacy|0
5148568|NCT01480180|17782886|P3|Main Phase|Lack of Efficacy|0
5148569|NCT01480180|17782887|P2|Main Phase|Lack of Efficacy|0
5148570|NCT01480180|17782888|P1|Main Phase|Lack of Efficacy|1
5148571|NCT01480180|17782883|P6|Main Phase|Withdrawal criteria|0
5148572|NCT01480180|17782884|P5|Main Phase|Withdrawal criteria|0
5148573|NCT01480180|17782885|P4|Main Phase|Withdrawal criteria|0
5148574|NCT01480180|17782886|P3|Main Phase|Withdrawal criteria|0
5148575|NCT01480180|17782887|P2|Main Phase|Withdrawal criteria|1
5148576|NCT01480180|17782888|P1|Main Phase|Withdrawal criteria|12
5148577|NCT01480076|17783056|P1|Overall Study|Other|52
5148578|NCT01480076|17783056|P1|Overall Study|Investigator Decision|13
5148579|NCT01480076|17783056|P1|Overall Study|Lost to Follow-up|7
5148580|NCT01480076|17783056|P1|Overall Study|Withdrawal by Subject|105
5148581|NCT01480076|17783056|P1|Overall Study|Non-compliance With Study Protocol|15
5148582|NCT01480076|17783056|P1|Overall Study|Disease Progression|5
5148583|NCT01480076|17783056|P1|Overall Study|Death|2
5148584|NCT01480076|17783056|P1|Overall Study|Adverse Event|39
5148585|NCT01480076|17783056|P1|Overall Study|Run-in Failure|52
5148586|NCT01479985|17783177|P2|Overall Study|No post-visit survey|3
5148587|NCT01479985|17783178|P1|Overall Study|No post-visit survey|5
5148588|NCT01479985|17783177|P2|Overall Study|No decisional conflict scale responses|2
5148589|NCT01479985|17783178|P1|Overall Study|No decisional conflict scale responses|0
5148590|NCT01479985|17783177|P2|Overall Study|Tablet malfunction, no data saved|1
5148591|NCT01479985|17783178|P1|Overall Study|Tablet malfunction, no data saved|1
5148592|NCT01479868|17783186|P1|Overall Study|Initiation of new HCV Therapy|1
5148593|NCT01479868|17783186|P1|Overall Study|Sponsor's Decision|1
5148594|NCT01479868|17783186|P1|Overall Study|Withdrawal by Subject|1
5148595|NCT01479868|17783186|P1|Overall Study|Protocol Violation|1
5148596|NCT01479868|17783186|P1|Overall Study|Lost to Follow-up|4
5148597|NCT01479868|17783186|P1|Overall Study|Adverse Event|1
5148598|NCT01479777|17783201|P1|Overall Study|Physician Decision|2
5148599|NCT01479764|17783213|P2|Treated|Lost to Follow-up|2
5148600|NCT01479764|17783214|P1|Treated|Lost to Follow-up|0
5148601|NCT01479764|17783213|P2|Randomized|Withdrawal by Subject|0
5148602|NCT01479764|17783214|P1|Randomized|Withdrawal by Subject|1
5148603|NCT01479764|17783213|P2|Randomized|Adverse Event|1
5148604|NCT01479764|17783214|P1|Randomized|Adverse Event|1
5148605|NCT01479621|17783237|P7|Treatment Period|Met stopping criteria|6
5148606|NCT01479621|17783238|P6|Treatment Period|Met stopping criteria|20
5148607|NCT01479621|17783239|P5|Treatment Period|Met stopping criteria|9
5148608|NCT01479621|17783240|P4|Treatment Period|Met stopping criteria|4
5148609|NCT01479621|17783241|P3|Treatment Period|Met stopping criteria|7
5148610|NCT01479621|17783242|P2|Treatment Period|Met stopping criteria|8
5148611|NCT01479621|17783243|P1|Treatment Period|Met stopping criteria|0
5148612|NCT01479621|17783237|P7|Treatment Period|Lost to Follow-up|1
5148613|NCT01479621|17783238|P6|Treatment Period|Lost to Follow-up|2
5148614|NCT01479621|17783239|P5|Treatment Period|Lost to Follow-up|2
5148615|NCT01479621|17783240|P4|Treatment Period|Lost to Follow-up|0
5148616|NCT01479621|17783241|P3|Treatment Period|Lost to Follow-up|1
5148617|NCT01479621|17783242|P2|Treatment Period|Lost to Follow-up|0
5148618|NCT01479621|17783243|P1|Treatment Period|Lost to Follow-up|0
5148619|NCT01479621|17783237|P7|Treatment Period|Sponsor request subject to be withdrawn|3
5148620|NCT01479621|17783238|P6|Treatment Period|Sponsor request subject to be withdrawn|1
5148621|NCT01479621|17783239|P5|Treatment Period|Sponsor request subject to be withdrawn|1
5148622|NCT01479621|17783240|P4|Treatment Period|Sponsor request subject to be withdrawn|1
5148623|NCT01479621|17783241|P3|Treatment Period|Sponsor request subject to be withdrawn|3
5148624|NCT01479621|17783242|P2|Treatment Period|Sponsor request subject to be withdrawn|2
5148625|NCT01479621|17783243|P1|Treatment Period|Sponsor request subject to be withdrawn|0
5148626|NCT01479621|17783237|P7|Treatment Period|Pregnancy|0
5148627|NCT01479621|17783238|P6|Treatment Period|Pregnancy|0
5148628|NCT01479621|17783239|P5|Treatment Period|Pregnancy|0
5148629|NCT01479621|17783240|P4|Treatment Period|Pregnancy|0
5148630|NCT01479621|17783241|P3|Treatment Period|Pregnancy|2
5148631|NCT01479621|17783242|P2|Treatment Period|Pregnancy|0
5148632|NCT01479621|17783243|P1|Treatment Period|Pregnancy|0
5148633|NCT01479621|17783237|P7|Treatment Period|Protocol Violation|6
5148634|NCT01479621|17783238|P6|Treatment Period|Protocol Violation|10
5148635|NCT01479621|17783239|P5|Treatment Period|Protocol Violation|2
5148636|NCT01479621|17783240|P4|Treatment Period|Protocol Violation|5
5148637|NCT01479621|17783241|P3|Treatment Period|Protocol Violation|6
5148638|NCT01479621|17783242|P2|Treatment Period|Protocol Violation|9
5148639|NCT01479621|17783243|P1|Treatment Period|Protocol Violation|0
5148640|NCT01479621|17783237|P7|Treatment Period|Non-compliance to study drug|1
5148641|NCT01479621|17783238|P6|Treatment Period|Non-compliance to study drug|0
5148642|NCT01479621|17783239|P5|Treatment Period|Non-compliance to study drug|0
5148643|NCT01479621|17783240|P4|Treatment Period|Non-compliance to study drug|0
5148644|NCT01479621|17783241|P3|Treatment Period|Non-compliance to study drug|0
5148645|NCT01479621|17783242|P2|Treatment Period|Non-compliance to study drug|1
5148646|NCT01479621|17783243|P1|Treatment Period|Non-compliance to study drug|0
5148647|NCT01479621|17783237|P7|Treatment Period|Physician Decision|0
5148648|NCT01479621|17783238|P6|Treatment Period|Physician Decision|1
5148649|NCT01479621|17783239|P5|Treatment Period|Physician Decision|1
5148650|NCT01479621|17783240|P4|Treatment Period|Physician Decision|0
5148651|NCT01479621|17783241|P3|Treatment Period|Physician Decision|0
5148652|NCT01479621|17783242|P2|Treatment Period|Physician Decision|0
5148653|NCT01479621|17783243|P1|Treatment Period|Physician Decision|0
5148654|NCT01479621|17783237|P7|Treatment Period|Withdrawal by Subject|1
5148655|NCT01479621|17783238|P6|Treatment Period|Withdrawal by Subject|5
5148656|NCT01479621|17783239|P5|Treatment Period|Withdrawal by Subject|5
5148657|NCT01479621|17783240|P4|Treatment Period|Withdrawal by Subject|2
5148658|NCT01479621|17783241|P3|Treatment Period|Withdrawal by Subject|2
5148659|NCT01479621|17783242|P2|Treatment Period|Withdrawal by Subject|4
5148660|NCT01479621|17783243|P1|Treatment Period|Withdrawal by Subject|0
5148661|NCT01479621|17783237|P7|Treatment Period|Adverse Event|2
5148662|NCT01479621|17783238|P6|Treatment Period|Adverse Event|2
5148663|NCT01479621|17783239|P5|Treatment Period|Adverse Event|1
5148664|NCT01479621|17783240|P4|Treatment Period|Adverse Event|0
5148665|NCT01479621|17783241|P3|Treatment Period|Adverse Event|0
5148666|NCT01479621|17783242|P2|Treatment Period|Adverse Event|0
5148667|NCT01479621|17783243|P1|Treatment Period|Adverse Event|0
5148668|NCT01479621|17783237|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
5148669|NCT01479621|17783238|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
5148670|NCT01479621|17783239|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
5148671|NCT01479621|17783240|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
5148672|NCT01479621|17783241|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
5148673|NCT01479621|17783242|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
5148674|NCT01479621|17783243|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
5148675|NCT01479621|17783237|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5148676|NCT01479621|17783238|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5148677|NCT01479621|17783239|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5148678|NCT01479621|17783240|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5148679|NCT01479621|17783241|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5148680|NCT01479621|17783242|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5148681|NCT01479621|17783243|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
5148682|NCT01479621|17783237|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5148683|NCT01479621|17783238|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5148684|NCT01479621|17783239|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5148685|NCT01479621|17783240|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5148686|NCT01479621|17783241|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5148687|NCT01479621|17783242|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5148688|NCT01479621|17783243|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
5148689|NCT01479621|17783237|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5148690|NCT01479621|17783238|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5148691|NCT01479621|17783239|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5148692|NCT01479621|17783240|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5148693|NCT01479621|17783241|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5148694|NCT01479621|17783242|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5148695|NCT01479621|17783243|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
5148696|NCT01479621|17783237|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5148697|NCT01479621|17783238|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5148698|NCT01479621|17783239|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5148699|NCT01479621|17783240|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5148700|NCT01479621|17783241|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5148701|NCT01479621|17783242|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5148702|NCT01479621|17783243|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
5148703|NCT01479595|17783331|P2|Overall Study|Adverse Event|1
5148704|NCT01479595|17783332|P1|Overall Study|Adverse Event|2
5148705|NCT01479595|17783331|P2|Overall Study|Protocol deviation|1
5148706|NCT01479595|17783332|P1|Overall Study|Protocol deviation|0
5148707|NCT01479530|17783377|P2|Overall Study|Withdrawal of Consent|2
5148708|NCT01479530|17783378|P1|Overall Study|Withdrawal of Consent|3
5148709|NCT01479530|17783377|P2|Overall Study|Protocol Violation|3
5148710|NCT01479530|17783378|P1|Overall Study|Protocol Violation|2
5148711|NCT01479530|17783377|P2|Overall Study|Lack of Efficacy|1
5148712|NCT01479530|17783378|P1|Overall Study|Lack of Efficacy|0
5148713|NCT01479530|17783377|P2|Overall Study|Adverse Event|6
5148714|NCT01479530|17783378|P1|Overall Study|Adverse Event|5
5148715|NCT01479465|17783459|P4|Overall Study|Lost to Follow-up|0
5148716|NCT01479465|17783460|P3|Overall Study|Lost to Follow-up|1
5148717|NCT01479465|17783461|P2|Overall Study|Lost to Follow-up|0
5148718|NCT01479465|17783462|P1|Overall Study|Lost to Follow-up|0
5148719|NCT01479465|17783459|P4|Overall Study|Death|1
5148720|NCT01479465|17783460|P3|Overall Study|Death|0
5148721|NCT01479465|17783461|P2|Overall Study|Death|0
5148722|NCT01479465|17783462|P1|Overall Study|Death|0
5148723|NCT01479465|17783459|P4|Overall Study|Protocol Violation|0
5148724|NCT01479465|17783460|P3|Overall Study|Protocol Violation|1
5148725|NCT01479465|17783461|P2|Overall Study|Protocol Violation|1
5148726|NCT01479465|17783462|P1|Overall Study|Protocol Violation|0
5148727|NCT01479465|17783459|P4|Overall Study|Subject Withdrew Consent|1
5148728|NCT01479465|17783460|P3|Overall Study|Subject Withdrew Consent|2
5148729|NCT01479465|17783461|P2|Overall Study|Subject Withdrew Consent|5
5148730|NCT01479465|17783462|P1|Overall Study|Subject Withdrew Consent|0
5148731|NCT01479465|17783459|P4|Overall Study|Subject Request|2
5148732|NCT01479465|17783460|P3|Overall Study|Subject Request|4
5148733|NCT01479465|17783461|P2|Overall Study|Subject Request|3
5148734|NCT01479465|17783462|P1|Overall Study|Subject Request|1
5148735|NCT01479465|17783459|P4|Overall Study|Investigator Discretion|4
5148736|NCT01479465|17783460|P3|Overall Study|Investigator Discretion|2
5148737|NCT01479465|17783461|P2|Overall Study|Investigator Discretion|4
5148738|NCT01479465|17783462|P1|Overall Study|Investigator Discretion|1
5148739|NCT01479465|17783459|P4|Overall Study|Adverse Event|4
5148740|NCT01479465|17783460|P3|Overall Study|Adverse Event|6
5148741|NCT01479465|17783461|P2|Overall Study|Adverse Event|3
5148742|NCT01479465|17783462|P1|Overall Study|Adverse Event|0
5148743|NCT01479465|17783459|P4|Overall Study|Study Discontinued by Sponsor|3
5148744|NCT01479465|17783460|P3|Overall Study|Study Discontinued by Sponsor|5
5148745|NCT01479465|17783461|P2|Overall Study|Study Discontinued by Sponsor|7
5148746|NCT01479465|17783462|P1|Overall Study|Study Discontinued by Sponsor|0
5148747|NCT01479465|17783459|P4|Overall Study|Disease Progression|70
5148748|NCT01479465|17783460|P3|Overall Study|Disease Progression|65
5148749|NCT01479465|17783461|P2|Overall Study|Disease Progression|61
5148750|NCT01479465|17783462|P1|Overall Study|Disease Progression|9
5148751|NCT01479439|17783483|P3|Overall Study|Protocol Violation|2
5148752|NCT01479439|17783484|P2|Overall Study|Protocol Violation|0
5148753|NCT01479439|17783485|P1|Overall Study|Protocol Violation|0
5148754|NCT01479439|17783483|P3|Overall Study|Lost to Follow-up|0
5148755|NCT01479439|17783484|P2|Overall Study|Lost to Follow-up|1
5148756|NCT01479439|17783485|P1|Overall Study|Lost to Follow-up|0
5148757|NCT01479439|17783483|P3|Overall Study|Adverse Event|0
5148758|NCT01479439|17783484|P2|Overall Study|Adverse Event|0
5148759|NCT01479439|17783485|P1|Overall Study|Adverse Event|1
5148760|NCT01479374|17783517|P3|Overall Study|Other|5
5148761|NCT01479374|17783518|P2|Overall Study|Other|4
5148762|NCT01479374|17783519|P1|Overall Study|Other|0
5148763|NCT01479374|17783517|P3|Overall Study|Decision Unrelated to Adverse Event|0
5148764|NCT01479374|17783518|P2|Overall Study|Decision Unrelated to Adverse Event|1
5148765|NCT01479374|17783519|P1|Overall Study|Decision Unrelated to Adverse Event|0
5148766|NCT01479374|17783517|P3|Overall Study|Lost to Follow-up|0
5148767|NCT01479374|17783518|P2|Overall Study|Lost to Follow-up|2
5148768|NCT01479374|17783519|P1|Overall Study|Lost to Follow-up|1
5148769|NCT01479374|17783517|P3|Overall Study|Adverse Event|0
5148770|NCT01479374|17783518|P2|Overall Study|Adverse Event|1
5148771|NCT01479374|17783519|P1|Overall Study|Adverse Event|2
5148772|NCT01478971|17783613|P1|Peginesatide Treatment Period|Other|4
5148773|NCT01478971|17783613|P1|Peginesatide Treatment Period|Lost to Follow-up|4
5148774|NCT01478971|17783613|P1|Peginesatide Treatment Period|Death|4
5148775|NCT01478971|17783613|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
5148776|NCT01478971|17783613|P1|Peginesatide Treatment Period|Adverse Event|1
5148777|NCT01478971|17783613|P1|Standard of Care Period|Other|4
5148778|NCT01478971|17783613|P1|Standard of Care Period|Lost to Follow-up|9
5148779|NCT01478971|17783613|P1|Standard of Care Period|Death|8
5148780|NCT01478971|17783613|P1|Standard of Care Period|Withdrawal by Subject|3
5148781|NCT01478971|17783613|P1|Standard of Care Period|Adverse Event|1
5148782|NCT01478958|17783630|P3|Overall Study|Unable to comply|2
5148783|NCT01478958|17783631|P2|Overall Study|Unable to comply|0
5148784|NCT01478958|17783632|P1|Overall Study|Unable to comply|0
5148785|NCT01478958|17783630|P3|Overall Study|Re-located|0
5148786|NCT01478958|17783631|P2|Overall Study|Re-located|1
5148787|NCT01478958|17783632|P1|Overall Study|Re-located|0
5148788|NCT01478958|17783630|P3|Overall Study|Weight loss|0
5148789|NCT01478958|17783631|P2|Overall Study|Weight loss|0
5148790|NCT01478958|17783632|P1|Overall Study|Weight loss|1
5148791|NCT01478958|17783630|P3|Overall Study|Withdrawal by Subject|1
5148792|NCT01478958|17783631|P2|Overall Study|Withdrawal by Subject|1
5148793|NCT01478958|17783632|P1|Overall Study|Withdrawal by Subject|1
5148794|NCT01478828|17783652|P1|Overall Study|Adverse Event|1
5148795|NCT01478620|17783663|P1|Overall Study|Lost to Follow-up|6
5148796|NCT01478594|17783669|P2|Overall Study|Study Closed by Sponsor|5
5148797|NCT01478594|17783670|P1|Overall Study|Study Closed by Sponsor|8
5148798|NCT01478594|17783669|P2|Overall Study|Withdrawal by Subject|3
5148799|NCT01478594|17783670|P1|Overall Study|Withdrawal by Subject|9
5148800|NCT01478594|17783669|P2|Overall Study|Lost to Follow-up|1
5148801|NCT01478594|17783670|P1|Overall Study|Lost to Follow-up|3
5148802|NCT01478594|17783669|P2|Overall Study|Death|18
5148803|NCT01478594|17783670|P1|Overall Study|Death|45
5148804|NCT01478594|17783669|P2|Overall Study|Randomized but Never Received Study Drug|1
5148805|NCT01478594|17783670|P1|Overall Study|Randomized but Never Received Study Drug|0
5148806|NCT01478373|17783799|P1|Survival Phase|Progressive Disease|27
5148807|NCT01478373|17783799|P1|Survival Phase|crossover to another study|2
5148808|NCT01478373|17783799|P1|Survival Phase|Protocol Violation|1
5148809|NCT01478373|17783799|P1|Survival Phase|Adverse Event|8
5148810|NCT01478373|17783799|P1|Treatment Phase|Protocol Violation|1
5148811|NCT01478360|17783812|P2|Overall Study|Administrative problems|2
5148812|NCT01478360|17783813|P1|Overall Study|Administrative problems|1
5148813|NCT01478360|17783812|P2|Overall Study|Adverse Event|1
5148814|NCT01478360|17783813|P1|Overall Study|Adverse Event|0
5148815|NCT01478360|17783812|P2|Overall Study|Lost to Follow-up|0
5148816|NCT01478360|17783813|P1|Overall Study|Lost to Follow-up|1
5148817|NCT01478347|17783819|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
5148818|NCT01478347|17783819|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
5148819|NCT01478347|17783819|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
5148820|NCT01478321|17783824|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
5148821|NCT01478321|17783824|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
5148822|NCT01478321|17783824|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
5148823|NCT01478321|17783824|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
5148824|NCT01478321|17783824|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
5148825|NCT01478321|17783824|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
5148826|NCT01478321|17783824|P1|Concurrent Therapy (5 Weeks)|Death|2
5148827|NCT01478321|17783824|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
5148828|NCT01478113|17783847|P2|Overall Study|Physician Decision|0
5148829|NCT01478113|17783848|P1|Overall Study|Physician Decision|1
5148830|NCT01478113|17783847|P2|Overall Study|Withdrawal by Subject|1
5148831|NCT01478113|17783848|P1|Overall Study|Withdrawal by Subject|0
5148832|NCT01478087|17783866|P1|Overall Study|due to sponsor closing study|1
5148833|NCT01478048|17783873|P2|Overall Study|no longer meets study criteria|0
5148834|NCT01478048|17783874|P1|Overall Study|no longer meets study criteria|1
5148835|NCT01478048|17783873|P2|Overall Study|poor/non-compliance|1
5148836|NCT01478048|17783874|P1|Overall Study|poor/non-compliance|0
5148837|NCT01478048|17783873|P2|Overall Study|non-specified|4
5148838|NCT01478048|17783874|P1|Overall Study|non-specified|6
5148839|NCT01478048|17783873|P2|Overall Study|Withdrawal by Subject|5
5148840|NCT01478048|17783874|P1|Overall Study|Withdrawal by Subject|2
5148841|NCT01478048|17783873|P2|Overall Study|subject request to discontinue treatment|5
5148842|NCT01478048|17783874|P1|Overall Study|subject request to discontinue treatment|3
5148843|NCT01478048|17783873|P2|Overall Study|Adverse Event|11
5148844|NCT01478048|17783874|P1|Overall Study|Adverse Event|2
5148845|NCT01478048|17783873|P2|Overall Study|study drug toxicity|14
5148846|NCT01478048|17783874|P1|Overall Study|study drug toxicity|11
5148847|NCT01478048|17783873|P2|Overall Study|Disease Progression|35
5148848|NCT01478048|17783874|P1|Overall Study|Disease Progression|52
5148849|NCT01477892|17783903|P2|Overall Study|Withdrawal by Subject|2
5148850|NCT01477892|17783904|P1|Overall Study|Withdrawal by Subject|0
5148851|NCT01477853|17783915|P3|Phase B|Study terminated by sponsor|11
5148852|NCT01477853|17783916|P2|Phase B|Study terminated by sponsor|10
5148853|NCT01477853|17783917|P1|Phase B|Study terminated by sponsor|12
5148854|NCT01477853|17783915|P3|Phase B|Lost to Follow-up|0
5148855|NCT01477853|17783916|P2|Phase B|Lost to Follow-up|1
5148856|NCT01477853|17783917|P1|Phase B|Lost to Follow-up|0
5148857|NCT01477853|17783915|P3|Phase A|Study terminated by sponsor|39
5148858|NCT01477853|17783916|P2|Phase A|Study terminated by sponsor|40
5148859|NCT01477853|17783917|P1|Phase A|Study terminated by sponsor|37
5148860|NCT01477853|17783915|P3|Phase A|Physician Decision|1
5148861|NCT01477853|17783916|P2|Phase A|Physician Decision|0
5148862|NCT01477853|17783917|P1|Phase A|Physician Decision|1
5148863|NCT01477853|17783915|P3|Phase A|Lost to Follow-up|2
5148864|NCT01477853|17783916|P2|Phase A|Lost to Follow-up|3
5148865|NCT01477853|17783917|P1|Phase A|Lost to Follow-up|4
5148866|NCT01477853|17783915|P3|Phase A|Adverse Event|2
5148867|NCT01477853|17783916|P2|Phase A|Adverse Event|2
5148868|NCT01477853|17783917|P1|Phase A|Adverse Event|1
5148869|NCT01477749|17783984|P1|Overall Study|Physician Decision|4
5148870|NCT01477333|17784092|P1|Overall Study|Clinical Deterioration|1
5148871|NCT01477333|17784092|P1|Overall Study|Withdrawal by Subject|1
5148872|NCT01477333|17784092|P1|Overall Study|Adverse Event|1
5148873|NCT01476722|17784143|P1|Overall Study|Adverse Event|1
5148874|NCT01476696|17784150|P3|Overall Study|Withdrawal by Subject|0
5148875|NCT01476696|17784151|P2|Overall Study|Withdrawal by Subject|0
5148876|NCT01476696|17784152|P1|Overall Study|Withdrawal by Subject|1
5148877|NCT01476696|17784150|P3|Overall Study|Sponsor decision|0
5148878|NCT01476696|17784151|P2|Overall Study|Sponsor decision|1
5148879|NCT01476696|17784152|P1|Overall Study|Sponsor decision|2
5148880|NCT01476644|17784166|P1|Overall Study|Withdrawal by Subject|13
5148881|NCT01476644|17784166|P1|Overall Study|Lost to Follow-up|19
5148882|NCT01476644|17784166|P1|Overall Study|moved to another state|2
5148883|NCT01476644|17784166|P1|Overall Study|Death|5
5148884|NCT01476475|17784173|P2|Overall Study|Other reasons|2
5148885|NCT01476475|17784174|P1|Overall Study|Other reasons|4
5148886|NCT01476475|17784173|P2|Overall Study|Poor compliance to protocol|1
5148887|NCT01476475|17784174|P1|Overall Study|Poor compliance to protocol|1
5148888|NCT01476475|17784173|P2|Overall Study|Adverse Event|0
5148889|NCT01476475|17784174|P1|Overall Study|Adverse Event|6
5148890|NCT01475851|17784625|P2|Overall Study|Protocol defined stopping criteria|0
5148891|NCT01475851|17784626|P1|Overall Study|Protocol defined stopping criteria|1
5148892|NCT01475838|17784654|P2|Extension Phase|Participant Noncompliance|0
5148893|NCT01475838|17784655|P1|Extension Phase|Participant Noncompliance|1
5148894|NCT01475838|17784654|P2|Randomized Phase|Protocol Violation|4
5148895|NCT01475838|17784655|P1|Randomized Phase|Protocol Violation|9
5148896|NCT01475838|17784654|P2|Randomized Phase|Participant Noncompliance|5
5148897|NCT01475838|17784655|P1|Randomized Phase|Participant Noncompliance|1
5148898|NCT01475838|17784654|P2|Randomized Phase|Lost to Follow-up|4
5148899|NCT01475838|17784655|P1|Randomized Phase|Lost to Follow-up|3
5148900|NCT01475838|17784654|P2|Randomized Phase|Withdrew Consent|14
5148901|NCT01475838|17784655|P1|Randomized Phase|Withdrew Consent|10
5148902|NCT01475838|17784654|P2|Randomized Phase|Investigators Discretion|2
5148903|NCT01475838|17784655|P1|Randomized Phase|Investigators Discretion|1
5148904|NCT01475838|17784654|P2|Randomized Phase|Pregnancy|1
5148905|NCT01475838|17784655|P1|Randomized Phase|Pregnancy|0
5148906|NCT01475838|17784654|P2|Randomized Phase|Adverse Event|1
5148907|NCT01475838|17784655|P1|Randomized Phase|Adverse Event|6
5148908|NCT01475838|17784654|P2|Randomized Phase|Randomized but Not Treated|5
5148909|NCT01475838|17784655|P1|Randomized Phase|Randomized but Not Treated|0
5148910|NCT01475825|17784672|P4|Overall Study|Did not enter OLC|11
5148911|NCT01475825|17784673|P3|Overall Study|Did not enter OLC|15
5148912|NCT01475825|17784674|P2|Overall Study|Did not enter OLC|11
5148913|NCT01475825|17784675|P1|Overall Study|Did not enter OLC|15
5148914|NCT01475825|17784672|P4|Overall Study|Withdrawal by Subject|7
5148915|NCT01475825|17784673|P3|Overall Study|Withdrawal by Subject|11
5148916|NCT01475825|17784674|P2|Overall Study|Withdrawal by Subject|3
5148917|NCT01475825|17784675|P1|Overall Study|Withdrawal by Subject|8
5148918|NCT01475825|17784672|P4|Overall Study|Physician Decision|0
5148919|NCT01475825|17784673|P3|Overall Study|Physician Decision|0
5148920|NCT01475825|17784674|P2|Overall Study|Physician Decision|1
5148921|NCT01475825|17784675|P1|Overall Study|Physician Decision|0
5148922|NCT01475825|17784672|P4|Overall Study|Protocol Violation|0
5148923|NCT01475825|17784673|P3|Overall Study|Protocol Violation|0
5148924|NCT01475825|17784674|P2|Overall Study|Protocol Violation|0
5148925|NCT01475825|17784675|P1|Overall Study|Protocol Violation|1
5148926|NCT01475825|17784672|P4|Overall Study|Other: Not available|0
5148927|NCT01475825|17784673|P3|Overall Study|Other: Not available|2
5148928|NCT01475825|17784674|P2|Overall Study|Other: Not available|0
5148929|NCT01475825|17784675|P1|Overall Study|Other: Not available|0
5148930|NCT01475825|17784672|P4|Overall Study|Non-compliance with Study Drug|0
5148931|NCT01475825|17784673|P3|Overall Study|Non-compliance with Study Drug|4
5148932|NCT01475825|17784674|P2|Overall Study|Non-compliance with Study Drug|2
5148933|NCT01475825|17784675|P1|Overall Study|Non-compliance with Study Drug|1
5148934|NCT01475825|17784672|P4|Overall Study|Lost to Follow-up|1
5148935|NCT01475825|17784673|P3|Overall Study|Lost to Follow-up|3
5148936|NCT01475825|17784674|P2|Overall Study|Lost to Follow-up|0
5148937|NCT01475825|17784675|P1|Overall Study|Lost to Follow-up|0
5148938|NCT01475825|17784672|P4|Overall Study|Lack of Efficacy|0
5148939|NCT01475825|17784673|P3|Overall Study|Lack of Efficacy|1
5148940|NCT01475825|17784674|P2|Overall Study|Lack of Efficacy|0
5148941|NCT01475825|17784675|P1|Overall Study|Lack of Efficacy|0
5148942|NCT01475825|17784672|P4|Overall Study|Death|0
5148943|NCT01475825|17784673|P3|Overall Study|Death|1
5148944|NCT01475825|17784674|P2|Overall Study|Death|0
5148945|NCT01475825|17784675|P1|Overall Study|Death|1
5148946|NCT01475825|17784672|P4|Overall Study|Adverse Event|11
5148947|NCT01475825|17784673|P3|Overall Study|Adverse Event|27
5148948|NCT01475825|17784674|P2|Overall Study|Adverse Event|15
5148949|NCT01475825|17784675|P1|Overall Study|Adverse Event|41
5148950|NCT01475734|17784707|P2|Overall Study|Physician Decision|1
5148951|NCT01475734|17784708|P1|Overall Study|Physician Decision|0
5148952|NCT01475734|17784707|P2|Overall Study|Protocol Violation|0
5148953|NCT01475734|17784708|P1|Overall Study|Protocol Violation|1
5148954|NCT01475734|17784707|P2|Overall Study|Withdrawal by Subject|0
5148955|NCT01475734|17784708|P1|Overall Study|Withdrawal by Subject|1
5148956|NCT01475721|17784736|P2|Overall Study|Withdrawal by Subject|8
5148957|NCT01475721|17784737|P1|Overall Study|Withdrawal by Subject|8
5148958|NCT01475721|17784736|P2|Overall Study|Death|6
5148959|NCT01475721|17784737|P1|Overall Study|Death|3
5148960|NCT01475487|17784803|P2|Overall Study|had to leave early for personal reasons|1
5148961|NCT01475487|17784804|P1|Overall Study|had to leave early for personal reasons|2
5148962|NCT01475474|17784816|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
5148963|NCT01475474|17784816|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
5148964|NCT01475461|17784827|P7|Treatment Period|Adverse Event|0
5148965|NCT01475461|17784828|P6|Treatment Period|Adverse Event|0
5148966|NCT01475461|17784829|P5|Treatment Period|Adverse Event|0
5148967|NCT01475461|17784830|P4|Treatment Period|Adverse Event|1
5148968|NCT01475461|17784831|P3|Treatment Period|Adverse Event|0
5148969|NCT01475461|17784832|P2|Treatment Period|Adverse Event|0
5148970|NCT01475461|17784833|P1|Treatment Period|Adverse Event|0
5148971|NCT01475461|17784827|P7|Treatment Period|Medication Error|0
5148972|NCT01475461|17784828|P6|Treatment Period|Medication Error|0
5148973|NCT01475461|17784829|P5|Treatment Period|Medication Error|0
5148974|NCT01475461|17784830|P4|Treatment Period|Medication Error|1
5148975|NCT01475461|17784831|P3|Treatment Period|Medication Error|0
5148976|NCT01475461|17784832|P2|Treatment Period|Medication Error|0
5148977|NCT01475461|17784833|P1|Treatment Period|Medication Error|0
5148978|NCT01475461|17784827|P7|Treatment Period|Lack of Efficacy|0
5148979|NCT01475461|17784828|P6|Treatment Period|Lack of Efficacy|1
5148980|NCT01475461|17784829|P5|Treatment Period|Lack of Efficacy|1
5148981|NCT01475461|17784830|P4|Treatment Period|Lack of Efficacy|2
5148982|NCT01475461|17784831|P3|Treatment Period|Lack of Efficacy|0
5148983|NCT01475461|17784832|P2|Treatment Period|Lack of Efficacy|2
5148984|NCT01475461|17784833|P1|Treatment Period|Lack of Efficacy|0
5148985|NCT01475461|17784827|P7|Treatment Period|Protocol Violation|1
5148986|NCT01475461|17784828|P6|Treatment Period|Protocol Violation|0
5148987|NCT01475461|17784829|P5|Treatment Period|Protocol Violation|0
5148988|NCT01475461|17784830|P4|Treatment Period|Protocol Violation|0
5148989|NCT01475461|17784831|P3|Treatment Period|Protocol Violation|0
5148990|NCT01475461|17784832|P2|Treatment Period|Protocol Violation|1
5148991|NCT01475461|17784833|P1|Treatment Period|Protocol Violation|0
5148992|NCT01475461|17784827|P7|Treatment Period|Other|0
5148993|NCT01475461|17784828|P6|Treatment Period|Other|0
5148994|NCT01475461|17784829|P5|Treatment Period|Other|0
5148995|NCT01475461|17784830|P4|Treatment Period|Other|0
5148996|NCT01475461|17784831|P3|Treatment Period|Other|0
5148997|NCT01475461|17784832|P2|Treatment Period|Other|1
5148998|NCT01475461|17784833|P1|Treatment Period|Other|0
5148999|NCT01475461|17784827|P7|Treatment Period|Withdrawal by Subject|0
5149000|NCT01475461|17784828|P6|Treatment Period|Withdrawal by Subject|2
5149001|NCT01475461|17784829|P5|Treatment Period|Withdrawal by Subject|2
5149002|NCT01475461|17784830|P4|Treatment Period|Withdrawal by Subject|0
5149003|NCT01475461|17784831|P3|Treatment Period|Withdrawal by Subject|2
5149004|NCT01475461|17784832|P2|Treatment Period|Withdrawal by Subject|2
5149005|NCT01475461|17784833|P1|Treatment Period|Withdrawal by Subject|0
5149006|NCT01475461|17784827|P7|Treatment Period|Lost to Follow-up|1
5149007|NCT01475461|17784828|P6|Treatment Period|Lost to Follow-up|2
5149008|NCT01475461|17784829|P5|Treatment Period|Lost to Follow-up|1
5149009|NCT01475461|17784830|P4|Treatment Period|Lost to Follow-up|3
5149010|NCT01475461|17784831|P3|Treatment Period|Lost to Follow-up|2
5149011|NCT01475461|17784832|P2|Treatment Period|Lost to Follow-up|3
5149012|NCT01475461|17784833|P1|Treatment Period|Lost to Follow-up|0
5149013|NCT01475461|17784827|P7|Treatment Period|Death|0
5149014|NCT01475461|17784828|P6|Treatment Period|Death|0
5149015|NCT01475461|17784829|P5|Treatment Period|Death|0
5149016|NCT01475461|17784830|P4|Treatment Period|Death|1
5149017|NCT01475461|17784831|P3|Treatment Period|Death|0
5149018|NCT01475461|17784832|P2|Treatment Period|Death|0
5149019|NCT01475461|17784833|P1|Treatment Period|Death|0
5149020|NCT01475461|17784827|P7|Run-in Period|Protocol Violation|0
5149021|NCT01475461|17784828|P6|Run-in Period|Protocol Violation|0
5149022|NCT01475461|17784829|P5|Run-in Period|Protocol Violation|0
5149023|NCT01475461|17784830|P4|Run-in Period|Protocol Violation|0
5149024|NCT01475461|17784831|P3|Run-in Period|Protocol Violation|0
5149025|NCT01475461|17784832|P2|Run-in Period|Protocol Violation|0
5149026|NCT01475461|17784833|P1|Run-in Period|Protocol Violation|4
5149027|NCT01475461|17784827|P7|Run-in Period|Other|0
5149028|NCT01475461|17784828|P6|Run-in Period|Other|0
5149029|NCT01475461|17784829|P5|Run-in Period|Other|0
5149030|NCT01475461|17784830|P4|Run-in Period|Other|0
5149031|NCT01475461|17784831|P3|Run-in Period|Other|0
5149032|NCT01475461|17784832|P2|Run-in Period|Other|0
5149033|NCT01475461|17784833|P1|Run-in Period|Other|3
5149034|NCT01475461|17784827|P7|Run-in Period|Withdrawal by Subject|0
5149035|NCT01475461|17784828|P6|Run-in Period|Withdrawal by Subject|0
5149036|NCT01475461|17784829|P5|Run-in Period|Withdrawal by Subject|0
5149037|NCT01475461|17784830|P4|Run-in Period|Withdrawal by Subject|0
5149038|NCT01475461|17784831|P3|Run-in Period|Withdrawal by Subject|0
5149039|NCT01475461|17784832|P2|Run-in Period|Withdrawal by Subject|0
5149040|NCT01475461|17784833|P1|Run-in Period|Withdrawal by Subject|11
5149041|NCT01475461|17784827|P7|Run-in Period|Lost to Follow-up|0
5149042|NCT01475461|17784828|P6|Run-in Period|Lost to Follow-up|0
5149043|NCT01475461|17784829|P5|Run-in Period|Lost to Follow-up|0
5149044|NCT01475461|17784830|P4|Run-in Period|Lost to Follow-up|0
5149045|NCT01475461|17784831|P3|Run-in Period|Lost to Follow-up|0
5149046|NCT01475461|17784832|P2|Run-in Period|Lost to Follow-up|0
5149047|NCT01475461|17784833|P1|Run-in Period|Lost to Follow-up|7
5149048|NCT01475461|17784827|P7|Run-in Period|Not meet eligibility criteria|0
5149049|NCT01475461|17784828|P6|Run-in Period|Not meet eligibility criteria|0
5149050|NCT01475461|17784829|P5|Run-in Period|Not meet eligibility criteria|0
5149051|NCT01475461|17784830|P4|Run-in Period|Not meet eligibility criteria|0
5149052|NCT01475461|17784831|P3|Run-in Period|Not meet eligibility criteria|0
5149053|NCT01475461|17784832|P2|Run-in Period|Not meet eligibility criteria|0
5149054|NCT01475461|17784833|P1|Run-in Period|Not meet eligibility criteria|16
5149055|NCT01475331|17784913|P2|Overall Study|cyst found to be prohibitively small|1
5149056|NCT01475331|17784914|P1|Overall Study|cyst found to be prohibitively small|0
5149057|NCT01475331|17784913|P2|Overall Study|Sign of malignancy during the procedure|0
5149058|NCT01475331|17784914|P1|Overall Study|Sign of malignancy during the procedure|2
5149059|NCT01475331|17784913|P2|Overall Study|Loss of needle positioning due pt. cough|0
5149060|NCT01475331|17784914|P1|Overall Study|Loss of needle positioning due pt. cough|1
5149061|NCT01475331|17784913|P2|Overall Study|excessive main duct communication|1
5149062|NCT01475331|17784914|P1|Overall Study|excessive main duct communication|1
5149063|NCT01475331|17784913|P2|Overall Study|Osteophyte obstruction of the proximal|0
5149064|NCT01475331|17784914|P1|Overall Study|Osteophyte obstruction of the proximal|1
5149065|NCT01475253|17784966|P4|Randomized, Blinded Study|Lost to Follow-up|0
5149066|NCT01475253|17784967|P3|Randomized, Blinded Study|Lost to Follow-up|0
5149067|NCT01475253|17784968|P2|Randomized, Blinded Study|Lost to Follow-up|0
5149068|NCT01475253|17784969|P1|Randomized, Blinded Study|Lost to Follow-up|1
5149069|NCT01475253|17784966|P4|Randomized, Blinded Study|Withdrawal by Subject|0
5149070|NCT01475253|17784967|P3|Randomized, Blinded Study|Withdrawal by Subject|0
5149071|NCT01475253|17784968|P2|Randomized, Blinded Study|Withdrawal by Subject|1
5149072|NCT01475253|17784969|P1|Randomized, Blinded Study|Withdrawal by Subject|1
5149073|NCT01475214|17784998|P3|Overall Study|Withdrawal by Subject|1
5149074|NCT01475214|17784999|P2|Overall Study|Withdrawal by Subject|4
5149075|NCT01475214|17785000|P1|Overall Study|Withdrawal by Subject|2
5149076|NCT01475214|17784998|P3|Overall Study|Physician Decision|0
5149077|NCT01475214|17784999|P2|Overall Study|Physician Decision|0
5149078|NCT01475214|17785000|P1|Overall Study|Physician Decision|2
5149079|NCT01475214|17784998|P3|Overall Study|Lost to Follow-up|1
5149080|NCT01475214|17784999|P2|Overall Study|Lost to Follow-up|0
5149081|NCT01475214|17785000|P1|Overall Study|Lost to Follow-up|1
5149082|NCT01475162|17785023|P1|Overall Study|Study closed for safety|3
5149083|NCT01475162|17785023|P1|Overall Study|Death|10
5149084|NCT01475162|17785023|P1|Overall Study|Physician Decision|1
5149085|NCT01475097|17785036|P2|Overall Study|Protocol Violation|1
5149086|NCT01475097|17785037|P1|Overall Study|Protocol Violation|1
5149087|NCT01475071|17785045|P1|Overall Study|Lost to Follow-up|1
5149088|NCT01475071|17785045|P1|Overall Study|Withdrawal by Subject|6
5149089|NCT01475071|17785045|P1|Overall Study|Physician Decision|1
5149090|NCT01474993|17785055|P2|Overall Study|Adverse Event|1
5149091|NCT01474993|17785056|P1|Overall Study|Adverse Event|0
5149092|NCT01474993|17785055|P2|Overall Study|Lost to Follow-up|2
5149093|NCT01474993|17785056|P1|Overall Study|Lost to Follow-up|1
5149094|NCT01474876|17785098|P3|Overall Study|Investigator's decision and pt request|0
5149095|NCT01474876|17785099|P2|Overall Study|Investigator's decision and pt request|0
5149096|NCT01474876|17785100|P1|Overall Study|Investigator's decision and pt request|1
5149097|NCT01474876|17785098|P3|Overall Study|Patient's request|0
5149098|NCT01474876|17785099|P2|Overall Study|Patient's request|5
5149099|NCT01474876|17785100|P1|Overall Study|Patient's request|19
5149100|NCT01474876|17785098|P3|Overall Study|Investigator's decision|0
5149101|NCT01474876|17785099|P2|Overall Study|Investigator's decision|6
5149102|NCT01474876|17785100|P1|Overall Study|Investigator's decision|28
5149103|NCT01474876|17785098|P3|Overall Study|Lost to Follow-up|0
5149104|NCT01474876|17785099|P2|Overall Study|Lost to Follow-up|4
5149105|NCT01474876|17785100|P1|Overall Study|Lost to Follow-up|5
5149106|NCT01474876|17785098|P3|Overall Study|Serious Adverse Event|0
5149107|NCT01474876|17785099|P2|Overall Study|Serious Adverse Event|3
5149108|NCT01474876|17785100|P1|Overall Study|Serious Adverse Event|2
5149109|NCT01474876|17785098|P3|Overall Study|Adverse Event|0
5149110|NCT01474876|17785099|P2|Overall Study|Adverse Event|5
5149111|NCT01474876|17785100|P1|Overall Study|Adverse Event|11
5149112|NCT01474772|17785146|P2|Follow-up|AE not Related to Study Drug|1
5149113|NCT01474772|17785147|P1|Follow-up|AE not Related to Study Drug|0
5149114|NCT01474772|17785146|P2|Period 2|Reason not Specified|2
5149115|NCT01474772|17785147|P1|Period 2|Reason not Specified|0
5149116|NCT01474772|17785146|P2|Period 2|Lost to Follow-up|1
5149117|NCT01474772|17785147|P1|Period 2|Lost to Follow-up|1
5149118|NCT01474772|17785146|P2|Period 2|Withdrawal by Subject|4
5149119|NCT01474772|17785147|P1|Period 2|Withdrawal by Subject|3
5149120|NCT01474772|17785146|P2|Period 2|Lack of Efficacy|0
5149121|NCT01474772|17785147|P1|Period 2|Lack of Efficacy|1
5149122|NCT01474772|17785146|P2|Period 2|AE not Related to Study Drug|1
5149123|NCT01474772|17785147|P1|Period 2|AE not Related to Study Drug|4
5149124|NCT01474772|17785146|P2|Period 2|AE Related to Study Drug|1
5149125|NCT01474772|17785147|P1|Period 2|AE Related to Study Drug|0
5149126|NCT01474772|17785146|P2|Period 2|Death|1
5149127|NCT01474772|17785147|P1|Period 2|Death|0
5149128|NCT01474772|17785146|P2|Washout|Reason not Specified|1
5149129|NCT01474772|17785147|P1|Washout|Reason not Specified|0
5149130|NCT01474772|17785146|P2|Washout|Lost to Follow-up|1
5149131|NCT01474772|17785147|P1|Washout|Lost to Follow-up|0
5149132|NCT01474772|17785146|P2|Washout|Withdrawal by Subject|0
5149133|NCT01474772|17785147|P1|Washout|Withdrawal by Subject|1
5149134|NCT01474772|17785146|P2|Washout|AE not Related to Study Drug|0
5149135|NCT01474772|17785147|P1|Washout|AE not Related to Study Drug|2
5149136|NCT01474772|17785146|P2|Period 1|Reason not Specified|1
5149137|NCT01474772|17785147|P1|Period 1|Reason not Specified|1
5149138|NCT01474772|17785146|P2|Period 1|Lost to Follow-up|0
5149139|NCT01474772|17785147|P1|Period 1|Lost to Follow-up|1
5149140|NCT01474772|17785146|P2|Period 1|Withdrawal by Subject|1
5149141|NCT01474772|17785147|P1|Period 1|Withdrawal by Subject|3
5149142|NCT01474772|17785146|P2|Period 1|AE not Related to Study Drug|0
5149143|NCT01474772|17785147|P1|Period 1|AE not Related to Study Drug|1
5149144|NCT01474772|17785146|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
5149145|NCT01474772|17785147|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
5149146|NCT01474746|17785197|P2|Overall Study|Withdrawal by Subject|1
5149147|NCT01474746|17785198|P1|Overall Study|Withdrawal by Subject|2
5149148|NCT01474746|17785197|P2|Overall Study|Lost to Follow-up|1
5149149|NCT01474746|17785198|P1|Overall Study|Lost to Follow-up|1
5149150|NCT01474681|17785262|P4|Overall Study|Death|6
5149151|NCT01474681|17785263|P3|Overall Study|Death|2
5149152|NCT01474681|17785264|P2|Overall Study|Death|3
5149153|NCT01474681|17785265|P1|Overall Study|Death|0
5149154|NCT01474551|17785316|P1|Overall Study|Death|1
5149155|NCT01474538|17785322|P2|Treatment Period 2|Protocol Violation|0
5149156|NCT01474538|17785323|P1|Treatment Period 2|Protocol Violation|1
5149157|NCT01474538|17785322|P2|Treatment Period 2|Physician Decision|1
5149158|NCT01474538|17785323|P1|Treatment Period 2|Physician Decision|0
5149159|NCT01474538|17785322|P2|Treatment Period 2|Sponsor decision|0
5149160|NCT01474538|17785323|P1|Treatment Period 2|Sponsor decision|1
5149161|NCT01474538|17785322|P2|Treatment Period 2|Withdrawal by Subject|0
5149162|NCT01474538|17785323|P1|Treatment Period 2|Withdrawal by Subject|2
5149163|NCT01474538|17785322|P2|Treatment Period 2|Adverse Event|1
5149164|NCT01474538|17785323|P1|Treatment Period 2|Adverse Event|1
5149165|NCT01474538|17785322|P2|Treatment Period 2|Death|0
5149166|NCT01474538|17785323|P1|Treatment Period 2|Death|1
5149167|NCT01474538|17785322|P2|Treatment Period 1|Protocol Violation|1
5149168|NCT01474538|17785323|P1|Treatment Period 1|Protocol Violation|0
5149169|NCT01474538|17785322|P2|Treatment Period 1|Withdrawal by Subject|3
5149170|NCT01474538|17785323|P1|Treatment Period 1|Withdrawal by Subject|1
5149171|NCT01474538|17785322|P2|Treatment Period 1|Physician Decision|0
5149172|NCT01474538|17785323|P1|Treatment Period 1|Physician Decision|1
5149173|NCT01474538|17785322|P2|Treatment Period 1|Death|0
5149174|NCT01474538|17785323|P1|Treatment Period 1|Death|1
5149175|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Death|0
5149176|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Death|1
5149177|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Death|0
5149178|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Death|0
5149179|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Death|0
5149180|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Death|0
5149181|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Death|0
5149182|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Death|0
5149183|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Death|0
5149184|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Death|0
5149185|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Death|0
5149186|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Death|0
5149187|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Death|0
5149188|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Death|0
5149189|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Death|0
5149190|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Death|0
5149191|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Death|0
5149192|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Death|0
5149193|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
5149194|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149195|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149196|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
5149197|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149198|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149199|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149200|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149201|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149202|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149203|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149204|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149205|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149206|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149207|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149208|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149209|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149210|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5149211|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Sponsor Decision|0
5149212|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Sponsor Decision|4
5149213|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Sponsor Decision|0
5149214|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Sponsor Decision|1
5149215|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Sponsor Decision|0
5149216|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Sponsor Decision|0
5149217|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Sponsor Decision|0
5149218|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Sponsor Decision|0
5149219|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Sponsor Decision|0
5149220|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Sponsor Decision|0
5149221|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Sponsor Decision|0
5149222|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Sponsor Decision|0
5149223|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Sponsor Decision|0
5149224|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Sponsor Decision|0
5149225|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Sponsor Decision|0
5149226|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Sponsor Decision|0
5149227|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Sponsor Decision|0
5149228|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Sponsor Decision|0
5149229|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Protocol Violation|0
5149230|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Protocol Violation|4
5149231|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Protocol Violation|2
5149232|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Protocol Violation|2
5149233|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Protocol Violation|0
5149234|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Protocol Violation|0
5149235|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Protocol Violation|0
5149236|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Protocol Violation|0
5149237|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Protocol Violation|0
5149238|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Protocol Violation|0
5149239|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Protocol Violation|0
5149240|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Protocol Violation|0
5149241|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Protocol Violation|0
5149242|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Protocol Violation|0
5149243|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Protocol Violation|0
5149244|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Protocol Violation|0
5149245|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Protocol Violation|0
5149246|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Protocol Violation|0
5149247|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Clinical Relapse|2
5149248|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Clinical Relapse|6
5149249|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Clinical Relapse|0
5149250|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Clinical Relapse|0
5149251|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Clinical Relapse|0
5149252|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Clinical Relapse|0
5149253|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Clinical Relapse|0
5149254|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Clinical Relapse|0
5149255|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Clinical Relapse|0
5149256|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Clinical Relapse|0
5149257|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Clinical Relapse|0
5149258|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Clinical Relapse|0
5149259|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Clinical Relapse|0
5149260|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Clinical Relapse|0
5149261|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Clinical Relapse|0
5149262|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Clinical Relapse|0
5149263|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Clinical Relapse|0
5149264|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Clinical Relapse|0
5149265|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Physician Decision|5
5149266|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Physician Decision|4
5149267|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Physician Decision|0
5149268|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Physician Decision|0
5149269|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Physician Decision|0
5149270|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Physician Decision|0
5149271|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Physician Decision|0
5149272|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Physician Decision|0
5149273|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Physician Decision|0
5149274|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Physician Decision|0
5149275|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Physician Decision|0
5149276|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Physician Decision|0
5149277|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Physician Decision|0
5149278|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Physician Decision|0
5149279|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Physician Decision|0
5149280|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Physician Decision|0
5149281|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Physician Decision|0
5149282|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Physician Decision|0
5149283|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
5149284|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
5149285|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
5149286|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
5149287|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
5149288|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
5149289|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
5149290|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
5149291|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
5149292|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
5149293|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
5149294|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
5149295|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
5149296|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
5149297|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
5149298|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
5149299|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
5149300|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
5149301|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
5149302|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
5149303|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
5149304|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
5149305|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
5149306|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
5149307|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
5149308|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
5149309|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
5149310|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
5149311|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
5149312|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
5149313|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
5149314|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
5149315|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
5149316|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
5149317|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
5149318|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
5149319|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
5149320|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
5149321|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
5149322|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
5149323|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149324|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149325|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149326|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149327|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149328|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149329|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149330|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149331|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149332|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149333|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149334|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149335|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149336|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
5149337|NCT01474512|17785340|P18|Post-Treatment Follow-Up|Adverse Event|11
5149338|NCT01474512|17785341|P17|Post-Treatment Follow-Up|Adverse Event|58
5149339|NCT01474512|17785342|P16|Post-Treatment Follow-Up|Adverse Event|2
5149340|NCT01474512|17785343|P15|Post-Treatment Follow-Up|Adverse Event|8
5149341|NCT01474512|17785344|P14|Post-Treatment Follow-Up|Adverse Event|0
5149342|NCT01474512|17785345|P13|Post-Treatment Follow-Up|Adverse Event|0
5149343|NCT01474512|17785346|P12|Post-Treatment Follow-Up|Adverse Event|0
5149344|NCT01474512|17785347|P11|Post-Treatment Follow-Up|Adverse Event|0
5149345|NCT01474512|17785348|P10|Post-Treatment Follow-Up|Adverse Event|0
5149346|NCT01474512|17785349|P9|Post-Treatment Follow-Up|Adverse Event|0
5149347|NCT01474512|17785350|P8|Post-Treatment Follow-Up|Adverse Event|0
5149348|NCT01474512|17785351|P7|Post-Treatment Follow-Up|Adverse Event|0
5149349|NCT01474512|17785352|P6|Post-Treatment Follow-Up|Adverse Event|0
5149350|NCT01474512|17785353|P5|Post-Treatment Follow-Up|Adverse Event|0
5149351|NCT01474512|17785354|P4|Post-Treatment Follow-Up|Adverse Event|0
5149352|NCT01474512|17785355|P3|Post-Treatment Follow-Up|Adverse Event|0
5149353|NCT01474512|17785356|P2|Post-Treatment Follow-Up|Adverse Event|0
5149354|NCT01474512|17785357|P1|Post-Treatment Follow-Up|Adverse Event|0
5149355|NCT01474512|17785340|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
5149356|NCT01474512|17785341|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
5149357|NCT01474512|17785342|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
5149358|NCT01474512|17785343|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
5149359|NCT01474512|17785344|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
5149360|NCT01474512|17785345|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
5149361|NCT01474512|17785346|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
5149362|NCT01474512|17785347|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
5149363|NCT01474512|17785348|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
5149364|NCT01474512|17785349|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
5149365|NCT01474512|17785350|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
5149366|NCT01474512|17785351|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
5149367|NCT01474512|17785352|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
5149368|NCT01474512|17785353|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
5149369|NCT01474512|17785354|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
5149370|NCT01474512|17785355|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
5149371|NCT01474512|17785356|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
5149372|NCT01474512|17785357|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
5149373|NCT01474512|17785340|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
5149374|NCT01474512|17785341|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
5149375|NCT01474512|17785342|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
5149376|NCT01474512|17785343|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
5149377|NCT01474512|17785344|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
5149378|NCT01474512|17785345|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
5149379|NCT01474512|17785346|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
5149380|NCT01474512|17785347|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
5149381|NCT01474512|17785348|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
5149382|NCT01474512|17785349|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
5149383|NCT01474512|17785350|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
5149384|NCT01474512|17785351|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
5149385|NCT01474512|17785352|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
5149386|NCT01474512|17785353|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
5149387|NCT01474512|17785354|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
5149388|NCT01474512|17785355|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
5149389|NCT01474512|17785356|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
5149390|NCT01474512|17785357|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
5149391|NCT01474512|17785340|P18|Long-Term Extension Period|Protocol Violation|0
5149392|NCT01474512|17785341|P17|Long-Term Extension Period|Protocol Violation|0
5149393|NCT01474512|17785342|P16|Long-Term Extension Period|Protocol Violation|0
5149394|NCT01474512|17785343|P15|Long-Term Extension Period|Protocol Violation|0
5149395|NCT01474512|17785344|P14|Long-Term Extension Period|Protocol Violation|5
5149396|NCT01474512|17785345|P13|Long-Term Extension Period|Protocol Violation|5
5149397|NCT01474512|17785346|P12|Long-Term Extension Period|Protocol Violation|0
5149398|NCT01474512|17785347|P11|Long-Term Extension Period|Protocol Violation|0
5149399|NCT01474512|17785348|P10|Long-Term Extension Period|Protocol Violation|0
5149400|NCT01474512|17785349|P9|Long-Term Extension Period|Protocol Violation|0
5149401|NCT01474512|17785350|P8|Long-Term Extension Period|Protocol Violation|0
5149402|NCT01474512|17785351|P7|Long-Term Extension Period|Protocol Violation|0
5149403|NCT01474512|17785352|P6|Long-Term Extension Period|Protocol Violation|0
5149404|NCT01474512|17785353|P5|Long-Term Extension Period|Protocol Violation|0
5149405|NCT01474512|17785354|P4|Long-Term Extension Period|Protocol Violation|0
5149406|NCT01474512|17785355|P3|Long-Term Extension Period|Protocol Violation|0
5149407|NCT01474512|17785356|P2|Long-Term Extension Period|Protocol Violation|0
5149408|NCT01474512|17785357|P1|Long-Term Extension Period|Protocol Violation|0
5149409|NCT01474512|17785340|P18|Long-Term Extension Period|Sponsor Decision|0
5149410|NCT01474512|17785341|P17|Long-Term Extension Period|Sponsor Decision|0
5149411|NCT01474512|17785342|P16|Long-Term Extension Period|Sponsor Decision|0
5149412|NCT01474512|17785343|P15|Long-Term Extension Period|Sponsor Decision|0
5149413|NCT01474512|17785344|P14|Long-Term Extension Period|Sponsor Decision|6
5149414|NCT01474512|17785345|P13|Long-Term Extension Period|Sponsor Decision|6
5149415|NCT01474512|17785346|P12|Long-Term Extension Period|Sponsor Decision|0
5149416|NCT01474512|17785347|P11|Long-Term Extension Period|Sponsor Decision|0
5149417|NCT01474512|17785348|P10|Long-Term Extension Period|Sponsor Decision|0
5149418|NCT01474512|17785349|P9|Long-Term Extension Period|Sponsor Decision|0
5149419|NCT01474512|17785350|P8|Long-Term Extension Period|Sponsor Decision|0
5149420|NCT01474512|17785351|P7|Long-Term Extension Period|Sponsor Decision|0
5149421|NCT01474512|17785352|P6|Long-Term Extension Period|Sponsor Decision|0
5149422|NCT01474512|17785353|P5|Long-Term Extension Period|Sponsor Decision|0
5149423|NCT01474512|17785354|P4|Long-Term Extension Period|Sponsor Decision|0
5149424|NCT01474512|17785355|P3|Long-Term Extension Period|Sponsor Decision|0
5149425|NCT01474512|17785356|P2|Long-Term Extension Period|Sponsor Decision|0
5149426|NCT01474512|17785357|P1|Long-Term Extension Period|Sponsor Decision|0
5149427|NCT01474512|17785340|P18|Long-Term Extension Period|Death|0
5149428|NCT01474512|17785341|P17|Long-Term Extension Period|Death|0
5149429|NCT01474512|17785342|P16|Long-Term Extension Period|Death|0
5149430|NCT01474512|17785343|P15|Long-Term Extension Period|Death|0
5149431|NCT01474512|17785344|P14|Long-Term Extension Period|Death|9
5149432|NCT01474512|17785345|P13|Long-Term Extension Period|Death|9
5149433|NCT01474512|17785346|P12|Long-Term Extension Period|Death|0
5149434|NCT01474512|17785347|P11|Long-Term Extension Period|Death|0
5149435|NCT01474512|17785348|P10|Long-Term Extension Period|Death|0
5149436|NCT01474512|17785349|P9|Long-Term Extension Period|Death|0
5149437|NCT01474512|17785350|P8|Long-Term Extension Period|Death|0
5149438|NCT01474512|17785351|P7|Long-Term Extension Period|Death|0
5149439|NCT01474512|17785352|P6|Long-Term Extension Period|Death|0
5149440|NCT01474512|17785353|P5|Long-Term Extension Period|Death|0
5149441|NCT01474512|17785354|P4|Long-Term Extension Period|Death|0
5149442|NCT01474512|17785355|P3|Long-Term Extension Period|Death|0
5149443|NCT01474512|17785356|P2|Long-Term Extension Period|Death|0
5149444|NCT01474512|17785357|P1|Long-Term Extension Period|Death|0
5149445|NCT01474512|17785340|P18|Long-Term Extension Period|Clinical Relapse|0
5149446|NCT01474512|17785341|P17|Long-Term Extension Period|Clinical Relapse|0
5149447|NCT01474512|17785342|P16|Long-Term Extension Period|Clinical Relapse|0
5149448|NCT01474512|17785343|P15|Long-Term Extension Period|Clinical Relapse|0
5149449|NCT01474512|17785344|P14|Long-Term Extension Period|Clinical Relapse|9
5149450|NCT01474512|17785345|P13|Long-Term Extension Period|Clinical Relapse|9
5149451|NCT01474512|17785346|P12|Long-Term Extension Period|Clinical Relapse|0
5149452|NCT01474512|17785347|P11|Long-Term Extension Period|Clinical Relapse|0
5149453|NCT01474512|17785348|P10|Long-Term Extension Period|Clinical Relapse|0
5149454|NCT01474512|17785349|P9|Long-Term Extension Period|Clinical Relapse|0
5149455|NCT01474512|17785350|P8|Long-Term Extension Period|Clinical Relapse|0
5149456|NCT01474512|17785351|P7|Long-Term Extension Period|Clinical Relapse|0
5149457|NCT01474512|17785352|P6|Long-Term Extension Period|Clinical Relapse|0
5149458|NCT01474512|17785353|P5|Long-Term Extension Period|Clinical Relapse|0
5149459|NCT01474512|17785354|P4|Long-Term Extension Period|Clinical Relapse|0
5149460|NCT01474512|17785355|P3|Long-Term Extension Period|Clinical Relapse|0
5149461|NCT01474512|17785356|P2|Long-Term Extension Period|Clinical Relapse|0
5149462|NCT01474512|17785357|P1|Long-Term Extension Period|Clinical Relapse|0
5149463|NCT01474512|17785340|P18|Long-Term Extension Period|Physician Decision|0
5149464|NCT01474512|17785341|P17|Long-Term Extension Period|Physician Decision|0
5149465|NCT01474512|17785342|P16|Long-Term Extension Period|Physician Decision|0
5149466|NCT01474512|17785343|P15|Long-Term Extension Period|Physician Decision|0
5149467|NCT01474512|17785344|P14|Long-Term Extension Period|Physician Decision|21
5149468|NCT01474512|17785345|P13|Long-Term Extension Period|Physician Decision|21
5149469|NCT01474512|17785346|P12|Long-Term Extension Period|Physician Decision|0
5149470|NCT01474512|17785347|P11|Long-Term Extension Period|Physician Decision|0
5149471|NCT01474512|17785348|P10|Long-Term Extension Period|Physician Decision|0
5149472|NCT01474512|17785349|P9|Long-Term Extension Period|Physician Decision|0
5149473|NCT01474512|17785350|P8|Long-Term Extension Period|Physician Decision|0
5149474|NCT01474512|17785351|P7|Long-Term Extension Period|Physician Decision|0
5149475|NCT01474512|17785352|P6|Long-Term Extension Period|Physician Decision|0
5149476|NCT01474512|17785353|P5|Long-Term Extension Period|Physician Decision|0
5149477|NCT01474512|17785354|P4|Long-Term Extension Period|Physician Decision|0
5149478|NCT01474512|17785355|P3|Long-Term Extension Period|Physician Decision|0
5149479|NCT01474512|17785356|P2|Long-Term Extension Period|Physician Decision|0
5149480|NCT01474512|17785357|P1|Long-Term Extension Period|Physician Decision|0
5149481|NCT01474512|17785340|P18|Long-Term Extension Period|Lack of Efficacy|0
5149482|NCT01474512|17785341|P17|Long-Term Extension Period|Lack of Efficacy|0
5149483|NCT01474512|17785342|P16|Long-Term Extension Period|Lack of Efficacy|0
5149484|NCT01474512|17785343|P15|Long-Term Extension Period|Lack of Efficacy|0
5149485|NCT01474512|17785344|P14|Long-Term Extension Period|Lack of Efficacy|25
5149486|NCT01474512|17785345|P13|Long-Term Extension Period|Lack of Efficacy|24
5149487|NCT01474512|17785346|P12|Long-Term Extension Period|Lack of Efficacy|1
5149488|NCT01474512|17785347|P11|Long-Term Extension Period|Lack of Efficacy|0
5149489|NCT01474512|17785348|P10|Long-Term Extension Period|Lack of Efficacy|0
5149490|NCT01474512|17785349|P9|Long-Term Extension Period|Lack of Efficacy|0
5149491|NCT01474512|17785350|P8|Long-Term Extension Period|Lack of Efficacy|0
5149492|NCT01474512|17785351|P7|Long-Term Extension Period|Lack of Efficacy|0
5149493|NCT01474512|17785352|P6|Long-Term Extension Period|Lack of Efficacy|0
5149494|NCT01474512|17785353|P5|Long-Term Extension Period|Lack of Efficacy|0
5149495|NCT01474512|17785354|P4|Long-Term Extension Period|Lack of Efficacy|0
5149496|NCT01474512|17785355|P3|Long-Term Extension Period|Lack of Efficacy|0
5149497|NCT01474512|17785356|P2|Long-Term Extension Period|Lack of Efficacy|0
5149498|NCT01474512|17785357|P1|Long-Term Extension Period|Lack of Efficacy|0
5149499|NCT01474512|17785340|P18|Long-Term Extension Period|Lost to Follow-up|0
5149500|NCT01474512|17785341|P17|Long-Term Extension Period|Lost to Follow-up|0
5149501|NCT01474512|17785342|P16|Long-Term Extension Period|Lost to Follow-up|0
5149502|NCT01474512|17785343|P15|Long-Term Extension Period|Lost to Follow-up|0
5149503|NCT01474512|17785344|P14|Long-Term Extension Period|Lost to Follow-up|25
5149504|NCT01474512|17785345|P13|Long-Term Extension Period|Lost to Follow-up|25
5149505|NCT01474512|17785346|P12|Long-Term Extension Period|Lost to Follow-up|0
5149506|NCT01474512|17785347|P11|Long-Term Extension Period|Lost to Follow-up|0
5149507|NCT01474512|17785348|P10|Long-Term Extension Period|Lost to Follow-up|0
5149508|NCT01474512|17785349|P9|Long-Term Extension Period|Lost to Follow-up|0
5149509|NCT01474512|17785350|P8|Long-Term Extension Period|Lost to Follow-up|0
5149510|NCT01474512|17785351|P7|Long-Term Extension Period|Lost to Follow-up|0
5149511|NCT01474512|17785352|P6|Long-Term Extension Period|Lost to Follow-up|0
5149512|NCT01474512|17785353|P5|Long-Term Extension Period|Lost to Follow-up|0
5149513|NCT01474512|17785354|P4|Long-Term Extension Period|Lost to Follow-up|0
5149514|NCT01474512|17785355|P3|Long-Term Extension Period|Lost to Follow-up|0
5149515|NCT01474512|17785356|P2|Long-Term Extension Period|Lost to Follow-up|0
5149516|NCT01474512|17785357|P1|Long-Term Extension Period|Lost to Follow-up|0
5149517|NCT01474512|17785340|P18|Long-Term Extension Period|Adverse Event|0
5149518|NCT01474512|17785341|P17|Long-Term Extension Period|Adverse Event|0
5149519|NCT01474512|17785342|P16|Long-Term Extension Period|Adverse Event|0
5149520|NCT01474512|17785343|P15|Long-Term Extension Period|Adverse Event|0
5149521|NCT01474512|17785344|P14|Long-Term Extension Period|Adverse Event|58
5149522|NCT01474512|17785345|P13|Long-Term Extension Period|Adverse Event|57
5149523|NCT01474512|17785346|P12|Long-Term Extension Period|Adverse Event|1
5149524|NCT01474512|17785347|P11|Long-Term Extension Period|Adverse Event|0
5149525|NCT01474512|17785348|P10|Long-Term Extension Period|Adverse Event|0
5149526|NCT01474512|17785349|P9|Long-Term Extension Period|Adverse Event|0
5149527|NCT01474512|17785350|P8|Long-Term Extension Period|Adverse Event|0
5149528|NCT01474512|17785351|P7|Long-Term Extension Period|Adverse Event|0
5149529|NCT01474512|17785352|P6|Long-Term Extension Period|Adverse Event|0
5149530|NCT01474512|17785353|P5|Long-Term Extension Period|Adverse Event|0
5149531|NCT01474512|17785354|P4|Long-Term Extension Period|Adverse Event|0
5149532|NCT01474512|17785355|P3|Long-Term Extension Period|Adverse Event|0
5149533|NCT01474512|17785356|P2|Long-Term Extension Period|Adverse Event|0
5149534|NCT01474512|17785357|P1|Long-Term Extension Period|Adverse Event|0
5149535|NCT01474512|17785340|P18|Long-Term Extension Period|Withdrawal by Subject|0
5149536|NCT01474512|17785341|P17|Long-Term Extension Period|Withdrawal by Subject|0
5149537|NCT01474512|17785342|P16|Long-Term Extension Period|Withdrawal by Subject|0
5149538|NCT01474512|17785343|P15|Long-Term Extension Period|Withdrawal by Subject|0
5149539|NCT01474512|17785344|P14|Long-Term Extension Period|Withdrawal by Subject|61
5149540|NCT01474512|17785345|P13|Long-Term Extension Period|Withdrawal by Subject|61
5149541|NCT01474512|17785346|P12|Long-Term Extension Period|Withdrawal by Subject|3
5149542|NCT01474512|17785347|P11|Long-Term Extension Period|Withdrawal by Subject|0
5149543|NCT01474512|17785348|P10|Long-Term Extension Period|Withdrawal by Subject|0
5149544|NCT01474512|17785349|P9|Long-Term Extension Period|Withdrawal by Subject|0
5149545|NCT01474512|17785350|P8|Long-Term Extension Period|Withdrawal by Subject|0
5149546|NCT01474512|17785351|P7|Long-Term Extension Period|Withdrawal by Subject|0
5149547|NCT01474512|17785352|P6|Long-Term Extension Period|Withdrawal by Subject|0
5149548|NCT01474512|17785353|P5|Long-Term Extension Period|Withdrawal by Subject|0
5149549|NCT01474512|17785354|P4|Long-Term Extension Period|Withdrawal by Subject|0
5149550|NCT01474512|17785355|P3|Long-Term Extension Period|Withdrawal by Subject|0
5149551|NCT01474512|17785356|P2|Long-Term Extension Period|Withdrawal by Subject|0
5149552|NCT01474512|17785357|P1|Long-Term Extension Period|Withdrawal by Subject|0
5149553|NCT01474512|17785340|P18|Maintenance Period|Treated but Discontinued in Induction|0
5149554|NCT01474512|17785341|P17|Maintenance Period|Treated but Discontinued in Induction|0
5149555|NCT01474512|17785342|P16|Maintenance Period|Treated but Discontinued in Induction|0
5149556|NCT01474512|17785343|P15|Maintenance Period|Treated but Discontinued in Induction|0
5149557|NCT01474512|17785344|P14|Maintenance Period|Treated but Discontinued in Induction|0
5149558|NCT01474512|17785345|P13|Maintenance Period|Treated but Discontinued in Induction|0
5149559|NCT01474512|17785346|P12|Maintenance Period|Treated but Discontinued in Induction|0
5149560|NCT01474512|17785347|P11|Maintenance Period|Treated but Discontinued in Induction|0
5149561|NCT01474512|17785348|P10|Maintenance Period|Treated but Discontinued in Induction|0
5149562|NCT01474512|17785349|P9|Maintenance Period|Treated but Discontinued in Induction|0
5149563|NCT01474512|17785350|P8|Maintenance Period|Treated but Discontinued in Induction|0
5149564|NCT01474512|17785351|P7|Maintenance Period|Treated but Discontinued in Induction|0
5149565|NCT01474512|17785352|P6|Maintenance Period|Treated but Discontinued in Induction|0
5149566|NCT01474512|17785353|P5|Maintenance Period|Treated but Discontinued in Induction|1
5149567|NCT01474512|17785354|P4|Maintenance Period|Treated but Discontinued in Induction|0
5149568|NCT01474512|17785355|P3|Maintenance Period|Treated but Discontinued in Induction|0
5149569|NCT01474512|17785356|P2|Maintenance Period|Treated but Discontinued in Induction|0
5149570|NCT01474512|17785357|P1|Maintenance Period|Treated but Discontinued in Induction|0
5149571|NCT01474512|17785340|P18|Maintenance Period|Protocol Violation|0
5149572|NCT01474512|17785341|P17|Maintenance Period|Protocol Violation|0
5149573|NCT01474512|17785342|P16|Maintenance Period|Protocol Violation|0
5149574|NCT01474512|17785343|P15|Maintenance Period|Protocol Violation|0
5149575|NCT01474512|17785344|P14|Maintenance Period|Protocol Violation|0
5149576|NCT01474512|17785345|P13|Maintenance Period|Protocol Violation|0
5149577|NCT01474512|17785346|P12|Maintenance Period|Protocol Violation|0
5149578|NCT01474512|17785347|P11|Maintenance Period|Protocol Violation|0
5149579|NCT01474512|17785348|P10|Maintenance Period|Protocol Violation|1
5149580|NCT01474512|17785349|P9|Maintenance Period|Protocol Violation|0
5149581|NCT01474512|17785350|P8|Maintenance Period|Protocol Violation|1
5149582|NCT01474512|17785351|P7|Maintenance Period|Protocol Violation|0
5149583|NCT01474512|17785352|P6|Maintenance Period|Protocol Violation|0
5149584|NCT01474512|17785353|P5|Maintenance Period|Protocol Violation|0
5149585|NCT01474512|17785354|P4|Maintenance Period|Protocol Violation|1
5149586|NCT01474512|17785355|P3|Maintenance Period|Protocol Violation|0
5149587|NCT01474512|17785356|P2|Maintenance Period|Protocol Violation|0
5149588|NCT01474512|17785357|P1|Maintenance Period|Protocol Violation|0
5149589|NCT01474512|17785340|P18|Maintenance Period|Lack of Efficacy|0
5149590|NCT01474512|17785341|P17|Maintenance Period|Lack of Efficacy|0
5149591|NCT01474512|17785342|P16|Maintenance Period|Lack of Efficacy|0
5149592|NCT01474512|17785343|P15|Maintenance Period|Lack of Efficacy|0
5149593|NCT01474512|17785344|P14|Maintenance Period|Lack of Efficacy|0
5149594|NCT01474512|17785345|P13|Maintenance Period|Lack of Efficacy|0
5149595|NCT01474512|17785346|P12|Maintenance Period|Lack of Efficacy|0
5149596|NCT01474512|17785347|P11|Maintenance Period|Lack of Efficacy|0
5149597|NCT01474512|17785348|P10|Maintenance Period|Lack of Efficacy|12
5149598|NCT01474512|17785349|P9|Maintenance Period|Lack of Efficacy|11
5149599|NCT01474512|17785350|P8|Maintenance Period|Lack of Efficacy|11
5149600|NCT01474512|17785351|P7|Maintenance Period|Lack of Efficacy|0
5149601|NCT01474512|17785352|P6|Maintenance Period|Lack of Efficacy|0
5149602|NCT01474512|17785353|P5|Maintenance Period|Lack of Efficacy|0
5149603|NCT01474512|17785354|P4|Maintenance Period|Lack of Efficacy|1
5149604|NCT01474512|17785355|P3|Maintenance Period|Lack of Efficacy|0
5149605|NCT01474512|17785356|P2|Maintenance Period|Lack of Efficacy|0
5149606|NCT01474512|17785357|P1|Maintenance Period|Lack of Efficacy|0
5149607|NCT01474512|17785340|P18|Maintenance Period|Clinical Relapse|0
5149608|NCT01474512|17785341|P17|Maintenance Period|Clinical Relapse|0
5149609|NCT01474512|17785342|P16|Maintenance Period|Clinical Relapse|0
5149610|NCT01474512|17785343|P15|Maintenance Period|Clinical Relapse|0
5149611|NCT01474512|17785344|P14|Maintenance Period|Clinical Relapse|0
5149612|NCT01474512|17785345|P13|Maintenance Period|Clinical Relapse|0
5149613|NCT01474512|17785346|P12|Maintenance Period|Clinical Relapse|0
5149614|NCT01474512|17785347|P11|Maintenance Period|Clinical Relapse|0
5149615|NCT01474512|17785348|P10|Maintenance Period|Clinical Relapse|0
5149616|NCT01474512|17785349|P9|Maintenance Period|Clinical Relapse|0
5149617|NCT01474512|17785350|P8|Maintenance Period|Clinical Relapse|0
5149618|NCT01474512|17785351|P7|Maintenance Period|Clinical Relapse|0
5149619|NCT01474512|17785352|P6|Maintenance Period|Clinical Relapse|0
5149620|NCT01474512|17785353|P5|Maintenance Period|Clinical Relapse|0
5149621|NCT01474512|17785354|P4|Maintenance Period|Clinical Relapse|1
5149622|NCT01474512|17785355|P3|Maintenance Period|Clinical Relapse|0
5149623|NCT01474512|17785356|P2|Maintenance Period|Clinical Relapse|0
5149624|NCT01474512|17785357|P1|Maintenance Period|Clinical Relapse|0
5149625|NCT01474512|17785340|P18|Maintenance Period|Physician Decision|0
5149626|NCT01474512|17785341|P17|Maintenance Period|Physician Decision|0
5149627|NCT01474512|17785342|P16|Maintenance Period|Physician Decision|0
5149628|NCT01474512|17785343|P15|Maintenance Period|Physician Decision|0
5149629|NCT01474512|17785344|P14|Maintenance Period|Physician Decision|0
5149630|NCT01474512|17785345|P13|Maintenance Period|Physician Decision|0
5149631|NCT01474512|17785346|P12|Maintenance Period|Physician Decision|0
5149632|NCT01474512|17785347|P11|Maintenance Period|Physician Decision|0
5149633|NCT01474512|17785348|P10|Maintenance Period|Physician Decision|0
5149634|NCT01474512|17785349|P9|Maintenance Period|Physician Decision|0
5149635|NCT01474512|17785350|P8|Maintenance Period|Physician Decision|2
5149636|NCT01474512|17785351|P7|Maintenance Period|Physician Decision|0
5149637|NCT01474512|17785352|P6|Maintenance Period|Physician Decision|1
5149638|NCT01474512|17785353|P5|Maintenance Period|Physician Decision|0
5149639|NCT01474512|17785354|P4|Maintenance Period|Physician Decision|0
5149640|NCT01474512|17785355|P3|Maintenance Period|Physician Decision|0
5149641|NCT01474512|17785356|P2|Maintenance Period|Physician Decision|0
5149642|NCT01474512|17785357|P1|Maintenance Period|Physician Decision|0
5149643|NCT01474512|17785340|P18|Maintenance Period|Death|0
5149644|NCT01474512|17785341|P17|Maintenance Period|Death|0
5149645|NCT01474512|17785342|P16|Maintenance Period|Death|0
5149646|NCT01474512|17785343|P15|Maintenance Period|Death|0
5149647|NCT01474512|17785344|P14|Maintenance Period|Death|0
5149648|NCT01474512|17785345|P13|Maintenance Period|Death|0
5149649|NCT01474512|17785346|P12|Maintenance Period|Death|0
5149650|NCT01474512|17785347|P11|Maintenance Period|Death|0
5149651|NCT01474512|17785348|P10|Maintenance Period|Death|0
5149652|NCT01474512|17785349|P9|Maintenance Period|Death|0
5149653|NCT01474512|17785350|P8|Maintenance Period|Death|0
5149654|NCT01474512|17785351|P7|Maintenance Period|Death|0
5149655|NCT01474512|17785352|P6|Maintenance Period|Death|2
5149656|NCT01474512|17785353|P5|Maintenance Period|Death|0
5149657|NCT01474512|17785354|P4|Maintenance Period|Death|0
5149658|NCT01474512|17785355|P3|Maintenance Period|Death|0
5149659|NCT01474512|17785356|P2|Maintenance Period|Death|0
5149660|NCT01474512|17785357|P1|Maintenance Period|Death|0
5149661|NCT01474512|17785340|P18|Maintenance Period|Lost to Follow-up|0
5149662|NCT01474512|17785341|P17|Maintenance Period|Lost to Follow-up|0
5149663|NCT01474512|17785342|P16|Maintenance Period|Lost to Follow-up|0
5149664|NCT01474512|17785343|P15|Maintenance Period|Lost to Follow-up|0
5149665|NCT01474512|17785344|P14|Maintenance Period|Lost to Follow-up|0
5149666|NCT01474512|17785345|P13|Maintenance Period|Lost to Follow-up|0
5149667|NCT01474512|17785346|P12|Maintenance Period|Lost to Follow-up|0
5149668|NCT01474512|17785347|P11|Maintenance Period|Lost to Follow-up|0
5149669|NCT01474512|17785348|P10|Maintenance Period|Lost to Follow-up|1
5149670|NCT01474512|17785349|P9|Maintenance Period|Lost to Follow-up|1
5149671|NCT01474512|17785350|P8|Maintenance Period|Lost to Follow-up|2
5149672|NCT01474512|17785351|P7|Maintenance Period|Lost to Follow-up|0
5149673|NCT01474512|17785352|P6|Maintenance Period|Lost to Follow-up|0
5149674|NCT01474512|17785353|P5|Maintenance Period|Lost to Follow-up|3
5149675|NCT01474512|17785354|P4|Maintenance Period|Lost to Follow-up|3
5149676|NCT01474512|17785355|P3|Maintenance Period|Lost to Follow-up|0
5149677|NCT01474512|17785356|P2|Maintenance Period|Lost to Follow-up|0
5149678|NCT01474512|17785357|P1|Maintenance Period|Lost to Follow-up|0
5149679|NCT01474512|17785340|P18|Maintenance Period|Withdrawal by Subject|0
5149680|NCT01474512|17785341|P17|Maintenance Period|Withdrawal by Subject|0
5149681|NCT01474512|17785342|P16|Maintenance Period|Withdrawal by Subject|0
5149682|NCT01474512|17785343|P15|Maintenance Period|Withdrawal by Subject|0
5149683|NCT01474512|17785344|P14|Maintenance Period|Withdrawal by Subject|0
5149684|NCT01474512|17785345|P13|Maintenance Period|Withdrawal by Subject|0
5149685|NCT01474512|17785346|P12|Maintenance Period|Withdrawal by Subject|0
5149686|NCT01474512|17785347|P11|Maintenance Period|Withdrawal by Subject|0
5149687|NCT01474512|17785348|P10|Maintenance Period|Withdrawal by Subject|1
5149688|NCT01474512|17785349|P9|Maintenance Period|Withdrawal by Subject|3
5149689|NCT01474512|17785350|P8|Maintenance Period|Withdrawal by Subject|6
5149690|NCT01474512|17785351|P7|Maintenance Period|Withdrawal by Subject|1
5149691|NCT01474512|17785352|P6|Maintenance Period|Withdrawal by Subject|3
5149692|NCT01474512|17785353|P5|Maintenance Period|Withdrawal by Subject|2
5149693|NCT01474512|17785354|P4|Maintenance Period|Withdrawal by Subject|6
5149694|NCT01474512|17785355|P3|Maintenance Period|Withdrawal by Subject|0
5149695|NCT01474512|17785356|P2|Maintenance Period|Withdrawal by Subject|0
5149696|NCT01474512|17785357|P1|Maintenance Period|Withdrawal by Subject|0
5149697|NCT01474512|17785340|P18|Maintenance Period|Adverse Event|0
5149698|NCT01474512|17785341|P17|Maintenance Period|Adverse Event|0
5149699|NCT01474512|17785342|P16|Maintenance Period|Adverse Event|0
5149700|NCT01474512|17785343|P15|Maintenance Period|Adverse Event|0
5149701|NCT01474512|17785344|P14|Maintenance Period|Adverse Event|0
5149702|NCT01474512|17785345|P13|Maintenance Period|Adverse Event|0
5149703|NCT01474512|17785346|P12|Maintenance Period|Adverse Event|0
5149704|NCT01474512|17785347|P11|Maintenance Period|Adverse Event|0
5149705|NCT01474512|17785348|P10|Maintenance Period|Adverse Event|3
5149706|NCT01474512|17785349|P9|Maintenance Period|Adverse Event|1
5149707|NCT01474512|17785350|P8|Maintenance Period|Adverse Event|19
5149708|NCT01474512|17785351|P7|Maintenance Period|Adverse Event|0
5149709|NCT01474512|17785352|P6|Maintenance Period|Adverse Event|7
5149710|NCT01474512|17785353|P5|Maintenance Period|Adverse Event|2
5149711|NCT01474512|17785354|P4|Maintenance Period|Adverse Event|4
5149712|NCT01474512|17785355|P3|Maintenance Period|Adverse Event|0
5149713|NCT01474512|17785356|P2|Maintenance Period|Adverse Event|0
5149714|NCT01474512|17785357|P1|Maintenance Period|Adverse Event|0
5149715|NCT01474512|17785340|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
5149716|NCT01474512|17785341|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
5149717|NCT01474512|17785342|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
5149718|NCT01474512|17785343|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
5149719|NCT01474512|17785344|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
5149720|NCT01474512|17785345|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
5149721|NCT01474512|17785346|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
5149722|NCT01474512|17785347|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
5149723|NCT01474512|17785348|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
5149724|NCT01474512|17785349|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
5149725|NCT01474512|17785350|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
5149726|NCT01474512|17785351|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
5149727|NCT01474512|17785352|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
5149728|NCT01474512|17785353|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
5149729|NCT01474512|17785354|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
5149730|NCT01474512|17785355|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
5149731|NCT01474512|17785356|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
5149732|NCT01474512|17785357|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
5149733|NCT01474512|17785340|P18|Induction Period|Lost to Follow-up|0
5149734|NCT01474512|17785341|P17|Induction Period|Lost to Follow-up|0
5149735|NCT01474512|17785342|P16|Induction Period|Lost to Follow-up|0
5149736|NCT01474512|17785343|P15|Induction Period|Lost to Follow-up|0
5149737|NCT01474512|17785344|P14|Induction Period|Lost to Follow-up|0
5149738|NCT01474512|17785345|P13|Induction Period|Lost to Follow-up|0
5149739|NCT01474512|17785346|P12|Induction Period|Lost to Follow-up|0
5149740|NCT01474512|17785347|P11|Induction Period|Lost to Follow-up|0
5149741|NCT01474512|17785348|P10|Induction Period|Lost to Follow-up|0
5149742|NCT01474512|17785349|P9|Induction Period|Lost to Follow-up|0
5149743|NCT01474512|17785350|P8|Induction Period|Lost to Follow-up|0
5149744|NCT01474512|17785351|P7|Induction Period|Lost to Follow-up|0
5149745|NCT01474512|17785352|P6|Induction Period|Lost to Follow-up|0
5149746|NCT01474512|17785353|P5|Induction Period|Lost to Follow-up|0
5149747|NCT01474512|17785354|P4|Induction Period|Lost to Follow-up|0
5149748|NCT01474512|17785355|P3|Induction Period|Lost to Follow-up|2
5149749|NCT01474512|17785356|P2|Induction Period|Lost to Follow-up|0
5149750|NCT01474512|17785357|P1|Induction Period|Lost to Follow-up|1
5149751|NCT01474512|17785340|P18|Induction Period|Sponsor Decision|0
5149752|NCT01474512|17785341|P17|Induction Period|Sponsor Decision|0
5149753|NCT01474512|17785342|P16|Induction Period|Sponsor Decision|0
5149754|NCT01474512|17785343|P15|Induction Period|Sponsor Decision|0
5149755|NCT01474512|17785344|P14|Induction Period|Sponsor Decision|0
5149756|NCT01474512|17785345|P13|Induction Period|Sponsor Decision|0
5149757|NCT01474512|17785346|P12|Induction Period|Sponsor Decision|0
5149758|NCT01474512|17785347|P11|Induction Period|Sponsor Decision|0
5149759|NCT01474512|17785348|P10|Induction Period|Sponsor Decision|0
5149760|NCT01474512|17785349|P9|Induction Period|Sponsor Decision|0
5149761|NCT01474512|17785350|P8|Induction Period|Sponsor Decision|0
5149762|NCT01474512|17785351|P7|Induction Period|Sponsor Decision|0
5149763|NCT01474512|17785352|P6|Induction Period|Sponsor Decision|0
5149764|NCT01474512|17785353|P5|Induction Period|Sponsor Decision|0
5149765|NCT01474512|17785354|P4|Induction Period|Sponsor Decision|0
5149766|NCT01474512|17785355|P3|Induction Period|Sponsor Decision|1
5149767|NCT01474512|17785356|P2|Induction Period|Sponsor Decision|1
5149768|NCT01474512|17785357|P1|Induction Period|Sponsor Decision|1
5149769|NCT01474512|17785340|P18|Induction Period|Protocol Violation|0
5149770|NCT01474512|17785341|P17|Induction Period|Protocol Violation|0
5149771|NCT01474512|17785342|P16|Induction Period|Protocol Violation|0
5149772|NCT01474512|17785343|P15|Induction Period|Protocol Violation|0
5149773|NCT01474512|17785344|P14|Induction Period|Protocol Violation|0
5149774|NCT01474512|17785345|P13|Induction Period|Protocol Violation|0
5149775|NCT01474512|17785346|P12|Induction Period|Protocol Violation|0
5149776|NCT01474512|17785347|P11|Induction Period|Protocol Violation|0
5149777|NCT01474512|17785348|P10|Induction Period|Protocol Violation|0
5149778|NCT01474512|17785349|P9|Induction Period|Protocol Violation|0
5149779|NCT01474512|17785350|P8|Induction Period|Protocol Violation|0
5149780|NCT01474512|17785351|P7|Induction Period|Protocol Violation|0
5149781|NCT01474512|17785352|P6|Induction Period|Protocol Violation|0
5149782|NCT01474512|17785353|P5|Induction Period|Protocol Violation|0
5149783|NCT01474512|17785354|P4|Induction Period|Protocol Violation|0
5149784|NCT01474512|17785355|P3|Induction Period|Protocol Violation|0
5149785|NCT01474512|17785356|P2|Induction Period|Protocol Violation|6
5149786|NCT01474512|17785357|P1|Induction Period|Protocol Violation|3
5149787|NCT01474512|17785340|P18|Induction Period|Withdrawal by Subject|0
5149788|NCT01474512|17785341|P17|Induction Period|Withdrawal by Subject|0
5149789|NCT01474512|17785342|P16|Induction Period|Withdrawal by Subject|0
5149790|NCT01474512|17785343|P15|Induction Period|Withdrawal by Subject|0
5149791|NCT01474512|17785344|P14|Induction Period|Withdrawal by Subject|0
5149792|NCT01474512|17785345|P13|Induction Period|Withdrawal by Subject|0
5149793|NCT01474512|17785346|P12|Induction Period|Withdrawal by Subject|0
5149794|NCT01474512|17785347|P11|Induction Period|Withdrawal by Subject|0
5149795|NCT01474512|17785348|P10|Induction Period|Withdrawal by Subject|0
5149796|NCT01474512|17785349|P9|Induction Period|Withdrawal by Subject|0
5149797|NCT01474512|17785350|P8|Induction Period|Withdrawal by Subject|0
5149798|NCT01474512|17785351|P7|Induction Period|Withdrawal by Subject|0
5149799|NCT01474512|17785352|P6|Induction Period|Withdrawal by Subject|0
5149800|NCT01474512|17785353|P5|Induction Period|Withdrawal by Subject|0
5149801|NCT01474512|17785354|P4|Induction Period|Withdrawal by Subject|0
5149802|NCT01474512|17785355|P3|Induction Period|Withdrawal by Subject|5
5149803|NCT01474512|17785356|P2|Induction Period|Withdrawal by Subject|6
5149804|NCT01474512|17785357|P1|Induction Period|Withdrawal by Subject|6
5149805|NCT01474512|17785340|P18|Induction Period|Lack of Efficacy|0
5149806|NCT01474512|17785341|P17|Induction Period|Lack of Efficacy|0
5149807|NCT01474512|17785342|P16|Induction Period|Lack of Efficacy|0
5149808|NCT01474512|17785343|P15|Induction Period|Lack of Efficacy|0
5149809|NCT01474512|17785344|P14|Induction Period|Lack of Efficacy|0
5149810|NCT01474512|17785345|P13|Induction Period|Lack of Efficacy|0
5149811|NCT01474512|17785346|P12|Induction Period|Lack of Efficacy|0
5149812|NCT01474512|17785347|P11|Induction Period|Lack of Efficacy|0
5149813|NCT01474512|17785348|P10|Induction Period|Lack of Efficacy|0
5149814|NCT01474512|17785349|P9|Induction Period|Lack of Efficacy|0
5149815|NCT01474512|17785350|P8|Induction Period|Lack of Efficacy|0
5149816|NCT01474512|17785351|P7|Induction Period|Lack of Efficacy|0
5149817|NCT01474512|17785352|P6|Induction Period|Lack of Efficacy|0
5149818|NCT01474512|17785353|P5|Induction Period|Lack of Efficacy|0
5149819|NCT01474512|17785354|P4|Induction Period|Lack of Efficacy|0
5149820|NCT01474512|17785355|P3|Induction Period|Lack of Efficacy|0
5149821|NCT01474512|17785356|P2|Induction Period|Lack of Efficacy|1
5149822|NCT01474512|17785357|P1|Induction Period|Lack of Efficacy|7
5149823|NCT01474512|17785340|P18|Induction Period|Adverse Event|0
5149824|NCT01474512|17785341|P17|Induction Period|Adverse Event|0
5149825|NCT01474512|17785342|P16|Induction Period|Adverse Event|0
5149826|NCT01474512|17785343|P15|Induction Period|Adverse Event|0
5149827|NCT01474512|17785344|P14|Induction Period|Adverse Event|0
5149828|NCT01474512|17785345|P13|Induction Period|Adverse Event|0
5149829|NCT01474512|17785346|P12|Induction Period|Adverse Event|0
5149830|NCT01474512|17785347|P11|Induction Period|Adverse Event|0
5149831|NCT01474512|17785348|P10|Induction Period|Adverse Event|0
5149832|NCT01474512|17785349|P9|Induction Period|Adverse Event|0
5149833|NCT01474512|17785350|P8|Induction Period|Adverse Event|0
5149834|NCT01474512|17785351|P7|Induction Period|Adverse Event|0
5149835|NCT01474512|17785352|P6|Induction Period|Adverse Event|0
5149836|NCT01474512|17785353|P5|Induction Period|Adverse Event|0
5149837|NCT01474512|17785354|P4|Induction Period|Adverse Event|0
5149838|NCT01474512|17785355|P3|Induction Period|Adverse Event|10
5149839|NCT01474512|17785356|P2|Induction Period|Adverse Event|10
5149840|NCT01474512|17785357|P1|Induction Period|Adverse Event|6
5149928|NCT01473589|17786017|P2|Overall Study|Withdrawal by Subject|11
5149841|NCT01474434|17785433|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5149842|NCT01474434|17785434|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5149843|NCT01474434|17785435|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5149844|NCT01474434|17785436|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
5149845|NCT01474434|17785433|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
5149846|NCT01474434|17785434|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5149847|NCT01474434|17785435|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5149848|NCT01474434|17785436|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5149849|NCT01474434|17785433|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
5149850|NCT01474434|17785434|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
5149851|NCT01474434|17785435|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
5149852|NCT01474434|17785436|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
5149853|NCT01474317|17785478|P1|Overall Study|Subject ineligible for study|1
5149854|NCT01474317|17785478|P1|Overall Study|Adverse Event|1
5149855|NCT01474291|17785487|P1|Overall Study|Death|2
5149856|NCT01474291|17785487|P1|Overall Study|No Reason Reported|10
5149857|NCT01474291|17785487|P1|Overall Study|Patient No Longer Wanted to Participate|12
5149858|NCT01474291|17785487|P1|Overall Study|Lost to Follow-up|29
5149859|NCT01474291|17785487|P1|Overall Study|Adverse Event|53
5149860|NCT01474291|17785487|P1|Overall Study|Lack of Treatment Efficacy|88
5149861|NCT01474291|17785487|P1|Overall Study|Not Evaluable for Efficacy|26
5149862|NCT01474239|17785531|P2|Overall Study|Withdrawal for Economic Reason|0
5149863|NCT01474239|17785532|P1|Overall Study|Withdrawal for Economic Reason|1
5149864|NCT01474239|17785531|P2|Overall Study|Clinical Disease Progression|1
5149865|NCT01474239|17785532|P1|Overall Study|Clinical Disease Progression|7
5149866|NCT01474239|17785531|P2|Overall Study|Death|1
5149867|NCT01474239|17785532|P1|Overall Study|Death|1
5149868|NCT01474239|17785531|P2|Overall Study|Withdrawal by Subject|2
5149869|NCT01474239|17785532|P1|Overall Study|Withdrawal by Subject|1
5149870|NCT01474239|17785531|P2|Overall Study|Adverse Event|3
5149871|NCT01474239|17785532|P1|Overall Study|Adverse Event|12
5149872|NCT01474239|17785531|P2|Overall Study|Disease Progression|25
5149873|NCT01474239|17785532|P1|Overall Study|Disease Progression|37
5149874|NCT01474018|17785704|P2|Overall Study|Withdrawal by Subject|2
5149875|NCT01474018|17785705|P1|Overall Study|Withdrawal by Subject|0
5149876|NCT01474018|17785704|P2|Overall Study|Lost to Follow-up|1
5149877|NCT01474018|17785705|P1|Overall Study|Lost to Follow-up|0
5149878|NCT01473953|17785737|P5|Overall Study|Other|0
5149879|NCT01473953|17785738|P4|Overall Study|Other|0
5149880|NCT01473953|17785739|P3|Overall Study|Other|0
5149881|NCT01473953|17785740|P2|Overall Study|Other|0
5149882|NCT01473953|17785741|P1|Overall Study|Other|1
5149883|NCT01473940|17785787|P4|Maintenance Therapy|Progressive Disease|4
5149884|NCT01473940|17785788|P3|Maintenance Therapy|Progressive Disease|1
5149885|NCT01473940|17785789|P2|Maintenance Therapy|Progressive Disease|2
5149886|NCT01473940|17785790|P1|Maintenance Therapy|Progressive Disease|1
5149887|NCT01473940|17785787|P4|Induction Therapy|Progressive Disease|0
5149888|NCT01473940|17785788|P3|Induction Therapy|Progressive Disease|1
5149889|NCT01473940|17785789|P2|Induction Therapy|Progressive Disease|1
5149890|NCT01473940|17785790|P1|Induction Therapy|Progressive Disease|0
5149891|NCT01473940|17785787|P4|Induction Therapy|Death|1
5149892|NCT01473940|17785788|P3|Induction Therapy|Death|1
5149893|NCT01473940|17785789|P2|Induction Therapy|Death|0
5149894|NCT01473940|17785790|P1|Induction Therapy|Death|0
5149895|NCT01473836|17785820|P1|Overall Study|Does not meet entrance criteria|1
5149896|NCT01473836|17785820|P1|Overall Study|Lack of Efficacy|1
5149897|NCT01473836|17785820|P1|Overall Study|Adverse Event|4
5149898|NCT01473758|17785831|P4|Cycle 2|Adverse Event|0
5149899|NCT01473758|17785832|P3|Cycle 2|Adverse Event|5
5149900|NCT01473758|17785833|P2|Cycle 2|Adverse Event|0
5149901|NCT01473758|17785834|P1|Cycle 2|Adverse Event|0
5149902|NCT01473758|17785831|P4|Cycle 1|Withdrawal by Subject|0
5149903|NCT01473758|17785832|P3|Cycle 1|Withdrawal by Subject|0
5149904|NCT01473758|17785833|P2|Cycle 1|Withdrawal by Subject|1
5149905|NCT01473758|17785834|P1|Cycle 1|Withdrawal by Subject|1
5149906|NCT01473758|17785831|P4|Cycle 1|Adverse Event|0
5149907|NCT01473758|17785832|P3|Cycle 1|Adverse Event|0
5149908|NCT01473758|17785833|P2|Cycle 1|Adverse Event|2
5149909|NCT01473758|17785834|P1|Cycle 1|Adverse Event|10
5149910|NCT01473732|17785971|P2|Overall Study|Death|0
5149911|NCT01473732|17785972|P1|Overall Study|Death|1
5149912|NCT01473732|17785971|P2|Overall Study|Adverse Event|0
5149913|NCT01473732|17785972|P1|Overall Study|Adverse Event|1
5149914|NCT01473602|17785980|P2|Overall Study|Physician Decision|0
5149915|NCT01473602|17785981|P1|Overall Study|Physician Decision|1
5149916|NCT01473602|17785980|P2|Overall Study|Withdrawal by Subject|4
5149917|NCT01473602|17785981|P1|Overall Study|Withdrawal by Subject|5
5149918|NCT01473602|17785980|P2|Overall Study|Lost to Follow-up|1
5149919|NCT01473602|17785981|P1|Overall Study|Lost to Follow-up|1
5149920|NCT01473602|17785980|P2|Overall Study|Death|1
5149921|NCT01473602|17785981|P1|Overall Study|Death|0
5149922|NCT01473602|17785980|P2|Overall Study|Adverse Event|2
5149923|NCT01473602|17785981|P1|Overall Study|Adverse Event|1
5149924|NCT01473589|17786017|P2|Overall Study|Entry criteria not met|1
5149925|NCT01473589|17786018|P1|Overall Study|Entry criteria not met|0
5149926|NCT01473589|17786017|P2|Overall Study|Physician Decision|1
5149927|NCT01473589|17786018|P1|Overall Study|Physician Decision|0
5149929|NCT01473589|17786018|P1|Overall Study|Withdrawal by Subject|5
5149930|NCT01473589|17786017|P2|Overall Study|Protocol Violation|0
5149931|NCT01473589|17786018|P1|Overall Study|Protocol Violation|1
5149932|NCT01473589|17786017|P2|Overall Study|Lost to Follow-up|2
5149933|NCT01473589|17786018|P1|Overall Study|Lost to Follow-up|2
5149934|NCT01473589|17786017|P2|Overall Study|Death|0
5149935|NCT01473589|17786018|P1|Overall Study|Death|2
5149936|NCT01473589|17786017|P2|Overall Study|Adverse Event|1
5149937|NCT01473589|17786018|P1|Overall Study|Adverse Event|1
5149938|NCT01473563|17786052|P1|Overall Study|Lost to FU post tx discontinuation|1
5149939|NCT01473524|17786074|P6|LTSE Phase|Protocol Violation|1
5149940|NCT01473524|17786075|P5|LTSE Phase|Protocol Violation|0
5149941|NCT01473524|17786076|P4|LTSE Phase|Protocol Violation|0
5149942|NCT01473524|17786077|P3|LTSE Phase|Protocol Violation|0
5149943|NCT01473524|17786078|P2|LTSE Phase|Protocol Violation|0
5149944|NCT01473524|17786079|P1|LTSE Phase|Protocol Violation|0
5149945|NCT01473524|17786074|P6|LTSE Phase|Pregnancy|0
5149946|NCT01473524|17786075|P5|LTSE Phase|Pregnancy|0
5149947|NCT01473524|17786076|P4|LTSE Phase|Pregnancy|1
5149948|NCT01473524|17786077|P3|LTSE Phase|Pregnancy|0
5149949|NCT01473524|17786078|P2|LTSE Phase|Pregnancy|0
5149950|NCT01473524|17786079|P1|LTSE Phase|Pregnancy|0
5149951|NCT01473524|17786074|P6|LTSE Phase|Liver Transplantation|1
5149952|NCT01473524|17786075|P5|LTSE Phase|Liver Transplantation|0
5149953|NCT01473524|17786076|P4|LTSE Phase|Liver Transplantation|0
5149954|NCT01473524|17786077|P3|LTSE Phase|Liver Transplantation|0
5149955|NCT01473524|17786078|P2|LTSE Phase|Liver Transplantation|0
5149956|NCT01473524|17786079|P1|LTSE Phase|Liver Transplantation|0
5149957|NCT01473524|17786074|P6|LTSE Phase|Principal Investigator Decision|3
5149958|NCT01473524|17786075|P5|LTSE Phase|Principal Investigator Decision|1
5149959|NCT01473524|17786076|P4|LTSE Phase|Principal Investigator Decision|1
5149960|NCT01473524|17786077|P3|LTSE Phase|Principal Investigator Decision|0
5149961|NCT01473524|17786078|P2|LTSE Phase|Principal Investigator Decision|0
5149962|NCT01473524|17786079|P1|LTSE Phase|Principal Investigator Decision|0
5149963|NCT01473524|17786074|P6|LTSE Phase|Lost to Follow-up|2
5149964|NCT01473524|17786075|P5|LTSE Phase|Lost to Follow-up|3
5149965|NCT01473524|17786076|P4|LTSE Phase|Lost to Follow-up|1
5149966|NCT01473524|17786077|P3|LTSE Phase|Lost to Follow-up|0
5149967|NCT01473524|17786078|P2|LTSE Phase|Lost to Follow-up|0
5149968|NCT01473524|17786079|P1|LTSE Phase|Lost to Follow-up|0
5149969|NCT01473524|17786074|P6|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
5149970|NCT01473524|17786075|P5|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
5149971|NCT01473524|17786076|P4|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
5149972|NCT01473524|17786077|P3|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5149973|NCT01473524|17786078|P2|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5149974|NCT01473524|17786079|P1|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5149975|NCT01473524|17786074|P6|LTSE Phase|Adverse Event of Pruritus|2
5149976|NCT01473524|17786075|P5|LTSE Phase|Adverse Event of Pruritus|5
5149977|NCT01473524|17786076|P4|LTSE Phase|Adverse Event of Pruritus|1
5149978|NCT01473524|17786077|P3|LTSE Phase|Adverse Event of Pruritus|0
5149979|NCT01473524|17786078|P2|LTSE Phase|Adverse Event of Pruritus|0
5149980|NCT01473524|17786079|P1|LTSE Phase|Adverse Event of Pruritus|0
5149981|NCT01473524|17786074|P6|LTSE Phase|Death|0
5149982|NCT01473524|17786075|P5|LTSE Phase|Death|1
5149983|NCT01473524|17786076|P4|LTSE Phase|Death|0
5149984|NCT01473524|17786077|P3|LTSE Phase|Death|0
5149985|NCT01473524|17786078|P2|LTSE Phase|Death|0
5149986|NCT01473524|17786079|P1|LTSE Phase|Death|0
5149987|NCT01473524|17786074|P6|LTSE Phase|Withdrawal by Subject|6
5149988|NCT01473524|17786075|P5|LTSE Phase|Withdrawal by Subject|3
5149989|NCT01473524|17786076|P4|LTSE Phase|Withdrawal by Subject|3
5149990|NCT01473524|17786077|P3|LTSE Phase|Withdrawal by Subject|0
5149991|NCT01473524|17786078|P2|LTSE Phase|Withdrawal by Subject|0
5149992|NCT01473524|17786079|P1|LTSE Phase|Withdrawal by Subject|0
5149993|NCT01473524|17786074|P6|DB Phase|Withdrawal by Subject|0
5149994|NCT01473524|17786075|P5|DB Phase|Withdrawal by Subject|0
5149995|NCT01473524|17786076|P4|DB Phase|Withdrawal by Subject|0
5149996|NCT01473524|17786077|P3|DB Phase|Withdrawal by Subject|1
5149997|NCT01473524|17786078|P2|DB Phase|Withdrawal by Subject|1
5149998|NCT01473524|17786079|P1|DB Phase|Withdrawal by Subject|2
5149999|NCT01473524|17786074|P6|DB Phase|Death|0
5150000|NCT01473524|17786075|P5|DB Phase|Death|0
5150001|NCT01473524|17786076|P4|DB Phase|Death|0
5150002|NCT01473524|17786077|P3|DB Phase|Death|0
5150003|NCT01473524|17786078|P2|DB Phase|Death|0
5150004|NCT01473524|17786079|P1|DB Phase|Death|1
5150005|NCT01473524|17786074|P6|DB Phase|Adverse Event|0
5150006|NCT01473524|17786075|P5|DB Phase|Adverse Event|0
5150007|NCT01473524|17786076|P4|DB Phase|Adverse Event|0
5150008|NCT01473524|17786077|P3|DB Phase|Adverse Event|2
5150009|NCT01473524|17786078|P2|DB Phase|Adverse Event|8
5150010|NCT01473524|17786079|P1|DB Phase|Adverse Event|4
5150011|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
5150012|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
5150013|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
5150014|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
5150015|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
5150016|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
5150017|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
5150018|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
5150019|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Site closure|1
5150020|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Site closure|3
5150021|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
5150022|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
5150023|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
5150024|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
5150025|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
5150026|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
5150027|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
5150028|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
5150029|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Physician Decision|2
5150030|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Physician Decision|1
5150031|NCT01473420|17786128|P2|Maintenance Period (16 Weeks)|Adverse Event|2
5150032|NCT01473420|17786129|P1|Maintenance Period (16 Weeks)|Adverse Event|3
5150033|NCT01473420|17786128|P2|Titration Period (18 Weeks)|Did not meet criteria|32
5150034|NCT01473420|17786129|P1|Titration Period (18 Weeks)|Did not meet criteria|32
5150035|NCT01473420|17786128|P2|Titration Period (18 Weeks)|Adverse Event|6
5150036|NCT01473420|17786129|P1|Titration Period (18 Weeks)|Adverse Event|4
5150037|NCT01473407|17786213|P2|Overall Study|Site Closure|0
5150038|NCT01473407|17786214|P1|Overall Study|Site Closure|1
5150039|NCT01473407|17786213|P2|Overall Study|Sponsor's Decision|10
5150040|NCT01473407|17786214|P1|Overall Study|Sponsor's Decision|10
5150041|NCT01473407|17786213|P2|Overall Study|Transfer to Another Facility/Unit|3
5150042|NCT01473407|17786214|P1|Overall Study|Transfer to Another Facility/Unit|4
5150043|NCT01473407|17786213|P2|Overall Study|Temperature Excursion|3
5150044|NCT01473407|17786214|P1|Overall Study|Temperature Excursion|2
5150045|NCT01473407|17786213|P2|Overall Study|Patient Lost Green Card Status|0
5150046|NCT01473407|17786214|P1|Overall Study|Patient Lost Green Card Status|1
5150047|NCT01473407|17786213|P2|Overall Study|Patient Received Aranesp|0
5150048|NCT01473407|17786214|P1|Overall Study|Patient Received Aranesp|1
5150049|NCT01473407|17786213|P2|Overall Study|Elevated Hemoglobin|0
5150050|NCT01473407|17786214|P1|Overall Study|Elevated Hemoglobin|1
5150051|NCT01473407|17786213|P2|Overall Study|Vacation/Travel|1
5150052|NCT01473407|17786214|P1|Overall Study|Vacation/Travel|1
5150053|NCT01473407|17786213|P2|Overall Study|Kidney Transplant|6
5150054|NCT01473407|17786214|P1|Overall Study|Kidney Transplant|7
5150055|NCT01473407|17786213|P2|Overall Study|Withdrawal by Subject|7
5150056|NCT01473407|17786214|P1|Overall Study|Withdrawal by Subject|4
5150057|NCT01473407|17786213|P2|Overall Study|Randomization Error|1
5150058|NCT01473407|17786214|P1|Overall Study|Randomization Error|3
5150059|NCT01473407|17786213|P2|Overall Study|Adverse Event|8
5150060|NCT01473407|17786214|P1|Overall Study|Adverse Event|8
5150061|NCT01473407|17786213|P2|Overall Study|Lost to Follow-up|4
5150062|NCT01473407|17786214|P1|Overall Study|Lost to Follow-up|10
5150063|NCT01473407|17786213|P2|Overall Study|Physician Decision|4
5150064|NCT01473407|17786214|P1|Overall Study|Physician Decision|1
5150065|NCT01473394|17786268|P2|Overall Study|Lost to Follow-up|11
5150066|NCT01473394|17786269|P1|Overall Study|Lost to Follow-up|9
5150067|NCT01473394|17786268|P2|Overall Study|Withdrew Consent|10
5150068|NCT01473394|17786269|P1|Overall Study|Withdrew Consent|12
5150069|NCT01473394|17786268|P2|Overall Study|Protocol Violation|5
5150070|NCT01473394|17786269|P1|Overall Study|Protocol Violation|7
5150071|NCT01473394|17786268|P2|Overall Study|Insufficient Therapeutic Response|1
5150072|NCT01473394|17786269|P1|Overall Study|Insufficient Therapeutic Response|4
5150073|NCT01473394|17786268|P2|Overall Study|Adverse Event|16
5150074|NCT01473394|17786269|P1|Overall Study|Adverse Event|13
5150075|NCT01473381|17786283|P4|Overall Study|Other Reasons|3
5150076|NCT01473381|17786284|P3|Overall Study|Other Reasons|1
5150077|NCT01473381|17786285|P2|Overall Study|Other Reasons|0
5150078|NCT01473381|17786286|P1|Overall Study|Other Reasons|0
5150079|NCT01473381|17786283|P4|Overall Study|Lost to Follow-up|23
5150080|NCT01473381|17786284|P3|Overall Study|Lost to Follow-up|35
5150081|NCT01473381|17786285|P2|Overall Study|Lost to Follow-up|28
5150082|NCT01473381|17786286|P1|Overall Study|Lost to Follow-up|25
5150083|NCT01473381|17786283|P4|Overall Study|Withdrawal of Consent|26
5150084|NCT01473381|17786284|P3|Overall Study|Withdrawal of Consent|20
5150085|NCT01473381|17786285|P2|Overall Study|Withdrawal of Consent|21
5150086|NCT01473381|17786286|P1|Overall Study|Withdrawal of Consent|20
5150087|NCT01473381|17786283|P4|Overall Study|Protocol Violation|17
5150088|NCT01473381|17786284|P3|Overall Study|Protocol Violation|19
5150089|NCT01473381|17786285|P2|Overall Study|Protocol Violation|23
5150090|NCT01473381|17786286|P1|Overall Study|Protocol Violation|17
5150091|NCT01473381|17786283|P4|Overall Study|Insufficient Therapeutic Response|3
5150092|NCT01473381|17786284|P3|Overall Study|Insufficient Therapeutic Response|2
5150093|NCT01473381|17786285|P2|Overall Study|Insufficient Therapeutic Response|1
5150094|NCT01473381|17786286|P1|Overall Study|Insufficient Therapeutic Response|10
5150095|NCT01473381|17786283|P4|Overall Study|Adverse Event|17
5150096|NCT01473381|17786284|P3|Overall Study|Adverse Event|25
5150097|NCT01473381|17786285|P2|Overall Study|Adverse Event|20
5150098|NCT01473381|17786286|P1|Overall Study|Adverse Event|8
5150099|NCT01473355|17786348|P1|Overall Study|Lost to Follow-up|2
5150100|NCT01473355|17786348|P1|Overall Study|Adverse Event|2
5150101|NCT01473355|17786348|P1|Overall Study|Protocol Violation|2
5150102|NCT01472965|17786377|P2|Overall Study|Withdrawal by Subject|0
5150103|NCT01472965|17786378|P1|Overall Study|Withdrawal by Subject|1
5150104|NCT01472939|17786398|P4|Overall Study|Withdrawal by Subject|4
5150105|NCT01472939|17786399|P3|Overall Study|Withdrawal by Subject|1
5150106|NCT01472939|17786400|P2|Overall Study|Withdrawal by Subject|3
5150107|NCT01472939|17786401|P1|Overall Study|Withdrawal by Subject|9
5150108|NCT01472939|17786398|P4|Overall Study|Protocol Violation|1
5150109|NCT01472939|17786399|P3|Overall Study|Protocol Violation|0
5150110|NCT01472939|17786400|P2|Overall Study|Protocol Violation|3
5150111|NCT01472939|17786401|P1|Overall Study|Protocol Violation|3
5150112|NCT01472939|17786398|P4|Overall Study|Withdrawal By PI|0
5150113|NCT01472939|17786399|P3|Overall Study|Withdrawal By PI|0
5150114|NCT01472939|17786400|P2|Overall Study|Withdrawal By PI|0
5150115|NCT01472939|17786401|P1|Overall Study|Withdrawal By PI|1
5150116|NCT01472939|17786398|P4|Overall Study|Prohibited Medication|0
5150117|NCT01472939|17786399|P3|Overall Study|Prohibited Medication|0
5150118|NCT01472939|17786400|P2|Overall Study|Prohibited Medication|1
5150119|NCT01472939|17786401|P1|Overall Study|Prohibited Medication|0
5150120|NCT01472939|17786398|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
5150121|NCT01472939|17786399|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
5150122|NCT01472939|17786400|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
5150123|NCT01472939|17786401|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
5150124|NCT01472939|17786398|P4|Overall Study|Lost to Follow-up|0
5150125|NCT01472939|17786399|P3|Overall Study|Lost to Follow-up|2
5150126|NCT01472939|17786400|P2|Overall Study|Lost to Follow-up|0
5150127|NCT01472939|17786401|P1|Overall Study|Lost to Follow-up|3
5150128|NCT01472939|17786398|P4|Overall Study|Lack of Efficacy|1
5150129|NCT01472939|17786399|P3|Overall Study|Lack of Efficacy|0
5150130|NCT01472939|17786400|P2|Overall Study|Lack of Efficacy|0
5150131|NCT01472939|17786401|P1|Overall Study|Lack of Efficacy|1
5150132|NCT01472939|17786398|P4|Overall Study|Adverse Event|14
5150133|NCT01472939|17786399|P3|Overall Study|Adverse Event|7
5150134|NCT01472939|17786400|P2|Overall Study|Adverse Event|7
5150135|NCT01472939|17786401|P1|Overall Study|Adverse Event|3
5150136|NCT01472835|17786445|P2|Overall Study|Lost to Follow-up|0
5150137|NCT01472835|17786446|P1|Overall Study|Lost to Follow-up|2
5150138|NCT01472757|17786481|P4|Overall Study|Other reasons|2
5150139|NCT01472757|17786482|P3|Overall Study|Other reasons|2
5150140|NCT01472757|17786483|P2|Overall Study|Other reasons|0
5150141|NCT01472757|17786484|P1|Overall Study|Other reasons|1
5150142|NCT01472757|17786481|P4|Overall Study|Protocol Violation|4
5150143|NCT01472757|17786482|P3|Overall Study|Protocol Violation|4
5150144|NCT01472757|17786483|P2|Overall Study|Protocol Violation|2
5150145|NCT01472757|17786484|P1|Overall Study|Protocol Violation|3
5150146|NCT01472757|17786481|P4|Overall Study|Treatment period withdrawal criteria met|12
5150147|NCT01472757|17786482|P3|Overall Study|Treatment period withdrawal criteria met|9
5150148|NCT01472757|17786483|P2|Overall Study|Treatment period withdrawal criteria met|8
5150149|NCT01472757|17786484|P1|Overall Study|Treatment period withdrawal criteria met|21
5150150|NCT01472757|17786481|P4|Overall Study|Asthma exacerbation|1
5150151|NCT01472757|17786482|P3|Overall Study|Asthma exacerbation|2
5150152|NCT01472757|17786483|P2|Overall Study|Asthma exacerbation|1
5150153|NCT01472757|17786484|P1|Overall Study|Asthma exacerbation|4
5150154|NCT01472757|17786481|P4|Overall Study|Withdrawal by Subject|0
5150155|NCT01472757|17786482|P3|Overall Study|Withdrawal by Subject|2
5150156|NCT01472757|17786483|P2|Overall Study|Withdrawal by Subject|2
5150157|NCT01472757|17786484|P1|Overall Study|Withdrawal by Subject|1
5150158|NCT01472380|17786599|P1|1 Day Period Between Dosing|Protocol Violation|1
5150159|NCT01472380|17786599|P1|Efavirenz Alone|Withdrawal by Subject|1
5150160|NCT01472341|17786610|P1|Overall Study|Death|9
5150161|NCT01472341|17786610|P1|Overall Study|Laboratory parameters unavailable|25
5150162|NCT01472341|17786610|P1|Overall Study|Lost to Follow-up|52
5150163|NCT01472341|17786610|P1|Overall Study|Withdrawal by Subject|39
5150164|NCT01472341|17786610|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
5150165|NCT01472341|17786610|P1|Overall Study|Started insulin therapy|55
5150166|NCT01472289|17786616|P1|Overall Study|Death|2
5150167|NCT01472185|17786628|P2|Overall Study|Subject Withdrew Consent|3
5150168|NCT01472185|17786629|P1|Overall Study|Subject Withdrew Consent|6
5150169|NCT01472185|17786628|P2|Overall Study|Subject Noncompliance|15
5150170|NCT01472185|17786629|P1|Overall Study|Subject Noncompliance|8
5150171|NCT01472185|17786628|P2|Overall Study|Protocol Violation|1
5150172|NCT01472185|17786629|P1|Overall Study|Protocol Violation|5
5150173|NCT01472185|17786628|P2|Overall Study|Lost to Follow-up|1
5150174|NCT01472185|17786629|P1|Overall Study|Lost to Follow-up|4
5150175|NCT01472185|17786628|P2|Overall Study|Investigator's Discretion|1
5150176|NCT01472185|17786629|P1|Overall Study|Investigator's Discretion|3
5150177|NCT01472185|17786628|P2|Overall Study|Hyperglycemia|2
5150178|NCT01472185|17786629|P1|Overall Study|Hyperglycemia|5
5150179|NCT01472185|17786628|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
5150180|NCT01472185|17786629|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
5150181|NCT01472185|17786628|P2|Overall Study|Randomized but Not Treated|1
5150182|NCT01472185|17786629|P1|Overall Study|Randomized but Not Treated|0
5150183|NCT01472081|17786649|P6|Overall Study|Subject request to discontinue treatment|0
5150184|NCT01472081|17786650|P5|Overall Study|Subject request to discontinue treatment|0
5150185|NCT01472081|17786651|P4|Overall Study|Subject request to discontinue treatment|1
5150186|NCT01472081|17786652|P3|Overall Study|Subject request to discontinue treatment|1
5150187|NCT01472081|17786653|P2|Overall Study|Subject request to discontinue treatment|3
5150188|NCT01472081|17786654|P1|Overall Study|Subject request to discontinue treatment|0
5150189|NCT01472081|17786649|P6|Overall Study|No longer meets study criteria|0
5150190|NCT01472081|17786650|P5|Overall Study|No longer meets study criteria|0
5150191|NCT01472081|17786651|P4|Overall Study|No longer meets study criteria|0
5150192|NCT01472081|17786652|P3|Overall Study|No longer meets study criteria|1
5150193|NCT01472081|17786653|P2|Overall Study|No longer meets study criteria|0
5150194|NCT01472081|17786654|P1|Overall Study|No longer meets study criteria|0
5150195|NCT01472081|17786649|P6|Overall Study|Poor/non-compliance|0
5150196|NCT01472081|17786650|P5|Overall Study|Poor/non-compliance|1
5150197|NCT01472081|17786651|P4|Overall Study|Poor/non-compliance|0
5150198|NCT01472081|17786652|P3|Overall Study|Poor/non-compliance|1
5150199|NCT01472081|17786653|P2|Overall Study|Poor/non-compliance|0
5150200|NCT01472081|17786654|P1|Overall Study|Poor/non-compliance|0
5150201|NCT01472081|17786649|P6|Overall Study|Withdrawal by Subject|1
5150202|NCT01472081|17786650|P5|Overall Study|Withdrawal by Subject|0
5150203|NCT01472081|17786651|P4|Overall Study|Withdrawal by Subject|0
5150204|NCT01472081|17786652|P3|Overall Study|Withdrawal by Subject|0
5150205|NCT01472081|17786653|P2|Overall Study|Withdrawal by Subject|0
5150206|NCT01472081|17786654|P1|Overall Study|Withdrawal by Subject|0
5150207|NCT01472081|17786649|P6|Overall Study|Adverse Event unrelated to study drug|0
5150208|NCT01472081|17786650|P5|Overall Study|Adverse Event unrelated to study drug|1
5150209|NCT01472081|17786651|P4|Overall Study|Adverse Event unrelated to study drug|0
5150210|NCT01472081|17786652|P3|Overall Study|Adverse Event unrelated to study drug|0
5150211|NCT01472081|17786653|P2|Overall Study|Adverse Event unrelated to study drug|0
5150212|NCT01472081|17786654|P1|Overall Study|Adverse Event unrelated to study drug|0
5150213|NCT01472081|17786649|P6|Overall Study|Death|0
5150214|NCT01472081|17786650|P5|Overall Study|Death|1
5150215|NCT01472081|17786651|P4|Overall Study|Death|0
5150216|NCT01472081|17786652|P3|Overall Study|Death|0
5150217|NCT01472081|17786653|P2|Overall Study|Death|0
5150218|NCT01472081|17786654|P1|Overall Study|Death|0
5150219|NCT01472081|17786649|P6|Overall Study|Study drug toxicity|2
5150220|NCT01472081|17786650|P5|Overall Study|Study drug toxicity|13
5150221|NCT01472081|17786651|P4|Overall Study|Study drug toxicity|6
5150222|NCT01472081|17786652|P3|Overall Study|Study drug toxicity|4
5150223|NCT01472081|17786653|P2|Overall Study|Study drug toxicity|9
5150224|NCT01472081|17786654|P1|Overall Study|Study drug toxicity|2
5150225|NCT01472081|17786649|P6|Overall Study|Disease Progression|3
5150226|NCT01472081|17786650|P5|Overall Study|Disease Progression|22
5150227|NCT01472081|17786651|P4|Overall Study|Disease Progression|31
5150228|NCT01472081|17786652|P3|Overall Study|Disease Progression|12
5150229|NCT01472081|17786653|P2|Overall Study|Disease Progression|10
5150230|NCT01472081|17786654|P1|Overall Study|Disease Progression|4
5150231|NCT01472081|17786649|P6|Overall Study|Continuing treatment at time of analysis|0
5150232|NCT01472081|17786650|P5|Overall Study|Continuing treatment at time of analysis|9
5150233|NCT01472081|17786651|P4|Overall Study|Continuing treatment at time of analysis|8
5150234|NCT01472081|17786652|P3|Overall Study|Continuing treatment at time of analysis|1
5150235|NCT01472081|17786653|P2|Overall Study|Continuing treatment at time of analysis|4
5150236|NCT01472081|17786654|P1|Overall Study|Continuing treatment at time of analysis|1
5150237|NCT01471782|17786703|P6|Overall Study|Death|1
5150238|NCT01471782|17786704|P5|Overall Study|Death|0
5150239|NCT01471782|17786705|P4|Overall Study|Death|0
5150240|NCT01471782|17786706|P3|Overall Study|Death|0
5150241|NCT01471782|17786707|P2|Overall Study|Death|0
5150242|NCT01471782|17786708|P1|Overall Study|Death|0
5150243|NCT01471782|17786703|P6|Overall Study|Withdrawal by Parent/Guardian|0
5150244|NCT01471782|17786704|P5|Overall Study|Withdrawal by Parent/Guardian|1
5150245|NCT01471782|17786705|P4|Overall Study|Withdrawal by Parent/Guardian|0
5150246|NCT01471782|17786706|P3|Overall Study|Withdrawal by Parent/Guardian|0
5150247|NCT01471782|17786707|P2|Overall Study|Withdrawal by Parent/Guardian|0
5150248|NCT01471782|17786708|P1|Overall Study|Withdrawal by Parent/Guardian|0
5150249|NCT01471782|17786703|P6|Overall Study|Physician Decision|8
5150250|NCT01471782|17786704|P5|Overall Study|Physician Decision|3
5150251|NCT01471782|17786705|P4|Overall Study|Physician Decision|0
5150252|NCT01471782|17786706|P3|Overall Study|Physician Decision|0
5150253|NCT01471782|17786707|P2|Overall Study|Physician Decision|0
5150254|NCT01471782|17786708|P1|Overall Study|Physician Decision|0
5150255|NCT01471782|17786703|P6|Overall Study|Disease Relapse|1
5150256|NCT01471782|17786704|P5|Overall Study|Disease Relapse|2
5150257|NCT01471782|17786705|P4|Overall Study|Disease Relapse|1
5150258|NCT01471782|17786706|P3|Overall Study|Disease Relapse|0
5150259|NCT01471782|17786707|P2|Overall Study|Disease Relapse|0
5150260|NCT01471782|17786708|P1|Overall Study|Disease Relapse|0
5150261|NCT01471782|17786703|P6|Overall Study|Change of Chemotherapy|4
5150262|NCT01471782|17786704|P5|Overall Study|Change of Chemotherapy|1
5150263|NCT01471782|17786705|P4|Overall Study|Change of Chemotherapy|0
5150264|NCT01471782|17786706|P3|Overall Study|Change of Chemotherapy|0
5150265|NCT01471782|17786707|P2|Overall Study|Change of Chemotherapy|1
5150266|NCT01471782|17786708|P1|Overall Study|Change of Chemotherapy|1
5150267|NCT01471782|17786703|P6|Overall Study|Other|5
5150268|NCT01471782|17786704|P5|Overall Study|Other|6
5150269|NCT01471782|17786705|P4|Overall Study|Other|1
5150270|NCT01471782|17786706|P3|Overall Study|Other|1
5150271|NCT01471782|17786707|P2|Overall Study|Other|0
5150272|NCT01471782|17786708|P1|Overall Study|Other|0
5150273|NCT01471782|17786703|P6|Overall Study|Adverse Event|1
5150274|NCT01471782|17786704|P5|Overall Study|Adverse Event|3
5150275|NCT01471782|17786705|P4|Overall Study|Adverse Event|2
5150276|NCT01471782|17786706|P3|Overall Study|Adverse Event|2
5150277|NCT01471782|17786707|P2|Overall Study|Adverse Event|1
5150278|NCT01471782|17786708|P1|Overall Study|Adverse Event|1
5150279|NCT01471782|17786703|P6|Overall Study|Lack of Efficacy|18
5150280|NCT01471782|17786704|P5|Overall Study|Lack of Efficacy|5
5150281|NCT01471782|17786705|P4|Overall Study|Lack of Efficacy|1
5150282|NCT01471782|17786706|P3|Overall Study|Lack of Efficacy|1
5150283|NCT01471782|17786707|P2|Overall Study|Lack of Efficacy|2
5150284|NCT01471782|17786708|P1|Overall Study|Lack of Efficacy|1
5150285|NCT01471782|17786703|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
5150286|NCT01471782|17786704|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
5150287|NCT01471782|17786705|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
5150288|NCT01471782|17786706|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
5150289|NCT01471782|17786707|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
5150290|NCT01471782|17786708|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
5150291|NCT01471691|17786762|P2|Overall Study|Lack of Efficacy|1
5150292|NCT01471691|17786763|P1|Overall Study|Lack of Efficacy|0
5150293|NCT01471379|17786772|P3|Overall Study|Study terminated|0
5150294|NCT01471379|17786773|P2|Overall Study|Study terminated|1
5150295|NCT01471379|17786774|P1|Overall Study|Study terminated|0
5150296|NCT01471379|17786772|P3|Overall Study|Adverse Event|0
5150297|NCT01471379|17786773|P2|Overall Study|Adverse Event|0
5150298|NCT01471379|17786774|P1|Overall Study|Adverse Event|1
5150299|NCT01471353|17786794|P1|Overall Study|remain on study|3
5150300|NCT01471340|17786805|P2|Overall Study|Invalid informed consent|0
5150301|NCT01471340|17786806|P1|Overall Study|Invalid informed consent|1
5150302|NCT01471340|17786805|P2|Overall Study|Investigational site closure|1
5150303|NCT01471340|17786806|P1|Overall Study|Investigational site closure|0
5150304|NCT01471340|17786805|P2|Overall Study|Lost to Follow-up|1
5150305|NCT01471340|17786806|P1|Overall Study|Lost to Follow-up|0
5150306|NCT01471340|17786805|P2|Overall Study|Death|4
5150307|NCT01471340|17786806|P1|Overall Study|Death|5
5150308|NCT01471574|17786829|P4|Follow-up Period|Follow-up no longer required|0
5150309|NCT01471574|17786830|P3|Follow-up Period|Follow-up no longer required|0
5150310|NCT01471574|17786831|P2|Follow-up Period|Follow-up no longer required|1
5150311|NCT01471574|17786832|P1|Follow-up Period|Follow-up no longer required|0
5150312|NCT01471574|17786829|P4|Follow-up Period|Death|0
5150313|NCT01471574|17786830|P3|Follow-up Period|Death|1
5150314|NCT01471574|17786831|P2|Follow-up Period|Death|0
5150315|NCT01471574|17786832|P1|Follow-up Period|Death|0
5150316|NCT01471574|17786829|P4|Follow-up Period|Lost to Follow-up|2
5150317|NCT01471574|17786830|P3|Follow-up Period|Lost to Follow-up|3
5150318|NCT01471574|17786831|P2|Follow-up Period|Lost to Follow-up|1
5150319|NCT01471574|17786832|P1|Follow-up Period|Lost to Follow-up|4
5150320|NCT01471574|17786829|P4|Follow-up Period|Withdrawal by Subject|1
5150321|NCT01471574|17786830|P3|Follow-up Period|Withdrawal by Subject|3
5150322|NCT01471574|17786831|P2|Follow-up Period|Withdrawal by Subject|0
5150323|NCT01471574|17786832|P1|Follow-up Period|Withdrawal by Subject|3
5150324|NCT01471574|17786829|P4|Treatment Period|Other|0
5150325|NCT01471574|17786830|P3|Treatment Period|Other|0
5150326|NCT01471574|17786831|P2|Treatment Period|Other|0
5150327|NCT01471574|17786832|P1|Treatment Period|Other|1
5150328|NCT01471574|17786829|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
5150329|NCT01471574|17786830|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
5150330|NCT01471574|17786831|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
5150331|NCT01471574|17786832|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
5150332|NCT01471574|17786829|P4|Treatment Period|Lost to Follow-up|0
5150333|NCT01471574|17786830|P3|Treatment Period|Lost to Follow-up|2
5150334|NCT01471574|17786831|P2|Treatment Period|Lost to Follow-up|2
5150335|NCT01471574|17786832|P1|Treatment Period|Lost to Follow-up|1
5150336|NCT01471574|17786829|P4|Treatment Period|Patient Requested Discontinue Study drug|1
5150337|NCT01471574|17786830|P3|Treatment Period|Patient Requested Discontinue Study drug|1
5150338|NCT01471574|17786831|P2|Treatment Period|Patient Requested Discontinue Study drug|0
5150339|NCT01471574|17786832|P1|Treatment Period|Patient Requested Discontinue Study drug|4
5150340|NCT01471574|17786829|P4|Treatment Period|Withdrawal by Subject|0
5150341|NCT01471574|17786830|P3|Treatment Period|Withdrawal by Subject|1
5150342|NCT01471574|17786831|P2|Treatment Period|Withdrawal by Subject|1
5150343|NCT01471574|17786832|P1|Treatment Period|Withdrawal by Subject|5
5150344|NCT01471574|17786829|P4|Treatment Period|Adverse Event|1
5150345|NCT01471574|17786830|P3|Treatment Period|Adverse Event|6
5150346|NCT01471574|17786831|P2|Treatment Period|Adverse Event|3
5150347|NCT01471574|17786832|P1|Treatment Period|Adverse Event|7
5150348|NCT01471574|17786829|P4|Treatment Period|Lack of Efficacy|1
5150349|NCT01471574|17786830|P3|Treatment Period|Lack of Efficacy|14
5150350|NCT01471574|17786831|P2|Treatment Period|Lack of Efficacy|4
5150351|NCT01471574|17786832|P1|Treatment Period|Lack of Efficacy|12
5150352|NCT01471522|17786863|P2|Overall Study|Lost to Follow-up|26
5150353|NCT01471522|17786864|P1|Overall Study|Lost to Follow-up|36
5150354|NCT01471522|17786863|P2|Overall Study|Withdrawal by Subject|22
5150355|NCT01471522|17786864|P1|Overall Study|Withdrawal by Subject|28
5150356|NCT01471197|17786901|P2|Overall Study|Study Drug Toxicity|0
5150357|NCT01471197|17786902|P1|Overall Study|Study Drug Toxicity|1
5150358|NCT01471197|17786901|P2|Overall Study|Death|0
5150359|NCT01471197|17786902|P1|Overall Study|Death|1
5150360|NCT01471197|17786901|P2|Overall Study|Disease Progression|2
5150361|NCT01471197|17786902|P1|Overall Study|Disease Progression|4
5150362|NCT01471171|17786912|P2|Treatment Period 2|Adverse Event|0
5150363|NCT01471171|17786913|P1|Treatment Period 2|Adverse Event|1
5150364|NCT01471171|17786912|P2|Treatment Period 1|Adverse Event|1
5150365|NCT01471171|17786913|P1|Treatment Period 1|Adverse Event|4
5150366|NCT01471054|17786925|P2|Overall Study|Study terminated prematurely|0
5150367|NCT01471054|17786926|P1|Overall Study|Study terminated prematurely|4
5150368|NCT01471028|17786949|P2|VTI-208E|Lost to Follow-up|2
5150369|NCT01471028|17786950|P1|VTI-208E|Lost to Follow-up|0
5150370|NCT01471028|17786949|P2|VTI-208E|Withdrawal by Subject|0
5150371|NCT01471028|17786950|P1|VTI-208E|Withdrawal by Subject|1
5150372|NCT01471028|17786949|P2|VTI-208E|Death|10
5150373|NCT01471028|17786950|P1|VTI-208E|Death|7
5150374|NCT01471028|17786949|P2|VTI-208|Lost to Follow-up|1
5150375|NCT01471028|17786950|P1|VTI-208|Lost to Follow-up|1
5150376|NCT01471028|17786949|P2|VTI-208|Withdrawal by Subject|2
5150377|NCT01471028|17786950|P1|VTI-208|Withdrawal by Subject|0
5150378|NCT01471028|17786949|P2|VTI-208|Adverse Event|41
5150379|NCT01471028|17786950|P1|VTI-208|Adverse Event|39
5150380|NCT01471015|17786965|P3|Overall Study|Death|1
5150381|NCT01471015|17786966|P2|Overall Study|Death|1
5150382|NCT01471015|17786967|P1|Overall Study|Death|0
5150383|NCT01470599|17787028|P2|Overall Study|Adverse event not related to study drug|5
5150384|NCT01470599|17787029|P1|Overall Study|Adverse event not related to study drug|1
5150385|NCT01470599|17787028|P2|Overall Study|Insufficient clinical response|27
5150386|NCT01470599|17787029|P1|Overall Study|Insufficient clinical response|6
5150387|NCT01470599|17787028|P2|Overall Study|Adverse event related to study drug|5
5150388|NCT01470599|17787029|P1|Overall Study|Adverse event related to study drug|2
5150389|NCT01470599|17787028|P2|Overall Study|Protocol Violation|1
5150390|NCT01470599|17787029|P1|Overall Study|Protocol Violation|3
5150391|NCT01470599|17787028|P2|Overall Study|Other|0
5150392|NCT01470599|17787029|P1|Overall Study|Other|1
5150393|NCT01470599|17787028|P2|Overall Study|Withdrawal by Subject|4
5150394|NCT01470599|17787029|P1|Overall Study|Withdrawal by Subject|3
5150395|NCT01470599|17787028|P2|Overall Study|Lost to Follow-up|1
5150396|NCT01470599|17787029|P1|Overall Study|Lost to Follow-up|2
5150397|NCT01470599|17787028|P2|Overall Study|Did not meet entrance criteria|0
5150398|NCT01470599|17787029|P1|Overall Study|Did not meet entrance criteria|1
5150399|NCT01470469|17787093|P2|Overall Study|Other|1
5150400|NCT01470469|17787094|P1|Overall Study|Other|2
5150401|NCT01470469|17787093|P2|Overall Study|Protocol Violation|1
5150402|NCT01470469|17787094|P1|Overall Study|Protocol Violation|1
5150403|NCT01470469|17787093|P2|Overall Study|Lost to Follow-up|2
5150404|NCT01470469|17787094|P1|Overall Study|Lost to Follow-up|2
5150405|NCT01470469|17787093|P2|Overall Study|Adverse Event|7
5150406|NCT01470469|17787094|P1|Overall Study|Adverse Event|0
5150407|NCT01470469|17787093|P2|Overall Study|Lack of Efficacy|7
5150408|NCT01470469|17787094|P1|Overall Study|Lack of Efficacy|1
5150409|NCT01470469|17787093|P2|Overall Study|Withdrawal by Subject|6
5150410|NCT01470469|17787094|P1|Overall Study|Withdrawal by Subject|4
5150411|NCT01470417|17787114|P2|Overall Study|Disease progression|2
5150412|NCT01470417|17787115|P1|Overall Study|Disease progression|0
5150413|NCT01470326|17787127|P1|Overall Study|No Visit After 1st Day of Treatment|119
5150414|NCT01470326|17787127|P1|Overall Study|No Drug Administration Information|2
5150415|NCT01470326|17787127|P1|Overall Study|Protocol Violation|32
5150416|NCT01470248|17787138|P1|Overall Study|Withdrawal by Subject|1
5150417|NCT01470144|17787194|P1|Overall Study|Patient's and investigator's decision|1
5150418|NCT01470144|17787194|P1|Overall Study|Lung transplant|6
5150419|NCT01470144|17787194|P1|Overall Study|Death|1
5150420|NCT01470144|17787194|P1|Overall Study|Adverse Event|2
5150421|NCT01470001|17787299|P2|Overall Study|Withdrawal by Subject|1
5150422|NCT01470001|17787300|P1|Overall Study|Withdrawal by Subject|2
5150423|NCT01470001|17787299|P2|Overall Study|Physician Decision|0
5150424|NCT01470001|17787300|P1|Overall Study|Physician Decision|2
5150425|NCT01470001|17787299|P2|Overall Study|Lost to Follow-up|1
5150426|NCT01470001|17787300|P1|Overall Study|Lost to Follow-up|1
5150427|NCT01469819|17787310|P1|Overall Study|Technical malfunction of SmartPill data|3
5150428|NCT01469819|17787310|P1|Overall Study|Could not swallow SmartPill|2
5150429|NCT01469819|17787310|P1|Overall Study|Did not meet inclusionary criteria|2
5150430|NCT01469819|17787310|P1|Overall Study|Withdrawal by Subject|1
5150431|NCT01469637|17787334|P2|Second Intervention|Incarcerated|0
5150432|NCT01469637|17787335|P1|Second Intervention|Incarcerated|1
5150433|NCT01469637|17787334|P2|First Intervention|Unacceptable behavior|1
5150434|NCT01469637|17787335|P1|First Intervention|Unacceptable behavior|0
5150435|NCT01469546|17787343|P1|Received 5 mg Dose|Physician Decision|3
5150436|NCT01469546|17787343|P1|Received 5 mg Dose|Progressive Disease|3
5150437|NCT01469546|17787343|P1|Received 5 mg Dose|Protocol Violation|2
5150438|NCT01469546|17787343|P1|Received 5 mg Dose|Death|2
5150439|NCT01469546|17787343|P1|Received 5 mg Dose|Adverse Event|13
5150440|NCT01469377|17787353|P3|Overall Study|Other Miscellaneous Reasons|0
5150441|NCT01469377|17787354|P2|Overall Study|Other Miscellaneous Reasons|0
5150442|NCT01469377|17787355|P1|Overall Study|Other Miscellaneous Reasons|2
5150443|NCT01469377|17787353|P3|Overall Study|Insufficient Therapeutic Response|0
5150444|NCT01469377|17787354|P2|Overall Study|Insufficient Therapeutic Response|4
5150445|NCT01469377|17787355|P1|Overall Study|Insufficient Therapeutic Response|3
5150446|NCT01469377|17787353|P3|Overall Study|Adverse Event|36
5150447|NCT01469377|17787354|P2|Overall Study|Adverse Event|18
5150448|NCT01469377|17787355|P1|Overall Study|Adverse Event|8
5150449|NCT01469377|17787353|P3|Overall Study|Withdrawal of Consent|15
5150450|NCT01469377|17787354|P2|Overall Study|Withdrawal of Consent|14
5150451|NCT01469377|17787355|P1|Overall Study|Withdrawal of Consent|12
5150452|NCT01469377|17787353|P3|Overall Study|Lost to Follow-up|5
5150453|NCT01469377|17787354|P2|Overall Study|Lost to Follow-up|2
5150454|NCT01469377|17787355|P1|Overall Study|Lost to Follow-up|3
5150455|NCT01469377|17787353|P3|Overall Study|Protocol Deviation|10
5150456|NCT01469377|17787354|P2|Overall Study|Protocol Deviation|10
5150457|NCT01469377|17787355|P1|Overall Study|Protocol Deviation|7
5150458|NCT01469364|17787366|P1|Overall Study|Withdrawal by Subject|1
5150459|NCT01469364|17787366|P1|Overall Study|Adverse Event|1
5150460|NCT01469221|17787417|P3|Double Blind Phase|Sponsor Terminate Study|0
5150461|NCT01469221|17787418|P2|Double Blind Phase|Sponsor Terminate Study|16
5150462|NCT01469221|17787419|P1|Double Blind Phase|Sponsor Terminate Study|12
5150463|NCT01469221|17787417|P3|Double Blind Phase|Physician Decision|0
5150464|NCT01469221|17787418|P2|Double Blind Phase|Physician Decision|1
5150465|NCT01469221|17787419|P1|Double Blind Phase|Physician Decision|1
5150466|NCT01469221|17787417|P3|Double Blind Phase|Protocol Violation|0
5150467|NCT01469221|17787418|P2|Double Blind Phase|Protocol Violation|0
5150468|NCT01469221|17787419|P1|Double Blind Phase|Protocol Violation|1
5150469|NCT01469182|17787430|P2|Overall Study|Did not meet Protocol Eligibility|0
5150470|NCT01469182|17787431|P1|Overall Study|Did not meet Protocol Eligibility|3
5150471|NCT01469182|17787430|P2|Overall Study|Protocol Violation|2
5150472|NCT01469182|17787431|P1|Overall Study|Protocol Violation|4
5150473|NCT01469182|17787430|P2|Overall Study|Withdrawal by Subject|1
5150474|NCT01469182|17787431|P1|Overall Study|Withdrawal by Subject|4
5150475|NCT01469182|17787430|P2|Overall Study|Lost to Follow-up|0
5150476|NCT01469182|17787431|P1|Overall Study|Lost to Follow-up|3
5150477|NCT01469182|17787430|P2|Overall Study|Adverse Event|3
5150478|NCT01469182|17787431|P1|Overall Study|Adverse Event|21
5150479|NCT01469065|17787458|P5|Overall Study|Other|0
5150480|NCT01469065|17787459|P4|Overall Study|Other|0
5150481|NCT01469065|17787460|P3|Overall Study|Other|0
5150482|NCT01469065|17787461|P2|Overall Study|Other|1
5150483|NCT01469065|17787462|P1|Overall Study|Other|0
5150484|NCT01469065|17787458|P5|Overall Study|Lack of Efficacy|1
5150485|NCT01469065|17787459|P4|Overall Study|Lack of Efficacy|0
5150486|NCT01469065|17787460|P3|Overall Study|Lack of Efficacy|0
5150487|NCT01469065|17787461|P2|Overall Study|Lack of Efficacy|0
5150488|NCT01469065|17787462|P1|Overall Study|Lack of Efficacy|0
5150489|NCT01469052|17787558|P6|Overall Study|Other|0
5150490|NCT01469052|17787559|P5|Overall Study|Other|1
5150491|NCT01469052|17787560|P4|Overall Study|Other|0
5150492|NCT01469052|17787561|P3|Overall Study|Other|0
5150493|NCT01469052|17787562|P2|Overall Study|Other|1
5150494|NCT01469052|17787563|P1|Overall Study|Other|0
5150495|NCT01469052|17787558|P6|Overall Study|Moved to rollover protocol|1
5150496|NCT01469052|17787559|P5|Overall Study|Moved to rollover protocol|0
5150497|NCT01469052|17787560|P4|Overall Study|Moved to rollover protocol|0
5150498|NCT01469052|17787561|P3|Overall Study|Moved to rollover protocol|1
5150499|NCT01469052|17787562|P2|Overall Study|Moved to rollover protocol|0
5150500|NCT01469052|17787563|P1|Overall Study|Moved to rollover protocol|1
5150501|NCT01469052|17787558|P6|Overall Study|Lack of Efficacy|2
5150502|NCT01469052|17787559|P5|Overall Study|Lack of Efficacy|0
5150503|NCT01469052|17787560|P4|Overall Study|Lack of Efficacy|0
5150504|NCT01469052|17787561|P3|Overall Study|Lack of Efficacy|0
5150505|NCT01469052|17787562|P2|Overall Study|Lack of Efficacy|0
5150506|NCT01469052|17787563|P1|Overall Study|Lack of Efficacy|0
5150507|NCT01469052|17787558|P6|Overall Study|Progressive disease|2
5150508|NCT01469052|17787559|P5|Overall Study|Progressive disease|7
5150509|NCT01469052|17787560|P4|Overall Study|Progressive disease|3
5150510|NCT01469052|17787561|P3|Overall Study|Progressive disease|5
5150511|NCT01469052|17787562|P2|Overall Study|Progressive disease|0
5150512|NCT01469052|17787563|P1|Overall Study|Progressive disease|3
5150513|NCT01469052|17787558|P6|Overall Study|Adverse Event|1
5150514|NCT01469052|17787559|P5|Overall Study|Adverse Event|0
5150515|NCT01469052|17787560|P4|Overall Study|Adverse Event|2
5150516|NCT01469052|17787561|P3|Overall Study|Adverse Event|0
5150517|NCT01469052|17787562|P2|Overall Study|Adverse Event|3
5150518|NCT01469052|17787563|P1|Overall Study|Adverse Event|2
5150519|NCT01469013|17787628|P13|Part B (Extension Period)|Withdrawal by Subject|3
5150520|NCT01469013|17787629|P12|Part B (Extension Period)|Withdrawal by Subject|0
5150521|NCT01469013|17787630|P11|Part B (Extension Period)|Withdrawal by Subject|1
5150522|NCT01469013|17787631|P10|Part B (Extension Period)|Withdrawal by Subject|0
5150523|NCT01469013|17787632|P9|Part B (Extension Period)|Withdrawal by Subject|1
5150524|NCT01469013|17787633|P8|Part B (Extension Period)|Withdrawal by Subject|0
5150525|NCT01469013|17787634|P7|Part B (Extension Period)|Withdrawal by Subject|0
5150526|NCT01469013|17787635|P6|Part B (Extension Period)|Withdrawal by Subject|0
5150527|NCT01469013|17787636|P5|Part B (Extension Period)|Withdrawal by Subject|0
5150528|NCT01469013|17787637|P4|Part B (Extension Period)|Withdrawal by Subject|0
5150529|NCT01469013|17787638|P3|Part B (Extension Period)|Withdrawal by Subject|0
5150530|NCT01469013|17787639|P2|Part B (Extension Period)|Withdrawal by Subject|0
5150531|NCT01469013|17787640|P1|Part B (Extension Period)|Withdrawal by Subject|0
5150532|NCT01469013|17787628|P13|Part B (Extension Period)|Adverse Event|3
5150533|NCT01469013|17787629|P12|Part B (Extension Period)|Adverse Event|6
5150534|NCT01469013|17787630|P11|Part B (Extension Period)|Adverse Event|1
5150535|NCT01469013|17787631|P10|Part B (Extension Period)|Adverse Event|3
5150536|NCT01469013|17787632|P9|Part B (Extension Period)|Adverse Event|3
5150537|NCT01469013|17787633|P8|Part B (Extension Period)|Adverse Event|5
5150538|NCT01469013|17787634|P7|Part B (Extension Period)|Adverse Event|5
5150539|NCT01469013|17787635|P6|Part B (Extension Period)|Adverse Event|2
5150540|NCT01469013|17787636|P5|Part B (Extension Period)|Adverse Event|0
5150541|NCT01469013|17787637|P4|Part B (Extension Period)|Adverse Event|0
5150542|NCT01469013|17787638|P3|Part B (Extension Period)|Adverse Event|0
5150543|NCT01469013|17787639|P2|Part B (Extension Period)|Adverse Event|0
5150544|NCT01469013|17787640|P1|Part B (Extension Period)|Adverse Event|0
5150545|NCT01469013|17787628|P13|Part A (Treatment Period)|Withdrawal by Subject|0
5150546|NCT01469013|17787629|P12|Part A (Treatment Period)|Withdrawal by Subject|0
5150547|NCT01469013|17787630|P11|Part A (Treatment Period)|Withdrawal by Subject|0
5150548|NCT01469013|17787631|P10|Part A (Treatment Period)|Withdrawal by Subject|0
5150549|NCT01469013|17787632|P9|Part A (Treatment Period)|Withdrawal by Subject|0
5150550|NCT01469013|17787633|P8|Part A (Treatment Period)|Withdrawal by Subject|0
5150551|NCT01469013|17787634|P7|Part A (Treatment Period)|Withdrawal by Subject|0
5150552|NCT01469013|17787635|P6|Part A (Treatment Period)|Withdrawal by Subject|0
5150553|NCT01469013|17787636|P5|Part A (Treatment Period)|Withdrawal by Subject|0
5150554|NCT01469013|17787637|P4|Part A (Treatment Period)|Withdrawal by Subject|0
5150555|NCT01469013|17787638|P3|Part A (Treatment Period)|Withdrawal by Subject|1
5150556|NCT01469013|17787639|P2|Part A (Treatment Period)|Withdrawal by Subject|0
5150557|NCT01469013|17787640|P1|Part A (Treatment Period)|Withdrawal by Subject|0
5150558|NCT01469013|17787628|P13|Part A (Treatment Period)|Adverse Event|0
5150559|NCT01469013|17787629|P12|Part A (Treatment Period)|Adverse Event|0
5150560|NCT01469013|17787630|P11|Part A (Treatment Period)|Adverse Event|0
5150561|NCT01469013|17787631|P10|Part A (Treatment Period)|Adverse Event|0
5150562|NCT01469013|17787632|P9|Part A (Treatment Period)|Adverse Event|0
5150563|NCT01469013|17787633|P8|Part A (Treatment Period)|Adverse Event|0
5150564|NCT01469013|17787634|P7|Part A (Treatment Period)|Adverse Event|0
5150565|NCT01469013|17787635|P6|Part A (Treatment Period)|Adverse Event|0
5150566|NCT01469013|17787636|P5|Part A (Treatment Period)|Adverse Event|1
5150567|NCT01469013|17787637|P4|Part A (Treatment Period)|Adverse Event|0
5150568|NCT01469013|17787638|P3|Part A (Treatment Period)|Adverse Event|0
5150569|NCT01469013|17787639|P2|Part A (Treatment Period)|Adverse Event|0
5150570|NCT01469013|17787640|P1|Part A (Treatment Period)|Adverse Event|1
5150571|NCT01469000|17787725|P2|Overall Study|Sponsor Decision|1
5150572|NCT01469000|17787726|P1|Overall Study|Sponsor Decision|4
5150573|NCT01469000|17787725|P2|Overall Study|Withdrawal by Subject|3
5150574|NCT01469000|17787726|P1|Overall Study|Withdrawal by Subject|16
5150575|NCT01468987|17787746|P2|Overall Study|Sponsor Decision|0
5150576|NCT01468987|17787747|P1|Overall Study|Sponsor Decision|1
5150577|NCT01468987|17787746|P2|Overall Study|Physician Decision|15
5150578|NCT01468987|17787747|P1|Overall Study|Physician Decision|8
5150579|NCT01468987|17787746|P2|Overall Study|Withdrawal by Subject|28
5150580|NCT01468987|17787747|P1|Overall Study|Withdrawal by Subject|28
5150581|NCT01468987|17787746|P2|Overall Study|Protocol Violation|2
5150582|NCT01468987|17787747|P1|Overall Study|Protocol Violation|8
5150583|NCT01468987|17787746|P2|Overall Study|Lost to Follow-up|5
5150584|NCT01468987|17787747|P1|Overall Study|Lost to Follow-up|10
5150585|NCT01468987|17787746|P2|Overall Study|Death|1
5150586|NCT01468987|17787747|P1|Overall Study|Death|4
5150587|NCT01468987|17787746|P2|Overall Study|Adverse Event|9
5150588|NCT01468987|17787747|P1|Overall Study|Adverse Event|12
5150589|NCT01468909|17787924|P2|Overall Study|Never Treated|2
5150590|NCT01468909|17787925|P1|Overall Study|Never Treated|2
5150591|NCT01468818|17787958|P1|Overall Study|Death during treatment|2
5150592|NCT01468597|17787972|P1|Overall Study|no platelet function data|5
5150593|NCT01468597|17787972|P1|Overall Study|off-pump CABG|1
5150594|NCT01468597|17787972|P1|Overall Study|concomitant valves|12
5150595|NCT01468597|17787972|P1|Overall Study|Found ineligible|17
5150596|NCT01468311|17788021|P1|Overall Study|Withdrawal by Subject|1
5150597|NCT01468311|17788021|P1|Overall Study|mobilization failure|1
5150598|NCT01468233|17788033|P6|Treatment Period 2|Other|0
5150599|NCT01468233|17788034|P5|Treatment Period 2|Other|1
5150600|NCT01468233|17788035|P4|Treatment Period 2|Other|0
5150601|NCT01468233|17788036|P3|Treatment Period 2|Other|3
5150602|NCT01468233|17788037|P2|Treatment Period 2|Other|0
5150603|NCT01468233|17788038|P1|Treatment Period 2|Other|0
5150604|NCT01468233|17788033|P6|Treatment Period 2|Lost to Follow-up|0
5150605|NCT01468233|17788034|P5|Treatment Period 2|Lost to Follow-up|2
5150606|NCT01468233|17788035|P4|Treatment Period 2|Lost to Follow-up|0
5150607|NCT01468233|17788036|P3|Treatment Period 2|Lost to Follow-up|3
5150608|NCT01468233|17788037|P2|Treatment Period 2|Lost to Follow-up|0
5150609|NCT01468233|17788038|P1|Treatment Period 2|Lost to Follow-up|0
5150610|NCT01468233|17788033|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
5150611|NCT01468233|17788034|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
5150612|NCT01468233|17788035|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
5150613|NCT01468233|17788036|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
5150614|NCT01468233|17788037|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
5150615|NCT01468233|17788038|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
5150616|NCT01468233|17788033|P6|Treatment Period 2|Withdrawal by Subject|1
5150617|NCT01468233|17788034|P5|Treatment Period 2|Withdrawal by Subject|1
5150618|NCT01468233|17788035|P4|Treatment Period 2|Withdrawal by Subject|1
5150619|NCT01468233|17788036|P3|Treatment Period 2|Withdrawal by Subject|9
5150620|NCT01468233|17788037|P2|Treatment Period 2|Withdrawal by Subject|0
5150621|NCT01468233|17788038|P1|Treatment Period 2|Withdrawal by Subject|0
5150622|NCT01468233|17788033|P6|Treatment Period 2|Lack of Efficacy|1
5150623|NCT01468233|17788034|P5|Treatment Period 2|Lack of Efficacy|0
5150624|NCT01468233|17788035|P4|Treatment Period 2|Lack of Efficacy|2
5150625|NCT01468233|17788036|P3|Treatment Period 2|Lack of Efficacy|9
5150626|NCT01468233|17788037|P2|Treatment Period 2|Lack of Efficacy|0
5150627|NCT01468233|17788038|P1|Treatment Period 2|Lack of Efficacy|0
5150628|NCT01468233|17788033|P6|Treatment Period 2|Adverse Event|1
5150629|NCT01468233|17788034|P5|Treatment Period 2|Adverse Event|2
5150630|NCT01468233|17788035|P4|Treatment Period 2|Adverse Event|0
5150631|NCT01468233|17788036|P3|Treatment Period 2|Adverse Event|3
5150632|NCT01468233|17788037|P2|Treatment Period 2|Adverse Event|0
5150633|NCT01468233|17788038|P1|Treatment Period 2|Adverse Event|0
5150634|NCT01468233|17788033|P6|Treatment Period 1|Other|0
5150635|NCT01468233|17788034|P5|Treatment Period 1|Other|0
5150636|NCT01468233|17788035|P4|Treatment Period 1|Other|0
5150637|NCT01468233|17788036|P3|Treatment Period 1|Other|0
5150638|NCT01468233|17788037|P2|Treatment Period 1|Other|1
5150639|NCT01468233|17788038|P1|Treatment Period 1|Other|1
5150640|NCT01468233|17788033|P6|Treatment Period 1|Lost to Follow-up|0
5150641|NCT01468233|17788034|P5|Treatment Period 1|Lost to Follow-up|0
5150642|NCT01468233|17788035|P4|Treatment Period 1|Lost to Follow-up|0
5150643|NCT01468233|17788036|P3|Treatment Period 1|Lost to Follow-up|0
5150644|NCT01468233|17788037|P2|Treatment Period 1|Lost to Follow-up|0
5150645|NCT01468233|17788038|P1|Treatment Period 1|Lost to Follow-up|3
5150646|NCT01468233|17788033|P6|Treatment Period 1|Withdrawal by Subject|0
5150647|NCT01468233|17788034|P5|Treatment Period 1|Withdrawal by Subject|0
5150648|NCT01468233|17788035|P4|Treatment Period 1|Withdrawal by Subject|0
5150649|NCT01468233|17788036|P3|Treatment Period 1|Withdrawal by Subject|0
5150650|NCT01468233|17788037|P2|Treatment Period 1|Withdrawal by Subject|4
5150651|NCT01468233|17788038|P1|Treatment Period 1|Withdrawal by Subject|3
5150652|NCT01468233|17788033|P6|Treatment Period 1|Adverse Event|0
5150653|NCT01468233|17788034|P5|Treatment Period 1|Adverse Event|0
5150654|NCT01468233|17788035|P4|Treatment Period 1|Adverse Event|0
5150655|NCT01468233|17788036|P3|Treatment Period 1|Adverse Event|0
5150656|NCT01468233|17788037|P2|Treatment Period 1|Adverse Event|3
5150657|NCT01468233|17788038|P1|Treatment Period 1|Adverse Event|5
5150658|NCT01468207|17788060|P6|Treatment Period 2|Other|2
5150659|NCT01468207|17788061|P5|Treatment Period 2|Other|1
5150660|NCT01468207|17788062|P4|Treatment Period 2|Other|1
5150661|NCT01468207|17788063|P3|Treatment Period 2|Other|5
5150662|NCT01468207|17788064|P2|Treatment Period 2|Other|0
5150663|NCT01468207|17788065|P1|Treatment Period 2|Other|0
5150664|NCT01468207|17788060|P6|Treatment Period 2|Lost to Follow-up|0
5150665|NCT01468207|17788061|P5|Treatment Period 2|Lost to Follow-up|0
5150666|NCT01468207|17788062|P4|Treatment Period 2|Lost to Follow-up|1
5150667|NCT01468207|17788063|P3|Treatment Period 2|Lost to Follow-up|5
5150668|NCT01468207|17788064|P2|Treatment Period 2|Lost to Follow-up|0
5150669|NCT01468207|17788065|P1|Treatment Period 2|Lost to Follow-up|0
5150670|NCT01468207|17788060|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
5150671|NCT01468207|17788061|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
5150672|NCT01468207|17788062|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
5150673|NCT01468207|17788063|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
5150674|NCT01468207|17788064|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
5150675|NCT01468207|17788065|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
5150676|NCT01468207|17788060|P6|Treatment Period 2|Withdrawal by Subject|2
5150677|NCT01468207|17788061|P5|Treatment Period 2|Withdrawal by Subject|0
5150678|NCT01468207|17788062|P4|Treatment Period 2|Withdrawal by Subject|0
5150679|NCT01468207|17788063|P3|Treatment Period 2|Withdrawal by Subject|5
5150680|NCT01468207|17788064|P2|Treatment Period 2|Withdrawal by Subject|0
5150681|NCT01468207|17788065|P1|Treatment Period 2|Withdrawal by Subject|0
5150682|NCT01468207|17788060|P6|Treatment Period 2|Lack of Efficacy|2
5150683|NCT01468207|17788061|P5|Treatment Period 2|Lack of Efficacy|0
5150684|NCT01468207|17788062|P4|Treatment Period 2|Lack of Efficacy|1
5150685|NCT01468207|17788063|P3|Treatment Period 2|Lack of Efficacy|1
5150686|NCT01468207|17788064|P2|Treatment Period 2|Lack of Efficacy|0
5150687|NCT01468207|17788065|P1|Treatment Period 2|Lack of Efficacy|0
5150688|NCT01468207|17788060|P6|Treatment Period 2|Adverse Event|1
5150689|NCT01468207|17788061|P5|Treatment Period 2|Adverse Event|2
5150690|NCT01468207|17788062|P4|Treatment Period 2|Adverse Event|1
5150691|NCT01468207|17788063|P3|Treatment Period 2|Adverse Event|6
5150692|NCT01468207|17788064|P2|Treatment Period 2|Adverse Event|0
5150693|NCT01468207|17788065|P1|Treatment Period 2|Adverse Event|0
5150694|NCT01468207|17788060|P6|Treatment Period 1|Other|0
5150695|NCT01468207|17788061|P5|Treatment Period 1|Other|0
5150696|NCT01468207|17788062|P4|Treatment Period 1|Other|0
5150697|NCT01468207|17788063|P3|Treatment Period 1|Other|0
5150698|NCT01468207|17788064|P2|Treatment Period 1|Other|2
5150699|NCT01468207|17788065|P1|Treatment Period 1|Other|0
5150700|NCT01468207|17788060|P6|Treatment Period 1|Lost to Follow-up|0
5150701|NCT01468207|17788061|P5|Treatment Period 1|Lost to Follow-up|0
5150702|NCT01468207|17788062|P4|Treatment Period 1|Lost to Follow-up|0
5150703|NCT01468207|17788063|P3|Treatment Period 1|Lost to Follow-up|0
5150704|NCT01468207|17788064|P2|Treatment Period 1|Lost to Follow-up|1
5150705|NCT01468207|17788065|P1|Treatment Period 1|Lost to Follow-up|2
5150706|NCT01468207|17788060|P6|Treatment Period 1|Withdrawal by Subject|0
5150707|NCT01468207|17788061|P5|Treatment Period 1|Withdrawal by Subject|0
5150708|NCT01468207|17788062|P4|Treatment Period 1|Withdrawal by Subject|0
5150709|NCT01468207|17788063|P3|Treatment Period 1|Withdrawal by Subject|0
5150710|NCT01468207|17788064|P2|Treatment Period 1|Withdrawal by Subject|4
5150711|NCT01468207|17788065|P1|Treatment Period 1|Withdrawal by Subject|5
5150712|NCT01468207|17788060|P6|Treatment Period 1|Protocol Violation|0
5150713|NCT01468207|17788061|P5|Treatment Period 1|Protocol Violation|0
5150714|NCT01468207|17788062|P4|Treatment Period 1|Protocol Violation|0
5150715|NCT01468207|17788063|P3|Treatment Period 1|Protocol Violation|0
5150716|NCT01468207|17788064|P2|Treatment Period 1|Protocol Violation|1
5150717|NCT01468207|17788065|P1|Treatment Period 1|Protocol Violation|1
5150718|NCT01468207|17788060|P6|Treatment Period 1|Adverse Event|0
5150719|NCT01468207|17788061|P5|Treatment Period 1|Adverse Event|0
5150720|NCT01468207|17788062|P4|Treatment Period 1|Adverse Event|0
5150721|NCT01468207|17788063|P3|Treatment Period 1|Adverse Event|0
5150722|NCT01468207|17788064|P2|Treatment Period 1|Adverse Event|0
5150723|NCT01468207|17788065|P1|Treatment Period 1|Adverse Event|1
5150724|NCT01468181|17788090|P5|Overall Study|Withdrawal by Subject|0
5150725|NCT01468181|17788091|P4|Overall Study|Withdrawal by Subject|0
5150726|NCT01468181|17788092|P3|Overall Study|Withdrawal by Subject|0
5150727|NCT01468181|17788093|P2|Overall Study|Withdrawal by Subject|1
5150728|NCT01468181|17788094|P1|Overall Study|Withdrawal by Subject|0
5150729|NCT01468181|17788090|P5|Overall Study|Lost to Follow-up|1
5150730|NCT01468181|17788091|P4|Overall Study|Lost to Follow-up|0
5150731|NCT01468181|17788092|P3|Overall Study|Lost to Follow-up|1
5150732|NCT01468181|17788093|P2|Overall Study|Lost to Follow-up|0
5150733|NCT01468181|17788094|P1|Overall Study|Lost to Follow-up|0
5150734|NCT01468181|17788090|P5|Overall Study|Physician Decision|1
5150735|NCT01468181|17788091|P4|Overall Study|Physician Decision|1
5150736|NCT01468181|17788092|P3|Overall Study|Physician Decision|0
5150737|NCT01468181|17788093|P2|Overall Study|Physician Decision|0
5150738|NCT01468181|17788094|P1|Overall Study|Physician Decision|0
5150739|NCT01468181|17788090|P5|Overall Study|Protocol Violation|1
5150740|NCT01468181|17788091|P4|Overall Study|Protocol Violation|0
5150741|NCT01468181|17788092|P3|Overall Study|Protocol Violation|1
5150742|NCT01468181|17788093|P2|Overall Study|Protocol Violation|0
5150743|NCT01468181|17788094|P1|Overall Study|Protocol Violation|2
5150744|NCT01468181|17788090|P5|Overall Study|Adverse Event|2
5150745|NCT01468181|17788091|P4|Overall Study|Adverse Event|2
5150746|NCT01468181|17788092|P3|Overall Study|Adverse Event|6
5150747|NCT01468181|17788093|P2|Overall Study|Adverse Event|1
5150748|NCT01468181|17788094|P1|Overall Study|Adverse Event|8
5150749|NCT01468077|17788143|P2|Overall Study|Physician Decision|0
5150750|NCT01468077|17788144|P1|Overall Study|Physician Decision|1
5150751|NCT01468077|17788143|P2|Overall Study|Lack of Efficacy|1
5150752|NCT01468077|17788144|P1|Overall Study|Lack of Efficacy|1
5150753|NCT01468077|17788143|P2|Overall Study|Adverse Event|2
5150754|NCT01468077|17788144|P1|Overall Study|Adverse Event|2
5150755|NCT01467960|17788206|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
5150756|NCT01467960|17788207|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
5150757|NCT01467960|17788208|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
5150758|NCT01467960|17788209|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
5150759|NCT01467960|17788210|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
5150760|NCT01467960|17788211|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
5150761|NCT01467713|17788270|P4|Overall Study|Reason not Specified|7
5150762|NCT01467713|17788271|P3|Overall Study|Reason not Specified|8
5150763|NCT01467713|17788272|P2|Overall Study|Reason not Specified|11
5150764|NCT01467713|17788273|P1|Overall Study|Reason not Specified|6
5150765|NCT01467713|17788270|P4|Overall Study|Relapse|35
5150766|NCT01467713|17788271|P3|Overall Study|Relapse|28
5150767|NCT01467713|17788272|P2|Overall Study|Relapse|25
5150768|NCT01467713|17788273|P1|Overall Study|Relapse|35
5150769|NCT01467713|17788270|P4|Overall Study|Pregnancy|3
5150770|NCT01467713|17788271|P3|Overall Study|Pregnancy|1
5150771|NCT01467713|17788272|P2|Overall Study|Pregnancy|1
5150772|NCT01467713|17788273|P1|Overall Study|Pregnancy|0
5150773|NCT01467713|17788270|P4|Overall Study|Study Termination|29
5150774|NCT01467713|17788271|P3|Overall Study|Study Termination|28
5150775|NCT01467713|17788272|P2|Overall Study|Study Termination|33
5150776|NCT01467713|17788273|P1|Overall Study|Study Termination|23
5150777|NCT01467713|17788270|P4|Overall Study|Voluntary Withdrawal|20
5150778|NCT01467713|17788271|P3|Overall Study|Voluntary Withdrawal|21
5150779|NCT01467713|17788272|P2|Overall Study|Voluntary Withdrawal|14
5150780|NCT01467713|17788273|P1|Overall Study|Voluntary Withdrawal|18
5150781|NCT01467713|17788270|P4|Overall Study|Lost to Follow-up|9
5150782|NCT01467713|17788271|P3|Overall Study|Lost to Follow-up|6
5150783|NCT01467713|17788272|P2|Overall Study|Lost to Follow-up|12
5150784|NCT01467713|17788273|P1|Overall Study|Lost to Follow-up|9
5150785|NCT01467713|17788270|P4|Overall Study|Major Protocol Deviation|1
5150786|NCT01467713|17788271|P3|Overall Study|Major Protocol Deviation|4
5150787|NCT01467713|17788272|P2|Overall Study|Major Protocol Deviation|4
5150788|NCT01467713|17788273|P1|Overall Study|Major Protocol Deviation|2
5150789|NCT01467713|17788270|P4|Overall Study|Pretreatment Event or Adverse Event|5
5150790|NCT01467713|17788271|P3|Overall Study|Pretreatment Event or Adverse Event|6
5150791|NCT01467713|17788272|P2|Overall Study|Pretreatment Event or Adverse Event|4
5150792|NCT01467713|17788273|P1|Overall Study|Pretreatment Event or Adverse Event|9
5150793|NCT01467700|17788327|P4|Overall Study|Reason not Specified|8
5150794|NCT01467700|17788328|P3|Overall Study|Reason not Specified|2
5150795|NCT01467700|17788329|P2|Overall Study|Reason not Specified|3
5150796|NCT01467700|17788330|P1|Overall Study|Reason not Specified|1
5150797|NCT01467700|17788327|P4|Overall Study|Lack of Efficacy|1
5150798|NCT01467700|17788328|P3|Overall Study|Lack of Efficacy|2
5150799|NCT01467700|17788329|P2|Overall Study|Lack of Efficacy|0
5150800|NCT01467700|17788330|P1|Overall Study|Lack of Efficacy|2
5150801|NCT01467700|17788327|P4|Overall Study|Pregnancy|0
5150802|NCT01467700|17788328|P3|Overall Study|Pregnancy|1
5150803|NCT01467700|17788329|P2|Overall Study|Pregnancy|1
5150804|NCT01467700|17788330|P1|Overall Study|Pregnancy|0
5150805|NCT01467700|17788327|P4|Overall Study|Study Termination|7
5150806|NCT01467700|17788328|P3|Overall Study|Study Termination|10
5150807|NCT01467700|17788329|P2|Overall Study|Study Termination|5
5150808|NCT01467700|17788330|P1|Overall Study|Study Termination|6
5150809|NCT01467700|17788327|P4|Overall Study|Voluntary Withdrawal|2
5150810|NCT01467700|17788328|P3|Overall Study|Voluntary Withdrawal|6
5150811|NCT01467700|17788329|P2|Overall Study|Voluntary Withdrawal|7
5150812|NCT01467700|17788330|P1|Overall Study|Voluntary Withdrawal|5
5150813|NCT01467700|17788327|P4|Overall Study|Lost to Follow-up|3
5150814|NCT01467700|17788328|P3|Overall Study|Lost to Follow-up|2
5150815|NCT01467700|17788329|P2|Overall Study|Lost to Follow-up|5
5150816|NCT01467700|17788330|P1|Overall Study|Lost to Follow-up|6
5150817|NCT01467700|17788327|P4|Overall Study|Major Protocol Deviation|3
5150818|NCT01467700|17788328|P3|Overall Study|Major Protocol Deviation|2
5150819|NCT01467700|17788329|P2|Overall Study|Major Protocol Deviation|3
5150820|NCT01467700|17788330|P1|Overall Study|Major Protocol Deviation|3
5150821|NCT01467700|17788327|P4|Overall Study|Pretreatment Event or Adverse Event|3
5150822|NCT01467700|17788328|P3|Overall Study|Pretreatment Event or Adverse Event|2
5150823|NCT01467700|17788329|P2|Overall Study|Pretreatment Event or Adverse Event|4
5150824|NCT01467700|17788330|P1|Overall Study|Pretreatment Event or Adverse Event|6
5150825|NCT01467661|17788372|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
5150826|NCT01467661|17788372|P1|Overall Study|Lack of Efficacy|3
5150827|NCT01467661|17788372|P1|Overall Study|Withdrawal by Subject|1
5150828|NCT01467661|17788372|P1|Overall Study|Adverse Event|16
5150829|NCT01467583|17788392|P3|Overall Study|Protocol Violation|2
5150830|NCT01467583|17788393|P2|Overall Study|Protocol Violation|0
5150831|NCT01467583|17788394|P1|Overall Study|Protocol Violation|0
5150832|NCT01467583|17788392|P3|Overall Study|Withdrawal by Subject|0
5150833|NCT01467583|17788393|P2|Overall Study|Withdrawal by Subject|0
5150834|NCT01467583|17788394|P1|Overall Study|Withdrawal by Subject|1
5150835|NCT01467583|17788392|P3|Overall Study|Death|0
5150836|NCT01467583|17788393|P2|Overall Study|Death|1
5150837|NCT01467583|17788394|P1|Overall Study|Death|1
5150838|NCT01467570|17788407|P2|Overall Study|Lost to Follow-up|9
5150839|NCT01467570|17788408|P1|Overall Study|Lost to Follow-up|8
5150840|NCT01467505|17788445|P2|Overall Study|Study Terminated by Sponsor|3
5150841|NCT01467505|17788446|P1|Overall Study|Study Terminated by Sponsor|28
5150842|NCT01467505|17788445|P2|Overall Study|Withdrawal by Subject|0
5150843|NCT01467505|17788446|P1|Overall Study|Withdrawal by Subject|4
5150844|NCT01467505|17788445|P2|Overall Study|Adverse Event|0
5150845|NCT01467505|17788446|P1|Overall Study|Adverse Event|1
5150846|NCT01467492|17788478|P2|Overall Study|Enrolled But Not Treated|0
5150847|NCT01467492|17788479|P1|Overall Study|Enrolled But Not Treated|1
5150848|NCT01467492|17788478|P2|Overall Study|Undefined|0
5150849|NCT01467492|17788479|P1|Overall Study|Undefined|2
5150850|NCT01467492|17788478|P2|Overall Study|Lost to Follow-up|2
5150851|NCT01467492|17788479|P1|Overall Study|Lost to Follow-up|3
5150852|NCT01467492|17788478|P2|Overall Study|Adverse Event|3
5150853|NCT01467492|17788479|P1|Overall Study|Adverse Event|4
5150854|NCT01467492|17788478|P2|Overall Study|Study Terminated by Sponsor|4
5150855|NCT01467492|17788479|P1|Overall Study|Study Terminated by Sponsor|6
5150856|NCT01467492|17788478|P2|Overall Study|Withdrawal by Subject|4
5150857|NCT01467492|17788479|P1|Overall Study|Withdrawal by Subject|6
5150858|NCT01467479|17788503|P3|Overall Study|Other|0
5150859|NCT01467479|17788504|P2|Overall Study|Other|0
5150860|NCT01467479|17788505|P1|Overall Study|Other|1
5150861|NCT01467479|17788503|P3|Overall Study|Study Terminated by Sponsor|3
5150862|NCT01467479|17788504|P2|Overall Study|Study Terminated by Sponsor|3
5150863|NCT01467479|17788505|P1|Overall Study|Study Terminated by Sponsor|1
5150864|NCT01467479|17788503|P3|Overall Study|Withdrawal of Consent|7
5150865|NCT01467479|17788504|P2|Overall Study|Withdrawal of Consent|7
5150866|NCT01467479|17788505|P1|Overall Study|Withdrawal of Consent|3
5150867|NCT01467479|17788503|P3|Overall Study|Lost to Follow-up|3
5150868|NCT01467479|17788504|P2|Overall Study|Lost to Follow-up|5
5150869|NCT01467479|17788505|P1|Overall Study|Lost to Follow-up|2
5150870|NCT01467479|17788503|P3|Overall Study|Death|1
5150871|NCT01467479|17788504|P2|Overall Study|Death|0
5150872|NCT01467479|17788505|P1|Overall Study|Death|0
5150873|NCT01467479|17788503|P3|Overall Study|Adverse Event|0
5150874|NCT01467479|17788504|P2|Overall Study|Adverse Event|2
5150875|NCT01467479|17788505|P1|Overall Study|Adverse Event|1
5150876|NCT01467479|17788503|P3|Overall Study|No Study Medication|2
5150877|NCT01467479|17788504|P2|Overall Study|No Study Medication|0
5150878|NCT01467479|17788505|P1|Overall Study|No Study Medication|1
5150879|NCT01467466|17788536|P4|Overall Study|No Endpoint Blood Draw|43
5150880|NCT01467466|17788537|P3|Overall Study|No Endpoint Blood Draw|51
5150881|NCT01467466|17788538|P2|Overall Study|No Endpoint Blood Draw|32
5150882|NCT01467466|17788539|P1|Overall Study|No Endpoint Blood Draw|38
5150883|NCT01467466|17788536|P4|Overall Study|Procedure Cancelled|29
5150884|NCT01467466|17788537|P3|Overall Study|Procedure Cancelled|25
5150885|NCT01467466|17788538|P2|Overall Study|Procedure Cancelled|45
5150886|NCT01467466|17788539|P1|Overall Study|Procedure Cancelled|46
5150887|NCT01467466|17788536|P4|Overall Study|Revoked Consent Prior To Procedure|5
5150888|NCT01467466|17788537|P3|Overall Study|Revoked Consent Prior To Procedure|15
5150889|NCT01467466|17788538|P2|Overall Study|Revoked Consent Prior To Procedure|9
5150890|NCT01467466|17788539|P1|Overall Study|Revoked Consent Prior To Procedure|10
5150891|NCT01467466|17788536|P4|Overall Study|Withdrawal by Subject|11
5150892|NCT01467466|17788537|P3|Overall Study|Withdrawal by Subject|13
5150893|NCT01467466|17788538|P2|Overall Study|Withdrawal by Subject|18
5150894|NCT01467466|17788539|P1|Overall Study|Withdrawal by Subject|15
5150895|NCT01467427|17788551|P2|Overall Study|Not continuing in extension phase|2
5150896|NCT01467427|17788552|P1|Overall Study|Not continuing in extension phase|0
5150897|NCT01467427|17788551|P2|Overall Study|Entered extension phase|11
5150898|NCT01467427|17788552|P1|Overall Study|Entered extension phase|11
5150899|NCT01467427|17788551|P2|Overall Study|Withdrawal by Subject|0
5150900|NCT01467427|17788552|P1|Overall Study|Withdrawal by Subject|1
5150901|NCT01467271|17788570|P1|Overall Study|Other reason|14
5150902|NCT01467271|17788570|P1|Overall Study|Retraction of patient's consent|21
5150903|NCT01467271|17788570|P1|Overall Study|Lost to Follow-up|83
5150904|NCT01467271|17788570|P1|Overall Study|Death|84
5150905|NCT01467076|17788577|P3|Overall Study|Lost to Follow-up|0
5150906|NCT01467076|17788578|P2|Overall Study|Lost to Follow-up|0
5150907|NCT01467076|17788579|P1|Overall Study|Lost to Follow-up|1
5150908|NCT01466881|17788651|P1|Overall Study|Other reason not protocol specified|5
5150909|NCT01466881|17788651|P1|Overall Study|Death|4
5150910|NCT01466881|17788651|P1|Overall Study|Progression/relapse|20
5150911|NCT01466881|17788651|P1|Overall Study|Adverse Event|6
5150912|NCT01466881|17788651|P1|Overall Study|Ineligible|5
5150913|NCT01466790|17788668|P8|Overall Study|Withdrawal by Subject|1
5150914|NCT01466790|17788669|P7|Overall Study|Withdrawal by Subject|1
5150915|NCT01466790|17788670|P6|Overall Study|Withdrawal by Subject|0
5150916|NCT01466790|17788671|P5|Overall Study|Withdrawal by Subject|1
5150917|NCT01466790|17788672|P4|Overall Study|Withdrawal by Subject|0
5150918|NCT01466790|17788673|P3|Overall Study|Withdrawal by Subject|0
5150919|NCT01466790|17788674|P2|Overall Study|Withdrawal by Subject|1
5150920|NCT01466790|17788675|P1|Overall Study|Withdrawal by Subject|1
5150921|NCT01466790|17788668|P8|Overall Study|Lost to Follow-up|0
5150922|NCT01466790|17788669|P7|Overall Study|Lost to Follow-up|0
5150923|NCT01466790|17788670|P6|Overall Study|Lost to Follow-up|0
5150924|NCT01466790|17788671|P5|Overall Study|Lost to Follow-up|0
5150925|NCT01466790|17788672|P4|Overall Study|Lost to Follow-up|0
5150926|NCT01466790|17788673|P3|Overall Study|Lost to Follow-up|0
5150927|NCT01466790|17788674|P2|Overall Study|Lost to Follow-up|0
5150928|NCT01466790|17788675|P1|Overall Study|Lost to Follow-up|2
5150929|NCT01466790|17788668|P8|Overall Study|Adverse Event|0
5150930|NCT01466790|17788669|P7|Overall Study|Adverse Event|0
5150931|NCT01466790|17788670|P6|Overall Study|Adverse Event|0
5150932|NCT01466790|17788671|P5|Overall Study|Adverse Event|2
5150933|NCT01466790|17788672|P4|Overall Study|Adverse Event|0
5150934|NCT01466790|17788673|P3|Overall Study|Adverse Event|0
5150935|NCT01466790|17788674|P2|Overall Study|Adverse Event|0
5150936|NCT01466790|17788675|P1|Overall Study|Adverse Event|1
5150937|NCT01466673|17788771|P2|Overall Study|Adverse Event|1
5150938|NCT01466673|17788772|P1|Overall Study|Adverse Event|2
5150939|NCT01466673|17788771|P2|Overall Study|Lost to Follow-up|5
5150940|NCT01466673|17788772|P1|Overall Study|Lost to Follow-up|3
5150941|NCT01466673|17788771|P2|Overall Study|Non-compliance with study treatment|0
5150942|NCT01466673|17788772|P1|Overall Study|Non-compliance with study treatment|2
5150943|NCT01466660|17788798|P2|Overall Study|Other reason not defined above|8
5150944|NCT01466660|17788799|P1|Overall Study|Other reason not defined above|10
5150945|NCT01466660|17788798|P2|Overall Study|Refused continuation of trial medication|3
5150946|NCT01466660|17788799|P1|Overall Study|Refused continuation of trial medication|4
5150947|NCT01466660|17788798|P2|Overall Study|Protocol Violation|1
5150948|NCT01466660|17788799|P1|Overall Study|Protocol Violation|2
5150949|NCT01466660|17788798|P2|Overall Study|Other adverse event|18
5150950|NCT01466660|17788799|P1|Overall Study|Other adverse event|19
5150951|NCT01466660|17788798|P2|Overall Study|Worsening of underlying cancer disease|2
5150952|NCT01466660|17788799|P1|Overall Study|Worsening of underlying cancer disease|5
5150953|NCT01466660|17788798|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
5150954|NCT01466660|17788799|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
5150955|NCT01466595|17788825|P2|Overall Study|Withdrawal by Subject|1
5150956|NCT01466595|17788826|P1|Overall Study|Withdrawal by Subject|0
5150957|NCT01466491|17788920|P4|Overall Study|Missing Data|0
5150958|NCT01466491|17788921|P3|Overall Study|Missing Data|1
5150959|NCT01466491|17788922|P2|Overall Study|Missing Data|0
5150960|NCT01466491|17788923|P1|Overall Study|Missing Data|0
5150961|NCT01466491|17788920|P4|Overall Study|Protocol Violation|0
5150962|NCT01466491|17788921|P3|Overall Study|Protocol Violation|2
5150963|NCT01466491|17788922|P2|Overall Study|Protocol Violation|3
5150964|NCT01466491|17788923|P1|Overall Study|Protocol Violation|0
5150965|NCT01466387|17788943|P6|Overall Study|Protocol Violation|0
5150966|NCT01466387|17788944|P5|Overall Study|Protocol Violation|0
5150967|NCT01466387|17788945|P4|Overall Study|Protocol Violation|1
5150968|NCT01466387|17788946|P3|Overall Study|Protocol Violation|0
5150969|NCT01466387|17788947|P2|Overall Study|Protocol Violation|0
5150970|NCT01466387|17788948|P1|Overall Study|Protocol Violation|1
5150971|NCT01466387|17788943|P6|Overall Study|Lost to Follow-up|1
5150972|NCT01466387|17788944|P5|Overall Study|Lost to Follow-up|0
5150973|NCT01466387|17788945|P4|Overall Study|Lost to Follow-up|0
5150974|NCT01466387|17788946|P3|Overall Study|Lost to Follow-up|0
5150975|NCT01466387|17788947|P2|Overall Study|Lost to Follow-up|0
5150976|NCT01466387|17788948|P1|Overall Study|Lost to Follow-up|0
5150977|NCT01466387|17788943|P6|Overall Study|Adverse Event|0
5150978|NCT01466387|17788944|P5|Overall Study|Adverse Event|0
5150979|NCT01466387|17788945|P4|Overall Study|Adverse Event|1
5150980|NCT01466387|17788946|P3|Overall Study|Adverse Event|1
5150981|NCT01466387|17788947|P2|Overall Study|Adverse Event|0
5150982|NCT01466387|17788948|P1|Overall Study|Adverse Event|0
5150983|NCT01466348|17789009|P2|Period I - First Intervention|Withdrawal by Subject|1
5150984|NCT01466348|17789010|P1|Period I - First Intervention|Withdrawal by Subject|0
5150985|NCT01466270|17789038|P2|Overall Study|Multiple|1
5150986|NCT01466270|17789039|P1|Overall Study|Multiple|1
5150987|NCT01466270|17789038|P2|Overall Study|Toxicity|1
5150988|NCT01466270|17789039|P1|Overall Study|Toxicity|4
5150989|NCT01466270|17789038|P2|Overall Study|Progression|0
5150990|NCT01466270|17789039|P1|Overall Study|Progression|1
5150991|NCT01466270|17789038|P2|Overall Study|Lost to Follow-up|3
5150992|NCT01466270|17789039|P1|Overall Study|Lost to Follow-up|1
5150993|NCT01466270|17789038|P2|Overall Study|Physician Decision|0
5150994|NCT01466270|17789039|P1|Overall Study|Physician Decision|1
5150995|NCT01466270|17789038|P2|Overall Study|Withdrawal by Subject|1
5150996|NCT01466270|17789039|P1|Overall Study|Withdrawal by Subject|4
5150997|NCT01466192|17789051|P1|Overall Study|Withdrawal by Subject|3
5150998|NCT01466192|17789051|P1|Overall Study|Physician Decision|1
5150999|NCT01466179|17789055|P1|Overall Study|Other|3
5151000|NCT01466179|17789055|P1|Overall Study|Protocol Violation|2
5151001|NCT01466179|17789055|P1|Overall Study|Withdrawal by Subject|7
5151002|NCT01466179|17789055|P1|Overall Study|Death|7
5151003|NCT01466179|17789055|P1|Overall Study|Lack of Efficacy|14
5151004|NCT01466179|17789055|P1|Overall Study|Disease relapse|23
5151005|NCT01466179|17789055|P1|Overall Study|Adverse Event|32
5151006|NCT01466179|17789055|P1|Overall Study|Progressive disease|43
5151007|NCT01466179|17789055|P1|Overall Study|Physician Decision|46
5151008|NCT01466179|17789055|P1|Overall Study|Ongoing in core study|2
5151009|NCT01466166|17789075|P1|Overall Study|Other|20
5151010|NCT01466166|17789075|P1|Overall Study|Protocol Violation/Noncompliance|2
5151011|NCT01466166|17789075|P1|Overall Study|Sponsor Decision|4
5151012|NCT01466166|17789075|P1|Overall Study|Withdrawal by Subject|13
5151013|NCT01466166|17789075|P1|Overall Study|Elevated Serum Uric Acid|78
5151014|NCT01466166|17789075|P1|Overall Study|Adverse Event (Other than IR)|11
5151015|NCT01466166|17789075|P1|Overall Study|Infusion Reaction (IR)|27
5151016|NCT01466166|17789075|P1|Overall Study|Lost to Follow-up|7
5151017|NCT01466166|17789075|P1|Overall Study|Death|1
5151018|NCT01466153|17789089|P3|Overall Study|Other-Unspecified|2
5151019|NCT01466153|17789090|P2|Overall Study|Other-Unspecified|4
5151020|NCT01466153|17789091|P1|Overall Study|Other-Unspecified|6
5151021|NCT01466153|17789089|P3|Overall Study|Randomized-Not Treated|4
5151022|NCT01466153|17789090|P2|Overall Study|Randomized-Not Treated|3
5151023|NCT01466153|17789091|P1|Overall Study|Randomized-Not Treated|2
5151024|NCT01466153|17789089|P3|Overall Study|Investigator Discretion|2
5151025|NCT01466153|17789090|P2|Overall Study|Investigator Discretion|2
5151026|NCT01466153|17789091|P1|Overall Study|Investigator Discretion|3
5151027|NCT01466153|17789089|P3|Overall Study|Withdrawal of Consent|0
5151028|NCT01466153|17789090|P2|Overall Study|Withdrawal of Consent|0
5151029|NCT01466153|17789091|P1|Overall Study|Withdrawal of Consent|2
5151030|NCT01466153|17789089|P3|Overall Study|Adverse Event|17
5151031|NCT01466153|17789090|P2|Overall Study|Adverse Event|13
5151032|NCT01466153|17789091|P1|Overall Study|Adverse Event|14
5151033|NCT01466153|17789089|P3|Overall Study|Disease Progression|0
5151034|NCT01466153|17789090|P2|Overall Study|Disease Progression|2
5151035|NCT01466153|17789091|P1|Overall Study|Disease Progression|2
5151036|NCT01466062|17789146|P1|Overall Study|Withdrawal by Subject|1
5151037|NCT01466062|17789146|P1|Overall Study|Adverse Event|1
5151038|NCT01465997|17789169|P2|Overall Study|subject left participation SP0993|1
5151039|NCT01465997|17789170|P1|Overall Study|subject left participation SP0993|0
5151040|NCT01465997|17789169|P2|Overall Study|decision by site staff|1
5151041|NCT01465997|17789170|P1|Overall Study|decision by site staff|0
5151042|NCT01465997|17789169|P2|Overall Study|withdrew before follow-up|13
5151043|NCT01465997|17789170|P1|Overall Study|withdrew before follow-up|0
5151044|NCT01465997|17789169|P2|Overall Study|local lab unblinded site|0
5151045|NCT01465997|17789170|P1|Overall Study|local lab unblinded site|1
5151046|NCT01465997|17789169|P2|Overall Study|subject withdrew consent|0
5151047|NCT01465997|17789170|P1|Overall Study|subject withdrew consent|1
5151048|NCT01465997|17789169|P2|Overall Study|sponsor's decision|1
5151049|NCT01465997|17789170|P1|Overall Study|sponsor's decision|1
5151050|NCT01465997|17789169|P2|Overall Study|Death|1
5151051|NCT01465997|17789170|P1|Overall Study|Death|0
5151052|NCT01465997|17789169|P2|Overall Study|investigator's decision|1
5151053|NCT01465997|17789170|P1|Overall Study|investigator's decision|1
5151054|NCT01465997|17789169|P2|Overall Study|Withdrawal by Subject|35
5151055|NCT01465997|17789170|P1|Overall Study|Withdrawal by Subject|32
5151056|NCT01465997|17789169|P2|Overall Study|Lost to Follow-up|9
5151057|NCT01465997|17789170|P1|Overall Study|Lost to Follow-up|6
5151058|NCT01465997|17789169|P2|Overall Study|Protocol Violation|4
5151059|NCT01465997|17789170|P1|Overall Study|Protocol Violation|1
5151060|NCT01465997|17789169|P2|Overall Study|Lack of Efficacy|1
5151061|NCT01465997|17789170|P1|Overall Study|Lack of Efficacy|13
5151062|NCT01465997|17789169|P2|Overall Study|Adverse Event|22
5151063|NCT01465997|17789170|P1|Overall Study|Adverse Event|12
5151064|NCT01465958|17789180|P2|Subcutaneous (SC) Phase|Adverse Event|1
5151065|NCT01465958|17789181|P1|Subcutaneous (SC) Phase|Adverse Event|0
5151066|NCT01465958|17789180|P2|Run-in Phase|Protocol Violation|0
5151067|NCT01465958|17789181|P1|Run-in Phase|Protocol Violation|1
5151068|NCT01465802|17789202|P5|Overall Study|Death|2
5151069|NCT01465802|17789203|P4|Overall Study|Death|10
5151070|NCT01465802|17789204|P3|Overall Study|Death|0
5151071|NCT01465802|17789205|P2|Overall Study|Death|12
5151072|NCT01465802|17789206|P1|Overall Study|Death|15
5151073|NCT01465802|17789202|P5|Overall Study|Reason not specified|2
5151074|NCT01465802|17789203|P4|Overall Study|Reason not specified|10
5151075|NCT01465802|17789204|P3|Overall Study|Reason not specified|0
5151076|NCT01465802|17789205|P2|Overall Study|Reason not specified|4
5151077|NCT01465802|17789206|P1|Overall Study|Reason not specified|9
5151078|NCT01465802|17789202|P5|Overall Study|Lost to Follow-up|0
5151079|NCT01465802|17789203|P4|Overall Study|Lost to Follow-up|0
5151080|NCT01465802|17789204|P3|Overall Study|Lost to Follow-up|0
5151081|NCT01465802|17789205|P2|Overall Study|Lost to Follow-up|1
5151082|NCT01465802|17789206|P1|Overall Study|Lost to Follow-up|1
5151083|NCT01465802|17789202|P5|Overall Study|Withdrawal by Subject|1
5151084|NCT01465802|17789203|P4|Overall Study|Withdrawal by Subject|8
5151085|NCT01465802|17789204|P3|Overall Study|Withdrawal by Subject|0
5151086|NCT01465802|17789205|P2|Overall Study|Withdrawal by Subject|7
5151087|NCT01465802|17789206|P1|Overall Study|Withdrawal by Subject|7
5151088|NCT01465802|17789202|P5|Overall Study|Study terminated by sponsor|7
5151089|NCT01465802|17789203|P4|Overall Study|Study terminated by sponsor|1
5151090|NCT01465802|17789204|P3|Overall Study|Study terminated by sponsor|0
5151091|NCT01465802|17789205|P2|Overall Study|Study terminated by sponsor|0
5151092|NCT01465802|17789206|P1|Overall Study|Study terminated by sponsor|1
5151093|NCT01465763|17789258|P3|Overall Study|Death|0
5151094|NCT01465763|17789259|P2|Overall Study|Death|0
5151095|NCT01465763|17789260|P1|Overall Study|Death|1
5151096|NCT01465763|17789258|P3|Overall Study|Protocol Violation|1
5151097|NCT01465763|17789259|P2|Overall Study|Protocol Violation|1
5151098|NCT01465763|17789260|P1|Overall Study|Protocol Violation|4
5151099|NCT01465763|17789258|P3|Overall Study|Other|0
5151100|NCT01465763|17789259|P2|Overall Study|Other|0
5151101|NCT01465763|17789260|P1|Overall Study|Other|2
5151102|NCT01465763|17789258|P3|Overall Study|Adverse Event|1
5151103|NCT01465763|17789259|P2|Overall Study|Adverse Event|0
5151104|NCT01465763|17789260|P1|Overall Study|Adverse Event|9
5151105|NCT01465763|17789258|P3|Overall Study|Insufficient Clinical Response|1
5151106|NCT01465763|17789259|P2|Overall Study|Insufficient Clinical Response|0
5151107|NCT01465763|17789260|P1|Overall Study|Insufficient Clinical Response|11
5151108|NCT01465763|17789258|P3|Overall Study|Withdrawal by Subject|1
5151109|NCT01465763|17789259|P2|Overall Study|Withdrawal by Subject|0
5151110|NCT01465763|17789260|P1|Overall Study|Withdrawal by Subject|4
5151111|NCT01465659|17789289|P4|Completed Follow for 1 Year|Still in FU|2
5151112|NCT01465659|17789290|P3|Completed Follow for 1 Year|Still in FU|1
5151113|NCT01465659|17789291|P2|Completed Follow for 1 Year|Still in FU|0
5151114|NCT01465659|17789292|P1|Completed Follow for 1 Year|Still in FU|0
5151115|NCT01465659|17789289|P4|Completed Follow for 1 Year|Death|4
5151116|NCT01465659|17789290|P3|Completed Follow for 1 Year|Death|1
5151117|NCT01465659|17789291|P2|Completed Follow for 1 Year|Death|3
5151118|NCT01465659|17789292|P1|Completed Follow for 1 Year|Death|6
5151119|NCT01465659|17789289|P4|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
5151120|NCT01465659|17789290|P3|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
5151121|NCT01465659|17789291|P2|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
5151122|NCT01465659|17789292|P1|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
5151123|NCT01465659|17789289|P4|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5151124|NCT01465659|17789290|P3|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5151125|NCT01465659|17789291|P2|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
5151126|NCT01465659|17789292|P1|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5151127|NCT01465659|17789289|P4|Completed 1 Cycle of Treatment|Adverse Event|1
5151128|NCT01465659|17789290|P3|Completed 1 Cycle of Treatment|Adverse Event|0
5151129|NCT01465659|17789291|P2|Completed 1 Cycle of Treatment|Adverse Event|0
5151130|NCT01465659|17789292|P1|Completed 1 Cycle of Treatment|Adverse Event|0
5151131|NCT01465659|17789289|P4|Completed 1 Cycle of Treatment|Death|0
5151132|NCT01465659|17789290|P3|Completed 1 Cycle of Treatment|Death|0
5151133|NCT01465659|17789291|P2|Completed 1 Cycle of Treatment|Death|1
5151134|NCT01465659|17789292|P1|Completed 1 Cycle of Treatment|Death|0
5151135|NCT01465464|17789302|P2|Overall Study|Ongoing treatment at cutoff date|166
5151136|NCT01465464|17789303|P1|Overall Study|Ongoing treatment at cutoff date|140
5151137|NCT01465464|17789302|P2|Overall Study|Other|3
5151138|NCT01465464|17789303|P1|Overall Study|Other|9
5151139|NCT01465464|17789302|P2|Overall Study|Withdrawal by Subject|30
5151140|NCT01465464|17789303|P1|Overall Study|Withdrawal by Subject|46
5151141|NCT01465464|17789302|P2|Overall Study|Protocol Violation|1
5151142|NCT01465464|17789303|P1|Overall Study|Protocol Violation|1
5151143|NCT01465464|17789302|P2|Overall Study|Physician Decision|5
5151144|NCT01465464|17789303|P1|Overall Study|Physician Decision|13
5151145|NCT01465464|17789302|P2|Overall Study|Lack of Efficacy|190
5151146|NCT01465464|17789303|P1|Overall Study|Lack of Efficacy|139
5151147|NCT01465464|17789302|P2|Overall Study|Adverse Event|49
5151148|NCT01465464|17789303|P1|Overall Study|Adverse Event|96
5151149|NCT01465386|17789356|P1|Overall Study|Adverse Event|1
5151150|NCT01465386|17789356|P1|Overall Study|Lack of Efficacy|3
5151151|NCT01465347|17789360|P2|Overall Study|Admitted to hospice|1
5151152|NCT01465347|17789361|P1|Overall Study|Admitted to hospice|0
5151153|NCT01465347|17789360|P2|Overall Study|Physician Decision|1
5151154|NCT01465347|17789361|P1|Overall Study|Physician Decision|0
5151155|NCT01465347|17789360|P2|Overall Study|Withdrawal by Subject|1
5151156|NCT01465347|17789361|P1|Overall Study|Withdrawal by Subject|1
5151157|NCT01465334|17789373|P2|Overall Study|Refractory Disease|3
5151158|NCT01465334|17789374|P1|Overall Study|Refractory Disease|0
5151159|NCT01465334|17789373|P2|Overall Study|Richter's transformation|3
5151160|NCT01465334|17789374|P1|Overall Study|Richter's transformation|0
5151161|NCT01465334|17789373|P2|Overall Study|Adverse Event|0
5151162|NCT01465334|17789374|P1|Overall Study|Adverse Event|1
5151163|NCT01465334|17789373|P2|Overall Study|Disease Progression|0
5151164|NCT01465334|17789374|P1|Overall Study|Disease Progression|1
5151165|NCT01465230|17789400|P1|Overall Study|Withdrawal by Subject|2
5151166|NCT01465178|17789406|P2|Overall Study|Withdrawal by Subject|0
5151167|NCT01465178|17789407|P1|Overall Study|Withdrawal by Subject|1
5151168|NCT01465022|17789431|P3|Overall Study|Not Randomized|70
5151169|NCT01465022|17789432|P2|Overall Study|Not Randomized|0
5151170|NCT01465022|17789433|P1|Overall Study|Not Randomized|0
5151171|NCT01465022|17789431|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
5151172|NCT01465022|17789432|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
5151173|NCT01465022|17789433|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
5151174|NCT01465022|17789431|P3|Overall Study|Lost to Follow-up|0
5151175|NCT01465022|17789432|P2|Overall Study|Lost to Follow-up|14
5151176|NCT01465022|17789433|P1|Overall Study|Lost to Follow-up|15
5151177|NCT01464931|17789467|P2|Overall Study|Withdrawal by Subject|0
5151178|NCT01464931|17789468|P1|Overall Study|Withdrawal by Subject|1
5151179|NCT01464879|17789505|P1|Overall Study|Non-compliance|1
5151180|NCT01464879|17789505|P1|Overall Study|Physician Decision|1
5151181|NCT01464827|17789566|P14|Overall Study|Not Treated|2
5151182|NCT01464827|17789567|P13|Overall Study|Not Treated|0
5151183|NCT01464827|17789568|P12|Overall Study|Not Treated|1
5151184|NCT01464827|17789569|P11|Overall Study|Not Treated|0
5151185|NCT01464827|17789570|P10|Overall Study|Not Treated|2
5151186|NCT01464827|17789571|P9|Overall Study|Not Treated|0
5151187|NCT01464827|17789572|P8|Overall Study|Not Treated|0
5151188|NCT01464827|17789573|P7|Overall Study|Not Treated|1
5151189|NCT01464827|17789574|P6|Overall Study|Not Treated|0
5151190|NCT01464827|17789575|P5|Overall Study|Not Treated|1
5151191|NCT01464827|17789576|P4|Overall Study|Not Treated|0
5151192|NCT01464827|17789577|P3|Overall Study|Not Treated|0
5151193|NCT01464827|17789578|P2|Overall Study|Not Treated|2
5151194|NCT01464827|17789579|P1|Overall Study|Not Treated|0
5151195|NCT01464827|17789566|P14|Overall Study|Other|0
5151196|NCT01464827|17789567|P13|Overall Study|Other|1
5151197|NCT01464827|17789568|P12|Overall Study|Other|0
5151198|NCT01464827|17789569|P11|Overall Study|Other|2
5151199|NCT01464827|17789570|P10|Overall Study|Other|1
5151200|NCT01464827|17789571|P9|Overall Study|Other|3
5151201|NCT01464827|17789572|P8|Overall Study|Other|0
5151202|NCT01464827|17789573|P7|Overall Study|Other|1
5151203|NCT01464827|17789574|P6|Overall Study|Other|0
5151204|NCT01464827|17789575|P5|Overall Study|Other|3
5151205|NCT01464827|17789576|P4|Overall Study|Other|2
5151206|NCT01464827|17789577|P3|Overall Study|Other|0
5151207|NCT01464827|17789578|P2|Overall Study|Other|3
5151208|NCT01464827|17789579|P1|Overall Study|Other|2
5151209|NCT01464827|17789566|P14|Overall Study|Lost to Follow-up|1
5151210|NCT01464827|17789567|P13|Overall Study|Lost to Follow-up|0
5151211|NCT01464827|17789568|P12|Overall Study|Lost to Follow-up|1
5151212|NCT01464827|17789569|P11|Overall Study|Lost to Follow-up|0
5151213|NCT01464827|17789570|P10|Overall Study|Lost to Follow-up|0
5151214|NCT01464827|17789571|P9|Overall Study|Lost to Follow-up|0
5151215|NCT01464827|17789572|P8|Overall Study|Lost to Follow-up|2
5151216|NCT01464827|17789573|P7|Overall Study|Lost to Follow-up|2
5151217|NCT01464827|17789574|P6|Overall Study|Lost to Follow-up|1
5151218|NCT01464827|17789575|P5|Overall Study|Lost to Follow-up|3
5151219|NCT01464827|17789576|P4|Overall Study|Lost to Follow-up|2
5151220|NCT01464827|17789577|P3|Overall Study|Lost to Follow-up|0
5151221|NCT01464827|17789578|P2|Overall Study|Lost to Follow-up|2
5151222|NCT01464827|17789579|P1|Overall Study|Lost to Follow-up|0
5151223|NCT01464827|17789566|P14|Overall Study|Withdrawal by Subject|0
5151224|NCT01464827|17789567|P13|Overall Study|Withdrawal by Subject|0
5151225|NCT01464827|17789568|P12|Overall Study|Withdrawal by Subject|0
5151226|NCT01464827|17789569|P11|Overall Study|Withdrawal by Subject|0
5151227|NCT01464827|17789570|P10|Overall Study|Withdrawal by Subject|0
5151228|NCT01464827|17789571|P9|Overall Study|Withdrawal by Subject|0
5151229|NCT01464827|17789572|P8|Overall Study|Withdrawal by Subject|1
5151230|NCT01464827|17789573|P7|Overall Study|Withdrawal by Subject|0
5151231|NCT01464827|17789574|P6|Overall Study|Withdrawal by Subject|0
5151232|NCT01464827|17789575|P5|Overall Study|Withdrawal by Subject|1
5151233|NCT01464827|17789576|P4|Overall Study|Withdrawal by Subject|0
5151234|NCT01464827|17789577|P3|Overall Study|Withdrawal by Subject|0
5151235|NCT01464827|17789578|P2|Overall Study|Withdrawal by Subject|0
5151236|NCT01464827|17789579|P1|Overall Study|Withdrawal by Subject|1
5151237|NCT01464827|17789566|P14|Overall Study|Adverse Event|0
5151238|NCT01464827|17789567|P13|Overall Study|Adverse Event|1
5151239|NCT01464827|17789568|P12|Overall Study|Adverse Event|0
5151240|NCT01464827|17789569|P11|Overall Study|Adverse Event|0
5151241|NCT01464827|17789570|P10|Overall Study|Adverse Event|0
5151242|NCT01464827|17789571|P9|Overall Study|Adverse Event|0
5151243|NCT01464827|17789572|P8|Overall Study|Adverse Event|0
5151244|NCT01464827|17789573|P7|Overall Study|Adverse Event|0
5151245|NCT01464827|17789574|P6|Overall Study|Adverse Event|0
5151246|NCT01464827|17789575|P5|Overall Study|Adverse Event|0
5151247|NCT01464827|17789576|P4|Overall Study|Adverse Event|0
5151248|NCT01464827|17789577|P3|Overall Study|Adverse Event|0
5151249|NCT01464827|17789578|P2|Overall Study|Adverse Event|0
5151250|NCT01464827|17789579|P1|Overall Study|Adverse Event|0
5151251|NCT01464788|17789626|P3|Overall Study|Patient had hemorrhage after tPA started|0
5151252|NCT01464788|17789627|P2|Overall Study|Patient had hemorrhage after tPA started|1
5151253|NCT01464788|17789628|P1|Overall Study|Patient had hemorrhage after tPA started|0
5151254|NCT01464788|17789626|P3|Overall Study|Lost to Follow-up|0
5151255|NCT01464788|17789627|P2|Overall Study|Lost to Follow-up|1
5151256|NCT01464788|17789628|P1|Overall Study|Lost to Follow-up|0
5151257|NCT01464619|17789714|P2|Overall Study|Lost to Follow-up|4
5151258|NCT01464619|17789715|P1|Overall Study|Lost to Follow-up|3
5151259|NCT01464424|17789735|P2|Period 1, First 6 Weeks|Adverse Event|1
5151260|NCT01464424|17789736|P1|Period 1, First 6 Weeks|Adverse Event|0
5151261|NCT01464346|17789756|P3|Overall Study|Withdrawal by Subject|1
5151262|NCT01464346|17789757|P2|Overall Study|Withdrawal by Subject|0
5151263|NCT01464346|17789758|P1|Overall Study|Withdrawal by Subject|0
5151264|NCT01464333|17789767|P1|Overall Study|No Hospital Visit|42
5151265|NCT01464333|17789767|P1|Overall Study|Other|4
5151266|NCT01464333|17789767|P1|Overall Study|Withdrawal by Subject|11
5151267|NCT01464333|17789767|P1|Overall Study|Lack of Efficacy|72
5151268|NCT01464333|17789767|P1|Overall Study|Adverse Event|34
5151269|NCT01464307|17789780|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
5151270|NCT01464307|17789781|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
5151271|NCT01464307|17789780|P2|Open-Label Extension Period|Non-compliance|0
5151272|NCT01464307|17789781|P1|Open-Label Extension Period|Non-compliance|9
5151273|NCT01464307|17789780|P2|Open-Label Extension Period|Lost to Follow-up|0
5151274|NCT01464307|17789781|P1|Open-Label Extension Period|Lost to Follow-up|1
5151275|NCT01464307|17789780|P2|Open-Label Extension Period|Death|0
5151276|NCT01464307|17789781|P1|Open-Label Extension Period|Death|1
5151277|NCT01464307|17789780|P2|Open-Label Extension Period|Lack of Efficacy|0
5151278|NCT01464307|17789781|P1|Open-Label Extension Period|Lack of Efficacy|5
5151279|NCT01464307|17789780|P2|Open-Label Extension Period|Withdrawal by Subject|0
5151280|NCT01464307|17789781|P1|Open-Label Extension Period|Withdrawal by Subject|14
5151281|NCT01464307|17789780|P2|Open-Label Extension Period|Adverse Event|0
5151282|NCT01464307|17789781|P1|Open-Label Extension Period|Adverse Event|15
5151283|NCT01464307|17789780|P2|Main Period|Predefined discontinuation criteria|1
5151284|NCT01464307|17789781|P1|Main Period|Predefined discontinuation criteria|2
5151285|NCT01464307|17789780|P2|Main Period|Withdrawal by Subject|2
5151286|NCT01464307|17789781|P1|Main Period|Withdrawal by Subject|5
5151287|NCT01464307|17789780|P2|Main Period|Lack of Efficacy|0
5151288|NCT01464307|17789781|P1|Main Period|Lack of Efficacy|2
5151289|NCT01464307|17789780|P2|Main Period|Adverse Event|1
5151290|NCT01464307|17789781|P1|Main Period|Adverse Event|6
5151291|NCT01464307|17789780|P2|Main Period|Death|1
5151292|NCT01464307|17789781|P1|Main Period|Death|0
5151293|NCT01464255|17789796|P2|Overall Study|unresolve corneal staining|1
5151294|NCT01464255|17789797|P1|Overall Study|unresolve corneal staining|0
5151295|NCT01464021|17789842|P1|Overall Study|various|11
5151296|NCT01464021|17789842|P1|Overall Study|Lack of Efficacy|1
5151297|NCT01464021|17789842|P1|Overall Study|Lost to Follow-up|1
5151298|NCT01464021|17789842|P1|Overall Study|Withdrawal by Subject|13
5151299|NCT01463982|17789858|P4|Overall Study|Treatment delay over 5 week|0
5151300|NCT01463982|17789859|P3|Overall Study|Treatment delay over 5 week|1
5151301|NCT01463982|17789860|P2|Overall Study|Treatment delay over 5 week|0
5151302|NCT01463982|17789861|P1|Overall Study|Treatment delay over 5 week|0
5151303|NCT01463982|17789858|P4|Overall Study|Withdrawal by Subject|0
5151304|NCT01463982|17789859|P3|Overall Study|Withdrawal by Subject|1
5151305|NCT01463982|17789860|P2|Overall Study|Withdrawal by Subject|1
5151306|NCT01463982|17789861|P1|Overall Study|Withdrawal by Subject|0
5151307|NCT01463878|17789877|P2|Overall Study|no longer met criteria for tube feed|2
5151308|NCT01463878|17789878|P1|Overall Study|no longer met criteria for tube feed|2
5151309|NCT01463696|17789892|P8|Overall Study|Not Treated|0
5151310|NCT01463696|17789893|P7|Overall Study|Not Treated|1
5151311|NCT01463696|17789894|P6|Overall Study|Not Treated|0
5151312|NCT01463696|17789895|P5|Overall Study|Not Treated|0
5151313|NCT01463696|17789896|P4|Overall Study|Not Treated|0
5151314|NCT01463696|17789897|P3|Overall Study|Not Treated|0
5151315|NCT01463696|17789898|P2|Overall Study|Not Treated|0
5151316|NCT01463696|17789899|P1|Overall Study|Not Treated|0
5151317|NCT01463696|17789892|P8|Overall Study|Withdrawal by Subject|0
5151318|NCT01463696|17789893|P7|Overall Study|Withdrawal by Subject|2
5151319|NCT01463696|17789894|P6|Overall Study|Withdrawal by Subject|1
5151320|NCT01463696|17789895|P5|Overall Study|Withdrawal by Subject|1
5151321|NCT01463696|17789896|P4|Overall Study|Withdrawal by Subject|1
5151322|NCT01463696|17789897|P3|Overall Study|Withdrawal by Subject|0
5151323|NCT01463696|17789898|P2|Overall Study|Withdrawal by Subject|0
5151324|NCT01463696|17789899|P1|Overall Study|Withdrawal by Subject|0
5151325|NCT01463696|17789892|P8|Overall Study|Progressive Disease|2
5151326|NCT01463696|17789893|P7|Overall Study|Progressive Disease|4
5151327|NCT01463696|17789894|P6|Overall Study|Progressive Disease|1
5151328|NCT01463696|17789895|P5|Overall Study|Progressive Disease|0
5151329|NCT01463696|17789896|P4|Overall Study|Progressive Disease|1
5151330|NCT01463696|17789897|P3|Overall Study|Progressive Disease|0
5151331|NCT01463696|17789898|P2|Overall Study|Progressive Disease|1
5151332|NCT01463696|17789899|P1|Overall Study|Progressive Disease|0
5151333|NCT01463696|17789892|P8|Overall Study|Lost to Follow-up|0
5151334|NCT01463696|17789893|P7|Overall Study|Lost to Follow-up|0
5151335|NCT01463696|17789894|P6|Overall Study|Lost to Follow-up|0
5151336|NCT01463696|17789895|P5|Overall Study|Lost to Follow-up|0
5151337|NCT01463696|17789896|P4|Overall Study|Lost to Follow-up|0
5151338|NCT01463696|17789897|P3|Overall Study|Lost to Follow-up|1
5151339|NCT01463696|17789898|P2|Overall Study|Lost to Follow-up|0
5151340|NCT01463696|17789899|P1|Overall Study|Lost to Follow-up|0
5151341|NCT01463696|17789892|P8|Overall Study|Adverse Event|2
5151342|NCT01463696|17789893|P7|Overall Study|Adverse Event|3
5151343|NCT01463696|17789894|P6|Overall Study|Adverse Event|1
5151344|NCT01463696|17789895|P5|Overall Study|Adverse Event|0
5151345|NCT01463696|17789896|P4|Overall Study|Adverse Event|2
5151346|NCT01463696|17789897|P3|Overall Study|Adverse Event|0
5151347|NCT01463696|17789898|P2|Overall Study|Adverse Event|1
5151348|NCT01463696|17789899|P1|Overall Study|Adverse Event|0
5151349|NCT01463683|17789952|P3|Overall Study|Withdrawal by Subject|2
5151350|NCT01463683|17789953|P2|Overall Study|Withdrawal by Subject|17
5151351|NCT01463683|17789954|P1|Overall Study|Withdrawal by Subject|5
5151352|NCT01463683|17789952|P3|Overall Study|Pregnancy|1
5151353|NCT01463683|17789953|P2|Overall Study|Pregnancy|2
5151354|NCT01463683|17789954|P1|Overall Study|Pregnancy|2
5151355|NCT01463683|17789952|P3|Overall Study|Physician Decision|1
5151356|NCT01463683|17789953|P2|Overall Study|Physician Decision|3
5151357|NCT01463683|17789954|P1|Overall Study|Physician Decision|0
5151358|NCT01463683|17789952|P3|Overall Study|Lost to Follow-up|7
5151359|NCT01463683|17789953|P2|Overall Study|Lost to Follow-up|9
5151360|NCT01463683|17789954|P1|Overall Study|Lost to Follow-up|10
5151361|NCT01463683|17789952|P3|Overall Study|Adverse Event|0
5151362|NCT01463683|17789953|P2|Overall Study|Adverse Event|0
5151363|NCT01463683|17789954|P1|Overall Study|Adverse Event|2
5151364|NCT01463631|17789971|P4|Overall Study|Progressive Disease|5
5151365|NCT01463631|17789972|P3|Overall Study|Progressive Disease|0
5151366|NCT01463631|17789973|P2|Overall Study|Progressive Disease|0
5151367|NCT01463631|17789974|P1|Overall Study|Progressive Disease|0
5151368|NCT01463631|17789971|P4|Overall Study|Death|0
5151369|NCT01463631|17789972|P3|Overall Study|Death|1
5151370|NCT01463631|17789973|P2|Overall Study|Death|0
5151371|NCT01463631|17789974|P1|Overall Study|Death|0
5151372|NCT01463631|17789971|P4|Overall Study|Withdrawal by Subject|1
5151373|NCT01463631|17789972|P3|Overall Study|Withdrawal by Subject|0
5151374|NCT01463631|17789973|P2|Overall Study|Withdrawal by Subject|0
5151375|NCT01463631|17789974|P1|Overall Study|Withdrawal by Subject|0
5151376|NCT01463527|17789996|P2|Overall Study|Crying >20% of sedation|6
5151377|NCT01463527|17789997|P1|Overall Study|Crying >20% of sedation|5
5151378|NCT01463527|17789996|P2|Overall Study|Protocol Violation|1
5151379|NCT01463527|17789997|P1|Overall Study|Protocol Violation|1
5151380|NCT01463306|17790020|P3|Overall Study|Approval expiry at site|0
5151381|NCT01463306|17790021|P2|Overall Study|Approval expiry at site|0
5151382|NCT01463306|17790022|P1|Overall Study|Approval expiry at site|1
5151383|NCT01463306|17790020|P3|Overall Study|Other|0
5151384|NCT01463306|17790021|P2|Overall Study|Other|13
5151385|NCT01463306|17790022|P1|Overall Study|Other|26
5151386|NCT01463306|17790020|P3|Overall Study|Withdrawal by Subject|1
5151387|NCT01463306|17790021|P2|Overall Study|Withdrawal by Subject|9
5151388|NCT01463306|17790022|P1|Overall Study|Withdrawal by Subject|19
5151389|NCT01463306|17790020|P3|Overall Study|Protocol Violation|0
5151390|NCT01463306|17790021|P2|Overall Study|Protocol Violation|0
5151391|NCT01463306|17790022|P1|Overall Study|Protocol Violation|4
5151392|NCT01463306|17790020|P3|Overall Study|Lost to Follow-up|0
5151393|NCT01463306|17790021|P2|Overall Study|Lost to Follow-up|2
5151394|NCT01463306|17790022|P1|Overall Study|Lost to Follow-up|5
5151395|NCT01463306|17790020|P3|Overall Study|Lack of Efficacy|1
5151396|NCT01463306|17790021|P2|Overall Study|Lack of Efficacy|16
5151397|NCT01463306|17790022|P1|Overall Study|Lack of Efficacy|22
5151398|NCT01463306|17790020|P3|Overall Study|Death|0
5151399|NCT01463306|17790021|P2|Overall Study|Death|3
5151400|NCT01463306|17790022|P1|Overall Study|Death|3
5151401|NCT01463306|17790020|P3|Overall Study|Adverse Event|3
5151402|NCT01463306|17790021|P2|Overall Study|Adverse Event|9
5151403|NCT01463306|17790022|P1|Overall Study|Adverse Event|6
5151404|NCT01463293|17790093|P3|Overall Study|Other|2
5151405|NCT01463293|17790094|P2|Overall Study|Other|0
5151406|NCT01463293|17790095|P1|Overall Study|Other|0
5151407|NCT01463293|17790093|P3|Overall Study|Withdrawal by Subject|5
5151408|NCT01463293|17790094|P2|Overall Study|Withdrawal by Subject|10
5151409|NCT01463293|17790095|P1|Overall Study|Withdrawal by Subject|4
5151410|NCT01463293|17790093|P3|Overall Study|Adverse Event|0
5151411|NCT01463293|17790094|P2|Overall Study|Adverse Event|2
5151412|NCT01463293|17790095|P1|Overall Study|Adverse Event|1
5151413|NCT01463293|17790093|P3|Overall Study|Lost to Follow-up|5
5151414|NCT01463293|17790094|P2|Overall Study|Lost to Follow-up|4
5151415|NCT01463293|17790095|P1|Overall Study|Lost to Follow-up|1
5151416|NCT01463111|17790139|P1|Overall Study|Physician Decision|2
5151417|NCT01463111|17790139|P1|Overall Study|Lost to Follow-up|5
5151418|NCT01463111|17790139|P1|Overall Study|Withdrawal by Subject|2
5151419|NCT01463098|17790161|P14|Part B (11 Days)|Participant Choice|0
5151420|NCT01463098|17790162|P13|Part B (11 Days)|Participant Choice|0
5151421|NCT01463098|17790163|P12|Part B (11 Days)|Participant Choice|1
5151422|NCT01463098|17790164|P11|Part B (11 Days)|Participant Choice|0
5151423|NCT01463098|17790165|P10|Part B (11 Days)|Participant Choice|0
5151424|NCT01463098|17790166|P9|Part B (11 Days)|Participant Choice|0
5151425|NCT01463098|17790167|P8|Part B (11 Days)|Participant Choice|0
5151426|NCT01463098|17790168|P7|Part B (11 Days)|Participant Choice|0
5151427|NCT01463098|17790169|P6|Part B (11 Days)|Participant Choice|0
5151428|NCT01463098|17790170|P5|Part B (11 Days)|Participant Choice|0
5151429|NCT01463098|17790171|P4|Part B (11 Days)|Participant Choice|0
5151430|NCT01463098|17790172|P3|Part B (11 Days)|Participant Choice|0
5151431|NCT01463098|17790173|P2|Part B (11 Days)|Participant Choice|0
5151432|NCT01463098|17790174|P1|Part B (11 Days)|Participant Choice|0
5151433|NCT01463098|17790161|P14|Part A (11 Days)|Lost to Follow-up|0
5151434|NCT01463098|17790162|P13|Part A (11 Days)|Lost to Follow-up|0
5151435|NCT01463098|17790163|P12|Part A (11 Days)|Lost to Follow-up|0
5151436|NCT01463098|17790164|P11|Part A (11 Days)|Lost to Follow-up|0
5151437|NCT01463098|17790165|P10|Part A (11 Days)|Lost to Follow-up|0
5151438|NCT01463098|17790166|P9|Part A (11 Days)|Lost to Follow-up|0
5151439|NCT01463098|17790167|P8|Part A (11 Days)|Lost to Follow-up|0
5151440|NCT01463098|17790168|P7|Part A (11 Days)|Lost to Follow-up|0
5151441|NCT01463098|17790169|P6|Part A (11 Days)|Lost to Follow-up|0
5151442|NCT01463098|17790170|P5|Part A (11 Days)|Lost to Follow-up|1
5151443|NCT01463098|17790171|P4|Part A (11 Days)|Lost to Follow-up|0
5151444|NCT01463098|17790172|P3|Part A (11 Days)|Lost to Follow-up|0
5151445|NCT01463098|17790173|P2|Part A (11 Days)|Lost to Follow-up|0
5151446|NCT01463098|17790174|P1|Part A (11 Days)|Lost to Follow-up|0
5151447|NCT01463098|17790161|P14|Part A (11 Days)|Participant Choice|0
5151448|NCT01463098|17790162|P13|Part A (11 Days)|Participant Choice|0
5151449|NCT01463098|17790163|P12|Part A (11 Days)|Participant Choice|0
5151450|NCT01463098|17790164|P11|Part A (11 Days)|Participant Choice|0
5151451|NCT01463098|17790165|P10|Part A (11 Days)|Participant Choice|0
5151452|NCT01463098|17790166|P9|Part A (11 Days)|Participant Choice|1
5151453|NCT01463098|17790167|P8|Part A (11 Days)|Participant Choice|0
5151454|NCT01463098|17790168|P7|Part A (11 Days)|Participant Choice|0
5151455|NCT01463098|17790169|P6|Part A (11 Days)|Participant Choice|0
5151456|NCT01463098|17790170|P5|Part A (11 Days)|Participant Choice|0
5151457|NCT01463098|17790171|P4|Part A (11 Days)|Participant Choice|0
5151458|NCT01463098|17790172|P3|Part A (11 Days)|Participant Choice|0
5151459|NCT01463098|17790173|P2|Part A (11 Days)|Participant Choice|0
5151460|NCT01463098|17790174|P1|Part A (11 Days)|Participant Choice|2
5151461|NCT01463033|17790497|P2|Overall Study|Death|2
5151462|NCT01463033|17790498|P1|Overall Study|Death|3
5151463|NCT01463033|17790497|P2|Overall Study|Lost to Follow-up|4
5151464|NCT01463033|17790498|P1|Overall Study|Lost to Follow-up|4
5151465|NCT01463007|17790505|P1|Overall Study|Physician Decision|1
5151466|NCT01462942|17790516|P5|Overall Study|Protocol Violation|6
5151467|NCT01462942|17790517|P4|Overall Study|Protocol Violation|9
5151468|NCT01462942|17790518|P3|Overall Study|Protocol Violation|9
5151469|NCT01462942|17790519|P2|Overall Study|Protocol Violation|6
5151470|NCT01462942|17790520|P1|Overall Study|Protocol Violation|4
5151471|NCT01462942|17790516|P5|Overall Study|Lost to Follow-up|1
5151472|NCT01462942|17790517|P4|Overall Study|Lost to Follow-up|1
5151473|NCT01462942|17790518|P3|Overall Study|Lost to Follow-up|1
5151474|NCT01462942|17790519|P2|Overall Study|Lost to Follow-up|1
5151475|NCT01462942|17790520|P1|Overall Study|Lost to Follow-up|0
5151476|NCT01462942|17790516|P5|Overall Study|Lack of Efficacy|3
5151477|NCT01462942|17790517|P4|Overall Study|Lack of Efficacy|5
5151478|NCT01462942|17790518|P3|Overall Study|Lack of Efficacy|4
5151479|NCT01462942|17790519|P2|Overall Study|Lack of Efficacy|0
5151480|NCT01462942|17790520|P1|Overall Study|Lack of Efficacy|6
5151481|NCT01462942|17790516|P5|Overall Study|Withdrawal by Subject|19
5151482|NCT01462942|17790517|P4|Overall Study|Withdrawal by Subject|16
5151483|NCT01462942|17790518|P3|Overall Study|Withdrawal by Subject|14
5151484|NCT01462942|17790519|P2|Overall Study|Withdrawal by Subject|10
5151485|NCT01462942|17790520|P1|Overall Study|Withdrawal by Subject|14
5151486|NCT01462942|17790516|P5|Overall Study|Other, including COPD exacerbation|5
5151487|NCT01462942|17790517|P4|Overall Study|Other, including COPD exacerbation|8
5151488|NCT01462942|17790518|P3|Overall Study|Other, including COPD exacerbation|2
5151489|NCT01462942|17790519|P2|Overall Study|Other, including COPD exacerbation|5
5151490|NCT01462942|17790520|P1|Overall Study|Other, including COPD exacerbation|3
5151491|NCT01462942|17790516|P5|Overall Study|Adverse Event|11
5151492|NCT01462942|17790517|P4|Overall Study|Adverse Event|11
5151493|NCT01462942|17790518|P3|Overall Study|Adverse Event|10
5151494|NCT01462942|17790519|P2|Overall Study|Adverse Event|12
5151495|NCT01462942|17790520|P1|Overall Study|Adverse Event|7
5151496|NCT01462929|17790550|P3|Overall Study|Lack of Efficacy|1
5151497|NCT01462929|17790551|P2|Overall Study|Lack of Efficacy|0
5151498|NCT01462929|17790552|P1|Overall Study|Lack of Efficacy|0
5151499|NCT01462929|17790550|P3|Overall Study|Withdrawal by Subject|0
5151500|NCT01462929|17790551|P2|Overall Study|Withdrawal by Subject|1
5151501|NCT01462929|17790552|P1|Overall Study|Withdrawal by Subject|2
5151502|NCT01462929|17790550|P3|Overall Study|Adverse Event|4
5151503|NCT01462929|17790551|P2|Overall Study|Adverse Event|3
5151504|NCT01462929|17790552|P1|Overall Study|Adverse Event|3
5151505|NCT01462695|17790593|P2|Overall Study|Inevaluable (did not receive study drug)|0
5151506|NCT01462695|17790594|P1|Overall Study|Inevaluable (did not receive study drug)|1
5151507|NCT01462695|17790593|P2|Overall Study|Withdrawal by Subject|0
5151508|NCT01462695|17790594|P1|Overall Study|Withdrawal by Subject|2
5151509|NCT01462695|17790593|P2|Overall Study|Physician Decision|0
5151510|NCT01462695|17790594|P1|Overall Study|Physician Decision|5
5151511|NCT01462695|17790593|P2|Overall Study|Lack of Efficacy|12
5151512|NCT01462695|17790594|P1|Overall Study|Lack of Efficacy|6
5151513|NCT01462695|17790593|P2|Overall Study|Death|0
5151514|NCT01462695|17790594|P1|Overall Study|Death|2
5151515|NCT01462695|17790593|P2|Overall Study|Adverse Event|1
5151516|NCT01462695|17790594|P1|Overall Study|Adverse Event|1
5151517|NCT01462435|17790622|P4|Overall Study|Lost to Follow-up|1
5151518|NCT01462435|17790623|P3|Overall Study|Lost to Follow-up|0
5151519|NCT01462435|17790624|P2|Overall Study|Lost to Follow-up|0
5151520|NCT01462435|17790625|P1|Overall Study|Lost to Follow-up|0
5151521|NCT01462435|17790622|P4|Overall Study|Withdrawal by Subject|1
5151522|NCT01462435|17790623|P3|Overall Study|Withdrawal by Subject|0
5151523|NCT01462435|17790624|P2|Overall Study|Withdrawal by Subject|0
5151524|NCT01462435|17790625|P1|Overall Study|Withdrawal by Subject|0
5151525|NCT01462435|17790622|P4|Overall Study|Physician Decision|0
5151526|NCT01462435|17790623|P3|Overall Study|Physician Decision|1
5151527|NCT01462435|17790624|P2|Overall Study|Physician Decision|0
5151528|NCT01462435|17790625|P1|Overall Study|Physician Decision|0
5151529|NCT01462435|17790622|P4|Overall Study|Lack of Efficacy|3
5151530|NCT01462435|17790623|P3|Overall Study|Lack of Efficacy|0
5151531|NCT01462435|17790624|P2|Overall Study|Lack of Efficacy|0
5151532|NCT01462435|17790625|P1|Overall Study|Lack of Efficacy|1
5151533|NCT01462370|17790663|P2|Overall Study|Withdrawal by Subject|3
5151534|NCT01462370|17790664|P1|Overall Study|Withdrawal by Subject|0
5151535|NCT01462370|17790663|P2|Overall Study|Physician Decision|1
5151536|NCT01462370|17790664|P1|Overall Study|Physician Decision|0
5151537|NCT01462370|17790663|P2|Overall Study|Lack of Qualifying Event|1
5151538|NCT01462370|17790664|P1|Overall Study|Lack of Qualifying Event|1
5151539|NCT01462357|17790699|P3|Overall Study|Lost to Follow-up|7
5151540|NCT01462357|17790700|P2|Overall Study|Lost to Follow-up|5
5151541|NCT01462357|17790701|P1|Overall Study|Lost to Follow-up|3
5151542|NCT01462357|17790699|P3|Overall Study|Migrated/moved from study area|1
5151543|NCT01462357|17790700|P2|Overall Study|Migrated/moved from study area|3
5151544|NCT01462357|17790701|P1|Overall Study|Migrated/moved from study area|2
5151545|NCT01462357|17790699|P3|Overall Study|Withdrawal by Subject|3
5151546|NCT01462357|17790700|P2|Overall Study|Withdrawal by Subject|11
5151547|NCT01462357|17790701|P1|Overall Study|Withdrawal by Subject|3
5151548|NCT01462357|17790699|P3|Overall Study|Death|1
5151549|NCT01462357|17790700|P2|Overall Study|Death|0
5151550|NCT01462357|17790701|P1|Overall Study|Death|0
5151551|NCT01462344|17790774|P2|Overall Study|Lost to Follow-up|7
5151552|NCT01462344|17790775|P1|Overall Study|Lost to Follow-up|7
5151553|NCT01462344|17790774|P2|Overall Study|Protocol Violation|53
5151554|NCT01462344|17790775|P1|Overall Study|Protocol Violation|68
5151555|NCT01462344|17790774|P2|Overall Study|Lack of Efficacy|6
5151556|NCT01462344|17790775|P1|Overall Study|Lack of Efficacy|5
5151557|NCT01462344|17790774|P2|Overall Study|Asthma Exacerbation|35
5151558|NCT01462344|17790775|P1|Overall Study|Asthma Exacerbation|34
5151559|NCT01462344|17790774|P2|Overall Study|Adverse Event|23
5151560|NCT01462344|17790775|P1|Overall Study|Adverse Event|24
5151561|NCT01462344|17790774|P2|Overall Study|Withdrawal by Subject|226
5151562|NCT01462344|17790775|P1|Overall Study|Withdrawal by Subject|245
5151563|NCT01462318|17790797|P3|Extension Phase|Adverse Event|22
5151564|NCT01462318|17790798|P2|Extension Phase|Adverse Event|0
5151565|NCT01462318|17790799|P1|Extension Phase|Adverse Event|0
5151566|NCT01462318|17790797|P3|Extension Phase|Investigator Decision|5
5151567|NCT01462318|17790798|P2|Extension Phase|Investigator Decision|0
5151568|NCT01462318|17790799|P1|Extension Phase|Investigator Decision|0
5151569|NCT01462318|17790797|P3|Extension Phase|Withdrawal by Subject|15
5151570|NCT01462318|17790798|P2|Extension Phase|Withdrawal by Subject|0
5151571|NCT01462318|17790799|P1|Extension Phase|Withdrawal by Subject|0
5151572|NCT01462318|17790797|P3|Extension Phase|Disease Progression|1
5151573|NCT01462318|17790798|P2|Extension Phase|Disease Progression|0
5151574|NCT01462318|17790799|P1|Extension Phase|Disease Progression|0
5151575|NCT01462318|17790797|P3|Extension Phase|Other|1
5151576|NCT01462318|17790798|P2|Extension Phase|Other|0
5151577|NCT01462318|17790799|P1|Extension Phase|Other|0
5151578|NCT01462318|17790797|P3|Extension Phase|Lost to Follow-up|1
5151579|NCT01462318|17790798|P2|Extension Phase|Lost to Follow-up|0
5151580|NCT01462318|17790799|P1|Extension Phase|Lost to Follow-up|0
5151581|NCT01462318|17790797|P3|Main Study / TP-DI Study|Adverse Event|0
5151582|NCT01462318|17790798|P2|Main Study / TP-DI Study|Adverse Event|0
5151583|NCT01462318|17790799|P1|Main Study / TP-DI Study|Adverse Event|4
5151584|NCT01462318|17790797|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
5151585|NCT01462318|17790798|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
5151586|NCT01462318|17790799|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
5151587|NCT01462318|17790797|P3|Main Study / TP-DI Study|Other|0
5151588|NCT01462318|17790798|P2|Main Study / TP-DI Study|Other|0
5151589|NCT01462318|17790799|P1|Main Study / TP-DI Study|Other|2
5151590|NCT01462266|17790900|P2|Overall Study|Screen failure|1
5151591|NCT01462266|17790901|P1|Overall Study|Screen failure|1
5151592|NCT01462266|17790900|P2|Overall Study|Withdrawal by Subject|2
5151593|NCT01462266|17790901|P1|Overall Study|Withdrawal by Subject|7
5151594|NCT01462266|17790900|P2|Overall Study|Protocol Violation|3
5151595|NCT01462266|17790901|P1|Overall Study|Protocol Violation|1
5151596|NCT01462266|17790900|P2|Overall Study|Physician Decision|5
5151597|NCT01462266|17790901|P1|Overall Study|Physician Decision|2
5151598|NCT01462266|17790900|P2|Overall Study|Creatinine and eGFR, excluded medication|4
5151599|NCT01462266|17790901|P1|Overall Study|Creatinine and eGFR, excluded medication|8
5151600|NCT01462266|17790900|P2|Overall Study|Non-compliance with study drug|0
5151601|NCT01462266|17790901|P1|Overall Study|Non-compliance with study drug|3
5151602|NCT01462266|17790900|P2|Overall Study|Lost to Follow-up|3
5151603|NCT01462266|17790901|P1|Overall Study|Lost to Follow-up|4
5151604|NCT01462266|17790900|P2|Overall Study|Lack of Efficacy|2
5151605|NCT01462266|17790901|P1|Overall Study|Lack of Efficacy|0
5151606|NCT01462266|17790900|P2|Overall Study|Death|1
5151607|NCT01462266|17790901|P1|Overall Study|Death|2
5151608|NCT01462266|17790900|P2|Overall Study|Adverse Event|6
5151609|NCT01462266|17790901|P1|Overall Study|Adverse Event|7
5151610|NCT01462227|17790926|P4|Second Assignment|Protocol Violation|0
5151611|NCT01462227|17790927|P3|Second Assignment|Protocol Violation|1
5151612|NCT01462227|17790928|P2|Second Assignment|Protocol Violation|1
5151613|NCT01462227|17790929|P1|Second Assignment|Protocol Violation|0
5151614|NCT01462227|17790926|P4|Second Assignment|Lost to Follow-up|0
5151615|NCT01462227|17790927|P3|Second Assignment|Lost to Follow-up|0
5151616|NCT01462227|17790928|P2|Second Assignment|Lost to Follow-up|0
5151617|NCT01462227|17790929|P1|Second Assignment|Lost to Follow-up|1
5151618|NCT01462162|17790947|P1|Overall Study|Other|2
5151619|NCT01462162|17790947|P1|Overall Study|Abnormal laboratory parameters|1
5151620|NCT01462162|17790947|P1|Overall Study|Lack of Efficacy|4
5151621|NCT01462162|17790947|P1|Overall Study|Adverse Event|5
5151622|NCT01462110|17790974|P2|Overall Study|Adverse Event|0
5151623|NCT01462110|17790975|P1|Overall Study|Adverse Event|1
5151624|NCT01462084|17790995|P2|Overall Study|Protocol Violation|1
5151625|NCT01462084|17790996|P1|Overall Study|Protocol Violation|1
5151626|NCT01462084|17790995|P2|Overall Study|Withdrawal by Subject|0
5151627|NCT01462084|17790996|P1|Overall Study|Withdrawal by Subject|1
5151628|NCT01462045|17791007|P3|Overall Study|Family matter|0
5151629|NCT01462045|17791008|P2|Overall Study|Family matter|1
5151630|NCT01462045|17791009|P1|Overall Study|Family matter|0
5151631|NCT01461993|17791023|P3|Overall Study|Other|6
5151632|NCT01461993|17791024|P2|Overall Study|Other|15
5151633|NCT01461993|17791025|P1|Overall Study|Other|13
5151634|NCT01461993|17791023|P3|Overall Study|Did not meet entrance criteria|0
5151635|NCT01461993|17791024|P2|Overall Study|Did not meet entrance criteria|3
5151636|NCT01461993|17791025|P1|Overall Study|Did not meet entrance criteria|2
5151637|NCT01461993|17791023|P3|Overall Study|No longer met eligibility criteria|10
5151638|NCT01461993|17791024|P2|Overall Study|No longer met eligibility criteria|18
5151639|NCT01461993|17791025|P1|Overall Study|No longer met eligibility criteria|13
5151640|NCT01461993|17791023|P3|Overall Study|Adverse Event|3
5151641|NCT01461993|17791024|P2|Overall Study|Adverse Event|11
5151642|NCT01461993|17791025|P1|Overall Study|Adverse Event|9
5151643|NCT01461993|17791023|P3|Overall Study|Protocol Violation|7
5151644|NCT01461993|17791024|P2|Overall Study|Protocol Violation|9
5151645|NCT01461993|17791025|P1|Overall Study|Protocol Violation|10
5151646|NCT01461993|17791023|P3|Overall Study|Lost to Follow-up|22
5151647|NCT01461993|17791024|P2|Overall Study|Lost to Follow-up|48
5151648|NCT01461993|17791025|P1|Overall Study|Lost to Follow-up|44
5151649|NCT01461993|17791023|P3|Overall Study|Withdrawal by Subject|16
5151650|NCT01461993|17791024|P2|Overall Study|Withdrawal by Subject|53
5151651|NCT01461993|17791025|P1|Overall Study|Withdrawal by Subject|60
5151652|NCT01461980|17791050|P3|Overall Study|Randomized but not vaccinated|7
5151653|NCT01461980|17791051|P2|Overall Study|Randomized but not vaccinated|8
5151654|NCT01461980|17791052|P1|Overall Study|Randomized but not vaccinated|4
5151655|NCT01461980|17791050|P3|Overall Study|No longer willing to participate|54
5151656|NCT01461980|17791051|P2|Overall Study|No longer willing to participate|38
5151657|NCT01461980|17791052|P1|Overall Study|No longer willing to participate|52
5151658|NCT01461980|17791050|P3|Overall Study|Lost to Follow-up|51
5151659|NCT01461980|17791051|P2|Overall Study|Lost to Follow-up|53
5151660|NCT01461980|17791052|P1|Overall Study|Lost to Follow-up|52
5151661|NCT01461980|17791050|P3|Overall Study|No longer meets eligibility criteria|19
5151662|NCT01461980|17791051|P2|Overall Study|No longer meets eligibility criteria|9
5151663|NCT01461980|17791052|P1|Overall Study|No longer meets eligibility criteria|18
5151664|NCT01461980|17791050|P3|Overall Study|Protocol Violation|16
5151665|NCT01461980|17791051|P2|Overall Study|Protocol Violation|19
5151666|NCT01461980|17791052|P1|Overall Study|Protocol Violation|12
5151667|NCT01461980|17791050|P3|Overall Study|Adverse Event|6
5151668|NCT01461980|17791051|P2|Overall Study|Adverse Event|5
5151669|NCT01461980|17791052|P1|Overall Study|Adverse Event|12
5151670|NCT01461980|17791050|P3|Overall Study|Medication error|6
5151671|NCT01461980|17791051|P2|Overall Study|Medication error|5
5151672|NCT01461980|17791052|P1|Overall Study|Medication error|7
5151673|NCT01461980|17791050|P3|Overall Study|Other|6
5151674|NCT01461980|17791051|P2|Overall Study|Other|8
5151675|NCT01461980|17791052|P1|Overall Study|Other|9
5151676|NCT01461928|17791082|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
5151677|NCT01461928|17791083|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
5151678|NCT01461928|17791084|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
5151679|NCT01461928|17791082|P3|Maintenance II (15 Months)|Withdrew informed consent|1
5151680|NCT01461928|17791083|P2|Maintenance II (15 Months)|Withdrew informed consent|0
5151681|NCT01461928|17791084|P1|Maintenance II (15 Months)|Withdrew informed consent|0
5151682|NCT01461928|17791082|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
5151683|NCT01461928|17791083|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
5151684|NCT01461928|17791084|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
5151685|NCT01461928|17791082|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
5151686|NCT01461928|17791083|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
5151687|NCT01461928|17791084|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
5151688|NCT01461928|17791082|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
5151689|NCT01461928|17791083|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
5151690|NCT01461928|17791084|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
5151691|NCT01461928|17791082|P3|Maintenance II (15 Months)|Disease progression|3
5151692|NCT01461928|17791083|P2|Maintenance II (15 Months)|Disease progression|0
5151693|NCT01461928|17791084|P1|Maintenance II (15 Months)|Disease progression|0
5151694|NCT01461928|17791082|P3|Maintenance II (15 Months)|Moved to another town|0
5151695|NCT01461928|17791083|P2|Maintenance II (15 Months)|Moved to another town|1
5151696|NCT01461928|17791084|P1|Maintenance II (15 Months)|Moved to another town|0
5151697|NCT01461928|17791082|P3|Maintenance II (15 Months)|Lost to Follow-up|0
5151698|NCT01461928|17791083|P2|Maintenance II (15 Months)|Lost to Follow-up|1
5151699|NCT01461928|17791084|P1|Maintenance II (15 Months)|Lost to Follow-up|0
5151700|NCT01461928|17791082|P3|Maintenance II (15 Months)|Physician Decision|4
5151701|NCT01461928|17791083|P2|Maintenance II (15 Months)|Physician Decision|0
5151702|NCT01461928|17791084|P1|Maintenance II (15 Months)|Physician Decision|0
5151703|NCT01461928|17791082|P3|Maintenance II (15 Months)|Death|8
5151704|NCT01461928|17791083|P2|Maintenance II (15 Months)|Death|10
5151705|NCT01461928|17791084|P1|Maintenance II (15 Months)|Death|0
5151706|NCT01461928|17791082|P3|Maintenance II (15 Months)|Adverse Event|0
5151707|NCT01461928|17791083|P2|Maintenance II (15 Months)|Adverse Event|2
5151708|NCT01461928|17791084|P1|Maintenance II (15 Months)|Adverse Event|0
5151709|NCT01461928|17791082|P3|Maintenance I (24 Months)|Did not meet criteria|0
5151710|NCT01461928|17791083|P2|Maintenance I (24 Months)|Did not meet criteria|0
5151711|NCT01461928|17791084|P1|Maintenance I (24 Months)|Did not meet criteria|5
5151712|NCT01461928|17791082|P3|Maintenance I (24 Months)|Not compliant|0
5151713|NCT01461928|17791083|P2|Maintenance I (24 Months)|Not compliant|0
5151714|NCT01461928|17791084|P1|Maintenance I (24 Months)|Not compliant|1
5151715|NCT01461928|17791082|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
5151716|NCT01461928|17791083|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
5151717|NCT01461928|17791084|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
5151718|NCT01461928|17791082|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
5151719|NCT01461928|17791083|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
5151720|NCT01461928|17791084|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
5151721|NCT01461928|17791082|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
5151722|NCT01461928|17791083|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
5151723|NCT01461928|17791084|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
5151724|NCT01461928|17791082|P3|Maintenance I (24 Months)|Physician Decision|0
5151725|NCT01461928|17791083|P2|Maintenance I (24 Months)|Physician Decision|0
5151726|NCT01461928|17791084|P1|Maintenance I (24 Months)|Physician Decision|9
5151727|NCT01461928|17791082|P3|Maintenance I (24 Months)|Adverse Event|0
5151728|NCT01461928|17791083|P2|Maintenance I (24 Months)|Adverse Event|0
5151729|NCT01461928|17791084|P1|Maintenance I (24 Months)|Adverse Event|70
5151730|NCT01461928|17791082|P3|Maintenance I (24 Months)|Diseases progression|0
5151731|NCT01461928|17791083|P2|Maintenance I (24 Months)|Diseases progression|0
5151732|NCT01461928|17791084|P1|Maintenance I (24 Months)|Diseases progression|91
5151733|NCT01461928|17791082|P3|Maintenance I (24 Months)|Lost to Follow-up|0
5151734|NCT01461928|17791083|P2|Maintenance I (24 Months)|Lost to Follow-up|0
5151735|NCT01461928|17791084|P1|Maintenance I (24 Months)|Lost to Follow-up|2
5151736|NCT01461928|17791082|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
5151737|NCT01461928|17791083|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
5151738|NCT01461928|17791084|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
5151739|NCT01461928|17791082|P3|Maintenance I (24 Months)|Death|0
5151740|NCT01461928|17791083|P2|Maintenance I (24 Months)|Death|0
5151741|NCT01461928|17791084|P1|Maintenance I (24 Months)|Death|3
5151742|NCT01461928|17791082|P3|Induction (up to 8 Months)|Medical advisor request|0
5151743|NCT01461928|17791083|P2|Induction (up to 8 Months)|Medical advisor request|0
5151744|NCT01461928|17791084|P1|Induction (up to 8 Months)|Medical advisor request|1
5151745|NCT01461928|17791082|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
5151746|NCT01461928|17791083|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
5151747|NCT01461928|17791084|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
5151748|NCT01461928|17791082|P3|Induction (up to 8 Months)|Promotor request|0
5151749|NCT01461928|17791083|P2|Induction (up to 8 Months)|Promotor request|0
5151750|NCT01461928|17791084|P1|Induction (up to 8 Months)|Promotor request|1
5151751|NCT01461928|17791082|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
5151752|NCT01461928|17791083|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
5151753|NCT01461928|17791084|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
5151754|NCT01461928|17791082|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
5151755|NCT01461928|17791083|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
5151756|NCT01461928|17791084|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
5151757|NCT01461928|17791082|P3|Induction (up to 8 Months)|Protocol deviation|0
5151758|NCT01461928|17791083|P2|Induction (up to 8 Months)|Protocol deviation|0
5151759|NCT01461928|17791084|P1|Induction (up to 8 Months)|Protocol deviation|2
5151760|NCT01461928|17791082|P3|Induction (up to 8 Months)|Sponsor decision|0
5151761|NCT01461928|17791083|P2|Induction (up to 8 Months)|Sponsor decision|0
5151762|NCT01461928|17791084|P1|Induction (up to 8 Months)|Sponsor decision|1
5151763|NCT01461928|17791082|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
5151764|NCT01461928|17791083|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
5151765|NCT01461928|17791084|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
5151766|NCT01461928|17791082|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
5151767|NCT01461928|17791083|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
5151768|NCT01461928|17791084|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
5151769|NCT01461928|17791082|P3|Induction (up to 8 Months)|Not responding to treatment|0
5151770|NCT01461928|17791083|P2|Induction (up to 8 Months)|Not responding to treatment|0
5151771|NCT01461928|17791084|P1|Induction (up to 8 Months)|Not responding to treatment|11
5151772|NCT01461928|17791082|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
5151773|NCT01461928|17791083|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
5151774|NCT01461928|17791084|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
5151775|NCT01461928|17791082|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
5151776|NCT01461928|17791083|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
5151777|NCT01461928|17791084|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
5151778|NCT01461928|17791082|P3|Induction (up to 8 Months)|Disease progression|0
5151779|NCT01461928|17791083|P2|Induction (up to 8 Months)|Disease progression|0
5151780|NCT01461928|17791084|P1|Induction (up to 8 Months)|Disease progression|45
5151781|NCT01461928|17791082|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
5151782|NCT01461928|17791083|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
5151783|NCT01461928|17791084|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
5151784|NCT01461928|17791082|P3|Induction (up to 8 Months)|Physician Decision|0
5151785|NCT01461928|17791083|P2|Induction (up to 8 Months)|Physician Decision|0
5151786|NCT01461928|17791084|P1|Induction (up to 8 Months)|Physician Decision|9
5151787|NCT01461928|17791082|P3|Induction (up to 8 Months)|Lost to Follow-up|0
5151788|NCT01461928|17791083|P2|Induction (up to 8 Months)|Lost to Follow-up|0
5151789|NCT01461928|17791084|P1|Induction (up to 8 Months)|Lost to Follow-up|5
5151790|NCT01461928|17791082|P3|Induction (up to 8 Months)|Death|0
5151791|NCT01461928|17791083|P2|Induction (up to 8 Months)|Death|0
5151792|NCT01461928|17791084|P1|Induction (up to 8 Months)|Death|3
5151793|NCT01461928|17791082|P3|Induction (up to 8 Months)|Adverse Event|0
5151794|NCT01461928|17791083|P2|Induction (up to 8 Months)|Adverse Event|0
5151795|NCT01461928|17791084|P1|Induction (up to 8 Months)|Adverse Event|76
5151796|NCT01461811|17791135|P2|Overall Study|Noncompliance|1
5151797|NCT01461811|17791136|P1|Overall Study|Noncompliance|1
5151798|NCT01461811|17791135|P2|Overall Study|Subject decision unrelated to an AE|1
5151799|NCT01461811|17791136|P1|Overall Study|Subject decision unrelated to an AE|1
5151800|NCT01461811|17791135|P2|Overall Study|Adverse Event|1
5151801|NCT01461811|17791136|P1|Overall Study|Adverse Event|2
5151802|NCT01461707|17791175|P2|Overall Study|Withdrawal by Subject|0
5151803|NCT01461707|17791176|P1|Overall Study|Withdrawal by Subject|1
5151804|NCT01461551|17791213|P3|Overall Study|Physician Decision|2
5151805|NCT01461551|17791214|P2|Overall Study|Physician Decision|1
5151806|NCT01461551|17791215|P1|Overall Study|Physician Decision|2
5151807|NCT01461538|17791226|P3|Overall Study|Withdrawal by Subject|0
5151808|NCT01461538|17791227|P2|Overall Study|Withdrawal by Subject|1
5151809|NCT01461538|17791228|P1|Overall Study|Withdrawal by Subject|1
5151810|NCT01461538|17791226|P3|Overall Study|Study Stopped by Sponsor|0
5151811|NCT01461538|17791227|P2|Overall Study|Study Stopped by Sponsor|1
5151812|NCT01461538|17791228|P1|Overall Study|Study Stopped by Sponsor|2
5151813|NCT01461538|17791226|P3|Overall Study|Death|2
5151814|NCT01461538|17791227|P2|Overall Study|Death|6
5151815|NCT01461538|17791228|P1|Overall Study|Death|15
5151816|NCT01461369|17791297|P3|Overall Study|Withdrawal by Subject|2
5151817|NCT01461369|17791298|P2|Overall Study|Withdrawal by Subject|3
5151818|NCT01461369|17791299|P1|Overall Study|Withdrawal by Subject|1
5151819|NCT01461369|17791297|P3|Overall Study|Protocol Violation|2
5151820|NCT01461369|17791298|P2|Overall Study|Protocol Violation|2
5151821|NCT01461369|17791299|P1|Overall Study|Protocol Violation|1
5151822|NCT01461369|17791297|P3|Overall Study|Adverse Event|4
5151823|NCT01461369|17791298|P2|Overall Study|Adverse Event|12
5151824|NCT01461369|17791299|P1|Overall Study|Adverse Event|9
5151825|NCT01461369|17791297|P3|Overall Study|Lost to Follow-up|3
5151826|NCT01461369|17791298|P2|Overall Study|Lost to Follow-up|0
5151827|NCT01461369|17791299|P1|Overall Study|Lost to Follow-up|0
5151828|NCT01461369|17791297|P3|Overall Study|Lack of Efficacy|6
5151829|NCT01461369|17791298|P2|Overall Study|Lack of Efficacy|0
5151830|NCT01461369|17791299|P1|Overall Study|Lack of Efficacy|2
5151831|NCT01461096|17791324|P2|Overall Study|Lost to Follow-up|4
5151832|NCT01461096|17791325|P1|Overall Study|Lost to Follow-up|8
5151833|NCT01461096|17791324|P2|Overall Study|Subj not willing to adhere to reqs|4
5151834|NCT01461096|17791325|P1|Overall Study|Subj not willing to adhere to reqs|3
5151835|NCT01461096|17791324|P2|Overall Study|Withdrawal by Subject|3
5151836|NCT01461096|17791325|P1|Overall Study|Withdrawal by Subject|5
5151837|NCT01461096|17791324|P2|Overall Study|Site is closing|30
5151838|NCT01461096|17791325|P1|Overall Study|Site is closing|27
5151839|NCT01461096|17791324|P2|Overall Study|Subj not able to get to clinic|13
5151840|NCT01461096|17791325|P1|Overall Study|Subj not able to get to clinic|15
5151841|NCT01461096|17791324|P2|Overall Study|Severe debilitation, unable to continue|1
5151842|NCT01461096|17791325|P1|Overall Study|Severe debilitation, unable to continue|1
5151843|NCT01461096|17791324|P2|Overall Study|Death|6
5151844|NCT01461096|17791325|P1|Overall Study|Death|3
5151845|NCT01461057|17791341|P2|Overall Study|Study Terminated by Sponsor|0
5151846|NCT01461057|17791342|P1|Overall Study|Study Terminated by Sponsor|2
5151847|NCT01461057|17791341|P2|Overall Study|Progression of Disease|0
5151848|NCT01461057|17791342|P1|Overall Study|Progression of Disease|1
5151849|NCT01461057|17791341|P2|Overall Study|Adverse Event|1
5151850|NCT01461057|17791342|P1|Overall Study|Adverse Event|0
5151851|NCT01461057|17791341|P2|Overall Study|Physician Decision|2
5151852|NCT01461057|17791342|P1|Overall Study|Physician Decision|0
5151853|NCT01461057|17791341|P2|Overall Study|Withdrawal by Subject|3
5151854|NCT01461057|17791342|P1|Overall Study|Withdrawal by Subject|2
5151855|NCT01461057|17791341|P2|Overall Study|Death|9
5151856|NCT01461057|17791342|P1|Overall Study|Death|10
5151857|NCT01461044|17791352|P2|Overall Study|Lost to Follow-up|5
5151858|NCT01461044|17791353|P1|Overall Study|Lost to Follow-up|12
5151859|NCT01461044|17791352|P2|Overall Study|Death|35
5151860|NCT01461044|17791353|P1|Overall Study|Death|58
5151861|NCT01461005|17791426|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
5151862|NCT01460901|17791449|P1|Overall Study|Withdrawal by Subject|2
5151863|NCT01460719|17791481|P1|Overall Study|Withdrawal by Subject|1
5151864|NCT01460719|17791481|P1|Overall Study|Adverse Event|1
5151865|NCT01460628|17791491|P1|Overall Study|Withdrawal by Subject|2
5151866|NCT01460628|17791491|P1|Overall Study|Adverse Event|3
5151867|NCT01460446|17791503|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
5151868|NCT01460446|17791504|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
5151869|NCT01460446|17791503|P2|Overall Study|Pregnancy|0
5151870|NCT01460446|17791504|P1|Overall Study|Pregnancy|1
5151871|NCT01460446|17791503|P2|Overall Study|Surgery/Illness|1
5151872|NCT01460446|17791504|P1|Overall Study|Surgery/Illness|1
5151873|NCT01460446|17791503|P2|Overall Study|Non-compliance & Consent Withdrawn|3
5151874|NCT01460446|17791504|P1|Overall Study|Non-compliance & Consent Withdrawn|1
5151875|NCT01460446|17791503|P2|Overall Study|Consent Withdrawn|4
5151876|NCT01460446|17791504|P1|Overall Study|Consent Withdrawn|0
5151877|NCT01460446|17791503|P2|Overall Study|Non-compliance|9
5151878|NCT01460446|17791504|P1|Overall Study|Non-compliance|2
5151879|NCT01460407|17791531|P2|Period 2: Day 6 to Day 14|Adverse Event|1
5151880|NCT01460407|17791532|P1|Period 2: Day 6 to Day 14|Adverse Event|0
5151881|NCT01460381|17791545|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
5151882|NCT01460381|17791546|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
5151883|NCT01460368|17791562|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5151884|NCT01460368|17791563|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5151885|NCT01460368|17791564|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5151886|NCT01460368|17791565|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5151887|NCT01460368|17791566|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5151888|NCT01460368|17791567|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5151889|NCT01460368|17791568|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5151890|NCT01460368|17791562|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
5151891|NCT01460368|17791563|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
5151892|NCT01460368|17791564|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
5151893|NCT01460368|17791565|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
5151894|NCT01460368|17791566|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
5151895|NCT01460368|17791567|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
5151896|NCT01460368|17791568|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
5151897|NCT01460368|17791562|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5151898|NCT01460368|17791563|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5151899|NCT01460368|17791564|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5151900|NCT01460368|17791565|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5151901|NCT01460368|17791566|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5151902|NCT01460368|17791567|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
5151903|NCT01460368|17791568|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5151904|NCT01460368|17791562|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
5151905|NCT01460368|17791563|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5151906|NCT01460368|17791564|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5151907|NCT01460368|17791565|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5151908|NCT01460368|17791566|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5151909|NCT01460368|17791567|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
5151910|NCT01460368|17791568|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5151911|NCT01460368|17791562|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5151912|NCT01460368|17791563|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5151913|NCT01460368|17791564|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
5151914|NCT01460368|17791565|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5151915|NCT01460368|17791566|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5151916|NCT01460368|17791567|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5151917|NCT01460368|17791568|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5151918|NCT01460342|17791580|P2|Overall Study|Lack of Efficacy|0
5151919|NCT01460342|17791581|P1|Overall Study|Lack of Efficacy|1
5151920|NCT01460342|17791580|P2|Overall Study|Physician Decision|3
5151921|NCT01460342|17791581|P1|Overall Study|Physician Decision|1
5151922|NCT01460342|17791580|P2|Overall Study|Withdrawal by Subject|4
5151923|NCT01460342|17791581|P1|Overall Study|Withdrawal by Subject|3
5151924|NCT01460342|17791580|P2|Overall Study|Protocol Violation|1
5151925|NCT01460342|17791581|P1|Overall Study|Protocol Violation|0
5151926|NCT01460342|17791580|P2|Overall Study|Lost to Follow-up|2
5151927|NCT01460342|17791581|P1|Overall Study|Lost to Follow-up|1
5151928|NCT01460342|17791580|P2|Overall Study|Adverse Event|4
5151929|NCT01460342|17791581|P1|Overall Study|Adverse Event|5
5151930|NCT01460290|17791612|P1|Overall Study|Elevated liver function|1
5151931|NCT01460290|17791612|P1|Overall Study|Adverse Event|3
5151932|NCT01460160|17791639|P2|Follow-up|Lost to Follow-up|0
5151933|NCT01460160|17791640|P1|Follow-up|Lost to Follow-up|1
5151934|NCT01460160|17791639|P2|Follow-up|Death|2
5151935|NCT01460160|17791640|P1|Follow-up|Death|7
5151936|NCT01460160|17791639|P2|Follow-up|Withdrawal by Subject|0
5151937|NCT01460160|17791640|P1|Follow-up|Withdrawal by Subject|3
5151938|NCT01460160|17791639|P2|Treatment|Subject refused to continue Chemo|0
5151939|NCT01460160|17791640|P1|Treatment|Subject refused to continue Chemo|1
5151940|NCT01460160|17791639|P2|Treatment|Family did not wish to restart after SCT|0
5151941|NCT01460160|17791640|P1|Treatment|Family did not wish to restart after SCT|1
5151942|NCT01460160|17791639|P2|Treatment|PI decision to pursue other options|1
5151943|NCT01460160|17791640|P1|Treatment|PI decision to pursue other options|1
5151944|NCT01460160|17791639|P2|Treatment|PI not to follow protocol therapy|0
5151945|NCT01460160|17791640|P1|Treatment|PI not to follow protocol therapy|1
5151946|NCT01460160|17791639|P2|Treatment|PI decision to not re-initiate after SCT|2
5151947|NCT01460160|17791640|P1|Treatment|PI decision to not re-initiate after SCT|2
5151948|NCT01460160|17791639|P2|Treatment|Death|2
5151949|NCT01460160|17791640|P1|Treatment|Death|0
5151950|NCT01460160|17791639|P2|Treatment|Withdrawal by Subject|0
5151951|NCT01460160|17791640|P1|Treatment|Withdrawal by Subject|4
5151952|NCT01460160|17791639|P2|Treatment|Adverse Event|0
5151953|NCT01460160|17791640|P1|Treatment|Adverse Event|8
5151954|NCT01460160|17791639|P2|Treatment|Study Drug Toxicity|0
5151955|NCT01460160|17791640|P1|Treatment|Study Drug Toxicity|2
5151956|NCT01460160|17791639|P2|Treatment|Lack of Efficacy|0
5151957|NCT01460160|17791640|P1|Treatment|Lack of Efficacy|3
5151958|NCT01459913|17791681|P4|Overall Study|Did Not Meet Inclusion Criteria|1
5151959|NCT01459913|17791682|P3|Overall Study|Did Not Meet Inclusion Criteria|0
5151960|NCT01459913|17791683|P2|Overall Study|Did Not Meet Inclusion Criteria|0
5151961|NCT01459913|17791684|P1|Overall Study|Did Not Meet Inclusion Criteria|0
5151962|NCT01459913|17791681|P4|Overall Study|Other|1
5151963|NCT01459913|17791682|P3|Overall Study|Other|3
5151964|NCT01459913|17791683|P2|Overall Study|Other|0
5151965|NCT01459913|17791684|P1|Overall Study|Other|0
5151966|NCT01459913|17791681|P4|Overall Study|Study Terminated by Sponsor|11
5151967|NCT01459913|17791682|P3|Overall Study|Study Terminated by Sponsor|9
5151968|NCT01459913|17791683|P2|Overall Study|Study Terminated by Sponsor|15
5151969|NCT01459913|17791684|P1|Overall Study|Study Terminated by Sponsor|30
5151970|NCT01459913|17791681|P4|Overall Study|Physician Decision|0
5151971|NCT01459913|17791682|P3|Overall Study|Physician Decision|0
5151972|NCT01459913|17791683|P2|Overall Study|Physician Decision|1
5151973|NCT01459913|17791684|P1|Overall Study|Physician Decision|0
5151974|NCT01459913|17791681|P4|Overall Study|Non- Compliance|3
5151975|NCT01459913|17791682|P3|Overall Study|Non- Compliance|0
5151976|NCT01459913|17791683|P2|Overall Study|Non- Compliance|0
5151977|NCT01459913|17791684|P1|Overall Study|Non- Compliance|0
5151978|NCT01459913|17791681|P4|Overall Study|Death|1
5151979|NCT01459913|17791682|P3|Overall Study|Death|0
5151980|NCT01459913|17791683|P2|Overall Study|Death|0
5151981|NCT01459913|17791684|P1|Overall Study|Death|0
5151982|NCT01459913|17791681|P4|Overall Study|Lost to Follow-up|8
5151983|NCT01459913|17791682|P3|Overall Study|Lost to Follow-up|1
5151984|NCT01459913|17791683|P2|Overall Study|Lost to Follow-up|4
5151985|NCT01459913|17791684|P1|Overall Study|Lost to Follow-up|7
5151986|NCT01459913|17791681|P4|Overall Study|Withdrawal by Subject|5
5151987|NCT01459913|17791682|P3|Overall Study|Withdrawal by Subject|0
5151988|NCT01459913|17791683|P2|Overall Study|Withdrawal by Subject|0
5151989|NCT01459913|17791684|P1|Overall Study|Withdrawal by Subject|4
5151990|NCT01459913|17791681|P4|Overall Study|Adverse Event|3
5151991|NCT01459913|17791682|P3|Overall Study|Adverse Event|0
5151992|NCT01459913|17791683|P2|Overall Study|Adverse Event|0
5151993|NCT01459913|17791684|P1|Overall Study|Adverse Event|0
5151994|NCT01459796|17791715|P2|Overall Study|Decision by the sponsor|108
5151995|NCT01459796|17791716|P1|Overall Study|Decision by the sponsor|75
5151996|NCT01459796|17791715|P2|Overall Study|Reason unspecified|2
5151997|NCT01459796|17791716|P1|Overall Study|Reason unspecified|1
5151998|NCT01459796|17791715|P2|Overall Study|Lost to Follow-up|4
5151999|NCT01459796|17791716|P1|Overall Study|Lost to Follow-up|5
5152000|NCT01459796|17791715|P2|Overall Study|Withdrawal by Subject|3
5152001|NCT01459796|17791716|P1|Overall Study|Withdrawal by Subject|6
5152002|NCT01459796|17791715|P2|Overall Study|Adverse Event|5
5152003|NCT01459796|17791716|P1|Overall Study|Adverse Event|5
5152004|NCT01459796|17791715|P2|Overall Study|Non compliance with protocol|4
5152005|NCT01459796|17791716|P1|Overall Study|Non compliance with protocol|2
5152006|NCT01459783|17791734|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
5152007|NCT01459783|17791735|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
5152008|NCT01459783|17791734|P2|6 Months to 12 Months|Lost to Follow-up|7
5152009|NCT01459783|17791735|P1|6 Months to 12 Months|Lost to Follow-up|2
5152010|NCT01459783|17791734|P2|6 Months to 12 Months|Withdrawal by Subject|5
5152011|NCT01459783|17791735|P1|6 Months to 12 Months|Withdrawal by Subject|6
5152012|NCT01459783|17791734|P2|6 Months to 12 Months|Death|1
5152013|NCT01459783|17791735|P1|6 Months to 12 Months|Death|0
5152014|NCT01459783|17791734|P2|Baseline to 6 Months|Lost to Follow-up|14
5152015|NCT01459783|17791735|P1|Baseline to 6 Months|Lost to Follow-up|19
5152016|NCT01459783|17791734|P2|Baseline to 6 Months|Withdrawal by Subject|6
5152017|NCT01459783|17791735|P1|Baseline to 6 Months|Withdrawal by Subject|12
5152018|NCT01459783|17791734|P2|Baseline to 6 Months|Death|0
5152019|NCT01459783|17791735|P1|Baseline to 6 Months|Death|1
5152020|NCT01459718|17791743|P1|Overall Study|Adverse Event|1
5152021|NCT01459718|17791743|P1|Overall Study|Lost to Follow-up|1
5152022|NCT01459718|17791743|P1|Overall Study|Physician Decision|1
5152023|NCT01459614|17791925|P2|Overall Study|Adverse Event|0
5152024|NCT01459614|17791926|P1|Overall Study|Adverse Event|1
5152025|NCT01459068|17791973|P2|Overall Study|Death|1
5152026|NCT01459068|17791974|P1|Overall Study|Death|0
5152027|NCT01459068|17791973|P2|Overall Study|Lost to Follow-up|15
5152028|NCT01459068|17791974|P1|Overall Study|Lost to Follow-up|31
5152029|NCT01459068|17791973|P2|Overall Study|Withdrawal by Subject|18
5152030|NCT01459068|17791974|P1|Overall Study|Withdrawal by Subject|8
5152031|NCT01459016|17791990|P1|Overall Study|Amendment Discontinuation Criteria|4
5152032|NCT01459016|17791990|P1|Overall Study|Withdrawal by Subject|11
5152033|NCT01458951|17792018|P3|Overall Study|Insufficient Clinical Response|11
5152034|NCT01458951|17792019|P2|Overall Study|Insufficient Clinical Response|0
5152035|NCT01458951|17792020|P1|Overall Study|Insufficient Clinical Response|17
5152036|NCT01458951|17792018|P3|Overall Study|Adverse Event|2
5152037|NCT01458951|17792019|P2|Overall Study|Adverse Event|0
5152038|NCT01458951|17792020|P1|Overall Study|Adverse Event|7
5152039|NCT01458951|17792018|P3|Overall Study|Withdrawal by Subject|2
5152040|NCT01458951|17792019|P2|Overall Study|Withdrawal by Subject|0
5152041|NCT01458951|17792020|P1|Overall Study|Withdrawal by Subject|2
5152042|NCT01458951|17792018|P3|Overall Study|Protocol Violation|0
5152043|NCT01458951|17792019|P2|Overall Study|Protocol Violation|1
5152044|NCT01458951|17792020|P1|Overall Study|Protocol Violation|5
5152045|NCT01458951|17792018|P3|Overall Study|Other|0
5152046|NCT01458951|17792019|P2|Overall Study|Other|0
5152047|NCT01458951|17792020|P1|Overall Study|Other|1
5152048|NCT01458639|17792045|P1|Overall Study|Inability to obtain subject blood sample|1
5152049|NCT01458639|17792045|P1|Overall Study|Equipment issue|1
5152050|NCT01458639|17792045|P1|Overall Study|Physician Decision|4
5152051|NCT01458587|17792057|P2|Overall Study|Withdrawal by Subject|0
5152052|NCT01458587|17792058|P1|Overall Study|Withdrawal by Subject|1
5152053|NCT01458574|17792221|P3|Overall Study|Randomized but not treated|0
5152054|NCT01458574|17792222|P2|Overall Study|Randomized but not treated|1
5152055|NCT01458574|17792223|P1|Overall Study|Randomized but not treated|0
5152056|NCT01458574|17792221|P3|Overall Study|Other|0
5152057|NCT01458574|17792222|P2|Overall Study|Other|1
5152058|NCT01458574|17792223|P1|Overall Study|Other|2
5152059|NCT01458574|17792221|P3|Overall Study|Withdrawal by Subject|5
5152060|NCT01458574|17792222|P2|Overall Study|Withdrawal by Subject|3
5152061|NCT01458574|17792223|P1|Overall Study|Withdrawal by Subject|6
5152062|NCT01458574|17792221|P3|Overall Study|Protocol Violation|0
5152063|NCT01458574|17792222|P2|Overall Study|Protocol Violation|1
5152064|NCT01458574|17792223|P1|Overall Study|Protocol Violation|0
5152065|NCT01458574|17792221|P3|Overall Study|Pregnancy|0
5152066|NCT01458574|17792222|P2|Overall Study|Pregnancy|1
5152067|NCT01458574|17792223|P1|Overall Study|Pregnancy|1
5152068|NCT01458574|17792221|P3|Overall Study|Lost to Follow-up|1
5152069|NCT01458574|17792222|P2|Overall Study|Lost to Follow-up|2
5152070|NCT01458574|17792223|P1|Overall Study|Lost to Follow-up|3
5152071|NCT01458574|17792221|P3|Overall Study|Lack of Efficacy|132
5152072|NCT01458574|17792222|P2|Overall Study|Lack of Efficacy|53
5152073|NCT01458574|17792223|P1|Overall Study|Lack of Efficacy|70
5152074|NCT01458574|17792221|P3|Overall Study|Adverse Event|7
5152075|NCT01458574|17792222|P2|Overall Study|Adverse Event|9
5152076|NCT01458574|17792223|P1|Overall Study|Adverse Event|5
5152077|NCT01458535|17792353|P6|Overall Study|Adverse Event|0
5152078|NCT01458535|17792354|P5|Overall Study|Adverse Event|0
5152079|NCT01458535|17792355|P4|Overall Study|Adverse Event|1
5152080|NCT01458535|17792356|P3|Overall Study|Adverse Event|0
5152081|NCT01458535|17792357|P2|Overall Study|Adverse Event|0
5152082|NCT01458535|17792358|P1|Overall Study|Adverse Event|0
5152083|NCT01458535|17792353|P6|Overall Study|Lost to Follow-up|2
5152084|NCT01458535|17792354|P5|Overall Study|Lost to Follow-up|2
5152085|NCT01458535|17792355|P4|Overall Study|Lost to Follow-up|3
5152086|NCT01458535|17792356|P3|Overall Study|Lost to Follow-up|0
5152087|NCT01458535|17792357|P2|Overall Study|Lost to Follow-up|2
5152088|NCT01458535|17792358|P1|Overall Study|Lost to Follow-up|0
5152089|NCT01458535|17792353|P6|Overall Study|Withdrawal by Subject|1
5152090|NCT01458535|17792354|P5|Overall Study|Withdrawal by Subject|1
5152091|NCT01458535|17792355|P4|Overall Study|Withdrawal by Subject|0
5152092|NCT01458535|17792356|P3|Overall Study|Withdrawal by Subject|2
5152093|NCT01458535|17792357|P2|Overall Study|Withdrawal by Subject|0
5152094|NCT01458535|17792358|P1|Overall Study|Withdrawal by Subject|0
5152095|NCT01458535|17792353|P6|Overall Study|Other|1
5152096|NCT01458535|17792354|P5|Overall Study|Other|1
5152097|NCT01458535|17792355|P4|Overall Study|Other|0
5152098|NCT01458535|17792356|P3|Overall Study|Other|0
5152099|NCT01458535|17792357|P2|Overall Study|Other|0
5152100|NCT01458535|17792358|P1|Overall Study|Other|0
5152101|NCT01458522|17792410|P2|Overall Study|Physician Decision|9
5152102|NCT01458522|17792411|P1|Overall Study|Physician Decision|1
5152103|NCT01458522|17792410|P2|Overall Study|Withdrawal by Subject|2
5152104|NCT01458522|17792411|P1|Overall Study|Withdrawal by Subject|2
5152105|NCT01458392|17792457|P3|Overall Study|Patient unwilling to comply with protoco|2
5152106|NCT01458392|17792458|P2|Overall Study|Patient unwilling to comply with protoco|0
5152107|NCT01458392|17792459|P1|Overall Study|Patient unwilling to comply with protoco|0
5152108|NCT01458392|17792457|P3|Overall Study|At the discretion of the sponsor|7
5152109|NCT01458392|17792458|P2|Overall Study|At the discretion of the sponsor|2
5152110|NCT01458392|17792459|P1|Overall Study|At the discretion of the sponsor|0
5152111|NCT01458392|17792457|P3|Overall Study|Death|22
5152112|NCT01458392|17792458|P2|Overall Study|Death|11
5152113|NCT01458392|17792459|P1|Overall Study|Death|2
5152114|NCT01458366|17792484|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
5152115|NCT01458366|17792485|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5152116|NCT01458366|17792486|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5152117|NCT01458366|17792487|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5152118|NCT01458366|17792488|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5152119|NCT01458366|17792484|P5|Period 1: 70mg/m^2|Physician Decision|0
5152120|NCT01458366|17792485|P4|Period 1: 70mg/m^2|Physician Decision|0
5152121|NCT01458366|17792486|P3|Period 1: 70mg/m^2|Physician Decision|0
5152122|NCT01458366|17792487|P2|Period 1: 70mg/m^2|Physician Decision|0
5152123|NCT01458366|17792488|P1|Period 1: 70mg/m^2|Physician Decision|2
5152124|NCT01458275|17792515|P3|Overall Study|Withdrawal by Subject|1
5152125|NCT01458275|17792516|P2|Overall Study|Withdrawal by Subject|2
5152126|NCT01458275|17792517|P1|Overall Study|Withdrawal by Subject|3
5152127|NCT01458275|17792515|P3|Overall Study|Protocol Violation|2
5152128|NCT01458275|17792516|P2|Overall Study|Protocol Violation|5
5152129|NCT01458275|17792517|P1|Overall Study|Protocol Violation|5
5152130|NCT01458275|17792515|P3|Overall Study|Lost to Follow-up|5
5152131|NCT01458275|17792516|P2|Overall Study|Lost to Follow-up|2
5152132|NCT01458275|17792517|P1|Overall Study|Lost to Follow-up|3
5152133|NCT01458275|17792515|P3|Overall Study|Adverse Event|1
5152134|NCT01458275|17792516|P2|Overall Study|Adverse Event|4
5152135|NCT01458275|17792517|P1|Overall Study|Adverse Event|3
5152136|NCT01458249|17792559|P1|Overall Study|Ongoing|1
5152137|NCT01458249|17792559|P1|Overall Study|Other|2
5152138|NCT01458249|17792559|P1|Overall Study|Adverse Event|4
5152139|NCT01458249|17792559|P1|Overall Study|Not treated|1
5152140|NCT01458210|17792578|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
5152141|NCT01458210|17792578|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
5152142|NCT01458210|17792578|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
5152143|NCT01458210|17792578|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
5152144|NCT01458171|17792595|P1|Overall Study|Adverse Event|1
5152145|NCT01458132|17792618|P2|Overall Study|Other|3
5152146|NCT01458132|17792619|P1|Overall Study|Other|15
5152147|NCT01458119|17792627|P1|Overall Study|Non-compliance With Study Drug|3
5152148|NCT01458119|17792627|P1|Overall Study|Consent Withdrawn by Participant|8
5152149|NCT01458119|17792627|P1|Overall Study|Adverse Event|1
5152150|NCT01458119|17792627|P1|Overall Study|Death|2
5152151|NCT01458119|17792627|P1|Overall Study|Pregnancy|1
5152152|NCT01458119|17792627|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
5152153|NCT01458119|17792627|P1|Overall Study|Physician Decision|4
5152154|NCT01458106|17792634|P2|Overall Study|Withdrawn Per Protocol|1
5152155|NCT01458106|17792635|P1|Overall Study|Withdrawn Per Protocol|0
5152156|NCT01458106|17792634|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
5152157|NCT01458106|17792635|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
5152158|NCT01458106|17792634|P2|Overall Study|Withdrawal by Subject|0
5152159|NCT01458106|17792635|P1|Overall Study|Withdrawal by Subject|2
5152160|NCT01457950|17792712|P4|Open-Label Phase|Withdrawal by Subject|0
5152161|NCT01457950|17792713|P3|Open-Label Phase|Withdrawal by Subject|2
5152162|NCT01457950|17792714|P2|Open-Label Phase|Withdrawal by Subject|0
5152163|NCT01457950|17792715|P1|Open-Label Phase|Withdrawal by Subject|0
5152164|NCT01457950|17792712|P4|Open-Label Phase|Protocol Violation|1
5152165|NCT01457950|17792713|P3|Open-Label Phase|Protocol Violation|0
5152166|NCT01457950|17792714|P2|Open-Label Phase|Protocol Violation|0
5152167|NCT01457950|17792715|P1|Open-Label Phase|Protocol Violation|0
5152168|NCT01457950|17792712|P4|Open-Label Phase|Adverse Event|1
5152169|NCT01457950|17792713|P3|Open-Label Phase|Adverse Event|0
5152170|NCT01457950|17792714|P2|Open-Label Phase|Adverse Event|0
5152171|NCT01457950|17792715|P1|Open-Label Phase|Adverse Event|0
5152172|NCT01457950|17792712|P4|Double-Blind Phase|Withdrawal by Subject|0
5152173|NCT01457950|17792713|P3|Double-Blind Phase|Withdrawal by Subject|0
5152174|NCT01457950|17792714|P2|Double-Blind Phase|Withdrawal by Subject|2
5152175|NCT01457950|17792715|P1|Double-Blind Phase|Withdrawal by Subject|6
5152176|NCT01457950|17792712|P4|Double-Blind Phase|Protocol Violation|0
5152177|NCT01457950|17792713|P3|Double-Blind Phase|Protocol Violation|0
5152178|NCT01457950|17792714|P2|Double-Blind Phase|Protocol Violation|1
5152179|NCT01457950|17792715|P1|Double-Blind Phase|Protocol Violation|2
5152180|NCT01457950|17792712|P4|Double-Blind Phase|Continuation Criteria Not Met|0
5152181|NCT01457950|17792713|P3|Double-Blind Phase|Continuation Criteria Not Met|0
5152182|NCT01457950|17792714|P2|Double-Blind Phase|Continuation Criteria Not Met|0
5152183|NCT01457950|17792715|P1|Double-Blind Phase|Continuation Criteria Not Met|1
5152184|NCT01457924|17792794|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5152185|NCT01457924|17792795|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
5152186|NCT01457924|17792796|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5152187|NCT01457924|17792797|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
5152188|NCT01457924|17792798|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5152189|NCT01457924|17792794|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
5152190|NCT01457924|17792795|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
5152191|NCT01457924|17792796|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
5152192|NCT01457924|17792797|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
5152193|NCT01457924|17792798|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
5152194|NCT01457924|17792794|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5152195|NCT01457924|17792795|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5152196|NCT01457924|17792796|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
5152197|NCT01457924|17792797|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5152198|NCT01457924|17792798|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
5152199|NCT01457924|17792794|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
5152200|NCT01457924|17792795|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
5152201|NCT01457924|17792796|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
5152202|NCT01457924|17792797|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
5152203|NCT01457924|17792798|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
5152204|NCT01457924|17792794|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
5152205|NCT01457924|17792795|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
5152206|NCT01457924|17792796|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
5152207|NCT01457924|17792797|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
5152208|NCT01457924|17792798|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
5152209|NCT01457924|17792794|P5|FUP (Weeks 24-48)|Physician Decision|0
5152210|NCT01457924|17792795|P4|FUP (Weeks 24-48)|Physician Decision|0
5152211|NCT01457924|17792796|P3|FUP (Weeks 24-48)|Physician Decision|1
5152212|NCT01457924|17792797|P2|FUP (Weeks 24-48)|Physician Decision|0
5152213|NCT01457924|17792798|P1|FUP (Weeks 24-48)|Physician Decision|1
5152214|NCT01457924|17792794|P5|FUP (Weeks 24-48)|Adverse Event|0
5152215|NCT01457924|17792795|P4|FUP (Weeks 24-48)|Adverse Event|0
5152216|NCT01457924|17792796|P3|FUP (Weeks 24-48)|Adverse Event|1
5152217|NCT01457924|17792797|P2|FUP (Weeks 24-48)|Adverse Event|0
5152218|NCT01457924|17792798|P1|FUP (Weeks 24-48)|Adverse Event|0
5152219|NCT01457924|17792794|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
5152220|NCT01457924|17792795|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
5152221|NCT01457924|17792796|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
5152222|NCT01457924|17792797|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
5152223|NCT01457924|17792798|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
5152224|NCT01457924|17792794|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
5152225|NCT01457924|17792795|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
5152226|NCT01457924|17792796|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5152227|NCT01457924|17792797|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5152228|NCT01457924|17792798|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5152229|NCT01457924|17792794|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5152230|NCT01457924|17792795|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5152231|NCT01457924|17792796|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
5152232|NCT01457924|17792797|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5152233|NCT01457924|17792798|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
5152234|NCT01457924|17792794|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5152235|NCT01457924|17792795|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5152236|NCT01457924|17792796|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5152237|NCT01457924|17792797|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5152238|NCT01457924|17792798|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
5152239|NCT01457924|17792794|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
5152240|NCT01457924|17792795|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
5152241|NCT01457924|17792796|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
5152242|NCT01457924|17792797|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
5152243|NCT01457924|17792798|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
5152244|NCT01457924|17792794|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
5152245|NCT01457924|17792795|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
5152246|NCT01457924|17792796|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
5152247|NCT01457924|17792797|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
5152248|NCT01457924|17792798|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
5152249|NCT01457846|17792868|P2|Overall Study|Lost to Follow-up|0
5152250|NCT01457846|17792869|P1|Overall Study|Lost to Follow-up|1
5152251|NCT01457846|17792868|P2|Overall Study|Withdrawal by Subject|1
5152252|NCT01457846|17792869|P1|Overall Study|Withdrawal by Subject|1
5152253|NCT01457846|17792868|P2|Overall Study|Unclassified reason for not completed|10
5152254|NCT01457846|17792869|P1|Overall Study|Unclassified reason for not completed|11
5152255|NCT01457846|17792868|P2|Overall Study|Death|16
5152256|NCT01457846|17792869|P1|Overall Study|Death|27
5152257|NCT01457846|17792868|P2|Overall Study|Did not receive treatment|1
5152258|NCT01457846|17792869|P1|Overall Study|Did not receive treatment|0
5152259|NCT01457846|17792868|P2|Overall Study|Death before treatment|2
5152260|NCT01457846|17792869|P1|Overall Study|Death before treatment|1
5152261|NCT01457703|17792885|P2|Overall Study|Withdrawal by Subject|4
5152262|NCT01457703|17792886|P1|Overall Study|Withdrawal by Subject|1
5152263|NCT01457703|17792885|P2|Overall Study|Screen Failure|7
5152264|NCT01457703|17792886|P1|Overall Study|Screen Failure|5
5152265|NCT01457352|17792997|P2|Period 3|Sponsor's withdrawal|1
5152266|NCT01457352|17792998|P1|Period 3|Sponsor's withdrawal|0
5152267|NCT01457352|17792997|P2|Period 3|incorrect treatment|1
5152268|NCT01457352|17792998|P1|Period 3|incorrect treatment|0
5152269|NCT01457352|17792997|P2|Period 3|Withdrawal by Subject|2
5152270|NCT01457352|17792998|P1|Period 3|Withdrawal by Subject|0
5152271|NCT01457352|17792997|P2|Period 3|Adverse Event|1
5152272|NCT01457352|17792998|P1|Period 3|Adverse Event|1
5152273|NCT01457352|17792997|P2|Period 2|Did not meet eligibility criteria|0
5152274|NCT01457352|17792998|P1|Period 2|Did not meet eligibility criteria|3
5152275|NCT01457352|17792997|P2|Period 2|Physician Decision|0
5152276|NCT01457352|17792998|P1|Period 2|Physician Decision|1
5152277|NCT01457352|17792997|P2|Period 2|dose change|0
5152278|NCT01457352|17792998|P1|Period 2|dose change|1
5152279|NCT01457352|17792997|P2|Period 2|Lost to Follow-up|0
5152280|NCT01457352|17792998|P1|Period 2|Lost to Follow-up|1
5152281|NCT01457352|17792997|P2|Period 2|Sponsor's withdrawal|0
5152282|NCT01457352|17792998|P1|Period 2|Sponsor's withdrawal|7
5152283|NCT01457352|17792997|P2|Period 2|Protocol Violation|0
5152284|NCT01457352|17792998|P1|Period 2|Protocol Violation|4
5152285|NCT01457352|17792997|P2|Period 2|Lack of Efficacy|0
5152286|NCT01457352|17792998|P1|Period 2|Lack of Efficacy|8
5152287|NCT01457352|17792997|P2|Period 2|no analysis|0
5152288|NCT01457352|17792998|P1|Period 2|no analysis|10
5152289|NCT01457352|17792997|P2|Period 2|Adverse Event|0
5152290|NCT01457352|17792998|P1|Period 2|Adverse Event|22
5152291|NCT01457352|17792997|P2|Period 2|Withdrawal by Subject|0
5152292|NCT01457352|17792998|P1|Period 2|Withdrawal by Subject|23
5152293|NCT01457352|17792997|P2|Period 1|Did not meet eligibility criteria|0
5152294|NCT01457352|17792998|P1|Period 1|Did not meet eligibility criteria|3
5152295|NCT01457352|17792997|P2|Period 1|Protocol Violation|0
5152296|NCT01457352|17792998|P1|Period 1|Protocol Violation|4
5152297|NCT01457352|17792997|P2|Period 1|withdrew per sponsor|0
5152298|NCT01457352|17792998|P1|Period 1|withdrew per sponsor|1
5152299|NCT01457352|17792997|P2|Period 1|Withdrawn|0
5152300|NCT01457352|17792998|P1|Period 1|Withdrawn|1
5152301|NCT01457352|17792997|P2|Period 1|MS related disease progression|0
5152302|NCT01457352|17792998|P1|Period 1|MS related disease progression|1
5152303|NCT01457352|17792997|P2|Period 1|Physician Decision|0
5152304|NCT01457352|17792998|P1|Period 1|Physician Decision|2
5152305|NCT01457352|17792997|P2|Period 1|Withdrawal by Subject|0
5152306|NCT01457352|17792998|P1|Period 1|Withdrawal by Subject|2
5152307|NCT01457352|17792997|P2|Period 1|Adverse Event|0
5152308|NCT01457352|17792998|P1|Period 1|Adverse Event|2
5152309|NCT01457339|17793010|P2|Period 6 (250 mg)|Personal appointment|1
5152310|NCT01457339|17793011|P1|Period 6 (250 mg)|Personal appointment|0
5152311|NCT01457339|17793010|P2|Period 6 (250 mg)|Family Emergency|0
5152312|NCT01457339|17793011|P1|Period 6 (250 mg)|Family Emergency|1
5152313|NCT01457339|17793010|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
5152314|NCT01457339|17793011|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
5152315|NCT01457339|17793010|P2|Period 3 (100 mg)|Adverse Event|1
5152316|NCT01457339|17793011|P1|Period 3 (100 mg)|Adverse Event|0
5152317|NCT01457053|17793183|P2|Overall Study|Unable to undergo selected treatment|1
5152318|NCT01457053|17793184|P1|Overall Study|Unable to undergo selected treatment|1
5152319|NCT01457014|17793190|P4|First Night|Withdrawal by Subject|0
5152320|NCT01457014|17793191|P3|First Night|Withdrawal by Subject|0
5152321|NCT01457014|17793192|P2|First Night|Withdrawal by Subject|0
5152322|NCT01457014|17793193|P1|First Night|Withdrawal by Subject|3
5152323|NCT01457014|17793190|P4|First Night|Didn't meet inclusion/exclusion criteria|0
5152324|NCT01457014|17793191|P3|First Night|Didn't meet inclusion/exclusion criteria|0
5152325|NCT01457014|17793192|P2|First Night|Didn't meet inclusion/exclusion criteria|0
5152326|NCT01457014|17793193|P1|First Night|Didn't meet inclusion/exclusion criteria|37
5152327|NCT01456962|17793210|P2|Overall Study|Lost to Follow-up|1
5152328|NCT01456962|17793211|P1|Overall Study|Lost to Follow-up|2
5152329|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
5152330|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
5152331|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
5152332|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
5152333|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
5152334|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
5152335|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
5152336|NCT01456949|17793217|P1|Study Cryoablation Procedure & Follow-up|Death|5
5152337|NCT01456949|17793217|P1|Enrollment|Withdrawal by Subject|7
5152338|NCT01456949|17793217|P1|Enrollment|Physician Decision|10
5152339|NCT01456949|17793217|P1|Enrollment|I/E criteria not met prior to procedure|13
5152340|NCT01456949|17793217|P1|Enrollment|Death|1
5152341|NCT01456949|17793217|P1|Enrollment|PI death- incomplete data|6
5152342|NCT01456936|17793228|P4|Overall Study|Randomized but not treated|21
5152343|NCT01456936|17793229|P3|Overall Study|Randomized but not treated|16
5152344|NCT01456936|17793230|P2|Overall Study|Randomized but not treated|28
5152345|NCT01456936|17793231|P1|Overall Study|Randomized but not treated|21
5152346|NCT01456936|17793228|P4|Overall Study|Death|3
5152347|NCT01456936|17793229|P3|Overall Study|Death|1
5152348|NCT01456936|17793230|P2|Overall Study|Death|3
5152349|NCT01456936|17793231|P1|Overall Study|Death|0
5152350|NCT01456936|17793228|P4|Overall Study|Adverse event (study drug unrelated)|9
5152351|NCT01456936|17793229|P3|Overall Study|Adverse event (study drug unrelated)|9
5152352|NCT01456936|17793230|P2|Overall Study|Adverse event (study drug unrelated)|7
5152353|NCT01456936|17793231|P1|Overall Study|Adverse event (study drug unrelated)|9
5152354|NCT01456936|17793228|P4|Overall Study|Adverse event (study drug)|17
5152355|NCT01456936|17793229|P3|Overall Study|Adverse event (study drug)|26
5152356|NCT01456936|17793230|P2|Overall Study|Adverse event (study drug)|21
5152357|NCT01456936|17793231|P1|Overall Study|Adverse event (study drug)|25
5152358|NCT01456936|17793228|P4|Overall Study|Medication error|1
5152359|NCT01456936|17793229|P3|Overall Study|Medication error|0
5152360|NCT01456936|17793230|P2|Overall Study|Medication error|1
5152361|NCT01456936|17793231|P1|Overall Study|Medication error|0
5152362|NCT01456936|17793228|P4|Overall Study|Lost to Follow-up|127
5152363|NCT01456936|17793229|P3|Overall Study|Lost to Follow-up|144
5152364|NCT01456936|17793230|P2|Overall Study|Lost to Follow-up|126
5152365|NCT01456936|17793231|P1|Overall Study|Lost to Follow-up|135
5152366|NCT01456936|17793228|P4|Overall Study|No longer willing to participate|248
5152367|NCT01456936|17793229|P3|Overall Study|No longer willing to participate|224
5152368|NCT01456936|17793230|P2|Overall Study|No longer willing to participate|218
5152369|NCT01456936|17793231|P1|Overall Study|No longer willing to participate|195
5152370|NCT01456936|17793228|P4|Overall Study|Insufficient clinical response|13
5152371|NCT01456936|17793229|P3|Overall Study|Insufficient clinical response|14
5152372|NCT01456936|17793230|P2|Overall Study|Insufficient clinical response|4
5152373|NCT01456936|17793231|P1|Overall Study|Insufficient clinical response|4
5152374|NCT01456936|17793228|P4|Overall Study|Pregnancy|1
5152375|NCT01456936|17793229|P3|Overall Study|Pregnancy|0
5152376|NCT01456936|17793230|P2|Overall Study|Pregnancy|0
5152377|NCT01456936|17793231|P1|Overall Study|Pregnancy|1
5152378|NCT01456936|17793228|P4|Overall Study|Protocol Violation|5
5152379|NCT01456936|17793229|P3|Overall Study|Protocol Violation|5
5152380|NCT01456936|17793230|P2|Overall Study|Protocol Violation|2
5152381|NCT01456936|17793231|P1|Overall Study|Protocol Violation|4
5152382|NCT01456936|17793228|P4|Overall Study|No longer meets eligibility criteria|5
5152383|NCT01456936|17793229|P3|Overall Study|No longer meets eligibility criteria|6
5152384|NCT01456936|17793230|P2|Overall Study|No longer meets eligibility criteria|8
5152385|NCT01456936|17793231|P1|Overall Study|No longer meets eligibility criteria|4
5152386|NCT01456936|17793228|P4|Overall Study|Other reason|33
5152387|NCT01456936|17793229|P3|Overall Study|Other reason|36
5152388|NCT01456936|17793230|P2|Overall Study|Other reason|30
5152389|NCT01456936|17793231|P1|Overall Study|Other reason|41
5152390|NCT01456897|17793339|P2|Overall Study|Lack of Efficacy|11
5152391|NCT01456897|17793340|P1|Overall Study|Lack of Efficacy|4
5152392|NCT01456897|17793339|P2|Overall Study|Withdrawal by Subject|17
5152393|NCT01456897|17793340|P1|Overall Study|Withdrawal by Subject|44
5152394|NCT01456897|17793339|P2|Overall Study|Physician Decision|3
5152395|NCT01456897|17793340|P1|Overall Study|Physician Decision|5
5152396|NCT01456897|17793339|P2|Overall Study|Protocol Violation|4
5152397|NCT01456897|17793340|P1|Overall Study|Protocol Violation|3
5152398|NCT01456897|17793339|P2|Overall Study|Adverse Event|22
5152399|NCT01456897|17793340|P1|Overall Study|Adverse Event|19
5152400|NCT01456780|17793359|P3|Overall Study|Lost to Follow-up|0
5152401|NCT01456780|17793360|P2|Overall Study|Lost to Follow-up|3
5152402|NCT01456780|17793361|P1|Overall Study|Lost to Follow-up|3
5152403|NCT01456221|17793410|P2|Overall Study|Incomplete data|2
5152404|NCT01456221|17793411|P1|Overall Study|Incomplete data|4
5152405|NCT01456221|17793410|P2|Overall Study|Received medication|2
5152406|NCT01456221|17793411|P1|Overall Study|Received medication|3
5152407|NCT01456221|17793410|P2|Overall Study|Lost to Follow-up|4
5152408|NCT01456221|17793411|P1|Overall Study|Lost to Follow-up|1
5152409|NCT01456221|17793410|P2|Overall Study|Withdrawal by Subject|49
5152410|NCT01456221|17793411|P1|Overall Study|Withdrawal by Subject|56
5152411|NCT01456195|17793426|P3|Overall Study|Other Reasons|3
5152412|NCT01456195|17793427|P2|Overall Study|Other Reasons|1
5152413|NCT01456195|17793428|P1|Overall Study|Other Reasons|2
5152414|NCT01456195|17793426|P3|Overall Study|Lack of Efficacy|0
5152415|NCT01456195|17793427|P2|Overall Study|Lack of Efficacy|1
5152416|NCT01456195|17793428|P1|Overall Study|Lack of Efficacy|0
5152417|NCT01456195|17793426|P3|Overall Study|Voluntary Withdrawal|7
5152418|NCT01456195|17793427|P2|Overall Study|Voluntary Withdrawal|3
5152419|NCT01456195|17793428|P1|Overall Study|Voluntary Withdrawal|5
5152420|NCT01456195|17793426|P3|Overall Study|Lost to Follow-up|3
5152421|NCT01456195|17793427|P2|Overall Study|Lost to Follow-up|1
5152422|NCT01456195|17793428|P1|Overall Study|Lost to Follow-up|3
5152423|NCT01456195|17793426|P3|Overall Study|Pretreatment Event/Adverse Event|1
5152424|NCT01456195|17793427|P2|Overall Study|Pretreatment Event/Adverse Event|4
5152425|NCT01456195|17793428|P1|Overall Study|Pretreatment Event/Adverse Event|1
5152426|NCT01456169|17793448|P3|Overall Study|Other|0
5152427|NCT01456169|17793449|P2|Overall Study|Other|1
5152428|NCT01456169|17793450|P1|Overall Study|Other|1
5152429|NCT01456169|17793448|P3|Overall Study|Lack of Efficacy|0
5152430|NCT01456169|17793449|P2|Overall Study|Lack of Efficacy|0
5152431|NCT01456169|17793450|P1|Overall Study|Lack of Efficacy|2
5152432|NCT01456169|17793448|P3|Overall Study|Voluntary Withdrawal|2
5152433|NCT01456169|17793449|P2|Overall Study|Voluntary Withdrawal|0
5152434|NCT01456169|17793450|P1|Overall Study|Voluntary Withdrawal|3
5152435|NCT01456169|17793448|P3|Overall Study|Major Protocol Deviation|3
5152436|NCT01456169|17793449|P2|Overall Study|Major Protocol Deviation|2
5152437|NCT01456169|17793450|P1|Overall Study|Major Protocol Deviation|3
5152438|NCT01456169|17793448|P3|Overall Study|Adverse Event|7
5152439|NCT01456169|17793449|P2|Overall Study|Adverse Event|2
5152440|NCT01456169|17793450|P1|Overall Study|Adverse Event|1
5152441|NCT01456130|17793510|P1|Overall Study|Other|1
5152442|NCT01456130|17793510|P1|Overall Study|Lack of Efficacy|4
5152443|NCT01456130|17793510|P1|Overall Study|Voluntary Withdrawal|1
5152444|NCT01456130|17793510|P1|Overall Study|Adverse Event|4
5152445|NCT01456052|17793520|P3|Overall Study|Treatment Failure|1
5152446|NCT01456052|17793521|P2|Overall Study|Treatment Failure|1
5152447|NCT01456052|17793522|P1|Overall Study|Treatment Failure|0
5152448|NCT01456052|17793520|P3|Overall Study|Physician Decision|1
5152449|NCT01456052|17793521|P2|Overall Study|Physician Decision|0
5152450|NCT01456052|17793522|P1|Overall Study|Physician Decision|1
5152451|NCT01456052|17793520|P3|Overall Study|Protocol Violation|0
5152452|NCT01456052|17793521|P2|Overall Study|Protocol Violation|1
5152453|NCT01456052|17793522|P1|Overall Study|Protocol Violation|0
5152454|NCT01456052|17793520|P3|Overall Study|Consent withdrawn|1
5152455|NCT01456052|17793521|P2|Overall Study|Consent withdrawn|2
5152456|NCT01456052|17793522|P1|Overall Study|Consent withdrawn|0
5152457|NCT01456052|17793520|P3|Overall Study|Adverse Event|2
5152458|NCT01456052|17793521|P2|Overall Study|Adverse Event|1
5152459|NCT01456052|17793522|P1|Overall Study|Adverse Event|1
5152460|NCT01456039|17793542|P3|Phase 2 (Second Step)|Other|1
5152461|NCT01456039|17793543|P2|Phase 2 (Second Step)|Other|0
5152462|NCT01456039|17793544|P1|Phase 2 (Second Step)|Other|0
5152463|NCT01456039|17793542|P3|Phase 2 (Second Step)|Protocol Violation|1
5152464|NCT01456039|17793543|P2|Phase 2 (Second Step)|Protocol Violation|0
5152465|NCT01456039|17793544|P1|Phase 2 (Second Step)|Protocol Violation|0
5152466|NCT01456039|17793542|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
5152467|NCT01456039|17793543|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
5152468|NCT01456039|17793544|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
5152469|NCT01456039|17793542|P3|Phase 2 (Second Step)|Adverse Event|10
5152470|NCT01456039|17793543|P2|Phase 2 (Second Step)|Adverse Event|0
5152471|NCT01456039|17793544|P1|Phase 2 (Second Step)|Adverse Event|0
5152472|NCT01456039|17793542|P3|Phase 2 (Second Step)|Disease Progression|17
5152473|NCT01456039|17793543|P2|Phase 2 (Second Step)|Disease Progression|0
5152474|NCT01456039|17793544|P1|Phase 2 (Second Step)|Disease Progression|0
5152475|NCT01456039|17793542|P3|Phase 1 (First Step)|Other|0
5152476|NCT01456039|17793543|P2|Phase 1 (First Step)|Other|1
5152477|NCT01456039|17793544|P1|Phase 1 (First Step)|Other|0
5152478|NCT01456039|17793542|P3|Phase 1 (First Step)|Adverse Event|0
5152479|NCT01456039|17793543|P2|Phase 1 (First Step)|Adverse Event|3
5152480|NCT01456039|17793544|P1|Phase 1 (First Step)|Adverse Event|0
5152481|NCT01456039|17793542|P3|Phase 1 (First Step)|Withdrawal by Subject|0
5152482|NCT01456039|17793543|P2|Phase 1 (First Step)|Withdrawal by Subject|2
5152483|NCT01456039|17793544|P1|Phase 1 (First Step)|Withdrawal by Subject|1
5152484|NCT01456039|17793542|P3|Phase 1 (First Step)|Disease Progression|0
5152485|NCT01456039|17793543|P2|Phase 1 (First Step)|Disease Progression|1
5152486|NCT01456039|17793544|P1|Phase 1 (First Step)|Disease Progression|1
5152487|NCT01455428|17793687|P2|Overall Study|Other|4
5152488|NCT01455428|17793688|P1|Overall Study|Other|2
5152489|NCT01455428|17793687|P2|Overall Study|Did not receive treatment|1
5152490|NCT01455428|17793688|P1|Overall Study|Did not receive treatment|1
5152491|NCT01455428|17793687|P2|Overall Study|Insufficient clinical response|2
5152492|NCT01455428|17793688|P1|Overall Study|Insufficient clinical response|0
5152493|NCT01455428|17793687|P2|Overall Study|Did not meet entrance criteria|2
5152494|NCT01455428|17793688|P1|Overall Study|Did not meet entrance criteria|0
5152495|NCT01455428|17793687|P2|Overall Study|Withdrawal by Subject|5
5152496|NCT01455428|17793688|P1|Overall Study|Withdrawal by Subject|2
5152497|NCT01455428|17793687|P2|Overall Study|Lost to Follow-up|1
5152498|NCT01455428|17793688|P1|Overall Study|Lost to Follow-up|1
5152499|NCT01455428|17793687|P2|Overall Study|Adverse Event|2
5152500|NCT01455428|17793688|P1|Overall Study|Adverse Event|6
5152501|NCT01455428|17793687|P2|Overall Study|Protocol Violation|1
5152502|NCT01455428|17793688|P1|Overall Study|Protocol Violation|2
5152503|NCT01455415|17793744|P2|Follow-up|Unspecified Reason|0
5152504|NCT01455415|17793745|P1|Follow-up|Unspecified Reason|1
5152505|NCT01455415|17793744|P2|Follow-up|Withdrawal by Subject|0
5152506|NCT01455415|17793745|P1|Follow-up|Withdrawal by Subject|2
5152507|NCT01455415|17793744|P2|Follow-up|Lack of Efficacy|1
5152508|NCT01455415|17793745|P1|Follow-up|Lack of Efficacy|0
5152509|NCT01455415|17793744|P2|Follow-up|AE Related to Study Drug|1
5152510|NCT01455415|17793745|P1|Follow-up|AE Related to Study Drug|0
5152511|NCT01455415|17793744|P2|Period 2|Protocol Violation|0
5152512|NCT01455415|17793745|P1|Period 2|Protocol Violation|2
5152513|NCT01455415|17793744|P2|Period 2|Unspecified Reason|3
5152514|NCT01455415|17793745|P1|Period 2|Unspecified Reason|2
5152515|NCT01455415|17793744|P2|Period 2|Withdrawal by Subject|3
5152516|NCT01455415|17793745|P1|Period 2|Withdrawal by Subject|2
5152517|NCT01455415|17793744|P2|Period 2|Lack of Efficacy|0
5152518|NCT01455415|17793745|P1|Period 2|Lack of Efficacy|2
5152519|NCT01455415|17793744|P2|Period 2|AE Not Related to Study Drug|1
5152520|NCT01455415|17793745|P1|Period 2|AE Not Related to Study Drug|2
5152521|NCT01455415|17793744|P2|Period 2|Lost to Follow-up|1
5152522|NCT01455415|17793745|P1|Period 2|Lost to Follow-up|2
5152523|NCT01455415|17793744|P2|Period 2|AE Related to Study Drug|2
5152524|NCT01455415|17793745|P1|Period 2|AE Related to Study Drug|1
5152525|NCT01455415|17793744|P2|Washout|Protocol Violation|1
5152526|NCT01455415|17793745|P1|Washout|Protocol Violation|0
5152527|NCT01455415|17793744|P2|Washout|Unspecified Reason|2
5152528|NCT01455415|17793745|P1|Washout|Unspecified Reason|1
5152529|NCT01455415|17793744|P2|Washout|AE Not Related to Study Drug|3
5152530|NCT01455415|17793745|P1|Washout|AE Not Related to Study Drug|2
5152531|NCT01455415|17793744|P2|Washout|Drug Error not Associated to AE|1
5152532|NCT01455415|17793745|P1|Washout|Drug Error not Associated to AE|2
5152533|NCT01455415|17793744|P2|Washout|Lost to Follow-up|0
5152534|NCT01455415|17793745|P1|Washout|Lost to Follow-up|1
5152535|NCT01455415|17793744|P2|Washout|AE Related to Study Drug|0
5152536|NCT01455415|17793745|P1|Washout|AE Related to Study Drug|2
5152537|NCT01455415|17793744|P2|Period 1|Protocol Violation|2
5152538|NCT01455415|17793745|P1|Period 1|Protocol Violation|0
5152539|NCT01455415|17793744|P2|Period 1|Unspecified Reason|1
5152540|NCT01455415|17793745|P1|Period 1|Unspecified Reason|1
5152541|NCT01455415|17793744|P2|Period 1|Withdrawal by Subject|5
5152542|NCT01455415|17793745|P1|Period 1|Withdrawal by Subject|4
5152543|NCT01455415|17793744|P2|Period 1|AE Not Related to Study Drug|6
5152544|NCT01455415|17793745|P1|Period 1|AE Not Related to Study Drug|2
5152545|NCT01455415|17793744|P2|Period 1|Drug Error not Associated to AE|1
5152546|NCT01455415|17793745|P1|Period 1|Drug Error not Associated to AE|0
5152547|NCT01455415|17793744|P2|Period 1|Lost To Follow-up Related to Study Drug|3
5152548|NCT01455415|17793745|P1|Period 1|Lost To Follow-up Related to Study Drug|3
5152549|NCT01455415|17793744|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
5152550|NCT01455415|17793745|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
5152551|NCT01455220|17793795|P1|Overall Study|screen fail|30
5152552|NCT01455194|17793805|P4|Overall Study|Miscellaneous|4
5152553|NCT01455194|17793806|P3|Overall Study|Miscellaneous|1
5152554|NCT01455194|17793807|P2|Overall Study|Miscellaneous|5
5152555|NCT01455194|17793808|P1|Overall Study|Miscellaneous|4
5152556|NCT01455194|17793805|P4|Overall Study|Discontinuation criterion fulfilled|2
5152557|NCT01455194|17793806|P3|Overall Study|Discontinuation criterion fulfilled|0
5152558|NCT01455194|17793807|P2|Overall Study|Discontinuation criterion fulfilled|2
5152559|NCT01455194|17793808|P1|Overall Study|Discontinuation criterion fulfilled|3
5152560|NCT01455194|17793805|P4|Overall Study|Pregnancy|0
5152561|NCT01455194|17793806|P3|Overall Study|Pregnancy|1
5152562|NCT01455194|17793807|P2|Overall Study|Pregnancy|1
5152563|NCT01455194|17793808|P1|Overall Study|Pregnancy|0
5152564|NCT01455194|17793805|P4|Overall Study|Lost to Follow-up|1
5152565|NCT01455194|17793806|P3|Overall Study|Lost to Follow-up|1
5152566|NCT01455194|17793807|P2|Overall Study|Lost to Follow-up|0
5152567|NCT01455194|17793808|P1|Overall Study|Lost to Follow-up|2
5152568|NCT01455194|17793805|P4|Overall Study|Withdrawal by Subject|9
5152569|NCT01455194|17793806|P3|Overall Study|Withdrawal by Subject|12
5152570|NCT01455194|17793807|P2|Overall Study|Withdrawal by Subject|16
5152571|NCT01455194|17793808|P1|Overall Study|Withdrawal by Subject|21
5152572|NCT01455194|17793805|P4|Overall Study|Adverse Event|3
5152573|NCT01455194|17793806|P3|Overall Study|Adverse Event|1
5152574|NCT01455194|17793807|P2|Overall Study|Adverse Event|1
5152575|NCT01455194|17793808|P1|Overall Study|Adverse Event|1
5152576|NCT01455194|17793805|P4|Overall Study|Deterioration in asthma|9
5152577|NCT01455194|17793806|P3|Overall Study|Deterioration in asthma|14
5152578|NCT01455194|17793807|P2|Overall Study|Deterioration in asthma|6
5152579|NCT01455194|17793808|P1|Overall Study|Deterioration in asthma|12
5152580|NCT01455194|17793805|P4|Overall Study|Randomisation Failure|0
5152581|NCT01455194|17793806|P3|Overall Study|Randomisation Failure|0
5152582|NCT01455194|17793807|P2|Overall Study|Randomisation Failure|0
5152583|NCT01455194|17793808|P1|Overall Study|Randomisation Failure|90
5152584|NCT01455194|17793805|P4|Overall Study|Screen Failure|0
5152585|NCT01455194|17793806|P3|Overall Study|Screen Failure|0
5152586|NCT01455194|17793807|P2|Overall Study|Screen Failure|0
5152587|NCT01455194|17793808|P1|Overall Study|Screen Failure|20
5152588|NCT01455012|17793871|P2|Overall Study|Unknown reason|0
5152589|NCT01455012|17793872|P1|Overall Study|Unknown reason|2
5152590|NCT01455012|17793871|P2|Overall Study|Withdrawal by Subject|1
5152591|NCT01455012|17793872|P1|Overall Study|Withdrawal by Subject|3
5152592|NCT01455012|17793871|P2|Overall Study|Lack of Efficacy|1
5152593|NCT01455012|17793872|P1|Overall Study|Lack of Efficacy|6
5152594|NCT01455012|17793871|P2|Overall Study|Adverse Event|2
5152595|NCT01455012|17793872|P1|Overall Study|Adverse Event|0
5152596|NCT01454934|17793939|P2|Overall Study|Not treated|2
5152597|NCT01454934|17793940|P1|Overall Study|Not treated|1
5152598|NCT01454934|17793939|P2|Overall Study|Lost to Follow-up|1
5152599|NCT01454934|17793940|P1|Overall Study|Lost to Follow-up|0
5152600|NCT01454934|17793939|P2|Overall Study|Disease progression|181
5152601|NCT01454934|17793940|P1|Overall Study|Disease progression|194
5152602|NCT01454934|17793939|P2|Overall Study|Withdrawal by Subject|15
5152603|NCT01454934|17793940|P1|Overall Study|Withdrawal by Subject|11
5152604|NCT01454934|17793939|P2|Overall Study|Withdrawn consent|5
5152605|NCT01454934|17793940|P1|Overall Study|Withdrawn consent|2
5152606|NCT01454934|17793939|P2|Overall Study|Adverse Event|24
5152607|NCT01454934|17793940|P1|Overall Study|Adverse Event|28
5152608|NCT01454934|17793939|P2|Overall Study|Other|17
5152609|NCT01454934|17793940|P1|Overall Study|Other|6
5152610|NCT01454934|17793939|P2|Overall Study|Clinical progression|25
5152611|NCT01454934|17793940|P1|Overall Study|Clinical progression|28
5152612|NCT01454830|17793952|P2|Overall Study|Withdrawal - no polysomnography|2
5152613|NCT01454830|17793953|P1|Overall Study|Withdrawal - no polysomnography|3
5152614|NCT01454830|17793952|P2|Overall Study|Post-allocation Exclude-other treatment|7
5152615|NCT01454830|17793953|P1|Overall Study|Post-allocation Exclude-other treatment|6
5152616|NCT01454830|17793952|P2|Overall Study|Post-allocation Exclude-refused PAP|2
5152617|NCT01454830|17793953|P1|Overall Study|Post-allocation Exclude-refused PAP|0
5152618|NCT01454830|17793952|P2|Overall Study|Post-allocation Exclude- AHI<10|12
5152619|NCT01454830|17793953|P1|Overall Study|Post-allocation Exclude- AHI<10|18
5152620|NCT01454830|17793952|P2|Overall Study|Withdrawal by Subject|4
5152621|NCT01454830|17793953|P1|Overall Study|Withdrawal by Subject|4
5152622|NCT01454778|17793984|P1|Overall Study|Death|1
5152623|NCT01454778|17793984|P1|Overall Study|Lost to Follow-up|2
5152624|NCT01454739|17793995|P2|Overall Study|Adverse Event|1
5152625|NCT01454739|17793996|P1|Overall Study|Adverse Event|0
5152626|NCT01454739|17793995|P2|Overall Study|Lost to Follow-up|1
5152627|NCT01454739|17793996|P1|Overall Study|Lost to Follow-up|0
5152628|NCT01454739|17793995|P2|Overall Study|Physician Decision|5
5152629|NCT01454739|17793996|P1|Overall Study|Physician Decision|0
5152630|NCT01454739|17793995|P2|Overall Study|Other|5
5152631|NCT01454739|17793996|P1|Overall Study|Other|3
5152632|NCT01454739|17793995|P2|Overall Study|Withdrawal by Subject|6
5152633|NCT01454739|17793996|P1|Overall Study|Withdrawal by Subject|2
5152634|NCT01454739|17793995|P2|Overall Study|Protocol Violation|3
5152635|NCT01454739|17793996|P1|Overall Study|Protocol Violation|2
5152636|NCT01454726|17794025|P2|Overall Study|Withdrawal by Subject|1
5152637|NCT01454726|17794026|P1|Overall Study|Withdrawal by Subject|0
5152638|NCT01454596|17794044|P12|Overall Study|Death|0
5152639|NCT01454596|17794045|P11|Overall Study|Death|1
5152640|NCT01454596|17794046|P10|Overall Study|Death|1
5152641|NCT01454596|17794047|P9|Overall Study|Death|0
5152642|NCT01454596|17794048|P8|Overall Study|Death|0
5152643|NCT01454596|17794049|P7|Overall Study|Death|0
5152644|NCT01454596|17794050|P6|Overall Study|Death|0
5152645|NCT01454596|17794051|P5|Overall Study|Death|0
5152646|NCT01454596|17794052|P4|Overall Study|Death|0
5152647|NCT01454596|17794053|P3|Overall Study|Death|0
5152648|NCT01454596|17794054|P2|Overall Study|Death|0
5152649|NCT01454596|17794055|P1|Overall Study|Death|0
5152650|NCT01454583|17794132|P3|3rd Year|Lost to Follow-up|297
5152651|NCT01454583|17794133|P2|3rd Year|Lost to Follow-up|512
5152652|NCT01454583|17794134|P1|3rd Year|Lost to Follow-up|1959
5152653|NCT01454583|17794132|P3|2nd Year|Lost to Follow-up|737
5152654|NCT01454583|17794133|P2|2nd Year|Lost to Follow-up|1049
5152655|NCT01454583|17794134|P1|2nd Year|Lost to Follow-up|3965
5152656|NCT01454583|17794132|P3|1st Year|Lost to Follow-up|180
5152657|NCT01454583|17794133|P2|1st Year|Lost to Follow-up|318
5152658|NCT01454583|17794134|P1|1st Year|Lost to Follow-up|1057
5152659|NCT01454570|17794202|P1|Overall Study|Screen Failure|7
5152660|NCT01454570|17794202|P1|Overall Study|Withdrawal by Subject|2
5152661|NCT01454531|17794206|P1|Overall Study|Other|1
5152662|NCT01454531|17794206|P1|Overall Study|Delay in IMP administration|1
5152663|NCT01454531|17794206|P1|Overall Study|Physician Decision|1
5152664|NCT01454531|17794206|P1|Overall Study|Lost to Follow-up|1
5152665|NCT01454531|17794206|P1|Overall Study|Withdrawal by Subject|5
5152666|NCT01454531|17794206|P1|Overall Study|Adverse Event|14
5152667|NCT01454401|17794242|P1|Overall Study|non-adherence|1
5152668|NCT01454401|17794242|P1|Overall Study|osteomyelitis|2
5152669|NCT01454401|17794242|P1|Overall Study|hospitalised|1
5152670|NCT01454401|17794242|P1|Overall Study|Death|1
5152671|NCT01454284|17794266|P2|Overall Study|Sponsor Decision|2
5152672|NCT01454284|17794267|P1|Overall Study|Sponsor Decision|0
5152673|NCT01454284|17794266|P2|Overall Study|Physician Decision|11
5152674|NCT01454284|17794267|P1|Overall Study|Physician Decision|16
5152675|NCT01454284|17794266|P2|Overall Study|Withdrawal by Subject|36
5152676|NCT01454284|17794267|P1|Overall Study|Withdrawal by Subject|58
5152677|NCT01454284|17794266|P2|Overall Study|Protocol Violation|6
5152678|NCT01454284|17794267|P1|Overall Study|Protocol Violation|9
5152679|NCT01454284|17794266|P2|Overall Study|Lost to Follow-up|8
5152680|NCT01454284|17794267|P1|Overall Study|Lost to Follow-up|13
5152681|NCT01454284|17794266|P2|Overall Study|Death|3
5152682|NCT01454284|17794267|P1|Overall Study|Death|0
5152683|NCT01454284|17794266|P2|Overall Study|Adverse Event|7
5152684|NCT01454284|17794267|P1|Overall Study|Adverse Event|20
5152685|NCT01454102|17794337|P16|Overall Study|Continuing in the treatment period|1
5152686|NCT01454102|17794338|P15|Overall Study|Continuing in the treatment period|3
5152687|NCT01454102|17794339|P14|Overall Study|Continuing in the treatment period|4
5152688|NCT01454102|17794340|P13|Overall Study|Continuing in the treatment period|7
5152689|NCT01454102|17794341|P12|Overall Study|Continuing in the treatment period|4
5152690|NCT01454102|17794342|P11|Overall Study|Continuing in the treatment period|0
5152691|NCT01454102|17794343|P10|Overall Study|Continuing in the treatment period|0
5152692|NCT01454102|17794344|P9|Overall Study|Continuing in the treatment period|1
5152693|NCT01454102|17794345|P8|Overall Study|Continuing in the treatment period|0
5152694|NCT01454102|17794346|P7|Overall Study|Continuing in the treatment period|2
5152695|NCT01454102|17794347|P6|Overall Study|Continuing in the treatment period|3
5152696|NCT01454102|17794348|P5|Overall Study|Continuing in the treatment period|3
5152697|NCT01454102|17794349|P4|Overall Study|Continuing in the treatment period|0
5152698|NCT01454102|17794350|P3|Overall Study|Continuing in the treatment period|0
5152699|NCT01454102|17794351|P2|Overall Study|Continuing in the treatment period|0
5152700|NCT01454102|17794352|P1|Overall Study|Continuing in the treatment period|0
5152701|NCT01454076|17794472|P5|Overall Study|Adverse Event|2
5152702|NCT01454076|17794473|P4|Overall Study|Adverse Event|0
5152703|NCT01454076|17794474|P3|Overall Study|Adverse Event|7
5152704|NCT01454076|17794475|P2|Overall Study|Adverse Event|2
5152705|NCT01454076|17794476|P1|Overall Study|Adverse Event|8
5152706|NCT01454076|17794472|P5|Overall Study|Withdrawal by Subject|2
5152707|NCT01454076|17794473|P4|Overall Study|Withdrawal by Subject|1
5152708|NCT01454076|17794474|P3|Overall Study|Withdrawal by Subject|2
5152709|NCT01454076|17794475|P2|Overall Study|Withdrawal by Subject|4
5152710|NCT01454076|17794476|P1|Overall Study|Withdrawal by Subject|3
5152711|NCT01454076|17794472|P5|Overall Study|Other|2
5152712|NCT01454076|17794473|P4|Overall Study|Other|1
5152713|NCT01454076|17794474|P3|Overall Study|Other|0
5152714|NCT01454076|17794475|P2|Overall Study|Other|0
5152715|NCT01454076|17794476|P1|Overall Study|Other|2
5152716|NCT01454063|17794529|P2|Randomized|Protocol Violation|1
5152717|NCT01454063|17794530|P1|Randomized|Protocol Violation|0
5152718|NCT01454063|17794529|P2|Randomized|Adverse Event|1
5152719|NCT01454063|17794530|P1|Randomized|Adverse Event|1
5152720|NCT01453998|17794551|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
5152721|NCT01453998|17794552|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
5152722|NCT01453998|17794553|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
5152723|NCT01453946|17794717|P1|Overall Study|Adverse Event|3
5152724|NCT01453946|17794717|P1|Overall Study|Lack of Efficacy|3
5152725|NCT01453946|17794717|P1|Overall Study|Protocol Violation|2
5152726|NCT01453946|17794717|P1|Overall Study|Did not receive drug for the taper phase|1
5152727|NCT01453855|17794734|P2|Overall Study|Other|1
5152728|NCT01453855|17794735|P1|Overall Study|Other|0
5152729|NCT01453855|17794734|P2|Overall Study|Inadequate Control of IOP|5
5152730|NCT01453855|17794735|P1|Overall Study|Inadequate Control of IOP|1
5152731|NCT01453855|17794734|P2|Overall Study|Noncompliance|0
5152732|NCT01453855|17794735|P1|Overall Study|Noncompliance|1
5152733|NCT01453855|17794734|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
5152734|NCT01453855|17794735|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
5152735|NCT01453855|17794734|P2|Overall Study|Lost to Follow-up|1
5152736|NCT01453855|17794735|P1|Overall Study|Lost to Follow-up|2
5152737|NCT01453855|17794734|P2|Overall Study|Adverse Event|4
5152738|NCT01453855|17794735|P1|Overall Study|Adverse Event|3
5152739|NCT01453725|17794743|P2|Overall Study|Physician Decision|1
5152740|NCT01453725|17794744|P1|Overall Study|Physician Decision|1
5152741|NCT01453725|17794743|P2|Overall Study|Pregnancy|0
5152742|NCT01453725|17794744|P1|Overall Study|Pregnancy|1
5152743|NCT01453725|17794743|P2|Overall Study|Pregnancy Wish|2
5152744|NCT01453725|17794744|P1|Overall Study|Pregnancy Wish|0
5152745|NCT01453725|17794743|P2|Overall Study|Withdrawal by Subject|3
5152746|NCT01453725|17794744|P1|Overall Study|Withdrawal by Subject|2
5152747|NCT01453725|17794743|P2|Overall Study|Protocol Violation|0
5152748|NCT01453725|17794744|P1|Overall Study|Protocol Violation|1
5152749|NCT01453725|17794743|P2|Overall Study|Non-compliance With Protocol|2
5152750|NCT01453725|17794744|P1|Overall Study|Non-compliance With Protocol|1
5152751|NCT01453725|17794743|P2|Overall Study|Lost to Follow-up|0
5152752|NCT01453725|17794744|P1|Overall Study|Lost to Follow-up|4
5152753|NCT01453725|17794743|P2|Overall Study|Adverse Event|3
5152754|NCT01453725|17794744|P1|Overall Study|Adverse Event|3
5152755|NCT01453595|17794767|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
5152756|NCT01453595|17794768|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
5152757|NCT01453595|17794769|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
5152758|NCT01453439|17794799|P2|Follow-up|Lost to Follow-up|10
5152759|NCT01453439|17794800|P1|Follow-up|Lost to Follow-up|5
5152760|NCT01453439|17794799|P2|Follow-up|Withdrawal by Subject|1
5152761|NCT01453439|17794800|P1|Follow-up|Withdrawal by Subject|0
5152762|NCT01453439|17794799|P2|Treatment Phase|Therapist conflict of interest|0
5152763|NCT01453439|17794800|P1|Treatment Phase|Therapist conflict of interest|1
5152764|NCT01453439|17794799|P2|Treatment Phase|Need for higher level of care|1
5152765|NCT01453439|17794800|P1|Treatment Phase|Need for higher level of care|1
5152766|NCT01453439|17794799|P2|Treatment Phase|Suicidal Ideation|0
5152767|NCT01453439|17794800|P1|Treatment Phase|Suicidal Ideation|2
5152768|NCT01453439|17794799|P2|Treatment Phase|Withdrawal by Subject|10
5152769|NCT01453439|17794800|P1|Treatment Phase|Withdrawal by Subject|13
5152770|NCT01453374|17794911|P1|Overall Study|Incarcerated|2
5152771|NCT01453374|17794911|P1|Overall Study|Withdrawal by Subject|5
5152772|NCT01453374|17794911|P1|Overall Study|Lost to Follow-up|3
5152773|NCT01453374|17794911|P1|Overall Study|Lack of Efficacy|1
5152774|NCT01453374|17794911|P1|Overall Study|Adverse Event|7
5152775|NCT01453361|17794927|P1|Overall Study|Screen-Failures|10
5152776|NCT01453361|17794927|P1|Overall Study|Disease Progression|6
5152777|NCT01453348|17794935|P3|Overall Study|Protocol Violation|0
5152778|NCT01453348|17794936|P2|Overall Study|Protocol Violation|0
5152779|NCT01453348|17794937|P1|Overall Study|Protocol Violation|1
5152780|NCT01453348|17794935|P3|Overall Study|Withdrawal by Subject|0
5152781|NCT01453348|17794936|P2|Overall Study|Withdrawal by Subject|1
5152782|NCT01453348|17794937|P1|Overall Study|Withdrawal by Subject|0
5152783|NCT01453348|17794935|P3|Overall Study|Death|1
5152784|NCT01453348|17794936|P2|Overall Study|Death|0
5152785|NCT01453348|17794937|P1|Overall Study|Death|0
5152786|NCT01453296|17794953|P2|Treatment Period 2|Withdrawal by Subject|0
5152787|NCT01453296|17794954|P1|Treatment Period 2|Withdrawal by Subject|1
5152788|NCT01453296|17794953|P2|Treatment Period 2|Adverse Event|0
5152789|NCT01453296|17794954|P1|Treatment Period 2|Adverse Event|1
5152790|NCT01453296|17794953|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
5152791|NCT01453296|17794954|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
5152792|NCT01453296|17794953|P2|Treatment Period 1|Adverse Event|1
5152793|NCT01453296|17794954|P1|Treatment Period 1|Adverse Event|0
5152794|NCT01453205|17795021|P3|Overall Study|Other|35
5152795|NCT01453205|17795022|P2|Overall Study|Other|27
5152796|NCT01453205|17795023|P1|Overall Study|Other|45
5152797|NCT01453205|17795021|P3|Overall Study|Death|18
5152798|NCT01453205|17795022|P2|Overall Study|Death|22
5152799|NCT01453205|17795023|P1|Overall Study|Death|24
5152800|NCT01453205|17795021|P3|Overall Study|Withdrawal by Subject|0
5152801|NCT01453205|17795022|P2|Overall Study|Withdrawal by Subject|3
5152802|NCT01453205|17795023|P1|Overall Study|Withdrawal by Subject|8
5152803|NCT01453205|17795021|P3|Overall Study|Lost to Follow-up|1
5152804|NCT01453205|17795022|P2|Overall Study|Lost to Follow-up|0
5152805|NCT01453205|17795023|P1|Overall Study|Lost to Follow-up|3
5152806|NCT01453153|17795099|P3|Overall Study|Adverse Event|1
5152807|NCT01453153|17795100|P2|Overall Study|Adverse Event|1
5152808|NCT01453153|17795101|P1|Overall Study|Adverse Event|1
5152809|NCT01453153|17795099|P3|Overall Study|Withdrawal by Subject|2
5152810|NCT01453153|17795100|P2|Overall Study|Withdrawal by Subject|1
5152811|NCT01453153|17795101|P1|Overall Study|Withdrawal by Subject|0
5152812|NCT01453153|17795099|P3|Overall Study|Progressive Disease|16
5152813|NCT01453153|17795100|P2|Overall Study|Progressive Disease|2
5152814|NCT01453153|17795101|P1|Overall Study|Progressive Disease|3
5152815|NCT01453153|17795099|P3|Overall Study|Physician Decision|1
5152816|NCT01453153|17795100|P2|Overall Study|Physician Decision|0
5152817|NCT01453153|17795101|P1|Overall Study|Physician Decision|0
5152818|NCT01453049|17795183|P2|Overall Study|Randomized in Error|0
5152819|NCT01453049|17795184|P1|Overall Study|Randomized in Error|1
5152820|NCT01453049|17795183|P2|Overall Study|Withdrawal by Subject|0
5152821|NCT01453049|17795184|P1|Overall Study|Withdrawal by Subject|1
5152822|NCT01453049|17795183|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
5152823|NCT01453049|17795184|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
5152824|NCT01453049|17795183|P2|Overall Study|Lost to Follow-up|1
5152825|NCT01453049|17795184|P1|Overall Study|Lost to Follow-up|2
5152826|NCT01453049|17795183|P2|Overall Study|Protocol Violation|5
5152827|NCT01453049|17795184|P1|Overall Study|Protocol Violation|2
5152828|NCT01453036|17795257|P3|Overall Study|Lost to Follow-up|31
5152829|NCT01453036|17795258|P2|Overall Study|Lost to Follow-up|115
5152830|NCT01453036|17795259|P1|Overall Study|Lost to Follow-up|26
5152831|NCT01453023|17795267|P2|Treatment Period 2|Protocol Violation|1
5152832|NCT01453023|17795268|P1|Treatment Period 2|Protocol Violation|0
5152833|NCT01453023|17795267|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
5152834|NCT01453023|17795268|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
5152835|NCT01453023|17795267|P2|Treatment Period (TP) 1|Protocol Violation|0
5152836|NCT01453023|17795268|P1|Treatment Period (TP) 1|Protocol Violation|1
5152837|NCT01452789|17795342|P2|Overall Study|Withdrawal by Subject|2
5152838|NCT01452789|17795343|P1|Overall Study|Withdrawal by Subject|3
5152839|NCT01452529|17795357|P3|Double-blind (DB) Period|Administrative|7
5152840|NCT01452529|17795358|P2|Double-blind (DB) Period|Administrative|11
5152841|NCT01452529|17795359|P1|Double-blind (DB) Period|Administrative|0
5152842|NCT01452529|17795357|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
5152843|NCT01452529|17795358|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
5152844|NCT01452529|17795359|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
5152845|NCT01452529|17795357|P3|Double-blind (DB) Period|Lack of Efficacy|44
5152846|NCT01452529|17795358|P2|Double-blind (DB) Period|Lack of Efficacy|16
5152847|NCT01452529|17795359|P1|Double-blind (DB) Period|Lack of Efficacy|0
5152848|NCT01452529|17795357|P3|Double-blind (DB) Period|Lost to Follow-up|3
5152849|NCT01452529|17795358|P2|Double-blind (DB) Period|Lost to Follow-up|5
5152850|NCT01452529|17795359|P1|Double-blind (DB) Period|Lost to Follow-up|0
5152851|NCT01452529|17795357|P3|Double-blind (DB) Period|Withdrawal by Subject|14
5152852|NCT01452529|17795358|P2|Double-blind (DB) Period|Withdrawal by Subject|15
5152853|NCT01452529|17795359|P1|Double-blind (DB) Period|Withdrawal by Subject|0
5152854|NCT01452529|17795357|P3|Double-blind (DB) Period|Adverse Event|11
5152855|NCT01452529|17795358|P2|Double-blind (DB) Period|Adverse Event|18
5152856|NCT01452529|17795359|P1|Double-blind (DB) Period|Adverse Event|0
5152857|NCT01452529|17795357|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
5152858|NCT01452529|17795358|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
5152859|NCT01452529|17795359|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
5152860|NCT01452529|17795357|P3|Run-in Period|Administrative|0
5152861|NCT01452529|17795358|P2|Run-in Period|Administrative|0
5152862|NCT01452529|17795359|P1|Run-in Period|Administrative|21
5152863|NCT01452529|17795357|P3|Run-in Period|Confirmed or suspected diversion|0
5152864|NCT01452529|17795358|P2|Run-in Period|Confirmed or suspected diversion|0
5152865|NCT01452529|17795359|P1|Run-in Period|Confirmed or suspected diversion|23
5152866|NCT01452529|17795357|P3|Run-in Period|Lack of Efficacy|0
5152867|NCT01452529|17795358|P2|Run-in Period|Lack of Efficacy|0
5152868|NCT01452529|17795359|P1|Run-in Period|Lack of Efficacy|46
5152869|NCT01452529|17795357|P3|Run-in Period|Lost to Follow-up|0
5152870|NCT01452529|17795358|P2|Run-in Period|Lost to Follow-up|0
5152871|NCT01452529|17795359|P1|Run-in Period|Lost to Follow-up|19
5152872|NCT01452529|17795357|P3|Run-in Period|Withdrawal by Subject|0
5152873|NCT01452529|17795358|P2|Run-in Period|Withdrawal by Subject|0
5152874|NCT01452529|17795359|P1|Run-in Period|Withdrawal by Subject|49
5152875|NCT01452529|17795357|P3|Run-in Period|Adverse Event|0
5152876|NCT01452529|17795358|P2|Run-in Period|Adverse Event|0
5152877|NCT01452529|17795359|P1|Run-in Period|Adverse Event|96
5152878|NCT01452412|17795381|P2|Overall Study|Other|0
5152879|NCT01452412|17795382|P1|Overall Study|Other|2
5152880|NCT01452412|17795381|P2|Overall Study|Initiated dialysis|0
5152881|NCT01452412|17795382|P1|Overall Study|Initiated dialysis|1
5152882|NCT01452412|17795381|P2|Overall Study|Death|0
5152883|NCT01452412|17795382|P1|Overall Study|Death|1
5152884|NCT01452412|17795381|P2|Overall Study|Lost to Follow-up|3
5152885|NCT01452412|17795382|P1|Overall Study|Lost to Follow-up|5
5152886|NCT01452412|17795381|P2|Overall Study|Adverse Event|3
5152887|NCT01452412|17795382|P1|Overall Study|Adverse Event|4
5152888|NCT01452412|17795381|P2|Overall Study|Withdrawal by Subject|11
5152889|NCT01452412|17795382|P1|Overall Study|Withdrawal by Subject|15
5152890|NCT01452347|17795398|P2|Overall Study|Other reason not defined above|0
5152891|NCT01452347|17795399|P1|Overall Study|Other reason not defined above|2
5152892|NCT01452347|17795398|P2|Overall Study|Not treated|3
5152893|NCT01452347|17795399|P1|Overall Study|Not treated|6
5152894|NCT01452347|17795398|P2|Overall Study|Withdrawal by Subject|3
5152895|NCT01452347|17795399|P1|Overall Study|Withdrawal by Subject|3
5152896|NCT01452347|17795398|P2|Overall Study|Lost to Follow-up|0
5152897|NCT01452347|17795399|P1|Overall Study|Lost to Follow-up|2
5152898|NCT01452347|17795398|P2|Overall Study|Non compliance protocol|0
5152899|NCT01452347|17795399|P1|Overall Study|Non compliance protocol|2
5152900|NCT01452347|17795398|P2|Overall Study|Adverse Event|1
5152901|NCT01452347|17795399|P1|Overall Study|Adverse Event|2
5152902|NCT01452152|17795459|P3|Overall Study|Study termination by sponsor|4
5152903|NCT01452152|17795460|P2|Overall Study|Study termination by sponsor|0
5152904|NCT01452152|17795461|P1|Overall Study|Study termination by sponsor|5
5152905|NCT01451931|17795533|P3|Overall Study|Withdrawal by Subject|22
5152906|NCT01451931|17795534|P2|Overall Study|Withdrawal by Subject|22
5152907|NCT01451931|17795535|P1|Overall Study|Withdrawal by Subject|16
5152908|NCT01451931|17795533|P3|Overall Study|Lost to Follow-up|21
5152909|NCT01451931|17795534|P2|Overall Study|Lost to Follow-up|36
5152910|NCT01451931|17795535|P1|Overall Study|Lost to Follow-up|17
5152911|NCT01451827|17795559|P4|Overall Study|Withdrawal by Subject|1
5152912|NCT01451827|17795560|P3|Overall Study|Withdrawal by Subject|1
5152913|NCT01451827|17795561|P2|Overall Study|Withdrawal by Subject|0
5152914|NCT01451827|17795562|P1|Overall Study|Withdrawal by Subject|0
5152915|NCT01451827|17795559|P4|Overall Study|Participant met withdrawal criteria|0
5152916|NCT01451827|17795560|P3|Overall Study|Participant met withdrawal criteria|0
5152917|NCT01451827|17795561|P2|Overall Study|Participant met withdrawal criteria|2
5152918|NCT01451827|17795562|P1|Overall Study|Participant met withdrawal criteria|0
5152919|NCT01451827|17795559|P4|Overall Study|Lost to Follow-up|2
5152920|NCT01451827|17795560|P3|Overall Study|Lost to Follow-up|0
5152921|NCT01451827|17795561|P2|Overall Study|Lost to Follow-up|3
5152922|NCT01451827|17795562|P1|Overall Study|Lost to Follow-up|0
5152923|NCT01451827|17795559|P4|Overall Study|Protocol deviation|0
5152924|NCT01451827|17795560|P3|Overall Study|Protocol deviation|0
5152925|NCT01451827|17795561|P2|Overall Study|Protocol deviation|0
5152926|NCT01451827|17795562|P1|Overall Study|Protocol deviation|1
5152927|NCT01451827|17795559|P4|Overall Study|Adverse Event|1
5152928|NCT01451827|17795560|P3|Overall Study|Adverse Event|1
5152929|NCT01451827|17795561|P2|Overall Study|Adverse Event|0
5152930|NCT01451827|17795562|P1|Overall Study|Adverse Event|2
5152931|NCT01451814|17795582|P2|Overall Study|Lost to Follow-up|4
5152932|NCT01451814|17795583|P1|Overall Study|Lost to Follow-up|5
5152933|NCT01451814|17795582|P2|Overall Study|Withdrawal by Subject|1
5152934|NCT01451814|17795583|P1|Overall Study|Withdrawal by Subject|1
5152935|NCT01451762|17795615|P3|Overall Study|Lost to Follow-up|6
5152936|NCT01451762|17795616|P2|Overall Study|Lost to Follow-up|6
5152937|NCT01451762|17795617|P1|Overall Study|Lost to Follow-up|3
5152938|NCT01451749|17795627|P2|Overall Study|Withdrawal by Subject|1
5152939|NCT01451749|17795628|P1|Overall Study|Withdrawal by Subject|0
5152940|NCT01451749|17795627|P2|Overall Study|Adverse Event|0
5152941|NCT01451749|17795628|P1|Overall Study|Adverse Event|2
5152942|NCT01451749|17795627|P2|Overall Study|Meet the exclusion criteria,and|1
5152943|NCT01451749|17795628|P1|Overall Study|Meet the exclusion criteria,and|1
5152944|NCT01451749|17795627|P2|Overall Study|Lost to Follow-up|5
5152945|NCT01451749|17795628|P1|Overall Study|Lost to Follow-up|15
5152946|NCT01451749|17795627|P2|Overall Study|Protocol Violation|7
5152947|NCT01451749|17795628|P1|Overall Study|Protocol Violation|14
5152948|NCT01451723|17795640|P2|Overall Study|study halted|5
5152949|NCT01451723|17795641|P1|Overall Study|study halted|6
5152950|NCT01451645|17795651|P2|Overall Study|Lost to Follow-up|3
5152951|NCT01451645|17795652|P1|Overall Study|Lost to Follow-up|4
5152952|NCT01451645|17795651|P2|Overall Study|Withdrawal by Subject|2
5152953|NCT01451645|17795652|P1|Overall Study|Withdrawal by Subject|4
5152954|NCT01451645|17795651|P2|Overall Study|Adverse Event|3
5152955|NCT01451645|17795652|P1|Overall Study|Adverse Event|0
5152956|NCT01451645|17795651|P2|Overall Study|Protocol Violation|0
5152957|NCT01451645|17795652|P1|Overall Study|Protocol Violation|1
5152958|NCT01451606|17795723|P2|Overall Study|Withdrawal by Subject|3
5152959|NCT01451606|17795724|P1|Overall Study|Withdrawal by Subject|4
5152960|NCT01451554|17795734|P2|Overall Study|Withdrawal by Subject|9
5152961|NCT01451554|17795735|P1|Overall Study|Withdrawal by Subject|14
5152962|NCT01451541|17795746|P3|Overall Study|randomization error, noncompliance|8
5152963|NCT01451541|17795747|P2|Overall Study|randomization error, noncompliance|10
5152964|NCT01451541|17795748|P1|Overall Study|randomization error, noncompliance|11
5152965|NCT01451541|17795746|P3|Overall Study|Withdrawal by Subject|6
5152966|NCT01451541|17795747|P2|Overall Study|Withdrawal by Subject|8
5152967|NCT01451541|17795748|P1|Overall Study|Withdrawal by Subject|15
5152968|NCT01451541|17795746|P3|Overall Study|Lost to Follow-up|7
5152969|NCT01451541|17795747|P2|Overall Study|Lost to Follow-up|4
5152970|NCT01451541|17795748|P1|Overall Study|Lost to Follow-up|4
5152971|NCT01451541|17795746|P3|Overall Study|Lack of Efficacy|0
5152972|NCT01451541|17795747|P2|Overall Study|Lack of Efficacy|0
5152973|NCT01451541|17795748|P1|Overall Study|Lack of Efficacy|2
5152974|NCT01451541|17795746|P3|Overall Study|Adverse Event|6
5152975|NCT01451541|17795747|P2|Overall Study|Adverse Event|3
5152976|NCT01451541|17795748|P1|Overall Study|Adverse Event|4
5152977|NCT01451437|17795806|P9|Overall Study|Withdrawal by Subject|0
5152978|NCT01451437|17795807|P8|Overall Study|Withdrawal by Subject|0
5152979|NCT01451437|17795808|P7|Overall Study|Withdrawal by Subject|1
5152980|NCT01451437|17795809|P6|Overall Study|Withdrawal by Subject|0
5152981|NCT01451437|17795810|P5|Overall Study|Withdrawal by Subject|1
5152982|NCT01451437|17795811|P4|Overall Study|Withdrawal by Subject|0
5152983|NCT01451437|17795812|P3|Overall Study|Withdrawal by Subject|0
5152984|NCT01451437|17795813|P2|Overall Study|Withdrawal by Subject|0
5152985|NCT01451437|17795814|P1|Overall Study|Withdrawal by Subject|0
5152986|NCT01451437|17795806|P9|Overall Study|Protocol Violation|0
5152987|NCT01451437|17795807|P8|Overall Study|Protocol Violation|0
5152988|NCT01451437|17795808|P7|Overall Study|Protocol Violation|1
5152989|NCT01451437|17795809|P6|Overall Study|Protocol Violation|0
5152990|NCT01451437|17795810|P5|Overall Study|Protocol Violation|0
5152991|NCT01451437|17795811|P4|Overall Study|Protocol Violation|0
5152992|NCT01451437|17795812|P3|Overall Study|Protocol Violation|0
5152993|NCT01451437|17795813|P2|Overall Study|Protocol Violation|0
5152994|NCT01451437|17795814|P1|Overall Study|Protocol Violation|0
5152995|NCT01451437|17795806|P9|Overall Study|Disease Progression|3
5152996|NCT01451437|17795807|P8|Overall Study|Disease Progression|1
5152997|NCT01451437|17795808|P7|Overall Study|Disease Progression|3
5152998|NCT01451437|17795809|P6|Overall Study|Disease Progression|2
5152999|NCT01451437|17795810|P5|Overall Study|Disease Progression|3
5153000|NCT01451437|17795811|P4|Overall Study|Disease Progression|1
5153001|NCT01451437|17795812|P3|Overall Study|Disease Progression|1
5153002|NCT01451437|17795813|P2|Overall Study|Disease Progression|0
5153003|NCT01451437|17795814|P1|Overall Study|Disease Progression|0
5153004|NCT01451437|17795806|P9|Overall Study|Physician Decision|0
5153005|NCT01451437|17795807|P8|Overall Study|Physician Decision|0
5153006|NCT01451437|17795808|P7|Overall Study|Physician Decision|0
5153007|NCT01451437|17795809|P6|Overall Study|Physician Decision|0
5153008|NCT01451437|17795810|P5|Overall Study|Physician Decision|0
5153009|NCT01451437|17795811|P4|Overall Study|Physician Decision|0
5153010|NCT01451437|17795812|P3|Overall Study|Physician Decision|2
5153011|NCT01451437|17795813|P2|Overall Study|Physician Decision|1
5153012|NCT01451437|17795814|P1|Overall Study|Physician Decision|1
5153013|NCT01451437|17795806|P9|Overall Study|Adverse Event|1
5153014|NCT01451437|17795807|P8|Overall Study|Adverse Event|2
5153015|NCT01451437|17795808|P7|Overall Study|Adverse Event|1
5153016|NCT01451437|17795809|P6|Overall Study|Adverse Event|1
5153017|NCT01451437|17795810|P5|Overall Study|Adverse Event|0
5153018|NCT01451437|17795811|P4|Overall Study|Adverse Event|0
5153019|NCT01451437|17795812|P3|Overall Study|Adverse Event|0
5153020|NCT01451437|17795813|P2|Overall Study|Adverse Event|0
5153021|NCT01451437|17795814|P1|Overall Study|Adverse Event|0
5153022|NCT01451424|17795946|P4|Overall Study|Adverse Event|1
5153023|NCT01451424|17795947|P3|Overall Study|Adverse Event|0
5153024|NCT01451424|17795948|P2|Overall Study|Adverse Event|0
5153025|NCT01451424|17795949|P1|Overall Study|Adverse Event|0
5153026|NCT01451424|17795946|P4|Overall Study|Physician Decision|1
5153027|NCT01451424|17795947|P3|Overall Study|Physician Decision|1
5153028|NCT01451424|17795948|P2|Overall Study|Physician Decision|0
5153029|NCT01451424|17795949|P1|Overall Study|Physician Decision|0
5153030|NCT01451424|17795946|P4|Overall Study|Lost to Follow-up|1
5153031|NCT01451424|17795947|P3|Overall Study|Lost to Follow-up|0
5153032|NCT01451424|17795948|P2|Overall Study|Lost to Follow-up|1
5153033|NCT01451424|17795949|P1|Overall Study|Lost to Follow-up|0
5153034|NCT01451424|17795946|P4|Overall Study|Withdrawal by Subject|2
5153035|NCT01451424|17795947|P3|Overall Study|Withdrawal by Subject|0
5153036|NCT01451424|17795948|P2|Overall Study|Withdrawal by Subject|1
5153037|NCT01451424|17795949|P1|Overall Study|Withdrawal by Subject|1
5153038|NCT01451398|17796007|P2|Overall Study|Lack of Efficacy|1
5153039|NCT01451398|17796008|P1|Overall Study|Lack of Efficacy|0
5153040|NCT01451398|17796007|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
5153041|NCT01451398|17796008|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
5153042|NCT01451398|17796007|P2|Overall Study|Moved out of country|1
5153043|NCT01451398|17796008|P1|Overall Study|Moved out of country|0
5153044|NCT01451398|17796007|P2|Overall Study|Non-compliance with protocol|1
5153045|NCT01451398|17796008|P1|Overall Study|Non-compliance with protocol|1
5153046|NCT01451398|17796007|P2|Overall Study|Non-compliance with study drug|3
5153047|NCT01451398|17796008|P1|Overall Study|Non-compliance with study drug|1
5153048|NCT01451398|17796007|P2|Overall Study|Lost to Follow-up|4
5153049|NCT01451398|17796008|P1|Overall Study|Lost to Follow-up|6
5153050|NCT01451398|17796007|P2|Overall Study|Withdrawal by Subject|14
5153051|NCT01451398|17796008|P1|Overall Study|Withdrawal by Subject|10
5153052|NCT01451398|17796007|P2|Overall Study|Physician Decision|1
5153053|NCT01451398|17796008|P1|Overall Study|Physician Decision|1
5153054|NCT01451398|17796007|P2|Overall Study|Protocol Violation|2
5153055|NCT01451398|17796008|P1|Overall Study|Protocol Violation|1
5153056|NCT01451398|17796007|P2|Overall Study|Adverse Event|9
5153057|NCT01451398|17796008|P1|Overall Study|Adverse Event|7
5153058|NCT01451203|17796059|P2|Post-treatment Period|Investigator decision|1
5153059|NCT01451203|17796060|P1|Post-treatment Period|Investigator decision|0
5153060|NCT01451203|17796059|P2|Post-treatment Period|Adverse Event|1
5153061|NCT01451203|17796060|P1|Post-treatment Period|Adverse Event|0
5153062|NCT01451203|17796059|P2|Post-treatment Period|Lack of Efficacy|28
5153063|NCT01451203|17796060|P1|Post-treatment Period|Lack of Efficacy|12
5153064|NCT01451203|17796059|P2|Post-treatment Period|Consent withdrawn|4
5153065|NCT01451203|17796060|P1|Post-treatment Period|Consent withdrawn|2
5153066|NCT01451203|17796059|P2|Double-blind Treatment Period|Investigator decision|0
5153067|NCT01451203|17796060|P1|Double-blind Treatment Period|Investigator decision|2
5153068|NCT01451203|17796059|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
5153069|NCT01451203|17796060|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
5153070|NCT01451203|17796059|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
5153071|NCT01451203|17796060|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
5153072|NCT01451203|17796059|P2|Double-blind Treatment Period|Adverse Event|9
5153073|NCT01451203|17796060|P1|Double-blind Treatment Period|Adverse Event|6
5153074|NCT01451203|17796059|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
5153075|NCT01451203|17796060|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
5153076|NCT01451203|17796059|P2|Double-blind Treatment Period|Lack of Efficacy|36
5153077|NCT01451203|17796060|P1|Double-blind Treatment Period|Lack of Efficacy|71
5153078|NCT01451203|17796059|P2|Double-blind Treatment Period|Consent Withdrawn|2
5153079|NCT01451203|17796060|P1|Double-blind Treatment Period|Consent Withdrawn|3
5153080|NCT01451203|17796059|P2|Double-blind Treatment Period|Did not receive treatment|2
5153081|NCT01451203|17796060|P1|Double-blind Treatment Period|Did not receive treatment|1
5153082|NCT01451164|17796078|P4|Overall Study|Lack of Efficacy|7
5153083|NCT01451164|17796079|P3|Overall Study|Lack of Efficacy|9
5153084|NCT01451164|17796080|P2|Overall Study|Lack of Efficacy|9
5153085|NCT01451164|17796081|P1|Overall Study|Lack of Efficacy|7
5153086|NCT01451164|17796078|P4|Overall Study|Protocol Violation|0
5153087|NCT01451164|17796079|P3|Overall Study|Protocol Violation|0
5153088|NCT01451164|17796080|P2|Overall Study|Protocol Violation|1
5153089|NCT01451164|17796081|P1|Overall Study|Protocol Violation|0
5153090|NCT01451164|17796078|P4|Overall Study|Withdrawal by Subject|17
5153091|NCT01451164|17796079|P3|Overall Study|Withdrawal by Subject|16
5153092|NCT01451164|17796080|P2|Overall Study|Withdrawal by Subject|11
5153093|NCT01451164|17796081|P1|Overall Study|Withdrawal by Subject|14
5153094|NCT01451164|17796078|P4|Overall Study|Physician Decision|0
5153095|NCT01451164|17796079|P3|Overall Study|Physician Decision|1
5153096|NCT01451164|17796080|P2|Overall Study|Physician Decision|0
5153097|NCT01451164|17796081|P1|Overall Study|Physician Decision|2
5153098|NCT01451164|17796078|P4|Overall Study|Withdrawal Criteria|1
5153099|NCT01451164|17796079|P3|Overall Study|Withdrawal Criteria|1
5153100|NCT01451164|17796080|P2|Overall Study|Withdrawal Criteria|1
5153101|NCT01451164|17796081|P1|Overall Study|Withdrawal Criteria|1
5153102|NCT01451164|17796078|P4|Overall Study|Adverse Event|21
5153103|NCT01451164|17796079|P3|Overall Study|Adverse Event|18
5153104|NCT01451164|17796080|P2|Overall Study|Adverse Event|12
5153105|NCT01451164|17796081|P1|Overall Study|Adverse Event|19
5153106|NCT01450943|17796110|P3|Overall Study|Screen failure, loss to follow-up|6
5153107|NCT01450943|17796111|P2|Overall Study|Screen failure, loss to follow-up|7
5153108|NCT01450943|17796112|P1|Overall Study|Screen failure, loss to follow-up|2
5153109|NCT01450813|17796145|P4|Overall Study|Physician Decision|3
5153110|NCT01450813|17796146|P3|Overall Study|Physician Decision|0
5153111|NCT01450813|17796147|P2|Overall Study|Physician Decision|1
5153112|NCT01450813|17796148|P1|Overall Study|Physician Decision|1
5153113|NCT01450800|17796162|P2|Overall Study|Protocol Violation|3
5153114|NCT01450800|17796163|P1|Overall Study|Protocol Violation|1
5153115|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
5153116|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
5153117|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
5153118|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
5153119|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Not reported|2
5153120|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Not reported|2
5153121|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
5153122|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
5153123|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
5153124|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
5153125|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
5153126|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
5153127|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
5153128|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
5153129|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Death|6
5153130|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Death|5
5153131|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
5153132|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
5153133|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
5153134|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
5153135|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
5153136|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
5153137|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
5153138|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
5153139|NCT01450761|17796198|P2|Treatment With Blinded Study Therapy|Disease progression|415
5153140|NCT01450761|17796199|P1|Treatment With Blinded Study Therapy|Disease progression|318
5153141|NCT01450761|17796198|P2|Lead-in Chemotherapy|Lost to Follow-up|0
5153142|NCT01450761|17796199|P1|Lead-in Chemotherapy|Lost to Follow-up|2
5153143|NCT01450761|17796198|P2|Lead-in Chemotherapy|Other|2
5153144|NCT01450761|17796199|P1|Lead-in Chemotherapy|Other|2
5153145|NCT01450761|17796198|P2|Lead-in Chemotherapy|Death|3
5153146|NCT01450761|17796199|P1|Lead-in Chemotherapy|Death|3
5153147|NCT01450761|17796198|P2|Lead-in Chemotherapy|No longer meets study criteria|7
5153148|NCT01450761|17796199|P1|Lead-in Chemotherapy|No longer meets study criteria|3
5153149|NCT01450761|17796198|P2|Lead-in Chemotherapy|Study drug toxicity|10
5153150|NCT01450761|17796199|P1|Lead-in Chemotherapy|Study drug toxicity|6
5153151|NCT01450761|17796198|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
5153152|NCT01450761|17796199|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
5153153|NCT01450761|17796198|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
5153154|NCT01450761|17796199|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
5153155|NCT01450761|17796198|P2|Lead-in Chemotherapy|Disease progression|32
5153156|NCT01450761|17796199|P1|Lead-in Chemotherapy|Disease progression|33
5153157|NCT01450761|17796198|P2|Randomization|Other|1
5153158|NCT01450761|17796199|P1|Randomization|Other|0
5153159|NCT01450761|17796198|P2|Randomization|Adverse Event unrelated to study drug|0
5153160|NCT01450761|17796199|P1|Randomization|Adverse Event unrelated to study drug|1
5153161|NCT01450761|17796198|P2|Randomization|Disease progression|2
5153162|NCT01450761|17796199|P1|Randomization|Disease progression|0
5153163|NCT01450761|17796198|P2|Randomization|Withdrawal by Subject|0
5153164|NCT01450761|17796199|P1|Randomization|Withdrawal by Subject|2
5153165|NCT01450761|17796198|P2|Randomization|Subject no longer meets study criteria|2
5153166|NCT01450761|17796199|P1|Randomization|Subject no longer meets study criteria|1
5153167|NCT01450696|17796211|P2|Overall Study|Study Terminated by Sponsor|58
5153168|NCT01450696|17796212|P1|Overall Study|Study Terminated by Sponsor|53
5153169|NCT01450696|17796211|P2|Overall Study|Withdrawal by Subject|2
5153170|NCT01450696|17796212|P1|Overall Study|Withdrawal by Subject|13
5153171|NCT01450696|17796211|P2|Overall Study|Non-Compliance|0
5153172|NCT01450696|17796212|P1|Overall Study|Non-Compliance|1
5153173|NCT01450696|17796211|P2|Overall Study|Lost to Follow-up|3
5153174|NCT01450696|17796212|P1|Overall Study|Lost to Follow-up|3
5153175|NCT01450696|17796211|P2|Overall Study|Death|84
5153176|NCT01450696|17796212|P1|Overall Study|Death|77
5153177|NCT01450696|17796211|P2|Overall Study|Never Treated|1
5153178|NCT01450696|17796212|P1|Overall Study|Never Treated|1
5153179|NCT01450683|17796234|P1|Overall Study|Adverse Event|2
5153180|NCT01450631|17796240|P2|Overall Study|Withdrawal by Subject|0
5153181|NCT01450631|17796241|P1|Overall Study|Withdrawal by Subject|1
5153182|NCT01450631|17796240|P2|Overall Study|Lost to Follow-up|4
5153183|NCT01450631|17796241|P1|Overall Study|Lost to Follow-up|2
5153184|NCT01450137|17796371|P2|Week 12 to Study End|Withdrawal by Subject|1
5153185|NCT01450137|17796372|P1|Week 12 to Study End|Withdrawal by Subject|0
5153186|NCT01450137|17796371|P2|Week 12 to Study End|Death|1
5153187|NCT01450137|17796372|P1|Week 12 to Study End|Death|0
5153188|NCT01450137|17796371|P2|Up to Week 12|Withdrawal by Subject|2
5153189|NCT01450137|17796372|P1|Up to Week 12|Withdrawal by Subject|0
5153190|NCT01450137|17796371|P2|Up to Week 12|Adverse Event|1
5153191|NCT01450137|17796372|P1|Up to Week 12|Adverse Event|2
5153192|NCT01450098|17796386|P2|Period 3|Withdrawal by Subject|2
5153193|NCT01450098|17796387|P1|Period 3|Withdrawal by Subject|0
5153194|NCT01450098|17796386|P2|Period 3|Protocol Violation|1
5153195|NCT01450098|17796387|P1|Period 3|Protocol Violation|0
5153196|NCT01450007|17796406|P3|Overall Study|Adverse Event|0
5153197|NCT01450007|17796407|P2|Overall Study|Adverse Event|1
5153198|NCT01450007|17796408|P1|Overall Study|Adverse Event|0
5153199|NCT01450007|17796406|P3|Overall Study|Protocol Violation|1
5153200|NCT01450007|17796407|P2|Overall Study|Protocol Violation|1
5153201|NCT01450007|17796408|P1|Overall Study|Protocol Violation|0
5153202|NCT01450007|17796406|P3|Overall Study|Late exclusion before treatment|2
5153203|NCT01450007|17796407|P2|Overall Study|Late exclusion before treatment|3
5153204|NCT01450007|17796408|P1|Overall Study|Late exclusion before treatment|2
5153205|NCT01449955|17796427|P2|Overall Study|Withdrawal by Subject|2
5153206|NCT01449955|17796428|P1|Overall Study|Withdrawal by Subject|1
5153207|NCT01449929|17796456|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
5153293|NCT01449526|17796752|P1|Overall Study|Cannot maintain visits|0
5153208|NCT01449929|17796457|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
5153209|NCT01449929|17796458|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
5153210|NCT01449929|17796456|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
5153211|NCT01449929|17796457|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
5153212|NCT01449929|17796458|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
5153213|NCT01449929|17796456|P3|Extension Phase Approximately 3 Years|Adverse Event|2
5153214|NCT01449929|17796457|P2|Extension Phase Approximately 3 Years|Adverse Event|0
5153215|NCT01449929|17796458|P1|Extension Phase Approximately 3 Years|Adverse Event|0
5153216|NCT01449929|17796456|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
5153217|NCT01449929|17796457|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
5153218|NCT01449929|17796458|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
5153219|NCT01449929|17796456|P3|Randomization Phase 96 Week|Physician Decision|0
5153220|NCT01449929|17796457|P2|Randomization Phase 96 Week|Physician Decision|3
5153221|NCT01449929|17796458|P1|Randomization Phase 96 Week|Physician Decision|2
5153222|NCT01449929|17796456|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
5153223|NCT01449929|17796457|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
5153224|NCT01449929|17796458|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
5153225|NCT01449929|17796456|P3|Randomization Phase 96 Week|Lost to Follow-up|0
5153226|NCT01449929|17796457|P2|Randomization Phase 96 Week|Lost to Follow-up|18
5153227|NCT01449929|17796458|P1|Randomization Phase 96 Week|Lost to Follow-up|15
5153228|NCT01449929|17796456|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
5153229|NCT01449929|17796457|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
5153230|NCT01449929|17796458|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
5153231|NCT01449929|17796456|P3|Randomization Phase 96 Week|Protocol Violation|0
5153232|NCT01449929|17796457|P2|Randomization Phase 96 Week|Protocol Violation|6
5153233|NCT01449929|17796458|P1|Randomization Phase 96 Week|Protocol Violation|5
5153234|NCT01449929|17796456|P3|Randomization Phase 96 Week|Lack of Efficacy|0
5153235|NCT01449929|17796457|P2|Randomization Phase 96 Week|Lack of Efficacy|4
5153236|NCT01449929|17796458|P1|Randomization Phase 96 Week|Lack of Efficacy|3
5153237|NCT01449929|17796456|P3|Randomization Phase 96 Week|Adverse Event|0
5153238|NCT01449929|17796457|P2|Randomization Phase 96 Week|Adverse Event|13
5153239|NCT01449929|17796458|P1|Randomization Phase 96 Week|Adverse Event|5
5153240|NCT01449812|17796503|P3|Overall Study|Lost to Follow-up|0
5153241|NCT01449812|17796504|P2|Overall Study|Lost to Follow-up|0
5153242|NCT01449812|17796505|P1|Overall Study|Lost to Follow-up|1
5153243|NCT01449812|17796503|P3|Overall Study|Withdrawal by Subject|1
5153244|NCT01449812|17796504|P2|Overall Study|Withdrawal by Subject|0
5153245|NCT01449812|17796505|P1|Overall Study|Withdrawal by Subject|0
5153246|NCT01449812|17796503|P3|Overall Study|Migrated/moved from study area|0
5153247|NCT01449812|17796504|P2|Overall Study|Migrated/moved from study area|0
5153248|NCT01449812|17796505|P1|Overall Study|Migrated/moved from study area|1
5153249|NCT01449721|17796620|P2|Overall Study|Physician Decision|1
5153250|NCT01449721|17796621|P1|Overall Study|Physician Decision|0
5153251|NCT01449721|17796620|P2|Overall Study|Physician Decision|1
5153252|NCT01449721|17796621|P1|Overall Study|Physician Decision|0
5153253|NCT01449708|17796633|P2|Overall Study|respiratory failure|0
5153254|NCT01449708|17796634|P1|Overall Study|respiratory failure|1
5153255|NCT01449708|17796633|P2|Overall Study|surgical complication|2
5153256|NCT01449708|17796634|P1|Overall Study|surgical complication|1
5153257|NCT01449708|17796633|P2|Overall Study|Protocol Violation|1
5153258|NCT01449708|17796634|P1|Overall Study|Protocol Violation|0
5153259|NCT01449682|17796645|P2|Overall Study|Adverse Event|0
5153260|NCT01449682|17796646|P1|Overall Study|Adverse Event|1
5153261|NCT01449682|17796645|P2|Overall Study|Death|1
5153262|NCT01449682|17796646|P1|Overall Study|Death|0
5153263|NCT01449630|17796667|P9|Period 2|Sponsor Decision|0
5153264|NCT01449630|17796668|P8|Period 2|Sponsor Decision|0
5153265|NCT01449630|17796669|P7|Period 2|Sponsor Decision|1
5153266|NCT01449630|17796670|P6|Period 2|Sponsor Decision|0
5153267|NCT01449630|17796671|P5|Period 2|Sponsor Decision|0
5153268|NCT01449630|17796672|P4|Period 2|Sponsor Decision|0
5153269|NCT01449630|17796673|P3|Period 2|Sponsor Decision|0
5153270|NCT01449630|17796674|P2|Period 2|Sponsor Decision|0
5153271|NCT01449630|17796675|P1|Period 2|Sponsor Decision|0
5153272|NCT01449630|17796667|P9|Period 1|Sponsor Decision|0
5153273|NCT01449630|17796668|P8|Period 1|Sponsor Decision|0
5153274|NCT01449630|17796669|P7|Period 1|Sponsor Decision|0
5153275|NCT01449630|17796670|P6|Period 1|Sponsor Decision|1
5153276|NCT01449630|17796671|P5|Period 1|Sponsor Decision|0
5153277|NCT01449630|17796672|P4|Period 1|Sponsor Decision|0
5153278|NCT01449630|17796673|P3|Period 1|Sponsor Decision|0
5153279|NCT01449630|17796674|P2|Period 1|Sponsor Decision|0
5153280|NCT01449630|17796675|P1|Period 1|Sponsor Decision|0
5153281|NCT01449630|17796667|P9|Period 1|Physician Decision|0
5153282|NCT01449630|17796668|P8|Period 1|Physician Decision|0
5153283|NCT01449630|17796669|P7|Period 1|Physician Decision|0
5153284|NCT01449630|17796670|P6|Period 1|Physician Decision|0
5153285|NCT01449630|17796671|P5|Period 1|Physician Decision|0
5153286|NCT01449630|17796672|P4|Period 1|Physician Decision|1
5153287|NCT01449630|17796673|P3|Period 1|Physician Decision|0
5153288|NCT01449630|17796674|P2|Period 1|Physician Decision|0
5153289|NCT01449630|17796675|P1|Period 1|Physician Decision|1
5153290|NCT01449539|17796745|P1|Overall Study|Toxicity not study related|1
5153291|NCT01449539|17796745|P1|Overall Study|Withdrawal by Subject|3
5153292|NCT01449526|17796751|P2|Overall Study|Cannot maintain visits|1
5153294|NCT01449526|17796751|P2|Overall Study|Lack of Motivation|1
5153295|NCT01449526|17796752|P1|Overall Study|Lack of Motivation|0
5153296|NCT01449526|17796751|P2|Overall Study|Symptoms/complaints|1
5153297|NCT01449526|17796752|P1|Overall Study|Symptoms/complaints|0
5153298|NCT01449526|17796751|P2|Overall Study|Withdrawal by Subject|1
5153299|NCT01449526|17796752|P1|Overall Study|Withdrawal by Subject|1
5153300|NCT01449526|17796751|P2|Overall Study|Lost to Follow-up|2
5153301|NCT01449526|17796752|P1|Overall Study|Lost to Follow-up|1
5153302|NCT01449461|17796821|P6|Overall Study|Reason not specified|1
5153303|NCT01449461|17796822|P5|Overall Study|Reason not specified|0
5153304|NCT01449461|17796823|P4|Overall Study|Reason not specified|3
5153305|NCT01449461|17796824|P3|Overall Study|Reason not specified|0
5153306|NCT01449461|17796825|P2|Overall Study|Reason not specified|1
5153307|NCT01449461|17796826|P1|Overall Study|Reason not specified|0
5153308|NCT01449461|17796821|P6|Overall Study|Clinical progressive disease|3
5153309|NCT01449461|17796822|P5|Overall Study|Clinical progressive disease|3
5153310|NCT01449461|17796823|P4|Overall Study|Clinical progressive disease|0
5153311|NCT01449461|17796824|P3|Overall Study|Clinical progressive disease|0
5153312|NCT01449461|17796825|P2|Overall Study|Clinical progressive disease|1
5153313|NCT01449461|17796826|P1|Overall Study|Clinical progressive disease|2
5153314|NCT01449461|17796821|P6|Overall Study|Documented progressive disease|5
5153315|NCT01449461|17796822|P5|Overall Study|Documented progressive disease|21
5153316|NCT01449461|17796823|P4|Overall Study|Documented progressive disease|11
5153317|NCT01449461|17796824|P3|Overall Study|Documented progressive disease|14
5153318|NCT01449461|17796825|P2|Overall Study|Documented progressive disease|6
5153319|NCT01449461|17796826|P1|Overall Study|Documented progressive disease|4
5153320|NCT01449461|17796821|P6|Overall Study|Death|1
5153321|NCT01449461|17796822|P5|Overall Study|Death|4
5153322|NCT01449461|17796823|P4|Overall Study|Death|0
5153323|NCT01449461|17796824|P3|Overall Study|Death|0
5153324|NCT01449461|17796825|P2|Overall Study|Death|1
5153325|NCT01449461|17796826|P1|Overall Study|Death|0
5153326|NCT01449461|17796821|P6|Overall Study|Adverse Event|3
5153327|NCT01449461|17796822|P5|Overall Study|Adverse Event|3
5153328|NCT01449461|17796823|P4|Overall Study|Adverse Event|3
5153329|NCT01449461|17796824|P3|Overall Study|Adverse Event|2
5153330|NCT01449461|17796825|P2|Overall Study|Adverse Event|3
5153331|NCT01449461|17796826|P1|Overall Study|Adverse Event|0
5153332|NCT01449461|17796821|P6|Overall Study|Ongoing|2
5153333|NCT01449461|17796822|P5|Overall Study|Ongoing|17
5153334|NCT01449461|17796823|P4|Overall Study|Ongoing|15
5153335|NCT01449461|17796824|P3|Overall Study|Ongoing|2
5153336|NCT01449461|17796825|P2|Overall Study|Ongoing|6
5153337|NCT01449461|17796826|P1|Overall Study|Ongoing|0
5153338|NCT01449370|17796963|P25|Overall Study|Death|1
5153339|NCT01449370|17796964|P24|Overall Study|Death|0
5153340|NCT01449370|17796965|P23|Overall Study|Death|0
5153341|NCT01449370|17796966|P22|Overall Study|Death|0
5153342|NCT01449370|17796967|P21|Overall Study|Death|0
5153343|NCT01449370|17796968|P20|Overall Study|Death|0
5153344|NCT01449370|17796969|P19|Overall Study|Death|0
5153345|NCT01449370|17796970|P18|Overall Study|Death|0
5153346|NCT01449370|17796971|P17|Overall Study|Death|0
5153347|NCT01449370|17796972|P16|Overall Study|Death|0
5153348|NCT01449370|17796973|P15|Overall Study|Death|0
5153349|NCT01449370|17796974|P14|Overall Study|Death|0
5153350|NCT01449370|17796975|P13|Overall Study|Death|0
5153351|NCT01449370|17796976|P12|Overall Study|Death|0
5153352|NCT01449370|17796977|P11|Overall Study|Death|0
5153353|NCT01449370|17796978|P10|Overall Study|Death|0
5153354|NCT01449370|17796979|P9|Overall Study|Death|0
5153355|NCT01449370|17796980|P8|Overall Study|Death|0
5153356|NCT01449370|17796981|P7|Overall Study|Death|0
5153357|NCT01449370|17796982|P6|Overall Study|Death|0
5153358|NCT01449370|17796983|P5|Overall Study|Death|0
5153359|NCT01449370|17796984|P4|Overall Study|Death|0
5153360|NCT01449370|17796985|P3|Overall Study|Death|0
5153361|NCT01449370|17796986|P2|Overall Study|Death|0
5153362|NCT01449370|17796987|P1|Overall Study|Death|0
5153363|NCT01449370|17796963|P25|Overall Study|Medication Prohibited by Protocol|0
5153364|NCT01449370|17796964|P24|Overall Study|Medication Prohibited by Protocol|1
5153365|NCT01449370|17796965|P23|Overall Study|Medication Prohibited by Protocol|0
5153366|NCT01449370|17796966|P22|Overall Study|Medication Prohibited by Protocol|0
5153367|NCT01449370|17796967|P21|Overall Study|Medication Prohibited by Protocol|0
5153368|NCT01449370|17796968|P20|Overall Study|Medication Prohibited by Protocol|0
5153369|NCT01449370|17796969|P19|Overall Study|Medication Prohibited by Protocol|0
5153370|NCT01449370|17796970|P18|Overall Study|Medication Prohibited by Protocol|0
5153371|NCT01449370|17796971|P17|Overall Study|Medication Prohibited by Protocol|0
5153372|NCT01449370|17796972|P16|Overall Study|Medication Prohibited by Protocol|0
5153373|NCT01449370|17796973|P15|Overall Study|Medication Prohibited by Protocol|0
5153374|NCT01449370|17796974|P14|Overall Study|Medication Prohibited by Protocol|0
5153375|NCT01449370|17796975|P13|Overall Study|Medication Prohibited by Protocol|0
5153376|NCT01449370|17796976|P12|Overall Study|Medication Prohibited by Protocol|0
5153377|NCT01449370|17796977|P11|Overall Study|Medication Prohibited by Protocol|0
5153378|NCT01449370|17796978|P10|Overall Study|Medication Prohibited by Protocol|0
5153379|NCT01449370|17796979|P9|Overall Study|Medication Prohibited by Protocol|0
5153380|NCT01449370|17796980|P8|Overall Study|Medication Prohibited by Protocol|0
5153381|NCT01449370|17796981|P7|Overall Study|Medication Prohibited by Protocol|0
5153382|NCT01449370|17796982|P6|Overall Study|Medication Prohibited by Protocol|0
5153383|NCT01449370|17796983|P5|Overall Study|Medication Prohibited by Protocol|0
5153384|NCT01449370|17796984|P4|Overall Study|Medication Prohibited by Protocol|0
5153385|NCT01449370|17796985|P3|Overall Study|Medication Prohibited by Protocol|0
5153386|NCT01449370|17796986|P2|Overall Study|Medication Prohibited by Protocol|0
5153387|NCT01449370|17796987|P1|Overall Study|Medication Prohibited by Protocol|0
5153388|NCT01449370|17796963|P25|Overall Study|Other|0
5153389|NCT01449370|17796964|P24|Overall Study|Other|1
5153390|NCT01449370|17796965|P23|Overall Study|Other|1
5153391|NCT01449370|17796966|P22|Overall Study|Other|0
5153392|NCT01449370|17796967|P21|Overall Study|Other|0
5153393|NCT01449370|17796968|P20|Overall Study|Other|0
5153394|NCT01449370|17796969|P19|Overall Study|Other|0
5153395|NCT01449370|17796970|P18|Overall Study|Other|0
5153396|NCT01449370|17796971|P17|Overall Study|Other|0
5153397|NCT01449370|17796972|P16|Overall Study|Other|0
5153398|NCT01449370|17796973|P15|Overall Study|Other|0
5153399|NCT01449370|17796974|P14|Overall Study|Other|0
5153400|NCT01449370|17796975|P13|Overall Study|Other|0
5153401|NCT01449370|17796976|P12|Overall Study|Other|0
5153402|NCT01449370|17796977|P11|Overall Study|Other|0
5153403|NCT01449370|17796978|P10|Overall Study|Other|1
5153404|NCT01449370|17796979|P9|Overall Study|Other|1
5153405|NCT01449370|17796980|P8|Overall Study|Other|0
5153406|NCT01449370|17796981|P7|Overall Study|Other|0
5153407|NCT01449370|17796982|P6|Overall Study|Other|0
5153408|NCT01449370|17796983|P5|Overall Study|Other|0
5153409|NCT01449370|17796984|P4|Overall Study|Other|0
5153410|NCT01449370|17796985|P3|Overall Study|Other|0
5153411|NCT01449370|17796986|P2|Overall Study|Other|0
5153412|NCT01449370|17796987|P1|Overall Study|Other|0
5153413|NCT01449370|17796963|P25|Overall Study|Lost to Follow-up|0
5153414|NCT01449370|17796964|P24|Overall Study|Lost to Follow-up|0
5153415|NCT01449370|17796965|P23|Overall Study|Lost to Follow-up|0
5153416|NCT01449370|17796966|P22|Overall Study|Lost to Follow-up|0
5153417|NCT01449370|17796967|P21|Overall Study|Lost to Follow-up|1
5153418|NCT01449370|17796968|P20|Overall Study|Lost to Follow-up|0
5153419|NCT01449370|17796969|P19|Overall Study|Lost to Follow-up|0
5153420|NCT01449370|17796970|P18|Overall Study|Lost to Follow-up|0
5153421|NCT01449370|17796971|P17|Overall Study|Lost to Follow-up|0
5153422|NCT01449370|17796972|P16|Overall Study|Lost to Follow-up|0
5153423|NCT01449370|17796973|P15|Overall Study|Lost to Follow-up|0
5153424|NCT01449370|17796974|P14|Overall Study|Lost to Follow-up|0
5153425|NCT01449370|17796975|P13|Overall Study|Lost to Follow-up|0
5153426|NCT01449370|17796976|P12|Overall Study|Lost to Follow-up|0
5153427|NCT01449370|17796977|P11|Overall Study|Lost to Follow-up|0
5153428|NCT01449370|17796978|P10|Overall Study|Lost to Follow-up|0
5153429|NCT01449370|17796979|P9|Overall Study|Lost to Follow-up|0
5153430|NCT01449370|17796980|P8|Overall Study|Lost to Follow-up|0
5153431|NCT01449370|17796981|P7|Overall Study|Lost to Follow-up|0
5153432|NCT01449370|17796982|P6|Overall Study|Lost to Follow-up|0
5153433|NCT01449370|17796983|P5|Overall Study|Lost to Follow-up|0
5153434|NCT01449370|17796984|P4|Overall Study|Lost to Follow-up|0
5153435|NCT01449370|17796985|P3|Overall Study|Lost to Follow-up|0
5153436|NCT01449370|17796986|P2|Overall Study|Lost to Follow-up|0
5153437|NCT01449370|17796987|P1|Overall Study|Lost to Follow-up|0
5153438|NCT01449370|17796963|P25|Overall Study|Participant Decision|1
5153439|NCT01449370|17796964|P24|Overall Study|Participant Decision|0
5153440|NCT01449370|17796965|P23|Overall Study|Participant Decision|0
5153441|NCT01449370|17796966|P22|Overall Study|Participant Decision|1
5153442|NCT01449370|17796967|P21|Overall Study|Participant Decision|0
5153443|NCT01449370|17796968|P20|Overall Study|Participant Decision|0
5153444|NCT01449370|17796969|P19|Overall Study|Participant Decision|1
5153445|NCT01449370|17796970|P18|Overall Study|Participant Decision|0
5153446|NCT01449370|17796971|P17|Overall Study|Participant Decision|3
5153447|NCT01449370|17796972|P16|Overall Study|Participant Decision|1
5153448|NCT01449370|17796973|P15|Overall Study|Participant Decision|0
5153449|NCT01449370|17796974|P14|Overall Study|Participant Decision|1
5153450|NCT01449370|17796975|P13|Overall Study|Participant Decision|1
5153451|NCT01449370|17796976|P12|Overall Study|Participant Decision|0
5153452|NCT01449370|17796977|P11|Overall Study|Participant Decision|0
5153453|NCT01449370|17796978|P10|Overall Study|Participant Decision|0
5153454|NCT01449370|17796979|P9|Overall Study|Participant Decision|1
5153455|NCT01449370|17796980|P8|Overall Study|Participant Decision|1
5153456|NCT01449370|17796981|P7|Overall Study|Participant Decision|0
5153457|NCT01449370|17796982|P6|Overall Study|Participant Decision|0
5153458|NCT01449370|17796983|P5|Overall Study|Participant Decision|0
5153459|NCT01449370|17796984|P4|Overall Study|Participant Decision|0
5153460|NCT01449370|17796985|P3|Overall Study|Participant Decision|0
5153461|NCT01449370|17796986|P2|Overall Study|Participant Decision|0
5153462|NCT01449370|17796987|P1|Overall Study|Participant Decision|0
5153463|NCT01449370|17796963|P25|Overall Study|Adverse Event|3
5153464|NCT01449370|17796964|P24|Overall Study|Adverse Event|1
5153465|NCT01449370|17796965|P23|Overall Study|Adverse Event|0
5153466|NCT01449370|17796966|P22|Overall Study|Adverse Event|1
5153467|NCT01449370|17796967|P21|Overall Study|Adverse Event|0
5153468|NCT01449370|17796968|P20|Overall Study|Adverse Event|1
5153469|NCT01449370|17796969|P19|Overall Study|Adverse Event|1
5153470|NCT01449370|17796970|P18|Overall Study|Adverse Event|0
5153471|NCT01449370|17796971|P17|Overall Study|Adverse Event|0
5153472|NCT01449370|17796972|P16|Overall Study|Adverse Event|1
5153473|NCT01449370|17796973|P15|Overall Study|Adverse Event|0
5153474|NCT01449370|17796974|P14|Overall Study|Adverse Event|2
5153475|NCT01449370|17796975|P13|Overall Study|Adverse Event|0
5153476|NCT01449370|17796976|P12|Overall Study|Adverse Event|0
5153477|NCT01449370|17796977|P11|Overall Study|Adverse Event|0
5153478|NCT01449370|17796978|P10|Overall Study|Adverse Event|1
5153479|NCT01449370|17796979|P9|Overall Study|Adverse Event|1
5153480|NCT01449370|17796980|P8|Overall Study|Adverse Event|0
5153481|NCT01449370|17796981|P7|Overall Study|Adverse Event|0
5153482|NCT01449370|17796982|P6|Overall Study|Adverse Event|0
5153483|NCT01449370|17796983|P5|Overall Study|Adverse Event|0
5153484|NCT01449370|17796984|P4|Overall Study|Adverse Event|1
5153485|NCT01449370|17796985|P3|Overall Study|Adverse Event|0
5153486|NCT01449370|17796986|P2|Overall Study|Adverse Event|2
5153487|NCT01449370|17796987|P1|Overall Study|Adverse Event|1
5153488|NCT01449370|17796963|P25|Overall Study|Disease Progression|3
5153489|NCT01449370|17796964|P24|Overall Study|Disease Progression|7
5153490|NCT01449370|17796965|P23|Overall Study|Disease Progression|3
5153491|NCT01449370|17796966|P22|Overall Study|Disease Progression|2
5153492|NCT01449370|17796967|P21|Overall Study|Disease Progression|5
5153493|NCT01449370|17796968|P20|Overall Study|Disease Progression|2
5153494|NCT01449370|17796969|P19|Overall Study|Disease Progression|1
5153495|NCT01449370|17796970|P18|Overall Study|Disease Progression|3
5153496|NCT01449370|17796971|P17|Overall Study|Disease Progression|4
5153497|NCT01449370|17796972|P16|Overall Study|Disease Progression|1
5153498|NCT01449370|17796973|P15|Overall Study|Disease Progression|3
5153499|NCT01449370|17796974|P14|Overall Study|Disease Progression|8
5153500|NCT01449370|17796975|P13|Overall Study|Disease Progression|2
5153501|NCT01449370|17796976|P12|Overall Study|Disease Progression|3
5153502|NCT01449370|17796977|P11|Overall Study|Disease Progression|3
5153503|NCT01449370|17796978|P10|Overall Study|Disease Progression|1
5153504|NCT01449370|17796979|P9|Overall Study|Disease Progression|9
5153505|NCT01449370|17796980|P8|Overall Study|Disease Progression|2
5153506|NCT01449370|17796981|P7|Overall Study|Disease Progression|3
5153507|NCT01449370|17796982|P6|Overall Study|Disease Progression|3
5153508|NCT01449370|17796983|P5|Overall Study|Disease Progression|3
5153509|NCT01449370|17796984|P4|Overall Study|Disease Progression|3
5153510|NCT01449370|17796985|P3|Overall Study|Disease Progression|8
5153511|NCT01449370|17796986|P2|Overall Study|Disease Progression|4
5153512|NCT01449370|17796987|P1|Overall Study|Disease Progression|5
5153513|NCT01449279|17797365|P1|Overall Study|Toxicity|2
5153514|NCT01449279|17797365|P1|Overall Study|Lack of Efficacy|5
5153515|NCT01449006|17797390|P2|Overall Study|Protocol Violation|0
5153516|NCT01449006|17797391|P1|Overall Study|Protocol Violation|1
5153517|NCT01449006|17797390|P2|Overall Study|Withdrawal by Subject|0
5153518|NCT01449006|17797391|P1|Overall Study|Withdrawal by Subject|1
5153519|NCT01449006|17797390|P2|Overall Study|Lost to Follow-up|0
5153520|NCT01449006|17797391|P1|Overall Study|Lost to Follow-up|1
5153521|NCT01448850|17797405|P2|Overall Study|Other|12
5153522|NCT01448850|17797406|P1|Overall Study|Other|15
5153523|NCT01448850|17797405|P2|Overall Study|Lost to Follow-up|1
5153524|NCT01448850|17797406|P1|Overall Study|Lost to Follow-up|3
5153525|NCT01448850|17797405|P2|Overall Study|Withdrawal by Subject|21
5153526|NCT01448850|17797406|P1|Overall Study|Withdrawal by Subject|13
5153527|NCT01448850|17797405|P2|Overall Study|Death|6
5153528|NCT01448850|17797406|P1|Overall Study|Death|3
5153529|NCT01448824|17797437|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
5153530|NCT01448824|17797438|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153531|NCT01448824|17797439|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153532|NCT01448824|17797440|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153533|NCT01448824|17797441|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153534|NCT01448824|17797442|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153535|NCT01448824|17797443|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153536|NCT01448824|17797444|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5153537|NCT01448824|17797437|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
5153538|NCT01448824|17797438|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153539|NCT01448824|17797439|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153540|NCT01448824|17797440|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153541|NCT01448824|17797441|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153542|NCT01448824|17797442|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153543|NCT01448824|17797443|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153544|NCT01448824|17797444|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5153545|NCT01448824|17797437|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
5153546|NCT01448824|17797438|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153547|NCT01448824|17797439|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153548|NCT01448824|17797440|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153549|NCT01448824|17797441|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153550|NCT01448824|17797442|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153551|NCT01448824|17797443|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153552|NCT01448824|17797444|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5153553|NCT01448824|17797437|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
5153554|NCT01448824|17797438|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153555|NCT01448824|17797439|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153556|NCT01448824|17797440|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153557|NCT01448824|17797441|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153558|NCT01448824|17797442|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153559|NCT01448824|17797443|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153560|NCT01448824|17797444|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5153561|NCT01448824|17797437|P8|Part 1: Washout Period|Lost to Follow-up|0
5153562|NCT01448824|17797438|P7|Part 1: Washout Period|Lost to Follow-up|0
5153563|NCT01448824|17797439|P6|Part 1: Washout Period|Lost to Follow-up|0
5153564|NCT01448824|17797440|P5|Part 1: Washout Period|Lost to Follow-up|0
5153565|NCT01448824|17797441|P4|Part 1: Washout Period|Lost to Follow-up|0
5153566|NCT01448824|17797442|P3|Part 1: Washout Period|Lost to Follow-up|0
5153567|NCT01448824|17797443|P2|Part 1: Washout Period|Lost to Follow-up|0
5153568|NCT01448824|17797444|P1|Part 1: Washout Period|Lost to Follow-up|1
5153569|NCT01448824|17797437|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153570|NCT01448824|17797438|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153571|NCT01448824|17797439|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
5153572|NCT01448824|17797440|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153573|NCT01448824|17797441|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153574|NCT01448824|17797442|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153575|NCT01448824|17797443|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153576|NCT01448824|17797444|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5153577|NCT01448824|17797437|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5153578|NCT01448824|17797438|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5153579|NCT01448824|17797439|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
5153580|NCT01448824|17797440|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
5153581|NCT01448824|17797441|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
5153582|NCT01448824|17797442|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5153583|NCT01448824|17797443|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5153584|NCT01448824|17797444|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5153585|NCT01448824|17797437|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153586|NCT01448824|17797438|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
5153587|NCT01448824|17797439|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153588|NCT01448824|17797440|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153589|NCT01448824|17797441|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153590|NCT01448824|17797442|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153591|NCT01448824|17797443|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153592|NCT01448824|17797444|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5153593|NCT01448707|17797495|P2|Overall Study|Other|4
5153594|NCT01448707|17797496|P1|Overall Study|Other|7
5153595|NCT01448707|17797495|P2|Overall Study|Withdrawal by Subject|7
5153596|NCT01448707|17797496|P1|Overall Study|Withdrawal by Subject|6
5153597|NCT01448707|17797495|P2|Overall Study|Lost to Follow-up|6
5153598|NCT01448707|17797496|P1|Overall Study|Lost to Follow-up|2
5153599|NCT01448707|17797495|P2|Overall Study|Adverse Event|1
5153600|NCT01448707|17797496|P1|Overall Study|Adverse Event|3
5153601|NCT01448616|17797517|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
5153602|NCT01448616|17797518|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
5153603|NCT01448616|17797519|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
5153604|NCT01448616|17797520|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
5153605|NCT01448616|17797517|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
5153606|NCT01448616|17797518|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
5153607|NCT01448616|17797519|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
5153608|NCT01448616|17797520|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
5153609|NCT01448616|17797517|P4|Study Drug (Treatment Phase)|Adverse Event|0
5153610|NCT01448616|17797518|P3|Study Drug (Treatment Phase)|Adverse Event|1
5153611|NCT01448616|17797519|P2|Study Drug (Treatment Phase)|Adverse Event|1
5153612|NCT01448616|17797520|P1|Study Drug (Treatment Phase)|Adverse Event|0
5153613|NCT01448616|17797517|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5153614|NCT01448616|17797518|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5153615|NCT01448616|17797519|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5153616|NCT01448616|17797520|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
5153617|NCT01448616|17797517|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
5153618|NCT01448616|17797518|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
5153619|NCT01448616|17797519|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
5153620|NCT01448616|17797520|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
5153621|NCT01448213|17797572|P2|Overall Study|Protocol Violation|2
5153622|NCT01448213|17797573|P1|Overall Study|Protocol Violation|1
5153623|NCT01448213|17797572|P2|Overall Study|Adverse Event|10
5153624|NCT01448213|17797573|P1|Overall Study|Adverse Event|4
5153625|NCT01448213|17797572|P2|Overall Study|Lost to Follow-up|10
5153626|NCT01448213|17797573|P1|Overall Study|Lost to Follow-up|12
5153627|NCT01448057|17797583|P2|Overall Study|Withdrawal by Subject|0
5153628|NCT01448057|17797584|P1|Overall Study|Withdrawal by Subject|2
5153629|NCT01448057|17797583|P2|Overall Study|Adverse Event|2
5153630|NCT01448057|17797584|P1|Overall Study|Adverse Event|0
5153631|NCT01448057|17797583|P2|Overall Study|Lost to Follow-up|0
5153632|NCT01448057|17797584|P1|Overall Study|Lost to Follow-up|3
5153633|NCT01448057|17797583|P2|Overall Study|Protocol Violation|2
5153634|NCT01448057|17797584|P1|Overall Study|Protocol Violation|3
5153635|NCT01448044|17797594|P2|Follow Up Period|Other|11
5153636|NCT01448044|17797595|P1|Follow Up Period|Other|5
5153637|NCT01448044|17797594|P2|Follow Up Period|Lost to Follow-up|2
5153638|NCT01448044|17797595|P1|Follow Up Period|Lost to Follow-up|6
5153639|NCT01448044|17797594|P2|Follow Up Period|Withdrawal by Subject|1
5153640|NCT01448044|17797595|P1|Follow Up Period|Withdrawal by Subject|1
5153641|NCT01448044|17797594|P2|Treatment Period|Other reason|0
5153642|NCT01448044|17797595|P1|Treatment Period|Other reason|2
5153643|NCT01448044|17797594|P2|Treatment Period|Lost to Follow-up|1
5153644|NCT01448044|17797595|P1|Treatment Period|Lost to Follow-up|2
5153645|NCT01448044|17797594|P2|Treatment Period|Participant does not meet study criteria|0
5153646|NCT01448044|17797595|P1|Treatment Period|Participant does not meet study criteria|1
5153647|NCT01448044|17797594|P2|Treatment Period|Completed 24 weeks treatment period only|0
5153648|NCT01448044|17797595|P1|Treatment Period|Completed 24 weeks treatment period only|8
5153649|NCT01448044|17797594|P2|Treatment Period|Subject requested discontinue study drug|0
5153650|NCT01448044|17797595|P1|Treatment Period|Subject requested discontinue study drug|1
5153651|NCT01448044|17797594|P2|Treatment Period|Lack of Efficacy|12
5153652|NCT01448044|17797595|P1|Treatment Period|Lack of Efficacy|5
5153653|NCT01448044|17797594|P2|Treatment Period|Adverse Event|3
5153654|NCT01448044|17797595|P1|Treatment Period|Adverse Event|4
5153655|NCT01447927|17797611|P2|Overall Study|Withdrawal by Subject|0
5153656|NCT01447927|17797612|P1|Overall Study|Withdrawal by Subject|1
5153657|NCT01447927|17797611|P2|Overall Study|Adverse Event|3
5153658|NCT01447927|17797612|P1|Overall Study|Adverse Event|4
5153659|NCT01447719|17797657|P1|Overall Study|Family withdrew autopsy consent|7
5153660|NCT01447719|17797657|P1|Overall Study|Withdrawal by Subject|2
5153661|NCT01447719|17797657|P1|Overall Study|Subject still living at end of study|79
5153662|NCT01447719|17797657|P1|Overall Study|Invalid image or not imaged|3
5153663|NCT01447719|17797657|P1|Overall Study|Image acquisition failure|2
5153664|NCT01447576|17797683|P1|Overall Study|Physician Decision|6
5153665|NCT01447576|17797683|P1|Overall Study|Lack of Efficacy|68
5153666|NCT01447576|17797683|P1|Overall Study|Protocol deviation|83
5153667|NCT01447576|17797683|P1|Overall Study|Withdrawal by Subject|100
5153668|NCT01447576|17797683|P1|Overall Study|Participant met withdrawal criteria|40
5153669|NCT01447576|17797683|P1|Overall Study|Adverse Event|127
5153670|NCT01447576|17797683|P1|Overall Study|Lost to Follow-up|52
5153671|NCT01447446|17797716|P6|Overall Study|Reason not Specified|0
5153672|NCT01447446|17797717|P5|Overall Study|Reason not Specified|1
5153673|NCT01447446|17797718|P4|Overall Study|Reason not Specified|1
5153674|NCT01447446|17797719|P3|Overall Study|Reason not Specified|1
5153675|NCT01447446|17797720|P2|Overall Study|Reason not Specified|1
5153676|NCT01447446|17797721|P1|Overall Study|Reason not Specified|1
5153677|NCT01447446|17797716|P6|Overall Study|New Treatment Started|0
5153678|NCT01447446|17797717|P5|Overall Study|New Treatment Started|2
5153679|NCT01447446|17797718|P4|Overall Study|New Treatment Started|0
5153680|NCT01447446|17797719|P3|Overall Study|New Treatment Started|1
5153681|NCT01447446|17797720|P2|Overall Study|New Treatment Started|2
5153682|NCT01447446|17797721|P1|Overall Study|New Treatment Started|8
5153683|NCT01447446|17797716|P6|Overall Study|SVR12 Assessment|5
5153684|NCT01447446|17797717|P5|Overall Study|SVR12 Assessment|5
5153685|NCT01447446|17797718|P4|Overall Study|SVR12 Assessment|1
5153686|NCT01447446|17797719|P3|Overall Study|SVR12 Assessment|2
5153687|NCT01447446|17797720|P2|Overall Study|SVR12 Assessment|1
5153688|NCT01447446|17797721|P1|Overall Study|SVR12 Assessment|13
5153689|NCT01447446|17797716|P6|Overall Study|Administrative/Other|4
5153690|NCT01447446|17797717|P5|Overall Study|Administrative/Other|33
5153691|NCT01447446|17797718|P4|Overall Study|Administrative/Other|2
5153692|NCT01447446|17797719|P3|Overall Study|Administrative/Other|10
5153693|NCT01447446|17797720|P2|Overall Study|Administrative/Other|9
5153694|NCT01447446|17797721|P1|Overall Study|Administrative/Other|34
5153695|NCT01447446|17797716|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
5153696|NCT01447446|17797717|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
5153697|NCT01447446|17797718|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
5153698|NCT01447446|17797719|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
5153699|NCT01447446|17797720|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
5153700|NCT01447446|17797721|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
5153701|NCT01447446|17797716|P6|Overall Study|Failure to Return/Consent Withdrawn|9
5153702|NCT01447446|17797717|P5|Overall Study|Failure to Return/Consent Withdrawn|69
5153703|NCT01447446|17797718|P4|Overall Study|Failure to Return/Consent Withdrawn|7
5153704|NCT01447446|17797719|P3|Overall Study|Failure to Return/Consent Withdrawn|31
5153705|NCT01447446|17797720|P2|Overall Study|Failure to Return/Consent Withdrawn|78
5153706|NCT01447446|17797721|P1|Overall Study|Failure to Return/Consent Withdrawn|357
5153707|NCT01447446|17797716|P6|Overall Study|Adverse Event|0
5153708|NCT01447446|17797717|P5|Overall Study|Adverse Event|2
5153709|NCT01447446|17797718|P4|Overall Study|Adverse Event|0
5153710|NCT01447446|17797719|P3|Overall Study|Adverse Event|1
5153711|NCT01447446|17797720|P2|Overall Study|Adverse Event|0
5153712|NCT01447446|17797721|P1|Overall Study|Adverse Event|3
5153713|NCT01447446|17797716|P6|Overall Study|Death|0
5153714|NCT01447446|17797717|P5|Overall Study|Death|7
5153715|NCT01447446|17797718|P4|Overall Study|Death|1
5153716|NCT01447446|17797719|P3|Overall Study|Death|2
5153717|NCT01447446|17797720|P2|Overall Study|Death|3
5153718|NCT01447446|17797721|P1|Overall Study|Death|6
5153719|NCT01447433|17797811|P2|Overall Study|Protocol Violation|1
5153720|NCT01447433|17797812|P1|Overall Study|Protocol Violation|1
5153721|NCT01447433|17797811|P2|Overall Study|Withdrawal by Subject|3
5153722|NCT01447433|17797812|P1|Overall Study|Withdrawal by Subject|3
5153723|NCT01447433|17797811|P2|Overall Study|Lost to Follow-up|2
5153724|NCT01447433|17797812|P1|Overall Study|Lost to Follow-up|0
5153725|NCT01447420|17797839|P3|Overall Study|Lack of Efficacy|8
5153726|NCT01447420|17797840|P2|Overall Study|Lack of Efficacy|19
5153727|NCT01447420|17797841|P1|Overall Study|Lack of Efficacy|1
5153728|NCT01447420|17797839|P3|Overall Study|Withdrawal by Subject|0
5153729|NCT01447420|17797840|P2|Overall Study|Withdrawal by Subject|1
5153730|NCT01447420|17797841|P1|Overall Study|Withdrawal by Subject|4
5153731|NCT01447420|17797839|P3|Overall Study|Protocol Violation|0
5153732|NCT01447420|17797840|P2|Overall Study|Protocol Violation|3
5153733|NCT01447420|17797841|P1|Overall Study|Protocol Violation|3
5153734|NCT01447420|17797839|P3|Overall Study|Adverse Event|2
5153735|NCT01447420|17797840|P2|Overall Study|Adverse Event|4
5153736|NCT01447420|17797841|P1|Overall Study|Adverse Event|2
5153737|NCT01447407|17797861|P4|Overall Study|Physician Decision|1
5153738|NCT01447407|17797862|P3|Overall Study|Physician Decision|1
5153739|NCT01447407|17797863|P2|Overall Study|Physician Decision|0
5153740|NCT01447407|17797864|P1|Overall Study|Physician Decision|0
5153741|NCT01447407|17797861|P4|Overall Study|Withdrawal by Subject|1
5153742|NCT01447407|17797862|P3|Overall Study|Withdrawal by Subject|0
5153743|NCT01447407|17797863|P2|Overall Study|Withdrawal by Subject|0
5153744|NCT01447407|17797864|P1|Overall Study|Withdrawal by Subject|2
5153745|NCT01446913|17797998|P3|Overall Study|Lost to Follow-up|3
5153746|NCT01446913|17797999|P2|Overall Study|Lost to Follow-up|5
5153747|NCT01446913|17798000|P1|Overall Study|Lost to Follow-up|3
5153748|NCT01446913|17797998|P3|Overall Study|Physician Decision|2
5153749|NCT01446913|17797999|P2|Overall Study|Physician Decision|0
5153750|NCT01446913|17798000|P1|Overall Study|Physician Decision|0
5153751|NCT01446913|17797998|P3|Overall Study|Withdrawal by Subject|5
5153752|NCT01446913|17797999|P2|Overall Study|Withdrawal by Subject|3
5153753|NCT01446913|17798000|P1|Overall Study|Withdrawal by Subject|5
5153754|NCT01446913|17797998|P3|Overall Study|Significant illness|1
5153755|NCT01446913|17797999|P2|Overall Study|Significant illness|1
5153756|NCT01446913|17798000|P1|Overall Study|Significant illness|1
5153757|NCT01446874|17798061|P3|Overall Study|Withdrawal by Subject|4
5153758|NCT01446874|17798062|P2|Overall Study|Withdrawal by Subject|0
5153759|NCT01446874|17798063|P1|Overall Study|Withdrawal by Subject|0
5153760|NCT01446874|17798061|P3|Overall Study|Antibiotics for pre-op infection|2
5153761|NCT01446874|17798062|P2|Overall Study|Antibiotics for pre-op infection|0
5153762|NCT01446874|17798063|P1|Overall Study|Antibiotics for pre-op infection|0
5153763|NCT01446874|17798061|P3|Overall Study|Non-compliance|0
5153764|NCT01446874|17798062|P2|Overall Study|Non-compliance|4
5153765|NCT01446874|17798063|P1|Overall Study|Non-compliance|0
5153766|NCT01446874|17798061|P3|Overall Study|No surgery/No qualifying surgery|12
5153767|NCT01446874|17798062|P2|Overall Study|No surgery/No qualifying surgery|0
5153768|NCT01446874|17798063|P1|Overall Study|No surgery/No qualifying surgery|1
5153769|NCT01446874|17798061|P3|Overall Study|Not eligible|0
5153770|NCT01446874|17798062|P2|Overall Study|Not eligible|0
5153771|NCT01446874|17798063|P1|Overall Study|Not eligible|1
5153772|NCT01446809|17798091|P3|Overall Study|Failure to complete study procedures|1
5153773|NCT01446809|17798092|P2|Overall Study|Failure to complete study procedures|0
5153774|NCT01446809|17798093|P1|Overall Study|Failure to complete study procedures|0
5153775|NCT01446809|17798091|P3|Overall Study|Adverse Event|1
5153776|NCT01446809|17798092|P2|Overall Study|Adverse Event|0
5153777|NCT01446809|17798093|P1|Overall Study|Adverse Event|0
5153778|NCT01446796|17798116|P2|Overall Study|Withdrawal by Subject|0
5153779|NCT01446796|17798117|P1|Overall Study|Withdrawal by Subject|1
5153780|NCT01446419|17798163|P2|Overall Study|Terminated per protocol|0
5153781|NCT01446419|17798164|P1|Overall Study|Terminated per protocol|3
5153782|NCT01446419|17798163|P2|Overall Study|Withdrawal by Subject|1
5153783|NCT01446419|17798164|P1|Overall Study|Withdrawal by Subject|1
5153784|NCT01446419|17798163|P2|Overall Study|Death|0
5153785|NCT01446419|17798164|P1|Overall Study|Death|1
5153786|NCT01446289|17798178|P4|Overall Study|Withdrawal by Subject|0
5153787|NCT01446289|17798179|P3|Overall Study|Withdrawal by Subject|1
5153788|NCT01446289|17798180|P2|Overall Study|Withdrawal by Subject|0
5153789|NCT01446289|17798181|P1|Overall Study|Withdrawal by Subject|1
5153790|NCT01446237|17798224|P1|Overall Study|Withdrawal by Subject|7
5153791|NCT01446237|17798224|P1|Overall Study|Lost to Follow-up|2
5153792|NCT01446237|17798224|P1|Overall Study|Adverse Event|1
5153793|NCT01446159|17798236|P4|Overall Study|Other|13
5153794|NCT01446159|17798237|P3|Overall Study|Other|13
5153795|NCT01446159|17798238|P2|Overall Study|Other|0
5153796|NCT01446159|17798239|P1|Overall Study|Other|0
5153797|NCT01446159|17798236|P4|Overall Study|Death|36
5153798|NCT01446159|17798237|P3|Overall Study|Death|43
5153799|NCT01446159|17798238|P2|Overall Study|Death|3
5153800|NCT01446159|17798239|P1|Overall Study|Death|2
5153801|NCT01446159|17798236|P4|Overall Study|Lost to Follow-up|2
5153802|NCT01446159|17798237|P3|Overall Study|Lost to Follow-up|1
5153803|NCT01446159|17798238|P2|Overall Study|Lost to Follow-up|0
5153804|NCT01446159|17798239|P1|Overall Study|Lost to Follow-up|0
5153805|NCT01446159|17798236|P4|Overall Study|Withdrawal by Subject|11
5153806|NCT01446159|17798237|P3|Overall Study|Withdrawal by Subject|14
5153807|NCT01446159|17798238|P2|Overall Study|Withdrawal by Subject|0
5153808|NCT01446159|17798239|P1|Overall Study|Withdrawal by Subject|1
5153809|NCT01446042|17798314|P3|Overall Study|Other reasons|1
5153810|NCT01446042|17798315|P2|Overall Study|Other reasons|1
5153811|NCT01446042|17798316|P1|Overall Study|Other reasons|2
5153812|NCT01446042|17798314|P3|Overall Study|Lost to Follow-up|0
5153813|NCT01446042|17798315|P2|Overall Study|Lost to Follow-up|0
5153814|NCT01446042|17798316|P1|Overall Study|Lost to Follow-up|5
5153815|NCT01446042|17798314|P3|Overall Study|Adverse Event|4
5153816|NCT01446042|17798315|P2|Overall Study|Adverse Event|0
5153817|NCT01446042|17798316|P1|Overall Study|Adverse Event|1
5153818|NCT01446042|17798314|P3|Overall Study|Withdrawal by Subject|4
5153819|NCT01446042|17798315|P2|Overall Study|Withdrawal by Subject|2
5153820|NCT01446042|17798316|P1|Overall Study|Withdrawal by Subject|12
5153821|NCT01446003|17798327|P2|Period 2|Adverse Event|0
5153822|NCT01446003|17798328|P1|Period 2|Adverse Event|1
5153823|NCT01446003|17798327|P2|Period 1|Protocol Violation|0
5153824|NCT01446003|17798328|P1|Period 1|Protocol Violation|2
5153825|NCT01445951|17798349|P3|Overall Study|Cough|0
5153826|NCT01445951|17798350|P2|Overall Study|Cough|1
5153827|NCT01445951|17798351|P1|Overall Study|Cough|0
5153828|NCT01445951|17798349|P3|Overall Study|Sponsor decision - subject travel|0
5153829|NCT01445951|17798350|P2|Overall Study|Sponsor decision - subject travel|1
5153830|NCT01445951|17798351|P1|Overall Study|Sponsor decision - subject travel|0
5153831|NCT01445951|17798349|P3|Overall Study|Non-compliance with protocol|0
5153832|NCT01445951|17798350|P2|Overall Study|Non-compliance with protocol|1
5153833|NCT01445951|17798351|P1|Overall Study|Non-compliance with protocol|0
5153834|NCT01445951|17798349|P3|Overall Study|Non-compliance with study drug|0
5153835|NCT01445951|17798350|P2|Overall Study|Non-compliance with study drug|2
5153836|NCT01445951|17798351|P1|Overall Study|Non-compliance with study drug|1
5153837|NCT01445951|17798349|P3|Overall Study|Death|1
5153838|NCT01445951|17798350|P2|Overall Study|Death|0
5153839|NCT01445951|17798351|P1|Overall Study|Death|0
5153840|NCT01445951|17798349|P3|Overall Study|Pregnancy|4
5153841|NCT01445951|17798350|P2|Overall Study|Pregnancy|1
5153842|NCT01445951|17798351|P1|Overall Study|Pregnancy|0
5153843|NCT01445951|17798349|P3|Overall Study|Lost to Follow-up|4
5153844|NCT01445951|17798350|P2|Overall Study|Lost to Follow-up|2
5153845|NCT01445951|17798351|P1|Overall Study|Lost to Follow-up|1
5153846|NCT01445951|17798349|P3|Overall Study|Physician Decision|0
5153847|NCT01445951|17798350|P2|Overall Study|Physician Decision|1
5153848|NCT01445951|17798351|P1|Overall Study|Physician Decision|3
5153849|NCT01445951|17798349|P3|Overall Study|Withdrawal by Subject|8
5153850|NCT01445951|17798350|P2|Overall Study|Withdrawal by Subject|16
5153851|NCT01445951|17798351|P1|Overall Study|Withdrawal by Subject|21
5153852|NCT01445951|17798349|P3|Overall Study|Protocol Violation|2
5153853|NCT01445951|17798350|P2|Overall Study|Protocol Violation|2
5153854|NCT01445951|17798351|P1|Overall Study|Protocol Violation|2
5153855|NCT01445951|17798349|P3|Overall Study|Adverse Event|0
5153856|NCT01445951|17798350|P2|Overall Study|Adverse Event|9
5153857|NCT01445951|17798351|P1|Overall Study|Adverse Event|16
5153858|NCT01445886|17798389|P1|Overall Study|Protocol Violation|3
5153859|NCT01445886|17798389|P1|Overall Study|Lost to Follow-up|2
5153860|NCT01445847|17798429|P2|Overall Study|Missed Data|0
5153861|NCT01445847|17798430|P1|Overall Study|Missed Data|1
5153862|NCT01445847|17798429|P2|Overall Study|Protocol Violation|14
5153863|NCT01445847|17798430|P1|Overall Study|Protocol Violation|13
5153864|NCT01445769|17798447|P1|Overall Study|Lost to Follow-up|5
5153865|NCT01445769|17798447|P1|Overall Study|Disease Progression|1
5153866|NCT01445769|17798447|P1|Overall Study|Consent Withdrawn|2
5153867|NCT01445678|17798467|P2|Overall Study|Withdrawal by Subject|5
5153868|NCT01445678|17798468|P1|Overall Study|Withdrawal by Subject|9
5153869|NCT01445678|17798467|P2|Overall Study|Protocol Violation|1
5153870|NCT01445678|17798468|P1|Overall Study|Protocol Violation|1
5153871|NCT01445678|17798467|P2|Overall Study|Lost to Follow-up|5
5153872|NCT01445678|17798468|P1|Overall Study|Lost to Follow-up|8
5153873|NCT01445678|17798467|P2|Overall Study|Lack of Efficacy|2
5153874|NCT01445678|17798468|P1|Overall Study|Lack of Efficacy|0
5153875|NCT01445678|17798467|P2|Overall Study|Adverse Event|8
5153876|NCT01445678|17798468|P1|Overall Study|Adverse Event|12
5153877|NCT01445652|17798486|P2|Overall Study|Adverse Event|0
5153878|NCT01445652|17798487|P1|Overall Study|Adverse Event|1
5153879|NCT01445652|17798486|P2|Overall Study|Failed teach session|0
5153880|NCT01445652|17798487|P1|Overall Study|Failed teach session|2
5153881|NCT01445652|17798486|P2|Overall Study|Failed to attend scheduled visit|3
5153882|NCT01445652|17798487|P1|Overall Study|Failed to attend scheduled visit|2
5153883|NCT01445652|17798486|P2|Overall Study|Not comfortable in lenses|0
5153884|NCT01445652|17798487|P1|Overall Study|Not comfortable in lenses|5
5153885|NCT01445613|17798505|P1|1-year Follow-up|Received a non-study stent|2
5153886|NCT01445613|17798505|P1|1-year Follow-up|Physician Decision|2
5153887|NCT01445613|17798505|P1|1-year Follow-up|Death|30
5153888|NCT01445613|17798505|P1|1-year Follow-up|Lost to Follow-up|2
5153889|NCT01445613|17798505|P1|1-year Follow-up|Missed visit|29
5153890|NCT01445613|17798505|P1|1-year Follow-up|Withdrawal by Subject|12
5153891|NCT01445613|17798505|P1|30-day Follow-up|Death|3
5153892|NCT01445613|17798505|P1|30-day Follow-up|Missed visit|23
5153893|NCT01445613|17798505|P1|30-day Follow-up|Physician Decision|3
5153894|NCT01445613|17798505|P1|30-day Follow-up|Withdrawal by Subject|6
5153895|NCT01445548|17798523|P1|Overall Study|Adverse Event|1
5153896|NCT01445535|17798549|P4|Overall Study|PI discretion|1
5153897|NCT01445535|17798550|P3|Overall Study|PI discretion|0
5153898|NCT01445535|17798551|P2|Overall Study|PI discretion|0
5153899|NCT01445535|17798552|P1|Overall Study|PI discretion|0
5153900|NCT01445535|17798549|P4|Overall Study|Disease progression|0
5153901|NCT01445535|17798550|P3|Overall Study|Disease progression|1
5153902|NCT01445535|17798551|P2|Overall Study|Disease progression|0
5153903|NCT01445535|17798552|P1|Overall Study|Disease progression|1
5153904|NCT01445535|17798549|P4|Overall Study|Enrolled/taken off study, no drug avail.|1
5153905|NCT01445535|17798550|P3|Overall Study|Enrolled/taken off study, no drug avail.|0
5153906|NCT01445535|17798551|P2|Overall Study|Enrolled/taken off study, no drug avail.|0
5153907|NCT01445535|17798552|P1|Overall Study|Enrolled/taken off study, no drug avail.|0
5153908|NCT01445301|17798576|P3|Overall Study|Withdrawal by Subject|4
5153909|NCT01445301|17798577|P2|Overall Study|Withdrawal by Subject|6
5153910|NCT01445301|17798578|P1|Overall Study|Withdrawal by Subject|5
5153911|NCT01445301|17798576|P3|Overall Study|Physician Decision|0
5153912|NCT01445301|17798577|P2|Overall Study|Physician Decision|2
5153913|NCT01445301|17798578|P1|Overall Study|Physician Decision|0
5153914|NCT01445301|17798576|P3|Overall Study|Protocol-Defined Stopping Criteria|1
5153915|NCT01445301|17798577|P2|Overall Study|Protocol-Defined Stopping Criteria|1
5153916|NCT01445301|17798578|P1|Overall Study|Protocol-Defined Stopping Criteria|0
5153917|NCT01445301|17798576|P3|Overall Study|Protocol Violation|0
5153918|NCT01445301|17798577|P2|Overall Study|Protocol Violation|0
5153919|NCT01445301|17798578|P1|Overall Study|Protocol Violation|1
5153920|NCT01445301|17798576|P3|Overall Study|Lack of Efficacy|0
5153921|NCT01445301|17798577|P2|Overall Study|Lack of Efficacy|1
5153922|NCT01445301|17798578|P1|Overall Study|Lack of Efficacy|0
5153923|NCT01445301|17798576|P3|Overall Study|Adverse Event|4
5153924|NCT01445301|17798577|P2|Overall Study|Adverse Event|25
5153925|NCT01445301|17798578|P1|Overall Study|Adverse Event|15
5153926|NCT01445171|17798613|P1|Overall Study|Consented but did not receive device|8
5153927|NCT01445171|17798613|P1|Overall Study|Subjects declined to return for followup|9
5153928|NCT01445171|17798613|P1|Overall Study|Death|51
5153929|NCT01445171|17798613|P1|Overall Study|Withdrawal by Subject|16
5153930|NCT01445171|17798613|P1|Overall Study|Lost to Follow-up|11
5153931|NCT01444898|17798669|P1|Overall Study|Withdrawal by Subject|1
5153932|NCT01444781|17798684|P3|Overall Study|Withdrawal by Subject|2
5153933|NCT01444781|17798685|P2|Overall Study|Withdrawal by Subject|1
5153934|NCT01444781|17798686|P1|Overall Study|Withdrawal by Subject|3
5153935|NCT01444781|17798684|P3|Overall Study|Lost to Follow-up|1
5153936|NCT01444781|17798685|P2|Overall Study|Lost to Follow-up|3
5153937|NCT01444781|17798686|P1|Overall Study|Lost to Follow-up|0
5153938|NCT01444742|17798724|P1|Overall Study|Death|1
5153939|NCT01444651|17798731|P2|Overall Study|Missing data|1
5153940|NCT01444651|17798732|P1|Overall Study|Missing data|1
5153941|NCT01444651|17798731|P2|Overall Study|Non-fasting|1
5153942|NCT01444651|17798732|P1|Overall Study|Non-fasting|2
5153943|NCT01444651|17798731|P2|Overall Study|Lost to Follow-up|5
5153944|NCT01444651|17798732|P1|Overall Study|Lost to Follow-up|5
5153945|NCT01444651|17798731|P2|Overall Study|Adverse Event|2
5153946|NCT01444651|17798732|P1|Overall Study|Adverse Event|3
5153947|NCT01444456|17798748|P1|Overall Study|Not treated|104
5153948|NCT01444456|17798748|P1|Overall Study|Other|18
5153949|NCT01444456|17798748|P1|Overall Study|Ineligibility determined|23
5153950|NCT01444456|17798748|P1|Overall Study|Death|73
5153951|NCT01444456|17798748|P1|Overall Study|Lost to Follow-up|37
5153952|NCT01444456|17798748|P1|Overall Study|Physician Decision|9
5153953|NCT01444456|17798748|P1|Overall Study|Withdrawal by Subject|21
5153954|NCT01444430|17798759|P2|Overall Study|CRF termination module not completed.|1
5153955|NCT01444430|17798760|P1|Overall Study|CRF termination module not completed.|0
5153956|NCT01444430|17798759|P2|Overall Study|Lost to Follow-up|0
5153957|NCT01444430|17798760|P1|Overall Study|Lost to Follow-up|2
5153958|NCT01444430|17798759|P2|Overall Study|Death|8
5153959|NCT01444430|17798760|P1|Overall Study|Death|6
5153960|NCT01444430|17798759|P2|Overall Study|Withdrawal by Subject|72
5153961|NCT01444430|17798760|P1|Overall Study|Withdrawal by Subject|53
5153962|NCT01444417|17798782|P2|Overall Study|Withdrawal by Subject|0
5153963|NCT01444417|17798783|P1|Overall Study|Withdrawal by Subject|2
5153964|NCT01444417|17798782|P2|Overall Study|Ineligibility Determined|1
5153965|NCT01444417|17798783|P1|Overall Study|Ineligibility Determined|0
5153966|NCT01444391|17798799|P1|Overall Study|Death|1
5153967|NCT01444378|17798807|P1|Overall Study|Missed Visits|10
5153968|NCT01444378|17798807|P1|Overall Study|Administrative Closure Of The Study|2
5153969|NCT01444378|17798807|P1|Overall Study|Death|3
5153970|NCT01444378|17798807|P1|Overall Study|Withdrawal by Subject|1
5153971|NCT01444378|17798807|P1|Overall Study|Lost to Follow-up|1
5153972|NCT01444300|17798919|P2|Overall Study|Adverse Event|0
5153973|NCT01444300|17798920|P1|Overall Study|Adverse Event|4
5153974|NCT01444092|17798952|P1|Overall Study|Other Eligibility criteria|7
5153975|NCT01444092|17798952|P1|Overall Study|Withdrawal by Subject|1
5153976|NCT01444092|17798952|P1|Overall Study|Protocol Violation|1
5153977|NCT01444092|17798952|P1|Overall Study|Adverse Event|8
5153978|NCT01444027|17798961|P3|Overall Study|Lost to Follow-up|14
5153979|NCT01444027|17798962|P2|Overall Study|Lost to Follow-up|20
5153980|NCT01444027|17798963|P1|Overall Study|Lost to Follow-up|26
5153981|NCT01444027|17798961|P3|Overall Study|Withdrawal by Subject|24
5153982|NCT01444027|17798962|P2|Overall Study|Withdrawal by Subject|10
5153983|NCT01444027|17798963|P1|Overall Study|Withdrawal by Subject|4
5153984|NCT01443923|17798985|P2|Overall Study|Adverse Event|0
5153985|NCT01443923|17798986|P1|Overall Study|Adverse Event|1
5153986|NCT01443858|17799003|P3|Overall Study|Lost to Follow-up|2
5153987|NCT01443858|17799004|P2|Overall Study|Lost to Follow-up|5
5153988|NCT01443858|17799005|P1|Overall Study|Lost to Follow-up|5
5153989|NCT01443858|17799003|P3|Overall Study|Lack of Efficacy|0
5153990|NCT01443858|17799004|P2|Overall Study|Lack of Efficacy|0
5153991|NCT01443858|17799005|P1|Overall Study|Lack of Efficacy|1
5153992|NCT01443858|17799003|P3|Overall Study|Withdrawal by Subject|5
5153993|NCT01443858|17799004|P2|Overall Study|Withdrawal by Subject|8
5153994|NCT01443858|17799005|P1|Overall Study|Withdrawal by Subject|9
5153995|NCT01443845|17799027|P2|Overall Study|Lost to Follow-up|13
5153996|NCT01443845|17799028|P1|Overall Study|Lost to Follow-up|9
5153997|NCT01443845|17799027|P2|Overall Study|Military Conflict - Site Terminated|21
5153998|NCT01443845|17799028|P1|Overall Study|Military Conflict - Site Terminated|20
5153999|NCT01443845|17799027|P2|Overall Study|Withdrawal by Subject|67
5154000|NCT01443845|17799028|P1|Overall Study|Withdrawal by Subject|63
5154001|NCT01443845|17799027|P2|Overall Study|Adverse Event|138
5154002|NCT01443845|17799028|P1|Overall Study|Adverse Event|64
5154003|NCT01443845|17799027|P2|Overall Study|Lack of Efficacy|5
5154004|NCT01443845|17799028|P1|Overall Study|Lack of Efficacy|10
5154005|NCT01443845|17799027|P2|Overall Study|Deterioration in pulmonary function|4
5154006|NCT01443845|17799028|P1|Overall Study|Deterioration in pulmonary function|1
5154007|NCT01443845|17799027|P2|Overall Study|Other reasons, such as COPD exacerbation|44
5154008|NCT01443845|17799028|P1|Overall Study|Other reasons, such as COPD exacerbation|44
5154009|NCT01443845|17799027|P2|Overall Study|Protocol Violation|45
5154010|NCT01443845|17799028|P1|Overall Study|Protocol Violation|43
5154011|NCT01443403|17799083|P4|Overall Study|Other - Miscellaneous|1
5154012|NCT01443403|17799084|P3|Overall Study|Other - Miscellaneous|0
5154013|NCT01443403|17799085|P2|Overall Study|Other - Miscellaneous|0
5154014|NCT01443403|17799086|P1|Overall Study|Other - Miscellaneous|1
5154015|NCT01443403|17799083|P4|Overall Study|Use of Prohibited Treatment|0
5154016|NCT01443403|17799084|P3|Overall Study|Use of Prohibited Treatment|0
5154017|NCT01443403|17799085|P2|Overall Study|Use of Prohibited Treatment|3
5154018|NCT01443403|17799086|P1|Overall Study|Use of Prohibited Treatment|2
5154019|NCT01443403|17799083|P4|Overall Study|Protocol Violation|1
5154020|NCT01443403|17799084|P3|Overall Study|Protocol Violation|1
5154021|NCT01443403|17799085|P2|Overall Study|Protocol Violation|1
5154022|NCT01443403|17799086|P1|Overall Study|Protocol Violation|2
5154023|NCT01443403|17799083|P4|Overall Study|Lost to Follow-up|1
5154024|NCT01443403|17799084|P3|Overall Study|Lost to Follow-up|0
5154025|NCT01443403|17799085|P2|Overall Study|Lost to Follow-up|0
5154026|NCT01443403|17799086|P1|Overall Study|Lost to Follow-up|0
5154027|NCT01443403|17799083|P4|Overall Study|Withdrawal by Subject|1
5154028|NCT01443403|17799084|P3|Overall Study|Withdrawal by Subject|2
5154029|NCT01443403|17799085|P2|Overall Study|Withdrawal by Subject|1
5154030|NCT01443403|17799086|P1|Overall Study|Withdrawal by Subject|0
5154031|NCT01443403|17799083|P4|Overall Study|Adverse Event|5
5154032|NCT01443403|17799084|P3|Overall Study|Adverse Event|4
5154033|NCT01443403|17799085|P2|Overall Study|Adverse Event|1
5154034|NCT01443403|17799086|P1|Overall Study|Adverse Event|1
5154035|NCT01443364|17799233|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5154036|NCT01443364|17799233|P1|Overall Study|AE, non-serious non-fatal|8
5154037|NCT01443364|17799233|P1|Overall Study|SAE, non-fatal|6
5154038|NCT01443364|17799233|P1|Overall Study|Other Reason|4
5154039|NCT01443364|17799233|P1|Overall Study|Withdrawal by Subject|5
5154040|NCT01443364|17799233|P1|Overall Study|Lost to Follow-up|3
5154041|NCT01443364|17799233|P1|Overall Study|Lack of Efficacy|14
5154042|NCT01443130|17799362|P6|Overall Study|Death of Subject's Infant|0
5154043|NCT01443130|17799363|P5|Overall Study|Death of Subject's Infant|0
5154044|NCT01443130|17799364|P4|Overall Study|Death of Subject's Infant|0
5154045|NCT01443130|17799365|P3|Overall Study|Death of Subject's Infant|11
5154046|NCT01443130|17799366|P2|Overall Study|Death of Subject's Infant|10
5154047|NCT01443130|17799367|P1|Overall Study|Death of Subject's Infant|5
5154048|NCT01443130|17799362|P6|Overall Study|Withdrawal by Subject|2
5154049|NCT01443130|17799363|P5|Overall Study|Withdrawal by Subject|7
5154050|NCT01443130|17799364|P4|Overall Study|Withdrawal by Subject|7
5154051|NCT01443130|17799365|P3|Overall Study|Withdrawal by Subject|12
5154052|NCT01443130|17799366|P2|Overall Study|Withdrawal by Subject|14
5154053|NCT01443130|17799367|P1|Overall Study|Withdrawal by Subject|15
5154054|NCT01443130|17799362|P6|Overall Study|Protocol Violation|3
5154055|NCT01443130|17799363|P5|Overall Study|Protocol Violation|2
5154056|NCT01443130|17799364|P4|Overall Study|Protocol Violation|2
5154057|NCT01443130|17799365|P3|Overall Study|Protocol Violation|3
5154058|NCT01443130|17799366|P2|Overall Study|Protocol Violation|1
5154059|NCT01443130|17799367|P1|Overall Study|Protocol Violation|2
5154060|NCT01443130|17799362|P6|Overall Study|Adverse Event|0
5154061|NCT01443130|17799363|P5|Overall Study|Adverse Event|0
5154062|NCT01443130|17799364|P4|Overall Study|Adverse Event|0
5154063|NCT01443130|17799365|P3|Overall Study|Adverse Event|1
5154064|NCT01443130|17799366|P2|Overall Study|Adverse Event|1
5154065|NCT01443130|17799367|P1|Overall Study|Adverse Event|2
5154066|NCT01443130|17799362|P6|Overall Study|Death|8
5154067|NCT01443130|17799363|P5|Overall Study|Death|10
5154068|NCT01443130|17799364|P4|Overall Study|Death|7
5154069|NCT01443130|17799365|P3|Overall Study|Death|0
5154070|NCT01443130|17799366|P2|Overall Study|Death|1
5154071|NCT01443130|17799367|P1|Overall Study|Death|0
5154072|NCT01443130|17799362|P6|Overall Study|Lost to Follow-up|21
5154073|NCT01443130|17799363|P5|Overall Study|Lost to Follow-up|25
5154074|NCT01443130|17799364|P4|Overall Study|Lost to Follow-up|23
5154075|NCT01443130|17799365|P3|Overall Study|Lost to Follow-up|50
5154076|NCT01443130|17799366|P2|Overall Study|Lost to Follow-up|42
5154077|NCT01443130|17799367|P1|Overall Study|Lost to Follow-up|44
5154078|NCT01443078|17799417|P1|Overall Study|Patient had brain mets|1
5154079|NCT01443078|17799417|P1|Overall Study|Withdrawal by Subject|1
5154080|NCT01443078|17799417|P1|Overall Study|Responded to neoadjuvant platinum txt|27
5154081|NCT01443026|17799424|P2|Overall Study|Lost to Follow-up|1
5154082|NCT01443026|17799425|P1|Overall Study|Lost to Follow-up|2
5154083|NCT01443026|17799424|P2|Overall Study|Withdrawal by Subject|3
5154084|NCT01443026|17799425|P1|Overall Study|Withdrawal by Subject|0
5154085|NCT01443026|17799424|P2|Overall Study|Death|1
5154086|NCT01443026|17799425|P1|Overall Study|Death|0
5154087|NCT01443026|17799424|P2|Overall Study|Physician Decision|0
5154088|NCT01443026|17799425|P1|Overall Study|Physician Decision|1
5154089|NCT01442779|17799440|P1|Overall Study|Non-compliance|1
5154090|NCT01442779|17799440|P1|Overall Study|Death|3
5154091|NCT01442779|17799440|P1|Overall Study|Withdrawal by Subject|3
5154092|NCT01442714|17799446|P1|Overall Study|Withdrawal by Subject|1
5154093|NCT01442714|17799446|P1|Overall Study|Death|11
5154094|NCT01442688|17799454|P2|Second Intervention|Adverse Event|0
5154095|NCT01442688|17799455|P1|Second Intervention|Adverse Event|1
5154096|NCT01442688|17799454|P2|First Intervention|subject incarcerated|0
5154097|NCT01442688|17799455|P1|First Intervention|subject incarcerated|1
5154098|NCT01442688|17799454|P2|First Intervention|Withdrawal by Subject|0
5154099|NCT01442688|17799455|P1|First Intervention|Withdrawal by Subject|1
5154100|NCT01442675|17799463|P1|Overall Study|Withdrawal by Subject|4
5154101|NCT01442675|17799463|P1|Overall Study|Lost to Follow-up|2
5154102|NCT01442675|17799463|P1|Overall Study|Protocol Violation|6
5154103|NCT01442493|17799475|P2|Overall Study|withdrawn from study|2
5154104|NCT01442493|17799476|P1|Overall Study|withdrawn from study|3
5154105|NCT01442376|17799497|P3|Overall Study|Not eligible for subsequent cycles|0
5154106|NCT01442376|17799498|P2|Overall Study|Not eligible for subsequent cycles|2
5154107|NCT01442376|17799499|P1|Overall Study|Not eligible for subsequent cycles|1
5154108|NCT01442376|17799497|P3|Overall Study|Patients not treated|1
5154109|NCT01442376|17799498|P2|Overall Study|Patients not treated|3
5154110|NCT01442376|17799499|P1|Overall Study|Patients not treated|2
5154111|NCT01442376|17799497|P3|Overall Study|Withdrawal of consent|1
5154112|NCT01442376|17799498|P2|Overall Study|Withdrawal of consent|0
5154113|NCT01442376|17799499|P1|Overall Study|Withdrawal of consent|0
5154114|NCT01442376|17799497|P3|Overall Study|Death|1
5154115|NCT01442376|17799498|P2|Overall Study|Death|1
5154116|NCT01442376|17799499|P1|Overall Study|Death|0
5154117|NCT01442376|17799497|P3|Overall Study|Adverse Event|2
5154118|NCT01442376|17799498|P2|Overall Study|Adverse Event|3
5154119|NCT01442376|17799499|P1|Overall Study|Adverse Event|0
5154120|NCT01442181|17799512|P2|Overall Study|atrial fibrillation not noted|1
5154121|NCT01442181|17799513|P1|Overall Study|atrial fibrillation not noted|0
5154122|NCT01442181|17799512|P2|Overall Study|patient in an additional study|0
5154123|NCT01442181|17799513|P1|Overall Study|patient in an additional study|1
5154124|NCT01442181|17799512|P2|Overall Study|Lost to Follow-up|1
5154125|NCT01442181|17799513|P1|Overall Study|Lost to Follow-up|1
5154126|NCT01442181|17799512|P2|Overall Study|low ejection factor|1
5154127|NCT01442181|17799513|P1|Overall Study|low ejection factor|0
5154128|NCT01442181|17799512|P2|Overall Study|no insurance for surgery|0
5154129|NCT01442181|17799513|P1|Overall Study|no insurance for surgery|1
5154130|NCT01442181|17799512|P2|Overall Study|patient refused surgery|0
5154131|NCT01442181|17799513|P1|Overall Study|patient refused surgery|1
5154132|NCT01442155|17799537|P1|Overall Study|Lost to Follow-up|2
5154133|NCT01442155|17799537|P1|Overall Study|Adverse Event|2
5154134|NCT01442155|17799537|P1|Overall Study|Recurrence|26
5154135|NCT01442155|17799537|P1|Overall Study|Complete remission|35
5154136|NCT01442103|17799553|P1|Overall Study|Lost to Follow-up|2
5154137|NCT01442064|17799563|P6|Overall Study|Condition mandated other intervention|2
5154138|NCT01442064|17799564|P5|Overall Study|Condition mandated other intervention|0
5154139|NCT01442064|17799565|P4|Overall Study|Condition mandated other intervention|0
5154140|NCT01442064|17799566|P3|Overall Study|Condition mandated other intervention|2
5154141|NCT01442064|17799567|P2|Overall Study|Condition mandated other intervention|1
5154142|NCT01442064|17799568|P1|Overall Study|Condition mandated other intervention|1
5154143|NCT01442064|17799563|P6|Overall Study|Subject non-compliance|2
5154144|NCT01442064|17799564|P5|Overall Study|Subject non-compliance|0
5154145|NCT01442064|17799565|P4|Overall Study|Subject non-compliance|0
5154146|NCT01442064|17799566|P3|Overall Study|Subject non-compliance|0
5154147|NCT01442064|17799567|P2|Overall Study|Subject non-compliance|0
5154148|NCT01442064|17799568|P1|Overall Study|Subject non-compliance|0
5154149|NCT01442064|17799563|P6|Overall Study|Sponsor decision|87
5154150|NCT01442064|17799564|P5|Overall Study|Sponsor decision|95
5154151|NCT01442064|17799565|P4|Overall Study|Sponsor decision|88
5154152|NCT01442064|17799566|P3|Overall Study|Sponsor decision|92
5154153|NCT01442064|17799567|P2|Overall Study|Sponsor decision|88
5154154|NCT01442064|17799568|P1|Overall Study|Sponsor decision|82
5154155|NCT01442064|17799563|P6|Overall Study|Withdrawal by Subject|1
5154156|NCT01442064|17799564|P5|Overall Study|Withdrawal by Subject|2
5154157|NCT01442064|17799565|P4|Overall Study|Withdrawal by Subject|2
5154158|NCT01442064|17799566|P3|Overall Study|Withdrawal by Subject|2
5154159|NCT01442064|17799567|P2|Overall Study|Withdrawal by Subject|3
5154160|NCT01442064|17799568|P1|Overall Study|Withdrawal by Subject|6
5154161|NCT01442064|17799563|P6|Overall Study|Physician Decision|1
5154162|NCT01442064|17799564|P5|Overall Study|Physician Decision|3
5154163|NCT01442064|17799565|P4|Overall Study|Physician Decision|3
5154164|NCT01442064|17799566|P3|Overall Study|Physician Decision|2
5154165|NCT01442064|17799567|P2|Overall Study|Physician Decision|1
5154166|NCT01442064|17799568|P1|Overall Study|Physician Decision|1
5154167|NCT01442064|17799563|P6|Overall Study|Lost to Follow-up|3
5154168|NCT01442064|17799564|P5|Overall Study|Lost to Follow-up|3
5154169|NCT01442064|17799565|P4|Overall Study|Lost to Follow-up|1
5154170|NCT01442064|17799566|P3|Overall Study|Lost to Follow-up|1
5154171|NCT01442064|17799567|P2|Overall Study|Lost to Follow-up|5
5154172|NCT01442064|17799568|P1|Overall Study|Lost to Follow-up|5
5154173|NCT01442064|17799563|P6|Overall Study|Death|3
5154174|NCT01442064|17799564|P5|Overall Study|Death|1
5154175|NCT01442064|17799565|P4|Overall Study|Death|3
5154176|NCT01442064|17799566|P3|Overall Study|Death|3
5154177|NCT01442064|17799567|P2|Overall Study|Death|1
5154178|NCT01442064|17799568|P1|Overall Study|Death|0
5154179|NCT01442064|17799563|P6|Overall Study|Adverse Event|0
5154180|NCT01442064|17799564|P5|Overall Study|Adverse Event|2
5154181|NCT01442064|17799565|P4|Overall Study|Adverse Event|1
5154182|NCT01442064|17799566|P3|Overall Study|Adverse Event|2
5154183|NCT01442064|17799567|P2|Overall Study|Adverse Event|2
5154184|NCT01442064|17799568|P1|Overall Study|Adverse Event|2
5154185|NCT01442038|17799605|P2|Overall Study|Study Terminated By Sponsor|3
5154186|NCT01442038|17799606|P1|Overall Study|Study Terminated By Sponsor|2
5154187|NCT01442038|17799605|P2|Overall Study|Investigator's Discretion|16
5154188|NCT01442038|17799606|P1|Overall Study|Investigator's Discretion|13
5154189|NCT01442038|17799605|P2|Overall Study|Protocol Deviation|20
5154190|NCT01442038|17799606|P1|Overall Study|Protocol Deviation|9
5154191|NCT01442038|17799605|P2|Overall Study|Adverse Event|15
5154192|NCT01442038|17799606|P1|Overall Study|Adverse Event|26
5154193|NCT01442038|17799605|P2|Overall Study|Lost to Follow-up|51
5154194|NCT01442038|17799606|P1|Overall Study|Lost to Follow-up|37
5154195|NCT01442038|17799605|P2|Overall Study|Participant Withdrew Consent|102
5154196|NCT01442038|17799606|P1|Overall Study|Participant Withdrew Consent|137
5154197|NCT01442038|17799605|P2|Overall Study|Investigator-Initiated Early Closure|43
5154198|NCT01442038|17799606|P1|Overall Study|Investigator-Initiated Early Closure|44
5154199|NCT01442038|17799605|P2|Overall Study|Death|29
5154200|NCT01442038|17799606|P1|Overall Study|Death|35
5154201|NCT01441973|17799620|P2|Overall Study|Participant withdrew consent|1
5154202|NCT01441973|17799621|P1|Overall Study|Participant withdrew consent|0
5154203|NCT01441973|17799620|P2|Overall Study|Administrative reason by sponsor|5
5154204|NCT01441973|17799621|P1|Overall Study|Administrative reason by sponsor|3
5154205|NCT01441973|17799620|P2|Overall Study|Poor compliance/noncompliance|1
5154206|NCT01441973|17799621|P1|Overall Study|Poor compliance/noncompliance|0
5154207|NCT01441973|17799620|P2|Overall Study|Participant request to discontinue|1
5154208|NCT01441973|17799621|P1|Overall Study|Participant request to discontinue|1
5154209|NCT01441973|17799620|P2|Overall Study|Adverse event unrelated to study drug|2
5154210|NCT01441973|17799621|P1|Overall Study|Adverse event unrelated to study drug|3
5154211|NCT01441973|17799620|P2|Overall Study|Disease progression|6
5154212|NCT01441973|17799621|P1|Overall Study|Disease progression|8
5154213|NCT01441960|17799643|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
5154214|NCT01441960|17799644|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
5154215|NCT01441960|17799643|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
5154216|NCT01441960|17799644|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
5154217|NCT01441960|17799643|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
5154218|NCT01441960|17799644|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
5154219|NCT01441765|17799669|P2|Overall Study|Death|0
5154220|NCT01441765|17799670|P1|Overall Study|Death|1
5154221|NCT01441635|17799694|P10|Overall Study|Other|0
5154222|NCT01441635|17799695|P9|Overall Study|Other|0
5154223|NCT01441635|17799696|P8|Overall Study|Other|1
5154224|NCT01441635|17799697|P7|Overall Study|Other|0
5154225|NCT01441635|17799698|P6|Overall Study|Other|0
5154226|NCT01441635|17799699|P5|Overall Study|Other|0
5154227|NCT01441635|17799700|P4|Overall Study|Other|0
5154228|NCT01441635|17799701|P3|Overall Study|Other|0
5154229|NCT01441635|17799702|P2|Overall Study|Other|0
5154230|NCT01441635|17799703|P1|Overall Study|Other|0
5154231|NCT01441635|17799694|P10|Overall Study|Received Exclusionary Medication|0
5154232|NCT01441635|17799695|P9|Overall Study|Received Exclusionary Medication|0
5154233|NCT01441635|17799696|P8|Overall Study|Received Exclusionary Medication|0
5154234|NCT01441635|17799697|P7|Overall Study|Received Exclusionary Medication|0
5154235|NCT01441635|17799698|P6|Overall Study|Received Exclusionary Medication|0
5154236|NCT01441635|17799699|P5|Overall Study|Received Exclusionary Medication|0
5154237|NCT01441635|17799700|P4|Overall Study|Received Exclusionary Medication|0
5154238|NCT01441635|17799701|P3|Overall Study|Received Exclusionary Medication|0
5154239|NCT01441635|17799702|P2|Overall Study|Received Exclusionary Medication|0
5154240|NCT01441635|17799703|P1|Overall Study|Received Exclusionary Medication|1
5154241|NCT01441635|17799694|P10|Overall Study|Surgery or Invasive Intervention|0
5154242|NCT01441635|17799695|P9|Overall Study|Surgery or Invasive Intervention|0
5154243|NCT01441635|17799696|P8|Overall Study|Surgery or Invasive Intervention|0
5154244|NCT01441635|17799697|P7|Overall Study|Surgery or Invasive Intervention|0
5154245|NCT01441635|17799698|P6|Overall Study|Surgery or Invasive Intervention|0
5154246|NCT01441635|17799699|P5|Overall Study|Surgery or Invasive Intervention|0
5154247|NCT01441635|17799700|P4|Overall Study|Surgery or Invasive Intervention|0
5154248|NCT01441635|17799701|P3|Overall Study|Surgery or Invasive Intervention|1
5154249|NCT01441635|17799702|P2|Overall Study|Surgery or Invasive Intervention|0
5154250|NCT01441635|17799703|P1|Overall Study|Surgery or Invasive Intervention|0
5154251|NCT01441635|17799694|P10|Overall Study|Noncompliance|0
5154252|NCT01441635|17799695|P9|Overall Study|Noncompliance|0
5154253|NCT01441635|17799696|P8|Overall Study|Noncompliance|0
5154254|NCT01441635|17799697|P7|Overall Study|Noncompliance|1
5154255|NCT01441635|17799698|P6|Overall Study|Noncompliance|0
5154256|NCT01441635|17799699|P5|Overall Study|Noncompliance|0
5154257|NCT01441635|17799700|P4|Overall Study|Noncompliance|0
5154258|NCT01441635|17799701|P3|Overall Study|Noncompliance|0
5154259|NCT01441635|17799702|P2|Overall Study|Noncompliance|1
5154260|NCT01441635|17799703|P1|Overall Study|Noncompliance|0
5154261|NCT01441635|17799694|P10|Overall Study|Lost to Follow-up|1
5154262|NCT01441635|17799695|P9|Overall Study|Lost to Follow-up|0
5154263|NCT01441635|17799696|P8|Overall Study|Lost to Follow-up|1
5154264|NCT01441635|17799697|P7|Overall Study|Lost to Follow-up|1
5154265|NCT01441635|17799698|P6|Overall Study|Lost to Follow-up|3
5154266|NCT01441635|17799699|P5|Overall Study|Lost to Follow-up|1
5154267|NCT01441635|17799700|P4|Overall Study|Lost to Follow-up|1
5154268|NCT01441635|17799701|P3|Overall Study|Lost to Follow-up|1
5154269|NCT01441635|17799702|P2|Overall Study|Lost to Follow-up|1
5154270|NCT01441635|17799703|P1|Overall Study|Lost to Follow-up|0
5154271|NCT01441635|17799694|P10|Overall Study|Withdrawal by Subject|1
5154272|NCT01441635|17799695|P9|Overall Study|Withdrawal by Subject|1
5154273|NCT01441635|17799696|P8|Overall Study|Withdrawal by Subject|0
5154274|NCT01441635|17799697|P7|Overall Study|Withdrawal by Subject|2
5154275|NCT01441635|17799698|P6|Overall Study|Withdrawal by Subject|0
5154276|NCT01441635|17799699|P5|Overall Study|Withdrawal by Subject|0
5154277|NCT01441635|17799700|P4|Overall Study|Withdrawal by Subject|1
5154278|NCT01441635|17799701|P3|Overall Study|Withdrawal by Subject|0
5154279|NCT01441635|17799702|P2|Overall Study|Withdrawal by Subject|1
5154280|NCT01441635|17799703|P1|Overall Study|Withdrawal by Subject|1
5154281|NCT01441635|17799694|P10|Overall Study|Adverse Event|0
5154282|NCT01441635|17799695|P9|Overall Study|Adverse Event|1
5154283|NCT01441635|17799696|P8|Overall Study|Adverse Event|2
5154284|NCT01441635|17799697|P7|Overall Study|Adverse Event|2
5154285|NCT01441635|17799698|P6|Overall Study|Adverse Event|2
5154286|NCT01441635|17799699|P5|Overall Study|Adverse Event|1
5154287|NCT01441635|17799700|P4|Overall Study|Adverse Event|5
5154288|NCT01441635|17799701|P3|Overall Study|Adverse Event|1
5154289|NCT01441635|17799702|P2|Overall Study|Adverse Event|3
5154290|NCT01441635|17799703|P1|Overall Study|Adverse Event|4
5154291|NCT01441596|17799918|P3|Overall Study|Not treated|1
5154292|NCT01441596|17799919|P2|Overall Study|Not treated|1
5154293|NCT01441596|17799920|P1|Overall Study|Not treated|0
5154294|NCT01441596|17799918|P3|Overall Study|Withdrawal by Subject|2
5154295|NCT01441596|17799919|P2|Overall Study|Withdrawal by Subject|0
5154296|NCT01441596|17799920|P1|Overall Study|Withdrawal by Subject|4
5154297|NCT01441596|17799918|P3|Overall Study|Other reason not defined below|1
5154298|NCT01441596|17799919|P2|Overall Study|Other reason not defined below|2
5154299|NCT01441596|17799920|P1|Overall Study|Other reason not defined below|0
5154300|NCT01441440|17799994|P3|Overall Study|Difficllty in keeping the schedule|0
5154301|NCT01441440|17799995|P2|Overall Study|Difficllty in keeping the schedule|1
5154302|NCT01441440|17799996|P1|Overall Study|Difficllty in keeping the schedule|1
5154303|NCT01441440|17799994|P3|Overall Study|Work-related matter|0
5154304|NCT01441440|17799995|P2|Overall Study|Work-related matter|1
5154305|NCT01441440|17799996|P1|Overall Study|Work-related matter|0
5154306|NCT01441440|17799994|P3|Overall Study|Moving|1
5154307|NCT01441440|17799995|P2|Overall Study|Moving|1
5154308|NCT01441440|17799996|P1|Overall Study|Moving|0
5154309|NCT01441440|17799994|P3|Overall Study|Lack of Efficacy|1
5154310|NCT01441440|17799995|P2|Overall Study|Lack of Efficacy|0
5154311|NCT01441440|17799996|P1|Overall Study|Lack of Efficacy|1
5154312|NCT01441440|17799994|P3|Overall Study|Pregnancy|0
5154313|NCT01441440|17799995|P2|Overall Study|Pregnancy|0
5154314|NCT01441440|17799996|P1|Overall Study|Pregnancy|1
5154315|NCT01441440|17799994|P3|Overall Study|Withdrawal by Subject|9
5154316|NCT01441440|17799995|P2|Overall Study|Withdrawal by Subject|9
5154317|NCT01441440|17799996|P1|Overall Study|Withdrawal by Subject|11
5154318|NCT01441440|17799994|P3|Overall Study|Lost to Follow-up|1
5154319|NCT01441440|17799995|P2|Overall Study|Lost to Follow-up|2
5154320|NCT01441440|17799996|P1|Overall Study|Lost to Follow-up|0
5154321|NCT01441440|17799994|P3|Overall Study|Adverse Event|9
5154322|NCT01441440|17799995|P2|Overall Study|Adverse Event|9
5154323|NCT01441440|17799996|P1|Overall Study|Adverse Event|2
5154324|NCT01441440|17799994|P3|Overall Study|Death|1
5154325|NCT01441440|17799995|P2|Overall Study|Death|0
5154326|NCT01441440|17799996|P1|Overall Study|Death|1
5154327|NCT01441414|17800019|P1|Overall Study|Subject refused further follow-up|1
5154328|NCT01441414|17800019|P1|Overall Study|Study terminated by sponsor|2
5154329|NCT01441414|17800019|P1|Overall Study|Other reasons|3
5154330|NCT01441414|17800019|P1|Overall Study|Participant died|9
5154331|NCT01441180|17800098|P3|Overall Study|Discontinued|2
5154332|NCT01441180|17800099|P2|Overall Study|Discontinued|0
5154333|NCT01441180|17800100|P1|Overall Study|Discontinued|0
5154334|NCT01441180|17800098|P3|Overall Study|Lost to Follow-up|1
5154335|NCT01441180|17800099|P2|Overall Study|Lost to Follow-up|1
5154336|NCT01441180|17800100|P1|Overall Study|Lost to Follow-up|1
5154337|NCT01441102|17800111|P1|Overall Study|Withdrawal by Subject|2
5154338|NCT01441102|17800111|P1|Overall Study|Adverse Event|1
5154339|NCT01441063|17800149|P1|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
5154340|NCT01441063|17800149|P1|Tocilizumab Alone|Required AZT/VGC addition|3
5154341|NCT01440972|17800184|P2|Overall Study|Withdrawal by Subject|2
5154342|NCT01440972|17800185|P1|Overall Study|Withdrawal by Subject|3
5154343|NCT01440946|17800209|P2|Overall Study|Physician Decision|0
5154344|NCT01440946|17800210|P1|Overall Study|Physician Decision|1
5154345|NCT01440946|17800209|P2|Overall Study|Lost to Follow-up|1
5154346|NCT01440946|17800210|P1|Overall Study|Lost to Follow-up|1
5154347|NCT01440881|17800249|P2|Overall Study|Death|1
5154348|NCT01440881|17800250|P1|Overall Study|Death|0
5154349|NCT01440816|17800264|P2|Overall Study|To Be Seen By Local Oncologist|2
5154350|NCT01440816|17800265|P1|Overall Study|To Be Seen By Local Oncologist|1
5154351|NCT01440816|17800264|P2|Overall Study|Disease Progression|9
5154352|NCT01440816|17800265|P1|Overall Study|Disease Progression|0
5154353|NCT01440803|17800281|P2|Overall Study|Withdrawal by Subject|1
5154354|NCT01440803|17800282|P1|Overall Study|Withdrawal by Subject|0
5154355|NCT01440803|17800281|P2|Overall Study|Lost to Follow-up|2
5154356|NCT01440803|17800282|P1|Overall Study|Lost to Follow-up|0
5154357|NCT01440803|17800281|P2|Overall Study|Met study stopping rule|1
5154358|NCT01440803|17800282|P1|Overall Study|Met study stopping rule|2
5154359|NCT01440647|17800318|P2|Overall Study|Death|3
5154360|NCT01440647|17800319|P1|Overall Study|Death|2
5154361|NCT01440595|17800338|P3|Overall Study|Study terminated by sponsor.|1
5154362|NCT01440595|17800339|P2|Overall Study|Study terminated by sponsor.|2
5154363|NCT01440595|17800340|P1|Overall Study|Study terminated by sponsor.|1
5154364|NCT01440595|17800338|P3|Overall Study|Lost to Follow-up|0
5154365|NCT01440595|17800339|P2|Overall Study|Lost to Follow-up|1
5154366|NCT01440595|17800340|P1|Overall Study|Lost to Follow-up|0
5154367|NCT01440569|17800360|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
5154368|NCT01440569|17800361|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
5154369|NCT01440569|17800360|P2|Open-Label Rollover Phase|Lost to Follow-up|3
5154370|NCT01440569|17800361|P1|Open-Label Rollover Phase|Lost to Follow-up|26
5154371|NCT01440569|17800360|P2|Open-Label Rollover Phase|Withdrew Consent|1
5154372|NCT01440569|17800361|P1|Open-Label Rollover Phase|Withdrew Consent|11
5154373|NCT01440569|17800360|P2|Open-Label Rollover Phase|Investigator's Discretion|1
5154374|NCT01440569|17800361|P1|Open-Label Rollover Phase|Investigator's Discretion|3
5154375|NCT01440569|17800360|P2|Open-Label Rollover Phase|Lack of Efficacy|0
5154376|NCT01440569|17800361|P1|Open-Label Rollover Phase|Lack of Efficacy|2
5154377|NCT01440569|17800360|P2|Open-Label Rollover Phase|Pregnancy|0
5154378|NCT01440569|17800361|P1|Open-Label Rollover Phase|Pregnancy|1
5154379|NCT01440569|17800360|P2|Open-Label Rollover Phase|Adverse Event|0
5154380|NCT01440569|17800361|P1|Open-Label Rollover Phase|Adverse Event|3
5154381|NCT01440569|17800360|P2|Main Study|Protocol Violation|0
5154382|NCT01440569|17800361|P1|Main Study|Protocol Violation|1
5154383|NCT01440569|17800360|P2|Main Study|Subject Non-Compliance|0
5154384|NCT01440569|17800361|P1|Main Study|Subject Non-Compliance|3
5154385|NCT01440569|17800360|P2|Main Study|Lost to Follow-up|2
5154386|NCT01440569|17800361|P1|Main Study|Lost to Follow-up|13
5154387|NCT01440569|17800360|P2|Main Study|Withdrew Consent|1
5154388|NCT01440569|17800361|P1|Main Study|Withdrew Consent|7
5154389|NCT01440569|17800360|P2|Main Study|Investigator's Discretion|1
5154390|NCT01440569|17800361|P1|Main Study|Investigator's Discretion|1
5154391|NCT01440569|17800360|P2|Main Study|Pregnancy|0
5154392|NCT01440569|17800361|P1|Main Study|Pregnancy|1
5154393|NCT01440569|17800360|P2|Main Study|Adverse Event|0
5154394|NCT01440569|17800361|P1|Main Study|Adverse Event|9
5154395|NCT01440569|17800360|P2|Main Study|Enrolled but not treated|0
5154396|NCT01440569|17800361|P1|Main Study|Enrolled but not treated|1
5154397|NCT01440517|17800396|P1|Overall Study|Subject withdrawn prior to dosing|1
5154398|NCT01440374|17800472|P4|Part 3: Extension|Physician Decision|14
5154399|NCT01440374|17800473|P3|Part 3: Extension|Physician Decision|0
5154400|NCT01440374|17800474|P2|Part 3: Extension|Physician Decision|0
5154401|NCT01440374|17800475|P1|Part 3: Extension|Physician Decision|0
5154402|NCT01440374|17800472|P4|Part 3: Extension|Adverse Event|13
5154403|NCT01440374|17800473|P3|Part 3: Extension|Adverse Event|0
5154404|NCT01440374|17800474|P2|Part 3: Extension|Adverse Event|0
5154405|NCT01440374|17800475|P1|Part 3: Extension|Adverse Event|0
5154406|NCT01440374|17800472|P4|Part 3: Extension|Withdrawal by Subject|5
5154407|NCT01440374|17800473|P3|Part 3: Extension|Withdrawal by Subject|0
5154408|NCT01440374|17800474|P2|Part 3: Extension|Withdrawal by Subject|0
5154409|NCT01440374|17800475|P1|Part 3: Extension|Withdrawal by Subject|0
5154410|NCT01440374|17800472|P4|Part 2; Double-blind Phase|Not treated|0
5154411|NCT01440374|17800473|P3|Part 2; Double-blind Phase|Not treated|1
5154412|NCT01440374|17800474|P2|Part 2; Double-blind Phase|Not treated|0
5154413|NCT01440374|17800475|P1|Part 2; Double-blind Phase|Not treated|0
5154414|NCT01440374|17800472|P4|Part 2; Double-blind Phase|Adverse Event|0
5154415|NCT01440374|17800473|P3|Part 2; Double-blind Phase|Adverse Event|31
5154416|NCT01440374|17800474|P2|Part 2; Double-blind Phase|Adverse Event|7
5154417|NCT01440374|17800475|P1|Part 2; Double-blind Phase|Adverse Event|0
5154418|NCT01440374|17800472|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
5154419|NCT01440374|17800473|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
5154420|NCT01440374|17800474|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
5154421|NCT01440374|17800475|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
5154422|NCT01440374|17800472|P4|Part 2; Double-blind Phase|Protocol Violation|0
5154423|NCT01440374|17800473|P3|Part 2; Double-blind Phase|Protocol Violation|1
5154424|NCT01440374|17800474|P2|Part 2; Double-blind Phase|Protocol Violation|0
5154425|NCT01440374|17800475|P1|Part 2; Double-blind Phase|Protocol Violation|0
5154426|NCT01440374|17800472|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
5154427|NCT01440374|17800473|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
5154428|NCT01440374|17800474|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
5154429|NCT01440374|17800475|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
5154430|NCT01440374|17800472|P4|Part 2; Double-blind Phase|Physician Decision|0
5154431|NCT01440374|17800473|P3|Part 2; Double-blind Phase|Physician Decision|17
5154432|NCT01440374|17800474|P2|Part 2; Double-blind Phase|Physician Decision|8
5154433|NCT01440374|17800475|P1|Part 2; Double-blind Phase|Physician Decision|0
5154434|NCT01440374|17800472|P4|Part 1: Open-label Phase|Physician Decision|0
5154435|NCT01440374|17800473|P3|Part 1: Open-label Phase|Physician Decision|0
5154436|NCT01440374|17800474|P2|Part 1: Open-label Phase|Physician Decision|0
5154437|NCT01440374|17800475|P1|Part 1: Open-label Phase|Physician Decision|1
5154438|NCT01440374|17800472|P4|Part 1: Open-label Phase|Adverse Event|0
5154439|NCT01440374|17800473|P3|Part 1: Open-label Phase|Adverse Event|0
5154440|NCT01440374|17800474|P2|Part 1: Open-label Phase|Adverse Event|0
5154441|NCT01440374|17800475|P1|Part 1: Open-label Phase|Adverse Event|5
5154442|NCT01440322|17800510|P2|Overall Study|Other Non-Product Related|0
5154443|NCT01440322|17800511|P1|Overall Study|Other Non-Product Related|1
5154444|NCT01440322|17800510|P2|Overall Study|Unrelated Medical Problem|1
5154445|NCT01440322|17800511|P1|Overall Study|Unrelated Medical Problem|0
5154446|NCT01440322|17800510|P2|Overall Study|Other Product Related|0
5154447|NCT01440322|17800511|P1|Overall Study|Other Product Related|1
5154448|NCT01440322|17800510|P2|Overall Study|Unacceptable Subjective Vision|0
5154449|NCT01440322|17800511|P1|Overall Study|Unacceptable Subjective Vision|1
5154450|NCT01440322|17800510|P2|Overall Study|Symptoms and Problems|0
5154451|NCT01440322|17800511|P1|Overall Study|Symptoms and Problems|1
5154452|NCT01440322|17800510|P2|Overall Study|Biomicroscopy|0
5154453|NCT01440322|17800511|P1|Overall Study|Biomicroscopy|1
5154454|NCT01440322|17800510|P2|Overall Study|Discomfort|0
5154455|NCT01440322|17800511|P1|Overall Study|Discomfort|2
5154456|NCT01440283|17800533|P1|Overall Study|Physician Decision|3
5154457|NCT01440283|17800533|P1|Overall Study|Withdrawal by Subject|4
5154458|NCT01440283|17800533|P1|Overall Study|Death|3
5154459|NCT01440101|17800548|P3|Overall Study|Other|0
5154460|NCT01440101|17800549|P2|Overall Study|Other|1
5154461|NCT01440101|17800550|P1|Overall Study|Other|0
5154462|NCT01440101|17800548|P3|Overall Study|Withdrawal by Subject|1
5154463|NCT01440101|17800549|P2|Overall Study|Withdrawal by Subject|3
5154464|NCT01440101|17800550|P1|Overall Study|Withdrawal by Subject|0
5154465|NCT01440101|17800548|P3|Overall Study|Adverse Event|0
5154466|NCT01440101|17800549|P2|Overall Study|Adverse Event|0
5154467|NCT01440101|17800550|P1|Overall Study|Adverse Event|2
5154468|NCT01440049|17800583|P1|Overall Study|Adverse Event|5
5154469|NCT01439971|17800615|P5|Overall Study|Required number in cohort dosed|1
5154470|NCT01439971|17800616|P4|Overall Study|Required number in cohort dosed|0
5154471|NCT01439971|17800617|P3|Overall Study|Required number in cohort dosed|2
5154472|NCT01439971|17800618|P2|Overall Study|Required number in cohort dosed|1
5154473|NCT01439971|17800619|P1|Overall Study|Required number in cohort dosed|0
5154474|NCT01439945|17800799|P4|Double-Blind Treatment Phase|Ineligible|1
5154475|NCT01439945|17800800|P3|Double-Blind Treatment Phase|Ineligible|0
5154476|NCT01439945|17800801|P2|Double-Blind Treatment Phase|Ineligible|2
5154477|NCT01439945|17800802|P1|Double-Blind Treatment Phase|Ineligible|1
5154478|NCT01439945|17800799|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
5154479|NCT01439945|17800800|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
5154480|NCT01439945|17800801|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
5154481|NCT01439945|17800802|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
5154482|NCT01439880|17800827|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
5154483|NCT01439880|17800828|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
5154484|NCT01439880|17800827|P2|All-IP Period (Years 2 to 5)|Other|31
5154485|NCT01439880|17800828|P1|All-IP Period (Years 2 to 5)|Other|14
5154486|NCT01439880|17800827|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
5154487|NCT01439880|17800828|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
5154488|NCT01439880|17800827|P2|All-IP Period (Years 2 to 5)|Death|13
5154489|NCT01439880|17800828|P1|All-IP Period (Years 2 to 5)|Death|3
5154490|NCT01439880|17800827|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
5154491|NCT01439880|17800828|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
5154492|NCT01439880|17800827|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
5154493|NCT01439880|17800828|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
5154494|NCT01439880|17800827|P2|SOC-controlled Period (Year 1)|Reason Missing|2
5154495|NCT01439880|17800828|P1|SOC-controlled Period (Year 1)|Reason Missing|0
5154496|NCT01439880|17800827|P2|SOC-controlled Period (Year 1)|Other|13
5154497|NCT01439880|17800828|P1|SOC-controlled Period (Year 1)|Other|8
5154498|NCT01439880|17800827|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
5154499|NCT01439880|17800828|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
5154500|NCT01439880|17800827|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
5154501|NCT01439880|17800828|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
5154502|NCT01439880|17800827|P2|SOC-controlled Period (Year 1)|Death|1
5154503|NCT01439880|17800828|P1|SOC-controlled Period (Year 1)|Death|2
5154504|NCT01439880|17800827|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
5154505|NCT01439880|17800828|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
5154506|NCT01439867|17800871|P2|Overall Study|Protocol-specified Criteria|0
5154507|NCT01439867|17800872|P1|Overall Study|Protocol-specified Criteria|1
5154508|NCT01439867|17800871|P2|Overall Study|Administrative Decision|5
5154509|NCT01439867|17800872|P1|Overall Study|Administrative Decision|4
5154510|NCT01439867|17800871|P2|Overall Study|Withdrawal by Subject|2
5154511|NCT01439867|17800872|P1|Overall Study|Withdrawal by Subject|1
5154512|NCT01439867|17800871|P2|Overall Study|Non-compliance|1
5154513|NCT01439867|17800872|P1|Overall Study|Non-compliance|0
5154514|NCT01439724|17800924|P2|Overall Study|missing consultation|8
5154515|NCT01439724|17800925|P1|Overall Study|missing consultation|9
5154516|NCT01439711|17800931|P1|Overall Study|No MRI|9
5154517|NCT01439711|17800931|P1|Overall Study|Noncompliance|3
5154518|NCT01439711|17800931|P1|Overall Study|Progression During Active Tx|3
5154519|NCT01439711|17800931|P1|Overall Study|Withdrawal by Subject|3
5154520|NCT01439711|17800931|P1|Overall Study|Adverse Event|5
5154521|NCT01439711|17800931|P1|Overall Study|Progression Prior to Beginning Tx|1
5154522|NCT01439711|17800931|P1|Overall Study|Cancel|3
5154523|NCT01439711|17800931|P1|Overall Study|Ineligible|13
5154524|NCT01439568|17800969|P2|Overall Study|Withdrawal by Subject|2
5154525|NCT01439568|17800970|P1|Overall Study|Withdrawal by Subject|2
5154526|NCT01439568|17800969|P2|Overall Study|Lost to Follow-up|0
5154527|NCT01439568|17800970|P1|Overall Study|Lost to Follow-up|1
5154528|NCT01439555|17800982|P1|Overall Study|Protocol Violation|1
5154529|NCT01439373|17800994|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
5154530|NCT01439373|17800995|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
5154531|NCT01439373|17800994|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
5154532|NCT01439373|17800995|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
5154533|NCT01439360|17801038|P2|Overall Study|Withdrawal by Subject|129
5154534|NCT01439360|17801039|P1|Overall Study|Withdrawal by Subject|140
5154535|NCT01439360|17801038|P2|Overall Study|Protocol Violation|0
5154536|NCT01439360|17801039|P1|Overall Study|Protocol Violation|1
5154537|NCT01439360|17801038|P2|Overall Study|Others|5
5154538|NCT01439360|17801039|P1|Overall Study|Others|10
5154539|NCT01439360|17801038|P2|Overall Study|Lost to Follow-up|58
5154540|NCT01439360|17801039|P1|Overall Study|Lost to Follow-up|43
5154541|NCT01439360|17801038|P2|Overall Study|Adverse Event|16
5154542|NCT01439360|17801039|P1|Overall Study|Adverse Event|4
5154543|NCT01439282|17801089|P2|Overall Study|Other|1
5154544|NCT01439282|17801090|P1|Overall Study|Other|1
5154545|NCT01439282|17801089|P2|Overall Study|Withdrawal by Subject|0
5154546|NCT01439282|17801090|P1|Overall Study|Withdrawal by Subject|2
5154547|NCT01439282|17801089|P2|Overall Study|Adverse Event|0
5154548|NCT01439282|17801090|P1|Overall Study|Adverse Event|5
5154549|NCT01439204|17801102|P2|Overall Study|poor/non-compliance|0
5154550|NCT01439204|17801103|P1|Overall Study|poor/non-compliance|3
5154551|NCT01439204|17801102|P2|Overall Study|No longer meets study criteria|0
5154552|NCT01439204|17801103|P1|Overall Study|No longer meets study criteria|1
5154553|NCT01439204|17801102|P2|Overall Study|Lost to Follow-up|2
5154554|NCT01439204|17801103|P1|Overall Study|Lost to Follow-up|0
5154555|NCT01439204|17801102|P2|Overall Study|Withdrawal by Subject|1
5154556|NCT01439204|17801103|P1|Overall Study|Withdrawal by Subject|0
5154557|NCT01439165|17801137|P2|Overall Study|Withdrawal by Subject|1
5154558|NCT01439165|17801138|P1|Overall Study|Withdrawal by Subject|7
5154559|NCT01439165|17801137|P2|Overall Study|Lost to Follow-up|1
5154560|NCT01439165|17801138|P1|Overall Study|Lost to Follow-up|11
5154561|NCT01439165|17801137|P2|Overall Study|Protocol Violation|0
5154562|NCT01439165|17801138|P1|Overall Study|Protocol Violation|3
5154563|NCT01439126|17801152|P2|Overall Study|Other-Miscellaneous|12
5154564|NCT01439126|17801153|P1|Overall Study|Other-Miscellaneous|12
5154565|NCT01439126|17801152|P2|Overall Study|Other-Use of prohibited treatment|2
5154566|NCT01439126|17801153|P1|Overall Study|Other-Use of prohibited treatment|0
5154567|NCT01439126|17801152|P2|Overall Study|Lost to Follow-up|3
5154568|NCT01439126|17801153|P1|Overall Study|Lost to Follow-up|6
5154569|NCT01439126|17801152|P2|Overall Study|Protocol Violation|4
5154570|NCT01439126|17801153|P1|Overall Study|Protocol Violation|6
5154571|NCT01439126|17801152|P2|Overall Study|Withdrawal by Subject|21
5154572|NCT01439126|17801153|P1|Overall Study|Withdrawal by Subject|5
5154573|NCT01439126|17801152|P2|Overall Study|Adverse Event|0
5154574|NCT01439126|17801153|P1|Overall Study|Adverse Event|2
5154575|NCT01439074|17801179|P2|Overall Study|Other|4
5154576|NCT01439074|17801180|P1|Overall Study|Other|4
5154577|NCT01439074|17801179|P2|Overall Study|Withdrawal by Subject|5
5154578|NCT01439074|17801180|P1|Overall Study|Withdrawal by Subject|1
5154579|NCT01439074|17801179|P2|Overall Study|Subject shedding|0
5154580|NCT01439074|17801180|P1|Overall Study|Subject shedding|1
5154581|NCT01439074|17801179|P2|Overall Study|Lost to Follow-up|4
5154582|NCT01439074|17801180|P1|Overall Study|Lost to Follow-up|3
5154583|NCT01439009|17801198|P2|Overall Study|Deviation of exclusion criteria|0
5154584|NCT01439009|17801199|P1|Overall Study|Deviation of exclusion criteria|1
5154585|NCT01439009|17801198|P2|Overall Study|Protocol Violation|0
5154586|NCT01439009|17801199|P1|Overall Study|Protocol Violation|2
5154587|NCT01439009|17801198|P2|Overall Study|Physician Decision|3
5154588|NCT01439009|17801199|P1|Overall Study|Physician Decision|5
5154589|NCT01438996|17801232|P3|Overall Study|Not meeting Inclusion Criteria|0
5154590|NCT01438996|17801233|P2|Overall Study|Not meeting Inclusion Criteria|1
5154591|NCT01438996|17801234|P1|Overall Study|Not meeting Inclusion Criteria|4
5154592|NCT01438840|17801268|P3|Extension Phase|Other|1
5154593|NCT01438840|17801269|P2|Extension Phase|Other|0
5154594|NCT01438840|17801270|P1|Extension Phase|Other|0
5154595|NCT01438840|17801268|P3|Extension Phase|Lack of Efficacy|2
5154596|NCT01438840|17801269|P2|Extension Phase|Lack of Efficacy|0
5154597|NCT01438840|17801270|P1|Extension Phase|Lack of Efficacy|0
5154598|NCT01438840|17801268|P3|Extension Phase|Withdrawal by Subject|3
5154599|NCT01438840|17801269|P2|Extension Phase|Withdrawal by Subject|0
5154600|NCT01438840|17801270|P1|Extension Phase|Withdrawal by Subject|0
5154601|NCT01438840|17801268|P3|Extension Phase|Lost to Follow-up|1
5154602|NCT01438840|17801269|P2|Extension Phase|Lost to Follow-up|0
5154603|NCT01438840|17801270|P1|Extension Phase|Lost to Follow-up|0
5154604|NCT01438840|17801268|P3|Extension Phase|Adverse Event|3
5154605|NCT01438840|17801269|P2|Extension Phase|Adverse Event|0
5154606|NCT01438840|17801270|P1|Extension Phase|Adverse Event|0
5154607|NCT01438840|17801268|P3|Core Study|Withdrawal of consent|0
5154608|NCT01438840|17801269|P2|Core Study|Withdrawal of consent|0
5154609|NCT01438840|17801270|P1|Core Study|Withdrawal of consent|1
5154610|NCT01438840|17801268|P3|Core Study|Lack of Efficacy|0
5154611|NCT01438840|17801269|P2|Core Study|Lack of Efficacy|7
5154612|NCT01438840|17801270|P1|Core Study|Lack of Efficacy|15
5154613|NCT01438840|17801268|P3|Core Study|Adverse Event|0
5154614|NCT01438840|17801269|P2|Core Study|Adverse Event|3
5154615|NCT01438840|17801270|P1|Core Study|Adverse Event|0
5154616|NCT01438814|17801283|P2|Overall Study|Other|4
5154617|NCT01438814|17801284|P1|Overall Study|Other|2
5154618|NCT01438814|17801283|P2|Overall Study|Withdrawal by Subject|2
5154619|NCT01438814|17801284|P1|Overall Study|Withdrawal by Subject|4
5154620|NCT01438814|17801283|P2|Overall Study|Lost to Follow-up|3
5154621|NCT01438814|17801284|P1|Overall Study|Lost to Follow-up|4
5154622|NCT01438814|17801283|P2|Overall Study|Protocol Violation|2
5154623|NCT01438814|17801284|P1|Overall Study|Protocol Violation|1
5154624|NCT01438814|17801283|P2|Overall Study|Adverse Event|3
5154625|NCT01438814|17801284|P1|Overall Study|Adverse Event|3
5154626|NCT01438541|17801320|P1|Overall Study|discharge from the hospital|5
5154627|NCT01438541|17801320|P1|Overall Study|Withdrawal by Subject|1
5154628|NCT01438541|17801320|P1|Overall Study|Physician Decision|1
5154629|NCT01438489|17801329|P3|Overall Study|Inadequate venous access|0
5154630|NCT01438489|17801330|P2|Overall Study|Inadequate venous access|2
5154631|NCT01438489|17801331|P1|Overall Study|Inadequate venous access|0
5154632|NCT01438489|17801329|P3|Overall Study|Did not complete all 3 follow-up visits|2
5154633|NCT01438489|17801330|P2|Overall Study|Did not complete all 3 follow-up visits|5
5154634|NCT01438489|17801331|P1|Overall Study|Did not complete all 3 follow-up visits|2
5154635|NCT01438489|17801329|P3|Overall Study|Received prohibited medication|0
5154636|NCT01438489|17801330|P2|Overall Study|Received prohibited medication|0
5154637|NCT01438489|17801331|P1|Overall Study|Received prohibited medication|1
5154638|NCT01438489|17801329|P3|Overall Study|AE/SAEs|1
5154639|NCT01438489|17801330|P2|Overall Study|AE/SAEs|1
5154640|NCT01438489|17801331|P1|Overall Study|AE/SAEs|2
5154641|NCT01438489|17801329|P3|Overall Study|Investigator decision|0
5154642|NCT01438489|17801330|P2|Overall Study|Investigator decision|1
5154643|NCT01438489|17801331|P1|Overall Study|Investigator decision|0
5154644|NCT01438489|17801329|P3|Overall Study|Subject choice/Subject moved|1
5154645|NCT01438489|17801330|P2|Overall Study|Subject choice/Subject moved|1
5154646|NCT01438489|17801331|P1|Overall Study|Subject choice/Subject moved|2
5154647|NCT01438489|17801329|P3|Overall Study|Sponsor decision|4
5154648|NCT01438489|17801330|P2|Overall Study|Sponsor decision|1
5154649|NCT01438489|17801331|P1|Overall Study|Sponsor decision|4
5154650|NCT01438489|17801329|P3|Overall Study|Death|1
5154651|NCT01438489|17801330|P2|Overall Study|Death|0
5154652|NCT01438489|17801331|P1|Overall Study|Death|0
5154653|NCT01438489|17801329|P3|Overall Study|Withdrawal by Subject|8
5154654|NCT01438489|17801330|P2|Overall Study|Withdrawal by Subject|3
5154655|NCT01438489|17801331|P1|Overall Study|Withdrawal by Subject|11
5154656|NCT01438489|17801329|P3|Overall Study|Lost to Follow-up|2
5154657|NCT01438489|17801330|P2|Overall Study|Lost to Follow-up|2
5154658|NCT01438489|17801331|P1|Overall Study|Lost to Follow-up|4
5154659|NCT01438476|17801376|P2|Overall Study|Communication barrier|1
5154660|NCT01438476|17801377|P1|Overall Study|Communication barrier|0
5154661|NCT01438476|17801376|P2|Overall Study|No Surgery- Disease|10
5154662|NCT01438476|17801377|P1|Overall Study|No Surgery- Disease|8
5154663|NCT01438476|17801376|P2|Overall Study|Withdrawal by Subject|0
5154664|NCT01438476|17801377|P1|Overall Study|Withdrawal by Subject|1
5154665|NCT01438476|17801376|P2|Overall Study|Protocol Violation|0
5154666|NCT01438476|17801377|P1|Overall Study|Protocol Violation|1
5154667|NCT01438424|17801383|P1|Overall Study|Participant noncompliance|20
5154668|NCT01438424|17801383|P1|Overall Study|No longer met inclusion criteria|1
5154669|NCT01438424|17801383|P1|Overall Study|Pregnancy|7
5154670|NCT01438424|17801383|P1|Overall Study|Need for drug prohibited by protocol|14
5154671|NCT01438424|17801383|P1|Overall Study|Abnormal laboratory test result|14
5154672|NCT01438424|17801383|P1|Overall Study|Lost to Follow-up|17
5154673|NCT01438424|17801383|P1|Overall Study|Adverse Event|17
5154674|NCT01438424|17801383|P1|Overall Study|Death|22
5154675|NCT01438424|17801383|P1|Overall Study|Progression of chronic hepatitis B|22
5154676|NCT01438424|17801383|P1|Overall Study|Withdrawal by Subject|104
5154677|NCT01438424|17801383|P1|Overall Study|Not identified|55
5154678|NCT01438424|17801383|P1|Overall Study|Minimal virologic response|95
5154679|NCT01438424|17801383|P1|Overall Study|Continuing treatment|29
5154680|NCT01438411|17801419|P1|Overall Study|Withdrawal by Subject|3
5154681|NCT01438411|17801419|P1|Overall Study|Lack of Efficacy|1
5154682|NCT01438411|17801419|P1|Overall Study|Lost to Follow-up|1
5154683|NCT01438411|17801419|P1|Overall Study|Adverse Event|8
5154684|NCT01438307|17801434|P2|Overall Study|Death|1
5154685|NCT01438307|17801435|P1|Overall Study|Death|1
5154686|NCT01438294|17801449|P2|Overall Study|Lost to Follow-up|7
5154687|NCT01438294|17801450|P1|Overall Study|Lost to Follow-up|3
5154688|NCT01438177|17801493|P1|Overall Study|Initiation of new therapy|1
5154689|NCT01438177|17801493|P1|Overall Study|Withdrawal by Subject|1
5154690|NCT01438151|17801500|P1|Overall Study|study terminated|8
5154691|NCT01438060|17801506|P2|On Study Beyond Week 140|Other Reason|3
5154692|NCT01438060|17801507|P1|On Study Beyond Week 140|Other Reason|0
5154693|NCT01438060|17801506|P2|On Study Beyond Week 140|Death|1
5154694|NCT01438060|17801507|P1|On Study Beyond Week 140|Death|0
5154695|NCT01438060|17801506|P2|On Study Beyond Week 140|Withdrawal by Subject|1
5154696|NCT01438060|17801507|P1|On Study Beyond Week 140|Withdrawal by Subject|0
5154697|NCT01438060|17801506|P2|On Study Beyond Week 140|Lack of Efficacy|1
5154698|NCT01438060|17801507|P1|On Study Beyond Week 140|Lack of Efficacy|0
5154699|NCT01438060|17801506|P2|On Study Beyond Week 140|Adverse Event|2
5154700|NCT01438060|17801507|P1|On Study Beyond Week 140|Adverse Event|0
5154701|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
5154702|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
5154703|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Death|12
5154704|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Death|22
5154705|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
5154706|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
5154707|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
5154708|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
5154709|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
5154710|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
5154711|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
5154712|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
5154713|NCT01438060|17801506|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
5154714|NCT01438060|17801507|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
5154715|NCT01438060|17801506|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
5154716|NCT01438060|17801507|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
5154717|NCT01438060|17801506|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
5154718|NCT01438060|17801507|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
5154719|NCT01438060|17801506|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
5154720|NCT01438060|17801507|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
5154721|NCT01438060|17801506|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
5154722|NCT01438060|17801507|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
5154723|NCT01438060|17801506|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
5154724|NCT01438060|17801507|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
5154725|NCT01438060|17801506|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
5154726|NCT01438060|17801507|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
5154727|NCT01437995|17801599|P3|Overall Study|Lost to Follow-up|20
5154728|NCT01437995|17801600|P2|Overall Study|Lost to Follow-up|18
5154729|NCT01437995|17801601|P1|Overall Study|Lost to Follow-up|11
5154730|NCT01437943|17801623|P2|Overall Study|Adverse Event|0
5154731|NCT01437943|17801624|P1|Overall Study|Adverse Event|2
5154732|NCT01437943|17801623|P2|Overall Study|Subject expressed pregnancy plans|0
5154733|NCT01437943|17801624|P1|Overall Study|Subject expressed pregnancy plans|1
5154734|NCT01437943|17801623|P2|Overall Study|Aliskiren trials terminated by Novartis|2
5154735|NCT01437943|17801624|P1|Overall Study|Aliskiren trials terminated by Novartis|4
5154736|NCT01437878|17801632|P2|Overall Study|Withdrawal by Subject|0
5154737|NCT01437878|17801633|P1|Overall Study|Withdrawal by Subject|1
5154738|NCT01437540|17801700|P2|Overall Study|Withdrawal by Subject|15
5154739|NCT01437540|17801701|P1|Overall Study|Withdrawal by Subject|31
5154740|NCT01437540|17801700|P2|Overall Study|Adverse Event|13
5154741|NCT01437540|17801701|P1|Overall Study|Adverse Event|26
5154742|NCT01437540|17801700|P2|Overall Study|Protocol Violation|12
5154743|NCT01437540|17801701|P1|Overall Study|Protocol Violation|24
5154744|NCT01437540|17801700|P2|Overall Study|Lack of Efficacy|11
5154745|NCT01437540|17801701|P1|Overall Study|Lack of Efficacy|23
5154746|NCT01437540|17801700|P2|Overall Study|Lost to Follow-up|5
5154747|NCT01437540|17801701|P1|Overall Study|Lost to Follow-up|3
5154748|NCT01437540|17801700|P2|Overall Study|COPD exacerbation|3
5154749|NCT01437540|17801701|P1|Overall Study|COPD exacerbation|13
5154750|NCT01437540|17801700|P2|Overall Study|Not listed below|6
5154751|NCT01437540|17801701|P1|Overall Study|Not listed below|7
5154752|NCT01437423|17801738|P1|Overall Study|Off label usage|3
5154753|NCT01437423|17801738|P1|Overall Study|Lost to Follow-up|12
5154754|NCT01437397|17801750|P5|Overall Study|Site termination/COPD exacerbation/other|14
5154755|NCT01437397|17801751|P4|Overall Study|Site termination/COPD exacerbation/other|9
5154756|NCT01437397|17801752|P3|Overall Study|Site termination/COPD exacerbation/other|9
5154757|NCT01437397|17801753|P2|Overall Study|Site termination/COPD exacerbation/other|8
5154758|NCT01437397|17801754|P1|Overall Study|Site termination/COPD exacerbation/other|10
5154759|NCT01437397|17801750|P5|Overall Study|Adverse Event|21
5154760|NCT01437397|17801751|P4|Overall Study|Adverse Event|14
5154761|NCT01437397|17801752|P3|Overall Study|Adverse Event|16
5154762|NCT01437397|17801753|P2|Overall Study|Adverse Event|22
5154763|NCT01437397|17801754|P1|Overall Study|Adverse Event|21
5154764|NCT01437397|17801750|P5|Overall Study|Lack of Efficacy|20
5154765|NCT01437397|17801751|P4|Overall Study|Lack of Efficacy|10
5154766|NCT01437397|17801752|P3|Overall Study|Lack of Efficacy|8
5154767|NCT01437397|17801753|P2|Overall Study|Lack of Efficacy|4
5154768|NCT01437397|17801754|P1|Overall Study|Lack of Efficacy|5
5154769|NCT01437397|17801750|P5|Overall Study|Protocol Violation|19
5154770|NCT01437397|17801751|P4|Overall Study|Protocol Violation|21
5154771|NCT01437397|17801752|P3|Overall Study|Protocol Violation|13
5154772|NCT01437397|17801753|P2|Overall Study|Protocol Violation|12
5154773|NCT01437397|17801754|P1|Overall Study|Protocol Violation|10
5154774|NCT01437397|17801750|P5|Overall Study|Withdrawal by Subject|22
5154775|NCT01437397|17801751|P4|Overall Study|Withdrawal by Subject|11
5154776|NCT01437397|17801752|P3|Overall Study|Withdrawal by Subject|24
5154777|NCT01437397|17801753|P2|Overall Study|Withdrawal by Subject|12
5154778|NCT01437397|17801754|P1|Overall Study|Withdrawal by Subject|11
5154779|NCT01437397|17801750|P5|Overall Study|Lost to Follow-up|5
5154780|NCT01437397|17801751|P4|Overall Study|Lost to Follow-up|4
5154781|NCT01437397|17801752|P3|Overall Study|Lost to Follow-up|2
5154782|NCT01437397|17801753|P2|Overall Study|Lost to Follow-up|4
5154783|NCT01437397|17801754|P1|Overall Study|Lost to Follow-up|9
5154784|NCT01437319|17801781|P3|Phase II|Protocol Violation|0
5154785|NCT01437319|17801782|P2|Phase II|Protocol Violation|1
5154786|NCT01437319|17801783|P1|Phase II|Protocol Violation|0
5154787|NCT01437319|17801781|P3|Phase II|Study related symptoms/complaints|19
5154788|NCT01437319|17801782|P2|Phase II|Study related symptoms/complaints|28
5154789|NCT01437319|17801783|P1|Phase II|Study related symptoms/complaints|0
5154790|NCT01437319|17801781|P3|Phase II|Lost to Follow-up|2
5154791|NCT01437319|17801782|P2|Phase II|Lost to Follow-up|7
5154792|NCT01437319|17801783|P1|Phase II|Lost to Follow-up|0
5154793|NCT01437319|17801781|P3|Phase II|Withdrawal by Subject|16
5154794|NCT01437319|17801782|P2|Phase II|Withdrawal by Subject|8
5154795|NCT01437319|17801783|P1|Phase II|Withdrawal by Subject|0
5154796|NCT01437319|17801781|P3|Phase I|Withdrawal by Subject|0
5154797|NCT01437319|17801782|P2|Phase I|Withdrawal by Subject|0
5154798|NCT01437319|17801783|P1|Phase I|Withdrawal by Subject|25
5154799|NCT01437319|17801781|P3|Phase I|Study related symptoms/complaints|0
5154800|NCT01437319|17801782|P2|Phase I|Study related symptoms/complaints|0
5154801|NCT01437319|17801783|P1|Phase I|Study related symptoms/complaints|27
5154802|NCT01437319|17801781|P3|Phase I|Protocol Violation|0
5154803|NCT01437319|17801782|P2|Phase I|Protocol Violation|0
5154804|NCT01437319|17801783|P1|Phase I|Protocol Violation|1
5154805|NCT01437319|17801781|P3|Phase I|Lost to Follow-up|0
5154806|NCT01437319|17801782|P2|Phase I|Lost to Follow-up|0
5154807|NCT01437319|17801783|P1|Phase I|Lost to Follow-up|2
5154808|NCT01437267|17801798|P6|Overall Study|Protocol Violation|0
5154809|NCT01437267|17801799|P5|Overall Study|Protocol Violation|0
5154810|NCT01437267|17801800|P4|Overall Study|Protocol Violation|0
5154811|NCT01437267|17801801|P3|Overall Study|Protocol Violation|0
5154812|NCT01437267|17801802|P2|Overall Study|Protocol Violation|1
5154813|NCT01437267|17801803|P1|Overall Study|Protocol Violation|0
5154814|NCT01437267|17801798|P6|Overall Study|Withdrawal by Subject|0
5154815|NCT01437267|17801799|P5|Overall Study|Withdrawal by Subject|0
5154816|NCT01437267|17801800|P4|Overall Study|Withdrawal by Subject|1
5154817|NCT01437267|17801801|P3|Overall Study|Withdrawal by Subject|0
5154818|NCT01437267|17801802|P2|Overall Study|Withdrawal by Subject|0
5154819|NCT01437267|17801803|P1|Overall Study|Withdrawal by Subject|0
5154820|NCT01437111|17801846|P1|Overall Study|Protocol Violation|1
5154821|NCT01437111|17801846|P1|Overall Study|Lost to Follow-up|5
5154822|NCT01437111|17801846|P1|Overall Study|Physician Decision|1
5154823|NCT01437111|17801846|P1|Overall Study|Not reported|5
5154824|NCT01437111|17801846|P1|Overall Study|Withdrawal by Subject|4
5154825|NCT01437111|17801846|P1|Overall Study|Adverse Event|2
5154826|NCT01436643|17801924|P4|Core Phase (16 Weeks)|Protocol Violation|0
5154827|NCT01436643|17801925|P3|Core Phase (16 Weeks)|Protocol Violation|1
5154828|NCT01436643|17801926|P2|Core Phase (16 Weeks)|Protocol Violation|1
5154829|NCT01436643|17801927|P1|Core Phase (16 Weeks)|Protocol Violation|1
5154830|NCT01436643|17801924|P4|Core Phase (16 Weeks)|Abnormal Test result|0
5154831|NCT01436643|17801925|P3|Core Phase (16 Weeks)|Abnormal Test result|1
5154832|NCT01436643|17801926|P2|Core Phase (16 Weeks)|Abnormal Test result|0
5154833|NCT01436643|17801927|P1|Core Phase (16 Weeks)|Abnormal Test result|0
5154834|NCT01436643|17801924|P4|Core Phase (16 Weeks)|Adverse Event|0
5154835|NCT01436643|17801925|P3|Core Phase (16 Weeks)|Adverse Event|1
5154836|NCT01436643|17801926|P2|Core Phase (16 Weeks)|Adverse Event|3
5154837|NCT01436643|17801927|P1|Core Phase (16 Weeks)|Adverse Event|0
5154838|NCT01436643|17801924|P4|2-week Pre-treatment|Protocol Violation|4
5154839|NCT01436643|17801925|P3|2-week Pre-treatment|Protocol Violation|0
5154840|NCT01436643|17801926|P2|2-week Pre-treatment|Protocol Violation|0
5154841|NCT01436643|17801927|P1|2-week Pre-treatment|Protocol Violation|0
5154842|NCT01436643|17801924|P4|2-week Pre-treatment|Adverse Event|5
5154843|NCT01436643|17801925|P3|2-week Pre-treatment|Adverse Event|0
5154844|NCT01436643|17801926|P2|2-week Pre-treatment|Adverse Event|0
5154845|NCT01436643|17801927|P1|2-week Pre-treatment|Adverse Event|0
5154846|NCT01436643|17801924|P4|2-week Pre-treatment|Abnormal test result|1
5154847|NCT01436643|17801925|P3|2-week Pre-treatment|Abnormal test result|0
5154848|NCT01436643|17801926|P2|2-week Pre-treatment|Abnormal test result|0
5154849|NCT01436643|17801927|P1|2-week Pre-treatment|Abnormal test result|0
5154850|NCT01436500|17801962|P5|Overall Study|Other|0
5154851|NCT01436500|17801963|P4|Overall Study|Other|1
5154852|NCT01436500|17801964|P3|Overall Study|Other|0
5154853|NCT01436500|17801965|P2|Overall Study|Other|1
5154854|NCT01436500|17801966|P1|Overall Study|Other|0
5154855|NCT01436500|17801962|P5|Overall Study|discontinued study drug|0
5154856|NCT01436500|17801963|P4|Overall Study|discontinued study drug|0
5154857|NCT01436500|17801964|P3|Overall Study|discontinued study drug|0
5154858|NCT01436500|17801965|P2|Overall Study|discontinued study drug|0
5154859|NCT01436500|17801966|P1|Overall Study|discontinued study drug|1
5154860|NCT01436500|17801962|P5|Overall Study|initiation of dialysis|1
5154861|NCT01436500|17801963|P4|Overall Study|initiation of dialysis|0
5154862|NCT01436500|17801964|P3|Overall Study|initiation of dialysis|0
5154863|NCT01436500|17801965|P2|Overall Study|initiation of dialysis|0
5154864|NCT01436500|17801966|P1|Overall Study|initiation of dialysis|0
5154865|NCT01436500|17801962|P5|Overall Study|liver transplant|0
5154866|NCT01436500|17801963|P4|Overall Study|liver transplant|0
5154867|NCT01436500|17801964|P3|Overall Study|liver transplant|0
5154868|NCT01436500|17801965|P2|Overall Study|liver transplant|0
5154869|NCT01436500|17801966|P1|Overall Study|liver transplant|1
5154870|NCT01436500|17801962|P5|Overall Study|Physician Decision|0
5154871|NCT01436500|17801963|P4|Overall Study|Physician Decision|0
5154872|NCT01436500|17801964|P3|Overall Study|Physician Decision|1
5154873|NCT01436500|17801965|P2|Overall Study|Physician Decision|0
5154874|NCT01436500|17801966|P1|Overall Study|Physician Decision|0
5154875|NCT01436500|17801962|P5|Overall Study|Withdrawal by Subject|2
5154876|NCT01436500|17801963|P4|Overall Study|Withdrawal by Subject|0
5154877|NCT01436500|17801964|P3|Overall Study|Withdrawal by Subject|2
5154878|NCT01436500|17801965|P2|Overall Study|Withdrawal by Subject|0
5154879|NCT01436500|17801966|P1|Overall Study|Withdrawal by Subject|0
5154880|NCT01436500|17801962|P5|Overall Study|Adverse Event|1
5154881|NCT01436500|17801963|P4|Overall Study|Adverse Event|0
5154882|NCT01436500|17801964|P3|Overall Study|Adverse Event|2
5154883|NCT01436500|17801965|P2|Overall Study|Adverse Event|2
5154884|NCT01436500|17801966|P1|Overall Study|Adverse Event|0
5154885|NCT01436500|17801962|P5|Overall Study|Death|0
5154886|NCT01436500|17801963|P4|Overall Study|Death|0
5154887|NCT01436500|17801964|P3|Overall Study|Death|0
5154888|NCT01436500|17801965|P2|Overall Study|Death|0
5154889|NCT01436500|17801966|P1|Overall Study|Death|1
5154890|NCT01436396|17802010|P2|Overall Study|Lost to Follow-up|3
5154891|NCT01436396|17802011|P1|Overall Study|Lost to Follow-up|3
5154892|NCT01436396|17802010|P2|Overall Study|Serious adverse event|3
5154893|NCT01436396|17802011|P1|Overall Study|Serious adverse event|2
5154894|NCT01436396|17802010|P2|Overall Study|Withdrawal by Subject|29
5154895|NCT01436396|17802011|P1|Overall Study|Withdrawal by Subject|19
5154896|NCT01436396|17802010|P2|Overall Study|Adverse Event|2
5154897|NCT01436396|17802011|P1|Overall Study|Adverse Event|1
5154898|NCT01436396|17802010|P2|Overall Study|Protocol Violation|5
5154899|NCT01436396|17802011|P1|Overall Study|Protocol Violation|7
5154900|NCT01436370|17802051|P8|Overall Study|Lost to Follow-up|0
5154901|NCT01436370|17802052|P7|Overall Study|Lost to Follow-up|0
5154902|NCT01436370|17802053|P6|Overall Study|Lost to Follow-up|0
5154903|NCT01436370|17802054|P5|Overall Study|Lost to Follow-up|1
5154904|NCT01436370|17802055|P4|Overall Study|Lost to Follow-up|0
5154905|NCT01436370|17802056|P3|Overall Study|Lost to Follow-up|0
5154906|NCT01436370|17802057|P2|Overall Study|Lost to Follow-up|0
5154907|NCT01436370|17802058|P1|Overall Study|Lost to Follow-up|0
5154908|NCT01436357|17802138|P2|Overall Study|Subject in rehab|1
5154909|NCT01436357|17802139|P1|Overall Study|Subject in rehab|0
5154910|NCT01436357|17802138|P2|Overall Study|Moved out of area|2
5154911|NCT01436357|17802139|P1|Overall Study|Moved out of area|1
5154912|NCT01436357|17802138|P2|Overall Study|Physician Decision|4
5154913|NCT01436357|17802139|P1|Overall Study|Physician Decision|3
5154914|NCT01436357|17802138|P2|Overall Study|Withdrawal by Subject|38
5154915|NCT01436357|17802139|P1|Overall Study|Withdrawal by Subject|26
5154916|NCT01436357|17802138|P2|Overall Study|Protocol Violation|0
5154917|NCT01436357|17802139|P1|Overall Study|Protocol Violation|1
5154918|NCT01436357|17802138|P2|Overall Study|Lost to Follow-up|61
5154919|NCT01436357|17802139|P1|Overall Study|Lost to Follow-up|67
5154920|NCT01436357|17802138|P2|Overall Study|Incarceration|20
5154921|NCT01436357|17802139|P1|Overall Study|Incarceration|18
5154922|NCT01436357|17802138|P2|Overall Study|Enrolled but not vaccinated|1
5154923|NCT01436357|17802139|P1|Overall Study|Enrolled but not vaccinated|1
5154924|NCT01436357|17802138|P2|Overall Study|Death|1
5154925|NCT01436357|17802139|P1|Overall Study|Death|5
5154926|NCT01436305|17802160|P3|Overall Study|Withdrawal by Subject|0
5154927|NCT01436305|17802161|P2|Overall Study|Withdrawal by Subject|3
5154928|NCT01436305|17802162|P1|Overall Study|Withdrawal by Subject|1
5154929|NCT01436305|17802160|P3|Overall Study|Lost to Follow-up|0
5154930|NCT01436305|17802161|P2|Overall Study|Lost to Follow-up|1
5154931|NCT01436305|17802162|P1|Overall Study|Lost to Follow-up|0
5154932|NCT01436305|17802160|P3|Overall Study|Death|0
5154933|NCT01436305|17802161|P2|Overall Study|Death|0
5154934|NCT01436305|17802162|P1|Overall Study|Death|1
5154935|NCT01436253|17802289|P1|Overall Study|Not meeting all eligibility criteria|117
5154936|NCT01436253|17802289|P1|Overall Study|Lost to Follow-up|182
5154937|NCT01436201|17802294|P1|Overall Study|Protocol Violation|1
5154938|NCT01436201|17802294|P1|Overall Study|Withdrawal by Subject|1
5154939|NCT01436201|17802294|P1|Overall Study|Adverse Event|2
5154940|NCT01436175|17802304|P1|Overall Study|Other|826
5154941|NCT01436175|17802304|P1|Overall Study|Met blood pressure or pulse withdrawal|63
5154942|NCT01436175|17802304|P1|Overall Study|Lack of Efficacy|24
5154943|NCT01436175|17802304|P1|Overall Study|Lost to Follow-up|89
5154944|NCT01436175|17802304|P1|Overall Study|Withdrawal by Subject|108
5154945|NCT01436175|17802304|P1|Overall Study|Protocol Violation|49
5154946|NCT01436175|17802304|P1|Overall Study|Adverse Event|111
5154947|NCT01436162|17802331|P3|Randomized Phase|Other|4
5154948|NCT01436162|17802332|P2|Randomized Phase|Other|5
5154949|NCT01436162|17802333|P1|Randomized Phase|Other|2
5154950|NCT01436162|17802331|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
5154951|NCT01436162|17802332|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
5154952|NCT01436162|17802333|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
5154953|NCT01436162|17802331|P3|Randomized Phase|Lack of Efficacy|1
5154954|NCT01436162|17802332|P2|Randomized Phase|Lack of Efficacy|1
5154955|NCT01436162|17802333|P1|Randomized Phase|Lack of Efficacy|0
5154956|NCT01436162|17802331|P3|Randomized Phase|Lost to Follow-up|4
5154957|NCT01436162|17802332|P2|Randomized Phase|Lost to Follow-up|5
5154958|NCT01436162|17802333|P1|Randomized Phase|Lost to Follow-up|17
5154959|NCT01436162|17802331|P3|Randomized Phase|Withdrawal by Subject|8
5154960|NCT01436162|17802332|P2|Randomized Phase|Withdrawal by Subject|9
5154961|NCT01436162|17802333|P1|Randomized Phase|Withdrawal by Subject|16
5154962|NCT01436162|17802331|P3|Randomized Phase|Protocol Violation|2
5154963|NCT01436162|17802332|P2|Randomized Phase|Protocol Violation|4
5154964|NCT01436162|17802333|P1|Randomized Phase|Protocol Violation|4
5154965|NCT01436162|17802331|P3|Randomized Phase|Adverse Event|6
5154966|NCT01436162|17802332|P2|Randomized Phase|Adverse Event|5
5154967|NCT01436162|17802333|P1|Randomized Phase|Adverse Event|1
5154968|NCT01436162|17802331|P3|Single-blind Lead-in Phase|Other|0
5154969|NCT01436162|17802332|P2|Single-blind Lead-in Phase|Other|0
5154970|NCT01436162|17802333|P1|Single-blind Lead-in Phase|Other|107
5154971|NCT01436162|17802331|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5154972|NCT01436162|17802332|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5154973|NCT01436162|17802333|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
5154974|NCT01436162|17802331|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
5154975|NCT01436162|17802332|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
5154976|NCT01436162|17802333|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
5154977|NCT01436162|17802331|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
5154978|NCT01436162|17802332|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
5154979|NCT01436162|17802333|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
5154980|NCT01436162|17802331|P3|Single-blind Lead-in Phase|Protocol Violation|0
5154981|NCT01436162|17802332|P2|Single-blind Lead-in Phase|Protocol Violation|0
5154982|NCT01436162|17802333|P1|Single-blind Lead-in Phase|Protocol Violation|24
5154983|NCT01436162|17802331|P3|Single-blind Lead-in Phase|Adverse Event|0
5154984|NCT01436162|17802332|P2|Single-blind Lead-in Phase|Adverse Event|0
5154985|NCT01436162|17802333|P1|Single-blind Lead-in Phase|Adverse Event|26
5154986|NCT01436149|17802367|P3|Randomized Phase|Other|11
5154987|NCT01436149|17802368|P2|Randomized Phase|Other|5
5154988|NCT01436149|17802369|P1|Randomized Phase|Other|12
5154989|NCT01436149|17802367|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
5154990|NCT01436149|17802368|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
5154991|NCT01436149|17802369|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
5154992|NCT01436149|17802367|P3|Randomized Phase|Lack of Efficacy|1
5154993|NCT01436149|17802368|P2|Randomized Phase|Lack of Efficacy|0
5154994|NCT01436149|17802369|P1|Randomized Phase|Lack of Efficacy|0
5154995|NCT01436149|17802367|P3|Randomized Phase|Lost to Follow-up|6
5154996|NCT01436149|17802368|P2|Randomized Phase|Lost to Follow-up|5
5154997|NCT01436149|17802369|P1|Randomized Phase|Lost to Follow-up|34
5154998|NCT01436149|17802367|P3|Randomized Phase|Withdrawal by Subject|10
5154999|NCT01436149|17802368|P2|Randomized Phase|Withdrawal by Subject|10
5155000|NCT01436149|17802369|P1|Randomized Phase|Withdrawal by Subject|16
5155001|NCT01436149|17802367|P3|Randomized Phase|Protocol Violation|0
5155002|NCT01436149|17802368|P2|Randomized Phase|Protocol Violation|5
5155003|NCT01436149|17802369|P1|Randomized Phase|Protocol Violation|4
5155004|NCT01436149|17802367|P3|Randomized Phase|Adverse Event|11
5155005|NCT01436149|17802368|P2|Randomized Phase|Adverse Event|10
5155006|NCT01436149|17802369|P1|Randomized Phase|Adverse Event|9
5155007|NCT01436149|17802367|P3|Antidepressant Lead-in Phase|Other|0
5155008|NCT01436149|17802368|P2|Antidepressant Lead-in Phase|Other|0
5155009|NCT01436149|17802369|P1|Antidepressant Lead-in Phase|Other|119
5155010|NCT01436149|17802367|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
5155011|NCT01436149|17802368|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
5155012|NCT01436149|17802369|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
5155013|NCT01436149|17802367|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155014|NCT01436149|17802368|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155015|NCT01436149|17802369|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
5155016|NCT01436149|17802367|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155017|NCT01436149|17802368|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155018|NCT01436149|17802369|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
5155019|NCT01436149|17802367|P3|Antidepressant Lead-in Phase|Protocol Violation|0
5155020|NCT01436149|17802368|P2|Antidepressant Lead-in Phase|Protocol Violation|0
5155021|NCT01436149|17802369|P1|Antidepressant Lead-in Phase|Protocol Violation|29
5155022|NCT01436149|17802367|P3|Antidepressant Lead-in Phase|Adverse Event|0
5155023|NCT01436149|17802368|P2|Antidepressant Lead-in Phase|Adverse Event|0
5155024|NCT01436149|17802369|P1|Antidepressant Lead-in Phase|Adverse Event|39
5155025|NCT01436110|17802400|P3|Overall Study|Did Not Receive Trial Medication|3
5155026|NCT01436110|17802401|P2|Overall Study|Did Not Receive Trial Medication|0
5155027|NCT01436110|17802402|P1|Overall Study|Did Not Receive Trial Medication|1
5155028|NCT01436110|17802400|P3|Overall Study|Protocol Violation|1
5155029|NCT01436110|17802401|P2|Overall Study|Protocol Violation|1
5155030|NCT01436110|17802402|P1|Overall Study|Protocol Violation|3
5155031|NCT01436110|17802400|P3|Overall Study|Lost to Follow-up|3
5155032|NCT01436110|17802401|P2|Overall Study|Lost to Follow-up|1
5155033|NCT01436110|17802402|P1|Overall Study|Lost to Follow-up|1
5155034|NCT01436110|17802400|P3|Overall Study|Physician Decision|1
5155035|NCT01436110|17802401|P2|Overall Study|Physician Decision|1
5155036|NCT01436110|17802402|P1|Overall Study|Physician Decision|3
5155037|NCT01436110|17802400|P3|Overall Study|Adverse Event|2
5155038|NCT01436110|17802401|P2|Overall Study|Adverse Event|1
5155039|NCT01436110|17802402|P1|Overall Study|Adverse Event|2
5155040|NCT01436110|17802400|P3|Overall Study|Withdrawal by Subject|4
5155041|NCT01436110|17802401|P2|Overall Study|Withdrawal by Subject|8
5155042|NCT01436110|17802402|P1|Overall Study|Withdrawal by Subject|6
5155043|NCT01436110|17802400|P3|Overall Study|Lack of Efficacy|9
5155044|NCT01436110|17802401|P2|Overall Study|Lack of Efficacy|14
5155045|NCT01436110|17802402|P1|Overall Study|Lack of Efficacy|23
5155046|NCT01436084|17802425|P1|Overall Study|Early Closure of Study|1
5155047|NCT01436084|17802425|P1|Overall Study|Withdrawal by Subject|1
5155048|NCT01436084|17802425|P1|Overall Study|Disease Progression|2
5155049|NCT01436071|17802431|P2|Overall Study|Did Not Receive Trial Medication|3
5155050|NCT01436071|17802432|P1|Overall Study|Did Not Receive Trial Medication|3
5155051|NCT01436071|17802431|P2|Overall Study|Withdrawal by Subject|2
5155052|NCT01436071|17802432|P1|Overall Study|Withdrawal by Subject|2
5155053|NCT01436071|17802431|P2|Overall Study|Physician Decision|0
5155054|NCT01436071|17802432|P1|Overall Study|Physician Decision|1
5155055|NCT01436071|17802431|P2|Overall Study|Lost to Follow-up|1
5155056|NCT01436071|17802432|P1|Overall Study|Lost to Follow-up|3
5155057|NCT01436071|17802431|P2|Overall Study|Protocol Violation|1
5155058|NCT01436071|17802432|P1|Overall Study|Protocol Violation|0
5155059|NCT01436071|17802431|P2|Overall Study|Lack of Efficacy|7
5155060|NCT01436071|17802432|P1|Overall Study|Lack of Efficacy|16
5155061|NCT01436071|17802431|P2|Overall Study|Adverse Event|0
5155062|NCT01436071|17802432|P1|Overall Study|Adverse Event|1
5155063|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Administrative|2
5155064|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Administrative|5
5155065|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Administrative|0
5155066|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
5155067|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
5155068|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
5155069|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
5155070|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
5155071|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
5155072|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
5155073|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
5155074|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
5155075|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
5155076|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
5155077|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
5155078|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
5155079|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
5155080|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
5155081|NCT01435928|17802474|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
5155082|NCT01435928|17802475|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
5155083|NCT01435928|17802476|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
5155084|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Administrative|0
5155085|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Administrative|0
5155086|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Administrative|14
5155087|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
5155088|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
5155089|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
5155090|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
5155091|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
5155092|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
5155093|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
5155094|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
5155095|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
5155096|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
5155097|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
5155098|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
5155099|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
5155100|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
5155101|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
5155102|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
5155103|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
5155104|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
5155105|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Death|0
5155106|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Death|0
5155107|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Death|1
5155108|NCT01435928|17802474|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
5155109|NCT01435928|17802475|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
5155110|NCT01435928|17802476|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
5155111|NCT01435798|17802522|P1|Overall Study|Withdrawal by Subject|1
5155112|NCT01435772|17802539|P3|Overall Study|Other - study termination|10
5155113|NCT01435772|17802540|P2|Overall Study|Other - study termination|2
5155114|NCT01435772|17802541|P1|Overall Study|Other - study termination|2
5155115|NCT01435772|17802539|P3|Overall Study|Withdrawal by Subject|3
5155116|NCT01435772|17802540|P2|Overall Study|Withdrawal by Subject|1
5155117|NCT01435772|17802541|P1|Overall Study|Withdrawal by Subject|0
5155118|NCT01435772|17802539|P3|Overall Study|Adverse Event|2
5155119|NCT01435772|17802540|P2|Overall Study|Adverse Event|0
5155120|NCT01435772|17802541|P1|Overall Study|Adverse Event|1
5155121|NCT01435759|17802591|P6|Double-blind Phase|Other|0
5155122|NCT01435759|17802592|P5|Double-blind Phase|Other|0
5155123|NCT01435759|17802593|P4|Double-blind Phase|Other|2
5155124|NCT01435759|17802594|P3|Double-blind Phase|Other|0
5155125|NCT01435759|17802595|P2|Double-blind Phase|Other|2
5155126|NCT01435759|17802596|P1|Double-blind Phase|Other|8
5155127|NCT01435759|17802591|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5155128|NCT01435759|17802592|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
5155129|NCT01435759|17802593|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5155130|NCT01435759|17802594|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5155131|NCT01435759|17802595|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5155132|NCT01435759|17802596|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
5155133|NCT01435759|17802591|P6|Double-blind Phase|Lost to Follow-up|3
5155134|NCT01435759|17802592|P5|Double-blind Phase|Lost to Follow-up|3
5155135|NCT01435759|17802593|P4|Double-blind Phase|Lost to Follow-up|0
5155136|NCT01435759|17802594|P3|Double-blind Phase|Lost to Follow-up|2
5155137|NCT01435759|17802595|P2|Double-blind Phase|Lost to Follow-up|1
5155138|NCT01435759|17802596|P1|Double-blind Phase|Lost to Follow-up|31
5155139|NCT01435759|17802591|P6|Double-blind Phase|Withdrawal by Subject|2
5155140|NCT01435759|17802592|P5|Double-blind Phase|Withdrawal by Subject|2
5155141|NCT01435759|17802593|P4|Double-blind Phase|Withdrawal by Subject|4
5155142|NCT01435759|17802594|P3|Double-blind Phase|Withdrawal by Subject|3
5155143|NCT01435759|17802595|P2|Double-blind Phase|Withdrawal by Subject|4
5155144|NCT01435759|17802596|P1|Double-blind Phase|Withdrawal by Subject|17
5155145|NCT01435759|17802591|P6|Double-blind Phase|Protocol Violation|1
5155146|NCT01435759|17802592|P5|Double-blind Phase|Protocol Violation|0
5155147|NCT01435759|17802593|P4|Double-blind Phase|Protocol Violation|2
5155148|NCT01435759|17802594|P3|Double-blind Phase|Protocol Violation|1
5155149|NCT01435759|17802595|P2|Double-blind Phase|Protocol Violation|0
5155150|NCT01435759|17802596|P1|Double-blind Phase|Protocol Violation|2
5155151|NCT01435759|17802591|P6|Double-blind Phase|Adverse Event|3
5155152|NCT01435759|17802592|P5|Double-blind Phase|Adverse Event|1
5155153|NCT01435759|17802593|P4|Double-blind Phase|Adverse Event|1
5155154|NCT01435759|17802594|P3|Double-blind Phase|Adverse Event|1
5155155|NCT01435759|17802595|P2|Double-blind Phase|Adverse Event|0
5155156|NCT01435759|17802596|P1|Double-blind Phase|Adverse Event|7
5155157|NCT01435759|17802591|P6|Antidepressant Lead-in Phase|Other|0
5155158|NCT01435759|17802592|P5|Antidepressant Lead-in Phase|Other|0
5155159|NCT01435759|17802593|P4|Antidepressant Lead-in Phase|Other|0
5155160|NCT01435759|17802594|P3|Antidepressant Lead-in Phase|Other|0
5155161|NCT01435759|17802595|P2|Antidepressant Lead-in Phase|Other|0
5155162|NCT01435759|17802596|P1|Antidepressant Lead-in Phase|Other|119
5155163|NCT01435759|17802591|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5155164|NCT01435759|17802592|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5155165|NCT01435759|17802593|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5155166|NCT01435759|17802594|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5155167|NCT01435759|17802595|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5155168|NCT01435759|17802596|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
5155169|NCT01435759|17802591|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155170|NCT01435759|17802592|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155171|NCT01435759|17802593|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155172|NCT01435759|17802594|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155173|NCT01435759|17802595|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
5155174|NCT01435759|17802596|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
5155175|NCT01435759|17802591|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155176|NCT01435759|17802592|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155177|NCT01435759|17802593|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155178|NCT01435759|17802594|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155179|NCT01435759|17802595|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5155180|NCT01435759|17802596|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
5155181|NCT01435759|17802591|P6|Antidepressant Lead-in Phase|Protocol Violation|0
5155182|NCT01435759|17802592|P5|Antidepressant Lead-in Phase|Protocol Violation|0
5155183|NCT01435759|17802593|P4|Antidepressant Lead-in Phase|Protocol Violation|0
5155184|NCT01435759|17802594|P3|Antidepressant Lead-in Phase|Protocol Violation|0
5155185|NCT01435759|17802595|P2|Antidepressant Lead-in Phase|Protocol Violation|0
5155186|NCT01435759|17802596|P1|Antidepressant Lead-in Phase|Protocol Violation|16
5155187|NCT01435759|17802591|P6|Antidepressant Lead-in Phase|Adverse Event|0
5155188|NCT01435759|17802592|P5|Antidepressant Lead-in Phase|Adverse Event|0
5155189|NCT01435759|17802593|P4|Antidepressant Lead-in Phase|Adverse Event|0
5155190|NCT01435759|17802594|P3|Antidepressant Lead-in Phase|Adverse Event|0
5155191|NCT01435759|17802595|P2|Antidepressant Lead-in Phase|Adverse Event|0
5155192|NCT01435759|17802596|P1|Antidepressant Lead-in Phase|Adverse Event|40
5155193|NCT01435655|17802623|P1|Overall Study|Other|1
5155194|NCT01435655|17802623|P1|Overall Study|Death|2
5155195|NCT01435616|17802637|P2|Overall Study|Sponsor Decision|0
5155196|NCT01435616|17802638|P1|Overall Study|Sponsor Decision|1
5155197|NCT01435616|17802637|P2|Overall Study|Physician Decision|7
5155198|NCT01435616|17802638|P1|Overall Study|Physician Decision|20
5155199|NCT01435616|17802637|P2|Overall Study|Withdrawal by Subject|24
5155200|NCT01435616|17802638|P1|Overall Study|Withdrawal by Subject|66
5155201|NCT01435616|17802637|P2|Overall Study|Protocol Violation|13
5155202|NCT01435616|17802638|P1|Overall Study|Protocol Violation|16
5155203|NCT01435616|17802637|P2|Overall Study|Lost to Follow-up|13
5155204|NCT01435616|17802638|P1|Overall Study|Lost to Follow-up|22
5155205|NCT01435616|17802637|P2|Overall Study|Death|2
5155206|NCT01435616|17802638|P1|Overall Study|Death|7
5155207|NCT01435616|17802637|P2|Overall Study|Adverse Event|21
5155208|NCT01435616|17802638|P1|Overall Study|Adverse Event|39
5155209|NCT01435577|17802693|P2|Overall Study|Alternative treatment started|1
5155210|NCT01435577|17802694|P1|Overall Study|Alternative treatment started|0
5155211|NCT01435577|17802693|P2|Overall Study|Lack of Efficacy|51
5155212|NCT01435577|17802694|P1|Overall Study|Lack of Efficacy|7
5155213|NCT01435577|17802693|P2|Overall Study|Adverse Event|0
5155214|NCT01435577|17802694|P1|Overall Study|Adverse Event|10
5155215|NCT01435460|17802755|P2|Overall Study|Did not meet eligibility criteria|0
5155216|NCT01435460|17802756|P1|Overall Study|Did not meet eligibility criteria|2
5155217|NCT01435460|17802755|P2|Overall Study|Protocol Violation|1
5155218|NCT01435460|17802756|P1|Overall Study|Protocol Violation|0
5155219|NCT01435460|17802755|P2|Overall Study|Withdrawal by Subject|3
5155220|NCT01435460|17802756|P1|Overall Study|Withdrawal by Subject|1
5155221|NCT01435460|17802755|P2|Overall Study|Lost to Follow-up|1
5155222|NCT01435460|17802756|P1|Overall Study|Lost to Follow-up|6
5155223|NCT01435460|17802755|P2|Overall Study|Adverse Event|1
5155224|NCT01435460|17802756|P1|Overall Study|Adverse Event|2
5155225|NCT01435382|17802772|P4|Overall Study|Withdrawal by Subject|1
5155226|NCT01435382|17802773|P3|Overall Study|Withdrawal by Subject|0
5155227|NCT01435382|17802774|P2|Overall Study|Withdrawal by Subject|2
5155228|NCT01435382|17802775|P1|Overall Study|Withdrawal by Subject|0
5155229|NCT01435382|17802772|P4|Overall Study|Lost to Follow-up|0
5155230|NCT01435382|17802773|P3|Overall Study|Lost to Follow-up|1
5155231|NCT01435382|17802774|P2|Overall Study|Lost to Follow-up|0
5155232|NCT01435382|17802775|P1|Overall Study|Lost to Follow-up|1
5155233|NCT01435356|17802864|P2|Overall Study|Patient moved to another city|1
5155234|NCT01435356|17802865|P1|Overall Study|Patient moved to another city|1
5155235|NCT01435356|17802864|P2|Overall Study|Patient decision|0
5155236|NCT01435356|17802865|P1|Overall Study|Patient decision|3
5155237|NCT01435356|17802864|P2|Overall Study|Physician Decision|0
5155238|NCT01435356|17802865|P1|Overall Study|Physician Decision|1
5155239|NCT01435356|17802864|P2|Overall Study|IC withdrawal due to study cancellation|0
5155240|NCT01435356|17802865|P1|Overall Study|IC withdrawal due to study cancellation|1
5155241|NCT01435356|17802864|P2|Overall Study|Facial palsy|0
5155242|NCT01435356|17802865|P1|Overall Study|Facial palsy|1
5155243|NCT01435356|17802864|P2|Overall Study|Withdrawal by Subject|1
5155244|NCT01435356|17802865|P1|Overall Study|Withdrawal by Subject|1
5155245|NCT01435356|17802864|P2|Overall Study|Study Discontinuation, amendment 4|11
5155246|NCT01435356|17802865|P1|Overall Study|Study Discontinuation, amendment 4|5
5155247|NCT01435356|17802864|P2|Overall Study|Protocol Violation|1
5155248|NCT01435356|17802865|P1|Overall Study|Protocol Violation|0
5155249|NCT01435356|17802864|P2|Overall Study|Disease progression/recurrence|10
5155250|NCT01435356|17802865|P1|Overall Study|Disease progression/recurrence|17
5155251|NCT01435356|17802864|P2|Overall Study|Adverse Event|0
5155252|NCT01435356|17802865|P1|Overall Study|Adverse Event|2
5155253|NCT01435265|17802898|P2|Overall Study|Lost to Follow-up|1
5155254|NCT01435265|17802899|P1|Overall Study|Lost to Follow-up|0
5155255|NCT01435122|17802913|P1|Overall Study|Early withdrawal due to toxicity|8
5155256|NCT01435031|17802922|P1|ITT at 4 Years|Lost to Follow-up|1
5155257|NCT01435031|17802922|P1|ITT at 4 Years|Withdrawal by Subject|2
5155258|NCT01435031|17802922|P1|ITT at 4 Years|Death|4
5155259|NCT01435031|17802922|P1|ITT at 3 Years|Lost to Follow-up|4
5155260|NCT01435031|17802922|P1|ITT at 3 Years|Withdrawal by Subject|2
5155261|NCT01435031|17802922|P1|ITT at 3 Years|Death|5
5155262|NCT01435031|17802922|P1|ITT at 2 Years|Lost to Follow-up|4
5155263|NCT01435031|17802922|P1|ITT at 2 Years|Withdrawal by Subject|2
5155264|NCT01435031|17802922|P1|ITT at 2 Years|Death|7
5155265|NCT01435031|17802922|P1|ITT at 1 Year|Lost to Follow-up|6
5155266|NCT01435031|17802922|P1|ITT at 1 Year|Withdrawal by Subject|2
5155267|NCT01435031|17802922|P1|ITT at 1 Year|Death|1
5155268|NCT01435031|17802922|P1|ITT at 6 Months|Lost to Follow-up|3
5155269|NCT01435031|17802922|P1|ITT at 6 Months|Death|2
5155270|NCT01435031|17802922|P1|ITT at 1 Month|Lost to Follow-up|4
5155271|NCT01435031|17802922|P1|ITT at 1 Month|Death|1
5155272|NCT01435031|17802922|P1|ITT at 1 Month|Withdrawal by Subject|1
5155273|NCT01435018|17803023|P3|Overall Study|Never started chemotherapy|1
5155274|NCT01435018|17803024|P2|Overall Study|Never started chemotherapy|0
5155275|NCT01435018|17803025|P1|Overall Study|Never started chemotherapy|3
5155276|NCT01435018|17803023|P3|Overall Study|Enrollment Violation|0
5155277|NCT01435018|17803024|P2|Overall Study|Enrollment Violation|1
5155278|NCT01435018|17803025|P1|Overall Study|Enrollment Violation|0
5155279|NCT01435018|17803023|P3|Overall Study|Unable to contact participant/parent|1
5155280|NCT01435018|17803024|P2|Overall Study|Unable to contact participant/parent|1
5155281|NCT01435018|17803025|P1|Overall Study|Unable to contact participant/parent|1
5155282|NCT01435018|17803023|P3|Overall Study|Severe debilitation, unable to continue|1
5155283|NCT01435018|17803024|P2|Overall Study|Severe debilitation, unable to continue|0
5155284|NCT01435018|17803025|P1|Overall Study|Severe debilitation, unable to continue|0
5155285|NCT01435018|17803023|P3|Overall Study|Not able to get to clinic|2
5155286|NCT01435018|17803024|P2|Overall Study|Not able to get to clinic|0
5155287|NCT01435018|17803025|P1|Overall Study|Not able to get to clinic|2
5155288|NCT01435018|17803023|P3|Overall Study|Not willing to adhere to requirements|3
5155289|NCT01435018|17803024|P2|Overall Study|Not willing to adhere to requirements|2
5155290|NCT01435018|17803025|P1|Overall Study|Not willing to adhere to requirements|0
5155291|NCT01435018|17803023|P3|Overall Study|Withdrew consent|1
5155292|NCT01435018|17803024|P2|Overall Study|Withdrew consent|3
5155293|NCT01435018|17803025|P1|Overall Study|Withdrew consent|0
5155294|NCT01435018|17803023|P3|Overall Study|Site is closing|7
5155295|NCT01435018|17803024|P2|Overall Study|Site is closing|9
5155296|NCT01435018|17803025|P1|Overall Study|Site is closing|4
5155297|NCT01435018|17803023|P3|Overall Study|Death|25
5155298|NCT01435018|17803024|P2|Overall Study|Death|18
5155299|NCT01435018|17803025|P1|Overall Study|Death|37
5155300|NCT01434823|17803118|P2|Overall Study|Incomplete data in medical record|7
5155301|NCT01434823|17803119|P1|Overall Study|Incomplete data in medical record|4
5155302|NCT01434810|17803137|P2|Overall Study|Missing data/received <5hr phototherapy|7
5155303|NCT01434810|17803138|P1|Overall Study|Missing data/received <5hr phototherapy|12
5155304|NCT01434810|17803137|P2|Overall Study|Did not receive treatment|3
5155305|NCT01434810|17803138|P1|Overall Study|Did not receive treatment|11
5155306|NCT01434693|17803173|P4|Overall Study|Lost to Follow-up|0
5155307|NCT01434693|17803174|P3|Overall Study|Lost to Follow-up|0
5155308|NCT01434693|17803175|P2|Overall Study|Lost to Follow-up|0
5155309|NCT01434693|17803176|P1|Overall Study|Lost to Follow-up|1
5155310|NCT01434693|17803173|P4|Overall Study|Withdrawal by Subject|1
5155311|NCT01434693|17803174|P3|Overall Study|Withdrawal by Subject|1
5155312|NCT01434693|17803175|P2|Overall Study|Withdrawal by Subject|0
5155313|NCT01434693|17803176|P1|Overall Study|Withdrawal by Subject|1
5155314|NCT01434693|17803173|P4|Overall Study|Adverse Event|0
5155315|NCT01434693|17803174|P3|Overall Study|Adverse Event|0
5155316|NCT01434693|17803175|P2|Overall Study|Adverse Event|0
5155317|NCT01434693|17803176|P1|Overall Study|Adverse Event|1
5155318|NCT01434680|17803190|P4|Overall Study|Protocol Violation|0
5155319|NCT01434680|17803191|P3|Overall Study|Protocol Violation|0
5155320|NCT01434680|17803192|P2|Overall Study|Protocol Violation|1
5155321|NCT01434680|17803193|P1|Overall Study|Protocol Violation|1
5155322|NCT01434680|17803190|P4|Overall Study|Lost to Follow-up|0
5155323|NCT01434680|17803191|P3|Overall Study|Lost to Follow-up|0
5155324|NCT01434680|17803192|P2|Overall Study|Lost to Follow-up|1
5155325|NCT01434680|17803193|P1|Overall Study|Lost to Follow-up|1
5155326|NCT01434680|17803190|P4|Overall Study|Withdrawal by Subject|0
5155327|NCT01434680|17803191|P3|Overall Study|Withdrawal by Subject|2
5155328|NCT01434680|17803192|P2|Overall Study|Withdrawal by Subject|0
5155329|NCT01434680|17803193|P1|Overall Study|Withdrawal by Subject|1
5155330|NCT01434667|17803210|P2|Overall Study|Lost to Follow-up|10
5155331|NCT01434667|17803211|P1|Overall Study|Lost to Follow-up|5
5155332|NCT01434654|17803237|P2|Overall Study|Lost to Follow-up|0
5155333|NCT01434654|17803238|P1|Overall Study|Lost to Follow-up|1
5155334|NCT01434654|17803237|P2|Overall Study|Withdrawal by Subject|0
5155335|NCT01434654|17803238|P1|Overall Study|Withdrawal by Subject|1
5155336|NCT01434290|17803285|P2|Overall Study|No protocol treatment|4
5155337|NCT01434290|17803286|P1|Overall Study|No protocol treatment|2
5155338|NCT01434290|17803285|P2|Overall Study|Protocol Violation|3
5155339|NCT01434290|17803286|P1|Overall Study|Protocol Violation|6
5155340|NCT01433978|17803359|P3|Extension Phase|Study Terminated by Sponsor|4
5155341|NCT01433978|17803360|P2|Extension Phase|Study Terminated by Sponsor|0
5155342|NCT01433978|17803361|P1|Extension Phase|Study Terminated by Sponsor|0
5155343|NCT01433978|17803359|P3|Extension Phase|Lack of Efficacy|1
5155344|NCT01433978|17803360|P2|Extension Phase|Lack of Efficacy|0
5155345|NCT01433978|17803361|P1|Extension Phase|Lack of Efficacy|0
5155346|NCT01433978|17803359|P3|Extension Phase|Adverse Event, Non-Fatal|1
5155347|NCT01433978|17803360|P2|Extension Phase|Adverse Event, Non-Fatal|0
5155348|NCT01433978|17803361|P1|Extension Phase|Adverse Event, Non-Fatal|0
5155349|NCT01433978|17803359|P3|Core Study|Study Terminated by Sponsor|0
5155350|NCT01433978|17803360|P2|Core Study|Study Terminated by Sponsor|9
5155351|NCT01433978|17803361|P1|Core Study|Study Terminated by Sponsor|6
5155352|NCT01433978|17803359|P3|Core Study|Lack of Efficacy|0
5155353|NCT01433978|17803360|P2|Core Study|Lack of Efficacy|1
5155354|NCT01433978|17803361|P1|Core Study|Lack of Efficacy|5
5155355|NCT01433978|17803359|P3|Core Study|Adverse Event, Non-Fatal|0
5155356|NCT01433978|17803360|P2|Core Study|Adverse Event, Non-Fatal|1
5155357|NCT01433978|17803361|P1|Core Study|Adverse Event, Non-Fatal|0
5155358|NCT01433549|17803418|P2|Phase 2: Second Study Product|Adverse Event|1
5155359|NCT01433549|17803419|P1|Phase 2: Second Study Product|Adverse Event|0
5155360|NCT01433471|17803429|P2|Overall Study|Withdrawal by Subject|1
5155361|NCT01433471|17803430|P1|Overall Study|Withdrawal by Subject|0
5155362|NCT01433354|17803446|P1|Overall Study|Subject Withdrew Consent|3
5155363|NCT01433354|17803446|P1|Overall Study|Lack of Efficacy|17
5155364|NCT01433354|17803446|P1|Overall Study|Protocol Violation|2
5155365|NCT01433354|17803446|P1|Overall Study|Administrative problems|90
5155366|NCT01433354|17803446|P1|Overall Study|Lost to Follow-up|1
5155367|NCT01433354|17803446|P1|Overall Study|Adverse Event|6
5155368|NCT01433263|17803462|P2|Overall Study|Withdrawal by Subject|7
5155369|NCT01433263|17803463|P1|Overall Study|Withdrawal by Subject|10
5155370|NCT01433263|17803462|P2|Overall Study|Protocol Deviation|0
5155371|NCT01433263|17803463|P1|Overall Study|Protocol Deviation|1
5155372|NCT01433263|17803462|P2|Overall Study|Lost to Follow-up|1
5155373|NCT01433263|17803463|P1|Overall Study|Lost to Follow-up|0
5155374|NCT01433263|17803462|P2|Overall Study|Death|3
5155375|NCT01433263|17803463|P1|Overall Study|Death|5
5155376|NCT01433263|17803462|P2|Overall Study|Adverse Event|1
5155377|NCT01433263|17803463|P1|Overall Study|Adverse Event|3
5155378|NCT01433250|17803492|P2|Overall Study|Withdrawal by Subject|2
5155379|NCT01433250|17803493|P1|Overall Study|Withdrawal by Subject|3
5155380|NCT01433250|17803492|P2|Overall Study|Protocol Violation|1
5155381|NCT01433250|17803493|P1|Overall Study|Protocol Violation|0
5155382|NCT01433172|17803512|P3|Overall Study|Death|0
5155383|NCT01433172|17803513|P2|Overall Study|Death|2
5155384|NCT01433172|17803514|P1|Overall Study|Death|0
5155385|NCT01433172|17803512|P3|Overall Study|Disease Progression|1
5155386|NCT01433172|17803513|P2|Overall Study|Disease Progression|0
5155387|NCT01433172|17803514|P1|Overall Study|Disease Progression|0
5155388|NCT01433172|17803512|P3|Overall Study|Withdrawal by Subject|0
5155389|NCT01433172|17803513|P2|Overall Study|Withdrawal by Subject|1
5155390|NCT01433172|17803514|P1|Overall Study|Withdrawal by Subject|0
5155391|NCT01433159|17803526|P2|Overall Study|Protocol Violation|1
5155392|NCT01433159|17803527|P1|Overall Study|Protocol Violation|0
5155393|NCT01433159|17803526|P2|Overall Study|Physician Decision|0
5155394|NCT01433159|17803527|P1|Overall Study|Physician Decision|1
5155395|NCT01433159|17803526|P2|Overall Study|Adverse Event|0
5155396|NCT01433159|17803527|P1|Overall Study|Adverse Event|1
5155397|NCT01433055|17803559|P2|Overall Study|Severely elevated triglycerides at entry|0
5155398|NCT01433055|17803560|P1|Overall Study|Severely elevated triglycerides at entry|1
5155399|NCT01433055|17803559|P2|Overall Study|Diagnosed with cancer unrelated to study|0
5155400|NCT01433055|17803560|P1|Overall Study|Diagnosed with cancer unrelated to study|1
5155401|NCT01432951|17803582|P1|Treatment Phase (Day 1 to 30)|Never Treated|1
5155402|NCT01432938|17803591|P2|Second Intervention|Adverse Event|0
5155403|NCT01432938|17803592|P1|Second Intervention|Adverse Event|1
5155404|NCT01432938|17803591|P2|First Intervention|Physician Decision|0
5155405|NCT01432938|17803592|P1|First Intervention|Physician Decision|1
5155406|NCT01432938|17803591|P2|First Intervention|Protocol Violation|0
5155407|NCT01432938|17803592|P1|First Intervention|Protocol Violation|1
5155408|NCT01432756|17803622|P4|Overall Study|Lost to Follow-up|1
5155409|NCT01432756|17803623|P3|Overall Study|Lost to Follow-up|2
5155410|NCT01432756|17803624|P2|Overall Study|Lost to Follow-up|0
5155411|NCT01432756|17803625|P1|Overall Study|Lost to Follow-up|1
5155412|NCT01432730|17803633|P2|Period 2|Adverse Event|4
5155413|NCT01432730|17803634|P1|Period 2|Adverse Event|0
5155414|NCT01432730|17803633|P2|Period 1|Adverse Event|0
5155415|NCT01432730|17803634|P1|Period 1|Adverse Event|2
5155416|NCT01432626|17803670|P1|Overall Study|Imaging agent not available|1
5155417|NCT01432626|17803670|P1|Overall Study|Only 1 image competed|2
5155418|NCT01432626|17803670|P1|Overall Study|Withdrawal by Subject|2
5155419|NCT01432626|17803670|P1|Overall Study|LV function recovered|2
5155420|NCT01432600|17803677|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
5155421|NCT01432600|17803678|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
5155422|NCT01432600|17803679|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
5155423|NCT01432574|17803695|P1|Overall Study|Not interested|1
5155424|NCT01432574|17803695|P1|Overall Study|Moved|2
5155425|NCT01432457|17803741|P3|Overall Study|Did not take study drug|3
5155426|NCT01432457|17803742|P2|Overall Study|Did not take study drug|6
5155427|NCT01432457|17803743|P1|Overall Study|Did not take study drug|6
5155428|NCT01432457|17803741|P3|Overall Study|Reasons not defined|4
5155429|NCT01432457|17803742|P2|Overall Study|Reasons not defined|3
5155430|NCT01432457|17803743|P1|Overall Study|Reasons not defined|2
5155431|NCT01432457|17803741|P3|Overall Study|Withdrawal by Subject|9
5155432|NCT01432457|17803742|P2|Overall Study|Withdrawal by Subject|11
5155433|NCT01432457|17803743|P1|Overall Study|Withdrawal by Subject|6
5155434|NCT01432457|17803741|P3|Overall Study|Protocol Violation|6
5155435|NCT01432457|17803742|P2|Overall Study|Protocol Violation|2
5155436|NCT01432457|17803743|P1|Overall Study|Protocol Violation|3
5155437|NCT01432457|17803741|P3|Overall Study|Lost to Follow-up|20
5155438|NCT01432457|17803742|P2|Overall Study|Lost to Follow-up|15
5155439|NCT01432457|17803743|P1|Overall Study|Lost to Follow-up|11
5155440|NCT01432457|17803741|P3|Overall Study|Lack of Efficacy|1
5155441|NCT01432457|17803742|P2|Overall Study|Lack of Efficacy|1
5155442|NCT01432457|17803743|P1|Overall Study|Lack of Efficacy|2
5155443|NCT01432457|17803741|P3|Overall Study|Adverse Event|16
5155444|NCT01432457|17803742|P2|Overall Study|Adverse Event|10
5155445|NCT01432457|17803743|P1|Overall Study|Adverse Event|7
5155446|NCT01432444|17803772|P3|Extension Phase|Withdrawal by Subject|13
5155447|NCT01432444|17803773|P2|Extension Phase|Withdrawal by Subject|0
5155448|NCT01432444|17803774|P1|Extension Phase|Withdrawal by Subject|0
5155449|NCT01432444|17803772|P3|Extension Phase|Physician Decision|1
5155450|NCT01432444|17803773|P2|Extension Phase|Physician Decision|0
5155451|NCT01432444|17803774|P1|Extension Phase|Physician Decision|0
5155452|NCT01432444|17803772|P3|Extension Phase|Met Withdrawal Criteria|144
5155453|NCT01432444|17803773|P2|Extension Phase|Met Withdrawal Criteria|0
5155454|NCT01432444|17803774|P1|Extension Phase|Met Withdrawal Criteria|0
5155455|NCT01432444|17803772|P3|Extension Phase|Sponsor Discontinued Trial|7
5155456|NCT01432444|17803773|P2|Extension Phase|Sponsor Discontinued Trial|0
5155457|NCT01432444|17803774|P1|Extension Phase|Sponsor Discontinued Trial|0
5155458|NCT01432444|17803772|P3|Extension Phase|Adverse Event|10
5155459|NCT01432444|17803773|P2|Extension Phase|Adverse Event|0
5155460|NCT01432444|17803774|P1|Extension Phase|Adverse Event|0
5155461|NCT01432444|17803772|P3|Extension Phase|Lost to Follow-up|17
5155462|NCT01432444|17803773|P2|Extension Phase|Lost to Follow-up|0
5155463|NCT01432444|17803774|P1|Extension Phase|Lost to Follow-up|0
5155464|NCT01432444|17803772|P3|Treatment Phase|Lack of Efficacy|0
5155465|NCT01432444|17803773|P2|Treatment Phase|Lack of Efficacy|10
5155466|NCT01432444|17803774|P1|Treatment Phase|Lack of Efficacy|0
5155467|NCT01432444|17803772|P3|Treatment Phase|Protocol Deviation|0
5155468|NCT01432444|17803773|P2|Treatment Phase|Protocol Deviation|3
5155469|NCT01432444|17803774|P1|Treatment Phase|Protocol Deviation|0
5155470|NCT01432444|17803772|P3|Treatment Phase|Withdrawal by Subject|0
5155471|NCT01432444|17803773|P2|Treatment Phase|Withdrawal by Subject|41
5155472|NCT01432444|17803774|P1|Treatment Phase|Withdrawal by Subject|0
5155473|NCT01432444|17803772|P3|Treatment Phase|Physician Decision|0
5155474|NCT01432444|17803773|P2|Treatment Phase|Physician Decision|5
5155475|NCT01432444|17803774|P1|Treatment Phase|Physician Decision|0
5155476|NCT01432444|17803772|P3|Treatment Phase|Met Withdrawal Criteria|0
5155477|NCT01432444|17803773|P2|Treatment Phase|Met Withdrawal Criteria|11
5155478|NCT01432444|17803774|P1|Treatment Phase|Met Withdrawal Criteria|0
5155479|NCT01432444|17803772|P3|Treatment Phase|Adverse Event|0
5155480|NCT01432444|17803773|P2|Treatment Phase|Adverse Event|37
5155481|NCT01432444|17803774|P1|Treatment Phase|Adverse Event|0
5155482|NCT01432444|17803772|P3|Treatment Phase|Lost to Follow-up|0
5155483|NCT01432444|17803773|P2|Treatment Phase|Lost to Follow-up|33
5155484|NCT01432444|17803774|P1|Treatment Phase|Lost to Follow-up|0
5155485|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
5155486|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
5155487|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
5155488|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
5155489|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
5155490|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
5155491|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
5155492|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
5155493|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
5155494|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Physician Decision|0
5155495|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Physician Decision|0
5155496|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Physician Decision|8
5155497|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
5155498|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
5155499|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
5155500|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Adverse Event|0
5155501|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Adverse Event|0
5155502|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Adverse Event|16
5155503|NCT01432444|17803772|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
5155504|NCT01432444|17803773|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
5155505|NCT01432444|17803774|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
5155506|NCT01432366|17803800|P1|Overall Study|Other|14
5155507|NCT01432366|17803800|P1|Overall Study|Investigator Forget to Complete Visits|1
5155508|NCT01432366|17803800|P1|Overall Study|Site Closed|20
5155509|NCT01432366|17803800|P1|Overall Study|Lack of Efficacy|1
5155510|NCT01432366|17803800|P1|Overall Study|Lost to Follow-up|13
5155511|NCT01432366|17803800|P1|Overall Study|Pregnancy|1
5155512|NCT01432366|17803800|P1|Overall Study|Withdrawal Due to Non-Compliance|3
5155513|NCT01432366|17803800|P1|Overall Study|Adverse Event|8
5155514|NCT01432366|17803800|P1|Overall Study|Non-Responder|7
5155515|NCT01432327|17803822|P4|Posttest 1 Year|Allergic reaction|1
5155516|NCT01432327|17803823|P3|Posttest 1 Year|Allergic reaction|1
5155517|NCT01432327|17803824|P2|Posttest 1 Year|Allergic reaction|0
5155518|NCT01432327|17803825|P1|Posttest 1 Year|Allergic reaction|0
5155519|NCT01432327|17803822|P4|Posttest 1 Year|Lost to Follow-up|2
5155520|NCT01432327|17803823|P3|Posttest 1 Year|Lost to Follow-up|4
5155521|NCT01432327|17803824|P2|Posttest 1 Year|Lost to Follow-up|0
5155522|NCT01432327|17803825|P1|Posttest 1 Year|Lost to Follow-up|0
5155523|NCT01432327|17803822|P4|Posttest 1 Year|Measurement have to take place in future|20
5155524|NCT01432327|17803823|P3|Posttest 1 Year|Measurement have to take place in future|15
5155525|NCT01432327|17803824|P2|Posttest 1 Year|Measurement have to take place in future|28
5155526|NCT01432327|17803825|P1|Posttest 1 Year|Measurement have to take place in future|24
5155527|NCT01432327|17803822|P4|Posttest 6 Months|Withdrawal by Subject|0
5155528|NCT01432327|17803823|P3|Posttest 6 Months|Withdrawal by Subject|1
5155529|NCT01432327|17803824|P2|Posttest 6 Months|Withdrawal by Subject|0
5155530|NCT01432327|17803825|P1|Posttest 6 Months|Withdrawal by Subject|0
5155531|NCT01432327|17803822|P4|Posttest 6 Months|Allergic reaction|0
5155532|NCT01432327|17803823|P3|Posttest 6 Months|Allergic reaction|1
5155533|NCT01432327|17803824|P2|Posttest 6 Months|Allergic reaction|0
5155534|NCT01432327|17803825|P1|Posttest 6 Months|Allergic reaction|0
5155535|NCT01432327|17803822|P4|Posttest 6 Months|Lost to Follow-up|2
5155536|NCT01432327|17803823|P3|Posttest 6 Months|Lost to Follow-up|3
5155537|NCT01432327|17803824|P2|Posttest 6 Months|Lost to Follow-up|0
5155538|NCT01432327|17803825|P1|Posttest 6 Months|Lost to Follow-up|0
5155539|NCT01432327|17803822|P4|Posttest 3 Months|Allergic reaction|0
5155540|NCT01432327|17803823|P3|Posttest 3 Months|Allergic reaction|0
5155541|NCT01432327|17803824|P2|Posttest 3 Months|Allergic reaction|2
5155542|NCT01432327|17803825|P1|Posttest 3 Months|Allergic reaction|0
5155543|NCT01432327|17803822|P4|Posttest 3 Months|Lost to Follow-up|1
5155544|NCT01432327|17803823|P3|Posttest 3 Months|Lost to Follow-up|2
5155545|NCT01432327|17803824|P2|Posttest 3 Months|Lost to Follow-up|0
5155546|NCT01432327|17803825|P1|Posttest 3 Months|Lost to Follow-up|1
5155547|NCT01432327|17803822|P4|Posttest 3 Months|depression|0
5155548|NCT01432327|17803823|P3|Posttest 3 Months|depression|0
5155549|NCT01432327|17803824|P2|Posttest 3 Months|depression|0
5155550|NCT01432327|17803825|P1|Posttest 3 Months|depression|3
5155551|NCT01432275|17803835|P2|ADC With Calculator (10 Days)|Protocol Violation|1
5155552|NCT01432275|17803836|P1|ADC With Calculator (10 Days)|Protocol Violation|0
5155553|NCT01432275|17803835|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
5155554|NCT01432275|17803836|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
5155555|NCT01432275|17803835|P2|ADC With Calculator (10 Days)|Physician Decision|1
5155556|NCT01432275|17803836|P1|ADC With Calculator (10 Days)|Physician Decision|1
5155557|NCT01432275|17803835|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
5155558|NCT01432275|17803836|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
5155559|NCT01432275|17803835|P2|Second BG Meter System (7 Days)|Physician Decision|1
5155560|NCT01432275|17803836|P1|Second BG Meter System (7 Days)|Physician Decision|0
5155561|NCT01432275|17803835|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
5155562|NCT01432275|17803836|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
5155563|NCT01432275|17803835|P2|Second BG Meter System (7 Days)|Adverse Event|1
5155564|NCT01432275|17803836|P1|Second BG Meter System (7 Days)|Adverse Event|1
5155565|NCT01432275|17803835|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
5155566|NCT01432275|17803836|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
5155567|NCT01432275|17803835|P2|First BG Meter System (7 Days)|Adverse Event|2
5155568|NCT01432275|17803836|P1|First BG Meter System (7 Days)|Adverse Event|0
5155569|NCT01432262|17803845|P2|Overall Study|Withdrawal by Subject|1
5155570|NCT01432262|17803846|P1|Overall Study|Withdrawal by Subject|2
5155571|NCT01432171|17803912|P2|Overall Study|Patient moved to palliative care|0
5155572|NCT01432171|17803913|P1|Overall Study|Patient moved to palliative care|1
5155573|NCT01432171|17803912|P2|Overall Study|Insurance denial trial coverage|0
5155574|NCT01432171|17803913|P1|Overall Study|Insurance denial trial coverage|1
5155575|NCT01432171|17803912|P2|Overall Study|Noncompliance|3
5155576|NCT01432171|17803913|P1|Overall Study|Noncompliance|2
5155577|NCT01432171|17803912|P2|Overall Study|Withdrawal by Subject|1
5155578|NCT01432171|17803913|P1|Overall Study|Withdrawal by Subject|3
5155579|NCT01432171|17803912|P2|Overall Study|Lost to Follow-up|5
5155580|NCT01432171|17803913|P1|Overall Study|Lost to Follow-up|6
5155581|NCT01432171|17803912|P2|Overall Study|Death|2
5155582|NCT01432171|17803913|P1|Overall Study|Death|1
5155583|NCT01431976|17803954|P1|Overall Study|Withdrawal by Subject|1
5155584|NCT01431976|17803954|P1|Overall Study|Physician Decision|1
5155585|NCT01431976|17803954|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
5155586|NCT01431976|17803954|P1|Overall Study|Lack of Efficacy|2
5155587|NCT01431976|17803954|P1|Overall Study|Adverse Event|6
5155588|NCT01431963|17803965|P1|Overall Study|Withdrawal by Subject|3
5155589|NCT01431963|17803965|P1|Overall Study|Physician Decision|4
5155590|NCT01431963|17803965|P1|Overall Study|Protocol-defined Stopping Criteria|2
5155591|NCT01431963|17803965|P1|Overall Study|Protocol Violation|1
5155592|NCT01431963|17803965|P1|Overall Study|Lack of Efficacy|7
5155593|NCT01431963|17803965|P1|Overall Study|Adverse Event|18
5155594|NCT01431950|17803973|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5155595|NCT01431950|17803974|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
5155596|NCT01431950|17803973|P2|Overall Study|Lost to Follow-up|1
5155597|NCT01431950|17803974|P1|Overall Study|Lost to Follow-up|0
5155598|NCT01431950|17803973|P2|Overall Study|Lack of Efficacy|1
5155599|NCT01431950|17803974|P1|Overall Study|Lack of Efficacy|2
5155600|NCT01431950|17803973|P2|Overall Study|Physician Decision|1
5155601|NCT01431950|17803974|P1|Overall Study|Physician Decision|2
5155602|NCT01431950|17803973|P2|Overall Study|Adverse Event|2
5155603|NCT01431950|17803974|P1|Overall Study|Adverse Event|2
5155604|NCT01431950|17803973|P2|Overall Study|Protocol Violation|3
5155605|NCT01431950|17803974|P1|Overall Study|Protocol Violation|2
5155606|NCT01431950|17803973|P2|Overall Study|Withdrawal by Subject|3
5155607|NCT01431950|17803974|P1|Overall Study|Withdrawal by Subject|4
5155608|NCT01431950|17803973|P2|Overall Study|Study Site Closed/Terminated|3
5155609|NCT01431950|17803974|P1|Overall Study|Study Site Closed/Terminated|7
5155610|NCT01431716|17804039|P1|Overall Study|Withdrawal of consent|1
5155611|NCT01431534|17804063|P3|Treatment Phase|Progressive Disease|10
5155612|NCT01431534|17804064|P2|Treatment Phase|Progressive Disease|3
5155613|NCT01431534|17804065|P1|Treatment Phase|Progressive Disease|4
5155614|NCT01431534|17804063|P3|Treatment Phase|Adverse Event|1
5155615|NCT01431534|17804064|P2|Treatment Phase|Adverse Event|0
5155616|NCT01431534|17804065|P1|Treatment Phase|Adverse Event|0
5155617|NCT01431521|17804080|P4|Overall Study|Withdrawal by Subject|0
5155618|NCT01431521|17804081|P3|Overall Study|Withdrawal by Subject|1
5155619|NCT01431521|17804082|P2|Overall Study|Withdrawal by Subject|0
5155620|NCT01431521|17804083|P1|Overall Study|Withdrawal by Subject|0
5155621|NCT01431508|17804104|P1|Overall Study|Unable to Follow Protocol Procedures|1
5155622|NCT01431508|17804104|P1|Overall Study|Lack of Efficacy|1
5155623|NCT01431287|17804189|P5|Overall Study|not stated above|1
5155624|NCT01431287|17804190|P4|Overall Study|not stated above|2
5155625|NCT01431287|17804191|P3|Overall Study|not stated above|2
5155626|NCT01431287|17804192|P2|Overall Study|not stated above|2
5155627|NCT01431287|17804193|P1|Overall Study|not stated above|4
5155628|NCT01431287|17804189|P5|Overall Study|Consent withdrawn not due to AE|29
5155629|NCT01431287|17804190|P4|Overall Study|Consent withdrawn not due to AE|19
5155630|NCT01431287|17804191|P3|Overall Study|Consent withdrawn not due to AE|34
5155631|NCT01431287|17804192|P2|Overall Study|Consent withdrawn not due to AE|30
5155632|NCT01431287|17804193|P1|Overall Study|Consent withdrawn not due to AE|29
5155633|NCT01431287|17804189|P5|Overall Study|Lost to Follow-up|1
5155634|NCT01431287|17804190|P4|Overall Study|Lost to Follow-up|3
5155635|NCT01431287|17804191|P3|Overall Study|Lost to Follow-up|2
5155636|NCT01431287|17804192|P2|Overall Study|Lost to Follow-up|3
5155637|NCT01431287|17804193|P1|Overall Study|Lost to Follow-up|0
5155638|NCT01431287|17804189|P5|Overall Study|Non compliant with protocol|5
5155639|NCT01431287|17804190|P4|Overall Study|Non compliant with protocol|6
5155640|NCT01431287|17804191|P3|Overall Study|Non compliant with protocol|5
5155641|NCT01431287|17804192|P2|Overall Study|Non compliant with protocol|6
5155642|NCT01431287|17804193|P1|Overall Study|Non compliant with protocol|6
5155643|NCT01431287|17804189|P5|Overall Study|Adverse Event|41
5155644|NCT01431287|17804190|P4|Overall Study|Adverse Event|33
5155645|NCT01431287|17804191|P3|Overall Study|Adverse Event|53
5155646|NCT01431287|17804192|P2|Overall Study|Adverse Event|57
5155647|NCT01431287|17804193|P1|Overall Study|Adverse Event|59
5155648|NCT01431287|17804189|P5|Overall Study|not treated|0
5155649|NCT01431287|17804190|P4|Overall Study|not treated|0
5155650|NCT01431287|17804191|P3|Overall Study|not treated|1
5155651|NCT01431287|17804192|P2|Overall Study|not treated|0
5155652|NCT01431287|17804193|P1|Overall Study|not treated|0
5155653|NCT01431274|17804355|P5|Overall Study|Other reason not stated above|4
5155654|NCT01431274|17804356|P4|Overall Study|Other reason not stated above|2
5155655|NCT01431274|17804357|P3|Overall Study|Other reason not stated above|7
5155656|NCT01431274|17804358|P2|Overall Study|Other reason not stated above|5
5155657|NCT01431274|17804359|P1|Overall Study|Other reason not stated above|6
5155658|NCT01431274|17804355|P5|Overall Study|Lost to Follow-up|0
5155659|NCT01431274|17804356|P4|Overall Study|Lost to Follow-up|4
5155660|NCT01431274|17804357|P3|Overall Study|Lost to Follow-up|1
5155661|NCT01431274|17804358|P2|Overall Study|Lost to Follow-up|7
5155662|NCT01431274|17804359|P1|Overall Study|Lost to Follow-up|6
5155663|NCT01431274|17804355|P5|Overall Study|Non compliant with protocol|4
5155664|NCT01431274|17804356|P4|Overall Study|Non compliant with protocol|4
5155665|NCT01431274|17804357|P3|Overall Study|Non compliant with protocol|4
5155666|NCT01431274|17804358|P2|Overall Study|Non compliant with protocol|8
5155667|NCT01431274|17804359|P1|Overall Study|Non compliant with protocol|5
5155668|NCT01431274|17804355|P5|Overall Study|Consent withdrawn not due to AE|11
5155669|NCT01431274|17804356|P4|Overall Study|Consent withdrawn not due to AE|20
5155670|NCT01431274|17804357|P3|Overall Study|Consent withdrawn not due to AE|17
5155671|NCT01431274|17804358|P2|Overall Study|Consent withdrawn not due to AE|20
5155672|NCT01431274|17804359|P1|Overall Study|Consent withdrawn not due to AE|29
5155673|NCT01431274|17804355|P5|Overall Study|Adverse Event|37
5155674|NCT01431274|17804356|P4|Overall Study|Adverse Event|30
5155675|NCT01431274|17804357|P3|Overall Study|Adverse Event|43
5155676|NCT01431274|17804358|P2|Overall Study|Adverse Event|37
5155677|NCT01431274|17804359|P1|Overall Study|Adverse Event|51
5155678|NCT01431144|17804537|P2|Overall Study|Implant mobility and removal|0
5155679|NCT01431144|17804538|P1|Overall Study|Implant mobility and removal|2
5155680|NCT01431079|17804561|P2|Overall Study|Lost to Follow-up|39
5155681|NCT01431079|17804562|P1|Overall Study|Lost to Follow-up|35
5155682|NCT01430754|17804641|P2|Run-In Phase|Lost to Follow-up|0
5155683|NCT01430754|17804642|P1|Run-In Phase|Lost to Follow-up|1
5155684|NCT01430754|17804641|P2|Run-In Phase|Withdrawal by Subject|0
5155685|NCT01430754|17804642|P1|Run-In Phase|Withdrawal by Subject|2
5155686|NCT01430754|17804641|P2|Run-In Phase|Other|0
5155687|NCT01430754|17804642|P1|Run-In Phase|Other|2
5155688|NCT01430754|17804641|P2|Run-In Phase|Adverse Event|0
5155689|NCT01430754|17804642|P1|Run-In Phase|Adverse Event|2
5155690|NCT01430754|17804641|P2|Run-In Phase|Protocol Violation|0
5155691|NCT01430754|17804642|P1|Run-In Phase|Protocol Violation|6
5155692|NCT01430754|17804641|P2|Run-In Phase|Circadian Period Ineligible|0
5155693|NCT01430754|17804642|P1|Run-In Phase|Circadian Period Ineligible|24
5155694|NCT01430624|17804700|P3|Overall Study|technical or eligibility|2
5155695|NCT01430624|17804701|P2|Overall Study|technical or eligibility|5
5155696|NCT01430624|17804702|P1|Overall Study|technical or eligibility|5
5155697|NCT01430624|17804700|P3|Overall Study|Lost to Follow-up|27
5155698|NCT01430624|17804701|P2|Overall Study|Lost to Follow-up|29
5155699|NCT01430624|17804702|P1|Overall Study|Lost to Follow-up|23
5155700|NCT01430611|17804733|P2|Overall Study|Withdrawal by Subject|14
5155701|NCT01430611|17804734|P1|Overall Study|Withdrawal by Subject|15
5155702|NCT01430611|17804733|P2|Overall Study|Lost to Follow-up|0
5155703|NCT01430611|17804734|P1|Overall Study|Lost to Follow-up|1
5155704|NCT01430611|17804733|P2|Overall Study|Protocol Violation|0
5155705|NCT01430611|17804734|P1|Overall Study|Protocol Violation|1
5155706|NCT01430611|17804733|P2|Overall Study|Adverse Event|1
5155707|NCT01430611|17804734|P1|Overall Study|Adverse Event|0
5155708|NCT01430585|17804752|P1|Overall Study|Other|7
5155709|NCT01430585|17804752|P1|Overall Study|Study Terminated by Sponsor|3
5155710|NCT01430585|17804752|P1|Overall Study|Objective Progression or Relapse|3
5155711|NCT01430585|17804752|P1|Overall Study|Death|1
5155712|NCT01430468|17804787|P2|Overall Study|Withdrawal by Subject|5
5155713|NCT01430468|17804788|P1|Overall Study|Withdrawal by Subject|5
5155714|NCT01430468|17804787|P2|Overall Study|Physician Decision|1
5155715|NCT01430468|17804788|P1|Overall Study|Physician Decision|2
5155716|NCT01430455|17804796|P1|Overall Study|Switched to follow-up phase|1
5155717|NCT01430455|17804796|P1|Overall Study|Withdrawal by Subject|1
5155718|NCT01430442|17804808|P8|Overall Study|Patient No Longer Meets Study Criteria|6
5155719|NCT01430442|17804809|P7|Overall Study|Patient No Longer Meets Study Criteria|9
5155720|NCT01430442|17804810|P6|Overall Study|Patient No Longer Meets Study Criteria|5
5155721|NCT01430442|17804811|P5|Overall Study|Patient No Longer Meets Study Criteria|5
5155722|NCT01430442|17804812|P4|Overall Study|Patient No Longer Meets Study Criteria|2
5155723|NCT01430442|17804813|P3|Overall Study|Patient No Longer Meets Study Criteria|3
5155724|NCT01430442|17804814|P2|Overall Study|Patient No Longer Meets Study Criteria|6
5155725|NCT01430442|17804815|P1|Overall Study|Patient No Longer Meets Study Criteria|7
5155726|NCT01430442|17804808|P8|Overall Study|Pregnancy|0
5155727|NCT01430442|17804809|P7|Overall Study|Pregnancy|0
5155728|NCT01430442|17804810|P6|Overall Study|Pregnancy|1
5155729|NCT01430442|17804811|P5|Overall Study|Pregnancy|0
5155730|NCT01430442|17804812|P4|Overall Study|Pregnancy|0
5155731|NCT01430442|17804813|P3|Overall Study|Pregnancy|0
5155732|NCT01430442|17804814|P2|Overall Study|Pregnancy|0
5155733|NCT01430442|17804815|P1|Overall Study|Pregnancy|1
5155734|NCT01430442|17804808|P8|Overall Study|Lost to Follow-up|1
5155735|NCT01430442|17804809|P7|Overall Study|Lost to Follow-up|5
5155736|NCT01430442|17804810|P6|Overall Study|Lost to Follow-up|1
5155737|NCT01430442|17804811|P5|Overall Study|Lost to Follow-up|2
5155738|NCT01430442|17804812|P4|Overall Study|Lost to Follow-up|2
5155739|NCT01430442|17804813|P3|Overall Study|Lost to Follow-up|1
5155740|NCT01430442|17804814|P2|Overall Study|Lost to Follow-up|0
5155741|NCT01430442|17804815|P1|Overall Study|Lost to Follow-up|2
5155742|NCT01430442|17804808|P8|Overall Study|Subject Withdrew Consent|2
5155743|NCT01430442|17804809|P7|Overall Study|Subject Withdrew Consent|5
5155744|NCT01430442|17804810|P6|Overall Study|Subject Withdrew Consent|1
5155745|NCT01430442|17804811|P5|Overall Study|Subject Withdrew Consent|2
5155746|NCT01430442|17804812|P4|Overall Study|Subject Withdrew Consent|0
5155747|NCT01430442|17804813|P3|Overall Study|Subject Withdrew Consent|1
5155748|NCT01430442|17804814|P2|Overall Study|Subject Withdrew Consent|0
5155749|NCT01430442|17804815|P1|Overall Study|Subject Withdrew Consent|3
5155750|NCT01430403|17804868|P3|Overall Study|Withdrawal by Subject|3
5155751|NCT01430403|17804869|P2|Overall Study|Withdrawal by Subject|1
5155752|NCT01430403|17804870|P1|Overall Study|Withdrawal by Subject|9
5155753|NCT01430403|17804868|P3|Overall Study|Protocol Violation|2
5155754|NCT01430403|17804869|P2|Overall Study|Protocol Violation|3
5155755|NCT01430403|17804870|P1|Overall Study|Protocol Violation|2
5155756|NCT01430403|17804868|P3|Overall Study|Physician Decision|0
5155757|NCT01430403|17804869|P2|Overall Study|Physician Decision|0
5155758|NCT01430403|17804870|P1|Overall Study|Physician Decision|1
5155759|NCT01430403|17804868|P3|Overall Study|Lost to Follow-up|3
5155760|NCT01430403|17804869|P2|Overall Study|Lost to Follow-up|5
5155761|NCT01430403|17804870|P1|Overall Study|Lost to Follow-up|5
5155762|NCT01430130|17804977|P1|Overall Study|Infection on Control Side of Incision|1
5155763|NCT01430130|17804977|P1|Overall Study|Lost to Follow-up|1
5155764|NCT01430104|17804983|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
5155765|NCT01429792|17805050|P1|Overall Study|Lost to Follow-up|88
5155766|NCT01429792|17805050|P1|Overall Study|Withdrawal by Subject|70
5155767|NCT01429792|17805050|P1|Overall Study|Positive HCV-RNA at Week 24|50
5155768|NCT01429792|17805050|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
5155769|NCT01429792|17805050|P1|Overall Study|Negative HCV-RNA at Week 12|4
5155770|NCT01429792|17805050|P1|Overall Study|Negative HCV-RNA at Week 4|1
5155771|NCT01429792|17805050|P1|Overall Study|Unknown Disposition|94
5155772|NCT01429792|17805050|P1|Overall Study|Other Reasons|67
5155773|NCT01429623|17805064|P2|Overall Study|No post baseline data|4
5155774|NCT01429623|17805065|P1|Overall Study|No post baseline data|4
5155775|NCT01429623|17805064|P2|Overall Study|Conversion to Alzheimer's disease|21
5155776|NCT01429623|17805065|P1|Overall Study|Conversion to Alzheimer's disease|14
5155777|NCT01429623|17805064|P2|Overall Study|Assorted|2
5155778|NCT01429623|17805065|P1|Overall Study|Assorted|1
5155779|NCT01429623|17805064|P2|Overall Study|Protocol Violation|2
5155780|NCT01429623|17805065|P1|Overall Study|Protocol Violation|3
5155781|NCT01429623|17805064|P2|Overall Study|Physician Decision|3
5155782|NCT01429623|17805065|P1|Overall Study|Physician Decision|2
5155783|NCT01429623|17805064|P2|Overall Study|Withdrawal by Subject|13
5155784|NCT01429623|17805065|P1|Overall Study|Withdrawal by Subject|19
5155785|NCT01429623|17805064|P2|Overall Study|Adverse Event|14
5155786|NCT01429623|17805065|P1|Overall Study|Adverse Event|7
5155787|NCT01429623|17805064|P2|Overall Study|Death|0
5155788|NCT01429623|17805065|P1|Overall Study|Death|1
5155789|NCT01429584|17805079|P2|Overall Study|Protocol Violation|1
5155790|NCT01429584|17805080|P1|Overall Study|Protocol Violation|0
5155791|NCT01429584|17805079|P2|Overall Study|Withdrawal by Subject|0
5155792|NCT01429584|17805080|P1|Overall Study|Withdrawal by Subject|1
5155793|NCT01429441|17805122|P2|Overall Study|Withdrawal by Subject|18
5155794|NCT01429441|17805123|P1|Overall Study|Withdrawal by Subject|27
5155795|NCT01429441|17805122|P2|Overall Study|Physician Decision|0
5155796|NCT01429441|17805123|P1|Overall Study|Physician Decision|1
5155797|NCT01429441|17805122|P2|Overall Study|Lost to Follow-up|2
5155798|NCT01429441|17805123|P1|Overall Study|Lost to Follow-up|5
5155799|NCT01429441|17805122|P2|Overall Study|Death|2
5155800|NCT01429441|17805123|P1|Overall Study|Death|0
5155801|NCT01429441|17805122|P2|Overall Study|Adverse Event|1
5155802|NCT01429441|17805123|P1|Overall Study|Adverse Event|5
5155803|NCT01429298|17805148|P2|Overall Study|Protocol Violation|6
5155804|NCT01429298|17805149|P1|Overall Study|Protocol Violation|4
5155805|NCT01429285|17805165|P2|Overall Study|Erroneously Enrolled Twice|2
5155806|NCT01429285|17805166|P1|Overall Study|Erroneously Enrolled Twice|8
5155807|NCT01429285|17805165|P2|Overall Study|Missing Data|3
5155808|NCT01429285|17805166|P1|Overall Study|Missing Data|5
5155809|NCT01429285|17805165|P2|Overall Study|Protocol Violation|4
5155810|NCT01429285|17805166|P1|Overall Study|Protocol Violation|9
5155811|NCT01429077|17805212|P2|Overall Study|Lost to Follow-up|3
5155812|NCT01429077|17805213|P1|Overall Study|Lost to Follow-up|0
5155813|NCT01429051|17805236|P1|Tolerability Phase|Other|2
5155814|NCT01429051|17805236|P1|Tolerability Phase|Physician Decision|1
5155815|NCT01429051|17805236|P1|Tolerability Phase|Withdrawal by Subject|5
5155816|NCT01429051|17805236|P1|Tolerability Phase|Adverse Event|2
5155817|NCT01429051|17805236|P1|Tolerability Phase|Death|5
5155818|NCT01429051|17805236|P1|Efficacy Phase|Death|1
5155819|NCT01429051|17805236|P1|Efficacy Phase|Adverse Event|1
5155820|NCT01429051|17805236|P1|Titration Phase|Less than 3 BTP episodes per week|2
5155821|NCT01429051|17805236|P1|Titration Phase|Unsuccessful titration at any dose|1
5155822|NCT01429051|17805236|P1|Titration Phase|Physician Decision|1
5155823|NCT01429051|17805236|P1|Titration Phase|Withdrawal by Subject|7
5155824|NCT01429051|17805236|P1|Titration Phase|Death|1
5155825|NCT01428882|17805259|P2|Overall Study|Protocol Violation|3
5155826|NCT01428882|17805260|P1|Overall Study|Protocol Violation|4
5155827|NCT01428882|17805259|P2|Overall Study|Lack of Efficacy|7
5155828|NCT01428882|17805260|P1|Overall Study|Lack of Efficacy|2
5155829|NCT01428713|17805283|P2|Overall Study|Adverse Event|2
5155830|NCT01428713|17805284|P1|Overall Study|Adverse Event|0
5155831|NCT01428713|17805283|P2|Overall Study|Withdrawal by Subject|1
5155832|NCT01428713|17805284|P1|Overall Study|Withdrawal by Subject|1
5155833|NCT01428713|17805283|P2|Overall Study|Non-compliance|2
5155834|NCT01428713|17805284|P1|Overall Study|Non-compliance|2
5155835|NCT01428661|17805293|P3|Open Label Extension|**Various|185
5155836|NCT01428661|17805294|P2|Open Label Extension|**Various|0
5155837|NCT01428661|17805295|P1|Open Label Extension|**Various|0
5155838|NCT01428661|17805293|P3|Open Label Extension|Lack of Efficacy|24
5155839|NCT01428661|17805294|P2|Open Label Extension|Lack of Efficacy|0
5155840|NCT01428661|17805295|P1|Open Label Extension|Lack of Efficacy|0
5155841|NCT01428661|17805293|P3|Open Label Extension|Withdrawal by Subject|49
5155842|NCT01428661|17805294|P2|Open Label Extension|Withdrawal by Subject|0
5155843|NCT01428661|17805295|P1|Open Label Extension|Withdrawal by Subject|0
5155844|NCT01428661|17805293|P3|Open Label Extension|Lost to Follow-up|38
5155845|NCT01428661|17805294|P2|Open Label Extension|Lost to Follow-up|0
5155846|NCT01428661|17805295|P1|Open Label Extension|Lost to Follow-up|0
5155847|NCT01428661|17805293|P3|Open Label Extension|Adverse Event|15
5155848|NCT01428661|17805294|P2|Open Label Extension|Adverse Event|0
5155849|NCT01428661|17805295|P1|Open Label Extension|Adverse Event|0
5155850|NCT01428661|17805293|P3|Open Label Extension|Protocol Violation|9
5155851|NCT01428661|17805294|P2|Open Label Extension|Protocol Violation|0
5155852|NCT01428661|17805295|P1|Open Label Extension|Protocol Violation|0
5155853|NCT01428661|17805293|P3|Double-Masked Phase|*Various|0
5155854|NCT01428661|17805294|P2|Double-Masked Phase|*Various|6
5155855|NCT01428661|17805295|P1|Double-Masked Phase|*Various|1
5155856|NCT01428661|17805293|P3|Double-Masked Phase|Lack of Efficacy|0
5155857|NCT01428661|17805294|P2|Double-Masked Phase|Lack of Efficacy|1
5155858|NCT01428661|17805295|P1|Double-Masked Phase|Lack of Efficacy|2
5155859|NCT01428661|17805293|P3|Double-Masked Phase|Withdrawal by Subject|0
5155860|NCT01428661|17805294|P2|Double-Masked Phase|Withdrawal by Subject|20
5155861|NCT01428661|17805295|P1|Double-Masked Phase|Withdrawal by Subject|18
5155862|NCT01428661|17805293|P3|Double-Masked Phase|Lost to Follow-up|0
5155863|NCT01428661|17805294|P2|Double-Masked Phase|Lost to Follow-up|14
5155864|NCT01428661|17805295|P1|Double-Masked Phase|Lost to Follow-up|14
5155865|NCT01428661|17805293|P3|Double-Masked Phase|Adverse Event|0
5155866|NCT01428661|17805294|P2|Double-Masked Phase|Adverse Event|4
5155867|NCT01428661|17805295|P1|Double-Masked Phase|Adverse Event|13
5155868|NCT01428661|17805293|P3|Double-Masked Phase|Protocol Violation|0
5155869|NCT01428661|17805294|P2|Double-Masked Phase|Protocol Violation|4
5155870|NCT01428661|17805295|P1|Double-Masked Phase|Protocol Violation|9
5155871|NCT01428583|17805303|P1|Overall Study|Other|6
5155872|NCT01428583|17805303|P1|Overall Study|Sponsor's request|3
5155873|NCT01428583|17805303|P1|Overall Study|Confirmed positive urine drug test|8
5155874|NCT01428583|17805303|P1|Overall Study|Non-compliant|25
5155875|NCT01428583|17805303|P1|Overall Study|Physician Decision|12
5155876|NCT01428583|17805303|P1|Overall Study|Protocol Violation|1
5155877|NCT01428583|17805303|P1|Overall Study|Pregnancy|1
5155878|NCT01428583|17805303|P1|Overall Study|Death|1
5155879|NCT01428583|17805303|P1|Overall Study|Lost to Follow-up|17
5155880|NCT01428583|17805303|P1|Overall Study|Lack of Efficacy|37
5155881|NCT01428583|17805303|P1|Overall Study|Withdrawal by Subject|51
5155882|NCT01428583|17805303|P1|Overall Study|Adverse Event|75
5155883|NCT01428453|17805327|P2|Overall Study|Withdrawal by Subject|1
5155884|NCT01428453|17805328|P1|Overall Study|Withdrawal by Subject|3
5155885|NCT01428453|17805327|P2|Overall Study|Lost to Follow-up|1
5155886|NCT01428453|17805328|P1|Overall Study|Lost to Follow-up|0
5155887|NCT01428453|17805327|P2|Overall Study|Protocol Violation|0
5155888|NCT01428453|17805328|P1|Overall Study|Protocol Violation|1
5155889|NCT01428453|17805327|P2|Overall Study|Adverse Event|7
5155890|NCT01428453|17805328|P1|Overall Study|Adverse Event|2
5155891|NCT01428258|17805367|P2|Intervention 1|Withdrawal by Subject|0
5155892|NCT01428258|17805368|P1|Intervention 1|Withdrawal by Subject|2
5155893|NCT01428219|17805386|P1|Overall Study|25 patients enrolled, 3 were not treated|3
5155894|NCT01428193|17805397|P1|Overall Study|Elevated screening liver enzymes|1
5155895|NCT01428193|17805397|P1|Overall Study|Physician Decision|1
5155896|NCT01428128|17805401|P1|Overall Study|Adverse Event|1
5155897|NCT01428128|17805401|P1|Overall Study|Received Neulasta in one cycle|2
5155898|NCT01428128|17805401|P1|Overall Study|Screen failure by p53|10
5155899|NCT01428128|17805401|P1|Overall Study|Withdrawal by Subject|4
5155900|NCT01428115|17805406|P1|Overall Study|Withdrawal by Subject|4
5155901|NCT01428115|17805406|P1|Overall Study|Protocol Violation|3
5155902|NCT01428115|17805406|P1|Overall Study|Pregnancy|1
5155903|NCT01428115|17805406|P1|Overall Study|Lost to Follow-up|10
5155904|NCT01428115|17805406|P1|Overall Study|Lack of Efficacy|3
5155905|NCT01428076|17805421|P2|Overall Study|Adverse Event|1
5155906|NCT01428076|17805422|P1|Overall Study|Adverse Event|0
5155907|NCT01428063|17805433|P3|Overall Study|No longer meets study criteria|0
5155908|NCT01428063|17805434|P2|Overall Study|No longer meets study criteria|1
5155909|NCT01428063|17805435|P1|Overall Study|No longer meets study criteria|0
5155910|NCT01428063|17805433|P3|Overall Study|Lost to Follow-up|0
5155911|NCT01428063|17805434|P2|Overall Study|Lost to Follow-up|2
5155912|NCT01428063|17805435|P1|Overall Study|Lost to Follow-up|0
5155913|NCT01428063|17805433|P3|Overall Study|Adverse Event|0
5155914|NCT01428063|17805434|P2|Overall Study|Adverse Event|3
5155915|NCT01428063|17805435|P1|Overall Study|Adverse Event|2
5155916|NCT01428063|17805433|P3|Overall Study|Lack of Efficacy|1
5155917|NCT01428063|17805434|P2|Overall Study|Lack of Efficacy|4
5155918|NCT01428063|17805435|P1|Overall Study|Lack of Efficacy|8
5155919|NCT01427972|17805536|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155920|NCT01427972|17805537|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155921|NCT01427972|17805538|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155922|NCT01427972|17805539|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155923|NCT01427972|17805540|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155924|NCT01427972|17805541|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155925|NCT01427972|17805542|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155926|NCT01427972|17805543|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155927|NCT01427972|17805544|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155928|NCT01427972|17805545|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155929|NCT01427972|17805546|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
5155930|NCT01427972|17805547|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5155931|NCT01427972|17805536|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155932|NCT01427972|17805537|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155933|NCT01427972|17805538|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155934|NCT01427972|17805539|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155935|NCT01427972|17805540|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155936|NCT01427972|17805541|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155937|NCT01427972|17805542|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
5155938|NCT01427972|17805543|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155939|NCT01427972|17805544|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155940|NCT01427972|17805545|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155941|NCT01427972|17805546|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155942|NCT01427972|17805547|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
5155943|NCT01427972|17805536|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
5155944|NCT01427972|17805537|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
5155945|NCT01427972|17805538|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
5155946|NCT01427972|17805539|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
5155947|NCT01427972|17805540|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
5155948|NCT01427972|17805541|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
5155949|NCT01427972|17805542|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
5155950|NCT01427972|17805543|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
5155951|NCT01427972|17805544|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
5155952|NCT01427972|17805545|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
5155953|NCT01427972|17805546|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
5155954|NCT01427972|17805547|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
5155955|NCT01427933|17805573|P2|Overall Study|Investigator's Decision|0
5155956|NCT01427933|17805574|P1|Overall Study|Investigator's Decision|1
5155957|NCT01427933|17805573|P2|Overall Study|Other|0
5155958|NCT01427933|17805574|P1|Overall Study|Other|1
5155959|NCT01427933|17805573|P2|Overall Study|Lost to Follow-up|5
5155960|NCT01427933|17805574|P1|Overall Study|Lost to Follow-up|1
5155961|NCT01427933|17805573|P2|Overall Study|Withdrawal by Subject|8
5155962|NCT01427933|17805574|P1|Overall Study|Withdrawal by Subject|5
5155963|NCT01427920|17805594|P2|Overall Study|Unclassified|8
5155964|NCT01427920|17805595|P1|Overall Study|Unclassified|2
5155965|NCT01427920|17805594|P2|Overall Study|Withdrawal Criteria|4
5155966|NCT01427920|17805595|P1|Overall Study|Withdrawal Criteria|4
5155967|NCT01427920|17805594|P2|Overall Study|Protocol Violation|3
5155968|NCT01427920|17805595|P1|Overall Study|Protocol Violation|1
5155969|NCT01427920|17805594|P2|Overall Study|Lack of Efficacy|0
5155970|NCT01427920|17805595|P1|Overall Study|Lack of Efficacy|1
5155971|NCT01427920|17805594|P2|Overall Study|Adverse Event|2
5155972|NCT01427920|17805595|P1|Overall Study|Adverse Event|1
5155973|NCT01427907|17805615|P2|Overall Study|Withdrawal by Subject|4
5155974|NCT01427907|17805616|P1|Overall Study|Withdrawal by Subject|3
5155975|NCT01427803|17805637|P2|Overall Study|did not take product|0
5155976|NCT01427803|17805638|P1|Overall Study|did not take product|1
5155977|NCT01427803|17805637|P2|Overall Study|Physician Decision|0
5155978|NCT01427803|17805638|P1|Overall Study|Physician Decision|3
5155979|NCT01427803|17805637|P2|Overall Study|Protocol Violation|0
5155980|NCT01427803|17805638|P1|Overall Study|Protocol Violation|1
5155981|NCT01427803|17805637|P2|Overall Study|Unable to complete full treatment period|0
5155982|NCT01427803|17805638|P1|Overall Study|Unable to complete full treatment period|6
5155983|NCT01427803|17805637|P2|Overall Study|Withdrawal by Subject|0
5155984|NCT01427803|17805638|P1|Overall Study|Withdrawal by Subject|20
5155985|NCT01427803|17805637|P2|Overall Study|Lost to Follow-up|26
5155986|NCT01427803|17805638|P1|Overall Study|Lost to Follow-up|32
5155987|NCT01427751|17805652|P2|Overall Study|Other miscellaneous reasons|4
5155988|NCT01427751|17805653|P1|Overall Study|Other miscellaneous reasons|6
5155989|NCT01427751|17805652|P2|Overall Study|Death|0
5155990|NCT01427751|17805653|P1|Overall Study|Death|2
5155991|NCT01427751|17805652|P2|Overall Study|Protocol Violation|4
5155992|NCT01427751|17805653|P1|Overall Study|Protocol Violation|6
5155993|NCT01427751|17805652|P2|Overall Study|Withdrawal of consent|2
5155994|NCT01427751|17805653|P1|Overall Study|Withdrawal of consent|2
5155995|NCT01427751|17805652|P2|Overall Study|Lost to Follow-up|1
5155996|NCT01427751|17805653|P1|Overall Study|Lost to Follow-up|3
5155997|NCT01427751|17805652|P2|Overall Study|No further treatment benefit expected|1
5155998|NCT01427751|17805653|P1|Overall Study|No further treatment benefit expected|5
5155999|NCT01427751|17805652|P2|Overall Study|Adverse Event|2
5156000|NCT01427751|17805653|P1|Overall Study|Adverse Event|18
5156001|NCT01427738|17805673|P2|Overall Study|Lost to Follow-up|5
5156002|NCT01427738|17805674|P1|Overall Study|Lost to Follow-up|1
5156003|NCT01427738|17805673|P2|Overall Study|Subject not willing to adhere to reqs|2
5156004|NCT01427738|17805674|P1|Overall Study|Subject not willing to adhere to reqs|1
5156005|NCT01427738|17805673|P2|Overall Study|Withdrawal by Subject|2
5156006|NCT01427738|17805674|P1|Overall Study|Withdrawal by Subject|0
5156007|NCT01427738|17805673|P2|Overall Study|Subject unable to get to clinic|2
5156008|NCT01427738|17805674|P1|Overall Study|Subject unable to get to clinic|5
5156009|NCT01427738|17805673|P2|Overall Study|Severe debilitation, unable to continue|1
5156010|NCT01427738|17805674|P1|Overall Study|Severe debilitation, unable to continue|0
5156011|NCT01427738|17805673|P2|Overall Study|Death|9
5156012|NCT01427738|17805674|P1|Overall Study|Death|12
5156013|NCT01427608|17805694|P2|Overall Study|Events not attributed to study meds|1
5156014|NCT01427608|17805695|P1|Overall Study|Events not attributed to study meds|0
5156015|NCT01427608|17805694|P2|Overall Study|Relapsed-all cause|34
5156016|NCT01427608|17805695|P1|Overall Study|Relapsed-all cause|13
5156017|NCT01427608|17805694|P2|Overall Study|Withdrawal by Subject|3
5156018|NCT01427608|17805695|P1|Overall Study|Withdrawal by Subject|7
5156019|NCT01427608|17805694|P2|Overall Study|Death|0
5156020|NCT01427608|17805695|P1|Overall Study|Death|1
5156021|NCT01427309|17805752|P4|Overall Study|Withdrawal by Subject|55
5156022|NCT01427309|17805753|P3|Overall Study|Withdrawal by Subject|61
5156023|NCT01427309|17805754|P2|Overall Study|Withdrawal by Subject|148
5156024|NCT01427309|17805755|P1|Overall Study|Withdrawal by Subject|148
5156025|NCT01427309|17805752|P4|Overall Study|Serious adverse event|61
5156026|NCT01427309|17805753|P3|Overall Study|Serious adverse event|50
5156027|NCT01427309|17805754|P2|Overall Study|Serious adverse event|45
5156028|NCT01427309|17805755|P1|Overall Study|Serious adverse event|52
5156029|NCT01427309|17805752|P4|Overall Study|Adverse Event|1
5156030|NCT01427309|17805753|P3|Overall Study|Adverse Event|3
5156031|NCT01427309|17805754|P2|Overall Study|Adverse Event|0
5156032|NCT01427309|17805755|P1|Overall Study|Adverse Event|0
5156033|NCT01427309|17805752|P4|Overall Study|Protocol Violation|124
5156034|NCT01427309|17805753|P3|Overall Study|Protocol Violation|125
5156035|NCT01427309|17805754|P2|Overall Study|Protocol Violation|69
5156036|NCT01427309|17805755|P1|Overall Study|Protocol Violation|42
5156037|NCT01427309|17805752|P4|Overall Study|Lost to Follow-up|135
5156038|NCT01427309|17805753|P3|Overall Study|Lost to Follow-up|122
5156039|NCT01427309|17805754|P2|Overall Study|Lost to Follow-up|145
5156040|NCT01427309|17805755|P1|Overall Study|Lost to Follow-up|130
5156041|NCT01426958|17805802|P1|Overall Study|Adverse Event|2
5156042|NCT01426854|17805831|P2|Overall Study|Other|2
5156043|NCT01426854|17805832|P1|Overall Study|Other|3
5156044|NCT01426854|17805831|P2|Overall Study|Protocol Deviation|1
5156045|NCT01426854|17805832|P1|Overall Study|Protocol Deviation|0
5156046|NCT01426854|17805831|P2|Overall Study|Treatment Failure|16
5156047|NCT01426854|17805832|P1|Overall Study|Treatment Failure|0
5156048|NCT01426854|17805831|P2|Overall Study|Noncompliance|1
5156049|NCT01426854|17805832|P1|Overall Study|Noncompliance|0
5156050|NCT01426854|17805831|P2|Overall Study|Lost to Follow-up|0
5156051|NCT01426854|17805832|P1|Overall Study|Lost to Follow-up|3
5156052|NCT01426854|17805831|P2|Overall Study|Subject Decision Unrelated to AE|6
5156053|NCT01426854|17805832|P1|Overall Study|Subject Decision Unrelated to AE|5
5156054|NCT01426854|17805831|P2|Overall Study|Adverse Event|5
5156055|NCT01426854|17805832|P1|Overall Study|Adverse Event|1
5156056|NCT01426789|17805842|P6|Part 2|Adverse Event|0
5156057|NCT01426789|17805843|P5|Part 2|Adverse Event|1
5156058|NCT01426789|17805844|P4|Part 2|Adverse Event|0
5156059|NCT01426789|17805845|P3|Part 2|Adverse Event|2
5156060|NCT01426789|17805846|P2|Part 2|Adverse Event|0
5156061|NCT01426789|17805847|P1|Part 2|Adverse Event|0
5156062|NCT01426789|17805842|P6|Part 2|Lack of Efficacy|0
5156063|NCT01426789|17805843|P5|Part 2|Lack of Efficacy|2
5156064|NCT01426789|17805844|P4|Part 2|Lack of Efficacy|0
5156065|NCT01426789|17805845|P3|Part 2|Lack of Efficacy|5
5156066|NCT01426789|17805846|P2|Part 2|Lack of Efficacy|0
5156067|NCT01426789|17805847|P1|Part 2|Lack of Efficacy|0
5156068|NCT01426789|17805842|P6|Part 2|Withdrawal by Subject|0
5156069|NCT01426789|17805843|P5|Part 2|Withdrawal by Subject|2
5156070|NCT01426789|17805844|P4|Part 2|Withdrawal by Subject|1
5156071|NCT01426789|17805845|P3|Part 2|Withdrawal by Subject|0
5156072|NCT01426789|17805846|P2|Part 2|Withdrawal by Subject|0
5156073|NCT01426789|17805847|P1|Part 2|Withdrawal by Subject|0
5156074|NCT01426789|17805842|P6|Part 2|Lost to Follow-up|0
5156075|NCT01426789|17805843|P5|Part 2|Lost to Follow-up|1
5156076|NCT01426789|17805844|P4|Part 2|Lost to Follow-up|0
5156077|NCT01426789|17805845|P3|Part 2|Lost to Follow-up|4
5156078|NCT01426789|17805846|P2|Part 2|Lost to Follow-up|0
5156079|NCT01426789|17805847|P1|Part 2|Lost to Follow-up|0
5156080|NCT01426789|17805842|P6|Part 2|Administrative problems|0
5156081|NCT01426789|17805843|P5|Part 2|Administrative problems|1
5156082|NCT01426789|17805844|P4|Part 2|Administrative problems|0
5156083|NCT01426789|17805845|P3|Part 2|Administrative problems|2
5156084|NCT01426789|17805846|P2|Part 2|Administrative problems|0
5156085|NCT01426789|17805847|P1|Part 2|Administrative problems|0
5156086|NCT01426789|17805842|P6|Part 2|Death|0
5156087|NCT01426789|17805843|P5|Part 2|Death|1
5156088|NCT01426789|17805844|P4|Part 2|Death|0
5156089|NCT01426789|17805845|P3|Part 2|Death|1
5156090|NCT01426789|17805846|P2|Part 2|Death|0
5156091|NCT01426789|17805847|P1|Part 2|Death|0
5156092|NCT01426789|17805842|P6|Part 2|Protocol deviation|0
5156093|NCT01426789|17805843|P5|Part 2|Protocol deviation|0
5156094|NCT01426789|17805844|P4|Part 2|Protocol deviation|0
5156095|NCT01426789|17805845|P3|Part 2|Protocol deviation|1
5156096|NCT01426789|17805846|P2|Part 2|Protocol deviation|0
5156097|NCT01426789|17805847|P1|Part 2|Protocol deviation|0
5156098|NCT01426789|17805842|P6|Part 1|Adverse Event|0
5156099|NCT01426789|17805843|P5|Part 1|Adverse Event|0
5156100|NCT01426789|17805844|P4|Part 1|Adverse Event|0
5156101|NCT01426789|17805845|P3|Part 1|Adverse Event|0
5156102|NCT01426789|17805846|P2|Part 1|Adverse Event|0
5156103|NCT01426789|17805847|P1|Part 1|Adverse Event|3
5156104|NCT01426789|17805842|P6|Part 1|Lack of Efficacy|0
5156105|NCT01426789|17805843|P5|Part 1|Lack of Efficacy|0
5156106|NCT01426789|17805844|P4|Part 1|Lack of Efficacy|0
5156107|NCT01426789|17805845|P3|Part 1|Lack of Efficacy|0
5156108|NCT01426789|17805846|P2|Part 1|Lack of Efficacy|1
5156109|NCT01426789|17805847|P1|Part 1|Lack of Efficacy|2
5156110|NCT01426789|17805842|P6|Part 1|Lost to Follow-up|0
5156111|NCT01426789|17805843|P5|Part 1|Lost to Follow-up|0
5156112|NCT01426789|17805844|P4|Part 1|Lost to Follow-up|0
5156113|NCT01426789|17805845|P3|Part 1|Lost to Follow-up|0
5156114|NCT01426789|17805846|P2|Part 1|Lost to Follow-up|2
5156115|NCT01426789|17805847|P1|Part 1|Lost to Follow-up|1
5156116|NCT01426789|17805842|P6|Part 1|Protocol deviation|0
5156117|NCT01426789|17805843|P5|Part 1|Protocol deviation|0
5156118|NCT01426789|17805844|P4|Part 1|Protocol deviation|0
5156119|NCT01426789|17805845|P3|Part 1|Protocol deviation|0
5156120|NCT01426789|17805846|P2|Part 1|Protocol deviation|1
5156121|NCT01426789|17805847|P1|Part 1|Protocol deviation|0
5156122|NCT01426438|17805909|P2|Overall Study|Missed Scan|2
5156123|NCT01426438|17805910|P1|Overall Study|Missed Scan|2
5156124|NCT01426438|17805909|P2|Overall Study|Poor scan quality|2
5156125|NCT01426438|17805910|P1|Overall Study|Poor scan quality|3
5156126|NCT01426438|17805909|P2|Overall Study|Off study Treatment|3
5156127|NCT01426438|17805910|P1|Overall Study|Off study Treatment|9
5156128|NCT01426438|17805909|P2|Overall Study|Lost to Follow-up|3
5156129|NCT01426438|17805910|P1|Overall Study|Lost to Follow-up|1
5156130|NCT01426425|17805942|P1|Overall Study|Met inclusion/exclusion, not treated|2
5156131|NCT01426425|17805942|P1|Overall Study|Inclusion/exclusion criteria not met|151
5156132|NCT01426425|17805942|P1|Overall Study|Exited prior to EP study|22
5156133|NCT01426412|17805957|P9|Overall Study|Withdrawal by Subject|1
5156134|NCT01426412|17805958|P8|Overall Study|Withdrawal by Subject|3
5156135|NCT01426412|17805959|P7|Overall Study|Withdrawal by Subject|0
5156136|NCT01426412|17805960|P6|Overall Study|Withdrawal by Subject|0
5156137|NCT01426412|17805961|P5|Overall Study|Withdrawal by Subject|1
5156138|NCT01426412|17805962|P4|Overall Study|Withdrawal by Subject|0
5156139|NCT01426412|17805963|P3|Overall Study|Withdrawal by Subject|0
5156140|NCT01426412|17805964|P2|Overall Study|Withdrawal by Subject|0
5156141|NCT01426412|17805965|P1|Overall Study|Withdrawal by Subject|1
5156142|NCT01426386|17806028|P6|Overall Study|Personal reasons|0
5156143|NCT01426386|17806029|P5|Overall Study|Personal reasons|1
5156144|NCT01426386|17806030|P4|Overall Study|Personal reasons|0
5156145|NCT01426386|17806031|P3|Overall Study|Personal reasons|0
5156146|NCT01426386|17806032|P2|Overall Study|Personal reasons|0
5156147|NCT01426386|17806033|P1|Overall Study|Personal reasons|0
5156148|NCT01426386|17806028|P6|Overall Study|Poor response|0
5156149|NCT01426386|17806029|P5|Overall Study|Poor response|1
5156150|NCT01426386|17806030|P4|Overall Study|Poor response|0
5156151|NCT01426386|17806031|P3|Overall Study|Poor response|2
5156152|NCT01426386|17806032|P2|Overall Study|Poor response|1
5156153|NCT01426386|17806033|P1|Overall Study|Poor response|2
5156154|NCT01426386|17806028|P6|Overall Study|Did not attend scheduled visit|1
5156155|NCT01426386|17806029|P5|Overall Study|Did not attend scheduled visit|2
5156156|NCT01426386|17806030|P4|Overall Study|Did not attend scheduled visit|0
5156157|NCT01426386|17806031|P3|Overall Study|Did not attend scheduled visit|0
5156158|NCT01426386|17806032|P2|Overall Study|Did not attend scheduled visit|4
5156159|NCT01426386|17806033|P1|Overall Study|Did not attend scheduled visit|1
5156160|NCT01426386|17806028|P6|Overall Study|Adverse Event|0
5156161|NCT01426386|17806029|P5|Overall Study|Adverse Event|0
5156162|NCT01426386|17806030|P4|Overall Study|Adverse Event|0
5156163|NCT01426386|17806031|P3|Overall Study|Adverse Event|0
5156164|NCT01426386|17806032|P2|Overall Study|Adverse Event|1
5156165|NCT01426386|17806033|P1|Overall Study|Adverse Event|0
5156166|NCT01426373|17806089|P1|Overall Study|Miscellaneous Reasons|4
5156167|NCT01426373|17806089|P1|Overall Study|Participant Convenience|10
5156168|NCT01426373|17806089|P1|Overall Study|Lost to Follow-up|14
5156169|NCT01426373|17806089|P1|Overall Study|Adverse Event|6
5156170|NCT01426347|17806122|P2|Overall Study|Withdrawal by Subject|0
5156171|NCT01426347|17806123|P1|Overall Study|Withdrawal by Subject|5
5156172|NCT01426347|17806122|P2|Overall Study|Protocol Violation|0
5156173|NCT01426347|17806123|P1|Overall Study|Protocol Violation|2
5156174|NCT01426347|17806122|P2|Overall Study|Lost to Follow-up|3
5156175|NCT01426347|17806123|P1|Overall Study|Lost to Follow-up|0
5156176|NCT01426269|17806131|P3|Period 2: 40 Weeks|Relapsed|18
5156177|NCT01426269|17806132|P2|Period 2: 40 Weeks|Relapsed|9
5156178|NCT01426269|17806133|P1|Period 2: 40 Weeks|Relapsed|0
5156179|NCT01426269|17806131|P3|Period 2: 40 Weeks|Site closed|5
5156180|NCT01426269|17806132|P2|Period 2: 40 Weeks|Site closed|6
5156181|NCT01426269|17806133|P1|Period 2: 40 Weeks|Site closed|0
5156182|NCT01426269|17806131|P3|Period 2: 40 Weeks|Lost to Follow-up|6
5156183|NCT01426269|17806132|P2|Period 2: 40 Weeks|Lost to Follow-up|8
5156184|NCT01426269|17806133|P1|Period 2: 40 Weeks|Lost to Follow-up|0
5156185|NCT01426269|17806131|P3|Period 2: 40 Weeks|Protocol Violation|5
5156186|NCT01426269|17806132|P2|Period 2: 40 Weeks|Protocol Violation|5
5156187|NCT01426269|17806133|P1|Period 2: 40 Weeks|Protocol Violation|0
5156188|NCT01426269|17806131|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
5156189|NCT01426269|17806132|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
5156190|NCT01426269|17806133|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
5156191|NCT01426269|17806131|P3|Period 2: 40 Weeks|Adverse Event|2
5156192|NCT01426269|17806132|P2|Period 2: 40 Weeks|Adverse Event|1
5156193|NCT01426269|17806133|P1|Period 2: 40 Weeks|Adverse Event|0
5156194|NCT01426269|17806131|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
5156195|NCT01426269|17806132|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
5156196|NCT01426269|17806133|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
5156197|NCT01426269|17806131|P3|Eligibility for Period 2, Randomization|Did not qualify|0
5156198|NCT01426269|17806132|P2|Eligibility for Period 2, Randomization|Did not qualify|0
5156199|NCT01426269|17806133|P1|Eligibility for Period 2, Randomization|Did not qualify|42
5156200|NCT01426269|17806131|P3|Period 1: 12 Weeks|Pregnancy|0
5156201|NCT01426269|17806132|P2|Period 1: 12 Weeks|Pregnancy|0
5156202|NCT01426269|17806133|P1|Period 1: 12 Weeks|Pregnancy|1
5156203|NCT01426269|17806131|P3|Period 1: 12 Weeks|Lost to Follow-up|0
5156204|NCT01426269|17806132|P2|Period 1: 12 Weeks|Lost to Follow-up|0
5156205|NCT01426269|17806133|P1|Period 1: 12 Weeks|Lost to Follow-up|22
5156206|NCT01426269|17806131|P3|Period 1: 12 Weeks|Protocol Violation|0
5156207|NCT01426269|17806132|P2|Period 1: 12 Weeks|Protocol Violation|0
5156208|NCT01426269|17806133|P1|Period 1: 12 Weeks|Protocol Violation|5
5156209|NCT01426269|17806131|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
5156210|NCT01426269|17806132|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
5156211|NCT01426269|17806133|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
5156212|NCT01426269|17806131|P3|Period 1: 12 Weeks|Adverse Event|0
5156213|NCT01426269|17806132|P2|Period 1: 12 Weeks|Adverse Event|0
5156214|NCT01426269|17806133|P1|Period 1: 12 Weeks|Adverse Event|5
5156215|NCT01426217|17806168|P2|Overall Study|lost sample|14
5156216|NCT01426217|17806169|P1|Overall Study|lost sample|8
5156217|NCT01426113|17806182|P2|Overall Study|Adverse Event|1
5156218|NCT01426113|17806183|P1|Overall Study|Adverse Event|0
5156219|NCT01426113|17806182|P2|Overall Study|Study Discontinued|1
5156220|NCT01426113|17806183|P1|Overall Study|Study Discontinued|1
5156221|NCT01426009|17806189|P1|Washout 4|Lost to Follow-up|1
5156222|NCT01426009|17806189|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
5156223|NCT01426009|17806189|P1|Washout 3|personal reasons|1
5156224|NCT01426009|17806189|P1|Washout 2|electrive surgery|1
5156225|NCT01426009|17806189|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
5156226|NCT01426009|17806189|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
5156227|NCT01426009|17806189|P1|Washout 1|Personal Reasons|1
5156228|NCT01426009|17806189|P1|Washout 1|Withdrawal by Subject|1
5156229|NCT01426009|17806189|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
5156230|NCT01426009|17806189|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
5156231|NCT01425814|17806285|P6|Period 5|Stability criteria not fulfilled|1
5156232|NCT01425814|17806286|P5|Period 5|Stability criteria not fulfilled|0
5156233|NCT01425814|17806287|P4|Period 5|Stability criteria not fulfilled|0
5156234|NCT01425814|17806288|P3|Period 5|Stability criteria not fulfilled|1
5156235|NCT01425814|17806289|P2|Period 5|Stability criteria not fulfilled|0
5156236|NCT01425814|17806290|P1|Period 5|Stability criteria not fulfilled|0
5156237|NCT01425814|17806285|P6|Period 4|Adverse Event|0
5156238|NCT01425814|17806286|P5|Period 4|Adverse Event|0
5156239|NCT01425814|17806287|P4|Period 4|Adverse Event|0
5156240|NCT01425814|17806288|P3|Period 4|Adverse Event|1
5156241|NCT01425814|17806289|P2|Period 4|Adverse Event|0
5156242|NCT01425814|17806290|P1|Period 4|Adverse Event|1
5156243|NCT01425814|17806285|P6|Period 3|Adverse Event|1
5156244|NCT01425814|17806286|P5|Period 3|Adverse Event|0
5156245|NCT01425814|17806287|P4|Period 3|Adverse Event|0
5156246|NCT01425814|17806288|P3|Period 3|Adverse Event|0
5156247|NCT01425814|17806289|P2|Period 3|Adverse Event|0
5156248|NCT01425814|17806290|P1|Period 3|Adverse Event|0
5156249|NCT01425814|17806285|P6|Period 2|Stability criteria not fulfilled|0
5156250|NCT01425814|17806286|P5|Period 2|Stability criteria not fulfilled|0
5156251|NCT01425814|17806287|P4|Period 2|Stability criteria not fulfilled|0
5156252|NCT01425814|17806288|P3|Period 2|Stability criteria not fulfilled|0
5156253|NCT01425814|17806289|P2|Period 2|Stability criteria not fulfilled|1
5156254|NCT01425814|17806290|P1|Period 2|Stability criteria not fulfilled|0
5156255|NCT01425814|17806285|P6|Period 1|Stability criteria not fulfilled|0
5156256|NCT01425814|17806286|P5|Period 1|Stability criteria not fulfilled|0
5156257|NCT01425814|17806287|P4|Period 1|Stability criteria not fulfilled|0
5156258|NCT01425814|17806288|P3|Period 1|Stability criteria not fulfilled|0
5156259|NCT01425814|17806289|P2|Period 1|Stability criteria not fulfilled|1
5156260|NCT01425814|17806290|P1|Period 1|Stability criteria not fulfilled|0
5156261|NCT01425801|17806382|P6|Period 4|Not able to maintain visit schedule|0
5156262|NCT01425801|17806383|P5|Period 4|Not able to maintain visit schedule|0
5156263|NCT01425801|17806384|P4|Period 4|Not able to maintain visit schedule|0
5156264|NCT01425801|17806385|P3|Period 4|Not able to maintain visit schedule|1
5156265|NCT01425801|17806386|P2|Period 4|Not able to maintain visit schedule|0
5156266|NCT01425801|17806387|P1|Period 4|Not able to maintain visit schedule|0
5156267|NCT01425801|17806382|P6|Period 3|Stability criteria not fullfilled|0
5156268|NCT01425801|17806383|P5|Period 3|Stability criteria not fullfilled|0
5156269|NCT01425801|17806384|P4|Period 3|Stability criteria not fullfilled|0
5156270|NCT01425801|17806385|P3|Period 3|Stability criteria not fullfilled|1
5156271|NCT01425801|17806386|P2|Period 3|Stability criteria not fullfilled|0
5156272|NCT01425801|17806387|P1|Period 3|Stability criteria not fullfilled|0
5156273|NCT01425801|17806382|P6|Period 2|Withdrawal by Subject|0
5156274|NCT01425801|17806383|P5|Period 2|Withdrawal by Subject|1
5156275|NCT01425801|17806384|P4|Period 2|Withdrawal by Subject|0
5156276|NCT01425801|17806385|P3|Period 2|Withdrawal by Subject|0
5156277|NCT01425801|17806386|P2|Period 2|Withdrawal by Subject|0
5156278|NCT01425801|17806387|P1|Period 2|Withdrawal by Subject|0
5156279|NCT01425801|17806382|P6|Period 1|Withdrawal by Subject|0
5156280|NCT01425801|17806383|P5|Period 1|Withdrawal by Subject|1
5156281|NCT01425801|17806384|P4|Period 1|Withdrawal by Subject|0
5156282|NCT01425801|17806385|P3|Period 1|Withdrawal by Subject|0
5156283|NCT01425801|17806386|P2|Period 1|Withdrawal by Subject|0
5156284|NCT01425801|17806387|P1|Period 1|Withdrawal by Subject|0
5156285|NCT01425749|17806493|P2|Overall Study|progression of melanoma|1
5156286|NCT01425749|17806494|P1|Overall Study|progression of melanoma|0
5156287|NCT01425723|17806511|P2|Overall Study|Other|10
5156288|NCT01425723|17806512|P1|Overall Study|Other|1
5156289|NCT01425723|17806511|P2|Overall Study|Physician Decision|0
5156290|NCT01425723|17806512|P1|Overall Study|Physician Decision|2
5156291|NCT01425723|17806511|P2|Overall Study|Lost to Follow-up|3
5156292|NCT01425723|17806512|P1|Overall Study|Lost to Follow-up|0
5156293|NCT01425723|17806511|P2|Overall Study|Withdrawal by Subject|4
5156294|NCT01425723|17806512|P1|Overall Study|Withdrawal by Subject|1
5156295|NCT01425723|17806511|P2|Overall Study|Lack of Efficacy|1
5156296|NCT01425723|17806512|P1|Overall Study|Lack of Efficacy|0
5156297|NCT01425632|17806542|P3|Overall Study|Withdrawal by Subject|1
5156298|NCT01425632|17806543|P2|Overall Study|Withdrawal by Subject|0
5156299|NCT01425632|17806544|P1|Overall Study|Withdrawal by Subject|0
5156300|NCT01425632|17806542|P3|Overall Study|Protocol Violation|2
5156301|NCT01425632|17806543|P2|Overall Study|Protocol Violation|0
5156302|NCT01425632|17806544|P1|Overall Study|Protocol Violation|0
5156303|NCT01425632|17806542|P3|Overall Study|Physician Decision|0
5156304|NCT01425632|17806543|P2|Overall Study|Physician Decision|0
5156305|NCT01425632|17806544|P1|Overall Study|Physician Decision|1
5156306|NCT01425632|17806542|P3|Overall Study|Adverse Event|1
5156307|NCT01425632|17806543|P2|Overall Study|Adverse Event|1
5156308|NCT01425632|17806544|P1|Overall Study|Adverse Event|0
5156309|NCT01425528|17806554|P2|Overall Study|Withdrawal by Subject|1
5156310|NCT01425528|17806555|P1|Overall Study|Withdrawal by Subject|1
5156311|NCT01425463|17806563|P2|Overall Study|Unknown Reason|7
5156312|NCT01425463|17806564|P1|Overall Study|Unknown Reason|4
5156313|NCT01425463|17806563|P2|Overall Study|Withdrawal by Subject|5
5156314|NCT01425463|17806564|P1|Overall Study|Withdrawal by Subject|7
5156315|NCT01425463|17806563|P2|Overall Study|Lost to Follow-up|2
5156316|NCT01425463|17806564|P1|Overall Study|Lost to Follow-up|5
5156317|NCT01425463|17806563|P2|Overall Study|Protocol Violation|2
5156318|NCT01425463|17806564|P1|Overall Study|Protocol Violation|2
5156319|NCT01425463|17806563|P2|Overall Study|Lack of Efficacy|1
5156320|NCT01425463|17806564|P1|Overall Study|Lack of Efficacy|1
5156321|NCT01425463|17806563|P2|Overall Study|Adverse Event|7
5156322|NCT01425463|17806564|P1|Overall Study|Adverse Event|5
5156323|NCT01425359|17806580|P2|Overall Study|Did Not Meet Qualifying Criteria|5
5156324|NCT01425359|17806581|P1|Overall Study|Did Not Meet Qualifying Criteria|3
5156325|NCT01425359|17806580|P2|Overall Study|Investigator's Discretion|0
5156326|NCT01425359|17806581|P1|Overall Study|Investigator's Discretion|2
5156327|NCT01425359|17806580|P2|Overall Study|Subject Withdrew Consent|2
5156328|NCT01425359|17806581|P1|Overall Study|Subject Withdrew Consent|1
5156329|NCT01425359|17806580|P2|Overall Study|Protocol Violation|2
5156330|NCT01425359|17806581|P1|Overall Study|Protocol Violation|1
5156331|NCT01425359|17806580|P2|Overall Study|Unsatisfactory Response|0
5156332|NCT01425359|17806581|P1|Overall Study|Unsatisfactory Response|1
5156333|NCT01425359|17806580|P2|Overall Study|Death|1
5156334|NCT01425359|17806581|P1|Overall Study|Death|0
5156335|NCT01425359|17806580|P2|Overall Study|Revascularization|1
5156336|NCT01425359|17806581|P1|Overall Study|Revascularization|0
5156337|NCT01425359|17806580|P2|Overall Study|Adverse Event|8
5156338|NCT01425359|17806581|P1|Overall Study|Adverse Event|9
5156339|NCT01425359|17806580|P2|Overall Study|Randomized but Not Treated|3
5156340|NCT01425359|17806581|P1|Overall Study|Randomized but Not Treated|2
5156341|NCT01425281|17806612|P2|At 5-year Clinical Follow-up|Refused/terminated|3
5156342|NCT01425281|17806613|P1|At 5-year Clinical Follow-up|Refused/terminated|9
5156343|NCT01425281|17806612|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
5156344|NCT01425281|17806613|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
5156345|NCT01425281|17806612|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
5156346|NCT01425281|17806613|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
5156347|NCT01425281|17806612|P2|At 5-year Clinical Follow-up|Death|0
5156348|NCT01425281|17806613|P1|At 5-year Clinical Follow-up|Death|2
5156349|NCT01425281|17806612|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
5156350|NCT01425281|17806613|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
5156351|NCT01425281|17806612|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
5156352|NCT01425281|17806613|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
5156353|NCT01425281|17806612|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
5156354|NCT01425281|17806613|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
5156355|NCT01425281|17806612|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
5156356|NCT01425281|17806613|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
5156357|NCT01425281|17806612|P2|At 4-year Clinical Follow-up|Death|3
5156358|NCT01425281|17806613|P1|At 4-year Clinical Follow-up|Death|7
5156359|NCT01425281|17806612|P2|At 3-year Clinical Follow-up|Death|3
5156360|NCT01425281|17806613|P1|At 3-year Clinical Follow-up|Death|2
5156361|NCT01425281|17806612|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
5156362|NCT01425281|17806613|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
5156363|NCT01425281|17806612|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
5156364|NCT01425281|17806613|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
5156365|NCT01425281|17806612|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
5156366|NCT01425281|17806613|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
5156367|NCT01425281|17806612|P2|At 2-year Clinical Follow-up|Death|0
5156368|NCT01425281|17806613|P1|At 2-year Clinical Follow-up|Death|2
5156369|NCT01425281|17806612|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
5156370|NCT01425281|17806613|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
5156371|NCT01425281|17806612|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
5156372|NCT01425281|17806613|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
5156373|NCT01425281|17806612|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
5156374|NCT01425281|17806613|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
5156375|NCT01425281|17806612|P2|At 180-day Clinical Follow-up|Death|1
5156376|NCT01425281|17806613|P1|At 180-day Clinical Follow-up|Death|0
5156377|NCT01425281|17806612|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
5156378|NCT01425281|17806613|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
5156379|NCT01425281|17806612|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
5156380|NCT01425281|17806613|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
5156381|NCT01425268|17806831|P2|Overall Study|Physician Decision|0
5156382|NCT01425268|17806832|P1|Overall Study|Physician Decision|1
5156383|NCT01425268|17806831|P2|Overall Study|Sponsor Decision|0
5156384|NCT01425268|17806832|P1|Overall Study|Sponsor Decision|5
5156385|NCT01425268|17806831|P2|Overall Study|Withdrawal by Subject|0
5156386|NCT01425268|17806832|P1|Overall Study|Withdrawal by Subject|2
5156387|NCT01425203|17806853|P3|Crossover Phase|Other virologic failure criteria|3
5156388|NCT01425203|17806854|P2|Crossover Phase|Other virologic failure criteria|0
5156389|NCT01425203|17806855|P1|Crossover Phase|Other virologic failure criteria|0
5156390|NCT01425203|17806853|P3|Crossover Phase|Failure at futility timepoint|3
5156391|NCT01425203|17806854|P2|Crossover Phase|Failure at futility timepoint|0
5156392|NCT01425203|17806855|P1|Crossover Phase|Failure at futility timepoint|0
5156393|NCT01425203|17806853|P3|Treatment Phase|Did not receive treatment|0
5156394|NCT01425203|17806854|P2|Treatment Phase|Did not receive treatment|1
5156395|NCT01425203|17806855|P1|Treatment Phase|Did not receive treatment|0
5156396|NCT01425203|17806853|P3|Treatment Phase|Unidentified reasons|0
5156397|NCT01425203|17806854|P2|Treatment Phase|Unidentified reasons|5
5156398|NCT01425203|17806855|P1|Treatment Phase|Unidentified reasons|11
5156399|NCT01425203|17806853|P3|Treatment Phase|Other virologic failure criteria|0
5156400|NCT01425203|17806854|P2|Treatment Phase|Other virologic failure criteria|3
5156401|NCT01425203|17806855|P1|Treatment Phase|Other virologic failure criteria|5
5156402|NCT01425203|17806853|P3|Treatment Phase|Failure at futility timepoint|0
5156403|NCT01425203|17806854|P2|Treatment Phase|Failure at futility timepoint|27
5156404|NCT01425203|17806855|P1|Treatment Phase|Failure at futility timepoint|8
5156405|NCT01425203|17806853|P3|Treatment Phase|DC during PR Lead-in Phase|0
5156406|NCT01425203|17806854|P2|Treatment Phase|DC during PR Lead-in Phase|1
5156407|NCT01425203|17806855|P1|Treatment Phase|DC during PR Lead-in Phase|3
5156408|NCT01425190|17806872|P3|Overall Study|Full dose not consumed.|0
5156409|NCT01425190|17806873|P2|Overall Study|Full dose not consumed.|0
5156410|NCT01425190|17806874|P1|Overall Study|Full dose not consumed.|1
5156411|NCT01425008|17806910|P19|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
5156412|NCT01425008|17806911|P18|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156413|NCT01425008|17806912|P17|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156414|NCT01425008|17806913|P16|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156415|NCT01425008|17806914|P15|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156416|NCT01425008|17806915|P14|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156417|NCT01425008|17806916|P13|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156418|NCT01425008|17806917|P12|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156419|NCT01425008|17806918|P11|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156420|NCT01425008|17806919|P10|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156421|NCT01425008|17806920|P9|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156422|NCT01425008|17806921|P8|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156423|NCT01425008|17806922|P7|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156424|NCT01425008|17806923|P6|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156425|NCT01425008|17806924|P5|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156426|NCT01425008|17806925|P4|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156427|NCT01425008|17806926|P3|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156428|NCT01425008|17806927|P2|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156429|NCT01425008|17806928|P1|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5156430|NCT01425008|17806910|P19|Dose Expansion Phase|Lost to Follow-up|0
5156431|NCT01425008|17806911|P18|Dose Expansion Phase|Lost to Follow-up|0
5156432|NCT01425008|17806912|P17|Dose Expansion Phase|Lost to Follow-up|1
5156433|NCT01425008|17806913|P16|Dose Expansion Phase|Lost to Follow-up|0
5156434|NCT01425008|17806914|P15|Dose Expansion Phase|Lost to Follow-up|0
5156435|NCT01425008|17806915|P14|Dose Expansion Phase|Lost to Follow-up|0
5156436|NCT01425008|17806916|P13|Dose Expansion Phase|Lost to Follow-up|0
5156437|NCT01425008|17806917|P12|Dose Expansion Phase|Lost to Follow-up|0
5156438|NCT01425008|17806918|P11|Dose Expansion Phase|Lost to Follow-up|0
5156439|NCT01425008|17806919|P10|Dose Expansion Phase|Lost to Follow-up|0
5156440|NCT01425008|17806920|P9|Dose Expansion Phase|Lost to Follow-up|0
5156441|NCT01425008|17806921|P8|Dose Expansion Phase|Lost to Follow-up|0
5156442|NCT01425008|17806922|P7|Dose Expansion Phase|Lost to Follow-up|0
5156443|NCT01425008|17806923|P6|Dose Expansion Phase|Lost to Follow-up|0
5156444|NCT01425008|17806924|P5|Dose Expansion Phase|Lost to Follow-up|0
5156445|NCT01425008|17806925|P4|Dose Expansion Phase|Lost to Follow-up|0
5156446|NCT01425008|17806926|P3|Dose Expansion Phase|Lost to Follow-up|0
5156447|NCT01425008|17806927|P2|Dose Expansion Phase|Lost to Follow-up|0
5156448|NCT01425008|17806928|P1|Dose Expansion Phase|Lost to Follow-up|0
5156449|NCT01425008|17806910|P19|Dose Expansion Phase|Adverse Event|3
5156450|NCT01425008|17806911|P18|Dose Expansion Phase|Adverse Event|0
5156451|NCT01425008|17806912|P17|Dose Expansion Phase|Adverse Event|5
5156452|NCT01425008|17806913|P16|Dose Expansion Phase|Adverse Event|1
5156453|NCT01425008|17806914|P15|Dose Expansion Phase|Adverse Event|1
5156454|NCT01425008|17806915|P14|Dose Expansion Phase|Adverse Event|0
5156455|NCT01425008|17806916|P13|Dose Expansion Phase|Adverse Event|3
5156456|NCT01425008|17806917|P12|Dose Expansion Phase|Adverse Event|3
5156457|NCT01425008|17806918|P11|Dose Expansion Phase|Adverse Event|2
5156458|NCT01425008|17806919|P10|Dose Expansion Phase|Adverse Event|0
5156459|NCT01425008|17806920|P9|Dose Expansion Phase|Adverse Event|0
5156460|NCT01425008|17806921|P8|Dose Expansion Phase|Adverse Event|0
5156461|NCT01425008|17806922|P7|Dose Expansion Phase|Adverse Event|0
5156462|NCT01425008|17806923|P6|Dose Expansion Phase|Adverse Event|0
5156463|NCT01425008|17806924|P5|Dose Expansion Phase|Adverse Event|0
5156464|NCT01425008|17806925|P4|Dose Expansion Phase|Adverse Event|0
5156465|NCT01425008|17806926|P3|Dose Expansion Phase|Adverse Event|0
5156466|NCT01425008|17806927|P2|Dose Expansion Phase|Adverse Event|0
5156467|NCT01425008|17806928|P1|Dose Expansion Phase|Adverse Event|0
5156468|NCT01425008|17806910|P19|Dose Expansion Phase|Symptomatic Deterioration|1
5156469|NCT01425008|17806911|P18|Dose Expansion Phase|Symptomatic Deterioration|0
5156470|NCT01425008|17806912|P17|Dose Expansion Phase|Symptomatic Deterioration|2
5156471|NCT01425008|17806913|P16|Dose Expansion Phase|Symptomatic Deterioration|1
5156472|NCT01425008|17806914|P15|Dose Expansion Phase|Symptomatic Deterioration|0
5156473|NCT01425008|17806915|P14|Dose Expansion Phase|Symptomatic Deterioration|0
5156474|NCT01425008|17806916|P13|Dose Expansion Phase|Symptomatic Deterioration|0
5156475|NCT01425008|17806917|P12|Dose Expansion Phase|Symptomatic Deterioration|1
5156476|NCT01425008|17806918|P11|Dose Expansion Phase|Symptomatic Deterioration|2
5156477|NCT01425008|17806919|P10|Dose Expansion Phase|Symptomatic Deterioration|0
5156478|NCT01425008|17806920|P9|Dose Expansion Phase|Symptomatic Deterioration|0
5156479|NCT01425008|17806921|P8|Dose Expansion Phase|Symptomatic Deterioration|0
5156480|NCT01425008|17806922|P7|Dose Expansion Phase|Symptomatic Deterioration|0
5156481|NCT01425008|17806923|P6|Dose Expansion Phase|Symptomatic Deterioration|0
5156482|NCT01425008|17806924|P5|Dose Expansion Phase|Symptomatic Deterioration|0
5156483|NCT01425008|17806925|P4|Dose Expansion Phase|Symptomatic Deterioration|0
5156484|NCT01425008|17806926|P3|Dose Expansion Phase|Symptomatic Deterioration|0
5156485|NCT01425008|17806927|P2|Dose Expansion Phase|Symptomatic Deterioration|0
5156486|NCT01425008|17806928|P1|Dose Expansion Phase|Symptomatic Deterioration|0
5156487|NCT01425008|17806910|P19|Dose Expansion Phase|Other|4
5156488|NCT01425008|17806911|P18|Dose Expansion Phase|Other|0
5156489|NCT01425008|17806912|P17|Dose Expansion Phase|Other|2
5156490|NCT01425008|17806913|P16|Dose Expansion Phase|Other|0
5156491|NCT01425008|17806914|P15|Dose Expansion Phase|Other|0
5156492|NCT01425008|17806915|P14|Dose Expansion Phase|Other|0
5156493|NCT01425008|17806916|P13|Dose Expansion Phase|Other|1
5156494|NCT01425008|17806917|P12|Dose Expansion Phase|Other|0
5156495|NCT01425008|17806918|P11|Dose Expansion Phase|Other|0
5156496|NCT01425008|17806919|P10|Dose Expansion Phase|Other|0
5156497|NCT01425008|17806920|P9|Dose Expansion Phase|Other|0
5156498|NCT01425008|17806921|P8|Dose Expansion Phase|Other|0
5156499|NCT01425008|17806922|P7|Dose Expansion Phase|Other|0
5156500|NCT01425008|17806923|P6|Dose Expansion Phase|Other|0
5156501|NCT01425008|17806924|P5|Dose Expansion Phase|Other|0
5156502|NCT01425008|17806925|P4|Dose Expansion Phase|Other|0
5156503|NCT01425008|17806926|P3|Dose Expansion Phase|Other|0
5156504|NCT01425008|17806927|P2|Dose Expansion Phase|Other|0
5156505|NCT01425008|17806928|P1|Dose Expansion Phase|Other|0
5156506|NCT01425008|17806910|P19|Dose Expansion Phase|Withdrawal by Subject|0
5156507|NCT01425008|17806911|P18|Dose Expansion Phase|Withdrawal by Subject|0
5156508|NCT01425008|17806912|P17|Dose Expansion Phase|Withdrawal by Subject|1
5156509|NCT01425008|17806913|P16|Dose Expansion Phase|Withdrawal by Subject|1
5156510|NCT01425008|17806914|P15|Dose Expansion Phase|Withdrawal by Subject|0
5156511|NCT01425008|17806915|P14|Dose Expansion Phase|Withdrawal by Subject|0
5156512|NCT01425008|17806916|P13|Dose Expansion Phase|Withdrawal by Subject|0
5156513|NCT01425008|17806917|P12|Dose Expansion Phase|Withdrawal by Subject|0
5156514|NCT01425008|17806918|P11|Dose Expansion Phase|Withdrawal by Subject|1
5156515|NCT01425008|17806919|P10|Dose Expansion Phase|Withdrawal by Subject|0
5156516|NCT01425008|17806920|P9|Dose Expansion Phase|Withdrawal by Subject|0
5156517|NCT01425008|17806921|P8|Dose Expansion Phase|Withdrawal by Subject|0
5156518|NCT01425008|17806922|P7|Dose Expansion Phase|Withdrawal by Subject|0
5156519|NCT01425008|17806923|P6|Dose Expansion Phase|Withdrawal by Subject|0
5156520|NCT01425008|17806924|P5|Dose Expansion Phase|Withdrawal by Subject|0
5156521|NCT01425008|17806925|P4|Dose Expansion Phase|Withdrawal by Subject|0
5156522|NCT01425008|17806926|P3|Dose Expansion Phase|Withdrawal by Subject|0
5156523|NCT01425008|17806927|P2|Dose Expansion Phase|Withdrawal by Subject|0
5156524|NCT01425008|17806928|P1|Dose Expansion Phase|Withdrawal by Subject|0
5156525|NCT01425008|17806910|P19|Dose Expansion Phase|Progressive Disease|10
5156526|NCT01425008|17806911|P18|Dose Expansion Phase|Progressive Disease|2
5156527|NCT01425008|17806912|P17|Dose Expansion Phase|Progressive Disease|9
5156528|NCT01425008|17806913|P16|Dose Expansion Phase|Progressive Disease|8
5156529|NCT01425008|17806914|P15|Dose Expansion Phase|Progressive Disease|5
5156530|NCT01425008|17806915|P14|Dose Expansion Phase|Progressive Disease|1
5156531|NCT01425008|17806916|P13|Dose Expansion Phase|Progressive Disease|12
5156532|NCT01425008|17806917|P12|Dose Expansion Phase|Progressive Disease|4
5156533|NCT01425008|17806918|P11|Dose Expansion Phase|Progressive Disease|10
5156534|NCT01425008|17806919|P10|Dose Expansion Phase|Progressive Disease|0
5156535|NCT01425008|17806920|P9|Dose Expansion Phase|Progressive Disease|0
5156536|NCT01425008|17806921|P8|Dose Expansion Phase|Progressive Disease|0
5156537|NCT01425008|17806922|P7|Dose Expansion Phase|Progressive Disease|0
5156538|NCT01425008|17806923|P6|Dose Expansion Phase|Progressive Disease|0
5156539|NCT01425008|17806924|P5|Dose Expansion Phase|Progressive Disease|0
5156540|NCT01425008|17806925|P4|Dose Expansion Phase|Progressive Disease|0
5156541|NCT01425008|17806926|P3|Dose Expansion Phase|Progressive Disease|0
5156542|NCT01425008|17806927|P2|Dose Expansion Phase|Progressive Disease|0
5156543|NCT01425008|17806928|P1|Dose Expansion Phase|Progressive Disease|0
5156544|NCT01425008|17806910|P19|Dose Escalation Phase|Other|0
5156545|NCT01425008|17806911|P18|Dose Escalation Phase|Other|0
5156546|NCT01425008|17806912|P17|Dose Escalation Phase|Other|0
5156547|NCT01425008|17806913|P16|Dose Escalation Phase|Other|0
5156548|NCT01425008|17806914|P15|Dose Escalation Phase|Other|0
5156549|NCT01425008|17806915|P14|Dose Escalation Phase|Other|0
5156550|NCT01425008|17806916|P13|Dose Escalation Phase|Other|0
5156551|NCT01425008|17806917|P12|Dose Escalation Phase|Other|0
5156552|NCT01425008|17806918|P11|Dose Escalation Phase|Other|0
5156553|NCT01425008|17806919|P10|Dose Escalation Phase|Other|0
5156554|NCT01425008|17806920|P9|Dose Escalation Phase|Other|1
5156555|NCT01425008|17806921|P8|Dose Escalation Phase|Other|0
5156556|NCT01425008|17806922|P7|Dose Escalation Phase|Other|0
5156557|NCT01425008|17806923|P6|Dose Escalation Phase|Other|0
5156558|NCT01425008|17806924|P5|Dose Escalation Phase|Other|0
5156559|NCT01425008|17806925|P4|Dose Escalation Phase|Other|0
5156560|NCT01425008|17806926|P3|Dose Escalation Phase|Other|0
5156561|NCT01425008|17806927|P2|Dose Escalation Phase|Other|0
5156562|NCT01425008|17806928|P1|Dose Escalation Phase|Other|0
5156563|NCT01425008|17806910|P19|Dose Escalation Phase|Symptomatic Deterioration|0
5156564|NCT01425008|17806911|P18|Dose Escalation Phase|Symptomatic Deterioration|0
5156565|NCT01425008|17806912|P17|Dose Escalation Phase|Symptomatic Deterioration|0
5156566|NCT01425008|17806913|P16|Dose Escalation Phase|Symptomatic Deterioration|0
5156567|NCT01425008|17806914|P15|Dose Escalation Phase|Symptomatic Deterioration|0
5156568|NCT01425008|17806915|P14|Dose Escalation Phase|Symptomatic Deterioration|0
5156569|NCT01425008|17806916|P13|Dose Escalation Phase|Symptomatic Deterioration|0
5156570|NCT01425008|17806917|P12|Dose Escalation Phase|Symptomatic Deterioration|0
5156571|NCT01425008|17806918|P11|Dose Escalation Phase|Symptomatic Deterioration|0
5156572|NCT01425008|17806919|P10|Dose Escalation Phase|Symptomatic Deterioration|2
5156573|NCT01425008|17806920|P9|Dose Escalation Phase|Symptomatic Deterioration|2
5156574|NCT01425008|17806921|P8|Dose Escalation Phase|Symptomatic Deterioration|0
5156575|NCT01425008|17806922|P7|Dose Escalation Phase|Symptomatic Deterioration|0
5156576|NCT01425008|17806923|P6|Dose Escalation Phase|Symptomatic Deterioration|0
5156577|NCT01425008|17806924|P5|Dose Escalation Phase|Symptomatic Deterioration|0
5156578|NCT01425008|17806925|P4|Dose Escalation Phase|Symptomatic Deterioration|0
5156579|NCT01425008|17806926|P3|Dose Escalation Phase|Symptomatic Deterioration|1
5156580|NCT01425008|17806927|P2|Dose Escalation Phase|Symptomatic Deterioration|0
5156581|NCT01425008|17806928|P1|Dose Escalation Phase|Symptomatic Deterioration|0
5156582|NCT01425008|17806910|P19|Dose Escalation Phase|Withdrawal by Subject|0
5156583|NCT01425008|17806911|P18|Dose Escalation Phase|Withdrawal by Subject|0
5156584|NCT01425008|17806912|P17|Dose Escalation Phase|Withdrawal by Subject|0
5156585|NCT01425008|17806913|P16|Dose Escalation Phase|Withdrawal by Subject|0
5156586|NCT01425008|17806914|P15|Dose Escalation Phase|Withdrawal by Subject|0
5156587|NCT01425008|17806915|P14|Dose Escalation Phase|Withdrawal by Subject|0
5156588|NCT01425008|17806916|P13|Dose Escalation Phase|Withdrawal by Subject|0
5156589|NCT01425008|17806917|P12|Dose Escalation Phase|Withdrawal by Subject|0
5156590|NCT01425008|17806918|P11|Dose Escalation Phase|Withdrawal by Subject|0
5156591|NCT01425008|17806919|P10|Dose Escalation Phase|Withdrawal by Subject|0
5156592|NCT01425008|17806920|P9|Dose Escalation Phase|Withdrawal by Subject|1
5156593|NCT01425008|17806921|P8|Dose Escalation Phase|Withdrawal by Subject|0
5156594|NCT01425008|17806922|P7|Dose Escalation Phase|Withdrawal by Subject|1
5156595|NCT01425008|17806923|P6|Dose Escalation Phase|Withdrawal by Subject|1
5156596|NCT01425008|17806924|P5|Dose Escalation Phase|Withdrawal by Subject|1
5156597|NCT01425008|17806925|P4|Dose Escalation Phase|Withdrawal by Subject|0
5156598|NCT01425008|17806926|P3|Dose Escalation Phase|Withdrawal by Subject|0
5156599|NCT01425008|17806927|P2|Dose Escalation Phase|Withdrawal by Subject|0
5156600|NCT01425008|17806928|P1|Dose Escalation Phase|Withdrawal by Subject|0
5156601|NCT01425008|17806910|P19|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156602|NCT01425008|17806911|P18|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156603|NCT01425008|17806912|P17|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156604|NCT01425008|17806913|P16|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156605|NCT01425008|17806914|P15|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156606|NCT01425008|17806915|P14|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156607|NCT01425008|17806916|P13|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156608|NCT01425008|17806917|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156609|NCT01425008|17806918|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156610|NCT01425008|17806919|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156611|NCT01425008|17806920|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5156612|NCT01425008|17806921|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5156613|NCT01425008|17806922|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
5156614|NCT01425008|17806923|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156615|NCT01425008|17806924|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5156616|NCT01425008|17806925|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156617|NCT01425008|17806926|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156618|NCT01425008|17806927|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156619|NCT01425008|17806928|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5156620|NCT01425008|17806910|P19|Dose Escalation Phase|Adverse Event|0
5156621|NCT01425008|17806911|P18|Dose Escalation Phase|Adverse Event|0
5156622|NCT01425008|17806912|P17|Dose Escalation Phase|Adverse Event|0
5156623|NCT01425008|17806913|P16|Dose Escalation Phase|Adverse Event|0
5156624|NCT01425008|17806914|P15|Dose Escalation Phase|Adverse Event|0
5156625|NCT01425008|17806915|P14|Dose Escalation Phase|Adverse Event|0
5156626|NCT01425008|17806916|P13|Dose Escalation Phase|Adverse Event|0
5156627|NCT01425008|17806917|P12|Dose Escalation Phase|Adverse Event|0
5156628|NCT01425008|17806918|P11|Dose Escalation Phase|Adverse Event|0
5156629|NCT01425008|17806919|P10|Dose Escalation Phase|Adverse Event|0
5156630|NCT01425008|17806920|P9|Dose Escalation Phase|Adverse Event|2
5156631|NCT01425008|17806921|P8|Dose Escalation Phase|Adverse Event|0
5156632|NCT01425008|17806922|P7|Dose Escalation Phase|Adverse Event|0
5156633|NCT01425008|17806923|P6|Dose Escalation Phase|Adverse Event|2
5156634|NCT01425008|17806924|P5|Dose Escalation Phase|Adverse Event|0
5156635|NCT01425008|17806925|P4|Dose Escalation Phase|Adverse Event|0
5156636|NCT01425008|17806926|P3|Dose Escalation Phase|Adverse Event|0
5156637|NCT01425008|17806927|P2|Dose Escalation Phase|Adverse Event|0
5156638|NCT01425008|17806928|P1|Dose Escalation Phase|Adverse Event|2
5156639|NCT01425008|17806910|P19|Dose Escalation Phase|Progressive Disease|0
5156640|NCT01425008|17806911|P18|Dose Escalation Phase|Progressive Disease|0
5156641|NCT01425008|17806912|P17|Dose Escalation Phase|Progressive Disease|0
5156642|NCT01425008|17806913|P16|Dose Escalation Phase|Progressive Disease|0
5156643|NCT01425008|17806914|P15|Dose Escalation Phase|Progressive Disease|0
5156644|NCT01425008|17806915|P14|Dose Escalation Phase|Progressive Disease|0
5156645|NCT01425008|17806916|P13|Dose Escalation Phase|Progressive Disease|0
5156646|NCT01425008|17806917|P12|Dose Escalation Phase|Progressive Disease|0
5156647|NCT01425008|17806918|P11|Dose Escalation Phase|Progressive Disease|0
5156648|NCT01425008|17806919|P10|Dose Escalation Phase|Progressive Disease|2
5156649|NCT01425008|17806920|P9|Dose Escalation Phase|Progressive Disease|6
5156650|NCT01425008|17806921|P8|Dose Escalation Phase|Progressive Disease|2
5156651|NCT01425008|17806922|P7|Dose Escalation Phase|Progressive Disease|0
5156652|NCT01425008|17806923|P6|Dose Escalation Phase|Progressive Disease|4
5156653|NCT01425008|17806924|P5|Dose Escalation Phase|Progressive Disease|5
5156654|NCT01425008|17806925|P4|Dose Escalation Phase|Progressive Disease|3
5156655|NCT01425008|17806926|P3|Dose Escalation Phase|Progressive Disease|2
5156656|NCT01425008|17806927|P2|Dose Escalation Phase|Progressive Disease|3
5156657|NCT01425008|17806928|P1|Dose Escalation Phase|Progressive Disease|2
5156658|NCT01424930|17807231|P2|Overall Study|Reason not specified|6
5156659|NCT01424930|17807232|P1|Overall Study|Reason not specified|0
5156660|NCT01424930|17807231|P2|Overall Study|Screen Failure|1
5156661|NCT01424930|17807232|P1|Overall Study|Screen Failure|0
5156662|NCT01424930|17807231|P2|Overall Study|Progressive Disease|6
5156663|NCT01424930|17807232|P1|Overall Study|Progressive Disease|3
5156664|NCT01424930|17807231|P2|Overall Study|Death|0
5156665|NCT01424930|17807232|P1|Overall Study|Death|1
5156666|NCT01424930|17807231|P2|Overall Study|Adverse Event|1
5156667|NCT01424930|17807232|P1|Overall Study|Adverse Event|0
5156668|NCT01424813|17807246|P2|Overall Study|Other|2
5156669|NCT01424813|17807247|P1|Overall Study|Other|1
5156670|NCT01424813|17807246|P2|Overall Study|Protocol Violation|0
5156671|NCT01424813|17807247|P1|Overall Study|Protocol Violation|1
5156672|NCT01424813|17807246|P2|Overall Study|Withdrawal by Subject|0
5156673|NCT01424813|17807247|P1|Overall Study|Withdrawal by Subject|3
5156674|NCT01424670|17807267|P2|Continuation Period|Withdrawal by Subject|4
5156675|NCT01424670|17807268|P1|Continuation Period|Withdrawal by Subject|13
5156676|NCT01424670|17807267|P2|Continuation Period|Physician Decision|4
5156677|NCT01424670|17807268|P1|Continuation Period|Physician Decision|5
5156678|NCT01424670|17807267|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
5156679|NCT01424670|17807268|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
5156680|NCT01424670|17807267|P2|Continuation Period|Lost to Follow-up|0
5156681|NCT01424670|17807268|P1|Continuation Period|Lost to Follow-up|2
5156682|NCT01424670|17807267|P2|Continuation Period|Adverse Event|5
5156683|NCT01424670|17807268|P1|Continuation Period|Adverse Event|13
5156684|NCT01424670|17807267|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
5156685|NCT01424670|17807268|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
5156686|NCT01424670|17807267|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
5156687|NCT01424670|17807268|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
5156688|NCT01424670|17807267|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
5156689|NCT01424670|17807268|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
5156690|NCT01424670|17807267|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
5156691|NCT01424670|17807268|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
5156692|NCT01424670|17807267|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
5156693|NCT01424670|17807268|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
5156694|NCT01424644|17807290|P2|Overall Study|Unable to Classify|0
5156695|NCT01424644|17807291|P1|Overall Study|Unable to Classify|1
5156696|NCT01424644|17807290|P2|Overall Study|Administrative Reason|0
5156697|NCT01424644|17807291|P1|Overall Study|Administrative Reason|1
5156698|NCT01424644|17807290|P2|Overall Study|Protocol Violation|3
5156699|NCT01424644|17807291|P1|Overall Study|Protocol Violation|4
5156700|NCT01424644|17807290|P2|Overall Study|Lost to Follow-up|12
5156701|NCT01424644|17807291|P1|Overall Study|Lost to Follow-up|16
5156702|NCT01424644|17807290|P2|Overall Study|Withdrawal by Subject|12
5156703|NCT01424644|17807291|P1|Overall Study|Withdrawal by Subject|9
5156704|NCT01424644|17807290|P2|Overall Study|Adverse Event|0
5156705|NCT01424644|17807291|P1|Overall Study|Adverse Event|2
5156706|NCT01424566|17807305|P3|Double-blind Treatment|Lack of Efficacy|1
5156707|NCT01424566|17807306|P2|Double-blind Treatment|Lack of Efficacy|1
5156708|NCT01424566|17807307|P1|Double-blind Treatment|Lack of Efficacy|0
5156709|NCT01424566|17807305|P3|Double-blind Treatment|Withdrawal by Investigator|1
5156710|NCT01424566|17807306|P2|Double-blind Treatment|Withdrawal by Investigator|1
5156711|NCT01424566|17807307|P1|Double-blind Treatment|Withdrawal by Investigator|0
5156712|NCT01424566|17807305|P3|Double-blind Treatment|Withdrawal by Subject|0
5156713|NCT01424566|17807306|P2|Double-blind Treatment|Withdrawal by Subject|2
5156714|NCT01424566|17807307|P1|Double-blind Treatment|Withdrawal by Subject|0
5156715|NCT01424566|17807305|P3|Double-blind Treatment|Adverse Event|13
5156716|NCT01424566|17807306|P2|Double-blind Treatment|Adverse Event|21
5156717|NCT01424566|17807307|P1|Double-blind Treatment|Adverse Event|0
5156718|NCT01424566|17807305|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
5156719|NCT01424566|17807306|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
5156720|NCT01424566|17807307|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
5156721|NCT01424566|17807305|P3|Single-blind Treatment|Met Exclusion Criteria|0
5156722|NCT01424566|17807306|P2|Single-blind Treatment|Met Exclusion Criteria|0
5156723|NCT01424566|17807307|P1|Single-blind Treatment|Met Exclusion Criteria|1
5156724|NCT01424566|17807305|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
5156725|NCT01424566|17807306|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
5156726|NCT01424566|17807307|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
5156727|NCT01424566|17807305|P3|Single-blind Treatment|Withdrawal by Investigator|0
5156728|NCT01424566|17807306|P2|Single-blind Treatment|Withdrawal by Investigator|0
5156729|NCT01424566|17807307|P1|Single-blind Treatment|Withdrawal by Investigator|2
5156730|NCT01424566|17807305|P3|Single-blind Treatment|Withdrawal by Subject|0
5156731|NCT01424566|17807306|P2|Single-blind Treatment|Withdrawal by Subject|0
5156732|NCT01424566|17807307|P1|Single-blind Treatment|Withdrawal by Subject|16
5156733|NCT01424566|17807305|P3|Single-blind Treatment|Adverse Event|0
5156734|NCT01424566|17807306|P2|Single-blind Treatment|Adverse Event|0
5156735|NCT01424566|17807307|P1|Single-blind Treatment|Adverse Event|71
5156736|NCT01424514|17807334|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
5156737|NCT01424514|17807335|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
5156738|NCT01424514|17807334|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
5156739|NCT01424514|17807335|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
5156740|NCT01424501|17807380|P6|Overall Study|Lost to Follow-up|0
5156741|NCT01424501|17807381|P5|Overall Study|Lost to Follow-up|0
5156742|NCT01424501|17807382|P4|Overall Study|Lost to Follow-up|0
5156743|NCT01424501|17807383|P3|Overall Study|Lost to Follow-up|1
5156744|NCT01424501|17807384|P2|Overall Study|Lost to Follow-up|1
5156745|NCT01424501|17807385|P1|Overall Study|Lost to Follow-up|0
5156746|NCT01424501|17807380|P6|Overall Study|Withdrawal by Subject|0
5156747|NCT01424501|17807381|P5|Overall Study|Withdrawal by Subject|0
5156748|NCT01424501|17807382|P4|Overall Study|Withdrawal by Subject|0
5156749|NCT01424501|17807383|P3|Overall Study|Withdrawal by Subject|1
5156750|NCT01424501|17807384|P2|Overall Study|Withdrawal by Subject|0
5156751|NCT01424501|17807385|P1|Overall Study|Withdrawal by Subject|1
5156752|NCT01424397|17807561|P12|Period-2 (8 Days)|Withdrawal by Subject|0
5156753|NCT01424397|17807562|P11|Period-2 (8 Days)|Withdrawal by Subject|0
5156754|NCT01424397|17807563|P10|Period-2 (8 Days)|Withdrawal by Subject|0
5156755|NCT01424397|17807564|P9|Period-2 (8 Days)|Withdrawal by Subject|0
5156756|NCT01424397|17807565|P8|Period-2 (8 Days)|Withdrawal by Subject|0
5156757|NCT01424397|17807566|P7|Period-2 (8 Days)|Withdrawal by Subject|0
5156758|NCT01424397|17807567|P6|Period-2 (8 Days)|Withdrawal by Subject|0
5156759|NCT01424397|17807568|P5|Period-2 (8 Days)|Withdrawal by Subject|0
5156760|NCT01424397|17807569|P4|Period-2 (8 Days)|Withdrawal by Subject|0
5156761|NCT01424397|17807570|P3|Period-2 (8 Days)|Withdrawal by Subject|1
5156762|NCT01424397|17807571|P2|Period-2 (8 Days)|Withdrawal by Subject|0
5156763|NCT01424397|17807572|P1|Period-2 (8 Days)|Withdrawal by Subject|0
5156764|NCT01424306|17807618|P6|Overall Study|Protocol Violation|0
5156765|NCT01424306|17807619|P5|Overall Study|Protocol Violation|1
5156766|NCT01424306|17807620|P4|Overall Study|Protocol Violation|0
5156767|NCT01424306|17807621|P3|Overall Study|Protocol Violation|0
5156768|NCT01424306|17807622|P2|Overall Study|Protocol Violation|0
5156769|NCT01424306|17807623|P1|Overall Study|Protocol Violation|0
5156770|NCT01424228|17807672|P2|Overall Study|Unplanned journey|1
5156771|NCT01424228|17807673|P1|Overall Study|Unplanned journey|0
5156772|NCT01424228|17807672|P2|Overall Study|Worsening of symptoms|0
5156773|NCT01424228|17807673|P1|Overall Study|Worsening of symptoms|1
5156774|NCT01424228|17807672|P2|Overall Study|Non-compliance|0
5156775|NCT01424228|17807673|P1|Overall Study|Non-compliance|2
5156776|NCT01424228|17807672|P2|Overall Study|inclusion/exclusion criteria not met|2
5156777|NCT01424228|17807673|P1|Overall Study|inclusion/exclusion criteria not met|2
5156778|NCT01424228|17807672|P2|Overall Study|Lack of Efficacy|7
5156779|NCT01424228|17807673|P1|Overall Study|Lack of Efficacy|5
5156780|NCT01424228|17807672|P2|Overall Study|Sponsor's decision|12
5156781|NCT01424228|17807673|P1|Overall Study|Sponsor's decision|9
5156782|NCT01424228|17807672|P2|Overall Study|Adverse Event|14
5156783|NCT01424228|17807673|P1|Overall Study|Adverse Event|10
5156784|NCT01424228|17807672|P2|Overall Study|Withdrawal by Subject|11
5156785|NCT01424228|17807673|P1|Overall Study|Withdrawal by Subject|27
5156786|NCT01424189|17807724|P2|Overall Study|Death|1
5156787|NCT01424189|17807725|P1|Overall Study|Death|3
5156788|NCT01424189|17807724|P2|Overall Study|Subject moved|0
5156789|NCT01424189|17807725|P1|Overall Study|Subject moved|1
5156790|NCT01424189|17807724|P2|Overall Study|Withdrawal by Subject|4
5156791|NCT01424189|17807725|P1|Overall Study|Withdrawal by Subject|4
5156792|NCT01424189|17807724|P2|Overall Study|Lost to Follow-up|1
5156793|NCT01424189|17807725|P1|Overall Study|Lost to Follow-up|4
5156794|NCT01424189|17807724|P2|Overall Study|Adverse Event|0
5156795|NCT01424189|17807725|P1|Overall Study|Adverse Event|1
5156796|NCT01423916|17807766|P3|Overall Study|Protocol Deviation|0
5156797|NCT01423916|17807767|P2|Overall Study|Protocol Deviation|0
5156798|NCT01423916|17807768|P1|Overall Study|Protocol Deviation|1
5156799|NCT01423916|17807766|P3|Overall Study|Withdrawal by Subject|3
5156800|NCT01423916|17807767|P2|Overall Study|Withdrawal by Subject|10
5156801|NCT01423916|17807768|P1|Overall Study|Withdrawal by Subject|3
5156802|NCT01423916|17807766|P3|Overall Study|Physician Decision|1
5156803|NCT01423916|17807767|P2|Overall Study|Physician Decision|0
5156804|NCT01423916|17807768|P1|Overall Study|Physician Decision|1
5156805|NCT01423916|17807766|P3|Overall Study|Met Withdrawal Criteria|1
5156806|NCT01423916|17807767|P2|Overall Study|Met Withdrawal Criteria|1
5156807|NCT01423916|17807768|P1|Overall Study|Met Withdrawal Criteria|1
5156808|NCT01423916|17807766|P3|Overall Study|Adverse Event|2
5156809|NCT01423916|17807767|P2|Overall Study|Adverse Event|9
5156810|NCT01423916|17807768|P1|Overall Study|Adverse Event|5
5156811|NCT01423812|17807824|P2|Overall Study|Withdrawal by Subject|2
5156812|NCT01423812|17807825|P1|Overall Study|Withdrawal by Subject|1
5156813|NCT01423812|17807824|P2|Overall Study|Lost to Follow-up|2
5156814|NCT01423812|17807825|P1|Overall Study|Lost to Follow-up|2
5156815|NCT01423617|17807853|P2|Overall Study|Lost to Follow-up|1
5156816|NCT01423617|17807854|P1|Overall Study|Lost to Follow-up|0
5156817|NCT01423604|17807871|P2|Randomized|Patient decision|9
5156818|NCT01423604|17807872|P1|Randomized|Patient decision|5
5156819|NCT01423604|17807871|P2|Randomized|Other - unspecified|31
5156820|NCT01423604|17807872|P1|Randomized|Other - unspecified|37
5156821|NCT01423604|17807871|P2|Randomized|Physician Decision|13
5156822|NCT01423604|17807872|P1|Randomized|Physician Decision|16
5156823|NCT01423604|17807871|P2|Randomized|Death|0
5156824|NCT01423604|17807872|P1|Randomized|Death|1
5156825|NCT01423604|17807871|P2|Randomized|Adverse Event|10
5156826|NCT01423604|17807872|P1|Randomized|Adverse Event|4
5156827|NCT01423604|17807871|P2|Safety Run-In|Patient decision|0
5156828|NCT01423604|17807872|P1|Safety Run-In|Patient decision|1
5156829|NCT01423604|17807871|P2|Safety Run-In|Disease progression|0
5156830|NCT01423604|17807872|P1|Safety Run-In|Disease progression|3
5156831|NCT01423604|17807871|P2|Safety Run-In|Physician Decision|0
5156832|NCT01423604|17807872|P1|Safety Run-In|Physician Decision|1
5156833|NCT01423604|17807871|P2|Safety Run-In|Death|0
5156834|NCT01423604|17807872|P1|Safety Run-In|Death|1
5156835|NCT01423604|17807871|P2|Safety Run-In|Adverse Event|0
5156836|NCT01423604|17807872|P1|Safety Run-In|Adverse Event|3
5156837|NCT01423253|17807887|P1|Overall Study|Withdrawal by Subject|2
5156838|NCT01423253|17807887|P1|Overall Study|Protocol Violation|2
5156839|NCT01423253|17807887|P1|Overall Study|Lost to Follow-up|1
5156840|NCT01423253|17807887|P1|Overall Study|Lack of Efficacy|2
5156841|NCT01423253|17807887|P1|Overall Study|Adverse Event|2
5156842|NCT01423084|17807909|P2|Overall Study|Withdrawal by Subject|3
5156843|NCT01423084|17807910|P1|Overall Study|Withdrawal by Subject|2
5156844|NCT01423084|17807909|P2|Overall Study|Adverse Event|1
5156845|NCT01423084|17807910|P1|Overall Study|Adverse Event|0
5156846|NCT01422915|17807940|P1|Overall Study|Adverse Event|1
5156847|NCT01422889|17807945|P1|Overall Study|No Data Entered for Study Stent|9
5156848|NCT01422876|17807960|P10|Week 52|Death|0
5156849|NCT01422876|17807961|P9|Week 52|Death|1
5156850|NCT01422876|17807962|P8|Week 52|Death|3
5156851|NCT01422876|17807963|P7|Week 52|Death|1
5156852|NCT01422876|17807964|P6|Week 52|Death|0
5156853|NCT01422876|17807965|P5|Week 52|Death|0
5156854|NCT01422876|17807966|P4|Week 52|Death|1
5156855|NCT01422876|17807967|P3|Week 52|Death|0
5156856|NCT01422876|17807968|P2|Week 52|Death|1
5156857|NCT01422876|17807969|P1|Week 52|Death|0
5156858|NCT01422876|17807960|P10|Week 52|Consent withdrawn|9
5156859|NCT01422876|17807961|P9|Week 52|Consent withdrawn|13
5156860|NCT01422876|17807962|P8|Week 52|Consent withdrawn|12
5156861|NCT01422876|17807963|P7|Week 52|Consent withdrawn|10
5156862|NCT01422876|17807964|P6|Week 52|Consent withdrawn|12
5156863|NCT01422876|17807965|P5|Week 52|Consent withdrawn|7
5156864|NCT01422876|17807966|P4|Week 52|Consent withdrawn|12
5156865|NCT01422876|17807967|P3|Week 52|Consent withdrawn|6
5156866|NCT01422876|17807968|P2|Week 52|Consent withdrawn|4
5156867|NCT01422876|17807969|P1|Week 52|Consent withdrawn|9
5156868|NCT01422876|17807960|P10|Week 52|Lost to Follow-up|8
5156869|NCT01422876|17807961|P9|Week 52|Lost to Follow-up|7
5156870|NCT01422876|17807962|P8|Week 52|Lost to Follow-up|8
5156871|NCT01422876|17807963|P7|Week 52|Lost to Follow-up|5
5156872|NCT01422876|17807964|P6|Week 52|Lost to Follow-up|5
5156873|NCT01422876|17807965|P5|Week 52|Lost to Follow-up|8
5156874|NCT01422876|17807966|P4|Week 52|Lost to Follow-up|5
5156875|NCT01422876|17807967|P3|Week 52|Lost to Follow-up|7
5156876|NCT01422876|17807968|P2|Week 52|Lost to Follow-up|5
5156877|NCT01422876|17807969|P1|Week 52|Lost to Follow-up|3
5156878|NCT01422876|17807960|P10|Week 24|Death|0
5156879|NCT01422876|17807961|P9|Week 24|Death|0
5156880|NCT01422876|17807962|P8|Week 24|Death|0
5156881|NCT01422876|17807963|P7|Week 24|Death|0
5156882|NCT01422876|17807964|P6|Week 24|Death|0
5156883|NCT01422876|17807965|P5|Week 24|Death|0
5156884|NCT01422876|17807966|P4|Week 24|Death|0
5156885|NCT01422876|17807967|P3|Week 24|Death|0
5156886|NCT01422876|17807968|P2|Week 24|Death|1
5156887|NCT01422876|17807969|P1|Week 24|Death|0
5156888|NCT01422876|17807960|P10|Week 24|Consent withdrawn|6
5156889|NCT01422876|17807961|P9|Week 24|Consent withdrawn|3
5156890|NCT01422876|17807962|P8|Week 24|Consent withdrawn|4
5156891|NCT01422876|17807963|P7|Week 24|Consent withdrawn|5
5156892|NCT01422876|17807964|P6|Week 24|Consent withdrawn|6
5156893|NCT01422876|17807965|P5|Week 24|Consent withdrawn|5
5156894|NCT01422876|17807966|P4|Week 24|Consent withdrawn|4
5156895|NCT01422876|17807967|P3|Week 24|Consent withdrawn|3
5156896|NCT01422876|17807968|P2|Week 24|Consent withdrawn|1
5156897|NCT01422876|17807969|P1|Week 24|Consent withdrawn|5
5156898|NCT01422876|17807960|P10|Week 24|Lost to Follow-up|4
5156899|NCT01422876|17807961|P9|Week 24|Lost to Follow-up|3
5156900|NCT01422876|17807962|P8|Week 24|Lost to Follow-up|3
5156901|NCT01422876|17807963|P7|Week 24|Lost to Follow-up|1
5156902|NCT01422876|17807964|P6|Week 24|Lost to Follow-up|0
5156903|NCT01422876|17807965|P5|Week 24|Lost to Follow-up|2
5156904|NCT01422876|17807966|P4|Week 24|Lost to Follow-up|4
5156905|NCT01422876|17807967|P3|Week 24|Lost to Follow-up|2
5156906|NCT01422876|17807968|P2|Week 24|Lost to Follow-up|1
5156907|NCT01422876|17807969|P1|Week 24|Lost to Follow-up|1
5156908|NCT01422850|17808016|P1|Overall Study|Physician Decision|3
5156909|NCT01422824|17808022|P1|Overall Study|Lost to Follow-up|37
5156910|NCT01422824|17808022|P1|Overall Study|Case record form not evaluated|1
5156911|NCT01422720|17808027|P1|Overall Study|Ineligibility|1
5156912|NCT01422720|17808027|P1|Overall Study|Withdrawal by Subject|4
5156913|NCT01422720|17808027|P1|Overall Study|Lack of Efficacy|1
5156914|NCT01422720|17808027|P1|Overall Study|Adverse Event|16
5156915|NCT01422538|17808038|P3|Overall Study|Missed visit|1
5156916|NCT01422538|17808039|P2|Overall Study|Missed visit|1
5156917|NCT01422538|17808040|P1|Overall Study|Missed visit|0
5156918|NCT01422538|17808038|P3|Overall Study|Lost to Follow-up|1
5156919|NCT01422538|17808039|P2|Overall Study|Lost to Follow-up|1
5156920|NCT01422538|17808040|P1|Overall Study|Lost to Follow-up|0
5156921|NCT01422408|17808084|P1|Overall Study|Withdrawal by Subject|3
5156922|NCT01422408|17808084|P1|Overall Study|Adverse Event|1
5156923|NCT01422382|17808113|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
5156924|NCT01422304|17808129|P2|Overall Study|Not Treated|11
5156925|NCT01422304|17808130|P1|Overall Study|Not Treated|3
5156926|NCT01422304|17808129|P2|Overall Study|Did Not Meet Protocol Eligibility|2
5156927|NCT01422304|17808130|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5156928|NCT01422304|17808129|P2|Overall Study|Withdrawal by Subject|2
5156929|NCT01422304|17808130|P1|Overall Study|Withdrawal by Subject|4
5156930|NCT01422304|17808129|P2|Overall Study|Protocol Violation|0
5156931|NCT01422304|17808130|P1|Overall Study|Protocol Violation|1
5156932|NCT01422304|17808129|P2|Overall Study|Never Entered Follow-up|1
5156933|NCT01422304|17808130|P1|Overall Study|Never Entered Follow-up|2
5156934|NCT01422304|17808129|P2|Overall Study|Lost to Follow-up|20
5156935|NCT01422304|17808130|P1|Overall Study|Lost to Follow-up|14
5156936|NCT01422304|17808129|P2|Overall Study|Adverse Event|1
5156937|NCT01422304|17808130|P1|Overall Study|Adverse Event|0
5156938|NCT01422239|17808162|P2|Overall Study|Lost to Follow-up|3
5156939|NCT01422239|17808163|P1|Overall Study|Lost to Follow-up|4
5156940|NCT01422213|17808185|P3|Overall Study|Administrative or Other Reason(s)|2
5156941|NCT01422213|17808186|P2|Overall Study|Administrative or Other Reason(s)|4
5156942|NCT01422213|17808187|P1|Overall Study|Administrative or Other Reason(s)|5
5156943|NCT01422213|17808185|P3|Overall Study|Lost to Follow-up|5
5156944|NCT01422213|17808186|P2|Overall Study|Lost to Follow-up|3
5156945|NCT01422213|17808187|P1|Overall Study|Lost to Follow-up|3
5156946|NCT01422213|17808185|P3|Overall Study|Withdrawal of Consent|5
5156947|NCT01422213|17808186|P2|Overall Study|Withdrawal of Consent|3
5156948|NCT01422213|17808187|P1|Overall Study|Withdrawal of Consent|7
5156949|NCT01422213|17808185|P3|Overall Study|Protocol Violation|4
5156950|NCT01422213|17808186|P2|Overall Study|Protocol Violation|2
5156951|NCT01422213|17808187|P1|Overall Study|Protocol Violation|0
5156952|NCT01422213|17808185|P3|Overall Study|Non-compliance with study drug|0
5156953|NCT01422213|17808186|P2|Overall Study|Non-compliance with study drug|1
5156954|NCT01422213|17808187|P1|Overall Study|Non-compliance with study drug|0
5156955|NCT01422213|17808185|P3|Overall Study|Lack of Efficacy|2
5156956|NCT01422213|17808186|P2|Overall Study|Lack of Efficacy|2
5156957|NCT01422213|17808187|P1|Overall Study|Lack of Efficacy|10
5156958|NCT01422213|17808185|P3|Overall Study|Adverse Event|11
5156959|NCT01422213|17808186|P2|Overall Study|Adverse Event|7
5156960|NCT01422213|17808187|P1|Overall Study|Adverse Event|8
5156961|NCT01422187|17808259|P3|Overall Study|Lost to Follow-up|0
5156962|NCT01422187|17808260|P2|Overall Study|Lost to Follow-up|1
5156963|NCT01422187|17808261|P1|Overall Study|Lost to Follow-up|0
5156964|NCT01422187|17808259|P3|Overall Study|Personal reason|0
5156965|NCT01422187|17808260|P2|Overall Study|Personal reason|0
5156966|NCT01422187|17808261|P1|Overall Study|Personal reason|1
5156967|NCT01421719|17808325|P1|Overall Study|Withdrawal by Subject|4
5156968|NCT01421667|17808334|P4|Overall Study|Lost to Follow-up|0
5156969|NCT01421667|17808335|P3|Overall Study|Lost to Follow-up|0
5156970|NCT01421667|17808336|P2|Overall Study|Lost to Follow-up|1
5156971|NCT01421667|17808337|P1|Overall Study|Lost to Follow-up|0
5156972|NCT01421667|17808334|P4|Overall Study|Withdrawal by Subject|1
5156973|NCT01421667|17808335|P3|Overall Study|Withdrawal by Subject|2
5156974|NCT01421667|17808336|P2|Overall Study|Withdrawal by Subject|1
5156975|NCT01421667|17808337|P1|Overall Study|Withdrawal by Subject|0
5156976|NCT01421641|17808398|P2|Overall Study|Protocol Violation|2
5156977|NCT01421641|17808399|P1|Overall Study|Protocol Violation|2
5156978|NCT01421511|17808421|P2|Overall Study|Death|1
5156979|NCT01421511|17808422|P1|Overall Study|Death|1
5156980|NCT01421511|17808421|P2|Overall Study|Withdrawal by Subject|5
5156981|NCT01421511|17808422|P1|Overall Study|Withdrawal by Subject|6
5156982|NCT01421511|17808421|P2|Overall Study|Physician Decision|1
5156983|NCT01421511|17808422|P1|Overall Study|Physician Decision|0
5156984|NCT01421511|17808421|P2|Overall Study|Randomized but didn't receive study drug|7
5156985|NCT01421511|17808422|P1|Overall Study|Randomized but didn't receive study drug|1
5156986|NCT01421511|17808421|P2|Overall Study|Lost to Follow-up|14
5156987|NCT01421511|17808422|P1|Overall Study|Lost to Follow-up|11
5156988|NCT01421459|17808472|P2|Overall Study|Withdrawal by Subject|16
5156989|NCT01421459|17808473|P1|Overall Study|Withdrawal by Subject|12
5156990|NCT01421459|17808472|P2|Overall Study|Protocol Violation|5
5156991|NCT01421459|17808473|P1|Overall Study|Protocol Violation|8
5156992|NCT01421459|17808472|P2|Overall Study|Physician Decision|9
5156993|NCT01421459|17808473|P1|Overall Study|Physician Decision|9
5156994|NCT01421459|17808472|P2|Overall Study|Lost to Follow-up|9
5156995|NCT01421459|17808473|P1|Overall Study|Lost to Follow-up|8
5156996|NCT01421459|17808472|P2|Overall Study|Lack of Efficacy|2
5156997|NCT01421459|17808473|P1|Overall Study|Lack of Efficacy|1
5156998|NCT01421459|17808472|P2|Overall Study|Death|1
5156999|NCT01421459|17808473|P1|Overall Study|Death|1
5157000|NCT01421459|17808472|P2|Overall Study|Adverse Event|10
5157001|NCT01421459|17808473|P1|Overall Study|Adverse Event|6
5157002|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
5157003|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
5157004|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
5157005|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5157006|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5157007|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5157008|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
5157009|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
5157010|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
5157011|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
5157012|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
5157013|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
5157014|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
5157015|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
5157016|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
5157017|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
5157018|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
5157019|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
5157020|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
5157021|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
5157022|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
5157023|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
5157024|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
5157025|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
5157026|NCT01421342|17808514|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
5157027|NCT01421342|17808515|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
5157028|NCT01421342|17808516|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
5157029|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
5157030|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
5157031|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
5157032|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
5157033|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
5157034|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
5157035|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
5157036|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
5157037|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
5157038|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
5157039|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
5157040|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
5157041|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
5157042|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
5157043|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
5157044|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
5157045|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
5157046|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
5157047|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
5157048|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
5157049|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
5157050|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
5157051|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
5157052|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
5157053|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
5157054|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
5157055|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
5157056|NCT01421342|17808514|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
5157057|NCT01421342|17808515|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
5157058|NCT01421342|17808516|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
5157059|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
5157060|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
5157061|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
5157062|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
5157063|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
5157064|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
5157065|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
5157066|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
5157067|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
5157068|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
5157069|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
5157070|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
5157071|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
5157072|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
5157073|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
5157074|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Death|3
5157075|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Death|0
5157076|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Death|0
5157077|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
5157078|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
5157079|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
5157080|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
5157081|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
5157082|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
5157083|NCT01421342|17808514|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
5157084|NCT01421342|17808515|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
5157085|NCT01421342|17808516|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
5157086|NCT01421303|17808533|P1|Overall Study|Withdrawal by Subject|1
5157087|NCT01421303|17808533|P1|Overall Study|Other|7
5157088|NCT01421303|17808533|P1|Overall Study|Non compliance with study procedure|1
5157089|NCT01421303|17808533|P1|Overall Study|Lost to Follow-up|13
5157090|NCT01421277|17808560|P2|Overall Study|Incomplete baseline data|31
5157091|NCT01421277|17808561|P1|Overall Study|Incomplete baseline data|0
5157092|NCT01421277|17808560|P2|Overall Study|Lack of qualifying event|61
5157093|NCT01421277|17808561|P1|Overall Study|Lack of qualifying event|0
5157094|NCT01421225|17808573|P2|Overall Study|Withdrawal by Subject|1
5157095|NCT01421225|17808574|P1|Overall Study|Withdrawal by Subject|0
5157096|NCT01421147|17808588|P2|Extension Period|Withdrawal by Subject|3
5157097|NCT01421147|17808589|P1|Extension Period|Withdrawal by Subject|5
5157098|NCT01421147|17808588|P2|Extension Period|Physician Decision|0
5157099|NCT01421147|17808589|P1|Extension Period|Physician Decision|1
5157100|NCT01421147|17808588|P2|Extension Period|Lost to Follow-up|5
5157101|NCT01421147|17808589|P1|Extension Period|Lost to Follow-up|2
5157102|NCT01421147|17808588|P2|Extension Period|Death|1
5157103|NCT01421147|17808589|P1|Extension Period|Death|0
5157104|NCT01421147|17808588|P2|Extension Period|Adverse Event|2
5157105|NCT01421147|17808589|P1|Extension Period|Adverse Event|0
5157106|NCT01421147|17808588|P2|Treatment Period|Withdrawal by Subject|5
5157107|NCT01421147|17808589|P1|Treatment Period|Withdrawal by Subject|10
5157108|NCT01421147|17808588|P2|Treatment Period|Physician Decision|2
5157109|NCT01421147|17808589|P1|Treatment Period|Physician Decision|2
5157110|NCT01421147|17808588|P2|Treatment Period|Lost to Follow-up|1
5157111|NCT01421147|17808589|P1|Treatment Period|Lost to Follow-up|2
5157112|NCT01421147|17808588|P2|Treatment Period|Adverse Event|3
5157113|NCT01421147|17808589|P1|Treatment Period|Adverse Event|2
5157114|NCT01421134|17808621|P2|Overall Study|Lost to Follow-up|1
5157115|NCT01421134|17808622|P1|Overall Study|Lost to Follow-up|1
5157116|NCT01421134|17808621|P2|Overall Study|Administrative|1
5157117|NCT01421134|17808622|P1|Overall Study|Administrative|0
5157118|NCT01421134|17808621|P2|Overall Study|Withdrawal by Subject|1
5157119|NCT01421134|17808622|P1|Overall Study|Withdrawal by Subject|1
5157120|NCT01421134|17808621|P2|Overall Study|Protocol Violation|3
5157121|NCT01421134|17808622|P1|Overall Study|Protocol Violation|0
5157122|NCT01421134|17808621|P2|Overall Study|Lack of Efficacy|4
5157123|NCT01421134|17808622|P1|Overall Study|Lack of Efficacy|2
5157124|NCT01421134|17808621|P2|Overall Study|Adverse Event|5
5157125|NCT01421134|17808622|P1|Overall Study|Adverse Event|3
5157126|NCT01420965|17808643|P3|Overall Study|Adverse Event|0
5157127|NCT01420965|17808644|P2|Overall Study|Adverse Event|1
5157128|NCT01420965|17808645|P1|Overall Study|Adverse Event|0
5157129|NCT01420965|17808643|P3|Overall Study|Withdrawal by Subject|0
5157130|NCT01420965|17808644|P2|Overall Study|Withdrawal by Subject|0
5157131|NCT01420965|17808645|P1|Overall Study|Withdrawal by Subject|1
5157132|NCT01420926|17808658|P2|Overall Study|Continues on active treatment|3
5157133|NCT01420926|17808659|P1|Overall Study|Continues on active treatment|1
5157134|NCT01420926|17808658|P2|Overall Study|Physician Decision|5
5157135|NCT01420926|17808659|P1|Overall Study|Physician Decision|7
5157136|NCT01420926|17808658|P2|Overall Study|Non-protocol treatment|20
5157137|NCT01420926|17808659|P1|Overall Study|Non-protocol treatment|17
5157138|NCT01420926|17808658|P2|Overall Study|Withdrawal by Subject|16
5157139|NCT01420926|17808659|P1|Overall Study|Withdrawal by Subject|11
5157140|NCT01420926|17808658|P2|Overall Study|Death|17
5157141|NCT01420926|17808659|P1|Overall Study|Death|18
5157142|NCT01420926|17808658|P2|Overall Study|Adverse Event|4
5157143|NCT01420926|17808659|P1|Overall Study|Adverse Event|6
5157144|NCT01420627|17808706|P1|EZN-2279 Treatment Period|Adverse Event|1
5157145|NCT01420549|17808722|P2|Overall Study|Non-adherence to medication|1
5157146|NCT01420549|17808723|P1|Overall Study|Non-adherence to medication|4
5157147|NCT01420549|17808722|P2|Overall Study|Protocol Violation|1
5157148|NCT01420549|17808723|P1|Overall Study|Protocol Violation|0
5157149|NCT01420549|17808722|P2|Overall Study|Lost to Follow-up|2
5157150|NCT01420549|17808723|P1|Overall Study|Lost to Follow-up|2
5157151|NCT01420549|17808722|P2|Overall Study|Adverse Event|1
5157152|NCT01420549|17808723|P1|Overall Study|Adverse Event|1
5157153|NCT01420081|17808757|P9|Overall Study|Other Reasons|0
5157154|NCT01420081|17808758|P8|Overall Study|Other Reasons|0
5157155|NCT01420081|17808759|P7|Overall Study|Other Reasons|0
5157156|NCT01420081|17808760|P6|Overall Study|Other Reasons|0
5157157|NCT01420081|17808761|P5|Overall Study|Other Reasons|0
5157158|NCT01420081|17808762|P4|Overall Study|Other Reasons|0
5157159|NCT01420081|17808763|P3|Overall Study|Other Reasons|1
5157160|NCT01420081|17808764|P2|Overall Study|Other Reasons|0
5157161|NCT01420081|17808765|P1|Overall Study|Other Reasons|0
5157162|NCT01420081|17808757|P9|Overall Study|Subject Refused Futher Follow-up|0
5157163|NCT01420081|17808758|P8|Overall Study|Subject Refused Futher Follow-up|0
5157164|NCT01420081|17808759|P7|Overall Study|Subject Refused Futher Follow-up|0
5157165|NCT01420081|17808760|P6|Overall Study|Subject Refused Futher Follow-up|0
5157166|NCT01420081|17808761|P5|Overall Study|Subject Refused Futher Follow-up|1
5157167|NCT01420081|17808762|P4|Overall Study|Subject Refused Futher Follow-up|0
5157168|NCT01420081|17808763|P3|Overall Study|Subject Refused Futher Follow-up|1
5157169|NCT01420081|17808764|P2|Overall Study|Subject Refused Futher Follow-up|0
5157170|NCT01420081|17808765|P1|Overall Study|Subject Refused Futher Follow-up|0
5157171|NCT01420081|17808757|P9|Overall Study|Study Terminated by Sponsor|2
5157172|NCT01420081|17808758|P8|Overall Study|Study Terminated by Sponsor|2
5157173|NCT01420081|17808759|P7|Overall Study|Study Terminated by Sponsor|3
5157174|NCT01420081|17808760|P6|Overall Study|Study Terminated by Sponsor|7
5157175|NCT01420081|17808761|P5|Overall Study|Study Terminated by Sponsor|11
5157176|NCT01420081|17808762|P4|Overall Study|Study Terminated by Sponsor|3
5157177|NCT01420081|17808763|P3|Overall Study|Study Terminated by Sponsor|1
5157178|NCT01420081|17808764|P2|Overall Study|Study Terminated by Sponsor|1
5157179|NCT01420081|17808765|P1|Overall Study|Study Terminated by Sponsor|2
5157180|NCT01420081|17808757|P9|Overall Study|Lost to Follow-up|0
5157181|NCT01420081|17808758|P8|Overall Study|Lost to Follow-up|0
5157182|NCT01420081|17808759|P7|Overall Study|Lost to Follow-up|0
5157183|NCT01420081|17808760|P6|Overall Study|Lost to Follow-up|1
5157184|NCT01420081|17808761|P5|Overall Study|Lost to Follow-up|1
5157185|NCT01420081|17808762|P4|Overall Study|Lost to Follow-up|0
5157186|NCT01420081|17808763|P3|Overall Study|Lost to Follow-up|0
5157187|NCT01420081|17808764|P2|Overall Study|Lost to Follow-up|0
5157188|NCT01420081|17808765|P1|Overall Study|Lost to Follow-up|0
5157189|NCT01420081|17808757|P9|Overall Study|Death|1
5157190|NCT01420081|17808758|P8|Overall Study|Death|1
5157191|NCT01420081|17808759|P7|Overall Study|Death|0
5157192|NCT01420081|17808760|P6|Overall Study|Death|12
5157193|NCT01420081|17808761|P5|Overall Study|Death|7
5157194|NCT01420081|17808762|P4|Overall Study|Death|0
5157195|NCT01420081|17808763|P3|Overall Study|Death|8
5157196|NCT01420081|17808764|P2|Overall Study|Death|0
5157197|NCT01420081|17808765|P1|Overall Study|Death|1
5157198|NCT01420068|17808846|P2|Overall Study|Withdrawal by Subject|2
5157199|NCT01420068|17808847|P1|Overall Study|Withdrawal by Subject|1
5157200|NCT01420068|17808846|P2|Overall Study|Administrative problems|3
5157201|NCT01420068|17808847|P1|Overall Study|Administrative problems|1
5157202|NCT01419769|17808918|P1|Overall Study|Not evaluable due to pigtail stents|1
5157203|NCT01419769|17808918|P1|Overall Study|Did not receive the AXIOS stent|3
5157204|NCT01419717|17808931|P1|Overall Study|Noncompliance|1
5157205|NCT01419717|17808931|P1|Overall Study|Administrative Decision|1
5157206|NCT01419717|17808931|P1|Overall Study|Lost to Follow-up|2
5157207|NCT01419717|17808931|P1|Overall Study|Other|4
5157208|NCT01419717|17808931|P1|Overall Study|Disease Progression|9
5157209|NCT01419717|17808931|P1|Overall Study|Withdrawal by Subject|10
5157210|NCT01419717|17808931|P1|Overall Study|Death|17
5157211|NCT01419717|17808931|P1|Overall Study|Adverse Event|19
5157212|NCT01419717|17808931|P1|Overall Study|Protocol-specified Criteria|62
5157213|NCT01419626|17808945|P3|Overall Study|Lost to Follow-up|1
5157214|NCT01419626|17808946|P2|Overall Study|Lost to Follow-up|1
5157215|NCT01419626|17808947|P1|Overall Study|Lost to Follow-up|0
5157216|NCT01419626|17808945|P3|Overall Study|Withdrawal by Subject|0
5157217|NCT01419626|17808946|P2|Overall Study|Withdrawal by Subject|0
5157218|NCT01419626|17808947|P1|Overall Study|Withdrawal by Subject|1
5157219|NCT01419626|17808945|P3|Overall Study|Protocol Violation|2
5157220|NCT01419626|17808946|P2|Overall Study|Protocol Violation|2
5157221|NCT01419626|17808947|P1|Overall Study|Protocol Violation|3
5157222|NCT01419314|17808978|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
5157223|NCT01419314|17808979|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
5157224|NCT01419314|17808978|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
5157225|NCT01419314|17808979|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
5157226|NCT01419314|17808978|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
5157227|NCT01419314|17808979|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
5157228|NCT01419236|17809020|P2|Overall Study|Entry Criteria Not Met|0
5157229|NCT01419236|17809021|P1|Overall Study|Entry Criteria Not Met|1
5157230|NCT01419236|17809020|P2|Overall Study|Withdrawal by Subject|4
5157231|NCT01419236|17809021|P1|Overall Study|Withdrawal by Subject|1
5157232|NCT01419236|17809020|P2|Overall Study|Physician Decision|0
5157233|NCT01419236|17809021|P1|Overall Study|Physician Decision|1
5157234|NCT01419236|17809020|P2|Overall Study|Lost to Follow-up|0
5157235|NCT01419236|17809021|P1|Overall Study|Lost to Follow-up|1
5157236|NCT01419236|17809020|P2|Overall Study|Lack of Efficacy|1
5157237|NCT01419236|17809021|P1|Overall Study|Lack of Efficacy|0
5157238|NCT01419236|17809020|P2|Overall Study|Adverse Event|0
5157239|NCT01419236|17809021|P1|Overall Study|Adverse Event|1
5157240|NCT01419197|17809045|P2|Overall Study|Lost to Follow-up|4
5157241|NCT01419197|17809046|P1|Overall Study|Lost to Follow-up|14
5157242|NCT01419197|17809045|P2|Overall Study|Reason Not Specified|1
5157243|NCT01419197|17809046|P1|Overall Study|Reason Not Specified|0
5157244|NCT01419197|17809045|P2|Overall Study|Study Completed by Sponsor|34
5157245|NCT01419197|17809046|P1|Overall Study|Study Completed by Sponsor|103
5157246|NCT01419197|17809045|P2|Overall Study|Withdrawal by Subject|32
5157247|NCT01419197|17809046|P1|Overall Study|Withdrawal by Subject|33
5157248|NCT01419197|17809045|P2|Overall Study|Non-compliance|1
5157249|NCT01419197|17809046|P1|Overall Study|Non-compliance|3
5157250|NCT01419197|17809045|P2|Overall Study|Physician Decision|4
5157251|NCT01419197|17809046|P1|Overall Study|Physician Decision|4
5157252|NCT01419197|17809045|P2|Overall Study|Death|122
5157253|NCT01419197|17809046|P1|Overall Study|Death|247
5157254|NCT01419184|17809071|P2|Overall Study|Participant randomized, not treated|0
5157255|NCT01419184|17809072|P1|Overall Study|Participant randomized, not treated|1
5157256|NCT01419184|17809071|P2|Overall Study|No IRLOS-No adverse event treatment date|1
5157257|NCT01419184|17809072|P1|Overall Study|No IRLOS-No adverse event treatment date|0
5157258|NCT01419184|17809071|P2|Overall Study|No IRLOS-non trial antibiotic used|2
5157259|NCT01419184|17809072|P1|Overall Study|No IRLOS-non trial antibiotic used|1
5157260|NCT01419184|17809071|P2|Overall Study|No IRLOS-randomized, not treated|4
5157261|NCT01419184|17809072|P1|Overall Study|No IRLOS-randomized, not treated|2
5157262|NCT01419184|17809071|P2|Overall Study|No IRLOS-No in-patient end date reported|6
5157263|NCT01419184|17809072|P1|Overall Study|No IRLOS-No in-patient end date reported|3
5157264|NCT01419184|17809071|P2|Overall Study|Site data not available|2
5157265|NCT01419184|17809072|P1|Overall Study|Site data not available|3
5157266|NCT01419080|17809105|P1|Overall Study|Too Ill|3
5157267|NCT01419080|17809105|P1|Overall Study|Lost to Follow-up|23
5157268|NCT01419080|17809105|P1|Overall Study|Death|30
5157269|NCT01419080|17809105|P1|Overall Study|Withdrawal by Subject|75
5157270|NCT01419015|17809116|P1|Overall Study|Death|2
5157271|NCT01418937|17809120|P1|Overall Study|Withdrawal by Subject|1
5157272|NCT01418937|17809120|P1|Overall Study|Pregnancy|1
5157273|NCT01418937|17809120|P1|Overall Study|Protocol Violation|1
5157274|NCT01418937|17809120|P1|Overall Study|Lost to Follow-up|5
5157275|NCT01418378|17809151|P2|Overall Study|developed chronic myopathy|1
5157276|NCT01418378|17809152|P1|Overall Study|developed chronic myopathy|0
5157277|NCT01418378|17809151|P2|Overall Study|ligament imbalance|1
5157278|NCT01418378|17809152|P1|Overall Study|ligament imbalance|0
5157279|NCT01418378|17809151|P2|Overall Study|Physician Decision|1
5157280|NCT01418378|17809152|P1|Overall Study|Physician Decision|0
5157281|NCT01418378|17809151|P2|Overall Study|Death|2
5157282|NCT01418378|17809152|P1|Overall Study|Death|1
5157283|NCT01418365|17809226|P2|Second Intervention|Withdrawal by Subject|1
5157284|NCT01418365|17809227|P1|Second Intervention|Withdrawal by Subject|0
5157285|NCT01418365|17809226|P2|First Intervention|Non-compliance|0
5157286|NCT01418365|17809227|P1|First Intervention|Non-compliance|1
5157287|NCT01418365|17809226|P2|First Intervention|Withdrawal by Subject|1
5157288|NCT01418365|17809227|P1|First Intervention|Withdrawal by Subject|0
5157289|NCT01418209|17809238|P3|Overall Study|Did not provide hot flash diary data|3
5157290|NCT01418209|17809239|P2|Overall Study|Did not provide hot flash diary data|3
5157291|NCT01418209|17809240|P1|Overall Study|Did not provide hot flash diary data|1
5157292|NCT01418209|17809238|P3|Overall Study|Withdrawal by Subject|1
5157293|NCT01418209|17809239|P2|Overall Study|Withdrawal by Subject|0
5157294|NCT01418209|17809240|P1|Overall Study|Withdrawal by Subject|1
5157295|NCT01417481|17809304|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
5157296|NCT01417481|17809305|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
5157297|NCT01417377|17809370|P1|Overall Study|Enrolled, but not treated|1
5157298|NCT01417377|17809370|P1|Overall Study|Lost to Follow-up|12
5157299|NCT01417234|17809377|P1|Overall Study|Subject non-compliant|3
5157300|NCT01417195|17809386|P2|Overall Study|No transfer due to elevated progesterone|0
5157301|NCT01417195|17809387|P1|Overall Study|No transfer due to elevated progesterone|1
5157302|NCT01417195|17809386|P2|Overall Study|No transfer due to risk of OHSS|0
5157303|NCT01417195|17809387|P1|Overall Study|No transfer due to risk of OHSS|1
5157304|NCT01417195|17809386|P2|Overall Study|No embryos for transfer|1
5157305|NCT01417195|17809387|P1|Overall Study|No embryos for transfer|0
5157306|NCT01417195|17809386|P2|Overall Study|Stimulation failure|0
5157307|NCT01417195|17809387|P1|Overall Study|Stimulation failure|1
5157308|NCT01417156|17809403|P1|Overall Study|Protocol Violation|2
5157309|NCT01417156|17809403|P1|Overall Study|Adverse Event|12
5157310|NCT01417104|17809413|P2|Overall Study|Adverse Event|0
5157311|NCT01417104|17809414|P1|Overall Study|Adverse Event|1
5157312|NCT01417104|17809413|P2|Overall Study|Failure to make contact|1
5157313|NCT01417104|17809414|P1|Overall Study|Failure to make contact|0
5157314|NCT01417104|17809413|P2|Overall Study|Withdrawal by Subject|1
5157315|NCT01417104|17809414|P1|Overall Study|Withdrawal by Subject|5
5157316|NCT01417078|17809424|P1|Overall Study|Withdrawal by Subject|1
5157317|NCT01417000|17809449|P2|Overall Study|Study Terminated by Sponsor|1
5157318|NCT01417000|17809450|P1|Overall Study|Study Terminated by Sponsor|1
5157319|NCT01417000|17809449|P2|Overall Study|Lost to Follow-up|0
5157320|NCT01417000|17809450|P1|Overall Study|Lost to Follow-up|1
5157321|NCT01417000|17809449|P2|Overall Study|Death|28
5157322|NCT01417000|17809450|P1|Overall Study|Death|59
5157323|NCT01416805|17809467|P2|Overall Study|Lost to Follow-up|4
5157324|NCT01416805|17809468|P1|Overall Study|Lost to Follow-up|4
5157325|NCT01416610|17809507|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
5157326|NCT01416610|17809507|P1|Overall Study|Lost to Follow-up|7
5157327|NCT01416610|17809507|P1|Overall Study|Withdrawal by Subject|13
5157328|NCT01416610|17809507|P1|Overall Study|No reason given|5
5157329|NCT01416610|17809507|P1|Overall Study|Lack of Efficacy|4
5157330|NCT01416610|17809507|P1|Overall Study|Adverse Event -Patient decision|3
5157331|NCT01416610|17809507|P1|Overall Study|Adverse Event|4
5157332|NCT01416571|17809561|P1|Overall Study|Lost to Follow-up|2
5157333|NCT01416389|17809590|P2|Overall Study|Started New Therapy|0
5157334|NCT01416389|17809591|P1|Overall Study|Started New Therapy|2
5157335|NCT01416389|17809590|P2|Overall Study|Lost to Follow-up|0
5157336|NCT01416389|17809591|P1|Overall Study|Lost to Follow-up|1
5157337|NCT01416272|17809608|P1|Overall Study|Study related complaints|1
5157338|NCT01416272|17809608|P1|Overall Study|Lost to Follow-up|1
5157339|NCT01416272|17809608|P1|Overall Study|Unacceptable distance visual acuity|2
5157340|NCT01416181|17809665|P2|Part 2|Lost to Follow-up|2
5157341|NCT01416181|17809666|P1|Part 2|Lost to Follow-up|2
5157342|NCT01416181|17809665|P2|Part 2|Lack of Efficacy|1
5157343|NCT01416181|17809666|P1|Part 2|Lack of Efficacy|4
5157344|NCT01416181|17809665|P2|Part 2|Withdrawal by Subject|5
5157345|NCT01416181|17809666|P1|Part 2|Withdrawal by Subject|14
5157346|NCT01416181|17809665|P2|Part 2|Investigator Decision|7
5157347|NCT01416181|17809666|P1|Part 2|Investigator Decision|6
5157348|NCT01416181|17809665|P2|Part 2|Other|267
5157349|NCT01416181|17809666|P1|Part 2|Other|234
5157350|NCT01416181|17809665|P2|Part 2|Adverse Event|4
5157351|NCT01416181|17809666|P1|Part 2|Adverse Event|11
5157352|NCT01416181|17809665|P2|Part 1|Ongoing in Follow-Up|8
5157353|NCT01416181|17809666|P1|Part 1|Ongoing in Follow-Up|14
5157354|NCT01416181|17809665|P2|Part 1|Adverse Event|18
5157355|NCT01416181|17809666|P1|Part 1|Adverse Event|15
5157356|NCT01416181|17809665|P2|Part 1|Lost to Follow-up|1
5157357|NCT01416181|17809666|P1|Part 1|Lost to Follow-up|1
5157358|NCT01416181|17809665|P2|Part 1|Lack of Efficacy|8
5157359|NCT01416181|17809666|P1|Part 1|Lack of Efficacy|16
5157360|NCT01416181|17809665|P2|Part 1|Withdrawal by Subject|48
5157361|NCT01416181|17809666|P1|Part 1|Withdrawal by Subject|74
5157362|NCT01416181|17809665|P2|Part 1|Investigator Decision|6
5157363|NCT01416181|17809666|P1|Part 1|Investigator Decision|7
5157364|NCT01416181|17809665|P2|Part 1|Death|1
5157365|NCT01416181|17809666|P1|Part 1|Death|0
5157366|NCT01416181|17809665|P2|Part 1|Other|24
5157367|NCT01416181|17809666|P1|Part 1|Other|10
5157368|NCT01416155|17809728|P1|Overall Study|Other|7
5157369|NCT01416155|17809728|P1|Overall Study|Investigator decision|8
5157370|NCT01416155|17809728|P1|Overall Study|Withdrawal by Subject|33
5157371|NCT01416155|17809728|P1|Overall Study|Positive for anti-BG00002 antibodies|2
5157372|NCT01416155|17809728|P1|Overall Study|Adverse Event|8
5157373|NCT01416142|17809735|P3|PureVision2 HD|Inability to maintain lens wear|1
5157374|NCT01416142|17809736|P2|PureVision2 HD|Inability to maintain lens wear|0
5157375|NCT01416142|17809737|P1|PureVision2 HD|Inability to maintain lens wear|0
5157376|NCT01415986|17809764|P1|Overall Study|Lost to Follow-up|1
5157377|NCT01415921|17809790|P2|Overall Study|Other|0
5157378|NCT01415921|17809791|P1|Overall Study|Other|2
5157379|NCT01415921|17809790|P2|Overall Study|Withdrawal by Subject|1
5157380|NCT01415921|17809791|P1|Overall Study|Withdrawal by Subject|0
5157381|NCT01415921|17809790|P2|Overall Study|Physician Decision|1
5157382|NCT01415921|17809791|P1|Overall Study|Physician Decision|1
5157383|NCT01415921|17809790|P2|Overall Study|Adverse Event|1
5157384|NCT01415921|17809791|P1|Overall Study|Adverse Event|0
5157385|NCT01415908|17809801|P2|Overall Study|Withdrawal by Subject|0
5157386|NCT01415908|17809802|P1|Overall Study|Withdrawal by Subject|1
5157387|NCT01415531|17809839|P2|Overall Study|Other Reasons|2
5157388|NCT01415531|17809840|P1|Overall Study|Other Reasons|3
5157389|NCT01415531|17809839|P2|Overall Study|Lack of Compliance|4
5157390|NCT01415531|17809840|P1|Overall Study|Lack of Compliance|1
5157391|NCT01415531|17809839|P2|Overall Study|Lost to Follow-up|14
5157392|NCT01415531|17809840|P1|Overall Study|Lost to Follow-up|6
5157393|NCT01415531|17809839|P2|Overall Study|Withdrawal by Subject|4
5157394|NCT01415531|17809840|P1|Overall Study|Withdrawal by Subject|5
5157395|NCT01415531|17809839|P2|Overall Study|Protocol Violation|1
5157396|NCT01415531|17809840|P1|Overall Study|Protocol Violation|0
5157397|NCT01415531|17809839|P2|Overall Study|Lack of Efficacy|2
5157398|NCT01415531|17809840|P1|Overall Study|Lack of Efficacy|3
5157399|NCT01415531|17809839|P2|Overall Study|Adverse Event|10
5157400|NCT01415531|17809840|P1|Overall Study|Adverse Event|7
5157401|NCT01415518|17809850|P2|Overall Study|Condition under Investigation Worsened|1
5157402|NCT01415518|17809851|P1|Overall Study|Condition under Investigation Worsened|1
5157403|NCT01415518|17809850|P2|Overall Study|Death|1
5157404|NCT01415518|17809851|P1|Overall Study|Death|1
5157405|NCT01415518|17809850|P2|Overall Study|Adverse Event|4
5157406|NCT01415518|17809851|P1|Overall Study|Adverse Event|3
5157407|NCT01415518|17809850|P2|Overall Study|Lost to Follow-up|5
5157408|NCT01415518|17809851|P1|Overall Study|Lost to Follow-up|3
5157409|NCT01415518|17809850|P2|Overall Study|Protocol Violation|8
5157410|NCT01415518|17809851|P1|Overall Study|Protocol Violation|6
5157411|NCT01415518|17809850|P2|Overall Study|Withdrawal by Subject|12
5157412|NCT01415518|17809851|P1|Overall Study|Withdrawal by Subject|2
5157413|NCT01415440|17809910|P3|Overall Study|Withdrawal by Subject|0
5157414|NCT01415440|17809911|P2|Overall Study|Withdrawal by Subject|0
5157415|NCT01415440|17809912|P1|Overall Study|Withdrawal by Subject|1
5157416|NCT01415440|17809910|P3|Overall Study|Physician Decision|0
5157417|NCT01415440|17809911|P2|Overall Study|Physician Decision|0
5157418|NCT01415440|17809912|P1|Overall Study|Physician Decision|3
5157419|NCT01415440|17809910|P3|Overall Study|Lost to Follow-up|2
5157420|NCT01415440|17809911|P2|Overall Study|Lost to Follow-up|1
5157421|NCT01415440|17809912|P1|Overall Study|Lost to Follow-up|0
5157422|NCT01415401|17809963|P1|Overall Study|Terminated by Sponsor|1
5157423|NCT01415401|17809963|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
5157424|NCT01415401|17809963|P1|Overall Study|Adverse Event|5
5157425|NCT01415349|17809968|P2|Treatment Period 1|Withdrawal by Subject|1
5157426|NCT01415349|17809969|P1|Treatment Period 1|Withdrawal by Subject|0
5157427|NCT01415349|17809968|P2|Treatment Period 1|Adverse Event|1
5157428|NCT01415349|17809969|P1|Treatment Period 1|Adverse Event|0
5157429|NCT01414855|17809981|P1|Overall Study|Withdrawal by Subject|7
5157430|NCT01414855|17809981|P1|Overall Study|Lost to Follow-up|5
5157431|NCT01414855|17809981|P1|Overall Study|Death|17
5157432|NCT01414257|17810030|P1|Overall Study|Protocol Violation|10
5157433|NCT01414257|17810030|P1|Overall Study|No Visit After First Day of Treatment|12
5157434|NCT01414205|17810058|P2|Overall Study|Randomized but not Treated|1
5157435|NCT01414205|17810059|P1|Overall Study|Randomized but not Treated|1
5157436|NCT01414205|17810058|P2|Overall Study|Physician Decision|1
5157437|NCT01414205|17810059|P1|Overall Study|Physician Decision|0
5157438|NCT01414205|17810058|P2|Overall Study|Lost to Follow-up|4
5157439|NCT01414205|17810059|P1|Overall Study|Lost to Follow-up|1
5157440|NCT01414205|17810058|P2|Overall Study|Death|1
5157441|NCT01414205|17810059|P1|Overall Study|Death|5
5157442|NCT01414166|17810128|P2|Overall Study|Withdrawal by Subject|5
5157443|NCT01414166|17810129|P1|Overall Study|Withdrawal by Subject|3
5157444|NCT01414166|17810128|P2|Overall Study|Study terminated by Sponsor|75
5157445|NCT01414166|17810129|P1|Overall Study|Study terminated by Sponsor|68
5157446|NCT01414166|17810128|P2|Overall Study|Protocol Violation|0
5157447|NCT01414166|17810129|P1|Overall Study|Protocol Violation|2
5157448|NCT01414166|17810128|P2|Overall Study|Physician Decision|0
5157449|NCT01414166|17810129|P1|Overall Study|Physician Decision|2
5157450|NCT01414166|17810128|P2|Overall Study|Non-compliance with study drug|0
5157451|NCT01414166|17810129|P1|Overall Study|Non-compliance with study drug|2
5157452|NCT01414166|17810128|P2|Overall Study|Lost to Follow-up|1
5157453|NCT01414166|17810129|P1|Overall Study|Lost to Follow-up|4
5157454|NCT01414166|17810128|P2|Overall Study|Adverse Event|2
5157455|NCT01414166|17810129|P1|Overall Study|Adverse Event|10
5157456|NCT01414114|17810192|P1|Overall Study|Other|2
5157457|NCT01414114|17810192|P1|Overall Study|Withdrawal by Subject|1
5157458|NCT01414114|17810192|P1|Overall Study|Adverse Event|2
5157459|NCT01413958|17810248|P2|Overall Study|Lost to Follow-up|1
5157460|NCT01413958|17810249|P1|Overall Study|Lost to Follow-up|0
5157461|NCT01413542|17810300|P4|Overall Study|Adverse Event|1
5157462|NCT01413542|17810301|P3|Overall Study|Adverse Event|0
5157463|NCT01413542|17810302|P2|Overall Study|Adverse Event|0
5157464|NCT01413542|17810303|P1|Overall Study|Adverse Event|0
5157465|NCT01413542|17810300|P4|Overall Study|Physician Decision|0
5157466|NCT01413542|17810301|P3|Overall Study|Physician Decision|3
5157467|NCT01413542|17810302|P2|Overall Study|Physician Decision|0
5157468|NCT01413542|17810303|P1|Overall Study|Physician Decision|1
5157469|NCT01413503|17810325|P1|Overall Study|Lost to Follow-up|1
5157470|NCT01413360|17810329|P1|Overall Study|Adverse Event|1
5157471|NCT01413360|17810329|P1|Overall Study|Lost to Follow-up|2
5157472|NCT01413204|17810337|P3|Overall Study|Fasting plasma glucose level increased|10
5157473|NCT01413204|17810338|P2|Overall Study|Fasting plasma glucose level increased|0
5157474|NCT01413204|17810339|P1|Overall Study|Fasting plasma glucose level increased|1
5157475|NCT01413204|17810337|P3|Overall Study|Clearly not eligible for the study|1
5157476|NCT01413204|17810338|P2|Overall Study|Clearly not eligible for the study|0
5157477|NCT01413204|17810339|P1|Overall Study|Clearly not eligible for the study|0
5157478|NCT01413204|17810337|P3|Overall Study|Withdrawal by Subject|4
5157479|NCT01413204|17810338|P2|Overall Study|Withdrawal by Subject|4
5157480|NCT01413204|17810339|P1|Overall Study|Withdrawal by Subject|1
5157481|NCT01413204|17810337|P3|Overall Study|Physician Decision|2
5157482|NCT01413204|17810338|P2|Overall Study|Physician Decision|0
5157483|NCT01413204|17810339|P1|Overall Study|Physician Decision|3
5157484|NCT01413204|17810337|P3|Overall Study|Adverse Event|2
5157485|NCT01413204|17810338|P2|Overall Study|Adverse Event|2
5157486|NCT01413204|17810339|P1|Overall Study|Adverse Event|1
5157487|NCT01413191|17810347|P1|Overall Study|Death|1
5157488|NCT01413191|17810347|P1|Overall Study|Disease Progression|5
5157489|NCT01413191|17810347|P1|Overall Study|Lost to Follow-up|5
5157490|NCT01413178|17810359|P2|Overall Study|Ineligible|2
5157491|NCT01413178|17810360|P1|Overall Study|Ineligible|0
5157492|NCT01413178|17810359|P2|Overall Study|Toxicity|0
5157493|NCT01413178|17810360|P1|Overall Study|Toxicity|1
5157494|NCT01412983|17810403|P2|1st Period|Inability to maintain wear|1
5157495|NCT01412983|17810404|P1|1st Period|Inability to maintain wear|0
5157496|NCT01412983|17810403|P2|1st Period|Unacceptable lens movement|1
5157497|NCT01412983|17810404|P1|1st Period|Unacceptable lens movement|0
5157498|NCT01412983|17810403|P2|1st Period|Positive slit lamp finding|1
5157499|NCT01412983|17810404|P1|1st Period|Positive slit lamp finding|0
5157500|NCT01412983|17810403|P2|1st Period|Ineligible|1
5157501|NCT01412983|17810404|P1|1st Period|Ineligible|0
5157502|NCT01412957|17810414|P2|Overall Study|Death|133
5157503|NCT01412957|17810415|P1|Overall Study|Death|136
5157504|NCT01412957|17810414|P2|Overall Study|Lost to Follow-up|2
5157505|NCT01412957|17810415|P1|Overall Study|Lost to Follow-up|7
5157506|NCT01412957|17810414|P2|Overall Study|Withdrawal by Subject|22
5157507|NCT01412957|17810415|P1|Overall Study|Withdrawal by Subject|6
5157508|NCT01412944|17810437|P6|Entire: IV + Maintenance|Adverse Event|0
5157509|NCT01412944|17810438|P5|Entire: IV + Maintenance|Adverse Event|0
5157510|NCT01412944|17810439|P4|Entire: IV + Maintenance|Adverse Event|0
5157511|NCT01412944|17810440|P3|Entire: IV + Maintenance|Adverse Event|0
5157512|NCT01412944|17810441|P2|Entire: IV + Maintenance|Adverse Event|1
5157513|NCT01412944|17810442|P1|Entire: IV + Maintenance|Adverse Event|0
5157514|NCT01412944|17810437|P6|Entire: IV + Maintenance|Lack of Efficacy|0
5157515|NCT01412944|17810438|P5|Entire: IV + Maintenance|Lack of Efficacy|0
5157516|NCT01412944|17810439|P4|Entire: IV + Maintenance|Lack of Efficacy|0
5157517|NCT01412944|17810440|P3|Entire: IV + Maintenance|Lack of Efficacy|0
5157518|NCT01412944|17810441|P2|Entire: IV + Maintenance|Lack of Efficacy|1
5157519|NCT01412944|17810442|P1|Entire: IV + Maintenance|Lack of Efficacy|0
5157520|NCT01412944|17810437|P6|Entire: IV + Maintenance|Lost to Follow-up|0
5157521|NCT01412944|17810438|P5|Entire: IV + Maintenance|Lost to Follow-up|0
5157522|NCT01412944|17810439|P4|Entire: IV + Maintenance|Lost to Follow-up|0
5157523|NCT01412944|17810440|P3|Entire: IV + Maintenance|Lost to Follow-up|0
5157524|NCT01412944|17810441|P2|Entire: IV + Maintenance|Lost to Follow-up|1
5157525|NCT01412944|17810442|P1|Entire: IV + Maintenance|Lost to Follow-up|0
5157526|NCT01412944|17810437|P6|Entire: IV + Maintenance|Protocol deviation|0
5157527|NCT01412944|17810438|P5|Entire: IV + Maintenance|Protocol deviation|0
5157528|NCT01412944|17810439|P4|Entire: IV + Maintenance|Protocol deviation|0
5157529|NCT01412944|17810440|P3|Entire: IV + Maintenance|Protocol deviation|0
5157530|NCT01412944|17810441|P2|Entire: IV + Maintenance|Protocol deviation|1
5157531|NCT01412944|17810442|P1|Entire: IV + Maintenance|Protocol deviation|0
5157532|NCT01412944|17810437|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
5157533|NCT01412944|17810438|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
5157534|NCT01412944|17810439|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
5157535|NCT01412944|17810440|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
5157536|NCT01412944|17810441|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
5157537|NCT01412944|17810442|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
5157538|NCT01412944|17810437|P6|Entire: IV + Maintenance|Lack of Efficacy|0
5157539|NCT01412944|17810438|P5|Entire: IV + Maintenance|Lack of Efficacy|1
5157540|NCT01412944|17810439|P4|Entire: IV + Maintenance|Lack of Efficacy|0
5157541|NCT01412944|17810440|P3|Entire: IV + Maintenance|Lack of Efficacy|0
5157542|NCT01412944|17810441|P2|Entire: IV + Maintenance|Lack of Efficacy|0
5157543|NCT01412944|17810442|P1|Entire: IV + Maintenance|Lack of Efficacy|0
5157544|NCT01412944|17810437|P6|Entire: IV + Maintenance|Lost to Follow-up|1
5157545|NCT01412944|17810438|P5|Entire: IV + Maintenance|Lost to Follow-up|0
5157546|NCT01412944|17810439|P4|Entire: IV + Maintenance|Lost to Follow-up|0
5157547|NCT01412944|17810440|P3|Entire: IV + Maintenance|Lost to Follow-up|0
5157548|NCT01412944|17810441|P2|Entire: IV + Maintenance|Lost to Follow-up|0
5157549|NCT01412944|17810442|P1|Entire: IV + Maintenance|Lost to Follow-up|0
5157550|NCT01412944|17810437|P6|Entire: IV + Maintenance|Protocol deviation|1
5157551|NCT01412944|17810438|P5|Entire: IV + Maintenance|Protocol deviation|0
5157552|NCT01412944|17810439|P4|Entire: IV + Maintenance|Protocol deviation|0
5157553|NCT01412944|17810440|P3|Entire: IV + Maintenance|Protocol deviation|0
5157554|NCT01412944|17810441|P2|Entire: IV + Maintenance|Protocol deviation|0
5157555|NCT01412944|17810442|P1|Entire: IV + Maintenance|Protocol deviation|0
5157556|NCT01412944|17810437|P6|Entire: IV + Maintenance|Adverse Event|0
5157557|NCT01412944|17810438|P5|Entire: IV + Maintenance|Adverse Event|1
5157558|NCT01412944|17810439|P4|Entire: IV + Maintenance|Adverse Event|0
5157559|NCT01412944|17810440|P3|Entire: IV + Maintenance|Adverse Event|0
5157560|NCT01412944|17810441|P2|Entire: IV + Maintenance|Adverse Event|0
5157561|NCT01412944|17810442|P1|Entire: IV + Maintenance|Adverse Event|0
5157562|NCT01412944|17810437|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
5157563|NCT01412944|17810438|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
5157564|NCT01412944|17810439|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
5157565|NCT01412944|17810440|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
5157566|NCT01412944|17810441|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
5157567|NCT01412944|17810442|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
5157568|NCT01412944|17810437|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
5157569|NCT01412944|17810438|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
5157570|NCT01412944|17810439|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
5157571|NCT01412944|17810440|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
5157572|NCT01412944|17810441|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
5157573|NCT01412944|17810442|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
5157574|NCT01412944|17810437|P6|IV: Per CAIN457A2307|Protocol deviation|0
5157575|NCT01412944|17810438|P5|IV: Per CAIN457A2307|Protocol deviation|0
5157576|NCT01412944|17810439|P4|IV: Per CAIN457A2307|Protocol deviation|0
5157577|NCT01412944|17810440|P3|IV: Per CAIN457A2307|Protocol deviation|0
5157578|NCT01412944|17810441|P2|IV: Per CAIN457A2307|Protocol deviation|1
5157579|NCT01412944|17810442|P1|IV: Per CAIN457A2307|Protocol deviation|0
5157580|NCT01412944|17810437|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
5157581|NCT01412944|17810438|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
5157582|NCT01412944|17810439|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
5157583|NCT01412944|17810440|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
5157584|NCT01412944|17810441|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
5157585|NCT01412944|17810442|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
5157586|NCT01412944|17810437|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
5157587|NCT01412944|17810438|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5157588|NCT01412944|17810439|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5157589|NCT01412944|17810440|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5157590|NCT01412944|17810441|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5157591|NCT01412944|17810442|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5157592|NCT01412944|17810437|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
5157593|NCT01412944|17810438|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5157594|NCT01412944|17810439|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5157595|NCT01412944|17810440|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5157596|NCT01412944|17810441|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5157597|NCT01412944|17810442|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5157598|NCT01412944|17810437|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5157599|NCT01412944|17810438|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5157600|NCT01412944|17810439|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5157601|NCT01412944|17810440|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
5157602|NCT01412944|17810441|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5157603|NCT01412944|17810442|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5157604|NCT01412879|17810488|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
5157605|NCT01412879|17810489|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
5157606|NCT01412879|17810490|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
5157607|NCT01412879|17810488|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
5157608|NCT01412879|17810489|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
5157609|NCT01412879|17810490|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
5157610|NCT01412879|17810488|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
5157611|NCT01412879|17810489|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
5157612|NCT01412879|17810490|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
5157613|NCT01412879|17810488|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
5157614|NCT01412879|17810489|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
5157615|NCT01412879|17810490|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
5157616|NCT01412879|17810488|P3|Initial Registration (Induction Therapy)|Adverse Event|0
5157617|NCT01412879|17810489|P2|Initial Registration (Induction Therapy)|Adverse Event|3
5157618|NCT01412879|17810490|P1|Initial Registration (Induction Therapy)|Adverse Event|5
5157619|NCT01412801|17810519|P6|Overall Study|Relocated to another area|0
5157620|NCT01412801|17810520|P5|Overall Study|Relocated to another area|0
5157621|NCT01412801|17810521|P4|Overall Study|Relocated to another area|0
5157622|NCT01412801|17810522|P3|Overall Study|Relocated to another area|2
5157623|NCT01412801|17810523|P2|Overall Study|Relocated to another area|0
5157624|NCT01412801|17810524|P1|Overall Study|Relocated to another area|0
5157625|NCT01412801|17810519|P6|Overall Study|Withdrawal by Subject|0
5157626|NCT01412801|17810520|P5|Overall Study|Withdrawal by Subject|0
5157627|NCT01412801|17810521|P4|Overall Study|Withdrawal by Subject|0
5157628|NCT01412801|17810522|P3|Overall Study|Withdrawal by Subject|1
5157629|NCT01412801|17810523|P2|Overall Study|Withdrawal by Subject|2
5157630|NCT01412801|17810524|P1|Overall Study|Withdrawal by Subject|3
5157631|NCT01412801|17810519|P6|Overall Study|Lost to Follow-up|1
5157632|NCT01412801|17810520|P5|Overall Study|Lost to Follow-up|1
5157633|NCT01412801|17810521|P4|Overall Study|Lost to Follow-up|0
5157634|NCT01412801|17810522|P3|Overall Study|Lost to Follow-up|4
5157635|NCT01412801|17810523|P2|Overall Study|Lost to Follow-up|2
5157636|NCT01412801|17810524|P1|Overall Study|Lost to Follow-up|1
5157637|NCT01412801|17810519|P6|Overall Study|Death|2
5157638|NCT01412801|17810520|P5|Overall Study|Death|2
5157639|NCT01412801|17810521|P4|Overall Study|Death|4
5157640|NCT01412801|17810522|P3|Overall Study|Death|0
5157641|NCT01412801|17810523|P2|Overall Study|Death|1
5157642|NCT01412801|17810524|P1|Overall Study|Death|0
5157643|NCT01412424|17810619|P1|Extension Treatment Period|Patient Request|2
5157644|NCT01412424|17810619|P1|Extension Treatment Period|Treatment Failure|2
5157645|NCT01412424|17810619|P1|Extension Treatment Period|Adverse Event|2
5157646|NCT01412424|17810619|P1|Core Treatment Period|Sponsor Request|1
5157647|NCT01412424|17810619|P1|Core Treatment Period|Lost to Follow-up|2
5157648|NCT01412424|17810619|P1|Core Treatment Period|Patient Request|5
5157649|NCT01412424|17810619|P1|Core Treatment Period|Adverse Event|21
5157650|NCT01412424|17810619|P1|Core Treatment Period|Treatment Failure|24
5157651|NCT01412333|17810637|P2|Overall Study|Lost to Follow-up|6
5157652|NCT01412333|17810638|P1|Overall Study|Lost to Follow-up|10
5157653|NCT01412333|17810637|P2|Overall Study|Adverse Event|16
5157654|NCT01412333|17810638|P1|Overall Study|Adverse Event|25
5157655|NCT01412333|17810637|P2|Overall Study|Consent withdrawn by participant|12
5157656|NCT01412333|17810638|P1|Overall Study|Consent withdrawn by participant|25
5157657|NCT01412333|17810637|P2|Overall Study|Pregnancy|0
5157658|NCT01412333|17810638|P1|Overall Study|Pregnancy|3
5157659|NCT01412333|17810637|P2|Overall Study|Lack of Efficacy|6
5157660|NCT01412333|17810638|P1|Overall Study|Lack of Efficacy|15
5157661|NCT01412333|17810637|P2|Overall Study|Non-compliance|3
5157662|NCT01412333|17810638|P1|Overall Study|Non-compliance|1
5157663|NCT01412333|17810637|P2|Overall Study|Protocol Violation|1
5157664|NCT01412333|17810638|P1|Overall Study|Protocol Violation|1
5157665|NCT01412333|17810637|P2|Overall Study|Non-compliance with study drug|1
5157666|NCT01412333|17810638|P1|Overall Study|Non-compliance with study drug|1
5157667|NCT01412333|17810637|P2|Overall Study|Reason not specified|10
5157668|NCT01412333|17810638|P1|Overall Study|Reason not specified|16
5157669|NCT01412333|17810637|P2|Overall Study|Physician Decision|1
5157670|NCT01412333|17810638|P1|Overall Study|Physician Decision|0
5157671|NCT01412333|17810637|P2|Overall Study|Death|1
5157672|NCT01412333|17810638|P1|Overall Study|Death|1
5157673|NCT01412229|17810698|P1|Overall Study|Physician Decision|1
5157674|NCT01412151|17810721|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
5157675|NCT01412151|17810721|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
5157676|NCT01412151|17810721|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
5157677|NCT01412151|17810721|P1|Week 0 - 306 - Treatment Period|Death|1
5157678|NCT01412060|17810732|P3|Double-blind Treatment Phase (DBP)|Relapse|25
5157679|NCT01412060|17810733|P2|Double-blind Treatment Phase (DBP)|Relapse|47
5157680|NCT01412060|17810734|P1|Double-blind Treatment Phase (DBP)|Relapse|0
5157681|NCT01412060|17810732|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
5157682|NCT01412060|17810733|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
5157683|NCT01412060|17810734|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
5157684|NCT01412060|17810732|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
5157685|NCT01412060|17810733|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
5157686|NCT01412060|17810734|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
5157687|NCT01412060|17810732|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
5157688|NCT01412060|17810733|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
5157689|NCT01412060|17810734|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
5157690|NCT01412060|17810732|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
5157691|NCT01412060|17810733|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
5157692|NCT01412060|17810734|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
5157693|NCT01412060|17810732|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
5157694|NCT01412060|17810733|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
5157695|NCT01412060|17810734|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
5157696|NCT01412060|17810732|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
5157697|NCT01412060|17810733|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
5157698|NCT01412060|17810734|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
5157699|NCT01412060|17810732|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
5157700|NCT01412060|17810733|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
5157701|NCT01412060|17810734|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
5157702|NCT01412060|17810732|P3|Period Between SP and DBP|Lost to Follow-up|0
5157703|NCT01412060|17810733|P2|Period Between SP and DBP|Lost to Follow-up|0
5157704|NCT01412060|17810734|P1|Period Between SP and DBP|Lost to Follow-up|1
5157705|NCT01412060|17810732|P3|Period Between SP and DBP|Withdrawal of Consent|0
5157706|NCT01412060|17810733|P2|Period Between SP and DBP|Withdrawal of Consent|0
5157707|NCT01412060|17810734|P1|Period Between SP and DBP|Withdrawal of Consent|2
5157708|NCT01412060|17810732|P3|Period Between SP and DBP|Protocol Violation|0
5157709|NCT01412060|17810733|P2|Period Between SP and DBP|Protocol Violation|0
5157710|NCT01412060|17810734|P1|Period Between SP and DBP|Protocol Violation|2
5157711|NCT01412060|17810732|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
5157712|NCT01412060|17810733|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
5157713|NCT01412060|17810734|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
5157714|NCT01412060|17810732|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
5157715|NCT01412060|17810733|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
5157716|NCT01412060|17810734|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
5157717|NCT01412060|17810732|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
5157718|NCT01412060|17810733|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
5157719|NCT01412060|17810734|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
5157720|NCT01412060|17810732|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
5157721|NCT01412060|17810733|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
5157722|NCT01412060|17810734|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
5157723|NCT01412060|17810732|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
5157724|NCT01412060|17810733|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
5157725|NCT01412060|17810734|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
5157726|NCT01412060|17810732|P3|Open-label Stabilization Period (SP)|Adverse Event|0
5157727|NCT01412060|17810733|P2|Open-label Stabilization Period (SP)|Adverse Event|0
5157728|NCT01412060|17810734|P1|Open-label Stabilization Period (SP)|Adverse Event|9
5157729|NCT01412060|17810732|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
5157730|NCT01412060|17810733|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
5157731|NCT01412060|17810734|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
5157732|NCT01412060|17810732|P3|Period Between RIP and SP|Lost to Follow-up|0
5157733|NCT01412060|17810733|P2|Period Between RIP and SP|Lost to Follow-up|0
5157734|NCT01412060|17810734|P1|Period Between RIP and SP|Lost to Follow-up|5
5157735|NCT01412060|17810732|P3|Period Between RIP and SP|Withdrawal of Consent|0
5157736|NCT01412060|17810733|P2|Period Between RIP and SP|Withdrawal of Consent|0
5157737|NCT01412060|17810734|P1|Period Between RIP and SP|Withdrawal of Consent|1
5157738|NCT01412060|17810732|P3|Period Between RIP and SP|Protocol Violation|0
5157739|NCT01412060|17810733|P2|Period Between RIP and SP|Protocol Violation|0
5157740|NCT01412060|17810734|P1|Period Between RIP and SP|Protocol Violation|2
5157741|NCT01412060|17810732|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
5157742|NCT01412060|17810733|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
5157743|NCT01412060|17810734|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
5157744|NCT01412060|17810732|P3|Period Between RIP and SP|Adverse Event|0
5157745|NCT01412060|17810733|P2|Period Between RIP and SP|Adverse Event|0
5157746|NCT01412060|17810734|P1|Period Between RIP and SP|Adverse Event|4
5157747|NCT01412060|17810732|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
5157748|NCT01412060|17810733|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
5157749|NCT01412060|17810734|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
5157750|NCT01412060|17810732|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
5157751|NCT01412060|17810733|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
5157752|NCT01412060|17810734|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
5157753|NCT01412060|17810732|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
5157754|NCT01412060|17810733|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
5157755|NCT01412060|17810734|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
5157756|NCT01412060|17810732|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
5157757|NCT01412060|17810733|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
5157758|NCT01412060|17810734|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
5157759|NCT01412060|17810732|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
5157760|NCT01412060|17810733|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
5157761|NCT01412060|17810734|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
5157762|NCT01412060|17810732|P3|Open-label Run-in Period (RIP)|Adverse Event|0
5157763|NCT01412060|17810733|P2|Open-label Run-in Period (RIP)|Adverse Event|0
5157764|NCT01412060|17810734|P1|Open-label Run-in Period (RIP)|Adverse Event|86
5157765|NCT01412021|17810744|P1|Overall Study|Transferred to Other Hospital|9
5157766|NCT01412021|17810744|P1|Overall Study|Treatment Prior to Approval|3
5157767|NCT01412021|17810744|P1|Overall Study|Case Report Forms Not Retrieved|7
5157768|NCT01411995|17810781|P2|Overall Study|Failed IUD insertion|1
5157769|NCT01411995|17810782|P1|Overall Study|Failed IUD insertion|0
5157770|NCT01411917|17810790|P2|Overall Study|Patient did not undergo scheduled surger|1
5157771|NCT01411917|17810791|P1|Overall Study|Patient did not undergo scheduled surger|0
5157772|NCT01411891|17810813|P2|Overall Study|Catheter dislodgement or loss to follow-|2
5157773|NCT01411891|17810814|P1|Overall Study|Catheter dislodgement or loss to follow-|3
5157774|NCT01411852|17810824|P2|Hospital Intervention Phase|Vascular access failed|0
5157775|NCT01411852|17810825|P1|Hospital Intervention Phase|Vascular access failed|1
5157776|NCT01411852|17810824|P2|Hospital Intervention Phase|Withdrawal by Subject|0
5157777|NCT01411852|17810825|P1|Hospital Intervention Phase|Withdrawal by Subject|1
5157778|NCT01411852|17810824|P2|Hospital Intervention Phase|Spinal cord injury|0
5157779|NCT01411852|17810825|P1|Hospital Intervention Phase|Spinal cord injury|2
5157780|NCT01411852|17810824|P2|Hospital Intervention Phase|Other ineligible|2
5157781|NCT01411852|17810825|P1|Hospital Intervention Phase|Other ineligible|2
5157782|NCT01411852|17810824|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
5157783|NCT01411852|17810825|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
5157784|NCT01411852|17810824|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
5157785|NCT01411852|17810825|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
5157786|NCT01411852|17810824|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
5157787|NCT01411852|17810825|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
5157788|NCT01411852|17810824|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
5157789|NCT01411852|17810825|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
5157790|NCT01411852|17810824|P2|Hospital Intervention Phase|CPR administered|1
5157791|NCT01411852|17810825|P1|Hospital Intervention Phase|CPR administered|3
5157792|NCT01411852|17810824|P2|Hospital Intervention Phase|Miscommunication error|2
5157793|NCT01411852|17810825|P1|Hospital Intervention Phase|Miscommunication error|1
5157794|NCT01411852|17810824|P2|Hospital Intervention Phase|No qualifying SBP|1
5157795|NCT01411852|17810825|P1|Hospital Intervention Phase|No qualifying SBP|5
5157796|NCT01411852|17810824|P2|Hospital Intervention Phase|Severe head injury|4
5157797|NCT01411852|17810825|P1|Hospital Intervention Phase|Severe head injury|5
5157798|NCT01411852|17810824|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
5157799|NCT01411852|17810825|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
5157800|NCT01411852|17810824|P2|Prehospital Intervention Phase|Found to be under age|1
5157801|NCT01411852|17810825|P1|Prehospital Intervention Phase|Found to be under age|0
5157890|NCT01410227|17811417|P2|Overall Study|Withdrawal by Subject|0
5157802|NCT01411852|17810824|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
5157803|NCT01411852|17810825|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
5157804|NCT01411852|17810824|P2|Prehospital Intervention Phase|No qualifying SBP|4
5157805|NCT01411852|17810825|P1|Prehospital Intervention Phase|No qualifying SBP|5
5157806|NCT01411839|17810870|P2|Overall Study|Lost to Follow-up|3
5157807|NCT01411839|17810871|P1|Overall Study|Lost to Follow-up|4
5157808|NCT01411774|17810883|P2|Overall Study|Withdrawal by Subject|3
5157809|NCT01411774|17810884|P1|Overall Study|Withdrawal by Subject|0
5157810|NCT01411241|17810999|P2|Overall Study|Lost to Follow-up|4
5157811|NCT01411241|17811000|P1|Overall Study|Lost to Follow-up|2
5157812|NCT01411241|17810999|P2|Overall Study|Serious Adverse Event|3
5157813|NCT01411241|17811000|P1|Overall Study|Serious Adverse Event|0
5157814|NCT01411241|17810999|P2|Overall Study|Withdrawal by Subject|10
5157815|NCT01411241|17811000|P1|Overall Study|Withdrawal by Subject|9
5157816|NCT01411241|17810999|P2|Overall Study|Protocol Violation|5
5157817|NCT01411241|17811000|P1|Overall Study|Protocol Violation|0
5157818|NCT01411228|17811025|P3|Overall Study|Withdrawal by Subject|0
5157819|NCT01411228|17811026|P2|Overall Study|Withdrawal by Subject|0
5157820|NCT01411228|17811027|P1|Overall Study|Withdrawal by Subject|1
5157821|NCT01411228|17811025|P3|Overall Study|Lost to Follow-up|1
5157822|NCT01411228|17811026|P2|Overall Study|Lost to Follow-up|0
5157823|NCT01411228|17811027|P1|Overall Study|Lost to Follow-up|0
5157824|NCT01411215|17811049|P2|Overall Study|Screen failure|1
5157825|NCT01411215|17811050|P1|Overall Study|Screen failure|0
5157826|NCT01411215|17811049|P2|Overall Study|Other|17
5157827|NCT01411215|17811050|P1|Overall Study|Other|12
5157828|NCT01411215|17811049|P2|Overall Study|Withdrawal by Subject|21
5157829|NCT01411215|17811050|P1|Overall Study|Withdrawal by Subject|34
5157830|NCT01411215|17811049|P2|Overall Study|Protocol Violation|5
5157831|NCT01411215|17811050|P1|Overall Study|Protocol Violation|3
5157832|NCT01411215|17811049|P2|Overall Study|Study terminated by sponsor|15
5157833|NCT01411215|17811050|P1|Overall Study|Study terminated by sponsor|2
5157834|NCT01411215|17811049|P2|Overall Study|Did not meet entrance criteria|1
5157835|NCT01411215|17811050|P1|Overall Study|Did not meet entrance criteria|0
5157836|NCT01411215|17811049|P2|Overall Study|Lost to Follow-up|18
5157837|NCT01411215|17811050|P1|Overall Study|Lost to Follow-up|12
5157838|NCT01411215|17811049|P2|Overall Study|Lack of Efficacy|4
5157839|NCT01411215|17811050|P1|Overall Study|Lack of Efficacy|2
5157840|NCT01411215|17811049|P2|Overall Study|Adverse Event|2
5157841|NCT01411215|17811050|P1|Overall Study|Adverse Event|1
5157842|NCT01411085|17811102|P1|Overall Study|Adverse Event|1
5157843|NCT01411085|17811102|P1|Overall Study|Protocol Violation|1
5157844|NCT01411085|17811102|P1|Overall Study|Physician Decision|1
5157845|NCT01410799|17811122|P1|Overall Study|PI decision|13
5157846|NCT01410604|17811138|P2|Overall Study|Physician Decision|1
5157847|NCT01410604|17811139|P1|Overall Study|Physician Decision|0
5157848|NCT01410604|17811138|P2|Overall Study|Lost to Follow-up|0
5157849|NCT01410604|17811139|P1|Overall Study|Lost to Follow-up|1
5157850|NCT01410604|17811138|P2|Overall Study|Adverse Event|1
5157851|NCT01410604|17811139|P1|Overall Study|Adverse Event|2
5157852|NCT01410474|17811180|P2|Overall Study|Withdrawal by Subject|1
5157853|NCT01410474|17811181|P1|Overall Study|Withdrawal by Subject|0
5157854|NCT01410448|17811204|P2|Overall Study|Death|3
5157855|NCT01410448|17811205|P1|Overall Study|Death|2
5157856|NCT01410448|17811204|P2|Overall Study|Protocol Violation|4
5157857|NCT01410448|17811205|P1|Overall Study|Protocol Violation|0
5157858|NCT01410448|17811204|P2|Overall Study|Withdrawal by Subject|2
5157859|NCT01410448|17811205|P1|Overall Study|Withdrawal by Subject|3
5157860|NCT01410448|17811204|P2|Overall Study|Lost to Follow-up|0
5157861|NCT01410448|17811205|P1|Overall Study|Lost to Follow-up|1
5157862|NCT01410448|17811204|P2|Overall Study|Administrative issues|1
5157863|NCT01410448|17811205|P1|Overall Study|Administrative issues|2
5157864|NCT01410448|17811204|P2|Overall Study|Graft loss|1
5157865|NCT01410448|17811205|P1|Overall Study|Graft loss|4
5157866|NCT01410448|17811204|P2|Overall Study|No conversion to everolimus|24
5157867|NCT01410448|17811205|P1|Overall Study|No conversion to everolimus|0
5157868|NCT01410357|17811270|P2|Overall Study|Lost to Follow-up|21
5157869|NCT01410357|17811271|P1|Overall Study|Lost to Follow-up|23
5157870|NCT01410357|17811270|P2|Overall Study|Withdrawal by Subject|2
5157871|NCT01410357|17811271|P1|Overall Study|Withdrawal by Subject|1
5157872|NCT01410357|17811270|P2|Overall Study|Death|1
5157873|NCT01410357|17811271|P1|Overall Study|Death|2
5157874|NCT01410240|17811342|P3|Overall Study|Missed week 6 assessments|1
5157875|NCT01410240|17811343|P2|Overall Study|Missed week 6 assessments|1
5157876|NCT01410240|17811344|P1|Overall Study|Missed week 6 assessments|1
5157877|NCT01410240|17811342|P3|Overall Study|Physician Decision|1
5157878|NCT01410240|17811343|P2|Overall Study|Physician Decision|0
5157879|NCT01410240|17811344|P1|Overall Study|Physician Decision|0
5157880|NCT01410227|17811415|P4|Overall Study|Met Excl. Criteria After Starting Study|0
5157881|NCT01410227|17811416|P3|Overall Study|Met Excl. Criteria After Starting Study|1
5157882|NCT01410227|17811417|P2|Overall Study|Met Excl. Criteria After Starting Study|0
5157883|NCT01410227|17811418|P1|Overall Study|Met Excl. Criteria After Starting Study|0
5157884|NCT01410227|17811415|P4|Overall Study|Pregnancy|1
5157885|NCT01410227|17811416|P3|Overall Study|Pregnancy|0
5157886|NCT01410227|17811417|P2|Overall Study|Pregnancy|0
5157887|NCT01410227|17811418|P1|Overall Study|Pregnancy|0
5157888|NCT01410227|17811415|P4|Overall Study|Withdrawal by Subject|0
5157889|NCT01410227|17811416|P3|Overall Study|Withdrawal by Subject|1
5157891|NCT01410227|17811418|P1|Overall Study|Withdrawal by Subject|3
5157892|NCT01410227|17811415|P4|Overall Study|Adverse Event|0
5157893|NCT01410227|17811416|P3|Overall Study|Adverse Event|0
5157894|NCT01410227|17811417|P2|Overall Study|Adverse Event|0
5157895|NCT01410227|17811418|P1|Overall Study|Adverse Event|1
5157896|NCT01410110|17811490|P2|Overall Study|Withdrawal by Subject|2
5157897|NCT01410110|17811491|P1|Overall Study|Withdrawal by Subject|4
5157898|NCT01409993|17811566|P4|Overall Study|Lost to Follow-up|0
5157899|NCT01409993|17811567|P3|Overall Study|Lost to Follow-up|0
5157900|NCT01409993|17811568|P2|Overall Study|Lost to Follow-up|1
5157901|NCT01409993|17811569|P1|Overall Study|Lost to Follow-up|0
5157902|NCT01409993|17811566|P4|Overall Study|Withdrawal by Subject|4
5157903|NCT01409993|17811567|P3|Overall Study|Withdrawal by Subject|0
5157904|NCT01409993|17811568|P2|Overall Study|Withdrawal by Subject|0
5157905|NCT01409993|17811569|P1|Overall Study|Withdrawal by Subject|0
5157906|NCT01409993|17811566|P4|Overall Study|Adverse Event|1
5157907|NCT01409993|17811567|P3|Overall Study|Adverse Event|3
5157908|NCT01409993|17811568|P2|Overall Study|Adverse Event|4
5157909|NCT01409993|17811569|P1|Overall Study|Adverse Event|4
5157910|NCT01409928|17811587|P1|Overall Study|Physician Decision|12
5157911|NCT01409837|17811593|P2|Overall Study|Physician Decision|1
5157912|NCT01409837|17811594|P1|Overall Study|Physician Decision|0
5157913|NCT01409837|17811593|P2|Overall Study|Lost to Follow-up|0
5157914|NCT01409837|17811594|P1|Overall Study|Lost to Follow-up|1
5157915|NCT01409837|17811593|P2|Overall Study|Withdrawal by Subject|1
5157916|NCT01409837|17811594|P1|Overall Study|Withdrawal by Subject|2
5157917|NCT01409811|17811616|P1|Overall Study|Insurance denial|1
5157918|NCT01409707|17811623|P3|Overall Study|Withdrawal by Subject|16
5157919|NCT01409707|17811624|P2|Overall Study|Withdrawal by Subject|17
5157920|NCT01409707|17811625|P1|Overall Study|Withdrawal by Subject|5
5157921|NCT01409564|17811637|P2|Overall Study|brain abnormalities found in T1 MR|2
5157922|NCT01409564|17811638|P1|Overall Study|brain abnormalities found in T1 MR|1
5157923|NCT01409564|17811637|P2|Overall Study|low medication compliance|3
5157924|NCT01409564|17811638|P1|Overall Study|low medication compliance|4
5157925|NCT01409434|17811656|P1|Overall Study|Protocol Violation|4
5157926|NCT01409382|17811666|P2|Overall Study|Had a 2nd trimester loss after accident|0
5157927|NCT01409382|17811667|P1|Overall Study|Had a 2nd trimester loss after accident|1
5157928|NCT01409382|17811666|P2|Overall Study|Did not manage to get pregnant|70
5157929|NCT01409382|17811667|P1|Overall Study|Did not manage to get pregnant|64
5157930|NCT01409382|17811666|P2|Overall Study|Still pregnant when study ended|2
5157931|NCT01409382|17811667|P1|Overall Study|Still pregnant when study ended|13
5157932|NCT01409382|17811666|P2|Overall Study|Multiple pregnancy|4
5157933|NCT01409382|17811667|P1|Overall Study|Multiple pregnancy|2
5157934|NCT01409382|17811666|P2|Overall Study|Protocol Violation|3
5157935|NCT01409382|17811667|P1|Overall Study|Protocol Violation|0
5157936|NCT01409382|17811666|P2|Overall Study|Lost to Follow-up|1
5157937|NCT01409382|17811667|P1|Overall Study|Lost to Follow-up|1
5157938|NCT01409031|17811721|P2|Overall Study|transferred to other hosp|0
5157939|NCT01409031|17811722|P1|Overall Study|transferred to other hosp|1
5157940|NCT01408914|17811753|P3|Overall Study|Change in local TB/HIV norms|1
5157941|NCT01408914|17811754|P2|Overall Study|Change in local TB/HIV norms|1
5157942|NCT01408914|17811755|P1|Overall Study|Change in local TB/HIV norms|0
5157943|NCT01408914|17811753|P3|Overall Study|Late exclusion|3
5157944|NCT01408914|17811754|P2|Overall Study|Late exclusion|3
5157945|NCT01408914|17811755|P1|Overall Study|Late exclusion|0
5157946|NCT01408914|17811753|P3|Overall Study|Moved out of study jurisdiction|0
5157947|NCT01408914|17811754|P2|Overall Study|Moved out of study jurisdiction|1
5157948|NCT01408914|17811755|P1|Overall Study|Moved out of study jurisdiction|1
5157949|NCT01408914|17811753|P3|Overall Study|Withdrawal by Subject|1
5157950|NCT01408914|17811754|P2|Overall Study|Withdrawal by Subject|0
5157951|NCT01408914|17811755|P1|Overall Study|Withdrawal by Subject|1
5157952|NCT01408914|17811753|P3|Overall Study|Physician Decision|0
5157953|NCT01408914|17811754|P2|Overall Study|Physician Decision|1
5157954|NCT01408914|17811755|P1|Overall Study|Physician Decision|1
5157955|NCT01408914|17811753|P3|Overall Study|Lost to Follow-up|2
5157956|NCT01408914|17811754|P2|Overall Study|Lost to Follow-up|1
5157957|NCT01408914|17811755|P1|Overall Study|Lost to Follow-up|4
5157958|NCT01408914|17811753|P3|Overall Study|Could not complete tx in protocol period|6
5157959|NCT01408914|17811754|P2|Overall Study|Could not complete tx in protocol period|5
5157960|NCT01408914|17811755|P1|Overall Study|Could not complete tx in protocol period|5
5157961|NCT01408901|17811773|P4|26-Week Follow-Up|Death|0
5157962|NCT01408901|17811774|P3|26-Week Follow-Up|Death|0
5157963|NCT01408901|17811775|P2|26-Week Follow-Up|Death|1
5157964|NCT01408901|17811776|P1|26-Week Follow-Up|Death|0
5157965|NCT01408901|17811773|P4|26-Week Follow-Up|Lost to Follow-up|1
5157966|NCT01408901|17811774|P3|26-Week Follow-Up|Lost to Follow-up|0
5157967|NCT01408901|17811775|P2|26-Week Follow-Up|Lost to Follow-up|1
5157968|NCT01408901|17811776|P1|26-Week Follow-Up|Lost to Follow-up|1
5157969|NCT01408901|17811773|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
5157970|NCT01408901|17811774|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
5157971|NCT01408901|17811775|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
5157972|NCT01408901|17811776|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
5157973|NCT01408901|17811773|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
5157974|NCT01408901|17811774|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
5157975|NCT01408901|17811775|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
5157976|NCT01408901|17811776|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
5157977|NCT01408901|17811773|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
5157978|NCT01408901|17811774|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5157979|NCT01408901|17811775|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5157980|NCT01408901|17811776|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5157981|NCT01408901|17811773|P4|6-Week Follow-Up|Cancelled visit|2
5157982|NCT01408901|17811774|P3|6-Week Follow-Up|Cancelled visit|0
5157983|NCT01408901|17811775|P2|6-Week Follow-Up|Cancelled visit|1
5157984|NCT01408901|17811776|P1|6-Week Follow-Up|Cancelled visit|0
5157985|NCT01408901|17811773|P4|6-Week Follow-Up|Death|0
5157986|NCT01408901|17811774|P3|6-Week Follow-Up|Death|0
5157987|NCT01408901|17811775|P2|6-Week Follow-Up|Death|0
5157988|NCT01408901|17811776|P1|6-Week Follow-Up|Death|1
5157989|NCT01408901|17811773|P4|6-Week Follow-Up|Lost to Follow-up|2
5157990|NCT01408901|17811774|P3|6-Week Follow-Up|Lost to Follow-up|3
5157991|NCT01408901|17811775|P2|6-Week Follow-Up|Lost to Follow-up|1
5157992|NCT01408901|17811776|P1|6-Week Follow-Up|Lost to Follow-up|2
5157993|NCT01408888|17811802|P2|Second Intervention|Adverse Event|0
5157994|NCT01408888|17811803|P1|Second Intervention|Adverse Event|1
5157995|NCT01408888|17811802|P2|Second Intervention|Withdrawal by Subject|0
5157996|NCT01408888|17811803|P1|Second Intervention|Withdrawal by Subject|1
5157997|NCT01408888|17811802|P2|First Intervention|Withdrawal by Subject|2
5157998|NCT01408888|17811803|P1|First Intervention|Withdrawal by Subject|0
5157999|NCT01408888|17811802|P2|First Intervention|Adverse Event|1
5158000|NCT01408888|17811803|P1|First Intervention|Adverse Event|0
5158001|NCT01408732|17811831|P2|Overall Study|Withdrawal by Subject|2
5158002|NCT01408732|17811832|P1|Overall Study|Withdrawal by Subject|2
5158003|NCT01408706|17811889|P2|Overall Study|Physician Decision|0
5158004|NCT01408706|17811890|P1|Overall Study|Physician Decision|1
5158005|NCT01408641|17811902|P2|Overall Study|Physician Decision|0
5158006|NCT01408641|17811903|P1|Overall Study|Physician Decision|1
5158007|NCT01408628|17811911|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
5158008|NCT01408628|17811911|P1|Completed 6 Month Follow-Up|Protocol Violation|6
5158009|NCT01408628|17811911|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
5158010|NCT01408628|17811911|P1|Consented|Withdrawal by Subject|12
5158011|NCT01408576|17811920|P3|Overall Study|Other|18
5158012|NCT01408576|17811921|P2|Overall Study|Other|16
5158013|NCT01408576|17811922|P1|Overall Study|Other|10
5158014|NCT01408576|17811920|P3|Overall Study|AE, unknown type|0
5158015|NCT01408576|17811921|P2|Overall Study|AE, unknown type|1
5158016|NCT01408576|17811922|P1|Overall Study|AE, unknown type|0
5158017|NCT01408576|17811920|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5158018|NCT01408576|17811921|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5158019|NCT01408576|17811922|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5158020|NCT01408576|17811920|P3|Overall Study|AE, non-serious non-fatal|11
5158021|NCT01408576|17811921|P2|Overall Study|AE, non-serious non-fatal|19
5158022|NCT01408576|17811922|P1|Overall Study|AE, non-serious non-fatal|12
5158023|NCT01408576|17811920|P3|Overall Study|SAE, non-fatal|14
5158024|NCT01408576|17811921|P2|Overall Study|SAE, non-fatal|23
5158025|NCT01408576|17811922|P1|Overall Study|SAE, non-fatal|11
5158026|NCT01408576|17811920|P3|Overall Study|AE, serious fatal|1
5158027|NCT01408576|17811921|P2|Overall Study|AE, serious fatal|4
5158028|NCT01408576|17811922|P1|Overall Study|AE, serious fatal|4
5158029|NCT01408576|17811920|P3|Overall Study|Sponsor terminated study|330
5158030|NCT01408576|17811921|P2|Overall Study|Sponsor terminated study|333
5158031|NCT01408576|17811922|P1|Overall Study|Sponsor terminated study|89
5158032|NCT01408576|17811920|P3|Overall Study|Withdrawal by Subject|66
5158033|NCT01408576|17811921|P2|Overall Study|Withdrawal by Subject|60
5158034|NCT01408576|17811922|P1|Overall Study|Withdrawal by Subject|34
5158035|NCT01408576|17811920|P3|Overall Study|Lost to Follow-up|17
5158036|NCT01408576|17811921|P2|Overall Study|Lost to Follow-up|9
5158037|NCT01408576|17811922|P1|Overall Study|Lost to Follow-up|10
5158038|NCT01408576|17811920|P3|Overall Study|Protocol Violation|2
5158039|NCT01408576|17811921|P2|Overall Study|Protocol Violation|2
5158040|NCT01408576|17811922|P1|Overall Study|Protocol Violation|1
5158041|NCT01408576|17811920|P3|Overall Study|Lack of Efficacy|48
5158042|NCT01408576|17811921|P2|Overall Study|Lack of Efficacy|30
5158043|NCT01408576|17811922|P1|Overall Study|Lack of Efficacy|17
5158044|NCT01408563|17811969|P1|Overall Study|Ineligible after consent/ registration|2
5158045|NCT01408537|17811985|P1|Overall Study|Lost to Follow-up|3
5158046|NCT01408537|17811985|P1|Overall Study|Protocol Violation|3
5158047|NCT01408537|17811985|P1|Overall Study|Withdrawal by Subject|2
5158048|NCT01408485|17812001|P1|Overall Study|Withdrawal by Subject|21
5158049|NCT01408303|17812019|P3|Overall Study|Noncompliance|1
5158050|NCT01408303|17812020|P2|Overall Study|Noncompliance|0
5158051|NCT01408303|17812021|P1|Overall Study|Noncompliance|1
5158052|NCT01408303|17812019|P3|Overall Study|Protocol Violation|0
5158053|NCT01408303|17812020|P2|Overall Study|Protocol Violation|1
5158054|NCT01408303|17812021|P1|Overall Study|Protocol Violation|0
5158055|NCT01408303|17812019|P3|Overall Study|Withdrawal by Subject|1
5158056|NCT01408303|17812020|P2|Overall Study|Withdrawal by Subject|3
5158057|NCT01408303|17812021|P1|Overall Study|Withdrawal by Subject|2
5158058|NCT01408303|17812019|P3|Overall Study|Lost to Follow-up|2
5158059|NCT01408303|17812020|P2|Overall Study|Lost to Follow-up|1
5158060|NCT01408303|17812021|P1|Overall Study|Lost to Follow-up|0
5158061|NCT01408303|17812019|P3|Overall Study|Adverse Event|2
5158062|NCT01408303|17812020|P2|Overall Study|Adverse Event|7
5158063|NCT01408303|17812021|P1|Overall Study|Adverse Event|3
5158064|NCT01408277|17812031|P2|Overall Study|Protocol Violation|0
5158065|NCT01408277|17812032|P1|Overall Study|Protocol Violation|2
5158066|NCT01408277|17812031|P2|Overall Study|Withdrawal by Subject|0
5158067|NCT01408277|17812032|P1|Overall Study|Withdrawal by Subject|2
5158068|NCT01408277|17812031|P2|Overall Study|Lost to Follow-up|0
5158069|NCT01408277|17812032|P1|Overall Study|Lost to Follow-up|1
5158070|NCT01408277|17812031|P2|Overall Study|Adverse Event|4
5158071|NCT01408277|17812032|P1|Overall Study|Adverse Event|3
5158072|NCT01408147|17812040|P2|Overall Study|Withdrawal by Subject|1
5158073|NCT01408147|17812041|P1|Overall Study|Withdrawal by Subject|0
5158074|NCT01408043|17812049|P1|Overall Study|unable to collect cells|1
5158075|NCT01408030|17812068|P4|Observation Phase (Off Drug)|Other|1
5158076|NCT01408030|17812069|P3|Observation Phase (Off Drug)|Other|1
5158077|NCT01408030|17812070|P2|Observation Phase (Off Drug)|Other|1
5158078|NCT01408030|17812071|P1|Observation Phase (Off Drug)|Other|1
5158079|NCT01408030|17812068|P4|Observation Phase (Off Drug)|Physician Decision|0
5158080|NCT01408030|17812069|P3|Observation Phase (Off Drug)|Physician Decision|2
5158081|NCT01408030|17812070|P2|Observation Phase (Off Drug)|Physician Decision|1
5158082|NCT01408030|17812071|P1|Observation Phase (Off Drug)|Physician Decision|0
5158083|NCT01408030|17812068|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
5158084|NCT01408030|17812069|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
5158085|NCT01408030|17812070|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
5158086|NCT01408030|17812071|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
5158087|NCT01408030|17812068|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
5158088|NCT01408030|17812069|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
5158089|NCT01408030|17812070|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
5158090|NCT01408030|17812071|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
5158091|NCT01408030|17812068|P4|Treatment Phase (on Drug)|Protocol Violation|0
5158092|NCT01408030|17812069|P3|Treatment Phase (on Drug)|Protocol Violation|0
5158093|NCT01408030|17812070|P2|Treatment Phase (on Drug)|Protocol Violation|1
5158094|NCT01408030|17812071|P1|Treatment Phase (on Drug)|Protocol Violation|0
5158095|NCT01408030|17812068|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
5158096|NCT01408030|17812069|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
5158097|NCT01408030|17812070|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
5158098|NCT01408030|17812071|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
5158099|NCT01408030|17812068|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
5158100|NCT01408030|17812069|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
5158101|NCT01408030|17812070|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
5158102|NCT01408030|17812071|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
5158103|NCT01407926|17812130|P1|Overall Study|Lost to Follow-up|55
5158104|NCT01407367|17812178|P2|Overall Study|Lost to Follow-up|2
5158105|NCT01407367|17812179|P1|Overall Study|Lost to Follow-up|0
5158106|NCT01407367|17812178|P2|Overall Study|Withdrawal by Subject|15
5158107|NCT01407367|17812179|P1|Overall Study|Withdrawal by Subject|4
5158108|NCT01407367|17812178|P2|Overall Study|Renal Replacement Therapy (RRT)|29
5158109|NCT01407367|17812179|P1|Overall Study|Renal Replacement Therapy (RRT)|12
5158110|NCT01407367|17812178|P2|Overall Study|Death|32
5158111|NCT01407367|17812179|P1|Overall Study|Death|24
5158112|NCT01407354|17812193|P2|First Intervention|Physician Decision|0
5158113|NCT01407354|17812194|P1|First Intervention|Physician Decision|1
5158114|NCT01407354|17812193|P2|First Intervention|Adverse Event|0
5158115|NCT01407354|17812194|P1|First Intervention|Adverse Event|1
5158116|NCT01407354|17812193|P2|First Intervention|Withdrawal by Subject|2
5158117|NCT01407354|17812194|P1|First Intervention|Withdrawal by Subject|0
5158118|NCT01407276|17812210|P8|Overall Study|Withdrawal by Subject|1
5158119|NCT01407276|17812211|P7|Overall Study|Withdrawal by Subject|0
5158120|NCT01407276|17812212|P6|Overall Study|Withdrawal by Subject|0
5158121|NCT01407276|17812213|P5|Overall Study|Withdrawal by Subject|0
5158122|NCT01407276|17812214|P4|Overall Study|Withdrawal by Subject|0
5158123|NCT01407276|17812215|P3|Overall Study|Withdrawal by Subject|0
5158124|NCT01407276|17812216|P2|Overall Study|Withdrawal by Subject|0
5158125|NCT01407276|17812217|P1|Overall Study|Withdrawal by Subject|0
5158126|NCT01406938|17812369|P6|Follow up|Lost to Follow-up|1
5158127|NCT01406938|17812370|P5|Follow up|Lost to Follow-up|2
5158128|NCT01406938|17812371|P4|Follow up|Lost to Follow-up|1
5158129|NCT01406938|17812372|P3|Follow up|Lost to Follow-up|0
5158130|NCT01406938|17812373|P2|Follow up|Lost to Follow-up|1
5158131|NCT01406938|17812374|P1|Follow up|Lost to Follow-up|1
5158132|NCT01406938|17812369|P6|Follow up|Physician Decision|1
5158133|NCT01406938|17812370|P5|Follow up|Physician Decision|3
5158134|NCT01406938|17812371|P4|Follow up|Physician Decision|0
5158135|NCT01406938|17812372|P3|Follow up|Physician Decision|2
5158136|NCT01406938|17812373|P2|Follow up|Physician Decision|0
5158137|NCT01406938|17812374|P1|Follow up|Physician Decision|0
5158138|NCT01406938|17812369|P6|Follow up|Protocol Violation|0
5158139|NCT01406938|17812370|P5|Follow up|Protocol Violation|0
5158140|NCT01406938|17812371|P4|Follow up|Protocol Violation|0
5158141|NCT01406938|17812372|P3|Follow up|Protocol Violation|1
5158142|NCT01406938|17812373|P2|Follow up|Protocol Violation|0
5158143|NCT01406938|17812374|P1|Follow up|Protocol Violation|0
5158144|NCT01406938|17812369|P6|Follow up|Patient/guardian decision|1
5158145|NCT01406938|17812370|P5|Follow up|Patient/guardian decision|4
5158146|NCT01406938|17812371|P4|Follow up|Patient/guardian decision|2
5158147|NCT01406938|17812372|P3|Follow up|Patient/guardian decision|4
5158148|NCT01406938|17812373|P2|Follow up|Patient/guardian decision|2
5158149|NCT01406938|17812374|P1|Follow up|Patient/guardian decision|4
5158150|NCT01406938|17812369|P6|Follow up|Lack of Efficacy|0
5158151|NCT01406938|17812370|P5|Follow up|Lack of Efficacy|0
5158152|NCT01406938|17812371|P4|Follow up|Lack of Efficacy|0
5158153|NCT01406938|17812372|P3|Follow up|Lack of Efficacy|1
5158154|NCT01406938|17812373|P2|Follow up|Lack of Efficacy|2
5158155|NCT01406938|17812374|P1|Follow up|Lack of Efficacy|3
5158156|NCT01406938|17812369|P6|Maintenance Period|Lack of Efficacy|5
5158157|NCT01406938|17812370|P5|Maintenance Period|Lack of Efficacy|3
5158158|NCT01406938|17812371|P4|Maintenance Period|Lack of Efficacy|1
5158159|NCT01406938|17812372|P3|Maintenance Period|Lack of Efficacy|2
5158160|NCT01406938|17812373|P2|Maintenance Period|Lack of Efficacy|0
5158161|NCT01406938|17812374|P1|Maintenance Period|Lack of Efficacy|0
5158162|NCT01406938|17812369|P6|Maintenance Period|Lost to Follow-up|0
5158163|NCT01406938|17812370|P5|Maintenance Period|Lost to Follow-up|4
5158164|NCT01406938|17812371|P4|Maintenance Period|Lost to Follow-up|0
5158165|NCT01406938|17812372|P3|Maintenance Period|Lost to Follow-up|0
5158166|NCT01406938|17812373|P2|Maintenance Period|Lost to Follow-up|0
5158167|NCT01406938|17812374|P1|Maintenance Period|Lost to Follow-up|0
5158168|NCT01406938|17812369|P6|Maintenance Period|Pregnancy|0
5158169|NCT01406938|17812370|P5|Maintenance Period|Pregnancy|1
5158170|NCT01406938|17812371|P4|Maintenance Period|Pregnancy|0
5158171|NCT01406938|17812372|P3|Maintenance Period|Pregnancy|0
5158172|NCT01406938|17812373|P2|Maintenance Period|Pregnancy|0
5158173|NCT01406938|17812374|P1|Maintenance Period|Pregnancy|0
5158174|NCT01406938|17812369|P6|Maintenance Period|Protocol Violation|2
5158175|NCT01406938|17812370|P5|Maintenance Period|Protocol Violation|2
5158176|NCT01406938|17812371|P4|Maintenance Period|Protocol Violation|2
5158177|NCT01406938|17812372|P3|Maintenance Period|Protocol Violation|2
5158178|NCT01406938|17812373|P2|Maintenance Period|Protocol Violation|0
5158179|NCT01406938|17812374|P1|Maintenance Period|Protocol Violation|0
5158180|NCT01406938|17812369|P6|Maintenance Period|Subject/guardian decision|7
5158181|NCT01406938|17812370|P5|Maintenance Period|Subject/guardian decision|10
5158182|NCT01406938|17812371|P4|Maintenance Period|Subject/guardian decision|7
5158183|NCT01406938|17812372|P3|Maintenance Period|Subject/guardian decision|11
5158184|NCT01406938|17812373|P2|Maintenance Period|Subject/guardian decision|0
5158185|NCT01406938|17812374|P1|Maintenance Period|Subject/guardian decision|0
5158186|NCT01406938|17812369|P6|Maintenance Period|Death|0
5158187|NCT01406938|17812370|P5|Maintenance Period|Death|1
5158188|NCT01406938|17812371|P4|Maintenance Period|Death|0
5158189|NCT01406938|17812372|P3|Maintenance Period|Death|0
5158190|NCT01406938|17812373|P2|Maintenance Period|Death|0
5158191|NCT01406938|17812374|P1|Maintenance Period|Death|0
5158192|NCT01406938|17812369|P6|Maintenance Period|Adverse Event|2
5158193|NCT01406938|17812370|P5|Maintenance Period|Adverse Event|4
5158194|NCT01406938|17812371|P4|Maintenance Period|Adverse Event|8
5158195|NCT01406938|17812372|P3|Maintenance Period|Adverse Event|2
5158196|NCT01406938|17812373|P2|Maintenance Period|Adverse Event|0
5158197|NCT01406938|17812374|P1|Maintenance Period|Adverse Event|0
5158198|NCT01406938|17812369|P6|Induction Period|Lost to Follow-up|0
5158199|NCT01406938|17812370|P5|Induction Period|Lost to Follow-up|0
5158200|NCT01406938|17812371|P4|Induction Period|Lost to Follow-up|0
5158201|NCT01406938|17812372|P3|Induction Period|Lost to Follow-up|0
5158202|NCT01406938|17812373|P2|Induction Period|Lost to Follow-up|3
5158203|NCT01406938|17812374|P1|Induction Period|Lost to Follow-up|2
5158204|NCT01406938|17812369|P6|Induction Period|Lack of Efficacy|0
5158205|NCT01406938|17812370|P5|Induction Period|Lack of Efficacy|0
5158206|NCT01406938|17812371|P4|Induction Period|Lack of Efficacy|0
5158207|NCT01406938|17812372|P3|Induction Period|Lack of Efficacy|0
5158208|NCT01406938|17812373|P2|Induction Period|Lack of Efficacy|0
5158209|NCT01406938|17812374|P1|Induction Period|Lack of Efficacy|1
5158210|NCT01406938|17812369|P6|Induction Period|Adverse Event|0
5158211|NCT01406938|17812370|P5|Induction Period|Adverse Event|0
5158212|NCT01406938|17812371|P4|Induction Period|Adverse Event|0
5158213|NCT01406938|17812372|P3|Induction Period|Adverse Event|0
5158214|NCT01406938|17812373|P2|Induction Period|Adverse Event|9
5158215|NCT01406938|17812374|P1|Induction Period|Adverse Event|8
5158216|NCT01406938|17812369|P6|Induction Period|Protocol deviation|0
5158217|NCT01406938|17812370|P5|Induction Period|Protocol deviation|0
5158218|NCT01406938|17812371|P4|Induction Period|Protocol deviation|0
5158219|NCT01406938|17812372|P3|Induction Period|Protocol deviation|0
5158220|NCT01406938|17812373|P2|Induction Period|Protocol deviation|0
5158221|NCT01406938|17812374|P1|Induction Period|Protocol deviation|1
5158222|NCT01406938|17812369|P6|Induction Period|Subject/guardian decision|0
5158223|NCT01406938|17812370|P5|Induction Period|Subject/guardian decision|0
5158224|NCT01406938|17812371|P4|Induction Period|Subject/guardian decision|0
5158225|NCT01406938|17812372|P3|Induction Period|Subject/guardian decision|0
5158226|NCT01406938|17812373|P2|Induction Period|Subject/guardian decision|8
5158227|NCT01406938|17812374|P1|Induction Period|Subject/guardian decision|6
5158228|NCT01406873|17812492|P2|Overall Study|Withdrawal by Subject|1
5158229|NCT01406873|17812493|P1|Overall Study|Withdrawal by Subject|1
5158230|NCT01406795|17812524|P1|Overall Study|Withdrawal by Subject|1
5158231|NCT01406717|17812540|P2|Overall Study|Non-completion of visit activity|1
5158232|NCT01406717|17812541|P1|Overall Study|Non-completion of visit activity|0
5158233|NCT01406717|17812540|P2|Overall Study|Lack of Efficacy|1
5158234|NCT01406717|17812541|P1|Overall Study|Lack of Efficacy|0
5158235|NCT01406717|17812540|P2|Overall Study|Adverse Event|2
5158236|NCT01406717|17812541|P1|Overall Study|Adverse Event|1
5158237|NCT01406717|17812540|P2|Overall Study|Withdrawal by Subject|15
5158238|NCT01406717|17812541|P1|Overall Study|Withdrawal by Subject|19
5158239|NCT01406717|17812540|P2|Overall Study|Lost to Follow-up|8
5158240|NCT01406717|17812541|P1|Overall Study|Lost to Follow-up|14
5158241|NCT01406717|17812540|P2|Overall Study|Protocol Violation|1
5158242|NCT01406717|17812541|P1|Overall Study|Protocol Violation|5
5158243|NCT01406717|17812540|P2|Overall Study|Subject non-compliance|3
5158244|NCT01406717|17812541|P1|Overall Study|Subject non-compliance|4
5158245|NCT01406652|17812571|P2|Overall Study|Infection not sure|10
5158246|NCT01406652|17812572|P1|Overall Study|Infection not sure|10
5158247|NCT01406652|17812571|P2|Overall Study|Insufficient follow-up|4
5158248|NCT01406652|17812572|P1|Overall Study|Insufficient follow-up|5
5158249|NCT01406652|17812571|P2|Overall Study|Withdrawal by Subject|2
5158250|NCT01406652|17812572|P1|Overall Study|Withdrawal by Subject|2
5158251|NCT01406652|17812571|P2|Overall Study|Lost-to-follow-up|4
5158252|NCT01406652|17812572|P1|Overall Study|Lost-to-follow-up|3
5158253|NCT01406574|17812580|P4|Overall Study|Definite progression of primary disease|0
5158254|NCT01406574|17812581|P3|Overall Study|Definite progression of primary disease|0
5158255|NCT01406574|17812582|P2|Overall Study|Definite progression of primary disease|0
5158256|NCT01406574|17812583|P1|Overall Study|Definite progression of primary disease|1
5158257|NCT01406574|17812580|P4|Overall Study|Withdrawal by Subject|0
5158258|NCT01406574|17812581|P3|Overall Study|Withdrawal by Subject|0
5158259|NCT01406574|17812582|P2|Overall Study|Withdrawal by Subject|1
5158260|NCT01406574|17812583|P1|Overall Study|Withdrawal by Subject|0
5158261|NCT01406574|17812580|P4|Overall Study|Physician Decision|1
5158262|NCT01406574|17812581|P3|Overall Study|Physician Decision|0
5158263|NCT01406574|17812582|P2|Overall Study|Physician Decision|0
5158264|NCT01406574|17812583|P1|Overall Study|Physician Decision|0
5158265|NCT01406574|17812580|P4|Overall Study|Adverse Event|3
5158266|NCT01406574|17812581|P3|Overall Study|Adverse Event|1
5158267|NCT01406574|17812582|P2|Overall Study|Adverse Event|0
5158268|NCT01406574|17812583|P1|Overall Study|Adverse Event|0
5158269|NCT01406015|17812634|P2|Overall Study|Withdrawal by Subject|3
5158270|NCT01406015|17812635|P1|Overall Study|Withdrawal by Subject|3
5158271|NCT01405950|17812651|P4|Overall Study|Withdrawal by Subject|0
5158272|NCT01405950|17812652|P3|Overall Study|Withdrawal by Subject|0
5158273|NCT01405950|17812653|P2|Overall Study|Withdrawal by Subject|0
5158274|NCT01405950|17812654|P1|Overall Study|Withdrawal by Subject|1
5158275|NCT01405924|17812689|P1|Overall Study|Missing/Incomplete Data|2
5158276|NCT01405924|17812689|P1|Overall Study|Protocol Violation|8
5158277|NCT01405911|17812702|P3|Overall Study|Withdrawal by Subject|1
5158278|NCT01405911|17812703|P2|Overall Study|Withdrawal by Subject|1
5158279|NCT01405911|17812704|P1|Overall Study|Withdrawal by Subject|3
5158280|NCT01405911|17812702|P3|Overall Study|Protocol Violation|0
5158281|NCT01405911|17812703|P2|Overall Study|Protocol Violation|0
5158282|NCT01405911|17812704|P1|Overall Study|Protocol Violation|1
5158283|NCT01405911|17812702|P3|Overall Study|Lost to Follow-up|0
5158284|NCT01405911|17812703|P2|Overall Study|Lost to Follow-up|1
5158285|NCT01405911|17812704|P1|Overall Study|Lost to Follow-up|0
5158286|NCT01405911|17812702|P3|Overall Study|Pre-treatment lab AE|0
5158287|NCT01405911|17812703|P2|Overall Study|Pre-treatment lab AE|1
5158288|NCT01405911|17812704|P1|Overall Study|Pre-treatment lab AE|0
5158289|NCT01405898|17812723|P2|Overall Study|Withdrawal by Subject|2
5158290|NCT01405898|17812724|P1|Overall Study|Withdrawal by Subject|2
5158291|NCT01405820|17812748|P6|Open-Label Treatment Period|Adverse Event|0
5158292|NCT01405820|17812749|P5|Open-Label Treatment Period|Adverse Event|0
5158293|NCT01405820|17812750|P4|Open-Label Treatment Period|Adverse Event|1
5158294|NCT01405820|17812751|P3|Open-Label Treatment Period|Adverse Event|0
5158295|NCT01405820|17812752|P2|Open-Label Treatment Period|Adverse Event|0
5158296|NCT01405820|17812753|P1|Open-Label Treatment Period|Adverse Event|0
5158297|NCT01405820|17812748|P6|Open-Label Treatment Period|Physician Decision|0
5158298|NCT01405820|17812749|P5|Open-Label Treatment Period|Physician Decision|1
5158299|NCT01405820|17812750|P4|Open-Label Treatment Period|Physician Decision|2
5158300|NCT01405820|17812751|P3|Open-Label Treatment Period|Physician Decision|1
5158301|NCT01405820|17812752|P2|Open-Label Treatment Period|Physician Decision|0
5158302|NCT01405820|17812753|P1|Open-Label Treatment Period|Physician Decision|0
5158303|NCT01405820|17812748|P6|Open-Label Treatment Period|Other|1
5158304|NCT01405820|17812749|P5|Open-Label Treatment Period|Other|1
5158305|NCT01405820|17812750|P4|Open-Label Treatment Period|Other|1
5158306|NCT01405820|17812751|P3|Open-Label Treatment Period|Other|1
5158307|NCT01405820|17812752|P2|Open-Label Treatment Period|Other|1
5158308|NCT01405820|17812753|P1|Open-Label Treatment Period|Other|1
5158309|NCT01405820|17812748|P6|Open-Label Treatment Period|Withdrawal by Subject|1
5158310|NCT01405820|17812749|P5|Open-Label Treatment Period|Withdrawal by Subject|0
5158311|NCT01405820|17812750|P4|Open-Label Treatment Period|Withdrawal by Subject|1
5158312|NCT01405820|17812751|P3|Open-Label Treatment Period|Withdrawal by Subject|1
5158313|NCT01405820|17812752|P2|Open-Label Treatment Period|Withdrawal by Subject|1
5158314|NCT01405820|17812753|P1|Open-Label Treatment Period|Withdrawal by Subject|3
5158315|NCT01405820|17812748|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
5158316|NCT01405820|17812749|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
5158317|NCT01405820|17812750|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
5158318|NCT01405820|17812751|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
5158319|NCT01405820|17812752|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
5158320|NCT01405820|17812753|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
5158321|NCT01405820|17812748|P6|Randomized Treatment Period|Death|0
5158322|NCT01405820|17812749|P5|Randomized Treatment Period|Death|0
5158323|NCT01405820|17812750|P4|Randomized Treatment Period|Death|1
5158324|NCT01405820|17812751|P3|Randomized Treatment Period|Death|0
5158325|NCT01405820|17812752|P2|Randomized Treatment Period|Death|0
5158326|NCT01405820|17812753|P1|Randomized Treatment Period|Death|0
5158327|NCT01405820|17812748|P6|Randomized Treatment Period|Treatment Arm Closed|28
5158328|NCT01405820|17812749|P5|Randomized Treatment Period|Treatment Arm Closed|33
5158329|NCT01405820|17812750|P4|Randomized Treatment Period|Treatment Arm Closed|36
5158330|NCT01405820|17812751|P3|Randomized Treatment Period|Treatment Arm Closed|20
5158331|NCT01405820|17812752|P2|Randomized Treatment Period|Treatment Arm Closed|0
5158332|NCT01405820|17812753|P1|Randomized Treatment Period|Treatment Arm Closed|0
5158333|NCT01405820|17812748|P6|Randomized Treatment Period|Incorrect Study Treatment|0
5158334|NCT01405820|17812749|P5|Randomized Treatment Period|Incorrect Study Treatment|2
5158335|NCT01405820|17812750|P4|Randomized Treatment Period|Incorrect Study Treatment|0
5158336|NCT01405820|17812751|P3|Randomized Treatment Period|Incorrect Study Treatment|3
5158337|NCT01405820|17812752|P2|Randomized Treatment Period|Incorrect Study Treatment|0
5158338|NCT01405820|17812753|P1|Randomized Treatment Period|Incorrect Study Treatment|0
5158339|NCT01405820|17812748|P6|Randomized Treatment Period|Rescue|8
5158340|NCT01405820|17812749|P5|Randomized Treatment Period|Rescue|8
5158341|NCT01405820|17812750|P4|Randomized Treatment Period|Rescue|10
5158342|NCT01405820|17812751|P3|Randomized Treatment Period|Rescue|13
5158343|NCT01405820|17812752|P2|Randomized Treatment Period|Rescue|1
5158344|NCT01405820|17812753|P1|Randomized Treatment Period|Rescue|0
5158345|NCT01405820|17812748|P6|Randomized Treatment Period|Physician Decision|0
5158346|NCT01405820|17812749|P5|Randomized Treatment Period|Physician Decision|0
5158347|NCT01405820|17812750|P4|Randomized Treatment Period|Physician Decision|0
5158348|NCT01405820|17812751|P3|Randomized Treatment Period|Physician Decision|1
5158349|NCT01405820|17812752|P2|Randomized Treatment Period|Physician Decision|2
5158350|NCT01405820|17812753|P1|Randomized Treatment Period|Physician Decision|0
5158351|NCT01405820|17812748|P6|Randomized Treatment Period|Other|0
5158352|NCT01405820|17812749|P5|Randomized Treatment Period|Other|0
5158353|NCT01405820|17812750|P4|Randomized Treatment Period|Other|1
5158354|NCT01405820|17812751|P3|Randomized Treatment Period|Other|1
5158355|NCT01405820|17812752|P2|Randomized Treatment Period|Other|2
5158356|NCT01405820|17812753|P1|Randomized Treatment Period|Other|2
5158357|NCT01405820|17812748|P6|Randomized Treatment Period|Withdrawal by Subject|0
5158358|NCT01405820|17812749|P5|Randomized Treatment Period|Withdrawal by Subject|0
5158359|NCT01405820|17812750|P4|Randomized Treatment Period|Withdrawal by Subject|2
5158360|NCT01405820|17812751|P3|Randomized Treatment Period|Withdrawal by Subject|2
5158361|NCT01405820|17812752|P2|Randomized Treatment Period|Withdrawal by Subject|2
5158362|NCT01405820|17812753|P1|Randomized Treatment Period|Withdrawal by Subject|6
5158363|NCT01405820|17812748|P6|Randomized Treatment Period|Adverse Event|1
5158364|NCT01405820|17812749|P5|Randomized Treatment Period|Adverse Event|2
5158365|NCT01405820|17812750|P4|Randomized Treatment Period|Adverse Event|0
5158366|NCT01405820|17812751|P3|Randomized Treatment Period|Adverse Event|3
5158367|NCT01405820|17812752|P2|Randomized Treatment Period|Adverse Event|3
5158368|NCT01405820|17812753|P1|Randomized Treatment Period|Adverse Event|3
5158369|NCT01405768|17812849|P2|Overall Study|Didn't complete questionnaire correctly|0
5158370|NCT01405768|17812850|P1|Overall Study|Didn't complete questionnaire correctly|4
5158371|NCT01405742|17812862|P2|Overall Study|Lost to Follow-up|0
5158372|NCT01405742|17812863|P1|Overall Study|Lost to Follow-up|1
5158373|NCT01405560|17812873|P1|Overall Study|Physician Decision|1
5158374|NCT01405508|17812888|P4|Overall Study|AE, non-serious non-fatal|0
5158375|NCT01405508|17812889|P3|Overall Study|AE, non-serious non-fatal|0
5158376|NCT01405508|17812890|P2|Overall Study|AE, non-serious non-fatal|1
5158377|NCT01405508|17812891|P1|Overall Study|AE, non-serious non-fatal|1
5158378|NCT01405456|17812923|P2|Overall Study|Physician Decision|0
5158379|NCT01405456|17812924|P1|Overall Study|Physician Decision|1
5158380|NCT01405456|17812923|P2|Overall Study|Lost to Follow-up|1
5158381|NCT01405456|17812924|P1|Overall Study|Lost to Follow-up|2
5158382|NCT01405196|17812964|P4|Overall Study|Lost to Follow-up|1
5158383|NCT01405196|17812965|P3|Overall Study|Lost to Follow-up|3
5158384|NCT01405196|17812966|P2|Overall Study|Lost to Follow-up|2
5158385|NCT01405196|17812967|P1|Overall Study|Lost to Follow-up|2
5158386|NCT01405196|17812964|P4|Overall Study|Death|0
5158387|NCT01405196|17812965|P3|Overall Study|Death|3
5158388|NCT01405196|17812966|P2|Overall Study|Death|0
5158389|NCT01405196|17812967|P1|Overall Study|Death|1
5158390|NCT01405196|17812964|P4|Overall Study|Adverse Event|2
5158391|NCT01405196|17812965|P3|Overall Study|Adverse Event|0
5158392|NCT01405196|17812966|P2|Overall Study|Adverse Event|2
5158393|NCT01405196|17812967|P1|Overall Study|Adverse Event|2
5158394|NCT01405196|17812964|P4|Overall Study|Withdrawal by Subject|6
5158395|NCT01405196|17812965|P3|Overall Study|Withdrawal by Subject|3
5158396|NCT01405196|17812966|P2|Overall Study|Withdrawal by Subject|6
5158397|NCT01405196|17812967|P1|Overall Study|Withdrawal by Subject|4
5158398|NCT01405196|17812964|P4|Overall Study|Other|0
5158399|NCT01405196|17812965|P3|Overall Study|Other|5
5158400|NCT01405196|17812966|P2|Overall Study|Other|2
5158401|NCT01405196|17812967|P1|Overall Study|Other|2
5158402|NCT01405196|17812964|P4|Overall Study|Study Terminated by Sponsor|0
5158403|NCT01405196|17812965|P3|Overall Study|Study Terminated by Sponsor|9
5158404|NCT01405196|17812966|P2|Overall Study|Study Terminated by Sponsor|0
5158405|NCT01405196|17812967|P1|Overall Study|Study Terminated by Sponsor|0
5158406|NCT01405053|17813054|P2|Overall Study|Other|1
5158407|NCT01405053|17813055|P1|Overall Study|Other|0
5158408|NCT01405053|17813054|P2|Overall Study|Withdrawal by Subject|4
5158409|NCT01405053|17813055|P1|Overall Study|Withdrawal by Subject|3
5158410|NCT01405053|17813054|P2|Overall Study|Inadequate therapeutic effect|1
5158411|NCT01405053|17813055|P1|Overall Study|Inadequate therapeutic effect|2
5158412|NCT01405053|17813054|P2|Overall Study|Participant choice|1
5158413|NCT01405053|17813055|P1|Overall Study|Participant choice|2
5158414|NCT01405053|17813054|P2|Overall Study|Lost to Follow-up|1
5158415|NCT01405053|17813055|P1|Overall Study|Lost to Follow-up|0
5158416|NCT01405053|17813054|P2|Overall Study|Adverse Event|0
5158417|NCT01405053|17813055|P1|Overall Study|Adverse Event|3
5158418|NCT01405027|17813081|P2|Overall Study|Other or Unknown|25
5158419|NCT01405027|17813082|P1|Overall Study|Other or Unknown|12
5158420|NCT01405027|17813081|P2|Overall Study|Death|0
5158421|NCT01405027|17813082|P1|Overall Study|Death|1
5158422|NCT01405027|17813081|P2|Overall Study|Investigator judgement|2
5158423|NCT01405027|17813082|P1|Overall Study|Investigator judgement|0
5158424|NCT01405027|17813081|P2|Overall Study|Lost to Follow-up|24
5158425|NCT01405027|17813082|P1|Overall Study|Lost to Follow-up|16
5158426|NCT01405027|17813081|P2|Overall Study|Withdrawn consent|0
5158427|NCT01405027|17813082|P1|Overall Study|Withdrawn consent|3
5158428|NCT01404988|17813099|P3|Overall Study|Lost to Follow-up|1
5158429|NCT01404988|17813100|P2|Overall Study|Lost to Follow-up|2
5158430|NCT01404988|17813101|P1|Overall Study|Lost to Follow-up|1
5158431|NCT01404988|17813099|P3|Overall Study|Withdrawal by Subject|0
5158432|NCT01404988|17813100|P2|Overall Study|Withdrawal by Subject|2
5158433|NCT01404988|17813101|P1|Overall Study|Withdrawal by Subject|2
5158434|NCT01404988|17813099|P3|Overall Study|Adverse Event|0
5158435|NCT01404988|17813100|P2|Overall Study|Adverse Event|0
5158436|NCT01404988|17813101|P1|Overall Study|Adverse Event|1
5158437|NCT01404988|17813099|P3|Overall Study|Death|2
5158438|NCT01404988|17813100|P2|Overall Study|Death|0
5158439|NCT01404988|17813101|P1|Overall Study|Death|2
5158440|NCT01404325|17813222|P2|Overall Study|non-specified reason|2
5158441|NCT01404325|17813223|P1|Overall Study|non-specified reason|0
5158442|NCT01404325|17813222|P2|Overall Study|Graft loss/Retransplantation|0
5158443|NCT01404325|17813223|P1|Overall Study|Graft loss/Retransplantation|1
5158444|NCT01404325|17813222|P2|Overall Study|Death|0
5158445|NCT01404325|17813223|P1|Overall Study|Death|2
5158446|NCT01404325|17813222|P2|Overall Study|Lost to Follow-up|0
5158447|NCT01404325|17813223|P1|Overall Study|Lost to Follow-up|1
5158448|NCT01404312|17813281|P2|Overall Study|Severe debilitation, unable to continue|2
5158449|NCT01404312|17813282|P1|Overall Study|Severe debilitation, unable to continue|1
5158450|NCT01404312|17813281|P2|Overall Study|Participant not willing to adhere to req|29
5158451|NCT01404312|17813282|P1|Overall Study|Participant not willing to adhere to req|31
5158452|NCT01404312|17813281|P2|Overall Study|Site closed|21
5158453|NCT01404312|17813282|P1|Overall Study|Site closed|22
5158454|NCT01404312|17813281|P2|Overall Study|Lost to Follow-up|111
5158455|NCT01404312|17813282|P1|Overall Study|Lost to Follow-up|115
5158456|NCT01404312|17813281|P2|Overall Study|Participant Unable to get to clinic|103
5158457|NCT01404312|17813282|P1|Overall Study|Participant Unable to get to clinic|93
5158458|NCT01404312|17813281|P2|Overall Study|Withdrawal by Subject|18
5158459|NCT01404312|17813282|P1|Overall Study|Withdrawal by Subject|15
5158460|NCT01404312|17813281|P2|Overall Study|Death|27
5158461|NCT01404312|17813282|P1|Overall Study|Death|21
5158462|NCT01404234|17813311|P1|Overall Study|Withdrawal by Subject|2
5158463|NCT01404208|17813327|P2|Overall Study|Discontinued|0
5158464|NCT01404208|17813328|P1|Overall Study|Discontinued|3
5158465|NCT01403987|17813393|P3|Overall Study|Residents forgot their secret PIN|18
5158466|NCT01403987|17813394|P2|Overall Study|Residents forgot their secret PIN|17
5158467|NCT01403987|17813395|P1|Overall Study|Residents forgot their secret PIN|18
5158468|NCT01403948|17813419|P10|Overall Study|other than above|0
5158469|NCT01403948|17813420|P9|Overall Study|other than above|0
5158470|NCT01403948|17813421|P8|Overall Study|other than above|0
5158471|NCT01403948|17813422|P7|Overall Study|other than above|2
5158472|NCT01403948|17813423|P6|Overall Study|other than above|1
5158473|NCT01403948|17813424|P5|Overall Study|other than above|1
5158474|NCT01403948|17813425|P4|Overall Study|other than above|0
5158475|NCT01403948|17813426|P3|Overall Study|other than above|1
5158476|NCT01403948|17813427|P2|Overall Study|other than above|2
5158477|NCT01403948|17813428|P1|Overall Study|other than above|1
5158478|NCT01403948|17813419|P10|Overall Study|Refused cont. medication|1
5158479|NCT01403948|17813420|P9|Overall Study|Refused cont. medication|0
5158480|NCT01403948|17813421|P8|Overall Study|Refused cont. medication|0
5158481|NCT01403948|17813422|P7|Overall Study|Refused cont. medication|0
5158482|NCT01403948|17813423|P6|Overall Study|Refused cont. medication|0
5158483|NCT01403948|17813424|P5|Overall Study|Refused cont. medication|1
5158484|NCT01403948|17813425|P4|Overall Study|Refused cont. medication|0
5158485|NCT01403948|17813426|P3|Overall Study|Refused cont. medication|0
5158486|NCT01403948|17813427|P2|Overall Study|Refused cont. medication|0
5158487|NCT01403948|17813428|P1|Overall Study|Refused cont. medication|0
5158488|NCT01403948|17813419|P10|Overall Study|Lost to Follow-up|1
5158489|NCT01403948|17813420|P9|Overall Study|Lost to Follow-up|0
5158490|NCT01403948|17813421|P8|Overall Study|Lost to Follow-up|0
5158491|NCT01403948|17813422|P7|Overall Study|Lost to Follow-up|0
5158492|NCT01403948|17813423|P6|Overall Study|Lost to Follow-up|0
5158493|NCT01403948|17813424|P5|Overall Study|Lost to Follow-up|0
5158494|NCT01403948|17813425|P4|Overall Study|Lost to Follow-up|0
5158495|NCT01403948|17813426|P3|Overall Study|Lost to Follow-up|0
5158496|NCT01403948|17813427|P2|Overall Study|Lost to Follow-up|0
5158497|NCT01403948|17813428|P1|Overall Study|Lost to Follow-up|0
5158498|NCT01403948|17813419|P10|Overall Study|Other Adverse Event (Other than DLT)|0
5158499|NCT01403948|17813420|P9|Overall Study|Other Adverse Event (Other than DLT)|1
5158500|NCT01403948|17813421|P8|Overall Study|Other Adverse Event (Other than DLT)|0
5158501|NCT01403948|17813422|P7|Overall Study|Other Adverse Event (Other than DLT)|2
5158502|NCT01403948|17813423|P6|Overall Study|Other Adverse Event (Other than DLT)|0
5158503|NCT01403948|17813424|P5|Overall Study|Other Adverse Event (Other than DLT)|2
5158504|NCT01403948|17813425|P4|Overall Study|Other Adverse Event (Other than DLT)|0
5158505|NCT01403948|17813426|P3|Overall Study|Other Adverse Event (Other than DLT)|0
5158506|NCT01403948|17813427|P2|Overall Study|Other Adverse Event (Other than DLT)|0
5158507|NCT01403948|17813428|P1|Overall Study|Other Adverse Event (Other than DLT)|0
5158508|NCT01403948|17813419|P10|Overall Study|Progressive disease|5
5158509|NCT01403948|17813420|P9|Overall Study|Progressive disease|5
5158510|NCT01403948|17813421|P8|Overall Study|Progressive disease|4
5158511|NCT01403948|17813422|P7|Overall Study|Progressive disease|2
5158512|NCT01403948|17813423|P6|Overall Study|Progressive disease|6
5158513|NCT01403948|17813424|P5|Overall Study|Progressive disease|2
5158514|NCT01403948|17813425|P4|Overall Study|Progressive disease|4
5158515|NCT01403948|17813426|P3|Overall Study|Progressive disease|2
5158516|NCT01403948|17813427|P2|Overall Study|Progressive disease|2
5158517|NCT01403948|17813428|P1|Overall Study|Progressive disease|0
5158518|NCT01403805|17813501|P2|Overall Study|Death|1
5158519|NCT01403805|17813502|P1|Overall Study|Death|0
5158520|NCT01403805|17813501|P2|Overall Study|Lost to Follow-up|2
5158521|NCT01403805|17813502|P1|Overall Study|Lost to Follow-up|0
5158522|NCT01403805|17813501|P2|Overall Study|Withdrawal by Subject|4
5158523|NCT01403805|17813502|P1|Overall Study|Withdrawal by Subject|0
5158524|NCT01403610|17813518|P4|Overall Study|Didn't recover from surgery sufficiently|0
5158525|NCT01403610|17813519|P3|Overall Study|Didn't recover from surgery sufficiently|0
5158526|NCT01403610|17813520|P2|Overall Study|Didn't recover from surgery sufficiently|3
5158527|NCT01403610|17813521|P1|Overall Study|Didn't recover from surgery sufficiently|0
5158528|NCT01403610|17813518|P4|Overall Study|Withdrawal by Subject|0
5158529|NCT01403610|17813519|P3|Overall Study|Withdrawal by Subject|0
5158530|NCT01403610|17813520|P2|Overall Study|Withdrawal by Subject|0
5158531|NCT01403610|17813521|P1|Overall Study|Withdrawal by Subject|2
5158532|NCT01403194|17813567|P1|Overall Study|Lost to Follow-up|8
5158533|NCT01403194|17813567|P1|Overall Study|Screen Failure|2
5158534|NCT01403116|17813575|P2|Overall Study|unable to keep appointments|2
5158535|NCT01403116|17813576|P1|Overall Study|unable to keep appointments|0
5158536|NCT01403116|17813575|P2|Overall Study|Hct >54%|0
5158537|NCT01403116|17813576|P1|Overall Study|Hct >54%|2
5158538|NCT01403116|17813575|P2|Overall Study|undisclosed Hx of Prostate Ca|0
5158539|NCT01403116|17813576|P1|Overall Study|undisclosed Hx of Prostate Ca|1
5158540|NCT01403116|17813575|P2|Overall Study|Protocol Violation|1
5158541|NCT01403116|17813576|P1|Overall Study|Protocol Violation|0
5158542|NCT01403116|17813575|P2|Overall Study|Non-compliance of study drug|0
5158543|NCT01403116|17813576|P1|Overall Study|Non-compliance of study drug|3
5158544|NCT01403116|17813575|P2|Overall Study|Withdrawal by Subject|15
5158545|NCT01403116|17813576|P1|Overall Study|Withdrawal by Subject|12
5158546|NCT01403116|17813575|P2|Overall Study|Lost to Follow-up|5
5158547|NCT01403116|17813576|P1|Overall Study|Lost to Follow-up|7
5158548|NCT01403116|17813575|P2|Overall Study|Adverse Event|4
5158549|NCT01403116|17813576|P1|Overall Study|Adverse Event|7
5158550|NCT01403051|17813589|P2|Overall Study|Lost to Follow-up|5
5158551|NCT01403051|17813590|P1|Overall Study|Lost to Follow-up|5
5158552|NCT01403051|17813589|P2|Overall Study|Withdrawal by Subject|1
5158553|NCT01403051|17813590|P1|Overall Study|Withdrawal by Subject|2
5158554|NCT01403051|17813589|P2|Overall Study|Death|0
5158555|NCT01403051|17813590|P1|Overall Study|Death|1
5158556|NCT01403051|17813589|P2|Overall Study|Protocol Violation|0
5158557|NCT01403051|17813590|P1|Overall Study|Protocol Violation|2
5158558|NCT01402986|17813626|P4|Overall Study|Other|6
5158559|NCT01402986|17813627|P3|Overall Study|Other|1
5158560|NCT01402986|17813628|P2|Overall Study|Other|5
5158561|NCT01402986|17813629|P1|Overall Study|Other|2
5158562|NCT01402986|17813626|P4|Overall Study|Lost to Follow-up|1
5158563|NCT01402986|17813627|P3|Overall Study|Lost to Follow-up|0
5158564|NCT01402986|17813628|P2|Overall Study|Lost to Follow-up|0
5158565|NCT01402986|17813629|P1|Overall Study|Lost to Follow-up|0
5158566|NCT01402986|17813626|P4|Overall Study|Death|2
5158567|NCT01402986|17813627|P3|Overall Study|Death|0
5158568|NCT01402986|17813628|P2|Overall Study|Death|0
5158569|NCT01402986|17813629|P1|Overall Study|Death|0
5158570|NCT01402986|17813626|P4|Overall Study|Withdrawal by Subject|13
5158571|NCT01402986|17813627|P3|Overall Study|Withdrawal by Subject|7
5158572|NCT01402986|17813628|P2|Overall Study|Withdrawal by Subject|10
5158573|NCT01402986|17813629|P1|Overall Study|Withdrawal by Subject|7
5158574|NCT01402947|17813764|P2|First Intervention|Adverse Event|1
5158575|NCT01402947|17813765|P1|First Intervention|Adverse Event|0
5158576|NCT01402869|17813776|P3|Overall Study|Required Tooth Extraction|1
5158577|NCT01402869|17813777|P2|Overall Study|Required Tooth Extraction|0
5158578|NCT01402869|17813778|P1|Overall Study|Required Tooth Extraction|0
5158579|NCT01402817|17813792|P1|Overall Study|Study Suspended by FDA|8
5158580|NCT01402817|17813792|P1|Overall Study|Withdrawal by Subject|3
5158581|NCT01402700|17813797|P1|Overall Study|Missed Visit|1
5158582|NCT01402700|17813797|P1|Overall Study|Withdrawal by Subject|3
5158583|NCT01402700|17813797|P1|Overall Study|Death|3
5158584|NCT01402570|17813801|P1|Overall Study|Adverse Event|1
5158585|NCT01402544|17813808|P1|Overall Study|Withdrawal by Subject|6
5158586|NCT01402284|17813882|P1|Overall Study|Disease progression on study|10
5158587|NCT01402284|17813882|P1|Overall Study|Physician Decision|1
5158588|NCT01402284|17813882|P1|Overall Study|Follows up at Memorial Sloan Kettering|1
5158589|NCT01402284|17813882|P1|Overall Study|Withdrawal consent|2
5158590|NCT01402102|17813964|P2|Overall Study|Withdrawal by Subject|2
5158591|NCT01402102|17813965|P1|Overall Study|Withdrawal by Subject|0
5158592|NCT01402102|17813964|P2|Overall Study|Insufficiency of compliance|1
5158593|NCT01402102|17813965|P1|Overall Study|Insufficiency of compliance|1
5158594|NCT01402102|17813964|P2|Overall Study|Protocol Violation|0
5158595|NCT01402102|17813965|P1|Overall Study|Protocol Violation|1
5158596|NCT01402063|17813985|P2|Overall Study|Withdrawal by Subject|3
5158597|NCT01402063|17813986|P1|Overall Study|Withdrawal by Subject|3
5158598|NCT01402011|17814004|P3|Nine Month Follow-up|Withdrawal by Subject|0
5158599|NCT01402011|17814005|P2|Nine Month Follow-up|Withdrawal by Subject|1
5158600|NCT01402011|17814006|P1|Nine Month Follow-up|Withdrawal by Subject|0
5158601|NCT01402011|17814004|P3|Active Treatment Period|Withdrawal by Subject|0
5158602|NCT01402011|17814005|P2|Active Treatment Period|Withdrawal by Subject|3
5158603|NCT01402011|17814006|P1|Active Treatment Period|Withdrawal by Subject|1
5158604|NCT01402011|17814004|P3|Delayed Treatment Period|Withdrawal by Subject|0
5158605|NCT01402011|17814005|P2|Delayed Treatment Period|Withdrawal by Subject|0
5158606|NCT01402011|17814006|P1|Delayed Treatment Period|Withdrawal by Subject|1
5158607|NCT01401959|17814035|P3|Treated|Protocol Violation|0
5158608|NCT01401959|17814036|P2|Treated|Protocol Violation|1
5158609|NCT01401959|17814037|P1|Treated|Protocol Violation|0
5158610|NCT01401959|17814035|P3|Treated|Withdrawal by Subject|2
5158611|NCT01401959|17814036|P2|Treated|Withdrawal by Subject|2
5158612|NCT01401959|17814037|P1|Treated|Withdrawal by Subject|1
5158613|NCT01401959|17814035|P3|Treated|Adverse Event|2
5158614|NCT01401959|17814036|P2|Treated|Adverse Event|3
5158615|NCT01401959|17814037|P1|Treated|Adverse Event|4
5158616|NCT01401959|17814035|P3|Treated|Disease Progression|1
5158617|NCT01401959|17814036|P2|Treated|Disease Progression|2
5158618|NCT01401959|17814037|P1|Treated|Disease Progression|2
5158619|NCT01401959|17814035|P3|Enrolled|Withdrawal by Subject|0
5158620|NCT01401959|17814036|P2|Enrolled|Withdrawal by Subject|0
5158621|NCT01401959|17814037|P1|Enrolled|Withdrawal by Subject|1
5158622|NCT01401842|17814076|P2|Overall Study|other/unknown|17
5158623|NCT01401842|17814077|P1|Overall Study|other/unknown|28
5158624|NCT01401842|17814076|P2|Overall Study|on profile|5
5158625|NCT01401842|17814077|P1|Overall Study|on profile|9
5158626|NCT01401842|17814076|P2|Overall Study|invalid follow-up strength data|4
5158627|NCT01401842|17814077|P1|Overall Study|invalid follow-up strength data|1
5158628|NCT01401842|17814076|P2|Overall Study|discharged from US Army|4
5158629|NCT01401842|17814077|P1|Overall Study|discharged from US Army|3
5158630|NCT01401842|17814076|P2|Overall Study|changed companies|34
5158631|NCT01401842|17814077|P1|Overall Study|changed companies|20
5158632|NCT01401842|17814076|P2|Overall Study|academic reason|1
5158633|NCT01401842|17814077|P1|Overall Study|academic reason|4
5158634|NCT01401842|17814076|P2|Overall Study|Withdrawal by Subject|2
5158635|NCT01401842|17814077|P1|Overall Study|Withdrawal by Subject|3
5158636|NCT01401647|17814094|P3|Overall Study|Lost to Follow-up|1
5158637|NCT01401647|17814095|P2|Overall Study|Lost to Follow-up|3
5158638|NCT01401647|17814096|P1|Overall Study|Lost to Follow-up|3
5158639|NCT01401647|17814094|P3|Overall Study|Withdrawal by Subject|2
5158640|NCT01401647|17814095|P2|Overall Study|Withdrawal by Subject|5
5158641|NCT01401647|17814096|P1|Overall Study|Withdrawal by Subject|1
5158642|NCT01401530|17814166|P3|Overall Study|Physician Decision|0
5158643|NCT01401530|17814167|P2|Overall Study|Physician Decision|1
5158644|NCT01401530|17814168|P1|Overall Study|Physician Decision|0
5158645|NCT01401530|17814166|P3|Overall Study|Participant Choice|1
5158646|NCT01401530|17814167|P2|Overall Study|Participant Choice|2
5158647|NCT01401530|17814168|P1|Overall Study|Participant Choice|1
5158648|NCT01401530|17814166|P3|Overall Study|Adverse Event|1
5158649|NCT01401530|17814167|P2|Overall Study|Adverse Event|1
5158650|NCT01401530|17814168|P1|Overall Study|Adverse Event|1
5158651|NCT01401530|17814166|P3|Overall Study|Disease Progression|1
5158652|NCT01401530|17814167|P2|Overall Study|Disease Progression|2
5158653|NCT01401530|17814168|P1|Overall Study|Disease Progression|1
5158654|NCT01401478|17814227|P1|Overall Study|Serious adverse event|1
5158655|NCT01401478|17814227|P1|Overall Study|Low intact parathyroid hormone|1
5158656|NCT01401478|17814227|P1|Overall Study|Hyperphosphatemia and adverse event|1
5158657|NCT01401478|17814227|P1|Overall Study|Blood samples not available|1
5158658|NCT01401478|17814227|P1|Overall Study|Withdrawal by Subject|3
5158659|NCT01401478|17814227|P1|Overall Study|Kidney transplantation|3
5158660|NCT01401478|17814227|P1|Overall Study|Lost to Follow-up|5
5158661|NCT01401478|17814227|P1|Overall Study|Hyperphosphatemia|5
5158662|NCT01401478|17814227|P1|Overall Study|Adverse Event|5
5158663|NCT01401478|17814227|P1|Overall Study|Study drug not available|6
5158664|NCT01401465|17814240|P2|Treatment Period 2|Withdrawal by Subject|1
5158665|NCT01401465|17814241|P1|Treatment Period 2|Withdrawal by Subject|0
5158666|NCT01401465|17814240|P2|Treatment Period 2|Lost to Follow-up|1
5158667|NCT01401465|17814241|P1|Treatment Period 2|Lost to Follow-up|0
5158668|NCT01401465|17814240|P2|Treatment Period 1|Scheduling Difficulties|1
5158669|NCT01401465|17814241|P1|Treatment Period 1|Scheduling Difficulties|1
5158670|NCT01401465|17814240|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
5158671|NCT01401465|17814241|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
5158672|NCT01401465|17814240|P2|Treatment Period 1|Non-Compliance to Study Drug|0
5158673|NCT01401465|17814241|P1|Treatment Period 1|Non-Compliance to Study Drug|1
5158674|NCT01401465|17814240|P2|Treatment Period 1|Withdrawal by Subject|4
5158675|NCT01401465|17814241|P1|Treatment Period 1|Withdrawal by Subject|1
5158676|NCT01401465|17814240|P2|Treatment Period 1|Protocol Violation|0
5158677|NCT01401465|17814241|P1|Treatment Period 1|Protocol Violation|5
5158678|NCT01401465|17814240|P2|Treatment Period 1|Pregnancy|1
5158679|NCT01401465|17814241|P1|Treatment Period 1|Pregnancy|0
5158680|NCT01401465|17814240|P2|Treatment Period 1|Adverse Event|1
5158681|NCT01401465|17814241|P1|Treatment Period 1|Adverse Event|4
5158682|NCT01401452|17814304|P1|Overall Study|Participant withdrew consent|1
5158683|NCT01401452|17814304|P1|Overall Study|Subject chose to discontinue treatment|1
5158684|NCT01401452|17814304|P1|Overall Study|Subject withdrew because of Tx success|1
5158685|NCT01401452|17814304|P1|Overall Study|Unsatisfactory output|1
5158686|NCT01401452|17814304|P1|Overall Study|Treatment failure|1
5158687|NCT01401452|17814304|P1|Overall Study|Discontinuation for personal reasons|1
5158688|NCT01401452|17814304|P1|Overall Study|Participant stopped Tx|2
5158689|NCT01401452|17814304|P1|Overall Study|Psoriatic arthritis|1
5158690|NCT01401452|17814304|P1|Overall Study|Subject's wife wants to get pregnant|1
5158691|NCT01401452|17814304|P1|Overall Study|Subject moved to another city|1
5158692|NCT01401452|17814304|P1|Overall Study|Subject didn't return for routine visits|1
5158693|NCT01401452|17814304|P1|Overall Study|Subject did not come to follow up visits|2
5158694|NCT01401452|17814304|P1|Overall Study|No more visits within the 36 wk followup|4
5158695|NCT01401452|17814304|P1|Overall Study|Tx stopped by psychiatrist|1
5158696|NCT01401452|17814304|P1|Overall Study|Tx stopped due to financial reasons|1
5158697|NCT01401452|17814304|P1|Overall Study|Participant developed breast cancer|1
5158698|NCT01401452|17814304|P1|Overall Study|Lack of Efficacy|30
5158699|NCT01401452|17814304|P1|Overall Study|Lost to Follow-up|12
5158700|NCT01401452|17814304|P1|Overall Study|Adverse reaction|9
5158701|NCT01401361|17814316|P1|Overall Study|Subject/family decision post procedure|2
5158702|NCT01401361|17814316|P1|Overall Study|Lost to Follow-up|3
5158703|NCT01401361|17814316|P1|Overall Study|Physician Decision|1
5158704|NCT01401361|17814316|P1|Overall Study|Lack of Efficacy|6
5158705|NCT01401361|17814316|P1|Overall Study|Withdrawal by Subject|16
5158706|NCT01401322|17814322|P1|Overall Study|Physician Decision|1
5158707|NCT01401322|17814322|P1|Overall Study|Withdrawal by Subject|1
5158708|NCT01401283|17814328|P2|Overall Study|suspicion of malignant hyperthermia|1
5158709|NCT01401283|17814329|P1|Overall Study|suspicion of malignant hyperthermia|0
5158710|NCT01401283|17814328|P2|Overall Study|no central venous access|1
5158711|NCT01401283|17814329|P1|Overall Study|no central venous access|0
5158712|NCT01401283|17814328|P2|Overall Study|preoperative arrhythmia|0
5158713|NCT01401283|17814329|P1|Overall Study|preoperative arrhythmia|5
5158714|NCT01401283|17814328|P2|Overall Study|surgery cancelled|8
5158715|NCT01401283|17814329|P1|Overall Study|surgery cancelled|5
5158716|NCT01401153|17814395|P2|Second Test Day|illness|5
5158717|NCT01401153|17814396|P1|Second Test Day|illness|0
5158718|NCT01401153|17814395|P2|First Test Day|Learning disabilities; illness|10
5158719|NCT01401153|17814396|P1|First Test Day|Learning disabilities; illness|1
5158720|NCT01401062|17814443|P2|Overall Study|Withdrawal by Subject|1
5158721|NCT01401062|17814444|P1|Overall Study|Withdrawal by Subject|1
5158722|NCT01401062|17814443|P2|Overall Study|Physician Decision|0
5158723|NCT01401062|17814444|P1|Overall Study|Physician Decision|1
5158724|NCT01401062|17814443|P2|Overall Study|Death|7
5158725|NCT01401062|17814444|P1|Overall Study|Death|9
5158726|NCT01401010|17814471|P2|Overall Study|Could not interpret assay results|0
5158727|NCT01401010|17814472|P1|Overall Study|Could not interpret assay results|1
5158728|NCT01400971|17814495|P1|Overall Study|Other|422
5158729|NCT01400971|17814495|P1|Overall Study|Withdrawal by Subject|158
5158730|NCT01400971|17814495|P1|Overall Study|Physician Decision|57
5158731|NCT01400971|17814495|P1|Overall Study|Lost to follow up + Subject Decision|2
5158732|NCT01400971|17814495|P1|Overall Study|Lost to Follow-up|196
5158733|NCT01400971|17814495|P1|Overall Study|Death|82
5158734|NCT01400958|17814504|P2|Overall Study|Adverse Event|0
5158735|NCT01400958|17814505|P1|Overall Study|Adverse Event|1
5158736|NCT01400958|17814504|P2|Overall Study|Withdrawal by Subject|1
5158737|NCT01400958|17814505|P1|Overall Study|Withdrawal by Subject|0
5158738|NCT01400958|17814504|P2|Overall Study|Physician Decision|1
5158739|NCT01400958|17814505|P1|Overall Study|Physician Decision|0
5158740|NCT01400932|17814515|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
5158741|NCT01400932|17814516|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5158742|NCT01400932|17814515|P2|Overall Study|Protocol Deviation|1
5158743|NCT01400932|17814516|P1|Overall Study|Protocol Deviation|0
5158744|NCT01400932|17814515|P2|Overall Study|Lost to Follow-up|0
5158745|NCT01400932|17814516|P1|Overall Study|Lost to Follow-up|1
5158746|NCT01400932|17814515|P2|Overall Study|Withdrawal by Subject|6
5158747|NCT01400932|17814516|P1|Overall Study|Withdrawal by Subject|2
5158748|NCT01400932|17814515|P2|Overall Study|Lack of Efficacy|3
5158749|NCT01400932|17814516|P1|Overall Study|Lack of Efficacy|0
5158750|NCT01400932|17814515|P2|Overall Study|Adverse Event|5
5158751|NCT01400932|17814516|P1|Overall Study|Adverse Event|10
5158752|NCT01400919|17814538|P1|Overall Study|Missed visit|2
5158753|NCT01400919|17814538|P1|Overall Study|Lost to Follow-up|2
5158754|NCT01400919|17814538|P1|Overall Study|Withdrawal by Subject|4
5158755|NCT01400893|17814581|P2|Overall Study|Lost to Follow-up|6
5158756|NCT01400893|17814582|P1|Overall Study|Lost to Follow-up|0
5158757|NCT01400893|17814581|P2|Overall Study|Death|21
5158758|NCT01400893|17814582|P1|Overall Study|Death|27
5158759|NCT01400841|17814594|P1|Extended Study Phase (2 Years)|Adverse Event|2
5158760|NCT01400841|17814594|P1|Initial Study Phase (6 Months)|Death|1
5158761|NCT01400698|17814632|P6|Overall Study|Other|0
5158762|NCT01400698|17814633|P5|Overall Study|Other|1
5158763|NCT01400698|17814634|P4|Overall Study|Other|2
5158764|NCT01400698|17814635|P3|Overall Study|Other|0
5158765|NCT01400698|17814636|P2|Overall Study|Other|2
5158766|NCT01400698|17814637|P1|Overall Study|Other|4
5158767|NCT01400698|17814632|P6|Overall Study|Adverse Event|0
5158768|NCT01400698|17814633|P5|Overall Study|Adverse Event|0
5158769|NCT01400698|17814634|P4|Overall Study|Adverse Event|0
5158770|NCT01400698|17814635|P3|Overall Study|Adverse Event|0
5158771|NCT01400698|17814636|P2|Overall Study|Adverse Event|0
5158772|NCT01400698|17814637|P1|Overall Study|Adverse Event|1
5158773|NCT01400698|17814632|P6|Overall Study|Non-compliance|0
5158774|NCT01400698|17814633|P5|Overall Study|Non-compliance|0
5158775|NCT01400698|17814634|P4|Overall Study|Non-compliance|1
5158776|NCT01400698|17814635|P3|Overall Study|Non-compliance|0
5158777|NCT01400698|17814636|P2|Overall Study|Non-compliance|1
5158778|NCT01400698|17814637|P1|Overall Study|Non-compliance|0
5158779|NCT01400698|17814632|P6|Overall Study|Protocol Violation|0
5158780|NCT01400698|17814633|P5|Overall Study|Protocol Violation|1
5158781|NCT01400698|17814634|P4|Overall Study|Protocol Violation|0
5158782|NCT01400698|17814635|P3|Overall Study|Protocol Violation|0
5158783|NCT01400698|17814636|P2|Overall Study|Protocol Violation|1
5158784|NCT01400698|17814637|P1|Overall Study|Protocol Violation|0
5158785|NCT01400698|17814632|P6|Overall Study|Withdrawal by Subject|3
5158786|NCT01400698|17814633|P5|Overall Study|Withdrawal by Subject|1
5158787|NCT01400698|17814634|P4|Overall Study|Withdrawal by Subject|4
5158788|NCT01400698|17814635|P3|Overall Study|Withdrawal by Subject|0
5158789|NCT01400698|17814636|P2|Overall Study|Withdrawal by Subject|2
5158790|NCT01400698|17814637|P1|Overall Study|Withdrawal by Subject|8
5158791|NCT01400698|17814632|P6|Overall Study|Lost to Follow-up|3
5158792|NCT01400698|17814633|P5|Overall Study|Lost to Follow-up|4
5158793|NCT01400698|17814634|P4|Overall Study|Lost to Follow-up|1
5158794|NCT01400698|17814635|P3|Overall Study|Lost to Follow-up|2
5158795|NCT01400698|17814636|P2|Overall Study|Lost to Follow-up|5
5158796|NCT01400698|17814637|P1|Overall Study|Lost to Follow-up|2
5158797|NCT01400516|17814661|P2|Primary Trial|Withdrawal by Subject|2
5158798|NCT01400516|17814662|P1|Primary Trial|Withdrawal by Subject|0
5158799|NCT01400503|17814672|P1|Overall Study|Other|1
5158800|NCT01400503|17814672|P1|Overall Study|Study Terminated by Sponsor|58
5158801|NCT01400503|17814672|P1|Overall Study|Withdrawal by Subject|1
5158802|NCT01400451|17814695|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
5158803|NCT01400451|17814696|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
5158804|NCT01400451|17814697|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
5158805|NCT01400451|17814695|P3|Combination Treatment (or Intended)|Disease Progression|1
5158806|NCT01400451|17814696|P2|Combination Treatment (or Intended)|Disease Progression|1
5158807|NCT01400451|17814697|P1|Combination Treatment (or Intended)|Disease Progression|3
5158808|NCT01400451|17814695|P3|Combination Treatment (or Intended)|Adverse Event|0
5158809|NCT01400451|17814696|P2|Combination Treatment (or Intended)|Adverse Event|0
5158810|NCT01400451|17814697|P1|Combination Treatment (or Intended)|Adverse Event|1
5158811|NCT01400451|17814695|P3|Combination Treatment (or Intended)|Drug Toxicity|0
5158812|NCT01400451|17814696|P2|Combination Treatment (or Intended)|Drug Toxicity|1
5158813|NCT01400451|17814697|P1|Combination Treatment (or Intended)|Drug Toxicity|0
5158814|NCT01400451|17814695|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
5158815|NCT01400451|17814696|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
5158816|NCT01400451|17814697|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
5158817|NCT01400425|17814711|P1|Overall Study|Withdrawal by Subject|10
5158818|NCT01400412|17814724|P2|Overall Study|Never started study treatment|3
5158819|NCT01400412|17814725|P1|Overall Study|Never started study treatment|0
5158820|NCT01400412|17814724|P2|Overall Study|Unable to complete|3
5158821|NCT01400412|17814725|P1|Overall Study|Unable to complete|3
5158822|NCT01400412|17814724|P2|Overall Study|Withdrawal by Subject|4
5158823|NCT01400412|17814725|P1|Overall Study|Withdrawal by Subject|3
5158824|NCT01400412|17814724|P2|Overall Study|Lost to Follow-up|7
5158825|NCT01400412|17814725|P1|Overall Study|Lost to Follow-up|4
5158826|NCT01400243|17814771|P2|Overall Study|Protocol Violation|11
5158827|NCT01400243|17814772|P1|Overall Study|Protocol Violation|8
5158828|NCT01400139|17814794|P1|HYD Extension Period|Administrative|10
5158829|NCT01400139|17814794|P1|HYD Extension Period|Withdrawal by Subject|5
5158830|NCT01400139|17814794|P1|HYD Extension Period|Adverse Event|8
5158831|NCT01400139|17814794|P1|HYD Core Study|Did not qualify for Maintenance Period|14
5158832|NCT01400139|17814794|P1|HYD Core Study|Administrative|56
5158833|NCT01400139|17814794|P1|HYD Core Study|Confirmed or suspected diversion|20
5158834|NCT01400139|17814794|P1|HYD Core Study|Lost to Follow-up|39
5158835|NCT01400139|17814794|P1|HYD Core Study|Withdrawal by Subject|114
5158836|NCT01400139|17814794|P1|HYD Core Study|Lack of Efficacy|59
5158837|NCT01400139|17814794|P1|HYD Core Study|Adverse Event|210
5158838|NCT01400113|17814817|P2|Overall Study|Withdrawal by Subject|1
5158839|NCT01400113|17814818|P1|Overall Study|Withdrawal by Subject|1
5158840|NCT01399905|17814826|P2|Overall Study|Withdrawal by Subject|1
5158841|NCT01399905|17814827|P1|Overall Study|Withdrawal by Subject|1
5158842|NCT01399788|17814875|P2|First Intervention Period|Adverse Event|0
5158843|NCT01399788|17814876|P1|First Intervention Period|Adverse Event|1
5158844|NCT01399736|17814898|P2|Overall Study|Lost to Follow-up|2
5158845|NCT01399736|17814899|P1|Overall Study|Lost to Follow-up|0
5158846|NCT01399736|17814898|P2|Overall Study|Withdrawal by Subject|2
5158847|NCT01399736|17814899|P1|Overall Study|Withdrawal by Subject|4
5158848|NCT01399723|17814975|P2|Overall Study|Lost to Follow-up|1
5158849|NCT01399723|17814976|P1|Overall Study|Lost to Follow-up|0
5158850|NCT01399697|17814989|P3|Overall Study|Sponsor Decision|0
5158851|NCT01399697|17814990|P2|Overall Study|Sponsor Decision|0
5158852|NCT01399697|17814991|P1|Overall Study|Sponsor Decision|1
5158853|NCT01399697|17814989|P3|Overall Study|Clinical RA remission|0
5158854|NCT01399697|17814990|P2|Overall Study|Clinical RA remission|0
5158855|NCT01399697|17814991|P1|Overall Study|Clinical RA remission|1
5158856|NCT01399697|17814989|P3|Overall Study|Positive result for hepatitis B|0
5158857|NCT01399697|17814990|P2|Overall Study|Positive result for hepatitis B|0
5158858|NCT01399697|17814991|P1|Overall Study|Positive result for hepatitis B|1
5158859|NCT01399697|17814989|P3|Overall Study|Inclusion Error|0
5158860|NCT01399697|17814990|P2|Overall Study|Inclusion Error|0
5158861|NCT01399697|17814991|P1|Overall Study|Inclusion Error|2
5158862|NCT01399697|17814989|P3|Overall Study|Non-Compliant|0
5158863|NCT01399697|17814990|P2|Overall Study|Non-Compliant|0
5158864|NCT01399697|17814991|P1|Overall Study|Non-Compliant|1
5158865|NCT01399697|17814989|P3|Overall Study|Protocol Violation|0
5158866|NCT01399697|17814990|P2|Overall Study|Protocol Violation|0
5158867|NCT01399697|17814991|P1|Overall Study|Protocol Violation|2
5158868|NCT01399697|17814989|P3|Overall Study|Lack of Efficacy|1
5158869|NCT01399697|17814990|P2|Overall Study|Lack of Efficacy|0
5158870|NCT01399697|17814991|P1|Overall Study|Lack of Efficacy|9
5158871|NCT01399697|17814989|P3|Overall Study|Investigator Decisión|2
5158872|NCT01399697|17814990|P2|Overall Study|Investigator Decisión|0
5158873|NCT01399697|17814991|P1|Overall Study|Investigator Decisión|1
5158874|NCT01399697|17814989|P3|Overall Study|Withdrawal by Subject|0
5158875|NCT01399697|17814990|P2|Overall Study|Withdrawal by Subject|0
5158876|NCT01399697|17814991|P1|Overall Study|Withdrawal by Subject|8
5158877|NCT01399697|17814989|P3|Overall Study|Lost to Follow-up|0
5158878|NCT01399697|17814990|P2|Overall Study|Lost to Follow-up|0
5158879|NCT01399697|17814991|P1|Overall Study|Lost to Follow-up|2
5158880|NCT01399697|17814989|P3|Overall Study|Adverse Event|1
5158881|NCT01399697|17814990|P2|Overall Study|Adverse Event|3
5158882|NCT01399697|17814991|P1|Overall Study|Adverse Event|13
5158883|NCT01399619|17815018|P4|Overall Study|Not treated|2
5158884|NCT01399619|17815019|P3|Overall Study|Not treated|0
5158885|NCT01399619|17815020|P2|Overall Study|Not treated|0
5158886|NCT01399619|17815021|P1|Overall Study|Not treated|0
5158887|NCT01399619|17815018|P4|Overall Study|Protocol Violation|1
5158888|NCT01399619|17815019|P3|Overall Study|Protocol Violation|0
5158889|NCT01399619|17815020|P2|Overall Study|Protocol Violation|0
5158890|NCT01399619|17815021|P1|Overall Study|Protocol Violation|0
5158891|NCT01399619|17815018|P4|Overall Study|Withdrawal by Subject|4
5158892|NCT01399619|17815019|P3|Overall Study|Withdrawal by Subject|3
5158893|NCT01399619|17815020|P2|Overall Study|Withdrawal by Subject|0
5158894|NCT01399619|17815021|P1|Overall Study|Withdrawal by Subject|6
5158895|NCT01399619|17815018|P4|Overall Study|Lack of Efficacy|0
5158896|NCT01399619|17815019|P3|Overall Study|Lack of Efficacy|5
5158897|NCT01399619|17815020|P2|Overall Study|Lack of Efficacy|0
5158898|NCT01399619|17815021|P1|Overall Study|Lack of Efficacy|9
5158899|NCT01399619|17815018|P4|Overall Study|Adverse Event|10
5158900|NCT01399619|17815019|P3|Overall Study|Adverse Event|4
5158901|NCT01399619|17815020|P2|Overall Study|Adverse Event|0
5158902|NCT01399619|17815021|P1|Overall Study|Adverse Event|10
5158903|NCT01399593|17815084|P2|Overall Study|Transplantectomy|1
5158904|NCT01399593|17815085|P1|Overall Study|Transplantectomy|0
5158905|NCT01399593|17815084|P2|Overall Study|Death|1
5158906|NCT01399593|17815085|P1|Overall Study|Death|1
5158907|NCT01399593|17815084|P2|Overall Study|Adverse Event|0
5158908|NCT01399593|17815085|P1|Overall Study|Adverse Event|1
5158909|NCT01399593|17815084|P2|Overall Study|Physician Decision|0
5158910|NCT01399593|17815085|P1|Overall Study|Physician Decision|1
5158911|NCT01399190|17815118|P1|Overall Study|Physician Decision|2
5158912|NCT01399190|17815118|P1|Overall Study|Participant's Request|5
5158913|NCT01399190|17815118|P1|Overall Study|Adverse Event|8
5158914|NCT01399190|17815118|P1|Overall Study|Not Eligible for Final Analysis|5
5158915|NCT01399125|17815126|P2|Overall Study|Protocol Deviation|2
5158916|NCT01399125|17815127|P1|Overall Study|Protocol Deviation|5
5158917|NCT01399125|17815126|P2|Overall Study|Death|1
5158918|NCT01399125|17815127|P1|Overall Study|Death|0
5158919|NCT01399125|17815126|P2|Overall Study|Administrative Problems|11
5158920|NCT01399125|17815127|P1|Overall Study|Administrative Problems|7
5158921|NCT01399125|17815126|P2|Overall Study|Lost to Follow-up|3
5158922|NCT01399125|17815127|P1|Overall Study|Lost to Follow-up|2
5158923|NCT01399125|17815126|P2|Overall Study|Withdrawal by Subject|8
5158924|NCT01399125|17815127|P1|Overall Study|Withdrawal by Subject|5
5158925|NCT01399125|17815126|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
5158926|NCT01399125|17815127|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
5158927|NCT01399125|17815126|P2|Overall Study|Abnormal Lab values|1
5158928|NCT01399125|17815127|P1|Overall Study|Abnormal Lab values|0
5158929|NCT01399125|17815126|P2|Overall Study|Adverse Event|30
5158930|NCT01399125|17815127|P1|Overall Study|Adverse Event|32
5158931|NCT01399099|17815141|P1|Overall Study|Miscellaneous|4
5158932|NCT01399099|17815141|P1|Overall Study|Infection|1
5158933|NCT01399099|17815141|P1|Overall Study|Skin Irritation|13
5158934|NCT01399099|17815141|P1|Overall Study|Protocol Violation|1
5158935|NCT01399099|17815141|P1|Overall Study|Physician Decision|1
5158936|NCT01399099|17815141|P1|Overall Study|Lost to Follow-up|11
5158937|NCT01399047|17815148|P2|Overall Study|Withdrawal by Subject|1
5158938|NCT01399047|17815149|P1|Overall Study|Withdrawal by Subject|0
5158939|NCT01398956|17815185|P1|Overall Study|Subject moved a long distance|1
5158940|NCT01398956|17815185|P1|Overall Study|Withdrawal Criteria No.3|1
5158941|NCT01398956|17815185|P1|Overall Study|AE, non-serious non-fatal|4
5158942|NCT01398956|17815185|P1|Overall Study|Withdrawal by Subject|4
5158943|NCT01398787|17815217|P1|Overall Study|Adverse Event|1
5158944|NCT01398514|17815235|P2|Overall Study|Failure to show a conditioned response|3
5158945|NCT01398514|17815236|P1|Overall Study|Failure to show a conditioned response|4
5158946|NCT01398514|17815235|P2|Overall Study|Physiologic non-responsiveness|3
5158947|NCT01398514|17815236|P1|Overall Study|Physiologic non-responsiveness|1
5158948|NCT01398514|17815235|P2|Overall Study|Non-compliance with study procedures|0
5158949|NCT01398514|17815236|P1|Overall Study|Non-compliance with study procedures|2
5158950|NCT01398514|17815235|P2|Overall Study|Adverse Event|0
5158951|NCT01398514|17815236|P1|Overall Study|Adverse Event|1
5158952|NCT01398410|17815271|P2|Overall Study|Other|29
5158953|NCT01398410|17815272|P1|Overall Study|Other|36
5158954|NCT01398410|17815271|P2|Overall Study|Inadequate Therapeutic Effect|0
5158955|NCT01398410|17815272|P1|Overall Study|Inadequate Therapeutic Effect|2
5158956|NCT01398410|17815271|P2|Overall Study|Participants Choice|11
5158957|NCT01398410|17815272|P1|Overall Study|Participants Choice|8
5158958|NCT01398410|17815271|P2|Overall Study|Adverse Event|16
5158959|NCT01398410|17815272|P1|Overall Study|Adverse Event|12
5158960|NCT01398358|17815283|P3|Overall Study|no longer eligible|1
5158961|NCT01398358|17815284|P2|Overall Study|no longer eligible|0
5158962|NCT01398358|17815285|P1|Overall Study|no longer eligible|1
5158963|NCT01398358|17815283|P3|Overall Study|Withdrawal by Subject|2
5158964|NCT01398358|17815284|P2|Overall Study|Withdrawal by Subject|2
5158965|NCT01398358|17815285|P1|Overall Study|Withdrawal by Subject|3
5158966|NCT01398358|17815283|P3|Overall Study|Lost to Follow-up|18
5158967|NCT01398358|17815284|P2|Overall Study|Lost to Follow-up|21
5158968|NCT01398358|17815285|P1|Overall Study|Lost to Follow-up|11
5158969|NCT01398176|17815307|P2|Overall Study|Physician Decision|3
5158970|NCT01398176|17815308|P1|Overall Study|Physician Decision|2
5158971|NCT01398176|17815307|P2|Overall Study|Lost to Follow-up|3
5158972|NCT01398176|17815308|P1|Overall Study|Lost to Follow-up|1
5158973|NCT01397890|17815341|P2|Overall Study|Others|1
5158974|NCT01397890|17815342|P1|Overall Study|Others|2
5158975|NCT01397890|17815341|P2|Overall Study|Severe Non-Compliance to Protocol|1
5158976|NCT01397890|17815342|P1|Overall Study|Severe Non-Compliance to Protocol|2
5158977|NCT01397890|17815341|P2|Overall Study|Adverse Event|2
5158978|NCT01397890|17815342|P1|Overall Study|Adverse Event|1
5158979|NCT01397890|17815341|P2|Overall Study|Condition under Investigation Worsened|3
5158980|NCT01397890|17815342|P1|Overall Study|Condition under Investigation Worsened|1
5158981|NCT01397890|17815341|P2|Overall Study|Lost to Follow-up|4
5158982|NCT01397890|17815342|P1|Overall Study|Lost to Follow-up|1
5158983|NCT01397890|17815341|P2|Overall Study|Death|3
5158984|NCT01397890|17815342|P1|Overall Study|Death|2
5158985|NCT01397890|17815341|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
5158986|NCT01397890|17815342|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
5158987|NCT01397890|17815341|P2|Overall Study|Withdrawal by Subject|11
5158988|NCT01397890|17815342|P1|Overall Study|Withdrawal by Subject|7
5158989|NCT01397825|17815413|P5|Overall Study|Withdrawal by Subject|0
5158990|NCT01397825|17815414|P4|Overall Study|Withdrawal by Subject|1
5158991|NCT01397825|17815415|P3|Overall Study|Withdrawal by Subject|5
5158992|NCT01397825|17815416|P2|Overall Study|Withdrawal by Subject|0
5158993|NCT01397825|17815417|P1|Overall Study|Withdrawal by Subject|1
5158994|NCT01397825|17815413|P5|Overall Study|Adverse Event|0
5158995|NCT01397825|17815414|P4|Overall Study|Adverse Event|1
5158996|NCT01397825|17815415|P3|Overall Study|Adverse Event|5
5158997|NCT01397825|17815416|P2|Overall Study|Adverse Event|1
5158998|NCT01397825|17815417|P1|Overall Study|Adverse Event|0
5158999|NCT01397825|17815413|P5|Overall Study|Symptomatic Deterioration|0
5159000|NCT01397825|17815414|P4|Overall Study|Symptomatic Deterioration|0
5159001|NCT01397825|17815415|P3|Overall Study|Symptomatic Deterioration|4
5159002|NCT01397825|17815416|P2|Overall Study|Symptomatic Deterioration|0
5159003|NCT01397825|17815417|P1|Overall Study|Symptomatic Deterioration|2
5159004|NCT01397825|17815413|P5|Overall Study|Progressive Disease|0
5159005|NCT01397825|17815414|P4|Overall Study|Progressive Disease|1
5159006|NCT01397825|17815415|P3|Overall Study|Progressive Disease|11
5159007|NCT01397825|17815416|P2|Overall Study|Progressive Disease|3
5159008|NCT01397825|17815417|P1|Overall Study|Progressive Disease|10
5159009|NCT01397786|17815487|P3|Phase B|Lack of Efficacy|14
5159010|NCT01397786|17815488|P2|Phase B|Lack of Efficacy|7
5159011|NCT01397786|17815489|P1|Phase B|Lack of Efficacy|22
5159012|NCT01397786|17815487|P3|Phase B|Protocol Deviation|4
5159013|NCT01397786|17815488|P2|Phase B|Protocol Deviation|2
5159014|NCT01397786|17815489|P1|Phase B|Protocol Deviation|1
5159015|NCT01397786|17815487|P3|Phase B|Withdrawal by Subject|30
5159016|NCT01397786|17815488|P2|Phase B|Withdrawal by Subject|45
5159017|NCT01397786|17815489|P1|Phase B|Withdrawal by Subject|102
5159018|NCT01397786|17815487|P3|Phase B|Physician Decision|3
5159019|NCT01397786|17815488|P2|Phase B|Physician Decision|1
5159020|NCT01397786|17815489|P1|Phase B|Physician Decision|9
5159021|NCT01397786|17815487|P3|Phase B|Subject Met Withdrawal Criteria|38
5159022|NCT01397786|17815488|P2|Phase B|Subject Met Withdrawal Criteria|5
5159023|NCT01397786|17815489|P1|Phase B|Subject Met Withdrawal Criteria|38
5159024|NCT01397786|17815487|P3|Phase B|Adverse Event|27
5159025|NCT01397786|17815488|P2|Phase B|Adverse Event|23
5159026|NCT01397786|17815489|P1|Phase B|Adverse Event|109
5159027|NCT01397786|17815487|P3|Phase B|Lost to Follow-up|22
5159028|NCT01397786|17815488|P2|Phase B|Lost to Follow-up|12
5159029|NCT01397786|17815489|P1|Phase B|Lost to Follow-up|22
5159030|NCT01397786|17815487|P3|Phase A|Lack of Efficacy|1
5159031|NCT01397786|17815488|P2|Phase A|Lack of Efficacy|0
5159032|NCT01397786|17815489|P1|Phase A|Lack of Efficacy|0
5159033|NCT01397786|17815487|P3|Phase A|Withdrawal by Subject|5
5159034|NCT01397786|17815488|P2|Phase A|Withdrawal by Subject|0
5159035|NCT01397786|17815489|P1|Phase A|Withdrawal by Subject|0
5159036|NCT01397786|17815487|P3|Phase A|Physician Decision|1
5159037|NCT01397786|17815488|P2|Phase A|Physician Decision|0
5159038|NCT01397786|17815489|P1|Phase A|Physician Decision|0
5159039|NCT01397786|17815487|P3|Phase A|Subject Met Withdrawal Criteria|7
5159040|NCT01397786|17815488|P2|Phase A|Subject Met Withdrawal Criteria|0
5159041|NCT01397786|17815489|P1|Phase A|Subject Met Withdrawal Criteria|0
5159042|NCT01397786|17815487|P3|Phase A|Adverse Event|8
5159043|NCT01397786|17815488|P2|Phase A|Adverse Event|0
5159044|NCT01397786|17815489|P1|Phase A|Adverse Event|0
5159045|NCT01397786|17815487|P3|Phase A|Lost to Follow-up|6
5159046|NCT01397786|17815488|P2|Phase A|Lost to Follow-up|0
5159047|NCT01397786|17815489|P1|Phase A|Lost to Follow-up|0
5159048|NCT01397747|17815555|P1|Overall Study|FIT excluded|34
5159049|NCT01397747|17815555|P1|Overall Study|Colonoscopy excluded|304
5159050|NCT01397747|17815555|P1|Overall Study|Multitarget DNA test excluded|689
5159051|NCT01397552|17815605|P2|Overall Study|Withdrawal by Subject|1
5159052|NCT01397552|17815606|P1|Overall Study|Withdrawal by Subject|2
5159053|NCT01397552|17815605|P2|Overall Study|Adverse Event|0
5159054|NCT01397552|17815606|P1|Overall Study|Adverse Event|1
5159055|NCT01397461|17815615|P3|Overall Study|Not treated|1
5159056|NCT01397461|17815616|P2|Overall Study|Not treated|0
5159057|NCT01397461|17815617|P1|Overall Study|Not treated|0
5159058|NCT01397461|17815615|P3|Overall Study|Lack of Efficacy|0
5159059|NCT01397461|17815616|P2|Overall Study|Lack of Efficacy|3
5159060|NCT01397461|17815617|P1|Overall Study|Lack of Efficacy|0
5159061|NCT01397461|17815615|P3|Overall Study|Lost to Follow-up|1
5159062|NCT01397461|17815616|P2|Overall Study|Lost to Follow-up|2
5159063|NCT01397461|17815617|P1|Overall Study|Lost to Follow-up|0
5159064|NCT01397461|17815615|P3|Overall Study|Withdrawal by Subject|0
5159065|NCT01397461|17815616|P2|Overall Study|Withdrawal by Subject|1
5159066|NCT01397461|17815617|P1|Overall Study|Withdrawal by Subject|2
5159067|NCT01397448|17815628|P3|Overall Study|Other|4
5159068|NCT01397448|17815629|P2|Overall Study|Other|7
5159069|NCT01397448|17815630|P1|Overall Study|Other|8
5159070|NCT01397448|17815628|P3|Overall Study|Lack of Efficacy|5
5159071|NCT01397448|17815629|P2|Overall Study|Lack of Efficacy|0
5159072|NCT01397448|17815630|P1|Overall Study|Lack of Efficacy|2
5159073|NCT01397448|17815628|P3|Overall Study|Withdrawal by Subject|3
5159074|NCT01397448|17815629|P2|Overall Study|Withdrawal by Subject|4
5159075|NCT01397448|17815630|P1|Overall Study|Withdrawal by Subject|4
5159076|NCT01397448|17815628|P3|Overall Study|Adverse Event|6
5159077|NCT01397448|17815629|P2|Overall Study|Adverse Event|4
5159078|NCT01397448|17815630|P1|Overall Study|Adverse Event|4
5159079|NCT01397422|17815645|P4|Overall Study|Increased bradykinesia related to PD|0
5159080|NCT01397422|17815646|P3|Overall Study|Increased bradykinesia related to PD|0
5159081|NCT01397422|17815647|P2|Overall Study|Increased bradykinesia related to PD|0
5159082|NCT01397422|17815648|P1|Overall Study|Increased bradykinesia related to PD|1
5159083|NCT01397422|17815645|P4|Overall Study|Withdrawal by Subject|0
5159084|NCT01397422|17815646|P3|Overall Study|Withdrawal by Subject|0
5159085|NCT01397422|17815647|P2|Overall Study|Withdrawal by Subject|0
5159086|NCT01397422|17815648|P1|Overall Study|Withdrawal by Subject|1
5159087|NCT01397422|17815645|P4|Overall Study|Adverse Event|8
5159088|NCT01397422|17815646|P3|Overall Study|Adverse Event|3
5159089|NCT01397422|17815647|P2|Overall Study|Adverse Event|3
5159090|NCT01397422|17815648|P1|Overall Study|Adverse Event|0
5159091|NCT01397409|17815688|P10|Stage 3|Other Miscellaneous Reasons|0
5159092|NCT01397409|17815689|P9|Stage 3|Other Miscellaneous Reasons|0
5159093|NCT01397409|17815690|P8|Stage 3|Other Miscellaneous Reasons|1
5159094|NCT01397409|17815691|P7|Stage 3|Other Miscellaneous Reasons|0
5159095|NCT01397409|17815692|P6|Stage 3|Other Miscellaneous Reasons|0
5159096|NCT01397409|17815693|P5|Stage 3|Other Miscellaneous Reasons|0
5159097|NCT01397409|17815694|P4|Stage 3|Other Miscellaneous Reasons|0
5159098|NCT01397409|17815695|P3|Stage 3|Other Miscellaneous Reasons|0
5159099|NCT01397409|17815696|P2|Stage 3|Other Miscellaneous Reasons|0
5159100|NCT01397409|17815697|P1|Stage 3|Other Miscellaneous Reasons|0
5159101|NCT01397409|17815688|P10|Stage 3|Adverse Event|0
5159102|NCT01397409|17815689|P9|Stage 3|Adverse Event|0
5159103|NCT01397409|17815690|P8|Stage 3|Adverse Event|1
5159104|NCT01397409|17815691|P7|Stage 3|Adverse Event|0
5159105|NCT01397409|17815692|P6|Stage 3|Adverse Event|0
5159106|NCT01397409|17815693|P5|Stage 3|Adverse Event|0
5159107|NCT01397409|17815694|P4|Stage 3|Adverse Event|0
5159108|NCT01397409|17815695|P3|Stage 3|Adverse Event|0
5159109|NCT01397409|17815696|P2|Stage 3|Adverse Event|0
5159110|NCT01397409|17815697|P1|Stage 3|Adverse Event|0
5159111|NCT01397409|17815688|P10|Stage 2|Other Miscellaneous Reasons|0
5159112|NCT01397409|17815689|P9|Stage 2|Other Miscellaneous Reasons|0
5159113|NCT01397409|17815690|P8|Stage 2|Other Miscellaneous Reasons|0
5159114|NCT01397409|17815691|P7|Stage 2|Other Miscellaneous Reasons|0
5159115|NCT01397409|17815692|P6|Stage 2|Other Miscellaneous Reasons|1
5159116|NCT01397409|17815693|P5|Stage 2|Other Miscellaneous Reasons|1
5159117|NCT01397409|17815694|P4|Stage 2|Other Miscellaneous Reasons|0
5159118|NCT01397409|17815695|P3|Stage 2|Other Miscellaneous Reasons|0
5159119|NCT01397409|17815696|P2|Stage 2|Other Miscellaneous Reasons|0
5159120|NCT01397409|17815697|P1|Stage 2|Other Miscellaneous Reasons|0
5159121|NCT01397409|17815688|P10|Stage 2|Personal Reasons|0
5159122|NCT01397409|17815689|P9|Stage 2|Personal Reasons|0
5159123|NCT01397409|17815690|P8|Stage 2|Personal Reasons|0
5159124|NCT01397409|17815691|P7|Stage 2|Personal Reasons|0
5159125|NCT01397409|17815692|P6|Stage 2|Personal Reasons|0
5159126|NCT01397409|17815693|P5|Stage 2|Personal Reasons|1
5159127|NCT01397409|17815694|P4|Stage 2|Personal Reasons|0
5159128|NCT01397409|17815695|P3|Stage 2|Personal Reasons|0
5159129|NCT01397409|17815696|P2|Stage 2|Personal Reasons|0
5159130|NCT01397409|17815697|P1|Stage 2|Personal Reasons|0
5159131|NCT01397409|17815688|P10|Stage 2|Adverse Event|0
5159132|NCT01397409|17815689|P9|Stage 2|Adverse Event|0
5159133|NCT01397409|17815690|P8|Stage 2|Adverse Event|0
5159134|NCT01397409|17815691|P7|Stage 2|Adverse Event|0
5159135|NCT01397409|17815692|P6|Stage 2|Adverse Event|3
5159136|NCT01397409|17815693|P5|Stage 2|Adverse Event|6
5159137|NCT01397409|17815694|P4|Stage 2|Adverse Event|0
5159138|NCT01397409|17815695|P3|Stage 2|Adverse Event|0
5159139|NCT01397409|17815696|P2|Stage 2|Adverse Event|0
5159140|NCT01397409|17815697|P1|Stage 2|Adverse Event|0
5159141|NCT01397253|17815737|P2|Overall Study|Reviewed by only 1 pharmacist|149
5159142|NCT01397253|17815738|P1|Overall Study|Reviewed by only 1 pharmacist|126
5159143|NCT01397084|17815744|P1|Overall Study|Used other proton pump inhibitor|1
5159144|NCT01397084|17815744|P1|Overall Study|Lost to Follow-up|1
5159145|NCT01397084|17815744|P1|Overall Study|Withdrawal by Subject|1
5159146|NCT01397084|17815744|P1|Overall Study|Adverse Event|2
5159147|NCT01397084|17815744|P1|Overall Study|Protocol Violation|2
5159148|NCT01397084|17815744|P1|Overall Study|Severe Non-Compliance to Protocol|1
5159149|NCT01396525|17815770|P1|Overall Study|Lost to Follow-up|4
5159150|NCT01396525|17815770|P1|Overall Study|Death|14
5159151|NCT01396525|17815770|P1|Overall Study|Withdrawal by Subject|8
5159152|NCT01396512|17815870|P2|Overall Study|Withdrawal by Subject|1
5159153|NCT01396512|17815871|P1|Overall Study|Withdrawal by Subject|0
5159154|NCT01396447|17815903|P4|Overall Study|Other Miscellaneous Reasons|0
5159155|NCT01396447|17815904|P3|Overall Study|Other Miscellaneous Reasons|1
5159156|NCT01396447|17815905|P2|Overall Study|Other Miscellaneous Reasons|2
5159157|NCT01396447|17815906|P1|Overall Study|Other Miscellaneous Reasons|0
5159158|NCT01396447|17815903|P4|Overall Study|Lost to Follow-up|9
5159159|NCT01396447|17815904|P3|Overall Study|Lost to Follow-up|7
5159160|NCT01396447|17815905|P2|Overall Study|Lost to Follow-up|8
5159161|NCT01396447|17815906|P1|Overall Study|Lost to Follow-up|4
5159162|NCT01396447|17815903|P4|Overall Study|Withdrawal of Consent|15
5159163|NCT01396447|17815904|P3|Overall Study|Withdrawal of Consent|4
5159164|NCT01396447|17815905|P2|Overall Study|Withdrawal of Consent|9
5159165|NCT01396447|17815906|P1|Overall Study|Withdrawal of Consent|11
5159166|NCT01396447|17815903|P4|Overall Study|Protocol Violation|7
5159167|NCT01396447|17815904|P3|Overall Study|Protocol Violation|3
5159168|NCT01396447|17815905|P2|Overall Study|Protocol Violation|2
5159169|NCT01396447|17815906|P1|Overall Study|Protocol Violation|5
5159170|NCT01396447|17815903|P4|Overall Study|Insufficient Therapeutic Response|4
5159171|NCT01396447|17815904|P3|Overall Study|Insufficient Therapeutic Response|2
5159172|NCT01396447|17815905|P2|Overall Study|Insufficient Therapeutic Response|5
5159173|NCT01396447|17815906|P1|Overall Study|Insufficient Therapeutic Response|5
5159174|NCT01396447|17815903|P4|Overall Study|Adverse Event|17
5159175|NCT01396447|17815904|P3|Overall Study|Adverse Event|12
5159176|NCT01396447|17815905|P2|Overall Study|Adverse Event|12
5159177|NCT01396447|17815906|P1|Overall Study|Adverse Event|15
5159178|NCT01396447|17815903|P4|Overall Study|Did Not Receive Treatment|0
5159179|NCT01396447|17815904|P3|Overall Study|Did Not Receive Treatment|1
5159180|NCT01396447|17815905|P2|Overall Study|Did Not Receive Treatment|2
5159181|NCT01396447|17815906|P1|Overall Study|Did Not Receive Treatment|3
5159182|NCT01396434|17815923|P3|Overall Study|Other|0
5159183|NCT01396434|17815924|P2|Overall Study|Other|0
5159184|NCT01396434|17815925|P1|Overall Study|Other|10
5159185|NCT01396434|17815923|P3|Overall Study|Lost to Follow-up|0
5159186|NCT01396434|17815924|P2|Overall Study|Lost to Follow-up|0
5159187|NCT01396434|17815925|P1|Overall Study|Lost to Follow-up|1
5159188|NCT01396421|17815937|P4|Overall Study|Lack of Efficacy|18
5159189|NCT01396421|17815938|P3|Overall Study|Lack of Efficacy|7
5159190|NCT01396421|17815939|P2|Overall Study|Lack of Efficacy|17
5159191|NCT01396421|17815940|P1|Overall Study|Lack of Efficacy|7
5159192|NCT01396421|17815937|P4|Overall Study|Protocol Deviation|0
5159193|NCT01396421|17815938|P3|Overall Study|Protocol Deviation|1
5159194|NCT01396421|17815939|P2|Overall Study|Protocol Deviation|1
5159195|NCT01396421|17815940|P1|Overall Study|Protocol Deviation|2
5159196|NCT01396421|17815937|P4|Overall Study|Withdrawal by Subject|21
5159197|NCT01396421|17815938|P3|Overall Study|Withdrawal by Subject|13
5159198|NCT01396421|17815939|P2|Overall Study|Withdrawal by Subject|24
5159199|NCT01396421|17815940|P1|Overall Study|Withdrawal by Subject|31
5159200|NCT01396421|17815937|P4|Overall Study|Physician Decision|3
5159201|NCT01396421|17815938|P3|Overall Study|Physician Decision|0
5159202|NCT01396421|17815939|P2|Overall Study|Physician Decision|1
5159203|NCT01396421|17815940|P1|Overall Study|Physician Decision|1
5159204|NCT01396421|17815937|P4|Overall Study|Participant Met Withdrawal Criteria|0
5159205|NCT01396421|17815938|P3|Overall Study|Participant Met Withdrawal Criteria|1
5159206|NCT01396421|17815939|P2|Overall Study|Participant Met Withdrawal Criteria|0
5159207|NCT01396421|17815940|P1|Overall Study|Participant Met Withdrawal Criteria|1
5159208|NCT01396421|17815937|P4|Overall Study|Adverse Event|32
5159209|NCT01396421|17815938|P3|Overall Study|Adverse Event|12
5159210|NCT01396421|17815939|P2|Overall Study|Adverse Event|15
5159211|NCT01396421|17815940|P1|Overall Study|Adverse Event|17
5159212|NCT01396421|17815937|P4|Overall Study|Lost to Follow-up|1
5159213|NCT01396421|17815938|P3|Overall Study|Lost to Follow-up|0
5159214|NCT01396421|17815939|P2|Overall Study|Lost to Follow-up|0
5159215|NCT01396421|17815940|P1|Overall Study|Lost to Follow-up|0
5159216|NCT01396395|17816012|P2|Overall Study|Other|1
5159217|NCT01396395|17816013|P1|Overall Study|Other|0
5159218|NCT01396395|17816012|P2|Overall Study|Lost to Follow-up|11
5159219|NCT01396395|17816013|P1|Overall Study|Lost to Follow-up|17
5159220|NCT01396395|17816012|P2|Overall Study|Adverse Event|2
5159221|NCT01396395|17816013|P1|Overall Study|Adverse Event|10
5159222|NCT01396395|17816012|P2|Overall Study|Protocol Violation|1
5159223|NCT01396395|17816013|P1|Overall Study|Protocol Violation|3
5159224|NCT01396395|17816012|P2|Overall Study|Withdrawal by Subject|12
5159225|NCT01396395|17816013|P1|Overall Study|Withdrawal by Subject|10
5159226|NCT01396317|17816055|P2|Overall Study|Adverse Event|0
5159227|NCT01396317|17816056|P1|Overall Study|Adverse Event|1
5159228|NCT01396265|17816070|P1|Rifa+Afatinib|Withdrawal by Subject|1
5159229|NCT01396187|17816159|P5|Overall Study|Other|1
5159230|NCT01396187|17816160|P4|Overall Study|Other|0
5159231|NCT01396187|17816161|P3|Overall Study|Other|0
5159232|NCT01396187|17816162|P2|Overall Study|Other|1
5159233|NCT01396187|17816163|P1|Overall Study|Other|1
5159234|NCT01396187|17816159|P5|Overall Study|Withdrawal by Subject|0
5159235|NCT01396187|17816160|P4|Overall Study|Withdrawal by Subject|0
5159236|NCT01396187|17816161|P3|Overall Study|Withdrawal by Subject|1
5159237|NCT01396187|17816162|P2|Overall Study|Withdrawal by Subject|1
5159238|NCT01396187|17816163|P1|Overall Study|Withdrawal by Subject|0
5159239|NCT01396187|17816159|P5|Overall Study|Adverse Event|0
5159240|NCT01396187|17816160|P4|Overall Study|Adverse Event|0
5159241|NCT01396187|17816161|P3|Overall Study|Adverse Event|0
5159242|NCT01396187|17816162|P2|Overall Study|Adverse Event|1
5159243|NCT01396187|17816163|P1|Overall Study|Adverse Event|0
5159244|NCT01396161|17816263|P7|Overall Study|Other|1
5159245|NCT01396161|17816264|P6|Overall Study|Other|0
5159246|NCT01396161|17816265|P5|Overall Study|Other|0
5159247|NCT01396161|17816266|P4|Overall Study|Other|0
5159248|NCT01396161|17816267|P3|Overall Study|Other|0
5159249|NCT01396161|17816268|P2|Overall Study|Other|0
5159250|NCT01396161|17816269|P1|Overall Study|Other|0
5159251|NCT01396161|17816263|P7|Overall Study|Withdrawal by Subject|0
5159252|NCT01396161|17816264|P6|Overall Study|Withdrawal by Subject|0
5159253|NCT01396161|17816265|P5|Overall Study|Withdrawal by Subject|1
5159254|NCT01396161|17816266|P4|Overall Study|Withdrawal by Subject|0
5159255|NCT01396161|17816267|P3|Overall Study|Withdrawal by Subject|0
5159256|NCT01396161|17816268|P2|Overall Study|Withdrawal by Subject|0
5159257|NCT01396161|17816269|P1|Overall Study|Withdrawal by Subject|0
5159258|NCT01396148|17816322|P1|Overall Study|Patient Decision|1
5159259|NCT01396083|17816352|P2|Overall Study|Lost to Follow-up|0
5159260|NCT01396083|17816353|P1|Overall Study|Lost to Follow-up|1
5159261|NCT01396083|17816352|P2|Overall Study|Administrative problems|0
5159262|NCT01396083|17816353|P1|Overall Study|Administrative problems|1
5159263|NCT01396083|17816352|P2|Overall Study|Abnormal laboratory value(s)|0
5159264|NCT01396083|17816353|P1|Overall Study|Abnormal laboratory value(s)|1
5159265|NCT01396083|17816352|P2|Overall Study|Protocol deviation(s)|1
5159266|NCT01396083|17816353|P1|Overall Study|Protocol deviation(s)|0
5159267|NCT01396083|17816352|P2|Overall Study|Consent withdrawn|5
5159268|NCT01396083|17816353|P1|Overall Study|Consent withdrawn|4
5159269|NCT01396083|17816352|P2|Overall Study|Unsatisfactory therapeutic effect|13
5159270|NCT01396083|17816353|P1|Overall Study|Unsatisfactory therapeutic effect|2
5159271|NCT01396083|17816352|P2|Overall Study|Adverse Event|28
5159272|NCT01396083|17816353|P1|Overall Study|Adverse Event|2
5159273|NCT01396070|17816377|P1|Overall Study|Lack of Efficacy|4
5159274|NCT01396070|17816377|P1|Overall Study|Physician Decision|3
5159275|NCT01396070|17816377|P1|Overall Study|Adverse Event|8
5159276|NCT01396070|17816377|P1|Overall Study|Death|2
5159277|NCT01396070|17816377|P1|Overall Study|Withdrawal by Subject|2
5159278|NCT01396057|17816386|P2|Overall Study|Consent withdrawn|2
5159279|NCT01396057|17816387|P1|Overall Study|Consent withdrawn|3
5159280|NCT01396057|17816386|P2|Overall Study|Protocol deviation|4
5159281|NCT01396057|17816387|P1|Overall Study|Protocol deviation|4
5159282|NCT01396057|17816386|P2|Overall Study|Unsatisfactory therapeutic effect|6
5159283|NCT01396057|17816387|P1|Overall Study|Unsatisfactory therapeutic effect|2
5159284|NCT01396057|17816386|P2|Overall Study|Adverse Event|6
5159285|NCT01396057|17816387|P1|Overall Study|Adverse Event|2
5159286|NCT01396005|17816436|P2|Overall Study|Non-compliance with protocol|1
5159287|NCT01396005|17816437|P1|Overall Study|Non-compliance with protocol|0
5159288|NCT01396005|17816436|P2|Overall Study|Withdrawal by Subject|1
5159289|NCT01396005|17816437|P1|Overall Study|Withdrawal by Subject|0
5159290|NCT01395914|17816468|P2|Overall Study|Lost to Follow-up|2
5159291|NCT01395914|17816469|P1|Overall Study|Lost to Follow-up|6
5159292|NCT01395914|17816468|P2|Overall Study|Study drug-related AE|0
5159293|NCT01395914|17816469|P1|Overall Study|Study drug-related AE|1
5159294|NCT01395914|17816468|P2|Overall Study|Withdrawal by patient|14
5159295|NCT01395914|17816469|P1|Overall Study|Withdrawal by patient|27
5159296|NCT01395914|17816468|P2|Overall Study|Other|3
5159297|NCT01395914|17816469|P1|Overall Study|Other|9
5159298|NCT01395914|17816468|P2|Overall Study|Death|17
5159299|NCT01395914|17816469|P1|Overall Study|Death|23
5159300|NCT01395914|17816468|P2|Overall Study|Unrelated to study drug AE|1
5159301|NCT01395914|17816469|P1|Overall Study|Unrelated to study drug AE|6
5159302|NCT01395901|17816483|P2|Overall Study|Withdrawal of consent|0
5159303|NCT01395901|17816484|P1|Overall Study|Withdrawal of consent|1
5159304|NCT01395901|17816483|P2|Overall Study|Adverse Event|1
5159305|NCT01395901|17816484|P1|Overall Study|Adverse Event|0
5159306|NCT01395901|17816483|P2|Overall Study|Randomized but not received study drug|4
5159307|NCT01395901|17816484|P1|Overall Study|Randomized but not received study drug|5
5159308|NCT01395901|17816483|P2|Overall Study|Lost to Follow-up|0
5159309|NCT01395901|17816484|P1|Overall Study|Lost to Follow-up|4
5159310|NCT01395888|17816500|P3|Treatment Period (TP)|Withdrawal by Subject|3
5159311|NCT01395888|17816501|P2|Treatment Period (TP)|Withdrawal by Subject|2
5159312|NCT01395888|17816502|P1|Treatment Period (TP)|Withdrawal by Subject|0
5159313|NCT01395888|17816500|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
5159314|NCT01395888|17816501|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
5159315|NCT01395888|17816502|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
5159316|NCT01395888|17816500|P3|Treatment Period (TP)|Protocol Violation|5
5159317|NCT01395888|17816501|P2|Treatment Period (TP)|Protocol Violation|1
5159318|NCT01395888|17816502|P1|Treatment Period (TP)|Protocol Violation|0
5159319|NCT01395888|17816500|P3|Treatment Period (TP)|Lack of Efficacy|3
5159320|NCT01395888|17816501|P2|Treatment Period (TP)|Lack of Efficacy|4
5159321|NCT01395888|17816502|P1|Treatment Period (TP)|Lack of Efficacy|0
5159322|NCT01395888|17816500|P3|Treatment Period (TP)|Adverse Event|6
5159323|NCT01395888|17816501|P2|Treatment Period (TP)|Adverse Event|7
5159324|NCT01395888|17816502|P1|Treatment Period (TP)|Adverse Event|0
5159325|NCT01395888|17816500|P3|2-week Run-in Period|Withdrawal by Subject|0
5159326|NCT01395888|17816501|P2|2-week Run-in Period|Withdrawal by Subject|0
5159327|NCT01395888|17816502|P1|2-week Run-in Period|Withdrawal by Subject|4
5159328|NCT01395888|17816500|P3|2-week Run-in Period|Protocol Violation|0
5159329|NCT01395888|17816501|P2|2-week Run-in Period|Protocol Violation|0
5159330|NCT01395888|17816502|P1|2-week Run-in Period|Protocol Violation|2
5159331|NCT01395888|17816500|P3|2-week Run-in Period|Lost to Follow-up|0
5159332|NCT01395888|17816501|P2|2-week Run-in Period|Lost to Follow-up|0
5159333|NCT01395888|17816502|P1|2-week Run-in Period|Lost to Follow-up|1
5159334|NCT01395888|17816500|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5159335|NCT01395888|17816501|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5159336|NCT01395888|17816502|P1|2-week Run-in Period|Continuation Criteria Not Met|13
5159337|NCT01395888|17816500|P3|2-week Run-in Period|Adverse Event|0
5159338|NCT01395888|17816501|P2|2-week Run-in Period|Adverse Event|0
5159339|NCT01395888|17816502|P1|2-week Run-in Period|Adverse Event|2
5159340|NCT01395823|17816510|P2|Overall Study|Withdrawal by Subject|4
5159341|NCT01395823|17816511|P1|Overall Study|Withdrawal by Subject|5
5159342|NCT01395823|17816510|P2|Overall Study|GI symptoms|0
5159343|NCT01395823|17816511|P1|Overall Study|GI symptoms|1
5159344|NCT01395823|17816510|P2|Overall Study|Transplant|0
5159345|NCT01395823|17816511|P1|Overall Study|Transplant|1
5159346|NCT01395823|17816510|P2|Overall Study|Lost to Follow-up|0
5159347|NCT01395823|17816511|P1|Overall Study|Lost to Follow-up|1
5159348|NCT01395823|17816510|P2|Overall Study|Physician Decision|1
5159349|NCT01395823|17816511|P1|Overall Study|Physician Decision|3
5159350|NCT01395823|17816510|P2|Overall Study|Death|4
5159351|NCT01395823|17816511|P1|Overall Study|Death|4
5159352|NCT01395810|17816521|P4|Overall Study|Unclassified|0
5159353|NCT01395810|17816522|P3|Overall Study|Unclassified|0
5159354|NCT01395810|17816523|P2|Overall Study|Unclassified|0
5159355|NCT01395810|17816524|P1|Overall Study|Unclassified|2
5159356|NCT01395810|17816521|P4|Overall Study|Withdrawal criteria|0
5159357|NCT01395810|17816522|P3|Overall Study|Withdrawal criteria|0
5159358|NCT01395810|17816523|P2|Overall Study|Withdrawal criteria|2
5159359|NCT01395810|17816524|P1|Overall Study|Withdrawal criteria|0
5159360|NCT01395810|17816521|P4|Overall Study|Lack of Efficacy|0
5159361|NCT01395810|17816522|P3|Overall Study|Lack of Efficacy|0
5159362|NCT01395810|17816523|P2|Overall Study|Lack of Efficacy|1
5159363|NCT01395810|17816524|P1|Overall Study|Lack of Efficacy|0
5159364|NCT01395810|17816521|P4|Overall Study|Adverse Event|0
5159365|NCT01395810|17816522|P3|Overall Study|Adverse Event|0
5159366|NCT01395810|17816523|P2|Overall Study|Adverse Event|1
5159367|NCT01395810|17816524|P1|Overall Study|Adverse Event|0
5159368|NCT01395784|17816583|P1|Overall Study|Physician Decision|5
5159369|NCT01395784|17816583|P1|Overall Study|Withdrawal by Subject|3
5159370|NCT01395784|17816583|P1|Overall Study|Lost to Follow-up|7
5159371|NCT01395758|17816590|P3|Open-label Treatment Period|Withdrawal by Subject|0
5159372|NCT01395758|17816591|P2|Open-label Treatment Period|Withdrawal by Subject|0
5159373|NCT01395758|17816592|P1|Open-label Treatment Period|Withdrawal by Subject|4
5159374|NCT01395524|17816612|P3|Overall Study|Subject had spinal surgery|1
5159375|NCT01395524|17816613|P2|Overall Study|Subject had spinal surgery|0
5159376|NCT01395524|17816614|P1|Overall Study|Subject had spinal surgery|0
5159377|NCT01395524|17816612|P3|Overall Study|Did not receive treatment|3
5159378|NCT01395524|17816613|P2|Overall Study|Did not receive treatment|1
5159379|NCT01395524|17816614|P1|Overall Study|Did not receive treatment|1
5159380|NCT01395524|17816612|P3|Overall Study|Withdrawal by Subject|8
5159381|NCT01395524|17816613|P2|Overall Study|Withdrawal by Subject|8
5159382|NCT01395524|17816614|P1|Overall Study|Withdrawal by Subject|4
5159383|NCT01395524|17816612|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
5159384|NCT01395524|17816613|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5159385|NCT01395524|17816614|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
5159386|NCT01395524|17816612|P3|Overall Study|Death|0
5159387|NCT01395524|17816613|P2|Overall Study|Death|0
5159388|NCT01395524|17816614|P1|Overall Study|Death|1
5159389|NCT01395524|17816612|P3|Overall Study|Adverse Event|3
5159390|NCT01395524|17816613|P2|Overall Study|Adverse Event|4
5159391|NCT01395524|17816614|P1|Overall Study|Adverse Event|4
5159392|NCT01395524|17816612|P3|Overall Study|Severe noncompliance with protocol|0
5159393|NCT01395524|17816613|P2|Overall Study|Severe noncompliance with protocol|0
5159394|NCT01395524|17816614|P1|Overall Study|Severe noncompliance with protocol|1
5159395|NCT01395524|17816612|P3|Overall Study|Study-Specific Withdrawal Criteria|0
5159396|NCT01395524|17816613|P2|Overall Study|Study-Specific Withdrawal Criteria|2
5159397|NCT01395524|17816614|P1|Overall Study|Study-Specific Withdrawal Criteria|1
5159398|NCT01395524|17816612|P3|Overall Study|Lost to Follow-up|1
5159399|NCT01395524|17816613|P2|Overall Study|Lost to Follow-up|1
5159400|NCT01395524|17816614|P1|Overall Study|Lost to Follow-up|3
5159401|NCT01395524|17816612|P3|Overall Study|Non-compliance with study schedule|1
5159402|NCT01395524|17816613|P2|Overall Study|Non-compliance with study schedule|0
5159403|NCT01395524|17816614|P1|Overall Study|Non-compliance with study schedule|1
5159404|NCT01395394|17816637|P3|Baseline Study Visit|Protocol Violation|0
5159405|NCT01395394|17816638|P2|Baseline Study Visit|Protocol Violation|0
5159406|NCT01395394|17816639|P1|Baseline Study Visit|Protocol Violation|1
5159407|NCT01395368|17816650|P1|Overall Study|Withdrawal by Subject|2
5159408|NCT01395368|17816650|P1|Overall Study|Physician Decision|14
5159409|NCT01395316|17816706|P1|Overall Study|poor MRI quality|1
5159410|NCT01395316|17816706|P1|Overall Study|Lost to Follow-up|2
5159411|NCT01395030|17816726|P1|Overall Study|Did not complete FCH PET/CT|7
5159412|NCT01395017|17816736|P2|Overall Study|Sponsor discontinued study|4
5159413|NCT01395017|17816737|P1|Overall Study|Sponsor discontinued study|1
5159414|NCT01395017|17816736|P2|Overall Study|Disease progression|58
5159415|NCT01395017|17816737|P1|Overall Study|Disease progression|42
5159416|NCT01395017|17816736|P2|Overall Study|Death|3
5159417|NCT01395017|17816737|P1|Overall Study|Death|4
5159418|NCT01395017|17816736|P2|Overall Study|Protocol deviation|2
5159419|NCT01395017|17816737|P1|Overall Study|Protocol deviation|1
5159420|NCT01395017|17816736|P2|Overall Study|Withdrawal by Subject|8
5159421|NCT01395017|17816737|P1|Overall Study|Withdrawal by Subject|14
5159422|NCT01395017|17816736|P2|Overall Study|Physician Decision|15
5159423|NCT01395017|17816737|P1|Overall Study|Physician Decision|11
5159424|NCT01395017|17816736|P2|Overall Study|Adverse Event|12
5159425|NCT01395017|17816737|P1|Overall Study|Adverse Event|26
5159426|NCT01395017|17816736|P2|Overall Study|Lost to Follow-up|0
5159427|NCT01395017|17816737|P1|Overall Study|Lost to Follow-up|1
5159428|NCT01394991|17816747|P2|Overall Study|Prematurely Termination of Trial|10
5159429|NCT01394991|17816748|P1|Overall Study|Prematurely Termination of Trial|9
5159430|NCT01394991|17816747|P2|Overall Study|Disease Progression|7
5159431|NCT01394991|17816748|P1|Overall Study|Disease Progression|7
5159432|NCT01394991|17816747|P2|Overall Study|Chemotherapy Termination|15
5159433|NCT01394991|17816748|P1|Overall Study|Chemotherapy Termination|10
5159434|NCT01394991|17816747|P2|Overall Study|Withdrawal by Subject|17
5159435|NCT01394991|17816748|P1|Overall Study|Withdrawal by Subject|20
5159436|NCT01394991|17816747|P2|Overall Study|Protocol Violation|1
5159437|NCT01394991|17816748|P1|Overall Study|Protocol Violation|1
5159438|NCT01394991|17816747|P2|Overall Study|Physician Decision|3
5159439|NCT01394991|17816748|P1|Overall Study|Physician Decision|1
5159440|NCT01394991|17816747|P2|Overall Study|Lost to Follow-up|8
5159441|NCT01394991|17816748|P1|Overall Study|Lost to Follow-up|6
5159442|NCT01394991|17816747|P2|Overall Study|Lack of Efficacy|7
5159443|NCT01394991|17816748|P1|Overall Study|Lack of Efficacy|5
5159444|NCT01394991|17816747|P2|Overall Study|Adverse Event|4
5159445|NCT01394991|17816748|P1|Overall Study|Adverse Event|0
5159446|NCT01394978|17816770|P2|Overall Study|Death|7
5159447|NCT01394978|17816771|P1|Overall Study|Death|6
5159448|NCT01394978|17816770|P2|Overall Study|Lost to Follow-up|20
5159449|NCT01394978|17816771|P1|Overall Study|Lost to Follow-up|13
5159450|NCT01394978|17816770|P2|Overall Study|Withdrawal by Subject|4
5159451|NCT01394978|17816771|P1|Overall Study|Withdrawal by Subject|2
5159452|NCT01394952|17816779|P2|Overall Study|Sponsor Decision|7
5159453|NCT01394952|17816780|P1|Overall Study|Sponsor Decision|5
5159454|NCT01394952|17816779|P2|Overall Study|Physician Decision|0
5159455|NCT01394952|17816780|P1|Overall Study|Physician Decision|2
5159456|NCT01394952|17816779|P2|Overall Study|Withdrawal by Subject|5
5159457|NCT01394952|17816780|P1|Overall Study|Withdrawal by Subject|10
5159458|NCT01394952|17816779|P2|Overall Study|Lost to Follow-up|5
5159459|NCT01394952|17816780|P1|Overall Study|Lost to Follow-up|0
5159460|NCT01394718|17816807|P2|Overall Study|Met protocol-specific stopping criteria|1
5159461|NCT01394718|17816808|P1|Overall Study|Met protocol-specific stopping criteria|2
5159462|NCT01394627|17816840|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
5159463|NCT01394627|17816841|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
5159464|NCT01394627|17816840|P2|First Intervention (1 Day)|poor intravenous access|1
5159465|NCT01394627|17816841|P1|First Intervention (1 Day)|poor intravenous access|0
5159466|NCT01394523|17816861|P3|Overall Study|Unable to place block|0
5159467|NCT01394523|17816862|P2|Overall Study|Unable to place block|0
5159468|NCT01394523|17816863|P1|Overall Study|Unable to place block|1
5159469|NCT01394276|17816877|P1|Overall Study|Symptoms of concurrent diseases|1
5159470|NCT01394276|17816877|P1|Overall Study|unavailability of drug at the Hospital|2
5159471|NCT01394276|17816877|P1|Overall Study|Pregnancy|1
5159472|NCT01394276|17816877|P1|Overall Study|Participant moved to another site|1
5159473|NCT01394276|17816877|P1|Overall Study|Lost to Follow-up|5
5159474|NCT01394276|17816877|P1|Overall Study|Insufficient compliance|9
5159475|NCT01394276|17816877|P1|Overall Study|Insufficient therapeutic effect|17
5159476|NCT01394276|17816877|P1|Overall Study|Remission of disease|2
5159477|NCT01394276|17816877|P1|Overall Study|Not related AEs|9
5159478|NCT01394276|17816877|P1|Overall Study|Related Adverse event (AEs)|15
5159479|NCT01394250|17816901|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
5159480|NCT01394250|17816902|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
5159481|NCT01394250|17816901|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
5159482|NCT01394250|17816902|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
5159483|NCT01394185|17816916|P6|Overall Study|Protocol Violation|1
5159484|NCT01394185|17816917|P5|Overall Study|Protocol Violation|0
5159485|NCT01394185|17816918|P4|Overall Study|Protocol Violation|1
5159486|NCT01394185|17816919|P3|Overall Study|Protocol Violation|0
5159487|NCT01394185|17816920|P2|Overall Study|Protocol Violation|0
5159488|NCT01394185|17816921|P1|Overall Study|Protocol Violation|1
5159489|NCT01394185|17816916|P6|Overall Study|Change in protocol|0
5159490|NCT01394185|17816917|P5|Overall Study|Change in protocol|3
5159491|NCT01394185|17816918|P4|Overall Study|Change in protocol|0
5159492|NCT01394185|17816919|P3|Overall Study|Change in protocol|0
5159493|NCT01394185|17816920|P2|Overall Study|Change in protocol|0
5159494|NCT01394185|17816921|P1|Overall Study|Change in protocol|3
5159495|NCT01394185|17816916|P6|Overall Study|Withdrawal by Subject|0
5159496|NCT01394185|17816917|P5|Overall Study|Withdrawal by Subject|1
5159497|NCT01394185|17816918|P4|Overall Study|Withdrawal by Subject|0
5159498|NCT01394185|17816919|P3|Overall Study|Withdrawal by Subject|0
5159499|NCT01394185|17816920|P2|Overall Study|Withdrawal by Subject|0
5159500|NCT01394185|17816921|P1|Overall Study|Withdrawal by Subject|2
5159501|NCT01393990|17817025|P18|Overall Study|Withdrawal by Subject|0
5159502|NCT01393990|17817026|P17|Overall Study|Withdrawal by Subject|0
5159503|NCT01393990|17817027|P16|Overall Study|Withdrawal by Subject|1
5159504|NCT01393990|17817028|P15|Overall Study|Withdrawal by Subject|1
5159505|NCT01393990|17817029|P14|Overall Study|Withdrawal by Subject|0
5159506|NCT01393990|17817030|P13|Overall Study|Withdrawal by Subject|0
5159507|NCT01393990|17817031|P12|Overall Study|Withdrawal by Subject|0
5159508|NCT01393990|17817032|P11|Overall Study|Withdrawal by Subject|0
5159509|NCT01393990|17817033|P10|Overall Study|Withdrawal by Subject|0
5159510|NCT01393990|17817034|P9|Overall Study|Withdrawal by Subject|0
5159511|NCT01393990|17817035|P8|Overall Study|Withdrawal by Subject|0
5159512|NCT01393990|17817036|P7|Overall Study|Withdrawal by Subject|0
5159513|NCT01393990|17817037|P6|Overall Study|Withdrawal by Subject|0
5159514|NCT01393990|17817038|P5|Overall Study|Withdrawal by Subject|0
5159515|NCT01393990|17817039|P4|Overall Study|Withdrawal by Subject|0
5159516|NCT01393990|17817040|P3|Overall Study|Withdrawal by Subject|0
5159517|NCT01393990|17817041|P2|Overall Study|Withdrawal by Subject|0
5159518|NCT01393990|17817042|P1|Overall Study|Withdrawal by Subject|0
5159519|NCT01393990|17817025|P18|Overall Study|Death|0
5159520|NCT01393990|17817026|P17|Overall Study|Death|0
5159521|NCT01393990|17817027|P16|Overall Study|Death|0
5159522|NCT01393990|17817028|P15|Overall Study|Death|1
5159523|NCT01393990|17817029|P14|Overall Study|Death|1
5159524|NCT01393990|17817030|P13|Overall Study|Death|0
5159525|NCT01393990|17817031|P12|Overall Study|Death|0
5159526|NCT01393990|17817032|P11|Overall Study|Death|0
5159527|NCT01393990|17817033|P10|Overall Study|Death|0
5159528|NCT01393990|17817034|P9|Overall Study|Death|0
5159529|NCT01393990|17817035|P8|Overall Study|Death|0
5159530|NCT01393990|17817036|P7|Overall Study|Death|0
5159531|NCT01393990|17817037|P6|Overall Study|Death|0
5159532|NCT01393990|17817038|P5|Overall Study|Death|1
5159533|NCT01393990|17817039|P4|Overall Study|Death|0
5159534|NCT01393990|17817040|P3|Overall Study|Death|0
5159535|NCT01393990|17817041|P2|Overall Study|Death|0
5159536|NCT01393990|17817042|P1|Overall Study|Death|0
5159537|NCT01393990|17817025|P18|Overall Study|Progressive Disease|0
5159538|NCT01393990|17817026|P17|Overall Study|Progressive Disease|0
5159539|NCT01393990|17817027|P16|Overall Study|Progressive Disease|1
5159540|NCT01393990|17817028|P15|Overall Study|Progressive Disease|6
5159541|NCT01393990|17817029|P14|Overall Study|Progressive Disease|1
5159542|NCT01393990|17817030|P13|Overall Study|Progressive Disease|0
5159543|NCT01393990|17817031|P12|Overall Study|Progressive Disease|0
5159544|NCT01393990|17817032|P11|Overall Study|Progressive Disease|0
5159545|NCT01393990|17817033|P10|Overall Study|Progressive Disease|1
5159546|NCT01393990|17817034|P9|Overall Study|Progressive Disease|3
5159547|NCT01393990|17817035|P8|Overall Study|Progressive Disease|1
5159548|NCT01393990|17817036|P7|Overall Study|Progressive Disease|1
5159549|NCT01393990|17817037|P6|Overall Study|Progressive Disease|1
5159550|NCT01393990|17817038|P5|Overall Study|Progressive Disease|1
5159551|NCT01393990|17817039|P4|Overall Study|Progressive Disease|1
5159552|NCT01393990|17817040|P3|Overall Study|Progressive Disease|0
5159553|NCT01393990|17817041|P2|Overall Study|Progressive Disease|0
5159554|NCT01393990|17817042|P1|Overall Study|Progressive Disease|1
5159555|NCT01393990|17817025|P18|Overall Study|Adverse Event|0
5159556|NCT01393990|17817026|P17|Overall Study|Adverse Event|0
5159557|NCT01393990|17817027|P16|Overall Study|Adverse Event|1
5159558|NCT01393990|17817028|P15|Overall Study|Adverse Event|1
5159559|NCT01393990|17817029|P14|Overall Study|Adverse Event|0
5159560|NCT01393990|17817030|P13|Overall Study|Adverse Event|0
5159561|NCT01393990|17817031|P12|Overall Study|Adverse Event|0
5159562|NCT01393990|17817032|P11|Overall Study|Adverse Event|0
5159563|NCT01393990|17817033|P10|Overall Study|Adverse Event|0
5159564|NCT01393990|17817034|P9|Overall Study|Adverse Event|0
5159565|NCT01393990|17817035|P8|Overall Study|Adverse Event|0
5159566|NCT01393990|17817036|P7|Overall Study|Adverse Event|0
5159567|NCT01393990|17817037|P6|Overall Study|Adverse Event|0
5159568|NCT01393990|17817038|P5|Overall Study|Adverse Event|0
5159569|NCT01393990|17817039|P4|Overall Study|Adverse Event|0
5159570|NCT01393990|17817040|P3|Overall Study|Adverse Event|0
5159571|NCT01393990|17817041|P2|Overall Study|Adverse Event|0
5159572|NCT01393990|17817042|P1|Overall Study|Adverse Event|0
5159573|NCT01393964|17817133|P3|Overall Study|Subject to receive non-protocol therapy|1
5159574|NCT01393964|17817134|P2|Overall Study|Subject to receive non-protocol therapy|0
5159575|NCT01393964|17817135|P1|Overall Study|Subject to receive non-protocol therapy|0
5159576|NCT01393964|17817133|P3|Overall Study|Subject converted to roll-over study|0
5159577|NCT01393964|17817134|P2|Overall Study|Subject converted to roll-over study|1
5159578|NCT01393964|17817135|P1|Overall Study|Subject converted to roll-over study|0
5159579|NCT01393964|17817133|P3|Overall Study|Investigator removed subject from study|0
5159580|NCT01393964|17817134|P2|Overall Study|Investigator removed subject from study|1
5159581|NCT01393964|17817135|P1|Overall Study|Investigator removed subject from study|0
5159582|NCT01393964|17817133|P3|Overall Study|Subject plateaued in terms of effect|0
5159583|NCT01393964|17817134|P2|Overall Study|Subject plateaued in terms of effect|0
5159584|NCT01393964|17817135|P1|Overall Study|Subject plateaued in terms of effect|1
5159585|NCT01393964|17817133|P3|Overall Study|Subject switched to commercial supply|2
5159586|NCT01393964|17817134|P2|Overall Study|Subject switched to commercial supply|0
5159587|NCT01393964|17817135|P1|Overall Study|Subject switched to commercial supply|1
5159588|NCT01393964|17817133|P3|Overall Study|Subject decided to move to transplant|0
5159589|NCT01393964|17817134|P2|Overall Study|Subject decided to move to transplant|0
5159590|NCT01393964|17817135|P1|Overall Study|Subject decided to move to transplant|1
5159591|NCT01393964|17817133|P3|Overall Study|Subject request stop study treatment|0
5159592|NCT01393964|17817134|P2|Overall Study|Subject request stop study treatment|1
5159593|NCT01393964|17817135|P1|Overall Study|Subject request stop study treatment|0
5159594|NCT01393964|17817133|P3|Overall Study|Adverse event unrelated to study drug|0
5159595|NCT01393964|17817134|P2|Overall Study|Adverse event unrelated to study drug|3
5159596|NCT01393964|17817135|P1|Overall Study|Adverse event unrelated to study drug|0
5159597|NCT01393964|17817133|P3|Overall Study|Withdrawal by Subject|1
5159598|NCT01393964|17817134|P2|Overall Study|Withdrawal by Subject|0
5159599|NCT01393964|17817135|P1|Overall Study|Withdrawal by Subject|0
5159600|NCT01393964|17817133|P3|Overall Study|Study drug toxicity|0
5159601|NCT01393964|17817134|P2|Overall Study|Study drug toxicity|0
5159602|NCT01393964|17817135|P1|Overall Study|Study drug toxicity|1
5159603|NCT01393964|17817133|P3|Overall Study|Disease Progression|5
5159604|NCT01393964|17817134|P2|Overall Study|Disease Progression|3
5159605|NCT01393964|17817135|P1|Overall Study|Disease Progression|4
5159606|NCT01393899|17817176|P3|Overall Study|Adverse Event|3
5159607|NCT01393899|17817177|P2|Overall Study|Adverse Event|5
5159608|NCT01393899|17817178|P1|Overall Study|Adverse Event|1
5159609|NCT01393899|17817176|P3|Overall Study|Lack of Efficacy|16
5159610|NCT01393899|17817177|P2|Overall Study|Lack of Efficacy|21
5159611|NCT01393899|17817178|P1|Overall Study|Lack of Efficacy|26
5159612|NCT01393899|17817176|P3|Overall Study|Does not meet entrance criteria|1
5159613|NCT01393899|17817177|P2|Overall Study|Does not meet entrance criteria|0
5159614|NCT01393899|17817178|P1|Overall Study|Does not meet entrance criteria|1
5159615|NCT01393899|17817176|P3|Overall Study|Lost to Follow-up|1
5159616|NCT01393899|17817177|P2|Overall Study|Lost to Follow-up|0
5159617|NCT01393899|17817178|P1|Overall Study|Lost to Follow-up|0
5159618|NCT01393899|17817176|P3|Overall Study|Withdrawal by Subject|1
5159619|NCT01393899|17817177|P2|Overall Study|Withdrawal by Subject|2
5159620|NCT01393899|17817178|P1|Overall Study|Withdrawal by Subject|2
5159621|NCT01393899|17817176|P3|Overall Study|Other|0
5159622|NCT01393899|17817177|P2|Overall Study|Other|0
5159623|NCT01393899|17817178|P1|Overall Study|Other|1
5159624|NCT01393899|17817176|P3|Overall Study|Study terminated by sponsor|1
5159625|NCT01393899|17817177|P2|Overall Study|Study terminated by sponsor|0
5159626|NCT01393899|17817178|P1|Overall Study|Study terminated by sponsor|1
5159627|NCT01393821|17817232|P2|Overall Study|not evaluable for primary endpoint|2
5159628|NCT01393821|17817233|P1|Overall Study|not evaluable for primary endpoint|4
5159629|NCT01393821|17817232|P2|Overall Study|Cancel|1
5159630|NCT01393821|17817233|P1|Overall Study|Cancel|1
5159631|NCT01393743|17817247|P3|Extension Phase|Other|14
5159632|NCT01393743|17817248|P2|Extension Phase|Other|0
5159633|NCT01393743|17817249|P1|Extension Phase|Other|0
5159634|NCT01393743|17817247|P3|Extension Phase|Pregnancy|1
5159635|NCT01393743|17817248|P2|Extension Phase|Pregnancy|0
5159636|NCT01393743|17817249|P1|Extension Phase|Pregnancy|0
5159637|NCT01393743|17817247|P3|Extension Phase|Withdrawal by Subject|8
5159638|NCT01393743|17817248|P2|Extension Phase|Withdrawal by Subject|0
5159639|NCT01393743|17817249|P1|Extension Phase|Withdrawal by Subject|0
5159640|NCT01393743|17817247|P3|Extension Phase|Inadequate therapeutic effect|7
5159641|NCT01393743|17817248|P2|Extension Phase|Inadequate therapeutic effect|0
5159642|NCT01393743|17817249|P1|Extension Phase|Inadequate therapeutic effect|0
5159643|NCT01393743|17817247|P3|Extension Phase|Participant choice|16
5159644|NCT01393743|17817248|P2|Extension Phase|Participant choice|0
5159645|NCT01393743|17817249|P1|Extension Phase|Participant choice|0
5159646|NCT01393743|17817247|P3|Extension Phase|Lost to Follow-up|2
5159647|NCT01393743|17817248|P2|Extension Phase|Lost to Follow-up|0
5159648|NCT01393743|17817249|P1|Extension Phase|Lost to Follow-up|0
5159649|NCT01393743|17817247|P3|Extension Phase|Adverse Event|12
5159650|NCT01393743|17817248|P2|Extension Phase|Adverse Event|0
5159651|NCT01393743|17817249|P1|Extension Phase|Adverse Event|0
5159652|NCT01393743|17817247|P3|Core Study|Inadequate therapeutic effect|0
5159653|NCT01393743|17817248|P2|Core Study|Inadequate therapeutic effect|0
5159654|NCT01393743|17817249|P1|Core Study|Inadequate therapeutic effect|2
5159655|NCT01393743|17817247|P3|Core Study|Participant's Choice|0
5159656|NCT01393743|17817248|P2|Core Study|Participant's Choice|3
5159657|NCT01393743|17817249|P1|Core Study|Participant's Choice|2
5159658|NCT01393743|17817247|P3|Core Study|Lost to Follow-up|0
5159659|NCT01393743|17817248|P2|Core Study|Lost to Follow-up|1
5159660|NCT01393743|17817249|P1|Core Study|Lost to Follow-up|1
5159661|NCT01393743|17817247|P3|Core Study|Adverse Event|0
5159662|NCT01393743|17817248|P2|Core Study|Adverse Event|9
5159663|NCT01393743|17817249|P1|Core Study|Adverse Event|5
5159664|NCT01393730|17817272|P1|Overall Study|Adverse Event|1
5159665|NCT01393730|17817272|P1|Overall Study|Other|2
5159666|NCT01393730|17817272|P1|Overall Study|Withdrawal by Subject|3
5159667|NCT01393626|17817318|P4|Overall Study|Protocol Violation|0
5159668|NCT01393626|17817319|P3|Overall Study|Protocol Violation|2
5159669|NCT01393626|17817320|P2|Overall Study|Protocol Violation|0
5159670|NCT01393626|17817321|P1|Overall Study|Protocol Violation|1
5159671|NCT01393626|17817318|P4|Overall Study|Other|0
5159672|NCT01393626|17817319|P3|Overall Study|Other|0
5159673|NCT01393626|17817320|P2|Overall Study|Other|0
5159674|NCT01393626|17817321|P1|Overall Study|Other|1
5159675|NCT01393626|17817318|P4|Overall Study|Withdrawal by Subject|0
5159676|NCT01393626|17817319|P3|Overall Study|Withdrawal by Subject|0
5159677|NCT01393626|17817320|P2|Overall Study|Withdrawal by Subject|4
5159678|NCT01393626|17817321|P1|Overall Study|Withdrawal by Subject|6
5159679|NCT01393626|17817318|P4|Overall Study|Lost to Follow-up|0
5159680|NCT01393626|17817319|P3|Overall Study|Lost to Follow-up|1
5159681|NCT01393626|17817320|P2|Overall Study|Lost to Follow-up|1
5159682|NCT01393626|17817321|P1|Overall Study|Lost to Follow-up|1
5159683|NCT01393626|17817318|P4|Overall Study|Lack of Efficacy|1
5159684|NCT01393626|17817319|P3|Overall Study|Lack of Efficacy|4
5159685|NCT01393626|17817320|P2|Overall Study|Lack of Efficacy|6
5159686|NCT01393626|17817321|P1|Overall Study|Lack of Efficacy|6
5159687|NCT01393626|17817318|P4|Overall Study|Did not meet entrance criteria|0
5159688|NCT01393626|17817319|P3|Overall Study|Did not meet entrance criteria|0
5159689|NCT01393626|17817320|P2|Overall Study|Did not meet entrance criteria|0
5159690|NCT01393626|17817321|P1|Overall Study|Did not meet entrance criteria|1
5159691|NCT01393626|17817318|P4|Overall Study|Adverse Event|0
5159692|NCT01393626|17817319|P3|Overall Study|Adverse Event|5
5159693|NCT01393626|17817320|P2|Overall Study|Adverse Event|1
5159694|NCT01393626|17817321|P1|Overall Study|Adverse Event|2
5159695|NCT01393613|17817401|P4|Overall Study|Lack of Efficacy|21
5159696|NCT01393613|17817402|P3|Overall Study|Lack of Efficacy|16
5159697|NCT01393613|17817403|P2|Overall Study|Lack of Efficacy|20
5159698|NCT01393613|17817404|P1|Overall Study|Lack of Efficacy|9
5159699|NCT01393613|17817401|P4|Overall Study|Protocol Deviation|0
5159700|NCT01393613|17817402|P3|Overall Study|Protocol Deviation|0
5159701|NCT01393613|17817403|P2|Overall Study|Protocol Deviation|1
5159702|NCT01393613|17817404|P1|Overall Study|Protocol Deviation|2
5159703|NCT01393613|17817401|P4|Overall Study|Withdrawal by Subject|21
5159704|NCT01393613|17817402|P3|Overall Study|Withdrawal by Subject|23
5159705|NCT01393613|17817403|P2|Overall Study|Withdrawal by Subject|25
5159706|NCT01393613|17817404|P1|Overall Study|Withdrawal by Subject|15
5159707|NCT01393613|17817401|P4|Overall Study|Physician Decision|1
5159708|NCT01393613|17817402|P3|Overall Study|Physician Decision|0
5159709|NCT01393613|17817403|P2|Overall Study|Physician Decision|0
5159710|NCT01393613|17817404|P1|Overall Study|Physician Decision|2
5159711|NCT01393613|17817401|P4|Overall Study|Participant Met Withdrawal Criteria|1
5159712|NCT01393613|17817402|P3|Overall Study|Participant Met Withdrawal Criteria|2
5159713|NCT01393613|17817403|P2|Overall Study|Participant Met Withdrawal Criteria|0
5159714|NCT01393613|17817404|P1|Overall Study|Participant Met Withdrawal Criteria|0
5159715|NCT01393613|17817401|P4|Overall Study|Adverse Event|22
5159716|NCT01393613|17817402|P3|Overall Study|Adverse Event|13
5159717|NCT01393613|17817403|P2|Overall Study|Adverse Event|11
5159718|NCT01393613|17817404|P1|Overall Study|Adverse Event|11
5159719|NCT01393600|17817466|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5159720|NCT01393600|17817467|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
5159721|NCT01393600|17817468|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5159722|NCT01393600|17817469|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5159723|NCT01393600|17817466|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5159724|NCT01393600|17817467|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
5159725|NCT01393600|17817468|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5159726|NCT01393600|17817469|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5159727|NCT01393600|17817466|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5159728|NCT01393600|17817467|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
5159729|NCT01393600|17817468|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5159730|NCT01393600|17817469|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5159731|NCT01393600|17817466|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
5159732|NCT01393600|17817467|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5159733|NCT01393600|17817468|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5159734|NCT01393600|17817469|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5159735|NCT01393600|17817466|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
5159736|NCT01393600|17817467|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5159737|NCT01393600|17817468|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5159738|NCT01393600|17817469|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5159739|NCT01393600|17817466|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5159740|NCT01393600|17817467|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
5159741|NCT01393600|17817468|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5159742|NCT01393600|17817469|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5159743|NCT01393600|17817466|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5159744|NCT01393600|17817467|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5159745|NCT01393600|17817468|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
5159746|NCT01393600|17817469|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5159747|NCT01393444|17817505|P1|Overall Study|Determined ineligible during screening.|2
5159748|NCT01393444|17817505|P1|Overall Study|Withdrawal by Subject|1
5159749|NCT01393405|17817510|P3|Maintenance Period Week|Lost to Follow-up|0
5159750|NCT01393405|17817511|P2|Maintenance Period Week|Lost to Follow-up|1
5159751|NCT01393405|17817512|P1|Maintenance Period Week|Lost to Follow-up|0
5159752|NCT01393405|17817510|P3|Maintenance Period Week|Withdrawal by Subject|0
5159753|NCT01393405|17817511|P2|Maintenance Period Week|Withdrawal by Subject|1
5159754|NCT01393405|17817512|P1|Maintenance Period Week|Withdrawal by Subject|0
5159755|NCT01393405|17817510|P3|Maintenance Period Week|Adverse Event|2
5159756|NCT01393405|17817511|P2|Maintenance Period Week|Adverse Event|5
5159757|NCT01393405|17817512|P1|Maintenance Period Week|Adverse Event|0
5159758|NCT01393405|17817510|P3|Maintenance Period Week|Lack of Efficacy|22
5159759|NCT01393405|17817511|P2|Maintenance Period Week|Lack of Efficacy|22
5159760|NCT01393405|17817512|P1|Maintenance Period Week|Lack of Efficacy|0
5159761|NCT01393405|17817510|P3|Induction Period (week1-16)|Withdrawal by Subject|0
5159762|NCT01393405|17817511|P2|Induction Period (week1-16)|Withdrawal by Subject|0
5159763|NCT01393405|17817512|P1|Induction Period (week1-16)|Withdrawal by Subject|9
5159764|NCT01393405|17817510|P3|Induction Period (week1-16)|Adverse Event|0
5159765|NCT01393405|17817511|P2|Induction Period (week1-16)|Adverse Event|0
5159766|NCT01393405|17817512|P1|Induction Period (week1-16)|Adverse Event|16
5159767|NCT01393405|17817510|P3|Induction Period (week1-16)|Lack of Efficacy|0
5159768|NCT01393405|17817511|P2|Induction Period (week1-16)|Lack of Efficacy|0
5159769|NCT01393405|17817512|P1|Induction Period (week1-16)|Lack of Efficacy|70
5159770|NCT01393301|17817550|P2|Overall Study|Completed <7 sessions (intervention)|0
5159771|NCT01393301|17817551|P1|Overall Study|Completed <7 sessions (intervention)|2
5159772|NCT01393301|17817550|P2|Overall Study|Withdrawal by Subject|0
5159773|NCT01393301|17817551|P1|Overall Study|Withdrawal by Subject|2
5159774|NCT01393301|17817550|P2|Overall Study|Lost to Follow-up|3
5159775|NCT01393301|17817551|P1|Overall Study|Lost to Follow-up|5
5159776|NCT01393158|17817564|P2|Overall Study|Adverse Event|0
5159777|NCT01393158|17817565|P1|Overall Study|Adverse Event|1
5159778|NCT01393106|17817592|P1|Overall Study|Lack of Efficacy|1
5159779|NCT01393106|17817592|P1|Overall Study|Withdrawal by Subject|1
5159780|NCT01393106|17817592|P1|Overall Study|Adverse Event|3
5159781|NCT01392963|17817619|P2|Week 24 Follow-up|Lost to Follow-up|0
5159782|NCT01392963|17817620|P1|Week 24 Follow-up|Lost to Follow-up|2
5159783|NCT01392963|17817619|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
5159784|NCT01392963|17817620|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
5159785|NCT01392963|17817619|P2|Week 0 (First Intervention)|Lost to Follow-up|1
5159786|NCT01392963|17817620|P1|Week 0 (First Intervention)|Lost to Follow-up|0
5159787|NCT01392742|17817628|P1|Overall Study|Missing information|13
5159788|NCT01392742|17817628|P1|Overall Study|Other|3
5159789|NCT01392742|17817628|P1|Overall Study|Protocol Violation|14
5159790|NCT01392742|17817628|P1|Overall Study|Adverse event/intercurrent illness|17
5159791|NCT01392742|17817628|P1|Overall Study|ITR and Protocol deviation|1
5159792|NCT01392742|17817628|P1|Overall Study|Insufficient therapeutic response (ITR)|30
5159793|NCT01392742|17817628|P1|Overall Study|Lost to Follow-up|34
5159794|NCT01392742|17817628|P1|Overall Study|No treatment/no cooperation/withdrew|12
5159795|NCT01392742|17817628|P1|Overall Study|Failure to return|35
5159796|NCT01392742|17817628|P1|Overall Study|Premature study termination|42
5159797|NCT01392677|17817674|P2|Overall Study|Other reason|2
5159798|NCT01392677|17817675|P1|Overall Study|Other reason|3
5159799|NCT01392677|17817674|P2|Overall Study|Incorrect enrollment|3
5159800|NCT01392677|17817675|P1|Overall Study|Incorrect enrollment|2
5159801|NCT01392677|17817674|P2|Overall Study|Withdrawal by Subject|2
5159802|NCT01392677|17817675|P1|Overall Study|Withdrawal by Subject|0
5159803|NCT01392677|17817674|P2|Overall Study|Adverse Event|1
5159804|NCT01392677|17817675|P1|Overall Study|Adverse Event|3
5159805|NCT01392573|17817710|P2|Overall Study|Unclassified|6
5159806|NCT01392573|17817711|P1|Overall Study|Unclassified|9
5159807|NCT01392573|17817710|P2|Overall Study|Site closure|7
5159808|NCT01392573|17817711|P1|Overall Study|Site closure|8
5159809|NCT01392573|17817710|P2|Overall Study|Withdrawal Criteria|15
5159810|NCT01392573|17817711|P1|Overall Study|Withdrawal Criteria|13
5159811|NCT01392573|17817710|P2|Overall Study|Protocol Violation|2
5159812|NCT01392573|17817711|P1|Overall Study|Protocol Violation|0
5159813|NCT01392573|17817710|P2|Overall Study|Lack of Efficacy|2
5159814|NCT01392573|17817711|P1|Overall Study|Lack of Efficacy|1
5159815|NCT01392573|17817710|P2|Overall Study|Adverse Event|3
5159816|NCT01392573|17817711|P1|Overall Study|Adverse Event|1
5159817|NCT01392560|17817719|P1|Overall Study|discontinued during placebo run-in|2
5159818|NCT01392560|17817719|P1|Overall Study|not entered|8
5159819|NCT01392560|17817719|P1|Overall Study|Adverse Event|2
5159820|NCT01392547|17817725|P1|Overall Study|Unclassified|1
5159821|NCT01392547|17817725|P1|Overall Study|Withdrawal criteria|3
5159822|NCT01392547|17817725|P1|Overall Study|Non-compliance|2
5159823|NCT01392547|17817725|P1|Overall Study|Adverse Event|2
5159824|NCT01392495|17817739|P1|Overall Study|Adverse Event|3
5159825|NCT01392495|17817739|P1|Overall Study|Withdrawal by Subject|2
5159826|NCT01392495|17817739|P1|Overall Study|Administrative problems|8
5159827|NCT01392495|17817739|P1|Overall Study|Death|3
5159828|NCT01392443|17817751|P1|Overall Study|Protocol Violation|1
5159829|NCT01392443|17817751|P1|Overall Study|Lost to Follow-up|1
5159830|NCT01392443|17817751|P1|Overall Study|Withdrawal by Subject|5
5159831|NCT01392443|17817751|P1|Overall Study|Death|7
5159832|NCT01392443|17817751|P1|Overall Study|Adverse Event|24
5159833|NCT01392443|17817751|P1|Overall Study|Disease progression|30
5159834|NCT01392378|17817764|P5|Toddler Dose|Withdrawal by Parent|1
5159835|NCT01392378|17817765|P4|Toddler Dose|Withdrawal by Parent|1
5159836|NCT01392378|17817766|P3|Toddler Dose|Withdrawal by Parent|0
5159837|NCT01392378|17817767|P2|Toddler Dose|Withdrawal by Parent|1
5159838|NCT01392378|17817768|P1|Toddler Dose|Withdrawal by Parent|0
5159839|NCT01392378|17817764|P5|Toddler Dose|Lost to Follow-up|0
5159840|NCT01392378|17817765|P4|Toddler Dose|Lost to Follow-up|1
5159841|NCT01392378|17817766|P3|Toddler Dose|Lost to Follow-up|0
5159842|NCT01392378|17817767|P2|Toddler Dose|Lost to Follow-up|0
5159843|NCT01392378|17817768|P1|Toddler Dose|Lost to Follow-up|0
5159844|NCT01392378|17817764|P5|After Infant Series|Withdrawal by Parent|1
5159845|NCT01392378|17817765|P4|After Infant Series|Withdrawal by Parent|0
5159846|NCT01392378|17817766|P3|After Infant Series|Withdrawal by Parent|1
5159847|NCT01392378|17817767|P2|After Infant Series|Withdrawal by Parent|1
5159848|NCT01392378|17817768|P1|After Infant Series|Withdrawal by Parent|0
5159849|NCT01392378|17817764|P5|After Infant Series|Lost to Follow-up|0
5159850|NCT01392378|17817765|P4|After Infant Series|Lost to Follow-up|0
5159851|NCT01392378|17817766|P3|After Infant Series|Lost to Follow-up|1
5159852|NCT01392378|17817767|P2|After Infant Series|Lost to Follow-up|0
5159853|NCT01392378|17817768|P1|After Infant Series|Lost to Follow-up|0
5159854|NCT01392378|17817764|P5|Infant Series|Withdrawal by Parent|0
5159855|NCT01392378|17817765|P4|Infant Series|Withdrawal by Parent|0
5159856|NCT01392378|17817766|P3|Infant Series|Withdrawal by Parent|0
5159857|NCT01392378|17817767|P2|Infant Series|Withdrawal by Parent|1
5159858|NCT01392378|17817768|P1|Infant Series|Withdrawal by Parent|4
5159859|NCT01392378|17817764|P5|Infant Series|Protocol Violation|0
5159860|NCT01392378|17817765|P4|Infant Series|Protocol Violation|0
5159861|NCT01392378|17817766|P3|Infant Series|Protocol Violation|0
5159862|NCT01392378|17817767|P2|Infant Series|Protocol Violation|1
5159863|NCT01392378|17817768|P1|Infant Series|Protocol Violation|0
5159864|NCT01392378|17817764|P5|Infant Series|Lost to Follow-up|0
5159865|NCT01392378|17817765|P4|Infant Series|Lost to Follow-up|1
5159866|NCT01392378|17817766|P3|Infant Series|Lost to Follow-up|0
5159867|NCT01392378|17817767|P2|Infant Series|Lost to Follow-up|0
5159868|NCT01392378|17817768|P1|Infant Series|Lost to Follow-up|0
5159869|NCT01392378|17817764|P5|Infant Series|Adverse Event|0
5159870|NCT01392378|17817765|P4|Infant Series|Adverse Event|1
5159871|NCT01392378|17817766|P3|Infant Series|Adverse Event|0
5159872|NCT01392378|17817767|P2|Infant Series|Adverse Event|0
5159873|NCT01392378|17817768|P1|Infant Series|Adverse Event|0
5159874|NCT01392326|17817908|P3|Overall Study|Adverse Event|11
5159875|NCT01392326|17817909|P2|Overall Study|Adverse Event|6
5159876|NCT01392326|17817910|P1|Overall Study|Adverse Event|9
5159877|NCT01392326|17817908|P3|Overall Study|Lack of Efficacy|15
5159878|NCT01392326|17817909|P2|Overall Study|Lack of Efficacy|10
5159879|NCT01392326|17817910|P1|Overall Study|Lack of Efficacy|14
5159880|NCT01392326|17817908|P3|Overall Study|Lost to Follow-up|4
5159881|NCT01392326|17817909|P2|Overall Study|Lost to Follow-up|3
5159882|NCT01392326|17817910|P1|Overall Study|Lost to Follow-up|1
5159883|NCT01392326|17817908|P3|Overall Study|Physician Decision|2
5159884|NCT01392326|17817909|P2|Overall Study|Physician Decision|5
5159885|NCT01392326|17817910|P1|Overall Study|Physician Decision|7
5159886|NCT01392326|17817908|P3|Overall Study|Pregnancy|1
5159887|NCT01392326|17817909|P2|Overall Study|Pregnancy|0
5159888|NCT01392326|17817910|P1|Overall Study|Pregnancy|0
5159889|NCT01392326|17817908|P3|Overall Study|Protocol Violation|0
5159890|NCT01392326|17817909|P2|Overall Study|Protocol Violation|0
5159891|NCT01392326|17817910|P1|Overall Study|Protocol Violation|2
5159892|NCT01392326|17817908|P3|Overall Study|Withdrawal by Subject|15
5159893|NCT01392326|17817909|P2|Overall Study|Withdrawal by Subject|11
5159894|NCT01392326|17817910|P1|Overall Study|Withdrawal by Subject|12
5159895|NCT01392326|17817908|P3|Overall Study|Death|0
5159896|NCT01392326|17817909|P2|Overall Study|Death|0
5159897|NCT01392326|17817910|P1|Overall Study|Death|2
5159898|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
5159899|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
5159900|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
5159901|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
5159902|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
5159903|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
5159904|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Adverse Event|7
5159905|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Adverse Event|0
5159906|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Adverse Event|0
5159907|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Death|4
5159908|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Death|0
5159909|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Death|0
5159910|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Non-compliance|1
5159911|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Non-compliance|0
5159912|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Non-compliance|0
5159913|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
5159914|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
5159915|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
5159916|NCT01392300|17817947|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
5159917|NCT01392300|17817948|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
5159918|NCT01392300|17817949|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
5159919|NCT01392300|17817947|P3|Main Period (MP)|Non-compliance|0
5159920|NCT01392300|17817948|P2|Main Period (MP)|Non-compliance|0
5159921|NCT01392300|17817949|P1|Main Period (MP)|Non-compliance|1
5159922|NCT01392300|17817947|P3|Main Period (MP)|Lost to Follow-up|0
5159923|NCT01392300|17817948|P2|Main Period (MP)|Lost to Follow-up|3
5159924|NCT01392300|17817949|P1|Main Period (MP)|Lost to Follow-up|3
5159925|NCT01392300|17817947|P3|Main Period (MP)|Withdrawal by Subject|0
5159926|NCT01392300|17817948|P2|Main Period (MP)|Withdrawal by Subject|1
5159927|NCT01392300|17817949|P1|Main Period (MP)|Withdrawal by Subject|5
5159928|NCT01392300|17817947|P3|Main Period (MP)|Predefined discontinuation criteria|0
5159929|NCT01392300|17817948|P2|Main Period (MP)|Predefined discontinuation criteria|3
5159930|NCT01392300|17817949|P1|Main Period (MP)|Predefined discontinuation criteria|2
5159931|NCT01392170|17818054|P1|Overall Study|Ineligible|1
5159932|NCT01392170|17818054|P1|Overall Study|Withdrawal by Subject|1
5159933|NCT01391832|17818104|P2|Overall Study|Lost to Follow-up|1
5159934|NCT01391832|17818105|P1|Overall Study|Lost to Follow-up|0
5159935|NCT01391832|17818104|P2|Overall Study|Withdrawal by Subject|22
5159936|NCT01391832|17818105|P1|Overall Study|Withdrawal by Subject|21
5159937|NCT01391819|17818113|P1|Overall Study|Other|9
5159938|NCT01391819|17818113|P1|Overall Study|Death|3
5159939|NCT01391819|17818113|P1|Overall Study|Lost to Follow-up|252
5159940|NCT01391819|17818113|P1|Overall Study|Migrated/moved from study area|82
5159941|NCT01391819|17818113|P1|Overall Study|Withdrawal by Subject|56
5159942|NCT01391793|17818157|P2|Overall Study|No DMSA|57
5159943|NCT01391793|17818158|P1|Overall Study|No DMSA|73
5159944|NCT01391793|17818157|P2|Overall Study|Urine Culture Negative or Indeterminate|87
5159945|NCT01391793|17818158|P1|Overall Study|Urine Culture Negative or Indeterminate|71
5159946|NCT01391793|17818157|P2|Overall Study|Ineligible|0
5159947|NCT01391793|17818158|P1|Overall Study|Ineligible|3
5159948|NCT01391663|17818172|P4|Overall Study|Withdrawal by Subject|0
5159949|NCT01391663|17818173|P3|Overall Study|Withdrawal by Subject|1
5159950|NCT01391663|17818174|P2|Overall Study|Withdrawal by Subject|0
5159951|NCT01391663|17818175|P1|Overall Study|Withdrawal by Subject|0
5159952|NCT01391546|17818219|P2|Overall Study|History of Herpes Zoster (HZ)|0
5159953|NCT01391546|17818220|P1|Overall Study|History of Herpes Zoster (HZ)|1
5159954|NCT01391507|17818242|P4|Overall Study|Protocol Violation|2
5159955|NCT01391507|17818243|P3|Overall Study|Protocol Violation|1
5159956|NCT01391507|17818244|P2|Overall Study|Protocol Violation|1
5159957|NCT01391507|17818245|P1|Overall Study|Protocol Violation|2
5159958|NCT01391507|17818242|P4|Overall Study|Lack of Efficacy|1
5159959|NCT01391507|17818243|P3|Overall Study|Lack of Efficacy|0
5159960|NCT01391507|17818244|P2|Overall Study|Lack of Efficacy|0
5159961|NCT01391507|17818245|P1|Overall Study|Lack of Efficacy|0
5159962|NCT01391507|17818242|P4|Overall Study|Withdrawal by Subject|1
5159963|NCT01391507|17818243|P3|Overall Study|Withdrawal by Subject|1
5159964|NCT01391507|17818244|P2|Overall Study|Withdrawal by Subject|2
5159965|NCT01391507|17818245|P1|Overall Study|Withdrawal by Subject|1
5159966|NCT01391507|17818242|P4|Overall Study|Adverse Event|2
5159967|NCT01391507|17818243|P3|Overall Study|Adverse Event|2
5159968|NCT01391507|17818244|P2|Overall Study|Adverse Event|1
5159969|NCT01391507|17818245|P1|Overall Study|Adverse Event|1
5159970|NCT01391507|17818242|P4|Overall Study|Death|1
5159971|NCT01391507|17818243|P3|Overall Study|Death|0
5159972|NCT01391507|17818244|P2|Overall Study|Death|0
5159973|NCT01391507|17818245|P1|Overall Study|Death|0
5159974|NCT01391130|17818396|P2|Overall Study|Did not Receive Drug|1
5159975|NCT01391130|17818397|P1|Overall Study|Did not Receive Drug|1
5159976|NCT01391130|17818396|P2|Overall Study|Physician Decision|3
5159977|NCT01391130|17818397|P1|Overall Study|Physician Decision|2
5159978|NCT01391130|17818396|P2|Overall Study|Withdrawal by Subject|2
5159979|NCT01391130|17818397|P1|Overall Study|Withdrawal by Subject|3
5159980|NCT01391000|17818454|P2|Overall Study|Lost to Follow-up|0
5159981|NCT01391000|17818455|P1|Overall Study|Lost to Follow-up|2
5159982|NCT01390948|17818468|P3|Overall Study|Death during follow-up|1
5159983|NCT01390948|17818469|P2|Overall Study|Death during follow-up|11
5159984|NCT01390948|17818470|P1|Overall Study|Death during follow-up|10
5159985|NCT01390948|17818468|P3|Overall Study|Progressive Disease|0
5159986|NCT01390948|17818469|P2|Overall Study|Progressive Disease|5
5159987|NCT01390948|17818470|P1|Overall Study|Progressive Disease|2
5159988|NCT01390948|17818468|P3|Overall Study|Withdrew consent|0
5159989|NCT01390948|17818469|P2|Overall Study|Withdrew consent|2
5159990|NCT01390948|17818470|P1|Overall Study|Withdrew consent|2
5159991|NCT01390948|17818468|P3|Overall Study|End of Study|0
5159992|NCT01390948|17818469|P2|Overall Study|End of Study|0
5159993|NCT01390948|17818470|P1|Overall Study|End of Study|1
5159994|NCT01390857|17818538|P1|Overall Study|No Visit after the First Visit|7
5159995|NCT01390857|17818538|P1|Overall Study|Lost to Follow-up|1
5159996|NCT01390857|17818538|P1|Overall Study|Protocol Violation|2
5159997|NCT01390844|17818549|P4|Follow-Up Phase|Non-Medical Reasons|0
5159998|NCT01390844|17818550|P3|Follow-Up Phase|Non-Medical Reasons|1
5159999|NCT01390844|17818551|P2|Follow-Up Phase|Non-Medical Reasons|1
5160000|NCT01390844|17818552|P1|Follow-Up Phase|Non-Medical Reasons|1
5160001|NCT01390844|17818549|P4|Treatment Phase|Non-GCP Compliant|3
5160002|NCT01390844|17818550|P3|Treatment Phase|Non-GCP Compliant|10
5160003|NCT01390844|17818551|P2|Treatment Phase|Non-GCP Compliant|0
5160004|NCT01390844|17818552|P1|Treatment Phase|Non-GCP Compliant|0
5160005|NCT01390844|17818549|P4|Treatment Phase|Non-Medical Reasons|1
5160006|NCT01390844|17818550|P3|Treatment Phase|Non-Medical Reasons|8
5160007|NCT01390844|17818551|P2|Treatment Phase|Non-Medical Reasons|1
5160008|NCT01390844|17818552|P1|Treatment Phase|Non-Medical Reasons|5
5160009|NCT01390844|17818549|P4|Treatment Phase|Treatment Failure|13
5160010|NCT01390844|17818550|P3|Treatment Phase|Treatment Failure|10
5160011|NCT01390844|17818551|P2|Treatment Phase|Treatment Failure|25
5160012|NCT01390844|17818552|P1|Treatment Phase|Treatment Failure|23
5160013|NCT01390844|17818549|P4|Treatment Phase|Adverse Event|2
5160014|NCT01390844|17818550|P3|Treatment Phase|Adverse Event|3
5160015|NCT01390844|17818551|P2|Treatment Phase|Adverse Event|2
5160016|NCT01390844|17818552|P1|Treatment Phase|Adverse Event|12
5160017|NCT01390779|17818879|P1|Overall Study|Physician Decision|1
5160018|NCT01390649|17818884|P1|Overall Study|Physician Decision|1
5160019|NCT01390441|17818894|P5|Extension Period|Protocol Violation|0
5160020|NCT01390441|17818895|P4|Extension Period|Protocol Violation|1
5160021|NCT01390441|17818896|P3|Extension Period|Protocol Violation|0
5160022|NCT01390441|17818897|P2|Extension Period|Protocol Violation|1
5160023|NCT01390441|17818898|P1|Extension Period|Protocol Violation|3
5160024|NCT01390441|17818894|P5|Treatment Period|Lost to Follow-up|0
5160025|NCT01390441|17818895|P4|Treatment Period|Lost to Follow-up|0
5160026|NCT01390441|17818896|P3|Treatment Period|Lost to Follow-up|0
5160027|NCT01390441|17818897|P2|Treatment Period|Lost to Follow-up|0
5160028|NCT01390441|17818898|P1|Treatment Period|Lost to Follow-up|1
5160029|NCT01390441|17818894|P5|Treatment Period|Withdrawal by Subject|1
5160030|NCT01390441|17818895|P4|Treatment Period|Withdrawal by Subject|0
5160031|NCT01390441|17818896|P3|Treatment Period|Withdrawal by Subject|1
5160032|NCT01390441|17818897|P2|Treatment Period|Withdrawal by Subject|0
5160033|NCT01390441|17818898|P1|Treatment Period|Withdrawal by Subject|0
5160034|NCT01390441|17818894|P5|Treatment Period|Adverse Event|2
5160035|NCT01390441|17818895|P4|Treatment Period|Adverse Event|1
5160036|NCT01390441|17818896|P3|Treatment Period|Adverse Event|1
5160037|NCT01390441|17818897|P2|Treatment Period|Adverse Event|0
5160038|NCT01390441|17818898|P1|Treatment Period|Adverse Event|0
5160039|NCT01390441|17818894|P5|Treatment Period|Unknown due to early stopping of study|7
5160040|NCT01390441|17818895|P4|Treatment Period|Unknown due to early stopping of study|11
5160041|NCT01390441|17818896|P3|Treatment Period|Unknown due to early stopping of study|8
5160042|NCT01390441|17818897|P2|Treatment Period|Unknown due to early stopping of study|0
5160043|NCT01390441|17818898|P1|Treatment Period|Unknown due to early stopping of study|0
5160044|NCT01390441|17818894|P5|Treatment Period|Lack of Efficacy|1
5160045|NCT01390441|17818895|P4|Treatment Period|Lack of Efficacy|0
5160046|NCT01390441|17818896|P3|Treatment Period|Lack of Efficacy|0
5160047|NCT01390441|17818897|P2|Treatment Period|Lack of Efficacy|0
5160048|NCT01390441|17818898|P1|Treatment Period|Lack of Efficacy|0
5160049|NCT01390441|17818894|P5|Treatment Period|Physician Decision|0
5160050|NCT01390441|17818895|P4|Treatment Period|Physician Decision|1
5160051|NCT01390441|17818896|P3|Treatment Period|Physician Decision|0
5160052|NCT01390441|17818897|P2|Treatment Period|Physician Decision|0
5160053|NCT01390441|17818898|P1|Treatment Period|Physician Decision|0
5160054|NCT01390441|17818894|P5|Treatment Period|Protocol Violation|0
5160055|NCT01390441|17818895|P4|Treatment Period|Protocol Violation|0
5160056|NCT01390441|17818896|P3|Treatment Period|Protocol Violation|0
5160057|NCT01390441|17818897|P2|Treatment Period|Protocol Violation|1
5160058|NCT01390441|17818898|P1|Treatment Period|Protocol Violation|0
5160059|NCT01390428|17818963|P6|Overall Study|Withdrawal by Subject|0
5160060|NCT01390428|17818964|P5|Overall Study|Withdrawal by Subject|0
5160061|NCT01390428|17818965|P4|Overall Study|Withdrawal by Subject|0
5160062|NCT01390428|17818966|P3|Overall Study|Withdrawal by Subject|1
5160063|NCT01390428|17818967|P2|Overall Study|Withdrawal by Subject|0
5160064|NCT01390428|17818968|P1|Overall Study|Withdrawal by Subject|0
5160065|NCT01390428|17818963|P6|Overall Study|Elective Surgery|0
5160066|NCT01390428|17818964|P5|Overall Study|Elective Surgery|1
5160067|NCT01390428|17818965|P4|Overall Study|Elective Surgery|0
5160068|NCT01390428|17818966|P3|Overall Study|Elective Surgery|0
5160069|NCT01390428|17818967|P2|Overall Study|Elective Surgery|0
5160070|NCT01390428|17818968|P1|Overall Study|Elective Surgery|0
5160071|NCT01390402|17819031|P1|Overall Study|Disease Progression|4
5160072|NCT01390402|17819031|P1|Overall Study|Death|1
5160073|NCT01390389|17819037|P2|Overall Study|Screen Fail|1
5160074|NCT01390389|17819038|P1|Overall Study|Screen Fail|2
5160075|NCT01390389|17819037|P2|Overall Study|Withdrawal by Subject|0
5160076|NCT01390389|17819038|P1|Overall Study|Withdrawal by Subject|2
5160077|NCT01390298|17819048|P1|Overall Study|Surgery cancelled|1
5160078|NCT01390298|17819048|P1|Overall Study|Lost to Follow-up|7
5160079|NCT01390298|17819048|P1|Overall Study|Withdrawal by Subject|14
5160080|NCT01390298|17819048|P1|Overall Study|long term ICU admission|1
5160081|NCT01390298|17819048|P1|Overall Study|Death|1
5160082|NCT01390272|17819054|P2|Overall Study|Patient moved, no longer eligible|8
5160083|NCT01390272|17819055|P1|Overall Study|Patient moved, no longer eligible|5
5160084|NCT01390272|17819054|P2|Overall Study|Withdrawal by Subject|5
5160085|NCT01390272|17819055|P1|Overall Study|Withdrawal by Subject|9
5160086|NCT01390272|17819054|P2|Overall Study|Death|2
5160087|NCT01390272|17819055|P1|Overall Study|Death|3
5160088|NCT01390220|17819123|P3|Comparative Phase|Withdrawal by Subject|0
5160089|NCT01390220|17819124|P2|Comparative Phase|Withdrawal by Subject|1
5160090|NCT01390220|17819125|P1|Comparative Phase|Withdrawal by Subject|0
5160091|NCT01390220|17819123|P3|Test Dose Phase|Logistical|0
5160092|NCT01390220|17819124|P2|Test Dose Phase|Logistical|0
5160093|NCT01390220|17819125|P1|Test Dose Phase|Logistical|6
5160094|NCT01390220|17819123|P3|Test Dose Phase|Noncompliance|0
5160095|NCT01390220|17819124|P2|Test Dose Phase|Noncompliance|0
5160096|NCT01390220|17819125|P1|Test Dose Phase|Noncompliance|2
5160097|NCT01390220|17819123|P3|Test Dose Phase|Caregiver no longer available|0
5160098|NCT01390220|17819124|P2|Test Dose Phase|Caregiver no longer available|0
5160099|NCT01390220|17819125|P1|Test Dose Phase|Caregiver no longer available|5
5160100|NCT01390220|17819123|P3|Test Dose Phase|Study/Site closure|0
5160101|NCT01390220|17819124|P2|Test Dose Phase|Study/Site closure|0
5160102|NCT01390220|17819125|P1|Test Dose Phase|Study/Site closure|6
5160103|NCT01390220|17819123|P3|Test Dose Phase|No treated seizure cluster episode|0
5160104|NCT01390220|17819124|P2|Test Dose Phase|No treated seizure cluster episode|0
5160105|NCT01390220|17819125|P1|Test Dose Phase|No treated seizure cluster episode|37
5160106|NCT01390220|17819123|P3|Test Dose Phase|Protocol Violation|0
5160107|NCT01390220|17819124|P2|Test Dose Phase|Protocol Violation|0
5160108|NCT01390220|17819125|P1|Test Dose Phase|Protocol Violation|8
5160109|NCT01390220|17819123|P3|Test Dose Phase|Lost to Follow-up|0
5160110|NCT01390220|17819124|P2|Test Dose Phase|Lost to Follow-up|0
5160111|NCT01390220|17819125|P1|Test Dose Phase|Lost to Follow-up|2
5160112|NCT01390220|17819123|P3|Test Dose Phase|Withdrawal by Subject|0
5160113|NCT01390220|17819124|P2|Test Dose Phase|Withdrawal by Subject|0
5160114|NCT01390220|17819125|P1|Test Dose Phase|Withdrawal by Subject|8
5160115|NCT01390220|17819123|P3|Test Dose Phase|Adverse Event|0
5160116|NCT01390220|17819124|P2|Test Dose Phase|Adverse Event|0
5160117|NCT01390220|17819125|P1|Test Dose Phase|Adverse Event|17
5160118|NCT01390181|17819140|P1|Overall Study|Study Terminated due to Low Accrual|3
5160119|NCT01390181|17819140|P1|Overall Study|Lost to Follow-up|1
5160120|NCT01390038|17819153|P1|Overall Study|Simpliciti System Removal|2
5160121|NCT01390038|17819153|P1|Overall Study|Withdrawal by Subject|4
5160122|NCT01390038|17819153|P1|Overall Study|Lost to Follow-up|1
5160123|NCT01390038|17819153|P1|Overall Study|Death|1
5160124|NCT01389973|17819163|P1|Overall Study|Other|10
5160125|NCT01389973|17819163|P1|Overall Study|Trial Stopped by Sponsor|9
5160126|NCT01389973|17819163|P1|Overall Study|Lost to Follow-up|1
5160127|NCT01389882|17819173|P2|Overall Study|Withdrawal by Subject|1
5160128|NCT01389882|17819174|P1|Overall Study|Withdrawal by Subject|0
5160129|NCT01389882|17819173|P2|Overall Study|Respiratory rate > 80/min during study|3
5160130|NCT01389882|17819174|P1|Overall Study|Respiratory rate > 80/min during study|1
5160131|NCT01389817|17819262|P2|Overall Study|Withdrawal by Subject|0
5160132|NCT01389817|17819263|P1|Overall Study|Withdrawal by Subject|2
5160133|NCT01389817|17819262|P2|Overall Study|Lost to Follow-up|0
5160134|NCT01389817|17819263|P1|Overall Study|Lost to Follow-up|1
5160135|NCT01389817|17819262|P2|Overall Study|Physician Decision|0
5160136|NCT01389817|17819263|P1|Overall Study|Physician Decision|1
5160137|NCT01389752|17819280|P2|Study Period 2|Sponsor decision|0
5160138|NCT01389752|17819281|P1|Study Period 2|Sponsor decision|1
5160139|NCT01389752|17819280|P2|Study Period 1|Sponsor decision|2
5160140|NCT01389752|17819281|P1|Study Period 1|Sponsor decision|0
5160141|NCT01389596|17819294|P3|Overall Study|Other Unspecified|0
5160142|NCT01389596|17819295|P2|Overall Study|Other Unspecified|1
5160143|NCT01389596|17819296|P1|Overall Study|Other Unspecified|2
5160144|NCT01389596|17819294|P3|Overall Study|Death|0
5160145|NCT01389596|17819295|P2|Overall Study|Death|1
5160146|NCT01389596|17819296|P1|Overall Study|Death|0
5160147|NCT01389596|17819294|P3|Overall Study|Adverse Event|0
5160148|NCT01389596|17819295|P2|Overall Study|Adverse Event|4
5160149|NCT01389596|17819296|P1|Overall Study|Adverse Event|1
5160150|NCT01389596|17819294|P3|Overall Study|Insufficient Clinical Response|5
5160151|NCT01389596|17819295|P2|Overall Study|Insufficient Clinical Response|4
5160152|NCT01389596|17819296|P1|Overall Study|Insufficient Clinical Response|3
5160153|NCT01389596|17819294|P3|Overall Study|Withdrawal by Subject|2
5160154|NCT01389596|17819295|P2|Overall Study|Withdrawal by Subject|2
5160155|NCT01389596|17819296|P1|Overall Study|Withdrawal by Subject|1
5160156|NCT01389596|17819294|P3|Overall Study|Protocol Violation|3
5160157|NCT01389596|17819295|P2|Overall Study|Protocol Violation|4
5160158|NCT01389596|17819296|P1|Overall Study|Protocol Violation|3
5160159|NCT01389323|17819355|P1|Follow-up Period (up to 48 Weeks)|Other|3
5160160|NCT01389323|17819355|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
5160161|NCT01389323|17819355|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
5160162|NCT01389323|17819355|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
5160163|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
5160164|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
5160165|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
5160166|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
5160167|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
5160168|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
5160169|NCT01389323|17819355|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
5160170|NCT01389258|17819412|P1|Overall Study|Lost to Follow-up|5
5160171|NCT01389245|17819422|P1|Overall Study|Withdrawal by Subject|2
5160172|NCT01389245|17819422|P1|Overall Study|Lost to Follow-up|3
5160173|NCT01389245|17819422|P1|Overall Study|Protocol Violation|10
5160174|NCT01389128|17819432|P2|Overall Study|Intolerance to procedure|2
5160175|NCT01389128|17819433|P1|Overall Study|Intolerance to procedure|0
5160176|NCT01389128|17819432|P2|Overall Study|Rapid labor evolution|2
5160177|NCT01389128|17819433|P1|Overall Study|Rapid labor evolution|3
5160178|NCT01389128|17819432|P2|Overall Study|Cervix dilation stop|2
5160179|NCT01389128|17819433|P1|Overall Study|Cervix dilation stop|1
5160180|NCT01389128|17819432|P2|Overall Study|Fetal distress|0
5160181|NCT01389128|17819433|P1|Overall Study|Fetal distress|1
5160182|NCT01389102|17819457|P6|Overall Study|Investigator Judgement|0
5160183|NCT01389102|17819458|P5|Overall Study|Investigator Judgement|0
5160184|NCT01389102|17819459|P4|Overall Study|Investigator Judgement|0
5160185|NCT01389102|17819460|P3|Overall Study|Investigator Judgement|0
5160186|NCT01389102|17819461|P2|Overall Study|Investigator Judgement|1
5160187|NCT01389102|17819462|P1|Overall Study|Investigator Judgement|0
5160188|NCT01389102|17819457|P6|Overall Study|Unavailable due to husband's illness|0
5160189|NCT01389102|17819458|P5|Overall Study|Unavailable due to husband's illness|0
5160190|NCT01389102|17819459|P4|Overall Study|Unavailable due to husband's illness|0
5160191|NCT01389102|17819460|P3|Overall Study|Unavailable due to husband's illness|0
5160192|NCT01389102|17819461|P2|Overall Study|Unavailable due to husband's illness|1
5160193|NCT01389102|17819462|P1|Overall Study|Unavailable due to husband's illness|0
5160194|NCT01389102|17819457|P6|Overall Study|Subject Moved|0
5160195|NCT01389102|17819458|P5|Overall Study|Subject Moved|0
5160196|NCT01389102|17819459|P4|Overall Study|Subject Moved|0
5160197|NCT01389102|17819460|P3|Overall Study|Subject Moved|1
5160198|NCT01389102|17819461|P2|Overall Study|Subject Moved|0
5160199|NCT01389102|17819462|P1|Overall Study|Subject Moved|2
5160200|NCT01389102|17819457|P6|Overall Study|Subject Traveling Out of Country|0
5160201|NCT01389102|17819458|P5|Overall Study|Subject Traveling Out of Country|0
5160202|NCT01389102|17819459|P4|Overall Study|Subject Traveling Out of Country|1
5160203|NCT01389102|17819460|P3|Overall Study|Subject Traveling Out of Country|0
5160204|NCT01389102|17819461|P2|Overall Study|Subject Traveling Out of Country|0
5160205|NCT01389102|17819462|P1|Overall Study|Subject Traveling Out of Country|0
5160206|NCT01389102|17819457|P6|Overall Study|Withdrawal by Subject|3
5160207|NCT01389102|17819458|P5|Overall Study|Withdrawal by Subject|3
5160208|NCT01389102|17819459|P4|Overall Study|Withdrawal by Subject|2
5160209|NCT01389102|17819460|P3|Overall Study|Withdrawal by Subject|9
5160210|NCT01389102|17819461|P2|Overall Study|Withdrawal by Subject|4
5160211|NCT01389102|17819462|P1|Overall Study|Withdrawal by Subject|7
5160212|NCT01389102|17819457|P6|Overall Study|Protocol Violation|1
5160213|NCT01389102|17819458|P5|Overall Study|Protocol Violation|1
5160214|NCT01389102|17819459|P4|Overall Study|Protocol Violation|0
5160215|NCT01389102|17819460|P3|Overall Study|Protocol Violation|3
5160216|NCT01389102|17819461|P2|Overall Study|Protocol Violation|0
5160217|NCT01389102|17819462|P1|Overall Study|Protocol Violation|0
5160218|NCT01389102|17819457|P6|Overall Study|Lost to Follow-up|1
5160219|NCT01389102|17819458|P5|Overall Study|Lost to Follow-up|4
5160220|NCT01389102|17819459|P4|Overall Study|Lost to Follow-up|2
5160221|NCT01389102|17819460|P3|Overall Study|Lost to Follow-up|1
5160222|NCT01389102|17819461|P2|Overall Study|Lost to Follow-up|1
5160223|NCT01389102|17819462|P1|Overall Study|Lost to Follow-up|4
5160224|NCT01389102|17819457|P6|Overall Study|Hurricane Katrina|1
5160225|NCT01389102|17819458|P5|Overall Study|Hurricane Katrina|3
5160226|NCT01389102|17819459|P4|Overall Study|Hurricane Katrina|0
5160227|NCT01389102|17819460|P3|Overall Study|Hurricane Katrina|3
5160228|NCT01389102|17819461|P2|Overall Study|Hurricane Katrina|2
5160229|NCT01389102|17819462|P1|Overall Study|Hurricane Katrina|4
5160230|NCT01389102|17819457|P6|Overall Study|Adverse Event|2
5160231|NCT01389102|17819458|P5|Overall Study|Adverse Event|2
5160232|NCT01389102|17819459|P4|Overall Study|Adverse Event|2
5160233|NCT01389102|17819460|P3|Overall Study|Adverse Event|2
5160234|NCT01389102|17819461|P2|Overall Study|Adverse Event|3
5160235|NCT01389102|17819462|P1|Overall Study|Adverse Event|1
5160236|NCT01388985|17819492|P2|Overall Study|Error of nurse|1
5160237|NCT01388985|17819493|P1|Overall Study|Error of nurse|5
5160238|NCT01388985|17819492|P2|Overall Study|Other (no reason)|1
5160239|NCT01388985|17819493|P1|Overall Study|Other (no reason)|0
5160240|NCT01388985|17819492|P2|Overall Study|Subject unavailable|1
5160241|NCT01388985|17819493|P1|Overall Study|Subject unavailable|1
5160242|NCT01388985|17819492|P2|Overall Study|Withdrawal by Subject|4
5160243|NCT01388985|17819493|P1|Overall Study|Withdrawal by Subject|13
5160244|NCT01388985|17819492|P2|Overall Study|Lost to Follow-up|30
5160245|NCT01388985|17819493|P1|Overall Study|Lost to Follow-up|30
5160246|NCT01388985|17819492|P2|Overall Study|Death|1
5160247|NCT01388985|17819493|P1|Overall Study|Death|0
5160248|NCT01388907|17819557|P2|Overall Study|Adverse Event|0
5160249|NCT01388907|17819558|P1|Overall Study|Adverse Event|2
5160250|NCT01388816|17819574|P4|Overall Study|Protocol Violation|0
5160251|NCT01388816|17819575|P3|Overall Study|Protocol Violation|2
5160252|NCT01388816|17819576|P2|Overall Study|Protocol Violation|0
5160253|NCT01388816|17819577|P1|Overall Study|Protocol Violation|0
5160254|NCT01388816|17819574|P4|Overall Study|Withdrawal by Subject|0
5160255|NCT01388816|17819575|P3|Overall Study|Withdrawal by Subject|1
5160256|NCT01388816|17819576|P2|Overall Study|Withdrawal by Subject|1
5160257|NCT01388816|17819577|P1|Overall Study|Withdrawal by Subject|2
5160258|NCT01388816|17819574|P4|Overall Study|Lost to Follow-up|0
5160259|NCT01388816|17819575|P3|Overall Study|Lost to Follow-up|0
5160260|NCT01388816|17819576|P2|Overall Study|Lost to Follow-up|1
5160261|NCT01388816|17819577|P1|Overall Study|Lost to Follow-up|0
5160262|NCT01388816|17819574|P4|Overall Study|Adverse Event|0
5160263|NCT01388816|17819575|P3|Overall Study|Adverse Event|0
5160264|NCT01388816|17819576|P2|Overall Study|Adverse Event|2
5160265|NCT01388816|17819577|P1|Overall Study|Adverse Event|0
5160266|NCT01388790|17819606|P1|Overall Study|Ongoing at data cut-off date|8
5160267|NCT01388647|17819617|P2|Overall Study|Adverse Event|2
5160268|NCT01388647|17819618|P1|Overall Study|Adverse Event|1
5160269|NCT01388543|17819631|P2|Day 14|Adverse Event|4
5160270|NCT01388543|17819632|P1|Day 14|Adverse Event|1
5160271|NCT01388530|17819638|P1|Overall Study|Lost to Follow-up|5
5160272|NCT01388491|17819647|P2|Overall Study|Pregnancy|0
5160273|NCT01388491|17819648|P1|Overall Study|Pregnancy|1
5160274|NCT01388491|17819647|P2|Overall Study|Noncompliance|0
5160275|NCT01388491|17819648|P1|Overall Study|Noncompliance|2
5160276|NCT01388491|17819647|P2|Overall Study|Protocol Violation|0
5160277|NCT01388491|17819648|P1|Overall Study|Protocol Violation|2
5160278|NCT01388491|17819647|P2|Overall Study|Lost to Follow-up|3
5160279|NCT01388491|17819648|P1|Overall Study|Lost to Follow-up|4
5160280|NCT01388491|17819647|P2|Overall Study|Withdrawal by Subject|10
5160281|NCT01388491|17819648|P1|Overall Study|Withdrawal by Subject|6
5160282|NCT01388491|17819647|P2|Overall Study|Sponsor Request|7
5160283|NCT01388491|17819648|P1|Overall Study|Sponsor Request|9
5160284|NCT01388491|17819647|P2|Overall Study|Adverse Event|9
5160285|NCT01388491|17819648|P1|Overall Study|Adverse Event|10
5160286|NCT01388361|17819683|P3|Overall Study|Unclassified|1
5160287|NCT01388361|17819684|P2|Overall Study|Unclassified|0
5160288|NCT01388361|17819685|P1|Overall Study|Unclassified|0
5160289|NCT01388361|17819683|P3|Overall Study|Withdrawal criteria|10
5160290|NCT01388361|17819684|P2|Overall Study|Withdrawal criteria|7
5160291|NCT01388361|17819685|P1|Overall Study|Withdrawal criteria|12
5160292|NCT01388361|17819683|P3|Overall Study|Protocol Violation|2
5160293|NCT01388361|17819684|P2|Overall Study|Protocol Violation|0
5160294|NCT01388361|17819685|P1|Overall Study|Protocol Violation|0
5160295|NCT01388361|17819683|P3|Overall Study|Adverse Event|1
5160296|NCT01388361|17819684|P2|Overall Study|Adverse Event|5
5160297|NCT01388361|17819685|P1|Overall Study|Adverse Event|0
5160298|NCT01388335|17819702|P1|Safety Extension|Progressive Disease|7
5160299|NCT01388335|17819702|P1|Period 2|Sponsor Decision|1
5160300|NCT01388335|17819702|P1|Period 2|Progressive Disease|2
5160301|NCT01388335|17819702|P1|Period 1|Progressive Disease|1
5160302|NCT01388166|17819729|P1|Overall Study|Others than specified above|13
5160303|NCT01388166|17819729|P1|Overall Study|Lost to Follow-up|30
5160304|NCT01388166|17819729|P1|Overall Study|Adverse Event|16
5160305|NCT01387789|17820032|P1|Overall Study|Lost to Follow-up|1
5160306|NCT01387789|17820032|P1|Overall Study|Lack of Efficacy|2
5160307|NCT01387789|17820032|P1|Overall Study|Adverse Event|5
5160308|NCT01387737|17820046|P2|Overall Study|Clearly not eligible for the study|3
5160309|NCT01387737|17820047|P1|Overall Study|Clearly not eligible for the study|1
5160310|NCT01387737|17820046|P2|Overall Study|Withdrawal by Subject|31
5160311|NCT01387737|17820047|P1|Overall Study|Withdrawal by Subject|27
5160312|NCT01387737|17820046|P2|Overall Study|Physician Decision|10
5160313|NCT01387737|17820047|P1|Overall Study|Physician Decision|3
5160314|NCT01387737|17820046|P2|Overall Study|Lack of Efficacy|0
5160315|NCT01387737|17820047|P1|Overall Study|Lack of Efficacy|1
5160316|NCT01387737|17820046|P2|Overall Study|Adverse Event|30
5160317|NCT01387737|17820047|P1|Overall Study|Adverse Event|20
5160318|NCT01387607|17820081|P2|Overall Study|Randomized, not treated|6
5160319|NCT01387607|17820082|P1|Overall Study|Randomized, not treated|3
5160320|NCT01387607|17820081|P2|Overall Study|Other|1
5160321|NCT01387607|17820082|P1|Overall Study|Other|1
5160322|NCT01387607|17820081|P2|Overall Study|Withdrawal by Subject|14
5160323|NCT01387607|17820082|P1|Overall Study|Withdrawal by Subject|13
5160324|NCT01387607|17820081|P2|Overall Study|Protocol Violation|5
5160325|NCT01387607|17820082|P1|Overall Study|Protocol Violation|1
5160326|NCT01387607|17820081|P2|Overall Study|No longer meets eligibility criteria|1
5160327|NCT01387607|17820082|P1|Overall Study|No longer meets eligibility criteria|0
5160328|NCT01387607|17820081|P2|Overall Study|Lost to Follow-up|1
5160329|NCT01387607|17820082|P1|Overall Study|Lost to Follow-up|2
5160330|NCT01387607|17820081|P2|Overall Study|Lack of Efficacy|6
5160331|NCT01387607|17820082|P1|Overall Study|Lack of Efficacy|8
5160332|NCT01387607|17820081|P2|Overall Study|Adverse Event|11
5160333|NCT01387607|17820082|P1|Overall Study|Adverse Event|23
5160334|NCT01387594|17820136|P2|Overall Study|Lost to Follow-up|1
5160335|NCT01387594|17820137|P1|Overall Study|Lost to Follow-up|0
5160336|NCT01387594|17820136|P2|Overall Study|Withdrawal by Subject|2
5160337|NCT01387594|17820137|P1|Overall Study|Withdrawal by Subject|0
5160338|NCT01387542|17820165|P1|Overall Study|Lost to Follow-up|1
5160339|NCT01387542|17820165|P1|Overall Study|Non-compliant|1
5160340|NCT01387542|17820165|P1|Overall Study|Insufficient response|1
5160341|NCT01387542|17820165|P1|Overall Study|Changed diagnosis|1
5160342|NCT01387542|17820165|P1|Overall Study|Withdrawal by Subject|1
5160343|NCT01387542|17820165|P1|Overall Study|Adverse Event|3
5160344|NCT01387516|17820176|P4|Overall Study|Death|1
5160345|NCT01387516|17820177|P3|Overall Study|Death|0
5160346|NCT01387516|17820178|P2|Overall Study|Death|0
5160347|NCT01387516|17820179|P1|Overall Study|Death|0
5160348|NCT01387516|17820176|P4|Overall Study|Withdrawal by Subject|0
5160349|NCT01387516|17820177|P3|Overall Study|Withdrawal by Subject|2
5160350|NCT01387516|17820178|P2|Overall Study|Withdrawal by Subject|1
5160351|NCT01387516|17820179|P1|Overall Study|Withdrawal by Subject|1
5160352|NCT01387516|17820176|P4|Overall Study|Lost to Follow-up|3
5160353|NCT01387516|17820177|P3|Overall Study|Lost to Follow-up|2
5160354|NCT01387516|17820178|P2|Overall Study|Lost to Follow-up|4
5160355|NCT01387516|17820179|P1|Overall Study|Lost to Follow-up|4
5160356|NCT01387347|17820212|P2|Overall Study|Lost to Follow-up|1
5160357|NCT01387347|17820213|P1|Overall Study|Lost to Follow-up|2
5160358|NCT01387282|17820225|P2|Overall Study|Lost to Follow-up|1
5160359|NCT01387282|17820226|P1|Overall Study|Lost to Follow-up|4
5160360|NCT01387282|17820225|P2|Overall Study|Study drug-related AE|2
5160361|NCT01387282|17820226|P1|Overall Study|Study drug-related AE|2
5160362|NCT01387282|17820225|P2|Overall Study|Withdrawal by patient|23
5160363|NCT01387282|17820226|P1|Overall Study|Withdrawal by patient|33
5160364|NCT01387282|17820225|P2|Overall Study|Unrelated AE|4
5160365|NCT01387282|17820226|P1|Overall Study|Unrelated AE|6
5160366|NCT01387282|17820225|P2|Overall Study|Other|1
5160367|NCT01387282|17820226|P1|Overall Study|Other|5
5160368|NCT01387282|17820225|P2|Overall Study|Death|16
5160369|NCT01387282|17820226|P1|Overall Study|Death|47
5160370|NCT01387269|17820242|P2|Overall Study|Lost to Follow-up|0
5160371|NCT01387269|17820243|P1|Overall Study|Lost to Follow-up|1
5160372|NCT01387269|17820242|P2|Overall Study|Study drug-related AE|0
5160373|NCT01387269|17820243|P1|Overall Study|Study drug-related AE|1
5160374|NCT01387269|17820242|P2|Overall Study|Withdrawal by patient|10
5160375|NCT01387269|17820243|P1|Overall Study|Withdrawal by patient|32
5160376|NCT01387269|17820242|P2|Overall Study|Unrelated AE|3
5160377|NCT01387269|17820243|P1|Overall Study|Unrelated AE|12
5160378|NCT01387269|17820242|P2|Overall Study|Other|7
5160379|NCT01387269|17820243|P1|Overall Study|Other|8
5160380|NCT01387269|17820242|P2|Overall Study|Death|20
5160381|NCT01387269|17820243|P1|Overall Study|Death|38
5160382|NCT01387230|17820260|P3|Overall Study|Withdrawal by Subject|0
5160383|NCT01387230|17820261|P2|Overall Study|Withdrawal by Subject|1
5160384|NCT01387230|17820262|P1|Overall Study|Withdrawal by Subject|4
5160385|NCT01387230|17820260|P3|Overall Study|Lost to Follow-up|1
5160386|NCT01387230|17820261|P2|Overall Study|Lost to Follow-up|0
5160387|NCT01387230|17820262|P1|Overall Study|Lost to Follow-up|0
5160388|NCT01387230|17820260|P3|Overall Study|Protocol-defined Stopping Criteria|5
5160389|NCT01387230|17820261|P2|Overall Study|Protocol-defined Stopping Criteria|0
5160390|NCT01387230|17820262|P1|Overall Study|Protocol-defined Stopping Criteria|6
5160391|NCT01387230|17820260|P3|Overall Study|Lack of Efficacy|4
5160392|NCT01387230|17820261|P2|Overall Study|Lack of Efficacy|5
5160393|NCT01387230|17820262|P1|Overall Study|Lack of Efficacy|8
5160394|NCT01387230|17820260|P3|Overall Study|Adverse Event|3
5160395|NCT01387230|17820261|P2|Overall Study|Adverse Event|1
5160396|NCT01387230|17820262|P1|Overall Study|Adverse Event|0
5160397|NCT01387074|17820308|P1|Overall Study|Lack of Efficacy|1
5160398|NCT01387074|17820308|P1|Overall Study|Lost to Follow-up|7
5160399|NCT01387022|17820321|P2|Overall Study|Lost to Follow-up|3
5160400|NCT01387022|17820322|P1|Overall Study|Lost to Follow-up|0
5160401|NCT01387022|17820321|P2|Overall Study|Death|1
5160402|NCT01387022|17820322|P1|Overall Study|Death|1
5160403|NCT01386970|17820351|P2|Overall Study|Adverse Event|1
5160404|NCT01386970|17820352|P1|Overall Study|Adverse Event|4
5160405|NCT01386970|17820351|P2|Overall Study|Withdrawal by Subject|1
5160406|NCT01386970|17820352|P1|Overall Study|Withdrawal by Subject|0
5160407|NCT01386944|17820360|P1|Overall Study|Unspecified reason|8
5160408|NCT01386944|17820360|P1|Overall Study|Lost to Follow-up|8
5160409|NCT01386944|17820360|P1|Overall Study|Lack of Efficacy|14
5160410|NCT01386944|17820360|P1|Overall Study|Adverse Event|26
5160411|NCT01386788|17820370|P1|Overall Study|Lost to Follow-up|2
5160412|NCT01386684|17820375|P1|Overall Study|Missing|3
5160413|NCT01386684|17820375|P1|Overall Study|Protocol Violation|4
5160414|NCT01386684|17820375|P1|Overall Study|Noncompliance|8
5160415|NCT01386684|17820375|P1|Overall Study|Adverse Event|20
5160416|NCT01386684|17820375|P1|Overall Study|Disease Progression|28
5160417|NCT01386684|17820375|P1|Overall Study|Alternative Therapy Required|37
5160418|NCT01386684|17820375|P1|Overall Study|Withdrawal of Consent|44
5160419|NCT01386684|17820375|P1|Overall Study|Death|47
5160420|NCT01386684|17820375|P1|Overall Study|Other|51
5160421|NCT01386684|17820375|P1|Overall Study|Lost to Follow-up|51
5160422|NCT01386658|17820416|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
5160423|NCT01386658|17820417|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
5160424|NCT01386658|17820416|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
5160425|NCT01386658|17820417|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
5160426|NCT01386645|17820483|P3|Overall Study|Withdrawal by Subject|1
5160427|NCT01386645|17820484|P2|Overall Study|Withdrawal by Subject|1
5160428|NCT01386645|17820485|P1|Overall Study|Withdrawal by Subject|0
5160429|NCT01386645|17820483|P3|Overall Study|Physician Decision|1
5160430|NCT01386645|17820484|P2|Overall Study|Physician Decision|0
5160431|NCT01386645|17820485|P1|Overall Study|Physician Decision|0
5160432|NCT01386606|17820514|P4|Overall Study|T levels too high|0
5160433|NCT01386606|17820515|P3|Overall Study|T levels too high|1
5160434|NCT01386606|17820516|P2|Overall Study|T levels too high|1
5160435|NCT01386606|17820517|P1|Overall Study|T levels too high|0
5160436|NCT01386606|17820514|P4|Overall Study|Unable to draw PK|0
5160437|NCT01386606|17820515|P3|Overall Study|Unable to draw PK|0
5160438|NCT01386606|17820516|P2|Overall Study|Unable to draw PK|0
5160439|NCT01386606|17820517|P1|Overall Study|Unable to draw PK|1
5160440|NCT01386606|17820514|P4|Overall Study|Subject incarcerated|0
5160441|NCT01386606|17820515|P3|Overall Study|Subject incarcerated|0
5160442|NCT01386606|17820516|P2|Overall Study|Subject incarcerated|1
5160443|NCT01386606|17820517|P1|Overall Study|Subject incarcerated|0
5160444|NCT01386606|17820514|P4|Overall Study|Lost to Follow-up|0
5160445|NCT01386606|17820515|P3|Overall Study|Lost to Follow-up|0
5160446|NCT01386606|17820516|P2|Overall Study|Lost to Follow-up|0
5160447|NCT01386606|17820517|P1|Overall Study|Lost to Follow-up|2
5160448|NCT01386606|17820514|P4|Overall Study|Protocol Violation|1
5160449|NCT01386606|17820515|P3|Overall Study|Protocol Violation|1
5160450|NCT01386606|17820516|P2|Overall Study|Protocol Violation|0
5160451|NCT01386606|17820517|P1|Overall Study|Protocol Violation|1
5160452|NCT01386606|17820514|P4|Overall Study|Withdrawal by Subject|0
5160453|NCT01386606|17820515|P3|Overall Study|Withdrawal by Subject|1
5160454|NCT01386606|17820516|P2|Overall Study|Withdrawal by Subject|1
5160455|NCT01386606|17820517|P1|Overall Study|Withdrawal by Subject|0
5160456|NCT01386606|17820514|P4|Overall Study|Adverse Event|0
5160457|NCT01386606|17820515|P3|Overall Study|Adverse Event|0
5160458|NCT01386606|17820516|P2|Overall Study|Adverse Event|1
5160459|NCT01386606|17820517|P1|Overall Study|Adverse Event|0
5160460|NCT01386554|17820548|P3|Overall Study|Reason not collected|0
5160461|NCT01386554|17820549|P2|Overall Study|Reason not collected|1
5160462|NCT01386554|17820550|P1|Overall Study|Reason not collected|0
5160463|NCT01386554|17820548|P3|Overall Study|Investigator discretion|1
5160464|NCT01386554|17820549|P2|Overall Study|Investigator discretion|0
5160465|NCT01386554|17820550|P1|Overall Study|Investigator discretion|0
5160466|NCT01386554|17820548|P3|Overall Study|Administration of live vaccines|0
5160467|NCT01386554|17820549|P2|Overall Study|Administration of live vaccines|1
5160468|NCT01386554|17820550|P1|Overall Study|Administration of live vaccines|0
5160469|NCT01386554|17820548|P3|Overall Study|Progressive disease|2
5160470|NCT01386554|17820549|P2|Overall Study|Progressive disease|2
5160471|NCT01386554|17820550|P1|Overall Study|Progressive disease|1
5160472|NCT01386554|17820548|P3|Overall Study|Adverse Event|2
5160473|NCT01386554|17820549|P2|Overall Study|Adverse Event|5
5160474|NCT01386554|17820550|P1|Overall Study|Adverse Event|2
5160475|NCT01386554|17820548|P3|Overall Study|Lost to Follow-up|1
5160476|NCT01386554|17820549|P2|Overall Study|Lost to Follow-up|0
5160477|NCT01386554|17820550|P1|Overall Study|Lost to Follow-up|0
5160478|NCT01386125|17820573|P2|Overall Study|Participant Leaving Country|0
5160479|NCT01386125|17820574|P1|Overall Study|Participant Leaving Country|1
5160480|NCT01386125|17820573|P2|Overall Study|Lack of Efficacy|1
5160481|NCT01386125|17820574|P1|Overall Study|Lack of Efficacy|0
5160482|NCT01386125|17820573|P2|Overall Study|Adverse Event|5
5160483|NCT01386125|17820574|P1|Overall Study|Adverse Event|2
5160484|NCT01386125|17820573|P2|Overall Study|Withdrawal by Subject|12
5160485|NCT01386125|17820574|P1|Overall Study|Withdrawal by Subject|13
5160486|NCT01386125|17820573|P2|Overall Study|Disease Progress|2
5160487|NCT01386125|17820574|P1|Overall Study|Disease Progress|1
5160488|NCT01386125|17820573|P2|Overall Study|Protocol Violation|7
5160489|NCT01386125|17820574|P1|Overall Study|Protocol Violation|5
5160490|NCT01386125|17820573|P2|Overall Study|Physician Decision|1
5160491|NCT01386125|17820574|P1|Overall Study|Physician Decision|0
5160492|NCT01386125|17820573|P2|Overall Study|Lost to Follow-up|9
5160493|NCT01386125|17820574|P1|Overall Study|Lost to Follow-up|3
5160494|NCT01386008|17820582|P1|Overall Study|Adverse Event|3
5160495|NCT01386008|17820582|P1|Overall Study|exited w/o incident /study discontinued|17
5160496|NCT01385995|17820591|P2|Period 1, 2 Months|Physician Decision|0
5160497|NCT01385995|17820592|P1|Period 1, 2 Months|Physician Decision|1
5160498|NCT01385748|17820609|P3|Overall Study|Adverse Event|1
5160499|NCT01385748|17820610|P2|Overall Study|Adverse Event|2
5160500|NCT01385748|17820611|P1|Overall Study|Adverse Event|4
5160501|NCT01385748|17820609|P3|Overall Study|Other|1
5160502|NCT01385748|17820610|P2|Overall Study|Other|7
5160503|NCT01385748|17820611|P1|Overall Study|Other|1
5160504|NCT01385748|17820609|P3|Overall Study|Noncompliance|6
5160505|NCT01385748|17820610|P2|Overall Study|Noncompliance|1
5160506|NCT01385748|17820611|P1|Overall Study|Noncompliance|3
5160507|NCT01385748|17820609|P3|Overall Study|Withdrawal by Subject|5
5160508|NCT01385748|17820610|P2|Overall Study|Withdrawal by Subject|4
5160509|NCT01385748|17820611|P1|Overall Study|Withdrawal by Subject|7
5160510|NCT01385566|17820696|P6|Overall Study|Withdrawal by Subject|0
5160511|NCT01385566|17820697|P5|Overall Study|Withdrawal by Subject|0
5160512|NCT01385566|17820698|P4|Overall Study|Withdrawal by Subject|1
5160513|NCT01385566|17820699|P3|Overall Study|Withdrawal by Subject|0
5160514|NCT01385566|17820700|P2|Overall Study|Withdrawal by Subject|0
5160515|NCT01385566|17820701|P1|Overall Study|Withdrawal by Subject|0
5160516|NCT01385566|17820696|P6|Overall Study|Lost to Follow-up|0
5160517|NCT01385566|17820697|P5|Overall Study|Lost to Follow-up|0
5160518|NCT01385566|17820698|P4|Overall Study|Lost to Follow-up|0
5160519|NCT01385566|17820699|P3|Overall Study|Lost to Follow-up|0
5160520|NCT01385566|17820700|P2|Overall Study|Lost to Follow-up|0
5160521|NCT01385566|17820701|P1|Overall Study|Lost to Follow-up|1
5160522|NCT01385371|17820755|P2|Overall Study|Administrative|2
5160523|NCT01385371|17820756|P1|Overall Study|Administrative|2
5160524|NCT01385371|17820755|P2|Overall Study|Protocol Violation|21
5160525|NCT01385371|17820756|P1|Overall Study|Protocol Violation|25
5160526|NCT01385371|17820755|P2|Overall Study|Withdrawal by Subject|39
5160527|NCT01385371|17820756|P1|Overall Study|Withdrawal by Subject|52
5160528|NCT01385371|17820755|P2|Overall Study|Lost to Follow-up|16
5160529|NCT01385371|17820756|P1|Overall Study|Lost to Follow-up|16
5160530|NCT01385371|17820755|P2|Overall Study|Adverse Event|19
5160531|NCT01385371|17820756|P1|Overall Study|Adverse Event|54
5160532|NCT01385202|17820804|P1|Overall Study|Withdrawn|1
5160533|NCT01385202|17820804|P1|Overall Study|Not Eligible|11
5160534|NCT01385202|17820804|P1|Overall Study|Lost to Follow-up|6
5160535|NCT01385176|17820841|P2|6-18 Month All VNS Active|Heart Transplant|0
5160536|NCT01385176|17820842|P1|6-18 Month All VNS Active|Heart Transplant|1
5160537|NCT01385176|17820841|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
5160538|NCT01385176|17820842|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
5160539|NCT01385176|17820841|P2|6-18 Month All VNS Active|Physician Decision|1
5160540|NCT01385176|17820842|P1|6-18 Month All VNS Active|Physician Decision|0
5160541|NCT01385176|17820841|P2|6-18 Month All VNS Active|Death|2
5160542|NCT01385176|17820842|P1|6-18 Month All VNS Active|Death|1
5160543|NCT01385176|17820841|P2|Randomization Phase|Death|2
5160544|NCT01385176|17820842|P1|Randomization Phase|Death|1
5160545|NCT01385098|17820873|P1|Overall Study|Lost to Follow-up|4
5160546|NCT01385098|17820873|P1|Overall Study|Adverse Event|10
5160547|NCT01384877|17820895|P2|Treatment 2|Lost to Follow-up|2
5160548|NCT01384877|17820896|P1|Treatment 2|Lost to Follow-up|2
5160549|NCT01384760|17820922|P2|Overall Study|Protocol Violation|0
5160550|NCT01384760|17820923|P1|Overall Study|Protocol Violation|16
5160551|NCT01384760|17820922|P2|Overall Study|Lost to Follow-up|6
5160552|NCT01384760|17820923|P1|Overall Study|Lost to Follow-up|0
5160553|NCT01384734|17820936|P5|Overall Study|Physician Decision|0
5160554|NCT01384734|17820937|P4|Overall Study|Physician Decision|0
5160555|NCT01384734|17820938|P3|Overall Study|Physician Decision|0
5160556|NCT01384734|17820939|P2|Overall Study|Physician Decision|0
5160557|NCT01384734|17820940|P1|Overall Study|Physician Decision|1
5160558|NCT01384734|17820936|P5|Overall Study|Early termination|1
5160559|NCT01384734|17820937|P4|Overall Study|Early termination|0
5160560|NCT01384734|17820938|P3|Overall Study|Early termination|0
5160561|NCT01384734|17820939|P2|Overall Study|Early termination|0
5160562|NCT01384734|17820940|P1|Overall Study|Early termination|0
5160563|NCT01384734|17820936|P5|Overall Study|Adhesion problem|0
5160564|NCT01384734|17820937|P4|Overall Study|Adhesion problem|1
5160565|NCT01384734|17820938|P3|Overall Study|Adhesion problem|0
5160566|NCT01384734|17820939|P2|Overall Study|Adhesion problem|0
5160567|NCT01384734|17820940|P1|Overall Study|Adhesion problem|0
5160568|NCT01384734|17820936|P5|Overall Study|Missed End of treatment visit|0
5160569|NCT01384734|17820937|P4|Overall Study|Missed End of treatment visit|1
5160570|NCT01384734|17820938|P3|Overall Study|Missed End of treatment visit|0
5160571|NCT01384734|17820939|P2|Overall Study|Missed End of treatment visit|0
5160572|NCT01384734|17820940|P1|Overall Study|Missed End of treatment visit|0
5160573|NCT01384734|17820936|P5|Overall Study|As per Exclusion criteria|0
5160574|NCT01384734|17820937|P4|Overall Study|As per Exclusion criteria|0
5160575|NCT01384734|17820938|P3|Overall Study|As per Exclusion criteria|0
5160576|NCT01384734|17820939|P2|Overall Study|As per Exclusion criteria|1
5160577|NCT01384734|17820940|P1|Overall Study|As per Exclusion criteria|0
5160578|NCT01384734|17820936|P5|Overall Study|Prison|0
5160579|NCT01384734|17820937|P4|Overall Study|Prison|0
5160580|NCT01384734|17820938|P3|Overall Study|Prison|1
5160581|NCT01384734|17820939|P2|Overall Study|Prison|0
5160582|NCT01384734|17820940|P1|Overall Study|Prison|0
5160583|NCT01384734|17820936|P5|Overall Study|Unable to come back for visit|0
5160584|NCT01384734|17820937|P4|Overall Study|Unable to come back for visit|1
5160585|NCT01384734|17820938|P3|Overall Study|Unable to come back for visit|1
5160586|NCT01384734|17820939|P2|Overall Study|Unable to come back for visit|0
5160587|NCT01384734|17820940|P1|Overall Study|Unable to come back for visit|1
5160588|NCT01384734|17820936|P5|Overall Study|Investigator relocating|1
5160589|NCT01384734|17820937|P4|Overall Study|Investigator relocating|3
5160590|NCT01384734|17820938|P3|Overall Study|Investigator relocating|0
5160591|NCT01384734|17820939|P2|Overall Study|Investigator relocating|2
5160592|NCT01384734|17820940|P1|Overall Study|Investigator relocating|0
5160593|NCT01384734|17820936|P5|Overall Study|Withdrawal by Subject|9
5160594|NCT01384734|17820937|P4|Overall Study|Withdrawal by Subject|7
5160595|NCT01384734|17820938|P3|Overall Study|Withdrawal by Subject|6
5160596|NCT01384734|17820939|P2|Overall Study|Withdrawal by Subject|5
5160597|NCT01384734|17820940|P1|Overall Study|Withdrawal by Subject|5
5160598|NCT01384734|17820936|P5|Overall Study|Sponsor terminated|1
5160599|NCT01384734|17820937|P4|Overall Study|Sponsor terminated|0
5160600|NCT01384734|17820938|P3|Overall Study|Sponsor terminated|0
5160601|NCT01384734|17820939|P2|Overall Study|Sponsor terminated|0
5160602|NCT01384734|17820940|P1|Overall Study|Sponsor terminated|0
5160603|NCT01384734|17820936|P5|Overall Study|Pregnancy|1
5160604|NCT01384734|17820937|P4|Overall Study|Pregnancy|0
5160605|NCT01384734|17820938|P3|Overall Study|Pregnancy|0
5160606|NCT01384734|17820939|P2|Overall Study|Pregnancy|1
5160607|NCT01384734|17820940|P1|Overall Study|Pregnancy|0
5160608|NCT01384734|17820936|P5|Overall Study|Non-compliance with study drug|2
5160609|NCT01384734|17820937|P4|Overall Study|Non-compliance with study drug|0
5160610|NCT01384734|17820938|P3|Overall Study|Non-compliance with study drug|6
5160611|NCT01384734|17820939|P2|Overall Study|Non-compliance with study drug|2
5160612|NCT01384734|17820940|P1|Overall Study|Non-compliance with study drug|1
5160613|NCT01384734|17820936|P5|Overall Study|Lost to Follow-up|5
5160614|NCT01384734|17820937|P4|Overall Study|Lost to Follow-up|8
5160615|NCT01384734|17820938|P3|Overall Study|Lost to Follow-up|3
5160616|NCT01384734|17820939|P2|Overall Study|Lost to Follow-up|3
5160617|NCT01384734|17820940|P1|Overall Study|Lost to Follow-up|5
5160618|NCT01384734|17820936|P5|Overall Study|Lack of Efficacy|2
5160619|NCT01384734|17820937|P4|Overall Study|Lack of Efficacy|4
5160620|NCT01384734|17820938|P3|Overall Study|Lack of Efficacy|4
5160621|NCT01384734|17820939|P2|Overall Study|Lack of Efficacy|7
5160622|NCT01384734|17820940|P1|Overall Study|Lack of Efficacy|3
5160623|NCT01384734|17820936|P5|Overall Study|Continuation criteria not met|0
5160624|NCT01384734|17820937|P4|Overall Study|Continuation criteria not met|1
5160625|NCT01384734|17820938|P3|Overall Study|Continuation criteria not met|1
5160626|NCT01384734|17820939|P2|Overall Study|Continuation criteria not met|0
5160627|NCT01384734|17820940|P1|Overall Study|Continuation criteria not met|0
5160628|NCT01384734|17820936|P5|Overall Study|Death|0
5160629|NCT01384734|17820937|P4|Overall Study|Death|0
5160630|NCT01384734|17820938|P3|Overall Study|Death|1
5160631|NCT01384734|17820939|P2|Overall Study|Death|0
5160632|NCT01384734|17820940|P1|Overall Study|Death|1
5160633|NCT01384734|17820936|P5|Overall Study|Adverse Event|7
5160634|NCT01384734|17820937|P4|Overall Study|Adverse Event|2
5160635|NCT01384734|17820938|P3|Overall Study|Adverse Event|0
5160636|NCT01384734|17820939|P2|Overall Study|Adverse Event|3
5160637|NCT01384734|17820940|P1|Overall Study|Adverse Event|0
5160638|NCT01384292|17821169|P3|Part B|Severe non-compliance to protocol|0
5160639|NCT01384292|17821170|P2|Part B|Severe non-compliance to protocol|0
5160640|NCT01384292|17821171|P1|Part B|Severe non-compliance to protocol|1
5160641|NCT01384019|17821183|P2|Overall Study|MRI refusal|6
5160642|NCT01384019|17821184|P1|Overall Study|MRI refusal|6
5160643|NCT01384019|17821183|P2|Overall Study|Death|0
5160644|NCT01384019|17821184|P1|Overall Study|Death|1
5160645|NCT01384019|17821183|P2|Overall Study|Withdrawal by Subject|0
5160646|NCT01384019|17821184|P1|Overall Study|Withdrawal by Subject|3
5160647|NCT01383993|17821193|P3|Overall Study|Marketed voriconazole in post-therapy|0
5160648|NCT01383993|17821194|P2|Overall Study|Marketed voriconazole in post-therapy|0
5160649|NCT01383993|17821195|P1|Overall Study|Marketed voriconazole in post-therapy|2
5160650|NCT01383993|17821193|P3|Overall Study|Withdrawal by Subject|1
5160651|NCT01383993|17821194|P2|Overall Study|Withdrawal by Subject|0
5160652|NCT01383993|17821195|P1|Overall Study|Withdrawal by Subject|0
5160653|NCT01383993|17821193|P3|Overall Study|Adverse Event|0
5160654|NCT01383993|17821194|P2|Overall Study|Adverse Event|1
5160655|NCT01383993|17821195|P1|Overall Study|Adverse Event|1
5160656|NCT01383954|17821242|P1|Overall Study|Reason Not Specified|9
5160657|NCT01383954|17821242|P1|Overall Study|Adverse Event|1
5160658|NCT01383954|17821242|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
5160659|NCT01383954|17821242|P1|Overall Study|Lack of Efficacy|2
5160660|NCT01383928|17821250|P3|Overall Study|Unsatisfactory Therapeutic Response|1
5160661|NCT01383928|17821251|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5160662|NCT01383928|17821252|P1|Overall Study|Unsatisfactory Therapeutic Response|0
5160663|NCT01383928|17821250|P3|Overall Study|Withdrawal by Subject|4
5160664|NCT01383928|17821251|P2|Overall Study|Withdrawal by Subject|0
5160665|NCT01383928|17821252|P1|Overall Study|Withdrawal by Subject|0
5160666|NCT01383928|17821250|P3|Overall Study|Progressive Disease|5
5160667|NCT01383928|17821251|P2|Overall Study|Progressive Disease|1
5160668|NCT01383928|17821252|P1|Overall Study|Progressive Disease|1
5160669|NCT01383928|17821250|P3|Overall Study|Other|4
5160670|NCT01383928|17821251|P2|Overall Study|Other|3
5160671|NCT01383928|17821252|P1|Overall Study|Other|1
5160672|NCT01383928|17821250|P3|Overall Study|Adverse Event|8
5160673|NCT01383928|17821251|P2|Overall Study|Adverse Event|2
5160674|NCT01383928|17821252|P1|Overall Study|Adverse Event|1
5160675|NCT01383928|17821250|P3|Overall Study|Initiation of ASCT|18
5160676|NCT01383928|17821251|P2|Overall Study|Initiation of ASCT|1
5160677|NCT01383928|17821252|P1|Overall Study|Initiation of ASCT|2
5160678|NCT01383707|17821333|P1|Overall Study|Progressive disease|23
5160679|NCT01383707|17821333|P1|Overall Study|Adverse Event|14
5160680|NCT01383707|17821333|P1|Overall Study|Sponsor's decision|2
5160681|NCT01383707|17821333|P1|Overall Study|Other|8
5160682|NCT01383707|17821333|P1|Overall Study|Death|19
5160683|NCT01383707|17821333|P1|Overall Study|Consent withdrawal|6
5160684|NCT01383499|17821373|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
5160685|NCT01383499|17821374|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
5160686|NCT01383499|17821375|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
5160687|NCT01383499|17821376|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
5160688|NCT01383486|17821426|P1|Overall Study|Did not take any product|6
5160689|NCT01383486|17821426|P1|Overall Study|Incomplete information for analysis|2
5160690|NCT01383486|17821426|P1|Overall Study|Lost to Follow-up|10
5160691|NCT01383356|17821503|P2|Period 1|Personal|2
5160692|NCT01383356|17821504|P1|Period 1|Personal|0
5160693|NCT01383356|17821503|P2|Period 1|Out of Range Mid-study-Test|1
5160694|NCT01383356|17821504|P1|Period 1|Out of Range Mid-study-Test|0
5160695|NCT01383356|17821503|P2|Period 1|Non-compliance|0
5160696|NCT01383356|17821504|P1|Period 1|Non-compliance|3
5160697|NCT01383356|17821503|P2|Period 1|Adverse Event|3
5160698|NCT01383356|17821504|P1|Period 1|Adverse Event|5
5160699|NCT01383317|17821516|P2|Overall Study|Adverse Event|1
5160700|NCT01383317|17821517|P1|Overall Study|Adverse Event|0
5160701|NCT01383317|17821516|P2|Overall Study|Death|0
5160702|NCT01383317|17821517|P1|Overall Study|Death|1
5160703|NCT01383317|17821516|P2|Overall Study|Lost to Follow-up|1
5160704|NCT01383317|17821517|P1|Overall Study|Lost to Follow-up|2
5160705|NCT01383174|17821559|P2|6 Month Assessment|Refused to complete|0
5160706|NCT01383174|17821560|P1|6 Month Assessment|Refused to complete|4
5160707|NCT01383174|17821559|P2|6 Month Assessment|Lost to Follow-up|1
5160708|NCT01383174|17821560|P1|6 Month Assessment|Lost to Follow-up|1
5160709|NCT01383174|17821559|P2|3 Month Assessment|Refused to complete|0
5160710|NCT01383174|17821560|P1|3 Month Assessment|Refused to complete|4
5160711|NCT01383174|17821559|P2|3 Month Assessment|Lost to Follow-up|0
5160712|NCT01383174|17821560|P1|3 Month Assessment|Lost to Follow-up|2
5160713|NCT01383174|17821559|P2|3 Month Assessment|Death|1
5160714|NCT01383174|17821560|P1|3 Month Assessment|Death|0
5160715|NCT01383161|17821586|P2|Overall Study|Lack of Efficacy|1
5160716|NCT01383161|17821587|P1|Overall Study|Lack of Efficacy|0
5160717|NCT01383161|17821586|P2|Overall Study|Withdrawal by Subject|2
5160718|NCT01383161|17821587|P1|Overall Study|Withdrawal by Subject|0
5160719|NCT01383161|17821586|P2|Overall Study|Adverse Event|1
5160720|NCT01383161|17821587|P1|Overall Study|Adverse Event|5
5160721|NCT01383096|17821606|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
5160722|NCT01383096|17821607|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
5160723|NCT01383096|17821608|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
5160724|NCT01383096|17821606|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
5160725|NCT01383096|17821607|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
5160726|NCT01383096|17821608|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
5160727|NCT01383096|17821606|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
5160728|NCT01383096|17821607|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
5160729|NCT01383096|17821608|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
5160730|NCT01383096|17821606|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5160731|NCT01383096|17821607|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5160732|NCT01383096|17821608|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5160733|NCT01383096|17821606|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
5160734|NCT01383096|17821607|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
5160735|NCT01383096|17821608|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
5160736|NCT01383096|17821606|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
5160737|NCT01383096|17821607|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
5160738|NCT01383096|17821608|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
5160739|NCT01383096|17821606|P3|Third Intervention (8 Days)|Adverse Event|0
5160740|NCT01383096|17821607|P2|Third Intervention (8 Days)|Adverse Event|0
5160741|NCT01383096|17821608|P1|Third Intervention (8 Days)|Adverse Event|1
5160742|NCT01383096|17821606|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5160743|NCT01383096|17821607|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
5160744|NCT01383096|17821608|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
5160745|NCT01383096|17821606|P3|Third Intervention (8 Days)|Elevated AST|0
5160746|NCT01383096|17821607|P2|Third Intervention (8 Days)|Elevated AST|1
5160747|NCT01383096|17821608|P1|Third Intervention (8 Days)|Elevated AST|0
5160748|NCT01383096|17821606|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5160749|NCT01383096|17821607|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5160750|NCT01383096|17821608|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5160751|NCT01383096|17821606|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
5160752|NCT01383096|17821607|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5160753|NCT01383096|17821608|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5160754|NCT01383018|17821654|P1|Overall Study|Subject Incarcerated|1
5160755|NCT01383018|17821654|P1|Overall Study|Patient moved away from site|1
5160756|NCT01383018|17821654|P1|Overall Study|Site closed early-not compliance related|7
5160757|NCT01383018|17821654|P1|Overall Study|Missed Visit|247
5160758|NCT01383018|17821654|P1|Overall Study|Subject not implanted|76
5160759|NCT01383018|17821654|P1|Overall Study|Withdrawal by Subject|9
5160760|NCT01383018|17821654|P1|Overall Study|Physician Decision|5
5160761|NCT01383018|17821654|P1|Overall Study|Lost to Follow-up|5
5160762|NCT01383018|17821654|P1|Overall Study|Death|10
5160763|NCT01383018|17821654|P1|Overall Study|Adverse Event|14
5160764|NCT01382940|17821716|P1|Overall Study|Protocol Violation|20
5160765|NCT01382940|17821716|P1|Overall Study|Withdrawal by Subject|23
5160766|NCT01382940|17821716|P1|Overall Study|Physician Decision|7
5160767|NCT01382940|17821716|P1|Overall Study|Lost to Follow-up|4
5160768|NCT01382940|17821716|P1|Overall Study|Adverse Event|19
5160769|NCT01382602|17821778|P2|Overall Study|Withdrawal by Subject|1
5160770|NCT01382602|17821779|P1|Overall Study|Withdrawal by Subject|0
5160771|NCT01382602|17821778|P2|Overall Study|Protocol Violation|3
5160772|NCT01382602|17821779|P1|Overall Study|Protocol Violation|0
5160773|NCT01382446|17821787|P2|Overall Study|Removal from Mechanical Ventilation|3
5160774|NCT01382446|17821788|P1|Overall Study|Removal from Mechanical Ventilation|3
5160775|NCT01382446|17821787|P2|Overall Study|Withdrawal by Subject|1
5160776|NCT01382446|17821788|P1|Overall Study|Withdrawal by Subject|0
5160777|NCT01382251|17821815|P2|Overall Study|Contacted after study closed|1
5160778|NCT01382251|17821816|P1|Overall Study|Contacted after study closed|1
5160779|NCT01382251|17821815|P2|Overall Study|Lost to Follow-up|4
5160780|NCT01382251|17821816|P1|Overall Study|Lost to Follow-up|4
5160781|NCT01382251|17821815|P2|Overall Study|Surgeries cancelled or delayed|16
5160782|NCT01382251|17821816|P1|Overall Study|Surgeries cancelled or delayed|16
5160783|NCT01382225|17821829|P2|Overall Study|Other|2
5160784|NCT01382225|17821830|P1|Overall Study|Other|4
5160785|NCT01382225|17821829|P2|Overall Study|Subject Withdrew Consent|2
5160786|NCT01382225|17821830|P1|Overall Study|Subject Withdrew Consent|5
5160787|NCT01382225|17821829|P2|Overall Study|Protocol Violation|1
5160788|NCT01382225|17821830|P1|Overall Study|Protocol Violation|2
5160789|NCT01382225|17821829|P2|Overall Study|Adverse Event|2
5160790|NCT01382225|17821830|P1|Overall Study|Adverse Event|3
5160791|NCT01382212|17821852|P1|Overall Study|Withdrew consent|1
5160792|NCT01382212|17821852|P1|Overall Study|Kidney transplant|1
5160793|NCT01381926|17821915|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
5160794|NCT01381926|17821916|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
5160795|NCT01381926|17821915|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
5160796|NCT01381926|17821916|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
5160797|NCT01381900|17821929|P3|Overall Study|Early withdraw|1
5160798|NCT01381900|17821930|P2|Overall Study|Early withdraw|1
5160799|NCT01381900|17821931|P1|Overall Study|Early withdraw|3
5160800|NCT01381900|17821929|P3|Overall Study|Withdrawal by Subject|1
5160801|NCT01381900|17821930|P2|Overall Study|Withdrawal by Subject|0
5160802|NCT01381900|17821931|P1|Overall Study|Withdrawal by Subject|0
5160803|NCT01381900|17821929|P3|Overall Study|Protocol Violation|1
5160804|NCT01381900|17821930|P2|Overall Study|Protocol Violation|1
5160805|NCT01381900|17821931|P1|Overall Study|Protocol Violation|0
5160806|NCT01381900|17821929|P3|Overall Study|Physician Decision|1
5160807|NCT01381900|17821930|P2|Overall Study|Physician Decision|1
5160808|NCT01381900|17821931|P1|Overall Study|Physician Decision|0
5160809|NCT01381900|17821929|P3|Overall Study|Noncompliance with study drug|1
5160810|NCT01381900|17821930|P2|Overall Study|Noncompliance with study drug|0
5160811|NCT01381900|17821931|P1|Overall Study|Noncompliance with study drug|0
5160812|NCT01381900|17821929|P3|Overall Study|Adverse Event|7
5160813|NCT01381900|17821930|P2|Overall Study|Adverse Event|6
5160814|NCT01381900|17821931|P1|Overall Study|Adverse Event|4
5160815|NCT01381900|17821929|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
5160816|NCT01381900|17821930|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
5160817|NCT01381900|17821931|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
5160818|NCT01381874|17821954|P3|Overall Study|Other|67
5160819|NCT01381874|17821955|P2|Overall Study|Other|52
5160820|NCT01381874|17821956|P1|Overall Study|Other|67
5160821|NCT01381874|17821954|P3|Overall Study|Withdrawal by Subject|9
5160822|NCT01381874|17821955|P2|Overall Study|Withdrawal by Subject|10
5160823|NCT01381874|17821956|P1|Overall Study|Withdrawal by Subject|9
5160824|NCT01381874|17821954|P3|Overall Study|Lost to Follow-up|0
5160825|NCT01381874|17821955|P2|Overall Study|Lost to Follow-up|1
5160826|NCT01381874|17821956|P1|Overall Study|Lost to Follow-up|1
5160827|NCT01381679|17821993|P1|Overall Study|Lost to Follow-up|885
5160828|NCT01381679|17821993|P1|Overall Study|Adverse Event|3
5160829|NCT01381575|17822008|P3|Overall Study|Lost to Follow-up|9
5160830|NCT01381575|17822009|P2|Overall Study|Lost to Follow-up|17
5160831|NCT01381575|17822010|P1|Overall Study|Lost to Follow-up|8
5160832|NCT01381575|17822008|P3|Overall Study|Migrated/moved from study area|2
5160833|NCT01381575|17822009|P2|Overall Study|Migrated/moved from study area|12
5160834|NCT01381575|17822010|P1|Overall Study|Migrated/moved from study area|2
5160835|NCT01381575|17822008|P3|Overall Study|Withdrawal by Subject|7
5160836|NCT01381575|17822009|P2|Overall Study|Withdrawal by Subject|9
5160837|NCT01381575|17822010|P1|Overall Study|Withdrawal by Subject|15
5160838|NCT01381575|17822008|P3|Overall Study|Protocol Violation|1
5160839|NCT01381575|17822009|P2|Overall Study|Protocol Violation|1
5160840|NCT01381575|17822010|P1|Overall Study|Protocol Violation|0
5160841|NCT01381575|17822008|P3|Overall Study|Non-Serious Adverse Event|1
5160842|NCT01381575|17822009|P2|Overall Study|Non-Serious Adverse Event|0
5160843|NCT01381575|17822010|P1|Overall Study|Non-Serious Adverse Event|0
5160844|NCT01381575|17822008|P3|Overall Study|Serious Adverse Event|0
5160845|NCT01381575|17822009|P2|Overall Study|Serious Adverse Event|0
5160846|NCT01381575|17822010|P1|Overall Study|Serious Adverse Event|1
5160847|NCT01381562|17822067|P3|Overall Study|Adverse Event|0
5160848|NCT01381562|17822068|P2|Overall Study|Adverse Event|1
5160849|NCT01381562|17822069|P1|Overall Study|Adverse Event|0
5160850|NCT01381549|17822137|P3|Overall Study|Ineligible: No organisms isolated|1
5160851|NCT01381549|17822138|P2|Overall Study|Ineligible: No organisms isolated|0
5160852|NCT01381549|17822139|P1|Overall Study|Ineligible: No organisms isolated|0
5160853|NCT01381068|17822265|P2|Overall Study|Death|0
5160854|NCT01381068|17822266|P1|Overall Study|Death|1
5160855|NCT01381016|17822286|P2|Overall Study|Physician Decision|2
5160856|NCT01381016|17822287|P1|Overall Study|Physician Decision|0
5160857|NCT01381016|17822286|P2|Overall Study|Withdrawal by Subject|1
5160858|NCT01381016|17822287|P1|Overall Study|Withdrawal by Subject|0
5160859|NCT01381016|17822286|P2|Overall Study|Screen Failure|2
5160860|NCT01381016|17822287|P1|Overall Study|Screen Failure|2
5160861|NCT01381016|17822286|P2|Overall Study|Lost to Follow-up|1
5160862|NCT01381016|17822287|P1|Overall Study|Lost to Follow-up|1
5160863|NCT01380834|17822297|P2|Overall Study|Physician Decision|0
5160864|NCT01380834|17822298|P1|Overall Study|Physician Decision|1
5160865|NCT01380782|17822310|P4|Overall Study|Withdrawal by Subject|1
5160866|NCT01380782|17822311|P3|Overall Study|Withdrawal by Subject|1
5160867|NCT01380782|17822312|P2|Overall Study|Withdrawal by Subject|0
5160868|NCT01380782|17822313|P1|Overall Study|Withdrawal by Subject|0
5160869|NCT01380782|17822310|P4|Overall Study|Physician Decision|0
5160870|NCT01380782|17822311|P3|Overall Study|Physician Decision|0
5160871|NCT01380782|17822312|P2|Overall Study|Physician Decision|0
5160872|NCT01380782|17822313|P1|Overall Study|Physician Decision|1
5160873|NCT01380782|17822310|P4|Overall Study|Lack of Efficacy|3
5160874|NCT01380782|17822311|P3|Overall Study|Lack of Efficacy|10
5160875|NCT01380782|17822312|P2|Overall Study|Lack of Efficacy|9
5160876|NCT01380782|17822313|P1|Overall Study|Lack of Efficacy|10
5160877|NCT01380782|17822310|P4|Overall Study|Death|0
5160878|NCT01380782|17822311|P3|Overall Study|Death|0
5160879|NCT01380782|17822312|P2|Overall Study|Death|0
5160880|NCT01380782|17822313|P1|Overall Study|Death|1
5160881|NCT01380782|17822310|P4|Overall Study|Adverse Event|0
5160882|NCT01380782|17822311|P3|Overall Study|Adverse Event|0
5160883|NCT01380782|17822312|P2|Overall Study|Adverse Event|1
5160884|NCT01380782|17822313|P1|Overall Study|Adverse Event|0
5160885|NCT01380769|17822336|P2|Overall Study|Protocol Violation|1
5160886|NCT01380769|17822337|P1|Overall Study|Protocol Violation|0
5160887|NCT01380769|17822336|P2|Overall Study|Adverse Event|1
5160888|NCT01380769|17822337|P1|Overall Study|Adverse Event|1
5160889|NCT01380769|17822336|P2|Overall Study|Physician Decision|1
5160890|NCT01380769|17822337|P1|Overall Study|Physician Decision|1
5160891|NCT01380769|17822336|P2|Overall Study|Withdrawal by Subject|11
5160892|NCT01380769|17822337|P1|Overall Study|Withdrawal by Subject|7
5160893|NCT01380730|17822398|P8|Overall Study|Death|0
5160894|NCT01380730|17822399|P7|Overall Study|Death|0
5160895|NCT01380730|17822400|P6|Overall Study|Death|0
5160896|NCT01380730|17822401|P5|Overall Study|Death|1
5160897|NCT01380730|17822402|P4|Overall Study|Death|0
5160898|NCT01380730|17822403|P3|Overall Study|Death|0
5160899|NCT01380730|17822404|P2|Overall Study|Death|0
5160900|NCT01380730|17822405|P1|Overall Study|Death|0
5160901|NCT01380691|17822463|P4|Washout (7 Days)|Withdrawal by Subject|0
5160902|NCT01380691|17822464|P3|Washout (7 Days)|Withdrawal by Subject|1
5160903|NCT01380691|17822465|P2|Washout (7 Days)|Withdrawal by Subject|0
5160904|NCT01380691|17822466|P1|Washout (7 Days)|Withdrawal by Subject|0
5160905|NCT01380691|17822463|P4|Washout (7 Days)|Protocol Violation|1
5160906|NCT01380691|17822464|P3|Washout (7 Days)|Protocol Violation|0
5160907|NCT01380691|17822465|P2|Washout (7 Days)|Protocol Violation|0
5160908|NCT01380691|17822466|P1|Washout (7 Days)|Protocol Violation|0
5160909|NCT01380535|17822527|P2|Overall Study|Lack of Efficacy|3
5160910|NCT01380535|17822528|P1|Overall Study|Lack of Efficacy|0
5160911|NCT01380535|17822527|P2|Overall Study|Protocol Violation|2
5160912|NCT01380535|17822528|P1|Overall Study|Protocol Violation|0
5160913|NCT01380535|17822527|P2|Overall Study|Withdrawal by Subject|2
5160914|NCT01380535|17822528|P1|Overall Study|Withdrawal by Subject|1
5160915|NCT01380535|17822527|P2|Overall Study|Study site closed|5
5160916|NCT01380535|17822528|P1|Overall Study|Study site closed|0
5160917|NCT01380535|17822527|P2|Overall Study|Death|0
5160918|NCT01380535|17822528|P1|Overall Study|Death|3
5160919|NCT01380535|17822527|P2|Overall Study|Adverse Event|3
5160920|NCT01380535|17822528|P1|Overall Study|Adverse Event|3
5160921|NCT01380379|17822534|P1|Overall Study|Pregnancy|1
5160922|NCT01380327|17822547|P3|Overall Study|Questionable onset of epilepsy|1
5160923|NCT01380327|17822548|P2|Overall Study|Questionable onset of epilepsy|0
5160924|NCT01380327|17822549|P1|Overall Study|Questionable onset of epilepsy|0
5160925|NCT01380327|17822547|P3|Overall Study|Housing situation precluded ability to k|1
5160926|NCT01380327|17822548|P2|Overall Study|Housing situation precluded ability to k|0
5160927|NCT01380327|17822549|P1|Overall Study|Housing situation precluded ability to k|0
5160928|NCT01380327|17822547|P3|Overall Study|Withdrawal by Subject|1
5160929|NCT01380327|17822548|P2|Overall Study|Withdrawal by Subject|0
5160930|NCT01380327|17822549|P1|Overall Study|Withdrawal by Subject|0
5160931|NCT01380327|17822547|P3|Overall Study|Protocol Violation|3
5160932|NCT01380327|17822548|P2|Overall Study|Protocol Violation|2
5160933|NCT01380327|17822549|P1|Overall Study|Protocol Violation|3
5160934|NCT01380327|17822547|P3|Overall Study|Lost to Follow-up|1
5160935|NCT01380327|17822548|P2|Overall Study|Lost to Follow-up|1
5160936|NCT01380327|17822549|P1|Overall Study|Lost to Follow-up|0
5160937|NCT01380184|17822580|P1|Part 2|Lost to Follow-up|1
5160938|NCT01380184|17822580|P1|Part 2|Disease Progression|8
5160939|NCT01380184|17822580|P1|Part 2|Adverse Event|5
5160940|NCT01380184|17822580|P1|Part 1 (19 Days)|Adverse Event|1
5160941|NCT01380145|17822591|P1|Overall Study|Progressive disease|4
5160942|NCT01380093|17822599|P9|Treatment Phase: Third Intervention|Other|1
5160943|NCT01380093|17822600|P8|Treatment Phase: Third Intervention|Other|0
5160944|NCT01380093|17822601|P7|Treatment Phase: Third Intervention|Other|0
5160945|NCT01380093|17822602|P6|Treatment Phase: Third Intervention|Other|0
5160946|NCT01380093|17822603|P5|Treatment Phase: Third Intervention|Other|0
5160947|NCT01380093|17822604|P4|Treatment Phase: Third Intervention|Other|0
5160948|NCT01380093|17822605|P3|Treatment Phase: Third Intervention|Other|0
5160949|NCT01380093|17822606|P2|Treatment Phase: Third Intervention|Other|0
5160950|NCT01380093|17822607|P1|Treatment Phase: Third Intervention|Other|0
5160951|NCT01380093|17822599|P9|Treatment Phase: Third Intervention|Non-compliance|1
5160952|NCT01380093|17822600|P8|Treatment Phase: Third Intervention|Non-compliance|0
5160953|NCT01380093|17822601|P7|Treatment Phase: Third Intervention|Non-compliance|0
5160954|NCT01380093|17822602|P6|Treatment Phase: Third Intervention|Non-compliance|0
5160955|NCT01380093|17822603|P5|Treatment Phase: Third Intervention|Non-compliance|0
5160956|NCT01380093|17822604|P4|Treatment Phase: Third Intervention|Non-compliance|0
5160957|NCT01380093|17822605|P3|Treatment Phase: Third Intervention|Non-compliance|0
5160958|NCT01380093|17822606|P2|Treatment Phase: Third Intervention|Non-compliance|0
5160959|NCT01380093|17822607|P1|Treatment Phase: Third Intervention|Non-compliance|0
5160960|NCT01380093|17822599|P9|Treatment Phase: Second Intervention|Other|0
5160961|NCT01380093|17822600|P8|Treatment Phase: Second Intervention|Other|0
5160962|NCT01380093|17822601|P7|Treatment Phase: Second Intervention|Other|0
5160963|NCT01380093|17822602|P6|Treatment Phase: Second Intervention|Other|0
5160964|NCT01380093|17822603|P5|Treatment Phase: Second Intervention|Other|0
5160965|NCT01380093|17822604|P4|Treatment Phase: Second Intervention|Other|1
5160966|NCT01380093|17822605|P3|Treatment Phase: Second Intervention|Other|0
5160967|NCT01380093|17822606|P2|Treatment Phase: Second Intervention|Other|0
5160968|NCT01380093|17822607|P1|Treatment Phase: Second Intervention|Other|0
5160969|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160970|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160971|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160972|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160973|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160974|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160975|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
5160976|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160977|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
5160978|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 2|Backup participant|0
5160979|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 2|Backup participant|0
5160980|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 2|Backup participant|0
5160981|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 2|Backup participant|0
5160982|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 2|Backup participant|0
5160983|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 2|Backup participant|0
5160984|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 2|Backup participant|1
5160985|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 2|Backup participant|0
5160986|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 2|Backup participant|0
5160987|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160988|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160989|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160990|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160991|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160992|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160993|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
5160994|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
5160995|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5160996|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
5160997|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
5160998|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
5160999|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
5161000|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
5161001|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
5161002|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
5161003|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
5161004|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
5161005|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161006|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161007|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161008|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161009|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161010|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161011|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161012|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
5161013|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5161014|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
5161015|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
5161016|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
5161017|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
5161018|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
5161019|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
5161020|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
5161021|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
5161022|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
5161023|NCT01380093|17822599|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161024|NCT01380093|17822600|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161025|NCT01380093|17822601|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161026|NCT01380093|17822602|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161027|NCT01380093|17822603|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161028|NCT01380093|17822604|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161029|NCT01380093|17822605|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161030|NCT01380093|17822606|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
5161031|NCT01380093|17822607|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
5161032|NCT01380093|17822599|P9|Naloxone Challenge Phase|Screen failures|0
5161033|NCT01380093|17822600|P8|Naloxone Challenge Phase|Screen failures|0
5161034|NCT01380093|17822601|P7|Naloxone Challenge Phase|Screen failures|0
5161035|NCT01380093|17822602|P6|Naloxone Challenge Phase|Screen failures|0
5161036|NCT01380093|17822603|P5|Naloxone Challenge Phase|Screen failures|0
5161037|NCT01380093|17822604|P4|Naloxone Challenge Phase|Screen failures|0
5161038|NCT01380093|17822605|P3|Naloxone Challenge Phase|Screen failures|0
5161039|NCT01380093|17822606|P2|Naloxone Challenge Phase|Screen failures|0
5161040|NCT01380093|17822607|P1|Naloxone Challenge Phase|Screen failures|21
5161041|NCT01380080|17822899|P2|Overall Study|Lost to Follow-up|0
5161042|NCT01380080|17822900|P1|Overall Study|Lost to Follow-up|2
5161043|NCT01380080|17822899|P2|Overall Study|Not willing to adhere to requirements|1
5161044|NCT01380080|17822900|P1|Overall Study|Not willing to adhere to requirements|3
5161045|NCT01380080|17822899|P2|Overall Study|Not able to get to clinic|0
5161046|NCT01380080|17822900|P1|Overall Study|Not able to get to clinic|4
5161047|NCT01380080|17822899|P2|Overall Study|Withdrawal by Subject|0
5161048|NCT01380080|17822900|P1|Overall Study|Withdrawal by Subject|4
5161049|NCT01380080|17822899|P2|Overall Study|Death|22
5161050|NCT01380080|17822900|P1|Overall Study|Death|20
5161051|NCT01379937|17822925|P4|Overall Study|Lost to Follow-up|0
5161052|NCT01379937|17822926|P3|Overall Study|Lost to Follow-up|2
5161053|NCT01379937|17822927|P2|Overall Study|Lost to Follow-up|2
5161054|NCT01379937|17822928|P1|Overall Study|Lost to Follow-up|1
5161055|NCT01379937|17822925|P4|Overall Study|Consent withdrawal|0
5161056|NCT01379937|17822926|P3|Overall Study|Consent withdrawal|0
5161057|NCT01379937|17822927|P2|Overall Study|Consent withdrawal|1
5161058|NCT01379937|17822928|P1|Overall Study|Consent withdrawal|0
5161059|NCT01379937|17822925|P4|Overall Study|Protocol Violation|1
5161060|NCT01379937|17822926|P3|Overall Study|Protocol Violation|0
5161061|NCT01379937|17822927|P2|Overall Study|Protocol Violation|0
5161062|NCT01379937|17822928|P1|Overall Study|Protocol Violation|0
5161063|NCT01379781|17823048|P2|Overall Study|Lost to Follow-up|8
5161064|NCT01379781|17823049|P1|Overall Study|Lost to Follow-up|11
5161065|NCT01379768|17823058|P3|Overall Study|Lost to Follow-up|0
5161066|NCT01379768|17823059|P2|Overall Study|Lost to Follow-up|0
5161067|NCT01379768|17823060|P1|Overall Study|Lost to Follow-up|2
5161068|NCT01379768|17823058|P3|Overall Study|Adverse Event|0
5161069|NCT01379768|17823059|P2|Overall Study|Adverse Event|1
5161070|NCT01379768|17823060|P1|Overall Study|Adverse Event|1
5161071|NCT01379703|17823083|P3|9 Months Through 18 Months|Reason Unknown|0
5161072|NCT01379703|17823084|P2|9 Months Through 18 Months|Reason Unknown|23
5161073|NCT01379703|17823085|P1|9 Months Through 18 Months|Reason Unknown|0
5161074|NCT01379703|17823083|P3|9 Months Through 18 Months|Fatigue|0
5161075|NCT01379703|17823084|P2|9 Months Through 18 Months|Fatigue|1
5161076|NCT01379703|17823085|P1|9 Months Through 18 Months|Fatigue|0
5161077|NCT01379703|17823083|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
5161078|NCT01379703|17823084|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
5161079|NCT01379703|17823085|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
5161080|NCT01379703|17823083|P3|9 Months Through 18 Months|Patient Noncompliance|0
5161081|NCT01379703|17823084|P2|9 Months Through 18 Months|Patient Noncompliance|4
5161082|NCT01379703|17823085|P1|9 Months Through 18 Months|Patient Noncompliance|0
5161083|NCT01379703|17823083|P3|9 Months Through 18 Months|Treatment failure|0
5161084|NCT01379703|17823084|P2|9 Months Through 18 Months|Treatment failure|5
5161085|NCT01379703|17823085|P1|9 Months Through 18 Months|Treatment failure|0
5161086|NCT01379703|17823083|P3|9 Months Through 18 Months|Adverse Event|0
5161087|NCT01379703|17823084|P2|9 Months Through 18 Months|Adverse Event|6
5161088|NCT01379703|17823085|P1|9 Months Through 18 Months|Adverse Event|0
5161089|NCT01379703|17823083|P3|9 Months Through 18 Months|Withdrawal by Subject|0
5161090|NCT01379703|17823084|P2|9 Months Through 18 Months|Withdrawal by Subject|11
5161091|NCT01379703|17823085|P1|9 Months Through 18 Months|Withdrawal by Subject|0
5161092|NCT01379703|17823083|P3|9 Months Through 18 Months|Lost to Follow-up|0
5161093|NCT01379703|17823084|P2|9 Months Through 18 Months|Lost to Follow-up|178
5161094|NCT01379703|17823085|P1|9 Months Through 18 Months|Lost to Follow-up|0
5161095|NCT01379703|17823083|P3|Study Start Through 9 Months|Reason unknown|24
5161096|NCT01379703|17823084|P2|Study Start Through 9 Months|Reason unknown|31
5161097|NCT01379703|17823085|P1|Study Start Through 9 Months|Reason unknown|2
5161098|NCT01379703|17823083|P3|Study Start Through 9 Months|Increased triglycerides|0
5161099|NCT01379703|17823084|P2|Study Start Through 9 Months|Increased triglycerides|1
5161100|NCT01379703|17823085|P1|Study Start Through 9 Months|Increased triglycerides|0
5161101|NCT01379703|17823083|P3|Study Start Through 9 Months|Poor general condition|0
5161102|NCT01379703|17823084|P2|Study Start Through 9 Months|Poor general condition|1
5161103|NCT01379703|17823085|P1|Study Start Through 9 Months|Poor general condition|0
5161104|NCT01379703|17823083|P3|Study Start Through 9 Months|Medication not available|1
5161105|NCT01379703|17823084|P2|Study Start Through 9 Months|Medication not available|2
5161106|NCT01379703|17823085|P1|Study Start Through 9 Months|Medication not available|0
5161107|NCT01379703|17823083|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
5161108|NCT01379703|17823084|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
5161109|NCT01379703|17823085|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
5161110|NCT01379703|17823083|P3|Study Start Through 9 Months|Patient Noncompliance|1
5161111|NCT01379703|17823084|P2|Study Start Through 9 Months|Patient Noncompliance|0
5161112|NCT01379703|17823085|P1|Study Start Through 9 Months|Patient Noncompliance|0
5161113|NCT01379703|17823083|P3|Study Start Through 9 Months|Treatment Failure|2
5161114|NCT01379703|17823084|P2|Study Start Through 9 Months|Treatment Failure|2
5161115|NCT01379703|17823085|P1|Study Start Through 9 Months|Treatment Failure|0
5161116|NCT01379703|17823083|P3|Study Start Through 9 Months|Withdrawal by Subject|1
5161117|NCT01379703|17823084|P2|Study Start Through 9 Months|Withdrawal by Subject|6
5161118|NCT01379703|17823085|P1|Study Start Through 9 Months|Withdrawal by Subject|0
5161119|NCT01379703|17823083|P3|Study Start Through 9 Months|Adverse Event|10
5161120|NCT01379703|17823084|P2|Study Start Through 9 Months|Adverse Event|14
5161121|NCT01379703|17823085|P1|Study Start Through 9 Months|Adverse Event|0
5161122|NCT01379703|17823083|P3|Study Start Through 9 Months|Lost to Follow-up|104
5161123|NCT01379703|17823084|P2|Study Start Through 9 Months|Lost to Follow-up|61
5161124|NCT01379703|17823085|P1|Study Start Through 9 Months|Lost to Follow-up|2
5161125|NCT01379573|17823183|P1|Overall Study|Screen Failure|10
5161126|NCT01379573|17823183|P1|Overall Study|Lost to Follow-up|1
5161127|NCT01379534|17823197|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
5161128|NCT01379534|17823198|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
5161129|NCT01379534|17823197|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
5161130|NCT01379534|17823198|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
5161131|NCT01379534|17823197|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
5161132|NCT01379534|17823198|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
5161133|NCT01379534|17823197|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
5161134|NCT01379534|17823198|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
5161135|NCT01379534|17823197|P2|Treatment Phase|Adverse Event|7
5161136|NCT01379534|17823198|P1|Treatment Phase|Adverse Event|7
5161137|NCT01379534|17823197|P2|Treatment Phase|Progressive disease|22
5161138|NCT01379534|17823198|P1|Treatment Phase|Progressive disease|13
5161139|NCT01379534|17823197|P2|Treatment Phase|Withdrawal by Subject|2
5161140|NCT01379534|17823198|P1|Treatment Phase|Withdrawal by Subject|2
5161141|NCT01379521|17823218|P2|Post-Treatment Evaluations|Death|0
5161142|NCT01379521|17823219|P1|Post-Treatment Evaluations|Death|1
5161143|NCT01379521|17823218|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
5161144|NCT01379521|17823219|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
5161145|NCT01379521|17823218|P2|Post-Treatment Evaluations|Disease Progression|20
5161146|NCT01379521|17823219|P1|Post-Treatment Evaluations|Disease Progression|22
5161147|NCT01379521|17823218|P2|Overall Study -Treatment Period|Death|1
5161148|NCT01379521|17823219|P1|Overall Study -Treatment Period|Death|2
5161149|NCT01379521|17823218|P2|Overall Study -Treatment Period|Administrative Problems|0
5161150|NCT01379521|17823219|P1|Overall Study -Treatment Period|Administrative Problems|1
5161151|NCT01379521|17823218|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
5161152|NCT01379521|17823219|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
5161153|NCT01379521|17823218|P2|Overall Study -Treatment Period|Protocol Deviation|2
5161154|NCT01379521|17823219|P1|Overall Study -Treatment Period|Protocol Deviation|0
5161155|NCT01379521|17823218|P2|Overall Study -Treatment Period|New Cancer Therapy|0
5161156|NCT01379521|17823219|P1|Overall Study -Treatment Period|New Cancer Therapy|1
5161157|NCT01379521|17823218|P2|Overall Study -Treatment Period|Disease Progression|22
5161158|NCT01379521|17823219|P1|Overall Study -Treatment Period|Disease Progression|23
5161159|NCT01379521|17823218|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
5161160|NCT01379521|17823219|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
5161161|NCT01379521|17823218|P2|Overall Study -Treatment Period|Adverse Event|0
5161162|NCT01379521|17823219|P1|Overall Study -Treatment Period|Adverse Event|3
5161163|NCT01379508|17823241|P4|Extension Period Weeks 109-156|Protocol Violation|0
5161164|NCT01379508|17823242|P3|Extension Period Weeks 109-156|Protocol Violation|0
5161165|NCT01379508|17823243|P2|Extension Period Weeks 109-156|Protocol Violation|1
5161166|NCT01379508|17823244|P1|Extension Period Weeks 109-156|Protocol Violation|2
5161167|NCT01379508|17823241|P4|Extension Period Weeks 109-156|Administrative problems|0
5161168|NCT01379508|17823242|P3|Extension Period Weeks 109-156|Administrative problems|1
5161169|NCT01379508|17823243|P2|Extension Period Weeks 109-156|Administrative problems|0
5161170|NCT01379508|17823244|P1|Extension Period Weeks 109-156|Administrative problems|3
5161171|NCT01379508|17823241|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
5161172|NCT01379508|17823242|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
5161173|NCT01379508|17823243|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
5161174|NCT01379508|17823244|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
5161175|NCT01379508|17823241|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
5161176|NCT01379508|17823242|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
5161177|NCT01379508|17823243|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
5161178|NCT01379508|17823244|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
5161179|NCT01379508|17823241|P4|Treatment to Week 104|Protocol Violation|0
5161180|NCT01379508|17823242|P3|Treatment to Week 104|Protocol Violation|1
5161181|NCT01379508|17823243|P2|Treatment to Week 104|Protocol Violation|1
5161182|NCT01379508|17823244|P1|Treatment to Week 104|Protocol Violation|1
5161183|NCT01379508|17823241|P4|Treatment to Week 104|Administrative problems|0
5161184|NCT01379508|17823242|P3|Treatment to Week 104|Administrative problems|0
5161185|NCT01379508|17823243|P2|Treatment to Week 104|Administrative problems|1
5161186|NCT01379508|17823244|P1|Treatment to Week 104|Administrative problems|3
5161187|NCT01379508|17823241|P4|Treatment to Week 104|Lost to Follow-up|0
5161188|NCT01379508|17823242|P3|Treatment to Week 104|Lost to Follow-up|3
5161189|NCT01379508|17823243|P2|Treatment to Week 104|Lost to Follow-up|0
5161190|NCT01379508|17823244|P1|Treatment to Week 104|Lost to Follow-up|5
5161191|NCT01379508|17823241|P4|Treatment to Week 104|Withdrawal by Subject|0
5161192|NCT01379508|17823242|P3|Treatment to Week 104|Withdrawal by Subject|4
5161193|NCT01379508|17823243|P2|Treatment to Week 104|Withdrawal by Subject|1
5161194|NCT01379508|17823244|P1|Treatment to Week 104|Withdrawal by Subject|6
5161195|NCT01379508|17823241|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
5161196|NCT01379508|17823242|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
5161197|NCT01379508|17823243|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
5161198|NCT01379508|17823244|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
5161199|NCT01379508|17823241|P4|Treatment to Week 104|Abnormal lab value|0
5161200|NCT01379508|17823242|P3|Treatment to Week 104|Abnormal lab value|0
5161201|NCT01379508|17823243|P2|Treatment to Week 104|Abnormal lab value|0
5161202|NCT01379508|17823244|P1|Treatment to Week 104|Abnormal lab value|1
5161203|NCT01379508|17823241|P4|Treatment to Week 104|Adverse Event|0
5161204|NCT01379508|17823242|P3|Treatment to Week 104|Adverse Event|5
5161205|NCT01379508|17823243|P2|Treatment to Week 104|Adverse Event|0
5161206|NCT01379508|17823244|P1|Treatment to Week 104|Adverse Event|2
5161207|NCT01379274|17823270|P1|Overall Study|funding withdrawn|1
5161208|NCT01378975|17823330|P2|Overall Study|Withdrew Consent|3
5161209|NCT01378975|17823331|P1|Overall Study|Withdrew Consent|4
5161210|NCT01378975|17823330|P2|Overall Study|Lost to Follow-up|1
5161211|NCT01378975|17823331|P1|Overall Study|Lost to Follow-up|4
5161212|NCT01378975|17823330|P2|Overall Study|Investigator Request|0
5161213|NCT01378975|17823331|P1|Overall Study|Investigator Request|1
5161214|NCT01378975|17823330|P2|Overall Study|Death|46
5161215|NCT01378975|17823331|P1|Overall Study|Death|77
5161216|NCT01378962|17823357|P1|Overall Study|Other|2
5161217|NCT01378962|17823357|P1|Overall Study|Lost to Follow-up|1
5161218|NCT01378962|17823357|P1|Overall Study|Death|14
5161219|NCT01378429|17823383|P2|Overall Study|Noncompliance with study drug|0
5161220|NCT01378429|17823384|P1|Overall Study|Noncompliance with study drug|1
5161221|NCT01378325|17823497|P2|Overall Study|Protocol Violation|1
5161222|NCT01378325|17823498|P1|Overall Study|Protocol Violation|0
5161223|NCT01378195|17823567|P2|Overall Study|Lost to Follow-up|18
5161224|NCT01378195|17823568|P1|Overall Study|Lost to Follow-up|29
5161225|NCT01378117|17823581|P3|Overall Study|discharged before med given|1
5161226|NCT01378117|17823582|P2|Overall Study|discharged before med given|0
5161227|NCT01378117|17823583|P1|Overall Study|discharged before med given|2
5161228|NCT01378117|17823581|P3|Overall Study|withdrawal|2
5161229|NCT01378117|17823582|P2|Overall Study|withdrawal|1
5161230|NCT01378117|17823583|P1|Overall Study|withdrawal|2
5161231|NCT01378104|17823617|P2|Overall Study|Withdrawal by Subject|13
5161232|NCT01378104|17823618|P1|Overall Study|Withdrawal by Subject|12
5161233|NCT01378104|17823617|P2|Overall Study|Lack of Efficacy|5
5161234|NCT01378104|17823618|P1|Overall Study|Lack of Efficacy|7
5161235|NCT01378104|17823617|P2|Overall Study|Adverse Event|8
5161236|NCT01378104|17823618|P1|Overall Study|Adverse Event|8
5161237|NCT01377987|17823663|P2|Washout (7 Days)|Withdrawal by Subject|1
5161238|NCT01377987|17823664|P1|Washout (7 Days)|Withdrawal by Subject|1
5161239|NCT01377922|17823682|P2|Overall Study|rescue tx after part 2, entered part 4|0
5161240|NCT01377922|17823683|P1|Overall Study|rescue tx after part 2, entered part 4|1
5161241|NCT01377480|17823768|P4|Overall Study|Other|6
5161242|NCT01377480|17823769|P3|Overall Study|Other|7
5161243|NCT01377480|17823770|P2|Overall Study|Other|0
5161244|NCT01377480|17823771|P1|Overall Study|Other|0
5161245|NCT01377480|17823768|P4|Overall Study|Serious adverse event|1
5161246|NCT01377480|17823769|P3|Overall Study|Serious adverse event|1
5161247|NCT01377480|17823770|P2|Overall Study|Serious adverse event|0
5161248|NCT01377480|17823771|P1|Overall Study|Serious adverse event|0
5161249|NCT01377480|17823768|P4|Overall Study|Withdrawal by Subject|0
5161250|NCT01377480|17823769|P3|Overall Study|Withdrawal by Subject|1
5161251|NCT01377480|17823770|P2|Overall Study|Withdrawal by Subject|0
5161252|NCT01377480|17823771|P1|Overall Study|Withdrawal by Subject|0
5161253|NCT01377480|17823768|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
5161254|NCT01377480|17823769|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
5161255|NCT01377480|17823770|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
5161256|NCT01377480|17823771|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
5161257|NCT01377480|17823768|P4|Overall Study|Protocol Violation|4
5161258|NCT01377480|17823769|P3|Overall Study|Protocol Violation|0
5161259|NCT01377480|17823770|P2|Overall Study|Protocol Violation|0
5161260|NCT01377480|17823771|P1|Overall Study|Protocol Violation|0
5161261|NCT01377389|17823847|P1|Overall Study|Screen failure|2
5161262|NCT01377389|17823847|P1|Overall Study|Withdrawal by Subject|1
5161263|NCT01377233|17823861|P5|Double-blind|Administrative or other|1
5161264|NCT01377233|17823862|P4|Double-blind|Administrative or other|1
5161265|NCT01377233|17823863|P3|Double-blind|Administrative or other|0
5161266|NCT01377233|17823864|P2|Double-blind|Administrative or other|0
5161267|NCT01377233|17823865|P1|Double-blind|Administrative or other|0
5161268|NCT01377233|17823861|P5|Double-blind|Withdrawal by Subject|0
5161269|NCT01377233|17823862|P4|Double-blind|Withdrawal by Subject|1
5161270|NCT01377233|17823863|P3|Double-blind|Withdrawal by Subject|0
5161271|NCT01377233|17823864|P2|Double-blind|Withdrawal by Subject|0
5161272|NCT01377233|17823865|P1|Double-blind|Withdrawal by Subject|0
5161273|NCT01377233|17823861|P5|Double-blind|Protocol Violation|1
5161274|NCT01377233|17823862|P4|Double-blind|Protocol Violation|0
5161275|NCT01377233|17823863|P3|Double-blind|Protocol Violation|0
5161276|NCT01377233|17823864|P2|Double-blind|Protocol Violation|0
5161277|NCT01377233|17823865|P1|Double-blind|Protocol Violation|0
5161278|NCT01377233|17823861|P5|Double-blind|Adverse Event|0
5161279|NCT01377233|17823862|P4|Double-blind|Adverse Event|2
5161280|NCT01377233|17823863|P3|Double-blind|Adverse Event|2
5161281|NCT01377233|17823864|P2|Double-blind|Adverse Event|1
5161282|NCT01377233|17823865|P1|Double-blind|Adverse Event|0
5161283|NCT01377233|17823861|P5|Open-label|Withdrawal by Subject|0
5161284|NCT01377233|17823862|P4|Open-label|Withdrawal by Subject|0
5161285|NCT01377233|17823863|P3|Open-label|Withdrawal by Subject|0
5161286|NCT01377233|17823864|P2|Open-label|Withdrawal by Subject|0
5161287|NCT01377233|17823865|P1|Open-label|Withdrawal by Subject|3
5161288|NCT01377233|17823861|P5|Open-label|Adverse Event|0
5161289|NCT01377233|17823862|P4|Open-label|Adverse Event|0
5161290|NCT01377233|17823863|P3|Open-label|Adverse Event|0
5161291|NCT01377233|17823864|P2|Open-label|Adverse Event|0
5161292|NCT01377233|17823865|P1|Open-label|Adverse Event|1
5161293|NCT01377194|17823892|P3|Overall Study|Lost to Follow-up|11
5161294|NCT01377194|17823893|P2|Overall Study|Lost to Follow-up|8
5161295|NCT01377194|17823894|P1|Overall Study|Lost to Follow-up|14
5161296|NCT01377194|17823892|P3|Overall Study|Withdrawal by Subject|7
5161297|NCT01377194|17823893|P2|Overall Study|Withdrawal by Subject|10
5161298|NCT01377194|17823894|P1|Overall Study|Withdrawal by Subject|8
5161299|NCT01377194|17823892|P3|Overall Study|Protocol Violation|6
5161300|NCT01377194|17823893|P2|Overall Study|Protocol Violation|10
5161301|NCT01377194|17823894|P1|Overall Study|Protocol Violation|4
5161302|NCT01377194|17823892|P3|Overall Study|Lack of Efficacy|3
5161303|NCT01377194|17823893|P2|Overall Study|Lack of Efficacy|3
5161304|NCT01377194|17823894|P1|Overall Study|Lack of Efficacy|3
5161305|NCT01377194|17823892|P3|Overall Study|Adverse Event|19
5161306|NCT01377194|17823893|P2|Overall Study|Adverse Event|12
5161307|NCT01377194|17823894|P1|Overall Study|Adverse Event|3
5161308|NCT01377012|17823908|P3|Extension Study, Weeks 104-260|Adverse Event|1
5161309|NCT01377012|17823909|P2|Extension Study, Weeks 104-260|Adverse Event|2
5161310|NCT01377012|17823910|P1|Extension Study, Weeks 104-260|Adverse Event|0
5161311|NCT01377012|17823908|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
5161312|NCT01377012|17823909|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
5161313|NCT01377012|17823910|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
5161314|NCT01377012|17823908|P3|Extension Study, Weeks 104-260|Physician Decision|0
5161315|NCT01377012|17823909|P2|Extension Study, Weeks 104-260|Physician Decision|0
5161316|NCT01377012|17823910|P1|Extension Study, Weeks 104-260|Physician Decision|1
5161317|NCT01377012|17823908|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
5161318|NCT01377012|17823909|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
5161319|NCT01377012|17823910|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
5161320|NCT01377012|17823908|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
5161321|NCT01377012|17823909|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
5161322|NCT01377012|17823910|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
5161323|NCT01377012|17823908|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
5161324|NCT01377012|17823909|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
5161325|NCT01377012|17823910|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
5161326|NCT01377012|17823908|P3|Core Study|Adverse Event|13
5161327|NCT01377012|17823909|P2|Core Study|Adverse Event|14
5161328|NCT01377012|17823910|P1|Core Study|Adverse Event|10
5161329|NCT01377012|17823908|P3|Core Study|Death|1
5161330|NCT01377012|17823909|P2|Core Study|Death|1
5161331|NCT01377012|17823910|P1|Core Study|Death|1
5161332|NCT01377012|17823908|P3|Core Study|Lack of Efficacy|37
5161333|NCT01377012|17823909|P2|Core Study|Lack of Efficacy|28
5161334|NCT01377012|17823910|P1|Core Study|Lack of Efficacy|41
5161335|NCT01377012|17823908|P3|Core Study|Lost to Follow-up|4
5161336|NCT01377012|17823909|P2|Core Study|Lost to Follow-up|5
5161337|NCT01377012|17823910|P1|Core Study|Lost to Follow-up|7
5161338|NCT01377012|17823908|P3|Core Study|No Longer require treatment|1
5161339|NCT01377012|17823909|P2|Core Study|No Longer require treatment|0
5161340|NCT01377012|17823910|P1|Core Study|No Longer require treatment|0
5161341|NCT01377012|17823908|P3|Core Study|Non-Compliant with study treatment|1
5161342|NCT01377012|17823909|P2|Core Study|Non-Compliant with study treatment|0
5161343|NCT01377012|17823910|P1|Core Study|Non-Compliant with study treatment|0
5161344|NCT01377012|17823908|P3|Core Study|Physician Decision|10
5161345|NCT01377012|17823909|P2|Core Study|Physician Decision|4
5161346|NCT01377012|17823910|P1|Core Study|Physician Decision|5
5161347|NCT01377012|17823908|P3|Core Study|Pregnancy|1
5161348|NCT01377012|17823909|P2|Core Study|Pregnancy|0
5161349|NCT01377012|17823910|P1|Core Study|Pregnancy|0
5161350|NCT01377012|17823908|P3|Core Study|Protocol Violation|2
5161351|NCT01377012|17823909|P2|Core Study|Protocol Violation|3
5161352|NCT01377012|17823910|P1|Core Study|Protocol Violation|7
5161353|NCT01377012|17823908|P3|Core Study|Withdrawal by Subject|18
5161354|NCT01377012|17823909|P2|Core Study|Withdrawal by Subject|23
5161355|NCT01377012|17823910|P1|Core Study|Withdrawal by Subject|15
5161356|NCT01377012|17823908|P3|Core Study|Technical problems|0
5161357|NCT01377012|17823909|P2|Core Study|Technical problems|0
5161358|NCT01377012|17823910|P1|Core Study|Technical problems|1
5161359|NCT01377012|17823908|P3|Core Study|Study terminated by Sponsor|46
5161360|NCT01377012|17823909|P2|Core Study|Study terminated by Sponsor|54
5161361|NCT01377012|17823910|P1|Core Study|Study terminated by Sponsor|47
5161362|NCT01376908|17823947|P2|Overall Study|Withdrawal by Subject|2
5161363|NCT01376908|17823948|P1|Overall Study|Withdrawal by Subject|1
5161364|NCT01376908|17823947|P2|Overall Study|Protocol Violation|1
5161365|NCT01376908|17823948|P1|Overall Study|Protocol Violation|1
5161366|NCT01376804|17823981|P1|Treatment Period|Patient did not receive study drug|1
5161367|NCT01376804|17823981|P1|Treatment Period|Adverse Event|6
5161368|NCT01376804|17823981|P1|Treatment Period|Withdrawal by Subject|1
5161369|NCT01376700|17823992|P1|Overall Study|Low or high titer inhibitor|8
5161370|NCT01376700|17823992|P1|Overall Study|Sponsor terminated study early|8
5161371|NCT01376388|17824054|P1|Overall Study|Withdrawal by Subject|3
5161372|NCT01376388|17824054|P1|Overall Study|Lack of Efficacy|2
5161373|NCT01376388|17824054|P1|Overall Study|Adverse Event|13
5161374|NCT01376349|17824092|P3|Raondomized Treatment|Alternative Treatment|1
5161375|NCT01376349|17824093|P2|Raondomized Treatment|Alternative Treatment|0
5161376|NCT01376349|17824094|P1|Raondomized Treatment|Alternative Treatment|0
5161377|NCT01376349|17824092|P3|Raondomized Treatment|Unkown|1
5161378|NCT01376349|17824093|P2|Raondomized Treatment|Unkown|2
5161379|NCT01376349|17824094|P1|Raondomized Treatment|Unkown|1
5161380|NCT01376349|17824092|P3|Raondomized Treatment|Adverse Event|14
5161381|NCT01376349|17824093|P2|Raondomized Treatment|Adverse Event|17
5161382|NCT01376349|17824094|P1|Raondomized Treatment|Adverse Event|13
5161383|NCT01376349|17824092|P3|Raondomized Treatment|Withdrawal by Subject|13
5161384|NCT01376349|17824093|P2|Raondomized Treatment|Withdrawal by Subject|16
5161385|NCT01376349|17824094|P1|Raondomized Treatment|Withdrawal by Subject|10
5161386|NCT01376323|17824108|P5|Overall Study|Withdrawal by Subject|0
5161387|NCT01376323|17824109|P4|Overall Study|Withdrawal by Subject|0
5161388|NCT01376323|17824110|P3|Overall Study|Withdrawal by Subject|1
5161389|NCT01376323|17824111|P2|Overall Study|Withdrawal by Subject|1
5161390|NCT01376323|17824112|P1|Overall Study|Withdrawal by Subject|0
5161391|NCT01376323|17824108|P5|Overall Study|Physician Decision|1
5161392|NCT01376323|17824109|P4|Overall Study|Physician Decision|1
5161393|NCT01376323|17824110|P3|Overall Study|Physician Decision|2
5161394|NCT01376323|17824111|P2|Overall Study|Physician Decision|0
5161395|NCT01376323|17824112|P1|Overall Study|Physician Decision|1
5161396|NCT01376323|17824108|P5|Overall Study|Lost to Follow-up|0
5161397|NCT01376323|17824109|P4|Overall Study|Lost to Follow-up|2
5161398|NCT01376323|17824110|P3|Overall Study|Lost to Follow-up|0
5161399|NCT01376323|17824111|P2|Overall Study|Lost to Follow-up|0
5161400|NCT01376323|17824112|P1|Overall Study|Lost to Follow-up|0
5161401|NCT01376323|17824108|P5|Overall Study|Adverse Event|0
5161402|NCT01376323|17824109|P4|Overall Study|Adverse Event|2
5161403|NCT01376323|17824110|P3|Overall Study|Adverse Event|0
5161404|NCT01376323|17824111|P2|Overall Study|Adverse Event|0
5161405|NCT01376323|17824112|P1|Overall Study|Adverse Event|1
5161406|NCT01376310|17824196|P2|Overall Study|Lost to Follow-up|0
5161407|NCT01376310|17824197|P1|Overall Study|Lost to Follow-up|1
5161408|NCT01376310|17824196|P2|Overall Study|Physician Decision|7
5161409|NCT01376310|17824197|P1|Overall Study|Physician Decision|26
5161410|NCT01376310|17824196|P2|Overall Study|Withdrawal by Subject|2
5161411|NCT01376310|17824197|P1|Overall Study|Withdrawal by Subject|8
5161412|NCT01376310|17824196|P2|Overall Study|Study closed/terminated|2
5161413|NCT01376310|17824197|P1|Overall Study|Study closed/terminated|1
5161414|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
5161415|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
5161416|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5161417|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
5161418|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5161419|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Physician Decision|0
5161420|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Physician Decision|1
5161421|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5161422|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Physician Decision|0
5161423|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5161424|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5161425|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5161426|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5161501|NCT01375777|17824380|P1|Overall Study|Other|1
5161427|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5161428|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5161429|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5161430|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
5161431|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
5161432|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
5161433|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5161434|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
5161435|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5161436|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
5161437|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
5161438|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5161439|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
5161440|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
5161441|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
5161442|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
5161443|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
5161444|NCT01376245|17824216|P5|24-week, Double-blind Treatment Period|Adverse Event|18
5161445|NCT01376245|17824217|P4|24-week, Double-blind Treatment Period|Adverse Event|8
5161446|NCT01376245|17824218|P3|24-week, Double-blind Treatment Period|Adverse Event|7
5161447|NCT01376245|17824219|P2|24-week, Double-blind Treatment Period|Adverse Event|16
5161448|NCT01376245|17824220|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5161449|NCT01376245|17824216|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5161450|NCT01376245|17824217|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5161451|NCT01376245|17824218|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5161452|NCT01376245|17824219|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5161453|NCT01376245|17824220|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
5161454|NCT01376245|17824216|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5161455|NCT01376245|17824217|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5161456|NCT01376245|17824218|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5161457|NCT01376245|17824219|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5161458|NCT01376245|17824220|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
5161459|NCT01376245|17824216|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5161460|NCT01376245|17824217|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5161461|NCT01376245|17824218|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5161462|NCT01376245|17824219|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5161463|NCT01376245|17824220|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
5161464|NCT01376245|17824216|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5161465|NCT01376245|17824217|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5161466|NCT01376245|17824218|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5161467|NCT01376245|17824219|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5161468|NCT01376245|17824220|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
5161469|NCT01376245|17824216|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5161470|NCT01376245|17824217|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5161471|NCT01376245|17824218|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5161472|NCT01376245|17824219|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5161473|NCT01376245|17824220|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
5161474|NCT01376167|17824237|P3|Overall Study|Withdrawal by Subject|4
5161475|NCT01376167|17824238|P2|Overall Study|Withdrawal by Subject|5
5161476|NCT01376167|17824239|P1|Overall Study|Withdrawal by Subject|1
5161477|NCT01376167|17824237|P3|Overall Study|Physician Decision|0
5161478|NCT01376167|17824238|P2|Overall Study|Physician Decision|1
5161479|NCT01376167|17824239|P1|Overall Study|Physician Decision|1
5161480|NCT01376167|17824237|P3|Overall Study|Lost to Follow-up|2
5161481|NCT01376167|17824238|P2|Overall Study|Lost to Follow-up|4
5161482|NCT01376167|17824239|P1|Overall Study|Lost to Follow-up|2
5161483|NCT01376089|17824310|P2|Overall Study|Patient received no contrast media|4
5161484|NCT01376089|17824311|P1|Overall Study|Patient received no contrast media|3
5161485|NCT01376037|17824334|P2|Overall Study|Lost to Follow-up|2
5161486|NCT01376037|17824335|P1|Overall Study|Lost to Follow-up|0
5161487|NCT01375959|17824343|P2|Second Intervention (6 Weeks)|Adverse Event|2
5161488|NCT01375959|17824344|P1|Second Intervention (6 Weeks)|Adverse Event|0
5161489|NCT01375959|17824343|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|1
5161490|NCT01375959|17824344|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|0
5161491|NCT01375959|17824343|P2|First Intervention (6 Weeks)|Adverse Event|3
5161492|NCT01375959|17824344|P1|First Intervention (6 Weeks)|Adverse Event|2
5161493|NCT01375777|17824372|P9|Overall Study|Other|1
5161494|NCT01375777|17824373|P8|Overall Study|Other|0
5161495|NCT01375777|17824374|P7|Overall Study|Other|0
5161496|NCT01375777|17824375|P6|Overall Study|Other|0
5161497|NCT01375777|17824376|P5|Overall Study|Other|0
5161498|NCT01375777|17824377|P4|Overall Study|Other|0
5161499|NCT01375777|17824378|P3|Overall Study|Other|0
5161500|NCT01375777|17824379|P2|Overall Study|Other|1
5161502|NCT01375777|17824372|P9|Overall Study|Lost to Follow-up|0
5161503|NCT01375777|17824373|P8|Overall Study|Lost to Follow-up|0
5161504|NCT01375777|17824374|P7|Overall Study|Lost to Follow-up|1
5161505|NCT01375777|17824375|P6|Overall Study|Lost to Follow-up|0
5161506|NCT01375777|17824376|P5|Overall Study|Lost to Follow-up|0
5161507|NCT01375777|17824377|P4|Overall Study|Lost to Follow-up|0
5161508|NCT01375777|17824378|P3|Overall Study|Lost to Follow-up|0
5161509|NCT01375777|17824379|P2|Overall Study|Lost to Follow-up|0
5161510|NCT01375777|17824380|P1|Overall Study|Lost to Follow-up|1
5161511|NCT01375777|17824372|P9|Overall Study|Withdrawal by Subject|1
5161512|NCT01375777|17824373|P8|Overall Study|Withdrawal by Subject|2
5161513|NCT01375777|17824374|P7|Overall Study|Withdrawal by Subject|1
5161514|NCT01375777|17824375|P6|Overall Study|Withdrawal by Subject|1
5161515|NCT01375777|17824376|P5|Overall Study|Withdrawal by Subject|1
5161516|NCT01375777|17824377|P4|Overall Study|Withdrawal by Subject|0
5161517|NCT01375777|17824378|P3|Overall Study|Withdrawal by Subject|1
5161518|NCT01375777|17824379|P2|Overall Study|Withdrawal by Subject|2
5161519|NCT01375777|17824380|P1|Overall Study|Withdrawal by Subject|0
5161520|NCT01375764|17824450|P5|Overall Study|Other|0
5161521|NCT01375764|17824451|P4|Overall Study|Other|1
5161522|NCT01375764|17824452|P3|Overall Study|Other|0
5161523|NCT01375764|17824453|P2|Overall Study|Other|0
5161524|NCT01375764|17824454|P1|Overall Study|Other|0
5161525|NCT01375764|17824450|P5|Overall Study|Withdrawal by Subject|1
5161526|NCT01375764|17824451|P4|Overall Study|Withdrawal by Subject|0
5161527|NCT01375764|17824452|P3|Overall Study|Withdrawal by Subject|0
5161528|NCT01375764|17824453|P2|Overall Study|Withdrawal by Subject|0
5161529|NCT01375764|17824454|P1|Overall Study|Withdrawal by Subject|2
5161530|NCT01375764|17824450|P5|Overall Study|Lost to Follow-up|0
5161531|NCT01375764|17824451|P4|Overall Study|Lost to Follow-up|0
5161532|NCT01375764|17824452|P3|Overall Study|Lost to Follow-up|0
5161533|NCT01375764|17824453|P2|Overall Study|Lost to Follow-up|1
5161534|NCT01375764|17824454|P1|Overall Study|Lost to Follow-up|0
5161535|NCT01375751|17824500|P3|Overall Study|Other|0
5161536|NCT01375751|17824501|P2|Overall Study|Other|1
5161537|NCT01375751|17824502|P1|Overall Study|Other|0
5161538|NCT01375673|17824527|P2|Overall Study|Withdrawal by Subject|1
5161539|NCT01375673|17824528|P1|Overall Study|Withdrawal by Subject|0
5161540|NCT01375608|17824559|P1|Overall Study|Withdrawal by Subject|2
5161541|NCT01375374|17824587|P1|Overall Study|Adverse Event|1
5161542|NCT01375205|17824596|P2|Overall Study|Withdrawal by Subject|1
5161543|NCT01375205|17824597|P1|Overall Study|Withdrawal by Subject|6
5161544|NCT01375205|17824596|P2|Overall Study|Lost to Follow-up|12
5161545|NCT01375205|17824597|P1|Overall Study|Lost to Follow-up|15
5161546|NCT01375075|17824670|P6|Overall Study|Withdrawal by Subject|1
5161547|NCT01375075|17824671|P5|Overall Study|Withdrawal by Subject|0
5161548|NCT01375075|17824672|P4|Overall Study|Withdrawal by Subject|0
5161549|NCT01375075|17824673|P3|Overall Study|Withdrawal by Subject|0
5161550|NCT01375075|17824674|P2|Overall Study|Withdrawal by Subject|1
5161551|NCT01375075|17824675|P1|Overall Study|Withdrawal by Subject|0
5161552|NCT01375075|17824670|P6|Overall Study|Entry Criterion Not Met|1
5161553|NCT01375075|17824671|P5|Overall Study|Entry Criterion Not Met|0
5161554|NCT01375075|17824672|P4|Overall Study|Entry Criterion Not Met|0
5161555|NCT01375075|17824673|P3|Overall Study|Entry Criterion Not Met|0
5161556|NCT01375075|17824674|P2|Overall Study|Entry Criterion Not Met|0
5161557|NCT01375075|17824675|P1|Overall Study|Entry Criterion Not Met|1
5161558|NCT01375075|17824670|P6|Overall Study|Adverse Event|1
5161559|NCT01375075|17824671|P5|Overall Study|Adverse Event|0
5161560|NCT01375075|17824672|P4|Overall Study|Adverse Event|1
5161561|NCT01375075|17824673|P3|Overall Study|Adverse Event|3
5161562|NCT01375075|17824674|P2|Overall Study|Adverse Event|0
5161563|NCT01375075|17824675|P1|Overall Study|Adverse Event|0
5161564|NCT01375049|17824759|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
5161565|NCT01375049|17824759|P1|Overall Study|Withdrawal by Subject|2
5161566|NCT01375049|17824759|P1|Overall Study|Lost to Follow-up|1
5161567|NCT01375049|17824759|P1|Overall Study|Adverse Event|2
5161568|NCT01375010|17824776|P2|Overall Study|Withdrawal by Subject|2
5161569|NCT01375010|17824777|P1|Overall Study|Withdrawal by Subject|4
5161570|NCT01375010|17824776|P2|Overall Study|Lost to Follow-up|2
5161571|NCT01375010|17824777|P1|Overall Study|Lost to Follow-up|8
5161572|NCT01374971|17824791|P1|Overall Study|Withdrawal by Subject|1
5161573|NCT01374919|17824796|P1|Overall Study|Withdrawal by Subject|2
5161574|NCT01374906|17824803|P2|Overall Study|Unsatisfactory therapeutic effect|19
5161575|NCT01374906|17824804|P1|Overall Study|Unsatisfactory therapeutic effect|11
5161576|NCT01374906|17824803|P2|Overall Study|Withdrawal by Subject|9
5161577|NCT01374906|17824804|P1|Overall Study|Withdrawal by Subject|15
5161578|NCT01374906|17824803|P2|Overall Study|Protocol Violation|2
5161579|NCT01374906|17824804|P1|Overall Study|Protocol Violation|2
5161580|NCT01374906|17824803|P2|Overall Study|Death|2
5161581|NCT01374906|17824804|P1|Overall Study|Death|0
5161582|NCT01374906|17824803|P2|Overall Study|Adverse Event|11
5161583|NCT01374906|17824804|P1|Overall Study|Adverse Event|10
5161584|NCT01374906|17824803|P2|Overall Study|Administrative problems|2
5161585|NCT01374906|17824804|P1|Overall Study|Administrative problems|2
5161586|NCT01374906|17824803|P2|Overall Study|Abnormal laboratory value(s)|3
5161587|NCT01374906|17824804|P1|Overall Study|Abnormal laboratory value(s)|0
5161588|NCT01374568|17824885|P2|Overall Study|Lab unable to analyze BTM|2
5161589|NCT01374568|17824886|P1|Overall Study|Lab unable to analyze BTM|0
5161590|NCT01374516|17824896|P2|Surveillance Expansion Period|Serious adverse event|5
5161591|NCT01374516|17824897|P1|Surveillance Expansion Period|Serious adverse event|20
5161592|NCT01374516|17824896|P2|Surveillance Expansion Period|Lost to Follow-up|45
5161593|NCT01374516|17824897|P1|Surveillance Expansion Period|Lost to Follow-up|73
5161594|NCT01374516|17824896|P2|Surveillance Expansion Period|Withdrawal by Subject|986
5161595|NCT01374516|17824897|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
5161596|NCT01374516|17824896|P2|Surveillance Expansion Period|Protocol Violation|217
5161597|NCT01374516|17824897|P1|Surveillance Expansion Period|Protocol Violation|386
5161598|NCT01374516|17824896|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
5161599|NCT01374516|17824897|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
5161600|NCT01374516|17824896|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
5161601|NCT01374516|17824897|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
5161602|NCT01374516|17824896|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
5161603|NCT01374516|17824897|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
5161604|NCT01374516|17824896|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
5161605|NCT01374516|17824897|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
5161606|NCT01374516|17824896|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
5161607|NCT01374516|17824897|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
5161608|NCT01374451|17824935|P2|Overall Study|Administrative problems|0
5161609|NCT01374451|17824936|P1|Overall Study|Administrative problems|1
5161610|NCT01374425|17824982|P2|Overall Study|Other|43
5161611|NCT01374425|17824983|P1|Overall Study|Other|41
5161612|NCT01374425|17824982|P2|Overall Study|Lost to Follow-up|1
5161613|NCT01374425|17824983|P1|Overall Study|Lost to Follow-up|2
5161614|NCT01374425|17824982|P2|Overall Study|Sponsor Decision|1
5161615|NCT01374425|17824983|P1|Overall Study|Sponsor Decision|0
5161616|NCT01374425|17824982|P2|Overall Study|Protocol Violation|3
5161617|NCT01374425|17824983|P1|Overall Study|Protocol Violation|2
5161618|NCT01374425|17824982|P2|Overall Study|Refused Treatment|24
5161619|NCT01374425|17824983|P1|Overall Study|Refused Treatment|10
5161620|NCT01374425|17824982|P2|Overall Study|Withdrawal by Subject|7
5161621|NCT01374425|17824983|P1|Overall Study|Withdrawal by Subject|6
5161622|NCT01374425|17824982|P2|Overall Study|Death (Adverse Event)|4
5161623|NCT01374425|17824983|P1|Overall Study|Death (Adverse Event)|2
5161624|NCT01374425|17824982|P2|Overall Study|Death (Progression of Disease)|0
5161625|NCT01374425|17824983|P1|Overall Study|Death (Progression of Disease)|1
5161626|NCT01374425|17824982|P2|Overall Study|Adverse Event|18
5161627|NCT01374425|17824983|P1|Overall Study|Adverse Event|29
5161628|NCT01374425|17824982|P2|Overall Study|Clinical Disease Progression|6
5161629|NCT01374425|17824983|P1|Overall Study|Clinical Disease Progression|9
5161630|NCT01374425|17824982|P2|Overall Study|Radiographic Disease Progression|81
5161631|NCT01374425|17824983|P1|Overall Study|Radiographic Disease Progression|86
5161632|NCT01374269|17825063|P2|Overall Study|closed research|2
5161633|NCT01374269|17825064|P1|Overall Study|closed research|1
5161634|NCT01374269|17825063|P2|Overall Study|Lost to Follow-up|3
5161635|NCT01374269|17825064|P1|Overall Study|Lost to Follow-up|1
5161636|NCT01374269|17825063|P2|Overall Study|Withdrawal by Subject|0
5161637|NCT01374269|17825064|P1|Overall Study|Withdrawal by Subject|4
5161638|NCT01374217|17825192|P1|Overall Study|Lack of Efficacy|13
5161639|NCT01374178|17825200|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
5161640|NCT01374178|17825201|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
5161641|NCT01374178|17825200|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
5161642|NCT01374178|17825201|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
5161643|NCT01374087|17825219|P2|Overall Study|Study discontinued|13
5161644|NCT01374087|17825220|P1|Overall Study|Study discontinued|13
5161645|NCT01374087|17825219|P2|Overall Study|Disease progression|2
5161646|NCT01374087|17825220|P1|Overall Study|Disease progression|2
5161647|NCT01374087|17825219|P2|Overall Study|Adverse Event|0
5161648|NCT01374087|17825220|P1|Overall Study|Adverse Event|1
5161649|NCT01373931|17825240|P2|Period 1|Withdrawal by Subject|2
5161650|NCT01373931|17825241|P1|Period 1|Withdrawal by Subject|0
5161651|NCT01373931|17825240|P2|Period 1|Adverse Event|0
5161652|NCT01373931|17825241|P1|Period 1|Adverse Event|2
5161653|NCT01373931|17825240|P2|Lead-in Period|Adverse Event|0
5161654|NCT01373931|17825241|P1|Lead-in Period|Adverse Event|2
5161655|NCT01373918|17825254|P2|Overall Study|Physician Decision|1
5161656|NCT01373918|17825255|P1|Overall Study|Physician Decision|0
5161657|NCT01373346|17825314|P1|Overall Study|Death|1
5161658|NCT01373294|17825337|P2|Overall Study|Adverse Event|0
5161659|NCT01373294|17825338|P1|Overall Study|Adverse Event|1
5161660|NCT01373281|17825347|P2|Surveillance Expansion Period|Serious adverse event|4
5161661|NCT01373281|17825348|P1|Surveillance Expansion Period|Serious adverse event|3
5161662|NCT01373281|17825347|P2|Surveillance Expansion Period|Lost to Follow-up|8
5161663|NCT01373281|17825348|P1|Surveillance Expansion Period|Lost to Follow-up|10
5161664|NCT01373281|17825347|P2|Surveillance Expansion Period|Protocol Violation|1
5161665|NCT01373281|17825348|P1|Surveillance Expansion Period|Protocol Violation|9
5161666|NCT01373281|17825347|P2|Surveillance Expansion Period|Withdrawal by Subject|105
5161667|NCT01373281|17825348|P1|Surveillance Expansion Period|Withdrawal by Subject|180
5161668|NCT01373281|17825347|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
5161669|NCT01373281|17825348|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
5161670|NCT01373281|17825347|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
5161671|NCT01373281|17825348|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
5161672|NCT01373281|17825347|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
5161673|NCT01373281|17825348|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
5161674|NCT01373281|17825347|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
5161675|NCT01373281|17825348|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
5161676|NCT01373229|17825396|P1|Overall Study|Physician Decision|3
5161677|NCT01373229|17825396|P1|Overall Study|Death|3
5161678|NCT01373164|17825410|P5|Overall Study|Withdrawal by Subject|2
5161679|NCT01373164|17825411|P4|Overall Study|Withdrawal by Subject|10
5161680|NCT01373164|17825412|P3|Overall Study|Withdrawal by Subject|0
5161681|NCT01373164|17825413|P2|Overall Study|Withdrawal by Subject|1
5161682|NCT01373164|17825414|P1|Overall Study|Withdrawal by Subject|0
5161683|NCT01373164|17825410|P5|Overall Study|Lost to Follow-up|0
5161684|NCT01373164|17825411|P4|Overall Study|Lost to Follow-up|2
5161685|NCT01373164|17825412|P3|Overall Study|Lost to Follow-up|1
5161686|NCT01373164|17825413|P2|Overall Study|Lost to Follow-up|0
5161687|NCT01373164|17825414|P1|Overall Study|Lost to Follow-up|0
5161688|NCT01372995|17825448|P3|Overall Study|Physician Decision|1
5161689|NCT01372995|17825449|P2|Overall Study|Physician Decision|0
5161690|NCT01372995|17825450|P1|Overall Study|Physician Decision|0
5161691|NCT01372995|17825448|P3|Overall Study|Spouse withdrew participant from study|0
5161692|NCT01372995|17825449|P2|Overall Study|Spouse withdrew participant from study|1
5161693|NCT01372995|17825450|P1|Overall Study|Spouse withdrew participant from study|0
5161694|NCT01372878|17825497|P1|Overall Study|incomplete study procedure|104
5161695|NCT01372878|17825497|P1|Overall Study|Protocol Violation|17
5161696|NCT01372878|17825497|P1|Overall Study|Withdrawal by Subject|63
5161697|NCT01372774|17825517|P2|Overall Study|Withdrawal prior to treatment|5
5161698|NCT01372774|17825518|P1|Overall Study|Withdrawal prior to treatment|4
5161699|NCT01372748|17825534|P2|Overall Study|Withdrawal by Subject|5
5161700|NCT01372748|17825535|P1|Overall Study|Withdrawal by Subject|7
5161701|NCT01372748|17825534|P2|Overall Study|Lost to Follow-up|34
5161702|NCT01372748|17825535|P1|Overall Study|Lost to Follow-up|16
5161703|NCT01372618|17825543|P1|Overall Study|PI Died. Study Terminated|9
5161704|NCT01372605|17825551|P2|Overall Study|Changed medical home|0
5161705|NCT01372605|17825552|P1|Overall Study|Changed medical home|2
5161706|NCT01372605|17825551|P2|Overall Study|Moved|0
5161707|NCT01372605|17825552|P1|Overall Study|Moved|3
5161708|NCT01372605|17825551|P2|Overall Study|Withdrawal by Subject|7
5161709|NCT01372605|17825552|P1|Overall Study|Withdrawal by Subject|4
5161710|NCT01372605|17825551|P2|Overall Study|Lost to Follow-up|1
5161711|NCT01372605|17825552|P1|Overall Study|Lost to Follow-up|2
5161712|NCT01372605|17825551|P2|Overall Study|Death|2
5161713|NCT01372605|17825552|P1|Overall Study|Death|1
5161714|NCT01372501|17825578|P1|Overall Study|Device migration|1
5161715|NCT01372501|17825578|P1|Overall Study|Adverse Event|4
5161716|NCT01372410|17825601|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161717|NCT01372410|17825602|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161718|NCT01372410|17825603|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
5161719|NCT01372410|17825604|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161720|NCT01372410|17825605|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161721|NCT01372410|17825606|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161722|NCT01372410|17825607|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161723|NCT01372410|17825608|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
5161724|NCT01372410|17825601|P8|Treatment Period 3 (7 Days)|Adverse Event|0
5161725|NCT01372410|17825602|P7|Treatment Period 3 (7 Days)|Adverse Event|0
5161726|NCT01372410|17825603|P6|Treatment Period 3 (7 Days)|Adverse Event|0
5161727|NCT01372410|17825604|P5|Treatment Period 3 (7 Days)|Adverse Event|0
5161728|NCT01372410|17825605|P4|Treatment Period 3 (7 Days)|Adverse Event|0
5161729|NCT01372410|17825606|P3|Treatment Period 3 (7 Days)|Adverse Event|1
5161730|NCT01372410|17825607|P2|Treatment Period 3 (7 Days)|Adverse Event|0
5161731|NCT01372410|17825608|P1|Treatment Period 3 (7 Days)|Adverse Event|0
5161732|NCT01372410|17825601|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
5161733|NCT01372410|17825602|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161734|NCT01372410|17825603|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161735|NCT01372410|17825604|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161736|NCT01372410|17825605|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161737|NCT01372410|17825606|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161738|NCT01372410|17825607|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161739|NCT01372410|17825608|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5161740|NCT01372410|17825601|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5161741|NCT01372410|17825602|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5161742|NCT01372410|17825603|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5161743|NCT01372410|17825604|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5161744|NCT01372410|17825605|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5161745|NCT01372410|17825606|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5161746|NCT01372410|17825607|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5161747|NCT01372410|17825608|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5161748|NCT01372410|17825601|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
5161749|NCT01372410|17825602|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
5161750|NCT01372410|17825603|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
5161751|NCT01372410|17825604|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
5161752|NCT01372410|17825605|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
5161753|NCT01372410|17825606|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
5161754|NCT01372410|17825607|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
5161755|NCT01372410|17825608|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
5161756|NCT01372410|17825601|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
5161757|NCT01372410|17825602|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5161758|NCT01372410|17825603|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5161759|NCT01372410|17825604|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5161760|NCT01372410|17825605|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5161761|NCT01372410|17825606|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5161762|NCT01372410|17825607|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5161763|NCT01372410|17825608|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
5161764|NCT01372410|17825601|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161765|NCT01372410|17825602|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
5161766|NCT01372410|17825603|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161767|NCT01372410|17825604|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161768|NCT01372410|17825605|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161769|NCT01372410|17825606|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161770|NCT01372410|17825607|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161771|NCT01372410|17825608|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5161772|NCT01372410|17825601|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161773|NCT01372410|17825602|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161774|NCT01372410|17825603|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161775|NCT01372410|17825604|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
5161776|NCT01372410|17825605|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161777|NCT01372410|17825606|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161778|NCT01372410|17825607|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161779|NCT01372410|17825608|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5161780|NCT01372410|17825601|P8|Treatment Period 1 (7 Days)|Adverse Event|0
5161781|NCT01372410|17825602|P7|Treatment Period 1 (7 Days)|Adverse Event|1
5161782|NCT01372410|17825603|P6|Treatment Period 1 (7 Days)|Adverse Event|0
5161783|NCT01372410|17825604|P5|Treatment Period 1 (7 Days)|Adverse Event|0
5161784|NCT01372410|17825605|P4|Treatment Period 1 (7 Days)|Adverse Event|0
5161785|NCT01372410|17825606|P3|Treatment Period 1 (7 Days)|Adverse Event|0
5161786|NCT01372410|17825607|P2|Treatment Period 1 (7 Days)|Adverse Event|1
5161787|NCT01372410|17825608|P1|Treatment Period 1 (7 Days)|Adverse Event|0
5161788|NCT01372410|17825601|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5161789|NCT01372410|17825602|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5161790|NCT01372410|17825603|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5161791|NCT01372410|17825604|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5161792|NCT01372410|17825605|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5161793|NCT01372410|17825606|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5161794|NCT01372410|17825607|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5161795|NCT01372410|17825608|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5161796|NCT01372384|17825645|P1|Overall Study|Progression of disease|3
5161797|NCT01372150|17825686|P3|Overall Study|Randomized but not treated|0
5161798|NCT01372150|17825687|P2|Overall Study|Randomized but not treated|1
5161799|NCT01372150|17825688|P1|Overall Study|Randomized but not treated|0
5161800|NCT01372150|17825686|P3|Overall Study|Adverse Event|2
5161801|NCT01372150|17825687|P2|Overall Study|Adverse Event|1
5161802|NCT01372150|17825688|P1|Overall Study|Adverse Event|2
5161803|NCT01372150|17825686|P3|Overall Study|Other|2
5161804|NCT01372150|17825687|P2|Overall Study|Other|0
5161805|NCT01372150|17825688|P1|Overall Study|Other|1
5161806|NCT01372150|17825686|P3|Overall Study|Withdrawal by Subject|2
5161807|NCT01372150|17825687|P2|Overall Study|Withdrawal by Subject|7
5161808|NCT01372150|17825688|P1|Overall Study|Withdrawal by Subject|2
5161809|NCT01372150|17825686|P3|Overall Study|Protocol Violation|3
5161810|NCT01372150|17825687|P2|Overall Study|Protocol Violation|0
5161811|NCT01372150|17825688|P1|Overall Study|Protocol Violation|1
5161812|NCT01372150|17825686|P3|Overall Study|Lost to Follow-up|6
5161813|NCT01372150|17825687|P2|Overall Study|Lost to Follow-up|5
5161814|NCT01372150|17825688|P1|Overall Study|Lost to Follow-up|4
5161815|NCT01372150|17825686|P3|Overall Study|Lack of Efficacy|1
5161816|NCT01372150|17825687|P2|Overall Study|Lack of Efficacy|0
5161817|NCT01372150|17825688|P1|Overall Study|Lack of Efficacy|3
5161818|NCT01372085|17825715|P10|Washout Period 3|Withdrawal by Subject|0
5161819|NCT01372085|17825716|P9|Washout Period 3|Withdrawal by Subject|0
5161820|NCT01372085|17825717|P8|Washout Period 3|Withdrawal by Subject|0
5161821|NCT01372085|17825718|P7|Washout Period 3|Withdrawal by Subject|0
5161822|NCT01372085|17825719|P6|Washout Period 3|Withdrawal by Subject|2
5161823|NCT01372085|17825720|P5|Washout Period 3|Withdrawal by Subject|0
5161824|NCT01372085|17825721|P4|Washout Period 3|Withdrawal by Subject|0
5161825|NCT01372085|17825722|P3|Washout Period 3|Withdrawal by Subject|0
5161826|NCT01372085|17825723|P2|Washout Period 3|Withdrawal by Subject|0
5161827|NCT01372085|17825724|P1|Washout Period 3|Withdrawal by Subject|0
5161828|NCT01372085|17825715|P10|Washout Period 2|Physician Decision|0
5161829|NCT01372085|17825716|P9|Washout Period 2|Physician Decision|0
5161830|NCT01372085|17825717|P8|Washout Period 2|Physician Decision|0
5161831|NCT01372085|17825718|P7|Washout Period 2|Physician Decision|0
5161832|NCT01372085|17825719|P6|Washout Period 2|Physician Decision|0
5161833|NCT01372085|17825720|P5|Washout Period 2|Physician Decision|1
5161834|NCT01372085|17825721|P4|Washout Period 2|Physician Decision|0
5161835|NCT01372085|17825722|P3|Washout Period 2|Physician Decision|0
5161836|NCT01372085|17825723|P2|Washout Period 2|Physician Decision|0
5161837|NCT01372085|17825724|P1|Washout Period 2|Physician Decision|0
5161838|NCT01371994|17825756|P2|Overall Study|Miscellaneous Reasons|4
5161839|NCT01371994|17825757|P1|Overall Study|Miscellaneous Reasons|6
5161840|NCT01371994|17825756|P2|Overall Study|Physician Decision|1
5161841|NCT01371994|17825757|P1|Overall Study|Physician Decision|1
5161842|NCT01371994|17825756|P2|Overall Study|Randomized but Never Received Study Drug|6
5161843|NCT01371994|17825757|P1|Overall Study|Randomized but Never Received Study Drug|6
5161844|NCT01371994|17825756|P2|Overall Study|Protocol Violation|17
5161845|NCT01371994|17825757|P1|Overall Study|Protocol Violation|24
5161846|NCT01371994|17825756|P2|Overall Study|Lost to Follow-up|1
5161847|NCT01371994|17825757|P1|Overall Study|Lost to Follow-up|1
5161848|NCT01371994|17825756|P2|Overall Study|Withdrawal by Subject|7
5161849|NCT01371994|17825757|P1|Overall Study|Withdrawal by Subject|13
5161850|NCT01371994|17825756|P2|Overall Study|Lack of Efficacy|0
5161851|NCT01371994|17825757|P1|Overall Study|Lack of Efficacy|3
5161852|NCT01371994|17825756|P2|Overall Study|Adverse Event|6
5161853|NCT01371994|17825757|P1|Overall Study|Adverse Event|3
5161854|NCT01371981|17825805|P6|Overall Study|Did not start treatment|2
5161855|NCT01371981|17825806|P5|Overall Study|Did not start treatment|0
5161856|NCT01371981|17825807|P4|Overall Study|Did not start treatment|0
5161857|NCT01371981|17825808|P3|Overall Study|Did not start treatment|0
5161858|NCT01371981|17825809|P2|Overall Study|Did not start treatment|3
5161859|NCT01371981|17825810|P1|Overall Study|Did not start treatment|2
5161860|NCT01371981|17825805|P6|Overall Study|Ineligible|4
5161861|NCT01371981|17825806|P5|Overall Study|Ineligible|0
5161862|NCT01371981|17825807|P4|Overall Study|Ineligible|0
5161863|NCT01371981|17825808|P3|Overall Study|Ineligible|0
5161864|NCT01371981|17825809|P2|Overall Study|Ineligible|13
5161865|NCT01371981|17825810|P1|Overall Study|Ineligible|19
5161866|NCT01371981|17825805|P6|Overall Study|Withdrawal by Subject|3
5161867|NCT01371981|17825806|P5|Overall Study|Withdrawal by Subject|10
5161868|NCT01371981|17825807|P4|Overall Study|Withdrawal by Subject|2
5161869|NCT01371981|17825808|P3|Overall Study|Withdrawal by Subject|1
5161870|NCT01371981|17825809|P2|Overall Study|Withdrawal by Subject|19
5161871|NCT01371981|17825810|P1|Overall Study|Withdrawal by Subject|12
5161872|NCT01371981|17825805|P6|Overall Study|Physician Decision|3
5161873|NCT01371981|17825806|P5|Overall Study|Physician Decision|14
5161874|NCT01371981|17825807|P4|Overall Study|Physician Decision|7
5161875|NCT01371981|17825808|P3|Overall Study|Physician Decision|1
5161876|NCT01371981|17825809|P2|Overall Study|Physician Decision|63
5161877|NCT01371981|17825810|P1|Overall Study|Physician Decision|48
5161878|NCT01371981|17825805|P6|Overall Study|Lack of Efficacy|0
5161879|NCT01371981|17825806|P5|Overall Study|Lack of Efficacy|5
5161880|NCT01371981|17825807|P4|Overall Study|Lack of Efficacy|8
5161881|NCT01371981|17825808|P3|Overall Study|Lack of Efficacy|4
5161882|NCT01371981|17825809|P2|Overall Study|Lack of Efficacy|61
5161883|NCT01371981|17825810|P1|Overall Study|Lack of Efficacy|69
5161884|NCT01371981|17825805|P6|Overall Study|Death|2
5161885|NCT01371981|17825806|P5|Overall Study|Death|2
5161886|NCT01371981|17825807|P4|Overall Study|Death|0
5161887|NCT01371981|17825808|P3|Overall Study|Death|0
5161888|NCT01371981|17825809|P2|Overall Study|Death|16
5161889|NCT01371981|17825810|P1|Overall Study|Death|22
5161890|NCT01371981|17825805|P6|Overall Study|Adverse Event|0
5161891|NCT01371981|17825806|P5|Overall Study|Adverse Event|1
5161892|NCT01371981|17825807|P4|Overall Study|Adverse Event|4
5161893|NCT01371981|17825808|P3|Overall Study|Adverse Event|0
5161894|NCT01371981|17825809|P2|Overall Study|Adverse Event|17
5161895|NCT01371981|17825810|P1|Overall Study|Adverse Event|12
5161896|NCT01371877|17825869|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
5161897|NCT01371877|17825870|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
5161898|NCT01371851|17825882|P2|Overall Study|Blood Pressure outside study parameters|0
5161899|NCT01371851|17825883|P1|Overall Study|Blood Pressure outside study parameters|2
5161900|NCT01371851|17825882|P2|Overall Study|non study related adverse event|0
5161901|NCT01371851|17825883|P1|Overall Study|non study related adverse event|1
5161902|NCT01371851|17825882|P2|Overall Study|was arrested and put in jail|1
5161903|NCT01371851|17825883|P1|Overall Study|was arrested and put in jail|0
5161904|NCT01371851|17825882|P2|Overall Study|Lost to Follow-up|8
5161905|NCT01371851|17825883|P1|Overall Study|Lost to Follow-up|5
5161906|NCT01371838|17825891|P2|Overall Study|Surgery|0
5161907|NCT01371838|17825892|P1|Overall Study|Surgery|1
5161908|NCT01371838|17825891|P2|Overall Study|Lack of therapeutic response|1
5161909|NCT01371838|17825892|P1|Overall Study|Lack of therapeutic response|0
5161910|NCT01371838|17825891|P2|Overall Study|Last follow-up visit not conducted|0
5161911|NCT01371838|17825892|P1|Overall Study|Last follow-up visit not conducted|2
5161912|NCT01371838|17825891|P2|Overall Study|Investigator Decision|8
5161913|NCT01371838|17825892|P1|Overall Study|Investigator Decision|3
5161914|NCT01371838|17825891|P2|Overall Study|Protocol Violation|0
5161915|NCT01371838|17825892|P1|Overall Study|Protocol Violation|3
5161916|NCT01371838|17825891|P2|Overall Study|Death|4
5161917|NCT01371838|17825892|P1|Overall Study|Death|3
5161918|NCT01371838|17825891|P2|Overall Study|Lost to Follow-up|20
5161919|NCT01371838|17825892|P1|Overall Study|Lost to Follow-up|10
5161920|NCT01371838|17825891|P2|Overall Study|Withdrawal by Subject|33
5161921|NCT01371838|17825892|P1|Overall Study|Withdrawal by Subject|27
5161922|NCT01371825|17825928|P1|Overall Study|Death|4
5161923|NCT01371747|17825962|P6|Overall Study|Other Reasons|1
5161924|NCT01371747|17825963|P5|Overall Study|Other Reasons|0
5161925|NCT01371747|17825964|P4|Overall Study|Other Reasons|0
5161926|NCT01371747|17825965|P3|Overall Study|Other Reasons|2
5161927|NCT01371747|17825966|P2|Overall Study|Other Reasons|1
5161928|NCT01371747|17825967|P1|Overall Study|Other Reasons|2
5161929|NCT01371747|17825962|P6|Overall Study|Withdrawal by Subject|4
5161930|NCT01371747|17825963|P5|Overall Study|Withdrawal by Subject|2
5161931|NCT01371747|17825964|P4|Overall Study|Withdrawal by Subject|2
5161932|NCT01371747|17825965|P3|Overall Study|Withdrawal by Subject|5
5161933|NCT01371747|17825966|P2|Overall Study|Withdrawal by Subject|12
5161934|NCT01371747|17825967|P1|Overall Study|Withdrawal by Subject|6
5161935|NCT01371747|17825962|P6|Overall Study|Physician Decision|0
5161936|NCT01371747|17825963|P5|Overall Study|Physician Decision|1
5161937|NCT01371747|17825964|P4|Overall Study|Physician Decision|0
5161938|NCT01371747|17825965|P3|Overall Study|Physician Decision|0
5161939|NCT01371747|17825966|P2|Overall Study|Physician Decision|0
5161940|NCT01371747|17825967|P1|Overall Study|Physician Decision|0
5161941|NCT01371747|17825962|P6|Overall Study|Non-Compliance|1
5161942|NCT01371747|17825963|P5|Overall Study|Non-Compliance|0
5161943|NCT01371747|17825964|P4|Overall Study|Non-Compliance|0
5161944|NCT01371747|17825965|P3|Overall Study|Non-Compliance|3
5161945|NCT01371747|17825966|P2|Overall Study|Non-Compliance|4
5161946|NCT01371747|17825967|P1|Overall Study|Non-Compliance|3
5161947|NCT01371747|17825962|P6|Overall Study|Protocol Violation|0
5161948|NCT01371747|17825963|P5|Overall Study|Protocol Violation|0
5161949|NCT01371747|17825964|P4|Overall Study|Protocol Violation|0
5161950|NCT01371747|17825965|P3|Overall Study|Protocol Violation|1
5161951|NCT01371747|17825966|P2|Overall Study|Protocol Violation|0
5161952|NCT01371747|17825967|P1|Overall Study|Protocol Violation|0
5161953|NCT01371747|17825962|P6|Overall Study|Low Serum Potassium Results|3
5161954|NCT01371747|17825963|P5|Overall Study|Low Serum Potassium Results|0
5161955|NCT01371747|17825964|P4|Overall Study|Low Serum Potassium Results|1
5161956|NCT01371747|17825965|P3|Overall Study|Low Serum Potassium Results|1
5161957|NCT01371747|17825966|P2|Overall Study|Low Serum Potassium Results|1
5161958|NCT01371747|17825967|P1|Overall Study|Low Serum Potassium Results|1
5161959|NCT01371747|17825962|P6|Overall Study|High Serum Potassium Results|2
5161960|NCT01371747|17825963|P5|Overall Study|High Serum Potassium Results|0
5161961|NCT01371747|17825964|P4|Overall Study|High Serum Potassium Results|2
5161962|NCT01371747|17825965|P3|Overall Study|High Serum Potassium Results|1
5161963|NCT01371747|17825966|P2|Overall Study|High Serum Potassium Results|1
5161964|NCT01371747|17825967|P1|Overall Study|High Serum Potassium Results|1
5161965|NCT01371747|17825962|P6|Overall Study|Abnormal Renal Function|1
5161966|NCT01371747|17825963|P5|Overall Study|Abnormal Renal Function|0
5161967|NCT01371747|17825964|P4|Overall Study|Abnormal Renal Function|1
5161968|NCT01371747|17825965|P3|Overall Study|Abnormal Renal Function|0
5161969|NCT01371747|17825966|P2|Overall Study|Abnormal Renal Function|2
5161970|NCT01371747|17825967|P1|Overall Study|Abnormal Renal Function|0
5161971|NCT01371747|17825962|P6|Overall Study|Death|0
5161972|NCT01371747|17825963|P5|Overall Study|Death|2
5161973|NCT01371747|17825964|P4|Overall Study|Death|1
5161974|NCT01371747|17825965|P3|Overall Study|Death|4
5161975|NCT01371747|17825966|P2|Overall Study|Death|0
5161976|NCT01371747|17825967|P1|Overall Study|Death|1
5161977|NCT01371747|17825962|P6|Overall Study|Adverse Event|2
5161978|NCT01371747|17825963|P5|Overall Study|Adverse Event|2
5161979|NCT01371747|17825964|P4|Overall Study|Adverse Event|2
5161980|NCT01371747|17825965|P3|Overall Study|Adverse Event|7
5161981|NCT01371747|17825966|P2|Overall Study|Adverse Event|2
5161982|NCT01371747|17825967|P1|Overall Study|Adverse Event|4
5161983|NCT01371734|17826032|P3|Overall Study|Lack of Efficacy|0
5161984|NCT01371734|17826033|P2|Overall Study|Lack of Efficacy|2
5161985|NCT01371734|17826034|P1|Overall Study|Lack of Efficacy|2
5161986|NCT01371734|17826032|P3|Overall Study|Adverse Event|3
5161987|NCT01371734|17826033|P2|Overall Study|Adverse Event|8
5161988|NCT01371734|17826034|P1|Overall Study|Adverse Event|8
5161989|NCT01371734|17826032|P3|Overall Study|Protocol Violation|2
5161990|NCT01371734|17826033|P2|Overall Study|Protocol Violation|1
5161991|NCT01371734|17826034|P1|Overall Study|Protocol Violation|3
5161992|NCT01371734|17826032|P3|Overall Study|Lost to Follow-up|1
5161993|NCT01371734|17826033|P2|Overall Study|Lost to Follow-up|3
5161994|NCT01371734|17826034|P1|Overall Study|Lost to Follow-up|5
5161995|NCT01371734|17826032|P3|Overall Study|Withdrawal by Subject|9
5161996|NCT01371734|17826033|P2|Overall Study|Withdrawal by Subject|4
5161997|NCT01371734|17826034|P1|Overall Study|Withdrawal by Subject|3
5161998|NCT01371734|17826032|P3|Overall Study|Other|2
5161999|NCT01371734|17826033|P2|Overall Study|Other|1
5162000|NCT01371734|17826034|P1|Overall Study|Other|2
5162001|NCT01371721|17826054|P3|Overall Study|Randomized but not treated|0
5162002|NCT01371721|17826055|P2|Overall Study|Randomized but not treated|0
5162003|NCT01371721|17826056|P1|Overall Study|Randomized but not treated|1
5162004|NCT01371721|17826054|P3|Overall Study|Lack of Efficacy|3
5162005|NCT01371721|17826055|P2|Overall Study|Lack of Efficacy|4
5162006|NCT01371721|17826056|P1|Overall Study|Lack of Efficacy|2
5162007|NCT01371721|17826054|P3|Overall Study|Other|0
5162008|NCT01371721|17826055|P2|Overall Study|Other|3
5162009|NCT01371721|17826056|P1|Overall Study|Other|2
5162010|NCT01371721|17826054|P3|Overall Study|Withdrawal by Subject|11
5162011|NCT01371721|17826055|P2|Overall Study|Withdrawal by Subject|7
5162012|NCT01371721|17826056|P1|Overall Study|Withdrawal by Subject|5
5162013|NCT01371721|17826054|P3|Overall Study|Lost to Follow-up|6
5162014|NCT01371721|17826055|P2|Overall Study|Lost to Follow-up|2
5162015|NCT01371721|17826056|P1|Overall Study|Lost to Follow-up|8
5162016|NCT01371721|17826054|P3|Overall Study|Protocol Violation|5
5162017|NCT01371721|17826055|P2|Overall Study|Protocol Violation|4
5162018|NCT01371721|17826056|P1|Overall Study|Protocol Violation|6
5162019|NCT01371721|17826054|P3|Overall Study|Adverse Event|5
5162020|NCT01371721|17826055|P2|Overall Study|Adverse Event|4
5162021|NCT01371721|17826056|P1|Overall Study|Adverse Event|5
5162022|NCT01371708|17826089|P3|Overall Study|Started but did not receive treatment|1
5162023|NCT01371708|17826090|P2|Overall Study|Started but did not receive treatment|0
5162024|NCT01371708|17826091|P1|Overall Study|Started but did not receive treatment|1
5162025|NCT01371708|17826089|P3|Overall Study|Adverse Event|12
5162026|NCT01371708|17826090|P2|Overall Study|Adverse Event|8
5162027|NCT01371708|17826091|P1|Overall Study|Adverse Event|5
5162028|NCT01371708|17826089|P3|Overall Study|Other|4
5162029|NCT01371708|17826090|P2|Overall Study|Other|2
5162030|NCT01371708|17826091|P1|Overall Study|Other|3
5162031|NCT01371708|17826089|P3|Overall Study|Medication error/not related to AE|0
5162032|NCT01371708|17826090|P2|Overall Study|Medication error/not related to AE|1
5162033|NCT01371708|17826091|P1|Overall Study|Medication error/not related to AE|0
5162034|NCT01371708|17826089|P3|Overall Study|No longer willing to participate|13
5162035|NCT01371708|17826090|P2|Overall Study|No longer willing to participate|7
5162036|NCT01371708|17826091|P1|Overall Study|No longer willing to participate|7
5162037|NCT01371708|17826089|P3|Overall Study|Protocol Violation|2
5162038|NCT01371708|17826090|P2|Overall Study|Protocol Violation|1
5162039|NCT01371708|17826091|P1|Overall Study|Protocol Violation|2
5162040|NCT01371708|17826089|P3|Overall Study|Lost to Follow-up|7
5162041|NCT01371708|17826090|P2|Overall Study|Lost to Follow-up|9
5162042|NCT01371708|17826091|P1|Overall Study|Lost to Follow-up|5
5162043|NCT01371708|17826089|P3|Overall Study|Insufficient clinical response|0
5162044|NCT01371708|17826090|P2|Overall Study|Insufficient clinical response|2
5162045|NCT01371708|17826091|P1|Overall Study|Insufficient clinical response|3
5162046|NCT01371656|17826123|P2|Overall Study|Ineligible|3
5162047|NCT01371656|17826124|P1|Overall Study|Ineligible|4
5162048|NCT01371656|17826123|P2|Overall Study|Withdrawal by Subject|0
5162049|NCT01371656|17826124|P1|Overall Study|Withdrawal by Subject|7
5162050|NCT01371656|17826123|P2|Overall Study|Physician Decision|7
5162051|NCT01371656|17826124|P1|Overall Study|Physician Decision|46
5162052|NCT01371656|17826123|P2|Overall Study|Death|4
5162053|NCT01371656|17826124|P1|Overall Study|Death|7
5162054|NCT01371643|17826144|P2|Overall Study|Withdrawal by Subject|0
5162055|NCT01371643|17826145|P1|Overall Study|Withdrawal by Subject|3
5162056|NCT01371565|17826155|P1|Overall Study|Resection of neuroendocrine tumor|1
5162057|NCT01371565|17826155|P1|Overall Study|Death|1
5162058|NCT01371565|17826155|P1|Overall Study|Withdrawal by Subject|1
5162059|NCT01371552|17826159|P6|Part 1, First 3 Days|Inconvenience|0
5162060|NCT01371552|17826160|P5|Part 1, First 3 Days|Inconvenience|0
5162061|NCT01371552|17826161|P4|Part 1, First 3 Days|Inconvenience|0
5162062|NCT01371552|17826162|P3|Part 1, First 3 Days|Inconvenience|1
5162063|NCT01371552|17826163|P2|Part 1, First 3 Days|Inconvenience|0
5162064|NCT01371552|17826164|P1|Part 1, First 3 Days|Inconvenience|0
5162065|NCT01371539|17826191|P2|Period Two: One Week|Time/job conflict|1
5162066|NCT01371539|17826192|P1|Period Two: One Week|Time/job conflict|0
5162067|NCT01371539|17826191|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
5162068|NCT01371539|17826192|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
5162069|NCT01371539|17826191|P2|Period Two: One Week|Lost to Follow-up|1
5162070|NCT01371539|17826192|P1|Period Two: One Week|Lost to Follow-up|0
5162071|NCT01371539|17826191|P2|Period One: One Week|Lost to Follow-up|1
5162072|NCT01371539|17826192|P1|Period One: One Week|Lost to Follow-up|0
5162073|NCT01371305|17826206|P6|Overall Study|Subject request|1
5162074|NCT01371305|17826207|P5|Overall Study|Subject request|0
5162075|NCT01371305|17826208|P4|Overall Study|Subject request|0
5162076|NCT01371305|17826209|P3|Overall Study|Subject request|0
5162077|NCT01371305|17826210|P2|Overall Study|Subject request|0
5162078|NCT01371305|17826211|P1|Overall Study|Subject request|0
5162079|NCT01371305|17826206|P6|Overall Study|Study terminated by sponsor|1
5162080|NCT01371305|17826207|P5|Overall Study|Study terminated by sponsor|3
5162081|NCT01371305|17826208|P4|Overall Study|Study terminated by sponsor|0
5162082|NCT01371305|17826209|P3|Overall Study|Study terminated by sponsor|0
5162083|NCT01371305|17826210|P2|Overall Study|Study terminated by sponsor|0
5162084|NCT01371305|17826211|P1|Overall Study|Study terminated by sponsor|0
5162085|NCT01371305|17826206|P6|Overall Study|Adverse Event|0
5162086|NCT01371305|17826207|P5|Overall Study|Adverse Event|1
5162087|NCT01371305|17826208|P4|Overall Study|Adverse Event|2
5162088|NCT01371305|17826209|P3|Overall Study|Adverse Event|0
5162089|NCT01371305|17826210|P2|Overall Study|Adverse Event|0
5162090|NCT01371305|17826211|P1|Overall Study|Adverse Event|0
5162091|NCT01371006|17826295|P2|Overall Study|Adverse Event|0
5162092|NCT01371006|17826296|P1|Overall Study|Adverse Event|1
5162093|NCT01370863|17826337|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5162094|NCT01370863|17826338|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
5162095|NCT01370863|17826337|P2|Overall Study|Did not want second pH/MII monitoring|1
5162096|NCT01370863|17826338|P1|Overall Study|Did not want second pH/MII monitoring|1
5162097|NCT01370863|17826337|P2|Overall Study|Adverse Event|1
5162098|NCT01370863|17826338|P1|Overall Study|Adverse Event|1
5162099|NCT01370733|17826363|P2|Overall Study|Protocol Violation|3
5162100|NCT01370733|17826364|P1|Overall Study|Protocol Violation|1
5162101|NCT01370733|17826363|P2|Overall Study|Physician Decision|2
5162102|NCT01370733|17826364|P1|Overall Study|Physician Decision|0
5162103|NCT01370733|17826363|P2|Overall Study|Lack of Efficacy|5
5162104|NCT01370733|17826364|P1|Overall Study|Lack of Efficacy|3
5162105|NCT01370733|17826363|P2|Overall Study|Adverse Event|4
5162106|NCT01370733|17826364|P1|Overall Study|Adverse Event|2
5162107|NCT01370733|17826363|P2|Overall Study|Lost to Follow-up|0
5162108|NCT01370733|17826364|P1|Overall Study|Lost to Follow-up|3
5162109|NCT01370733|17826363|P2|Overall Study|Withdrawal by Subject|8
5162110|NCT01370733|17826364|P1|Overall Study|Withdrawal by Subject|8
5162111|NCT01370694|17826386|P1|Overall Study|Progressive disease|2
5162112|NCT01370694|17826386|P1|Overall Study|Switched to rituximab|4
5162113|NCT01370655|17826408|P12|Period 2|Withdrawal by Subject|0
5162114|NCT01370655|17826409|P11|Period 2|Withdrawal by Subject|0
5162115|NCT01370655|17826410|P10|Period 2|Withdrawal by Subject|0
5162116|NCT01370655|17826411|P9|Period 2|Withdrawal by Subject|1
5162117|NCT01370655|17826412|P8|Period 2|Withdrawal by Subject|0
5162118|NCT01370655|17826413|P7|Period 2|Withdrawal by Subject|0
5162119|NCT01370655|17826414|P6|Period 2|Withdrawal by Subject|0
5162120|NCT01370655|17826415|P5|Period 2|Withdrawal by Subject|0
5162121|NCT01370655|17826416|P4|Period 2|Withdrawal by Subject|0
5162122|NCT01370655|17826417|P3|Period 2|Withdrawal by Subject|0
5162123|NCT01370655|17826418|P2|Period 2|Withdrawal by Subject|0
5162124|NCT01370655|17826419|P1|Period 2|Withdrawal by Subject|0
5162125|NCT01370655|17826408|P12|Period 2|met protocol specified stopping criteria|0
5162126|NCT01370655|17826409|P11|Period 2|met protocol specified stopping criteria|1
5162127|NCT01370655|17826410|P10|Period 2|met protocol specified stopping criteria|0
5162128|NCT01370655|17826411|P9|Period 2|met protocol specified stopping criteria|1
5162129|NCT01370655|17826412|P8|Period 2|met protocol specified stopping criteria|0
5162130|NCT01370655|17826413|P7|Period 2|met protocol specified stopping criteria|1
5162131|NCT01370655|17826414|P6|Period 2|met protocol specified stopping criteria|0
5162132|NCT01370655|17826415|P5|Period 2|met protocol specified stopping criteria|0
5162133|NCT01370655|17826416|P4|Period 2|met protocol specified stopping criteria|0
5162134|NCT01370655|17826417|P3|Period 2|met protocol specified stopping criteria|1
5162135|NCT01370655|17826418|P2|Period 2|met protocol specified stopping criteria|0
5162136|NCT01370655|17826419|P1|Period 2|met protocol specified stopping criteria|0
5162137|NCT01370655|17826408|P12|Period 2|Adverse Event|0
5162138|NCT01370655|17826409|P11|Period 2|Adverse Event|0
5162139|NCT01370655|17826410|P10|Period 2|Adverse Event|0
5162140|NCT01370655|17826411|P9|Period 2|Adverse Event|0
5162141|NCT01370655|17826412|P8|Period 2|Adverse Event|1
5162142|NCT01370655|17826413|P7|Period 2|Adverse Event|0
5162143|NCT01370655|17826414|P6|Period 2|Adverse Event|0
5162144|NCT01370655|17826415|P5|Period 2|Adverse Event|1
5162145|NCT01370655|17826416|P4|Period 2|Adverse Event|0
5162146|NCT01370655|17826417|P3|Period 2|Adverse Event|1
5162147|NCT01370655|17826418|P2|Period 2|Adverse Event|0
5162148|NCT01370655|17826419|P1|Period 2|Adverse Event|0
5162149|NCT01370655|17826408|P12|Period 1|Adverse Event|0
5162150|NCT01370655|17826409|P11|Period 1|Adverse Event|0
5162151|NCT01370655|17826410|P10|Period 1|Adverse Event|0
5162152|NCT01370655|17826411|P9|Period 1|Adverse Event|0
5162153|NCT01370655|17826412|P8|Period 1|Adverse Event|0
5162154|NCT01370655|17826413|P7|Period 1|Adverse Event|1
5162155|NCT01370655|17826414|P6|Period 1|Adverse Event|0
5162156|NCT01370655|17826415|P5|Period 1|Adverse Event|0
5162157|NCT01370655|17826416|P4|Period 1|Adverse Event|0
5162158|NCT01370655|17826417|P3|Period 1|Adverse Event|0
5162159|NCT01370655|17826418|P2|Period 1|Adverse Event|0
5162160|NCT01370655|17826419|P1|Period 1|Adverse Event|2
5162161|NCT01370642|17826456|P3|Overall Study|Withdrawal by Subject|3
5162162|NCT01370642|17826457|P2|Overall Study|Withdrawal by Subject|4
5162163|NCT01370642|17826458|P1|Overall Study|Withdrawal by Subject|2
5162164|NCT01370642|17826456|P3|Overall Study|Physician Decision|2
5162165|NCT01370642|17826457|P2|Overall Study|Physician Decision|1
5162166|NCT01370642|17826458|P1|Overall Study|Physician Decision|4
5162167|NCT01370642|17826456|P3|Overall Study|Lost to Follow-up|1
5162168|NCT01370642|17826457|P2|Overall Study|Lost to Follow-up|0
5162169|NCT01370642|17826458|P1|Overall Study|Lost to Follow-up|0
5162170|NCT01370642|17826456|P3|Overall Study|Detectable HCV RNA|22
5162171|NCT01370642|17826457|P2|Overall Study|Detectable HCV RNA|0
5162172|NCT01370642|17826458|P1|Overall Study|Detectable HCV RNA|0
5162173|NCT01370642|17826456|P3|Overall Study|Adverse Event|1
5162174|NCT01370642|17826457|P2|Overall Study|Adverse Event|1
5162175|NCT01370642|17826458|P1|Overall Study|Adverse Event|2
5162176|NCT01370616|17826497|P2|Overall Study|Withdrawal by Subject|34
5162177|NCT01370616|17826498|P1|Overall Study|Withdrawal by Subject|34
5162178|NCT01370616|17826497|P2|Overall Study|Technical Problems|5
5162179|NCT01370616|17826498|P1|Overall Study|Technical Problems|3
5162180|NCT01370616|17826497|P2|Overall Study|Recovery|0
5162181|NCT01370616|17826498|P1|Overall Study|Recovery|1
5162182|NCT01370616|17826497|P2|Overall Study|Progressive Disease|1
5162183|NCT01370616|17826498|P1|Overall Study|Progressive Disease|0
5162184|NCT01370616|17826497|P2|Overall Study|Physician Decision|6
5162185|NCT01370616|17826498|P1|Overall Study|Physician Decision|6
5162186|NCT01370616|17826497|P2|Overall Study|Lost to Follow-up|3
5162187|NCT01370616|17826498|P1|Overall Study|Lost to Follow-up|0
5162188|NCT01370616|17826497|P2|Overall Study|Lack of Efficacy|2
5162189|NCT01370616|17826498|P1|Overall Study|Lack of Efficacy|6
5162190|NCT01370616|17826497|P2|Overall Study|Death|0
5162191|NCT01370616|17826498|P1|Overall Study|Death|1
5162192|NCT01370616|17826497|P2|Overall Study|Adverse Event|16
5162193|NCT01370616|17826498|P1|Overall Study|Adverse Event|11
5162194|NCT01370603|17826522|P2|Period 2|Withdrawal by Subject|0
5162195|NCT01370603|17826523|P1|Period 2|Withdrawal by Subject|1
5162196|NCT01370603|17826522|P2|Period 2|Lost to Follow-up|0
5162197|NCT01370603|17826523|P1|Period 2|Lost to Follow-up|1
5162198|NCT01370603|17826522|P2|Period 2|Adverse Event|4
5162199|NCT01370603|17826523|P1|Period 2|Adverse Event|1
5162200|NCT01370603|17826522|P2|Crossover Washout|Non-compliance with Study Drug|2
5162201|NCT01370603|17826523|P1|Crossover Washout|Non-compliance with Study Drug|0
5162202|NCT01370603|17826522|P2|Crossover Washout|Withdrawal by Subject|1
5162203|NCT01370603|17826523|P1|Crossover Washout|Withdrawal by Subject|4
5162204|NCT01370603|17826522|P2|Crossover Washout|Protocol Violation|0
5162205|NCT01370603|17826523|P1|Crossover Washout|Protocol Violation|1
5162206|NCT01370603|17826522|P2|Crossover Washout|Lost to Follow-up|0
5162207|NCT01370603|17826523|P1|Crossover Washout|Lost to Follow-up|2
5162208|NCT01370603|17826522|P2|Crossover Washout|Adverse Event|1
5162209|NCT01370603|17826523|P1|Crossover Washout|Adverse Event|2
5162210|NCT01370603|17826522|P2|Period 1|Withdrawal by Subject|5
5162211|NCT01370603|17826523|P1|Period 1|Withdrawal by Subject|5
5162212|NCT01370603|17826522|P2|Period 1|Protocol Violation|2
5162213|NCT01370603|17826523|P1|Period 1|Protocol Violation|2
5162214|NCT01370603|17826522|P2|Period 1|Lost to Follow-up|0
5162215|NCT01370603|17826523|P1|Period 1|Lost to Follow-up|2
5162216|NCT01370603|17826522|P2|Period 1|Adverse Event|3
5162217|NCT01370603|17826523|P1|Period 1|Adverse Event|5
5162218|NCT01370590|17826541|P2|Period 2|Withdrawal by Subject|1
5162219|NCT01370590|17826542|P1|Period 2|Withdrawal by Subject|1
5162220|NCT01370590|17826541|P2|Period 2|Adverse Event|1
5162221|NCT01370590|17826542|P1|Period 2|Adverse Event|0
5162222|NCT01370590|17826541|P2|Crossover Washout Period|Withdrawal by Subject|2
5162223|NCT01370590|17826542|P1|Crossover Washout Period|Withdrawal by Subject|2
5162224|NCT01370590|17826541|P2|Crossover Washout Period|Non-compliance with Study Drug|0
5162225|NCT01370590|17826542|P1|Crossover Washout Period|Non-compliance with Study Drug|1
5162226|NCT01370590|17826541|P2|Crossover Washout Period|Lost to Follow-up|0
5162227|NCT01370590|17826542|P1|Crossover Washout Period|Lost to Follow-up|2
5162228|NCT01370590|17826541|P2|Crossover Washout Period|Adverse Event|4
5162229|NCT01370590|17826542|P1|Crossover Washout Period|Adverse Event|1
5162230|NCT01370590|17826541|P2|Period 1|Could not access randomization system|1
5162231|NCT01370590|17826542|P1|Period 1|Could not access randomization system|0
5162232|NCT01370590|17826541|P2|Period 1|Withdrawal by Subject|2
5162233|NCT01370590|17826542|P1|Period 1|Withdrawal by Subject|4
5162234|NCT01370590|17826541|P2|Period 1|Protocol Violation|2
5162235|NCT01370590|17826542|P1|Period 1|Protocol Violation|2
5162236|NCT01370590|17826541|P2|Period 1|Lost to Follow-up|2
5162237|NCT01370590|17826542|P1|Period 1|Lost to Follow-up|2
5162238|NCT01370590|17826541|P2|Period 1|Adverse Event|4
5162239|NCT01370590|17826542|P1|Period 1|Adverse Event|8
5162240|NCT01370538|17826570|P2|Overall Study|Lost to follow up|10
5162241|NCT01370538|17826571|P1|Overall Study|Lost to follow up|6
5162242|NCT01370538|17826570|P2|Overall Study|Development of study specific withdrawal|1
5162243|NCT01370538|17826571|P1|Overall Study|Development of study specific withdrawal|1
5162244|NCT01370538|17826570|P2|Overall Study|Protocol Violation|5
5162245|NCT01370538|17826571|P1|Overall Study|Protocol Violation|8
5162246|NCT01370538|17826570|P2|Overall Study|Adverse Event|0
5162247|NCT01370538|17826571|P1|Overall Study|Adverse Event|1
5162248|NCT01370538|17826570|P2|Overall Study|Eligibility criteria not fulfilled|1
5162249|NCT01370538|17826571|P1|Overall Study|Eligibility criteria not fulfilled|0
5162250|NCT01370538|17826570|P2|Overall Study|Voluntary Discontinuation by Subject|2
5162251|NCT01370538|17826571|P1|Overall Study|Voluntary Discontinuation by Subject|3
5162252|NCT01370525|17826587|P2|Overall Study|Lost to follow up|6
5162253|NCT01370525|17826588|P1|Overall Study|Lost to follow up|2
5162254|NCT01370525|17826587|P2|Overall Study|Protocol Violation|1
5162255|NCT01370525|17826588|P1|Overall Study|Protocol Violation|2
5162256|NCT01370525|17826587|P2|Overall Study|Adverse Event|1
5162257|NCT01370525|17826588|P1|Overall Study|Adverse Event|0
5162258|NCT01370525|17826587|P2|Overall Study|Eligibility criteria not fulfilled|0
5162259|NCT01370525|17826588|P1|Overall Study|Eligibility criteria not fulfilled|2
5162260|NCT01370525|17826587|P2|Overall Study|Voluntary Discontinuation by Subject|3
5162261|NCT01370525|17826588|P1|Overall Study|Voluntary Discontinuation by Subject|2
5162262|NCT01370499|17826604|P2|Overall Study|Sponsor Decision|15
5162263|NCT01370499|17826605|P1|Overall Study|Sponsor Decision|41
5162264|NCT01370499|17826604|P2|Overall Study|Withdrawal by Subject|7
5162265|NCT01370499|17826605|P1|Overall Study|Withdrawal by Subject|18
5162266|NCT01370499|17826604|P2|Overall Study|Protocol Violation|4
5162267|NCT01370499|17826605|P1|Overall Study|Protocol Violation|5
5162268|NCT01370499|17826604|P2|Overall Study|Physician Decision|3
5162269|NCT01370499|17826605|P1|Overall Study|Physician Decision|3
5162270|NCT01370499|17826604|P2|Overall Study|Lost to Follow-up|1
5162271|NCT01370499|17826605|P1|Overall Study|Lost to Follow-up|2
5162272|NCT01370499|17826604|P2|Overall Study|Lack of Efficacy|2
5162273|NCT01370499|17826605|P1|Overall Study|Lack of Efficacy|4
5162274|NCT01370499|17826604|P2|Overall Study|Adverse Event|12
5162275|NCT01370499|17826605|P1|Overall Study|Adverse Event|38
5162276|NCT01370408|17826647|P1|Overall Study|treatment failure|9
5162277|NCT01370356|17826707|P2|Overall Study|AE Not Related to Study Drug|4
5162278|NCT01370356|17826708|P1|Overall Study|AE Not Related to Study Drug|1
5162279|NCT01370356|17826707|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
5162280|NCT01370356|17826708|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
5162281|NCT01370356|17826707|P2|Overall Study|Protocol Violation|3
5162282|NCT01370356|17826708|P1|Overall Study|Protocol Violation|3
5162283|NCT01370356|17826707|P2|Overall Study|Reason not specified|43
5162284|NCT01370356|17826708|P1|Overall Study|Reason not specified|39
5162285|NCT01370356|17826707|P2|Overall Study|Withdrawal by Subject|59
5162286|NCT01370356|17826708|P1|Overall Study|Withdrawal by Subject|54
5162287|NCT01370356|17826707|P2|Overall Study|Lost to Follow-up|81
5162288|NCT01370356|17826708|P1|Overall Study|Lost to Follow-up|76
5162289|NCT01370356|17826707|P2|Overall Study|Lack of Efficacy|28
5162290|NCT01370356|17826708|P1|Overall Study|Lack of Efficacy|6
5162291|NCT01370356|17826707|P2|Overall Study|Death|0
5162292|NCT01370356|17826708|P1|Overall Study|Death|1
5162293|NCT01370317|17826724|P2|Overall Study|Protocol deviation|1
5162294|NCT01370317|17826725|P1|Overall Study|Protocol deviation|0
5162295|NCT01370317|17826724|P2|Overall Study|Participant withdrew consent|0
5162296|NCT01370317|17826725|P1|Overall Study|Participant withdrew consent|1
5162297|NCT01370265|17826736|P2|First Intervention|Adverse Event|1
5162298|NCT01370265|17826737|P1|First Intervention|Adverse Event|1
5162299|NCT01370213|17826757|P3|Overall Study|Not evaluable|0
5162300|NCT01370213|17826758|P2|Overall Study|Not evaluable|2
5162301|NCT01370213|17826759|P1|Overall Study|Not evaluable|0
5162302|NCT01370213|17826757|P3|Overall Study|Early Death|0
5162303|NCT01370213|17826758|P2|Overall Study|Early Death|0
5162304|NCT01370213|17826759|P1|Overall Study|Early Death|1
5162305|NCT01370083|17826779|P2|Overall Study|Adverse Event|1
5162306|NCT01370083|17826780|P1|Overall Study|Adverse Event|0
5162307|NCT01370083|17826779|P2|Overall Study|Lost to Follow-up|0
5162308|NCT01370083|17826780|P1|Overall Study|Lost to Follow-up|2
5162309|NCT01370005|17826793|P3|Overall Study|Other reason not defined above|2
5162310|NCT01370005|17826794|P2|Overall Study|Other reason not defined above|0
5162311|NCT01370005|17826795|P1|Overall Study|Other reason not defined above|3
5162312|NCT01370005|17826793|P3|Overall Study|Patient refusal to continue,not due toAE|0
5162313|NCT01370005|17826794|P2|Overall Study|Patient refusal to continue,not due toAE|4
5162314|NCT01370005|17826795|P1|Overall Study|Patient refusal to continue,not due toAE|5
5162315|NCT01370005|17826793|P3|Overall Study|Lost to Follow-up|1
5162316|NCT01370005|17826794|P2|Overall Study|Lost to Follow-up|1
5162317|NCT01370005|17826795|P1|Overall Study|Lost to Follow-up|1
5162318|NCT01370005|17826793|P3|Overall Study|Non compliant with protocol|2
5162319|NCT01370005|17826794|P2|Overall Study|Non compliant with protocol|1
5162320|NCT01370005|17826795|P1|Overall Study|Non compliant with protocol|0
5162321|NCT01370005|17826793|P3|Overall Study|Lack of Efficacy|0
5162322|NCT01370005|17826794|P2|Overall Study|Lack of Efficacy|0
5162323|NCT01370005|17826795|P1|Overall Study|Lack of Efficacy|1
5162324|NCT01370005|17826793|P3|Overall Study|Adverse Event|6
5162325|NCT01370005|17826794|P2|Overall Study|Adverse Event|5
5162326|NCT01370005|17826795|P1|Overall Study|Adverse Event|5
5162327|NCT01370005|17826793|P3|Overall Study|Not treated|0
5162328|NCT01370005|17826794|P2|Overall Study|Not treated|0
5162329|NCT01370005|17826795|P1|Overall Study|Not treated|1
5162330|NCT01369849|17826877|P3|Overall Study|Ineligible after receiving treatment|0
5162331|NCT01369849|17826878|P2|Overall Study|Ineligible after receiving treatment|1
5162332|NCT01369849|17826879|P1|Overall Study|Ineligible after receiving treatment|0
5162333|NCT01369849|17826877|P3|Overall Study|Ineligible prior to treatment|1
5162334|NCT01369849|17826878|P2|Overall Study|Ineligible prior to treatment|0
5162335|NCT01369849|17826879|P1|Overall Study|Ineligible prior to treatment|0
5162336|NCT01369784|17826901|P1|Overall Study|Protocol Violation|12
5162337|NCT01369680|17826989|P4|Overall Study|Lost to Follow-up|2
5162338|NCT01369680|17826990|P3|Overall Study|Lost to Follow-up|1
5162339|NCT01369680|17826991|P2|Overall Study|Lost to Follow-up|0
5162340|NCT01369680|17826992|P1|Overall Study|Lost to Follow-up|0
5162341|NCT01369641|17827013|P1|Overall Study|Withdrawal by Subject|1
5162342|NCT01369615|17827019|P2|Overall Study|Lost to Follow-up|1
5162343|NCT01369615|17827020|P1|Overall Study|Lost to Follow-up|0
5162344|NCT01369615|17827019|P2|Overall Study|Withdrawal by Subject|1
5162345|NCT01369615|17827020|P1|Overall Study|Withdrawal by Subject|0
5162346|NCT01369511|17827030|P4|Overall Study|Withdrawal by Subject|6
5162347|NCT01369511|17827031|P3|Overall Study|Withdrawal by Subject|4
5162348|NCT01369511|17827032|P2|Overall Study|Withdrawal by Subject|6
5162349|NCT01369511|17827033|P1|Overall Study|Withdrawal by Subject|5
5162350|NCT01369511|17827030|P4|Overall Study|Sponsor decision|0
5162351|NCT01369511|17827031|P3|Overall Study|Sponsor decision|1
5162352|NCT01369511|17827032|P2|Overall Study|Sponsor decision|0
5162353|NCT01369511|17827033|P1|Overall Study|Sponsor decision|2
5162354|NCT01369511|17827030|P4|Overall Study|Physician Decision|0
5162355|NCT01369511|17827031|P3|Overall Study|Physician Decision|0
5162356|NCT01369511|17827032|P2|Overall Study|Physician Decision|4
5162357|NCT01369511|17827033|P1|Overall Study|Physician Decision|3
5162358|NCT01369511|17827030|P4|Overall Study|Protocol Violation|2
5162359|NCT01369511|17827031|P3|Overall Study|Protocol Violation|0
5162360|NCT01369511|17827032|P2|Overall Study|Protocol Violation|1
5162361|NCT01369511|17827033|P1|Overall Study|Protocol Violation|0
5162362|NCT01369511|17827030|P4|Overall Study|Lost to Follow-up|2
5162363|NCT01369511|17827031|P3|Overall Study|Lost to Follow-up|1
5162364|NCT01369511|17827032|P2|Overall Study|Lost to Follow-up|1
5162365|NCT01369511|17827033|P1|Overall Study|Lost to Follow-up|0
5162366|NCT01369511|17827030|P4|Overall Study|Entry criteria not met|1
5162367|NCT01369511|17827031|P3|Overall Study|Entry criteria not met|0
5162368|NCT01369511|17827032|P2|Overall Study|Entry criteria not met|0
5162369|NCT01369511|17827033|P1|Overall Study|Entry criteria not met|2
5162370|NCT01369511|17827030|P4|Overall Study|Adverse Event|0
5162371|NCT01369511|17827031|P3|Overall Study|Adverse Event|5
5162372|NCT01369511|17827032|P2|Overall Study|Adverse Event|1
5162373|NCT01369511|17827033|P1|Overall Study|Adverse Event|1
5162374|NCT01369498|17827051|P4|Overall Study|Disease Progression|1
5162375|NCT01369498|17827052|P3|Overall Study|Disease Progression|0
5162376|NCT01369498|17827053|P2|Overall Study|Disease Progression|0
5162377|NCT01369498|17827054|P1|Overall Study|Disease Progression|0
5162378|NCT01369498|17827051|P4|Overall Study|Unknown Reason|6
5162379|NCT01369498|17827052|P3|Overall Study|Unknown Reason|11
5162380|NCT01369498|17827053|P2|Overall Study|Unknown Reason|0
5162381|NCT01369498|17827054|P1|Overall Study|Unknown Reason|1
5162382|NCT01369498|17827051|P4|Overall Study|Investigator's Discretion|3
5162383|NCT01369498|17827052|P3|Overall Study|Investigator's Discretion|1
5162384|NCT01369498|17827053|P2|Overall Study|Investigator's Discretion|0
5162385|NCT01369498|17827054|P1|Overall Study|Investigator's Discretion|1
5162386|NCT01369498|17827051|P4|Overall Study|Death|0
5162387|NCT01369498|17827052|P3|Overall Study|Death|1
5162388|NCT01369498|17827053|P2|Overall Study|Death|0
5162389|NCT01369498|17827054|P1|Overall Study|Death|0
5162390|NCT01369498|17827051|P4|Overall Study|Withdrawal of Consent|1
5162391|NCT01369498|17827052|P3|Overall Study|Withdrawal of Consent|1
5162392|NCT01369498|17827053|P2|Overall Study|Withdrawal of Consent|1
5162393|NCT01369498|17827054|P1|Overall Study|Withdrawal of Consent|0
5162394|NCT01369498|17827051|P4|Overall Study|Adverse Event|1
5162395|NCT01369498|17827052|P3|Overall Study|Adverse Event|0
5162396|NCT01369498|17827053|P2|Overall Study|Adverse Event|2
5162397|NCT01369498|17827054|P1|Overall Study|Adverse Event|1
5162398|NCT01369498|17827051|P4|Overall Study|Lack of Efficacy|3
5162399|NCT01369498|17827052|P3|Overall Study|Lack of Efficacy|1
5162400|NCT01369498|17827053|P2|Overall Study|Lack of Efficacy|9
5162401|NCT01369498|17827054|P1|Overall Study|Lack of Efficacy|9
5162402|NCT01369485|17827086|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
5162403|NCT01369485|17827087|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
5162404|NCT01369485|17827086|P2|Open Label Phase (Week 12 to Month 12)|Death|1
5162405|NCT01369485|17827087|P1|Open Label Phase (Week 12 to Month 12)|Death|0
5162406|NCT01369485|17827086|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
5162407|NCT01369485|17827087|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
5162408|NCT01369485|17827086|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
5162409|NCT01369485|17827087|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
5162410|NCT01369485|17827086|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
5162411|NCT01369485|17827087|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
5162412|NCT01369485|17827086|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
5162413|NCT01369485|17827087|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
5162414|NCT01369485|17827086|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
5162415|NCT01369485|17827087|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
5162416|NCT01369485|17827086|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
5162417|NCT01369485|17827087|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
5162418|NCT01369485|17827086|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
5162419|NCT01369485|17827087|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
5162420|NCT01369485|17827086|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
5162421|NCT01369485|17827087|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
5162422|NCT01369433|17827129|P2|Overall Study|Progressive Disease|12
5162423|NCT01369433|17827130|P1|Overall Study|Progressive Disease|92
5162424|NCT01369433|17827129|P2|Overall Study|Investigator discretion|1
5162425|NCT01369433|17827130|P1|Overall Study|Investigator discretion|6
5162426|NCT01369433|17827129|P2|Overall Study|Death|0
5162427|NCT01369433|17827130|P1|Overall Study|Death|5
5162428|NCT01369433|17827129|P2|Overall Study|Lost to Follow-up|0
5162429|NCT01369433|17827130|P1|Overall Study|Lost to Follow-up|1
5162430|NCT01369433|17827129|P2|Overall Study|Study terminated by Sponsor|0
5162431|NCT01369433|17827130|P1|Overall Study|Study terminated by Sponsor|67
5162432|NCT01369433|17827129|P2|Overall Study|Withdrawal by Subject|2
5162433|NCT01369433|17827130|P1|Overall Study|Withdrawal by Subject|5
5162434|NCT01369433|17827129|P2|Overall Study|Non-compliance|0
5162435|NCT01369433|17827130|P1|Overall Study|Non-compliance|1
5162436|NCT01369433|17827129|P2|Overall Study|Required significant surgical procedure|0
5162437|NCT01369433|17827130|P1|Overall Study|Required significant surgical procedure|1
5162438|NCT01369433|17827129|P2|Overall Study|Adverse Event|1
5162439|NCT01369433|17827130|P1|Overall Study|Adverse Event|31
5162440|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Other|17
5162441|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Other|9
5162442|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Other|110
5162443|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Other|0
5162444|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Other|0
5162445|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Other|0
5162446|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Other|0
5162447|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Other|0
5162448|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Other|0
5162449|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
5162450|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
5162451|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
5162452|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5162453|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5162454|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5162455|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5162456|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5162457|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5162458|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Lost to Follow-up|9
5162459|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Lost to Follow-up|5
5162460|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Lost to Follow-up|1
5162461|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5162462|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5162463|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5162464|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5162465|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5162466|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5162467|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Physician Decision|11
5162468|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Physician Decision|5
5162469|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Physician Decision|1
5162470|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Physician Decision|0
5162471|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Physician Decision|0
5162472|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Physician Decision|0
5162473|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Physician Decision|0
5162474|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Physician Decision|0
5162475|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Physician Decision|0
5162476|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Protocol Violation|2
5162477|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Protocol Violation|1
5162478|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Protocol Violation|0
5162479|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Protocol Violation|0
5162480|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Protocol Violation|0
5162481|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Protocol Violation|0
5162482|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Protocol Violation|0
5162483|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Protocol Violation|0
5162484|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Protocol Violation|0
5162485|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Lack of Efficacy|29
5162486|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Lack of Efficacy|26
5162487|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Lack of Efficacy|12
5162488|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5162489|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5162490|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5162491|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5162492|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5162493|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5162494|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Death|3
5162495|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Death|1
5162496|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Death|0
5162497|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Death|0
5162498|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Death|0
5162499|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Death|0
5162500|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Death|0
5162501|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Death|0
5162502|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Death|0
5162503|NCT01369355|17827142|P9|Long-term Extension (Week 44-272)|Adverse Event|53
5162504|NCT01369355|17827143|P8|Long-term Extension (Week 44-272)|Adverse Event|29
5162505|NCT01369355|17827144|P7|Long-term Extension (Week 44-272)|Adverse Event|15
5162506|NCT01369355|17827145|P6|Long-term Extension (Week 44-272)|Adverse Event|0
5162507|NCT01369355|17827146|P5|Long-term Extension (Week 44-272)|Adverse Event|0
5162508|NCT01369355|17827147|P4|Long-term Extension (Week 44-272)|Adverse Event|0
5162509|NCT01369355|17827148|P3|Long-term Extension (Week 44-272)|Adverse Event|0
5162510|NCT01369355|17827149|P2|Long-term Extension (Week 44-272)|Adverse Event|0
5162511|NCT01369355|17827150|P1|Long-term Extension (Week 44-272)|Adverse Event|0
5162512|NCT01369355|17827142|P9|Week 0 - Week 44 (Maintenance)|Other|0
5162513|NCT01369355|17827143|P8|Week 0 - Week 44 (Maintenance)|Other|0
5162514|NCT01369355|17827144|P7|Week 0 - Week 44 (Maintenance)|Other|0
5162515|NCT01369355|17827145|P6|Week 0 - Week 44 (Maintenance)|Other|0
5162516|NCT01369355|17827146|P5|Week 0 - Week 44 (Maintenance)|Other|1
5162517|NCT01369355|17827147|P4|Week 0 - Week 44 (Maintenance)|Other|0
5162518|NCT01369355|17827148|P3|Week 0 - Week 44 (Maintenance)|Other|1
5162519|NCT01369355|17827149|P2|Week 0 - Week 44 (Maintenance)|Other|0
5162520|NCT01369355|17827150|P1|Week 0 - Week 44 (Maintenance)|Other|0
5162521|NCT01369355|17827142|P9|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5162522|NCT01369355|17827143|P8|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5162523|NCT01369355|17827144|P7|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5162524|NCT01369355|17827145|P6|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
5162525|NCT01369355|17827146|P5|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
5162526|NCT01369355|17827147|P4|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
5162527|NCT01369355|17827148|P3|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
5162528|NCT01369355|17827149|P2|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
5162529|NCT01369355|17827150|P1|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
5162530|NCT01369355|17827142|P9|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5162531|NCT01369355|17827143|P8|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5162532|NCT01369355|17827144|P7|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5162533|NCT01369355|17827145|P6|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
5162534|NCT01369355|17827146|P5|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
5162535|NCT01369355|17827147|P4|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
5162536|NCT01369355|17827148|P3|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
5162537|NCT01369355|17827149|P2|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5162538|NCT01369355|17827150|P1|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
5162539|NCT01369355|17827142|P9|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5162540|NCT01369355|17827143|P8|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5162541|NCT01369355|17827144|P7|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5162542|NCT01369355|17827145|P6|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
5162543|NCT01369355|17827146|P5|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5162544|NCT01369355|17827147|P4|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5162545|NCT01369355|17827148|P3|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
5162546|NCT01369355|17827149|P2|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
5162547|NCT01369355|17827150|P1|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5162548|NCT01369355|17827142|P9|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5162549|NCT01369355|17827143|P8|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5162550|NCT01369355|17827144|P7|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5162551|NCT01369355|17827145|P6|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
5162552|NCT01369355|17827146|P5|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
5162553|NCT01369355|17827147|P4|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5162554|NCT01369355|17827148|P3|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5162555|NCT01369355|17827149|P2|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
5162556|NCT01369355|17827150|P1|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5162557|NCT01369355|17827142|P9|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5162558|NCT01369355|17827143|P8|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5162559|NCT01369355|17827144|P7|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5162560|NCT01369355|17827145|P6|Week 0 - Week 44 (Maintenance)|Adverse Event|25
5162561|NCT01369355|17827146|P5|Week 0 - Week 44 (Maintenance)|Adverse Event|14
5162562|NCT01369355|17827147|P4|Week 0 - Week 44 (Maintenance)|Adverse Event|7
5162563|NCT01369355|17827148|P3|Week 0 - Week 44 (Maintenance)|Adverse Event|6
5162564|NCT01369355|17827149|P2|Week 0 - Week 44 (Maintenance)|Adverse Event|12
5162565|NCT01369355|17827150|P1|Week 0 - Week 44 (Maintenance)|Adverse Event|9
5162566|NCT01369342|17827182|P3|Overall Study|Not Treated|0
5162567|NCT01369342|17827183|P2|Overall Study|Not Treated|0
5162568|NCT01369342|17827184|P1|Overall Study|Not Treated|1
5162569|NCT01369342|17827182|P3|Overall Study|Lost to Follow-up|1
5162570|NCT01369342|17827183|P2|Overall Study|Lost to Follow-up|2
5162571|NCT01369342|17827184|P1|Overall Study|Lost to Follow-up|5
5162572|NCT01369342|17827182|P3|Overall Study|Withdrawal by Subject|2
5162573|NCT01369342|17827183|P2|Overall Study|Withdrawal by Subject|7
5162574|NCT01369342|17827184|P1|Overall Study|Withdrawal by Subject|7
5162575|NCT01369329|17827207|P3|Overall Study|Other|2
5162576|NCT01369329|17827208|P2|Overall Study|Other|3
5162577|NCT01369329|17827209|P1|Overall Study|Other|2
5162578|NCT01369329|17827207|P3|Overall Study|Lost to Follow-up|2
5162579|NCT01369329|17827208|P2|Overall Study|Lost to Follow-up|2
5162580|NCT01369329|17827209|P1|Overall Study|Lost to Follow-up|2
5162581|NCT01369329|17827207|P3|Overall Study|Withdrawal by Subject|10
5162582|NCT01369329|17827208|P2|Overall Study|Withdrawal by Subject|6
5162583|NCT01369329|17827209|P1|Overall Study|Withdrawal by Subject|8
5162584|NCT01369225|17827235|P6|Overall Study|Adverse Event|0
5162585|NCT01369225|17827236|P5|Overall Study|Adverse Event|1
5162586|NCT01369225|17827237|P4|Overall Study|Adverse Event|1
5162587|NCT01369225|17827238|P3|Overall Study|Adverse Event|0
5162588|NCT01369225|17827239|P2|Overall Study|Adverse Event|0
5162589|NCT01369225|17827240|P1|Overall Study|Adverse Event|0
5162590|NCT01369225|17827235|P6|Overall Study|Other|0
5162591|NCT01369225|17827236|P5|Overall Study|Other|1
5162592|NCT01369225|17827237|P4|Overall Study|Other|0
5162593|NCT01369225|17827238|P3|Overall Study|Other|0
5162594|NCT01369225|17827239|P2|Overall Study|Other|0
5162595|NCT01369225|17827240|P1|Overall Study|Other|1
5162596|NCT01369225|17827235|P6|Overall Study|Does Not Meet Entrance Criteria|0
5162597|NCT01369225|17827236|P5|Overall Study|Does Not Meet Entrance Criteria|0
5162598|NCT01369225|17827237|P4|Overall Study|Does Not Meet Entrance Criteria|0
5162599|NCT01369225|17827238|P3|Overall Study|Does Not Meet Entrance Criteria|1
5162600|NCT01369225|17827239|P2|Overall Study|Does Not Meet Entrance Criteria|0
5162601|NCT01369225|17827240|P1|Overall Study|Does Not Meet Entrance Criteria|0
5162602|NCT01369225|17827235|P6|Overall Study|Withdrawal by Subject|0
5162603|NCT01369225|17827236|P5|Overall Study|Withdrawal by Subject|0
5162604|NCT01369225|17827237|P4|Overall Study|Withdrawal by Subject|1
5162605|NCT01369225|17827238|P3|Overall Study|Withdrawal by Subject|2
5162606|NCT01369225|17827239|P2|Overall Study|Withdrawal by Subject|0
5162607|NCT01369225|17827240|P1|Overall Study|Withdrawal by Subject|1
5162608|NCT01369199|17827332|P1|Overall Study|Lost to Follow-up|2
5162609|NCT01369199|17827332|P1|Overall Study|Withdrawal by Subject|1
5162610|NCT01369069|17827364|P2|Overall Study|Withdrawal by Subject|7
5162611|NCT01369069|17827365|P1|Overall Study|Withdrawal by Subject|9
5162612|NCT01369069|17827364|P2|Overall Study|Lost to Follow-up|9
5162613|NCT01369069|17827365|P1|Overall Study|Lost to Follow-up|8
5162614|NCT01368965|17827387|P1|Overall Study|Lost to Follow-up|12
5162615|NCT01368900|17827396|P1|Overall Study|Lost to Follow-up|7
5162616|NCT01368835|17827471|P1|Overall Study|Lost to Follow-up|11
5162617|NCT01368835|17827471|P1|Overall Study|Inclusion criteria/photography quality|22
5162618|NCT01368614|17827510|P4|Study Period|Lost to Follow-up|0
5162619|NCT01368614|17827511|P3|Study Period|Lost to Follow-up|1
5162620|NCT01368614|17827512|P2|Study Period|Lost to Follow-up|0
5162621|NCT01368614|17827513|P1|Study Period|Lost to Follow-up|0
5162622|NCT01368614|17827510|P4|Study Period|Withdrawal by Subject|3
5162623|NCT01368614|17827511|P3|Study Period|Withdrawal by Subject|1
5162624|NCT01368614|17827512|P2|Study Period|Withdrawal by Subject|1
5162625|NCT01368614|17827513|P1|Study Period|Withdrawal by Subject|0
5162626|NCT01368614|17827510|P4|Screening Period|Screen Failure|0
5162627|NCT01368614|17827511|P3|Screening Period|Screen Failure|0
5162628|NCT01368614|17827512|P2|Screening Period|Screen Failure|0
5162629|NCT01368614|17827513|P1|Screening Period|Screen Failure|58
5162630|NCT01368562|17827566|P1|Overall Study|Other than specified|2
5162631|NCT01368562|17827566|P1|Overall Study|Other|3
5162632|NCT01368562|17827566|P1|Overall Study|Unresponsive to treatment|5
5162633|NCT01368562|17827566|P1|Overall Study|Death|6
5162634|NCT01368562|17827566|P1|Overall Study|Lost to Follow-up|1
5162635|NCT01368562|17827566|P1|Overall Study|Disease progression|1
5162636|NCT01368562|17827566|P1|Overall Study|Adverse Event|1
5162637|NCT01368536|17827573|P3|Overall Study|Protocol deviation|1
5162638|NCT01368536|17827574|P2|Overall Study|Protocol deviation|3
5162639|NCT01368536|17827575|P1|Overall Study|Protocol deviation|0
5162640|NCT01368536|17827573|P3|Overall Study|Administrative problems|35
5162641|NCT01368536|17827574|P2|Overall Study|Administrative problems|39
5162642|NCT01368536|17827575|P1|Overall Study|Administrative problems|34
5162643|NCT01368536|17827573|P3|Overall Study|Lost to Follow-up|5
5162644|NCT01368536|17827574|P2|Overall Study|Lost to Follow-up|3
5162645|NCT01368536|17827575|P1|Overall Study|Lost to Follow-up|3
5162646|NCT01368536|17827573|P3|Overall Study|Withdrawal by Subject|4
5162647|NCT01368536|17827574|P2|Overall Study|Withdrawal by Subject|5
5162648|NCT01368536|17827575|P1|Overall Study|Withdrawal by Subject|2
5162649|NCT01368536|17827573|P3|Overall Study|No longer required study medication|1
5162650|NCT01368536|17827574|P2|Overall Study|No longer required study medication|0
5162651|NCT01368536|17827575|P1|Overall Study|No longer required study medication|0
5162652|NCT01368536|17827573|P3|Overall Study|Unsatisfactory therapeutic effect|2
5162653|NCT01368536|17827574|P2|Overall Study|Unsatisfactory therapeutic effect|2
5162654|NCT01368536|17827575|P1|Overall Study|Unsatisfactory therapeutic effect|7
5162655|NCT01368536|17827573|P3|Overall Study|Abnormal test procedure result(s)|1
5162656|NCT01368536|17827574|P2|Overall Study|Abnormal test procedure result(s)|0
5162657|NCT01368536|17827575|P1|Overall Study|Abnormal test procedure result(s)|0
5162658|NCT01368536|17827573|P3|Overall Study|Abnormal laboratory value(s)|2
5162659|NCT01368536|17827574|P2|Overall Study|Abnormal laboratory value(s)|1
5162660|NCT01368536|17827575|P1|Overall Study|Abnormal laboratory value(s)|0
5162661|NCT01368536|17827573|P3|Overall Study|Adverse Event|8
5162662|NCT01368536|17827574|P2|Overall Study|Adverse Event|6
5162663|NCT01368536|17827575|P1|Overall Study|Adverse Event|5
5162664|NCT01368497|17827596|P1|Overall Study|Lost to Follow-up|2
5162665|NCT01368432|17827625|P2|Overall Study|Lost to Follow-up|1
5162666|NCT01368432|17827626|P1|Overall Study|Lost to Follow-up|0
5162667|NCT01368406|17827660|P2|Overall Study|started working|3
5162668|NCT01368406|17827661|P1|Overall Study|started working|2
5162669|NCT01368406|17827660|P2|Overall Study|relapse of the disease|2
5162670|NCT01368406|17827661|P1|Overall Study|relapse of the disease|3
5162671|NCT01368406|17827660|P2|Overall Study|Withdrawal by Subject|4
5162672|NCT01368406|17827661|P1|Overall Study|Withdrawal by Subject|8
5162673|NCT01368406|17827660|P2|Overall Study|Lost to Follow-up|4
5162674|NCT01368406|17827661|P1|Overall Study|Lost to Follow-up|8
5162675|NCT01368276|17827669|P2|Overall Study|Death|10
5162676|NCT01368276|17827670|P1|Overall Study|Death|1
5162677|NCT01368211|17827707|P2|Second Platelets Transfusion|No need for additional transfusion|2
5162678|NCT01368211|17827708|P1|Second Platelets Transfusion|No need for additional transfusion|1
5162679|NCT01368081|17827736|P13|Overall Study|Other reason not defined above|3
5162680|NCT01368081|17827737|P12|Overall Study|Other reason not defined above|0
5162681|NCT01368081|17827738|P11|Overall Study|Other reason not defined above|0
5162682|NCT01368081|17827739|P10|Overall Study|Other reason not defined above|1
5162683|NCT01368081|17827740|P9|Overall Study|Other reason not defined above|0
5162684|NCT01368081|17827741|P8|Overall Study|Other reason not defined above|0
5162685|NCT01368081|17827742|P7|Overall Study|Other reason not defined above|2
5162686|NCT01368081|17827743|P6|Overall Study|Other reason not defined above|1
5162687|NCT01368081|17827744|P5|Overall Study|Other reason not defined above|0
5162688|NCT01368081|17827745|P4|Overall Study|Other reason not defined above|1
5162689|NCT01368081|17827746|P3|Overall Study|Other reason not defined above|0
5162690|NCT01368081|17827747|P2|Overall Study|Other reason not defined above|0
5162691|NCT01368081|17827748|P1|Overall Study|Other reason not defined above|2
5162692|NCT01368081|17827736|P13|Overall Study|Withdrawal by Subject|0
5162693|NCT01368081|17827737|P12|Overall Study|Withdrawal by Subject|2
5162694|NCT01368081|17827738|P11|Overall Study|Withdrawal by Subject|3
5162695|NCT01368081|17827739|P10|Overall Study|Withdrawal by Subject|4
5162696|NCT01368081|17827740|P9|Overall Study|Withdrawal by Subject|5
5162697|NCT01368081|17827741|P8|Overall Study|Withdrawal by Subject|2
5162698|NCT01368081|17827742|P7|Overall Study|Withdrawal by Subject|4
5162699|NCT01368081|17827743|P6|Overall Study|Withdrawal by Subject|3
5162700|NCT01368081|17827744|P5|Overall Study|Withdrawal by Subject|0
5162701|NCT01368081|17827745|P4|Overall Study|Withdrawal by Subject|1
5162702|NCT01368081|17827746|P3|Overall Study|Withdrawal by Subject|1
5162703|NCT01368081|17827747|P2|Overall Study|Withdrawal by Subject|4
5162704|NCT01368081|17827748|P1|Overall Study|Withdrawal by Subject|4
5162705|NCT01368081|17827736|P13|Overall Study|Lost to Follow-up|1
5162706|NCT01368081|17827737|P12|Overall Study|Lost to Follow-up|0
5162707|NCT01368081|17827738|P11|Overall Study|Lost to Follow-up|0
5162708|NCT01368081|17827739|P10|Overall Study|Lost to Follow-up|0
5162709|NCT01368081|17827740|P9|Overall Study|Lost to Follow-up|0
5162710|NCT01368081|17827741|P8|Overall Study|Lost to Follow-up|0
5162711|NCT01368081|17827742|P7|Overall Study|Lost to Follow-up|0
5162712|NCT01368081|17827743|P6|Overall Study|Lost to Follow-up|0
5162713|NCT01368081|17827744|P5|Overall Study|Lost to Follow-up|0
5162714|NCT01368081|17827745|P4|Overall Study|Lost to Follow-up|0
5162715|NCT01368081|17827746|P3|Overall Study|Lost to Follow-up|0
5162716|NCT01368081|17827747|P2|Overall Study|Lost to Follow-up|0
5162717|NCT01368081|17827748|P1|Overall Study|Lost to Follow-up|0
5162718|NCT01368081|17827736|P13|Overall Study|Protocol Violation|0
5162719|NCT01368081|17827737|P12|Overall Study|Protocol Violation|0
5162720|NCT01368081|17827738|P11|Overall Study|Protocol Violation|0
5162721|NCT01368081|17827739|P10|Overall Study|Protocol Violation|0
5162722|NCT01368081|17827740|P9|Overall Study|Protocol Violation|0
5162723|NCT01368081|17827741|P8|Overall Study|Protocol Violation|1
5162724|NCT01368081|17827742|P7|Overall Study|Protocol Violation|0
5162725|NCT01368081|17827743|P6|Overall Study|Protocol Violation|1
5162726|NCT01368081|17827744|P5|Overall Study|Protocol Violation|0
5162727|NCT01368081|17827745|P4|Overall Study|Protocol Violation|0
5162728|NCT01368081|17827746|P3|Overall Study|Protocol Violation|0
5162729|NCT01368081|17827747|P2|Overall Study|Protocol Violation|0
5162730|NCT01368081|17827748|P1|Overall Study|Protocol Violation|0
5162731|NCT01368081|17827736|P13|Overall Study|Lack of Efficacy|0
5162732|NCT01368081|17827737|P12|Overall Study|Lack of Efficacy|0
5162733|NCT01368081|17827738|P11|Overall Study|Lack of Efficacy|0
5162734|NCT01368081|17827739|P10|Overall Study|Lack of Efficacy|0
5162735|NCT01368081|17827740|P9|Overall Study|Lack of Efficacy|0
5162736|NCT01368081|17827741|P8|Overall Study|Lack of Efficacy|2
5162737|NCT01368081|17827742|P7|Overall Study|Lack of Efficacy|0
5162738|NCT01368081|17827743|P6|Overall Study|Lack of Efficacy|0
5162739|NCT01368081|17827744|P5|Overall Study|Lack of Efficacy|0
5162740|NCT01368081|17827745|P4|Overall Study|Lack of Efficacy|1
5162741|NCT01368081|17827746|P3|Overall Study|Lack of Efficacy|0
5162742|NCT01368081|17827747|P2|Overall Study|Lack of Efficacy|1
5162743|NCT01368081|17827748|P1|Overall Study|Lack of Efficacy|0
5162744|NCT01368081|17827736|P13|Overall Study|Adverse Event|3
5162745|NCT01368081|17827737|P12|Overall Study|Adverse Event|1
5162746|NCT01368081|17827738|P11|Overall Study|Adverse Event|6
5162747|NCT01368081|17827739|P10|Overall Study|Adverse Event|5
5162748|NCT01368081|17827740|P9|Overall Study|Adverse Event|3
5162749|NCT01368081|17827741|P8|Overall Study|Adverse Event|2
5162750|NCT01368081|17827742|P7|Overall Study|Adverse Event|6
5162751|NCT01368081|17827743|P6|Overall Study|Adverse Event|5
5162752|NCT01368081|17827744|P5|Overall Study|Adverse Event|2
5162753|NCT01368081|17827745|P4|Overall Study|Adverse Event|2
5162754|NCT01368081|17827746|P3|Overall Study|Adverse Event|3
5162755|NCT01368081|17827747|P2|Overall Study|Adverse Event|4
5162756|NCT01368081|17827748|P1|Overall Study|Adverse Event|4
5162757|NCT01368042|17827802|P1|Overall Study|Transplanted|1
5162758|NCT01368042|17827802|P1|Overall Study|Lost to Follow-up|4
5162759|NCT01368042|17827802|P1|Overall Study|Protocol Violation|11
5162760|NCT01368042|17827802|P1|Overall Study|Death|14
5162761|NCT01367886|17827822|P1|Overall Study|Death|1
5162762|NCT01367886|17827822|P1|Overall Study|Lack of Efficacy|2
5162763|NCT01367886|17827822|P1|Overall Study|Lost to Follow-up|4
5162764|NCT01367847|17827872|P2|Overall Study|Withdrawal by Subject|2
5162765|NCT01367847|17827873|P1|Overall Study|Withdrawal by Subject|2
5162766|NCT01367834|17827889|P2|Overall Study|Study was ended.|1
5162767|NCT01367834|17827890|P1|Overall Study|Study was ended.|0
5162768|NCT01367834|17827889|P2|Overall Study|Withdrawal by Subject|2
5162769|NCT01367834|17827890|P1|Overall Study|Withdrawal by Subject|2
5162770|NCT01367704|17827914|P2|Overall Study|Lost to Follow-up|161
5162771|NCT01367704|17827915|P1|Overall Study|Lost to Follow-up|47
5162772|NCT01367665|17827927|P2|Overall Study|Not Done|14
5162773|NCT01367665|17827928|P1|Overall Study|Not Done|118
5162774|NCT01367665|17827927|P2|Overall Study|Lost to Follow-up|22
5162775|NCT01367665|17827928|P1|Overall Study|Lost to Follow-up|222
5162776|NCT01367665|17827927|P2|Overall Study|Death|19
5162777|NCT01367665|17827928|P1|Overall Study|Death|102
5162778|NCT01367457|17827959|P3|Overall Study|Suspected DP/suspected active infection|0
5162779|NCT01367457|17827960|P2|Overall Study|Suspected DP/suspected active infection|0
5162780|NCT01367457|17827961|P1|Overall Study|Suspected DP/suspected active infection|1
5162781|NCT01367457|17827959|P3|Overall Study|Palliative. Overall decline|0
5162782|NCT01367457|17827960|P2|Overall Study|Palliative. Overall decline|0
5162783|NCT01367457|17827961|P1|Overall Study|Palliative. Overall decline|1
5162784|NCT01367457|17827959|P3|Overall Study|Patient's Wish|0
5162785|NCT01367457|17827960|P2|Overall Study|Patient's Wish|0
5162786|NCT01367457|17827961|P1|Overall Study|Patient's Wish|1
5162787|NCT01367457|17827959|P3|Overall Study|CD, Suspected disease progression (DP)|0
5162788|NCT01367457|17827960|P2|Overall Study|CD, Suspected disease progression (DP)|0
5162789|NCT01367457|17827961|P1|Overall Study|CD, Suspected disease progression (DP)|1
5162790|NCT01367457|17827959|P3|Overall Study|Death from septic shock|0
5162791|NCT01367457|17827960|P2|Overall Study|Death from septic shock|0
5162792|NCT01367457|17827961|P1|Overall Study|Death from septic shock|1
5162793|NCT01367457|17827959|P3|Overall Study|Lost to Follow-up|0
5162794|NCT01367457|17827960|P2|Overall Study|Lost to Follow-up|0
5162795|NCT01367457|17827961|P1|Overall Study|Lost to Follow-up|1
5162796|NCT01367457|17827959|P3|Overall Study|Rejection of treatment|0
5162797|NCT01367457|17827960|P2|Overall Study|Rejection of treatment|0
5162798|NCT01367457|17827961|P1|Overall Study|Rejection of treatment|1
5162799|NCT01367457|17827959|P3|Overall Study|Overall decline|0
5162800|NCT01367457|17827960|P2|Overall Study|Overall decline|0
5162801|NCT01367457|17827961|P1|Overall Study|Overall decline|1
5162802|NCT01367457|17827959|P3|Overall Study|Intestinal obstruction with necrosis|0
5162803|NCT01367457|17827960|P2|Overall Study|Intestinal obstruction with necrosis|0
5162804|NCT01367457|17827961|P1|Overall Study|Intestinal obstruction with necrosis|1
5162805|NCT01367457|17827959|P3|Overall Study|No clinical benefit|0
5162806|NCT01367457|17827960|P2|Overall Study|No clinical benefit|0
5162807|NCT01367457|17827961|P1|Overall Study|No clinical benefit|1
5162808|NCT01367457|17827959|P3|Overall Study|Stabilisation + frequent infections|0
5162809|NCT01367457|17827960|P2|Overall Study|Stabilisation + frequent infections|0
5162810|NCT01367457|17827961|P1|Overall Study|Stabilisation + frequent infections|1
5162811|NCT01367457|17827959|P3|Overall Study|Overall status worsens to grade 4|0
5162812|NCT01367457|17827960|P2|Overall Study|Overall status worsens to grade 4|0
5162813|NCT01367457|17827961|P1|Overall Study|Overall status worsens to grade 4|1
5162814|NCT01367457|17827959|P3|Overall Study|Uncontrolled pain|0
5162815|NCT01367457|17827960|P2|Overall Study|Uncontrolled pain|0
5162816|NCT01367457|17827961|P1|Overall Study|Uncontrolled pain|1
5162817|NCT01367457|17827959|P3|Overall Study|CD, associated leukaemia|0
5162818|NCT01367457|17827960|P2|Overall Study|CD, associated leukaemia|0
5162819|NCT01367457|17827961|P1|Overall Study|CD, associated leukaemia|1
5162820|NCT01367457|17827959|P3|Overall Study|Withdrawal by Subject|0
5162821|NCT01367457|17827960|P2|Overall Study|Withdrawal by Subject|0
5162822|NCT01367457|17827961|P1|Overall Study|Withdrawal by Subject|1
5162823|NCT01367457|17827959|P3|Overall Study|Choledocolithiasis and pancreatitis|0
5162824|NCT01367457|17827960|P2|Overall Study|Choledocolithiasis and pancreatitis|0
5162825|NCT01367457|17827961|P1|Overall Study|Choledocolithiasis and pancreatitis|1
5162826|NCT01367457|17827959|P3|Overall Study|low grade toxicities + stable disease|0
5162827|NCT01367457|17827960|P2|Overall Study|low grade toxicities + stable disease|0
5162828|NCT01367457|17827961|P1|Overall Study|low grade toxicities + stable disease|1
5162829|NCT01367457|17827959|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
5162830|NCT01367457|17827960|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
5162831|NCT01367457|17827961|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
5162832|NCT01367457|17827959|P3|Overall Study|Bleeding from cavernous haemangioma|0
5162833|NCT01367457|17827960|P2|Overall Study|Bleeding from cavernous haemangioma|0
5162834|NCT01367457|17827961|P1|Overall Study|Bleeding from cavernous haemangioma|1
5162835|NCT01367457|17827959|P3|Overall Study|Investigator's opinion, stable disease|0
5162836|NCT01367457|17827960|P2|Overall Study|Investigator's opinion, stable disease|0
5162837|NCT01367457|17827961|P1|Overall Study|Investigator's opinion, stable disease|1
5162838|NCT01367457|17827959|P3|Overall Study|Patient asks for rest + slow progression|0
5162839|NCT01367457|17827960|P2|Overall Study|Patient asks for rest + slow progression|0
5162840|NCT01367457|17827961|P1|Overall Study|Patient asks for rest + slow progression|1
5162841|NCT01367457|17827959|P3|Overall Study|Progression|0
5162842|NCT01367457|17827960|P2|Overall Study|Progression|0
5162843|NCT01367457|17827961|P1|Overall Study|Progression|137
5162844|NCT01367457|17827959|P3|Overall Study|Toxicity|0
5162845|NCT01367457|17827960|P2|Overall Study|Toxicity|0
5162846|NCT01367457|17827961|P1|Overall Study|Toxicity|16
5162847|NCT01367457|17827959|P3|Overall Study|Progression and death|0
5162848|NCT01367457|17827960|P2|Overall Study|Progression and death|0
5162849|NCT01367457|17827961|P1|Overall Study|Progression and death|8
5162850|NCT01367457|17827959|P3|Overall Study|Clinical decline (CD)|0
5162851|NCT01367457|17827960|P2|Overall Study|Clinical decline (CD)|0
5162852|NCT01367457|17827961|P1|Overall Study|Clinical decline (CD)|2
5162853|NCT01367457|17827959|P3|Overall Study|Investigator's decision|0
5162854|NCT01367457|17827960|P2|Overall Study|Investigator's decision|0
5162855|NCT01367457|17827961|P1|Overall Study|Investigator's decision|2
5162856|NCT01367457|17827959|P3|Overall Study|Death|0
5162857|NCT01367457|17827960|P2|Overall Study|Death|0
5162858|NCT01367457|17827961|P1|Overall Study|Death|2
5162859|NCT01367275|17828017|P1|Overall Study|Disease Progression|2
5162860|NCT01367275|17828017|P1|Overall Study|Ineligible|1
5162861|NCT01367249|17828034|P2|Overall Study|Other|10
5162862|NCT01367249|17828035|P1|Overall Study|Other|3
5162863|NCT01367249|17828034|P2|Overall Study|Withdrawal by Subject|6
5162864|NCT01367249|17828035|P1|Overall Study|Withdrawal by Subject|6
5162865|NCT01367236|17828045|P2|Overall Study|Withdrawal by Subject|1
5162866|NCT01367236|17828046|P1|Overall Study|Withdrawal by Subject|3
5162867|NCT01367158|17828065|P11|Overall Study|Protocol Violation|0
5162868|NCT01367158|17828066|P10|Overall Study|Protocol Violation|0
5162869|NCT01367158|17828067|P9|Overall Study|Protocol Violation|0
5162870|NCT01367158|17828068|P8|Overall Study|Protocol Violation|0
5162871|NCT01367158|17828069|P7|Overall Study|Protocol Violation|0
5162872|NCT01367158|17828070|P6|Overall Study|Protocol Violation|0
5162873|NCT01367158|17828071|P5|Overall Study|Protocol Violation|0
5162874|NCT01367158|17828072|P4|Overall Study|Protocol Violation|0
5162875|NCT01367158|17828073|P3|Overall Study|Protocol Violation|0
5162876|NCT01367158|17828074|P2|Overall Study|Protocol Violation|1
5162877|NCT01367158|17828075|P1|Overall Study|Protocol Violation|0
5162878|NCT01367158|17828065|P11|Overall Study|Lost to Follow-up|1
5162879|NCT01367158|17828066|P10|Overall Study|Lost to Follow-up|0
5162880|NCT01367158|17828067|P9|Overall Study|Lost to Follow-up|0
5162881|NCT01367158|17828068|P8|Overall Study|Lost to Follow-up|1
5162882|NCT01367158|17828069|P7|Overall Study|Lost to Follow-up|0
5162883|NCT01367158|17828070|P6|Overall Study|Lost to Follow-up|2
5162884|NCT01367158|17828071|P5|Overall Study|Lost to Follow-up|0
5162885|NCT01367158|17828072|P4|Overall Study|Lost to Follow-up|1
5162886|NCT01367158|17828073|P3|Overall Study|Lost to Follow-up|0
5162887|NCT01367158|17828074|P2|Overall Study|Lost to Follow-up|0
5162888|NCT01367158|17828075|P1|Overall Study|Lost to Follow-up|0
5162889|NCT01367158|17828065|P11|Overall Study|Withdrew consent|0
5162890|NCT01367158|17828066|P10|Overall Study|Withdrew consent|0
5162891|NCT01367158|17828067|P9|Overall Study|Withdrew consent|0
5162892|NCT01367158|17828068|P8|Overall Study|Withdrew consent|1
5162893|NCT01367158|17828069|P7|Overall Study|Withdrew consent|0
5162894|NCT01367158|17828070|P6|Overall Study|Withdrew consent|0
5162895|NCT01367158|17828071|P5|Overall Study|Withdrew consent|2
5162896|NCT01367158|17828072|P4|Overall Study|Withdrew consent|0
5162897|NCT01367158|17828073|P3|Overall Study|Withdrew consent|1
5162898|NCT01367158|17828074|P2|Overall Study|Withdrew consent|2
5162899|NCT01367158|17828075|P1|Overall Study|Withdrew consent|0
5162900|NCT01367119|17828219|P2|Overall Study|Withdrawal by Subject|1
5162901|NCT01367119|17828220|P1|Overall Study|Withdrawal by Subject|1
5162902|NCT01367119|17828219|P2|Overall Study|Adverse Event|0
5162903|NCT01367119|17828220|P1|Overall Study|Adverse Event|1
5162904|NCT01366846|17828275|P4|Overall Study|Scheduling Conflicts|0
5162905|NCT01366846|17828276|P3|Overall Study|Scheduling Conflicts|1
5162906|NCT01366846|17828277|P2|Overall Study|Scheduling Conflicts|0
5162907|NCT01366846|17828278|P1|Overall Study|Scheduling Conflicts|0
5162908|NCT01366846|17828275|P4|Overall Study|Communication Difficulties|1
5162909|NCT01366846|17828276|P3|Overall Study|Communication Difficulties|0
5162910|NCT01366846|17828277|P2|Overall Study|Communication Difficulties|4
5162911|NCT01366846|17828278|P1|Overall Study|Communication Difficulties|1
5162912|NCT01366846|17828275|P4|Overall Study|Withdrawal by Subject|0
5162913|NCT01366846|17828276|P3|Overall Study|Withdrawal by Subject|0
5162914|NCT01366846|17828277|P2|Overall Study|Withdrawal by Subject|0
5162915|NCT01366846|17828278|P1|Overall Study|Withdrawal by Subject|2
5162916|NCT01366638|17828301|P3|Overall Study|Other|0
5162917|NCT01366638|17828302|P2|Overall Study|Other|0
5162918|NCT01366638|17828303|P1|Overall Study|Other|1
5162919|NCT01366638|17828301|P3|Overall Study|Withdrawal by Subject|6
5162920|NCT01366638|17828302|P2|Overall Study|Withdrawal by Subject|0
5162921|NCT01366638|17828303|P1|Overall Study|Withdrawal by Subject|0
5162922|NCT01366534|17828340|P3|Overall Study|Declined challenged|0
5162923|NCT01366534|17828341|P2|Overall Study|Declined challenged|1
5162924|NCT01366534|17828342|P1|Overall Study|Declined challenged|0
5162925|NCT01366534|17828340|P3|Overall Study|Migrated|0
5162926|NCT01366534|17828341|P2|Overall Study|Migrated|1
5162927|NCT01366534|17828342|P1|Overall Study|Migrated|1
5162928|NCT01366534|17828340|P3|Overall Study|Lost to Follow-up|0
5162929|NCT01366534|17828341|P2|Overall Study|Lost to Follow-up|0
5162930|NCT01366534|17828342|P1|Overall Study|Lost to Follow-up|1
5162931|NCT01366521|17828392|P4|Overall Study|Withdrawal by Subject|0
5162932|NCT01366521|17828393|P3|Overall Study|Withdrawal by Subject|0
5162933|NCT01366521|17828394|P2|Overall Study|Withdrawal by Subject|1
5162934|NCT01366521|17828395|P1|Overall Study|Withdrawal by Subject|0
5162935|NCT01366521|17828392|P4|Overall Study|Physician Decision|0
5162936|NCT01366521|17828393|P3|Overall Study|Physician Decision|1
5162937|NCT01366521|17828394|P2|Overall Study|Physician Decision|0
5162938|NCT01366521|17828395|P1|Overall Study|Physician Decision|0
5162939|NCT01366521|17828392|P4|Overall Study|Protocol Violation|0
5162940|NCT01366521|17828393|P3|Overall Study|Protocol Violation|1
5162941|NCT01366521|17828394|P2|Overall Study|Protocol Violation|0
5162942|NCT01366521|17828395|P1|Overall Study|Protocol Violation|0
5162943|NCT01366521|17828392|P4|Overall Study|Adverse Event|0
5162944|NCT01366521|17828393|P3|Overall Study|Adverse Event|0
5162945|NCT01366521|17828394|P2|Overall Study|Adverse Event|0
5162946|NCT01366521|17828395|P1|Overall Study|Adverse Event|1
5162947|NCT01366443|17828491|P1|Overall Study|Under 18 yo|1
5162948|NCT01366443|17828491|P1|Overall Study|Lost to Follow-up|2
5162949|NCT01366209|17828505|P2|Overall Study|Withdrew consent|3
5162950|NCT01366209|17828506|P1|Overall Study|Withdrew consent|4
5162951|NCT01366209|17828505|P2|Overall Study|Sponsors decision|1
5162952|NCT01366209|17828506|P1|Overall Study|Sponsors decision|0
5162953|NCT01366209|17828505|P2|Overall Study|Physician Decision|0
5162954|NCT01366209|17828506|P1|Overall Study|Physician Decision|1
5162955|NCT01366209|17828505|P2|Overall Study|Lost to Follow-up|1
5162956|NCT01366209|17828506|P1|Overall Study|Lost to Follow-up|2
5162957|NCT01366209|17828505|P2|Overall Study|Lung transplantation|1
5162958|NCT01366209|17828506|P1|Overall Study|Lung transplantation|6
5162959|NCT01366209|17828505|P2|Overall Study|Death|19
5162960|NCT01366209|17828506|P1|Overall Study|Death|12
5162961|NCT01366209|17828505|P2|Overall Study|Withdrawal by Subject|4
5162962|NCT01366209|17828506|P1|Overall Study|Withdrawal by Subject|4
5162963|NCT01366209|17828505|P2|Overall Study|Adverse Event|7
5162964|NCT01366209|17828506|P1|Overall Study|Adverse Event|6
5162965|NCT01366092|17828529|P1|Overall Study|Withdrawal by Subject|1
5162966|NCT01366092|17828529|P1|Overall Study|Physician Decision|1
5162967|NCT01366092|17828529|P1|Overall Study|Progressive cGVHD|2
5162968|NCT01365910|17828538|P1|Overall Study|pt did not get tx, nausea/vomiting|1
5162969|NCT01365910|17828538|P1|Overall Study|other complicating disease|1
5162970|NCT01365910|17828538|P1|Overall Study|Adverse Event|3
5162971|NCT01365910|17828538|P1|Overall Study|disease progression|18
5162972|NCT01365910|17828538|P1|Overall Study|Withdrawal by Subject|7
5162973|NCT01365546|17828674|P1|Overall Study|Study termination|1
5162974|NCT01365546|17828674|P1|Overall Study|Screen failure|9
5162975|NCT01365546|17828674|P1|Overall Study|Withdrawal by Subject|1
5162976|NCT01365507|17828684|P2|Overall Study|Unclassified|4
5162977|NCT01365507|17828685|P1|Overall Study|Unclassified|1
5162978|NCT01365507|17828684|P2|Overall Study|Withdrawal Criteria|5
5162979|NCT01365507|17828685|P1|Overall Study|Withdrawal Criteria|8
5162980|NCT01365494|17828701|P2|Overall Study|Lost to Follow-up|2
5162981|NCT01365494|17828702|P1|Overall Study|Lost to Follow-up|1
5162982|NCT01365494|17828701|P2|Overall Study|Withdrawal by Subject|1
5162983|NCT01365494|17828702|P1|Overall Study|Withdrawal by Subject|0
5162984|NCT01365494|17828701|P2|Overall Study|Adverse Event|0
5162985|NCT01365494|17828702|P1|Overall Study|Adverse Event|1
5162986|NCT01365481|17828718|P4|Overall Study|Unsatisfactory therapeutic effect|0
5162987|NCT01365481|17828719|P3|Overall Study|Unsatisfactory therapeutic effect|1
5162988|NCT01365481|17828720|P2|Overall Study|Unsatisfactory therapeutic effect|0
5162989|NCT01365481|17828721|P1|Overall Study|Unsatisfactory therapeutic effect|0
5162990|NCT01365481|17828718|P4|Overall Study|Protocol deviation|1
5162991|NCT01365481|17828719|P3|Overall Study|Protocol deviation|0
5162992|NCT01365481|17828720|P2|Overall Study|Protocol deviation|1
5162993|NCT01365481|17828721|P1|Overall Study|Protocol deviation|0
5162994|NCT01365481|17828718|P4|Overall Study|Administrative problems|0
5162995|NCT01365481|17828719|P3|Overall Study|Administrative problems|0
5162996|NCT01365481|17828720|P2|Overall Study|Administrative problems|1
5162997|NCT01365481|17828721|P1|Overall Study|Administrative problems|0
5162998|NCT01365481|17828718|P4|Overall Study|Abnormal laboratory value(s)|0
5162999|NCT01365481|17828719|P3|Overall Study|Abnormal laboratory value(s)|0
5163000|NCT01365481|17828720|P2|Overall Study|Abnormal laboratory value(s)|1
5163001|NCT01365481|17828721|P1|Overall Study|Abnormal laboratory value(s)|0
5163002|NCT01365481|17828718|P4|Overall Study|Lost to Follow-up|3
5163003|NCT01365481|17828719|P3|Overall Study|Lost to Follow-up|2
5163004|NCT01365481|17828720|P2|Overall Study|Lost to Follow-up|1
5163005|NCT01365481|17828721|P1|Overall Study|Lost to Follow-up|1
5163006|NCT01365481|17828718|P4|Overall Study|Withdrawal by Subject|1
5163007|NCT01365481|17828719|P3|Overall Study|Withdrawal by Subject|1
5163008|NCT01365481|17828720|P2|Overall Study|Withdrawal by Subject|2
5163009|NCT01365481|17828721|P1|Overall Study|Withdrawal by Subject|0
5163010|NCT01365481|17828718|P4|Overall Study|Adverse Event|2
5163011|NCT01365481|17828719|P3|Overall Study|Adverse Event|0
5163012|NCT01365481|17828720|P2|Overall Study|Adverse Event|9
5163013|NCT01365481|17828721|P1|Overall Study|Adverse Event|6
5163014|NCT01365468|17828741|P2|Overall Study|Lost to Follow-up|0
5163015|NCT01365468|17828742|P1|Overall Study|Lost to Follow-up|2
5163016|NCT01365468|17828741|P2|Overall Study|Disease progression|0
5163017|NCT01365468|17828742|P1|Overall Study|Disease progression|1
5163018|NCT01365468|17828741|P2|Overall Study|Physician Decision|0
5163019|NCT01365468|17828742|P1|Overall Study|Physician Decision|1
5163020|NCT01365455|17828757|P5|Maintenance Period|Subject/guardian decision|1
5163021|NCT01365455|17828758|P4|Maintenance Period|Subject/guardian decision|4
5163022|NCT01365455|17828759|P3|Maintenance Period|Subject/guardian decision|2
5163023|NCT01365455|17828760|P2|Maintenance Period|Subject/guardian decision|6
5163024|NCT01365455|17828761|P1|Maintenance Period|Subject/guardian decision|4
5163025|NCT01365455|17828757|P5|Maintenance Period|Protocol deviation|0
5163026|NCT01365455|17828758|P4|Maintenance Period|Protocol deviation|0
5163027|NCT01365455|17828759|P3|Maintenance Period|Protocol deviation|0
5163028|NCT01365455|17828760|P2|Maintenance Period|Protocol deviation|1
5163029|NCT01365455|17828761|P1|Maintenance Period|Protocol deviation|1
5163030|NCT01365455|17828757|P5|Maintenance Period|Pregnancy|2
5163031|NCT01365455|17828758|P4|Maintenance Period|Pregnancy|0
5163032|NCT01365455|17828759|P3|Maintenance Period|Pregnancy|0
5163033|NCT01365455|17828760|P2|Maintenance Period|Pregnancy|4
5163034|NCT01365455|17828761|P1|Maintenance Period|Pregnancy|0
5163035|NCT01365455|17828757|P5|Maintenance Period|Physician Decision|1
5163036|NCT01365455|17828758|P4|Maintenance Period|Physician Decision|0
5163037|NCT01365455|17828759|P3|Maintenance Period|Physician Decision|0
5163038|NCT01365455|17828760|P2|Maintenance Period|Physician Decision|1
5163039|NCT01365455|17828761|P1|Maintenance Period|Physician Decision|0
5163040|NCT01365455|17828757|P5|Maintenance Period|Non-compliance with study treatment|0
5163041|NCT01365455|17828758|P4|Maintenance Period|Non-compliance with study treatment|1
5163042|NCT01365455|17828759|P3|Maintenance Period|Non-compliance with study treatment|0
5163043|NCT01365455|17828760|P2|Maintenance Period|Non-compliance with study treatment|0
5163044|NCT01365455|17828761|P1|Maintenance Period|Non-compliance with study treatment|0
5163045|NCT01365455|17828757|P5|Maintenance Period|Lost to Follow-up|3
5163046|NCT01365455|17828758|P4|Maintenance Period|Lost to Follow-up|0
5163047|NCT01365455|17828759|P3|Maintenance Period|Lost to Follow-up|0
5163048|NCT01365455|17828760|P2|Maintenance Period|Lost to Follow-up|4
5163049|NCT01365455|17828761|P1|Maintenance Period|Lost to Follow-up|2
5163050|NCT01365455|17828757|P5|Maintenance Period|Lack of Efficacy|2
5163051|NCT01365455|17828758|P4|Maintenance Period|Lack of Efficacy|2
5163052|NCT01365455|17828759|P3|Maintenance Period|Lack of Efficacy|0
5163053|NCT01365455|17828760|P2|Maintenance Period|Lack of Efficacy|2
5163054|NCT01365455|17828761|P1|Maintenance Period|Lack of Efficacy|10
5163055|NCT01365455|17828757|P5|Maintenance Period|Adverse Event|4
5163056|NCT01365455|17828758|P4|Maintenance Period|Adverse Event|2
5163057|NCT01365455|17828759|P3|Maintenance Period|Adverse Event|1
5163058|NCT01365455|17828760|P2|Maintenance Period|Adverse Event|5
5163059|NCT01365455|17828761|P1|Maintenance Period|Adverse Event|12
5163060|NCT01365455|17828757|P5|Induction Period|Lost to Follow-up|0
5163061|NCT01365455|17828758|P4|Induction Period|Lost to Follow-up|0
5163062|NCT01365455|17828759|P3|Induction Period|Lost to Follow-up|3
5163063|NCT01365455|17828760|P2|Induction Period|Lost to Follow-up|0
5163064|NCT01365455|17828761|P1|Induction Period|Lost to Follow-up|0
5163065|NCT01365455|17828757|P5|Induction Period|Subject/guardian decision|0
5163066|NCT01365455|17828758|P4|Induction Period|Subject/guardian decision|0
5163067|NCT01365455|17828759|P3|Induction Period|Subject/guardian decision|8
5163068|NCT01365455|17828760|P2|Induction Period|Subject/guardian decision|1
5163069|NCT01365455|17828761|P1|Induction Period|Subject/guardian decision|9
5163070|NCT01365455|17828757|P5|Induction Period|Protocol deviation|0
5163071|NCT01365455|17828758|P4|Induction Period|Protocol deviation|0
5163072|NCT01365455|17828759|P3|Induction Period|Protocol deviation|1
5163073|NCT01365455|17828760|P2|Induction Period|Protocol deviation|1
5163074|NCT01365455|17828761|P1|Induction Period|Protocol deviation|0
5163075|NCT01365455|17828757|P5|Induction Period|Pregnancy|0
5163076|NCT01365455|17828758|P4|Induction Period|Pregnancy|0
5163077|NCT01365455|17828759|P3|Induction Period|Pregnancy|0
5163078|NCT01365455|17828760|P2|Induction Period|Pregnancy|1
5163079|NCT01365455|17828761|P1|Induction Period|Pregnancy|0
5163080|NCT01365455|17828757|P5|Induction Period|Lack of Efficacy|0
5163081|NCT01365455|17828758|P4|Induction Period|Lack of Efficacy|0
5163082|NCT01365455|17828759|P3|Induction Period|Lack of Efficacy|0
5163083|NCT01365455|17828760|P2|Induction Period|Lack of Efficacy|1
5163084|NCT01365455|17828761|P1|Induction Period|Lack of Efficacy|1
5163085|NCT01365455|17828757|P5|Induction Period|Adverse Event|0
5163086|NCT01365455|17828758|P4|Induction Period|Adverse Event|0
5163087|NCT01365455|17828759|P3|Induction Period|Adverse Event|4
5163088|NCT01365455|17828760|P2|Induction Period|Adverse Event|3
5163089|NCT01365455|17828761|P1|Induction Period|Adverse Event|5
5163090|NCT01365273|17828851|P2|Overall Study|Physician Decision|0
5163091|NCT01365273|17828852|P1|Overall Study|Physician Decision|1
5163092|NCT01365273|17828851|P2|Overall Study|Protocol Violation|1
5163093|NCT01365273|17828852|P1|Overall Study|Protocol Violation|0
5163094|NCT01365273|17828851|P2|Overall Study|Lost to Follow-up|0
5163095|NCT01365273|17828852|P1|Overall Study|Lost to Follow-up|1
5163096|NCT01365130|17828862|P1|Overall Study|Progression/worsening of Dx prior to txt|2
5163097|NCT01365091|17828871|P4|Period 2|Adverse Event|0
5163098|NCT01365091|17828872|P3|Period 2|Adverse Event|1
5163099|NCT01365091|17828873|P2|Period 2|Adverse Event|0
5163100|NCT01365091|17828874|P1|Period 2|Adverse Event|0
5163101|NCT01365091|17828871|P4|Period 2|Withdrawal by Subject|0
5163102|NCT01365091|17828872|P3|Period 2|Withdrawal by Subject|0
5163103|NCT01365091|17828873|P2|Period 2|Withdrawal by Subject|0
5163104|NCT01365091|17828874|P1|Period 2|Withdrawal by Subject|1
5163105|NCT01365091|17828871|P4|Period 1|Personal reasons|0
5163106|NCT01365091|17828872|P3|Period 1|Personal reasons|1
5163107|NCT01365091|17828873|P2|Period 1|Personal reasons|0
5163108|NCT01365091|17828874|P1|Period 1|Personal reasons|0
5163109|NCT01365091|17828871|P4|Period 1|Withdrawal by Subject|0
5163110|NCT01365091|17828872|P3|Period 1|Withdrawal by Subject|0
5163111|NCT01365091|17828873|P2|Period 1|Withdrawal by Subject|1
5163112|NCT01365091|17828874|P1|Period 1|Withdrawal by Subject|0
5163113|NCT01365091|17828871|P4|Period 1|No longer met study criteria|0
5163114|NCT01365091|17828872|P3|Period 1|No longer met study criteria|0
5163115|NCT01365091|17828873|P2|Period 1|No longer met study criteria|1
5163116|NCT01365091|17828874|P1|Period 1|No longer met study criteria|0
5163117|NCT01365091|17828871|P4|Period 1|Positive test result for drugs of abuse|0
5163118|NCT01365091|17828872|P3|Period 1|Positive test result for drugs of abuse|0
5163119|NCT01365091|17828873|P2|Period 1|Positive test result for drugs of abuse|0
5163120|NCT01365091|17828874|P1|Period 1|Positive test result for drugs of abuse|1
5163121|NCT01365091|17828871|P4|Period 1|Adverse Event|3
5163122|NCT01365091|17828872|P3|Period 1|Adverse Event|2
5163123|NCT01365091|17828873|P2|Period 1|Adverse Event|0
5163124|NCT01365091|17828874|P1|Period 1|Adverse Event|1
5163125|NCT01365052|17828902|P2|Overall Study|Adverse Event|4
5163126|NCT01365052|17828903|P1|Overall Study|Adverse Event|4
5163127|NCT01365039|17828919|P2|Overall Study|Study related symptoms and complaints|0
5163128|NCT01365039|17828920|P1|Overall Study|Study related symptoms and complaints|1
5163129|NCT01364922|17828931|P3|Double-Blind (DB) Period|Other, Unspecified|0
5163130|NCT01364922|17828932|P2|Double-Blind (DB) Period|Other, Unspecified|1
5163131|NCT01364922|17828933|P1|Double-Blind (DB) Period|Other, Unspecified|0
5163132|NCT01364922|17828931|P3|Double-Blind (DB) Period|Adverse Event|1
5163133|NCT01364922|17828932|P2|Double-Blind (DB) Period|Adverse Event|0
5163134|NCT01364922|17828933|P1|Double-Blind (DB) Period|Adverse Event|0
5163135|NCT01364922|17828931|P3|Double-Blind (DB) Period|Subject Noncompliant|0
5163136|NCT01364922|17828932|P2|Double-Blind (DB) Period|Subject Noncompliant|1
5163137|NCT01364922|17828933|P1|Double-Blind (DB) Period|Subject Noncompliant|0
5163138|NCT01364922|17828931|P3|Double-Blind (DB) Period|Lack of Efficacy|4
5163139|NCT01364922|17828932|P2|Double-Blind (DB) Period|Lack of Efficacy|3
5163140|NCT01364922|17828933|P1|Double-Blind (DB) Period|Lack of Efficacy|0
5163141|NCT01364922|17828931|P3|Open-label (OL) Period|Other, Unspecified|0
5163142|NCT01364922|17828932|P2|Open-label (OL) Period|Other, Unspecified|0
5163143|NCT01364922|17828933|P1|Open-label (OL) Period|Other, Unspecified|1
5163144|NCT01364922|17828931|P3|Open-label (OL) Period|Lost to Follow-up|0
5163145|NCT01364922|17828932|P2|Open-label (OL) Period|Lost to Follow-up|0
5163146|NCT01364922|17828933|P1|Open-label (OL) Period|Lost to Follow-up|1
5163147|NCT01364922|17828931|P3|Open-label (OL) Period|Lack of Efficacy|0
5163148|NCT01364922|17828932|P2|Open-label (OL) Period|Lack of Efficacy|0
5163149|NCT01364922|17828933|P1|Open-label (OL) Period|Lack of Efficacy|3
5163150|NCT01364922|17828931|P3|Open-label (OL) Period|Withdrawal by Subject|0
5163151|NCT01364922|17828932|P2|Open-label (OL) Period|Withdrawal by Subject|0
5163152|NCT01364922|17828933|P1|Open-label (OL) Period|Withdrawal by Subject|4
5163153|NCT01364922|17828931|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
5163154|NCT01364922|17828932|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
5163155|NCT01364922|17828933|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
5163156|NCT01364922|17828931|P3|Open-label (OL) Period|Adverse Event|0
5163157|NCT01364922|17828932|P2|Open-label (OL) Period|Adverse Event|0
5163158|NCT01364922|17828933|P1|Open-label (OL) Period|Adverse Event|7
5163159|NCT01364870|17828955|P3|Overall Study|Protocol Violation|0
5163160|NCT01364870|17828956|P2|Overall Study|Protocol Violation|0
5163161|NCT01364870|17828957|P1|Overall Study|Protocol Violation|1
5163162|NCT01364870|17828955|P3|Overall Study|Adverse Event|4
5163163|NCT01364870|17828956|P2|Overall Study|Adverse Event|6
5163164|NCT01364870|17828957|P1|Overall Study|Adverse Event|8
5163165|NCT01364870|17828955|P3|Overall Study|Withdrawal by Subject|10
5163166|NCT01364870|17828956|P2|Overall Study|Withdrawal by Subject|24
5163167|NCT01364870|17828957|P1|Overall Study|Withdrawal by Subject|13
5163168|NCT01364727|17828976|P1|Overall Study|Not Eligible|2
5163169|NCT01364649|17828984|P2|Overall Study|Other|1
5163170|NCT01364649|17828985|P1|Overall Study|Other|4
5163171|NCT01364649|17828984|P2|Overall Study|Lost to Follow-up|13
5163172|NCT01364649|17828985|P1|Overall Study|Lost to Follow-up|12
5163173|NCT01364649|17828984|P2|Overall Study|Withdrawal of Consent|7
5163174|NCT01364649|17828985|P1|Overall Study|Withdrawal of Consent|9
5163175|NCT01364649|17828984|P2|Overall Study|Protocol Deviations|8
5163176|NCT01364649|17828985|P1|Overall Study|Protocol Deviations|4
5163177|NCT01364649|17828984|P2|Overall Study|Non-compliance with Investigational Drug|0
5163178|NCT01364649|17828985|P1|Overall Study|Non-compliance with Investigational Drug|1
5163179|NCT01364649|17828984|P2|Overall Study|Lack of Efficacy|0
5163180|NCT01364649|17828985|P1|Overall Study|Lack of Efficacy|6
5163181|NCT01364649|17828984|P2|Overall Study|Pretreatment Event or Adverse Event|14
5163182|NCT01364649|17828985|P1|Overall Study|Pretreatment Event or Adverse Event|20
5163183|NCT01364467|17829073|P2|Overall Study|Lost to Follow-up|2
5163184|NCT01364467|17829074|P1|Overall Study|Lost to Follow-up|1
5163185|NCT01364428|17829086|P2|Overall Study|Other|3
5163186|NCT01364428|17829087|P1|Overall Study|Other|3
5163187|NCT01364428|17829086|P2|Overall Study|Withdrawal Criteria|10
5163188|NCT01364428|17829087|P1|Overall Study|Withdrawal Criteria|14
5163189|NCT01364428|17829086|P2|Overall Study|Protocol Violation|0
5163190|NCT01364428|17829087|P1|Overall Study|Protocol Violation|2
5163191|NCT01364428|17829086|P2|Overall Study|Adverse Event|2
5163192|NCT01364428|17829087|P1|Overall Study|Adverse Event|1
5163193|NCT01364389|17829104|P3|Overall Study|Adverse Event|0
5163194|NCT01364389|17829105|P2|Overall Study|Adverse Event|0
5163195|NCT01364389|17829106|P1|Overall Study|Adverse Event|1
5163196|NCT01364389|17829104|P3|Overall Study|Administrative problems|0
5163197|NCT01364389|17829105|P2|Overall Study|Administrative problems|0
5163198|NCT01364389|17829106|P1|Overall Study|Administrative problems|1
5163199|NCT01364389|17829104|P3|Overall Study|Protocol deviation|1
5163200|NCT01364389|17829105|P2|Overall Study|Protocol deviation|0
5163201|NCT01364389|17829106|P1|Overall Study|Protocol deviation|0
5163202|NCT01364389|17829104|P3|Overall Study|Withdrawal by Subject|0
5163203|NCT01364389|17829105|P2|Overall Study|Withdrawal by Subject|1
5163204|NCT01364389|17829106|P1|Overall Study|Withdrawal by Subject|0
5163205|NCT01364298|17829125|P2|Overall Study|Other|3
5163206|NCT01364298|17829126|P1|Overall Study|Other|1
5163207|NCT01364298|17829125|P2|Overall Study|Withdrawal by Subject|3
5163208|NCT01364298|17829126|P1|Overall Study|Withdrawal by Subject|3
5163209|NCT01364298|17829125|P2|Overall Study|Lost to Follow-up|10
5163210|NCT01364298|17829126|P1|Overall Study|Lost to Follow-up|5
5163211|NCT01364298|17829125|P2|Overall Study|Lack of Efficacy|0
5163212|NCT01364298|17829126|P1|Overall Study|Lack of Efficacy|1
5163213|NCT01364298|17829125|P2|Overall Study|Lack of adherence to treatment|3
5163214|NCT01364298|17829126|P1|Overall Study|Lack of adherence to treatment|1
5163215|NCT01364298|17829125|P2|Overall Study|Adverse Event|4
5163216|NCT01364298|17829126|P1|Overall Study|Adverse Event|3
5163217|NCT01364233|17829159|P1|Overall Study|Lost to Follow-up|1
5163218|NCT01363986|17829204|P1|Overall Study|Disease progression|1
5163219|NCT01363908|17829214|P2|Chronic Dosing (CD) Phase|Early study termination|3
5163220|NCT01363908|17829215|P1|Chronic Dosing (CD) Phase|Early study termination|9
5163221|NCT01363908|17829214|P2|Chronic Dosing (CD) Phase|Physician Decision|1
5163222|NCT01363908|17829215|P1|Chronic Dosing (CD) Phase|Physician Decision|0
5163223|NCT01363908|17829214|P2|Chronic Dosing (CD) Phase|Patient decision|1
5163224|NCT01363908|17829215|P1|Chronic Dosing (CD) Phase|Patient decision|0
5163225|NCT01363908|17829214|P2|Chronic Dosing (CD) Phase|Adverse Event|1
5163226|NCT01363908|17829215|P1|Chronic Dosing (CD) Phase|Adverse Event|1
5163227|NCT01363765|17829252|P2|Overall Study|smear during intervention|0
5163228|NCT01363765|17829253|P1|Overall Study|smear during intervention|2170
5163229|NCT01363765|17829252|P2|Overall Study|age not recorded (used for cross-linkage|354
5163230|NCT01363765|17829253|P1|Overall Study|age not recorded (used for cross-linkage|117
5163231|NCT01363765|17829252|P2|Overall Study|non-resident|76
5163232|NCT01363765|17829253|P1|Overall Study|non-resident|156
5163233|NCT01363765|17829252|P2|Overall Study|duplicate records|3177
5163234|NCT01363765|17829253|P1|Overall Study|duplicate records|736
5163235|NCT01363765|17829252|P2|Overall Study|non-diagnostic|1124
5163236|NCT01363765|17829253|P1|Overall Study|non-diagnostic|2621
5163237|NCT01363713|17829265|P1|Overall Study|Withdrawal by Subject|2
5163238|NCT01363713|17829265|P1|Overall Study|Protocol Violation|3
5163239|NCT01363713|17829265|P1|Overall Study|Adverse Event|1
5163240|NCT01363700|17829274|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5163241|NCT01363700|17829275|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5163242|NCT01363700|17829276|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5163243|NCT01363700|17829277|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
5163244|NCT01363700|17829278|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5163245|NCT01363661|17829297|P2|Overall Study|Lost to Follow-up|1
5163246|NCT01363661|17829298|P1|Overall Study|Lost to Follow-up|3
5163247|NCT01363661|17829297|P2|Overall Study|Protocol Violation|0
5163248|NCT01363661|17829298|P1|Overall Study|Protocol Violation|1
5163249|NCT01363661|17829297|P2|Overall Study|Withdrawal by Subject|1
5163250|NCT01363661|17829298|P1|Overall Study|Withdrawal by Subject|1
5163251|NCT01363661|17829297|P2|Overall Study|Adverse Event|2
5163252|NCT01363661|17829298|P1|Overall Study|Adverse Event|9
5163253|NCT01363440|17829339|P3|Overall Study|Other|2
5163254|NCT01363440|17829340|P2|Overall Study|Other|5
5163255|NCT01363440|17829341|P1|Overall Study|Other|4
5163256|NCT01363440|17829339|P3|Overall Study|Lost to Follow-up|5
5163257|NCT01363440|17829340|P2|Overall Study|Lost to Follow-up|4
5163258|NCT01363440|17829341|P1|Overall Study|Lost to Follow-up|2
5163259|NCT01363440|17829339|P3|Overall Study|Withdrawal by Subject|11
5163260|NCT01363440|17829340|P2|Overall Study|Withdrawal by Subject|11
5163261|NCT01363440|17829341|P1|Overall Study|Withdrawal by Subject|9
5163262|NCT01363440|17829339|P3|Overall Study|Death|5
5163263|NCT01363440|17829340|P2|Overall Study|Death|7
5163264|NCT01363440|17829341|P1|Overall Study|Death|3
5163265|NCT01363440|17829339|P3|Overall Study|Adverse Event|4
5163266|NCT01363440|17829340|P2|Overall Study|Adverse Event|4
5163267|NCT01363440|17829341|P1|Overall Study|Adverse Event|5
5163268|NCT01363349|17829400|P2|Overall Study|missing|2
5163269|NCT01363349|17829401|P1|Overall Study|missing|1
5163270|NCT01363349|17829400|P2|Overall Study|Not reported|37
5163271|NCT01363349|17829401|P1|Overall Study|Not reported|36
5163272|NCT01363349|17829400|P2|Overall Study|Lost to Follow-up|6
5163273|NCT01363349|17829401|P1|Overall Study|Lost to Follow-up|5
5163274|NCT01363349|17829400|P2|Overall Study|Withdrawal by Subject|6
5163275|NCT01363349|17829401|P1|Overall Study|Withdrawal by Subject|14
5163276|NCT01363349|17829400|P2|Overall Study|Non compliance/Protocol deviations|2
5163277|NCT01363349|17829401|P1|Overall Study|Non compliance/Protocol deviations|2
5163278|NCT01363349|17829400|P2|Overall Study|Lack of Efficacy|10
5163279|NCT01363349|17829401|P1|Overall Study|Lack of Efficacy|3
5163280|NCT01363349|17829400|P2|Overall Study|Adverse Event|7
5163281|NCT01363349|17829401|P1|Overall Study|Adverse Event|6
5163282|NCT01363297|17829412|P5|Overall Study|Death|30
5163283|NCT01363297|17829413|P4|Overall Study|Death|10
5163284|NCT01363297|17829414|P3|Overall Study|Death|6
5163285|NCT01363297|17829415|P2|Overall Study|Death|6
5163286|NCT01363297|17829416|P1|Overall Study|Death|3
5163287|NCT01363297|17829412|P5|Overall Study|Other|1
5163288|NCT01363297|17829413|P4|Overall Study|Other|0
5163289|NCT01363297|17829414|P3|Overall Study|Other|0
5163290|NCT01363297|17829415|P2|Overall Study|Other|0
5163291|NCT01363297|17829416|P1|Overall Study|Other|0
5163292|NCT01363076|17829519|P2|Overall Study|Withdrawal by Subject|1
5163293|NCT01363076|17829520|P1|Overall Study|Withdrawal by Subject|0
5163294|NCT01363011|17829552|P2|Extension Phase|Rolled Over to Another Gilead Study|1
5163295|NCT01363011|17829553|P1|Extension Phase|Rolled Over to Another Gilead Study|2
5163296|NCT01363011|17829552|P2|Extension Phase|Lost to Follow-up|2
5163297|NCT01363011|17829553|P1|Extension Phase|Lost to Follow-up|0
5163298|NCT01363011|17829552|P2|Extension Phase|Withdrew Consent|1
5163299|NCT01363011|17829553|P1|Extension Phase|Withdrew Consent|0
5163300|NCT01363011|17829552|P2|Extension Phase|Investigator's Discretion|2
5163301|NCT01363011|17829553|P1|Extension Phase|Investigator's Discretion|2
5163302|NCT01363011|17829552|P2|Extension Phase|Lack of Efficacy|1
5163303|NCT01363011|17829553|P1|Extension Phase|Lack of Efficacy|0
5163304|NCT01363011|17829552|P2|Extension Phase|Adverse Event|1
5163305|NCT01363011|17829553|P1|Extension Phase|Adverse Event|1
5163306|NCT01363011|17829552|P2|Main Study|Protocol Violation|1
5163307|NCT01363011|17829553|P1|Main Study|Protocol Violation|0
5163308|NCT01363011|17829552|P2|Main Study|Withdrew Consent|4
5163309|NCT01363011|17829553|P1|Main Study|Withdrew Consent|1
5163310|NCT01363011|17829552|P2|Main Study|Investigator's Discretion|1
5163311|NCT01363011|17829553|P1|Main Study|Investigator's Discretion|1
5163312|NCT01363011|17829552|P2|Main Study|Adverse Event|3
5163313|NCT01363011|17829553|P1|Main Study|Adverse Event|2
5163314|NCT01362790|17829680|P7|Dose De-escalation of Regimen A|Progressive disease|0
5163315|NCT01362790|17829681|P6|Dose De-escalation of Regimen A|Progressive disease|0
5163316|NCT01362790|17829682|P5|Dose De-escalation of Regimen A|Progressive disease|2
5163317|NCT01362790|17829683|P4|Dose De-escalation of Regimen A|Progressive disease|0
5163318|NCT01362790|17829684|P3|Dose De-escalation of Regimen A|Progressive disease|0
5163319|NCT01362790|17829685|P2|Dose De-escalation of Regimen A|Progressive disease|0
5163320|NCT01362790|17829686|P1|Dose De-escalation of Regimen A|Progressive disease|0
5163321|NCT01362790|17829680|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
5163322|NCT01362790|17829681|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
5163323|NCT01362790|17829682|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
5163324|NCT01362790|17829683|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
5163325|NCT01362790|17829684|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
5163326|NCT01362790|17829685|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
5163327|NCT01362790|17829686|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
5163328|NCT01362790|17829680|P7|Dose De-escalation of Regimen A|Adverse Event|0
5163329|NCT01362790|17829681|P6|Dose De-escalation of Regimen A|Adverse Event|0
5163330|NCT01362790|17829682|P5|Dose De-escalation of Regimen A|Adverse Event|1
5163331|NCT01362790|17829683|P4|Dose De-escalation of Regimen A|Adverse Event|0
5163332|NCT01362790|17829684|P3|Dose De-escalation of Regimen A|Adverse Event|0
5163333|NCT01362790|17829685|P2|Dose De-escalation of Regimen A|Adverse Event|0
5163334|NCT01362790|17829686|P1|Dose De-escalation of Regimen A|Adverse Event|0
5163335|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Death on study|0
5163336|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Death on study|0
5163337|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Death on study|0
5163338|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Death on study|1
5163339|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Death on study|0
5163340|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Death on study|0
5163341|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Death on study|0
5163342|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5163343|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5163344|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5163345|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5163346|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5163347|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
5163348|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5163349|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5163350|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5163351|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5163352|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5163353|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5163354|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5163355|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
5163356|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Progressive disease|0
5163357|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Progressive disease|2
5163358|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Progressive disease|0
5163359|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Progressive disease|3
5163360|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Progressive disease|2
5163361|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Progressive disease|2
5163362|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Progressive disease|1
5163363|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Refused further treatment|0
5163364|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Refused further treatment|0
5163365|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Refused further treatment|0
5163366|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Refused further treatment|0
5163367|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Refused further treatment|0
5163368|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Refused further treatment|1
5163369|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Refused further treatment|0
5163370|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Developed antibodies|0
5163371|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Developed antibodies|0
5163372|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Developed antibodies|0
5163373|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Developed antibodies|8
5163374|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Developed antibodies|3
5163375|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Developed antibodies|2
5163376|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Developed antibodies|7
5163377|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Physician Decision|0
5163378|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Physician Decision|0
5163379|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Physician Decision|0
5163380|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Physician Decision|1
5163381|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Physician Decision|0
5163382|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Physician Decision|0
5163383|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Physician Decision|0
5163384|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Adverse Event|0
5163385|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Adverse Event|2
5163386|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Adverse Event|0
5163387|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Adverse Event|1
5163388|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Adverse Event|0
5163389|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Adverse Event|1
5163390|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Adverse Event|0
5163391|NCT01362790|17829680|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5163392|NCT01362790|17829681|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5163393|NCT01362790|17829682|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5163394|NCT01362790|17829683|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5163395|NCT01362790|17829684|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5163396|NCT01362790|17829685|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5163397|NCT01362790|17829686|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
5163398|NCT01362608|17829754|P2|Overall Study|Adverse Event|2
5163399|NCT01362608|17829755|P1|Overall Study|Adverse Event|0
5163400|NCT01362608|17829754|P2|Overall Study|Lack of Efficacy|2
5163401|NCT01362608|17829755|P1|Overall Study|Lack of Efficacy|0
5163402|NCT01362608|17829754|P2|Overall Study|Withdrawal by Subject|2
5163403|NCT01362608|17829755|P1|Overall Study|Withdrawal by Subject|1
5163404|NCT01362608|17829754|P2|Overall Study|Lost to Follow-up|1
5163405|NCT01362608|17829755|P1|Overall Study|Lost to Follow-up|3
5163406|NCT01362608|17829754|P2|Overall Study|Protocol Violation|1
5163407|NCT01362608|17829755|P1|Overall Study|Protocol Violation|0
5163408|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
5163409|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
5163410|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
5163411|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
5163412|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
5163413|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
5163414|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
5163415|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
5163416|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
5163417|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
5163418|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
5163419|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
5163420|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
5163421|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
5163422|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
5163423|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
5163424|NCT01362530|17829793|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
5163425|NCT01362530|17829794|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
5163426|NCT01362530|17829793|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
5163427|NCT01362530|17829794|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
5163428|NCT01362530|17829793|P2|Base Study (Cycle 1)|Protocol Violation|0
5163429|NCT01362530|17829794|P1|Base Study (Cycle 1)|Protocol Violation|2
5163430|NCT01362530|17829793|P2|Base Study (Cycle 1)|Physician Decision|1
5163431|NCT01362530|17829794|P1|Base Study (Cycle 1)|Physician Decision|0
5163432|NCT01362530|17829793|P2|Base Study (Cycle 1)|Adverse Event|0
5163433|NCT01362530|17829794|P1|Base Study (Cycle 1)|Adverse Event|2
5163434|NCT01362517|17829807|P1|Overall Study|Lost to Follow-up|1
5163435|NCT01362517|17829807|P1|Overall Study|Protocol Violation|1
5163436|NCT01362491|17829818|P3|Overall Study|Ineligible|0
5163437|NCT01362491|17829819|P2|Overall Study|Ineligible|0
5163438|NCT01362491|17829820|P1|Overall Study|Ineligible|1
5163439|NCT01362439|17829868|P1|Overall Study|Participant who withdrew consent|8
5163440|NCT01362439|17829868|P1|Overall Study|Study medication non-compliant|1
5163441|NCT01362439|17829868|P1|Overall Study|Lost to Follow-up|2
5163442|NCT01362439|17829868|P1|Overall Study|Lack of Efficacy|3
5163443|NCT01362439|17829868|P1|Overall Study|Adverse Event|1
5163444|NCT01362348|17829883|P1|Overall Study|Study closed/terminated|5
5163445|NCT01362348|17829883|P1|Overall Study|Protocol-defined stopping criteria|9
5163446|NCT01362322|17829902|P2|Overall Study|Lost to Follow-up|6
5163447|NCT01362322|17829903|P1|Overall Study|Lost to Follow-up|2
5163448|NCT01362322|17829902|P2|Overall Study|Withdrawal by Subject|1
5163449|NCT01362322|17829903|P1|Overall Study|Withdrawal by Subject|3
5163450|NCT01362296|17829935|P4|Crossover Phase|Study Closed/Terminated|0
5163451|NCT01362296|17829936|P3|Crossover Phase|Study Closed/Terminated|1
5163452|NCT01362296|17829937|P2|Crossover Phase|Study Closed/Terminated|0
5163453|NCT01362296|17829938|P1|Crossover Phase|Study Closed/Terminated|0
5163454|NCT01362296|17829935|P4|Crossover Phase|Adverse Event|0
5163455|NCT01362296|17829936|P3|Crossover Phase|Adverse Event|4
5163456|NCT01362296|17829937|P2|Crossover Phase|Adverse Event|0
5163457|NCT01362296|17829938|P1|Crossover Phase|Adverse Event|0
5163458|NCT01362296|17829935|P4|Crossover Phase|Withdrawal by Subject|1
5163459|NCT01362296|17829936|P3|Crossover Phase|Withdrawal by Subject|2
5163460|NCT01362296|17829937|P2|Crossover Phase|Withdrawal by Subject|0
5163461|NCT01362296|17829938|P1|Crossover Phase|Withdrawal by Subject|0
5163462|NCT01362296|17829935|P4|Crossover Phase|PD including Death due to PD|1
5163463|NCT01362296|17829936|P3|Crossover Phase|PD including Death due to PD|16
5163464|NCT01362296|17829937|P2|Crossover Phase|PD including Death due to PD|0
5163465|NCT01362296|17829938|P1|Crossover Phase|PD including Death due to PD|0
5163466|NCT01362296|17829935|P4|Randomized Phase (RP)|Study Closed/Terminated|0
5163467|NCT01362296|17829936|P3|Randomized Phase (RP)|Study Closed/Terminated|0
5163468|NCT01362296|17829937|P2|Randomized Phase (RP)|Study Closed/Terminated|1
5163469|NCT01362296|17829938|P1|Randomized Phase (RP)|Study Closed/Terminated|8
5163470|NCT01362296|17829935|P4|Randomized Phase (RP)|Adverse Event|0
5163471|NCT01362296|17829936|P3|Randomized Phase (RP)|Adverse Event|0
5163472|NCT01362296|17829937|P2|Randomized Phase (RP)|Adverse Event|4
5163473|NCT01362296|17829938|P1|Randomized Phase (RP)|Adverse Event|20
5163474|NCT01362296|17829935|P4|Randomized Phase (RP)|Withdrawal by Subject|0
5163475|NCT01362296|17829936|P3|Randomized Phase (RP)|Withdrawal by Subject|0
5163476|NCT01362296|17829937|P2|Randomized Phase (RP)|Withdrawal by Subject|1
5163477|NCT01362296|17829938|P1|Randomized Phase (RP)|Withdrawal by Subject|2
5163478|NCT01362296|17829935|P4|Randomized Phase (RP)|Physician Decision|0
5163479|NCT01362296|17829936|P3|Randomized Phase (RP)|Physician Decision|0
5163480|NCT01362296|17829937|P2|Randomized Phase (RP)|Physician Decision|9
5163481|NCT01362296|17829938|P1|Randomized Phase (RP)|Physician Decision|1
5163482|NCT01362296|17829935|P4|Randomized Phase (RP)|PD including Death due to PD|0
5163483|NCT01362296|17829936|P3|Randomized Phase (RP)|PD including Death due to PD|0
5163484|NCT01362296|17829937|P2|Randomized Phase (RP)|PD including Death due to PD|28
5163485|NCT01362296|17829938|P1|Randomized Phase (RP)|PD including Death due to PD|56
5163486|NCT01362270|17829986|P2|Overall Study|Met excl. criteria before 1st session|1
5163487|NCT01362270|17829987|P1|Overall Study|Met excl. criteria before 1st session|1
5163488|NCT01362270|17829986|P2|Overall Study|Met exclusion criteria after 1st session|1
5163489|NCT01362270|17829987|P1|Overall Study|Met exclusion criteria after 1st session|0
5163490|NCT01362270|17829986|P2|Overall Study|Withdrawal by Subject|0
5163491|NCT01362270|17829987|P1|Overall Study|Withdrawal by Subject|1
5163492|NCT01362244|17829999|P2|Overall Study|Protocol Defined Stopping Criteria|1
5163493|NCT01362244|17830000|P1|Overall Study|Protocol Defined Stopping Criteria|0
5163494|NCT01362244|17829999|P2|Overall Study|Did not Meet Continuation Criteria|11
5163495|NCT01362244|17830000|P1|Overall Study|Did not Meet Continuation Criteria|17
5163496|NCT01362244|17829999|P2|Overall Study|Withdrawal by Subject|1
5163497|NCT01362244|17830000|P1|Overall Study|Withdrawal by Subject|2
5163498|NCT01362244|17829999|P2|Overall Study|Protocol Violation|1
5163499|NCT01362244|17830000|P1|Overall Study|Protocol Violation|5
5163500|NCT01362244|17829999|P2|Overall Study|Lost to Follow-up|2
5163501|NCT01362244|17830000|P1|Overall Study|Lost to Follow-up|0
5163502|NCT01362244|17829999|P2|Overall Study|Lack of Efficacy|11
5163503|NCT01362244|17830000|P1|Overall Study|Lack of Efficacy|5
5163504|NCT01362244|17829999|P2|Overall Study|Adverse Event|5
5163505|NCT01362244|17830000|P1|Overall Study|Adverse Event|3
5163506|NCT01362140|17830112|P2|Overall Study|Discontinued Without Receiving Treatment|1
5163507|NCT01362140|17830113|P1|Overall Study|Discontinued Without Receiving Treatment|0
5163508|NCT01362140|17830112|P2|Overall Study|Protocol-specified Criteria|2
5163509|NCT01362140|17830113|P1|Overall Study|Protocol-specified Criteria|1
5163510|NCT01362140|17830112|P2|Overall Study|Other|1
5163511|NCT01362140|17830113|P1|Overall Study|Other|1
5163512|NCT01362140|17830112|P2|Overall Study|Death|1
5163513|NCT01362140|17830113|P1|Overall Study|Death|2
5163514|NCT01362140|17830112|P2|Overall Study|Administrative Decision|1
5163515|NCT01362140|17830113|P1|Overall Study|Administrative Decision|0
5163516|NCT01362140|17830112|P2|Overall Study|Withdrawal by Subject|3
5163517|NCT01362140|17830113|P1|Overall Study|Withdrawal by Subject|3
5163518|NCT01362140|17830112|P2|Overall Study|Adverse Event|2
5163519|NCT01362140|17830113|P1|Overall Study|Adverse Event|2
5163520|NCT01362140|17830112|P2|Overall Study|Noncompliance|0
5163521|NCT01362140|17830113|P1|Overall Study|Noncompliance|1
5163522|NCT01362062|17830150|P2|Overall Study|Had significant improvement|0
5163523|NCT01362062|17830151|P1|Overall Study|Had significant improvement|9
5163524|NCT01362062|17830150|P2|Overall Study|Detected with Spondylo-arthritis|0
5163525|NCT01362062|17830151|P1|Overall Study|Detected with Spondylo-arthritis|1
5163526|NCT01362062|17830150|P2|Overall Study|Non-compliant participant|0
5163527|NCT01362062|17830151|P1|Overall Study|Non-compliant participant|2
5163528|NCT01362062|17830150|P2|Overall Study|Withdrawal by Subject|0
5163529|NCT01362062|17830151|P1|Overall Study|Withdrawal by Subject|2
5163530|NCT01362062|17830150|P2|Overall Study|Lost to Follow-up|0
5163531|NCT01362062|17830151|P1|Overall Study|Lost to Follow-up|11
5163532|NCT01362062|17830150|P2|Overall Study|Adverse Event|0
5163533|NCT01362062|17830151|P1|Overall Study|Adverse Event|1
5163534|NCT01362049|17830172|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
5163535|NCT01362049|17830173|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
5163536|NCT01362049|17830174|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
5163537|NCT01362049|17830175|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
5163538|NCT01362049|17830172|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
5163539|NCT01362049|17830173|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
5163540|NCT01362049|17830174|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
5163541|NCT01362049|17830175|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
5163542|NCT01361919|17830216|P3|Overall Study|technical issues|10
5163543|NCT01361919|17830217|P2|Overall Study|technical issues|12
5163544|NCT01361919|17830218|P1|Overall Study|technical issues|10
5163545|NCT01361607|17830259|P2|Overall Study|Met Withdrawal Criteria|1
5163546|NCT01361607|17830260|P1|Overall Study|Met Withdrawal Criteria|1
5163547|NCT01361607|17830259|P2|Overall Study|Lost to Follow-up|0
5163548|NCT01361607|17830260|P1|Overall Study|Lost to Follow-up|1
5163549|NCT01361607|17830259|P2|Overall Study|Withdrawal by Investigator|3
5163550|NCT01361607|17830260|P1|Overall Study|Withdrawal by Investigator|5
5163551|NCT01361607|17830259|P2|Overall Study|Withdrawal by Subject|8
5163552|NCT01361607|17830260|P1|Overall Study|Withdrawal by Subject|19
5163553|NCT01361607|17830259|P2|Overall Study|Adverse Event|29
5163554|NCT01361607|17830260|P1|Overall Study|Adverse Event|38
5163555|NCT01361594|17830288|P2|Overall Study|Withdrawal by Subject|2
5163556|NCT01361594|17830289|P1|Overall Study|Withdrawal by Subject|1
5163557|NCT01361568|17830303|P6|Overall Study|Withdrawal by Subject|1
5163558|NCT01361568|17830304|P5|Overall Study|Withdrawal by Subject|0
5163559|NCT01361568|17830305|P4|Overall Study|Withdrawal by Subject|0
5163560|NCT01361568|17830306|P3|Overall Study|Withdrawal by Subject|0
5163561|NCT01361568|17830307|P2|Overall Study|Withdrawal by Subject|1
5163562|NCT01361568|17830308|P1|Overall Study|Withdrawal by Subject|2
5163563|NCT01361568|17830303|P6|Overall Study|Physician Decision|1
5163564|NCT01361568|17830304|P5|Overall Study|Physician Decision|0
5163565|NCT01361568|17830305|P4|Overall Study|Physician Decision|0
5163566|NCT01361568|17830306|P3|Overall Study|Physician Decision|0
5163567|NCT01361568|17830307|P2|Overall Study|Physician Decision|0
5163568|NCT01361568|17830308|P1|Overall Study|Physician Decision|0
5163569|NCT01361568|17830303|P6|Overall Study|Adverse Event|0
5163570|NCT01361568|17830304|P5|Overall Study|Adverse Event|1
5163571|NCT01361568|17830305|P4|Overall Study|Adverse Event|0
5163572|NCT01361568|17830306|P3|Overall Study|Adverse Event|0
5163573|NCT01361568|17830307|P2|Overall Study|Adverse Event|0
5163574|NCT01361568|17830308|P1|Overall Study|Adverse Event|0
5163575|NCT01361464|17830338|P1|Overall Study|Withdrawal by Subject|2
5163576|NCT01361464|17830338|P1|Overall Study|Death|1
5163577|NCT01361308|17830347|P2|Overall Study|Other|1
5163578|NCT01361308|17830348|P1|Overall Study|Other|0
5163579|NCT01361308|17830347|P2|Overall Study|Failed C-SSRS|2
5163580|NCT01361308|17830348|P1|Overall Study|Failed C-SSRS|5
5163581|NCT01361308|17830347|P2|Overall Study|Eligibility Criteria Not Met|3
5163582|NCT01361308|17830348|P1|Overall Study|Eligibility Criteria Not Met|2
5163583|NCT01361308|17830347|P2|Overall Study|Adverse Event|4
5163584|NCT01361308|17830348|P1|Overall Study|Adverse Event|8
5163585|NCT01361308|17830347|P2|Overall Study|Lost to Follow-up|4
5163586|NCT01361308|17830348|P1|Overall Study|Lost to Follow-up|5
5163587|NCT01361308|17830347|P2|Overall Study|Protocol Violation|0
5163588|NCT01361308|17830348|P1|Overall Study|Protocol Violation|1
5163589|NCT01361308|17830347|P2|Overall Study|Lack of Efficacy|0
5163590|NCT01361308|17830348|P1|Overall Study|Lack of Efficacy|2
5163591|NCT01361308|17830347|P2|Overall Study|Physician Decision|3
5163592|NCT01361308|17830348|P1|Overall Study|Physician Decision|3
5163593|NCT01361308|17830347|P2|Overall Study|Withdrawal by Subject|13
5163594|NCT01361308|17830348|P1|Overall Study|Withdrawal by Subject|9
5163595|NCT01361178|17830396|P2|Overall Study|Death|0
5163596|NCT01361178|17830397|P1|Overall Study|Death|13
5163597|NCT01361126|17830405|P2|Overall Study|Sponsor decision|2
5163598|NCT01361126|17830406|P1|Overall Study|Sponsor decision|0
5163599|NCT01361009|17830445|P1|Overall Study|Protocol Violation|116
5163600|NCT01360996|17830455|P3|Overall Study|Noncompliant|0
5163601|NCT01360996|17830456|P2|Overall Study|Noncompliant|0
5163602|NCT01360996|17830457|P1|Overall Study|Noncompliant|2
5163603|NCT01360996|17830455|P3|Overall Study|Withdrawal by Subject|2
5163604|NCT01360996|17830456|P2|Overall Study|Withdrawal by Subject|3
5163605|NCT01360996|17830457|P1|Overall Study|Withdrawal by Subject|4
5163606|NCT01360866|17830480|P4|Overall Study|Lack of Efficacy|4
5163607|NCT01360866|17830481|P3|Overall Study|Lack of Efficacy|30
5163608|NCT01360866|17830482|P2|Overall Study|Lack of Efficacy|40
5163609|NCT01360866|17830483|P1|Overall Study|Lack of Efficacy|30
5163610|NCT01360866|17830480|P4|Overall Study|Protocol Deviation|2
5163611|NCT01360866|17830481|P3|Overall Study|Protocol Deviation|61
5163612|NCT01360866|17830482|P2|Overall Study|Protocol Deviation|33
5163613|NCT01360866|17830483|P1|Overall Study|Protocol Deviation|25
5163614|NCT01360866|17830480|P4|Overall Study|Withdrawal by participant|8
5163615|NCT01360866|17830481|P3|Overall Study|Withdrawal by participant|168
5163616|NCT01360866|17830482|P2|Overall Study|Withdrawal by participant|89
5163617|NCT01360866|17830483|P1|Overall Study|Withdrawal by participant|79
5163618|NCT01360866|17830480|P4|Overall Study|Withdrawn by Investigator|2
5163619|NCT01360866|17830481|P3|Overall Study|Withdrawn by Investigator|31
5163620|NCT01360866|17830482|P2|Overall Study|Withdrawn by Investigator|8
5163621|NCT01360866|17830483|P1|Overall Study|Withdrawn by Investigator|9
5163622|NCT01360866|17830480|P4|Overall Study|Paticipant met withdrawal criteria|0
5163623|NCT01360866|17830481|P3|Overall Study|Paticipant met withdrawal criteria|54
5163624|NCT01360866|17830482|P2|Overall Study|Paticipant met withdrawal criteria|28
5163625|NCT01360866|17830483|P1|Overall Study|Paticipant met withdrawal criteria|11
5163626|NCT01360866|17830480|P4|Overall Study|Adverse Event|6
5163627|NCT01360866|17830481|P3|Overall Study|Adverse Event|134
5163628|NCT01360866|17830482|P2|Overall Study|Adverse Event|61
5163629|NCT01360866|17830483|P1|Overall Study|Adverse Event|56
5163630|NCT01360866|17830480|P4|Overall Study|Lost to Follow-up|0
5163631|NCT01360866|17830481|P3|Overall Study|Lost to Follow-up|41
5163632|NCT01360866|17830482|P2|Overall Study|Lost to Follow-up|28
5163633|NCT01360866|17830483|P1|Overall Study|Lost to Follow-up|11
5163634|NCT01360840|17830512|P3|Overall Study|Ongoing at data cut-off|9
5163635|NCT01360840|17830513|P2|Overall Study|Ongoing at data cut-off|10
5163636|NCT01360840|17830514|P1|Overall Study|Ongoing at data cut-off|10
5163637|NCT01360762|17830564|P1|Whole Study Period|Discontinuation of study drug for safety|1
5163638|NCT01360762|17830564|P1|Whole Study Period|Patient relapsed|18
5163639|NCT01360762|17830564|P1|Whole Study Period|Death|7
5163640|NCT01360762|17830564|P1|Whole Study Period|Lost to Follow-up|10
5163641|NCT01360762|17830564|P1|Main Study Period (12-month Treatment)|Discontinuation|1
5163642|NCT01360762|17830564|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
5163643|NCT01360762|17830564|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
5163644|NCT01360762|17830564|P1|Main Study Period (12-month Treatment)|Death|5
5163645|NCT01360762|17830564|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
5163646|NCT01360645|17830574|P4|Phase A+|Protocol Deviation|4
5163647|NCT01360645|17830575|P3|Phase A+|Protocol Deviation|0
5163648|NCT01360645|17830576|P2|Phase A+|Protocol Deviation|0
5163649|NCT01360645|17830577|P1|Phase A+|Protocol Deviation|0
5163650|NCT01360645|17830574|P4|Phase A+|Withdrawal by Subject|5
5163651|NCT01360645|17830575|P3|Phase A+|Withdrawal by Subject|0
5163652|NCT01360645|17830576|P2|Phase A+|Withdrawal by Subject|0
5163653|NCT01360645|17830577|P1|Phase A+|Withdrawal by Subject|0
5163654|NCT01360645|17830574|P4|Phase A+|Physician Decision|2
5163655|NCT01360645|17830575|P3|Phase A+|Physician Decision|0
5163656|NCT01360645|17830576|P2|Phase A+|Physician Decision|0
5163657|NCT01360645|17830577|P1|Phase A+|Physician Decision|0
5163658|NCT01360645|17830574|P4|Phase A+|Met Withdrawal Criteria|4
5163659|NCT01360645|17830575|P3|Phase A+|Met Withdrawal Criteria|0
5163660|NCT01360645|17830576|P2|Phase A+|Met Withdrawal Criteria|0
5163661|NCT01360645|17830577|P1|Phase A+|Met Withdrawal Criteria|0
5163662|NCT01360645|17830574|P4|Phase A+|Adverse Event|2
5163663|NCT01360645|17830575|P3|Phase A+|Adverse Event|0
5163664|NCT01360645|17830576|P2|Phase A+|Adverse Event|0
5163665|NCT01360645|17830577|P1|Phase A+|Adverse Event|0
5163666|NCT01360645|17830574|P4|Phase A+|Lost to Follow-up|7
5163667|NCT01360645|17830575|P3|Phase A+|Lost to Follow-up|0
5163668|NCT01360645|17830576|P2|Phase A+|Lost to Follow-up|0
5163669|NCT01360645|17830577|P1|Phase A+|Lost to Follow-up|0
5163670|NCT01360645|17830574|P4|Phase B (6 Weeks)|Protocol Deviation|0
5163671|NCT01360645|17830575|P3|Phase B (6 Weeks)|Protocol Deviation|3
5163672|NCT01360645|17830576|P2|Phase B (6 Weeks)|Protocol Deviation|1
5163673|NCT01360645|17830577|P1|Phase B (6 Weeks)|Protocol Deviation|0
5163674|NCT01360645|17830574|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
5163675|NCT01360645|17830575|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
5163676|NCT01360645|17830576|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
5163677|NCT01360645|17830577|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
5163678|NCT01360645|17830574|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5163679|NCT01360645|17830575|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
5163680|NCT01360645|17830576|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
5163681|NCT01360645|17830577|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5163682|NCT01360645|17830574|P4|Phase B (6 Weeks)|Adverse Event|0
5163683|NCT01360645|17830575|P3|Phase B (6 Weeks)|Adverse Event|0
5163684|NCT01360645|17830576|P2|Phase B (6 Weeks)|Adverse Event|6
5163685|NCT01360645|17830577|P1|Phase B (6 Weeks)|Adverse Event|0
5163686|NCT01360645|17830574|P4|Phase B (6 Weeks)|Lost to Follow-up|0
5163687|NCT01360645|17830575|P3|Phase B (6 Weeks)|Lost to Follow-up|0
5163688|NCT01360645|17830576|P2|Phase B (6 Weeks)|Lost to Follow-up|1
5163689|NCT01360645|17830577|P1|Phase B (6 Weeks)|Lost to Follow-up|0
5163690|NCT01360645|17830574|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5163691|NCT01360645|17830575|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5163692|NCT01360645|17830576|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5163693|NCT01360645|17830577|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
5163694|NCT01360645|17830574|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5163695|NCT01360645|17830575|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5163696|NCT01360645|17830576|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5163697|NCT01360645|17830577|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
5163698|NCT01360645|17830574|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5163699|NCT01360645|17830575|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5163700|NCT01360645|17830576|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5163701|NCT01360645|17830577|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
5163702|NCT01360645|17830574|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5163703|NCT01360645|17830575|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5163704|NCT01360645|17830576|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5163705|NCT01360645|17830577|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
5163706|NCT01360645|17830574|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5163707|NCT01360645|17830575|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5163708|NCT01360645|17830576|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5163709|NCT01360645|17830577|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
5163710|NCT01360645|17830574|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5163711|NCT01360645|17830575|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5163712|NCT01360645|17830576|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5163713|NCT01360645|17830577|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
5163714|NCT01360632|17830632|P5|Phase A+|Protocol Deviation|3
5163715|NCT01360632|17830633|P4|Phase A+|Protocol Deviation|0
5163716|NCT01360632|17830634|P3|Phase A+|Protocol Deviation|0
5163717|NCT01360632|17830635|P2|Phase A+|Protocol Deviation|0
5163718|NCT01360632|17830636|P1|Phase A+|Protocol Deviation|0
5163719|NCT01360632|17830632|P5|Phase A+|Withdrawal by Subject|8
5163720|NCT01360632|17830633|P4|Phase A+|Withdrawal by Subject|0
5163721|NCT01360632|17830634|P3|Phase A+|Withdrawal by Subject|0
5163722|NCT01360632|17830635|P2|Phase A+|Withdrawal by Subject|0
5163723|NCT01360632|17830636|P1|Phase A+|Withdrawal by Subject|0
5163724|NCT01360632|17830632|P5|Phase A+|Physician Decision|3
5163725|NCT01360632|17830633|P4|Phase A+|Physician Decision|0
5163726|NCT01360632|17830634|P3|Phase A+|Physician Decision|0
5163727|NCT01360632|17830635|P2|Phase A+|Physician Decision|0
5163728|NCT01360632|17830636|P1|Phase A+|Physician Decision|0
5163729|NCT01360632|17830632|P5|Phase A+|Met Withdrawal Criteria|7
5163730|NCT01360632|17830633|P4|Phase A+|Met Withdrawal Criteria|0
5163731|NCT01360632|17830634|P3|Phase A+|Met Withdrawal Criteria|0
5163732|NCT01360632|17830635|P2|Phase A+|Met Withdrawal Criteria|0
5163733|NCT01360632|17830636|P1|Phase A+|Met Withdrawal Criteria|0
5163734|NCT01360632|17830632|P5|Phase A+|Adverse Event|2
5163735|NCT01360632|17830633|P4|Phase A+|Adverse Event|0
5163736|NCT01360632|17830634|P3|Phase A+|Adverse Event|0
5163737|NCT01360632|17830635|P2|Phase A+|Adverse Event|0
5163738|NCT01360632|17830636|P1|Phase A+|Adverse Event|0
5163739|NCT01360632|17830632|P5|Phase A+|Lost to Follow-up|2
5163740|NCT01360632|17830633|P4|Phase A+|Lost to Follow-up|0
5163741|NCT01360632|17830634|P3|Phase A+|Lost to Follow-up|0
5163742|NCT01360632|17830635|P2|Phase A+|Lost to Follow-up|0
5163743|NCT01360632|17830636|P1|Phase A+|Lost to Follow-up|0
5163744|NCT01360632|17830632|P5|Phase B (6 Weeks)|Lack of Efficacy|0
5163745|NCT01360632|17830633|P4|Phase B (6 Weeks)|Lack of Efficacy|0
5163746|NCT01360632|17830634|P3|Phase B (6 Weeks)|Lack of Efficacy|0
5163747|NCT01360632|17830635|P2|Phase B (6 Weeks)|Lack of Efficacy|1
5163748|NCT01360632|17830636|P1|Phase B (6 Weeks)|Lack of Efficacy|0
5163749|NCT01360632|17830632|P5|Phase B (6 Weeks)|Protocol Deviation|0
5163750|NCT01360632|17830633|P4|Phase B (6 Weeks)|Protocol Deviation|1
5163751|NCT01360632|17830634|P3|Phase B (6 Weeks)|Protocol Deviation|4
5163752|NCT01360632|17830635|P2|Phase B (6 Weeks)|Protocol Deviation|1
5163753|NCT01360632|17830636|P1|Phase B (6 Weeks)|Protocol Deviation|0
5163754|NCT01360632|17830632|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
5163755|NCT01360632|17830633|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
5163756|NCT01360632|17830634|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
5163757|NCT01360632|17830635|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
5163758|NCT01360632|17830636|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
5163759|NCT01360632|17830632|P5|Phase B (6 Weeks)|Physician Decision|0
5163760|NCT01360632|17830633|P4|Phase B (6 Weeks)|Physician Decision|1
5163761|NCT01360632|17830634|P3|Phase B (6 Weeks)|Physician Decision|0
5163762|NCT01360632|17830635|P2|Phase B (6 Weeks)|Physician Decision|0
5163763|NCT01360632|17830636|P1|Phase B (6 Weeks)|Physician Decision|0
5163764|NCT01360632|17830632|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5163765|NCT01360632|17830633|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
5163766|NCT01360632|17830634|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
5163767|NCT01360632|17830635|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5163768|NCT01360632|17830636|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5163769|NCT01360632|17830632|P5|Phase B (6 Weeks)|Adverse Event|0
5163770|NCT01360632|17830633|P4|Phase B (6 Weeks)|Adverse Event|3
5163771|NCT01360632|17830634|P3|Phase B (6 Weeks)|Adverse Event|9
5163772|NCT01360632|17830635|P2|Phase B (6 Weeks)|Adverse Event|3
5163773|NCT01360632|17830636|P1|Phase B (6 Weeks)|Adverse Event|0
5163774|NCT01360632|17830632|P5|Phase B (6 Weeks)|Lost to Follow-up|0
5163775|NCT01360632|17830633|P4|Phase B (6 Weeks)|Lost to Follow-up|0
5163776|NCT01360632|17830634|P3|Phase B (6 Weeks)|Lost to Follow-up|1
5163777|NCT01360632|17830635|P2|Phase B (6 Weeks)|Lost to Follow-up|1
5163778|NCT01360632|17830636|P1|Phase B (6 Weeks)|Lost to Follow-up|0
5163779|NCT01360632|17830632|P5|Phase A (8 Weeks)|Protocol Deviation|0
5163780|NCT01360632|17830633|P4|Phase A (8 Weeks)|Protocol Deviation|0
5163781|NCT01360632|17830634|P3|Phase A (8 Weeks)|Protocol Deviation|0
5163782|NCT01360632|17830635|P2|Phase A (8 Weeks)|Protocol Deviation|0
5163783|NCT01360632|17830636|P1|Phase A (8 Weeks)|Protocol Deviation|39
5163784|NCT01360632|17830632|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
5163785|NCT01360632|17830633|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
5163786|NCT01360632|17830634|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
5163787|NCT01360632|17830635|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
5163788|NCT01360632|17830636|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
5163789|NCT01360632|17830632|P5|Phase A (8 Weeks)|Physician Decision|0
5163790|NCT01360632|17830633|P4|Phase A (8 Weeks)|Physician Decision|0
5163791|NCT01360632|17830634|P3|Phase A (8 Weeks)|Physician Decision|0
5163792|NCT01360632|17830635|P2|Phase A (8 Weeks)|Physician Decision|0
5163793|NCT01360632|17830636|P1|Phase A (8 Weeks)|Physician Decision|10
5163794|NCT01360632|17830632|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5163795|NCT01360632|17830633|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5163796|NCT01360632|17830634|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5163797|NCT01360632|17830635|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5163798|NCT01360632|17830636|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
5163799|NCT01360632|17830632|P5|Phase A (8 Weeks)|Adverse Event|0
5163800|NCT01360632|17830633|P4|Phase A (8 Weeks)|Adverse Event|0
5163801|NCT01360632|17830634|P3|Phase A (8 Weeks)|Adverse Event|0
5163802|NCT01360632|17830635|P2|Phase A (8 Weeks)|Adverse Event|0
5163803|NCT01360632|17830636|P1|Phase A (8 Weeks)|Adverse Event|60
5163804|NCT01360632|17830632|P5|Phase A (8 Weeks)|Lost to Follow-up|0
5163805|NCT01360632|17830633|P4|Phase A (8 Weeks)|Lost to Follow-up|0
5163806|NCT01360632|17830634|P3|Phase A (8 Weeks)|Lost to Follow-up|0
5163807|NCT01360632|17830635|P2|Phase A (8 Weeks)|Lost to Follow-up|0
5163808|NCT01360632|17830636|P1|Phase A (8 Weeks)|Lost to Follow-up|27
5163809|NCT01360554|17830715|P2|Overall Study|Randomized but not treated.|3
5163810|NCT01360554|17830716|P1|Overall Study|Randomized but not treated.|3
5163811|NCT01360554|17830715|P2|Overall Study|Other, not specified|0
5163812|NCT01360554|17830716|P1|Overall Study|Other, not specified|1
5163813|NCT01360554|17830715|P2|Overall Study|Study terminated by sponsor|37
5163814|NCT01360554|17830716|P1|Overall Study|Study terminated by sponsor|49
5163815|NCT01360554|17830715|P2|Overall Study|Withdrawal by Subject|24
5163816|NCT01360554|17830716|P1|Overall Study|Withdrawal by Subject|23
5163817|NCT01360554|17830715|P2|Overall Study|Lost to Follow-up|4
5163818|NCT01360554|17830716|P1|Overall Study|Lost to Follow-up|4
5163819|NCT01360554|17830715|P2|Overall Study|Death|371
5163820|NCT01360554|17830716|P1|Overall Study|Death|359
5163821|NCT01360398|17830765|P1|Overall Study|Migrated/moved from study area|1
5163822|NCT01360398|17830765|P1|Overall Study|Other|7
5163823|NCT01360398|17830765|P1|Overall Study|Withdrawal by Subject|14
5163824|NCT01360021|17830799|P3|Overall Study|Adverse Event|3
5163825|NCT01360021|17830800|P2|Overall Study|Adverse Event|3
5163826|NCT01360021|17830801|P1|Overall Study|Adverse Event|2
5163827|NCT01360021|17830799|P3|Overall Study|Withdrawal by Subject|2
5163828|NCT01360021|17830800|P2|Overall Study|Withdrawal by Subject|0
5163829|NCT01360021|17830801|P1|Overall Study|Withdrawal by Subject|4
5163830|NCT01360021|17830799|P3|Overall Study|Protocol Violation|1
5163831|NCT01360021|17830800|P2|Overall Study|Protocol Violation|0
5163832|NCT01360021|17830801|P1|Overall Study|Protocol Violation|0
5163833|NCT01360021|17830799|P3|Overall Study|Eligibility criteria + other|1
5163834|NCT01360021|17830800|P2|Overall Study|Eligibility criteria + other|1
5163835|NCT01360021|17830801|P1|Overall Study|Eligibility criteria + other|2
5163836|NCT01359956|17830828|P4|Overall Study|Death|58
5163837|NCT01359956|17830829|P3|Overall Study|Death|67
5163838|NCT01359956|17830830|P2|Overall Study|Death|64
5163839|NCT01359956|17830831|P1|Overall Study|Death|61
5163840|NCT01359943|17830856|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
5163841|NCT01359943|17830857|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
5163842|NCT01359943|17830858|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
5163843|NCT01359943|17830856|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
5163844|NCT01359943|17830857|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
5163845|NCT01359943|17830858|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
5163846|NCT01359943|17830856|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5163847|NCT01359943|17830857|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5163848|NCT01359943|17830858|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5163849|NCT01359943|17830856|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
5163850|NCT01359943|17830857|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
5163851|NCT01359943|17830858|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
5163852|NCT01359943|17830856|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
5163853|NCT01359943|17830857|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
5163854|NCT01359943|17830858|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
5163855|NCT01359943|17830856|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
5163856|NCT01359943|17830857|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
5163857|NCT01359943|17830858|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
5163858|NCT01359943|17830856|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
5163859|NCT01359943|17830857|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
5163860|NCT01359943|17830858|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
5163861|NCT01359943|17830856|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
5163862|NCT01359943|17830857|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
5163863|NCT01359943|17830858|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
5163864|NCT01359943|17830856|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5163865|NCT01359943|17830857|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5163866|NCT01359943|17830858|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5163867|NCT01359943|17830856|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
5163868|NCT01359943|17830857|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
5163869|NCT01359943|17830858|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
5163870|NCT01359943|17830856|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
5163871|NCT01359943|17830857|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
5163872|NCT01359943|17830858|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
5163873|NCT01359943|17830856|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
5163874|NCT01359943|17830857|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
5163875|NCT01359943|17830858|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
5163876|NCT01359943|17830856|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
5163877|NCT01359943|17830857|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
5163878|NCT01359943|17830858|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
5163879|NCT01359943|17830856|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
5163880|NCT01359943|17830857|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
5163881|NCT01359943|17830858|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
5163882|NCT01359943|17830856|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
5163883|NCT01359943|17830857|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
5163884|NCT01359943|17830858|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
5163885|NCT01359904|17830906|P2|Overall Study|Withdrawal by Subject|0
5163886|NCT01359904|17830907|P1|Overall Study|Withdrawal by Subject|1
5163887|NCT01359644|17830961|P10|Follow-up Period|Lost to Follow-up|0
5163888|NCT01359644|17830962|P9|Follow-up Period|Lost to Follow-up|0
5163889|NCT01359644|17830963|P8|Follow-up Period|Lost to Follow-up|2
5163890|NCT01359644|17830964|P7|Follow-up Period|Lost to Follow-up|1
5163891|NCT01359644|17830965|P6|Follow-up Period|Lost to Follow-up|0
5163892|NCT01359644|17830966|P5|Follow-up Period|Lost to Follow-up|0
5163893|NCT01359644|17830967|P4|Follow-up Period|Lost to Follow-up|0
5163894|NCT01359644|17830968|P3|Follow-up Period|Lost to Follow-up|0
5163895|NCT01359644|17830969|P2|Follow-up Period|Lost to Follow-up|0
5163896|NCT01359644|17830970|P1|Follow-up Period|Lost to Follow-up|0
5163897|NCT01359644|17830961|P10|Follow-up Period|Withdrawal by Subject|0
5163898|NCT01359644|17830962|P9|Follow-up Period|Withdrawal by Subject|0
5163899|NCT01359644|17830963|P8|Follow-up Period|Withdrawal by Subject|0
5163900|NCT01359644|17830964|P7|Follow-up Period|Withdrawal by Subject|0
5163901|NCT01359644|17830965|P6|Follow-up Period|Withdrawal by Subject|1
5163902|NCT01359644|17830966|P5|Follow-up Period|Withdrawal by Subject|0
5163903|NCT01359644|17830967|P4|Follow-up Period|Withdrawal by Subject|0
5163904|NCT01359644|17830968|P3|Follow-up Period|Withdrawal by Subject|0
5163905|NCT01359644|17830969|P2|Follow-up Period|Withdrawal by Subject|0
5163906|NCT01359644|17830970|P1|Follow-up Period|Withdrawal by Subject|0
5163907|NCT01359644|17830961|P10|Treatment Period|Lost to Follow-up|0
5163908|NCT01359644|17830962|P9|Treatment Period|Lost to Follow-up|0
5163909|NCT01359644|17830963|P8|Treatment Period|Lost to Follow-up|0
5163910|NCT01359644|17830964|P7|Treatment Period|Lost to Follow-up|0
5163911|NCT01359644|17830965|P6|Treatment Period|Lost to Follow-up|1
5163912|NCT01359644|17830966|P5|Treatment Period|Lost to Follow-up|0
5163913|NCT01359644|17830967|P4|Treatment Period|Lost to Follow-up|0
5163914|NCT01359644|17830968|P3|Treatment Period|Lost to Follow-up|0
5163915|NCT01359644|17830969|P2|Treatment Period|Lost to Follow-up|0
5163916|NCT01359644|17830970|P1|Treatment Period|Lost to Follow-up|0
5163917|NCT01359644|17830961|P10|Treatment Period|Adverse Event|0
5163918|NCT01359644|17830962|P9|Treatment Period|Adverse Event|0
5163919|NCT01359644|17830963|P8|Treatment Period|Adverse Event|0
5163920|NCT01359644|17830964|P7|Treatment Period|Adverse Event|0
5163921|NCT01359644|17830965|P6|Treatment Period|Adverse Event|1
5163922|NCT01359644|17830966|P5|Treatment Period|Adverse Event|0
5163923|NCT01359644|17830967|P4|Treatment Period|Adverse Event|0
5163924|NCT01359644|17830968|P3|Treatment Period|Adverse Event|1
5163925|NCT01359644|17830969|P2|Treatment Period|Adverse Event|0
5163926|NCT01359644|17830970|P1|Treatment Period|Adverse Event|0
5163927|NCT01359644|17830961|P10|Treatment Period|Lack of Efficacy|0
5163928|NCT01359644|17830962|P9|Treatment Period|Lack of Efficacy|0
5163929|NCT01359644|17830963|P8|Treatment Period|Lack of Efficacy|0
5163930|NCT01359644|17830964|P7|Treatment Period|Lack of Efficacy|0
5163931|NCT01359644|17830965|P6|Treatment Period|Lack of Efficacy|0
5163932|NCT01359644|17830966|P5|Treatment Period|Lack of Efficacy|0
5163933|NCT01359644|17830967|P4|Treatment Period|Lack of Efficacy|0
5163934|NCT01359644|17830968|P3|Treatment Period|Lack of Efficacy|0
5163935|NCT01359644|17830969|P2|Treatment Period|Lack of Efficacy|1
5163936|NCT01359644|17830970|P1|Treatment Period|Lack of Efficacy|0
5163937|NCT01359449|17831014|P2|Overall Study|Withdrawal by Subject|2
5163938|NCT01359449|17831015|P1|Overall Study|Withdrawal by Subject|3
5163939|NCT01359449|17831014|P2|Overall Study|Protocol Violation|2
5163940|NCT01359449|17831015|P1|Overall Study|Protocol Violation|0
5163941|NCT01359449|17831014|P2|Overall Study|Lost to Follow-up|0
5163942|NCT01359449|17831015|P1|Overall Study|Lost to Follow-up|1
5163943|NCT01359254|17831065|P2|Overall Study|Death|0
5163944|NCT01359254|17831066|P1|Overall Study|Death|1
5163945|NCT01359150|17831076|P2|Overall Study|Other|0
5163946|NCT01359150|17831077|P1|Overall Study|Other|1
5163947|NCT01359150|17831076|P2|Overall Study|Adverse Event|3
5163948|NCT01359150|17831077|P1|Overall Study|Adverse Event|4
5163949|NCT01359150|17831076|P2|Overall Study|Withdrawal by Subject|1
5163950|NCT01359150|17831077|P1|Overall Study|Withdrawal by Subject|1
5163951|NCT01359150|17831076|P2|Overall Study|Lack of Efficacy|1
5163952|NCT01359150|17831077|P1|Overall Study|Lack of Efficacy|1
5163953|NCT01359046|17831108|P2|Overall Study|Physician Decision|11
5163954|NCT01359046|17831109|P1|Overall Study|Physician Decision|1
5163955|NCT01359046|17831108|P2|Overall Study|Did not receive allocated intervention|6
5163956|NCT01359046|17831109|P1|Overall Study|Did not receive allocated intervention|6
5163957|NCT01358981|17831132|P7|Period 1|Withdrawal by Subject|0
5163958|NCT01358981|17831133|P6|Period 1|Withdrawal by Subject|0
5163959|NCT01358981|17831134|P5|Period 1|Withdrawal by Subject|0
5163960|NCT01358981|17831135|P4|Period 1|Withdrawal by Subject|1
5163961|NCT01358981|17831136|P3|Period 1|Withdrawal by Subject|0
5163962|NCT01358981|17831137|P2|Period 1|Withdrawal by Subject|0
5163963|NCT01358981|17831138|P1|Period 1|Withdrawal by Subject|0
5163964|NCT01358968|17831199|P4|Continued Access Phase|Death|1
5163965|NCT01358968|17831200|P3|Continued Access Phase|Death|1
5163966|NCT01358968|17831201|P2|Continued Access Phase|Death|0
5163967|NCT01358968|17831202|P1|Continued Access Phase|Death|0
5163968|NCT01358968|17831199|P4|Continued Access Phase|Withdrawal by Subject|0
5163969|NCT01358968|17831200|P3|Continued Access Phase|Withdrawal by Subject|3
5163970|NCT01358968|17831201|P2|Continued Access Phase|Withdrawal by Subject|0
5163971|NCT01358968|17831202|P1|Continued Access Phase|Withdrawal by Subject|0
5163972|NCT01358968|17831199|P4|Continued Access Phase|Protocol Violation|2
5163973|NCT01358968|17831200|P3|Continued Access Phase|Protocol Violation|0
5163974|NCT01358968|17831201|P2|Continued Access Phase|Protocol Violation|0
5163975|NCT01358968|17831202|P1|Continued Access Phase|Protocol Violation|0
5163976|NCT01358968|17831199|P4|Continued Access Phase|Progression of Disease|4
5163977|NCT01358968|17831200|P3|Continued Access Phase|Progression of Disease|8
5163978|NCT01358968|17831201|P2|Continued Access Phase|Progression of Disease|0
5163979|NCT01358968|17831202|P1|Continued Access Phase|Progression of Disease|0
5163980|NCT01358968|17831199|P4|Period 2|Adverse Event|0
5163981|NCT01358968|17831200|P3|Period 2|Adverse Event|0
5163982|NCT01358968|17831201|P2|Period 2|Adverse Event|1
5163983|NCT01358968|17831202|P1|Period 2|Adverse Event|0
5163984|NCT01358877|17831218|P2|Overall Study|Other|129
5163985|NCT01358877|17831219|P1|Overall Study|Other|142
5163986|NCT01358877|17831218|P2|Overall Study|Ongoing follow-up for overall survival|5
5163987|NCT01358877|17831219|P1|Overall Study|Ongoing follow-up for overall survival|7
5163988|NCT01358877|17831218|P2|Overall Study|Ongoing follow-up for IDFS event|2073
5163989|NCT01358877|17831219|P1|Overall Study|Ongoing follow-up for IDFS event|2084
5163990|NCT01358877|17831218|P2|Overall Study|Ongoing follow-up for post-recurrence|108
5163991|NCT01358877|17831219|P1|Overall Study|Ongoing follow-up for post-recurrence|87
5163992|NCT01358877|17831218|P2|Overall Study|Death|89
5163993|NCT01358877|17831219|P1|Overall Study|Death|80
5163994|NCT01358864|17831289|P8|Overall Study|Not treated|0
5163995|NCT01358864|17831290|P7|Overall Study|Not treated|1
5163996|NCT01358864|17831291|P6|Overall Study|Not treated|0
5163997|NCT01358864|17831292|P5|Overall Study|Not treated|0
5163998|NCT01358864|17831293|P4|Overall Study|Not treated|0
5163999|NCT01358864|17831294|P3|Overall Study|Not treated|0
5164000|NCT01358864|17831295|P2|Overall Study|Not treated|0
5164001|NCT01358864|17831296|P1|Overall Study|Not treated|0
5164002|NCT01358864|17831289|P8|Overall Study|Other reason not defined above|0
5164003|NCT01358864|17831290|P7|Overall Study|Other reason not defined above|2
5164004|NCT01358864|17831291|P6|Overall Study|Other reason not defined above|0
5164005|NCT01358864|17831292|P5|Overall Study|Other reason not defined above|0
5164006|NCT01358864|17831293|P4|Overall Study|Other reason not defined above|0
5164007|NCT01358864|17831294|P3|Overall Study|Other reason not defined above|0
5164008|NCT01358864|17831295|P2|Overall Study|Other reason not defined above|0
5164009|NCT01358864|17831296|P1|Overall Study|Other reason not defined above|2
5164010|NCT01358864|17831289|P8|Overall Study|Withdrawal by Subject|3
5164011|NCT01358864|17831290|P7|Overall Study|Withdrawal by Subject|1
5164012|NCT01358864|17831291|P6|Overall Study|Withdrawal by Subject|1
5164013|NCT01358864|17831292|P5|Overall Study|Withdrawal by Subject|0
5164014|NCT01358864|17831293|P4|Overall Study|Withdrawal by Subject|0
5164015|NCT01358864|17831294|P3|Overall Study|Withdrawal by Subject|2
5164016|NCT01358864|17831295|P2|Overall Study|Withdrawal by Subject|4
5164017|NCT01358864|17831296|P1|Overall Study|Withdrawal by Subject|3
5164018|NCT01358864|17831289|P8|Overall Study|Lost to Follow-up|1
5164019|NCT01358864|17831290|P7|Overall Study|Lost to Follow-up|0
5164020|NCT01358864|17831291|P6|Overall Study|Lost to Follow-up|0
5164021|NCT01358864|17831292|P5|Overall Study|Lost to Follow-up|0
5164022|NCT01358864|17831293|P4|Overall Study|Lost to Follow-up|0
5164023|NCT01358864|17831294|P3|Overall Study|Lost to Follow-up|1
5164024|NCT01358864|17831295|P2|Overall Study|Lost to Follow-up|0
5164025|NCT01358864|17831296|P1|Overall Study|Lost to Follow-up|0
5164026|NCT01358864|17831289|P8|Overall Study|Lack of Efficacy|44
5164027|NCT01358864|17831290|P7|Overall Study|Lack of Efficacy|49
5164028|NCT01358864|17831291|P6|Overall Study|Lack of Efficacy|4
5164029|NCT01358864|17831292|P5|Overall Study|Lack of Efficacy|7
5164030|NCT01358864|17831293|P4|Overall Study|Lack of Efficacy|19
5164031|NCT01358864|17831294|P3|Overall Study|Lack of Efficacy|4
5164032|NCT01358864|17831295|P2|Overall Study|Lack of Efficacy|3
5164033|NCT01358864|17831296|P1|Overall Study|Lack of Efficacy|26
5164034|NCT01358864|17831289|P8|Overall Study|Adverse Event|7
5164035|NCT01358864|17831290|P7|Overall Study|Adverse Event|12
5164036|NCT01358864|17831291|P6|Overall Study|Adverse Event|8
5164037|NCT01358864|17831292|P5|Overall Study|Adverse Event|4
5164038|NCT01358864|17831293|P4|Overall Study|Adverse Event|0
5164039|NCT01358864|17831294|P3|Overall Study|Adverse Event|9
5164040|NCT01358864|17831295|P2|Overall Study|Adverse Event|6
5164041|NCT01358864|17831296|P1|Overall Study|Adverse Event|0
5164042|NCT01358825|17831387|P2|Overall Study|Blood sample not drawn|1
5164043|NCT01358825|17831388|P1|Overall Study|Blood sample not drawn|0
5164044|NCT01358760|17831412|P3|Overall Study|Entry criteria not met/Non-compliance|16
5164045|NCT01358760|17831413|P2|Overall Study|Entry criteria not met/Non-compliance|12
5164046|NCT01358760|17831414|P1|Overall Study|Entry criteria not met/Non-compliance|12
5164047|NCT01358760|17831412|P3|Overall Study|Physician Decision|1
5164048|NCT01358760|17831413|P2|Overall Study|Physician Decision|0
5164049|NCT01358760|17831414|P1|Overall Study|Physician Decision|1
5164050|NCT01358760|17831412|P3|Overall Study|Withdrawal by Subject|2
5164051|NCT01358760|17831413|P2|Overall Study|Withdrawal by Subject|3
5164052|NCT01358760|17831414|P1|Overall Study|Withdrawal by Subject|5
5164053|NCT01358760|17831412|P3|Overall Study|Lost to Follow-up|3
5164054|NCT01358760|17831413|P2|Overall Study|Lost to Follow-up|1
5164055|NCT01358760|17831414|P1|Overall Study|Lost to Follow-up|1
5164056|NCT01358760|17831412|P3|Overall Study|Adverse Event|3
5164057|NCT01358760|17831413|P2|Overall Study|Adverse Event|4
5164058|NCT01358760|17831414|P1|Overall Study|Adverse Event|3
5164059|NCT01358734|17831449|P3|Overall Study|Protocol Violation|2
5164060|NCT01358734|17831450|P2|Overall Study|Protocol Violation|0
5164061|NCT01358734|17831451|P1|Overall Study|Protocol Violation|0
5164062|NCT01358734|17831449|P3|Overall Study|Other|4
5164063|NCT01358734|17831450|P2|Overall Study|Other|5
5164064|NCT01358734|17831451|P1|Overall Study|Other|2
5164065|NCT01358734|17831449|P3|Overall Study|Non-compliance with study drug|1
5164066|NCT01358734|17831450|P2|Overall Study|Non-compliance with study drug|0
5164067|NCT01358734|17831451|P1|Overall Study|Non-compliance with study drug|0
5164068|NCT01358734|17831449|P3|Overall Study|Progressive Disease|16
5164069|NCT01358734|17831450|P2|Overall Study|Progressive Disease|13
5164070|NCT01358734|17831451|P1|Overall Study|Progressive Disease|5
5164071|NCT01358734|17831449|P3|Overall Study|Death|2
5164072|NCT01358734|17831450|P2|Overall Study|Death|7
5164073|NCT01358734|17831451|P1|Overall Study|Death|3
5164074|NCT01358734|17831449|P3|Overall Study|Withdrawal by Subject|3
5164075|NCT01358734|17831450|P2|Overall Study|Withdrawal by Subject|6
5164076|NCT01358734|17831451|P1|Overall Study|Withdrawal by Subject|1
5164077|NCT01358734|17831449|P3|Overall Study|Lack of Efficacy|3
5164078|NCT01358734|17831450|P2|Overall Study|Lack of Efficacy|1
5164079|NCT01358734|17831451|P1|Overall Study|Lack of Efficacy|0
5164080|NCT01358734|17831449|P3|Overall Study|Adverse Event|3
5164081|NCT01358734|17831450|P2|Overall Study|Adverse Event|7
5164082|NCT01358734|17831451|P1|Overall Study|Adverse Event|4
5164083|NCT01358721|17831499|P4|Overall Study|Out of State/Unmet Criteria|0
5164084|NCT01358721|17831500|P3|Overall Study|Out of State/Unmet Criteria|1
5164085|NCT01358721|17831501|P2|Overall Study|Out of State/Unmet Criteria|0
5164086|NCT01358721|17831502|P1|Overall Study|Out of State/Unmet Criteria|0
5164087|NCT01358721|17831499|P4|Overall Study|Disease Progression|15
5164088|NCT01358721|17831500|P3|Overall Study|Disease Progression|17
5164089|NCT01358721|17831501|P2|Overall Study|Disease Progression|15
5164090|NCT01358721|17831502|P1|Overall Study|Disease Progression|19
5164091|NCT01358721|17831499|P4|Overall Study|Adverse Event related to study drug|1
5164092|NCT01358721|17831500|P3|Overall Study|Adverse Event related to study drug|0
5164093|NCT01358721|17831501|P2|Overall Study|Adverse Event related to study drug|0
5164094|NCT01358721|17831502|P1|Overall Study|Adverse Event related to study drug|1
5164095|NCT01358721|17831499|P4|Overall Study|Subject No Longer Meets Study Criteria|1
5164096|NCT01358721|17831500|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5164097|NCT01358721|17831501|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5164098|NCT01358721|17831502|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5164099|NCT01358721|17831499|P4|Overall Study|SUBJ request to discontinue study TRT|1
5164100|NCT01358721|17831500|P3|Overall Study|SUBJ request to discontinue study TRT|0
5164101|NCT01358721|17831501|P2|Overall Study|SUBJ request to discontinue study TRT|0
5164102|NCT01358721|17831502|P1|Overall Study|SUBJ request to discontinue study TRT|0
5164103|NCT01358721|17831499|P4|Overall Study|Study Drug Toxicity|5
5164104|NCT01358721|17831500|P3|Overall Study|Study Drug Toxicity|4
5164105|NCT01358721|17831501|P2|Overall Study|Study Drug Toxicity|3
5164106|NCT01358721|17831502|P1|Overall Study|Study Drug Toxicity|1
5164107|NCT01358721|17831499|P4|Overall Study|Death|0
5164108|NCT01358721|17831500|P3|Overall Study|Death|0
5164109|NCT01358721|17831501|P2|Overall Study|Death|2
5164110|NCT01358721|17831502|P1|Overall Study|Death|0
5164111|NCT01358721|17831499|P4|Overall Study|Withdrawal by Subject|1
5164112|NCT01358721|17831500|P3|Overall Study|Withdrawal by Subject|0
5164113|NCT01358721|17831501|P2|Overall Study|Withdrawal by Subject|0
5164114|NCT01358721|17831502|P1|Overall Study|Withdrawal by Subject|0
5164115|NCT01358708|17831554|P2|Double-Blind Treatment Phase|Protocol Violation|0
5164116|NCT01358708|17831555|P1|Double-Blind Treatment Phase|Protocol Violation|1
5164117|NCT01358708|17831554|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
5164118|NCT01358708|17831555|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
5164119|NCT01358578|17831578|P6|Follow-up Period|Physician Decision|0
5164120|NCT01358578|17831579|P5|Follow-up Period|Physician Decision|0
5164121|NCT01358578|17831580|P4|Follow-up Period|Physician Decision|2
5164122|NCT01358578|17831581|P3|Follow-up Period|Physician Decision|0
5164123|NCT01358578|17831582|P2|Follow-up Period|Physician Decision|1
5164124|NCT01358578|17831583|P1|Follow-up Period|Physician Decision|1
5164125|NCT01358578|17831578|P6|Follow-up Period|Withdrawal by Subject|0
5164126|NCT01358578|17831579|P5|Follow-up Period|Withdrawal by Subject|0
5164127|NCT01358578|17831580|P4|Follow-up Period|Withdrawal by Subject|12
5164128|NCT01358578|17831581|P3|Follow-up Period|Withdrawal by Subject|1
5164129|NCT01358578|17831582|P2|Follow-up Period|Withdrawal by Subject|3
5164130|NCT01358578|17831583|P1|Follow-up Period|Withdrawal by Subject|3
5164131|NCT01358578|17831578|P6|Follow-up Period|Pregnancy|0
5164132|NCT01358578|17831579|P5|Follow-up Period|Pregnancy|0
5164133|NCT01358578|17831580|P4|Follow-up Period|Pregnancy|0
5164134|NCT01358578|17831581|P3|Follow-up Period|Pregnancy|0
5164135|NCT01358578|17831582|P2|Follow-up Period|Pregnancy|0
5164136|NCT01358578|17831583|P1|Follow-up Period|Pregnancy|1
5164137|NCT01358578|17831578|P6|Follow-up Period|non- compliance with study treatment|0
5164138|NCT01358578|17831579|P5|Follow-up Period|non- compliance with study treatment|0
5164139|NCT01358578|17831580|P4|Follow-up Period|non- compliance with study treatment|0
5164140|NCT01358578|17831581|P3|Follow-up Period|non- compliance with study treatment|0
5164141|NCT01358578|17831582|P2|Follow-up Period|non- compliance with study treatment|0
5164142|NCT01358578|17831583|P1|Follow-up Period|non- compliance with study treatment|1
5164143|NCT01358578|17831578|P6|Follow-up Period|Lost to Follow-up|0
5164144|NCT01358578|17831579|P5|Follow-up Period|Lost to Follow-up|0
5164145|NCT01358578|17831580|P4|Follow-up Period|Lost to Follow-up|4
5164146|NCT01358578|17831581|P3|Follow-up Period|Lost to Follow-up|0
5164147|NCT01358578|17831582|P2|Follow-up Period|Lost to Follow-up|1
5164148|NCT01358578|17831583|P1|Follow-up Period|Lost to Follow-up|0
5164149|NCT01358578|17831578|P6|Follow-up Period|Lack of Efficacy|0
5164150|NCT01358578|17831579|P5|Follow-up Period|Lack of Efficacy|0
5164151|NCT01358578|17831580|P4|Follow-up Period|Lack of Efficacy|1
5164152|NCT01358578|17831581|P3|Follow-up Period|Lack of Efficacy|4
5164153|NCT01358578|17831582|P2|Follow-up Period|Lack of Efficacy|0
5164154|NCT01358578|17831583|P1|Follow-up Period|Lack of Efficacy|3
5164155|NCT01358578|17831578|P6|Follow-up Period|Adverse Event|0
5164156|NCT01358578|17831579|P5|Follow-up Period|Adverse Event|0
5164157|NCT01358578|17831580|P4|Follow-up Period|Adverse Event|0
5164158|NCT01358578|17831581|P3|Follow-up Period|Adverse Event|0
5164159|NCT01358578|17831582|P2|Follow-up Period|Adverse Event|1
5164160|NCT01358578|17831583|P1|Follow-up Period|Adverse Event|1
5164161|NCT01358578|17831578|P6|Maintenance Period|Withdrawal by Subject|3
5164162|NCT01358578|17831579|P5|Maintenance Period|Withdrawal by Subject|6
5164163|NCT01358578|17831580|P4|Maintenance Period|Withdrawal by Subject|15
5164164|NCT01358578|17831581|P3|Maintenance Period|Withdrawal by Subject|2
5164165|NCT01358578|17831582|P2|Maintenance Period|Withdrawal by Subject|7
5164166|NCT01358578|17831583|P1|Maintenance Period|Withdrawal by Subject|12
5164167|NCT01358578|17831578|P6|Maintenance Period|Protocol deviation|2
5164168|NCT01358578|17831579|P5|Maintenance Period|Protocol deviation|2
5164169|NCT01358578|17831580|P4|Maintenance Period|Protocol deviation|2
5164170|NCT01358578|17831581|P3|Maintenance Period|Protocol deviation|0
5164171|NCT01358578|17831582|P2|Maintenance Period|Protocol deviation|4
5164172|NCT01358578|17831583|P1|Maintenance Period|Protocol deviation|7
5164173|NCT01358578|17831578|P6|Maintenance Period|Pregnancy|0
5164174|NCT01358578|17831579|P5|Maintenance Period|Pregnancy|0
5164175|NCT01358578|17831580|P4|Maintenance Period|Pregnancy|0
5164176|NCT01358578|17831581|P3|Maintenance Period|Pregnancy|0
5164177|NCT01358578|17831582|P2|Maintenance Period|Pregnancy|0
5164178|NCT01358578|17831583|P1|Maintenance Period|Pregnancy|1
5164179|NCT01358578|17831578|P6|Maintenance Period|Physician Decision|0
5164180|NCT01358578|17831579|P5|Maintenance Period|Physician Decision|0
5164181|NCT01358578|17831580|P4|Maintenance Period|Physician Decision|1
5164182|NCT01358578|17831581|P3|Maintenance Period|Physician Decision|0
5164183|NCT01358578|17831582|P2|Maintenance Period|Physician Decision|1
5164184|NCT01358578|17831583|P1|Maintenance Period|Physician Decision|0
5164185|NCT01358578|17831578|P6|Maintenance Period|Non-compliance with study treatment|2
5164186|NCT01358578|17831579|P5|Maintenance Period|Non-compliance with study treatment|1
5164187|NCT01358578|17831580|P4|Maintenance Period|Non-compliance with study treatment|2
5164188|NCT01358578|17831581|P3|Maintenance Period|Non-compliance with study treatment|0
5164189|NCT01358578|17831582|P2|Maintenance Period|Non-compliance with study treatment|1
5164190|NCT01358578|17831583|P1|Maintenance Period|Non-compliance with study treatment|3
5164191|NCT01358578|17831578|P6|Maintenance Period|Lost to Follow-up|1
5164192|NCT01358578|17831579|P5|Maintenance Period|Lost to Follow-up|1
5164193|NCT01358578|17831580|P4|Maintenance Period|Lost to Follow-up|5
5164194|NCT01358578|17831581|P3|Maintenance Period|Lost to Follow-up|0
5164195|NCT01358578|17831582|P2|Maintenance Period|Lost to Follow-up|0
5164196|NCT01358578|17831583|P1|Maintenance Period|Lost to Follow-up|4
5164197|NCT01358578|17831578|P6|Maintenance Period|Lack of Efficacy|0
5164198|NCT01358578|17831579|P5|Maintenance Period|Lack of Efficacy|3
5164199|NCT01358578|17831580|P4|Maintenance Period|Lack of Efficacy|11
5164200|NCT01358578|17831581|P3|Maintenance Period|Lack of Efficacy|0
5164201|NCT01358578|17831582|P2|Maintenance Period|Lack of Efficacy|2
5164202|NCT01358578|17831583|P1|Maintenance Period|Lack of Efficacy|10
5164203|NCT01358578|17831578|P6|Maintenance Period|Adverse Event|3
5164204|NCT01358578|17831579|P5|Maintenance Period|Adverse Event|4
5164205|NCT01358578|17831580|P4|Maintenance Period|Adverse Event|6
5164206|NCT01358578|17831581|P3|Maintenance Period|Adverse Event|0
5164207|NCT01358578|17831582|P2|Maintenance Period|Adverse Event|7
5164208|NCT01358578|17831583|P1|Maintenance Period|Adverse Event|2
5164209|NCT01358578|17831578|P6|Induction Period|Withdrawal by Subject|0
5164210|NCT01358578|17831579|P5|Induction Period|Withdrawal by Subject|0
5164211|NCT01358578|17831580|P4|Induction Period|Withdrawal by Subject|6
5164212|NCT01358578|17831581|P3|Induction Period|Withdrawal by Subject|10
5164213|NCT01358578|17831582|P2|Induction Period|Withdrawal by Subject|5
5164214|NCT01358578|17831583|P1|Induction Period|Withdrawal by Subject|5
5164215|NCT01358578|17831578|P6|Induction Period|technical problems|0
5164216|NCT01358578|17831579|P5|Induction Period|technical problems|0
5164217|NCT01358578|17831580|P4|Induction Period|technical problems|1
5164218|NCT01358578|17831581|P3|Induction Period|technical problems|1
5164219|NCT01358578|17831582|P2|Induction Period|technical problems|0
5164220|NCT01358578|17831583|P1|Induction Period|technical problems|0
5164221|NCT01358578|17831578|P6|Induction Period|Protocol Deviation|0
5164222|NCT01358578|17831579|P5|Induction Period|Protocol Deviation|0
5164223|NCT01358578|17831580|P4|Induction Period|Protocol Deviation|3
5164224|NCT01358578|17831581|P3|Induction Period|Protocol Deviation|0
5164225|NCT01358578|17831582|P2|Induction Period|Protocol Deviation|5
5164226|NCT01358578|17831583|P1|Induction Period|Protocol Deviation|3
5164227|NCT01358578|17831578|P6|Induction Period|Physician Decision|0
5164228|NCT01358578|17831579|P5|Induction Period|Physician Decision|0
5164229|NCT01358578|17831580|P4|Induction Period|Physician Decision|0
5164230|NCT01358578|17831581|P3|Induction Period|Physician Decision|2
5164231|NCT01358578|17831582|P2|Induction Period|Physician Decision|1
5164232|NCT01358578|17831583|P1|Induction Period|Physician Decision|2
5164233|NCT01358578|17831578|P6|Induction Period|Lost to Follow-up|0
5164234|NCT01358578|17831579|P5|Induction Period|Lost to Follow-up|0
5164235|NCT01358578|17831580|P4|Induction Period|Lost to Follow-up|4
5164236|NCT01358578|17831581|P3|Induction Period|Lost to Follow-up|1
5164237|NCT01358578|17831582|P2|Induction Period|Lost to Follow-up|0
5164238|NCT01358578|17831583|P1|Induction Period|Lost to Follow-up|0
5164239|NCT01358578|17831578|P6|Induction Period|Lack of Efficacy|0
5164240|NCT01358578|17831579|P5|Induction Period|Lack of Efficacy|0
5164241|NCT01358578|17831580|P4|Induction Period|Lack of Efficacy|1
5164242|NCT01358578|17831581|P3|Induction Period|Lack of Efficacy|9
5164243|NCT01358578|17831582|P2|Induction Period|Lack of Efficacy|0
5164244|NCT01358578|17831583|P1|Induction Period|Lack of Efficacy|0
5164245|NCT01358578|17831578|P6|Induction Period|Adverse Event|0
5164246|NCT01358578|17831579|P5|Induction Period|Adverse Event|0
5164247|NCT01358578|17831580|P4|Induction Period|Adverse Event|6
5164248|NCT01358578|17831581|P3|Induction Period|Adverse Event|2
5164249|NCT01358578|17831582|P2|Induction Period|Adverse Event|4
5164250|NCT01358578|17831583|P1|Induction Period|Adverse Event|2
5164251|NCT01358526|17831635|P3|Double-blind Phase|Administrative|10
5164252|NCT01358526|17831636|P2|Double-blind Phase|Administrative|6
5164253|NCT01358526|17831637|P1|Double-blind Phase|Administrative|0
5164254|NCT01358526|17831635|P3|Double-blind Phase|Confirmed or suspected diversion|6
5164255|NCT01358526|17831636|P2|Double-blind Phase|Confirmed or suspected diversion|5
5164256|NCT01358526|17831637|P1|Double-blind Phase|Confirmed or suspected diversion|0
5164257|NCT01358526|17831635|P3|Double-blind Phase|Lack of Efficacy|73
5164258|NCT01358526|17831636|P2|Double-blind Phase|Lack of Efficacy|31
5164259|NCT01358526|17831637|P1|Double-blind Phase|Lack of Efficacy|0
5164260|NCT01358526|17831635|P3|Double-blind Phase|Lost to Follow-up|1
5164261|NCT01358526|17831636|P2|Double-blind Phase|Lost to Follow-up|4
5164262|NCT01358526|17831637|P1|Double-blind Phase|Lost to Follow-up|0
5164263|NCT01358526|17831635|P3|Double-blind Phase|Withdrawal by Subject|8
5164264|NCT01358526|17831636|P2|Double-blind Phase|Withdrawal by Subject|10
5164265|NCT01358526|17831637|P1|Double-blind Phase|Withdrawal by Subject|0
5164266|NCT01358526|17831635|P3|Double-blind Phase|Adverse Event|23
5164267|NCT01358526|17831636|P2|Double-blind Phase|Adverse Event|24
5164268|NCT01358526|17831637|P1|Double-blind Phase|Adverse Event|0
5164269|NCT01358526|17831635|P3|Open-label Titration Period|Did not qualify|0
5164270|NCT01358526|17831636|P2|Open-label Titration Period|Did not qualify|0
5164271|NCT01358526|17831637|P1|Open-label Titration Period|Did not qualify|178
5164272|NCT01358526|17831635|P3|Open-label Titration Period|Administrative|0
5164273|NCT01358526|17831636|P2|Open-label Titration Period|Administrative|0
5164274|NCT01358526|17831637|P1|Open-label Titration Period|Administrative|8
5164275|NCT01358526|17831635|P3|Open-label Titration Period|Confirmed or suspected diversion|0
5164276|NCT01358526|17831636|P2|Open-label Titration Period|Confirmed or suspected diversion|0
5164277|NCT01358526|17831637|P1|Open-label Titration Period|Confirmed or suspected diversion|16
5164278|NCT01358526|17831635|P3|Open-label Titration Period|Lack of Efficacy|0
5164279|NCT01358526|17831636|P2|Open-label Titration Period|Lack of Efficacy|0
5164280|NCT01358526|17831637|P1|Open-label Titration Period|Lack of Efficacy|107
5164281|NCT01358526|17831635|P3|Open-label Titration Period|Lost to Follow-up|0
5164282|NCT01358526|17831636|P2|Open-label Titration Period|Lost to Follow-up|0
5164283|NCT01358526|17831637|P1|Open-label Titration Period|Lost to Follow-up|25
5164284|NCT01358526|17831635|P3|Open-label Titration Period|Withdrawal by Subject|0
5164285|NCT01358526|17831636|P2|Open-label Titration Period|Withdrawal by Subject|0
5164286|NCT01358526|17831637|P1|Open-label Titration Period|Withdrawal by Subject|65
5164287|NCT01358526|17831635|P3|Open-label Titration Period|Adverse Event|0
5164288|NCT01358526|17831636|P2|Open-label Titration Period|Adverse Event|0
5164289|NCT01358526|17831637|P1|Open-label Titration Period|Adverse Event|95
5164290|NCT01358357|17831654|P3|Double-Blind Phase|Administrative|0
5164291|NCT01358357|17831655|P2|Double-Blind Phase|Administrative|1
5164292|NCT01358357|17831656|P1|Double-Blind Phase|Administrative|0
5164293|NCT01358357|17831654|P3|Double-Blind Phase|Recurrence of mood event|0
5164294|NCT01358357|17831655|P2|Double-Blind Phase|Recurrence of mood event|64
5164295|NCT01358357|17831656|P1|Double-Blind Phase|Recurrence of mood event|48
5164296|NCT01358357|17831654|P3|Double-Blind Phase|Terminated at study completion|0
5164297|NCT01358357|17831655|P2|Double-Blind Phase|Terminated at study completion|0
5164298|NCT01358357|17831656|P1|Double-Blind Phase|Terminated at study completion|2
5164299|NCT01358357|17831654|P3|Double-Blind Phase|Protocol Violation|0
5164300|NCT01358357|17831655|P2|Double-Blind Phase|Protocol Violation|12
5164301|NCT01358357|17831656|P1|Double-Blind Phase|Protocol Violation|16
5164302|NCT01358357|17831654|P3|Double-Blind Phase|Protocol Violation|0
5164303|NCT01358357|17831655|P2|Double-Blind Phase|Protocol Violation|11
5164304|NCT01358357|17831656|P1|Double-Blind Phase|Protocol Violation|1
5164305|NCT01358357|17831654|P3|Double-Blind Phase|Lost to Follow-up|0
5164306|NCT01358357|17831655|P2|Double-Blind Phase|Lost to Follow-up|7
5164307|NCT01358357|17831656|P1|Double-Blind Phase|Lost to Follow-up|5
5164308|NCT01358357|17831654|P3|Double-Blind Phase|Adverse Event|0
5164309|NCT01358357|17831655|P2|Double-Blind Phase|Adverse Event|5
5164310|NCT01358357|17831656|P1|Double-Blind Phase|Adverse Event|8
5164311|NCT01358357|17831654|P3|Open Label Phase|Mood episode|42
5164312|NCT01358357|17831655|P2|Open Label Phase|Mood episode|0
5164313|NCT01358357|17831656|P1|Open Label Phase|Mood episode|0
5164314|NCT01358357|17831654|P3|Open Label Phase|Terminated at study completion|5
5164315|NCT01358357|17831655|P2|Open Label Phase|Terminated at study completion|0
5164316|NCT01358357|17831656|P1|Open Label Phase|Terminated at study completion|0
5164317|NCT01358357|17831654|P3|Open Label Phase|Did not meet criteria for DB phase|16
5164318|NCT01358357|17831655|P2|Open Label Phase|Did not meet criteria for DB phase|0
5164319|NCT01358357|17831656|P1|Open Label Phase|Did not meet criteria for DB phase|0
5164320|NCT01358357|17831654|P3|Open Label Phase|Withdrawal by Subject|112
5164321|NCT01358357|17831655|P2|Open Label Phase|Withdrawal by Subject|0
5164322|NCT01358357|17831656|P1|Open Label Phase|Withdrawal by Subject|0
5164323|NCT01358357|17831654|P3|Open Label Phase|Protocol Violation|45
5164324|NCT01358357|17831655|P2|Open Label Phase|Protocol Violation|0
5164325|NCT01358357|17831656|P1|Open Label Phase|Protocol Violation|0
5164326|NCT01358357|17831654|P3|Open Label Phase|Lost to Follow-up|76
5164327|NCT01358357|17831655|P2|Open Label Phase|Lost to Follow-up|0
5164328|NCT01358357|17831656|P1|Open Label Phase|Lost to Follow-up|0
5164329|NCT01358357|17831654|P3|Open Label Phase|Lack of Efficacy|107
5164330|NCT01358357|17831655|P2|Open Label Phase|Lack of Efficacy|0
5164331|NCT01358357|17831656|P1|Open Label Phase|Lack of Efficacy|0
5164332|NCT01358357|17831654|P3|Open Label Phase|Adverse Event|59
5164333|NCT01358357|17831655|P2|Open Label Phase|Adverse Event|0
5164334|NCT01358357|17831656|P1|Open Label Phase|Adverse Event|0
5164335|NCT01358331|17831695|P6|Overall Study|Progress of disease under investigation|0
5164336|NCT01358331|17831696|P5|Overall Study|Progress of disease under investigation|3
5164337|NCT01358331|17831697|P4|Overall Study|Progress of disease under investigation|1
5164338|NCT01358331|17831698|P3|Overall Study|Progress of disease under investigation|3
5164339|NCT01358331|17831699|P2|Overall Study|Progress of disease under investigation|2
5164340|NCT01358331|17831700|P1|Overall Study|Progress of disease under investigation|1
5164341|NCT01358331|17831695|P6|Overall Study|Participants did not wish to continue|0
5164342|NCT01358331|17831696|P5|Overall Study|Participants did not wish to continue|1
5164343|NCT01358331|17831697|P4|Overall Study|Participants did not wish to continue|0
5164344|NCT01358331|17831698|P3|Overall Study|Participants did not wish to continue|0
5164345|NCT01358331|17831699|P2|Overall Study|Participants did not wish to continue|0
5164346|NCT01358331|17831700|P1|Overall Study|Participants did not wish to continue|0
5164347|NCT01358331|17831695|P6|Overall Study|Symptomatic Deterioration|0
5164348|NCT01358331|17831696|P5|Overall Study|Symptomatic Deterioration|1
5164349|NCT01358331|17831697|P4|Overall Study|Symptomatic Deterioration|0
5164350|NCT01358331|17831698|P3|Overall Study|Symptomatic Deterioration|0
5164351|NCT01358331|17831699|P2|Overall Study|Symptomatic Deterioration|0
5164352|NCT01358331|17831700|P1|Overall Study|Symptomatic Deterioration|0
5164353|NCT01358331|17831695|P6|Overall Study|Adverse Events|5
5164354|NCT01358331|17831696|P5|Overall Study|Adverse Events|1
5164355|NCT01358331|17831697|P4|Overall Study|Adverse Events|0
5164356|NCT01358331|17831698|P3|Overall Study|Adverse Events|1
5164357|NCT01358331|17831699|P2|Overall Study|Adverse Events|1
5164358|NCT01358331|17831700|P1|Overall Study|Adverse Events|1
5164359|NCT01358331|17831695|P6|Overall Study|Withdrawal by Subject|1
5164360|NCT01358331|17831696|P5|Overall Study|Withdrawal by Subject|1
5164361|NCT01358331|17831697|P4|Overall Study|Withdrawal by Subject|1
5164362|NCT01358331|17831698|P3|Overall Study|Withdrawal by Subject|0
5164363|NCT01358331|17831699|P2|Overall Study|Withdrawal by Subject|0
5164364|NCT01358331|17831700|P1|Overall Study|Withdrawal by Subject|0
5164365|NCT01358331|17831695|P6|Overall Study|Lost to Follow-up|0
5164366|NCT01358331|17831696|P5|Overall Study|Lost to Follow-up|0
5164367|NCT01358331|17831697|P4|Overall Study|Lost to Follow-up|1
5164368|NCT01358331|17831698|P3|Overall Study|Lost to Follow-up|0
5164369|NCT01358331|17831699|P2|Overall Study|Lost to Follow-up|0
5164370|NCT01358331|17831700|P1|Overall Study|Lost to Follow-up|0
5164371|NCT01358175|17831752|P3|Overall Study|Adverse Event|11
5164372|NCT01358175|17831753|P2|Overall Study|Adverse Event|11
5164373|NCT01358175|17831754|P1|Overall Study|Adverse Event|6
5164374|NCT01358175|17831752|P3|Overall Study|Lack of Efficacy|6
5164375|NCT01358175|17831753|P2|Overall Study|Lack of Efficacy|8
5164376|NCT01358175|17831754|P1|Overall Study|Lack of Efficacy|3
5164377|NCT01358175|17831752|P3|Overall Study|Lost to Follow-up|3
5164378|NCT01358175|17831753|P2|Overall Study|Lost to Follow-up|1
5164379|NCT01358175|17831754|P1|Overall Study|Lost to Follow-up|1
5164380|NCT01358175|17831752|P3|Overall Study|Non Compliance with Study Treatment|1
5164381|NCT01358175|17831753|P2|Overall Study|Non Compliance with Study Treatment|1
5164382|NCT01358175|17831754|P1|Overall Study|Non Compliance with Study Treatment|0
5164383|NCT01358175|17831752|P3|Overall Study|Physician Decision|0
5164384|NCT01358175|17831753|P2|Overall Study|Physician Decision|0
5164385|NCT01358175|17831754|P1|Overall Study|Physician Decision|1
5164386|NCT01358175|17831752|P3|Overall Study|Pregnancy|0
5164387|NCT01358175|17831753|P2|Overall Study|Pregnancy|1
5164388|NCT01358175|17831754|P1|Overall Study|Pregnancy|0
5164389|NCT01358175|17831752|P3|Overall Study|Technical issues|0
5164390|NCT01358175|17831753|P2|Overall Study|Technical issues|1
5164391|NCT01358175|17831754|P1|Overall Study|Technical issues|0
5164392|NCT01358175|17831752|P3|Overall Study|Withdrawal by Subject|10
5164393|NCT01358175|17831753|P2|Overall Study|Withdrawal by Subject|5
5164394|NCT01358175|17831754|P1|Overall Study|Withdrawal by Subject|9
5164395|NCT01358175|17831752|P3|Overall Study|Death|1
5164396|NCT01358175|17831753|P2|Overall Study|Death|0
5164397|NCT01358175|17831754|P1|Overall Study|Death|1
5164398|NCT01357980|17831791|P4|Overall Study|Consent withdrawn|0
5164399|NCT01357980|17831792|P3|Overall Study|Consent withdrawn|1
5164400|NCT01357980|17831793|P2|Overall Study|Consent withdrawn|0
5164401|NCT01357980|17831794|P1|Overall Study|Consent withdrawn|0
5164402|NCT01357980|17831791|P4|Overall Study|Lack of Efficacy|0
5164403|NCT01357980|17831792|P3|Overall Study|Lack of Efficacy|0
5164404|NCT01357980|17831793|P2|Overall Study|Lack of Efficacy|1
5164405|NCT01357980|17831794|P1|Overall Study|Lack of Efficacy|0
5164406|NCT01357915|17831838|P2|Overall Study|Lost to Follow-up|0
5164407|NCT01357915|17831839|P1|Overall Study|Lost to Follow-up|3
5164408|NCT01357889|17831857|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
5164409|NCT01357889|17831858|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
5164410|NCT01357889|17831857|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
5164411|NCT01357889|17831858|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
5164412|NCT01357889|17831857|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
5164413|NCT01357889|17831858|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
5164414|NCT01357889|17831857|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
5164415|NCT01357889|17831858|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
5164416|NCT01357889|17831857|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
5164417|NCT01357889|17831858|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
5164418|NCT01357889|17831857|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
5164419|NCT01357889|17831858|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
5164420|NCT01357889|17831857|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
5164421|NCT01357889|17831858|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
5164422|NCT01357889|17831857|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
5164423|NCT01357889|17831858|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
5164424|NCT01357889|17831857|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
5164425|NCT01357889|17831858|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
5164426|NCT01357889|17831857|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
5164427|NCT01357889|17831858|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
5164428|NCT01357889|17831857|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
5164429|NCT01357889|17831858|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
5164430|NCT01357889|17831857|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
5164431|NCT01357889|17831858|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
5164432|NCT01357889|17831857|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
5164433|NCT01357889|17831858|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
5164434|NCT01357850|17831902|P4|Overall Study|Lost to Follow-up|0
5164435|NCT01357850|17831903|P3|Overall Study|Lost to Follow-up|0
5164436|NCT01357850|17831904|P2|Overall Study|Lost to Follow-up|0
5164437|NCT01357850|17831905|P1|Overall Study|Lost to Follow-up|1
5164438|NCT01357655|17831996|P2|Overall Study|Subject Withdrew Consent|0
5164439|NCT01357655|17831997|P1|Overall Study|Subject Withdrew Consent|1
5164440|NCT01357655|17831996|P2|Overall Study|Study Drug Toxicity|0
5164441|NCT01357655|17831997|P1|Overall Study|Study Drug Toxicity|11
5164442|NCT01357655|17831996|P2|Overall Study|Reason Unspecified|0
5164443|NCT01357655|17831997|P1|Overall Study|Reason Unspecified|1
5164444|NCT01357655|17831996|P2|Overall Study|Maximum Clinical Benefit|0
5164445|NCT01357655|17831997|P1|Overall Study|Maximum Clinical Benefit|2
5164446|NCT01357655|17831996|P2|Overall Study|Lost to Follow-up|0
5164447|NCT01357655|17831997|P1|Overall Study|Lost to Follow-up|2
5164448|NCT01357655|17831996|P2|Overall Study|Disease Progression|0
5164449|NCT01357655|17831997|P1|Overall Study|Disease Progression|1
5164450|NCT01357655|17831996|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
5164451|NCT01357655|17831997|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
5164452|NCT01357655|17831996|P2|Overall Study|Administrative Reason by Sponsor|0
5164453|NCT01357655|17831997|P1|Overall Study|Administrative Reason by Sponsor|45
5164454|NCT01357616|17832014|P2|Overall Study|Withdrawal by Subject|0
5164455|NCT01357616|17832015|P1|Overall Study|Withdrawal by Subject|1
5164456|NCT01357616|17832014|P2|Overall Study|Decision Unrelated to Adverse Event|1
5164457|NCT01357616|17832015|P1|Overall Study|Decision Unrelated to Adverse Event|3
5164458|NCT01357616|17832014|P2|Overall Study|Inadequate Control of IOP|2
5164459|NCT01357616|17832015|P1|Overall Study|Inadequate Control of IOP|1
5164460|NCT01357616|17832014|P2|Overall Study|Protocol Violation|2
5164461|NCT01357616|17832015|P1|Overall Study|Protocol Violation|0
5164462|NCT01357616|17832014|P2|Overall Study|Lost to Follow-up|3
5164463|NCT01357616|17832015|P1|Overall Study|Lost to Follow-up|4
5164464|NCT01357616|17832014|P2|Overall Study|Adverse Event|1
5164465|NCT01357616|17832015|P1|Overall Study|Adverse Event|1
5164466|NCT01357577|17832029|P2|Overall Study|look at data in database?|2
5164467|NCT01357577|17832030|P1|Overall Study|look at data in database?|1
5164468|NCT01357577|17832029|P2|Overall Study|Withdrawal by Subject|8
5164469|NCT01357577|17832030|P1|Overall Study|Withdrawal by Subject|16
5164470|NCT01357577|17832029|P2|Overall Study|Lost to Follow-up|16
5164471|NCT01357577|17832030|P1|Overall Study|Lost to Follow-up|20
5164472|NCT01357551|17832057|P2|Overall Study|Lost to Follow-up|6
5164473|NCT01357551|17832058|P1|Overall Study|Lost to Follow-up|16
5164474|NCT01357551|17832057|P2|Overall Study|Death|1
5164475|NCT01357551|17832058|P1|Overall Study|Death|0
5164476|NCT01357551|17832057|P2|Overall Study|Withdrawal by Subject|4
5164477|NCT01357551|17832058|P1|Overall Study|Withdrawal by Subject|6
5164478|NCT01357239|17832106|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
5164479|NCT01357239|17832107|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
5164480|NCT01357239|17832108|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
5164481|NCT01357239|17832109|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
5164482|NCT01357239|17832106|P4|Stratum II: Partially-Methylated|Adverse Event|1
5164483|NCT01357239|17832107|P3|Stratum II: Partially-Methylated|Adverse Event|0
5164484|NCT01357239|17832108|P2|Stratum II: Partially-Methylated|Adverse Event|0
5164485|NCT01357239|17832109|P1|Stratum II: Partially-Methylated|Adverse Event|0
5164486|NCT01357239|17832106|P4|Stratum I: Fully-Methylated|Adverse Event|0
5164487|NCT01357239|17832107|P3|Stratum I: Fully-Methylated|Adverse Event|1
5164488|NCT01357239|17832108|P2|Stratum I: Fully-Methylated|Adverse Event|0
5164489|NCT01357239|17832109|P1|Stratum I: Fully-Methylated|Adverse Event|0
5164490|NCT01357239|17832106|P4|Stratum: All Patients|Subject withdrew consent|1
5164491|NCT01357239|17832107|P3|Stratum: All Patients|Subject withdrew consent|1
5164492|NCT01357239|17832108|P2|Stratum: All Patients|Subject withdrew consent|0
5164493|NCT01357239|17832109|P1|Stratum: All Patients|Subject withdrew consent|0
5164494|NCT01357239|17832106|P4|Stratum: All Patients|Adverse Event|1
5164495|NCT01357239|17832107|P3|Stratum: All Patients|Adverse Event|1
5164496|NCT01357239|17832108|P2|Stratum: All Patients|Adverse Event|0
5164497|NCT01357239|17832109|P1|Stratum: All Patients|Adverse Event|0
5164498|NCT01357161|17832167|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
5164499|NCT01357161|17832168|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
5164500|NCT01357161|17832169|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
5164501|NCT01357161|17832167|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
5164502|NCT01357161|17832168|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
5164503|NCT01357161|17832169|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
5164504|NCT01357161|17832167|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
5164505|NCT01357161|17832168|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
5164506|NCT01357161|17832169|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
5164507|NCT01357161|17832167|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
5164508|NCT01357161|17832168|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
5164509|NCT01357161|17832169|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
5164510|NCT01357161|17832167|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
5164511|NCT01357161|17832168|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
5164512|NCT01357161|17832169|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
5164513|NCT01357161|17832167|P3|Part 2 (Double-Blind Comparison)|Death|19
5164514|NCT01357161|17832168|P2|Part 2 (Double-Blind Comparison)|Death|22
5164515|NCT01357161|17832169|P1|Part 2 (Double-Blind Comparison)|Death|0
5164516|NCT01357161|17832167|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
5164517|NCT01357161|17832168|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
5164518|NCT01357161|17832169|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
5164519|NCT01357161|17832167|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
5164520|NCT01357161|17832168|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
5164521|NCT01357161|17832169|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
5164522|NCT01357161|17832167|P3|Part 1 (Open Label Run-in)|Physician Decision|0
5164523|NCT01357161|17832168|P2|Part 1 (Open Label Run-in)|Physician Decision|0
5164524|NCT01357161|17832169|P1|Part 1 (Open Label Run-in)|Physician Decision|1
5164525|NCT01357161|17832167|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
5164526|NCT01357161|17832168|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
5164527|NCT01357161|17832169|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
5164528|NCT01357161|17832167|P3|Part 1 (Open Label Run-in)|Death|0
5164529|NCT01357161|17832168|P2|Part 1 (Open Label Run-in)|Death|0
5164530|NCT01357161|17832169|P1|Part 1 (Open Label Run-in)|Death|5
5164531|NCT01356966|17832221|P2|Overall Study|Physician Decision|0
5164532|NCT01356966|17832222|P1|Overall Study|Physician Decision|1
5164533|NCT01356966|17832221|P2|Overall Study|Withdrawal by Subject|2
5164534|NCT01356966|17832222|P1|Overall Study|Withdrawal by Subject|1
5164535|NCT01356940|17832234|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
5164536|NCT01356940|17832235|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
5164537|NCT01356940|17832234|P2|First Intervention (28 Days)|Adverse Event|0
5164538|NCT01356940|17832235|P1|First Intervention (28 Days)|Adverse Event|1
5164539|NCT01356602|17832264|P3|Overall Study|Adverse Event|1
5164540|NCT01356602|17832265|P2|Overall Study|Adverse Event|1
5164541|NCT01356602|17832266|P1|Overall Study|Adverse Event|0
5164542|NCT01356602|17832264|P3|Overall Study|Lack of Efficacy|4
5164543|NCT01356602|17832265|P2|Overall Study|Lack of Efficacy|1
5164544|NCT01356602|17832266|P1|Overall Study|Lack of Efficacy|0
5164545|NCT01356602|17832264|P3|Overall Study|Withdrawal by Subject|7
5164546|NCT01356602|17832265|P2|Overall Study|Withdrawal by Subject|3
5164547|NCT01356602|17832266|P1|Overall Study|Withdrawal by Subject|4
5164548|NCT01356602|17832264|P3|Overall Study|Lost to Follow-up|6
5164549|NCT01356602|17832265|P2|Overall Study|Lost to Follow-up|5
5164550|NCT01356602|17832266|P1|Overall Study|Lost to Follow-up|4
5164551|NCT01356602|17832264|P3|Overall Study|Administrative Problems|5
5164552|NCT01356602|17832265|P2|Overall Study|Administrative Problems|4
5164553|NCT01356602|17832266|P1|Overall Study|Administrative Problems|1
5164554|NCT01356602|17832264|P3|Overall Study|Protocol Deviation|1
5164555|NCT01356602|17832265|P2|Overall Study|Protocol Deviation|1
5164556|NCT01356602|17832266|P1|Overall Study|Protocol Deviation|0
5164557|NCT01356589|17832325|P1|Overall Study|Dose data not recorded|2
5164558|NCT01356589|17832325|P1|Overall Study|Enrolled, but not treated|3
5164559|NCT01356407|17832382|P2|Overall Study|Not complete Endoscopy|2
5164560|NCT01356407|17832383|P1|Overall Study|Not complete Endoscopy|2
5164561|NCT01356407|17832382|P2|Overall Study|Could not afford IMP administration|1
5164562|NCT01356407|17832383|P1|Overall Study|Could not afford IMP administration|0
5164563|NCT01356407|17832382|P2|Overall Study|Patient Withdrew Consent|1
5164564|NCT01356407|17832383|P1|Overall Study|Patient Withdrew Consent|2
5164565|NCT01356407|17832382|P2|Overall Study|Lost to Follow-up|0
5164566|NCT01356407|17832383|P1|Overall Study|Lost to Follow-up|2
5164567|NCT01355679|17832455|P1|Overall Study|benign tumor types found at biopsy|2
5164568|NCT01355627|17832464|P2|Overall Study|Other|1
5164569|NCT01355627|17832465|P1|Overall Study|Other|1
5164570|NCT01355627|17832464|P2|Overall Study|Fatal Adverse Event|23
5164571|NCT01355627|17832465|P1|Overall Study|Fatal Adverse Event|19
5164572|NCT01355627|17832464|P2|Overall Study|Lost to Follow-up|7
5164573|NCT01355627|17832465|P1|Overall Study|Lost to Follow-up|8
5164574|NCT01355627|17832464|P2|Overall Study|Request By the Patient to Discontinue|7
5164575|NCT01355627|17832465|P1|Overall Study|Request By the Patient to Discontinue|5
5164576|NCT01355575|17832502|P1|Overall Study|Withdrawal by Subject|2
5164577|NCT01355523|17832514|P2|Overall Study|Adverse Event|2
5164578|NCT01355523|17832515|P1|Overall Study|Adverse Event|0
5164579|NCT01355523|17832514|P2|Overall Study|Protocol Violation|2
5164580|NCT01355523|17832515|P1|Overall Study|Protocol Violation|0
5164581|NCT01355523|17832514|P2|Overall Study|Lost to Follow-up|2
5164582|NCT01355523|17832515|P1|Overall Study|Lost to Follow-up|0
5164583|NCT01355523|17832514|P2|Overall Study|Withdrawal by Subject|4
5164584|NCT01355523|17832515|P1|Overall Study|Withdrawal by Subject|1
5164585|NCT01355497|17832559|P2|Overall Study|Adverse Event|10
5164586|NCT01355497|17832560|P1|Overall Study|Adverse Event|11
5164587|NCT01355497|17832559|P2|Overall Study|progressive disease|8
5164588|NCT01355497|17832560|P1|Overall Study|progressive disease|11
5164589|NCT01355497|17832559|P2|Overall Study|noncompliance|2
5164590|NCT01355497|17832560|P1|Overall Study|noncompliance|1
5164591|NCT01355497|17832559|P2|Overall Study|Withdrawal by Subject|20
5164592|NCT01355497|17832560|P1|Overall Study|Withdrawal by Subject|12
5164593|NCT01355497|17832559|P2|Overall Study|other-not provided|4
5164594|NCT01355497|17832560|P1|Overall Study|other-not provided|9
5164595|NCT01355497|17832559|P2|Overall Study|Protocol Violation|1
5164596|NCT01355497|17832560|P1|Overall Study|Protocol Violation|0
5164597|NCT01355497|17832559|P2|Overall Study|Lost to Follow-up|0
5164598|NCT01355497|17832560|P1|Overall Study|Lost to Follow-up|3
5164599|NCT01355497|17832559|P2|Overall Study|Death|18
5164600|NCT01355497|17832560|P1|Overall Study|Death|19
5164601|NCT01355302|17832602|P3|Phase 1b|Study terminated by sponsor|0
5164602|NCT01355302|17832603|P2|Phase 1b|Study terminated by sponsor|0
5164603|NCT01355302|17832604|P1|Phase 1b|Study terminated by sponsor|2
5164604|NCT01355302|17832602|P3|Phase 1b|Death|0
5164605|NCT01355302|17832603|P2|Phase 1b|Death|0
5164606|NCT01355302|17832604|P1|Phase 1b|Death|4
5164607|NCT01355289|17832619|P5|Open Label Extension|Other|3
5164608|NCT01355289|17832620|P4|Open Label Extension|Other|0
5164609|NCT01355289|17832621|P3|Open Label Extension|Other|0
5164610|NCT01355289|17832622|P2|Open Label Extension|Other|0
5164611|NCT01355289|17832623|P1|Open Label Extension|Other|0
5164612|NCT01355289|17832619|P5|Open Label Extension|Inadequate Therapeutic Effect|29
5164613|NCT01355289|17832620|P4|Open Label Extension|Inadequate Therapeutic Effect|0
5164614|NCT01355289|17832621|P3|Open Label Extension|Inadequate Therapeutic Effect|0
5164615|NCT01355289|17832622|P2|Open Label Extension|Inadequate Therapeutic Effect|0
5164616|NCT01355289|17832623|P1|Open Label Extension|Inadequate Therapeutic Effect|0
5164617|NCT01355289|17832619|P5|Open Label Extension|Lost to Follow-up|1
5164618|NCT01355289|17832620|P4|Open Label Extension|Lost to Follow-up|0
5164619|NCT01355289|17832621|P3|Open Label Extension|Lost to Follow-up|0
5164620|NCT01355289|17832622|P2|Open Label Extension|Lost to Follow-up|0
5164621|NCT01355289|17832623|P1|Open Label Extension|Lost to Follow-up|0
5164622|NCT01355289|17832619|P5|Open Label Extension|Adverse Event, Non-Fatal|1
5164623|NCT01355289|17832620|P4|Open Label Extension|Adverse Event, Non-Fatal|0
5164624|NCT01355289|17832621|P3|Open Label Extension|Adverse Event, Non-Fatal|0
5164625|NCT01355289|17832622|P2|Open Label Extension|Adverse Event, Non-Fatal|0
5164626|NCT01355289|17832623|P1|Open Label Extension|Adverse Event, Non-Fatal|0
5164627|NCT01355289|17832619|P5|Core Study|Other|0
5164628|NCT01355289|17832620|P4|Core Study|Other|1
5164629|NCT01355289|17832621|P3|Core Study|Other|0
5164630|NCT01355289|17832622|P2|Core Study|Other|0
5164631|NCT01355289|17832623|P1|Core Study|Other|0
5164632|NCT01355289|17832619|P5|Core Study|Inadequate Therapeutic Effect|0
5164633|NCT01355289|17832620|P4|Core Study|Inadequate Therapeutic Effect|1
5164634|NCT01355289|17832621|P3|Core Study|Inadequate Therapeutic Effect|0
5164635|NCT01355289|17832622|P2|Core Study|Inadequate Therapeutic Effect|0
5164636|NCT01355289|17832623|P1|Core Study|Inadequate Therapeutic Effect|0
5164637|NCT01355289|17832619|P5|Core Study|Adverse Event, Non-Fatal|0
5164638|NCT01355289|17832620|P4|Core Study|Adverse Event, Non-Fatal|0
5164639|NCT01355289|17832621|P3|Core Study|Adverse Event, Non-Fatal|0
5164640|NCT01355289|17832622|P2|Core Study|Adverse Event, Non-Fatal|0
5164641|NCT01355289|17832623|P1|Core Study|Adverse Event, Non-Fatal|1
5164642|NCT01355159|17832675|P2|Overall Study|Early intrauterine fetal death|6
5164643|NCT01355159|17832676|P1|Overall Study|Early intrauterine fetal death|6
5164644|NCT01355159|17832675|P2|Overall Study|Spontaneous abortion (<20 weeks)|15
5164645|NCT01355159|17832676|P1|Overall Study|Spontaneous abortion (<20 weeks)|22
5164646|NCT01355159|17832675|P2|Overall Study|No primary outcome data|11
5164647|NCT01355159|17832676|P1|Overall Study|No primary outcome data|17
5164648|NCT01355159|17832675|P2|Overall Study|Withdrew consent|47
5164649|NCT01355159|17832676|P1|Overall Study|Withdrew consent|39
5164650|NCT01355081|17832733|P3|Overall Study|Non Compliance with Study Medication|0
5164651|NCT01355081|17832734|P2|Overall Study|Non Compliance with Study Medication|1
5164652|NCT01355081|17832735|P1|Overall Study|Non Compliance with Study Medication|0
5164653|NCT01355081|17832733|P3|Overall Study|Lack of Efficacy|1
5164654|NCT01355081|17832734|P2|Overall Study|Lack of Efficacy|1
5164655|NCT01355081|17832735|P1|Overall Study|Lack of Efficacy|2
5164656|NCT01355081|17832733|P3|Overall Study|Withdrawal of Consent|3
5164657|NCT01355081|17832734|P2|Overall Study|Withdrawal of Consent|3
5164658|NCT01355081|17832735|P1|Overall Study|Withdrawal of Consent|2
5164659|NCT01355081|17832733|P3|Overall Study|Lost to Follow-up|1
5164660|NCT01355081|17832734|P2|Overall Study|Lost to Follow-up|0
5164661|NCT01355081|17832735|P1|Overall Study|Lost to Follow-up|0
5164662|NCT01355081|17832733|P3|Overall Study|Major Protocol Deviation|0
5164663|NCT01355081|17832734|P2|Overall Study|Major Protocol Deviation|1
5164664|NCT01355081|17832735|P1|Overall Study|Major Protocol Deviation|0
5164665|NCT01355081|17832733|P3|Overall Study|Pretreatment Event or Adverse Event|6
5164666|NCT01355081|17832734|P2|Overall Study|Pretreatment Event or Adverse Event|4
5164667|NCT01355081|17832735|P1|Overall Study|Pretreatment Event or Adverse Event|3
5164668|NCT01355068|17832758|P2|First Intervention Period|Withdrawal by Subject|1
5164669|NCT01355068|17832759|P1|First Intervention Period|Withdrawal by Subject|0
5164670|NCT01355068|17832758|P2|First Intervention Period|Adverse Event|1
5164671|NCT01355068|17832759|P1|First Intervention Period|Adverse Event|0
5164672|NCT01354964|17832784|P2|Overall Study|Physician Decision|0
5164673|NCT01354964|17832785|P1|Overall Study|Physician Decision|1
5164674|NCT01354964|17832784|P2|Overall Study|IV access issues|1
5164675|NCT01354964|17832785|P1|Overall Study|IV access issues|1
5164676|NCT01354964|17832784|P2|Overall Study|Lost to Follow-up|0
5164677|NCT01354964|17832785|P1|Overall Study|Lost to Follow-up|2
5164678|NCT01354938|17832808|P1|Overall Study|Lost to Follow-up|1
5164679|NCT01354899|17832814|P1|Overall Study|Protocol Violation|1
5164680|NCT01354899|17832814|P1|Overall Study|discharge from the hospital|2
5164681|NCT01354496|17832866|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
5164682|NCT01354496|17832867|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
5164683|NCT01354496|17832868|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
5164684|NCT01354496|17832869|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
5164685|NCT01354496|17832870|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
5164686|NCT01354496|17832871|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
5164687|NCT01354496|17832866|P6|Period 2|Adverse Event|0
5164688|NCT01354496|17832867|P5|Period 2|Adverse Event|0
5164689|NCT01354496|17832868|P4|Period 2|Adverse Event|1
5164690|NCT01354496|17832869|P3|Period 2|Adverse Event|0
5164691|NCT01354496|17832870|P2|Period 2|Adverse Event|0
5164692|NCT01354496|17832871|P1|Period 2|Adverse Event|0
5164693|NCT01354496|17832866|P6|Period 1|Physician Decision|0
5164694|NCT01354496|17832867|P5|Period 1|Physician Decision|0
5164695|NCT01354496|17832868|P4|Period 1|Physician Decision|0
5164696|NCT01354496|17832869|P3|Period 1|Physician Decision|1
5164697|NCT01354496|17832870|P2|Period 1|Physician Decision|0
5164698|NCT01354496|17832871|P1|Period 1|Physician Decision|0
5164699|NCT01354496|17832866|P6|Period 1|Adverse Event|0
5164700|NCT01354496|17832867|P5|Period 1|Adverse Event|0
5164701|NCT01354496|17832868|P4|Period 1|Adverse Event|0
5164702|NCT01354496|17832869|P3|Period 1|Adverse Event|1
5164703|NCT01354496|17832870|P2|Period 1|Adverse Event|0
5164704|NCT01354496|17832871|P1|Period 1|Adverse Event|0
5164705|NCT01354431|17832914|P3|Participants Treated|Withdrawal by Subject|1
5164706|NCT01354431|17832915|P2|Participants Treated|Withdrawal by Subject|2
5164707|NCT01354431|17832916|P1|Participants Treated|Withdrawal by Subject|1
5164708|NCT01354431|17832914|P3|Participants Treated|Adverse Event|4
5164709|NCT01354431|17832915|P2|Participants Treated|Adverse Event|2
5164710|NCT01354431|17832916|P1|Participants Treated|Adverse Event|1
5164711|NCT01354431|17832914|P3|Participants Treated|Death|0
5164712|NCT01354431|17832915|P2|Participants Treated|Death|1
5164713|NCT01354431|17832916|P1|Participants Treated|Death|0
5164714|NCT01354431|17832914|P3|Participants Treated|Study Drug Toxicity|4
5164715|NCT01354431|17832915|P2|Participants Treated|Study Drug Toxicity|7
5164716|NCT01354431|17832916|P1|Participants Treated|Study Drug Toxicity|2
5164717|NCT01354431|17832914|P3|Participants Treated|Disease Progression|41
5164718|NCT01354431|17832915|P2|Participants Treated|Disease Progression|40
5164719|NCT01354431|17832916|P1|Participants Treated|Disease Progression|49
5164720|NCT01354431|17832914|P3|Participants Treated|Continuing Treatment|4
5164721|NCT01354431|17832915|P2|Participants Treated|Continuing Treatment|2
5164722|NCT01354431|17832916|P1|Participants Treated|Continuing Treatment|6
5164723|NCT01354431|17832914|P3|Randomized to Enter Treatment Period|No longer met criteria|0
5164724|NCT01354431|17832915|P2|Randomized to Enter Treatment Period|No longer met criteria|0
5164725|NCT01354431|17832916|P1|Randomized to Enter Treatment Period|No longer met criteria|1
5164726|NCT01354314|17832940|P4|Overall Study|Less than 90% Adherence|4
5164727|NCT01354314|17832941|P3|Overall Study|Less than 90% Adherence|6
5164728|NCT01354314|17832942|P2|Overall Study|Less than 90% Adherence|2
5164729|NCT01354314|17832943|P1|Overall Study|Less than 90% Adherence|4
5164730|NCT01354314|17832940|P4|Overall Study|Protocol Violation|0
5164731|NCT01354314|17832941|P3|Overall Study|Protocol Violation|0
5164732|NCT01354314|17832942|P2|Overall Study|Protocol Violation|1
5164733|NCT01354314|17832943|P1|Overall Study|Protocol Violation|1
5164734|NCT01354314|17832940|P4|Overall Study|Adverse Event|1
5164735|NCT01354314|17832941|P3|Overall Study|Adverse Event|0
5164736|NCT01354314|17832942|P2|Overall Study|Adverse Event|0
5164737|NCT01354314|17832943|P1|Overall Study|Adverse Event|0
5164738|NCT01354314|17832940|P4|Overall Study|Withdrawal by Subject|0
5164739|NCT01354314|17832941|P3|Overall Study|Withdrawal by Subject|1
5164740|NCT01354314|17832942|P2|Overall Study|Withdrawal by Subject|0
5164741|NCT01354314|17832943|P1|Overall Study|Withdrawal by Subject|0
5164742|NCT01354314|17832940|P4|Overall Study|Lost to Follow-up|1
5164743|NCT01354314|17832941|P3|Overall Study|Lost to Follow-up|1
5164744|NCT01354314|17832942|P2|Overall Study|Lost to Follow-up|0
5164745|NCT01354314|17832943|P1|Overall Study|Lost to Follow-up|1
5164746|NCT01354223|17833079|P2|Overall Study|Withdrawal by Subject|1
5164747|NCT01354223|17833080|P1|Overall Study|Withdrawal by Subject|3
5164748|NCT01354132|17833139|P2|1 Month Post Study Medication|Withdrawal by Subject|3
5164749|NCT01354132|17833140|P1|1 Month Post Study Medication|Withdrawal by Subject|1
5164750|NCT01354132|17833139|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
5164751|NCT01354132|17833140|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
5164752|NCT01354132|17833139|P2|Double Blind (Visits 1-7)|Adverse Event|0
5164753|NCT01354132|17833140|P1|Double Blind (Visits 1-7)|Adverse Event|1
5164754|NCT01354132|17833139|P2|Randomization|Withdrawal by Subject|1
5164755|NCT01354132|17833140|P1|Randomization|Withdrawal by Subject|0
5164756|NCT01354132|17833139|P2|Randomization|Physician Decision|0
5164757|NCT01354132|17833140|P1|Randomization|Physician Decision|1
5164758|NCT01354106|17833178|P1|Overall Study|Withdrawal by Subject|2
5164759|NCT01354028|17833184|P2|Overall Study|No quiet alert state|1
5164760|NCT01354028|17833185|P1|Overall Study|No quiet alert state|0
5164761|NCT01354028|17833184|P2|Overall Study|Discharged before study start|2
5164762|NCT01354028|17833185|P1|Overall Study|Discharged before study start|2
5164763|NCT01354028|17833184|P2|Overall Study|Physician Decision|2
5164764|NCT01354028|17833185|P1|Overall Study|Physician Decision|0
5164765|NCT01353963|17833221|P1|Overall Study|Adverse Event|2
5164766|NCT01353911|17833239|P8|Overall Study|Status Not Recorded|0
5164767|NCT01353911|17833240|P7|Overall Study|Status Not Recorded|0
5164768|NCT01353911|17833241|P6|Overall Study|Status Not Recorded|0
5164769|NCT01353911|17833242|P5|Overall Study|Status Not Recorded|0
5164770|NCT01353911|17833243|P4|Overall Study|Status Not Recorded|0
5164771|NCT01353911|17833244|P3|Overall Study|Status Not Recorded|1
5164772|NCT01353911|17833245|P2|Overall Study|Status Not Recorded|0
5164773|NCT01353911|17833246|P1|Overall Study|Status Not Recorded|4
5164774|NCT01353911|17833239|P8|Overall Study|Withdrawal by Subject|9
5164775|NCT01353911|17833240|P7|Overall Study|Withdrawal by Subject|3
5164776|NCT01353911|17833241|P6|Overall Study|Withdrawal by Subject|3
5164777|NCT01353911|17833242|P5|Overall Study|Withdrawal by Subject|2
5164778|NCT01353911|17833243|P4|Overall Study|Withdrawal by Subject|2
5164779|NCT01353911|17833244|P3|Overall Study|Withdrawal by Subject|4
5164780|NCT01353911|17833245|P2|Overall Study|Withdrawal by Subject|3
5164781|NCT01353911|17833246|P1|Overall Study|Withdrawal by Subject|2
5164782|NCT01353911|17833239|P8|Overall Study|Lost to Follow-up|6
5164783|NCT01353911|17833240|P7|Overall Study|Lost to Follow-up|3
5164784|NCT01353911|17833241|P6|Overall Study|Lost to Follow-up|4
5164785|NCT01353911|17833242|P5|Overall Study|Lost to Follow-up|4
5164786|NCT01353911|17833243|P4|Overall Study|Lost to Follow-up|0
5164787|NCT01353911|17833244|P3|Overall Study|Lost to Follow-up|4
5164788|NCT01353911|17833245|P2|Overall Study|Lost to Follow-up|6
5164789|NCT01353911|17833246|P1|Overall Study|Lost to Follow-up|2
5164790|NCT01353898|17833326|P6|Overall Study|Study site terminated|1
5164791|NCT01353898|17833327|P5|Overall Study|Study site terminated|0
5164792|NCT01353898|17833328|P4|Overall Study|Study site terminated|0
5164793|NCT01353898|17833329|P3|Overall Study|Study site terminated|0
5164794|NCT01353898|17833330|P2|Overall Study|Study site terminated|0
5164795|NCT01353898|17833331|P1|Overall Study|Study site terminated|0
5164796|NCT01353859|17833357|P1|Overall Study|Lack of Efficacy|1
5164797|NCT01353859|17833357|P1|Overall Study|Adverse Event|3
5164798|NCT01353703|17833372|P2|Overall Study|Migrated/moved from study area|0
5164799|NCT01353703|17833373|P1|Overall Study|Migrated/moved from study area|1
5164800|NCT01353664|17833419|P1|Overall Study|Disease Progression|16
5164801|NCT01353664|17833419|P1|Overall Study|Other|3
5164802|NCT01353586|17833425|P2|Overall Study|Neurological exam not done|1
5164803|NCT01353586|17833426|P1|Overall Study|Neurological exam not done|0
5164804|NCT01353586|17833425|P2|Overall Study|Never had insertion of study catheter|1
5164805|NCT01353586|17833426|P1|Overall Study|Never had insertion of study catheter|4
5164806|NCT01353586|17833425|P2|Overall Study|Procedure terminated prior to ablation|0
5164807|NCT01353586|17833426|P1|Overall Study|Procedure terminated prior to ablation|3
5164808|NCT01353508|17833444|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5164809|NCT01353508|17833445|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5164810|NCT01353508|17833446|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5164811|NCT01353508|17833447|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
5164812|NCT01353508|17833444|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
5164813|NCT01353508|17833445|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
5164814|NCT01353508|17833446|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
5164815|NCT01353508|17833447|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
5164816|NCT01353274|17833525|P1|Overall Study|No case report form (CRF) collected|28
5164817|NCT01353222|17833535|P2|Overall Study|Site closed research department|0
5164818|NCT01353222|17833536|P1|Overall Study|Site closed research department|1
5164819|NCT01353222|17833535|P2|Overall Study|Study Terminated|37
5164820|NCT01353222|17833536|P1|Overall Study|Study Terminated|31
5164821|NCT01353222|17833535|P2|Overall Study|Withdrawal by Subject|5
5164822|NCT01353222|17833536|P1|Overall Study|Withdrawal by Subject|8
5164823|NCT01353222|17833535|P2|Overall Study|Death|30
5164824|NCT01353222|17833536|P1|Overall Study|Death|30
5164825|NCT01352845|17833579|P2|Overall Study|Death|0
5164826|NCT01352845|17833580|P1|Overall Study|Death|3
5164827|NCT01352845|17833579|P2|Overall Study|Protocol Violation|6
5164828|NCT01352845|17833580|P1|Overall Study|Protocol Violation|12
5164829|NCT01352845|17833579|P2|Overall Study|Other|7
5164830|NCT01352845|17833580|P1|Overall Study|Other|17
5164831|NCT01352845|17833579|P2|Overall Study|Adverse Event|6
5164832|NCT01352845|17833580|P1|Overall Study|Adverse Event|22
5164833|NCT01352845|17833579|P2|Overall Study|Pregnancy|7
5164834|NCT01352845|17833580|P1|Overall Study|Pregnancy|27
5164835|NCT01352845|17833579|P2|Overall Study|No Longer Meets Eligibility Criteria|11
5164836|NCT01352845|17833580|P1|Overall Study|No Longer Meets Eligibility Criteria|24
5164837|NCT01352845|17833579|P2|Overall Study|Withdrawal by Subject|16
5164838|NCT01352845|17833580|P1|Overall Study|Withdrawal by Subject|48
5164839|NCT01352845|17833579|P2|Overall Study|No Longer Willing to Participate|58
5164840|NCT01352845|17833580|P1|Overall Study|No Longer Willing to Participate|205
5164841|NCT01352845|17833579|P2|Overall Study|Lost to Follow-up|92
5164842|NCT01352845|17833580|P1|Overall Study|Lost to Follow-up|313
5164843|NCT01352793|17833669|P2|Overall Study|No longer meets eligibility criteria|15
5164844|NCT01352793|17833670|P1|Overall Study|No longer meets eligibility criteria|25
5164845|NCT01352793|17833669|P2|Overall Study|Randomized but not vaccinated|0
5164846|NCT01352793|17833670|P1|Overall Study|Randomized but not vaccinated|8
5164847|NCT01352793|17833669|P2|Overall Study|Death|0
5164848|NCT01352793|17833670|P1|Overall Study|Death|1
5164849|NCT01352793|17833669|P2|Overall Study|Medication error|2
5164850|NCT01352793|17833670|P1|Overall Study|Medication error|2
5164851|NCT01352793|17833669|P2|Overall Study|Other|7
5164852|NCT01352793|17833670|P1|Overall Study|Other|25
5164853|NCT01352793|17833669|P2|Overall Study|Pregnancy|8
5164854|NCT01352793|17833670|P1|Overall Study|Pregnancy|26
5164855|NCT01352793|17833669|P2|Overall Study|Physician Decision|0
5164856|NCT01352793|17833670|P1|Overall Study|Physician Decision|1
5164857|NCT01352793|17833669|P2|Overall Study|Adverse Event|10
5164858|NCT01352793|17833670|P1|Overall Study|Adverse Event|44
5164859|NCT01352793|17833669|P2|Overall Study|Protocol Violation|23
5164860|NCT01352793|17833670|P1|Overall Study|Protocol Violation|44
5164861|NCT01352793|17833669|P2|Overall Study|Withdrawal by Subject|55
5164862|NCT01352793|17833670|P1|Overall Study|Withdrawal by Subject|120
5164863|NCT01352793|17833669|P2|Overall Study|Lost to Follow-up|125
5164864|NCT01352793|17833670|P1|Overall Study|Lost to Follow-up|289
5164865|NCT01352741|17833694|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
5164866|NCT01352741|17833695|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
5164867|NCT01352741|17833694|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
5164868|NCT01352741|17833695|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
5164869|NCT01352741|17833694|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
5164870|NCT01352741|17833695|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
5164871|NCT01352741|17833694|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
5164872|NCT01352741|17833695|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
5164873|NCT01352741|17833694|P2|Double-blind Comparative Period|Other|2
5164874|NCT01352741|17833695|P1|Double-blind Comparative Period|Other|1
5164875|NCT01352741|17833694|P2|Double-blind Comparative Period|Withdrawal of consent|3
5164876|NCT01352741|17833695|P1|Double-blind Comparative Period|Withdrawal of consent|8
5164877|NCT01352741|17833694|P2|Double-blind Comparative Period|Death|1
5164878|NCT01352741|17833695|P1|Double-blind Comparative Period|Death|0
5164879|NCT01352741|17833694|P2|Double-blind Comparative Period|Lost to Follow-up|0
5164880|NCT01352741|17833695|P1|Double-blind Comparative Period|Lost to Follow-up|1
5164881|NCT01352741|17833694|P2|Double-blind Comparative Period|Adverse Event|17
5164882|NCT01352741|17833695|P1|Double-blind Comparative Period|Adverse Event|16
5164883|NCT01352741|17833694|P2|Double-blind Comparative Period|Lack of Efficacy|3
5164884|NCT01352741|17833695|P1|Double-blind Comparative Period|Lack of Efficacy|0
5164885|NCT01352741|17833694|P2|Double-blind Comparative Period|Protocol Violation|0
5164886|NCT01352741|17833695|P1|Double-blind Comparative Period|Protocol Violation|2
5164887|NCT01352741|17833694|P2|Open-label Tapentadol Titration Period|Other|0
5164888|NCT01352741|17833695|P1|Open-label Tapentadol Titration Period|Other|4
5164889|NCT01352741|17833694|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
5164890|NCT01352741|17833695|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
5164891|NCT01352741|17833694|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
5164892|NCT01352741|17833695|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
5164893|NCT01352741|17833694|P2|Open-label Tapentadol Titration Period|Adverse Event|0
5164894|NCT01352741|17833695|P1|Open-label Tapentadol Titration Period|Adverse Event|34
5164895|NCT01352741|17833694|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
5164896|NCT01352741|17833695|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
5164897|NCT01352741|17833694|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
5164898|NCT01352741|17833695|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
5164899|NCT01352715|17833789|P2|Overall Study|major ineligibility|1
5164900|NCT01352715|17833790|P1|Overall Study|major ineligibility|2
5164901|NCT01352715|17833789|P2|Overall Study|no final visit in closeout period|12
5164902|NCT01352715|17833790|P1|Overall Study|no final visit in closeout period|15
5164903|NCT01352715|17833789|P2|Overall Study|site closure|15
5164904|NCT01352715|17833790|P1|Overall Study|site closure|16
5164905|NCT01352715|17833789|P2|Overall Study|Withdrawal by Subject|8
5164906|NCT01352715|17833790|P1|Overall Study|Withdrawal by Subject|4
5164907|NCT01352715|17833789|P2|Overall Study|Lost to Follow-up|7
5164908|NCT01352715|17833790|P1|Overall Study|Lost to Follow-up|5
5164909|NCT01352715|17833789|P2|Overall Study|Death|3
5164910|NCT01352715|17833790|P1|Overall Study|Death|3
5164911|NCT01352585|17833834|P1|Overall Study|Other|7
5164912|NCT01352585|17833834|P1|Overall Study|Lost to Follow-up|1
5164913|NCT01352585|17833834|P1|Overall Study|Adverse Event|3
5164914|NCT01352507|17833851|P2|Treatment Period 2|Lack of Efficacy|0
5164915|NCT01352507|17833852|P1|Treatment Period 2|Lack of Efficacy|1
5164916|NCT01352507|17833851|P2|Treatment Period 2|Withdrawal by Subject|3
5164917|NCT01352507|17833852|P1|Treatment Period 2|Withdrawal by Subject|4
5164918|NCT01352507|17833851|P2|Treatment Period 2|Entry Criteria Not Met|0
5164919|NCT01352507|17833852|P1|Treatment Period 2|Entry Criteria Not Met|1
5164920|NCT01352507|17833851|P2|Washout Period|Withdrawal by Subject|1
5164921|NCT01352507|17833852|P1|Washout Period|Withdrawal by Subject|0
5164922|NCT01352507|17833851|P2|Treatment Period 1|Physician Decision|0
5164923|NCT01352507|17833852|P1|Treatment Period 1|Physician Decision|1
5164924|NCT01352507|17833851|P2|Treatment Period 1|Withdrawal by Subject|5
5164925|NCT01352507|17833852|P1|Treatment Period 1|Withdrawal by Subject|7
5164926|NCT01352507|17833851|P2|Treatment Period 1|Lost to Follow-up|4
5164927|NCT01352507|17833852|P1|Treatment Period 1|Lost to Follow-up|3
5164928|NCT01352507|17833851|P2|Treatment Period 1|Adverse Event|0
5164929|NCT01352507|17833852|P1|Treatment Period 1|Adverse Event|3
5164930|NCT01352416|17833905|P4|Overall Study|Physician Decision|1
5164931|NCT01352416|17833906|P3|Overall Study|Physician Decision|2
5164932|NCT01352416|17833907|P2|Overall Study|Physician Decision|2
5164933|NCT01352416|17833908|P1|Overall Study|Physician Decision|1
5164934|NCT01352221|17833930|P4|Open-label Phase|Worsening of IBD|0
5164935|NCT01352221|17833931|P3|Open-label Phase|Worsening of IBD|1
5164936|NCT01352221|17833932|P2|Open-label Phase|Worsening of IBD|0
5164937|NCT01352221|17833933|P1|Open-label Phase|Worsening of IBD|0
5164938|NCT01352221|17833930|P4|Open-label Phase|Withdrawal by Subject|6
5164939|NCT01352221|17833931|P3|Open-label Phase|Withdrawal by Subject|1
5164940|NCT01352221|17833932|P2|Open-label Phase|Withdrawal by Subject|0
5164941|NCT01352221|17833933|P1|Open-label Phase|Withdrawal by Subject|0
5164942|NCT01352221|17833930|P4|Open-label Phase|Adverse Event|4
5164943|NCT01352221|17833931|P3|Open-label Phase|Adverse Event|8
5164944|NCT01352221|17833932|P2|Open-label Phase|Adverse Event|0
5164945|NCT01352221|17833933|P1|Open-label Phase|Adverse Event|0
5164946|NCT01352221|17833930|P4|Open-label Phase|Pregnancy|0
5164947|NCT01352221|17833931|P3|Open-label Phase|Pregnancy|1
5164948|NCT01352221|17833932|P2|Open-label Phase|Pregnancy|0
5164949|NCT01352221|17833933|P1|Open-label Phase|Pregnancy|0
5164950|NCT01352221|17833930|P4|Open-label Phase|Physician Decision|1
5164951|NCT01352221|17833931|P3|Open-label Phase|Physician Decision|2
5164952|NCT01352221|17833932|P2|Open-label Phase|Physician Decision|0
5164953|NCT01352221|17833933|P1|Open-label Phase|Physician Decision|0
5164954|NCT01352221|17833930|P4|Double-blind Phase|Protocol Violation|0
5164955|NCT01352221|17833931|P3|Double-blind Phase|Protocol Violation|0
5164956|NCT01352221|17833932|P2|Double-blind Phase|Protocol Violation|1
5164957|NCT01352221|17833933|P1|Double-blind Phase|Protocol Violation|0
5164958|NCT01352221|17833930|P4|Double-blind Phase|Lost to Follow-up|0
5164959|NCT01352221|17833931|P3|Double-blind Phase|Lost to Follow-up|0
5164960|NCT01352221|17833932|P2|Double-blind Phase|Lost to Follow-up|1
5164961|NCT01352221|17833933|P1|Double-blind Phase|Lost to Follow-up|0
5164962|NCT01352221|17833930|P4|Double-blind Phase|Withdrawal by Subject|0
5164963|NCT01352221|17833931|P3|Double-blind Phase|Withdrawal by Subject|0
5164964|NCT01352221|17833932|P2|Double-blind Phase|Withdrawal by Subject|5
5164965|NCT01352221|17833933|P1|Double-blind Phase|Withdrawal by Subject|3
5164966|NCT01352221|17833930|P4|Double-blind Phase|Adverse Event|0
5164967|NCT01352221|17833931|P3|Double-blind Phase|Adverse Event|0
5164968|NCT01352221|17833932|P2|Double-blind Phase|Adverse Event|4
5164969|NCT01352221|17833933|P1|Double-blind Phase|Adverse Event|6
5164970|NCT01352117|17834012|P2|Overall Study|Ineligible (no KS diagnosis)|0
5164971|NCT01352117|17834013|P1|Overall Study|Ineligible (no KS diagnosis)|1
5164972|NCT01352117|17834012|P2|Overall Study|Did not initiate study treatment|0
5164973|NCT01352117|17834013|P1|Overall Study|Did not initiate study treatment|1
5164974|NCT01352117|17834012|P2|Overall Study|Non-adherent to study requirements|1
5164975|NCT01352117|17834013|P1|Overall Study|Non-adherent to study requirements|1
5164976|NCT01352117|17834012|P2|Overall Study|Lost to Follow-up|7
5164977|NCT01352117|17834013|P1|Overall Study|Lost to Follow-up|2
5164978|NCT01352117|17834012|P2|Overall Study|Withdrawal by Subject|0
5164979|NCT01352117|17834013|P1|Overall Study|Withdrawal by Subject|1
5164980|NCT01352117|17834012|P2|Overall Study|Death|16
5164981|NCT01352117|17834013|P1|Overall Study|Death|15
5164982|NCT01351623|17834076|P1|Overall Study|Death|2
5164983|NCT01351623|17834076|P1|Overall Study|Withdrawal by Subject|1
5164984|NCT01351623|17834076|P1|Overall Study|Adverse Event|4
5164985|NCT01351623|17834076|P1|Overall Study|Protocol Violation|2
5164986|NCT01351415|17834102|P2|Overall Study|Never Started|5
5164987|NCT01351415|17834103|P1|Overall Study|Never Started|5
5164988|NCT01351415|17834102|P2|Overall Study|Reason unknown|2
5164989|NCT01351415|17834103|P1|Overall Study|Reason unknown|0
5164990|NCT01351415|17834102|P2|Overall Study|Physician Decision|3
5164991|NCT01351415|17834103|P1|Overall Study|Physician Decision|2
5164992|NCT01351415|17834102|P2|Overall Study|Death|187
5164993|NCT01351415|17834103|P1|Overall Study|Death|190
5164994|NCT01351415|17834102|P2|Overall Study|Lost to Follow-up|7
5164995|NCT01351415|17834103|P1|Overall Study|Lost to Follow-up|5
5164996|NCT01351415|17834102|P2|Overall Study|Trial termination by the Sponsor|19
5164997|NCT01351415|17834103|P1|Overall Study|Trial termination by the Sponsor|28
5164998|NCT01351415|17834102|P2|Overall Study|Withdrawal by Subject|17
5164999|NCT01351415|17834103|P1|Overall Study|Withdrawal by Subject|15
5165000|NCT01351350|17834139|P5|Overall Study|Enrolled but not Treated|0
5165001|NCT01351350|17834140|P4|Overall Study|Enrolled but not Treated|0
5165002|NCT01351350|17834141|P3|Overall Study|Enrolled but not Treated|1
5165003|NCT01351350|17834142|P2|Overall Study|Enrolled but not Treated|0
5165004|NCT01351350|17834143|P1|Overall Study|Enrolled but not Treated|0
5165005|NCT01351350|17834139|P5|Overall Study|Participant Decision|2
5165006|NCT01351350|17834140|P4|Overall Study|Participant Decision|3
5165007|NCT01351350|17834141|P3|Overall Study|Participant Decision|3
5165008|NCT01351350|17834142|P2|Overall Study|Participant Decision|6
5165009|NCT01351350|17834143|P1|Overall Study|Participant Decision|2
5165010|NCT01351350|17834139|P5|Overall Study|Adverse Event|0
5165011|NCT01351350|17834140|P4|Overall Study|Adverse Event|2
5165012|NCT01351350|17834141|P3|Overall Study|Adverse Event|1
5165013|NCT01351350|17834142|P2|Overall Study|Adverse Event|10
5165014|NCT01351350|17834143|P1|Overall Study|Adverse Event|1
5165015|NCT01351350|17834139|P5|Overall Study|Disease Progression|5
5165016|NCT01351350|17834140|P4|Overall Study|Disease Progression|8
5165017|NCT01351350|17834141|P3|Overall Study|Disease Progression|6
5165018|NCT01351350|17834142|P2|Overall Study|Disease Progression|13
5165019|NCT01351350|17834143|P1|Overall Study|Disease Progression|5
5165020|NCT01351025|17834314|P2|Week 24 - 44|unable to get to clinic|1
5165021|NCT01351025|17834315|P1|Week 24 - 44|unable to get to clinic|1
5165022|NCT01351025|17834314|P2|Week 24 - 44|Site closed|1
5165023|NCT01351025|17834315|P1|Week 24 - 44|Site closed|0
5165024|NCT01351025|17834314|P2|Week 24 - 44|Lost to Follow-up|2
5165025|NCT01351025|17834315|P1|Week 24 - 44|Lost to Follow-up|0
5165026|NCT01351025|17834314|P2|Week 0 - 20|Withdrawal by Subject|0
5165027|NCT01351025|17834315|P1|Week 0 - 20|Withdrawal by Subject|1
5165028|NCT01351025|17834314|P2|Week 0 - 20|Lost to Follow-up|1
5165029|NCT01351025|17834315|P1|Week 0 - 20|Lost to Follow-up|2
5165030|NCT01350999|17834348|P3|Overall Study|Difficulty Making it to Study Visit|5
5165031|NCT01350999|17834349|P2|Overall Study|Difficulty Making it to Study Visit|1
5165032|NCT01350999|17834350|P1|Overall Study|Difficulty Making it to Study Visit|1
5165033|NCT01350999|17834348|P3|Overall Study|Voluntary withdrawal|6
5165034|NCT01350999|17834349|P2|Overall Study|Voluntary withdrawal|4
5165035|NCT01350999|17834350|P1|Overall Study|Voluntary withdrawal|3
5165036|NCT01350999|17834348|P3|Overall Study|Adverse Event|10
5165037|NCT01350999|17834349|P2|Overall Study|Adverse Event|9
5165038|NCT01350999|17834350|P1|Overall Study|Adverse Event|4
5165039|NCT01350973|17834388|P3|Overall Study|Voluntary Withdrawal|1
5165040|NCT01350973|17834389|P2|Overall Study|Voluntary Withdrawal|1
5165041|NCT01350973|17834390|P1|Overall Study|Voluntary Withdrawal|2
5165042|NCT01350973|17834388|P3|Overall Study|Adverse Event|7
5165043|NCT01350973|17834389|P2|Overall Study|Adverse Event|7
5165044|NCT01350973|17834390|P1|Overall Study|Adverse Event|4
5165045|NCT01350934|17834431|P2|Extension Study|Withdrawal by Subject|1
5165046|NCT01350934|17834432|P1|Extension Study|Withdrawal by Subject|0
5165047|NCT01350934|17834431|P2|Extension Study|Lack of Efficacy|1
5165048|NCT01350934|17834432|P1|Extension Study|Lack of Efficacy|0
5165049|NCT01350934|17834431|P2|Extension Study|Protocol Violation|1
5165050|NCT01350934|17834432|P1|Extension Study|Protocol Violation|1
5165051|NCT01350934|17834431|P2|Extension Study|Lost to Follow-up|0
5165052|NCT01350934|17834432|P1|Extension Study|Lost to Follow-up|2
5165053|NCT01350934|17834431|P2|Extension Study|Adverse Event|1
5165054|NCT01350934|17834432|P1|Extension Study|Adverse Event|2
5165055|NCT01350934|17834431|P2|Base Study|Non-Compliance With Study Drug|0
5165056|NCT01350934|17834432|P1|Base Study|Non-Compliance With Study Drug|2
5165057|NCT01350934|17834431|P2|Base Study|Withdrawal by Subject|2
5165058|NCT01350934|17834432|P1|Base Study|Withdrawal by Subject|1
5165059|NCT01350934|17834431|P2|Base Study|Protocol Violation|1
5165060|NCT01350934|17834432|P1|Base Study|Protocol Violation|1
5165061|NCT01350934|17834431|P2|Base Study|Lost to Follow-up|0
5165062|NCT01350934|17834432|P1|Base Study|Lost to Follow-up|1
5165063|NCT01350934|17834431|P2|Base Study|Adverse Event|0
5165064|NCT01350934|17834432|P1|Base Study|Adverse Event|6
5165065|NCT01350804|17834454|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
5165066|NCT01350804|17834455|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
5165067|NCT01350804|17834456|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
5165068|NCT01350804|17834457|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
5165069|NCT01350804|17834454|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
5165070|NCT01350804|17834455|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
5165071|NCT01350804|17834456|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
5165072|NCT01350804|17834457|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
5165073|NCT01350804|17834454|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5165074|NCT01350804|17834455|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5165075|NCT01350804|17834456|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
5165076|NCT01350804|17834457|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5165077|NCT01350804|17834454|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
5165078|NCT01350804|17834455|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
5165079|NCT01350804|17834456|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
5165080|NCT01350804|17834457|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
5165081|NCT01350804|17834454|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
5165082|NCT01350804|17834455|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
5165083|NCT01350804|17834456|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
5165084|NCT01350804|17834457|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
5165085|NCT01350804|17834454|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
5165086|NCT01350804|17834455|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
5165087|NCT01350804|17834456|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
5165088|NCT01350804|17834457|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
5165089|NCT01350804|17834454|P4|Core Study|Adverse Event|8
5165090|NCT01350804|17834455|P3|Core Study|Adverse Event|8
5165091|NCT01350804|17834456|P2|Core Study|Adverse Event|10
5165092|NCT01350804|17834457|P1|Core Study|Adverse Event|8
5165093|NCT01350804|17834454|P4|Core Study|Death|0
5165094|NCT01350804|17834455|P3|Core Study|Death|1
5165095|NCT01350804|17834456|P2|Core Study|Death|1
5165096|NCT01350804|17834457|P1|Core Study|Death|1
5165097|NCT01350804|17834454|P4|Core Study|Lack of Efficacy|5
5165098|NCT01350804|17834455|P3|Core Study|Lack of Efficacy|18
5165099|NCT01350804|17834456|P2|Core Study|Lack of Efficacy|19
5165100|NCT01350804|17834457|P1|Core Study|Lack of Efficacy|16
5165101|NCT01350804|17834454|P4|Core Study|Lost to Follow-up|1
5165102|NCT01350804|17834455|P3|Core Study|Lost to Follow-up|2
5165103|NCT01350804|17834456|P2|Core Study|Lost to Follow-up|0
5165104|NCT01350804|17834457|P1|Core Study|Lost to Follow-up|3
5165105|NCT01350804|17834454|P4|Core Study|Physician Decision|3
5165106|NCT01350804|17834455|P3|Core Study|Physician Decision|1
5165107|NCT01350804|17834456|P2|Core Study|Physician Decision|0
5165108|NCT01350804|17834457|P1|Core Study|Physician Decision|1
5165109|NCT01350804|17834454|P4|Core Study|Protocol deviation|0
5165110|NCT01350804|17834455|P3|Core Study|Protocol deviation|1
5165111|NCT01350804|17834456|P2|Core Study|Protocol deviation|0
5165112|NCT01350804|17834457|P1|Core Study|Protocol deviation|1
5165113|NCT01350804|17834454|P4|Core Study|Study terminated by Sponsor|2
5165114|NCT01350804|17834455|P3|Core Study|Study terminated by Sponsor|0
5165115|NCT01350804|17834456|P2|Core Study|Study terminated by Sponsor|0
5165116|NCT01350804|17834457|P1|Core Study|Study terminated by Sponsor|0
5165117|NCT01350804|17834454|P4|Core Study|Withdrawal by Subject|7
5165118|NCT01350804|17834455|P3|Core Study|Withdrawal by Subject|16
5165119|NCT01350804|17834456|P2|Core Study|Withdrawal by Subject|17
5165120|NCT01350804|17834457|P1|Core Study|Withdrawal by Subject|11
5165121|NCT01350544|17834554|P2|Overall Study|Lost to Follow-up|15
5165122|NCT01350544|17834555|P1|Overall Study|Lost to Follow-up|18
5165123|NCT01350544|17834554|P2|Overall Study|Incarceration|0
5165124|NCT01350544|17834555|P1|Overall Study|Incarceration|1
5165125|NCT01350544|17834554|P2|Overall Study|Withdrawal by Subject|1
5165126|NCT01350544|17834555|P1|Overall Study|Withdrawal by Subject|0
5165127|NCT01350544|17834554|P2|Overall Study|Medical Issues|1
5165128|NCT01350544|17834555|P1|Overall Study|Medical Issues|1
5165129|NCT01350544|17834554|P2|Overall Study|Moved out of LA County|2
5165130|NCT01350544|17834555|P1|Overall Study|Moved out of LA County|2
5165131|NCT01350544|17834554|P2|Overall Study|Death|2
5165132|NCT01350544|17834555|P1|Overall Study|Death|1
5165133|NCT01350544|17834554|P2|Overall Study|Administrative Withdrawal|1
5165134|NCT01350544|17834555|P1|Overall Study|Administrative Withdrawal|0
5165135|NCT01350505|17834561|P1|Overall Study|Lost to Follow-up|4
5165136|NCT01350492|17834567|P2|Post Intervention Follow-Up|Withdrawal by Subject|1
5165137|NCT01350492|17834568|P1|Post Intervention Follow-Up|Withdrawal by Subject|0
5165138|NCT01350492|17834567|P2|Post Intervention Follow-Up|Lost to Follow-up|1
5165139|NCT01350492|17834568|P1|Post Intervention Follow-Up|Lost to Follow-up|6
5165140|NCT01350492|17834567|P2|Intervention|Withdrawal by Subject|1
5165141|NCT01350492|17834568|P1|Intervention|Withdrawal by Subject|3
5165142|NCT01350492|17834567|P2|Intervention|Lost to Follow-up|5
5165143|NCT01350492|17834568|P1|Intervention|Lost to Follow-up|2
5165144|NCT01350414|17834610|P1|Overall Study|Physician Decision|2
5165145|NCT01350414|17834610|P1|Overall Study|Withdrawal by Subject|4
5165146|NCT01350414|17834610|P1|Overall Study|Lost to Follow-up|13
5165147|NCT01350271|17834659|P3|Overall Study|Lost to Follow-up|26
5165148|NCT01350271|17834660|P2|Overall Study|Lost to Follow-up|17
5165149|NCT01350271|17834661|P1|Overall Study|Lost to Follow-up|21
5165150|NCT01350141|17834703|P3|Overall Study|Randomized but not treated|0
5165151|NCT01350141|17834704|P2|Overall Study|Randomized but not treated|0
5165152|NCT01350141|17834705|P1|Overall Study|Randomized but not treated|1
5165153|NCT01350141|17834703|P3|Overall Study|Withdrawal by Subject|0
5165154|NCT01350141|17834704|P2|Overall Study|Withdrawal by Subject|0
5165155|NCT01350141|17834705|P1|Overall Study|Withdrawal by Subject|1
5165156|NCT01350141|17834703|P3|Overall Study|Lost to Follow-up|1
5165157|NCT01350141|17834704|P2|Overall Study|Lost to Follow-up|0
5165158|NCT01350141|17834705|P1|Overall Study|Lost to Follow-up|1
5165159|NCT01350128|17834739|P1|Overall Study|Lost to Follow-up|2
5165160|NCT01350128|17834739|P1|Overall Study|Physician Decision|1
5165161|NCT01350128|17834739|P1|Overall Study|Protocol discontinuation criteria|8
5165162|NCT01350128|17834739|P1|Overall Study|Withdrawal by Subject|3
5165163|NCT01350115|17834803|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
5165164|NCT01350115|17834804|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
5165165|NCT01350115|17834803|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
5165166|NCT01350115|17834804|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
5165167|NCT01350115|17834803|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
5165168|NCT01350115|17834804|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
5165169|NCT01350102|17834820|P4|Overall Study|Adverse Event|0
5165170|NCT01350102|17834821|P3|Overall Study|Adverse Event|1
5165171|NCT01350102|17834822|P2|Overall Study|Adverse Event|0
5165172|NCT01350102|17834823|P1|Overall Study|Adverse Event|0
5165173|NCT01349959|17834860|P1|Overall Study|Adverse Event|7
5165174|NCT01349907|17834901|P2|Overall Study|Administrative|1
5165175|NCT01349907|17834902|P1|Overall Study|Administrative|1
5165176|NCT01349907|17834901|P2|Overall Study|Protocol Violation|13
5165177|NCT01349907|17834902|P1|Overall Study|Protocol Violation|33
5165178|NCT01349907|17834901|P2|Overall Study|Withdrawal by Subject|8
5165179|NCT01349907|17834902|P1|Overall Study|Withdrawal by Subject|30
5165180|NCT01349907|17834901|P2|Overall Study|Lost to Follow-up|6
5165181|NCT01349907|17834902|P1|Overall Study|Lost to Follow-up|25
5165182|NCT01349907|17834901|P2|Overall Study|Treatment failure|4
5165183|NCT01349907|17834902|P1|Overall Study|Treatment failure|13
5165184|NCT01349907|17834901|P2|Overall Study|Adverse Event|11
5165185|NCT01349907|17834902|P1|Overall Study|Adverse Event|37
5165186|NCT01349829|17834940|P2|Overall Study|Migrated/moved|7
5165187|NCT01349829|17834941|P1|Overall Study|Migrated/moved|2
5165188|NCT01349829|17834940|P2|Overall Study|Consent withdrawal|8
5165189|NCT01349829|17834941|P1|Overall Study|Consent withdrawal|3
5165190|NCT01349829|17834940|P2|Overall Study|Lost to Follow-up|8
5165191|NCT01349829|17834941|P1|Overall Study|Lost to Follow-up|4
5165192|NCT01349816|17834959|P1|Overall Study|Protocol-specified criteria|8
5165193|NCT01349816|17834959|P1|Overall Study|Protocol Violation|1
5165194|NCT01349816|17834959|P1|Overall Study|Lost to Follow-up|2
5165195|NCT01349816|17834959|P1|Overall Study|Adverse Event|14
5165196|NCT01349816|17834959|P1|Overall Study|Physician Decision|1
5165197|NCT01349816|17834959|P1|Overall Study|Withdrawal by Subject|4
5165198|NCT01349803|17835025|P4|Overall Study|Protocol-specified criteria|0
5165199|NCT01349803|17835026|P3|Overall Study|Protocol-specified criteria|3
5165200|NCT01349803|17835027|P2|Overall Study|Protocol-specified criteria|1
5165201|NCT01349803|17835028|P1|Overall Study|Protocol-specified criteria|0
5165202|NCT01349803|17835025|P4|Overall Study|Withdrawal by Subject|0
5165203|NCT01349803|17835026|P3|Overall Study|Withdrawal by Subject|0
5165204|NCT01349803|17835027|P2|Overall Study|Withdrawal by Subject|0
5165205|NCT01349803|17835028|P1|Overall Study|Withdrawal by Subject|1
5165206|NCT01349803|17835025|P4|Overall Study|Adverse Event|2
5165207|NCT01349803|17835026|P3|Overall Study|Adverse Event|0
5165208|NCT01349803|17835027|P2|Overall Study|Adverse Event|0
5165209|NCT01349803|17835028|P1|Overall Study|Adverse Event|0
5165210|NCT01349790|17835098|P1|Overall Study|Lost to Follow-up|1
5165211|NCT01349790|17835098|P1|Overall Study|Adverse Event|1
5165212|NCT01349790|17835098|P1|Overall Study|Withdrawal by Patient|2
5165213|NCT01349790|17835098|P1|Overall Study|Death|2
5165214|NCT01349790|17835098|P1|Overall Study|Investigator Judgement|3
5165215|NCT01349673|17835117|P1|Overall Study|Lack of Efficacy|8
5165216|NCT01349673|17835117|P1|Overall Study|Study Terminated By Sponsor|50
5165217|NCT01349673|17835117|P1|Overall Study|Adverse Event|17
5165218|NCT01349673|17835117|P1|Overall Study|Lost to Follow-up|6
5165219|NCT01349673|17835117|P1|Overall Study|Withdrawal by Subject|21
5165220|NCT01349673|17835117|P1|Overall Study|Site Closure|10
5165221|NCT01349673|17835117|P1|Overall Study|No Longer Qualified For Study|1
5165222|NCT01349673|17835117|P1|Overall Study|Progression Of Disease Past 40 cm|1
5165223|NCT01349660|17835127|P3|Overall Study|Declining Performance Status|1
5165224|NCT01349660|17835128|P2|Overall Study|Declining Performance Status|0
5165225|NCT01349660|17835129|P1|Overall Study|Declining Performance Status|0
5165226|NCT01349660|17835127|P3|Overall Study|Study Compliance|1
5165227|NCT01349660|17835128|P2|Overall Study|Study Compliance|0
5165228|NCT01349660|17835129|P1|Overall Study|Study Compliance|0
5165229|NCT01349660|17835127|P3|Overall Study|Non-Permitted Interventions|2
5165230|NCT01349660|17835128|P2|Overall Study|Non-Permitted Interventions|0
5165231|NCT01349660|17835129|P1|Overall Study|Non-Permitted Interventions|0
5165232|NCT01349660|17835127|P3|Overall Study|Death|0
5165233|NCT01349660|17835128|P2|Overall Study|Death|1
5165234|NCT01349660|17835129|P1|Overall Study|Death|1
5165235|NCT01349660|17835127|P3|Overall Study|Withdrawal by Subject|9
5165236|NCT01349660|17835128|P2|Overall Study|Withdrawal by Subject|0
5165237|NCT01349660|17835129|P1|Overall Study|Withdrawal by Subject|2
5165238|NCT01349660|17835127|P3|Overall Study|Adverse Event|12
5165239|NCT01349660|17835128|P2|Overall Study|Adverse Event|1
5165240|NCT01349660|17835129|P1|Overall Study|Adverse Event|1
5165241|NCT01349660|17835127|P3|Overall Study|Disease Progression|50
5165242|NCT01349660|17835128|P2|Overall Study|Disease Progression|4
5165243|NCT01349660|17835129|P1|Overall Study|Disease Progression|2
5165244|NCT01349660|17835127|P3|Overall Study|Still Receiving Study Treatment|1
5165245|NCT01349660|17835128|P2|Overall Study|Still Receiving Study Treatment|0
5165246|NCT01349660|17835129|P1|Overall Study|Still Receiving Study Treatment|0
5165247|NCT01349595|17835147|P2|Overall Study|Lack of funding|2
5165248|NCT01349595|17835148|P1|Overall Study|Lack of funding|2
5165249|NCT01349569|17835154|P1|Overall Study|Lack of Efficacy|4
5165250|NCT01349465|17835175|P2|Overall Study|Subject Ineligible To Continue The Trial|19
5165251|NCT01349465|17835176|P1|Overall Study|Subject Ineligible To Continue The Trial|0
5165252|NCT01349465|17835175|P2|Overall Study|Withdrawal by Subject|2
5165253|NCT01349465|17835176|P1|Overall Study|Withdrawal by Subject|4
5165254|NCT01349465|17835175|P2|Overall Study|Lost to Follow-up|1
5165255|NCT01349465|17835176|P1|Overall Study|Lost to Follow-up|10
5165256|NCT01349465|17835175|P2|Overall Study|Death|0
5165257|NCT01349465|17835176|P1|Overall Study|Death|3
5165258|NCT01349465|17835175|P2|Overall Study|Adverse Event|0
5165259|NCT01349465|17835176|P1|Overall Study|Adverse Event|1
5165260|NCT01349192|17835197|P2|Overall Study|Failure to adhere to Protocol|0
5165261|NCT01349192|17835198|P1|Overall Study|Failure to adhere to Protocol|2
5165262|NCT01349192|17835197|P2|Overall Study|Lost to Follow-up|3
5165263|NCT01349192|17835198|P1|Overall Study|Lost to Follow-up|1
5165264|NCT01349192|17835197|P2|Overall Study|Withdrawal by Subject|2
5165265|NCT01349192|17835198|P1|Overall Study|Withdrawal by Subject|0
5165266|NCT01349192|17835197|P2|Overall Study|Protocol Violation|1
5165267|NCT01349192|17835198|P1|Overall Study|Protocol Violation|0
5165268|NCT01349049|17835230|P9|Overall Study|Withdrawal by Subject|6
5165269|NCT01349049|17835231|P8|Overall Study|Withdrawal by Subject|0
5165270|NCT01349049|17835232|P7|Overall Study|Withdrawal by Subject|0
5165271|NCT01349049|17835233|P6|Overall Study|Withdrawal by Subject|0
5165272|NCT01349049|17835234|P5|Overall Study|Withdrawal by Subject|0
5165273|NCT01349049|17835235|P4|Overall Study|Withdrawal by Subject|0
5165274|NCT01349049|17835236|P3|Overall Study|Withdrawal by Subject|0
5165275|NCT01349049|17835237|P2|Overall Study|Withdrawal by Subject|0
5165276|NCT01349049|17835238|P1|Overall Study|Withdrawal by Subject|0
5165277|NCT01349049|17835230|P9|Overall Study|Non-compliance|0
5165278|NCT01349049|17835231|P8|Overall Study|Non-compliance|0
5165279|NCT01349049|17835232|P7|Overall Study|Non-compliance|0
5165280|NCT01349049|17835233|P6|Overall Study|Non-compliance|0
5165281|NCT01349049|17835234|P5|Overall Study|Non-compliance|0
5165282|NCT01349049|17835235|P4|Overall Study|Non-compliance|1
5165283|NCT01349049|17835236|P3|Overall Study|Non-compliance|0
5165284|NCT01349049|17835237|P2|Overall Study|Non-compliance|0
5165285|NCT01349049|17835238|P1|Overall Study|Non-compliance|0
5165286|NCT01349049|17835230|P9|Overall Study|Death|5
5165287|NCT01349049|17835231|P8|Overall Study|Death|1
5165288|NCT01349049|17835232|P7|Overall Study|Death|0
5165289|NCT01349049|17835233|P6|Overall Study|Death|0
5165290|NCT01349049|17835234|P5|Overall Study|Death|0
5165291|NCT01349049|17835235|P4|Overall Study|Death|0
5165292|NCT01349049|17835236|P3|Overall Study|Death|0
5165293|NCT01349049|17835237|P2|Overall Study|Death|0
5165294|NCT01349049|17835238|P1|Overall Study|Death|0
5165295|NCT01349049|17835230|P9|Overall Study|Other|4
5165296|NCT01349049|17835231|P8|Overall Study|Other|0
5165297|NCT01349049|17835232|P7|Overall Study|Other|0
5165298|NCT01349049|17835233|P6|Overall Study|Other|1
5165299|NCT01349049|17835234|P5|Overall Study|Other|0
5165300|NCT01349049|17835235|P4|Overall Study|Other|0
5165301|NCT01349049|17835236|P3|Overall Study|Other|0
5165302|NCT01349049|17835237|P2|Overall Study|Other|0
5165303|NCT01349049|17835238|P1|Overall Study|Other|0
5165304|NCT01349049|17835230|P9|Overall Study|Hematopoietic stem cell transplant|0
5165305|NCT01349049|17835231|P8|Overall Study|Hematopoietic stem cell transplant|1
5165306|NCT01349049|17835232|P7|Overall Study|Hematopoietic stem cell transplant|1
5165307|NCT01349049|17835233|P6|Overall Study|Hematopoietic stem cell transplant|0
5165308|NCT01349049|17835234|P5|Overall Study|Hematopoietic stem cell transplant|1
5165309|NCT01349049|17835235|P4|Overall Study|Hematopoietic stem cell transplant|0
5165310|NCT01349049|17835236|P3|Overall Study|Hematopoietic stem cell transplant|0
5165311|NCT01349049|17835237|P2|Overall Study|Hematopoietic stem cell transplant|0
5165312|NCT01349049|17835238|P1|Overall Study|Hematopoietic stem cell transplant|0
5165313|NCT01349049|17835230|P9|Overall Study|Protocol Violation|1
5165314|NCT01349049|17835231|P8|Overall Study|Protocol Violation|0
5165315|NCT01349049|17835232|P7|Overall Study|Protocol Violation|0
5165316|NCT01349049|17835233|P6|Overall Study|Protocol Violation|0
5165317|NCT01349049|17835234|P5|Overall Study|Protocol Violation|0
5165318|NCT01349049|17835235|P4|Overall Study|Protocol Violation|0
5165319|NCT01349049|17835236|P3|Overall Study|Protocol Violation|0
5165320|NCT01349049|17835237|P2|Overall Study|Protocol Violation|0
5165321|NCT01349049|17835238|P1|Overall Study|Protocol Violation|0
5165322|NCT01349049|17835230|P9|Overall Study|Physician Decision|2
5165323|NCT01349049|17835231|P8|Overall Study|Physician Decision|0
5165324|NCT01349049|17835232|P7|Overall Study|Physician Decision|0
5165325|NCT01349049|17835233|P6|Overall Study|Physician Decision|0
5165326|NCT01349049|17835234|P5|Overall Study|Physician Decision|0
5165327|NCT01349049|17835235|P4|Overall Study|Physician Decision|0
5165328|NCT01349049|17835236|P3|Overall Study|Physician Decision|0
5165329|NCT01349049|17835237|P2|Overall Study|Physician Decision|1
5165330|NCT01349049|17835238|P1|Overall Study|Physician Decision|0
5165331|NCT01349049|17835230|P9|Overall Study|Adverse Event|4
5165332|NCT01349049|17835231|P8|Overall Study|Adverse Event|0
5165333|NCT01349049|17835232|P7|Overall Study|Adverse Event|1
5165334|NCT01349049|17835233|P6|Overall Study|Adverse Event|3
5165335|NCT01349049|17835234|P5|Overall Study|Adverse Event|0
5165336|NCT01349049|17835235|P4|Overall Study|Adverse Event|0
5165337|NCT01349049|17835236|P3|Overall Study|Adverse Event|0
5165338|NCT01349049|17835237|P2|Overall Study|Adverse Event|1
5165339|NCT01349049|17835238|P1|Overall Study|Adverse Event|0
5165340|NCT01349049|17835230|P9|Overall Study|Disease progression|33
5165341|NCT01349049|17835231|P8|Overall Study|Disease progression|2
5165342|NCT01349049|17835232|P7|Overall Study|Disease progression|3
5165343|NCT01349049|17835233|P6|Overall Study|Disease progression|2
5165344|NCT01349049|17835234|P5|Overall Study|Disease progression|2
5165345|NCT01349049|17835235|P4|Overall Study|Disease progression|2
5165346|NCT01349049|17835236|P3|Overall Study|Disease progression|3
5165347|NCT01349049|17835237|P2|Overall Study|Disease progression|5
5165348|NCT01349049|17835238|P1|Overall Study|Disease progression|3
5165349|NCT01349036|17835292|P2|Overall Study|Withdrawal by Subject|2
5165350|NCT01349036|17835293|P1|Overall Study|Withdrawal by Subject|0
5165351|NCT01349036|17835292|P2|Overall Study|Other|0
5165352|NCT01349036|17835293|P1|Overall Study|Other|1
5165353|NCT01349036|17835292|P2|Overall Study|Disease progression|22
5165354|NCT01349036|17835293|P1|Overall Study|Disease progression|13
5165355|NCT01348854|17835311|P2|Overall Study|Withdrawal by Subject|0
5165356|NCT01348854|17835312|P1|Overall Study|Withdrawal by Subject|1
5165357|NCT01348854|17835311|P2|Overall Study|Lost to Follow-up|1
5165358|NCT01348854|17835312|P1|Overall Study|Lost to Follow-up|2
5165359|NCT01348789|17835320|P1|Overall Study|Withdrawal by Subject|2
5165360|NCT01348789|17835320|P1|Overall Study|Protocol Violation|2
5165361|NCT01348776|17835331|P1|Overall Study|Lost to Follow-up|3
5165362|NCT01348763|17835344|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
5165363|NCT01348763|17835344|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
5165364|NCT01348698|17835349|P1|Overall Study|PI decision to close study|68
5165365|NCT01348698|17835349|P1|Overall Study|Death|3
5165366|NCT01348698|17835349|P1|Overall Study|Does not meet lesion size criteria|1
5165367|NCT01348542|17835374|P2|Overall Study|Withdrawal by Subject|0
5165368|NCT01348542|17835375|P1|Overall Study|Withdrawal by Subject|3
5165369|NCT01348490|17835391|P1|Overall Study|Other Unspecified|8
5165370|NCT01348490|17835391|P1|Overall Study|Termination of clinical trial by sponsor|1
5165371|NCT01348490|17835391|P1|Overall Study|Lost to Follow-up|1
5165372|NCT01348490|17835391|P1|Overall Study|Disease progression|3
5165373|NCT01348490|17835391|P1|Overall Study|Consent withdrawn|7
5165374|NCT01348490|17835391|P1|Overall Study|Adverse Event|3
5165375|NCT01348490|17835391|P1|Overall Study|Death|1
5165376|NCT01348425|17835449|P2|Overall Study|Imaging was not taken.|1
5165377|NCT01348425|17835450|P1|Overall Study|Imaging was not taken.|1
5165378|NCT01348347|17835458|P3|Overall Study|Progressive disease|5
5165379|NCT01348347|17835459|P2|Overall Study|Progressive disease|5
5165380|NCT01348347|17835460|P1|Overall Study|Progressive disease|2
5165381|NCT01348347|17835458|P3|Overall Study|Withdrawal by Subject|1
5165382|NCT01348347|17835459|P2|Overall Study|Withdrawal by Subject|1
5165383|NCT01348347|17835460|P1|Overall Study|Withdrawal by Subject|1
5165384|NCT01348165|17835491|P7|Overall Study|Adverse Event|1
5165385|NCT01348165|17835492|P6|Overall Study|Adverse Event|0
5165386|NCT01348165|17835493|P5|Overall Study|Adverse Event|0
5165387|NCT01348165|17835494|P4|Overall Study|Adverse Event|0
5165388|NCT01348165|17835495|P3|Overall Study|Adverse Event|0
5165389|NCT01348165|17835496|P2|Overall Study|Adverse Event|0
5165390|NCT01348165|17835497|P1|Overall Study|Adverse Event|0
5165391|NCT01348139|17835626|P6|Period 1|Adverse Event|0
5165392|NCT01348139|17835627|P5|Period 1|Adverse Event|0
5165393|NCT01348139|17835628|P4|Period 1|Adverse Event|0
5165394|NCT01348139|17835629|P3|Period 1|Adverse Event|0
5165395|NCT01348139|17835630|P2|Period 1|Adverse Event|0
5165396|NCT01348139|17835631|P1|Period 1|Adverse Event|1
5165397|NCT01348100|17835712|P7|Overall Study|Administrative Problems|1
5165398|NCT01348100|17835713|P6|Overall Study|Administrative Problems|1
5165399|NCT01348100|17835714|P5|Overall Study|Administrative Problems|0
5165400|NCT01348100|17835715|P4|Overall Study|Administrative Problems|0
5165401|NCT01348100|17835716|P3|Overall Study|Administrative Problems|0
5165402|NCT01348100|17835717|P2|Overall Study|Administrative Problems|0
5165403|NCT01348100|17835718|P1|Overall Study|Administrative Problems|0
5165404|NCT01348100|17835712|P7|Overall Study|Lost to Follow-up|1
5165405|NCT01348100|17835713|P6|Overall Study|Lost to Follow-up|0
5165406|NCT01348100|17835714|P5|Overall Study|Lost to Follow-up|0
5165407|NCT01348100|17835715|P4|Overall Study|Lost to Follow-up|0
5165408|NCT01348100|17835716|P3|Overall Study|Lost to Follow-up|0
5165409|NCT01348100|17835717|P2|Overall Study|Lost to Follow-up|0
5165410|NCT01348100|17835718|P1|Overall Study|Lost to Follow-up|0
5165411|NCT01348100|17835712|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
5165412|NCT01348100|17835713|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
5165413|NCT01348100|17835714|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
5165414|NCT01348100|17835715|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
5165415|NCT01348100|17835716|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
5165416|NCT01348100|17835717|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5165417|NCT01348100|17835718|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
5165418|NCT01348100|17835712|P7|Overall Study|Protocol Deviation|0
5165419|NCT01348100|17835713|P6|Overall Study|Protocol Deviation|0
5165420|NCT01348100|17835714|P5|Overall Study|Protocol Deviation|0
5165421|NCT01348100|17835715|P4|Overall Study|Protocol Deviation|1
5165422|NCT01348100|17835716|P3|Overall Study|Protocol Deviation|0
5165423|NCT01348100|17835717|P2|Overall Study|Protocol Deviation|0
5165424|NCT01348100|17835718|P1|Overall Study|Protocol Deviation|0
5165425|NCT01348100|17835712|P7|Overall Study|Subject Withdrew Consent|1
5165426|NCT01348100|17835713|P6|Overall Study|Subject Withdrew Consent|0
5165427|NCT01348100|17835714|P5|Overall Study|Subject Withdrew Consent|1
5165428|NCT01348100|17835715|P4|Overall Study|Subject Withdrew Consent|0
5165429|NCT01348100|17835716|P3|Overall Study|Subject Withdrew Consent|2
5165430|NCT01348100|17835717|P2|Overall Study|Subject Withdrew Consent|0
5165431|NCT01348100|17835718|P1|Overall Study|Subject Withdrew Consent|0
5165432|NCT01348087|17835763|P1|Overall Study|Adverse Event|25
5165433|NCT01348087|17835763|P1|Overall Study|Subject withdrew consent|7
5165434|NCT01348087|17835763|P1|Overall Study|Lost to Follow-up|1
5165435|NCT01348087|17835763|P1|Overall Study|protocol deviation|1
5165436|NCT01348087|17835763|P1|Overall Study|Administrative problems|79
5165437|NCT01348087|17835763|P1|Overall Study|Unsatisfactory therapeutic effect|35
5165438|NCT01347931|17835777|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
5165439|NCT01347879|17835789|P2|Overall Study|Other|3
5165440|NCT01347879|17835790|P1|Overall Study|Other|2
5165441|NCT01347879|17835789|P2|Overall Study|Withdrawal by Subject|2
5165442|NCT01347879|17835790|P1|Overall Study|Withdrawal by Subject|3
5165443|NCT01347879|17835789|P2|Overall Study|Lost to Follow-up|0
5165444|NCT01347879|17835790|P1|Overall Study|Lost to Follow-up|2
5165445|NCT01347879|17835789|P2|Overall Study|Adverse Event|12
5165446|NCT01347879|17835790|P1|Overall Study|Adverse Event|0
5165447|NCT01347866|17835839|P17|Overall Study|Subject refused further follow-up|2
5165448|NCT01347866|17835840|P16|Overall Study|Subject refused further follow-up|0
5165449|NCT01347866|17835841|P15|Overall Study|Subject refused further follow-up|1
5165450|NCT01347866|17835842|P14|Overall Study|Subject refused further follow-up|3
5165451|NCT01347866|17835843|P13|Overall Study|Subject refused further follow-up|1
5165452|NCT01347866|17835844|P12|Overall Study|Subject refused further follow-up|0
5165453|NCT01347866|17835845|P11|Overall Study|Subject refused further follow-up|0
5165454|NCT01347866|17835846|P10|Overall Study|Subject refused further follow-up|1
5165455|NCT01347866|17835847|P9|Overall Study|Subject refused further follow-up|4
5165456|NCT01347866|17835848|P8|Overall Study|Subject refused further follow-up|0
5165457|NCT01347866|17835849|P7|Overall Study|Subject refused further follow-up|0
5165458|NCT01347866|17835850|P6|Overall Study|Subject refused further follow-up|1
5165459|NCT01347866|17835851|P5|Overall Study|Subject refused further follow-up|0
5165460|NCT01347866|17835852|P4|Overall Study|Subject refused further follow-up|2
5165461|NCT01347866|17835853|P3|Overall Study|Subject refused further follow-up|0
5165462|NCT01347866|17835854|P2|Overall Study|Subject refused further follow-up|0
5165463|NCT01347866|17835855|P1|Overall Study|Subject refused further follow-up|2
5165464|NCT01347866|17835839|P17|Overall Study|Other|0
5165465|NCT01347866|17835840|P16|Overall Study|Other|3
5165466|NCT01347866|17835841|P15|Overall Study|Other|2
5165467|NCT01347866|17835842|P14|Overall Study|Other|4
5165468|NCT01347866|17835843|P13|Overall Study|Other|4
5165469|NCT01347866|17835844|P12|Overall Study|Other|3
5165470|NCT01347866|17835845|P11|Overall Study|Other|0
5165471|NCT01347866|17835846|P10|Overall Study|Other|5
5165472|NCT01347866|17835847|P9|Overall Study|Other|22
5165473|NCT01347866|17835848|P8|Overall Study|Other|3
5165474|NCT01347866|17835849|P7|Overall Study|Other|5
5165475|NCT01347866|17835850|P6|Overall Study|Other|0
5165476|NCT01347866|17835851|P5|Overall Study|Other|5
5165477|NCT01347866|17835852|P4|Overall Study|Other|4
5165478|NCT01347866|17835853|P3|Overall Study|Other|1
5165479|NCT01347866|17835854|P2|Overall Study|Other|1
5165480|NCT01347866|17835855|P1|Overall Study|Other|3
5165481|NCT01347866|17835839|P17|Overall Study|Lost to Follow-up|0
5165482|NCT01347866|17835840|P16|Overall Study|Lost to Follow-up|0
5165483|NCT01347866|17835841|P15|Overall Study|Lost to Follow-up|0
5165484|NCT01347866|17835842|P14|Overall Study|Lost to Follow-up|0
5165485|NCT01347866|17835843|P13|Overall Study|Lost to Follow-up|0
5165486|NCT01347866|17835844|P12|Overall Study|Lost to Follow-up|0
5165487|NCT01347866|17835845|P11|Overall Study|Lost to Follow-up|0
5165488|NCT01347866|17835846|P10|Overall Study|Lost to Follow-up|0
5165489|NCT01347866|17835847|P9|Overall Study|Lost to Follow-up|1
5165490|NCT01347866|17835848|P8|Overall Study|Lost to Follow-up|1
5165491|NCT01347866|17835849|P7|Overall Study|Lost to Follow-up|0
5165492|NCT01347866|17835850|P6|Overall Study|Lost to Follow-up|0
5165493|NCT01347866|17835851|P5|Overall Study|Lost to Follow-up|0
5165494|NCT01347866|17835852|P4|Overall Study|Lost to Follow-up|0
5165495|NCT01347866|17835853|P3|Overall Study|Lost to Follow-up|0
5165496|NCT01347866|17835854|P2|Overall Study|Lost to Follow-up|0
5165497|NCT01347866|17835855|P1|Overall Study|Lost to Follow-up|0
5165498|NCT01347866|17835839|P17|Overall Study|Death|0
5165499|NCT01347866|17835840|P16|Overall Study|Death|1
5165500|NCT01347866|17835841|P15|Overall Study|Death|0
5165501|NCT01347866|17835842|P14|Overall Study|Death|0
5165502|NCT01347866|17835843|P13|Overall Study|Death|2
5165503|NCT01347866|17835844|P12|Overall Study|Death|1
5165504|NCT01347866|17835845|P11|Overall Study|Death|3
5165505|NCT01347866|17835846|P10|Overall Study|Death|1
5165506|NCT01347866|17835847|P9|Overall Study|Death|4
5165507|NCT01347866|17835848|P8|Overall Study|Death|0
5165508|NCT01347866|17835849|P7|Overall Study|Death|1
5165509|NCT01347866|17835850|P6|Overall Study|Death|2
5165510|NCT01347866|17835851|P5|Overall Study|Death|2
5165511|NCT01347866|17835852|P4|Overall Study|Death|1
5165512|NCT01347866|17835853|P3|Overall Study|Death|0
5165513|NCT01347866|17835854|P2|Overall Study|Death|0
5165514|NCT01347866|17835855|P1|Overall Study|Death|0
5165515|NCT01347840|17836229|P1|Overall Study|Withdrawal by Subject|1
5165516|NCT01347762|17836256|P4|Overall Study|Withdrawal by Subject|3
5165517|NCT01347762|17836257|P3|Overall Study|Withdrawal by Subject|3
5165518|NCT01347762|17836258|P2|Overall Study|Withdrawal by Subject|1
5165519|NCT01347762|17836259|P1|Overall Study|Withdrawal by Subject|4
5165520|NCT01347762|17836256|P4|Overall Study|Lost to Follow-up|5
5165521|NCT01347762|17836257|P3|Overall Study|Lost to Follow-up|6
5165522|NCT01347762|17836258|P2|Overall Study|Lost to Follow-up|1
5165523|NCT01347762|17836259|P1|Overall Study|Lost to Follow-up|0
5165524|NCT01347710|17836285|P1|Overall Study|Other|3
5165525|NCT01347710|17836285|P1|Overall Study|Physician Decision|2
5165526|NCT01347710|17836285|P1|Overall Study|Lost to Follow-up|1
5165527|NCT01347710|17836285|P1|Overall Study|issue with vitals prior to dosing|1
5165528|NCT01347710|17836285|P1|Overall Study|Angio or SPECT not completed|18
5165529|NCT01347710|17836285|P1|Overall Study|Adverse Event|4
5165530|NCT01347710|17836285|P1|Overall Study|Withdrawal by Subject|2
5165531|NCT01347580|17836307|P2|Overall Study|Had other reason|6
5165532|NCT01347580|17836308|P1|Overall Study|Had other reason|9
5165533|NCT01347580|17836307|P2|Overall Study|Lost to Follow-up|1
5165534|NCT01347580|17836308|P1|Overall Study|Lost to Follow-up|3
5165535|NCT01347580|17836307|P2|Overall Study|Protocol Violation|7
5165536|NCT01347580|17836308|P1|Overall Study|Protocol Violation|10
5165537|NCT01347580|17836307|P2|Overall Study|Death|19
5165538|NCT01347580|17836308|P1|Overall Study|Death|30
5165539|NCT01347580|17836307|P2|Overall Study|Withdrawal by Subject|23
5165540|NCT01347580|17836308|P1|Overall Study|Withdrawal by Subject|13
5165541|NCT01347554|17836338|P2|Overall Study|Lack of Efficacy|11
5165542|NCT01347554|17836339|P1|Overall Study|Lack of Efficacy|7
5165543|NCT01347307|17836364|P2|Overall Study|Physician Decision|1
5165544|NCT01347307|17836365|P1|Overall Study|Physician Decision|0
5165545|NCT01347307|17836364|P2|Overall Study|Death|4
5165546|NCT01347307|17836365|P1|Overall Study|Death|0
5165547|NCT01347112|17836400|P2|Overall Study|Lost to Follow-up|5
5165548|NCT01347112|17836401|P1|Overall Study|Lost to Follow-up|3
5165549|NCT01347112|17836400|P2|Overall Study|Withdrawal by Subject|7
5165550|NCT01347112|17836401|P1|Overall Study|Withdrawal by Subject|1
5165551|NCT01347086|17836421|P10|Overall Study|failed screening visit|1
5165552|NCT01347086|17836422|P9|Overall Study|failed screening visit|0
5165553|NCT01347086|17836423|P8|Overall Study|failed screening visit|1
5165554|NCT01347086|17836424|P7|Overall Study|failed screening visit|1
5165555|NCT01347086|17836425|P6|Overall Study|failed screening visit|0
5165556|NCT01347086|17836426|P5|Overall Study|failed screening visit|0
5165557|NCT01347086|17836427|P4|Overall Study|failed screening visit|0
5165558|NCT01347086|17836428|P3|Overall Study|failed screening visit|1
5165559|NCT01347086|17836429|P2|Overall Study|failed screening visit|0
5165560|NCT01347086|17836430|P1|Overall Study|failed screening visit|0
5165561|NCT01347073|17836529|P1|Overall Study|Liver Transplant|1
5165562|NCT01347073|17836529|P1|Overall Study|Adverse Event|1
5165563|NCT01346774|17836608|P2|Overall Study|Adverse Event|2
5165564|NCT01346774|17836609|P1|Overall Study|Adverse Event|1
5165565|NCT01346774|17836608|P2|Overall Study|Protocol Violation|3
5165566|NCT01346774|17836609|P1|Overall Study|Protocol Violation|2
5165567|NCT01346774|17836608|P2|Overall Study|Withdrawal by Subject|4
5165568|NCT01346774|17836609|P1|Overall Study|Withdrawal by Subject|1
5165569|NCT01346774|17836608|P2|Overall Study|Lost to Follow-up|4
5165570|NCT01346774|17836609|P1|Overall Study|Lost to Follow-up|3
5165571|NCT01346774|17836608|P2|Overall Study|Did not take a single dose|4
5165572|NCT01346774|17836609|P1|Overall Study|Did not take a single dose|6
5165573|NCT01346696|17836615|P1|Overall Study|Death|1
5165574|NCT01346592|17836637|P3|Overall Study|Unable to Classify|6
5165575|NCT01346592|17836638|P2|Overall Study|Unable to Classify|3
5165576|NCT01346592|17836639|P1|Overall Study|Unable to Classify|7
5165577|NCT01346592|17836637|P3|Overall Study|Administrative reason|0
5165578|NCT01346592|17836638|P2|Overall Study|Administrative reason|0
5165579|NCT01346592|17836639|P1|Overall Study|Administrative reason|1
5165580|NCT01346592|17836637|P3|Overall Study|Inappropriate enrollment|1
5165581|NCT01346592|17836638|P2|Overall Study|Inappropriate enrollment|1
5165582|NCT01346592|17836639|P1|Overall Study|Inappropriate enrollment|3
5165583|NCT01346592|17836637|P3|Overall Study|Withdrawal by Subject|38
5165584|NCT01346592|17836638|P2|Overall Study|Withdrawal by Subject|51
5165585|NCT01346592|17836639|P1|Overall Study|Withdrawal by Subject|77
5165586|NCT01346592|17836637|P3|Overall Study|Adverse Event|0
5165587|NCT01346592|17836638|P2|Overall Study|Adverse Event|1
5165588|NCT01346592|17836639|P1|Overall Study|Adverse Event|0
5165589|NCT01346592|17836637|P3|Overall Study|Death|4
5165590|NCT01346592|17836638|P2|Overall Study|Death|3
5165591|NCT01346592|17836639|P1|Overall Study|Death|1
5165592|NCT01346592|17836637|P3|Overall Study|Protocol Violation|0
5165593|NCT01346592|17836638|P2|Overall Study|Protocol Violation|1
5165594|NCT01346592|17836639|P1|Overall Study|Protocol Violation|2
5165595|NCT01346592|17836637|P3|Overall Study|Lost to Follow-up|29
5165596|NCT01346592|17836638|P2|Overall Study|Lost to Follow-up|29
5165597|NCT01346592|17836639|P1|Overall Study|Lost to Follow-up|62
5165598|NCT01346540|17836731|P2|Overall Study|Adverse Event|4
5165599|NCT01346540|17836732|P1|Overall Study|Adverse Event|0
5165689|NCT01345786|17836946|P4|Overall Study|Administrative|0
5165600|NCT01346540|17836731|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
5165601|NCT01346540|17836732|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
5165602|NCT01346514|17836743|P2|Overall Study|Death|4
5165603|NCT01346514|17836744|P1|Overall Study|Death|3
5165604|NCT01346514|17836743|P2|Overall Study|Withdrawal by Subject|3
5165605|NCT01346514|17836744|P1|Overall Study|Withdrawal by Subject|7
5165606|NCT01346514|17836743|P2|Overall Study|Lost to Follow-up|30
5165607|NCT01346514|17836744|P1|Overall Study|Lost to Follow-up|19
5165608|NCT01346501|17836764|P2|Overall Study|Other|12
5165609|NCT01346501|17836765|P1|Overall Study|Other|8
5165610|NCT01346501|17836764|P2|Overall Study|Initiated Other Biological Agents|1
5165611|NCT01346501|17836765|P1|Overall Study|Initiated Other Biological Agents|3
5165612|NCT01346475|17836798|P2|First Intervention|Lost to Follow-up|3
5165613|NCT01346475|17836799|P1|First Intervention|Lost to Follow-up|4
5165614|NCT01346410|17836811|P1|Overall Study|Death|1
5165615|NCT01346371|17836829|P2|Overall Study|Lost to Follow-up|0
5165616|NCT01346371|17836830|P1|Overall Study|Lost to Follow-up|2
5165617|NCT01346293|17836838|P2|Overall Study|Other|0
5165618|NCT01346293|17836839|P1|Overall Study|Other|1
5165619|NCT01346293|17836838|P2|Overall Study|Withdrawal by Subject|4
5165620|NCT01346293|17836839|P1|Overall Study|Withdrawal by Subject|15
5165621|NCT01346293|17836838|P2|Overall Study|Lost to Follow-up|8
5165622|NCT01346293|17836839|P1|Overall Study|Lost to Follow-up|21
5165623|NCT01346293|17836838|P2|Overall Study|Protocol Violation|9
5165624|NCT01346293|17836839|P1|Overall Study|Protocol Violation|30
5165625|NCT01346189|17836869|P4|Overall Study|Travel|3
5165626|NCT01346189|17836870|P3|Overall Study|Travel|0
5165627|NCT01346189|17836871|P2|Overall Study|Travel|0
5165628|NCT01346189|17836872|P1|Overall Study|Travel|0
5165629|NCT01346189|17836869|P4|Overall Study|Non-health system primary care physician|0
5165630|NCT01346189|17836870|P3|Overall Study|Non-health system primary care physician|0
5165631|NCT01346189|17836871|P2|Overall Study|Non-health system primary care physician|5
5165632|NCT01346189|17836872|P1|Overall Study|Non-health system primary care physician|0
5165633|NCT01346189|17836869|P4|Overall Study|Death|0
5165634|NCT01346189|17836870|P3|Overall Study|Death|0
5165635|NCT01346189|17836871|P2|Overall Study|Death|3
5165636|NCT01346189|17836872|P1|Overall Study|Death|0
5165637|NCT01346189|17836869|P4|Overall Study|Other|3
5165638|NCT01346189|17836870|P3|Overall Study|Other|7
5165639|NCT01346189|17836871|P2|Overall Study|Other|4
5165640|NCT01346189|17836872|P1|Overall Study|Other|2
5165641|NCT01346189|17836869|P4|Overall Study|Moved|0
5165642|NCT01346189|17836870|P3|Overall Study|Moved|4
5165643|NCT01346189|17836871|P2|Overall Study|Moved|0
5165644|NCT01346189|17836872|P1|Overall Study|Moved|3
5165645|NCT01346189|17836869|P4|Overall Study|Physician Decision|0
5165646|NCT01346189|17836870|P3|Overall Study|Physician Decision|0
5165647|NCT01346189|17836871|P2|Overall Study|Physician Decision|0
5165648|NCT01346189|17836872|P1|Overall Study|Physician Decision|4
5165649|NCT01346189|17836869|P4|Overall Study|Withdrawal by Subject|5
5165650|NCT01346189|17836870|P3|Overall Study|Withdrawal by Subject|3
5165651|NCT01346189|17836871|P2|Overall Study|Withdrawal by Subject|5
5165652|NCT01346189|17836872|P1|Overall Study|Withdrawal by Subject|7
5165653|NCT01346176|17836889|P3|Completed Satisfaction Survey|Lost to Follow-up|4
5165654|NCT01346176|17836890|P2|Completed Satisfaction Survey|Lost to Follow-up|4
5165655|NCT01346176|17836891|P1|Completed Satisfaction Survey|Lost to Follow-up|3
5165656|NCT01346176|17836889|P3|Completed Satisfaction Survey|Death|2
5165657|NCT01346176|17836890|P2|Completed Satisfaction Survey|Death|0
5165658|NCT01346176|17836891|P1|Completed Satisfaction Survey|Death|3
5165659|NCT01346176|17836889|P3|Completed Advance Directive|Other reason did not complete AD|7
5165660|NCT01346176|17836890|P2|Completed Advance Directive|Other reason did not complete AD|12
5165661|NCT01346176|17836891|P1|Completed Advance Directive|Other reason did not complete AD|7
5165662|NCT01346176|17836889|P3|Completed Advance Directive|Became Ineligible|1
5165663|NCT01346176|17836890|P2|Completed Advance Directive|Became Ineligible|0
5165664|NCT01346176|17836891|P1|Completed Advance Directive|Became Ineligible|3
5165665|NCT01346176|17836889|P3|Completed Advance Directive|Death|2
5165666|NCT01346176|17836890|P2|Completed Advance Directive|Death|2
5165667|NCT01346176|17836891|P1|Completed Advance Directive|Death|3
5165668|NCT01346176|17836889|P3|Recruited|Protocol Violation|0
5165669|NCT01346176|17836890|P2|Recruited|Protocol Violation|0
5165670|NCT01346176|17836891|P1|Recruited|Protocol Violation|1
5165671|NCT01346059|17836920|P2|Overall Study|Withdrawal by Subject|0
5165672|NCT01346059|17836921|P1|Overall Study|Withdrawal by Subject|1
5165673|NCT01345929|17836933|P2|Overall Study|Patient withdrawal|1
5165674|NCT01345929|17836934|P1|Overall Study|Patient withdrawal|0
5165675|NCT01345929|17836933|P2|Overall Study|40,000 CFU/ML|0
5165676|NCT01345929|17836934|P1|Overall Study|40,000 CFU/ML|1
5165677|NCT01345929|17836933|P2|Overall Study|Didn't meet eligibility criteria|0
5165678|NCT01345929|17836934|P1|Overall Study|Didn't meet eligibility criteria|2
5165679|NCT01345929|17836933|P2|Overall Study|Adverse Event|1
5165680|NCT01345929|17836934|P1|Overall Study|Adverse Event|0
5165681|NCT01345929|17836933|P2|Overall Study|Lost to Follow-up|9
5165682|NCT01345929|17836934|P1|Overall Study|Lost to Follow-up|9
5165683|NCT01345929|17836933|P2|Overall Study|Withdrawal by Subject|8
5165684|NCT01345929|17836934|P1|Overall Study|Withdrawal by Subject|9
5165685|NCT01345786|17836946|P4|Overall Study|Lost to Follow-up|2
5165686|NCT01345786|17836947|P3|Overall Study|Lost to Follow-up|0
5165687|NCT01345786|17836948|P2|Overall Study|Lost to Follow-up|0
5165688|NCT01345786|17836949|P1|Overall Study|Lost to Follow-up|0
5165690|NCT01345786|17836947|P3|Overall Study|Administrative|0
5165691|NCT01345786|17836948|P2|Overall Study|Administrative|5
5165692|NCT01345786|17836949|P1|Overall Study|Administrative|3
5165693|NCT01345786|17836946|P4|Overall Study|Noncompliance with protocol|0
5165694|NCT01345786|17836947|P3|Overall Study|Noncompliance with protocol|1
5165695|NCT01345786|17836948|P2|Overall Study|Noncompliance with protocol|0
5165696|NCT01345786|17836949|P1|Overall Study|Noncompliance with protocol|1
5165697|NCT01345786|17836946|P4|Overall Study|Subject withdrew consent|0
5165698|NCT01345786|17836947|P3|Overall Study|Subject withdrew consent|1
5165699|NCT01345786|17836948|P2|Overall Study|Subject withdrew consent|2
5165700|NCT01345786|17836949|P1|Overall Study|Subject withdrew consent|2
5165701|NCT01345786|17836946|P4|Overall Study|Adverse Event|1
5165702|NCT01345786|17836947|P3|Overall Study|Adverse Event|3
5165703|NCT01345786|17836948|P2|Overall Study|Adverse Event|1
5165704|NCT01345786|17836949|P1|Overall Study|Adverse Event|0
5165705|NCT01345682|17837029|P2|Overall Study|Reason other than those specified above|3
5165706|NCT01345682|17837030|P1|Overall Study|Reason other than those specified above|4
5165707|NCT01345682|17837029|P2|Overall Study|Not treated|1
5165708|NCT01345682|17837030|P1|Overall Study|Not treated|2
5165709|NCT01345682|17837029|P2|Overall Study|Refused to continue trial medication|9
5165710|NCT01345682|17837030|P1|Overall Study|Refused to continue trial medication|16
5165711|NCT01345682|17837029|P2|Overall Study|Lost to Follow-up|1
5165712|NCT01345682|17837030|P1|Overall Study|Lost to Follow-up|0
5165713|NCT01345682|17837029|P2|Overall Study|Non-compliance with protocol|1
5165714|NCT01345682|17837030|P1|Overall Study|Non-compliance with protocol|0
5165715|NCT01345682|17837029|P2|Overall Study|Adverse Event|41
5165716|NCT01345682|17837030|P1|Overall Study|Adverse Event|51
5165717|NCT01345682|17837029|P2|Overall Study|Worsening of underlying cancer disease|12
5165718|NCT01345682|17837030|P1|Overall Study|Worsening of underlying cancer disease|23
5165719|NCT01345682|17837029|P2|Overall Study|Progressive disease per RECIST|93
5165720|NCT01345682|17837030|P1|Overall Study|Progressive disease per RECIST|226
5165721|NCT01345669|17837064|P2|Overall Study|Other Reasons|60
5165722|NCT01345669|17837065|P1|Overall Study|Other Reasons|111
5165723|NCT01345669|17837064|P2|Overall Study|Withdrawal by Subject|13
5165724|NCT01345669|17837065|P1|Overall Study|Withdrawal by Subject|52
5165725|NCT01345669|17837064|P2|Overall Study|Lost to Follow-up|1
5165726|NCT01345669|17837065|P1|Overall Study|Lost to Follow-up|1
5165727|NCT01345669|17837064|P2|Overall Study|Protocol Violation|1
5165728|NCT01345669|17837065|P1|Overall Study|Protocol Violation|3
5165729|NCT01345669|17837064|P2|Overall Study|Adverse Event|9
5165730|NCT01345669|17837065|P1|Overall Study|Adverse Event|63
5165731|NCT01345669|17837064|P2|Overall Study|Second primary tumour|3
5165732|NCT01345669|17837065|P1|Overall Study|Second primary tumour|4
5165733|NCT01345669|17837064|P2|Overall Study|Primary tumour recurrence|32
5165734|NCT01345669|17837065|P1|Overall Study|Primary tumour recurrence|53
5165735|NCT01345630|17837083|P2|Overall Study|Insufficient clinical response|11
5165736|NCT01345630|17837084|P1|Overall Study|Insufficient clinical response|48
5165737|NCT01345630|17837083|P2|Overall Study|No longer willing to participate|12
5165738|NCT01345630|17837084|P1|Overall Study|No longer willing to participate|9
5165739|NCT01345630|17837083|P2|Overall Study|Withdrawn due to pregnancy|2
5165740|NCT01345630|17837084|P1|Overall Study|Withdrawn due to pregnancy|1
5165741|NCT01345630|17837083|P2|Overall Study|Other reasons|8
5165742|NCT01345630|17837084|P1|Overall Study|Other reasons|6
5165743|NCT01345630|17837083|P2|Overall Study|Study terminated by sponsor|285
5165744|NCT01345630|17837084|P1|Overall Study|Study terminated by sponsor|254
5165745|NCT01345630|17837083|P2|Overall Study|Medication error without associated AE|1
5165746|NCT01345630|17837084|P1|Overall Study|Medication error without associated AE|0
5165747|NCT01345630|17837083|P2|Overall Study|Protocol Violation|1
5165748|NCT01345630|17837084|P1|Overall Study|Protocol Violation|4
5165749|NCT01345630|17837083|P2|Overall Study|Lost to Follow-up|16
5165750|NCT01345630|17837084|P1|Overall Study|Lost to Follow-up|17
5165751|NCT01345630|17837083|P2|Overall Study|Adverse Event|23
5165752|NCT01345630|17837084|P1|Overall Study|Adverse Event|22
5165753|NCT01345591|17837140|P1|Overall Study|Lost to Follow-up|1
5165754|NCT01345318|17837156|P1|Overall Study|Other|3
5165755|NCT01345318|17837156|P1|Overall Study|Withdrawal by Subject|41
5165756|NCT01345318|17837156|P1|Overall Study|Protocol Violation|1
5165757|NCT01345318|17837156|P1|Overall Study|Lost to Follow-up|2
5165758|NCT01345318|17837156|P1|Overall Study|Lack of Efficacy|17
5165759|NCT01345318|17837156|P1|Overall Study|Adverse Event|16
5165760|NCT01345292|17837164|P3|Overall Study|Withdrawal by Subject|1
5165761|NCT01345292|17837165|P2|Overall Study|Withdrawal by Subject|0
5165762|NCT01345292|17837166|P1|Overall Study|Withdrawal by Subject|2
5165763|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
5165764|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
5165765|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
5165766|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
5165767|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
5165768|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
5165769|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
5165770|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
5165771|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
5165772|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
5165773|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
5165774|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
5165775|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
5165776|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
5165777|NCT01345253|17837197|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
5165778|NCT01345253|17837198|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
5165779|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
5165780|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
5165781|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
5165782|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
5165783|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
5165784|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
5165785|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
5165786|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
5165787|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
5165788|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
5165789|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
5165790|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
5165791|NCT01345253|17837197|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
5165792|NCT01345253|17837198|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
5165793|NCT01345240|17837219|P5|Overall Study|Lost to Follow-up|9
5165794|NCT01345240|17837220|P4|Overall Study|Lost to Follow-up|7
5165795|NCT01345240|17837221|P3|Overall Study|Lost to Follow-up|14
5165796|NCT01345240|17837222|P2|Overall Study|Lost to Follow-up|9
5165797|NCT01345240|17837223|P1|Overall Study|Lost to Follow-up|8
5165798|NCT01345240|17837219|P5|Overall Study|Adverse Event|1
5165799|NCT01345240|17837220|P4|Overall Study|Adverse Event|2
5165800|NCT01345240|17837221|P3|Overall Study|Adverse Event|4
5165801|NCT01345240|17837222|P2|Overall Study|Adverse Event|5
5165802|NCT01345240|17837223|P1|Overall Study|Adverse Event|3
5165803|NCT01345188|17837343|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
5165804|NCT01345188|17837343|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
5165805|NCT01345162|17837355|P2|Overall Study|Protocol Violation|4
5165806|NCT01345162|17837356|P1|Overall Study|Protocol Violation|2
5165807|NCT01345123|17837365|P3|Overall Study|participants no longer with health plan|88
5165808|NCT01345123|17837366|P2|Overall Study|participants no longer with health plan|85
5165809|NCT01345123|17837367|P1|Overall Study|participants no longer with health plan|79
5165810|NCT01345058|17837389|P2|Overall Study|Participant No-Show at Multiple Visits|0
5165811|NCT01345058|17837390|P1|Overall Study|Participant No-Show at Multiple Visits|1
5165812|NCT01345058|17837389|P2|Overall Study|Participant Stopped Taking Study Drug|0
5165813|NCT01345058|17837390|P1|Overall Study|Participant Stopped Taking Study Drug|1
5165814|NCT01345058|17837389|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
5165815|NCT01345058|17837390|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
5165816|NCT01345058|17837389|P2|Overall Study|Participant Reported Increase in Events|0
5165817|NCT01345058|17837390|P1|Overall Study|Participant Reported Increase in Events|1
5165818|NCT01345058|17837389|P2|Overall Study|Withdrawal by Subject|0
5165819|NCT01345058|17837390|P1|Overall Study|Withdrawal by Subject|1
5165820|NCT01345019|17837406|P2|Open Label Treatment Phase|Protocol Violation|1
5165821|NCT01345019|17837407|P1|Open Label Treatment Phase|Protocol Violation|0
5165822|NCT01345019|17837406|P2|Open Label Treatment Phase|Other, Not Specified|7
5165823|NCT01345019|17837407|P1|Open Label Treatment Phase|Other, Not Specified|9
5165824|NCT01345019|17837406|P2|Open Label Treatment Phase|Pregnancy|0
5165825|NCT01345019|17837407|P1|Open Label Treatment Phase|Pregnancy|1
5165826|NCT01345019|17837406|P2|Open Label Treatment Phase|Lost to Follow-up|2
5165827|NCT01345019|17837407|P1|Open Label Treatment Phase|Lost to Follow-up|1
5165828|NCT01345019|17837406|P2|Open Label Treatment Phase|Noncompliance|4
5165829|NCT01345019|17837407|P1|Open Label Treatment Phase|Noncompliance|5
5165830|NCT01345019|17837406|P2|Open Label Treatment Phase|Disease Progression|18
5165831|NCT01345019|17837407|P1|Open Label Treatment Phase|Disease Progression|17
5165832|NCT01345019|17837406|P2|Open Label Treatment Phase|Administrative Decision|15
5165833|NCT01345019|17837407|P1|Open Label Treatment Phase|Administrative Decision|30
5165834|NCT01345019|17837406|P2|Open Label Treatment Phase|Adverse Event|51
5165835|NCT01345019|17837407|P1|Open Label Treatment Phase|Adverse Event|30
5165836|NCT01345019|17837406|P2|Open Label Treatment Phase|Withdrawal by Subject|47
5165837|NCT01345019|17837407|P1|Open Label Treatment Phase|Withdrawal by Subject|49
5165838|NCT01345019|17837406|P2|Open Label Treatment Phase|Death|48
5165839|NCT01345019|17837407|P1|Open Label Treatment Phase|Death|49
5165840|NCT01345019|17837406|P2|Blinded Treatment Phase|Lost to Follow-up|3
5165841|NCT01345019|17837407|P1|Blinded Treatment Phase|Lost to Follow-up|6
5165842|NCT01345019|17837406|P2|Blinded Treatment Phase|Other, Not Specified|3
5165843|NCT01345019|17837407|P1|Blinded Treatment Phase|Other, Not Specified|2
5165844|NCT01345019|17837406|P2|Blinded Treatment Phase|Protocol Deviation|0
5165845|NCT01345019|17837407|P1|Blinded Treatment Phase|Protocol Deviation|5
5165846|NCT01345019|17837406|P2|Blinded Treatment Phase|Ineligibility Determined|6
5165847|NCT01345019|17837407|P1|Blinded Treatment Phase|Ineligibility Determined|1
5165848|NCT01345019|17837406|P2|Blinded Treatment Phase|Noncompliance|3
5165849|NCT01345019|17837407|P1|Blinded Treatment Phase|Noncompliance|5
5165850|NCT01345019|17837406|P2|Blinded Treatment Phase|Administrative Decision|8
5165851|NCT01345019|17837407|P1|Blinded Treatment Phase|Administrative Decision|10
5165852|NCT01345019|17837406|P2|Blinded Treatment Phase|Adverse Event|13
5165853|NCT01345019|17837407|P1|Blinded Treatment Phase|Adverse Event|6
5165854|NCT01345019|17837406|P2|Blinded Treatment Phase|Disease Progression|10
5165855|NCT01345019|17837407|P1|Blinded Treatment Phase|Disease Progression|12
5165856|NCT01345019|17837406|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
5165857|NCT01345019|17837407|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
5165858|NCT01345019|17837406|P2|Blinded Treatment Phase|Withdrawal by Subject|112
5165859|NCT01345019|17837407|P1|Blinded Treatment Phase|Withdrawal by Subject|103
5165860|NCT01345019|17837406|P2|Blinded Treatment Phase|Death|137
5165861|NCT01345019|17837407|P1|Blinded Treatment Phase|Death|147
5165862|NCT01344876|17837429|P5|Overall Study|Definite progression of primary disease|0
5165863|NCT01344876|17837430|P4|Overall Study|Definite progression of primary disease|3
5165864|NCT01344876|17837431|P3|Overall Study|Definite progression of primary disease|0
5165865|NCT01344876|17837432|P2|Overall Study|Definite progression of primary disease|0
5165866|NCT01344876|17837433|P1|Overall Study|Definite progression of primary disease|1
5165867|NCT01344876|17837429|P5|Overall Study|Withdrawal by Subject|0
5165868|NCT01344876|17837430|P4|Overall Study|Withdrawal by Subject|0
5165869|NCT01344876|17837431|P3|Overall Study|Withdrawal by Subject|1
5165870|NCT01344876|17837432|P2|Overall Study|Withdrawal by Subject|0
5165871|NCT01344876|17837433|P1|Overall Study|Withdrawal by Subject|0
5165872|NCT01344876|17837429|P5|Overall Study|Adverse Event|1
5165873|NCT01344876|17837430|P4|Overall Study|Adverse Event|0
5165874|NCT01344876|17837431|P3|Overall Study|Adverse Event|0
5165875|NCT01344876|17837432|P2|Overall Study|Adverse Event|0
5165876|NCT01344876|17837433|P1|Overall Study|Adverse Event|0
5165877|NCT01344824|17837447|P1|Overall Study|Progression|15
5165878|NCT01344824|17837447|P1|Overall Study|Other complicating disease|1
5165879|NCT01344824|17837447|P1|Overall Study|Withdrawal by Subject|6
5165880|NCT01344824|17837447|P1|Overall Study|Adverse Event|15
5165881|NCT01344759|17837455|P2|Overall Study|Patients failed to reach sedation level|2
5165882|NCT01344759|17837456|P1|Overall Study|Patients failed to reach sedation level|0
5165883|NCT01344629|17837488|P2|Crossover Period 2|Withdrawal by Subject|1
5165884|NCT01344629|17837489|P1|Crossover Period 2|Withdrawal by Subject|0
5165885|NCT01344538|17837518|P2|Overall Study|Lost to Follow-up|0
5165886|NCT01344538|17837519|P1|Overall Study|Lost to Follow-up|1
5165887|NCT01344538|17837518|P2|Overall Study|Adverse Event|1
5165888|NCT01344538|17837519|P1|Overall Study|Adverse Event|1
5165889|NCT01344460|17837525|P1|Overall Study|Lost to Follow-up|2
5165890|NCT01344460|17837525|P1|Overall Study|Withdrawal by Subject|1
5165891|NCT01344447|17837570|P1|Overall Study|Error of power injector|1
5165892|NCT01344447|17837570|P1|Overall Study|Bolus tracking failed|1
5165893|NCT01344447|17837570|P1|Overall Study|MRA unsuccessful|1
5165894|NCT01344447|17837570|P1|Overall Study|Physician Decision|1
5165895|NCT01344447|17837570|P1|Overall Study|The contrast was not seen|1
5165896|NCT01344447|17837570|P1|Overall Study|Withdrawal by Subject|1
5165897|NCT01344447|17837570|P1|Overall Study|Protocol Violation|1
5165898|NCT01344447|17837570|P1|Overall Study|Adverse Event|1
5165899|NCT01344369|17837614|P2|Second Intervention|Emesis within 2 x Tmax|1
5165900|NCT01344369|17837615|P1|Second Intervention|Emesis within 2 x Tmax|0
5165901|NCT01344369|17837614|P2|Washout of 28 Days|Physician Decision|1
5165902|NCT01344369|17837615|P1|Washout of 28 Days|Physician Decision|0
5165903|NCT01344369|17837614|P2|Washout of 28 Days|Withdrawal by Subject|0
5165904|NCT01344369|17837615|P1|Washout of 28 Days|Withdrawal by Subject|1
5165905|NCT01344356|17837633|P2|Overall Study|Lost to Follow-up|6
5165906|NCT01344356|17837634|P1|Overall Study|Lost to Follow-up|0
5165907|NCT01344356|17837633|P2|Overall Study|Physician Decision|3
5165908|NCT01344356|17837634|P1|Overall Study|Physician Decision|0
5165909|NCT01344226|17837646|P1|Overall Study|Lack of Efficacy|3
5165910|NCT01344226|17837646|P1|Overall Study|Withdrawal by Subject|3
5165911|NCT01344226|17837646|P1|Overall Study|Protocol Violation|2
5165912|NCT01344161|17837655|P2|Overall Study|Protocol Violation|1
5165913|NCT01344161|17837656|P1|Overall Study|Protocol Violation|1
5165914|NCT01344161|17837655|P2|Overall Study|Pregnancy|1
5165915|NCT01344161|17837656|P1|Overall Study|Pregnancy|0
5165916|NCT01344161|17837655|P2|Overall Study|Lost to Follow-up|1
5165917|NCT01344161|17837656|P1|Overall Study|Lost to Follow-up|4
5165918|NCT01344057|17837668|P1|Overall Study|Premature Withdrawal|1
5165919|NCT01343901|17837675|P1|Overall Study|Participant decision|1
5165920|NCT01343901|17837675|P1|Overall Study|Management by another medical team|11
5165921|NCT01343901|17837675|P1|Overall Study|Lost to Follow-up|12
5165922|NCT01343901|17837675|P1|Overall Study|Physician Decision|4
5165923|NCT01343901|17837675|P1|Overall Study|Death|85
5165924|NCT01343888|17837699|P3|Overall Study|other than stated above|1
5165925|NCT01343888|17837700|P2|Overall Study|other than stated above|0
5165926|NCT01343888|17837701|P1|Overall Study|other than stated above|0
5165927|NCT01343888|17837699|P3|Overall Study|Withdrawal by Subject|2
5165928|NCT01343888|17837700|P2|Overall Study|Withdrawal by Subject|4
5165929|NCT01343888|17837701|P1|Overall Study|Withdrawal by Subject|4
5165930|NCT01343888|17837699|P3|Overall Study|Protocol Violation|0
5165931|NCT01343888|17837700|P2|Overall Study|Protocol Violation|2
5165932|NCT01343888|17837701|P1|Overall Study|Protocol Violation|0
5165933|NCT01343888|17837699|P3|Overall Study|Lost to Follow-up|1
5165934|NCT01343888|17837700|P2|Overall Study|Lost to Follow-up|2
5165935|NCT01343888|17837701|P1|Overall Study|Lost to Follow-up|0
5165936|NCT01343888|17837699|P3|Overall Study|Lack of Efficacy|13
5165937|NCT01343888|17837700|P2|Overall Study|Lack of Efficacy|9
5165938|NCT01343888|17837701|P1|Overall Study|Lack of Efficacy|9
5165939|NCT01343888|17837699|P3|Overall Study|Adverse Event|5
5165940|NCT01343888|17837700|P2|Overall Study|Adverse Event|22
5165941|NCT01343888|17837701|P1|Overall Study|Adverse Event|12
5165942|NCT01343823|17837743|P4|Overall Study|Withdrawal by Subject|0
5165943|NCT01343823|17837744|P3|Overall Study|Withdrawal by Subject|0
5165944|NCT01343823|17837745|P2|Overall Study|Withdrawal by Subject|0
5165945|NCT01343823|17837746|P1|Overall Study|Withdrawal by Subject|1
5165946|NCT01343823|17837743|P4|Overall Study|Study Terminated|1
5165947|NCT01343823|17837744|P3|Overall Study|Study Terminated|0
5165948|NCT01343823|17837745|P2|Overall Study|Study Terminated|0
5165949|NCT01343823|17837746|P1|Overall Study|Study Terminated|1
5165950|NCT01343693|17837760|P1|Overall Study|Lost to Follow-up|9
5165951|NCT01343407|17837783|P6|Second Washout (Part 2)|Withdrawal by Subject|0
5165952|NCT01343407|17837784|P5|Second Washout (Part 2)|Withdrawal by Subject|0
5165953|NCT01343407|17837785|P4|Second Washout (Part 2)|Withdrawal by Subject|0
5165954|NCT01343407|17837786|P3|Second Washout (Part 2)|Withdrawal by Subject|1
5165955|NCT01343407|17837787|P2|Second Washout (Part 2)|Withdrawal by Subject|0
5165956|NCT01343407|17837788|P1|Second Washout (Part 2)|Withdrawal by Subject|0
5165957|NCT01343407|17837783|P6|Second Treatment Period (Part 2)|Adverse Event|0
5165958|NCT01343407|17837784|P5|Second Treatment Period (Part 2)|Adverse Event|0
5165959|NCT01343407|17837785|P4|Second Treatment Period (Part 2)|Adverse Event|0
5165960|NCT01343407|17837786|P3|Second Treatment Period (Part 2)|Adverse Event|1
5165961|NCT01343407|17837787|P2|Second Treatment Period (Part 2)|Adverse Event|0
5165962|NCT01343407|17837788|P1|Second Treatment Period (Part 2)|Adverse Event|0
5165963|NCT01343368|17837816|P2|Overall Study|Lost to Follow-up|0
5165964|NCT01343368|17837817|P1|Overall Study|Lost to Follow-up|1
5165965|NCT01343368|17837816|P2|Overall Study|Death|0
5165966|NCT01343368|17837817|P1|Overall Study|Death|1
5165967|NCT01343277|17837853|P2|Overall Study|Subsequent anticancer therapy|0
5165968|NCT01343277|17837854|P1|Overall Study|Subsequent anticancer therapy|1
5165969|NCT01343277|17837853|P2|Overall Study|Treatment ongoing|2
5165970|NCT01343277|17837854|P1|Overall Study|Treatment ongoing|8
5165971|NCT01343277|17837853|P2|Overall Study|Randomized not treated|21
5165972|NCT01343277|17837854|P1|Overall Study|Randomized not treated|6
5165973|NCT01343277|17837853|P2|Overall Study|Disease progression|138
5165974|NCT01343277|17837854|P1|Overall Study|Disease progression|270
5165975|NCT01343277|17837853|P2|Overall Study|Adverse Event|13
5165976|NCT01343277|17837854|P1|Overall Study|Adverse Event|67
5165977|NCT01343277|17837853|P2|Overall Study|Death|1
5165978|NCT01343277|17837854|P1|Overall Study|Death|10
5165979|NCT01343277|17837853|P2|Overall Study|Physician Decision|2
5165980|NCT01343277|17837854|P1|Overall Study|Physician Decision|1
5165981|NCT01343277|17837853|P2|Overall Study|Withdrawal by Subject|13
5165982|NCT01343277|17837854|P1|Overall Study|Withdrawal by Subject|18
5165983|NCT01343277|17837853|P2|Overall Study|Other|3
5165984|NCT01343277|17837854|P1|Overall Study|Other|3
5165985|NCT01343082|17837915|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
5165986|NCT01343082|17837916|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
5165987|NCT01343082|17837917|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
5165988|NCT01343082|17837915|P3|Treatment Period , Switched to DE-111|Physician Decision|2
5165989|NCT01343082|17837916|P2|Treatment Period , Switched to DE-111|Physician Decision|2
5165990|NCT01343082|17837917|P1|Treatment Period , Switched to DE-111|Physician Decision|0
5165991|NCT01343082|17837915|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
5165992|NCT01343082|17837916|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
5165993|NCT01343082|17837917|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
5165994|NCT01343082|17837915|P3|Treatment Period , Switched to DE-111|Adverse Event|3
5165995|NCT01343082|17837916|P2|Treatment Period , Switched to DE-111|Adverse Event|4
5165996|NCT01343082|17837917|P1|Treatment Period , Switched to DE-111|Adverse Event|1
5165997|NCT01343082|17837915|P3|The run-in Period|Not meeting criteria|5
5165998|NCT01343082|17837916|P2|The run-in Period|Not meeting criteria|4
5165999|NCT01343082|17837917|P1|The run-in Period|Not meeting criteria|3
5166000|NCT01343056|17837925|P4|Overall Study|Lost to Follow-up|9
5166001|NCT01343056|17837926|P3|Overall Study|Lost to Follow-up|3
5166002|NCT01343056|17837927|P2|Overall Study|Lost to Follow-up|5
5166003|NCT01343056|17837928|P1|Overall Study|Lost to Follow-up|7
5166004|NCT01343043|17837970|P4|Overall Study|Death|1
5166005|NCT01343043|17837971|P3|Overall Study|Death|0
5166006|NCT01343043|17837972|P2|Overall Study|Death|1
5166007|NCT01343043|17837973|P1|Overall Study|Death|1
5166008|NCT01343043|17837970|P4|Overall Study|Withdrawal by Subject|0
5166009|NCT01343043|17837971|P3|Overall Study|Withdrawal by Subject|0
5166010|NCT01343043|17837972|P2|Overall Study|Withdrawal by Subject|0
5166011|NCT01343043|17837973|P1|Overall Study|Withdrawal by Subject|1
5166012|NCT01343043|17837970|P4|Overall Study|Disease progression before treatment|0
5166013|NCT01343043|17837971|P3|Overall Study|Disease progression before treatment|0
5166014|NCT01343043|17837972|P2|Overall Study|Disease progression before treatment|0
5166015|NCT01343043|17837973|P1|Overall Study|Disease progression before treatment|1
5166016|NCT01342965|17838061|P2|Overall Study|Withdrawal by Subject|9
5166017|NCT01342965|17838062|P1|Overall Study|Withdrawal by Subject|2
5166018|NCT01342965|17838061|P2|Overall Study|Other Reasons- Unspecified|38
5166019|NCT01342965|17838062|P1|Overall Study|Other Reasons- Unspecified|44
5166020|NCT01342965|17838061|P2|Overall Study|Lost to Follow-up|3
5166021|NCT01342965|17838062|P1|Overall Study|Lost to Follow-up|5
5166022|NCT01342965|17838061|P2|Overall Study|Death|57
5166023|NCT01342965|17838062|P1|Overall Study|Death|58
5166024|NCT01342926|17838080|P4|Overall Study|Withdrawal by Subject|5
5166025|NCT01342926|17838081|P3|Overall Study|Withdrawal by Subject|3
5166026|NCT01342926|17838082|P2|Overall Study|Withdrawal by Subject|4
5166027|NCT01342926|17838083|P1|Overall Study|Withdrawal by Subject|2
5166028|NCT01342926|17838080|P4|Overall Study|Investigator Discretion|0
5166029|NCT01342926|17838081|P3|Overall Study|Investigator Discretion|0
5166030|NCT01342926|17838082|P2|Overall Study|Investigator Discretion|2
5166031|NCT01342926|17838083|P1|Overall Study|Investigator Discretion|2
5166032|NCT01342926|17838080|P4|Overall Study|Lost to Follow-up|0
5166033|NCT01342926|17838081|P3|Overall Study|Lost to Follow-up|1
5166034|NCT01342926|17838082|P2|Overall Study|Lost to Follow-up|1
5166035|NCT01342926|17838083|P1|Overall Study|Lost to Follow-up|0
5166036|NCT01342926|17838080|P4|Overall Study|Adverse Event|7
5166037|NCT01342926|17838081|P3|Overall Study|Adverse Event|10
5166038|NCT01342926|17838082|P2|Overall Study|Adverse Event|8
5166039|NCT01342926|17838083|P1|Overall Study|Adverse Event|5
5166040|NCT01342913|17838163|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
5166041|NCT01342913|17838164|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
5166042|NCT01342913|17838165|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5166043|NCT01342913|17838163|P3|Double-Blind Treatment Period|Physician Decision|0
5166044|NCT01342913|17838164|P2|Double-Blind Treatment Period|Physician Decision|2
5166045|NCT01342913|17838165|P1|Double-Blind Treatment Period|Physician Decision|0
5166046|NCT01342913|17838163|P3|Double-Blind Treatment Period|Lost to Follow-up|3
5166047|NCT01342913|17838164|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5166048|NCT01342913|17838165|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5166049|NCT01342913|17838163|P3|Double-Blind Treatment Period|Protocol Violation|9
5166050|NCT01342913|17838164|P2|Double-Blind Treatment Period|Protocol Violation|6
5166051|NCT01342913|17838165|P1|Double-Blind Treatment Period|Protocol Violation|0
5166052|NCT01342913|17838163|P3|Double-Blind Treatment Period|Lack of Efficacy|3
5166053|NCT01342913|17838164|P2|Double-Blind Treatment Period|Lack of Efficacy|2
5166054|NCT01342913|17838165|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5166055|NCT01342913|17838163|P3|Double-Blind Treatment Period|Adverse Event|6
5166056|NCT01342913|17838164|P2|Double-Blind Treatment Period|Adverse Event|3
5166057|NCT01342913|17838165|P1|Double-Blind Treatment Period|Adverse Event|0
5166058|NCT01342913|17838163|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5166059|NCT01342913|17838164|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5166060|NCT01342913|17838165|P1|2-week Run-in Period|Continuation Criteria Not Met|88
5166061|NCT01342913|17838163|P3|2-week Run-in Period|Protocol Violation|0
5166062|NCT01342913|17838164|P2|2-week Run-in Period|Protocol Violation|0
5166063|NCT01342913|17838165|P1|2-week Run-in Period|Protocol Violation|5
5166064|NCT01342913|17838163|P3|2-week Run-in Period|Adverse Event|0
5166065|NCT01342913|17838164|P2|2-week Run-in Period|Adverse Event|0
5166066|NCT01342913|17838165|P1|2-week Run-in Period|Adverse Event|2
5166067|NCT01342913|17838163|P3|2-week Run-in Period|Withdrawal by Subject|0
5166068|NCT01342913|17838164|P2|2-week Run-in Period|Withdrawal by Subject|0
5166069|NCT01342913|17838165|P1|2-week Run-in Period|Withdrawal by Subject|7
5166070|NCT01342913|17838163|P3|2-week Run-in Period|Physician Decision|0
5166071|NCT01342913|17838164|P2|2-week Run-in Period|Physician Decision|0
5166072|NCT01342913|17838165|P1|2-week Run-in Period|Physician Decision|6
5166073|NCT01342913|17838163|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5166074|NCT01342913|17838164|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5166075|NCT01342913|17838165|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
5166076|NCT01342887|17838175|P1|Overall Study|Death|2
5166077|NCT01342640|17838216|P1|Overall Study|Other|1
5166078|NCT01342640|17838216|P1|Overall Study|Lost to Follow-up|21
5166079|NCT01342640|17838216|P1|Overall Study|Protocol Violation|16
5166080|NCT01342640|17838216|P1|Overall Study|Adverse Event|3
5166081|NCT01342510|17838311|P4|Overall Study|Protocol Violation|11
5166082|NCT01342510|17838312|P3|Overall Study|Protocol Violation|13
5166083|NCT01342510|17838313|P2|Overall Study|Protocol Violation|6
5166084|NCT01342510|17838314|P1|Overall Study|Protocol Violation|12
5166085|NCT01342484|17838331|P3|Overall Study|Withdrawal by Subject|0
5166086|NCT01342484|17838332|P2|Overall Study|Withdrawal by Subject|0
5166087|NCT01342484|17838333|P1|Overall Study|Withdrawal by Subject|1
5166088|NCT01342484|17838331|P3|Overall Study|Protocol Violation|1
5166089|NCT01342484|17838332|P2|Overall Study|Protocol Violation|0
5166090|NCT01342484|17838333|P1|Overall Study|Protocol Violation|0
5166091|NCT01342484|17838331|P3|Overall Study|Other Reasons|0
5166092|NCT01342484|17838332|P2|Overall Study|Other Reasons|0
5166093|NCT01342484|17838333|P1|Overall Study|Other Reasons|1
5166094|NCT01342445|17838389|P2|Overall Study|Experienced side effects|2
5166095|NCT01342445|17838390|P1|Overall Study|Experienced side effects|0
5166096|NCT01342341|17838406|P2|Overall Study|Lost to Follow-up|4
5166097|NCT01342341|17838407|P1|Overall Study|Lost to Follow-up|4
5166098|NCT01342211|17838418|P5|Overall Study|Randomized, but not Treated|1
5166099|NCT01342211|17838419|P4|Overall Study|Randomized, but not Treated|0
5166100|NCT01342211|17838420|P3|Overall Study|Randomized, but not Treated|0
5166101|NCT01342211|17838421|P2|Overall Study|Randomized, but not Treated|2
5166102|NCT01342211|17838422|P1|Overall Study|Randomized, but not Treated|0
5166103|NCT01342211|17838418|P5|Overall Study|Withdrawal by Subject|0
5166104|NCT01342211|17838419|P4|Overall Study|Withdrawal by Subject|1
5166105|NCT01342211|17838420|P3|Overall Study|Withdrawal by Subject|0
5166106|NCT01342211|17838421|P2|Overall Study|Withdrawal by Subject|0
5166107|NCT01342211|17838422|P1|Overall Study|Withdrawal by Subject|0
5166108|NCT01342211|17838418|P5|Overall Study|Adverse Event|1
5166109|NCT01342211|17838419|P4|Overall Study|Adverse Event|0
5166110|NCT01342211|17838420|P3|Overall Study|Adverse Event|0
5166111|NCT01342211|17838421|P2|Overall Study|Adverse Event|0
5166112|NCT01342211|17838422|P1|Overall Study|Adverse Event|0
5166113|NCT01342211|17838418|P5|Overall Study|Lost to Follow-up|0
5166114|NCT01342211|17838419|P4|Overall Study|Lost to Follow-up|1
5166115|NCT01342211|17838420|P3|Overall Study|Lost to Follow-up|0
5166116|NCT01342211|17838421|P2|Overall Study|Lost to Follow-up|0
5166117|NCT01342211|17838422|P1|Overall Study|Lost to Follow-up|0
5166118|NCT01342094|17838510|P2|Overall Study|Withdrawal by Subject|2
5166119|NCT01342094|17838511|P1|Overall Study|Withdrawal by Subject|0
5166120|NCT01342094|17838510|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5166121|NCT01342094|17838511|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
5166122|NCT01342094|17838510|P2|Overall Study|Adverse Event|0
5166123|NCT01342094|17838511|P1|Overall Study|Adverse Event|5
5166124|NCT01342081|17838520|P3|Overall Study|Withdrawal by Subject|0
5166125|NCT01342081|17838521|P2|Overall Study|Withdrawal by Subject|1
5166126|NCT01342081|17838522|P1|Overall Study|Withdrawal by Subject|1
5166127|NCT01342081|17838520|P3|Overall Study|Physician Decision|0
5166128|NCT01342081|17838521|P2|Overall Study|Physician Decision|1
5166129|NCT01342081|17838522|P1|Overall Study|Physician Decision|0
5166130|NCT01342081|17838520|P3|Overall Study|Adverse Event|0
5166131|NCT01342081|17838521|P2|Overall Study|Adverse Event|0
5166132|NCT01342081|17838522|P1|Overall Study|Adverse Event|1
5166133|NCT01342081|17838520|P3|Overall Study|Did not receive allocated intervention|1
5166134|NCT01342081|17838521|P2|Overall Study|Did not receive allocated intervention|0
5166135|NCT01342081|17838522|P1|Overall Study|Did not receive allocated intervention|0
5166136|NCT01341990|17838541|P2|Overall Study|Withdrawal by Subject|0
5166137|NCT01341990|17838542|P1|Overall Study|Withdrawal by Subject|2
5166138|NCT01341990|17838541|P2|Overall Study|Torn Study Lens|0
5166139|NCT01341990|17838542|P1|Overall Study|Torn Study Lens|1
5166140|NCT01341990|17838541|P2|Overall Study|Adverse Event|1
5166141|NCT01341990|17838542|P1|Overall Study|Adverse Event|0
5166142|NCT01341782|17838566|P2|Overall Study|Other|0
5166143|NCT01341782|17838567|P1|Overall Study|Other|5
5166144|NCT01341782|17838566|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
5166145|NCT01341782|17838567|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
5166146|NCT01341782|17838566|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
5166147|NCT01341782|17838567|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
5166148|NCT01341782|17838566|P2|Overall Study|Missed 3 consecutive doses|4
5166149|NCT01341782|17838567|P1|Overall Study|Missed 3 consecutive doses|0
5166150|NCT01341782|17838566|P2|Overall Study|Withdrawal by Subject|5
5166151|NCT01341782|17838567|P1|Overall Study|Withdrawal by Subject|6
5166152|NCT01341782|17838566|P2|Overall Study|Adverse Event|1
5166153|NCT01341782|17838567|P1|Overall Study|Adverse Event|1
5166154|NCT01341652|17838596|P2|Overall Study|ineligible; presence metastatic disease|1
5166155|NCT01341652|17838597|P1|Overall Study|ineligible; presence metastatic disease|0
5166156|NCT01341652|17838596|P2|Overall Study|Incorrect Random Assignment|1
5166157|NCT01341652|17838597|P1|Overall Study|Incorrect Random Assignment|0
5166158|NCT01341639|17838613|P2|Post-Treatment|Adverse Event|2
5166159|NCT01341639|17838614|P1|Post-Treatment|Adverse Event|0
5166160|NCT01341639|17838613|P2|Post-Treatment|Withdrawal by Subject|1
5166161|NCT01341639|17838614|P1|Post-Treatment|Withdrawal by Subject|0
5166162|NCT01341639|17838613|P2|Interim Period|Protocol Violation|1
5166163|NCT01341639|17838614|P1|Interim Period|Protocol Violation|0
5166164|NCT01341639|17838613|P2|Interim Period|Physician Decision|1
5166165|NCT01341639|17838614|P1|Interim Period|Physician Decision|0
5166166|NCT01341639|17838613|P2|Interim Period|Lost to Follow-up|0
5166167|NCT01341639|17838614|P1|Interim Period|Lost to Follow-up|2
5166168|NCT01341639|17838613|P2|Interim Period|Withdrawal by Subject|7
5166169|NCT01341639|17838614|P1|Interim Period|Withdrawal by Subject|6
5166170|NCT01341639|17838613|P2|Infant Series|Site 0048 Participants|16
5166171|NCT01341639|17838614|P1|Infant Series|Site 0048 Participants|17
5166172|NCT01341639|17838613|P2|Infant Series|Lost to Follow-up|2
5166173|NCT01341639|17838614|P1|Infant Series|Lost to Follow-up|0
5166174|NCT01341639|17838613|P2|Infant Series|Withdrawal by Subject|8
5166175|NCT01341639|17838614|P1|Infant Series|Withdrawal by Subject|11
5166176|NCT01341639|17838613|P2|Infant Series|Adverse Event|5
5166177|NCT01341639|17838614|P1|Infant Series|Adverse Event|0
5166178|NCT01341639|17838613|P2|Infant Series|Not Vaccinated|1
5166179|NCT01341639|17838614|P1|Infant Series|Not Vaccinated|0
5166180|NCT01341639|17838613|P2|Infant Series|Protocol Violation|0
5166181|NCT01341639|17838614|P1|Infant Series|Protocol Violation|1
5166182|NCT01341587|17838659|P2|Overall Study|stopped using the meters|10
5166183|NCT01341587|17838660|P1|Overall Study|stopped using the meters|2
5166184|NCT01341587|17838659|P2|Overall Study|Lost to Follow-up|0
5166185|NCT01341587|17838660|P1|Overall Study|Lost to Follow-up|2
5166186|NCT01341470|17838672|P6|Overall Study|Sponsor decision|1
5166187|NCT01341470|17838673|P5|Overall Study|Sponsor decision|0
5166188|NCT01341470|17838674|P4|Overall Study|Sponsor decision|1
5166189|NCT01341470|17838675|P3|Overall Study|Sponsor decision|1
5166190|NCT01341470|17838676|P2|Overall Study|Sponsor decision|0
5166191|NCT01341470|17838677|P1|Overall Study|Sponsor decision|0
5166192|NCT01341457|17838711|P2|Overall Study|Adverse Event|0
5166193|NCT01341457|17838712|P1|Overall Study|Adverse Event|2
5166194|NCT01340976|17838757|P6|Overall Study|Adverse Event|0
5166195|NCT01340976|17838758|P5|Overall Study|Adverse Event|0
5166196|NCT01340976|17838759|P4|Overall Study|Adverse Event|0
5166197|NCT01340976|17838760|P3|Overall Study|Adverse Event|0
5166198|NCT01340976|17838761|P2|Overall Study|Adverse Event|1
5166199|NCT01340976|17838762|P1|Overall Study|Adverse Event|0
5166200|NCT01340976|17838757|P6|Overall Study|Other anemia treatment|1
5166201|NCT01340976|17838758|P5|Overall Study|Other anemia treatment|0
5166202|NCT01340976|17838759|P4|Overall Study|Other anemia treatment|1
5166203|NCT01340976|17838760|P3|Overall Study|Other anemia treatment|2
5166204|NCT01340976|17838761|P2|Overall Study|Other anemia treatment|0
5166205|NCT01340976|17838762|P1|Overall Study|Other anemia treatment|1
5166206|NCT01340976|17838757|P6|Overall Study|Withdrawal by Subject|0
5166207|NCT01340976|17838758|P5|Overall Study|Withdrawal by Subject|1
5166208|NCT01340976|17838759|P4|Overall Study|Withdrawal by Subject|1
5166209|NCT01340976|17838760|P3|Overall Study|Withdrawal by Subject|0
5166210|NCT01340976|17838761|P2|Overall Study|Withdrawal by Subject|0
5166211|NCT01340976|17838762|P1|Overall Study|Withdrawal by Subject|0
5166212|NCT01340976|17838757|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5166213|NCT01340976|17838758|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5166214|NCT01340976|17838759|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5166215|NCT01340976|17838760|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5166216|NCT01340976|17838761|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5166217|NCT01340976|17838762|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
5166218|NCT01340976|17838757|P6|Overall Study|Death|0
5166219|NCT01340976|17838758|P5|Overall Study|Death|0
5166220|NCT01340976|17838759|P4|Overall Study|Death|0
5166221|NCT01340976|17838760|P3|Overall Study|Death|0
5166222|NCT01340976|17838761|P2|Overall Study|Death|1
5166223|NCT01340976|17838762|P1|Overall Study|Death|0
5166224|NCT01340976|17838757|P6|Overall Study|Physician Decision|0
5166225|NCT01340976|17838758|P5|Overall Study|Physician Decision|1
5166226|NCT01340976|17838759|P4|Overall Study|Physician Decision|1
5166227|NCT01340976|17838760|P3|Overall Study|Physician Decision|1
5166228|NCT01340976|17838761|P2|Overall Study|Physician Decision|0
5166229|NCT01340976|17838762|P1|Overall Study|Physician Decision|2
5166230|NCT01340937|17838800|P4|Period 3: Toddler Vaccinations|Technical problem|0
5166231|NCT01340937|17838801|P3|Period 3: Toddler Vaccinations|Technical problem|1
5166232|NCT01340937|17838802|P2|Period 3: Toddler Vaccinations|Technical problem|1
5166233|NCT01340937|17838803|P1|Period 3: Toddler Vaccinations|Technical problem|1
5166234|NCT01340937|17838800|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
5166235|NCT01340937|17838801|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
5166236|NCT01340937|17838802|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
5166237|NCT01340937|17838803|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
5166238|NCT01340937|17838800|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
5166239|NCT01340937|17838801|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
5166240|NCT01340937|17838802|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
5166241|NCT01340937|17838803|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
5166242|NCT01340937|17838800|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
5166243|NCT01340937|17838801|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
5166244|NCT01340937|17838802|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
5166245|NCT01340937|17838803|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
5166246|NCT01340937|17838800|P4|Period 2: Interim Period|Technical problems|3
5166247|NCT01340937|17838801|P3|Period 2: Interim Period|Technical problems|6
5166248|NCT01340937|17838802|P2|Period 2: Interim Period|Technical problems|4
5166249|NCT01340937|17838803|P1|Period 2: Interim Period|Technical problems|4
5166250|NCT01340937|17838800|P4|Period 2: Interim Period|Protocol Violation|3
5166251|NCT01340937|17838801|P3|Period 2: Interim Period|Protocol Violation|6
5166252|NCT01340937|17838802|P2|Period 2: Interim Period|Protocol Violation|3
5166253|NCT01340937|17838803|P1|Period 2: Interim Period|Protocol Violation|5
5166254|NCT01340937|17838800|P4|Period 2: Interim Period|Physician Decision|0
5166255|NCT01340937|17838801|P3|Period 2: Interim Period|Physician Decision|1
5166256|NCT01340937|17838802|P2|Period 2: Interim Period|Physician Decision|1
5166257|NCT01340937|17838803|P1|Period 2: Interim Period|Physician Decision|0
5166258|NCT01340937|17838800|P4|Period 2: Interim Period|Lost to Follow-up|23
5166259|NCT01340937|17838801|P3|Period 2: Interim Period|Lost to Follow-up|53
5166260|NCT01340937|17838802|P2|Period 2: Interim Period|Lost to Follow-up|48
5166261|NCT01340937|17838803|P1|Period 2: Interim Period|Lost to Follow-up|29
5166262|NCT01340937|17838800|P4|Period 2: Interim Period|Adverse Event|0
5166263|NCT01340937|17838801|P3|Period 2: Interim Period|Adverse Event|1
5166264|NCT01340937|17838802|P2|Period 2: Interim Period|Adverse Event|0
5166265|NCT01340937|17838803|P1|Period 2: Interim Period|Adverse Event|1
5166266|NCT01340937|17838800|P4|Period 2: Interim Period|Withdrawal by Subject|12
5166267|NCT01340937|17838801|P3|Period 2: Interim Period|Withdrawal by Subject|17
5166268|NCT01340937|17838802|P2|Period 2: Interim Period|Withdrawal by Subject|23
5166269|NCT01340937|17838803|P1|Period 2: Interim Period|Withdrawal by Subject|28
5166270|NCT01340937|17838800|P4|Period 1: Infant Series|Randomized but not vaccinated|1
5166271|NCT01340937|17838801|P3|Period 1: Infant Series|Randomized but not vaccinated|2
5166272|NCT01340937|17838802|P2|Period 1: Infant Series|Randomized but not vaccinated|5
5166273|NCT01340937|17838803|P1|Period 1: Infant Series|Randomized but not vaccinated|0
5166274|NCT01340937|17838800|P4|Period 1: Infant Series|Withdrawal by Subject|15
5166275|NCT01340937|17838801|P3|Period 1: Infant Series|Withdrawal by Subject|30
5166276|NCT01340937|17838802|P2|Period 1: Infant Series|Withdrawal by Subject|32
5166277|NCT01340937|17838803|P1|Period 1: Infant Series|Withdrawal by Subject|33
5166278|NCT01340937|17838800|P4|Period 1: Infant Series|Protocol Violation|3
5166279|NCT01340937|17838801|P3|Period 1: Infant Series|Protocol Violation|4
5166280|NCT01340937|17838802|P2|Period 1: Infant Series|Protocol Violation|4
5166281|NCT01340937|17838803|P1|Period 1: Infant Series|Protocol Violation|1
5166282|NCT01340937|17838800|P4|Period 1: Infant Series|Physician Decision|0
5166283|NCT01340937|17838801|P3|Period 1: Infant Series|Physician Decision|1
5166284|NCT01340937|17838802|P2|Period 1: Infant Series|Physician Decision|3
5166285|NCT01340937|17838803|P1|Period 1: Infant Series|Physician Decision|2
5166286|NCT01340937|17838800|P4|Period 1: Infant Series|Lost to Follow-up|13
5166287|NCT01340937|17838801|P3|Period 1: Infant Series|Lost to Follow-up|12
5166288|NCT01340937|17838802|P2|Period 1: Infant Series|Lost to Follow-up|14
5166289|NCT01340937|17838803|P1|Period 1: Infant Series|Lost to Follow-up|20
5166290|NCT01340937|17838800|P4|Period 1: Infant Series|Death|0
5166291|NCT01340937|17838801|P3|Period 1: Infant Series|Death|2
5166292|NCT01340937|17838802|P2|Period 1: Infant Series|Death|0
5166293|NCT01340937|17838803|P1|Period 1: Infant Series|Death|2
5166294|NCT01340937|17838800|P4|Period 1: Infant Series|Adverse Event|0
5166295|NCT01340937|17838801|P3|Period 1: Infant Series|Adverse Event|4
5166296|NCT01340937|17838802|P2|Period 1: Infant Series|Adverse Event|1
5166297|NCT01340937|17838803|P1|Period 1: Infant Series|Adverse Event|0
5166298|NCT01340937|17838800|P4|Period 1: Infant Series|Other protocol criterion not met|0
5166299|NCT01340937|17838801|P3|Period 1: Infant Series|Other protocol criterion not met|1
5166300|NCT01340937|17838802|P2|Period 1: Infant Series|Other protocol criterion not met|1
5166301|NCT01340937|17838803|P1|Period 1: Infant Series|Other protocol criterion not met|0
5166302|NCT01340898|17838963|P3|Booster Phase|Lost to Follow-up|3
5166303|NCT01340898|17838964|P2|Booster Phase|Lost to Follow-up|2
5166304|NCT01340898|17838965|P1|Booster Phase|Lost to Follow-up|4
5166305|NCT01340898|17838963|P3|Booster Phase|Migrated/moved from study area|0
5166306|NCT01340898|17838964|P2|Booster Phase|Migrated/moved from study area|0
5166307|NCT01340898|17838965|P1|Booster Phase|Migrated/moved from study area|3
5166308|NCT01340898|17838963|P3|Booster Phase|Withdrawal by Subject|4
5166309|NCT01340898|17838964|P2|Booster Phase|Withdrawal by Subject|0
5166310|NCT01340898|17838965|P1|Booster Phase|Withdrawal by Subject|3
5166311|NCT01340898|17838963|P3|Primary Phase|Lost to Follow-up|0
5166312|NCT01340898|17838964|P2|Primary Phase|Lost to Follow-up|1
5166313|NCT01340898|17838965|P1|Primary Phase|Lost to Follow-up|4
5166314|NCT01340898|17838963|P3|Primary Phase|Migrated/moved from study area|0
5166315|NCT01340898|17838964|P2|Primary Phase|Migrated/moved from study area|1
5166316|NCT01340898|17838965|P1|Primary Phase|Migrated/moved from study area|4
5166317|NCT01340898|17838963|P3|Primary Phase|Withdrawal by Subject|5
5166318|NCT01340898|17838964|P2|Primary Phase|Withdrawal by Subject|7
5166319|NCT01340898|17838965|P1|Primary Phase|Withdrawal by Subject|8
5166320|NCT01340898|17838963|P3|Primary Phase|Serious Adverse Events|1
5166321|NCT01340898|17838964|P2|Primary Phase|Serious Adverse Events|0
5166322|NCT01340898|17838965|P1|Primary Phase|Serious Adverse Events|0
5166323|NCT01340872|17839095|P4|Open-label Phase|Worsening of IBD|0
5166324|NCT01340872|17839096|P3|Open-label Phase|Worsening of IBD|1
5166325|NCT01340872|17839097|P2|Open-label Phase|Worsening of IBD|0
5166326|NCT01340872|17839098|P1|Open-label Phase|Worsening of IBD|0
5166327|NCT01340872|17839095|P4|Open-label Phase|Withdrawal by Subject|6
5166328|NCT01340872|17839096|P3|Open-label Phase|Withdrawal by Subject|1
5166329|NCT01340872|17839097|P2|Open-label Phase|Withdrawal by Subject|0
5166330|NCT01340872|17839098|P1|Open-label Phase|Withdrawal by Subject|0
5166331|NCT01340872|17839095|P4|Open-label Phase|Adverse Event|4
5166332|NCT01340872|17839096|P3|Open-label Phase|Adverse Event|8
5166333|NCT01340872|17839097|P2|Open-label Phase|Adverse Event|0
5166334|NCT01340872|17839098|P1|Open-label Phase|Adverse Event|0
5166335|NCT01340872|17839095|P4|Open-label Phase|Pregnancy|0
5166336|NCT01340872|17839096|P3|Open-label Phase|Pregnancy|1
5166337|NCT01340872|17839097|P2|Open-label Phase|Pregnancy|0
5166338|NCT01340872|17839098|P1|Open-label Phase|Pregnancy|0
5166339|NCT01340872|17839095|P4|Open-label Phase|Physician Decision|1
5166340|NCT01340872|17839096|P3|Open-label Phase|Physician Decision|2
5166341|NCT01340872|17839097|P2|Open-label Phase|Physician Decision|0
5166342|NCT01340872|17839098|P1|Open-label Phase|Physician Decision|0
5166343|NCT01340872|17839095|P4|Double-blind Phase|Protocol Violation|0
5166344|NCT01340872|17839096|P3|Double-blind Phase|Protocol Violation|0
5166345|NCT01340872|17839097|P2|Double-blind Phase|Protocol Violation|1
5166346|NCT01340872|17839098|P1|Double-blind Phase|Protocol Violation|0
5166347|NCT01340872|17839095|P4|Double-blind Phase|Lost to Follow-up|0
5166348|NCT01340872|17839096|P3|Double-blind Phase|Lost to Follow-up|0
5166349|NCT01340872|17839097|P2|Double-blind Phase|Lost to Follow-up|1
5166350|NCT01340872|17839098|P1|Double-blind Phase|Lost to Follow-up|0
5166351|NCT01340872|17839095|P4|Double-blind Phase|Withdrawal by Subject|0
5166352|NCT01340872|17839096|P3|Double-blind Phase|Withdrawal by Subject|0
5166353|NCT01340872|17839097|P2|Double-blind Phase|Withdrawal by Subject|5
5166354|NCT01340872|17839098|P1|Double-blind Phase|Withdrawal by Subject|3
5166355|NCT01340872|17839095|P4|Double-blind Phase|Adverse Event|0
5166356|NCT01340872|17839096|P3|Double-blind Phase|Adverse Event|0
5166357|NCT01340872|17839097|P2|Double-blind Phase|Adverse Event|4
5166358|NCT01340872|17839098|P1|Double-blind Phase|Adverse Event|6
5166359|NCT01340794|17839158|P2|Overall Study|Withdrawal by Subject|1
5166360|NCT01340794|17839159|P1|Overall Study|Withdrawal by Subject|0
5166361|NCT01340768|17839175|P2|Overall Study|Other|0
5166362|NCT01340768|17839176|P1|Overall Study|Other|2
5166363|NCT01340768|17839175|P2|Overall Study|Withdrawal by Subject|1
5166364|NCT01340768|17839176|P1|Overall Study|Withdrawal by Subject|5
5166365|NCT01340768|17839175|P2|Overall Study|Lost to Follow-up|4
5166366|NCT01340768|17839176|P1|Overall Study|Lost to Follow-up|10
5166367|NCT01340664|17839187|P3|Overall Study|Other|2
5166368|NCT01340664|17839188|P2|Overall Study|Other|2
5166369|NCT01340664|17839189|P1|Overall Study|Other|1
5166370|NCT01340664|17839187|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
5166371|NCT01340664|17839188|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
5166372|NCT01340664|17839189|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
5166373|NCT01340664|17839187|P3|Overall Study|Glycemic withdrawal criteria|0
5166374|NCT01340664|17839188|P2|Overall Study|Glycemic withdrawal criteria|0
5166375|NCT01340664|17839189|P1|Overall Study|Glycemic withdrawal criteria|2
5166376|NCT01340664|17839187|P3|Overall Study|Withdrawal by Subject|0
5166377|NCT01340664|17839188|P2|Overall Study|Withdrawal by Subject|4
5166378|NCT01340664|17839189|P1|Overall Study|Withdrawal by Subject|2
5166379|NCT01340664|17839187|P3|Overall Study|Lost to Follow-up|2
5166380|NCT01340664|17839188|P2|Overall Study|Lost to Follow-up|0
5166381|NCT01340664|17839189|P1|Overall Study|Lost to Follow-up|2
5166382|NCT01340664|17839187|P3|Overall Study|Adverse Event|7
5166383|NCT01340664|17839188|P2|Overall Study|Adverse Event|1
5166384|NCT01340664|17839189|P1|Overall Study|Adverse Event|0
5166385|NCT01340651|17839206|P1|Overall Study|Commercial Supply per Sponsor|12
5166386|NCT01340651|17839206|P1|Overall Study|Consent Withdrawn|2
5166387|NCT01340651|17839206|P1|Overall Study|Adverse Event|3
5166388|NCT01340625|17839222|P2|Washout Period of 28 Days|Withdrawal by Subject|0
5166389|NCT01340625|17839223|P1|Washout Period of 28 Days|Withdrawal by Subject|1
5166390|NCT01340625|17839222|P2|First Intervention|Adverse Event|0
5166391|NCT01340625|17839223|P1|First Intervention|Adverse Event|1
5166392|NCT01340495|17839328|P1|Overall Study|Withdrawal by Subject|1
5166393|NCT01340482|17839338|P3|Overall Study|Adverse Event|0
5166394|NCT01340482|17839339|P2|Overall Study|Adverse Event|0
5166395|NCT01340482|17839340|P1|Overall Study|Adverse Event|2
5166396|NCT01340300|17839355|P4|Overall Study|Unrelated sickness|1
5166397|NCT01340300|17839356|P3|Overall Study|Unrelated sickness|0
5166398|NCT01340300|17839357|P2|Overall Study|Unrelated sickness|2
5166399|NCT01340300|17839358|P1|Overall Study|Unrelated sickness|0
5166400|NCT01340300|17839355|P4|Overall Study|Physician Decision|0
5166401|NCT01340300|17839356|P3|Overall Study|Physician Decision|0
5166402|NCT01340300|17839357|P2|Overall Study|Physician Decision|1
5166403|NCT01340300|17839358|P1|Overall Study|Physician Decision|0
5166404|NCT01340300|17839355|P4|Overall Study|Adverse Event|0
5166405|NCT01340300|17839356|P3|Overall Study|Adverse Event|4
5166406|NCT01340300|17839357|P2|Overall Study|Adverse Event|0
5166407|NCT01340300|17839358|P1|Overall Study|Adverse Event|1
5166408|NCT01340300|17839355|P4|Overall Study|Withdrawal by Subject|3
5166409|NCT01340300|17839356|P3|Overall Study|Withdrawal by Subject|6
5166410|NCT01340300|17839357|P2|Overall Study|Withdrawal by Subject|6
5166411|NCT01340300|17839358|P1|Overall Study|Withdrawal by Subject|5
5166412|NCT01340300|17839355|P4|Overall Study|Lost to Follow-up|10
5166413|NCT01340300|17839356|P3|Overall Study|Lost to Follow-up|5
5166414|NCT01340300|17839357|P2|Overall Study|Lost to Follow-up|0
5166415|NCT01340300|17839358|P1|Overall Study|Lost to Follow-up|3
5166416|NCT01340209|17839391|P3|Overall Study|Other reason not defined above|4
5166417|NCT01340209|17839392|P2|Overall Study|Other reason not defined above|5
5166418|NCT01340209|17839393|P1|Overall Study|Other reason not defined above|3
5166419|NCT01340209|17839391|P3|Overall Study|Withdrawal by Subject|1
5166420|NCT01340209|17839392|P2|Overall Study|Withdrawal by Subject|0
5166421|NCT01340209|17839393|P1|Overall Study|Withdrawal by Subject|0
5166422|NCT01340209|17839391|P3|Overall Study|Protocol Violation|1
5166423|NCT01340209|17839392|P2|Overall Study|Protocol Violation|2
5166424|NCT01340209|17839393|P1|Overall Study|Protocol Violation|1
5166425|NCT01340209|17839391|P3|Overall Study|Adverse Event|2
5166426|NCT01340209|17839392|P2|Overall Study|Adverse Event|1
5166427|NCT01340209|17839393|P1|Overall Study|Adverse Event|1
5166428|NCT01340196|17839428|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
5166429|NCT01340066|17839468|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
5166430|NCT01340066|17839469|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
5166431|NCT01340066|17839470|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
5166432|NCT01340066|17839468|P3|5 Week Double Blind Randomization Period|Physician Decision|0
5166433|NCT01340066|17839469|P2|5 Week Double Blind Randomization Period|Physician Decision|1
5166434|NCT01340066|17839470|P1|5 Week Double Blind Randomization Period|Physician Decision|0
5166435|NCT01340066|17839468|P3|5 Week Double Blind Randomization Period|Adverse Event|2
5166436|NCT01340066|17839469|P2|5 Week Double Blind Randomization Period|Adverse Event|2
5166437|NCT01340066|17839470|P1|5 Week Double Blind Randomization Period|Adverse Event|0
5166438|NCT01340066|17839468|P3|Placebo Run in Period|Screen Failures|0
5166439|NCT01340066|17839469|P2|Placebo Run in Period|Screen Failures|0
5166440|NCT01340066|17839470|P1|Placebo Run in Period|Screen Failures|27
5166441|NCT01340027|17839510|P12|Overall Study|Miscellaneous|0
5166442|NCT01340027|17839511|P11|Overall Study|Miscellaneous|1
5166443|NCT01340027|17839512|P10|Overall Study|Miscellaneous|0
5166444|NCT01340027|17839513|P9|Overall Study|Miscellaneous|0
5166445|NCT01340027|17839514|P8|Overall Study|Miscellaneous|0
5166446|NCT01340027|17839515|P7|Overall Study|Miscellaneous|0
5166447|NCT01340027|17839516|P6|Overall Study|Miscellaneous|0
5166448|NCT01340027|17839517|P5|Overall Study|Miscellaneous|0
5166449|NCT01340027|17839518|P4|Overall Study|Miscellaneous|1
5166450|NCT01340027|17839519|P3|Overall Study|Miscellaneous|0
5166451|NCT01340027|17839520|P2|Overall Study|Miscellaneous|0
5166452|NCT01340027|17839521|P1|Overall Study|Miscellaneous|0
5166453|NCT01340027|17839510|P12|Overall Study|Withdrawal by Subject|1
5166454|NCT01340027|17839511|P11|Overall Study|Withdrawal by Subject|0
5166455|NCT01340027|17839512|P10|Overall Study|Withdrawal by Subject|2
5166456|NCT01340027|17839513|P9|Overall Study|Withdrawal by Subject|1
5166457|NCT01340027|17839514|P8|Overall Study|Withdrawal by Subject|4
5166458|NCT01340027|17839515|P7|Overall Study|Withdrawal by Subject|3
5166459|NCT01340027|17839516|P6|Overall Study|Withdrawal by Subject|2
5166460|NCT01340027|17839517|P5|Overall Study|Withdrawal by Subject|3
5166461|NCT01340027|17839518|P4|Overall Study|Withdrawal by Subject|3
5166462|NCT01340027|17839519|P3|Overall Study|Withdrawal by Subject|1
5166463|NCT01340027|17839520|P2|Overall Study|Withdrawal by Subject|3
5166464|NCT01340027|17839521|P1|Overall Study|Withdrawal by Subject|4
5166465|NCT01340027|17839510|P12|Overall Study|Protocol Violation|0
5166466|NCT01340027|17839511|P11|Overall Study|Protocol Violation|0
5166467|NCT01340027|17839512|P10|Overall Study|Protocol Violation|2
5166468|NCT01340027|17839513|P9|Overall Study|Protocol Violation|2
5166469|NCT01340027|17839514|P8|Overall Study|Protocol Violation|1
5166470|NCT01340027|17839515|P7|Overall Study|Protocol Violation|0
5166471|NCT01340027|17839516|P6|Overall Study|Protocol Violation|0
5166472|NCT01340027|17839517|P5|Overall Study|Protocol Violation|6
5166473|NCT01340027|17839518|P4|Overall Study|Protocol Violation|0
5166474|NCT01340027|17839519|P3|Overall Study|Protocol Violation|0
5166475|NCT01340027|17839520|P2|Overall Study|Protocol Violation|2
5166476|NCT01340027|17839521|P1|Overall Study|Protocol Violation|1
5166477|NCT01340027|17839510|P12|Overall Study|Lost to Follow-up|0
5166478|NCT01340027|17839511|P11|Overall Study|Lost to Follow-up|0
5166479|NCT01340027|17839512|P10|Overall Study|Lost to Follow-up|1
5166480|NCT01340027|17839513|P9|Overall Study|Lost to Follow-up|0
5166481|NCT01340027|17839514|P8|Overall Study|Lost to Follow-up|0
5166482|NCT01340027|17839515|P7|Overall Study|Lost to Follow-up|1
5166483|NCT01340027|17839516|P6|Overall Study|Lost to Follow-up|0
5166484|NCT01340027|17839517|P5|Overall Study|Lost to Follow-up|0
5166485|NCT01340027|17839518|P4|Overall Study|Lost to Follow-up|0
5166486|NCT01340027|17839519|P3|Overall Study|Lost to Follow-up|0
5166487|NCT01340027|17839520|P2|Overall Study|Lost to Follow-up|1
5166488|NCT01340027|17839521|P1|Overall Study|Lost to Follow-up|0
5166489|NCT01340027|17839510|P12|Overall Study|Lack of Efficacy|0
5166490|NCT01340027|17839511|P11|Overall Study|Lack of Efficacy|0
5166491|NCT01340027|17839512|P10|Overall Study|Lack of Efficacy|0
5166492|NCT01340027|17839513|P9|Overall Study|Lack of Efficacy|1
5166493|NCT01340027|17839514|P8|Overall Study|Lack of Efficacy|1
5166494|NCT01340027|17839515|P7|Overall Study|Lack of Efficacy|1
5166495|NCT01340027|17839516|P6|Overall Study|Lack of Efficacy|0
5166496|NCT01340027|17839517|P5|Overall Study|Lack of Efficacy|0
5166497|NCT01340027|17839518|P4|Overall Study|Lack of Efficacy|0
5166498|NCT01340027|17839519|P3|Overall Study|Lack of Efficacy|0
5166499|NCT01340027|17839520|P2|Overall Study|Lack of Efficacy|0
5166500|NCT01340027|17839521|P1|Overall Study|Lack of Efficacy|0
5166501|NCT01340027|17839510|P12|Overall Study|Adverse Event|3
5166502|NCT01340027|17839511|P11|Overall Study|Adverse Event|1
5166503|NCT01340027|17839512|P10|Overall Study|Adverse Event|1
5166504|NCT01340027|17839513|P9|Overall Study|Adverse Event|4
5166505|NCT01340027|17839514|P8|Overall Study|Adverse Event|1
5166506|NCT01340027|17839515|P7|Overall Study|Adverse Event|2
5166507|NCT01340027|17839516|P6|Overall Study|Adverse Event|2
5166508|NCT01340027|17839517|P5|Overall Study|Adverse Event|1
5166509|NCT01340027|17839518|P4|Overall Study|Adverse Event|0
5166510|NCT01340027|17839519|P3|Overall Study|Adverse Event|2
5166511|NCT01340027|17839520|P2|Overall Study|Adverse Event|1
5166512|NCT01340027|17839521|P1|Overall Study|Adverse Event|0
5166513|NCT01340027|17839510|P12|Overall Study|Randomized but Never Received Study Drug|0
5166514|NCT01340027|17839511|P11|Overall Study|Randomized but Never Received Study Drug|0
5166515|NCT01340027|17839512|P10|Overall Study|Randomized but Never Received Study Drug|0
5166516|NCT01340027|17839513|P9|Overall Study|Randomized but Never Received Study Drug|0
5166517|NCT01340027|17839514|P8|Overall Study|Randomized but Never Received Study Drug|0
5166518|NCT01340027|17839515|P7|Overall Study|Randomized but Never Received Study Drug|0
5166519|NCT01340027|17839516|P6|Overall Study|Randomized but Never Received Study Drug|0
5166520|NCT01340027|17839517|P5|Overall Study|Randomized but Never Received Study Drug|0
5166521|NCT01340027|17839518|P4|Overall Study|Randomized but Never Received Study Drug|0
5166522|NCT01340027|17839519|P3|Overall Study|Randomized but Never Received Study Drug|1
5166523|NCT01340027|17839520|P2|Overall Study|Randomized but Never Received Study Drug|0
5166524|NCT01340027|17839521|P1|Overall Study|Randomized but Never Received Study Drug|0
5166525|NCT01340014|17839897|P2|Period 2, Second 7 Days|Adverse Event|1
5166526|NCT01340014|17839898|P1|Period 2, Second 7 Days|Adverse Event|0
5166527|NCT01340014|17839897|P2|Period 1, First 7 Days|Personal Reasons|0
5166528|NCT01340014|17839898|P1|Period 1, First 7 Days|Personal Reasons|1
5166529|NCT01340014|17839897|P2|Period 1, First 7 Days|Adverse Event|0
5166530|NCT01340014|17839898|P1|Period 1, First 7 Days|Adverse Event|1
5166531|NCT01339923|17839919|P7|Overall Study|Withdrawal by Subject|2
5166532|NCT01339923|17839920|P6|Overall Study|Withdrawal by Subject|3
5166533|NCT01339923|17839921|P5|Overall Study|Withdrawal by Subject|4
5166534|NCT01339923|17839922|P4|Overall Study|Withdrawal by Subject|1
5166535|NCT01339923|17839923|P3|Overall Study|Withdrawal by Subject|6
5166536|NCT01339923|17839924|P2|Overall Study|Withdrawal by Subject|11
5166537|NCT01339923|17839925|P1|Overall Study|Withdrawal by Subject|7
5166538|NCT01339923|17839919|P7|Overall Study|Unable to Classify|5
5166539|NCT01339923|17839920|P6|Overall Study|Unable to Classify|1
5166540|NCT01339923|17839921|P5|Overall Study|Unable to Classify|0
5166541|NCT01339923|17839922|P4|Overall Study|Unable to Classify|0
5166542|NCT01339923|17839923|P3|Overall Study|Unable to Classify|1
5166543|NCT01339923|17839924|P2|Overall Study|Unable to Classify|0
5166544|NCT01339923|17839925|P1|Overall Study|Unable to Classify|1
5166545|NCT01339923|17839919|P7|Overall Study|Protocol Violation|1
5166546|NCT01339923|17839920|P6|Overall Study|Protocol Violation|3
5166547|NCT01339923|17839921|P5|Overall Study|Protocol Violation|0
5166548|NCT01339923|17839922|P4|Overall Study|Protocol Violation|0
5166549|NCT01339923|17839923|P3|Overall Study|Protocol Violation|0
5166550|NCT01339923|17839924|P2|Overall Study|Protocol Violation|0
5166551|NCT01339923|17839925|P1|Overall Study|Protocol Violation|0
5166552|NCT01339923|17839919|P7|Overall Study|Lost to Follow-up|5
5166553|NCT01339923|17839920|P6|Overall Study|Lost to Follow-up|1
5166554|NCT01339923|17839921|P5|Overall Study|Lost to Follow-up|1
5166555|NCT01339923|17839922|P4|Overall Study|Lost to Follow-up|3
5166556|NCT01339923|17839923|P3|Overall Study|Lost to Follow-up|0
5166557|NCT01339923|17839924|P2|Overall Study|Lost to Follow-up|4
5166558|NCT01339923|17839925|P1|Overall Study|Lost to Follow-up|4
5166559|NCT01339923|17839919|P7|Overall Study|Inappropriate Enrollment|0
5166560|NCT01339923|17839920|P6|Overall Study|Inappropriate Enrollment|1
5166561|NCT01339923|17839921|P5|Overall Study|Inappropriate Enrollment|0
5166562|NCT01339923|17839922|P4|Overall Study|Inappropriate Enrollment|0
5166563|NCT01339923|17839923|P3|Overall Study|Inappropriate Enrollment|0
5166564|NCT01339923|17839924|P2|Overall Study|Inappropriate Enrollment|0
5166565|NCT01339923|17839925|P1|Overall Study|Inappropriate Enrollment|1
5166566|NCT01339923|17839919|P7|Overall Study|Adverse Event|1
5166567|NCT01339923|17839920|P6|Overall Study|Adverse Event|0
5166568|NCT01339923|17839921|P5|Overall Study|Adverse Event|0
5166569|NCT01339923|17839922|P4|Overall Study|Adverse Event|0
5166570|NCT01339923|17839923|P3|Overall Study|Adverse Event|1
5166571|NCT01339923|17839924|P2|Overall Study|Adverse Event|1
5166572|NCT01339923|17839925|P1|Overall Study|Adverse Event|1
5166573|NCT01339910|17839996|P2|Overall Study|Disease relapse|4
5166574|NCT01339910|17839997|P1|Overall Study|Disease relapse|1
5166575|NCT01339910|17839996|P2|Overall Study|Physician Decision|0
5166576|NCT01339910|17839997|P1|Overall Study|Physician Decision|1
5166577|NCT01339910|17839996|P2|Overall Study|Withdrawal by Subject|0
5166578|NCT01339910|17839997|P1|Overall Study|Withdrawal by Subject|1
5166579|NCT01339897|17840035|P4|Overall Study|Adverse Event|1
5166580|NCT01339897|17840036|P3|Overall Study|Adverse Event|0
5166581|NCT01339897|17840037|P2|Overall Study|Adverse Event|0
5166582|NCT01339897|17840038|P1|Overall Study|Adverse Event|1
5166583|NCT01339832|17840091|P1|Overall Study|Death|11
5166584|NCT01339832|17840091|P1|Overall Study|Lost to Follow-up|3
5166585|NCT01339559|17840102|P1|Overall Study|PI decision|1
5166586|NCT01339559|17840102|P1|Overall Study|Patient didn't wish to continue|1
5166587|NCT01339559|17840102|P1|Overall Study|Investigator decision|2
5166588|NCT01339559|17840102|P1|Overall Study|Left the country|1
5166589|NCT01339559|17840102|P1|Overall Study|Pregnancy planned|2
5166590|NCT01339559|17840102|P1|Overall Study|Epilepsy surgery|1
5166591|NCT01339559|17840102|P1|Overall Study|Incarcerated|2
5166592|NCT01339559|17840102|P1|Overall Study|Study closure at site|1
5166593|NCT01339559|17840102|P1|Overall Study|Protocol Violation|15
5166594|NCT01339559|17840102|P1|Overall Study|Subject choice|89
5166595|NCT01339559|17840102|P1|Overall Study|Lost to Follow-up|22
5166596|NCT01339559|17840102|P1|Overall Study|Lack of Efficacy|164
5166597|NCT01339559|17840102|P1|Overall Study|Death|5
5166598|NCT01339559|17840102|P1|Overall Study|Adverse Event|92
5166599|NCT01339429|17840111|P1|Overall Study|Physician Decision|3
5166600|NCT01339429|17840111|P1|Overall Study|Withdrawal by Subject|1
5166601|NCT01339390|17840151|P2|Overall Study|Lost to Follow-up|127
5166602|NCT01339390|17840152|P1|Overall Study|Lost to Follow-up|125
5166603|NCT01339390|17840151|P2|Overall Study|Death|29
5166604|NCT01339390|17840152|P1|Overall Study|Death|32
5166605|NCT01339273|17840169|P2|Overall Study|Lost to Follow-up|8
5166606|NCT01339273|17840170|P1|Overall Study|Lost to Follow-up|8
5166607|NCT01339052|17840245|P2|Overall Study|Physician Decision|0
5166608|NCT01339052|17840246|P1|Overall Study|Physician Decision|1
5166609|NCT01339052|17840245|P2|Overall Study|Withdrawal by Subject|3
5166610|NCT01339052|17840246|P1|Overall Study|Withdrawal by Subject|0
5166611|NCT01339052|17840245|P2|Overall Study|Adverse Event|1
5166612|NCT01339052|17840246|P1|Overall Study|Adverse Event|1
5166613|NCT01339052|17840245|P2|Overall Study|Disease progression|46
5166614|NCT01339052|17840246|P1|Overall Study|Disease progression|13
5166615|NCT01339000|17840272|P2|Overall Study|study closed due to lack of drug supply|0
5166616|NCT01339000|17840273|P1|Overall Study|study closed due to lack of drug supply|1
5166617|NCT01338987|17840292|P5|Overall Study|Disease progression on study|0
5166618|NCT01338987|17840293|P4|Overall Study|Disease progression on study|0
5166619|NCT01338987|17840294|P3|Overall Study|Disease progression on study|1
5166620|NCT01338987|17840295|P2|Overall Study|Disease progression on study|1
5166621|NCT01338987|17840296|P1|Overall Study|Disease progression on study|2
5166622|NCT01338987|17840292|P5|Overall Study|enrolled on new protocol|0
5166623|NCT01338987|17840293|P4|Overall Study|enrolled on new protocol|0
5166624|NCT01338987|17840294|P3|Overall Study|enrolled on new protocol|1
5166625|NCT01338987|17840295|P2|Overall Study|enrolled on new protocol|0
5166626|NCT01338987|17840296|P1|Overall Study|enrolled on new protocol|0
5166627|NCT01338870|17840317|P6|Overall Study|Adverse Event|1
5166628|NCT01338870|17840318|P5|Overall Study|Adverse Event|4
5166629|NCT01338870|17840319|P4|Overall Study|Adverse Event|5
5166630|NCT01338870|17840320|P3|Overall Study|Adverse Event|1
5166631|NCT01338870|17840321|P2|Overall Study|Adverse Event|4
5166632|NCT01338870|17840322|P1|Overall Study|Adverse Event|4
5166633|NCT01338870|17840317|P6|Overall Study|Protocol Violation|1
5166634|NCT01338870|17840318|P5|Overall Study|Protocol Violation|1
5166635|NCT01338870|17840319|P4|Overall Study|Protocol Violation|2
5166636|NCT01338870|17840320|P3|Overall Study|Protocol Violation|2
5166637|NCT01338870|17840321|P2|Overall Study|Protocol Violation|2
5166638|NCT01338870|17840322|P1|Overall Study|Protocol Violation|0
5166639|NCT01338870|17840317|P6|Overall Study|Other|2
5166640|NCT01338870|17840318|P5|Overall Study|Other|0
5166641|NCT01338870|17840319|P4|Overall Study|Other|2
5166642|NCT01338870|17840320|P3|Overall Study|Other|3
5166643|NCT01338870|17840321|P2|Overall Study|Other|3
5166644|NCT01338870|17840322|P1|Overall Study|Other|3
5166645|NCT01338870|17840317|P6|Overall Study|Withdrawal by Subject|2
5166646|NCT01338870|17840318|P5|Overall Study|Withdrawal by Subject|0
5166647|NCT01338870|17840319|P4|Overall Study|Withdrawal by Subject|0
5166648|NCT01338870|17840320|P3|Overall Study|Withdrawal by Subject|4
5166649|NCT01338870|17840321|P2|Overall Study|Withdrawal by Subject|3
5166650|NCT01338870|17840322|P1|Overall Study|Withdrawal by Subject|2
5166651|NCT01338870|17840317|P6|Overall Study|Lost to Follow-up|0
5166652|NCT01338870|17840318|P5|Overall Study|Lost to Follow-up|1
5166653|NCT01338870|17840319|P4|Overall Study|Lost to Follow-up|0
5166654|NCT01338870|17840320|P3|Overall Study|Lost to Follow-up|1
5166655|NCT01338870|17840321|P2|Overall Study|Lost to Follow-up|0
5166656|NCT01338870|17840322|P1|Overall Study|Lost to Follow-up|0
5166657|NCT01338818|17840377|P1|Overall Study|Protocol Deviation|4
5166658|NCT01338818|17840377|P1|Overall Study|Administrative problems|3
5166659|NCT01338818|17840377|P1|Overall Study|Lost to Follow-up|4
5166660|NCT01338818|17840377|P1|Overall Study|Withdrawal by Subject|11
5166661|NCT01338818|17840377|P1|Overall Study|no longer require study drug|1
5166662|NCT01338818|17840377|P1|Overall Study|Lack of Efficacy|5
5166663|NCT01338818|17840377|P1|Overall Study|Adverse Event|8
5166664|NCT01338792|17840383|P1|Overall Study|Withdrawal by Subject|1
5166665|NCT01338792|17840383|P1|Overall Study|Death|1
5166666|NCT01338792|17840383|P1|Overall Study|Adverse Event|2
5166667|NCT01338636|17840398|P1|Overall Study|Withdrawn due to lack of improvement|8
5166668|NCT01338610|17840412|P3|Overall Study|Adverse Event|0
5166669|NCT01338610|17840413|P2|Overall Study|Adverse Event|0
5166670|NCT01338610|17840414|P1|Overall Study|Adverse Event|3
5166671|NCT01338610|17840412|P3|Overall Study|Protocol Violation|1
5166672|NCT01338610|17840413|P2|Overall Study|Protocol Violation|0
5166673|NCT01338610|17840414|P1|Overall Study|Protocol Violation|1
5166674|NCT01338610|17840412|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
5166675|NCT01338610|17840413|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
5166676|NCT01338610|17840414|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
5166677|NCT01338493|17840440|P1|12 Months Follow up|Lost to Follow-up|9
5166678|NCT01338493|17840440|P1|6 Months Follow up|Missed visit|8
5166679|NCT01338493|17840440|P1|6 Months Follow up|Lost to Follow-up|11
5166680|NCT01338493|17840440|P1|Discharge|Missed visit|1
5166681|NCT01338493|17840440|P1|Discharge|Death|1
5166682|NCT01338493|17840440|P1|Enrolled|Patient not implanted|4
5166683|NCT01338493|17840440|P1|Enrolled|Withdrawal by Subject|1
5166684|NCT01338415|17840447|P2|Overall Study|Other (administrative reason)|0
5166685|NCT01338415|17840448|P1|Overall Study|Other (administrative reason)|1
5166686|NCT01338415|17840447|P2|Overall Study|Other (PAH not the main etiology of PH)|2
5166687|NCT01338415|17840448|P1|Overall Study|Other (PAH not the main etiology of PH)|0
5166688|NCT01338415|17840447|P2|Overall Study|Withdrawal by Subject|1
5166689|NCT01338415|17840448|P1|Overall Study|Withdrawal by Subject|1
5166690|NCT01338415|17840447|P2|Overall Study|Adverse Event|6
5166691|NCT01338415|17840448|P1|Overall Study|Adverse Event|8
5166692|NCT01338298|17840470|P2|Overall Study|Non-adherence|0
5166693|NCT01338298|17840471|P1|Overall Study|Non-adherence|1
5166694|NCT01338298|17840470|P2|Overall Study|Depressive symptoms and nausea|0
5166695|NCT01338298|17840471|P1|Overall Study|Depressive symptoms and nausea|1
5166696|NCT01338298|17840470|P2|Overall Study|Positive symptom worsening|0
5166697|NCT01338298|17840471|P1|Overall Study|Positive symptom worsening|1
5166698|NCT01338298|17840470|P2|Overall Study|Administrative error|1
5166699|NCT01338298|17840471|P1|Overall Study|Administrative error|0
5166700|NCT01338298|17840470|P2|Overall Study|Abdominal Pain and scheduled surgery|1
5166701|NCT01338298|17840471|P1|Overall Study|Abdominal Pain and scheduled surgery|0
5166702|NCT01338298|17840470|P2|Overall Study|Withdrawal by Subject|1
5166703|NCT01338298|17840471|P1|Overall Study|Withdrawal by Subject|1
5166704|NCT01338025|17840481|P2|Overall Study|Found ineligible after starting|0
5166705|NCT01338025|17840482|P1|Overall Study|Found ineligible after starting|1
5166706|NCT01338025|17840481|P2|Overall Study|Withdrawal by Subject|2
5166707|NCT01338025|17840482|P1|Overall Study|Withdrawal by Subject|0
5166708|NCT01338025|17840481|P2|Overall Study|Unexpected closure of study|9
5166709|NCT01338025|17840482|P1|Overall Study|Unexpected closure of study|10
5166710|NCT01338012|17840494|P1|Overall Study|Study terminated|4
5166711|NCT01338012|17840494|P1|Overall Study|Death|4
5166712|NCT01337986|17840500|P2|Overall Study|Protocol Violation|3
5166713|NCT01337986|17840501|P1|Overall Study|Protocol Violation|0
5166714|NCT01337986|17840500|P2|Overall Study|Lost to Follow-up|0
5166715|NCT01337986|17840501|P1|Overall Study|Lost to Follow-up|1
5166716|NCT01337986|17840500|P2|Overall Study|Adverse Event|2
5166717|NCT01337986|17840501|P1|Overall Study|Adverse Event|2
5166718|NCT01337973|17840538|P3|Overall Study|missing data on primary outcome|3
5166719|NCT01337973|17840539|P2|Overall Study|missing data on primary outcome|1
5166720|NCT01337973|17840540|P1|Overall Study|missing data on primary outcome|3
5166721|NCT01337973|17840538|P3|Overall Study|Withdrawal by Subject|4
5166722|NCT01337973|17840539|P2|Overall Study|Withdrawal by Subject|8
5166723|NCT01337973|17840540|P1|Overall Study|Withdrawal by Subject|10
5166724|NCT01337973|17840538|P3|Overall Study|Death|1
5166725|NCT01337973|17840539|P2|Overall Study|Death|2
5166726|NCT01337973|17840540|P1|Overall Study|Death|1
5166727|NCT01337973|17840538|P3|Overall Study|Lost to Follow-up|3
5166728|NCT01337973|17840539|P2|Overall Study|Lost to Follow-up|4
5166729|NCT01337973|17840540|P1|Overall Study|Lost to Follow-up|2
5166730|NCT01337960|17840554|P3|Overall Study|Withdrawal by Subject|0
5166731|NCT01337960|17840555|P2|Overall Study|Withdrawal by Subject|0
5166732|NCT01337960|17840556|P1|Overall Study|Withdrawal by Subject|1
5166733|NCT01337960|17840554|P3|Overall Study|Lost to Follow-up|0
5166734|NCT01337960|17840555|P2|Overall Study|Lost to Follow-up|0
5166735|NCT01337960|17840556|P1|Overall Study|Lost to Follow-up|1
5166736|NCT01337674|17840621|P4|Treatment Period 2|Withdrawal by Subject|0
5166737|NCT01337674|17840622|P3|Treatment Period 2|Withdrawal by Subject|1
5166738|NCT01337674|17840623|P2|Treatment Period 2|Withdrawal by Subject|0
5166739|NCT01337674|17840624|P1|Treatment Period 2|Withdrawal by Subject|0
5166740|NCT01337674|17840621|P4|Treatment Period 1|Discontinued due to blood draws|1
5166741|NCT01337674|17840622|P3|Treatment Period 1|Discontinued due to blood draws|0
5166742|NCT01337674|17840623|P2|Treatment Period 1|Discontinued due to blood draws|0
5166743|NCT01337674|17840624|P1|Treatment Period 1|Discontinued due to blood draws|0
5166744|NCT01337674|17840621|P4|Treatment Period 1|Adverse Event|0
5166745|NCT01337674|17840622|P3|Treatment Period 1|Adverse Event|0
5166746|NCT01337674|17840623|P2|Treatment Period 1|Adverse Event|1
5166747|NCT01337674|17840624|P1|Treatment Period 1|Adverse Event|0
5166748|NCT01337635|17840642|P2|Overall Study|Lost to Follow-up|1
5166749|NCT01337635|17840643|P1|Overall Study|Lost to Follow-up|0
5166750|NCT01337596|17840685|P9|Overall Study|Withdrawal by Subject|0
5166751|NCT01337596|17840686|P8|Overall Study|Withdrawal by Subject|0
5166752|NCT01337596|17840687|P7|Overall Study|Withdrawal by Subject|0
5166753|NCT01337596|17840688|P6|Overall Study|Withdrawal by Subject|0
5166754|NCT01337596|17840689|P5|Overall Study|Withdrawal by Subject|2
5166755|NCT01337596|17840690|P4|Overall Study|Withdrawal by Subject|0
5166756|NCT01337596|17840691|P3|Overall Study|Withdrawal by Subject|0
5166757|NCT01337596|17840692|P2|Overall Study|Withdrawal by Subject|0
5166758|NCT01337596|17840693|P1|Overall Study|Withdrawal by Subject|0
5166759|NCT01337297|17840744|P2|Overall Study|Lost to Follow-up|3
5166760|NCT01337297|17840745|P1|Overall Study|Lost to Follow-up|1
5166761|NCT01337297|17840744|P2|Overall Study|They entered to single anodal tDCS|3
5166762|NCT01337297|17840745|P1|Overall Study|They entered to single anodal tDCS|4
5166763|NCT01337167|17840753|P2|Toddler Vaccinations|Withdrawal by Subject|0
5166764|NCT01337167|17840754|P1|Toddler Vaccinations|Withdrawal by Subject|3
5166765|NCT01337167|17840753|P2|Toddler Vaccinations|Protocol Violation|1
5166766|NCT01337167|17840754|P1|Toddler Vaccinations|Protocol Violation|0
5166767|NCT01337167|17840753|P2|Toddler Vaccinations|Lost to Follow-up|12
5166768|NCT01337167|17840754|P1|Toddler Vaccinations|Lost to Follow-up|11
5166769|NCT01337167|17840753|P2|Interim Period|Other protocol criterion not met|1
5166770|NCT01337167|17840754|P1|Interim Period|Other protocol criterion not met|0
5166771|NCT01337167|17840753|P2|Interim Period|Withdrawal by Subject|10
5166772|NCT01337167|17840754|P1|Interim Period|Withdrawal by Subject|18
5166773|NCT01337167|17840753|P2|Interim Period|Protocol Violation|3
5166774|NCT01337167|17840754|P1|Interim Period|Protocol Violation|5
5166775|NCT01337167|17840753|P2|Interim Period|Physician Decision|3
5166776|NCT01337167|17840754|P1|Interim Period|Physician Decision|6
5166777|NCT01337167|17840753|P2|Interim Period|Non-compliance with study drug|0
5166778|NCT01337167|17840754|P1|Interim Period|Non-compliance with study drug|1
5166779|NCT01337167|17840753|P2|Interim Period|Lost to Follow-up|23
5166780|NCT01337167|17840754|P1|Interim Period|Lost to Follow-up|51
5166781|NCT01337167|17840753|P2|Infant Series|Randomized but not vaccinated|3
5166782|NCT01337167|17840754|P1|Infant Series|Randomized but not vaccinated|5
5166783|NCT01337167|17840753|P2|Infant Series|Withdrawal by Subject|4
5166784|NCT01337167|17840754|P1|Infant Series|Withdrawal by Subject|15
5166785|NCT01337167|17840753|P2|Infant Series|Protocol Violation|9
5166786|NCT01337167|17840754|P1|Infant Series|Protocol Violation|22
5166787|NCT01337167|17840753|P2|Infant Series|Physician Decision|1
5166788|NCT01337167|17840754|P1|Infant Series|Physician Decision|3
5166789|NCT01337167|17840753|P2|Infant Series|Non-compliance with study drug|1
5166790|NCT01337167|17840754|P1|Infant Series|Non-compliance with study drug|2
5166791|NCT01337167|17840753|P2|Infant Series|Lost to Follow-up|7
5166792|NCT01337167|17840754|P1|Infant Series|Lost to Follow-up|13
5166793|NCT01337167|17840753|P2|Infant Series|Death|1
5166794|NCT01337167|17840754|P1|Infant Series|Death|1
5166795|NCT01337167|17840753|P2|Infant Series|Adverse Event|1
5166796|NCT01337167|17840754|P1|Infant Series|Adverse Event|1
5166797|NCT01337115|17840822|P2|Overall Study|Protocol Violation|0
5166798|NCT01337115|17840823|P1|Overall Study|Protocol Violation|2
5166799|NCT01337089|17840835|P1|Overall Study|Lost to Follow-up|2
5166800|NCT01337089|17840835|P1|Overall Study|Met Withdrawal Criteria|3
5166801|NCT01337089|17840835|P1|Overall Study|Withdrawal by Investigator|33
5166802|NCT01337089|17840835|P1|Overall Study|Withdrawal by Subject|129
5166803|NCT01337089|17840835|P1|Overall Study|Adverse Event|237
5166804|NCT01337050|17840850|P3|Overall Study|Participants refused further follow-up|7
5166805|NCT01337050|17840851|P2|Overall Study|Participants refused further follow-up|7
5166806|NCT01337050|17840852|P1|Overall Study|Participants refused further follow-up|0
5166807|NCT01337050|17840850|P3|Overall Study|Other|8
5166808|NCT01337050|17840851|P2|Overall Study|Other|6
5166809|NCT01337050|17840852|P1|Overall Study|Other|4
5166810|NCT01337050|17840850|P3|Overall Study|Death|4
5166811|NCT01337050|17840851|P2|Overall Study|Death|0
5166812|NCT01337050|17840852|P1|Overall Study|Death|0
5166813|NCT01336972|17840913|P3|Overall Study|Adverse Event|0
5166814|NCT01336972|17840914|P2|Overall Study|Adverse Event|1
5166815|NCT01336972|17840915|P1|Overall Study|Adverse Event|1
5166816|NCT01336894|17840977|P2|Follow-up|Study terminated prematurely|7
5166817|NCT01336894|17840978|P1|Follow-up|Study terminated prematurely|2
5166818|NCT01336764|17841010|P2|Overall Study|Withdrawal by Subject|5
5166819|NCT01336764|17841011|P1|Overall Study|Withdrawal by Subject|5
5166820|NCT01336738|17841022|P5|Overall Study|Other|4
5166821|NCT01336738|17841023|P4|Overall Study|Other|3
5166822|NCT01336738|17841024|P3|Overall Study|Other|2
5166823|NCT01336738|17841025|P2|Overall Study|Other|3
5166824|NCT01336738|17841026|P1|Overall Study|Other|3
5166825|NCT01336738|17841022|P5|Overall Study|Withdrawal by Subject|1
5166826|NCT01336738|17841023|P4|Overall Study|Withdrawal by Subject|1
5166827|NCT01336738|17841024|P3|Overall Study|Withdrawal by Subject|2
5166828|NCT01336738|17841025|P2|Overall Study|Withdrawal by Subject|0
5166829|NCT01336738|17841026|P1|Overall Study|Withdrawal by Subject|2
5166830|NCT01336738|17841022|P5|Overall Study|Protocol Violation|0
5166831|NCT01336738|17841023|P4|Overall Study|Protocol Violation|0
5166832|NCT01336738|17841024|P3|Overall Study|Protocol Violation|0
5166833|NCT01336738|17841025|P2|Overall Study|Protocol Violation|1
5166834|NCT01336738|17841026|P1|Overall Study|Protocol Violation|0
5166835|NCT01336738|17841022|P5|Overall Study|Did not meet entrance criteria|0
5166836|NCT01336738|17841023|P4|Overall Study|Did not meet entrance criteria|0
5166837|NCT01336738|17841024|P3|Overall Study|Did not meet entrance criteria|0
5166838|NCT01336738|17841025|P2|Overall Study|Did not meet entrance criteria|1
5166839|NCT01336738|17841026|P1|Overall Study|Did not meet entrance criteria|0
5166840|NCT01336738|17841022|P5|Overall Study|Lost to Follow-up|2
5166841|NCT01336738|17841023|P4|Overall Study|Lost to Follow-up|2
5166842|NCT01336738|17841024|P3|Overall Study|Lost to Follow-up|2
5166843|NCT01336738|17841025|P2|Overall Study|Lost to Follow-up|1
5166844|NCT01336738|17841026|P1|Overall Study|Lost to Follow-up|2
5166845|NCT01336738|17841022|P5|Overall Study|Adverse Event|3
5166846|NCT01336738|17841023|P4|Overall Study|Adverse Event|1
5166847|NCT01336738|17841024|P3|Overall Study|Adverse Event|2
5166848|NCT01336738|17841025|P2|Overall Study|Adverse Event|3
5166849|NCT01336738|17841026|P1|Overall Study|Adverse Event|0
5166850|NCT01336712|17841068|P1|Overall Study|Lack of Efficacy|1
5166851|NCT01336712|17841068|P1|Overall Study|Death|2
5166852|NCT01336647|17841081|P3|Overall Study|Lost to Follow-up|3
5166853|NCT01336647|17841082|P2|Overall Study|Lost to Follow-up|1
5166854|NCT01336647|17841083|P1|Overall Study|Lost to Follow-up|4
5166855|NCT01336634|17841097|P3|Overall Study|Ongoing|24
5166856|NCT01336634|17841098|P2|Overall Study|Ongoing|22
5166857|NCT01336634|17841099|P1|Overall Study|Ongoing|15
5166858|NCT01336634|17841097|P3|Overall Study|Physician Decision|0
5166859|NCT01336634|17841098|P2|Overall Study|Physician Decision|1
5166860|NCT01336634|17841099|P1|Overall Study|Physician Decision|1
5166861|NCT01336634|17841097|P3|Overall Study|Withdrawal by Subject|1
5166862|NCT01336634|17841098|P2|Overall Study|Withdrawal by Subject|0
5166863|NCT01336634|17841099|P1|Overall Study|Withdrawal by Subject|6
5166864|NCT01336634|17841097|P3|Overall Study|Lost to Follow-up|1
5166865|NCT01336634|17841098|P2|Overall Study|Lost to Follow-up|1
5166866|NCT01336634|17841099|P1|Overall Study|Lost to Follow-up|2
5166867|NCT01336634|17841097|P3|Overall Study|Death|10
5166868|NCT01336634|17841098|P2|Overall Study|Death|33
5166869|NCT01336634|17841099|P1|Overall Study|Death|60
5166870|NCT01336621|17841140|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
5166871|NCT01336621|17841140|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
5166872|NCT01336621|17841140|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
5166873|NCT01336621|17841140|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
5166874|NCT01336621|17841140|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
5166875|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
5166876|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
5166877|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
5166878|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
5166879|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
5166880|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
5166881|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
5166882|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
5166883|NCT01336621|17841140|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
5166884|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
5166885|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
5166886|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5166887|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5166888|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Physician Decision|1
5166889|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5166890|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Physician Decision|3
5166891|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5166892|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5166893|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5166894|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5166895|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5166896|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
5166897|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
5166898|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
5166899|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
5166900|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
5166901|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
5166902|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
5166903|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5166904|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
5166905|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5166906|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5166907|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5166908|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5166909|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5166910|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5166911|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5166912|NCT01336608|17841190|P4|24-week, Double-blind Treatment Period|Adverse Event|7
5166913|NCT01336608|17841191|P3|24-week, Double-blind Treatment Period|Adverse Event|6
5166914|NCT01336608|17841192|P2|24-week, Double-blind Treatment Period|Adverse Event|8
5166915|NCT01336608|17841193|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5166916|NCT01336608|17841190|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5166917|NCT01336608|17841191|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5166918|NCT01336608|17841192|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5166919|NCT01336608|17841193|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
5166920|NCT01336608|17841190|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5166921|NCT01336608|17841191|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5166922|NCT01336608|17841192|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5166923|NCT01336608|17841193|P1|2-week, Single-blind Run-In Period|Physician Decision|1
5166924|NCT01336608|17841190|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5166925|NCT01336608|17841191|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5166926|NCT01336608|17841192|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5166927|NCT01336608|17841193|P1|2-week, Single-blind Run-In Period|Adverse Event|1
5166928|NCT01336608|17841190|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5166929|NCT01336608|17841191|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5166930|NCT01336608|17841192|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5166931|NCT01336608|17841193|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
5166932|NCT01336608|17841190|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5166933|NCT01336608|17841191|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5166934|NCT01336608|17841192|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5166935|NCT01336608|17841193|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
5166936|NCT01336569|17841207|P1|Overall Study|Lost to Follow-up|4
5166937|NCT01336205|17841255|P2|Overall Study|Did not receive treatment|0
5166938|NCT01336205|17841256|P1|Overall Study|Did not receive treatment|4
5166939|NCT01336205|17841255|P2|Overall Study|Withdrawal by Subject|38
5166940|NCT01336205|17841256|P1|Overall Study|Withdrawal by Subject|72
5166941|NCT01336205|17841255|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
5166942|NCT01336205|17841256|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
5166943|NCT01336205|17841255|P2|Overall Study|Death|1
5166944|NCT01336205|17841256|P1|Overall Study|Death|1
5166945|NCT01336205|17841255|P2|Overall Study|Adverse Event|6
5166946|NCT01336205|17841256|P1|Overall Study|Adverse Event|56
5166947|NCT01336205|17841255|P2|Overall Study|Severe noncompliance with protocol|2
5166948|NCT01336205|17841256|P1|Overall Study|Severe noncompliance with protocol|9
5166949|NCT01336205|17841255|P2|Overall Study|Lack of Efficacy|0
5166950|NCT01336205|17841256|P1|Overall Study|Lack of Efficacy|4
5166951|NCT01336205|17841255|P2|Overall Study|Study-Specific Withdrawal Criteria|7
5166952|NCT01336205|17841256|P1|Overall Study|Study-Specific Withdrawal Criteria|16
5166953|NCT01336205|17841255|P2|Overall Study|Lost to Follow-up|20
5166954|NCT01336205|17841256|P1|Overall Study|Lost to Follow-up|40
5166955|NCT01336205|17841255|P2|Overall Study|Other|9
5166956|NCT01336205|17841256|P1|Overall Study|Other|22
5166957|NCT01336023|17841284|P3|Week 27 to 52|Unclassified|9
5166958|NCT01336023|17841285|P2|Week 27 to 52|Unclassified|18
5166959|NCT01336023|17841286|P1|Week 27 to 52|Unclassified|13
5166960|NCT01336023|17841284|P3|Week 27 to 52|Withdrawal Criteria|16
5166961|NCT01336023|17841285|P2|Week 27 to 52|Withdrawal Criteria|19
5166962|NCT01336023|17841286|P1|Week 27 to 52|Withdrawal Criteria|14
5166963|NCT01336023|17841284|P3|Week 27 to 52|Protocol Violation|1
5166964|NCT01336023|17841285|P2|Week 27 to 52|Protocol Violation|2
5166965|NCT01336023|17841286|P1|Week 27 to 52|Protocol Violation|0
5166966|NCT01336023|17841284|P3|Week 27 to 52|Adverse Event|2
5166967|NCT01336023|17841285|P2|Week 27 to 52|Adverse Event|5
5166968|NCT01336023|17841286|P1|Week 27 to 52|Adverse Event|1
5166969|NCT01336023|17841284|P3|Week 0 to Week 26|Unclassified|9
5166970|NCT01336023|17841285|P2|Week 0 to Week 26|Unclassified|16
5166971|NCT01336023|17841286|P1|Week 0 to Week 26|Unclassified|5
5166972|NCT01336023|17841284|P3|Week 0 to Week 26|Withdrawal Criteria|40
5166973|NCT01336023|17841285|P2|Week 0 to Week 26|Withdrawal Criteria|69
5166974|NCT01336023|17841286|P1|Week 0 to Week 26|Withdrawal Criteria|34
5166975|NCT01336023|17841284|P3|Week 0 to Week 26|Protocol Violation|0
5166976|NCT01336023|17841285|P2|Week 0 to Week 26|Protocol Violation|2
5166977|NCT01336023|17841286|P1|Week 0 to Week 26|Protocol Violation|1
5166978|NCT01336023|17841284|P3|Week 0 to Week 26|Lack of Efficacy|0
5166979|NCT01336023|17841285|P2|Week 0 to Week 26|Lack of Efficacy|1
5166980|NCT01336023|17841286|P1|Week 0 to Week 26|Lack of Efficacy|0
5166981|NCT01336023|17841284|P3|Week 0 to Week 26|Adverse Event|24
5166982|NCT01336023|17841285|P2|Week 0 to Week 26|Adverse Event|10
5166983|NCT01336023|17841286|P1|Week 0 to Week 26|Adverse Event|8
5166984|NCT01335997|17841307|P2|Period III|Lost to Follow-up|0
5166985|NCT01335997|17841308|P1|Period III|Lost to Follow-up|1
5166986|NCT01335997|17841307|P2|Period III|Protocol Violation|1
5166987|NCT01335997|17841308|P1|Period III|Protocol Violation|0
5166988|NCT01335997|17841307|P2|Period III|Study Terminated by Sponsor|76
5166989|NCT01335997|17841308|P1|Period III|Study Terminated by Sponsor|77
5166990|NCT01335997|17841307|P2|Period III|Adverse Event|2
5166991|NCT01335997|17841308|P1|Period III|Adverse Event|0
5166992|NCT01335997|17841307|P2|Period I and II|Physician Decision|1
5166993|NCT01335997|17841308|P1|Period I and II|Physician Decision|2
5166994|NCT01335997|17841307|P2|Period I and II|Protocol Violation|10
5166995|NCT01335997|17841308|P1|Period I and II|Protocol Violation|9
5166996|NCT01335997|17841307|P2|Period I and II|Study Terminated by Sponsor|415
5166997|NCT01335997|17841308|P1|Period I and II|Study Terminated by Sponsor|406
5166998|NCT01335997|17841307|P2|Period I and II|Withdrawal by Subject|4
5166999|NCT01335997|17841308|P1|Period I and II|Withdrawal by Subject|9
5167000|NCT01335997|17841307|P2|Period I and II|Lost to Follow-up|5
5167001|NCT01335997|17841308|P1|Period I and II|Lost to Follow-up|3
5167002|NCT01335997|17841307|P2|Period I and II|Noncompliance with Study Drug|1
5167003|NCT01335997|17841308|P1|Period I and II|Noncompliance with Study Drug|1
5167004|NCT01335997|17841307|P2|Period I and II|Adverse Event|43
5167005|NCT01335997|17841308|P1|Period I and II|Adverse Event|63
5167006|NCT01335971|17841321|P3|Overall Study|Did not complete bronchoscopy|1
5167007|NCT01335971|17841322|P2|Overall Study|Did not complete bronchoscopy|1
5167008|NCT01335971|17841323|P1|Overall Study|Did not complete bronchoscopy|1
5167009|NCT01335971|17841321|P3|Overall Study|Withdrawal by Subject|0
5167010|NCT01335971|17841322|P2|Overall Study|Withdrawal by Subject|0
5167011|NCT01335971|17841323|P1|Overall Study|Withdrawal by Subject|1
5167012|NCT01335698|17841566|P5|Treatment Stage 2|Switched to another formulation|0
5167013|NCT01335698|17841567|P4|Treatment Stage 2|Switched to another formulation|0
5167014|NCT01335698|17841568|P3|Treatment Stage 2|Switched to another formulation|0
5167015|NCT01335698|17841569|P2|Treatment Stage 2|Switched to another formulation|1
5167016|NCT01335698|17841570|P1|Treatment Stage 2|Switched to another formulation|1
5167017|NCT01335698|17841566|P5|Treatment Stage 2|Subject no longer meets study criteria|0
5167018|NCT01335698|17841567|P4|Treatment Stage 2|Subject no longer meets study criteria|1
5167019|NCT01335698|17841568|P3|Treatment Stage 2|Subject no longer meets study criteria|0
5167020|NCT01335698|17841569|P2|Treatment Stage 2|Subject no longer meets study criteria|0
5167021|NCT01335698|17841570|P1|Treatment Stage 2|Subject no longer meets study criteria|0
5167022|NCT01335698|17841566|P5|Treatment Stage 2|Capsules received at state hospital|0
5167023|NCT01335698|17841567|P4|Treatment Stage 2|Capsules received at state hospital|0
5167024|NCT01335698|17841568|P3|Treatment Stage 2|Capsules received at state hospital|0
5167025|NCT01335698|17841569|P2|Treatment Stage 2|Capsules received at state hospital|0
5167026|NCT01335698|17841570|P1|Treatment Stage 2|Capsules received at state hospital|1
5167027|NCT01335698|17841566|P5|Treatment Stage 2|Lost to Follow-up|0
5167028|NCT01335698|17841567|P4|Treatment Stage 2|Lost to Follow-up|0
5167029|NCT01335698|17841568|P3|Treatment Stage 2|Lost to Follow-up|0
5167030|NCT01335698|17841569|P2|Treatment Stage 2|Lost to Follow-up|0
5167031|NCT01335698|17841570|P1|Treatment Stage 2|Lost to Follow-up|1
5167032|NCT01335698|17841566|P5|Treatment Stage 2|Poor compliance/noncompliance|1
5167033|NCT01335698|17841567|P4|Treatment Stage 2|Poor compliance/noncompliance|3
5167034|NCT01335698|17841568|P3|Treatment Stage 2|Poor compliance/noncompliance|1
5167035|NCT01335698|17841569|P2|Treatment Stage 2|Poor compliance/noncompliance|0
5167036|NCT01335698|17841570|P1|Treatment Stage 2|Poor compliance/noncompliance|1
5167037|NCT01335698|17841566|P5|Treatment Stage 2|Withdrawal by Subject|0
5167038|NCT01335698|17841567|P4|Treatment Stage 2|Withdrawal by Subject|0
5167039|NCT01335698|17841568|P3|Treatment Stage 2|Withdrawal by Subject|1
5167040|NCT01335698|17841569|P2|Treatment Stage 2|Withdrawal by Subject|1
5167041|NCT01335698|17841570|P1|Treatment Stage 2|Withdrawal by Subject|3
5167042|NCT01335698|17841566|P5|Treatment Stage 2|Adverse Event|0
5167043|NCT01335698|17841567|P4|Treatment Stage 2|Adverse Event|3
5167044|NCT01335698|17841568|P3|Treatment Stage 2|Adverse Event|0
5167045|NCT01335698|17841569|P2|Treatment Stage 2|Adverse Event|0
5167046|NCT01335698|17841570|P1|Treatment Stage 2|Adverse Event|2
5167047|NCT01335698|17841566|P5|Treatment Stage 2|Lack of Efficacy|0
5167048|NCT01335698|17841567|P4|Treatment Stage 2|Lack of Efficacy|1
5167049|NCT01335698|17841568|P3|Treatment Stage 2|Lack of Efficacy|3
5167050|NCT01335698|17841569|P2|Treatment Stage 2|Lack of Efficacy|1
5167051|NCT01335698|17841570|P1|Treatment Stage 2|Lack of Efficacy|2
5167052|NCT01335698|17841566|P5|Treatment Stage 1|Other|0
5167053|NCT01335698|17841567|P4|Treatment Stage 1|Other|1
5167054|NCT01335698|17841568|P3|Treatment Stage 1|Other|0
5167055|NCT01335698|17841569|P2|Treatment Stage 1|Other|0
5167056|NCT01335698|17841570|P1|Treatment Stage 1|Other|1
5167057|NCT01335698|17841566|P5|Treatment Stage 1|No longer meets study criteria|0
5167058|NCT01335698|17841567|P4|Treatment Stage 1|No longer meets study criteria|1
5167059|NCT01335698|17841568|P3|Treatment Stage 1|No longer meets study criteria|0
5167060|NCT01335698|17841569|P2|Treatment Stage 1|No longer meets study criteria|1
5167061|NCT01335698|17841570|P1|Treatment Stage 1|No longer meets study criteria|1
5167062|NCT01335698|17841566|P5|Treatment Stage 1|Poor compliance/noncompliance|0
5167063|NCT01335698|17841567|P4|Treatment Stage 1|Poor compliance/noncompliance|2
5167064|NCT01335698|17841568|P3|Treatment Stage 1|Poor compliance/noncompliance|0
5167065|NCT01335698|17841569|P2|Treatment Stage 1|Poor compliance/noncompliance|1
5167066|NCT01335698|17841570|P1|Treatment Stage 1|Poor compliance/noncompliance|0
5167067|NCT01335698|17841566|P5|Treatment Stage 1|Lost to Follow-up|0
5167068|NCT01335698|17841567|P4|Treatment Stage 1|Lost to Follow-up|0
5167069|NCT01335698|17841568|P3|Treatment Stage 1|Lost to Follow-up|0
5167070|NCT01335698|17841569|P2|Treatment Stage 1|Lost to Follow-up|1
5167071|NCT01335698|17841570|P1|Treatment Stage 1|Lost to Follow-up|1
5167072|NCT01335698|17841566|P5|Treatment Stage 1|Withdrawal by Subject|0
5167073|NCT01335698|17841567|P4|Treatment Stage 1|Withdrawal by Subject|1
5167074|NCT01335698|17841568|P3|Treatment Stage 1|Withdrawal by Subject|0
5167075|NCT01335698|17841569|P2|Treatment Stage 1|Withdrawal by Subject|2
5167076|NCT01335698|17841570|P1|Treatment Stage 1|Withdrawal by Subject|1
5167077|NCT01335698|17841566|P5|Treatment Stage 1|Adverse Event|1
5167078|NCT01335698|17841567|P4|Treatment Stage 1|Adverse Event|1
5167079|NCT01335698|17841568|P3|Treatment Stage 1|Adverse Event|2
5167080|NCT01335698|17841569|P2|Treatment Stage 1|Adverse Event|2
5167081|NCT01335698|17841570|P1|Treatment Stage 1|Adverse Event|1
5167082|NCT01335698|17841566|P5|Treatment Stage 1|Lack of Efficacy|1
5167083|NCT01335698|17841567|P4|Treatment Stage 1|Lack of Efficacy|3
5167084|NCT01335698|17841568|P3|Treatment Stage 1|Lack of Efficacy|3
5167085|NCT01335698|17841569|P2|Treatment Stage 1|Lack of Efficacy|1
5167086|NCT01335698|17841570|P1|Treatment Stage 1|Lack of Efficacy|3
5167087|NCT01335685|17841635|P8|Overall Study|Reason not Specified|0
5167088|NCT01335685|17841636|P7|Overall Study|Reason not Specified|0
5167089|NCT01335685|17841637|P6|Overall Study|Reason not Specified|1
5167090|NCT01335685|17841638|P5|Overall Study|Reason not Specified|0
5167091|NCT01335685|17841639|P4|Overall Study|Reason not Specified|0
5167092|NCT01335685|17841640|P3|Overall Study|Reason not Specified|1
5167093|NCT01335685|17841641|P2|Overall Study|Reason not Specified|0
5167094|NCT01335685|17841642|P1|Overall Study|Reason not Specified|0
5167095|NCT01335685|17841635|P8|Overall Study|Withdrawal by Subject|0
5167096|NCT01335685|17841636|P7|Overall Study|Withdrawal by Subject|0
5167097|NCT01335685|17841637|P6|Overall Study|Withdrawal by Subject|0
5167098|NCT01335685|17841638|P5|Overall Study|Withdrawal by Subject|0
5167099|NCT01335685|17841639|P4|Overall Study|Withdrawal by Subject|1
5167100|NCT01335685|17841640|P3|Overall Study|Withdrawal by Subject|0
5167101|NCT01335685|17841641|P2|Overall Study|Withdrawal by Subject|0
5167102|NCT01335685|17841642|P1|Overall Study|Withdrawal by Subject|1
5167103|NCT01335685|17841635|P8|Overall Study|Study Terminated by Sponsor|3
5167104|NCT01335685|17841636|P7|Overall Study|Study Terminated by Sponsor|2
5167105|NCT01335685|17841637|P6|Overall Study|Study Terminated by Sponsor|4
5167106|NCT01335685|17841638|P5|Overall Study|Study Terminated by Sponsor|0
5167107|NCT01335685|17841639|P4|Overall Study|Study Terminated by Sponsor|10
5167108|NCT01335685|17841640|P3|Overall Study|Study Terminated by Sponsor|1
5167109|NCT01335685|17841641|P2|Overall Study|Study Terminated by Sponsor|1
5167110|NCT01335685|17841642|P1|Overall Study|Study Terminated by Sponsor|2
5167111|NCT01335477|17841762|P2|Overall Study|Reason other than those stated above|2
5167112|NCT01335477|17841763|P1|Overall Study|Reason other than those stated above|2
5167113|NCT01335477|17841762|P2|Overall Study|Not treated|2
5167114|NCT01335477|17841763|P1|Overall Study|Not treated|1
5167115|NCT01335477|17841762|P2|Overall Study|Consent withdrawn, not due to AE|9
5167116|NCT01335477|17841763|P1|Overall Study|Consent withdrawn, not due to AE|7
5167117|NCT01335477|17841762|P2|Overall Study|Lost to Follow-up|2
5167118|NCT01335477|17841763|P1|Overall Study|Lost to Follow-up|1
5167119|NCT01335477|17841762|P2|Overall Study|Non compliant with protocol|2
5167120|NCT01335477|17841763|P1|Overall Study|Non compliant with protocol|0
5167121|NCT01335477|17841762|P2|Overall Study|Adverse Event|42
5167122|NCT01335477|17841763|P1|Overall Study|Adverse Event|30
5167123|NCT01335464|17841827|P2|Overall Study|Reason other than those stated above|1
5167124|NCT01335464|17841828|P1|Overall Study|Reason other than those stated above|1
5167125|NCT01335464|17841827|P2|Overall Study|Not treated|0
5167126|NCT01335464|17841828|P1|Overall Study|Not treated|2
5167127|NCT01335464|17841827|P2|Overall Study|Consent withdrawn, not due to AE|23
5167128|NCT01335464|17841828|P1|Overall Study|Consent withdrawn, not due to AE|12
5167129|NCT01335464|17841827|P2|Overall Study|Non compliant with protocol|0
5167130|NCT01335464|17841828|P1|Overall Study|Non compliant with protocol|2
5167131|NCT01335464|17841827|P2|Overall Study|Adverse Event|25
5167132|NCT01335464|17841828|P1|Overall Study|Adverse Event|15
5167133|NCT01335399|17841892|P2|Treatment Period|Not reported|0
5167134|NCT01335399|17841893|P1|Treatment Period|Not reported|1
5167135|NCT01335399|17841892|P2|Treatment Period|No longer meet study criteria|1
5167136|NCT01335399|17841893|P1|Treatment Period|No longer meet study criteria|0
5167137|NCT01335399|17841892|P2|Treatment Period|Maximum clinical benefit|1
5167138|NCT01335399|17841893|P1|Treatment Period|Maximum clinical benefit|1
5167139|NCT01335399|17841892|P2|Treatment Period|Lost to Follow-up|2
5167140|NCT01335399|17841893|P1|Treatment Period|Lost to Follow-up|0
5167141|NCT01335399|17841892|P2|Treatment Period|Poor/Non-compliance|4
5167142|NCT01335399|17841893|P1|Treatment Period|Poor/Non-compliance|3
5167143|NCT01335399|17841892|P2|Treatment Period|Death|8
5167144|NCT01335399|17841893|P1|Treatment Period|Death|7
5167145|NCT01335399|17841892|P2|Treatment Period|Consent withdrawal|6
5167146|NCT01335399|17841893|P1|Treatment Period|Consent withdrawal|10
5167147|NCT01335399|17841892|P2|Treatment Period|Other reasons|26
5167148|NCT01335399|17841893|P1|Treatment Period|Other reasons|14
5167149|NCT01335399|17841892|P2|Treatment Period|Participant request to discontinue|21
5167150|NCT01335399|17841893|P1|Treatment Period|Participant request to discontinue|27
5167151|NCT01335399|17841892|P2|Treatment Period|Study drug toxicity|64
5167152|NCT01335399|17841893|P1|Treatment Period|Study drug toxicity|51
5167153|NCT01335399|17841892|P2|Treatment Period|Adverse event unrelated to study drug|65
5167154|NCT01335399|17841893|P1|Treatment Period|Adverse event unrelated to study drug|105
5167155|NCT01335399|17841892|P2|Treatment Period|Disease progression|141
5167156|NCT01335399|17841893|P1|Treatment Period|Disease progression|114
5167157|NCT01335399|17841892|P2|Pre-treatment Period|Consent withdrawal|0
5167158|NCT01335399|17841893|P1|Pre-treatment Period|Consent withdrawal|3
5167159|NCT01335399|17841892|P2|Pre-treatment Period|Adverse event unrelated to study drug|1
5167160|NCT01335399|17841893|P1|Pre-treatment Period|Adverse event unrelated to study drug|0
5167161|NCT01335399|17841892|P2|Pre-treatment Period|Participant request to discontinue|1
5167162|NCT01335399|17841893|P1|Pre-treatment Period|Participant request to discontinue|0
5167163|NCT01335399|17841892|P2|Pre-treatment Period|No longer meeting study criteria|1
5167164|NCT01335399|17841893|P1|Pre-treatment Period|No longer meeting study criteria|0
5167165|NCT01334918|17842014|P2|Overall Study|Withdrawal by Subject|1
5167166|NCT01334918|17842015|P1|Overall Study|Withdrawal by Subject|0
5167167|NCT01334918|17842014|P2|Overall Study|Adverse Event|0
5167168|NCT01334918|17842015|P1|Overall Study|Adverse Event|2
5167169|NCT01334918|17842014|P2|Overall Study|Did not receive study drug|0
5167170|NCT01334918|17842015|P1|Overall Study|Did not receive study drug|6
5167171|NCT01334866|17842041|P1|Overall Study|medically necessary post-procedure|1
5167172|NCT01334866|17842041|P1|Overall Study|medically necessary prior to procedure|2
5167173|NCT01334866|17842041|P1|Overall Study|Physician Decision|3
5167174|NCT01334866|17842041|P1|Overall Study|Lost to Follow-up|3
5167175|NCT01334866|17842041|P1|Overall Study|Withdrawal by Subject|10
5167176|NCT01334710|17842078|P1|Overall Study|Trial was terminated|3
5167177|NCT01334606|17842083|P1|Overall Study|Study Terminated due to slow enrolment|18
5167178|NCT01334554|17842091|P2|Overall Study|Adverse Event|2
5167179|NCT01334554|17842092|P1|Overall Study|Adverse Event|4
5167180|NCT01334515|17842102|P2|Overall Study|Withdrawal by Subject|1
5167181|NCT01334515|17842103|P1|Overall Study|Withdrawal by Subject|1
5167182|NCT01334515|17842102|P2|Overall Study|Physician Decision|1
5167183|NCT01334515|17842103|P1|Overall Study|Physician Decision|1
5167184|NCT01334515|17842102|P2|Overall Study|Lack of Efficacy|21
5167185|NCT01334515|17842103|P1|Overall Study|Lack of Efficacy|8
5167186|NCT01334515|17842102|P2|Overall Study|Death|0
5167187|NCT01334515|17842103|P1|Overall Study|Death|1
5167188|NCT01334515|17842102|P2|Overall Study|Adverse Event|6
5167189|NCT01334515|17842103|P1|Overall Study|Adverse Event|1
5167190|NCT01334125|17842141|P2|Overall Study|Lost to Follow-up|3
5167191|NCT01334125|17842142|P1|Overall Study|Lost to Follow-up|3
5167192|NCT01333956|17842158|P4|Overall Study|Withdrawal by Subject|0
5167193|NCT01333956|17842159|P3|Overall Study|Withdrawal by Subject|1
5167194|NCT01333956|17842160|P2|Overall Study|Withdrawal by Subject|2
5167195|NCT01333956|17842161|P1|Overall Study|Withdrawal by Subject|0
5167196|NCT01333956|17842158|P4|Overall Study|Unable to complete study procedure|1
5167197|NCT01333956|17842159|P3|Overall Study|Unable to complete study procedure|0
5167198|NCT01333956|17842160|P2|Overall Study|Unable to complete study procedure|0
5167199|NCT01333956|17842161|P1|Overall Study|Unable to complete study procedure|1
5167200|NCT01333956|17842158|P4|Overall Study|Lost to Follow-up|1
5167201|NCT01333956|17842159|P3|Overall Study|Lost to Follow-up|0
5167202|NCT01333956|17842160|P2|Overall Study|Lost to Follow-up|2
5167203|NCT01333956|17842161|P1|Overall Study|Lost to Follow-up|1
5167204|NCT01333943|17842197|P2|Overall Study|Known neuropathy|0
5167205|NCT01333943|17842198|P1|Overall Study|Known neuropathy|1
5167206|NCT01333865|17842214|P1|Overall Study|Adverse Event|2
5167207|NCT01333722|17842234|P2|Overall Study|Withdrawal by Subject|1
5167208|NCT01333722|17842235|P1|Overall Study|Withdrawal by Subject|0
5167209|NCT01333722|17842234|P2|Overall Study|Lack of Efficacy|2
5167210|NCT01333722|17842235|P1|Overall Study|Lack of Efficacy|0
5167211|NCT01333501|17842260|P2|Overall Study|Withdrawn consent|12
5167212|NCT01333501|17842261|P1|Overall Study|Withdrawn consent|3
5167213|NCT01333501|17842260|P2|Overall Study|Unsatisfactory therapeutic effect|7
5167214|NCT01333501|17842261|P1|Overall Study|Unsatisfactory therapeutic effect|1
5167215|NCT01333501|17842260|P2|Overall Study|Abnormal laboratory value|1
5167216|NCT01333501|17842261|P1|Overall Study|Abnormal laboratory value|2
5167217|NCT01333501|17842260|P2|Overall Study|Adverse Event|1
5167218|NCT01333501|17842261|P1|Overall Study|Adverse Event|3
5167219|NCT01333475|17842328|P2|Overall Study|Toxicity|3
5167220|NCT01333475|17842329|P1|Overall Study|Toxicity|1
5167221|NCT01333475|17842328|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
5167222|NCT01333475|17842329|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
5167223|NCT01333397|17842355|P5|Overall Study|Lost to Follow-up|0
5167224|NCT01333397|17842356|P4|Overall Study|Lost to Follow-up|1
5167225|NCT01333397|17842357|P3|Overall Study|Lost to Follow-up|0
5167226|NCT01333397|17842358|P2|Overall Study|Lost to Follow-up|0
5167227|NCT01333397|17842359|P1|Overall Study|Lost to Follow-up|1
5167228|NCT01333189|17842433|P2|Overall Study|Moved from region|1
5167229|NCT01333189|17842434|P1|Overall Study|Moved from region|0
5167230|NCT01333189|17842433|P2|Overall Study|Transportation difficulties|1
5167231|NCT01333189|17842434|P1|Overall Study|Transportation difficulties|0
5167232|NCT01333189|17842433|P2|Overall Study|Adverse Event|0
5167233|NCT01333189|17842434|P1|Overall Study|Adverse Event|1
5167234|NCT01333189|17842433|P2|Overall Study|Time constraints|0
5167235|NCT01333189|17842434|P1|Overall Study|Time constraints|1
5167236|NCT01333111|17842465|P3|Overall Study|Ineffective therapy|1
5167237|NCT01333111|17842466|P2|Overall Study|Ineffective therapy|0
5167238|NCT01333111|17842467|P1|Overall Study|Ineffective therapy|0
5167239|NCT01333111|17842465|P3|Overall Study|Non-compliance|0
5167240|NCT01333111|17842466|P2|Overall Study|Non-compliance|0
5167241|NCT01333111|17842467|P1|Overall Study|Non-compliance|1
5167242|NCT01333111|17842465|P3|Overall Study|withdrawal criteria|0
5167243|NCT01333111|17842466|P2|Overall Study|withdrawal criteria|1
5167244|NCT01333111|17842467|P1|Overall Study|withdrawal criteria|0
5167245|NCT01333111|17842465|P3|Overall Study|unclassified|0
5167246|NCT01333111|17842466|P2|Overall Study|unclassified|0
5167247|NCT01333111|17842467|P1|Overall Study|unclassified|1
5167248|NCT01333111|17842465|P3|Overall Study|personal reasons|1
5167249|NCT01333111|17842466|P2|Overall Study|personal reasons|0
5167250|NCT01333111|17842467|P1|Overall Study|personal reasons|0
5167251|NCT01333111|17842465|P3|Overall Study|patient undergoing major surgery|0
5167252|NCT01333111|17842466|P2|Overall Study|patient undergoing major surgery|2
5167253|NCT01333111|17842467|P1|Overall Study|patient undergoing major surgery|0
5167254|NCT01333072|17842502|P2|Overall Study|Physician Decision|0
5167255|NCT01333072|17842503|P1|Overall Study|Physician Decision|1
5167256|NCT01333072|17842502|P2|Overall Study|Adverse Event|4
5167257|NCT01333072|17842503|P1|Overall Study|Adverse Event|2
5167258|NCT01333072|17842502|P2|Overall Study|Lost to Follow-up|0
5167259|NCT01333072|17842503|P1|Overall Study|Lost to Follow-up|3
5167260|NCT01333059|17842511|P2|Overall Study|Protocol Violation|0
5167261|NCT01333059|17842512|P1|Overall Study|Protocol Violation|3
5167262|NCT01333059|17842511|P2|Overall Study|Physician Decision|3
5167263|NCT01333059|17842512|P1|Overall Study|Physician Decision|3
5167264|NCT01332994|17842522|P1|Overall Study|Other|8
5167265|NCT01332994|17842522|P1|Overall Study|Administrative Problem|2
5167266|NCT01332994|17842522|P1|Overall Study|Withdrawal by Subject|15
5167267|NCT01332994|17842522|P1|Overall Study|Protocol Violation|6
5167268|NCT01332994|17842522|P1|Overall Study|Lost to Follow-up|4
5167269|NCT01332994|17842522|P1|Overall Study|Lack of Efficacy|1
5167270|NCT01332994|17842522|P1|Overall Study|Death|1
5167271|NCT01332994|17842522|P1|Overall Study|Adverse Event|34
5167272|NCT01332968|17842591|P8|Follow-Up Period|Lost to Follow-up|2
5167273|NCT01332968|17842592|P7|Follow-Up Period|Lost to Follow-up|1
5167274|NCT01332968|17842593|P6|Follow-Up Period|Lost to Follow-up|0
5167275|NCT01332968|17842594|P5|Follow-Up Period|Lost to Follow-up|0
5167276|NCT01332968|17842595|P4|Follow-Up Period|Lost to Follow-up|0
5167277|NCT01332968|17842596|P3|Follow-Up Period|Lost to Follow-up|0
5167278|NCT01332968|17842597|P2|Follow-Up Period|Lost to Follow-up|0
5167279|NCT01332968|17842598|P1|Follow-Up Period|Lost to Follow-up|0
5167280|NCT01332968|17842591|P8|Follow-Up Period|Withdrawal by Subject|2
5167281|NCT01332968|17842592|P7|Follow-Up Period|Withdrawal by Subject|1
5167282|NCT01332968|17842593|P6|Follow-Up Period|Withdrawal by Subject|0
5167283|NCT01332968|17842594|P5|Follow-Up Period|Withdrawal by Subject|0
5167284|NCT01332968|17842595|P4|Follow-Up Period|Withdrawal by Subject|0
5167285|NCT01332968|17842596|P3|Follow-Up Period|Withdrawal by Subject|0
5167286|NCT01332968|17842597|P2|Follow-Up Period|Withdrawal by Subject|0
5167287|NCT01332968|17842598|P1|Follow-Up Period|Withdrawal by Subject|0
5167288|NCT01332968|17842591|P8|Follow-Up Period|Follow-up ongoing|505
5167289|NCT01332968|17842592|P7|Follow-Up Period|Follow-up ongoing|502
5167290|NCT01332968|17842593|P6|Follow-Up Period|Follow-up ongoing|0
5167291|NCT01332968|17842594|P5|Follow-Up Period|Follow-up ongoing|0
5167292|NCT01332968|17842595|P4|Follow-Up Period|Follow-up ongoing|0
5167293|NCT01332968|17842596|P3|Follow-Up Period|Follow-up ongoing|0
5167294|NCT01332968|17842597|P2|Follow-Up Period|Follow-up ongoing|0
5167295|NCT01332968|17842598|P1|Follow-Up Period|Follow-up ongoing|0
5167296|NCT01332968|17842591|P8|Follow-Up Period|Death|22
5167297|NCT01332968|17842592|P7|Follow-Up Period|Death|38
5167298|NCT01332968|17842593|P6|Follow-Up Period|Death|0
5167299|NCT01332968|17842594|P5|Follow-Up Period|Death|0
5167300|NCT01332968|17842595|P4|Follow-Up Period|Death|0
5167301|NCT01332968|17842596|P3|Follow-Up Period|Death|0
5167302|NCT01332968|17842597|P2|Follow-Up Period|Death|0
5167303|NCT01332968|17842598|P1|Follow-Up Period|Death|0
5167304|NCT01332968|17842591|P8|Maintenance/Observation Period|Treatment ongoing|0
5167305|NCT01332968|17842592|P7|Maintenance/Observation Period|Treatment ongoing|0
5167306|NCT01332968|17842593|P6|Maintenance/Observation Period|Treatment ongoing|8
5167307|NCT01332968|17842594|P5|Maintenance/Observation Period|Treatment ongoing|10
5167308|NCT01332968|17842595|P4|Maintenance/Observation Period|Treatment ongoing|62
5167309|NCT01332968|17842596|P3|Maintenance/Observation Period|Treatment ongoing|54
5167310|NCT01332968|17842597|P2|Maintenance/Observation Period|Treatment ongoing|0
5167311|NCT01332968|17842598|P1|Maintenance/Observation Period|Treatment ongoing|0
5167312|NCT01332968|17842591|P8|Maintenance/Observation Period|Adverse Event|0
5167313|NCT01332968|17842592|P7|Maintenance/Observation Period|Adverse Event|0
5167314|NCT01332968|17842593|P6|Maintenance/Observation Period|Adverse Event|0
5167315|NCT01332968|17842594|P5|Maintenance/Observation Period|Adverse Event|0
5167316|NCT01332968|17842595|P4|Maintenance/Observation Period|Adverse Event|65
5167317|NCT01332968|17842596|P3|Maintenance/Observation Period|Adverse Event|50
5167318|NCT01332968|17842597|P2|Maintenance/Observation Period|Adverse Event|0
5167319|NCT01332968|17842598|P1|Maintenance/Observation Period|Adverse Event|0
5167320|NCT01332968|17842591|P8|Maintenance/Observation Period|Death|0
5167321|NCT01332968|17842592|P7|Maintenance/Observation Period|Death|0
5167322|NCT01332968|17842593|P6|Maintenance/Observation Period|Death|0
5167323|NCT01332968|17842594|P5|Maintenance/Observation Period|Death|0
5167324|NCT01332968|17842595|P4|Maintenance/Observation Period|Death|6
5167325|NCT01332968|17842596|P3|Maintenance/Observation Period|Death|5
5167326|NCT01332968|17842597|P2|Maintenance/Observation Period|Death|0
5167327|NCT01332968|17842598|P1|Maintenance/Observation Period|Death|0
5167328|NCT01332968|17842591|P8|Maintenance/Observation Period|Lost to Follow-up|0
5167329|NCT01332968|17842592|P7|Maintenance/Observation Period|Lost to Follow-up|0
5167330|NCT01332968|17842593|P6|Maintenance/Observation Period|Lost to Follow-up|0
5167331|NCT01332968|17842594|P5|Maintenance/Observation Period|Lost to Follow-up|0
5167332|NCT01332968|17842595|P4|Maintenance/Observation Period|Lost to Follow-up|2
5167333|NCT01332968|17842596|P3|Maintenance/Observation Period|Lost to Follow-up|1
5167334|NCT01332968|17842597|P2|Maintenance/Observation Period|Lost to Follow-up|0
5167335|NCT01332968|17842598|P1|Maintenance/Observation Period|Lost to Follow-up|0
5167336|NCT01332968|17842591|P8|Maintenance/Observation Period|Non-compliance|0
5167337|NCT01332968|17842592|P7|Maintenance/Observation Period|Non-compliance|0
5167338|NCT01332968|17842593|P6|Maintenance/Observation Period|Non-compliance|1
5167339|NCT01332968|17842594|P5|Maintenance/Observation Period|Non-compliance|0
5167340|NCT01332968|17842595|P4|Maintenance/Observation Period|Non-compliance|3
5167341|NCT01332968|17842596|P3|Maintenance/Observation Period|Non-compliance|2
5167342|NCT01332968|17842597|P2|Maintenance/Observation Period|Non-compliance|0
5167343|NCT01332968|17842598|P1|Maintenance/Observation Period|Non-compliance|0
5167344|NCT01332968|17842591|P8|Maintenance/Observation Period|Other|0
5167345|NCT01332968|17842592|P7|Maintenance/Observation Period|Other|0
5167346|NCT01332968|17842593|P6|Maintenance/Observation Period|Other|0
5167347|NCT01332968|17842594|P5|Maintenance/Observation Period|Other|0
5167348|NCT01332968|17842595|P4|Maintenance/Observation Period|Other|5
5167349|NCT01332968|17842596|P3|Maintenance/Observation Period|Other|4
5167350|NCT01332968|17842597|P2|Maintenance/Observation Period|Other|0
5167351|NCT01332968|17842598|P1|Maintenance/Observation Period|Other|0
5167352|NCT01332968|17842591|P8|Maintenance/Observation Period|Physician Decision|0
5167353|NCT01332968|17842592|P7|Maintenance/Observation Period|Physician Decision|0
5167354|NCT01332968|17842593|P6|Maintenance/Observation Period|Physician Decision|0
5167355|NCT01332968|17842594|P5|Maintenance/Observation Period|Physician Decision|0
5167356|NCT01332968|17842595|P4|Maintenance/Observation Period|Physician Decision|19
5167357|NCT01332968|17842596|P3|Maintenance/Observation Period|Physician Decision|14
5167358|NCT01332968|17842597|P2|Maintenance/Observation Period|Physician Decision|0
5167359|NCT01332968|17842598|P1|Maintenance/Observation Period|Physician Decision|0
5167360|NCT01332968|17842591|P8|Maintenance/Observation Period|Progressive disease|0
5167361|NCT01332968|17842592|P7|Maintenance/Observation Period|Progressive disease|0
5167362|NCT01332968|17842593|P6|Maintenance/Observation Period|Progressive disease|0
5167363|NCT01332968|17842594|P5|Maintenance/Observation Period|Progressive disease|0
5167364|NCT01332968|17842595|P4|Maintenance/Observation Period|Progressive disease|39
5167365|NCT01332968|17842596|P3|Maintenance/Observation Period|Progressive disease|72
5167366|NCT01332968|17842597|P2|Maintenance/Observation Period|Progressive disease|0
5167367|NCT01332968|17842598|P1|Maintenance/Observation Period|Progressive disease|0
5167368|NCT01332968|17842591|P8|Maintenance/Observation Period|Protocol Violation|0
5167369|NCT01332968|17842592|P7|Maintenance/Observation Period|Protocol Violation|0
5167370|NCT01332968|17842593|P6|Maintenance/Observation Period|Protocol Violation|0
5167371|NCT01332968|17842594|P5|Maintenance/Observation Period|Protocol Violation|0
5167372|NCT01332968|17842595|P4|Maintenance/Observation Period|Protocol Violation|1
5167373|NCT01332968|17842596|P3|Maintenance/Observation Period|Protocol Violation|1
5167374|NCT01332968|17842597|P2|Maintenance/Observation Period|Protocol Violation|0
5167375|NCT01332968|17842598|P1|Maintenance/Observation Period|Protocol Violation|0
5167376|NCT01332968|17842591|P8|Maintenance/Observation Period|Withdrawal by Subject|0
5167377|NCT01332968|17842592|P7|Maintenance/Observation Period|Withdrawal by Subject|0
5167378|NCT01332968|17842593|P6|Maintenance/Observation Period|Withdrawal by Subject|0
5167379|NCT01332968|17842594|P5|Maintenance/Observation Period|Withdrawal by Subject|0
5167380|NCT01332968|17842595|P4|Maintenance/Observation Period|Withdrawal by Subject|5
5167381|NCT01332968|17842596|P3|Maintenance/Observation Period|Withdrawal by Subject|10
5167382|NCT01332968|17842597|P2|Maintenance/Observation Period|Withdrawal by Subject|0
5167383|NCT01332968|17842598|P1|Maintenance/Observation Period|Withdrawal by Subject|0
5167384|NCT01332968|17842591|P8|Induction Period|Randomized, but not treated|0
5167385|NCT01332968|17842592|P7|Induction Period|Randomized, but not treated|0
5167386|NCT01332968|17842593|P6|Induction Period|Randomized, but not treated|0
5167387|NCT01332968|17842594|P5|Induction Period|Randomized, but not treated|0
5167388|NCT01332968|17842595|P4|Induction Period|Randomized, but not treated|0
5167389|NCT01332968|17842596|P3|Induction Period|Randomized, but not treated|0
5167390|NCT01332968|17842597|P2|Induction Period|Randomized, but not treated|7
5167391|NCT01332968|17842598|P1|Induction Period|Randomized, but not treated|4
5167392|NCT01332968|17842591|P8|Induction Period|Adverse Event|0
5167393|NCT01332968|17842592|P7|Induction Period|Adverse Event|0
5167394|NCT01332968|17842593|P6|Induction Period|Adverse Event|0
5167395|NCT01332968|17842594|P5|Induction Period|Adverse Event|0
5167396|NCT01332968|17842595|P4|Induction Period|Adverse Event|0
5167397|NCT01332968|17842596|P3|Induction Period|Adverse Event|0
5167398|NCT01332968|17842597|P2|Induction Period|Adverse Event|26
5167399|NCT01332968|17842598|P1|Induction Period|Adverse Event|23
5167400|NCT01332968|17842591|P8|Induction Period|Death|0
5167401|NCT01332968|17842592|P7|Induction Period|Death|0
5167402|NCT01332968|17842593|P6|Induction Period|Death|0
5167403|NCT01332968|17842594|P5|Induction Period|Death|0
5167404|NCT01332968|17842595|P4|Induction Period|Death|0
5167405|NCT01332968|17842596|P3|Induction Period|Death|0
5167406|NCT01332968|17842597|P2|Induction Period|Death|4
5167407|NCT01332968|17842598|P1|Induction Period|Death|1
5167408|NCT01332968|17842591|P8|Induction Period|Non-compliance|0
5167409|NCT01332968|17842592|P7|Induction Period|Non-compliance|0
5167410|NCT01332968|17842593|P6|Induction Period|Non-compliance|0
5167411|NCT01332968|17842594|P5|Induction Period|Non-compliance|0
5167412|NCT01332968|17842595|P4|Induction Period|Non-compliance|0
5167413|NCT01332968|17842596|P3|Induction Period|Non-compliance|0
5167414|NCT01332968|17842597|P2|Induction Period|Non-compliance|0
5167415|NCT01332968|17842598|P1|Induction Period|Non-compliance|1
5167416|NCT01332968|17842591|P8|Induction Period|Other|0
5167417|NCT01332968|17842592|P7|Induction Period|Other|0
5167418|NCT01332968|17842593|P6|Induction Period|Other|0
5167419|NCT01332968|17842594|P5|Induction Period|Other|0
5167420|NCT01332968|17842595|P4|Induction Period|Other|0
5167421|NCT01332968|17842596|P3|Induction Period|Other|0
5167422|NCT01332968|17842597|P2|Induction Period|Other|2
5167423|NCT01332968|17842598|P1|Induction Period|Other|2
5167424|NCT01332968|17842591|P8|Induction Period|Physician Decision|0
5167425|NCT01332968|17842592|P7|Induction Period|Physician Decision|0
5167426|NCT01332968|17842593|P6|Induction Period|Physician Decision|0
5167427|NCT01332968|17842594|P5|Induction Period|Physician Decision|0
5167428|NCT01332968|17842595|P4|Induction Period|Physician Decision|0
5167429|NCT01332968|17842596|P3|Induction Period|Physician Decision|0
5167430|NCT01332968|17842597|P2|Induction Period|Physician Decision|1
5167431|NCT01332968|17842598|P1|Induction Period|Physician Decision|6
5167432|NCT01332968|17842591|P8|Induction Period|Progressive disease|0
5167433|NCT01332968|17842592|P7|Induction Period|Progressive disease|0
5167434|NCT01332968|17842593|P6|Induction Period|Progressive disease|0
5167435|NCT01332968|17842594|P5|Induction Period|Progressive disease|0
5167436|NCT01332968|17842595|P4|Induction Period|Progressive disease|0
5167437|NCT01332968|17842596|P3|Induction Period|Progressive disease|0
5167438|NCT01332968|17842597|P2|Induction Period|Progressive disease|7
5167439|NCT01332968|17842598|P1|Induction Period|Progressive disease|15
5167440|NCT01332968|17842591|P8|Induction Period|Protocol Violation|0
5167441|NCT01332968|17842592|P7|Induction Period|Protocol Violation|0
5167442|NCT01332968|17842593|P6|Induction Period|Protocol Violation|0
5167443|NCT01332968|17842594|P5|Induction Period|Protocol Violation|0
5167444|NCT01332968|17842595|P4|Induction Period|Protocol Violation|0
5167445|NCT01332968|17842596|P3|Induction Period|Protocol Violation|0
5167446|NCT01332968|17842597|P2|Induction Period|Protocol Violation|4
5167447|NCT01332968|17842598|P1|Induction Period|Protocol Violation|3
5167448|NCT01332968|17842591|P8|Induction Period|Withdrawal by Subject|0
5167449|NCT01332968|17842592|P7|Induction Period|Withdrawal by Subject|0
5167450|NCT01332968|17842593|P6|Induction Period|Withdrawal by Subject|0
5167451|NCT01332968|17842594|P5|Induction Period|Withdrawal by Subject|0
5167452|NCT01332968|17842595|P4|Induction Period|Withdrawal by Subject|0
5167453|NCT01332968|17842596|P3|Induction Period|Withdrawal by Subject|0
5167454|NCT01332968|17842597|P2|Induction Period|Withdrawal by Subject|5
5167455|NCT01332968|17842598|P1|Induction Period|Withdrawal by Subject|3
5167456|NCT01332851|17842664|P2|Overall Study|Lost to Follow-up|11
5167457|NCT01332851|17842665|P1|Overall Study|Lost to Follow-up|7
5167458|NCT01332851|17842664|P2|Overall Study|Withdrawal by Subject|2
5167459|NCT01332851|17842665|P1|Overall Study|Withdrawal by Subject|4
5167460|NCT01332799|17842699|P2|Overall Study|Insufficient funding|10
5167461|NCT01332799|17842700|P1|Overall Study|Insufficient funding|10
5167462|NCT01332630|17842716|P1|Overall Study|Withdrawal by Subject|3
5167463|NCT01332331|17842832|P2|Overall Study|Physician Decision|0
5167464|NCT01332331|17842833|P1|Overall Study|Physician Decision|1
5167465|NCT01332331|17842832|P2|Overall Study|Adverse Event|1
5167466|NCT01332331|17842833|P1|Overall Study|Adverse Event|1
5167467|NCT01332331|17842832|P2|Overall Study|Lost to Follow-up|1
5167468|NCT01332331|17842833|P1|Overall Study|Lost to Follow-up|0
5167469|NCT01332318|17842885|P4|Overall Study|Protocol Violation|1
5167470|NCT01332318|17842886|P3|Overall Study|Protocol Violation|1
5167471|NCT01332318|17842887|P2|Overall Study|Protocol Violation|0
5167472|NCT01332318|17842888|P1|Overall Study|Protocol Violation|1
5167473|NCT01332318|17842885|P4|Overall Study|Withdrawal by Subject|1
5167474|NCT01332318|17842886|P3|Overall Study|Withdrawal by Subject|0
5167475|NCT01332318|17842887|P2|Overall Study|Withdrawal by Subject|1
5167476|NCT01332318|17842888|P1|Overall Study|Withdrawal by Subject|1
5167477|NCT01332318|17842885|P4|Overall Study|Adverse Event|0
5167478|NCT01332318|17842886|P3|Overall Study|Adverse Event|0
5167479|NCT01332318|17842887|P2|Overall Study|Adverse Event|3
5167480|NCT01332318|17842888|P1|Overall Study|Adverse Event|0
5167481|NCT01332305|17842999|P5|Overall Study|Physician Decision|0
5167482|NCT01332305|17843000|P4|Overall Study|Physician Decision|1
5167483|NCT01332305|17843001|P3|Overall Study|Physician Decision|0
5167484|NCT01332305|17843002|P2|Overall Study|Physician Decision|0
5167485|NCT01332305|17843003|P1|Overall Study|Physician Decision|0
5167486|NCT01332305|17842999|P5|Overall Study|Treatment Failure|0
5167487|NCT01332305|17843000|P4|Overall Study|Treatment Failure|0
5167488|NCT01332305|17843001|P3|Overall Study|Treatment Failure|0
5167489|NCT01332305|17843002|P2|Overall Study|Treatment Failure|1
5167490|NCT01332305|17843003|P1|Overall Study|Treatment Failure|1
5167491|NCT01332305|17842999|P5|Overall Study|Withdrawal by Sponsor|1
5167492|NCT01332305|17843000|P4|Overall Study|Withdrawal by Sponsor|1
5167493|NCT01332305|17843001|P3|Overall Study|Withdrawal by Sponsor|0
5167494|NCT01332305|17843002|P2|Overall Study|Withdrawal by Sponsor|0
5167495|NCT01332305|17843003|P1|Overall Study|Withdrawal by Sponsor|1
5167496|NCT01332305|17842999|P5|Overall Study|Protocol Violation|3
5167497|NCT01332305|17843000|P4|Overall Study|Protocol Violation|0
5167498|NCT01332305|17843001|P3|Overall Study|Protocol Violation|1
5167499|NCT01332305|17843002|P2|Overall Study|Protocol Violation|2
5167500|NCT01332305|17843003|P1|Overall Study|Protocol Violation|1
5167501|NCT01332305|17842999|P5|Overall Study|Lost to Follow-up|3
5167502|NCT01332305|17843000|P4|Overall Study|Lost to Follow-up|2
5167503|NCT01332305|17843001|P3|Overall Study|Lost to Follow-up|3
5167504|NCT01332305|17843002|P2|Overall Study|Lost to Follow-up|2
5167505|NCT01332305|17843003|P1|Overall Study|Lost to Follow-up|0
5167506|NCT01332305|17842999|P5|Overall Study|Withdrawal by Subject|0
5167507|NCT01332305|17843000|P4|Overall Study|Withdrawal by Subject|1
5167508|NCT01332305|17843001|P3|Overall Study|Withdrawal by Subject|4
5167509|NCT01332305|17843002|P2|Overall Study|Withdrawal by Subject|5
5167510|NCT01332305|17843003|P1|Overall Study|Withdrawal by Subject|6
5167511|NCT01332305|17842999|P5|Overall Study|Adverse Event|5
5167512|NCT01332305|17843000|P4|Overall Study|Adverse Event|3
5167513|NCT01332305|17843001|P3|Overall Study|Adverse Event|6
5167514|NCT01332305|17843002|P2|Overall Study|Adverse Event|4
5167515|NCT01332305|17843003|P1|Overall Study|Adverse Event|1
5167516|NCT01332292|17843025|P2|Treatment Period 2 (14 Days)|Physician Decision|1
5167517|NCT01332292|17843026|P1|Treatment Period 2 (14 Days)|Physician Decision|1
5167518|NCT01332292|17843025|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
5167519|NCT01332292|17843026|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
5167520|NCT01332292|17843025|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5167521|NCT01332292|17843026|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5167522|NCT01332227|17843117|P2|Overall Study|Patient began prohibited medication|1
5167523|NCT01332227|17843118|P1|Overall Study|Patient began prohibited medication|0
5167524|NCT01332227|17843117|P2|Overall Study|Patient moved from area|0
5167525|NCT01332227|17843118|P1|Overall Study|Patient moved from area|1
5167526|NCT01332227|17843117|P2|Overall Study|Poor compliance/noncompliance|1
5167527|NCT01332227|17843118|P1|Overall Study|Poor compliance/noncompliance|1
5167528|NCT01332227|17843117|P2|Overall Study|Lack of Efficacy|1
5167529|NCT01332227|17843118|P1|Overall Study|Lack of Efficacy|3
5167530|NCT01332227|17843117|P2|Overall Study|Lost to Follow-up|0
5167531|NCT01332227|17843118|P1|Overall Study|Lost to Follow-up|2
5167532|NCT01332227|17843117|P2|Overall Study|Withdrawal by Subject|1
5167533|NCT01332227|17843118|P1|Overall Study|Withdrawal by Subject|5
5167534|NCT01332227|17843117|P2|Overall Study|Adverse Event|1
5167535|NCT01332227|17843118|P1|Overall Study|Adverse Event|4
5167536|NCT01332149|17843299|P2|Overall Study|Randomized but not treated|2
5167537|NCT01332149|17843300|P1|Overall Study|Randomized but not treated|1
5167538|NCT01332149|17843299|P2|Overall Study|Did not meet entrance criteria|4
5167539|NCT01332149|17843300|P1|Overall Study|Did not meet entrance criteria|3
5167540|NCT01332149|17843299|P2|Overall Study|Insufficient clinical response|7
5167541|NCT01332149|17843300|P1|Overall Study|Insufficient clinical response|4
5167542|NCT01332149|17843299|P2|Overall Study|Lost to Follow-up|1
5167543|NCT01332149|17843300|P1|Overall Study|Lost to Follow-up|1
5167544|NCT01332149|17843299|P2|Overall Study|Withdrawal by Subject|5
5167545|NCT01332149|17843300|P1|Overall Study|Withdrawal by Subject|4
5167546|NCT01332149|17843299|P2|Overall Study|Protocol Violation|3
5167547|NCT01332149|17843300|P1|Overall Study|Protocol Violation|1
5167548|NCT01332149|17843299|P2|Overall Study|Other unspecified|7
5167549|NCT01332149|17843300|P1|Overall Study|Other unspecified|5
5167550|NCT01332149|17843299|P2|Overall Study|Adverse Event|9
5167551|NCT01332149|17843300|P1|Overall Study|Adverse Event|11
5167552|NCT01332019|17843378|P2|Overall Study|Adverse Event|22
5167553|NCT01332019|17843379|P1|Overall Study|Adverse Event|13
5167554|NCT01332019|17843378|P2|Overall Study|Lost to Follow-up|7
5167555|NCT01332019|17843379|P1|Overall Study|Lost to Follow-up|4
5167556|NCT01332019|17843378|P2|Overall Study|Withdrawal by Subject|71
5167557|NCT01332019|17843379|P1|Overall Study|Withdrawal by Subject|73
5167558|NCT01332019|17843378|P2|Overall Study|Physician Decision|3
5167559|NCT01332019|17843379|P1|Overall Study|Physician Decision|4
5167560|NCT01332019|17843378|P2|Overall Study|Death|1
5167561|NCT01332019|17843379|P1|Overall Study|Death|2
5167562|NCT01332019|17843378|P2|Overall Study|Other|18
5167563|NCT01332019|17843379|P1|Overall Study|Other|16
5167564|NCT01332019|17843378|P2|Overall Study|Was Not Dosed|0
5167565|NCT01332019|17843379|P1|Overall Study|Was Not Dosed|1
5167566|NCT01331837|17843463|P2|Overall Study|Withdrawal by Subject|16
5167567|NCT01331837|17843464|P1|Overall Study|Withdrawal by Subject|13
5167568|NCT01331837|17843463|P2|Overall Study|Info not recorded|16
5167569|NCT01331837|17843464|P1|Overall Study|Info not recorded|10
5167570|NCT01331837|17843463|P2|Overall Study|Lost to Follow-up|1
5167571|NCT01331837|17843464|P1|Overall Study|Lost to Follow-up|3
5167572|NCT01331837|17843463|P2|Overall Study|Death|34
5167573|NCT01331837|17843464|P1|Overall Study|Death|30
5167574|NCT01331824|17843504|P1|Overall Study|Withdrawal by Subject|1
5167575|NCT01331824|17843504|P1|Overall Study|Disease Progression|9
5167576|NCT01331824|17843504|P1|Overall Study|Death|1
5167577|NCT01331824|17843504|P1|Overall Study|Adverse Event|2
5167578|NCT01331681|17843539|P3|Overall Study|Not Received Study Treatment|2
5167579|NCT01331681|17843540|P2|Overall Study|Not Received Study Treatment|0
5167580|NCT01331681|17843541|P1|Overall Study|Not Received Study Treatment|0
5167581|NCT01331681|17843539|P3|Overall Study|Switching to other therapy|1
5167582|NCT01331681|17843540|P2|Overall Study|Switching to other therapy|0
5167583|NCT01331681|17843541|P1|Overall Study|Switching to other therapy|0
5167584|NCT01331681|17843539|P3|Overall Study|Sponsor decision|0
5167585|NCT01331681|17843540|P2|Overall Study|Sponsor decision|1
5167586|NCT01331681|17843541|P1|Overall Study|Sponsor decision|1
5167587|NCT01331681|17843539|P3|Overall Study|Therapeutic procedure required|0
5167588|NCT01331681|17843540|P2|Overall Study|Therapeutic procedure required|0
5167589|NCT01331681|17843541|P1|Overall Study|Therapeutic procedure required|1
5167590|NCT01331681|17843539|P3|Overall Study|Physician Decision|4
5167591|NCT01331681|17843540|P2|Overall Study|Physician Decision|0
5167592|NCT01331681|17843541|P1|Overall Study|Physician Decision|2
5167593|NCT01331681|17843539|P3|Overall Study|Lost to Follow-up|1
5167594|NCT01331681|17843540|P2|Overall Study|Lost to Follow-up|4
5167595|NCT01331681|17843541|P1|Overall Study|Lost to Follow-up|2
5167596|NCT01331681|17843539|P3|Overall Study|Protocol Violation|0
5167597|NCT01331681|17843540|P2|Overall Study|Protocol Violation|1
5167598|NCT01331681|17843541|P1|Overall Study|Protocol Violation|1
5167599|NCT01331681|17843539|P3|Overall Study|Withdrawal by Subject|15
5167600|NCT01331681|17843540|P2|Overall Study|Withdrawal by Subject|8
5167601|NCT01331681|17843541|P1|Overall Study|Withdrawal by Subject|12
5167602|NCT01331681|17843539|P3|Overall Study|Lack of Efficacy|0
5167603|NCT01331681|17843540|P2|Overall Study|Lack of Efficacy|1
5167604|NCT01331681|17843541|P1|Overall Study|Lack of Efficacy|0
5167605|NCT01331681|17843539|P3|Overall Study|Death|2
5167606|NCT01331681|17843540|P2|Overall Study|Death|6
5167607|NCT01331681|17843541|P1|Overall Study|Death|6
5167608|NCT01331681|17843539|P3|Overall Study|Adverse Event|10
5167609|NCT01331681|17843540|P2|Overall Study|Adverse Event|13
5167610|NCT01331681|17843541|P1|Overall Study|Adverse Event|10
5167611|NCT01331291|17843590|P2|Overall Study|Death|1
5167612|NCT01331291|17843591|P1|Overall Study|Death|0
5167613|NCT01331291|17843590|P2|Overall Study|Lack of Efficacy|8
5167614|NCT01331291|17843591|P1|Overall Study|Lack of Efficacy|2
5167615|NCT01331161|17843625|P2|Overall Study|Pregnancy|1
5167616|NCT01331161|17843626|P1|Overall Study|Pregnancy|0
5167617|NCT01331161|17843625|P2|Overall Study|Lost to Follow-up|1
5167618|NCT01331161|17843626|P1|Overall Study|Lost to Follow-up|0
5167619|NCT01331161|17843625|P2|Overall Study|Physician Decision|0
5167620|NCT01331161|17843626|P1|Overall Study|Physician Decision|1
5167621|NCT01331109|17843634|P1|Overall Study|Study Terminated by Sponsor|38
5167622|NCT01331109|17843634|P1|Overall Study|Lost to Follow-up|1
5167623|NCT01331109|17843634|P1|Overall Study|Withdrawal by Subject|7
5167624|NCT01331109|17843634|P1|Overall Study|Protocol Violation|3
5167625|NCT01331109|17843634|P1|Overall Study|Lack of Efficacy|2
5167626|NCT01331109|17843634|P1|Overall Study|Adverse Event|6
5167627|NCT01331005|17843661|P2|Overall Study|Withdrawal by Subject|3
5167628|NCT01331005|17843662|P1|Overall Study|Withdrawal by Subject|2
5167629|NCT01331005|17843661|P2|Overall Study|Lost to Follow-up|1
5167630|NCT01331005|17843662|P1|Overall Study|Lost to Follow-up|2
5167631|NCT01330914|17843733|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
5167632|NCT01330914|17843733|P1|Overall Study|Withdrawal by Subject|4
5167633|NCT01330628|17843741|P2|Overall Study|Didn't receive study treatment|0
5167634|NCT01330628|17843742|P1|Overall Study|Didn't receive study treatment|1
5167635|NCT01330628|17843741|P2|Overall Study|Withdrawn|6
5167636|NCT01330628|17843742|P1|Overall Study|Withdrawn|18
5167637|NCT01330628|17843741|P2|Overall Study|Adverse Event|25
5167638|NCT01330628|17843742|P1|Overall Study|Adverse Event|44
5167639|NCT01330628|17843741|P2|Overall Study|Lost to Follow-up|6
5167640|NCT01330628|17843742|P1|Overall Study|Lost to Follow-up|5
5167641|NCT01330628|17843741|P2|Overall Study|Death|3
5167642|NCT01330628|17843742|P1|Overall Study|Death|2
5167643|NCT01330459|17843752|P2|Overall Study|Physician Decision|2
5167644|NCT01330459|17843753|P1|Overall Study|Physician Decision|0
5167645|NCT01330433|17843769|P2|Overall Study|Lost to Follow-up|0
5167646|NCT01330433|17843770|P1|Overall Study|Lost to Follow-up|1
5167647|NCT01330433|17843769|P2|Overall Study|Death|3
5167648|NCT01330433|17843770|P1|Overall Study|Death|1
5167649|NCT01330381|17843809|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
5167650|NCT01330381|17843810|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
5167651|NCT01330381|17843811|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
5167652|NCT01330381|17843809|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
5167653|NCT01330381|17843810|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
5167654|NCT01330381|17843811|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
5167655|NCT01330381|17843809|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
5167656|NCT01330381|17843810|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
5167657|NCT01330381|17843811|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
5167658|NCT01330381|17843809|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
5167659|NCT01330381|17843810|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
5167660|NCT01330381|17843811|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
5167661|NCT01330381|17843809|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
5167662|NCT01330381|17843810|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
5167663|NCT01330381|17843811|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
5167664|NCT01330381|17843809|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
5167665|NCT01330381|17843810|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
5167666|NCT01330381|17843811|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
5167667|NCT01330381|17843809|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
5167668|NCT01330381|17843810|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
5167669|NCT01330381|17843811|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
5167670|NCT01330381|17843809|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
5167671|NCT01330381|17843810|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
5167672|NCT01330381|17843811|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
5167673|NCT01330381|17843809|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
5167674|NCT01330381|17843810|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
5167675|NCT01330381|17843811|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
5167676|NCT01330381|17843809|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
5167677|NCT01330381|17843810|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
5167678|NCT01330381|17843811|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
5167679|NCT01330316|17843872|P2|Overall Study|other than above|1
5167680|NCT01330316|17843873|P1|Overall Study|other than above|0
5167681|NCT01330316|17843872|P2|Overall Study|Withdrawal by Subject|1
5167682|NCT01330316|17843873|P1|Overall Study|Withdrawal by Subject|0
5167683|NCT01330316|17843872|P2|Overall Study|Lost to Follow-up|1
5167684|NCT01330316|17843873|P1|Overall Study|Lost to Follow-up|0
5167685|NCT01330316|17843872|P2|Overall Study|Lack of Efficacy|10
5167686|NCT01330316|17843873|P1|Overall Study|Lack of Efficacy|0
5167687|NCT01330316|17843872|P2|Overall Study|Adverse Event|2
5167688|NCT01330316|17843873|P1|Overall Study|Adverse Event|2
5167689|NCT01330303|17843909|P2|Period 1|Withdrawal by Subject|1
5167690|NCT01330303|17843910|P1|Period 1|Withdrawal by Subject|0
5167691|NCT01330303|17843909|P2|Period 1|Protocol Violation|1
5167692|NCT01330303|17843910|P1|Period 1|Protocol Violation|0
5167693|NCT01330303|17843909|P2|Period 1|Adverse Event|0
5167694|NCT01330303|17843910|P1|Period 1|Adverse Event|1
5167695|NCT01330108|17843957|P1|Overall Study|Withdrawal by Subject|4
5167696|NCT01330030|17843975|P2|Overall Study|Lost to Follow-up|17
5167697|NCT01330030|17843976|P1|Overall Study|Lost to Follow-up|16
5167698|NCT01330017|17843987|P5|Overall Study|Unknown Reason|2
5167699|NCT01330017|17843988|P4|Overall Study|Unknown Reason|7
5167700|NCT01330017|17843989|P3|Overall Study|Unknown Reason|5
5167701|NCT01330017|17843990|P2|Overall Study|Unknown Reason|3
5167702|NCT01330017|17843991|P1|Overall Study|Unknown Reason|5
5167703|NCT01330017|17843987|P5|Overall Study|Protocol Violation|0
5167704|NCT01330017|17843988|P4|Overall Study|Protocol Violation|1
5167705|NCT01330017|17843989|P3|Overall Study|Protocol Violation|0
5167706|NCT01330017|17843990|P2|Overall Study|Protocol Violation|0
5167707|NCT01330017|17843991|P1|Overall Study|Protocol Violation|0
5167708|NCT01330017|17843987|P5|Overall Study|Lost to Follow-up|0
5167709|NCT01330017|17843988|P4|Overall Study|Lost to Follow-up|0
5167710|NCT01330017|17843989|P3|Overall Study|Lost to Follow-up|1
5167711|NCT01330017|17843990|P2|Overall Study|Lost to Follow-up|0
5167712|NCT01330017|17843991|P1|Overall Study|Lost to Follow-up|0
5167713|NCT01330017|17843987|P5|Overall Study|Withdrawal by Subject|1
5167714|NCT01330017|17843988|P4|Overall Study|Withdrawal by Subject|0
5167715|NCT01330017|17843989|P3|Overall Study|Withdrawal by Subject|1
5167716|NCT01330017|17843990|P2|Overall Study|Withdrawal by Subject|0
5167717|NCT01330017|17843991|P1|Overall Study|Withdrawal by Subject|0
5167718|NCT01330017|17843987|P5|Overall Study|Adverse Event|0
5167719|NCT01330017|17843988|P4|Overall Study|Adverse Event|4
5167720|NCT01330017|17843989|P3|Overall Study|Adverse Event|1
5167721|NCT01330017|17843990|P2|Overall Study|Adverse Event|1
5167722|NCT01330017|17843991|P1|Overall Study|Adverse Event|0
5167723|NCT01329978|17844040|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
5167724|NCT01329978|17844041|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
5167725|NCT01329978|17844042|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
5167726|NCT01329978|17844043|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
5167727|NCT01329978|17844044|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
5167728|NCT01329978|17844040|P5|Rerandomization Treatment Period|Lost to Follow-up|3
5167729|NCT01329978|17844041|P4|Rerandomization Treatment Period|Lost to Follow-up|5
5167730|NCT01329978|17844042|P3|Rerandomization Treatment Period|Lost to Follow-up|0
5167731|NCT01329978|17844043|P2|Rerandomization Treatment Period|Lost to Follow-up|0
5167732|NCT01329978|17844044|P1|Rerandomization Treatment Period|Lost to Follow-up|0
5167733|NCT01329978|17844040|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5167734|NCT01329978|17844041|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5167735|NCT01329978|17844042|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5167736|NCT01329978|17844043|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
5167737|NCT01329978|17844044|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5167738|NCT01329978|17844040|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5167739|NCT01329978|17844041|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5167740|NCT01329978|17844042|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5167741|NCT01329978|17844043|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
5167742|NCT01329978|17844044|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5167743|NCT01329978|17844040|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
5167744|NCT01329978|17844041|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
5167745|NCT01329978|17844042|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
5167746|NCT01329978|17844043|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
5167747|NCT01329978|17844044|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
5167748|NCT01329978|17844040|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
5167749|NCT01329978|17844041|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
5167750|NCT01329978|17844042|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
5167751|NCT01329978|17844043|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
5167752|NCT01329978|17844044|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
5167753|NCT01329978|17844040|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5167754|NCT01329978|17844041|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5167755|NCT01329978|17844042|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5167756|NCT01329978|17844043|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
5167757|NCT01329978|17844044|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
5167758|NCT01329939|17844118|P4|Overall Study|Adverse Event|3
5167759|NCT01329939|17844119|P3|Overall Study|Adverse Event|0
5167760|NCT01329939|17844120|P2|Overall Study|Adverse Event|0
5167761|NCT01329939|17844121|P1|Overall Study|Adverse Event|0
5167762|NCT01329939|17844118|P4|Overall Study|Withdrawal by Subject|0
5167763|NCT01329939|17844119|P3|Overall Study|Withdrawal by Subject|0
5167764|NCT01329939|17844120|P2|Overall Study|Withdrawal by Subject|1
5167765|NCT01329939|17844121|P1|Overall Study|Withdrawal by Subject|0
5167766|NCT01329939|17844118|P4|Overall Study|Lost to Follow-up|2
5167767|NCT01329939|17844119|P3|Overall Study|Lost to Follow-up|1
5167768|NCT01329939|17844120|P2|Overall Study|Lost to Follow-up|0
5167769|NCT01329939|17844121|P1|Overall Study|Lost to Follow-up|3
5167770|NCT01329900|17844159|P1|Overall Study|Elevated creatinine/renal function|1
5167771|NCT01329562|17844189|P2|Overall Study|Physician Decision|1
5167772|NCT01329562|17844190|P1|Overall Study|Physician Decision|0
5167773|NCT01329562|17844189|P2|Overall Study|Subject withdrew due to personal issues.|2
5167774|NCT01329562|17844190|P1|Overall Study|Subject withdrew due to personal issues.|3
5167775|NCT01329562|17844189|P2|Overall Study|Lost to Follow-up|1
5167776|NCT01329562|17844190|P1|Overall Study|Lost to Follow-up|1
5167777|NCT01329562|17844189|P2|Overall Study|Protocol Violation|3
5167778|NCT01329562|17844190|P1|Overall Study|Protocol Violation|5
5167779|NCT01329549|17844239|P1|Overall Study|Adverse Event|1
5167780|NCT01329549|17844239|P1|Overall Study|Withdrawal by Subject|1
5167781|NCT01329419|17844250|P1|Overall Study|Protocol Violation|235
5167782|NCT01329328|17844269|P3|Overall Study|Withdrawal by Subject|3
5167783|NCT01329328|17844270|P2|Overall Study|Withdrawal by Subject|4
5167784|NCT01329328|17844271|P1|Overall Study|Withdrawal by Subject|2
5167785|NCT01329263|17844284|P2|Overall Study|Withdrawal by Subject|2
5167786|NCT01329263|17844285|P1|Overall Study|Withdrawal by Subject|1
5167787|NCT01329263|17844284|P2|Overall Study|Lost to Follow-up|21
5167788|NCT01329263|17844285|P1|Overall Study|Lost to Follow-up|4
5167789|NCT01329029|17844322|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
5167790|NCT01329029|17844323|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
5167791|NCT01329029|17844322|P2|Overall Study|Lost to Follow-up|5
5167792|NCT01329029|17844323|P1|Overall Study|Lost to Follow-up|8
5167793|NCT01329029|17844322|P2|Overall Study|Physician Decision|13
5167794|NCT01329029|17844323|P1|Overall Study|Physician Decision|16
5167795|NCT01329029|17844322|P2|Overall Study|COPD Exacerbation|18
5167796|NCT01329029|17844323|P1|Overall Study|COPD Exacerbation|11
5167797|NCT01329029|17844322|P2|Overall Study|Other|20
5167798|NCT01329029|17844323|P1|Overall Study|Other|14
5167799|NCT01329029|17844322|P2|Overall Study|Death|19
5167800|NCT01329029|17844323|P1|Overall Study|Death|16
5167801|NCT01329029|17844322|P2|Overall Study|Adverse Event|29
5167802|NCT01329029|17844323|P1|Overall Study|Adverse Event|82
5167803|NCT01329029|17844322|P2|Overall Study|Withdrawal by Subject|87
5167804|NCT01329029|17844323|P1|Overall Study|Withdrawal by Subject|117
5167805|NCT01328951|17844413|P2|Overall Study|Other|6
5167806|NCT01328951|17844414|P1|Overall Study|Other|11
5167807|NCT01328951|17844413|P2|Overall Study|Study Closed by the Sponsor|31
5167808|NCT01328951|17844414|P1|Overall Study|Study Closed by the Sponsor|36
5167809|NCT01328951|17844413|P2|Overall Study|Withdrawal by Subject|6
5167810|NCT01328951|17844414|P1|Overall Study|Withdrawal by Subject|6
5167811|NCT01328951|17844413|P2|Overall Study|Lost to Follow-up|7
5167812|NCT01328951|17844414|P1|Overall Study|Lost to Follow-up|6
5167813|NCT01328951|17844413|P2|Overall Study|Death|258
5167814|NCT01328951|17844414|P1|Overall Study|Death|243
5167815|NCT01328951|17844413|P2|Overall Study|Adverse Event|0
5167816|NCT01328951|17844414|P1|Overall Study|Adverse Event|2
5167817|NCT01328951|17844413|P2|Overall Study|Disease Progression|14
5167818|NCT01328951|17844414|P1|Overall Study|Disease Progression|17
5167819|NCT01328756|17844483|P1|Overall Study|Other|29
5167820|NCT01328756|17844483|P1|Overall Study|Lost to Follow-up|5
5167821|NCT01328756|17844483|P1|Overall Study|Withdrawal by Subject|41
5167822|NCT01328756|17844483|P1|Overall Study|Lack of Efficacy|5
5167823|NCT01328756|17844483|P1|Overall Study|Adverse Event|39
5167824|NCT01328756|17844483|P1|Overall Study|Protocol Violation|4
5167825|NCT01328717|17844519|P1|Overall Study|Adverse Event|1
5167826|NCT01328574|17844528|P1|Overall Study|Refused further treatment|1
5167827|NCT01328548|17844542|P2|Overall Study|Protocol Violation|0
5167828|NCT01328548|17844543|P1|Overall Study|Protocol Violation|1
5167829|NCT01328548|17844542|P2|Overall Study|Death|0
5167830|NCT01328548|17844543|P1|Overall Study|Death|3
5167831|NCT01328535|17844561|P1|Overall Study|Ineligible|1
5167832|NCT01328496|17844572|P2|Overall Study|Significant Change in Health Status|0
5167833|NCT01328496|17844573|P1|Overall Study|Significant Change in Health Status|1
5167834|NCT01328444|17844591|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5167835|NCT01328444|17844592|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5167836|NCT01328444|17844593|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5167837|NCT01328444|17844594|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5167838|NCT01328444|17844595|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5167839|NCT01328444|17844596|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5167840|NCT01328444|17844591|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
5167841|NCT01328444|17844592|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5167842|NCT01328444|17844593|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5167843|NCT01328444|17844594|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5167844|NCT01328444|17844595|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5167845|NCT01328444|17844596|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5167846|NCT01328444|17844591|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5167847|NCT01328444|17844592|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
5167848|NCT01328444|17844593|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
5167849|NCT01328444|17844594|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5167850|NCT01328444|17844595|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5167851|NCT01328444|17844596|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5167852|NCT01328444|17844591|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5167853|NCT01328444|17844592|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
5167854|NCT01328444|17844593|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5167855|NCT01328444|17844594|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5167856|NCT01328444|17844595|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5167857|NCT01328444|17844596|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
5167858|NCT01328444|17844591|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
5167859|NCT01328444|17844592|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
5167860|NCT01328444|17844593|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5167861|NCT01328444|17844594|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5167862|NCT01328444|17844595|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5167863|NCT01328444|17844596|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
5167864|NCT01328444|17844591|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
5167865|NCT01328444|17844592|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
5167866|NCT01328444|17844593|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
5167867|NCT01328444|17844594|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
5167868|NCT01328444|17844595|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
5167869|NCT01328444|17844596|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
5167870|NCT01328444|17844591|P6|Washout Period (14 Days)|Withdrawal by Subject|1
5167871|NCT01328444|17844592|P5|Washout Period (14 Days)|Withdrawal by Subject|0
5167872|NCT01328444|17844593|P4|Washout Period (14 Days)|Withdrawal by Subject|0
5167873|NCT01328444|17844594|P3|Washout Period (14 Days)|Withdrawal by Subject|0
5167874|NCT01328444|17844595|P2|Washout Period (14 Days)|Withdrawal by Subject|0
5167875|NCT01328444|17844596|P1|Washout Period (14 Days)|Withdrawal by Subject|0
5167876|NCT01328444|17844591|P6|Washout Period (14 Days)|Lack of Efficacy|1
5167877|NCT01328444|17844592|P5|Washout Period (14 Days)|Lack of Efficacy|0
5167878|NCT01328444|17844593|P4|Washout Period (14 Days)|Lack of Efficacy|0
5167879|NCT01328444|17844594|P3|Washout Period (14 Days)|Lack of Efficacy|0
5167880|NCT01328444|17844595|P2|Washout Period (14 Days)|Lack of Efficacy|0
5167881|NCT01328444|17844596|P1|Washout Period (14 Days)|Lack of Efficacy|0
5167882|NCT01328444|17844591|P6|Washout Period (14 Days)|Adverse Event|2
5167883|NCT01328444|17844592|P5|Washout Period (14 Days)|Adverse Event|1
5167884|NCT01328444|17844593|P4|Washout Period (14 Days)|Adverse Event|1
5167885|NCT01328444|17844594|P3|Washout Period (14 Days)|Adverse Event|0
5167886|NCT01328444|17844595|P2|Washout Period (14 Days)|Adverse Event|1
5167887|NCT01328444|17844596|P1|Washout Period (14 Days)|Adverse Event|1
5167888|NCT01328444|17844591|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5167889|NCT01328444|17844592|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5167890|NCT01328444|17844593|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
5167891|NCT01328444|17844594|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5167892|NCT01328444|17844595|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
5167893|NCT01328444|17844596|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5167894|NCT01328444|17844591|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5167895|NCT01328444|17844592|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5167896|NCT01328444|17844593|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5167897|NCT01328444|17844594|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5167898|NCT01328444|17844595|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5167899|NCT01328444|17844596|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
5167900|NCT01328444|17844591|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5167901|NCT01328444|17844592|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
5167902|NCT01328444|17844593|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5167903|NCT01328444|17844594|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5167904|NCT01328444|17844595|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
5167905|NCT01328444|17844596|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5167906|NCT01328444|17844591|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5167907|NCT01328444|17844592|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5167908|NCT01328444|17844593|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5167909|NCT01328444|17844594|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5167910|NCT01328444|17844595|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5167911|NCT01328444|17844596|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5167912|NCT01328444|17844591|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
5167913|NCT01328444|17844592|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5167914|NCT01328444|17844593|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5167915|NCT01328444|17844594|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5167916|NCT01328444|17844595|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5167917|NCT01328444|17844596|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5167918|NCT01328444|17844591|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
5167919|NCT01328444|17844592|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
5167920|NCT01328444|17844593|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
5167921|NCT01328444|17844594|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
5167922|NCT01328444|17844595|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
5167923|NCT01328444|17844596|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
5167924|NCT01328431|17844642|P2|12 Month (12M)|Lost to Follow-up|91
5167925|NCT01328431|17844643|P1|12 Month (12M)|Lost to Follow-up|82
5167926|NCT01328431|17844642|P2|12 Month (12M)|Death|6
5167927|NCT01328431|17844643|P1|12 Month (12M)|Death|2
5167928|NCT01328431|17844642|P2|3 Month (3M)|Lost to Follow-up|70
5167929|NCT01328431|17844643|P1|3 Month (3M)|Lost to Follow-up|75
5167930|NCT01328431|17844642|P2|3 Month (3M)|Death|2
5167931|NCT01328431|17844643|P1|3 Month (3M)|Death|2
5167932|NCT01328431|17844642|P2|1 Month (1M)|Lost to Follow-up|58
5167933|NCT01328431|17844643|P1|1 Month (1M)|Lost to Follow-up|55
5167934|NCT01328431|17844642|P2|Baseline|Protocol Violation|2
5167935|NCT01328431|17844643|P1|Baseline|Protocol Violation|0
5167936|NCT01328366|17844699|P1|Overall Study|Lost to Follow-up|7
5167937|NCT01328366|17844699|P1|Overall Study|Withdrawal by Subject|2
5167938|NCT01328366|17844699|P1|Overall Study|Death|1
5167939|NCT01328249|17844719|P2|Overall Study|Protocol Violation|1
5167940|NCT01328249|17844720|P1|Overall Study|Protocol Violation|0
5167941|NCT01328249|17844719|P2|Overall Study|Subject choice|1
5167942|NCT01328249|17844720|P1|Overall Study|Subject choice|1
5167943|NCT01328249|17844719|P2|Overall Study|Moved before end of treatment visit|0
5167944|NCT01328249|17844720|P1|Overall Study|Moved before end of treatment visit|1
5167945|NCT01328249|17844719|P2|Overall Study|Withdrawal by Subject|1
5167946|NCT01328249|17844720|P1|Overall Study|Withdrawal by Subject|1
5167947|NCT01328249|17844719|P2|Overall Study|Disease progression|0
5167948|NCT01328249|17844720|P1|Overall Study|Disease progression|1
5167949|NCT01328249|17844719|P2|Overall Study|Adverse Event|0
5167950|NCT01328249|17844720|P1|Overall Study|Adverse Event|3
5167951|NCT01328080|17844806|P1|Overall Study|Lost to Follow-up|5
5167952|NCT01328054|17844810|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
5167953|NCT01328054|17844811|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
5167954|NCT01328054|17844810|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
5167955|NCT01328054|17844811|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
5167956|NCT01328054|17844810|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
5167957|NCT01328054|17844811|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
5167958|NCT01328041|17844836|P1|Overall Study|Withdrawal by Subject|7
5167959|NCT01328041|17844836|P1|Overall Study|Physician Decision|2
5167960|NCT01328041|17844836|P1|Overall Study|Lost to Follow-up|7
5167961|NCT01328041|17844836|P1|Overall Study|Protocol Violation|7
5167962|NCT01328041|17844836|P1|Overall Study|Lack of Efficacy|27
5167963|NCT01328041|17844836|P1|Overall Study|Adverse Event|7
5167964|NCT01328002|17844858|P2|Double-Blind Period|Lack of Efficacy|0
5167965|NCT01328002|17844859|P1|Double-Blind Period|Lack of Efficacy|1
5167966|NCT01328002|17844858|P2|Double-Blind Period|Adverse Event|0
5167967|NCT01328002|17844859|P1|Double-Blind Period|Adverse Event|1
5167968|NCT01328002|17844858|P2|Open-Label Period|Other Reason|0
5167969|NCT01328002|17844859|P1|Open-Label Period|Other Reason|2
5167970|NCT01328002|17844858|P2|Open-Label Period|Lost to Follow-up|0
5167971|NCT01328002|17844859|P1|Open-Label Period|Lost to Follow-up|6
5167972|NCT01328002|17844858|P2|Open-Label Period|Withdrawal by Subject|0
5167973|NCT01328002|17844859|P1|Open-Label Period|Withdrawal by Subject|9
5167974|NCT01328002|17844858|P2|Open-Label Period|Protocol Violation|0
5167975|NCT01328002|17844859|P1|Open-Label Period|Protocol Violation|2
5167976|NCT01328002|17844858|P2|Open-Label Period|Lack of Efficacy|0
5167977|NCT01328002|17844859|P1|Open-Label Period|Lack of Efficacy|3
5167978|NCT01328002|17844858|P2|Open-Label Period|Adverse Event|0
5167979|NCT01328002|17844859|P1|Open-Label Period|Adverse Event|8
5167980|NCT01328002|17844858|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
5167981|NCT01328002|17844859|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
5167982|NCT01327885|17844895|P2|Overall Study|Administrative decision|1
5167983|NCT01327885|17844896|P1|Overall Study|Administrative decision|0
5167984|NCT01327885|17844895|P2|Overall Study|Not treated|1
5167985|NCT01327885|17844896|P1|Overall Study|Not treated|1
5167986|NCT01327885|17844895|P2|Overall Study|Withdrawal of consent from study|4
5167987|NCT01327885|17844896|P1|Overall Study|Withdrawal of consent from study|3
5167988|NCT01327885|17844895|P2|Overall Study|Other|6
5167989|NCT01327885|17844896|P1|Overall Study|Other|8
5167990|NCT01327885|17844895|P2|Overall Study|Subject choice|10
5167991|NCT01327885|17844896|P1|Overall Study|Subject choice|5
5167992|NCT01327885|17844895|P2|Overall Study|Adverse Event|10
5167993|NCT01327885|17844896|P1|Overall Study|Adverse Event|14
5167994|NCT01327885|17844895|P2|Overall Study|Clinical progression|27
5167995|NCT01327885|17844896|P1|Overall Study|Clinical progression|24
5167996|NCT01327885|17844895|P2|Overall Study|Disease progression-according to RECIST|165
5167997|NCT01327885|17844896|P1|Overall Study|Disease progression-according to RECIST|173
5167998|NCT01327846|17844912|P4|Extension Phase|Technical Problems|2
5167999|NCT01327846|17844913|P3|Extension Phase|Technical Problems|2
5168000|NCT01327846|17844914|P2|Extension Phase|Technical Problems|4
5168001|NCT01327846|17844915|P1|Extension Phase|Technical Problems|2
5168002|NCT01327846|17844912|P4|Extension Phase|Lost to Follow-up|7
5168003|NCT01327846|17844913|P3|Extension Phase|Lost to Follow-up|4
5168004|NCT01327846|17844914|P2|Extension Phase|Lost to Follow-up|3
5168005|NCT01327846|17844915|P1|Extension Phase|Lost to Follow-up|4
5168006|NCT01327846|17844912|P4|Extension Phase|Withdrawal by Subject|37
5168007|NCT01327846|17844913|P3|Extension Phase|Withdrawal by Subject|19
5168008|NCT01327846|17844914|P2|Extension Phase|Withdrawal by Subject|13
5168009|NCT01327846|17844915|P1|Extension Phase|Withdrawal by Subject|20
5168010|NCT01327846|17844912|P4|Extension Phase|Study terminated by sponsor|1660
5168011|NCT01327846|17844913|P3|Extension Phase|Study terminated by sponsor|1067
5168012|NCT01327846|17844914|P2|Extension Phase|Study terminated by sponsor|1124
5168013|NCT01327846|17844915|P1|Extension Phase|Study terminated by sponsor|1073
5168014|NCT01327846|17844912|P4|Core Phase|Lost to Follow-up|5
5168015|NCT01327846|17844913|P3|Core Phase|Lost to Follow-up|4
5168016|NCT01327846|17844914|P2|Core Phase|Lost to Follow-up|3
5168017|NCT01327846|17844915|P1|Core Phase|Lost to Follow-up|3
5168018|NCT01327846|17844912|P4|Core Phase|Subject decision (vital stat: alive)|20
5168019|NCT01327846|17844913|P3|Core Phase|Subject decision (vital stat: alive)|13
5168020|NCT01327846|17844914|P2|Core Phase|Subject decision (vital stat: alive)|24
5168021|NCT01327846|17844915|P1|Core Phase|Subject decision (vital stat: alive)|23
5168022|NCT01327846|17844912|P4|Core Phase|Subject decision (vital stat: dead)|4
5168023|NCT01327846|17844913|P3|Core Phase|Subject decision (vital stat: dead)|4
5168024|NCT01327846|17844914|P2|Core Phase|Subject decision (vital stat: dead)|3
5168025|NCT01327846|17844915|P1|Core Phase|Subject decision (vital stat: dead)|1
5168026|NCT01327846|17844912|P4|Core Phase|Subject decision (vital stat: unkn)|3
5168027|NCT01327846|17844913|P3|Core Phase|Subject decision (vital stat: unkn)|3
5168028|NCT01327846|17844914|P2|Core Phase|Subject decision (vital stat: unkn)|0
5168029|NCT01327846|17844915|P1|Core Phase|Subject decision (vital stat: unkn)|0
5168030|NCT01327846|17844912|P4|Core Phase|Subject decision (vital status: missing)|1
5168031|NCT01327846|17844913|P3|Core Phase|Subject decision (vital status: missing)|2
5168032|NCT01327846|17844914|P2|Core Phase|Subject decision (vital status: missing)|2
5168033|NCT01327846|17844915|P1|Core Phase|Subject decision (vital status: missing)|1
5168034|NCT01327703|17844990|P2|Second Treatment Period|Protocol Violation|1
5168035|NCT01327703|17844991|P1|Second Treatment Period|Protocol Violation|0
5168036|NCT01327703|17844990|P2|Second Treatment Period|Adverse Event|1
5168037|NCT01327703|17844991|P1|Second Treatment Period|Adverse Event|1
5168038|NCT01327651|17845047|P9|Post Study Follow-up|Lost to Follow-up|2
5168039|NCT01327651|17845048|P8|Post Study Follow-up|Lost to Follow-up|1
5168040|NCT01327651|17845049|P7|Post Study Follow-up|Lost to Follow-up|4
5168041|NCT01327651|17845050|P6|Post Study Follow-up|Lost to Follow-up|0
5168042|NCT01327651|17845051|P5|Post Study Follow-up|Lost to Follow-up|0
5168043|NCT01327651|17845052|P4|Post Study Follow-up|Lost to Follow-up|0
5168044|NCT01327651|17845053|P3|Post Study Follow-up|Lost to Follow-up|1
5168045|NCT01327651|17845054|P2|Post Study Follow-up|Lost to Follow-up|1
5168046|NCT01327651|17845055|P1|Post Study Follow-up|Lost to Follow-up|0
5168047|NCT01327651|17845047|P9|Self-administered Dosing Period|Withdrawal by Subject|1
5168048|NCT01327651|17845048|P8|Self-administered Dosing Period|Withdrawal by Subject|1
5168049|NCT01327651|17845049|P7|Self-administered Dosing Period|Withdrawal by Subject|2
5168050|NCT01327651|17845050|P6|Self-administered Dosing Period|Withdrawal by Subject|0
5168051|NCT01327651|17845051|P5|Self-administered Dosing Period|Withdrawal by Subject|0
5168052|NCT01327651|17845052|P4|Self-administered Dosing Period|Withdrawal by Subject|1
5168053|NCT01327651|17845053|P3|Self-administered Dosing Period|Withdrawal by Subject|0
5168054|NCT01327651|17845054|P2|Self-administered Dosing Period|Withdrawal by Subject|1
5168055|NCT01327651|17845055|P1|Self-administered Dosing Period|Withdrawal by Subject|0
5168056|NCT01327651|17845047|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168057|NCT01327651|17845048|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168058|NCT01327651|17845049|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168059|NCT01327651|17845050|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168060|NCT01327651|17845051|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168061|NCT01327651|17845052|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168062|NCT01327651|17845053|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168063|NCT01327651|17845054|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
5168064|NCT01327651|17845055|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
5168065|NCT01327651|17845047|P9|Self-administered Dosing Period|Lost to Follow-up|10
5168066|NCT01327651|17845048|P8|Self-administered Dosing Period|Lost to Follow-up|9
5168067|NCT01327651|17845049|P7|Self-administered Dosing Period|Lost to Follow-up|8
5168068|NCT01327651|17845050|P6|Self-administered Dosing Period|Lost to Follow-up|0
5168069|NCT01327651|17845051|P5|Self-administered Dosing Period|Lost to Follow-up|3
5168070|NCT01327651|17845052|P4|Self-administered Dosing Period|Lost to Follow-up|2
5168071|NCT01327651|17845053|P3|Self-administered Dosing Period|Lost to Follow-up|4
5168072|NCT01327651|17845054|P2|Self-administered Dosing Period|Lost to Follow-up|2
5168073|NCT01327651|17845055|P1|Self-administered Dosing Period|Lost to Follow-up|3
5168074|NCT01327599|17845174|P1|Overall Study|Withdrawal of Consent|1
5168075|NCT01327599|17845174|P1|Overall Study|Could Not Attend Visit|1
5168076|NCT01327599|17845174|P1|Overall Study|Adverse Event|1
5168077|NCT01327573|17845184|P2|Overall Study|Physician Decision|1
5168078|NCT01327573|17845185|P1|Overall Study|Physician Decision|3
5168079|NCT01327547|17845196|P2|Overall Study|By investigator in subject's interest|1
5168080|NCT01327547|17845197|P1|Overall Study|By investigator in subject's interest|0
5168081|NCT01327547|17845196|P2|Overall Study|Non-compliance with study procedures|0
5168082|NCT01327547|17845197|P1|Overall Study|Non-compliance with study procedures|1
5168083|NCT01327547|17845196|P2|Overall Study|Required prohibited medication|0
5168084|NCT01327547|17845197|P1|Overall Study|Required prohibited medication|2
5168085|NCT01327547|17845196|P2|Overall Study|Non-compliance due to alcohol intake|1
5168086|NCT01327547|17845197|P1|Overall Study|Non-compliance due to alcohol intake|0
5168087|NCT01327547|17845196|P2|Overall Study|Protocol Violation|0
5168088|NCT01327547|17845197|P1|Overall Study|Protocol Violation|1
5168089|NCT01327547|17845196|P2|Overall Study|Does Not Meet Entrance Criteria|2
5168090|NCT01327547|17845197|P1|Overall Study|Does Not Meet Entrance Criteria|2
5168091|NCT01327547|17845196|P2|Overall Study|Withdrawal by Subject|7
5168092|NCT01327547|17845197|P1|Overall Study|Withdrawal by Subject|3
5168093|NCT01327547|17845196|P2|Overall Study|Non-Compliance With Study Treatment|2
5168094|NCT01327547|17845197|P1|Overall Study|Non-Compliance With Study Treatment|0
5168095|NCT01327547|17845196|P2|Overall Study|Lost to Follow-up|6
5168096|NCT01327547|17845197|P1|Overall Study|Lost to Follow-up|6
5168097|NCT01327547|17845196|P2|Overall Study|Death|2
5168098|NCT01327547|17845197|P1|Overall Study|Death|1
5168099|NCT01327547|17845196|P2|Overall Study|Adverse Event|1
5168100|NCT01327547|17845197|P1|Overall Study|Adverse Event|4
5168101|NCT01327495|17845265|P6|Overall Study|Physician Decision|0
5168102|NCT01327495|17845266|P5|Overall Study|Physician Decision|2
5168103|NCT01327495|17845267|P4|Overall Study|Physician Decision|0
5168104|NCT01327495|17845268|P3|Overall Study|Physician Decision|0
5168105|NCT01327495|17845269|P2|Overall Study|Physician Decision|0
5168106|NCT01327495|17845270|P1|Overall Study|Physician Decision|0
5168107|NCT01327495|17845265|P6|Overall Study|Withdrawal by Subject|0
5168108|NCT01327495|17845266|P5|Overall Study|Withdrawal by Subject|1
5168109|NCT01327495|17845267|P4|Overall Study|Withdrawal by Subject|0
5168110|NCT01327495|17845268|P3|Overall Study|Withdrawal by Subject|1
5168111|NCT01327495|17845269|P2|Overall Study|Withdrawal by Subject|1
5168112|NCT01327495|17845270|P1|Overall Study|Withdrawal by Subject|0
5168113|NCT01327495|17845265|P6|Overall Study|Adverse Event|2
5168114|NCT01327495|17845266|P5|Overall Study|Adverse Event|0
5168115|NCT01327495|17845267|P4|Overall Study|Adverse Event|0
5168116|NCT01327495|17845268|P3|Overall Study|Adverse Event|1
5168117|NCT01327495|17845269|P2|Overall Study|Adverse Event|1
5168118|NCT01327495|17845270|P1|Overall Study|Adverse Event|2
5168119|NCT01327482|17845362|P1|Overall Study|Adverse Event|1
5168120|NCT01327339|17845367|P1|Overall Study|Protocol Violation|8
5168121|NCT01327300|17845502|P2|Washout (3 Weeks)|Withdrawal by Subject|0
5168122|NCT01327300|17845503|P1|Washout (3 Weeks)|Withdrawal by Subject|1
5168123|NCT01327053|17845543|P2|Overall Study|Untreated|1
5168124|NCT01327053|17845544|P1|Overall Study|Untreated|0
5168125|NCT01327053|17845543|P2|Overall Study|Protocol Violation|1
5168126|NCT01327053|17845544|P1|Overall Study|Protocol Violation|0
5168127|NCT01327053|17845543|P2|Overall Study|Progressive disease|26
5168128|NCT01327053|17845544|P1|Overall Study|Progressive disease|31
5168129|NCT01327053|17845543|P2|Overall Study|Study terminated by Sponsor|3
5168130|NCT01327053|17845544|P1|Overall Study|Study terminated by Sponsor|1
5168131|NCT01327053|17845543|P2|Overall Study|Non-compliance with study treatment|5
5168132|NCT01327053|17845544|P1|Overall Study|Non-compliance with study treatment|0
5168133|NCT01327053|17845543|P2|Overall Study|Lost to Follow-up|4
5168134|NCT01327053|17845544|P1|Overall Study|Lost to Follow-up|2
5168135|NCT01327053|17845543|P2|Overall Study|Death|5
5168136|NCT01327053|17845544|P1|Overall Study|Death|1
5168137|NCT01327053|17845543|P2|Overall Study|Physician Decision|14
5168138|NCT01327053|17845544|P1|Overall Study|Physician Decision|10
5168139|NCT01327053|17845543|P2|Overall Study|Patient/guardian decision|35
5168140|NCT01327053|17845544|P1|Overall Study|Patient/guardian decision|11
5168141|NCT01327053|17845543|P2|Overall Study|Adverse Event|57
5168142|NCT01327053|17845544|P1|Overall Study|Adverse Event|23
5168143|NCT01326962|17845618|P1|Overall Study|Other|2
5168144|NCT01326962|17845618|P1|Overall Study|Lost to Follow-up|3
5168145|NCT01326962|17845618|P1|Overall Study|Withdrawal by Subject|1
5168146|NCT01326962|17845618|P1|Overall Study|Adverse Event|1
5168147|NCT01326910|17845641|P2|Overall Study|Protocol Violation|1
5168148|NCT01326910|17845642|P1|Overall Study|Protocol Violation|1
5168149|NCT01326910|17845641|P2|Overall Study|Withdrawal by Subject|2
5168150|NCT01326910|17845642|P1|Overall Study|Withdrawal by Subject|3
5168151|NCT01326845|17845656|P2|Overall Study|Misisng|3
5168152|NCT01326845|17845657|P1|Overall Study|Misisng|1
5168153|NCT01326845|17845656|P2|Overall Study|Adverse Event|0
5168154|NCT01326845|17845657|P1|Overall Study|Adverse Event|1
5168155|NCT01326845|17845656|P2|Overall Study|Administrative Problems|2
5168156|NCT01326845|17845657|P1|Overall Study|Administrative Problems|5
5168157|NCT01326728|17845718|P2|Overall Study|Early closure of study|9
5168158|NCT01326728|17845719|P1|Overall Study|Early closure of study|34
5168159|NCT01326728|17845718|P2|Overall Study|Death|0
5168160|NCT01326728|17845719|P1|Overall Study|Death|13
5168161|NCT01326702|17845743|P7|Overall Study|Not Treated|0
5168162|NCT01326702|17845744|P6|Overall Study|Not Treated|1
5168163|NCT01326702|17845745|P5|Overall Study|Not Treated|0
5168164|NCT01326702|17845746|P4|Overall Study|Not Treated|1
5168165|NCT01326702|17845747|P3|Overall Study|Not Treated|0
5168166|NCT01326702|17845748|P2|Overall Study|Not Treated|0
5168167|NCT01326702|17845749|P1|Overall Study|Not Treated|0
5168168|NCT01326702|17845743|P7|Overall Study|Withdrawal by Subject|3
5168169|NCT01326702|17845744|P6|Overall Study|Withdrawal by Subject|1
5168170|NCT01326702|17845745|P5|Overall Study|Withdrawal by Subject|1
5168171|NCT01326702|17845746|P4|Overall Study|Withdrawal by Subject|0
5168172|NCT01326702|17845747|P3|Overall Study|Withdrawal by Subject|1
5168173|NCT01326702|17845748|P2|Overall Study|Withdrawal by Subject|0
5168174|NCT01326702|17845749|P1|Overall Study|Withdrawal by Subject|0
5168175|NCT01326702|17845743|P7|Overall Study|Adverse Event|1
5168176|NCT01326702|17845744|P6|Overall Study|Adverse Event|3
5168177|NCT01326702|17845745|P5|Overall Study|Adverse Event|0
5168178|NCT01326702|17845746|P4|Overall Study|Adverse Event|1
5168179|NCT01326702|17845747|P3|Overall Study|Adverse Event|1
5168180|NCT01326702|17845748|P2|Overall Study|Adverse Event|0
5168181|NCT01326702|17845749|P1|Overall Study|Adverse Event|0
5168182|NCT01326702|17845743|P7|Overall Study|Death|0
5168183|NCT01326702|17845744|P6|Overall Study|Death|0
5168184|NCT01326702|17845745|P5|Overall Study|Death|0
5168185|NCT01326702|17845746|P4|Overall Study|Death|0
5168186|NCT01326702|17845747|P3|Overall Study|Death|0
5168187|NCT01326702|17845748|P2|Overall Study|Death|1
5168188|NCT01326702|17845749|P1|Overall Study|Death|0
5168189|NCT01326702|17845743|P7|Overall Study|progressive disease|3
5168190|NCT01326702|17845744|P6|Overall Study|progressive disease|2
5168191|NCT01326702|17845745|P5|Overall Study|progressive disease|3
5168192|NCT01326702|17845746|P4|Overall Study|progressive disease|1
5168193|NCT01326702|17845747|P3|Overall Study|progressive disease|3
5168194|NCT01326702|17845748|P2|Overall Study|progressive disease|1
5168195|NCT01326702|17845749|P1|Overall Study|progressive disease|1
5168196|NCT01326702|17845743|P7|Overall Study|Other|0
5168197|NCT01326702|17845744|P6|Overall Study|Other|1
5168198|NCT01326702|17845745|P5|Overall Study|Other|0
5168199|NCT01326702|17845746|P4|Overall Study|Other|0
5168200|NCT01326702|17845747|P3|Overall Study|Other|0
5168201|NCT01326702|17845748|P2|Overall Study|Other|0
5168202|NCT01326702|17845749|P1|Overall Study|Other|1
5168203|NCT01326546|17845805|P2|Overall Study|Withdrawal by Subject|1
5168204|NCT01326546|17845806|P1|Overall Study|Withdrawal by Subject|5
5168205|NCT01326546|17845805|P2|Overall Study|Adverse Event|0
5168206|NCT01326546|17845806|P1|Overall Study|Adverse Event|1
5168207|NCT01326546|17845805|P2|Overall Study|Pregnancy|1
5168208|NCT01326546|17845806|P1|Overall Study|Pregnancy|0
5168209|NCT01326546|17845805|P2|Overall Study|Protocol Violation|4
5168210|NCT01326546|17845806|P1|Overall Study|Protocol Violation|3
5168211|NCT01326546|17845805|P2|Overall Study|Lost to Follow-up|7
5168212|NCT01326546|17845806|P1|Overall Study|Lost to Follow-up|8
5168213|NCT01326533|17845814|P2|Overall Study|Adverse Event|0
5168214|NCT01326533|17845815|P1|Overall Study|Adverse Event|1
5168215|NCT01326533|17845814|P2|Overall Study|Withdrawal by Subject|0
5168216|NCT01326533|17845815|P1|Overall Study|Withdrawal by Subject|1
5168217|NCT01326533|17845814|P2|Overall Study|Lost to Follow-up|0
5168218|NCT01326533|17845815|P1|Overall Study|Lost to Follow-up|2
5168219|NCT01326481|17845823|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
5168220|NCT01326026|17845832|P2|Overall Study|Other|3
5168221|NCT01326026|17845833|P1|Overall Study|Other|3
5168222|NCT01326026|17845832|P2|Overall Study|Withdrawal Criteria|7
5168223|NCT01326026|17845833|P1|Overall Study|Withdrawal Criteria|5
5168224|NCT01326026|17845832|P2|Overall Study|Adverse Event|3
5168225|NCT01326026|17845833|P1|Overall Study|Adverse Event|4
5168226|NCT01325701|17845898|P2|Overall Study|Rollerover Extension Study|0
5168227|NCT01325701|17845899|P1|Overall Study|Rollerover Extension Study|4
5168228|NCT01325701|17845898|P2|Overall Study|Withdrawal by Subject|1
5168229|NCT01325701|17845899|P1|Overall Study|Withdrawal by Subject|2
5168230|NCT01325701|17845898|P2|Overall Study|Physician Decision|2
5168231|NCT01325701|17845899|P1|Overall Study|Physician Decision|2
5168232|NCT01325701|17845898|P2|Overall Study|Protocol Violation|0
5168233|NCT01325701|17845899|P1|Overall Study|Protocol Violation|1
5168234|NCT01325701|17845898|P2|Overall Study|Adverse Event|0
5168235|NCT01325701|17845899|P1|Overall Study|Adverse Event|12
5168236|NCT01325623|17845909|P1|Overall Study|Withdrawal by Subject|3
5168237|NCT01325584|17845951|P1|Overall Study|Death|1
5168238|NCT01325532|17845961|P2|Overall Study|Withdrawal by Subject|0
5168239|NCT01325532|17845962|P1|Overall Study|Withdrawal by Subject|2
5168240|NCT01325493|17845974|P2|Overall Study|Allergy|0
5168241|NCT01325493|17845975|P1|Overall Study|Allergy|1
5168242|NCT01325493|17845974|P2|Overall Study|loss of neuromonitoring signals|2
5168243|NCT01325493|17845975|P1|Overall Study|loss of neuromonitoring signals|0
5168244|NCT01325493|17845974|P2|Overall Study|Protocol Violation|1
5168245|NCT01325493|17845975|P1|Overall Study|Protocol Violation|0
5168246|NCT01325428|17845987|P1|Part B|Other reason not defined above|1
5168247|NCT01325428|17845987|P1|Part B|Refused continue taking trial medication|2
5168248|NCT01325428|17845987|P1|Part A|Other reason not defined above|2
5168249|NCT01325428|17845987|P1|Part A|Refused continue taking trial medication|2
5168250|NCT01325428|17845987|P1|Part A|Other adverse event|1
5168251|NCT01325428|17845987|P1|Part A|Clinical signs, symptoms of progression|2
5168252|NCT01325428|17845987|P1|Part A|Progressive disease according to RECIST|9
5168253|NCT01325350|17846007|P5|Overall Study|Did Not Receive Treatment|1
5168254|NCT01325350|17846008|P4|Overall Study|Did Not Receive Treatment|0
5168255|NCT01325350|17846009|P3|Overall Study|Did Not Receive Treatment|1
5168256|NCT01325350|17846010|P2|Overall Study|Did Not Receive Treatment|1
5168257|NCT01325350|17846011|P1|Overall Study|Did Not Receive Treatment|0
5168258|NCT01325350|17846007|P5|Overall Study|Withdrawal by Subject|0
5168259|NCT01325350|17846008|P4|Overall Study|Withdrawal by Subject|1
5168260|NCT01325350|17846009|P3|Overall Study|Withdrawal by Subject|1
5168261|NCT01325350|17846010|P2|Overall Study|Withdrawal by Subject|0
5168262|NCT01325350|17846011|P1|Overall Study|Withdrawal by Subject|0
5168263|NCT01325350|17846007|P5|Overall Study|Protocol Violation|0
5168264|NCT01325350|17846008|P4|Overall Study|Protocol Violation|1
5168265|NCT01325350|17846009|P3|Overall Study|Protocol Violation|0
5168266|NCT01325350|17846010|P2|Overall Study|Protocol Violation|0
5168267|NCT01325350|17846011|P1|Overall Study|Protocol Violation|0
5168268|NCT01325350|17846007|P5|Overall Study|Personal Reasons|3
5168269|NCT01325350|17846008|P4|Overall Study|Personal Reasons|5
5168270|NCT01325350|17846009|P3|Overall Study|Personal Reasons|6
5168271|NCT01325350|17846010|P2|Overall Study|Personal Reasons|1
5168272|NCT01325350|17846011|P1|Overall Study|Personal Reasons|2
5168273|NCT01325350|17846007|P5|Overall Study|Lost to Follow-up|5
5168274|NCT01325350|17846008|P4|Overall Study|Lost to Follow-up|1
5168275|NCT01325350|17846009|P3|Overall Study|Lost to Follow-up|5
5168276|NCT01325350|17846010|P2|Overall Study|Lost to Follow-up|0
5168277|NCT01325350|17846011|P1|Overall Study|Lost to Follow-up|1
5168278|NCT01325350|17846007|P5|Overall Study|Pregnancy|1
5168279|NCT01325350|17846008|P4|Overall Study|Pregnancy|0
5168280|NCT01325350|17846009|P3|Overall Study|Pregnancy|1
5168281|NCT01325350|17846010|P2|Overall Study|Pregnancy|0
5168282|NCT01325350|17846011|P1|Overall Study|Pregnancy|0
5168283|NCT01325350|17846007|P5|Overall Study|Adverse Event|2
5168284|NCT01325350|17846008|P4|Overall Study|Adverse Event|1
5168285|NCT01325350|17846009|P3|Overall Study|Adverse Event|3
5168286|NCT01325350|17846010|P2|Overall Study|Adverse Event|3
5168287|NCT01325350|17846011|P1|Overall Study|Adverse Event|3
5168288|NCT01325337|17846053|P5|Overall Study|Withdrawal by Subject|1
5168289|NCT01325337|17846054|P4|Overall Study|Withdrawal by Subject|0
5168290|NCT01325337|17846055|P3|Overall Study|Withdrawal by Subject|1
5168291|NCT01325337|17846056|P2|Overall Study|Withdrawal by Subject|0
5168292|NCT01325337|17846057|P1|Overall Study|Withdrawal by Subject|1
5168293|NCT01325337|17846053|P5|Overall Study|Personal Reasons|3
5168294|NCT01325337|17846054|P4|Overall Study|Personal Reasons|8
5168295|NCT01325337|17846055|P3|Overall Study|Personal Reasons|4
5168296|NCT01325337|17846056|P2|Overall Study|Personal Reasons|5
5168297|NCT01325337|17846057|P1|Overall Study|Personal Reasons|2
5168298|NCT01325337|17846053|P5|Overall Study|Lost to Follow-up|2
5168299|NCT01325337|17846054|P4|Overall Study|Lost to Follow-up|1
5168300|NCT01325337|17846055|P3|Overall Study|Lost to Follow-up|2
5168301|NCT01325337|17846056|P2|Overall Study|Lost to Follow-up|2
5168302|NCT01325337|17846057|P1|Overall Study|Lost to Follow-up|2
5168303|NCT01325337|17846053|P5|Overall Study|Adverse Event|2
5168304|NCT01325337|17846054|P4|Overall Study|Adverse Event|1
5168305|NCT01325337|17846055|P3|Overall Study|Adverse Event|2
5168306|NCT01325337|17846056|P2|Overall Study|Adverse Event|2
5168307|NCT01325337|17846057|P1|Overall Study|Adverse Event|0
5168308|NCT01325207|17846137|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5168309|NCT01325207|17846138|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
5168310|NCT01325207|17846139|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5168311|NCT01325207|17846140|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5168312|NCT01325207|17846141|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5168313|NCT01325207|17846142|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5168314|NCT01325207|17846137|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
5168315|NCT01325207|17846138|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5168316|NCT01325207|17846139|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5168317|NCT01325207|17846140|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5168318|NCT01325207|17846141|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5168319|NCT01325207|17846142|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5168320|NCT01325207|17846137|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
5168321|NCT01325207|17846138|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5168322|NCT01325207|17846139|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5168323|NCT01325207|17846140|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5168324|NCT01325207|17846141|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5168325|NCT01325207|17846142|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5168326|NCT01325207|17846137|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5168327|NCT01325207|17846138|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5168328|NCT01325207|17846139|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5168329|NCT01325207|17846140|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5168330|NCT01325207|17846141|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
5168331|NCT01325207|17846142|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5168332|NCT01325207|17846137|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
5168333|NCT01325207|17846138|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
5168334|NCT01325207|17846139|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5168335|NCT01325207|17846140|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5168336|NCT01325207|17846141|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5168337|NCT01325207|17846142|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5168338|NCT01325207|17846137|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
5168339|NCT01325207|17846138|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
5168340|NCT01325207|17846139|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
5168341|NCT01325207|17846140|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
5168342|NCT01325207|17846141|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
5168343|NCT01325207|17846142|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
5168344|NCT01325207|17846137|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5168345|NCT01325207|17846138|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
5168346|NCT01325207|17846139|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5168347|NCT01325207|17846140|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5168348|NCT01325207|17846141|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5168349|NCT01325207|17846142|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5168350|NCT01324999|17846174|P1|Overall Study|Withdrawal by Subject|2
5168351|NCT01324999|17846174|P1|Overall Study|Adverse Event|3
5168352|NCT01324947|17846185|P1|Overall Study|1 discontinued before starting drug|1
5168353|NCT01324947|17846185|P1|Overall Study|Withdrawal by Subject|3
5168354|NCT01324947|17846185|P1|Overall Study|Progressive Disease|50
5168355|NCT01324947|17846185|P1|Overall Study|Other|3
5168356|NCT01324947|17846185|P1|Overall Study|Death|10
5168357|NCT01324947|17846185|P1|Overall Study|Adverse Event|7
5168358|NCT01324830|17846226|P19|Overall Study|Withdrawal by Subject|1
5168359|NCT01324830|17846227|P18|Overall Study|Withdrawal by Subject|0
5168360|NCT01324830|17846228|P17|Overall Study|Withdrawal by Subject|0
5168361|NCT01324830|17846229|P16|Overall Study|Withdrawal by Subject|0
5168362|NCT01324830|17846230|P15|Overall Study|Withdrawal by Subject|0
5168363|NCT01324830|17846231|P14|Overall Study|Withdrawal by Subject|0
5168364|NCT01324830|17846232|P13|Overall Study|Withdrawal by Subject|0
5168365|NCT01324830|17846233|P12|Overall Study|Withdrawal by Subject|0
5168366|NCT01324830|17846234|P11|Overall Study|Withdrawal by Subject|1
5168367|NCT01324830|17846235|P10|Overall Study|Withdrawal by Subject|0
5168368|NCT01324830|17846236|P9|Overall Study|Withdrawal by Subject|0
5168369|NCT01324830|17846237|P8|Overall Study|Withdrawal by Subject|0
5168370|NCT01324830|17846238|P7|Overall Study|Withdrawal by Subject|0
5168371|NCT01324830|17846239|P6|Overall Study|Withdrawal by Subject|1
5168372|NCT01324830|17846240|P5|Overall Study|Withdrawal by Subject|0
5168373|NCT01324830|17846241|P4|Overall Study|Withdrawal by Subject|0
5168374|NCT01324830|17846242|P3|Overall Study|Withdrawal by Subject|0
5168375|NCT01324830|17846243|P2|Overall Study|Withdrawal by Subject|0
5168376|NCT01324830|17846244|P1|Overall Study|Withdrawal by Subject|0
5168377|NCT01324830|17846226|P19|Overall Study|Adverse Event, non-fatal|0
5168378|NCT01324830|17846227|P18|Overall Study|Adverse Event, non-fatal|1
5168379|NCT01324830|17846228|P17|Overall Study|Adverse Event, non-fatal|0
5168380|NCT01324830|17846229|P16|Overall Study|Adverse Event, non-fatal|0
5168381|NCT01324830|17846230|P15|Overall Study|Adverse Event, non-fatal|0
5168382|NCT01324830|17846231|P14|Overall Study|Adverse Event, non-fatal|0
5168383|NCT01324830|17846232|P13|Overall Study|Adverse Event, non-fatal|0
5168384|NCT01324830|17846233|P12|Overall Study|Adverse Event, non-fatal|0
5168385|NCT01324830|17846234|P11|Overall Study|Adverse Event, non-fatal|1
5168386|NCT01324830|17846235|P10|Overall Study|Adverse Event, non-fatal|0
5168387|NCT01324830|17846236|P9|Overall Study|Adverse Event, non-fatal|2
5168388|NCT01324830|17846237|P8|Overall Study|Adverse Event, non-fatal|0
5168389|NCT01324830|17846238|P7|Overall Study|Adverse Event, non-fatal|0
5168390|NCT01324830|17846239|P6|Overall Study|Adverse Event, non-fatal|0
5168391|NCT01324830|17846240|P5|Overall Study|Adverse Event, non-fatal|0
5168392|NCT01324830|17846241|P4|Overall Study|Adverse Event, non-fatal|0
5168393|NCT01324830|17846242|P3|Overall Study|Adverse Event, non-fatal|0
5168394|NCT01324830|17846243|P2|Overall Study|Adverse Event, non-fatal|0
5168395|NCT01324830|17846244|P1|Overall Study|Adverse Event, non-fatal|0
5168396|NCT01324830|17846226|P19|Overall Study|Adverse Event, serious fatal|0
5168397|NCT01324830|17846227|P18|Overall Study|Adverse Event, serious fatal|0
5168398|NCT01324830|17846228|P17|Overall Study|Adverse Event, serious fatal|0
5168399|NCT01324830|17846229|P16|Overall Study|Adverse Event, serious fatal|0
5168400|NCT01324830|17846230|P15|Overall Study|Adverse Event, serious fatal|0
5168401|NCT01324830|17846231|P14|Overall Study|Adverse Event, serious fatal|0
5168402|NCT01324830|17846232|P13|Overall Study|Adverse Event, serious fatal|0
5168403|NCT01324830|17846233|P12|Overall Study|Adverse Event, serious fatal|0
5168404|NCT01324830|17846234|P11|Overall Study|Adverse Event, serious fatal|0
5168405|NCT01324830|17846235|P10|Overall Study|Adverse Event, serious fatal|0
5168406|NCT01324830|17846236|P9|Overall Study|Adverse Event, serious fatal|0
5168407|NCT01324830|17846237|P8|Overall Study|Adverse Event, serious fatal|0
5168408|NCT01324830|17846238|P7|Overall Study|Adverse Event, serious fatal|0
5168409|NCT01324830|17846239|P6|Overall Study|Adverse Event, serious fatal|0
5168410|NCT01324830|17846240|P5|Overall Study|Adverse Event, serious fatal|0
5168411|NCT01324830|17846241|P4|Overall Study|Adverse Event, serious fatal|0
5168412|NCT01324830|17846242|P3|Overall Study|Adverse Event, serious fatal|0
5168413|NCT01324830|17846243|P2|Overall Study|Adverse Event, serious fatal|1
5168414|NCT01324830|17846244|P1|Overall Study|Adverse Event, serious fatal|0
5168415|NCT01324830|17846226|P19|Overall Study|Reason not mentioned above|0
5168416|NCT01324830|17846227|P18|Overall Study|Reason not mentioned above|1
5168417|NCT01324830|17846228|P17|Overall Study|Reason not mentioned above|0
5168418|NCT01324830|17846229|P16|Overall Study|Reason not mentioned above|0
5168419|NCT01324830|17846230|P15|Overall Study|Reason not mentioned above|0
5168420|NCT01324830|17846231|P14|Overall Study|Reason not mentioned above|0
5168421|NCT01324830|17846232|P13|Overall Study|Reason not mentioned above|0
5168422|NCT01324830|17846233|P12|Overall Study|Reason not mentioned above|0
5168423|NCT01324830|17846234|P11|Overall Study|Reason not mentioned above|0
5168424|NCT01324830|17846235|P10|Overall Study|Reason not mentioned above|0
5168425|NCT01324830|17846236|P9|Overall Study|Reason not mentioned above|0
5168426|NCT01324830|17846237|P8|Overall Study|Reason not mentioned above|0
5168427|NCT01324830|17846238|P7|Overall Study|Reason not mentioned above|0
5168428|NCT01324830|17846239|P6|Overall Study|Reason not mentioned above|0
5168429|NCT01324830|17846240|P5|Overall Study|Reason not mentioned above|0
5168430|NCT01324830|17846241|P4|Overall Study|Reason not mentioned above|0
5168431|NCT01324830|17846242|P3|Overall Study|Reason not mentioned above|0
5168432|NCT01324830|17846243|P2|Overall Study|Reason not mentioned above|0
5168433|NCT01324830|17846244|P1|Overall Study|Reason not mentioned above|0
5168434|NCT01324830|17846226|P19|Overall Study|Dose limiting toxicity|1
5168435|NCT01324830|17846227|P18|Overall Study|Dose limiting toxicity|1
5168436|NCT01324830|17846228|P17|Overall Study|Dose limiting toxicity|1
5168437|NCT01324830|17846229|P16|Overall Study|Dose limiting toxicity|0
5168438|NCT01324830|17846230|P15|Overall Study|Dose limiting toxicity|0
5168439|NCT01324830|17846231|P14|Overall Study|Dose limiting toxicity|0
5168440|NCT01324830|17846232|P13|Overall Study|Dose limiting toxicity|0
5168441|NCT01324830|17846233|P12|Overall Study|Dose limiting toxicity|0
5168442|NCT01324830|17846234|P11|Overall Study|Dose limiting toxicity|0
5168443|NCT01324830|17846235|P10|Overall Study|Dose limiting toxicity|0
5168444|NCT01324830|17846236|P9|Overall Study|Dose limiting toxicity|0
5168445|NCT01324830|17846237|P8|Overall Study|Dose limiting toxicity|0
5168446|NCT01324830|17846238|P7|Overall Study|Dose limiting toxicity|0
5168447|NCT01324830|17846239|P6|Overall Study|Dose limiting toxicity|0
5168448|NCT01324830|17846240|P5|Overall Study|Dose limiting toxicity|1
5168449|NCT01324830|17846241|P4|Overall Study|Dose limiting toxicity|0
5168450|NCT01324830|17846242|P3|Overall Study|Dose limiting toxicity|0
5168451|NCT01324830|17846243|P2|Overall Study|Dose limiting toxicity|0
5168452|NCT01324830|17846244|P1|Overall Study|Dose limiting toxicity|0
5168453|NCT01324830|17846226|P19|Overall Study|Progressive Disease|4
5168454|NCT01324830|17846227|P18|Overall Study|Progressive Disease|3
5168455|NCT01324830|17846228|P17|Overall Study|Progressive Disease|2
5168456|NCT01324830|17846229|P16|Overall Study|Progressive Disease|3
5168457|NCT01324830|17846230|P15|Overall Study|Progressive Disease|1
5168458|NCT01324830|17846231|P14|Overall Study|Progressive Disease|1
5168459|NCT01324830|17846232|P13|Overall Study|Progressive Disease|1
5168460|NCT01324830|17846233|P12|Overall Study|Progressive Disease|1
5168461|NCT01324830|17846234|P11|Overall Study|Progressive Disease|2
5168462|NCT01324830|17846235|P10|Overall Study|Progressive Disease|6
5168463|NCT01324830|17846236|P9|Overall Study|Progressive Disease|3
5168464|NCT01324830|17846237|P8|Overall Study|Progressive Disease|3
5168465|NCT01324830|17846238|P7|Overall Study|Progressive Disease|3
5168466|NCT01324830|17846239|P6|Overall Study|Progressive Disease|6
5168467|NCT01324830|17846240|P5|Overall Study|Progressive Disease|6
5168468|NCT01324830|17846241|P4|Overall Study|Progressive Disease|3
5168469|NCT01324830|17846242|P3|Overall Study|Progressive Disease|3
5168470|NCT01324830|17846243|P2|Overall Study|Progressive Disease|2
5168471|NCT01324830|17846244|P1|Overall Study|Progressive Disease|3
5168472|NCT01324622|17846390|P2|Overall Study|Lack of Efficacy|0
5168473|NCT01324622|17846391|P1|Overall Study|Lack of Efficacy|1
5168474|NCT01324622|17846390|P2|Overall Study|Death|0
5168475|NCT01324622|17846391|P1|Overall Study|Death|1
5168476|NCT01324622|17846390|P2|Overall Study|Lost to Follow-up|7
5168477|NCT01324622|17846391|P1|Overall Study|Lost to Follow-up|7
5168478|NCT01324570|17846421|P2|Overall Study|Administrative|2
5168479|NCT01324570|17846422|P1|Overall Study|Administrative|0
5168480|NCT01324570|17846421|P2|Overall Study|Confirmed or suspected diversion|1
5168481|NCT01324570|17846422|P1|Overall Study|Confirmed or suspected diversion|0
5168482|NCT01324570|17846421|P2|Overall Study|Lack of Efficacy|1
5168483|NCT01324570|17846422|P1|Overall Study|Lack of Efficacy|0
5168484|NCT01324570|17846421|P2|Overall Study|Withdrawal by Subject|3
5168485|NCT01324570|17846422|P1|Overall Study|Withdrawal by Subject|0
5168486|NCT01324570|17846421|P2|Overall Study|Adverse Event|7
5168487|NCT01324570|17846422|P1|Overall Study|Adverse Event|4
5168488|NCT01324440|17846459|P2|Overall Study|Subject moved|1
5168489|NCT01324440|17846460|P1|Overall Study|Subject moved|0
5168490|NCT01324401|17846474|P2|Overall Study|Adverse Event|3
5168491|NCT01324401|17846475|P1|Overall Study|Adverse Event|1
5168492|NCT01324401|17846474|P2|Overall Study|Withdrawn before any treatment|3
5168493|NCT01324401|17846475|P1|Overall Study|Withdrawn before any treatment|0
5168494|NCT01324388|17846486|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5168495|NCT01324388|17846487|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
5168496|NCT01324388|17846488|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5168497|NCT01324388|17846489|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5168498|NCT01324388|17846486|P4|Part 2 of Study: First Intervention|Protocol Violation|1
5168499|NCT01324388|17846487|P3|Part 2 of Study: First Intervention|Protocol Violation|0
5168500|NCT01324388|17846488|P2|Part 2 of Study: First Intervention|Protocol Violation|0
5168501|NCT01324388|17846489|P1|Part 2 of Study: First Intervention|Protocol Violation|0
5168502|NCT01324388|17846486|P4|Part 1 of Study|Physician Decision|0
5168503|NCT01324388|17846487|P3|Part 1 of Study|Physician Decision|0
5168504|NCT01324388|17846488|P2|Part 1 of Study|Physician Decision|0
5168505|NCT01324388|17846489|P1|Part 1 of Study|Physician Decision|1
5168506|NCT01324388|17846486|P4|Part 1 of Study|Protocol Violation|0
5168507|NCT01324388|17846487|P3|Part 1 of Study|Protocol Violation|0
5168508|NCT01324388|17846488|P2|Part 1 of Study|Protocol Violation|2
5168509|NCT01324388|17846489|P1|Part 1 of Study|Protocol Violation|1
5168510|NCT01324388|17846486|P4|Part 1 of Study|Adverse Event|0
5168511|NCT01324388|17846487|P3|Part 1 of Study|Adverse Event|0
5168512|NCT01324388|17846488|P2|Part 1 of Study|Adverse Event|0
5168513|NCT01324388|17846489|P1|Part 1 of Study|Adverse Event|2
5168514|NCT01324349|17846510|P2|Overall Study|Withdrawal by Subject|1
5168515|NCT01324349|17846511|P1|Overall Study|Withdrawal by Subject|0
5168516|NCT01324349|17846510|P2|Overall Study|Death|1
5168517|NCT01324349|17846511|P1|Overall Study|Death|1
5168518|NCT01324323|17846521|P1|Overall Study|Withdrawal by Subject|1
5168519|NCT01324310|17846541|P1|Overall Study|Disease Progression|1
5168520|NCT01324310|17846541|P1|Overall Study|Adverse Event|1
5168521|NCT01324271|17846561|P2|Overall Study|Physician Decision|0
5168522|NCT01324271|17846562|P1|Overall Study|Physician Decision|1
5168523|NCT01324271|17846561|P2|Overall Study|Lost to Follow-up|0
5168524|NCT01324271|17846562|P1|Overall Study|Lost to Follow-up|3
5168525|NCT01324102|17846585|P2|Overall Study|illness|6
5168526|NCT01324102|17846586|P1|Overall Study|illness|1
5168527|NCT01324024|17846593|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5168528|NCT01324024|17846594|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
5168529|NCT01323972|17846632|P4|Overall Study|Lost to Follow-up|1
5168530|NCT01323972|17846633|P3|Overall Study|Lost to Follow-up|1
5168531|NCT01323972|17846634|P2|Overall Study|Lost to Follow-up|1
5168532|NCT01323972|17846635|P1|Overall Study|Lost to Follow-up|0
5168533|NCT01323972|17846632|P4|Overall Study|Migrated/moved from study area|0
5168534|NCT01323972|17846633|P3|Overall Study|Migrated/moved from study area|0
5168535|NCT01323972|17846634|P2|Overall Study|Migrated/moved from study area|2
5168536|NCT01323972|17846635|P1|Overall Study|Migrated/moved from study area|1
5168537|NCT01323972|17846632|P4|Overall Study|Withdrawal by Subject|0
5168538|NCT01323972|17846633|P3|Overall Study|Withdrawal by Subject|1
5168539|NCT01323972|17846634|P2|Overall Study|Withdrawal by Subject|0
5168540|NCT01323972|17846635|P1|Overall Study|Withdrawal by Subject|1
5168541|NCT01323946|17846731|P3|Overall Study|Withdrawal by Subject|0
5168542|NCT01323946|17846732|P2|Overall Study|Withdrawal by Subject|2
5168543|NCT01323946|17846733|P1|Overall Study|Withdrawal by Subject|2
5168544|NCT01323946|17846731|P3|Overall Study|Parents refused the last blood draw|0
5168545|NCT01323946|17846732|P2|Overall Study|Parents refused the last blood draw|0
5168546|NCT01323946|17846733|P1|Overall Study|Parents refused the last blood draw|1
5168547|NCT01323946|17846731|P3|Overall Study|Lost to Follow-up|0
5168548|NCT01323946|17846732|P2|Overall Study|Lost to Follow-up|1
5168549|NCT01323946|17846733|P1|Overall Study|Lost to Follow-up|0
5168550|NCT01323920|17846854|P1|Overall Study|Withdrawal by Subject|1
5168551|NCT01323920|17846854|P1|Overall Study|Death|5
5168552|NCT01323790|17846895|P3|Overall Study|Severe non-compliance with protocol|2
5168553|NCT01323790|17846896|P2|Overall Study|Severe non-compliance with protocol|2
5168554|NCT01323790|17846897|P1|Overall Study|Severe non-compliance with protocol|2
5168555|NCT01323790|17846895|P3|Overall Study|Did Not Receive Treatment|1
5168556|NCT01323790|17846896|P2|Overall Study|Did Not Receive Treatment|0
5168557|NCT01323790|17846897|P1|Overall Study|Did Not Receive Treatment|2
5168558|NCT01323790|17846895|P3|Overall Study|Withdrawal by Subject|13
5168559|NCT01323790|17846896|P2|Overall Study|Withdrawal by Subject|20
5168560|NCT01323790|17846897|P1|Overall Study|Withdrawal by Subject|23
5168561|NCT01323790|17846895|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
5168562|NCT01323790|17846896|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5168563|NCT01323790|17846897|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5168564|NCT01323790|17846895|P3|Overall Study|Adverse Event|12
5168565|NCT01323790|17846896|P2|Overall Study|Adverse Event|24
5168566|NCT01323790|17846897|P1|Overall Study|Adverse Event|11
5168567|NCT01323790|17846895|P3|Overall Study|Lack of Efficacy|3
5168568|NCT01323790|17846896|P2|Overall Study|Lack of Efficacy|0
5168569|NCT01323790|17846897|P1|Overall Study|Lack of Efficacy|3
5168570|NCT01323790|17846895|P3|Overall Study|Study-Specific Withdrawal Criteria|3
5168571|NCT01323790|17846896|P2|Overall Study|Study-Specific Withdrawal Criteria|3
5168572|NCT01323790|17846897|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5168573|NCT01323790|17846895|P3|Overall Study|Lost to Follow-up|9
5168574|NCT01323790|17846896|P2|Overall Study|Lost to Follow-up|9
5168575|NCT01323790|17846897|P1|Overall Study|Lost to Follow-up|11
5168576|NCT01323790|17846895|P3|Overall Study|Other|1
5168577|NCT01323790|17846896|P2|Overall Study|Other|2
5168578|NCT01323790|17846897|P1|Overall Study|Other|3
5168579|NCT01323673|17846948|P2|Overall Study|Withdrawal by Subject|3
5168580|NCT01323673|17846949|P1|Overall Study|Withdrawal by Subject|2
5168581|NCT01323673|17846948|P2|Overall Study|Protocol Violation|0
5168582|NCT01323673|17846949|P1|Overall Study|Protocol Violation|1
5168583|NCT01323673|17846948|P2|Overall Study|Lost to Follow-up|1
5168584|NCT01323673|17846949|P1|Overall Study|Lost to Follow-up|0
5168585|NCT01323673|17846948|P2|Overall Study|Adverse Event|1
5168586|NCT01323673|17846949|P1|Overall Study|Adverse Event|0
5168587|NCT01323660|17846969|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5168588|NCT01323660|17846970|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
5168589|NCT01323660|17846971|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5168590|NCT01323660|17846972|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5168591|NCT01323660|17846973|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5168592|NCT01323660|17846974|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5168593|NCT01323660|17846969|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5168594|NCT01323660|17846970|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5168595|NCT01323660|17846971|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5168596|NCT01323660|17846972|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5168597|NCT01323660|17846973|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5168598|NCT01323660|17846974|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5168599|NCT01323660|17846969|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
5168600|NCT01323660|17846970|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5168601|NCT01323660|17846971|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5168602|NCT01323660|17846972|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5168603|NCT01323660|17846973|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5168604|NCT01323660|17846974|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5168605|NCT01323660|17846969|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
5168606|NCT01323660|17846970|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5168607|NCT01323660|17846971|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5168608|NCT01323660|17846972|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5168609|NCT01323660|17846973|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5168610|NCT01323660|17846974|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
5168611|NCT01323660|17846969|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
5168612|NCT01323660|17846970|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
5168613|NCT01323660|17846971|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
5168614|NCT01323660|17846972|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
5168615|NCT01323660|17846973|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
5168616|NCT01323660|17846974|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
5168617|NCT01323660|17846969|P6|Washout Period (14 Days)|Lack of Efficacy|2
5168618|NCT01323660|17846970|P5|Washout Period (14 Days)|Lack of Efficacy|2
5168619|NCT01323660|17846971|P4|Washout Period (14 Days)|Lack of Efficacy|3
5168620|NCT01323660|17846972|P3|Washout Period (14 Days)|Lack of Efficacy|1
5168621|NCT01323660|17846973|P2|Washout Period (14 Days)|Lack of Efficacy|0
5168622|NCT01323660|17846974|P1|Washout Period (14 Days)|Lack of Efficacy|0
5168623|NCT01323660|17846969|P6|Washout Period (14 Days)|Adverse Event|0
5168624|NCT01323660|17846970|P5|Washout Period (14 Days)|Adverse Event|1
5168625|NCT01323660|17846971|P4|Washout Period (14 Days)|Adverse Event|0
5168626|NCT01323660|17846972|P3|Washout Period (14 Days)|Adverse Event|0
5168627|NCT01323660|17846973|P2|Washout Period (14 Days)|Adverse Event|0
5168628|NCT01323660|17846974|P1|Washout Period (14 Days)|Adverse Event|0
5168629|NCT01323660|17846969|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5168630|NCT01323660|17846970|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
5168631|NCT01323660|17846971|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5168632|NCT01323660|17846972|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5168633|NCT01323660|17846973|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5168787|NCT01323192|17847146|P2|Overall Study|Adverse Event|1
5168634|NCT01323660|17846974|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
5168635|NCT01323660|17846969|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5168636|NCT01323660|17846970|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5168637|NCT01323660|17846971|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5168638|NCT01323660|17846972|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5168639|NCT01323660|17846973|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5168640|NCT01323660|17846974|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5168641|NCT01323660|17846969|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5168642|NCT01323660|17846970|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
5168643|NCT01323660|17846971|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5168644|NCT01323660|17846972|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5168645|NCT01323660|17846973|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5168646|NCT01323660|17846974|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5168647|NCT01323660|17846969|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5168648|NCT01323660|17846970|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5168649|NCT01323660|17846971|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5168650|NCT01323660|17846972|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5168651|NCT01323660|17846973|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5168652|NCT01323660|17846974|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5168653|NCT01323660|17846969|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
5168654|NCT01323660|17846970|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5168655|NCT01323660|17846971|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
5168656|NCT01323660|17846972|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
5168657|NCT01323660|17846973|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
5168658|NCT01323660|17846974|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5168659|NCT01323660|17846969|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
5168660|NCT01323660|17846970|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
5168661|NCT01323660|17846971|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
5168662|NCT01323660|17846972|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
5168663|NCT01323660|17846973|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
5168664|NCT01323660|17846974|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
5168665|NCT01323647|17847020|P2|Overall Study|Lost to Follow-up|0
5168666|NCT01323647|17847021|P1|Overall Study|Lost to Follow-up|2
5168667|NCT01323647|17847020|P2|Overall Study|Withdrawal by Subject|0
5168668|NCT01323647|17847021|P1|Overall Study|Withdrawal by Subject|5
5168669|NCT01323647|17847020|P2|Overall Study|Migrated/moved from study area|0
5168670|NCT01323647|17847021|P1|Overall Study|Migrated/moved from study area|2
5168671|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
5168672|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
5168673|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
5168674|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
5168675|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
5168676|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5168677|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
5168678|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
5168679|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
5168680|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5168681|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5168682|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5168683|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
5168684|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
5168685|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
5168686|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
5168687|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5168688|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5168689|NCT01323634|17847038|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
5168690|NCT01323634|17847039|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
5168691|NCT01323634|17847040|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
5168692|NCT01323634|17847038|P3|2-week Run-in Period|Adverse Event|0
5168693|NCT01323634|17847039|P2|2-week Run-in Period|Adverse Event|0
5168694|NCT01323634|17847040|P1|2-week Run-in Period|Adverse Event|1
5168695|NCT01323634|17847038|P3|2-week Run-in Period|Protocol Violation|0
5168696|NCT01323634|17847039|P2|2-week Run-in Period|Protocol Violation|0
5168697|NCT01323634|17847040|P1|2-week Run-in Period|Protocol Violation|1
5168698|NCT01323634|17847038|P3|2-week Run-in Period|Physician Decision|0
5168699|NCT01323634|17847039|P2|2-week Run-in Period|Physician Decision|0
5168700|NCT01323634|17847040|P1|2-week Run-in Period|Physician Decision|5
5168701|NCT01323634|17847038|P3|2-week Run-in Period|Withdrawal by Subject|0
5168702|NCT01323634|17847039|P2|2-week Run-in Period|Withdrawal by Subject|0
5168703|NCT01323634|17847040|P1|2-week Run-in Period|Withdrawal by Subject|7
5168704|NCT01323634|17847038|P3|2-week Run-in Period|Continuation Criteria not Met|0
5168705|NCT01323634|17847039|P2|2-week Run-in Period|Continuation Criteria not Met|0
5168706|NCT01323634|17847040|P1|2-week Run-in Period|Continuation Criteria not Met|73
5168707|NCT01323634|17847038|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
5168708|NCT01323634|17847039|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
5168709|NCT01323634|17847040|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
5168710|NCT01323621|17847050|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
5168711|NCT01323621|17847051|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
5168712|NCT01323621|17847052|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
5168713|NCT01323621|17847050|P3|12-week, Double-blind Treatment Period|Physician Decision|1
5168714|NCT01323621|17847051|P2|12-week, Double-blind Treatment Period|Physician Decision|2
5168715|NCT01323621|17847052|P1|12-week, Double-blind Treatment Period|Physician Decision|0
5168716|NCT01323621|17847050|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
5168717|NCT01323621|17847051|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
5168718|NCT01323621|17847052|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
5168719|NCT01323621|17847050|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
5168720|NCT01323621|17847051|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
5168721|NCT01323621|17847052|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
5168722|NCT01323621|17847050|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
5168723|NCT01323621|17847051|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
5168724|NCT01323621|17847052|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
5168725|NCT01323621|17847050|P3|12-week, Double-blind Treatment Period|Adverse Event|5
5168726|NCT01323621|17847051|P2|12-week, Double-blind Treatment Period|Adverse Event|1
5168727|NCT01323621|17847052|P1|12-week, Double-blind Treatment Period|Adverse Event|0
5168728|NCT01323621|17847050|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
5168729|NCT01323621|17847051|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
5168730|NCT01323621|17847052|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
5168731|NCT01323621|17847050|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
5168732|NCT01323621|17847051|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
5168733|NCT01323621|17847052|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
5168734|NCT01323621|17847050|P3|2-week, Single-blind Run In Period|Protocol Violation|0
5168735|NCT01323621|17847051|P2|2-week, Single-blind Run In Period|Protocol Violation|0
5168736|NCT01323621|17847052|P1|2-week, Single-blind Run In Period|Protocol Violation|1
5168737|NCT01323621|17847050|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
5168738|NCT01323621|17847051|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
5168739|NCT01323621|17847052|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
5168740|NCT01323621|17847050|P3|2-week, Single-blind Run In Period|Physician Decision|0
5168741|NCT01323621|17847051|P2|2-week, Single-blind Run In Period|Physician Decision|0
5168742|NCT01323621|17847052|P1|2-week, Single-blind Run In Period|Physician Decision|7
5168743|NCT01323621|17847050|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
5168744|NCT01323621|17847051|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
5168745|NCT01323621|17847052|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
5168746|NCT01323582|17847073|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
5168747|NCT01323582|17847074|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
5168748|NCT01323582|17847073|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
5168749|NCT01323582|17847074|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
5168750|NCT01323582|17847073|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
5168751|NCT01323582|17847074|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
5168752|NCT01323478|17847097|P1|Overall Study|Administrative or Other Reasons|8
5168753|NCT01323478|17847097|P1|Overall Study|Withdrawal of Consent|1
5168754|NCT01323478|17847097|P1|Overall Study|Protocol Violation|1
5168755|NCT01323478|17847097|P1|Overall Study|Non-compliance With Study Product|3
5168756|NCT01323478|17847097|P1|Overall Study|Lack of Efficacy|4
5168757|NCT01323478|17847097|P1|Overall Study|Adverse Event|7
5168758|NCT01323387|17847110|P1|Overall Study|Randomized but Never Treated|16
5168759|NCT01323387|17847110|P1|Overall Study|Protocol Violation|12
5168760|NCT01323387|17847110|P1|Overall Study|Revision|14
5168761|NCT01323387|17847110|P1|Overall Study|Radiographic Data Unavailable|1
5168762|NCT01323387|17847110|P1|Overall Study|Withdrawal by Subject|41
5168763|NCT01323270|17847123|P2|Overall Study|Randomized, but not vaccinated|0
5168764|NCT01323270|17847124|P1|Overall Study|Randomized, but not vaccinated|1
5168765|NCT01323270|17847123|P2|Overall Study|Death|0
5168766|NCT01323270|17847124|P1|Overall Study|Death|1
5168767|NCT01323270|17847123|P2|Overall Study|Not eligible|1
5168768|NCT01323270|17847124|P1|Overall Study|Not eligible|1
5168769|NCT01323270|17847123|P2|Overall Study|Physician Decision|2
5168770|NCT01323270|17847124|P1|Overall Study|Physician Decision|0
5168771|NCT01323270|17847123|P2|Overall Study|Other|3
5168772|NCT01323270|17847124|P1|Overall Study|Other|0
5168773|NCT01323270|17847123|P2|Overall Study|Adverse Event|0
5168774|NCT01323270|17847124|P1|Overall Study|Adverse Event|8
5168775|NCT01323270|17847123|P2|Overall Study|Lost to Follow-up|6
5168776|NCT01323270|17847124|P1|Overall Study|Lost to Follow-up|4
5168777|NCT01323270|17847123|P2|Overall Study|Protocol Violation|7
5168778|NCT01323270|17847124|P1|Overall Study|Protocol Violation|9
5168779|NCT01323270|17847123|P2|Overall Study|Withdrawal by Subject|10
5168780|NCT01323270|17847124|P1|Overall Study|Withdrawal by Subject|19
5168781|NCT01323192|17847146|P2|Overall Study|Nonmedical reasons|1
5168782|NCT01323192|17847147|P1|Overall Study|Nonmedical reasons|0
5168783|NCT01323192|17847146|P2|Overall Study|Noncompliance with study medication|3
5168784|NCT01323192|17847147|P1|Overall Study|Noncompliance with study medication|0
5168785|NCT01323192|17847146|P2|Overall Study|Withdrawal by Subject|1
5168786|NCT01323192|17847147|P1|Overall Study|Withdrawal by Subject|3
5168788|NCT01323192|17847147|P1|Overall Study|Adverse Event|6
5168789|NCT01322490|17847396|P3|Long Term Follow-up Period|Unknown/Missing|1
5168790|NCT01322490|17847397|P2|Long Term Follow-up Period|Unknown/Missing|1
5168791|NCT01322490|17847398|P1|Long Term Follow-up Period|Unknown/Missing|0
5168792|NCT01322490|17847396|P3|Long Term Follow-up Period|Other per report|2
5168793|NCT01322490|17847397|P2|Long Term Follow-up Period|Other per report|2
5168794|NCT01322490|17847398|P1|Long Term Follow-up Period|Other per report|3
5168795|NCT01322490|17847396|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
5168796|NCT01322490|17847397|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
5168797|NCT01322490|17847398|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
5168798|NCT01322490|17847396|P3|Long Term Follow-up Period|Withdrawal by Subject|6
5168799|NCT01322490|17847397|P2|Long Term Follow-up Period|Withdrawal by Subject|6
5168800|NCT01322490|17847398|P1|Long Term Follow-up Period|Withdrawal by Subject|9
5168801|NCT01322490|17847396|P3|Long Term Follow-up Period|Lost to Follow-up|3
5168802|NCT01322490|17847397|P2|Long Term Follow-up Period|Lost to Follow-up|2
5168803|NCT01322490|17847398|P1|Long Term Follow-up Period|Lost to Follow-up|2
5168804|NCT01322490|17847396|P3|Long Term Follow-up Period|Death|236
5168805|NCT01322490|17847397|P2|Long Term Follow-up Period|Death|239
5168806|NCT01322490|17847398|P1|Long Term Follow-up Period|Death|235
5168807|NCT01322490|17847396|P3|Treatment Period|Randomized but Not Treated|5
5168808|NCT01322490|17847397|P2|Treatment Period|Randomized but Not Treated|3
5168809|NCT01322490|17847398|P1|Treatment Period|Randomized but Not Treated|3
5168810|NCT01322490|17847396|P3|Treatment Period|Other per report|1
5168811|NCT01322490|17847397|P2|Treatment Period|Other per report|2
5168812|NCT01322490|17847398|P1|Treatment Period|Other per report|2
5168813|NCT01322490|17847396|P3|Treatment Period|Non-compliance with study drug|1
5168814|NCT01322490|17847397|P2|Treatment Period|Non-compliance with study drug|0
5168815|NCT01322490|17847398|P1|Treatment Period|Non-compliance with study drug|0
5168816|NCT01322490|17847396|P3|Treatment Period|Withdrawal by Subject|11
5168817|NCT01322490|17847397|P2|Treatment Period|Withdrawal by Subject|16
5168818|NCT01322490|17847398|P1|Treatment Period|Withdrawal by Subject|14
5168819|NCT01322490|17847396|P3|Treatment Period|Protocol Violation|4
5168820|NCT01322490|17847397|P2|Treatment Period|Protocol Violation|5
5168821|NCT01322490|17847398|P1|Treatment Period|Protocol Violation|7
5168822|NCT01322490|17847396|P3|Treatment Period|Physician Decision|1
5168823|NCT01322490|17847397|P2|Treatment Period|Physician Decision|2
5168824|NCT01322490|17847398|P1|Treatment Period|Physician Decision|0
5168825|NCT01322490|17847396|P3|Treatment Period|Lack of Efficacy|112
5168826|NCT01322490|17847397|P2|Treatment Period|Lack of Efficacy|100
5168827|NCT01322490|17847398|P1|Treatment Period|Lack of Efficacy|89
5168828|NCT01322490|17847396|P3|Treatment Period|Death|3
5168829|NCT01322490|17847397|P2|Treatment Period|Death|7
5168830|NCT01322490|17847398|P1|Treatment Period|Death|5
5168831|NCT01322490|17847396|P3|Treatment Period|Adverse Event|15
5168832|NCT01322490|17847397|P2|Treatment Period|Adverse Event|18
5168833|NCT01322490|17847398|P1|Treatment Period|Adverse Event|12
5168834|NCT01322386|17847411|P2|Overall Study|Physician Decision|1
5168835|NCT01322386|17847412|P1|Overall Study|Physician Decision|0
5168836|NCT01322386|17847411|P2|Overall Study|Protocol Violation|1
5168837|NCT01322386|17847412|P1|Overall Study|Protocol Violation|0
5168838|NCT01322347|17847427|P2|Overall Study|moved/changed dialysis|4
5168839|NCT01322347|17847428|P1|Overall Study|moved/changed dialysis|2
5168840|NCT01322347|17847427|P2|Overall Study|study drug withheld > 12 wks|1
5168841|NCT01322347|17847428|P1|Overall Study|study drug withheld > 12 wks|0
5168842|NCT01322347|17847427|P2|Overall Study|kidney transplant|1
5168843|NCT01322347|17847428|P1|Overall Study|kidney transplant|3
5168844|NCT01322347|17847427|P2|Overall Study|ineligible|3
5168845|NCT01322347|17847428|P1|Overall Study|ineligible|6
5168846|NCT01322347|17847427|P2|Overall Study|sponsor decision|3
5168847|NCT01322347|17847428|P1|Overall Study|sponsor decision|1
5168848|NCT01322347|17847427|P2|Overall Study|blood transfusion|5
5168849|NCT01322347|17847428|P1|Overall Study|blood transfusion|5
5168850|NCT01322347|17847427|P2|Overall Study|non-protocol change to ESA or IV iron|6
5168851|NCT01322347|17847428|P1|Overall Study|non-protocol change to ESA or IV iron|14
5168852|NCT01322347|17847427|P2|Overall Study|Withdrawal by Subject|4
5168853|NCT01322347|17847428|P1|Overall Study|Withdrawal by Subject|1
5168854|NCT01322347|17847427|P2|Overall Study|Protocol Violation|2
5168855|NCT01322347|17847428|P1|Overall Study|Protocol Violation|5
5168856|NCT01322347|17847427|P2|Overall Study|Physician Decision|1
5168857|NCT01322347|17847428|P1|Overall Study|Physician Decision|2
5168858|NCT01322347|17847427|P2|Overall Study|Death|3
5168859|NCT01322347|17847428|P1|Overall Study|Death|5
5168860|NCT01322347|17847427|P2|Overall Study|Adverse Event|2
5168861|NCT01322347|17847428|P1|Overall Study|Adverse Event|7
5168862|NCT01322009|17847491|P2|Overall Study|ng tube discontinued|1
5168863|NCT01322009|17847492|P1|Overall Study|ng tube discontinued|0
5168864|NCT01322009|17847491|P2|Overall Study|Adverse Event|1
5168865|NCT01322009|17847492|P1|Overall Study|Adverse Event|0
5168866|NCT01322009|17847491|P2|Overall Study|Death|1
5168867|NCT01322009|17847492|P1|Overall Study|Death|0
5168868|NCT01321879|17847500|P1|Overall Study|Withdrawal by Subject|1
5168869|NCT01321879|17847500|P1|Overall Study|Death|3
5168870|NCT01321879|17847500|P1|Overall Study|Adverse Event|5
5168871|NCT01321879|17847500|P1|Overall Study|Lack of Efficacy|5
5168872|NCT01321749|17847506|P2|Overall Study|Withdrawal by Subject|4
5168873|NCT01321749|17847507|P1|Overall Study|Withdrawal by Subject|5
5168874|NCT01321749|17847506|P2|Overall Study|Protocol Violation|7
5168875|NCT01321749|17847507|P1|Overall Study|Protocol Violation|4
5168876|NCT01321749|17847506|P2|Overall Study|Lost to Follow-up|11
5168877|NCT01321749|17847507|P1|Overall Study|Lost to Follow-up|4
5168878|NCT01321723|17847516|P3|Overall Study|Withdrawal by Subject|2
5168879|NCT01321723|17847517|P2|Overall Study|Withdrawal by Subject|0
5168880|NCT01321723|17847518|P1|Overall Study|Withdrawal by Subject|2
5168881|NCT01321723|17847516|P3|Overall Study|Adverse Event|2
5168882|NCT01321723|17847517|P2|Overall Study|Adverse Event|5
5168883|NCT01321723|17847518|P1|Overall Study|Adverse Event|3
5168884|NCT01321710|17847540|P3|Overall Study|Lost to Follow-up|0
5168885|NCT01321710|17847541|P2|Overall Study|Lost to Follow-up|5
5168886|NCT01321710|17847542|P1|Overall Study|Lost to Follow-up|4
5168887|NCT01321697|17847557|P1|Overall Study|Study Terminated|7
5168888|NCT01321606|17847563|P4|Overall Study|Lost to Follow-up|1
5168889|NCT01321606|17847564|P3|Overall Study|Lost to Follow-up|0
5168890|NCT01321606|17847565|P2|Overall Study|Lost to Follow-up|0
5168891|NCT01321606|17847566|P1|Overall Study|Lost to Follow-up|0
5168892|NCT01321073|17847602|P1|Overall Study|Death|3
5168893|NCT01321073|17847602|P1|Overall Study|Did not attempt implant|4
5168894|NCT01321008|17847606|P1|Overall Study|Early Study Termination|1
5168895|NCT01320943|17847612|P2|Overall Study|Randomized but not Treated|1
5168896|NCT01320943|17847613|P1|Overall Study|Randomized but not Treated|0
5168897|NCT01320943|17847612|P2|Overall Study|Physician Decision|1
5168898|NCT01320943|17847613|P1|Overall Study|Physician Decision|0
5168899|NCT01320943|17847612|P2|Overall Study|Lost to Follow-up|0
5168900|NCT01320943|17847613|P1|Overall Study|Lost to Follow-up|1
5168901|NCT01320735|17847647|P1|Overall Study|Investigator Unable to be Contacted|17
5168902|NCT01320735|17847647|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
5168903|NCT01320735|17847647|P1|Overall Study|Other|1
5168904|NCT01320735|17847647|P1|Overall Study|Protocol Violation|1
5168905|NCT01320735|17847647|P1|Overall Study|Progression/Hormone-Refractory Pca|55
5168906|NCT01320735|17847647|P1|Overall Study|Administrative Reason|6
5168907|NCT01320735|17847647|P1|Overall Study|Lost to Follow-up|13
5168908|NCT01320735|17847647|P1|Overall Study|Withdrawal by Subject|3
5168909|NCT01320735|17847647|P1|Overall Study|Adverse Event|3
5168910|NCT01320722|17847669|P5|Overall Study|Withdrew due to Health Condition|1
5168911|NCT01320722|17847670|P4|Overall Study|Withdrew due to Health Condition|0
5168912|NCT01320722|17847671|P3|Overall Study|Withdrew due to Health Condition|0
5168913|NCT01320722|17847672|P2|Overall Study|Withdrew due to Health Condition|0
5168914|NCT01320722|17847673|P1|Overall Study|Withdrew due to Health Condition|0
5168915|NCT01320722|17847669|P5|Overall Study|Started an Exclusionary Medication|1
5168916|NCT01320722|17847670|P4|Overall Study|Started an Exclusionary Medication|0
5168917|NCT01320722|17847671|P3|Overall Study|Started an Exclusionary Medication|0
5168918|NCT01320722|17847672|P2|Overall Study|Started an Exclusionary Medication|0
5168919|NCT01320722|17847673|P1|Overall Study|Started an Exclusionary Medication|0
5168920|NCT01320722|17847669|P5|Overall Study|Pregnancy|0
5168921|NCT01320722|17847670|P4|Overall Study|Pregnancy|1
5168922|NCT01320722|17847671|P3|Overall Study|Pregnancy|0
5168923|NCT01320722|17847672|P2|Overall Study|Pregnancy|0
5168924|NCT01320722|17847673|P1|Overall Study|Pregnancy|0
5168925|NCT01320722|17847669|P5|Overall Study|Not Compliant with Study Procedures|0
5168926|NCT01320722|17847670|P4|Overall Study|Not Compliant with Study Procedures|4
5168927|NCT01320722|17847671|P3|Overall Study|Not Compliant with Study Procedures|0
5168928|NCT01320722|17847672|P2|Overall Study|Not Compliant with Study Procedures|0
5168929|NCT01320722|17847673|P1|Overall Study|Not Compliant with Study Procedures|0
5168930|NCT01320722|17847669|P5|Overall Study|Adverse Event|0
5168931|NCT01320722|17847670|P4|Overall Study|Adverse Event|6
5168932|NCT01320722|17847671|P3|Overall Study|Adverse Event|3
5168933|NCT01320722|17847672|P2|Overall Study|Adverse Event|0
5168934|NCT01320722|17847673|P1|Overall Study|Adverse Event|0
5168935|NCT01320722|17847669|P5|Overall Study|Non-compliant with Medication|0
5168936|NCT01320722|17847670|P4|Overall Study|Non-compliant with Medication|0
5168937|NCT01320722|17847671|P3|Overall Study|Non-compliant with Medication|1
5168938|NCT01320722|17847672|P2|Overall Study|Non-compliant with Medication|0
5168939|NCT01320722|17847673|P1|Overall Study|Non-compliant with Medication|0
5168940|NCT01320722|17847669|P5|Overall Study|Participant Developed a Rash|1
5168941|NCT01320722|17847670|P4|Overall Study|Participant Developed a Rash|1
5168942|NCT01320722|17847671|P3|Overall Study|Participant Developed a Rash|2
5168943|NCT01320722|17847672|P2|Overall Study|Participant Developed a Rash|0
5168944|NCT01320722|17847673|P1|Overall Study|Participant Developed a Rash|0
5168945|NCT01320722|17847669|P5|Overall Study|Not Available for the 8 Week Visit|0
5168946|NCT01320722|17847670|P4|Overall Study|Not Available for the 8 Week Visit|0
5168947|NCT01320722|17847671|P3|Overall Study|Not Available for the 8 Week Visit|0
5168948|NCT01320722|17847672|P2|Overall Study|Not Available for the 8 Week Visit|3
5168949|NCT01320722|17847673|P1|Overall Study|Not Available for the 8 Week Visit|0
5168950|NCT01320722|17847669|P5|Overall Study|Lost to Follow-up|3
5168951|NCT01320722|17847670|P4|Overall Study|Lost to Follow-up|1
5168952|NCT01320722|17847671|P3|Overall Study|Lost to Follow-up|0
5168953|NCT01320722|17847672|P2|Overall Study|Lost to Follow-up|1
5168954|NCT01320722|17847673|P1|Overall Study|Lost to Follow-up|0
5168955|NCT01320722|17847669|P5|Overall Study|Did not Receive Intervention|2
5168956|NCT01320722|17847670|P4|Overall Study|Did not Receive Intervention|1
5168957|NCT01320722|17847671|P3|Overall Study|Did not Receive Intervention|1
5168958|NCT01320722|17847672|P2|Overall Study|Did not Receive Intervention|2
5168959|NCT01320722|17847673|P1|Overall Study|Did not Receive Intervention|3
5168960|NCT01320683|17847710|P1|Overall Study|Positive antibody response|1
5168961|NCT01320293|17847736|P1|Overall Study|Adverse Event|1
5168962|NCT01320293|17847736|P1|Overall Study|Lack of Efficacy|1
5168963|NCT01320202|17847744|P2|Overall Study|regained renal function|0
5168964|NCT01320202|17847745|P1|Overall Study|regained renal function|1
5168965|NCT01320202|17847744|P2|Overall Study|ineligible|0
5168966|NCT01320202|17847745|P1|Overall Study|ineligible|3
5168967|NCT01320202|17847744|P2|Overall Study|sponsor request|0
5168968|NCT01320202|17847745|P1|Overall Study|sponsor request|2
5168969|NCT01320202|17847744|P2|Overall Study|moved/changed dialysis|2
5168970|NCT01320202|17847745|P1|Overall Study|moved/changed dialysis|5
5168971|NCT01320202|17847744|P2|Overall Study|blood transfusion|7
5168972|NCT01320202|17847745|P1|Overall Study|blood transfusion|1
5168973|NCT01320202|17847744|P2|Overall Study|kidney transplant|2
5168974|NCT01320202|17847745|P1|Overall Study|kidney transplant|1
5168975|NCT01320202|17847744|P2|Overall Study|non-protocol change to ESA or IV iron|20
5168976|NCT01320202|17847745|P1|Overall Study|non-protocol change to ESA or IV iron|17
5168977|NCT01320202|17847744|P2|Overall Study|Withdrawal by Subject|3
5168978|NCT01320202|17847745|P1|Overall Study|Withdrawal by Subject|10
5168979|NCT01320202|17847744|P2|Overall Study|Protocol Violation|1
5168980|NCT01320202|17847745|P1|Overall Study|Protocol Violation|2
5168981|NCT01320202|17847744|P2|Overall Study|Physician Decision|1
5168982|NCT01320202|17847745|P1|Overall Study|Physician Decision|3
5168983|NCT01320202|17847744|P2|Overall Study|Lost to Follow-up|0
5168984|NCT01320202|17847745|P1|Overall Study|Lost to Follow-up|1
5168985|NCT01320202|17847744|P2|Overall Study|Death|3
5168986|NCT01320202|17847745|P1|Overall Study|Death|5
5168987|NCT01320202|17847744|P2|Overall Study|Adverse Event|5
5168988|NCT01320202|17847745|P1|Overall Study|Adverse Event|5
5168989|NCT01320150|17847782|P1|Overall Study|Lost to Follow-up|44
5168990|NCT01320150|17847782|P1|Overall Study|Death|2
5168991|NCT01320150|17847782|P1|Overall Study|Withdrawal by Subject|5
5168992|NCT01320150|17847782|P1|Overall Study|Protocol Violation|15
5168993|NCT01320033|17847816|P3|Overall Study|Other|1
5168994|NCT01320033|17847817|P2|Overall Study|Other|3
5168995|NCT01320033|17847818|P1|Overall Study|Other|2
5168996|NCT01320033|17847816|P3|Overall Study|Lost to Follow-up|17
5168997|NCT01320033|17847817|P2|Overall Study|Lost to Follow-up|26
5168998|NCT01320033|17847818|P1|Overall Study|Lost to Follow-up|22
5168999|NCT01320033|17847816|P3|Overall Study|Protocol Violation|3
5169000|NCT01320033|17847817|P2|Overall Study|Protocol Violation|5
5169001|NCT01320033|17847818|P1|Overall Study|Protocol Violation|3
5169002|NCT01320033|17847816|P3|Overall Study|Withdrawal by Subject|23
5169003|NCT01320033|17847817|P2|Overall Study|Withdrawal by Subject|23
5169004|NCT01320033|17847818|P1|Overall Study|Withdrawal by Subject|22
5169005|NCT01320033|17847816|P3|Overall Study|Adverse Event|8
5169006|NCT01320033|17847817|P2|Overall Study|Adverse Event|7
5169007|NCT01320033|17847818|P1|Overall Study|Adverse Event|9
5169008|NCT01320033|17847816|P3|Overall Study|Lack of Efficacy|1
5169009|NCT01320033|17847817|P2|Overall Study|Lack of Efficacy|0
5169010|NCT01320033|17847818|P1|Overall Study|Lack of Efficacy|0
5169011|NCT01319994|17847846|P2|Overall Study|Protocol Violation|6
5169012|NCT01319994|17847847|P1|Overall Study|Protocol Violation|7
5169013|NCT01319929|17847857|P2|Second Treatment Period (4 Weeks)|Sponsor Decision|1
5169014|NCT01319929|17847858|P1|Second Treatment Period (4 Weeks)|Sponsor Decision|0
5169015|NCT01319929|17847857|P2|Second Treatment Period (4 Weeks)|Adverse Event|0
5169016|NCT01319929|17847858|P1|Second Treatment Period (4 Weeks)|Adverse Event|1
5169017|NCT01319929|17847857|P2|First Treatment Period (4 Weeks)|Protocol Violation|1
5169018|NCT01319929|17847858|P1|First Treatment Period (4 Weeks)|Protocol Violation|0
5169019|NCT01319929|17847857|P2|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
5169020|NCT01319929|17847858|P1|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
5169021|NCT01319929|17847857|P2|First Treatment Period (4 Weeks)|Adverse Event|0
5169022|NCT01319929|17847858|P1|First Treatment Period (4 Weeks)|Adverse Event|2
5169023|NCT01319877|17847890|P2|Overall Study|Reason Not Specified|5
5169024|NCT01319877|17847891|P1|Overall Study|Reason Not Specified|4
5169025|NCT01319877|17847890|P2|Overall Study|Withdrawal by Subject|1
5169026|NCT01319877|17847891|P1|Overall Study|Withdrawal by Subject|0
5169027|NCT01319877|17847890|P2|Overall Study|Disease Progression|2
5169028|NCT01319877|17847891|P1|Overall Study|Disease Progression|2
5169029|NCT01319877|17847890|P2|Overall Study|Physician Decision|0
5169030|NCT01319877|17847891|P1|Overall Study|Physician Decision|2
5169031|NCT01319877|17847890|P2|Overall Study|Lost to Follow-up|37
5169032|NCT01319877|17847891|P1|Overall Study|Lost to Follow-up|100
5169033|NCT01319721|17848059|P2|Overall Study|Lost to Follow-up|6
5169034|NCT01319721|17848060|P1|Overall Study|Lost to Follow-up|1
5169035|NCT01319422|17848113|P2|Overall Study|Withdrawal by Subject|0
5169036|NCT01319422|17848114|P1|Overall Study|Withdrawal by Subject|1
5169037|NCT01319383|17848132|P2|Overall Study|No in vivo response to interval doses|1
5169038|NCT01319383|17848133|P1|Overall Study|No in vivo response to interval doses|0
5169039|NCT01319383|17848132|P2|Overall Study|Lack of Efficacy|9
5169040|NCT01319383|17848133|P1|Overall Study|Lack of Efficacy|5
5169041|NCT01319383|17848132|P2|Overall Study|Physician Decision|0
5169042|NCT01319383|17848133|P1|Overall Study|Physician Decision|3
5169043|NCT01319383|17848132|P2|Overall Study|No ex vivo or in vivo response|0
5169044|NCT01319383|17848133|P1|Overall Study|No ex vivo or in vivo response|4
5169045|NCT01318993|17848172|P1|Overall Study|Withdrawal by Subject|24
5169046|NCT01318993|17848172|P1|Overall Study|Physician Decision|13
5169047|NCT01318993|17848172|P1|Overall Study|Lost to Follow-up|4
5169048|NCT01318993|17848172|P1|Overall Study|Study closed or terminated|174
5169049|NCT01318993|17848172|P1|Overall Study|Protocol based stopping criteria|6
5169050|NCT01318993|17848172|P1|Overall Study|Protocol Violation|3
5169051|NCT01318993|17848172|P1|Overall Study|Lack of Efficacy|121
5169052|NCT01318993|17848172|P1|Overall Study|Adverse Event|53
5169053|NCT01318915|17848193|P1|Overall Study|Lost to Follow-up|1
5169054|NCT01318902|17848222|P4|Overall Study|Terminated by Sponsor|0
5169055|NCT01318902|17848223|P3|Overall Study|Terminated by Sponsor|1
5169056|NCT01318902|17848224|P2|Overall Study|Terminated by Sponsor|0
5169057|NCT01318902|17848225|P1|Overall Study|Terminated by Sponsor|0
5169058|NCT01318902|17848222|P4|Overall Study|Adverse Event|0
5169059|NCT01318902|17848223|P3|Overall Study|Adverse Event|0
5169060|NCT01318902|17848224|P2|Overall Study|Adverse Event|1
5169061|NCT01318902|17848225|P1|Overall Study|Adverse Event|0
5169062|NCT01318902|17848222|P4|Overall Study|Unsatisfactory Therapeutic Response|1
5169063|NCT01318902|17848223|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5169064|NCT01318902|17848224|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5169065|NCT01318902|17848225|P1|Overall Study|Unsatisfactory Therapeutic Response|1
5169066|NCT01318902|17848222|P4|Overall Study|Withdrawal by Patient|3
5169067|NCT01318902|17848223|P3|Overall Study|Withdrawal by Patient|0
5169068|NCT01318902|17848224|P2|Overall Study|Withdrawal by Patient|1
5169069|NCT01318902|17848225|P1|Overall Study|Withdrawal by Patient|0
5169070|NCT01318902|17848222|P4|Overall Study|Symptomatic Deterioration|2
5169071|NCT01318902|17848223|P3|Overall Study|Symptomatic Deterioration|1
5169072|NCT01318902|17848224|P2|Overall Study|Symptomatic Deterioration|1
5169073|NCT01318902|17848225|P1|Overall Study|Symptomatic Deterioration|0
5169074|NCT01318876|17848302|P1|Day 29 Survey|survey not completed-don't know why|1825
5169075|NCT01318876|17848302|P1|Day 8 Survey|survey not completed-don't know why|1724
5169076|NCT01318876|17848302|P1|Day 8 Survey|email address invalid|96
5169077|NCT01318811|17848309|P2|Overall Study|CRRT stopped for head MRI|1
5169078|NCT01318811|17848310|P1|Overall Study|CRRT stopped for head MRI|0
5169079|NCT01318811|17848309|P2|Overall Study|Death|1
5169080|NCT01318811|17848310|P1|Overall Study|Death|0
5169081|NCT01318811|17848309|P2|Overall Study|CRRT stopped for head CT|1
5169082|NCT01318811|17848310|P1|Overall Study|CRRT stopped for head CT|0
5169083|NCT01318811|17848309|P2|Overall Study|Physician Decision|1
5169084|NCT01318811|17848310|P1|Overall Study|Physician Decision|1
5169085|NCT01318512|17848420|P1|Maintenance Period (6 Months)|Protocol Violation|9
5169086|NCT01318512|17848420|P1|Maintenance Period (6 Months)|Death|2
5169087|NCT01318499|17848439|P3|Overall Study|Other|22
5169088|NCT01318499|17848440|P2|Overall Study|Other|10
5169089|NCT01318499|17848441|P1|Overall Study|Other|7
5169090|NCT01318499|17848439|P3|Overall Study|Patient Did Not Use Study Medication|14
5169091|NCT01318499|17848440|P2|Overall Study|Patient Did Not Use Study Medication|28
5169092|NCT01318499|17848441|P1|Overall Study|Patient Did Not Use Study Medication|18
5169093|NCT01318499|17848439|P3|Overall Study|Protocol Violation|2
5169094|NCT01318499|17848440|P2|Overall Study|Protocol Violation|4
5169095|NCT01318499|17848441|P1|Overall Study|Protocol Violation|2
5169096|NCT01318499|17848439|P3|Overall Study|Treatment Failure|101
5169097|NCT01318499|17848440|P2|Overall Study|Treatment Failure|19
5169098|NCT01318499|17848441|P1|Overall Study|Treatment Failure|19
5169099|NCT01318499|17848439|P3|Overall Study|Noncompliance|0
5169100|NCT01318499|17848440|P2|Overall Study|Noncompliance|3
5169101|NCT01318499|17848441|P1|Overall Study|Noncompliance|2
5169102|NCT01318499|17848439|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
5169103|NCT01318499|17848440|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
5169104|NCT01318499|17848441|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
5169105|NCT01318499|17848439|P3|Overall Study|Adverse Event|6
5169106|NCT01318499|17848440|P2|Overall Study|Adverse Event|11
5169107|NCT01318499|17848441|P1|Overall Study|Adverse Event|16
5169108|NCT01318382|17848464|P1|Overall Study|Protocol Violation|1
5169109|NCT01318382|17848464|P1|Overall Study|Device Malfunction|10
5169110|NCT01318382|17848464|P1|Overall Study|Physician Decision|2
5169111|NCT01318135|17848522|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
5169112|NCT01318135|17848523|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169113|NCT01318135|17848524|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169114|NCT01318135|17848525|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169115|NCT01318135|17848526|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169116|NCT01318135|17848527|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169117|NCT01318135|17848528|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169118|NCT01318135|17848529|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5169119|NCT01318135|17848522|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
5169120|NCT01318135|17848523|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
5169121|NCT01318135|17848524|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
5169122|NCT01318135|17848525|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
5169123|NCT01318135|17848526|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
5169124|NCT01318135|17848527|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
5169125|NCT01318135|17848528|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
5169126|NCT01318135|17848529|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
5169293|NCT01317641|17848977|P3|Overall Study|Not treated|0
5169127|NCT01318135|17848522|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5169128|NCT01318135|17848523|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5169129|NCT01318135|17848524|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5169130|NCT01318135|17848525|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5169131|NCT01318135|17848526|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5169132|NCT01318135|17848527|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5169133|NCT01318135|17848528|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5169134|NCT01318135|17848529|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5169135|NCT01318135|17848522|P8|Entered - Long-Term Extension Study|Protocol Violation|0
5169136|NCT01318135|17848523|P7|Entered - Long-Term Extension Study|Protocol Violation|0
5169137|NCT01318135|17848524|P6|Entered - Long-Term Extension Study|Protocol Violation|0
5169138|NCT01318135|17848525|P5|Entered - Long-Term Extension Study|Protocol Violation|1
5169139|NCT01318135|17848526|P4|Entered - Long-Term Extension Study|Protocol Violation|0
5169140|NCT01318135|17848527|P3|Entered - Long-Term Extension Study|Protocol Violation|0
5169141|NCT01318135|17848528|P2|Entered - Long-Term Extension Study|Protocol Violation|1
5169142|NCT01318135|17848529|P1|Entered - Long-Term Extension Study|Protocol Violation|1
5169143|NCT01318135|17848522|P8|Entered - Long-Term Extension Study|Adverse Event|0
5169144|NCT01318135|17848523|P7|Entered - Long-Term Extension Study|Adverse Event|0
5169145|NCT01318135|17848524|P6|Entered - Long-Term Extension Study|Adverse Event|2
5169146|NCT01318135|17848525|P5|Entered - Long-Term Extension Study|Adverse Event|4
5169147|NCT01318135|17848526|P4|Entered - Long-Term Extension Study|Adverse Event|3
5169148|NCT01318135|17848527|P3|Entered - Long-Term Extension Study|Adverse Event|4
5169149|NCT01318135|17848528|P2|Entered - Long-Term Extension Study|Adverse Event|3
5169150|NCT01318135|17848529|P1|Entered - Long-Term Extension Study|Adverse Event|9
5169151|NCT01318135|17848522|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169152|NCT01318135|17848523|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169153|NCT01318135|17848524|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169154|NCT01318135|17848525|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169155|NCT01318135|17848526|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169156|NCT01318135|17848527|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169157|NCT01318135|17848528|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
5169158|NCT01318135|17848529|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
5169159|NCT01318135|17848522|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
5169160|NCT01318135|17848523|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
5169161|NCT01318135|17848524|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
5169162|NCT01318135|17848525|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
5169163|NCT01318135|17848526|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
5169164|NCT01318135|17848527|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
5169165|NCT01318135|17848528|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5169166|NCT01318135|17848529|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
5169167|NCT01318122|17848661|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
5169168|NCT01318122|17848662|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
5169169|NCT01318122|17848663|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
5169170|NCT01318122|17848664|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
5169171|NCT01318122|17848661|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5169172|NCT01318122|17848662|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5169173|NCT01318122|17848663|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
5169174|NCT01318122|17848664|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5169175|NCT01318122|17848661|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
5169176|NCT01318122|17848662|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
5169177|NCT01318122|17848663|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
5169178|NCT01318122|17848664|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
5169179|NCT01318122|17848661|P4|Entered - Long-Term Extension Study|Adverse Event|4
5169180|NCT01318122|17848662|P3|Entered - Long-Term Extension Study|Adverse Event|2
5169181|NCT01318122|17848663|P2|Entered - Long-Term Extension Study|Adverse Event|6
5169182|NCT01318122|17848664|P1|Entered - Long-Term Extension Study|Adverse Event|6
5169183|NCT01318122|17848661|P4|Enrolled - Long-Term Extension Study|Other|0
5169184|NCT01318122|17848662|P3|Enrolled - Long-Term Extension Study|Other|0
5169185|NCT01318122|17848663|P2|Enrolled - Long-Term Extension Study|Other|0
5169186|NCT01318122|17848664|P1|Enrolled - Long-Term Extension Study|Other|1
5169187|NCT01318122|17848661|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
5169188|NCT01318122|17848662|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
5169189|NCT01318122|17848663|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5169190|NCT01318122|17848664|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
5169191|NCT01318109|17848733|P3|Overall Study|Schedule Conflict|0
5169192|NCT01318109|17848734|P2|Overall Study|Schedule Conflict|1
5169193|NCT01318109|17848735|P1|Overall Study|Schedule Conflict|0
5169194|NCT01318109|17848733|P3|Overall Study|Withdrawal by Subject|0
5169195|NCT01318109|17848734|P2|Overall Study|Withdrawal by Subject|0
5169196|NCT01318109|17848735|P1|Overall Study|Withdrawal by Subject|1
5169197|NCT01318109|17848733|P3|Overall Study|Adverse Event|0
5169198|NCT01318109|17848734|P2|Overall Study|Adverse Event|2
5169199|NCT01318109|17848735|P1|Overall Study|Adverse Event|0
5169200|NCT01318083|17848770|P3|Overall Study|Lack of Study Medication Compliance|0
5169201|NCT01318083|17848771|P2|Overall Study|Lack of Study Medication Compliance|1
5169202|NCT01318083|17848772|P1|Overall Study|Lack of Study Medication Compliance|0
5169203|NCT01318083|17848770|P3|Overall Study|Treatment Complications|0
5169204|NCT01318083|17848771|P2|Overall Study|Treatment Complications|0
5169205|NCT01318083|17848772|P1|Overall Study|Treatment Complications|1
5169206|NCT01318083|17848770|P3|Overall Study|Lack of Efficacy|1
5169207|NCT01318083|17848771|P2|Overall Study|Lack of Efficacy|0
5169208|NCT01318083|17848772|P1|Overall Study|Lack of Efficacy|0
5169209|NCT01318083|17848770|P3|Overall Study|Withdrawal by Subject|2
5169210|NCT01318083|17848771|P2|Overall Study|Withdrawal by Subject|0
5169211|NCT01318083|17848772|P1|Overall Study|Withdrawal by Subject|1
5169212|NCT01318083|17848770|P3|Overall Study|Adverse Event|2
5169213|NCT01318083|17848771|P2|Overall Study|Adverse Event|1
5169214|NCT01318083|17848772|P1|Overall Study|Adverse Event|4
5169215|NCT01318070|17848807|P3|Overall Study|Principal Investigator Discretion|0
5169216|NCT01318070|17848808|P2|Overall Study|Principal Investigator Discretion|0
5169217|NCT01318070|17848809|P1|Overall Study|Principal Investigator Discretion|1
5169218|NCT01318070|17848807|P3|Overall Study|Lack of Efficacy|1
5169219|NCT01318070|17848808|P2|Overall Study|Lack of Efficacy|0
5169220|NCT01318070|17848809|P1|Overall Study|Lack of Efficacy|0
5169221|NCT01318070|17848807|P3|Overall Study|Withdrawal by Subject|1
5169222|NCT01318070|17848808|P2|Overall Study|Withdrawal by Subject|1
5169223|NCT01318070|17848809|P1|Overall Study|Withdrawal by Subject|0
5169224|NCT01318070|17848807|P3|Overall Study|Adverse Event|5
5169225|NCT01318070|17848808|P2|Overall Study|Adverse Event|1
5169226|NCT01318070|17848809|P1|Overall Study|Adverse Event|1
5169227|NCT01317940|17848856|P6|Overall Study|Change in therapy plan|0
5169228|NCT01317940|17848857|P5|Overall Study|Change in therapy plan|0
5169229|NCT01317940|17848858|P4|Overall Study|Change in therapy plan|0
5169230|NCT01317940|17848859|P3|Overall Study|Change in therapy plan|3
5169231|NCT01317940|17848860|P2|Overall Study|Change in therapy plan|0
5169232|NCT01317940|17848861|P1|Overall Study|Change in therapy plan|0
5169233|NCT01317940|17848856|P6|Overall Study|Lost to Follow-up|0
5169234|NCT01317940|17848857|P5|Overall Study|Lost to Follow-up|1
5169235|NCT01317940|17848858|P4|Overall Study|Lost to Follow-up|1
5169236|NCT01317940|17848859|P3|Overall Study|Lost to Follow-up|1
5169237|NCT01317940|17848860|P2|Overall Study|Lost to Follow-up|0
5169238|NCT01317940|17848861|P1|Overall Study|Lost to Follow-up|0
5169239|NCT01317940|17848856|P6|Overall Study|Death|0
5169240|NCT01317940|17848857|P5|Overall Study|Death|0
5169241|NCT01317940|17848858|P4|Overall Study|Death|0
5169242|NCT01317940|17848859|P3|Overall Study|Death|1
5169243|NCT01317940|17848860|P2|Overall Study|Death|0
5169244|NCT01317940|17848861|P1|Overall Study|Death|1
5169245|NCT01317797|17848892|P3|Overall Study|Withdrawal of Patient|1
5169246|NCT01317797|17848893|P2|Overall Study|Withdrawal of Patient|0
5169247|NCT01317797|17848894|P1|Overall Study|Withdrawal of Patient|0
5169248|NCT01317797|17848892|P3|Overall Study|Other|0
5169249|NCT01317797|17848893|P2|Overall Study|Other|1
5169250|NCT01317797|17848894|P1|Overall Study|Other|0
5169251|NCT01317641|17848971|P9|Overall Study|Withdrawal by Subject|0
5169252|NCT01317641|17848972|P8|Overall Study|Withdrawal by Subject|0
5169253|NCT01317641|17848973|P7|Overall Study|Withdrawal by Subject|1
5169254|NCT01317641|17848974|P6|Overall Study|Withdrawal by Subject|0
5169255|NCT01317641|17848975|P5|Overall Study|Withdrawal by Subject|0
5169256|NCT01317641|17848976|P4|Overall Study|Withdrawal by Subject|0
5169257|NCT01317641|17848977|P3|Overall Study|Withdrawal by Subject|0
5169258|NCT01317641|17848978|P2|Overall Study|Withdrawal by Subject|0
5169259|NCT01317641|17848979|P1|Overall Study|Withdrawal by Subject|0
5169260|NCT01317641|17848971|P9|Overall Study|Disease progression|4
5169261|NCT01317641|17848972|P8|Overall Study|Disease progression|3
5169262|NCT01317641|17848973|P7|Overall Study|Disease progression|0
5169263|NCT01317641|17848974|P6|Overall Study|Disease progression|0
5169264|NCT01317641|17848975|P5|Overall Study|Disease progression|0
5169265|NCT01317641|17848976|P4|Overall Study|Disease progression|0
5169266|NCT01317641|17848977|P3|Overall Study|Disease progression|0
5169267|NCT01317641|17848978|P2|Overall Study|Disease progression|0
5169268|NCT01317641|17848979|P1|Overall Study|Disease progression|0
5169269|NCT01317641|17848971|P9|Overall Study|Protocol Violation|0
5169270|NCT01317641|17848972|P8|Overall Study|Protocol Violation|0
5169271|NCT01317641|17848973|P7|Overall Study|Protocol Violation|0
5169272|NCT01317641|17848974|P6|Overall Study|Protocol Violation|0
5169273|NCT01317641|17848975|P5|Overall Study|Protocol Violation|0
5169274|NCT01317641|17848976|P4|Overall Study|Protocol Violation|0
5169275|NCT01317641|17848977|P3|Overall Study|Protocol Violation|0
5169276|NCT01317641|17848978|P2|Overall Study|Protocol Violation|0
5169277|NCT01317641|17848979|P1|Overall Study|Protocol Violation|1
5169278|NCT01317641|17848971|P9|Overall Study|Adverse Event|0
5169279|NCT01317641|17848972|P8|Overall Study|Adverse Event|1
5169280|NCT01317641|17848973|P7|Overall Study|Adverse Event|2
5169281|NCT01317641|17848974|P6|Overall Study|Adverse Event|0
5169282|NCT01317641|17848975|P5|Overall Study|Adverse Event|0
5169283|NCT01317641|17848976|P4|Overall Study|Adverse Event|1
5169284|NCT01317641|17848977|P3|Overall Study|Adverse Event|0
5169285|NCT01317641|17848978|P2|Overall Study|Adverse Event|1
5169286|NCT01317641|17848979|P1|Overall Study|Adverse Event|0
5169287|NCT01317641|17848971|P9|Overall Study|Not treated|1
5169288|NCT01317641|17848972|P8|Overall Study|Not treated|1
5169289|NCT01317641|17848973|P7|Overall Study|Not treated|0
5169290|NCT01317641|17848974|P6|Overall Study|Not treated|0
5169291|NCT01317641|17848975|P5|Overall Study|Not treated|0
5169292|NCT01317641|17848976|P4|Overall Study|Not treated|0
5169294|NCT01317641|17848978|P2|Overall Study|Not treated|0
5169295|NCT01317641|17848979|P1|Overall Study|Not treated|0
5169296|NCT01317615|17849081|P1|Overall Study|Adverse Event|7
5169297|NCT01317615|17849081|P1|Overall Study|Abnormal laboratory value(s)|1
5169298|NCT01317615|17849081|P1|Overall Study|Withdrawal by Subject|5
5169299|NCT01317615|17849081|P1|Overall Study|Death|6
5169300|NCT01317615|17849081|P1|Overall Study|New cancer therapy|5
5169301|NCT01317615|17849081|P1|Overall Study|Disease progression|25
5169302|NCT01317550|17849094|P4|Overall Study|Lack of compliance study med|0
5169303|NCT01317550|17849095|P3|Overall Study|Lack of compliance study med|0
5169304|NCT01317550|17849096|P2|Overall Study|Lack of compliance study med|0
5169305|NCT01317550|17849097|P1|Overall Study|Lack of compliance study med|1
5169306|NCT01317550|17849094|P4|Overall Study|Withdrawal by Subject|0
5169307|NCT01317550|17849095|P3|Overall Study|Withdrawal by Subject|0
5169308|NCT01317550|17849096|P2|Overall Study|Withdrawal by Subject|0
5169309|NCT01317550|17849097|P1|Overall Study|Withdrawal by Subject|1
5169310|NCT01317472|17849109|P2|Overall Study|Unrelated hospitalization|0
5169311|NCT01317472|17849110|P1|Overall Study|Unrelated hospitalization|1
5169312|NCT01317472|17849109|P2|Overall Study|Withdrawal by Subject|0
5169313|NCT01317472|17849110|P1|Overall Study|Withdrawal by Subject|1
5169314|NCT01317199|17849120|P4|Randomized Phase 2|Patient transferred to other facility|0
5169315|NCT01317199|17849121|P3|Randomized Phase 2|Patient transferred to other facility|1
5169316|NCT01317199|17849122|P2|Randomized Phase 2|Patient transferred to other facility|0
5169317|NCT01317199|17849123|P1|Randomized Phase 2|Patient transferred to other facility|0
5169318|NCT01317199|17849120|P4|Randomized Phase 2|Patient stopped taking study drug|1
5169319|NCT01317199|17849121|P3|Randomized Phase 2|Patient stopped taking study drug|0
5169320|NCT01317199|17849122|P2|Randomized Phase 2|Patient stopped taking study drug|0
5169321|NCT01317199|17849123|P1|Randomized Phase 2|Patient stopped taking study drug|0
5169322|NCT01317199|17849120|P4|Randomized Phase 2|Disenrolled before treatment|2
5169323|NCT01317199|17849121|P3|Randomized Phase 2|Disenrolled before treatment|1
5169324|NCT01317199|17849122|P2|Randomized Phase 2|Disenrolled before treatment|1
5169325|NCT01317199|17849123|P1|Randomized Phase 2|Disenrolled before treatment|0
5169326|NCT01317199|17849120|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
5169327|NCT01317199|17849121|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
5169328|NCT01317199|17849122|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
5169329|NCT01317199|17849123|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
5169330|NCT01317199|17849120|P4|Randomized Phase 2|Comorbidities|2
5169331|NCT01317199|17849121|P3|Randomized Phase 2|Comorbidities|2
5169332|NCT01317199|17849122|P2|Randomized Phase 2|Comorbidities|2
5169333|NCT01317199|17849123|P1|Randomized Phase 2|Comorbidities|0
5169334|NCT01317199|17849120|P4|Randomized Phase 2|Adverse Event|1
5169335|NCT01317199|17849121|P3|Randomized Phase 2|Adverse Event|0
5169336|NCT01317199|17849122|P2|Randomized Phase 2|Adverse Event|0
5169337|NCT01317199|17849123|P1|Randomized Phase 2|Adverse Event|0
5169338|NCT01317199|17849120|P4|Randomized Phase 2|Withdrawal by Subject|4
5169339|NCT01317199|17849121|P3|Randomized Phase 2|Withdrawal by Subject|5
5169340|NCT01317199|17849122|P2|Randomized Phase 2|Withdrawal by Subject|3
5169341|NCT01317199|17849123|P1|Randomized Phase 2|Withdrawal by Subject|0
5169342|NCT01317199|17849120|P4|Randomized Phase 2|Disease progression|5
5169343|NCT01317199|17849121|P3|Randomized Phase 2|Disease progression|7
5169344|NCT01317199|17849122|P2|Randomized Phase 2|Disease progression|3
5169345|NCT01317199|17849123|P1|Randomized Phase 2|Disease progression|0
5169346|NCT01317199|17849120|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5169347|NCT01317199|17849121|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5169348|NCT01317199|17849122|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5169349|NCT01317199|17849123|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
5169350|NCT01317199|17849120|P4|Dose-escalation Phase 1|Disease progression|0
5169351|NCT01317199|17849121|P3|Dose-escalation Phase 1|Disease progression|0
5169352|NCT01317199|17849122|P2|Dose-escalation Phase 1|Disease progression|0
5169353|NCT01317199|17849123|P1|Dose-escalation Phase 1|Disease progression|1
5169354|NCT01317199|17849120|P4|Dose-escalation Phase 1|Physician Decision|0
5169355|NCT01317199|17849121|P3|Dose-escalation Phase 1|Physician Decision|0
5169356|NCT01317199|17849122|P2|Dose-escalation Phase 1|Physician Decision|0
5169357|NCT01317199|17849123|P1|Dose-escalation Phase 1|Physician Decision|5
5169358|NCT01317160|17849152|P2|Overall Study|Withdrawal by Subject|2
5169359|NCT01317160|17849153|P1|Overall Study|Withdrawal by Subject|0
5169360|NCT01317160|17849152|P2|Overall Study|Lost to Follow-up|3
5169361|NCT01317160|17849153|P1|Overall Study|Lost to Follow-up|3
5169362|NCT01317160|17849152|P2|Overall Study|Incorrect inclusion|1
5169363|NCT01317160|17849153|P1|Overall Study|Incorrect inclusion|1
5169364|NCT01317004|17849187|P2|Overall Study|Adverse Event|3
5169365|NCT01317004|17849188|P1|Overall Study|Adverse Event|3
5169366|NCT01317004|17849187|P2|Overall Study|Protocol Violation|2
5169367|NCT01317004|17849188|P1|Overall Study|Protocol Violation|0
5169368|NCT01317004|17849187|P2|Overall Study|Withdrawal by Subject|4
5169369|NCT01317004|17849188|P1|Overall Study|Withdrawal by Subject|1
5169370|NCT01316939|17849209|P3|Overall Study|Protocol Violation|0
5169371|NCT01316939|17849210|P2|Overall Study|Protocol Violation|1
5169372|NCT01316939|17849211|P1|Overall Study|Protocol Violation|0
5169373|NCT01316939|17849209|P3|Overall Study|Met Liver chemistry stopping criteria|1
5169374|NCT01316939|17849210|P2|Overall Study|Met Liver chemistry stopping criteria|0
5169375|NCT01316939|17849211|P1|Overall Study|Met Liver chemistry stopping criteria|1
5169376|NCT01316939|17849209|P3|Overall Study|Lost to Follow-up|2
5169377|NCT01316939|17849210|P2|Overall Study|Lost to Follow-up|0
5169378|NCT01316939|17849211|P1|Overall Study|Lost to Follow-up|0
5169379|NCT01316939|17849209|P3|Overall Study|Physician Decision|1
5169380|NCT01316939|17849210|P2|Overall Study|Physician Decision|2
5169381|NCT01316939|17849211|P1|Overall Study|Physician Decision|2
5169382|NCT01316939|17849209|P3|Overall Study|Withdrawal by Subject|6
5169383|NCT01316939|17849210|P2|Overall Study|Withdrawal by Subject|3
5169384|NCT01316939|17849211|P1|Overall Study|Withdrawal by Subject|1
5169385|NCT01316939|17849209|P3|Overall Study|Adverse Event|11
5169386|NCT01316939|17849210|P2|Overall Study|Adverse Event|12
5169387|NCT01316939|17849211|P1|Overall Study|Adverse Event|9
5169388|NCT01316939|17849209|P3|Overall Study|Lack of Efficacy|25
5169389|NCT01316939|17849210|P2|Overall Study|Lack of Efficacy|25
5169390|NCT01316939|17849211|P1|Overall Study|Lack of Efficacy|24
5169391|NCT01316939|17849209|P3|Overall Study|Study closed/terminated|23
5169392|NCT01316939|17849210|P2|Overall Study|Study closed/terminated|25
5169393|NCT01316939|17849211|P1|Overall Study|Study closed/terminated|26
5169394|NCT01316913|17849306|P4|Overall Study|Withdrawal by Subject|6
5169395|NCT01316913|17849307|P3|Overall Study|Withdrawal by Subject|10
5169396|NCT01316913|17849308|P2|Overall Study|Withdrawal by Subject|9
5169397|NCT01316913|17849309|P1|Overall Study|Withdrawal by Subject|10
5169398|NCT01316913|17849306|P4|Overall Study|Lost to Follow-up|2
5169399|NCT01316913|17849307|P3|Overall Study|Lost to Follow-up|0
5169400|NCT01316913|17849308|P2|Overall Study|Lost to Follow-up|1
5169401|NCT01316913|17849309|P1|Overall Study|Lost to Follow-up|0
5169402|NCT01316913|17849306|P4|Overall Study|Protocol-defined Stopping Criteria|6
5169403|NCT01316913|17849307|P3|Overall Study|Protocol-defined Stopping Criteria|11
5169404|NCT01316913|17849308|P2|Overall Study|Protocol-defined Stopping Criteria|8
5169405|NCT01316913|17849309|P1|Overall Study|Protocol-defined Stopping Criteria|7
5169406|NCT01316913|17849306|P4|Overall Study|Protocol Violation|1
5169407|NCT01316913|17849307|P3|Overall Study|Protocol Violation|4
5169408|NCT01316913|17849308|P2|Overall Study|Protocol Violation|4
5169409|NCT01316913|17849309|P1|Overall Study|Protocol Violation|1
5169410|NCT01316913|17849306|P4|Overall Study|Lack of Efficacy|13
5169411|NCT01316913|17849307|P3|Overall Study|Lack of Efficacy|9
5169412|NCT01316913|17849308|P2|Overall Study|Lack of Efficacy|12
5169413|NCT01316913|17849309|P1|Overall Study|Lack of Efficacy|22
5169414|NCT01316913|17849306|P4|Overall Study|Adverse Event|11
5169415|NCT01316913|17849307|P3|Overall Study|Adverse Event|15
5169416|NCT01316913|17849308|P2|Overall Study|Adverse Event|20
5169417|NCT01316913|17849309|P1|Overall Study|Adverse Event|17
5169418|NCT01316900|17849331|P4|Overall Study|Withdrawal by Subject|9
5169419|NCT01316900|17849332|P3|Overall Study|Withdrawal by Subject|6
5169420|NCT01316900|17849333|P2|Overall Study|Withdrawal by Subject|8
5169421|NCT01316900|17849334|P1|Overall Study|Withdrawal by Subject|7
5169422|NCT01316900|17849331|P4|Overall Study|Lost to Follow-up|1
5169423|NCT01316900|17849332|P3|Overall Study|Lost to Follow-up|1
5169424|NCT01316900|17849333|P2|Overall Study|Lost to Follow-up|0
5169425|NCT01316900|17849334|P1|Overall Study|Lost to Follow-up|1
5169426|NCT01316900|17849331|P4|Overall Study|Protocol-defined Stopping Criteria|5
5169427|NCT01316900|17849332|P3|Overall Study|Protocol-defined Stopping Criteria|10
5169428|NCT01316900|17849333|P2|Overall Study|Protocol-defined Stopping Criteria|3
5169429|NCT01316900|17849334|P1|Overall Study|Protocol-defined Stopping Criteria|2
5169430|NCT01316900|17849331|P4|Overall Study|Protocol Violation|0
5169431|NCT01316900|17849332|P3|Overall Study|Protocol Violation|4
5169432|NCT01316900|17849333|P2|Overall Study|Protocol Violation|1
5169433|NCT01316900|17849334|P1|Overall Study|Protocol Violation|7
5169434|NCT01316900|17849331|P4|Overall Study|Lack of Efficacy|7
5169435|NCT01316900|17849332|P3|Overall Study|Lack of Efficacy|5
5169436|NCT01316900|17849333|P2|Overall Study|Lack of Efficacy|9
5169437|NCT01316900|17849334|P1|Overall Study|Lack of Efficacy|17
5169438|NCT01316900|17849331|P4|Overall Study|Adverse Event|9
5169439|NCT01316900|17849332|P3|Overall Study|Adverse Event|15
5169440|NCT01316900|17849333|P2|Overall Study|Adverse Event|10
5169441|NCT01316900|17849334|P1|Overall Study|Adverse Event|10
5169442|NCT01316887|17849355|P3|Overall Study|Withdrawal by Subject|15
5169443|NCT01316887|17849356|P2|Overall Study|Withdrawal by Subject|16
5169444|NCT01316887|17849357|P1|Overall Study|Withdrawal by Subject|8
5169445|NCT01316887|17849355|P3|Overall Study|Lost to Follow-up|5
5169446|NCT01316887|17849356|P2|Overall Study|Lost to Follow-up|7
5169447|NCT01316887|17849357|P1|Overall Study|Lost to Follow-up|1
5169448|NCT01316887|17849355|P3|Overall Study|Study Closed/Terminated|3
5169449|NCT01316887|17849356|P2|Overall Study|Study Closed/Terminated|4
5169450|NCT01316887|17849357|P1|Overall Study|Study Closed/Terminated|2
5169451|NCT01316887|17849355|P3|Overall Study|Protocol-defined Stopping Criteria|36
5169452|NCT01316887|17849356|P2|Overall Study|Protocol-defined Stopping Criteria|37
5169453|NCT01316887|17849357|P1|Overall Study|Protocol-defined Stopping Criteria|8
5169454|NCT01316887|17849355|P3|Overall Study|Protocol Violation|6
5169455|NCT01316887|17849356|P2|Overall Study|Protocol Violation|6
5169456|NCT01316887|17849357|P1|Overall Study|Protocol Violation|2
5169457|NCT01316887|17849355|P3|Overall Study|Lack of Efficacy|1
5169458|NCT01316887|17849356|P2|Overall Study|Lack of Efficacy|3
5169459|NCT01316887|17849357|P1|Overall Study|Lack of Efficacy|9
5169460|NCT01316887|17849355|P3|Overall Study|Adverse Event|17
5169461|NCT01316887|17849356|P2|Overall Study|Adverse Event|21
5169462|NCT01316887|17849357|P1|Overall Study|Adverse Event|13
5169463|NCT01316692|17849482|P1|Overall Study|Disease Progression|7
5169464|NCT01316692|17849482|P1|Overall Study|Adverse Event|5
5169465|NCT01316614|17849491|P1|Overall Study|Medically unstable|1
5169466|NCT01316614|17849491|P1|Overall Study|Inadequate number of passes|2
5169467|NCT01316614|17849491|P1|Overall Study|Cystic lesion|5
5169468|NCT01316614|17849491|P1|Overall Study|Cytology slides not available for review|4
5169469|NCT01316614|17849491|P1|Overall Study|No solid lesion and FNA not indicated|25
5169470|NCT01316575|17849508|P2|Overall Study|Required alternate treatment|1
5169471|NCT01316575|17849509|P1|Overall Study|Required alternate treatment|0
5169472|NCT01316575|17849508|P2|Overall Study|Withdrawal by Subject|0
5169473|NCT01316575|17849509|P1|Overall Study|Withdrawal by Subject|2
5169474|NCT01316419|17849532|P1|Overall Study|Lost to Follow-up|19
5169475|NCT01316419|17849532|P1|Overall Study|Violated inclusion/exclusion criterion|143
5169476|NCT01316419|17849532|P1|Overall Study|Not treated|103
5169477|NCT01316380|17849558|P3|Overall Study|Not treated|0
5169478|NCT01316380|17849559|P2|Overall Study|Not treated|0
5169479|NCT01316380|17849560|P1|Overall Study|Not treated|1
5169480|NCT01316380|17849558|P3|Overall Study|Other|1
5169481|NCT01316380|17849559|P2|Overall Study|Other|1
5169482|NCT01316380|17849560|P1|Overall Study|Other|0
5169483|NCT01316380|17849558|P3|Overall Study|Withdrawal by Subject|0
5169484|NCT01316380|17849559|P2|Overall Study|Withdrawal by Subject|2
5169485|NCT01316380|17849560|P1|Overall Study|Withdrawal by Subject|1
5169486|NCT01316380|17849558|P3|Overall Study|Protocol Violation|1
5169487|NCT01316380|17849559|P2|Overall Study|Protocol Violation|0
5169488|NCT01316380|17849560|P1|Overall Study|Protocol Violation|0
5169489|NCT01316380|17849558|P3|Overall Study|Adverse Event|1
5169490|NCT01316380|17849559|P2|Overall Study|Adverse Event|2
5169491|NCT01316380|17849560|P1|Overall Study|Adverse Event|0
5169492|NCT01316276|17849697|P1|Overall Study|Other|22
5169493|NCT01316276|17849697|P1|Overall Study|Lost to Follow-up|1
5169494|NCT01316276|17849697|P1|Overall Study|Withdrawal of consent|24
5169495|NCT01316276|17849697|P1|Overall Study|Adverse Event|19
5169496|NCT01316276|17849697|P1|Overall Study|Death|1
5169497|NCT01316224|17849745|P1|Overall Study|Other|1
5169498|NCT01316224|17849745|P1|Overall Study|Adverse Event With Treatment Failure|1
5169499|NCT01316224|17849745|P1|Overall Study|Withdrawal by Subject|1
5169500|NCT01316224|17849745|P1|Overall Study|Lack of Efficacy|1
5169501|NCT01316224|17849745|P1|Overall Study|Adverse Event|3
5169502|NCT01316224|17849745|P1|Overall Study|Protocol Violation|3
5169503|NCT01316055|17849798|P3|Overall Study|Lost to Follow-up|0
5169504|NCT01316055|17849799|P2|Overall Study|Lost to Follow-up|0
5169505|NCT01316055|17849800|P1|Overall Study|Lost to Follow-up|1
5169506|NCT01315847|17849831|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
5169507|NCT01315847|17849832|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
5169508|NCT01315847|17849831|P2|Part I, Period 1|Reached maximum number of arterial lines|0
5169509|NCT01315847|17849832|P1|Part I, Period 1|Reached maximum number of arterial lines|3
5169510|NCT01315678|17849846|P2|Overall Study|similar reason to those listed above|2
5169511|NCT01315678|17849847|P1|Overall Study|similar reason to those listed above|3
5169512|NCT01315678|17849846|P2|Overall Study|Lost to Follow-up|0
5169513|NCT01315678|17849847|P1|Overall Study|Lost to Follow-up|1
5169514|NCT01315678|17849846|P2|Overall Study|Adverse Event|1
5169515|NCT01315678|17849847|P1|Overall Study|Adverse Event|3
5169516|NCT01315678|17849846|P2|Overall Study|Withdrawal by Subject|3
5169517|NCT01315678|17849847|P1|Overall Study|Withdrawal by Subject|7
5169518|NCT01315353|17849898|P3|Overall Study|Inadvertent randomization/assignment|2
5169519|NCT01315353|17849899|P2|Overall Study|Inadvertent randomization/assignment|0
5169520|NCT01315353|17849900|P1|Overall Study|Inadvertent randomization/assignment|0
5169521|NCT01315353|17849898|P3|Overall Study|Taken off study by site in error|0
5169522|NCT01315353|17849899|P2|Overall Study|Taken off study by site in error|1
5169523|NCT01315353|17849900|P1|Overall Study|Taken off study by site in error|0
5169524|NCT01315353|17849898|P3|Overall Study|Site closing|0
5169525|NCT01315353|17849899|P2|Overall Study|Site closing|4
5169526|NCT01315353|17849900|P1|Overall Study|Site closing|7
5169527|NCT01315353|17849898|P3|Overall Study|Unwilling to adhere to requirements|4
5169528|NCT01315353|17849899|P2|Overall Study|Unwilling to adhere to requirements|5
5169529|NCT01315353|17849900|P1|Overall Study|Unwilling to adhere to requirements|5
5169530|NCT01315353|17849898|P3|Overall Study|Lost to Follow-up|6
5169531|NCT01315353|17849899|P2|Overall Study|Lost to Follow-up|6
5169532|NCT01315353|17849900|P1|Overall Study|Lost to Follow-up|13
5169533|NCT01315353|17849898|P3|Overall Study|Withdrawal by Subject|1
5169534|NCT01315353|17849899|P2|Overall Study|Withdrawal by Subject|6
5169535|NCT01315353|17849900|P1|Overall Study|Withdrawal by Subject|2
5169536|NCT01315353|17849898|P3|Overall Study|Death|0
5169537|NCT01315353|17849899|P2|Overall Study|Death|1
5169538|NCT01315353|17849900|P1|Overall Study|Death|2
5169539|NCT01315249|17849927|P2|Overall Study|Death|1
5169540|NCT01315249|17849928|P1|Overall Study|Death|0
5169541|NCT01315249|17849927|P2|Overall Study|Lost to Follow-up|2
5169542|NCT01315249|17849928|P1|Overall Study|Lost to Follow-up|0
5169543|NCT01315249|17849927|P2|Overall Study|Lack of Efficacy|1
5169544|NCT01315249|17849928|P1|Overall Study|Lack of Efficacy|0
5169545|NCT01315249|17849927|P2|Overall Study|inability to use device|0
5169546|NCT01315249|17849928|P1|Overall Study|inability to use device|1
5169547|NCT01315249|17849927|P2|Overall Study|Administrative problems|0
5169548|NCT01315249|17849928|P1|Overall Study|Administrative problems|1
5169549|NCT01315249|17849927|P2|Overall Study|Abnormal test results|2
5169550|NCT01315249|17849928|P1|Overall Study|Abnormal test results|1
5169551|NCT01315249|17849927|P2|Overall Study|Protocol Violation|5
5169552|NCT01315249|17849928|P1|Overall Study|Protocol Violation|8
5169553|NCT01315249|17849927|P2|Overall Study|Withdrawal by Subject|10
5169554|NCT01315249|17849928|P1|Overall Study|Withdrawal by Subject|11
5169555|NCT01315249|17849927|P2|Overall Study|Adverse Event|26
5169556|NCT01315249|17849928|P1|Overall Study|Adverse Event|22
5169557|NCT01315236|17849956|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
5169558|NCT01315236|17849957|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
5169559|NCT01315236|17849956|P2|12-Month Follow-up Period|Death|1
5169560|NCT01315236|17849957|P1|12-Month Follow-up Period|Death|0
5169561|NCT01315236|17849956|P2|Open-label Phase|Other|1
5169562|NCT01315236|17849957|P1|Open-label Phase|Other|0
5169563|NCT01315236|17849956|P2|Open-label Phase|Adverse Event|1
5169564|NCT01315236|17849957|P1|Open-label Phase|Adverse Event|0
5169565|NCT01315236|17849956|P2|Open-label Phase|Death|0
5169566|NCT01315236|17849957|P1|Open-label Phase|Death|1
5169567|NCT01315236|17849956|P2|Double-blind Phase|Lost to Follow-up|0
5169568|NCT01315236|17849957|P1|Double-blind Phase|Lost to Follow-up|1
5169569|NCT01315236|17849956|P2|Double-blind Phase|Withdrawal of Consent|0
5169570|NCT01315236|17849957|P1|Double-blind Phase|Withdrawal of Consent|1
5169571|NCT01315236|17849956|P2|Double-blind Phase|Adverse Event|0
5169572|NCT01315236|17849957|P1|Double-blind Phase|Adverse Event|1
5169573|NCT01315236|17849956|P2|Double-blind Phase|Death|0
5169574|NCT01315236|17849957|P1|Double-blind Phase|Death|1
5169575|NCT01315132|17850013|P1|Overall Study|not treated due to disease progression|1
5169576|NCT01315028|17850020|P2|Overall Study|Death|1
5169577|NCT01315028|17850021|P1|Overall Study|Death|0
5169578|NCT01315028|17850020|P2|Overall Study|Lost to Follow-up|0
5169579|NCT01315028|17850021|P1|Overall Study|Lost to Follow-up|1
5169580|NCT01314911|17850048|P2|Overall Study|Never Started Treatment|0
5169581|NCT01314911|17850049|P1|Overall Study|Never Started Treatment|1
5169582|NCT01314911|17850048|P2|Overall Study|Received Non-randomized Study Drug|1
5169583|NCT01314911|17850049|P1|Overall Study|Received Non-randomized Study Drug|0
5169584|NCT01314911|17850048|P2|Overall Study|Withdrawal by Subject|3
5169585|NCT01314911|17850049|P1|Overall Study|Withdrawal by Subject|1
5169586|NCT01314911|17850048|P2|Overall Study|Lost to Follow-up|2
5169587|NCT01314911|17850049|P1|Overall Study|Lost to Follow-up|3
5169588|NCT01314872|17850100|P15|Period 2|Lost to Follow-up|6
5169589|NCT01314872|17850101|P14|Period 2|Lost to Follow-up|2
5169590|NCT01314872|17850102|P13|Period 2|Lost to Follow-up|7
5169591|NCT01314872|17850103|P12|Period 2|Lost to Follow-up|6
5169592|NCT01314872|17850104|P11|Period 2|Lost to Follow-up|0
5169593|NCT01314872|17850105|P10|Period 2|Lost to Follow-up|0
5169594|NCT01314872|17850106|P9|Period 2|Lost to Follow-up|0
5169595|NCT01314872|17850107|P8|Period 2|Lost to Follow-up|0
5169596|NCT01314872|17850108|P7|Period 2|Lost to Follow-up|0
5169597|NCT01314872|17850109|P6|Period 2|Lost to Follow-up|0
5169598|NCT01314872|17850110|P5|Period 2|Lost to Follow-up|0
5169599|NCT01314872|17850111|P4|Period 2|Lost to Follow-up|0
5169600|NCT01314872|17850112|P3|Period 2|Lost to Follow-up|0
5169601|NCT01314872|17850113|P2|Period 2|Lost to Follow-up|0
5169602|NCT01314872|17850114|P1|Period 2|Lost to Follow-up|0
5169603|NCT01314872|17850100|P15|Period 2|Withdrawal by Subject|4
5169604|NCT01314872|17850101|P14|Period 2|Withdrawal by Subject|12
5169605|NCT01314872|17850102|P13|Period 2|Withdrawal by Subject|17
5169606|NCT01314872|17850103|P12|Period 2|Withdrawal by Subject|14
5169607|NCT01314872|17850104|P11|Period 2|Withdrawal by Subject|0
5169608|NCT01314872|17850105|P10|Period 2|Withdrawal by Subject|0
5169609|NCT01314872|17850106|P9|Period 2|Withdrawal by Subject|0
5169610|NCT01314872|17850107|P8|Period 2|Withdrawal by Subject|0
5169611|NCT01314872|17850108|P7|Period 2|Withdrawal by Subject|0
5169612|NCT01314872|17850109|P6|Period 2|Withdrawal by Subject|0
5169613|NCT01314872|17850110|P5|Period 2|Withdrawal by Subject|0
5169614|NCT01314872|17850111|P4|Period 2|Withdrawal by Subject|0
5169615|NCT01314872|17850112|P3|Period 2|Withdrawal by Subject|0
5169616|NCT01314872|17850113|P2|Period 2|Withdrawal by Subject|0
5169617|NCT01314872|17850114|P1|Period 2|Withdrawal by Subject|0
5169618|NCT01314872|17850100|P15|Period 2|Adverse event, non-fatal|9
5169619|NCT01314872|17850101|P14|Period 2|Adverse event, non-fatal|24
5169620|NCT01314872|17850102|P13|Period 2|Adverse event, non-fatal|16
5169621|NCT01314872|17850103|P12|Period 2|Adverse event, non-fatal|13
5169622|NCT01314872|17850104|P11|Period 2|Adverse event, non-fatal|0
5169623|NCT01314872|17850105|P10|Period 2|Adverse event, non-fatal|0
5169624|NCT01314872|17850106|P9|Period 2|Adverse event, non-fatal|0
5169625|NCT01314872|17850107|P8|Period 2|Adverse event, non-fatal|0
5169626|NCT01314872|17850108|P7|Period 2|Adverse event, non-fatal|0
5169627|NCT01314872|17850109|P6|Period 2|Adverse event, non-fatal|0
5169628|NCT01314872|17850110|P5|Period 2|Adverse event, non-fatal|0
5169629|NCT01314872|17850111|P4|Period 2|Adverse event, non-fatal|0
5169630|NCT01314872|17850112|P3|Period 2|Adverse event, non-fatal|0
5169631|NCT01314872|17850113|P2|Period 2|Adverse event, non-fatal|0
5169632|NCT01314872|17850114|P1|Period 2|Adverse event, non-fatal|0
5169633|NCT01314872|17850100|P15|Period 2|Study terminated by Sponsor|0
5169634|NCT01314872|17850101|P14|Period 2|Study terminated by Sponsor|3
5169635|NCT01314872|17850102|P13|Period 2|Study terminated by Sponsor|2
5169636|NCT01314872|17850103|P12|Period 2|Study terminated by Sponsor|2
5169637|NCT01314872|17850104|P11|Period 2|Study terminated by Sponsor|0
5169638|NCT01314872|17850105|P10|Period 2|Study terminated by Sponsor|0
5169639|NCT01314872|17850106|P9|Period 2|Study terminated by Sponsor|0
5169640|NCT01314872|17850107|P8|Period 2|Study terminated by Sponsor|0
5169641|NCT01314872|17850108|P7|Period 2|Study terminated by Sponsor|0
5169642|NCT01314872|17850109|P6|Period 2|Study terminated by Sponsor|0
5169643|NCT01314872|17850110|P5|Period 2|Study terminated by Sponsor|0
5169644|NCT01314872|17850111|P4|Period 2|Study terminated by Sponsor|0
5169645|NCT01314872|17850112|P3|Period 2|Study terminated by Sponsor|0
5169646|NCT01314872|17850113|P2|Period 2|Study terminated by Sponsor|0
5169647|NCT01314872|17850114|P1|Period 2|Study terminated by Sponsor|0
5169648|NCT01314872|17850100|P15|Period 2|Pregnancy|1
5169649|NCT01314872|17850101|P14|Period 2|Pregnancy|0
5169650|NCT01314872|17850102|P13|Period 2|Pregnancy|0
5169651|NCT01314872|17850103|P12|Period 2|Pregnancy|0
5169652|NCT01314872|17850104|P11|Period 2|Pregnancy|0
5169653|NCT01314872|17850105|P10|Period 2|Pregnancy|0
5169654|NCT01314872|17850106|P9|Period 2|Pregnancy|0
5169655|NCT01314872|17850107|P8|Period 2|Pregnancy|0
5169656|NCT01314872|17850108|P7|Period 2|Pregnancy|0
5169657|NCT01314872|17850109|P6|Period 2|Pregnancy|0
5169658|NCT01314872|17850110|P5|Period 2|Pregnancy|0
5169659|NCT01314872|17850111|P4|Period 2|Pregnancy|0
5169660|NCT01314872|17850112|P3|Period 2|Pregnancy|0
5169661|NCT01314872|17850113|P2|Period 2|Pregnancy|0
5169662|NCT01314872|17850114|P1|Period 2|Pregnancy|0
5169663|NCT01314872|17850100|P15|Period 2|Lack of Efficacy|2
5169664|NCT01314872|17850101|P14|Period 2|Lack of Efficacy|9
5169665|NCT01314872|17850102|P13|Period 2|Lack of Efficacy|12
5169666|NCT01314872|17850103|P12|Period 2|Lack of Efficacy|7
5169667|NCT01314872|17850104|P11|Period 2|Lack of Efficacy|0
5169668|NCT01314872|17850105|P10|Period 2|Lack of Efficacy|0
5169669|NCT01314872|17850106|P9|Period 2|Lack of Efficacy|0
5169670|NCT01314872|17850107|P8|Period 2|Lack of Efficacy|0
5169671|NCT01314872|17850108|P7|Period 2|Lack of Efficacy|0
5169672|NCT01314872|17850109|P6|Period 2|Lack of Efficacy|0
5169673|NCT01314872|17850110|P5|Period 2|Lack of Efficacy|0
5169674|NCT01314872|17850111|P4|Period 2|Lack of Efficacy|0
5169675|NCT01314872|17850112|P3|Period 2|Lack of Efficacy|0
5169676|NCT01314872|17850113|P2|Period 2|Lack of Efficacy|0
5169677|NCT01314872|17850114|P1|Period 2|Lack of Efficacy|0
5169678|NCT01314872|17850100|P15|Period 2|Non-compliance with study drug|2
5169679|NCT01314872|17850101|P14|Period 2|Non-compliance with study drug|1
5169680|NCT01314872|17850102|P13|Period 2|Non-compliance with study drug|3
5169681|NCT01314872|17850103|P12|Period 2|Non-compliance with study drug|3
5169682|NCT01314872|17850104|P11|Period 2|Non-compliance with study drug|0
5169683|NCT01314872|17850105|P10|Period 2|Non-compliance with study drug|0
5169684|NCT01314872|17850106|P9|Period 2|Non-compliance with study drug|0
5169685|NCT01314872|17850107|P8|Period 2|Non-compliance with study drug|0
5169686|NCT01314872|17850108|P7|Period 2|Non-compliance with study drug|0
5169687|NCT01314872|17850109|P6|Period 2|Non-compliance with study drug|0
5169688|NCT01314872|17850110|P5|Period 2|Non-compliance with study drug|0
5169689|NCT01314872|17850111|P4|Period 2|Non-compliance with study drug|0
5169690|NCT01314872|17850112|P3|Period 2|Non-compliance with study drug|0
5169691|NCT01314872|17850113|P2|Period 2|Non-compliance with study drug|0
5169692|NCT01314872|17850114|P1|Period 2|Non-compliance with study drug|0
5169693|NCT01314872|17850100|P15|Period 2|Protocol Violation|0
5169694|NCT01314872|17850101|P14|Period 2|Protocol Violation|2
5169695|NCT01314872|17850102|P13|Period 2|Protocol Violation|3
5169696|NCT01314872|17850103|P12|Period 2|Protocol Violation|3
5169697|NCT01314872|17850104|P11|Period 2|Protocol Violation|0
5169698|NCT01314872|17850105|P10|Period 2|Protocol Violation|0
5169699|NCT01314872|17850106|P9|Period 2|Protocol Violation|0
5169700|NCT01314872|17850107|P8|Period 2|Protocol Violation|0
5169701|NCT01314872|17850108|P7|Period 2|Protocol Violation|0
5169702|NCT01314872|17850109|P6|Period 2|Protocol Violation|0
5169703|NCT01314872|17850110|P5|Period 2|Protocol Violation|0
5169704|NCT01314872|17850111|P4|Period 2|Protocol Violation|0
5169705|NCT01314872|17850112|P3|Period 2|Protocol Violation|0
5169706|NCT01314872|17850113|P2|Period 2|Protocol Violation|0
5169707|NCT01314872|17850114|P1|Period 2|Protocol Violation|0
5169708|NCT01314872|17850100|P15|Treatment Period 1|Lost to Follow-up|0
5169709|NCT01314872|17850101|P14|Treatment Period 1|Lost to Follow-up|0
5169710|NCT01314872|17850102|P13|Treatment Period 1|Lost to Follow-up|0
5169711|NCT01314872|17850103|P12|Treatment Period 1|Lost to Follow-up|0
5169712|NCT01314872|17850104|P11|Treatment Period 1|Lost to Follow-up|0
5169713|NCT01314872|17850105|P10|Treatment Period 1|Lost to Follow-up|0
5169714|NCT01314872|17850106|P9|Treatment Period 1|Lost to Follow-up|1
5169715|NCT01314872|17850107|P8|Treatment Period 1|Lost to Follow-up|1
5169716|NCT01314872|17850108|P7|Treatment Period 1|Lost to Follow-up|1
5169717|NCT01314872|17850109|P6|Treatment Period 1|Lost to Follow-up|1
5169718|NCT01314872|17850110|P5|Treatment Period 1|Lost to Follow-up|1
5169719|NCT01314872|17850111|P4|Treatment Period 1|Lost to Follow-up|2
5169720|NCT01314872|17850112|P3|Treatment Period 1|Lost to Follow-up|2
5169721|NCT01314872|17850113|P2|Treatment Period 1|Lost to Follow-up|1
5169722|NCT01314872|17850114|P1|Treatment Period 1|Lost to Follow-up|0
5169723|NCT01314872|17850100|P15|Treatment Period 1|Withdrawal by Subject|0
5169724|NCT01314872|17850101|P14|Treatment Period 1|Withdrawal by Subject|0
5169725|NCT01314872|17850102|P13|Treatment Period 1|Withdrawal by Subject|0
5169726|NCT01314872|17850103|P12|Treatment Period 1|Withdrawal by Subject|0
5169727|NCT01314872|17850104|P11|Treatment Period 1|Withdrawal by Subject|1
5169728|NCT01314872|17850105|P10|Treatment Period 1|Withdrawal by Subject|2
5169729|NCT01314872|17850106|P9|Treatment Period 1|Withdrawal by Subject|2
5169730|NCT01314872|17850107|P8|Treatment Period 1|Withdrawal by Subject|2
5169731|NCT01314872|17850108|P7|Treatment Period 1|Withdrawal by Subject|3
5169732|NCT01314872|17850109|P6|Treatment Period 1|Withdrawal by Subject|1
5169733|NCT01314872|17850110|P5|Treatment Period 1|Withdrawal by Subject|3
5169734|NCT01314872|17850111|P4|Treatment Period 1|Withdrawal by Subject|2
5169735|NCT01314872|17850112|P3|Treatment Period 1|Withdrawal by Subject|0
5169736|NCT01314872|17850113|P2|Treatment Period 1|Withdrawal by Subject|1
5169737|NCT01314872|17850114|P1|Treatment Period 1|Withdrawal by Subject|3
5169738|NCT01314872|17850100|P15|Treatment Period 1|Adverse event, non-fatal|0
5169739|NCT01314872|17850101|P14|Treatment Period 1|Adverse event, non-fatal|0
5169740|NCT01314872|17850102|P13|Treatment Period 1|Adverse event, non-fatal|0
5169741|NCT01314872|17850103|P12|Treatment Period 1|Adverse event, non-fatal|0
5169742|NCT01314872|17850104|P11|Treatment Period 1|Adverse event, non-fatal|1
5169743|NCT01314872|17850105|P10|Treatment Period 1|Adverse event, non-fatal|0
5169744|NCT01314872|17850106|P9|Treatment Period 1|Adverse event, non-fatal|3
5169745|NCT01314872|17850107|P8|Treatment Period 1|Adverse event, non-fatal|2
5169746|NCT01314872|17850108|P7|Treatment Period 1|Adverse event, non-fatal|4
5169747|NCT01314872|17850109|P6|Treatment Period 1|Adverse event, non-fatal|4
5169748|NCT01314872|17850110|P5|Treatment Period 1|Adverse event, non-fatal|2
5169749|NCT01314872|17850111|P4|Treatment Period 1|Adverse event, non-fatal|2
5169750|NCT01314872|17850112|P3|Treatment Period 1|Adverse event, non-fatal|3
5169751|NCT01314872|17850113|P2|Treatment Period 1|Adverse event, non-fatal|2
5169752|NCT01314872|17850114|P1|Treatment Period 1|Adverse event, non-fatal|4
5169753|NCT01314872|17850100|P15|Treatment Period 1|Lack of Efficacy|0
5169754|NCT01314872|17850101|P14|Treatment Period 1|Lack of Efficacy|0
5169755|NCT01314872|17850102|P13|Treatment Period 1|Lack of Efficacy|0
5169756|NCT01314872|17850103|P12|Treatment Period 1|Lack of Efficacy|0
5169757|NCT01314872|17850104|P11|Treatment Period 1|Lack of Efficacy|0
5169758|NCT01314872|17850105|P10|Treatment Period 1|Lack of Efficacy|0
5169759|NCT01314872|17850106|P9|Treatment Period 1|Lack of Efficacy|0
5169760|NCT01314872|17850107|P8|Treatment Period 1|Lack of Efficacy|2
5169761|NCT01314872|17850108|P7|Treatment Period 1|Lack of Efficacy|0
5169762|NCT01314872|17850109|P6|Treatment Period 1|Lack of Efficacy|1
5169763|NCT01314872|17850110|P5|Treatment Period 1|Lack of Efficacy|0
5169764|NCT01314872|17850111|P4|Treatment Period 1|Lack of Efficacy|0
5169765|NCT01314872|17850112|P3|Treatment Period 1|Lack of Efficacy|0
5169766|NCT01314872|17850113|P2|Treatment Period 1|Lack of Efficacy|0
5169767|NCT01314872|17850114|P1|Treatment Period 1|Lack of Efficacy|1
5169768|NCT01314872|17850100|P15|Treatment Period 1|Physician Decision|0
5169769|NCT01314872|17850101|P14|Treatment Period 1|Physician Decision|0
5169770|NCT01314872|17850102|P13|Treatment Period 1|Physician Decision|0
5169771|NCT01314872|17850103|P12|Treatment Period 1|Physician Decision|0
5169772|NCT01314872|17850104|P11|Treatment Period 1|Physician Decision|0
5169773|NCT01314872|17850105|P10|Treatment Period 1|Physician Decision|1
5169774|NCT01314872|17850106|P9|Treatment Period 1|Physician Decision|0
5169775|NCT01314872|17850107|P8|Treatment Period 1|Physician Decision|0
5169776|NCT01314872|17850108|P7|Treatment Period 1|Physician Decision|0
5169777|NCT01314872|17850109|P6|Treatment Period 1|Physician Decision|0
5169778|NCT01314872|17850110|P5|Treatment Period 1|Physician Decision|0
5169779|NCT01314872|17850111|P4|Treatment Period 1|Physician Decision|1
5169780|NCT01314872|17850112|P3|Treatment Period 1|Physician Decision|0
5169781|NCT01314872|17850113|P2|Treatment Period 1|Physician Decision|1
5169782|NCT01314872|17850114|P1|Treatment Period 1|Physician Decision|0
5169783|NCT01314872|17850100|P15|Treatment Period 1|Protocol Violation|0
5169784|NCT01314872|17850101|P14|Treatment Period 1|Protocol Violation|0
5169785|NCT01314872|17850102|P13|Treatment Period 1|Protocol Violation|0
5169786|NCT01314872|17850103|P12|Treatment Period 1|Protocol Violation|0
5169787|NCT01314872|17850104|P11|Treatment Period 1|Protocol Violation|1
5169788|NCT01314872|17850105|P10|Treatment Period 1|Protocol Violation|1
5169789|NCT01314872|17850106|P9|Treatment Period 1|Protocol Violation|0
5169790|NCT01314872|17850107|P8|Treatment Period 1|Protocol Violation|0
5169791|NCT01314872|17850108|P7|Treatment Period 1|Protocol Violation|0
5169792|NCT01314872|17850109|P6|Treatment Period 1|Protocol Violation|0
5169793|NCT01314872|17850110|P5|Treatment Period 1|Protocol Violation|1
5169794|NCT01314872|17850111|P4|Treatment Period 1|Protocol Violation|0
5169795|NCT01314872|17850112|P3|Treatment Period 1|Protocol Violation|1
5169796|NCT01314872|17850113|P2|Treatment Period 1|Protocol Violation|1
5169797|NCT01314872|17850114|P1|Treatment Period 1|Protocol Violation|2
5169798|NCT01314716|17850218|P2|Open-Label Phase|Physician Decision|4
5169799|NCT01314716|17850219|P1|Open-Label Phase|Physician Decision|5
5169800|NCT01314716|17850218|P2|Open-Label Phase|Withdrawal by Subject|2
5169801|NCT01314716|17850219|P1|Open-Label Phase|Withdrawal by Subject|1
5169802|NCT01314716|17850218|P2|Open-Label Phase|Adverse Event|6
5169803|NCT01314716|17850219|P1|Open-Label Phase|Adverse Event|4
5169804|NCT01314716|17850218|P2|Double-Blind Phase|Physician Decision|1
5169805|NCT01314716|17850219|P1|Double-Blind Phase|Physician Decision|0
5169806|NCT01314716|17850218|P2|Double-Blind Phase|Sponsor request|2
5169807|NCT01314716|17850219|P1|Double-Blind Phase|Sponsor request|1
5169808|NCT01314716|17850218|P2|Double-Blind Phase|Lost to Follow-up|1
5169809|NCT01314716|17850219|P1|Double-Blind Phase|Lost to Follow-up|0
5169810|NCT01314716|17850218|P2|Double-Blind Phase|Withdrawal by Subject|6
5169811|NCT01314716|17850219|P1|Double-Blind Phase|Withdrawal by Subject|5
5169812|NCT01314716|17850218|P2|Double-Blind Phase|Adverse Event|4
5169813|NCT01314716|17850219|P1|Double-Blind Phase|Adverse Event|10
5169814|NCT01314716|17850218|P2|Double-Blind Phase|Randomized but not treated|1
5169815|NCT01314716|17850219|P1|Double-Blind Phase|Randomized but not treated|1
5169816|NCT01314703|17850231|P1|Overall Study|screen failure and closed enrollment|8
5169817|NCT01314443|17850240|P4|Overall Study|Protocol Violation|1
5169818|NCT01314443|17850241|P3|Overall Study|Protocol Violation|1
5169819|NCT01314443|17850242|P2|Overall Study|Protocol Violation|2
5169820|NCT01314443|17850243|P1|Overall Study|Protocol Violation|2
5169821|NCT01314443|17850240|P4|Overall Study|Withdrawal by Subject|1
5169822|NCT01314443|17850241|P3|Overall Study|Withdrawal by Subject|1
5169823|NCT01314443|17850242|P2|Overall Study|Withdrawal by Subject|1
5169824|NCT01314443|17850243|P1|Overall Study|Withdrawal by Subject|2
5169825|NCT01314261|17850313|P4|Overall Study|Virologic Failure|1
5169826|NCT01314261|17850314|P3|Overall Study|Virologic Failure|0
5169827|NCT01314261|17850315|P2|Overall Study|Virologic Failure|1
5169828|NCT01314261|17850316|P1|Overall Study|Virologic Failure|0
5169829|NCT01314261|17850313|P4|Overall Study|Lost to Follow-up|2
5169830|NCT01314261|17850314|P3|Overall Study|Lost to Follow-up|2
5169831|NCT01314261|17850315|P2|Overall Study|Lost to Follow-up|0
5169832|NCT01314261|17850316|P1|Overall Study|Lost to Follow-up|1
5169833|NCT01314261|17850313|P4|Overall Study|Withdrawal by Subject|0
5169834|NCT01314261|17850314|P3|Overall Study|Withdrawal by Subject|1
5169835|NCT01314261|17850315|P2|Overall Study|Withdrawal by Subject|3
5169836|NCT01314261|17850316|P1|Overall Study|Withdrawal by Subject|0
5169837|NCT01314261|17850313|P4|Overall Study|Adverse Event|0
5169838|NCT01314261|17850314|P3|Overall Study|Adverse Event|0
5169839|NCT01314261|17850315|P2|Overall Study|Adverse Event|0
5169840|NCT01314261|17850316|P1|Overall Study|Adverse Event|1
5169841|NCT01314118|17850367|P1|Overall Study|Ongoing|62
5169842|NCT01314118|17850367|P1|Overall Study|Other|2
5169843|NCT01314118|17850367|P1|Overall Study|Withdrawal by Subject|11
5169844|NCT01314118|17850367|P1|Overall Study|Protocol Violation|5
5169845|NCT01314118|17850367|P1|Overall Study|Death|4
5169846|NCT01314118|17850367|P1|Overall Study|Physician Decision|11
5169847|NCT01314118|17850367|P1|Overall Study|Progressive disease|27
5169848|NCT01314118|17850367|P1|Overall Study|Adverse Event|9
5169849|NCT01314105|17850376|P2|Overall Study|Other Adverse Event|1
5169850|NCT01314105|17850377|P1|Overall Study|Other Adverse Event|1
5169851|NCT01314105|17850376|P2|Overall Study|Refused to continue taking medication|1
5169852|NCT01314105|17850377|P1|Overall Study|Refused to continue taking medication|0
5169853|NCT01314105|17850376|P2|Overall Study|Progressive Disease|10
5169854|NCT01314105|17850377|P1|Overall Study|Progressive Disease|6
5169855|NCT01313923|17850495|P1|Overall Study|Physician Decision|3
5169856|NCT01313884|17850511|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
5169857|NCT01313858|17850519|P3|Overall Study|Lost to Follow-up|47
5169858|NCT01313858|17850520|P2|Overall Study|Lost to Follow-up|51
5169859|NCT01313858|17850521|P1|Overall Study|Lost to Follow-up|35
5169860|NCT01313858|17850519|P3|Overall Study|Premature Treatment Termination|191
5169861|NCT01313858|17850520|P2|Overall Study|Premature Treatment Termination|219
5169862|NCT01313858|17850521|P1|Overall Study|Premature Treatment Termination|251
5169863|NCT01313780|17850544|P2|Overall Study|missing data|3
5169864|NCT01313780|17850545|P1|Overall Study|missing data|3
5169865|NCT01313780|17850544|P2|Overall Study|Protocol Violation|4
5169866|NCT01313780|17850545|P1|Overall Study|Protocol Violation|10
5169867|NCT01313780|17850544|P2|Overall Study|Withdrawal by Subject|8
5169868|NCT01313780|17850545|P1|Overall Study|Withdrawal by Subject|2
5169869|NCT01313780|17850544|P2|Overall Study|Adverse Event|11
5169870|NCT01313780|17850545|P1|Overall Study|Adverse Event|6
5169871|NCT01313780|17850544|P2|Overall Study|Lack of Efficacy|2
5169872|NCT01313780|17850545|P1|Overall Study|Lack of Efficacy|4
5169873|NCT01313767|17850555|P2|Overall Study|Protocol Violation|1
5169874|NCT01313767|17850556|P1|Overall Study|Protocol Violation|3
5169875|NCT01313767|17850555|P2|Overall Study|Withdrawal by Subject|1
5169876|NCT01313767|17850556|P1|Overall Study|Withdrawal by Subject|2
5169877|NCT01313767|17850555|P2|Overall Study|Lost to Follow-up|0
5169878|NCT01313767|17850556|P1|Overall Study|Lost to Follow-up|1
5169879|NCT01313767|17850555|P2|Overall Study|Adverse Event|0
5169880|NCT01313767|17850556|P1|Overall Study|Adverse Event|1
5169881|NCT01313728|17850598|P1|Informed Consent to Baseline|Withdrawal by Subject|1
5169882|NCT01313689|17850618|P5|24-Week Randomization 2|Physician Decision|4
5169883|NCT01313689|17850619|P4|24-Week Randomization 2|Physician Decision|0
5169884|NCT01313689|17850620|P3|24-Week Randomization 2|Physician Decision|0
5169885|NCT01313689|17850621|P2|24-Week Randomization 2|Physician Decision|0
5169886|NCT01313689|17850622|P1|24-Week Randomization 2|Physician Decision|0
5169887|NCT01313689|17850618|P5|24-Week Randomization 2|Withdrawal by Subject|3
5169888|NCT01313689|17850619|P4|24-Week Randomization 2|Withdrawal by Subject|1
5169889|NCT01313689|17850620|P3|24-Week Randomization 2|Withdrawal by Subject|1
5169890|NCT01313689|17850621|P2|24-Week Randomization 2|Withdrawal by Subject|0
5169891|NCT01313689|17850622|P1|24-Week Randomization 2|Withdrawal by Subject|0
5169892|NCT01313689|17850618|P5|24-Week Randomization 2|Adverse Event|8
5169893|NCT01313689|17850619|P4|24-Week Randomization 2|Adverse Event|0
5169894|NCT01313689|17850620|P3|24-Week Randomization 2|Adverse Event|2
5169895|NCT01313689|17850621|P2|24-Week Randomization 2|Adverse Event|0
5169896|NCT01313689|17850622|P1|24-Week Randomization 2|Adverse Event|0
5169897|NCT01313689|17850618|P5|24-Week Randomization 1|Withdrawal by Subject|0
5169898|NCT01313689|17850619|P4|24-Week Randomization 1|Withdrawal by Subject|0
5169899|NCT01313689|17850620|P3|24-Week Randomization 1|Withdrawal by Subject|0
5169900|NCT01313689|17850621|P2|24-Week Randomization 1|Withdrawal by Subject|0
5169901|NCT01313689|17850622|P1|24-Week Randomization 1|Withdrawal by Subject|5
5169902|NCT01313689|17850618|P5|24-Week Randomization 1|Physician Decision|0
5169903|NCT01313689|17850619|P4|24-Week Randomization 1|Physician Decision|0
5169904|NCT01313689|17850620|P3|24-Week Randomization 1|Physician Decision|0
5169905|NCT01313689|17850621|P2|24-Week Randomization 1|Physician Decision|5
5169906|NCT01313689|17850622|P1|24-Week Randomization 1|Physician Decision|4
5169907|NCT01313689|17850618|P5|24-Week Randomization 1|Adverse Event|0
5169908|NCT01313689|17850619|P4|24-Week Randomization 1|Adverse Event|0
5169909|NCT01313689|17850620|P3|24-Week Randomization 1|Adverse Event|0
5169910|NCT01313689|17850621|P2|24-Week Randomization 1|Adverse Event|5
5169911|NCT01313689|17850622|P1|24-Week Randomization 1|Adverse Event|10
5169912|NCT01313676|17850701|P4|Overall Study|Missing|0
5169913|NCT01313676|17850702|P3|Overall Study|Missing|1
5169914|NCT01313676|17850703|P2|Overall Study|Missing|1
5169915|NCT01313676|17850704|P1|Overall Study|Missing|1
5169916|NCT01313676|17850701|P4|Overall Study|Investigator Site Closed|10
5169917|NCT01313676|17850702|P3|Overall Study|Investigator Site Closed|15
5169918|NCT01313676|17850703|P2|Overall Study|Investigator Site Closed|11
5169919|NCT01313676|17850704|P1|Overall Study|Investigator Site Closed|12
5169920|NCT01313676|17850701|P4|Overall Study|Sponsor Terminated Study Treatment|1
5169921|NCT01313676|17850702|P3|Overall Study|Sponsor Terminated Study Treatment|0
5169922|NCT01313676|17850703|P2|Overall Study|Sponsor Terminated Study Treatment|1
5169923|NCT01313676|17850704|P1|Overall Study|Sponsor Terminated Study Treatment|1
5169924|NCT01313676|17850701|P4|Overall Study|Decision by Participant or Proxy|492
5169925|NCT01313676|17850702|P3|Overall Study|Decision by Participant or Proxy|515
5169926|NCT01313676|17850703|P2|Overall Study|Decision by Participant or Proxy|527
5169927|NCT01313676|17850704|P1|Overall Study|Decision by Participant or Proxy|643
5169928|NCT01313676|17850701|P4|Overall Study|Physician Decision|48
5169929|NCT01313676|17850702|P3|Overall Study|Physician Decision|62
5169930|NCT01313676|17850703|P2|Overall Study|Physician Decision|64
5169931|NCT01313676|17850704|P1|Overall Study|Physician Decision|53
5169932|NCT01313676|17850701|P4|Overall Study|Lost to Follow-up|0
5169933|NCT01313676|17850702|P3|Overall Study|Lost to Follow-up|1
5169934|NCT01313676|17850703|P2|Overall Study|Lost to Follow-up|0
5169935|NCT01313676|17850704|P1|Overall Study|Lost to Follow-up|0
5169936|NCT01313676|17850701|P4|Overall Study|Study Closed/terminated|9
5169937|NCT01313676|17850702|P3|Overall Study|Study Closed/terminated|9
5169938|NCT01313676|17850703|P2|Overall Study|Study Closed/terminated|6
5169939|NCT01313676|17850704|P1|Overall Study|Study Closed/terminated|7
5169940|NCT01313676|17850701|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
5169941|NCT01313676|17850702|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
5169942|NCT01313676|17850703|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
5169943|NCT01313676|17850704|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
5169944|NCT01313676|17850701|P4|Overall Study|Protocol Violation|44
5169945|NCT01313676|17850702|P3|Overall Study|Protocol Violation|46
5169946|NCT01313676|17850703|P2|Overall Study|Protocol Violation|44
5169947|NCT01313676|17850704|P1|Overall Study|Protocol Violation|37
5169948|NCT01313676|17850701|P4|Overall Study|Lack of Efficacy|46
5169949|NCT01313676|17850702|P3|Overall Study|Lack of Efficacy|65
5169950|NCT01313676|17850703|P2|Overall Study|Lack of Efficacy|90
5169951|NCT01313676|17850704|P1|Overall Study|Lack of Efficacy|98
5169952|NCT01313676|17850701|P4|Overall Study|Adverse Event|333
5169953|NCT01313676|17850702|P3|Overall Study|Adverse Event|372
5169954|NCT01313676|17850703|P2|Overall Study|Adverse Event|365
5169955|NCT01313676|17850704|P1|Overall Study|Adverse Event|395
5169956|NCT01313663|17850724|P2|Overall Study|Withdrawal by Subject|1
5169957|NCT01313663|17850725|P1|Overall Study|Withdrawal by Subject|2
5169958|NCT01313663|17850724|P2|Overall Study|Physician Decision|2
5169959|NCT01313663|17850725|P1|Overall Study|Physician Decision|0
5169960|NCT01313663|17850724|P2|Overall Study|Lost to Follow-up|1
5169961|NCT01313663|17850725|P1|Overall Study|Lost to Follow-up|0
5169962|NCT01313663|17850724|P2|Overall Study|Study Closed/Terminated|4
5169963|NCT01313663|17850725|P1|Overall Study|Study Closed/Terminated|2
5169964|NCT01313650|17850763|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
5169965|NCT01313650|17850764|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
5169966|NCT01313650|17850765|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
5169967|NCT01313650|17850766|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
5169968|NCT01313650|17850763|P4|Overall Study|Protocol Violation|6
5169969|NCT01313650|17850764|P3|Overall Study|Protocol Violation|5
5169970|NCT01313650|17850765|P2|Overall Study|Protocol Violation|7
5169971|NCT01313650|17850766|P1|Overall Study|Protocol Violation|4
5169972|NCT01313650|17850763|P4|Overall Study|Withdrawal by Subject|15
5169973|NCT01313650|17850764|P3|Overall Study|Withdrawal by Subject|15
5169974|NCT01313650|17850765|P2|Overall Study|Withdrawal by Subject|20
5169975|NCT01313650|17850766|P1|Overall Study|Withdrawal by Subject|16
5169976|NCT01313650|17850763|P4|Overall Study|Lost to Follow-up|2
5169977|NCT01313650|17850764|P3|Overall Study|Lost to Follow-up|3
5169978|NCT01313650|17850765|P2|Overall Study|Lost to Follow-up|0
5169979|NCT01313650|17850766|P1|Overall Study|Lost to Follow-up|1
5169980|NCT01313650|17850763|P4|Overall Study|Lack of Efficacy|20
5169981|NCT01313650|17850764|P3|Overall Study|Lack of Efficacy|32
5169982|NCT01313650|17850765|P2|Overall Study|Lack of Efficacy|20
5169983|NCT01313650|17850766|P1|Overall Study|Lack of Efficacy|37
5169984|NCT01313650|17850763|P4|Overall Study|Adverse Event|23
5169985|NCT01313650|17850764|P3|Overall Study|Adverse Event|24
5169986|NCT01313650|17850765|P2|Overall Study|Adverse Event|34
5169987|NCT01313650|17850766|P1|Overall Study|Adverse Event|9
5169988|NCT01313637|17850792|P4|Overall Study|Withdrawal by Subject|15
5169989|NCT01313637|17850793|P3|Overall Study|Withdrawal by Subject|18
5169990|NCT01313637|17850794|P2|Overall Study|Withdrawal by Subject|13
5169991|NCT01313637|17850795|P1|Overall Study|Withdrawal by Subject|11
5169992|NCT01313637|17850792|P4|Overall Study|Lost to Follow-up|3
5169993|NCT01313637|17850793|P3|Overall Study|Lost to Follow-up|1
5169994|NCT01313637|17850794|P2|Overall Study|Lost to Follow-up|2
5169995|NCT01313637|17850795|P1|Overall Study|Lost to Follow-up|0
5169996|NCT01313637|17850792|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
5169997|NCT01313637|17850793|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
5169998|NCT01313637|17850794|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
5169999|NCT01313637|17850795|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
5170000|NCT01313637|17850792|P4|Overall Study|Protocol Violation|5
5170001|NCT01313637|17850793|P3|Overall Study|Protocol Violation|11
5170002|NCT01313637|17850794|P2|Overall Study|Protocol Violation|3
5170003|NCT01313637|17850795|P1|Overall Study|Protocol Violation|4
5170004|NCT01313637|17850792|P4|Overall Study|Lack of Efficacy|24
5170005|NCT01313637|17850793|P3|Overall Study|Lack of Efficacy|37
5170006|NCT01313637|17850794|P2|Overall Study|Lack of Efficacy|38
5170007|NCT01313637|17850795|P1|Overall Study|Lack of Efficacy|44
5170008|NCT01313637|17850792|P4|Overall Study|Adverse Event|18
5170009|NCT01313637|17850793|P3|Overall Study|Adverse Event|25
5170010|NCT01313637|17850794|P2|Overall Study|Adverse Event|24
5170011|NCT01313637|17850795|P1|Overall Study|Adverse Event|17
5170012|NCT01313624|17850819|P2|Open-Label Phase|Lost to Follow-up|1
5170013|NCT01313624|17850820|P1|Open-Label Phase|Lost to Follow-up|1
5170014|NCT01313624|17850819|P2|Open-Label Phase|Withdrawal by Subject|2
5170015|NCT01313624|17850820|P1|Open-Label Phase|Withdrawal by Subject|2
5170016|NCT01313624|17850819|P2|Open-Label Phase|Adverse Event|10
5170017|NCT01313624|17850820|P1|Open-Label Phase|Adverse Event|1
5170018|NCT01313624|17850819|P2|Double-Blind Phase|Lack of Efficacy|0
5170019|NCT01313624|17850820|P1|Double-Blind Phase|Lack of Efficacy|1
5170020|NCT01313624|17850819|P2|Double-Blind Phase|Physician Decision|0
5170021|NCT01313624|17850820|P1|Double-Blind Phase|Physician Decision|1
5170022|NCT01313624|17850819|P2|Double-Blind Phase|Lost to Follow-up|2
5170023|NCT01313624|17850820|P1|Double-Blind Phase|Lost to Follow-up|0
5170024|NCT01313624|17850819|P2|Double-Blind Phase|Withdrawal by Subject|4
5170025|NCT01313624|17850820|P1|Double-Blind Phase|Withdrawal by Subject|9
5170026|NCT01313624|17850819|P2|Double-Blind Phase|Adverse Event|4
5170027|NCT01313624|17850820|P1|Double-Blind Phase|Adverse Event|27
5170028|NCT01313559|17850834|P2|Overall Study|Rising PSA|0
5170029|NCT01313559|17850835|P1|Overall Study|Rising PSA|2
5170030|NCT01313559|17850834|P2|Overall Study|Disease progression|0
5170031|NCT01313559|17850835|P1|Overall Study|Disease progression|1
5170032|NCT01313559|17850834|P2|Overall Study|Withdrawal by Subject|2
5170033|NCT01313559|17850835|P1|Overall Study|Withdrawal by Subject|1
5170034|NCT01313312|17850936|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
5170035|NCT01313312|17850936|P1|Overall Study|Subject Withdrawn Early in Error|4
5170036|NCT01313312|17850936|P1|Overall Study|Observational Phase|1
5170037|NCT01313312|17850936|P1|Overall Study|Investigator Decision|1
5170038|NCT01313312|17850936|P1|Overall Study|Lack of Efficacy|3
5170039|NCT01313312|17850936|P1|Overall Study|Withdrawal by Subject|18
5170040|NCT01313312|17850936|P1|Overall Study|Adverse Event|5
5170041|NCT01313299|17850983|P3|Overall Study|Lack of subject compliance|1
5170042|NCT01313299|17850984|P2|Overall Study|Lack of subject compliance|0
5170043|NCT01313299|17850985|P1|Overall Study|Lack of subject compliance|0
5170044|NCT01313299|17850983|P3|Overall Study|Family reason and moved out of state|0
5170045|NCT01313299|17850984|P2|Overall Study|Family reason and moved out of state|2
5170046|NCT01313299|17850985|P1|Overall Study|Family reason and moved out of state|0
5170047|NCT01313299|17850983|P3|Overall Study|Withdrawal by Subject|2
5170048|NCT01313299|17850984|P2|Overall Study|Withdrawal by Subject|0
5170049|NCT01313299|17850985|P1|Overall Study|Withdrawal by Subject|1
5170050|NCT01313299|17850983|P3|Overall Study|Protocol Violation|0
5170051|NCT01313299|17850984|P2|Overall Study|Protocol Violation|0
5170052|NCT01313299|17850985|P1|Overall Study|Protocol Violation|2
5170053|NCT01313299|17850983|P3|Overall Study|Lost to Follow-up|0
5170054|NCT01313299|17850984|P2|Overall Study|Lost to Follow-up|0
5170055|NCT01313299|17850985|P1|Overall Study|Lost to Follow-up|1
5170056|NCT01313299|17850983|P3|Overall Study|Adverse Event|1
5170057|NCT01313299|17850984|P2|Overall Study|Adverse Event|1
5170058|NCT01313299|17850985|P1|Overall Study|Adverse Event|3
5170059|NCT01313286|17850999|P2|Period 1|Withdrawal by Subject|0
5170060|NCT01313286|17851000|P1|Period 1|Withdrawal by Subject|2
5170061|NCT01313273|17851010|P2|Overall Study|Screening Chromogranin A-in normal range|1
5170062|NCT01313273|17851011|P1|Overall Study|Screening Chromogranin A-in normal range|0
5170063|NCT01313273|17851010|P2|Overall Study|Withdrawal by Subject|0
5170064|NCT01313273|17851011|P1|Overall Study|Withdrawal by Subject|1
5170065|NCT01313273|17851010|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
5170066|NCT01313273|17851011|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
5170067|NCT01313221|17851026|P3|Overall Study|Pregnancy|2
5170068|NCT01313221|17851027|P2|Overall Study|Pregnancy|0
5170069|NCT01313221|17851028|P1|Overall Study|Pregnancy|0
5170070|NCT01313221|17851026|P3|Overall Study|Physician Decision|2
5170071|NCT01313221|17851027|P2|Overall Study|Physician Decision|0
5170072|NCT01313221|17851028|P1|Overall Study|Physician Decision|0
5170073|NCT01313221|17851026|P3|Overall Study|Disease progression|2
5170074|NCT01313221|17851027|P2|Overall Study|Disease progression|0
5170075|NCT01313221|17851028|P1|Overall Study|Disease progression|0
5170076|NCT01313221|17851026|P3|Overall Study|Adverse Event|7
5170077|NCT01313221|17851027|P2|Overall Study|Adverse Event|0
5170078|NCT01313221|17851028|P1|Overall Study|Adverse Event|0
5170079|NCT01313221|17851026|P3|Overall Study|Other|0
5170080|NCT01313221|17851027|P2|Overall Study|Other|0
5170081|NCT01313221|17851028|P1|Overall Study|Other|1
5170082|NCT01313221|17851026|P3|Overall Study|Lost to Follow-up|1
5170083|NCT01313221|17851027|P2|Overall Study|Lost to Follow-up|3
5170084|NCT01313221|17851028|P1|Overall Study|Lost to Follow-up|6
5170085|NCT01313221|17851026|P3|Overall Study|Requirement for alternative therapy|1
5170086|NCT01313221|17851027|P2|Overall Study|Requirement for alternative therapy|1
5170087|NCT01313221|17851028|P1|Overall Study|Requirement for alternative therapy|0
5170088|NCT01313221|17851026|P3|Overall Study|Withdrawal by Subject|5
5170089|NCT01313221|17851027|P2|Overall Study|Withdrawal by Subject|3
5170090|NCT01313221|17851028|P1|Overall Study|Withdrawal by Subject|2
5170091|NCT01313221|17851026|P3|Overall Study|Non-compliance|2
5170092|NCT01313221|17851027|P2|Overall Study|Non-compliance|0
5170093|NCT01313221|17851028|P1|Overall Study|Non-compliance|3
5170094|NCT01313221|17851026|P3|Overall Study|Protocol Violation|1
5170095|NCT01313221|17851027|P2|Overall Study|Protocol Violation|1
5170096|NCT01313221|17851028|P1|Overall Study|Protocol Violation|0
5170097|NCT01313208|17851080|P2|Open-label Phase (Weeks 13 - 24)|Other|0
5170098|NCT01313208|17851081|P1|Open-label Phase (Weeks 13 - 24)|Other|2
5170099|NCT01313208|17851080|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
5170100|NCT01313208|17851081|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
5170101|NCT01313208|17851080|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
5170102|NCT01313208|17851081|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
5170103|NCT01313208|17851080|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
5170104|NCT01313208|17851081|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
5170105|NCT01313208|17851080|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
5170106|NCT01313208|17851081|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
5170107|NCT01313208|17851080|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
5170108|NCT01313208|17851081|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
5170109|NCT01313208|17851080|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
5170110|NCT01313208|17851081|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
5170111|NCT01313208|17851080|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
5170112|NCT01313208|17851081|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
5170113|NCT01313208|17851080|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
5170114|NCT01313208|17851081|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
5170115|NCT01313182|17851171|P2|Overall Study|Protocol Violation|92
5170116|NCT01313182|17851172|P1|Overall Study|Protocol Violation|66
5170117|NCT01313117|17851184|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
5170118|NCT01313117|17851184|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
5170119|NCT01313078|17851191|P1|Overall Study|Withdrawal by Subject|1
5170120|NCT01313078|17851191|P1|Overall Study|Discontinued study drug|1
5170121|NCT01313078|17851191|P1|Overall Study|Death|1
5170122|NCT01313039|17851196|P1|Overall Study|Adverse Event|1
5170123|NCT01313039|17851196|P1|Overall Study|Physician Decision|1
5170124|NCT01312961|17851202|P2|Overall Study|Other than specified above|3
5170125|NCT01312961|17851203|P1|Overall Study|Other than specified above|2
5170126|NCT01312961|17851202|P2|Overall Study|Poor compliance to protocol|0
5170127|NCT01312961|17851203|P1|Overall Study|Poor compliance to protocol|1
5170128|NCT01312961|17851202|P2|Overall Study|Lack of Efficacy|1
5170129|NCT01312961|17851203|P1|Overall Study|Lack of Efficacy|11
5170130|NCT01312961|17851202|P2|Overall Study|Adverse Event|3
5170131|NCT01312961|17851203|P1|Overall Study|Adverse Event|3
5170132|NCT01312909|17851239|P3|Overall Study|Entrance criteria not met|2
5170133|NCT01312909|17851240|P2|Overall Study|Entrance criteria not met|0
5170134|NCT01312909|17851241|P1|Overall Study|Entrance criteria not met|0
5170135|NCT01312909|17851239|P3|Overall Study|Insufficient clinical response|1
5170136|NCT01312909|17851240|P2|Overall Study|Insufficient clinical response|0
5170137|NCT01312909|17851241|P1|Overall Study|Insufficient clinical response|0
5170138|NCT01312909|17851239|P3|Overall Study|Lost to Follow-up|20
5170139|NCT01312909|17851240|P2|Overall Study|Lost to Follow-up|17
5170140|NCT01312909|17851241|P1|Overall Study|Lost to Follow-up|21
5170141|NCT01312909|17851239|P3|Overall Study|Withdrawal by Subject|7
5170142|NCT01312909|17851240|P2|Overall Study|Withdrawal by Subject|10
5170143|NCT01312909|17851241|P1|Overall Study|Withdrawal by Subject|8
5170144|NCT01312909|17851239|P3|Overall Study|Other|11
5170145|NCT01312909|17851240|P2|Overall Study|Other|6
5170146|NCT01312909|17851241|P1|Overall Study|Other|9
5170147|NCT01312909|17851239|P3|Overall Study|Protocol Violation|2
5170148|NCT01312909|17851240|P2|Overall Study|Protocol Violation|0
5170149|NCT01312909|17851241|P1|Overall Study|Protocol Violation|2
5170150|NCT01312909|17851239|P3|Overall Study|Adverse Event|3
5170151|NCT01312909|17851240|P2|Overall Study|Adverse Event|0
5170152|NCT01312909|17851241|P1|Overall Study|Adverse Event|1
5170153|NCT01312909|17851239|P3|Overall Study|Randomized but not treated|1
5170154|NCT01312909|17851240|P2|Overall Study|Randomized but not treated|3
5170155|NCT01312909|17851241|P1|Overall Study|Randomized but not treated|1
5170156|NCT01312779|17851328|P1|Overall Study|Not Implanted with Device|27
5170157|NCT01312779|17851328|P1|Overall Study|Death|3
5170158|NCT01312779|17851328|P1|Overall Study|Withdrawal by Subject|2
5170159|NCT01312467|17851411|P1|Overall Study|Ineligible|4
5170160|NCT01312467|17851411|P1|Overall Study|Another medical condition|1
5170161|NCT01312467|17851411|P1|Overall Study|Deported to country of origin|1
5170162|NCT01312467|17851411|P1|Overall Study|Withdrawal by Subject|2
5170163|NCT01312467|17851411|P1|Overall Study|Lost to Follow-up|1
5170164|NCT01312467|17851411|P1|Overall Study|Adverse Event|4
5170165|NCT01312428|17851420|P2|Overall Study|Study Termination|4
5170166|NCT01312428|17851421|P1|Overall Study|Study Termination|3
5170167|NCT01312129|17851491|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
5170168|NCT01312129|17851492|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
5170169|NCT01311661|17851577|P1|Overall Study|Withdrawal by Subject|2
5170170|NCT01311661|17851577|P1|Overall Study|Protocol Violation|3
5170171|NCT01311661|17851577|P1|Overall Study|Adverse Event|2
5170172|NCT01311648|17851722|P3|Overall Study|Withdrawal by Subject|2
5170173|NCT01311648|17851723|P2|Overall Study|Withdrawal by Subject|0
5170174|NCT01311648|17851724|P1|Overall Study|Withdrawal by Subject|0
5170175|NCT01311648|17851722|P3|Overall Study|Inhibitor management|17
5170176|NCT01311648|17851723|P2|Overall Study|Inhibitor management|0
5170177|NCT01311648|17851724|P1|Overall Study|Inhibitor management|0
5170178|NCT01311648|17851722|P3|Overall Study|Adverse Event|1
5170179|NCT01311648|17851723|P2|Overall Study|Adverse Event|0
5170180|NCT01311648|17851724|P1|Overall Study|Adverse Event|0
5170181|NCT01311648|17851722|P3|Overall Study|Protocol Violation|1
5170182|NCT01311648|17851723|P2|Overall Study|Protocol Violation|0
5170183|NCT01311648|17851724|P1|Overall Study|Protocol Violation|0
5170184|NCT01311557|17851769|P2|Overall Study|Withdrawal by Subject|2
5170185|NCT01311557|17851770|P1|Overall Study|Withdrawal by Subject|1
5170186|NCT01311557|17851769|P2|Overall Study|Lost to Follow-up|1
5170187|NCT01311557|17851770|P1|Overall Study|Lost to Follow-up|0
5170188|NCT01311557|17851769|P2|Overall Study|Protocol Violation|2
5170189|NCT01311557|17851770|P1|Overall Study|Protocol Violation|4
5170190|NCT01311557|17851769|P2|Overall Study|Serious adverse event|1
5170191|NCT01311557|17851770|P1|Overall Study|Serious adverse event|0
5170192|NCT01311505|17851786|P2|First Intervention Period|Protocol Violation|1
5170193|NCT01311505|17851787|P1|First Intervention Period|Protocol Violation|0
5170194|NCT01311024|17851843|P2|Overall Study|Protocol Violation|22
5170195|NCT01311024|17851844|P1|Overall Study|Protocol Violation|35
5170196|NCT01310868|17851850|P1|Overall Study|Do not have histologically confirmed GBM|13
5170197|NCT01310803|17851867|P2|Overall Study|Subject terminated by Sponsor|0
5170198|NCT01310803|17851868|P1|Overall Study|Subject terminated by Sponsor|1
5170199|NCT01310777|17851879|P3|Overall Study|Other|2
5170200|NCT01310777|17851880|P2|Overall Study|Other|1
5170201|NCT01310777|17851881|P1|Overall Study|Other|4
5170202|NCT01310777|17851879|P3|Overall Study|Inadequate Control of IOP|10
5170203|NCT01310777|17851880|P2|Overall Study|Inadequate Control of IOP|7
5170204|NCT01310777|17851881|P1|Overall Study|Inadequate Control of IOP|5
5170205|NCT01310777|17851879|P3|Overall Study|Patient's Decision Unrelated to AE|2
5170206|NCT01310777|17851880|P2|Overall Study|Patient's Decision Unrelated to AE|1
5170207|NCT01310777|17851881|P1|Overall Study|Patient's Decision Unrelated to AE|1
5170208|NCT01310777|17851879|P3|Overall Study|Lost to Follow-up|1
5170209|NCT01310777|17851880|P2|Overall Study|Lost to Follow-up|4
5170210|NCT01310777|17851881|P1|Overall Study|Lost to Follow-up|0
5170211|NCT01310777|17851879|P3|Overall Study|Adverse Event|15
5170212|NCT01310777|17851880|P2|Overall Study|Adverse Event|1
5170213|NCT01310777|17851881|P1|Overall Study|Adverse Event|23
5170214|NCT01310699|17851891|P2|Overall Study|Patients did not complete tandem.|6
5170215|NCT01310699|17851892|P1|Overall Study|Patients did not complete tandem.|4
5170216|NCT01310413|17851919|P7|From Day U0 to Day U385|Lost to Follow-up|2
5170217|NCT01310413|17851920|P6|From Day U0 to Day U385|Lost to Follow-up|0
5170218|NCT01310413|17851921|P5|From Day U0 to Day U385|Lost to Follow-up|0
5170219|NCT01310413|17851922|P4|From Day U0 to Day U385|Lost to Follow-up|0
5170220|NCT01310413|17851923|P3|From Day U0 to Day U385|Lost to Follow-up|0
5170221|NCT01310413|17851924|P2|From Day U0 to Day U385|Lost to Follow-up|0
5170222|NCT01310413|17851925|P1|From Day U0 to Day U385|Lost to Follow-up|0
5170223|NCT01310413|17851919|P7|From Day U0 to Day U385|Withdrawal by Subject|1
5170224|NCT01310413|17851920|P6|From Day U0 to Day U385|Withdrawal by Subject|0
5170225|NCT01310413|17851921|P5|From Day U0 to Day U385|Withdrawal by Subject|0
5170226|NCT01310413|17851922|P4|From Day U0 to Day U385|Withdrawal by Subject|0
5170227|NCT01310413|17851923|P3|From Day U0 to Day U385|Withdrawal by Subject|0
5170228|NCT01310413|17851924|P2|From Day U0 to Day U385|Withdrawal by Subject|0
5170229|NCT01310413|17851925|P1|From Day U0 to Day U385|Withdrawal by Subject|0
5170230|NCT01310413|17851919|P7|Day 0 to Day 385|Other|0
5170231|NCT01310413|17851920|P6|Day 0 to Day 385|Other|0
5170232|NCT01310413|17851921|P5|Day 0 to Day 385|Other|0
5170233|NCT01310413|17851922|P4|Day 0 to Day 385|Other|0
5170234|NCT01310413|17851923|P3|Day 0 to Day 385|Other|3
5170235|NCT01310413|17851924|P2|Day 0 to Day 385|Other|0
5170236|NCT01310413|17851925|P1|Day 0 to Day 385|Other|1
5170237|NCT01310413|17851919|P7|Day 0 to Day 385|Migrated/moved from study area|0
5170238|NCT01310413|17851920|P6|Day 0 to Day 385|Migrated/moved from study area|0
5170239|NCT01310413|17851921|P5|Day 0 to Day 385|Migrated/moved from study area|1
5170240|NCT01310413|17851922|P4|Day 0 to Day 385|Migrated/moved from study area|1
5170241|NCT01310413|17851923|P3|Day 0 to Day 385|Migrated/moved from study area|1
5170242|NCT01310413|17851924|P2|Day 0 to Day 385|Migrated/moved from study area|3
5170243|NCT01310413|17851925|P1|Day 0 to Day 385|Migrated/moved from study area|3
5170244|NCT01310413|17851919|P7|Day 0 to Day 385|Lost to Follow-up|0
5170245|NCT01310413|17851920|P6|Day 0 to Day 385|Lost to Follow-up|2
5170246|NCT01310413|17851921|P5|Day 0 to Day 385|Lost to Follow-up|1
5170247|NCT01310413|17851922|P4|Day 0 to Day 385|Lost to Follow-up|5
5170248|NCT01310413|17851923|P3|Day 0 to Day 385|Lost to Follow-up|3
5170249|NCT01310413|17851924|P2|Day 0 to Day 385|Lost to Follow-up|3
5170250|NCT01310413|17851925|P1|Day 0 to Day 385|Lost to Follow-up|18
5170251|NCT01310413|17851919|P7|Day 0 to Day 385|Withdrawal by Subject|0
5170252|NCT01310413|17851920|P6|Day 0 to Day 385|Withdrawal by Subject|1
5170253|NCT01310413|17851921|P5|Day 0 to Day 385|Withdrawal by Subject|1
5170254|NCT01310413|17851922|P4|Day 0 to Day 385|Withdrawal by Subject|2
5170255|NCT01310413|17851923|P3|Day 0 to Day 385|Withdrawal by Subject|0
5170256|NCT01310413|17851924|P2|Day 0 to Day 385|Withdrawal by Subject|2
5170257|NCT01310413|17851925|P1|Day 0 to Day 385|Withdrawal by Subject|5
5170258|NCT01310127|17852107|P2|Overall Study|advanced psc cataract outlier|0
5170259|NCT01310127|17852108|P1|Overall Study|advanced psc cataract outlier|1
5170260|NCT01310127|17852107|P2|Overall Study|Protocol Violation|1
5170261|NCT01310127|17852108|P1|Overall Study|Protocol Violation|1
5170262|NCT01310075|17852122|P2|Overall Study|Withdrawal by Subject|1
5170263|NCT01310075|17852123|P1|Overall Study|Withdrawal by Subject|1
5170264|NCT01310075|17852122|P2|Overall Study|Protocol Violation|2
5170265|NCT01310075|17852123|P1|Overall Study|Protocol Violation|2
5170266|NCT01310075|17852122|P2|Overall Study|Physician Decision|7
5170267|NCT01310075|17852123|P1|Overall Study|Physician Decision|10
5170268|NCT01310075|17852122|P2|Overall Study|Lost to Follow-up|0
5170269|NCT01310075|17852123|P1|Overall Study|Lost to Follow-up|1
5170270|NCT01310036|17852129|P1|Overall Study|Adverse event or intercurrent illness|12
5170271|NCT01310036|17852129|P1|Overall Study|Death|1
5170272|NCT01310036|17852129|P1|Overall Study|Progression of Disease|164
5170273|NCT01310036|17852129|P1|Overall Study|Refused Treatment/Did not Cooperate|4
5170274|NCT01310036|17852129|P1|Overall Study|Withdrew Consent|11
5170275|NCT01310036|17852129|P1|Overall Study|Administrative/other|10
5170276|NCT01309997|17852142|P2|Overall Study|Withdrawal by Subject|1
5170277|NCT01309997|17852143|P1|Overall Study|Withdrawal by Subject|1
5170278|NCT01309997|17852142|P2|Overall Study|Lack of Efficacy|2
5170279|NCT01309997|17852143|P1|Overall Study|Lack of Efficacy|2
5170280|NCT01309997|17852142|P2|Overall Study|Death|3
5170281|NCT01309997|17852143|P1|Overall Study|Death|1
5170282|NCT01309997|17852142|P2|Overall Study|Adverse Event|0
5170283|NCT01309997|17852143|P1|Overall Study|Adverse Event|1
5170284|NCT01309919|17852167|P2|Overall Study|Did not receive a postpartum IUD|48
5170285|NCT01309919|17852168|P1|Overall Study|Did not receive a postpartum IUD|17
5170286|NCT01309893|17852191|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
5170287|NCT01309893|17852192|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
5170288|NCT01309893|17852191|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
5170289|NCT01309893|17852192|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
5170290|NCT01309841|17852229|P3|Overall Study|Severe non-compliance with protocol|2
5170291|NCT01309841|17852230|P2|Overall Study|Severe non-compliance with protocol|5
5170292|NCT01309841|17852231|P1|Overall Study|Severe non-compliance with protocol|0
5170293|NCT01309841|17852229|P3|Overall Study|Did Not Receive Treatment|1
5170294|NCT01309841|17852230|P2|Overall Study|Did Not Receive Treatment|0
5170295|NCT01309841|17852231|P1|Overall Study|Did Not Receive Treatment|2
5170296|NCT01309841|17852229|P3|Overall Study|Withdrawal by Subject|13
5170297|NCT01309841|17852230|P2|Overall Study|Withdrawal by Subject|6
5170298|NCT01309841|17852231|P1|Overall Study|Withdrawal by Subject|17
5170299|NCT01309841|17852229|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
5170300|NCT01309841|17852230|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5170301|NCT01309841|17852231|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5170302|NCT01309841|17852229|P3|Overall Study|Death|0
5170303|NCT01309841|17852230|P2|Overall Study|Death|0
5170304|NCT01309841|17852231|P1|Overall Study|Death|1
5170305|NCT01309841|17852229|P3|Overall Study|Adverse Event|11
5170306|NCT01309841|17852230|P2|Overall Study|Adverse Event|22
5170307|NCT01309841|17852231|P1|Overall Study|Adverse Event|9
5170308|NCT01309841|17852229|P3|Overall Study|Lack of Efficacy|2
5170309|NCT01309841|17852230|P2|Overall Study|Lack of Efficacy|0
5170310|NCT01309841|17852231|P1|Overall Study|Lack of Efficacy|0
5170311|NCT01309841|17852229|P3|Overall Study|Study-Specific Withdrawal Criteria|2
5170312|NCT01309841|17852230|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5170313|NCT01309841|17852231|P1|Overall Study|Study-Specific Withdrawal Criteria|3
5170314|NCT01309841|17852229|P3|Overall Study|Lost to Follow-up|4
5170315|NCT01309841|17852230|P2|Overall Study|Lost to Follow-up|6
5170316|NCT01309841|17852231|P1|Overall Study|Lost to Follow-up|7
5170317|NCT01309841|17852229|P3|Overall Study|Other|1
5170318|NCT01309841|17852230|P2|Overall Study|Other|1
5170319|NCT01309841|17852231|P1|Overall Study|Other|0
5170320|NCT01309828|17852271|P2|Overall Study|Other|0
5170321|NCT01309828|17852272|P1|Overall Study|Other|1
5170322|NCT01309828|17852271|P2|Overall Study|Major Protocol Deviation|1
5170323|NCT01309828|17852272|P1|Overall Study|Major Protocol Deviation|0
5170324|NCT01309828|17852271|P2|Overall Study|Voluntary Withdrawal|4
5170325|NCT01309828|17852272|P1|Overall Study|Voluntary Withdrawal|5
5170326|NCT01309828|17852271|P2|Overall Study|Adverse Event|11
5170327|NCT01309828|17852272|P1|Overall Study|Adverse Event|10
5170328|NCT01309737|17852306|P5|Week 16 to 52|Other|0
5170329|NCT01309737|17852307|P4|Week 16 to 52|Other|2
5170330|NCT01309737|17852308|P3|Week 16 to 52|Other|0
5170331|NCT01309737|17852309|P2|Week 16 to 52|Other|12
5170332|NCT01309737|17852310|P1|Week 16 to 52|Other|10
5170333|NCT01309737|17852306|P5|Week 16 to 52|Withdrawal by Subject|2
5170334|NCT01309737|17852307|P4|Week 16 to 52|Withdrawal by Subject|0
5170335|NCT01309737|17852308|P3|Week 16 to 52|Withdrawal by Subject|0
5170336|NCT01309737|17852309|P2|Week 16 to 52|Withdrawal by Subject|6
5170337|NCT01309737|17852310|P1|Week 16 to 52|Withdrawal by Subject|5
5170338|NCT01309737|17852306|P5|Week 16 to 52|Lost to Follow-up|4
5170339|NCT01309737|17852307|P4|Week 16 to 52|Lost to Follow-up|1
5170340|NCT01309737|17852308|P3|Week 16 to 52|Lost to Follow-up|0
5170341|NCT01309737|17852309|P2|Week 16 to 52|Lost to Follow-up|2
5170342|NCT01309737|17852310|P1|Week 16 to 52|Lost to Follow-up|4
5170343|NCT01309737|17852306|P5|Week 16 to 52|Lack of Efficacy|21
5170344|NCT01309737|17852307|P4|Week 16 to 52|Lack of Efficacy|25
5170345|NCT01309737|17852308|P3|Week 16 to 52|Lack of Efficacy|0
5170346|NCT01309737|17852309|P2|Week 16 to 52|Lack of Efficacy|76
5170347|NCT01309737|17852310|P1|Week 16 to 52|Lack of Efficacy|107
5170348|NCT01309737|17852306|P5|Week 16 to 52|Adverse Event|5
5170349|NCT01309737|17852307|P4|Week 16 to 52|Adverse Event|6
5170350|NCT01309737|17852308|P3|Week 16 to 52|Adverse Event|0
5170351|NCT01309737|17852309|P2|Week 16 to 52|Adverse Event|7
5170352|NCT01309737|17852310|P1|Week 16 to 52|Adverse Event|7
5170353|NCT01309737|17852306|P5|Week 16 to 52|Death|1
5170354|NCT01309737|17852307|P4|Week 16 to 52|Death|0
5170355|NCT01309737|17852308|P3|Week 16 to 52|Death|0
5170356|NCT01309737|17852309|P2|Week 16 to 52|Death|0
5170357|NCT01309737|17852310|P1|Week 16 to 52|Death|0
5170358|NCT01309737|17852306|P5|Week 0 to 16|Randomized, but not treated|0
5170359|NCT01309737|17852307|P4|Week 0 to 16|Randomized, but not treated|0
5170360|NCT01309737|17852308|P3|Week 0 to 16|Randomized, but not treated|0
5170361|NCT01309737|17852309|P2|Week 0 to 16|Randomized, but not treated|0
5170362|NCT01309737|17852310|P1|Week 0 to 16|Randomized, but not treated|1
5170363|NCT01309737|17852306|P5|Week 0 to 16|Other|0
5170364|NCT01309737|17852307|P4|Week 0 to 16|Other|0
5170365|NCT01309737|17852308|P3|Week 0 to 16|Other|4
5170366|NCT01309737|17852309|P2|Week 0 to 16|Other|14
5170367|NCT01309737|17852310|P1|Week 0 to 16|Other|10
5170368|NCT01309737|17852306|P5|Week 0 to 16|Withdrawal by Subject|0
5170369|NCT01309737|17852307|P4|Week 0 to 16|Withdrawal by Subject|0
5170370|NCT01309737|17852308|P3|Week 0 to 16|Withdrawal by Subject|7
5170371|NCT01309737|17852309|P2|Week 0 to 16|Withdrawal by Subject|6
5170372|NCT01309737|17852310|P1|Week 0 to 16|Withdrawal by Subject|7
5170373|NCT01309737|17852306|P5|Week 0 to 16|Lost to Follow-up|0
5170374|NCT01309737|17852307|P4|Week 0 to 16|Lost to Follow-up|0
5170375|NCT01309737|17852308|P3|Week 0 to 16|Lost to Follow-up|3
5170376|NCT01309737|17852309|P2|Week 0 to 16|Lost to Follow-up|8
5170377|NCT01309737|17852310|P1|Week 0 to 16|Lost to Follow-up|7
5170378|NCT01309737|17852306|P5|Week 0 to 16|Lack of Efficacy|0
5170379|NCT01309737|17852307|P4|Week 0 to 16|Lack of Efficacy|0
5170380|NCT01309737|17852308|P3|Week 0 to 16|Lack of Efficacy|24
5170381|NCT01309737|17852309|P2|Week 0 to 16|Lack of Efficacy|2
5170382|NCT01309737|17852310|P1|Week 0 to 16|Lack of Efficacy|15
5170383|NCT01309737|17852306|P5|Week 0 to 16|Adverse Event|0
5170384|NCT01309737|17852307|P4|Week 0 to 16|Adverse Event|0
5170385|NCT01309737|17852308|P3|Week 0 to 16|Adverse Event|5
5170386|NCT01309737|17852309|P2|Week 0 to 16|Adverse Event|10
5170387|NCT01309737|17852310|P1|Week 0 to 16|Adverse Event|11
5170388|NCT01309737|17852306|P5|Week 0 to 16|Death|0
5170389|NCT01309737|17852307|P4|Week 0 to 16|Death|0
5170390|NCT01309737|17852308|P3|Week 0 to 16|Death|1
5170391|NCT01309737|17852309|P2|Week 0 to 16|Death|0
5170392|NCT01309737|17852310|P1|Week 0 to 16|Death|1
5170393|NCT01309672|17852505|P1|Overall Study|Withdrawal by Subject|3
5170394|NCT01309672|17852505|P1|Overall Study|Adverse Event|5
5170395|NCT01309672|17852505|P1|Overall Study|Other|9
5170396|NCT01309672|17852505|P1|Overall Study|Lack of Efficacy|20
5170397|NCT01309659|17852515|P2|Overall Study|Protocol Violation|1
5170398|NCT01309659|17852516|P1|Overall Study|Protocol Violation|0
5170399|NCT01309386|17852621|P2|Overall Study|Adverse Event|8
5170400|NCT01309386|17852622|P1|Overall Study|Adverse Event|5
5170401|NCT01309386|17852621|P2|Overall Study|Lack of Efficacy|1
5170402|NCT01309386|17852622|P1|Overall Study|Lack of Efficacy|3
5170403|NCT01309386|17852621|P2|Overall Study|Physician Decision|1
5170404|NCT01309386|17852622|P1|Overall Study|Physician Decision|1
5170405|NCT01309386|17852621|P2|Overall Study|Progressive disease|11
5170406|NCT01309386|17852622|P1|Overall Study|Progressive disease|9
5170407|NCT01309386|17852621|P2|Overall Study|Withdrawal by Subject|0
5170408|NCT01309386|17852622|P1|Overall Study|Withdrawal by Subject|2
5170409|NCT01309386|17852621|P2|Overall Study|Other|0
5170410|NCT01309386|17852622|P1|Overall Study|Other|2
5170411|NCT01309308|17852670|P2|Overall Study|Lost to Follow-up|4
5170412|NCT01309308|17852671|P1|Overall Study|Lost to Follow-up|6
5170413|NCT01309282|17852679|P1|Overall Study|Lost to Follow-up|1
5170414|NCT01309269|17852696|P1|Overall Study|Enrolled but not Treated|107
5170415|NCT01309269|17852696|P1|Overall Study|Study Completion Data Not Recorded|95
5170416|NCT01309269|17852696|P1|Overall Study|Other|1
5170417|NCT01309269|17852696|P1|Overall Study|Other|256
5170418|NCT01309269|17852696|P1|Overall Study|Administrative Problems|141
5170419|NCT01309269|17852696|P1|Overall Study|Kidney Transplant|25
5170420|NCT01309269|17852696|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
5170421|NCT01309269|17852696|P1|Overall Study|Lack of Acceptance|15
5170422|NCT01309269|17852696|P1|Overall Study|Withdrawal by Subject|25
5170423|NCT01309269|17852696|P1|Overall Study|Adverse Event|56
5170424|NCT01309243|17852704|P2|Extension Phase|Lost to Follow-up|0
5170425|NCT01309243|17852705|P1|Extension Phase|Lost to Follow-up|6
5170426|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Protocol Violation|1
5170427|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Protocol Violation|1
5170428|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
5170429|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
5170430|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
5170431|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
5170432|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Withdrew Consent|18
5170433|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Withdrew Consent|12
5170434|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Investigators Discretion|6
5170435|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Investigators Discretion|3
5170436|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
5170437|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
5170438|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Pregnancy|0
5170439|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Pregnancy|2
5170440|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Death|1
5170441|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Death|0
5170442|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Adverse Event|43
5170443|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Adverse Event|12
5170444|NCT01309243|17852704|P2|Randomized Phase Through Week 96|Randomized but not treated|7
5170445|NCT01309243|17852705|P1|Randomized Phase Through Week 96|Randomized but not treated|6
5170446|NCT01309204|17852731|P2|Overall Study|Other|1
5170447|NCT01309204|17852732|P1|Overall Study|Other|4
5170448|NCT01309204|17852731|P2|Overall Study|Inadequate control of IOP|4
5170449|NCT01309204|17852732|P1|Overall Study|Inadequate control of IOP|4
5170450|NCT01309204|17852731|P2|Overall Study|Subject's decision unrelated to an AE|10
5170451|NCT01309204|17852732|P1|Overall Study|Subject's decision unrelated to an AE|9
5170452|NCT01309204|17852731|P2|Overall Study|Lost to Follow-up|2
5170453|NCT01309204|17852732|P1|Overall Study|Lost to Follow-up|2
5170454|NCT01309204|17852731|P2|Overall Study|Adverse Event|58
5170455|NCT01309204|17852732|P1|Overall Study|Adverse Event|48
5170456|NCT01309165|17852740|P2|Overall Study|Admitted to hospital for second stroke|0
5170457|NCT01309165|17852741|P1|Overall Study|Admitted to hospital for second stroke|1
5170458|NCT01309165|17852740|P2|Overall Study|No transportation|1
5170459|NCT01309165|17852741|P1|Overall Study|No transportation|0
5170460|NCT01309165|17852740|P2|Overall Study|Left country|1
5170461|NCT01309165|17852741|P1|Overall Study|Left country|0
5170462|NCT01309165|17852740|P2|Overall Study|Return to work|2
5170463|NCT01309165|17852741|P1|Overall Study|Return to work|1
5170464|NCT01309165|17852740|P2|Overall Study|Lost to Follow-up|3
5170465|NCT01309165|17852741|P1|Overall Study|Lost to Follow-up|4
5170466|NCT01309100|17852753|P1|Overall Study|Positive Slit lamp finding|1
5170467|NCT01309100|17852753|P1|Overall Study|Protocol Violation|1
5170468|NCT01308853|17852771|P1|Overall Study|Insertion of permanent implants|1
5170469|NCT01308853|17852771|P1|Overall Study|Lost to Follow-up|2
5170470|NCT01308853|17852771|P1|Overall Study|Adverse Event|1
5170471|NCT01308788|17852806|P2|2-year Treatment|medication change by treating physician|11
5170472|NCT01308788|17852807|P1|2-year Treatment|medication change by treating physician|4
5170473|NCT01308762|17852842|P3|Overall Study|Protocol Violation|0
5170474|NCT01308762|17852843|P2|Overall Study|Protocol Violation|1
5170475|NCT01308762|17852844|P1|Overall Study|Protocol Violation|0
5170476|NCT01308749|17852857|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
5170477|NCT01308749|17852858|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
5170478|NCT01308749|17852857|P2|Period 2: Open Label Treatment|Adverse Event|1
5170479|NCT01308749|17852858|P1|Period 2: Open Label Treatment|Adverse Event|0
5170480|NCT01308749|17852857|P2|Period 1: Double Blind Treatment|Adverse Event|0
5170481|NCT01308749|17852858|P1|Period 1: Double Blind Treatment|Adverse Event|1
5170482|NCT01308736|17852888|P2|Overall Study|Did not attend a single session|5
5170483|NCT01308736|17852889|P1|Overall Study|Did not attend a single session|6
5170484|NCT01308580|17852912|P2|Overall Study|Lost to Follow-up|7
5170485|NCT01308580|17852913|P1|Overall Study|Lost to Follow-up|12
5170486|NCT01308567|17852956|P3|Overall Study|Lost to Follow-up|4
5170487|NCT01308567|17852957|P2|Overall Study|Lost to Follow-up|4
5170488|NCT01308567|17852958|P1|Overall Study|Lost to Follow-up|2
5170489|NCT01308476|17852998|P2|Overall Study|Other|0
5170490|NCT01308476|17852999|P1|Overall Study|Other|1
5170491|NCT01308476|17852998|P2|Overall Study|Lost to Follow-up|2
5170492|NCT01308476|17852999|P1|Overall Study|Lost to Follow-up|2
5170493|NCT01308463|17853019|P1|Overall Study|Revision|2
5170494|NCT01308463|17853019|P1|Overall Study|Death|4
5170495|NCT01308463|17853019|P1|Overall Study|Study Discontinued|23
5170496|NCT01308424|17853032|P3|Randomization|Physician Decision|1
5170497|NCT01308424|17853033|P2|Randomization|Physician Decision|1
5170498|NCT01308424|17853034|P1|Randomization|Physician Decision|0
5170499|NCT01308424|17853032|P3|Randomization|Lost to Follow-up|0
5170500|NCT01308424|17853033|P2|Randomization|Lost to Follow-up|1
5170501|NCT01308424|17853034|P1|Randomization|Lost to Follow-up|0
5170502|NCT01308424|17853032|P3|Randomization|Adverse Event|1
5170503|NCT01308424|17853033|P2|Randomization|Adverse Event|1
5170504|NCT01308424|17853034|P1|Randomization|Adverse Event|0
5170505|NCT01308424|17853032|P3|Baseline Eligibility|Screen Failures|0
5170506|NCT01308424|17853033|P2|Baseline Eligibility|Screen Failures|0
5170507|NCT01308424|17853034|P1|Baseline Eligibility|Screen Failures|71
5170508|NCT01308008|17853086|P2|4 Weeks|Illness, disinterest, time|2
5170509|NCT01308008|17853087|P1|4 Weeks|Illness, disinterest, time|9
5170510|NCT01307891|17853110|P2|Overall Study|Progressive Disease|1
5170511|NCT01307891|17853111|P1|Overall Study|Progressive Disease|3
5170512|NCT01307787|17853123|P2|Overall Study|Withdrawal by Subject|0
5170513|NCT01307787|17853124|P1|Overall Study|Withdrawal by Subject|2
5170514|NCT01307579|17853193|P2|Overall Study|Ineligible|4
5170515|NCT01307579|17853194|P1|Overall Study|Ineligible|3
5170516|NCT01307579|17853193|P2|Overall Study|Refractory or relapsed AML|23
5170517|NCT01307579|17853194|P1|Overall Study|Refractory or relapsed AML|38
5170518|NCT01307579|17853193|P2|Overall Study|Begin conditioning for HSCT|44
5170519|NCT01307579|17853194|P1|Overall Study|Begin conditioning for HSCT|42
5170520|NCT01307579|17853193|P2|Overall Study|Institutional diagnosis of IFD|36
5170521|NCT01307579|17853194|P1|Overall Study|Institutional diagnosis of IFD|21
5170522|NCT01307579|17853193|P2|Overall Study|Withdrawal by Subject|3
5170523|NCT01307579|17853194|P1|Overall Study|Withdrawal by Subject|7
5170524|NCT01307579|17853193|P2|Overall Study|Physician Decision|29
5170525|NCT01307579|17853194|P1|Overall Study|Physician Decision|26
5170526|NCT01307579|17853193|P2|Overall Study|Death|6
5170527|NCT01307579|17853194|P1|Overall Study|Death|3
5170528|NCT01307501|17853206|P1|Overall Study|Starting Hospice|1
5170529|NCT01307501|17853206|P1|Overall Study|Lost to Follow-up|1
5170530|NCT01307501|17853206|P1|Overall Study|Death|20
5170531|NCT01307501|17853206|P1|Overall Study|Treatment Failure|1
5170532|NCT01307449|17853236|P4|Overall Study|Adverse Event|0
5170533|NCT01307449|17853237|P3|Overall Study|Adverse Event|0
5170534|NCT01307449|17853238|P2|Overall Study|Adverse Event|0
5170535|NCT01307449|17853239|P1|Overall Study|Adverse Event|1
5170536|NCT01307423|17853272|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
5170537|NCT01307423|17853273|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
5170538|NCT01307423|17853274|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
5170539|NCT01307423|17853275|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
5170540|NCT01307423|17853276|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
5170541|NCT01307423|17853277|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
5170542|NCT01307423|17853278|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
5170543|NCT01307423|17853279|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
5170544|NCT01307423|17853280|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
5170545|NCT01307423|17853272|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170546|NCT01307423|17853273|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170547|NCT01307423|17853274|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170548|NCT01307423|17853275|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170549|NCT01307423|17853276|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170550|NCT01307423|17853277|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170551|NCT01307423|17853278|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170552|NCT01307423|17853279|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
5170553|NCT01307423|17853280|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5170554|NCT01307423|17853272|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5170555|NCT01307423|17853273|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5170556|NCT01307423|17853274|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5170557|NCT01307423|17853275|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5170558|NCT01307423|17853276|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5170559|NCT01307423|17853277|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5170560|NCT01307423|17853278|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
5170561|NCT01307423|17853279|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
5170562|NCT01307423|17853280|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5170563|NCT01307423|17853272|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170564|NCT01307423|17853273|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170565|NCT01307423|17853274|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170566|NCT01307423|17853275|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170567|NCT01307423|17853276|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170568|NCT01307423|17853277|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170569|NCT01307423|17853278|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
5170570|NCT01307423|17853279|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
5170571|NCT01307423|17853280|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5170572|NCT01307423|17853272|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
5170573|NCT01307423|17853273|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
5170574|NCT01307423|17853274|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
5170575|NCT01307423|17853275|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
5170576|NCT01307423|17853276|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
5170577|NCT01307423|17853277|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
5170578|NCT01307423|17853278|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
5170579|NCT01307423|17853279|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
5170580|NCT01307423|17853280|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
5170581|NCT01307423|17853272|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170582|NCT01307423|17853273|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
5170583|NCT01307423|17853274|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170584|NCT01307423|17853275|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170585|NCT01307423|17853276|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170586|NCT01307423|17853277|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170587|NCT01307423|17853278|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170588|NCT01307423|17853279|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170589|NCT01307423|17853280|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
5170590|NCT01307423|17853272|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170591|NCT01307423|17853273|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170592|NCT01307423|17853274|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170593|NCT01307423|17853275|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170594|NCT01307423|17853276|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170595|NCT01307423|17853277|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170596|NCT01307423|17853278|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
5170597|NCT01307423|17853279|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170598|NCT01307423|17853280|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5170599|NCT01307423|17853272|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
5170600|NCT01307423|17853273|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
5170601|NCT01307423|17853274|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5170602|NCT01307423|17853275|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5170603|NCT01307423|17853276|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5170604|NCT01307423|17853277|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5170605|NCT01307423|17853278|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
5170606|NCT01307423|17853279|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
5170607|NCT01307423|17853280|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5170608|NCT01307423|17853272|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5170609|NCT01307423|17853273|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170610|NCT01307423|17853274|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170611|NCT01307423|17853275|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170612|NCT01307423|17853276|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170613|NCT01307423|17853277|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170614|NCT01307423|17853278|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170615|NCT01307423|17853279|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5170616|NCT01307423|17853280|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5170617|NCT01307423|17853272|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
5170618|NCT01307423|17853273|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
5170619|NCT01307423|17853274|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
5170620|NCT01307423|17853275|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
5170621|NCT01307423|17853276|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
5170622|NCT01307423|17853277|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
5170623|NCT01307423|17853278|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
5170624|NCT01307423|17853279|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
5170625|NCT01307423|17853280|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
5170626|NCT01307423|17853272|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170627|NCT01307423|17853273|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
5170628|NCT01307423|17853274|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170629|NCT01307423|17853275|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170630|NCT01307423|17853276|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170631|NCT01307423|17853277|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170632|NCT01307423|17853278|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170633|NCT01307423|17853279|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
5170634|NCT01307423|17853280|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
5170635|NCT01307423|17853272|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5170636|NCT01307423|17853273|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5170637|NCT01307423|17853274|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5170638|NCT01307423|17853275|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5170639|NCT01307423|17853276|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5170640|NCT01307423|17853277|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5170641|NCT01307423|17853278|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
5170642|NCT01307423|17853279|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
5170643|NCT01307423|17853280|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5170644|NCT01307423|17853272|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
5170645|NCT01307423|17853273|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
5170646|NCT01307423|17853274|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5170647|NCT01307423|17853275|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5170648|NCT01307423|17853276|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5170649|NCT01307423|17853277|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5170650|NCT01307423|17853278|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
5170651|NCT01307423|17853279|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
5170652|NCT01307423|17853280|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5170653|NCT01307423|17853272|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170654|NCT01307423|17853273|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170798|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170655|NCT01307423|17853274|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170656|NCT01307423|17853275|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170657|NCT01307423|17853276|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170658|NCT01307423|17853277|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170659|NCT01307423|17853278|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
5170660|NCT01307423|17853279|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
5170661|NCT01307423|17853280|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5170662|NCT01307423|17853272|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5170663|NCT01307423|17853273|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
5170664|NCT01307423|17853274|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5170665|NCT01307423|17853275|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5170666|NCT01307423|17853276|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5170667|NCT01307423|17853277|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5170668|NCT01307423|17853278|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
5170669|NCT01307423|17853279|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5170670|NCT01307423|17853280|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5170671|NCT01307423|17853272|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
5170672|NCT01307423|17853273|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
5170673|NCT01307423|17853274|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
5170674|NCT01307423|17853275|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
5170675|NCT01307423|17853276|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
5170676|NCT01307423|17853277|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
5170677|NCT01307423|17853278|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
5170678|NCT01307423|17853279|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
5170679|NCT01307423|17853280|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
5170680|NCT01307423|17853272|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
5170681|NCT01307423|17853273|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
5170682|NCT01307423|17853274|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
5170683|NCT01307423|17853275|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
5170684|NCT01307423|17853276|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
5170685|NCT01307423|17853277|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
5170686|NCT01307423|17853278|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
5170687|NCT01307423|17853279|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
5170688|NCT01307423|17853280|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
5170689|NCT01307423|17853272|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
5170690|NCT01307423|17853273|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
5170691|NCT01307423|17853274|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5170692|NCT01307423|17853275|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5170693|NCT01307423|17853276|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5170694|NCT01307423|17853277|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5170695|NCT01307423|17853278|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
5170696|NCT01307423|17853279|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
5170697|NCT01307423|17853280|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5170698|NCT01307423|17853272|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170699|NCT01307423|17853273|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170700|NCT01307423|17853274|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170701|NCT01307423|17853275|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170702|NCT01307423|17853276|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170703|NCT01307423|17853277|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170704|NCT01307423|17853278|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
5170705|NCT01307423|17853279|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170706|NCT01307423|17853280|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5170707|NCT01307423|17853272|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
5170708|NCT01307423|17853273|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
5170709|NCT01307423|17853274|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5170710|NCT01307423|17853275|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5170711|NCT01307423|17853276|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5170712|NCT01307423|17853277|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5170713|NCT01307423|17853278|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
5170714|NCT01307423|17853279|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
5170715|NCT01307423|17853280|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5170716|NCT01307423|17853272|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
5170717|NCT01307423|17853273|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
5170718|NCT01307423|17853274|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
5170719|NCT01307423|17853275|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
5170720|NCT01307423|17853276|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
5170721|NCT01307423|17853277|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
5170722|NCT01307423|17853278|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
5170723|NCT01307423|17853279|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
5170724|NCT01307423|17853280|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
5170725|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170726|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170727|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170728|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
5170729|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170730|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170731|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170732|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170733|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5170734|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Other|0
5170735|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Other|0
5170736|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Other|0
5170737|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Other|0
5170738|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Other|0
5170739|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Other|1
5170740|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Other|0
5170741|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Other|0
5170742|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Other|0
5170743|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170744|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170745|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170746|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170747|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170748|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
5170749|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170750|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170751|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5170752|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5170753|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5170754|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
5170755|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
5170756|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5170757|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5170758|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
5170759|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
5170760|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5170761|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170762|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170763|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170764|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
5170765|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170766|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170767|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170768|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170769|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5170770|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5170771|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5170772|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5170773|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5170774|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
5170775|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
5170776|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
5170777|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
5170778|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5170779|NCT01307423|17853272|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
5170780|NCT01307423|17853273|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
5170781|NCT01307423|17853274|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
5170782|NCT01307423|17853275|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
5170783|NCT01307423|17853276|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
5170784|NCT01307423|17853277|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
5170785|NCT01307423|17853278|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
5170786|NCT01307423|17853279|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
5170787|NCT01307423|17853280|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
5170788|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170789|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170790|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170791|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170792|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170793|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170794|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
5170795|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
5170796|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5170797|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170799|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170800|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170801|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170802|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170803|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
5170804|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
5170805|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
5170806|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170807|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170808|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170809|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170810|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170811|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170812|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170813|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5170814|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5170815|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5170816|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5170817|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5170818|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5170819|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5170820|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5170821|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
5170822|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5170823|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
5170824|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170825|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170826|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170827|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170828|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170829|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170830|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
5170831|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170832|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5170833|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5170834|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5170835|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5170836|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5170837|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5170838|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5170839|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
5170840|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5170841|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
5170842|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5170843|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5170844|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5170845|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5170846|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5170847|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5170848|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5170849|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5170850|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
5170851|NCT01307423|17853272|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5170852|NCT01307423|17853273|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5170853|NCT01307423|17853274|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5170854|NCT01307423|17853275|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5170855|NCT01307423|17853276|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5170856|NCT01307423|17853277|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5170857|NCT01307423|17853278|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
5170858|NCT01307423|17853279|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5170859|NCT01307423|17853280|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5170860|NCT01307319|17853486|P3|Overall Study|Other|3
5170861|NCT01307319|17853487|P2|Overall Study|Other|4
5170862|NCT01307319|17853488|P1|Overall Study|Other|0
5170863|NCT01307319|17853486|P3|Overall Study|Withdrawal by Subject|2
5170864|NCT01307319|17853487|P2|Overall Study|Withdrawal by Subject|1
5170865|NCT01307319|17853488|P1|Overall Study|Withdrawal by Subject|0
5170866|NCT01307319|17853486|P3|Overall Study|Protocol Violation|0
5170867|NCT01307319|17853487|P2|Overall Study|Protocol Violation|1
5170868|NCT01307319|17853488|P1|Overall Study|Protocol Violation|1
5170869|NCT01307319|17853486|P3|Overall Study|Lost to Follow-up|1
5170870|NCT01307319|17853487|P2|Overall Study|Lost to Follow-up|0
5170871|NCT01307319|17853488|P1|Overall Study|Lost to Follow-up|1
5170872|NCT01307319|17853486|P3|Overall Study|Adverse Event|1
5170873|NCT01307319|17853487|P2|Overall Study|Adverse Event|2
5170874|NCT01307319|17853488|P1|Overall Study|Adverse Event|2
5170875|NCT01307267|17853522|P23|Overall Study|Other|2
5170876|NCT01307267|17853523|P22|Overall Study|Other|3
5170877|NCT01307267|17853524|P21|Overall Study|Other|2
5170878|NCT01307267|17853525|P20|Overall Study|Other|19
5170879|NCT01307267|17853526|P19|Overall Study|Other|0
5170880|NCT01307267|17853527|P18|Overall Study|Other|0
5170881|NCT01307267|17853528|P17|Overall Study|Other|0
5170882|NCT01307267|17853529|P16|Overall Study|Other|1
5170883|NCT01307267|17853530|P15|Overall Study|Other|2
5170884|NCT01307267|17853531|P14|Overall Study|Other|0
5170885|NCT01307267|17853532|P13|Overall Study|Other|1
5170886|NCT01307267|17853533|P12|Overall Study|Other|1
5170887|NCT01307267|17853534|P11|Overall Study|Other|1
5170888|NCT01307267|17853535|P10|Overall Study|Other|0
5170889|NCT01307267|17853536|P9|Overall Study|Other|3
5170890|NCT01307267|17853537|P8|Overall Study|Other|1
5170891|NCT01307267|17853538|P7|Overall Study|Other|0
5170892|NCT01307267|17853539|P6|Overall Study|Other|7
5170893|NCT01307267|17853540|P5|Overall Study|Other|0
5170894|NCT01307267|17853541|P4|Overall Study|Other|0
5170895|NCT01307267|17853542|P3|Overall Study|Other|0
5170896|NCT01307267|17853543|P2|Overall Study|Other|0
5170897|NCT01307267|17853544|P1|Overall Study|Other|0
5170898|NCT01307267|17853522|P23|Overall Study|Withdrawal by Subject|0
5170899|NCT01307267|17853523|P22|Overall Study|Withdrawal by Subject|0
5170900|NCT01307267|17853524|P21|Overall Study|Withdrawal by Subject|0
5170901|NCT01307267|17853525|P20|Overall Study|Withdrawal by Subject|3
5170902|NCT01307267|17853526|P19|Overall Study|Withdrawal by Subject|0
5170903|NCT01307267|17853527|P18|Overall Study|Withdrawal by Subject|0
5170904|NCT01307267|17853528|P17|Overall Study|Withdrawal by Subject|0
5170905|NCT01307267|17853529|P16|Overall Study|Withdrawal by Subject|0
5170906|NCT01307267|17853530|P15|Overall Study|Withdrawal by Subject|0
5170907|NCT01307267|17853531|P14|Overall Study|Withdrawal by Subject|0
5170908|NCT01307267|17853532|P13|Overall Study|Withdrawal by Subject|0
5170909|NCT01307267|17853533|P12|Overall Study|Withdrawal by Subject|1
5170910|NCT01307267|17853534|P11|Overall Study|Withdrawal by Subject|1
5170911|NCT01307267|17853535|P10|Overall Study|Withdrawal by Subject|1
5170912|NCT01307267|17853536|P9|Overall Study|Withdrawal by Subject|5
5170913|NCT01307267|17853537|P8|Overall Study|Withdrawal by Subject|1
5170914|NCT01307267|17853538|P7|Overall Study|Withdrawal by Subject|0
5170915|NCT01307267|17853539|P6|Overall Study|Withdrawal by Subject|1
5170916|NCT01307267|17853540|P5|Overall Study|Withdrawal by Subject|0
5170917|NCT01307267|17853541|P4|Overall Study|Withdrawal by Subject|0
5170918|NCT01307267|17853542|P3|Overall Study|Withdrawal by Subject|0
5170919|NCT01307267|17853543|P2|Overall Study|Withdrawal by Subject|0
5170920|NCT01307267|17853544|P1|Overall Study|Withdrawal by Subject|0
5170921|NCT01307267|17853522|P23|Overall Study|Lost to Follow-up|0
5170922|NCT01307267|17853523|P22|Overall Study|Lost to Follow-up|0
5170923|NCT01307267|17853524|P21|Overall Study|Lost to Follow-up|0
5170924|NCT01307267|17853525|P20|Overall Study|Lost to Follow-up|2
5170925|NCT01307267|17853526|P19|Overall Study|Lost to Follow-up|0
5170926|NCT01307267|17853527|P18|Overall Study|Lost to Follow-up|0
5170927|NCT01307267|17853528|P17|Overall Study|Lost to Follow-up|0
5170928|NCT01307267|17853529|P16|Overall Study|Lost to Follow-up|0
5170929|NCT01307267|17853530|P15|Overall Study|Lost to Follow-up|0
5170930|NCT01307267|17853531|P14|Overall Study|Lost to Follow-up|0
5170931|NCT01307267|17853532|P13|Overall Study|Lost to Follow-up|0
5170932|NCT01307267|17853533|P12|Overall Study|Lost to Follow-up|0
5170933|NCT01307267|17853534|P11|Overall Study|Lost to Follow-up|1
5170934|NCT01307267|17853535|P10|Overall Study|Lost to Follow-up|2
5170935|NCT01307267|17853536|P9|Overall Study|Lost to Follow-up|1
5170936|NCT01307267|17853537|P8|Overall Study|Lost to Follow-up|0
5170937|NCT01307267|17853538|P7|Overall Study|Lost to Follow-up|0
5170938|NCT01307267|17853539|P6|Overall Study|Lost to Follow-up|7
5170939|NCT01307267|17853540|P5|Overall Study|Lost to Follow-up|0
5170940|NCT01307267|17853541|P4|Overall Study|Lost to Follow-up|0
5170941|NCT01307267|17853542|P3|Overall Study|Lost to Follow-up|0
5170942|NCT01307267|17853543|P2|Overall Study|Lost to Follow-up|0
5170943|NCT01307267|17853544|P1|Overall Study|Lost to Follow-up|0
5170944|NCT01307267|17853522|P23|Overall Study|Death|2
5170945|NCT01307267|17853523|P22|Overall Study|Death|2
5170946|NCT01307267|17853524|P21|Overall Study|Death|1
5170947|NCT01307267|17853525|P20|Overall Study|Death|8
5170948|NCT01307267|17853526|P19|Overall Study|Death|2
5170949|NCT01307267|17853527|P18|Overall Study|Death|1
5170950|NCT01307267|17853528|P17|Overall Study|Death|1
5170951|NCT01307267|17853529|P16|Overall Study|Death|0
5170952|NCT01307267|17853530|P15|Overall Study|Death|0
5170953|NCT01307267|17853531|P14|Overall Study|Death|0
5170954|NCT01307267|17853532|P13|Overall Study|Death|0
5170955|NCT01307267|17853533|P12|Overall Study|Death|9
5170956|NCT01307267|17853534|P11|Overall Study|Death|3
5170957|NCT01307267|17853535|P10|Overall Study|Death|2
5170958|NCT01307267|17853536|P9|Overall Study|Death|21
5170959|NCT01307267|17853537|P8|Overall Study|Death|2
5170960|NCT01307267|17853538|P7|Overall Study|Death|2
5170961|NCT01307267|17853539|P6|Overall Study|Death|26
5170962|NCT01307267|17853540|P5|Overall Study|Death|1
5170963|NCT01307267|17853541|P4|Overall Study|Death|3
5170964|NCT01307267|17853542|P3|Overall Study|Death|5
5170965|NCT01307267|17853543|P2|Overall Study|Death|3
5170966|NCT01307267|17853544|P1|Overall Study|Death|4
5170967|NCT01307111|17854135|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
5170968|NCT01307111|17854136|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
5170969|NCT01307111|17854135|P2|IUD Insertion|Lost to Follow-up|0
5170970|NCT01307111|17854136|P1|IUD Insertion|Lost to Follow-up|2
5170971|NCT01307046|17854159|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
5170972|NCT01307046|17854160|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
5170973|NCT01307046|17854159|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
5170974|NCT01307046|17854160|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
5170975|NCT01307046|17854159|P2|Overall Study|Withdrawal by Subject|1
5170976|NCT01307046|17854160|P1|Overall Study|Withdrawal by Subject|1
5170977|NCT01307046|17854159|P2|Overall Study|Physician Decision|0
5170978|NCT01307046|17854160|P1|Overall Study|Physician Decision|2
5170979|NCT01307046|17854159|P2|Overall Study|Lack of Efficacy|2
5170980|NCT01307046|17854160|P1|Overall Study|Lack of Efficacy|0
5170981|NCT01307046|17854159|P2|Overall Study|Adverse Event|3
5170982|NCT01307046|17854160|P1|Overall Study|Adverse Event|3
5170983|NCT01307033|17854172|P4|44-week Open-label Extension|Death|1
5170984|NCT01307033|17854173|P3|44-week Open-label Extension|Death|0
5170985|NCT01307033|17854174|P2|44-week Open-label Extension|Death|0
5170986|NCT01307033|17854175|P1|44-week Open-label Extension|Death|0
5170987|NCT01307033|17854172|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
5170988|NCT01307033|17854173|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
5170989|NCT01307033|17854174|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
5170990|NCT01307033|17854175|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
5170991|NCT01307033|17854172|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
5170992|NCT01307033|17854173|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5170993|NCT01307033|17854174|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5170994|NCT01307033|17854175|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5170995|NCT01307033|17854172|P4|44-week Open-label Extension|Physician Decision|0
5170996|NCT01307033|17854173|P3|44-week Open-label Extension|Physician Decision|1
5170997|NCT01307033|17854174|P2|44-week Open-label Extension|Physician Decision|0
5170998|NCT01307033|17854175|P1|44-week Open-label Extension|Physician Decision|0
5170999|NCT01307033|17854172|P4|44-week Open-label Extension|Withdrawal by Subject|1
5171000|NCT01307033|17854173|P3|44-week Open-label Extension|Withdrawal by Subject|2
5171001|NCT01307033|17854174|P2|44-week Open-label Extension|Withdrawal by Subject|0
5171002|NCT01307033|17854175|P1|44-week Open-label Extension|Withdrawal by Subject|0
5171003|NCT01307033|17854172|P4|44-week Open-label Extension|Adverse Event|1
5171004|NCT01307033|17854173|P3|44-week Open-label Extension|Adverse Event|2
5171005|NCT01307033|17854174|P2|44-week Open-label Extension|Adverse Event|0
5171006|NCT01307033|17854175|P1|44-week Open-label Extension|Adverse Event|0
5171007|NCT01307033|17854172|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
5171008|NCT01307033|17854173|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
5171009|NCT01307033|17854174|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
5171010|NCT01307033|17854175|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
5171011|NCT01307033|17854172|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5171012|NCT01307033|17854173|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5171013|NCT01307033|17854174|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
5171014|NCT01307033|17854175|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5171015|NCT01307033|17854172|P4|8-week Double-blind Period|Lack of Efficacy|0
5171016|NCT01307033|17854173|P3|8-week Double-blind Period|Lack of Efficacy|0
5171017|NCT01307033|17854174|P2|8-week Double-blind Period|Lack of Efficacy|0
5171018|NCT01307033|17854175|P1|8-week Double-blind Period|Lack of Efficacy|1
5171019|NCT01307033|17854172|P4|8-week Double-blind Period|Withdrawal by Subject|0
5171020|NCT01307033|17854173|P3|8-week Double-blind Period|Withdrawal by Subject|0
5171021|NCT01307033|17854174|P2|8-week Double-blind Period|Withdrawal by Subject|1
5171022|NCT01307033|17854175|P1|8-week Double-blind Period|Withdrawal by Subject|4
5171023|NCT01307033|17854172|P4|8-week Double-blind Period|Adverse Event|0
5171024|NCT01307033|17854173|P3|8-week Double-blind Period|Adverse Event|0
5171025|NCT01307033|17854174|P2|8-week Double-blind Period|Adverse Event|0
5171026|NCT01307033|17854175|P1|8-week Double-blind Period|Adverse Event|2
5171027|NCT01307020|17854197|P10|Overall Study|Electronic data capture failure|0
5171028|NCT01307020|17854198|P9|Overall Study|Electronic data capture failure|0
5171029|NCT01307020|17854199|P8|Overall Study|Electronic data capture failure|0
5171030|NCT01307020|17854200|P7|Overall Study|Electronic data capture failure|0
5171031|NCT01307020|17854201|P6|Overall Study|Electronic data capture failure|0
5171032|NCT01307020|17854202|P5|Overall Study|Electronic data capture failure|0
5171033|NCT01307020|17854203|P4|Overall Study|Electronic data capture failure|0
5171034|NCT01307020|17854204|P3|Overall Study|Electronic data capture failure|0
5171035|NCT01307020|17854205|P2|Overall Study|Electronic data capture failure|1
5171036|NCT01307020|17854206|P1|Overall Study|Electronic data capture failure|0
5171037|NCT01307020|17854197|P10|Overall Study|Lost to Follow-up|0
5171038|NCT01307020|17854198|P9|Overall Study|Lost to Follow-up|0
5171039|NCT01307020|17854199|P8|Overall Study|Lost to Follow-up|0
5171040|NCT01307020|17854200|P7|Overall Study|Lost to Follow-up|1
5171041|NCT01307020|17854201|P6|Overall Study|Lost to Follow-up|0
5171042|NCT01307020|17854202|P5|Overall Study|Lost to Follow-up|0
5171043|NCT01307020|17854203|P4|Overall Study|Lost to Follow-up|1
5171044|NCT01307020|17854204|P3|Overall Study|Lost to Follow-up|1
5171045|NCT01307020|17854205|P2|Overall Study|Lost to Follow-up|0
5171046|NCT01307020|17854206|P1|Overall Study|Lost to Follow-up|0
5171047|NCT01306968|17854261|P4|Overall Study|Withdrew over privacy concerns|1
5171048|NCT01306968|17854262|P3|Overall Study|Withdrew over privacy concerns|0
5171049|NCT01306968|17854263|P2|Overall Study|Withdrew over privacy concerns|0
5171050|NCT01306968|17854264|P1|Overall Study|Withdrew over privacy concerns|0
5171051|NCT01306968|17854261|P4|Overall Study|Withdrew - time commitment|2
5171052|NCT01306968|17854262|P3|Overall Study|Withdrew - time commitment|0
5171053|NCT01306968|17854263|P2|Overall Study|Withdrew - time commitment|0
5171054|NCT01306968|17854264|P1|Overall Study|Withdrew - time commitment|0
5171055|NCT01306968|17854261|P4|Overall Study|Relocated and left active duty|1
5171056|NCT01306968|17854262|P3|Overall Study|Relocated and left active duty|1
5171057|NCT01306968|17854263|P2|Overall Study|Relocated and left active duty|1
5171058|NCT01306968|17854264|P1|Overall Study|Relocated and left active duty|0
5171059|NCT01306968|17854261|P4|Overall Study|Physician Decision|0
5171060|NCT01306968|17854262|P3|Overall Study|Physician Decision|0
5171061|NCT01306968|17854263|P2|Overall Study|Physician Decision|1
5171062|NCT01306968|17854264|P1|Overall Study|Physician Decision|0
5171063|NCT01306968|17854261|P4|Overall Study|Lost to Follow-up|0
5171064|NCT01306968|17854262|P3|Overall Study|Lost to Follow-up|0
5171065|NCT01306968|17854263|P2|Overall Study|Lost to Follow-up|1
5171066|NCT01306968|17854264|P1|Overall Study|Lost to Follow-up|1
5171067|NCT01306942|17854289|P4|Phase II|Protocol Violation|1
5171068|NCT01306942|17854290|P3|Phase II|Protocol Violation|0
5171069|NCT01306942|17854291|P2|Phase II|Protocol Violation|0
5171070|NCT01306942|17854292|P1|Phase II|Protocol Violation|0
5171071|NCT01306942|17854289|P4|Phase II|Not finished treatment|1
5171072|NCT01306942|17854290|P3|Phase II|Not finished treatment|0
5171073|NCT01306942|17854291|P2|Phase II|Not finished treatment|0
5171074|NCT01306942|17854292|P1|Phase II|Not finished treatment|0
5171075|NCT01306942|17854289|P4|Phase II|Death|1
5171076|NCT01306942|17854290|P3|Phase II|Death|0
5171077|NCT01306942|17854291|P2|Phase II|Death|0
5171078|NCT01306942|17854292|P1|Phase II|Death|0
5171079|NCT01306942|17854289|P4|Phase II|Withdrawal by Subject|2
5171080|NCT01306942|17854290|P3|Phase II|Withdrawal by Subject|0
5171081|NCT01306942|17854291|P2|Phase II|Withdrawal by Subject|0
5171082|NCT01306942|17854292|P1|Phase II|Withdrawal by Subject|0
5171083|NCT01306942|17854289|P4|Phase II|Physician Decision|5
5171084|NCT01306942|17854290|P3|Phase II|Physician Decision|0
5171085|NCT01306942|17854291|P2|Phase II|Physician Decision|0
5171086|NCT01306942|17854292|P1|Phase II|Physician Decision|2
5171087|NCT01306942|17854289|P4|Phase II|Adverse Event|6
5171088|NCT01306942|17854290|P3|Phase II|Adverse Event|0
5171089|NCT01306942|17854291|P2|Phase II|Adverse Event|0
5171090|NCT01306942|17854292|P1|Phase II|Adverse Event|0
5171091|NCT01306942|17854289|P4|Phase I|Physician Decision|0
5171092|NCT01306942|17854290|P3|Phase I|Physician Decision|0
5171093|NCT01306942|17854291|P2|Phase I|Physician Decision|1
5171094|NCT01306942|17854292|P1|Phase I|Physician Decision|3
5171095|NCT01306942|17854289|P4|Phase I|Adverse Event|0
5171096|NCT01306942|17854290|P3|Phase I|Adverse Event|0
5171097|NCT01306942|17854291|P2|Phase I|Adverse Event|2
5171098|NCT01306942|17854292|P1|Phase I|Adverse Event|2
5171099|NCT01306890|17854324|P1|Overall Study|No discontinuation documentation|41
5171100|NCT01306890|17854324|P1|Overall Study|Study Termination|3
5171101|NCT01306890|17854324|P1|Overall Study|Unspecified reasons|104
5171102|NCT01306890|17854324|P1|Overall Study|Withdrawal by Subject|88
5171103|NCT01306890|17854324|P1|Overall Study|Lost to Follow-up|58
5171104|NCT01306890|17854324|P1|Overall Study|Death|1223
5171105|NCT01306890|17854324|P1|Overall Study|Adverse Event|2
5171106|NCT01306877|17854331|P2|Overall Study|Physician Decision|1
5171107|NCT01306877|17854332|P1|Overall Study|Physician Decision|0
5171108|NCT01306877|17854331|P2|Overall Study|Lost to Follow-up|3
5171109|NCT01306877|17854332|P1|Overall Study|Lost to Follow-up|3
5171110|NCT01306656|17854352|P2|Overall Study|Lost to Follow-up|0
5171111|NCT01306656|17854353|P1|Overall Study|Lost to Follow-up|1
5171112|NCT01306643|17854365|P1|Overall Study|Other: Change in Eligibility Status|1
5171113|NCT01306643|17854365|P1|Overall Study|Disease Progression|7
5171114|NCT01306643|17854365|P1|Overall Study|Adverse Event|5
5171115|NCT01306617|17854377|P3|Overall Study|Non-compliance|0
5171116|NCT01306617|17854378|P2|Overall Study|Non-compliance|1
5171117|NCT01306617|17854379|P1|Overall Study|Non-compliance|0
5171118|NCT01306617|17854377|P3|Overall Study|Virologic Failure|5
5171119|NCT01306617|17854378|P2|Overall Study|Virologic Failure|0
5171120|NCT01306617|17854379|P1|Overall Study|Virologic Failure|0
5171121|NCT01306617|17854377|P3|Overall Study|Adverse Event|0
5171122|NCT01306617|17854378|P2|Overall Study|Adverse Event|0
5171123|NCT01306617|17854379|P1|Overall Study|Adverse Event|1
5171124|NCT01306331|17854422|P2|Overall Study|Other|32
5171125|NCT01306331|17854423|P1|Overall Study|Other|34
5171126|NCT01306331|17854422|P2|Overall Study|Meth. no longer prim. meth. birth cntrl|20
5171127|NCT01306331|17854423|P1|Overall Study|Meth. no longer prim. meth. birth cntrl|10
5171128|NCT01306331|17854422|P2|Overall Study|Not sexually active|28
5171129|NCT01306331|17854423|P1|Overall Study|Not sexually active|29
5171130|NCT01306331|17854422|P2|Overall Study|Withdrawal by Subject|152
5171131|NCT01306331|17854423|P1|Overall Study|Withdrawal by Subject|163
5171132|NCT01306331|17854422|P2|Overall Study|Protocol Violation|124
5171133|NCT01306331|17854423|P1|Overall Study|Protocol Violation|154
5171134|NCT01306331|17854422|P2|Overall Study|Pregnancy|151
5171135|NCT01306331|17854423|P1|Overall Study|Pregnancy|136
5171136|NCT01306331|17854422|P2|Overall Study|Physician Decision|22
5171137|NCT01306331|17854423|P1|Overall Study|Physician Decision|26
5171138|NCT01306331|17854422|P2|Overall Study|Lost to Follow-up|323
5171139|NCT01306331|17854423|P1|Overall Study|Lost to Follow-up|321
5171140|NCT01306331|17854422|P2|Overall Study|Adverse Event|25
5171141|NCT01306331|17854423|P1|Overall Study|Adverse Event|28
5171142|NCT01306305|17854433|P2|Overall Study|Withdrew consent|0
5171143|NCT01306305|17854434|P1|Overall Study|Withdrew consent|1
5171144|NCT01306305|17854433|P2|Overall Study|Lost to Follow-up|0
5171145|NCT01306305|17854434|P1|Overall Study|Lost to Follow-up|1
5171146|NCT01306253|17854471|P2|Overall Study|Lost to Follow-up|1
5171147|NCT01306253|17854472|P1|Overall Study|Lost to Follow-up|1
5171148|NCT01306214|17854489|P3|Overall Study|Not treated|1
5171149|NCT01306214|17854490|P2|Overall Study|Not treated|1
5171150|NCT01306214|17854491|P1|Overall Study|Not treated|1
5171151|NCT01306214|17854489|P3|Overall Study|Withdrawal by Subject|16
5171152|NCT01306214|17854490|P2|Overall Study|Withdrawal by Subject|22
5171153|NCT01306214|17854491|P1|Overall Study|Withdrawal by Subject|24
5171154|NCT01306214|17854489|P3|Overall Study|Lost to Follow-up|4
5171155|NCT01306214|17854490|P2|Overall Study|Lost to Follow-up|5
5171156|NCT01306214|17854491|P1|Overall Study|Lost to Follow-up|3
5171157|NCT01306214|17854489|P3|Overall Study|Death|1
5171158|NCT01306214|17854490|P2|Overall Study|Death|0
5171159|NCT01306214|17854491|P1|Overall Study|Death|0
5171160|NCT01306201|17854508|P1|Overall Study|Files unreadable|3
5171161|NCT01306201|17854508|P1|Overall Study|Files could not be processed|3
5171162|NCT01306201|17854508|P1|Overall Study|Arrhythmia|4
5171163|NCT01306162|17854530|P4|Washout 1|Non-compliance to protocol|0
5171164|NCT01306162|17854531|P3|Washout 1|Non-compliance to protocol|0
5171165|NCT01306162|17854532|P2|Washout 1|Non-compliance to protocol|1
5171166|NCT01306162|17854533|P1|Washout 1|Non-compliance to protocol|0
5171167|NCT01306162|17854530|P4|Period 1|Adverse Event|1
5171168|NCT01306162|17854531|P3|Period 1|Adverse Event|0
5171169|NCT01306162|17854532|P2|Period 1|Adverse Event|0
5171170|NCT01306162|17854533|P1|Period 1|Adverse Event|0
5171171|NCT01306058|17854561|P1|Overall Study|Enrolled but did not get treatment|1
5171172|NCT01306058|17854561|P1|Overall Study|Death|1
5171173|NCT01306032|17854588|P6|Disease Progression/Crossover|other/symptomatic progression|0
5171174|NCT01306032|17854589|P5|Disease Progression/Crossover|other/symptomatic progression|0
5171175|NCT01306032|17854590|P4|Disease Progression/Crossover|other/symptomatic progression|2
5171176|NCT01306032|17854591|P3|Disease Progression/Crossover|other/symptomatic progression|0
5171177|NCT01306032|17854592|P2|Disease Progression/Crossover|other/symptomatic progression|2
5171178|NCT01306032|17854593|P1|Disease Progression/Crossover|other/symptomatic progression|0
5171179|NCT01306032|17854588|P6|Disease Progression/Crossover|Withdrawal by Subject|0
5171180|NCT01306032|17854589|P5|Disease Progression/Crossover|Withdrawal by Subject|0
5171181|NCT01306032|17854590|P4|Disease Progression/Crossover|Withdrawal by Subject|1
5171182|NCT01306032|17854591|P3|Disease Progression/Crossover|Withdrawal by Subject|0
5171183|NCT01306032|17854592|P2|Disease Progression/Crossover|Withdrawal by Subject|0
5171184|NCT01306032|17854593|P1|Disease Progression/Crossover|Withdrawal by Subject|0
5171185|NCT01306032|17854588|P6|First Intervention|Progressive disease|0
5171186|NCT01306032|17854589|P5|First Intervention|Progressive disease|2
5171187|NCT01306032|17854590|P4|First Intervention|Progressive disease|0
5171188|NCT01306032|17854591|P3|First Intervention|Progressive disease|0
5171189|NCT01306032|17854592|P2|First Intervention|Progressive disease|0
5171190|NCT01306032|17854593|P1|First Intervention|Progressive disease|0
5171191|NCT01306032|17854588|P6|First Intervention|Ineligible|1
5171192|NCT01306032|17854589|P5|First Intervention|Ineligible|0
5171193|NCT01306032|17854590|P4|First Intervention|Ineligible|0
5171194|NCT01306032|17854591|P3|First Intervention|Ineligible|0
5171195|NCT01306032|17854592|P2|First Intervention|Ineligible|0
5171196|NCT01306032|17854593|P1|First Intervention|Ineligible|0
5171197|NCT01306032|17854588|P6|First Intervention|Death|0
5171198|NCT01306032|17854589|P5|First Intervention|Death|0
5171199|NCT01306032|17854590|P4|First Intervention|Death|0
5171200|NCT01306032|17854591|P3|First Intervention|Death|1
5171201|NCT01306032|17854592|P2|First Intervention|Death|0
5171202|NCT01306032|17854593|P1|First Intervention|Death|0
5171203|NCT01306032|17854588|P6|First Intervention|Withdrawal by Subject|0
5171204|NCT01306032|17854589|P5|First Intervention|Withdrawal by Subject|0
5171205|NCT01306032|17854590|P4|First Intervention|Withdrawal by Subject|1
5171206|NCT01306032|17854591|P3|First Intervention|Withdrawal by Subject|0
5171207|NCT01306032|17854592|P2|First Intervention|Withdrawal by Subject|2
5171208|NCT01306032|17854593|P1|First Intervention|Withdrawal by Subject|0
5171209|NCT01306032|17854588|P6|First Intervention|Adverse Event|1
5171210|NCT01306032|17854589|P5|First Intervention|Adverse Event|0
5171211|NCT01306032|17854590|P4|First Intervention|Adverse Event|0
5171212|NCT01306032|17854591|P3|First Intervention|Adverse Event|1
5171213|NCT01306032|17854592|P2|First Intervention|Adverse Event|0
5171214|NCT01306032|17854593|P1|First Intervention|Adverse Event|1
5171215|NCT01305941|17854645|P1|Overall Study|Death|1
5171216|NCT01305941|17854645|P1|Overall Study|Withdrawal by Subject|1
5171217|NCT01305941|17854645|P1|Overall Study|Clinical decline|2
5171218|NCT01305941|17854645|P1|Overall Study|Adverse Event|6
5171219|NCT01305577|17854685|P3|Overall Study|Protocol Deviation|1
5171220|NCT01305577|17854686|P2|Overall Study|Protocol Deviation|1
5171221|NCT01305577|17854687|P1|Overall Study|Protocol Deviation|0
5171222|NCT01305577|17854685|P3|Overall Study|Lost to Follow-up|2
5171223|NCT01305577|17854686|P2|Overall Study|Lost to Follow-up|3
5171224|NCT01305577|17854687|P1|Overall Study|Lost to Follow-up|4
5171225|NCT01305577|17854685|P3|Overall Study|Withdrawal by Subject|6
5171226|NCT01305577|17854686|P2|Overall Study|Withdrawal by Subject|5
5171227|NCT01305577|17854687|P1|Overall Study|Withdrawal by Subject|7
5171228|NCT01305577|17854685|P3|Overall Study|Adverse Event|1
5171229|NCT01305577|17854686|P2|Overall Study|Adverse Event|2
5171230|NCT01305577|17854687|P1|Overall Study|Adverse Event|2
5171231|NCT01305564|17854716|P1|Overall Study|Physician Decision|3
5171232|NCT01305564|17854716|P1|Overall Study|Withdrawal by Subject|1
5171233|NCT01305564|17854716|P1|Overall Study|Lost to Follow-up|12
5171234|NCT01305564|17854716|P1|Overall Study|Death|21
5171235|NCT01305408|17854743|P2|Overall Study|Other|0
5171236|NCT01305408|17854744|P1|Overall Study|Other|1
5171237|NCT01305408|17854743|P2|Overall Study|Noncompliance with study procedures|1
5171238|NCT01305408|17854744|P1|Overall Study|Noncompliance with study procedures|0
5171239|NCT01305408|17854743|P2|Overall Study|Noncompliance with study medication|1
5171240|NCT01305408|17854744|P1|Overall Study|Noncompliance with study medication|0
5171241|NCT01305408|17854743|P2|Overall Study|Lost to Follow-up|3
5171242|NCT01305408|17854744|P1|Overall Study|Lost to Follow-up|5
5171243|NCT01305408|17854743|P2|Overall Study|Protocol Violation|6
5171244|NCT01305408|17854744|P1|Overall Study|Protocol Violation|4
5171245|NCT01305408|17854743|P2|Overall Study|Withdrawal by Subject|9
5171246|NCT01305408|17854744|P1|Overall Study|Withdrawal by Subject|9
5171247|NCT01305408|17854743|P2|Overall Study|Lack of Efficacy|4
5171248|NCT01305408|17854744|P1|Overall Study|Lack of Efficacy|3
5171249|NCT01305408|17854743|P2|Overall Study|Adverse Event|7
5171250|NCT01305408|17854744|P1|Overall Study|Adverse Event|10
5171251|NCT01305239|17854837|P1|Overall Study|Exemestane taken prior to inclusion only|1
5171252|NCT01305239|17854837|P1|Overall Study|Adverse Event|22
5171253|NCT01305200|17854867|P3|Overall Study|Death|0
5171254|NCT01305200|17854868|P2|Overall Study|Death|2
5171255|NCT01305200|17854869|P1|Overall Study|Death|0
5171256|NCT01305200|17854867|P3|Overall Study|Ineligible|1
5171257|NCT01305200|17854868|P2|Overall Study|Ineligible|2
5171258|NCT01305200|17854869|P1|Overall Study|Ineligible|1
5171259|NCT01305200|17854867|P3|Overall Study|Withdrawal by Subject|1
5171260|NCT01305200|17854868|P2|Overall Study|Withdrawal by Subject|21
5171261|NCT01305200|17854869|P1|Overall Study|Withdrawal by Subject|24
5171262|NCT01305200|17854867|P3|Overall Study|Physician Decision|1
5171263|NCT01305200|17854868|P2|Overall Study|Physician Decision|6
5171264|NCT01305200|17854869|P1|Overall Study|Physician Decision|4
5171265|NCT01305044|17854899|P2|Overall Study|Withdrawal by Subject|6
5171266|NCT01305044|17854900|P1|Overall Study|Withdrawal by Subject|3
5171267|NCT01304940|17854932|P2|Overall Study|not meet symptom severity requirement|0
5171268|NCT01304940|17854933|P1|Overall Study|not meet symptom severity requirement|3
5171269|NCT01304706|17854939|P1|Overall Study|Discontinued due to failed drug admin.|1
5171270|NCT01304706|17854939|P1|Overall Study|Lost to Follow-up|7
5171271|NCT01304706|17854939|P1|Overall Study|Withdrawal by Subject|3
5171272|NCT01304706|17854939|P1|Overall Study|Death|3
5171273|NCT01304706|17854939|P1|Overall Study|Lack of Efficacy|1
5171274|NCT01304706|17854939|P1|Overall Study|Adverse Event|2
5171275|NCT01304693|17854948|P5|Overall Study|Decision Unrelated to an Adverse Event|0
5171276|NCT01304693|17854949|P4|Overall Study|Decision Unrelated to an Adverse Event|1
5171277|NCT01304693|17854950|P3|Overall Study|Decision Unrelated to an Adverse Event|1
5171278|NCT01304693|17854951|P2|Overall Study|Decision Unrelated to an Adverse Event|0
5171279|NCT01304693|17854952|P1|Overall Study|Decision Unrelated to an Adverse Event|0
5171280|NCT01304693|17854948|P5|Overall Study|Adverse Event|1
5171281|NCT01304693|17854949|P4|Overall Study|Adverse Event|0
5171282|NCT01304693|17854950|P3|Overall Study|Adverse Event|0
5171283|NCT01304693|17854951|P2|Overall Study|Adverse Event|0
5171284|NCT01304693|17854952|P1|Overall Study|Adverse Event|0
5171285|NCT01304498|17854999|P2|Overall Study|Lost to Follow-up|1
5171286|NCT01304498|17855000|P1|Overall Study|Lost to Follow-up|2
5171287|NCT01304498|17854999|P2|Overall Study|Protocol Violation|0
5171288|NCT01304498|17855000|P1|Overall Study|Protocol Violation|1
5171289|NCT01304498|17854999|P2|Overall Study|Withdrawal by Subject|3
5171290|NCT01304498|17855000|P1|Overall Study|Withdrawal by Subject|2
5171291|NCT01304498|17854999|P2|Overall Study|Adverse Event|1
5171292|NCT01304498|17855000|P1|Overall Study|Adverse Event|1
5171293|NCT01304329|17855024|P6|Third Intervention (3 Days)|Adverse Event|0
5171294|NCT01304329|17855025|P5|Third Intervention (3 Days)|Adverse Event|0
5171295|NCT01304329|17855026|P4|Third Intervention (3 Days)|Adverse Event|0
5171296|NCT01304329|17855027|P3|Third Intervention (3 Days)|Adverse Event|0
5171297|NCT01304329|17855028|P2|Third Intervention (3 Days)|Adverse Event|1
5171298|NCT01304329|17855029|P1|Third Intervention (3 Days)|Adverse Event|0
5171299|NCT01304147|17855163|P2|Second Intervention (7days)|Withdrawal by Subject|1
5171300|NCT01304147|17855164|P1|Second Intervention (7days)|Withdrawal by Subject|1
5171301|NCT01303965|17855195|P2|Overall Study|Disease Progression|6
5171302|NCT01303965|17855196|P1|Overall Study|Disease Progression|1
5171303|NCT01303965|17855195|P2|Overall Study|Withdrawal by Subject|0
5171304|NCT01303965|17855196|P1|Overall Study|Withdrawal by Subject|1
5171305|NCT01303965|17855195|P2|Overall Study|Death|3
5171306|NCT01303965|17855196|P1|Overall Study|Death|0
5171307|NCT01303965|17855195|P2|Overall Study|Adverse Event|1
5171308|NCT01303965|17855196|P1|Overall Study|Adverse Event|1
5171309|NCT01303861|17855224|P4|Overall Study|Pregnancy|0
5171310|NCT01303861|17855225|P3|Overall Study|Pregnancy|0
5171311|NCT01303861|17855226|P2|Overall Study|Pregnancy|0
5171312|NCT01303861|17855227|P1|Overall Study|Pregnancy|1
5171313|NCT01303861|17855224|P4|Overall Study|Adverse Event|5
5171314|NCT01303861|17855225|P3|Overall Study|Adverse Event|0
5171315|NCT01303861|17855226|P2|Overall Study|Adverse Event|1
5171316|NCT01303861|17855227|P1|Overall Study|Adverse Event|4
5171317|NCT01303861|17855224|P4|Overall Study|Withdrawal by Subject|23
5171318|NCT01303861|17855225|P3|Overall Study|Withdrawal by Subject|8
5171319|NCT01303861|17855226|P2|Overall Study|Withdrawal by Subject|8
5171320|NCT01303861|17855227|P1|Overall Study|Withdrawal by Subject|16
5171321|NCT01303861|17855224|P4|Overall Study|Lack of Efficacy|0
5171322|NCT01303861|17855225|P3|Overall Study|Lack of Efficacy|1
5171323|NCT01303861|17855226|P2|Overall Study|Lack of Efficacy|2
5171324|NCT01303861|17855227|P1|Overall Study|Lack of Efficacy|3
5171325|NCT01303861|17855224|P4|Overall Study|Lost to Follow-up|31
5171326|NCT01303861|17855225|P3|Overall Study|Lost to Follow-up|27
5171327|NCT01303861|17855226|P2|Overall Study|Lost to Follow-up|14
5171328|NCT01303861|17855227|P1|Overall Study|Lost to Follow-up|34
5171329|NCT01303627|17855286|P2|Overall Study|the failure while performing URS|1
5171330|NCT01303627|17855287|P1|Overall Study|the failure while performing URS|0
5171331|NCT01303510|17855295|P2|Overall Study|Lost to Follow-up|0
5171332|NCT01303510|17855296|P1|Overall Study|Lost to Follow-up|1
5171333|NCT01303445|17855310|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
5171334|NCT01303445|17855311|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
5171335|NCT01303445|17855310|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
5171336|NCT01303445|17855311|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
5171337|NCT01303445|17855310|P2|Washout (14 Days)|Lost to Follow-up|2
5171338|NCT01303445|17855311|P1|Washout (14 Days)|Lost to Follow-up|0
5171339|NCT01303445|17855310|P2|Washout (14 Days)|Protocol Violation|0
5171340|NCT01303445|17855311|P1|Washout (14 Days)|Protocol Violation|1
5171341|NCT01303445|17855310|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
5171342|NCT01303445|17855311|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
5171343|NCT01303445|17855310|P2|Second Intervention (7 Days)|Adverse Event|2
5171344|NCT01303445|17855311|P1|Second Intervention (7 Days)|Adverse Event|0
5171345|NCT01303445|17855310|P2|First Intervention (7 Days)|Withdrawal by Subject|0
5171346|NCT01303445|17855311|P1|First Intervention (7 Days)|Withdrawal by Subject|1
5171347|NCT01303419|17855341|P1|Overall Study|Did not meet all I/E after screening|31
5171348|NCT01303419|17855341|P1|Overall Study|Did not complete both imaging methods|5
5171349|NCT01303419|17855341|P1|Overall Study|Discontinuation of study|60
5171350|NCT01303380|17855360|P1|Overall Study|Lack of compliance to study procedures|1
5171351|NCT01303159|17855419|P1|Overall Study|Study Termination|7
5171352|NCT01303159|17855419|P1|Overall Study|Death|16
5171353|NCT01302964|17855437|P2|Overall Study|Adverse Event|0
5171354|NCT01302964|17855438|P1|Overall Study|Adverse Event|1
5171355|NCT01302938|17855448|P2|Overall Study|Adverse Event|0
5171356|NCT01302938|17855449|P1|Overall Study|Adverse Event|1
5171357|NCT01302938|17855448|P2|Overall Study|Withdrawal by Subject|0
5171358|NCT01302938|17855449|P1|Overall Study|Withdrawal by Subject|1
5171359|NCT01302899|17855494|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
5171360|NCT01302899|17855495|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
5171361|NCT01302899|17855494|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
5171362|NCT01302899|17855495|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
5171363|NCT01302834|17855559|P2|Overall Study|HIV positive|3
5171364|NCT01302834|17855560|P1|Overall Study|HIV positive|1
5171365|NCT01302834|17855559|P2|Overall Study|Protocol Violation|23
5171366|NCT01302834|17855560|P1|Overall Study|Protocol Violation|17
5171367|NCT01302691|17855620|P2|Overall Study|Protocol Violation|0
5171368|NCT01302691|17855621|P1|Overall Study|Protocol Violation|1
5171369|NCT01302691|17855620|P2|Overall Study|Physician Decision|1
5171370|NCT01302691|17855621|P1|Overall Study|Physician Decision|0
5171371|NCT01302691|17855620|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
5171372|NCT01302691|17855621|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
5171373|NCT01302691|17855620|P2|Overall Study|Lost to Follow-up|0
5171374|NCT01302691|17855621|P1|Overall Study|Lost to Follow-up|1
5171375|NCT01302691|17855620|P2|Overall Study|Death|1
5171376|NCT01302691|17855621|P1|Overall Study|Death|0
5171377|NCT01302691|17855620|P2|Overall Study|Adverse Event|0
5171378|NCT01302691|17855621|P1|Overall Study|Adverse Event|2
5171379|NCT01302548|17855641|P2|Overall Study|Lost to Follow-up|1
5171380|NCT01302548|17855642|P1|Overall Study|Lost to Follow-up|2
5171381|NCT01302418|17855692|P1|Overall Study|Non-evaluable|9
5171382|NCT01302418|17855692|P1|Overall Study|Protocol Violation|9
5171383|NCT01302392|17855698|P2|Overall Study|Withdrawal by Subject|1
5171384|NCT01302392|17855699|P1|Overall Study|Withdrawal by Subject|6
5171385|NCT01302392|17855698|P2|Overall Study|Lost to Follow-up|0
5171386|NCT01302392|17855699|P1|Overall Study|Lost to Follow-up|1
5171387|NCT01302366|17855750|P1|Overall Study|patient choice or noncompliance|5
5171388|NCT01302119|17855758|P2|Overall Study|Non-specific|1
5171389|NCT01302119|17855759|P1|Overall Study|Non-specific|4
5171390|NCT01302119|17855758|P2|Overall Study|Non-compliance|2
5171391|NCT01302119|17855759|P1|Overall Study|Non-compliance|4
5171392|NCT01302119|17855758|P2|Overall Study|Adverse Event|1
5171393|NCT01302119|17855759|P1|Overall Study|Adverse Event|2
5171394|NCT01302119|17855758|P2|Overall Study|Lost to Follow-up|4
5171395|NCT01302119|17855759|P1|Overall Study|Lost to Follow-up|10
5171396|NCT01302119|17855758|P2|Overall Study|Withdrawal by Subject|20
5171397|NCT01302119|17855759|P1|Overall Study|Withdrawal by Subject|30
5171398|NCT01302067|17855774|P3|Overall Study|Adverse Event|45
5171399|NCT01302067|17855775|P2|Overall Study|Adverse Event|14
5171400|NCT01302067|17855776|P1|Overall Study|Adverse Event|27
5171401|NCT01302067|17855774|P3|Overall Study|Protocol Violation|8
5171402|NCT01302067|17855775|P2|Overall Study|Protocol Violation|0
5171403|NCT01302067|17855776|P1|Overall Study|Protocol Violation|11
5171404|NCT01302067|17855774|P3|Overall Study|Other|3
5171405|NCT01302067|17855775|P2|Overall Study|Other|1
5171406|NCT01302067|17855776|P1|Overall Study|Other|1
5171407|NCT01302067|17855774|P3|Overall Study|Withdrawal by Subject|10
5171408|NCT01302067|17855775|P2|Overall Study|Withdrawal by Subject|6
5171409|NCT01302067|17855776|P1|Overall Study|Withdrawal by Subject|13
5171410|NCT01302067|17855774|P3|Overall Study|Lost to Follow-up|15
5171411|NCT01302067|17855775|P2|Overall Study|Lost to Follow-up|4
5171412|NCT01302067|17855776|P1|Overall Study|Lost to Follow-up|9
5171413|NCT01302067|17855774|P3|Overall Study|Lack of Efficacy|2
5171414|NCT01302067|17855775|P2|Overall Study|Lack of Efficacy|4
5171415|NCT01302067|17855776|P1|Overall Study|Lack of Efficacy|8
5171416|NCT01302067|17855774|P3|Overall Study|Physician Decision|14
5171417|NCT01302067|17855775|P2|Overall Study|Physician Decision|5
5171418|NCT01302067|17855776|P1|Overall Study|Physician Decision|9
5171419|NCT01302067|17855774|P3|Overall Study|Death|1
5171420|NCT01302067|17855775|P2|Overall Study|Death|0
5171421|NCT01302067|17855776|P1|Overall Study|Death|0
5171422|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Other|9
5171423|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Other|4
5171424|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Other|0
5171425|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
5171426|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
5171427|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
5171428|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Adverse Event|10
5171429|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Adverse Event|10
5171430|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Adverse Event|0
5171431|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Protocol Violation|6
5171432|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Protocol Violation|3
5171433|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Protocol Violation|0
5171434|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
5171435|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
5171436|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
5171437|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
5171438|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
5171439|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
5171440|NCT01302054|17855847|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
5171441|NCT01302054|17855848|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
5171442|NCT01302054|17855849|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
5171443|NCT01302054|17855847|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
5171444|NCT01302054|17855848|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
5171445|NCT01302054|17855849|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
5171446|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Other|0
5171447|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Other|0
5171448|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Other|7
5171449|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
5171450|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
5171451|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
5171452|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
5171453|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
5171454|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
5171455|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
5171456|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
5171457|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
5171458|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
5171459|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
5171460|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
5171461|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
5171462|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
5171463|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
5171464|NCT01302054|17855847|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
5171465|NCT01302054|17855848|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
5171466|NCT01302054|17855849|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
5171467|NCT01302041|17855876|P1|Overall Study|Other-Miscellaneous Reason|2
5171468|NCT01302041|17855876|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
5171469|NCT01302041|17855876|P1|Overall Study|Withdrawal by Subject|4
5171470|NCT01302041|17855876|P1|Overall Study|Death|5
5171471|NCT01301950|17855918|P2|Overall Study|Surgery was cancelled by patient|1
5171472|NCT01301950|17855919|P1|Overall Study|Surgery was cancelled by patient|0
5171473|NCT01301833|17855937|P4|Overall Study|Personal matter|0
5171474|NCT01301833|17855938|P3|Overall Study|Personal matter|0
5171475|NCT01301833|17855939|P2|Overall Study|Personal matter|0
5171476|NCT01301833|17855940|P1|Overall Study|Personal matter|1
5171477|NCT01301833|17855937|P4|Overall Study|Withdrawal by Subject|2
5171478|NCT01301833|17855938|P3|Overall Study|Withdrawal by Subject|1
5171479|NCT01301833|17855939|P2|Overall Study|Withdrawal by Subject|1
5171480|NCT01301833|17855940|P1|Overall Study|Withdrawal by Subject|3
5171481|NCT01301833|17855937|P4|Overall Study|Physician Decision|0
5171482|NCT01301833|17855938|P3|Overall Study|Physician Decision|1
5171483|NCT01301833|17855939|P2|Overall Study|Physician Decision|1
5171484|NCT01301833|17855940|P1|Overall Study|Physician Decision|3
5171485|NCT01301833|17855937|P4|Overall Study|Lack of Efficacy|0
5171486|NCT01301833|17855938|P3|Overall Study|Lack of Efficacy|0
5171487|NCT01301833|17855939|P2|Overall Study|Lack of Efficacy|1
5171488|NCT01301833|17855940|P1|Overall Study|Lack of Efficacy|1
5171489|NCT01301833|17855937|P4|Overall Study|Adverse Event|5
5171490|NCT01301833|17855938|P3|Overall Study|Adverse Event|5
5171491|NCT01301833|17855939|P2|Overall Study|Adverse Event|5
5171492|NCT01301833|17855940|P1|Overall Study|Adverse Event|7
5171493|NCT01301729|17855978|P1|Overall Study|Violated Selection Criteria|1
5171494|NCT01301729|17855978|P1|Overall Study|Participant did not Return for Treatment|1
5171495|NCT01301729|17855978|P1|Overall Study|Withdrawal by Subject|2
5171496|NCT01301625|17855989|P1|Overall Study|Lost to Follow-up|1
5171497|NCT01301625|17855989|P1|Overall Study|Expected|8
5171498|NCT01301625|17855989|P1|Overall Study|Not Due|21
5171499|NCT01301625|17855989|P1|Overall Study|Death|5
5171500|NCT01301508|17856061|P2|Overall Study|Lost to Follow-up|1
5171501|NCT01301508|17856062|P1|Overall Study|Lost to Follow-up|0
5171502|NCT01301508|17856061|P2|Overall Study|Withdrawal by Subject|2
5171503|NCT01301508|17856062|P1|Overall Study|Withdrawal by Subject|1
5171504|NCT01301456|17856092|P12|Stage 2|Adverse Event|0
5171505|NCT01301456|17856093|P11|Stage 2|Adverse Event|1
5171506|NCT01301456|17856094|P10|Stage 2|Adverse Event|0
5171507|NCT01301456|17856095|P9|Stage 2|Adverse Event|0
5171508|NCT01301456|17856096|P8|Stage 2|Adverse Event|0
5171509|NCT01301456|17856097|P7|Stage 2|Adverse Event|0
5171510|NCT01301456|17856098|P6|Stage 2|Adverse Event|0
5171511|NCT01301456|17856099|P5|Stage 2|Adverse Event|0
5171512|NCT01301456|17856100|P4|Stage 2|Adverse Event|0
5171513|NCT01301456|17856101|P3|Stage 2|Adverse Event|0
5171514|NCT01301456|17856102|P2|Stage 2|Adverse Event|0
5171515|NCT01301456|17856103|P1|Stage 2|Adverse Event|0
5171516|NCT01301456|17856092|P12|Stage 1|Randomized but not treated|0
5171517|NCT01301456|17856093|P11|Stage 1|Randomized but not treated|0
5171518|NCT01301456|17856094|P10|Stage 1|Randomized but not treated|0
5171519|NCT01301456|17856095|P9|Stage 1|Randomized but not treated|0
5171520|NCT01301456|17856096|P8|Stage 1|Randomized but not treated|0
5171521|NCT01301456|17856097|P7|Stage 1|Randomized but not treated|1
5171522|NCT01301456|17856098|P6|Stage 1|Randomized but not treated|0
5171523|NCT01301456|17856099|P5|Stage 1|Randomized but not treated|0
5171524|NCT01301456|17856100|P4|Stage 1|Randomized but not treated|0
5171525|NCT01301456|17856101|P3|Stage 1|Randomized but not treated|0
5171526|NCT01301456|17856102|P2|Stage 1|Randomized but not treated|0
5171527|NCT01301456|17856103|P1|Stage 1|Randomized but not treated|0
5171528|NCT01301456|17856092|P12|Stage 1|Withdrawal by Subject|0
5171529|NCT01301456|17856093|P11|Stage 1|Withdrawal by Subject|0
5171530|NCT01301456|17856094|P10|Stage 1|Withdrawal by Subject|0
5171531|NCT01301456|17856095|P9|Stage 1|Withdrawal by Subject|0
5171532|NCT01301456|17856096|P8|Stage 1|Withdrawal by Subject|0
5171533|NCT01301456|17856097|P7|Stage 1|Withdrawal by Subject|0
5171534|NCT01301456|17856098|P6|Stage 1|Withdrawal by Subject|0
5171535|NCT01301456|17856099|P5|Stage 1|Withdrawal by Subject|1
5171536|NCT01301456|17856100|P4|Stage 1|Withdrawal by Subject|0
5171537|NCT01301456|17856101|P3|Stage 1|Withdrawal by Subject|1
5171538|NCT01301456|17856102|P2|Stage 1|Withdrawal by Subject|0
5171539|NCT01301456|17856103|P1|Stage 1|Withdrawal by Subject|0
5171540|NCT01301391|17856329|P1|Overall Study|Sponsor's decision|8
5171541|NCT01301391|17856329|P1|Overall Study|Physician Decision|2
5171542|NCT01301391|17856329|P1|Overall Study|Lost to Follow-up|3
5171543|NCT01301391|17856329|P1|Overall Study|Death|13
5171544|NCT01301274|17856341|P2|Overall Study|Physician Decision|1
5171545|NCT01301274|17856342|P1|Overall Study|Physician Decision|2
5171546|NCT01301092|17856357|P3|Overall Study|Lost to Follow-up|1
5171547|NCT01301092|17856358|P2|Overall Study|Lost to Follow-up|0
5171548|NCT01301092|17856359|P1|Overall Study|Lost to Follow-up|0
5171549|NCT01301079|17856376|P2|Overall Study|Lost to Follow-up|2
5171550|NCT01301079|17856377|P1|Overall Study|Lost to Follow-up|2
5171551|NCT01301066|17856455|P2|Overall Study|Other|0
5171552|NCT01301066|17856456|P1|Overall Study|Other|2
5171553|NCT01301066|17856455|P2|Overall Study|Physician Decision|1
5171554|NCT01301066|17856456|P1|Overall Study|Physician Decision|0
5171555|NCT01301066|17856455|P2|Overall Study|Sponsor Decision|1
5171556|NCT01301066|17856456|P1|Overall Study|Sponsor Decision|2
5171557|NCT01301066|17856455|P2|Overall Study|Adverse Event|6
5171558|NCT01301066|17856456|P1|Overall Study|Adverse Event|6
5171559|NCT01301066|17856455|P2|Overall Study|Withdrawal by Subject|9
5171560|NCT01301066|17856456|P1|Overall Study|Withdrawal by Subject|4
5171561|NCT01301066|17856455|P2|Overall Study|Protocol Violation|7
5171562|NCT01301066|17856456|P1|Overall Study|Protocol Violation|8
5171563|NCT01301066|17856455|P2|Overall Study|Lost to Follow-up|11
5171564|NCT01301066|17856456|P1|Overall Study|Lost to Follow-up|5
5171565|NCT01301027|17856464|P2|Overall Study|Volume Overload|0
5171566|NCT01301027|17856465|P1|Overall Study|Volume Overload|3
5171567|NCT01301027|17856464|P2|Overall Study|Transplant|2
5171568|NCT01301027|17856465|P1|Overall Study|Transplant|0
5171569|NCT01301027|17856464|P2|Overall Study|Fracture|3
5171570|NCT01301027|17856465|P1|Overall Study|Fracture|1
5171571|NCT01301027|17856464|P2|Overall Study|Adverse Event|2
5171572|NCT01301027|17856465|P1|Overall Study|Adverse Event|0
5171573|NCT01301027|17856464|P2|Overall Study|Withdrawal by Subject|3
5171574|NCT01301027|17856465|P1|Overall Study|Withdrawal by Subject|2
5171575|NCT01301027|17856464|P2|Overall Study|Physician Decision|0
5171576|NCT01301027|17856465|P1|Overall Study|Physician Decision|2
5171577|NCT01301001|17856477|P2|Second Intervention|Withdrawal by Subject|0
5171578|NCT01301001|17856478|P1|Second Intervention|Withdrawal by Subject|2
5171579|NCT01301001|17856477|P2|Second Intervention|Adverse Event|0
5171580|NCT01301001|17856478|P1|Second Intervention|Adverse Event|2
5171581|NCT01301001|17856477|P2|First Intervention|Protocol Violation|1
5171582|NCT01301001|17856478|P1|First Intervention|Protocol Violation|0
5171583|NCT01301001|17856477|P2|First Intervention|Adverse Event|0
5171584|NCT01301001|17856478|P1|First Intervention|Adverse Event|5
5171585|NCT01301001|17856477|P2|First Intervention|Withdrawal by Subject|4
5171586|NCT01301001|17856478|P1|First Intervention|Withdrawal by Subject|1
5171587|NCT01301001|17856477|P2|First Intervention|Lost to Follow-up|4
5171588|NCT01301001|17856478|P1|First Intervention|Lost to Follow-up|4
5171589|NCT01300923|17856501|P2|Overall Study|Physician Decision|2
5171590|NCT01300923|17856502|P1|Overall Study|Physician Decision|0
5171591|NCT01300819|17856515|P2|Overall Study|Follow up call was not done|0
5171592|NCT01300819|17856516|P1|Overall Study|Follow up call was not done|1
5171593|NCT01300819|17856515|P2|Overall Study|Safety follow up not done by mistake|1
5171594|NCT01300819|17856516|P1|Overall Study|Safety follow up not done by mistake|0
5171595|NCT01300819|17856515|P2|Overall Study|Administrative reason|1
5171596|NCT01300819|17856516|P1|Overall Study|Administrative reason|0
5171597|NCT01300819|17856515|P2|Overall Study|Refusal to down titrate study drug|1
5171598|NCT01300819|17856516|P1|Overall Study|Refusal to down titrate study drug|0
5171599|NCT01300819|17856515|P2|Overall Study|Patient was 1 month late for Visit 10|1
5171600|NCT01300819|17856516|P1|Overall Study|Patient was 1 month late for Visit 10|0
5171601|NCT01300819|17856515|P2|Overall Study|Withdrawal by Subject|12
5171602|NCT01300819|17856516|P1|Overall Study|Withdrawal by Subject|10
5171603|NCT01300819|17856515|P2|Overall Study|Lack of Efficacy|1
5171604|NCT01300819|17856516|P1|Overall Study|Lack of Efficacy|2
5171605|NCT01300819|17856515|P2|Overall Study|Adverse Event|27
5171606|NCT01300819|17856516|P1|Overall Study|Adverse Event|9
5171607|NCT01300767|17856544|P1|Overall Study|Unacceptable fit|1
5171608|NCT01300767|17856544|P1|Overall Study|Biomicroscopy|1
5171609|NCT01300767|17856544|P1|Overall Study|Discomfort|2
5171610|NCT01300741|17856572|P1|Overall Study|Discomfort|1
5171611|NCT01300741|17856572|P1|Overall Study|Lost to Follow-up|1
5171612|NCT01300741|17856572|P1|Overall Study|Lens deposits|1
5171613|NCT01300728|17856602|P2|Overall Study|Physician Decision|0
5171614|NCT01300728|17856603|P1|Overall Study|Physician Decision|1
5171615|NCT01300728|17856602|P2|Overall Study|Withdrawal by Subject|1
5171616|NCT01300728|17856603|P1|Overall Study|Withdrawal by Subject|1
5171617|NCT01300650|17856617|P1|Overall Study|Adverse Event|1
5171618|NCT01300572|17856633|P1|Overall Study|HAMA + post dosimetry|1
5171619|NCT01300546|17856657|P2|Overall Study|Adverse Event|1
5171620|NCT01300546|17856658|P1|Overall Study|Adverse Event|0
5171621|NCT01300546|17856657|P2|Overall Study|Lack of Efficacy|3
5171622|NCT01300546|17856658|P1|Overall Study|Lack of Efficacy|0
5171623|NCT01300546|17856657|P2|Overall Study|Lost to Follow-up|2
5171624|NCT01300546|17856658|P1|Overall Study|Lost to Follow-up|0
5171625|NCT01300546|17856657|P2|Overall Study|Withdrawal by Subject|0
5171626|NCT01300546|17856658|P1|Overall Study|Withdrawal by Subject|1
5171627|NCT01300455|17856688|P2|Washout|Withdrawal by Subject|0
5171628|NCT01300455|17856689|P1|Washout|Withdrawal by Subject|1
5171629|NCT01300351|17856709|P2|Overall Study|Withdrawal by Subject|10
5171630|NCT01300351|17856710|P1|Overall Study|Withdrawal by Subject|7
5171631|NCT01300351|17856709|P2|Overall Study|Adverse Event|4
5171632|NCT01300351|17856710|P1|Overall Study|Adverse Event|0
5171633|NCT01300351|17856709|P2|Overall Study|Lost to Follow-up|1
5171634|NCT01300351|17856710|P1|Overall Study|Lost to Follow-up|0
5171635|NCT01300351|17856709|P2|Overall Study|Ongoing treatment at data cut-off|23
5171636|NCT01300351|17856710|P1|Overall Study|Ongoing treatment at data cut-off|27
5171637|NCT01300351|17856709|P2|Overall Study|Did not receive treatment|0
5171638|NCT01300351|17856710|P1|Overall Study|Did not receive treatment|2
5171639|NCT01300338|17856726|P2|Overall Study|Lost to Follow-up|0
5171640|NCT01300338|17856727|P1|Overall Study|Lost to Follow-up|5
5171641|NCT01300286|17856735|P1|Overall Study|did not get dosed|1
5171642|NCT01300260|17856745|P2|Period 2 of Study: Second Intervention|Adverse Event|1
5171643|NCT01300260|17856746|P1|Period 2 of Study: Second Intervention|Adverse Event|0
5171644|NCT01300260|17856745|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
5171645|NCT01300260|17856746|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
5171646|NCT01300260|17856745|P2|Period 1 of Study: First Intervention|Adverse Event|1
5171647|NCT01300260|17856746|P1|Period 1 of Study: First Intervention|Adverse Event|0
5171648|NCT01300247|17856778|P2|Overall Study|Non-Compliance|1
5171649|NCT01300247|17856779|P1|Overall Study|Non-Compliance|0
5171650|NCT01300247|17856778|P2|Overall Study|Withdrawal by Subject|0
5171651|NCT01300247|17856779|P1|Overall Study|Withdrawal by Subject|1
5171652|NCT01300247|17856778|P2|Overall Study|Lost to Follow-up|0
5171653|NCT01300247|17856779|P1|Overall Study|Lost to Follow-up|2
5171654|NCT01300247|17856778|P2|Overall Study|Death|1
5171655|NCT01300247|17856779|P1|Overall Study|Death|1
5171656|NCT01300234|17856811|P2|Overall Study|Participant refused return to hospital|0
5171657|NCT01300234|17856812|P1|Overall Study|Participant refused return to hospital|1
5171658|NCT01300234|17856811|P2|Overall Study|Participant stopped medication|1
5171659|NCT01300234|17856812|P1|Overall Study|Participant stopped medication|1
5171660|NCT01300234|17856811|P2|Overall Study|Participant reached stopping critera|0
5171661|NCT01300234|17856812|P1|Overall Study|Participant reached stopping critera|2
5171662|NCT01300234|17856811|P2|Overall Study|Pregnancy|1
5171663|NCT01300234|17856812|P1|Overall Study|Pregnancy|2
5171664|NCT01300234|17856811|P2|Overall Study|Lost to Follow-up|12
5171665|NCT01300234|17856812|P1|Overall Study|Lost to Follow-up|14
5171666|NCT01300234|17856811|P2|Overall Study|Withdrawal by Subject|9
5171667|NCT01300234|17856812|P1|Overall Study|Withdrawal by Subject|5
5171668|NCT01300234|17856811|P2|Overall Study|Protocol Violation|3
5171669|NCT01300234|17856812|P1|Overall Study|Protocol Violation|2
5171670|NCT01300234|17856811|P2|Overall Study|Adverse Event|1
5171671|NCT01300234|17856812|P1|Overall Study|Adverse Event|1
5171672|NCT01300052|17856859|P2|Overall Study|Protocol Violation|1
5171673|NCT01300052|17856860|P1|Overall Study|Protocol Violation|1
5171674|NCT01300052|17856859|P2|Overall Study|Withdrawal by Subject|2
5171675|NCT01300052|17856860|P1|Overall Study|Withdrawal by Subject|2
5171676|NCT01300052|17856859|P2|Overall Study|Adverse Event|0
5171677|NCT01300052|17856860|P1|Overall Study|Adverse Event|3
5171678|NCT01299961|17856878|P1|Overall Study|Lost to Follow-up|1
5171679|NCT01299961|17856878|P1|Overall Study|Lack of Efficacy|2
5171680|NCT01299961|17856878|P1|Overall Study|Adverse Event|3
5171681|NCT01299909|17856887|P3|Overall Study|Lost to Follow-up|17
5171682|NCT01299909|17856888|P2|Overall Study|Lost to Follow-up|18
5171683|NCT01299909|17856889|P1|Overall Study|Lost to Follow-up|22
5171684|NCT01299896|17856904|P2|Overall Study|Lost to Follow-up|11
5171685|NCT01299896|17856905|P1|Overall Study|Lost to Follow-up|0
5171686|NCT01299896|17856904|P2|Overall Study|Withdrawal by Subject|7
5171687|NCT01299896|17856905|P1|Overall Study|Withdrawal by Subject|1
5171688|NCT01299805|17856913|P2|Overall Study|Adverse Event|0
5171689|NCT01299805|17856914|P1|Overall Study|Adverse Event|2
5171690|NCT01299766|17856944|P2|Overall Study|Withdrawal by Subject|19
5171691|NCT01299766|17856945|P1|Overall Study|Withdrawal by Subject|29
5171692|NCT01299766|17856944|P2|Overall Study|Death|4
5171693|NCT01299766|17856945|P1|Overall Study|Death|5
5171694|NCT01299727|17856956|P3|Overall Study|Completed the Treatment Period|3
5171695|NCT01299727|17856957|P2|Overall Study|Completed the Treatment Period|4
5171696|NCT01299727|17856958|P1|Overall Study|Completed the Treatment Period|3
5171697|NCT01299727|17856956|P3|Overall Study|Adverse Event|1
5171698|NCT01299727|17856957|P2|Overall Study|Adverse Event|0
5171699|NCT01299727|17856958|P1|Overall Study|Adverse Event|0
5171700|NCT01299727|17856956|P3|Overall Study|Withdrawal by Subject|0
5171701|NCT01299727|17856957|P2|Overall Study|Withdrawal by Subject|0
5171702|NCT01299727|17856958|P1|Overall Study|Withdrawal by Subject|1
5171703|NCT01299584|17857052|P1|Overall Study|Protocol Violation|9
5171704|NCT01299571|17857059|P1|Overall Study|Protocol Violation|107
5171705|NCT01299480|17857070|P5|Overall Study|Started, but not vaccinated|0
5171706|NCT01299480|17857071|P4|Overall Study|Started, but not vaccinated|1
5171707|NCT01299480|17857072|P3|Overall Study|Started, but not vaccinated|1
5171708|NCT01299480|17857073|P2|Overall Study|Started, but not vaccinated|0
5171709|NCT01299480|17857074|P1|Overall Study|Started, but not vaccinated|0
5171710|NCT01299480|17857070|P5|Overall Study|Other|3
5171711|NCT01299480|17857071|P4|Overall Study|Other|0
5171712|NCT01299480|17857072|P3|Overall Study|Other|3
5171713|NCT01299480|17857073|P2|Overall Study|Other|2
5171714|NCT01299480|17857074|P1|Overall Study|Other|3
5171715|NCT01299480|17857070|P5|Overall Study|Lost to Follow-up|2
5171716|NCT01299480|17857071|P4|Overall Study|Lost to Follow-up|1
5171717|NCT01299480|17857072|P3|Overall Study|Lost to Follow-up|2
5171718|NCT01299480|17857073|P2|Overall Study|Lost to Follow-up|1
5171719|NCT01299480|17857074|P1|Overall Study|Lost to Follow-up|3
5171720|NCT01299480|17857070|P5|Overall Study|Physician Decision|0
5171721|NCT01299480|17857071|P4|Overall Study|Physician Decision|2
5171722|NCT01299480|17857072|P3|Overall Study|Physician Decision|0
5171723|NCT01299480|17857073|P2|Overall Study|Physician Decision|1
5171724|NCT01299480|17857074|P1|Overall Study|Physician Decision|1
5171725|NCT01299480|17857070|P5|Overall Study|Withdrawal due to pregnancy|0
5171726|NCT01299480|17857071|P4|Overall Study|Withdrawal due to pregnancy|0
5171727|NCT01299480|17857072|P3|Overall Study|Withdrawal due to pregnancy|1
5171728|NCT01299480|17857073|P2|Overall Study|Withdrawal due to pregnancy|1
5171729|NCT01299480|17857074|P1|Overall Study|Withdrawal due to pregnancy|0
5171730|NCT01299480|17857070|P5|Overall Study|Adverse Event|0
5171731|NCT01299480|17857071|P4|Overall Study|Adverse Event|4
5171732|NCT01299480|17857072|P3|Overall Study|Adverse Event|5
5171733|NCT01299480|17857073|P2|Overall Study|Adverse Event|4
5171734|NCT01299480|17857074|P1|Overall Study|Adverse Event|6
5171735|NCT01299480|17857070|P5|Overall Study|Withdrawal by Subject|4
5171736|NCT01299480|17857071|P4|Overall Study|Withdrawal by Subject|3
5171737|NCT01299480|17857072|P3|Overall Study|Withdrawal by Subject|7
5171738|NCT01299480|17857073|P2|Overall Study|Withdrawal by Subject|4
5171739|NCT01299480|17857074|P1|Overall Study|Withdrawal by Subject|3
5171740|NCT01299480|17857070|P5|Overall Study|Protocol Violation|1
5171741|NCT01299480|17857071|P4|Overall Study|Protocol Violation|1
5171742|NCT01299480|17857072|P3|Overall Study|Protocol Violation|8
5171743|NCT01299480|17857073|P2|Overall Study|Protocol Violation|5
5171744|NCT01299480|17857074|P1|Overall Study|Protocol Violation|7
5171745|NCT01299480|17857070|P5|Overall Study|No longer willing to participate|10
5171746|NCT01299480|17857071|P4|Overall Study|No longer willing to participate|13
5171747|NCT01299480|17857072|P3|Overall Study|No longer willing to participate|14
5171748|NCT01299480|17857073|P2|Overall Study|No longer willing to participate|17
5171749|NCT01299480|17857074|P1|Overall Study|No longer willing to participate|19
5171750|NCT01299389|17857276|P4|Post-observational|Other|6
5171751|NCT01299389|17857277|P3|Post-observational|Other|12
5171752|NCT01299389|17857278|P2|Post-observational|Other|0
5171753|NCT01299389|17857279|P1|Post-observational|Other|0
5171754|NCT01299389|17857276|P4|Double-blind|"fail to meet study population criteria"|0
5171755|NCT01299389|17857277|P3|Double-blind|"fail to meet study population criteria"|0
5171756|NCT01299389|17857278|P2|Double-blind|"fail to meet study population criteria"|1
5171757|NCT01299389|17857279|P1|Double-blind|"fail to meet study population criteria"|0
5171758|NCT01299389|17857276|P4|Double-blind|Other|0
5171759|NCT01299389|17857277|P3|Double-blind|Other|0
5171760|NCT01299389|17857278|P2|Double-blind|Other|1
5171761|NCT01299389|17857279|P1|Double-blind|Other|1
5171762|NCT01299389|17857276|P4|Double-blind|Withdrawal by Subject|0
5171763|NCT01299389|17857277|P3|Double-blind|Withdrawal by Subject|0
5171764|NCT01299389|17857278|P2|Double-blind|Withdrawal by Subject|13
5171765|NCT01299389|17857279|P1|Double-blind|Withdrawal by Subject|16
5171766|NCT01299389|17857276|P4|Double-blind|Lost to Follow-up|0
5171767|NCT01299389|17857277|P3|Double-blind|Lost to Follow-up|0
5171768|NCT01299389|17857278|P2|Double-blind|Lost to Follow-up|1
5171769|NCT01299389|17857279|P1|Double-blind|Lost to Follow-up|2
5171770|NCT01299389|17857276|P4|Double-blind|Lack of Efficacy|0
5171771|NCT01299389|17857277|P3|Double-blind|Lack of Efficacy|0
5171772|NCT01299389|17857278|P2|Double-blind|Lack of Efficacy|21
5171773|NCT01299389|17857279|P1|Double-blind|Lack of Efficacy|45
5171774|NCT01299389|17857276|P4|Double-blind|Adverse Event|0
5171775|NCT01299389|17857277|P3|Double-blind|Adverse Event|0
5171776|NCT01299389|17857278|P2|Double-blind|Adverse Event|27
5171777|NCT01299389|17857279|P1|Double-blind|Adverse Event|45
5171778|NCT01299376|17857301|P2|Extension (Weeks 9 to 52)|Physician Decision|0
5171779|NCT01299376|17857302|P1|Extension (Weeks 9 to 52)|Physician Decision|1
5171780|NCT01299376|17857301|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
5171781|NCT01299376|17857302|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
5171782|NCT01299376|17857301|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
5171783|NCT01299376|17857302|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
5171784|NCT01299376|17857301|P2|Extension (Weeks 9 to 52)|Adverse Event|3
5171785|NCT01299376|17857302|P1|Extension (Weeks 9 to 52)|Adverse Event|2
5171786|NCT01299376|17857301|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
5171787|NCT01299376|17857302|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
5171788|NCT01299376|17857301|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
5171789|NCT01299376|17857302|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
5171790|NCT01299376|17857301|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
5171791|NCT01299376|17857302|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
5171792|NCT01299376|17857301|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
5171793|NCT01299376|17857302|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
5171794|NCT01299376|17857301|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
5171795|NCT01299376|17857302|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
5171796|NCT01299376|17857301|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
5171797|NCT01299376|17857302|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
5171798|NCT01299376|17857301|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
5171799|NCT01299376|17857302|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
5171800|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
5171801|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
5171802|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
5171803|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
5171804|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Physician Decision|1
5171805|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Physician Decision|2
5171806|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Physician Decision|0
5171807|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Physician Decision|0
5171808|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
5171809|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
5171810|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
5171811|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
5171812|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
5171813|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
5171814|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
5171815|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
5171816|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
5171817|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
5171818|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
5171819|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
5171820|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Adverse Event|9
5171821|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Adverse Event|8
5171822|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Adverse Event|0
5171823|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Adverse Event|0
5171824|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
5171825|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
5171826|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
5171827|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
5171828|NCT01299272|17857345|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
5171829|NCT01299272|17857346|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
5171830|NCT01299272|17857347|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
5171831|NCT01299272|17857348|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
5171832|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Physician Decision|0
5171833|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Physician Decision|0
5171834|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Physician Decision|3
5171835|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Physician Decision|0
5171836|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5171837|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5171838|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
5171839|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5171840|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5171841|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5171842|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
5171843|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5171844|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5171845|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5171846|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
5171847|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5171848|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
5171849|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
5171850|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
5171851|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
5171852|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5171853|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5171854|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
5171855|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5171856|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Adverse Event|0
5171857|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Adverse Event|0
5171858|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Adverse Event|42
5171859|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Adverse Event|0
5171860|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
5171861|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
5171862|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
5171863|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
5171864|NCT01299272|17857345|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5171865|NCT01299272|17857346|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5171866|NCT01299272|17857347|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
5171867|NCT01299272|17857348|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5171868|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Physician Decision|0
5171869|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Physician Decision|0
5171870|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Physician Decision|0
5171871|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Physician Decision|5
5171872|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
5171873|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
5171874|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
5171875|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
5171876|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Sponsor Decision|0
5171877|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Sponsor Decision|0
5171878|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Sponsor Decision|0
5171879|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Sponsor Decision|13
5171880|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
5171881|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
5171882|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
5171883|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
5171884|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Protocol Violation|0
5171885|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Protocol Violation|0
5171886|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Protocol Violation|0
5171887|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Protocol Violation|36
5171888|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
5171889|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
5171890|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
5171891|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
5171892|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Adverse Event|0
5171893|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Adverse Event|0
5171894|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Adverse Event|0
5171895|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Adverse Event|140
5171896|NCT01299272|17857345|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5171897|NCT01299272|17857346|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5171898|NCT01299272|17857347|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5171899|NCT01299272|17857348|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
5171900|NCT01299116|17857403|P3|Overall Study|Lost to Follow-up|11
5171901|NCT01299116|17857404|P2|Overall Study|Lost to Follow-up|9
5171902|NCT01299116|17857405|P1|Overall Study|Lost to Follow-up|65
5171903|NCT01299038|17857450|P2|Overall Study|Withdrawal by Subject|0
5171904|NCT01299038|17857451|P1|Overall Study|Withdrawal by Subject|1
5171905|NCT01299025|17857459|P2|Overall Study|Lost to Follow-up|0
5171906|NCT01299025|17857460|P1|Overall Study|Lost to Follow-up|1
5171907|NCT01299025|17857459|P2|Overall Study|Withdrawal by Subject|1
5171908|NCT01299025|17857460|P1|Overall Study|Withdrawal by Subject|2
5171909|NCT01298778|17857485|P2|Overall Study|not meet inclusion/exclusion criteria|1
5171910|NCT01298778|17857486|P1|Overall Study|not meet inclusion/exclusion criteria|0
5171911|NCT01298778|17857485|P2|Overall Study|Protocol Violation|1
5171912|NCT01298778|17857486|P1|Overall Study|Protocol Violation|0
5171913|NCT01298778|17857485|P2|Overall Study|Withdrawal by Subject|1
5171914|NCT01298778|17857486|P1|Overall Study|Withdrawal by Subject|0
5171915|NCT01298778|17857485|P2|Overall Study|Incorrect use of VAS|0
5171916|NCT01298778|17857486|P1|Overall Study|Incorrect use of VAS|1
5171917|NCT01298778|17857485|P2|Overall Study|Lost to Follow-up|3
5171918|NCT01298778|17857486|P1|Overall Study|Lost to Follow-up|2
5171919|NCT01298765|17857506|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
5171920|NCT01298765|17857506|P1|Long-Term Treatment Period|Physician Decision|1
5171921|NCT01298765|17857506|P1|Long-Term Treatment Period|Withdrawal by Subject|19
5171922|NCT01298765|17857506|P1|Long-Term Treatment Period|Lost to Follow-up|8
5171923|NCT01298765|17857506|P1|Long-Term Treatment Period|Lack of Efficacy|6
5171924|NCT01298765|17857506|P1|Long-Term Treatment Period|Adverse Event|19
5171925|NCT01298765|17857506|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
5171926|NCT01298765|17857506|P1|Titration Period|Withdrawal by Subject|10
5171927|NCT01298765|17857506|P1|Titration Period|Physician Decision|1
5171928|NCT01298765|17857506|P1|Titration Period|Lost to Follow-up|9
5171929|NCT01298765|17857506|P1|Titration Period|Lack of Efficacy|21
5171930|NCT01298765|17857506|P1|Titration Period|Death|1
5171931|NCT01298765|17857506|P1|Titration Period|Adverse Event|26
5171932|NCT01298700|17857527|P2|Overall Study|Did not Receive Study Drug|5
5171933|NCT01298700|17857528|P1|Overall Study|Did not Receive Study Drug|3
5171934|NCT01298700|17857527|P2|Overall Study|Other Miscellaneous Reasons|15
5171935|NCT01298700|17857528|P1|Overall Study|Other Miscellaneous Reasons|16
5171936|NCT01298700|17857527|P2|Overall Study|Protocol Violation|4
5171937|NCT01298700|17857528|P1|Overall Study|Protocol Violation|6
5171938|NCT01298700|17857527|P2|Overall Study|Withdrawal by Subject|9
5171939|NCT01298700|17857528|P1|Overall Study|Withdrawal by Subject|12
5171940|NCT01298700|17857527|P2|Overall Study|Lost to Follow-up|2
5171941|NCT01298700|17857528|P1|Overall Study|Lost to Follow-up|5
5171942|NCT01298700|17857527|P2|Overall Study|Lack of Efficacy|14
5171943|NCT01298700|17857528|P1|Overall Study|Lack of Efficacy|9
5171944|NCT01298700|17857527|P2|Overall Study|Adverse Event|51
5171945|NCT01298700|17857528|P1|Overall Study|Adverse Event|50
5171946|NCT01298661|17857539|P3|Overall Study|Withdrawal by Subject|2
5171947|NCT01298661|17857540|P2|Overall Study|Withdrawal by Subject|0
5171948|NCT01298661|17857541|P1|Overall Study|Withdrawal by Subject|2
5171949|NCT01298648|17857619|P1|Overall Study|Lost to Follow-up|21
5171950|NCT01298648|17857619|P1|Overall Study|Withdrawal by Subject|2
5171951|NCT01298596|17857630|P2|Overall Study|Referred for further management|15
5171952|NCT01298596|17857631|P1|Overall Study|Referred for further management|16
5171953|NCT01298596|17857630|P2|Overall Study|Lost to Follow-up|14
5171954|NCT01298596|17857631|P1|Overall Study|Lost to Follow-up|6
5171955|NCT01298596|17857630|P2|Overall Study|Death|3
5171956|NCT01298596|17857631|P1|Overall Study|Death|5
5171957|NCT01298596|17857630|P2|Overall Study|Withdrawal by Subject|1
5171958|NCT01298596|17857631|P1|Overall Study|Withdrawal by Subject|1
5171959|NCT01298570|17857641|P2|Overall Study|Ineligibility|1
5171960|NCT01298570|17857642|P1|Overall Study|Ineligibility|0
5171961|NCT01298570|17857641|P2|Overall Study|Death|1
5171962|NCT01298570|17857642|P1|Overall Study|Death|0
5171963|NCT01298570|17857641|P2|Overall Study|Symptomatic progression/deterioration|2
5171964|NCT01298570|17857642|P1|Overall Study|Symptomatic progression/deterioration|3
5171965|NCT01298570|17857641|P2|Overall Study|Surgery|1
5171966|NCT01298570|17857642|P1|Overall Study|Surgery|2
5171967|NCT01298570|17857641|P2|Overall Study|Other complicating disease|1
5171968|NCT01298570|17857642|P1|Overall Study|Other complicating disease|2
5171969|NCT01298570|17857641|P2|Overall Study|Physician Decision|2
5171970|NCT01298570|17857642|P1|Overall Study|Physician Decision|4
5171971|NCT01298570|17857641|P2|Overall Study|Treatment delay > 4 weeks|5
5171972|NCT01298570|17857642|P1|Overall Study|Treatment delay > 4 weeks|4
5171973|NCT01298570|17857641|P2|Overall Study|Withdrawal by Subject|6
5171974|NCT01298570|17857642|P1|Overall Study|Withdrawal by Subject|21
5171975|NCT01298570|17857641|P2|Overall Study|Adverse Event|2
5171976|NCT01298570|17857642|P1|Overall Study|Adverse Event|20
5171977|NCT01298570|17857641|P2|Overall Study|Disease progression, relapse during acti|40
5171978|NCT01298570|17857642|P1|Overall Study|Disease progression, relapse during acti|64
5171979|NCT01298531|17857669|P2|Overall Study|Other|1
5171980|NCT01298531|17857670|P1|Overall Study|Other|2
5171981|NCT01298531|17857669|P2|Overall Study|Does not meet entrance criteria|1
5171982|NCT01298531|17857670|P1|Overall Study|Does not meet entrance criteria|0
5171983|NCT01298531|17857669|P2|Overall Study|Adverse Event|3
5171984|NCT01298531|17857670|P1|Overall Study|Adverse Event|4
5171985|NCT01298531|17857669|P2|Overall Study|Protocol Violation|1
5171986|NCT01298531|17857670|P1|Overall Study|Protocol Violation|1
5171987|NCT01298531|17857669|P2|Overall Study|Lost to Follow-up|0
5171988|NCT01298531|17857670|P1|Overall Study|Lost to Follow-up|2
5171989|NCT01298531|17857669|P2|Overall Study|Lack of Efficacy|1
5171990|NCT01298531|17857670|P1|Overall Study|Lack of Efficacy|0
5171991|NCT01298518|17857799|P3|Overall Study|Withdrawal by Subject|1
5171992|NCT01298518|17857800|P2|Overall Study|Withdrawal by Subject|0
5171993|NCT01298518|17857801|P1|Overall Study|Withdrawal by Subject|0
5171994|NCT01298492|17857853|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
5171995|NCT01298492|17857853|P1|Overall Study|Adverse Event(Related to Study Drug)|8
5171996|NCT01298492|17857853|P1|Overall Study|Protocol Violation|2
5171997|NCT01298492|17857853|P1|Overall Study|Withdrawn Due to Pregnancy|1
5171998|NCT01298492|17857853|P1|Overall Study|Other (Unspecified)|7
5171999|NCT01298492|17857853|P1|Overall Study|Withdrawal by Subject|47
5172000|NCT01298492|17857853|P1|Overall Study|Lost to Follow-up|12
5172001|NCT01298492|17857853|P1|Overall Study|Insufficient Clinical Response|22
5172002|NCT01298492|17857853|P1|Overall Study|Death|2
5172003|NCT01298362|17857861|P2|Overall Study|Did not provide 12month BMD measurements|43
5172004|NCT01298362|17857862|P1|Overall Study|Did not provide 12month BMD measurements|38
5172005|NCT01298323|17857882|P2|Overall Study|Eligibility criteria not fulfilled|1
5172006|NCT01298323|17857883|P1|Overall Study|Eligibility criteria not fulfilled|0
5172007|NCT01298323|17857882|P2|Overall Study|Ongoing|55
5172008|NCT01298323|17857883|P1|Overall Study|Ongoing|55
5172009|NCT01298323|17857882|P2|Overall Study|Other|9
5172010|NCT01298323|17857883|P1|Overall Study|Other|10
5172011|NCT01298323|17857882|P2|Overall Study|Protocol Violation|0
5172012|NCT01298323|17857883|P1|Overall Study|Protocol Violation|1
5172013|NCT01298323|17857882|P2|Overall Study|Withdrawal by Subject|3
5172014|NCT01298323|17857883|P1|Overall Study|Withdrawal by Subject|6
5172015|NCT01298323|17857882|P2|Overall Study|Lost to Follow-up|0
5172016|NCT01298323|17857883|P1|Overall Study|Lost to Follow-up|1
5172017|NCT01298323|17857882|P2|Overall Study|Death|16
5172018|NCT01298323|17857883|P1|Overall Study|Death|11
5172019|NCT01298323|17857882|P2|Overall Study|Adverse Event|4
5172020|NCT01298323|17857883|P1|Overall Study|Adverse Event|2
5172021|NCT01298193|17857906|P1|Efficacy Phase (Second Cycle)|Death|1
5172022|NCT01298193|17857906|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
5172023|NCT01298193|17857906|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
5172024|NCT01298193|17857906|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
5172025|NCT01298141|17857928|P1|Overall Study|Not treated|4
5172026|NCT01298141|17857928|P1|Overall Study|Death|6
5172027|NCT01298141|17857928|P1|Overall Study|Lost to Follow-up|1
5172028|NCT01298141|17857928|P1|Overall Study|Other|5
5172029|NCT01298141|17857928|P1|Overall Study|Termination of Study by the Investigator|5
5172030|NCT01298141|17857928|P1|Overall Study|Withdrawal by Subject|6
5172031|NCT01298141|17857928|P1|Overall Study|Refusal of Required Study Procedures|1
5172032|NCT01298141|17857928|P1|Overall Study|Adverse Event|3
5172033|NCT01297920|17858003|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
5172034|NCT01297920|17858004|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
5172035|NCT01297920|17858005|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
5172036|NCT01297920|17858003|P3|Overall Study|Inadequate Control of IOP|17
5172037|NCT01297920|17858004|P2|Overall Study|Inadequate Control of IOP|9
5172038|NCT01297920|17858005|P1|Overall Study|Inadequate Control of IOP|7
5172039|NCT01297920|17858003|P3|Overall Study|Protocol Violation|0
5172040|NCT01297920|17858004|P2|Overall Study|Protocol Violation|3
5172041|NCT01297920|17858005|P1|Overall Study|Protocol Violation|1
5172042|NCT01297920|17858003|P3|Overall Study|Noncompliance|0
5172043|NCT01297920|17858004|P2|Overall Study|Noncompliance|0
5172044|NCT01297920|17858005|P1|Overall Study|Noncompliance|1
5172045|NCT01297920|17858003|P3|Overall Study|Patient Decision Unrelated to AE|2
5172046|NCT01297920|17858004|P2|Overall Study|Patient Decision Unrelated to AE|5
5172047|NCT01297920|17858005|P1|Overall Study|Patient Decision Unrelated to AE|6
5172048|NCT01297920|17858003|P3|Overall Study|Adverse Event|38
5172049|NCT01297920|17858004|P2|Overall Study|Adverse Event|10
5172050|NCT01297920|17858005|P1|Overall Study|Adverse Event|42
5172051|NCT01297517|17858049|P3|Overall Study|Inadequate Control of IOP|2
5172052|NCT01297517|17858050|P2|Overall Study|Inadequate Control of IOP|1
5172053|NCT01297517|17858051|P1|Overall Study|Inadequate Control of IOP|1
5172054|NCT01297517|17858049|P3|Overall Study|Protocol Violation|1
5172055|NCT01297517|17858050|P2|Overall Study|Protocol Violation|1
5172056|NCT01297517|17858051|P1|Overall Study|Protocol Violation|1
5172057|NCT01297517|17858049|P3|Overall Study|Noncompliance|0
5172058|NCT01297517|17858050|P2|Overall Study|Noncompliance|0
5172059|NCT01297517|17858051|P1|Overall Study|Noncompliance|1
5172060|NCT01297517|17858049|P3|Overall Study|Patient Decision Unrelated to AE|7
5172061|NCT01297517|17858050|P2|Overall Study|Patient Decision Unrelated to AE|3
5172062|NCT01297517|17858051|P1|Overall Study|Patient Decision Unrelated to AE|2
5172063|NCT01297517|17858049|P3|Overall Study|Lost to Follow-up|1
5172064|NCT01297517|17858050|P2|Overall Study|Lost to Follow-up|0
5172065|NCT01297517|17858051|P1|Overall Study|Lost to Follow-up|1
5172066|NCT01297517|17858049|P3|Overall Study|Adverse Event|16
5172067|NCT01297517|17858050|P2|Overall Study|Adverse Event|7
5172068|NCT01297517|17858051|P1|Overall Study|Adverse Event|21
5172069|NCT01297504|17858059|P1|Overall Study|Protocol Violation|3
5172070|NCT01297504|17858059|P1|Overall Study|Site Closure|3
5172071|NCT01297504|17858059|P1|Overall Study|Withdrawal by Subject|9
5172072|NCT01297504|17858059|P1|Overall Study|Lost to Follow-up|43
5172073|NCT01297504|17858059|P1|Overall Study|Death|3
5172074|NCT01297504|17858059|P1|Overall Study|No Study Visits|4
5172075|NCT01297504|17858059|P1|Overall Study|Received Palivizumab in Previous Season|1
5172076|NCT01297504|17858059|P1|Overall Study|Invalid Consent|1
5172077|NCT01297491|17858073|P2|Overall Study|Death|1
5172078|NCT01297491|17858074|P1|Overall Study|Death|2
5172079|NCT01297491|17858073|P2|Overall Study|Patient/Guardian decision|4
5172080|NCT01297491|17858074|P1|Overall Study|Patient/Guardian decision|3
5172081|NCT01297491|17858073|P2|Overall Study|Progressive disease|20
5172082|NCT01297491|17858074|P1|Overall Study|Progressive disease|11
5172083|NCT01297491|17858073|P2|Overall Study|Physician Decision|2
5172084|NCT01297491|17858074|P1|Overall Study|Physician Decision|3
5172085|NCT01297491|17858073|P2|Overall Study|Adverse Event|6
5172086|NCT01297491|17858074|P1|Overall Study|Adverse Event|11
5172087|NCT01297465|17858092|P2|Overall Study|Intention to Freeze all Embryos|1
5172088|NCT01297465|17858093|P1|Overall Study|Intention to Freeze all Embryos|0
5172089|NCT01297465|17858092|P2|Overall Study|All Embryos Discarded|1
5172090|NCT01297465|17858093|P1|Overall Study|All Embryos Discarded|0
5172091|NCT01297465|17858092|P2|Overall Study|No Fertilization|4
5172092|NCT01297465|17858093|P1|Overall Study|No Fertilization|6
5172093|NCT01297465|17858092|P2|Overall Study|Poor oocyte quality|1
5172094|NCT01297465|17858093|P1|Overall Study|Poor oocyte quality|0
5172095|NCT01297465|17858092|P2|Overall Study|No Oocytes Retrieved|1
5172096|NCT01297465|17858093|P1|Overall Study|No Oocytes Retrieved|1
5172097|NCT01297465|17858092|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
5172098|NCT01297465|17858093|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
5172099|NCT01297465|17858092|P2|Overall Study|Lack of Ovarian Response|1
5172100|NCT01297465|17858093|P1|Overall Study|Lack of Ovarian Response|1
5172101|NCT01297322|17858146|P2|Overall Study|Protocol Violation|3
5172102|NCT01297322|17858147|P1|Overall Study|Protocol Violation|0
5172103|NCT01297322|17858146|P2|Overall Study|Withdrawal by Subject|1
5172104|NCT01297322|17858147|P1|Overall Study|Withdrawal by Subject|0
5172105|NCT01297322|17858146|P2|Overall Study|Lost to Follow-up|0
5172106|NCT01297322|17858147|P1|Overall Study|Lost to Follow-up|1
5172107|NCT01297309|17858166|P1|Overall Study|Participant not entering extensionperiod|1
5172108|NCT01297309|17858166|P1|Overall Study|Death|1
5172109|NCT01297309|17858166|P1|Overall Study|Investigator Decision|2
5172110|NCT01297309|17858166|P1|Overall Study|Adverse Event|1
5172111|NCT01297309|17858166|P1|Overall Study|Withdrawal by Subject|5
5172112|NCT01297309|17858166|P1|Overall Study|Screen failure|2
5172113|NCT01297309|17858166|P1|Overall Study|Eligibility failure|2
5172114|NCT01297270|17858191|P3|Overall Study|Not treated|0
5172115|NCT01297270|17858192|P2|Overall Study|Not treated|1
5172116|NCT01297270|17858193|P1|Overall Study|Not treated|0
5172117|NCT01297270|17858191|P3|Overall Study|Other reason not defined above|1
5172118|NCT01297270|17858192|P2|Overall Study|Other reason not defined above|3
5172119|NCT01297270|17858193|P1|Overall Study|Other reason not defined above|3
5172120|NCT01297270|17858191|P3|Overall Study|Withdrawal by Subject|7
5172121|NCT01297270|17858192|P2|Overall Study|Withdrawal by Subject|15
5172122|NCT01297270|17858193|P1|Overall Study|Withdrawal by Subject|7
5172123|NCT01297270|17858191|P3|Overall Study|Protocol Violation|0
5172124|NCT01297270|17858192|P2|Overall Study|Protocol Violation|2
5172125|NCT01297270|17858193|P1|Overall Study|Protocol Violation|0
5172126|NCT01297270|17858191|P3|Overall Study|Lost to Follow-up|1
5172127|NCT01297270|17858192|P2|Overall Study|Lost to Follow-up|2
5172128|NCT01297270|17858193|P1|Overall Study|Lost to Follow-up|1
5172129|NCT01297270|17858191|P3|Overall Study|Lack of Efficacy|15
5172130|NCT01297270|17858192|P2|Overall Study|Lack of Efficacy|17
5172131|NCT01297270|17858193|P1|Overall Study|Lack of Efficacy|15
5172132|NCT01297270|17858191|P3|Overall Study|Adverse Event|5
5172133|NCT01297270|17858192|P2|Overall Study|Adverse Event|32
5172134|NCT01297270|17858193|P1|Overall Study|Adverse Event|19
5172135|NCT01297244|17858238|P2|Overall Study|Withdrawal by Subject|0
5172136|NCT01297244|17858239|P1|Overall Study|Withdrawal by Subject|2
5172137|NCT01297244|17858238|P2|Overall Study|Clinical progression|1
5172138|NCT01297244|17858239|P1|Overall Study|Clinical progression|1
5172139|NCT01297244|17858238|P2|Overall Study|Death|1
5172140|NCT01297244|17858239|P1|Overall Study|Death|1
5172141|NCT01297244|17858238|P2|Overall Study|Adverse Event|1
5172142|NCT01297244|17858239|P1|Overall Study|Adverse Event|9
5172143|NCT01297244|17858238|P2|Overall Study|Progressive disease|3
5172144|NCT01297244|17858239|P1|Overall Study|Progressive disease|22
5172145|NCT01297062|17858259|P7|Overall Study|Subject Decision|2
5172146|NCT01297062|17858260|P6|Overall Study|Subject Decision|1
5172147|NCT01297062|17858261|P5|Overall Study|Subject Decision|1
5172148|NCT01297062|17858262|P4|Overall Study|Subject Decision|1
5172149|NCT01297062|17858263|P3|Overall Study|Subject Decision|0
5172150|NCT01297062|17858264|P2|Overall Study|Subject Decision|1
5172151|NCT01297062|17858265|P1|Overall Study|Subject Decision|1
5172152|NCT01297062|17858259|P7|Overall Study|Protocol Violation|0
5172153|NCT01297062|17858260|P6|Overall Study|Protocol Violation|0
5172154|NCT01297062|17858261|P5|Overall Study|Protocol Violation|1
5172155|NCT01297062|17858262|P4|Overall Study|Protocol Violation|0
5172156|NCT01297062|17858263|P3|Overall Study|Protocol Violation|0
5172157|NCT01297062|17858264|P2|Overall Study|Protocol Violation|0
5172158|NCT01297062|17858265|P1|Overall Study|Protocol Violation|0
5172159|NCT01297062|17858259|P7|Overall Study|Physician Decision|6
5172160|NCT01297062|17858260|P6|Overall Study|Physician Decision|0
5172161|NCT01297062|17858261|P5|Overall Study|Physician Decision|0
5172162|NCT01297062|17858262|P4|Overall Study|Physician Decision|0
5172163|NCT01297062|17858263|P3|Overall Study|Physician Decision|1
5172164|NCT01297062|17858264|P2|Overall Study|Physician Decision|0
5172165|NCT01297062|17858265|P1|Overall Study|Physician Decision|1
5172166|NCT01297062|17858259|P7|Overall Study|Adverse Event|0
5172167|NCT01297062|17858260|P6|Overall Study|Adverse Event|0
5172168|NCT01297062|17858261|P5|Overall Study|Adverse Event|0
5172169|NCT01297062|17858262|P4|Overall Study|Adverse Event|0
5172170|NCT01297062|17858263|P3|Overall Study|Adverse Event|1
5172171|NCT01297062|17858264|P2|Overall Study|Adverse Event|0
5172172|NCT01297062|17858265|P1|Overall Study|Adverse Event|2
5172173|NCT01296932|17858296|P9|Overall Study|Dosage already reduced, AE still present|1
5172174|NCT01296932|17858297|P8|Overall Study|Dosage already reduced, AE still present|0
5172175|NCT01296932|17858298|P7|Overall Study|Dosage already reduced, AE still present|0
5172176|NCT01296932|17858299|P6|Overall Study|Dosage already reduced, AE still present|0
5172177|NCT01296932|17858300|P5|Overall Study|Dosage already reduced, AE still present|0
5172178|NCT01296932|17858301|P4|Overall Study|Dosage already reduced, AE still present|0
5172179|NCT01296932|17858302|P3|Overall Study|Dosage already reduced, AE still present|0
5172180|NCT01296932|17858303|P2|Overall Study|Dosage already reduced, AE still present|0
5172181|NCT01296932|17858304|P1|Overall Study|Dosage already reduced, AE still present|0
5172182|NCT01296932|17858296|P9|Overall Study|No adequate treatment response|0
5172183|NCT01296932|17858297|P8|Overall Study|No adequate treatment response|1
5172184|NCT01296932|17858298|P7|Overall Study|No adequate treatment response|0
5172185|NCT01296932|17858299|P6|Overall Study|No adequate treatment response|0
5172186|NCT01296932|17858300|P5|Overall Study|No adequate treatment response|0
5172187|NCT01296932|17858301|P4|Overall Study|No adequate treatment response|0
5172188|NCT01296932|17858302|P3|Overall Study|No adequate treatment response|0
5172189|NCT01296932|17858303|P2|Overall Study|No adequate treatment response|0
5172190|NCT01296932|17858304|P1|Overall Study|No adequate treatment response|0
5172191|NCT01296932|17858296|P9|Overall Study|Low benefit and too many side effects|0
5172192|NCT01296932|17858297|P8|Overall Study|Low benefit and too many side effects|1
5172193|NCT01296932|17858298|P7|Overall Study|Low benefit and too many side effects|0
5172194|NCT01296932|17858299|P6|Overall Study|Low benefit and too many side effects|0
5172195|NCT01296932|17858300|P5|Overall Study|Low benefit and too many side effects|0
5172196|NCT01296932|17858301|P4|Overall Study|Low benefit and too many side effects|0
5172197|NCT01296932|17858302|P3|Overall Study|Low benefit and too many side effects|0
5172198|NCT01296932|17858303|P2|Overall Study|Low benefit and too many side effects|0
5172199|NCT01296932|17858304|P1|Overall Study|Low benefit and too many side effects|0
5172200|NCT01296932|17858296|P9|Overall Study|per protocol|0
5172201|NCT01296932|17858297|P8|Overall Study|per protocol|0
5172202|NCT01296932|17858298|P7|Overall Study|per protocol|0
5172203|NCT01296932|17858299|P6|Overall Study|per protocol|0
5172204|NCT01296932|17858300|P5|Overall Study|per protocol|0
5172205|NCT01296932|17858301|P4|Overall Study|per protocol|1
5172206|NCT01296932|17858302|P3|Overall Study|per protocol|1
5172207|NCT01296932|17858303|P2|Overall Study|per protocol|0
5172208|NCT01296932|17858304|P1|Overall Study|per protocol|0
5172209|NCT01296932|17858296|P9|Overall Study|IV problems, administration not possible|0
5172210|NCT01296932|17858297|P8|Overall Study|IV problems, administration not possible|0
5172211|NCT01296932|17858298|P7|Overall Study|IV problems, administration not possible|0
5172212|NCT01296932|17858299|P6|Overall Study|IV problems, administration not possible|0
5172213|NCT01296932|17858300|P5|Overall Study|IV problems, administration not possible|0
5172214|NCT01296932|17858301|P4|Overall Study|IV problems, administration not possible|0
5172215|NCT01296932|17858302|P3|Overall Study|IV problems, administration not possible|1
5172216|NCT01296932|17858303|P2|Overall Study|IV problems, administration not possible|0
5172217|NCT01296932|17858304|P1|Overall Study|IV problems, administration not possible|0
5172218|NCT01296932|17858296|P9|Overall Study|Physician Decision|0
5172219|NCT01296932|17858297|P8|Overall Study|Physician Decision|0
5172220|NCT01296932|17858298|P7|Overall Study|Physician Decision|0
5172221|NCT01296932|17858299|P6|Overall Study|Physician Decision|0
5172222|NCT01296932|17858300|P5|Overall Study|Physician Decision|0
5172223|NCT01296932|17858301|P4|Overall Study|Physician Decision|0
5172224|NCT01296932|17858302|P3|Overall Study|Physician Decision|1
5172225|NCT01296932|17858303|P2|Overall Study|Physician Decision|0
5172226|NCT01296932|17858304|P1|Overall Study|Physician Decision|0
5172227|NCT01296932|17858296|P9|Overall Study|No clinical benefit anymore|0
5172228|NCT01296932|17858297|P8|Overall Study|No clinical benefit anymore|0
5172229|NCT01296932|17858298|P7|Overall Study|No clinical benefit anymore|0
5172230|NCT01296932|17858299|P6|Overall Study|No clinical benefit anymore|0
5172231|NCT01296932|17858300|P5|Overall Study|No clinical benefit anymore|0
5172232|NCT01296932|17858301|P4|Overall Study|No clinical benefit anymore|0
5172233|NCT01296932|17858302|P3|Overall Study|No clinical benefit anymore|0
5172234|NCT01296932|17858303|P2|Overall Study|No clinical benefit anymore|1
5172235|NCT01296932|17858304|P1|Overall Study|No clinical benefit anymore|0
5172236|NCT01296932|17858296|P9|Overall Study|Investigator decision|1
5172237|NCT01296932|17858297|P8|Overall Study|Investigator decision|0
5172238|NCT01296932|17858298|P7|Overall Study|Investigator decision|1
5172239|NCT01296932|17858299|P6|Overall Study|Investigator decision|0
5172240|NCT01296932|17858300|P5|Overall Study|Investigator decision|0
5172241|NCT01296932|17858301|P4|Overall Study|Investigator decision|1
5172242|NCT01296932|17858302|P3|Overall Study|Investigator decision|0
5172243|NCT01296932|17858303|P2|Overall Study|Investigator decision|1
5172244|NCT01296932|17858304|P1|Overall Study|Investigator decision|0
5172245|NCT01296932|17858296|P9|Overall Study|Adverse Event|1
5172246|NCT01296932|17858297|P8|Overall Study|Adverse Event|0
5172247|NCT01296932|17858298|P7|Overall Study|Adverse Event|0
5172248|NCT01296932|17858299|P6|Overall Study|Adverse Event|0
5172249|NCT01296932|17858300|P5|Overall Study|Adverse Event|1
5172250|NCT01296932|17858301|P4|Overall Study|Adverse Event|2
5172251|NCT01296932|17858302|P3|Overall Study|Adverse Event|1
5172252|NCT01296932|17858303|P2|Overall Study|Adverse Event|1
5172253|NCT01296932|17858304|P1|Overall Study|Adverse Event|1
5172254|NCT01296932|17858296|P9|Overall Study|Withdrawal by Subject|0
5172255|NCT01296932|17858297|P8|Overall Study|Withdrawal by Subject|0
5172256|NCT01296932|17858298|P7|Overall Study|Withdrawal by Subject|3
5172257|NCT01296932|17858299|P6|Overall Study|Withdrawal by Subject|0
5172258|NCT01296932|17858300|P5|Overall Study|Withdrawal by Subject|0
5172259|NCT01296932|17858301|P4|Overall Study|Withdrawal by Subject|1
5172260|NCT01296932|17858302|P3|Overall Study|Withdrawal by Subject|1
5172261|NCT01296932|17858303|P2|Overall Study|Withdrawal by Subject|0
5172262|NCT01296932|17858304|P1|Overall Study|Withdrawal by Subject|0
5172263|NCT01296932|17858296|P9|Overall Study|Progressive disease|0
5172264|NCT01296932|17858297|P8|Overall Study|Progressive disease|0
5172265|NCT01296932|17858298|P7|Overall Study|Progressive disease|1
5172266|NCT01296932|17858299|P6|Overall Study|Progressive disease|3
5172267|NCT01296932|17858300|P5|Overall Study|Progressive disease|2
5172268|NCT01296932|17858301|P4|Overall Study|Progressive disease|1
5172269|NCT01296932|17858302|P3|Overall Study|Progressive disease|1
5172270|NCT01296932|17858303|P2|Overall Study|Progressive disease|0
5172271|NCT01296932|17858304|P1|Overall Study|Progressive disease|2
5172272|NCT01296932|17858296|P9|Overall Study|Dose limiting toxicity|1
5172273|NCT01296932|17858297|P8|Overall Study|Dose limiting toxicity|0
5172274|NCT01296932|17858298|P7|Overall Study|Dose limiting toxicity|1
5172275|NCT01296932|17858299|P6|Overall Study|Dose limiting toxicity|0
5172276|NCT01296932|17858300|P5|Overall Study|Dose limiting toxicity|0
5172277|NCT01296932|17858301|P4|Overall Study|Dose limiting toxicity|0
5172278|NCT01296932|17858302|P3|Overall Study|Dose limiting toxicity|0
5172279|NCT01296932|17858303|P2|Overall Study|Dose limiting toxicity|0
5172280|NCT01296932|17858304|P1|Overall Study|Dose limiting toxicity|0
5172281|NCT01296698|17858428|P2|Overall Study|Study Terminated by Sponsor|12
5172282|NCT01296698|17858429|P1|Overall Study|Study Terminated by Sponsor|209
5172283|NCT01296698|17858428|P2|Overall Study|Difficulty Contacting Subject|0
5172284|NCT01296698|17858429|P1|Overall Study|Difficulty Contacting Subject|2
5172285|NCT01296698|17858428|P2|Overall Study|Withdrawal by Subject|0
5172286|NCT01296698|17858429|P1|Overall Study|Withdrawal by Subject|12
5172287|NCT01296698|17858428|P2|Overall Study|Lost to Follow-up|1
5172288|NCT01296698|17858429|P1|Overall Study|Lost to Follow-up|19
5172289|NCT01296698|17858428|P2|Overall Study|Death|0
5172290|NCT01296698|17858429|P1|Overall Study|Death|1
5172291|NCT01296698|17858428|P2|Overall Study|Adverse Event|0
5172292|NCT01296698|17858429|P1|Overall Study|Adverse Event|1
5172293|NCT01296672|17858483|P2|Overall Study|Lost to Follow-up|18
5172294|NCT01296672|17858484|P1|Overall Study|Lost to Follow-up|73
5172295|NCT01296568|17858505|P1|Continued Access Phase|Disease Progression|1
5172296|NCT01296568|17858505|P1|Continued Access Phase|Withdrawal by Subject|1
5172297|NCT01296568|17858505|P1|Continued Access Phase|Lost to Follow-up|1
5172298|NCT01296412|17858521|P2|Overall Study|Withdrawal by Subject|13
5172299|NCT01296412|17858522|P1|Overall Study|Withdrawal by Subject|10
5172300|NCT01296412|17858521|P2|Overall Study|Pregnancy|1
5172301|NCT01296412|17858522|P1|Overall Study|Pregnancy|0
5172302|NCT01296412|17858521|P2|Overall Study|Physician Decision|3
5172303|NCT01296412|17858522|P1|Overall Study|Physician Decision|1
5172304|NCT01296412|17858521|P2|Overall Study|Other reason not specified|15
5172305|NCT01296412|17858522|P1|Overall Study|Other reason not specified|20
5172306|NCT01296412|17858521|P2|Overall Study|Non-compliance with study drug|2
5172307|NCT01296412|17858522|P1|Overall Study|Non-compliance with study drug|1
5172308|NCT01296412|17858521|P2|Overall Study|Lost to Follow-up|7
5172309|NCT01296412|17858522|P1|Overall Study|Lost to Follow-up|10
5172310|NCT01296412|17858521|P2|Overall Study|Lack of Efficacy|0
5172311|NCT01296412|17858522|P1|Overall Study|Lack of Efficacy|1
5172312|NCT01296412|17858521|P2|Overall Study|Adverse Event|29
5172313|NCT01296412|17858522|P1|Overall Study|Adverse Event|8
5172314|NCT01296347|17858545|P2|12 Month Follow up|Withdrawal by Subject|1
5172315|NCT01296347|17858546|P1|12 Month Follow up|Withdrawal by Subject|0
5172316|NCT01296347|17858545|P2|12 Month Follow up|Death|1
5172317|NCT01296347|17858546|P1|12 Month Follow up|Death|1
5172318|NCT01296347|17858545|P2|12 Month Follow up|Lost to Follow-up|1
5172319|NCT01296347|17858546|P1|12 Month Follow up|Lost to Follow-up|3
5172320|NCT01296347|17858545|P2|6 Month Follow up|Lost to Follow-up|1
5172321|NCT01296347|17858546|P1|6 Month Follow up|Lost to Follow-up|0
5172322|NCT01296347|17858545|P2|6 Month Follow up|Death|1
5172323|NCT01296347|17858546|P1|6 Month Follow up|Death|2
5172324|NCT01296347|17858545|P2|3 Month Follow up|Lost to Follow-up|1
5172325|NCT01296347|17858546|P1|3 Month Follow up|Lost to Follow-up|0
5172326|NCT01296347|17858545|P2|3 Month Follow up|Death|0
5172327|NCT01296347|17858546|P1|3 Month Follow up|Death|1
5172328|NCT01296347|17858545|P2|6 Week Follow up|Death|1
5172329|NCT01296347|17858546|P1|6 Week Follow up|Death|0
5172330|NCT01296347|17858545|P2|Allocation|not received infusion|0
5172331|NCT01296347|17858546|P1|Allocation|not received infusion|1
5172332|NCT01296347|17858545|P2|Allocation|Lack of Efficacy|2
5172333|NCT01296347|17858546|P1|Allocation|Lack of Efficacy|1
5172334|NCT01296347|17858545|P2|Allocation|Withdrawal by Subject|2
5172335|NCT01296347|17858546|P1|Allocation|Withdrawal by Subject|1
5172336|NCT01296152|17858571|P1|Overall Study|Unwilling to adhere to study requirement|1
5172337|NCT01296035|17858598|P1|Overall Study|Withdrawal by Subject|1
5172338|NCT01295905|17858605|P2|Overall Study|Met exclusion criteria|0
5172339|NCT01295905|17858606|P1|Overall Study|Met exclusion criteria|1
5172340|NCT01295905|17858605|P2|Overall Study|Did not meet inclusion criteria|0
5172341|NCT01295905|17858606|P1|Overall Study|Did not meet inclusion criteria|1
5172342|NCT01295827|17858650|P15|Overall Study|Other|0
5172343|NCT01295827|17858651|P14|Overall Study|Other|0
5172344|NCT01295827|17858652|P13|Overall Study|Other|0
5172345|NCT01295827|17858653|P12|Overall Study|Other|0
5172346|NCT01295827|17858654|P11|Overall Study|Other|2
5172347|NCT01295827|17858655|P10|Overall Study|Other|0
5172348|NCT01295827|17858656|P9|Overall Study|Other|1
5172349|NCT01295827|17858657|P8|Overall Study|Other|1
5172350|NCT01295827|17858658|P7|Overall Study|Other|1
5172351|NCT01295827|17858659|P6|Overall Study|Other|0
5172352|NCT01295827|17858660|P5|Overall Study|Other|0
5172353|NCT01295827|17858661|P4|Overall Study|Other|0
5172354|NCT01295827|17858662|P3|Overall Study|Other|0
5172355|NCT01295827|17858663|P2|Overall Study|Other|0
5172356|NCT01295827|17858664|P1|Overall Study|Other|0
5172357|NCT01295827|17858650|P15|Overall Study|Withdrawal by Subject|0
5172358|NCT01295827|17858651|P14|Overall Study|Withdrawal by Subject|0
5172359|NCT01295827|17858652|P13|Overall Study|Withdrawal by Subject|0
5172360|NCT01295827|17858653|P12|Overall Study|Withdrawal by Subject|13
5172361|NCT01295827|17858654|P11|Overall Study|Withdrawal by Subject|18
5172362|NCT01295827|17858655|P10|Overall Study|Withdrawal by Subject|2
5172363|NCT01295827|17858656|P9|Overall Study|Withdrawal by Subject|11
5172364|NCT01295827|17858657|P8|Overall Study|Withdrawal by Subject|35
5172365|NCT01295827|17858658|P7|Overall Study|Withdrawal by Subject|13
5172366|NCT01295827|17858659|P6|Overall Study|Withdrawal by Subject|1
5172367|NCT01295827|17858660|P5|Overall Study|Withdrawal by Subject|0
5172368|NCT01295827|17858661|P4|Overall Study|Withdrawal by Subject|0
5172369|NCT01295827|17858662|P3|Overall Study|Withdrawal by Subject|2
5172370|NCT01295827|17858663|P2|Overall Study|Withdrawal by Subject|0
5172371|NCT01295827|17858664|P1|Overall Study|Withdrawal by Subject|1
5172372|NCT01295827|17858650|P15|Overall Study|Screen Failure|0
5172373|NCT01295827|17858651|P14|Overall Study|Screen Failure|0
5172374|NCT01295827|17858652|P13|Overall Study|Screen Failure|0
5172375|NCT01295827|17858653|P12|Overall Study|Screen Failure|0
5172376|NCT01295827|17858654|P11|Overall Study|Screen Failure|1
5172377|NCT01295827|17858655|P10|Overall Study|Screen Failure|0
5172378|NCT01295827|17858656|P9|Overall Study|Screen Failure|2
5172379|NCT01295827|17858657|P8|Overall Study|Screen Failure|2
5172380|NCT01295827|17858658|P7|Overall Study|Screen Failure|2
5172381|NCT01295827|17858659|P6|Overall Study|Screen Failure|0
5172382|NCT01295827|17858660|P5|Overall Study|Screen Failure|0
5172383|NCT01295827|17858661|P4|Overall Study|Screen Failure|0
5172384|NCT01295827|17858662|P3|Overall Study|Screen Failure|0
5172385|NCT01295827|17858663|P2|Overall Study|Screen Failure|0
5172386|NCT01295827|17858664|P1|Overall Study|Screen Failure|0
5172387|NCT01295827|17858650|P15|Overall Study|Progressive Disease|0
5172388|NCT01295827|17858651|P14|Overall Study|Progressive Disease|0
5172389|NCT01295827|17858652|P13|Overall Study|Progressive Disease|0
5172390|NCT01295827|17858653|P12|Overall Study|Progressive Disease|136
5172391|NCT01295827|17858654|P11|Overall Study|Progressive Disease|175
5172392|NCT01295827|17858655|P10|Overall Study|Progressive Disease|40
5172393|NCT01295827|17858656|P9|Overall Study|Progressive Disease|85
5172394|NCT01295827|17858657|P8|Overall Study|Progressive Disease|144
5172395|NCT01295827|17858658|P7|Overall Study|Progressive Disease|87
5172396|NCT01295827|17858659|P6|Overall Study|Progressive Disease|1
5172397|NCT01295827|17858660|P5|Overall Study|Progressive Disease|0
5172398|NCT01295827|17858661|P4|Overall Study|Progressive Disease|2
5172399|NCT01295827|17858662|P3|Overall Study|Progressive Disease|5
5172400|NCT01295827|17858663|P2|Overall Study|Progressive Disease|1
5172401|NCT01295827|17858664|P1|Overall Study|Progressive Disease|2
5172402|NCT01295827|17858650|P15|Overall Study|Not Reported|0
5172403|NCT01295827|17858651|P14|Overall Study|Not Reported|0
5172404|NCT01295827|17858652|P13|Overall Study|Not Reported|0
5172405|NCT01295827|17858653|P12|Overall Study|Not Reported|13
5172406|NCT01295827|17858654|P11|Overall Study|Not Reported|23
5172407|NCT01295827|17858655|P10|Overall Study|Not Reported|2
5172408|NCT01295827|17858656|P9|Overall Study|Not Reported|41
5172409|NCT01295827|17858657|P8|Overall Study|Not Reported|58
5172410|NCT01295827|17858658|P7|Overall Study|Not Reported|24
5172411|NCT01295827|17858659|P6|Overall Study|Not Reported|0
5172412|NCT01295827|17858660|P5|Overall Study|Not Reported|0
5172413|NCT01295827|17858661|P4|Overall Study|Not Reported|1
5172414|NCT01295827|17858662|P3|Overall Study|Not Reported|0
5172415|NCT01295827|17858663|P2|Overall Study|Not Reported|0
5172416|NCT01295827|17858664|P1|Overall Study|Not Reported|0
5172417|NCT01295827|17858650|P15|Overall Study|Lost to Follow-up|0
5172418|NCT01295827|17858651|P14|Overall Study|Lost to Follow-up|0
5172419|NCT01295827|17858652|P13|Overall Study|Lost to Follow-up|0
5172420|NCT01295827|17858653|P12|Overall Study|Lost to Follow-up|3
5172421|NCT01295827|17858654|P11|Overall Study|Lost to Follow-up|7
5172422|NCT01295827|17858655|P10|Overall Study|Lost to Follow-up|4
5172423|NCT01295827|17858656|P9|Overall Study|Lost to Follow-up|7
5172424|NCT01295827|17858657|P8|Overall Study|Lost to Follow-up|8
5172425|NCT01295827|17858658|P7|Overall Study|Lost to Follow-up|4
5172426|NCT01295827|17858659|P6|Overall Study|Lost to Follow-up|0
5172427|NCT01295827|17858660|P5|Overall Study|Lost to Follow-up|1
5172428|NCT01295827|17858661|P4|Overall Study|Lost to Follow-up|0
5172429|NCT01295827|17858662|P3|Overall Study|Lost to Follow-up|3
5172430|NCT01295827|17858663|P2|Overall Study|Lost to Follow-up|0
5172431|NCT01295827|17858664|P1|Overall Study|Lost to Follow-up|0
5172432|NCT01295827|17858650|P15|Overall Study|Adverse Event|0
5172433|NCT01295827|17858651|P14|Overall Study|Adverse Event|0
5172434|NCT01295827|17858652|P13|Overall Study|Adverse Event|0
5172435|NCT01295827|17858653|P12|Overall Study|Adverse Event|21
5172436|NCT01295827|17858654|P11|Overall Study|Adverse Event|50
5172437|NCT01295827|17858655|P10|Overall Study|Adverse Event|7
5172438|NCT01295827|17858656|P9|Overall Study|Adverse Event|22
5172439|NCT01295827|17858657|P8|Overall Study|Adverse Event|49
5172440|NCT01295827|17858658|P7|Overall Study|Adverse Event|15
5172441|NCT01295827|17858659|P6|Overall Study|Adverse Event|4
5172442|NCT01295827|17858660|P5|Overall Study|Adverse Event|1
5172443|NCT01295827|17858661|P4|Overall Study|Adverse Event|1
5172444|NCT01295827|17858662|P3|Overall Study|Adverse Event|2
5172445|NCT01295827|17858663|P2|Overall Study|Adverse Event|2
5172446|NCT01295827|17858664|P1|Overall Study|Adverse Event|1
5172447|NCT01295814|17859037|P2|Overall Study|Withdrawal by Subject|0
5172448|NCT01295814|17859038|P1|Overall Study|Withdrawal by Subject|2
5172449|NCT01295814|17859037|P2|Overall Study|Lack of Efficacy|2
5172450|NCT01295814|17859038|P1|Overall Study|Lack of Efficacy|0
5172451|NCT01295671|17859118|P3|Overall Study|Withdrawal by Subject|0
5172452|NCT01295671|17859119|P2|Overall Study|Withdrawal by Subject|1
5172453|NCT01295671|17859120|P1|Overall Study|Withdrawal by Subject|3
5172454|NCT01295671|17859118|P3|Overall Study|Lost to Follow-up|3
5172455|NCT01295671|17859119|P2|Overall Study|Lost to Follow-up|6
5172456|NCT01295671|17859120|P1|Overall Study|Lost to Follow-up|4
5172457|NCT01295320|17859166|P1|Overall Study|Unable to travel|1
5172458|NCT01295320|17859166|P1|Overall Study|Subject was bedridden|1
5172459|NCT01295320|17859166|P1|Overall Study|Withdrawal by Subject|2
5172460|NCT01295320|17859166|P1|Overall Study|Lost to Follow-up|4
5172461|NCT01295320|17859166|P1|Overall Study|Adverse Event|2
5172462|NCT01295281|17859183|P2|First Intervention (7 Days)|Death|1
5172463|NCT01295281|17859184|P1|First Intervention (7 Days)|Death|0
5172464|NCT01295034|17859222|P2|Overall Study|Lost to Follow-up|5
5172465|NCT01295034|17859223|P1|Overall Study|Lost to Follow-up|5
5172466|NCT01294917|17859231|P1|Overall Study|Inconvenience|1
5172467|NCT01294917|17859231|P1|Overall Study|Relocation|5
5172468|NCT01294800|17859241|P4|Overall Study|Did Not Meet Protocol Eligibility|0
5172469|NCT01294800|17859242|P3|Overall Study|Did Not Meet Protocol Eligibility|1
5172470|NCT01294800|17859243|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5172471|NCT01294800|17859244|P1|Overall Study|Did Not Meet Protocol Eligibility|2
5172472|NCT01294800|17859241|P4|Overall Study|Non-compliance With Protocol|0
5172473|NCT01294800|17859242|P3|Overall Study|Non-compliance With Protocol|1
5172474|NCT01294800|17859243|P2|Overall Study|Non-compliance With Protocol|1
5172475|NCT01294800|17859244|P1|Overall Study|Non-compliance With Protocol|0
5172476|NCT01294800|17859241|P4|Overall Study|Lost to Follow-up|0
5172477|NCT01294800|17859242|P3|Overall Study|Lost to Follow-up|1
5172478|NCT01294800|17859243|P2|Overall Study|Lost to Follow-up|0
5172479|NCT01294800|17859244|P1|Overall Study|Lost to Follow-up|0
5172480|NCT01294800|17859241|P4|Overall Study|Subject Withdrew Consent|11
5172481|NCT01294800|17859242|P3|Overall Study|Subject Withdrew Consent|2
5172482|NCT01294800|17859243|P2|Overall Study|Subject Withdrew Consent|2
5172483|NCT01294800|17859244|P1|Overall Study|Subject Withdrew Consent|2
5172484|NCT01294800|17859241|P4|Overall Study|Adverse Event|5
5172485|NCT01294800|17859242|P3|Overall Study|Adverse Event|12
5172486|NCT01294800|17859243|P2|Overall Study|Adverse Event|6
5172487|NCT01294800|17859244|P1|Overall Study|Adverse Event|7
5172488|NCT01294787|17859270|P6|Period 3|Adverse Event|0
5172489|NCT01294787|17859271|P5|Period 3|Adverse Event|1
5172490|NCT01294787|17859272|P4|Period 3|Adverse Event|0
5172491|NCT01294787|17859273|P3|Period 3|Adverse Event|0
5172492|NCT01294787|17859274|P2|Period 3|Adverse Event|0
5172493|NCT01294787|17859275|P1|Period 3|Adverse Event|0
5172494|NCT01294787|17859270|P6|Period 2|No longer needs study drug|0
5172495|NCT01294787|17859271|P5|Period 2|No longer needs study drug|0
5172496|NCT01294787|17859272|P4|Period 2|No longer needs study drug|1
5172497|NCT01294787|17859273|P3|Period 2|No longer needs study drug|0
5172498|NCT01294787|17859274|P2|Period 2|No longer needs study drug|0
5172499|NCT01294787|17859275|P1|Period 2|No longer needs study drug|0
5172500|NCT01294787|17859270|P6|Period 2|Adverse Event|0
5172501|NCT01294787|17859271|P5|Period 2|Adverse Event|0
5172502|NCT01294787|17859272|P4|Period 2|Adverse Event|1
5172503|NCT01294787|17859273|P3|Period 2|Adverse Event|0
5172504|NCT01294787|17859274|P2|Period 2|Adverse Event|3
5172505|NCT01294787|17859275|P1|Period 2|Adverse Event|0
5172506|NCT01294787|17859270|P6|Period 1|Administrative problem|1
5172507|NCT01294787|17859271|P5|Period 1|Administrative problem|0
5172508|NCT01294787|17859272|P4|Period 1|Administrative problem|0
5172509|NCT01294787|17859273|P3|Period 1|Administrative problem|1
5172510|NCT01294787|17859274|P2|Period 1|Administrative problem|0
5172511|NCT01294787|17859275|P1|Period 1|Administrative problem|0
5172512|NCT01294787|17859270|P6|Period 1|Withdrawal by Subject|1
5172513|NCT01294787|17859271|P5|Period 1|Withdrawal by Subject|1
5172514|NCT01294787|17859272|P4|Period 1|Withdrawal by Subject|1
5172515|NCT01294787|17859273|P3|Period 1|Withdrawal by Subject|0
5172516|NCT01294787|17859274|P2|Period 1|Withdrawal by Subject|0
5172517|NCT01294787|17859275|P1|Period 1|Withdrawal by Subject|0
5172518|NCT01294787|17859270|P6|Period 1|Adverse Event|0
5172519|NCT01294787|17859271|P5|Period 1|Adverse Event|1
5172520|NCT01294787|17859272|P4|Period 1|Adverse Event|0
5172521|NCT01294787|17859273|P3|Period 1|Adverse Event|0
5172522|NCT01294787|17859274|P2|Period 1|Adverse Event|0
5172523|NCT01294787|17859275|P1|Period 1|Adverse Event|0
5172524|NCT01294696|17859366|P1|Overall Study|Site closure|52
5172525|NCT01294696|17859366|P1|Overall Study|Missing BPI Response|7
5172526|NCT01294696|17859366|P1|Overall Study|Protocol Violation|8
5172527|NCT01294696|17859366|P1|Overall Study|Screening failures|7
5172528|NCT01294683|17859380|P2|Post Crossover (Period III)|Withdrawal by Subject|2
5172529|NCT01294683|17859381|P1|Post Crossover (Period III)|Withdrawal by Subject|3
5172530|NCT01294683|17859380|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
5172531|NCT01294683|17859381|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
5172532|NCT01294683|17859380|P2|Post Crossover (Period III)|Lost to Follow-up|3
5172533|NCT01294683|17859381|P1|Post Crossover (Period III)|Lost to Follow-up|1
5172534|NCT01294683|17859380|P2|Post Crossover (Period III)|Adverse Event|6
5172535|NCT01294683|17859381|P1|Post Crossover (Period III)|Adverse Event|6
5172536|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
5172537|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
5172538|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Technical Problems|1
5172539|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Technical Problems|0
5172540|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
5172541|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
5172542|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Protocol Violation|5
5172543|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Protocol Violation|5
5172544|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Physician Decision|0
5172545|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Physician Decision|1
5172546|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
5172547|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
5172548|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
5172549|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
5172550|NCT01294683|17859380|P2|Precrossover (Periods I/II)|Adverse Event|52
5172551|NCT01294683|17859381|P1|Precrossover (Periods I/II)|Adverse Event|49
5172552|NCT01294644|17859434|P3|Overall Study|Miscellaneous Reason|4
5172553|NCT01294644|17859435|P2|Overall Study|Miscellaneous Reason|1
5172554|NCT01294644|17859436|P1|Overall Study|Miscellaneous Reason|2
5172555|NCT01294644|17859434|P3|Overall Study|Lost to Follow-up|5
5172556|NCT01294644|17859435|P2|Overall Study|Lost to Follow-up|2
5172557|NCT01294644|17859436|P1|Overall Study|Lost to Follow-up|3
5172558|NCT01294644|17859434|P3|Overall Study|Withdrawal by Subject|4
5172559|NCT01294644|17859435|P2|Overall Study|Withdrawal by Subject|7
5172560|NCT01294644|17859436|P1|Overall Study|Withdrawal by Subject|3
5172561|NCT01294644|17859434|P3|Overall Study|Adverse Event|1
5172562|NCT01294644|17859435|P2|Overall Study|Adverse Event|0
5172563|NCT01294644|17859436|P1|Overall Study|Adverse Event|2
5172564|NCT01294592|17859467|P2|Overall Study|Withdrawal by Subject|28
5172565|NCT01294592|17859468|P1|Overall Study|Withdrawal by Subject|28
5172566|NCT01294592|17859467|P2|Overall Study|Physician Decision|11
5172567|NCT01294592|17859468|P1|Overall Study|Physician Decision|6
5172568|NCT01294592|17859467|P2|Overall Study|Lost to Follow-up|9
5172569|NCT01294592|17859468|P1|Overall Study|Lost to Follow-up|7
5172570|NCT01294592|17859467|P2|Overall Study|Protocol Violation|7
5172571|NCT01294592|17859468|P1|Overall Study|Protocol Violation|1
5172572|NCT01294592|17859467|P2|Overall Study|Lack of Efficacy|5
5172573|NCT01294592|17859468|P1|Overall Study|Lack of Efficacy|7
5172574|NCT01294592|17859467|P2|Overall Study|Adverse Event|13
5172575|NCT01294592|17859468|P1|Overall Study|Adverse Event|28
5172576|NCT01294579|17859496|P1|Overall Study|Withdrawal by Subject|5
5172577|NCT01294579|17859496|P1|Overall Study|Physician Decision|3
5172578|NCT01294579|17859496|P1|Overall Study|Lost to Follow-up|1
5172579|NCT01294579|17859496|P1|Overall Study|Study closed/terminated|3
5172580|NCT01294579|17859496|P1|Overall Study|Adverse Event|11
5172581|NCT01294579|17859496|P1|Overall Study|Disease progression|12
5172582|NCT01294553|17859506|P1|Overall Study|Protocol Violation|268
5172583|NCT01294553|17859506|P1|Overall Study|Duplicated Participants|1
5172584|NCT01294514|17859512|P1|Overall Study|Excluded due to Arrhythmia|1
5172585|NCT01294462|17859522|P2|Overall Study|Withdrawal by Subject|63
5172586|NCT01294462|17859523|P1|Overall Study|Withdrawal by Subject|65
5172587|NCT01294462|17859522|P2|Overall Study|Lost to Follow-up|0
5172588|NCT01294462|17859523|P1|Overall Study|Lost to Follow-up|1
5172589|NCT01294449|17859537|P2|Overall Study|Withdrawal by Subject|3
5172590|NCT01294449|17859538|P1|Overall Study|Withdrawal by Subject|1
5172591|NCT01294449|17859537|P2|Overall Study|Death|12
5172592|NCT01294449|17859538|P1|Overall Study|Death|11
5172593|NCT01294436|17859546|P2|Overall Study|poor/non-compliance|5
5172594|NCT01294436|17859547|P1|Overall Study|poor/non-compliance|2
5172595|NCT01294436|17859546|P2|Overall Study|subject no longer meets study criteria|20
5172596|NCT01294436|17859547|P1|Overall Study|subject no longer meets study criteria|5
5172597|NCT01294436|17859546|P2|Overall Study|Withdrawal by Subject|28
5172598|NCT01294436|17859547|P1|Overall Study|Withdrawal by Subject|11
5172599|NCT01294436|17859546|P2|Overall Study|Adverse Event|17
5172600|NCT01294436|17859547|P1|Overall Study|Adverse Event|10
5172601|NCT01294423|17859582|P3|Overall Study|poor/non-compliance|1
5172602|NCT01294423|17859583|P2|Overall Study|poor/non-compliance|0
5172603|NCT01294423|17859584|P1|Overall Study|poor/non-compliance|1
5172604|NCT01294423|17859582|P3|Overall Study|subject no longer meets study criteria|2
5172605|NCT01294423|17859583|P2|Overall Study|subject no longer meets study criteria|5
5172606|NCT01294423|17859584|P1|Overall Study|subject no longer meets study criteria|2
5172607|NCT01294423|17859582|P3|Overall Study|Withdrawal by Subject|2
5172608|NCT01294423|17859583|P2|Overall Study|Withdrawal by Subject|2
5172609|NCT01294423|17859584|P1|Overall Study|Withdrawal by Subject|1
5172610|NCT01294423|17859582|P3|Overall Study|Adverse Event|3
5172611|NCT01294423|17859583|P2|Overall Study|Adverse Event|2
5172612|NCT01294423|17859584|P1|Overall Study|Adverse Event|1
5172613|NCT01294397|17859598|P1|Overall Study|Administrative Decision|1
5172614|NCT01294397|17859598|P1|Overall Study|Withdrawal by Subject|1
5172615|NCT01294371|17859642|P1|Overall Study|Other|14
5172616|NCT01294371|17859642|P1|Overall Study|Administrative Reason|1
5172617|NCT01294371|17859642|P1|Overall Study|Lost to Follow-up|6
5172618|NCT01294371|17859642|P1|Overall Study|Withdrawal by Subject|12
5172619|NCT01294371|17859642|P1|Overall Study|Adverse Event|1
5172620|NCT01294358|17859650|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
5172621|NCT01294358|17859651|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5172622|NCT01294358|17859652|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5172623|NCT01294358|17859653|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5172624|NCT01294358|17859654|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5172625|NCT01294358|17859650|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5172626|NCT01294358|17859651|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
5172627|NCT01294358|17859652|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5172628|NCT01294358|17859653|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5172629|NCT01294358|17859654|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5172630|NCT01294358|17859650|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5172631|NCT01294358|17859651|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5172632|NCT01294358|17859652|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
5172633|NCT01294358|17859653|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5172634|NCT01294358|17859654|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5172635|NCT01294358|17859650|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5172636|NCT01294358|17859651|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5172637|NCT01294358|17859652|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5172638|NCT01294358|17859653|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
5172639|NCT01294358|17859654|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5172640|NCT01294150|17859782|P2|Overall Study|Physician Decision|2
5172641|NCT01294150|17859783|P1|Overall Study|Physician Decision|2
5172642|NCT01294046|17859812|P1|Overall Study|Stimulation response inadqequate|1
5172643|NCT01294046|17859812|P1|Overall Study|Eligibility criteria expanded|1
5172644|NCT01294046|17859812|P1|Overall Study|Infection and surgical explant|1
5172645|NCT01293968|17859827|P2|Overall Study|non-cooperation|3
5172646|NCT01293968|17859828|P1|Overall Study|non-cooperation|3
5172647|NCT01293695|17859848|P2|Overall Study|Lost to Follow-up|6
5172648|NCT01293695|17859849|P1|Overall Study|Lost to Follow-up|8
5172649|NCT01293695|17859848|P2|Overall Study|Withdrawal by Subject|1
5172650|NCT01293695|17859849|P1|Overall Study|Withdrawal by Subject|7
5172651|NCT01293539|17859868|P1|Overall Study|Physician Decision|1
5172652|NCT01293240|17859872|P1|Overall Study|Noncompliance|2
5172653|NCT01293123|17859889|P2|Overall Study|Lost to Follow-up|1
5172654|NCT01293123|17859890|P1|Overall Study|Lost to Follow-up|0
5172655|NCT01293084|17859904|P1|Overall Study|Withdrawal by Subject|2
5172656|NCT01293084|17859904|P1|Overall Study|Physician Decision|3
5172657|NCT01293032|17859916|P4|Treatment|Disease Progression, relapse|0
5172658|NCT01293032|17859917|P3|Treatment|Disease Progression, relapse|0
5172659|NCT01293032|17859918|P2|Treatment|Disease Progression, relapse|1
5172660|NCT01293032|17859919|P1|Treatment|Disease Progression, relapse|0
5172661|NCT01293032|17859916|P4|Treatment|Withdrawal by Subject|0
5172662|NCT01293032|17859917|P3|Treatment|Withdrawal by Subject|0
5172663|NCT01293032|17859918|P2|Treatment|Withdrawal by Subject|4
5172664|NCT01293032|17859919|P1|Treatment|Withdrawal by Subject|2
5172665|NCT01293032|17859916|P4|Treatment|Adverse Event|1
5172666|NCT01293032|17859917|P3|Treatment|Adverse Event|1
5172667|NCT01293032|17859918|P2|Treatment|Adverse Event|0
5172668|NCT01293032|17859919|P1|Treatment|Adverse Event|0
5172669|NCT01293032|17859916|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5172670|NCT01293032|17859917|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
5172671|NCT01293032|17859918|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5172672|NCT01293032|17859919|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5172673|NCT01293006|17859930|P4|Period 2|Lost to Follow-up|0
5172674|NCT01293006|17859931|P3|Period 2|Lost to Follow-up|0
5172675|NCT01293006|17859932|P2|Period 2|Lost to Follow-up|0
5172676|NCT01293006|17859933|P1|Period 2|Lost to Follow-up|1
5172677|NCT01292928|17859954|P1|Overall Study|Physician Decision|2
5172678|NCT01292928|17859954|P1|Overall Study|Lost to Follow-up|6
5172679|NCT01292928|17859954|P1|Overall Study|Withdrawal by Subject|8
5172680|NCT01292928|17859954|P1|Overall Study|Death|8
5172681|NCT01292876|17859971|P1|Overall Study|Physician Decision|4
5172682|NCT01292837|17859977|P1|Overall Study|Further treatment determined|1
5172683|NCT01292837|17859977|P1|Overall Study|Adverse Event|1
5172684|NCT01292603|17860014|P6|Overall Survival Status|Death|10
5172685|NCT01292603|17860015|P5|Overall Survival Status|Death|16
5172686|NCT01292603|17860016|P4|Overall Survival Status|Death|1
5172687|NCT01292603|17860017|P3|Overall Survival Status|Death|3
5172688|NCT01292603|17860018|P2|Overall Survival Status|Death|1
5172689|NCT01292603|17860019|P1|Overall Survival Status|Death|3
5172690|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Adverse Event|2
5172691|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Adverse Event|2
5172692|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Adverse Event|0
5172693|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Adverse Event|0
5172694|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Adverse Event|0
5172695|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Adverse Event|0
5172696|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
5172697|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
5172698|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
5172699|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
5172700|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
5172701|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
5172702|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Physician Decision|0
5172703|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Physician Decision|2
5172704|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Physician Decision|0
5172705|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Physician Decision|0
5172706|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Physician Decision|0
5172707|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Physician Decision|0
5172708|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Protocol Violation|0
5172709|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Protocol Violation|2
5172710|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Protocol Violation|0
5172711|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Protocol Violation|0
5172712|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Protocol Violation|0
5172713|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Protocol Violation|0
5172714|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
5172715|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5172716|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5172717|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5172718|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5172719|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5172720|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Noncompliance|0
5172721|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Noncompliance|1
5172722|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Noncompliance|0
5172723|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Noncompliance|0
5172724|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Noncompliance|0
5172725|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Noncompliance|0
5172726|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Disease Progression|5
5172727|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Disease Progression|5
5172728|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Disease Progression|0
5172729|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Disease Progression|0
5172730|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Disease Progression|0
5172731|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Disease Progression|0
5172732|NCT01292603|17860014|P6|Part 2: Regular Follow-Up|Death|3
5172733|NCT01292603|17860015|P5|Part 2: Regular Follow-Up|Death|6
5172734|NCT01292603|17860016|P4|Part 2: Regular Follow-Up|Death|0
5172735|NCT01292603|17860017|P3|Part 2: Regular Follow-Up|Death|0
5172736|NCT01292603|17860018|P2|Part 2: Regular Follow-Up|Death|0
5172737|NCT01292603|17860019|P1|Part 2: Regular Follow-Up|Death|0
5172738|NCT01292603|17860014|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
5172739|NCT01292603|17860015|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5172740|NCT01292603|17860016|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5172741|NCT01292603|17860017|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5172742|NCT01292603|17860018|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5172743|NCT01292603|17860019|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5172744|NCT01292603|17860014|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
5172745|NCT01292603|17860015|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
5172746|NCT01292603|17860016|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
5172747|NCT01292603|17860017|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
5172748|NCT01292603|17860018|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
5172749|NCT01292603|17860019|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
5172750|NCT01292603|17860014|P6|Part 2: Dose Confirmation Period|Adverse Event|9
5172751|NCT01292603|17860015|P5|Part 2: Dose Confirmation Period|Adverse Event|7
5172752|NCT01292603|17860016|P4|Part 2: Dose Confirmation Period|Adverse Event|0
5172753|NCT01292603|17860017|P3|Part 2: Dose Confirmation Period|Adverse Event|0
5172754|NCT01292603|17860018|P2|Part 2: Dose Confirmation Period|Adverse Event|0
5172755|NCT01292603|17860019|P1|Part 2: Dose Confirmation Period|Adverse Event|0
5172756|NCT01292603|17860014|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
5172836|NCT01292239|17860157|P2|Overall Study|Other|1
5172757|NCT01292603|17860015|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
5172758|NCT01292603|17860016|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5172759|NCT01292603|17860017|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5172760|NCT01292603|17860018|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5172761|NCT01292603|17860019|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5172762|NCT01292603|17860014|P6|Part 2: Dose Confirmation Period|Physician Decision|0
5172763|NCT01292603|17860015|P5|Part 2: Dose Confirmation Period|Physician Decision|2
5172764|NCT01292603|17860016|P4|Part 2: Dose Confirmation Period|Physician Decision|0
5172765|NCT01292603|17860017|P3|Part 2: Dose Confirmation Period|Physician Decision|0
5172766|NCT01292603|17860018|P2|Part 2: Dose Confirmation Period|Physician Decision|0
5172767|NCT01292603|17860019|P1|Part 2: Dose Confirmation Period|Physician Decision|0
5172768|NCT01292603|17860014|P6|Part 2: Dose Confirmation Period|Death|0
5172769|NCT01292603|17860015|P5|Part 2: Dose Confirmation Period|Death|1
5172770|NCT01292603|17860016|P4|Part 2: Dose Confirmation Period|Death|0
5172771|NCT01292603|17860017|P3|Part 2: Dose Confirmation Period|Death|0
5172772|NCT01292603|17860018|P2|Part 2: Dose Confirmation Period|Death|0
5172773|NCT01292603|17860019|P1|Part 2: Dose Confirmation Period|Death|0
5172774|NCT01292603|17860014|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
5172775|NCT01292603|17860015|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
5172776|NCT01292603|17860016|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
5172777|NCT01292603|17860017|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
5172778|NCT01292603|17860018|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
5172779|NCT01292603|17860019|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
5172780|NCT01292603|17860014|P6|Part 1: Regular Follow-Up Period|Death|0
5172781|NCT01292603|17860015|P5|Part 1: Regular Follow-Up Period|Death|0
5172782|NCT01292603|17860016|P4|Part 1: Regular Follow-Up Period|Death|1
5172783|NCT01292603|17860017|P3|Part 1: Regular Follow-Up Period|Death|3
5172784|NCT01292603|17860018|P2|Part 1: Regular Follow-Up Period|Death|1
5172785|NCT01292603|17860019|P1|Part 1: Regular Follow-Up Period|Death|3
5172786|NCT01292603|17860014|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5172787|NCT01292603|17860015|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5172788|NCT01292603|17860016|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
5172789|NCT01292603|17860017|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5172790|NCT01292603|17860018|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5172791|NCT01292603|17860019|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5172792|NCT01292603|17860014|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5172793|NCT01292603|17860015|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5172794|NCT01292603|17860016|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
5172795|NCT01292603|17860017|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5172796|NCT01292603|17860018|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5172797|NCT01292603|17860019|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5172798|NCT01292603|17860014|P6|Part 1: Pilot Dose Selection Period|Death|0
5172799|NCT01292603|17860015|P5|Part 1: Pilot Dose Selection Period|Death|0
5172800|NCT01292603|17860016|P4|Part 1: Pilot Dose Selection Period|Death|1
5172801|NCT01292603|17860017|P3|Part 1: Pilot Dose Selection Period|Death|0
5172802|NCT01292603|17860018|P2|Part 1: Pilot Dose Selection Period|Death|0
5172803|NCT01292603|17860019|P1|Part 1: Pilot Dose Selection Period|Death|0
5172804|NCT01292603|17860014|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
5172805|NCT01292603|17860015|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
5172806|NCT01292603|17860016|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
5172807|NCT01292603|17860017|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
5172808|NCT01292603|17860018|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
5172809|NCT01292603|17860019|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
5172810|NCT01292486|17860072|P1|Overall Study|Physician Decision|1
5172811|NCT01292486|17860072|P1|Overall Study|Adverse Event|1
5172812|NCT01292486|17860072|P1|Overall Study|Did not meet screening criteria|2
5172813|NCT01292486|17860072|P1|Overall Study|Protocol Violation|2
5172814|NCT01292473|17860086|P4|Overall Study|Disease Progression|6
5172815|NCT01292473|17860087|P3|Overall Study|Disease Progression|3
5172816|NCT01292473|17860088|P2|Overall Study|Disease Progression|1
5172817|NCT01292473|17860089|P1|Overall Study|Disease Progression|0
5172818|NCT01292473|17860086|P4|Overall Study|Physician Decision|0
5172819|NCT01292473|17860087|P3|Overall Study|Physician Decision|0
5172820|NCT01292473|17860088|P2|Overall Study|Physician Decision|1
5172821|NCT01292473|17860089|P1|Overall Study|Physician Decision|0
5172822|NCT01292473|17860086|P4|Overall Study|Withdrawal by Subject|3
5172823|NCT01292473|17860087|P3|Overall Study|Withdrawal by Subject|3
5172824|NCT01292473|17860088|P2|Overall Study|Withdrawal by Subject|4
5172825|NCT01292473|17860089|P1|Overall Study|Withdrawal by Subject|3
5172826|NCT01292473|17860086|P4|Overall Study|Lost to Follow-up|2
5172827|NCT01292473|17860087|P3|Overall Study|Lost to Follow-up|2
5172828|NCT01292473|17860088|P2|Overall Study|Lost to Follow-up|1
5172829|NCT01292473|17860089|P1|Overall Study|Lost to Follow-up|1
5172830|NCT01292473|17860086|P4|Overall Study|Adverse Event|1
5172831|NCT01292473|17860087|P3|Overall Study|Adverse Event|1
5172832|NCT01292473|17860088|P2|Overall Study|Adverse Event|0
5172833|NCT01292473|17860089|P1|Overall Study|Adverse Event|1
5172834|NCT01292239|17860157|P2|Overall Study|Withdrawal by Subject|6
5172835|NCT01292239|17860158|P1|Overall Study|Withdrawal by Subject|3
5172837|NCT01292239|17860158|P1|Overall Study|Other|1
5172838|NCT01292226|17860179|P1|Overall Study|Other|2
5172839|NCT01292226|17860179|P1|Overall Study|Withdrawal by Subject|1
5172840|NCT01292226|17860179|P1|Overall Study|Protocol Violation|3
5172841|NCT01292226|17860179|P1|Overall Study|Graft loss|1
5172842|NCT01292226|17860179|P1|Overall Study|Death|1
5172843|NCT01292226|17860179|P1|Overall Study|Adverse Event|5
5172844|NCT01292187|17860212|P2|Overall Study|All other reasons|3
5172845|NCT01292187|17860213|P1|Overall Study|All other reasons|1
5172846|NCT01292187|17860212|P2|Overall Study|Withdrawal by Subject|5
5172847|NCT01292187|17860213|P1|Overall Study|Withdrawal by Subject|6
5172848|NCT01292187|17860212|P2|Overall Study|Adverse Event|5
5172849|NCT01292187|17860213|P1|Overall Study|Adverse Event|10
5172850|NCT01292057|17860248|P2|Overall Study|Lost to Follow-up|1
5172851|NCT01292057|17860249|P1|Overall Study|Lost to Follow-up|1
5172852|NCT01292057|17860248|P2|Overall Study|Protocol Violation|1
5172853|NCT01292057|17860249|P1|Overall Study|Protocol Violation|1
5172854|NCT01291277|17860321|P2|Overall Study|Lost to Follow-up|1
5172855|NCT01291277|17860322|P1|Overall Study|Lost to Follow-up|3
5172856|NCT01291277|17860321|P2|Overall Study|Death|2
5172857|NCT01291277|17860322|P1|Overall Study|Death|2
5172858|NCT01291225|17860334|P2|Overall Study|Lost to Follow-up|39
5172859|NCT01291225|17860335|P1|Overall Study|Lost to Follow-up|85
5172860|NCT01291173|17860349|P4|Overall Study|Excluded therapy|0
5172861|NCT01291173|17860350|P3|Overall Study|Excluded therapy|1
5172862|NCT01291173|17860351|P2|Overall Study|Excluded therapy|0
5172863|NCT01291173|17860352|P1|Overall Study|Excluded therapy|0
5172864|NCT01291173|17860349|P4|Overall Study|Subject was unblinded|0
5172865|NCT01291173|17860350|P3|Overall Study|Subject was unblinded|1
5172866|NCT01291173|17860351|P2|Overall Study|Subject was unblinded|0
5172867|NCT01291173|17860352|P1|Overall Study|Subject was unblinded|0
5172868|NCT01291173|17860349|P4|Overall Study|Lack of compliance|1
5172869|NCT01291173|17860350|P3|Overall Study|Lack of compliance|0
5172870|NCT01291173|17860351|P2|Overall Study|Lack of compliance|0
5172871|NCT01291173|17860352|P1|Overall Study|Lack of compliance|0
5172872|NCT01291173|17860349|P4|Overall Study|Unable to meet visit schedule|0
5172873|NCT01291173|17860350|P3|Overall Study|Unable to meet visit schedule|1
5172874|NCT01291173|17860351|P2|Overall Study|Unable to meet visit schedule|0
5172875|NCT01291173|17860352|P1|Overall Study|Unable to meet visit schedule|0
5172876|NCT01291173|17860349|P4|Overall Study|Lost to Follow-up|2
5172877|NCT01291173|17860350|P3|Overall Study|Lost to Follow-up|3
5172878|NCT01291173|17860351|P2|Overall Study|Lost to Follow-up|6
5172879|NCT01291173|17860352|P1|Overall Study|Lost to Follow-up|4
5172880|NCT01291173|17860349|P4|Overall Study|Withdrawal by Subject|2
5172881|NCT01291173|17860350|P3|Overall Study|Withdrawal by Subject|4
5172882|NCT01291173|17860351|P2|Overall Study|Withdrawal by Subject|4
5172883|NCT01291173|17860352|P1|Overall Study|Withdrawal by Subject|6
5172884|NCT01291173|17860349|P4|Overall Study|Protocol Violation|5
5172885|NCT01291173|17860350|P3|Overall Study|Protocol Violation|2
5172886|NCT01291173|17860351|P2|Overall Study|Protocol Violation|2
5172887|NCT01291173|17860352|P1|Overall Study|Protocol Violation|7
5172888|NCT01291173|17860349|P4|Overall Study|Adverse Event|3
5172889|NCT01291173|17860350|P3|Overall Study|Adverse Event|1
5172890|NCT01291173|17860351|P2|Overall Study|Adverse Event|3
5172891|NCT01291173|17860352|P1|Overall Study|Adverse Event|0
5172892|NCT01291017|17860461|P1|Overall Study|Withdrawal by Subject|3
5172893|NCT01291017|17860461|P1|Overall Study|Lost to Follow-up|2
5172894|NCT01290887|17860494|P2|Overall Study|Other|6
5172895|NCT01290887|17860495|P1|Overall Study|Other|3
5172896|NCT01290887|17860494|P2|Overall Study|Sponsor closure of study|476
5172897|NCT01290887|17860495|P1|Overall Study|Sponsor closure of study|420
5172898|NCT01290887|17860494|P2|Overall Study|Non-compliance to study medications|0
5172899|NCT01290887|17860495|P1|Overall Study|Non-compliance to study medications|1
5172900|NCT01290887|17860494|P2|Overall Study|Non-compliance to study procedures|1
5172901|NCT01290887|17860495|P1|Overall Study|Non-compliance to study procedures|0
5172902|NCT01290887|17860494|P2|Overall Study|Lost to Follow-up|4
5172903|NCT01290887|17860495|P1|Overall Study|Lost to Follow-up|4
5172904|NCT01290887|17860494|P2|Overall Study|Protocol Violation|1
5172905|NCT01290887|17860495|P1|Overall Study|Protocol Violation|2
5172906|NCT01290887|17860494|P2|Overall Study|Withdrawal by Subject|32
5172907|NCT01290887|17860495|P1|Overall Study|Withdrawal by Subject|26
5172908|NCT01290887|17860494|P2|Overall Study|Lack of Efficacy|5
5172909|NCT01290887|17860495|P1|Overall Study|Lack of Efficacy|4
5172910|NCT01290887|17860494|P2|Overall Study|Adverse Event|11
5172911|NCT01290887|17860495|P1|Overall Study|Adverse Event|6
5172912|NCT01290822|17860556|P1|Overall Study|Physician Decision|10
5172913|NCT01290822|17860556|P1|Overall Study|Withdrawal by Subject|1
5172914|NCT01290796|17860565|P1|Overall Study|Withdrawal by Sponsor|1
5172915|NCT01290796|17860565|P1|Overall Study|Secondary Surgical Intervention|2
5172916|NCT01290796|17860565|P1|Overall Study|Physician Decision|2
5172917|NCT01290796|17860565|P1|Overall Study|Withdrawal by Subject|4
5172918|NCT01290796|17860565|P1|Overall Study|Lost to Follow-up|21
5172919|NCT01290757|17860581|P2|Overall Study|Other|1
5172920|NCT01290757|17860582|P1|Overall Study|Other|0
5172921|NCT01290757|17860581|P2|Overall Study|Protocol Violation|1
5172922|NCT01290757|17860582|P1|Overall Study|Protocol Violation|1
5172923|NCT01290757|17860581|P2|Overall Study|Adverse Event|0
5172924|NCT01290757|17860582|P1|Overall Study|Adverse Event|1
5172925|NCT01290731|17860598|P1|Overall Study|Withdrawal by Subject|1
5172926|NCT01290718|17860610|P1|Overall Study|Early termination of the study|4
5172927|NCT01290679|17860619|P2|Overall Study|Subject Entered Another Trial|5
5172928|NCT01290679|17860620|P1|Overall Study|Subject Entered Another Trial|0
5172929|NCT01290679|17860619|P2|Overall Study|Withdrawal by Subject|5
5172930|NCT01290679|17860620|P1|Overall Study|Withdrawal by Subject|6
5172931|NCT01290679|17860619|P2|Overall Study|Protocol Violation|1
5172932|NCT01290679|17860620|P1|Overall Study|Protocol Violation|0
5172933|NCT01290679|17860619|P2|Overall Study|Lost to Follow-up|10
5172934|NCT01290679|17860620|P1|Overall Study|Lost to Follow-up|8
5172935|NCT01290679|17860619|P2|Overall Study|Adverse Event|0
5172936|NCT01290679|17860620|P1|Overall Study|Adverse Event|2
5172937|NCT01290666|17860689|P1|Overall Study|Early Termination of Study|4
5172938|NCT01290666|17860689|P1|Overall Study|Withdrawal by Subject|23
5172939|NCT01290666|17860689|P1|Overall Study|Lost to Follow-up|11
5172940|NCT01290601|17860742|P4|Overall Study|Protocol Violation|0
5172941|NCT01290601|17860743|P3|Overall Study|Protocol Violation|0
5172942|NCT01290601|17860744|P2|Overall Study|Protocol Violation|0
5172943|NCT01290601|17860745|P1|Overall Study|Protocol Violation|1
5172944|NCT01290601|17860742|P4|Overall Study|Other|0
5172945|NCT01290601|17860743|P3|Overall Study|Other|0
5172946|NCT01290601|17860744|P2|Overall Study|Other|0
5172947|NCT01290601|17860745|P1|Overall Study|Other|1
5172948|NCT01290601|17860742|P4|Overall Study|Lost to Follow-up|0
5172949|NCT01290601|17860743|P3|Overall Study|Lost to Follow-up|0
5172950|NCT01290601|17860744|P2|Overall Study|Lost to Follow-up|2
5172951|NCT01290601|17860745|P1|Overall Study|Lost to Follow-up|7
5172952|NCT01290601|17860742|P4|Overall Study|Lack of Efficacy|0
5172953|NCT01290601|17860743|P3|Overall Study|Lack of Efficacy|0
5172954|NCT01290601|17860744|P2|Overall Study|Lack of Efficacy|1
5172955|NCT01290601|17860745|P1|Overall Study|Lack of Efficacy|2
5172956|NCT01290601|17860742|P4|Overall Study|Adverse Event|0
5172957|NCT01290601|17860743|P3|Overall Study|Adverse Event|0
5172958|NCT01290601|17860744|P2|Overall Study|Adverse Event|2
5172959|NCT01290601|17860745|P1|Overall Study|Adverse Event|0
5172960|NCT01290523|17860766|P1|Overall Study|Death|3
5172961|NCT01290341|17860805|P2|Overall Study|Negative baseline culture and others|11
5172962|NCT01290341|17860806|P1|Overall Study|Negative baseline culture and others|44
5172963|NCT01290341|17860805|P2|Overall Study|Withdrawal by Subject|5
5172964|NCT01290341|17860806|P1|Overall Study|Withdrawal by Subject|19
5172965|NCT01290341|17860805|P2|Overall Study|Lost to Follow-up|10
5172966|NCT01290341|17860806|P1|Overall Study|Lost to Follow-up|21
5172967|NCT01290341|17860805|P2|Overall Study|Adverse Event|0
5172968|NCT01290341|17860806|P1|Overall Study|Adverse Event|1
5172969|NCT01290341|17860805|P2|Overall Study|Protocol Violation|3
5172970|NCT01290341|17860806|P1|Overall Study|Protocol Violation|7
5172971|NCT01290315|17860818|P4|Overall Study|Withdrawal by Subject|0
5172972|NCT01290315|17860819|P3|Overall Study|Withdrawal by Subject|0
5172973|NCT01290315|17860820|P2|Overall Study|Withdrawal by Subject|1
5172974|NCT01290315|17860821|P1|Overall Study|Withdrawal by Subject|1
5172975|NCT01290315|17860818|P4|Overall Study|Lost to Follow-up|0
5172976|NCT01290315|17860819|P3|Overall Study|Lost to Follow-up|0
5172977|NCT01290315|17860820|P2|Overall Study|Lost to Follow-up|1
5172978|NCT01290315|17860821|P1|Overall Study|Lost to Follow-up|0
5172979|NCT01290315|17860818|P4|Overall Study|Selection criteria/compliance|2
5172980|NCT01290315|17860819|P3|Overall Study|Selection criteria/compliance|0
5172981|NCT01290315|17860820|P2|Overall Study|Selection criteria/compliance|1
5172982|NCT01290315|17860821|P1|Overall Study|Selection criteria/compliance|2
5172983|NCT01290315|17860818|P4|Overall Study|Adverse Event|3
5172984|NCT01290315|17860819|P3|Overall Study|Adverse Event|0
5172985|NCT01290315|17860820|P2|Overall Study|Adverse Event|0
5172986|NCT01290315|17860821|P1|Overall Study|Adverse Event|0
5172987|NCT01290263|17860843|P5|Overall Study|Participant Non-Compliance|1
5172988|NCT01290263|17860844|P4|Overall Study|Participant Non-Compliance|1
5172989|NCT01290263|17860845|P3|Overall Study|Participant Non-Compliance|0
5172990|NCT01290263|17860846|P2|Overall Study|Participant Non-Compliance|0
5172991|NCT01290263|17860847|P1|Overall Study|Participant Non-Compliance|0
5172992|NCT01290263|17860843|P5|Overall Study|Withdrawal by Subject|2
5172993|NCT01290263|17860844|P4|Overall Study|Withdrawal by Subject|1
5172994|NCT01290263|17860845|P3|Overall Study|Withdrawal by Subject|0
5172995|NCT01290263|17860846|P2|Overall Study|Withdrawal by Subject|1
5172996|NCT01290263|17860847|P1|Overall Study|Withdrawal by Subject|3
5172997|NCT01290263|17860843|P5|Overall Study|Lack of Efficacy|33
5172998|NCT01290263|17860844|P4|Overall Study|Lack of Efficacy|24
5172999|NCT01290263|17860845|P3|Overall Study|Lack of Efficacy|7
5173000|NCT01290263|17860846|P2|Overall Study|Lack of Efficacy|2
5173001|NCT01290263|17860847|P1|Overall Study|Lack of Efficacy|8
5173002|NCT01290263|17860843|P5|Overall Study|Adverse Event|1
5173003|NCT01290263|17860844|P4|Overall Study|Adverse Event|1
5173004|NCT01290263|17860845|P3|Overall Study|Adverse Event|0
5173005|NCT01290263|17860846|P2|Overall Study|Adverse Event|0
5173006|NCT01290263|17860847|P1|Overall Study|Adverse Event|0
5173007|NCT01290224|17860874|P1|Overall Study|Refused Further Treatment|4
5173008|NCT01290224|17860874|P1|Overall Study|Adverse Event|1
5173009|NCT01290094|17860885|P1|Overall Study|Lost to Follow-up|5
5173010|NCT01290094|17860885|P1|Overall Study|Withdrawal by Subject|1
5173011|NCT01290068|17860898|P2|Overall Study|Other|1
5173012|NCT01290068|17860899|P1|Overall Study|Other|3
5173013|NCT01290068|17860898|P2|Overall Study|Withdrawal by subject prior to implant|2
5173014|NCT01290068|17860899|P1|Overall Study|Withdrawal by subject prior to implant|0
5173015|NCT01290068|17860898|P2|Overall Study|Lost to Follow-up|0
5173016|NCT01290068|17860899|P1|Overall Study|Lost to Follow-up|3
5173017|NCT01290068|17860898|P2|Overall Study|Adverse Event|3
5173018|NCT01290068|17860899|P1|Overall Study|Adverse Event|1
5173019|NCT01290029|17860911|P1|Overall Study|Other|2
5173020|NCT01289990|17860937|P13|Overall Study|Not treated|0
5173021|NCT01289990|17860938|P12|Overall Study|Not treated|2
5173022|NCT01289990|17860939|P11|Overall Study|Not treated|1
5173023|NCT01289990|17860940|P10|Overall Study|Not treated|0
5173024|NCT01289990|17860941|P9|Overall Study|Not treated|1
5173025|NCT01289990|17860942|P8|Overall Study|Not treated|0
5173026|NCT01289990|17860943|P7|Overall Study|Not treated|1
5173027|NCT01289990|17860944|P6|Overall Study|Not treated|0
5173028|NCT01289990|17860945|P5|Overall Study|Not treated|0
5173029|NCT01289990|17860946|P4|Overall Study|Not treated|0
5173030|NCT01289990|17860947|P3|Overall Study|Not treated|0
5173031|NCT01289990|17860948|P2|Overall Study|Not treated|0
5173032|NCT01289990|17860949|P1|Overall Study|Not treated|0
5173033|NCT01289990|17860937|P13|Overall Study|did not continue in extension|56
5173034|NCT01289990|17860938|P12|Overall Study|did not continue in extension|34
5173035|NCT01289990|17860939|P11|Overall Study|did not continue in extension|45
5173036|NCT01289990|17860940|P10|Overall Study|did not continue in extension|48
5173037|NCT01289990|17860941|P9|Overall Study|did not continue in extension|44
5173038|NCT01289990|17860942|P8|Overall Study|did not continue in extension|36
5173039|NCT01289990|17860943|P7|Overall Study|did not continue in extension|54
5173040|NCT01289990|17860944|P6|Overall Study|did not continue in extension|50
5173041|NCT01289990|17860945|P5|Overall Study|did not continue in extension|48
5173042|NCT01289990|17860946|P4|Overall Study|did not continue in extension|51
5173043|NCT01289990|17860947|P3|Overall Study|did not continue in extension|51
5173044|NCT01289990|17860948|P2|Overall Study|did not continue in extension|45
5173045|NCT01289990|17860949|P1|Overall Study|did not continue in extension|41
5173046|NCT01289990|17860937|P13|Overall Study|discontinued in preceding trial|24
5173047|NCT01289990|17860938|P12|Overall Study|discontinued in preceding trial|17
5173048|NCT01289990|17860939|P11|Overall Study|discontinued in preceding trial|17
5173049|NCT01289990|17860940|P10|Overall Study|discontinued in preceding trial|21
5173050|NCT01289990|17860941|P9|Overall Study|discontinued in preceding trial|17
5173051|NCT01289990|17860942|P8|Overall Study|discontinued in preceding trial|8
5173052|NCT01289990|17860943|P7|Overall Study|discontinued in preceding trial|18
5173053|NCT01289990|17860944|P6|Overall Study|discontinued in preceding trial|12
5173054|NCT01289990|17860945|P5|Overall Study|discontinued in preceding trial|11
5173055|NCT01289990|17860946|P4|Overall Study|discontinued in preceding trial|17
5173056|NCT01289990|17860947|P3|Overall Study|discontinued in preceding trial|41
5173057|NCT01289990|17860948|P2|Overall Study|discontinued in preceding trial|20
5173058|NCT01289990|17860949|P1|Overall Study|discontinued in preceding trial|18
5173059|NCT01289990|17860937|P13|Overall Study|Withdrawal by Subject|16
5173060|NCT01289990|17860938|P12|Overall Study|Withdrawal by Subject|13
5173061|NCT01289990|17860939|P11|Overall Study|Withdrawal by Subject|11
5173062|NCT01289990|17860940|P10|Overall Study|Withdrawal by Subject|13
5173063|NCT01289990|17860941|P9|Overall Study|Withdrawal by Subject|12
5173064|NCT01289990|17860942|P8|Overall Study|Withdrawal by Subject|9
5173065|NCT01289990|17860943|P7|Overall Study|Withdrawal by Subject|13
5173066|NCT01289990|17860944|P6|Overall Study|Withdrawal by Subject|7
5173067|NCT01289990|17860945|P5|Overall Study|Withdrawal by Subject|8
5173068|NCT01289990|17860946|P4|Overall Study|Withdrawal by Subject|13
5173069|NCT01289990|17860947|P3|Overall Study|Withdrawal by Subject|12
5173070|NCT01289990|17860948|P2|Overall Study|Withdrawal by Subject|14
5173071|NCT01289990|17860949|P1|Overall Study|Withdrawal by Subject|15
5173072|NCT01289990|17860937|P13|Overall Study|Lost to Follow-up|2
5173073|NCT01289990|17860938|P12|Overall Study|Lost to Follow-up|1
5173074|NCT01289990|17860939|P11|Overall Study|Lost to Follow-up|2
5173075|NCT01289990|17860940|P10|Overall Study|Lost to Follow-up|4
5173076|NCT01289990|17860941|P9|Overall Study|Lost to Follow-up|1
5173077|NCT01289990|17860942|P8|Overall Study|Lost to Follow-up|2
5173078|NCT01289990|17860943|P7|Overall Study|Lost to Follow-up|2
5173079|NCT01289990|17860944|P6|Overall Study|Lost to Follow-up|4
5173080|NCT01289990|17860945|P5|Overall Study|Lost to Follow-up|3
5173081|NCT01289990|17860946|P4|Overall Study|Lost to Follow-up|5
5173082|NCT01289990|17860947|P3|Overall Study|Lost to Follow-up|5
5173083|NCT01289990|17860948|P2|Overall Study|Lost to Follow-up|2
5173084|NCT01289990|17860949|P1|Overall Study|Lost to Follow-up|3
5173085|NCT01289990|17860937|P13|Overall Study|Death|0
5173086|NCT01289990|17860938|P12|Overall Study|Death|1
5173087|NCT01289990|17860939|P11|Overall Study|Death|0
5173088|NCT01289990|17860940|P10|Overall Study|Death|0
5173089|NCT01289990|17860941|P9|Overall Study|Death|0
5173090|NCT01289990|17860942|P8|Overall Study|Death|0
5173091|NCT01289990|17860943|P7|Overall Study|Death|0
5173092|NCT01289990|17860944|P6|Overall Study|Death|1
5173093|NCT01289990|17860945|P5|Overall Study|Death|2
5173094|NCT01289990|17860946|P4|Overall Study|Death|1
5173095|NCT01289990|17860947|P3|Overall Study|Death|0
5173096|NCT01289990|17860948|P2|Overall Study|Death|0
5173097|NCT01289990|17860949|P1|Overall Study|Death|0
5173098|NCT01289847|17861166|P1|Overall Study|Patient could not comply with visits|1
5173099|NCT01289821|17861175|P1|Survival Follow-up Period|Clinical endpoint reached|16
5173100|NCT01289821|17861175|P1|Survival Follow-up Period|Lost to Follow-up|1
5173101|NCT01289821|17861175|P1|Survival Follow-up Period|Protocol Violation|1
5173102|NCT01289821|17861175|P1|Safety Follow-up Period|Unspecified reason|1
5173103|NCT01289821|17861175|P1|Safety Follow-up Period|Protocol Violation|3
5173104|NCT01289821|17861175|P1|Safety Follow-up Period|Withdrawal by Subject|1
5173105|NCT01289821|17861175|P1|Treatment Period|Therapeutic procedure required|1
5173106|NCT01289821|17861175|P1|Treatment Period|Clinical Progression|2
5173107|NCT01289821|17861175|P1|Treatment Period|Radiological Progression|43
5173108|NCT01289821|17861175|P1|Treatment Period|Adverse Event|4
5173109|NCT01289821|17861175|P1|Treatment Period|Physician Decision|3
5173110|NCT01289821|17861175|P1|Treatment Period|Withdrawal by Subject|1
5173111|NCT01289782|17861186|P2|Overall Study|Reason not specified|2
5173112|NCT01289782|17861187|P1|Overall Study|Reason not specified|1
5173113|NCT01289782|17861186|P2|Overall Study|Sponsor's Decision|0
5173114|NCT01289782|17861187|P1|Overall Study|Sponsor's Decision|1
5173115|NCT01289782|17861186|P2|Overall Study|Withdrawal by Subject|2
5173116|NCT01289782|17861187|P1|Overall Study|Withdrawal by Subject|8
5173117|NCT01289782|17861186|P2|Overall Study|Protocol Violation|1
5173118|NCT01289782|17861187|P1|Overall Study|Protocol Violation|1
5173119|NCT01289782|17861186|P2|Overall Study|Lost to Follow-up|7
5173120|NCT01289782|17861187|P1|Overall Study|Lost to Follow-up|14
5173121|NCT01289678|17861256|P1|Overall Study|Physician Decision|6
5173122|NCT01289639|17861272|P3|Overall Study|Lost to Follow-up|0
5173123|NCT01289639|17861273|P2|Overall Study|Lost to Follow-up|0
5173124|NCT01289639|17861274|P1|Overall Study|Lost to Follow-up|1
5173125|NCT01289574|17861300|P3|Overall Study|Subject wanted alternate treatment|0
5173126|NCT01289574|17861301|P2|Overall Study|Subject wanted alternate treatment|1
5173127|NCT01289574|17861302|P1|Overall Study|Subject wanted alternate treatment|0
5173128|NCT01289574|17861300|P3|Overall Study|Adverse Event|0
5173129|NCT01289574|17861301|P2|Overall Study|Adverse Event|1
5173130|NCT01289574|17861302|P1|Overall Study|Adverse Event|0
5173131|NCT01289574|17861300|P3|Overall Study|Withdrawal by Subject|1
5173132|NCT01289574|17861301|P2|Overall Study|Withdrawal by Subject|1
5173133|NCT01289574|17861302|P1|Overall Study|Withdrawal by Subject|1
5173134|NCT01289574|17861300|P3|Overall Study|Lost to Follow-up|1
5173135|NCT01289574|17861301|P2|Overall Study|Lost to Follow-up|0
5173136|NCT01289574|17861302|P1|Overall Study|Lost to Follow-up|2
5173137|NCT01289574|17861300|P3|Overall Study|Lack of Efficacy|1
5173138|NCT01289574|17861301|P2|Overall Study|Lack of Efficacy|0
5173139|NCT01289574|17861302|P1|Overall Study|Lack of Efficacy|4
5173140|NCT01289418|17861446|P1|Day 29 Survey|participants did not complete the survey|2185
5173141|NCT01289418|17861446|P1|Day 29 Survey|email address invalid|283
5173142|NCT01289418|17861446|P1|Day 8 Survey|participants did not complete the survey|1935
5173143|NCT01289418|17861446|P1|Day 8 Survey|email address invalid|283
5173144|NCT01289210|17861494|P1|Overall Study|Adverse Event|1
5173145|NCT01289119|17861504|P6|Overall Study|Other|0
5173146|NCT01289119|17861505|P5|Overall Study|Other|0
5173147|NCT01289119|17861506|P4|Overall Study|Other|0
5173148|NCT01289119|17861507|P3|Overall Study|Other|1
5173149|NCT01289119|17861508|P2|Overall Study|Other|0
5173150|NCT01289119|17861509|P1|Overall Study|Other|1
5173151|NCT01289119|17861504|P6|Overall Study|Lack of Efficacy|1
5173152|NCT01289119|17861505|P5|Overall Study|Lack of Efficacy|1
5173153|NCT01289119|17861506|P4|Overall Study|Lack of Efficacy|1
5173154|NCT01289119|17861507|P3|Overall Study|Lack of Efficacy|1
5173155|NCT01289119|17861508|P2|Overall Study|Lack of Efficacy|1
5173156|NCT01289119|17861509|P1|Overall Study|Lack of Efficacy|0
5173157|NCT01289119|17861504|P6|Overall Study|Pregnancy|0
5173158|NCT01289119|17861505|P5|Overall Study|Pregnancy|0
5173159|NCT01289119|17861506|P4|Overall Study|Pregnancy|0
5173160|NCT01289119|17861507|P3|Overall Study|Pregnancy|0
5173161|NCT01289119|17861508|P2|Overall Study|Pregnancy|1
5173162|NCT01289119|17861509|P1|Overall Study|Pregnancy|0
5173163|NCT01289119|17861504|P6|Overall Study|Withdrawal by Subject|1
5173164|NCT01289119|17861505|P5|Overall Study|Withdrawal by Subject|1
5173165|NCT01289119|17861506|P4|Overall Study|Withdrawal by Subject|3
5173166|NCT01289119|17861507|P3|Overall Study|Withdrawal by Subject|4
5173167|NCT01289119|17861508|P2|Overall Study|Withdrawal by Subject|2
5173168|NCT01289119|17861509|P1|Overall Study|Withdrawal by Subject|4
5173169|NCT01289119|17861504|P6|Overall Study|Lost to Follow-up|1
5173170|NCT01289119|17861505|P5|Overall Study|Lost to Follow-up|0
5173171|NCT01289119|17861506|P4|Overall Study|Lost to Follow-up|0
5173172|NCT01289119|17861507|P3|Overall Study|Lost to Follow-up|0
5173173|NCT01289119|17861508|P2|Overall Study|Lost to Follow-up|3
5173174|NCT01289119|17861509|P1|Overall Study|Lost to Follow-up|0
5173175|NCT01289119|17861504|P6|Overall Study|Major Protocol Deviation|1
5173176|NCT01289119|17861505|P5|Overall Study|Major Protocol Deviation|2
5173177|NCT01289119|17861506|P4|Overall Study|Major Protocol Deviation|0
5173178|NCT01289119|17861507|P3|Overall Study|Major Protocol Deviation|3
5173179|NCT01289119|17861508|P2|Overall Study|Major Protocol Deviation|1
5173180|NCT01289119|17861509|P1|Overall Study|Major Protocol Deviation|2
5173181|NCT01289119|17861504|P6|Overall Study|Adverse Event|0
5173182|NCT01289119|17861505|P5|Overall Study|Adverse Event|1
5173183|NCT01289119|17861506|P4|Overall Study|Adverse Event|2
5173184|NCT01289119|17861507|P3|Overall Study|Adverse Event|0
5173185|NCT01289119|17861508|P2|Overall Study|Adverse Event|1
5173186|NCT01289119|17861509|P1|Overall Study|Adverse Event|2
5173187|NCT01289041|17861630|P1|Overall Study|Death|1
5173188|NCT01289041|17861630|P1|Overall Study|Withdrawal by Subject|3
5173189|NCT01289041|17861630|P1|Overall Study|Progressive Disease|41
5173190|NCT01289041|17861630|P1|Overall Study|Physician Decision|1
5173191|NCT01289041|17861630|P1|Overall Study|Adverse Event|24
5173192|NCT01289028|17861642|P1|Overall Study|Missing reason for discon|1
5173193|NCT01289028|17861642|P1|Overall Study|Abnormal Lab Value|1
5173194|NCT01289028|17861642|P1|Overall Study|New Cancer Therapy|2
5173195|NCT01289028|17861642|P1|Overall Study|Lost to Follow-up|2
5173196|NCT01289028|17861642|P1|Overall Study|No longer required|2
5173197|NCT01289028|17861642|P1|Overall Study|Lack of Efficacy|2
5173198|NCT01289028|17861642|P1|Overall Study|Death|4
5173199|NCT01289028|17861642|P1|Overall Study|Withdrawal by Subject|6
5173200|NCT01289028|17861642|P1|Overall Study|Adverse Event|14
5173201|NCT01289028|17861642|P1|Overall Study|Progressive Disease|49
5173202|NCT01289015|17861656|P2|Overall Study|Negative baseline culture and others|20
5173203|NCT01289015|17861657|P1|Overall Study|Negative baseline culture and others|33
5173204|NCT01289015|17861656|P2|Overall Study|Disease progression|0
5173205|NCT01289015|17861657|P1|Overall Study|Disease progression|1
5173206|NCT01289015|17861656|P2|Overall Study|Withdrawal by Subject|8
5173207|NCT01289015|17861657|P1|Overall Study|Withdrawal by Subject|17
5173208|NCT01289015|17861656|P2|Overall Study|Lost to Follow-up|17
5173209|NCT01289015|17861657|P1|Overall Study|Lost to Follow-up|33
5173210|NCT01289015|17861656|P2|Overall Study|Adverse Event|0
5173211|NCT01289015|17861657|P1|Overall Study|Adverse Event|3
5173212|NCT01289015|17861656|P2|Overall Study|Protocol Violation|9
5173213|NCT01289015|17861657|P1|Overall Study|Protocol Violation|12
5173214|NCT01288989|17861670|P5|Overall Study|Withdrawal by Subject|3
5173215|NCT01288989|17861671|P4|Overall Study|Withdrawal by Subject|0
5173216|NCT01288989|17861672|P3|Overall Study|Withdrawal by Subject|0
5173217|NCT01288989|17861673|P2|Overall Study|Withdrawal by Subject|0
5173218|NCT01288989|17861674|P1|Overall Study|Withdrawal by Subject|0
5173219|NCT01288989|17861670|P5|Overall Study|Physician Decision|1
5173220|NCT01288989|17861671|P4|Overall Study|Physician Decision|0
5173221|NCT01288989|17861672|P3|Overall Study|Physician Decision|0
5173222|NCT01288989|17861673|P2|Overall Study|Physician Decision|0
5173223|NCT01288989|17861674|P1|Overall Study|Physician Decision|0
5173224|NCT01288989|17861670|P5|Overall Study|Adverse Event|2
5173225|NCT01288989|17861671|P4|Overall Study|Adverse Event|0
5173226|NCT01288989|17861672|P3|Overall Study|Adverse Event|0
5173227|NCT01288989|17861673|P2|Overall Study|Adverse Event|0
5173228|NCT01288989|17861674|P1|Overall Study|Adverse Event|0
5173229|NCT01288989|17861670|P5|Overall Study|Dose limiting toxicity|0
5173230|NCT01288989|17861671|P4|Overall Study|Dose limiting toxicity|0
5173231|NCT01288989|17861672|P3|Overall Study|Dose limiting toxicity|0
5173232|NCT01288989|17861673|P2|Overall Study|Dose limiting toxicity|0
5173233|NCT01288989|17861674|P1|Overall Study|Dose limiting toxicity|1
5173234|NCT01288989|17861670|P5|Overall Study|Death|0
5173235|NCT01288989|17861671|P4|Overall Study|Death|1
5173236|NCT01288989|17861672|P3|Overall Study|Death|0
5173237|NCT01288989|17861673|P2|Overall Study|Death|0
5173238|NCT01288989|17861674|P1|Overall Study|Death|0
5173239|NCT01288976|17861735|P3|Overall Study|Data unavailable|7
5173240|NCT01288976|17861736|P2|Overall Study|Data unavailable|9
5173241|NCT01288976|17861737|P1|Overall Study|Data unavailable|22
5173242|NCT01288976|17861735|P3|Overall Study|Death|4
5173243|NCT01288976|17861736|P2|Overall Study|Death|6
5173244|NCT01288976|17861737|P1|Overall Study|Death|98
5173245|NCT01288976|17861735|P3|Overall Study|Withdrawal by Subject|9
5173246|NCT01288976|17861736|P2|Overall Study|Withdrawal by Subject|12
5173247|NCT01288976|17861737|P1|Overall Study|Withdrawal by Subject|58
5173248|NCT01288937|17861766|P2|Overall Study|Adverse Event|0
5173249|NCT01288937|17861767|P1|Overall Study|Adverse Event|1
5173250|NCT01288911|17861775|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
5173251|NCT01288911|17861776|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
5173252|NCT01288911|17861775|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
5173253|NCT01288911|17861776|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
5173254|NCT01288911|17861775|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
5173255|NCT01288911|17861776|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
5173256|NCT01288911|17861775|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
5173257|NCT01288911|17861776|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
5173258|NCT01288911|17861775|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
5173259|NCT01288911|17861776|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
5173260|NCT01288911|17861775|P2|Open-label Period (All Enzalutamide)|Death|1
5173261|NCT01288911|17861776|P1|Open-label Period (All Enzalutamide)|Death|0
5173262|NCT01288911|17861775|P2|Double-blind Period|Randomized but never received study drug|2
5173263|NCT01288911|17861776|P1|Double-blind Period|Randomized but never received study drug|1
5173264|NCT01288911|17861775|P2|Double-blind Period|Miscellaneous Reason|42
5173265|NCT01288911|17861776|P1|Double-blind Period|Miscellaneous Reason|29
5173266|NCT01288911|17861775|P2|Double-blind Period|Withdrawal by Subject|26
5173267|NCT01288911|17861776|P1|Double-blind Period|Withdrawal by Subject|25
5173268|NCT01288911|17861775|P2|Double-blind Period|Protocol Violation|0
5173269|NCT01288911|17861776|P1|Double-blind Period|Protocol Violation|1
5173270|NCT01288911|17861775|P2|Double-blind Period|Progressive Disease|103
5173271|NCT01288911|17861776|P1|Double-blind Period|Progressive Disease|75
5173272|NCT01288911|17861775|P2|Double-blind Period|Lost to Follow-up|2
5173273|NCT01288911|17861776|P1|Double-blind Period|Lost to Follow-up|0
5173274|NCT01288911|17861775|P2|Double-blind Period|Death|7
5173275|NCT01288911|17861776|P1|Double-blind Period|Death|11
5173276|NCT01288729|17861886|P2|Overall Study|Withdrawal by Subject|0
5173277|NCT01288729|17861887|P1|Overall Study|Withdrawal by Subject|1
5173278|NCT01288612|17861896|P3|Overall Study|Unable to intubate|0
5173279|NCT01288612|17861897|P2|Overall Study|Unable to intubate|3
5173280|NCT01288612|17861898|P1|Overall Study|Unable to intubate|0
5173281|NCT01288612|17861896|P3|Overall Study|Declined|62
5173282|NCT01288612|17861897|P2|Overall Study|Declined|63
5173283|NCT01288612|17861898|P1|Overall Study|Declined|78
5173284|NCT01288612|17861896|P3|Overall Study|Unable to contact|20
5173285|NCT01288612|17861897|P2|Overall Study|Unable to contact|16
5173286|NCT01288612|17861898|P1|Overall Study|Unable to contact|11
5173287|NCT01288469|17861947|P3|Overall Study|Exclusion criteria finally met|0
5173288|NCT01288469|17861948|P2|Overall Study|Exclusion criteria finally met|0
5173289|NCT01288469|17861949|P1|Overall Study|Exclusion criteria finally met|1
5173290|NCT01288469|17861947|P3|Overall Study|Consent withdrawn by subject|1
5173291|NCT01288469|17861948|P2|Overall Study|Consent withdrawn by subject|1
5173292|NCT01288469|17861949|P1|Overall Study|Consent withdrawn by subject|1
5173293|NCT01288469|17861947|P3|Overall Study|Participant Moved|0
5173294|NCT01288469|17861948|P2|Overall Study|Participant Moved|0
5173295|NCT01288469|17861949|P1|Overall Study|Participant Moved|1
5173296|NCT01288469|17861947|P3|Overall Study|Poor compliance to protocol|0
5173297|NCT01288469|17861948|P2|Overall Study|Poor compliance to protocol|1
5173298|NCT01288469|17861949|P1|Overall Study|Poor compliance to protocol|0
5173299|NCT01288469|17861947|P3|Overall Study|Adverse Event|1
5173300|NCT01288469|17861948|P2|Overall Study|Adverse Event|1
5173301|NCT01288469|17861949|P1|Overall Study|Adverse Event|4
5173302|NCT01288443|17861981|P6|Overall Study|Other than above|0
5173303|NCT01288443|17861982|P5|Overall Study|Other than above|1
5173304|NCT01288443|17861983|P4|Overall Study|Other than above|2
5173305|NCT01288443|17861984|P3|Overall Study|Other than above|0
5173306|NCT01288443|17861985|P2|Overall Study|Other than above|0
5173307|NCT01288443|17861986|P1|Overall Study|Other than above|0
5173308|NCT01288443|17861981|P6|Overall Study|Study drug auto-injector administration|1
5173309|NCT01288443|17861982|P5|Overall Study|Study drug auto-injector administration|1
5173310|NCT01288443|17861983|P4|Overall Study|Study drug auto-injector administration|0
5173311|NCT01288443|17861984|P3|Overall Study|Study drug auto-injector administration|0
5173312|NCT01288443|17861985|P2|Overall Study|Study drug auto-injector administration|0
5173313|NCT01288443|17861986|P1|Overall Study|Study drug auto-injector administration|0
5173314|NCT01288443|17861981|P6|Overall Study|Lost to Follow-up|0
5173315|NCT01288443|17861982|P5|Overall Study|Lost to Follow-up|0
5173316|NCT01288443|17861983|P4|Overall Study|Lost to Follow-up|0
5173317|NCT01288443|17861984|P3|Overall Study|Lost to Follow-up|0
5173318|NCT01288443|17861985|P2|Overall Study|Lost to Follow-up|1
5173319|NCT01288443|17861986|P1|Overall Study|Lost to Follow-up|0
5173320|NCT01288443|17861981|P6|Overall Study|Consent withdrawn by Participant|1
5173321|NCT01288443|17861982|P5|Overall Study|Consent withdrawn by Participant|0
5173322|NCT01288443|17861983|P4|Overall Study|Consent withdrawn by Participant|0
5173323|NCT01288443|17861984|P3|Overall Study|Consent withdrawn by Participant|0
5173324|NCT01288443|17861985|P2|Overall Study|Consent withdrawn by Participant|0
5173325|NCT01288443|17861986|P1|Overall Study|Consent withdrawn by Participant|0
5173326|NCT01288443|17861981|P6|Overall Study|Participant Moved|1
5173327|NCT01288443|17861982|P5|Overall Study|Participant Moved|2
5173328|NCT01288443|17861983|P4|Overall Study|Participant Moved|1
5173329|NCT01288443|17861984|P3|Overall Study|Participant Moved|0
5173330|NCT01288443|17861985|P2|Overall Study|Participant Moved|0
5173331|NCT01288443|17861986|P1|Overall Study|Participant Moved|0
5173332|NCT01288443|17861981|P6|Overall Study|Poor compliance to protocol|1
5173333|NCT01288443|17861982|P5|Overall Study|Poor compliance to protocol|0
5173334|NCT01288443|17861983|P4|Overall Study|Poor compliance to protocol|0
5173335|NCT01288443|17861984|P3|Overall Study|Poor compliance to protocol|0
5173336|NCT01288443|17861985|P2|Overall Study|Poor compliance to protocol|0
5173337|NCT01288443|17861986|P1|Overall Study|Poor compliance to protocol|0
5173338|NCT01288443|17861981|P6|Overall Study|Adverse Event|1
5173339|NCT01288443|17861982|P5|Overall Study|Adverse Event|3
5173340|NCT01288443|17861983|P4|Overall Study|Adverse Event|1
5173341|NCT01288443|17861984|P3|Overall Study|Adverse Event|1
5173342|NCT01288443|17861985|P2|Overall Study|Adverse Event|0
5173343|NCT01288443|17861986|P1|Overall Study|Adverse Event|0
5173344|NCT01288430|17862046|P10|Part 2|Other|1
5173345|NCT01288430|17862047|P9|Part 2|Other|0
5173346|NCT01288430|17862048|P8|Part 2|Other|0
5173347|NCT01288430|17862049|P7|Part 2|Other|0
5173348|NCT01288430|17862050|P6|Part 2|Other|0
5173349|NCT01288430|17862051|P5|Part 2|Other|0
5173350|NCT01288430|17862052|P4|Part 2|Other|0
5173351|NCT01288430|17862053|P3|Part 2|Other|0
5173352|NCT01288430|17862054|P2|Part 2|Other|0
5173353|NCT01288430|17862055|P1|Part 2|Other|0
5173354|NCT01288430|17862046|P10|Part 2|Adverse Event|0
5173355|NCT01288430|17862047|P9|Part 2|Adverse Event|1
5173356|NCT01288430|17862048|P8|Part 2|Adverse Event|1
5173357|NCT01288430|17862049|P7|Part 2|Adverse Event|0
5173358|NCT01288430|17862050|P6|Part 2|Adverse Event|0
5173359|NCT01288430|17862051|P5|Part 2|Adverse Event|0
5173360|NCT01288430|17862052|P4|Part 2|Adverse Event|0
5173361|NCT01288430|17862053|P3|Part 2|Adverse Event|0
5173362|NCT01288430|17862054|P2|Part 2|Adverse Event|0
5173363|NCT01288430|17862055|P1|Part 2|Adverse Event|0
5173364|NCT01288430|17862046|P10|Part 2|Withdrawal by Subject|0
5173365|NCT01288430|17862047|P9|Part 2|Withdrawal by Subject|4
5173366|NCT01288430|17862048|P8|Part 2|Withdrawal by Subject|1
5173367|NCT01288430|17862049|P7|Part 2|Withdrawal by Subject|0
5173368|NCT01288430|17862050|P6|Part 2|Withdrawal by Subject|0
5173369|NCT01288430|17862051|P5|Part 2|Withdrawal by Subject|0
5173370|NCT01288430|17862052|P4|Part 2|Withdrawal by Subject|0
5173371|NCT01288430|17862053|P3|Part 2|Withdrawal by Subject|0
5173372|NCT01288430|17862054|P2|Part 2|Withdrawal by Subject|0
5173373|NCT01288430|17862055|P1|Part 2|Withdrawal by Subject|0
5173374|NCT01288430|17862046|P10|Part 2|Clinical disease progression|0
5173375|NCT01288430|17862047|P9|Part 2|Clinical disease progression|0
5173376|NCT01288430|17862048|P8|Part 2|Clinical disease progression|2
5173377|NCT01288430|17862049|P7|Part 2|Clinical disease progression|0
5173378|NCT01288430|17862050|P6|Part 2|Clinical disease progression|0
5173379|NCT01288430|17862051|P5|Part 2|Clinical disease progression|0
5173380|NCT01288430|17862052|P4|Part 2|Clinical disease progression|0
5173381|NCT01288430|17862053|P3|Part 2|Clinical disease progression|0
5173382|NCT01288430|17862054|P2|Part 2|Clinical disease progression|0
5173383|NCT01288430|17862055|P1|Part 2|Clinical disease progression|0
5173384|NCT01288430|17862046|P10|Part 2|Progressive disease|2
5173385|NCT01288430|17862047|P9|Part 2|Progressive disease|7
5173386|NCT01288430|17862048|P8|Part 2|Progressive disease|8
5173387|NCT01288430|17862049|P7|Part 2|Progressive disease|0
5173388|NCT01288430|17862050|P6|Part 2|Progressive disease|0
5173389|NCT01288430|17862051|P5|Part 2|Progressive disease|0
5173390|NCT01288430|17862052|P4|Part 2|Progressive disease|0
5173391|NCT01288430|17862053|P3|Part 2|Progressive disease|0
5173392|NCT01288430|17862054|P2|Part 2|Progressive disease|0
5173393|NCT01288430|17862055|P1|Part 2|Progressive disease|0
5173394|NCT01288430|17862046|P10|Part 1|Other|0
5173395|NCT01288430|17862047|P9|Part 1|Other|0
5173396|NCT01288430|17862048|P8|Part 1|Other|0
5173397|NCT01288430|17862049|P7|Part 1|Other|1
5173398|NCT01288430|17862050|P6|Part 1|Other|0
5173399|NCT01288430|17862051|P5|Part 1|Other|0
5173400|NCT01288430|17862052|P4|Part 1|Other|0
5173401|NCT01288430|17862053|P3|Part 1|Other|0
5173402|NCT01288430|17862054|P2|Part 1|Other|2
5173403|NCT01288430|17862055|P1|Part 1|Other|0
5173404|NCT01288430|17862046|P10|Part 1|Adverse Event|0
5173405|NCT01288430|17862047|P9|Part 1|Adverse Event|0
5173406|NCT01288430|17862048|P8|Part 1|Adverse Event|0
5173407|NCT01288430|17862049|P7|Part 1|Adverse Event|2
5173408|NCT01288430|17862050|P6|Part 1|Adverse Event|0
5173409|NCT01288430|17862051|P5|Part 1|Adverse Event|0
5173410|NCT01288430|17862052|P4|Part 1|Adverse Event|1
5173411|NCT01288430|17862053|P3|Part 1|Adverse Event|3
5173412|NCT01288430|17862054|P2|Part 1|Adverse Event|0
5173413|NCT01288430|17862055|P1|Part 1|Adverse Event|0
5173414|NCT01288430|17862046|P10|Part 1|Death due to disease progression|0
5173415|NCT01288430|17862047|P9|Part 1|Death due to disease progression|0
5173416|NCT01288430|17862048|P8|Part 1|Death due to disease progression|0
5173417|NCT01288430|17862049|P7|Part 1|Death due to disease progression|0
5173418|NCT01288430|17862050|P6|Part 1|Death due to disease progression|0
5173419|NCT01288430|17862051|P5|Part 1|Death due to disease progression|1
5173420|NCT01288430|17862052|P4|Part 1|Death due to disease progression|0
5173421|NCT01288430|17862053|P3|Part 1|Death due to disease progression|0
5173422|NCT01288430|17862054|P2|Part 1|Death due to disease progression|0
5173423|NCT01288430|17862055|P1|Part 1|Death due to disease progression|0
5173424|NCT01288430|17862046|P10|Part 1|Clinical disease progression|0
5173425|NCT01288430|17862047|P9|Part 1|Clinical disease progression|0
5173426|NCT01288430|17862048|P8|Part 1|Clinical disease progression|0
5173427|NCT01288430|17862049|P7|Part 1|Clinical disease progression|2
5173428|NCT01288430|17862050|P6|Part 1|Clinical disease progression|2
5173429|NCT01288430|17862051|P5|Part 1|Clinical disease progression|0
5173430|NCT01288430|17862052|P4|Part 1|Clinical disease progression|0
5173431|NCT01288430|17862053|P3|Part 1|Clinical disease progression|1
5173432|NCT01288430|17862054|P2|Part 1|Clinical disease progression|0
5173433|NCT01288430|17862055|P1|Part 1|Clinical disease progression|0
5173434|NCT01288430|17862046|P10|Part 1|Progressive disease|0
5173435|NCT01288430|17862047|P9|Part 1|Progressive disease|0
5173436|NCT01288430|17862048|P8|Part 1|Progressive disease|0
5173437|NCT01288430|17862049|P7|Part 1|Progressive disease|2
5173438|NCT01288430|17862050|P6|Part 1|Progressive disease|4
5173439|NCT01288430|17862051|P5|Part 1|Progressive disease|2
5173440|NCT01288430|17862052|P4|Part 1|Progressive disease|6
5173441|NCT01288430|17862053|P3|Part 1|Progressive disease|1
5173442|NCT01288430|17862054|P2|Part 1|Progressive disease|1
5173443|NCT01288430|17862055|P1|Part 1|Progressive disease|2
5173444|NCT01288287|17862179|P1|Overall Study|Unknown Status|7
5173445|NCT01288287|17862179|P1|Overall Study|Unknown Reason|1
5173446|NCT01288287|17862179|P1|Overall Study|Other Reason|13
5173447|NCT01288287|17862179|P1|Overall Study|Lack of Efficacy|13
5173448|NCT01288287|17862179|P1|Overall Study|Withdrawal by Subject|4
5173449|NCT01288287|17862179|P1|Overall Study|Lost to Follow-up|8
5173450|NCT01288209|17862194|P2|Overall Study|Other|0
5173451|NCT01288209|17862195|P1|Overall Study|Other|1
5173452|NCT01288209|17862194|P2|Overall Study|Withdrawal by Subject|3
5173453|NCT01288209|17862195|P1|Overall Study|Withdrawal by Subject|1
5173454|NCT01288079|17862225|P4|Overall Study|Other or Study Termination|8
5173455|NCT01288079|17862226|P3|Overall Study|Other or Study Termination|14
5173456|NCT01288079|17862227|P2|Overall Study|Other or Study Termination|15
5173457|NCT01288079|17862228|P1|Overall Study|Other or Study Termination|11
5173458|NCT01288079|17862225|P4|Overall Study|Lost to Follow-up|0
5173459|NCT01288079|17862226|P3|Overall Study|Lost to Follow-up|1
5173460|NCT01288079|17862227|P2|Overall Study|Lost to Follow-up|1
5173461|NCT01288079|17862228|P1|Overall Study|Lost to Follow-up|1
5173462|NCT01288079|17862225|P4|Overall Study|Study-Specific Withdrawal Criteria|0
5173463|NCT01288079|17862226|P3|Overall Study|Study-Specific Withdrawal Criteria|0
5173464|NCT01288079|17862227|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5173465|NCT01288079|17862228|P1|Overall Study|Study-Specific Withdrawal Criteria|1
5173466|NCT01288079|17862225|P4|Overall Study|Lack of Efficacy|2
5173467|NCT01288079|17862226|P3|Overall Study|Lack of Efficacy|0
5173468|NCT01288079|17862227|P2|Overall Study|Lack of Efficacy|2
5173469|NCT01288079|17862228|P1|Overall Study|Lack of Efficacy|2
5173470|NCT01288079|17862225|P4|Overall Study|Condition under Investigation Worsened|1
5173471|NCT01288079|17862226|P3|Overall Study|Condition under Investigation Worsened|0
5173472|NCT01288079|17862227|P2|Overall Study|Condition under Investigation Worsened|0
5173473|NCT01288079|17862228|P1|Overall Study|Condition under Investigation Worsened|0
5173474|NCT01288079|17862225|P4|Overall Study|Severe Non-Compliance to Protocol|3
5173475|NCT01288079|17862226|P3|Overall Study|Severe Non-Compliance to Protocol|1
5173476|NCT01288079|17862227|P2|Overall Study|Severe Non-Compliance to Protocol|3
5173477|NCT01288079|17862228|P1|Overall Study|Severe Non-Compliance to Protocol|1
5173478|NCT01288079|17862225|P4|Overall Study|Adverse Event|3
5173479|NCT01288079|17862226|P3|Overall Study|Adverse Event|2
5173480|NCT01288079|17862227|P2|Overall Study|Adverse Event|1
5173481|NCT01288079|17862228|P1|Overall Study|Adverse Event|2
5173482|NCT01288079|17862225|P4|Overall Study|Withdrawal by Subject|0
5173483|NCT01288079|17862226|P3|Overall Study|Withdrawal by Subject|1
5173484|NCT01288079|17862227|P2|Overall Study|Withdrawal by Subject|4
5173485|NCT01288079|17862228|P1|Overall Study|Withdrawal by Subject|2
5173486|NCT01288053|17862238|P1|Overall Study|Death|1
5173487|NCT01287897|17862256|P4|Overall Study|Other|0
5173488|NCT01287897|17862257|P3|Overall Study|Other|1
5173489|NCT01287897|17862258|P2|Overall Study|Other|0
5173490|NCT01287897|17862259|P1|Overall Study|Other|1
5173491|NCT01287897|17862256|P4|Overall Study|Not meeting entrance criteria|0
5173492|NCT01287897|17862257|P3|Overall Study|Not meeting entrance criteria|0
5173493|NCT01287897|17862258|P2|Overall Study|Not meeting entrance criteria|1
5173494|NCT01287897|17862259|P1|Overall Study|Not meeting entrance criteria|1
5173495|NCT01287897|17862256|P4|Overall Study|Not consented properly|0
5173496|NCT01287897|17862257|P3|Overall Study|Not consented properly|0
5173497|NCT01287897|17862258|P2|Overall Study|Not consented properly|1
5173498|NCT01287897|17862259|P1|Overall Study|Not consented properly|0
5173499|NCT01287897|17862256|P4|Overall Study|Withdrawal by Subject|2
5173500|NCT01287897|17862257|P3|Overall Study|Withdrawal by Subject|3
5173501|NCT01287897|17862258|P2|Overall Study|Withdrawal by Subject|5
5173502|NCT01287897|17862259|P1|Overall Study|Withdrawal by Subject|1
5173503|NCT01287897|17862256|P4|Overall Study|Lost to Follow-up|0
5173504|NCT01287897|17862257|P3|Overall Study|Lost to Follow-up|2
5173505|NCT01287897|17862258|P2|Overall Study|Lost to Follow-up|0
5173506|NCT01287897|17862259|P1|Overall Study|Lost to Follow-up|0
5173507|NCT01287897|17862256|P4|Overall Study|Protocol Violation|1
5173508|NCT01287897|17862257|P3|Overall Study|Protocol Violation|0
5173509|NCT01287897|17862258|P2|Overall Study|Protocol Violation|1
5173510|NCT01287897|17862259|P1|Overall Study|Protocol Violation|1
5173511|NCT01287897|17862256|P4|Overall Study|Lack of Efficacy|0
5173512|NCT01287897|17862257|P3|Overall Study|Lack of Efficacy|0
5173513|NCT01287897|17862258|P2|Overall Study|Lack of Efficacy|0
5173514|NCT01287897|17862259|P1|Overall Study|Lack of Efficacy|2
5173515|NCT01287897|17862256|P4|Overall Study|Adverse Event|4
5173516|NCT01287897|17862257|P3|Overall Study|Adverse Event|6
5173517|NCT01287897|17862258|P2|Overall Study|Adverse Event|3
5173518|NCT01287897|17862259|P1|Overall Study|Adverse Event|5
5173519|NCT01287832|17862310|P2|Overall Study|Death|1
5173520|NCT01287832|17862311|P1|Overall Study|Death|0
5173521|NCT01287832|17862310|P2|Overall Study|Adverse Event|0
5173522|NCT01287832|17862311|P1|Overall Study|Adverse Event|1
5173523|NCT01287754|17862319|P2|Overall Study|Protocol Violation|3
5173524|NCT01287754|17862320|P1|Overall Study|Protocol Violation|0
5173525|NCT01287754|17862319|P2|Overall Study|Lost to Follow-up|6
5173526|NCT01287754|17862320|P1|Overall Study|Lost to Follow-up|1
5173527|NCT01287754|17862319|P2|Overall Study|Death|12
5173528|NCT01287754|17862320|P1|Overall Study|Death|2
5173529|NCT01287741|17862332|P2|Overall Study|Reason not specified|9
5173530|NCT01287741|17862333|P1|Overall Study|Reason not specified|23
5173531|NCT01287741|17862332|P2|Overall Study|Progressive disease|166
5173532|NCT01287741|17862333|P1|Overall Study|Progressive disease|190
5173533|NCT01287741|17862332|P2|Overall Study|Study terminated by Sponsor|315
5173534|NCT01287741|17862333|P1|Overall Study|Study terminated by Sponsor|307
5173535|NCT01287741|17862332|P2|Overall Study|Adverse Event|6
5173536|NCT01287741|17862333|P1|Overall Study|Adverse Event|4
5173537|NCT01287741|17862332|P2|Overall Study|Death|44
5173538|NCT01287741|17862333|P1|Overall Study|Death|32
5173539|NCT01287741|17862332|P2|Overall Study|Lost to Follow-up|8
5173540|NCT01287741|17862333|P1|Overall Study|Lost to Follow-up|10
5173541|NCT01287741|17862332|P2|Overall Study|Non-compliance|6
5173542|NCT01287741|17862333|P1|Overall Study|Non-compliance|8
5173543|NCT01287741|17862332|P2|Overall Study|Physician Decision|23
5173544|NCT01287741|17862333|P1|Overall Study|Physician Decision|15
5173545|NCT01287741|17862332|P2|Overall Study|Protocol Violation|0
5173546|NCT01287741|17862333|P1|Overall Study|Protocol Violation|2
5173547|NCT01287741|17862332|P2|Overall Study|Withdrawal by Subject|38
5173548|NCT01287741|17862333|P1|Overall Study|Withdrawal by Subject|35
5173549|NCT01287611|17862369|P2|Overall Study|Exclusion due to expanded Kerr incision|3
5173550|NCT01287611|17862370|P1|Overall Study|Exclusion due to expanded Kerr incision|4
5173551|NCT01287611|17862369|P2|Overall Study|Lost to Follow-up|16
5173552|NCT01287611|17862370|P1|Overall Study|Lost to Follow-up|29
5173553|NCT01287520|17862387|P9|Overall Study|Withdrawal by Subject|1
5173554|NCT01287520|17862388|P8|Overall Study|Withdrawal by Subject|0
5173555|NCT01287520|17862389|P7|Overall Study|Withdrawal by Subject|0
5173556|NCT01287520|17862390|P6|Overall Study|Withdrawal by Subject|1
5173557|NCT01287520|17862391|P5|Overall Study|Withdrawal by Subject|0
5173558|NCT01287520|17862392|P4|Overall Study|Withdrawal by Subject|0
5173559|NCT01287520|17862393|P3|Overall Study|Withdrawal by Subject|0
5173560|NCT01287520|17862394|P2|Overall Study|Withdrawal by Subject|0
5173561|NCT01287520|17862395|P1|Overall Study|Withdrawal by Subject|0
5173562|NCT01287520|17862387|P9|Overall Study|Progressive disease|4
5173563|NCT01287520|17862388|P8|Overall Study|Progressive disease|2
5173564|NCT01287520|17862389|P7|Overall Study|Progressive disease|2
5173565|NCT01287520|17862390|P6|Overall Study|Progressive disease|0
5173566|NCT01287520|17862391|P5|Overall Study|Progressive disease|1
5173567|NCT01287520|17862392|P4|Overall Study|Progressive disease|6
5173568|NCT01287520|17862393|P3|Overall Study|Progressive disease|1
5173569|NCT01287520|17862394|P2|Overall Study|Progressive disease|4
5173570|NCT01287520|17862395|P1|Overall Study|Progressive disease|0
5173571|NCT01287520|17862387|P9|Overall Study|Physician Decision|0
5173572|NCT01287520|17862388|P8|Overall Study|Physician Decision|1
5173573|NCT01287520|17862389|P7|Overall Study|Physician Decision|0
5173574|NCT01287520|17862390|P6|Overall Study|Physician Decision|1
5173575|NCT01287520|17862391|P5|Overall Study|Physician Decision|1
5173576|NCT01287520|17862392|P4|Overall Study|Physician Decision|0
5173577|NCT01287520|17862393|P3|Overall Study|Physician Decision|2
5173578|NCT01287520|17862394|P2|Overall Study|Physician Decision|1
5173579|NCT01287520|17862395|P1|Overall Study|Physician Decision|1
5173580|NCT01287520|17862387|P9|Overall Study|Adverse Event|0
5173581|NCT01287520|17862388|P8|Overall Study|Adverse Event|2
5173582|NCT01287520|17862389|P7|Overall Study|Adverse Event|0
5173583|NCT01287520|17862390|P6|Overall Study|Adverse Event|2
5173584|NCT01287520|17862391|P5|Overall Study|Adverse Event|1
5173585|NCT01287520|17862392|P4|Overall Study|Adverse Event|1
5173586|NCT01287520|17862393|P3|Overall Study|Adverse Event|2
5173587|NCT01287520|17862394|P2|Overall Study|Adverse Event|2
5173588|NCT01287520|17862395|P1|Overall Study|Adverse Event|2
5173589|NCT01287416|17862459|P2|6 Month Follow-up|Lost to Follow-up|2
5173590|NCT01287416|17862460|P1|6 Month Follow-up|Lost to Follow-up|3
5173591|NCT01287416|17862459|P2|Pre-post Training|Lost to Follow-up|1
5173592|NCT01287416|17862460|P1|Pre-post Training|Lost to Follow-up|5
5173593|NCT01287416|17862459|P2|Pre-post Training|Withdrawal by Subject|24
5173594|NCT01287416|17862460|P1|Pre-post Training|Withdrawal by Subject|17
5173595|NCT01287403|17862496|P1|1st Intervention (1 Day)|Adverse Event|1
5173596|NCT01287364|17862528|P2|Overall Study|Other Reason|2
5173597|NCT01287364|17862529|P1|Overall Study|Other Reason|4
5173598|NCT01287364|17862528|P2|Overall Study|Protocol Violation|5
5173599|NCT01287364|17862529|P1|Overall Study|Protocol Violation|5
5173600|NCT01287364|17862528|P2|Overall Study|Adverse Event|3
5173601|NCT01287364|17862529|P1|Overall Study|Adverse Event|0
5173602|NCT01287221|17862551|P2|Overall Study|Withdrawal by Subject|1
5173603|NCT01287221|17862552|P1|Overall Study|Withdrawal by Subject|0
5173604|NCT01287221|17862551|P2|Overall Study|Adverse Event|3
5173605|NCT01287221|17862552|P1|Overall Study|Adverse Event|3
5173606|NCT01287221|17862551|P2|Overall Study|Lack of Perceived Benefit|1
5173607|NCT01287221|17862552|P1|Overall Study|Lack of Perceived Benefit|1
5173608|NCT01287195|17862587|P1|Overall Study|Withdrawal by Subject|2
5173609|NCT01287117|17862602|P4|Overall Study|Disease Progression|5
5173610|NCT01287117|17862603|P3|Overall Study|Disease Progression|6
5173611|NCT01287117|17862604|P2|Overall Study|Disease Progression|5
5173612|NCT01287117|17862605|P1|Overall Study|Disease Progression|10
5173613|NCT01287117|17862602|P4|Overall Study|Patient/Legal Guardian's Decision|5
5173614|NCT01287117|17862603|P3|Overall Study|Patient/Legal Guardian's Decision|8
5173615|NCT01287117|17862604|P2|Overall Study|Patient/Legal Guardian's Decision|6
5173616|NCT01287117|17862605|P1|Overall Study|Patient/Legal Guardian's Decision|2
5173617|NCT01287117|17862602|P4|Overall Study|Physician Decision|1
5173618|NCT01287117|17862603|P3|Overall Study|Physician Decision|1
5173619|NCT01287117|17862604|P2|Overall Study|Physician Decision|1
5173620|NCT01287117|17862605|P1|Overall Study|Physician Decision|0
5173621|NCT01287117|17862602|P4|Overall Study|Lost to Follow-up|0
5173622|NCT01287117|17862603|P3|Overall Study|Lost to Follow-up|0
5173623|NCT01287117|17862604|P2|Overall Study|Lost to Follow-up|1
5173624|NCT01287117|17862605|P1|Overall Study|Lost to Follow-up|1
5173625|NCT01287117|17862602|P4|Overall Study|Adverse Event|1
5173626|NCT01287117|17862603|P3|Overall Study|Adverse Event|1
5173627|NCT01287117|17862604|P2|Overall Study|Adverse Event|1
5173628|NCT01287117|17862605|P1|Overall Study|Adverse Event|2
5173629|NCT01287104|17862655|P4|Overall Study|NK cells did not meet release criteria|0
5173630|NCT01287104|17862656|P3|Overall Study|NK cells did not meet release criteria|0
5173631|NCT01287104|17862657|P2|Overall Study|NK cells did not meet release criteria|1
5173632|NCT01287104|17862658|P1|Overall Study|NK cells did not meet release criteria|0
5173633|NCT01287104|17862655|P4|Overall Study|Low donor chimerism|0
5173634|NCT01287104|17862656|P3|Overall Study|Low donor chimerism|0
5173635|NCT01287104|17862657|P2|Overall Study|Low donor chimerism|1
5173636|NCT01287104|17862658|P1|Overall Study|Low donor chimerism|0
5173637|NCT01287104|17862655|P4|Overall Study|Developed GVHD or complications of BMT|0
5173638|NCT01287104|17862656|P3|Overall Study|Developed GVHD or complications of BMT|4
5173639|NCT01287104|17862657|P2|Overall Study|Developed GVHD or complications of BMT|1
5173640|NCT01287104|17862658|P1|Overall Study|Developed GVHD or complications of BMT|0
5173641|NCT01287104|17862655|P4|Overall Study|Donor anaphylaxis|1
5173642|NCT01287104|17862656|P3|Overall Study|Donor anaphylaxis|0
5173643|NCT01287104|17862657|P2|Overall Study|Donor anaphylaxis|1
5173644|NCT01287104|17862658|P1|Overall Study|Donor anaphylaxis|0
5173645|NCT01287104|17862655|P4|Overall Study|Patient developed progressive disease|2
5173646|NCT01287104|17862656|P3|Overall Study|Patient developed progressive disease|3
5173647|NCT01287104|17862657|P2|Overall Study|Patient developed progressive disease|1
5173648|NCT01287104|17862658|P1|Overall Study|Patient developed progressive disease|1
5173649|NCT01287065|17862714|P6|Treatment Period 1|Withdrawal by Subject|1
5173650|NCT01287065|17862715|P5|Treatment Period 1|Withdrawal by Subject|0
5173651|NCT01287065|17862716|P4|Treatment Period 1|Withdrawal by Subject|0
5173652|NCT01287065|17862717|P3|Treatment Period 1|Withdrawal by Subject|0
5173653|NCT01287065|17862718|P2|Treatment Period 1|Withdrawal by Subject|0
5173654|NCT01287065|17862719|P1|Treatment Period 1|Withdrawal by Subject|0
5173655|NCT01287065|17862714|P6|Treatment Period 1|Adverse Event|0
5173656|NCT01287065|17862715|P5|Treatment Period 1|Adverse Event|1
5173657|NCT01287065|17862716|P4|Treatment Period 1|Adverse Event|0
5173658|NCT01287065|17862717|P3|Treatment Period 1|Adverse Event|0
5173659|NCT01287065|17862718|P2|Treatment Period 1|Adverse Event|0
5173660|NCT01287065|17862719|P1|Treatment Period 1|Adverse Event|0
5173661|NCT01287039|17862738|P2|Overall Study|Lost to Follow-up|2
5173662|NCT01287039|17862739|P1|Overall Study|Lost to Follow-up|3
5173663|NCT01287039|17862738|P2|Overall Study|Withdrawal by Subject|11
5173664|NCT01287039|17862739|P1|Overall Study|Withdrawal by Subject|14
5173665|NCT01287039|17862738|P2|Overall Study|Adverse Event|4
5173666|NCT01287039|17862739|P1|Overall Study|Adverse Event|7
5173667|NCT01287039|17862738|P2|Overall Study|Change of residence|0
5173668|NCT01287039|17862739|P1|Overall Study|Change of residence|1
5173669|NCT01287039|17862738|P2|Overall Study|Death|0
5173670|NCT01287039|17862739|P1|Overall Study|Death|1
5173671|NCT01287039|17862738|P2|Overall Study|Problem with travel|1
5173672|NCT01287039|17862739|P1|Overall Study|Problem with travel|0
5173673|NCT01287039|17862738|P2|Overall Study|Noncompliance with study medication|1
5173674|NCT01287039|17862739|P1|Overall Study|Noncompliance with study medication|0
5173675|NCT01287039|17862738|P2|Overall Study|Excluded medication taken|0
5173676|NCT01287039|17862739|P1|Overall Study|Excluded medication taken|1
5173677|NCT01287039|17862738|P2|Overall Study|Protocol Violation|3
5173678|NCT01287039|17862739|P1|Overall Study|Protocol Violation|2
5173679|NCT01287039|17862738|P2|Overall Study|Elective surgery|1
5173680|NCT01287039|17862739|P1|Overall Study|Elective surgery|0
5173681|NCT01287039|17862738|P2|Overall Study|Change of location/residence|3
5173682|NCT01287039|17862739|P1|Overall Study|Change of location/residence|0
5173683|NCT01287039|17862738|P2|Overall Study|Noncompliance with study procedures|1
5173684|NCT01287039|17862739|P1|Overall Study|Noncompliance with study procedures|0
5173685|NCT01287013|17862772|P3|Overall Study|Non-evaluable|21
5173686|NCT01287013|17862773|P2|Overall Study|Non-evaluable|5
5173687|NCT01287013|17862774|P1|Overall Study|Non-evaluable|3
5173688|NCT01286987|17862804|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
5173689|NCT01286987|17862805|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
5173690|NCT01286987|17862806|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
5173691|NCT01286987|17862807|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
5173692|NCT01286987|17862808|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
5173693|NCT01286987|17862809|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
5173694|NCT01286987|17862810|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
5173695|NCT01286987|17862811|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
5173696|NCT01286987|17862812|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
5173697|NCT01286987|17862813|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
5173698|NCT01286987|17862814|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
5173699|NCT01286987|17862815|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
5173700|NCT01286987|17862816|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
5173701|NCT01286987|17862817|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
5173702|NCT01286987|17862818|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
5173703|NCT01286987|17862804|P15|Part 2: Dose Expansion|Clinical Progression|0
5173704|NCT01286987|17862805|P14|Part 2: Dose Expansion|Clinical Progression|2
5173705|NCT01286987|17862806|P13|Part 2: Dose Expansion|Clinical Progression|0
5173706|NCT01286987|17862807|P12|Part 2: Dose Expansion|Clinical Progression|2
5173707|NCT01286987|17862808|P11|Part 2: Dose Expansion|Clinical Progression|2
5173708|NCT01286987|17862809|P10|Part 2: Dose Expansion|Clinical Progression|0
5173709|NCT01286987|17862810|P9|Part 2: Dose Expansion|Clinical Progression|0
5173710|NCT01286987|17862811|P8|Part 2: Dose Expansion|Clinical Progression|0
5173711|NCT01286987|17862812|P7|Part 2: Dose Expansion|Clinical Progression|0
5173712|NCT01286987|17862813|P6|Part 2: Dose Expansion|Clinical Progression|0
5173713|NCT01286987|17862814|P5|Part 2: Dose Expansion|Clinical Progression|0
5173714|NCT01286987|17862815|P4|Part 2: Dose Expansion|Clinical Progression|0
5173715|NCT01286987|17862816|P3|Part 2: Dose Expansion|Clinical Progression|0
5173716|NCT01286987|17862817|P2|Part 2: Dose Expansion|Clinical Progression|0
5173717|NCT01286987|17862818|P1|Part 2: Dose Expansion|Clinical Progression|0
5173718|NCT01286987|17862804|P15|Part 2: Dose Expansion|Progressive Disease|2
5173719|NCT01286987|17862805|P14|Part 2: Dose Expansion|Progressive Disease|19
5173720|NCT01286987|17862806|P13|Part 2: Dose Expansion|Progressive Disease|11
5173721|NCT01286987|17862807|P12|Part 2: Dose Expansion|Progressive Disease|7
5173722|NCT01286987|17862808|P11|Part 2: Dose Expansion|Progressive Disease|6
5173723|NCT01286987|17862809|P10|Part 2: Dose Expansion|Progressive Disease|11
5173724|NCT01286987|17862810|P9|Part 2: Dose Expansion|Progressive Disease|0
5173725|NCT01286987|17862811|P8|Part 2: Dose Expansion|Progressive Disease|0
5173726|NCT01286987|17862812|P7|Part 2: Dose Expansion|Progressive Disease|0
5173727|NCT01286987|17862813|P6|Part 2: Dose Expansion|Progressive Disease|0
5173728|NCT01286987|17862814|P5|Part 2: Dose Expansion|Progressive Disease|0
5173729|NCT01286987|17862815|P4|Part 2: Dose Expansion|Progressive Disease|0
5173730|NCT01286987|17862816|P3|Part 2: Dose Expansion|Progressive Disease|0
5173731|NCT01286987|17862817|P2|Part 2: Dose Expansion|Progressive Disease|0
5173732|NCT01286987|17862818|P1|Part 2: Dose Expansion|Progressive Disease|0
5173733|NCT01286987|17862804|P15|Part 2: Dose Expansion|Other|0
5173734|NCT01286987|17862805|P14|Part 2: Dose Expansion|Other|1
5173735|NCT01286987|17862806|P13|Part 2: Dose Expansion|Other|0
5173736|NCT01286987|17862807|P12|Part 2: Dose Expansion|Other|0
5173737|NCT01286987|17862808|P11|Part 2: Dose Expansion|Other|0
5173738|NCT01286987|17862809|P10|Part 2: Dose Expansion|Other|0
5173739|NCT01286987|17862810|P9|Part 2: Dose Expansion|Other|0
5173740|NCT01286987|17862811|P8|Part 2: Dose Expansion|Other|0
5173741|NCT01286987|17862812|P7|Part 2: Dose Expansion|Other|0
5173742|NCT01286987|17862813|P6|Part 2: Dose Expansion|Other|0
5173743|NCT01286987|17862814|P5|Part 2: Dose Expansion|Other|0
5173744|NCT01286987|17862815|P4|Part 2: Dose Expansion|Other|0
5173745|NCT01286987|17862816|P3|Part 2: Dose Expansion|Other|0
5173746|NCT01286987|17862817|P2|Part 2: Dose Expansion|Other|0
5173747|NCT01286987|17862818|P1|Part 2: Dose Expansion|Other|0
5173748|NCT01286987|17862804|P15|Part 2: Dose Expansion|Physician Decision|0
5173749|NCT01286987|17862805|P14|Part 2: Dose Expansion|Physician Decision|1
5173750|NCT01286987|17862806|P13|Part 2: Dose Expansion|Physician Decision|0
5173751|NCT01286987|17862807|P12|Part 2: Dose Expansion|Physician Decision|1
5173752|NCT01286987|17862808|P11|Part 2: Dose Expansion|Physician Decision|1
5173753|NCT01286987|17862809|P10|Part 2: Dose Expansion|Physician Decision|0
5173754|NCT01286987|17862810|P9|Part 2: Dose Expansion|Physician Decision|0
5173755|NCT01286987|17862811|P8|Part 2: Dose Expansion|Physician Decision|0
5173756|NCT01286987|17862812|P7|Part 2: Dose Expansion|Physician Decision|0
5173757|NCT01286987|17862813|P6|Part 2: Dose Expansion|Physician Decision|0
5173758|NCT01286987|17862814|P5|Part 2: Dose Expansion|Physician Decision|0
5173759|NCT01286987|17862815|P4|Part 2: Dose Expansion|Physician Decision|0
5173760|NCT01286987|17862816|P3|Part 2: Dose Expansion|Physician Decision|0
5173761|NCT01286987|17862817|P2|Part 2: Dose Expansion|Physician Decision|0
5173762|NCT01286987|17862818|P1|Part 2: Dose Expansion|Physician Decision|0
5173763|NCT01286987|17862804|P15|Part 2: Dose Expansion|Death|0
5173764|NCT01286987|17862805|P14|Part 2: Dose Expansion|Death|1
5173765|NCT01286987|17862806|P13|Part 2: Dose Expansion|Death|1
5173766|NCT01286987|17862807|P12|Part 2: Dose Expansion|Death|0
5173767|NCT01286987|17862808|P11|Part 2: Dose Expansion|Death|0
5173768|NCT01286987|17862809|P10|Part 2: Dose Expansion|Death|0
5173769|NCT01286987|17862810|P9|Part 2: Dose Expansion|Death|0
5173770|NCT01286987|17862811|P8|Part 2: Dose Expansion|Death|0
5173771|NCT01286987|17862812|P7|Part 2: Dose Expansion|Death|0
5173772|NCT01286987|17862813|P6|Part 2: Dose Expansion|Death|0
5173773|NCT01286987|17862814|P5|Part 2: Dose Expansion|Death|0
5173774|NCT01286987|17862815|P4|Part 2: Dose Expansion|Death|0
5173775|NCT01286987|17862816|P3|Part 2: Dose Expansion|Death|0
5173776|NCT01286987|17862817|P2|Part 2: Dose Expansion|Death|0
5173777|NCT01286987|17862818|P1|Part 2: Dose Expansion|Death|0
5173778|NCT01286987|17862804|P15|Part 1: Dose Escalation|Physician Decision|0
5173779|NCT01286987|17862805|P14|Part 1: Dose Escalation|Physician Decision|0
5173780|NCT01286987|17862806|P13|Part 1: Dose Escalation|Physician Decision|0
5173781|NCT01286987|17862807|P12|Part 1: Dose Escalation|Physician Decision|0
5173782|NCT01286987|17862808|P11|Part 1: Dose Escalation|Physician Decision|0
5173783|NCT01286987|17862809|P10|Part 1: Dose Escalation|Physician Decision|0
5173784|NCT01286987|17862810|P9|Part 1: Dose Escalation|Physician Decision|0
5173785|NCT01286987|17862811|P8|Part 1: Dose Escalation|Physician Decision|0
5173786|NCT01286987|17862812|P7|Part 1: Dose Escalation|Physician Decision|0
5173787|NCT01286987|17862813|P6|Part 1: Dose Escalation|Physician Decision|0
5173788|NCT01286987|17862814|P5|Part 1: Dose Escalation|Physician Decision|1
5173789|NCT01286987|17862815|P4|Part 1: Dose Escalation|Physician Decision|0
5173790|NCT01286987|17862816|P3|Part 1: Dose Escalation|Physician Decision|0
5173791|NCT01286987|17862817|P2|Part 1: Dose Escalation|Physician Decision|0
5173792|NCT01286987|17862818|P1|Part 1: Dose Escalation|Physician Decision|0
5173793|NCT01286987|17862804|P15|Part 1: Dose Escalation|Progressive Disease|0
5173794|NCT01286987|17862805|P14|Part 1: Dose Escalation|Progressive Disease|0
5173795|NCT01286987|17862806|P13|Part 1: Dose Escalation|Progressive Disease|0
5173796|NCT01286987|17862807|P12|Part 1: Dose Escalation|Progressive Disease|0
5173797|NCT01286987|17862808|P11|Part 1: Dose Escalation|Progressive Disease|0
5173798|NCT01286987|17862809|P10|Part 1: Dose Escalation|Progressive Disease|0
5173799|NCT01286987|17862810|P9|Part 1: Dose Escalation|Progressive Disease|5
5173800|NCT01286987|17862811|P8|Part 1: Dose Escalation|Progressive Disease|3
5173801|NCT01286987|17862812|P7|Part 1: Dose Escalation|Progressive Disease|5
5173802|NCT01286987|17862813|P6|Part 1: Dose Escalation|Progressive Disease|5
5173803|NCT01286987|17862814|P5|Part 1: Dose Escalation|Progressive Disease|1
5173804|NCT01286987|17862815|P4|Part 1: Dose Escalation|Progressive Disease|2
5173805|NCT01286987|17862816|P3|Part 1: Dose Escalation|Progressive Disease|3
5173806|NCT01286987|17862817|P2|Part 1: Dose Escalation|Progressive Disease|2
5173807|NCT01286987|17862818|P1|Part 1: Dose Escalation|Progressive Disease|2
5173808|NCT01286987|17862804|P15|Part 1: Dose Escalation|Clinical Progression|0
5173809|NCT01286987|17862805|P14|Part 1: Dose Escalation|Clinical Progression|0
5173810|NCT01286987|17862806|P13|Part 1: Dose Escalation|Clinical Progression|0
5173811|NCT01286987|17862807|P12|Part 1: Dose Escalation|Clinical Progression|0
5173812|NCT01286987|17862808|P11|Part 1: Dose Escalation|Clinical Progression|0
5173813|NCT01286987|17862809|P10|Part 1: Dose Escalation|Clinical Progression|0
5173814|NCT01286987|17862810|P9|Part 1: Dose Escalation|Clinical Progression|1
5173815|NCT01286987|17862811|P8|Part 1: Dose Escalation|Clinical Progression|2
5173816|NCT01286987|17862812|P7|Part 1: Dose Escalation|Clinical Progression|0
5173817|NCT01286987|17862813|P6|Part 1: Dose Escalation|Clinical Progression|1
5173818|NCT01286987|17862814|P5|Part 1: Dose Escalation|Clinical Progression|1
5173819|NCT01286987|17862815|P4|Part 1: Dose Escalation|Clinical Progression|1
5173820|NCT01286987|17862816|P3|Part 1: Dose Escalation|Clinical Progression|0
5173821|NCT01286987|17862817|P2|Part 1: Dose Escalation|Clinical Progression|1
5173822|NCT01286987|17862818|P1|Part 1: Dose Escalation|Clinical Progression|1
5173823|NCT01286779|17862999|P1|Overall Study|Discontinued by sponsor|1
5173824|NCT01286779|17862999|P1|Overall Study|Participant moved to another country|1
5173825|NCT01286779|17862999|P1|Overall Study|Participant had scheduled surgery|1
5173826|NCT01286779|17862999|P1|Overall Study|Physician Decision|2
5173827|NCT01286779|17862999|P1|Overall Study|Protocol Violation|5
5173828|NCT01286779|17862999|P1|Overall Study|Withdrawal by Subject|9
5173829|NCT01286753|17863051|P2|Overall Study|Participant to Receive Radiotherapy|0
5173830|NCT01286753|17863052|P1|Overall Study|Participant to Receive Radiotherapy|1
5173831|NCT01286753|17863051|P2|Overall Study|Discontinued to Join Extension Study|4
5173832|NCT01286753|17863052|P1|Overall Study|Discontinued to Join Extension Study|6
5173833|NCT01286753|17863051|P2|Overall Study|Withdrawal of Consent|2
5173834|NCT01286753|17863052|P1|Overall Study|Withdrawal of Consent|0
5173835|NCT01286753|17863051|P2|Overall Study|Refused Treatment|0
5173836|NCT01286753|17863052|P1|Overall Study|Refused Treatment|1
5173837|NCT01286753|17863051|P2|Overall Study|Progression|13
5173838|NCT01286753|17863052|P1|Overall Study|Progression|11
5173839|NCT01286753|17863051|P2|Overall Study|Adverse Event|6
5173840|NCT01286753|17863052|P1|Overall Study|Adverse Event|7
5173841|NCT01286740|17863070|P1|Overall Study|Protocol Violation|1
5173842|NCT01286740|17863070|P1|Overall Study|Enrolled but not treated|1
5173843|NCT01286558|17863088|P2|Overall Study|Withdrawal by Subject|1
5173844|NCT01286558|17863089|P1|Overall Study|Withdrawal by Subject|0
5173845|NCT01286558|17863088|P2|Overall Study|Adverse Event|1
5173846|NCT01286558|17863089|P1|Overall Study|Adverse Event|1
5173847|NCT01286480|17863125|P2|Overall Study|Withdrawal by Subject|3
5173848|NCT01286480|17863126|P1|Overall Study|Withdrawal by Subject|5
5173849|NCT01286311|17863233|P2|Overall Study|Physician did not want outreach sent|0
5173850|NCT01286311|17863234|P1|Overall Study|Physician did not want outreach sent|14
5173851|NCT01286272|17863250|P2|Overall Study|Ineligible after beginning treatment|3
5173852|NCT01286272|17863251|P1|Overall Study|Ineligible after beginning treatment|1
5173853|NCT01286207|17863271|P3|Overall Study|Other|13
5173854|NCT01286207|17863272|P2|Overall Study|Other|47
5173855|NCT01286207|17863273|P1|Overall Study|Other|37
5173856|NCT01286207|17863271|P3|Overall Study|Lack of Response|8
5173857|NCT01286207|17863272|P2|Overall Study|Lack of Response|38
5173858|NCT01286207|17863273|P1|Overall Study|Lack of Response|92
5173859|NCT01286207|17863271|P3|Overall Study|Withdrawal by Subject|41
5173860|NCT01286207|17863272|P2|Overall Study|Withdrawal by Subject|79
5173861|NCT01286207|17863273|P1|Overall Study|Withdrawal by Subject|93
5173862|NCT01286207|17863271|P3|Overall Study|Lost to Follow-up|20
5173863|NCT01286207|17863272|P2|Overall Study|Lost to Follow-up|43
5173864|NCT01286207|17863273|P1|Overall Study|Lost to Follow-up|49
5173865|NCT01286207|17863271|P3|Overall Study|Adverse Event|8
5173866|NCT01286207|17863272|P2|Overall Study|Adverse Event|41
5173867|NCT01286207|17863273|P1|Overall Study|Adverse Event|27
5173868|NCT01286168|17863293|P1|Overall Study|Surgical Drains Fell Out at Home|2
5173869|NCT01286168|17863293|P1|Overall Study|Withdrawal by Subject|1
5173870|NCT01286129|17863307|P2|Overall Study|Could not comply with study requirements|4
5173871|NCT01286129|17863308|P1|Overall Study|Could not comply with study requirements|4
5173872|NCT01286129|17863307|P2|Overall Study|Withdrawal by Subject|1
5173873|NCT01286129|17863308|P1|Overall Study|Withdrawal by Subject|4
5173874|NCT01286077|17863318|P2|Overall Study|refill medication not received in time|0
5173875|NCT01286077|17863319|P1|Overall Study|refill medication not received in time|1
5173876|NCT01286077|17863318|P2|Overall Study|Progression of disease|1
5173877|NCT01286077|17863319|P1|Overall Study|Progression of disease|0
5173878|NCT01286077|17863318|P2|Overall Study|Patient's decision to stop treatment|0
5173879|NCT01286077|17863319|P1|Overall Study|Patient's decision to stop treatment|3
5173880|NCT01286077|17863318|P2|Overall Study|The subject starts with alternative MMY|3
5173881|NCT01286077|17863319|P1|Overall Study|The subject starts with alternative MMY|0
5173882|NCT01286077|17863318|P2|Overall Study|Non-compliance|0
5173883|NCT01286077|17863319|P1|Overall Study|Non-compliance|1
5173884|NCT01286077|17863318|P2|Overall Study|Intercurrent illness|0
5173885|NCT01286077|17863319|P1|Overall Study|Intercurrent illness|1
5173886|NCT01286077|17863318|P2|Overall Study|Withdrawal by Subject|2
5173887|NCT01286077|17863319|P1|Overall Study|Withdrawal by Subject|0
5173888|NCT01286077|17863318|P2|Overall Study|Protocol Violation|1
5173889|NCT01286077|17863319|P1|Overall Study|Protocol Violation|1
5173890|NCT01286077|17863318|P2|Overall Study|Death|0
5173891|NCT01286077|17863319|P1|Overall Study|Death|1
5173892|NCT01286077|17863318|P2|Overall Study|Adverse Event|0
5173893|NCT01286077|17863319|P1|Overall Study|Adverse Event|2
5173894|NCT01286012|17863355|P2|Overall Study|peritoneal dialysis, randomized in error|3
5173895|NCT01286012|17863356|P1|Overall Study|peritoneal dialysis, randomized in error|1
5173896|NCT01286012|17863355|P2|Overall Study|Physician Decision|0
5173897|NCT01286012|17863356|P1|Overall Study|Physician Decision|2
5173898|NCT01286012|17863355|P2|Overall Study|Withdrawal by Subject|4
5173899|NCT01286012|17863356|P1|Overall Study|Withdrawal by Subject|4
5173900|NCT01286012|17863355|P2|Overall Study|Protocol Violation|1
5173901|NCT01286012|17863356|P1|Overall Study|Protocol Violation|1
5173902|NCT01286012|17863355|P2|Overall Study|Death|3
5173903|NCT01286012|17863356|P1|Overall Study|Death|2
5173904|NCT01286012|17863355|P2|Overall Study|Adverse Event|3
5173905|NCT01286012|17863356|P1|Overall Study|Adverse Event|3
5173906|NCT01285960|17863370|P1|Overall Study|2 subjects received less 10 sonications|2
5173907|NCT01285960|17863370|P1|Overall Study|Lost to Follow-up|2
5173908|NCT01285960|17863370|P1|Overall Study|Withdrawal by Subject|2
5173909|NCT01285908|17863383|P3|Baseline Measurement|unable to tolerate procedure|0
5173910|NCT01285908|17863384|P2|Baseline Measurement|unable to tolerate procedure|0
5173911|NCT01285908|17863385|P1|Baseline Measurement|unable to tolerate procedure|1
5173912|NCT01285908|17863383|P3|Baseline Measurement|History of stroke, exclusion criteria|0
5173913|NCT01285908|17863384|P2|Baseline Measurement|History of stroke, exclusion criteria|0
5173914|NCT01285908|17863385|P1|Baseline Measurement|History of stroke, exclusion criteria|1
5173915|NCT01285908|17863383|P3|Baseline Measurement|unable to insert catheter|0
5173916|NCT01285908|17863384|P2|Baseline Measurement|unable to insert catheter|0
5173917|NCT01285908|17863385|P1|Baseline Measurement|unable to insert catheter|1
5173918|NCT01285609|17863479|P2|Treated With Blinded Therapy|Worsening of general condition|1
5173919|NCT01285609|17863480|P1|Treated With Blinded Therapy|Worsening of general condition|0
5173920|NCT01285609|17863479|P2|Treated With Blinded Therapy|PI decision to discontinue|1
5173921|NCT01285609|17863480|P1|Treated With Blinded Therapy|PI decision to discontinue|0
5173922|NCT01285609|17863479|P2|Treated With Blinded Therapy|Investigator's assessment|0
5173923|NCT01285609|17863480|P1|Treated With Blinded Therapy|Investigator's assessment|1
5173924|NCT01285609|17863479|P2|Treated With Blinded Therapy|Participant hospitalized|0
5173925|NCT01285609|17863480|P1|Treated With Blinded Therapy|Participant hospitalized|1
5173926|NCT01285609|17863479|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
5173927|NCT01285609|17863480|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
5173928|NCT01285609|17863479|P2|Treated With Blinded Therapy|Participant refused participation|0
5173929|NCT01285609|17863480|P1|Treated With Blinded Therapy|Participant refused participation|1
5173930|NCT01285609|17863479|P2|Treated With Blinded Therapy|Physician and Patient decision|3
5173931|NCT01285609|17863480|P1|Treated With Blinded Therapy|Physician and Patient decision|1
5173932|NCT01285609|17863479|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
5173933|NCT01285609|17863480|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
5173934|NCT01285609|17863479|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
5173935|NCT01285609|17863480|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
5173936|NCT01285609|17863479|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
5173937|NCT01285609|17863480|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
5173938|NCT01285609|17863479|P2|Treated With Blinded Therapy|Not Reported|2
5173939|NCT01285609|17863480|P1|Treated With Blinded Therapy|Not Reported|0
5173940|NCT01285609|17863479|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
5173941|NCT01285609|17863480|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
5173942|NCT01285609|17863479|P2|Treated With Blinded Therapy|Death|3
5173943|NCT01285609|17863480|P1|Treated With Blinded Therapy|Death|11
5173944|NCT01285609|17863479|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
5173945|NCT01285609|17863480|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
5173946|NCT01285609|17863479|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
5173947|NCT01285609|17863480|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
5173948|NCT01285609|17863479|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
5173949|NCT01285609|17863480|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
5173950|NCT01285609|17863479|P2|Treated With Blinded Therapy|Progressive Disease|305
5173951|NCT01285609|17863480|P1|Treated With Blinded Therapy|Progressive Disease|223
5173952|NCT01285609|17863479|P2|Randomized|Randomized but not Treated|4
5173953|NCT01285609|17863480|P1|Randomized|Randomized but not Treated|4
5173954|NCT01285609|17863479|P2|Randomized|Undisclosed Reasons|0
5173955|NCT01285609|17863480|P1|Randomized|Undisclosed Reasons|1
5173956|NCT01285609|17863479|P2|Randomized|Subject No Longer Met Study Criteria|1
5173957|NCT01285609|17863480|P1|Randomized|Subject No Longer Met Study Criteria|1
5173958|NCT01285609|17863479|P2|Randomized|Withdrawal by Subject|11
5173959|NCT01285609|17863480|P1|Randomized|Withdrawal by Subject|8
5173960|NCT01285609|17863479|P2|Randomized|Death|7
5173961|NCT01285609|17863480|P1|Randomized|Death|5
5173962|NCT01285609|17863479|P2|Randomized|Study Drug Toxicity|14
5173963|NCT01285609|17863480|P1|Randomized|Study Drug Toxicity|13
5173964|NCT01285609|17863479|P2|Randomized|Adverse Event Unrelated to Study Drug|18
5173965|NCT01285609|17863480|P1|Randomized|Adverse Event Unrelated to Study Drug|18
5173966|NCT01285609|17863479|P2|Randomized|Progressive Disease|61
5173967|NCT01285609|17863480|P1|Randomized|Progressive Disease|41
5173968|NCT01285518|17863498|P8|Overall Study|Lost to Follow-up|0
5173969|NCT01285518|17863499|P7|Overall Study|Lost to Follow-up|0
5173970|NCT01285518|17863500|P6|Overall Study|Lost to Follow-up|1
5173971|NCT01285518|17863501|P5|Overall Study|Lost to Follow-up|0
5173972|NCT01285518|17863502|P4|Overall Study|Lost to Follow-up|0
5173973|NCT01285518|17863503|P3|Overall Study|Lost to Follow-up|0
5173974|NCT01285518|17863504|P2|Overall Study|Lost to Follow-up|0
5173975|NCT01285518|17863505|P1|Overall Study|Lost to Follow-up|0
5173976|NCT01285492|17863765|P2|Overall Study|Death|0
5173977|NCT01285492|17863766|P1|Overall Study|Death|1
5173978|NCT01285492|17863765|P2|Overall Study|Withdrawal by Subject|1
5173979|NCT01285492|17863766|P1|Overall Study|Withdrawal by Subject|2
5173980|NCT01285492|17863765|P2|Overall Study|Protocol Violation|0
5173981|NCT01285492|17863766|P1|Overall Study|Protocol Violation|3
5173982|NCT01285492|17863765|P2|Overall Study|Adverse Event|0
5173983|NCT01285492|17863766|P1|Overall Study|Adverse Event|11
5173984|NCT01285401|17863798|P2|Overall Study|Prematurely withdrawn from the study|29
5173985|NCT01285401|17863799|P1|Overall Study|Prematurely withdrawn from the study|17
5173986|NCT01285349|17863840|P3|Overall Study|Lost to Follow-up|27
5173987|NCT01285349|17863841|P2|Overall Study|Lost to Follow-up|20
5173988|NCT01285349|17863842|P1|Overall Study|Lost to Follow-up|27
5173989|NCT01285323|17863855|P2|Overall Study|Other|3
5173990|NCT01285323|17863856|P1|Overall Study|Other|1
5173991|NCT01285323|17863855|P2|Overall Study|Lost to Follow-up|1
5173992|NCT01285323|17863856|P1|Overall Study|Lost to Follow-up|1
5173993|NCT01285323|17863855|P2|Overall Study|Non-compliance with study procedures|3
5173994|NCT01285323|17863856|P1|Overall Study|Non-compliance with study procedures|2
5173995|NCT01285323|17863855|P2|Overall Study|Protocol Violation|2
5173996|NCT01285323|17863856|P1|Overall Study|Protocol Violation|1
5173997|NCT01285323|17863855|P2|Overall Study|Withdrawal by Subject|11
5173998|NCT01285323|17863856|P1|Overall Study|Withdrawal by Subject|15
5173999|NCT01285323|17863855|P2|Overall Study|Lack of Efficacy|2
5174000|NCT01285323|17863856|P1|Overall Study|Lack of Efficacy|4
5174001|NCT01285323|17863855|P2|Overall Study|Adverse Event|8
5174002|NCT01285323|17863856|P1|Overall Study|Adverse Event|9
5174003|NCT01285310|17863891|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
5174004|NCT01285310|17863892|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5174005|NCT01285310|17863893|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5174006|NCT01285310|17863894|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5174007|NCT01285310|17863895|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
5174008|NCT01285310|17863891|P5|Active Treatment Phase: Weeks 25-52|Other|0
5174009|NCT01285310|17863892|P4|Active Treatment Phase: Weeks 25-52|Other|0
5174010|NCT01285310|17863893|P3|Active Treatment Phase: Weeks 25-52|Other|0
5174011|NCT01285310|17863894|P2|Active Treatment Phase: Weeks 25-52|Other|1
5174012|NCT01285310|17863895|P1|Active Treatment Phase: Weeks 25-52|Other|0
5174013|NCT01285310|17863891|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
5174014|NCT01285310|17863892|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
5174015|NCT01285310|17863893|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
5174016|NCT01285310|17863894|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
5174017|NCT01285310|17863895|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
5174018|NCT01285310|17863891|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
5174019|NCT01285310|17863892|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
5174020|NCT01285310|17863893|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
5174021|NCT01285310|17863894|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
5174022|NCT01285310|17863895|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
5174023|NCT01285310|17863891|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
5174024|NCT01285310|17863892|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
5174025|NCT01285310|17863893|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
5174026|NCT01285310|17863894|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
5174027|NCT01285310|17863895|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
5174028|NCT01285310|17863891|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
5174029|NCT01285310|17863892|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
5174030|NCT01285310|17863893|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
5174031|NCT01285310|17863894|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
5174032|NCT01285310|17863895|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
5174033|NCT01285310|17863891|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
5174034|NCT01285310|17863892|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
5174035|NCT01285310|17863893|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
5174036|NCT01285310|17863894|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
5174037|NCT01285310|17863895|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
5174038|NCT01285310|17863891|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5174039|NCT01285310|17863892|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5174040|NCT01285310|17863893|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
5174041|NCT01285310|17863894|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
5174042|NCT01285310|17863895|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5174043|NCT01285310|17863891|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
5174044|NCT01285310|17863892|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
5174045|NCT01285310|17863893|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
5174046|NCT01285310|17863894|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
5174047|NCT01285310|17863895|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
5174048|NCT01285310|17863891|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5174049|NCT01285310|17863892|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5174050|NCT01285310|17863893|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
5174051|NCT01285310|17863894|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5174052|NCT01285310|17863895|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
5174053|NCT01285310|17863891|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
5174054|NCT01285310|17863892|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
5174055|NCT01285310|17863893|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
5174056|NCT01285310|17863894|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
5174057|NCT01285310|17863895|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
5174058|NCT01285310|17863891|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
5174059|NCT01285310|17863892|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
5174060|NCT01285310|17863893|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
5174061|NCT01285310|17863894|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
5174062|NCT01285310|17863895|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
5174063|NCT01284959|17864160|P3|Overall Study|Adverse Event|1
5174064|NCT01284959|17864161|P2|Overall Study|Adverse Event|0
5174065|NCT01284959|17864162|P1|Overall Study|Adverse Event|0
5174066|NCT01284959|17864160|P3|Overall Study|Withdrawal by Subject|0
5174067|NCT01284959|17864161|P2|Overall Study|Withdrawal by Subject|0
5174068|NCT01284959|17864162|P1|Overall Study|Withdrawal by Subject|1
5174069|NCT01284634|17864192|P4|Overall Study|Adverse Event|1
5174070|NCT01284634|17864193|P3|Overall Study|Adverse Event|2
5174071|NCT01284634|17864194|P2|Overall Study|Adverse Event|0
5174072|NCT01284634|17864195|P1|Overall Study|Adverse Event|1
5174073|NCT01284621|17864225|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5174074|NCT01284621|17864226|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
5174075|NCT01284621|17864227|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5174076|NCT01284621|17864228|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5174077|NCT01284621|17864229|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5174078|NCT01284621|17864230|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5174079|NCT01284491|17864298|P1|Overall Study|Study termination|13
5174080|NCT01284361|17864308|P1|Overall Study|Lost to Follow-up|2
5174081|NCT01284361|17864308|P1|Overall Study|Adverse Event|1
5174082|NCT01284361|17864308|P1|Overall Study|Protocol Violation|5
5174083|NCT01284361|17864308|P1|Overall Study|Withdrawal by Subject|1
5174084|NCT01284140|17864404|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
5174085|NCT01284140|17864405|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
5174086|NCT01284140|17864404|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
5174087|NCT01284140|17864405|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
5174088|NCT01284127|17864419|P1|Overall Study|Physician Decision|1
5174089|NCT01284127|17864419|P1|Overall Study|Withdrawal by Subject|4
5174090|NCT01284127|17864419|P1|Overall Study|Adverse Event|2
5174091|NCT01284114|17864428|P1|Overall Study|dizziness|1
5174092|NCT01284114|17864428|P1|Overall Study|Symptomatic hypotension|1
5174093|NCT01284114|17864428|P1|Overall Study|From the results of ALLTITUDE study|1
5174094|NCT01284114|17864428|P1|Overall Study|viral infection|1
5174095|NCT01284062|17864440|P4|Overall Study|Site Closed|0
5174096|NCT01284062|17864441|P3|Overall Study|Site Closed|1
5174097|NCT01284062|17864442|P2|Overall Study|Site Closed|0
5174098|NCT01284062|17864443|P1|Overall Study|Site Closed|0
5174099|NCT01284062|17864440|P4|Overall Study|Other|1
5174100|NCT01284062|17864441|P3|Overall Study|Other|0
5174101|NCT01284062|17864442|P2|Overall Study|Other|0
5174102|NCT01284062|17864443|P1|Overall Study|Other|0
5174103|NCT01284062|17864440|P4|Overall Study|Withdrawal by Subject|5
5174104|NCT01284062|17864441|P3|Overall Study|Withdrawal by Subject|2
5174105|NCT01284062|17864442|P2|Overall Study|Withdrawal by Subject|1
5174106|NCT01284062|17864443|P1|Overall Study|Withdrawal by Subject|3
5174107|NCT01284062|17864440|P4|Overall Study|Protocol Violation|2
5174108|NCT01284062|17864441|P3|Overall Study|Protocol Violation|0
5174109|NCT01284062|17864442|P2|Overall Study|Protocol Violation|0
5174110|NCT01284062|17864443|P1|Overall Study|Protocol Violation|1
5174111|NCT01284062|17864440|P4|Overall Study|Medication error without adverse event|0
5174112|NCT01284062|17864441|P3|Overall Study|Medication error without adverse event|1
5174113|NCT01284062|17864442|P2|Overall Study|Medication error without adverse event|0
5174114|NCT01284062|17864443|P1|Overall Study|Medication error without adverse event|0
5174115|NCT01284062|17864440|P4|Overall Study|Lack of Efficacy|1
5174116|NCT01284062|17864441|P3|Overall Study|Lack of Efficacy|2
5174117|NCT01284062|17864442|P2|Overall Study|Lack of Efficacy|2
5174118|NCT01284062|17864443|P1|Overall Study|Lack of Efficacy|3
5174119|NCT01284062|17864440|P4|Overall Study|Adverse Event|5
5174120|NCT01284062|17864441|P3|Overall Study|Adverse Event|0
5174121|NCT01284062|17864442|P2|Overall Study|Adverse Event|5
5174122|NCT01284062|17864443|P1|Overall Study|Adverse Event|4
5174123|NCT01283971|17864517|P2|Overall Study|Administrative reasons|1
5174124|NCT01283971|17864518|P1|Overall Study|Administrative reasons|1
5174125|NCT01283971|17864517|P2|Overall Study|Failure to return|1
5174126|NCT01283971|17864518|P1|Overall Study|Failure to return|0
5174127|NCT01283971|17864517|P2|Overall Study|Refused treatment|1
5174128|NCT01283971|17864518|P1|Overall Study|Refused treatment|3
5174129|NCT01283971|17864517|P2|Overall Study|Protocol Violation|1
5174130|NCT01283971|17864518|P1|Overall Study|Protocol Violation|5
5174131|NCT01283971|17864517|P2|Overall Study|Insufficient therapeutic responses|3
5174132|NCT01283971|17864518|P1|Overall Study|Insufficient therapeutic responses|3
5174133|NCT01283971|17864517|P2|Overall Study|Adverse Event|5
5174134|NCT01283971|17864518|P1|Overall Study|Adverse Event|3
5174135|NCT01283581|17864565|P3|Overall Study|"Early termination"|1
5174136|NCT01283581|17864566|P2|Overall Study|"Early termination"|0
5174137|NCT01283581|17864567|P1|Overall Study|"Early termination"|0
5174138|NCT01283581|17864565|P3|Overall Study|Investigator unblinded|1
5174139|NCT01283581|17864566|P2|Overall Study|Investigator unblinded|0
5174140|NCT01283581|17864567|P1|Overall Study|Investigator unblinded|0
5174141|NCT01283581|17864565|P3|Overall Study|Noncompliance|0
5174142|NCT01283581|17864566|P2|Overall Study|Noncompliance|0
5174143|NCT01283581|17864567|P1|Overall Study|Noncompliance|1
5174144|NCT01283581|17864565|P3|Overall Study|Protocol Violation|2
5174145|NCT01283581|17864566|P2|Overall Study|Protocol Violation|1
5174146|NCT01283581|17864567|P1|Overall Study|Protocol Violation|0
5174147|NCT01283581|17864565|P3|Overall Study|Physician Decision|2
5174148|NCT01283581|17864566|P2|Overall Study|Physician Decision|1
5174149|NCT01283581|17864567|P1|Overall Study|Physician Decision|0
5174150|NCT01283581|17864565|P3|Overall Study|Adverse Event|4
5174151|NCT01283581|17864566|P2|Overall Study|Adverse Event|1
5174152|NCT01283581|17864567|P1|Overall Study|Adverse Event|1
5174153|NCT01283581|17864565|P3|Overall Study|Withdrawal by Subject|2
5174154|NCT01283581|17864566|P2|Overall Study|Withdrawal by Subject|5
5174155|NCT01283581|17864567|P1|Overall Study|Withdrawal by Subject|2
5174156|NCT01283581|17864565|P3|Overall Study|Lost to Follow-up|8
5174157|NCT01283581|17864566|P2|Overall Study|Lost to Follow-up|6
5174158|NCT01283581|17864567|P1|Overall Study|Lost to Follow-up|8
5174159|NCT01283542|17864637|P1|Extension Phase|Administrative problems|1
5174160|NCT01283542|17864637|P1|Extension Phase|Adverse Event|1
5174161|NCT01283542|17864637|P1|Extension Phase|Physician Decision|1
5174162|NCT01283542|17864637|P1|Main Phase|abnormal laboratory values|5
5174163|NCT01283542|17864637|P1|Main Phase|Uncontrolled diabetes mellitus|1
5174164|NCT01283542|17864637|P1|Main Phase|Acute or progressive vision loss|1
5174165|NCT01283516|17864702|P9|Overall Study|Lost to Follow-up|1
5174166|NCT01283516|17864703|P8|Overall Study|Lost to Follow-up|0
5174167|NCT01283516|17864704|P7|Overall Study|Lost to Follow-up|0
5174168|NCT01283516|17864705|P6|Overall Study|Lost to Follow-up|0
5174169|NCT01283516|17864706|P5|Overall Study|Lost to Follow-up|0
5174170|NCT01283516|17864707|P4|Overall Study|Lost to Follow-up|0
5174171|NCT01283516|17864708|P3|Overall Study|Lost to Follow-up|0
5174172|NCT01283516|17864709|P2|Overall Study|Lost to Follow-up|0
5174173|NCT01283516|17864710|P1|Overall Study|Lost to Follow-up|0
5174174|NCT01283516|17864702|P9|Overall Study|Administrative problems|39
5174175|NCT01283516|17864703|P8|Overall Study|Administrative problems|1
5174176|NCT01283516|17864704|P7|Overall Study|Administrative problems|1
5174177|NCT01283516|17864705|P6|Overall Study|Administrative problems|1
5174178|NCT01283516|17864706|P5|Overall Study|Administrative problems|0
5174179|NCT01283516|17864707|P4|Overall Study|Administrative problems|0
5174180|NCT01283516|17864708|P3|Overall Study|Administrative problems|0
5174181|NCT01283516|17864709|P2|Overall Study|Administrative problems|0
5174182|NCT01283516|17864710|P1|Overall Study|Administrative problems|0
5174183|NCT01283516|17864702|P9|Overall Study|Withdrawal by Subject|36
5174184|NCT01283516|17864703|P8|Overall Study|Withdrawal by Subject|0
5174185|NCT01283516|17864704|P7|Overall Study|Withdrawal by Subject|1
5174186|NCT01283516|17864705|P6|Overall Study|Withdrawal by Subject|0
5174187|NCT01283516|17864706|P5|Overall Study|Withdrawal by Subject|1
5174188|NCT01283516|17864707|P4|Overall Study|Withdrawal by Subject|0
5174189|NCT01283516|17864708|P3|Overall Study|Withdrawal by Subject|0
5174190|NCT01283516|17864709|P2|Overall Study|Withdrawal by Subject|0
5174191|NCT01283516|17864710|P1|Overall Study|Withdrawal by Subject|0
5174192|NCT01283516|17864702|P9|Overall Study|Disease Progression|139
5174193|NCT01283516|17864703|P8|Overall Study|Disease Progression|3
5174194|NCT01283516|17864704|P7|Overall Study|Disease Progression|6
5174195|NCT01283516|17864705|P6|Overall Study|Disease Progression|8
5174196|NCT01283516|17864706|P5|Overall Study|Disease Progression|13
5174197|NCT01283516|17864707|P4|Overall Study|Disease Progression|3
5174198|NCT01283516|17864708|P3|Overall Study|Disease Progression|3
5174199|NCT01283516|17864709|P2|Overall Study|Disease Progression|2
5174200|NCT01283516|17864710|P1|Overall Study|Disease Progression|2
5174201|NCT01283516|17864702|P9|Overall Study|Death|12
5174202|NCT01283516|17864703|P8|Overall Study|Death|1
5174203|NCT01283516|17864704|P7|Overall Study|Death|0
5174204|NCT01283516|17864705|P6|Overall Study|Death|1
5174205|NCT01283516|17864706|P5|Overall Study|Death|0
5174206|NCT01283516|17864707|P4|Overall Study|Death|0
5174207|NCT01283516|17864708|P3|Overall Study|Death|0
5174208|NCT01283516|17864709|P2|Overall Study|Death|0
5174209|NCT01283516|17864710|P1|Overall Study|Death|0
5174210|NCT01283516|17864702|P9|Overall Study|Adverse Event|28
5174211|NCT01283516|17864703|P8|Overall Study|Adverse Event|0
5174212|NCT01283516|17864704|P7|Overall Study|Adverse Event|2
5174213|NCT01283516|17864705|P6|Overall Study|Adverse Event|0
5174214|NCT01283516|17864706|P5|Overall Study|Adverse Event|0
5174215|NCT01283516|17864707|P4|Overall Study|Adverse Event|0
5174216|NCT01283516|17864708|P3|Overall Study|Adverse Event|0
5174217|NCT01283516|17864709|P2|Overall Study|Adverse Event|0
5174218|NCT01283516|17864710|P1|Overall Study|Adverse Event|0
5174219|NCT01283464|17864832|P2|Overall Study|Physician Decision|0
5174220|NCT01283464|17864833|P1|Overall Study|Physician Decision|1
5174221|NCT01283464|17864832|P2|Overall Study|Withdrawal by Subject|0
5174222|NCT01283464|17864833|P1|Overall Study|Withdrawal by Subject|1
5174223|NCT01283464|17864832|P2|Overall Study|Lost to Follow-up|1
5174224|NCT01283464|17864833|P1|Overall Study|Lost to Follow-up|0
5174225|NCT01283386|17864841|P2|Overall Study|Protocol Violation|1
5174226|NCT01283386|17864842|P1|Overall Study|Protocol Violation|0
5174227|NCT01283386|17864841|P2|Overall Study|Reason not specified|0
5174228|NCT01283386|17864842|P1|Overall Study|Reason not specified|1
5174229|NCT01283386|17864841|P2|Overall Study|Progression of underlying disease|7
5174230|NCT01283386|17864842|P1|Overall Study|Progression of underlying disease|2
5174231|NCT01283386|17864841|P2|Overall Study|Relapse of underlying disease|3
5174232|NCT01283386|17864842|P1|Overall Study|Relapse of underlying disease|1
5174233|NCT01283386|17864841|P2|Overall Study|Withdrawal by Subject|1
5174234|NCT01283386|17864842|P1|Overall Study|Withdrawal by Subject|2
5174235|NCT01283386|17864841|P2|Overall Study|Death|0
5174236|NCT01283386|17864842|P1|Overall Study|Death|2
5174237|NCT01283334|17864866|P1|Overall Study|Physician Decision|1
5174238|NCT01283334|17864866|P1|Overall Study|Adverse Event|4
5174239|NCT01283334|17864866|P1|Overall Study|Inability to Swallow Everolimus Pills|1
5174240|NCT01283334|17864866|P1|Overall Study|Withdrawal by Subject|1
5174241|NCT01283282|17864889|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
5174242|NCT01283282|17864890|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
5174243|NCT01283282|17864889|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
5174244|NCT01283282|17864890|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
5174245|NCT01283282|17864889|P2|First Intervention (6 Weeks)|Physician Decision|1
5174246|NCT01283282|17864890|P1|First Intervention (6 Weeks)|Physician Decision|0
5174247|NCT01283152|17864910|P2|Overall Study|Refused HESA|0
5174248|NCT01283152|17864911|P1|Overall Study|Refused HESA|1
5174249|NCT01283152|17864910|P2|Overall Study|Discharged prior to 24 hr assessment|0
5174250|NCT01283152|17864911|P1|Overall Study|Discharged prior to 24 hr assessment|1
5174251|NCT01283139|17864925|P4|Overall Study|Participant randomized in error|0
5174252|NCT01283139|17864926|P3|Overall Study|Participant randomized in error|1
5174253|NCT01283139|17864927|P2|Overall Study|Participant randomized in error|0
5174254|NCT01283139|17864928|P1|Overall Study|Participant randomized in error|0
5174255|NCT01283139|17864925|P4|Overall Study|Missed follow-up visit|2
5174256|NCT01283139|17864926|P3|Overall Study|Missed follow-up visit|2
5174257|NCT01283139|17864927|P2|Overall Study|Missed follow-up visit|1
5174258|NCT01283139|17864928|P1|Overall Study|Missed follow-up visit|0
5174259|NCT01283139|17864925|P4|Overall Study|Pregnancy|0
5174260|NCT01283139|17864926|P3|Overall Study|Pregnancy|1
5174261|NCT01283139|17864927|P2|Overall Study|Pregnancy|1
5174262|NCT01283139|17864928|P1|Overall Study|Pregnancy|0
5174263|NCT01283139|17864925|P4|Overall Study|Participant's refusal to continue|1
5174264|NCT01283139|17864926|P3|Overall Study|Participant's refusal to continue|1
5174265|NCT01283139|17864927|P2|Overall Study|Participant's refusal to continue|3
5174266|NCT01283139|17864928|P1|Overall Study|Participant's refusal to continue|0
5174267|NCT01283139|17864925|P4|Overall Study|Early termination due to AE/SAE|0
5174268|NCT01283139|17864926|P3|Overall Study|Early termination due to AE/SAE|0
5174269|NCT01283139|17864927|P2|Overall Study|Early termination due to AE/SAE|1
5174270|NCT01283139|17864928|P1|Overall Study|Early termination due to AE/SAE|1
5174271|NCT01283139|17864925|P4|Overall Study|Lack of Efficacy|1
5174272|NCT01283139|17864926|P3|Overall Study|Lack of Efficacy|2
5174273|NCT01283139|17864927|P2|Overall Study|Lack of Efficacy|2
5174274|NCT01283139|17864928|P1|Overall Study|Lack of Efficacy|1
5174275|NCT01283139|17864925|P4|Overall Study|Death|2
5174276|NCT01283139|17864926|P3|Overall Study|Death|2
5174277|NCT01283139|17864927|P2|Overall Study|Death|0
5174278|NCT01283139|17864928|P1|Overall Study|Death|2
5174279|NCT01283139|17864925|P4|Overall Study|Withdrawal by Subject|8
5174280|NCT01283139|17864926|P3|Overall Study|Withdrawal by Subject|6
5174281|NCT01283139|17864927|P2|Overall Study|Withdrawal by Subject|8
5174282|NCT01283139|17864928|P1|Overall Study|Withdrawal by Subject|8
5174283|NCT01283139|17864925|P4|Overall Study|Lost to Follow-up|1
5174284|NCT01283139|17864926|P3|Overall Study|Lost to Follow-up|3
5174285|NCT01283139|17864927|P2|Overall Study|Lost to Follow-up|2
5174286|NCT01283139|17864928|P1|Overall Study|Lost to Follow-up|5
5174287|NCT01283035|17864970|P1|Overall Study|Subject later found ineligible|1
5174288|NCT01283009|17864987|P2|Overall Study|Patient Withdrawn by LAR/DPOA|4
5174289|NCT01283009|17864988|P1|Overall Study|Patient Withdrawn by LAR/DPOA|0
5174290|NCT01283009|17864987|P2|Overall Study|Lost to Follow-up|0
5174291|NCT01283009|17864988|P1|Overall Study|Lost to Follow-up|1
5174292|NCT01283009|17864987|P2|Overall Study|Physician Decision|1
5174293|NCT01283009|17864988|P1|Overall Study|Physician Decision|1
5174294|NCT01283009|17864987|P2|Overall Study|Withdrawal by Subject|8
5174295|NCT01283009|17864988|P1|Overall Study|Withdrawal by Subject|10
5174296|NCT01283009|17864987|P2|Overall Study|Study ended early|26
5174297|NCT01283009|17864988|P1|Overall Study|Study ended early|23
5174298|NCT01283009|17864987|P2|Overall Study|Death|78
5174299|NCT01283009|17864988|P1|Overall Study|Death|83
5174300|NCT01282866|17864994|P1|Overall Study|Adverse Event|1
5174301|NCT01282814|17865002|P2|Washout of 7 Days|Withdrawal by Subject|0
5174302|NCT01282814|17865003|P1|Washout of 7 Days|Withdrawal by Subject|2
5174303|NCT01282814|17865002|P2|First Intervention|Emesis During Dosing Interval|3
5174304|NCT01282814|17865003|P1|First Intervention|Emesis During Dosing Interval|0
5174305|NCT01282801|17865015|P2|Second Intervention|Emesis During Critical Breakfast|1
5174306|NCT01282801|17865016|P1|Second Intervention|Emesis During Critical Breakfast|0
5174307|NCT01282476|17865040|P1|Overall Study|Death|11
5174308|NCT01282463|17865049|P3|Overall Study|Physician Decision|0
5174309|NCT01282463|17865050|P2|Overall Study|Physician Decision|0
5174310|NCT01282463|17865051|P1|Overall Study|Physician Decision|1
5174311|NCT01282463|17865049|P3|Overall Study|Protocol Violation|1
5174312|NCT01282463|17865050|P2|Overall Study|Protocol Violation|0
5174313|NCT01282463|17865051|P1|Overall Study|Protocol Violation|0
5174314|NCT01282463|17865049|P3|Overall Study|"Never Treated PD"|0
5174315|NCT01282463|17865050|P2|Overall Study|"Never Treated PD"|1
5174316|NCT01282463|17865051|P1|Overall Study|"Never Treated PD"|0
5174317|NCT01282463|17865049|P3|Overall Study|"Never Treated Death"|0
5174318|NCT01282463|17865050|P2|Overall Study|"Never Treated Death"|1
5174319|NCT01282463|17865051|P1|Overall Study|"Never Treated Death"|0
5174320|NCT01282463|17865049|P3|Overall Study|Withdrawal by Subject|3
5174321|NCT01282463|17865050|P2|Overall Study|Withdrawal by Subject|2
5174322|NCT01282463|17865051|P1|Overall Study|Withdrawal by Subject|6
5174323|NCT01282463|17865049|P3|Overall Study|Lost to Follow-up|0
5174324|NCT01282463|17865050|P2|Overall Study|Lost to Follow-up|0
5174325|NCT01282463|17865051|P1|Overall Study|Lost to Follow-up|1
5174326|NCT01282424|17865089|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
5174327|NCT01282424|17865089|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
5174328|NCT01282424|17865089|P1|Long-term Follow-up Period (5 Years)|Death|40
5174329|NCT01282424|17865089|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
5174330|NCT01282424|17865089|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
5174331|NCT01282424|17865089|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
5174332|NCT01282424|17865089|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
5174333|NCT01282424|17865089|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
5174334|NCT01282372|17865106|P1|Overall Study|Adverse Event|12
5174335|NCT01282372|17865106|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
5174336|NCT01282372|17865106|P1|Overall Study|Presence of AE, Regression of Symptoms|1
5174337|NCT01282372|17865106|P1|Overall Study|Presence of AE, Lack of Efficacy|1
5174338|NCT01282372|17865106|P1|Overall Study|Death|1
5174339|NCT01282372|17865106|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
5174340|NCT01282372|17865106|P1|Overall Study|Withdrawal by Subject|11
5174341|NCT01282372|17865106|P1|Overall Study|Lost to Follow-up|23
5174342|NCT01282372|17865106|P1|Overall Study|Lack of Efficacy / Exacerbation|25
5174343|NCT01282294|17865134|P1|Overall Study|Physician Decision|1
5174344|NCT01282294|17865134|P1|Overall Study|Patient non-compliance|2
5174345|NCT01282294|17865134|P1|Overall Study|Adverse Event|1
5174346|NCT01282294|17865134|P1|Overall Study|Screening failure|1
5174347|NCT01282294|17865134|P1|Overall Study|Lost to Follow-up|14
5174348|NCT01282229|17865163|P1|Overall Study|Protocol Violation|2
5174349|NCT01282216|17865195|P4|Overall Study|Death|0
5174350|NCT01282216|17865196|P3|Overall Study|Death|2
5174351|NCT01282216|17865197|P2|Overall Study|Death|0
5174352|NCT01282216|17865198|P1|Overall Study|Death|0
5174353|NCT01282216|17865195|P4|Overall Study|Relapse|6
5174354|NCT01282216|17865196|P3|Overall Study|Relapse|17
5174355|NCT01282216|17865197|P2|Overall Study|Relapse|0
5174356|NCT01282216|17865198|P1|Overall Study|Relapse|0
5174357|NCT01282216|17865195|P4|Overall Study|Physician Decision|0
5174358|NCT01282216|17865196|P3|Overall Study|Physician Decision|11
5174359|NCT01282216|17865197|P2|Overall Study|Physician Decision|0
5174360|NCT01282216|17865198|P1|Overall Study|Physician Decision|0
5174361|NCT01282216|17865195|P4|Overall Study|Graft failure|2
5174362|NCT01282216|17865196|P3|Overall Study|Graft failure|3
5174363|NCT01282216|17865197|P2|Overall Study|Graft failure|0
5174364|NCT01282216|17865198|P1|Overall Study|Graft failure|0
5174365|NCT01282203|17865208|P1|Overall Study|Adverse Event|1
5174366|NCT01282164|17865230|P2|Overall Study|Lack of hypoglycemia during ITT|0
5174367|NCT01282164|17865231|P1|Overall Study|Lack of hypoglycemia during ITT|1
5174368|NCT01281969|17865284|P3|Overall Study|not randomized, child consent not given|2
5174369|NCT01281969|17865285|P2|Overall Study|not randomized, child consent not given|0
5174370|NCT01281969|17865286|P1|Overall Study|not randomized, child consent not given|0
5174371|NCT01281969|17865284|P3|Overall Study|AE during LP prior to IVIG admin|3
5174372|NCT01281969|17865285|P2|Overall Study|AE during LP prior to IVIG admin|0
5174373|NCT01281969|17865286|P1|Overall Study|AE during LP prior to IVIG admin|1
5174374|NCT01281969|17865284|P3|Overall Study|not randomized didn't meet criteria|7
5174375|NCT01281969|17865285|P2|Overall Study|not randomized didn't meet criteria|0
5174376|NCT01281969|17865286|P1|Overall Study|not randomized didn't meet criteria|0
5174377|NCT01281956|17865298|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
5174378|NCT01281956|17865299|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
5174379|NCT01281917|17865330|P1|Overall Study|Withdrawal by Subject|1
5174380|NCT01281865|17865342|P2|Overall Study|Lack of Efficacy|0
5174381|NCT01281865|17865343|P1|Overall Study|Lack of Efficacy|1
5174382|NCT01281865|17865342|P2|Overall Study|Withdrawal by Subject|0
5174383|NCT01281865|17865343|P1|Overall Study|Withdrawal by Subject|1
5174384|NCT01281865|17865342|P2|Overall Study|Adverse Event|1
5174385|NCT01281865|17865343|P1|Overall Study|Adverse Event|1
5174386|NCT01281839|17865351|P2|Overall Study|Reason not specified|1
5174387|NCT01281839|17865352|P1|Overall Study|Reason not specified|0
5174388|NCT01281839|17865351|P2|Overall Study|Withdrawal by Subject|10
5174389|NCT01281839|17865352|P1|Overall Study|Withdrawal by Subject|4
5174390|NCT01281839|17865351|P2|Overall Study|Lost to Follow-up|3
5174391|NCT01281839|17865352|P1|Overall Study|Lost to Follow-up|6
5174392|NCT01281644|17865413|P1|Overall Study|Withdrawal by Subject|2
5174393|NCT01281644|17865413|P1|Overall Study|Lost to Follow-up|3
5174394|NCT01281306|17865454|P7|Overall Study|Randomized in error|0
5174395|NCT01281306|17865455|P6|Overall Study|Randomized in error|0
5174396|NCT01281306|17865456|P5|Overall Study|Randomized in error|0
5174397|NCT01281306|17865457|P4|Overall Study|Randomized in error|1
5174398|NCT01281306|17865458|P3|Overall Study|Randomized in error|0
5174399|NCT01281306|17865459|P2|Overall Study|Randomized in error|0
5174400|NCT01281306|17865460|P1|Overall Study|Randomized in error|1
5174401|NCT01281306|17865454|P7|Overall Study|Adverse Event|3
5174402|NCT01281306|17865455|P6|Overall Study|Adverse Event|3
5174403|NCT01281306|17865456|P5|Overall Study|Adverse Event|5
5174404|NCT01281306|17865457|P4|Overall Study|Adverse Event|3
5174405|NCT01281306|17865458|P3|Overall Study|Adverse Event|2
5174406|NCT01281306|17865459|P2|Overall Study|Adverse Event|2
5174407|NCT01281306|17865460|P1|Overall Study|Adverse Event|3
5174408|NCT01281306|17865454|P7|Overall Study|Death|0
5174409|NCT01281306|17865455|P6|Overall Study|Death|0
5174410|NCT01281306|17865456|P5|Overall Study|Death|0
5174411|NCT01281306|17865457|P4|Overall Study|Death|0
5174412|NCT01281306|17865458|P3|Overall Study|Death|0
5174413|NCT01281306|17865459|P2|Overall Study|Death|0
5174414|NCT01281306|17865460|P1|Overall Study|Death|1
5174415|NCT01281306|17865454|P7|Overall Study|Lost to Follow-up|1
5174416|NCT01281306|17865455|P6|Overall Study|Lost to Follow-up|0
5174417|NCT01281306|17865456|P5|Overall Study|Lost to Follow-up|0
5174418|NCT01281306|17865457|P4|Overall Study|Lost to Follow-up|2
5174419|NCT01281306|17865458|P3|Overall Study|Lost to Follow-up|0
5174420|NCT01281306|17865459|P2|Overall Study|Lost to Follow-up|0
5174421|NCT01281306|17865460|P1|Overall Study|Lost to Follow-up|1
5174422|NCT01281306|17865454|P7|Overall Study|Condition no longer requires study drug|1
5174423|NCT01281306|17865455|P6|Overall Study|Condition no longer requires study drug|1
5174424|NCT01281306|17865456|P5|Overall Study|Condition no longer requires study drug|0
5174425|NCT01281306|17865457|P4|Overall Study|Condition no longer requires study drug|0
5174426|NCT01281306|17865458|P3|Overall Study|Condition no longer requires study drug|0
5174427|NCT01281306|17865459|P2|Overall Study|Condition no longer requires study drug|0
5174428|NCT01281306|17865460|P1|Overall Study|Condition no longer requires study drug|1
5174429|NCT01281306|17865454|P7|Overall Study|Protocol deviation|0
5174430|NCT01281306|17865455|P6|Overall Study|Protocol deviation|0
5174431|NCT01281306|17865456|P5|Overall Study|Protocol deviation|1
5174432|NCT01281306|17865457|P4|Overall Study|Protocol deviation|1
5174433|NCT01281306|17865458|P3|Overall Study|Protocol deviation|1
5174434|NCT01281306|17865459|P2|Overall Study|Protocol deviation|1
5174435|NCT01281306|17865460|P1|Overall Study|Protocol deviation|0
5174436|NCT01281306|17865454|P7|Overall Study|Withdrawal by Subject|1
5174437|NCT01281306|17865455|P6|Overall Study|Withdrawal by Subject|3
5174438|NCT01281306|17865456|P5|Overall Study|Withdrawal by Subject|1
5174439|NCT01281306|17865457|P4|Overall Study|Withdrawal by Subject|4
5174440|NCT01281306|17865458|P3|Overall Study|Withdrawal by Subject|2
5174441|NCT01281306|17865459|P2|Overall Study|Withdrawal by Subject|0
5174442|NCT01281306|17865460|P1|Overall Study|Withdrawal by Subject|1
5174443|NCT01281306|17865454|P7|Overall Study|Lack of Efficacy|1
5174444|NCT01281306|17865455|P6|Overall Study|Lack of Efficacy|0
5174445|NCT01281306|17865456|P5|Overall Study|Lack of Efficacy|2
5174446|NCT01281306|17865457|P4|Overall Study|Lack of Efficacy|0
5174447|NCT01281306|17865458|P3|Overall Study|Lack of Efficacy|3
5174448|NCT01281306|17865459|P2|Overall Study|Lack of Efficacy|1
5174449|NCT01281306|17865460|P1|Overall Study|Lack of Efficacy|0
5174450|NCT01281202|17865576|P2|Overall Study|Incarceration|3
5174451|NCT01281202|17865577|P1|Overall Study|Incarceration|0
5174452|NCT01281202|17865576|P2|Overall Study|Lost to Follow-up|13
5174453|NCT01281202|17865577|P1|Overall Study|Lost to Follow-up|11
5174454|NCT01281202|17865576|P2|Overall Study|Administrative|8
5174455|NCT01281202|17865577|P1|Overall Study|Administrative|2
5174456|NCT01281202|17865576|P2|Overall Study|Protocol Violation|10
5174457|NCT01281202|17865577|P1|Overall Study|Protocol Violation|11
5174458|NCT01281202|17865576|P2|Overall Study|Withdrawal by Subject|2
5174459|NCT01281202|17865577|P1|Overall Study|Withdrawal by Subject|2
5174460|NCT01281202|17865576|P2|Overall Study|Adverse Event|0
5174461|NCT01281202|17865577|P1|Overall Study|Adverse Event|2
5174462|NCT01281124|17865585|P1|Overall Study|Death|1
5174463|NCT01280981|17865600|P1|Overall Study|Study site closure|1
5174464|NCT01280981|17865600|P1|Overall Study|Elective surgery|2
5174465|NCT01280981|17865600|P1|Overall Study|Withdrawal of consent|3
5174466|NCT01280981|17865600|P1|Overall Study|Non-compliance with protocol|3
5174467|NCT01280981|17865600|P1|Overall Study|Failed to return|45
5174468|NCT01280981|17865600|P1|Overall Study|Irregular or discontinued menses|3
5174469|NCT01280981|17865600|P1|Overall Study|Adverse Event|6
5174470|NCT01280981|17865600|P1|Overall Study|Lost to Follow-up|3
5174471|NCT01280981|17865600|P1|Overall Study|Lack of Efficacy|13
5174472|NCT01280981|17865600|P1|Overall Study|Protocol Violation|2
5174473|NCT01280981|17865600|P1|Overall Study|Withdrawal by Subject|11
5174474|NCT01280968|17865611|P2|Overall Study|Unable to Smoke in Supine Position|0
5174475|NCT01280968|17865612|P1|Overall Study|Unable to Smoke in Supine Position|1
5174476|NCT01280968|17865611|P2|Overall Study|Pre-existing Neurological Condition|0
5174477|NCT01280968|17865612|P1|Overall Study|Pre-existing Neurological Condition|1
5174478|NCT01280968|17865611|P2|Overall Study|Scheduling Conflicts|1
5174479|NCT01280968|17865612|P1|Overall Study|Scheduling Conflicts|1
5174480|NCT01280968|17865611|P2|Overall Study|Adverse Event|0
5174481|NCT01280968|17865612|P1|Overall Study|Adverse Event|1
5174482|NCT01280968|17865611|P2|Overall Study|Anxiety|0
5174483|NCT01280968|17865612|P1|Overall Study|Anxiety|2
5174484|NCT01280968|17865611|P2|Overall Study|Commuting Problems|0
5174485|NCT01280968|17865612|P1|Overall Study|Commuting Problems|2
5174486|NCT01280968|17865611|P2|Overall Study|Unable to Follow Experimental Protocol|0
5174487|NCT01280968|17865612|P1|Overall Study|Unable to Follow Experimental Protocol|2
5174488|NCT01280968|17865611|P2|Overall Study|Lost to Follow-up|2
5174489|NCT01280968|17865612|P1|Overall Study|Lost to Follow-up|8
5174490|NCT01280955|17865628|P1|Overall Study|Withdrawal by Subject|1
5174491|NCT01280955|17865628|P1|Overall Study|Death|2
5174492|NCT01280903|17865672|P2|Overall Study|Lost to Follow-up|16
5174493|NCT01280903|17865673|P1|Overall Study|Lost to Follow-up|23
5174494|NCT01280812|17865740|P3|Overall Study|Lost to Follow-up|1
5174495|NCT01280812|17865741|P2|Overall Study|Lost to Follow-up|1
5174496|NCT01280812|17865742|P1|Overall Study|Lost to Follow-up|1
5174497|NCT01280812|17865740|P3|Overall Study|Withdrawal by Subject|0
5174498|NCT01280812|17865741|P2|Overall Study|Withdrawal by Subject|1
5174499|NCT01280812|17865742|P1|Overall Study|Withdrawal by Subject|2
5174500|NCT01280721|17865765|P1|Overall Study|No tolerability for the lowest dose|2
5174501|NCT01280721|17865765|P1|Overall Study|eGFR under the withdrawal criteria|7
5174502|NCT01280721|17865765|P1|Overall Study|Withdrawal by Subject|6
5174503|NCT01280721|17865765|P1|Overall Study|Physician Decision|3
5174504|NCT01280721|17865765|P1|Overall Study|Adverse Event|4
5174505|NCT01280656|17865829|P3|Overall Study|Other|7
5174506|NCT01280656|17865830|P2|Overall Study|Other|7
5174507|NCT01280656|17865831|P1|Overall Study|Other|1
5174508|NCT01280656|17865829|P3|Overall Study|Treatment shortening (RGT)|5
5174509|NCT01280656|17865830|P2|Overall Study|Treatment shortening (RGT)|4
5174510|NCT01280656|17865831|P1|Overall Study|Treatment shortening (RGT)|0
5174511|NCT01280656|17865829|P3|Overall Study|Lack of Efficacy|38
5174512|NCT01280656|17865830|P2|Overall Study|Lack of Efficacy|22
5174513|NCT01280656|17865831|P1|Overall Study|Lack of Efficacy|1
5174514|NCT01280656|17865829|P3|Overall Study|Adverse Event|13
5174515|NCT01280656|17865830|P2|Overall Study|Adverse Event|14
5174516|NCT01280656|17865831|P1|Overall Study|Adverse Event|1
5174517|NCT01280591|17865898|P4|Overall Study|Does not meet exclusion #27 criteria|1
5174518|NCT01280591|17865899|P3|Overall Study|Does not meet exclusion #27 criteria|0
5174519|NCT01280591|17865900|P2|Overall Study|Does not meet exclusion #27 criteria|0
5174520|NCT01280591|17865901|P1|Overall Study|Does not meet exclusion #27 criteria|0
5174521|NCT01280591|17865898|P4|Overall Study|Withdrawal by Subject|2
5174522|NCT01280591|17865899|P3|Overall Study|Withdrawal by Subject|0
5174523|NCT01280591|17865900|P2|Overall Study|Withdrawal by Subject|0
5174524|NCT01280591|17865901|P1|Overall Study|Withdrawal by Subject|0
5174525|NCT01280357|17866039|P1|Overall Study|IInsufficient data/No data supplied|12
5174526|NCT01280357|17866039|P1|Overall Study|Excluded no internal monitoring|14
5174527|NCT01280266|17866048|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
5174528|NCT01280266|17866049|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
5174529|NCT01280266|17866048|P2|First Intervention (Week 1-4)|Adverse Event|0
5174530|NCT01280266|17866049|P1|First Intervention (Week 1-4)|Adverse Event|1
5174531|NCT01279954|17866140|P2|Overall Study|Lack of Efficacy|4
5174532|NCT01279954|17866141|P1|Overall Study|Lack of Efficacy|3
5174533|NCT01279850|17866152|P1|Overall Study|No Visit After Treatment|34
5174534|NCT01279850|17866152|P1|Overall Study|No Drug Administration Information|7
5174535|NCT01279850|17866152|P1|Overall Study|Protocol Violation|50
5174536|NCT01279681|17866168|P2|Overall Study|Other Reason|2
5174537|NCT01279681|17866169|P1|Overall Study|Other Reason|0
5174538|NCT01279681|17866168|P2|Overall Study|Physician Decision|0
5174539|NCT01279681|17866169|P1|Overall Study|Physician Decision|1
5174540|NCT01279681|17866168|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
5174541|NCT01279681|17866169|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
5174542|NCT01279681|17866168|P2|Overall Study|Death|1
5174543|NCT01279681|17866169|P1|Overall Study|Death|0
5174544|NCT01279681|17866168|P2|Overall Study|Adverse Event|3
5174545|NCT01279681|17866169|P1|Overall Study|Adverse Event|2
5174546|NCT01279681|17866168|P2|Overall Study|Withdrawal by Subject|4
5174547|NCT01279681|17866169|P1|Overall Study|Withdrawal by Subject|3
5174548|NCT01279681|17866168|P2|Overall Study|Disease Progression|6
5174549|NCT01279681|17866169|P1|Overall Study|Disease Progression|9
5174550|NCT01279616|17866181|P1|Overall Study|no signs of sickle cell disease|2
5174551|NCT01279616|17866181|P1|Overall Study|donor could not be located|5
5174552|NCT01279486|17866194|P1|Overall Study|Lost to Follow-up|1
5174553|NCT01279447|17866200|P2|Overall Study|Lost to Follow-up|1
5174554|NCT01279447|17866201|P1|Overall Study|Lost to Follow-up|3
5174555|NCT01279343|17866209|P2|Overall Study|Did not receive treatment|6
5174556|NCT01279343|17866210|P1|Overall Study|Did not receive treatment|2
5174557|NCT01279200|17866255|P2|Overall Study|Adverse Event|0
5174558|NCT01279200|17866256|P1|Overall Study|Adverse Event|1
5174559|NCT01279200|17866255|P2|Overall Study|Lost to Follow-up|1
5174560|NCT01279200|17866256|P1|Overall Study|Lost to Follow-up|0
5174561|NCT01279200|17866255|P2|Overall Study|ultrasound screening failure|1
5174562|NCT01279200|17866256|P1|Overall Study|ultrasound screening failure|0
5174563|NCT01279200|17866255|P2|Overall Study|Inconvenience of ultrasound visit|1
5174564|NCT01279200|17866256|P1|Overall Study|Inconvenience of ultrasound visit|0
5174565|NCT01279200|17866255|P2|Overall Study|Patient withdrawal due to high cost|1
5174566|NCT01279200|17866256|P1|Overall Study|Patient withdrawal due to high cost|0
5174567|NCT01279200|17866255|P2|Overall Study|Withdrawal by Subject|3
5174568|NCT01279200|17866256|P1|Overall Study|Withdrawal by Subject|1
5174569|NCT01279070|17866294|P2|Overall Study|Acute exacerbation|1
5174570|NCT01279070|17866295|P1|Overall Study|Acute exacerbation|3
5174571|NCT01279070|17866294|P2|Overall Study|Withdrawal by Subject|3
5174572|NCT01279070|17866295|P1|Overall Study|Withdrawal by Subject|2
5174573|NCT01279044|17866314|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
5174574|NCT01279044|17866315|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
5174575|NCT01279044|17866316|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
5174576|NCT01279044|17866314|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
5174577|NCT01279044|17866315|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
5174578|NCT01279044|17866316|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
5174579|NCT01279044|17866314|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
5174580|NCT01279044|17866315|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
5174581|NCT01279044|17866316|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
5174582|NCT01278862|17866392|P2|Overall Study|Lost to Follow-up|1
5174583|NCT01278862|17866393|P1|Overall Study|Lost to Follow-up|1
5174584|NCT01278797|17866401|P2|Period 1|Protocol Violation|0
5174585|NCT01278797|17866402|P1|Period 1|Protocol Violation|1
5174586|NCT01278797|17866401|P2|Period 1|Adverse Event|1
5174587|NCT01278797|17866402|P1|Period 1|Adverse Event|0
5174588|NCT01278745|17866414|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
5174589|NCT01278745|17866415|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
5174590|NCT01278745|17866416|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
5174591|NCT01278745|17866417|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
5174592|NCT01278745|17866414|P4|Overall Study|Ineligible|61
5174593|NCT01278745|17866415|P3|Overall Study|Ineligible|42
5174594|NCT01278745|17866416|P2|Overall Study|Ineligible|0
5174595|NCT01278745|17866417|P1|Overall Study|Ineligible|0
5174596|NCT01278745|17866414|P4|Overall Study|Sponsor Decision|6
5174597|NCT01278745|17866415|P3|Overall Study|Sponsor Decision|62
5174598|NCT01278745|17866416|P2|Overall Study|Sponsor Decision|0
5174599|NCT01278745|17866417|P1|Overall Study|Sponsor Decision|1
5174600|NCT01278745|17866414|P4|Overall Study|Withdrawal by Subject|1
5174601|NCT01278745|17866415|P3|Overall Study|Withdrawal by Subject|5
5174602|NCT01278745|17866416|P2|Overall Study|Withdrawal by Subject|1
5174603|NCT01278745|17866417|P1|Overall Study|Withdrawal by Subject|1
5174604|NCT01278745|17866414|P4|Overall Study|Physician Decision|9
5174605|NCT01278745|17866415|P3|Overall Study|Physician Decision|0
5174606|NCT01278745|17866416|P2|Overall Study|Physician Decision|0
5174607|NCT01278745|17866417|P1|Overall Study|Physician Decision|1
5174608|NCT01278745|17866414|P4|Overall Study|Death|0
5174609|NCT01278745|17866415|P3|Overall Study|Death|7
5174610|NCT01278745|17866416|P2|Overall Study|Death|5
5174611|NCT01278745|17866417|P1|Overall Study|Death|2
5174612|NCT01278615|17866449|P1|Overall Study|Withdrawal by Subject|2
5174613|NCT01278407|17866475|P5|Extension Phase|Other|3
5174614|NCT01278407|17866476|P4|Extension Phase|Other|1
5174615|NCT01278407|17866477|P3|Extension Phase|Other|0
5174616|NCT01278407|17866478|P2|Extension Phase|Other|0
5174617|NCT01278407|17866479|P1|Extension Phase|Other|0
5174618|NCT01278407|17866475|P5|Extension Phase|Participant's Choice|11
5174619|NCT01278407|17866476|P4|Extension Phase|Participant's Choice|4
5174620|NCT01278407|17866477|P3|Extension Phase|Participant's Choice|0
5174621|NCT01278407|17866478|P2|Extension Phase|Participant's Choice|0
5174622|NCT01278407|17866479|P1|Extension Phase|Participant's Choice|0
5174623|NCT01278407|17866475|P5|Extension Phase|Adverse Event|16
5174624|NCT01278407|17866476|P4|Extension Phase|Adverse Event|7
5174625|NCT01278407|17866477|P3|Extension Phase|Adverse Event|0
5174626|NCT01278407|17866478|P2|Extension Phase|Adverse Event|0
5174627|NCT01278407|17866479|P1|Extension Phase|Adverse Event|0
5174628|NCT01278407|17866475|P5|Confirmatory Phase|Other|0
5174629|NCT01278407|17866476|P4|Confirmatory Phase|Other|0
5174630|NCT01278407|17866477|P3|Confirmatory Phase|Other|2
5174631|NCT01278407|17866478|P2|Confirmatory Phase|Other|1
5174632|NCT01278407|17866479|P1|Confirmatory Phase|Other|1
5174633|NCT01278407|17866475|P5|Confirmatory Phase|Participant's Choice|0
5174634|NCT01278407|17866476|P4|Confirmatory Phase|Participant's Choice|0
5174635|NCT01278407|17866477|P3|Confirmatory Phase|Participant's Choice|3
5174636|NCT01278407|17866478|P2|Confirmatory Phase|Participant's Choice|5
5174637|NCT01278407|17866479|P1|Confirmatory Phase|Participant's Choice|3
5174638|NCT01278407|17866475|P5|Confirmatory Phase|Adverse Event|0
5174639|NCT01278407|17866476|P4|Confirmatory Phase|Adverse Event|0
5174640|NCT01278407|17866477|P3|Confirmatory Phase|Adverse Event|1
5174641|NCT01278407|17866478|P2|Confirmatory Phase|Adverse Event|10
5174642|NCT01278407|17866479|P1|Confirmatory Phase|Adverse Event|5
5174643|NCT01278394|17866492|P1|Overall Study|Lost to Follow-up|1
5174644|NCT01278342|17866505|P3|Overall Study|Other|0
5174645|NCT01278342|17866506|P2|Overall Study|Other|0
5174646|NCT01278342|17866507|P1|Overall Study|Other|1
5174647|NCT01278342|17866505|P3|Overall Study|Administrative problems|0
5174648|NCT01278342|17866506|P2|Overall Study|Administrative problems|0
5174649|NCT01278342|17866507|P1|Overall Study|Administrative problems|2
5174650|NCT01278342|17866505|P3|Overall Study|Lost to Follow-up|0
5174651|NCT01278342|17866506|P2|Overall Study|Lost to Follow-up|0
5174652|NCT01278342|17866507|P1|Overall Study|Lost to Follow-up|1
5174653|NCT01278342|17866505|P3|Overall Study|Physician Decision|0
5174654|NCT01278342|17866506|P2|Overall Study|Physician Decision|1
5174655|NCT01278342|17866507|P1|Overall Study|Physician Decision|0
5174656|NCT01278173|17866527|P1|Overall Study|Withdrawal by Subject|1
5174657|NCT01278173|17866527|P1|Overall Study|Protocol Violation|1
5174658|NCT01278173|17866527|P1|Overall Study|Administrative or other reason|4
5174659|NCT01278173|17866527|P1|Overall Study|Adverse Event|8
5174660|NCT01278173|17866527|P1|Overall Study|Lack of Efficacy|13
5174661|NCT01278160|17866534|P2|Overall Study|Unclassified|2
5174662|NCT01278160|17866535|P1|Overall Study|Unclassified|1
5174663|NCT01278160|17866534|P2|Overall Study|Withdrawal by Subject|2
5174664|NCT01278160|17866535|P1|Overall Study|Withdrawal by Subject|3
5174665|NCT01278160|17866534|P2|Overall Study|Lost to Follow-up|1
5174666|NCT01278160|17866535|P1|Overall Study|Lost to Follow-up|0
5174667|NCT01278160|17866534|P2|Overall Study|Adverse Event|1
5174668|NCT01278160|17866535|P1|Overall Study|Adverse Event|1
5174669|NCT01278030|17866551|P2|Overall Study|Withdrawal by Subject|4
5174670|NCT01278030|17866552|P1|Overall Study|Withdrawal by Subject|8
5174671|NCT01277887|17866560|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
5174672|NCT01277887|17866561|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
5174673|NCT01277887|17866560|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
5174674|NCT01277887|17866561|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
5174675|NCT01277887|17866560|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
5174676|NCT01277887|17866561|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
5174677|NCT01277861|17866573|P2|Overall Study|Physician Decision|2
5174678|NCT01277861|17866574|P1|Overall Study|Physician Decision|2
5174679|NCT01277822|17866586|P2|Overall Study|Participant moved|0
5174680|NCT01277822|17866587|P1|Overall Study|Participant moved|1
5174681|NCT01277822|17866586|P2|Overall Study|Contraindicated medication used|1
5174682|NCT01277822|17866587|P1|Overall Study|Contraindicated medication used|2
5174683|NCT01277822|17866586|P2|Overall Study|Lost to Follow-up|1
5174684|NCT01277822|17866587|P1|Overall Study|Lost to Follow-up|2
5174685|NCT01277822|17866586|P2|Overall Study|Protocol Violation|0
5174686|NCT01277822|17866587|P1|Overall Study|Protocol Violation|1
5174687|NCT01277822|17866586|P2|Overall Study|Physician Decision|1
5174688|NCT01277822|17866587|P1|Overall Study|Physician Decision|1
5174689|NCT01277822|17866586|P2|Overall Study|Withdrawal by Subject|7
5174690|NCT01277822|17866587|P1|Overall Study|Withdrawal by Subject|6
5174691|NCT01277822|17866586|P2|Overall Study|Adverse Event|1
5174692|NCT01277822|17866587|P1|Overall Study|Adverse Event|2
5174693|NCT01277757|17866623|P1|Overall Study|Withdrawal by Subject|1
5174694|NCT01277757|17866623|P1|Overall Study|Disease Progression|1
5174695|NCT01277744|17866630|P1|Overall Study|Physician Decision|2
5174696|NCT01277718|17866635|P2|Period 2 - Second Intervention|Physician Decision|2
5174697|NCT01277718|17866636|P1|Period 2 - Second Intervention|Physician Decision|0
5174698|NCT01277718|17866635|P2|Period 2 - Second Intervention|Protocol Violation|1
5174699|NCT01277718|17866636|P1|Period 2 - Second Intervention|Protocol Violation|0
5174700|NCT01277666|17866650|P3|Overall Study|Death|1
5174701|NCT01277666|17866651|P2|Overall Study|Death|0
5174702|NCT01277666|17866652|P1|Overall Study|Death|0
5174703|NCT01277666|17866650|P3|Overall Study|Withdrawal by Subject|6
5174704|NCT01277666|17866651|P2|Overall Study|Withdrawal by Subject|8
5174705|NCT01277666|17866652|P1|Overall Study|Withdrawal by Subject|7
5174706|NCT01277666|17866650|P3|Overall Study|Lost to Follow-up|2
5174707|NCT01277666|17866651|P2|Overall Study|Lost to Follow-up|1
5174708|NCT01277666|17866652|P1|Overall Study|Lost to Follow-up|1
5174709|NCT01277666|17866650|P3|Overall Study|Protocol Defined Stopping criteria|6
5174710|NCT01277666|17866651|P2|Overall Study|Protocol Defined Stopping criteria|2
5174711|NCT01277666|17866652|P1|Overall Study|Protocol Defined Stopping criteria|1
5174712|NCT01277666|17866650|P3|Overall Study|Protocol Violation|2
5174713|NCT01277666|17866651|P2|Overall Study|Protocol Violation|3
5174714|NCT01277666|17866652|P1|Overall Study|Protocol Violation|2
5174715|NCT01277666|17866650|P3|Overall Study|Lack of Efficacy|12
5174716|NCT01277666|17866651|P2|Overall Study|Lack of Efficacy|20
5174717|NCT01277666|17866652|P1|Overall Study|Lack of Efficacy|8
5174718|NCT01277666|17866650|P3|Overall Study|Adverse Event|20
5174719|NCT01277666|17866651|P2|Overall Study|Adverse Event|25
5174720|NCT01277666|17866652|P1|Overall Study|Adverse Event|26
5174721|NCT01277601|17866685|P4|Overall Study|Subject Terminated from Study by Sponsor|2
5174722|NCT01277601|17866686|P3|Overall Study|Subject Terminated from Study by Sponsor|0
5174723|NCT01277601|17866687|P2|Overall Study|Subject Terminated from Study by Sponsor|1
5174724|NCT01277601|17866688|P1|Overall Study|Subject Terminated from Study by Sponsor|0
5174725|NCT01277601|17866685|P4|Overall Study|Protocol Violation|0
5174726|NCT01277601|17866686|P3|Overall Study|Protocol Violation|5
5174727|NCT01277601|17866687|P2|Overall Study|Protocol Violation|2
5174728|NCT01277601|17866688|P1|Overall Study|Protocol Violation|0
5174729|NCT01277601|17866685|P4|Overall Study|Subject Never Dosed with Study Drug|1
5174730|NCT01277601|17866686|P3|Overall Study|Subject Never Dosed with Study Drug|3
5174731|NCT01277601|17866687|P2|Overall Study|Subject Never Dosed with Study Drug|2
5174732|NCT01277601|17866688|P1|Overall Study|Subject Never Dosed with Study Drug|1
5174733|NCT01277601|17866685|P4|Overall Study|Noncompliance with Study Drug|0
5174734|NCT01277601|17866686|P3|Overall Study|Noncompliance with Study Drug|2
5174735|NCT01277601|17866687|P2|Overall Study|Noncompliance with Study Drug|3
5174736|NCT01277601|17866688|P1|Overall Study|Noncompliance with Study Drug|1
5174737|NCT01277601|17866685|P4|Overall Study|Pregnancy|1
5174738|NCT01277601|17866686|P3|Overall Study|Pregnancy|4
5174739|NCT01277601|17866687|P2|Overall Study|Pregnancy|2
5174740|NCT01277601|17866688|P1|Overall Study|Pregnancy|2
5174741|NCT01277601|17866685|P4|Overall Study|Physician Decision|6
5174742|NCT01277601|17866686|P3|Overall Study|Physician Decision|1
5174743|NCT01277601|17866687|P2|Overall Study|Physician Decision|5
5174744|NCT01277601|17866688|P1|Overall Study|Physician Decision|3
5174745|NCT01277601|17866685|P4|Overall Study|Lost to Follow-up|2
5174746|NCT01277601|17866686|P3|Overall Study|Lost to Follow-up|4
5174747|NCT01277601|17866687|P2|Overall Study|Lost to Follow-up|9
5174748|NCT01277601|17866688|P1|Overall Study|Lost to Follow-up|7
5174749|NCT01277601|17866685|P4|Overall Study|Withdrawal by Subject|17
5174750|NCT01277601|17866686|P3|Overall Study|Withdrawal by Subject|8
5174751|NCT01277601|17866687|P2|Overall Study|Withdrawal by Subject|21
5174752|NCT01277601|17866688|P1|Overall Study|Withdrawal by Subject|18
5174753|NCT01277601|17866685|P4|Overall Study|Adverse Event|7
5174754|NCT01277601|17866686|P3|Overall Study|Adverse Event|0
5174755|NCT01277601|17866687|P2|Overall Study|Adverse Event|3
5174756|NCT01277601|17866688|P1|Overall Study|Adverse Event|5
5174757|NCT01277549|17866779|P2|Overall Study|Physician Decision|1
5174758|NCT01277549|17866780|P1|Overall Study|Physician Decision|2
5174759|NCT01277549|17866779|P2|Overall Study|Protocol Violation|1
5174760|NCT01277549|17866780|P1|Overall Study|Protocol Violation|10
5174761|NCT01277549|17866779|P2|Overall Study|Withdrawal by Subject|3
5174762|NCT01277549|17866780|P1|Overall Study|Withdrawal by Subject|1
5174763|NCT01277549|17866779|P2|Overall Study|Failed to meet eligibility criteria|9
5174764|NCT01277549|17866780|P1|Overall Study|Failed to meet eligibility criteria|13
5174765|NCT01277523|17866797|P3|Overall Study|Other Reason not Defined|0
5174766|NCT01277523|17866798|P2|Overall Study|Other Reason not Defined|1
5174767|NCT01277523|17866799|P1|Overall Study|Other Reason not Defined|0
5174768|NCT01277523|17866797|P3|Overall Study|Protocol Violation|0
5174769|NCT01277523|17866798|P2|Overall Study|Protocol Violation|0
5174770|NCT01277523|17866799|P1|Overall Study|Protocol Violation|2
5174771|NCT01277523|17866797|P3|Overall Study|Adverse Event|0
5174772|NCT01277523|17866798|P2|Overall Study|Adverse Event|0
5174773|NCT01277523|17866799|P1|Overall Study|Adverse Event|1
5174774|NCT01277510|17866851|P2|Open-label Phase|Never received investigational product|0
5174775|NCT01277510|17866852|P1|Open-label Phase|Never received investigational product|2
5174776|NCT01277510|17866851|P2|Open-label Phase|Protocol-specified criteria|0
5174777|NCT01277510|17866852|P1|Open-label Phase|Protocol-specified criteria|1
5174778|NCT01277510|17866851|P2|Open-label Phase|Administrative decision|3
5174779|NCT01277510|17866852|P1|Open-label Phase|Administrative decision|4
5174780|NCT01277510|17866851|P2|Double-blind Phase|Other|1
5174781|NCT01277510|17866852|P1|Double-blind Phase|Other|1
5174782|NCT01277510|17866851|P2|Double-blind Phase|Protocol-specified criteria|6
5174783|NCT01277510|17866852|P1|Double-blind Phase|Protocol-specified criteria|2
5174784|NCT01277510|17866851|P2|Double-blind Phase|Death|1
5174785|NCT01277510|17866852|P1|Double-blind Phase|Death|0
5174786|NCT01277510|17866851|P2|Double-blind Phase|Administrative decision|9
5174787|NCT01277510|17866852|P1|Double-blind Phase|Administrative decision|7
5174788|NCT01277510|17866851|P2|Double-blind Phase|Withdrawal by Subject|0
5174789|NCT01277510|17866852|P1|Double-blind Phase|Withdrawal by Subject|2
5174790|NCT01277510|17866851|P2|Double-blind Phase|Adverse Event|0
5174791|NCT01277510|17866852|P1|Double-blind Phase|Adverse Event|1
5174792|NCT01277510|17866851|P2|Double-blind Phase|Non-compliance|1
5174793|NCT01277510|17866852|P1|Double-blind Phase|Non-compliance|0
5174794|NCT01277302|17866903|P3|8-Month Alternate Dose Regimen Period|Relocation|1
5174795|NCT01277302|17866904|P2|8-Month Alternate Dose Regimen Period|Relocation|0
5174796|NCT01277302|17866905|P1|8-Month Alternate Dose Regimen Period|Relocation|1
5174797|NCT01277302|17866903|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
5174798|NCT01277302|17866904|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
5174799|NCT01277302|17866905|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
5174800|NCT01277302|17866903|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
5174801|NCT01277302|17866904|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
5174802|NCT01277302|17866905|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
5174803|NCT01277302|17866903|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
5174804|NCT01277302|17866904|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
5174805|NCT01277302|17866905|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
5174806|NCT01277302|17866903|P3|8-Month Alternate Dose Regimen Period|Death|0
5174807|NCT01277302|17866904|P2|8-Month Alternate Dose Regimen Period|Death|1
5174808|NCT01277302|17866905|P1|8-Month Alternate Dose Regimen Period|Death|0
5174809|NCT01277302|17866903|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
5174810|NCT01277302|17866904|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
5174811|NCT01277302|17866905|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
5174812|NCT01277302|17866903|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
5174813|NCT01277302|17866904|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
5174814|NCT01277302|17866905|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
5174815|NCT01277302|17866903|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
5174816|NCT01277302|17866904|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
5174817|NCT01277302|17866905|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
5174818|NCT01277302|17866903|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
5174819|NCT01277302|17866904|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
5174820|NCT01277302|17866905|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
5174821|NCT01277211|17866937|P2|Overall Study|Discontinued prior to treatment|13
5174822|NCT01277211|17866938|P1|Overall Study|Discontinued prior to treatment|24
5174823|NCT01277211|17866937|P2|Overall Study|Pregnancy wish|2
5174824|NCT01277211|17866938|P1|Overall Study|Pregnancy wish|0
5174825|NCT01277211|17866937|P2|Overall Study|Administrative|0
5174826|NCT01277211|17866938|P1|Overall Study|Administrative|3
5174827|NCT01277211|17866937|P2|Overall Study|Did not meet protocol eligibility|0
5174828|NCT01277211|17866938|P1|Overall Study|Did not meet protocol eligibility|1
5174829|NCT01277211|17866937|P2|Overall Study|Non-compliance with protocol|4
5174830|NCT01277211|17866938|P1|Overall Study|Non-compliance with protocol|13
5174831|NCT01277211|17866937|P2|Overall Study|Withdrew Consent|9
5174832|NCT01277211|17866938|P1|Overall Study|Withdrew Consent|9
5174833|NCT01277211|17866937|P2|Overall Study|Did not wish to continue|0
5174834|NCT01277211|17866938|P1|Overall Study|Did not wish to continue|17
5174835|NCT01277211|17866937|P2|Overall Study|Lost to Follow-up|9
5174836|NCT01277211|17866938|P1|Overall Study|Lost to Follow-up|14
5174837|NCT01277211|17866937|P2|Overall Study|Pregnancy|4
5174838|NCT01277211|17866938|P1|Overall Study|Pregnancy|9
5174839|NCT01277211|17866937|P2|Overall Study|Adverse Event|22
5174840|NCT01277211|17866938|P1|Overall Study|Adverse Event|60
5174841|NCT01277042|17866990|P2|Overall Study|Withdrawal by Subject|0
5174842|NCT01277042|17866991|P1|Overall Study|Withdrawal by Subject|2
5174843|NCT01277042|17866990|P2|Overall Study|Lost to Follow-up|2
5174844|NCT01277042|17866991|P1|Overall Study|Lost to Follow-up|2
5174845|NCT01277042|17866990|P2|Overall Study|Adverse Event|3
5174846|NCT01277042|17866991|P1|Overall Study|Adverse Event|4
5174847|NCT01276847|17867027|P3|Overall Study|Withdrawal by Subject|0
5174848|NCT01276847|17867028|P2|Overall Study|Withdrawal by Subject|0
5174849|NCT01276847|17867029|P1|Overall Study|Withdrawal by Subject|1
5174850|NCT01276821|17867039|P2|Overall Study|Protocol Violation|1
5174851|NCT01276821|17867040|P1|Overall Study|Protocol Violation|0
5174852|NCT01276756|17867060|P2|Overall Study|Adverse Event|2
5174853|NCT01276756|17867061|P1|Overall Study|Adverse Event|3
5174854|NCT01276756|17867060|P2|Overall Study|Lost to Follow-up|0
5174855|NCT01276756|17867061|P1|Overall Study|Lost to Follow-up|2
5174856|NCT01276639|17867106|P5|Week 16 to 52|Other|3
5174857|NCT01276639|17867107|P4|Week 16 to 52|Other|1
5174858|NCT01276639|17867108|P3|Week 16 to 52|Other|0
5174859|NCT01276639|17867109|P2|Week 16 to 52|Other|12
5174860|NCT01276639|17867110|P1|Week 16 to 52|Other|10
5174861|NCT01276639|17867106|P5|Week 16 to 52|Withdrawal by Subject|1
5174862|NCT01276639|17867107|P4|Week 16 to 52|Withdrawal by Subject|0
5174863|NCT01276639|17867108|P3|Week 16 to 52|Withdrawal by Subject|0
5174864|NCT01276639|17867109|P2|Week 16 to 52|Withdrawal by Subject|4
5174865|NCT01276639|17867110|P1|Week 16 to 52|Withdrawal by Subject|4
5174866|NCT01276639|17867106|P5|Week 16 to 52|Lost to Follow-up|1
5174867|NCT01276639|17867107|P4|Week 16 to 52|Lost to Follow-up|0
5174868|NCT01276639|17867108|P3|Week 16 to 52|Lost to Follow-up|0
5174869|NCT01276639|17867109|P2|Week 16 to 52|Lost to Follow-up|1
5174870|NCT01276639|17867110|P1|Week 16 to 52|Lost to Follow-up|3
5174871|NCT01276639|17867106|P5|Week 16 to 52|Lack of Efficacy|13
5174872|NCT01276639|17867107|P4|Week 16 to 52|Lack of Efficacy|14
5174873|NCT01276639|17867108|P3|Week 16 to 52|Lack of Efficacy|0
5174874|NCT01276639|17867109|P2|Week 16 to 52|Lack of Efficacy|71
5174875|NCT01276639|17867110|P1|Week 16 to 52|Lack of Efficacy|99
5174876|NCT01276639|17867106|P5|Week 16 to 52|Adverse Event|3
5174877|NCT01276639|17867107|P4|Week 16 to 52|Adverse Event|1
5174878|NCT01276639|17867108|P3|Week 16 to 52|Adverse Event|0
5174879|NCT01276639|17867109|P2|Week 16 to 52|Adverse Event|13
5174880|NCT01276639|17867110|P1|Week 16 to 52|Adverse Event|10
5174881|NCT01276639|17867106|P5|Week 16 to 52|Death|0
5174882|NCT01276639|17867107|P4|Week 16 to 52|Death|0
5174883|NCT01276639|17867108|P3|Week 16 to 52|Death|0
5174884|NCT01276639|17867109|P2|Week 16 to 52|Death|0
5174885|NCT01276639|17867110|P1|Week 16 to 52|Death|1
5174886|NCT01276639|17867106|P5|Week 0 to 16|Randomized, But Not Treated|0
5174887|NCT01276639|17867107|P4|Week 0 to 16|Randomized, But Not Treated|0
5174888|NCT01276639|17867108|P3|Week 0 to 16|Randomized, But Not Treated|0
5174889|NCT01276639|17867109|P2|Week 0 to 16|Randomized, But Not Treated|1
5174890|NCT01276639|17867110|P1|Week 0 to 16|Randomized, But Not Treated|0
5174891|NCT01276639|17867106|P5|Week 0 to 16|Other|0
5174892|NCT01276639|17867107|P4|Week 0 to 16|Other|0
5174893|NCT01276639|17867108|P3|Week 0 to 16|Other|2
5174894|NCT01276639|17867109|P2|Week 0 to 16|Other|7
5174895|NCT01276639|17867110|P1|Week 0 to 16|Other|7
5174896|NCT01276639|17867106|P5|Week 0 to 16|Withdrawal by Subject|0
5174897|NCT01276639|17867107|P4|Week 0 to 16|Withdrawal by Subject|0
5174898|NCT01276639|17867108|P3|Week 0 to 16|Withdrawal by Subject|4
5174899|NCT01276639|17867109|P2|Week 0 to 16|Withdrawal by Subject|5
5174900|NCT01276639|17867110|P1|Week 0 to 16|Withdrawal by Subject|8
5174901|NCT01276639|17867106|P5|Week 0 to 16|Lost to Follow-up|0
5174902|NCT01276639|17867107|P4|Week 0 to 16|Lost to Follow-up|0
5174903|NCT01276639|17867108|P3|Week 0 to 16|Lost to Follow-up|3
5174904|NCT01276639|17867109|P2|Week 0 to 16|Lost to Follow-up|5
5174905|NCT01276639|17867110|P1|Week 0 to 16|Lost to Follow-up|3
5174906|NCT01276639|17867106|P5|Week 0 to 16|Lack of Efficacy|0
5174907|NCT01276639|17867107|P4|Week 0 to 16|Lack of Efficacy|0
5174908|NCT01276639|17867108|P3|Week 0 to 16|Lack of Efficacy|25
5174909|NCT01276639|17867109|P2|Week 0 to 16|Lack of Efficacy|15
5174910|NCT01276639|17867110|P1|Week 0 to 16|Lack of Efficacy|20
5174911|NCT01276639|17867106|P5|Week 0 to 16|Adverse Event|0
5174912|NCT01276639|17867107|P4|Week 0 to 16|Adverse Event|0
5174913|NCT01276639|17867108|P3|Week 0 to 16|Adverse Event|11
5174914|NCT01276639|17867109|P2|Week 0 to 16|Adverse Event|8
5174915|NCT01276639|17867110|P1|Week 0 to 16|Adverse Event|11
5174916|NCT01276639|17867106|P5|Week 0 to 16|Death|0
5174917|NCT01276639|17867107|P4|Week 0 to 16|Death|0
5174918|NCT01276639|17867108|P3|Week 0 to 16|Death|0
5174919|NCT01276639|17867109|P2|Week 0 to 16|Death|0
5174920|NCT01276639|17867110|P1|Week 0 to 16|Death|1
5174921|NCT01276509|17867315|P4|Overall Study|Other|0
5174922|NCT01276509|17867316|P3|Overall Study|Other|0
5174923|NCT01276509|17867317|P2|Overall Study|Other|1
5174924|NCT01276509|17867318|P1|Overall Study|Other|0
5174925|NCT01276509|17867315|P4|Overall Study|Withdrawal by Subject|0
5174926|NCT01276509|17867316|P3|Overall Study|Withdrawal by Subject|0
5174927|NCT01276509|17867317|P2|Overall Study|Withdrawal by Subject|2
5174928|NCT01276509|17867318|P1|Overall Study|Withdrawal by Subject|1
5174929|NCT01276509|17867315|P4|Overall Study|Pregnancy|0
5174930|NCT01276509|17867316|P3|Overall Study|Pregnancy|0
5174931|NCT01276509|17867317|P2|Overall Study|Pregnancy|0
5174932|NCT01276509|17867318|P1|Overall Study|Pregnancy|1
5174933|NCT01276509|17867315|P4|Overall Study|Lack of Efficacy|2
5174934|NCT01276509|17867316|P3|Overall Study|Lack of Efficacy|1
5174935|NCT01276509|17867317|P2|Overall Study|Lack of Efficacy|1
5174936|NCT01276509|17867318|P1|Overall Study|Lack of Efficacy|2
5174937|NCT01276509|17867315|P4|Overall Study|Adverse Event|3
5174938|NCT01276509|17867316|P3|Overall Study|Adverse Event|4
5174939|NCT01276509|17867317|P2|Overall Study|Adverse Event|8
5174940|NCT01276509|17867318|P1|Overall Study|Adverse Event|9
5174941|NCT01276457|17867371|P2|Extension Study|Lack of Efficacy|1
5174942|NCT01276457|17867372|P1|Extension Study|Lack of Efficacy|3
5174943|NCT01276457|17867371|P2|Extension Study|Death|1
5174944|NCT01276457|17867372|P1|Extension Study|Death|0
5174945|NCT01276457|17867371|P2|Extension Study|Lost to Follow-up|0
5174946|NCT01276457|17867372|P1|Extension Study|Lost to Follow-up|3
5174947|NCT01276457|17867371|P2|Core Study|Lack of Efficacy|12
5174948|NCT01276457|17867372|P1|Core Study|Lack of Efficacy|3
5174949|NCT01276457|17867371|P2|Core Study|Death|2
5174950|NCT01276457|17867372|P1|Core Study|Death|2
5174951|NCT01276457|17867371|P2|Core Study|Administrative problems|1
5174952|NCT01276457|17867372|P1|Core Study|Administrative problems|1
5174953|NCT01276457|17867371|P2|Core Study|Lost to Follow-up|2
5174954|NCT01276457|17867372|P1|Core Study|Lost to Follow-up|1
5174955|NCT01276457|17867371|P2|Core Study|Adverse Event|3
5174956|NCT01276457|17867372|P1|Core Study|Adverse Event|6
5174957|NCT01276353|17867386|P2|Extension|Prohibited concomitant medications|1
5174958|NCT01276353|17867387|P1|Extension|Prohibited concomitant medications|0
5174959|NCT01276353|17867386|P2|Extension|Physician Decision|0
5174960|NCT01276353|17867387|P1|Extension|Physician Decision|1
5174961|NCT01276353|17867386|P2|Extension|Withdrawal of study drug 4 days in a row|1
5174962|NCT01276353|17867387|P1|Extension|Withdrawal of study drug 4 days in a row|3
5174963|NCT01276353|17867386|P2|Extension|Withdrawal by Subject|2
5174964|NCT01276353|17867387|P1|Extension|Withdrawal by Subject|1
5174965|NCT01276353|17867386|P2|Extension|Adverse Event|5
5174966|NCT01276353|17867387|P1|Extension|Adverse Event|2
5174967|NCT01276353|17867386|P2|Double-blind|Withdrawal by Subject|0
5174968|NCT01276353|17867387|P1|Double-blind|Withdrawal by Subject|1
5174969|NCT01276353|17867386|P2|Double-blind|Adverse Event|0
5174970|NCT01276353|17867387|P1|Double-blind|Adverse Event|2
5174971|NCT01276327|17867399|P2|Overall Study|Withdrawal by Subject|0
5174972|NCT01276327|17867400|P1|Overall Study|Withdrawal by Subject|1
5174973|NCT01276327|17867399|P2|Overall Study|Adverse Event|3
5174974|NCT01276327|17867400|P1|Overall Study|Adverse Event|1
5174975|NCT01276288|17867467|P4|Overall Study|not treated|0
5174976|NCT01276288|17867468|P3|Overall Study|not treated|0
5174977|NCT01276288|17867469|P2|Overall Study|not treated|0
5174978|NCT01276288|17867470|P1|Overall Study|not treated|1
5174979|NCT01276288|17867467|P4|Overall Study|Adverse Event|0
5174980|NCT01276288|17867468|P3|Overall Study|Adverse Event|0
5174981|NCT01276288|17867469|P2|Overall Study|Adverse Event|1
5174982|NCT01276288|17867470|P1|Overall Study|Adverse Event|1
5174983|NCT01276223|17867597|P3|Overall Study|Protocol Violation|0
5174984|NCT01276223|17867598|P2|Overall Study|Protocol Violation|0
5174985|NCT01276223|17867599|P1|Overall Study|Protocol Violation|1
5174986|NCT01276223|17867597|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
5174987|NCT01276223|17867598|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
5174988|NCT01276223|17867599|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
5174989|NCT01276223|17867597|P3|Overall Study|Other|1
5174990|NCT01276223|17867598|P2|Overall Study|Other|0
5174991|NCT01276223|17867599|P1|Overall Study|Other|0
5174992|NCT01276223|17867597|P3|Overall Study|Lost to Follow-up|1
5174993|NCT01276223|17867598|P2|Overall Study|Lost to Follow-up|0
5174994|NCT01276223|17867599|P1|Overall Study|Lost to Follow-up|0
5174995|NCT01276223|17867597|P3|Overall Study|Adverse Event|1
5174996|NCT01276223|17867598|P2|Overall Study|Adverse Event|4
5174997|NCT01276223|17867599|P1|Overall Study|Adverse Event|7
5174998|NCT01276106|17867640|P4|Overall Study|Insufficient therapeutic effects|0
5174999|NCT01276106|17867641|P3|Overall Study|Insufficient therapeutic effects|2
5175000|NCT01276106|17867642|P2|Overall Study|Insufficient therapeutic effects|0
5175254|NCT01273064|17868682|P2|Overall Study|Study Termination|27
5175001|NCT01276106|17867643|P1|Overall Study|Insufficient therapeutic effects|0
5175002|NCT01276106|17867640|P4|Overall Study|Protocol Violation|2
5175003|NCT01276106|17867641|P3|Overall Study|Protocol Violation|0
5175004|NCT01276106|17867642|P2|Overall Study|Protocol Violation|1
5175005|NCT01276106|17867643|P1|Overall Study|Protocol Violation|1
5175006|NCT01276106|17867640|P4|Overall Study|Physician Decision|1
5175007|NCT01276106|17867641|P3|Overall Study|Physician Decision|1
5175008|NCT01276106|17867642|P2|Overall Study|Physician Decision|0
5175009|NCT01276106|17867643|P1|Overall Study|Physician Decision|0
5175010|NCT01276106|17867640|P4|Overall Study|Lost to Follow-up|0
5175011|NCT01276106|17867641|P3|Overall Study|Lost to Follow-up|1
5175012|NCT01276106|17867642|P2|Overall Study|Lost to Follow-up|1
5175013|NCT01276106|17867643|P1|Overall Study|Lost to Follow-up|2
5175014|NCT01276106|17867640|P4|Overall Study|Lack of Efficacy|1
5175015|NCT01276106|17867641|P3|Overall Study|Lack of Efficacy|0
5175016|NCT01276106|17867642|P2|Overall Study|Lack of Efficacy|1
5175017|NCT01276106|17867643|P1|Overall Study|Lack of Efficacy|0
5175018|NCT01276106|17867640|P4|Overall Study|Withdrawal by Subject|6
5175019|NCT01276106|17867641|P3|Overall Study|Withdrawal by Subject|1
5175020|NCT01276106|17867642|P2|Overall Study|Withdrawal by Subject|3
5175021|NCT01276106|17867643|P1|Overall Study|Withdrawal by Subject|6
5175022|NCT01276106|17867640|P4|Overall Study|Adverse Event|3
5175023|NCT01276106|17867641|P3|Overall Study|Adverse Event|11
5175024|NCT01276106|17867642|P2|Overall Study|Adverse Event|3
5175025|NCT01276106|17867643|P1|Overall Study|Adverse Event|3
5175026|NCT01276054|17867655|P2|Overall Study|No one to oversee trial after P.I. left|2
5175027|NCT01276054|17867656|P1|Overall Study|No one to oversee trial after P.I. left|2
5175028|NCT01276041|17867662|P1|Overall Study|Protocol Violation|1
5175029|NCT01276041|17867662|P1|Overall Study|Adverse Event|2
5175030|NCT01275833|17867671|P2|Overall Study|Study terminated|1
5175031|NCT01275833|17867672|P1|Overall Study|Study terminated|1
5175032|NCT01275755|17867680|P2|Run-out Placebo Period|Lost to Follow-up|0
5175033|NCT01275755|17867681|P1|Run-out Placebo Period|Lost to Follow-up|1
5175034|NCT01275755|17867680|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5175035|NCT01275755|17867681|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5175036|NCT01275755|17867680|P2|Double-blind Treatment Period|Lost to Follow-up|1
5175037|NCT01275755|17867681|P1|Double-blind Treatment Period|Lost to Follow-up|1
5175038|NCT01275755|17867680|P2|Double-blind Treatment Period|Adverse Event|2
5175039|NCT01275755|17867681|P1|Double-blind Treatment Period|Adverse Event|0
5175040|NCT01275677|17867689|P2|Overall Study|No clinical follow up.|4
5175041|NCT01275677|17867690|P1|Overall Study|No clinical follow up.|1
5175042|NCT01275677|17867689|P2|Overall Study|No follow-up|37
5175043|NCT01275677|17867690|P1|Overall Study|No follow-up|26
5175044|NCT01275677|17867689|P2|Overall Study|Not at risk for recurrence.|1
5175045|NCT01275677|17867690|P1|Overall Study|Not at risk for recurrence.|1
5175046|NCT01275625|17867716|P1|Overall Study|Other|1
5175047|NCT01275625|17867716|P1|Overall Study|Adverse Event|4
5175048|NCT01275625|17867716|P1|Overall Study|Protocol Violation|1
5175049|NCT01275625|17867716|P1|Overall Study|Withdrawal by Subject|3
5175050|NCT01275625|17867716|P1|Overall Study|Lost to Follow-up|1
5175051|NCT01275625|17867716|P1|Overall Study|Lack of Efficacy|2
5175052|NCT01275625|17867716|P1|Overall Study|Death|1
5175053|NCT01275430|17867734|P1|Overall Study|Inability to achieve maximum p-wave|1
5175054|NCT01275430|17867734|P1|Overall Study|Device Malfunction|1
5175055|NCT01275430|17867734|P1|Overall Study|No Contrast Injection|6
5175056|NCT01275430|17867734|P1|Overall Study|Adverse Event|1
5175057|NCT01275339|17867799|P4|Overall Study|Withdrawal by Subject|0
5175058|NCT01275339|17867800|P3|Overall Study|Withdrawal by Subject|1
5175059|NCT01275339|17867801|P2|Overall Study|Withdrawal by Subject|0
5175060|NCT01275339|17867802|P1|Overall Study|Withdrawal by Subject|0
5175061|NCT01275339|17867799|P4|Overall Study|Referred for surgery for AS symptoms|0
5175062|NCT01275339|17867800|P3|Overall Study|Referred for surgery for AS symptoms|0
5175063|NCT01275339|17867801|P2|Overall Study|Referred for surgery for AS symptoms|0
5175064|NCT01275339|17867802|P1|Overall Study|Referred for surgery for AS symptoms|1
5175065|NCT01275196|17867830|P2|Overall Study|Suboptimal response/treatment failure|6
5175066|NCT01275196|17867831|P1|Overall Study|Suboptimal response/treatment failure|5
5175067|NCT01275196|17867830|P2|Overall Study|Protocol Violation|0
5175068|NCT01275196|17867831|P1|Overall Study|Protocol Violation|1
5175069|NCT01275196|17867830|P2|Overall Study|Disease Progression|5
5175070|NCT01275196|17867831|P1|Overall Study|Disease Progression|6
5175071|NCT01275196|17867830|P2|Overall Study|Lost to Follow-up|0
5175072|NCT01275196|17867831|P1|Overall Study|Lost to Follow-up|1
5175073|NCT01275196|17867830|P2|Overall Study|Withdrawal by Subject|5
5175074|NCT01275196|17867831|P1|Overall Study|Withdrawal by Subject|4
5175075|NCT01275196|17867830|P2|Overall Study|Adverse Event|5
5175076|NCT01275196|17867831|P1|Overall Study|Adverse Event|3
5175077|NCT01275170|17867878|P8|Part 1: Period 1|Equipment malfunction before study drug|0
5175078|NCT01275170|17867879|P7|Part 1: Period 1|Equipment malfunction before study drug|0
5175079|NCT01275170|17867880|P6|Part 1: Period 1|Equipment malfunction before study drug|0
5175080|NCT01275170|17867881|P5|Part 1: Period 1|Equipment malfunction before study drug|0
5175081|NCT01275170|17867882|P4|Part 1: Period 1|Equipment malfunction before study drug|0
5175082|NCT01275170|17867883|P3|Part 1: Period 1|Equipment malfunction before study drug|0
5175083|NCT01275170|17867884|P2|Part 1: Period 1|Equipment malfunction before study drug|0
5175084|NCT01275170|17867885|P1|Part 1: Period 1|Equipment malfunction before study drug|1
5175085|NCT01275144|17868103|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
5175086|NCT01275144|17868104|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
5175087|NCT01275131|17868162|P4|Period 2 (Crossover)|Withdrawal by Subject|2
5175088|NCT01275131|17868163|P3|Period 2 (Crossover)|Withdrawal by Subject|1
5175089|NCT01275131|17868164|P2|Period 2 (Crossover)|Withdrawal by Subject|0
5175090|NCT01275131|17868165|P1|Period 2 (Crossover)|Withdrawal by Subject|1
5175091|NCT01275131|17868162|P4|Period 2 (Crossover)|Adverse Event|0
5175092|NCT01275131|17868163|P3|Period 2 (Crossover)|Adverse Event|0
5175093|NCT01275131|17868164|P2|Period 2 (Crossover)|Adverse Event|1
5175094|NCT01275131|17868165|P1|Period 2 (Crossover)|Adverse Event|0
5175095|NCT01275131|17868162|P4|Period 1|Physician Decision|0
5175096|NCT01275131|17868163|P3|Period 1|Physician Decision|0
5175097|NCT01275131|17868164|P2|Period 1|Physician Decision|0
5175098|NCT01275131|17868165|P1|Period 1|Physician Decision|1
5175099|NCT01275131|17868162|P4|Period 1|Withdrawal by Subject|2
5175100|NCT01275131|17868163|P3|Period 1|Withdrawal by Subject|3
5175101|NCT01275131|17868164|P2|Period 1|Withdrawal by Subject|0
5175102|NCT01275131|17868165|P1|Period 1|Withdrawal by Subject|1
5175103|NCT01275066|17868208|P3|Overall Study|Not Diagnosed w/ Disease|0
5175104|NCT01275066|17868209|P2|Overall Study|Not Diagnosed w/ Disease|0
5175105|NCT01275066|17868210|P1|Overall Study|Not Diagnosed w/ Disease|1
5175106|NCT01275066|17868208|P3|Overall Study|Withdrawal by Subject|1
5175107|NCT01275066|17868209|P2|Overall Study|Withdrawal by Subject|0
5175108|NCT01275066|17868210|P1|Overall Study|Withdrawal by Subject|0
5175109|NCT01274715|17868243|P1|Overall Study|After consent, met exclusion criteria.|1
5175110|NCT01274715|17868243|P1|Overall Study|After consent, met exclusion criteria.|1
5175111|NCT01274715|17868243|P1|Overall Study|After consent, met exclusion criteria.|1
5175112|NCT01274715|17868243|P1|Overall Study|Lost to Follow-up|1
5175113|NCT01274637|17868250|P2|Overall Study|Lost to Follow-up|1
5175114|NCT01274637|17868251|P1|Overall Study|Lost to Follow-up|0
5175115|NCT01274637|17868250|P2|Overall Study|Withdrawal by Subject|1
5175116|NCT01274637|17868251|P1|Overall Study|Withdrawal by Subject|0
5175117|NCT01274559|17868290|P2|Overall Study|Withdrawal by Subject|13
5175118|NCT01274559|17868291|P1|Overall Study|Withdrawal by Subject|25
5175119|NCT01274559|17868290|P2|Overall Study|Study Terminated by Sponsor|87
5175120|NCT01274559|17868291|P1|Overall Study|Study Terminated by Sponsor|79
5175121|NCT01274559|17868290|P2|Overall Study|Protocol Violation|23
5175122|NCT01274559|17868291|P1|Overall Study|Protocol Violation|28
5175123|NCT01274559|17868290|P2|Overall Study|Physician Decision|1
5175124|NCT01274559|17868291|P1|Overall Study|Physician Decision|2
5175125|NCT01274559|17868290|P2|Overall Study|Non-compliance with Study Drug|4
5175126|NCT01274559|17868291|P1|Overall Study|Non-compliance with Study Drug|2
5175127|NCT01274559|17868290|P2|Overall Study|Lost to Follow-up|3
5175128|NCT01274559|17868291|P1|Overall Study|Lost to Follow-up|3
5175129|NCT01274559|17868290|P2|Overall Study|Death|1
5175130|NCT01274559|17868291|P1|Overall Study|Death|1
5175131|NCT01274559|17868290|P2|Overall Study|Adverse Event|13
5175132|NCT01274559|17868291|P1|Overall Study|Adverse Event|57
5175133|NCT01274533|17868341|P1|Overall Study|Disease progression|2
5175134|NCT01274533|17868341|P1|Overall Study|Non-compliance|1
5175135|NCT01274533|17868341|P1|Overall Study|Withdrawal by Subject|1
5175136|NCT01274429|17868377|P1|Overall Study|Study closed do to lack of funding|5
5175137|NCT01274351|17868382|P1|Overall Study|hospitalization|1
5175138|NCT01274351|17868382|P1|Overall Study|progression of disease|3
5175139|NCT01274351|17868382|P1|Overall Study|Adverse Event|8
5175140|NCT01274351|17868382|P1|Overall Study|Withdrawal by Subject|3
5175141|NCT01274351|17868382|P1|Overall Study|Death|2
5175142|NCT01274351|17868382|P1|Overall Study|Pregnancy|1
5175143|NCT01274351|17868382|P1|Overall Study|patient not compliant with the protocol|1
5175144|NCT01274351|17868382|P1|Overall Study|Lost to Follow-up|1
5175145|NCT01274182|17868394|P3|Overall Study|Death|1
5175146|NCT01274182|17868395|P2|Overall Study|Death|0
5175147|NCT01274182|17868396|P1|Overall Study|Death|1
5175148|NCT01274182|17868394|P3|Overall Study|Protocol Violation|0
5175149|NCT01274182|17868395|P2|Overall Study|Protocol Violation|2
5175150|NCT01274182|17868396|P1|Overall Study|Protocol Violation|3
5175151|NCT01274182|17868394|P3|Overall Study|Lost to Follow-up|1
5175152|NCT01274182|17868395|P2|Overall Study|Lost to Follow-up|3
5175153|NCT01274182|17868396|P1|Overall Study|Lost to Follow-up|2
5175154|NCT01274182|17868394|P3|Overall Study|Withdrawal by Subject|3
5175155|NCT01274182|17868395|P2|Overall Study|Withdrawal by Subject|5
5175156|NCT01274182|17868396|P1|Overall Study|Withdrawal by Subject|5
5175157|NCT01274182|17868394|P3|Overall Study|Adverse Event|3
5175158|NCT01274182|17868395|P2|Overall Study|Adverse Event|5
5175159|NCT01274182|17868396|P1|Overall Study|Adverse Event|4
5175160|NCT01274182|17868394|P3|Overall Study|Unsatisfactory therapeutic effect|4
5175161|NCT01274182|17868395|P2|Overall Study|Unsatisfactory therapeutic effect|3
5175162|NCT01274182|17868396|P1|Overall Study|Unsatisfactory therapeutic effect|6
5175163|NCT01273883|17868437|P2|Second Intervention|Lack of Efficacy|0
5175164|NCT01273883|17868438|P1|Second Intervention|Lack of Efficacy|1
5175165|NCT01273883|17868437|P2|Second Intervention|Lost to Follow-up|1
5175166|NCT01273883|17868438|P1|Second Intervention|Lost to Follow-up|1
5175167|NCT01273883|17868437|P2|First Intervention|Adverse Event|1
5175168|NCT01273883|17868438|P1|First Intervention|Adverse Event|2
5175169|NCT01273818|17868464|P3|Overall Study|Physician Decision|9
5175170|NCT01273818|17868465|P2|Overall Study|Physician Decision|2
5175171|NCT01273818|17868466|P1|Overall Study|Physician Decision|13
5175172|NCT01273805|17868476|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
5175173|NCT01273805|17868477|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
5175174|NCT01273623|17868508|P1|Overall Study|did not meet IVUS criteria|29
5175175|NCT01273597|17868515|P1|Overall Study|Reason Not Reported|1
5175176|NCT01273597|17868515|P1|Overall Study|Underwent Kidney Transplantation|2
5175177|NCT01273597|17868515|P1|Overall Study|Adverse Event|5
5175178|NCT01273519|17868530|P3|Overall Study|Other|1
5175179|NCT01273519|17868531|P2|Overall Study|Other|1
5175180|NCT01273519|17868532|P1|Overall Study|Other|6
5175181|NCT01273519|17868530|P3|Overall Study|Lack of Efficacy|4
5175182|NCT01273519|17868531|P2|Overall Study|Lack of Efficacy|3
5175183|NCT01273519|17868532|P1|Overall Study|Lack of Efficacy|8
5175184|NCT01273519|17868530|P3|Overall Study|Lost to Follow-up|3
5175185|NCT01273519|17868531|P2|Overall Study|Lost to Follow-up|1
5175186|NCT01273519|17868532|P1|Overall Study|Lost to Follow-up|2
5175187|NCT01273519|17868530|P3|Overall Study|Adverse Event|0
5175188|NCT01273519|17868531|P2|Overall Study|Adverse Event|0
5175189|NCT01273519|17868532|P1|Overall Study|Adverse Event|3
5175190|NCT01273181|17868575|P4|Phase 2, Dose 2|Death during treatment|1
5175191|NCT01273181|17868576|P3|Phase 2, Dose 2|Death during treatment|0
5175192|NCT01273181|17868577|P2|Phase 2, Dose 2|Death during treatment|0
5175193|NCT01273181|17868578|P1|Phase 2, Dose 2|Death during treatment|0
5175194|NCT01273181|17868575|P4|Phase 2, Dose 1|Study termination|0
5175195|NCT01273181|17868576|P3|Phase 2, Dose 1|Study termination|1
5175196|NCT01273181|17868577|P2|Phase 2, Dose 1|Study termination|0
5175197|NCT01273181|17868578|P1|Phase 2, Dose 1|Study termination|0
5175198|NCT01273181|17868575|P4|Phase I, Dose 2|Death during treatment|0
5175199|NCT01273181|17868576|P3|Phase I, Dose 2|Death during treatment|0
5175200|NCT01273181|17868577|P2|Phase I, Dose 2|Death during treatment|1
5175201|NCT01273181|17868578|P1|Phase I, Dose 2|Death during treatment|0
5175202|NCT01273181|17868575|P4|Phase I, Dose 1|Study termination|0
5175203|NCT01273181|17868576|P3|Phase I, Dose 1|Study termination|0
5175204|NCT01273181|17868577|P2|Phase I, Dose 1|Study termination|0
5175205|NCT01273181|17868578|P1|Phase I, Dose 1|Study termination|1
5175206|NCT01273155|17868596|P7|Overall Study|Withdrew during C1/refused further trmt|0
5175207|NCT01273155|17868597|P6|Overall Study|Withdrew during C1/refused further trmt|1
5175208|NCT01273155|17868598|P5|Overall Study|Withdrew during C1/refused further trmt|1
5175209|NCT01273155|17868599|P4|Overall Study|Withdrew during C1/refused further trmt|0
5175210|NCT01273155|17868600|P3|Overall Study|Withdrew during C1/refused further trmt|1
5175211|NCT01273155|17868601|P2|Overall Study|Withdrew during C1/refused further trmt|0
5175212|NCT01273155|17868602|P1|Overall Study|Withdrew during C1/refused further trmt|0
5175213|NCT01273155|17868596|P7|Overall Study|Died during Cycle 1|2
5175214|NCT01273155|17868597|P6|Overall Study|Died during Cycle 1|2
5175215|NCT01273155|17868598|P5|Overall Study|Died during Cycle 1|0
5175216|NCT01273155|17868599|P4|Overall Study|Died during Cycle 1|1
5175217|NCT01273155|17868600|P3|Overall Study|Died during Cycle 1|1
5175218|NCT01273155|17868601|P2|Overall Study|Died during Cycle 1|0
5175219|NCT01273155|17868602|P1|Overall Study|Died during Cycle 1|0
5175220|NCT01273155|17868596|P7|Overall Study|Off study prior to C1/due to toxicity|1
5175221|NCT01273155|17868597|P6|Overall Study|Off study prior to C1/due to toxicity|0
5175222|NCT01273155|17868598|P5|Overall Study|Off study prior to C1/due to toxicity|0
5175223|NCT01273155|17868599|P4|Overall Study|Off study prior to C1/due to toxicity|0
5175224|NCT01273155|17868600|P3|Overall Study|Off study prior to C1/due to toxicity|2
5175225|NCT01273155|17868601|P2|Overall Study|Off study prior to C1/due to toxicity|0
5175226|NCT01273155|17868602|P1|Overall Study|Off study prior to C1/due to toxicity|0
5175227|NCT01273155|17868596|P7|Overall Study|Change in liver function/no longer eval.|0
5175228|NCT01273155|17868597|P6|Overall Study|Change in liver function/no longer eval.|0
5175229|NCT01273155|17868598|P5|Overall Study|Change in liver function/no longer eval.|1
5175230|NCT01273155|17868599|P4|Overall Study|Change in liver function/no longer eval.|0
5175231|NCT01273155|17868600|P3|Overall Study|Change in liver function/no longer eval.|0
5175232|NCT01273155|17868601|P2|Overall Study|Change in liver function/no longer eval.|1
5175233|NCT01273155|17868602|P1|Overall Study|Change in liver function/no longer eval.|0
5175234|NCT01273155|17868596|P7|Overall Study|Off study trmt prior to end of C1/PD|3
5175235|NCT01273155|17868597|P6|Overall Study|Off study trmt prior to end of C1/PD|2
5175236|NCT01273155|17868598|P5|Overall Study|Off study trmt prior to end of C1/PD|0
5175237|NCT01273155|17868599|P4|Overall Study|Off study trmt prior to end of C1/PD|0
5175238|NCT01273155|17868600|P3|Overall Study|Off study trmt prior to end of C1/PD|8
5175239|NCT01273155|17868601|P2|Overall Study|Off study trmt prior to end of C1/PD|3
5175240|NCT01273155|17868602|P1|Overall Study|Off study trmt prior to end of C1/PD|2
5175241|NCT01273064|17868679|P5|Overall Study|Physician Decision|1
5175242|NCT01273064|17868680|P4|Overall Study|Physician Decision|0
5175243|NCT01273064|17868681|P3|Overall Study|Physician Decision|0
5175244|NCT01273064|17868682|P2|Overall Study|Physician Decision|0
5175245|NCT01273064|17868683|P1|Overall Study|Physician Decision|0
5175246|NCT01273064|17868679|P5|Overall Study|Lost to Follow-up|0
5175247|NCT01273064|17868680|P4|Overall Study|Lost to Follow-up|0
5175248|NCT01273064|17868681|P3|Overall Study|Lost to Follow-up|0
5175249|NCT01273064|17868682|P2|Overall Study|Lost to Follow-up|0
5175250|NCT01273064|17868683|P1|Overall Study|Lost to Follow-up|1
5175251|NCT01273064|17868679|P5|Overall Study|Study Termination|8
5175252|NCT01273064|17868680|P4|Overall Study|Study Termination|16
5175253|NCT01273064|17868681|P3|Overall Study|Study Termination|26
5175255|NCT01273064|17868683|P1|Overall Study|Study Termination|13
5175256|NCT01273064|17868679|P5|Overall Study|Withdrawal by Subject|0
5175257|NCT01273064|17868680|P4|Overall Study|Withdrawal by Subject|2
5175258|NCT01273064|17868681|P3|Overall Study|Withdrawal by Subject|2
5175259|NCT01273064|17868682|P2|Overall Study|Withdrawal by Subject|2
5175260|NCT01273064|17868683|P1|Overall Study|Withdrawal by Subject|4
5175261|NCT01273064|17868679|P5|Overall Study|Adverse Event|1
5175262|NCT01273064|17868680|P4|Overall Study|Adverse Event|2
5175263|NCT01273064|17868681|P3|Overall Study|Adverse Event|3
5175264|NCT01273064|17868682|P2|Overall Study|Adverse Event|1
5175265|NCT01273064|17868683|P1|Overall Study|Adverse Event|5
5175266|NCT01273038|17868702|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5175267|NCT01273038|17868703|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5175268|NCT01273038|17868702|P2|Second Intervention (14 Days)|Adverse Event|1
5175269|NCT01273038|17868703|P1|Second Intervention (14 Days)|Adverse Event|0
5175270|NCT01272947|17868753|P2|Overall Study|Abnormal Laboratory Value|2
5175271|NCT01272947|17868754|P1|Overall Study|Abnormal Laboratory Value|2
5175272|NCT01272934|17868764|P2|Overall Study|Abnormal Laboratory Value|1
5175273|NCT01272934|17868765|P1|Overall Study|Abnormal Laboratory Value|0
5175274|NCT01272934|17868764|P2|Overall Study|Adverse Event|1
5175275|NCT01272934|17868765|P1|Overall Study|Adverse Event|0
5175276|NCT01272921|17868775|P2|Overall Study|Protocol Violation|1
5175277|NCT01272921|17868776|P1|Overall Study|Protocol Violation|2
5175278|NCT01272908|17868784|P1|Re-Treatment Period|Withdrawal by Subject|1
5175279|NCT01272908|17868784|P1|Re-Treatment Period|Lack of Efficacy|3
5175280|NCT01272908|17868784|P1|Re-Treatment Period|Adverse Event|2
5175281|NCT01272908|17868784|P1|Initial Treatment Period|Withdrawal by Subject|1
5175282|NCT01272908|17868784|P1|Initial Treatment Period|Protocol Violation|1
5175283|NCT01272908|17868784|P1|Initial Treatment Period|Lack of Efficacy|5
5175284|NCT01272908|17868784|P1|Initial Treatment Period|Adverse Event|1
5175285|NCT01272869|17868824|P2|Period 2 (14 Days)|Adverse Event|0
5175286|NCT01272869|17868825|P1|Period 2 (14 Days)|Adverse Event|1
5175287|NCT01272804|17868852|P6|Overall Study|Adverse Event|1
5175288|NCT01272804|17868853|P5|Overall Study|Adverse Event|2
5175289|NCT01272804|17868854|P4|Overall Study|Adverse Event|0
5175290|NCT01272804|17868855|P3|Overall Study|Adverse Event|0
5175291|NCT01272804|17868856|P2|Overall Study|Adverse Event|0
5175292|NCT01272804|17868857|P1|Overall Study|Adverse Event|1
5175293|NCT01272661|17869015|P3|Overall Study|lost to followup/case closed/ no birth|72
5175294|NCT01272661|17869016|P2|Overall Study|lost to followup/case closed/ no birth|209
5175295|NCT01272661|17869017|P1|Overall Study|lost to followup/case closed/ no birth|126
5175296|NCT01272635|17869042|P4|Overall Study|Lost to Follow-up|23
5175297|NCT01272635|17869043|P3|Overall Study|Lost to Follow-up|31
5175298|NCT01272635|17869044|P2|Overall Study|Lost to Follow-up|20
5175299|NCT01272635|17869045|P1|Overall Study|Lost to Follow-up|31
5175300|NCT01272232|17869129|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
5175301|NCT01272232|17869130|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
5175302|NCT01272232|17869131|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
5175303|NCT01272232|17869129|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
5175304|NCT01272232|17869130|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
5175305|NCT01272232|17869131|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
5175306|NCT01272232|17869129|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
5175307|NCT01272232|17869130|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
5175308|NCT01272232|17869131|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
5175309|NCT01272232|17869129|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
5175310|NCT01272232|17869130|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
5175311|NCT01272232|17869131|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
5175312|NCT01272232|17869129|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
5175313|NCT01272232|17869130|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
5175314|NCT01272232|17869131|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
5175315|NCT01272232|17869129|P3|Weeks 0-56|Unclassified|12
5175316|NCT01272232|17869130|P2|Weeks 0-56|Unclassified|7
5175317|NCT01272232|17869131|P1|Weeks 0-56|Unclassified|16
5175318|NCT01272232|17869129|P3|Weeks 0-56|Withdrawal criteria|37
5175319|NCT01272232|17869130|P2|Weeks 0-56|Withdrawal criteria|14
5175320|NCT01272232|17869131|P1|Weeks 0-56|Withdrawal criteria|32
5175321|NCT01272232|17869129|P3|Weeks 0-56|Protocol Violation|13
5175322|NCT01272232|17869130|P2|Weeks 0-56|Protocol Violation|8
5175323|NCT01272232|17869131|P1|Weeks 0-56|Protocol Violation|12
5175324|NCT01272232|17869129|P3|Weeks 0-56|Lack of Efficacy|3
5175325|NCT01272232|17869130|P2|Weeks 0-56|Lack of Efficacy|0
5175326|NCT01272232|17869131|P1|Weeks 0-56|Lack of Efficacy|0
5175327|NCT01272232|17869129|P3|Weeks 0-56|Adverse Event|7
5175328|NCT01272232|17869130|P2|Weeks 0-56|Adverse Event|18
5175329|NCT01272232|17869131|P1|Weeks 0-56|Adverse Event|39
5175330|NCT01272219|17869176|P6|Main + Extension Period: Week 0-172|Unclassified|51
5175331|NCT01272219|17869177|P5|Main + Extension Period: Week 0-172|Unclassified|61
5175332|NCT01272219|17869178|P4|Main + Extension Period: Week 0-172|Unclassified|0
5175333|NCT01272219|17869179|P3|Main + Extension Period: Week 0-172|Unclassified|0
5175334|NCT01272219|17869180|P2|Main + Extension Period: Week 0-172|Unclassified|0
5175335|NCT01272219|17869181|P1|Main + Extension Period: Week 0-172|Unclassified|0
5175336|NCT01272219|17869176|P6|Main + Extension Period: Week 0-172|Missing reason|0
5175337|NCT01272219|17869177|P5|Main + Extension Period: Week 0-172|Missing reason|1
5175338|NCT01272219|17869178|P4|Main + Extension Period: Week 0-172|Missing reason|0
5175339|NCT01272219|17869179|P3|Main + Extension Period: Week 0-172|Missing reason|0
5175340|NCT01272219|17869180|P2|Main + Extension Period: Week 0-172|Missing reason|0
5175341|NCT01272219|17869181|P1|Main + Extension Period: Week 0-172|Missing reason|0
5175342|NCT01272219|17869176|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
5175343|NCT01272219|17869177|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
5175344|NCT01272219|17869178|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5175345|NCT01272219|17869179|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5175346|NCT01272219|17869180|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5175347|NCT01272219|17869181|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5175348|NCT01272219|17869176|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
5175349|NCT01272219|17869177|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
5175350|NCT01272219|17869178|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
5175351|NCT01272219|17869179|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
5175352|NCT01272219|17869180|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
5175353|NCT01272219|17869181|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
5175354|NCT01272219|17869176|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
5175355|NCT01272219|17869177|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
5175356|NCT01272219|17869178|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5175357|NCT01272219|17869179|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5175358|NCT01272219|17869180|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5175359|NCT01272219|17869181|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5175360|NCT01272219|17869176|P6|Main + Extension Period: Week 0-172|Adverse Event|43
5175361|NCT01272219|17869177|P5|Main + Extension Period: Week 0-172|Adverse Event|191
5175362|NCT01272219|17869178|P4|Main + Extension Period: Week 0-172|Adverse Event|0
5175363|NCT01272219|17869179|P3|Main + Extension Period: Week 0-172|Adverse Event|0
5175364|NCT01272219|17869180|P2|Main + Extension Period: Week 0-172|Adverse Event|0
5175365|NCT01272219|17869181|P1|Main + Extension Period: Week 0-172|Adverse Event|0
5175366|NCT01272219|17869176|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5175367|NCT01272219|17869177|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5175368|NCT01272219|17869178|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
5175369|NCT01272219|17869179|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
5175370|NCT01272219|17869180|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
5175371|NCT01272219|17869181|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5175372|NCT01272219|17869176|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5175373|NCT01272219|17869177|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5175374|NCT01272219|17869178|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
5175375|NCT01272219|17869179|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
5175376|NCT01272219|17869180|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
5175377|NCT01272219|17869181|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5175378|NCT01272219|17869176|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5175379|NCT01272219|17869177|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5175380|NCT01272219|17869178|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
5175381|NCT01272219|17869179|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5175382|NCT01272219|17869180|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
5175383|NCT01272219|17869181|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5175384|NCT01272219|17869176|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5175385|NCT01272219|17869177|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5175386|NCT01272219|17869178|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
5175387|NCT01272219|17869179|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5175388|NCT01272219|17869180|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5175389|NCT01272219|17869181|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5175390|NCT01272219|17869176|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5175391|NCT01272219|17869177|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5175392|NCT01272219|17869178|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
5175393|NCT01272219|17869179|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
5175394|NCT01272219|17869180|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
5175395|NCT01272219|17869181|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5175396|NCT01272219|17869176|P6|Main Period: Week 0 to Week 56|Unclassified|34
5175397|NCT01272219|17869177|P5|Main Period: Week 0 to Week 56|Unclassified|42
5175398|NCT01272219|17869178|P4|Main Period: Week 0 to Week 56|Unclassified|29
5175399|NCT01272219|17869179|P3|Main Period: Week 0 to Week 56|Unclassified|0
5175400|NCT01272219|17869180|P2|Main Period: Week 0 to Week 56|Unclassified|0
5175401|NCT01272219|17869181|P1|Main Period: Week 0 to Week 56|Unclassified|36
5175402|NCT01272219|17869176|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
5175403|NCT01272219|17869177|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
5175404|NCT01272219|17869178|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
5175405|NCT01272219|17869179|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
5175406|NCT01272219|17869180|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
5175407|NCT01272219|17869181|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
5175408|NCT01272219|17869176|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
5175409|NCT01272219|17869177|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
5175492|NCT01271933|17869331|P1|Single-Blind Phase|Withdrawal by Subject|15
5175410|NCT01272219|17869178|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
5175411|NCT01272219|17869179|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
5175412|NCT01272219|17869180|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
5175413|NCT01272219|17869181|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
5175414|NCT01272219|17869176|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
5175415|NCT01272219|17869177|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
5175416|NCT01272219|17869178|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
5175417|NCT01272219|17869179|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
5175418|NCT01272219|17869180|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
5175419|NCT01272219|17869181|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
5175420|NCT01272219|17869176|P6|Main Period: Week 0 to Week 56|Adverse Event|29
5175421|NCT01272219|17869177|P5|Main Period: Week 0 to Week 56|Adverse Event|152
5175422|NCT01272219|17869178|P4|Main Period: Week 0 to Week 56|Adverse Event|16
5175423|NCT01272219|17869179|P3|Main Period: Week 0 to Week 56|Adverse Event|0
5175424|NCT01272219|17869180|P2|Main Period: Week 0 to Week 56|Adverse Event|0
5175425|NCT01272219|17869181|P1|Main Period: Week 0 to Week 56|Adverse Event|86
5175426|NCT01272193|17869215|P2|Overall Study|Unclassified|7
5175427|NCT01272193|17869216|P1|Overall Study|Unclassified|8
5175428|NCT01272193|17869215|P2|Overall Study|Withdrawal Criteria|1
5175429|NCT01272193|17869216|P1|Overall Study|Withdrawal Criteria|1
5175430|NCT01272193|17869215|P2|Overall Study|Lack of Efficacy|3
5175431|NCT01272193|17869216|P1|Overall Study|Lack of Efficacy|0
5175432|NCT01272193|17869215|P2|Overall Study|Adverse Event|1
5175433|NCT01272193|17869216|P1|Overall Study|Adverse Event|1
5175434|NCT01272180|17869236|P4|Overall Study|Protocol Violation|1
5175435|NCT01272180|17869237|P3|Overall Study|Protocol Violation|0
5175436|NCT01272180|17869238|P2|Overall Study|Protocol Violation|1
5175437|NCT01272180|17869239|P1|Overall Study|Protocol Violation|0
5175438|NCT01272180|17869236|P4|Overall Study|Inappropriate enrollment|1
5175439|NCT01272180|17869237|P3|Overall Study|Inappropriate enrollment|1
5175440|NCT01272180|17869238|P2|Overall Study|Inappropriate enrollment|0
5175441|NCT01272180|17869239|P1|Overall Study|Inappropriate enrollment|0
5175442|NCT01272180|17869236|P4|Overall Study|Lost to Follow-up|10
5175443|NCT01272180|17869237|P3|Overall Study|Lost to Follow-up|8
5175444|NCT01272180|17869238|P2|Overall Study|Lost to Follow-up|14
5175445|NCT01272180|17869239|P1|Overall Study|Lost to Follow-up|15
5175446|NCT01272180|17869236|P4|Overall Study|Withdrawal by Subject|2
5175447|NCT01272180|17869237|P3|Overall Study|Withdrawal by Subject|3
5175448|NCT01272180|17869238|P2|Overall Study|Withdrawal by Subject|6
5175449|NCT01272180|17869239|P1|Overall Study|Withdrawal by Subject|2
5175450|NCT01272180|17869236|P4|Overall Study|Adverse Event|0
5175451|NCT01272180|17869237|P3|Overall Study|Adverse Event|1
5175452|NCT01272180|17869238|P2|Overall Study|Adverse Event|0
5175453|NCT01272180|17869239|P1|Overall Study|Adverse Event|0
5175454|NCT01272011|17869291|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
5175455|NCT01272011|17869292|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
5175456|NCT01272011|17869293|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
5175457|NCT01271933|17869329|P3|Double-Blind Phase|Participant request-personal reason|0
5175458|NCT01271933|17869330|P2|Double-Blind Phase|Participant request-personal reason|1
5175459|NCT01271933|17869331|P1|Double-Blind Phase|Participant request-personal reason|0
5175460|NCT01271933|17869329|P3|Double-Blind Phase|Adverse Event|0
5175461|NCT01271933|17869330|P2|Double-Blind Phase|Adverse Event|3
5175462|NCT01271933|17869331|P1|Double-Blind Phase|Adverse Event|0
5175463|NCT01271933|17869329|P3|Double-Blind Phase|Withdrawal by Subject|1
5175464|NCT01271933|17869330|P2|Double-Blind Phase|Withdrawal by Subject|6
5175465|NCT01271933|17869331|P1|Double-Blind Phase|Withdrawal by Subject|0
5175466|NCT01271933|17869329|P3|Double-Blind Phase|Lost to Follow-up|1
5175467|NCT01271933|17869330|P2|Double-Blind Phase|Lost to Follow-up|1
5175468|NCT01271933|17869331|P1|Double-Blind Phase|Lost to Follow-up|0
5175469|NCT01271933|17869329|P3|Double-Blind Phase|Lack of Efficacy|9
5175470|NCT01271933|17869330|P2|Double-Blind Phase|Lack of Efficacy|6
5175471|NCT01271933|17869331|P1|Double-Blind Phase|Lack of Efficacy|0
5175472|NCT01271933|17869329|P3|Double-Blind Phase|Randomized but not treated|1
5175473|NCT01271933|17869330|P2|Double-Blind Phase|Randomized but not treated|0
5175474|NCT01271933|17869331|P1|Double-Blind Phase|Randomized but not treated|0
5175475|NCT01271933|17869329|P3|Single-Blind Phase|(Participant request-personal reason)|0
5175476|NCT01271933|17869330|P2|Single-Blind Phase|(Participant request-personal reason)|0
5175477|NCT01271933|17869331|P1|Single-Blind Phase|(Participant request-personal reason)|1
5175478|NCT01271933|17869329|P3|Single-Blind Phase|(Protocol non-compliance)|0
5175479|NCT01271933|17869330|P2|Single-Blind Phase|(Protocol non-compliance)|0
5175480|NCT01271933|17869331|P1|Single-Blind Phase|(Protocol non-compliance)|2
5175481|NCT01271933|17869329|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
5175482|NCT01271933|17869330|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
5175483|NCT01271933|17869331|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
5175484|NCT01271933|17869329|P3|Single-Blind Phase|Adverse Event|0
5175485|NCT01271933|17869330|P2|Single-Blind Phase|Adverse Event|0
5175486|NCT01271933|17869331|P1|Single-Blind Phase|Adverse Event|52
5175487|NCT01271933|17869329|P3|Single-Blind Phase|Protocol Violation|0
5175488|NCT01271933|17869330|P2|Single-Blind Phase|Protocol Violation|0
5175489|NCT01271933|17869331|P1|Single-Blind Phase|Protocol Violation|3
5175490|NCT01271933|17869329|P3|Single-Blind Phase|Withdrawal by Subject|0
5175491|NCT01271933|17869330|P2|Single-Blind Phase|Withdrawal by Subject|0
5175493|NCT01271933|17869329|P3|Single-Blind Phase|Lost to Follow-up|0
5175494|NCT01271933|17869330|P2|Single-Blind Phase|Lost to Follow-up|0
5175495|NCT01271933|17869331|P1|Single-Blind Phase|Lost to Follow-up|10
5175496|NCT01271933|17869329|P3|Single-Blind Phase|Lack of Efficacy|0
5175497|NCT01271933|17869330|P2|Single-Blind Phase|Lack of Efficacy|0
5175498|NCT01271933|17869331|P1|Single-Blind Phase|Lack of Efficacy|37
5175499|NCT01271803|17869474|P3|Overall Study|Lost to Follow-up|0
5175500|NCT01271803|17869475|P2|Overall Study|Lost to Follow-up|0
5175501|NCT01271803|17869476|P1|Overall Study|Lost to Follow-up|1
5175502|NCT01271803|17869474|P3|Overall Study|Withdrawal by Subject|0
5175503|NCT01271803|17869475|P2|Overall Study|Withdrawal by Subject|5
5175504|NCT01271803|17869476|P1|Overall Study|Withdrawal by Subject|1
5175505|NCT01271803|17869474|P3|Overall Study|Death|0
5175506|NCT01271803|17869475|P2|Overall Study|Death|34
5175507|NCT01271803|17869476|P1|Overall Study|Death|53
5175508|NCT01271803|17869474|P3|Overall Study|Progressive disease|2
5175509|NCT01271803|17869475|P2|Overall Study|Progressive disease|0
5175510|NCT01271803|17869476|P1|Overall Study|Progressive disease|0
5175511|NCT01271725|17869638|P2|Part B|Withdrawal by Subject|6
5175512|NCT01271725|17869639|P1|Part B|Withdrawal by Subject|0
5175513|NCT01271725|17869638|P2|Part B|Protocol Violation|1
5175514|NCT01271725|17869639|P1|Part B|Protocol Violation|0
5175515|NCT01271725|17869638|P2|Part B|Other Adverse Event|1
5175516|NCT01271725|17869639|P1|Part B|Other Adverse Event|0
5175517|NCT01271725|17869638|P2|Part B|Clinical signs/symptoms of progression|2
5175518|NCT01271725|17869639|P1|Part B|Clinical signs/symptoms of progression|0
5175519|NCT01271725|17869638|P2|Part B|Other than specified|2
5175520|NCT01271725|17869639|P1|Part B|Other than specified|0
5175521|NCT01271725|17869638|P2|Part A|Protocol Violation|0
5175522|NCT01271725|17869639|P1|Part A|Protocol Violation|1
5175523|NCT01271725|17869638|P2|Part A|Other than specified|0
5175524|NCT01271725|17869639|P1|Part A|Other than specified|3
5175525|NCT01271725|17869638|P2|Part A|Withdrawal by Subject|0
5175526|NCT01271725|17869639|P1|Part A|Withdrawal by Subject|12
5175527|NCT01271725|17869638|P2|Part A|Lost to Follow-up|0
5175528|NCT01271725|17869639|P1|Part A|Lost to Follow-up|1
5175529|NCT01271725|17869638|P2|Part A|Other Adverse Event|0
5175530|NCT01271725|17869639|P1|Part A|Other Adverse Event|8
5175531|NCT01271725|17869638|P2|Part A|Clinical signs/symptoms of progression|0
5175532|NCT01271725|17869639|P1|Part A|Clinical signs/symptoms of progression|2
5175533|NCT01271725|17869638|P2|Part A|Progressive disease according to RECIST|0
5175534|NCT01271725|17869639|P1|Part A|Progressive disease according to RECIST|8
5175535|NCT01271712|17869668|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
5175536|NCT01271712|17869669|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
5175537|NCT01271712|17869668|P2|Safety Follow-up|Progressive disease|0
5175538|NCT01271712|17869669|P1|Safety Follow-up|Progressive disease|1
5175539|NCT01271712|17869668|P2|Safety Follow-up|No follow-up|1
5175540|NCT01271712|17869669|P1|Safety Follow-up|No follow-up|1
5175541|NCT01271712|17869668|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
5175542|NCT01271712|17869669|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
5175543|NCT01271712|17869668|P2|Safety Follow-up|Protocol Violation|1
5175544|NCT01271712|17869669|P1|Safety Follow-up|Protocol Violation|1
5175545|NCT01271712|17869668|P2|Safety Follow-up|Withdrawal by Subject|2
5175546|NCT01271712|17869669|P1|Safety Follow-up|Withdrawal by Subject|4
5175547|NCT01271712|17869668|P2|Safety Follow-up|Death|7
5175548|NCT01271712|17869669|P1|Safety Follow-up|Death|11
5175549|NCT01271712|17869668|P2|Open Label Treatment|Switching to other therapy|1
5175550|NCT01271712|17869669|P1|Open Label Treatment|Switching to other therapy|2
5175551|NCT01271712|17869668|P2|Open Label Treatment|Protocol Violation|1
5175552|NCT01271712|17869669|P1|Open Label Treatment|Protocol Violation|0
5175553|NCT01271712|17869668|P2|Open Label Treatment|Non-compliance with study drug|0
5175554|NCT01271712|17869669|P1|Open Label Treatment|Non-compliance with study drug|1
5175555|NCT01271712|17869668|P2|Open Label Treatment|transferred to rollover study|0
5175556|NCT01271712|17869669|P1|Open Label Treatment|transferred to rollover study|1
5175557|NCT01271712|17869668|P2|Open Label Treatment|Progressive disease|32
5175558|NCT01271712|17869669|P1|Open Label Treatment|Progressive disease|59
5175559|NCT01271712|17869668|P2|Open Label Treatment|Adverse Event|8
5175560|NCT01271712|17869669|P1|Open Label Treatment|Adverse Event|14
5175561|NCT01271712|17869668|P2|Open Label Treatment|Physician Decision|0
5175562|NCT01271712|17869669|P1|Open Label Treatment|Physician Decision|2
5175563|NCT01271712|17869668|P2|Open Label Treatment|Withdrawal by Subject|11
5175564|NCT01271712|17869669|P1|Open Label Treatment|Withdrawal by Subject|6
5175565|NCT01271712|17869668|P2|Open Label Treatment|Death|5
5175566|NCT01271712|17869669|P1|Open Label Treatment|Death|6
5175567|NCT01271712|17869668|P2|Double Blind Treatment|receive no study drug|0
5175568|NCT01271712|17869669|P1|Double Blind Treatment|receive no study drug|1
5175569|NCT01271712|17869668|P2|Double Blind Treatment|Non compliance with study drug|0
5175570|NCT01271712|17869669|P1|Double Blind Treatment|Non compliance with study drug|2
5175571|NCT01271712|17869668|P2|Double Blind Treatment|Withdrawal by Subject|1
5175572|NCT01271712|17869669|P1|Double Blind Treatment|Withdrawal by Subject|4
5175573|NCT01271712|17869668|P2|Double Blind Treatment|Progressive disease|3
5175574|NCT01271712|17869669|P1|Double Blind Treatment|Progressive disease|23
5175575|NCT01271712|17869668|P2|Double Blind Treatment|Adverse Event|4
5175576|NCT01271712|17869669|P1|Double Blind Treatment|Adverse Event|9
5175577|NCT01271712|17869668|P2|Double Blind Treatment|Lack of Efficacy|0
5175578|NCT01271712|17869669|P1|Double Blind Treatment|Lack of Efficacy|1
5175579|NCT01271712|17869668|P2|Double Blind Treatment|Death|0
5175580|NCT01271712|17869669|P1|Double Blind Treatment|Death|2
5175581|NCT01271010|17869765|P1|Overall Study|Disease progression|27
5175582|NCT01271010|17869765|P1|Overall Study|Withdrawal by Subject|18
5175583|NCT01271010|17869765|P1|Overall Study|Progression and relapse of disease|1
5175584|NCT01271010|17869765|P1|Overall Study|Death|2
5175585|NCT01271010|17869765|P1|Overall Study|Protocol Violation|1
5175586|NCT01271010|17869765|P1|Overall Study|Start of new CLL therapy|1
5175587|NCT01271010|17869765|P1|Overall Study|Reason not specified|11
5175588|NCT01270971|17869780|P2|Overall Study|Non-specific|3
5175589|NCT01270971|17869781|P1|Overall Study|Non-specific|7
5175590|NCT01270971|17869780|P2|Overall Study|Non compliance|2
5175591|NCT01270971|17869781|P1|Overall Study|Non compliance|2
5175592|NCT01270971|17869780|P2|Overall Study|Adverse Event|2
5175593|NCT01270971|17869781|P1|Overall Study|Adverse Event|1
5175594|NCT01270971|17869780|P2|Overall Study|Lost to Follow-up|5
5175595|NCT01270971|17869781|P1|Overall Study|Lost to Follow-up|18
5175596|NCT01270971|17869780|P2|Overall Study|Withdrawal by Subject|11
5175597|NCT01270971|17869781|P1|Overall Study|Withdrawal by Subject|24
5175598|NCT01270958|17869793|P1|Overall Study|Did not meet inclusion criteria for age|2
5175599|NCT01270958|17869793|P1|Overall Study|Lost to Follow-up|2
5175600|NCT01270880|17869822|P1|Overall Study|Never rec'd treatment, but registered.|1
5175601|NCT01270841|17869852|P4|Overall Study|Enrolled in error|0
5175602|NCT01270841|17869853|P3|Overall Study|Enrolled in error|0
5175603|NCT01270841|17869854|P2|Overall Study|Enrolled in error|1
5175604|NCT01270841|17869855|P1|Overall Study|Enrolled in error|0
5175605|NCT01270841|17869852|P4|Overall Study|Protocol Violation|0
5175606|NCT01270841|17869853|P3|Overall Study|Protocol Violation|0
5175607|NCT01270841|17869854|P2|Overall Study|Protocol Violation|5
5175608|NCT01270841|17869855|P1|Overall Study|Protocol Violation|1
5175609|NCT01270841|17869852|P4|Overall Study|Did not qualify|5
5175610|NCT01270841|17869853|P3|Overall Study|Did not qualify|4
5175611|NCT01270841|17869854|P2|Overall Study|Did not qualify|3
5175612|NCT01270841|17869855|P1|Overall Study|Did not qualify|6
5175613|NCT01270841|17869852|P4|Overall Study|Physician Decision|0
5175614|NCT01270841|17869853|P3|Overall Study|Physician Decision|0
5175615|NCT01270841|17869854|P2|Overall Study|Physician Decision|1
5175616|NCT01270841|17869855|P1|Overall Study|Physician Decision|0
5175617|NCT01270841|17869852|P4|Overall Study|Lost to Follow-up|2
5175618|NCT01270841|17869853|P3|Overall Study|Lost to Follow-up|4
5175619|NCT01270841|17869854|P2|Overall Study|Lost to Follow-up|1
5175620|NCT01270841|17869855|P1|Overall Study|Lost to Follow-up|3
5175621|NCT01270841|17869852|P4|Overall Study|Withdrawal by Subject|3
5175622|NCT01270841|17869853|P3|Overall Study|Withdrawal by Subject|3
5175623|NCT01270841|17869854|P2|Overall Study|Withdrawal by Subject|2
5175624|NCT01270841|17869855|P1|Overall Study|Withdrawal by Subject|3
5175625|NCT01270841|17869852|P4|Overall Study|Adverse Event|3
5175626|NCT01270841|17869853|P3|Overall Study|Adverse Event|0
5175627|NCT01270841|17869854|P2|Overall Study|Adverse Event|1
5175628|NCT01270841|17869855|P1|Overall Study|Adverse Event|0
5175629|NCT01270828|17869879|P3|Double Blind Phase|Adverse event related to study drug|0
5175630|NCT01270828|17869880|P2|Double Blind Phase|Adverse event related to study drug|7
5175631|NCT01270828|17869881|P1|Double Blind Phase|Adverse event related to study drug|5
5175632|NCT01270828|17869879|P3|Double Blind Phase|Adverse event not related to study drug|0
5175633|NCT01270828|17869880|P2|Double Blind Phase|Adverse event not related to study drug|1
5175634|NCT01270828|17869881|P1|Double Blind Phase|Adverse event not related to study drug|1
5175635|NCT01270828|17869879|P3|Double Blind Phase|Lack of Efficacy|0
5175636|NCT01270828|17869880|P2|Double Blind Phase|Lack of Efficacy|11
5175637|NCT01270828|17869881|P1|Double Blind Phase|Lack of Efficacy|2
5175638|NCT01270828|17869879|P3|Double Blind Phase|Lost to Follow-up|0
5175639|NCT01270828|17869880|P2|Double Blind Phase|Lost to Follow-up|2
5175640|NCT01270828|17869881|P1|Double Blind Phase|Lost to Follow-up|1
5175641|NCT01270828|17869879|P3|Double Blind Phase|Withdrawal by Subject|0
5175642|NCT01270828|17869880|P2|Double Blind Phase|Withdrawal by Subject|15
5175643|NCT01270828|17869881|P1|Double Blind Phase|Withdrawal by Subject|6
5175644|NCT01270828|17869879|P3|Double Blind Phase|Reason Unspecified|0
5175645|NCT01270828|17869880|P2|Double Blind Phase|Reason Unspecified|4
5175646|NCT01270828|17869881|P1|Double Blind Phase|Reason Unspecified|7
5175647|NCT01270828|17869879|P3|Double Blind Phase|Protocol and GCP non-compliance|0
5175648|NCT01270828|17869880|P2|Double Blind Phase|Protocol and GCP non-compliance|3
5175649|NCT01270828|17869881|P1|Double Blind Phase|Protocol and GCP non-compliance|4
5175650|NCT01270828|17869879|P3|Double Blind Phase|Protocol Violation|0
5175651|NCT01270828|17869880|P2|Double Blind Phase|Protocol Violation|1
5175652|NCT01270828|17869881|P1|Double Blind Phase|Protocol Violation|0
5175653|NCT01270828|17869879|P3|Double Blind Phase|Death|0
5175654|NCT01270828|17869880|P2|Double Blind Phase|Death|1
5175655|NCT01270828|17869881|P1|Double Blind Phase|Death|0
5175656|NCT01270828|17869879|P3|Pregabalin CR SB|Protocol Violation|8
5175657|NCT01270828|17869880|P2|Pregabalin CR SB|Protocol Violation|0
5175658|NCT01270828|17869881|P1|Pregabalin CR SB|Protocol Violation|0
5175659|NCT01270828|17869879|P3|Pregabalin CR SB|Unrelated AE|8
5175660|NCT01270828|17869880|P2|Pregabalin CR SB|Unrelated AE|0
5175661|NCT01270828|17869881|P1|Pregabalin CR SB|Unrelated AE|0
5175662|NCT01270828|17869879|P3|Pregabalin CR SB|Lost to Follow-up|10
5175663|NCT01270828|17869880|P2|Pregabalin CR SB|Lost to Follow-up|0
5175664|NCT01270828|17869881|P1|Pregabalin CR SB|Lost to Follow-up|0
5175665|NCT01270828|17869879|P3|Pregabalin CR SB|Withdrawal by Subject|29
5175666|NCT01270828|17869880|P2|Pregabalin CR SB|Withdrawal by Subject|0
5175667|NCT01270828|17869881|P1|Pregabalin CR SB|Withdrawal by Subject|0
5175668|NCT01270828|17869879|P3|Pregabalin CR SB|Lack of Efficacy|32
5175669|NCT01270828|17869880|P2|Pregabalin CR SB|Lack of Efficacy|0
5175670|NCT01270828|17869881|P1|Pregabalin CR SB|Lack of Efficacy|0
5175671|NCT01270828|17869879|P3|Pregabalin CR SB|Related adverse event|46
5175672|NCT01270828|17869880|P2|Pregabalin CR SB|Related adverse event|0
5175673|NCT01270828|17869881|P1|Pregabalin CR SB|Related adverse event|0
5175674|NCT01270828|17869879|P3|Pregabalin CR SB|Enrolled but not treated|5
5175675|NCT01270828|17869880|P2|Pregabalin CR SB|Enrolled but not treated|0
5175676|NCT01270828|17869881|P1|Pregabalin CR SB|Enrolled but not treated|0
5175677|NCT01270828|17869879|P3|Pregabalin CR SB|Reason Unspecified|8
5175678|NCT01270828|17869880|P2|Pregabalin CR SB|Reason Unspecified|0
5175679|NCT01270828|17869881|P1|Pregabalin CR SB|Reason Unspecified|0
5175680|NCT01270802|17869923|P2|Overall Study|Lost to Follow-up|1
5175681|NCT01270802|17869924|P1|Overall Study|Lost to Follow-up|0
5175682|NCT01270802|17869923|P2|Overall Study|Adverse Event|0
5175683|NCT01270802|17869924|P1|Overall Study|Adverse Event|1
5175684|NCT01270802|17869923|P2|Overall Study|Withdrawal by Subject|0
5175685|NCT01270802|17869924|P1|Overall Study|Withdrawal by Subject|1
5175686|NCT01270620|17870071|P2|Overall Study|Withdrawal by Subject|3
5175687|NCT01270620|17870072|P1|Overall Study|Withdrawal by Subject|1
5175688|NCT01270503|17870167|P1|Overall Study|Lost to Follow-up|1
5175689|NCT01270464|17870175|P3|Overall Study|Other|3
5175690|NCT01270464|17870176|P2|Overall Study|Other|1
5175691|NCT01270464|17870177|P1|Overall Study|Other|1
5175692|NCT01270464|17870175|P3|Overall Study|Lost to Follow-up|1
5175693|NCT01270464|17870176|P2|Overall Study|Lost to Follow-up|3
5175694|NCT01270464|17870177|P1|Overall Study|Lost to Follow-up|2
5175695|NCT01270464|17870175|P3|Overall Study|Withdrawal by Subject|4
5175696|NCT01270464|17870176|P2|Overall Study|Withdrawal by Subject|1
5175697|NCT01270464|17870177|P1|Overall Study|Withdrawal by Subject|2
5175698|NCT01270464|17870175|P3|Overall Study|Adverse Event|7
5175699|NCT01270464|17870176|P2|Overall Study|Adverse Event|1
5175700|NCT01270464|17870177|P1|Overall Study|Adverse Event|9
5175701|NCT01270464|17870175|P3|Overall Study|Lack of Efficacy|1
5175702|NCT01270464|17870176|P2|Overall Study|Lack of Efficacy|3
5175703|NCT01270464|17870177|P1|Overall Study|Lack of Efficacy|2
5175704|NCT01270464|17870175|P3|Overall Study|Protocol Violation|2
5175705|NCT01270464|17870176|P2|Overall Study|Protocol Violation|3
5175706|NCT01270464|17870177|P1|Overall Study|Protocol Violation|4
5175707|NCT01270321|17870227|P3|Overall Study|Adverse Event|5
5175708|NCT01270321|17870228|P2|Overall Study|Adverse Event|9
5175709|NCT01270321|17870229|P1|Overall Study|Adverse Event|7
5175710|NCT01270321|17870227|P3|Overall Study|Death|4
5175711|NCT01270321|17870228|P2|Overall Study|Death|1
5175712|NCT01270321|17870229|P1|Overall Study|Death|3
5175713|NCT01270256|17870242|P2|Overall Study|Withdrawal by Subject|0
5175714|NCT01270256|17870243|P1|Overall Study|Withdrawal by Subject|1
5175715|NCT01270139|17870252|P3|Overall Study|Lost to Follow-up|2
5175716|NCT01270139|17870253|P2|Overall Study|Lost to Follow-up|9
5175717|NCT01270139|17870254|P1|Overall Study|Lost to Follow-up|10
5175718|NCT01270139|17870252|P3|Overall Study|Adverse Event|18
5175719|NCT01270139|17870253|P2|Overall Study|Adverse Event|17
5175720|NCT01270139|17870254|P1|Overall Study|Adverse Event|8
5175721|NCT01269918|17870323|P2|Overall Study|Did not receive study drug|3
5175722|NCT01269918|17870324|P1|Overall Study|Did not receive study drug|0
5175723|NCT01269385|17870399|P4|Overall Study|Adverse Event|0
5175724|NCT01269385|17870400|P3|Overall Study|Adverse Event|0
5175725|NCT01269385|17870401|P2|Overall Study|Adverse Event|1
5175726|NCT01269385|17870402|P1|Overall Study|Adverse Event|1
5175727|NCT01269346|17870427|P1|Extension Phase|Started a prohibited con med|1
5175728|NCT01269346|17870427|P1|Extension Phase|Clinical progression|1
5175729|NCT01269346|17870427|P1|Extension Phase|Physician decision or participant choice|9
5175730|NCT01269346|17870427|P1|Extension Phase|Disease progression|22
5175731|NCT01269346|17870427|P1|Extension Phase|Withdrawal by Subject|4
5175732|NCT01269346|17870427|P1|Extension Phase|Adverse Event|6
5175733|NCT01269346|17870427|P1|Treatment Phase|Other|2
5175734|NCT01269346|17870427|P1|Treatment Phase|Withdrawal by Subject|1
5175735|NCT01269346|17870427|P1|Treatment Phase|Adverse Event|3
5175736|NCT01269346|17870427|P1|Treatment Phase|Disease progression|3
5175737|NCT01269125|17870438|P3|Overall Study|Lost to Follow-up|0
5175738|NCT01269125|17870439|P2|Overall Study|Lost to Follow-up|0
5175739|NCT01269125|17870440|P1|Overall Study|Lost to Follow-up|4
5175740|NCT01269125|17870438|P3|Overall Study|Adverse Event|0
5175741|NCT01269125|17870439|P2|Overall Study|Adverse Event|5
5175742|NCT01269125|17870440|P1|Overall Study|Adverse Event|3
5175743|NCT01268891|17870499|P2|Overall Study|Administrative or other reason(s)|0
5175744|NCT01268891|17870500|P1|Overall Study|Administrative or other reason(s)|1
5175745|NCT01268891|17870499|P2|Overall Study|Withdrawal of Consent|1
5175746|NCT01268891|17870500|P1|Overall Study|Withdrawal of Consent|3
5175747|NCT01268891|17870499|P2|Overall Study|Lack of Efficacy|0
5175748|NCT01268891|17870500|P1|Overall Study|Lack of Efficacy|1
5175749|NCT01268891|17870499|P2|Overall Study|Adverse Event|7
5175750|NCT01268891|17870500|P1|Overall Study|Adverse Event|3
5175751|NCT01268566|17870526|P1|Overall Study|Death|30
5175752|NCT01268566|17870526|P1|Overall Study|Withdrawal by Subject|12
5175753|NCT01268566|17870526|P1|Overall Study|Lost to Follow-up|1
5175754|NCT01268514|17870553|P1|Overall Study|Withdrawal by Surgeon|5
5175755|NCT01268514|17870553|P1|Overall Study|Withdrawal by Subject|3
5175756|NCT01268514|17870553|P1|Overall Study|Lost to Follow-up|5
5175757|NCT01268514|17870553|P1|Overall Study|Death|8
5175758|NCT01268514|17870553|P1|Overall Study|Adverse Event|20
5175759|NCT01268501|17870562|P1|Overall Study|Handling Difficulties|2
5175760|NCT01268501|17870562|P1|Overall Study|Unacceptable Subjective Vision|3
5175761|NCT01268501|17870562|P1|Overall Study|Withdrawal by Subject|3
5175762|NCT01268501|17870562|P1|Overall Study|Lost to Follow-up|1
5175763|NCT01268488|17870566|P1|Overall Study|Physician Decision|2
5175764|NCT01268488|17870566|P1|Overall Study|Adverse Event|3
5175765|NCT01268306|17870573|P1|Overall Study|Lost to Follow-up|1
5175766|NCT01268293|17870577|P1|Overall Study|Subject choice|1
5175767|NCT01268293|17870577|P1|Overall Study|Adverse Event|1
5175768|NCT01268293|17870577|P1|Overall Study|Disease progression|7
5175769|NCT01268267|17870582|P1|Overall Study|Protocol Violation|1
5175770|NCT01268150|17870603|P1|Extension Phase|Other|6
5175771|NCT01268150|17870603|P1|Extension Phase|Disease progression|18
5175772|NCT01268150|17870603|P1|Extension Phase|Adverse Event|3
5175773|NCT01268150|17870603|P1|Treatment Phase|Other|4
5175774|NCT01268150|17870603|P1|Treatment Phase|Withdrawal by Subject|3
5175775|NCT01268150|17870603|P1|Treatment Phase|Adverse Event|3
5175776|NCT01268150|17870603|P1|Treatment Phase|Progression of disease|18
5175777|NCT01268098|17870622|P2|Overall Study|Adverse Event|0
5175778|NCT01268098|17870623|P1|Overall Study|Adverse Event|1
5175779|NCT01268046|17870635|P4|Overall Study|Lost to Follow-up|0
5175780|NCT01268046|17870636|P3|Overall Study|Lost to Follow-up|1
5175781|NCT01268046|17870637|P2|Overall Study|Lost to Follow-up|0
5175782|NCT01268046|17870638|P1|Overall Study|Lost to Follow-up|0
5175783|NCT01268046|17870635|P4|Overall Study|Withdrawal by Subject|1
5175784|NCT01268046|17870636|P3|Overall Study|Withdrawal by Subject|0
5175785|NCT01268046|17870637|P2|Overall Study|Withdrawal by Subject|0
5175786|NCT01268046|17870638|P1|Overall Study|Withdrawal by Subject|1
5175787|NCT01267994|17870648|P1|Overall Study|Adverse Event|2
5175788|NCT01267955|17870653|P1|Stage 2 (6 Months)|Protocol Violation|1
5175789|NCT01267955|17870653|P1|Stage 2 (6 Months)|Death|5
5175790|NCT01267955|17870653|P1|Stage 1 (6 Months)|Death|3
5175791|NCT01267825|17870690|P2|Overall Study|study terminated. no data collected.|0
5175792|NCT01267825|17870691|P1|Overall Study|study terminated. no data collected.|1
5175793|NCT01267266|17870773|P2|Lead-in Phase|Withdrawal by Subject|0
5175794|NCT01267266|17870774|P1|Lead-in Phase|Withdrawal by Subject|1
5175795|NCT01267266|17870773|P2|Lead-in Phase|Adverse Event|0
5175796|NCT01267266|17870774|P1|Lead-in Phase|Adverse Event|2
5175797|NCT01267266|17870773|P2|Lead-in Phase|Lack of Efficacy|0
5175798|NCT01267266|17870774|P1|Lead-in Phase|Lack of Efficacy|20
5175799|NCT01267266|17870773|P2|Enrollment Phase|Withdrawal by Subject|0
5175800|NCT01267266|17870774|P1|Enrollment Phase|Withdrawal by Subject|2
5175801|NCT01267253|17870787|P1|Overall Study|Inevaluable-never received study treatme|2
5175802|NCT01267253|17870787|P1|Overall Study|Ineligible - required test not done|1
5175803|NCT01267201|17870826|P6|Second Intervention Period|Withdrawal by Subject|0
5175804|NCT01267201|17870827|P5|Second Intervention Period|Withdrawal by Subject|0
5175805|NCT01267201|17870828|P4|Second Intervention Period|Withdrawal by Subject|0
5175806|NCT01267201|17870829|P3|Second Intervention Period|Withdrawal by Subject|0
5175807|NCT01267201|17870830|P2|Second Intervention Period|Withdrawal by Subject|1
5175808|NCT01267201|17870831|P1|Second Intervention Period|Withdrawal by Subject|0
5175809|NCT01267201|17870826|P6|First Intervention Period|Withdrawal by Subject|0
5175810|NCT01267201|17870827|P5|First Intervention Period|Withdrawal by Subject|0
5175811|NCT01267201|17870828|P4|First Intervention Period|Withdrawal by Subject|0
5175812|NCT01267201|17870829|P3|First Intervention Period|Withdrawal by Subject|0
5175813|NCT01267201|17870830|P2|First Intervention Period|Withdrawal by Subject|0
5175814|NCT01267201|17870831|P1|First Intervention Period|Withdrawal by Subject|1
5175815|NCT01267175|17870848|P1|Overall Study|Lost to Follow-up|1
5175816|NCT01267175|17870848|P1|Overall Study|Withdrawal by Subject|1
5175817|NCT01266993|17870920|P2|Booster Phase (Month 68-69)|Withdrawal by Subject|1
5175818|NCT01266993|17870921|P1|Booster Phase (Month 68-69)|Withdrawal by Subject|0
5175819|NCT01266993|17870920|P2|Booster Phase (Month 68-69)|Lost to Follow-up|1
5175820|NCT01266993|17870921|P1|Booster Phase (Month 68-69)|Lost to Follow-up|5
5175821|NCT01266967|17870991|P2|Overall Study|Withdrawal by Subject|3
5175822|NCT01266967|17870992|P1|Overall Study|Withdrawal by Subject|3
5175823|NCT01266967|17870991|P2|Overall Study|Physician Decision|1
5175824|NCT01266967|17870992|P1|Overall Study|Physician Decision|0
5175825|NCT01266967|17870991|P2|Overall Study|Lost to Follow-up|1
5175826|NCT01266967|17870992|P1|Overall Study|Lost to Follow-up|2
5175827|NCT01266967|17870991|P2|Overall Study|Study Closed/Terminated|17
5175828|NCT01266967|17870992|P1|Overall Study|Study Closed/Terminated|15
5175829|NCT01266967|17870991|P2|Overall Study|Death|61
5175830|NCT01266967|17870992|P1|Overall Study|Death|69
5175831|NCT01266876|17871044|P5|Overall Study|Adverse Event|0
5175832|NCT01266876|17871045|P4|Overall Study|Adverse Event|1
5175833|NCT01266876|17871046|P3|Overall Study|Adverse Event|0
5175834|NCT01266876|17871047|P2|Overall Study|Adverse Event|0
5175835|NCT01266876|17871048|P1|Overall Study|Adverse Event|0
5175836|NCT01266850|17871155|P5|Overall Study|Site Closure|0
5175837|NCT01266850|17871156|P4|Overall Study|Site Closure|1
5175838|NCT01266850|17871157|P3|Overall Study|Site Closure|1
5175839|NCT01266850|17871158|P2|Overall Study|Site Closure|1
5175840|NCT01266850|17871159|P1|Overall Study|Site Closure|0
5175841|NCT01266850|17871155|P5|Overall Study|Adverse Event|1
5175842|NCT01266850|17871156|P4|Overall Study|Adverse Event|0
5175843|NCT01266850|17871157|P3|Overall Study|Adverse Event|0
5175844|NCT01266850|17871158|P2|Overall Study|Adverse Event|0
5175845|NCT01266850|17871159|P1|Overall Study|Adverse Event|0
5175846|NCT01266850|17871155|P5|Overall Study|Protocol Violation|2
5175847|NCT01266850|17871156|P4|Overall Study|Protocol Violation|1
5175848|NCT01266850|17871157|P3|Overall Study|Protocol Violation|0
5175849|NCT01266850|17871158|P2|Overall Study|Protocol Violation|1
5175850|NCT01266850|17871159|P1|Overall Study|Protocol Violation|0
5175851|NCT01266850|17871155|P5|Overall Study|Physician Decision|3
5175852|NCT01266850|17871156|P4|Overall Study|Physician Decision|4
5175853|NCT01266850|17871157|P3|Overall Study|Physician Decision|4
5175854|NCT01266850|17871158|P2|Overall Study|Physician Decision|6
5175855|NCT01266850|17871159|P1|Overall Study|Physician Decision|3
5175856|NCT01266850|17871155|P5|Overall Study|Withdrawal by Subject|12
5175857|NCT01266850|17871156|P4|Overall Study|Withdrawal by Subject|9
5175858|NCT01266850|17871157|P3|Overall Study|Withdrawal by Subject|6
5175859|NCT01266850|17871158|P2|Overall Study|Withdrawal by Subject|9
5175860|NCT01266850|17871159|P1|Overall Study|Withdrawal by Subject|8
5175861|NCT01266850|17871155|P5|Overall Study|Lost to Follow-up|12
5175862|NCT01266850|17871156|P4|Overall Study|Lost to Follow-up|13
5175863|NCT01266850|17871157|P3|Overall Study|Lost to Follow-up|13
5175864|NCT01266850|17871158|P2|Overall Study|Lost to Follow-up|19
5175865|NCT01266850|17871159|P1|Overall Study|Lost to Follow-up|19
5175866|NCT01266824|17871213|P2|Overall Study|Study terminated prior to completion|3
5175867|NCT01266824|17871214|P1|Overall Study|Study terminated prior to completion|2
5175868|NCT01266603|17871226|P1|Overall Study|Failed screening; MAGE-A3 negative|26
5175869|NCT01266603|17871226|P1|Overall Study|Withdrawal by Subject|1
5175870|NCT01266603|17871226|P1|Overall Study|Lack of Efficacy|14
5175871|NCT01266603|17871226|P1|Overall Study|Adverse Event|1
5175872|NCT01266590|17871232|P1|Overall Study|Physician Decision|1
5175873|NCT01266590|17871232|P1|Overall Study|Withdrawal by Subject|1
5175874|NCT01266590|17871232|P1|Overall Study|Lost to Follow-up|1
5175875|NCT01266590|17871232|P1|Overall Study|Adverse Event|3
5175876|NCT01266460|17871243|P1|Overall Study|Not otherwise specified|8
5175877|NCT01266460|17871243|P1|Overall Study|Disease Progression|18
5175878|NCT01266460|17871243|P1|Overall Study|Withdrawal by Subject|5
5175879|NCT01266460|17871243|P1|Overall Study|Adverse Event|3
5175880|NCT01266317|17871261|P1|Overall Study|Withdrawal by Subject|2
5175881|NCT01266291|17871266|P1|Overall Study|Adverse Event|1
5175882|NCT01266265|17871273|P2|Overall Study|Clinical worsening|1
5175883|NCT01266265|17871274|P1|Overall Study|Clinical worsening|1
5175884|NCT01266265|17871273|P2|Overall Study|Site closed early|3
5175885|NCT01266265|17871274|P1|Overall Study|Site closed early|4
5175886|NCT01266265|17871273|P2|Overall Study|Lung transplant|5
5175887|NCT01266265|17871274|P1|Overall Study|Lung transplant|6
5175888|NCT01266265|17871273|P2|Overall Study|Non-compliance|5
5175889|NCT01266265|17871274|P1|Overall Study|Non-compliance|8
5175890|NCT01266265|17871273|P2|Overall Study|Enrolled in another clinical study|26
5175891|NCT01266265|17871274|P1|Overall Study|Enrolled in another clinical study|15
5175892|NCT01266265|17871273|P2|Overall Study|Stopped/changed PAH medication(s)|9
5175893|NCT01266265|17871274|P1|Overall Study|Stopped/changed PAH medication(s)|16
5175894|NCT01266265|17871273|P2|Overall Study|Transferred care to another provider|28
5175895|NCT01266265|17871274|P1|Overall Study|Transferred care to another provider|22
5175896|NCT01266265|17871273|P2|Overall Study|Respiratory-related adverse event|1
5175897|NCT01266265|17871274|P1|Overall Study|Respiratory-related adverse event|2
5175898|NCT01266265|17871273|P2|Overall Study|Withdrawal by Subject|11
5175899|NCT01266265|17871274|P1|Overall Study|Withdrawal by Subject|13
5175900|NCT01266265|17871273|P2|Overall Study|Lost to Follow-up|28
5175901|NCT01266265|17871274|P1|Overall Study|Lost to Follow-up|23
5175902|NCT01266265|17871273|P2|Overall Study|Death|73
5175903|NCT01266265|17871274|P1|Overall Study|Death|95
5175904|NCT01266161|17871282|P2|Overall Study|Vomited within 4 hours of dosing|0
5175905|NCT01266161|17871283|P1|Overall Study|Vomited within 4 hours of dosing|3
5175906|NCT01266161|17871282|P2|Overall Study|Lack of Efficacy|1
5175907|NCT01266161|17871283|P1|Overall Study|Lack of Efficacy|0
5175908|NCT01266161|17871282|P2|Overall Study|Ineligible|0
5175909|NCT01266161|17871283|P1|Overall Study|Ineligible|1
5175910|NCT01266148|17871315|P2|Overall Study|missing mGFR value + AE|0
5175911|NCT01266148|17871316|P1|Overall Study|missing mGFR value + AE|1
5175912|NCT01266148|17871315|P2|Overall Study|Death|3
5175913|NCT01266148|17871316|P1|Overall Study|Death|2
5175914|NCT01266148|17871315|P2|Overall Study|2 2R rejections|0
5175915|NCT01266148|17871316|P1|Overall Study|2 2R rejections|1
5175916|NCT01266148|17871315|P2|Overall Study|Ongoing rejection|0
5175917|NCT01266148|17871316|P1|Overall Study|Ongoing rejection|1
5175918|NCT01266148|17871315|P2|Overall Study|Adverse Event|0
5175919|NCT01266148|17871316|P1|Overall Study|Adverse Event|2
5175920|NCT01266122|17871344|P2|Overall Study|Lost to Follow-up|6
5175921|NCT01266122|17871345|P1|Overall Study|Lost to Follow-up|6
5175922|NCT01266070|17871353|P1|Overall Study|Protocol Violation|1
5175923|NCT01266070|17871353|P1|Overall Study|Adverse Event|3
5175924|NCT01266031|17871361|P3|Overall Study|Not treated|2
5175925|NCT01266031|17871362|P2|Overall Study|Not treated|3
5175926|NCT01266031|17871363|P1|Overall Study|Not treated|0
5175927|NCT01266018|17871390|P2|Overall Study|Progressive disease|1
5175928|NCT01266018|17871391|P1|Overall Study|Progressive disease|0
5175929|NCT01266018|17871390|P2|Overall Study|Physician Decision|0
5175930|NCT01266018|17871391|P1|Overall Study|Physician Decision|1
5175931|NCT01265992|17871402|P1|Overall Study|Did not receive treatment|1
5175932|NCT01265992|17871402|P1|Overall Study|Stopped treatment|3
5175933|NCT01265992|17871402|P1|Overall Study|Administrative reasons|2
5175934|NCT01265992|17871402|P1|Overall Study|Adverse Event|1
5175935|NCT01265992|17871402|P1|Overall Study|Withdrawal by Subject|1
5175936|NCT01265992|17871402|P1|Overall Study|Lost to Follow-up|1
5175937|NCT01265953|17871430|P2|Overall Study|Non compliance|3
5175938|NCT01265953|17871431|P1|Overall Study|Non compliance|5
5175939|NCT01265875|17871443|P1|Overall Study|Uncooperative/unreliable|1
5175940|NCT01265823|17871451|P1|Overall Study|Participant Request|1
5175941|NCT01265823|17871451|P1|Overall Study|Protocol Violation|1
5175942|NCT01265823|17871451|P1|Overall Study|Failure to Return|4
5175943|NCT01265823|17871451|P1|Overall Study|Unsatisfactory Response Efficacy|1
5175944|NCT01265797|17871480|P2|Open Label Month|Lost to Follow-up|1
5175945|NCT01265797|17871481|P1|Open Label Month|Lost to Follow-up|0
5175946|NCT01265797|17871480|P2|Blinded Month|Diary data incomplete|1
5175947|NCT01265797|17871481|P1|Blinded Month|Diary data incomplete|0
5175948|NCT01265797|17871480|P2|Blinded Month|Adverse Event|0
5175949|NCT01265797|17871481|P1|Blinded Month|Adverse Event|2
5175950|NCT01265797|17871480|P2|Blinded Month|Protocol Violation|1
5175951|NCT01265797|17871481|P1|Blinded Month|Protocol Violation|2
5175952|NCT01265797|17871480|P2|Blinded Month|Lost to Follow-up|0
5175953|NCT01265797|17871481|P1|Blinded Month|Lost to Follow-up|1
5175954|NCT01265797|17871480|P2|Blinded Month|Lack of Efficacy|0
5175955|NCT01265797|17871481|P1|Blinded Month|Lack of Efficacy|5
5175956|NCT01265797|17871480|P2|Run-in Month|1st seizure during run-in month|1
5175957|NCT01265797|17871481|P1|Run-in Month|1st seizure during run-in month|0
5175958|NCT01265797|17871480|P2|Run-in Month|Withdrawal by Subject|4
5175959|NCT01265797|17871481|P1|Run-in Month|Withdrawal by Subject|0
5175960|NCT01265784|17871512|P3|Overall Study|Incorrectly Randomized|1
5175961|NCT01265784|17871513|P2|Overall Study|Incorrectly Randomized|0
5175962|NCT01265784|17871514|P1|Overall Study|Incorrectly Randomized|0
5175963|NCT01265784|17871512|P3|Overall Study|Protocol Violation|0
5175964|NCT01265784|17871513|P2|Overall Study|Protocol Violation|0
5175965|NCT01265784|17871514|P1|Overall Study|Protocol Violation|2
5175966|NCT01265784|17871512|P3|Overall Study|Death|0
5175967|NCT01265784|17871513|P2|Overall Study|Death|0
5175968|NCT01265784|17871514|P1|Overall Study|Death|3
5175969|NCT01265784|17871512|P3|Overall Study|Adverse Event|0
5175970|NCT01265784|17871513|P2|Overall Study|Adverse Event|0
5175971|NCT01265784|17871514|P1|Overall Study|Adverse Event|1
5175972|NCT01265784|17871512|P3|Overall Study|Physician Decision|1
5175973|NCT01265784|17871513|P2|Overall Study|Physician Decision|0
5175974|NCT01265784|17871514|P1|Overall Study|Physician Decision|1
5175975|NCT01265784|17871512|P3|Overall Study|Withdrawal by Subject|0
5175976|NCT01265784|17871513|P2|Overall Study|Withdrawal by Subject|5
5175977|NCT01265784|17871514|P1|Overall Study|Withdrawal by Subject|0
5175978|NCT01265784|17871512|P3|Overall Study|Lost to Follow-up|2
5175979|NCT01265784|17871513|P2|Overall Study|Lost to Follow-up|3
5175980|NCT01265784|17871514|P1|Overall Study|Lost to Follow-up|5
5175981|NCT01265719|17871582|P2|Overall Study|Adverse Event|0
5175982|NCT01265719|17871583|P1|Overall Study|Adverse Event|2
5175983|NCT01265719|17871582|P2|Overall Study|Lost to Follow-up|7
5175984|NCT01265719|17871583|P1|Overall Study|Lost to Follow-up|2
5175985|NCT01265719|17871582|P2|Overall Study|Withdrawal by Subject|3
5175986|NCT01265719|17871583|P1|Overall Study|Withdrawal by Subject|8
5175987|NCT01265719|17871582|P2|Overall Study|Other reasons|0
5175988|NCT01265719|17871583|P1|Overall Study|Other reasons|2
5175989|NCT01265719|17871582|P2|Overall Study|Does not meet entrance criteria|3
5175990|NCT01265719|17871583|P1|Overall Study|Does not meet entrance criteria|0
5175991|NCT01265615|17871634|P4|Overall Study|Protocol Violation|3
5175992|NCT01265615|17871635|P3|Overall Study|Protocol Violation|4
5175993|NCT01265615|17871636|P2|Overall Study|Protocol Violation|2
5175994|NCT01265615|17871637|P1|Overall Study|Protocol Violation|2
5175995|NCT01265563|17871688|P5|Overall Study|Withdrawal by Subject|2
5175996|NCT01265563|17871689|P4|Overall Study|Withdrawal by Subject|0
5175997|NCT01265563|17871690|P3|Overall Study|Withdrawal by Subject|1
5175998|NCT01265563|17871691|P2|Overall Study|Withdrawal by Subject|1
5175999|NCT01265563|17871692|P1|Overall Study|Withdrawal by Subject|0
5176000|NCT01265550|17871718|P4|Pre Randomization|Functional heartburn|99
5176001|NCT01265550|17871719|P3|Pre Randomization|Functional heartburn|0
5176002|NCT01265550|17871720|P2|Pre Randomization|Functional heartburn|0
5176003|NCT01265550|17871721|P1|Pre Randomization|Functional heartburn|0
5176004|NCT01265550|17871718|P4|Pre Randomization|Non-GERD organic disorders|23
5176005|NCT01265550|17871719|P3|Pre Randomization|Non-GERD organic disorders|0
5176006|NCT01265550|17871720|P2|Pre Randomization|Non-GERD organic disorders|0
5176007|NCT01265550|17871721|P1|Pre Randomization|Non-GERD organic disorders|0
5176008|NCT01265550|17871718|P4|Pre Randomization|GERD, PPI-Responsive|42
5176009|NCT01265550|17871719|P3|Pre Randomization|GERD, PPI-Responsive|0
5176010|NCT01265550|17871720|P2|Pre Randomization|GERD, PPI-Responsive|0
5176011|NCT01265550|17871721|P1|Pre Randomization|GERD, PPI-Responsive|0
5176012|NCT01265550|17871718|P4|Pre Randomization|Technical Exclusions|54
5176013|NCT01265550|17871719|P3|Pre Randomization|Technical Exclusions|0
5176014|NCT01265550|17871720|P2|Pre Randomization|Technical Exclusions|0
5176015|NCT01265550|17871721|P1|Pre Randomization|Technical Exclusions|0
5176016|NCT01265550|17871718|P4|Pre Randomization|Withdrawal by Subject|70
5176017|NCT01265550|17871719|P3|Pre Randomization|Withdrawal by Subject|0
5176018|NCT01265550|17871720|P2|Pre Randomization|Withdrawal by Subject|0
5176019|NCT01265550|17871721|P1|Pre Randomization|Withdrawal by Subject|0
5176020|NCT01265537|17871813|P2|Overall Study|Physician Decision|1
5176021|NCT01265537|17871814|P1|Overall Study|Physician Decision|0
5176022|NCT01265537|17871813|P2|Overall Study|Adverse Event|1
5176023|NCT01265537|17871814|P1|Overall Study|Adverse Event|2
5176024|NCT01265511|17871865|P2|Overall Study|Met stopping rules|2
5176025|NCT01265511|17871866|P1|Overall Study|Met stopping rules|0
5176026|NCT01265511|17871865|P2|Overall Study|Lack of Efficacy|1
5176027|NCT01265511|17871866|P1|Overall Study|Lack of Efficacy|2
5176028|NCT01265498|17871880|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
5176029|NCT01265498|17871881|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
5176030|NCT01265420|17872017|P1|Overall Study|Lost to Follow-up|1
5176031|NCT01265394|17872021|P1|Overall Study|Subjects withdrawn|37
5176032|NCT01265056|17872028|P2|Follow up|Lost to Follow-up|3
5176033|NCT01265056|17872029|P1|Follow up|Lost to Follow-up|7
5176034|NCT01265056|17872028|P2|Initial Study Period|Withdrawal by Subject|1
5176035|NCT01265056|17872029|P1|Initial Study Period|Withdrawal by Subject|1
5176036|NCT01265056|17872028|P2|Initial Study Period|Withdrawal by Subject|1
5176037|NCT01265056|17872029|P1|Initial Study Period|Withdrawal by Subject|1
5176038|NCT01264939|17872060|P2|Overall Study|Disease Progression|11
5176039|NCT01264939|17872061|P1|Overall Study|Disease Progression|8
5176040|NCT01264939|17872060|P2|Overall Study|Patient/Guardian Decision|10
5176041|NCT01264939|17872061|P1|Overall Study|Patient/Guardian Decision|8
5176042|NCT01264939|17872060|P2|Overall Study|Physician Decision|1
5176043|NCT01264939|17872061|P1|Overall Study|Physician Decision|1
5176044|NCT01264939|17872060|P2|Overall Study|Lost to Follow-up|3
5176045|NCT01264939|17872061|P1|Overall Study|Lost to Follow-up|0
5176046|NCT01264939|17872060|P2|Overall Study|Adverse Event|3
5176047|NCT01264939|17872061|P1|Overall Study|Adverse Event|1
5176048|NCT01264887|17872087|P1|Overall Study|Other|2
5176049|NCT01264887|17872087|P1|Overall Study|Sponsor Decision Administrative Reasons|2
5176050|NCT01264887|17872087|P1|Overall Study|Withdrawal by Subject|6
5176051|NCT01264887|17872087|P1|Overall Study|Physician Decision|4
5176052|NCT01264887|17872087|P1|Overall Study|Lack of Efficacy|5
5176053|NCT01264887|17872087|P1|Overall Study|Death|7
5176054|NCT01264887|17872087|P1|Overall Study|Adverse Event|5
5176055|NCT01264835|17872098|P1|Overall Study|Lost to Follow-up|1
5176056|NCT01264770|17872108|P6|Overall Study|Adverse Event|1
5176057|NCT01264770|17872109|P5|Overall Study|Adverse Event|2
5176058|NCT01264770|17872110|P4|Overall Study|Adverse Event|0
5176059|NCT01264770|17872111|P3|Overall Study|Adverse Event|8
5176060|NCT01264770|17872112|P2|Overall Study|Adverse Event|7
5176061|NCT01264770|17872113|P1|Overall Study|Adverse Event|7
5176062|NCT01264770|17872108|P6|Overall Study|Lost to Follow-up|0
5176063|NCT01264770|17872109|P5|Overall Study|Lost to Follow-up|0
5176064|NCT01264770|17872110|P4|Overall Study|Lost to Follow-up|1
5176065|NCT01264770|17872111|P3|Overall Study|Lost to Follow-up|1
5176066|NCT01264770|17872112|P2|Overall Study|Lost to Follow-up|0
5176067|NCT01264770|17872113|P1|Overall Study|Lost to Follow-up|0
5176068|NCT01264770|17872108|P6|Overall Study|Dev. of study specific discont. criteria|1
5176069|NCT01264770|17872109|P5|Overall Study|Dev. of study specific discont. criteria|1
5176070|NCT01264770|17872110|P4|Overall Study|Dev. of study specific discont. criteria|0
5176071|NCT01264770|17872111|P3|Overall Study|Dev. of study specific discont. criteria|0
5176072|NCT01264770|17872112|P2|Overall Study|Dev. of study specific discont. criteria|0
5176073|NCT01264770|17872113|P1|Overall Study|Dev. of study specific discont. criteria|2
5176074|NCT01264770|17872108|P6|Overall Study|Lack of therapeutic response|0
5176075|NCT01264770|17872109|P5|Overall Study|Lack of therapeutic response|1
5176076|NCT01264770|17872110|P4|Overall Study|Lack of therapeutic response|1
5176077|NCT01264770|17872111|P3|Overall Study|Lack of therapeutic response|2
5176078|NCT01264770|17872112|P2|Overall Study|Lack of therapeutic response|0
5176079|NCT01264770|17872113|P1|Overall Study|Lack of therapeutic response|1
5176080|NCT01264770|17872108|P6|Overall Study|Severe non-compliance to protocol|0
5176081|NCT01264770|17872109|P5|Overall Study|Severe non-compliance to protocol|0
5176082|NCT01264770|17872110|P4|Overall Study|Severe non-compliance to protocol|1
5176083|NCT01264770|17872111|P3|Overall Study|Severe non-compliance to protocol|1
5176084|NCT01264770|17872112|P2|Overall Study|Severe non-compliance to protocol|0
5176085|NCT01264770|17872113|P1|Overall Study|Severe non-compliance to protocol|0
5176086|NCT01264770|17872108|P6|Overall Study|e.g., change in circumstances|4
5176087|NCT01264770|17872109|P5|Overall Study|e.g., change in circumstances|4
5176088|NCT01264770|17872110|P4|Overall Study|e.g., change in circumstances|3
5176089|NCT01264770|17872111|P3|Overall Study|e.g., change in circumstances|3
5176090|NCT01264770|17872112|P2|Overall Study|e.g., change in circumstances|3
5176091|NCT01264770|17872113|P1|Overall Study|e.g., change in circumstances|8
5176092|NCT01264770|17872108|P6|Overall Study|Not reported|0
5176093|NCT01264770|17872109|P5|Overall Study|Not reported|0
5176094|NCT01264770|17872110|P4|Overall Study|Not reported|0
5176095|NCT01264770|17872111|P3|Overall Study|Not reported|1
5176096|NCT01264770|17872112|P2|Overall Study|Not reported|0
5176097|NCT01264770|17872113|P1|Overall Study|Not reported|0
5176098|NCT01264718|17872199|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
5176099|NCT01264718|17872200|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
5176100|NCT01264718|17872199|P2|Overall Study|Withdrawal by Subject|15
5176101|NCT01264718|17872200|P1|Overall Study|Withdrawal by Subject|9
5176102|NCT01264718|17872199|P2|Overall Study|Lost to Follow-up|2
5176103|NCT01264718|17872200|P1|Overall Study|Lost to Follow-up|3
5176104|NCT01264679|17872237|P1|Overall Study|Withdrawal by Subject|1
5176105|NCT01264679|17872237|P1|Overall Study|Sponsor's Suspension of Dosing|2
5176106|NCT01264679|17872237|P1|Overall Study|Physician Decision|1
5176107|NCT01264679|17872237|P1|Overall Study|Participation in Another Clinical Trial|1
5176108|NCT01264419|17872271|P1|Overall Study|Lost to Follow-up|3
5176109|NCT01264380|17872276|P3|Period C|Adverse Event|1
5176110|NCT01264380|17872277|P2|Period C|Adverse Event|0
5176111|NCT01264380|17872278|P1|Period C|Adverse Event|0
5176112|NCT01264380|17872276|P3|Period C|Withdrawal by Subject|1
5176113|NCT01264380|17872277|P2|Period C|Withdrawal by Subject|0
5176114|NCT01264380|17872278|P1|Period C|Withdrawal by Subject|0
5176115|NCT01264380|17872276|P3|Period C|Follow-up for survival status|6
5176116|NCT01264380|17872277|P2|Period C|Follow-up for survival status|0
5176117|NCT01264380|17872278|P1|Period C|Follow-up for survival status|0
5176118|NCT01264380|17872276|P3|Period C|Death|2
5176119|NCT01264380|17872277|P2|Period C|Death|0
5176120|NCT01264380|17872278|P1|Period C|Death|0
5176121|NCT01264380|17872276|P3|Period C|Disease Progression|4
5176122|NCT01264380|17872277|P2|Period C|Disease Progression|0
5176123|NCT01264380|17872278|P1|Period C|Disease Progression|0
5176124|NCT01264081|17872299|P1|Started Treatment|Not complete cycle 1 due to death|1
5176125|NCT01264081|17872299|P1|Started Treatment|Withdrawal by Subject|1
5176126|NCT01264081|17872299|P1|Participants Screened|Screening failures|30
5176127|NCT01264016|17872304|P1|Overall Study|Felt faint at sight of blood|1
5176128|NCT01264016|17872304|P1|Overall Study|Withdrawal by Subject|1
5176129|NCT01263925|17872319|P2|Overall Study|Withdrawal/ Not specified|1
5176130|NCT01263925|17872320|P1|Overall Study|Withdrawal/ Not specified|0
5176131|NCT01263925|17872319|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
5176132|NCT01263925|17872320|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
5176133|NCT01263925|17872319|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
5176134|NCT01263925|17872320|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
5176135|NCT01263925|17872319|P2|Overall Study|AE/ Withdrawal|4
5176136|NCT01263925|17872320|P1|Overall Study|AE/ Withdrawal|1
5176137|NCT01263925|17872319|P2|Overall Study|AE/ Unsatisfactory Compliance|2
5176138|NCT01263925|17872320|P1|Overall Study|AE/ Unsatisfactory Compliance|2
5176139|NCT01263925|17872319|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
5176140|NCT01263925|17872320|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
5176141|NCT01263925|17872319|P2|Overall Study|Lost to Follow-up|1
5176142|NCT01263925|17872320|P1|Overall Study|Lost to Follow-up|3
5176143|NCT01263925|17872319|P2|Overall Study|Other|4
5176144|NCT01263925|17872320|P1|Overall Study|Other|4
5176145|NCT01263925|17872319|P2|Overall Study|Withdrawal by Subject|8
5176146|NCT01263925|17872320|P1|Overall Study|Withdrawal by Subject|6
5176147|NCT01263925|17872319|P2|Overall Study|Unsatisfactory Compliance of Subject|5
5176148|NCT01263925|17872320|P1|Overall Study|Unsatisfactory Compliance of Subject|8
5176149|NCT01263925|17872319|P2|Overall Study|Adverse Event|22
5176150|NCT01263925|17872320|P1|Overall Study|Adverse Event|23
5176151|NCT01263925|17872319|P2|Overall Study|Lack of Efficacy|1
5176152|NCT01263925|17872320|P1|Overall Study|Lack of Efficacy|0
5176153|NCT01263925|17872319|P2|Overall Study|Protocol Violation|0
5176154|NCT01263925|17872320|P1|Overall Study|Protocol Violation|1
5176155|NCT01263873|17872354|P2|Overall Study|One provider unable to complete numbers|1
5176156|NCT01263873|17872355|P1|Overall Study|One provider unable to complete numbers|1
5176157|NCT01263782|17872369|P4|Overall Study|Inevaluable|0
5176158|NCT01263782|17872370|P3|Overall Study|Inevaluable|1
5176159|NCT01263782|17872371|P2|Overall Study|Inevaluable|0
5176160|NCT01263782|17872372|P1|Overall Study|Inevaluable|0
5176161|NCT01263782|17872369|P4|Overall Study|Too early|0
5176162|NCT01263782|17872370|P3|Overall Study|Too early|1
5176163|NCT01263782|17872371|P2|Overall Study|Too early|0
5176164|NCT01263782|17872372|P1|Overall Study|Too early|0
5176165|NCT01263782|17872369|P4|Overall Study|Progressive disease|1
5176166|NCT01263782|17872370|P3|Overall Study|Progressive disease|0
5176167|NCT01263782|17872371|P2|Overall Study|Progressive disease|0
5176168|NCT01263782|17872372|P1|Overall Study|Progressive disease|0
5176169|NCT01263782|17872369|P4|Overall Study|Death|0
5176170|NCT01263782|17872370|P3|Overall Study|Death|1
5176171|NCT01263782|17872371|P2|Overall Study|Death|0
5176172|NCT01263782|17872372|P1|Overall Study|Death|0
5176173|NCT01263704|17872417|P1|Overall Study|Principal Investigator (PI) decision|1
5176174|NCT01263704|17872417|P1|Overall Study|Colon metastases|1
5176175|NCT01263704|17872417|P1|Overall Study|Lost to Follow-up|1
5176176|NCT01263704|17872417|P1|Overall Study|Eligibility criteria not fulfilled|1
5176177|NCT01263704|17872417|P1|Overall Study|Patient withdrew consent|2
5176178|NCT01263704|17872417|P1|Overall Study|Death|2
5176179|NCT01263704|17872417|P1|Overall Study|Adverse Event|3
5176180|NCT01263704|17872417|P1|Overall Study|Progressive disease|18
5176181|NCT01263691|17872432|P6|Overall Study|Adverse Event|0
5176182|NCT01263691|17872433|P5|Overall Study|Adverse Event|0
5176183|NCT01263691|17872434|P4|Overall Study|Adverse Event|0
5176184|NCT01263691|17872435|P3|Overall Study|Adverse Event|0
5176185|NCT01263691|17872436|P2|Overall Study|Adverse Event|0
5176186|NCT01263691|17872437|P1|Overall Study|Adverse Event|1
5176187|NCT01263691|17872432|P6|Overall Study|Withdrawal by Subject|0
5176188|NCT01263691|17872433|P5|Overall Study|Withdrawal by Subject|0
5176189|NCT01263691|17872434|P4|Overall Study|Withdrawal by Subject|0
5176190|NCT01263691|17872435|P3|Overall Study|Withdrawal by Subject|0
5176191|NCT01263691|17872436|P2|Overall Study|Withdrawal by Subject|0
5176192|NCT01263691|17872437|P1|Overall Study|Withdrawal by Subject|1
5176193|NCT01263691|17872432|P6|Overall Study|Lost to Follow-up|0
5176194|NCT01263691|17872433|P5|Overall Study|Lost to Follow-up|0
5176195|NCT01263691|17872434|P4|Overall Study|Lost to Follow-up|1
5176196|NCT01263691|17872435|P3|Overall Study|Lost to Follow-up|1
5176197|NCT01263691|17872436|P2|Overall Study|Lost to Follow-up|0
5176198|NCT01263691|17872437|P1|Overall Study|Lost to Follow-up|1
5176199|NCT01263665|17872547|P1|Overall Study|Surgical Bypass|2
5176200|NCT01263665|17872547|P1|Overall Study|Amputation above the ankle|1
5176201|NCT01263665|17872547|P1|Overall Study|Death|2
5176202|NCT01263665|17872547|P1|Overall Study|Lost to Follow-up|3
5176203|NCT01263665|17872547|P1|Overall Study|Withdrew Consent|1
5176204|NCT01263639|17872554|P2|Overall Study|Exclusion =Admission greater than 7 days|9
5176205|NCT01263639|17872555|P1|Overall Study|Exclusion =Admission greater than 7 days|7
5176206|NCT01263639|17872554|P2|Overall Study|Lost to Follow-up|70
5176207|NCT01263639|17872555|P1|Overall Study|Lost to Follow-up|66
5176208|NCT01263561|17872563|P2|Overall Study|Death|2
5176209|NCT01263561|17872564|P1|Overall Study|Death|1
5176210|NCT01263509|17872576|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
5176211|NCT01263509|17872577|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5176212|NCT01263509|17872578|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5176213|NCT01263509|17872579|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5176214|NCT01263509|17872576|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
5176215|NCT01263509|17872577|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
5176216|NCT01263509|17872578|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
5176217|NCT01263509|17872579|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
5176218|NCT01263509|17872576|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5176219|NCT01263509|17872577|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5176220|NCT01263509|17872578|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5176221|NCT01263509|17872579|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5176222|NCT01263509|17872576|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
5176223|NCT01263509|17872577|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
5176224|NCT01263509|17872578|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
5176225|NCT01263509|17872579|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
5176226|NCT01263509|17872576|P4|Entered - Long-Term Extension Study|Adverse Event|1
5176227|NCT01263509|17872577|P3|Entered - Long-Term Extension Study|Adverse Event|4
5176228|NCT01263509|17872578|P2|Entered - Long-Term Extension Study|Adverse Event|5
5176229|NCT01263509|17872579|P1|Entered - Long-Term Extension Study|Adverse Event|5
5176230|NCT01263496|17872708|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
5176231|NCT01263496|17872709|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
5176232|NCT01263496|17872710|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
5176233|NCT01263496|17872711|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
5176234|NCT01263496|17872712|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
5176235|NCT01263496|17872713|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
5176236|NCT01263496|17872714|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
5176237|NCT01263496|17872715|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
5176238|NCT01263496|17872716|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
5176239|NCT01263496|17872708|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
5176240|NCT01263496|17872709|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
5176241|NCT01263496|17872710|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
5176242|NCT01263496|17872711|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
5176243|NCT01263496|17872712|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
5176244|NCT01263496|17872713|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
5176245|NCT01263496|17872714|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
5176246|NCT01263496|17872715|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
5176247|NCT01263496|17872716|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
5176248|NCT01263496|17872708|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5176249|NCT01263496|17872709|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5176250|NCT01263496|17872710|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5176251|NCT01263496|17872711|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5176252|NCT01263496|17872712|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
5176253|NCT01263496|17872713|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5176254|NCT01263496|17872714|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5176255|NCT01263496|17872715|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5176256|NCT01263496|17872716|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5176257|NCT01263496|17872708|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176258|NCT01263496|17872709|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176259|NCT01263496|17872710|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176260|NCT01263496|17872711|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176261|NCT01263496|17872712|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176262|NCT01263496|17872713|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176263|NCT01263496|17872714|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176264|NCT01263496|17872715|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
5176265|NCT01263496|17872716|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
5176266|NCT01263496|17872708|P9|Entered - Long-Term Extension Study|Adverse Event|1
5176267|NCT01263496|17872709|P8|Entered - Long-Term Extension Study|Adverse Event|0
5176268|NCT01263496|17872710|P7|Entered - Long-Term Extension Study|Adverse Event|0
5176269|NCT01263496|17872711|P6|Entered - Long-Term Extension Study|Adverse Event|0
5176270|NCT01263496|17872712|P5|Entered - Long-Term Extension Study|Adverse Event|1
5176271|NCT01263496|17872713|P4|Entered - Long-Term Extension Study|Adverse Event|3
5176272|NCT01263496|17872714|P3|Entered - Long-Term Extension Study|Adverse Event|6
5176273|NCT01263496|17872715|P2|Entered - Long-Term Extension Study|Adverse Event|5
5176274|NCT01263496|17872716|P1|Entered - Long-Term Extension Study|Adverse Event|0
5176275|NCT01263496|17872708|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
5176276|NCT01263496|17872709|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
5176277|NCT01263496|17872710|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
5176278|NCT01263496|17872711|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
5176279|NCT01263496|17872712|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
5176280|NCT01263496|17872713|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
5176281|NCT01263496|17872714|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
5176282|NCT01263496|17872715|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5176283|NCT01263496|17872716|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
5176284|NCT01263496|17872708|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176285|NCT01263496|17872709|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176286|NCT01263496|17872710|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176287|NCT01263496|17872711|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176288|NCT01263496|17872712|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176289|NCT01263496|17872713|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176290|NCT01263496|17872714|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176291|NCT01263496|17872715|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
5176292|NCT01263496|17872716|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
5176293|NCT01263483|17873011|P3|Overall Study|Participant Unavailability|1
5176294|NCT01263483|17873012|P2|Overall Study|Participant Unavailability|1
5176295|NCT01263483|17873013|P1|Overall Study|Participant Unavailability|0
5176296|NCT01263483|17873011|P3|Overall Study|Protocol Violation|1
5176297|NCT01263483|17873012|P2|Overall Study|Protocol Violation|1
5176298|NCT01263483|17873013|P1|Overall Study|Protocol Violation|0
5176299|NCT01263483|17873011|P3|Overall Study|Lack of Efficacy|0
5176300|NCT01263483|17873012|P2|Overall Study|Lack of Efficacy|0
5176301|NCT01263483|17873013|P1|Overall Study|Lack of Efficacy|2
5176302|NCT01263483|17873011|P3|Overall Study|Withdrawal by Subject|0
5176303|NCT01263483|17873012|P2|Overall Study|Withdrawal by Subject|0
5176304|NCT01263483|17873013|P1|Overall Study|Withdrawal by Subject|1
5176305|NCT01263483|17873011|P3|Overall Study|Adverse Event|3
5176306|NCT01263483|17873012|P2|Overall Study|Adverse Event|0
5176307|NCT01263483|17873013|P1|Overall Study|Adverse Event|4
5176308|NCT01263470|17873075|P6|Overall Study|Study Drug Non-compliance|0
5176309|NCT01263470|17873076|P5|Overall Study|Study Drug Non-compliance|1
5176310|NCT01263470|17873077|P4|Overall Study|Study Drug Non-compliance|0
5176311|NCT01263470|17873078|P3|Overall Study|Study Drug Non-compliance|0
5176312|NCT01263470|17873079|P2|Overall Study|Study Drug Non-compliance|0
5176313|NCT01263470|17873080|P1|Overall Study|Study Drug Non-compliance|0
5176314|NCT01263470|17873075|P6|Overall Study|Participant Unavailability|0
5176315|NCT01263470|17873076|P5|Overall Study|Participant Unavailability|0
5176316|NCT01263470|17873077|P4|Overall Study|Participant Unavailability|0
5176317|NCT01263470|17873078|P3|Overall Study|Participant Unavailability|0
5176318|NCT01263470|17873079|P2|Overall Study|Participant Unavailability|1
5176319|NCT01263470|17873080|P1|Overall Study|Participant Unavailability|0
5176320|NCT01263470|17873075|P6|Overall Study|Lack of Efficacy|0
5176321|NCT01263470|17873076|P5|Overall Study|Lack of Efficacy|0
5176322|NCT01263470|17873077|P4|Overall Study|Lack of Efficacy|0
5176323|NCT01263470|17873078|P3|Overall Study|Lack of Efficacy|2
5176324|NCT01263470|17873079|P2|Overall Study|Lack of Efficacy|0
5176325|NCT01263470|17873080|P1|Overall Study|Lack of Efficacy|0
5176326|NCT01263470|17873075|P6|Overall Study|Withdrawal by Subject|2
5176327|NCT01263470|17873076|P5|Overall Study|Withdrawal by Subject|0
5176328|NCT01263470|17873077|P4|Overall Study|Withdrawal by Subject|2
5176329|NCT01263470|17873078|P3|Overall Study|Withdrawal by Subject|1
5176330|NCT01263470|17873079|P2|Overall Study|Withdrawal by Subject|1
5176331|NCT01263470|17873080|P1|Overall Study|Withdrawal by Subject|0
5176332|NCT01263470|17873075|P6|Overall Study|Protocol Violation|1
5176333|NCT01263470|17873076|P5|Overall Study|Protocol Violation|0
5176334|NCT01263470|17873077|P4|Overall Study|Protocol Violation|0
5176335|NCT01263470|17873078|P3|Overall Study|Protocol Violation|0
5176336|NCT01263470|17873079|P2|Overall Study|Protocol Violation|1
5176337|NCT01263470|17873080|P1|Overall Study|Protocol Violation|0
5176338|NCT01263470|17873075|P6|Overall Study|Adverse Event|2
5176339|NCT01263470|17873076|P5|Overall Study|Adverse Event|2
5176340|NCT01263470|17873077|P4|Overall Study|Adverse Event|1
5176341|NCT01263470|17873078|P3|Overall Study|Adverse Event|1
5176342|NCT01263470|17873079|P2|Overall Study|Adverse Event|2
5176343|NCT01263470|17873080|P1|Overall Study|Adverse Event|2
5176344|NCT01263444|17873190|P1|Overall Study|Protocol Violation|1
5176345|NCT01263444|17873190|P1|Overall Study|Withdrawal by Subject|1
5176346|NCT01263444|17873190|P1|Overall Study|Adverse Event|8
5176347|NCT01263223|17873327|P2|7-day Follow-up|Lost to Follow-up|0
5176348|NCT01263223|17873328|P1|7-day Follow-up|Lost to Follow-up|1
5176349|NCT01263223|17873327|P2|7-day Follow-up|Withdrawal by Subject|1
5176350|NCT01263223|17873328|P1|7-day Follow-up|Withdrawal by Subject|0
5176351|NCT01263223|17873327|P2|Period 2|Withdrawal by Subject|1
5176352|NCT01263223|17873328|P1|Period 2|Withdrawal by Subject|0
5176353|NCT01263197|17873351|P6|Third Intervention (Period 3)|Adverse Event|0
5176354|NCT01263197|17873352|P5|Third Intervention (Period 3)|Adverse Event|0
5176355|NCT01263197|17873353|P4|Third Intervention (Period 3)|Adverse Event|0
5176356|NCT01263197|17873354|P3|Third Intervention (Period 3)|Adverse Event|0
5176357|NCT01263197|17873355|P2|Third Intervention (Period 3)|Adverse Event|1
5176358|NCT01263197|17873356|P1|Third Intervention (Period 3)|Adverse Event|0
5176359|NCT01263197|17873351|P6|Washout Period 2|Protocol Violation|0
5176360|NCT01263197|17873352|P5|Washout Period 2|Protocol Violation|0
5176361|NCT01263197|17873353|P4|Washout Period 2|Protocol Violation|1
5176362|NCT01263197|17873354|P3|Washout Period 2|Protocol Violation|0
5176363|NCT01263197|17873355|P2|Washout Period 2|Protocol Violation|0
5176364|NCT01263197|17873356|P1|Washout Period 2|Protocol Violation|0
5176365|NCT01263197|17873351|P6|Washout Period 2|Physician Decision|1
5176366|NCT01263197|17873352|P5|Washout Period 2|Physician Decision|0
5176367|NCT01263197|17873353|P4|Washout Period 2|Physician Decision|0
5176368|NCT01263197|17873354|P3|Washout Period 2|Physician Decision|0
5176369|NCT01263197|17873355|P2|Washout Period 2|Physician Decision|0
5176370|NCT01263197|17873356|P1|Washout Period 2|Physician Decision|0
5176371|NCT01263197|17873351|P6|Washout Period 1|Protocol Violation|0
5176372|NCT01263197|17873352|P5|Washout Period 1|Protocol Violation|1
5176373|NCT01263197|17873353|P4|Washout Period 1|Protocol Violation|0
5176374|NCT01263197|17873354|P3|Washout Period 1|Protocol Violation|0
5176375|NCT01263197|17873355|P2|Washout Period 1|Protocol Violation|0
5176376|NCT01263197|17873356|P1|Washout Period 1|Protocol Violation|0
5176377|NCT01263197|17873351|P6|First Intervention (Period 1)|Adverse Event|1
5176378|NCT01263197|17873352|P5|First Intervention (Period 1)|Adverse Event|0
5176379|NCT01263197|17873353|P4|First Intervention (Period 1)|Adverse Event|0
5176380|NCT01263197|17873354|P3|First Intervention (Period 1)|Adverse Event|0
5176381|NCT01263197|17873355|P2|First Intervention (Period 1)|Adverse Event|0
5176382|NCT01263197|17873356|P1|First Intervention (Period 1)|Adverse Event|0
5176383|NCT01263119|17873399|P1|Period 2|Adverse Event|2
5176384|NCT01263119|17873399|P1|Period 1|Protocol Violation|2
5176385|NCT01263106|17873420|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
5176386|NCT01263106|17873421|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
5176387|NCT01263093|17873436|P2|Period 2|Adverse Event|0
5176388|NCT01263093|17873437|P1|Period 2|Adverse Event|1
5176389|NCT01263093|17873436|P2|Washout|Physician Decision|0
5176390|NCT01263093|17873437|P1|Washout|Physician Decision|1
5176391|NCT01263054|17873454|P2|Overall Study|Other|1
5176392|NCT01263054|17873455|P1|Overall Study|Other|0
5176393|NCT01263054|17873454|P2|Overall Study|Qualification Violation|0
5176394|NCT01263054|17873455|P1|Overall Study|Qualification Violation|1
5176395|NCT01263054|17873454|P2|Overall Study|Withdrawal by Subject|3
5176396|NCT01263054|17873455|P1|Overall Study|Withdrawal by Subject|1
5176397|NCT01263054|17873454|P2|Overall Study|Lost to Follow-up|2
5176398|NCT01263054|17873455|P1|Overall Study|Lost to Follow-up|2
5176399|NCT01263054|17873454|P2|Overall Study|Death|0
5176400|NCT01263054|17873455|P1|Overall Study|Death|1
5176401|NCT01263028|17873473|P1|Overall Study|Study terminated due to low enrollment.|4
5176402|NCT01263028|17873473|P1|Overall Study|Adverse Event|1
5176403|NCT01263028|17873473|P1|Overall Study|Withdrawal by Subject|1
5176404|NCT01263015|17873483|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
5176405|NCT01263015|17873484|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
5176406|NCT01263015|17873483|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
5176407|NCT01263015|17873484|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
5176408|NCT01263015|17873483|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
5176409|NCT01263015|17873484|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
5176410|NCT01263015|17873483|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
5176411|NCT01263015|17873484|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
5176412|NCT01263015|17873483|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
5176413|NCT01263015|17873484|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
5176414|NCT01263015|17873483|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
5176415|NCT01263015|17873484|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
5176416|NCT01263015|17873483|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
5176417|NCT01263015|17873484|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
5176418|NCT01263015|17873483|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
5176419|NCT01263015|17873484|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
5176420|NCT01263015|17873483|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
5176421|NCT01263015|17873484|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
5176422|NCT01263015|17873483|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
5176423|NCT01263015|17873484|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
5176424|NCT01263015|17873483|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
5176425|NCT01263015|17873484|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
5176426|NCT01263015|17873483|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
5176427|NCT01263015|17873484|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
5176428|NCT01262989|17873510|P2|Period 2|Intercurrent disease|1
5176429|NCT01262989|17873511|P1|Period 2|Intercurrent disease|0
5176430|NCT01262989|17873510|P2|Period 1|Positive answer for exclusion criteria|1
5176431|NCT01262989|17873511|P1|Period 1|Positive answer for exclusion criteria|0
5176432|NCT01262989|17873510|P2|Period 1|Intercurrent disease|1
5176433|NCT01262989|17873511|P1|Period 1|Intercurrent disease|0
5176434|NCT01262989|17873510|P2|Period 1|Lost to Follow-up|1
5176435|NCT01262989|17873511|P1|Period 1|Lost to Follow-up|1
5176436|NCT01262976|17873527|P6|Up to Year 3|Other|0
5176437|NCT01262976|17873528|P5|Up to Year 3|Other|0
5176438|NCT01262976|17873529|P4|Up to Year 3|Other|0
5176439|NCT01262976|17873530|P3|Up to Year 3|Other|0
5176440|NCT01262976|17873531|P2|Up to Year 3|Other|0
5176441|NCT01262976|17873532|P1|Up to Year 3|Other|3
5176442|NCT01262976|17873527|P6|Up to Year 3|Subjects with unknown completion status|0
5176443|NCT01262976|17873528|P5|Up to Year 3|Subjects with unknown completion status|0
5176444|NCT01262976|17873529|P4|Up to Year 3|Subjects with unknown completion status|0
5176445|NCT01262976|17873530|P3|Up to Year 3|Subjects with unknown completion status|1
5176446|NCT01262976|17873531|P2|Up to Year 3|Subjects with unknown completion status|0
5176447|NCT01262976|17873532|P1|Up to Year 3|Subjects with unknown completion status|0
5176448|NCT01262976|17873527|P6|Up to Year 3|Lost to Follow-up|3
5176449|NCT01262976|17873528|P5|Up to Year 3|Lost to Follow-up|1
5176450|NCT01262976|17873529|P4|Up to Year 3|Lost to Follow-up|3
5176451|NCT01262976|17873530|P3|Up to Year 3|Lost to Follow-up|4
5176452|NCT01262976|17873531|P2|Up to Year 3|Lost to Follow-up|2
5176453|NCT01262976|17873532|P1|Up to Year 3|Lost to Follow-up|2
5176454|NCT01262976|17873527|P6|Up to Year 3|Migrated/moved from study area|1
5176455|NCT01262976|17873528|P5|Up to Year 3|Migrated/moved from study area|1
5176456|NCT01262976|17873529|P4|Up to Year 3|Migrated/moved from study area|2
5176457|NCT01262976|17873530|P3|Up to Year 3|Migrated/moved from study area|0
5176458|NCT01262976|17873531|P2|Up to Year 3|Migrated/moved from study area|0
5176459|NCT01262976|17873532|P1|Up to Year 3|Migrated/moved from study area|0
5176460|NCT01262976|17873527|P6|Up to Year 3|Withdrawal by Subject|0
5176461|NCT01262976|17873528|P5|Up to Year 3|Withdrawal by Subject|0
5176462|NCT01262976|17873529|P4|Up to Year 3|Withdrawal by Subject|0
5176463|NCT01262976|17873530|P3|Up to Year 3|Withdrawal by Subject|0
5176464|NCT01262976|17873531|P2|Up to Year 3|Withdrawal by Subject|0
5176465|NCT01262976|17873532|P1|Up to Year 3|Withdrawal by Subject|1
5176466|NCT01262976|17873527|P6|Up to Year 3|Serious Adverse Event|0
5176467|NCT01262976|17873528|P5|Up to Year 3|Serious Adverse Event|0
5176468|NCT01262976|17873529|P4|Up to Year 3|Serious Adverse Event|0
5176469|NCT01262976|17873530|P3|Up to Year 3|Serious Adverse Event|2
5176470|NCT01262976|17873531|P2|Up to Year 3|Serious Adverse Event|0
5176471|NCT01262976|17873532|P1|Up to Year 3|Serious Adverse Event|0
5176472|NCT01262976|17873527|P6|Up to Year 2|Other|0
5176473|NCT01262976|17873528|P5|Up to Year 2|Other|0
5176474|NCT01262976|17873529|P4|Up to Year 2|Other|0
5176475|NCT01262976|17873530|P3|Up to Year 2|Other|0
5176476|NCT01262976|17873531|P2|Up to Year 2|Other|0
5176477|NCT01262976|17873532|P1|Up to Year 2|Other|3
5176478|NCT01262976|17873527|P6|Up to Year 2|Subjects with unknown completion status|0
5176479|NCT01262976|17873528|P5|Up to Year 2|Subjects with unknown completion status|0
5176480|NCT01262976|17873529|P4|Up to Year 2|Subjects with unknown completion status|0
5176481|NCT01262976|17873530|P3|Up to Year 2|Subjects with unknown completion status|1
5176482|NCT01262976|17873531|P2|Up to Year 2|Subjects with unknown completion status|0
5176483|NCT01262976|17873532|P1|Up to Year 2|Subjects with unknown completion status|0
5176484|NCT01262976|17873527|P6|Up to Year 2|Lost to Follow-up|3
5176485|NCT01262976|17873528|P5|Up to Year 2|Lost to Follow-up|3
5176486|NCT01262976|17873529|P4|Up to Year 2|Lost to Follow-up|2
5176487|NCT01262976|17873530|P3|Up to Year 2|Lost to Follow-up|2
5176488|NCT01262976|17873531|P2|Up to Year 2|Lost to Follow-up|1
5176489|NCT01262976|17873532|P1|Up to Year 2|Lost to Follow-up|1
5176490|NCT01262976|17873527|P6|Up to Year 2|Migrated/moved from study area|2
5176491|NCT01262976|17873528|P5|Up to Year 2|Migrated/moved from study area|1
5176492|NCT01262976|17873529|P4|Up to Year 2|Migrated/moved from study area|2
5176493|NCT01262976|17873530|P3|Up to Year 2|Migrated/moved from study area|0
5176494|NCT01262976|17873531|P2|Up to Year 2|Migrated/moved from study area|0
5176495|NCT01262976|17873532|P1|Up to Year 2|Migrated/moved from study area|0
5176496|NCT01262976|17873527|P6|Up to Year 2|Withdrawal by Subject|0
5176497|NCT01262976|17873528|P5|Up to Year 2|Withdrawal by Subject|0
5176498|NCT01262976|17873529|P4|Up to Year 2|Withdrawal by Subject|0
5176499|NCT01262976|17873530|P3|Up to Year 2|Withdrawal by Subject|0
5176500|NCT01262976|17873531|P2|Up to Year 2|Withdrawal by Subject|0
5176501|NCT01262976|17873532|P1|Up to Year 2|Withdrawal by Subject|1
5176502|NCT01262976|17873527|P6|Up to Year 2|Serious Adverse Event|0
5176503|NCT01262976|17873528|P5|Up to Year 2|Serious Adverse Event|0
5176504|NCT01262976|17873529|P4|Up to Year 2|Serious Adverse Event|0
5176505|NCT01262976|17873530|P3|Up to Year 2|Serious Adverse Event|2
5176506|NCT01262976|17873531|P2|Up to Year 2|Serious Adverse Event|0
5176507|NCT01262976|17873532|P1|Up to Year 2|Serious Adverse Event|0
5176508|NCT01262976|17873527|P6|Up to Year 1|Subjects with unknown completion status|1
5176509|NCT01262976|17873528|P5|Up to Year 1|Subjects with unknown completion status|0
5176510|NCT01262976|17873529|P4|Up to Year 1|Subjects with unknown completion status|0
5176511|NCT01262976|17873530|P3|Up to Year 1|Subjects with unknown completion status|1
5176512|NCT01262976|17873531|P2|Up to Year 1|Subjects with unknown completion status|0
5176513|NCT01262976|17873532|P1|Up to Year 1|Subjects with unknown completion status|0
5176514|NCT01262976|17873527|P6|Up to Year 1|Other|1
5176515|NCT01262976|17873528|P5|Up to Year 1|Other|2
5176516|NCT01262976|17873529|P4|Up to Year 1|Other|0
5176517|NCT01262976|17873530|P3|Up to Year 1|Other|0
5176518|NCT01262976|17873531|P2|Up to Year 1|Other|1
5176519|NCT01262976|17873532|P1|Up to Year 1|Other|3
5176520|NCT01262976|17873527|P6|Up to Year 1|Lost to Follow-up|5
5176521|NCT01262976|17873528|P5|Up to Year 1|Lost to Follow-up|6
5176522|NCT01262976|17873529|P4|Up to Year 1|Lost to Follow-up|1
5176523|NCT01262976|17873530|P3|Up to Year 1|Lost to Follow-up|0
5176524|NCT01262976|17873531|P2|Up to Year 1|Lost to Follow-up|0
5176525|NCT01262976|17873532|P1|Up to Year 1|Lost to Follow-up|4
5176526|NCT01262976|17873527|P6|Up to Year 1|Migrated/moved from study area|2
5176527|NCT01262976|17873528|P5|Up to Year 1|Migrated/moved from study area|3
5176528|NCT01262976|17873529|P4|Up to Year 1|Migrated/moved from study area|3
5176529|NCT01262976|17873530|P3|Up to Year 1|Migrated/moved from study area|0
5176530|NCT01262976|17873531|P2|Up to Year 1|Migrated/moved from study area|0
5176531|NCT01262976|17873532|P1|Up to Year 1|Migrated/moved from study area|1
5176532|NCT01262976|17873527|P6|Up to Year 1|Withdrawal by Subject|0
5176533|NCT01262976|17873528|P5|Up to Year 1|Withdrawal by Subject|0
5176534|NCT01262976|17873529|P4|Up to Year 1|Withdrawal by Subject|0
5176535|NCT01262976|17873530|P3|Up to Year 1|Withdrawal by Subject|0
5176536|NCT01262976|17873531|P2|Up to Year 1|Withdrawal by Subject|0
5176537|NCT01262976|17873532|P1|Up to Year 1|Withdrawal by Subject|1
5176538|NCT01262976|17873527|P6|Up to Year 1|Serious Adverse Event|0
5176539|NCT01262976|17873528|P5|Up to Year 1|Serious Adverse Event|0
5176540|NCT01262976|17873529|P4|Up to Year 1|Serious Adverse Event|0
5176541|NCT01262976|17873530|P3|Up to Year 1|Serious Adverse Event|2
5176542|NCT01262976|17873531|P2|Up to Year 1|Serious Adverse Event|0
5176543|NCT01262976|17873532|P1|Up to Year 1|Serious Adverse Event|0
5176544|NCT01262976|17873527|P6|Up to Month 7|Other|0
5176545|NCT01262976|17873528|P5|Up to Month 7|Other|0
5176546|NCT01262976|17873529|P4|Up to Month 7|Other|0
5176547|NCT01262976|17873530|P3|Up to Month 7|Other|2
5176548|NCT01262976|17873531|P2|Up to Month 7|Other|0
5176549|NCT01262976|17873532|P1|Up to Month 7|Other|3
5176550|NCT01262976|17873527|P6|Up to Month 7|Lost to Follow-up|3
5176551|NCT01262976|17873528|P5|Up to Month 7|Lost to Follow-up|1
5176552|NCT01262976|17873529|P4|Up to Month 7|Lost to Follow-up|3
5176553|NCT01262976|17873530|P3|Up to Month 7|Lost to Follow-up|1
5176554|NCT01262976|17873531|P2|Up to Month 7|Lost to Follow-up|0
5176555|NCT01262976|17873532|P1|Up to Month 7|Lost to Follow-up|1
5176556|NCT01262976|17873527|P6|Up to Month 7|Migrated/moved from study area|1
5176557|NCT01262976|17873528|P5|Up to Month 7|Migrated/moved from study area|1
5176558|NCT01262976|17873529|P4|Up to Month 7|Migrated/moved from study area|3
5176559|NCT01262976|17873530|P3|Up to Month 7|Migrated/moved from study area|1
5176560|NCT01262976|17873531|P2|Up to Month 7|Migrated/moved from study area|0
5176561|NCT01262976|17873532|P1|Up to Month 7|Migrated/moved from study area|0
5176562|NCT01262976|17873527|P6|Up to Month 7|Withdrawal by Subject|0
5176563|NCT01262976|17873528|P5|Up to Month 7|Withdrawal by Subject|0
5176564|NCT01262976|17873529|P4|Up to Month 7|Withdrawal by Subject|0
5176565|NCT01262976|17873530|P3|Up to Month 7|Withdrawal by Subject|0
5176566|NCT01262976|17873531|P2|Up to Month 7|Withdrawal by Subject|0
5176567|NCT01262976|17873532|P1|Up to Month 7|Withdrawal by Subject|1
5176568|NCT01262976|17873527|P6|Up to Month 7|Serious Adverse Event|0
5176569|NCT01262976|17873528|P5|Up to Month 7|Serious Adverse Event|0
5176570|NCT01262976|17873529|P4|Up to Month 7|Serious Adverse Event|0
5176571|NCT01262976|17873530|P3|Up to Month 7|Serious Adverse Event|2
5176572|NCT01262976|17873531|P2|Up to Month 7|Serious Adverse Event|0
5176573|NCT01262976|17873532|P1|Up to Month 7|Serious Adverse Event|0
5176574|NCT01262976|17873527|P6|Up to Month 2|Other|2
5176575|NCT01262976|17873528|P5|Up to Month 2|Other|0
5176576|NCT01262976|17873529|P4|Up to Month 2|Other|1
5176577|NCT01262976|17873530|P3|Up to Month 2|Other|0
5176578|NCT01262976|17873531|P2|Up to Month 2|Other|0
5176579|NCT01262976|17873532|P1|Up to Month 2|Other|1
5176580|NCT01262976|17873527|P6|Up to Month 2|Lost to Follow-up|1
5176581|NCT01262976|17873528|P5|Up to Month 2|Lost to Follow-up|1
5176582|NCT01262976|17873529|P4|Up to Month 2|Lost to Follow-up|1
5176583|NCT01262976|17873530|P3|Up to Month 2|Lost to Follow-up|0
5176584|NCT01262976|17873531|P2|Up to Month 2|Lost to Follow-up|0
5176585|NCT01262976|17873532|P1|Up to Month 2|Lost to Follow-up|1
5176586|NCT01262976|17873527|P6|Up to Month 2|Migrated/moved from study area|1
5176587|NCT01262976|17873528|P5|Up to Month 2|Migrated/moved from study area|1
5176588|NCT01262976|17873529|P4|Up to Month 2|Migrated/moved from study area|0
5176589|NCT01262976|17873530|P3|Up to Month 2|Migrated/moved from study area|0
5176590|NCT01262976|17873531|P2|Up to Month 2|Migrated/moved from study area|1
5176591|NCT01262976|17873532|P1|Up to Month 2|Migrated/moved from study area|0
5176592|NCT01262976|17873527|P6|Up to Month 2|Withdrawal by Subject|0
5176593|NCT01262976|17873528|P5|Up to Month 2|Withdrawal by Subject|0
5176594|NCT01262976|17873529|P4|Up to Month 2|Withdrawal by Subject|0
5176595|NCT01262976|17873530|P3|Up to Month 2|Withdrawal by Subject|0
5176596|NCT01262976|17873531|P2|Up to Month 2|Withdrawal by Subject|0
5176597|NCT01262976|17873532|P1|Up to Month 2|Withdrawal by Subject|1
5176598|NCT01262976|17873527|P6|Up to Month 2|Serious Adverse Event|0
5176599|NCT01262976|17873528|P5|Up to Month 2|Serious Adverse Event|0
5176600|NCT01262976|17873529|P4|Up to Month 2|Serious Adverse Event|0
5176601|NCT01262976|17873530|P3|Up to Month 2|Serious Adverse Event|1
5176602|NCT01262976|17873531|P2|Up to Month 2|Serious Adverse Event|0
5176603|NCT01262976|17873532|P1|Up to Month 2|Serious Adverse Event|0
5176604|NCT01262898|17873688|P4|Overall Study|Withdrawal by Subject|0
5176605|NCT01262898|17873689|P3|Overall Study|Withdrawal by Subject|0
5176606|NCT01262898|17873690|P2|Overall Study|Withdrawal by Subject|1
5176607|NCT01262898|17873691|P1|Overall Study|Withdrawal by Subject|1
5176608|NCT01262898|17873688|P4|Overall Study|Lost to Follow-up|0
5176609|NCT01262898|17873689|P3|Overall Study|Lost to Follow-up|0
5176610|NCT01262898|17873690|P2|Overall Study|Lost to Follow-up|0
5176611|NCT01262898|17873691|P1|Overall Study|Lost to Follow-up|1
5176612|NCT01262898|17873688|P4|Overall Study|Protocol Violation|0
5176613|NCT01262898|17873689|P3|Overall Study|Protocol Violation|0
5176614|NCT01262898|17873690|P2|Overall Study|Protocol Violation|1
5176615|NCT01262898|17873691|P1|Overall Study|Protocol Violation|1
5176616|NCT01262872|17873819|P8|Step 2|Migrated/moved from study area|3
5176617|NCT01262872|17873820|P7|Step 2|Migrated/moved from study area|2
5176618|NCT01262872|17873821|P6|Step 2|Migrated/moved from study area|6
5176619|NCT01262872|17873822|P5|Step 2|Migrated/moved from study area|2
5176620|NCT01262872|17873823|P4|Step 2|Migrated/moved from study area|3
5176621|NCT01262872|17873824|P3|Step 2|Migrated/moved from study area|4
5176622|NCT01262872|17873825|P2|Step 2|Migrated/moved from study area|0
5176623|NCT01262872|17873826|P1|Step 2|Migrated/moved from study area|0
5176624|NCT01262872|17873819|P8|Step 2|Withdrawal by Subject|1
5176625|NCT01262872|17873820|P7|Step 2|Withdrawal by Subject|2
5176626|NCT01262872|17873821|P6|Step 2|Withdrawal by Subject|1
5176627|NCT01262872|17873822|P5|Step 2|Withdrawal by Subject|3
5176628|NCT01262872|17873823|P4|Step 2|Withdrawal by Subject|6
5176629|NCT01262872|17873824|P3|Step 2|Withdrawal by Subject|4
5176630|NCT01262872|17873825|P2|Step 2|Withdrawal by Subject|0
5176631|NCT01262872|17873826|P1|Step 2|Withdrawal by Subject|0
5176632|NCT01262872|17873819|P8|Step 2|Protocol Violation|1
5176633|NCT01262872|17873820|P7|Step 2|Protocol Violation|3
5176634|NCT01262872|17873821|P6|Step 2|Protocol Violation|0
5176635|NCT01262872|17873822|P5|Step 2|Protocol Violation|0
5176636|NCT01262872|17873823|P4|Step 2|Protocol Violation|0
5176637|NCT01262872|17873824|P3|Step 2|Protocol Violation|1
5176638|NCT01262872|17873825|P2|Step 2|Protocol Violation|0
5176639|NCT01262872|17873826|P1|Step 2|Protocol Violation|0
5176640|NCT01262872|17873819|P8|Step 2|Death|1
5176641|NCT01262872|17873820|P7|Step 2|Death|2
5176642|NCT01262872|17873821|P6|Step 2|Death|2
5176643|NCT01262872|17873822|P5|Step 2|Death|0
5176644|NCT01262872|17873823|P4|Step 2|Death|1
5176645|NCT01262872|17873824|P3|Step 2|Death|0
5176646|NCT01262872|17873825|P2|Step 2|Death|0
5176647|NCT01262872|17873826|P1|Step 2|Death|0
5176648|NCT01262820|17874100|P1|Overall Study|Drug held for 21+ days|1
5176649|NCT01262820|17874100|P1|Overall Study|Lack of Efficacy|9
5176650|NCT01262820|17874100|P1|Overall Study|Adverse Event|5
5176651|NCT01262677|17874114|P3|Overall Study|Adverse Event (AE) related to study drug|3
5176652|NCT01262677|17874115|P2|Overall Study|Adverse Event (AE) related to study drug|8
5176653|NCT01262677|17874116|P1|Overall Study|Adverse Event (AE) related to study drug|3
5176654|NCT01262677|17874114|P3|Overall Study|Protocol Violation|1
5176655|NCT01262677|17874115|P2|Overall Study|Protocol Violation|1
5176656|NCT01262677|17874116|P1|Overall Study|Protocol Violation|0
5176657|NCT01262677|17874114|P3|Overall Study|Reason not provided|3
5176658|NCT01262677|17874115|P2|Overall Study|Reason not provided|1
5176659|NCT01262677|17874116|P1|Overall Study|Reason not provided|2
5176660|NCT01262677|17874114|P3|Overall Study|No longer willing to participate|2
5176661|NCT01262677|17874115|P2|Overall Study|No longer willing to participate|3
5176662|NCT01262677|17874116|P1|Overall Study|No longer willing to participate|3
5176663|NCT01262677|17874114|P3|Overall Study|Lost to Follow-up|2
5176664|NCT01262677|17874115|P2|Overall Study|Lost to Follow-up|0
5176665|NCT01262677|17874116|P1|Overall Study|Lost to Follow-up|1
5176666|NCT01262677|17874114|P3|Overall Study|Insufficient clinical response|1
5176667|NCT01262677|17874115|P2|Overall Study|Insufficient clinical response|0
5176668|NCT01262677|17874116|P1|Overall Study|Insufficient clinical response|0
5176669|NCT01262677|17874114|P3|Overall Study|Does not meet entrance criteria|0
5176670|NCT01262677|17874115|P2|Overall Study|Does not meet entrance criteria|2
5176671|NCT01262677|17874116|P1|Overall Study|Does not meet entrance criteria|0
5176672|NCT01262651|17874207|P2|Overall Study|Met Withdrawal Criteria|0
5176673|NCT01262651|17874208|P1|Overall Study|Met Withdrawal Criteria|1
5176674|NCT01262651|17874207|P2|Overall Study|Withdrawal by Investigator|2
5176675|NCT01262651|17874208|P1|Overall Study|Withdrawal by Investigator|2
5176676|NCT01262651|17874207|P2|Overall Study|Withdrawal by Subject|11
5176677|NCT01262651|17874208|P1|Overall Study|Withdrawal by Subject|15
5176678|NCT01262651|17874207|P2|Overall Study|Adverse Event|35
5176679|NCT01262651|17874208|P1|Overall Study|Adverse Event|40
5176680|NCT01262573|17874249|P2|Overall Study|Withdrawal by Subject|1
5176681|NCT01262573|17874250|P1|Overall Study|Withdrawal by Subject|0
5176682|NCT01262560|17874261|P3|Overall Study|Protocol Violation|2
5176683|NCT01262560|17874262|P2|Overall Study|Protocol Violation|1
5176684|NCT01262560|17874263|P1|Overall Study|Protocol Violation|0
5176685|NCT01262456|17874312|P3|1-Month Open-Label Extension Period|Other Reason|0
5176686|NCT01262456|17874313|P2|1-Month Open-Label Extension Period|Other Reason|1
5176687|NCT01262456|17874314|P1|1-Month Open-Label Extension Period|Other Reason|0
5176688|NCT01262456|17874312|P3|1-Month Open-Label Extension Period|Protocol Violation|2
5176689|NCT01262456|17874313|P2|1-Month Open-Label Extension Period|Protocol Violation|0
5176690|NCT01262456|17874314|P1|1-Month Open-Label Extension Period|Protocol Violation|1
5176859|NCT01261611|17874568|P3|Treatment Cycle 3|Withdrawal by Subject|0
5176691|NCT01262456|17874312|P3|1-Month Open-Label Extension Period|Adverse Event|2
5176692|NCT01262456|17874313|P2|1-Month Open-Label Extension Period|Adverse Event|0
5176693|NCT01262456|17874314|P1|1-Month Open-Label Extension Period|Adverse Event|2
5176694|NCT01262456|17874312|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
5176695|NCT01262456|17874313|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
5176696|NCT01262456|17874314|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
5176697|NCT01262456|17874312|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5176698|NCT01262456|17874313|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5176699|NCT01262456|17874314|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5176700|NCT01262456|17874312|P3|3-Month Double-Blind Period|Protocol Violation|6
5176701|NCT01262456|17874313|P2|3-Month Double-Blind Period|Protocol Violation|6
5176702|NCT01262456|17874314|P1|3-Month Double-Blind Period|Protocol Violation|3
5176703|NCT01262456|17874312|P3|3-Month Double-Blind Period|Adverse Event|8
5176704|NCT01262456|17874313|P2|3-Month Double-Blind Period|Adverse Event|4
5176705|NCT01262456|17874314|P1|3-Month Double-Blind Period|Adverse Event|6
5176706|NCT01262456|17874312|P3|3-Month Double-Blind Period|Lost to Follow-up|3
5176707|NCT01262456|17874313|P2|3-Month Double-Blind Period|Lost to Follow-up|5
5176708|NCT01262456|17874314|P1|3-Month Double-Blind Period|Lost to Follow-up|4
5176709|NCT01262456|17874312|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
5176710|NCT01262456|17874313|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
5176711|NCT01262456|17874314|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
5176712|NCT01262365|17874358|P3|Overall Study|Patient unavailable|1
5176713|NCT01262365|17874359|P2|Overall Study|Patient unavailable|0
5176714|NCT01262365|17874360|P1|Overall Study|Patient unavailable|0
5176715|NCT01262365|17874358|P3|Overall Study|Cannot tolerate the protocol|0
5176716|NCT01262365|17874359|P2|Overall Study|Cannot tolerate the protocol|1
5176717|NCT01262365|17874360|P1|Overall Study|Cannot tolerate the protocol|0
5176718|NCT01262365|17874358|P3|Overall Study|Toxicity related to study drug|0
5176719|NCT01262365|17874359|P2|Overall Study|Toxicity related to study drug|1
5176720|NCT01262365|17874360|P1|Overall Study|Toxicity related to study drug|0
5176721|NCT01262365|17874358|P3|Overall Study|Patient pregnant|1
5176722|NCT01262365|17874359|P2|Overall Study|Patient pregnant|0
5176723|NCT01262365|17874360|P1|Overall Study|Patient pregnant|1
5176724|NCT01262365|17874358|P3|Overall Study|Suspected pregnancy|0
5176725|NCT01262365|17874359|P2|Overall Study|Suspected pregnancy|0
5176726|NCT01262365|17874360|P1|Overall Study|Suspected pregnancy|1
5176727|NCT01262365|17874358|P3|Overall Study|Non-compliance|2
5176728|NCT01262365|17874359|P2|Overall Study|Non-compliance|0
5176729|NCT01262365|17874360|P1|Overall Study|Non-compliance|1
5176730|NCT01262365|17874358|P3|Overall Study|Randomization error|2
5176731|NCT01262365|17874359|P2|Overall Study|Randomization error|0
5176732|NCT01262365|17874360|P1|Overall Study|Randomization error|1
5176733|NCT01262365|17874358|P3|Overall Study|sponsor decision|0
5176734|NCT01262365|17874359|P2|Overall Study|sponsor decision|1
5176735|NCT01262365|17874360|P1|Overall Study|sponsor decision|1
5176736|NCT01262365|17874358|P3|Overall Study|Adverse Event|11
5176737|NCT01262365|17874359|P2|Overall Study|Adverse Event|16
5176738|NCT01262365|17874360|P1|Overall Study|Adverse Event|26
5176739|NCT01262365|17874358|P3|Overall Study|Death|1
5176740|NCT01262365|17874359|P2|Overall Study|Death|2
5176741|NCT01262365|17874360|P1|Overall Study|Death|1
5176742|NCT01262365|17874358|P3|Overall Study|Withdrawal by Subject|22
5176743|NCT01262365|17874359|P2|Overall Study|Withdrawal by Subject|22
5176744|NCT01262365|17874360|P1|Overall Study|Withdrawal by Subject|17
5176745|NCT01262365|17874358|P3|Overall Study|Lost to Follow-up|6
5176746|NCT01262365|17874359|P2|Overall Study|Lost to Follow-up|7
5176747|NCT01262365|17874360|P1|Overall Study|Lost to Follow-up|3
5176748|NCT01262365|17874358|P3|Overall Study|Protocol Violation|1
5176749|NCT01262365|17874359|P2|Overall Study|Protocol Violation|1
5176750|NCT01262365|17874360|P1|Overall Study|Protocol Violation|3
5176751|NCT01262365|17874358|P3|Overall Study|Lack of Efficacy|47
5176752|NCT01262365|17874359|P2|Overall Study|Lack of Efficacy|30
5176753|NCT01262365|17874360|P1|Overall Study|Lack of Efficacy|35
5176754|NCT01262352|17874385|P2|Washout|Extended Washout|1
5176755|NCT01262352|17874386|P1|Washout|Extended Washout|0
5176756|NCT01262352|17874385|P2|Washout|Adverse Event|1
5176757|NCT01262352|17874386|P1|Washout|Adverse Event|1
5176758|NCT01262352|17874385|P2|Period 1|Illness after randomization|0
5176759|NCT01262352|17874386|P1|Period 1|Illness after randomization|1
5176760|NCT01262287|17874404|P2|Overall Study|Lost to Follow-up|1
5176761|NCT01262287|17874405|P1|Overall Study|Lost to Follow-up|2
5176762|NCT01262092|17874466|P2|Gabapentin Taper|noncompliance - missed medications|0
5176763|NCT01262092|17874467|P1|Gabapentin Taper|noncompliance - missed medications|1
5176764|NCT01262092|17874466|P2|Buprenorphine Taper|noncompliance - missed medication|1
5176765|NCT01262092|17874467|P1|Buprenorphine Taper|noncompliance - missed medication|1
5176766|NCT01262092|17874466|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
5176767|NCT01262092|17874467|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
5176768|NCT01262092|17874466|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
5176769|NCT01262092|17874467|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
5176770|NCT01262027|17874473|P1|Overall Study|Protocol Violation|1
5176771|NCT01262027|17874473|P1|Overall Study|Withdrawal by Subject|3
5176772|NCT01262027|17874473|P1|Overall Study|Adverse Event|1
5176773|NCT01261975|17874478|P1|Overall Study|Surgical complication|1
5176774|NCT01261793|17874509|P3|Overall Study|Patient unable to start IV line|1
5176775|NCT01261793|17874510|P2|Overall Study|Patient unable to start IV line|0
5176776|NCT01261793|17874511|P1|Overall Study|Patient unable to start IV line|0
5176777|NCT01261793|17874509|P3|Overall Study|Randomization error|0
5176778|NCT01261793|17874510|P2|Overall Study|Randomization error|1
5176779|NCT01261793|17874511|P1|Overall Study|Randomization error|0
5176780|NCT01261793|17874509|P3|Overall Study|Patient withdrew after cardiology visit|0
5176781|NCT01261793|17874510|P2|Overall Study|Patient withdrew after cardiology visit|1
5176782|NCT01261793|17874511|P1|Overall Study|Patient withdrew after cardiology visit|0
5176783|NCT01261793|17874509|P3|Overall Study|Lack of efficacy & patient not available|0
5176784|NCT01261793|17874510|P2|Overall Study|Lack of efficacy & patient not available|1
5176785|NCT01261793|17874511|P1|Overall Study|Lack of efficacy & patient not available|0
5176786|NCT01261793|17874509|P3|Overall Study|Outside the study area|1
5176787|NCT01261793|17874510|P2|Overall Study|Outside the study area|2
5176788|NCT01261793|17874511|P1|Overall Study|Outside the study area|0
5176789|NCT01261793|17874509|P3|Overall Study|Patient pregnant|0
5176790|NCT01261793|17874510|P2|Overall Study|Patient pregnant|0
5176791|NCT01261793|17874511|P1|Overall Study|Patient pregnant|1
5176792|NCT01261793|17874509|P3|Overall Study|Patient non-compliance|1
5176793|NCT01261793|17874510|P2|Overall Study|Patient non-compliance|0
5176794|NCT01261793|17874511|P1|Overall Study|Patient non-compliance|1
5176795|NCT01261793|17874509|P3|Overall Study|Suspected pregnancy|0
5176796|NCT01261793|17874510|P2|Overall Study|Suspected pregnancy|1
5176797|NCT01261793|17874511|P1|Overall Study|Suspected pregnancy|1
5176798|NCT01261793|17874509|P3|Overall Study|Patient non-availability|1
5176799|NCT01261793|17874510|P2|Overall Study|Patient non-availability|1
5176800|NCT01261793|17874511|P1|Overall Study|Patient non-availability|1
5176801|NCT01261793|17874509|P3|Overall Study|Adverse Event|19
5176802|NCT01261793|17874510|P2|Overall Study|Adverse Event|24
5176803|NCT01261793|17874511|P1|Overall Study|Adverse Event|9
5176804|NCT01261793|17874509|P3|Overall Study|Death|0
5176805|NCT01261793|17874510|P2|Overall Study|Death|1
5176806|NCT01261793|17874511|P1|Overall Study|Death|3
5176807|NCT01261793|17874509|P3|Overall Study|Withdrawal by Subject|14
5176808|NCT01261793|17874510|P2|Overall Study|Withdrawal by Subject|14
5176809|NCT01261793|17874511|P1|Overall Study|Withdrawal by Subject|12
5176810|NCT01261793|17874509|P3|Overall Study|Lost to Follow-up|7
5176811|NCT01261793|17874510|P2|Overall Study|Lost to Follow-up|3
5176812|NCT01261793|17874511|P1|Overall Study|Lost to Follow-up|10
5176813|NCT01261793|17874509|P3|Overall Study|Protocol Violation|6
5176814|NCT01261793|17874510|P2|Overall Study|Protocol Violation|5
5176815|NCT01261793|17874511|P1|Overall Study|Protocol Violation|3
5176816|NCT01261793|17874509|P3|Overall Study|Lack of Efficacy|32
5176817|NCT01261793|17874510|P2|Overall Study|Lack of Efficacy|37
5176818|NCT01261793|17874511|P1|Overall Study|Lack of Efficacy|44
5176819|NCT01261780|17874536|P2|Overall Study|Event not related to subject|2
5176820|NCT01261780|17874537|P1|Overall Study|Event not related to subject|1
5176821|NCT01261780|17874536|P2|Overall Study|Withdrawal by Subject|0
5176822|NCT01261780|17874537|P1|Overall Study|Withdrawal by Subject|1
5176823|NCT01261624|17874547|P2|Week 13 to Week 24|Insufficient Response|1
5176824|NCT01261624|17874548|P1|Week 13 to Week 24|Insufficient Response|0
5176825|NCT01261624|17874547|P2|Week 0 to Week 12|Insufficient Response|2
5176826|NCT01261624|17874548|P1|Week 0 to Week 12|Insufficient Response|0
5176827|NCT01261624|17874547|P2|Week 0 to Week 12|Disease Progression|1
5176828|NCT01261624|17874548|P1|Week 0 to Week 12|Disease Progression|1
5176829|NCT01261611|17874568|P3|Treatment Cycle 5|Lost to Follow-up|0
5176830|NCT01261611|17874569|P2|Treatment Cycle 5|Lost to Follow-up|0
5176831|NCT01261611|17874570|P1|Treatment Cycle 5|Lost to Follow-up|1
5176832|NCT01261611|17874568|P3|Treatment Cycle 5|Adverse Event|0
5176833|NCT01261611|17874569|P2|Treatment Cycle 5|Adverse Event|0
5176834|NCT01261611|17874570|P1|Treatment Cycle 5|Adverse Event|1
5176835|NCT01261611|17874568|P3|Treatment Cycle 5|Withdrawal by Subject|0
5176836|NCT01261611|17874569|P2|Treatment Cycle 5|Withdrawal by Subject|0
5176837|NCT01261611|17874570|P1|Treatment Cycle 5|Withdrawal by Subject|1
5176838|NCT01261611|17874568|P3|Treatment Cycle 4|Not otherwise specified|0
5176839|NCT01261611|17874569|P2|Treatment Cycle 4|Not otherwise specified|0
5176840|NCT01261611|17874570|P1|Treatment Cycle 4|Not otherwise specified|3
5176841|NCT01261611|17874568|P3|Treatment Cycle 4|Lost to Follow-up|0
5176842|NCT01261611|17874569|P2|Treatment Cycle 4|Lost to Follow-up|0
5176843|NCT01261611|17874570|P1|Treatment Cycle 4|Lost to Follow-up|2
5176844|NCT01261611|17874568|P3|Treatment Cycle 4|Adverse Event|0
5176845|NCT01261611|17874569|P2|Treatment Cycle 4|Adverse Event|0
5176846|NCT01261611|17874570|P1|Treatment Cycle 4|Adverse Event|1
5176847|NCT01261611|17874568|P3|Treatment Cycle 4|Withdrawal by Subject|0
5176848|NCT01261611|17874569|P2|Treatment Cycle 4|Withdrawal by Subject|0
5176849|NCT01261611|17874570|P1|Treatment Cycle 4|Withdrawal by Subject|3
5176850|NCT01261611|17874568|P3|Treatment Cycle 4|Completed study|0
5176851|NCT01261611|17874569|P2|Treatment Cycle 4|Completed study|0
5176852|NCT01261611|17874570|P1|Treatment Cycle 4|Completed study|87
5176853|NCT01261611|17874568|P3|Treatment Cycle 3|Lost to Follow-up|0
5176854|NCT01261611|17874569|P2|Treatment Cycle 3|Lost to Follow-up|0
5176855|NCT01261611|17874570|P1|Treatment Cycle 3|Lost to Follow-up|1
5176856|NCT01261611|17874568|P3|Treatment Cycle 3|Adverse Event|0
5176857|NCT01261611|17874569|P2|Treatment Cycle 3|Adverse Event|0
5176858|NCT01261611|17874570|P1|Treatment Cycle 3|Adverse Event|1
5176860|NCT01261611|17874569|P2|Treatment Cycle 3|Withdrawal by Subject|0
5176861|NCT01261611|17874570|P1|Treatment Cycle 3|Withdrawal by Subject|4
5176862|NCT01261611|17874568|P3|Treatment Cycle 3|Completed study|0
5176863|NCT01261611|17874569|P2|Treatment Cycle 3|Completed study|0
5176864|NCT01261611|17874570|P1|Treatment Cycle 3|Completed study|24
5176865|NCT01261611|17874568|P3|Treatment Cycle 2|Not otherwise specified|0
5176866|NCT01261611|17874569|P2|Treatment Cycle 2|Not otherwise specified|0
5176867|NCT01261611|17874570|P1|Treatment Cycle 2|Not otherwise specified|2
5176868|NCT01261611|17874568|P3|Treatment Cycle 2|Protocol Violation|0
5176869|NCT01261611|17874569|P2|Treatment Cycle 2|Protocol Violation|0
5176870|NCT01261611|17874570|P1|Treatment Cycle 2|Protocol Violation|2
5176871|NCT01261611|17874568|P3|Treatment Cycle 2|Adverse Event|0
5176872|NCT01261611|17874569|P2|Treatment Cycle 2|Adverse Event|0
5176873|NCT01261611|17874570|P1|Treatment Cycle 2|Adverse Event|1
5176874|NCT01261611|17874568|P3|Treatment Cycle 2|Withdrawal by Subject|0
5176875|NCT01261611|17874569|P2|Treatment Cycle 2|Withdrawal by Subject|0
5176876|NCT01261611|17874570|P1|Treatment Cycle 2|Withdrawal by Subject|4
5176877|NCT01261611|17874568|P3|Treatment Cycle 2|Completed study|0
5176878|NCT01261611|17874569|P2|Treatment Cycle 2|Completed study|0
5176879|NCT01261611|17874570|P1|Treatment Cycle 2|Completed study|4
5176880|NCT01261611|17874568|P3|Treatment Cycle 1|Protocol Violation|2
5176881|NCT01261611|17874569|P2|Treatment Cycle 1|Protocol Violation|0
5176882|NCT01261611|17874570|P1|Treatment Cycle 1|Protocol Violation|0
5176883|NCT01261611|17874568|P3|Treatment Cycle 1|Adverse Event|0
5176884|NCT01261611|17874569|P2|Treatment Cycle 1|Adverse Event|1
5176885|NCT01261611|17874570|P1|Treatment Cycle 1|Adverse Event|0
5176886|NCT01261611|17874568|P3|Treatment Cycle 1|Lost to Follow-up|0
5176887|NCT01261611|17874569|P2|Treatment Cycle 1|Lost to Follow-up|0
5176888|NCT01261611|17874570|P1|Treatment Cycle 1|Lost to Follow-up|1
5176889|NCT01261611|17874568|P3|Treatment Cycle 1|Withdrawal by Subject|0
5176890|NCT01261611|17874569|P2|Treatment Cycle 1|Withdrawal by Subject|2
5176891|NCT01261611|17874570|P1|Treatment Cycle 1|Withdrawal by Subject|3
5176892|NCT01261390|17874634|P4|Overall Study|Lost to Follow-up|6
5176893|NCT01261390|17874635|P3|Overall Study|Lost to Follow-up|5
5176894|NCT01261390|17874636|P2|Overall Study|Lost to Follow-up|6
5176895|NCT01261390|17874637|P1|Overall Study|Lost to Follow-up|1
5176896|NCT01261390|17874634|P4|Overall Study|Loss of Interest in the Study|0
5176897|NCT01261390|17874635|P3|Overall Study|Loss of Interest in the Study|0
5176898|NCT01261390|17874636|P2|Overall Study|Loss of Interest in the Study|1
5176899|NCT01261390|17874637|P1|Overall Study|Loss of Interest in the Study|3
5176900|NCT01261390|17874634|P4|Overall Study|Relocation|0
5176901|NCT01261390|17874635|P3|Overall Study|Relocation|0
5176902|NCT01261390|17874636|P2|Overall Study|Relocation|1
5176903|NCT01261390|17874637|P1|Overall Study|Relocation|0
5176904|NCT01261390|17874634|P4|Overall Study|Dissatisfaction with Treatment|2
5176905|NCT01261390|17874635|P3|Overall Study|Dissatisfaction with Treatment|1
5176906|NCT01261390|17874636|P2|Overall Study|Dissatisfaction with Treatment|1
5176907|NCT01261390|17874637|P1|Overall Study|Dissatisfaction with Treatment|2
5176908|NCT01261390|17874634|P4|Overall Study|Significant Concurrent Illness|0
5176909|NCT01261390|17874635|P3|Overall Study|Significant Concurrent Illness|1
5176910|NCT01261390|17874636|P2|Overall Study|Significant Concurrent Illness|0
5176911|NCT01261390|17874637|P1|Overall Study|Significant Concurrent Illness|1
5176912|NCT01261338|17874801|P2|Overall Study|Withdrawal by Subject|2
5176913|NCT01261338|17874802|P1|Overall Study|Withdrawal by Subject|3
5176914|NCT01261325|17874813|P3|Overall Study|AE, serious fatal|2
5176915|NCT01261325|17874814|P2|Overall Study|AE, serious fatal|0
5176916|NCT01261325|17874815|P1|Overall Study|AE, serious fatal|0
5176917|NCT01261325|17874813|P3|Overall Study|Lost to Follow-up|3
5176918|NCT01261325|17874814|P2|Overall Study|Lost to Follow-up|1
5176919|NCT01261325|17874815|P1|Overall Study|Lost to Follow-up|0
5176920|NCT01261325|17874813|P3|Overall Study|Protocol Violation|1
5176921|NCT01261325|17874814|P2|Overall Study|Protocol Violation|3
5176922|NCT01261325|17874815|P1|Overall Study|Protocol Violation|0
5176923|NCT01261325|17874813|P3|Overall Study|Randomized in Error|1
5176924|NCT01261325|17874814|P2|Overall Study|Randomized in Error|0
5176925|NCT01261325|17874815|P1|Overall Study|Randomized in Error|0
5176926|NCT01261325|17874813|P3|Overall Study|Screen Failure|0
5176927|NCT01261325|17874814|P2|Overall Study|Screen Failure|0
5176928|NCT01261325|17874815|P1|Overall Study|Screen Failure|1
5176929|NCT01261325|17874813|P3|Overall Study|Erroneously Randomized|0
5176930|NCT01261325|17874814|P2|Overall Study|Erroneously Randomized|0
5176931|NCT01261325|17874815|P1|Overall Study|Erroneously Randomized|1
5176932|NCT01261325|17874813|P3|Overall Study|Patient Randomized by Mistake|0
5176933|NCT01261325|17874814|P2|Overall Study|Patient Randomized by Mistake|1
5176934|NCT01261325|17874815|P1|Overall Study|Patient Randomized by Mistake|0
5176935|NCT01261325|17874813|P3|Overall Study|Non Compliance|0
5176936|NCT01261325|17874814|P2|Overall Study|Non Compliance|0
5176937|NCT01261325|17874815|P1|Overall Study|Non Compliance|2
5176938|NCT01261325|17874813|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5176939|NCT01261325|17874814|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5176940|NCT01261325|17874815|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5176941|NCT01261325|17874813|P3|Overall Study|AE, non-serious non-fatal|13
5176942|NCT01261325|17874814|P2|Overall Study|AE, non-serious non-fatal|15
5176943|NCT01261325|17874815|P1|Overall Study|AE, non-serious non-fatal|9
5176944|NCT01261325|17874813|P3|Overall Study|SAE, non-fatal|1
5176945|NCT01261325|17874814|P2|Overall Study|SAE, non-fatal|5
5176946|NCT01261325|17874815|P1|Overall Study|SAE, non-fatal|1
5176947|NCT01261325|17874813|P3|Overall Study|Withdrawal by Subject|4
5176948|NCT01261325|17874814|P2|Overall Study|Withdrawal by Subject|2
5176949|NCT01261325|17874815|P1|Overall Study|Withdrawal by Subject|2
5176950|NCT01261325|17874813|P3|Overall Study|Lack of Efficacy|0
5176951|NCT01261325|17874814|P2|Overall Study|Lack of Efficacy|1
5176952|NCT01261325|17874815|P1|Overall Study|Lack of Efficacy|1
5176953|NCT01261247|17874847|P1|Overall Study|Ineligible|2
5176954|NCT01261000|17874860|P1|Overall Study|Screen failure|1
5176955|NCT01260948|17874866|P2|Second Intervention|Emesis|1
5176956|NCT01260948|17874867|P1|Second Intervention|Emesis|0
5176957|NCT01260948|17874866|P2|Washout of 28 Days|Withdrawal by Subject|3
5176958|NCT01260948|17874867|P1|Washout of 28 Days|Withdrawal by Subject|1
5176959|NCT01260922|17874877|P2|Second Intervention|Emesis|2
5176960|NCT01260922|17874878|P1|Second Intervention|Emesis|0
5176961|NCT01260922|17874877|P2|Washout of 28 Days|Withdrawal by Subject|2
5176962|NCT01260922|17874878|P1|Washout of 28 Days|Withdrawal by Subject|4
5176963|NCT01260922|17874877|P2|First Intervention|Withdrawal by Subject|1
5176964|NCT01260922|17874878|P1|First Intervention|Withdrawal by Subject|0
5176965|NCT01260896|17874888|P2|First Intervention|Withdrawn Due to Emesis|0
5176966|NCT01260896|17874889|P1|First Intervention|Withdrawn Due to Emesis|2
5176967|NCT01260701|17874947|P1|Overall Study|Did not begin protocol therapy|1
5176968|NCT01260701|17874947|P1|Overall Study|Ineligible|4
5176969|NCT01260701|17874947|P1|Overall Study|Under review|1
5176970|NCT01260701|17874947|P1|Overall Study|Not protocol specified|3
5176971|NCT01260701|17874947|P1|Overall Study|Death|2
5176972|NCT01260701|17874947|P1|Overall Study|Progression|53
5176973|NCT01260701|17874947|P1|Overall Study|Withdrawal by Subject|2
5176974|NCT01260701|17874947|P1|Overall Study|Adverse Event|9
5176975|NCT01260584|17875028|P4|Period 2|Withdrawal by Subject|0
5176976|NCT01260584|17875029|P3|Period 2|Withdrawal by Subject|0
5176977|NCT01260584|17875030|P2|Period 2|Withdrawal by Subject|1
5176978|NCT01260584|17875031|P1|Period 2|Withdrawal by Subject|0
5176979|NCT01260584|17875028|P4|Period 2|Adverse Event|0
5176980|NCT01260584|17875029|P3|Period 2|Adverse Event|2
5176981|NCT01260584|17875030|P2|Period 2|Adverse Event|0
5176982|NCT01260584|17875031|P1|Period 2|Adverse Event|1
5176983|NCT01260584|17875028|P4|Period 2|Protocol Violation|1
5176984|NCT01260584|17875029|P3|Period 2|Protocol Violation|3
5176985|NCT01260584|17875030|P2|Period 2|Protocol Violation|2
5176986|NCT01260584|17875031|P1|Period 2|Protocol Violation|0
5176987|NCT01260584|17875028|P4|Period 1|Adverse Event|0
5176988|NCT01260584|17875029|P3|Period 1|Adverse Event|1
5176989|NCT01260584|17875030|P2|Period 1|Adverse Event|0
5176990|NCT01260584|17875031|P1|Period 1|Adverse Event|0
5176991|NCT01260584|17875028|P4|Period 1|Protocol Violation|1
5176992|NCT01260584|17875029|P3|Period 1|Protocol Violation|1
5176993|NCT01260584|17875030|P2|Period 1|Protocol Violation|0
5176994|NCT01260584|17875031|P1|Period 1|Protocol Violation|0
5176995|NCT01260467|17875074|P1|Overall Study|Withdrawal by Subject|2
5176996|NCT01260350|17875106|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
5176997|NCT01260350|17875107|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
5176998|NCT01260350|17875108|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
5176999|NCT01260350|17875109|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177000|NCT01260350|17875110|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177001|NCT01260350|17875111|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177002|NCT01260350|17875112|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177003|NCT01260350|17875113|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177004|NCT01260350|17875114|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177005|NCT01260350|17875115|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177006|NCT01260350|17875116|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177007|NCT01260350|17875117|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177008|NCT01260350|17875118|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177009|NCT01260350|17875119|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
5177010|NCT01260350|17875120|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177011|NCT01260350|17875121|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177012|NCT01260350|17875122|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177013|NCT01260350|17875123|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177014|NCT01260350|17875124|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177015|NCT01260350|17875125|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177016|NCT01260350|17875126|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177017|NCT01260350|17875127|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
5177018|NCT01260350|17875106|P22|Overall Study|Lack of Efficacy|0
5177019|NCT01260350|17875107|P21|Overall Study|Lack of Efficacy|3
5177020|NCT01260350|17875108|P20|Overall Study|Lack of Efficacy|0
5177021|NCT01260350|17875109|P19|Overall Study|Lack of Efficacy|0
5177022|NCT01260350|17875110|P18|Overall Study|Lack of Efficacy|1
5177023|NCT01260350|17875111|P17|Overall Study|Lack of Efficacy|0
5177024|NCT01260350|17875112|P16|Overall Study|Lack of Efficacy|0
5177025|NCT01260350|17875113|P15|Overall Study|Lack of Efficacy|0
5177026|NCT01260350|17875114|P14|Overall Study|Lack of Efficacy|0
5177027|NCT01260350|17875115|P13|Overall Study|Lack of Efficacy|0
5177028|NCT01260350|17875116|P12|Overall Study|Lack of Efficacy|0
5177029|NCT01260350|17875117|P11|Overall Study|Lack of Efficacy|0
5177030|NCT01260350|17875118|P10|Overall Study|Lack of Efficacy|0
5177031|NCT01260350|17875119|P9|Overall Study|Lack of Efficacy|0
5177032|NCT01260350|17875120|P8|Overall Study|Lack of Efficacy|0
5177033|NCT01260350|17875121|P7|Overall Study|Lack of Efficacy|0
5177034|NCT01260350|17875122|P6|Overall Study|Lack of Efficacy|0
5177035|NCT01260350|17875123|P5|Overall Study|Lack of Efficacy|0
5177036|NCT01260350|17875124|P4|Overall Study|Lack of Efficacy|0
5177037|NCT01260350|17875125|P3|Overall Study|Lack of Efficacy|0
5177038|NCT01260350|17875126|P2|Overall Study|Lack of Efficacy|0
5177039|NCT01260350|17875127|P1|Overall Study|Lack of Efficacy|0
5177040|NCT01260311|17875334|P1|Overall Study|Fesoterodine Started Before Enrollment|1
5177041|NCT01260311|17875334|P1|Overall Study|Medication Stopped|1
5177042|NCT01260311|17875334|P1|Overall Study|Gone to Province|2
5177043|NCT01260311|17875334|P1|Overall Study|Financial Constraints|77
5177044|NCT01260311|17875334|P1|Overall Study|Withdrawal by Subject|6
5177045|NCT01260311|17875334|P1|Overall Study|Lost to Follow-up|25
5177046|NCT01260311|17875334|P1|Overall Study|Lack of Efficacy|4
5177047|NCT01260311|17875334|P1|Overall Study|Adverse Event|11
5177048|NCT01260194|17875365|P1|Overall Study|Withdrawal of Consent|1
5177049|NCT01260181|17875377|P1|Overall Study|Decision of Investigator|1
5177050|NCT01260142|17875392|P6|Treatment Period 1|Withdrawal by Subject|1
5177051|NCT01260142|17875393|P5|Treatment Period 1|Withdrawal by Subject|0
5177052|NCT01260142|17875394|P4|Treatment Period 1|Withdrawal by Subject|0
5177053|NCT01260142|17875395|P3|Treatment Period 1|Withdrawal by Subject|0
5177054|NCT01260142|17875396|P2|Treatment Period 1|Withdrawal by Subject|0
5177055|NCT01260142|17875397|P1|Treatment Period 1|Withdrawal by Subject|0
5177056|NCT01260142|17875392|P6|Treatment Period 1|Unexplained elevated sys. BP|0
5177057|NCT01260142|17875393|P5|Treatment Period 1|Unexplained elevated sys. BP|1
5177058|NCT01260142|17875394|P4|Treatment Period 1|Unexplained elevated sys. BP|0
5177059|NCT01260142|17875395|P3|Treatment Period 1|Unexplained elevated sys. BP|0
5177060|NCT01260142|17875396|P2|Treatment Period 1|Unexplained elevated sys. BP|0
5177061|NCT01260142|17875397|P1|Treatment Period 1|Unexplained elevated sys. BP|0
5177062|NCT01260142|17875392|P6|Treatment Period 1|Study on hold|2
5177063|NCT01260142|17875393|P5|Treatment Period 1|Study on hold|1
5177064|NCT01260142|17875394|P4|Treatment Period 1|Study on hold|0
5177065|NCT01260142|17875395|P3|Treatment Period 1|Study on hold|0
5177066|NCT01260142|17875396|P2|Treatment Period 1|Study on hold|1
5177067|NCT01260142|17875397|P1|Treatment Period 1|Study on hold|1
5177068|NCT01259869|17875447|P1|Overall Study|Duplicated registration|1
5177069|NCT01259856|17875453|P2|Overall Study|Unknown/missing|2
5177070|NCT01259856|17875454|P1|Overall Study|Unknown/missing|2
5177071|NCT01259856|17875453|P2|Overall Study|Transfer to another study|1
5177072|NCT01259856|17875454|P1|Overall Study|Transfer to another study|0
5177073|NCT01259856|17875453|P2|Overall Study|Patient developed other disease|1
5177074|NCT01259856|17875454|P1|Overall Study|Patient developed other disease|0
5177075|NCT01259856|17875453|P2|Overall Study|Study closure by sponsor|41
5177076|NCT01259856|17875454|P1|Overall Study|Study closure by sponsor|40
5177077|NCT01259856|17875453|P2|Overall Study|Treatment never started|6
5177078|NCT01259856|17875454|P1|Overall Study|Treatment never started|0
5177079|NCT01259856|17875453|P2|Overall Study|Withdrawal by Subject|10
5177080|NCT01259856|17875454|P1|Overall Study|Withdrawal by Subject|9
5177081|NCT01259856|17875453|P2|Overall Study|Physician Decision|1
5177082|NCT01259856|17875454|P1|Overall Study|Physician Decision|2
5177083|NCT01259856|17875453|P2|Overall Study|Lost to Follow-up|1
5177084|NCT01259856|17875454|P1|Overall Study|Lost to Follow-up|1
5177085|NCT01259856|17875453|P2|Overall Study|Lack of Efficacy|1
5177086|NCT01259856|17875454|P1|Overall Study|Lack of Efficacy|3
5177087|NCT01259856|17875453|P2|Overall Study|Death|1
5177088|NCT01259856|17875454|P1|Overall Study|Death|0
5177089|NCT01259856|17875453|P2|Overall Study|Adverse Event|9
5177090|NCT01259856|17875454|P1|Overall Study|Adverse Event|12
5177091|NCT01259726|17875478|P4|Overall Study|Lost to Follow-up|3
5177092|NCT01259726|17875479|P3|Overall Study|Lost to Follow-up|1
5177093|NCT01259726|17875480|P2|Overall Study|Lost to Follow-up|1
5177094|NCT01259726|17875481|P1|Overall Study|Lost to Follow-up|1
5177095|NCT01259726|17875478|P4|Overall Study|Withdrawal by Subject|1
5177096|NCT01259726|17875479|P3|Overall Study|Withdrawal by Subject|2
5177097|NCT01259726|17875480|P2|Overall Study|Withdrawal by Subject|3
5177098|NCT01259726|17875481|P1|Overall Study|Withdrawal by Subject|1
5177099|NCT01259726|17875478|P4|Overall Study|Physician Decision|1
5177100|NCT01259726|17875479|P3|Overall Study|Physician Decision|1
5177101|NCT01259726|17875480|P2|Overall Study|Physician Decision|0
5177102|NCT01259726|17875481|P1|Overall Study|Physician Decision|2
5177103|NCT01259726|17875478|P4|Overall Study|Death|0
5177104|NCT01259726|17875479|P3|Overall Study|Death|0
5177105|NCT01259726|17875480|P2|Overall Study|Death|0
5177106|NCT01259726|17875481|P1|Overall Study|Death|1
5177107|NCT01259713|17875513|P2|Overall Study|Subject Withdrew Consent|7
5177108|NCT01259713|17875514|P1|Overall Study|Subject Withdrew Consent|12
5177109|NCT01259713|17875513|P2|Overall Study|Protocol Violation|4
5177110|NCT01259713|17875514|P1|Overall Study|Protocol Violation|5
5177111|NCT01259713|17875513|P2|Overall Study|Lack of Efficacy|0
5177112|NCT01259713|17875514|P1|Overall Study|Lack of Efficacy|2
5177113|NCT01259713|17875513|P2|Overall Study|Investigators Discretion|6
5177114|NCT01259713|17875514|P1|Overall Study|Investigators Discretion|14
5177115|NCT01259713|17875513|P2|Overall Study|Death Not Related to IFI|1
5177116|NCT01259713|17875514|P1|Overall Study|Death Not Related to IFI|8
5177117|NCT01259713|17875513|P2|Overall Study|Adverse Event|23
5177118|NCT01259713|17875514|P1|Overall Study|Adverse Event|54
5177119|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
5177120|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
5177121|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
5177122|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
5177123|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5177124|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
5177125|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5177126|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5177127|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
5177128|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
5177129|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
5177130|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
5177131|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
5177132|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
5177133|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
5177134|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
5177135|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5177136|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5177137|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5177138|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
5177139|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
5177140|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
5177141|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
5177142|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
5177143|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5177144|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
5177145|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5177146|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5177147|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
5177148|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5177149|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5177150|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5177151|NCT01259492|17875561|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
5177152|NCT01259492|17875562|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
5177153|NCT01259492|17875563|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
5177154|NCT01259492|17875564|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
5177155|NCT01259492|17875561|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
5177156|NCT01259492|17875562|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
5177157|NCT01259492|17875563|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
5177158|NCT01259492|17875564|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
5177159|NCT01259492|17875561|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5177160|NCT01259492|17875562|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
5177161|NCT01259492|17875563|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5177162|NCT01259492|17875564|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5177163|NCT01259492|17875561|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
5177164|NCT01259492|17875562|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
5177165|NCT01259492|17875563|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
5177166|NCT01259492|17875564|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
5177167|NCT01259492|17875561|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
5177168|NCT01259492|17875562|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
5177169|NCT01259492|17875563|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
5177170|NCT01259492|17875564|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
5177171|NCT01259492|17875561|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
5177172|NCT01259492|17875562|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
5177173|NCT01259492|17875563|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
5177174|NCT01259492|17875564|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
5177175|NCT01259492|17875561|P4|Period 1 (9 Weeks)|Protocol Violation|1
5177176|NCT01259492|17875562|P3|Period 1 (9 Weeks)|Protocol Violation|3
5177177|NCT01259492|17875563|P2|Period 1 (9 Weeks)|Protocol Violation|6
5177178|NCT01259492|17875564|P1|Period 1 (9 Weeks)|Protocol Violation|5
5177179|NCT01259492|17875561|P4|Period 1 (9 Weeks)|Administrative Problems|2
5177180|NCT01259492|17875562|P3|Period 1 (9 Weeks)|Administrative Problems|1
5177181|NCT01259492|17875563|P2|Period 1 (9 Weeks)|Administrative Problems|1
5177182|NCT01259492|17875564|P1|Period 1 (9 Weeks)|Administrative Problems|0
5177183|NCT01259492|17875561|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
5177184|NCT01259492|17875562|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
5177185|NCT01259492|17875563|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
5177186|NCT01259492|17875564|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
5177187|NCT01259492|17875561|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
5177188|NCT01259492|17875562|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
5177189|NCT01259492|17875563|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
5177190|NCT01259492|17875564|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
5177191|NCT01259492|17875561|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
5177192|NCT01259492|17875562|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
5177193|NCT01259492|17875563|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
5177194|NCT01259492|17875564|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
5177195|NCT01259492|17875561|P4|Period 1 (9 Weeks)|Adverse Event|3
5177196|NCT01259492|17875562|P3|Period 1 (9 Weeks)|Adverse Event|26
5177197|NCT01259492|17875563|P2|Period 1 (9 Weeks)|Adverse Event|18
5177198|NCT01259492|17875564|P1|Period 1 (9 Weeks)|Adverse Event|13
5177199|NCT01259466|17875613|P2|Overall Study|Withdrawal by Subject|9
5177200|NCT01259466|17875614|P1|Overall Study|Withdrawal by Subject|1
5177201|NCT01259401|17875652|P2|4-month Follow-up|Lost to Follow-up|1
5177202|NCT01259401|17875653|P1|4-month Follow-up|Lost to Follow-up|0
5177203|NCT01259401|17875652|P2|4-month Follow-up|Death|1
5177204|NCT01259401|17875653|P1|4-month Follow-up|Death|0
5177205|NCT01259388|17875663|P2|Overall Study|Physician Decision|0
5177206|NCT01259388|17875664|P1|Overall Study|Physician Decision|1
5177207|NCT01259388|17875663|P2|Overall Study|Withdrawal by Subject|1
5177208|NCT01259388|17875664|P1|Overall Study|Withdrawal by Subject|1
5177209|NCT01259388|17875663|P2|Overall Study|Adverse Event|0
5177210|NCT01259388|17875664|P1|Overall Study|Adverse Event|3
5177211|NCT01259375|17875674|P1|Overall Study|Adverse Event|1
5177212|NCT01259297|17875691|P8|Double Blind Randomized Period|Other reasons|1
5177213|NCT01259297|17875692|P7|Double Blind Randomized Period|Other reasons|3
5177214|NCT01259297|17875693|P6|Double Blind Randomized Period|Other reasons|2
5177215|NCT01259297|17875694|P5|Double Blind Randomized Period|Other reasons|1
5177216|NCT01259297|17875695|P4|Double Blind Randomized Period|Other reasons|0
5177217|NCT01259297|17875696|P3|Double Blind Randomized Period|Other reasons|0
5177218|NCT01259297|17875697|P2|Double Blind Randomized Period|Other reasons|1
5177219|NCT01259297|17875698|P1|Double Blind Randomized Period|Other reasons|0
5177220|NCT01259297|17875691|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5177221|NCT01259297|17875692|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5177222|NCT01259297|17875693|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5177223|NCT01259297|17875694|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
5177224|NCT01259297|17875695|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
5177225|NCT01259297|17875696|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
5177226|NCT01259297|17875697|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5177227|NCT01259297|17875698|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5177228|NCT01259297|17875691|P8|Double Blind Randomized Period|Death|1
5177229|NCT01259297|17875692|P7|Double Blind Randomized Period|Death|2
5177230|NCT01259297|17875693|P6|Double Blind Randomized Period|Death|5
5177231|NCT01259297|17875694|P5|Double Blind Randomized Period|Death|1
5177232|NCT01259297|17875695|P4|Double Blind Randomized Period|Death|2
5177233|NCT01259297|17875696|P3|Double Blind Randomized Period|Death|1
5177234|NCT01259297|17875697|P2|Double Blind Randomized Period|Death|1
5177235|NCT01259297|17875698|P1|Double Blind Randomized Period|Death|1
5177236|NCT01259284|17875729|P3|Overall Study|Study Termination|0
5177237|NCT01259284|17875730|P2|Overall Study|Study Termination|0
5177238|NCT01259284|17875731|P1|Overall Study|Study Termination|2
5177239|NCT01259245|17875741|P2|Overall Study|Death|2
5177240|NCT01259245|17875742|P1|Overall Study|Death|1
5177241|NCT01259245|17875741|P2|Overall Study|Withdrawal by Subject|24
5177242|NCT01259245|17875742|P1|Overall Study|Withdrawal by Subject|27
5177243|NCT01259115|17875779|P2|Period 2|Adverse Event|0
5177244|NCT01259115|17875780|P1|Period 2|Adverse Event|1
5177245|NCT01259115|17875779|P2|Period 1|Lost to Follow-up|1
5177246|NCT01259115|17875780|P1|Period 1|Lost to Follow-up|0
5177247|NCT01259115|17875779|P2|Period 1|Protocol Violation|0
5177248|NCT01259115|17875780|P1|Period 1|Protocol Violation|2
5177249|NCT01259115|17875779|P2|Period 1|Adverse Event|0
5177250|NCT01259115|17875780|P1|Period 1|Adverse Event|1
5177251|NCT01259102|17875816|P5|Overall Study|Other|1
5177252|NCT01259102|17875817|P4|Overall Study|Other|1
5177253|NCT01259102|17875818|P3|Overall Study|Other|1
5177254|NCT01259102|17875819|P2|Overall Study|Other|0
5177255|NCT01259102|17875820|P1|Overall Study|Other|0
5177256|NCT01259102|17875816|P5|Overall Study|Adverse Event|0
5177257|NCT01259102|17875817|P4|Overall Study|Adverse Event|1
5177258|NCT01259102|17875818|P3|Overall Study|Adverse Event|1
5177259|NCT01259102|17875819|P2|Overall Study|Adverse Event|0
5177260|NCT01259102|17875820|P1|Overall Study|Adverse Event|1
5177261|NCT01259089|17875877|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
5177262|NCT01259089|17875878|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
5177263|NCT01259089|17875879|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
5177264|NCT01259089|17875880|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
5177265|NCT01259089|17875881|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
5177266|NCT01259089|17875882|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
5177267|NCT01259089|17875877|P6|Survival Follow up for Two Years|Lost to Follow-up|2
5177268|NCT01259089|17875878|P5|Survival Follow up for Two Years|Lost to Follow-up|0
5177269|NCT01259089|17875879|P4|Survival Follow up for Two Years|Lost to Follow-up|0
5177270|NCT01259089|17875880|P3|Survival Follow up for Two Years|Lost to Follow-up|0
5177271|NCT01259089|17875881|P2|Survival Follow up for Two Years|Lost to Follow-up|0
5177272|NCT01259089|17875882|P1|Survival Follow up for Two Years|Lost to Follow-up|0
5177273|NCT01259089|17875877|P6|Survival Follow up for Two Years|Death|13
5177274|NCT01259089|17875878|P5|Survival Follow up for Two Years|Death|6
5177275|NCT01259089|17875879|P4|Survival Follow up for Two Years|Death|3
5177276|NCT01259089|17875880|P3|Survival Follow up for Two Years|Death|2
5177277|NCT01259089|17875881|P2|Survival Follow up for Two Years|Death|2
5177278|NCT01259089|17875882|P1|Survival Follow up for Two Years|Death|3
5177279|NCT01259089|17875877|P6|Continued Treatment After 8 Weeks|Progressive disease|0
5177280|NCT01259089|17875878|P5|Continued Treatment After 8 Weeks|Progressive disease|0
5177281|NCT01259089|17875879|P4|Continued Treatment After 8 Weeks|Progressive disease|1
5177282|NCT01259089|17875880|P3|Continued Treatment After 8 Weeks|Progressive disease|1
5177283|NCT01259089|17875881|P2|Continued Treatment After 8 Weeks|Progressive disease|1
5177284|NCT01259089|17875882|P1|Continued Treatment After 8 Weeks|Progressive disease|1
5177285|NCT01259089|17875877|P6|Continued Treatment After 8 Weeks|Adverse Event|1
5177286|NCT01259089|17875878|P5|Continued Treatment After 8 Weeks|Adverse Event|2
5177287|NCT01259089|17875879|P4|Continued Treatment After 8 Weeks|Adverse Event|0
5177288|NCT01259089|17875880|P3|Continued Treatment After 8 Weeks|Adverse Event|0
5177289|NCT01259089|17875881|P2|Continued Treatment After 8 Weeks|Adverse Event|0
5177290|NCT01259089|17875882|P1|Continued Treatment After 8 Weeks|Adverse Event|0
5177291|NCT01259089|17875877|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5177292|NCT01259089|17875878|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5177293|NCT01259089|17875879|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5177294|NCT01259089|17875880|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5177295|NCT01259089|17875881|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5177296|NCT01259089|17875882|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
5177297|NCT01259089|17875877|P6|Confirmed Response at 8 Weeks|Progressive disease|7
5177298|NCT01259089|17875878|P5|Confirmed Response at 8 Weeks|Progressive disease|3
5177299|NCT01259089|17875879|P4|Confirmed Response at 8 Weeks|Progressive disease|1
5177300|NCT01259089|17875880|P3|Confirmed Response at 8 Weeks|Progressive disease|1
5177301|NCT01259089|17875881|P2|Confirmed Response at 8 Weeks|Progressive disease|0
5177302|NCT01259089|17875882|P1|Confirmed Response at 8 Weeks|Progressive disease|0
5177303|NCT01259089|17875877|P6|Confirmed Response at 8 Weeks|Adverse Event|2
5177304|NCT01259089|17875878|P5|Confirmed Response at 8 Weeks|Adverse Event|1
5177305|NCT01259089|17875879|P4|Confirmed Response at 8 Weeks|Adverse Event|0
5177306|NCT01259089|17875880|P3|Confirmed Response at 8 Weeks|Adverse Event|0
5177307|NCT01259089|17875881|P2|Confirmed Response at 8 Weeks|Adverse Event|0
5177308|NCT01259089|17875882|P1|Confirmed Response at 8 Weeks|Adverse Event|0
5177309|NCT01259089|17875877|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
5177310|NCT01259089|17875878|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5177311|NCT01259089|17875879|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5177312|NCT01259089|17875880|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5177313|NCT01259089|17875881|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5177314|NCT01259089|17875882|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5177315|NCT01259089|17875877|P6|Reached First Response at 4 Weeks|Adverse Event|1
5177316|NCT01259089|17875878|P5|Reached First Response at 4 Weeks|Adverse Event|0
5177317|NCT01259089|17875879|P4|Reached First Response at 4 Weeks|Adverse Event|0
5177318|NCT01259089|17875880|P3|Reached First Response at 4 Weeks|Adverse Event|0
5177319|NCT01259089|17875881|P2|Reached First Response at 4 Weeks|Adverse Event|0
5177320|NCT01259089|17875882|P1|Reached First Response at 4 Weeks|Adverse Event|0
5177321|NCT01259089|17875877|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
5177322|NCT01259089|17875878|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
5177323|NCT01259089|17875879|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
5177324|NCT01259089|17875880|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
5177325|NCT01259089|17875881|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
5177326|NCT01259089|17875882|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
5177327|NCT01259024|17875910|P1|Overall Study|Physician Decision|1
5177328|NCT01258998|17875930|P1|Overall Study|Ineligible|1
5177329|NCT01258803|17875991|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
5177330|NCT01258803|17875992|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
5177331|NCT01258803|17875993|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
5177332|NCT01258803|17875994|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
5177333|NCT01258803|17875995|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
5177334|NCT01258803|17875996|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
5177335|NCT01258803|17875991|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5177336|NCT01258803|17875992|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5177337|NCT01258803|17875993|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5177338|NCT01258803|17875994|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5177339|NCT01258803|17875995|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
5177340|NCT01258803|17875996|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5177341|NCT01258803|17875991|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
5177342|NCT01258803|17875992|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
5177343|NCT01258803|17875993|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
5177344|NCT01258803|17875994|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
5177345|NCT01258803|17875995|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
5177346|NCT01258803|17875996|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
5177347|NCT01258738|17876033|P2|Open-label Period|Withdrawn due to pregnancy|1
5177348|NCT01258738|17876034|P1|Open-label Period|Withdrawn due to pregnancy|1
5177349|NCT01258738|17876033|P2|Open-label Period|Other Reasons|1
5177350|NCT01258738|17876034|P1|Open-label Period|Other Reasons|0
5177351|NCT01258738|17876033|P2|Open-label Period|Adverse Event|5
5177352|NCT01258738|17876034|P1|Open-label Period|Adverse Event|4
5177353|NCT01258738|17876033|P2|Open-label Period|Protocol Violation|2
5177354|NCT01258738|17876034|P1|Open-label Period|Protocol Violation|2
5177355|NCT01258738|17876033|P2|Open-label Period|Withdrawal by Subject|6
5177356|NCT01258738|17876034|P1|Open-label Period|Withdrawal by Subject|5
5177357|NCT01258738|17876033|P2|Open-label Period|Lost to Follow-up|2
5177358|NCT01258738|17876034|P1|Open-label Period|Lost to Follow-up|0
5177359|NCT01258738|17876033|P2|Open-label Period|Insufficient clinical response|3
5177360|NCT01258738|17876034|P1|Open-label Period|Insufficient clinical response|5
5177361|NCT01258738|17876033|P2|Open-label Period|Did not meet inclusion criteria|1
5177362|NCT01258738|17876034|P1|Open-label Period|Did not meet inclusion criteria|0
5177363|NCT01258738|17876033|P2|Double-blind Period|Adverse Event|1
5177364|NCT01258738|17876034|P1|Double-blind Period|Adverse Event|3
5177365|NCT01258738|17876033|P2|Double-blind Period|Protocol Violation|1
5177366|NCT01258738|17876034|P1|Double-blind Period|Protocol Violation|1
5177367|NCT01258738|17876033|P2|Double-blind Period|Withdrawal by Subject|2
5177368|NCT01258738|17876034|P1|Double-blind Period|Withdrawal by Subject|2
5177369|NCT01258738|17876033|P2|Double-blind Period|Did not meet inclusion criteria|3
5177370|NCT01258738|17876034|P1|Double-blind Period|Did not meet inclusion criteria|3
5177371|NCT01258660|17876172|P2|Overall Study|Invalid for primary analysis data set|6
5177372|NCT01258660|17876173|P1|Overall Study|Invalid for primary analysis data set|4
5177373|NCT01258660|17876172|P2|Overall Study|Protocol Violation|1
5177374|NCT01258660|17876173|P1|Overall Study|Protocol Violation|0
5177375|NCT01258660|17876172|P2|Overall Study|due to relocation|0
5177376|NCT01258660|17876173|P1|Overall Study|due to relocation|2
5177377|NCT01258660|17876172|P2|Overall Study|Withdrawal by Subject|0
5177378|NCT01258660|17876173|P1|Overall Study|Withdrawal by Subject|3
5177379|NCT01258660|17876172|P2|Overall Study|Adverse Event|4
5177380|NCT01258660|17876173|P1|Overall Study|Adverse Event|2
5177381|NCT01258608|17876192|P2|Overall Study|Withdrawal by Subject|5
5177382|NCT01258608|17876193|P1|Overall Study|Withdrawal by Subject|6
5177383|NCT01258608|17876192|P2|Overall Study|Adverse Event|10
5177384|NCT01258608|17876193|P1|Overall Study|Adverse Event|6
5177385|NCT01258608|17876192|P2|Overall Study|Lack of Efficacy|1
5177386|NCT01258608|17876193|P1|Overall Study|Lack of Efficacy|0
5177387|NCT01258608|17876192|P2|Overall Study|Lack of compliance|0
5177388|NCT01258608|17876193|P1|Overall Study|Lack of compliance|1
5177389|NCT01258608|17876192|P2|Overall Study|Lost to Follow-up|1
5177390|NCT01258608|17876193|P1|Overall Study|Lost to Follow-up|0
5177391|NCT01258608|17876192|P2|Overall Study|Physician Decision|1
5177392|NCT01258608|17876193|P1|Overall Study|Physician Decision|6
5177393|NCT01258608|17876192|P2|Overall Study|Sponsor decision|1
5177394|NCT01258608|17876193|P1|Overall Study|Sponsor decision|0
5177395|NCT01258608|17876192|P2|Overall Study|Clinical progression|0
5177396|NCT01258608|17876193|P1|Overall Study|Clinical progression|1
5177397|NCT01258608|17876192|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
5177398|NCT01258608|17876193|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
5177399|NCT01258595|17876241|P2|Overall Study|Withdrawal by Subject|1
5177400|NCT01258595|17876242|P1|Overall Study|Withdrawal by Subject|0
5177401|NCT01258595|17876241|P2|Overall Study|Lost to Follow-up|0
5177402|NCT01258595|17876242|P1|Overall Study|Lost to Follow-up|1
5177403|NCT01258348|17876339|P5|Overall Study|Withdrawal by Subject|0
5177404|NCT01258348|17876340|P4|Overall Study|Withdrawal by Subject|0
5177405|NCT01258348|17876341|P3|Overall Study|Withdrawal by Subject|0
5177406|NCT01258348|17876342|P2|Overall Study|Withdrawal by Subject|1
5177407|NCT01258348|17876343|P1|Overall Study|Withdrawal by Subject|0
5177408|NCT01258348|17876339|P5|Overall Study|Physician Decision|0
5177409|NCT01258348|17876340|P4|Overall Study|Physician Decision|2
5177410|NCT01258348|17876341|P3|Overall Study|Physician Decision|0
5177411|NCT01258348|17876342|P2|Overall Study|Physician Decision|0
5177412|NCT01258348|17876343|P1|Overall Study|Physician Decision|0
5177413|NCT01258348|17876339|P5|Overall Study|Progressive Disease|2
5177414|NCT01258348|17876340|P4|Overall Study|Progressive Disease|2
5177415|NCT01258348|17876341|P3|Overall Study|Progressive Disease|0
5177416|NCT01258348|17876342|P2|Overall Study|Progressive Disease|3
5177417|NCT01258348|17876343|P1|Overall Study|Progressive Disease|0
5177418|NCT01258348|17876339|P5|Overall Study|Adverse Event|4
5177419|NCT01258348|17876340|P4|Overall Study|Adverse Event|2
5177420|NCT01258348|17876341|P3|Overall Study|Adverse Event|3
5177421|NCT01258348|17876342|P2|Overall Study|Adverse Event|1
5177422|NCT01258348|17876343|P1|Overall Study|Adverse Event|1
5177423|NCT01258101|17876400|P4|Overall Study|Other reason|8
5177424|NCT01258101|17876401|P3|Overall Study|Other reason|1
5177425|NCT01258101|17876402|P2|Overall Study|Other reason|8
5177426|NCT01258101|17876403|P1|Overall Study|Other reason|7
5177427|NCT01258101|17876400|P4|Overall Study|PCR positive at week 24|1
5177428|NCT01258101|17876401|P3|Overall Study|PCR positive at week 24|0
5177429|NCT01258101|17876402|P2|Overall Study|PCR positive at week 24|0
5177430|NCT01258101|17876403|P1|Overall Study|PCR positive at week 24|0
5177431|NCT01258101|17876400|P4|Overall Study|Lost to Follow-up|6
5177432|NCT01258101|17876401|P3|Overall Study|Lost to Follow-up|0
5177433|NCT01258101|17876402|P2|Overall Study|Lost to Follow-up|5
5177434|NCT01258101|17876403|P1|Overall Study|Lost to Follow-up|5
5177435|NCT01258101|17876400|P4|Overall Study|Patient´s compliance|2
5177436|NCT01258101|17876401|P3|Overall Study|Patient´s compliance|1
5177437|NCT01258101|17876402|P2|Overall Study|Patient´s compliance|3
5177438|NCT01258101|17876403|P1|Overall Study|Patient´s compliance|4
5177439|NCT01258101|17876400|P4|Overall Study|Patient is not able to attend visits|6
5177440|NCT01258101|17876401|P3|Overall Study|Patient is not able to attend visits|7
5177441|NCT01258101|17876402|P2|Overall Study|Patient is not able to attend visits|9
5177442|NCT01258101|17876403|P1|Overall Study|Patient is not able to attend visits|8
5177443|NCT01258101|17876400|P4|Overall Study|Informed consent has been withdrawn|1
5177444|NCT01258101|17876401|P3|Overall Study|Informed consent has been withdrawn|1
5177445|NCT01258101|17876402|P2|Overall Study|Informed consent has been withdrawn|2
5177446|NCT01258101|17876403|P1|Overall Study|Informed consent has been withdrawn|2
5177447|NCT01258101|17876400|P4|Overall Study|Extra exclusion criterion amended|1
5177448|NCT01258101|17876401|P3|Overall Study|Extra exclusion criterion amended|1
5177449|NCT01258101|17876402|P2|Overall Study|Extra exclusion criterion amended|1
5177450|NCT01258101|17876403|P1|Overall Study|Extra exclusion criterion amended|2
5177451|NCT01258101|17876400|P4|Overall Study|Adverse Event|0
5177452|NCT01258101|17876401|P3|Overall Study|Adverse Event|0
5177453|NCT01258101|17876402|P2|Overall Study|Adverse Event|6
5177454|NCT01258101|17876403|P1|Overall Study|Adverse Event|5
5177455|NCT01257737|17876533|P2|Overall Study|Withdrew from study|1
5177456|NCT01257737|17876534|P1|Overall Study|Withdrew from study|0
5177457|NCT01257737|17876533|P2|Overall Study|Relocation out of the country|1
5177458|NCT01257737|17876534|P1|Overall Study|Relocation out of the country|0
5177459|NCT01257737|17876533|P2|Overall Study|Liver transplant|0
5177460|NCT01257737|17876534|P1|Overall Study|Liver transplant|1
5177461|NCT01257737|17876533|P2|Overall Study|Lost to Follow-up|2
5177462|NCT01257737|17876534|P1|Overall Study|Lost to Follow-up|1
5177463|NCT01257698|17876554|P2|Overall Study|Protocol Violation|0
5177464|NCT01257698|17876555|P1|Overall Study|Protocol Violation|4
5177465|NCT01257581|17876564|P3|Overall Study|Death|4
5177466|NCT01257581|17876565|P2|Overall Study|Death|2
5177467|NCT01257581|17876566|P1|Overall Study|Death|2
5177468|NCT01257581|17876564|P3|Overall Study|Early Termination|2
5177469|NCT01257581|17876565|P2|Overall Study|Early Termination|1
5177470|NCT01257581|17876566|P1|Overall Study|Early Termination|3
5177471|NCT01257568|17876604|P1|Overall Study|Component Revision|24
5177472|NCT01257568|17876604|P1|Overall Study|Terminated|1
5177473|NCT01257568|17876604|P1|Overall Study|Withdrawal by Subject|6
5177474|NCT01257568|17876604|P1|Overall Study|Lost to Follow-up|2
5177475|NCT01257542|17876618|P2|Overall Study|Withdrawal by Subject|2
5177476|NCT01257542|17876619|P1|Overall Study|Withdrawal by Subject|0
5177477|NCT01257542|17876618|P2|Overall Study|Protocol Violation|5
5177478|NCT01257542|17876619|P1|Overall Study|Protocol Violation|3
5177479|NCT01257503|17876639|P2|Overall Study|strep culture positive at enrollment|0
5177480|NCT01257503|17876640|P1|Overall Study|strep culture positive at enrollment|1
5177481|NCT01257503|17876639|P2|Overall Study|Over 5 years old at enrollment|1
5177482|NCT01257503|17876640|P1|Overall Study|Over 5 years old at enrollment|0
5177483|NCT01257503|17876639|P2|Overall Study|Lost to Follow-up|10
5177484|NCT01257503|17876640|P1|Overall Study|Lost to Follow-up|7
5177485|NCT01257425|17876669|P2|Overall Study|Death|0
5177486|NCT01257425|17876670|P1|Overall Study|Death|1
5177487|NCT01257425|17876669|P2|Overall Study|Withdrawal by Subject|1
5177488|NCT01257425|17876670|P1|Overall Study|Withdrawal by Subject|0
5177489|NCT01257425|17876669|P2|Overall Study|Protocol Violation|1
5177490|NCT01257425|17876670|P1|Overall Study|Protocol Violation|1
5177491|NCT01257425|17876669|P2|Overall Study|Adverse Event|1
5177492|NCT01257425|17876670|P1|Overall Study|Adverse Event|1
5177493|NCT01257425|17876669|P2|Overall Study|Lack of Efficacy|3
5177494|NCT01257425|17876670|P1|Overall Study|Lack of Efficacy|3
5177495|NCT01257230|17876712|P3|Overall Study|Other reason not defined above|3
5177496|NCT01257230|17876713|P2|Overall Study|Other reason not defined above|5
5177497|NCT01257230|17876714|P1|Overall Study|Other reason not defined above|1
5177498|NCT01257230|17876712|P3|Overall Study|Withdrawal by Subject|1
5177499|NCT01257230|17876713|P2|Overall Study|Withdrawal by Subject|4
5177500|NCT01257230|17876714|P1|Overall Study|Withdrawal by Subject|0
5177501|NCT01257230|17876712|P3|Overall Study|Protocol Violation|1
5177502|NCT01257230|17876713|P2|Overall Study|Protocol Violation|0
5177503|NCT01257230|17876714|P1|Overall Study|Protocol Violation|3
5177504|NCT01257230|17876712|P3|Overall Study|Lack of Efficacy|0
5177505|NCT01257230|17876713|P2|Overall Study|Lack of Efficacy|1
5177506|NCT01257230|17876714|P1|Overall Study|Lack of Efficacy|0
5177507|NCT01257230|17876712|P3|Overall Study|Adverse Event|0
5177508|NCT01257230|17876713|P2|Overall Study|Adverse Event|0
5177509|NCT01257230|17876714|P1|Overall Study|Adverse Event|2
5177510|NCT01257230|17876712|P3|Overall Study|Not Treated|1
5177511|NCT01257230|17876713|P2|Overall Study|Not Treated|0
5177512|NCT01257230|17876714|P1|Overall Study|Not Treated|0
5177513|NCT01257204|17876791|P3|Follow-up Period (up to Week 48)|Other|5
5177514|NCT01257204|17876792|P2|Follow-up Period (up to Week 48)|Other|0
5177515|NCT01257204|17876793|P1|Follow-up Period (up to Week 48)|Other|0
5177516|NCT01257204|17876791|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
5177517|NCT01257204|17876792|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
5177518|NCT01257204|17876793|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
5177519|NCT01257204|17876791|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
5177520|NCT01257204|17876792|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
5177521|NCT01257204|17876793|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
5177604|NCT01256450|17877083|P3|Double-blind Treatment|Withdrawal by Subject|1
5177522|NCT01257204|17876791|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
5177523|NCT01257204|17876792|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
5177524|NCT01257204|17876793|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
5177525|NCT01257204|17876791|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
5177526|NCT01257204|17876792|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
5177527|NCT01257204|17876793|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
5177528|NCT01257204|17876791|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
5177529|NCT01257204|17876792|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
5177530|NCT01257204|17876793|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
5177531|NCT01257204|17876791|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
5177532|NCT01257204|17876792|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
5177533|NCT01257204|17876793|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
5177534|NCT01257204|17876791|P3|Treatment Period (up to Week 24)|Adverse Event|2
5177535|NCT01257204|17876792|P2|Treatment Period (up to Week 24)|Adverse Event|1
5177536|NCT01257204|17876793|P1|Treatment Period (up to Week 24)|Adverse Event|3
5177537|NCT01257204|17876791|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
5177538|NCT01257204|17876792|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
5177539|NCT01257204|17876793|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
5177540|NCT01256879|17876901|P1|Overall Study|Withdrawal by Subject|1
5177541|NCT01256788|17876927|P3|Overall Study|Lost to Follow-up|3
5177542|NCT01256788|17876928|P2|Overall Study|Lost to Follow-up|8
5177543|NCT01256788|17876929|P1|Overall Study|Lost to Follow-up|5
5177544|NCT01256684|17876940|P3|Overall Study|Entry criteria not met/non-compliance|6
5177545|NCT01256684|17876941|P2|Overall Study|Entry criteria not met/non-compliance|7
5177546|NCT01256684|17876942|P1|Overall Study|Entry criteria not met/non-compliance|4
5177547|NCT01256684|17876940|P3|Overall Study|Lack of Efficacy|1
5177548|NCT01256684|17876941|P2|Overall Study|Lack of Efficacy|1
5177549|NCT01256684|17876942|P1|Overall Study|Lack of Efficacy|0
5177550|NCT01256684|17876940|P3|Overall Study|Physician Decision|0
5177551|NCT01256684|17876941|P2|Overall Study|Physician Decision|1
5177552|NCT01256684|17876942|P1|Overall Study|Physician Decision|0
5177553|NCT01256684|17876940|P3|Overall Study|Withdrawal by Subject|2
5177554|NCT01256684|17876941|P2|Overall Study|Withdrawal by Subject|0
5177555|NCT01256684|17876942|P1|Overall Study|Withdrawal by Subject|4
5177556|NCT01256684|17876940|P3|Overall Study|Adverse Event|2
5177557|NCT01256684|17876941|P2|Overall Study|Adverse Event|4
5177558|NCT01256684|17876942|P1|Overall Study|Adverse Event|1
5177559|NCT01256671|17876974|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
5177560|NCT01256671|17876974|P1|Overall Study|Lack of Efficacy|4
5177561|NCT01256671|17876974|P1|Overall Study|Physician Decision|3
5177562|NCT01256671|17876974|P1|Overall Study|Withdrawal by Subject|31
5177563|NCT01256671|17876974|P1|Overall Study|Lost to Follow-up|16
5177564|NCT01256671|17876974|P1|Overall Study|Adverse Event|29
5177565|NCT01256658|17876987|P2|Period 1|Death|44
5177566|NCT01256658|17876988|P1|Period 1|Death|48
5177567|NCT01256658|17876987|P2|Period 1|Withdrawal by Subject|43
5177568|NCT01256658|17876988|P1|Period 1|Withdrawal by Subject|35
5177569|NCT01256658|17876987|P2|Period 1|Lost to Follow-up|661
5177570|NCT01256658|17876988|P1|Period 1|Lost to Follow-up|837
5177571|NCT01256593|17877038|P1|Overall Study|No Visit After Treatment|186
5177572|NCT01256593|17877038|P1|Overall Study|No Drug Administration Information|2
5177573|NCT01256593|17877038|P1|Overall Study|Protocol Violation|26
5177574|NCT01256567|17877052|P1|Overall Study|Withdrawal by Subject|1
5177575|NCT01256502|17877062|P1|Overall Study|Protocol deviation|1
5177576|NCT01256502|17877062|P1|Overall Study|Personal reasons|5
5177577|NCT01256502|17877062|P1|Overall Study|Had scaffold removed|4
5177578|NCT01256476|17877074|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
5177579|NCT01256476|17877075|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
5177580|NCT01256476|17877074|P2|Overall Study|Subject non-compliance|1
5177581|NCT01256476|17877075|P1|Overall Study|Subject non-compliance|0
5177582|NCT01256476|17877074|P2|Overall Study|Physician Decision|1
5177583|NCT01256476|17877075|P1|Overall Study|Physician Decision|0
5177584|NCT01256476|17877074|P2|Overall Study|Persistent ALT or AST elevation|0
5177585|NCT01256476|17877075|P1|Overall Study|Persistent ALT or AST elevation|1
5177586|NCT01256476|17877074|P2|Overall Study|Lost to Follow-up|2
5177587|NCT01256476|17877075|P1|Overall Study|Lost to Follow-up|1
5177588|NCT01256476|17877074|P2|Overall Study|Withdrawal by Subject|1
5177589|NCT01256476|17877075|P1|Overall Study|Withdrawal by Subject|2
5177590|NCT01256476|17877074|P2|Overall Study|Adverse Event|1
5177591|NCT01256476|17877075|P1|Overall Study|Adverse Event|2
5177592|NCT01256450|17877083|P3|Double-blind Treatment|Other|12
5177593|NCT01256450|17877084|P2|Double-blind Treatment|Other|9
5177594|NCT01256450|17877085|P1|Double-blind Treatment|Other|0
5177595|NCT01256450|17877083|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
5177596|NCT01256450|17877084|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
5177597|NCT01256450|17877085|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
5177598|NCT01256450|17877083|P3|Double-blind Treatment|Non-compliance|4
5177599|NCT01256450|17877084|P2|Double-blind Treatment|Non-compliance|5
5177600|NCT01256450|17877085|P1|Double-blind Treatment|Non-compliance|0
5177601|NCT01256450|17877083|P3|Double-blind Treatment|Lack of analgesic effect|6
5177602|NCT01256450|17877084|P2|Double-blind Treatment|Lack of analgesic effect|5
5177603|NCT01256450|17877085|P1|Double-blind Treatment|Lack of analgesic effect|0
5177605|NCT01256450|17877084|P2|Double-blind Treatment|Withdrawal by Subject|0
5177606|NCT01256450|17877085|P1|Double-blind Treatment|Withdrawal by Subject|0
5177607|NCT01256450|17877083|P3|Double-blind Treatment|Lost to Follow-up|7
5177608|NCT01256450|17877084|P2|Double-blind Treatment|Lost to Follow-up|1
5177609|NCT01256450|17877085|P1|Double-blind Treatment|Lost to Follow-up|0
5177610|NCT01256450|17877083|P3|Double-blind Treatment|Adverse Event|6
5177611|NCT01256450|17877084|P2|Double-blind Treatment|Adverse Event|8
5177612|NCT01256450|17877085|P1|Double-blind Treatment|Adverse Event|0
5177613|NCT01256450|17877083|P3|Open-label Titration|Other|0
5177614|NCT01256450|17877084|P2|Open-label Titration|Other|0
5177615|NCT01256450|17877085|P1|Open-label Titration|Other|13
5177616|NCT01256450|17877083|P3|Open-label Titration|Screen failure|0
5177617|NCT01256450|17877084|P2|Open-label Titration|Screen failure|0
5177618|NCT01256450|17877085|P1|Open-label Titration|Screen failure|1
5177619|NCT01256450|17877083|P3|Open-label Titration|Non-compliance|0
5177620|NCT01256450|17877084|P2|Open-label Titration|Non-compliance|0
5177621|NCT01256450|17877085|P1|Open-label Titration|Non-compliance|9
5177622|NCT01256450|17877083|P3|Open-label Titration|Lack of analgesic effect|0
5177623|NCT01256450|17877084|P2|Open-label Titration|Lack of analgesic effect|0
5177624|NCT01256450|17877085|P1|Open-label Titration|Lack of analgesic effect|30
5177625|NCT01256450|17877083|P3|Open-label Titration|Lost to Follow-up|0
5177626|NCT01256450|17877084|P2|Open-label Titration|Lost to Follow-up|0
5177627|NCT01256450|17877085|P1|Open-label Titration|Lost to Follow-up|7
5177628|NCT01256450|17877083|P3|Open-label Titration|Adverse Event|0
5177629|NCT01256450|17877084|P2|Open-label Titration|Adverse Event|0
5177630|NCT01256450|17877085|P1|Open-label Titration|Adverse Event|39
5177631|NCT01256411|17877143|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
5177632|NCT01256411|17877144|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
5177633|NCT01256411|17877145|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5177634|NCT01256411|17877146|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5177635|NCT01256411|17877147|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5177636|NCT01256411|17877148|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5177637|NCT01256411|17877143|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
5177638|NCT01256411|17877144|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
5177639|NCT01256411|17877145|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5177640|NCT01256411|17877146|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5177641|NCT01256411|17877147|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5177642|NCT01256411|17877148|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5177643|NCT01256411|17877143|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5177644|NCT01256411|17877144|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
5177645|NCT01256411|17877145|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5177646|NCT01256411|17877146|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5177647|NCT01256411|17877147|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5177648|NCT01256411|17877148|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5177649|NCT01256411|17877143|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
5177650|NCT01256411|17877144|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
5177651|NCT01256411|17877145|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
5177652|NCT01256411|17877146|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
5177653|NCT01256411|17877147|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
5177654|NCT01256411|17877148|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
5177655|NCT01256411|17877143|P6|Extension by Mono or Combination Therapy|Adverse Event|1
5177656|NCT01256411|17877144|P5|Extension by Mono or Combination Therapy|Adverse Event|6
5177657|NCT01256411|17877145|P4|Extension by Mono or Combination Therapy|Adverse Event|0
5177658|NCT01256411|17877146|P3|Extension by Mono or Combination Therapy|Adverse Event|0
5177659|NCT01256411|17877147|P2|Extension by Mono or Combination Therapy|Adverse Event|0
5177660|NCT01256411|17877148|P1|Extension by Mono or Combination Therapy|Adverse Event|0
5177661|NCT01256411|17877143|P6|Extension by Maximum Treatment|Adverse Event|0
5177662|NCT01256411|17877144|P5|Extension by Maximum Treatment|Adverse Event|0
5177663|NCT01256411|17877145|P4|Extension by Maximum Treatment|Adverse Event|0
5177664|NCT01256411|17877146|P3|Extension by Maximum Treatment|Adverse Event|1
5177665|NCT01256411|17877147|P2|Extension by Maximum Treatment|Adverse Event|2
5177666|NCT01256411|17877148|P1|Extension by Maximum Treatment|Adverse Event|4
5177667|NCT01256411|17877143|P6|Extension by Maximum Treatment|Lack of Efficacy|0
5177668|NCT01256411|17877144|P5|Extension by Maximum Treatment|Lack of Efficacy|0
5177669|NCT01256411|17877145|P4|Extension by Maximum Treatment|Lack of Efficacy|0
5177670|NCT01256411|17877146|P3|Extension by Maximum Treatment|Lack of Efficacy|1
5177671|NCT01256411|17877147|P2|Extension by Maximum Treatment|Lack of Efficacy|0
5177672|NCT01256411|17877148|P1|Extension by Maximum Treatment|Lack of Efficacy|1
5177673|NCT01256411|17877143|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
5177674|NCT01256411|17877144|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
5177675|NCT01256411|17877145|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
5177676|NCT01256411|17877146|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
5177677|NCT01256411|17877147|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
5177678|NCT01256411|17877148|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
5177679|NCT01256411|17877143|P6|Extension by Maximum Treatment|Lost to Follow-up|0
5177680|NCT01256411|17877144|P5|Extension by Maximum Treatment|Lost to Follow-up|0
5177681|NCT01256411|17877145|P4|Extension by Maximum Treatment|Lost to Follow-up|0
5177682|NCT01256411|17877146|P3|Extension by Maximum Treatment|Lost to Follow-up|0
5177683|NCT01256411|17877147|P2|Extension by Maximum Treatment|Lost to Follow-up|2
5177684|NCT01256411|17877148|P1|Extension by Maximum Treatment|Lost to Follow-up|1
5177685|NCT01256411|17877143|P6|Extension by Maximum Treatment|Protocol deviation|0
5177686|NCT01256411|17877144|P5|Extension by Maximum Treatment|Protocol deviation|0
5177687|NCT01256411|17877145|P4|Extension by Maximum Treatment|Protocol deviation|0
5177688|NCT01256411|17877146|P3|Extension by Maximum Treatment|Protocol deviation|1
5177689|NCT01256411|17877147|P2|Extension by Maximum Treatment|Protocol deviation|0
5177690|NCT01256411|17877148|P1|Extension by Maximum Treatment|Protocol deviation|0
5177691|NCT01256398|17877172|P1|Overall Study|Withdrawal by Subject|1
5177692|NCT01256385|17877178|P2|Overall Study|Withdrawal by Subject|2
5177693|NCT01256385|17877179|P1|Overall Study|Withdrawal by Subject|2
5177694|NCT01256385|17877178|P2|Overall Study|Physician Decision|1
5177695|NCT01256385|17877179|P1|Overall Study|Physician Decision|1
5177696|NCT01256294|17877199|P2|Overall Study|Protocol deviation|1
5177697|NCT01256294|17877200|P1|Overall Study|Protocol deviation|2
5177698|NCT01256294|17877199|P2|Overall Study|Withdrawal by Subject|1
5177699|NCT01256294|17877200|P1|Overall Study|Withdrawal by Subject|1
5177700|NCT01256294|17877199|P2|Overall Study|Adverse Event|0
5177701|NCT01256294|17877200|P1|Overall Study|Adverse Event|1
5177702|NCT01256190|17877222|P2|Overall Study|Lost to Follow-up|0
5177703|NCT01256190|17877223|P1|Overall Study|Lost to Follow-up|2
5177704|NCT01256177|17877239|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
5177705|NCT01256177|17877240|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
5177706|NCT01256177|17877239|P2|Overall Study|Lack of Efficacy|2
5177707|NCT01256177|17877240|P1|Overall Study|Lack of Efficacy|11
5177708|NCT01256177|17877239|P2|Overall Study|Condition under Investigation Worsened|0
5177709|NCT01256177|17877240|P1|Overall Study|Condition under Investigation Worsened|1
5177710|NCT01256177|17877239|P2|Overall Study|Severe Non-Compliance to Protocol|2
5177711|NCT01256177|17877240|P1|Overall Study|Severe Non-Compliance to Protocol|4
5177712|NCT01256177|17877239|P2|Overall Study|Adverse Event|9
5177713|NCT01256177|17877240|P1|Overall Study|Adverse Event|8
5177714|NCT01256177|17877239|P2|Overall Study|Lost to Follow-up|2
5177715|NCT01256177|17877240|P1|Overall Study|Lost to Follow-up|2
5177716|NCT01256177|17877239|P2|Overall Study|Withdrawal by Subject|22
5177717|NCT01256177|17877240|P1|Overall Study|Withdrawal by Subject|23
5177718|NCT01256060|17877296|P4|Overall Study|Lost to Follow-up|0
5177719|NCT01256060|17877297|P3|Overall Study|Lost to Follow-up|0
5177720|NCT01256060|17877298|P2|Overall Study|Lost to Follow-up|1
5177721|NCT01256060|17877299|P1|Overall Study|Lost to Follow-up|0
5177722|NCT01256008|17877318|P3|Overall Study|Withdrawal by Subject|10
5177723|NCT01256008|17877319|P2|Overall Study|Withdrawal by Subject|3
5177724|NCT01256008|17877320|P1|Overall Study|Withdrawal by Subject|2
5177725|NCT01256008|17877318|P3|Overall Study|Lost to Follow-up|11
5177726|NCT01256008|17877319|P2|Overall Study|Lost to Follow-up|4
5177727|NCT01256008|17877320|P1|Overall Study|Lost to Follow-up|6
5177728|NCT01255904|17877342|P2|Overall Study|Physician Decision|4
5177729|NCT01255904|17877343|P1|Overall Study|Physician Decision|1
5177730|NCT01255787|17877382|P4|Overall Study|Noncompliance with Study Drug|0
5177731|NCT01255787|17877383|P3|Overall Study|Noncompliance with Study Drug|0
5177732|NCT01255787|17877384|P2|Overall Study|Noncompliance with Study Drug|1
5177733|NCT01255787|17877385|P1|Overall Study|Noncompliance with Study Drug|3
5177734|NCT01255787|17877382|P4|Overall Study|Lack of Efficacy|2
5177735|NCT01255787|17877383|P3|Overall Study|Lack of Efficacy|2
5177736|NCT01255787|17877384|P2|Overall Study|Lack of Efficacy|2
5177737|NCT01255787|17877385|P1|Overall Study|Lack of Efficacy|2
5177738|NCT01255787|17877382|P4|Overall Study|Pregnancy|1
5177739|NCT01255787|17877383|P3|Overall Study|Pregnancy|0
5177740|NCT01255787|17877384|P2|Overall Study|Pregnancy|0
5177741|NCT01255787|17877385|P1|Overall Study|Pregnancy|0
5177742|NCT01255787|17877382|P4|Overall Study|Withdrawal of Consent|4
5177743|NCT01255787|17877383|P3|Overall Study|Withdrawal of Consent|3
5177744|NCT01255787|17877384|P2|Overall Study|Withdrawal of Consent|9
5177745|NCT01255787|17877385|P1|Overall Study|Withdrawal of Consent|3
5177746|NCT01255787|17877382|P4|Overall Study|Lost to Follow-up|2
5177747|NCT01255787|17877383|P3|Overall Study|Lost to Follow-up|4
5177748|NCT01255787|17877384|P2|Overall Study|Lost to Follow-up|2
5177749|NCT01255787|17877385|P1|Overall Study|Lost to Follow-up|1
5177750|NCT01255787|17877382|P4|Overall Study|Major Protocol Deviation|4
5177751|NCT01255787|17877383|P3|Overall Study|Major Protocol Deviation|0
5177752|NCT01255787|17877384|P2|Overall Study|Major Protocol Deviation|1
5177753|NCT01255787|17877385|P1|Overall Study|Major Protocol Deviation|1
5177754|NCT01255787|17877382|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
5177755|NCT01255787|17877383|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
5177756|NCT01255787|17877384|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
5177757|NCT01255787|17877385|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
5177758|NCT01255761|17877413|P2|Overall Study|Other Reasons|18
5177759|NCT01255761|17877414|P1|Overall Study|Other Reasons|37
5177760|NCT01255761|17877413|P2|Overall Study|Withdrawal by Subject|27
5177761|NCT01255761|17877414|P1|Overall Study|Withdrawal by Subject|11
5177762|NCT01255761|17877413|P2|Overall Study|Lost to Follow-up|8
5177763|NCT01255761|17877414|P1|Overall Study|Lost to Follow-up|10
5177764|NCT01255761|17877413|P2|Overall Study|Protocol Violation|5
5177765|NCT01255761|17877414|P1|Overall Study|Protocol Violation|9
5177766|NCT01255761|17877413|P2|Overall Study|Lack of Efficacy|74
5177767|NCT01255761|17877414|P1|Overall Study|Lack of Efficacy|86
5177768|NCT01255761|17877413|P2|Overall Study|Adverse Event|43
5177769|NCT01255761|17877414|P1|Overall Study|Adverse Event|29
5177770|NCT01255722|17877499|P3|Overall Study|beta-blocker contraindicated|0
5177771|NCT01255722|17877500|P2|Overall Study|beta-blocker contraindicated|0
5177772|NCT01255722|17877501|P1|Overall Study|beta-blocker contraindicated|2
5177773|NCT01255722|17877499|P3|Overall Study|asymptomatic patient|0
5177774|NCT01255722|17877500|P2|Overall Study|asymptomatic patient|0
5177775|NCT01255722|17877501|P1|Overall Study|asymptomatic patient|1
5177776|NCT01255722|17877499|P3|Overall Study|Adverse Event|1
5177777|NCT01255722|17877500|P2|Overall Study|Adverse Event|1
5177778|NCT01255722|17877501|P1|Overall Study|Adverse Event|0
5177779|NCT01255631|17877526|P2|Overall Study|poor enrollment, no data analyzed|6
5177780|NCT01255631|17877527|P1|Overall Study|poor enrollment, no data analyzed|9
5177781|NCT01255592|17877545|P2|Overall Study|Other|1
5177782|NCT01255592|17877546|P1|Overall Study|Other|0
5177783|NCT01255592|17877545|P2|Overall Study|Withdrawal by Subject|0
5177784|NCT01255592|17877546|P1|Overall Study|Withdrawal by Subject|1
5177785|NCT01255592|17877545|P2|Overall Study|Adverse Event|0
5177786|NCT01255592|17877546|P1|Overall Study|Adverse Event|5
5177787|NCT01255436|17877609|P2|Overall Study|Death, stroke, or MI|3
5177788|NCT01255436|17877610|P1|Overall Study|Death, stroke, or MI|4
5177789|NCT01255436|17877609|P2|Overall Study|Lost to Follow-up|191
5177790|NCT01255436|17877610|P1|Overall Study|Lost to Follow-up|178
5177791|NCT01255423|17877624|P2|Overall Study|Use of prohibited medications|1
5177792|NCT01255423|17877625|P1|Overall Study|Use of prohibited medications|0
5177793|NCT01255423|17877624|P2|Overall Study|Abnormal Laboratory value|2
5177794|NCT01255423|17877625|P1|Overall Study|Abnormal Laboratory value|3
5177795|NCT01255306|17877641|P2|Overall Study|Physician Decision|1
5177796|NCT01255306|17877642|P1|Overall Study|Physician Decision|1
5177797|NCT01255163|17877653|P2|Overall Study|AstraZeneca stopped support of the study|3
5177798|NCT01255163|17877654|P1|Overall Study|AstraZeneca stopped support of the study|1
5177799|NCT01255163|17877653|P2|Overall Study|Adverse Event|2
5177800|NCT01255163|17877654|P1|Overall Study|Adverse Event|0
5177801|NCT01255163|17877653|P2|Overall Study|Lost to Follow-up|0
5177802|NCT01255163|17877654|P1|Overall Study|Lost to Follow-up|2
5177803|NCT01255163|17877653|P2|Overall Study|Withdrawal by Subject|0
5177804|NCT01255163|17877654|P1|Overall Study|Withdrawal by Subject|1
5177805|NCT01254890|17877683|P2|Overall Study|Disease Progression|5
5177806|NCT01254890|17877684|P1|Overall Study|Disease Progression|0
5177807|NCT01254890|17877683|P2|Overall Study|Withdrawal by Subject|2
5177808|NCT01254890|17877684|P1|Overall Study|Withdrawal by Subject|1
5177809|NCT01254890|17877683|P2|Overall Study|Ineligible|3
5177810|NCT01254890|17877684|P1|Overall Study|Ineligible|0
5177811|NCT01254747|17877746|P4|Overall Study|Discomfort|0
5177812|NCT01254747|17877747|P3|Overall Study|Discomfort|0
5177813|NCT01254747|17877748|P2|Overall Study|Discomfort|4
5177814|NCT01254747|17877749|P1|Overall Study|Discomfort|0
5177815|NCT01254747|17877746|P4|Overall Study|Biomicroscopy|0
5177816|NCT01254747|17877747|P3|Overall Study|Biomicroscopy|1
5177817|NCT01254747|17877748|P2|Overall Study|Biomicroscopy|0
5177818|NCT01254747|17877749|P1|Overall Study|Biomicroscopy|0
5177819|NCT01254747|17877746|P4|Overall Study|Lost to Follow-up|0
5177820|NCT01254747|17877747|P3|Overall Study|Lost to Follow-up|1
5177821|NCT01254747|17877748|P2|Overall Study|Lost to Follow-up|0
5177822|NCT01254747|17877749|P1|Overall Study|Lost to Follow-up|0
5177823|NCT01254747|17877746|P4|Overall Study|Symptoms and problems|0
5177824|NCT01254747|17877747|P3|Overall Study|Symptoms and problems|1
5177825|NCT01254747|17877748|P2|Overall Study|Symptoms and problems|2
5177826|NCT01254747|17877749|P1|Overall Study|Symptoms and problems|0
5177827|NCT01254747|17877746|P4|Overall Study|Difficult removal handling|0
5177828|NCT01254747|17877747|P3|Overall Study|Difficult removal handling|1
5177829|NCT01254747|17877748|P2|Overall Study|Difficult removal handling|0
5177830|NCT01254747|17877749|P1|Overall Study|Difficult removal handling|0
5177831|NCT01254747|17877746|P4|Overall Study|Unacceptable subjective vision|2
5177832|NCT01254747|17877747|P3|Overall Study|Unacceptable subjective vision|0
5177833|NCT01254747|17877748|P2|Overall Study|Unacceptable subjective vision|0
5177834|NCT01254747|17877749|P1|Overall Study|Unacceptable subjective vision|0
5177835|NCT01254721|17877789|P2|Overall Study|Wrongly randomization|1
5177836|NCT01254721|17877790|P1|Overall Study|Wrongly randomization|0
5177837|NCT01254721|17877789|P2|Overall Study|Withdrawal by Subject|11
5177838|NCT01254721|17877790|P1|Overall Study|Withdrawal by Subject|8
5177839|NCT01254721|17877789|P2|Overall Study|Adverse Event|3
5177840|NCT01254721|17877790|P1|Overall Study|Adverse Event|2
5177841|NCT01254721|17877789|P2|Overall Study|technical problum|0
5177842|NCT01254721|17877790|P1|Overall Study|technical problum|1
5177843|NCT01254721|17877789|P2|Overall Study|Death|1
5177844|NCT01254721|17877790|P1|Overall Study|Death|0
5177845|NCT01254721|17877789|P2|Overall Study|Lack of Efficacy|2
5177846|NCT01254721|17877790|P1|Overall Study|Lack of Efficacy|4
5177847|NCT01254721|17877789|P2|Overall Study|Lost to Follow-up|4
5177848|NCT01254721|17877790|P1|Overall Study|Lost to Follow-up|0
5177849|NCT01254669|17877800|P2|Overall Study|called to clinic during intervention|1
5177850|NCT01254669|17877801|P1|Overall Study|called to clinic during intervention|1
5177851|NCT01254669|17877800|P2|Overall Study|time constraint|2
5177852|NCT01254669|17877801|P1|Overall Study|time constraint|2
5177853|NCT01254669|17877800|P2|Overall Study|Withdrawal by Subject|1
5177854|NCT01254669|17877801|P1|Overall Study|Withdrawal by Subject|0
5177855|NCT01254656|17877812|P3|Overall Study|Death|0
5177856|NCT01254656|17877813|P2|Overall Study|Death|1
5177857|NCT01254656|17877814|P1|Overall Study|Death|0
5177858|NCT01254656|17877812|P3|Overall Study|Adverse Event|0
5177859|NCT01254656|17877813|P2|Overall Study|Adverse Event|1
5177860|NCT01254656|17877814|P1|Overall Study|Adverse Event|1
5177861|NCT01254656|17877812|P3|Overall Study|Pregnancy|2
5177862|NCT01254656|17877813|P2|Overall Study|Pregnancy|0
5177863|NCT01254656|17877814|P1|Overall Study|Pregnancy|0
5177864|NCT01254656|17877812|P3|Overall Study|Withdrawal by Subject|1
5177865|NCT01254656|17877813|P2|Overall Study|Withdrawal by Subject|2
5177866|NCT01254656|17877814|P1|Overall Study|Withdrawal by Subject|2
5177867|NCT01254656|17877812|P3|Overall Study|Lost to Follow-up|2
5177868|NCT01254656|17877813|P2|Overall Study|Lost to Follow-up|0
5177869|NCT01254656|17877814|P1|Overall Study|Lost to Follow-up|1
5177870|NCT01254656|17877812|P3|Overall Study|Lack of Efficacy|0
5177871|NCT01254656|17877813|P2|Overall Study|Lack of Efficacy|0
5177872|NCT01254656|17877814|P1|Overall Study|Lack of Efficacy|3
5177873|NCT01254656|17877812|P3|Overall Study|Discontinued due to termination of study|13
5177874|NCT01254656|17877813|P2|Overall Study|Discontinued due to termination of study|39
5177875|NCT01254656|17877814|P1|Overall Study|Discontinued due to termination of study|40
5177876|NCT01254643|17877840|P1|Overall Study|Withdrawal by Subject|1
5177877|NCT01254630|17877852|P4|Overall Study|Status not recorded|0
5177878|NCT01254630|17877853|P3|Overall Study|Status not recorded|1
5177879|NCT01254630|17877854|P2|Overall Study|Status not recorded|0
5177880|NCT01254630|17877855|P1|Overall Study|Status not recorded|0
5177881|NCT01254630|17877852|P4|Overall Study|Study terminated by sponsor|1010
5177882|NCT01254630|17877853|P3|Overall Study|Study terminated by sponsor|0
5177883|NCT01254630|17877854|P2|Overall Study|Study terminated by sponsor|994
5177884|NCT01254630|17877855|P1|Overall Study|Study terminated by sponsor|0
5177885|NCT01254630|17877852|P4|Overall Study|Withdrawal by Subject|89
5177886|NCT01254630|17877853|P3|Overall Study|Withdrawal by Subject|188
5177887|NCT01254630|17877854|P2|Overall Study|Withdrawal by Subject|94
5177888|NCT01254630|17877855|P1|Overall Study|Withdrawal by Subject|201
5177889|NCT01254630|17877852|P4|Overall Study|Physician Decision|7
5177890|NCT01254630|17877853|P3|Overall Study|Physician Decision|16
5177891|NCT01254630|17877854|P2|Overall Study|Physician Decision|8
5177892|NCT01254630|17877855|P1|Overall Study|Physician Decision|24
5177893|NCT01254630|17877852|P4|Overall Study|Lost to Follow-up|32
5177894|NCT01254630|17877853|P3|Overall Study|Lost to Follow-up|89
5177895|NCT01254630|17877854|P2|Overall Study|Lost to Follow-up|26
5177896|NCT01254630|17877855|P1|Overall Study|Lost to Follow-up|80
5177897|NCT01254630|17877852|P4|Overall Study|Death|139
5177898|NCT01254630|17877853|P3|Overall Study|Death|478
5177899|NCT01254630|17877854|P2|Overall Study|Death|151
5177900|NCT01254630|17877855|P1|Overall Study|Death|461
5177901|NCT01254630|17877852|P4|Overall Study|Adverse Event|8
5177902|NCT01254630|17877853|P3|Overall Study|Adverse Event|40
5177903|NCT01254630|17877854|P2|Overall Study|Adverse Event|15
5177904|NCT01254630|17877855|P1|Overall Study|Adverse Event|36
5177905|NCT01254604|17877875|P2|Overall Study|Adverse Event|2
5177906|NCT01254604|17877876|P1|Overall Study|Adverse Event|3
5177907|NCT01254604|17877875|P2|Overall Study|Withdrawal by Subject|4
5177908|NCT01254604|17877876|P1|Overall Study|Withdrawal by Subject|2
5177909|NCT01254604|17877875|P2|Overall Study|Protocol Violation|2
5177910|NCT01254604|17877876|P1|Overall Study|Protocol Violation|2
5177911|NCT01254604|17877875|P2|Overall Study|Lost to Follow-up|1
5177912|NCT01254604|17877876|P1|Overall Study|Lost to Follow-up|1
5177913|NCT01254565|17877894|P6|Overall Study|Other|0
5177914|NCT01254565|17877895|P5|Overall Study|Other|0
5177915|NCT01254565|17877896|P4|Overall Study|Other|1
5177916|NCT01254565|17877897|P3|Overall Study|Other|0
5177917|NCT01254565|17877898|P2|Overall Study|Other|0
5177918|NCT01254565|17877899|P1|Overall Study|Other|0
5177919|NCT01254565|17877894|P6|Overall Study|Did not Receive Treatment|4
5177920|NCT01254565|17877895|P5|Overall Study|Did not Receive Treatment|3
5177921|NCT01254565|17877896|P4|Overall Study|Did not Receive Treatment|0
5177922|NCT01254565|17877897|P3|Overall Study|Did not Receive Treatment|0
5177923|NCT01254565|17877898|P2|Overall Study|Did not Receive Treatment|1
5177924|NCT01254565|17877899|P1|Overall Study|Did not Receive Treatment|1
5177925|NCT01254565|17877894|P6|Overall Study|Non-compliance to Study Procedures|0
5177926|NCT01254565|17877895|P5|Overall Study|Non-compliance to Study Procedures|1
5177927|NCT01254565|17877896|P4|Overall Study|Non-compliance to Study Procedures|0
5177928|NCT01254565|17877897|P3|Overall Study|Non-compliance to Study Procedures|0
5177929|NCT01254565|17877898|P2|Overall Study|Non-compliance to Study Procedures|0
5177930|NCT01254565|17877899|P1|Overall Study|Non-compliance to Study Procedures|0
5177931|NCT01254422|17877959|P2|Overall Study|Lost to Follow-up|0
5177932|NCT01254422|17877960|P1|Overall Study|Lost to Follow-up|1
5177933|NCT01254422|17877959|P2|Overall Study|Serious adverse event|1
5177934|NCT01254422|17877960|P1|Overall Study|Serious adverse event|0
5177935|NCT01254422|17877959|P2|Overall Study|Adverse Event|0
5177936|NCT01254422|17877960|P1|Overall Study|Adverse Event|1
5177937|NCT01254422|17877959|P2|Overall Study|Protocol Violation|0
5177938|NCT01254422|17877960|P1|Overall Study|Protocol Violation|1
5177939|NCT01254409|17877988|P4|Overall Study|Adverse Event|0
5177940|NCT01254409|17877989|P3|Overall Study|Adverse Event|0
5177941|NCT01254409|17877990|P2|Overall Study|Adverse Event|1
5177942|NCT01254409|17877991|P1|Overall Study|Adverse Event|0
5177943|NCT01254344|17878060|P2|Overall Study|Withdrawal by Subject|6
5177944|NCT01254344|17878061|P1|Overall Study|Withdrawal by Subject|3
5177945|NCT01254344|17878060|P2|Overall Study|Protocol Violation|4
5177946|NCT01254344|17878061|P1|Overall Study|Protocol Violation|1
5177947|NCT01254344|17878060|P2|Overall Study|Physician Decision|4
5177948|NCT01254344|17878061|P1|Overall Study|Physician Decision|7
5177949|NCT01254344|17878060|P2|Overall Study|Adverse Event|5
5177950|NCT01254344|17878061|P1|Overall Study|Adverse Event|2
5177951|NCT01254331|17878069|P1|Extension Phase|Lost to Follow-up|3
5177952|NCT01254331|17878069|P1|Extension Phase|Lack of Efficacy|1
5177953|NCT01254331|17878069|P1|Initial Phase|Pregnancy|1
5177954|NCT01254331|17878069|P1|Initial Phase|Withdrawal by Subject|1
5177955|NCT01254331|17878069|P1|Initial Phase|Adverse Event|3
5177956|NCT01254318|17878087|P1|Overall Study|Death|47
5177957|NCT01254318|17878087|P1|Overall Study|Lost to Follow-up|5
5177958|NCT01254305|17878096|P3|Overall Study|Other Reasons|2
5177959|NCT01254305|17878097|P2|Overall Study|Other Reasons|0
5177960|NCT01254305|17878098|P1|Overall Study|Other Reasons|0
5177961|NCT01254305|17878096|P3|Overall Study|Lost to Follow-up|5
5177962|NCT01254305|17878097|P2|Overall Study|Lost to Follow-up|6
5177963|NCT01254305|17878098|P1|Overall Study|Lost to Follow-up|10
5177964|NCT01254305|17878096|P3|Overall Study|Withdrawal by Subject|4
5177965|NCT01254305|17878097|P2|Overall Study|Withdrawal by Subject|2
5177966|NCT01254305|17878098|P1|Overall Study|Withdrawal by Subject|4
5177967|NCT01254305|17878096|P3|Overall Study|Protocol Violation|3
5177968|NCT01254305|17878097|P2|Overall Study|Protocol Violation|7
5177969|NCT01254305|17878098|P1|Overall Study|Protocol Violation|1
5177970|NCT01254305|17878096|P3|Overall Study|Lack of Efficacy|1
5177971|NCT01254305|17878097|P2|Overall Study|Lack of Efficacy|0
5177972|NCT01254305|17878098|P1|Overall Study|Lack of Efficacy|1
5177973|NCT01254305|17878096|P3|Overall Study|Adverse Event|2
5177974|NCT01254305|17878097|P2|Overall Study|Adverse Event|3
5177975|NCT01254305|17878098|P1|Overall Study|Adverse Event|6
5177976|NCT01254292|17878114|P2|LCS12 Extension Phase|Lost to Follow-up|0
5177977|NCT01254292|17878115|P1|LCS12 Extension Phase|Lost to Follow-up|1
5177978|NCT01254292|17878114|P2|LCS12 Extension Phase|Pregnancy|0
5177979|NCT01254292|17878115|P1|LCS12 Extension Phase|Pregnancy|2
5177980|NCT01254292|17878114|P2|LCS12 Extension Phase|Other unknown|0
5177981|NCT01254292|17878115|P1|LCS12 Extension Phase|Other unknown|4
5177982|NCT01254292|17878114|P2|LCS12 Extension Phase|Withdrawal by Subject|0
5177983|NCT01254292|17878115|P1|LCS12 Extension Phase|Withdrawal by Subject|7
5177984|NCT01254292|17878114|P2|LCS12 Extension Phase|Adverse Event|0
5177985|NCT01254292|17878115|P1|LCS12 Extension Phase|Adverse Event|9
5177986|NCT01254292|17878114|P2|LCS12 Extension Phase|Wish for pregnancy|0
5177987|NCT01254292|17878115|P1|LCS12 Extension Phase|Wish for pregnancy|14
5177988|NCT01254292|17878114|P2|Comparative Phase|Wish for pregnancy|6
5177989|NCT01254292|17878115|P1|Comparative Phase|Wish for pregnancy|4
5177990|NCT01254292|17878114|P2|Comparative Phase|Protocol Violation|2
5177991|NCT01254292|17878115|P1|Comparative Phase|Protocol Violation|1
5177992|NCT01254292|17878114|P2|Comparative Phase|Withdrawal by Subject|21
5177993|NCT01254292|17878115|P1|Comparative Phase|Withdrawal by Subject|20
5177994|NCT01254292|17878114|P2|Comparative Phase|Pregnancy|6
5177995|NCT01254292|17878115|P1|Comparative Phase|Pregnancy|2
5177996|NCT01254292|17878114|P2|Comparative Phase|Lost to Follow-up|21
5177997|NCT01254292|17878115|P1|Comparative Phase|Lost to Follow-up|3
5177998|NCT01254292|17878114|P2|Comparative Phase|Adverse Event|25
5177999|NCT01254292|17878115|P1|Comparative Phase|Adverse Event|25
5178000|NCT01254188|17878192|P1|Overall Study|per investigator discretion|20
5178001|NCT01254188|17878192|P1|Overall Study|Adverse Event|43
5178002|NCT01254188|17878192|P1|Overall Study|Withdrawal by Subject|7
5178003|NCT01254188|17878192|P1|Overall Study|Lost to Follow-up|5
5178004|NCT01254188|17878192|P1|Overall Study|Death|4
5178005|NCT01254188|17878192|P1|Overall Study|Pregnancy|2
5178006|NCT01254188|17878192|P1|Overall Study|Protocol Violation|6
5178007|NCT01254188|17878192|P1|Overall Study|Disease Progression|6
5178008|NCT01254045|17878203|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5178009|NCT01254045|17878204|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5178010|NCT01254045|17878205|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5178011|NCT01254045|17878206|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5178012|NCT01254045|17878207|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5178013|NCT01254045|17878208|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
5178014|NCT01254019|17878221|P2|Overall Study|Withdrawal by Subject|2
5178015|NCT01254019|17878222|P1|Overall Study|Withdrawal by Subject|0
5178016|NCT01254019|17878221|P2|Overall Study|Protocol Violation|0
5178017|NCT01254019|17878222|P1|Overall Study|Protocol Violation|1
5178018|NCT01254019|17878221|P2|Overall Study|Adverse Event|2
5178019|NCT01254019|17878222|P1|Overall Study|Adverse Event|0
5178020|NCT01253811|17878316|P1|Overall Study|Withdrawal criteria|1
5178021|NCT01253577|17878347|P1|Overall Study|Lost to Follow-up|3
5178022|NCT01253564|17878355|P1|Overall Study|Serious Adverse Event|1
5178023|NCT01253564|17878355|P1|Overall Study|Withdrawal by Subject|1
5178024|NCT01253564|17878355|P1|Overall Study|Disease Progression|22
5178025|NCT01253447|17878404|P1|Overall Study|Adverse Event|2
5178026|NCT01253421|17878414|P5|Drug+Scanning Visit|Physician Decision|1
5178027|NCT01253421|17878415|P4|Drug+Scanning Visit|Physician Decision|0
5178028|NCT01253421|17878416|P3|Drug+Scanning Visit|Physician Decision|0
5178029|NCT01253421|17878417|P2|Drug+Scanning Visit|Physician Decision|0
5178030|NCT01253421|17878418|P1|Drug+Scanning Visit|Physician Decision|0
5178031|NCT01253421|17878414|P5|Assessment and Scheduling|Physician Decision|0
5178032|NCT01253421|17878415|P4|Assessment and Scheduling|Physician Decision|0
5178033|NCT01253421|17878416|P3|Assessment and Scheduling|Physician Decision|0
5178034|NCT01253421|17878417|P2|Assessment and Scheduling|Physician Decision|0
5178035|NCT01253421|17878418|P1|Assessment and Scheduling|Physician Decision|1
5178036|NCT01253421|17878414|P5|Assessment and Scheduling|Withdrawal by Subject|0
5178037|NCT01253421|17878415|P4|Assessment and Scheduling|Withdrawal by Subject|0
5178038|NCT01253421|17878416|P3|Assessment and Scheduling|Withdrawal by Subject|0
5178039|NCT01253421|17878417|P2|Assessment and Scheduling|Withdrawal by Subject|0
5178040|NCT01253421|17878418|P1|Assessment and Scheduling|Withdrawal by Subject|7
5178041|NCT01253421|17878414|P5|Assessment and Scheduling|Lost to Follow-up|0
5178042|NCT01253421|17878415|P4|Assessment and Scheduling|Lost to Follow-up|0
5178043|NCT01253421|17878416|P3|Assessment and Scheduling|Lost to Follow-up|0
5178044|NCT01253421|17878417|P2|Assessment and Scheduling|Lost to Follow-up|0
5178045|NCT01253421|17878418|P1|Assessment and Scheduling|Lost to Follow-up|17
5178046|NCT01253421|17878414|P5|Assessment and Scheduling|Found to be Ineligible|0
5178047|NCT01253421|17878415|P4|Assessment and Scheduling|Found to be Ineligible|0
5178048|NCT01253421|17878416|P3|Assessment and Scheduling|Found to be Ineligible|0
5178049|NCT01253421|17878417|P2|Assessment and Scheduling|Found to be Ineligible|0
5178050|NCT01253421|17878418|P1|Assessment and Scheduling|Found to be Ineligible|74
5178051|NCT01253408|17878467|P3|Overall Study|Adverse Event|0
5178052|NCT01253408|17878468|P2|Overall Study|Adverse Event|1
5178053|NCT01253408|17878469|P1|Overall Study|Adverse Event|0
5178054|NCT01253369|17878492|P1|Overall Study|Not Evaluable|3
5178055|NCT01253369|17878492|P1|Overall Study|Progressive disease|23
5178056|NCT01253369|17878492|P1|Overall Study|Death|1
5178057|NCT01253369|17878492|P1|Overall Study|Withdrawal by Subject|2
5178058|NCT01253369|17878492|P1|Overall Study|Adverse Event|4
5178059|NCT01253317|17878522|P1|Overall Study|Adverse Event|2
5178060|NCT01253304|17878534|P4|Overall Study|Adverse Event|1
5178061|NCT01253304|17878535|P3|Overall Study|Adverse Event|0
5178062|NCT01253304|17878536|P2|Overall Study|Adverse Event|0
5178063|NCT01253304|17878537|P1|Overall Study|Adverse Event|0
5178064|NCT01253291|17878576|P5|Overall Study|Physician Decision|2
5178065|NCT01253291|17878577|P4|Overall Study|Physician Decision|0
5178066|NCT01253291|17878578|P3|Overall Study|Physician Decision|0
5178067|NCT01253291|17878579|P2|Overall Study|Physician Decision|0
5178068|NCT01253291|17878580|P1|Overall Study|Physician Decision|2
5178069|NCT01253291|17878576|P5|Overall Study|Lack of Efficacy|0
5178070|NCT01253291|17878577|P4|Overall Study|Lack of Efficacy|0
5178071|NCT01253291|17878578|P3|Overall Study|Lack of Efficacy|0
5178072|NCT01253291|17878579|P2|Overall Study|Lack of Efficacy|0
5178073|NCT01253291|17878580|P1|Overall Study|Lack of Efficacy|1
5178074|NCT01253291|17878576|P5|Overall Study|Adverse Event|0
5178075|NCT01253291|17878577|P4|Overall Study|Adverse Event|0
5178076|NCT01253291|17878578|P3|Overall Study|Adverse Event|0
5178077|NCT01253291|17878579|P2|Overall Study|Adverse Event|1
5178078|NCT01253291|17878580|P1|Overall Study|Adverse Event|0
5178079|NCT01253291|17878576|P5|Overall Study|Withdrawal by Subject|0
5178080|NCT01253291|17878577|P4|Overall Study|Withdrawal by Subject|0
5178081|NCT01253291|17878578|P3|Overall Study|Withdrawal by Subject|0
5178082|NCT01253291|17878579|P2|Overall Study|Withdrawal by Subject|1
5178083|NCT01253291|17878580|P1|Overall Study|Withdrawal by Subject|1
5178084|NCT01253265|17878604|P5|Overall Study|Withdrawal by Subject|1
5178085|NCT01253265|17878605|P4|Overall Study|Withdrawal by Subject|0
5178086|NCT01253265|17878606|P3|Overall Study|Withdrawal by Subject|0
5178087|NCT01253265|17878607|P2|Overall Study|Withdrawal by Subject|0
5178088|NCT01253265|17878608|P1|Overall Study|Withdrawal by Subject|0
5178089|NCT01253265|17878604|P5|Overall Study|Met Predefined Discontinuation Criteria|0
5178090|NCT01253265|17878605|P4|Overall Study|Met Predefined Discontinuation Criteria|0
5178091|NCT01253265|17878606|P3|Overall Study|Met Predefined Discontinuation Criteria|0
5178092|NCT01253265|17878607|P2|Overall Study|Met Predefined Discontinuation Criteria|0
5178093|NCT01253265|17878608|P1|Overall Study|Met Predefined Discontinuation Criteria|1
5178094|NCT01253226|17878657|P5|Overall Study|Withdrawal by Subject|0
5178095|NCT01253226|17878658|P4|Overall Study|Withdrawal by Subject|1
5178096|NCT01253226|17878659|P3|Overall Study|Withdrawal by Subject|0
5178097|NCT01253226|17878660|P2|Overall Study|Withdrawal by Subject|0
5178098|NCT01253226|17878661|P1|Overall Study|Withdrawal by Subject|0
5178099|NCT01253226|17878657|P5|Overall Study|Physician Decision|2
5178100|NCT01253226|17878658|P4|Overall Study|Physician Decision|0
5178101|NCT01253226|17878659|P3|Overall Study|Physician Decision|0
5178102|NCT01253226|17878660|P2|Overall Study|Physician Decision|0
5178103|NCT01253226|17878661|P1|Overall Study|Physician Decision|0
5178104|NCT01253226|17878657|P5|Overall Study|Death|0
5178105|NCT01253226|17878658|P4|Overall Study|Death|0
5178106|NCT01253226|17878659|P3|Overall Study|Death|0
5178107|NCT01253226|17878660|P2|Overall Study|Death|1
5178108|NCT01253226|17878661|P1|Overall Study|Death|0
5178109|NCT01253226|17878657|P5|Overall Study|Adverse Event|0
5178110|NCT01253226|17878658|P4|Overall Study|Adverse Event|0
5178111|NCT01253226|17878659|P3|Overall Study|Adverse Event|1
5178112|NCT01253226|17878660|P2|Overall Study|Adverse Event|0
5178113|NCT01253226|17878661|P1|Overall Study|Adverse Event|0
5178114|NCT01253200|17878721|P5|Overall Study|Attempts|0
5178115|NCT01253200|17878722|P4|Overall Study|Attempts|2
5178116|NCT01253200|17878723|P3|Overall Study|Attempts|1
5178117|NCT01253200|17878724|P2|Overall Study|Attempts|4
5178118|NCT01253200|17878725|P1|Overall Study|Attempts|6
5178119|NCT01253200|17878721|P5|Overall Study|intents|0
5178120|NCT01253200|17878722|P4|Overall Study|intents|3
5178121|NCT01253200|17878723|P3|Overall Study|intents|1
5178122|NCT01253200|17878724|P2|Overall Study|intents|10
5178123|NCT01253200|17878725|P1|Overall Study|intents|10
5178124|NCT01253200|17878721|P5|Overall Study|Protocol Violation|5
5178125|NCT01253200|17878722|P4|Overall Study|Protocol Violation|0
5178126|NCT01253200|17878723|P3|Overall Study|Protocol Violation|0
5178127|NCT01253200|17878724|P2|Overall Study|Protocol Violation|4
5178128|NCT01253200|17878725|P1|Overall Study|Protocol Violation|1
5178129|NCT01253200|17878721|P5|Overall Study|Withdrawal by Subject|0
5178130|NCT01253200|17878722|P4|Overall Study|Withdrawal by Subject|0
5178131|NCT01253200|17878723|P3|Overall Study|Withdrawal by Subject|0
5178132|NCT01253200|17878724|P2|Overall Study|Withdrawal by Subject|0
5178133|NCT01253200|17878725|P1|Overall Study|Withdrawal by Subject|2
5178134|NCT01253200|17878721|P5|Overall Study|Lost to Follow-up|0
5178135|NCT01253200|17878722|P4|Overall Study|Lost to Follow-up|0
5178136|NCT01253200|17878723|P3|Overall Study|Lost to Follow-up|0
5178137|NCT01253200|17878724|P2|Overall Study|Lost to Follow-up|1
5178138|NCT01253200|17878725|P1|Overall Study|Lost to Follow-up|1
5178139|NCT01253200|17878721|P5|Overall Study|Death|0
5178140|NCT01253200|17878722|P4|Overall Study|Death|0
5178141|NCT01253200|17878723|P3|Overall Study|Death|0
5178142|NCT01253200|17878724|P2|Overall Study|Death|0
5178143|NCT01253200|17878725|P1|Overall Study|Death|1
5178144|NCT01253187|17878740|P6|Period 3|non-compliance|0
5178145|NCT01253187|17878741|P5|Period 3|non-compliance|1
5178146|NCT01253187|17878742|P4|Period 3|non-compliance|0
5178147|NCT01253187|17878743|P3|Period 3|non-compliance|0
5178148|NCT01253187|17878744|P2|Period 3|non-compliance|0
5178149|NCT01253187|17878745|P1|Period 3|non-compliance|0
5178150|NCT01253187|17878740|P6|Period 3|difficulty with blood sampling|0
5178151|NCT01253187|17878741|P5|Period 3|difficulty with blood sampling|0
5178152|NCT01253187|17878742|P4|Period 3|difficulty with blood sampling|0
5178153|NCT01253187|17878743|P3|Period 3|difficulty with blood sampling|0
5178154|NCT01253187|17878744|P2|Period 3|difficulty with blood sampling|1
5178155|NCT01253187|17878745|P1|Period 3|difficulty with blood sampling|0
5178156|NCT01253187|17878740|P6|Period 3|Pregnancy|0
5178157|NCT01253187|17878741|P5|Period 3|Pregnancy|0
5178158|NCT01253187|17878742|P4|Period 3|Pregnancy|0
5178159|NCT01253187|17878743|P3|Period 3|Pregnancy|0
5178160|NCT01253187|17878744|P2|Period 3|Pregnancy|0
5178161|NCT01253187|17878745|P1|Period 3|Pregnancy|1
5178162|NCT01253187|17878740|P6|Period 2|Withdrawal by Subject|0
5178163|NCT01253187|17878741|P5|Period 2|Withdrawal by Subject|1
5178164|NCT01253187|17878742|P4|Period 2|Withdrawal by Subject|0
5178165|NCT01253187|17878743|P3|Period 2|Withdrawal by Subject|0
5178166|NCT01253187|17878744|P2|Period 2|Withdrawal by Subject|0
5178167|NCT01253187|17878745|P1|Period 2|Withdrawal by Subject|0
5178168|NCT01253174|17878774|P6|Period 3|Pregnancy|0
5178169|NCT01253174|17878775|P5|Period 3|Pregnancy|0
5178170|NCT01253174|17878776|P4|Period 3|Pregnancy|0
5178171|NCT01253174|17878777|P3|Period 3|Pregnancy|1
5178172|NCT01253174|17878778|P2|Period 3|Pregnancy|0
5178173|NCT01253174|17878779|P1|Period 3|Pregnancy|0
5178174|NCT01253174|17878774|P6|Period 3|Withdrawal by Subject|0
5178175|NCT01253174|17878775|P5|Period 3|Withdrawal by Subject|1
5178176|NCT01253174|17878776|P4|Period 3|Withdrawal by Subject|0
5178177|NCT01253174|17878777|P3|Period 3|Withdrawal by Subject|0
5178178|NCT01253174|17878778|P2|Period 3|Withdrawal by Subject|1
5178179|NCT01253174|17878779|P1|Period 3|Withdrawal by Subject|0
5178180|NCT01253174|17878774|P6|Period 2|Adverse Event|0
5178181|NCT01253174|17878775|P5|Period 2|Adverse Event|0
5178182|NCT01253174|17878776|P4|Period 2|Adverse Event|0
5178183|NCT01253174|17878777|P3|Period 2|Adverse Event|1
5178184|NCT01253174|17878778|P2|Period 2|Adverse Event|0
5178185|NCT01253174|17878779|P1|Period 2|Adverse Event|0
5178186|NCT01253174|17878774|P6|Period 1|Randomized but not treated|0
5178187|NCT01253174|17878775|P5|Period 1|Randomized but not treated|1
5178188|NCT01253174|17878776|P4|Period 1|Randomized but not treated|0
5178189|NCT01253174|17878777|P3|Period 1|Randomized but not treated|1
5178190|NCT01253174|17878778|P2|Period 1|Randomized but not treated|1
5178191|NCT01253174|17878779|P1|Period 1|Randomized but not treated|0
5178192|NCT01253135|17878814|P1|Amended Protocol|Non-compliance|1
5178193|NCT01253135|17878814|P1|Original Protocol|Protocol Amendment|15
5178194|NCT01253044|17878833|P2|Overall Study|Lost to Follow-up|29
5178195|NCT01253044|17878834|P1|Overall Study|Lost to Follow-up|38
5178196|NCT01253018|17878844|P2|Overall Study|Withdrawal by Subject|1
5178197|NCT01253018|17878845|P1|Overall Study|Withdrawal by Subject|1
5178198|NCT01253018|17878844|P2|Overall Study|Robot Repair Issues|0
5178199|NCT01253018|17878845|P1|Overall Study|Robot Repair Issues|2
5178200|NCT01253018|17878844|P2|Overall Study|Lost to Follow-up|1
5178201|NCT01253018|17878845|P1|Overall Study|Lost to Follow-up|1
5178202|NCT01252966|17878859|P2|Overall Study|Withdrawal by Subject|3
5178203|NCT01252966|17878860|P1|Overall Study|Withdrawal by Subject|7
5178204|NCT01252966|17878859|P2|Overall Study|Lost to Follow-up|10
5178205|NCT01252966|17878860|P1|Overall Study|Lost to Follow-up|16
5178206|NCT01252953|17878876|P2|Overall Study|Lost to Follow-up|21
5178207|NCT01252953|17878877|P1|Overall Study|Lost to Follow-up|22
5178208|NCT01252953|17878876|P2|Overall Study|Withdrawal by Subject|17
5178209|NCT01252953|17878877|P1|Overall Study|Withdrawal by Subject|16
5178210|NCT01252940|17878891|P2|Extension Phase|Withdrawal by Subject|1
5178211|NCT01252940|17878892|P1|Extension Phase|Withdrawal by Subject|1
5178212|NCT01252940|17878891|P2|Extension Phase|Subject Non-compliance|0
5178213|NCT01252940|17878892|P1|Extension Phase|Subject Non-compliance|1
5178214|NCT01252940|17878891|P2|Extension Phase|Physician Decision|1
5178215|NCT01252940|17878892|P1|Extension Phase|Physician Decision|0
5178216|NCT01252940|17878891|P2|Extension Phase|Lost to Follow-up|0
5178217|NCT01252940|17878892|P1|Extension Phase|Lost to Follow-up|5
5178218|NCT01252940|17878891|P2|Extension Phase|Lack of Efficacy|0
5178219|NCT01252940|17878892|P1|Extension Phase|Lack of Efficacy|1
5178220|NCT01252940|17878891|P2|Extension Phase|Adverse Event|1
5178221|NCT01252940|17878892|P1|Extension Phase|Adverse Event|2
5178222|NCT01252940|17878891|P2|Main Study Phase|Subject Non-compliance|1
5178223|NCT01252940|17878892|P1|Main Study Phase|Subject Non-compliance|1
5178224|NCT01252940|17878891|P2|Main Study Phase|Withdrawal by Subject|5
5178225|NCT01252940|17878892|P1|Main Study Phase|Withdrawal by Subject|6
5178226|NCT01252940|17878891|P2|Main Study Phase|Protocol Violation|2
5178227|NCT01252940|17878892|P1|Main Study Phase|Protocol Violation|4
5178228|NCT01252940|17878891|P2|Main Study Phase|Physician Decision|0
5178229|NCT01252940|17878892|P1|Main Study Phase|Physician Decision|1
5178230|NCT01252940|17878891|P2|Main Study Phase|Lost to Follow-up|1
5178231|NCT01252940|17878892|P1|Main Study Phase|Lost to Follow-up|6
5178232|NCT01252940|17878891|P2|Main Study Phase|Lack of Efficacy|0
5178233|NCT01252940|17878892|P1|Main Study Phase|Lack of Efficacy|1
5178234|NCT01252940|17878891|P2|Main Study Phase|Adverse Event|1
5178235|NCT01252940|17878892|P1|Main Study Phase|Adverse Event|3
5178236|NCT01252940|17878891|P2|Main Study Phase|Randomized but not treated|2
5178237|NCT01252940|17878892|P1|Main Study Phase|Randomized but not treated|4
5178238|NCT01252810|17878923|P2|Overall Study|Various reasons|0
5178239|NCT01252810|17878924|P1|Overall Study|Various reasons|8
5178240|NCT01252810|17878923|P2|Overall Study|Physician Decision|1
5178241|NCT01252810|17878924|P1|Overall Study|Physician Decision|2
5178242|NCT01252810|17878923|P2|Overall Study|Lost to Follow-up|1
5178243|NCT01252810|17878924|P1|Overall Study|Lost to Follow-up|0
5178244|NCT01252810|17878923|P2|Overall Study|Withdrawal by Subject|1
5178245|NCT01252810|17878924|P1|Overall Study|Withdrawal by Subject|4
5178246|NCT01252667|17878959|P6|Overall Study|Transplant aborted post-conditioning|1
5178247|NCT01252667|17878960|P5|Overall Study|Transplant aborted post-conditioning|0
5178248|NCT01252667|17878961|P4|Overall Study|Transplant aborted post-conditioning|0
5178249|NCT01252667|17878962|P3|Overall Study|Transplant aborted post-conditioning|0
5178250|NCT01252667|17878963|P2|Overall Study|Transplant aborted post-conditioning|0
5178251|NCT01252667|17878964|P1|Overall Study|Transplant aborted post-conditioning|0
5178252|NCT01252563|17879026|P1|Overall Study|No drug administration|6
5178253|NCT01252563|17879026|P1|Overall Study|No visit after first day of treatment|194
5178254|NCT01252563|17879026|P1|Overall Study|Lost to Follow-up|161
5178255|NCT01252563|17879026|P1|Overall Study|Centralized Registration Deviation|30
5178256|NCT01252563|17879026|P1|Overall Study|Contract Deviation|41
5178257|NCT01252355|17879066|P3|Overall Study|Other Than Above|7
5178258|NCT01252355|17879067|P2|Overall Study|Other Than Above|7
5178259|NCT01252355|17879068|P1|Overall Study|Other Than Above|8
5178260|NCT01252355|17879066|P3|Overall Study|Randomized but not Treated|0
5178261|NCT01252355|17879067|P2|Overall Study|Randomized but not Treated|0
5178262|NCT01252355|17879068|P1|Overall Study|Randomized but not Treated|2
5178263|NCT01252355|17879066|P3|Overall Study|Sponsor Early Termination of Study|146
5178264|NCT01252355|17879067|P2|Overall Study|Sponsor Early Termination of Study|149
5178265|NCT01252355|17879068|P1|Overall Study|Sponsor Early Termination of Study|149
5178266|NCT01252355|17879066|P3|Overall Study|Progressive Disease|0
5178267|NCT01252355|17879067|P2|Overall Study|Progressive Disease|0
5178268|NCT01252355|17879068|P1|Overall Study|Progressive Disease|2
5178269|NCT01252355|17879066|P3|Overall Study|Poor Compliance to Protocol|1
5178270|NCT01252355|17879067|P2|Overall Study|Poor Compliance to Protocol|1
5178271|NCT01252355|17879068|P1|Overall Study|Poor Compliance to Protocol|1
5178272|NCT01252355|17879066|P3|Overall Study|Lost to Follow-up|1
5178273|NCT01252355|17879067|P2|Overall Study|Lost to Follow-up|0
5178274|NCT01252355|17879068|P1|Overall Study|Lost to Follow-up|0
5178275|NCT01252355|17879066|P3|Overall Study|Lack of Efficacy|2
5178276|NCT01252355|17879067|P2|Overall Study|Lack of Efficacy|4
5178277|NCT01252355|17879068|P1|Overall Study|Lack of Efficacy|6
5178278|NCT01252355|17879066|P3|Overall Study|Adverse Event|22
5178279|NCT01252355|17879067|P2|Overall Study|Adverse Event|17
5178280|NCT01252355|17879068|P1|Overall Study|Adverse Event|9
5178281|NCT01252290|17879106|P1|Overall Study|Withdrawal by Subject|1
5178282|NCT01252251|17879122|P1|Overall Study|Withdrawal by Subject|1
5178283|NCT01252238|17879134|P3|Overall Study|Sponsor terminated study|4
5178284|NCT01252238|17879135|P2|Overall Study|Sponsor terminated study|4
5178285|NCT01252238|17879136|P1|Overall Study|Sponsor terminated study|4
5178286|NCT01252186|17879153|P3|Overall Study|Other - Miscellaneous Reasons|7
5178287|NCT01252186|17879154|P2|Overall Study|Other - Miscellaneous Reasons|5
5178288|NCT01252186|17879155|P1|Overall Study|Other - Miscellaneous Reasons|5
5178289|NCT01252186|17879153|P3|Overall Study|Lost to Follow-up|11
5178290|NCT01252186|17879154|P2|Overall Study|Lost to Follow-up|10
5178291|NCT01252186|17879155|P1|Overall Study|Lost to Follow-up|10
5178292|NCT01252186|17879153|P3|Overall Study|Sponsor Request|0
5178293|NCT01252186|17879154|P2|Overall Study|Sponsor Request|1
5178294|NCT01252186|17879155|P1|Overall Study|Sponsor Request|2
5178295|NCT01252186|17879153|P3|Overall Study|Pregnancy|0
5178296|NCT01252186|17879154|P2|Overall Study|Pregnancy|2
5178297|NCT01252186|17879155|P1|Overall Study|Pregnancy|2
5178298|NCT01252186|17879153|P3|Overall Study|Protocol Violation|1
5178299|NCT01252186|17879154|P2|Overall Study|Protocol Violation|0
5178300|NCT01252186|17879155|P1|Overall Study|Protocol Violation|0
5178301|NCT01252186|17879153|P3|Overall Study|Non-compliance|4
5178302|NCT01252186|17879154|P2|Overall Study|Non-compliance|3
5178303|NCT01252186|17879155|P1|Overall Study|Non-compliance|0
5178304|NCT01252186|17879153|P3|Overall Study|Physician Decision|1
5178305|NCT01252186|17879154|P2|Overall Study|Physician Decision|0
5178306|NCT01252186|17879155|P1|Overall Study|Physician Decision|0
5178307|NCT01252186|17879153|P3|Overall Study|Withdrawal by Subject|2
5178308|NCT01252186|17879154|P2|Overall Study|Withdrawal by Subject|5
5178309|NCT01252186|17879155|P1|Overall Study|Withdrawal by Subject|2
5178310|NCT01252186|17879153|P3|Overall Study|Adverse Event|8
5178311|NCT01252186|17879154|P2|Overall Study|Adverse Event|6
5178312|NCT01252186|17879155|P1|Overall Study|Adverse Event|9
5178313|NCT01252134|17879228|P6|Period 1, 8 Hours|Personal Reasons|0
5178314|NCT01252134|17879229|P5|Period 1, 8 Hours|Personal Reasons|0
5178315|NCT01252134|17879230|P4|Period 1, 8 Hours|Personal Reasons|0
5178316|NCT01252134|17879231|P3|Period 1, 8 Hours|Personal Reasons|1
5178317|NCT01252134|17879232|P2|Period 1, 8 Hours|Personal Reasons|1
5178318|NCT01252134|17879233|P1|Period 1, 8 Hours|Personal Reasons|0
5178319|NCT01252095|17879252|P2|Overall Study|Disease progression|0
5178320|NCT01252095|17879253|P1|Overall Study|Disease progression|1
5178321|NCT01251965|17879274|P3|Overall Study|Death|11
5178322|NCT01251965|17879275|P2|Overall Study|Death|0
5178323|NCT01251965|17879276|P1|Overall Study|Death|0
5178324|NCT01251965|17879274|P3|Overall Study|Participant/physician decision|0
5178325|NCT01251965|17879275|P2|Overall Study|Participant/physician decision|2
5178326|NCT01251965|17879276|P1|Overall Study|Participant/physician decision|1
5178327|NCT01251952|17879288|P1|Overall Study|Adverse Event|1
5178328|NCT01251861|17879294|P2|Overall Study|Potential interaction of drugs|1
5178329|NCT01251861|17879295|P1|Overall Study|Potential interaction of drugs|0
5178330|NCT01251861|17879294|P2|Overall Study|Never started therapy|1
5178331|NCT01251861|17879295|P1|Overall Study|Never started therapy|4
5178332|NCT01251861|17879294|P2|Overall Study|Other|0
5178333|NCT01251861|17879295|P1|Overall Study|Other|1
5178334|NCT01251861|17879294|P2|Overall Study|Continued treatment beyond 18 cycles|0
5178335|NCT01251861|17879295|P1|Overall Study|Continued treatment beyond 18 cycles|1
5178336|NCT01251861|17879294|P2|Overall Study|Physician Decision|0
5178337|NCT01251861|17879295|P1|Overall Study|Physician Decision|1
5178338|NCT01251861|17879294|P2|Overall Study|Other complicating disease|1
5178339|NCT01251861|17879295|P1|Overall Study|Other complicating disease|0
5178340|NCT01251861|17879294|P2|Overall Study|Alternative therapy|0
5178341|NCT01251861|17879295|P1|Overall Study|Alternative therapy|1
5178342|NCT01251861|17879294|P2|Overall Study|Withdrawal by Subject|2
5178343|NCT01251861|17879295|P1|Overall Study|Withdrawal by Subject|2
5178344|NCT01251861|17879294|P2|Overall Study|Adverse Event|17
5178345|NCT01251861|17879295|P1|Overall Study|Adverse Event|2
5178346|NCT01251861|17879294|P2|Overall Study|Disease progression|6
5178347|NCT01251861|17879295|P1|Overall Study|Disease progression|6
5178348|NCT01251770|17879323|P2|Overall Study|Protocol Violation|7
5178349|NCT01251770|17879324|P1|Overall Study|Protocol Violation|13
5178350|NCT01251744|17879368|P2|Overall Study|Lost to Follow-up|0
5178351|NCT01251744|17879369|P1|Overall Study|Lost to Follow-up|1
5178352|NCT01251653|17879427|P9|Overall Study|Other reason not mentioned above|0
5178353|NCT01251653|17879428|P8|Overall Study|Other reason not mentioned above|2
5178354|NCT01251653|17879429|P7|Overall Study|Other reason not mentioned above|0
5178355|NCT01251653|17879430|P6|Overall Study|Other reason not mentioned above|0
5178356|NCT01251653|17879431|P5|Overall Study|Other reason not mentioned above|0
5178357|NCT01251653|17879432|P4|Overall Study|Other reason not mentioned above|0
5178358|NCT01251653|17879433|P3|Overall Study|Other reason not mentioned above|0
5178359|NCT01251653|17879434|P2|Overall Study|Other reason not mentioned above|0
5178360|NCT01251653|17879435|P1|Overall Study|Other reason not mentioned above|0
5178361|NCT01251653|17879427|P9|Overall Study|Withdrawal by Subject|0
5178362|NCT01251653|17879428|P8|Overall Study|Withdrawal by Subject|1
5178363|NCT01251653|17879429|P7|Overall Study|Withdrawal by Subject|0
5178364|NCT01251653|17879430|P6|Overall Study|Withdrawal by Subject|1
5178365|NCT01251653|17879431|P5|Overall Study|Withdrawal by Subject|1
5178366|NCT01251653|17879432|P4|Overall Study|Withdrawal by Subject|0
5178367|NCT01251653|17879433|P3|Overall Study|Withdrawal by Subject|1
5178368|NCT01251653|17879434|P2|Overall Study|Withdrawal by Subject|0
5178369|NCT01251653|17879435|P1|Overall Study|Withdrawal by Subject|1
5178370|NCT01251653|17879427|P9|Overall Study|Adverse Event|1
5178371|NCT01251653|17879428|P8|Overall Study|Adverse Event|2
5178372|NCT01251653|17879429|P7|Overall Study|Adverse Event|2
5178373|NCT01251653|17879430|P6|Overall Study|Adverse Event|0
5178374|NCT01251653|17879431|P5|Overall Study|Adverse Event|1
5178375|NCT01251653|17879432|P4|Overall Study|Adverse Event|1
5178376|NCT01251653|17879433|P3|Overall Study|Adverse Event|2
5178377|NCT01251653|17879434|P2|Overall Study|Adverse Event|0
5178378|NCT01251653|17879435|P1|Overall Study|Adverse Event|1
5178379|NCT01251653|17879427|P9|Overall Study|Dose-limiting toxicity|0
5178380|NCT01251653|17879428|P8|Overall Study|Dose-limiting toxicity|0
5178381|NCT01251653|17879429|P7|Overall Study|Dose-limiting toxicity|2
5178382|NCT01251653|17879430|P6|Overall Study|Dose-limiting toxicity|0
5178383|NCT01251653|17879431|P5|Overall Study|Dose-limiting toxicity|0
5178384|NCT01251653|17879432|P4|Overall Study|Dose-limiting toxicity|1
5178385|NCT01251653|17879433|P3|Overall Study|Dose-limiting toxicity|1
5178386|NCT01251653|17879434|P2|Overall Study|Dose-limiting toxicity|1
5178387|NCT01251653|17879435|P1|Overall Study|Dose-limiting toxicity|0
5178388|NCT01251653|17879427|P9|Overall Study|Progressive Disease|5
5178389|NCT01251653|17879428|P8|Overall Study|Progressive Disease|7
5178390|NCT01251653|17879429|P7|Overall Study|Progressive Disease|14
5178391|NCT01251653|17879430|P6|Overall Study|Progressive Disease|17
5178392|NCT01251653|17879431|P5|Overall Study|Progressive Disease|0
5178393|NCT01251653|17879432|P4|Overall Study|Progressive Disease|4
5178394|NCT01251653|17879433|P3|Overall Study|Progressive Disease|16
5178395|NCT01251653|17879434|P2|Overall Study|Progressive Disease|7
5178396|NCT01251653|17879435|P1|Overall Study|Progressive Disease|1
5178397|NCT01251614|17879563|P3|Overall Study|Lost to Follow-up|0
5178398|NCT01251614|17879564|P2|Overall Study|Lost to Follow-up|1
5178399|NCT01251614|17879565|P1|Overall Study|Lost to Follow-up|0
5178400|NCT01251614|17879563|P3|Overall Study|Withdrawal by Subject|1
5178401|NCT01251614|17879564|P2|Overall Study|Withdrawal by Subject|2
5178402|NCT01251614|17879565|P1|Overall Study|Withdrawal by Subject|0
5178403|NCT01251614|17879563|P3|Overall Study|Loss of Disease Control|0
5178404|NCT01251614|17879564|P2|Overall Study|Loss of Disease Control|1
5178405|NCT01251614|17879565|P1|Overall Study|Loss of Disease Control|0
5178406|NCT01251614|17879563|P3|Overall Study|Pregnancy|2
5178407|NCT01251614|17879564|P2|Overall Study|Pregnancy|0
5178408|NCT01251614|17879565|P1|Overall Study|Pregnancy|0
5178409|NCT01251614|17879563|P3|Overall Study|Clearing of Psoriatic Lesions|0
5178410|NCT01251614|17879564|P2|Overall Study|Clearing of Psoriatic Lesions|0
5178411|NCT01251614|17879565|P1|Overall Study|Clearing of Psoriatic Lesions|1
5178412|NCT01251614|17879563|P3|Overall Study|Lack of Efficacy|4
5178413|NCT01251614|17879564|P2|Overall Study|Lack of Efficacy|9
5178414|NCT01251614|17879565|P1|Overall Study|Lack of Efficacy|1
5178415|NCT01251614|17879563|P3|Overall Study|Adverse Event|1
5178416|NCT01251614|17879564|P2|Overall Study|Adverse Event|0
5178417|NCT01251614|17879565|P1|Overall Study|Adverse Event|1
5178418|NCT01251380|17879763|P1|Overall Study|Lost to Follow-up|2
5178419|NCT01251380|17879763|P1|Overall Study|Adverse Event|1
5178420|NCT01251380|17879763|P1|Overall Study|Lack of Efficacy|1
5178421|NCT01251380|17879763|P1|Overall Study|Withdrawal by Subject|6
5178422|NCT01251380|17879763|P1|Overall Study|Other (Not otherwise specified)|12
5178423|NCT01251367|17879787|P1|Overall Study|End of Study Visit Performed in Error|1
5178424|NCT01251367|17879787|P1|Overall Study|Subject had Personal or Medical Issues|4
5178425|NCT01251367|17879787|P1|Overall Study|No Study Drug Available|1
5178426|NCT01251367|17879787|P1|Overall Study|Subject Required Alternative Treatment|7
5178427|NCT01251367|17879787|P1|Overall Study|Lost to Follow-up|5
5178428|NCT01251367|17879787|P1|Overall Study|Withdrawal by Subject|36
5178429|NCT01251367|17879787|P1|Overall Study|Adverse Event|19
5178430|NCT01251367|17879787|P1|Overall Study|Lack of Efficacy|2
5178431|NCT01251367|17879787|P1|Overall Study|Protocol Violation|1
5178432|NCT01251354|17879822|P1|Overall Study|Disease Progression|4
5178433|NCT01251354|17879822|P1|Overall Study|Investigator's Decision|1
5178434|NCT01251354|17879822|P1|Overall Study|Adverse Event|1
5178435|NCT01251276|17879865|P2|Overall Study|Lost to Follow-up|1
5178436|NCT01251276|17879866|P1|Overall Study|Lost to Follow-up|0
5178437|NCT01251276|17879865|P2|Overall Study|Protocol Violation|0
5178438|NCT01251276|17879866|P1|Overall Study|Protocol Violation|1
5178439|NCT01251146|17879884|P2|Overall Study|Lost to Follow-up|10
5178440|NCT01251146|17879885|P1|Overall Study|Lost to Follow-up|3
5178441|NCT01251120|17879907|P2|Overall Study|Lack of Efficacy|1
5178442|NCT01251120|17879908|P1|Overall Study|Lack of Efficacy|0
5178443|NCT01250925|17879988|P3|Overall Study|Adverse Event|1
5178444|NCT01250925|17879989|P2|Overall Study|Adverse Event|0
5178445|NCT01250925|17879990|P1|Overall Study|Adverse Event|0
5178446|NCT01250925|17879988|P3|Overall Study|Physician Decision|1
5178447|NCT01250925|17879989|P2|Overall Study|Physician Decision|2
5178448|NCT01250925|17879990|P1|Overall Study|Physician Decision|0
5178449|NCT01250925|17879988|P3|Overall Study|Protocol Violation|0
5178450|NCT01250925|17879989|P2|Overall Study|Protocol Violation|0
5178451|NCT01250925|17879990|P1|Overall Study|Protocol Violation|2
5178452|NCT01250925|17879988|P3|Overall Study|Withdrawal by Subject|0
5178453|NCT01250925|17879989|P2|Overall Study|Withdrawal by Subject|0
5178454|NCT01250925|17879990|P1|Overall Study|Withdrawal by Subject|2
5178455|NCT01250925|17879988|P3|Overall Study|Lost to Follow-up|0
5178456|NCT01250925|17879989|P2|Overall Study|Lost to Follow-up|1
5178457|NCT01250925|17879990|P1|Overall Study|Lost to Follow-up|1
5178458|NCT01250873|17880035|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
5178459|NCT01250873|17880035|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
5178460|NCT01250769|17880067|P4|Overall Study|Adverse Event|0
5178461|NCT01250769|17880068|P3|Overall Study|Adverse Event|1
5178462|NCT01250769|17880069|P2|Overall Study|Adverse Event|0
5178463|NCT01250769|17880070|P1|Overall Study|Adverse Event|0
5178464|NCT01250769|17880067|P4|Overall Study|Withdrawal by Subject|0
5178465|NCT01250769|17880068|P3|Overall Study|Withdrawal by Subject|1
5178466|NCT01250769|17880069|P2|Overall Study|Withdrawal by Subject|1
5178467|NCT01250769|17880070|P1|Overall Study|Withdrawal by Subject|0
5178468|NCT01250756|17880102|P2|After Toddler Dose|Adverse Event|1
5178469|NCT01250756|17880103|P1|After Toddler Dose|Adverse Event|0
5178470|NCT01250756|17880102|P2|Toddler Dose|Adverse Event|1
5178471|NCT01250756|17880103|P1|Toddler Dose|Adverse Event|0
5178472|NCT01250756|17880102|P2|After Infant Series|Other|1
5178473|NCT01250756|17880103|P1|After Infant Series|Other|2
5178474|NCT01250756|17880102|P2|After Infant Series|Withdrawal by Subject|1
5178475|NCT01250756|17880103|P1|After Infant Series|Withdrawal by Subject|4
5178476|NCT01250756|17880102|P2|After Infant Series|Adverse Event|2
5178477|NCT01250756|17880103|P1|After Infant Series|Adverse Event|5
5178478|NCT01250756|17880102|P2|Infant Series|Other|0
5178479|NCT01250756|17880103|P1|Infant Series|Other|22
5178480|NCT01250756|17880102|P2|Infant Series|Randomized, Not Vaccinated|2
5178481|NCT01250756|17880103|P1|Infant Series|Randomized, Not Vaccinated|2
5178482|NCT01250756|17880102|P2|Infant Series|Withdrawal by Subject|5
5178483|NCT01250756|17880103|P1|Infant Series|Withdrawal by Subject|4
5178484|NCT01250509|17880220|P2|Overall Study|Lost to Follow-up|2
5178485|NCT01250509|17880221|P1|Overall Study|Lost to Follow-up|5
5178486|NCT01250418|17880235|P2|Overall Study|monitor data failure|1
5178487|NCT01250418|17880236|P1|Overall Study|monitor data failure|1
5178488|NCT01250379|17880244|P2|Overall Study|Participant noncompliance|0
5178489|NCT01250379|17880245|P1|Overall Study|Participant noncompliance|2
5178490|NCT01250379|17880244|P2|Overall Study|Other|4
5178491|NCT01250379|17880245|P1|Overall Study|Other|0
5178492|NCT01250379|17880244|P2|Overall Study|Adverse Event|4
5178493|NCT01250379|17880245|P1|Overall Study|Adverse Event|5
5178494|NCT01250379|17880244|P2|Overall Study|Lost to Follow-up|6
5178495|NCT01250379|17880245|P1|Overall Study|Lost to Follow-up|9
5178496|NCT01250379|17880244|P2|Overall Study|Protocol Violation|8
5178497|NCT01250379|17880245|P1|Overall Study|Protocol Violation|2
5178498|NCT01250379|17880244|P2|Overall Study|Physician Decision|3
5178499|NCT01250379|17880245|P1|Overall Study|Physician Decision|11
5178500|NCT01250379|17880244|P2|Overall Study|Withdrawal by Subject|20
5178501|NCT01250379|17880245|P1|Overall Study|Withdrawal by Subject|32
5178502|NCT01250379|17880244|P2|Overall Study|Death|148
5178503|NCT01250379|17880245|P1|Overall Study|Death|141
5178504|NCT01250171|17880350|P3|Overall Study|Administrative reasons|0
5178505|NCT01250171|17880351|P2|Overall Study|Administrative reasons|0
5178506|NCT01250171|17880352|P1|Overall Study|Administrative reasons|1
5178507|NCT01250145|17880383|P2|Overall Study|Withdrawal by Subject|4
5178508|NCT01250145|17880384|P1|Overall Study|Withdrawal by Subject|0
5178509|NCT01250145|17880383|P2|Overall Study|Adverse Event|1
5178510|NCT01250145|17880384|P1|Overall Study|Adverse Event|2
5178511|NCT01250119|17880404|P2|Treatment Phase|Unknown reason|4
5178512|NCT01250119|17880405|P1|Treatment Phase|Unknown reason|0
5178513|NCT01250119|17880404|P2|Treatment Phase|Adverse Event|2
5178514|NCT01250119|17880405|P1|Treatment Phase|Adverse Event|0
5178515|NCT01250119|17880404|P2|Treatment Phase|Withdrawal by Subject|1
5178516|NCT01250119|17880405|P1|Treatment Phase|Withdrawal by Subject|0
5178517|NCT01250119|17880404|P2|Treatment Phase|Death|2
5178518|NCT01250119|17880405|P1|Treatment Phase|Death|0
5178519|NCT01250119|17880404|P2|Treatment Phase|Progressive Disease|32
5178520|NCT01250119|17880405|P1|Treatment Phase|Progressive Disease|0
5178521|NCT01250119|17880404|P2|Diagnostic Phase|Participants Not Tested|0
5178522|NCT01250119|17880405|P1|Diagnostic Phase|Participants Not Tested|44
5178523|NCT01250119|17880404|P2|Diagnostic Phase|Failed to Produce a Test Results|0
5178524|NCT01250119|17880405|P1|Diagnostic Phase|Failed to Produce a Test Results|69
5178525|NCT01250054|17880420|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
5178526|NCT01250054|17880421|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
5178527|NCT01250002|17880429|P2|Overall Study|Change to open surgical procedure|3
5178528|NCT01250002|17880430|P1|Overall Study|Change to open surgical procedure|4
5178529|NCT01249833|17880495|P2|Overall Study|Lost to Follow-up|1
5178530|NCT01249833|17880496|P1|Overall Study|Lost to Follow-up|0
5178531|NCT01249664|17880510|P2|Overall Study|Adverse Event|0
5178532|NCT01249664|17880511|P1|Overall Study|Adverse Event|1
5178533|NCT01249664|17880510|P2|Overall Study|Withdrawal by Subject|0
5178534|NCT01249664|17880511|P1|Overall Study|Withdrawal by Subject|5
5178535|NCT01249651|17880561|P1|Overall Study|Sponsor Decision|1
5178536|NCT01249651|17880561|P1|Overall Study|Protocol Violation|1
5178537|NCT01249651|17880561|P1|Overall Study|Adverse Event|1
5178538|NCT01249651|17880561|P1|Overall Study|Withdrawal by Subject|4
5178539|NCT01249417|17880590|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
5178540|NCT01249417|17880591|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
5178541|NCT01249417|17880592|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
5178542|NCT01249417|17880590|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
5178543|NCT01249417|17880591|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
5178544|NCT01249417|17880592|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
5178545|NCT01249417|17880590|P3|Treatment Phase - ITT Population|Adverse Event|1
5178546|NCT01249417|17880591|P2|Treatment Phase - ITT Population|Adverse Event|0
5178547|NCT01249417|17880592|P1|Treatment Phase - ITT Population|Adverse Event|0
5178548|NCT01249417|17880590|P3|Treatment Phase - ITT Population|Other|1
5178549|NCT01249417|17880591|P2|Treatment Phase - ITT Population|Other|0
5178550|NCT01249417|17880592|P1|Treatment Phase - ITT Population|Other|0
5178551|NCT01249417|17880590|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
5178552|NCT01249417|17880591|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
5178553|NCT01249417|17880592|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
5178554|NCT01249417|17880590|P3|Randomised Population|Study treatment not received|2
5178555|NCT01249417|17880591|P2|Randomised Population|Study treatment not received|0
5178556|NCT01249417|17880592|P1|Randomised Population|Study treatment not received|0
5178557|NCT01249404|17880609|P3|Overall Study|Non compliance to visit schedule|0
5178558|NCT01249404|17880610|P2|Overall Study|Non compliance to visit schedule|1
5178559|NCT01249404|17880611|P1|Overall Study|Non compliance to visit schedule|0
5178560|NCT01249404|17880609|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
5178561|NCT01249404|17880610|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
5178562|NCT01249404|17880611|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
5178563|NCT01249404|17880609|P3|Overall Study|Withdrawal by Subject|0
5178564|NCT01249404|17880610|P2|Overall Study|Withdrawal by Subject|2
5178565|NCT01249404|17880611|P1|Overall Study|Withdrawal by Subject|2
5178566|NCT01249404|17880609|P3|Overall Study|Adverse Event|2
5178567|NCT01249404|17880610|P2|Overall Study|Adverse Event|2
5178568|NCT01249404|17880611|P1|Overall Study|Adverse Event|2
5178569|NCT01249404|17880609|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
5178570|NCT01249404|17880610|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
5178571|NCT01249404|17880611|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
5178572|NCT01249404|17880609|P3|Overall Study|Study treatment not received|2
5178573|NCT01249404|17880610|P2|Overall Study|Study treatment not received|1
5178574|NCT01249404|17880611|P1|Overall Study|Study treatment not received|0
5178575|NCT01249365|17880688|P1|Overall Study|Lost to Follow-up|1
5178576|NCT01249274|17880696|P2|Overall Study|Received inpatient substance treatment|2
5178577|NCT01249274|17880697|P1|Overall Study|Received inpatient substance treatment|1
5178578|NCT01249274|17880696|P2|Overall Study|Lost to Follow-up|4
5178579|NCT01249274|17880697|P1|Overall Study|Lost to Follow-up|3
5178580|NCT01249261|17880723|P2|Overall Study|Withdrawal by Subject|0
5178581|NCT01249261|17880724|P1|Overall Study|Withdrawal by Subject|1
5178582|NCT01249157|17880752|P1|Overall Study|Withdrawal by Subject|1
5178583|NCT01249131|17880756|P6|Washout Period of 10 Days|Adverse Event|0
5178584|NCT01249131|17880757|P5|Washout Period of 10 Days|Adverse Event|1
5178585|NCT01249131|17880758|P4|Washout Period of 10 Days|Adverse Event|0
5178586|NCT01249131|17880759|P3|Washout Period of 10 Days|Adverse Event|0
5178587|NCT01249131|17880760|P2|Washout Period of 10 Days|Adverse Event|0
5178588|NCT01249131|17880761|P1|Washout Period of 10 Days|Adverse Event|0
5178589|NCT01249118|17880781|P3|First Washout Period|Physician Decision|0
5178590|NCT01249118|17880782|P2|First Washout Period|Physician Decision|1
5178591|NCT01249118|17880783|P1|First Washout Period|Physician Decision|0
5178592|NCT01249092|17880817|P1|Overall Study|Unable to tolerate expected SE -nausea|1
5178593|NCT01249092|17880817|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
5178594|NCT01248962|17880894|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
5178595|NCT01248962|17880895|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
5178596|NCT01248962|17880894|P2|Overall Study|Complete Response after 3 Cycles|1
5178597|NCT01248962|17880895|P1|Overall Study|Complete Response after 3 Cycles|0
5178598|NCT01248962|17880894|P2|Overall Study|Complete Response after 4 Cycles|0
5178599|NCT01248962|17880895|P1|Overall Study|Complete Response after 4 Cycles|1
5178600|NCT01248962|17880894|P2|Overall Study|Adverse Event|1
5178601|NCT01248962|17880895|P1|Overall Study|Adverse Event|2
5178602|NCT01248962|17880894|P2|Overall Study|Withdrawal by Subject|1
5178603|NCT01248962|17880895|P1|Overall Study|Withdrawal by Subject|1
5178604|NCT01248949|17880911|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5178605|NCT01248949|17880912|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5178606|NCT01248949|17880913|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
5178607|NCT01248949|17880914|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5178608|NCT01248949|17880915|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5178609|NCT01248949|17880911|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
5178610|NCT01248949|17880912|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
5178611|NCT01248949|17880913|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
5178612|NCT01248949|17880914|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
5178613|NCT01248949|17880915|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
5178614|NCT01248949|17880911|P5|Overall Study|Pi Decision Due To Declining Status|0
5178615|NCT01248949|17880912|P4|Overall Study|Pi Decision Due To Declining Status|0
5178616|NCT01248949|17880913|P3|Overall Study|Pi Decision Due To Declining Status|1
5178617|NCT01248949|17880914|P2|Overall Study|Pi Decision Due To Declining Status|0
5178618|NCT01248949|17880915|P1|Overall Study|Pi Decision Due To Declining Status|0
5178619|NCT01248949|17880911|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
5178620|NCT01248949|17880912|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
5178621|NCT01248949|17880913|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
5178622|NCT01248949|17880914|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
5178623|NCT01248949|17880915|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
5178624|NCT01248949|17880911|P5|Overall Study|Participant Went To Hospice|0
5178625|NCT01248949|17880912|P4|Overall Study|Participant Went To Hospice|0
5178626|NCT01248949|17880913|P3|Overall Study|Participant Went To Hospice|1
5178627|NCT01248949|17880914|P2|Overall Study|Participant Went To Hospice|0
5178628|NCT01248949|17880915|P1|Overall Study|Participant Went To Hospice|0
5178629|NCT01248949|17880911|P5|Overall Study|Entered Hospice And Refused Follow Up|1
5178630|NCT01248949|17880912|P4|Overall Study|Entered Hospice And Refused Follow Up|0
5178631|NCT01248949|17880913|P3|Overall Study|Entered Hospice And Refused Follow Up|0
5178632|NCT01248949|17880914|P2|Overall Study|Entered Hospice And Refused Follow Up|0
5178633|NCT01248949|17880915|P1|Overall Study|Entered Hospice And Refused Follow Up|0
5178634|NCT01248949|17880911|P5|Overall Study|Palliative Radiation To Brain Metastases|0
5178725|NCT01248130|17881316|P2|Overall Study|Ineligible|0
5178635|NCT01248949|17880912|P4|Overall Study|Palliative Radiation To Brain Metastases|0
5178636|NCT01248949|17880913|P3|Overall Study|Palliative Radiation To Brain Metastases|0
5178637|NCT01248949|17880914|P2|Overall Study|Palliative Radiation To Brain Metastases|0
5178638|NCT01248949|17880915|P1|Overall Study|Palliative Radiation To Brain Metastases|1
5178639|NCT01248949|17880911|P5|Overall Study|Alternative Therapy.|0
5178640|NCT01248949|17880912|P4|Overall Study|Alternative Therapy.|0
5178641|NCT01248949|17880913|P3|Overall Study|Alternative Therapy.|0
5178642|NCT01248949|17880914|P2|Overall Study|Alternative Therapy.|0
5178643|NCT01248949|17880915|P1|Overall Study|Alternative Therapy.|1
5178644|NCT01248949|17880911|P5|Overall Study|Alternative Therapy|0
5178645|NCT01248949|17880912|P4|Overall Study|Alternative Therapy|0
5178646|NCT01248949|17880913|P3|Overall Study|Alternative Therapy|0
5178647|NCT01248949|17880914|P2|Overall Study|Alternative Therapy|0
5178648|NCT01248949|17880915|P1|Overall Study|Alternative Therapy|1
5178649|NCT01248949|17880911|P5|Overall Study|Death|2
5178650|NCT01248949|17880912|P4|Overall Study|Death|6
5178651|NCT01248949|17880913|P3|Overall Study|Death|21
5178652|NCT01248949|17880914|P2|Overall Study|Death|7
5178653|NCT01248949|17880915|P1|Overall Study|Death|22
5178654|NCT01248949|17880911|P5|Overall Study|Withdrawal by Subject|1
5178655|NCT01248949|17880912|P4|Overall Study|Withdrawal by Subject|3
5178656|NCT01248949|17880913|P3|Overall Study|Withdrawal by Subject|11
5178657|NCT01248949|17880914|P2|Overall Study|Withdrawal by Subject|3
5178658|NCT01248949|17880915|P1|Overall Study|Withdrawal by Subject|5
5178659|NCT01248949|17880911|P5|Overall Study|Lost to Follow-up|0
5178660|NCT01248949|17880912|P4|Overall Study|Lost to Follow-up|1
5178661|NCT01248949|17880913|P3|Overall Study|Lost to Follow-up|2
5178662|NCT01248949|17880914|P2|Overall Study|Lost to Follow-up|2
5178663|NCT01248949|17880915|P1|Overall Study|Lost to Follow-up|2
5178664|NCT01248936|17881027|P1|Overall Study|Other reason|3
5178665|NCT01248936|17881027|P1|Overall Study|Refused Treatment|1
5178666|NCT01248936|17881027|P1|Overall Study|Lost to Follow-up|7
5178667|NCT01248936|17881027|P1|Overall Study|Adverse Event|8
5178668|NCT01248936|17881027|P1|Overall Study|Withdrawal of Consent|20
5178669|NCT01248936|17881027|P1|Overall Study|Death|26
5178670|NCT01248936|17881027|P1|Overall Study|Progression of Disease|50
5178671|NCT01248936|17881027|P1|Overall Study|Sponsor Decision|259
5178672|NCT01248884|17881040|P3|Overall Study|Adverse Event|0
5178673|NCT01248884|17881041|P2|Overall Study|Adverse Event|0
5178674|NCT01248884|17881042|P1|Overall Study|Adverse Event|1
5178675|NCT01248884|17881040|P3|Overall Study|Withdrawal by Subject|1
5178676|NCT01248884|17881041|P2|Overall Study|Withdrawal by Subject|3
5178677|NCT01248884|17881042|P1|Overall Study|Withdrawal by Subject|1
5178678|NCT01248793|17881100|P2|Overall Study|Withdrawal by Subject|3
5178679|NCT01248793|17881101|P1|Overall Study|Withdrawal by Subject|3
5178680|NCT01248793|17881100|P2|Overall Study|Protocol Violation|1
5178681|NCT01248793|17881101|P1|Overall Study|Protocol Violation|0
5178682|NCT01248793|17881100|P2|Overall Study|Adverse Event|1
5178683|NCT01248793|17881101|P1|Overall Study|Adverse Event|1
5178684|NCT01248793|17881100|P2|Overall Study|Lost to Follow-up|1
5178685|NCT01248793|17881101|P1|Overall Study|Lost to Follow-up|0
5178686|NCT01248780|17881115|P2|Overall Study|Not treated|1
5178687|NCT01248780|17881116|P1|Overall Study|Not treated|0
5178688|NCT01248780|17881115|P2|Overall Study|Withdrawal by Subject|4
5178689|NCT01248780|17881116|P1|Overall Study|Withdrawal by Subject|4
5178690|NCT01248780|17881115|P2|Overall Study|Protocol Violation|1
5178691|NCT01248780|17881116|P1|Overall Study|Protocol Violation|1
5178692|NCT01248780|17881115|P2|Overall Study|Adverse Event|7
5178693|NCT01248780|17881116|P1|Overall Study|Adverse Event|2
5178694|NCT01248780|17881115|P2|Overall Study|Death|1
5178695|NCT01248780|17881116|P1|Overall Study|Death|0
5178696|NCT01248780|17881115|P2|Overall Study|Lost to Follow-up|1
5178697|NCT01248780|17881116|P1|Overall Study|Lost to Follow-up|0
5178698|NCT01248780|17881115|P2|Overall Study|Lack of Efficacy|0
5178699|NCT01248780|17881116|P1|Overall Study|Lack of Efficacy|2
5178700|NCT01248728|17881130|P2|Overall Study|Lack of Efficacy|0
5178701|NCT01248728|17881131|P1|Overall Study|Lack of Efficacy|1
5178702|NCT01248728|17881130|P2|Overall Study|Withdrawal by Subject|1
5178703|NCT01248728|17881131|P1|Overall Study|Withdrawal by Subject|2
5178704|NCT01248728|17881130|P2|Overall Study|Adverse Event|1
5178705|NCT01248728|17881131|P1|Overall Study|Adverse Event|1
5178706|NCT01248715|17881147|P2|Overall Study|Not influenza positive|510
5178707|NCT01248715|17881148|P1|Overall Study|Not influenza positive|501
5178708|NCT01248468|17881186|P3|Overall Study|Withdrawal by Subject|0
5178709|NCT01248468|17881187|P2|Overall Study|Withdrawal by Subject|2
5178710|NCT01248468|17881188|P1|Overall Study|Withdrawal by Subject|4
5178711|NCT01248468|17881186|P3|Overall Study|Pregnancy|0
5178712|NCT01248468|17881187|P2|Overall Study|Pregnancy|0
5178713|NCT01248468|17881188|P1|Overall Study|Pregnancy|1
5178714|NCT01248468|17881186|P3|Overall Study|Lost to Follow-up|4
5178715|NCT01248468|17881187|P2|Overall Study|Lost to Follow-up|12
5178716|NCT01248468|17881188|P1|Overall Study|Lost to Follow-up|9
5178717|NCT01248468|17881186|P3|Overall Study|Administrative problem|0
5178718|NCT01248468|17881187|P2|Overall Study|Administrative problem|0
5178719|NCT01248468|17881188|P1|Overall Study|Administrative problem|1
5178720|NCT01248455|17881205|P1|Overall Study|switched to alternate treatment|1
5178721|NCT01248364|17881250|P4|Overall Study|Adverse Event|0
5178722|NCT01248364|17881251|P3|Overall Study|Adverse Event|0
5178723|NCT01248364|17881252|P2|Overall Study|Adverse Event|1
5178724|NCT01248364|17881253|P1|Overall Study|Adverse Event|0
5178726|NCT01248130|17881317|P1|Overall Study|Ineligible|1
5178727|NCT01248130|17881316|P2|Overall Study|Protocol Violation|0
5178728|NCT01248130|17881317|P1|Overall Study|Protocol Violation|1
5178729|NCT01248065|17881336|P2|Overall Study|Other|5
5178730|NCT01248065|17881337|P1|Overall Study|Other|3
5178731|NCT01248065|17881336|P2|Overall Study|Third treatment failure event|1
5178732|NCT01248065|17881337|P1|Overall Study|Third treatment failure event|3
5178733|NCT01248065|17881336|P2|Overall Study|Adverse Event|0
5178734|NCT01248065|17881337|P1|Overall Study|Adverse Event|3
5178735|NCT01248065|17881336|P2|Overall Study|Withdrawal by Subject|11
5178736|NCT01248065|17881337|P1|Overall Study|Withdrawal by Subject|14
5178737|NCT01248065|17881336|P2|Overall Study|Lost to Follow-up|5
5178738|NCT01248065|17881337|P1|Overall Study|Lost to Follow-up|3
5178739|NCT01248013|17881347|P1|Overall Study|Withdrawal by Subject|14
5178740|NCT01247922|17881362|P1|Overall Study|Disease progression|4
5178741|NCT01247350|17881460|P5|Overall Study|Entry criteria not met|1
5178742|NCT01247350|17881461|P4|Overall Study|Entry criteria not met|0
5178743|NCT01247350|17881462|P3|Overall Study|Entry criteria not met|0
5178744|NCT01247350|17881463|P2|Overall Study|Entry criteria not met|0
5178745|NCT01247350|17881464|P1|Overall Study|Entry criteria not met|0
5178746|NCT01247350|17881460|P5|Overall Study|Withdrawal by Subject|0
5178747|NCT01247350|17881461|P4|Overall Study|Withdrawal by Subject|1
5178748|NCT01247350|17881462|P3|Overall Study|Withdrawal by Subject|0
5178749|NCT01247350|17881463|P2|Overall Study|Withdrawal by Subject|0
5178750|NCT01247350|17881464|P1|Overall Study|Withdrawal by Subject|0
5178751|NCT01247350|17881460|P5|Overall Study|Adverse Event|0
5178752|NCT01247350|17881461|P4|Overall Study|Adverse Event|0
5178753|NCT01247350|17881462|P3|Overall Study|Adverse Event|1
5178754|NCT01247350|17881463|P2|Overall Study|Adverse Event|0
5178755|NCT01247350|17881464|P1|Overall Study|Adverse Event|0
5178756|NCT01247324|17881522|P2|Overall Study|Lost to Follow-up|1
5178757|NCT01247324|17881523|P1|Overall Study|Lost to Follow-up|1
5178758|NCT01247324|17881522|P2|Overall Study|Adverse Event|13
5178759|NCT01247324|17881523|P1|Overall Study|Adverse Event|25
5178760|NCT01247324|17881522|P2|Overall Study|Consent withdrawn by participant|8
5178761|NCT01247324|17881523|P1|Overall Study|Consent withdrawn by participant|13
5178762|NCT01247324|17881522|P2|Overall Study|Reason not specified|8
5178763|NCT01247324|17881523|P1|Overall Study|Reason not specified|11
5178764|NCT01247324|17881522|P2|Overall Study|Protocol Violation|2
5178765|NCT01247324|17881523|P1|Overall Study|Protocol Violation|1
5178766|NCT01247324|17881522|P2|Overall Study|Pregnancy|3
5178767|NCT01247324|17881523|P1|Overall Study|Pregnancy|2
5178768|NCT01247324|17881522|P2|Overall Study|Non-compliance|0
5178769|NCT01247324|17881523|P1|Overall Study|Non-compliance|2
5178770|NCT01247324|17881522|P2|Overall Study|Lack of Efficacy|8
5178771|NCT01247324|17881523|P1|Overall Study|Lack of Efficacy|12
5178772|NCT01247324|17881522|P2|Overall Study|Non-compliance with study drug|0
5178773|NCT01247324|17881523|P1|Overall Study|Non-compliance with study drug|3
5178774|NCT01247324|17881522|P2|Overall Study|Physician Decision|1
5178775|NCT01247324|17881523|P1|Overall Study|Physician Decision|0
5178776|NCT01247324|17881522|P2|Overall Study|Death|0
5178777|NCT01247324|17881523|P1|Overall Study|Death|1
5178778|NCT01247090|17881616|P3|Overall Study|Withdrawal by Subject|0
5178779|NCT01247090|17881617|P2|Overall Study|Withdrawal by Subject|1
5178780|NCT01247090|17881618|P1|Overall Study|Withdrawal by Subject|0
5178781|NCT01247090|17881616|P3|Overall Study|Physician Decision|0
5178782|NCT01247090|17881617|P2|Overall Study|Physician Decision|0
5178783|NCT01247090|17881618|P1|Overall Study|Physician Decision|1
5178784|NCT01246999|17881647|P4|Overall Study|Withdrawal by Subject|2
5178785|NCT01246999|17881648|P3|Overall Study|Withdrawal by Subject|0
5178786|NCT01246999|17881649|P2|Overall Study|Withdrawal by Subject|0
5178787|NCT01246999|17881650|P1|Overall Study|Withdrawal by Subject|0
5178788|NCT01246999|17881647|P4|Overall Study|Lost to Follow-up|0
5178789|NCT01246999|17881648|P3|Overall Study|Lost to Follow-up|0
5178790|NCT01246999|17881649|P2|Overall Study|Lost to Follow-up|1
5178791|NCT01246999|17881650|P1|Overall Study|Lost to Follow-up|0
5178792|NCT01246986|17881690|P7|Overall Study|Withdrawal by Subject|0
5178793|NCT01246986|17881691|P6|Overall Study|Withdrawal by Subject|0
5178794|NCT01246986|17881692|P5|Overall Study|Withdrawal by Subject|4
5178795|NCT01246986|17881693|P4|Overall Study|Withdrawal by Subject|0
5178796|NCT01246986|17881694|P3|Overall Study|Withdrawal by Subject|3
5178797|NCT01246986|17881695|P2|Overall Study|Withdrawal by Subject|4
5178798|NCT01246986|17881696|P1|Overall Study|Withdrawal by Subject|3
5178799|NCT01246986|17881690|P7|Overall Study|On Treatment|0
5178800|NCT01246986|17881691|P6|Overall Study|On Treatment|0
5178801|NCT01246986|17881692|P5|Overall Study|On Treatment|1
5178802|NCT01246986|17881693|P4|Overall Study|On Treatment|0
5178803|NCT01246986|17881694|P3|Overall Study|On Treatment|0
5178804|NCT01246986|17881695|P2|Overall Study|On Treatment|0
5178805|NCT01246986|17881696|P1|Overall Study|On Treatment|0
5178806|NCT01246986|17881690|P7|Overall Study|Lost to Follow-up|0
5178807|NCT01246986|17881691|P6|Overall Study|Lost to Follow-up|1
5178808|NCT01246986|17881692|P5|Overall Study|Lost to Follow-up|0
5178809|NCT01246986|17881693|P4|Overall Study|Lost to Follow-up|0
5178810|NCT01246986|17881694|P3|Overall Study|Lost to Follow-up|3
5178811|NCT01246986|17881695|P2|Overall Study|Lost to Follow-up|1
5178812|NCT01246986|17881696|P1|Overall Study|Lost to Follow-up|0
5178813|NCT01246973|17881756|P2|Overall Study|Withdrawal by Subject|13
5178814|NCT01246973|17881757|P1|Overall Study|Withdrawal by Subject|7
5178815|NCT01246973|17881756|P2|Overall Study|Adverse Event|9
5178816|NCT01246973|17881757|P1|Overall Study|Adverse Event|16
5178817|NCT01246973|17881756|P2|Overall Study|Other|25
5178818|NCT01246973|17881757|P1|Overall Study|Other|38
5178819|NCT01246960|17881767|P2|Overall Study|Withdrawal (by participant or physician)|3
5178820|NCT01246960|17881768|P1|Overall Study|Withdrawal (by participant or physician)|3
5178821|NCT01246960|17881767|P2|Overall Study|Lost to Follow-up|1
5178822|NCT01246960|17881768|P1|Overall Study|Lost to Follow-up|3
5178823|NCT01246206|17881880|P1|Overall Study|Patient did not receive study regiments.|1
5178824|NCT01246011|17881958|P3|Overall Study|Withdrawal by Subject|1
5178825|NCT01246011|17881959|P2|Overall Study|Withdrawal by Subject|0
5178826|NCT01246011|17881960|P1|Overall Study|Withdrawal by Subject|0
5178827|NCT01246011|17881958|P3|Overall Study|If needed warfarin clinically, withdrawn|3
5178828|NCT01246011|17881959|P2|Overall Study|If needed warfarin clinically, withdrawn|0
5178829|NCT01246011|17881960|P1|Overall Study|If needed warfarin clinically, withdrawn|0
5178830|NCT01245764|17881988|P4|Study Phase A|Lost to Follow-up|0
5178831|NCT01245764|17881989|P3|Study Phase A|Lost to Follow-up|5
5178832|NCT01245764|17881990|P2|Study Phase A|Lost to Follow-up|0
5178833|NCT01245764|17881991|P1|Study Phase A|Lost to Follow-up|0
5178834|NCT01245764|17881988|P4|Study Phase A|Protocol Violation|2
5178835|NCT01245764|17881989|P3|Study Phase A|Protocol Violation|2
5178836|NCT01245764|17881990|P2|Study Phase A|Protocol Violation|3
5178837|NCT01245764|17881991|P1|Study Phase A|Protocol Violation|6
5178838|NCT01245764|17881988|P4|Study Phase A|Other|1
5178839|NCT01245764|17881989|P3|Study Phase A|Other|3
5178840|NCT01245764|17881990|P2|Study Phase A|Other|2
5178841|NCT01245764|17881991|P1|Study Phase A|Other|3
5178842|NCT01245751|17882029|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5178843|NCT01245751|17882030|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5178844|NCT01245751|17882031|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
5178845|NCT01245751|17882032|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5178846|NCT01245751|17882029|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
5178847|NCT01245751|17882030|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5178848|NCT01245751|17882031|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5178849|NCT01245751|17882032|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5178850|NCT01245751|17882029|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
5178851|NCT01245751|17882030|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
5178852|NCT01245751|17882031|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
5178853|NCT01245751|17882032|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
5178854|NCT01245673|17882081|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
5178855|NCT01245387|17882149|P1|Overall Study|Missing discontinuation status|369
5178856|NCT01245387|17882149|P1|Overall Study|Other|131
5178857|NCT01245387|17882149|P1|Overall Study|Death|3
5178858|NCT01245387|17882149|P1|Overall Study|Adverse Event|9
5178859|NCT01245387|17882149|P1|Overall Study|Lack of Efficacy|195
5178860|NCT01245387|17882149|P1|Overall Study|Lost to Follow-up|106
5178861|NCT01245374|17882198|P1|Overall Study|Withdrawal by Subject|3
5178862|NCT01245374|17882198|P1|Overall Study|Protocol Violation|1
5178863|NCT01245283|17882221|P3|Overall Study|Lost to Follow-up|11
5178864|NCT01245283|17882222|P2|Overall Study|Lost to Follow-up|11
5178865|NCT01245283|17882223|P1|Overall Study|Lost to Follow-up|14
5178866|NCT01245140|17882268|P2|Overall Study|Refused Treatment/Did Not Coopera|1
5178867|NCT01245140|17882269|P1|Overall Study|Refused Treatment/Did Not Coopera|0
5178868|NCT01245140|17882268|P2|Overall Study|Withdrawal by Subject|1
5178869|NCT01245140|17882269|P1|Overall Study|Withdrawal by Subject|0
5178870|NCT01245140|17882268|P2|Overall Study|Protocol Violation|1
5178871|NCT01245140|17882269|P1|Overall Study|Protocol Violation|0
5178872|NCT01245140|17882268|P2|Overall Study|Lack of Efficacy|4
5178873|NCT01245140|17882269|P1|Overall Study|Lack of Efficacy|2
5178874|NCT01245140|17882268|P2|Overall Study|Adverse Event|3
5178875|NCT01245140|17882269|P1|Overall Study|Adverse Event|1
5178876|NCT01245101|17882325|P2|Period 3 (Treatment)|Withdrawal by Subject|0
5178877|NCT01245101|17882326|P1|Period 3 (Treatment)|Withdrawal by Subject|1
5178878|NCT01245101|17882325|P2|Period 2 (Washout)|Withdrawal by Subject|0
5178879|NCT01245101|17882326|P1|Period 2 (Washout)|Withdrawal by Subject|1
5178880|NCT01245101|17882325|P2|Period 1 (Treatment)|Withdrawal by Subject|0
5178881|NCT01245101|17882326|P1|Period 1 (Treatment)|Withdrawal by Subject|2
5178882|NCT01245062|17882336|P3|Cross-over Phase|Study closed/ terminated|11
5178883|NCT01245062|17882337|P2|Cross-over Phase|Study closed/ terminated|0
5178884|NCT01245062|17882338|P1|Cross-over Phase|Study closed/ terminated|0
5178885|NCT01245062|17882336|P3|Cross-over Phase|Withdrew Consent|4
5178886|NCT01245062|17882337|P2|Cross-over Phase|Withdrew Consent|0
5178887|NCT01245062|17882338|P1|Cross-over Phase|Withdrew Consent|0
5178888|NCT01245062|17882336|P3|Cross-over Phase|Physician Decision|1
5178889|NCT01245062|17882337|P2|Cross-over Phase|Physician Decision|0
5178890|NCT01245062|17882338|P1|Cross-over Phase|Physician Decision|0
5178891|NCT01245062|17882336|P3|Cross-over Phase|Lost to Follow-up|1
5178892|NCT01245062|17882337|P2|Cross-over Phase|Lost to Follow-up|0
5178893|NCT01245062|17882338|P1|Cross-over Phase|Lost to Follow-up|0
5178894|NCT01245062|17882336|P3|Randomization and Crossover Phase|Study closed/ terminated|0
5178895|NCT01245062|17882337|P2|Randomization and Crossover Phase|Study closed/ terminated|14
5178896|NCT01245062|17882338|P1|Randomization and Crossover Phase|Study closed/ terminated|23
5178897|NCT01245062|17882336|P3|Randomization and Crossover Phase|Withdrew Consent|0
5178898|NCT01245062|17882337|P2|Randomization and Crossover Phase|Withdrew Consent|11
5179070|NCT01244035|17882884|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
5178899|NCT01245062|17882338|P1|Randomization and Crossover Phase|Withdrew Consent|12
5178900|NCT01245062|17882336|P3|Randomization and Crossover Phase|Physician Decision|0
5178901|NCT01245062|17882337|P2|Randomization and Crossover Phase|Physician Decision|4
5178902|NCT01245062|17882338|P1|Randomization and Crossover Phase|Physician Decision|2
5178903|NCT01245062|17882336|P3|Randomization and Crossover Phase|Lost to Follow-up|0
5178904|NCT01245062|17882337|P2|Randomization and Crossover Phase|Lost to Follow-up|2
5178905|NCT01245062|17882338|P1|Randomization and Crossover Phase|Lost to Follow-up|4
5178906|NCT01245049|17882376|P2|Overall Study|Lost to Follow-up|2
5178907|NCT01245049|17882377|P1|Overall Study|Lost to Follow-up|1
5178908|NCT01245049|17882376|P2|Overall Study|Withdrawal by Subject|1
5178909|NCT01245049|17882377|P1|Overall Study|Withdrawal by Subject|0
5178910|NCT01245049|17882376|P2|Overall Study|Migrated/moved from study area|1
5178911|NCT01245049|17882377|P1|Overall Study|Migrated/moved from study area|0
5178912|NCT01244984|17882430|P3|Overall Study|Withdrawal by Subject|2
5178913|NCT01244984|17882431|P2|Overall Study|Withdrawal by Subject|2
5178914|NCT01244984|17882432|P1|Overall Study|Withdrawal by Subject|1
5178915|NCT01244984|17882430|P3|Overall Study|Protocol Defined Stopping Criteria|0
5178916|NCT01244984|17882431|P2|Overall Study|Protocol Defined Stopping Criteria|1
5178917|NCT01244984|17882432|P1|Overall Study|Protocol Defined Stopping Criteria|1
5178918|NCT01244984|17882430|P3|Overall Study|Protocol Violation|0
5178919|NCT01244984|17882431|P2|Overall Study|Protocol Violation|0
5178920|NCT01244984|17882432|P1|Overall Study|Protocol Violation|1
5178921|NCT01244984|17882430|P3|Overall Study|Adverse Event|2
5178922|NCT01244984|17882431|P2|Overall Study|Adverse Event|11
5178923|NCT01244984|17882432|P1|Overall Study|Adverse Event|2
5178924|NCT01244906|17882506|P1|Overall Study|Progression of disease post treatment|6
5178925|NCT01244906|17882506|P1|Overall Study|Death|2
5178926|NCT01244893|17882515|P2|1-Week Follow Up|Lost to Follow-up|0
5178927|NCT01244893|17882516|P1|1-Week Follow Up|Lost to Follow-up|1
5178928|NCT01244893|17882515|P2|Baseline|Protocol Violation|1
5178929|NCT01244893|17882516|P1|Baseline|Protocol Violation|0
5178930|NCT01244828|17882528|P1|Overall Study|Other reason (not specified)|1
5178931|NCT01244828|17882528|P1|Overall Study|Lost to Follow-up|2
5178932|NCT01244828|17882528|P1|Overall Study|Lack of Efficacy|7
5178933|NCT01244828|17882528|P1|Overall Study|Withdrawal by Subject|31
5178934|NCT01244828|17882528|P1|Overall Study|Adverse Event|37
5178935|NCT01244815|17882544|P4|Overall Study|Did Not Meet Protocol Eligibility|0
5178936|NCT01244815|17882545|P3|Overall Study|Did Not Meet Protocol Eligibility|0
5178937|NCT01244815|17882546|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5178938|NCT01244815|17882547|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5178939|NCT01244815|17882544|P4|Overall Study|Protocol Violation|1
5178940|NCT01244815|17882545|P3|Overall Study|Protocol Violation|3
5178941|NCT01244815|17882546|P2|Overall Study|Protocol Violation|4
5178942|NCT01244815|17882547|P1|Overall Study|Protocol Violation|7
5178943|NCT01244815|17882544|P4|Overall Study|Withdrawal by Subject|3
5178944|NCT01244815|17882545|P3|Overall Study|Withdrawal by Subject|0
5178945|NCT01244815|17882546|P2|Overall Study|Withdrawal by Subject|2
5178946|NCT01244815|17882547|P1|Overall Study|Withdrawal by Subject|0
5178947|NCT01244815|17882544|P4|Overall Study|Lost to Follow-up|2
5178948|NCT01244815|17882545|P3|Overall Study|Lost to Follow-up|3
5178949|NCT01244815|17882546|P2|Overall Study|Lost to Follow-up|2
5178950|NCT01244815|17882547|P1|Overall Study|Lost to Follow-up|3
5178951|NCT01244815|17882544|P4|Overall Study|Treatment Failure|1
5178952|NCT01244815|17882545|P3|Overall Study|Treatment Failure|0
5178953|NCT01244815|17882546|P2|Overall Study|Treatment Failure|0
5178954|NCT01244815|17882547|P1|Overall Study|Treatment Failure|0
5178955|NCT01244815|17882544|P4|Overall Study|Adverse Event|5
5178956|NCT01244815|17882545|P3|Overall Study|Adverse Event|5
5178957|NCT01244815|17882546|P2|Overall Study|Adverse Event|7
5178958|NCT01244815|17882547|P1|Overall Study|Adverse Event|4
5178959|NCT01244815|17882544|P4|Overall Study|Not Treated|0
5178960|NCT01244815|17882545|P3|Overall Study|Not Treated|0
5178961|NCT01244815|17882546|P2|Overall Study|Not Treated|1
5178962|NCT01244815|17882547|P1|Overall Study|Not Treated|0
5178963|NCT01244620|17882634|P4|Overall Study|Study terminated|4
5178964|NCT01244620|17882635|P3|Overall Study|Study terminated|4
5178965|NCT01244620|17882636|P2|Overall Study|Study terminated|4
5178966|NCT01244620|17882637|P1|Overall Study|Study terminated|4
5178967|NCT01244516|17882696|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
5178968|NCT01244516|17882697|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
5178969|NCT01244516|17882698|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
5178970|NCT01244516|17882696|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
5178971|NCT01244516|17882697|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
5178972|NCT01244516|17882698|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
5178973|NCT01244516|17882696|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
5178974|NCT01244516|17882697|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
5178975|NCT01244516|17882698|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
5178976|NCT01244516|17882696|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
5178977|NCT01244516|17882697|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
5178978|NCT01244516|17882698|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
5178979|NCT01244516|17882696|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
5178980|NCT01244516|17882697|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
5178981|NCT01244516|17882698|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
5178982|NCT01244516|17882696|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
5178983|NCT01244516|17882697|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
5178984|NCT01244516|17882698|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
5178985|NCT01244516|17882696|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
5178986|NCT01244516|17882697|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
5178987|NCT01244516|17882698|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
5178988|NCT01244490|17882719|P3|Overall Study|Other|1
5178989|NCT01244490|17882720|P2|Overall Study|Other|0
5178990|NCT01244490|17882721|P1|Overall Study|Other|0
5178991|NCT01244490|17882719|P3|Overall Study|Lost to Follow-up|3
5178992|NCT01244490|17882720|P2|Overall Study|Lost to Follow-up|6
5178993|NCT01244490|17882721|P1|Overall Study|Lost to Follow-up|0
5178994|NCT01244490|17882719|P3|Overall Study|Adverse Event|5
5178995|NCT01244490|17882720|P2|Overall Study|Adverse Event|9
5178996|NCT01244490|17882721|P1|Overall Study|Adverse Event|1
5178997|NCT01244490|17882719|P3|Overall Study|Withdrawal by Subject|9
5178998|NCT01244490|17882720|P2|Overall Study|Withdrawal by Subject|4
5178999|NCT01244490|17882721|P1|Overall Study|Withdrawal by Subject|4
5179000|NCT01244490|17882719|P3|Overall Study|Lack of Efficacy|5
5179001|NCT01244490|17882720|P2|Overall Study|Lack of Efficacy|5
5179002|NCT01244490|17882721|P1|Overall Study|Lack of Efficacy|14
5179003|NCT01244425|17882798|P2|Overall Study|Adverse Event|1
5179004|NCT01244425|17882799|P1|Overall Study|Adverse Event|1
5179005|NCT01244425|17882798|P2|Overall Study|Withdrawal by Subject|2
5179006|NCT01244425|17882799|P1|Overall Study|Withdrawal by Subject|2
5179007|NCT01244191|17882830|P2|Overall Study|'Missing' or 'Terminated by sponsor'|8
5179008|NCT01244191|17882831|P1|Overall Study|'Missing' or 'Terminated by sponsor'|12
5179009|NCT01244191|17882830|P2|Overall Study|Withdrawal by Subject|23
5179010|NCT01244191|17882831|P1|Overall Study|Withdrawal by Subject|31
5179011|NCT01244191|17882830|P2|Overall Study|Protocol Violation|2
5179012|NCT01244191|17882831|P1|Overall Study|Protocol Violation|1
5179013|NCT01244191|17882830|P2|Overall Study|Lost to Follow-up|2
5179014|NCT01244191|17882831|P1|Overall Study|Lost to Follow-up|0
5179015|NCT01244191|17882830|P2|Overall Study|Death|29
5179016|NCT01244191|17882831|P1|Overall Study|Death|22
5179017|NCT01244191|17882830|P2|Overall Study|Adverse Event|48
5179018|NCT01244191|17882831|P1|Overall Study|Adverse Event|65
5179019|NCT01244191|17882830|P2|Overall Study|Clinical disease progression|36
5179020|NCT01244191|17882831|P1|Overall Study|Clinical disease progression|54
5179021|NCT01244191|17882830|P2|Overall Study|Progressive disease|350
5179022|NCT01244191|17882831|P1|Overall Study|Progressive disease|295
5179023|NCT01244126|17882854|P3|Overall Study|Protocol Violation|9
5179024|NCT01244126|17882855|P2|Overall Study|Protocol Violation|3
5179025|NCT01244126|17882856|P1|Overall Study|Protocol Violation|3
5179026|NCT01244061|17882869|P2|Overall Study|Randomized but not treated|2
5179027|NCT01244061|17882870|P1|Overall Study|Randomized but not treated|2
5179028|NCT01244061|17882869|P2|Overall Study|Adverse Event|2
5179029|NCT01244061|17882870|P1|Overall Study|Adverse Event|5
5179030|NCT01244061|17882869|P2|Overall Study|Protocol Violation|1
5179031|NCT01244061|17882870|P1|Overall Study|Protocol Violation|1
5179032|NCT01244061|17882869|P2|Overall Study|Other|19
5179033|NCT01244061|17882870|P1|Overall Study|Other|8
5179034|NCT01244061|17882869|P2|Overall Study|Withdrawal by Subject|46
5179035|NCT01244061|17882870|P1|Overall Study|Withdrawal by Subject|29
5179036|NCT01244061|17882869|P2|Overall Study|Lost to Follow-up|30
5179037|NCT01244061|17882870|P1|Overall Study|Lost to Follow-up|34
5179038|NCT01244061|17882869|P2|Overall Study|Lack of Efficacy|3
5179039|NCT01244061|17882870|P1|Overall Study|Lack of Efficacy|1
5179040|NCT01244061|17882869|P2|Overall Study|Did not meet entrance criteria|0
5179041|NCT01244061|17882870|P1|Overall Study|Did not meet entrance criteria|1
5179042|NCT01244061|17882869|P2|Overall Study|Death|0
5179043|NCT01244061|17882870|P1|Overall Study|Death|1
5179044|NCT01244035|17882882|P6|Part 1: Period 3|Protocol Deviation|0
5179045|NCT01244035|17882883|P5|Part 1: Period 3|Protocol Deviation|0
5179046|NCT01244035|17882884|P4|Part 1: Period 3|Protocol Deviation|0
5179047|NCT01244035|17882885|P3|Part 1: Period 3|Protocol Deviation|0
5179048|NCT01244035|17882886|P2|Part 1: Period 3|Protocol Deviation|1
5179049|NCT01244035|17882887|P1|Part 1: Period 3|Protocol Deviation|0
5179050|NCT01244035|17882882|P6|Part 1: Period 3|Withdrawal by Subject|0
5179051|NCT01244035|17882883|P5|Part 1: Period 3|Withdrawal by Subject|1
5179052|NCT01244035|17882884|P4|Part 1: Period 3|Withdrawal by Subject|0
5179053|NCT01244035|17882885|P3|Part 1: Period 3|Withdrawal by Subject|0
5179054|NCT01244035|17882886|P2|Part 1: Period 3|Withdrawal by Subject|0
5179055|NCT01244035|17882887|P1|Part 1: Period 3|Withdrawal by Subject|0
5179056|NCT01244035|17882882|P6|Part 1: Period 3|Adverse Event|1
5179057|NCT01244035|17882883|P5|Part 1: Period 3|Adverse Event|0
5179058|NCT01244035|17882884|P4|Part 1: Period 3|Adverse Event|0
5179059|NCT01244035|17882885|P3|Part 1: Period 3|Adverse Event|0
5179060|NCT01244035|17882886|P2|Part 1: Period 3|Adverse Event|0
5179061|NCT01244035|17882887|P1|Part 1: Period 3|Adverse Event|0
5179062|NCT01244035|17882882|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
5179063|NCT01244035|17882883|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
5179064|NCT01244035|17882884|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
5179065|NCT01244035|17882885|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
5179066|NCT01244035|17882886|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
5179067|NCT01244035|17882887|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
5179068|NCT01244035|17882882|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
5179069|NCT01244035|17882883|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
5179071|NCT01244035|17882885|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
5179072|NCT01244035|17882886|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
5179073|NCT01244035|17882887|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
5179074|NCT01244035|17882882|P6|Part 1: Period 1|Withdrawal by Subject|0
5179075|NCT01244035|17882883|P5|Part 1: Period 1|Withdrawal by Subject|0
5179076|NCT01244035|17882884|P4|Part 1: Period 1|Withdrawal by Subject|0
5179077|NCT01244035|17882885|P3|Part 1: Period 1|Withdrawal by Subject|0
5179078|NCT01244035|17882886|P2|Part 1: Period 1|Withdrawal by Subject|2
5179079|NCT01244035|17882887|P1|Part 1: Period 1|Withdrawal by Subject|0
5179080|NCT01244035|17882882|P6|Part 1: Period 1|Adverse Event|1
5179081|NCT01244035|17882883|P5|Part 1: Period 1|Adverse Event|0
5179082|NCT01244035|17882884|P4|Part 1: Period 1|Adverse Event|0
5179083|NCT01244035|17882885|P3|Part 1: Period 1|Adverse Event|0
5179084|NCT01244035|17882886|P2|Part 1: Period 1|Adverse Event|0
5179085|NCT01244035|17882887|P1|Part 1: Period 1|Adverse Event|0
5179086|NCT01243944|17882928|P2|Overall Study|Non-compliance with study treatment|0
5179087|NCT01243944|17882929|P1|Overall Study|Non-compliance with study treatment|1
5179088|NCT01243944|17882928|P2|Overall Study|Death|3
5179089|NCT01243944|17882929|P1|Overall Study|Death|2
5179090|NCT01243944|17882928|P2|Overall Study|Participant decision|15
5179091|NCT01243944|17882929|P1|Overall Study|Participant decision|10
5179092|NCT01243944|17882928|P2|Overall Study|Protocol deviation|1
5179093|NCT01243944|17882929|P1|Overall Study|Protocol deviation|1
5179094|NCT01243944|17882928|P2|Overall Study|Disease progression|11
5179095|NCT01243944|17882929|P1|Overall Study|Disease progression|12
5179096|NCT01243944|17882928|P2|Overall Study|Physician Decision|7
5179097|NCT01243944|17882929|P1|Overall Study|Physician Decision|2
5179098|NCT01243944|17882928|P2|Overall Study|Lost to Follow-up|1
5179099|NCT01243944|17882929|P1|Overall Study|Lost to Follow-up|2
5179100|NCT01243944|17882928|P2|Overall Study|Adverse Event|13
5179101|NCT01243944|17882929|P1|Overall Study|Adverse Event|15
5179102|NCT01243892|17882957|P2|Overall Study|Did not meet eligibility criteria|0
5179103|NCT01243892|17882958|P1|Overall Study|Did not meet eligibility criteria|2
5179104|NCT01243775|17882968|P1|Overall Study|Withdrawal by Subject|2
5179105|NCT01243762|17882982|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5179106|NCT01243762|17882983|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5179107|NCT01243762|17882984|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
5179108|NCT01243762|17882985|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
5179109|NCT01243762|17882986|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5179110|NCT01243762|17882987|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5179111|NCT01243762|17882988|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5179112|NCT01243762|17882982|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5179113|NCT01243762|17882983|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5179114|NCT01243762|17882984|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
5179115|NCT01243762|17882985|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5179116|NCT01243762|17882986|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5179117|NCT01243762|17882987|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
5179118|NCT01243762|17882988|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5179119|NCT01243762|17882982|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
5179120|NCT01243762|17882983|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
5179121|NCT01243762|17882984|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
5179122|NCT01243762|17882985|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
5179123|NCT01243762|17882986|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
5179124|NCT01243762|17882987|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
5179125|NCT01243762|17882988|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
5179126|NCT01243762|17882982|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
5179127|NCT01243762|17882983|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5179128|NCT01243762|17882984|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5179129|NCT01243762|17882985|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5179130|NCT01243762|17882986|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5179131|NCT01243762|17882987|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
5179132|NCT01243762|17882988|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5179133|NCT01243762|17882982|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5179134|NCT01243762|17882983|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5179135|NCT01243762|17882984|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5179136|NCT01243762|17882985|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5179137|NCT01243762|17882986|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5179138|NCT01243762|17882987|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
5179139|NCT01243762|17882988|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5179140|NCT01243762|17882982|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
5179141|NCT01243762|17882983|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
5179142|NCT01243762|17882984|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
5179143|NCT01243762|17882985|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
5179144|NCT01243762|17882986|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
5179145|NCT01243762|17882987|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
5179146|NCT01243762|17882988|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
5179147|NCT01243762|17882982|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5179148|NCT01243762|17882983|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5179149|NCT01243762|17882984|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5179150|NCT01243762|17882985|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
5179151|NCT01243762|17882986|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5179152|NCT01243762|17882987|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
5179153|NCT01243762|17882988|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5179154|NCT01243762|17882982|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5179155|NCT01243762|17882983|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
5179156|NCT01243762|17882984|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
5179157|NCT01243762|17882985|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5179158|NCT01243762|17882986|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5179159|NCT01243762|17882987|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
5179160|NCT01243762|17882988|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5179161|NCT01243671|17883007|P1|Overall Study|Other|1
5179162|NCT01243671|17883007|P1|Overall Study|Anti-adalimumab antibody positive|1
5179163|NCT01243671|17883007|P1|Overall Study|Adverse Event|3
5179164|NCT01243424|17883086|P2|Discontinuation From Treatment|Other than listed above|211
5179165|NCT01243424|17883087|P1|Discontinuation From Treatment|Other than listed above|230
5179166|NCT01243424|17883086|P2|Discontinuation From Treatment|Withdrawal by Subject|328
5179167|NCT01243424|17883087|P1|Discontinuation From Treatment|Withdrawal by Subject|309
5179168|NCT01243424|17883086|P2|Discontinuation From Treatment|Lost to Follow-up|28
5179169|NCT01243424|17883087|P1|Discontinuation From Treatment|Lost to Follow-up|24
5179170|NCT01243424|17883086|P2|Discontinuation From Treatment|Protocol Violation|47
5179171|NCT01243424|17883087|P1|Discontinuation From Treatment|Protocol Violation|46
5179172|NCT01243424|17883086|P2|Discontinuation From Treatment|Lack of Efficacy|41
5179173|NCT01243424|17883087|P1|Discontinuation From Treatment|Lack of Efficacy|61
5179174|NCT01243424|17883086|P2|Discontinuation From Treatment|Adverse Event|523
5179175|NCT01243424|17883087|P1|Discontinuation From Treatment|Adverse Event|457
5179176|NCT01243424|17883086|P2|Discontinuation From Treatment|Not treated|4
5179177|NCT01243424|17883087|P1|Discontinuation From Treatment|Not treated|5
5179178|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|Not treated|4
5179179|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|Not treated|5
5179180|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
5179181|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
5179182|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
5179183|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
5179184|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
5179185|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
5179186|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
5179187|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
5179188|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
5179189|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
5179190|NCT01243424|17883086|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
5179191|NCT01243424|17883087|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
5179192|NCT01243411|17883129|P1|Overall Study|Other|8
5179193|NCT01243411|17883129|P1|Overall Study|Adverse Event|5
5179194|NCT01243411|17883129|P1|Overall Study|Lost to Follow-up|10
5179195|NCT01243411|17883129|P1|Overall Study|Withdrawal by Subject|18
5179196|NCT01243268|17883240|P1|Overall Study|Duplicate subject|2
5179197|NCT01243268|17883240|P1|Overall Study|Deviation with contract date|7
5179198|NCT01243268|17883240|P1|Overall Study|Protocol Violation|51
5179199|NCT01243268|17883240|P1|Overall Study|Lost to Follow-up|4
5179200|NCT01243242|17883250|P2|Overall Study|non compliance|0
5179201|NCT01243242|17883251|P1|Overall Study|non compliance|1
5179202|NCT01243242|17883250|P2|Overall Study|sponsor decision|1
5179203|NCT01243242|17883251|P1|Overall Study|sponsor decision|0
5179204|NCT01243242|17883250|P2|Overall Study|Physician Decision|1
5179205|NCT01243242|17883251|P1|Overall Study|Physician Decision|0
5179206|NCT01243242|17883250|P2|Overall Study|Withdrawal by Subject|1
5179207|NCT01243242|17883251|P1|Overall Study|Withdrawal by Subject|1
5179208|NCT01243242|17883250|P2|Overall Study|Adverse Event|1
5179209|NCT01243242|17883251|P1|Overall Study|Adverse Event|1
5179210|NCT01243177|17883265|P2|Overall Study|Other Reason|12
5179211|NCT01243177|17883266|P1|Overall Study|Other Reason|11
5179212|NCT01243177|17883265|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5179213|NCT01243177|17883266|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5179214|NCT01243177|17883265|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
5179215|NCT01243177|17883266|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
5179216|NCT01243177|17883265|P2|Overall Study|AE, non-serious non-fatal|58
5179217|NCT01243177|17883266|P1|Overall Study|AE, non-serious non-fatal|40
5179218|NCT01243177|17883265|P2|Overall Study|SAE, non-fatal|9
5179219|NCT01243177|17883266|P1|Overall Study|SAE, non-fatal|7
5179220|NCT01243177|17883265|P2|Overall Study|AE, serious fatal|1
5179221|NCT01243177|17883266|P1|Overall Study|AE, serious fatal|0
5179222|NCT01243177|17883265|P2|Overall Study|Withdrawal by Subject|38
5179223|NCT01243177|17883266|P1|Overall Study|Withdrawal by Subject|46
5179224|NCT01243177|17883265|P2|Overall Study|Lost to Follow-up|18
5179225|NCT01243177|17883266|P1|Overall Study|Lost to Follow-up|15
5179226|NCT01243177|17883265|P2|Overall Study|Protocol Violation|10
5179227|NCT01243177|17883266|P1|Overall Study|Protocol Violation|11
5179228|NCT01243177|17883265|P2|Overall Study|Lack of Efficacy|31
5179229|NCT01243177|17883266|P1|Overall Study|Lack of Efficacy|47
5179230|NCT01243151|17883287|P5|Overall Study|Randomized but not treated|0
5179231|NCT01243151|17883288|P4|Overall Study|Randomized but not treated|1
5179232|NCT01243151|17883289|P3|Overall Study|Randomized but not treated|0
5179233|NCT01243151|17883290|P2|Overall Study|Randomized but not treated|0
5179234|NCT01243151|17883291|P1|Overall Study|Randomized but not treated|0
5179235|NCT01243151|17883287|P5|Overall Study|Other|0
5179236|NCT01243151|17883288|P4|Overall Study|Other|1
5179237|NCT01243151|17883289|P3|Overall Study|Other|0
5179238|NCT01243151|17883290|P2|Overall Study|Other|0
5179239|NCT01243151|17883291|P1|Overall Study|Other|0
5179240|NCT01243151|17883287|P5|Overall Study|Protocol Violation|0
5179241|NCT01243151|17883288|P4|Overall Study|Protocol Violation|0
5179242|NCT01243151|17883289|P3|Overall Study|Protocol Violation|1
5179243|NCT01243151|17883290|P2|Overall Study|Protocol Violation|0
5179244|NCT01243151|17883291|P1|Overall Study|Protocol Violation|0
5179245|NCT01243151|17883287|P5|Overall Study|Adverse Event|0
5179246|NCT01243151|17883288|P4|Overall Study|Adverse Event|0
5179247|NCT01243151|17883289|P3|Overall Study|Adverse Event|0
5179248|NCT01243151|17883290|P2|Overall Study|Adverse Event|1
5179249|NCT01243151|17883291|P1|Overall Study|Adverse Event|0
5179250|NCT01242813|17883535|P1|Overall Study|Lost to Follow-up|2
5179251|NCT01242748|17883557|P2|Overall Study|Miscellaneous reasons|3
5179252|NCT01242748|17883558|P1|Overall Study|Miscellaneous reasons|8
5179253|NCT01242748|17883557|P2|Overall Study|Withdrawal by Subject|2
5179254|NCT01242748|17883558|P1|Overall Study|Withdrawal by Subject|10
5179255|NCT01242748|17883557|P2|Overall Study|Protocol Violation|0
5179256|NCT01242748|17883558|P1|Overall Study|Protocol Violation|1
5179257|NCT01242748|17883557|P2|Overall Study|Physician Decision|2
5179258|NCT01242748|17883558|P1|Overall Study|Physician Decision|3
5179259|NCT01242748|17883557|P2|Overall Study|Lost to Follow-up|2
5179260|NCT01242748|17883558|P1|Overall Study|Lost to Follow-up|6
5179261|NCT01242748|17883557|P2|Overall Study|Adverse Event|5
5179262|NCT01242748|17883558|P1|Overall Study|Adverse Event|10
5179263|NCT01242514|17883632|P3|Overall Study|Adverse Event|19
5179264|NCT01242514|17883633|P2|Overall Study|Adverse Event|18
5179265|NCT01242514|17883634|P1|Overall Study|Adverse Event|129
5179266|NCT01242514|17883632|P3|Overall Study|Lost to Follow-up|4
5179267|NCT01242514|17883633|P2|Overall Study|Lost to Follow-up|5
5179268|NCT01242514|17883634|P1|Overall Study|Lost to Follow-up|14
5179269|NCT01242514|17883632|P3|Overall Study|Dev. of study specific discont. criteria|5
5179270|NCT01242514|17883633|P2|Overall Study|Dev. of study specific discont. criteria|3
5179271|NCT01242514|17883634|P1|Overall Study|Dev. of study specific discont. criteria|21
5179272|NCT01242514|17883632|P3|Overall Study|Lack of therapeutic response|10
5179273|NCT01242514|17883633|P2|Overall Study|Lack of therapeutic response|16
5179274|NCT01242514|17883634|P1|Overall Study|Lack of therapeutic response|99
5179275|NCT01242514|17883632|P3|Overall Study|Severe non-compliance to protocol|1
5179276|NCT01242514|17883633|P2|Overall Study|Severe non-compliance to protocol|2
5179277|NCT01242514|17883634|P1|Overall Study|Severe non-compliance to protocol|5
5179278|NCT01242514|17883632|P3|Overall Study|Subject decision|2
5179279|NCT01242514|17883633|P2|Overall Study|Subject decision|8
5179280|NCT01242514|17883634|P1|Overall Study|Subject decision|33
5179281|NCT01242514|17883632|P3|Overall Study|e.g., project closure|171
5179282|NCT01242514|17883633|P2|Overall Study|e.g., project closure|305
5179283|NCT01242514|17883634|P1|Overall Study|e.g., project closure|1042
5179284|NCT01242371|17883653|P2|Overall Study|Protocol Violation|3
5179285|NCT01242371|17883654|P1|Overall Study|Protocol Violation|0
5179286|NCT01242371|17883653|P2|Overall Study|Withdrawal by Subject|2
5179287|NCT01242371|17883654|P1|Overall Study|Withdrawal by Subject|2
5179288|NCT01242176|17883660|P2|Washout Period of 7 Days|Non-compliant with protocol|0
5179289|NCT01242176|17883661|P1|Washout Period of 7 Days|Non-compliant with protocol|1
5179290|NCT01242176|17883660|P2|Washout Period of 7 Days|Adverse Event|2
5179291|NCT01242176|17883661|P1|Washout Period of 7 Days|Adverse Event|0
5179292|NCT01242111|17883671|P1|Overall Study|Did not consent to MOR-100 follow-up|1
5179293|NCT01242111|17883671|P1|Overall Study|Withdrawal by Subject|1
5179294|NCT01242111|17883671|P1|Overall Study|Adverse Event|1
5179295|NCT01242085|17883683|P3|Overall Study|medically unable to have surgery|0
5179296|NCT01242085|17883684|P2|Overall Study|medically unable to have surgery|5
5179297|NCT01242085|17883685|P1|Overall Study|medically unable to have surgery|4
5179298|NCT01242085|17883683|P3|Overall Study|Withdrawal by Subject|0
5179299|NCT01242085|17883684|P2|Overall Study|Withdrawal by Subject|2
5179300|NCT01242085|17883685|P1|Overall Study|Withdrawal by Subject|4
5179301|NCT01242020|17883695|P2|Overall Study|Failed screening|0
5179302|NCT01242020|17883696|P1|Overall Study|Failed screening|1
5179303|NCT01242020|17883695|P2|Overall Study|Withdrawal by Subject|0
5179304|NCT01242020|17883696|P1|Overall Study|Withdrawal by Subject|2
5179305|NCT01241760|17883726|P2|Overall Study|Other|1
5179306|NCT01241760|17883727|P1|Overall Study|Other|1
5179307|NCT01241760|17883726|P2|Overall Study|Switch To Commercially Available Medicat|4
5179308|NCT01241760|17883727|P1|Overall Study|Switch To Commercially Available Medicat|1
5179309|NCT01241760|17883726|P2|Overall Study|Withdrawal by Subject|13
5179310|NCT01241760|17883727|P1|Overall Study|Withdrawal by Subject|13
5179311|NCT01241760|17883726|P2|Overall Study|Lost to Follow-up|22
5179312|NCT01241760|17883727|P1|Overall Study|Lost to Follow-up|18
5179313|NCT01241760|17883726|P2|Overall Study|Adverse Event|0
5179314|NCT01241760|17883727|P1|Overall Study|Adverse Event|1
5179315|NCT01241604|17883746|P3|Screening Period|Screen Failure|0
5179316|NCT01241604|17883747|P2|Screening Period|Screen Failure|0
5179317|NCT01241604|17883748|P1|Screening Period|Screen Failure|3
5179318|NCT01241591|17883793|P4|Overall Study|Adverse Event|4
5179319|NCT01241591|17883794|P3|Overall Study|Adverse Event|12
5179320|NCT01241591|17883795|P2|Overall Study|Adverse Event|11
5179321|NCT01241591|17883796|P1|Overall Study|Adverse Event|3
5179322|NCT01241591|17883793|P4|Overall Study|Other|1
5179323|NCT01241591|17883794|P3|Overall Study|Other|0
5179324|NCT01241591|17883795|P2|Overall Study|Other|1
5179325|NCT01241591|17883796|P1|Overall Study|Other|0
5179326|NCT01241591|17883793|P4|Overall Study|Withdrawal by Subject|2
5179327|NCT01241591|17883794|P3|Overall Study|Withdrawal by Subject|2
5179328|NCT01241591|17883795|P2|Overall Study|Withdrawal by Subject|4
5179329|NCT01241591|17883796|P1|Overall Study|Withdrawal by Subject|6
5179330|NCT01241591|17883793|P4|Overall Study|Screen Failure|0
5179331|NCT01241591|17883794|P3|Overall Study|Screen Failure|1
5179332|NCT01241591|17883795|P2|Overall Study|Screen Failure|2
5179333|NCT01241591|17883796|P1|Overall Study|Screen Failure|3
5179334|NCT01241591|17883793|P4|Overall Study|Lost to Follow-up|2
5179335|NCT01241591|17883794|P3|Overall Study|Lost to Follow-up|2
5179336|NCT01241591|17883795|P2|Overall Study|Lost to Follow-up|2
5179337|NCT01241591|17883796|P1|Overall Study|Lost to Follow-up|1
5179338|NCT01241591|17883793|P4|Overall Study|Protocol Violation|0
5179339|NCT01241591|17883794|P3|Overall Study|Protocol Violation|3
5179340|NCT01241591|17883795|P2|Overall Study|Protocol Violation|2
5179341|NCT01241591|17883796|P1|Overall Study|Protocol Violation|5
5179342|NCT01241591|17883793|P4|Overall Study|Lack of Efficacy|3
5179343|NCT01241591|17883794|P3|Overall Study|Lack of Efficacy|2
5179344|NCT01241591|17883795|P2|Overall Study|Lack of Efficacy|2
5179345|NCT01241591|17883796|P1|Overall Study|Lack of Efficacy|5
5179346|NCT01241552|17883999|P4|Overall Study|Lost to Follow-up|16
5179347|NCT01241552|17884000|P3|Overall Study|Lost to Follow-up|15
5179348|NCT01241552|17884001|P2|Overall Study|Lost to Follow-up|11
5179349|NCT01241552|17884002|P1|Overall Study|Lost to Follow-up|2
5179350|NCT01241552|17883999|P4|Overall Study|Physician Decision|3
5179351|NCT01241552|17884000|P3|Overall Study|Physician Decision|2
5179352|NCT01241552|17884001|P2|Overall Study|Physician Decision|4
5179353|NCT01241552|17884002|P1|Overall Study|Physician Decision|2
5179354|NCT01241552|17883999|P4|Overall Study|Withdrawal by Subject|15
5179355|NCT01241552|17884000|P3|Overall Study|Withdrawal by Subject|14
5179356|NCT01241552|17884001|P2|Overall Study|Withdrawal by Subject|15
5179357|NCT01241552|17884002|P1|Overall Study|Withdrawal by Subject|7
5179358|NCT01241552|17883999|P4|Overall Study|Protocol Violation|1
5179359|NCT01241552|17884000|P3|Overall Study|Protocol Violation|6
5179360|NCT01241552|17884001|P2|Overall Study|Protocol Violation|2
5179361|NCT01241552|17884002|P1|Overall Study|Protocol Violation|0
5179362|NCT01241552|17883999|P4|Overall Study|Progressive Disease|2
5179363|NCT01241552|17884000|P3|Overall Study|Progressive Disease|1
5179364|NCT01241552|17884001|P2|Overall Study|Progressive Disease|0
5179365|NCT01241552|17884002|P1|Overall Study|Progressive Disease|0
5179366|NCT01241552|17883999|P4|Overall Study|Technical Problems|2
5179367|NCT01241552|17884000|P3|Overall Study|Technical Problems|2
5179368|NCT01241552|17884001|P2|Overall Study|Technical Problems|0
5179369|NCT01241552|17884002|P1|Overall Study|Technical Problems|2
5179370|NCT01241552|17883999|P4|Overall Study|Adverse Event|0
5179371|NCT01241552|17884000|P3|Overall Study|Adverse Event|0
5179372|NCT01241552|17884001|P2|Overall Study|Adverse Event|1
5179373|NCT01241552|17884002|P1|Overall Study|Adverse Event|1
5179374|NCT01241552|17883999|P4|Overall Study|Death|25
5179375|NCT01241552|17884000|P3|Overall Study|Death|20
5179376|NCT01241552|17884001|P2|Overall Study|Death|30
5179377|NCT01241552|17884002|P1|Overall Study|Death|26
5179378|NCT01241552|17883999|P4|Overall Study|Lack of Efficacy|0
5179379|NCT01241552|17884000|P3|Overall Study|Lack of Efficacy|0
5179380|NCT01241552|17884001|P2|Overall Study|Lack of Efficacy|0
5179381|NCT01241552|17884002|P1|Overall Study|Lack of Efficacy|1
5179382|NCT01241461|17884097|P2|Overall Study|Progressive Disease|6
5179383|NCT01241461|17884098|P1|Overall Study|Progressive Disease|3
5179384|NCT01241448|17884118|P4|Overall Study|Excluded due to data integrity issues|2
5179385|NCT01241448|17884119|P3|Overall Study|Excluded due to data integrity issues|2
5179386|NCT01241448|17884120|P2|Overall Study|Excluded due to data integrity issues|2
5179387|NCT01241448|17884121|P1|Overall Study|Excluded due to data integrity issues|3
5179388|NCT01241448|17884118|P4|Overall Study|Withdrawal by Subject|6
5179389|NCT01241448|17884119|P3|Overall Study|Withdrawal by Subject|3
5179390|NCT01241448|17884120|P2|Overall Study|Withdrawal by Subject|5
5179391|NCT01241448|17884121|P1|Overall Study|Withdrawal by Subject|4
5179392|NCT01241448|17884118|P4|Overall Study|Sponsor Decision|6
5179393|NCT01241448|17884119|P3|Overall Study|Sponsor Decision|12
5179394|NCT01241448|17884120|P2|Overall Study|Sponsor Decision|14
5179395|NCT01241448|17884121|P1|Overall Study|Sponsor Decision|17
5179396|NCT01241448|17884118|P4|Overall Study|Protocol Violation|6
5179397|NCT01241448|17884119|P3|Overall Study|Protocol Violation|3
5179398|NCT01241448|17884120|P2|Overall Study|Protocol Violation|5
5179399|NCT01241448|17884121|P1|Overall Study|Protocol Violation|10
5179400|NCT01241448|17884118|P4|Overall Study|Physician Decision|0
5179401|NCT01241448|17884119|P3|Overall Study|Physician Decision|0
5179402|NCT01241448|17884120|P2|Overall Study|Physician Decision|2
5179403|NCT01241448|17884121|P1|Overall Study|Physician Decision|0
5179404|NCT01241448|17884118|P4|Overall Study|Lost to Follow-up|1
5179405|NCT01241448|17884119|P3|Overall Study|Lost to Follow-up|1
5179406|NCT01241448|17884120|P2|Overall Study|Lost to Follow-up|1
5179407|NCT01241448|17884121|P1|Overall Study|Lost to Follow-up|2
5179408|NCT01241448|17884118|P4|Overall Study|Adverse Event|2
5179409|NCT01241448|17884119|P3|Overall Study|Adverse Event|2
5179410|NCT01241448|17884120|P2|Overall Study|Adverse Event|0
5179411|NCT01241448|17884121|P1|Overall Study|Adverse Event|1
5179412|NCT01241318|17884212|P2|Overall Study|Woman: Stillborn infant|146
5179413|NCT01241318|17884213|P1|Overall Study|Woman: Stillborn infant|129
5179414|NCT01241318|17884212|P2|Overall Study|Withdrew/Lost to Follow after delivery|38
5179415|NCT01241318|17884213|P1|Overall Study|Withdrew/Lost to Follow after delivery|60
5179416|NCT01241318|17884212|P2|Overall Study|Death|4
5179417|NCT01241318|17884213|P1|Overall Study|Death|2
5179418|NCT01241318|17884212|P2|Overall Study|Lost to Follow-up|455
5179419|NCT01241318|17884213|P1|Overall Study|Lost to Follow-up|740
5179420|NCT01241318|17884212|P2|Overall Study|Withdrawal by Subject|46
5179421|NCT01241318|17884213|P1|Overall Study|Withdrawal by Subject|175
5179422|NCT01241318|17884212|P2|Overall Study|Woman: miscarriage/abortion|38
5179423|NCT01241318|17884213|P1|Overall Study|Woman: miscarriage/abortion|46
5179424|NCT01241318|17884212|P2|Overall Study|Woman: false pregnancies|15
5179425|NCT01241318|17884213|P1|Overall Study|Woman: false pregnancies|27
5179426|NCT01241292|17884230|P2|Overall Study|Participant Discontinued Treatment|2
5179427|NCT01241292|17884231|P1|Overall Study|Participant Discontinued Treatment|0
5179428|NCT01241292|17884230|P2|Overall Study|Study Drug Toxicity|1
5179429|NCT01241292|17884231|P1|Overall Study|Study Drug Toxicity|0
5179430|NCT01241292|17884230|P2|Overall Study|Disease Progression|0
5179431|NCT01241292|17884231|P1|Overall Study|Disease Progression|2
5179432|NCT01241292|17884230|P2|Overall Study|Administrative Reason by Sponsor|0
5179433|NCT01241292|17884231|P1|Overall Study|Administrative Reason by Sponsor|1
5179434|NCT01241279|17884255|P2|Overall Study|Lost to Follow-up|1
5179435|NCT01241279|17884256|P1|Overall Study|Lost to Follow-up|0
5179436|NCT01241240|17884266|P2|Overall Study|Personal Reasons|1
5179437|NCT01241240|17884267|P1|Overall Study|Personal Reasons|1
5179438|NCT01241240|17884266|P2|Overall Study|Lost to Follow-up|4
5179439|NCT01241240|17884267|P1|Overall Study|Lost to Follow-up|2
5179440|NCT01241240|17884266|P2|Overall Study|Adverse Event|4
5179441|NCT01241240|17884267|P1|Overall Study|Adverse Event|5
5179442|NCT01240915|17884285|P9|Overall Study|Insufficient Clinical Response|3
5179443|NCT01240915|17884286|P8|Overall Study|Insufficient Clinical Response|0
5179444|NCT01240915|17884287|P7|Overall Study|Insufficient Clinical Response|6
5179445|NCT01240915|17884288|P6|Overall Study|Insufficient Clinical Response|3
5179446|NCT01240915|17884289|P5|Overall Study|Insufficient Clinical Response|1
5179447|NCT01240915|17884290|P4|Overall Study|Insufficient Clinical Response|0
5179448|NCT01240915|17884291|P3|Overall Study|Insufficient Clinical Response|0
5179449|NCT01240915|17884292|P2|Overall Study|Insufficient Clinical Response|0
5179450|NCT01240915|17884293|P1|Overall Study|Insufficient Clinical Response|0
5179451|NCT01240915|17884285|P9|Overall Study|Other|0
5179452|NCT01240915|17884286|P8|Overall Study|Other|0
5179453|NCT01240915|17884287|P7|Overall Study|Other|0
5179454|NCT01240915|17884288|P6|Overall Study|Other|0
5179455|NCT01240915|17884289|P5|Overall Study|Other|2
5179456|NCT01240915|17884290|P4|Overall Study|Other|0
5179457|NCT01240915|17884291|P3|Overall Study|Other|0
5179458|NCT01240915|17884292|P2|Overall Study|Other|0
5179459|NCT01240915|17884293|P1|Overall Study|Other|0
5179460|NCT01240915|17884285|P9|Overall Study|Withdrawal by Subject|3
5179461|NCT01240915|17884286|P8|Overall Study|Withdrawal by Subject|3
5179462|NCT01240915|17884287|P7|Overall Study|Withdrawal by Subject|2
5179463|NCT01240915|17884288|P6|Overall Study|Withdrawal by Subject|4
5179464|NCT01240915|17884289|P5|Overall Study|Withdrawal by Subject|0
5179465|NCT01240915|17884290|P4|Overall Study|Withdrawal by Subject|2
5179466|NCT01240915|17884291|P3|Overall Study|Withdrawal by Subject|0
5179467|NCT01240915|17884292|P2|Overall Study|Withdrawal by Subject|1
5179468|NCT01240915|17884293|P1|Overall Study|Withdrawal by Subject|2
5179469|NCT01240915|17884285|P9|Overall Study|Lost to Follow-up|1
5179470|NCT01240915|17884286|P8|Overall Study|Lost to Follow-up|1
5179471|NCT01240915|17884287|P7|Overall Study|Lost to Follow-up|0
5179472|NCT01240915|17884288|P6|Overall Study|Lost to Follow-up|1
5179473|NCT01240915|17884289|P5|Overall Study|Lost to Follow-up|1
5179474|NCT01240915|17884290|P4|Overall Study|Lost to Follow-up|0
5179475|NCT01240915|17884291|P3|Overall Study|Lost to Follow-up|0
5179476|NCT01240915|17884292|P2|Overall Study|Lost to Follow-up|0
5179477|NCT01240915|17884293|P1|Overall Study|Lost to Follow-up|0
5179478|NCT01240915|17884285|P9|Overall Study|Adverse Event|1
5179479|NCT01240915|17884286|P8|Overall Study|Adverse Event|0
5179480|NCT01240915|17884287|P7|Overall Study|Adverse Event|0
5179481|NCT01240915|17884288|P6|Overall Study|Adverse Event|2
5179482|NCT01240915|17884289|P5|Overall Study|Adverse Event|0
5179483|NCT01240915|17884290|P4|Overall Study|Adverse Event|1
5179484|NCT01240915|17884291|P3|Overall Study|Adverse Event|0
5179485|NCT01240915|17884292|P2|Overall Study|Adverse Event|0
5179486|NCT01240915|17884293|P1|Overall Study|Adverse Event|0
5179487|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
5179488|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
5179489|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
5179490|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Other|5
5179491|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Other|1
5179492|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Other|0
5179493|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
5179494|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
5179495|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
5179496|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
5179497|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
5179498|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
5179499|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
5179500|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
5179501|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
5179502|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
5179503|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
5179504|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5179505|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
5179506|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
5179507|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5179508|NCT01240863|17884567|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
5179509|NCT01240863|17884568|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
5179510|NCT01240863|17884569|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
5179511|NCT01240863|17884567|P3|Open-label Titration Period|Other|0
5179512|NCT01240863|17884568|P2|Open-label Titration Period|Other|0
5179513|NCT01240863|17884569|P1|Open-label Titration Period|Other|7
5179514|NCT01240863|17884567|P3|Open-label Titration Period|Dropped out prior to dosing|0
5179515|NCT01240863|17884568|P2|Open-label Titration Period|Dropped out prior to dosing|0
5179516|NCT01240863|17884569|P1|Open-label Titration Period|Dropped out prior to dosing|2
5179517|NCT01240863|17884567|P3|Open-label Titration Period|Noncompliance to study procedures|0
5179518|NCT01240863|17884568|P2|Open-label Titration Period|Noncompliance to study procedures|0
5179519|NCT01240863|17884569|P1|Open-label Titration Period|Noncompliance to study procedures|3
5179520|NCT01240863|17884567|P3|Open-label Titration Period|Noncompliance to study drug admin|0
5179521|NCT01240863|17884568|P2|Open-label Titration Period|Noncompliance to study drug admin|0
5179522|NCT01240863|17884569|P1|Open-label Titration Period|Noncompliance to study drug admin|3
5179523|NCT01240863|17884567|P3|Open-label Titration Period|Protocol Violation|0
5179524|NCT01240863|17884568|P2|Open-label Titration Period|Protocol Violation|0
5179525|NCT01240863|17884569|P1|Open-label Titration Period|Protocol Violation|7
5179526|NCT01240863|17884567|P3|Open-label Titration Period|Withdrawal by Subject|0
5179527|NCT01240863|17884568|P2|Open-label Titration Period|Withdrawal by Subject|0
5179528|NCT01240863|17884569|P1|Open-label Titration Period|Withdrawal by Subject|9
5179529|NCT01240863|17884567|P3|Open-label Titration Period|Lack of Efficacy|0
5179530|NCT01240863|17884568|P2|Open-label Titration Period|Lack of Efficacy|0
5179531|NCT01240863|17884569|P1|Open-label Titration Period|Lack of Efficacy|19
5179532|NCT01240863|17884567|P3|Open-label Titration Period|Adverse Event|0
5179533|NCT01240863|17884568|P2|Open-label Titration Period|Adverse Event|0
5179534|NCT01240863|17884569|P1|Open-label Titration Period|Adverse Event|47
5179535|NCT01240811|17884631|P3|Overall Study|Withdrawal by Subject|1
5179536|NCT01240811|17884632|P2|Overall Study|Withdrawal by Subject|0
5179537|NCT01240811|17884633|P1|Overall Study|Withdrawal by Subject|0
5179538|NCT01240811|17884631|P3|Overall Study|Physician Decision|0
5179539|NCT01240811|17884632|P2|Overall Study|Physician Decision|1
5179540|NCT01240811|17884633|P1|Overall Study|Physician Decision|0
5179541|NCT01240785|17884649|P2|Overall Study|Protocol Violation|3
5179542|NCT01240785|17884650|P1|Overall Study|Protocol Violation|0
5179543|NCT01240785|17884649|P2|Overall Study|Lost to Follow-up|0
5179544|NCT01240785|17884650|P1|Overall Study|Lost to Follow-up|1
5179545|NCT01240746|17884681|P3|Overall Study|Withdrawal by Subject|59
5179546|NCT01240746|17884682|P2|Overall Study|Withdrawal by Subject|13
5179547|NCT01240746|17884683|P1|Overall Study|Withdrawal by Subject|10
5179548|NCT01240746|17884681|P3|Overall Study|Protocol Violation|72
5179549|NCT01240746|17884682|P2|Overall Study|Protocol Violation|15
5179550|NCT01240746|17884683|P1|Overall Study|Protocol Violation|24
5179551|NCT01240746|17884681|P3|Overall Study|Lost to Follow-up|102
5179552|NCT01240746|17884682|P2|Overall Study|Lost to Follow-up|20
5179553|NCT01240746|17884683|P1|Overall Study|Lost to Follow-up|23
5179554|NCT01240746|17884681|P3|Overall Study|Adverse Event|10
5179555|NCT01240746|17884682|P2|Overall Study|Adverse Event|0
5179556|NCT01240746|17884683|P1|Overall Study|Adverse Event|2
5179557|NCT01240590|17884738|P5|Phase II|Refused further treatment|1
5179558|NCT01240590|17884739|P4|Phase II|Refused further treatment|2
5179559|NCT01240590|17884740|P3|Phase II|Refused further treatment|0
5179560|NCT01240590|17884741|P2|Phase II|Refused further treatment|0
5179561|NCT01240590|17884742|P1|Phase II|Refused further treatment|0
5179562|NCT01240590|17884738|P5|Phase I|Refused further treatment|0
5179563|NCT01240590|17884739|P4|Phase I|Refused further treatment|0
5179564|NCT01240590|17884740|P3|Phase I|Refused further treatment|3
5179565|NCT01240590|17884741|P2|Phase I|Refused further treatment|0
5179566|NCT01240590|17884742|P1|Phase I|Refused further treatment|0
5179567|NCT01240551|17884770|P2|Overall Study|Lost to Follow-up|1
5179568|NCT01240551|17884771|P1|Overall Study|Lost to Follow-up|1
5179569|NCT01240551|17884770|P2|Overall Study|Refused further treatment|2
5179570|NCT01240551|17884771|P1|Overall Study|Refused further treatment|3
5179571|NCT01240382|17884781|P2|Overall Study|Fear of adverse events|1
5179572|NCT01240382|17884782|P1|Overall Study|Fear of adverse events|0
5179573|NCT01240382|17884781|P2|Overall Study|Lack of Efficacy|2
5179574|NCT01240382|17884782|P1|Overall Study|Lack of Efficacy|0
5179575|NCT01240382|17884781|P2|Overall Study|Adverse Event|1
5179576|NCT01240382|17884782|P1|Overall Study|Adverse Event|2
5179577|NCT01240356|17884792|P2|Overall Study|MRI contraindication|0
5179578|NCT01240356|17884793|P1|Overall Study|MRI contraindication|1
5179579|NCT01240356|17884792|P2|Overall Study|Withdrawal by Subject|0
5179580|NCT01240356|17884793|P1|Overall Study|Withdrawal by Subject|2
5179581|NCT01240200|17884816|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
5179582|NCT01240200|17884817|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
5179583|NCT01240135|17884835|P2|Period Two, 14 Days of Wear|Adverse Event|1
5179584|NCT01240135|17884836|P1|Period Two, 14 Days of Wear|Adverse Event|0
5179585|NCT01240135|17884835|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
5179586|NCT01240135|17884836|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
5179587|NCT01239992|17884853|P1|Overall Study|Withdrawal by Subject|2
5179588|NCT01239797|17884862|P2|Treated Participants|Poor/Non-compliance|1
5179589|NCT01239797|17884863|P1|Treated Participants|Poor/Non-compliance|0
5179590|NCT01239797|17884862|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
5179591|NCT01239797|17884863|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
5179592|NCT01239797|17884862|P2|Treated Participants|Death|1
5179593|NCT01239797|17884863|P1|Treated Participants|Death|1
5179594|NCT01239797|17884862|P2|Treated Participants|Non-specified|11
5179595|NCT01239797|17884863|P1|Treated Participants|Non-specified|1
5179596|NCT01239797|17884862|P2|Treated Participants|Withdrawal by Subject|23
5179597|NCT01239797|17884863|P1|Treated Participants|Withdrawal by Subject|27
5179598|NCT01239797|17884862|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
5179599|NCT01239797|17884863|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
5179600|NCT01239797|17884862|P2|Treated Participants|Study Drug Toxicity|44
5179601|NCT01239797|17884863|P1|Treated Participants|Study Drug Toxicity|30
5179602|NCT01239797|17884862|P2|Treated Participants|Disease Progression|161
5179603|NCT01239797|17884863|P1|Treated Participants|Disease Progression|153
5179604|NCT01239745|17884871|P1|Overall Study|Adverse Event|1
5179605|NCT01239745|17884871|P1|Overall Study|Study terminated by sponsor|45
5179606|NCT01239732|17884882|P1|Overall Study|Other|19
5179607|NCT01239732|17884882|P1|Overall Study|Treatment failure|2
5179608|NCT01239732|17884882|P1|Overall Study|Investigator's decision|4
5179609|NCT01239732|17884882|P1|Overall Study|Study termination by sponsor|2
5179610|NCT01239732|17884882|P1|Overall Study|Participant non compliance|5
5179611|NCT01239732|17884882|P1|Overall Study|Protocol Violation|3
5179612|NCT01239732|17884882|P1|Overall Study|Adverse Event|6
5179613|NCT01239732|17884882|P1|Overall Study|Withdrawal by Subject|87
5179614|NCT01239732|17884882|P1|Overall Study|Death|226
5179615|NCT01239732|17884882|P1|Overall Study|Termination of study per protocol|667
5179616|NCT01239680|17884895|P2|Overall Study|Withdrawal by Subject|0
5179617|NCT01239680|17884896|P1|Overall Study|Withdrawal by Subject|2
5179618|NCT01239472|17884921|P2|Overall Study|Lack of Efficacy|1
5179619|NCT01239472|17884922|P1|Overall Study|Lack of Efficacy|0
5179620|NCT01239472|17884921|P2|Overall Study|Adverse Event|1
5179621|NCT01239472|17884922|P1|Overall Study|Adverse Event|0
5179622|NCT01239472|17884921|P2|Overall Study|Withdrawal by Subject|1
5179623|NCT01239472|17884922|P1|Overall Study|Withdrawal by Subject|5
5179624|NCT01239394|17884930|P1|Overall Study|Adverse Event|1
5179625|NCT01239381|17884937|P1|Overall Study|Withdrawal by Subject|1
5179626|NCT01239381|17884937|P1|Overall Study|Protocol Violation|1
5179627|NCT01239368|17884957|P10|Overall Study|Death|0
5179628|NCT01239368|17884958|P9|Overall Study|Death|0
5179629|NCT01239368|17884959|P8|Overall Study|Death|0
5179630|NCT01239368|17884960|P7|Overall Study|Death|1
5179631|NCT01239368|17884961|P6|Overall Study|Death|0
5179632|NCT01239368|17884962|P5|Overall Study|Death|0
5179633|NCT01239368|17884963|P4|Overall Study|Death|0
5179634|NCT01239368|17884964|P3|Overall Study|Death|0
5179635|NCT01239368|17884965|P2|Overall Study|Death|0
5179636|NCT01239368|17884966|P1|Overall Study|Death|0
5179637|NCT01239368|17884957|P10|Overall Study|Refused further treatment|1
5179638|NCT01239368|17884958|P9|Overall Study|Refused further treatment|0
5179639|NCT01239368|17884959|P8|Overall Study|Refused further treatment|0
5179640|NCT01239368|17884960|P7|Overall Study|Refused further treatment|0
5179641|NCT01239368|17884961|P6|Overall Study|Refused further treatment|0
5179642|NCT01239368|17884962|P5|Overall Study|Refused further treatment|0
5179643|NCT01239368|17884963|P4|Overall Study|Refused further treatment|0
5179644|NCT01239368|17884964|P3|Overall Study|Refused further treatment|0
5179645|NCT01239368|17884965|P2|Overall Study|Refused further treatment|0
5179646|NCT01239368|17884966|P1|Overall Study|Refused further treatment|0
5179647|NCT01239368|17884957|P10|Overall Study|Disease progression on study|2
5179648|NCT01239368|17884958|P9|Overall Study|Disease progression on study|0
5179649|NCT01239368|17884959|P8|Overall Study|Disease progression on study|0
5179650|NCT01239368|17884960|P7|Overall Study|Disease progression on study|5
5179651|NCT01239368|17884961|P6|Overall Study|Disease progression on study|2
5179652|NCT01239368|17884962|P5|Overall Study|Disease progression on study|4
5179653|NCT01239368|17884963|P4|Overall Study|Disease progression on study|1
5179654|NCT01239368|17884964|P3|Overall Study|Disease progression on study|1
5179655|NCT01239368|17884965|P2|Overall Study|Disease progression on study|1
5179656|NCT01239368|17884966|P1|Overall Study|Disease progression on study|1
5179657|NCT01239368|17884957|P10|Overall Study|Principal investigator discretion|1
5179658|NCT01239368|17884958|P9|Overall Study|Principal investigator discretion|0
5179659|NCT01239368|17884959|P8|Overall Study|Principal investigator discretion|0
5179660|NCT01239368|17884960|P7|Overall Study|Principal investigator discretion|0
5179661|NCT01239368|17884961|P6|Overall Study|Principal investigator discretion|2
5179662|NCT01239368|17884962|P5|Overall Study|Principal investigator discretion|1
5179663|NCT01239368|17884963|P4|Overall Study|Principal investigator discretion|0
5179664|NCT01239368|17884964|P3|Overall Study|Principal investigator discretion|0
5179665|NCT01239368|17884965|P2|Overall Study|Principal investigator discretion|0
5179666|NCT01239368|17884966|P1|Overall Study|Principal investigator discretion|1
5179667|NCT01239342|17885018|P2|Overall Study|Reason Unknown|1
5179668|NCT01239342|17885019|P1|Overall Study|Reason Unknown|1
5179669|NCT01239342|17885018|P2|Overall Study|Withdrawal by Subject|5
5179670|NCT01239342|17885019|P1|Overall Study|Withdrawal by Subject|1
5179671|NCT01239342|17885018|P2|Overall Study|Adverse Event|0
5179672|NCT01239342|17885019|P1|Overall Study|Adverse Event|1
5179673|NCT01239316|17885035|P1|Overall Study|Adverse Event|1
5179674|NCT01239316|17885035|P1|Overall Study|Progression/Relapse|11
5179675|NCT01239160|17885049|P3|Overall Study|Early Termination Due to Study Closure|6
5179676|NCT01239160|17885050|P2|Overall Study|Early Termination Due to Study Closure|1
5179677|NCT01239160|17885051|P1|Overall Study|Early Termination Due to Study Closure|0
5179678|NCT01239160|17885049|P3|Overall Study|Physician Decision|2
5179679|NCT01239160|17885050|P2|Overall Study|Physician Decision|7
5179680|NCT01239160|17885051|P1|Overall Study|Physician Decision|5
5179681|NCT01239160|17885049|P3|Overall Study|Withdrawal by Subject|2
5179682|NCT01239160|17885050|P2|Overall Study|Withdrawal by Subject|6
5179683|NCT01239160|17885051|P1|Overall Study|Withdrawal by Subject|17
5179684|NCT01239160|17885049|P3|Overall Study|Lost to Follow-up|0
5179685|NCT01239160|17885050|P2|Overall Study|Lost to Follow-up|5
5179686|NCT01239160|17885051|P1|Overall Study|Lost to Follow-up|3
5179687|NCT01239121|17885064|P3|Overall Study|Withdrawal by Subject|0
5179688|NCT01239121|17885065|P2|Overall Study|Withdrawal by Subject|4
5179689|NCT01239121|17885066|P1|Overall Study|Withdrawal by Subject|2
5179690|NCT01239043|17885088|P2|Overall Study|Protocol Violation|1
5179691|NCT01239043|17885089|P1|Overall Study|Protocol Violation|2
5179692|NCT01238991|17885117|P10|Overall Study|Admission to a nursing home|0
5179693|NCT01238991|17885118|P9|Overall Study|Admission to a nursing home|0
5179694|NCT01238991|17885119|P8|Overall Study|Admission to a nursing home|0
5179695|NCT01238991|17885120|P7|Overall Study|Admission to a nursing home|0
5179696|NCT01238991|17885121|P6|Overall Study|Admission to a nursing home|0
5179697|NCT01238991|17885122|P5|Overall Study|Admission to a nursing home|0
5179698|NCT01238991|17885123|P4|Overall Study|Admission to a nursing home|0
5179699|NCT01238991|17885124|P3|Overall Study|Admission to a nursing home|1
5179700|NCT01238991|17885125|P2|Overall Study|Admission to a nursing home|0
5179701|NCT01238991|17885126|P1|Overall Study|Admission to a nursing home|1
5179702|NCT01238991|17885117|P10|Overall Study|Caregiver's request|0
5179703|NCT01238991|17885118|P9|Overall Study|Caregiver's request|1
5179704|NCT01238991|17885119|P8|Overall Study|Caregiver's request|0
5179705|NCT01238991|17885120|P7|Overall Study|Caregiver's request|0
5179706|NCT01238991|17885121|P6|Overall Study|Caregiver's request|0
5179707|NCT01238991|17885122|P5|Overall Study|Caregiver's request|0
5179708|NCT01238991|17885123|P4|Overall Study|Caregiver's request|0
5179709|NCT01238991|17885124|P3|Overall Study|Caregiver's request|0
5179710|NCT01238991|17885125|P2|Overall Study|Caregiver's request|0
5179711|NCT01238991|17885126|P1|Overall Study|Caregiver's request|0
5179712|NCT01238991|17885117|P10|Overall Study|Study Terminated by Sponsor|2
5179713|NCT01238991|17885118|P9|Overall Study|Study Terminated by Sponsor|2
5179714|NCT01238991|17885119|P8|Overall Study|Study Terminated by Sponsor|4
5179715|NCT01238991|17885120|P7|Overall Study|Study Terminated by Sponsor|7
5179716|NCT01238991|17885121|P6|Overall Study|Study Terminated by Sponsor|0
5179717|NCT01238991|17885122|P5|Overall Study|Study Terminated by Sponsor|1
5179718|NCT01238991|17885123|P4|Overall Study|Study Terminated by Sponsor|0
5179719|NCT01238991|17885124|P3|Overall Study|Study Terminated by Sponsor|0
5179720|NCT01238991|17885125|P2|Overall Study|Study Terminated by Sponsor|0
5179721|NCT01238991|17885126|P1|Overall Study|Study Terminated by Sponsor|0
5179722|NCT01238991|17885117|P10|Overall Study|Withdrawal by Subject|0
5179723|NCT01238991|17885118|P9|Overall Study|Withdrawal by Subject|0
5179724|NCT01238991|17885119|P8|Overall Study|Withdrawal by Subject|0
5179725|NCT01238991|17885120|P7|Overall Study|Withdrawal by Subject|0
5179726|NCT01238991|17885121|P6|Overall Study|Withdrawal by Subject|0
5179727|NCT01238991|17885122|P5|Overall Study|Withdrawal by Subject|0
5179728|NCT01238991|17885123|P4|Overall Study|Withdrawal by Subject|0
5179729|NCT01238991|17885124|P3|Overall Study|Withdrawal by Subject|1
5179730|NCT01238991|17885125|P2|Overall Study|Withdrawal by Subject|0
5179731|NCT01238991|17885126|P1|Overall Study|Withdrawal by Subject|0
5179732|NCT01238991|17885117|P10|Overall Study|Lack of Efficacy|0
5179733|NCT01238991|17885118|P9|Overall Study|Lack of Efficacy|1
5179734|NCT01238991|17885119|P8|Overall Study|Lack of Efficacy|0
5179735|NCT01238991|17885120|P7|Overall Study|Lack of Efficacy|0
5179736|NCT01238991|17885121|P6|Overall Study|Lack of Efficacy|0
5179737|NCT01238991|17885122|P5|Overall Study|Lack of Efficacy|0
5179738|NCT01238991|17885123|P4|Overall Study|Lack of Efficacy|0
5179739|NCT01238991|17885124|P3|Overall Study|Lack of Efficacy|1
5179740|NCT01238991|17885125|P2|Overall Study|Lack of Efficacy|0
5179741|NCT01238991|17885126|P1|Overall Study|Lack of Efficacy|0
5179742|NCT01238991|17885117|P10|Overall Study|Death|0
5179743|NCT01238991|17885118|P9|Overall Study|Death|0
5179744|NCT01238991|17885119|P8|Overall Study|Death|0
5179745|NCT01238991|17885120|P7|Overall Study|Death|0
5179746|NCT01238991|17885121|P6|Overall Study|Death|0
5179747|NCT01238991|17885122|P5|Overall Study|Death|0
5179748|NCT01238991|17885123|P4|Overall Study|Death|1
5179749|NCT01238991|17885124|P3|Overall Study|Death|0
5179750|NCT01238991|17885125|P2|Overall Study|Death|0
5179751|NCT01238991|17885126|P1|Overall Study|Death|0
5179752|NCT01238991|17885117|P10|Overall Study|Adverse Event|0
5179753|NCT01238991|17885118|P9|Overall Study|Adverse Event|0
5179754|NCT01238991|17885119|P8|Overall Study|Adverse Event|1
5179755|NCT01238991|17885120|P7|Overall Study|Adverse Event|1
5179756|NCT01238991|17885121|P6|Overall Study|Adverse Event|0
5179757|NCT01238991|17885122|P5|Overall Study|Adverse Event|1
5179758|NCT01238991|17885123|P4|Overall Study|Adverse Event|1
5179759|NCT01238991|17885124|P3|Overall Study|Adverse Event|3
5179760|NCT01238991|17885125|P2|Overall Study|Adverse Event|0
5179761|NCT01238991|17885126|P1|Overall Study|Adverse Event|1
5179762|NCT01238900|17885213|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
5179763|NCT01238900|17885213|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
5179764|NCT01238861|17885227|P6|Overall Study|Withdrawal by Subject|9
5179765|NCT01238861|17885228|P5|Overall Study|Withdrawal by Subject|10
5179766|NCT01238861|17885229|P4|Overall Study|Withdrawal by Subject|8
5179767|NCT01238861|17885230|P3|Overall Study|Withdrawal by Subject|4
5179768|NCT01238861|17885231|P2|Overall Study|Withdrawal by Subject|5
5179769|NCT01238861|17885232|P1|Overall Study|Withdrawal by Subject|6
5179770|NCT01238861|17885227|P6|Overall Study|Adverse Event|0
5179771|NCT01238861|17885228|P5|Overall Study|Adverse Event|0
5179772|NCT01238861|17885229|P4|Overall Study|Adverse Event|0
5179773|NCT01238861|17885230|P3|Overall Study|Adverse Event|0
5179774|NCT01238861|17885231|P2|Overall Study|Adverse Event|1
5179775|NCT01238861|17885232|P1|Overall Study|Adverse Event|0
5179776|NCT01238861|17885227|P6|Overall Study|Lack of compliance|1
5179777|NCT01238861|17885228|P5|Overall Study|Lack of compliance|0
5179778|NCT01238861|17885229|P4|Overall Study|Lack of compliance|0
5179779|NCT01238861|17885230|P3|Overall Study|Lack of compliance|0
5179780|NCT01238861|17885231|P2|Overall Study|Lack of compliance|0
5179781|NCT01238861|17885232|P1|Overall Study|Lack of compliance|0
5179782|NCT01238861|17885227|P6|Overall Study|Serious adverse event|1
5179783|NCT01238861|17885228|P5|Overall Study|Serious adverse event|0
5179784|NCT01238861|17885229|P4|Overall Study|Serious adverse event|0
5179785|NCT01238861|17885230|P3|Overall Study|Serious adverse event|0
5179786|NCT01238861|17885231|P2|Overall Study|Serious adverse event|0
5179787|NCT01238861|17885232|P1|Overall Study|Serious adverse event|0
5179788|NCT01238861|17885227|P6|Overall Study|Unable to continue visits|1
5179789|NCT01238861|17885228|P5|Overall Study|Unable to continue visits|0
5179790|NCT01238861|17885229|P4|Overall Study|Unable to continue visits|1
5179791|NCT01238861|17885230|P3|Overall Study|Unable to continue visits|0
5179792|NCT01238861|17885231|P2|Overall Study|Unable to continue visits|0
5179793|NCT01238861|17885232|P1|Overall Study|Unable to continue visits|0
5179794|NCT01238861|17885227|P6|Overall Study|Personal problems|0
5179795|NCT01238861|17885228|P5|Overall Study|Personal problems|0
5179796|NCT01238861|17885229|P4|Overall Study|Personal problems|1
5179797|NCT01238861|17885230|P3|Overall Study|Personal problems|0
5179798|NCT01238861|17885231|P2|Overall Study|Personal problems|0
5179799|NCT01238861|17885232|P1|Overall Study|Personal problems|0
5179800|NCT01238861|17885227|P6|Overall Study|Strongyloides stercoralis antibodies +|0
5179801|NCT01238861|17885228|P5|Overall Study|Strongyloides stercoralis antibodies +|0
5179802|NCT01238861|17885229|P4|Overall Study|Strongyloides stercoralis antibodies +|1
5179803|NCT01238861|17885230|P3|Overall Study|Strongyloides stercoralis antibodies +|0
5179804|NCT01238861|17885231|P2|Overall Study|Strongyloides stercoralis antibodies +|0
5179805|NCT01238861|17885232|P1|Overall Study|Strongyloides stercoralis antibodies +|0
5179806|NCT01238861|17885227|P6|Overall Study|Subject moved out of state/area|0
5179807|NCT01238861|17885228|P5|Overall Study|Subject moved out of state/area|0
5179808|NCT01238861|17885229|P4|Overall Study|Subject moved out of state/area|1
5179809|NCT01238861|17885230|P3|Overall Study|Subject moved out of state/area|1
5179810|NCT01238861|17885231|P2|Overall Study|Subject moved out of state/area|0
5179811|NCT01238861|17885232|P1|Overall Study|Subject moved out of state/area|0
5179812|NCT01238861|17885227|P6|Overall Study|Subject traveled to Argentina by 1 year|0
5179813|NCT01238861|17885228|P5|Overall Study|Subject traveled to Argentina by 1 year|0
5179814|NCT01238861|17885229|P4|Overall Study|Subject traveled to Argentina by 1 year|0
5179815|NCT01238861|17885230|P3|Overall Study|Subject traveled to Argentina by 1 year|1
5179816|NCT01238861|17885231|P2|Overall Study|Subject traveled to Argentina by 1 year|0
5179817|NCT01238861|17885232|P1|Overall Study|Subject traveled to Argentina by 1 year|0
5179818|NCT01238861|17885227|P6|Overall Study|Incorrect enrollment/randomization|0
5179819|NCT01238861|17885228|P5|Overall Study|Incorrect enrollment/randomization|1
5179820|NCT01238861|17885229|P4|Overall Study|Incorrect enrollment/randomization|0
5179821|NCT01238861|17885230|P3|Overall Study|Incorrect enrollment/randomization|1
5179822|NCT01238861|17885231|P2|Overall Study|Incorrect enrollment/randomization|0
5179823|NCT01238861|17885232|P1|Overall Study|Incorrect enrollment/randomization|0
5179824|NCT01238861|17885227|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
5179825|NCT01238861|17885228|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
5179826|NCT01238861|17885229|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
5179827|NCT01238861|17885230|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
5179828|NCT01238861|17885231|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
5179829|NCT01238861|17885232|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
5179830|NCT01238861|17885227|P6|Overall Study|Unplanned surgery|0
5179831|NCT01238861|17885228|P5|Overall Study|Unplanned surgery|0
5179832|NCT01238861|17885229|P4|Overall Study|Unplanned surgery|0
5179833|NCT01238861|17885230|P3|Overall Study|Unplanned surgery|0
5179834|NCT01238861|17885231|P2|Overall Study|Unplanned surgery|0
5179835|NCT01238861|17885232|P1|Overall Study|Unplanned surgery|1
5179836|NCT01238861|17885227|P6|Overall Study|Lost to Follow-up|2
5179837|NCT01238861|17885228|P5|Overall Study|Lost to Follow-up|1
5179838|NCT01238861|17885229|P4|Overall Study|Lost to Follow-up|1
5179839|NCT01238861|17885230|P3|Overall Study|Lost to Follow-up|3
5179840|NCT01238861|17885231|P2|Overall Study|Lost to Follow-up|2
5179841|NCT01238861|17885232|P1|Overall Study|Lost to Follow-up|4
5179842|NCT01238848|17885312|P2|Overall Study|Physician Decision|5
5179843|NCT01238848|17885313|P1|Overall Study|Physician Decision|13
5179844|NCT01238835|17885321|P1|Overall Study|Site early discontinuation|2
5179845|NCT01238835|17885321|P1|Overall Study|Lost to Follow-up|1
5179846|NCT01238835|17885321|P1|Overall Study|Withdrawal by Subject|9
5179847|NCT01238835|17885321|P1|Overall Study|Death|124
5179848|NCT01238822|17885326|P1|Overall Study|COULD NOT SWALLOW PILLS|3
5179849|NCT01238588|17885353|P1|Overall Study|Physician Decision|2
5179850|NCT01238588|17885353|P1|Overall Study|Withdrawal by Subject|1
5179851|NCT01238575|17885366|P2|Overall Study|Adverse Event|0
5179852|NCT01238575|17885367|P1|Overall Study|Adverse Event|2
5179853|NCT01238575|17885366|P2|Overall Study|Lack of Efficacy|4
5179854|NCT01238575|17885367|P1|Overall Study|Lack of Efficacy|2
5179855|NCT01238211|17885451|P1|Overall Study|Investigator/Patient Decision|3
5179856|NCT01238211|17885451|P1|Overall Study|Non-protocol treatment|4
5179857|NCT01238211|17885451|P1|Overall Study|Withdrawal by Subject|7
5179858|NCT01238211|17885451|P1|Overall Study|Relapse/Progression|2
5179859|NCT01238211|17885451|P1|Overall Study|Death|4
5179860|NCT01238211|17885451|P1|Overall Study|Adverse Event|7
5179861|NCT01238211|17885451|P1|Overall Study|Continues active treatment|31
5179862|NCT01238172|17885457|P2|Overall Study|Ineligible: based on Central Path Review|19
5179863|NCT01238172|17885458|P1|Overall Study|Ineligible: based on Central Path Review|9
5179864|NCT01238172|17885457|P2|Overall Study|Ineligible: based on Eligibility Review|5
5179865|NCT01238172|17885458|P1|Overall Study|Ineligible: based on Eligibility Review|2
5179866|NCT01237951|17885470|P1|Overall Study|Death|1
5179867|NCT01237899|17885488|P11|Washout Period of at Least 7 Days|Adverse Event|0
5179868|NCT01237899|17885489|P10|Washout Period of at Least 7 Days|Adverse Event|0
5179869|NCT01237899|17885490|P9|Washout Period of at Least 7 Days|Adverse Event|0
5179870|NCT01237899|17885491|P8|Washout Period of at Least 7 Days|Adverse Event|0
5179871|NCT01237899|17885492|P7|Washout Period of at Least 7 Days|Adverse Event|0
5179872|NCT01237899|17885493|P6|Washout Period of at Least 7 Days|Adverse Event|0
5179873|NCT01237899|17885494|P5|Washout Period of at Least 7 Days|Adverse Event|0
5179874|NCT01237899|17885495|P4|Washout Period of at Least 7 Days|Adverse Event|0
5179875|NCT01237899|17885496|P3|Washout Period of at Least 7 Days|Adverse Event|1
5179876|NCT01237899|17885497|P2|Washout Period of at Least 7 Days|Adverse Event|0
5179877|NCT01237899|17885498|P1|Washout Period of at Least 7 Days|Adverse Event|0
5179878|NCT01237678|17885578|P3|Phase II|Randomized but were not treated|3
5179879|NCT01237678|17885579|P2|Phase II|Randomized but were not treated|4
5179880|NCT01237678|17885580|P1|Phase II|Randomized but were not treated|0
5179881|NCT01237678|17885578|P3|Phase II|Sponsor Decision/Study Closed|7
5179882|NCT01237678|17885579|P2|Phase II|Sponsor Decision/Study Closed|18
5179883|NCT01237678|17885580|P1|Phase II|Sponsor Decision/Study Closed|0
5179884|NCT01237678|17885578|P3|Phase II|Completed Cycles 4-6|21
5179885|NCT01237678|17885579|P2|Phase II|Completed Cycles 4-6|11
5179886|NCT01237678|17885580|P1|Phase II|Completed Cycles 4-6|0
5179887|NCT01237678|17885578|P3|Phase II|Withdrawal by Subject|5
5179888|NCT01237678|17885579|P2|Phase II|Withdrawal by Subject|1
5179889|NCT01237678|17885580|P1|Phase II|Withdrawal by Subject|0
5179890|NCT01237678|17885578|P3|Phase II|Lack of Efficacy|3
5179891|NCT01237678|17885579|P2|Phase II|Lack of Efficacy|25
5179892|NCT01237678|17885580|P1|Phase II|Lack of Efficacy|0
5179893|NCT01237678|17885578|P3|Phase II|Death|2
5179894|NCT01237678|17885579|P2|Phase II|Death|0
5179895|NCT01237678|17885580|P1|Phase II|Death|0
5179896|NCT01237678|17885578|P3|Phase II|Adverse Event|9
5179897|NCT01237678|17885579|P2|Phase II|Adverse Event|39
5179898|NCT01237678|17885580|P1|Phase II|Adverse Event|0
5179899|NCT01237678|17885578|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
5179900|NCT01237678|17885579|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
5179901|NCT01237678|17885580|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
5179902|NCT01237678|17885578|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
5179903|NCT01237678|17885579|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
5179904|NCT01237678|17885580|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
5179905|NCT01237678|17885578|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
5179906|NCT01237678|17885579|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
5179907|NCT01237678|17885580|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
5179908|NCT01237678|17885578|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
5180135|NCT01236352|17886111|P4|Overall Study|Lack of response to drug|0
5179909|NCT01237678|17885579|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
5179910|NCT01237678|17885580|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
5179911|NCT01237587|17885625|P2|Taper Phase|Withdrawal by Subject|1
5179912|NCT01237587|17885626|P1|Taper Phase|Withdrawal by Subject|0
5179913|NCT01237587|17885625|P2|Taper Phase|Sponsor Decision|0
5179914|NCT01237587|17885626|P1|Taper Phase|Sponsor Decision|1
5179915|NCT01237587|17885625|P2|Taper Phase|Parent/Guardian Decision|2
5179916|NCT01237587|17885626|P1|Taper Phase|Parent/Guardian Decision|0
5179917|NCT01237587|17885625|P2|Taper Phase|Lack of Efficacy|5
5179918|NCT01237587|17885626|P1|Taper Phase|Lack of Efficacy|2
5179919|NCT01237587|17885625|P2|Taper Phase|Protocol Violation|0
5179920|NCT01237587|17885626|P1|Taper Phase|Protocol Violation|2
5179921|NCT01237587|17885625|P2|Taper Phase|Adverse Event|2
5179922|NCT01237587|17885626|P1|Taper Phase|Adverse Event|0
5179923|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
5179924|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
5179925|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
5179926|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
5179927|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
5179928|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
5179929|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
5179930|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
5179931|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
5179932|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
5179933|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
5179934|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
5179935|NCT01237587|17885625|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
5179936|NCT01237587|17885626|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
5179937|NCT01237587|17885625|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
5179938|NCT01237587|17885626|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
5179939|NCT01237587|17885625|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
5179940|NCT01237587|17885626|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
5179941|NCT01237587|17885625|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
5179942|NCT01237587|17885626|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
5179943|NCT01237587|17885625|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
5179944|NCT01237587|17885626|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
5179945|NCT01237587|17885625|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
5179946|NCT01237587|17885626|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
5179947|NCT01237587|17885625|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
5179948|NCT01237587|17885626|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
5179949|NCT01237340|17885678|P1|Overall Study|Early termination of the trial|36
5179950|NCT01237340|17885678|P1|Overall Study|Withdrawal by Subject|1
5179951|NCT01237340|17885678|P1|Overall Study|Adverse Event|3
5179952|NCT01237327|17885692|P2|Overall Study|Lost to Follow-up|0
5179953|NCT01237327|17885693|P1|Overall Study|Lost to Follow-up|3
5179954|NCT01237327|17885692|P2|Overall Study|Withdrawal by Subject|3
5179955|NCT01237327|17885693|P1|Overall Study|Withdrawal by Subject|1
5179956|NCT01237327|17885692|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
5179957|NCT01237327|17885693|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
5179958|NCT01237327|17885692|P2|Overall Study|Progression of Disease: Extension Study|13
5179959|NCT01237327|17885693|P1|Overall Study|Progression of Disease: Extension Study|15
5179960|NCT01237327|17885692|P2|Overall Study|Progression of Disease: Core Study|22
5179961|NCT01237327|17885693|P1|Overall Study|Progression of Disease: Core Study|18
5179962|NCT01237327|17885692|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
5179963|NCT01237327|17885693|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
5179964|NCT01237327|17885692|P2|Overall Study|Protocol Violation: Core Study|0
5179965|NCT01237327|17885693|P1|Overall Study|Protocol Violation: Core Study|1
5179966|NCT01237223|17885728|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5179967|NCT01237223|17885729|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5179968|NCT01237223|17885730|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
5179969|NCT01237223|17885731|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5179970|NCT01237223|17885732|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5179971|NCT01237223|17885733|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
5179972|NCT01237223|17885728|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
5179973|NCT01237223|17885729|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5179974|NCT01237223|17885730|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5179975|NCT01237223|17885731|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5179976|NCT01237223|17885732|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5179977|NCT01237223|17885733|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5179978|NCT01237223|17885728|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5179979|NCT01237223|17885729|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5179980|NCT01237223|17885730|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
5179981|NCT01237223|17885731|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
5179982|NCT01237223|17885732|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
5179983|NCT01237223|17885733|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5179984|NCT01237223|17885728|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
5179985|NCT01237223|17885729|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
5179986|NCT01237223|17885730|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
5179987|NCT01237223|17885731|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
5179988|NCT01237223|17885732|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
5179989|NCT01237223|17885733|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
5179990|NCT01237223|17885728|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
5179991|NCT01237223|17885729|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
5179992|NCT01237223|17885730|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
5179993|NCT01237223|17885731|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
5179994|NCT01237223|17885732|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
5179995|NCT01237223|17885733|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
5179996|NCT01237223|17885728|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5179997|NCT01237223|17885729|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5179998|NCT01237223|17885730|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5179999|NCT01237223|17885731|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5180000|NCT01237223|17885732|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5180001|NCT01237223|17885733|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
5180002|NCT01237223|17885728|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5180003|NCT01237223|17885729|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5180004|NCT01237223|17885730|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5180005|NCT01237223|17885731|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5180006|NCT01237223|17885732|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5180007|NCT01237223|17885733|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
5180008|NCT01237223|17885728|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5180009|NCT01237223|17885729|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5180010|NCT01237223|17885730|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5180011|NCT01237223|17885731|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5180012|NCT01237223|17885732|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5180013|NCT01237223|17885733|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
5180014|NCT01237223|17885728|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5180015|NCT01237223|17885729|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5180016|NCT01237223|17885730|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5180017|NCT01237223|17885731|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5180018|NCT01237223|17885732|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5180019|NCT01237223|17885733|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
5180020|NCT01237223|17885728|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5180021|NCT01237223|17885729|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5180022|NCT01237223|17885730|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5180023|NCT01237223|17885731|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5180024|NCT01237223|17885732|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5180025|NCT01237223|17885733|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
5180026|NCT01237054|17885792|P1|Overall Study|imaging 10C0096|1
5180027|NCT01236755|17885861|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
5180028|NCT01236755|17885861|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
5180029|NCT01236755|17885861|P1|Spectacles Wearing Phase|Lost to Follow-up|9
5180030|NCT01236755|17885861|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
5180031|NCT01236534|17885884|P2|Overall Study|Adverse Event|0
5180032|NCT01236534|17885885|P1|Overall Study|Adverse Event|3
5180033|NCT01236365|17885903|P2|Overall Study|Dropped at Randomization due to high LFT|0
5180034|NCT01236365|17885904|P1|Overall Study|Dropped at Randomization due to high LFT|1
5180035|NCT01236365|17885903|P2|Overall Study|Moved Out of State|0
5180036|NCT01236365|17885904|P1|Overall Study|Moved Out of State|1
5180037|NCT01236365|17885903|P2|Overall Study|Lost to Follow-up|2
5180038|NCT01236365|17885904|P1|Overall Study|Lost to Follow-up|0
5180039|NCT01236339|17885928|P2|Overall Study|Termination of study by sponsor|13
5180040|NCT01236339|17885929|P1|Overall Study|Termination of study by sponsor|11
5180041|NCT01235793|17885958|P1|Overall Study|Death|6
5180042|NCT01236573|17885974|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
5180043|NCT01236573|17885975|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180044|NCT01236573|17885976|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180045|NCT01236573|17885977|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180046|NCT01236573|17885978|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180047|NCT01236573|17885979|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180048|NCT01236573|17885980|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180049|NCT01236573|17885981|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180050|NCT01236573|17885982|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180051|NCT01236573|17885983|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180052|NCT01236573|17885984|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5180053|NCT01236573|17885974|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180054|NCT01236573|17885975|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180055|NCT01236573|17885976|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
5180056|NCT01236573|17885977|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180057|NCT01236573|17885978|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180058|NCT01236573|17885979|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180059|NCT01236573|17885980|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180060|NCT01236573|17885981|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180061|NCT01236573|17885982|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180062|NCT01236573|17885983|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180063|NCT01236573|17885984|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5180064|NCT01236573|17885974|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180065|NCT01236573|17885975|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5180066|NCT01236573|17885976|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5180067|NCT01236573|17885977|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180068|NCT01236573|17885978|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5180069|NCT01236573|17885979|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180070|NCT01236573|17885980|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180071|NCT01236573|17885981|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180072|NCT01236573|17885982|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180073|NCT01236573|17885983|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180074|NCT01236573|17885984|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5180075|NCT01236560|17886026|P6|Overall Study|Progressive disease|0
5180076|NCT01236560|17886027|P5|Overall Study|Progressive disease|0
5180077|NCT01236560|17886028|P4|Overall Study|Progressive disease|16
5180078|NCT01236560|17886029|P3|Overall Study|Progressive disease|9
5180079|NCT01236560|17886030|P2|Overall Study|Progressive disease|19
5180080|NCT01236560|17886031|P1|Overall Study|Progressive disease|5
5180081|NCT01236560|17886026|P6|Overall Study|Withdrawal by Subject|0
5180082|NCT01236560|17886027|P5|Overall Study|Withdrawal by Subject|0
5180083|NCT01236560|17886028|P4|Overall Study|Withdrawal by Subject|2
5180084|NCT01236560|17886029|P3|Overall Study|Withdrawal by Subject|1
5180085|NCT01236560|17886030|P2|Overall Study|Withdrawal by Subject|0
5180086|NCT01236560|17886031|P1|Overall Study|Withdrawal by Subject|0
5180087|NCT01236560|17886026|P6|Overall Study|Physician Decision|0
5180088|NCT01236560|17886027|P5|Overall Study|Physician Decision|0
5180089|NCT01236560|17886028|P4|Overall Study|Physician Decision|0
5180090|NCT01236560|17886029|P3|Overall Study|Physician Decision|8
5180091|NCT01236560|17886030|P2|Overall Study|Physician Decision|1
5180092|NCT01236560|17886031|P1|Overall Study|Physician Decision|0
5180093|NCT01236560|17886026|P6|Overall Study|Lost to Follow-up|0
5180094|NCT01236560|17886027|P5|Overall Study|Lost to Follow-up|0
5180095|NCT01236560|17886028|P4|Overall Study|Lost to Follow-up|0
5180096|NCT01236560|17886029|P3|Overall Study|Lost to Follow-up|1
5180097|NCT01236560|17886030|P2|Overall Study|Lost to Follow-up|1
5180098|NCT01236560|17886031|P1|Overall Study|Lost to Follow-up|0
5180099|NCT01236560|17886026|P6|Overall Study|Death|0
5180100|NCT01236560|17886027|P5|Overall Study|Death|0
5180101|NCT01236560|17886028|P4|Overall Study|Death|1
5180102|NCT01236560|17886029|P3|Overall Study|Death|0
5180103|NCT01236560|17886030|P2|Overall Study|Death|1
5180104|NCT01236560|17886031|P1|Overall Study|Death|0
5180105|NCT01236560|17886026|P6|Overall Study|Adverse Event|0
5180106|NCT01236560|17886027|P5|Overall Study|Adverse Event|0
5180107|NCT01236560|17886028|P4|Overall Study|Adverse Event|3
5180108|NCT01236560|17886029|P3|Overall Study|Adverse Event|1
5180109|NCT01236560|17886030|P2|Overall Study|Adverse Event|2
5180110|NCT01236560|17886031|P1|Overall Study|Adverse Event|0
5180111|NCT01236521|17886052|P2|Overall Study|Lost to Follow-up|7
5180112|NCT01236521|17886053|P1|Overall Study|Lost to Follow-up|7
5180113|NCT01236521|17886052|P2|Overall Study|Death|1
5180114|NCT01236521|17886053|P1|Overall Study|Death|2
5180115|NCT01236521|17886052|P2|Overall Study|Withdrawal by Subject|17
5180116|NCT01236521|17886053|P1|Overall Study|Withdrawal by Subject|12
5180117|NCT01236352|17886104|P11|Overall Study|Patient transferred to IST|6
5180118|NCT01236352|17886105|P10|Overall Study|Patient transferred to IST|2
5180119|NCT01236352|17886106|P9|Overall Study|Patient transferred to IST|0
5180120|NCT01236352|17886107|P8|Overall Study|Patient transferred to IST|0
5180121|NCT01236352|17886108|P7|Overall Study|Patient transferred to IST|0
5180122|NCT01236352|17886109|P6|Overall Study|Patient transferred to IST|0
5180123|NCT01236352|17886110|P5|Overall Study|Patient transferred to IST|0
5180124|NCT01236352|17886111|P4|Overall Study|Patient transferred to IST|0
5180125|NCT01236352|17886112|P3|Overall Study|Patient transferred to IST|0
5180126|NCT01236352|17886113|P2|Overall Study|Patient transferred to IST|0
5180127|NCT01236352|17886114|P1|Overall Study|Patient transferred to IST|0
5180128|NCT01236352|17886104|P11|Overall Study|Lack of response to drug|1
5180129|NCT01236352|17886105|P10|Overall Study|Lack of response to drug|1
5180130|NCT01236352|17886106|P9|Overall Study|Lack of response to drug|0
5180131|NCT01236352|17886107|P8|Overall Study|Lack of response to drug|0
5180132|NCT01236352|17886108|P7|Overall Study|Lack of response to drug|0
5180133|NCT01236352|17886109|P6|Overall Study|Lack of response to drug|0
5180134|NCT01236352|17886110|P5|Overall Study|Lack of response to drug|0
5180136|NCT01236352|17886112|P3|Overall Study|Lack of response to drug|0
5180137|NCT01236352|17886113|P2|Overall Study|Lack of response to drug|0
5180138|NCT01236352|17886114|P1|Overall Study|Lack of response to drug|0
5180139|NCT01236352|17886104|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
5180140|NCT01236352|17886105|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
5180141|NCT01236352|17886106|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
5180142|NCT01236352|17886107|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
5180143|NCT01236352|17886108|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
5180144|NCT01236352|17886109|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
5180145|NCT01236352|17886110|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
5180146|NCT01236352|17886111|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
5180147|NCT01236352|17886112|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
5180148|NCT01236352|17886113|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
5180149|NCT01236352|17886114|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
5180150|NCT01236352|17886104|P11|Overall Study|Patient moving to allogeneic transplant|0
5180151|NCT01236352|17886105|P10|Overall Study|Patient moving to allogeneic transplant|0
5180152|NCT01236352|17886106|P9|Overall Study|Patient moving to allogeneic transplant|0
5180153|NCT01236352|17886107|P8|Overall Study|Patient moving to allogeneic transplant|0
5180154|NCT01236352|17886108|P7|Overall Study|Patient moving to allogeneic transplant|1
5180155|NCT01236352|17886109|P6|Overall Study|Patient moving to allogeneic transplant|0
5180156|NCT01236352|17886110|P5|Overall Study|Patient moving to allogeneic transplant|0
5180157|NCT01236352|17886111|P4|Overall Study|Patient moving to allogeneic transplant|0
5180158|NCT01236352|17886112|P3|Overall Study|Patient moving to allogeneic transplant|0
5180159|NCT01236352|17886113|P2|Overall Study|Patient moving to allogeneic transplant|0
5180160|NCT01236352|17886114|P1|Overall Study|Patient moving to allogeneic transplant|0
5180161|NCT01236352|17886104|P11|Overall Study|Subject to receive drug via EAP|0
5180162|NCT01236352|17886105|P10|Overall Study|Subject to receive drug via EAP|4
5180163|NCT01236352|17886106|P9|Overall Study|Subject to receive drug via EAP|0
5180164|NCT01236352|17886107|P8|Overall Study|Subject to receive drug via EAP|2
5180165|NCT01236352|17886108|P7|Overall Study|Subject to receive drug via EAP|0
5180166|NCT01236352|17886109|P6|Overall Study|Subject to receive drug via EAP|0
5180167|NCT01236352|17886110|P5|Overall Study|Subject to receive drug via EAP|0
5180168|NCT01236352|17886111|P4|Overall Study|Subject to receive drug via EAP|0
5180169|NCT01236352|17886112|P3|Overall Study|Subject to receive drug via EAP|1
5180170|NCT01236352|17886113|P2|Overall Study|Subject to receive drug via EAP|1
5180171|NCT01236352|17886114|P1|Overall Study|Subject to receive drug via EAP|1
5180172|NCT01236352|17886104|P11|Overall Study|Subject request to discontinue treatment|4
5180173|NCT01236352|17886105|P10|Overall Study|Subject request to discontinue treatment|1
5180174|NCT01236352|17886106|P9|Overall Study|Subject request to discontinue treatment|0
5180175|NCT01236352|17886107|P8|Overall Study|Subject request to discontinue treatment|0
5180176|NCT01236352|17886108|P7|Overall Study|Subject request to discontinue treatment|0
5180177|NCT01236352|17886109|P6|Overall Study|Subject request to discontinue treatment|1
5180178|NCT01236352|17886110|P5|Overall Study|Subject request to discontinue treatment|0
5180179|NCT01236352|17886111|P4|Overall Study|Subject request to discontinue treatment|1
5180180|NCT01236352|17886112|P3|Overall Study|Subject request to discontinue treatment|1
5180181|NCT01236352|17886113|P2|Overall Study|Subject request to discontinue treatment|0
5180182|NCT01236352|17886114|P1|Overall Study|Subject request to discontinue treatment|0
5180183|NCT01236352|17886104|P11|Overall Study|Maximum clinical benefit|2
5180184|NCT01236352|17886105|P10|Overall Study|Maximum clinical benefit|4
5180185|NCT01236352|17886106|P9|Overall Study|Maximum clinical benefit|1
5180186|NCT01236352|17886107|P8|Overall Study|Maximum clinical benefit|1
5180187|NCT01236352|17886108|P7|Overall Study|Maximum clinical benefit|3
5180188|NCT01236352|17886109|P6|Overall Study|Maximum clinical benefit|0
5180189|NCT01236352|17886110|P5|Overall Study|Maximum clinical benefit|2
5180190|NCT01236352|17886111|P4|Overall Study|Maximum clinical benefit|0
5180191|NCT01236352|17886112|P3|Overall Study|Maximum clinical benefit|1
5180192|NCT01236352|17886113|P2|Overall Study|Maximum clinical benefit|1
5180193|NCT01236352|17886114|P1|Overall Study|Maximum clinical benefit|1
5180194|NCT01236352|17886104|P11|Overall Study|Poor/Non-compliance|0
5180195|NCT01236352|17886105|P10|Overall Study|Poor/Non-compliance|0
5180196|NCT01236352|17886106|P9|Overall Study|Poor/Non-compliance|0
5180197|NCT01236352|17886107|P8|Overall Study|Poor/Non-compliance|0
5180198|NCT01236352|17886108|P7|Overall Study|Poor/Non-compliance|0
5180199|NCT01236352|17886109|P6|Overall Study|Poor/Non-compliance|0
5180200|NCT01236352|17886110|P5|Overall Study|Poor/Non-compliance|0
5180201|NCT01236352|17886111|P4|Overall Study|Poor/Non-compliance|0
5180202|NCT01236352|17886112|P3|Overall Study|Poor/Non-compliance|0
5180203|NCT01236352|17886113|P2|Overall Study|Poor/Non-compliance|0
5180204|NCT01236352|17886114|P1|Overall Study|Poor/Non-compliance|1
5180205|NCT01236352|17886104|P11|Overall Study|Disease progression|2
5180206|NCT01236352|17886105|P10|Overall Study|Disease progression|2
5180207|NCT01236352|17886106|P9|Overall Study|Disease progression|2
5180208|NCT01236352|17886107|P8|Overall Study|Disease progression|3
5180209|NCT01236352|17886108|P7|Overall Study|Disease progression|1
5180210|NCT01236352|17886109|P6|Overall Study|Disease progression|2
5180211|NCT01236352|17886110|P5|Overall Study|Disease progression|2
5180212|NCT01236352|17886111|P4|Overall Study|Disease progression|2
5180213|NCT01236352|17886112|P3|Overall Study|Disease progression|1
5180214|NCT01236352|17886113|P2|Overall Study|Disease progression|2
5180215|NCT01236352|17886114|P1|Overall Study|Disease progression|1
5180216|NCT01236352|17886104|P11|Overall Study|Study drug toxicity|2
5180217|NCT01236352|17886105|P10|Overall Study|Study drug toxicity|2
5180218|NCT01236352|17886106|P9|Overall Study|Study drug toxicity|0
5180219|NCT01236352|17886107|P8|Overall Study|Study drug toxicity|0
5180220|NCT01236352|17886108|P7|Overall Study|Study drug toxicity|1
5180221|NCT01236352|17886109|P6|Overall Study|Study drug toxicity|1
5180222|NCT01236352|17886110|P5|Overall Study|Study drug toxicity|0
5180223|NCT01236352|17886111|P4|Overall Study|Study drug toxicity|0
5180224|NCT01236352|17886112|P3|Overall Study|Study drug toxicity|0
5180225|NCT01236352|17886113|P2|Overall Study|Study drug toxicity|0
5180226|NCT01236352|17886114|P1|Overall Study|Study drug toxicity|0
5180227|NCT01236352|17886104|P11|Overall Study|Adverse Event|1
5180228|NCT01236352|17886105|P10|Overall Study|Adverse Event|4
5180229|NCT01236352|17886106|P9|Overall Study|Adverse Event|0
5180230|NCT01236352|17886107|P8|Overall Study|Adverse Event|0
5180231|NCT01236352|17886108|P7|Overall Study|Adverse Event|2
5180232|NCT01236352|17886109|P6|Overall Study|Adverse Event|0
5180233|NCT01236352|17886110|P5|Overall Study|Adverse Event|0
5180234|NCT01236352|17886111|P4|Overall Study|Adverse Event|0
5180235|NCT01236352|17886112|P3|Overall Study|Adverse Event|0
5180236|NCT01236352|17886113|P2|Overall Study|Adverse Event|0
5180237|NCT01236352|17886114|P1|Overall Study|Adverse Event|0
5180238|NCT01236352|17886104|P11|Overall Study|Withdrawal by Subject|1
5180239|NCT01236352|17886105|P10|Overall Study|Withdrawal by Subject|2
5180240|NCT01236352|17886106|P9|Overall Study|Withdrawal by Subject|0
5180241|NCT01236352|17886107|P8|Overall Study|Withdrawal by Subject|0
5180242|NCT01236352|17886108|P7|Overall Study|Withdrawal by Subject|0
5180243|NCT01236352|17886109|P6|Overall Study|Withdrawal by Subject|0
5180244|NCT01236352|17886110|P5|Overall Study|Withdrawal by Subject|0
5180245|NCT01236352|17886111|P4|Overall Study|Withdrawal by Subject|0
5180246|NCT01236352|17886112|P3|Overall Study|Withdrawal by Subject|0
5180247|NCT01236352|17886113|P2|Overall Study|Withdrawal by Subject|0
5180248|NCT01236352|17886114|P1|Overall Study|Withdrawal by Subject|0
5180249|NCT01236352|17886104|P11|Overall Study|Death|0
5180250|NCT01236352|17886105|P10|Overall Study|Death|0
5180251|NCT01236352|17886106|P9|Overall Study|Death|0
5180252|NCT01236352|17886107|P8|Overall Study|Death|1
5180253|NCT01236352|17886108|P7|Overall Study|Death|0
5180254|NCT01236352|17886109|P6|Overall Study|Death|0
5180255|NCT01236352|17886110|P5|Overall Study|Death|0
5180256|NCT01236352|17886111|P4|Overall Study|Death|0
5180257|NCT01236352|17886112|P3|Overall Study|Death|0
5180258|NCT01236352|17886113|P2|Overall Study|Death|0
5180259|NCT01236352|17886114|P1|Overall Study|Death|0
5180260|NCT01236118|17886332|P3|Overall Study|Withdrawal by Subject|1
5180261|NCT01236118|17886333|P2|Overall Study|Withdrawal by Subject|0
5180262|NCT01236118|17886334|P1|Overall Study|Withdrawal by Subject|0
5180263|NCT01236118|17886332|P3|Overall Study|Physician Decision|0
5180264|NCT01236118|17886333|P2|Overall Study|Physician Decision|1
5180265|NCT01236118|17886334|P1|Overall Study|Physician Decision|0
5180266|NCT01236118|17886332|P3|Overall Study|Adverse Event|2
5180267|NCT01236118|17886333|P2|Overall Study|Adverse Event|0
5180268|NCT01236118|17886334|P1|Overall Study|Adverse Event|2
5180269|NCT01236001|17886535|P2|Overall Study|Planned Visit After End of Study|1
5180270|NCT01236001|17886536|P1|Overall Study|Planned Visit After End of Study|0
5180271|NCT01236001|17886535|P2|Overall Study|Incompliance|0
5180272|NCT01236001|17886536|P1|Overall Study|Incompliance|1
5180273|NCT01236001|17886535|P2|Overall Study|Lost to Follow-up|1
5180274|NCT01236001|17886536|P1|Overall Study|Lost to Follow-up|6
5180275|NCT01236001|17886535|P2|Overall Study|Lack of Efficacy|6
5180276|NCT01236001|17886536|P1|Overall Study|Lack of Efficacy|6
5180277|NCT01236001|17886535|P2|Overall Study|Adverse Event|14
5180278|NCT01236001|17886536|P1|Overall Study|Adverse Event|5
5180279|NCT01235975|17886568|P2|Overall Study|Lost to Follow-up|3
5180280|NCT01235975|17886569|P1|Overall Study|Lost to Follow-up|7
5180281|NCT01235975|17886568|P2|Overall Study|Migrated/moved from study area|1
5180282|NCT01235975|17886569|P1|Overall Study|Migrated/moved from study area|2
5180283|NCT01235975|17886568|P2|Overall Study|Withdrawal by Subject|2
5180284|NCT01235975|17886569|P1|Overall Study|Withdrawal by Subject|8
5180285|NCT01235975|17886568|P2|Overall Study|Serious Adverse Event|1
5180286|NCT01235975|17886569|P1|Overall Study|Serious Adverse Event|0
5180287|NCT01235962|17886605|P4|Overall Study|Physician Decision|5
5180288|NCT01235962|17886606|P3|Overall Study|Physician Decision|9
5180289|NCT01235962|17886607|P2|Overall Study|Physician Decision|0
5180290|NCT01235962|17886608|P1|Overall Study|Physician Decision|5
5180291|NCT01235962|17886605|P4|Overall Study|Lost to Follow-up|32
5180292|NCT01235962|17886606|P3|Overall Study|Lost to Follow-up|47
5180293|NCT01235962|17886607|P2|Overall Study|Lost to Follow-up|16
5180294|NCT01235962|17886608|P1|Overall Study|Lost to Follow-up|21
5180295|NCT01235962|17886605|P4|Overall Study|Withdrawal by Subject|49
5180296|NCT01235962|17886606|P3|Overall Study|Withdrawal by Subject|62
5180297|NCT01235962|17886607|P2|Overall Study|Withdrawal by Subject|19
5180298|NCT01235962|17886608|P1|Overall Study|Withdrawal by Subject|20
5180299|NCT01235949|17886678|P18|Booster Phase|Lost to Follow-up|1
5180300|NCT01235949|17886679|P17|Booster Phase|Lost to Follow-up|0
5180301|NCT01235949|17886680|P16|Booster Phase|Lost to Follow-up|0
5180302|NCT01235949|17886681|P15|Booster Phase|Lost to Follow-up|0
5180303|NCT01235949|17886682|P14|Booster Phase|Lost to Follow-up|0
5180304|NCT01235949|17886683|P13|Booster Phase|Lost to Follow-up|0
5180305|NCT01235949|17886684|P12|Booster Phase|Lost to Follow-up|1
5180306|NCT01235949|17886685|P11|Booster Phase|Lost to Follow-up|1
5180307|NCT01235949|17886686|P10|Booster Phase|Lost to Follow-up|1
5180308|NCT01235949|17886687|P9|Booster Phase|Lost to Follow-up|1
5180309|NCT01235949|17886688|P8|Booster Phase|Lost to Follow-up|0
5180310|NCT01235949|17886689|P7|Booster Phase|Lost to Follow-up|0
5180311|NCT01235949|17886690|P6|Booster Phase|Lost to Follow-up|0
5180312|NCT01235949|17886691|P5|Booster Phase|Lost to Follow-up|0
5180313|NCT01235949|17886692|P4|Booster Phase|Lost to Follow-up|0
5180314|NCT01235949|17886693|P3|Booster Phase|Lost to Follow-up|0
5180315|NCT01235949|17886694|P2|Booster Phase|Lost to Follow-up|0
5180316|NCT01235949|17886695|P1|Booster Phase|Lost to Follow-up|0
5180317|NCT01235949|17886678|P18|Booster Phase|Withdrawal by Subject|0
5180318|NCT01235949|17886679|P17|Booster Phase|Withdrawal by Subject|0
5180319|NCT01235949|17886680|P16|Booster Phase|Withdrawal by Subject|0
5180320|NCT01235949|17886681|P15|Booster Phase|Withdrawal by Subject|2
5180321|NCT01235949|17886682|P14|Booster Phase|Withdrawal by Subject|0
5180322|NCT01235949|17886683|P13|Booster Phase|Withdrawal by Subject|2
5180323|NCT01235949|17886684|P12|Booster Phase|Withdrawal by Subject|1
5180324|NCT01235949|17886685|P11|Booster Phase|Withdrawal by Subject|1
5180325|NCT01235949|17886686|P10|Booster Phase|Withdrawal by Subject|0
5180326|NCT01235949|17886687|P9|Booster Phase|Withdrawal by Subject|1
5180327|NCT01235949|17886688|P8|Booster Phase|Withdrawal by Subject|1
5180328|NCT01235949|17886689|P7|Booster Phase|Withdrawal by Subject|0
5180329|NCT01235949|17886690|P6|Booster Phase|Withdrawal by Subject|0
5180330|NCT01235949|17886691|P5|Booster Phase|Withdrawal by Subject|0
5180331|NCT01235949|17886692|P4|Booster Phase|Withdrawal by Subject|0
5180332|NCT01235949|17886693|P3|Booster Phase|Withdrawal by Subject|0
5180333|NCT01235949|17886694|P2|Booster Phase|Withdrawal by Subject|0
5180334|NCT01235949|17886695|P1|Booster Phase|Withdrawal by Subject|0
5180335|NCT01235949|17886678|P18|Booster Phase|Adverse Event|0
5180336|NCT01235949|17886679|P17|Booster Phase|Adverse Event|0
5180337|NCT01235949|17886680|P16|Booster Phase|Adverse Event|1
5180338|NCT01235949|17886681|P15|Booster Phase|Adverse Event|0
5180339|NCT01235949|17886682|P14|Booster Phase|Adverse Event|0
5180340|NCT01235949|17886683|P13|Booster Phase|Adverse Event|0
5180341|NCT01235949|17886684|P12|Booster Phase|Adverse Event|0
5180342|NCT01235949|17886685|P11|Booster Phase|Adverse Event|0
5180343|NCT01235949|17886686|P10|Booster Phase|Adverse Event|0
5180344|NCT01235949|17886687|P9|Booster Phase|Adverse Event|0
5180345|NCT01235949|17886688|P8|Booster Phase|Adverse Event|0
5180346|NCT01235949|17886689|P7|Booster Phase|Adverse Event|0
5180347|NCT01235949|17886690|P6|Booster Phase|Adverse Event|0
5180348|NCT01235949|17886691|P5|Booster Phase|Adverse Event|0
5180349|NCT01235949|17886692|P4|Booster Phase|Adverse Event|0
5180350|NCT01235949|17886693|P3|Booster Phase|Adverse Event|0
5180351|NCT01235949|17886694|P2|Booster Phase|Adverse Event|0
5180352|NCT01235949|17886695|P1|Booster Phase|Adverse Event|0
5180353|NCT01235949|17886678|P18|Booster Phase|Migrated/moved from study area|1
5180354|NCT01235949|17886679|P17|Booster Phase|Migrated/moved from study area|0
5180355|NCT01235949|17886680|P16|Booster Phase|Migrated/moved from study area|0
5180356|NCT01235949|17886681|P15|Booster Phase|Migrated/moved from study area|0
5180357|NCT01235949|17886682|P14|Booster Phase|Migrated/moved from study area|0
5180358|NCT01235949|17886683|P13|Booster Phase|Migrated/moved from study area|1
5180359|NCT01235949|17886684|P12|Booster Phase|Migrated/moved from study area|1
5180360|NCT01235949|17886685|P11|Booster Phase|Migrated/moved from study area|0
5180361|NCT01235949|17886686|P10|Booster Phase|Migrated/moved from study area|0
5180362|NCT01235949|17886687|P9|Booster Phase|Migrated/moved from study area|0
5180363|NCT01235949|17886688|P8|Booster Phase|Migrated/moved from study area|0
5180364|NCT01235949|17886689|P7|Booster Phase|Migrated/moved from study area|0
5180365|NCT01235949|17886690|P6|Booster Phase|Migrated/moved from study area|0
5180366|NCT01235949|17886691|P5|Booster Phase|Migrated/moved from study area|0
5180367|NCT01235949|17886692|P4|Booster Phase|Migrated/moved from study area|0
5180368|NCT01235949|17886693|P3|Booster Phase|Migrated/moved from study area|0
5180369|NCT01235949|17886694|P2|Booster Phase|Migrated/moved from study area|0
5180370|NCT01235949|17886695|P1|Booster Phase|Migrated/moved from study area|0
5180371|NCT01235949|17886678|P18|Primary Phase|Lost to Follow-up|0
5180372|NCT01235949|17886679|P17|Primary Phase|Lost to Follow-up|0
5180373|NCT01235949|17886680|P16|Primary Phase|Lost to Follow-up|0
5180374|NCT01235949|17886681|P15|Primary Phase|Lost to Follow-up|0
5180375|NCT01235949|17886682|P14|Primary Phase|Lost to Follow-up|0
5180376|NCT01235949|17886683|P13|Primary Phase|Lost to Follow-up|0
5180377|NCT01235949|17886684|P12|Primary Phase|Lost to Follow-up|0
5180378|NCT01235949|17886685|P11|Primary Phase|Lost to Follow-up|0
5180379|NCT01235949|17886686|P10|Primary Phase|Lost to Follow-up|0
5180380|NCT01235949|17886687|P9|Primary Phase|Lost to Follow-up|0
5180381|NCT01235949|17886688|P8|Primary Phase|Lost to Follow-up|0
5180382|NCT01235949|17886689|P7|Primary Phase|Lost to Follow-up|0
5180383|NCT01235949|17886690|P6|Primary Phase|Lost to Follow-up|2
5180384|NCT01235949|17886691|P5|Primary Phase|Lost to Follow-up|0
5180385|NCT01235949|17886692|P4|Primary Phase|Lost to Follow-up|1
5180386|NCT01235949|17886693|P3|Primary Phase|Lost to Follow-up|1
5180387|NCT01235949|17886694|P2|Primary Phase|Lost to Follow-up|0
5180388|NCT01235949|17886695|P1|Primary Phase|Lost to Follow-up|0
5180389|NCT01235949|17886678|P18|Primary Phase|Withdrawal by Subject|0
5180390|NCT01235949|17886679|P17|Primary Phase|Withdrawal by Subject|0
5180391|NCT01235949|17886680|P16|Primary Phase|Withdrawal by Subject|0
5180392|NCT01235949|17886681|P15|Primary Phase|Withdrawal by Subject|0
5180393|NCT01235949|17886682|P14|Primary Phase|Withdrawal by Subject|0
5180394|NCT01235949|17886683|P13|Primary Phase|Withdrawal by Subject|0
5180395|NCT01235949|17886684|P12|Primary Phase|Withdrawal by Subject|0
5180396|NCT01235949|17886685|P11|Primary Phase|Withdrawal by Subject|0
5180397|NCT01235949|17886686|P10|Primary Phase|Withdrawal by Subject|0
5180398|NCT01235949|17886687|P9|Primary Phase|Withdrawal by Subject|0
5180399|NCT01235949|17886688|P8|Primary Phase|Withdrawal by Subject|0
5180400|NCT01235949|17886689|P7|Primary Phase|Withdrawal by Subject|0
5180401|NCT01235949|17886690|P6|Primary Phase|Withdrawal by Subject|3
5180402|NCT01235949|17886691|P5|Primary Phase|Withdrawal by Subject|0
5180403|NCT01235949|17886692|P4|Primary Phase|Withdrawal by Subject|0
5180404|NCT01235949|17886693|P3|Primary Phase|Withdrawal by Subject|2
5180405|NCT01235949|17886694|P2|Primary Phase|Withdrawal by Subject|2
5180406|NCT01235949|17886695|P1|Primary Phase|Withdrawal by Subject|3
5180407|NCT01235949|17886678|P18|Primary Phase|Adverse Event|0
5180408|NCT01235949|17886679|P17|Primary Phase|Adverse Event|0
5180409|NCT01235949|17886680|P16|Primary Phase|Adverse Event|0
5180410|NCT01235949|17886681|P15|Primary Phase|Adverse Event|0
5180411|NCT01235949|17886682|P14|Primary Phase|Adverse Event|0
5180412|NCT01235949|17886683|P13|Primary Phase|Adverse Event|0
5180413|NCT01235949|17886684|P12|Primary Phase|Adverse Event|0
5180414|NCT01235949|17886685|P11|Primary Phase|Adverse Event|0
5180415|NCT01235949|17886686|P10|Primary Phase|Adverse Event|0
5180416|NCT01235949|17886687|P9|Primary Phase|Adverse Event|0
5180417|NCT01235949|17886688|P8|Primary Phase|Adverse Event|0
5180418|NCT01235949|17886689|P7|Primary Phase|Adverse Event|0
5180419|NCT01235949|17886690|P6|Primary Phase|Adverse Event|0
5180420|NCT01235949|17886691|P5|Primary Phase|Adverse Event|0
5180421|NCT01235949|17886692|P4|Primary Phase|Adverse Event|1
5180422|NCT01235949|17886693|P3|Primary Phase|Adverse Event|0
5180423|NCT01235949|17886694|P2|Primary Phase|Adverse Event|0
5180424|NCT01235949|17886695|P1|Primary Phase|Adverse Event|0
5180425|NCT01235949|17886678|P18|Primary Phase|Migrated/moved from study area|0
5180426|NCT01235949|17886679|P17|Primary Phase|Migrated/moved from study area|0
5180427|NCT01235949|17886680|P16|Primary Phase|Migrated/moved from study area|0
5180428|NCT01235949|17886681|P15|Primary Phase|Migrated/moved from study area|0
5180429|NCT01235949|17886682|P14|Primary Phase|Migrated/moved from study area|0
5180430|NCT01235949|17886683|P13|Primary Phase|Migrated/moved from study area|0
5180431|NCT01235949|17886684|P12|Primary Phase|Migrated/moved from study area|0
5180432|NCT01235949|17886685|P11|Primary Phase|Migrated/moved from study area|0
5180433|NCT01235949|17886686|P10|Primary Phase|Migrated/moved from study area|0
5180434|NCT01235949|17886687|P9|Primary Phase|Migrated/moved from study area|0
5180435|NCT01235949|17886688|P8|Primary Phase|Migrated/moved from study area|0
5180436|NCT01235949|17886689|P7|Primary Phase|Migrated/moved from study area|0
5180437|NCT01235949|17886690|P6|Primary Phase|Migrated/moved from study area|2
5180438|NCT01235949|17886691|P5|Primary Phase|Migrated/moved from study area|1
5180439|NCT01235949|17886692|P4|Primary Phase|Migrated/moved from study area|0
5180440|NCT01235949|17886693|P3|Primary Phase|Migrated/moved from study area|0
5180441|NCT01235949|17886694|P2|Primary Phase|Migrated/moved from study area|1
5180442|NCT01235949|17886695|P1|Primary Phase|Migrated/moved from study area|1
5180443|NCT01235741|17886945|P3|Follow-Up Post Treatment up to Month 6|Other|0
5180444|NCT01235741|17886946|P2|Follow-Up Post Treatment up to Month 6|Other|1
5180445|NCT01235741|17886947|P1|Follow-Up Post Treatment up to Month 6|Other|0
5180446|NCT01235741|17886945|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
5180447|NCT01235741|17886946|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
5180448|NCT01235741|17886947|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
5180449|NCT01235741|17886945|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
5180450|NCT01235741|17886946|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
5180451|NCT01235741|17886947|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
5180452|NCT01235741|17886945|P3|Randomized to Treatment|Sponsor terminated study|34
5180453|NCT01235741|17886946|P2|Randomized to Treatment|Sponsor terminated study|35
5180454|NCT01235741|17886947|P1|Randomized to Treatment|Sponsor terminated study|0
5180455|NCT01235741|17886945|P3|Randomized to Treatment|Adverse Event|1
5180456|NCT01235741|17886946|P2|Randomized to Treatment|Adverse Event|1
5180457|NCT01235741|17886947|P1|Randomized to Treatment|Adverse Event|0
5180458|NCT01235741|17886945|P3|Randomized to Treatment|Withdrawal by Subject|1
5180459|NCT01235741|17886946|P2|Randomized to Treatment|Withdrawal by Subject|0
5180460|NCT01235741|17886947|P1|Randomized to Treatment|Withdrawal by Subject|0
5180461|NCT01235741|17886945|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
5180462|NCT01235741|17886946|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
5180463|NCT01235741|17886947|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
5180464|NCT01235741|17886945|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
5180465|NCT01235741|17886946|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
5180466|NCT01235741|17886947|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
5180467|NCT01235741|17886945|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
5180468|NCT01235741|17886946|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
5180469|NCT01235741|17886947|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
5180470|NCT01235741|17886945|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
5180471|NCT01235741|17886946|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
5180472|NCT01235741|17886947|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
5180473|NCT01235741|17886945|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
5180474|NCT01235741|17886946|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
5180475|NCT01235741|17886947|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
5180476|NCT01235741|17886945|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
5180477|NCT01235741|17886946|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
5180478|NCT01235741|17886947|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
5180479|NCT01235728|17886974|P8|Overall Study|Protocol Violation|0
5180480|NCT01235728|17886975|P7|Overall Study|Protocol Violation|0
5180481|NCT01235728|17886976|P6|Overall Study|Protocol Violation|0
5180482|NCT01235728|17886977|P5|Overall Study|Protocol Violation|0
5180483|NCT01235728|17886978|P4|Overall Study|Protocol Violation|1
5180484|NCT01235728|17886979|P3|Overall Study|Protocol Violation|0
5180485|NCT01235728|17886980|P2|Overall Study|Protocol Violation|0
5180486|NCT01235728|17886981|P1|Overall Study|Protocol Violation|0
5180487|NCT01235715|17886991|P2|Overall Study|Physician Decision|2
5180488|NCT01235715|17886992|P1|Overall Study|Physician Decision|0
5180489|NCT01235689|17887032|P2|Overall Study|Miscellaneous|5
5180490|NCT01235689|17887033|P1|Overall Study|Miscellaneous|1
5180491|NCT01235689|17887032|P2|Overall Study|Lost to Follow-up|2
5180492|NCT01235689|17887033|P1|Overall Study|Lost to Follow-up|1
5180493|NCT01235689|17887032|P2|Overall Study|Withdrawal by Subject|4
5180494|NCT01235689|17887033|P1|Overall Study|Withdrawal by Subject|3
5180495|NCT01235689|17887032|P2|Overall Study|Lack of Efficacy|5
5180496|NCT01235689|17887033|P1|Overall Study|Lack of Efficacy|12
5180497|NCT01235689|17887032|P2|Overall Study|Adverse Event|16
5180498|NCT01235689|17887033|P1|Overall Study|Adverse Event|12
5180499|NCT01235598|17887105|P2|Overall Study|Withdrawal by Subject|0
5180500|NCT01235598|17887106|P1|Overall Study|Withdrawal by Subject|1
5180501|NCT01235598|17887105|P2|Overall Study|Lack of Efficacy|1
5180502|NCT01235598|17887106|P1|Overall Study|Lack of Efficacy|0
5180503|NCT01235598|17887105|P2|Overall Study|Adverse Event|3
5180504|NCT01235598|17887106|P1|Overall Study|Adverse Event|0
5180505|NCT01235546|17887151|P2|Overall Study|Protocol Violation|1
5180506|NCT01235546|17887152|P1|Overall Study|Protocol Violation|1
5180507|NCT01235546|17887151|P2|Overall Study|Staff error, medication not administered|0
5180508|NCT01235546|17887152|P1|Overall Study|Staff error, medication not administered|1
5180509|NCT01235507|17887176|P1|Overall Study|Withdrawal by Subject|1
5180510|NCT01235507|17887176|P1|Overall Study|Adverse Event|1
5180511|NCT01235442|17887190|P2|Overall Study|Other unspecified|2
5180512|NCT01235442|17887191|P1|Overall Study|Other unspecified|1
5180513|NCT01235442|17887190|P2|Overall Study|Administrative decision|2
5180514|NCT01235442|17887191|P1|Overall Study|Administrative decision|1
5180515|NCT01235442|17887190|P2|Overall Study|Noncompliance|2
5180516|NCT01235442|17887191|P1|Overall Study|Noncompliance|1
5180517|NCT01235442|17887190|P2|Overall Study|Lack of Efficacy|3
5180518|NCT01235442|17887191|P1|Overall Study|Lack of Efficacy|1
5180519|NCT01235442|17887190|P2|Overall Study|Withdrawal by Subject|9
5180520|NCT01235442|17887191|P1|Overall Study|Withdrawal by Subject|15
5180521|NCT01235442|17887190|P2|Overall Study|Adverse Event|6
5180522|NCT01235442|17887191|P1|Overall Study|Adverse Event|4
5180523|NCT01235442|17887190|P2|Overall Study|Protocol Violation|3
5180524|NCT01235442|17887191|P1|Overall Study|Protocol Violation|3
5180525|NCT01235442|17887190|P2|Overall Study|Ineligibility determined|4
5180526|NCT01235442|17887191|P1|Overall Study|Ineligibility determined|5
5180527|NCT01235442|17887190|P2|Overall Study|Pregnancy|1
5180528|NCT01235442|17887191|P1|Overall Study|Pregnancy|1
5180529|NCT01235442|17887190|P2|Overall Study|Death|2
5180530|NCT01235442|17887191|P1|Overall Study|Death|0
5180531|NCT01235442|17887190|P2|Overall Study|Lost to Follow-up|10
5180532|NCT01235442|17887191|P1|Overall Study|Lost to Follow-up|12
5180533|NCT01235403|17887209|P1|Overall Study|Other reasons for premature termination|4
5180534|NCT01235403|17887209|P1|Overall Study|Lack of Efficacy|2
5180535|NCT01235403|17887209|P1|Overall Study|Withdrawal by Subject|4
5180536|NCT01235403|17887209|P1|Overall Study|Lost to Follow-up|2
5180537|NCT01235403|17887209|P1|Overall Study|Adverse Event|14
5180538|NCT01235351|17887226|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
5180539|NCT01235351|17887227|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
5180540|NCT01235338|17887239|P2|Overall Study|Prohibited meds|0
5180541|NCT01235338|17887240|P1|Overall Study|Prohibited meds|1
5180542|NCT01235338|17887239|P2|Overall Study|Positive drug screen|1
5180543|NCT01235338|17887240|P1|Overall Study|Positive drug screen|0
5180544|NCT01235338|17887239|P2|Overall Study|Exclusion criteria violations|1
5180545|NCT01235338|17887240|P1|Overall Study|Exclusion criteria violations|1
5180546|NCT01235338|17887239|P2|Overall Study|Withdrawal by Subject|0
5180547|NCT01235338|17887240|P1|Overall Study|Withdrawal by Subject|5
5180548|NCT01235338|17887239|P2|Overall Study|Protocol Violation|1
5180549|NCT01235338|17887240|P1|Overall Study|Protocol Violation|1
5180550|NCT01235338|17887239|P2|Overall Study|Adverse Event|2
5180551|NCT01235338|17887240|P1|Overall Study|Adverse Event|3
5180552|NCT01235234|17887285|P3|Overall Study|Adverse Event|1
5180553|NCT01235234|17887286|P2|Overall Study|Adverse Event|2
5180554|NCT01235234|17887287|P1|Overall Study|Adverse Event|2
5180555|NCT01234883|17887335|P2|Overall Study|Inclusion/exclusion failure|0
5180556|NCT01234883|17887336|P1|Overall Study|Inclusion/exclusion failure|1
5180557|NCT01234883|17887335|P2|Overall Study|Technical difficulties with IV infusion|1
5180558|NCT01234883|17887336|P1|Overall Study|Technical difficulties with IV infusion|0
5180559|NCT01234883|17887335|P2|Overall Study|Parent/guardian withdrew consent|2
5180560|NCT01234883|17887336|P1|Overall Study|Parent/guardian withdrew consent|1
5180561|NCT01234883|17887335|P2|Overall Study|Early treatment release|10
5180562|NCT01234883|17887336|P1|Overall Study|Early treatment release|8
5180563|NCT01234675|17887383|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
5180564|NCT01234675|17887384|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
5180565|NCT01234675|17887383|P2|First Intervention (6 Weeks)|Adverse Event|1
5180566|NCT01234675|17887384|P1|First Intervention (6 Weeks)|Adverse Event|0
5180567|NCT01234649|17887416|P2|Overall Study|Lack of Efficacy|3
5180568|NCT01234649|17887417|P1|Overall Study|Lack of Efficacy|0
5180569|NCT01234649|17887416|P2|Overall Study|Allergic reaction|0
5180570|NCT01234649|17887417|P1|Overall Study|Allergic reaction|1
5180571|NCT01234649|17887416|P2|Overall Study|intolerant to side effects|3
5180572|NCT01234649|17887417|P1|Overall Study|intolerant to side effects|4
5180573|NCT01234649|17887416|P2|Overall Study|Pregnancy|6
5180574|NCT01234649|17887417|P1|Overall Study|Pregnancy|6
5180575|NCT01234649|17887416|P2|Overall Study|Withdrawal by Subject|26
5180576|NCT01234649|17887417|P1|Overall Study|Withdrawal by Subject|32
5180577|NCT01234467|17887465|P1|Overall Study|Other complicating disease (stroke)|1
5180578|NCT01234467|17887465|P1|Overall Study|Physician Decision|1
5180579|NCT01234467|17887465|P1|Overall Study|Clinical deterioration|1
5180580|NCT01234467|17887465|P1|Overall Study|Disease Progression|2
5180581|NCT01234467|17887465|P1|Overall Study|Withdrawal by Subject|2
5180582|NCT01234467|17887465|P1|Overall Study|Death|2
5180583|NCT01234467|17887465|P1|Overall Study|Adverse Event|3
5180584|NCT01234402|17887477|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
5180585|NCT01234402|17887478|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
5180586|NCT01234402|17887479|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
5180587|NCT01234402|17887477|P3|Overall Study|Never treated: Withdrawal By Subject|0
5180588|NCT01234402|17887478|P2|Overall Study|Never treated: Withdrawal By Subject|1
5180589|NCT01234402|17887479|P1|Overall Study|Never treated: Withdrawal By Subject|0
5180590|NCT01234402|17887477|P3|Overall Study|Never treated: Death|1
5180591|NCT01234402|17887478|P2|Overall Study|Never treated: Death|0
5180592|NCT01234402|17887479|P1|Overall Study|Never treated: Death|0
5180593|NCT01234402|17887477|P3|Overall Study|Withdrawal by Subject|4
5180594|NCT01234402|17887478|P2|Overall Study|Withdrawal by Subject|3
5180595|NCT01234402|17887479|P1|Overall Study|Withdrawal by Subject|1
5180596|NCT01234402|17887477|P3|Overall Study|Lost to Follow-up|3
5180597|NCT01234402|17887478|P2|Overall Study|Lost to Follow-up|1
5180598|NCT01234402|17887479|P1|Overall Study|Lost to Follow-up|0
5180599|NCT01234350|17887520|P2|Overall Study|Covers a diverse set of reasons|92
5180600|NCT01234350|17887521|P1|Overall Study|Covers a diverse set of reasons|234
5180601|NCT01234350|17887520|P2|Overall Study|Lost to Follow-up|47
5180602|NCT01234350|17887521|P1|Overall Study|Lost to Follow-up|115
5180603|NCT01234350|17887520|P2|Overall Study|Withdrawal by Subject|36
5180604|NCT01234350|17887521|P1|Overall Study|Withdrawal by Subject|61
5180605|NCT01234350|17887520|P2|Overall Study|Adverse Event|92
5180606|NCT01234350|17887521|P1|Overall Study|Adverse Event|277
5180607|NCT01234337|17887547|P2|Overall Study|Switch to commercial drug|1
5180608|NCT01234337|17887548|P1|Overall Study|Switch to commercial drug|0
5180609|NCT01234337|17887547|P2|Overall Study|Death|1
5180610|NCT01234337|17887548|P1|Overall Study|Death|0
5180611|NCT01234337|17887547|P2|Overall Study|Withdrawal by Subject|9
5180612|NCT01234337|17887548|P1|Overall Study|Withdrawal by Subject|11
5180613|NCT01234337|17887547|P2|Overall Study|Protocol Violation|3
5180614|NCT01234337|17887548|P1|Overall Study|Protocol Violation|2
5180615|NCT01234337|17887547|P2|Overall Study|Lost to Follow-up|1
5180616|NCT01234337|17887548|P1|Overall Study|Lost to Follow-up|0
5180617|NCT01234337|17887547|P2|Overall Study|Randomized but not treated|4
5180618|NCT01234337|17887548|P1|Overall Study|Randomized but not treated|6
5180619|NCT01234337|17887547|P2|Overall Study|Non-compliant with study medication|2
5180620|NCT01234337|17887548|P1|Overall Study|Non-compliant with study medication|3
5180621|NCT01234337|17887547|P2|Overall Study|Investi. decision not protocol driven|6
5180622|NCT01234337|17887548|P1|Overall Study|Investi. decision not protocol driven|5
5180623|NCT01234337|17887547|P2|Overall Study|Disease progression/recurrence/relapse|223
5180624|NCT01234337|17887548|P1|Overall Study|Disease progression/recurrence/relapse|181
5180625|NCT01234337|17887547|P2|Overall Study|Adverse Event|21
5180626|NCT01234337|17887548|P1|Overall Study|Adverse Event|58
5180627|NCT01233999|17887608|P1|Overall Study|Lost to Follow-up|1
5180628|NCT01233999|17887608|P1|Overall Study|Withdrawal by Subject|1
5180629|NCT01233869|17887627|P4|Extended Treatment Period (46 Months)|Adverse Event|1
5180630|NCT01233869|17887628|P3|Extended Treatment Period (46 Months)|Adverse Event|0
5180631|NCT01233869|17887629|P2|Extended Treatment Period (46 Months)|Adverse Event|0
5180632|NCT01233869|17887630|P1|Extended Treatment Period (46 Months)|Adverse Event|1
5180633|NCT01233869|17887627|P4|Extended Treatment Period (46 Months)|Other|3
5180634|NCT01233869|17887628|P3|Extended Treatment Period (46 Months)|Other|0
5180635|NCT01233869|17887629|P2|Extended Treatment Period (46 Months)|Other|0
5180636|NCT01233869|17887630|P1|Extended Treatment Period (46 Months)|Other|3
5180637|NCT01233869|17887627|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
5180638|NCT01233869|17887628|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
5180639|NCT01233869|17887629|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
5180640|NCT01233869|17887630|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
5180641|NCT01233869|17887627|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
5180642|NCT01233869|17887628|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5180643|NCT01233869|17887629|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5180644|NCT01233869|17887630|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5180645|NCT01233869|17887627|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
5180646|NCT01233869|17887628|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
5180647|NCT01233869|17887629|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
5180648|NCT01233869|17887630|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
5180649|NCT01233869|17887627|P4|Initial Treatment Period (24 Months)|Adverse Event|3
5180650|NCT01233869|17887628|P3|Initial Treatment Period (24 Months)|Adverse Event|0
5180651|NCT01233869|17887629|P2|Initial Treatment Period (24 Months)|Adverse Event|17
5180652|NCT01233869|17887630|P1|Initial Treatment Period (24 Months)|Adverse Event|9
5180653|NCT01233869|17887627|P4|Initial Treatment Period (24 Months)|Death|0
5180654|NCT01233869|17887628|P3|Initial Treatment Period (24 Months)|Death|0
5180655|NCT01233869|17887629|P2|Initial Treatment Period (24 Months)|Death|0
5180656|NCT01233869|17887630|P1|Initial Treatment Period (24 Months)|Death|1
5180657|NCT01233817|17887716|P1|Overall Study|Withdrawal by Subject|2
5180658|NCT01233817|17887716|P1|Overall Study|Lost to Follow-up|1
5180659|NCT01233687|17887763|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
5180660|NCT01233687|17887763|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
5180661|NCT01233687|17887763|P1|Phase II AMG 102 + Erlotinib|Death|1
5180662|NCT01233609|17887773|P2|Overall Study|Withdrawal by Subject|0
5180663|NCT01233609|17887774|P1|Overall Study|Withdrawal by Subject|3
5180664|NCT01233609|17887773|P2|Overall Study|Adverse Event|1
5180665|NCT01233609|17887774|P1|Overall Study|Adverse Event|2
5180666|NCT01233609|17887773|P2|Overall Study|Lost to Follow-up|1
5180667|NCT01233609|17887774|P1|Overall Study|Lost to Follow-up|3
5180668|NCT01233609|17887773|P2|Overall Study|Death|0
5180669|NCT01233609|17887774|P1|Overall Study|Death|1
5180670|NCT01233284|17887798|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
5180671|NCT01233284|17887799|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
5180672|NCT01233284|17887800|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
5180673|NCT01233284|17887801|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
5180674|NCT01233284|17887802|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
5180675|NCT01233284|17887798|P5|Period 4 (4 Weeks)|Adverse Event|0
5180676|NCT01233284|17887799|P4|Period 4 (4 Weeks)|Adverse Event|0
5180677|NCT01233284|17887800|P3|Period 4 (4 Weeks)|Adverse Event|0
5180678|NCT01233284|17887801|P2|Period 4 (4 Weeks)|Adverse Event|1
5180679|NCT01233284|17887802|P1|Period 4 (4 Weeks)|Adverse Event|0
5180680|NCT01233284|17887798|P5|Period 3 (4 Weeks)|Other|0
5180681|NCT01233284|17887799|P4|Period 3 (4 Weeks)|Other|1
5180682|NCT01233284|17887800|P3|Period 3 (4 Weeks)|Other|0
5180683|NCT01233284|17887801|P2|Period 3 (4 Weeks)|Other|0
5180684|NCT01233284|17887802|P1|Period 3 (4 Weeks)|Other|0
5180685|NCT01233284|17887798|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
5180686|NCT01233284|17887799|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
5180687|NCT01233284|17887800|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
5180688|NCT01233284|17887801|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
5180689|NCT01233284|17887802|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
5180690|NCT01233284|17887798|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
5180691|NCT01233284|17887799|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
5180692|NCT01233284|17887800|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
5180693|NCT01233284|17887801|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
5180694|NCT01233284|17887802|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
5180695|NCT01233284|17887798|P5|Period 1 (4 Weeks)|Other|0
5180696|NCT01233284|17887799|P4|Period 1 (4 Weeks)|Other|0
5180697|NCT01233284|17887800|P3|Period 1 (4 Weeks)|Other|1
5180698|NCT01233284|17887801|P2|Period 1 (4 Weeks)|Other|0
5180699|NCT01233284|17887802|P1|Period 1 (4 Weeks)|Other|0
5180700|NCT01233284|17887798|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
5180701|NCT01233284|17887799|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
5180702|NCT01233284|17887800|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
5180703|NCT01233284|17887801|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
5180704|NCT01233284|17887802|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
5180705|NCT01233284|17887798|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
5180706|NCT01233284|17887799|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
5180707|NCT01233284|17887800|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
5180708|NCT01233284|17887801|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
5180709|NCT01233284|17887802|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
5180710|NCT01233258|17887883|P6|First Intervention (6 Months)|Non-compliance with study medication|0
5180711|NCT01233258|17887884|P5|First Intervention (6 Months)|Non-compliance with study medication|0
5180712|NCT01233258|17887885|P4|First Intervention (6 Months)|Non-compliance with study medication|0
5180713|NCT01233258|17887886|P3|First Intervention (6 Months)|Non-compliance with study medication|0
5180714|NCT01233258|17887887|P2|First Intervention (6 Months)|Non-compliance with study medication|0
5180715|NCT01233258|17887888|P1|First Intervention (6 Months)|Non-compliance with study medication|1
5180716|NCT01233258|17887883|P6|First Intervention (6 Months)|Protocol Violation|0
5180717|NCT01233258|17887884|P5|First Intervention (6 Months)|Protocol Violation|0
5180718|NCT01233258|17887885|P4|First Intervention (6 Months)|Protocol Violation|0
5180719|NCT01233258|17887886|P3|First Intervention (6 Months)|Protocol Violation|1
5180720|NCT01233258|17887887|P2|First Intervention (6 Months)|Protocol Violation|0
5180721|NCT01233258|17887888|P1|First Intervention (6 Months)|Protocol Violation|0
5180722|NCT01233258|17887883|P6|First Intervention (6 Months)|Withdrawal by Subject|1
5180723|NCT01233258|17887884|P5|First Intervention (6 Months)|Withdrawal by Subject|0
5180724|NCT01233258|17887885|P4|First Intervention (6 Months)|Withdrawal by Subject|1
5180725|NCT01233258|17887886|P3|First Intervention (6 Months)|Withdrawal by Subject|0
5180726|NCT01233258|17887887|P2|First Intervention (6 Months)|Withdrawal by Subject|0
5180727|NCT01233258|17887888|P1|First Intervention (6 Months)|Withdrawal by Subject|0
5180728|NCT01233232|17887908|P3|Overall Study|Voluntary Discontinuation by Subject|0
5180729|NCT01233232|17887909|P2|Overall Study|Voluntary Discontinuation by Subject|0
5180730|NCT01233232|17887910|P1|Overall Study|Voluntary Discontinuation by Subject|1
5180731|NCT01233076|17887963|P2|Period 2, One Week|Lost to Follow-up|0
5180732|NCT01233076|17887964|P1|Period 2, One Week|Lost to Follow-up|1
5180733|NCT01233050|17887972|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
5180734|NCT01233050|17887973|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
5180735|NCT01232894|17888025|P2|Overall Study|Physician Decision|1
5180736|NCT01232894|17888026|P1|Overall Study|Physician Decision|2
5180737|NCT01232894|17888025|P2|Overall Study|Withdrawal by Subject|5
5180738|NCT01232894|17888026|P1|Overall Study|Withdrawal by Subject|8
5180739|NCT01232894|17888025|P2|Overall Study|Protocol Violation|1
5180740|NCT01232894|17888026|P1|Overall Study|Protocol Violation|1
5180741|NCT01232894|17888025|P2|Overall Study|Death|0
5180742|NCT01232894|17888026|P1|Overall Study|Death|1
5180743|NCT01232894|17888025|P2|Overall Study|Lost to Follow-up|1
5180744|NCT01232894|17888026|P1|Overall Study|Lost to Follow-up|0
5180745|NCT01232868|17888034|P2|Overall Study|Lost to Follow-up|4
5180746|NCT01232868|17888035|P1|Overall Study|Lost to Follow-up|2
5180747|NCT01232790|17888049|P2|Second Crossover|Withdrawal by Subject|2
5180748|NCT01232790|17888050|P1|Second Crossover|Withdrawal by Subject|1
5180749|NCT01232790|17888049|P2|First Crossover|Withdrawal by Subject|0
5180750|NCT01232790|17888050|P1|First Crossover|Withdrawal by Subject|1
5180751|NCT01232790|17888049|P2|Initial Assessment|Withdrawal by Subject|1
5180752|NCT01232790|17888050|P1|Initial Assessment|Withdrawal by Subject|0
5180753|NCT01232790|17888049|P2|Randomization|Physician Decision|1
5180754|NCT01232790|17888050|P1|Randomization|Physician Decision|0
5180755|NCT01232790|17888049|P2|Randomization|Protocol Violation|1
5180756|NCT01232790|17888050|P1|Randomization|Protocol Violation|0
5180757|NCT01232790|17888049|P2|Randomization|Withdrawal by Subject|0
5180758|NCT01232790|17888050|P1|Randomization|Withdrawal by Subject|2
5180759|NCT01232738|17888104|P1|Overall Study|Adverse Event|5
5180760|NCT01232738|17888104|P1|Overall Study|Withdrawal by Subject|2
5180761|NCT01232738|17888104|P1|Overall Study|Lost to Follow-up|1
5180762|NCT01232738|17888104|P1|Overall Study|Physician Decision|2
5180763|NCT01232738|17888104|P1|Overall Study|Death|3
5180764|NCT01232569|17888120|P4|Double-blind Treatment Period|Death|0
5180765|NCT01232569|17888121|P3|Double-blind Treatment Period|Death|0
5180766|NCT01232569|17888122|P2|Double-blind Treatment Period|Death|0
5180767|NCT01232569|17888123|P1|Double-blind Treatment Period|Death|2
5180768|NCT01232569|17888120|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
5180769|NCT01232569|17888121|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
5180770|NCT01232569|17888122|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
5180771|NCT01232569|17888123|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
5180772|NCT01232569|17888120|P4|Double-blind Treatment Period|Physician Decision|0
5180773|NCT01232569|17888121|P3|Double-blind Treatment Period|Physician Decision|0
5180774|NCT01232569|17888122|P2|Double-blind Treatment Period|Physician Decision|0
5180775|NCT01232569|17888123|P1|Double-blind Treatment Period|Physician Decision|1
5180776|NCT01232569|17888120|P4|Double-blind Treatment Period|Lack of Efficacy|0
5180777|NCT01232569|17888121|P3|Double-blind Treatment Period|Lack of Efficacy|0
5180778|NCT01232569|17888122|P2|Double-blind Treatment Period|Lack of Efficacy|2
5180779|NCT01232569|17888123|P1|Double-blind Treatment Period|Lack of Efficacy|1
5180780|NCT01232569|17888120|P4|Double-blind Treatment Period|Lost to Follow-up|0
5180781|NCT01232569|17888121|P3|Double-blind Treatment Period|Lost to Follow-up|0
5180782|NCT01232569|17888122|P2|Double-blind Treatment Period|Lost to Follow-up|0
5180783|NCT01232569|17888123|P1|Double-blind Treatment Period|Lost to Follow-up|4
5180784|NCT01232569|17888120|P4|Double-blind Treatment Period|Escape|0
5180785|NCT01232569|17888121|P3|Double-blind Treatment Period|Escape|0
5180786|NCT01232569|17888122|P2|Double-blind Treatment Period|Escape|2
5180787|NCT01232569|17888123|P1|Double-blind Treatment Period|Escape|2
5180788|NCT01232569|17888120|P4|Double-blind Treatment Period|Withdrawal by Subject|0
5180789|NCT01232569|17888121|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5180790|NCT01232569|17888122|P2|Double-blind Treatment Period|Withdrawal by Subject|2
5180791|NCT01232569|17888123|P1|Double-blind Treatment Period|Withdrawal by Subject|9
5180792|NCT01232556|17888166|P2|Overall Study|Other|4
5180793|NCT01232556|17888167|P1|Overall Study|Other|6
5180794|NCT01232556|17888166|P2|Overall Study|Terminated by Sponsor|51
5180795|NCT01232556|17888167|P1|Overall Study|Terminated by Sponsor|35
5180796|NCT01232556|17888166|P2|Overall Study|Lost to Follow-up|2
5180797|NCT01232556|17888167|P1|Overall Study|Lost to Follow-up|0
5180798|NCT01232556|17888166|P2|Overall Study|Death|97
5180799|NCT01232556|17888167|P1|Overall Study|Death|97
5180800|NCT01232556|17888166|P2|Overall Study|Withdrawal by Subject|17
5180801|NCT01232556|17888167|P1|Overall Study|Withdrawal by Subject|21
5180802|NCT01232491|17888226|P2|Overall Study|Other|18
5180803|NCT01232491|17888227|P1|Overall Study|Other|21
5180804|NCT01232491|17888226|P2|Overall Study|Withdrawal Criteria|21
5180805|NCT01232491|17888227|P1|Overall Study|Withdrawal Criteria|12
5180806|NCT01232491|17888226|P2|Overall Study|Protocol Violation|11
5180807|NCT01232491|17888227|P1|Overall Study|Protocol Violation|13
5180808|NCT01232491|17888226|P2|Overall Study|Lack of Efficacy|5
5180809|NCT01232491|17888227|P1|Overall Study|Lack of Efficacy|1
5180810|NCT01232491|17888226|P2|Overall Study|Adverse Event|8
5180811|NCT01232491|17888227|P1|Overall Study|Adverse Event|13
5180812|NCT01232452|17888256|P2|Overall Study|Protocol Violation|1
5180813|NCT01232452|17888257|P1|Overall Study|Protocol Violation|0
5180814|NCT01232452|17888256|P2|Overall Study|Sponsor Decision|1
5180815|NCT01232452|17888257|P1|Overall Study|Sponsor Decision|3
5180816|NCT01232452|17888256|P2|Overall Study|Protocol entry criterion not met|2
5180817|NCT01232452|17888257|P1|Overall Study|Protocol entry criterion not met|0
5180818|NCT01232452|17888256|P2|Overall Study|Physician Decision|12
5180819|NCT01232452|17888257|P1|Overall Study|Physician Decision|8
5180820|NCT01232452|17888256|P2|Overall Study|Withdrawal by Subject|8
5180821|NCT01232452|17888257|P1|Overall Study|Withdrawal by Subject|11
5180822|NCT01232452|17888256|P2|Overall Study|Adverse Event|15
5180823|NCT01232452|17888257|P1|Overall Study|Adverse Event|17
5180824|NCT01232296|17888283|P2|Overall Study|Death|6
5180825|NCT01232296|17888284|P1|Overall Study|Death|1
5180826|NCT01232296|17888283|P2|Overall Study|Subject/guardian decision|2
5180827|NCT01232296|17888284|P1|Overall Study|Subject/guardian decision|10
5180828|NCT01232296|17888283|P2|Overall Study|Technical problems|0
5180829|NCT01232296|17888284|P1|Overall Study|Technical problems|3
5180830|NCT01232296|17888283|P2|Overall Study|Study terminated by sponsor|1
5180831|NCT01232296|17888284|P1|Overall Study|Study terminated by sponsor|0
5180832|NCT01232296|17888283|P2|Overall Study|Progressive disease|61
5180833|NCT01232296|17888284|P1|Overall Study|Progressive disease|43
5180834|NCT01232296|17888283|P2|Overall Study|Physician Decision|1
5180835|NCT01232296|17888284|P1|Overall Study|Physician Decision|1
5180836|NCT01232296|17888283|P2|Overall Study|Adverse Event|12
5180837|NCT01232296|17888284|P1|Overall Study|Adverse Event|24
5180838|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
5180839|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
5180840|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180841|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180842|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180843|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180844|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180845|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180846|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180847|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5180848|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180849|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
5180850|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180851|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180852|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180853|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180854|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180855|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180856|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180857|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5180858|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180859|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
5180860|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180861|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180862|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180863|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180864|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180865|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180866|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180867|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
5180868|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
5180869|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
5180870|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180871|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180872|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180873|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180874|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180875|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180876|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180877|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5180878|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
5180879|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
5180880|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180881|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180882|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180883|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180884|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180885|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180886|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180887|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5180888|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
5180889|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
5180890|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180891|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180892|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180893|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180894|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180895|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180896|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180897|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5180898|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
5180899|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
5180900|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180901|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180902|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180903|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180904|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180905|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180906|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180907|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5180908|NCT01232283|17888301|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
5180909|NCT01232283|17888302|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
5180910|NCT01232283|17888303|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180911|NCT01232283|17888304|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180912|NCT01232283|17888305|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180913|NCT01232283|17888306|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180914|NCT01232283|17888307|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180915|NCT01232283|17888308|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180916|NCT01232283|17888309|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180917|NCT01232283|17888310|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5180918|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180919|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180920|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180921|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180922|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
5180923|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180924|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180925|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180926|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180927|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5180928|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180929|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180930|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
5180931|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180932|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180933|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180934|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180935|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180936|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180937|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5180938|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180939|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180940|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
5180941|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
5180942|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180943|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
5180944|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180945|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180946|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180947|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5180948|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180949|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180950|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180951|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180952|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180953|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
5180954|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180955|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180956|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180957|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5180958|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5180959|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5180960|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
5180961|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5180962|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5180963|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5180964|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5180965|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5180966|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5180967|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5180968|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180969|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180970|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
5180971|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
5180972|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180973|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
5180974|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180975|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180976|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180977|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5180978|NCT01232283|17888301|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180979|NCT01232283|17888302|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180980|NCT01232283|17888303|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
5180981|NCT01232283|17888304|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180982|NCT01232283|17888305|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
5180983|NCT01232283|17888306|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
5180984|NCT01232283|17888307|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180985|NCT01232283|17888308|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180986|NCT01232283|17888309|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180987|NCT01232283|17888310|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5180988|NCT01232283|17888301|P10|Maintenance Phase (Weeks16-32)|Other|0
5180989|NCT01232283|17888302|P9|Maintenance Phase (Weeks16-32)|Other|0
5180990|NCT01232283|17888303|P8|Maintenance Phase (Weeks16-32)|Other|0
5180991|NCT01232283|17888304|P7|Maintenance Phase (Weeks16-32)|Other|0
5180992|NCT01232283|17888305|P6|Maintenance Phase (Weeks16-32)|Other|0
5180993|NCT01232283|17888306|P5|Maintenance Phase (Weeks16-32)|Other|0
5180994|NCT01232283|17888307|P4|Maintenance Phase (Weeks16-32)|Other|0
5180995|NCT01232283|17888308|P3|Maintenance Phase (Weeks16-32)|Other|2
5180996|NCT01232283|17888309|P2|Maintenance Phase (Weeks16-32)|Other|0
5180997|NCT01232283|17888310|P1|Maintenance Phase (Weeks16-32)|Other|0
5180998|NCT01232283|17888301|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5180999|NCT01232283|17888302|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181000|NCT01232283|17888303|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181001|NCT01232283|17888304|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181002|NCT01232283|17888305|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181003|NCT01232283|17888306|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181004|NCT01232283|17888307|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
5181005|NCT01232283|17888308|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
5181006|NCT01232283|17888309|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181007|NCT01232283|17888310|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5181008|NCT01232283|17888301|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181009|NCT01232283|17888302|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181010|NCT01232283|17888303|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181011|NCT01232283|17888304|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181012|NCT01232283|17888305|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181013|NCT01232283|17888306|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181014|NCT01232283|17888307|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
5181015|NCT01232283|17888308|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
5181016|NCT01232283|17888309|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181017|NCT01232283|17888310|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5181018|NCT01232283|17888301|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181019|NCT01232283|17888302|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181020|NCT01232283|17888303|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181021|NCT01232283|17888304|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181022|NCT01232283|17888305|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181023|NCT01232283|17888306|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181024|NCT01232283|17888307|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181025|NCT01232283|17888308|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
5181026|NCT01232283|17888309|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181027|NCT01232283|17888310|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5181028|NCT01232283|17888301|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181029|NCT01232283|17888302|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181030|NCT01232283|17888303|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181031|NCT01232283|17888304|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181032|NCT01232283|17888305|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181033|NCT01232283|17888306|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181034|NCT01232283|17888307|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
5181035|NCT01232283|17888308|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
5181036|NCT01232283|17888309|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181037|NCT01232283|17888310|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5181038|NCT01232283|17888301|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181039|NCT01232283|17888302|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181040|NCT01232283|17888303|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181041|NCT01232283|17888304|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181042|NCT01232283|17888305|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181043|NCT01232283|17888306|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181044|NCT01232283|17888307|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
5181045|NCT01232283|17888308|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
5181046|NCT01232283|17888309|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181047|NCT01232283|17888310|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
5181048|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181049|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181050|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181051|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181052|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181053|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181054|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181055|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
5181056|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
5181057|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
5181058|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181059|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181060|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181061|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181062|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181063|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181064|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181065|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5181066|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
5181067|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
5181068|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181069|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181070|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181071|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181072|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181073|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181074|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181075|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5181076|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
5181077|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
5181078|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181079|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181080|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181081|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181082|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181083|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181084|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181085|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5181086|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
5181087|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
5181088|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181089|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181090|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181091|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181092|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181093|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181094|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181095|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181096|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5181097|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
5181181|NCT01231607|17888558|P4|Overall Study|Withdrawal by Subject|17
5181098|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181099|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181100|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181101|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181102|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181103|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181104|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181105|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5181106|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
5181107|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
5181108|NCT01232283|17888301|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181109|NCT01232283|17888302|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181110|NCT01232283|17888303|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181111|NCT01232283|17888304|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181112|NCT01232283|17888305|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181113|NCT01232283|17888306|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181114|NCT01232283|17888307|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181115|NCT01232283|17888308|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5181116|NCT01232283|17888309|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
5181117|NCT01232283|17888310|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
5181118|NCT01232127|17888351|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
5181119|NCT01232127|17888352|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
5181120|NCT01232127|17888353|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
5181121|NCT01231984|17888377|P4|Study Period 2|Did not continue to meet I/E Criteria|1
5181122|NCT01231984|17888378|P3|Study Period 2|Did not continue to meet I/E Criteria|0
5181123|NCT01231984|17888379|P2|Study Period 2|Did not continue to meet I/E Criteria|1
5181124|NCT01231984|17888380|P1|Study Period 2|Did not continue to meet I/E Criteria|1
5181125|NCT01231984|17888377|P4|Study Period 2|Lost to Follow-up|3
5181126|NCT01231984|17888378|P3|Study Period 2|Lost to Follow-up|0
5181127|NCT01231984|17888379|P2|Study Period 2|Lost to Follow-up|0
5181128|NCT01231984|17888380|P1|Study Period 2|Lost to Follow-up|1
5181129|NCT01231984|17888377|P4|Study Period 2|Withdrawal by Subject|0
5181130|NCT01231984|17888378|P3|Study Period 2|Withdrawal by Subject|0
5181131|NCT01231984|17888379|P2|Study Period 2|Withdrawal by Subject|1
5181132|NCT01231984|17888380|P1|Study Period 2|Withdrawal by Subject|1
5181133|NCT01231984|17888377|P4|Study Period 1|Other|1
5181134|NCT01231984|17888378|P3|Study Period 1|Other|0
5181135|NCT01231984|17888379|P2|Study Period 1|Other|0
5181136|NCT01231984|17888380|P1|Study Period 1|Other|0
5181137|NCT01231984|17888377|P4|Study Period 1|Adverse Event|0
5181138|NCT01231984|17888378|P3|Study Period 1|Adverse Event|0
5181139|NCT01231984|17888379|P2|Study Period 1|Adverse Event|0
5181140|NCT01231984|17888380|P1|Study Period 1|Adverse Event|1
5181141|NCT01231984|17888377|P4|Study Period 1|Protocol Violation|3
5181142|NCT01231984|17888378|P3|Study Period 1|Protocol Violation|2
5181143|NCT01231984|17888379|P2|Study Period 1|Protocol Violation|4
5181144|NCT01231984|17888380|P1|Study Period 1|Protocol Violation|3
5181145|NCT01231984|17888377|P4|Study Period 1|Non-compliance with study requirements|1
5181146|NCT01231984|17888378|P3|Study Period 1|Non-compliance with study requirements|2
5181147|NCT01231984|17888379|P2|Study Period 1|Non-compliance with study requirements|0
5181148|NCT01231984|17888380|P1|Study Period 1|Non-compliance with study requirements|5
5181149|NCT01231984|17888377|P4|Study Period 1|Screen Failure|1
5181150|NCT01231984|17888378|P3|Study Period 1|Screen Failure|0
5181151|NCT01231984|17888379|P2|Study Period 1|Screen Failure|0
5181152|NCT01231984|17888380|P1|Study Period 1|Screen Failure|0
5181153|NCT01231984|17888377|P4|Study Period 1|Did not continue to meet I/E Criteria|2
5181154|NCT01231984|17888378|P3|Study Period 1|Did not continue to meet I/E Criteria|2
5181155|NCT01231984|17888379|P2|Study Period 1|Did not continue to meet I/E Criteria|2
5181156|NCT01231984|17888380|P1|Study Period 1|Did not continue to meet I/E Criteria|2
5181157|NCT01231984|17888377|P4|Study Period 1|Lost to Follow-up|0
5181158|NCT01231984|17888378|P3|Study Period 1|Lost to Follow-up|1
5181159|NCT01231984|17888379|P2|Study Period 1|Lost to Follow-up|1
5181160|NCT01231984|17888380|P1|Study Period 1|Lost to Follow-up|1
5181161|NCT01231984|17888377|P4|Study Period 1|Withdrawal by Subject|1
5181162|NCT01231984|17888378|P3|Study Period 1|Withdrawal by Subject|0
5181163|NCT01231984|17888379|P2|Study Period 1|Withdrawal by Subject|0
5181164|NCT01231984|17888380|P1|Study Period 1|Withdrawal by Subject|0
5181165|NCT01231620|17888449|P3|Overall Study|Lost to Follow-up|9
5181166|NCT01231620|17888450|P2|Overall Study|Lost to Follow-up|4
5181167|NCT01231620|17888451|P1|Overall Study|Lost to Follow-up|3
5181168|NCT01231620|17888449|P3|Overall Study|Withdrawal by Subject|8
5181169|NCT01231620|17888450|P2|Overall Study|Withdrawal by Subject|6
5181170|NCT01231620|17888451|P1|Overall Study|Withdrawal by Subject|6
5181171|NCT01231620|17888449|P3|Overall Study|Adverse Event|1
5181172|NCT01231620|17888450|P2|Overall Study|Adverse Event|2
5181173|NCT01231620|17888451|P1|Overall Study|Adverse Event|2
5181174|NCT01231620|17888449|P3|Overall Study|Death|11
5181175|NCT01231620|17888450|P2|Overall Study|Death|14
5181176|NCT01231620|17888451|P1|Overall Study|Death|12
5181177|NCT01231620|17888449|P3|Overall Study|Physician Decision|10
5181178|NCT01231620|17888450|P2|Overall Study|Physician Decision|5
5181179|NCT01231620|17888451|P1|Overall Study|Physician Decision|3
5181180|NCT01231607|17888557|P5|Overall Study|Withdrawal by Subject|9
5181182|NCT01231607|17888559|P3|Overall Study|Withdrawal by Subject|14
5181183|NCT01231607|17888560|P2|Overall Study|Withdrawal by Subject|9
5181184|NCT01231607|17888561|P1|Overall Study|Withdrawal by Subject|9
5181185|NCT01231607|17888557|P5|Overall Study|Protocol Violation|2
5181186|NCT01231607|17888558|P4|Overall Study|Protocol Violation|2
5181187|NCT01231607|17888559|P3|Overall Study|Protocol Violation|0
5181188|NCT01231607|17888560|P2|Overall Study|Protocol Violation|2
5181189|NCT01231607|17888561|P1|Overall Study|Protocol Violation|3
5181190|NCT01231607|17888557|P5|Overall Study|Physician Decision|4
5181191|NCT01231607|17888558|P4|Overall Study|Physician Decision|5
5181192|NCT01231607|17888559|P3|Overall Study|Physician Decision|3
5181193|NCT01231607|17888560|P2|Overall Study|Physician Decision|4
5181194|NCT01231607|17888561|P1|Overall Study|Physician Decision|4
5181195|NCT01231607|17888557|P5|Overall Study|Lost to Follow-up|4
5181196|NCT01231607|17888558|P4|Overall Study|Lost to Follow-up|10
5181197|NCT01231607|17888559|P3|Overall Study|Lost to Follow-up|10
5181198|NCT01231607|17888560|P2|Overall Study|Lost to Follow-up|11
5181199|NCT01231607|17888561|P1|Overall Study|Lost to Follow-up|13
5181200|NCT01231607|17888557|P5|Overall Study|Adverse Event|5
5181201|NCT01231607|17888558|P4|Overall Study|Adverse Event|4
5181202|NCT01231607|17888559|P3|Overall Study|Adverse Event|4
5181203|NCT01231607|17888560|P2|Overall Study|Adverse Event|8
5181204|NCT01231607|17888561|P1|Overall Study|Adverse Event|0
5181205|NCT01231581|17888653|P2|Overall Study|Ongoing|0
5181206|NCT01231581|17888654|P1|Overall Study|Ongoing|1
5181207|NCT01231581|17888653|P2|Overall Study|Death|64
5181208|NCT01231581|17888654|P1|Overall Study|Death|65
5181209|NCT01231581|17888653|P2|Overall Study|Study Closed/Terminated|5
5181210|NCT01231581|17888654|P1|Overall Study|Study Closed/Terminated|6
5181211|NCT01231581|17888653|P2|Overall Study|Withdrawal by Subject|9
5181212|NCT01231581|17888654|P1|Overall Study|Withdrawal by Subject|6
5181213|NCT01231581|17888653|P2|Overall Study|Lost to Follow-up|2
5181214|NCT01231581|17888654|P1|Overall Study|Lost to Follow-up|2
5181215|NCT01231555|17888675|P3|Overall Study|Withdrawal by Subject|0
5181216|NCT01231555|17888676|P2|Overall Study|Withdrawal by Subject|2
5181217|NCT01231555|17888677|P1|Overall Study|Withdrawal by Subject|0
5181218|NCT01231555|17888675|P3|Overall Study|Study terminated|8
5181219|NCT01231555|17888676|P2|Overall Study|Study terminated|5
5181220|NCT01231555|17888677|P1|Overall Study|Study terminated|8
5181221|NCT01231516|17888708|P2|Open-label Phase|Ongoing at the time of analysis|23
5181222|NCT01231516|17888709|P1|Open-label Phase|Ongoing at the time of analysis|282
5181223|NCT01231516|17888708|P2|Open-label Phase|Withdrawal by Subject|0
5181224|NCT01231516|17888709|P1|Open-label Phase|Withdrawal by Subject|1
5181225|NCT01231516|17888708|P2|Open-label Phase|Lost to Follow-up|0
5181226|NCT01231516|17888709|P1|Open-label Phase|Lost to Follow-up|3
5181227|NCT01231516|17888708|P2|Open-label Phase|Protocol Violation|0
5181228|NCT01231516|17888709|P1|Open-label Phase|Protocol Violation|2
5181229|NCT01231516|17888708|P2|Open-label Phase|Lack of Efficacy|3
5181230|NCT01231516|17888709|P1|Open-label Phase|Lack of Efficacy|7
5181231|NCT01231516|17888708|P2|48 Week Double-blind Phase|Site Closed|1
5181232|NCT01231516|17888709|P1|48 Week Double-blind Phase|Site Closed|3
5181233|NCT01231516|17888708|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
5181234|NCT01231516|17888709|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
5181235|NCT01231516|17888708|P2|48 Week Double-blind Phase|Physician Decision|1
5181236|NCT01231516|17888709|P1|48 Week Double-blind Phase|Physician Decision|1
5181237|NCT01231516|17888708|P2|48 Week Double-blind Phase|Lost to Follow-up|10
5181238|NCT01231516|17888709|P1|48 Week Double-blind Phase|Lost to Follow-up|5
5181239|NCT01231516|17888708|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
5181240|NCT01231516|17888709|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
5181241|NCT01231516|17888708|P2|48 Week Double-blind Phase|Protocol Violation|6
5181242|NCT01231516|17888709|P1|48 Week Double-blind Phase|Protocol Violation|9
5181243|NCT01231516|17888708|P2|48 Week Double-blind Phase|Lack of Efficacy|42
5181244|NCT01231516|17888709|P1|48 Week Double-blind Phase|Lack of Efficacy|20
5181245|NCT01231516|17888708|P2|48 Week Double-blind Phase|Adverse Event|11
5181246|NCT01231516|17888709|P1|48 Week Double-blind Phase|Adverse Event|4
5181247|NCT01231503|17888739|P8|Overall Study|Protocol Violation|0
5181248|NCT01231503|17888740|P7|Overall Study|Protocol Violation|0
5181249|NCT01231503|17888741|P6|Overall Study|Protocol Violation|0
5181250|NCT01231503|17888742|P5|Overall Study|Protocol Violation|0
5181251|NCT01231503|17888743|P4|Overall Study|Protocol Violation|1
5181252|NCT01231503|17888744|P3|Overall Study|Protocol Violation|0
5181253|NCT01231503|17888745|P2|Overall Study|Protocol Violation|0
5181254|NCT01231503|17888746|P1|Overall Study|Protocol Violation|0
5181255|NCT01231503|17888739|P8|Overall Study|Lost to Follow-up|6
5181256|NCT01231503|17888740|P7|Overall Study|Lost to Follow-up|6
5181257|NCT01231503|17888741|P6|Overall Study|Lost to Follow-up|9
5181258|NCT01231503|17888742|P5|Overall Study|Lost to Follow-up|7
5181259|NCT01231503|17888743|P4|Overall Study|Lost to Follow-up|5
5181260|NCT01231503|17888744|P3|Overall Study|Lost to Follow-up|8
5181261|NCT01231503|17888745|P2|Overall Study|Lost to Follow-up|10
5181262|NCT01231503|17888746|P1|Overall Study|Lost to Follow-up|8
5181263|NCT01231503|17888739|P8|Overall Study|Withdrawal by Subject|2
5181264|NCT01231503|17888740|P7|Overall Study|Withdrawal by Subject|1
5181265|NCT01231503|17888741|P6|Overall Study|Withdrawal by Subject|5
5181266|NCT01231503|17888742|P5|Overall Study|Withdrawal by Subject|3
5181267|NCT01231503|17888743|P4|Overall Study|Withdrawal by Subject|1
5181268|NCT01231503|17888744|P3|Overall Study|Withdrawal by Subject|3
5181269|NCT01231503|17888745|P2|Overall Study|Withdrawal by Subject|3
5181270|NCT01231503|17888746|P1|Overall Study|Withdrawal by Subject|6
5181271|NCT01231503|17888739|P8|Overall Study|Adverse event, serious fatal|0
5181272|NCT01231503|17888740|P7|Overall Study|Adverse event, serious fatal|0
5181273|NCT01231503|17888741|P6|Overall Study|Adverse event, serious fatal|1
5181274|NCT01231503|17888742|P5|Overall Study|Adverse event, serious fatal|0
5181275|NCT01231503|17888743|P4|Overall Study|Adverse event, serious fatal|1
5181276|NCT01231503|17888744|P3|Overall Study|Adverse event, serious fatal|1
5181277|NCT01231503|17888745|P2|Overall Study|Adverse event, serious fatal|0
5181278|NCT01231503|17888746|P1|Overall Study|Adverse event, serious fatal|0
5181279|NCT01231503|17888739|P8|Overall Study|Adverse Event|0
5181280|NCT01231503|17888740|P7|Overall Study|Adverse Event|0
5181281|NCT01231503|17888741|P6|Overall Study|Adverse Event|1
5181282|NCT01231503|17888742|P5|Overall Study|Adverse Event|0
5181283|NCT01231503|17888743|P4|Overall Study|Adverse Event|0
5181284|NCT01231503|17888744|P3|Overall Study|Adverse Event|0
5181285|NCT01231503|17888745|P2|Overall Study|Adverse Event|0
5181286|NCT01231503|17888746|P1|Overall Study|Adverse Event|0
5181287|NCT01231464|17888986|P2|Overall Study|Withdrawal by Subject|2
5181288|NCT01231464|17888987|P1|Overall Study|Withdrawal by Subject|3
5181289|NCT01231464|17888986|P2|Overall Study|Lost to Follow-up|2
5181290|NCT01231464|17888987|P1|Overall Study|Lost to Follow-up|1
5181291|NCT01231464|17888986|P2|Overall Study|Protocol Violation|2
5181292|NCT01231464|17888987|P1|Overall Study|Protocol Violation|1
5181293|NCT01231464|17888986|P2|Overall Study|Adverse Event|1
5181294|NCT01231464|17888987|P1|Overall Study|Adverse Event|0
5181295|NCT01231373|17889036|P4|Overall Study|Withdrew Consent|0
5181296|NCT01231373|17889037|P3|Overall Study|Withdrew Consent|0
5181297|NCT01231373|17889038|P2|Overall Study|Withdrew Consent|0
5181298|NCT01231373|17889039|P1|Overall Study|Withdrew Consent|1
5181299|NCT01231373|17889036|P4|Overall Study|Lost to Follow-up|1
5181300|NCT01231373|17889037|P3|Overall Study|Lost to Follow-up|0
5181301|NCT01231373|17889038|P2|Overall Study|Lost to Follow-up|0
5181302|NCT01231373|17889039|P1|Overall Study|Lost to Follow-up|0
5181303|NCT01231373|17889036|P4|Overall Study|Withdrew consent prior to randomization|0
5181304|NCT01231373|17889037|P3|Overall Study|Withdrew consent prior to randomization|0
5181305|NCT01231373|17889038|P2|Overall Study|Withdrew consent prior to randomization|1
5181306|NCT01231373|17889039|P1|Overall Study|Withdrew consent prior to randomization|2
5181307|NCT01231321|17889078|P1|Overall Study|Lack of Efficacy|2
5181308|NCT01231321|17889078|P1|Overall Study|Adverse Event|3
5181309|NCT01230892|17889126|P2|Overall Study|Lost to Follow-up|0
5181310|NCT01230892|17889127|P1|Overall Study|Lost to Follow-up|2
5181311|NCT01230892|17889126|P2|Overall Study|Withdrawal by Subject|1
5181312|NCT01230892|17889127|P1|Overall Study|Withdrawal by Subject|1
5181313|NCT01230827|17889137|P4|Overall Study|Study terminated by Sponsor|63
5181314|NCT01230827|17889138|P3|Overall Study|Study terminated by Sponsor|56
5181315|NCT01230827|17889139|P2|Overall Study|Study terminated by Sponsor|2
5181316|NCT01230827|17889140|P1|Overall Study|Study terminated by Sponsor|0
5181317|NCT01230827|17889137|P4|Overall Study|Recovery|0
5181318|NCT01230827|17889138|P3|Overall Study|Recovery|0
5181319|NCT01230827|17889139|P2|Overall Study|Recovery|6
5181320|NCT01230827|17889140|P1|Overall Study|Recovery|0
5181321|NCT01230827|17889137|P4|Overall Study|Adverse Event|7
5181322|NCT01230827|17889138|P3|Overall Study|Adverse Event|3
5181323|NCT01230827|17889139|P2|Overall Study|Adverse Event|2
5181324|NCT01230827|17889140|P1|Overall Study|Adverse Event|4
5181325|NCT01230827|17889137|P4|Overall Study|Lack of Efficacy|3
5181326|NCT01230827|17889138|P3|Overall Study|Lack of Efficacy|2
5181327|NCT01230827|17889139|P2|Overall Study|Lack of Efficacy|1
5181328|NCT01230827|17889140|P1|Overall Study|Lack of Efficacy|14
5181329|NCT01230827|17889137|P4|Overall Study|Withdrawal by Subject|2
5181330|NCT01230827|17889138|P3|Overall Study|Withdrawal by Subject|3
5181331|NCT01230827|17889139|P2|Overall Study|Withdrawal by Subject|0
5181332|NCT01230827|17889140|P1|Overall Study|Withdrawal by Subject|1
5181333|NCT01230827|17889137|P4|Overall Study|Lost to Follow-up|3
5181334|NCT01230827|17889138|P3|Overall Study|Lost to Follow-up|1
5181335|NCT01230827|17889139|P2|Overall Study|Lost to Follow-up|0
5181336|NCT01230827|17889140|P1|Overall Study|Lost to Follow-up|0
5181337|NCT01230814|17889156|P2|Overall Study|Discontinued (not due to adverse event)|1
5181338|NCT01230814|17889157|P1|Overall Study|Discontinued (not due to adverse event)|2
5181339|NCT01230814|17889156|P2|Overall Study|Lost to Follow-up|3
5181340|NCT01230814|17889157|P1|Overall Study|Lost to Follow-up|11
5181341|NCT01230788|17889207|P1|Overall Study|Prescribed exclusion drug|1
5181342|NCT01230749|17889219|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
5181343|NCT01230749|17889220|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
5181344|NCT01230749|17889221|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
5181345|NCT01230749|17889222|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
5181346|NCT01230749|17889219|P4|Overall Study|Withdrawal by Subject|0
5181347|NCT01230749|17889220|P3|Overall Study|Withdrawal by Subject|0
5181348|NCT01230749|17889221|P2|Overall Study|Withdrawal by Subject|1
5181349|NCT01230749|17889222|P1|Overall Study|Withdrawal by Subject|0
5181350|NCT01230749|17889219|P4|Overall Study|Physician Decision|0
5181351|NCT01230749|17889220|P3|Overall Study|Physician Decision|1
5181352|NCT01230749|17889221|P2|Overall Study|Physician Decision|0
5181353|NCT01230749|17889222|P1|Overall Study|Physician Decision|0
5181354|NCT01230749|17889219|P4|Overall Study|Adverse Event|1
5181355|NCT01230749|17889220|P3|Overall Study|Adverse Event|0
5181356|NCT01230749|17889221|P2|Overall Study|Adverse Event|0
5181357|NCT01230749|17889222|P1|Overall Study|Adverse Event|0
5181358|NCT01230710|17889257|P1|Overall Study|Withdrawal of Consent|1
5181359|NCT01230710|17889257|P1|Overall Study|Death|4
5181360|NCT01230710|17889257|P1|Overall Study|Lost to Follow-up|3
5181361|NCT01230710|17889257|P1|Overall Study|Disease Progression|41
5181362|NCT01230554|17889281|P1|Overall Study|Inability to maintain visit schedule|1
5181363|NCT01230554|17889281|P1|Overall Study|Lost to Follow-up|2
5181364|NCT01230489|17889304|P1|Overall Study|Treatment modality changed|1
5181365|NCT01230489|17889304|P1|Overall Study|Adverse Event|2
5181366|NCT01230489|17889304|P1|Overall Study|Death|2
5181367|NCT01230307|17889339|P2|Overall Study|LVAD Placement|2
5181368|NCT01230307|17889340|P1|Overall Study|LVAD Placement|0
5181369|NCT01230060|17889373|P1|Overall Study|Withdrawal by Subject|1
5181370|NCT01229735|17889446|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5181371|NCT01229735|17889447|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5181372|NCT01229735|17889446|P2|Overall Study|AE, non-serious non-fatal|17
5181373|NCT01229735|17889447|P1|Overall Study|AE, non-serious non-fatal|13
5181374|NCT01229735|17889446|P2|Overall Study|SAE, non-fatal|4
5181375|NCT01229735|17889447|P1|Overall Study|SAE, non-fatal|0
5181376|NCT01229735|17889446|P2|Overall Study|Other Reason|10
5181377|NCT01229735|17889447|P1|Overall Study|Other Reason|13
5181378|NCT01229735|17889446|P2|Overall Study|Withdrawal by Subject|17
5181379|NCT01229735|17889447|P1|Overall Study|Withdrawal by Subject|18
5181380|NCT01229735|17889446|P2|Overall Study|Lost to Follow-up|2
5181381|NCT01229735|17889447|P1|Overall Study|Lost to Follow-up|0
5181382|NCT01229735|17889446|P2|Overall Study|Protocol Violation|8
5181383|NCT01229735|17889447|P1|Overall Study|Protocol Violation|13
5181384|NCT01229735|17889446|P2|Overall Study|Lack of Efficacy|8
5181385|NCT01229735|17889447|P1|Overall Study|Lack of Efficacy|8
5181386|NCT01229449|17889504|P5|Overall Study|Physician Decision|0
5181387|NCT01229449|17889505|P4|Overall Study|Physician Decision|0
5181388|NCT01229449|17889506|P3|Overall Study|Physician Decision|1
5181389|NCT01229449|17889507|P2|Overall Study|Physician Decision|0
5181390|NCT01229449|17889508|P1|Overall Study|Physician Decision|0
5181391|NCT01229449|17889504|P5|Overall Study|Lost to Follow-up|0
5181392|NCT01229449|17889505|P4|Overall Study|Lost to Follow-up|0
5181393|NCT01229449|17889506|P3|Overall Study|Lost to Follow-up|1
5181394|NCT01229449|17889507|P2|Overall Study|Lost to Follow-up|1
5181395|NCT01229449|17889508|P1|Overall Study|Lost to Follow-up|1
5181396|NCT01229449|17889504|P5|Overall Study|Withdrawal by Subject|1
5181397|NCT01229449|17889505|P4|Overall Study|Withdrawal by Subject|1
5181398|NCT01229449|17889506|P3|Overall Study|Withdrawal by Subject|0
5181399|NCT01229449|17889507|P2|Overall Study|Withdrawal by Subject|3
5181400|NCT01229449|17889508|P1|Overall Study|Withdrawal by Subject|0
5181401|NCT01229436|17889565|P1|Overall Study|Lost to Follow-up|3
5181402|NCT01229436|17889565|P1|Overall Study|Withdrawal by Subject|2
5181403|NCT01229397|17889627|P2|Overall Study|Migrated/moved from study area|0
5181404|NCT01229397|17889628|P1|Overall Study|Migrated/moved from study area|1
5181405|NCT01229397|17889627|P2|Overall Study|Lost to Follow-up|6
5181406|NCT01229397|17889628|P1|Overall Study|Lost to Follow-up|7
5181407|NCT01229397|17889627|P2|Overall Study|Withdrawal by Subject|3
5181408|NCT01229397|17889628|P1|Overall Study|Withdrawal by Subject|3
5181409|NCT01229371|17889646|P4|Overall Study|Withdrawal by Subject|0
5181410|NCT01229371|17889647|P3|Overall Study|Withdrawal by Subject|0
5181411|NCT01229371|17889648|P2|Overall Study|Withdrawal by Subject|1
5181412|NCT01229371|17889649|P1|Overall Study|Withdrawal by Subject|0
5181413|NCT01229267|17889676|P5|Overall Study|Lost to Follow-up|22
5181414|NCT01229267|17889677|P4|Overall Study|Lost to Follow-up|3
5181415|NCT01229267|17889678|P3|Overall Study|Lost to Follow-up|8
5181416|NCT01229267|17889679|P2|Overall Study|Lost to Follow-up|5
5181417|NCT01229267|17889680|P1|Overall Study|Lost to Follow-up|6
5181418|NCT01229267|17889676|P5|Overall Study|Physician Decision|25
5181419|NCT01229267|17889677|P4|Overall Study|Physician Decision|3
5181420|NCT01229267|17889678|P3|Overall Study|Physician Decision|8
5181421|NCT01229267|17889679|P2|Overall Study|Physician Decision|11
5181422|NCT01229267|17889680|P1|Overall Study|Physician Decision|8
5181423|NCT01229267|17889676|P5|Overall Study|Progressive disease|1
5181424|NCT01229267|17889677|P4|Overall Study|Progressive disease|0
5181425|NCT01229267|17889678|P3|Overall Study|Progressive disease|0
5181426|NCT01229267|17889679|P2|Overall Study|Progressive disease|0
5181427|NCT01229267|17889680|P1|Overall Study|Progressive disease|0
5181428|NCT01229267|17889676|P5|Overall Study|Protocol Violation|0
5181429|NCT01229267|17889677|P4|Overall Study|Protocol Violation|0
5181430|NCT01229267|17889678|P3|Overall Study|Protocol Violation|0
5181431|NCT01229267|17889679|P2|Overall Study|Protocol Violation|1
5181432|NCT01229267|17889680|P1|Overall Study|Protocol Violation|0
5181433|NCT01229267|17889676|P5|Overall Study|Withdrawal by Subject|59
5181434|NCT01229267|17889677|P4|Overall Study|Withdrawal by Subject|14
5181435|NCT01229267|17889678|P3|Overall Study|Withdrawal by Subject|32
5181436|NCT01229267|17889679|P2|Overall Study|Withdrawal by Subject|22
5181437|NCT01229267|17889680|P1|Overall Study|Withdrawal by Subject|23
5181438|NCT01229267|17889676|P5|Overall Study|Death|103
5181439|NCT01229267|17889677|P4|Overall Study|Death|13
5181440|NCT01229267|17889678|P3|Overall Study|Death|35
5181441|NCT01229267|17889679|P2|Overall Study|Death|37
5181442|NCT01229267|17889680|P1|Overall Study|Death|40
5181443|NCT01229267|17889676|P5|Overall Study|Adverse Event|10
5181444|NCT01229267|17889677|P4|Overall Study|Adverse Event|2
5181445|NCT01229267|17889678|P3|Overall Study|Adverse Event|3
5181446|NCT01229267|17889679|P2|Overall Study|Adverse Event|6
5181447|NCT01229267|17889680|P1|Overall Study|Adverse Event|4
5181448|NCT01229254|17889699|P3|Overall Study|Non-compliance with Study Drug|1
5181449|NCT01229254|17889700|P2|Overall Study|Non-compliance with Study Drug|1
5181450|NCT01229254|17889701|P1|Overall Study|Non-compliance with Study Drug|0
5181451|NCT01229254|17889699|P3|Overall Study|Withdrawal by Subject|1
5181452|NCT01229254|17889700|P2|Overall Study|Withdrawal by Subject|0
5181453|NCT01229254|17889701|P1|Overall Study|Withdrawal by Subject|1
5181454|NCT01229254|17889699|P3|Overall Study|Protocol Violation|5
5181455|NCT01229254|17889700|P2|Overall Study|Protocol Violation|6
5181456|NCT01229254|17889701|P1|Overall Study|Protocol Violation|4
5181457|NCT01229254|17889699|P3|Overall Study|Physician Decision|0
5181458|NCT01229254|17889700|P2|Overall Study|Physician Decision|3
5181459|NCT01229254|17889701|P1|Overall Study|Physician Decision|0
5181460|NCT01229254|17889699|P3|Overall Study|Lost to Follow-up|1
5181461|NCT01229254|17889700|P2|Overall Study|Lost to Follow-up|0
5181462|NCT01229254|17889701|P1|Overall Study|Lost to Follow-up|3
5181463|NCT01229254|17889699|P3|Overall Study|Adverse Event|3
5181464|NCT01229254|17889700|P2|Overall Study|Adverse Event|5
5181465|NCT01229254|17889701|P1|Overall Study|Adverse Event|4
5181466|NCT01229254|17889699|P3|Overall Study|Not Continuing Into Safety Extension|1
5181467|NCT01229254|17889700|P2|Overall Study|Not Continuing Into Safety Extension|1
5181468|NCT01229254|17889701|P1|Overall Study|Not Continuing Into Safety Extension|3
5181469|NCT01229176|17889739|P8|Overall Study|Lost to Follow-up|2
5181470|NCT01229176|17889740|P7|Overall Study|Lost to Follow-up|0
5181471|NCT01229176|17889741|P6|Overall Study|Lost to Follow-up|1
5181472|NCT01229176|17889742|P5|Overall Study|Lost to Follow-up|1
5181473|NCT01229176|17889743|P4|Overall Study|Lost to Follow-up|0
5181474|NCT01229176|17889744|P3|Overall Study|Lost to Follow-up|0
5181475|NCT01229176|17889745|P2|Overall Study|Lost to Follow-up|3
5181476|NCT01229176|17889746|P1|Overall Study|Lost to Follow-up|0
5181477|NCT01229176|17889739|P8|Overall Study|Withdrawal by Subject|1
5181478|NCT01229176|17889740|P7|Overall Study|Withdrawal by Subject|0
5181479|NCT01229176|17889741|P6|Overall Study|Withdrawal by Subject|1
5181480|NCT01229176|17889742|P5|Overall Study|Withdrawal by Subject|1
5181481|NCT01229176|17889743|P4|Overall Study|Withdrawal by Subject|1
5181482|NCT01229176|17889744|P3|Overall Study|Withdrawal by Subject|0
5181483|NCT01229176|17889745|P2|Overall Study|Withdrawal by Subject|0
5181484|NCT01229176|17889746|P1|Overall Study|Withdrawal by Subject|0
5181485|NCT01229150|17889800|P4|Overall Study|Toxicity|0
5181486|NCT01229150|17889801|P3|Overall Study|Toxicity|0
5181487|NCT01229150|17889802|P2|Overall Study|Toxicity|2
5181488|NCT01229150|17889803|P1|Overall Study|Toxicity|2
5181489|NCT01229111|17889860|P1|Overall Study|Death|1
5181490|NCT01228747|17889909|P2|Overall Study|Other Reason|5
5181491|NCT01228747|17889910|P1|Overall Study|Other Reason|2
5181492|NCT01228747|17889909|P2|Overall Study|Withdrawal by Subject|1
5181493|NCT01228747|17889910|P1|Overall Study|Withdrawal by Subject|5
5181494|NCT01228747|17889909|P2|Overall Study|Lost to Follow-up|3
5181495|NCT01228747|17889910|P1|Overall Study|Lost to Follow-up|4
5181496|NCT01228747|17889909|P2|Overall Study|Protocol Violation|5
5181497|NCT01228747|17889910|P1|Overall Study|Protocol Violation|6
5181498|NCT01228747|17889909|P2|Overall Study|Lack of Efficacy|27
5181499|NCT01228747|17889910|P1|Overall Study|Lack of Efficacy|40
5181500|NCT01228747|17889909|P2|Overall Study|Adverse Event|4
5181501|NCT01228747|17889910|P1|Overall Study|Adverse Event|8
5181502|NCT01228734|17889926|P2|Overall Study|Randomized, but not treated|4
5181503|NCT01228734|17889927|P1|Overall Study|Randomized, but not treated|0
5181504|NCT01228591|17889941|P2|Baseline|Lack of Efficacy|2
5181505|NCT01228591|17889942|P1|Baseline|Lack of Efficacy|1
5181506|NCT01228318|17889971|P2|Overall Study|Incarcerated|0
5181507|NCT01228318|17889972|P1|Overall Study|Incarcerated|1
5181508|NCT01228318|17889971|P2|Overall Study|Moved|2
5181509|NCT01228318|17889972|P1|Overall Study|Moved|0
5181510|NCT01228318|17889971|P2|Overall Study|Unable to contact|5
5181511|NCT01228318|17889972|P1|Overall Study|Unable to contact|2
5181512|NCT01228318|17889971|P2|Overall Study|Clinic no show to receive intervention|0
5181513|NCT01228318|17889972|P1|Overall Study|Clinic no show to receive intervention|1
5181514|NCT01228175|17889988|P2|Overall Study|Physician Decision|1
5181515|NCT01228175|17889989|P1|Overall Study|Physician Decision|1
5181516|NCT01228175|17889988|P2|Overall Study|Withdrawal by Subject|2
5181517|NCT01228175|17889989|P1|Overall Study|Withdrawal by Subject|1
5181518|NCT01228175|17889988|P2|Overall Study|Lost to Follow-up|50
5181519|NCT01228175|17889989|P1|Overall Study|Lost to Follow-up|64
5181520|NCT01228071|17890031|P1|Overall Study|Withdrawal by Subject|1
5181521|NCT01228071|17890031|P1|Overall Study|Protocol Violation|1
5181522|NCT01228019|17890037|P1|Overall Study|Violation of Entry Criterion|9
5181523|NCT01228019|17890037|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
5181524|NCT01228019|17890037|P1|Overall Study|Missing pre-treatment data|72
5181525|NCT01228019|17890037|P1|Overall Study|Duplicate enrollment|1
5181526|NCT01228019|17890037|P1|Overall Study|Dose Violation|70
5181527|NCT01227967|17890103|P2|Overall Study|Taking Additional Antiviral Drug|0
5181528|NCT01227967|17890104|P1|Overall Study|Taking Additional Antiviral Drug|1
5181529|NCT01227967|17890103|P2|Overall Study|Never Started Treatment|4
5181530|NCT01227967|17890104|P1|Overall Study|Never Started Treatment|0
5181531|NCT01227967|17890103|P2|Overall Study|Physician Decision|1
5181532|NCT01227967|17890104|P1|Overall Study|Physician Decision|0
5181533|NCT01227967|17890103|P2|Overall Study|Withdrawal by Subject|3
5181534|NCT01227967|17890104|P1|Overall Study|Withdrawal by Subject|4
5181535|NCT01227967|17890103|P2|Overall Study|Lost to Follow-up|3
5181536|NCT01227967|17890104|P1|Overall Study|Lost to Follow-up|8
5181537|NCT01227967|17890103|P2|Overall Study|Death|1
5181538|NCT01227967|17890104|P1|Overall Study|Death|0
5181539|NCT01227967|17890103|P2|Overall Study|Protocol Violation|1
5181540|NCT01227967|17890104|P1|Overall Study|Protocol Violation|3
5181541|NCT01227954|17890138|P1|Overall Study|No protocol treatment|7
5181542|NCT01227954|17890138|P1|Overall Study|Protocol Violation|6
5181543|NCT01227928|17890152|P2|Overall Study|Death|12
5181544|NCT01227928|17890153|P1|Overall Study|Death|14
5181545|NCT01227928|17890152|P2|Overall Study|Withdrawal by Subject|3
5181546|NCT01227928|17890153|P1|Overall Study|Withdrawal by Subject|4
5181547|NCT01227928|17890152|P2|Overall Study|Lost to Follow-up|2
5181548|NCT01227928|17890153|P1|Overall Study|Lost to Follow-up|4
5181549|NCT01227902|17890191|P4|Overall Study|Withdrawal by Subject|3
5181550|NCT01227902|17890192|P3|Overall Study|Withdrawal by Subject|4
5181551|NCT01227902|17890193|P2|Overall Study|Withdrawal by Subject|2
5181552|NCT01227902|17890194|P1|Overall Study|Withdrawal by Subject|4
5181553|NCT01227902|17890191|P4|Overall Study|Physician Decision|0
5181554|NCT01227902|17890192|P3|Overall Study|Physician Decision|1
5181555|NCT01227902|17890193|P2|Overall Study|Physician Decision|1
5181556|NCT01227902|17890194|P1|Overall Study|Physician Decision|0
5181557|NCT01227902|17890191|P4|Overall Study|Lost to Follow-up|2
5181558|NCT01227902|17890192|P3|Overall Study|Lost to Follow-up|1
5181559|NCT01227902|17890193|P2|Overall Study|Lost to Follow-up|0
5181560|NCT01227902|17890194|P1|Overall Study|Lost to Follow-up|0
5181561|NCT01227902|17890191|P4|Overall Study|Protocol Violation|0
5181562|NCT01227902|17890192|P3|Overall Study|Protocol Violation|0
5181563|NCT01227902|17890193|P2|Overall Study|Protocol Violation|0
5181564|NCT01227902|17890194|P1|Overall Study|Protocol Violation|1
5181565|NCT01227902|17890191|P4|Overall Study|Lack of Efficacy|1
5181566|NCT01227902|17890192|P3|Overall Study|Lack of Efficacy|2
5181567|NCT01227902|17890193|P2|Overall Study|Lack of Efficacy|2
5181568|NCT01227902|17890194|P1|Overall Study|Lack of Efficacy|1
5181569|NCT01227902|17890191|P4|Overall Study|Adverse Event|4
5181570|NCT01227902|17890192|P3|Overall Study|Adverse Event|11
5181571|NCT01227902|17890193|P2|Overall Study|Adverse Event|8
5181572|NCT01227902|17890194|P1|Overall Study|Adverse Event|12
5181573|NCT01227889|17890287|P2|Crossover Phase|Withdrawal by Subject|1
5181574|NCT01227889|17890288|P1|Crossover Phase|Withdrawal by Subject|0
5181575|NCT01227889|17890287|P2|Crossover Phase|Study Terminated By Sponsor|1
5181576|NCT01227889|17890288|P1|Crossover Phase|Study Terminated By Sponsor|0
5181577|NCT01227889|17890287|P2|Crossover Phase|Progressive Disease|31
5181578|NCT01227889|17890288|P1|Crossover Phase|Progressive Disease|0
5181579|NCT01227889|17890287|P2|Crossover Phase|Physician Decision|3
5181580|NCT01227889|17890288|P1|Crossover Phase|Physician Decision|0
5181581|NCT01227889|17890287|P2|Crossover Phase|Adverse Event|1
5181582|NCT01227889|17890288|P1|Crossover Phase|Adverse Event|0
5181583|NCT01227889|17890287|P2|Randomized Phase (RP)|Withdrawal by Subject|3
5181584|NCT01227889|17890288|P1|Randomized Phase (RP)|Withdrawal by Subject|15
5181585|NCT01227889|17890287|P2|Randomized Phase (RP)|Missing|3
5181586|NCT01227889|17890288|P1|Randomized Phase (RP)|Missing|1
5181587|NCT01227889|17890287|P2|Randomized Phase (RP)|Study terminated by sponsor|0
5181588|NCT01227889|17890288|P1|Randomized Phase (RP)|Study terminated by sponsor|10
5181589|NCT01227889|17890287|P2|Randomized Phase (RP)|Progressive Disease|52
5181590|NCT01227889|17890288|P1|Randomized Phase (RP)|Progressive Disease|135
5181591|NCT01227889|17890287|P2|Randomized Phase (RP)|Physician Decision|5
5181592|NCT01227889|17890288|P1|Randomized Phase (RP)|Physician Decision|13
5181593|NCT01227889|17890287|P2|Randomized Phase (RP)|Adverse Event|0
5181594|NCT01227889|17890288|P1|Randomized Phase (RP)|Adverse Event|13
5181595|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
5181596|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
5181597|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
5181598|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
5181599|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
5181600|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
5181601|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
5181602|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
5181603|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
5181604|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
5181605|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
5181606|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
5181607|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
5181608|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
5181609|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
5181610|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
5181611|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
5181612|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
5181613|NCT01227824|17890315|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
5181614|NCT01227824|17890316|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
5181615|NCT01227824|17890317|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
5181616|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
5181617|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
5181618|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
5181619|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
5181620|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
5181621|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
5181622|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
5181623|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
5181624|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
5181625|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
5181626|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
5181627|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
5181628|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
5181629|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
5181630|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
5181631|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
5181632|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
5181633|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
5181634|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
5181635|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
5181636|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
5181637|NCT01227824|17890315|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
5181638|NCT01227824|17890316|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
5181639|NCT01227824|17890317|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
5181640|NCT01227707|17890412|P1|Overall Study|Death|1
5181641|NCT01227707|17890412|P1|Overall Study|Medical decision|6
5181642|NCT01227707|17890412|P1|Overall Study|Patient non-compliance|3
5181643|NCT01227707|17890412|P1|Overall Study|Withdrawal by Subject|1
5181644|NCT01227707|17890412|P1|Overall Study|Progression of disease|3
5181645|NCT01227707|17890412|P1|Overall Study|Adverse Event|10
5181646|NCT01227668|17890439|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
5181647|NCT01227668|17890440|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
5181648|NCT01227668|17890439|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
5181649|NCT01227668|17890440|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
5181650|NCT01227668|17890439|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
5181651|NCT01227668|17890440|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
5181652|NCT01227668|17890439|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
5181653|NCT01227668|17890440|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
5181654|NCT01227668|17890439|P2|Phase 2 (Randomization Phase)|Adverse Event|1
5181655|NCT01227668|17890440|P1|Phase 2 (Randomization Phase)|Adverse Event|0
5181656|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
5181657|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
5181658|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
5181659|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
5181660|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
5181661|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
5181662|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
5181663|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
5181664|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
5181665|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
5181666|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
5181667|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
5181668|NCT01227668|17890439|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
5181669|NCT01227668|17890440|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
5181670|NCT01227629|17890486|P10|Overall Study|Other|1
5181671|NCT01227629|17890487|P9|Overall Study|Other|2
5181672|NCT01227629|17890488|P8|Overall Study|Other|0
5181673|NCT01227629|17890489|P7|Overall Study|Other|0
5181674|NCT01227629|17890490|P6|Overall Study|Other|0
5181675|NCT01227629|17890491|P5|Overall Study|Other|0
5181676|NCT01227629|17890492|P4|Overall Study|Other|1
5181677|NCT01227629|17890493|P3|Overall Study|Other|0
5181678|NCT01227629|17890494|P2|Overall Study|Other|0
5181679|NCT01227629|17890495|P1|Overall Study|Other|0
5181680|NCT01227629|17890486|P10|Overall Study|Withdrawal by Subject|1
5181681|NCT01227629|17890487|P9|Overall Study|Withdrawal by Subject|0
5181682|NCT01227629|17890488|P8|Overall Study|Withdrawal by Subject|0
5181683|NCT01227629|17890489|P7|Overall Study|Withdrawal by Subject|2
5181684|NCT01227629|17890490|P6|Overall Study|Withdrawal by Subject|0
5181685|NCT01227629|17890491|P5|Overall Study|Withdrawal by Subject|0
5181686|NCT01227629|17890492|P4|Overall Study|Withdrawal by Subject|0
5181687|NCT01227629|17890493|P3|Overall Study|Withdrawal by Subject|0
5181688|NCT01227629|17890494|P2|Overall Study|Withdrawal by Subject|0
5181689|NCT01227629|17890495|P1|Overall Study|Withdrawal by Subject|0
5181690|NCT01227629|17890486|P10|Overall Study|Lost to Follow-up|0
5181691|NCT01227629|17890487|P9|Overall Study|Lost to Follow-up|0
5181692|NCT01227629|17890488|P8|Overall Study|Lost to Follow-up|0
5181693|NCT01227629|17890489|P7|Overall Study|Lost to Follow-up|0
5181694|NCT01227629|17890490|P6|Overall Study|Lost to Follow-up|0
5181695|NCT01227629|17890491|P5|Overall Study|Lost to Follow-up|1
5181696|NCT01227629|17890492|P4|Overall Study|Lost to Follow-up|0
5181697|NCT01227629|17890493|P3|Overall Study|Lost to Follow-up|0
5181698|NCT01227629|17890494|P2|Overall Study|Lost to Follow-up|0
5181699|NCT01227629|17890495|P1|Overall Study|Lost to Follow-up|0
5181700|NCT01227629|17890486|P10|Overall Study|Protocol Violation|0
5181701|NCT01227629|17890487|P9|Overall Study|Protocol Violation|0
5181702|NCT01227629|17890488|P8|Overall Study|Protocol Violation|0
5181703|NCT01227629|17890489|P7|Overall Study|Protocol Violation|0
5181704|NCT01227629|17890490|P6|Overall Study|Protocol Violation|0
5181705|NCT01227629|17890491|P5|Overall Study|Protocol Violation|0
5181706|NCT01227629|17890492|P4|Overall Study|Protocol Violation|1
5181707|NCT01227629|17890493|P3|Overall Study|Protocol Violation|0
5181708|NCT01227629|17890494|P2|Overall Study|Protocol Violation|0
5181709|NCT01227629|17890495|P1|Overall Study|Protocol Violation|0
5181710|NCT01227629|17890486|P10|Overall Study|Adverse Event|0
5181711|NCT01227629|17890487|P9|Overall Study|Adverse Event|4
5181712|NCT01227629|17890488|P8|Overall Study|Adverse Event|6
5181713|NCT01227629|17890489|P7|Overall Study|Adverse Event|6
5181714|NCT01227629|17890490|P6|Overall Study|Adverse Event|1
5181715|NCT01227629|17890491|P5|Overall Study|Adverse Event|1
5181716|NCT01227629|17890492|P4|Overall Study|Adverse Event|6
5181717|NCT01227629|17890493|P3|Overall Study|Adverse Event|1
5181718|NCT01227629|17890494|P2|Overall Study|Adverse Event|2
5181719|NCT01227629|17890495|P1|Overall Study|Adverse Event|2
5181720|NCT01227577|17890744|P1|Overall Study|Adverse Event|17
5181721|NCT01227577|17890744|P1|Overall Study|Lack of Efficacy|5
5181722|NCT01227577|17890744|P1|Overall Study|Withdrawal by Subject|4
5181723|NCT01227577|17890744|P1|Overall Study|Lost to Follow-up|1
5181724|NCT01227577|17890744|P1|Overall Study|Administrative problems|2
5181725|NCT01227577|17890744|P1|Overall Study|Death|3
5181726|NCT01227577|17890744|P1|Overall Study|Protocol deviation|3
5181727|NCT01227564|17890759|P3|Overall Study|Participant moved to another town|1
5181728|NCT01227564|17890760|P2|Overall Study|Participant moved to another town|0
5181729|NCT01227564|17890761|P1|Overall Study|Participant moved to another town|0
5181730|NCT01227564|17890759|P3|Overall Study|No Longer Willing to Participate|5
5181731|NCT01227564|17890760|P2|Overall Study|No Longer Willing to Participate|2
5181732|NCT01227564|17890761|P1|Overall Study|No Longer Willing to Participate|4
5181733|NCT01227512|17890899|P2|Overall Study|Participant met withdrawal criteria|1
5181734|NCT01227512|17890900|P1|Overall Study|Participant met withdrawal criteria|0
5181735|NCT01227512|17890899|P2|Overall Study|Withdrawal by Subject|0
5181736|NCT01227512|17890900|P1|Overall Study|Withdrawal by Subject|3
5181737|NCT01227512|17890899|P2|Overall Study|Adverse Event|3
5181738|NCT01227512|17890900|P1|Overall Study|Adverse Event|4
5181739|NCT01227512|17890899|P2|Overall Study|Physician Decision|6
5181740|NCT01227512|17890900|P1|Overall Study|Physician Decision|6
5181741|NCT01227421|17890934|P3|Overall Study|Randomized in error|0
5181742|NCT01227421|17890935|P2|Overall Study|Randomized in error|1
5181743|NCT01227421|17890936|P1|Overall Study|Randomized in error|1
5181744|NCT01227421|17890934|P3|Overall Study|Protocol Violation|2
5181745|NCT01227421|17890935|P2|Overall Study|Protocol Violation|1
5181746|NCT01227421|17890936|P1|Overall Study|Protocol Violation|1
5181747|NCT01227421|17890934|P3|Overall Study|Withdrawal by Subject|1
5181748|NCT01227421|17890935|P2|Overall Study|Withdrawal by Subject|2
5181749|NCT01227421|17890936|P1|Overall Study|Withdrawal by Subject|1
5181750|NCT01227421|17890934|P3|Overall Study|Adverse Event|2
5181751|NCT01227421|17890935|P2|Overall Study|Adverse Event|7
5181752|NCT01227421|17890936|P1|Overall Study|Adverse Event|2
5181753|NCT01227421|17890934|P3|Overall Study|Lost to Follow-up|5
5181754|NCT01227421|17890935|P2|Overall Study|Lost to Follow-up|7
5181755|NCT01227421|17890936|P1|Overall Study|Lost to Follow-up|6
5181756|NCT01227395|17890988|P2|Overall Study|Protocol Violation|1
5181757|NCT01227395|17890989|P1|Overall Study|Protocol Violation|0
5181758|NCT01227278|17891029|P2|Overall Study|Other|2
5181759|NCT01227278|17891030|P1|Overall Study|Other|1
5181760|NCT01227278|17891029|P2|Overall Study|Death|2
5181761|NCT01227278|17891030|P1|Overall Study|Death|0
5181762|NCT01227278|17891029|P2|Overall Study|Withdrawal by Subject|4
5181763|NCT01227278|17891030|P1|Overall Study|Withdrawal by Subject|4
5181764|NCT01227265|17891057|P3|Overall Study|Adverse Event|5
5181765|NCT01227265|17891058|P2|Overall Study|Adverse Event|10
5181766|NCT01227265|17891059|P1|Overall Study|Adverse Event|6
5181767|NCT01227265|17891057|P3|Overall Study|Lost to Follow-up|3
5181768|NCT01227265|17891058|P2|Overall Study|Lost to Follow-up|0
5181769|NCT01227265|17891059|P1|Overall Study|Lost to Follow-up|2
5181770|NCT01227265|17891057|P3|Overall Study|Withdrawal by Subject|3
5181771|NCT01227265|17891058|P2|Overall Study|Withdrawal by Subject|7
5181772|NCT01227265|17891059|P1|Overall Study|Withdrawal by Subject|7
5181773|NCT01227265|17891057|P3|Overall Study|Protocol Violation|0
5181774|NCT01227265|17891058|P2|Overall Study|Protocol Violation|1
5181775|NCT01227265|17891059|P1|Overall Study|Protocol Violation|2
5181776|NCT01227265|17891057|P3|Overall Study|Did Not Meet Protocol Eligibility|1
5181777|NCT01227265|17891058|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5181778|NCT01227265|17891059|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5181779|NCT01227265|17891057|P3|Overall Study|Administrative|2
5181780|NCT01227265|17891058|P2|Overall Study|Administrative|0
5181781|NCT01227265|17891059|P1|Overall Study|Administrative|1
5181782|NCT01227265|17891057|P3|Overall Study|Did Not Receive Treatment|0
5181783|NCT01227265|17891058|P2|Overall Study|Did Not Receive Treatment|2
5181784|NCT01227265|17891059|P1|Overall Study|Did Not Receive Treatment|1
5181785|NCT01227252|17891089|P4|Overall Study|Withdrawal by Subject|0
5181786|NCT01227252|17891090|P3|Overall Study|Withdrawal by Subject|0
5181787|NCT01227252|17891091|P2|Overall Study|Withdrawal by Subject|1
5181788|NCT01227252|17891092|P1|Overall Study|Withdrawal by Subject|0
5181789|NCT01227252|17891089|P4|Overall Study|Lost to Follow-up|0
5181790|NCT01227252|17891090|P3|Overall Study|Lost to Follow-up|0
5181791|NCT01227252|17891091|P2|Overall Study|Lost to Follow-up|1
5181792|NCT01227252|17891092|P1|Overall Study|Lost to Follow-up|0
5181793|NCT01227252|17891089|P4|Overall Study|Sponsor Decision|0
5181794|NCT01227252|17891090|P3|Overall Study|Sponsor Decision|0
5181795|NCT01227252|17891091|P2|Overall Study|Sponsor Decision|1
5181796|NCT01227252|17891092|P1|Overall Study|Sponsor Decision|0
5181797|NCT01227044|17891134|P2|Overall Study|Discontinued Intervention|2
5181798|NCT01227044|17891135|P1|Overall Study|Discontinued Intervention|1
5181799|NCT01227044|17891134|P2|Overall Study|Lost to Follow-up|7
5181800|NCT01227044|17891135|P1|Overall Study|Lost to Follow-up|5
5181801|NCT01227018|17891143|P1|Overall Study|Withdrew after beginning treatment|4
5181802|NCT01227018|17891143|P1|Overall Study|Toxicity|2
5181803|NCT01227018|17891143|P1|Overall Study|Disease progression|9
5181804|NCT01226745|17891188|P6|Overall Study|Other|1
5181805|NCT01226745|17891189|P5|Overall Study|Other|3
5181806|NCT01226745|17891190|P4|Overall Study|Other|4
5181807|NCT01226745|17891191|P3|Overall Study|Other|8
5181808|NCT01226745|17891192|P2|Overall Study|Other|7
5181809|NCT01226745|17891193|P1|Overall Study|Other|6
5181810|NCT01226745|17891188|P6|Overall Study|Death|1
5181811|NCT01226745|17891189|P5|Overall Study|Death|0
5181812|NCT01226745|17891190|P4|Overall Study|Death|0
5181813|NCT01226745|17891191|P3|Overall Study|Death|0
5181814|NCT01226745|17891192|P2|Overall Study|Death|0
5181815|NCT01226745|17891193|P1|Overall Study|Death|1
5181816|NCT01226745|17891188|P6|Overall Study|Lost to Follow-up|2
5181817|NCT01226745|17891189|P5|Overall Study|Lost to Follow-up|1
5181818|NCT01226745|17891190|P4|Overall Study|Lost to Follow-up|1
5181819|NCT01226745|17891191|P3|Overall Study|Lost to Follow-up|6
5181820|NCT01226745|17891192|P2|Overall Study|Lost to Follow-up|6
5181821|NCT01226745|17891193|P1|Overall Study|Lost to Follow-up|2
5181822|NCT01226745|17891188|P6|Overall Study|Did not complete schedule of assessments|1
5181823|NCT01226745|17891189|P5|Overall Study|Did not complete schedule of assessments|0
5181824|NCT01226745|17891190|P4|Overall Study|Did not complete schedule of assessments|0
5181825|NCT01226745|17891191|P3|Overall Study|Did not complete schedule of assessments|6
5181826|NCT01226745|17891192|P2|Overall Study|Did not complete schedule of assessments|3
5181827|NCT01226745|17891193|P1|Overall Study|Did not complete schedule of assessments|8
5181828|NCT01226511|17891389|P2|Taper Period|Parent/Caregiver Decision|1
5181829|NCT01226511|17891390|P1|Taper Period|Parent/Caregiver Decision|1
5181830|NCT01226511|17891389|P2|Taper Period|Protocol Violation|0
5181831|NCT01226511|17891390|P1|Taper Period|Protocol Violation|1
5181832|NCT01226511|17891389|P2|Taper Period|Lost to Follow-up|2
5181833|NCT01226511|17891390|P1|Taper Period|Lost to Follow-up|2
5181834|NCT01226511|17891389|P2|Taper Period|Adverse Event|0
5181835|NCT01226511|17891390|P1|Taper Period|Adverse Event|1
5181836|NCT01226511|17891389|P2|Extension Treatment Period|Sponsor Decision|1
5181837|NCT01226511|17891390|P1|Extension Treatment Period|Sponsor Decision|1
5181838|NCT01226511|17891389|P2|Extension Treatment Period|Parent/Caregiver Decision|8
5181839|NCT01226511|17891390|P1|Extension Treatment Period|Parent/Caregiver Decision|8
5181840|NCT01226511|17891389|P2|Extension Treatment Period|Withdrawal by Subject|3
5181841|NCT01226511|17891390|P1|Extension Treatment Period|Withdrawal by Subject|1
5181842|NCT01226511|17891389|P2|Extension Treatment Period|Protocol Violation|2
5181843|NCT01226511|17891390|P1|Extension Treatment Period|Protocol Violation|2
5181844|NCT01226511|17891389|P2|Extension Treatment Period|Lost to Follow-up|3
5181845|NCT01226511|17891390|P1|Extension Treatment Period|Lost to Follow-up|4
5181846|NCT01226511|17891389|P2|Extension Treatment Period|Lack of Efficacy|2
5181847|NCT01226511|17891390|P1|Extension Treatment Period|Lack of Efficacy|3
5181848|NCT01226511|17891389|P2|Extension Treatment Period|Adverse Event|8
5181849|NCT01226511|17891390|P1|Extension Treatment Period|Adverse Event|8
5181850|NCT01226511|17891389|P2|Acute Treatment Period|Withdrawal by Subject|6
5181851|NCT01226511|17891390|P1|Acute Treatment Period|Withdrawal by Subject|10
5181852|NCT01226511|17891389|P2|Acute Treatment Period|Protocol Violation|5
5181853|NCT01226511|17891390|P1|Acute Treatment Period|Protocol Violation|5
5181854|NCT01226511|17891389|P2|Acute Treatment Period|Parent/caregiver decision|7
5181855|NCT01226511|17891390|P1|Acute Treatment Period|Parent/caregiver decision|5
5181856|NCT01226511|17891389|P2|Acute Treatment Period|Lost to Follow-up|6
5181857|NCT01226511|17891390|P1|Acute Treatment Period|Lost to Follow-up|3
5181858|NCT01226511|17891389|P2|Acute Treatment Period|Lack of Efficacy|1
5181859|NCT01226511|17891390|P1|Acute Treatment Period|Lack of Efficacy|2
5181860|NCT01226511|17891389|P2|Acute Treatment Period|Adverse Event|6
5181861|NCT01226511|17891390|P1|Acute Treatment Period|Adverse Event|7
5181862|NCT01226459|17891490|P2|Overall Study|Pregnancy|0
5181863|NCT01226459|17891491|P1|Overall Study|Pregnancy|1
5181864|NCT01226459|17891490|P2|Overall Study|Lost to Follow-up|8
5181865|NCT01226459|17891491|P1|Overall Study|Lost to Follow-up|4
5181866|NCT01226459|17891490|P2|Overall Study|Withdrawal by Subject|13
5181867|NCT01226459|17891491|P1|Overall Study|Withdrawal by Subject|10
5181868|NCT01226459|17891490|P2|Overall Study|Protocol Violation|3
5181869|NCT01226459|17891491|P1|Overall Study|Protocol Violation|4
5181870|NCT01226459|17891490|P2|Overall Study|Adverse Event|8
5181871|NCT01226459|17891491|P1|Overall Study|Adverse Event|2
5181872|NCT01226121|17891509|P3|Overall Study|Lost to Follow-up|1
5181873|NCT01226121|17891510|P2|Overall Study|Lost to Follow-up|0
5181874|NCT01226121|17891511|P1|Overall Study|Lost to Follow-up|2
5181875|NCT01226095|17891522|P1|Overall Study|Poor compliance|1
5181876|NCT01226043|17891547|P4|30-week Observational Phase|Physician Decision|2
5181877|NCT01226043|17891548|P3|30-week Observational Phase|Physician Decision|2
5181878|NCT01226043|17891549|P2|30-week Observational Phase|Physician Decision|0
5181879|NCT01226043|17891550|P1|30-week Observational Phase|Physician Decision|0
5181880|NCT01226043|17891547|P4|30-week Observational Phase|Withdrawal by Subject|7
5181881|NCT01226043|17891548|P3|30-week Observational Phase|Withdrawal by Subject|1
5181882|NCT01226043|17891549|P2|30-week Observational Phase|Withdrawal by Subject|0
5181883|NCT01226043|17891550|P1|30-week Observational Phase|Withdrawal by Subject|0
5181884|NCT01226043|17891547|P4|30-week Observational Phase|Lost to Follow-up|2
5181885|NCT01226043|17891548|P3|30-week Observational Phase|Lost to Follow-up|2
5181886|NCT01226043|17891549|P2|30-week Observational Phase|Lost to Follow-up|0
5181887|NCT01226043|17891550|P1|30-week Observational Phase|Lost to Follow-up|0
5181888|NCT01226043|17891547|P4|30-week Observational Phase|Protocol Violation|1
5181889|NCT01226043|17891548|P3|30-week Observational Phase|Protocol Violation|0
5181890|NCT01226043|17891549|P2|30-week Observational Phase|Protocol Violation|0
5181891|NCT01226043|17891550|P1|30-week Observational Phase|Protocol Violation|0
5181892|NCT01226043|17891547|P4|30-week Observational Phase|Adverse Event|1
5181893|NCT01226043|17891548|P3|30-week Observational Phase|Adverse Event|1
5181894|NCT01226043|17891549|P2|30-week Observational Phase|Adverse Event|0
5181895|NCT01226043|17891550|P1|30-week Observational Phase|Adverse Event|0
5181896|NCT01226043|17891547|P4|6-week Re-randomization Phase|completed in error|1
5181897|NCT01226043|17891548|P3|6-week Re-randomization Phase|completed in error|0
5181898|NCT01226043|17891549|P2|6-week Re-randomization Phase|completed in error|0
5181899|NCT01226043|17891550|P1|6-week Re-randomization Phase|completed in error|0
5181900|NCT01226043|17891547|P4|6-week Re-randomization Phase|Physician Decision|2
5181901|NCT01226043|17891548|P3|6-week Re-randomization Phase|Physician Decision|3
5181902|NCT01226043|17891549|P2|6-week Re-randomization Phase|Physician Decision|0
5181903|NCT01226043|17891550|P1|6-week Re-randomization Phase|Physician Decision|0
5181904|NCT01226043|17891547|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
5181905|NCT01226043|17891548|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
5181906|NCT01226043|17891549|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
5181907|NCT01226043|17891550|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
5181908|NCT01226043|17891547|P4|6-week Re-randomization Phase|Lost to Follow-up|3
5181909|NCT01226043|17891548|P3|6-week Re-randomization Phase|Lost to Follow-up|1
5181910|NCT01226043|17891549|P2|6-week Re-randomization Phase|Lost to Follow-up|0
5181911|NCT01226043|17891550|P1|6-week Re-randomization Phase|Lost to Follow-up|0
5181912|NCT01226043|17891547|P4|6-week Re-randomization Phase|Protocol Violation|1
5181913|NCT01226043|17891548|P3|6-week Re-randomization Phase|Protocol Violation|1
5181914|NCT01226043|17891549|P2|6-week Re-randomization Phase|Protocol Violation|0
5181915|NCT01226043|17891550|P1|6-week Re-randomization Phase|Protocol Violation|0
5181916|NCT01226043|17891547|P4|6-week Re-randomization Phase|Adverse Event|1
5181917|NCT01226043|17891548|P3|6-week Re-randomization Phase|Adverse Event|1
5181918|NCT01226043|17891549|P2|6-week Re-randomization Phase|Adverse Event|0
5181919|NCT01226043|17891550|P1|6-week Re-randomization Phase|Adverse Event|0
5181920|NCT01226043|17891547|P4|4-week Crossover Phase - Period 2|Physician Decision|0
5181921|NCT01226043|17891548|P3|4-week Crossover Phase - Period 2|Physician Decision|0
5181922|NCT01226043|17891549|P2|4-week Crossover Phase - Period 2|Physician Decision|5
5181923|NCT01226043|17891550|P1|4-week Crossover Phase - Period 2|Physician Decision|4
5181924|NCT01226043|17891547|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5181925|NCT01226043|17891548|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5181926|NCT01226043|17891549|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
5181927|NCT01226043|17891550|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5181928|NCT01226043|17891547|P4|4-week Crossover Phase - Period 1|Physician Decision|0
5181929|NCT01226043|17891548|P3|4-week Crossover Phase - Period 1|Physician Decision|0
5181930|NCT01226043|17891549|P2|4-week Crossover Phase - Period 1|Physician Decision|6
5181931|NCT01226043|17891550|P1|4-week Crossover Phase - Period 1|Physician Decision|0
5181932|NCT01226043|17891547|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5181933|NCT01226043|17891548|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5181934|NCT01226043|17891549|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5181935|NCT01226043|17891550|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
5181936|NCT01226043|17891547|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5181937|NCT01226043|17891548|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5181938|NCT01226043|17891549|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
5181939|NCT01226043|17891550|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5181940|NCT01226043|17891547|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
5181941|NCT01226043|17891548|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
5181942|NCT01226043|17891549|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
5181943|NCT01226043|17891550|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
5181944|NCT01225991|17891588|P1|Overall Study|Withdrawal by Subject|6
5181945|NCT01225952|17891599|P3|Overall Study|Surgical complications|0
5181946|NCT01225952|17891600|P2|Overall Study|Surgical complications|0
5181947|NCT01225952|17891601|P1|Overall Study|Surgical complications|1
5181948|NCT01225952|17891599|P3|Overall Study|Withdrawal by Subject|5
5181949|NCT01225952|17891600|P2|Overall Study|Withdrawal by Subject|4
5181950|NCT01225952|17891601|P1|Overall Study|Withdrawal by Subject|4
5181951|NCT01225952|17891599|P3|Overall Study|Study Eye Explanted|1
5181952|NCT01225952|17891600|P2|Overall Study|Study Eye Explanted|0
5181953|NCT01225952|17891601|P1|Overall Study|Study Eye Explanted|0
5181954|NCT01225952|17891599|P3|Overall Study|Lost to Follow-up|0
5181955|NCT01225952|17891600|P2|Overall Study|Lost to Follow-up|0
5181956|NCT01225952|17891601|P1|Overall Study|Lost to Follow-up|1
5181957|NCT01225887|17891693|P1|Overall Study|Ineligible:inadequate pathology|2
5181958|NCT01225887|17891693|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
5181959|NCT01225887|17891693|P1|Overall Study|Ineligible:required test not done|2
5181960|NCT01225835|17891703|P2|Overall Study|Other|1
5181961|NCT01225835|17891704|P1|Overall Study|Other|1
5181962|NCT01225835|17891703|P2|Overall Study|Adverse Event|1
5181963|NCT01225835|17891704|P1|Overall Study|Adverse Event|2
5181964|NCT01225835|17891703|P2|Overall Study|Did not meet hCG criterion|0
5181965|NCT01225835|17891704|P1|Overall Study|Did not meet hCG criterion|2
5181966|NCT01225835|17891703|P2|Overall Study|Completed protocol|1
5181967|NCT01225835|17891704|P1|Overall Study|Completed protocol|2
5181968|NCT01225822|17891752|P5|Overall Study|Other|7
5181969|NCT01225822|17891753|P4|Overall Study|Other|10
5181970|NCT01225822|17891754|P3|Overall Study|Other|7
5181971|NCT01225822|17891755|P2|Overall Study|Other|10
5181972|NCT01225822|17891756|P1|Overall Study|Other|13
5181973|NCT01225822|17891752|P5|Overall Study|Withdrawal by Subject|6
5181974|NCT01225822|17891753|P4|Overall Study|Withdrawal by Subject|11
5181975|NCT01225822|17891754|P3|Overall Study|Withdrawal by Subject|7
5181976|NCT01225822|17891755|P2|Overall Study|Withdrawal by Subject|7
5181977|NCT01225822|17891756|P1|Overall Study|Withdrawal by Subject|6
5181978|NCT01225822|17891752|P5|Overall Study|Lost to Follow-up|0
5181979|NCT01225822|17891753|P4|Overall Study|Lost to Follow-up|1
5181980|NCT01225822|17891754|P3|Overall Study|Lost to Follow-up|0
5181981|NCT01225822|17891755|P2|Overall Study|Lost to Follow-up|0
5181982|NCT01225822|17891756|P1|Overall Study|Lost to Follow-up|0
5181983|NCT01225822|17891752|P5|Overall Study|Protocol Violation|4
5181984|NCT01225822|17891753|P4|Overall Study|Protocol Violation|7
5181985|NCT01225822|17891754|P3|Overall Study|Protocol Violation|6
5181986|NCT01225822|17891755|P2|Overall Study|Protocol Violation|8
5181987|NCT01225822|17891756|P1|Overall Study|Protocol Violation|6
5181988|NCT01225822|17891752|P5|Overall Study|Adverse Event|14
5181989|NCT01225822|17891753|P4|Overall Study|Adverse Event|23
5181990|NCT01225822|17891754|P3|Overall Study|Adverse Event|18
5181991|NCT01225822|17891755|P2|Overall Study|Adverse Event|31
5181992|NCT01225822|17891756|P1|Overall Study|Adverse Event|13
5181993|NCT01225731|17891823|P13|Part 3|Withdrawal by Subject|4
5181994|NCT01225731|17891824|P12|Part 3|Withdrawal by Subject|6
5181995|NCT01225731|17891825|P11|Part 3|Withdrawal by Subject|4
5181996|NCT01225731|17891826|P10|Part 3|Withdrawal by Subject|0
5181997|NCT01225731|17891827|P9|Part 3|Withdrawal by Subject|0
5181998|NCT01225731|17891828|P8|Part 3|Withdrawal by Subject|0
5181999|NCT01225731|17891829|P7|Part 3|Withdrawal by Subject|0
5182000|NCT01225731|17891830|P6|Part 3|Withdrawal by Subject|0
5182001|NCT01225731|17891831|P5|Part 3|Withdrawal by Subject|0
5182002|NCT01225731|17891832|P4|Part 3|Withdrawal by Subject|0
5182003|NCT01225731|17891833|P3|Part 3|Withdrawal by Subject|0
5182004|NCT01225731|17891834|P2|Part 3|Withdrawal by Subject|0
5182005|NCT01225731|17891835|P1|Part 3|Withdrawal by Subject|0
5182006|NCT01225731|17891823|P13|Part 3|Physician Decision|2
5182007|NCT01225731|17891824|P12|Part 3|Physician Decision|1
5182008|NCT01225731|17891825|P11|Part 3|Physician Decision|0
5182009|NCT01225731|17891826|P10|Part 3|Physician Decision|0
5182010|NCT01225731|17891827|P9|Part 3|Physician Decision|0
5182011|NCT01225731|17891828|P8|Part 3|Physician Decision|0
5182012|NCT01225731|17891829|P7|Part 3|Physician Decision|0
5182013|NCT01225731|17891830|P6|Part 3|Physician Decision|0
5182014|NCT01225731|17891831|P5|Part 3|Physician Decision|0
5182015|NCT01225731|17891832|P4|Part 3|Physician Decision|0
5182016|NCT01225731|17891833|P3|Part 3|Physician Decision|0
5182017|NCT01225731|17891834|P2|Part 3|Physician Decision|0
5182018|NCT01225731|17891835|P1|Part 3|Physician Decision|0
5182019|NCT01225731|17891823|P13|Part 3|Lost to Follow-up|1
5182020|NCT01225731|17891824|P12|Part 3|Lost to Follow-up|2
5182021|NCT01225731|17891825|P11|Part 3|Lost to Follow-up|1
5182022|NCT01225731|17891826|P10|Part 3|Lost to Follow-up|0
5182023|NCT01225731|17891827|P9|Part 3|Lost to Follow-up|0
5182024|NCT01225731|17891828|P8|Part 3|Lost to Follow-up|0
5182025|NCT01225731|17891829|P7|Part 3|Lost to Follow-up|0
5182026|NCT01225731|17891830|P6|Part 3|Lost to Follow-up|0
5182027|NCT01225731|17891831|P5|Part 3|Lost to Follow-up|0
5182028|NCT01225731|17891832|P4|Part 3|Lost to Follow-up|0
5182029|NCT01225731|17891833|P3|Part 3|Lost to Follow-up|0
5182030|NCT01225731|17891834|P2|Part 3|Lost to Follow-up|0
5182031|NCT01225731|17891835|P1|Part 3|Lost to Follow-up|0
5182032|NCT01225731|17891823|P13|Part 3|Adverse Event|0
5182033|NCT01225731|17891824|P12|Part 3|Adverse Event|1
5182034|NCT01225731|17891825|P11|Part 3|Adverse Event|1
5182035|NCT01225731|17891826|P10|Part 3|Adverse Event|0
5182036|NCT01225731|17891827|P9|Part 3|Adverse Event|0
5182037|NCT01225731|17891828|P8|Part 3|Adverse Event|0
5182038|NCT01225731|17891829|P7|Part 3|Adverse Event|0
5182039|NCT01225731|17891830|P6|Part 3|Adverse Event|0
5182040|NCT01225731|17891831|P5|Part 3|Adverse Event|0
5182041|NCT01225731|17891832|P4|Part 3|Adverse Event|0
5182042|NCT01225731|17891833|P3|Part 3|Adverse Event|0
5182043|NCT01225731|17891834|P2|Part 3|Adverse Event|0
5182044|NCT01225731|17891835|P1|Part 3|Adverse Event|0
5182045|NCT01225731|17891823|P13|Part 2|Withdrawal by Subject|0
5182046|NCT01225731|17891824|P12|Part 2|Withdrawal by Subject|0
5182047|NCT01225731|17891825|P11|Part 2|Withdrawal by Subject|0
5182048|NCT01225731|17891826|P10|Part 2|Withdrawal by Subject|0
5182049|NCT01225731|17891827|P9|Part 2|Withdrawal by Subject|1
5182050|NCT01225731|17891828|P8|Part 2|Withdrawal by Subject|4
5182051|NCT01225731|17891829|P7|Part 2|Withdrawal by Subject|3
5182052|NCT01225731|17891830|P6|Part 2|Withdrawal by Subject|1
5182053|NCT01225731|17891831|P5|Part 2|Withdrawal by Subject|0
5182054|NCT01225731|17891832|P4|Part 2|Withdrawal by Subject|0
5182055|NCT01225731|17891833|P3|Part 2|Withdrawal by Subject|0
5182056|NCT01225731|17891834|P2|Part 2|Withdrawal by Subject|0
5182057|NCT01225731|17891835|P1|Part 2|Withdrawal by Subject|0
5182058|NCT01225731|17891823|P13|Part 2|Physician Decision|0
5182059|NCT01225731|17891824|P12|Part 2|Physician Decision|0
5182060|NCT01225731|17891825|P11|Part 2|Physician Decision|0
5182061|NCT01225731|17891826|P10|Part 2|Physician Decision|0
5182062|NCT01225731|17891827|P9|Part 2|Physician Decision|2
5182063|NCT01225731|17891828|P8|Part 2|Physician Decision|2
5182064|NCT01225731|17891829|P7|Part 2|Physician Decision|0
5182065|NCT01225731|17891830|P6|Part 2|Physician Decision|0
5182066|NCT01225731|17891831|P5|Part 2|Physician Decision|0
5182067|NCT01225731|17891832|P4|Part 2|Physician Decision|0
5182068|NCT01225731|17891833|P3|Part 2|Physician Decision|0
5182069|NCT01225731|17891834|P2|Part 2|Physician Decision|0
5182070|NCT01225731|17891835|P1|Part 2|Physician Decision|0
5182071|NCT01225731|17891823|P13|Part 2|Lost to Follow-up|0
5182072|NCT01225731|17891824|P12|Part 2|Lost to Follow-up|0
5182073|NCT01225731|17891825|P11|Part 2|Lost to Follow-up|0
5182074|NCT01225731|17891826|P10|Part 2|Lost to Follow-up|0
5182075|NCT01225731|17891827|P9|Part 2|Lost to Follow-up|1
5182076|NCT01225731|17891828|P8|Part 2|Lost to Follow-up|3
5182077|NCT01225731|17891829|P7|Part 2|Lost to Follow-up|0
5182078|NCT01225731|17891830|P6|Part 2|Lost to Follow-up|0
5182079|NCT01225731|17891831|P5|Part 2|Lost to Follow-up|0
5182080|NCT01225731|17891832|P4|Part 2|Lost to Follow-up|0
5182081|NCT01225731|17891833|P3|Part 2|Lost to Follow-up|0
5182082|NCT01225731|17891834|P2|Part 2|Lost to Follow-up|0
5182083|NCT01225731|17891835|P1|Part 2|Lost to Follow-up|0
5182084|NCT01225731|17891823|P13|Part 2|Pregnancy|0
5182085|NCT01225731|17891824|P12|Part 2|Pregnancy|0
5182086|NCT01225731|17891825|P11|Part 2|Pregnancy|0
5182087|NCT01225731|17891826|P10|Part 2|Pregnancy|0
5182088|NCT01225731|17891827|P9|Part 2|Pregnancy|1
5182089|NCT01225731|17891828|P8|Part 2|Pregnancy|0
5182090|NCT01225731|17891829|P7|Part 2|Pregnancy|1
5182091|NCT01225731|17891830|P6|Part 2|Pregnancy|0
5182092|NCT01225731|17891831|P5|Part 2|Pregnancy|0
5182093|NCT01225731|17891832|P4|Part 2|Pregnancy|0
5182094|NCT01225731|17891833|P3|Part 2|Pregnancy|0
5182095|NCT01225731|17891834|P2|Part 2|Pregnancy|0
5182096|NCT01225731|17891835|P1|Part 2|Pregnancy|0
5182097|NCT01225731|17891823|P13|Part 2|Lack of Efficacy|0
5182098|NCT01225731|17891824|P12|Part 2|Lack of Efficacy|0
5182099|NCT01225731|17891825|P11|Part 2|Lack of Efficacy|0
5182100|NCT01225731|17891826|P10|Part 2|Lack of Efficacy|0
5182101|NCT01225731|17891827|P9|Part 2|Lack of Efficacy|3
5182102|NCT01225731|17891828|P8|Part 2|Lack of Efficacy|12
5182103|NCT01225731|17891829|P7|Part 2|Lack of Efficacy|0
5182104|NCT01225731|17891830|P6|Part 2|Lack of Efficacy|1
5182105|NCT01225731|17891831|P5|Part 2|Lack of Efficacy|0
5182106|NCT01225731|17891832|P4|Part 2|Lack of Efficacy|0
5182107|NCT01225731|17891833|P3|Part 2|Lack of Efficacy|0
5182108|NCT01225731|17891834|P2|Part 2|Lack of Efficacy|0
5182109|NCT01225731|17891835|P1|Part 2|Lack of Efficacy|0
5182110|NCT01225731|17891823|P13|Part 2|Adverse Event|0
5182111|NCT01225731|17891824|P12|Part 2|Adverse Event|0
5182112|NCT01225731|17891825|P11|Part 2|Adverse Event|0
5182113|NCT01225731|17891826|P10|Part 2|Adverse Event|0
5182114|NCT01225731|17891827|P9|Part 2|Adverse Event|2
5182115|NCT01225731|17891828|P8|Part 2|Adverse Event|4
5182116|NCT01225731|17891829|P7|Part 2|Adverse Event|4
5182117|NCT01225731|17891830|P6|Part 2|Adverse Event|0
5182118|NCT01225731|17891831|P5|Part 2|Adverse Event|0
5182119|NCT01225731|17891832|P4|Part 2|Adverse Event|0
5182120|NCT01225731|17891833|P3|Part 2|Adverse Event|0
5182121|NCT01225731|17891834|P2|Part 2|Adverse Event|0
5182122|NCT01225731|17891835|P1|Part 2|Adverse Event|0
5182123|NCT01225731|17891823|P13|Part 2|Protocol Violation|0
5182124|NCT01225731|17891824|P12|Part 2|Protocol Violation|0
5182125|NCT01225731|17891825|P11|Part 2|Protocol Violation|0
5182126|NCT01225731|17891826|P10|Part 2|Protocol Violation|0
5182127|NCT01225731|17891827|P9|Part 2|Protocol Violation|1
5182128|NCT01225731|17891828|P8|Part 2|Protocol Violation|0
5182129|NCT01225731|17891829|P7|Part 2|Protocol Violation|0
5182130|NCT01225731|17891830|P6|Part 2|Protocol Violation|1
5182131|NCT01225731|17891831|P5|Part 2|Protocol Violation|0
5182132|NCT01225731|17891832|P4|Part 2|Protocol Violation|0
5182133|NCT01225731|17891833|P3|Part 2|Protocol Violation|0
5182134|NCT01225731|17891834|P2|Part 2|Protocol Violation|0
5182135|NCT01225731|17891835|P1|Part 2|Protocol Violation|0
5182136|NCT01225731|17891823|P13|Part 1|Protocol Violation|0
5182137|NCT01225731|17891824|P12|Part 1|Protocol Violation|0
5182138|NCT01225731|17891825|P11|Part 1|Protocol Violation|0
5182139|NCT01225731|17891826|P10|Part 1|Protocol Violation|0
5182140|NCT01225731|17891827|P9|Part 1|Protocol Violation|0
5182141|NCT01225731|17891828|P8|Part 1|Protocol Violation|0
5182142|NCT01225731|17891829|P7|Part 1|Protocol Violation|0
5182143|NCT01225731|17891830|P6|Part 1|Protocol Violation|0
5182144|NCT01225731|17891831|P5|Part 1|Protocol Violation|0
5182145|NCT01225731|17891832|P4|Part 1|Protocol Violation|1
5182146|NCT01225731|17891833|P3|Part 1|Protocol Violation|0
5182147|NCT01225731|17891834|P2|Part 1|Protocol Violation|0
5182148|NCT01225731|17891835|P1|Part 1|Protocol Violation|0
5182149|NCT01225731|17891823|P13|Part 1|Withdrawal by Subject|0
5182150|NCT01225731|17891824|P12|Part 1|Withdrawal by Subject|0
5182151|NCT01225731|17891825|P11|Part 1|Withdrawal by Subject|0
5182152|NCT01225731|17891826|P10|Part 1|Withdrawal by Subject|0
5182153|NCT01225731|17891827|P9|Part 1|Withdrawal by Subject|0
5182154|NCT01225731|17891828|P8|Part 1|Withdrawal by Subject|0
5182155|NCT01225731|17891829|P7|Part 1|Withdrawal by Subject|0
5182156|NCT01225731|17891830|P6|Part 1|Withdrawal by Subject|0
5182157|NCT01225731|17891831|P5|Part 1|Withdrawal by Subject|4
5182158|NCT01225731|17891832|P4|Part 1|Withdrawal by Subject|0
5182159|NCT01225731|17891833|P3|Part 1|Withdrawal by Subject|0
5182160|NCT01225731|17891834|P2|Part 1|Withdrawal by Subject|3
5182161|NCT01225731|17891835|P1|Part 1|Withdrawal by Subject|0
5182162|NCT01225731|17891823|P13|Part 1|Adverse Event|0
5182163|NCT01225731|17891824|P12|Part 1|Adverse Event|0
5182164|NCT01225731|17891825|P11|Part 1|Adverse Event|0
5182165|NCT01225731|17891826|P10|Part 1|Adverse Event|0
5182166|NCT01225731|17891827|P9|Part 1|Adverse Event|0
5182167|NCT01225731|17891828|P8|Part 1|Adverse Event|0
5182168|NCT01225731|17891829|P7|Part 1|Adverse Event|0
5182169|NCT01225731|17891830|P6|Part 1|Adverse Event|0
5182170|NCT01225731|17891831|P5|Part 1|Adverse Event|1
5182171|NCT01225731|17891832|P4|Part 1|Adverse Event|1
5182172|NCT01225731|17891833|P3|Part 1|Adverse Event|1
5182173|NCT01225731|17891834|P2|Part 1|Adverse Event|2
5182174|NCT01225731|17891835|P1|Part 1|Adverse Event|1
5182175|NCT01225731|17891823|P13|Part 1|Did not meet eligibility criteria|0
5182176|NCT01225731|17891824|P12|Part 1|Did not meet eligibility criteria|0
5182177|NCT01225731|17891825|P11|Part 1|Did not meet eligibility criteria|0
5182178|NCT01225731|17891826|P10|Part 1|Did not meet eligibility criteria|0
5182179|NCT01225731|17891827|P9|Part 1|Did not meet eligibility criteria|0
5182180|NCT01225731|17891828|P8|Part 1|Did not meet eligibility criteria|0
5182181|NCT01225731|17891829|P7|Part 1|Did not meet eligibility criteria|0
5182182|NCT01225731|17891830|P6|Part 1|Did not meet eligibility criteria|0
5182183|NCT01225731|17891831|P5|Part 1|Did not meet eligibility criteria|1
5182184|NCT01225731|17891832|P4|Part 1|Did not meet eligibility criteria|0
5182185|NCT01225731|17891833|P3|Part 1|Did not meet eligibility criteria|0
5182186|NCT01225731|17891834|P2|Part 1|Did not meet eligibility criteria|0
5182187|NCT01225731|17891835|P1|Part 1|Did not meet eligibility criteria|1
5182188|NCT01225562|17891930|P3|Overall Study|Lost to Follow-up|1
5182189|NCT01225562|17891931|P2|Overall Study|Lost to Follow-up|6
5182190|NCT01225562|17891932|P1|Overall Study|Lost to Follow-up|3
5182191|NCT01225562|17891930|P3|Overall Study|Withdrawal by Subject|52
5182192|NCT01225562|17891931|P2|Overall Study|Withdrawal by Subject|50
5182193|NCT01225562|17891932|P1|Overall Study|Withdrawal by Subject|52
5182194|NCT01225549|17891949|P10|Period 6 - Washout|Disallowed medication|0
5182195|NCT01225549|17891950|P9|Period 6 - Washout|Disallowed medication|0
5182196|NCT01225549|17891951|P8|Period 6 - Washout|Disallowed medication|0
5182197|NCT01225549|17891952|P7|Period 6 - Washout|Disallowed medication|0
5182198|NCT01225549|17891953|P6|Period 6 - Washout|Disallowed medication|0
5182199|NCT01225549|17891954|P5|Period 6 - Washout|Disallowed medication|0
5182200|NCT01225549|17891955|P4|Period 6 - Washout|Disallowed medication|1
5182201|NCT01225549|17891956|P3|Period 6 - Washout|Disallowed medication|0
5182202|NCT01225549|17891957|P2|Period 6 - Washout|Disallowed medication|0
5182203|NCT01225549|17891958|P1|Period 6 - Washout|Disallowed medication|0
5182204|NCT01225549|17891949|P10|Period 4 - Washout|Disallowed medication|0
5182205|NCT01225549|17891950|P9|Period 4 - Washout|Disallowed medication|0
5182206|NCT01225549|17891951|P8|Period 4 - Washout|Disallowed medication|0
5182207|NCT01225549|17891952|P7|Period 4 - Washout|Disallowed medication|0
5182208|NCT01225549|17891953|P6|Period 4 - Washout|Disallowed medication|0
5182209|NCT01225549|17891954|P5|Period 4 - Washout|Disallowed medication|0
5182210|NCT01225549|17891955|P4|Period 4 - Washout|Disallowed medication|0
5182211|NCT01225549|17891956|P3|Period 4 - Washout|Disallowed medication|0
5182212|NCT01225549|17891957|P2|Period 4 - Washout|Disallowed medication|1
5182213|NCT01225549|17891958|P1|Period 4 - Washout|Disallowed medication|0
5182214|NCT01225211|17892064|P10|Overall Study|Other|1
5182215|NCT01225211|17892065|P9|Overall Study|Other|0
5182216|NCT01225211|17892066|P8|Overall Study|Other|0
5182217|NCT01225211|17892067|P7|Overall Study|Other|0
5182218|NCT01225211|17892068|P6|Overall Study|Other|0
5182219|NCT01225211|17892069|P5|Overall Study|Other|0
5182220|NCT01225211|17892070|P4|Overall Study|Other|0
5182221|NCT01225211|17892071|P3|Overall Study|Other|0
5182222|NCT01225211|17892072|P2|Overall Study|Other|0
5182223|NCT01225211|17892073|P1|Overall Study|Other|0
5182224|NCT01225211|17892064|P10|Overall Study|Withdrawal by Subject|3
5182225|NCT01225211|17892065|P9|Overall Study|Withdrawal by Subject|1
5182226|NCT01225211|17892066|P8|Overall Study|Withdrawal by Subject|0
5182227|NCT01225211|17892067|P7|Overall Study|Withdrawal by Subject|1
5182228|NCT01225211|17892068|P6|Overall Study|Withdrawal by Subject|0
5182229|NCT01225211|17892069|P5|Overall Study|Withdrawal by Subject|0
5182230|NCT01225211|17892070|P4|Overall Study|Withdrawal by Subject|0
5182231|NCT01225211|17892071|P3|Overall Study|Withdrawal by Subject|0
5182232|NCT01225211|17892072|P2|Overall Study|Withdrawal by Subject|0
5182233|NCT01225211|17892073|P1|Overall Study|Withdrawal by Subject|0
5182234|NCT01225211|17892064|P10|Overall Study|Adverse Event|1
5182235|NCT01225211|17892065|P9|Overall Study|Adverse Event|0
5182236|NCT01225211|17892066|P8|Overall Study|Adverse Event|0
5182237|NCT01225211|17892067|P7|Overall Study|Adverse Event|0
5182238|NCT01225211|17892068|P6|Overall Study|Adverse Event|0
5182239|NCT01225211|17892069|P5|Overall Study|Adverse Event|0
5182240|NCT01225211|17892070|P4|Overall Study|Adverse Event|0
5182241|NCT01225211|17892071|P3|Overall Study|Adverse Event|1
5182242|NCT01225211|17892072|P2|Overall Study|Adverse Event|0
5182243|NCT01225211|17892073|P1|Overall Study|Adverse Event|0
5182244|NCT01225172|17892176|P2|Overall Study|Withdrawal by Subject|0
5182245|NCT01225172|17892177|P1|Overall Study|Withdrawal by Subject|1
5182246|NCT01225172|17892176|P2|Overall Study|Subject no longer meets study criteria|0
5182247|NCT01225172|17892177|P1|Overall Study|Subject no longer meets study criteria|1
5182248|NCT01225172|17892176|P2|Overall Study|Subject request to discontinue treatment|1
5182249|NCT01225172|17892177|P1|Overall Study|Subject request to discontinue treatment|3
5182250|NCT01225172|17892176|P2|Overall Study|Subject decision to stop|0
5182251|NCT01225172|17892177|P1|Overall Study|Subject decision to stop|1
5182252|NCT01225159|17892199|P2|Overall Study|Change operation|0
5182253|NCT01225159|17892200|P1|Overall Study|Change operation|1
5182254|NCT01225146|17892210|P2|Overall Study|Sponsor discontinued making 2mg drug|2
5182255|NCT01225146|17892211|P1|Overall Study|Sponsor discontinued making 2mg drug|0
5182256|NCT01224925|17892279|P2|Overall Study|Lost to Follow-up|2
5182257|NCT01224925|17892280|P1|Overall Study|Lost to Follow-up|3
5182258|NCT01224821|17892288|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
5182259|NCT01224821|17892288|P1|Long-Term Follow-Up|Death|2
5182260|NCT01224821|17892288|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
5182261|NCT01224821|17892288|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
5182262|NCT01224821|17892288|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
5182263|NCT01224821|17892288|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
5182264|NCT01224821|17892288|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
5182265|NCT01224821|17892288|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
5182266|NCT01224782|17892307|P1|Overall Study|Transplantation|1
5182267|NCT01224782|17892307|P1|Overall Study|Deterioration|1
5182268|NCT01224782|17892307|P1|Overall Study|Financial Reasons|1
5182269|NCT01224782|17892307|P1|Overall Study|Change of Treatment|1
5182270|NCT01224782|17892307|P1|Overall Study|Start of Dialysis|3
5182271|NCT01224782|17892307|P1|Overall Study|Other|4
5182272|NCT01224782|17892307|P1|Overall Study|Noncompliance|10
5182273|NCT01224782|17892307|P1|Overall Study|Adverse Reaction|11
5182274|NCT01224782|17892307|P1|Overall Study|Adverse Event|12
5182275|NCT01224782|17892307|P1|Overall Study|Improvement|13
5182276|NCT01224782|17892307|P1|Overall Study|Death|14
5182277|NCT01224782|17892307|P1|Overall Study|Withdrawal by Subject|16
5182278|NCT01224782|17892307|P1|Overall Study|Lost to Follow-up|177
5182279|NCT01224639|17892333|P8|Overall Study|Adverse Event|1
5182280|NCT01224639|17892334|P7|Overall Study|Adverse Event|0
5182281|NCT01224639|17892335|P6|Overall Study|Adverse Event|0
5182282|NCT01224639|17892336|P5|Overall Study|Adverse Event|0
5182283|NCT01224639|17892337|P4|Overall Study|Adverse Event|0
5182284|NCT01224639|17892338|P3|Overall Study|Adverse Event|0
5182285|NCT01224639|17892339|P2|Overall Study|Adverse Event|0
5182286|NCT01224639|17892340|P1|Overall Study|Adverse Event|0
5182287|NCT01224639|17892333|P8|Overall Study|Withdrawal by Subject|1
5182288|NCT01224639|17892334|P7|Overall Study|Withdrawal by Subject|1
5182289|NCT01224639|17892335|P6|Overall Study|Withdrawal by Subject|0
5182290|NCT01224639|17892336|P5|Overall Study|Withdrawal by Subject|2
5182291|NCT01224639|17892337|P4|Overall Study|Withdrawal by Subject|0
5182292|NCT01224639|17892338|P3|Overall Study|Withdrawal by Subject|0
5182293|NCT01224639|17892339|P2|Overall Study|Withdrawal by Subject|0
5182294|NCT01224639|17892340|P1|Overall Study|Withdrawal by Subject|0
5182295|NCT01224431|17892458|P2|Overall Study|no video record|1
5182296|NCT01224431|17892459|P1|Overall Study|no video record|0
5182297|NCT01224431|17892458|P2|Overall Study|not randomized|4
5182298|NCT01224431|17892459|P1|Overall Study|not randomized|0
5182299|NCT01224171|17892480|P2|Overall Study|Lost to Follow-up|3
5182300|NCT01224171|17892481|P1|Overall Study|Lost to Follow-up|0
5182301|NCT01224171|17892480|P2|Overall Study|Withdrawal of Consent|4
5182302|NCT01224171|17892481|P1|Overall Study|Withdrawal of Consent|2
5182303|NCT01224171|17892480|P2|Overall Study|Lack of Efficacy|1
5182304|NCT01224171|17892481|P1|Overall Study|Lack of Efficacy|5
5182305|NCT01224171|17892480|P2|Overall Study|Protocol Violation|1
5182306|NCT01224171|17892481|P1|Overall Study|Protocol Violation|0
5182307|NCT01224171|17892480|P2|Overall Study|Adverse Event|4
5182308|NCT01224171|17892481|P1|Overall Study|Adverse Event|8
5182309|NCT01224158|17892503|P2|Overall Study|Withdrawal by Subject|0
5182310|NCT01224158|17892504|P1|Overall Study|Withdrawal by Subject|1
5182311|NCT01223937|17892548|P2|Overall Study|Other|1
5182312|NCT01223937|17892549|P1|Overall Study|Other|4
5182313|NCT01223937|17892548|P2|Overall Study|Protocol Violation|7
5182314|NCT01223937|17892549|P1|Overall Study|Protocol Violation|8
5182315|NCT01223937|17892548|P2|Overall Study|Adverse Event|4
5182316|NCT01223937|17892549|P1|Overall Study|Adverse Event|1
5182317|NCT01223937|17892548|P2|Overall Study|Lost to Follow-up|4
5182318|NCT01223937|17892549|P1|Overall Study|Lost to Follow-up|1
5182319|NCT01223937|17892548|P2|Overall Study|Withdrawal by Subject|2
5182320|NCT01223937|17892549|P1|Overall Study|Withdrawal by Subject|3
5182321|NCT01223404|17892595|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
5182322|NCT01223404|17892596|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
5182323|NCT01223404|17892597|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
5182324|NCT01223404|17892598|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
5182325|NCT01223404|17892599|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
5182326|NCT01223404|17892600|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
5182327|NCT01223404|17892595|P6|Second Intervention (1 Day)|Adverse Event|0
5182328|NCT01223404|17892596|P5|Second Intervention (1 Day)|Adverse Event|0
5182329|NCT01223404|17892597|P4|Second Intervention (1 Day)|Adverse Event|0
5182330|NCT01223404|17892598|P3|Second Intervention (1 Day)|Adverse Event|0
5182331|NCT01223404|17892599|P2|Second Intervention (1 Day)|Adverse Event|0
5182332|NCT01223404|17892600|P1|Second Intervention (1 Day)|Adverse Event|1
5182333|NCT01223404|17892595|P6|First Intervention (1 Day)|Adverse Event|0
5182334|NCT01223404|17892596|P5|First Intervention (1 Day)|Adverse Event|0
5182335|NCT01223404|17892597|P4|First Intervention (1 Day)|Adverse Event|1
5182336|NCT01223404|17892598|P3|First Intervention (1 Day)|Adverse Event|0
5182337|NCT01223404|17892599|P2|First Intervention (1 Day)|Adverse Event|0
5182338|NCT01223404|17892600|P1|First Intervention (1 Day)|Adverse Event|0
5182339|NCT01223365|17892664|P1|Open-label Treatment Period|Physician Decision|2
5182340|NCT01223365|17892664|P1|Open-label Treatment Period|Starting physical therapy|1
5182341|NCT01223365|17892664|P1|Open-label Treatment Period|"Out of window"|1
5182342|NCT01223365|17892664|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
5182343|NCT01223365|17892664|P1|Open-label Treatment Period|Moved out of area|2
5182344|NCT01223365|17892664|P1|Open-label Treatment Period|Noncompliance with study procedures|6
5182345|NCT01223365|17892664|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
5182346|NCT01223365|17892664|P1|Open-label Treatment Period|Lost to Follow-up|7
5182347|NCT01223365|17892664|P1|Open-label Treatment Period|Protocol Violation|15
5182348|NCT01223365|17892664|P1|Open-label Treatment Period|Withdrawal by Subject|19
5182349|NCT01223365|17892664|P1|Open-label Treatment Period|Lack of Efficacy|2
5182350|NCT01223365|17892664|P1|Open-label Treatment Period|Adverse Event|39
5182351|NCT01223365|17892664|P1|Open-label Titration Period|Starting physical therapy|1
5182352|NCT01223365|17892664|P1|Open-label Titration Period|Noncompliance with study procedures|2
5182353|NCT01223365|17892664|P1|Open-label Titration Period|Noncompliance with study drug admin|1
5182354|NCT01223365|17892664|P1|Open-label Titration Period|Lost to Follow-up|2
5182355|NCT01223365|17892664|P1|Open-label Titration Period|Protocol Violation|1
5182356|NCT01223365|17892664|P1|Open-label Titration Period|Withdrawal by Subject|5
5182357|NCT01223365|17892664|P1|Open-label Titration Period|Lack of Efficacy|3
5182358|NCT01223365|17892664|P1|Open-label Titration Period|Adverse Event|23
5182359|NCT01223365|17892664|P1|Open-label Titration Period|Enrolled but not treated|1
5182360|NCT01223235|17892728|P1|Overall Study|Withdrawal by Subject|1
5182361|NCT01223196|17892736|P2|Overall Study|Withdrawal by Subject|0
5182362|NCT01223196|17892737|P1|Overall Study|Withdrawal by Subject|1
5182363|NCT01223196|17892736|P2|Overall Study|Physician Decision|0
5182364|NCT01223196|17892737|P1|Overall Study|Physician Decision|1
5182365|NCT01223196|17892736|P2|Overall Study|Lost to Follow-up|0
5182366|NCT01223196|17892737|P1|Overall Study|Lost to Follow-up|2
5182367|NCT01223183|17892749|P2|Washout Period (5-24 Days)|Physician Decision|0
5182368|NCT01223183|17892750|P1|Washout Period (5-24 Days)|Physician Decision|1
5182369|NCT01223183|17892749|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
5182370|NCT01223183|17892750|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
5182371|NCT01223183|17892749|P2|Imaging Day 1|Physician Decision|1
5182372|NCT01223183|17892750|P1|Imaging Day 1|Physician Decision|0
5182373|NCT01223027|17892760|P2|Overall Study|Study terminated by sponsor|8
5182374|NCT01223027|17892761|P1|Overall Study|Study terminated by sponsor|2
5182375|NCT01223027|17892760|P2|Overall Study|New therapy for study indication|8
5182376|NCT01223027|17892761|P1|Overall Study|New therapy for study indication|17
5182377|NCT01223027|17892760|P2|Overall Study|Subject/guardian decicion|16
5182378|NCT01223027|17892761|P1|Overall Study|Subject/guardian decicion|18
5182379|NCT01223027|17892760|P2|Overall Study|Protocol Violation|1
5182380|NCT01223027|17892761|P1|Overall Study|Protocol Violation|2
5182381|NCT01223027|17892760|P2|Overall Study|Progressive Disease|183
5182382|NCT01223027|17892761|P1|Overall Study|Progressive Disease|167
5182383|NCT01223027|17892760|P2|Overall Study|Physician Decision|8
5182384|NCT01223027|17892761|P1|Overall Study|Physician Decision|4
5182385|NCT01223027|17892760|P2|Overall Study|Lost to Follow-up|1
5182386|NCT01223027|17892761|P1|Overall Study|Lost to Follow-up|2
5182387|NCT01223027|17892760|P2|Overall Study|Death|42
5182388|NCT01223027|17892761|P1|Overall Study|Death|42
5182389|NCT01223027|17892760|P2|Overall Study|Adverse Event|10
5182390|NCT01223027|17892761|P1|Overall Study|Adverse Event|20
5182391|NCT01222715|17892823|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
5182392|NCT01222715|17892824|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
5182393|NCT01222715|17892823|P2|Overall Study|Ineligible|1
5182394|NCT01222715|17892824|P1|Overall Study|Ineligible|0
5182395|NCT01222715|17892823|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
5182396|NCT01222715|17892824|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
5182397|NCT01222715|17892823|P2|Overall Study|Refusal of further protocol therapy|4
5182398|NCT01222715|17892824|P1|Overall Study|Refusal of further protocol therapy|0
5182399|NCT01222715|17892823|P2|Overall Study|Physician Decision|2
5182400|NCT01222715|17892824|P1|Overall Study|Physician Decision|12
5182401|NCT01222715|17892823|P2|Overall Study|Lack of Efficacy|14
5182402|NCT01222715|17892824|P1|Overall Study|Lack of Efficacy|22
5182403|NCT01222715|17892823|P2|Overall Study|Death|1
5182404|NCT01222715|17892824|P1|Overall Study|Death|0
5182405|NCT01222715|17892823|P2|Overall Study|Adverse Event|4
5182406|NCT01222715|17892824|P1|Overall Study|Adverse Event|0
5182407|NCT01222533|17892863|P1|Overall Study|Other|4
5182408|NCT01222533|17892863|P1|Overall Study|Withdrawal by Subject|5
5182409|NCT01222533|17892863|P1|Overall Study|Adverse Event|5
5182410|NCT01222520|17893002|P2|Double-blind Period|Study medication stolen|0
5182411|NCT01222520|17893003|P1|Double-blind Period|Study medication stolen|1
5182412|NCT01222520|17893002|P2|Double-blind Period|Lack of Efficacy|1
5182413|NCT01222520|17893003|P1|Double-blind Period|Lack of Efficacy|0
5182414|NCT01222520|17893002|P2|Double-blind Period|Adverse Event|1
5182415|NCT01222520|17893003|P1|Double-blind Period|Adverse Event|0
5182416|NCT01222520|17893002|P2|Open-label run-in Period|Number of patients fulfilled|3
5182417|NCT01222520|17893003|P1|Open-label run-in Period|Number of patients fulfilled|0
5182418|NCT01222520|17893002|P2|Open-label run-in Period|Blood pressure criteria not met|18
5182419|NCT01222520|17893003|P1|Open-label run-in Period|Blood pressure criteria not met|0
5182420|NCT01222520|17893002|P2|Open-label run-in Period|Withdrawal by Subject|2
5182421|NCT01222520|17893003|P1|Open-label run-in Period|Withdrawal by Subject|0
5182422|NCT01222507|17893021|P1|Overall Study|Withdrawal by Subject|1
5182423|NCT01222507|17893021|P1|Overall Study|Physician Decision|1
5182424|NCT01222416|17893049|P2|Overall Study|Death|0
5182425|NCT01222416|17893050|P1|Overall Study|Death|1
5182426|NCT01222416|17893049|P2|Overall Study|missed view/scan|0
5182427|NCT01222416|17893050|P1|Overall Study|missed view/scan|1
5182428|NCT01222416|17893049|P2|Overall Study|scheduling|0
5182429|NCT01222416|17893050|P1|Overall Study|scheduling|6
5182430|NCT01222416|17893049|P2|Overall Study|Withdrawal by Subject|0
5182431|NCT01222416|17893050|P1|Overall Study|Withdrawal by Subject|5
5182432|NCT01222416|17893049|P2|Overall Study|Adverse Event|0
5182433|NCT01222416|17893050|P1|Overall Study|Adverse Event|4
5182434|NCT01222416|17893049|P2|Overall Study|ineligible;metastasis|0
5182435|NCT01222416|17893050|P1|Overall Study|ineligible;metastasis|3
5182436|NCT01222403|17893060|P2|Overall Study|Inappropriate enrollment|2
5182437|NCT01222403|17893061|P1|Overall Study|Inappropriate enrollment|0
5182438|NCT01222247|17893122|P2|Overall Study|Lost to Follow-up|2
5182439|NCT01222247|17893123|P1|Overall Study|Lost to Follow-up|2
5182440|NCT01222104|17893259|P1|Overall Study|Death|10
5182441|NCT01222104|17893259|P1|Overall Study|Lost to Follow-up|37
5182442|NCT01222078|17893282|P1|Overall Study|Early termination of the study|1
5182443|NCT01221948|17893316|P1|Overall Study|Protocol Violation|4
5182444|NCT01221948|17893316|P1|Overall Study|Death|1
5182445|NCT01221948|17893316|P1|Overall Study|not disclosed|2
5182446|NCT01221948|17893316|P1|Overall Study|Withdrawal by Subject|2
5182447|NCT01221948|17893316|P1|Overall Study|Physician Decision|5
5182448|NCT01221753|17893335|P1|Overall Study|Adverse Event|1
5182449|NCT01221727|17893342|P2|Overall Study|Withdrawal by Subject|1
5182450|NCT01221727|17893343|P1|Overall Study|Withdrawal by Subject|1
5182451|NCT01221727|17893342|P2|Overall Study|Physician Decision|0
5182452|NCT01221727|17893343|P1|Overall Study|Physician Decision|2
5182453|NCT01221623|17893364|P2|Overall Study|Other|2
5182454|NCT01221623|17893365|P1|Overall Study|Other|5
5182455|NCT01221623|17893364|P2|Overall Study|Death|0
5182456|NCT01221623|17893365|P1|Overall Study|Death|1
5182457|NCT01221623|17893364|P2|Overall Study|Adverse Event|3
5182458|NCT01221623|17893365|P1|Overall Study|Adverse Event|6
5182459|NCT01221623|17893364|P2|Overall Study|Lost to Follow-up|1
5182460|NCT01221623|17893365|P1|Overall Study|Lost to Follow-up|7
5182461|NCT01221623|17893364|P2|Overall Study|Withdrawal by Subject|8
5182462|NCT01221623|17893365|P1|Overall Study|Withdrawal by Subject|19
5182463|NCT01221597|17893389|P2|Overall Study|Death|0
5182464|NCT01221597|17893390|P1|Overall Study|Death|2
5182465|NCT01221597|17893389|P2|Overall Study|Other|4
5182466|NCT01221597|17893390|P1|Overall Study|Other|3
5182467|NCT01221597|17893389|P2|Overall Study|Protocol Violation|0
5182468|NCT01221597|17893390|P1|Overall Study|Protocol Violation|1
5182469|NCT01221597|17893389|P2|Overall Study|Lost to Follow-up|5
5182470|NCT01221597|17893390|P1|Overall Study|Lost to Follow-up|6
5182471|NCT01221597|17893389|P2|Overall Study|Withdrawal by Subject|6
5182472|NCT01221597|17893390|P1|Overall Study|Withdrawal by Subject|20
5182473|NCT01221597|17893389|P2|Overall Study|Adverse Event|1
5182474|NCT01221597|17893390|P1|Overall Study|Adverse Event|4
5182475|NCT01221363|17893447|P2|Overall Study|Withdrawal by Subject|5
5182476|NCT01221363|17893448|P1|Overall Study|Withdrawal by Subject|11
5182477|NCT01221363|17893447|P2|Overall Study|Pregnancy|0
5182478|NCT01221363|17893448|P1|Overall Study|Pregnancy|1
5182479|NCT01221350|17893458|P2|Overall Study|Withdrawal by Subject|2
5182480|NCT01221350|17893459|P1|Overall Study|Withdrawal by Subject|4
5182481|NCT01221350|17893458|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
5182482|NCT01221350|17893459|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
5182483|NCT01221350|17893458|P2|Overall Study|Discontinued intervention (GERD)|0
5182484|NCT01221350|17893459|P1|Overall Study|Discontinued intervention (GERD)|1
5182485|NCT01221285|17893518|P1|Overall Study|Withdrawal by Subject|1
5182486|NCT01221272|17893527|P2|Period 2|Adverse Event|2
5182487|NCT01221272|17893528|P1|Period 2|Adverse Event|0
5182488|NCT01221272|17893527|P2|Period 1|Significant Dosing Noncompliance|1
5182489|NCT01221272|17893528|P1|Period 1|Significant Dosing Noncompliance|0
5182490|NCT01221272|17893527|P2|Period 1|Consent Withdrawal|1
5182491|NCT01221272|17893528|P1|Period 1|Consent Withdrawal|0
5182492|NCT01221272|17893527|P2|Period 1|Adverse Event|0
5182493|NCT01221272|17893528|P1|Period 1|Adverse Event|2
5182494|NCT01221233|17893545|P2|Overall Study|Withdrawal by Subject|1
5182495|NCT01221233|17893546|P1|Overall Study|Withdrawal by Subject|3
5182496|NCT01221181|17893574|P1|Overall Study|Lost to Follow-up|1
5182497|NCT01221090|17893582|P4|Overall Study|Withdrawal by Subject|2
5182498|NCT01221090|17893583|P3|Overall Study|Withdrawal by Subject|27
5182499|NCT01221090|17893584|P2|Overall Study|Withdrawal by Subject|22
5182500|NCT01221090|17893585|P1|Overall Study|Withdrawal by Subject|0
5182501|NCT01221090|17893582|P4|Overall Study|Non-Compliant or Unable to Contact|20
5182502|NCT01221090|17893583|P3|Overall Study|Non-Compliant or Unable to Contact|15
5182503|NCT01221090|17893584|P2|Overall Study|Non-Compliant or Unable to Contact|12
5182504|NCT01221090|17893585|P1|Overall Study|Non-Compliant or Unable to Contact|15
5182505|NCT01220999|17893616|P5|Overall Study|Progressive disease|0
5182506|NCT01220999|17893617|P4|Overall Study|Progressive disease|0
5182507|NCT01220999|17893618|P3|Overall Study|Progressive disease|1
5182508|NCT01220999|17893619|P2|Overall Study|Progressive disease|0
5182509|NCT01220999|17893620|P1|Overall Study|Progressive disease|0
5182510|NCT01220609|17893770|P1|Overall Study|Ineligible-Never treated|1
5182511|NCT01220609|17893770|P1|Overall Study|Ineligible- Wrong cell type|1
5182512|NCT01220609|17893770|P1|Overall Study|Ineligible-Wrong primary cancer site|1
5182513|NCT01220557|17893784|P2|Overall Study|attended less than 6 lessons|2
5182514|NCT01220557|17893785|P1|Overall Study|attended less than 6 lessons|1
5182515|NCT01220557|17893784|P2|Overall Study|Lost to Follow-up|3
5182516|NCT01220557|17893785|P1|Overall Study|Lost to Follow-up|5
5182517|NCT01220414|17893818|P4|Overall Study|Withdrawal by Subject|1
5182518|NCT01220414|17893819|P3|Overall Study|Withdrawal by Subject|0
5182519|NCT01220414|17893820|P2|Overall Study|Withdrawal by Subject|0
5182520|NCT01220414|17893821|P1|Overall Study|Withdrawal by Subject|1
5182521|NCT01220401|17893828|P1|Overall Study|Protocol Violation|1
5182522|NCT01220401|17893828|P1|Overall Study|Withdrawal by Subject|2
5182523|NCT01220297|17893837|P1|Overall Study|Lost to Follow-up|1
5182524|NCT01220297|17893837|P1|Overall Study|Death|2
5182525|NCT01220180|17893854|P1|Overall Study|Randomized but not treated|1
5182526|NCT01220180|17893854|P1|Overall Study|Death|1
5182527|NCT01220180|17893854|P1|Overall Study|Lack of Efficacy|22
5182528|NCT01220180|17893854|P1|Overall Study|Adverse Event|35
5182529|NCT01220180|17893854|P1|Overall Study|Other|72
5182530|NCT01220180|17893854|P1|Overall Study|Lost to Follow-up|76
5182531|NCT01220167|17893880|P3|Period 3|Urine positive for substance abuse|0
5182532|NCT01220167|17893881|P2|Period 3|Urine positive for substance abuse|1
5182533|NCT01220167|17893882|P1|Period 3|Urine positive for substance abuse|0
5182534|NCT01220128|17893895|P7|Overall Study|Consent withdrawn by subject|0
5182535|NCT01220128|17893896|P6|Overall Study|Consent withdrawn by subject|0
5182536|NCT01220128|17893897|P5|Overall Study|Consent withdrawn by subject|0
5182537|NCT01220128|17893898|P4|Overall Study|Consent withdrawn by subject|0
5182538|NCT01220128|17893899|P3|Overall Study|Consent withdrawn by subject|0
5182539|NCT01220128|17893900|P2|Overall Study|Consent withdrawn by subject|0
5182540|NCT01220128|17893901|P1|Overall Study|Consent withdrawn by subject|1
5182541|NCT01220128|17893895|P7|Overall Study|Other|0
5182542|NCT01220128|17893896|P6|Overall Study|Other|0
5182543|NCT01220128|17893897|P5|Overall Study|Other|0
5182544|NCT01220128|17893898|P4|Overall Study|Other|0
5182545|NCT01220128|17893899|P3|Overall Study|Other|1
5182546|NCT01220128|17893900|P2|Overall Study|Other|0
5182547|NCT01220128|17893901|P1|Overall Study|Other|0
5182548|NCT01220128|17893895|P7|Overall Study|Adverse event, non-fatal|3
5182549|NCT01220128|17893896|P6|Overall Study|Adverse event, non-fatal|0
5182550|NCT01220128|17893897|P5|Overall Study|Adverse event, non-fatal|0
5182551|NCT01220128|17893898|P4|Overall Study|Adverse event, non-fatal|0
5182552|NCT01220128|17893899|P3|Overall Study|Adverse event, non-fatal|0
5182553|NCT01220128|17893900|P2|Overall Study|Adverse event, non-fatal|0
5182554|NCT01220128|17893901|P1|Overall Study|Adverse event, non-fatal|1
5182555|NCT01220128|17893895|P7|Overall Study|Adverse event, serious fatal|1
5182556|NCT01220128|17893896|P6|Overall Study|Adverse event, serious fatal|0
5182557|NCT01220128|17893897|P5|Overall Study|Adverse event, serious fatal|0
5182558|NCT01220128|17893898|P4|Overall Study|Adverse event, serious fatal|0
5182559|NCT01220128|17893899|P3|Overall Study|Adverse event, serious fatal|0
5182560|NCT01220128|17893900|P2|Overall Study|Adverse event, serious fatal|0
5182561|NCT01220128|17893901|P1|Overall Study|Adverse event, serious fatal|2
5182562|NCT01220128|17893895|P7|Overall Study|Sponsor study termination|1
5182563|NCT01220128|17893896|P6|Overall Study|Sponsor study termination|0
5182564|NCT01220128|17893897|P5|Overall Study|Sponsor study termination|0
5182565|NCT01220128|17893898|P4|Overall Study|Sponsor study termination|0
5182566|NCT01220128|17893899|P3|Overall Study|Sponsor study termination|0
5182567|NCT01220128|17893900|P2|Overall Study|Sponsor study termination|1
5182568|NCT01220128|17893901|P1|Overall Study|Sponsor study termination|0
5182569|NCT01220128|17893895|P7|Overall Study|Progressive disease|0
5182570|NCT01220128|17893896|P6|Overall Study|Progressive disease|0
5182571|NCT01220128|17893897|P5|Overall Study|Progressive disease|0
5182572|NCT01220128|17893898|P4|Overall Study|Progressive disease|0
5182573|NCT01220128|17893899|P3|Overall Study|Progressive disease|2
5182574|NCT01220128|17893900|P2|Overall Study|Progressive disease|0
5182575|NCT01220128|17893901|P1|Overall Study|Progressive disease|0
5182576|NCT01219985|17894106|P1|Overall Study|Physician Decision|20
5182577|NCT01219959|17894114|P2|Overall Study|Other|0
5182578|NCT01219959|17894115|P1|Overall Study|Other|1
5182579|NCT01219959|17894114|P2|Overall Study|Renal Transplantation|3
5182580|NCT01219959|17894115|P1|Overall Study|Renal Transplantation|0
5182581|NCT01219959|17894114|P2|Overall Study|Withdrawal by Subject|2
5182582|NCT01219959|17894115|P1|Overall Study|Withdrawal by Subject|0
5182583|NCT01219959|17894114|P2|Overall Study|Physician Decision|4
5182584|NCT01219959|17894115|P1|Overall Study|Physician Decision|0
5182585|NCT01219959|17894114|P2|Overall Study|Adverse Event|14
5182586|NCT01219959|17894115|P1|Overall Study|Adverse Event|6
5182587|NCT01219933|17894163|P1|Overall Study|Lack of Efficacy|1
5182588|NCT01219933|17894163|P1|Overall Study|Protocol Violation|8
5182589|NCT01219933|17894163|P1|Overall Study|Withdrawal by Subject|5
5182590|NCT01219933|17894163|P1|Overall Study|GC free|1
5182591|NCT01219933|17894163|P1|Overall Study|Lost to Follow-up|3
5182592|NCT01219933|17894163|P1|Overall Study|No LDA maintained|7
5182593|NCT01219933|17894163|P1|Overall Study|No LDA reached|5
5182594|NCT01219933|17894163|P1|Overall Study|Adverse Event|8
5182595|NCT01218867|17894373|P11|Overall Study|Death during treatment|0
5182596|NCT01218867|17894374|P10|Overall Study|Death during treatment|0
5182597|NCT01218867|17894375|P9|Overall Study|Death during treatment|0
5182598|NCT01218867|17894376|P8|Overall Study|Death during treatment|0
5182599|NCT01218867|17894377|P7|Overall Study|Death during treatment|1
5182600|NCT01218867|17894378|P6|Overall Study|Death during treatment|0
5182601|NCT01218867|17894379|P5|Overall Study|Death during treatment|0
5182602|NCT01218867|17894380|P4|Overall Study|Death during treatment|0
5182603|NCT01218867|17894381|P3|Overall Study|Death during treatment|0
5182604|NCT01218867|17894382|P2|Overall Study|Death during treatment|0
5182605|NCT01218867|17894383|P1|Overall Study|Death during treatment|0
5182606|NCT01218802|17894431|P2|Overall Study|Incarcerated|0
5182607|NCT01218802|17894432|P1|Overall Study|Incarcerated|2
5182608|NCT01218802|17894431|P2|Overall Study|Adverse Event|2
5182609|NCT01218802|17894432|P1|Overall Study|Adverse Event|0
5182610|NCT01218802|17894431|P2|Overall Study|Withdrawal by Subject|10
5182611|NCT01218802|17894432|P1|Overall Study|Withdrawal by Subject|3
5182612|NCT01218802|17894431|P2|Overall Study|Lost to Follow-up|6
5182613|NCT01218802|17894432|P1|Overall Study|Lost to Follow-up|5
5182614|NCT01218659|17894469|P3|12-Month OLE|Declined to participate in the OLE|4
5182615|NCT01218659|17894470|P2|12-Month OLE|Declined to participate in the OLE|0
5182616|NCT01218659|17894471|P1|12-Month OLE|Declined to participate in the OLE|0
5182617|NCT01218659|17894469|P3|12-Month OLE|Lack of Efficacy|1
5182618|NCT01218659|17894470|P2|12-Month OLE|Lack of Efficacy|0
5182619|NCT01218659|17894471|P1|12-Month OLE|Lack of Efficacy|0
5182620|NCT01218659|17894469|P3|12-Month OLE|Pregnancy|1
5182621|NCT01218659|17894470|P2|12-Month OLE|Pregnancy|0
5182622|NCT01218659|17894471|P1|12-Month OLE|Pregnancy|0
5182623|NCT01218659|17894469|P3|12-Month OLE|Lost to Follow-up|1
5182624|NCT01218659|17894470|P2|12-Month OLE|Lost to Follow-up|0
5182625|NCT01218659|17894471|P1|12-Month OLE|Lost to Follow-up|0
5182626|NCT01218659|17894469|P3|12-Month OLE|Physician Decision|1
5182627|NCT01218659|17894470|P2|12-Month OLE|Physician Decision|0
5182628|NCT01218659|17894471|P1|12-Month OLE|Physician Decision|0
5182629|NCT01218659|17894469|P3|12-Month OLE|Withdrawal by Subject|2
5182630|NCT01218659|17894470|P2|12-Month OLE|Withdrawal by Subject|0
5182631|NCT01218659|17894471|P1|12-Month OLE|Withdrawal by Subject|0
5182632|NCT01218659|17894469|P3|18-Month Randomized Period|Did not receive study drug|0
5182633|NCT01218659|17894470|P2|18-Month Randomized Period|Did not receive study drug|3
5182634|NCT01218659|17894471|P1|18-Month Randomized Period|Did not receive study drug|0
5182635|NCT01218659|17894469|P3|18-Month Randomized Period|Withdrawal by Subject|0
5182636|NCT01218659|17894470|P2|18-Month Randomized Period|Withdrawal by Subject|3
5182637|NCT01218659|17894471|P1|18-Month Randomized Period|Withdrawal by Subject|2
5182638|NCT01218646|17894486|P4|Overall Study|Protocol Violation|1
5182639|NCT01218646|17894487|P3|Overall Study|Protocol Violation|1
5182640|NCT01218646|17894488|P2|Overall Study|Protocol Violation|0
5182641|NCT01218646|17894489|P1|Overall Study|Protocol Violation|0
5182642|NCT01218646|17894486|P4|Overall Study|Lost to Follow-up|0
5182643|NCT01218646|17894487|P3|Overall Study|Lost to Follow-up|0
5182644|NCT01218646|17894488|P2|Overall Study|Lost to Follow-up|0
5182645|NCT01218646|17894489|P1|Overall Study|Lost to Follow-up|1
5182646|NCT01218646|17894486|P4|Overall Study|Adverse Event|0
5182647|NCT01218646|17894487|P3|Overall Study|Adverse Event|1
5182648|NCT01218646|17894488|P2|Overall Study|Adverse Event|0
5182649|NCT01218646|17894489|P1|Overall Study|Adverse Event|0
5182650|NCT01218594|17894527|P1|Overall Study|Physician Decision|6
5182651|NCT01218594|17894527|P1|Overall Study|Adverse Event|2
5182652|NCT01218594|17894527|P1|Overall Study|Withdrawal by Subject|3
5182653|NCT01218594|17894527|P1|Overall Study|Death|1
5182654|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
5182655|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
5182656|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
5182657|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
5182658|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
5182659|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
5182660|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
5182661|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
5182662|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5182663|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5182664|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
5182665|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5182666|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Other|0
5182667|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Other|0
5182668|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Other|4
5182669|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Other|3
5182670|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5182671|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5182672|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
5182673|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5182674|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5182675|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5182676|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
5182677|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5182678|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5182679|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5182680|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
5182681|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5182682|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
5182683|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
5182684|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
5182685|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
5182686|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5182687|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5182688|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5182689|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
5182690|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Physician Decision|0
5182691|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Physician Decision|0
5182692|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Physician Decision|2
5182693|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Physician Decision|2
5182694|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5182695|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5182696|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
5182697|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5182698|NCT01218516|17894533|P4|Combination Therapy (up to 4.5 Months)|Death|0
5182699|NCT01218516|17894534|P3|Combination Therapy (up to 4.5 Months)|Death|0
5182700|NCT01218516|17894535|P2|Combination Therapy (up to 4.5 Months)|Death|1
5182701|NCT01218516|17894536|P1|Combination Therapy (up to 4.5 Months)|Death|2
5182702|NCT01218477|17894558|P4|Overall Study|Maximum clinical benefit|0
5182703|NCT01218477|17894559|P3|Overall Study|Maximum clinical benefit|0
5182704|NCT01218477|17894560|P2|Overall Study|Maximum clinical benefit|2
5182705|NCT01218477|17894561|P1|Overall Study|Maximum clinical benefit|0
5182706|NCT01218477|17894558|P4|Overall Study|Administrative reason by sponsor|0
5182707|NCT01218477|17894559|P3|Overall Study|Administrative reason by sponsor|1
5182708|NCT01218477|17894560|P2|Overall Study|Administrative reason by sponsor|0
5182709|NCT01218477|17894561|P1|Overall Study|Administrative reason by sponsor|0
5182710|NCT01218477|17894558|P4|Overall Study|Prepared for cell transplantation|0
5182711|NCT01218477|17894559|P3|Overall Study|Prepared for cell transplantation|1
5182712|NCT01218477|17894560|P2|Overall Study|Prepared for cell transplantation|1
5182713|NCT01218477|17894561|P1|Overall Study|Prepared for cell transplantation|0
5182714|NCT01218477|17894558|P4|Overall Study|Withdrawal by Subject|0
5182715|NCT01218477|17894559|P3|Overall Study|Withdrawal by Subject|1
5182716|NCT01218477|17894560|P2|Overall Study|Withdrawal by Subject|0
5182717|NCT01218477|17894561|P1|Overall Study|Withdrawal by Subject|0
5182718|NCT01218477|17894558|P4|Overall Study|No longer meets study criteria|0
5182719|NCT01218477|17894559|P3|Overall Study|No longer meets study criteria|0
5182720|NCT01218477|17894560|P2|Overall Study|No longer meets study criteria|0
5182721|NCT01218477|17894561|P1|Overall Study|No longer meets study criteria|1
5182722|NCT01218477|17894558|P4|Overall Study|Study drug toxicity|0
5182723|NCT01218477|17894559|P3|Overall Study|Study drug toxicity|5
5182724|NCT01218477|17894560|P2|Overall Study|Study drug toxicity|2
5182725|NCT01218477|17894561|P1|Overall Study|Study drug toxicity|0
5182726|NCT01218477|17894558|P4|Overall Study|Disease progression|2
5182727|NCT01218477|17894559|P3|Overall Study|Disease progression|6
5182728|NCT01218477|17894560|P2|Overall Study|Disease progression|3
5182729|NCT01218477|17894561|P1|Overall Study|Disease progression|2
5182730|NCT01218438|17894578|P1|Epoch 4|Withdrawal by Subject|2
5182731|NCT01218438|17894578|P1|Epoch 4|Physician Decision|1
5182732|NCT01218438|17894578|P1|Epoch 3|Adverse Event|1
5182733|NCT01218438|17894578|P1|Epoch 3|Withdrawal by Subject|3
5182734|NCT01218438|17894578|P1|Epoch 1|Adverse Event|1
5182735|NCT01218438|17894578|P1|Epoch 1|Physician Decision|2
5182736|NCT01218308|17894744|P2|Overall Study|Other|21
5182737|NCT01218308|17894745|P1|Overall Study|Other|14
5182738|NCT01218308|17894744|P2|Overall Study|Lost to Follow-up|31
5182739|NCT01218308|17894745|P1|Overall Study|Lost to Follow-up|27
5182740|NCT01218308|17894744|P2|Overall Study|Withdrawal by Subject|64
5182741|NCT01218308|17894745|P1|Overall Study|Withdrawal by Subject|61
5182742|NCT01218308|17894744|P2|Overall Study|Protocol Violation|2
5182743|NCT01218308|17894745|P1|Overall Study|Protocol Violation|0
5182744|NCT01218308|17894744|P2|Overall Study|Adverse Event|2
5182745|NCT01218308|17894745|P1|Overall Study|Adverse Event|1
5182746|NCT01218243|17894789|P2|Overall Study|Protocol Violation|10
5182747|NCT01218243|17894790|P1|Overall Study|Protocol Violation|5
5182748|NCT01218243|17894789|P2|Overall Study|Lost to Follow-up|3
5182749|NCT01218243|17894790|P1|Overall Study|Lost to Follow-up|3
5182750|NCT01218243|17894789|P2|Overall Study|Lack of Efficacy|1
5182751|NCT01218243|17894790|P1|Overall Study|Lack of Efficacy|1
5182752|NCT01218204|17894806|P4|Part B Pooled Treatment Arm|Protocol Violation|1
5182753|NCT01218204|17894807|P3|Part B Pooled Treatment Arm|Protocol Violation|0
5182754|NCT01218204|17894808|P2|Part B Pooled Treatment Arm|Protocol Violation|0
5182755|NCT01218204|17894809|P1|Part B Pooled Treatment Arm|Protocol Violation|0
5182756|NCT01218204|17894806|P4|Part B Pooled Treatment Arm|Adverse Event|2
5182757|NCT01218204|17894807|P3|Part B Pooled Treatment Arm|Adverse Event|0
5182758|NCT01218204|17894808|P2|Part B Pooled Treatment Arm|Adverse Event|0
5182759|NCT01218204|17894809|P1|Part B Pooled Treatment Arm|Adverse Event|0
5182760|NCT01218204|17894806|P4|Part B Run-in|Withdrawal by Subject|0
5182761|NCT01218204|17894807|P3|Part B Run-in|Withdrawal by Subject|3
5182762|NCT01218204|17894808|P2|Part B Run-in|Withdrawal by Subject|0
5182763|NCT01218204|17894809|P1|Part B Run-in|Withdrawal by Subject|0
5182764|NCT01218204|17894806|P4|Part B Run-in|Protocol Violation|0
5182765|NCT01218204|17894807|P3|Part B Run-in|Protocol Violation|2
5182766|NCT01218204|17894808|P2|Part B Run-in|Protocol Violation|0
5182767|NCT01218204|17894809|P1|Part B Run-in|Protocol Violation|0
5182768|NCT01218204|17894806|P4|Part B Run-in|Adverse Event|0
5182769|NCT01218204|17894807|P3|Part B Run-in|Adverse Event|1
5182770|NCT01218204|17894808|P2|Part B Run-in|Adverse Event|0
5182771|NCT01218204|17894809|P1|Part B Run-in|Adverse Event|0
5182772|NCT01218204|17894806|P4|Part B Washout|Did not meet continuation criteria|0
5182773|NCT01218204|17894807|P3|Part B Washout|Did not meet continuation criteria|0
5182774|NCT01218204|17894808|P2|Part B Washout|Did not meet continuation criteria|112
5182775|NCT01218204|17894809|P1|Part B Washout|Did not meet continuation criteria|0
5182776|NCT01218204|17894806|P4|Part B Washout|Reached defined stopping criteria|0
5182777|NCT01218204|17894807|P3|Part B Washout|Reached defined stopping criteria|0
5182778|NCT01218204|17894808|P2|Part B Washout|Reached defined stopping criteria|2
5182779|NCT01218204|17894809|P1|Part B Washout|Reached defined stopping criteria|0
5182780|NCT01218204|17894806|P4|Part B Washout|Withdrawal by Subject|0
5182781|NCT01218204|17894807|P3|Part B Washout|Withdrawal by Subject|0
5182782|NCT01218204|17894808|P2|Part B Washout|Withdrawal by Subject|14
5182783|NCT01218204|17894809|P1|Part B Washout|Withdrawal by Subject|0
5182784|NCT01218204|17894806|P4|Part B Washout|Physician Decision|0
5182785|NCT01218204|17894807|P3|Part B Washout|Physician Decision|0
5182786|NCT01218204|17894808|P2|Part B Washout|Physician Decision|14
5182787|NCT01218204|17894809|P1|Part B Washout|Physician Decision|0
5182788|NCT01218204|17894806|P4|Part B Washout|Lost to Follow-up|0
5182789|NCT01218204|17894807|P3|Part B Washout|Lost to Follow-up|0
5182790|NCT01218204|17894808|P2|Part B Washout|Lost to Follow-up|2
5182791|NCT01218204|17894809|P1|Part B Washout|Lost to Follow-up|0
5182792|NCT01218204|17894806|P4|Part B Washout|Adverse Event|0
5182793|NCT01218204|17894807|P3|Part B Washout|Adverse Event|0
5182794|NCT01218204|17894808|P2|Part B Washout|Adverse Event|1
5182795|NCT01218204|17894809|P1|Part B Washout|Adverse Event|0
5182796|NCT01218126|17895073|P4|Overall Study|Withdrawal by Subject|6
5182797|NCT01218126|17895074|P3|Overall Study|Withdrawal by Subject|4
5182798|NCT01218126|17895075|P2|Overall Study|Withdrawal by Subject|5
5182799|NCT01218126|17895076|P1|Overall Study|Withdrawal by Subject|2
5182800|NCT01218126|17895073|P4|Overall Study|Physician Decision|2
5182801|NCT01218126|17895074|P3|Overall Study|Physician Decision|4
5182802|NCT01218126|17895075|P2|Overall Study|Physician Decision|2
5182803|NCT01218126|17895076|P1|Overall Study|Physician Decision|1
5182804|NCT01218126|17895073|P4|Overall Study|Lost to Follow-up|2
5182805|NCT01218126|17895074|P3|Overall Study|Lost to Follow-up|0
5182806|NCT01218126|17895075|P2|Overall Study|Lost to Follow-up|0
5182807|NCT01218126|17895076|P1|Overall Study|Lost to Follow-up|0
5182808|NCT01218126|17895073|P4|Overall Study|Protocol-defined stopping criteria|0
5182809|NCT01218126|17895074|P3|Overall Study|Protocol-defined stopping criteria|0
5182810|NCT01218126|17895075|P2|Overall Study|Protocol-defined stopping criteria|1
5182811|NCT01218126|17895076|P1|Overall Study|Protocol-defined stopping criteria|1
5182812|NCT01218126|17895073|P4|Overall Study|Protocol Violation|3
5182813|NCT01218126|17895074|P3|Overall Study|Protocol Violation|2
5182814|NCT01218126|17895075|P2|Overall Study|Protocol Violation|2
5182815|NCT01218126|17895076|P1|Overall Study|Protocol Violation|5
5182816|NCT01218126|17895073|P4|Overall Study|Lack of Efficacy|6
5182817|NCT01218126|17895074|P3|Overall Study|Lack of Efficacy|2
5182818|NCT01218126|17895075|P2|Overall Study|Lack of Efficacy|2
5182819|NCT01218126|17895076|P1|Overall Study|Lack of Efficacy|7
5182820|NCT01218126|17895073|P4|Overall Study|Adverse Event|16
5182821|NCT01218126|17895074|P3|Overall Study|Adverse Event|12
5182822|NCT01218126|17895075|P2|Overall Study|Adverse Event|10
5182823|NCT01218126|17895076|P1|Overall Study|Adverse Event|8
5182824|NCT01218113|17895117|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
5182825|NCT01218113|17895118|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
5182826|NCT01218113|17895119|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
5182827|NCT01218113|17895117|P3|Overall Study|Lost to Follow-up|4
5182828|NCT01218113|17895118|P2|Overall Study|Lost to Follow-up|1
5182829|NCT01218113|17895119|P1|Overall Study|Lost to Follow-up|4
5182830|NCT01218113|17895117|P3|Overall Study|Withdrawal by Subject|1
5182831|NCT01218113|17895118|P2|Overall Study|Withdrawal by Subject|0
5182832|NCT01218113|17895119|P1|Overall Study|Withdrawal by Subject|1
5182833|NCT01218100|17895300|P4|Overall Study|Other Reason|4
5182834|NCT01218100|17895301|P3|Overall Study|Other Reason|6
5182835|NCT01218100|17895302|P2|Overall Study|Other Reason|2
5182836|NCT01218100|17895303|P1|Overall Study|Other Reason|2
5182837|NCT01218100|17895300|P4|Overall Study|Lost to Follow-up|1
5182838|NCT01218100|17895301|P3|Overall Study|Lost to Follow-up|2
5182839|NCT01218100|17895302|P2|Overall Study|Lost to Follow-up|8
5182840|NCT01218100|17895303|P1|Overall Study|Lost to Follow-up|3
5182841|NCT01218100|17895300|P4|Overall Study|Withdrawal by Subject|7
5182842|NCT01218100|17895301|P3|Overall Study|Withdrawal by Subject|6
5182843|NCT01218100|17895302|P2|Overall Study|Withdrawal by Subject|2
5182844|NCT01218100|17895303|P1|Overall Study|Withdrawal by Subject|5
5182845|NCT01218100|17895300|P4|Overall Study|Protocol Violation|1
5182846|NCT01218100|17895301|P3|Overall Study|Protocol Violation|1
5182847|NCT01218100|17895302|P2|Overall Study|Protocol Violation|0
5182848|NCT01218100|17895303|P1|Overall Study|Protocol Violation|0
5182849|NCT01218100|17895300|P4|Overall Study|Lack of Efficacy|12
5182850|NCT01218100|17895301|P3|Overall Study|Lack of Efficacy|5
5182851|NCT01218100|17895302|P2|Overall Study|Lack of Efficacy|6
5182852|NCT01218100|17895303|P1|Overall Study|Lack of Efficacy|9
5182853|NCT01218100|17895300|P4|Overall Study|Adverse Event|7
5182854|NCT01218100|17895301|P3|Overall Study|Adverse Event|6
5182855|NCT01218100|17895302|P2|Overall Study|Adverse Event|6
5182856|NCT01218100|17895303|P1|Overall Study|Adverse Event|4
5182857|NCT01218100|17895300|P4|Overall Study|Did not meet InclusionExclusion criteria|2
5182858|NCT01218100|17895301|P3|Overall Study|Did not meet InclusionExclusion criteria|1
5182859|NCT01218100|17895302|P2|Overall Study|Did not meet InclusionExclusion criteria|1
5182860|NCT01218100|17895303|P1|Overall Study|Did not meet InclusionExclusion criteria|1
5182861|NCT01218087|17895319|P2|Overall Study|Transferred|5
5182862|NCT01218087|17895320|P1|Overall Study|Transferred|8
5182863|NCT01218087|17895319|P2|Overall Study|Withdrawal by Subject|0
5182864|NCT01218087|17895320|P1|Overall Study|Withdrawal by Subject|5
5182865|NCT01218087|17895319|P2|Overall Study|Death|1
5182866|NCT01218087|17895320|P1|Overall Study|Death|2
5182867|NCT01218009|17895342|P2|Overall Study|Sponsor terminated study|163
5182868|NCT01218009|17895343|P1|Overall Study|Sponsor terminated study|161
5182869|NCT01218009|17895342|P2|Overall Study|Withdrawal by Subject|1
5182870|NCT01218009|17895343|P1|Overall Study|Withdrawal by Subject|3
5182871|NCT01218009|17895342|P2|Overall Study|Protocol Violation|1
5182872|NCT01218009|17895343|P1|Overall Study|Protocol Violation|2
5182873|NCT01217957|17895366|P5|Phase 2|Withdrawal by Patient|1
5182874|NCT01217957|17895367|P4|Phase 2|Withdrawal by Patient|0
5182875|NCT01217957|17895368|P3|Phase 2|Withdrawal by Patient|0
5182876|NCT01217957|17895369|P2|Phase 2|Withdrawal by Patient|0
5182877|NCT01217957|17895370|P1|Phase 2|Withdrawal by Patient|0
5182878|NCT01217957|17895366|P5|Phase 1|Withdrawal by Patient|0
5182879|NCT01217957|17895367|P4|Phase 1|Withdrawal by Patient|1
5182880|NCT01217957|17895368|P3|Phase 1|Withdrawal by Patient|1
5182881|NCT01217957|17895369|P2|Phase 1|Withdrawal by Patient|0
5182882|NCT01217957|17895370|P1|Phase 1|Withdrawal by Patient|1
5182883|NCT01217944|17895429|P3|Overall Study|Lack of Efficacy|0
5182884|NCT01217944|17895430|P2|Overall Study|Lack of Efficacy|0
5182885|NCT01217944|17895431|P1|Overall Study|Lack of Efficacy|1
5182886|NCT01217944|17895429|P3|Overall Study|Withdrawal by Subject|0
5182887|NCT01217944|17895430|P2|Overall Study|Withdrawal by Subject|2
5182888|NCT01217944|17895431|P1|Overall Study|Withdrawal by Subject|1
5182889|NCT01217944|17895429|P3|Overall Study|Lost to Follow-up|0
5182890|NCT01217944|17895430|P2|Overall Study|Lost to Follow-up|1
5182891|NCT01217944|17895431|P1|Overall Study|Lost to Follow-up|3
5182892|NCT01217944|17895429|P3|Overall Study|Protocol Violation|0
5182893|NCT01217944|17895430|P2|Overall Study|Protocol Violation|1
5182894|NCT01217944|17895431|P1|Overall Study|Protocol Violation|1
5182895|NCT01217892|17895474|P4|Overall Study|Poor/Non-Compliance|0
5182896|NCT01217892|17895475|P3|Overall Study|Poor/Non-Compliance|1
5182897|NCT01217892|17895476|P2|Overall Study|Poor/Non-Compliance|0
5182898|NCT01217892|17895477|P1|Overall Study|Poor/Non-Compliance|0
5182899|NCT01217892|17895474|P4|Overall Study|Incorrect enrollment|0
5182900|NCT01217892|17895475|P3|Overall Study|Incorrect enrollment|1
5182901|NCT01217892|17895476|P2|Overall Study|Incorrect enrollment|1
5182902|NCT01217892|17895477|P1|Overall Study|Incorrect enrollment|0
5182903|NCT01217892|17895474|P4|Overall Study|Subject no longer meets study criteria|8
5182904|NCT01217892|17895475|P3|Overall Study|Subject no longer meets study criteria|4
5182905|NCT01217892|17895476|P2|Overall Study|Subject no longer meets study criteria|2
5182906|NCT01217892|17895477|P1|Overall Study|Subject no longer meets study criteria|5
5182907|NCT01217892|17895474|P4|Overall Study|Lab value|0
5182908|NCT01217892|17895475|P3|Overall Study|Lab value|1
5182909|NCT01217892|17895476|P2|Overall Study|Lab value|0
5182910|NCT01217892|17895477|P1|Overall Study|Lab value|1
5182911|NCT01217892|17895474|P4|Overall Study|Withdrawal by Subject|0
5182912|NCT01217892|17895475|P3|Overall Study|Withdrawal by Subject|1
5182913|NCT01217892|17895476|P2|Overall Study|Withdrawal by Subject|2
5182914|NCT01217892|17895477|P1|Overall Study|Withdrawal by Subject|0
5182915|NCT01217892|17895474|P4|Overall Study|Adverse Event|0
5182916|NCT01217892|17895475|P3|Overall Study|Adverse Event|1
5182917|NCT01217892|17895476|P2|Overall Study|Adverse Event|1
5182918|NCT01217892|17895477|P1|Overall Study|Adverse Event|1
5182919|NCT01217814|17895540|P3|Overall Study|Lack of Efficacy|1
5182920|NCT01217814|17895541|P2|Overall Study|Lack of Efficacy|0
5182921|NCT01217814|17895542|P1|Overall Study|Lack of Efficacy|0
5182922|NCT01217814|17895540|P3|Overall Study|Adverse Event|0
5182923|NCT01217814|17895541|P2|Overall Study|Adverse Event|1
5182924|NCT01217814|17895542|P1|Overall Study|Adverse Event|1
5182925|NCT01217801|17895568|P2|Period 1|Withdrawal by Subject|1
5182926|NCT01217801|17895569|P1|Period 1|Withdrawal by Subject|0
5182927|NCT01217801|17895568|P2|Period 1|Protocol Violation|1
5182928|NCT01217801|17895569|P1|Period 1|Protocol Violation|1
5182929|NCT01217606|17895598|P2|9-Month Masked Extension|Lack of Efficacy|0
5182930|NCT01217606|17895599|P1|9-Month Masked Extension|Lack of Efficacy|2
5182931|NCT01217606|17895598|P2|9-Month Masked Extension|Pregnancy|0
5182932|NCT01217606|17895599|P1|9-Month Masked Extension|Pregnancy|1
5182933|NCT01217606|17895598|P2|9-Month Masked Extension|Lost to Follow-up|0
5182934|NCT01217606|17895599|P1|9-Month Masked Extension|Lost to Follow-up|1
5182935|NCT01217606|17895598|P2|9-Month Masked Extension|Personal Reasons|1
5182936|NCT01217606|17895599|P1|9-Month Masked Extension|Personal Reasons|2
5182937|NCT01217606|17895598|P2|9-Month Masked Extension|Other Reasons|4
5182938|NCT01217606|17895599|P1|9-Month Masked Extension|Other Reasons|4
5182939|NCT01217606|17895598|P2|9-Month Masked Extension|Adverse Event|6
5182940|NCT01217606|17895599|P1|9-Month Masked Extension|Adverse Event|3
5182941|NCT01217606|17895598|P2|Initial Treatment Phase|Adverse Event|6
5182942|NCT01217606|17895599|P1|Initial Treatment Phase|Adverse Event|10
5182943|NCT01217606|17895598|P2|Initial Treatment Phase|Lack of Efficacy|0
5182944|NCT01217606|17895599|P1|Initial Treatment Phase|Lack of Efficacy|1
5182945|NCT01217606|17895598|P2|Initial Treatment Phase|Personal Reasons|2
5182946|NCT01217606|17895599|P1|Initial Treatment Phase|Personal Reasons|0
5182947|NCT01217606|17895598|P2|Initial Treatment Phase|Protocol Violation|2
5182948|NCT01217606|17895599|P1|Initial Treatment Phase|Protocol Violation|3
5182949|NCT01217606|17895598|P2|Initial Treatment Phase|Other Reasons|2
5182950|NCT01217606|17895599|P1|Initial Treatment Phase|Other Reasons|0
5182951|NCT01217476|17895630|P2|Overall Study|Other|0
5182952|NCT01217476|17895631|P1|Overall Study|Other|2
5182953|NCT01217476|17895630|P2|Overall Study|Protocol Deviation|0
5182954|NCT01217476|17895631|P1|Overall Study|Protocol Deviation|1
5182955|NCT01217476|17895630|P2|Overall Study|Surgery on the Target Limb|2
5182956|NCT01217476|17895631|P1|Overall Study|Surgery on the Target Limb|0
5182957|NCT01217476|17895630|P2|Overall Study|Withdrawal by Subject|3
5182958|NCT01217476|17895631|P1|Overall Study|Withdrawal by Subject|3
5182959|NCT01217476|17895630|P2|Overall Study|Physician Decision|1
5182960|NCT01217476|17895631|P1|Overall Study|Physician Decision|0
5182961|NCT01217476|17895630|P2|Overall Study|Adverse Event|1
5182962|NCT01217476|17895631|P1|Overall Study|Adverse Event|6
5182963|NCT01217463|17895641|P2|Overall Study|Other|1
5182964|NCT01217463|17895642|P1|Overall Study|Other|1
5182965|NCT01217463|17895641|P2|Overall Study|Patient Non-compliant|0
5182966|NCT01217463|17895642|P1|Overall Study|Patient Non-compliant|1
5182967|NCT01217463|17895641|P2|Overall Study|Surgery on the Target Limb|1
5182968|NCT01217463|17895642|P1|Overall Study|Surgery on the Target Limb|0
5182969|NCT01217463|17895641|P2|Overall Study|Withdrawal by Subject|0
5182970|NCT01217463|17895642|P1|Overall Study|Withdrawal by Subject|3
5182971|NCT01217463|17895641|P2|Overall Study|Physician Decision|1
5182972|NCT01217463|17895642|P1|Overall Study|Physician Decision|0
5182973|NCT01217463|17895641|P2|Overall Study|Adverse Event|5
5182974|NCT01217463|17895642|P1|Overall Study|Adverse Event|8
5182975|NCT01217437|17895652|P2|Overall Study|Ineligible|1
5182976|NCT01217437|17895653|P1|Overall Study|Ineligible|1
5182977|NCT01217437|17895652|P2|Overall Study|Withdrawal by Subject|2
5182978|NCT01217437|17895653|P1|Overall Study|Withdrawal by Subject|0
5182979|NCT01217437|17895652|P2|Overall Study|Physician Decision|5
5182980|NCT01217437|17895653|P1|Overall Study|Physician Decision|8
5182981|NCT01217437|17895652|P2|Overall Study|Lack of Efficacy|25
5182982|NCT01217437|17895653|P1|Overall Study|Lack of Efficacy|29
5182983|NCT01217437|17895652|P2|Overall Study|Death|0
5182984|NCT01217437|17895653|P1|Overall Study|Death|5
5182985|NCT01217437|17895652|P2|Overall Study|Adverse Event|8
5182986|NCT01217437|17895653|P1|Overall Study|Adverse Event|0
5182987|NCT01217385|17895674|P1|Overall Study|Normal Breast TOI not available|10
5182988|NCT01217385|17895674|P1|Overall Study|Central Path not Available|1
5182989|NCT01217385|17895674|P1|Overall Study|DOSI not performed/not eval|12
5182990|NCT01217385|17895674|P1|Overall Study|Withdrawal by Subject|3
5182991|NCT01217307|17895686|P2|Overall Study|Withdrawal by Subject|1
5182992|NCT01217307|17895687|P1|Overall Study|Withdrawal by Subject|0
5182993|NCT01217229|17895693|P1|Overall Study|Disease progression not confirmed|2
5182994|NCT01217229|17895693|P1|Overall Study|Protocol Violation|1
5182995|NCT01217229|17895693|P1|Overall Study|Disease progression, Cheson criteria|14
5182996|NCT01217229|17895693|P1|Overall Study|Disease progression, deterioration|2
5182997|NCT01217229|17895693|P1|Overall Study|Adverse Event|1
5182998|NCT01217190|17895702|P2|Second Dosing|Withdrawal by Subject|2
5182999|NCT01217190|17895703|P1|Second Dosing|Withdrawal by Subject|0
5183000|NCT01217112|17895718|P5|Overall Study|Physician Decision|1
5183001|NCT01217112|17895719|P4|Overall Study|Physician Decision|0
5183002|NCT01217112|17895720|P3|Overall Study|Physician Decision|0
5183003|NCT01217112|17895721|P2|Overall Study|Physician Decision|0
5183004|NCT01217112|17895722|P1|Overall Study|Physician Decision|0
5183005|NCT01217112|17895718|P5|Overall Study|Withdrawal by Subject|0
5183006|NCT01217112|17895719|P4|Overall Study|Withdrawal by Subject|0
5183007|NCT01217112|17895720|P3|Overall Study|Withdrawal by Subject|1
5183008|NCT01217112|17895721|P2|Overall Study|Withdrawal by Subject|0
5183009|NCT01217112|17895722|P1|Overall Study|Withdrawal by Subject|0
5183010|NCT01217112|17895718|P5|Overall Study|Adverse Event|0
5183011|NCT01217112|17895719|P4|Overall Study|Adverse Event|2
5183012|NCT01217112|17895720|P3|Overall Study|Adverse Event|0
5183013|NCT01217112|17895721|P2|Overall Study|Adverse Event|2
5183014|NCT01217112|17895722|P1|Overall Study|Adverse Event|0
5183015|NCT01217073|17895955|P8|Extension Period|Withdrawal by Subject|8
5183016|NCT01217073|17895956|P7|Extension Period|Withdrawal by Subject|30
5183017|NCT01217073|17895957|P6|Extension Period|Withdrawal by Subject|0
5183018|NCT01217073|17895958|P5|Extension Period|Withdrawal by Subject|0
5183019|NCT01217073|17895959|P4|Extension Period|Withdrawal by Subject|0
5183020|NCT01217073|17895960|P3|Extension Period|Withdrawal by Subject|0
5183021|NCT01217073|17895961|P2|Extension Period|Withdrawal by Subject|0
5183022|NCT01217073|17895962|P1|Extension Period|Withdrawal by Subject|0
5183023|NCT01217073|17895955|P8|Extension Period|Site discontinued study participation|2
5183024|NCT01217073|17895956|P7|Extension Period|Site discontinued study participation|7
5183025|NCT01217073|17895957|P6|Extension Period|Site discontinued study participation|0
5183026|NCT01217073|17895958|P5|Extension Period|Site discontinued study participation|0
5183027|NCT01217073|17895959|P4|Extension Period|Site discontinued study participation|0
5183028|NCT01217073|17895960|P3|Extension Period|Site discontinued study participation|0
5183029|NCT01217073|17895961|P2|Extension Period|Site discontinued study participation|0
5183030|NCT01217073|17895962|P1|Extension Period|Site discontinued study participation|0
5183031|NCT01217073|17895955|P8|Extension Period|Protocol Violation|1
5183032|NCT01217073|17895956|P7|Extension Period|Protocol Violation|2
5183033|NCT01217073|17895957|P6|Extension Period|Protocol Violation|0
5183034|NCT01217073|17895958|P5|Extension Period|Protocol Violation|0
5183035|NCT01217073|17895959|P4|Extension Period|Protocol Violation|0
5183036|NCT01217073|17895960|P3|Extension Period|Protocol Violation|0
5183037|NCT01217073|17895961|P2|Extension Period|Protocol Violation|0
5183038|NCT01217073|17895962|P1|Extension Period|Protocol Violation|0
5183039|NCT01217073|17895955|P8|Extension Period|Physician Decision|1
5183040|NCT01217073|17895956|P7|Extension Period|Physician Decision|4
5183041|NCT01217073|17895957|P6|Extension Period|Physician Decision|0
5183042|NCT01217073|17895958|P5|Extension Period|Physician Decision|0
5183043|NCT01217073|17895959|P4|Extension Period|Physician Decision|0
5183044|NCT01217073|17895960|P3|Extension Period|Physician Decision|0
5183045|NCT01217073|17895961|P2|Extension Period|Physician Decision|0
5183046|NCT01217073|17895962|P1|Extension Period|Physician Decision|0
5183047|NCT01217073|17895955|P8|Extension Period|Non-compliance with study drug|1
5183048|NCT01217073|17895956|P7|Extension Period|Non-compliance with study drug|0
5183049|NCT01217073|17895957|P6|Extension Period|Non-compliance with study drug|0
5183050|NCT01217073|17895958|P5|Extension Period|Non-compliance with study drug|0
5183051|NCT01217073|17895959|P4|Extension Period|Non-compliance with study drug|0
5183052|NCT01217073|17895960|P3|Extension Period|Non-compliance with study drug|0
5183053|NCT01217073|17895961|P2|Extension Period|Non-compliance with study drug|0
5183054|NCT01217073|17895962|P1|Extension Period|Non-compliance with study drug|0
5183055|NCT01217073|17895955|P8|Extension Period|Lost to Follow-up|1
5183056|NCT01217073|17895956|P7|Extension Period|Lost to Follow-up|9
5183057|NCT01217073|17895957|P6|Extension Period|Lost to Follow-up|0
5183058|NCT01217073|17895958|P5|Extension Period|Lost to Follow-up|0
5183059|NCT01217073|17895959|P4|Extension Period|Lost to Follow-up|0
5183060|NCT01217073|17895960|P3|Extension Period|Lost to Follow-up|0
5183061|NCT01217073|17895961|P2|Extension Period|Lost to Follow-up|0
5183062|NCT01217073|17895962|P1|Extension Period|Lost to Follow-up|0
5183063|NCT01217073|17895955|P8|Extension Period|Lack of Efficacy|0
5183064|NCT01217073|17895956|P7|Extension Period|Lack of Efficacy|3
5183065|NCT01217073|17895957|P6|Extension Period|Lack of Efficacy|0
5183066|NCT01217073|17895958|P5|Extension Period|Lack of Efficacy|0
5183067|NCT01217073|17895959|P4|Extension Period|Lack of Efficacy|0
5183068|NCT01217073|17895960|P3|Extension Period|Lack of Efficacy|0
5183069|NCT01217073|17895961|P2|Extension Period|Lack of Efficacy|0
5183070|NCT01217073|17895962|P1|Extension Period|Lack of Efficacy|0
5183071|NCT01217073|17895955|P8|Extension Period|Excluded medication|0
5183072|NCT01217073|17895956|P7|Extension Period|Excluded medication|2
5183073|NCT01217073|17895957|P6|Extension Period|Excluded medication|0
5183074|NCT01217073|17895958|P5|Extension Period|Excluded medication|0
5183075|NCT01217073|17895959|P4|Extension Period|Excluded medication|0
5183076|NCT01217073|17895960|P3|Extension Period|Excluded medication|0
5183077|NCT01217073|17895961|P2|Extension Period|Excluded medication|0
5183078|NCT01217073|17895962|P1|Extension Period|Excluded medication|0
5183079|NCT01217073|17895955|P8|Extension Period|Death|0
5183080|NCT01217073|17895956|P7|Extension Period|Death|1
5183081|NCT01217073|17895957|P6|Extension Period|Death|0
5183082|NCT01217073|17895958|P5|Extension Period|Death|0
5183083|NCT01217073|17895959|P4|Extension Period|Death|0
5183084|NCT01217073|17895960|P3|Extension Period|Death|0
5183085|NCT01217073|17895961|P2|Extension Period|Death|0
5183086|NCT01217073|17895962|P1|Extension Period|Death|0
5183087|NCT01217073|17895955|P8|Extension Period|Creatinine/eGFR|1
5183088|NCT01217073|17895956|P7|Extension Period|Creatinine/eGFR|11
5183089|NCT01217073|17895957|P6|Extension Period|Creatinine/eGFR|0
5183090|NCT01217073|17895958|P5|Extension Period|Creatinine/eGFR|0
5183091|NCT01217073|17895959|P4|Extension Period|Creatinine/eGFR|0
5183092|NCT01217073|17895960|P3|Extension Period|Creatinine/eGFR|0
5183093|NCT01217073|17895961|P2|Extension Period|Creatinine/eGFR|0
5183094|NCT01217073|17895962|P1|Extension Period|Creatinine/eGFR|0
5183095|NCT01217073|17895955|P8|Extension Period|Contraindication to study medication|0
5183096|NCT01217073|17895956|P7|Extension Period|Contraindication to study medication|1
5183097|NCT01217073|17895957|P6|Extension Period|Contraindication to study medication|0
5183098|NCT01217073|17895958|P5|Extension Period|Contraindication to study medication|0
5183099|NCT01217073|17895959|P4|Extension Period|Contraindication to study medication|0
5183100|NCT01217073|17895960|P3|Extension Period|Contraindication to study medication|0
5183101|NCT01217073|17895961|P2|Extension Period|Contraindication to study medication|0
5183102|NCT01217073|17895962|P1|Extension Period|Contraindication to study medication|0
5183103|NCT01217073|17895955|P8|Extension Period|ALT/AST|0
5183104|NCT01217073|17895956|P7|Extension Period|ALT/AST|2
5183105|NCT01217073|17895957|P6|Extension Period|ALT/AST|0
5183106|NCT01217073|17895958|P5|Extension Period|ALT/AST|0
5183107|NCT01217073|17895959|P4|Extension Period|ALT/AST|0
5183108|NCT01217073|17895960|P3|Extension Period|ALT/AST|0
5183109|NCT01217073|17895961|P2|Extension Period|ALT/AST|0
5183110|NCT01217073|17895962|P1|Extension Period|ALT/AST|0
5183111|NCT01217073|17895955|P8|Extension Period|Adverse Event|5
5183112|NCT01217073|17895956|P7|Extension Period|Adverse Event|19
5183113|NCT01217073|17895957|P6|Extension Period|Adverse Event|0
5183114|NCT01217073|17895958|P5|Extension Period|Adverse Event|0
5183115|NCT01217073|17895959|P4|Extension Period|Adverse Event|0
5183116|NCT01217073|17895960|P3|Extension Period|Adverse Event|0
5183117|NCT01217073|17895961|P2|Extension Period|Adverse Event|0
5183118|NCT01217073|17895962|P1|Extension Period|Adverse Event|0
5183119|NCT01217073|17895955|P8|Base Period|Withdrawal by Subject|0
5183120|NCT01217073|17895956|P7|Base Period|Withdrawal by Subject|0
5183121|NCT01217073|17895957|P6|Base Period|Withdrawal by Subject|5
5183122|NCT01217073|17895958|P5|Base Period|Withdrawal by Subject|5
5183123|NCT01217073|17895959|P4|Base Period|Withdrawal by Subject|1
5183124|NCT01217073|17895960|P3|Base Period|Withdrawal by Subject|5
5183125|NCT01217073|17895961|P2|Base Period|Withdrawal by Subject|5
5183126|NCT01217073|17895962|P1|Base Period|Withdrawal by Subject|4
5183127|NCT01217073|17895955|P8|Base Period|Protocol Violation|0
5183128|NCT01217073|17895956|P7|Base Period|Protocol Violation|0
5183129|NCT01217073|17895957|P6|Base Period|Protocol Violation|2
5183130|NCT01217073|17895958|P5|Base Period|Protocol Violation|1
5183131|NCT01217073|17895959|P4|Base Period|Protocol Violation|0
5183132|NCT01217073|17895960|P3|Base Period|Protocol Violation|0
5183133|NCT01217073|17895961|P2|Base Period|Protocol Violation|0
5183134|NCT01217073|17895962|P1|Base Period|Protocol Violation|1
5183135|NCT01217073|17895955|P8|Base Period|Physician Decision|0
5183136|NCT01217073|17895956|P7|Base Period|Physician Decision|0
5183137|NCT01217073|17895957|P6|Base Period|Physician Decision|0
5183138|NCT01217073|17895958|P5|Base Period|Physician Decision|1
5183139|NCT01217073|17895959|P4|Base Period|Physician Decision|0
5183140|NCT01217073|17895960|P3|Base Period|Physician Decision|0
5183141|NCT01217073|17895961|P2|Base Period|Physician Decision|0
5183142|NCT01217073|17895962|P1|Base Period|Physician Decision|0
5183143|NCT01217073|17895955|P8|Base Period|Lost to Follow-up|0
5183144|NCT01217073|17895956|P7|Base Period|Lost to Follow-up|0
5183145|NCT01217073|17895957|P6|Base Period|Lost to Follow-up|0
5183146|NCT01217073|17895958|P5|Base Period|Lost to Follow-up|3
5183147|NCT01217073|17895959|P4|Base Period|Lost to Follow-up|1
5183148|NCT01217073|17895960|P3|Base Period|Lost to Follow-up|1
5183149|NCT01217073|17895961|P2|Base Period|Lost to Follow-up|0
5183150|NCT01217073|17895962|P1|Base Period|Lost to Follow-up|0
5183151|NCT01217073|17895955|P8|Base Period|Lack of Efficacy|0
5183152|NCT01217073|17895956|P7|Base Period|Lack of Efficacy|0
5183153|NCT01217073|17895957|P6|Base Period|Lack of Efficacy|1
5183154|NCT01217073|17895958|P5|Base Period|Lack of Efficacy|0
5183155|NCT01217073|17895959|P4|Base Period|Lack of Efficacy|0
5183156|NCT01217073|17895960|P3|Base Period|Lack of Efficacy|0
5183157|NCT01217073|17895961|P2|Base Period|Lack of Efficacy|0
5183158|NCT01217073|17895962|P1|Base Period|Lack of Efficacy|0
5183159|NCT01217073|17895955|P8|Base Period|Excluded medication|0
5183160|NCT01217073|17895956|P7|Base Period|Excluded medication|0
5183161|NCT01217073|17895957|P6|Base Period|Excluded medication|0
5183162|NCT01217073|17895958|P5|Base Period|Excluded medication|1
5183163|NCT01217073|17895959|P4|Base Period|Excluded medication|0
5183164|NCT01217073|17895960|P3|Base Period|Excluded medication|0
5183165|NCT01217073|17895961|P2|Base Period|Excluded medication|0
5183166|NCT01217073|17895962|P1|Base Period|Excluded medication|0
5183167|NCT01217073|17895955|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
5183168|NCT01217073|17895956|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
5183169|NCT01217073|17895957|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
5183170|NCT01217073|17895958|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
5183171|NCT01217073|17895959|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
5183172|NCT01217073|17895960|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
5183173|NCT01217073|17895961|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
5183174|NCT01217073|17895962|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
5183175|NCT01217073|17895955|P8|Base Period|Adverse Event|0
5183176|NCT01217073|17895956|P7|Base Period|Adverse Event|0
5183177|NCT01217073|17895957|P6|Base Period|Adverse Event|1
5183178|NCT01217073|17895958|P5|Base Period|Adverse Event|4
5183179|NCT01217073|17895959|P4|Base Period|Adverse Event|0
5183180|NCT01217073|17895960|P3|Base Period|Adverse Event|1
5183181|NCT01217073|17895961|P2|Base Period|Adverse Event|0
5183182|NCT01217073|17895962|P1|Base Period|Adverse Event|1
5183183|NCT01216332|17896153|P2|Overall Study|Withdrawal by Subject|0
5183184|NCT01216332|17896154|P1|Overall Study|Withdrawal by Subject|4
5183185|NCT01216319|17896172|P1|Overall Study|Unanticipated chemo for breast cancer|2
5183186|NCT01216319|17896172|P1|Overall Study|Lost to Follow-up|2
5183187|NCT01216176|17896189|P3|Overall Study|Physician Decision|1
5183188|NCT01216176|17896190|P2|Overall Study|Physician Decision|0
5183189|NCT01216176|17896191|P1|Overall Study|Physician Decision|0
5183190|NCT01216176|17896189|P3|Overall Study|Adverse Event|0
5183191|NCT01216176|17896190|P2|Overall Study|Adverse Event|8
5183192|NCT01216176|17896191|P1|Overall Study|Adverse Event|0
5183193|NCT01216163|17896214|P3|Overall Study|Withdrawal by Subject|0
5183194|NCT01216163|17896215|P2|Overall Study|Withdrawal by Subject|1
5183195|NCT01216163|17896216|P1|Overall Study|Withdrawal by Subject|1
5183196|NCT01216072|17896268|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
5183197|NCT01216072|17896269|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
5183198|NCT01216072|17896268|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
5183199|NCT01216072|17896269|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
5183200|NCT01216072|17896268|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
5183201|NCT01216072|17896269|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
5183202|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
5183203|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
5183204|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
5183205|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
5183206|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
5183207|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
5183208|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
5183209|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
5183210|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
5183211|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
5183212|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
5183213|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
5183214|NCT01216072|17896268|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
5183215|NCT01216072|17896269|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
5183216|NCT01215981|17896297|P2|Overall Study|Withdrawal by Subject|0
5183217|NCT01215981|17896298|P1|Overall Study|Withdrawal by Subject|1
5183218|NCT01215981|17896297|P2|Overall Study|Protocol Violation|0
5183219|NCT01215981|17896298|P1|Overall Study|Protocol Violation|1
5183220|NCT01215981|17896297|P2|Overall Study|Physician Decision|1
5183221|NCT01215981|17896298|P1|Overall Study|Physician Decision|0
5183222|NCT01215968|17896308|P2|Overall Study|Not received study drug|1
5183223|NCT01215968|17896309|P1|Overall Study|Not received study drug|0
5183224|NCT01215968|17896308|P2|Overall Study|Protocol Violation|4
5183225|NCT01215968|17896309|P1|Overall Study|Protocol Violation|2
5183226|NCT01215968|17896308|P2|Overall Study|Adverse Event|2
5183227|NCT01215968|17896309|P1|Overall Study|Adverse Event|0
5183228|NCT01215955|17896329|P4|Overall Study|Quality Issues|2
5183229|NCT01215955|17896330|P3|Overall Study|Quality Issues|3
5183230|NCT01215955|17896331|P2|Overall Study|Quality Issues|0
5183231|NCT01215955|17896332|P1|Overall Study|Quality Issues|0
5183232|NCT01215955|17896329|P4|Overall Study|Withdrawal by Subject|9
5183233|NCT01215955|17896330|P3|Overall Study|Withdrawal by Subject|13
5183234|NCT01215955|17896331|P2|Overall Study|Withdrawal by Subject|15
5183235|NCT01215955|17896332|P1|Overall Study|Withdrawal by Subject|14
5183236|NCT01215955|17896329|P4|Overall Study|Sponsor Decision|1
5183237|NCT01215955|17896330|P3|Overall Study|Sponsor Decision|0
5183238|NCT01215955|17896331|P2|Overall Study|Sponsor Decision|2
5183239|NCT01215955|17896332|P1|Overall Study|Sponsor Decision|1
5183240|NCT01215955|17896329|P4|Overall Study|Protocol Violation|8
5183241|NCT01215955|17896330|P3|Overall Study|Protocol Violation|8
5183242|NCT01215955|17896331|P2|Overall Study|Protocol Violation|13
5183243|NCT01215955|17896332|P1|Overall Study|Protocol Violation|17
5183244|NCT01215955|17896329|P4|Overall Study|Physician Decision|11
5183245|NCT01215955|17896330|P3|Overall Study|Physician Decision|8
5183246|NCT01215955|17896331|P2|Overall Study|Physician Decision|10
5183247|NCT01215955|17896332|P1|Overall Study|Physician Decision|4
5183248|NCT01215955|17896329|P4|Overall Study|Lost to Follow-up|9
5183249|NCT01215955|17896330|P3|Overall Study|Lost to Follow-up|8
5183250|NCT01215955|17896331|P2|Overall Study|Lost to Follow-up|4
5183251|NCT01215955|17896332|P1|Overall Study|Lost to Follow-up|4
5183252|NCT01215955|17896329|P4|Overall Study|Lack of Efficacy|0
5183253|NCT01215955|17896330|P3|Overall Study|Lack of Efficacy|1
5183254|NCT01215955|17896331|P2|Overall Study|Lack of Efficacy|2
5183255|NCT01215955|17896332|P1|Overall Study|Lack of Efficacy|1
5183256|NCT01215955|17896329|P4|Overall Study|Entry Criteria Not Met|7
5183257|NCT01215955|17896330|P3|Overall Study|Entry Criteria Not Met|4
5183258|NCT01215955|17896331|P2|Overall Study|Entry Criteria Not Met|3
5183259|NCT01215955|17896332|P1|Overall Study|Entry Criteria Not Met|1
5183260|NCT01215955|17896329|P4|Overall Study|Death|3
5183261|NCT01215955|17896330|P3|Overall Study|Death|1
5183262|NCT01215955|17896331|P2|Overall Study|Death|0
5183263|NCT01215955|17896332|P1|Overall Study|Death|2
5183264|NCT01215955|17896329|P4|Overall Study|Adverse Event|3
5183265|NCT01215955|17896330|P3|Overall Study|Adverse Event|2
5183266|NCT01215955|17896331|P2|Overall Study|Adverse Event|4
5183267|NCT01215955|17896332|P1|Overall Study|Adverse Event|1
5183268|NCT01215942|17896400|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
5183269|NCT01215942|17896401|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
5183270|NCT01215942|17896400|P2|Post-Treatment Follow-Up Period|Physician Decision|2
5183271|NCT01215942|17896401|P1|Post-Treatment Follow-Up Period|Physician Decision|1
5183272|NCT01215942|17896400|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
5183273|NCT01215942|17896401|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
5183274|NCT01215942|17896400|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5183275|NCT01215942|17896401|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5183276|NCT01215942|17896400|P2|Post-Treatment Follow-Up Period|Death|1
5183277|NCT01215942|17896401|P1|Post-Treatment Follow-Up Period|Death|0
5183278|NCT01215942|17896400|P2|Treatment Period|Sponsor Decision|530
5183279|NCT01215942|17896401|P1|Treatment Period|Sponsor Decision|349
5183280|NCT01215942|17896400|P2|Treatment Period|Protocol Violation|1
5183281|NCT01215942|17896401|P1|Treatment Period|Protocol Violation|0
5183282|NCT01215942|17896400|P2|Treatment Period|Physician Decision|5
5183283|NCT01215942|17896401|P1|Treatment Period|Physician Decision|5
5183284|NCT01215942|17896400|P2|Treatment Period|Withdrawal by Subject|40
5183285|NCT01215942|17896401|P1|Treatment Period|Withdrawal by Subject|17
5183286|NCT01215942|17896400|P2|Treatment Period|Lost to Follow-up|4
5183287|NCT01215942|17896401|P1|Treatment Period|Lost to Follow-up|3
5183288|NCT01215942|17896400|P2|Treatment Period|Lack of Efficacy|62
5183289|NCT01215942|17896401|P1|Treatment Period|Lack of Efficacy|23
5183290|NCT01215942|17896400|P2|Treatment Period|Death|4
5183291|NCT01215942|17896401|P1|Treatment Period|Death|2
5183292|NCT01215942|17896400|P2|Treatment Period|Adverse Event|26
5183293|NCT01215942|17896401|P1|Treatment Period|Adverse Event|15
5183294|NCT01215916|17896534|P9|Overall Study|Physician Decision|0
5183295|NCT01215916|17896535|P8|Overall Study|Physician Decision|0
5183296|NCT01215916|17896536|P7|Overall Study|Physician Decision|0
5183297|NCT01215916|17896537|P6|Overall Study|Physician Decision|0
5183298|NCT01215916|17896538|P5|Overall Study|Physician Decision|0
5183299|NCT01215916|17896539|P4|Overall Study|Physician Decision|1
5183300|NCT01215916|17896540|P3|Overall Study|Physician Decision|1
5183301|NCT01215916|17896541|P2|Overall Study|Physician Decision|0
5183302|NCT01215916|17896542|P1|Overall Study|Physician Decision|0
5183303|NCT01215916|17896534|P9|Overall Study|Death|1
5183304|NCT01215916|17896535|P8|Overall Study|Death|0
5183305|NCT01215916|17896536|P7|Overall Study|Death|0
5183306|NCT01215916|17896537|P6|Overall Study|Death|0
5183307|NCT01215916|17896538|P5|Overall Study|Death|1
5183308|NCT01215916|17896539|P4|Overall Study|Death|0
5183309|NCT01215916|17896540|P3|Overall Study|Death|0
5183310|NCT01215916|17896541|P2|Overall Study|Death|1
5183311|NCT01215916|17896542|P1|Overall Study|Death|0
5183312|NCT01215916|17896534|P9|Overall Study|Withdrawal by Subject|0
5183313|NCT01215916|17896535|P8|Overall Study|Withdrawal by Subject|0
5183314|NCT01215916|17896536|P7|Overall Study|Withdrawal by Subject|1
5183315|NCT01215916|17896537|P6|Overall Study|Withdrawal by Subject|0
5183316|NCT01215916|17896538|P5|Overall Study|Withdrawal by Subject|0
5183317|NCT01215916|17896539|P4|Overall Study|Withdrawal by Subject|2
5183318|NCT01215916|17896540|P3|Overall Study|Withdrawal by Subject|1
5183319|NCT01215916|17896541|P2|Overall Study|Withdrawal by Subject|1
5183320|NCT01215916|17896542|P1|Overall Study|Withdrawal by Subject|0
5183321|NCT01215916|17896534|P9|Overall Study|Adverse Event|0
5183322|NCT01215916|17896535|P8|Overall Study|Adverse Event|0
5183323|NCT01215916|17896536|P7|Overall Study|Adverse Event|3
5183324|NCT01215916|17896537|P6|Overall Study|Adverse Event|0
5183325|NCT01215916|17896538|P5|Overall Study|Adverse Event|0
5183326|NCT01215916|17896539|P4|Overall Study|Adverse Event|1
5183327|NCT01215916|17896540|P3|Overall Study|Adverse Event|0
5183328|NCT01215916|17896541|P2|Overall Study|Adverse Event|1
5183329|NCT01215916|17896542|P1|Overall Study|Adverse Event|1
5183330|NCT01215916|17896534|P9|Overall Study|Progressive Disease|1
5183331|NCT01215916|17896535|P8|Overall Study|Progressive Disease|3
5183332|NCT01215916|17896536|P7|Overall Study|Progressive Disease|5
5183333|NCT01215916|17896537|P6|Overall Study|Progressive Disease|4
5183334|NCT01215916|17896538|P5|Overall Study|Progressive Disease|5
5183335|NCT01215916|17896539|P4|Overall Study|Progressive Disease|2
5183336|NCT01215916|17896540|P3|Overall Study|Progressive Disease|1
5183337|NCT01215916|17896541|P2|Overall Study|Progressive Disease|2
5183338|NCT01215916|17896542|P1|Overall Study|Progressive Disease|0
5183339|NCT01215851|17896576|P6|Follow up Period|Lost to Follow-up|1
5183340|NCT01215851|17896577|P5|Follow up Period|Lost to Follow-up|0
5183341|NCT01215851|17896578|P4|Follow up Period|Lost to Follow-up|0
5183342|NCT01215851|17896579|P3|Follow up Period|Lost to Follow-up|0
5183343|NCT01215851|17896580|P2|Follow up Period|Lost to Follow-up|0
5183344|NCT01215851|17896581|P1|Follow up Period|Lost to Follow-up|0
5183345|NCT01215851|17896576|P6|Treatment Period|Adverse Event|1
5183346|NCT01215851|17896577|P5|Treatment Period|Adverse Event|0
5183347|NCT01215851|17896578|P4|Treatment Period|Adverse Event|3
5183348|NCT01215851|17896579|P3|Treatment Period|Adverse Event|1
5183349|NCT01215851|17896580|P2|Treatment Period|Adverse Event|1
5183350|NCT01215851|17896581|P1|Treatment Period|Adverse Event|1
5183351|NCT01215734|17896640|P2|Overall Study|Death|1
5183352|NCT01215734|17896641|P1|Overall Study|Death|0
5183353|NCT01215721|17896649|P1|Overall Study|Adverse Event|2
5183354|NCT01215513|17896781|P1|Overall Study|Miscellaneous reasons (CS42A)|2
5183355|NCT01215513|17896781|P1|Overall Study|Withdrawal by subject (CS42A)|5
5183356|NCT01215513|17896781|P1|Overall Study|Physician decision (CS42A)|6
5183357|NCT01215513|17896781|P1|Overall Study|Adverse event (CS42A)|2
5183358|NCT01215513|17896781|P1|Overall Study|Not enrolled from CS42 to CS42A|21
5183359|NCT01215513|17896781|P1|Overall Study|Not completed CS42|9
5183360|NCT01215435|17896790|P2|Overall Study|Unclassified|5
5183361|NCT01215435|17896791|P1|Overall Study|Unclassified|5
5183362|NCT01215435|17896790|P2|Overall Study|Lost to Follow-up|0
5183363|NCT01215435|17896791|P1|Overall Study|Lost to Follow-up|3
5183364|NCT01215435|17896790|P2|Overall Study|Withdrawal Criteria|11
5183365|NCT01215435|17896791|P1|Overall Study|Withdrawal Criteria|8
5183366|NCT01215435|17896790|P2|Overall Study|Protocol Violation|0
5183367|NCT01215435|17896791|P1|Overall Study|Protocol Violation|2
5183368|NCT01215435|17896790|P2|Overall Study|Adverse Event|0
5183369|NCT01215435|17896791|P1|Overall Study|Adverse Event|1
5183370|NCT01215422|17896805|P4|Overall Study|Did not complete all intubations|0
5183371|NCT01215422|17896806|P3|Overall Study|Did not complete all intubations|0
5183372|NCT01215422|17896807|P2|Overall Study|Did not complete all intubations|0
5183373|NCT01215422|17896808|P1|Overall Study|Did not complete all intubations|7
5183374|NCT01215422|17896805|P4|Overall Study|Failed intubations|8
5183375|NCT01215422|17896806|P3|Overall Study|Failed intubations|3
5183376|NCT01215422|17896807|P2|Overall Study|Failed intubations|0
5183377|NCT01215422|17896808|P1|Overall Study|Failed intubations|0
5183378|NCT01215422|17896805|P4|Overall Study|Relocation|0
5183379|NCT01215422|17896806|P3|Overall Study|Relocation|0
5183380|NCT01215422|17896807|P2|Overall Study|Relocation|0
5183381|NCT01215422|17896808|P1|Overall Study|Relocation|1
5183382|NCT01215357|17896830|P1|Overall Study|Protocol Violation|9
5183383|NCT01215357|17896830|P1|Overall Study|Withdrawal by Subject|3
5183384|NCT01215253|17896956|P2|Overall Study|Other|12
5183385|NCT01215253|17896957|P1|Overall Study|Other|14
5183386|NCT01215253|17896956|P2|Overall Study|Lost to Follow-up|4
5183387|NCT01215253|17896957|P1|Overall Study|Lost to Follow-up|6
5183388|NCT01215253|17896956|P2|Overall Study|Physician Decision|12
5183389|NCT01215253|17896957|P1|Overall Study|Physician Decision|9
5183390|NCT01215253|17896956|P2|Overall Study|Withdrawal by Subject|35
5183391|NCT01215253|17896957|P1|Overall Study|Withdrawal by Subject|57
5183392|NCT01215227|17897010|P6|Overall Study|Randomized but not treated|1
5183393|NCT01215227|17897011|P5|Overall Study|Randomized but not treated|0
5183394|NCT01215227|17897012|P4|Overall Study|Randomized but not treated|1
5183395|NCT01215227|17897013|P3|Overall Study|Randomized but not treated|1
5183396|NCT01215227|17897014|P2|Overall Study|Randomized but not treated|0
5183397|NCT01215227|17897015|P1|Overall Study|Randomized but not treated|0
5183398|NCT01215227|17897010|P6|Overall Study|Missing Status|0
5183399|NCT01215227|17897011|P5|Overall Study|Missing Status|0
5183400|NCT01215227|17897012|P4|Overall Study|Missing Status|0
5183401|NCT01215227|17897013|P3|Overall Study|Missing Status|0
5183402|NCT01215227|17897014|P2|Overall Study|Missing Status|1
5183403|NCT01215227|17897015|P1|Overall Study|Missing Status|0
5183404|NCT01215227|17897010|P6|Overall Study|Administrative|40
5183405|NCT01215227|17897011|P5|Overall Study|Administrative|28
5183406|NCT01215227|17897012|P4|Overall Study|Administrative|24
5183407|NCT01215227|17897013|P3|Overall Study|Administrative|42
5183408|NCT01215227|17897014|P2|Overall Study|Administrative|73
5183409|NCT01215227|17897015|P1|Overall Study|Administrative|83
5183410|NCT01215227|17897010|P6|Overall Study|Non-Compliance With Protocol|0
5183411|NCT01215227|17897011|P5|Overall Study|Non-Compliance With Protocol|0
5183412|NCT01215227|17897012|P4|Overall Study|Non-Compliance With Protocol|0
5183413|NCT01215227|17897013|P3|Overall Study|Non-Compliance With Protocol|1
5183414|NCT01215227|17897014|P2|Overall Study|Non-Compliance With Protocol|6
5183415|NCT01215227|17897015|P1|Overall Study|Non-Compliance With Protocol|2
5183416|NCT01215227|17897010|P6|Overall Study|Subject Withdrew Consent|8
5183417|NCT01215227|17897011|P5|Overall Study|Subject Withdrew Consent|11
5183418|NCT01215227|17897012|P4|Overall Study|Subject Withdrew Consent|10
5183419|NCT01215227|17897013|P3|Overall Study|Subject Withdrew Consent|7
5183420|NCT01215227|17897014|P2|Overall Study|Subject Withdrew Consent|20
5183421|NCT01215227|17897015|P1|Overall Study|Subject Withdrew Consent|16
5183422|NCT01215227|17897010|P6|Overall Study|Lost to Follow-up|2
5183423|NCT01215227|17897011|P5|Overall Study|Lost to Follow-up|1
5183424|NCT01215227|17897012|P4|Overall Study|Lost to Follow-up|1
5183425|NCT01215227|17897013|P3|Overall Study|Lost to Follow-up|1
5183426|NCT01215227|17897014|P2|Overall Study|Lost to Follow-up|4
5183427|NCT01215227|17897015|P1|Overall Study|Lost to Follow-up|1
5183428|NCT01215227|17897010|P6|Overall Study|Treatment Failure|1
5183429|NCT01215227|17897011|P5|Overall Study|Treatment Failure|1
5183430|NCT01215227|17897012|P4|Overall Study|Treatment Failure|5
5183431|NCT01215227|17897013|P3|Overall Study|Treatment Failure|1
5183432|NCT01215227|17897014|P2|Overall Study|Treatment Failure|4
5183433|NCT01215227|17897015|P1|Overall Study|Treatment Failure|8
5183434|NCT01215227|17897010|P6|Overall Study|Adverse Event|6
5183435|NCT01215227|17897011|P5|Overall Study|Adverse Event|7
5183436|NCT01215227|17897012|P4|Overall Study|Adverse Event|8
5183437|NCT01215227|17897013|P3|Overall Study|Adverse Event|4
5183438|NCT01215227|17897014|P2|Overall Study|Adverse Event|11
5183439|NCT01215227|17897015|P1|Overall Study|Adverse Event|11
5183440|NCT01215188|17897062|P3|Overall Study|Withdrawal by Subject|31
5183441|NCT01215188|17897063|P2|Overall Study|Withdrawal by Subject|34
5183442|NCT01215188|17897064|P1|Overall Study|Withdrawal by Subject|32
5183443|NCT01215188|17897062|P3|Overall Study|Protocol Violation|1
5183444|NCT01215188|17897063|P2|Overall Study|Protocol Violation|1
5183445|NCT01215188|17897064|P1|Overall Study|Protocol Violation|1
5183446|NCT01215188|17897062|P3|Overall Study|Lack of Efficacy|1
5183447|NCT01215188|17897063|P2|Overall Study|Lack of Efficacy|0
5183448|NCT01215188|17897064|P1|Overall Study|Lack of Efficacy|0
5183449|NCT01215188|17897062|P3|Overall Study|Physician Decision|0
5183450|NCT01215188|17897063|P2|Overall Study|Physician Decision|1
5183451|NCT01215188|17897064|P1|Overall Study|Physician Decision|2
5183452|NCT01215188|17897062|P3|Overall Study|Adverse Event|3
5183453|NCT01215188|17897063|P2|Overall Study|Adverse Event|1
5183454|NCT01215188|17897064|P1|Overall Study|Adverse Event|1
5183455|NCT01215188|17897062|P3|Overall Study|Lost to Follow-up|16
5183456|NCT01215188|17897063|P2|Overall Study|Lost to Follow-up|22
5183457|NCT01215188|17897064|P1|Overall Study|Lost to Follow-up|22
5183458|NCT01215175|17897116|P5|Overall Study|Lost to Follow-up|0
5183459|NCT01215175|17897117|P4|Overall Study|Lost to Follow-up|1
5183460|NCT01215175|17897118|P3|Overall Study|Lost to Follow-up|0
5183461|NCT01215175|17897119|P2|Overall Study|Lost to Follow-up|1
5183462|NCT01215175|17897120|P1|Overall Study|Lost to Follow-up|0
5183463|NCT01215097|17897237|P2|Overall Study|patient's private reason|1
5183464|NCT01215097|17897238|P1|Overall Study|patient's private reason|1
5183465|NCT01215097|17897237|P2|Overall Study|patient's refusal to come|2
5183466|NCT01215097|17897238|P1|Overall Study|patient's refusal to come|2
5183467|NCT01215097|17897237|P2|Overall Study|Lack of Efficacy|3
5183468|NCT01215097|17897238|P1|Overall Study|Lack of Efficacy|0
5183469|NCT01215097|17897237|P2|Overall Study|Withdrawal by Subject|3
5183470|NCT01215097|17897238|P1|Overall Study|Withdrawal by Subject|6
5183471|NCT01215097|17897237|P2|Overall Study|Lost to Follow-up|0
5183472|NCT01215097|17897238|P1|Overall Study|Lost to Follow-up|2
5183473|NCT01215097|17897237|P2|Overall Study|Protocol Violation|2
5183474|NCT01215097|17897238|P1|Overall Study|Protocol Violation|0
5183475|NCT01215097|17897237|P2|Overall Study|Adverse Event|3
5183476|NCT01215097|17897238|P1|Overall Study|Adverse Event|1
5183477|NCT01215032|17897270|P1|Overall Study|Lack of Efficacy|17
5183478|NCT01215032|17897270|P1|Overall Study|Adverse Event|3
5183479|NCT01214915|17897295|P1|Overall Study|Lack of Efficacy|3
5183480|NCT01214915|17897295|P1|Overall Study|Adverse Event|8
5183481|NCT01214850|17897306|P3|Overall Study|Unable to classify|1
5183482|NCT01214850|17897307|P2|Overall Study|Unable to classify|1
5183483|NCT01214850|17897308|P1|Overall Study|Unable to classify|2
5183484|NCT01214850|17897306|P3|Overall Study|Administrative reason|0
5183485|NCT01214850|17897307|P2|Overall Study|Administrative reason|0
5183486|NCT01214850|17897308|P1|Overall Study|Administrative reason|1
5183487|NCT01214850|17897306|P3|Overall Study|Inappropriate enrollment|0
5183488|NCT01214850|17897307|P2|Overall Study|Inappropriate enrollment|1
5183489|NCT01214850|17897308|P1|Overall Study|Inappropriate enrollment|2
5183490|NCT01214850|17897306|P3|Overall Study|Adverse event or death|3
5183491|NCT01214850|17897307|P2|Overall Study|Adverse event or death|8
5183492|NCT01214850|17897308|P1|Overall Study|Adverse event or death|11
5183493|NCT01214850|17897306|P3|Overall Study|Protocol Violation|6
5183494|NCT01214850|17897307|P2|Overall Study|Protocol Violation|5
5183495|NCT01214850|17897308|P1|Overall Study|Protocol Violation|5
5183496|NCT01214850|17897306|P3|Overall Study|Lost to Follow-up|123
5183497|NCT01214850|17897307|P2|Overall Study|Lost to Follow-up|98
5183498|NCT01214850|17897308|P1|Overall Study|Lost to Follow-up|124
5183499|NCT01214850|17897306|P3|Overall Study|Withdrawal by Subject|28
5183500|NCT01214850|17897307|P2|Overall Study|Withdrawal by Subject|31
5183501|NCT01214850|17897308|P1|Overall Study|Withdrawal by Subject|38
5183502|NCT01214837|17897392|P3|Overall Study|Unable to Classify|0
5183503|NCT01214837|17897393|P2|Overall Study|Unable to Classify|3
5183504|NCT01214837|17897394|P1|Overall Study|Unable to Classify|1
5183505|NCT01214837|17897392|P3|Overall Study|Protocol Violation|5
5183506|NCT01214837|17897393|P2|Overall Study|Protocol Violation|1
5183507|NCT01214837|17897394|P1|Overall Study|Protocol Violation|3
5183508|NCT01214837|17897392|P3|Overall Study|Administrative Reason|4
5183509|NCT01214837|17897393|P2|Overall Study|Administrative Reason|6
5183510|NCT01214837|17897394|P1|Overall Study|Administrative Reason|2
5183511|NCT01214837|17897392|P3|Overall Study|Inappropriate Enrolment|2
5183512|NCT01214837|17897393|P2|Overall Study|Inappropriate Enrolment|1
5183513|NCT01214837|17897394|P1|Overall Study|Inappropriate Enrolment|0
5183514|NCT01214837|17897392|P3|Overall Study|Lost to Follow-up|21
5183515|NCT01214837|17897393|P2|Overall Study|Lost to Follow-up|15
5183516|NCT01214837|17897394|P1|Overall Study|Lost to Follow-up|20
5183517|NCT01214837|17897392|P3|Overall Study|Withdrawal by Subject|28
5183518|NCT01214837|17897393|P2|Overall Study|Withdrawal by Subject|36
5183519|NCT01214837|17897394|P1|Overall Study|Withdrawal by Subject|27
5183520|NCT01214837|17897392|P3|Overall Study|Adverse Event|1
5183521|NCT01214837|17897393|P2|Overall Study|Adverse Event|2
5183522|NCT01214837|17897394|P1|Overall Study|Adverse Event|1
5183523|NCT01214837|17897392|P3|Overall Study|Death|1
5183524|NCT01214837|17897393|P2|Overall Study|Death|0
5183525|NCT01214837|17897394|P1|Overall Study|Death|0
5183526|NCT01214720|17897450|P2|Overall Study|Lost to Follow-up|2
5183527|NCT01214720|17897451|P1|Overall Study|Lost to Follow-up|6
5183528|NCT01214720|17897450|P2|Overall Study|Alive and in follow-up|48
5183529|NCT01214720|17897451|P1|Overall Study|Alive and in follow-up|45
5183530|NCT01214720|17897450|P2|Overall Study|Alive and still on treatment|18
5183531|NCT01214720|17897451|P1|Overall Study|Alive and still on treatment|34
5183532|NCT01214668|17897474|P6|Overall Study|Withdrawal by Subject|0
5183533|NCT01214668|17897475|P5|Overall Study|Withdrawal by Subject|1
5183534|NCT01214668|17897476|P4|Overall Study|Withdrawal by Subject|0
5183535|NCT01214668|17897477|P3|Overall Study|Withdrawal by Subject|0
5183536|NCT01214668|17897478|P2|Overall Study|Withdrawal by Subject|0
5183537|NCT01214668|17897479|P1|Overall Study|Withdrawal by Subject|0
5183538|NCT01214668|17897474|P6|Overall Study|Progressive Disease|5
5183539|NCT01214668|17897475|P5|Overall Study|Progressive Disease|4
5183540|NCT01214668|17897476|P4|Overall Study|Progressive Disease|4
5183541|NCT01214668|17897477|P3|Overall Study|Progressive Disease|5
5183542|NCT01214668|17897478|P2|Overall Study|Progressive Disease|2
5183543|NCT01214668|17897479|P1|Overall Study|Progressive Disease|4
5183544|NCT01214668|17897474|P6|Overall Study|Death|0
5183545|NCT01214668|17897475|P5|Overall Study|Death|0
5183546|NCT01214668|17897476|P4|Overall Study|Death|0
5183547|NCT01214668|17897477|P3|Overall Study|Death|1
5183548|NCT01214668|17897478|P2|Overall Study|Death|0
5183549|NCT01214668|17897479|P1|Overall Study|Death|0
5183550|NCT01214668|17897474|P6|Overall Study|Adverse Event|1
5183551|NCT01214668|17897475|P5|Overall Study|Adverse Event|1
5183552|NCT01214668|17897476|P4|Overall Study|Adverse Event|2
5183553|NCT01214668|17897477|P3|Overall Study|Adverse Event|0
5183554|NCT01214668|17897478|P2|Overall Study|Adverse Event|1
5183555|NCT01214668|17897479|P1|Overall Study|Adverse Event|0
5183556|NCT01214655|17897516|P3|Part C|Physician Decision|1
5183557|NCT01214655|17897517|P2|Part C|Physician Decision|0
5183558|NCT01214655|17897518|P1|Part C|Physician Decision|0
5183559|NCT01214655|17897516|P3|Part C|Death|1
5183560|NCT01214655|17897517|P2|Part C|Death|0
5183561|NCT01214655|17897518|P1|Part C|Death|0
5183562|NCT01214655|17897516|P3|Part C|Progressive Disease|5
5183563|NCT01214655|17897517|P2|Part C|Progressive Disease|0
5183564|NCT01214655|17897518|P1|Part C|Progressive Disease|0
5183565|NCT01214655|17897516|P3|Part B|Withdrawal by Subject|0
5183566|NCT01214655|17897517|P2|Part B|Withdrawal by Subject|2
5183567|NCT01214655|17897518|P1|Part B|Withdrawal by Subject|0
5183568|NCT01214655|17897516|P3|Part B|Death|0
5183569|NCT01214655|17897517|P2|Part B|Death|1
5183570|NCT01214655|17897518|P1|Part B|Death|0
5183571|NCT01214655|17897516|P3|Part B|Progressive disease|0
5183572|NCT01214655|17897517|P2|Part B|Progressive disease|10
5183573|NCT01214655|17897518|P1|Part B|Progressive disease|0
5183574|NCT01214655|17897516|P3|Part A|Physician Decision|0
5183575|NCT01214655|17897517|P2|Part A|Physician Decision|0
5183576|NCT01214655|17897518|P1|Part A|Physician Decision|1
5183577|NCT01214655|17897516|P3|Part A|Progressive Disease|0
5183578|NCT01214655|17897517|P2|Part A|Progressive Disease|0
5183579|NCT01214655|17897518|P1|Part A|Progressive Disease|7
5183580|NCT01214642|17897591|P12|Overall Study|Physician Decision|2
5183581|NCT01214642|17897592|P11|Overall Study|Physician Decision|0
5183582|NCT01214642|17897593|P10|Overall Study|Physician Decision|0
5183583|NCT01214642|17897594|P9|Overall Study|Physician Decision|0
5183584|NCT01214642|17897595|P8|Overall Study|Physician Decision|0
5183585|NCT01214642|17897596|P7|Overall Study|Physician Decision|0
5183586|NCT01214642|17897597|P6|Overall Study|Physician Decision|0
5183587|NCT01214642|17897598|P5|Overall Study|Physician Decision|1
5183588|NCT01214642|17897599|P4|Overall Study|Physician Decision|1
5183589|NCT01214642|17897600|P3|Overall Study|Physician Decision|1
5183590|NCT01214642|17897601|P2|Overall Study|Physician Decision|0
5183591|NCT01214642|17897602|P1|Overall Study|Physician Decision|0
5183592|NCT01214642|17897591|P12|Overall Study|Withdrawal by Subject|0
5183593|NCT01214642|17897592|P11|Overall Study|Withdrawal by Subject|1
5183594|NCT01214642|17897593|P10|Overall Study|Withdrawal by Subject|1
5183595|NCT01214642|17897594|P9|Overall Study|Withdrawal by Subject|3
5183596|NCT01214642|17897595|P8|Overall Study|Withdrawal by Subject|0
5183597|NCT01214642|17897596|P7|Overall Study|Withdrawal by Subject|0
5183598|NCT01214642|17897597|P6|Overall Study|Withdrawal by Subject|0
5183599|NCT01214642|17897598|P5|Overall Study|Withdrawal by Subject|0
5183600|NCT01214642|17897599|P4|Overall Study|Withdrawal by Subject|0
5183601|NCT01214642|17897600|P3|Overall Study|Withdrawal by Subject|1
5183602|NCT01214642|17897601|P2|Overall Study|Withdrawal by Subject|0
5183603|NCT01214642|17897602|P1|Overall Study|Withdrawal by Subject|0
5183604|NCT01214642|17897591|P12|Overall Study|Death|0
5183605|NCT01214642|17897592|P11|Overall Study|Death|1
5183606|NCT01214642|17897593|P10|Overall Study|Death|0
5183607|NCT01214642|17897594|P9|Overall Study|Death|0
5183608|NCT01214642|17897595|P8|Overall Study|Death|0
5183609|NCT01214642|17897596|P7|Overall Study|Death|0
5183610|NCT01214642|17897597|P6|Overall Study|Death|0
5183611|NCT01214642|17897598|P5|Overall Study|Death|0
5183612|NCT01214642|17897599|P4|Overall Study|Death|0
5183613|NCT01214642|17897600|P3|Overall Study|Death|1
5183614|NCT01214642|17897601|P2|Overall Study|Death|0
5183615|NCT01214642|17897602|P1|Overall Study|Death|0
5183616|NCT01214642|17897591|P12|Overall Study|Adverse Event|0
5183617|NCT01214642|17897592|P11|Overall Study|Adverse Event|1
5183618|NCT01214642|17897593|P10|Overall Study|Adverse Event|1
5183619|NCT01214642|17897594|P9|Overall Study|Adverse Event|0
5183620|NCT01214642|17897595|P8|Overall Study|Adverse Event|0
5183621|NCT01214642|17897596|P7|Overall Study|Adverse Event|1
5183622|NCT01214642|17897597|P6|Overall Study|Adverse Event|0
5183623|NCT01214642|17897598|P5|Overall Study|Adverse Event|0
5183624|NCT01214642|17897599|P4|Overall Study|Adverse Event|0
5183625|NCT01214642|17897600|P3|Overall Study|Adverse Event|0
5183626|NCT01214642|17897601|P2|Overall Study|Adverse Event|1
5183627|NCT01214642|17897602|P1|Overall Study|Adverse Event|0
5183628|NCT01214642|17897591|P12|Overall Study|Progressive Disease|4
5183629|NCT01214642|17897592|P11|Overall Study|Progressive Disease|1
5183630|NCT01214642|17897593|P10|Overall Study|Progressive Disease|2
5183631|NCT01214642|17897594|P9|Overall Study|Progressive Disease|10
5183632|NCT01214642|17897595|P8|Overall Study|Progressive Disease|3
5183633|NCT01214642|17897596|P7|Overall Study|Progressive Disease|5
5183634|NCT01214642|17897597|P6|Overall Study|Progressive Disease|3
5183635|NCT01214642|17897598|P5|Overall Study|Progressive Disease|5
5183636|NCT01214642|17897599|P4|Overall Study|Progressive Disease|5
5183637|NCT01214642|17897600|P3|Overall Study|Progressive Disease|3
5183638|NCT01214642|17897601|P2|Overall Study|Progressive Disease|2
5183639|NCT01214642|17897602|P1|Overall Study|Progressive Disease|3
5183640|NCT01214629|17897682|P11|Overall Study|Withdrawal by Subject|0
5183641|NCT01214629|17897683|P10|Overall Study|Withdrawal by Subject|1
5183642|NCT01214629|17897684|P9|Overall Study|Withdrawal by Subject|0
5183643|NCT01214629|17897685|P8|Overall Study|Withdrawal by Subject|0
5183644|NCT01214629|17897686|P7|Overall Study|Withdrawal by Subject|0
5183645|NCT01214629|17897687|P6|Overall Study|Withdrawal by Subject|0
5183646|NCT01214629|17897688|P5|Overall Study|Withdrawal by Subject|0
5183647|NCT01214629|17897689|P4|Overall Study|Withdrawal by Subject|0
5183648|NCT01214629|17897690|P3|Overall Study|Withdrawal by Subject|0
5183649|NCT01214629|17897691|P2|Overall Study|Withdrawal by Subject|0
5183650|NCT01214629|17897692|P1|Overall Study|Withdrawal by Subject|0
5183651|NCT01214629|17897682|P11|Overall Study|Physician Decision|1
5183652|NCT01214629|17897683|P10|Overall Study|Physician Decision|0
5183653|NCT01214629|17897684|P9|Overall Study|Physician Decision|0
5183654|NCT01214629|17897685|P8|Overall Study|Physician Decision|0
5183655|NCT01214629|17897686|P7|Overall Study|Physician Decision|0
5183656|NCT01214629|17897687|P6|Overall Study|Physician Decision|0
5183657|NCT01214629|17897688|P5|Overall Study|Physician Decision|0
5183658|NCT01214629|17897689|P4|Overall Study|Physician Decision|0
5183659|NCT01214629|17897690|P3|Overall Study|Physician Decision|0
5183660|NCT01214629|17897691|P2|Overall Study|Physician Decision|0
5183661|NCT01214629|17897692|P1|Overall Study|Physician Decision|0
5183662|NCT01214629|17897682|P11|Overall Study|Adverse Event|0
5183663|NCT01214629|17897683|P10|Overall Study|Adverse Event|1
5183664|NCT01214629|17897684|P9|Overall Study|Adverse Event|0
5183665|NCT01214629|17897685|P8|Overall Study|Adverse Event|0
5183666|NCT01214629|17897686|P7|Overall Study|Adverse Event|0
5183667|NCT01214629|17897687|P6|Overall Study|Adverse Event|1
5183668|NCT01214629|17897688|P5|Overall Study|Adverse Event|0
5183669|NCT01214629|17897689|P4|Overall Study|Adverse Event|1
5183670|NCT01214629|17897690|P3|Overall Study|Adverse Event|0
5183671|NCT01214629|17897691|P2|Overall Study|Adverse Event|0
5183672|NCT01214629|17897692|P1|Overall Study|Adverse Event|0
5183673|NCT01214629|17897682|P11|Overall Study|Progressive Disease|1
5183674|NCT01214629|17897683|P10|Overall Study|Progressive Disease|5
5183675|NCT01214629|17897684|P9|Overall Study|Progressive Disease|1
5183676|NCT01214629|17897685|P8|Overall Study|Progressive Disease|1
5183677|NCT01214629|17897686|P7|Overall Study|Progressive Disease|1
5183678|NCT01214629|17897687|P6|Overall Study|Progressive Disease|3
5183679|NCT01214629|17897688|P5|Overall Study|Progressive Disease|2
5183680|NCT01214629|17897689|P4|Overall Study|Progressive Disease|1
5183681|NCT01214629|17897690|P3|Overall Study|Progressive Disease|0
5183682|NCT01214629|17897691|P2|Overall Study|Progressive Disease|1
5183683|NCT01214629|17897692|P1|Overall Study|Progressive Disease|1
5183684|NCT01214616|17897757|P4|Overall Study|Withdrawal by Subject|1
5183685|NCT01214616|17897758|P3|Overall Study|Withdrawal by Subject|0
5183686|NCT01214616|17897759|P2|Overall Study|Withdrawal by Subject|0
5183687|NCT01214616|17897760|P1|Overall Study|Withdrawal by Subject|1
5183688|NCT01214616|17897757|P4|Overall Study|Other adverse events|1
5183689|NCT01214616|17897758|P3|Overall Study|Other adverse events|1
5183690|NCT01214616|17897759|P2|Overall Study|Other adverse events|1
5183691|NCT01214616|17897760|P1|Overall Study|Other adverse events|0
5183692|NCT01214616|17897757|P4|Overall Study|Dose limiting toxicity|0
5183693|NCT01214616|17897758|P3|Overall Study|Dose limiting toxicity|0
5183694|NCT01214616|17897759|P2|Overall Study|Dose limiting toxicity|2
5183695|NCT01214616|17897760|P1|Overall Study|Dose limiting toxicity|0
5183696|NCT01214616|17897757|P4|Overall Study|Progressive disease|4
5183697|NCT01214616|17897758|P3|Overall Study|Progressive disease|2
5183698|NCT01214616|17897759|P2|Overall Study|Progressive disease|2
5183699|NCT01214616|17897760|P1|Overall Study|Progressive disease|2
5183700|NCT01214603|17897797|P3|Overall Study|Progressive Disease|3
5183701|NCT01214603|17897798|P2|Overall Study|Progressive Disease|1
5183702|NCT01214603|17897799|P1|Overall Study|Progressive Disease|4
5183703|NCT01214603|17897797|P3|Overall Study|Death|0
5183704|NCT01214603|17897798|P2|Overall Study|Death|0
5183705|NCT01214603|17897799|P1|Overall Study|Death|1
5183706|NCT01214603|17897797|P3|Overall Study|Adverse Event|1
5183707|NCT01214603|17897798|P2|Overall Study|Adverse Event|0
5183708|NCT01214603|17897799|P1|Overall Study|Adverse Event|0
5183709|NCT01214434|17897822|P2|Overall Study|Site error|0
5183710|NCT01214434|17897823|P1|Overall Study|Site error|1
5183711|NCT01214434|17897822|P2|Overall Study|Lost to Follow-up|2
5183712|NCT01214434|17897823|P1|Overall Study|Lost to Follow-up|2
5183713|NCT01214434|17897822|P2|Overall Study|Withdrawal by Subject|0
5183714|NCT01214434|17897823|P1|Overall Study|Withdrawal by Subject|1
5183715|NCT01214395|17897839|P1|Overall Study|All patients had infection|5
5183716|NCT01214252|17897868|P1|Overall Study|Not eligible per protocol|82
5183717|NCT01214239|17897876|P2|Overall Study|patient's private reason|1
5183718|NCT01214239|17897877|P1|Overall Study|patient's private reason|1
5183719|NCT01214239|17897876|P2|Overall Study|Lack of Efficacy|2
5183720|NCT01214239|17897877|P1|Overall Study|Lack of Efficacy|1
5183721|NCT01214239|17897876|P2|Overall Study|Withdrawal by Subject|9
5183722|NCT01214239|17897877|P1|Overall Study|Withdrawal by Subject|4
5183723|NCT01214239|17897876|P2|Overall Study|Lost to Follow-up|1
5183724|NCT01214239|17897877|P1|Overall Study|Lost to Follow-up|1
5183725|NCT01214239|17897876|P2|Overall Study|Protocol Violation|1
5183726|NCT01214239|17897877|P1|Overall Study|Protocol Violation|2
5183727|NCT01214239|17897876|P2|Overall Study|Adverse Event|4
5183728|NCT01214239|17897877|P1|Overall Study|Adverse Event|3
5183729|NCT01214200|17897909|P1|Overall Study|Withdrawal by Subject|2
5183730|NCT01214200|17897909|P1|Overall Study|Did not meet inclusion/exclusion|9
5183731|NCT01214187|17897923|P2|Overall Study|Withdrawal by Subject|3
5183732|NCT01214187|17897924|P1|Overall Study|Withdrawal by Subject|0
5183733|NCT01214187|17897923|P2|Overall Study|Death|1
5183734|NCT01214187|17897924|P1|Overall Study|Death|1
5183735|NCT01214187|17897923|P2|Overall Study|Adverse Event|2
5183736|NCT01214187|17897924|P1|Overall Study|Adverse Event|6
5183737|NCT01214174|17897941|P3|Overall Study|Withdrawal by Subject|1
5183738|NCT01214174|17897942|P2|Overall Study|Withdrawal by Subject|0
5183739|NCT01214174|17897943|P1|Overall Study|Withdrawal by Subject|0
5183740|NCT01214044|17898093|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
5183741|NCT01214044|17898093|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
5183742|NCT01214044|17898093|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
5183743|NCT01214044|17898093|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
5183744|NCT01214044|17898093|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
5183745|NCT01214044|17898093|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
5183746|NCT01213966|17898107|P4|Overall Study|Protocol Violation|1
5183747|NCT01213966|17898108|P3|Overall Study|Protocol Violation|3
5183748|NCT01213966|17898109|P2|Overall Study|Protocol Violation|0
5183749|NCT01213966|17898110|P1|Overall Study|Protocol Violation|1
5183750|NCT01213836|17898122|P2|Period 1, First Intervention|Withdrawal by Subject|1
5183751|NCT01213836|17898123|P1|Period 1, First Intervention|Withdrawal by Subject|1
5183752|NCT01213836|17898122|P2|Period 1, First Intervention|Protocol Violation|1
5183753|NCT01213836|17898123|P1|Period 1, First Intervention|Protocol Violation|0
5183754|NCT01213836|17898122|P2|Period 1, First Intervention|Adverse Event|1
5183755|NCT01213836|17898123|P1|Period 1, First Intervention|Adverse Event|2
5183756|NCT01213524|17898210|P1|Session 4|Withdrawal by Subject|2
5183757|NCT01213524|17898210|P1|Session 4|Physician Decision|1
5183758|NCT01213524|17898210|P1|Session 3|Withdrawal by Subject|4
5183759|NCT01213524|17898210|P1|Session 2|Withdrawal by Subject|5
5183760|NCT01213524|17898210|P1|Baseline|Physician Decision|1
5183761|NCT01213524|17898210|P1|Baseline|high breath alcohol levels|1
5183762|NCT01213524|17898210|P1|Baseline|Withdrawal by Subject|5
5183763|NCT01213472|17898224|P1|Overall Study|Physician Decision|1
5183764|NCT01213472|17898224|P1|Overall Study|Withdrawal by Subject|1
5183765|NCT01213472|17898224|P1|Overall Study|Recurrence/Progressive disease|25
5183766|NCT01213264|17898273|P3|Overall Study|Lost to Follow-up|6
5183767|NCT01213264|17898274|P2|Overall Study|Lost to Follow-up|2
5183768|NCT01213264|17898275|P1|Overall Study|Lost to Follow-up|1
5183769|NCT01213264|17898273|P3|Overall Study|Adverse Event|0
5183770|NCT01213264|17898274|P2|Overall Study|Adverse Event|0
5183771|NCT01213264|17898275|P1|Overall Study|Adverse Event|1
5183772|NCT01213251|17898295|P3|Overall Study|Missed 18-Month Follow-up|1
5183773|NCT01213251|17898296|P2|Overall Study|Missed 18-Month Follow-up|0
5183774|NCT01213251|17898297|P1|Overall Study|Missed 18-Month Follow-up|0
5183775|NCT01213251|17898295|P3|Overall Study|Protocol Violation|0
5183776|NCT01213251|17898296|P2|Overall Study|Protocol Violation|1
5183777|NCT01213251|17898297|P1|Overall Study|Protocol Violation|1
5183778|NCT01213251|17898295|P3|Overall Study|Exit|8
5183779|NCT01213251|17898296|P2|Overall Study|Exit|2
5183780|NCT01213251|17898297|P1|Overall Study|Exit|3
5183781|NCT01213251|17898295|P3|Overall Study|Death|2
5183782|NCT01213251|17898296|P2|Overall Study|Death|1
5183783|NCT01213251|17898297|P1|Overall Study|Death|2
5183784|NCT01213173|17898324|P2|Overall Study|Incorrect Enrollment|3
5183785|NCT01213173|17898325|P1|Overall Study|Incorrect Enrollment|1
5183786|NCT01213173|17898324|P2|Overall Study|Withdrawal by Subject|5
5183787|NCT01213173|17898325|P1|Overall Study|Withdrawal by Subject|5
5183788|NCT01213173|17898324|P2|Overall Study|Adverse Event|8
5183789|NCT01213173|17898325|P1|Overall Study|Adverse Event|4
5183790|NCT01213173|17898324|P2|Overall Study|Protocol Violation|0
5183791|NCT01213173|17898325|P1|Overall Study|Protocol Violation|2
5183792|NCT01213082|17898358|P3|Overall Study|Physician Decision|1
5183793|NCT01213082|17898359|P2|Overall Study|Physician Decision|0
5183794|NCT01213082|17898360|P1|Overall Study|Physician Decision|0
5183795|NCT01213082|17898358|P3|Overall Study|Lost to Follow-up|4
5183796|NCT01213082|17898359|P2|Overall Study|Lost to Follow-up|7
5183797|NCT01213082|17898360|P1|Overall Study|Lost to Follow-up|6
5183798|NCT01212991|17898402|P3|Open-label|Other|3
5183799|NCT01212991|17898403|P2|Open-label|Other|0
5183800|NCT01212991|17898404|P1|Open-label|Other|0
5183801|NCT01212991|17898402|P3|Open-label|Sponsor decision|53
5183802|NCT01212991|17898403|P2|Open-label|Sponsor decision|0
5183803|NCT01212991|17898404|P1|Open-label|Sponsor decision|0
5183804|NCT01212991|17898402|P3|Open-label|Withdrawal by Subject|7
5183805|NCT01212991|17898403|P2|Open-label|Withdrawal by Subject|0
5183806|NCT01212991|17898404|P1|Open-label|Withdrawal by Subject|0
5183807|NCT01212991|17898402|P3|Open-label|Lost to Follow-up|5
5183808|NCT01212991|17898403|P2|Open-label|Lost to Follow-up|0
5183809|NCT01212991|17898404|P1|Open-label|Lost to Follow-up|0
5183810|NCT01212991|17898402|P3|Open-label|Death|166
5183811|NCT01212991|17898403|P2|Open-label|Death|0
5183812|NCT01212991|17898404|P1|Open-label|Death|0
5183813|NCT01212991|17898402|P3|Double-blind|Sponsor decision|0
5183814|NCT01212991|17898403|P2|Double-blind|Sponsor decision|38
5183815|NCT01212991|17898404|P1|Double-blind|Sponsor decision|142
5183816|NCT01212991|17898402|P3|Double-blind|Other|0
5183817|NCT01212991|17898403|P2|Double-blind|Other|0
5183818|NCT01212991|17898404|P1|Double-blind|Other|7
5183819|NCT01212991|17898402|P3|Double-blind|Withdrawal by Subject|0
5183820|NCT01212991|17898403|P2|Double-blind|Withdrawal by Subject|19
5183821|NCT01212991|17898404|P1|Double-blind|Withdrawal by Subject|16
5183822|NCT01212991|17898402|P3|Double-blind|Death|0
5183823|NCT01212991|17898403|P2|Double-blind|Death|550
5183824|NCT01212991|17898404|P1|Double-blind|Death|699
5183825|NCT01212991|17898402|P3|Double-blind|Lost to Follow-up|0
5183826|NCT01212991|17898403|P2|Double-blind|Lost to Follow-up|4
5183827|NCT01212991|17898404|P1|Double-blind|Lost to Follow-up|8
5183828|NCT01212770|17898476|P9|Long-term Safety Phase (Year 5)|Death|0
5183829|NCT01212770|17898477|P8|Long-term Safety Phase (Year 5)|Death|1
5183830|NCT01212770|17898478|P7|Long-term Safety Phase (Year 5)|Death|0
5183831|NCT01212770|17898479|P6|Long-term Safety Phase (Year 5)|Death|0
5183832|NCT01212770|17898480|P5|Long-term Safety Phase (Year 5)|Death|0
5183833|NCT01212770|17898481|P4|Long-term Safety Phase (Year 5)|Death|0
5183834|NCT01212770|17898482|P3|Long-term Safety Phase (Year 5)|Death|0
5183835|NCT01212770|17898483|P2|Long-term Safety Phase (Year 5)|Death|0
5183836|NCT01212770|17898484|P1|Long-term Safety Phase (Year 5)|Death|0
5183837|NCT01212770|17898476|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5183838|NCT01212770|17898477|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5183839|NCT01212770|17898478|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5183840|NCT01212770|17898479|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5183841|NCT01212770|17898480|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5183842|NCT01212770|17898481|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5183843|NCT01212770|17898482|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5183844|NCT01212770|17898483|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
5183845|NCT01212770|17898484|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5183846|NCT01212770|17898476|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183847|NCT01212770|17898477|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183848|NCT01212770|17898478|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183849|NCT01212770|17898479|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183850|NCT01212770|17898480|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183851|NCT01212770|17898481|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183852|NCT01212770|17898482|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
5183853|NCT01212770|17898483|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183854|NCT01212770|17898484|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5183855|NCT01212770|17898476|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
5183856|NCT01212770|17898477|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
5183857|NCT01212770|17898478|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
5183858|NCT01212770|17898479|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
5183859|NCT01212770|17898480|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
5183860|NCT01212770|17898481|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
5183861|NCT01212770|17898482|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
5183862|NCT01212770|17898483|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
5183863|NCT01212770|17898484|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
5183864|NCT01212770|17898476|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183865|NCT01212770|17898477|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183866|NCT01212770|17898478|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183867|NCT01212770|17898479|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183868|NCT01212770|17898480|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183869|NCT01212770|17898481|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183870|NCT01212770|17898482|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
5183871|NCT01212770|17898483|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183872|NCT01212770|17898484|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
5183873|NCT01212770|17898476|P9|Long-term Safety Phase (Year 5)|Missing|0
5183874|NCT01212770|17898477|P8|Long-term Safety Phase (Year 5)|Missing|0
5183875|NCT01212770|17898478|P7|Long-term Safety Phase (Year 5)|Missing|0
5183876|NCT01212770|17898479|P6|Long-term Safety Phase (Year 5)|Missing|0
5183877|NCT01212770|17898480|P5|Long-term Safety Phase (Year 5)|Missing|0
5183878|NCT01212770|17898481|P4|Long-term Safety Phase (Year 5)|Missing|0
5183879|NCT01212770|17898482|P3|Long-term Safety Phase (Year 5)|Missing|1
5183880|NCT01212770|17898483|P2|Long-term Safety Phase (Year 5)|Missing|0
5183881|NCT01212770|17898484|P1|Long-term Safety Phase (Year 5)|Missing|0
5183882|NCT01212770|17898476|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
5183883|NCT01212770|17898477|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183884|NCT01212770|17898478|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183885|NCT01212770|17898479|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183886|NCT01212770|17898480|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183887|NCT01212770|17898481|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183888|NCT01212770|17898482|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183889|NCT01212770|17898483|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
5183890|NCT01212770|17898484|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
5183891|NCT01212770|17898476|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183892|NCT01212770|17898477|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183893|NCT01212770|17898478|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183894|NCT01212770|17898479|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183895|NCT01212770|17898480|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183896|NCT01212770|17898481|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183897|NCT01212770|17898482|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
5183898|NCT01212770|17898483|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183899|NCT01212770|17898484|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5183900|NCT01212770|17898476|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183901|NCT01212770|17898477|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183902|NCT01212770|17898478|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183903|NCT01212770|17898479|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183904|NCT01212770|17898480|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183905|NCT01212770|17898481|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183906|NCT01212770|17898482|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
5183907|NCT01212770|17898483|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
5183908|NCT01212770|17898484|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5183909|NCT01212770|17898476|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5183910|NCT01212770|17898477|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5183911|NCT01212770|17898478|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5183912|NCT01212770|17898479|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5183913|NCT01212770|17898480|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5183914|NCT01212770|17898481|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5183915|NCT01212770|17898482|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5183916|NCT01212770|17898483|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5183917|NCT01212770|17898484|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5183918|NCT01212770|17898476|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5183919|NCT01212770|17898477|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
5183920|NCT01212770|17898478|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5183921|NCT01212770|17898479|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5183922|NCT01212770|17898480|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5183923|NCT01212770|17898481|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5183924|NCT01212770|17898482|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
5183925|NCT01212770|17898483|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5183926|NCT01212770|17898484|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5183927|NCT01212770|17898476|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
5183928|NCT01212770|17898477|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
5183929|NCT01212770|17898478|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
5183930|NCT01212770|17898479|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
5183931|NCT01212770|17898480|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
5183932|NCT01212770|17898481|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
5183933|NCT01212770|17898482|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
5183934|NCT01212770|17898483|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
5183935|NCT01212770|17898484|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
5183936|NCT01212770|17898476|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
5183937|NCT01212770|17898477|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
5183938|NCT01212770|17898478|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
5183939|NCT01212770|17898479|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
5183940|NCT01212770|17898480|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
5183941|NCT01212770|17898481|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
5183942|NCT01212770|17898482|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
5183943|NCT01212770|17898483|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
5183944|NCT01212770|17898484|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
5183945|NCT01212770|17898476|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183946|NCT01212770|17898477|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
5183947|NCT01212770|17898478|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183948|NCT01212770|17898479|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183949|NCT01212770|17898480|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183950|NCT01212770|17898481|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183951|NCT01212770|17898482|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183952|NCT01212770|17898483|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183953|NCT01212770|17898484|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
5183954|NCT01212770|17898476|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183955|NCT01212770|17898477|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183956|NCT01212770|17898478|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183957|NCT01212770|17898479|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183958|NCT01212770|17898480|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183959|NCT01212770|17898481|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183960|NCT01212770|17898482|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183961|NCT01212770|17898483|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5183962|NCT01212770|17898484|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5183963|NCT01212770|17898476|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
5183964|NCT01212770|17898477|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
5183965|NCT01212770|17898478|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5183966|NCT01212770|17898479|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5183967|NCT01212770|17898480|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5183968|NCT01212770|17898481|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5183969|NCT01212770|17898482|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
5183970|NCT01212770|17898483|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
5183971|NCT01212770|17898484|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5183972|NCT01212770|17898476|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5183973|NCT01212770|17898477|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5183974|NCT01212770|17898478|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5183975|NCT01212770|17898479|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5183976|NCT01212770|17898480|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5183977|NCT01212770|17898481|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5183978|NCT01212770|17898482|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
5183979|NCT01212770|17898483|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
5183980|NCT01212770|17898484|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5183981|NCT01212770|17898476|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
5183982|NCT01212770|17898477|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
5183983|NCT01212770|17898478|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
5183984|NCT01212770|17898479|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
5183985|NCT01212770|17898480|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
5183986|NCT01212770|17898481|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
5183987|NCT01212770|17898482|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
5183988|NCT01212770|17898483|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
5183989|NCT01212770|17898484|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
5183990|NCT01212770|17898476|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
5183991|NCT01212770|17898477|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
5183992|NCT01212770|17898478|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
5183993|NCT01212770|17898479|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
5183994|NCT01212770|17898480|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
5183995|NCT01212770|17898481|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
5183996|NCT01212770|17898482|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
5183997|NCT01212770|17898483|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
5183998|NCT01212770|17898484|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
5183999|NCT01212770|17898476|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5184000|NCT01212770|17898477|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5184001|NCT01212770|17898478|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5184002|NCT01212770|17898479|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5184003|NCT01212770|17898480|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5184004|NCT01212770|17898481|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5184005|NCT01212770|17898482|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5184006|NCT01212770|17898483|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
5184007|NCT01212770|17898484|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5184008|NCT01212770|17898476|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
5184009|NCT01212770|17898477|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
5184010|NCT01212770|17898478|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5184011|NCT01212770|17898479|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5184012|NCT01212770|17898480|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5184013|NCT01212770|17898481|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5184014|NCT01212770|17898482|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
5184015|NCT01212770|17898483|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
5184016|NCT01212770|17898484|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5184017|NCT01212770|17898476|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184018|NCT01212770|17898477|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184019|NCT01212770|17898478|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184020|NCT01212770|17898479|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184021|NCT01212770|17898480|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184022|NCT01212770|17898481|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184023|NCT01212770|17898482|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184024|NCT01212770|17898483|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
5184025|NCT01212770|17898484|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5184026|NCT01212770|17898476|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
5184027|NCT01212770|17898477|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
5184028|NCT01212770|17898478|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5184029|NCT01212770|17898479|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5184030|NCT01212770|17898480|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5184031|NCT01212770|17898481|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5184032|NCT01212770|17898482|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
5184033|NCT01212770|17898483|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
5184034|NCT01212770|17898484|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5184035|NCT01212770|17898476|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
5184036|NCT01212770|17898477|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
5184037|NCT01212770|17898478|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
5184038|NCT01212770|17898479|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
5184039|NCT01212770|17898480|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
5184040|NCT01212770|17898481|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
5184041|NCT01212770|17898482|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
5184042|NCT01212770|17898483|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
5184043|NCT01212770|17898484|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
5184044|NCT01212770|17898476|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184045|NCT01212770|17898477|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184046|NCT01212770|17898478|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184047|NCT01212770|17898479|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184048|NCT01212770|17898480|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184049|NCT01212770|17898481|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
5184050|NCT01212770|17898482|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
5184051|NCT01212770|17898483|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184052|NCT01212770|17898484|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5184053|NCT01212770|17898476|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184054|NCT01212770|17898477|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184055|NCT01212770|17898478|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184056|NCT01212770|17898479|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184057|NCT01212770|17898480|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184058|NCT01212770|17898481|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
5184059|NCT01212770|17898482|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184060|NCT01212770|17898483|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184061|NCT01212770|17898484|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5184062|NCT01212770|17898476|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184063|NCT01212770|17898477|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184064|NCT01212770|17898478|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184065|NCT01212770|17898479|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184066|NCT01212770|17898480|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184067|NCT01212770|17898481|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184068|NCT01212770|17898482|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
5184069|NCT01212770|17898483|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184070|NCT01212770|17898484|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5184071|NCT01212770|17898476|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5184072|NCT01212770|17898477|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5184073|NCT01212770|17898478|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5184074|NCT01212770|17898479|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5184075|NCT01212770|17898480|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5184076|NCT01212770|17898481|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
5184077|NCT01212770|17898482|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
5184078|NCT01212770|17898483|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
5184079|NCT01212770|17898484|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5184080|NCT01212770|17898476|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5184081|NCT01212770|17898477|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5184082|NCT01212770|17898478|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5184083|NCT01212770|17898479|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
5184084|NCT01212770|17898480|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
5184085|NCT01212770|17898481|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
5184086|NCT01212770|17898482|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
5184087|NCT01212770|17898483|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
5184088|NCT01212770|17898484|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5184089|NCT01212770|17898476|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5184090|NCT01212770|17898477|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5184091|NCT01212770|17898478|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
5184092|NCT01212770|17898479|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5184093|NCT01212770|17898480|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5184094|NCT01212770|17898481|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
5184095|NCT01212770|17898482|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
5184096|NCT01212770|17898483|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
5184097|NCT01212770|17898484|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5184098|NCT01212770|17898476|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5184099|NCT01212770|17898477|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5184100|NCT01212770|17898478|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5184101|NCT01212770|17898479|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5184102|NCT01212770|17898480|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5184103|NCT01212770|17898481|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5184104|NCT01212770|17898482|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
5184105|NCT01212770|17898483|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
5184106|NCT01212770|17898484|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
5184107|NCT01212770|17898476|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184108|NCT01212770|17898477|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184109|NCT01212770|17898478|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184110|NCT01212770|17898479|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184111|NCT01212770|17898480|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184112|NCT01212770|17898481|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184113|NCT01212770|17898482|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5184114|NCT01212770|17898483|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184115|NCT01212770|17898484|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184116|NCT01212770|17898476|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184117|NCT01212770|17898477|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184118|NCT01212770|17898478|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184119|NCT01212770|17898479|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184120|NCT01212770|17898480|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184121|NCT01212770|17898481|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184122|NCT01212770|17898482|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
5184123|NCT01212770|17898483|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184124|NCT01212770|17898484|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5184125|NCT01212770|17898476|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184126|NCT01212770|17898477|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184127|NCT01212770|17898478|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184128|NCT01212770|17898479|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184129|NCT01212770|17898480|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184130|NCT01212770|17898481|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184131|NCT01212770|17898482|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
5184132|NCT01212770|17898483|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5184133|NCT01212770|17898484|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
5184134|NCT01212770|17898476|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184135|NCT01212770|17898477|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184136|NCT01212770|17898478|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184137|NCT01212770|17898479|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184138|NCT01212770|17898480|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184139|NCT01212770|17898481|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184140|NCT01212770|17898482|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
5184141|NCT01212770|17898483|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
5184142|NCT01212770|17898484|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
5184143|NCT01212770|17898476|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184144|NCT01212770|17898477|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184145|NCT01212770|17898478|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184146|NCT01212770|17898479|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184147|NCT01212770|17898480|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184148|NCT01212770|17898481|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184149|NCT01212770|17898482|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
5184150|NCT01212770|17898483|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
5184151|NCT01212770|17898484|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
5184152|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184153|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184154|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184155|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184156|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184157|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184158|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
5184159|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
5184160|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5184161|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184162|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184163|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184164|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184165|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184166|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184167|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184168|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
5184169|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5184170|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
5184171|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
5184172|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5184173|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5184174|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5184175|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5184176|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
5184177|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
5184178|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5184179|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
5184180|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
5184181|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
5184182|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
5184183|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
5184184|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
5184185|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
5184186|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
5184187|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
5184188|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
5184189|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
5184190|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5184191|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5184192|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5184193|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5184194|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
5184195|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
5184196|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5184197|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184198|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
5184199|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184200|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184201|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184202|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184203|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184204|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184205|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5184206|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 4)|Death|1
5184207|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 4)|Death|0
5184208|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 4)|Death|0
5184209|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 4)|Death|0
5184210|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 4)|Death|0
5184211|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 4)|Death|0
5184212|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 4)|Death|1
5184213|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 4)|Death|0
5184214|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 4)|Death|0
5184215|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
5184216|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
5184217|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5184218|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5184219|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5184220|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5184221|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
5184222|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
5184223|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5184224|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
5184225|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
5184226|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5184227|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5184228|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5184229|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5184230|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
5184231|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
5184232|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5184233|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
5184234|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
5184235|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
5184236|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
5184237|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
5184238|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
5184239|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
5184240|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
5184241|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
5184242|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
5184243|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184244|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184245|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184246|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184247|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184248|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184249|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
5184250|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5184251|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
5184252|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184253|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184254|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184255|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184256|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184257|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
5184258|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184259|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5184260|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184261|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184262|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184263|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184264|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184265|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184266|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184267|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
5184268|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5184269|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
5184270|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184271|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184272|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184273|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184274|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184275|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184276|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184277|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5184278|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5184279|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5184280|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5184281|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5184282|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5184283|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5184284|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5184285|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
5184286|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5184287|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184288|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184289|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184290|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184291|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184292|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184293|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
5184294|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184295|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5184296|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
5184297|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
5184298|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5184299|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5184300|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5184301|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5184302|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
5184303|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
5184304|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5184305|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
5184306|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
5184307|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
5184308|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
5184309|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
5184310|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
5184311|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
5184312|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
5184313|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
5184314|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184315|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184316|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184317|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184318|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184319|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184320|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
5184321|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184322|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5184323|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
5184324|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
5184325|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5184326|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5184327|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5184328|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5184329|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
5184330|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
5184331|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5184332|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5184333|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
5184334|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5184335|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5184336|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5184337|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5184338|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
5184339|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
5184340|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5184341|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
5184342|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
5184343|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
5184344|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
5184345|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
5184346|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
5184347|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
5184348|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
5184349|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
5184350|NCT01212757|17898681|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
5184351|NCT01212757|17898682|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184352|NCT01212757|17898683|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184353|NCT01212757|17898684|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184354|NCT01212757|17898685|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184355|NCT01212757|17898686|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184356|NCT01212757|17898687|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184357|NCT01212757|17898688|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184358|NCT01212757|17898689|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5184359|NCT01212757|17898681|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184360|NCT01212757|17898682|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184361|NCT01212757|17898683|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184362|NCT01212757|17898684|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184363|NCT01212757|17898685|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184364|NCT01212757|17898686|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184365|NCT01212757|17898687|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
5184366|NCT01212757|17898688|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
5184367|NCT01212757|17898689|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
5184368|NCT01212757|17898681|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184369|NCT01212757|17898682|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184370|NCT01212757|17898683|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184371|NCT01212757|17898684|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184372|NCT01212757|17898685|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5184373|NCT01212757|17898686|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184374|NCT01212757|17898687|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184375|NCT01212757|17898688|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5184376|NCT01212757|17898689|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5184377|NCT01212757|17898681|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5184378|NCT01212757|17898682|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5184379|NCT01212757|17898683|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5184380|NCT01212757|17898684|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5184381|NCT01212757|17898685|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
5184382|NCT01212757|17898686|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5184383|NCT01212757|17898687|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
5184384|NCT01212757|17898688|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5184385|NCT01212757|17898689|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5184386|NCT01212757|17898681|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184387|NCT01212757|17898682|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184388|NCT01212757|17898683|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184389|NCT01212757|17898684|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184390|NCT01212757|17898685|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184391|NCT01212757|17898686|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184392|NCT01212757|17898687|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
5184393|NCT01212757|17898688|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184394|NCT01212757|17898689|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5184395|NCT01212757|17898681|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5184396|NCT01212757|17898682|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5184397|NCT01212757|17898683|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5184398|NCT01212757|17898684|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
5184399|NCT01212757|17898685|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5184400|NCT01212757|17898686|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
5184401|NCT01212757|17898687|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
5184402|NCT01212757|17898688|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
5184403|NCT01212757|17898689|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5184404|NCT01212757|17898681|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5184405|NCT01212757|17898682|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5184406|NCT01212757|17898683|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5184407|NCT01212757|17898684|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
5184408|NCT01212757|17898685|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5184409|NCT01212757|17898686|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
5184410|NCT01212757|17898687|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
5184411|NCT01212757|17898688|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
5184412|NCT01212757|17898689|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5184413|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184414|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184415|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184416|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184417|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184418|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184419|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
5184420|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
5184421|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
5184422|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184423|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184424|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184425|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184426|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184427|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184428|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5184429|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5184430|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5184431|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184432|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184433|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184434|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184435|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184436|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5184437|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
5184438|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5184439|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5184440|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184441|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184442|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184443|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184444|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184445|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184446|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
5184447|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5184448|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
5184449|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184450|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184451|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184452|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184453|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184454|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5184455|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
5184456|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
5184457|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
5184458|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184459|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184460|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184461|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184462|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184463|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5184464|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5184465|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5184466|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5184467|NCT01212757|17898681|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184468|NCT01212757|17898682|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184469|NCT01212757|17898683|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184470|NCT01212757|17898684|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184471|NCT01212757|17898685|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184472|NCT01212757|17898686|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5184473|NCT01212757|17898687|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
5184474|NCT01212757|17898688|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
5184475|NCT01212757|17898689|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5184476|NCT01212744|17898873|P1|Overall Study|Withdrawal by Subject|1
5184477|NCT01212588|17898892|P2|Overall Study|Protocol Violation|1
5184478|NCT01212588|17898893|P1|Overall Study|Protocol Violation|1
5184479|NCT01212588|17898892|P2|Overall Study|Physician Decision|1
5184480|NCT01212588|17898893|P1|Overall Study|Physician Decision|0
5184481|NCT01212185|17898991|P2|Overall Study|Protocol Violation|1
5184482|NCT01212185|17898992|P1|Overall Study|Protocol Violation|2
5184483|NCT01212159|17899011|P2|Overall Study|Withdrawal by Subject|12
5184484|NCT01212159|17899012|P1|Overall Study|Withdrawal by Subject|12
5184485|NCT01212094|17899111|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
5184486|NCT01212094|17899112|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
5184487|NCT01212094|17899113|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
5184488|NCT01212094|17899111|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
5184489|NCT01212094|17899112|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
5184490|NCT01212094|17899113|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
5184491|NCT01212094|17899111|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
5184492|NCT01212094|17899112|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
5184493|NCT01212094|17899113|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
5184494|NCT01212094|17899111|P3|Year 1: Baseline Monitoring|Started on DMT|0
5184495|NCT01212094|17899112|P2|Year 1: Baseline Monitoring|Started on DMT|0
5184496|NCT01212094|17899113|P1|Year 1: Baseline Monitoring|Started on DMT|2
5184497|NCT01212094|17899111|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
5184498|NCT01212094|17899112|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
5184499|NCT01212094|17899113|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
5184500|NCT01212094|17899111|P3|Year 1: Baseline Monitoring|Study terminated|0
5184501|NCT01212094|17899112|P2|Year 1: Baseline Monitoring|Study terminated|0
5184502|NCT01212094|17899113|P1|Year 1: Baseline Monitoring|Study terminated|7
5184503|NCT01211769|17899172|P4|Overall Study|Adverse Event|1
5184504|NCT01211769|17899173|P3|Overall Study|Adverse Event|1
5184505|NCT01211769|17899174|P2|Overall Study|Adverse Event|1
5184506|NCT01211769|17899175|P1|Overall Study|Adverse Event|0
5184507|NCT01211769|17899172|P4|Overall Study|Physician Decision|1
5184508|NCT01211769|17899173|P3|Overall Study|Physician Decision|2
5184509|NCT01211769|17899174|P2|Overall Study|Physician Decision|0
5184510|NCT01211769|17899175|P1|Overall Study|Physician Decision|2
5184511|NCT01211769|17899172|P4|Overall Study|Lost to Follow-up|9
5184512|NCT01211769|17899173|P3|Overall Study|Lost to Follow-up|5
5184513|NCT01211769|17899174|P2|Overall Study|Lost to Follow-up|9
5184514|NCT01211769|17899175|P1|Overall Study|Lost to Follow-up|7
5184515|NCT01211665|17899230|P2|Overall Study|Death|0
5184516|NCT01211665|17899231|P1|Overall Study|Death|1
5184517|NCT01211665|17899230|P2|Overall Study|Withdrawal by Subject|0
5184518|NCT01211665|17899231|P1|Overall Study|Withdrawal by Subject|1
5184519|NCT01211613|17899258|P3|Overall Study|Withdrawal by Subject|0
5184520|NCT01211613|17899259|P2|Overall Study|Withdrawal by Subject|0
5184521|NCT01211613|17899260|P1|Overall Study|Withdrawal by Subject|1
5184522|NCT01211613|17899258|P3|Overall Study|Lost to Follow-up|2
5184523|NCT01211613|17899259|P2|Overall Study|Lost to Follow-up|2
5184524|NCT01211613|17899260|P1|Overall Study|Lost to Follow-up|2
5184525|NCT01211535|17899306|P2|Overall Study|Adverse Event|1
5184526|NCT01211535|17899307|P1|Overall Study|Adverse Event|0
5184527|NCT01211522|17899316|P3|Overall Study|Withdrawal by Subject|5
5184528|NCT01211522|17899317|P2|Overall Study|Withdrawal by Subject|7
5184529|NCT01211522|17899318|P1|Overall Study|Withdrawal by Subject|3
5184530|NCT01211288|17899368|P2|Overall Study|Lost to Follow-up|1
5184531|NCT01211288|17899369|P1|Overall Study|Lost to Follow-up|1
5184532|NCT01211262|17899387|P2|Overall Study|Other|1
5184533|NCT01211262|17899388|P1|Overall Study|Other|0
5184534|NCT01211262|17899387|P2|Overall Study|Withdrawal of Consent|0
5184535|NCT01211262|17899388|P1|Overall Study|Withdrawal of Consent|1
5184536|NCT01211262|17899387|P2|Overall Study|Adverse Event|0
5184537|NCT01211262|17899388|P1|Overall Study|Adverse Event|4
5184538|NCT01211262|17899387|P2|Overall Study|Progressive Disease|9
5184539|NCT01211262|17899388|P1|Overall Study|Progressive Disease|18
5184540|NCT01211197|17899428|P6|Washout Period 2 (7 Days)|Adverse Event|0
5184541|NCT01211197|17899429|P5|Washout Period 2 (7 Days)|Adverse Event|0
5184542|NCT01211197|17899430|P4|Washout Period 2 (7 Days)|Adverse Event|0
5184543|NCT01211197|17899431|P3|Washout Period 2 (7 Days)|Adverse Event|0
5184544|NCT01211197|17899432|P2|Washout Period 2 (7 Days)|Adverse Event|0
5184545|NCT01211197|17899433|P1|Washout Period 2 (7 Days)|Adverse Event|1
5184546|NCT01211197|17899428|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5184547|NCT01211197|17899429|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5184548|NCT01211197|17899430|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5184549|NCT01211197|17899431|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5184550|NCT01211197|17899432|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5184551|NCT01211197|17899433|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5184552|NCT01211184|17899480|P3|Overall Study|Withdrawal by Subject|1
5184553|NCT01211184|17899481|P2|Overall Study|Withdrawal by Subject|2
5184554|NCT01211184|17899482|P1|Overall Study|Withdrawal by Subject|0
5184555|NCT01211145|17899497|P4|Overall Study|Patient decision|2
5184556|NCT01211145|17899498|P3|Overall Study|Patient decision|0
5184557|NCT01211145|17899499|P2|Overall Study|Patient decision|1
5184558|NCT01211145|17899500|P1|Overall Study|Patient decision|2
5184559|NCT01211145|17899497|P4|Overall Study|Eligibility criteria not fulfilled|15
5184560|NCT01211145|17899498|P3|Overall Study|Eligibility criteria not fulfilled|10
5184561|NCT01211145|17899499|P2|Overall Study|Eligibility criteria not fulfilled|12
5184562|NCT01211145|17899500|P1|Overall Study|Eligibility criteria not fulfilled|16
5184563|NCT01211145|17899497|P4|Overall Study|Severe noncompliance to protocol|0
5184564|NCT01211145|17899498|P3|Overall Study|Severe noncompliance to protocol|0
5184565|NCT01211145|17899499|P2|Overall Study|Severe noncompliance to protocol|0
5184566|NCT01211145|17899500|P1|Overall Study|Severe noncompliance to protocol|1
5184567|NCT01211145|17899497|P4|Overall Study|Study-specific withdrawal criteria|0
5184568|NCT01211145|17899498|P3|Overall Study|Study-specific withdrawal criteria|0
5184569|NCT01211145|17899499|P2|Overall Study|Study-specific withdrawal criteria|0
5184570|NCT01211145|17899500|P1|Overall Study|Study-specific withdrawal criteria|1
5184571|NCT01211145|17899497|P4|Overall Study|Lost to Follow-up|2
5184572|NCT01211145|17899498|P3|Overall Study|Lost to Follow-up|1
5184573|NCT01211145|17899499|P2|Overall Study|Lost to Follow-up|2
5184574|NCT01211145|17899500|P1|Overall Study|Lost to Follow-up|3
5184575|NCT01211145|17899497|P4|Overall Study|Reason not specified|1
5184576|NCT01211145|17899498|P3|Overall Study|Reason not specified|2
5184577|NCT01211145|17899499|P2|Overall Study|Reason not specified|2
5184578|NCT01211145|17899500|P1|Overall Study|Reason not specified|3
5184579|NCT01210807|17899554|P2|Overall Study|Not implanted bilaterally|1
5184580|NCT01210807|17899555|P1|Overall Study|Not implanted bilaterally|2
5184581|NCT01210807|17899554|P2|Overall Study|Lost to Follow-up|2
5184582|NCT01210807|17899555|P1|Overall Study|Lost to Follow-up|1
5184583|NCT01210690|17899570|P1|Overall Study|Patient could not take glucose|1
5184584|NCT01210690|17899570|P1|Overall Study|Patient refused to swallow|1
5184585|NCT01210690|17899570|P1|Overall Study|Withdrawal by Subject|1
5184586|NCT01210690|17899570|P1|Overall Study|Disease Remission|1
5184587|NCT01210690|17899570|P1|Overall Study|Lost to Follow-up|3
5184588|NCT01210690|17899570|P1|Overall Study|Lack of Efficacy|12
5184589|NCT01210690|17899570|P1|Overall Study|Adverse Event|7
5184590|NCT01210664|17899583|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
5184591|NCT01210664|17899584|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5184592|NCT01210664|17899585|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5184593|NCT01210664|17899586|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5184594|NCT01210664|17899583|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5184595|NCT01210664|17899584|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
5184596|NCT01210664|17899585|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5184597|NCT01210664|17899586|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5184598|NCT01210664|17899583|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5184599|NCT01210664|17899584|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
5184600|NCT01210664|17899585|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5184601|NCT01210664|17899586|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5184602|NCT01210651|17899614|P2|Overall Study|Injury outside study|0
5184603|NCT01210651|17899615|P1|Overall Study|Injury outside study|2
5184604|NCT01210651|17899614|P2|Overall Study|Withdrawal by Subject|1
5184605|NCT01210651|17899615|P1|Overall Study|Withdrawal by Subject|1
5184606|NCT01210651|17899614|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
5184607|NCT01210651|17899615|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
5184608|NCT01210651|17899614|P2|Overall Study|schedule conflicts|5
5184609|NCT01210651|17899615|P1|Overall Study|schedule conflicts|1
5184610|NCT01210651|17899614|P2|Overall Study|Lost to Follow-up|1
5184611|NCT01210651|17899615|P1|Overall Study|Lost to Follow-up|1
5184612|NCT01210495|17899735|P4|Overall Study|Other unspecified|0
5184613|NCT01210495|17899736|P3|Overall Study|Other unspecified|6
5184614|NCT01210495|17899737|P2|Overall Study|Other unspecified|0
5184615|NCT01210495|17899738|P1|Overall Study|Other unspecified|0
5184616|NCT01210495|17899735|P4|Overall Study|Lost to Follow-up|1
5184617|NCT01210495|17899736|P3|Overall Study|Lost to Follow-up|1
5184618|NCT01210495|17899737|P2|Overall Study|Lost to Follow-up|0
5184619|NCT01210495|17899738|P1|Overall Study|Lost to Follow-up|0
5184620|NCT01210495|17899735|P4|Overall Study|Study Terminated by Sponsor|11
5184621|NCT01210495|17899736|P3|Overall Study|Study Terminated by Sponsor|4
5184622|NCT01210495|17899737|P2|Overall Study|Study Terminated by Sponsor|0
5184623|NCT01210495|17899738|P1|Overall Study|Study Terminated by Sponsor|0
5184624|NCT01210495|17899735|P4|Overall Study|Death|54
5184625|NCT01210495|17899736|P3|Overall Study|Death|112
5184626|NCT01210495|17899737|P2|Overall Study|Death|7
5184627|NCT01210495|17899738|P1|Overall Study|Death|14
5184628|NCT01210495|17899735|P4|Overall Study|Participant Refused Further Follow-Up|2
5184629|NCT01210495|17899736|P3|Overall Study|Participant Refused Further Follow-Up|11
5184630|NCT01210495|17899737|P2|Overall Study|Participant Refused Further Follow-Up|0
5184631|NCT01210495|17899738|P1|Overall Study|Participant Refused Further Follow-Up|1
5184632|NCT01210443|17899800|P1|Overall Study|Study terminated by sponsor|2
5184633|NCT01210352|17899817|P9|Overall Study|Patient Discharged Early|0
5184634|NCT01210352|17899818|P8|Overall Study|Patient Discharged Early|0
5184635|NCT01210352|17899819|P7|Overall Study|Patient Discharged Early|0
5184636|NCT01210352|17899820|P6|Overall Study|Patient Discharged Early|0
5184637|NCT01210352|17899821|P5|Overall Study|Patient Discharged Early|0
5184638|NCT01210352|17899822|P4|Overall Study|Patient Discharged Early|0
5184639|NCT01210352|17899823|P3|Overall Study|Patient Discharged Early|1
5184640|NCT01210352|17899824|P2|Overall Study|Patient Discharged Early|0
5184641|NCT01210352|17899825|P1|Overall Study|Patient Discharged Early|0
5184642|NCT01210352|17899817|P9|Overall Study|Withdrawal by Subject|1
5184643|NCT01210352|17899818|P8|Overall Study|Withdrawal by Subject|0
5184644|NCT01210352|17899819|P7|Overall Study|Withdrawal by Subject|1
5184645|NCT01210352|17899820|P6|Overall Study|Withdrawal by Subject|0
5184646|NCT01210352|17899821|P5|Overall Study|Withdrawal by Subject|0
5184647|NCT01210352|17899822|P4|Overall Study|Withdrawal by Subject|0
5184648|NCT01210352|17899823|P3|Overall Study|Withdrawal by Subject|1
5184649|NCT01210352|17899824|P2|Overall Study|Withdrawal by Subject|0
5184650|NCT01210352|17899825|P1|Overall Study|Withdrawal by Subject|0
5184651|NCT01210352|17899817|P9|Overall Study|Physician Decision|2
5184652|NCT01210352|17899818|P8|Overall Study|Physician Decision|1
5184653|NCT01210352|17899819|P7|Overall Study|Physician Decision|0
5184654|NCT01210352|17899820|P6|Overall Study|Physician Decision|0
5184655|NCT01210352|17899821|P5|Overall Study|Physician Decision|0
5184656|NCT01210352|17899822|P4|Overall Study|Physician Decision|0
5184657|NCT01210352|17899823|P3|Overall Study|Physician Decision|0
5184658|NCT01210352|17899824|P2|Overall Study|Physician Decision|0
5184659|NCT01210352|17899825|P1|Overall Study|Physician Decision|0
5184660|NCT01210352|17899817|P9|Overall Study|Lack of Efficacy|0
5184661|NCT01210352|17899818|P8|Overall Study|Lack of Efficacy|0
5184662|NCT01210352|17899819|P7|Overall Study|Lack of Efficacy|1
5184663|NCT01210352|17899820|P6|Overall Study|Lack of Efficacy|0
5184664|NCT01210352|17899821|P5|Overall Study|Lack of Efficacy|0
5184665|NCT01210352|17899822|P4|Overall Study|Lack of Efficacy|0
5184666|NCT01210352|17899823|P3|Overall Study|Lack of Efficacy|0
5184667|NCT01210352|17899824|P2|Overall Study|Lack of Efficacy|0
5184668|NCT01210352|17899825|P1|Overall Study|Lack of Efficacy|0
5184669|NCT01210352|17899817|P9|Overall Study|Adverse Event|1
5184670|NCT01210352|17899818|P8|Overall Study|Adverse Event|2
5184671|NCT01210352|17899819|P7|Overall Study|Adverse Event|0
5184672|NCT01210352|17899820|P6|Overall Study|Adverse Event|0
5184673|NCT01210352|17899821|P5|Overall Study|Adverse Event|0
5184674|NCT01210352|17899822|P4|Overall Study|Adverse Event|0
5184675|NCT01210352|17899823|P3|Overall Study|Adverse Event|0
5184676|NCT01210352|17899824|P2|Overall Study|Adverse Event|0
5184677|NCT01210352|17899825|P1|Overall Study|Adverse Event|0
5184678|NCT01210222|17900016|P1|Overall Study|Never treated|1
5184679|NCT01210222|17900016|P1|Overall Study|Ineligible|2
5184680|NCT01210144|17900052|P2|Overall Study|No transfer|0
5184681|NCT01210144|17900053|P1|Overall Study|No transfer|1
5184682|NCT01210144|17900052|P2|Overall Study|No fertilization|0
5184683|NCT01210144|17900053|P1|Overall Study|No fertilization|1
5184684|NCT01210144|17900052|P2|Overall Study|Lack of ovarian response|0
5184685|NCT01210144|17900053|P1|Overall Study|Lack of ovarian response|1
5184686|NCT01210118|17900075|P2|Overall Study|Spontaneous abortion|3
5184687|NCT01210118|17900076|P1|Overall Study|Spontaneous abortion|1
5184688|NCT01210118|17900075|P2|Overall Study|Protocol Violation|1
5184689|NCT01210118|17900076|P1|Overall Study|Protocol Violation|1
5184690|NCT01210118|17900075|P2|Overall Study|Lost to Follow-up|1
5184691|NCT01210118|17900076|P1|Overall Study|Lost to Follow-up|1
5184692|NCT01210001|17900100|P3|Overall Study|Other reason not defined above|1
5184693|NCT01210001|17900101|P2|Overall Study|Other reason not defined above|2
5184694|NCT01210001|17900102|P1|Overall Study|Other reason not defined above|2
5184695|NCT01210001|17900100|P3|Overall Study|Patient refusal to continue,not due toAE|1
5184696|NCT01210001|17900101|P2|Overall Study|Patient refusal to continue,not due toAE|2
5184697|NCT01210001|17900102|P1|Overall Study|Patient refusal to continue,not due toAE|6
5184698|NCT01210001|17900100|P3|Overall Study|Lost to Follow-up|2
5184699|NCT01210001|17900101|P2|Overall Study|Lost to Follow-up|3
5184700|NCT01210001|17900102|P1|Overall Study|Lost to Follow-up|4
5184701|NCT01210001|17900100|P3|Overall Study|Non compliant with protocol|3
5184702|NCT01210001|17900101|P2|Overall Study|Non compliant with protocol|2
5184703|NCT01210001|17900102|P1|Overall Study|Non compliant with protocol|2
5184704|NCT01210001|17900100|P3|Overall Study|Adverse Event|5
5184705|NCT01210001|17900101|P2|Overall Study|Adverse Event|2
5184706|NCT01210001|17900102|P1|Overall Study|Adverse Event|4
5184707|NCT01210001|17900100|P3|Overall Study|Not treated|0
5184708|NCT01210001|17900101|P2|Overall Study|Not treated|0
5184709|NCT01210001|17900102|P1|Overall Study|Not treated|1
5184710|NCT01209949|17900122|P1|Overall Study|Lost to Follow-up|3
5184711|NCT01209832|17900128|P1|Period 2|Sponsor Decision|1
5184712|NCT01209832|17900128|P1|Period 1|Sponsor Decision and was not dosed|1
5184713|NCT01209780|17900147|P5|Overall Study|Inappropriate enrollment|1
5184714|NCT01209780|17900148|P4|Overall Study|Inappropriate enrollment|0
5184715|NCT01209780|17900149|P3|Overall Study|Inappropriate enrollment|0
5184716|NCT01209780|17900150|P2|Overall Study|Inappropriate enrollment|2
5184717|NCT01209780|17900151|P1|Overall Study|Inappropriate enrollment|0
5184718|NCT01209780|17900147|P5|Overall Study|Protocol Violation|0
5184719|NCT01209780|17900148|P4|Overall Study|Protocol Violation|0
5184720|NCT01209780|17900149|P3|Overall Study|Protocol Violation|0
5184721|NCT01209780|17900150|P2|Overall Study|Protocol Violation|1
5184722|NCT01209780|17900151|P1|Overall Study|Protocol Violation|0
5184723|NCT01209780|17900147|P5|Overall Study|Lost to Follow-up|4
5184724|NCT01209780|17900148|P4|Overall Study|Lost to Follow-up|9
5184725|NCT01209780|17900149|P3|Overall Study|Lost to Follow-up|3
5184726|NCT01209780|17900150|P2|Overall Study|Lost to Follow-up|12
5184727|NCT01209780|17900151|P1|Overall Study|Lost to Follow-up|17
5184728|NCT01209780|17900147|P5|Overall Study|Withdrawal by Subject|0
5184729|NCT01209780|17900148|P4|Overall Study|Withdrawal by Subject|1
5184730|NCT01209780|17900149|P3|Overall Study|Withdrawal by Subject|1
5184731|NCT01209780|17900150|P2|Overall Study|Withdrawal by Subject|2
5184732|NCT01209780|17900151|P1|Overall Study|Withdrawal by Subject|9
5184733|NCT01209780|17900147|P5|Overall Study|Adverse Event|0
5184734|NCT01209780|17900148|P4|Overall Study|Adverse Event|0
5184735|NCT01209780|17900149|P3|Overall Study|Adverse Event|0
5184736|NCT01209780|17900150|P2|Overall Study|Adverse Event|1
5184737|NCT01209780|17900151|P1|Overall Study|Adverse Event|0
5184738|NCT01209767|17900177|P1|Overall Study|Lost to Follow-up|3
5184739|NCT01209767|17900177|P1|Overall Study|Withdrawal by Subject|1
5184740|NCT01209689|17900246|P2|Overall Study|Sponsor's Decision to Stop the Study|17
5184741|NCT01209689|17900247|P1|Overall Study|Sponsor's Decision to Stop the Study|68
5184742|NCT01209689|17900246|P2|Overall Study|Failure to Return|0
5184743|NCT01209689|17900247|P1|Overall Study|Failure to Return|3
5184744|NCT01209689|17900246|P2|Overall Study|Violation of Selection Criteria at Entry|0
5184745|NCT01209689|17900247|P1|Overall Study|Violation of Selection Criteria at Entry|1
5184746|NCT01209689|17900246|P2|Overall Study|Adverse Event|0
5184747|NCT01209689|17900247|P1|Overall Study|Adverse Event|4
5184748|NCT01209689|17900246|P2|Overall Study|Refused Treatment|3
5184749|NCT01209689|17900247|P1|Overall Study|Refused Treatment|8
5184750|NCT01209689|17900246|P2|Overall Study|Insufficient Therapeutic Response|2
5184751|NCT01209689|17900247|P1|Overall Study|Insufficient Therapeutic Response|7
5184752|NCT01209624|17900253|P1|Overall Study|Other|4
5184753|NCT01209624|17900253|P1|Overall Study|Lost to Follow-up|290
5184754|NCT01209624|17900253|P1|Overall Study|Lack of Efficacy|17
5184755|NCT01209624|17900253|P1|Overall Study|Adverse Event|13
5184756|NCT01209624|17900253|P1|Overall Study|Death|2
5184757|NCT01209598|17900286|P2|Overall Study|Withdrawal by Subject|0
5184758|NCT01209598|17900287|P1|Overall Study|Withdrawal by Subject|1
5184759|NCT01209520|17900295|P1|Overall Study|Withdrawal by Subject|3
5184760|NCT01209325|17900305|P1|Overall Study|Incarceration|2
5184761|NCT01209325|17900305|P1|Overall Study|Refusal prior to therapy|1
5184762|NCT01209325|17900305|P1|Overall Study|Protocol Violation|4
5184763|NCT01209325|17900305|P1|Overall Study|Refusal after starting therapy|8
5184764|NCT01209325|17900305|P1|Overall Study|Relocated|3
5184765|NCT01209325|17900305|P1|Overall Study|Adverse Event|1
5184766|NCT01209325|17900305|P1|Overall Study|Lost to Follow-up|24
5184767|NCT01209286|17900360|P3|Overall Study|Other|0
5184768|NCT01209286|17900361|P2|Overall Study|Other|1
5184769|NCT01209286|17900362|P1|Overall Study|Other|0
5184770|NCT01209286|17900360|P3|Overall Study|Physician Decision|0
5184771|NCT01209286|17900361|P2|Overall Study|Physician Decision|2
5184772|NCT01209286|17900362|P1|Overall Study|Physician Decision|0
5184773|NCT01209286|17900360|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
5184774|NCT01209286|17900361|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
5184775|NCT01209286|17900362|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
5184776|NCT01209286|17900360|P3|Overall Study|Hematological Relapse After Remission|1
5184777|NCT01209286|17900361|P2|Overall Study|Hematological Relapse After Remission|1
5184778|NCT01209286|17900362|P1|Overall Study|Hematological Relapse After Remission|0
5184779|NCT01209286|17900360|P3|Overall Study|Adverse Event|1
5184780|NCT01209286|17900361|P2|Overall Study|Adverse Event|3
5184781|NCT01209286|17900362|P1|Overall Study|Adverse Event|4
5184782|NCT01209143|17900482|P2|Overall Study|Disease progression|16
5184783|NCT01209143|17900483|P1|Overall Study|Disease progression|11
5184784|NCT01209143|17900482|P2|Overall Study|Withdrawal by Subject|1
5184785|NCT01209143|17900483|P1|Overall Study|Withdrawal by Subject|2
5184786|NCT01209143|17900482|P2|Overall Study|Lost to Follow-up|0
5184787|NCT01209143|17900483|P1|Overall Study|Lost to Follow-up|1
5184788|NCT01209143|17900482|P2|Overall Study|Physician Decision|1
5184789|NCT01209143|17900483|P1|Overall Study|Physician Decision|3
5184790|NCT01209143|17900482|P2|Overall Study|Death|1
5184791|NCT01209143|17900483|P1|Overall Study|Death|0
5184792|NCT01209143|17900482|P2|Overall Study|Adverse Event|1
5184793|NCT01209143|17900483|P1|Overall Study|Adverse Event|2
5184794|NCT01209078|17900493|P2|Overall Study|Withdrawal by Subject|1
5184795|NCT01209078|17900494|P1|Overall Study|Withdrawal by Subject|2
5184796|NCT01209078|17900493|P2|Overall Study|Physician Decision|2
5184797|NCT01209078|17900494|P1|Overall Study|Physician Decision|5
5184798|NCT01209078|17900493|P2|Overall Study|Lost to Follow-up|0
5184799|NCT01209078|17900494|P1|Overall Study|Lost to Follow-up|4
5184800|NCT01209078|17900493|P2|Overall Study|Adverse Event|0
5184801|NCT01209078|17900494|P1|Overall Study|Adverse Event|5
5184802|NCT01208961|17900569|P2|High-Fat Period III|Protocol Violation|0
5184803|NCT01208961|17900570|P1|High-Fat Period III|Protocol Violation|1
5184804|NCT01208870|17900592|P2|Overall Study|Lost to Follow-up|8
5184805|NCT01208870|17900593|P1|Overall Study|Lost to Follow-up|2
5184806|NCT01208415|17900609|P1|Overall Study|Still be eligible for follow-up|33
5184807|NCT01208415|17900609|P1|Overall Study|Device not placed|1
5184808|NCT01208415|17900609|P1|Overall Study|Withdrawal by Subject|3
5184809|NCT01208415|17900609|P1|Overall Study|Lost to Follow-up|2
5184810|NCT01208415|17900609|P1|Overall Study|Death|1
5184811|NCT01208402|17900615|P2|Overall Study|Withdrawal by Subject|0
5184812|NCT01208402|17900616|P1|Overall Study|Withdrawal by Subject|1
5184813|NCT01208337|17900632|P1|Overall Study|Death|3
5184814|NCT01208233|17900646|P6|Overall Study|Withdrawal by Subject|2
5184815|NCT01208233|17900647|P5|Overall Study|Withdrawal by Subject|4
5184816|NCT01208233|17900648|P4|Overall Study|Withdrawal by Subject|1
5184817|NCT01208233|17900649|P3|Overall Study|Withdrawal by Subject|1
5184818|NCT01208233|17900650|P2|Overall Study|Withdrawal by Subject|0
5184819|NCT01208233|17900651|P1|Overall Study|Withdrawal by Subject|1
5184820|NCT01208233|17900646|P6|Overall Study|Other|1
5184821|NCT01208233|17900647|P5|Overall Study|Other|0
5184822|NCT01208233|17900648|P4|Overall Study|Other|0
5184823|NCT01208233|17900649|P3|Overall Study|Other|0
5184824|NCT01208233|17900650|P2|Overall Study|Other|1
5184825|NCT01208233|17900651|P1|Overall Study|Other|2
5184826|NCT01208233|17900646|P6|Overall Study|Protocol Violation|0
5184827|NCT01208233|17900647|P5|Overall Study|Protocol Violation|3
5184828|NCT01208233|17900648|P4|Overall Study|Protocol Violation|0
5184829|NCT01208233|17900649|P3|Overall Study|Protocol Violation|0
5184830|NCT01208233|17900650|P2|Overall Study|Protocol Violation|0
5184831|NCT01208233|17900651|P1|Overall Study|Protocol Violation|0
5184832|NCT01208233|17900646|P6|Overall Study|Study terminated by sponsor|7
5184833|NCT01208233|17900647|P5|Overall Study|Study terminated by sponsor|10
5184834|NCT01208233|17900648|P4|Overall Study|Study terminated by sponsor|0
5184835|NCT01208233|17900649|P3|Overall Study|Study terminated by sponsor|0
5184836|NCT01208233|17900650|P2|Overall Study|Study terminated by sponsor|0
5184837|NCT01208233|17900651|P1|Overall Study|Study terminated by sponsor|0
5184838|NCT01208233|17900646|P6|Overall Study|Medication error without adverse event|1
5184839|NCT01208233|17900647|P5|Overall Study|Medication error without adverse event|0
5184840|NCT01208233|17900648|P4|Overall Study|Medication error without adverse event|0
5184841|NCT01208233|17900649|P3|Overall Study|Medication error without adverse event|0
5184842|NCT01208233|17900650|P2|Overall Study|Medication error without adverse event|0
5184843|NCT01208233|17900651|P1|Overall Study|Medication error without adverse event|0
5184844|NCT01208233|17900646|P6|Overall Study|Did not meet entrance criteria|0
5184845|NCT01208233|17900647|P5|Overall Study|Did not meet entrance criteria|1
5184846|NCT01208233|17900648|P4|Overall Study|Did not meet entrance criteria|0
5184847|NCT01208233|17900649|P3|Overall Study|Did not meet entrance criteria|1
5184848|NCT01208233|17900650|P2|Overall Study|Did not meet entrance criteria|1
5184849|NCT01208233|17900651|P1|Overall Study|Did not meet entrance criteria|2
5184850|NCT01208233|17900646|P6|Overall Study|Death|5
5184851|NCT01208233|17900647|P5|Overall Study|Death|3
5184852|NCT01208233|17900648|P4|Overall Study|Death|0
5184853|NCT01208233|17900649|P3|Overall Study|Death|0
5184854|NCT01208233|17900650|P2|Overall Study|Death|0
5184855|NCT01208233|17900651|P1|Overall Study|Death|0
5184856|NCT01208233|17900646|P6|Overall Study|Adverse Event|5
5184857|NCT01208233|17900647|P5|Overall Study|Adverse Event|3
5184858|NCT01208233|17900648|P4|Overall Study|Adverse Event|0
5184859|NCT01208233|17900649|P3|Overall Study|Adverse Event|2
5184860|NCT01208233|17900650|P2|Overall Study|Adverse Event|1
5184861|NCT01208233|17900651|P1|Overall Study|Adverse Event|0
5184862|NCT01208207|17900776|P7|Part II|Technical Problems|0
5184863|NCT01208207|17900777|P6|Part II|Technical Problems|1
5184864|NCT01208207|17900778|P5|Part II|Technical Problems|0
5184865|NCT01208207|17900779|P4|Part II|Technical Problems|1
5184866|NCT01208207|17900780|P3|Part II|Technical Problems|0
5184867|NCT01208207|17900781|P2|Part II|Technical Problems|0
5184868|NCT01208207|17900782|P1|Part II|Technical Problems|0
5184869|NCT01208207|17900776|P7|Part II|Protocol Violation|0
5184870|NCT01208207|17900777|P6|Part II|Protocol Violation|0
5184871|NCT01208207|17900778|P5|Part II|Protocol Violation|0
5184872|NCT01208207|17900779|P4|Part II|Protocol Violation|1
5184873|NCT01208207|17900780|P3|Part II|Protocol Violation|0
5184874|NCT01208207|17900781|P2|Part II|Protocol Violation|0
5184875|NCT01208207|17900782|P1|Part II|Protocol Violation|0
5184876|NCT01208207|17900776|P7|Part II|Physician Decision|0
5184877|NCT01208207|17900777|P6|Part II|Physician Decision|2
5184878|NCT01208207|17900778|P5|Part II|Physician Decision|0
5184879|NCT01208207|17900779|P4|Part II|Physician Decision|1
5184880|NCT01208207|17900780|P3|Part II|Physician Decision|0
5184881|NCT01208207|17900781|P2|Part II|Physician Decision|0
5184882|NCT01208207|17900782|P1|Part II|Physician Decision|0
5184883|NCT01208207|17900776|P7|Part II|Non-Compliance With Study Drug|0
5184884|NCT01208207|17900777|P6|Part II|Non-Compliance With Study Drug|1
5184885|NCT01208207|17900778|P5|Part II|Non-Compliance With Study Drug|1
5184886|NCT01208207|17900779|P4|Part II|Non-Compliance With Study Drug|4
5184887|NCT01208207|17900780|P3|Part II|Non-Compliance With Study Drug|0
5184888|NCT01208207|17900781|P2|Part II|Non-Compliance With Study Drug|0
5184889|NCT01208207|17900782|P1|Part II|Non-Compliance With Study Drug|0
5184890|NCT01208207|17900776|P7|Part II|Lost to Follow-up|1
5184891|NCT01208207|17900777|P6|Part II|Lost to Follow-up|2
5184892|NCT01208207|17900778|P5|Part II|Lost to Follow-up|0
5184893|NCT01208207|17900779|P4|Part II|Lost to Follow-up|4
5184894|NCT01208207|17900780|P3|Part II|Lost to Follow-up|0
5184895|NCT01208207|17900781|P2|Part II|Lost to Follow-up|0
5184896|NCT01208207|17900782|P1|Part II|Lost to Follow-up|0
5184897|NCT01208207|17900776|P7|Part II|Lack of Efficacy|3
5184898|NCT01208207|17900777|P6|Part II|Lack of Efficacy|3
5184899|NCT01208207|17900778|P5|Part II|Lack of Efficacy|4
5184900|NCT01208207|17900779|P4|Part II|Lack of Efficacy|6
5184901|NCT01208207|17900780|P3|Part II|Lack of Efficacy|0
5184902|NCT01208207|17900781|P2|Part II|Lack of Efficacy|0
5184903|NCT01208207|17900782|P1|Part II|Lack of Efficacy|0
5184904|NCT01208207|17900776|P7|Part II|Adverse Event|2
5184905|NCT01208207|17900777|P6|Part II|Adverse Event|4
5184906|NCT01208207|17900778|P5|Part II|Adverse Event|9
5184907|NCT01208207|17900779|P4|Part II|Adverse Event|5
5184908|NCT01208207|17900780|P3|Part II|Adverse Event|0
5184909|NCT01208207|17900781|P2|Part II|Adverse Event|0
5184910|NCT01208207|17900782|P1|Part II|Adverse Event|0
5184911|NCT01208207|17900776|P7|Part II|Withdrawal by Subject|5
5184912|NCT01208207|17900777|P6|Part II|Withdrawal by Subject|3
5184913|NCT01208207|17900778|P5|Part II|Withdrawal by Subject|9
5184914|NCT01208207|17900779|P4|Part II|Withdrawal by Subject|10
5184915|NCT01208207|17900780|P3|Part II|Withdrawal by Subject|0
5184916|NCT01208207|17900781|P2|Part II|Withdrawal by Subject|0
5184917|NCT01208207|17900782|P1|Part II|Withdrawal by Subject|0
5184918|NCT01208207|17900776|P7|Part I|Withdrawal by Subject|0
5184919|NCT01208207|17900777|P6|Part I|Withdrawal by Subject|0
5184920|NCT01208207|17900778|P5|Part I|Withdrawal by Subject|0
5184921|NCT01208207|17900779|P4|Part I|Withdrawal by Subject|0
5184922|NCT01208207|17900780|P3|Part I|Withdrawal by Subject|4
5184923|NCT01208207|17900781|P2|Part I|Withdrawal by Subject|4
5184924|NCT01208207|17900782|P1|Part I|Withdrawal by Subject|14
5184925|NCT01208207|17900776|P7|Part I|Protocol Violation|0
5184926|NCT01208207|17900777|P6|Part I|Protocol Violation|0
5184927|NCT01208207|17900778|P5|Part I|Protocol Violation|0
5184928|NCT01208207|17900779|P4|Part I|Protocol Violation|0
5184929|NCT01208207|17900780|P3|Part I|Protocol Violation|2
5184930|NCT01208207|17900781|P2|Part I|Protocol Violation|0
5184931|NCT01208207|17900782|P1|Part I|Protocol Violation|8
5184932|NCT01208207|17900776|P7|Part I|Progressive Disease|0
5184933|NCT01208207|17900777|P6|Part I|Progressive Disease|0
5184934|NCT01208207|17900778|P5|Part I|Progressive Disease|0
5184935|NCT01208207|17900779|P4|Part I|Progressive Disease|0
5184936|NCT01208207|17900780|P3|Part I|Progressive Disease|0
5184937|NCT01208207|17900781|P2|Part I|Progressive Disease|0
5184938|NCT01208207|17900782|P1|Part I|Progressive Disease|1
5184939|NCT01208207|17900776|P7|Part I|Physician Decision|0
5184940|NCT01208207|17900777|P6|Part I|Physician Decision|0
5184941|NCT01208207|17900778|P5|Part I|Physician Decision|0
5184942|NCT01208207|17900779|P4|Part I|Physician Decision|0
5184943|NCT01208207|17900780|P3|Part I|Physician Decision|0
5184944|NCT01208207|17900781|P2|Part I|Physician Decision|1
5184945|NCT01208207|17900782|P1|Part I|Physician Decision|0
5184946|NCT01208207|17900776|P7|Part I|Non-Compliance With Study Drug|0
5184947|NCT01208207|17900777|P6|Part I|Non-Compliance With Study Drug|0
5184948|NCT01208207|17900778|P5|Part I|Non-Compliance With Study Drug|0
5184949|NCT01208207|17900779|P4|Part I|Non-Compliance With Study Drug|0
5184950|NCT01208207|17900780|P3|Part I|Non-Compliance With Study Drug|1
5184951|NCT01208207|17900781|P2|Part I|Non-Compliance With Study Drug|0
5184952|NCT01208207|17900782|P1|Part I|Non-Compliance With Study Drug|1
5184953|NCT01208207|17900776|P7|Part I|Lost to Follow-up|0
5184954|NCT01208207|17900777|P6|Part I|Lost to Follow-up|0
5184955|NCT01208207|17900778|P5|Part I|Lost to Follow-up|0
5184956|NCT01208207|17900779|P4|Part I|Lost to Follow-up|0
5184957|NCT01208207|17900780|P3|Part I|Lost to Follow-up|0
5184958|NCT01208207|17900781|P2|Part I|Lost to Follow-up|1
5184959|NCT01208207|17900782|P1|Part I|Lost to Follow-up|6
5184960|NCT01208207|17900776|P7|Part I|Lack of Efficacy|0
5184961|NCT01208207|17900777|P6|Part I|Lack of Efficacy|0
5184962|NCT01208207|17900778|P5|Part I|Lack of Efficacy|0
5184963|NCT01208207|17900779|P4|Part I|Lack of Efficacy|0
5184964|NCT01208207|17900780|P3|Part I|Lack of Efficacy|2
5184965|NCT01208207|17900781|P2|Part I|Lack of Efficacy|3
5184966|NCT01208207|17900782|P1|Part I|Lack of Efficacy|21
5184967|NCT01208207|17900776|P7|Part I|Adverse Event|0
5184968|NCT01208207|17900777|P6|Part I|Adverse Event|0
5184969|NCT01208207|17900778|P5|Part I|Adverse Event|0
5184970|NCT01208207|17900779|P4|Part I|Adverse Event|0
5184971|NCT01208207|17900780|P3|Part I|Adverse Event|6
5184972|NCT01208207|17900781|P2|Part I|Adverse Event|2
5184973|NCT01208207|17900782|P1|Part I|Adverse Event|19
5184974|NCT01208181|17900809|P5|Part 2|Lack of Efficacy|0
5184975|NCT01208181|17900810|P4|Part 2|Lack of Efficacy|7
5184976|NCT01208181|17900811|P3|Part 2|Lack of Efficacy|5
5184977|NCT01208181|17900812|P2|Part 2|Lack of Efficacy|0
5184978|NCT01208181|17900813|P1|Part 2|Lack of Efficacy|0
5184979|NCT01208181|17900809|P5|Part 2|Lost to Follow-up|0
5184980|NCT01208181|17900810|P4|Part 2|Lost to Follow-up|2
5184981|NCT01208181|17900811|P3|Part 2|Lost to Follow-up|1
5184982|NCT01208181|17900812|P2|Part 2|Lost to Follow-up|0
5184983|NCT01208181|17900813|P1|Part 2|Lost to Follow-up|0
5184984|NCT01208181|17900809|P5|Part 2|Non-compliance with study drug|0
5184985|NCT01208181|17900810|P4|Part 2|Non-compliance with study drug|1
5184986|NCT01208181|17900811|P3|Part 2|Non-compliance with study drug|1
5184987|NCT01208181|17900812|P2|Part 2|Non-compliance with study drug|0
5184988|NCT01208181|17900813|P1|Part 2|Non-compliance with study drug|0
5184989|NCT01208181|17900809|P5|Part 2|Physician Decision|0
5184990|NCT01208181|17900810|P4|Part 2|Physician Decision|2
5184991|NCT01208181|17900811|P3|Part 2|Physician Decision|1
5184992|NCT01208181|17900812|P2|Part 2|Physician Decision|0
5184993|NCT01208181|17900813|P1|Part 2|Physician Decision|0
5184994|NCT01208181|17900809|P5|Part 2|Protocol Violation|0
5184995|NCT01208181|17900810|P4|Part 2|Protocol Violation|0
5184996|NCT01208181|17900811|P3|Part 2|Protocol Violation|1
5184997|NCT01208181|17900812|P2|Part 2|Protocol Violation|0
5184998|NCT01208181|17900813|P1|Part 2|Protocol Violation|0
5184999|NCT01208181|17900809|P5|Part 2|Withdrawal by Subject|0
5185000|NCT01208181|17900810|P4|Part 2|Withdrawal by Subject|1
5185001|NCT01208181|17900811|P3|Part 2|Withdrawal by Subject|1
5185002|NCT01208181|17900812|P2|Part 2|Withdrawal by Subject|0
5185003|NCT01208181|17900813|P1|Part 2|Withdrawal by Subject|0
5185004|NCT01208181|17900809|P5|Part 2|Adverse Event|0
5185005|NCT01208181|17900810|P4|Part 2|Adverse Event|7
5185006|NCT01208181|17900811|P3|Part 2|Adverse Event|6
5185007|NCT01208181|17900812|P2|Part 2|Adverse Event|0
5185008|NCT01208181|17900813|P1|Part 2|Adverse Event|0
5185009|NCT01208181|17900809|P5|Part 1|Adverse Event|4
5185010|NCT01208181|17900810|P4|Part 1|Adverse Event|0
5185011|NCT01208181|17900811|P3|Part 1|Adverse Event|0
5185012|NCT01208181|17900812|P2|Part 1|Adverse Event|24
5185013|NCT01208181|17900813|P1|Part 1|Adverse Event|26
5185014|NCT01208181|17900809|P5|Part 1|Lack of Efficacy|17
5185015|NCT01208181|17900810|P4|Part 1|Lack of Efficacy|0
5185016|NCT01208181|17900811|P3|Part 1|Lack of Efficacy|0
5185017|NCT01208181|17900812|P2|Part 1|Lack of Efficacy|12
5185018|NCT01208181|17900813|P1|Part 1|Lack of Efficacy|37
5185019|NCT01208181|17900809|P5|Part 1|Lost to Follow-up|1
5185020|NCT01208181|17900810|P4|Part 1|Lost to Follow-up|0
5185021|NCT01208181|17900811|P3|Part 1|Lost to Follow-up|0
5185022|NCT01208181|17900812|P2|Part 1|Lost to Follow-up|3
5185023|NCT01208181|17900813|P1|Part 1|Lost to Follow-up|5
5185024|NCT01208181|17900809|P5|Part 1|Non-compliance with study drug|0
5185025|NCT01208181|17900810|P4|Part 1|Non-compliance with study drug|0
5185026|NCT01208181|17900811|P3|Part 1|Non-compliance with study drug|0
5185027|NCT01208181|17900812|P2|Part 1|Non-compliance with study drug|1
5185028|NCT01208181|17900813|P1|Part 1|Non-compliance with study drug|1
5185029|NCT01208181|17900809|P5|Part 1|Physician Decision|0
5185030|NCT01208181|17900810|P4|Part 1|Physician Decision|0
5185031|NCT01208181|17900811|P3|Part 1|Physician Decision|0
5185032|NCT01208181|17900812|P2|Part 1|Physician Decision|0
5185033|NCT01208181|17900813|P1|Part 1|Physician Decision|4
5185034|NCT01208181|17900809|P5|Part 1|Protocol Violation|0
5185035|NCT01208181|17900810|P4|Part 1|Protocol Violation|0
5185036|NCT01208181|17900811|P3|Part 1|Protocol Violation|0
5185037|NCT01208181|17900812|P2|Part 1|Protocol Violation|5
5185038|NCT01208181|17900813|P1|Part 1|Protocol Violation|10
5185039|NCT01208181|17900809|P5|Part 1|Technical problem|0
5185040|NCT01208181|17900810|P4|Part 1|Technical problem|0
5185041|NCT01208181|17900811|P3|Part 1|Technical problem|0
5185042|NCT01208181|17900812|P2|Part 1|Technical problem|0
5185043|NCT01208181|17900813|P1|Part 1|Technical problem|5
5185044|NCT01208181|17900809|P5|Part 1|Withdrawal by Subject|0
5185045|NCT01208181|17900810|P4|Part 1|Withdrawal by Subject|0
5185046|NCT01208181|17900811|P3|Part 1|Withdrawal by Subject|0
5185047|NCT01208181|17900812|P2|Part 1|Withdrawal by Subject|10
5185048|NCT01208181|17900813|P1|Part 1|Withdrawal by Subject|11
5185049|NCT01208103|17900842|P1|Overall Study|Withdrawal by Subject|1
5185050|NCT01208103|17900842|P1|Overall Study|Adverse Event|1
5185051|NCT01208038|17900850|P1|Overall Study|Withdrawal by Subject|1
5185052|NCT01207687|17900906|P1|Overall Study|Withdrawal by Subject|1
5185053|NCT01207687|17900906|P1|Overall Study|Adverse Event|1
5185054|NCT01207596|17900944|P1|Overall Study|Withdrawal by Subject|1
5185055|NCT01207596|17900944|P1|Overall Study|Adverse Event|3
5185056|NCT01207596|17900944|P1|Overall Study|Lack of Efficacy|1
5185057|NCT01207596|17900944|P1|Overall Study|Physician Decision|4
5185058|NCT01207583|17900957|P3|Overall Study|Lost to Follow-up|0
5185059|NCT01207583|17900958|P2|Overall Study|Lost to Follow-up|2
5185060|NCT01207583|17900959|P1|Overall Study|Lost to Follow-up|0
5185061|NCT01207583|17900957|P3|Overall Study|Participant failed to return|0
5185062|NCT01207583|17900958|P2|Overall Study|Participant failed to return|0
5185063|NCT01207583|17900959|P1|Overall Study|Participant failed to return|1
5185064|NCT01207583|17900957|P3|Overall Study|Withdrawal by Subject|1
5185065|NCT01207583|17900958|P2|Overall Study|Withdrawal by Subject|3
5185066|NCT01207583|17900959|P1|Overall Study|Withdrawal by Subject|0
5185067|NCT01207492|17901012|P1|Overall Study|Toxicity|1
5185068|NCT01207492|17901012|P1|Overall Study|Progressive disease|3
5185069|NCT01207492|17901012|P1|Overall Study|Physician Decision|1
5185070|NCT01207492|17901012|P1|Overall Study|Withdrawal by Subject|9
5185071|NCT01207492|17901012|P1|Overall Study|Still on study|1
5185072|NCT01207453|17901027|P2|2nd Intervention|Lost to Follow-up|0
5185073|NCT01207453|17901028|P1|2nd Intervention|Lost to Follow-up|1
5185074|NCT01207453|17901027|P2|2nd Intervention|Adverse Event|2
5185075|NCT01207453|17901028|P1|2nd Intervention|Adverse Event|1
5185076|NCT01207453|17901027|P2|Washout|Lost to Follow-up|0
5185077|NCT01207453|17901028|P1|Washout|Lost to Follow-up|1
5185078|NCT01207453|17901027|P2|Washout|Adverse Event|0
5185079|NCT01207453|17901028|P1|Washout|Adverse Event|1
5185080|NCT01207453|17901027|P2|First Intervention|Adverse Event|1
5185081|NCT01207453|17901028|P1|First Intervention|Adverse Event|2
5185082|NCT01207440|17901054|P7|Overall Study|Reason Not Specified|0
5185083|NCT01207440|17901055|P6|Overall Study|Reason Not Specified|3
5185084|NCT01207440|17901056|P5|Overall Study|Reason Not Specified|4
5185085|NCT01207440|17901057|P4|Overall Study|Reason Not Specified|0
5185086|NCT01207440|17901058|P3|Overall Study|Reason Not Specified|7
5185087|NCT01207440|17901059|P2|Overall Study|Reason Not Specified|10
5185088|NCT01207440|17901060|P1|Overall Study|Reason Not Specified|10
5185089|NCT01207440|17901054|P7|Overall Study|Withdrawal by Subject|0
5185090|NCT01207440|17901055|P6|Overall Study|Withdrawal by Subject|2
5185091|NCT01207440|17901056|P5|Overall Study|Withdrawal by Subject|2
5185092|NCT01207440|17901057|P4|Overall Study|Withdrawal by Subject|3
5185093|NCT01207440|17901058|P3|Overall Study|Withdrawal by Subject|5
5185094|NCT01207440|17901059|P2|Overall Study|Withdrawal by Subject|4
5185095|NCT01207440|17901060|P1|Overall Study|Withdrawal by Subject|29
5185096|NCT01207440|17901054|P7|Overall Study|Site Terminated by Sponsor|2
5185097|NCT01207440|17901055|P6|Overall Study|Site Terminated by Sponsor|0
5185098|NCT01207440|17901056|P5|Overall Study|Site Terminated by Sponsor|3
5185099|NCT01207440|17901057|P4|Overall Study|Site Terminated by Sponsor|2
5185100|NCT01207440|17901058|P3|Overall Study|Site Terminated by Sponsor|12
5185101|NCT01207440|17901059|P2|Overall Study|Site Terminated by Sponsor|19
5185102|NCT01207440|17901060|P1|Overall Study|Site Terminated by Sponsor|69
5185103|NCT01207440|17901054|P7|Overall Study|Protocol Violation|0
5185104|NCT01207440|17901055|P6|Overall Study|Protocol Violation|0
5185105|NCT01207440|17901056|P5|Overall Study|Protocol Violation|0
5185106|NCT01207440|17901057|P4|Overall Study|Protocol Violation|0
5185107|NCT01207440|17901058|P3|Overall Study|Protocol Violation|0
5185108|NCT01207440|17901059|P2|Overall Study|Protocol Violation|0
5185109|NCT01207440|17901060|P1|Overall Study|Protocol Violation|2
5185110|NCT01207440|17901054|P7|Overall Study|Progressive Disease|0
5185111|NCT01207440|17901055|P6|Overall Study|Progressive Disease|27
5185112|NCT01207440|17901056|P5|Overall Study|Progressive Disease|23
5185113|NCT01207440|17901057|P4|Overall Study|Progressive Disease|7
5185114|NCT01207440|17901058|P3|Overall Study|Progressive Disease|19
5185115|NCT01207440|17901059|P2|Overall Study|Progressive Disease|10
5185116|NCT01207440|17901060|P1|Overall Study|Progressive Disease|19
5185117|NCT01207440|17901054|P7|Overall Study|Physician Decision|0
5185118|NCT01207440|17901055|P6|Overall Study|Physician Decision|0
5185119|NCT01207440|17901056|P5|Overall Study|Physician Decision|1
5185120|NCT01207440|17901057|P4|Overall Study|Physician Decision|0
5185121|NCT01207440|17901058|P3|Overall Study|Physician Decision|5
5185122|NCT01207440|17901059|P2|Overall Study|Physician Decision|5
5185123|NCT01207440|17901060|P1|Overall Study|Physician Decision|6
5185124|NCT01207440|17901054|P7|Overall Study|Non-compliance with Study Drug|0
5185125|NCT01207440|17901055|P6|Overall Study|Non-compliance with Study Drug|0
5185126|NCT01207440|17901056|P5|Overall Study|Non-compliance with Study Drug|0
5185127|NCT01207440|17901057|P4|Overall Study|Non-compliance with Study Drug|0
5185128|NCT01207440|17901058|P3|Overall Study|Non-compliance with Study Drug|1
5185129|NCT01207440|17901059|P2|Overall Study|Non-compliance with Study Drug|0
5185130|NCT01207440|17901060|P1|Overall Study|Non-compliance with Study Drug|3
5185131|NCT01207440|17901054|P7|Overall Study|Lost to Follow-up|0
5185132|NCT01207440|17901055|P6|Overall Study|Lost to Follow-up|0
5185133|NCT01207440|17901056|P5|Overall Study|Lost to Follow-up|0
5185134|NCT01207440|17901057|P4|Overall Study|Lost to Follow-up|1
5185135|NCT01207440|17901058|P3|Overall Study|Lost to Follow-up|2
5185136|NCT01207440|17901059|P2|Overall Study|Lost to Follow-up|0
5185137|NCT01207440|17901060|P1|Overall Study|Lost to Follow-up|0
5185138|NCT01207440|17901054|P7|Overall Study|Lack of Efficacy|0
5185139|NCT01207440|17901055|P6|Overall Study|Lack of Efficacy|3
5185140|NCT01207440|17901056|P5|Overall Study|Lack of Efficacy|2
5185141|NCT01207440|17901057|P4|Overall Study|Lack of Efficacy|1
5185142|NCT01207440|17901058|P3|Overall Study|Lack of Efficacy|5
5185143|NCT01207440|17901059|P2|Overall Study|Lack of Efficacy|2
5185144|NCT01207440|17901060|P1|Overall Study|Lack of Efficacy|13
5185145|NCT01207440|17901054|P7|Overall Study|Death|1
5185146|NCT01207440|17901055|P6|Overall Study|Death|5
5185147|NCT01207440|17901056|P5|Overall Study|Death|7
5185148|NCT01207440|17901057|P4|Overall Study|Death|2
5185149|NCT01207440|17901058|P3|Overall Study|Death|2
5185150|NCT01207440|17901059|P2|Overall Study|Death|3
5185151|NCT01207440|17901060|P1|Overall Study|Death|6
5185152|NCT01207440|17901054|P7|Overall Study|Adverse Event|2
5185153|NCT01207440|17901055|P6|Overall Study|Adverse Event|6
5185154|NCT01207440|17901056|P5|Overall Study|Adverse Event|6
5185155|NCT01207440|17901057|P4|Overall Study|Adverse Event|2
5185156|NCT01207440|17901058|P3|Overall Study|Adverse Event|7
5185157|NCT01207440|17901059|P2|Overall Study|Adverse Event|11
5185158|NCT01207440|17901060|P1|Overall Study|Adverse Event|46
5185159|NCT01207427|17901127|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5185160|NCT01207427|17901128|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5185161|NCT01207427|17901129|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5185162|NCT01207427|17901127|P3|Double-blind Treatment Period|Protocol Violation|1
5185163|NCT01207427|17901128|P2|Double-blind Treatment Period|Protocol Violation|1
5185164|NCT01207427|17901129|P1|Double-blind Treatment Period|Protocol Violation|2
5185165|NCT01207427|17901127|P3|Double-blind Treatment Period|Lost to Follow-up|1
5185166|NCT01207427|17901128|P2|Double-blind Treatment Period|Lost to Follow-up|0
5185167|NCT01207427|17901129|P1|Double-blind Treatment Period|Lost to Follow-up|0
5185168|NCT01207427|17901127|P3|Double-blind Treatment Period|Adverse Event|0
5185169|NCT01207427|17901128|P2|Double-blind Treatment Period|Adverse Event|1
5185170|NCT01207427|17901129|P1|Double-blind Treatment Period|Adverse Event|0
5185171|NCT01207414|17901139|P2|Overall Study|Randomized in error|0
5185172|NCT01207414|17901140|P1|Overall Study|Randomized in error|1
5185173|NCT01207414|17901139|P2|Overall Study|Protocol deviation|9
5185174|NCT01207414|17901140|P1|Overall Study|Protocol deviation|12
5185175|NCT01207414|17901139|P2|Overall Study|Administrative problems|1
5185176|NCT01207414|17901140|P1|Overall Study|Administrative problems|1
5185177|NCT01207414|17901139|P2|Overall Study|Lost to Follow-up|17
5185178|NCT01207414|17901140|P1|Overall Study|Lost to Follow-up|15
5185179|NCT01207414|17901139|P2|Overall Study|Patient withdrew consent|11
5185180|NCT01207414|17901140|P1|Overall Study|Patient withdrew consent|14
5185181|NCT01207414|17901139|P2|Overall Study|Unsatisfactory therapeutic effect|4
5185182|NCT01207414|17901140|P1|Overall Study|Unsatisfactory therapeutic effect|5
5185183|NCT01207414|17901139|P2|Overall Study|Abnormal test procedure results|1
5185184|NCT01207414|17901140|P1|Overall Study|Abnormal test procedure results|0
5185185|NCT01207414|17901139|P2|Overall Study|Adverse Event|39
5185186|NCT01207414|17901140|P1|Overall Study|Adverse Event|25
5185187|NCT01207388|17901165|P1|Overall Study|Withdrawal by Subject|1
5185188|NCT01207388|17901165|P1|Overall Study|Death|67
5185189|NCT01207219|17901190|P3|Overall Study|Lost to Follow-up|6
5185190|NCT01207219|17901191|P2|Overall Study|Lost to Follow-up|8
5185191|NCT01207219|17901192|P1|Overall Study|Lost to Follow-up|6
5185192|NCT01207219|17901190|P3|Overall Study|changed diagnosis during study period|1
5185193|NCT01207219|17901191|P2|Overall Study|changed diagnosis during study period|3
5185194|NCT01207219|17901192|P1|Overall Study|changed diagnosis during study period|5
5185195|NCT01207102|17901212|P1|Overall Study|Withdrawal by Treating Physician|1
5185196|NCT01207102|17901212|P1|Overall Study|progression|2
5185197|NCT01207102|17901212|P1|Overall Study|Adverse Event|2
5185198|NCT01207102|17901212|P1|Overall Study|Withdrawal by Subject|5
5185199|NCT01206816|17901224|P7|Overall Study|other than stated above|1
5185200|NCT01206816|17901225|P6|Overall Study|other than stated above|0
5185201|NCT01206816|17901226|P5|Overall Study|other than stated above|0
5185202|NCT01206816|17901227|P4|Overall Study|other than stated above|0
5185203|NCT01206816|17901228|P3|Overall Study|other than stated above|1
5185204|NCT01206816|17901229|P2|Overall Study|other than stated above|0
5185205|NCT01206816|17901230|P1|Overall Study|other than stated above|0
5185206|NCT01206816|17901224|P7|Overall Study|Other AE|2
5185207|NCT01206816|17901225|P6|Overall Study|Other AE|3
5185208|NCT01206816|17901226|P5|Overall Study|Other AE|0
5185209|NCT01206816|17901227|P4|Overall Study|Other AE|0
5185210|NCT01206816|17901228|P3|Overall Study|Other AE|4
5185211|NCT01206816|17901229|P2|Overall Study|Other AE|0
5185212|NCT01206816|17901230|P1|Overall Study|Other AE|0
5185213|NCT01206816|17901224|P7|Overall Study|Progressive disease|3
5185214|NCT01206816|17901225|P6|Overall Study|Progressive disease|16
5185215|NCT01206816|17901226|P5|Overall Study|Progressive disease|3
5185216|NCT01206816|17901227|P4|Overall Study|Progressive disease|3
5185217|NCT01206816|17901228|P3|Overall Study|Progressive disease|13
5185218|NCT01206816|17901229|P2|Overall Study|Progressive disease|3
5185219|NCT01206816|17901230|P1|Overall Study|Progressive disease|3
5185220|NCT01206816|17901224|P7|Overall Study|Withdrawal by Subject|0
5185221|NCT01206816|17901225|P6|Overall Study|Withdrawal by Subject|0
5185222|NCT01206816|17901226|P5|Overall Study|Withdrawal by Subject|0
5185223|NCT01206816|17901227|P4|Overall Study|Withdrawal by Subject|0
5185224|NCT01206816|17901228|P3|Overall Study|Withdrawal by Subject|1
5185225|NCT01206816|17901229|P2|Overall Study|Withdrawal by Subject|0
5185226|NCT01206816|17901230|P1|Overall Study|Withdrawal by Subject|0
5185227|NCT01206816|17901224|P7|Overall Study|Protocol Violation|0
5185228|NCT01206816|17901225|P6|Overall Study|Protocol Violation|0
5185229|NCT01206816|17901226|P5|Overall Study|Protocol Violation|0
5185230|NCT01206816|17901227|P4|Overall Study|Protocol Violation|0
5185231|NCT01206816|17901228|P3|Overall Study|Protocol Violation|1
5185232|NCT01206816|17901229|P2|Overall Study|Protocol Violation|0
5185233|NCT01206816|17901230|P1|Overall Study|Protocol Violation|0
5185234|NCT01206777|17901276|P1|Overall Study|Adverse Event|1
5185235|NCT01206777|17901276|P1|Overall Study|Death|1
5185236|NCT01206764|17901282|P1|Overall Study|Protocol deviation|3
5185237|NCT01206764|17901282|P1|Overall Study|Disease progression|88
5185238|NCT01206764|17901282|P1|Overall Study|New cancer therapy|2
5185239|NCT01206764|17901282|P1|Overall Study|Death|11
5185240|NCT01206764|17901282|P1|Overall Study|Lost to Follow-up|6
5185241|NCT01206764|17901282|P1|Overall Study|Patient withdrew consent|5
5185242|NCT01206764|17901282|P1|Overall Study|Abnormal test procedure result|1
5185243|NCT01206764|17901282|P1|Overall Study|Abnormal laboratory value|2
5185244|NCT01206764|17901282|P1|Overall Study|Adverse Event|20
5185245|NCT01206582|17901340|P2|Overall Study|Discontinued intervention before week 8|2
5185333|NCT01205126|17902082|P1|Maintenance Phase|Other|11
5185246|NCT01206582|17901341|P1|Overall Study|Discontinued intervention before week 8|1
5185247|NCT01206582|17901340|P2|Overall Study|Withdrew prior to study|0
5185248|NCT01206582|17901341|P1|Overall Study|Withdrew prior to study|1
5185249|NCT01206517|17901373|P6|Overall Study|Withdrawal by Subject|0
5185250|NCT01206517|17901374|P5|Overall Study|Withdrawal by Subject|1
5185251|NCT01206517|17901375|P4|Overall Study|Withdrawal by Subject|0
5185252|NCT01206517|17901376|P3|Overall Study|Withdrawal by Subject|2
5185253|NCT01206517|17901377|P2|Overall Study|Withdrawal by Subject|0
5185254|NCT01206517|17901378|P1|Overall Study|Withdrawal by Subject|0
5185255|NCT01206439|17901458|P1|Overall Study|subject did not meet inclusion criteria|1
5185256|NCT01206322|17901481|P4|Overall Study|Adverse Event|1
5185257|NCT01206322|17901482|P3|Overall Study|Adverse Event|0
5185258|NCT01206322|17901483|P2|Overall Study|Adverse Event|0
5185259|NCT01206322|17901484|P1|Overall Study|Adverse Event|0
5185260|NCT01206140|17901500|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
5185261|NCT01206140|17901501|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
5185262|NCT01206101|17901513|P2|Overall Study|Unclassified|0
5185263|NCT01206101|17901514|P1|Overall Study|Unclassified|1
5185264|NCT01206101|17901513|P2|Overall Study|Physician Decision|1
5185265|NCT01206101|17901514|P1|Overall Study|Physician Decision|0
5185266|NCT01206101|17901513|P2|Overall Study|Adverse Event|0
5185267|NCT01206101|17901514|P1|Overall Study|Adverse Event|1
5185268|NCT01205776|17901555|P2|Overall Study|Withdrawal by Subject|34
5185269|NCT01205776|17901556|P1|Overall Study|Withdrawal by Subject|11
5185270|NCT01205776|17901555|P2|Overall Study|Lost to Follow-up|61
5185271|NCT01205776|17901556|P1|Overall Study|Lost to Follow-up|53
5185272|NCT01205685|17901744|P1|Overall Study|Withdrawal by Subject|1
5185273|NCT01205685|17901744|P1|Overall Study|Disease Progression|10
5185274|NCT01205581|17901764|P6|Overall Study|Withdrawal by Subject|0
5185275|NCT01205581|17901765|P5|Overall Study|Withdrawal by Subject|0
5185276|NCT01205581|17901766|P4|Overall Study|Withdrawal by Subject|0
5185277|NCT01205581|17901767|P3|Overall Study|Withdrawal by Subject|0
5185278|NCT01205581|17901768|P2|Overall Study|Withdrawal by Subject|0
5185279|NCT01205581|17901769|P1|Overall Study|Withdrawal by Subject|1
5185280|NCT01205529|17901839|P1|Overall Study|No longer met criteria|30
5185281|NCT01205529|17901839|P1|Overall Study|Unstable post op|15
5185282|NCT01205529|17901839|P1|Overall Study|Physician Decision|4
5185283|NCT01205529|17901839|P1|Overall Study|Withdrawal by Subject|2
5185284|NCT01205529|17901839|P1|Overall Study|Procedure Cancelled|4
5185285|NCT01205451|17901862|P2|Overall Study|Withdrawal by Subject|9
5185286|NCT01205451|17901863|P1|Overall Study|Withdrawal by Subject|5
5185287|NCT01205451|17901862|P2|Overall Study|Lost to Follow-up|1
5185288|NCT01205451|17901863|P1|Overall Study|Lost to Follow-up|1
5185289|NCT01205438|17901908|P3|Overall Study|Sponsor Decision|1
5185290|NCT01205438|17901909|P2|Overall Study|Sponsor Decision|1
5185291|NCT01205438|17901910|P1|Overall Study|Sponsor Decision|0
5185292|NCT01205438|17901908|P3|Overall Study|Protocol Violation|4
5185293|NCT01205438|17901909|P2|Overall Study|Protocol Violation|7
5185294|NCT01205438|17901910|P1|Overall Study|Protocol Violation|2
5185295|NCT01205438|17901908|P3|Overall Study|Physician Decision|2
5185296|NCT01205438|17901909|P2|Overall Study|Physician Decision|3
5185297|NCT01205438|17901910|P1|Overall Study|Physician Decision|0
5185298|NCT01205438|17901908|P3|Overall Study|Withdrawal by Subject|19
5185299|NCT01205438|17901909|P2|Overall Study|Withdrawal by Subject|25
5185300|NCT01205438|17901910|P1|Overall Study|Withdrawal by Subject|19
5185301|NCT01205438|17901908|P3|Overall Study|Lost to Follow-up|8
5185302|NCT01205438|17901909|P2|Overall Study|Lost to Follow-up|7
5185303|NCT01205438|17901910|P1|Overall Study|Lost to Follow-up|6
5185304|NCT01205438|17901908|P3|Overall Study|Lack of Efficacy|14
5185305|NCT01205438|17901909|P2|Overall Study|Lack of Efficacy|11
5185306|NCT01205438|17901910|P1|Overall Study|Lack of Efficacy|14
5185307|NCT01205438|17901908|P3|Overall Study|Entry Criteria Not Met|13
5185308|NCT01205438|17901909|P2|Overall Study|Entry Criteria Not Met|15
5185309|NCT01205438|17901910|P1|Overall Study|Entry Criteria Not Met|16
5185310|NCT01205438|17901908|P3|Overall Study|Death|3
5185311|NCT01205438|17901909|P2|Overall Study|Death|1
5185312|NCT01205438|17901910|P1|Overall Study|Death|1
5185313|NCT01205438|17901908|P3|Overall Study|Adverse Event|24
5185314|NCT01205438|17901909|P2|Overall Study|Adverse Event|17
5185315|NCT01205438|17901910|P1|Overall Study|Adverse Event|19
5185316|NCT01205269|17901966|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
5185317|NCT01205269|17901967|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
5185318|NCT01205269|17901968|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
5185319|NCT01205269|17901969|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
5185320|NCT01205269|17901970|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
5185321|NCT01205269|17901971|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
5185322|NCT01205230|17902011|P2|Overall Study|Physician Decision|0
5185323|NCT01205230|17902012|P1|Overall Study|Physician Decision|1
5185324|NCT01205230|17902011|P2|Overall Study|Adverse Event|0
5185325|NCT01205230|17902012|P1|Overall Study|Adverse Event|4
5185326|NCT01205165|17902055|P1|Overall Study|Lost to Follow-up|2
5185327|NCT01205152|17902068|P1|Overall Study|Death|1
5185328|NCT01205126|17902081|P2|Maintenance Phase|Withdrawal by Subject|11
5185329|NCT01205126|17902082|P1|Maintenance Phase|Withdrawal by Subject|8
5185330|NCT01205126|17902081|P2|Maintenance Phase|Lost to Follow-up|5
5185331|NCT01205126|17902082|P1|Maintenance Phase|Lost to Follow-up|5
5185332|NCT01205126|17902081|P2|Maintenance Phase|Other|8
5185334|NCT01205126|17902081|P2|Maintenance Phase|Prohibited drugs used|0
5185335|NCT01205126|17902082|P1|Maintenance Phase|Prohibited drugs used|1
5185336|NCT01205126|17902081|P2|Maintenance Phase|More than the maximum dosage required|5
5185337|NCT01205126|17902082|P1|Maintenance Phase|More than the maximum dosage required|5
5185338|NCT01205126|17902081|P2|Maintenance Phase|Death|4
5185339|NCT01205126|17902082|P1|Maintenance Phase|Death|4
5185340|NCT01205126|17902081|P2|Maintenance Phase|Adverse Event|7
5185341|NCT01205126|17902082|P1|Maintenance Phase|Adverse Event|3
5185342|NCT01205126|17902081|P2|Between Titration & Maintenance Phase|Other|4
5185343|NCT01205126|17902082|P1|Between Titration & Maintenance Phase|Other|0
5185344|NCT01205126|17902081|P2|Titration Phase|Other|6
5185345|NCT01205126|17902082|P1|Titration Phase|Other|8
5185346|NCT01205126|17902081|P2|Titration Phase|More than maximum dosage required|3
5185347|NCT01205126|17902082|P1|Titration Phase|More than maximum dosage required|2
5185348|NCT01205126|17902081|P2|Titration Phase|No stable titration dose|0
5185349|NCT01205126|17902082|P1|Titration Phase|No stable titration dose|1
5185350|NCT01205126|17902081|P2|Titration Phase|Lost to Follow-up|2
5185351|NCT01205126|17902082|P1|Titration Phase|Lost to Follow-up|2
5185352|NCT01205126|17902081|P2|Titration Phase|Withdrawal by Subject|5
5185353|NCT01205126|17902082|P1|Titration Phase|Withdrawal by Subject|5
5185354|NCT01205126|17902081|P2|Titration Phase|Adverse Event|3
5185355|NCT01205126|17902082|P1|Titration Phase|Adverse Event|5
5185356|NCT01205035|17902100|P2|Overall Study|Physician Decision|0
5185357|NCT01205035|17902101|P1|Overall Study|Physician Decision|1
5185358|NCT01205035|17902100|P2|Overall Study|Withdrawal by Subject|0
5185359|NCT01205035|17902101|P1|Overall Study|Withdrawal by Subject|1
5185360|NCT01204918|17902118|P3|Overall Study|Withdrawal by Subject|5
5185361|NCT01204918|17902119|P2|Overall Study|Withdrawal by Subject|10
5185362|NCT01204918|17902120|P1|Overall Study|Withdrawal by Subject|4
5185363|NCT01204775|17902163|P2|Overall Study|Withdrawal by Subject|0
5185364|NCT01204775|17902164|P1|Overall Study|Withdrawal by Subject|1
5185365|NCT01204775|17902163|P2|Overall Study|Poor/non-compliance|1
5185366|NCT01204775|17902164|P1|Overall Study|Poor/non-compliance|0
5185367|NCT01204710|17902189|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
5185368|NCT01204710|17902190|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
5185369|NCT01204710|17902189|P2|Optional Olaratumab Monotherapy|Physician Decision|1
5185370|NCT01204710|17902190|P1|Optional Olaratumab Monotherapy|Physician Decision|0
5185371|NCT01204710|17902189|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
5185372|NCT01204710|17902190|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
5185373|NCT01204710|17902189|P2|Randomization Treatment|Moved and Followed for Survival|1
5185374|NCT01204710|17902190|P1|Randomization Treatment|Moved and Followed for Survival|0
5185375|NCT01204710|17902189|P2|Randomization Treatment|Worsening of General condition|1
5185376|NCT01204710|17902190|P1|Randomization Treatment|Worsening of General condition|0
5185377|NCT01204710|17902189|P2|Randomization Treatment|Sponsor Decision|1
5185378|NCT01204710|17902190|P1|Randomization Treatment|Sponsor Decision|0
5185379|NCT01204710|17902189|P2|Randomization Treatment|Adverse Event|2
5185380|NCT01204710|17902190|P1|Randomization Treatment|Adverse Event|4
5185381|NCT01204710|17902189|P2|Randomization Treatment|Entry criteria not met|1
5185382|NCT01204710|17902190|P1|Randomization Treatment|Entry criteria not met|0
5185383|NCT01204710|17902189|P2|Randomization Treatment|Physician Decision|2
5185384|NCT01204710|17902190|P1|Randomization Treatment|Physician Decision|3
5185385|NCT01204710|17902189|P2|Randomization Treatment|Withdrawal by Subject|5
5185386|NCT01204710|17902190|P1|Randomization Treatment|Withdrawal by Subject|6
5185387|NCT01204710|17902189|P2|Randomization Treatment|Lost to Follow-up|0
5185388|NCT01204710|17902190|P1|Randomization Treatment|Lost to Follow-up|1
5185389|NCT01204697|17902226|P2|Overall Study|Randomized, but not treated|1
5185390|NCT01204697|17902227|P1|Overall Study|Randomized, but not treated|0
5185391|NCT01204697|17902226|P2|Overall Study|Withdrawal by Subject|4
5185392|NCT01204697|17902227|P1|Overall Study|Withdrawal by Subject|2
5185393|NCT01204697|17902226|P2|Overall Study|Lost to Follow-up|4
5185394|NCT01204697|17902227|P1|Overall Study|Lost to Follow-up|3
5185395|NCT01204697|17902226|P2|Overall Study|Death|27
5185396|NCT01204697|17902227|P1|Overall Study|Death|26
5185397|NCT01204671|17902248|P5|Overall Study|Physician Decision|0
5185398|NCT01204671|17902249|P4|Overall Study|Physician Decision|1
5185399|NCT01204671|17902250|P3|Overall Study|Physician Decision|0
5185400|NCT01204671|17902251|P2|Overall Study|Physician Decision|0
5185401|NCT01204671|17902252|P1|Overall Study|Physician Decision|0
5185402|NCT01204671|17902248|P5|Overall Study|Unknown Completion Status|0
5185403|NCT01204671|17902249|P4|Overall Study|Unknown Completion Status|0
5185404|NCT01204671|17902250|P3|Overall Study|Unknown Completion Status|0
5185405|NCT01204671|17902251|P2|Overall Study|Unknown Completion Status|1
5185406|NCT01204671|17902252|P1|Overall Study|Unknown Completion Status|1
5185407|NCT01204671|17902248|P5|Overall Study|Lost to Follow-up|0
5185408|NCT01204671|17902249|P4|Overall Study|Lost to Follow-up|4
5185409|NCT01204671|17902250|P3|Overall Study|Lost to Follow-up|6
5185410|NCT01204671|17902251|P2|Overall Study|Lost to Follow-up|8
5185411|NCT01204671|17902252|P1|Overall Study|Lost to Follow-up|7
5185412|NCT01204671|17902248|P5|Overall Study|Withdrawal by Subject|3
5185413|NCT01204671|17902249|P4|Overall Study|Withdrawal by Subject|5
5185414|NCT01204671|17902250|P3|Overall Study|Withdrawal by Subject|4
5185415|NCT01204671|17902251|P2|Overall Study|Withdrawal by Subject|3
5185416|NCT01204671|17902252|P1|Overall Study|Withdrawal by Subject|2
5185417|NCT01204671|17902248|P5|Overall Study|Adverse Event|1
5185418|NCT01204671|17902249|P4|Overall Study|Adverse Event|3
5185419|NCT01204671|17902250|P3|Overall Study|Adverse Event|3
5185420|NCT01204671|17902251|P2|Overall Study|Adverse Event|3
5185421|NCT01204671|17902252|P1|Overall Study|Adverse Event|4
5185422|NCT01204658|17902314|P4|Primary Phase|Adverse Event|0
5185423|NCT01204658|17902315|P3|Primary Phase|Adverse Event|1
5185424|NCT01204658|17902316|P2|Primary Phase|Adverse Event|0
5185425|NCT01204658|17902317|P1|Primary Phase|Adverse Event|0
5185426|NCT01204398|17902435|P1|Overall Study|Adverse Event|1
5185427|NCT01204294|17902452|P7|Overall Study|Other (house moving)|0
5185428|NCT01204294|17902453|P6|Overall Study|Other (house moving)|0
5185429|NCT01204294|17902454|P5|Overall Study|Other (house moving)|0
5185430|NCT01204294|17902455|P4|Overall Study|Other (house moving)|0
5185431|NCT01204294|17902456|P3|Overall Study|Other (house moving)|1
5185432|NCT01204294|17902457|P2|Overall Study|Other (house moving)|0
5185433|NCT01204294|17902458|P1|Overall Study|Other (house moving)|0
5185434|NCT01204294|17902452|P7|Overall Study|Lack of Efficacy|0
5185435|NCT01204294|17902453|P6|Overall Study|Lack of Efficacy|0
5185436|NCT01204294|17902454|P5|Overall Study|Lack of Efficacy|0
5185437|NCT01204294|17902455|P4|Overall Study|Lack of Efficacy|2
5185438|NCT01204294|17902456|P3|Overall Study|Lack of Efficacy|0
5185439|NCT01204294|17902457|P2|Overall Study|Lack of Efficacy|0
5185440|NCT01204294|17902458|P1|Overall Study|Lack of Efficacy|0
5185441|NCT01204294|17902452|P7|Overall Study|Withdrawal by Subject|2
5185442|NCT01204294|17902453|P6|Overall Study|Withdrawal by Subject|1
5185443|NCT01204294|17902454|P5|Overall Study|Withdrawal by Subject|1
5185444|NCT01204294|17902455|P4|Overall Study|Withdrawal by Subject|1
5185445|NCT01204294|17902456|P3|Overall Study|Withdrawal by Subject|2
5185446|NCT01204294|17902457|P2|Overall Study|Withdrawal by Subject|2
5185447|NCT01204294|17902458|P1|Overall Study|Withdrawal by Subject|0
5185448|NCT01204294|17902452|P7|Overall Study|Protocol Violation|0
5185449|NCT01204294|17902453|P6|Overall Study|Protocol Violation|0
5185450|NCT01204294|17902454|P5|Overall Study|Protocol Violation|0
5185451|NCT01204294|17902455|P4|Overall Study|Protocol Violation|1
5185452|NCT01204294|17902456|P3|Overall Study|Protocol Violation|2
5185453|NCT01204294|17902457|P2|Overall Study|Protocol Violation|0
5185454|NCT01204294|17902458|P1|Overall Study|Protocol Violation|1
5185455|NCT01204294|17902452|P7|Overall Study|Adverse Event|0
5185456|NCT01204294|17902453|P6|Overall Study|Adverse Event|4
5185457|NCT01204294|17902454|P5|Overall Study|Adverse Event|1
5185458|NCT01204294|17902455|P4|Overall Study|Adverse Event|7
5185459|NCT01204294|17902456|P3|Overall Study|Adverse Event|0
5185460|NCT01204294|17902457|P2|Overall Study|Adverse Event|6
5185461|NCT01204294|17902458|P1|Overall Study|Adverse Event|2
5185462|NCT01203956|17902492|P2|Second Two-week Period|Non-compliant: no evaluable results|6
5185463|NCT01203956|17902493|P1|Second Two-week Period|Non-compliant: no evaluable results|5
5185464|NCT01203930|17902502|P2|Overall Study|Adverse Event|5
5185465|NCT01203930|17902503|P1|Overall Study|Adverse Event|17
5185466|NCT01203930|17902502|P2|Overall Study|Poor tolerance of study drug|1
5185467|NCT01203930|17902503|P1|Overall Study|Poor tolerance of study drug|0
5185468|NCT01203930|17902502|P2|Overall Study|Study Terminated by Sponsor|12
5185469|NCT01203930|17902503|P1|Overall Study|Study Terminated by Sponsor|0
5185470|NCT01203930|17902502|P2|Overall Study|Investigator Request|8
5185471|NCT01203930|17902503|P1|Overall Study|Investigator Request|0
5185472|NCT01203930|17902502|P2|Overall Study|Withdrew Consent|10
5185473|NCT01203930|17902503|P1|Overall Study|Withdrew Consent|1
5185474|NCT01203930|17902502|P2|Overall Study|Death|1
5185475|NCT01203930|17902503|P1|Overall Study|Death|3
5185476|NCT01203930|17902502|P2|Overall Study|Disease Progression|4
5185477|NCT01203930|17902503|P1|Overall Study|Disease Progression|0
5185478|NCT01203917|17902525|P1|Overall Study|Due to EGFR M+I patient|1
5185479|NCT01203917|17902525|P1|Overall Study|Due to objective disease progression|1
5185480|NCT01203917|17902525|P1|Overall Study|Withdrawal by Subject|3
5185481|NCT01203917|17902525|P1|Overall Study|Lost to Follow-up|2
5185482|NCT01203917|17902525|P1|Overall Study|Death|29
5185483|NCT01203878|17902538|P3|Overall Study|Adverse Event|2
5185484|NCT01203878|17902539|P2|Overall Study|Adverse Event|0
5185485|NCT01203878|17902540|P1|Overall Study|Adverse Event|0
5185486|NCT01203878|17902538|P3|Overall Study|Withdrawal by Subject|1
5185487|NCT01203878|17902539|P2|Overall Study|Withdrawal by Subject|0
5185488|NCT01203878|17902540|P1|Overall Study|Withdrawal by Subject|0
5185489|NCT01203852|17902551|P1|Washout 2 Weeks|Physician Decision|46
5185490|NCT01203852|17902551|P1|Metoprolol 8 Weeks|Physician Decision|470
5185491|NCT01203787|17902569|P2|Overall Study|Adverse Event|15
5185492|NCT01203787|17902570|P1|Overall Study|Adverse Event|11
5185493|NCT01203787|17902569|P2|Overall Study|Lost to Follow-up|0
5185494|NCT01203787|17902570|P1|Overall Study|Lost to Follow-up|2
5185495|NCT01203787|17902569|P2|Overall Study|Withdrawal by Subject|2
5185496|NCT01203787|17902570|P1|Overall Study|Withdrawal by Subject|6
5185497|NCT01203787|17902569|P2|Overall Study|Death|10
5185498|NCT01203787|17902570|P1|Overall Study|Death|12
5185499|NCT01203098|17902641|P3|Overall Study|Withdrawal by Subject|3
5185500|NCT01203098|17902642|P2|Overall Study|Withdrawal by Subject|1
5185501|NCT01203098|17902643|P1|Overall Study|Withdrawal by Subject|1
5185502|NCT01203098|17902641|P3|Overall Study|Physician Decision|0
5185503|NCT01203098|17902642|P2|Overall Study|Physician Decision|2
5185504|NCT01203098|17902643|P1|Overall Study|Physician Decision|2
5185505|NCT01203098|17902641|P3|Overall Study|Lost to Follow-up|1
5185506|NCT01203098|17902642|P2|Overall Study|Lost to Follow-up|0
5185507|NCT01203098|17902643|P1|Overall Study|Lost to Follow-up|0
5185508|NCT01203098|17902641|P3|Overall Study|Adverse Event|7
5185509|NCT01203098|17902642|P2|Overall Study|Adverse Event|1
5185510|NCT01203098|17902643|P1|Overall Study|Adverse Event|3
5185511|NCT01203072|17902659|P5|Overall Study|Withdrawal by Subject|3
5185512|NCT01203072|17902660|P4|Overall Study|Withdrawal by Subject|2
5185513|NCT01203072|17902661|P3|Overall Study|Withdrawal by Subject|1
5185514|NCT01203072|17902662|P2|Overall Study|Withdrawal by Subject|2
5185515|NCT01203072|17902663|P1|Overall Study|Withdrawal by Subject|2
5185516|NCT01203072|17902659|P5|Overall Study|Protocol Violation|1
5185517|NCT01203072|17902660|P4|Overall Study|Protocol Violation|0
5185518|NCT01203072|17902661|P3|Overall Study|Protocol Violation|0
5185519|NCT01203072|17902662|P2|Overall Study|Protocol Violation|0
5185520|NCT01203072|17902663|P1|Overall Study|Protocol Violation|2
5185521|NCT01203072|17902659|P5|Overall Study|Lost to Follow-up|0
5185522|NCT01203072|17902660|P4|Overall Study|Lost to Follow-up|0
5185523|NCT01203072|17902661|P3|Overall Study|Lost to Follow-up|0
5185524|NCT01203072|17902662|P2|Overall Study|Lost to Follow-up|1
5185525|NCT01203072|17902663|P1|Overall Study|Lost to Follow-up|0
5185526|NCT01203072|17902659|P5|Overall Study|Lack of Efficacy|0
5185527|NCT01203072|17902660|P4|Overall Study|Lack of Efficacy|0
5185528|NCT01203072|17902661|P3|Overall Study|Lack of Efficacy|0
5185529|NCT01203072|17902662|P2|Overall Study|Lack of Efficacy|0
5185530|NCT01203072|17902663|P1|Overall Study|Lack of Efficacy|1
5185531|NCT01203072|17902659|P5|Overall Study|Adverse Event|2
5185532|NCT01203072|17902660|P4|Overall Study|Adverse Event|4
5185533|NCT01203072|17902661|P3|Overall Study|Adverse Event|2
5185534|NCT01203072|17902662|P2|Overall Study|Adverse Event|3
5185535|NCT01203072|17902663|P1|Overall Study|Adverse Event|5
5185536|NCT01202955|17902698|P2|Period 1: 10 Days|Withdrawal by Subject|2
5185537|NCT01202955|17902699|P1|Period 1: 10 Days|Withdrawal by Subject|0
5185538|NCT01202903|17902711|P2|Overall Study|Withdrawal by Subject|4
5185539|NCT01202903|17902712|P1|Overall Study|Withdrawal by Subject|4
5185540|NCT01202903|17902711|P2|Overall Study|Adverse Event|3
5185541|NCT01202903|17902712|P1|Overall Study|Adverse Event|3
5185542|NCT01202903|17902711|P2|Overall Study|Lack of Efficacy|3
5185543|NCT01202903|17902712|P1|Overall Study|Lack of Efficacy|1
5185544|NCT01202903|17902711|P2|Overall Study|Lost to Follow-up|1
5185545|NCT01202903|17902712|P1|Overall Study|Lost to Follow-up|1
5185546|NCT01202903|17902711|P2|Overall Study|Death|0
5185547|NCT01202903|17902712|P1|Overall Study|Death|1
5185548|NCT01202903|17902711|P2|Overall Study|Protocol Violation|1
5185549|NCT01202903|17902712|P1|Overall Study|Protocol Violation|0
5185550|NCT01202903|17902711|P2|Overall Study|Administrative Probelms|4
5185551|NCT01202903|17902712|P1|Overall Study|Administrative Probelms|1
5185552|NCT01202877|17902739|P3|Overall Study|Death|1
5185553|NCT01202877|17902740|P2|Overall Study|Death|0
5185554|NCT01202877|17902741|P1|Overall Study|Death|0
5185555|NCT01202877|17902739|P3|Overall Study|Withdrawal by Subject|1
5185556|NCT01202877|17902740|P2|Overall Study|Withdrawal by Subject|0
5185557|NCT01202877|17902741|P1|Overall Study|Withdrawal by Subject|0
5185558|NCT01202877|17902739|P3|Overall Study|Adverse Event|2
5185559|NCT01202877|17902740|P2|Overall Study|Adverse Event|0
5185560|NCT01202877|17902741|P1|Overall Study|Adverse Event|0
5185561|NCT01202877|17902739|P3|Overall Study|Disease Progression|2
5185562|NCT01202877|17902740|P2|Overall Study|Disease Progression|1
5185563|NCT01202877|17902741|P1|Overall Study|Disease Progression|0
5185564|NCT01202773|17902755|P3|Overall Study|Sponsor Decision|23
5185565|NCT01202773|17902756|P2|Overall Study|Sponsor Decision|20
5185566|NCT01202773|17902757|P1|Overall Study|Sponsor Decision|19
5185567|NCT01202773|17902755|P3|Overall Study|Protocol Violation|10
5185568|NCT01202773|17902756|P2|Overall Study|Protocol Violation|6
5185569|NCT01202773|17902757|P1|Overall Study|Protocol Violation|11
5185570|NCT01202773|17902755|P3|Overall Study|Physician Decision|0
5185571|NCT01202773|17902756|P2|Overall Study|Physician Decision|0
5185572|NCT01202773|17902757|P1|Overall Study|Physician Decision|2
5185573|NCT01202773|17902755|P3|Overall Study|Withdrawal by Subject|5
5185574|NCT01202773|17902756|P2|Overall Study|Withdrawal by Subject|6
5185575|NCT01202773|17902757|P1|Overall Study|Withdrawal by Subject|13
5185576|NCT01202773|17902755|P3|Overall Study|Lost to Follow-up|2
5185577|NCT01202773|17902756|P2|Overall Study|Lost to Follow-up|2
5185578|NCT01202773|17902757|P1|Overall Study|Lost to Follow-up|1
5185579|NCT01202773|17902755|P3|Overall Study|Entry Criteria Not Met|1
5185580|NCT01202773|17902756|P2|Overall Study|Entry Criteria Not Met|0
5185581|NCT01202773|17902757|P1|Overall Study|Entry Criteria Not Met|2
5185582|NCT01202773|17902755|P3|Overall Study|Lack of Efficacy|9
5185583|NCT01202773|17902756|P2|Overall Study|Lack of Efficacy|4
5185584|NCT01202773|17902757|P1|Overall Study|Lack of Efficacy|5
5185585|NCT01202773|17902755|P3|Overall Study|Adverse Event|5
5185586|NCT01202773|17902756|P2|Overall Study|Adverse Event|5
5185587|NCT01202773|17902757|P1|Overall Study|Adverse Event|4
5185588|NCT01202760|17902834|P3|Overall Study|Sponsor Decision|0
5185589|NCT01202760|17902835|P2|Overall Study|Sponsor Decision|4
5185590|NCT01202760|17902836|P1|Overall Study|Sponsor Decision|4
5185591|NCT01202760|17902834|P3|Overall Study|Protocol Violation|2
5185592|NCT01202760|17902835|P2|Overall Study|Protocol Violation|5
5185593|NCT01202760|17902836|P1|Overall Study|Protocol Violation|7
5185594|NCT01202760|17902834|P3|Overall Study|Physician Decision|0
5185595|NCT01202760|17902835|P2|Overall Study|Physician Decision|1
5185596|NCT01202760|17902836|P1|Overall Study|Physician Decision|0
5185597|NCT01202760|17902834|P3|Overall Study|Withdrawal by Subject|14
5185598|NCT01202760|17902835|P2|Overall Study|Withdrawal by Subject|18
5185599|NCT01202760|17902836|P1|Overall Study|Withdrawal by Subject|17
5185600|NCT01202760|17902834|P3|Overall Study|Parent / Caregiver Decision|0
5185601|NCT01202760|17902835|P2|Overall Study|Parent / Caregiver Decision|1
5185602|NCT01202760|17902836|P1|Overall Study|Parent / Caregiver Decision|0
5185603|NCT01202760|17902834|P3|Overall Study|Lost to Follow-up|1
5185604|NCT01202760|17902835|P2|Overall Study|Lost to Follow-up|2
5185605|NCT01202760|17902836|P1|Overall Study|Lost to Follow-up|0
5185606|NCT01202760|17902834|P3|Overall Study|Lack of Efficacy|7
5185607|NCT01202760|17902835|P2|Overall Study|Lack of Efficacy|8
5185608|NCT01202760|17902836|P1|Overall Study|Lack of Efficacy|6
5185609|NCT01202760|17902834|P3|Overall Study|Death|0
5185610|NCT01202760|17902835|P2|Overall Study|Death|1
5185611|NCT01202760|17902836|P1|Overall Study|Death|2
5185612|NCT01202760|17902834|P3|Overall Study|Adverse Event|10
5185613|NCT01202760|17902835|P2|Overall Study|Adverse Event|9
5185614|NCT01202760|17902836|P1|Overall Study|Adverse Event|11
5185615|NCT01202760|17902834|P3|Overall Study|Entry Criteria Not Met|1
5185616|NCT01202760|17902835|P2|Overall Study|Entry Criteria Not Met|3
5185617|NCT01202760|17902836|P1|Overall Study|Entry Criteria Not Met|0
5185618|NCT01202747|17902904|P1|Overall Study|Withdrawal by Subject|1
5185619|NCT01202591|17902957|P6|Overall Study|Objective Disease Progression|0
5185620|NCT01202591|17902958|P5|Overall Study|Objective Disease Progression|2
5185621|NCT01202591|17902959|P4|Overall Study|Objective Disease Progression|0
5185622|NCT01202591|17902960|P3|Overall Study|Objective Disease Progression|0
5185623|NCT01202591|17902961|P2|Overall Study|Objective Disease Progression|0
5185624|NCT01202591|17902962|P1|Overall Study|Objective Disease Progression|0
5185625|NCT01202591|17902957|P6|Overall Study|Withdrawal by Subject|1
5185626|NCT01202591|17902958|P5|Overall Study|Withdrawal by Subject|2
5185627|NCT01202591|17902959|P4|Overall Study|Withdrawal by Subject|0
5185628|NCT01202591|17902960|P3|Overall Study|Withdrawal by Subject|0
5185629|NCT01202591|17902961|P2|Overall Study|Withdrawal by Subject|0
5185630|NCT01202591|17902962|P1|Overall Study|Withdrawal by Subject|0
5185631|NCT01202591|17902957|P6|Overall Study|Other reason as per investigator|3
5185632|NCT01202591|17902958|P5|Overall Study|Other reason as per investigator|1
5185633|NCT01202591|17902959|P4|Overall Study|Other reason as per investigator|3
5185634|NCT01202591|17902960|P3|Overall Study|Other reason as per investigator|7
5185635|NCT01202591|17902961|P2|Overall Study|Other reason as per investigator|4
5185636|NCT01202591|17902962|P1|Overall Study|Other reason as per investigator|3
5185637|NCT01202591|17902957|P6|Overall Study|Adverse Event|0
5185638|NCT01202591|17902958|P5|Overall Study|Adverse Event|0
5185639|NCT01202591|17902959|P4|Overall Study|Adverse Event|4
5185640|NCT01202591|17902960|P3|Overall Study|Adverse Event|4
5185641|NCT01202591|17902961|P2|Overall Study|Adverse Event|1
5185642|NCT01202591|17902962|P1|Overall Study|Adverse Event|2
5185643|NCT01202409|17903006|P1|Overall Study|Ineligible - KRAS mutants|7
5185644|NCT01202409|17903006|P1|Overall Study|Adverse Event|1
5185645|NCT01202279|17903013|P2|Overall Study|study compliance|2
5185646|NCT01202279|17903014|P1|Overall Study|study compliance|5
5185647|NCT01202279|17903013|P2|Overall Study|Protocol Violation|1
5185648|NCT01202279|17903014|P1|Overall Study|Protocol Violation|1
5185649|NCT01202279|17903013|P2|Overall Study|Lost to Follow-up|7
5185650|NCT01202279|17903014|P1|Overall Study|Lost to Follow-up|10
5185651|NCT01202279|17903013|P2|Overall Study|Physician Decision|1
5185652|NCT01202279|17903014|P1|Overall Study|Physician Decision|0
5185653|NCT01202279|17903013|P2|Overall Study|Withdrawal by Subject|10
5185654|NCT01202279|17903014|P1|Overall Study|Withdrawal by Subject|13
5185655|NCT01202279|17903013|P2|Overall Study|Adverse Event|6
5185656|NCT01202279|17903014|P1|Overall Study|Adverse Event|8
5185657|NCT01202227|17903066|P1|Overall Study|Lack of Efficacy|1
5185658|NCT01202227|17903066|P1|Overall Study|Withdrawal by Subject|2
5185659|NCT01202227|17903066|P1|Overall Study|Adverse Event|16
5185660|NCT01202188|17903090|P5|Overall Study|Abnormal test procedure result (s)|0
5185661|NCT01202188|17903091|P4|Overall Study|Abnormal test procedure result (s)|0
5185662|NCT01202188|17903092|P3|Overall Study|Abnormal test procedure result (s)|2
5185663|NCT01202188|17903093|P2|Overall Study|Abnormal test procedure result (s)|0
5185664|NCT01202188|17903094|P1|Overall Study|Abnormal test procedure result (s)|0
5185665|NCT01202188|17903090|P5|Overall Study|Death|0
5185666|NCT01202188|17903091|P4|Overall Study|Death|1
5185667|NCT01202188|17903092|P3|Overall Study|Death|1
5185668|NCT01202188|17903093|P2|Overall Study|Death|1
5185669|NCT01202188|17903094|P1|Overall Study|Death|1
5185670|NCT01202188|17903090|P5|Overall Study|Lost to Follow-up|1
5185671|NCT01202188|17903091|P4|Overall Study|Lost to Follow-up|4
5185672|NCT01202188|17903092|P3|Overall Study|Lost to Follow-up|0
5185673|NCT01202188|17903093|P2|Overall Study|Lost to Follow-up|1
5185674|NCT01202188|17903094|P1|Overall Study|Lost to Follow-up|1
5185675|NCT01202188|17903090|P5|Overall Study|Unsatisfactory therapeutic effect|8
5185676|NCT01202188|17903091|P4|Overall Study|Unsatisfactory therapeutic effect|5
5185677|NCT01202188|17903092|P3|Overall Study|Unsatisfactory therapeutic effect|2
5185678|NCT01202188|17903093|P2|Overall Study|Unsatisfactory therapeutic effect|8
5185679|NCT01202188|17903094|P1|Overall Study|Unsatisfactory therapeutic effect|2
5185680|NCT01202188|17903090|P5|Overall Study|Administrative problems|2
5185681|NCT01202188|17903091|P4|Overall Study|Administrative problems|1
5185682|NCT01202188|17903092|P3|Overall Study|Administrative problems|1
5185683|NCT01202188|17903093|P2|Overall Study|Administrative problems|2
5185684|NCT01202188|17903094|P1|Overall Study|Administrative problems|3
5185685|NCT01202188|17903090|P5|Overall Study|Adverse Event|10
5185686|NCT01202188|17903091|P4|Overall Study|Adverse Event|10
5185687|NCT01202188|17903092|P3|Overall Study|Adverse Event|13
5185688|NCT01202188|17903093|P2|Overall Study|Adverse Event|23
5185689|NCT01202188|17903094|P1|Overall Study|Adverse Event|5
5185690|NCT01202188|17903090|P5|Overall Study|Subject withdrew consent|13
5185691|NCT01202188|17903091|P4|Overall Study|Subject withdrew consent|11
5185692|NCT01202188|17903092|P3|Overall Study|Subject withdrew consent|22
5185693|NCT01202188|17903093|P2|Overall Study|Subject withdrew consent|13
5185694|NCT01202188|17903094|P1|Overall Study|Subject withdrew consent|12
5185695|NCT01202188|17903090|P5|Overall Study|Protocol deviation|11
5185696|NCT01202188|17903091|P4|Overall Study|Protocol deviation|10
5185697|NCT01202188|17903092|P3|Overall Study|Protocol deviation|12
5185698|NCT01202188|17903093|P2|Overall Study|Protocol deviation|8
5185699|NCT01202188|17903094|P1|Overall Study|Protocol deviation|14
5185700|NCT01202175|17903202|P1|Overall Study|Adverse Event|2
5185701|NCT01202175|17903202|P1|Overall Study|Withdrawal by Subject|1
5185702|NCT01202175|17903202|P1|Overall Study|Lost to Follow-up|2
5185703|NCT01201967|17903270|P2|Overall Study|Lost to Follow-up|5
5185704|NCT01201967|17903271|P1|Overall Study|Lost to Follow-up|6
5185705|NCT01201915|17903296|P3|Overall Study|Target Lesion Progression|0
5185706|NCT01201915|17903297|P2|Overall Study|Target Lesion Progression|3
5185707|NCT01201915|17903298|P1|Overall Study|Target Lesion Progression|0
5185708|NCT01201915|17903296|P3|Overall Study|Subject Decision|5
5185709|NCT01201915|17903297|P2|Overall Study|Subject Decision|3
5185710|NCT01201915|17903298|P1|Overall Study|Subject Decision|3
5185711|NCT01201915|17903296|P3|Overall Study|Physician Decision|0
5185712|NCT01201915|17903297|P2|Overall Study|Physician Decision|0
5185713|NCT01201915|17903298|P1|Overall Study|Physician Decision|3
5185714|NCT01201915|17903296|P3|Overall Study|Lost to Follow-up|0
5185715|NCT01201915|17903297|P2|Overall Study|Lost to Follow-up|4
5185716|NCT01201915|17903298|P1|Overall Study|Lost to Follow-up|0
5185717|NCT01201915|17903296|P3|Overall Study|Adverse Event|1
5185718|NCT01201915|17903297|P2|Overall Study|Adverse Event|1
5185719|NCT01201915|17903298|P1|Overall Study|Adverse Event|2
5185720|NCT01201811|17903309|P1|Overall Study|Physician Decision|1
5185721|NCT01201811|17903309|P1|Overall Study|Treatment Failure|2
5185722|NCT01201811|17903309|P1|Overall Study|Death|4
5185723|NCT01201811|17903309|P1|Overall Study|Withdrawal by Subject|3
5185724|NCT01201811|17903309|P1|Overall Study|Disease progression|3
5185725|NCT01201811|17903309|P1|Overall Study|Adverse Event|6
5185726|NCT01201798|17903331|P2|Overall Study|Treatment Failure|8
5185727|NCT01201798|17903332|P1|Overall Study|Treatment Failure|1
5185728|NCT01201798|17903331|P2|Overall Study|Protocol Violation|1
5185729|NCT01201798|17903332|P1|Overall Study|Protocol Violation|1
5185730|NCT01201798|17903331|P2|Overall Study|Noncompliance|0
5185731|NCT01201798|17903332|P1|Overall Study|Noncompliance|1
5185732|NCT01201798|17903331|P2|Overall Study|Decision Unrelated to an Adverse Event|1
5185733|NCT01201798|17903332|P1|Overall Study|Decision Unrelated to an Adverse Event|1
5185734|NCT01201798|17903331|P2|Overall Study|Lost to Follow-up|5
5185735|NCT01201798|17903332|P1|Overall Study|Lost to Follow-up|3
5185736|NCT01201798|17903331|P2|Overall Study|Adverse Event|0
5185737|NCT01201798|17903332|P1|Overall Study|Adverse Event|2
5185738|NCT01201785|17903356|P1|Overall Study|Lost to Follow-up|16
5185739|NCT01201759|17903373|P2|Visit 4 Crossover|Lost to Follow-up|1
5185740|NCT01201759|17903374|P1|Visit 4 Crossover|Lost to Follow-up|0
5185741|NCT01201759|17903373|P2|Visit 3 - Washout|Lost to Follow-up|0
5185742|NCT01201759|17903374|P1|Visit 3 - Washout|Lost to Follow-up|1
5185743|NCT01201759|17903373|P2|Visit 3 - Washout|Adverse Event|3
5185744|NCT01201759|17903374|P1|Visit 3 - Washout|Adverse Event|0
5185745|NCT01201759|17903373|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
5185746|NCT01201759|17903374|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
5185747|NCT01201356|17903403|P1|Overall Study|Protocol Violation|12
5185748|NCT01201356|17903403|P1|Overall Study|Death|16
5185749|NCT01201356|17903403|P1|Overall Study|administrative problems|74
5185750|NCT01201356|17903403|P1|Overall Study|Lost to Follow-up|50
5185751|NCT01201356|17903403|P1|Overall Study|Withdrawal by Subject|144
5185752|NCT01201356|17903403|P1|Overall Study|Condition no longer requires study drug|12
5185753|NCT01201356|17903403|P1|Overall Study|Unsatisfactory therapeutic effect|112
5185754|NCT01201356|17903403|P1|Overall Study|Abnormal test procedure result(s)|3
5185755|NCT01201356|17903403|P1|Overall Study|Abnormal laboratory value(s)|51
5185756|NCT01201356|17903403|P1|Overall Study|Adverse Event|170
5185757|NCT01201343|17903417|P1|Overall Study|Randomized, not treated|3
5185758|NCT01201343|17903417|P1|Overall Study|Participant wrongly included in trial|1
5185759|NCT01201343|17903417|P1|Overall Study|Lack of Efficacy|2
5185760|NCT01201343|17903417|P1|Overall Study|Lost to Follow-up|2
5185761|NCT01201343|17903417|P1|Overall Study|Withdrawal by Subject|5
5185762|NCT01201343|17903417|P1|Overall Study|Adverse Event|6
5185763|NCT01201317|17903431|P3|Overall Study|Safety, possible history of tuberculosis|1
5185764|NCT01201317|17903432|P2|Overall Study|Safety, possible history of tuberculosis|0
5185765|NCT01201317|17903433|P1|Overall Study|Safety, possible history of tuberculosis|0
5185766|NCT01201317|17903431|P3|Overall Study|Lack of Efficacy|0
5185767|NCT01201317|17903432|P2|Overall Study|Lack of Efficacy|0
5185768|NCT01201317|17903433|P1|Overall Study|Lack of Efficacy|1
5185769|NCT01201317|17903431|P3|Overall Study|Decrease in renal function|0
5185770|NCT01201317|17903432|P2|Overall Study|Decrease in renal function|1
5185771|NCT01201317|17903433|P1|Overall Study|Decrease in renal function|0
5185772|NCT01201317|17903431|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
5185773|NCT01201317|17903432|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
5185774|NCT01201317|17903433|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
5185775|NCT01201317|17903431|P3|Overall Study|Study-specific withdrawal criteria|1
5185776|NCT01201317|17903432|P2|Overall Study|Study-specific withdrawal criteria|0
5185777|NCT01201317|17903433|P1|Overall Study|Study-specific withdrawal criteria|0
5185778|NCT01201317|17903431|P3|Overall Study|Death|0
5185779|NCT01201317|17903432|P2|Overall Study|Death|1
5185780|NCT01201317|17903433|P1|Overall Study|Death|0
5185781|NCT01201317|17903431|P3|Overall Study|Protocol Violation|1
5185782|NCT01201317|17903432|P2|Overall Study|Protocol Violation|1
5185783|NCT01201317|17903433|P1|Overall Study|Protocol Violation|0
5185784|NCT01201317|17903431|P3|Overall Study|Screen failure|0
5185785|NCT01201317|17903432|P2|Overall Study|Screen failure|1
5185786|NCT01201317|17903433|P1|Overall Study|Screen failure|1
5185787|NCT01201317|17903431|P3|Overall Study|Adverse Event|2
5185788|NCT01201317|17903432|P2|Overall Study|Adverse Event|2
5185789|NCT01201317|17903433|P1|Overall Study|Adverse Event|2
5185790|NCT01201317|17903431|P3|Overall Study|Withdrawal by Subject|3
5185791|NCT01201317|17903432|P2|Overall Study|Withdrawal by Subject|0
5185792|NCT01201317|17903433|P1|Overall Study|Withdrawal by Subject|5
5185793|NCT01201265|17903453|P1|Overall Study|Disease Progression|4
5185794|NCT01201265|17903453|P1|Overall Study|Withdrawal by Subject|7
5185795|NCT01201265|17903453|P1|Overall Study|Lost to Follow-up|10
5185796|NCT01201265|17903453|P1|Overall Study|Insufficient Therapeutic Response|3
5185797|NCT01201265|17903453|P1|Overall Study|Death|14
5185798|NCT01200992|17903500|P2|Overall Study|Randomized but not treated|0
5185799|NCT01200992|17903501|P1|Overall Study|Randomized but not treated|2
5185800|NCT01200992|17903500|P2|Overall Study|Study terminated early|41
5185801|NCT01200992|17903501|P1|Overall Study|Study terminated early|35
5185802|NCT01200810|17903532|P2|Overall Study|Sponsor stopped making study drug|3
5185803|NCT01200810|17903533|P1|Overall Study|Sponsor stopped making study drug|3
5185804|NCT01200810|17903532|P2|Overall Study|Withdrawal by Subject|2
5185805|NCT01200810|17903533|P1|Overall Study|Withdrawal by Subject|1
5185806|NCT01200810|17903532|P2|Overall Study|Physician Decision|0
5185807|NCT01200810|17903533|P1|Overall Study|Physician Decision|1
5185808|NCT01200797|17903553|P1|Overall Study|Disease Progression|13
5185809|NCT01200797|17903553|P1|Overall Study|Adverse Event|4
5185810|NCT01200797|17903553|P1|Overall Study|symptomatic deterioration|2
5185811|NCT01200758|17903563|P4|Stage 2|Death|5
5185812|NCT01200758|17903564|P3|Stage 2|Death|3
5185813|NCT01200758|17903565|P2|Stage 2|Death|0
5185814|NCT01200758|17903566|P1|Stage 2|Death|0
5185815|NCT01200758|17903563|P4|Stage 2|Protocol Violation|4
5185816|NCT01200758|17903564|P3|Stage 2|Protocol Violation|1
5185817|NCT01200758|17903565|P2|Stage 2|Protocol Violation|0
5185818|NCT01200758|17903566|P1|Stage 2|Protocol Violation|0
5185819|NCT01200758|17903563|P4|Stage 2|Lost to Follow-up|1
5185820|NCT01200758|17903564|P3|Stage 2|Lost to Follow-up|3
5185821|NCT01200758|17903565|P2|Stage 2|Lost to Follow-up|0
5185822|NCT01200758|17903566|P1|Stage 2|Lost to Follow-up|0
5185823|NCT01200758|17903563|P4|Stage 2|Withdrawal by Subject|1
5185824|NCT01200758|17903564|P3|Stage 2|Withdrawal by Subject|4
5185825|NCT01200758|17903565|P2|Stage 2|Withdrawal by Subject|0
5185826|NCT01200758|17903566|P1|Stage 2|Withdrawal by Subject|0
5185827|NCT01200758|17903563|P4|Stage 2|Adverse Event|9
5185828|NCT01200758|17903564|P3|Stage 2|Adverse Event|5
5185829|NCT01200758|17903565|P2|Stage 2|Adverse Event|0
5185830|NCT01200758|17903566|P1|Stage 2|Adverse Event|0
5185831|NCT01200758|17903563|P4|Stage 2|Physician Decision|7
5185832|NCT01200758|17903564|P3|Stage 2|Physician Decision|5
5185833|NCT01200758|17903565|P2|Stage 2|Physician Decision|0
5185834|NCT01200758|17903566|P1|Stage 2|Physician Decision|0
5185835|NCT01200758|17903563|P4|Stage 2|Lack of Efficacy|2
5185836|NCT01200758|17903564|P3|Stage 2|Lack of Efficacy|4
5185837|NCT01200758|17903565|P2|Stage 2|Lack of Efficacy|0
5185838|NCT01200758|17903566|P1|Stage 2|Lack of Efficacy|0
5185839|NCT01200758|17903563|P4|Stage 2|Disease Progression|21
5185840|NCT01200758|17903564|P3|Stage 2|Disease Progression|16
5185841|NCT01200758|17903565|P2|Stage 2|Disease Progression|0
5185842|NCT01200758|17903566|P1|Stage 2|Disease Progression|0
5185843|NCT01200758|17903563|P4|Stage I|Disease Progression|0
5185844|NCT01200758|17903564|P3|Stage I|Disease Progression|0
5185845|NCT01200758|17903565|P2|Stage I|Disease Progression|7
5185846|NCT01200758|17903566|P1|Stage I|Disease Progression|9
5185847|NCT01200758|17903563|P4|Stage I|Withdrawal by Subject|0
5185848|NCT01200758|17903564|P3|Stage I|Withdrawal by Subject|0
5185849|NCT01200758|17903565|P2|Stage I|Withdrawal by Subject|2
5185850|NCT01200758|17903566|P1|Stage I|Withdrawal by Subject|1
5185851|NCT01200758|17903563|P4|Stage I|Adverse Event|0
5185852|NCT01200758|17903564|P3|Stage I|Adverse Event|0
5185853|NCT01200758|17903565|P2|Stage I|Adverse Event|5
5185854|NCT01200758|17903566|P1|Stage I|Adverse Event|5
5185855|NCT01200758|17903563|P4|Stage I|Lack of Efficacy|0
5185856|NCT01200758|17903564|P3|Stage I|Lack of Efficacy|0
5185857|NCT01200758|17903565|P2|Stage I|Lack of Efficacy|1
5185858|NCT01200758|17903566|P1|Stage I|Lack of Efficacy|2
5185859|NCT01200758|17903563|P4|Stage I|Physician Decision|0
5185860|NCT01200758|17903564|P3|Stage I|Physician Decision|0
5185861|NCT01200758|17903565|P2|Stage I|Physician Decision|1
5185862|NCT01200758|17903566|P1|Stage I|Physician Decision|1
5185863|NCT01200758|17903563|P4|Stage I|Death|0
5185864|NCT01200758|17903564|P3|Stage I|Death|0
5185865|NCT01200758|17903565|P2|Stage I|Death|1
5185866|NCT01200758|17903566|P1|Stage I|Death|0
5185867|NCT01200589|17903639|P2|Overall Study|Study terminated|172
5185868|NCT01200589|17903640|P1|Overall Study|Study terminated|170
5185869|NCT01200589|17903639|P2|Overall Study|Lost to Follow-up|4
5185870|NCT01200589|17903640|P1|Overall Study|Lost to Follow-up|5
5185871|NCT01200589|17903639|P2|Overall Study|Physician Decision|2
5185872|NCT01200589|17903640|P1|Overall Study|Physician Decision|2
5185873|NCT01200589|17903639|P2|Overall Study|Withdrawal by Subject|11
5185874|NCT01200589|17903640|P1|Overall Study|Withdrawal by Subject|13
5185875|NCT01200524|17903667|P3|Overall Study|Non availability of study nurse|1
5185876|NCT01200524|17903668|P2|Overall Study|Non availability of study nurse|0
5185877|NCT01200524|17903669|P1|Overall Study|Non availability of study nurse|0
5185878|NCT01200524|17903667|P3|Overall Study|Adverse Event|0
5185879|NCT01200524|17903668|P2|Overall Study|Adverse Event|0
5185880|NCT01200524|17903669|P1|Overall Study|Adverse Event|1
5185881|NCT01200524|17903667|P3|Overall Study|Withdrawal by Subject|3
5185882|NCT01200524|17903668|P2|Overall Study|Withdrawal by Subject|1
5185883|NCT01200524|17903669|P1|Overall Study|Withdrawal by Subject|1
5185884|NCT01200511|17903689|P1|Overall Study|Adverse Event|1
5185885|NCT01200511|17903689|P1|Overall Study|Withdrawal by Subject|1
5185886|NCT01200511|17903689|P1|Overall Study|Lost to Follow-up|3
5185887|NCT01200485|17903701|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
5185888|NCT01200485|17903702|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
5185889|NCT01200485|17903703|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
5185890|NCT01200485|17903701|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
5185891|NCT01200485|17903702|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
5185892|NCT01200485|17903703|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
5185893|NCT01200394|17903737|P2|Overall Study|Other|1
5185894|NCT01200394|17903738|P1|Overall Study|Other|0
5185895|NCT01200394|17903737|P2|Overall Study|Withdrawal by Subject|5
5185896|NCT01200394|17903738|P1|Overall Study|Withdrawal by Subject|0
5185897|NCT01200394|17903737|P2|Overall Study|Protocol Violation|3
5185898|NCT01200394|17903738|P1|Overall Study|Protocol Violation|0
5185899|NCT01200394|17903737|P2|Overall Study|Did Not Meet Entrance Criteria|4
5185900|NCT01200394|17903738|P1|Overall Study|Did Not Meet Entrance Criteria|1
5185901|NCT01200394|17903737|P2|Overall Study|Lost to Follow-up|1
5185902|NCT01200394|17903738|P1|Overall Study|Lost to Follow-up|0
5185903|NCT01200394|17903737|P2|Overall Study|Death|0
5185904|NCT01200394|17903738|P1|Overall Study|Death|1
5185905|NCT01200394|17903737|P2|Overall Study|Adverse Event|14
5185906|NCT01200394|17903738|P1|Overall Study|Adverse Event|0
5185907|NCT01200368|17903776|P3|Toddler Dose|Adverse Event|1
5185908|NCT01200368|17903777|P2|Toddler Dose|Adverse Event|3
5185909|NCT01200368|17903778|P1|Toddler Dose|Adverse Event|0
5185910|NCT01200368|17903776|P3|After Infant Series|Other|2
5185911|NCT01200368|17903777|P2|After Infant Series|Other|2
5185912|NCT01200368|17903778|P1|After Infant Series|Other|1
5185913|NCT01200368|17903776|P3|After Infant Series|Lost to Follow-up|0
5185914|NCT01200368|17903777|P2|After Infant Series|Lost to Follow-up|0
5185915|NCT01200368|17903778|P1|After Infant Series|Lost to Follow-up|1
5185916|NCT01200368|17903776|P3|After Infant Series|Withdrawal by Subject|4
5185917|NCT01200368|17903777|P2|After Infant Series|Withdrawal by Subject|8
5185918|NCT01200368|17903778|P1|After Infant Series|Withdrawal by Subject|10
5185919|NCT01200368|17903776|P3|After Infant Series|Adverse Event|3
5185920|NCT01200368|17903777|P2|After Infant Series|Adverse Event|6
5185921|NCT01200368|17903778|P1|After Infant Series|Adverse Event|6
5185922|NCT01200368|17903776|P3|Infant Series|Other|0
5185923|NCT01200368|17903777|P2|Infant Series|Other|0
5185924|NCT01200368|17903778|P1|Infant Series|Other|1
5185925|NCT01200368|17903776|P3|Infant Series|Randomized, not vaccinated|1
5185926|NCT01200368|17903777|P2|Infant Series|Randomized, not vaccinated|1
5185927|NCT01200368|17903778|P1|Infant Series|Randomized, not vaccinated|0
5185928|NCT01200368|17903776|P3|Infant Series|Did not meet entrance criteria|0
5185929|NCT01200368|17903777|P2|Infant Series|Did not meet entrance criteria|1
5185930|NCT01200368|17903778|P1|Infant Series|Did not meet entrance criteria|0
5185931|NCT01200368|17903776|P3|Infant Series|Withdrawal by Subject|2
5185932|NCT01200368|17903777|P2|Infant Series|Withdrawal by Subject|2
5185933|NCT01200368|17903778|P1|Infant Series|Withdrawal by Subject|0
5185934|NCT01200368|17903776|P3|Infant Series|Adverse Event|3
5185935|NCT01200368|17903777|P2|Infant Series|Adverse Event|2
5185936|NCT01200368|17903778|P1|Infant Series|Adverse Event|2
5185937|NCT01200355|17903844|P2|Overall Study|Death|2
5185938|NCT01200355|17903845|P1|Overall Study|Death|7
5185939|NCT01200342|17903859|P1|Overall Study|Disease Progression|1
5185940|NCT01200329|17903864|P1|Overall Study|Progressive disease|1
5185941|NCT01200329|17903864|P1|Overall Study|Lack of financial coverage|2
5185942|NCT01200290|17903869|P1|Post-Treatment Follow-Up Period|Death|2
5185943|NCT01200290|17903869|P1|Treatment Period|Adverse Event|1
5185944|NCT01200238|17903882|P2|Overall Study|Withdrawal by Subject|1
5185945|NCT01200238|17903883|P1|Overall Study|Withdrawal by Subject|0
5185946|NCT01200238|17903882|P2|Overall Study|Progressive Disease|8
5185947|NCT01200238|17903883|P1|Overall Study|Progressive Disease|5
5185948|NCT01200238|17903882|P2|Overall Study|Adverse Event|1
5185949|NCT01200238|17903883|P1|Overall Study|Adverse Event|2
5185950|NCT01200069|17903907|P2|Overall Study|Withdrawal by Subject|1
5185951|NCT01200069|17903908|P1|Overall Study|Withdrawal by Subject|0
5185952|NCT01199939|17904004|P1|Overall Study|Reached a virologic endpoint|4
5185953|NCT01199939|17904004|P1|Overall Study|Lost to Follow-up|2
5185954|NCT01199939|17904004|P1|Overall Study|Protocol Violation|3
5185955|NCT01199939|17904004|P1|Overall Study|Adverse Event|4
5185956|NCT01199861|17904036|P2|Overall Study|Adverse Event|0
5185957|NCT01199861|17904037|P1|Overall Study|Adverse Event|1
5185958|NCT01199861|17904036|P2|Overall Study|Administrative problems|0
5185959|NCT01199861|17904037|P1|Overall Study|Administrative problems|1
5185960|NCT01199822|17904058|P3|Overall Study|Investigator discontinued therapy|0
5185961|NCT01199822|17904059|P2|Overall Study|Investigator discontinued therapy|1
5185962|NCT01199822|17904060|P1|Overall Study|Investigator discontinued therapy|0
5185963|NCT01199731|17904109|P3|Overall Study|Withdrawal by Subject|0
5185964|NCT01199731|17904110|P2|Overall Study|Withdrawal by Subject|0
5185965|NCT01199731|17904111|P1|Overall Study|Withdrawal by Subject|2
5185966|NCT01199731|17904109|P3|Overall Study|Physician Decision|1
5185967|NCT01199731|17904110|P2|Overall Study|Physician Decision|1
5185968|NCT01199731|17904111|P1|Overall Study|Physician Decision|0
5185969|NCT01199731|17904109|P3|Overall Study|Lost to Follow-up|2
5185970|NCT01199731|17904110|P2|Overall Study|Lost to Follow-up|0
5185971|NCT01199731|17904111|P1|Overall Study|Lost to Follow-up|0
5185972|NCT01199731|17904109|P3|Overall Study|Study closed/terminated|7
5185973|NCT01199731|17904110|P2|Overall Study|Study closed/terminated|9
5185974|NCT01199731|17904111|P1|Overall Study|Study closed/terminated|7
5185975|NCT01199731|17904109|P3|Overall Study|Adverse Event|0
5185976|NCT01199731|17904110|P2|Overall Study|Adverse Event|1
5185977|NCT01199731|17904111|P1|Overall Study|Adverse Event|0
5185978|NCT01199705|17904149|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
5185979|NCT01199601|17904181|P2|Overall Study|Insecurity prevented staff interviewing.|9
5185980|NCT01199601|17904182|P1|Overall Study|Insecurity prevented staff interviewing.|7
5185981|NCT01199601|17904181|P2|Overall Study|Withdrawal by Subject|3
5185982|NCT01199601|17904182|P1|Overall Study|Withdrawal by Subject|15
5185983|NCT01199601|17904181|P2|Overall Study|Lost to Follow-up|66
5185984|NCT01199601|17904182|P1|Overall Study|Lost to Follow-up|47
5185985|NCT01199575|17904192|P1|Overall Study|Withdrawal by Subject|5
5185986|NCT01199471|17904197|P1|Overall Study|Physician Decision|1
5185987|NCT01199471|17904197|P1|Overall Study|Withdrawal by Subject|1
5185988|NCT01199471|17904197|P1|Overall Study|Protocol Violation|4
5185989|NCT01199263|17904217|P2|Overall Study|Never Treated|0
5185990|NCT01199263|17904218|P1|Overall Study|Never Treated|6
5185991|NCT01199263|17904217|P2|Overall Study|Ineligible|2
5185992|NCT01199263|17904218|P1|Overall Study|Ineligible|0
5185993|NCT01199198|17904251|P2|Overall Study|Hospice-care transfer|2
5185994|NCT01199198|17904252|P1|Overall Study|Hospice-care transfer|1
5185995|NCT01199198|17904251|P2|Overall Study|ICU Transfer|2
5185996|NCT01199198|17904252|P1|Overall Study|ICU Transfer|1
5185997|NCT01199198|17904251|P2|Overall Study|Withdrawal by Subject|2
5185998|NCT01199198|17904252|P1|Overall Study|Withdrawal by Subject|1
5185999|NCT01199198|17904251|P2|Overall Study|Lost to Follow-up|5
5186000|NCT01199198|17904252|P1|Overall Study|Lost to Follow-up|1
5186001|NCT01199198|17904251|P2|Overall Study|Adverse Event|0
5186002|NCT01199198|17904252|P1|Overall Study|Adverse Event|3
5186003|NCT01199068|17904269|P3|Overall Study|Withdrawal by Subject|1
5186004|NCT01199068|17904270|P2|Overall Study|Withdrawal by Subject|0
5186005|NCT01199068|17904271|P1|Overall Study|Withdrawal by Subject|0
5186006|NCT01199068|17904269|P3|Overall Study|Progressive disease|6
5186007|NCT01199068|17904270|P2|Overall Study|Progressive disease|3
5186008|NCT01199068|17904271|P1|Overall Study|Progressive disease|3
5186009|NCT01199068|17904269|P3|Overall Study|Unacceptable toxicity|2
5186010|NCT01199068|17904270|P2|Overall Study|Unacceptable toxicity|0
5186011|NCT01199068|17904271|P1|Overall Study|Unacceptable toxicity|0
5186012|NCT01199055|17904305|P3|Overall Study|Withdrawal by Subject|1
5186013|NCT01199055|17904306|P2|Overall Study|Withdrawal by Subject|0
5186014|NCT01199055|17904307|P1|Overall Study|Withdrawal by Subject|0
5186015|NCT01199055|17904305|P3|Overall Study|Progressive disease|2
5186016|NCT01199055|17904306|P2|Overall Study|Progressive disease|1
5186017|NCT01199055|17904307|P1|Overall Study|Progressive disease|2
5186018|NCT01199055|17904305|P3|Overall Study|Physician Decision|1
5186019|NCT01199055|17904306|P2|Overall Study|Physician Decision|1
5186020|NCT01199055|17904307|P1|Overall Study|Physician Decision|0
5186021|NCT01199055|17904305|P3|Overall Study|Death|0
5186022|NCT01199055|17904306|P2|Overall Study|Death|1
5186023|NCT01199055|17904307|P1|Overall Study|Death|0
5186024|NCT01199042|17904332|P1|At Home (3 Months)|Lost to Follow-up|1
5186025|NCT01199042|17904332|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
5186026|NCT01199016|17904341|P1|Overall Study|Lost to Follow-up|25
5186027|NCT01199016|17904341|P1|Overall Study|Withdrawal by Subject|21
5186028|NCT01199016|17904341|P1|Overall Study|Other|13
5186029|NCT01199016|17904341|P1|Overall Study|Protocol Violation|9
5186030|NCT01199016|17904341|P1|Overall Study|Entrance criteria|5
5186031|NCT01199016|17904341|P1|Overall Study|No longer meets eligibility criteria|4
5186032|NCT01198977|17904350|P2|Overall Study|Lost to Follow-up|0
5186033|NCT01198977|17904351|P1|Overall Study|Lost to Follow-up|1
5186034|NCT01198873|17904363|P2|Overall Study|Other than above|2
5186035|NCT01198873|17904364|P1|Overall Study|Other than above|4
5186036|NCT01198873|17904363|P2|Overall Study|Study closure|23
5186037|NCT01198873|17904364|P1|Overall Study|Study closure|29
5186038|NCT01198873|17904363|P2|Overall Study|Adverse Event|7
5186039|NCT01198873|17904364|P1|Overall Study|Adverse Event|4
5186040|NCT01198795|17904378|P1|Overall Study|Other Reason|4
5186041|NCT01198795|17904378|P1|Overall Study|Protocol Violation|2
5186042|NCT01198795|17904378|P1|Overall Study|Lack of Efficacy|5
5186043|NCT01198795|17904378|P1|Overall Study|Adverse Event|9
5186044|NCT01198795|17904378|P1|Overall Study|Lost to Follow-up|15
5186045|NCT01198795|17904378|P1|Overall Study|Withdrawal by Subject|17
5186046|NCT01198795|17904378|P1|Overall Study|Did not meet InclusionExclusion criteria|30
5186047|NCT01198756|17904395|P4|Overall Study|Lost to Follow-up|18
5186048|NCT01198756|17904396|P3|Overall Study|Lost to Follow-up|23
5186049|NCT01198756|17904397|P2|Overall Study|Lost to Follow-up|36
5186050|NCT01198756|17904398|P1|Overall Study|Lost to Follow-up|29
5186051|NCT01198756|17904395|P4|Overall Study|Withdrawal by Subject|5
5186052|NCT01198756|17904396|P3|Overall Study|Withdrawal by Subject|7
5186053|NCT01198756|17904397|P2|Overall Study|Withdrawal by Subject|4
5186054|NCT01198756|17904398|P1|Overall Study|Withdrawal by Subject|9
5186055|NCT01198756|17904395|P4|Overall Study|Protocol Violation|2
5186056|NCT01198756|17904396|P3|Overall Study|Protocol Violation|0
5186057|NCT01198756|17904397|P2|Overall Study|Protocol Violation|0
5186058|NCT01198756|17904398|P1|Overall Study|Protocol Violation|0
5186059|NCT01198756|17904395|P4|Overall Study|Adverse Event|1
5186060|NCT01198756|17904396|P3|Overall Study|Adverse Event|0
5186061|NCT01198756|17904397|P2|Overall Study|Adverse Event|0
5186062|NCT01198756|17904398|P1|Overall Study|Adverse Event|0
5186063|NCT01198600|17904509|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5186064|NCT01198600|17904510|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
5186065|NCT01198600|17904511|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5186066|NCT01198600|17904512|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5186067|NCT01198600|17904509|P4|Phase 2: 56 Days of Wear|Relocation|0
5186068|NCT01198600|17904510|P3|Phase 2: 56 Days of Wear|Relocation|2
5186069|NCT01198600|17904511|P2|Phase 2: 56 Days of Wear|Relocation|0
5186070|NCT01198600|17904512|P1|Phase 2: 56 Days of Wear|Relocation|0
5186071|NCT01198600|17904509|P4|Phase 2: 56 Days of Wear|Inconvenience|0
5186072|NCT01198600|17904510|P3|Phase 2: 56 Days of Wear|Inconvenience|2
5186073|NCT01198600|17904511|P2|Phase 2: 56 Days of Wear|Inconvenience|0
5186074|NCT01198600|17904512|P1|Phase 2: 56 Days of Wear|Inconvenience|0
5186075|NCT01198600|17904509|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5186076|NCT01198600|17904510|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5186077|NCT01198600|17904511|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
5186078|NCT01198600|17904512|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5186079|NCT01198600|17904509|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5186080|NCT01198600|17904510|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5186081|NCT01198600|17904511|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
5186082|NCT01198600|17904512|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5186083|NCT01198600|17904509|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5186084|NCT01198600|17904510|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5186085|NCT01198600|17904511|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5186086|NCT01198600|17904512|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
5186087|NCT01198600|17904509|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5186088|NCT01198600|17904510|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5186089|NCT01198600|17904511|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5186090|NCT01198600|17904512|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
5186091|NCT01198587|17904538|P4|Overall Study|Lost to Follow-up|0
5186092|NCT01198587|17904539|P3|Overall Study|Lost to Follow-up|9
5186093|NCT01198587|17904540|P2|Overall Study|Lost to Follow-up|0
5186094|NCT01198587|17904541|P1|Overall Study|Lost to Follow-up|8
5186095|NCT01198574|17904563|P4|Overall Study|Resigned from schools|4
5186096|NCT01198574|17904564|P3|Overall Study|Resigned from schools|1
5186097|NCT01198574|17904565|P2|Overall Study|Resigned from schools|1
5186098|NCT01198574|17904566|P1|Overall Study|Resigned from schools|4
5186099|NCT01198548|17904584|P1|Overall Study|Administrative Decision|1
5186100|NCT01198548|17904584|P1|Overall Study|Disease Progression|9
5186101|NCT01198509|17904599|P6|Overall Study|Withdrawal by Subject|0
5186102|NCT01198509|17904600|P5|Overall Study|Withdrawal by Subject|0
5186103|NCT01198509|17904601|P4|Overall Study|Withdrawal by Subject|0
5186104|NCT01198509|17904602|P3|Overall Study|Withdrawal by Subject|0
5186105|NCT01198509|17904603|P2|Overall Study|Withdrawal by Subject|0
5186106|NCT01198509|17904604|P1|Overall Study|Withdrawal by Subject|1
5186107|NCT01198470|17904621|P1|Overall Study|Adverse Event|2
5186108|NCT01198275|17904687|P2|Overall Study|spontaneous return to sinus rhythm|2
5186109|NCT01198275|17904688|P1|Overall Study|spontaneous return to sinus rhythm|4
5186110|NCT01198275|17904687|P2|Overall Study|Adverse Event|3
5186111|NCT01198275|17904688|P1|Overall Study|Adverse Event|2
5186112|NCT01198145|17904711|P2|Overall Study|Withdrawal by Subject|1
5186113|NCT01198145|17904712|P1|Overall Study|Withdrawal by Subject|1
5186114|NCT01198132|17904734|P2|Overall Study|Protocol Violation|0
5186115|NCT01198132|17904735|P1|Overall Study|Protocol Violation|1
5186116|NCT01198132|17904734|P2|Overall Study|Adverse Event|1
5186117|NCT01198132|17904735|P1|Overall Study|Adverse Event|0
5186118|NCT01198132|17904734|P2|Overall Study|Abnormal/clinically significant biologic|1
5186119|NCT01198132|17904735|P1|Overall Study|Abnormal/clinically significant biologic|1
5186120|NCT01198132|17904734|P2|Overall Study|Sign/symptoms of underlying disease|1
5186121|NCT01198132|17904735|P1|Overall Study|Sign/symptoms of underlying disease|2
5186122|NCT01198132|17904734|P2|Overall Study|Lack of Efficacy|3
5186123|NCT01198132|17904735|P1|Overall Study|Lack of Efficacy|2
5186124|NCT01198132|17904734|P2|Overall Study|Other Unspecified|6
5186125|NCT01198132|17904735|P1|Overall Study|Other Unspecified|3
5186126|NCT01198132|17904734|P2|Overall Study|Physician Decision|4
5186127|NCT01198132|17904735|P1|Overall Study|Physician Decision|5
5186128|NCT01198132|17904734|P2|Overall Study|Withdrawal by Subject|5
5186129|NCT01198132|17904735|P1|Overall Study|Withdrawal by Subject|4
5186130|NCT01198028|17904759|P1|Overall Study|Physician Decision|2
5186131|NCT01198028|17904759|P1|Overall Study|Death|3
5186132|NCT01198028|17904759|P1|Overall Study|Adverse Event|5
5186133|NCT01198002|17904771|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
5186134|NCT01198002|17904772|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
5186135|NCT01198002|17904773|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
5186136|NCT01198002|17904771|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
5186137|NCT01198002|17904772|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
5186138|NCT01198002|17904773|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
5186139|NCT01198002|17904771|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
5186140|NCT01198002|17904772|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
5186141|NCT01198002|17904773|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
5186142|NCT01198002|17904771|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
5186143|NCT01198002|17904772|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
5186144|NCT01198002|17904773|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
5186145|NCT01198002|17904771|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
5186146|NCT01198002|17904772|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
5186147|NCT01198002|17904773|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
5186148|NCT01198002|17904771|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
5186149|NCT01198002|17904772|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
5186150|NCT01198002|17904773|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
5186151|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
5186152|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
5186153|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
5186154|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
5186155|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
5186156|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
5186157|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
5186158|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
5186159|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
5186160|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
5186161|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
5186162|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
5186163|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
5186164|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
5186165|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
5186166|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
5186167|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
5186168|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
5186169|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
5186170|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
5186171|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
5186172|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Death|1
5186173|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Death|0
5186174|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Death|2
5186175|NCT01198002|17904771|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
5186176|NCT01198002|17904772|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
5186177|NCT01198002|17904773|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
5186178|NCT01197911|17904888|P3|Overall Study|Adverse Event|1
5186179|NCT01197911|17904889|P2|Overall Study|Adverse Event|0
5186180|NCT01197911|17904890|P1|Overall Study|Adverse Event|0
5186181|NCT01197794|17905005|P7|Overall Study|Other|4
5186182|NCT01197794|17905006|P6|Overall Study|Other|2
5186183|NCT01197794|17905007|P5|Overall Study|Other|2
5186184|NCT01197794|17905008|P4|Overall Study|Other|0
5186185|NCT01197794|17905009|P3|Overall Study|Other|3
5186186|NCT01197794|17905010|P2|Overall Study|Other|1
5186187|NCT01197794|17905011|P1|Overall Study|Other|1
5186188|NCT01197794|17905005|P7|Overall Study|Lost to Follow-up|0
5186189|NCT01197794|17905006|P6|Overall Study|Lost to Follow-up|1
5186190|NCT01197794|17905007|P5|Overall Study|Lost to Follow-up|0
5186191|NCT01197794|17905008|P4|Overall Study|Lost to Follow-up|1
5186192|NCT01197794|17905009|P3|Overall Study|Lost to Follow-up|0
5186193|NCT01197794|17905010|P2|Overall Study|Lost to Follow-up|1
5186194|NCT01197794|17905011|P1|Overall Study|Lost to Follow-up|1
5186195|NCT01197794|17905005|P7|Overall Study|Withdrawal by Subject|6
5186196|NCT01197794|17905006|P6|Overall Study|Withdrawal by Subject|5
5186197|NCT01197794|17905007|P5|Overall Study|Withdrawal by Subject|1
5186198|NCT01197794|17905008|P4|Overall Study|Withdrawal by Subject|1
5186199|NCT01197794|17905009|P3|Overall Study|Withdrawal by Subject|4
5186200|NCT01197794|17905010|P2|Overall Study|Withdrawal by Subject|3
5186201|NCT01197794|17905011|P1|Overall Study|Withdrawal by Subject|3
5186202|NCT01197794|17905005|P7|Overall Study|Eligibility criteria not fulfilled|6
5186203|NCT01197794|17905006|P6|Overall Study|Eligibility criteria not fulfilled|9
5186204|NCT01197794|17905007|P5|Overall Study|Eligibility criteria not fulfilled|5
5186205|NCT01197794|17905008|P4|Overall Study|Eligibility criteria not fulfilled|5
5186206|NCT01197794|17905009|P3|Overall Study|Eligibility criteria not fulfilled|2
5186207|NCT01197794|17905010|P2|Overall Study|Eligibility criteria not fulfilled|8
5186208|NCT01197794|17905011|P1|Overall Study|Eligibility criteria not fulfilled|5
5186209|NCT01197794|17905005|P7|Overall Study|Development of study withdrawal criteria|1
5186210|NCT01197794|17905006|P6|Overall Study|Development of study withdrawal criteria|0
5186211|NCT01197794|17905007|P5|Overall Study|Development of study withdrawal criteria|0
5186212|NCT01197794|17905008|P4|Overall Study|Development of study withdrawal criteria|1
5186213|NCT01197794|17905009|P3|Overall Study|Development of study withdrawal criteria|0
5186214|NCT01197794|17905010|P2|Overall Study|Development of study withdrawal criteria|0
5186215|NCT01197794|17905011|P1|Overall Study|Development of study withdrawal criteria|3
5186216|NCT01197794|17905005|P7|Overall Study|Protocol Violation|1
5186217|NCT01197794|17905006|P6|Overall Study|Protocol Violation|0
5186218|NCT01197794|17905007|P5|Overall Study|Protocol Violation|2
5186219|NCT01197794|17905008|P4|Overall Study|Protocol Violation|0
5186220|NCT01197794|17905009|P3|Overall Study|Protocol Violation|0
5186221|NCT01197794|17905010|P2|Overall Study|Protocol Violation|0
5186222|NCT01197794|17905011|P1|Overall Study|Protocol Violation|0
5186223|NCT01197794|17905005|P7|Overall Study|Adverse Event|3
5186224|NCT01197794|17905006|P6|Overall Study|Adverse Event|2
5186225|NCT01197794|17905007|P5|Overall Study|Adverse Event|4
5186226|NCT01197794|17905008|P4|Overall Study|Adverse Event|4
5186227|NCT01197794|17905009|P3|Overall Study|Adverse Event|4
5186228|NCT01197794|17905010|P2|Overall Study|Adverse Event|2
5186229|NCT01197794|17905011|P1|Overall Study|Adverse Event|3
5186230|NCT01197755|17905093|P3|Overall Study|eg, change in circumstances|2
5186231|NCT01197755|17905094|P2|Overall Study|eg, change in circumstances|3
5186232|NCT01197755|17905095|P1|Overall Study|eg, change in circumstances|7
5186233|NCT01197755|17905093|P3|Overall Study|Lost to Follow-up|1
5186234|NCT01197755|17905094|P2|Overall Study|Lost to Follow-up|0
5186235|NCT01197755|17905095|P1|Overall Study|Lost to Follow-up|0
5186236|NCT01197755|17905093|P3|Overall Study|Withdrawal by Subject|0
5186237|NCT01197755|17905094|P2|Overall Study|Withdrawal by Subject|0
5186238|NCT01197755|17905095|P1|Overall Study|Withdrawal by Subject|1
5186239|NCT01197755|17905093|P3|Overall Study|Severe non-compliance to the protocol|2
5186240|NCT01197755|17905094|P2|Overall Study|Severe non-compliance to the protocol|1
5186241|NCT01197755|17905095|P1|Overall Study|Severe non-compliance to the protocol|2
5186242|NCT01197755|17905093|P3|Overall Study|Lack of therapeutic response|4
5186243|NCT01197755|17905094|P2|Overall Study|Lack of therapeutic response|7
5186244|NCT01197755|17905095|P1|Overall Study|Lack of therapeutic response|0
5186245|NCT01197755|17905093|P3|Overall Study|Entered the long-term extension study|35
5186246|NCT01197755|17905094|P2|Overall Study|Entered the long-term extension study|21
5186247|NCT01197755|17905095|P1|Overall Study|Entered the long-term extension study|18
5186248|NCT01197755|17905093|P3|Overall Study|Study-specific discontinuation criteria|0
5186249|NCT01197755|17905094|P2|Overall Study|Study-specific discontinuation criteria|1
5186250|NCT01197755|17905095|P1|Overall Study|Study-specific discontinuation criteria|2
5186251|NCT01197755|17905093|P3|Overall Study|Adverse Event|10
5186252|NCT01197755|17905094|P2|Overall Study|Adverse Event|10
5186253|NCT01197755|17905095|P1|Overall Study|Adverse Event|8
5186254|NCT01197560|17905167|P2|Overall Study|Missing|1
5186255|NCT01197560|17905168|P1|Overall Study|Missing|0
5186256|NCT01197560|17905167|P2|Overall Study|Miscellaneous|3
5186257|NCT01197560|17905168|P1|Overall Study|Miscellaneous|4
5186258|NCT01197560|17905167|P2|Overall Study|Disease progression|35
5186259|NCT01197560|17905168|P1|Overall Study|Disease progression|40
5186260|NCT01197560|17905167|P2|Overall Study|Withdrawal by Subject|1
5186261|NCT01197560|17905168|P1|Overall Study|Withdrawal by Subject|1
5186262|NCT01197560|17905167|P2|Overall Study|Death|5
5186263|NCT01197560|17905168|P1|Overall Study|Death|3
5186264|NCT01197560|17905167|P2|Overall Study|Adverse Event|8
5186265|NCT01197560|17905168|P1|Overall Study|Adverse Event|6
5186266|NCT01197534|17905215|P3|Overall Study|Adverse Event|24
5186267|NCT01197534|17905216|P2|Overall Study|Adverse Event|36
5186268|NCT01197534|17905217|P1|Overall Study|Adverse Event|35
5186269|NCT01197534|17905215|P3|Overall Study|Lost to Follow-up|2
5186270|NCT01197534|17905216|P2|Overall Study|Lost to Follow-up|4
5186271|NCT01197534|17905217|P1|Overall Study|Lost to Follow-up|1
5186272|NCT01197534|17905215|P3|Overall Study|Dev. of study specific discont. criteria|2
5186273|NCT01197534|17905216|P2|Overall Study|Dev. of study specific discont. criteria|6
5186274|NCT01197534|17905217|P1|Overall Study|Dev. of study specific discont. criteria|13
5186275|NCT01197534|17905215|P3|Overall Study|Lack of therapeutic response|9
5186276|NCT01197534|17905216|P2|Overall Study|Lack of therapeutic response|4
5186277|NCT01197534|17905217|P1|Overall Study|Lack of therapeutic response|9
5186278|NCT01197534|17905215|P3|Overall Study|Severe non-compliance to protocol|1
5186279|NCT01197534|17905216|P2|Overall Study|Severe non-compliance to protocol|4
5186280|NCT01197534|17905217|P1|Overall Study|Severe non-compliance to protocol|3
5186281|NCT01197534|17905215|P3|Overall Study|Enrolment in long term extension|119
5186282|NCT01197534|17905216|P2|Overall Study|Enrolment in long term extension|66
5186283|NCT01197534|17905217|P1|Overall Study|Enrolment in long term extension|57
5186284|NCT01197534|17905215|P3|Overall Study|Not reported|16
5186285|NCT01197534|17905216|P2|Overall Study|Not reported|10
5186286|NCT01197534|17905217|P1|Overall Study|Not reported|16
5186287|NCT01197521|17905261|P3|Overall Study|Adverse Event|24
5186288|NCT01197521|17905262|P2|Overall Study|Adverse Event|28
5186289|NCT01197521|17905263|P1|Overall Study|Adverse Event|25
5186290|NCT01197521|17905261|P3|Overall Study|Lost to Follow-up|2
5186291|NCT01197521|17905262|P2|Overall Study|Lost to Follow-up|2
5186292|NCT01197521|17905263|P1|Overall Study|Lost to Follow-up|3
5186293|NCT01197521|17905261|P3|Overall Study|Dev. of study specific discont. criteria|2
5186294|NCT01197521|17905262|P2|Overall Study|Dev. of study specific discont. criteria|16
5186295|NCT01197521|17905263|P1|Overall Study|Dev. of study specific discont. criteria|6
5186296|NCT01197521|17905261|P3|Overall Study|Lack of therapeutic response|4
5186297|NCT01197521|17905262|P2|Overall Study|Lack of therapeutic response|3
5186298|NCT01197521|17905263|P1|Overall Study|Lack of therapeutic response|2
5186299|NCT01197521|17905261|P3|Overall Study|Severe non-compliance to protocol|3
5186300|NCT01197521|17905262|P2|Overall Study|Severe non-compliance to protocol|3
5186301|NCT01197521|17905263|P1|Overall Study|Severe non-compliance to protocol|1
5186302|NCT01197521|17905261|P3|Overall Study|Enrolment in long term extension|87
5186303|NCT01197521|17905262|P2|Overall Study|Enrolment in long term extension|36
5186304|NCT01197521|17905263|P1|Overall Study|Enrolment in long term extension|42
5186305|NCT01197521|17905261|P3|Overall Study|Not reported|21
5186306|NCT01197521|17905262|P2|Overall Study|Not reported|25
5186307|NCT01197521|17905263|P1|Overall Study|Not reported|24
5186308|NCT01197508|17905308|P4|Overall Study|Other|2
5186309|NCT01197508|17905309|P3|Overall Study|Other|2
5186310|NCT01197508|17905310|P2|Overall Study|Other|3
5186311|NCT01197508|17905311|P1|Overall Study|Other|2
5186312|NCT01197508|17905308|P4|Overall Study|Lost to Follow-up|0
5186313|NCT01197508|17905309|P3|Overall Study|Lost to Follow-up|2
5186314|NCT01197508|17905310|P2|Overall Study|Lost to Follow-up|1
5186315|NCT01197508|17905311|P1|Overall Study|Lost to Follow-up|1
5186316|NCT01197508|17905308|P4|Overall Study|Study-specific withdrawal criteria|2
5186317|NCT01197508|17905309|P3|Overall Study|Study-specific withdrawal criteria|1
5186318|NCT01197508|17905310|P2|Overall Study|Study-specific withdrawal criteria|0
5186319|NCT01197508|17905311|P1|Overall Study|Study-specific withdrawal criteria|0
5186320|NCT01197508|17905308|P4|Overall Study|Lack of Efficacy|1
5186321|NCT01197508|17905309|P3|Overall Study|Lack of Efficacy|2
5186322|NCT01197508|17905310|P2|Overall Study|Lack of Efficacy|2
5186323|NCT01197508|17905311|P1|Overall Study|Lack of Efficacy|1
5186324|NCT01197508|17905308|P4|Overall Study|Condition under investigation worsened|1
5186325|NCT01197508|17905309|P3|Overall Study|Condition under investigation worsened|1
5186326|NCT01197508|17905310|P2|Overall Study|Condition under investigation worsened|1
5186327|NCT01197508|17905311|P1|Overall Study|Condition under investigation worsened|1
5186328|NCT01197508|17905308|P4|Overall Study|Severe non-compliance to protocol|3
5186329|NCT01197508|17905309|P3|Overall Study|Severe non-compliance to protocol|1
5186330|NCT01197508|17905310|P2|Overall Study|Severe non-compliance to protocol|3
5186331|NCT01197508|17905311|P1|Overall Study|Severe non-compliance to protocol|0
5186332|NCT01197508|17905308|P4|Overall Study|Adverse Event|3
5186333|NCT01197508|17905309|P3|Overall Study|Adverse Event|23
5186334|NCT01197508|17905310|P2|Overall Study|Adverse Event|13
5186335|NCT01197508|17905311|P1|Overall Study|Adverse Event|10
5186336|NCT01197508|17905308|P4|Overall Study|Eligiblity criteria not fulfilled|0
5186337|NCT01197508|17905309|P3|Overall Study|Eligiblity criteria not fulfilled|2
5186338|NCT01197508|17905310|P2|Overall Study|Eligiblity criteria not fulfilled|0
5186339|NCT01197508|17905311|P1|Overall Study|Eligiblity criteria not fulfilled|0
5186340|NCT01197508|17905308|P4|Overall Study|Withdrawal by Subject|4
5186341|NCT01197508|17905309|P3|Overall Study|Withdrawal by Subject|15
5186342|NCT01197508|17905310|P2|Overall Study|Withdrawal by Subject|7
5186343|NCT01197508|17905311|P1|Overall Study|Withdrawal by Subject|8
5186344|NCT01197417|17905432|P2|Overall Study|No 25-hour magnesium level|2
5186345|NCT01197417|17905433|P1|Overall Study|No 25-hour magnesium level|0
5186346|NCT01197417|17905432|P2|Overall Study|Found to be ineligible|5
5186347|NCT01197417|17905433|P1|Overall Study|Found to be ineligible|2
5186348|NCT01197417|17905432|P2|Overall Study|Hypotension|2
5186349|NCT01197417|17905433|P1|Overall Study|Hypotension|1
5186350|NCT01197417|17905432|P2|Overall Study|Not consented in time to receive drug|1
5186351|NCT01197417|17905433|P1|Overall Study|Not consented in time to receive drug|0
5186352|NCT01197417|17905432|P2|Overall Study|Subject transferred to intensive care|1
5186353|NCT01197417|17905433|P1|Overall Study|Subject transferred to intensive care|0
5186354|NCT01197417|17905432|P2|Overall Study|Site miscommunication|1
5186355|NCT01197417|17905433|P1|Overall Study|Site miscommunication|0
5186356|NCT01197417|17905432|P2|Overall Study|Withdrawal by Subject|4
5186357|NCT01197417|17905433|P1|Overall Study|Withdrawal by Subject|2
5186358|NCT01197417|17905432|P2|Overall Study|Physician Decision|2
5186359|NCT01197417|17905433|P1|Overall Study|Physician Decision|3
5186360|NCT01197378|17905451|P1|Overall Study|Other|2
5186361|NCT01197378|17905451|P1|Overall Study|Physician Decision|1
5186362|NCT01197378|17905451|P1|Overall Study|Withdrawal by Subject|1
5186363|NCT01197378|17905451|P1|Overall Study|Adverse Event|3
5186364|NCT01197300|17905470|P2|Overall Study|Protocol Violation|1
5186365|NCT01197300|17905471|P1|Overall Study|Protocol Violation|0
5186366|NCT01197300|17905470|P2|Overall Study|Lost to Follow-up|1
5186367|NCT01197300|17905471|P1|Overall Study|Lost to Follow-up|0
5186368|NCT01196988|17905503|P4|Overall Study|Other|0
5186369|NCT01196988|17905504|P3|Overall Study|Other|0
5186370|NCT01196988|17905505|P2|Overall Study|Other|0
5186371|NCT01196988|17905506|P1|Overall Study|Other|2
5186372|NCT01196988|17905503|P4|Overall Study|Lost to Follow-up|1
5186373|NCT01196988|17905504|P3|Overall Study|Lost to Follow-up|21
5186374|NCT01196988|17905505|P2|Overall Study|Lost to Follow-up|29
5186375|NCT01196988|17905506|P1|Overall Study|Lost to Follow-up|16
5186376|NCT01196988|17905503|P4|Overall Study|Withdrawal by Subject|0
5186377|NCT01196988|17905504|P3|Overall Study|Withdrawal by Subject|4
5186378|NCT01196988|17905505|P2|Overall Study|Withdrawal by Subject|1
5186379|NCT01196988|17905506|P1|Overall Study|Withdrawal by Subject|5
5186380|NCT01196988|17905503|P4|Overall Study|Adverse Event|0
5186381|NCT01196988|17905504|P3|Overall Study|Adverse Event|0
5186382|NCT01196988|17905505|P2|Overall Study|Adverse Event|2
5186383|NCT01196988|17905506|P1|Overall Study|Adverse Event|1
5186384|NCT01196975|17905600|P5|Overall Study|Lost to Follow-up|11
5186385|NCT01196975|17905601|P4|Overall Study|Lost to Follow-up|5
5186386|NCT01196975|17905602|P3|Overall Study|Lost to Follow-up|5
5186387|NCT01196975|17905603|P2|Overall Study|Lost to Follow-up|6
5186388|NCT01196975|17905604|P1|Overall Study|Lost to Follow-up|11
5186389|NCT01196975|17905600|P5|Overall Study|Withdrawal by Subject|0
5186390|NCT01196975|17905601|P4|Overall Study|Withdrawal by Subject|1
5186391|NCT01196975|17905602|P3|Overall Study|Withdrawal by Subject|0
5186392|NCT01196975|17905603|P2|Overall Study|Withdrawal by Subject|1
5186393|NCT01196975|17905604|P1|Overall Study|Withdrawal by Subject|2
5186394|NCT01196975|17905600|P5|Overall Study|Adverse Event|2
5186395|NCT01196975|17905601|P4|Overall Study|Adverse Event|0
5186396|NCT01196975|17905602|P3|Overall Study|Adverse Event|0
5186397|NCT01196975|17905603|P2|Overall Study|Adverse Event|2
5186398|NCT01196975|17905604|P1|Overall Study|Adverse Event|2
5186399|NCT01196741|17905888|P2|Overall Study|Protocol Violation|1
5186400|NCT01196741|17905889|P1|Overall Study|Protocol Violation|2
5186401|NCT01196741|17905888|P2|Overall Study|Other|2
5186402|NCT01196741|17905889|P1|Overall Study|Other|3
5186403|NCT01196741|17905888|P2|Overall Study|Other reason|3
5186404|NCT01196741|17905889|P1|Overall Study|Other reason|3
5186405|NCT01196741|17905888|P2|Overall Study|Withdrawal by Subject|0
5186406|NCT01196741|17905889|P1|Overall Study|Withdrawal by Subject|3
5186407|NCT01196741|17905888|P2|Overall Study|Dose limiting Adverse Event|1
5186408|NCT01196741|17905889|P1|Overall Study|Dose limiting Adverse Event|2
5186409|NCT01196741|17905888|P2|Overall Study|Serious Adverse Event|1
5186410|NCT01196741|17905889|P1|Overall Study|Serious Adverse Event|3
5186411|NCT01196741|17905888|P2|Overall Study|Adverse Event|6
5186412|NCT01196741|17905889|P1|Overall Study|Adverse Event|10
5186413|NCT01196741|17905888|P2|Overall Study|Disease progression|14
5186414|NCT01196741|17905889|P1|Overall Study|Disease progression|34
5186415|NCT01196429|17905919|P2|Overall Study|Refused - Never Treated|0
5186416|NCT01196429|17905920|P1|Overall Study|Refused - Never Treated|1
5186417|NCT01196429|17905919|P2|Overall Study|Ineligible - wrong cell type|0
5186418|NCT01196429|17905920|P1|Overall Study|Ineligible - wrong cell type|1
5186419|NCT01196429|17905919|P2|Overall Study|Ineligible - inadequate pathology|0
5186420|NCT01196429|17905920|P1|Overall Study|Ineligible - inadequate pathology|1
5186421|NCT01196416|17905936|P1|Overall Study|Withdrawal by Subject|2
5186422|NCT01196104|17905994|P2|Overall Study|Various|1
5186423|NCT01196104|17905995|P1|Overall Study|Various|0
5186424|NCT01196104|17905994|P2|Overall Study|Withdrawal by Subject|3
5186425|NCT01196104|17905995|P1|Overall Study|Withdrawal by Subject|3
5186426|NCT01196104|17905994|P2|Overall Study|Physician Decision|1
5186427|NCT01196104|17905995|P1|Overall Study|Physician Decision|0
5186428|NCT01196104|17905994|P2|Overall Study|Lost to Follow-up|0
5186429|NCT01196104|17905995|P1|Overall Study|Lost to Follow-up|1
5186430|NCT01196091|17906038|P3|Overall Study|Randomized, No Study Drug Received|1
5186431|NCT01196091|17906039|P2|Overall Study|Randomized, No Study Drug Received|0
5186432|NCT01196091|17906040|P1|Overall Study|Randomized, No Study Drug Received|1
5186433|NCT01196091|17906038|P3|Overall Study|Excluded Site|8
5186434|NCT01196091|17906039|P2|Overall Study|Excluded Site|11
5186435|NCT01196091|17906040|P1|Overall Study|Excluded Site|5
5186436|NCT01196091|17906038|P3|Overall Study|Sponsor Decision|4
5186437|NCT01196091|17906039|P2|Overall Study|Sponsor Decision|5
5186438|NCT01196091|17906040|P1|Overall Study|Sponsor Decision|6
5186439|NCT01196091|17906038|P3|Overall Study|Protocol Violation|3
5186440|NCT01196091|17906039|P2|Overall Study|Protocol Violation|3
5186441|NCT01196091|17906040|P1|Overall Study|Protocol Violation|1
5186442|NCT01196091|17906038|P3|Overall Study|Physician Decision|4
5186443|NCT01196091|17906039|P2|Overall Study|Physician Decision|3
5186444|NCT01196091|17906040|P1|Overall Study|Physician Decision|3
5186445|NCT01196091|17906038|P3|Overall Study|Withdrawal by Subject|22
5186446|NCT01196091|17906039|P2|Overall Study|Withdrawal by Subject|19
5186447|NCT01196091|17906040|P1|Overall Study|Withdrawal by Subject|16
5186448|NCT01196091|17906038|P3|Overall Study|Parent/Caregiver Decision|1
5186449|NCT01196091|17906039|P2|Overall Study|Parent/Caregiver Decision|0
5186450|NCT01196091|17906040|P1|Overall Study|Parent/Caregiver Decision|0
5186451|NCT01196091|17906038|P3|Overall Study|Lost to Follow-up|6
5186452|NCT01196091|17906039|P2|Overall Study|Lost to Follow-up|5
5186453|NCT01196091|17906040|P1|Overall Study|Lost to Follow-up|5
5186454|NCT01196091|17906038|P3|Overall Study|Lack of Efficacy|17
5186455|NCT01196091|17906039|P2|Overall Study|Lack of Efficacy|12
5186456|NCT01196091|17906040|P1|Overall Study|Lack of Efficacy|15
5186457|NCT01196091|17906038|P3|Overall Study|Entry Criteria Not Met|10
5186458|NCT01196091|17906039|P2|Overall Study|Entry Criteria Not Met|11
5186459|NCT01196091|17906040|P1|Overall Study|Entry Criteria Not Met|11
5186460|NCT01196091|17906038|P3|Overall Study|Death|2
5186461|NCT01196091|17906039|P2|Overall Study|Death|2
5186462|NCT01196091|17906040|P1|Overall Study|Death|3
5186463|NCT01196091|17906038|P3|Overall Study|Adverse Event|26
5186464|NCT01196091|17906039|P2|Overall Study|Adverse Event|27
5186465|NCT01196091|17906040|P1|Overall Study|Adverse Event|22
5186466|NCT01196078|17906092|P2|Overall Study|Death|4
5186467|NCT01196078|17906093|P1|Overall Study|Death|6
5186468|NCT01196078|17906092|P2|Overall Study|Lost to Follow-up|0
5186469|NCT01196078|17906093|P1|Overall Study|Lost to Follow-up|1
5186470|NCT01196078|17906092|P2|Overall Study|Lack of Efficacy|23
5186471|NCT01196078|17906093|P1|Overall Study|Lack of Efficacy|17
5186472|NCT01196078|17906092|P2|Overall Study|Protocol Violation|1
5186473|NCT01196078|17906093|P1|Overall Study|Protocol Violation|2
5186474|NCT01196078|17906092|P2|Overall Study|Adverse Event|4
5186475|NCT01196078|17906093|P1|Overall Study|Adverse Event|4
5186476|NCT01196078|17906092|P2|Overall Study|Withdrawal by Subject|5
5186477|NCT01196078|17906093|P1|Overall Study|Withdrawal by Subject|3
5186478|NCT01196052|17906121|P1|Overall Study|Withdrawal by Subject|6
5186479|NCT01196052|17906121|P1|Overall Study|Reason not Specified|5
5186480|NCT01196052|17906121|P1|Overall Study|Noncompliance to Protocol Requirements|2
5186481|NCT01196052|17906121|P1|Overall Study|Lost to Follow-up|1
5186482|NCT01196052|17906121|P1|Overall Study|Adverse Event|9
5186483|NCT01196026|17906138|P6|Overall Study|Other|0
5186484|NCT01196026|17906139|P5|Overall Study|Other|0
5186485|NCT01196026|17906140|P4|Overall Study|Other|0
5186486|NCT01196026|17906141|P3|Overall Study|Other|0
5186487|NCT01196026|17906142|P2|Overall Study|Other|1
5186488|NCT01196026|17906143|P1|Overall Study|Other|0
5186489|NCT01196026|17906138|P6|Overall Study|Lost to Follow-up|0
5186490|NCT01196026|17906139|P5|Overall Study|Lost to Follow-up|1
5186491|NCT01196026|17906140|P4|Overall Study|Lost to Follow-up|0
5186492|NCT01196026|17906141|P3|Overall Study|Lost to Follow-up|0
5186493|NCT01196026|17906142|P2|Overall Study|Lost to Follow-up|3
5186494|NCT01196026|17906143|P1|Overall Study|Lost to Follow-up|0
5186495|NCT01196026|17906138|P6|Overall Study|Withdrawal by Subject|0
5186496|NCT01196026|17906139|P5|Overall Study|Withdrawal by Subject|0
5186497|NCT01196026|17906140|P4|Overall Study|Withdrawal by Subject|0
5186498|NCT01196026|17906141|P3|Overall Study|Withdrawal by Subject|0
5186499|NCT01196026|17906142|P2|Overall Study|Withdrawal by Subject|4
5186500|NCT01196026|17906143|P1|Overall Study|Withdrawal by Subject|1
5186501|NCT01195948|17906377|P3|Overall Study|Lost to Follow-up|2
5186502|NCT01195948|17906378|P2|Overall Study|Lost to Follow-up|1
5186503|NCT01195948|17906379|P1|Overall Study|Lost to Follow-up|0
5186504|NCT01195844|17906432|P1|Overall Study|Fecal sample not collected|40
5186505|NCT01195831|17906449|P2|Overall Study|Protocol Violation|2
5186506|NCT01195831|17906450|P1|Overall Study|Protocol Violation|0
5186507|NCT01195831|17906449|P2|Overall Study|Adverse Event|2
5186508|NCT01195831|17906450|P1|Overall Study|Adverse Event|4
5186509|NCT01195831|17906449|P2|Overall Study|Withdrawal by Subject|2
5186510|NCT01195831|17906450|P1|Overall Study|Withdrawal by Subject|2
5186511|NCT01195831|17906449|P2|Overall Study|Lost to Follow-up|4
5186512|NCT01195831|17906450|P1|Overall Study|Lost to Follow-up|2
5186513|NCT01195675|17906690|P1|Overall Study|Withdrawal by Subject|2
5186514|NCT01195675|17906690|P1|Overall Study|Adverse Event|1
5186515|NCT01195662|17906723|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
5186516|NCT01195662|17906724|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
5186517|NCT01195662|17906725|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
5186518|NCT01195662|17906723|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
5186519|NCT01195662|17906724|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
5186520|NCT01195662|17906725|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
5186521|NCT01195662|17906723|P3|Double Blind Treatment Period|Missing disposition information|1
5186522|NCT01195662|17906724|P2|Double Blind Treatment Period|Missing disposition information|1
5186523|NCT01195662|17906725|P1|Double Blind Treatment Period|Missing disposition information|0
5186524|NCT01195662|17906723|P3|Double Blind Treatment Period|Non-specified|0
5186525|NCT01195662|17906724|P2|Double Blind Treatment Period|Non-specified|0
5186526|NCT01195662|17906725|P1|Double Blind Treatment Period|Non-specified|3
5186527|NCT01195662|17906723|P3|Double Blind Treatment Period|Lack of Efficacy|0
5186528|NCT01195662|17906724|P2|Double Blind Treatment Period|Lack of Efficacy|0
5186529|NCT01195662|17906725|P1|Double Blind Treatment Period|Lack of Efficacy|2
5186530|NCT01195662|17906723|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
5186531|NCT01195662|17906724|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
5186532|NCT01195662|17906725|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
5186533|NCT01195662|17906723|P3|Double Blind Treatment Period|Requested discontinue treatment|1
5186534|NCT01195662|17906724|P2|Double Blind Treatment Period|Requested discontinue treatment|0
5186535|NCT01195662|17906725|P1|Double Blind Treatment Period|Requested discontinue treatment|1
5186536|NCT01195662|17906723|P3|Double Blind Treatment Period|Administrative reason|1
5186537|NCT01195662|17906724|P2|Double Blind Treatment Period|Administrative reason|1
5186538|NCT01195662|17906725|P1|Double Blind Treatment Period|Administrative reason|2
5186539|NCT01195662|17906723|P3|Double Blind Treatment Period|Lost to Follow-up|3
5186540|NCT01195662|17906724|P2|Double Blind Treatment Period|Lost to Follow-up|2
5186541|NCT01195662|17906725|P1|Double Blind Treatment Period|Lost to Follow-up|3
5186542|NCT01195662|17906723|P3|Double Blind Treatment Period|Withdrawal by Subject|4
5186543|NCT01195662|17906724|P2|Double Blind Treatment Period|Withdrawal by Subject|4
5186544|NCT01195662|17906725|P1|Double Blind Treatment Period|Withdrawal by Subject|6
5186545|NCT01195662|17906723|P3|Double Blind Treatment Period|Adverse Event|2
5186546|NCT01195662|17906724|P2|Double Blind Treatment Period|Adverse Event|1
5186547|NCT01195662|17906725|P1|Double Blind Treatment Period|Adverse Event|4
5186548|NCT01195636|17906755|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
5186549|NCT01195636|17906756|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5186550|NCT01195636|17906755|P2|Second Intervention (3 Weeks)|Adverse Event|1
5186551|NCT01195636|17906756|P1|Second Intervention (3 Weeks)|Adverse Event|1
5186552|NCT01195636|17906755|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
5186553|NCT01195636|17906756|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
5186554|NCT01195636|17906755|P2|Washout Period (2 Weeks)|Adverse Event|1
5186555|NCT01195636|17906756|P1|Washout Period (2 Weeks)|Adverse Event|1
5186556|NCT01195636|17906755|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
5186557|NCT01195636|17906756|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
5186558|NCT01195636|17906755|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
5186559|NCT01195636|17906756|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5186560|NCT01195636|17906755|P2|First Intervention (3 Weeks)|Protocol Violation|0
5186561|NCT01195636|17906756|P1|First Intervention (3 Weeks)|Protocol Violation|1
5186562|NCT01195636|17906755|P2|First Intervention (3 Weeks)|Adverse Event|3
5186563|NCT01195636|17906756|P1|First Intervention (3 Weeks)|Adverse Event|2
5186564|NCT01195623|17906782|P2|Overall Study|Lost to Follow-up|37
5186565|NCT01195623|17906783|P1|Overall Study|Lost to Follow-up|35
5186566|NCT01195545|17906812|P1|Overall Study|Protocol Violation|4
5186567|NCT01195415|17906824|P1|Overall Study|No repeat biopsy due to progression|2
5186568|NCT01195363|17906833|P2|Overall Study|incarceration|0
5186569|NCT01195363|17906834|P1|Overall Study|incarceration|1
5186570|NCT01195363|17906833|P2|Overall Study|Lack of Efficacy|4
5186571|NCT01195363|17906834|P1|Overall Study|Lack of Efficacy|0
5186572|NCT01195363|17906833|P2|Overall Study|Adverse Event|1
5186573|NCT01195363|17906834|P1|Overall Study|Adverse Event|3
5186574|NCT01195363|17906833|P2|Overall Study|Lost to Follow-up|4
5186575|NCT01195363|17906834|P1|Overall Study|Lost to Follow-up|7
5186576|NCT01195272|17906840|P1|Overall Study|Lack of Efficacy|3
5186577|NCT01195272|17906840|P1|Overall Study|Adverse Event|1
5186578|NCT01195103|17906869|P3|Overall Study|Withdrawal by Subject|0
5186579|NCT01195103|17906870|P2|Overall Study|Withdrawal by Subject|0
5186580|NCT01195103|17906871|P1|Overall Study|Withdrawal by Subject|1
5186581|NCT01195090|17906881|P2|Overall Study|Protocol Violation|4
5186582|NCT01195090|17906882|P1|Overall Study|Protocol Violation|3
5186583|NCT01195090|17906881|P2|Overall Study|Lost to Follow-up|2
5186584|NCT01195090|17906882|P1|Overall Study|Lost to Follow-up|2
5186585|NCT01195090|17906881|P2|Overall Study|Adverse Event|2
5186586|NCT01195090|17906882|P1|Overall Study|Adverse Event|1
5186587|NCT01194999|17906951|P1|Overall Study|Lost to Follow-up|17
5186588|NCT01194973|17906955|P1|26 Week Treatment Period|Pregnancy|1
5186589|NCT01194973|17906955|P1|26 Week Treatment Period|Lack of Efficacy|1
5186590|NCT01194973|17906955|P1|26 Week Treatment Period|Adverse Event|1
5186591|NCT01194973|17906955|P1|Screening Period|Screen Failure|3
5186592|NCT01194869|17906975|P1|Overall Study|Toxicity|2
5186593|NCT01194869|17906975|P1|Overall Study|Disease Progression|2
5186594|NCT01194830|17907006|P2|Overall Study|Other Reason|8
5186595|NCT01194830|17907007|P1|Overall Study|Other Reason|12
5186596|NCT01194830|17907006|P2|Overall Study|Non-compliance issues|4
5186597|NCT01194830|17907007|P1|Overall Study|Non-compliance issues|4
5186598|NCT01194830|17907006|P2|Overall Study|Lack of Efficacy|1
5186599|NCT01194830|17907007|P1|Overall Study|Lack of Efficacy|1
5186600|NCT01194830|17907006|P2|Overall Study|Withdrawal by Subject|1
5186601|NCT01194830|17907007|P1|Overall Study|Withdrawal by Subject|2
5186602|NCT01194830|17907006|P2|Overall Study|Lost to Follow-up|7
5186603|NCT01194830|17907007|P1|Overall Study|Lost to Follow-up|9
5186604|NCT01194830|17907006|P2|Overall Study|Protocol Violation|4
5186605|NCT01194830|17907007|P1|Overall Study|Protocol Violation|5
5186606|NCT01194830|17907006|P2|Overall Study|Adverse Event|2
5186607|NCT01194830|17907007|P1|Overall Study|Adverse Event|3
5186608|NCT01194804|17907029|P1|Overall Study|Withdrawal by Subject|1
5186609|NCT01194570|17907051|P2|Overall Study|Lost to Follow-up|4
5186610|NCT01194570|17907052|P1|Overall Study|Lost to Follow-up|1
5186611|NCT01194570|17907051|P2|Overall Study|Pregnancy|1
5186612|NCT01194570|17907052|P1|Overall Study|Pregnancy|1
5186613|NCT01194570|17907051|P2|Overall Study|Withdrawal by Subject|22
5186614|NCT01194570|17907052|P1|Overall Study|Withdrawal by Subject|21
5186615|NCT01194570|17907051|P2|Overall Study|Lack of Efficacy|21
5186616|NCT01194570|17907052|P1|Overall Study|Lack of Efficacy|27
5186617|NCT01194570|17907051|P2|Overall Study|Non-compliance|2
5186618|NCT01194570|17907052|P1|Overall Study|Non-compliance|2
5186619|NCT01194570|17907051|P2|Overall Study|Adverse Event|18
5186620|NCT01194570|17907052|P1|Overall Study|Adverse Event|12
5186621|NCT01194570|17907051|P2|Overall Study|Non-compliance with study drug|2
5186622|NCT01194570|17907052|P1|Overall Study|Non-compliance with study drug|2
5186623|NCT01194570|17907051|P2|Overall Study|Protocol Violation|2
5186624|NCT01194570|17907052|P1|Overall Study|Protocol Violation|0
5186625|NCT01194570|17907051|P2|Overall Study|Reason not specified|20
5186626|NCT01194570|17907052|P1|Overall Study|Reason not specified|13
5186627|NCT01194570|17907051|P2|Overall Study|Physician Decision|6
5186628|NCT01194570|17907052|P1|Overall Study|Physician Decision|2
5186629|NCT01194570|17907051|P2|Overall Study|Ongoing at CCOD|387
5186630|NCT01194570|17907052|P1|Overall Study|Ongoing at CCOD|162
5186631|NCT01194570|17907051|P2|Overall Study|Death|3
5186632|NCT01194570|17907052|P1|Overall Study|Death|1
5186633|NCT01194531|17907072|P2|Overall Study|Physician Decision|2
5186634|NCT01194531|17907073|P1|Overall Study|Physician Decision|0
5186635|NCT01194531|17907072|P2|Overall Study|Protocol Violation|1
5186636|NCT01194531|17907073|P1|Overall Study|Protocol Violation|4
5186637|NCT01194531|17907072|P2|Overall Study|Withdrawal by Subject|0
5186638|NCT01194531|17907073|P1|Overall Study|Withdrawal by Subject|1
5186639|NCT01194440|17907127|P1|6-months (2nd Dose)|Change in therapy|4
5186640|NCT01194440|17907127|P1|Baseline (First Dose)|Adverse Event|1
5186641|NCT01194440|17907127|P1|Baseline (First Dose)|Change in therapy|1
5186642|NCT01194440|17907127|P1|Baseline (First Dose)|Lack of Efficacy|1
5186643|NCT01194440|17907127|P1|Baseline (First Dose)|Reason not specified|4
5186644|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Death|2
5186645|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Death|0
5186646|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Death|2
5186647|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Death|1
5186648|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
5186649|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
5186650|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
5186651|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
5186652|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Adverse Event|12
5186653|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Adverse Event|2
5186654|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Adverse Event|21
5186655|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Adverse Event|35
5186656|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Protocol Violation|1
5186657|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Protocol Violation|0
5186658|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Protocol Violation|0
5186659|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Protocol Violation|0
5186660|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Other|0
5186661|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Other|0
5186662|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Other|1
5186663|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Other|2
5186664|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Pregnancy|1
5186665|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Pregnancy|1
5186666|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Pregnancy|3
5186667|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Pregnancy|1
5186668|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
5186669|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
5186670|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
5186671|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
5186672|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
5186673|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
5186674|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
5186675|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
5186676|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
5186677|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
5186678|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
5186679|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
5186680|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
5186681|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
5186682|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
5186683|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
5186684|NCT01194414|17907140|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
5186685|NCT01194414|17907141|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
5186686|NCT01194414|17907142|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
5186687|NCT01194414|17907143|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
5186688|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Death|0
5186689|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Death|0
5186690|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Death|1
5186691|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Death|0
5186692|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
5186693|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
5186694|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
5186695|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
5186696|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Adverse Event|0
5186697|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Adverse Event|0
5186698|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Adverse Event|40
5186699|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Adverse Event|28
5186700|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Other|0
5186701|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Other|0
5186702|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Other|1
5186703|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Other|0
5186704|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
5186705|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
5186706|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
5186707|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
5186708|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Pregnancy|0
5186709|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Pregnancy|0
5186710|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Pregnancy|2
5186711|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Pregnancy|2
5186712|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5186713|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5186714|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
5186715|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5186716|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Protocol Violation|0
5186717|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Protocol Violation|0
5186718|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Protocol Violation|3
5186719|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Protocol Violation|5
5186720|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
5186721|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
5186722|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
5186723|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
5186724|NCT01194414|17907140|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
5186725|NCT01194414|17907141|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
5186726|NCT01194414|17907142|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
5186727|NCT01194414|17907143|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
5186728|NCT01194271|17907214|P1|Overall Study|Death|1
5186729|NCT01194271|17907214|P1|Overall Study|Ineligible, Screen Failure|1
5186730|NCT01194271|17907214|P1|Overall Study|Withdrawal by Subject|1
5186731|NCT01194258|17907218|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
5186732|NCT01194258|17907219|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
5186733|NCT01194258|17907220|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
5186734|NCT01194258|17907221|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
5186735|NCT01194258|17907222|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
5186736|NCT01194258|17907218|P5|Period 2 (12 Weeks)|Adverse Event|0
5186737|NCT01194258|17907219|P4|Period 2 (12 Weeks)|Adverse Event|0
5186738|NCT01194258|17907220|P3|Period 2 (12 Weeks)|Adverse Event|0
5186739|NCT01194258|17907221|P2|Period 2 (12 Weeks)|Adverse Event|1
5186740|NCT01194258|17907222|P1|Period 2 (12 Weeks)|Adverse Event|0
5186741|NCT01194258|17907218|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
5186742|NCT01194258|17907219|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
5186743|NCT01194258|17907220|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
5186744|NCT01194258|17907221|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
5186745|NCT01194258|17907222|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
5186746|NCT01194258|17907218|P5|Period 1 (12 Weeks)|Death|1
5186747|NCT01194258|17907219|P4|Period 1 (12 Weeks)|Death|0
5186748|NCT01194258|17907220|P3|Period 1 (12 Weeks)|Death|0
5186749|NCT01194258|17907221|P2|Period 1 (12 Weeks)|Death|0
5186750|NCT01194258|17907222|P1|Period 1 (12 Weeks)|Death|0
5186751|NCT01194258|17907218|P5|Titration Period|Titration failure|0
5186752|NCT01194258|17907219|P4|Titration Period|Titration failure|0
5186753|NCT01194258|17907220|P3|Titration Period|Titration failure|0
5186754|NCT01194258|17907221|P2|Titration Period|Titration failure|0
5186755|NCT01194258|17907222|P1|Titration Period|Titration failure|3
5186756|NCT01194258|17907218|P5|Titration Period|Lost to Follow-up|0
5186757|NCT01194258|17907219|P4|Titration Period|Lost to Follow-up|0
5186758|NCT01194258|17907220|P3|Titration Period|Lost to Follow-up|0
5186759|NCT01194258|17907221|P2|Titration Period|Lost to Follow-up|0
5186760|NCT01194258|17907222|P1|Titration Period|Lost to Follow-up|2
5186761|NCT01194258|17907218|P5|Titration Period|Withdrawal by Subject|0
5186762|NCT01194258|17907219|P4|Titration Period|Withdrawal by Subject|0
5186763|NCT01194258|17907220|P3|Titration Period|Withdrawal by Subject|0
5186764|NCT01194258|17907221|P2|Titration Period|Withdrawal by Subject|0
5186765|NCT01194258|17907222|P1|Titration Period|Withdrawal by Subject|6
5186766|NCT01194245|17907246|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5186767|NCT01194245|17907247|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5186768|NCT01194245|17907248|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5186769|NCT01194245|17907249|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
5186770|NCT01194245|17907250|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
5186771|NCT01194245|17907246|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
5186772|NCT01194245|17907247|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5186773|NCT01194245|17907248|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5186774|NCT01194245|17907249|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5186775|NCT01194245|17907250|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5186776|NCT01194245|17907246|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5186777|NCT01194245|17907247|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5186778|NCT01194245|17907248|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5186779|NCT01194245|17907249|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5186780|NCT01194245|17907250|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
5186781|NCT01194245|17907246|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
5186782|NCT01194245|17907247|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
5186783|NCT01194245|17907248|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
5186784|NCT01194245|17907249|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
5186785|NCT01194245|17907250|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
5186786|NCT01194245|17907246|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
5186787|NCT01194245|17907247|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
5186788|NCT01194245|17907248|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
5186789|NCT01194245|17907249|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
5186790|NCT01194245|17907250|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
5186791|NCT01194245|17907246|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5186792|NCT01194245|17907247|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5186793|NCT01194245|17907248|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5186794|NCT01194245|17907249|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5186795|NCT01194245|17907250|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
5186796|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
5186797|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
5186798|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186799|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186800|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186801|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186802|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186803|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186804|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186805|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5186806|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186807|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
5186808|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186809|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186810|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186811|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186812|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186813|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186814|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186815|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5186816|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
5186817|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
5186818|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186819|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186820|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186821|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186822|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186823|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186824|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186825|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5186826|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Death|1
5186827|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Death|1
5186828|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Death|0
5186829|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Death|0
5186830|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Death|0
5186831|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Death|0
5186832|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Death|0
5186833|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Death|0
5186834|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Death|0
5186835|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Death|0
5186836|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
5186837|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
5186838|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186839|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186840|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186841|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186842|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186843|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186844|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186845|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5186846|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
5186847|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
5186848|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186849|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186850|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186851|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186852|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186853|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186854|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5186855|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5187158|NCT01193920|17907356|P10|Overall Study|Withdrawal by Subject|0
5186856|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
5186857|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
5186858|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186859|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186860|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186861|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186862|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186863|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186864|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186865|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5186866|NCT01194219|17907271|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
5186867|NCT01194219|17907272|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
5186868|NCT01194219|17907273|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186869|NCT01194219|17907274|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186870|NCT01194219|17907275|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186871|NCT01194219|17907276|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186872|NCT01194219|17907277|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186873|NCT01194219|17907278|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186874|NCT01194219|17907279|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186875|NCT01194219|17907280|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5186876|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186877|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186878|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186879|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
5186880|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186881|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186882|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186883|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186884|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186885|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5186886|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186887|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186888|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
5186889|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186890|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186891|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186892|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186893|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186894|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186895|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5186896|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186897|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186898|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186899|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
5186900|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
5186901|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
5186902|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186903|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186904|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186905|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5186906|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186907|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186908|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
5186909|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
5186910|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186911|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
5186912|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186913|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186914|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186915|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5186916|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186917|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186918|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186919|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
5186920|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186921|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
5186922|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186923|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186924|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186925|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5186926|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5186927|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5186928|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
5186929|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
5186930|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
5186931|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
5186932|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5186933|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5186934|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5186935|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5186936|NCT01194219|17907271|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186937|NCT01194219|17907272|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186938|NCT01194219|17907273|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
5186939|NCT01194219|17907274|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
5186940|NCT01194219|17907275|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
5186941|NCT01194219|17907276|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186942|NCT01194219|17907277|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186943|NCT01194219|17907278|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186944|NCT01194219|17907279|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186945|NCT01194219|17907280|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5186946|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Other|0
5186947|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Other|0
5186948|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Other|0
5186949|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Other|0
5186950|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Other|0
5186951|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Other|0
5186952|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Other|1
5186953|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Other|2
5186954|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Other|0
5186955|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Other|0
5186956|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
5186957|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
5186958|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
5186959|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
5186960|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
5186961|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
5186962|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
5186963|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
5186964|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
5186965|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
5186966|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186967|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186968|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186969|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186970|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186971|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186972|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186973|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
5186974|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186975|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5186976|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186977|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186978|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186979|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186980|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186981|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186982|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
5186983|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
5186984|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186985|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5186986|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186987|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186988|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186989|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186990|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186991|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186992|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
5186993|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
5186994|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186995|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5186996|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5186997|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5186998|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5186999|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5187000|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5187001|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5187002|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
5187003|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
5187004|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5187005|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5187006|NCT01194219|17907271|P10|Maintenance Phase Weeks16-32|Adverse Event|0
5187007|NCT01194219|17907272|P9|Maintenance Phase Weeks16-32|Adverse Event|0
5187008|NCT01194219|17907273|P8|Maintenance Phase Weeks16-32|Adverse Event|0
5187009|NCT01194219|17907274|P7|Maintenance Phase Weeks16-32|Adverse Event|0
5187010|NCT01194219|17907275|P6|Maintenance Phase Weeks16-32|Adverse Event|0
5187011|NCT01194219|17907276|P5|Maintenance Phase Weeks16-32|Adverse Event|0
5187012|NCT01194219|17907277|P4|Maintenance Phase Weeks16-32|Adverse Event|9
5187013|NCT01194219|17907278|P3|Maintenance Phase Weeks16-32|Adverse Event|8
5187014|NCT01194219|17907279|P2|Maintenance Phase Weeks16-32|Adverse Event|0
5187015|NCT01194219|17907280|P1|Maintenance Phase Weeks16-32|Adverse Event|0
5187016|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187017|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187018|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187019|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187020|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187021|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187022|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187023|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5187024|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
5187025|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
5187026|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187027|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187028|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187029|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187030|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187031|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187032|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187033|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5187034|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
5187035|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
5187036|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187037|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187038|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187039|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187040|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187041|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187042|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187043|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5187044|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
5187045|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
5187046|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
5187047|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
5187048|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
5187049|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
5187050|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
5187051|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
5187052|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
5187053|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
5187054|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
5187055|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
5187056|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187057|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187058|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187059|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187060|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187061|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187062|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187063|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5187064|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
5187065|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
5187066|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187067|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187068|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187069|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187070|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187071|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187072|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187073|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187074|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5187075|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
5187076|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187077|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187078|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187079|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187080|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187081|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187082|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187083|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5187084|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
5187085|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
5187086|NCT01194219|17907271|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187087|NCT01194219|17907272|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187088|NCT01194219|17907273|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187089|NCT01194219|17907274|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187090|NCT01194219|17907275|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187091|NCT01194219|17907276|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187092|NCT01194219|17907277|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187093|NCT01194219|17907278|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5187094|NCT01194219|17907279|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
5187095|NCT01194219|17907280|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
5187096|NCT01194154|17907314|P2|Overall Study|Did not receive study medication|4
5187097|NCT01194154|17907315|P1|Overall Study|Did not receive study medication|2
5187098|NCT01194154|17907314|P2|Overall Study|Other|0
5187099|NCT01194154|17907315|P1|Overall Study|Other|4
5187100|NCT01194154|17907314|P2|Overall Study|Treatment with prohibited medication|5
5187101|NCT01194154|17907315|P1|Overall Study|Treatment with prohibited medication|4
5187102|NCT01194154|17907314|P2|Overall Study|Skipping of CERA treatment at two visits|0
5187103|NCT01194154|17907315|P1|Overall Study|Skipping of CERA treatment at two visits|3
5187104|NCT01194154|17907314|P2|Overall Study|Hemoglobin increase|3
5187105|NCT01194154|17907315|P1|Overall Study|Hemoglobin increase|12
5187106|NCT01194154|17907314|P2|Overall Study|Hemoglobin decrease|1
5187107|NCT01194154|17907315|P1|Overall Study|Hemoglobin decrease|0
5187108|NCT01194154|17907314|P2|Overall Study|Blood pressure increase|3
5187109|NCT01194154|17907315|P1|Overall Study|Blood pressure increase|5
5187110|NCT01194154|17907314|P2|Overall Study|Withdrawal by Subject|6
5187111|NCT01194154|17907315|P1|Overall Study|Withdrawal by Subject|5
5187112|NCT01194154|17907314|P2|Overall Study|Protocol Violation|1
5187113|NCT01194154|17907315|P1|Overall Study|Protocol Violation|0
5187114|NCT01194154|17907314|P2|Overall Study|Lost to Follow-up|3
5187115|NCT01194154|17907315|P1|Overall Study|Lost to Follow-up|2
5187116|NCT01194154|17907314|P2|Overall Study|Adverse Event|7
5187117|NCT01194154|17907315|P1|Overall Study|Adverse Event|12
5187118|NCT01193920|17907356|P10|Overall Study|Unable to classify|0
5187119|NCT01193920|17907357|P9|Overall Study|Unable to classify|0
5187120|NCT01193920|17907358|P8|Overall Study|Unable to classify|1
5187121|NCT01193920|17907359|P7|Overall Study|Unable to classify|0
5187122|NCT01193920|17907360|P6|Overall Study|Unable to classify|0
5187123|NCT01193920|17907361|P5|Overall Study|Unable to classify|0
5187124|NCT01193920|17907362|P4|Overall Study|Unable to classify|1
5187125|NCT01193920|17907363|P3|Overall Study|Unable to classify|0
5187126|NCT01193920|17907364|P2|Overall Study|Unable to classify|0
5187127|NCT01193920|17907365|P1|Overall Study|Unable to classify|0
5187128|NCT01193920|17907356|P10|Overall Study|Death|4
5187129|NCT01193920|17907357|P9|Overall Study|Death|2
5187130|NCT01193920|17907358|P8|Overall Study|Death|3
5187131|NCT01193920|17907359|P7|Overall Study|Death|2
5187132|NCT01193920|17907360|P6|Overall Study|Death|0
5187133|NCT01193920|17907361|P5|Overall Study|Death|0
5187134|NCT01193920|17907362|P4|Overall Study|Death|1
5187135|NCT01193920|17907363|P3|Overall Study|Death|0
5187136|NCT01193920|17907364|P2|Overall Study|Death|0
5187137|NCT01193920|17907365|P1|Overall Study|Death|0
5187138|NCT01193920|17907356|P10|Overall Study|Protocol Violation|0
5187139|NCT01193920|17907357|P9|Overall Study|Protocol Violation|0
5187140|NCT01193920|17907358|P8|Overall Study|Protocol Violation|0
5187141|NCT01193920|17907359|P7|Overall Study|Protocol Violation|0
5187142|NCT01193920|17907360|P6|Overall Study|Protocol Violation|0
5187143|NCT01193920|17907361|P5|Overall Study|Protocol Violation|0
5187144|NCT01193920|17907362|P4|Overall Study|Protocol Violation|0
5187145|NCT01193920|17907363|P3|Overall Study|Protocol Violation|0
5187146|NCT01193920|17907364|P2|Overall Study|Protocol Violation|0
5187147|NCT01193920|17907365|P1|Overall Study|Protocol Violation|1
5187148|NCT01193920|17907356|P10|Overall Study|Lost to Follow-up|3
5187149|NCT01193920|17907357|P9|Overall Study|Lost to Follow-up|2
5187150|NCT01193920|17907358|P8|Overall Study|Lost to Follow-up|0
5187151|NCT01193920|17907359|P7|Overall Study|Lost to Follow-up|1
5187152|NCT01193920|17907360|P6|Overall Study|Lost to Follow-up|3
5187153|NCT01193920|17907361|P5|Overall Study|Lost to Follow-up|3
5187154|NCT01193920|17907362|P4|Overall Study|Lost to Follow-up|1
5187155|NCT01193920|17907363|P3|Overall Study|Lost to Follow-up|1
5187156|NCT01193920|17907364|P2|Overall Study|Lost to Follow-up|0
5187157|NCT01193920|17907365|P1|Overall Study|Lost to Follow-up|1
5187159|NCT01193920|17907357|P9|Overall Study|Withdrawal by Subject|1
5187160|NCT01193920|17907358|P8|Overall Study|Withdrawal by Subject|0
5187161|NCT01193920|17907359|P7|Overall Study|Withdrawal by Subject|3
5187162|NCT01193920|17907360|P6|Overall Study|Withdrawal by Subject|1
5187163|NCT01193920|17907361|P5|Overall Study|Withdrawal by Subject|3
5187164|NCT01193920|17907362|P4|Overall Study|Withdrawal by Subject|1
5187165|NCT01193920|17907363|P3|Overall Study|Withdrawal by Subject|5
5187166|NCT01193920|17907364|P2|Overall Study|Withdrawal by Subject|0
5187167|NCT01193920|17907365|P1|Overall Study|Withdrawal by Subject|1
5187168|NCT01193842|17907461|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
5187169|NCT01193842|17907462|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
5187170|NCT01193842|17907463|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5187171|NCT01193842|17907464|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5187172|NCT01193842|17907465|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5187173|NCT01193842|17907461|P5|Phase II: Randomized Groups|Ineligible|1
5187174|NCT01193842|17907462|P4|Phase II: Randomized Groups|Ineligible|0
5187175|NCT01193842|17907463|P3|Phase II: Randomized Groups|Ineligible|0
5187176|NCT01193842|17907464|P2|Phase II: Randomized Groups|Ineligible|0
5187177|NCT01193842|17907465|P1|Phase II: Randomized Groups|Ineligible|0
5187178|NCT01193842|17907461|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
5187179|NCT01193842|17907462|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
5187180|NCT01193842|17907463|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
5187181|NCT01193842|17907464|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
5187182|NCT01193842|17907465|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
5187183|NCT01193842|17907461|P5|Phase II: Randomized Groups|Adverse Event|3
5187184|NCT01193842|17907462|P4|Phase II: Randomized Groups|Adverse Event|5
5187185|NCT01193842|17907463|P3|Phase II: Randomized Groups|Adverse Event|0
5187186|NCT01193842|17907464|P2|Phase II: Randomized Groups|Adverse Event|0
5187187|NCT01193842|17907465|P1|Phase II: Randomized Groups|Adverse Event|0
5187188|NCT01193842|17907461|P5|Phase II: Randomized Groups|Death|1
5187189|NCT01193842|17907462|P4|Phase II: Randomized Groups|Death|1
5187190|NCT01193842|17907463|P3|Phase II: Randomized Groups|Death|0
5187191|NCT01193842|17907464|P2|Phase II: Randomized Groups|Death|0
5187192|NCT01193842|17907465|P1|Phase II: Randomized Groups|Death|0
5187193|NCT01193842|17907461|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5187194|NCT01193842|17907462|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5187195|NCT01193842|17907463|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
5187196|NCT01193842|17907464|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5187197|NCT01193842|17907465|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5187198|NCT01193842|17907461|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5187199|NCT01193842|17907462|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5187200|NCT01193842|17907463|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5187201|NCT01193842|17907464|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5187202|NCT01193842|17907465|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
5187203|NCT01193842|17907461|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5187204|NCT01193842|17907462|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5187205|NCT01193842|17907463|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5187206|NCT01193842|17907464|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
5187207|NCT01193842|17907465|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5187208|NCT01193686|17907500|P2|Overall Study|Removed by Investigators; unable to matc|0
5187209|NCT01193686|17907501|P1|Overall Study|Removed by Investigators; unable to matc|3
5187210|NCT01193686|17907500|P2|Overall Study|Withdrawal by Subject|1
5187211|NCT01193686|17907501|P1|Overall Study|Withdrawal by Subject|4
5187212|NCT01193660|17907518|P3|Overall Study|Physician Decision|1
5187213|NCT01193660|17907519|P2|Overall Study|Physician Decision|0
5187214|NCT01193660|17907520|P1|Overall Study|Physician Decision|1
5187215|NCT01193660|17907518|P3|Overall Study|Death|0
5187216|NCT01193660|17907519|P2|Overall Study|Death|0
5187217|NCT01193660|17907520|P1|Overall Study|Death|1
5187218|NCT01193660|17907518|P3|Overall Study|Withdrawal by Subject|1
5187219|NCT01193660|17907519|P2|Overall Study|Withdrawal by Subject|3
5187220|NCT01193660|17907520|P1|Overall Study|Withdrawal by Subject|2
5187221|NCT01193608|17907564|P6|Overall Study|Adverse Event|0
5187222|NCT01193608|17907565|P5|Overall Study|Adverse Event|1
5187223|NCT01193608|17907566|P4|Overall Study|Adverse Event|0
5187224|NCT01193608|17907567|P3|Overall Study|Adverse Event|0
5187225|NCT01193608|17907568|P2|Overall Study|Adverse Event|0
5187226|NCT01193608|17907569|P1|Overall Study|Adverse Event|0
5187227|NCT01193608|17907564|P6|Overall Study|Lost to Follow-up|2
5187228|NCT01193608|17907565|P5|Overall Study|Lost to Follow-up|1
5187229|NCT01193608|17907566|P4|Overall Study|Lost to Follow-up|0
5187230|NCT01193608|17907567|P3|Overall Study|Lost to Follow-up|0
5187231|NCT01193608|17907568|P2|Overall Study|Lost to Follow-up|0
5187232|NCT01193608|17907569|P1|Overall Study|Lost to Follow-up|0
5187233|NCT01193608|17907564|P6|Overall Study|Withdrawal by Subject|0
5187234|NCT01193608|17907565|P5|Overall Study|Withdrawal by Subject|3
5187235|NCT01193608|17907566|P4|Overall Study|Withdrawal by Subject|3
5187236|NCT01193608|17907567|P3|Overall Study|Withdrawal by Subject|2
5187237|NCT01193608|17907568|P2|Overall Study|Withdrawal by Subject|1
5187238|NCT01193608|17907569|P1|Overall Study|Withdrawal by Subject|0
5187239|NCT01193608|17907564|P6|Overall Study|Other|0
5187240|NCT01193608|17907565|P5|Overall Study|Other|0
5187241|NCT01193608|17907566|P4|Overall Study|Other|0
5187242|NCT01193608|17907567|P3|Overall Study|Other|0
5187243|NCT01193608|17907568|P2|Overall Study|Other|1
5187244|NCT01193608|17907569|P1|Overall Study|Other|0
5187245|NCT01193582|17907806|P4|12 Month Follow-up|Withdrawal by Subject|11
5187246|NCT01193582|17907807|P3|12 Month Follow-up|Withdrawal by Subject|3
5187247|NCT01193582|17907808|P2|12 Month Follow-up|Withdrawal by Subject|0
5187248|NCT01193582|17907809|P1|12 Month Follow-up|Withdrawal by Subject|6
5187249|NCT01193582|17907806|P4|12 Month Follow-up|Death|0
5187250|NCT01193582|17907807|P3|12 Month Follow-up|Death|1
5187251|NCT01193582|17907808|P2|12 Month Follow-up|Death|0
5187252|NCT01193582|17907809|P1|12 Month Follow-up|Death|0
5187253|NCT01193582|17907806|P4|Vaccination Series|Withdrawal by Subject|3
5187254|NCT01193582|17907807|P3|Vaccination Series|Withdrawal by Subject|8
5187255|NCT01193582|17907808|P2|Vaccination Series|Withdrawal by Subject|13
5187256|NCT01193582|17907809|P1|Vaccination Series|Withdrawal by Subject|11
5187257|NCT01193556|17907839|P2|Overall Study|Study termination|25
5187258|NCT01193556|17907840|P1|Overall Study|Study termination|26
5187259|NCT01193530|17907850|P2|Overall Study|Non-Compliance|1
5187260|NCT01193530|17907851|P1|Overall Study|Non-Compliance|0
5187261|NCT01193530|17907850|P2|Overall Study|Returned home - out of state|1
5187262|NCT01193530|17907851|P1|Overall Study|Returned home - out of state|0
5187263|NCT01193530|17907850|P2|Overall Study|Lost Light Box|1
5187264|NCT01193530|17907851|P1|Overall Study|Lost Light Box|0
5187265|NCT01193530|17907850|P2|Overall Study|Began Contraindicated Therapy|0
5187266|NCT01193530|17907851|P1|Overall Study|Began Contraindicated Therapy|1
5187267|NCT01193530|17907850|P2|Overall Study|Withdrawal by Subject|2
5187268|NCT01193530|17907851|P1|Overall Study|Withdrawal by Subject|2
5187269|NCT01193517|17907860|P3|Overall Study|Early Progression|0
5187270|NCT01193517|17907861|P2|Overall Study|Early Progression|0
5187271|NCT01193517|17907862|P1|Overall Study|Early Progression|1
5187272|NCT01193348|17907871|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
5187273|NCT01193348|17907871|P1|Extension Treatment Period|Physician Decision|1
5187274|NCT01193348|17907871|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
5187275|NCT01193348|17907871|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
5187276|NCT01193348|17907871|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
5187277|NCT01193348|17907871|P1|Screening Period|Screen Failure|5
5187278|NCT01193335|17907891|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
5187279|NCT01193335|17907892|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
5187280|NCT01193335|17907891|P2|2-Year Follow-up|No Longer Willing to Participate|6
5187281|NCT01193335|17907892|P1|2-Year Follow-up|No Longer Willing to Participate|5
5187282|NCT01193335|17907891|P2|1-Year Follow-up|Lost to Follow-up|0
5187283|NCT01193335|17907892|P1|1-Year Follow-up|Lost to Follow-up|4
5187284|NCT01193335|17907891|P2|1-Year Follow-up|No Longer Willing to Participate|9
5187285|NCT01193335|17907892|P1|1-Year Follow-up|No Longer Willing to Participate|7
5187286|NCT01193335|17907891|P2|After Infant Series|No Longer Met Eligibility Criteria|1
5187287|NCT01193335|17907892|P1|After Infant Series|No Longer Met Eligibility Criteria|0
5187288|NCT01193335|17907891|P2|After Infant Series|Lost to Follow-up|2
5187289|NCT01193335|17907892|P1|After Infant Series|Lost to Follow-up|1
5187290|NCT01193283|17907987|P1|Overall Study|Death|1
5187291|NCT01193257|17907993|P2|Overall Study|Unblinded due to futility|251
5187292|NCT01193257|17907994|P1|Overall Study|Unblinded due to futility|135
5187293|NCT01193257|17907993|P2|Overall Study|Lost to Follow-up|3
5187294|NCT01193257|17907994|P1|Overall Study|Lost to Follow-up|2
5187295|NCT01193257|17907993|P2|Overall Study|Withdrawal by Subject|86
5187296|NCT01193257|17907994|P1|Overall Study|Withdrawal by Subject|26
5187297|NCT01193257|17907993|P2|Overall Study|Study termination by sponsor|3
5187298|NCT01193257|17907994|P1|Overall Study|Study termination by sponsor|0
5187299|NCT01193257|17907993|P2|Overall Study|Death|391
5187300|NCT01193257|17907994|P1|Overall Study|Death|202
5187301|NCT01193244|17908044|P2|Overall Study|Lost to Follow-up|15
5187302|NCT01193244|17908045|P1|Overall Study|Lost to Follow-up|6
5187303|NCT01193244|17908044|P2|Overall Study|Other|278
5187304|NCT01193244|17908045|P1|Overall Study|Other|303
5187305|NCT01193244|17908044|P2|Overall Study|Withdrawal by Subject|97
5187306|NCT01193244|17908045|P1|Overall Study|Withdrawal by Subject|79
5187307|NCT01193218|17908100|P8|12-52 Weeks|Other reason than above|0
5187308|NCT01193218|17908101|P7|12-52 Weeks|Other reason than above|0
5187309|NCT01193218|17908102|P6|12-52 Weeks|Other reason than above|0
5187310|NCT01193218|17908103|P5|12-52 Weeks|Other reason than above|1
5187311|NCT01193218|17908104|P4|12-52 Weeks|Other reason than above|1
5187312|NCT01193218|17908105|P3|12-52 Weeks|Other reason than above|0
5187313|NCT01193218|17908106|P2|12-52 Weeks|Other reason than above|0
5187314|NCT01193218|17908107|P1|12-52 Weeks|Other reason than above|1
5187315|NCT01193218|17908100|P8|12-52 Weeks|Withdrawal by Subject|2
5187316|NCT01193218|17908101|P7|12-52 Weeks|Withdrawal by Subject|1
5187317|NCT01193218|17908102|P6|12-52 Weeks|Withdrawal by Subject|2
5187318|NCT01193218|17908103|P5|12-52 Weeks|Withdrawal by Subject|0
5187319|NCT01193218|17908104|P4|12-52 Weeks|Withdrawal by Subject|0
5187320|NCT01193218|17908105|P3|12-52 Weeks|Withdrawal by Subject|3
5187321|NCT01193218|17908106|P2|12-52 Weeks|Withdrawal by Subject|0
5187322|NCT01193218|17908107|P1|12-52 Weeks|Withdrawal by Subject|3
5187323|NCT01193218|17908100|P8|12-52 Weeks|Lack of Efficacy|0
5187324|NCT01193218|17908101|P7|12-52 Weeks|Lack of Efficacy|1
5187325|NCT01193218|17908102|P6|12-52 Weeks|Lack of Efficacy|0
5187326|NCT01193218|17908103|P5|12-52 Weeks|Lack of Efficacy|0
5187327|NCT01193218|17908104|P4|12-52 Weeks|Lack of Efficacy|0
5187328|NCT01193218|17908105|P3|12-52 Weeks|Lack of Efficacy|0
5187329|NCT01193218|17908106|P2|12-52 Weeks|Lack of Efficacy|0
5187330|NCT01193218|17908107|P1|12-52 Weeks|Lack of Efficacy|0
5187331|NCT01193218|17908100|P8|12-52 Weeks|Adverse Event|2
5187332|NCT01193218|17908101|P7|12-52 Weeks|Adverse Event|1
5187333|NCT01193218|17908102|P6|12-52 Weeks|Adverse Event|3
5187334|NCT01193218|17908103|P5|12-52 Weeks|Adverse Event|3
5187335|NCT01193218|17908104|P4|12-52 Weeks|Adverse Event|2
5187336|NCT01193218|17908105|P3|12-52 Weeks|Adverse Event|1
5187337|NCT01193218|17908106|P2|12-52 Weeks|Adverse Event|0
5187338|NCT01193218|17908107|P1|12-52 Weeks|Adverse Event|1
5187339|NCT01193218|17908100|P8|0-12 Weeks|Withdrawal by Subject|0
5187340|NCT01193218|17908101|P7|0-12 Weeks|Withdrawal by Subject|1
5187341|NCT01193218|17908102|P6|0-12 Weeks|Withdrawal by Subject|0
5187342|NCT01193218|17908103|P5|0-12 Weeks|Withdrawal by Subject|0
5187343|NCT01193218|17908104|P4|0-12 Weeks|Withdrawal by Subject|0
5187344|NCT01193218|17908105|P3|0-12 Weeks|Withdrawal by Subject|2
5187345|NCT01193218|17908106|P2|0-12 Weeks|Withdrawal by Subject|0
5187346|NCT01193218|17908107|P1|0-12 Weeks|Withdrawal by Subject|3
5187347|NCT01193218|17908100|P8|0-12 Weeks|Protocol Violation|0
5187348|NCT01193218|17908101|P7|0-12 Weeks|Protocol Violation|0
5187349|NCT01193218|17908102|P6|0-12 Weeks|Protocol Violation|1
5187350|NCT01193218|17908103|P5|0-12 Weeks|Protocol Violation|1
5187351|NCT01193218|17908104|P4|0-12 Weeks|Protocol Violation|0
5187352|NCT01193218|17908105|P3|0-12 Weeks|Protocol Violation|0
5187353|NCT01193218|17908106|P2|0-12 Weeks|Protocol Violation|0
5187354|NCT01193218|17908107|P1|0-12 Weeks|Protocol Violation|0
5187355|NCT01193218|17908100|P8|0-12 Weeks|Adverse Event|0
5187356|NCT01193218|17908101|P7|0-12 Weeks|Adverse Event|2
5187357|NCT01193218|17908102|P6|0-12 Weeks|Adverse Event|2
5187358|NCT01193218|17908103|P5|0-12 Weeks|Adverse Event|0
5187359|NCT01193218|17908104|P4|0-12 Weeks|Adverse Event|0
5187360|NCT01193218|17908105|P3|0-12 Weeks|Adverse Event|1
5187361|NCT01193218|17908106|P2|0-12 Weeks|Adverse Event|0
5187362|NCT01193218|17908107|P1|0-12 Weeks|Adverse Event|6
5187363|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
5187364|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
5187365|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
5187366|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
5187367|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
5187368|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
5187369|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Pregnancy|0
5187370|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Pregnancy|1
5187371|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
5187372|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
5187373|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Death|0
5187374|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Death|2
5187375|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Adverse Event|3
5187376|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Adverse Event|12
5187377|NCT01193153|17908138|P2|Double Blind Relapse Prevention Period|Other|3
5187378|NCT01193153|17908139|P1|Double Blind Relapse Prevention Period|Other|2
5187379|NCT01193153|17908138|P2|Open-label Stabilization Period|Other|0
5187380|NCT01193153|17908139|P1|Open-label Stabilization Period|Other|8
5187381|NCT01193153|17908138|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
5187382|NCT01193153|17908139|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
5187383|NCT01193153|17908138|P2|Open-label Stabilization Period|Withdrawal by Subject|0
5187384|NCT01193153|17908139|P1|Open-label Stabilization Period|Withdrawal by Subject|29
5187385|NCT01193153|17908138|P2|Open-label Stabilization Period|Lack of Efficacy|0
5187386|NCT01193153|17908139|P1|Open-label Stabilization Period|Lack of Efficacy|5
5187387|NCT01193153|17908138|P2|Open-label Stabilization Period|Lost to Follow-up|0
5187388|NCT01193153|17908139|P1|Open-label Stabilization Period|Lost to Follow-up|10
5187389|NCT01193153|17908138|P2|Open-label Stabilization Period|Death|0
5187390|NCT01193153|17908139|P1|Open-label Stabilization Period|Death|2
5187391|NCT01193153|17908138|P2|Open-label Stabilization Period|Adverse Event|0
5187392|NCT01193153|17908139|P1|Open-label Stabilization Period|Adverse Event|9
5187393|NCT01193153|17908138|P2|Open-label Lead in Period|Lack of Efficacy|0
5187394|NCT01193153|17908139|P1|Open-label Lead in Period|Lack of Efficacy|26
5187395|NCT01193153|17908138|P2|Open-label Lead in Period|Death|0
5187396|NCT01193153|17908139|P1|Open-label Lead in Period|Death|1
5187397|NCT01193153|17908138|P2|Open-label Lead in Period|Adverse Event|0
5187398|NCT01193153|17908139|P1|Open-label Lead in Period|Adverse Event|41
5187399|NCT01193153|17908138|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
5187400|NCT01193153|17908139|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
5187401|NCT01193153|17908138|P2|Open-label Lead in Period|Other|0
5187402|NCT01193153|17908139|P1|Open-label Lead in Period|Other|14
5187403|NCT01193153|17908138|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
5187404|NCT01193153|17908139|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
5187405|NCT01193153|17908138|P2|Open-label Lead in Period|Withdrawal by Subject|0
5187406|NCT01193153|17908139|P1|Open-label Lead in Period|Withdrawal by Subject|69
5187407|NCT01193153|17908138|P2|Open-label Lead in Period|Pregnancy|0
5187408|NCT01193153|17908139|P1|Open-label Lead in Period|Pregnancy|1
5187409|NCT01193153|17908138|P2|Open-label Lead in Period|Lost to Follow-up|0
5187410|NCT01193153|17908139|P1|Open-label Lead in Period|Lost to Follow-up|32
5187411|NCT01193127|17908174|P4|Treated|Withdrawal by Subject|1
5187412|NCT01193127|17908175|P3|Treated|Withdrawal by Subject|0
5187413|NCT01193127|17908176|P2|Treated|Withdrawal by Subject|0
5187414|NCT01193127|17908177|P1|Treated|Withdrawal by Subject|0
5187415|NCT01193127|17908174|P4|Randomized|Surgery Cancelled|1
5187416|NCT01193127|17908175|P3|Randomized|Surgery Cancelled|0
5187417|NCT01193127|17908176|P2|Randomized|Surgery Cancelled|0
5187418|NCT01193127|17908177|P1|Randomized|Surgery Cancelled|0
5187419|NCT01193101|17908502|P4|Overall Study|Abnormal test procedure results|0
5187420|NCT01193101|17908503|P3|Overall Study|Abnormal test procedure results|0
5187421|NCT01193101|17908504|P2|Overall Study|Abnormal test procedure results|1
5187422|NCT01193101|17908505|P1|Overall Study|Abnormal test procedure results|0
5187423|NCT01193101|17908502|P4|Overall Study|Administrative problems|0
5187424|NCT01193101|17908503|P3|Overall Study|Administrative problems|1
5187425|NCT01193101|17908504|P2|Overall Study|Administrative problems|0
5187426|NCT01193101|17908505|P1|Overall Study|Administrative problems|0
5187427|NCT01193101|17908502|P4|Overall Study|Withdrawal by Subject|1
5187428|NCT01193101|17908503|P3|Overall Study|Withdrawal by Subject|1
5187429|NCT01193101|17908504|P2|Overall Study|Withdrawal by Subject|4
5187430|NCT01193101|17908505|P1|Overall Study|Withdrawal by Subject|2
5187431|NCT01193101|17908502|P4|Overall Study|Lack of Efficacy|8
5187432|NCT01193101|17908503|P3|Overall Study|Lack of Efficacy|0
5187433|NCT01193101|17908504|P2|Overall Study|Lack of Efficacy|1
5187434|NCT01193101|17908505|P1|Overall Study|Lack of Efficacy|3
5187435|NCT01193101|17908502|P4|Overall Study|Adverse Event|3
5187436|NCT01193101|17908503|P3|Overall Study|Adverse Event|1
5187437|NCT01193101|17908504|P2|Overall Study|Adverse Event|1
5187438|NCT01193101|17908505|P1|Overall Study|Adverse Event|0
5187439|NCT01192815|17908622|P1|Overall Study|Lack of Efficacy|1
5187440|NCT01192815|17908622|P1|Overall Study|Withdrawal by Subject|1
5187441|NCT01192776|17908637|P4|Overall Study|Lost to Follow-up|5
5187442|NCT01192776|17908638|P3|Overall Study|Lost to Follow-up|3
5187443|NCT01192776|17908639|P2|Overall Study|Lost to Follow-up|6
5187444|NCT01192776|17908640|P1|Overall Study|Lost to Follow-up|3
5187445|NCT01192776|17908637|P4|Overall Study|Death|15
5187446|NCT01192776|17908638|P3|Overall Study|Death|18
5187447|NCT01192776|17908639|P2|Overall Study|Death|15
5187448|NCT01192776|17908640|P1|Overall Study|Death|8
5187449|NCT01192516|17908718|P3|Overall Study|Unable to follow Actiwatch instructions|0
5187450|NCT01192516|17908719|P2|Overall Study|Unable to follow Actiwatch instructions|2
5187451|NCT01192516|17908720|P1|Overall Study|Unable to follow Actiwatch instructions|4
5187452|NCT01192516|17908718|P3|Overall Study|started new treatment|0
5187453|NCT01192516|17908719|P2|Overall Study|started new treatment|1
5187454|NCT01192516|17908720|P1|Overall Study|started new treatment|5
5187455|NCT01192516|17908718|P3|Overall Study|Withdrawal by Subject|1
5187456|NCT01192516|17908719|P2|Overall Study|Withdrawal by Subject|4
5187457|NCT01192516|17908720|P1|Overall Study|Withdrawal by Subject|4
5187458|NCT01192516|17908718|P3|Overall Study|Lost to Follow-up|7
5187459|NCT01192516|17908719|P2|Overall Study|Lost to Follow-up|10
5187460|NCT01192516|17908720|P1|Overall Study|Lost to Follow-up|7
5187461|NCT01192412|17908754|P2|Overall Study|Withdrawal by Subject|1
5187462|NCT01192412|17908755|P1|Overall Study|Withdrawal by Subject|2
5187463|NCT01192412|17908754|P2|Overall Study|Lost to Follow-up|1
5187464|NCT01192412|17908755|P1|Overall Study|Lost to Follow-up|2
5187465|NCT01192399|17908763|P1|Overall Study|Lack of Efficacy|2
5187466|NCT01192347|17908773|P1|Overall Study|Patient did not show up for visits|1
5187467|NCT01192347|17908773|P1|Overall Study|Patient not visiting hospital regularly|1
5187468|NCT01192347|17908773|P1|Overall Study|Patient seen in different hospital|1
5187469|NCT01192347|17908773|P1|Overall Study|Suspected serious adverse drug reaction|1
5187470|NCT01192347|17908773|P1|Overall Study|Adverse Event|1
5187471|NCT01192347|17908773|P1|Overall Study|Withdrawal by Subject|1
5187472|NCT01192347|17908773|P1|Overall Study|Lost to Follow-up|3
5187473|NCT01192347|17908773|P1|Overall Study|Death|3
5187474|NCT01192295|17908796|P2|Overall Study|Administrative|6
5187475|NCT01192295|17908797|P1|Overall Study|Administrative|4
5187476|NCT01192295|17908796|P2|Overall Study|Lack of Efficacy|5
5187477|NCT01192295|17908797|P1|Overall Study|Lack of Efficacy|0
5187478|NCT01192295|17908796|P2|Overall Study|Lost to Follow-up|1
5187479|NCT01192295|17908797|P1|Overall Study|Lost to Follow-up|0
5187480|NCT01192295|17908796|P2|Overall Study|Withdrawal by Subject|4
5187481|NCT01192295|17908797|P1|Overall Study|Withdrawal by Subject|3
5187482|NCT01192295|17908796|P2|Overall Study|Adverse Event|7
5187483|NCT01192295|17908797|P1|Overall Study|Adverse Event|3
5187484|NCT01192204|17908835|P2|Overall Study|could not keep recall appointments|0
5187485|NCT01192204|17908836|P1|Overall Study|could not keep recall appointments|1
5187486|NCT01192191|17908848|P2|Overall Study|Withdrawal by Subject|6
5187487|NCT01192191|17908849|P1|Overall Study|Withdrawal by Subject|1
5187488|NCT01192191|17908848|P2|Overall Study|Lost to Follow-up|1
5187489|NCT01192191|17908849|P1|Overall Study|Lost to Follow-up|0
5187490|NCT01192191|17908848|P2|Overall Study|Participants Reached Stopping Criteria|2
5187491|NCT01192191|17908849|P1|Overall Study|Participants Reached Stopping Criteria|3
5187492|NCT01192191|17908848|P2|Overall Study|Adverse Event|12
5187493|NCT01192191|17908849|P1|Overall Study|Adverse Event|7
5187494|NCT01192178|17908875|P2|Overall Study|Lack of Efficacy|2
5187495|NCT01192178|17908876|P1|Overall Study|Lack of Efficacy|1
5187496|NCT01192178|17908875|P2|Overall Study|Adverse Event|1
5187497|NCT01192178|17908876|P1|Overall Study|Adverse Event|2
5187498|NCT01192178|17908875|P2|Overall Study|Lost to Follow-up|3
5187499|NCT01192178|17908876|P1|Overall Study|Lost to Follow-up|3
5187500|NCT01192178|17908875|P2|Overall Study|Physician Decision|4
5187501|NCT01192178|17908876|P1|Overall Study|Physician Decision|2
5187502|NCT01192178|17908875|P2|Overall Study|Protocol Violation|3
5187503|NCT01192178|17908876|P1|Overall Study|Protocol Violation|10
5187504|NCT01192178|17908875|P2|Overall Study|Withdrawal by Subject|10
5187505|NCT01192178|17908876|P1|Overall Study|Withdrawal by Subject|6
5187506|NCT01192152|17908896|P2|Period 3|family emergency|0
5187507|NCT01192152|17908897|P1|Period 3|family emergency|1
5187508|NCT01192152|17908896|P2|Period 1|left prematurely (while on treatment B)|1
5187509|NCT01192152|17908897|P1|Period 1|left prematurely (while on treatment B)|0
5187510|NCT01192126|17909068|P2|First Intervention (1 Week)|Lost to Follow-up|1
5187511|NCT01192126|17909069|P1|First Intervention (1 Week)|Lost to Follow-up|1
5187512|NCT01192126|17909068|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
5187513|NCT01192126|17909069|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
5187514|NCT01192100|17909077|P6|Overall Study|Protocol Violation|0
5187515|NCT01192100|17909078|P5|Overall Study|Protocol Violation|0
5187516|NCT01192100|17909079|P4|Overall Study|Protocol Violation|1
5187517|NCT01192100|17909080|P3|Overall Study|Protocol Violation|0
5187518|NCT01192100|17909081|P2|Overall Study|Protocol Violation|0
5187519|NCT01192100|17909082|P1|Overall Study|Protocol Violation|0
5187520|NCT01192100|17909077|P6|Overall Study|Withdrawal by Subject|0
5187521|NCT01192100|17909078|P5|Overall Study|Withdrawal by Subject|1
5187522|NCT01192100|17909079|P4|Overall Study|Withdrawal by Subject|0
5187523|NCT01192100|17909080|P3|Overall Study|Withdrawal by Subject|0
5187524|NCT01192100|17909081|P2|Overall Study|Withdrawal by Subject|0
5187525|NCT01192100|17909082|P1|Overall Study|Withdrawal by Subject|0
5187526|NCT01192022|17909102|P5|Overall Study|Parents did not allow all follow up|0
5187527|NCT01192022|17909103|P4|Overall Study|Parents did not allow all follow up|1
5187528|NCT01192022|17909104|P3|Overall Study|Parents did not allow all follow up|0
5187529|NCT01192022|17909105|P2|Overall Study|Parents did not allow all follow up|0
5187530|NCT01192022|17909106|P1|Overall Study|Parents did not allow all follow up|0
5187531|NCT01192022|17909102|P5|Overall Study|Patient needed surgery|0
5187532|NCT01192022|17909103|P4|Overall Study|Patient needed surgery|0
5187533|NCT01192022|17909104|P3|Overall Study|Patient needed surgery|0
5187534|NCT01192022|17909105|P2|Overall Study|Patient needed surgery|1
5187535|NCT01192022|17909106|P1|Overall Study|Patient needed surgery|0
5187536|NCT01192022|17909102|P5|Overall Study|Patient too sick from chemotherapy|0
5187537|NCT01192022|17909103|P4|Overall Study|Patient too sick from chemotherapy|0
5187538|NCT01192022|17909104|P3|Overall Study|Patient too sick from chemotherapy|0
5187539|NCT01192022|17909105|P2|Overall Study|Patient too sick from chemotherapy|1
5187540|NCT01192022|17909106|P1|Overall Study|Patient too sick from chemotherapy|0
5187541|NCT01192022|17909102|P5|Overall Study|Physician withdrew-patient hardship|0
5187542|NCT01192022|17909103|P4|Overall Study|Physician withdrew-patient hardship|0
5187543|NCT01192022|17909104|P3|Overall Study|Physician withdrew-patient hardship|0
5187544|NCT01192022|17909105|P2|Overall Study|Physician withdrew-patient hardship|0
5187545|NCT01192022|17909106|P1|Overall Study|Physician withdrew-patient hardship|1
5187546|NCT01192022|17909102|P5|Overall Study|Fatal Adverse Event|1
5187547|NCT01192022|17909103|P4|Overall Study|Fatal Adverse Event|0
5187548|NCT01192022|17909104|P3|Overall Study|Fatal Adverse Event|0
5187549|NCT01192022|17909105|P2|Overall Study|Fatal Adverse Event|6
5187550|NCT01192022|17909106|P1|Overall Study|Fatal Adverse Event|4
5187551|NCT01192022|17909102|P5|Overall Study|Adverse Event|0
5187552|NCT01192022|17909103|P4|Overall Study|Adverse Event|0
5187553|NCT01192022|17909104|P3|Overall Study|Adverse Event|0
5187554|NCT01192022|17909105|P2|Overall Study|Adverse Event|0
5187555|NCT01192022|17909106|P1|Overall Study|Adverse Event|1
5187556|NCT01192022|17909102|P5|Overall Study|Lost to Follow-up|0
5187557|NCT01192022|17909103|P4|Overall Study|Lost to Follow-up|1
5187558|NCT01192022|17909104|P3|Overall Study|Lost to Follow-up|1
5187559|NCT01192022|17909105|P2|Overall Study|Lost to Follow-up|2
5187560|NCT01192022|17909106|P1|Overall Study|Lost to Follow-up|4
5187561|NCT01192022|17909102|P5|Overall Study|Withdrawal of Consent|0
5187562|NCT01192022|17909103|P4|Overall Study|Withdrawal of Consent|0
5187563|NCT01192022|17909104|P3|Overall Study|Withdrawal of Consent|0
5187564|NCT01192022|17909105|P2|Overall Study|Withdrawal of Consent|1
5187565|NCT01192022|17909106|P1|Overall Study|Withdrawal of Consent|3
5187566|NCT01191944|17909129|P2|Overall Study|Other|3
5187567|NCT01191944|17909130|P1|Overall Study|Other|1
5187568|NCT01191944|17909129|P2|Overall Study|Withdrawal by Subject|2
5187569|NCT01191944|17909130|P1|Overall Study|Withdrawal by Subject|4
5187570|NCT01191944|17909129|P2|Overall Study|Protocol Violation|2
5187571|NCT01191944|17909130|P1|Overall Study|Protocol Violation|1
5187572|NCT01191944|17909129|P2|Overall Study|Adverse Event|12
5187573|NCT01191944|17909130|P1|Overall Study|Adverse Event|11
5187574|NCT01191840|17909176|P2|Overall Study|Withdrawal by Subject|0
5187575|NCT01191840|17909177|P1|Overall Study|Withdrawal by Subject|2
5187576|NCT01191840|17909176|P2|Overall Study|lab error speciation - non Staph infecti|1
5187577|NCT01191840|17909177|P1|Overall Study|lab error speciation - non Staph infecti|0
5187578|NCT01191840|17909176|P2|Overall Study|IRB approval lapse|2
5187579|NCT01191840|17909177|P1|Overall Study|IRB approval lapse|0
5187580|NCT01191840|17909176|P2|Overall Study|ineligible at enrollment|0
5187581|NCT01191840|17909177|P1|Overall Study|ineligible at enrollment|1
5187582|NCT01191840|17909176|P2|Overall Study|Non Staph Infection|3
5187583|NCT01191840|17909177|P1|Overall Study|Non Staph Infection|4
5187584|NCT01191840|17909176|P2|Overall Study|Lost to Follow-up|6
5187585|NCT01191840|17909177|P1|Overall Study|Lost to Follow-up|4
5187586|NCT01191840|17909176|P2|Overall Study|Subject discontinued treatment|2
5187587|NCT01191840|17909177|P1|Overall Study|Subject discontinued treatment|1
5187588|NCT01191840|17909176|P2|Overall Study|withdrew consent|1
5187589|NCT01191840|17909177|P1|Overall Study|withdrew consent|2
5187590|NCT01191801|17909202|P2|Overall Study|Not Provided|27
5187591|NCT01191801|17909203|P1|Overall Study|Not Provided|45
5187592|NCT01191801|17909202|P2|Overall Study|Withdrawal by Subject|4
5187593|NCT01191801|17909203|P1|Overall Study|Withdrawal by Subject|1
5187594|NCT01191801|17909202|P2|Overall Study|Physician Decision|24
5187595|NCT01191801|17909203|P1|Overall Study|Physician Decision|47
5187596|NCT01191801|17909202|P2|Overall Study|Protocol Violation|4
5187597|NCT01191801|17909203|P1|Overall Study|Protocol Violation|2
5187598|NCT01191801|17909202|P2|Overall Study|Adverse Event|8
5187599|NCT01191801|17909203|P1|Overall Study|Adverse Event|9
5187600|NCT01191801|17909202|P2|Overall Study|Lack of Efficacy|258
5187601|NCT01191801|17909203|P1|Overall Study|Lack of Efficacy|176
5187602|NCT01191801|17909202|P2|Overall Study|Death|12
5187603|NCT01191801|17909203|P1|Overall Study|Death|36
5187604|NCT01191788|17909223|P2|Overall Study|Lost to Follow-up|22
5187605|NCT01191788|17909224|P1|Overall Study|Lost to Follow-up|21
5187606|NCT01191762|17909234|P2|Overall Study|Adverse Event|0
5187607|NCT01191762|17909235|P1|Overall Study|Adverse Event|1
5187608|NCT01191268|17909393|P3|Overall Study|Sponsor Decision|0
5187609|NCT01191268|17909394|P2|Overall Study|Sponsor Decision|2
5187610|NCT01191268|17909395|P1|Overall Study|Sponsor Decision|0
5187611|NCT01191268|17909393|P3|Overall Study|Protocol Violation|1
5187612|NCT01191268|17909394|P2|Overall Study|Protocol Violation|0
5187613|NCT01191268|17909395|P1|Overall Study|Protocol Violation|1
5187614|NCT01191268|17909393|P3|Overall Study|Death|3
5187615|NCT01191268|17909394|P2|Overall Study|Death|1
5187616|NCT01191268|17909395|P1|Overall Study|Death|0
5187617|NCT01191268|17909393|P3|Overall Study|Entry Criteria Not Met|1
5187618|NCT01191268|17909394|P2|Overall Study|Entry Criteria Not Met|1
5187619|NCT01191268|17909395|P1|Overall Study|Entry Criteria Not Met|3
5187620|NCT01191268|17909393|P3|Overall Study|Lost to Follow-up|9
5187621|NCT01191268|17909394|P2|Overall Study|Lost to Follow-up|5
5187622|NCT01191268|17909395|P1|Overall Study|Lost to Follow-up|8
5187623|NCT01191268|17909393|P3|Overall Study|Physician Decision|9
5187624|NCT01191268|17909394|P2|Overall Study|Physician Decision|8
5187625|NCT01191268|17909395|P1|Overall Study|Physician Decision|6
5187626|NCT01191268|17909393|P3|Overall Study|Adverse Event|8
5187627|NCT01191268|17909394|P2|Overall Study|Adverse Event|13
5187628|NCT01191268|17909395|P1|Overall Study|Adverse Event|21
5187629|NCT01191268|17909393|P3|Overall Study|Withdrawal by Subject|21
5187630|NCT01191268|17909394|P2|Overall Study|Withdrawal by Subject|25
5187631|NCT01191268|17909395|P1|Overall Study|Withdrawal by Subject|19
5187632|NCT01191190|17909536|P1|Overall Study|Withdrawal by Subject|1
5187633|NCT01191086|17909549|P1|Overall Study|Other|1
5187634|NCT01191086|17909549|P1|Overall Study|Discontinuation criterion met|1
5187635|NCT01191086|17909549|P1|Overall Study|Withdrawal by Subject|24
5187636|NCT01191086|17909549|P1|Overall Study|Physician Decision|2
5187637|NCT01191086|17909549|P1|Overall Study|Lost to Follow-up|4
5187638|NCT01191086|17909549|P1|Overall Study|Lack of Efficacy|10
5187639|NCT01191086|17909549|P1|Overall Study|Adverse Event|20
5187640|NCT01191008|17909553|P1|Overall Study|Lost to Follow-up|8
5187641|NCT01191008|17909553|P1|Overall Study|Protocol Violation|7
5187642|NCT01190930|17909561|P10|Maintenance|Still on therapy|0
5187643|NCT01190930|17909562|P9|Maintenance|Still on therapy|0
5187644|NCT01190930|17909563|P8|Maintenance|Still on therapy|0
5187645|NCT01190930|17909564|P7|Maintenance|Still on therapy|0
5187646|NCT01190930|17909565|P6|Maintenance|Still on therapy|0
5187647|NCT01190930|17909566|P5|Maintenance|Still on therapy|0
5187648|NCT01190930|17909567|P4|Maintenance|Still on therapy|29
5187649|NCT01190930|17909568|P3|Maintenance|Still on therapy|0
5187650|NCT01190930|17909569|P2|Maintenance|Still on therapy|8
5187651|NCT01190930|17909570|P1|Maintenance|Still on therapy|0
5187652|NCT01190930|17909561|P10|Maintenance|Relapse|11
5187653|NCT01190930|17909562|P9|Maintenance|Relapse|11
5187654|NCT01190930|17909563|P8|Maintenance|Relapse|13
5187655|NCT01190930|17909564|P7|Maintenance|Relapse|6
5187656|NCT01190930|17909565|P6|Maintenance|Relapse|1
5187657|NCT01190930|17909566|P5|Maintenance|Relapse|0
5187658|NCT01190930|17909567|P4|Maintenance|Relapse|2
5187659|NCT01190930|17909568|P3|Maintenance|Relapse|0
5187660|NCT01190930|17909569|P2|Maintenance|Relapse|0
5187661|NCT01190930|17909570|P1|Maintenance|Relapse|0
5187662|NCT01190930|17909561|P10|Maintenance|Enrollment onto another COG Protocol|0
5187663|NCT01190930|17909562|P9|Maintenance|Enrollment onto another COG Protocol|1
5187664|NCT01190930|17909563|P8|Maintenance|Enrollment onto another COG Protocol|0
5187665|NCT01190930|17909564|P7|Maintenance|Enrollment onto another COG Protocol|0
5187666|NCT01190930|17909565|P6|Maintenance|Enrollment onto another COG Protocol|0
5187667|NCT01190930|17909566|P5|Maintenance|Enrollment onto another COG Protocol|0
5187668|NCT01190930|17909567|P4|Maintenance|Enrollment onto another COG Protocol|0
5187669|NCT01190930|17909568|P3|Maintenance|Enrollment onto another COG Protocol|0
5187670|NCT01190930|17909569|P2|Maintenance|Enrollment onto another COG Protocol|0
5187671|NCT01190930|17909570|P1|Maintenance|Enrollment onto another COG Protocol|0
5187672|NCT01190930|17909561|P10|Maintenance|Inevaluable|0
5187673|NCT01190930|17909562|P9|Maintenance|Inevaluable|0
5187674|NCT01190930|17909563|P8|Maintenance|Inevaluable|1
5187675|NCT01190930|17909564|P7|Maintenance|Inevaluable|1
5187676|NCT01190930|17909565|P6|Maintenance|Inevaluable|1
5187677|NCT01190930|17909566|P5|Maintenance|Inevaluable|0
5187678|NCT01190930|17909567|P4|Maintenance|Inevaluable|0
5187679|NCT01190930|17909568|P3|Maintenance|Inevaluable|0
5187680|NCT01190930|17909569|P2|Maintenance|Inevaluable|0
5187681|NCT01190930|17909570|P1|Maintenance|Inevaluable|0
5187682|NCT01190930|17909561|P10|Maintenance|second malignant neoplasm|0
5187683|NCT01190930|17909562|P9|Maintenance|second malignant neoplasm|1
5187684|NCT01190930|17909563|P8|Maintenance|second malignant neoplasm|0
5187685|NCT01190930|17909564|P7|Maintenance|second malignant neoplasm|0
5187686|NCT01190930|17909565|P6|Maintenance|second malignant neoplasm|1
5187687|NCT01190930|17909566|P5|Maintenance|second malignant neoplasm|0
5187688|NCT01190930|17909567|P4|Maintenance|second malignant neoplasm|1
5187689|NCT01190930|17909568|P3|Maintenance|second malignant neoplasm|0
5187690|NCT01190930|17909569|P2|Maintenance|second malignant neoplasm|0
5187691|NCT01190930|17909570|P1|Maintenance|second malignant neoplasm|0
5187692|NCT01190930|17909561|P10|Maintenance|Refusal|6
5187693|NCT01190930|17909562|P9|Maintenance|Refusal|13
5187694|NCT01190930|17909563|P8|Maintenance|Refusal|17
5187695|NCT01190930|17909564|P7|Maintenance|Refusal|5
5187696|NCT01190930|17909565|P6|Maintenance|Refusal|4
5187697|NCT01190930|17909566|P5|Maintenance|Refusal|0
5187698|NCT01190930|17909567|P4|Maintenance|Refusal|2
5187699|NCT01190930|17909568|P3|Maintenance|Refusal|0
5187700|NCT01190930|17909569|P2|Maintenance|Refusal|1
5187701|NCT01190930|17909570|P1|Maintenance|Refusal|0
5187702|NCT01190930|17909561|P10|Maintenance|Withdrawal by Subject|1
5187703|NCT01190930|17909562|P9|Maintenance|Withdrawal by Subject|4
5187704|NCT01190930|17909563|P8|Maintenance|Withdrawal by Subject|1
5187705|NCT01190930|17909564|P7|Maintenance|Withdrawal by Subject|2
5187706|NCT01190930|17909565|P6|Maintenance|Withdrawal by Subject|0
5187707|NCT01190930|17909566|P5|Maintenance|Withdrawal by Subject|0
5187708|NCT01190930|17909567|P4|Maintenance|Withdrawal by Subject|0
5187709|NCT01190930|17909568|P3|Maintenance|Withdrawal by Subject|0
5187710|NCT01190930|17909569|P2|Maintenance|Withdrawal by Subject|0
5187711|NCT01190930|17909570|P1|Maintenance|Withdrawal by Subject|0
5187712|NCT01190930|17909561|P10|Maintenance|Physician Decision|17
5187713|NCT01190930|17909562|P9|Maintenance|Physician Decision|10
5187714|NCT01190930|17909563|P8|Maintenance|Physician Decision|8
5187715|NCT01190930|17909564|P7|Maintenance|Physician Decision|8
5187716|NCT01190930|17909565|P6|Maintenance|Physician Decision|4
5187717|NCT01190930|17909566|P5|Maintenance|Physician Decision|9
5187718|NCT01190930|17909567|P4|Maintenance|Physician Decision|5
5187719|NCT01190930|17909568|P3|Maintenance|Physician Decision|0
5187720|NCT01190930|17909569|P2|Maintenance|Physician Decision|1
5187721|NCT01190930|17909570|P1|Maintenance|Physician Decision|0
5187722|NCT01190930|17909561|P10|Maintenance|Lost to Follow-up|0
5187723|NCT01190930|17909562|P9|Maintenance|Lost to Follow-up|1
5187724|NCT01190930|17909563|P8|Maintenance|Lost to Follow-up|1
5187725|NCT01190930|17909564|P7|Maintenance|Lost to Follow-up|1
5187726|NCT01190930|17909565|P6|Maintenance|Lost to Follow-up|0
5187727|NCT01190930|17909566|P5|Maintenance|Lost to Follow-up|0
5187728|NCT01190930|17909567|P4|Maintenance|Lost to Follow-up|0
5187729|NCT01190930|17909568|P3|Maintenance|Lost to Follow-up|0
5187730|NCT01190930|17909569|P2|Maintenance|Lost to Follow-up|0
5187731|NCT01190930|17909570|P1|Maintenance|Lost to Follow-up|0
5187732|NCT01190930|17909561|P10|Maintenance|Death|2
5187733|NCT01190930|17909562|P9|Maintenance|Death|2
5187734|NCT01190930|17909563|P8|Maintenance|Death|2
5187735|NCT01190930|17909564|P7|Maintenance|Death|2
5187736|NCT01190930|17909565|P6|Maintenance|Death|0
5187737|NCT01190930|17909566|P5|Maintenance|Death|0
5187738|NCT01190930|17909567|P4|Maintenance|Death|1
5187739|NCT01190930|17909568|P3|Maintenance|Death|0
5187740|NCT01190930|17909569|P2|Maintenance|Death|0
5187741|NCT01190930|17909570|P1|Maintenance|Death|0
5187742|NCT01190930|17909561|P10|Maintenance|Adverse Event|0
5187743|NCT01190930|17909562|P9|Maintenance|Adverse Event|3
5187744|NCT01190930|17909563|P8|Maintenance|Adverse Event|3
5187745|NCT01190930|17909564|P7|Maintenance|Adverse Event|1
5187746|NCT01190930|17909565|P6|Maintenance|Adverse Event|1
5187747|NCT01190930|17909566|P5|Maintenance|Adverse Event|0
5187748|NCT01190930|17909567|P4|Maintenance|Adverse Event|0
5187749|NCT01190930|17909568|P3|Maintenance|Adverse Event|0
5187750|NCT01190930|17909569|P2|Maintenance|Adverse Event|0
5187751|NCT01190930|17909570|P1|Maintenance|Adverse Event|0
5187752|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Relapse|0
5187753|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Relapse|0
5187754|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Relapse|0
5187755|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Relapse|0
5187756|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Relapse|0
5187757|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Relapse|0
5187758|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Relapse|0
5187759|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Relapse|1
5187760|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Relapse|0
5187761|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Relapse|0
5187762|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Progressive disease|0
5187763|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Progressive disease|0
5187764|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Progressive disease|0
5187765|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Progressive disease|0
5187766|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Progressive disease|0
5187767|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Progressive disease|0
5187768|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Progressive disease|0
5187769|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Progressive disease|1
5187770|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Progressive disease|0
5187771|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Progressive disease|0
5187772|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187773|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187774|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187775|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187776|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187777|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187778|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187779|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187780|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
5187781|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5187782|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Inevaluable|0
5187783|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Inevaluable|0
5187784|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Inevaluable|0
5187785|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Inevaluable|0
5187786|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Inevaluable|0
5187787|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Inevaluable|0
5187788|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Inevaluable|0
5187789|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Inevaluable|6
5187790|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Inevaluable|0
5187791|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Inevaluable|0
5187792|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Refusal|0
5187793|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Refusal|0
5187794|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Refusal|0
5187795|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Refusal|0
5187796|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Refusal|3
5187797|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Refusal|0
5187798|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Refusal|4
5187799|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Refusal|694
5187800|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Refusal|2
5187801|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Refusal|0
5187802|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187803|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187804|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187805|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187806|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187807|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187808|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Withdrawal by Subject|2
5187809|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Withdrawal by Subject|5
5187810|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Withdrawal by Subject|1
5187811|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5187812|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Physician Decision|0
5187813|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Physician Decision|0
5187814|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Physician Decision|0
5187815|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Physician Decision|0
5187816|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Physician Decision|3
5187817|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Physician Decision|5
5187818|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Physician Decision|7
5187819|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Physician Decision|35
5187820|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Physician Decision|2
5187821|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Physician Decision|0
5187822|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Death|0
5187823|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Death|0
5187824|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Death|0
5187825|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Death|0
5187826|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Death|0
5187827|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Death|0
5187828|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Death|4
5187829|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Death|8
5187830|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Death|0
5187831|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Death|0
5187832|NCT01190930|17909561|P10|Post Induction Pre-Maintenance|Adverse Event|0
5187833|NCT01190930|17909562|P9|Post Induction Pre-Maintenance|Adverse Event|0
5187834|NCT01190930|17909563|P8|Post Induction Pre-Maintenance|Adverse Event|0
5187835|NCT01190930|17909564|P7|Post Induction Pre-Maintenance|Adverse Event|0
5187836|NCT01190930|17909565|P6|Post Induction Pre-Maintenance|Adverse Event|0
5187837|NCT01190930|17909566|P5|Post Induction Pre-Maintenance|Adverse Event|0
5187838|NCT01190930|17909567|P4|Post Induction Pre-Maintenance|Adverse Event|0
5187839|NCT01190930|17909568|P3|Post Induction Pre-Maintenance|Adverse Event|8
5187840|NCT01190930|17909569|P2|Post Induction Pre-Maintenance|Adverse Event|0
5187841|NCT01190930|17909570|P1|Post Induction Pre-Maintenance|Adverse Event|0
5187842|NCT01190930|17909561|P10|Induction|Ineligible|0
5187843|NCT01190930|17909562|P9|Induction|Ineligible|0
5187844|NCT01190930|17909563|P8|Induction|Ineligible|0
5187845|NCT01190930|17909564|P7|Induction|Ineligible|0
5187846|NCT01190930|17909565|P6|Induction|Ineligible|0
5187847|NCT01190930|17909566|P5|Induction|Ineligible|0
5187848|NCT01190930|17909567|P4|Induction|Ineligible|0
5187849|NCT01190930|17909568|P3|Induction|Ineligible|0
5187850|NCT01190930|17909569|P2|Induction|Ineligible|4
5187851|NCT01190930|17909570|P1|Induction|Ineligible|69
5187852|NCT01190930|17909561|P10|Induction|No treatment|0
5187853|NCT01190930|17909562|P9|Induction|No treatment|0
5187854|NCT01190930|17909563|P8|Induction|No treatment|0
5187855|NCT01190930|17909564|P7|Induction|No treatment|0
5187856|NCT01190930|17909565|P6|Induction|No treatment|0
5187857|NCT01190930|17909566|P5|Induction|No treatment|0
5187858|NCT01190930|17909567|P4|Induction|No treatment|0
5187859|NCT01190930|17909568|P3|Induction|No treatment|0
5187860|NCT01190930|17909569|P2|Induction|No treatment|0
5187861|NCT01190930|17909570|P1|Induction|No treatment|3
5187862|NCT01190930|17909561|P10|Induction|Progressive disease|0
5187863|NCT01190930|17909562|P9|Induction|Progressive disease|0
5187864|NCT01190930|17909563|P8|Induction|Progressive disease|0
5187865|NCT01190930|17909564|P7|Induction|Progressive disease|0
5187866|NCT01190930|17909565|P6|Induction|Progressive disease|0
5187867|NCT01190930|17909566|P5|Induction|Progressive disease|0
5187868|NCT01190930|17909567|P4|Induction|Progressive disease|0
5187869|NCT01190930|17909568|P3|Induction|Progressive disease|0
5187870|NCT01190930|17909569|P2|Induction|Progressive disease|1
5187871|NCT01190930|17909570|P1|Induction|Progressive disease|0
5187872|NCT01190930|17909561|P10|Induction|Incomplete Induction data|0
5187873|NCT01190930|17909562|P9|Induction|Incomplete Induction data|0
5187874|NCT01190930|17909563|P8|Induction|Incomplete Induction data|0
5187875|NCT01190930|17909564|P7|Induction|Incomplete Induction data|0
5187876|NCT01190930|17909565|P6|Induction|Incomplete Induction data|0
5187877|NCT01190930|17909566|P5|Induction|Incomplete Induction data|0
5187878|NCT01190930|17909567|P4|Induction|Incomplete Induction data|0
5187879|NCT01190930|17909568|P3|Induction|Incomplete Induction data|0
5187880|NCT01190930|17909569|P2|Induction|Incomplete Induction data|0
5187881|NCT01190930|17909570|P1|Induction|Incomplete Induction data|63
5187882|NCT01190930|17909561|P10|Induction|Philadelphia chromosome-positive|0
5187883|NCT01190930|17909562|P9|Induction|Philadelphia chromosome-positive|0
5187884|NCT01190930|17909563|P8|Induction|Philadelphia chromosome-positive|0
5187885|NCT01190930|17909564|P7|Induction|Philadelphia chromosome-positive|0
5187886|NCT01190930|17909565|P6|Induction|Philadelphia chromosome-positive|0
5187887|NCT01190930|17909566|P5|Induction|Philadelphia chromosome-positive|0
5187888|NCT01190930|17909567|P4|Induction|Philadelphia chromosome-positive|0
5187889|NCT01190930|17909568|P3|Induction|Philadelphia chromosome-positive|0
5187890|NCT01190930|17909569|P2|Induction|Philadelphia chromosome-positive|0
5187891|NCT01190930|17909570|P1|Induction|Philadelphia chromosome-positive|99
5187892|NCT01190930|17909561|P10|Induction|Very High Risk|0
5187893|NCT01190930|17909562|P9|Induction|Very High Risk|0
5187894|NCT01190930|17909563|P8|Induction|Very High Risk|0
5187895|NCT01190930|17909564|P7|Induction|Very High Risk|0
5187896|NCT01190930|17909565|P6|Induction|Very High Risk|0
5187897|NCT01190930|17909566|P5|Induction|Very High Risk|0
5187898|NCT01190930|17909567|P4|Induction|Very High Risk|0
5187899|NCT01190930|17909568|P3|Induction|Very High Risk|0
5187900|NCT01190930|17909569|P2|Induction|Very High Risk|0
5187901|NCT01190930|17909570|P1|Induction|Very High Risk|1012
5187902|NCT01190930|17909561|P10|Induction|Low Risk|0
5187903|NCT01190930|17909562|P9|Induction|Low Risk|0
5187904|NCT01190930|17909563|P8|Induction|Low Risk|0
5187905|NCT01190930|17909564|P7|Induction|Low Risk|0
5187906|NCT01190930|17909565|P6|Induction|Low Risk|0
5187907|NCT01190930|17909566|P5|Induction|Low Risk|0
5187908|NCT01190930|17909567|P4|Induction|Low Risk|0
5187909|NCT01190930|17909568|P3|Induction|Low Risk|0
5187910|NCT01190930|17909569|P2|Induction|Low Risk|0
5187911|NCT01190930|17909570|P1|Induction|Low Risk|443
5187912|NCT01190930|17909561|P10|Induction|High Risk|0
5187913|NCT01190930|17909562|P9|Induction|High Risk|0
5187914|NCT01190930|17909563|P8|Induction|High Risk|0
5187915|NCT01190930|17909564|P7|Induction|High Risk|0
5187916|NCT01190930|17909565|P6|Induction|High Risk|0
5187917|NCT01190930|17909566|P5|Induction|High Risk|0
5187918|NCT01190930|17909567|P4|Induction|High Risk|0
5187919|NCT01190930|17909568|P3|Induction|High Risk|0
5187920|NCT01190930|17909569|P2|Induction|High Risk|0
5187921|NCT01190930|17909570|P1|Induction|High Risk|1227
5187922|NCT01190930|17909561|P10|Induction|Average Risk|0
5187923|NCT01190930|17909562|P9|Induction|Average Risk|0
5187924|NCT01190930|17909563|P8|Induction|Average Risk|0
5187925|NCT01190930|17909564|P7|Induction|Average Risk|0
5187926|NCT01190930|17909565|P6|Induction|Average Risk|0
5187927|NCT01190930|17909566|P5|Induction|Average Risk|0
5187928|NCT01190930|17909567|P4|Induction|Average Risk|0
5187929|NCT01190930|17909568|P3|Induction|Average Risk|0
5187930|NCT01190930|17909569|P2|Induction|Average Risk|0
5187931|NCT01190930|17909570|P1|Induction|Average Risk|1847
5187932|NCT01190930|17909561|P10|Induction|Enrollment onto another COG Protocol|0
5187933|NCT01190930|17909562|P9|Induction|Enrollment onto another COG Protocol|0
5188026|NCT01190930|17909565|P6|Induction|Adverse Event|0
5187934|NCT01190930|17909563|P8|Induction|Enrollment onto another COG Protocol|0
5187935|NCT01190930|17909564|P7|Induction|Enrollment onto another COG Protocol|0
5187936|NCT01190930|17909565|P6|Induction|Enrollment onto another COG Protocol|0
5187937|NCT01190930|17909566|P5|Induction|Enrollment onto another COG Protocol|0
5187938|NCT01190930|17909567|P4|Induction|Enrollment onto another COG Protocol|0
5187939|NCT01190930|17909568|P3|Induction|Enrollment onto another COG Protocol|0
5187940|NCT01190930|17909569|P2|Induction|Enrollment onto another COG Protocol|0
5187941|NCT01190930|17909570|P1|Induction|Enrollment onto another COG Protocol|1
5187942|NCT01190930|17909561|P10|Induction|High Risk Downs|0
5187943|NCT01190930|17909562|P9|Induction|High Risk Downs|0
5187944|NCT01190930|17909563|P8|Induction|High Risk Downs|0
5187945|NCT01190930|17909564|P7|Induction|High Risk Downs|0
5187946|NCT01190930|17909565|P6|Induction|High Risk Downs|0
5187947|NCT01190930|17909566|P5|Induction|High Risk Downs|0
5187948|NCT01190930|17909567|P4|Induction|High Risk Downs|0
5187949|NCT01190930|17909568|P3|Induction|High Risk Downs|0
5187950|NCT01190930|17909569|P2|Induction|High Risk Downs|0
5187951|NCT01190930|17909570|P1|Induction|High Risk Downs|80
5187952|NCT01190930|17909561|P10|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187953|NCT01190930|17909562|P9|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187954|NCT01190930|17909563|P8|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187955|NCT01190930|17909564|P7|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187956|NCT01190930|17909565|P6|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187957|NCT01190930|17909566|P5|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187958|NCT01190930|17909567|P4|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187959|NCT01190930|17909568|P3|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187960|NCT01190930|17909569|P2|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5187961|NCT01190930|17909570|P1|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
5187962|NCT01190930|17909561|P10|Induction|Inevaluable|0
5187963|NCT01190930|17909562|P9|Induction|Inevaluable|0
5187964|NCT01190930|17909563|P8|Induction|Inevaluable|0
5187965|NCT01190930|17909564|P7|Induction|Inevaluable|0
5187966|NCT01190930|17909565|P6|Induction|Inevaluable|0
5187967|NCT01190930|17909566|P5|Induction|Inevaluable|0
5187968|NCT01190930|17909567|P4|Induction|Inevaluable|0
5187969|NCT01190930|17909568|P3|Induction|Inevaluable|0
5187970|NCT01190930|17909569|P2|Induction|Inevaluable|1
5187971|NCT01190930|17909570|P1|Induction|Inevaluable|23
5187972|NCT01190930|17909561|P10|Induction|Refusal|0
5187973|NCT01190930|17909562|P9|Induction|Refusal|0
5187974|NCT01190930|17909563|P8|Induction|Refusal|0
5187975|NCT01190930|17909564|P7|Induction|Refusal|0
5187976|NCT01190930|17909565|P6|Induction|Refusal|0
5187977|NCT01190930|17909566|P5|Induction|Refusal|0
5187978|NCT01190930|17909567|P4|Induction|Refusal|0
5187979|NCT01190930|17909568|P3|Induction|Refusal|0
5187980|NCT01190930|17909569|P2|Induction|Refusal|0
5187981|NCT01190930|17909570|P1|Induction|Refusal|235
5187982|NCT01190930|17909561|P10|Induction|Withdrawal by Subject|0
5187983|NCT01190930|17909562|P9|Induction|Withdrawal by Subject|0
5187984|NCT01190930|17909563|P8|Induction|Withdrawal by Subject|0
5187985|NCT01190930|17909564|P7|Induction|Withdrawal by Subject|0
5187986|NCT01190930|17909565|P6|Induction|Withdrawal by Subject|0
5187987|NCT01190930|17909566|P5|Induction|Withdrawal by Subject|0
5187988|NCT01190930|17909567|P4|Induction|Withdrawal by Subject|0
5187989|NCT01190930|17909568|P3|Induction|Withdrawal by Subject|0
5187990|NCT01190930|17909569|P2|Induction|Withdrawal by Subject|0
5187991|NCT01190930|17909570|P1|Induction|Withdrawal by Subject|9
5187992|NCT01190930|17909561|P10|Induction|Physician Decision|0
5187993|NCT01190930|17909562|P9|Induction|Physician Decision|0
5187994|NCT01190930|17909563|P8|Induction|Physician Decision|0
5187995|NCT01190930|17909564|P7|Induction|Physician Decision|0
5187996|NCT01190930|17909565|P6|Induction|Physician Decision|0
5187997|NCT01190930|17909566|P5|Induction|Physician Decision|0
5187998|NCT01190930|17909567|P4|Induction|Physician Decision|0
5187999|NCT01190930|17909568|P3|Induction|Physician Decision|0
5188000|NCT01190930|17909569|P2|Induction|Physician Decision|3
5188001|NCT01190930|17909570|P1|Induction|Physician Decision|125
5188002|NCT01190930|17909561|P10|Induction|Lost to Follow-up|0
5188003|NCT01190930|17909562|P9|Induction|Lost to Follow-up|0
5188004|NCT01190930|17909563|P8|Induction|Lost to Follow-up|0
5188005|NCT01190930|17909564|P7|Induction|Lost to Follow-up|0
5188006|NCT01190930|17909565|P6|Induction|Lost to Follow-up|0
5188007|NCT01190930|17909566|P5|Induction|Lost to Follow-up|0
5188008|NCT01190930|17909567|P4|Induction|Lost to Follow-up|0
5188009|NCT01190930|17909568|P3|Induction|Lost to Follow-up|0
5188010|NCT01190930|17909569|P2|Induction|Lost to Follow-up|0
5188011|NCT01190930|17909570|P1|Induction|Lost to Follow-up|1
5188012|NCT01190930|17909561|P10|Induction|Death|0
5188013|NCT01190930|17909562|P9|Induction|Death|0
5188014|NCT01190930|17909563|P8|Induction|Death|0
5188015|NCT01190930|17909564|P7|Induction|Death|0
5188016|NCT01190930|17909565|P6|Induction|Death|0
5188017|NCT01190930|17909566|P5|Induction|Death|0
5188018|NCT01190930|17909567|P4|Induction|Death|0
5188019|NCT01190930|17909568|P3|Induction|Death|0
5188020|NCT01190930|17909569|P2|Induction|Death|0
5188021|NCT01190930|17909570|P1|Induction|Death|34
5188022|NCT01190930|17909561|P10|Induction|Adverse Event|0
5188023|NCT01190930|17909562|P9|Induction|Adverse Event|0
5188024|NCT01190930|17909563|P8|Induction|Adverse Event|0
5188025|NCT01190930|17909564|P7|Induction|Adverse Event|0
5188027|NCT01190930|17909566|P5|Induction|Adverse Event|0
5188028|NCT01190930|17909567|P4|Induction|Adverse Event|0
5188029|NCT01190930|17909568|P3|Induction|Adverse Event|0
5188030|NCT01190930|17909569|P2|Induction|Adverse Event|0
5188031|NCT01190930|17909570|P1|Induction|Adverse Event|17
5188032|NCT01190891|17909594|P2|Overall Study|Withdrawal by Subject|0
5188033|NCT01190891|17909595|P1|Overall Study|Withdrawal by Subject|5
5188034|NCT01190891|17909594|P2|Overall Study|Protocol Violation|0
5188035|NCT01190891|17909595|P1|Overall Study|Protocol Violation|1
5188036|NCT01190865|17909620|P1|Overall Study|Non-compliance|2
5188037|NCT01190865|17909620|P1|Overall Study|Withdrawal by Subject|1
5188038|NCT01190839|17909627|P2|Overall Study|Randomized but not treated|4
5188039|NCT01190839|17909628|P1|Overall Study|Randomized but not treated|2
5188040|NCT01190839|17909627|P2|Overall Study|Undefined|31
5188041|NCT01190839|17909628|P1|Overall Study|Undefined|35
5188042|NCT01190839|17909627|P2|Overall Study|Trial stopped by Sponsor|68
5188043|NCT01190839|17909628|P1|Overall Study|Trial stopped by Sponsor|71
5188044|NCT01190839|17909627|P2|Overall Study|Death|0
5188045|NCT01190839|17909628|P1|Overall Study|Death|1
5188046|NCT01190839|17909627|P2|Overall Study|Lost to Follow-up|1
5188047|NCT01190839|17909628|P1|Overall Study|Lost to Follow-up|7
5188048|NCT01190839|17909627|P2|Overall Study|Protocol Violation|2
5188049|NCT01190839|17909628|P1|Overall Study|Protocol Violation|2
5188050|NCT01190839|17909627|P2|Overall Study|Adverse Event|41
5188051|NCT01190839|17909628|P1|Overall Study|Adverse Event|32
5188052|NCT01190813|17909642|P2|Overall Study|Adverse Event|1
5188053|NCT01190813|17909643|P1|Overall Study|Adverse Event|0
5188054|NCT01190813|17909642|P2|Overall Study|Refused study treatment after randomized|0
5188055|NCT01190813|17909643|P1|Overall Study|Refused study treatment after randomized|1
5188056|NCT01190813|17909642|P2|Overall Study|Withdrawal by Subject|1
5188057|NCT01190813|17909643|P1|Overall Study|Withdrawal by Subject|2
5188058|NCT01190813|17909642|P2|Overall Study|Lost to Follow-up|2
5188059|NCT01190813|17909643|P1|Overall Study|Lost to Follow-up|1
5188060|NCT01190514|17909764|P4|Third Intervention (Period 3)|Adverse Event|0
5188061|NCT01190514|17909765|P3|Third Intervention (Period 3)|Adverse Event|0
5188062|NCT01190514|17909766|P2|Third Intervention (Period 3)|Adverse Event|0
5188063|NCT01190514|17909767|P1|Third Intervention (Period 3)|Adverse Event|1
5188064|NCT01190514|17909764|P4|First Intervention (Period 1)|Adverse Event|0
5188065|NCT01190514|17909765|P3|First Intervention (Period 1)|Adverse Event|0
5188066|NCT01190514|17909766|P2|First Intervention (Period 1)|Adverse Event|0
5188067|NCT01190514|17909767|P1|First Intervention (Period 1)|Adverse Event|1
5188068|NCT01190475|17909800|P3|Overall Study|Withdrawal by Subject|1
5188069|NCT01190475|17909801|P2|Overall Study|Withdrawal by Subject|0
5188070|NCT01190475|17909802|P1|Overall Study|Withdrawal by Subject|0
5188071|NCT01190449|17909818|P2|Overall Study|Ineligible|4
5188072|NCT01190449|17909819|P1|Overall Study|Ineligible|0
5188073|NCT01190436|17909827|P1|Overall Study|Other|4
5188074|NCT01190436|17909827|P1|Overall Study|Lost to Follow-up|35
5188075|NCT01190410|17909843|P2|Overall Study|PI discretion|2
5188076|NCT01190410|17909844|P1|Overall Study|PI discretion|0
5188077|NCT01190410|17909843|P2|Overall Study|Administrative decision|0
5188078|NCT01190410|17909844|P1|Overall Study|Administrative decision|1
5188079|NCT01190410|17909843|P2|Overall Study|Withdrawal by Subject|2
5188080|NCT01190410|17909844|P1|Overall Study|Withdrawal by Subject|0
5188081|NCT01190410|17909843|P2|Overall Study|Lack of Efficacy|2
5188082|NCT01190410|17909844|P1|Overall Study|Lack of Efficacy|0
5188083|NCT01190410|17909843|P2|Overall Study|Adverse Event|3
5188084|NCT01190410|17909844|P1|Overall Study|Adverse Event|0
5188085|NCT01190267|17909872|P2|Overall Study|Protocol Violation|1
5188086|NCT01190267|17909873|P1|Overall Study|Protocol Violation|8
5188087|NCT01190267|17909872|P2|Overall Study|Withdrawal by Subject|1
5188088|NCT01190267|17909873|P1|Overall Study|Withdrawal by Subject|13
5188089|NCT01190267|17909872|P2|Overall Study|Lost to Follow-up|0
5188090|NCT01190267|17909873|P1|Overall Study|Lost to Follow-up|2
5188091|NCT01190267|17909872|P2|Overall Study|Treatment Failure|2
5188092|NCT01190267|17909873|P1|Overall Study|Treatment Failure|8
5188093|NCT01190267|17909872|P2|Overall Study|Adverse Event|0
5188094|NCT01190267|17909873|P1|Overall Study|Adverse Event|10
5188095|NCT01190254|17909884|P3|Overall Study|Did not meet protocol eligibility|0
5188096|NCT01190254|17909885|P2|Overall Study|Did not meet protocol eligibility|0
5188097|NCT01190254|17909886|P1|Overall Study|Did not meet protocol eligibility|1
5188098|NCT01190254|17909884|P3|Overall Study|Protocol Violation|2
5188099|NCT01190254|17909885|P2|Overall Study|Protocol Violation|0
5188100|NCT01190254|17909886|P1|Overall Study|Protocol Violation|2
5188101|NCT01190254|17909884|P3|Overall Study|Withdrawal by Subject|7
5188102|NCT01190254|17909885|P2|Overall Study|Withdrawal by Subject|5
5188103|NCT01190254|17909886|P1|Overall Study|Withdrawal by Subject|4
5188104|NCT01190254|17909884|P3|Overall Study|Lost to Follow-up|0
5188105|NCT01190254|17909885|P2|Overall Study|Lost to Follow-up|2
5188106|NCT01190254|17909886|P1|Overall Study|Lost to Follow-up|4
5188107|NCT01190254|17909884|P3|Overall Study|Lack of Efficacy|5
5188108|NCT01190254|17909885|P2|Overall Study|Lack of Efficacy|4
5188109|NCT01190254|17909886|P1|Overall Study|Lack of Efficacy|7
5188110|NCT01190254|17909884|P3|Overall Study|Adverse Event|8
5188111|NCT01190254|17909885|P2|Overall Study|Adverse Event|6
5188112|NCT01190254|17909886|P1|Overall Study|Adverse Event|3
5188113|NCT01190228|17909951|P3|Overall Study|Withdrawal by Subject|0
5188114|NCT01190228|17909952|P2|Overall Study|Withdrawal by Subject|0
5188115|NCT01190228|17909953|P1|Overall Study|Withdrawal by Subject|1
5188116|NCT01190228|17909951|P3|Overall Study|Protocol Violation|0
5188117|NCT01190228|17909952|P2|Overall Study|Protocol Violation|0
5188118|NCT01190228|17909953|P1|Overall Study|Protocol Violation|4
5188119|NCT01190215|17909976|P2|Up to Month 6|Lost to Follow-up|0
5188120|NCT01190215|17909977|P1|Up to Month 6|Lost to Follow-up|2
5188121|NCT01190189|17910310|P1|Overall Study|Migrated/moved from study area|1
5188122|NCT01190189|17910310|P1|Overall Study|Withdrawal by Subject|1
5188123|NCT01190189|17910310|P1|Overall Study|Lost to Follow-up|4
5188124|NCT01190176|17910317|P1|Overall Study|Lost to Follow-up|1
5188125|NCT01190176|17910317|P1|Overall Study|Withdrawal by Subject|1
5188126|NCT01190150|17910338|P2|Washout|Difficulty in adherence|1
5188127|NCT01190150|17910339|P1|Washout|Difficulty in adherence|0
5188128|NCT01190150|17910338|P2|Washout|Withdrawal by Subject|1
5188129|NCT01190150|17910339|P1|Washout|Withdrawal by Subject|0
5188130|NCT01190150|17910338|P2|First Treatment|Withdrawal by Subject|0
5188131|NCT01190150|17910339|P1|First Treatment|Withdrawal by Subject|1
5188132|NCT01190124|17910366|P3|Overall Study|Lost to Follow-up|0
5188133|NCT01190124|17910367|P2|Overall Study|Lost to Follow-up|0
5188134|NCT01190124|17910368|P1|Overall Study|Lost to Follow-up|2
5188135|NCT01190124|17910366|P3|Overall Study|Therapeutic Failure|1
5188136|NCT01190124|17910367|P2|Overall Study|Therapeutic Failure|0
5188137|NCT01190124|17910368|P1|Overall Study|Therapeutic Failure|12
5188138|NCT01190124|17910366|P3|Overall Study|Death|0
5188139|NCT01190124|17910367|P2|Overall Study|Death|0
5188140|NCT01190124|17910368|P1|Overall Study|Death|3
5188141|NCT01190098|17910406|P2|Overall Study|Other|1
5188142|NCT01190098|17910407|P1|Overall Study|Other|0
5188143|NCT01190098|17910406|P2|Overall Study|Lack of transportation|0
5188144|NCT01190098|17910407|P1|Overall Study|Lack of transportation|1
5188145|NCT01190098|17910406|P2|Overall Study|Patient coomorbidity|1
5188146|NCT01190098|17910407|P1|Overall Study|Patient coomorbidity|0
5188147|NCT01190098|17910406|P2|Overall Study|Adverse Event|0
5188148|NCT01190098|17910407|P1|Overall Study|Adverse Event|2
5188149|NCT01190020|17910448|P2|Overall Study|Withdrawal by Subject|0
5188150|NCT01190020|17910449|P1|Overall Study|Withdrawal by Subject|3
5188151|NCT01190020|17910448|P2|Overall Study|Lost to Follow-up|0
5188152|NCT01190020|17910449|P1|Overall Study|Lost to Follow-up|2
5188153|NCT01190020|17910448|P2|Overall Study|Adverse Event|0
5188154|NCT01190020|17910449|P1|Overall Study|Adverse Event|2
5188155|NCT01190007|17910461|P1|Overall Study|Participant was arrested|1
5188156|NCT01190007|17910461|P1|Overall Study|Difficulty of visit for complications|1
5188157|NCT01190007|17910461|P1|Overall Study|Adverse Event|8
5188158|NCT01190007|17910461|P1|Overall Study|Withdrawal by Subject|4
5188159|NCT01189890|17910478|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
5188160|NCT01189890|17910479|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
5188161|NCT01189890|17910478|P2|Overall Study|Physician Decision|4
5188162|NCT01189890|17910479|P1|Overall Study|Physician Decision|5
5188163|NCT01189890|17910478|P2|Overall Study|Non Compliance|1
5188164|NCT01189890|17910479|P1|Overall Study|Non Compliance|0
5188165|NCT01189890|17910478|P2|Overall Study|Withdrawal by Subject|11
5188166|NCT01189890|17910479|P1|Overall Study|Withdrawal by Subject|15
5188167|NCT01189890|17910478|P2|Overall Study|Protocol Violation|5
5188168|NCT01189890|17910479|P1|Overall Study|Protocol Violation|1
5188169|NCT01189890|17910478|P2|Overall Study|Lost to Follow-up|7
5188170|NCT01189890|17910479|P1|Overall Study|Lost to Follow-up|1
5188171|NCT01189890|17910478|P2|Overall Study|Lack of Efficacy|2
5188172|NCT01189890|17910479|P1|Overall Study|Lack of Efficacy|7
5188173|NCT01189890|17910478|P2|Overall Study|Adverse Event|4
5188174|NCT01189890|17910479|P1|Overall Study|Adverse Event|3
5188175|NCT01189812|17910501|P2|Overall Study|Moved out of State|2
5188176|NCT01189812|17910502|P1|Overall Study|Moved out of State|1
5188177|NCT01189812|17910501|P2|Overall Study|Out of Window|3
5188178|NCT01189812|17910502|P1|Overall Study|Out of Window|4
5188179|NCT01189812|17910501|P2|Overall Study|Adverse Event|0
5188180|NCT01189812|17910502|P1|Overall Study|Adverse Event|1
5188181|NCT01189812|17910501|P2|Overall Study|Withdrawal by Subject|3
5188182|NCT01189812|17910502|P1|Overall Study|Withdrawal by Subject|2
5188183|NCT01189604|17910586|P7|Overall Study|Withdrawal by Subject|0
5188184|NCT01189604|17910587|P6|Overall Study|Withdrawal by Subject|0
5188185|NCT01189604|17910588|P5|Overall Study|Withdrawal by Subject|0
5188186|NCT01189604|17910589|P4|Overall Study|Withdrawal by Subject|0
5188187|NCT01189604|17910590|P3|Overall Study|Withdrawal by Subject|0
5188188|NCT01189604|17910591|P2|Overall Study|Withdrawal by Subject|0
5188189|NCT01189604|17910592|P1|Overall Study|Withdrawal by Subject|1
5188190|NCT01189604|17910586|P7|Overall Study|Adverse Event|1
5188191|NCT01189604|17910587|P6|Overall Study|Adverse Event|0
5188192|NCT01189604|17910588|P5|Overall Study|Adverse Event|2
5188193|NCT01189604|17910589|P4|Overall Study|Adverse Event|0
5188194|NCT01189604|17910590|P3|Overall Study|Adverse Event|0
5188195|NCT01189604|17910591|P2|Overall Study|Adverse Event|1
5188196|NCT01189604|17910592|P1|Overall Study|Adverse Event|0
5188197|NCT01189604|17910586|P7|Overall Study|Impossible to visit|0
5188198|NCT01189604|17910587|P6|Overall Study|Impossible to visit|1
5188199|NCT01189604|17910588|P5|Overall Study|Impossible to visit|0
5188200|NCT01189604|17910589|P4|Overall Study|Impossible to visit|0
5188201|NCT01189604|17910590|P3|Overall Study|Impossible to visit|0
5188202|NCT01189604|17910591|P2|Overall Study|Impossible to visit|0
5188203|NCT01189604|17910592|P1|Overall Study|Impossible to visit|0
5188204|NCT01189500|17910636|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
5188205|NCT01189500|17910636|P1|Period 1: TAMOX Alone|Adverse Event|1
5188206|NCT01189487|17910697|P1|Overall Study|Adverse Event|1
5188207|NCT01189487|17910697|P1|Overall Study|Lack of Efficacy|2
5188208|NCT01189461|17910705|P1|Overall Study|Other|8
5188209|NCT01189461|17910705|P1|Overall Study|Did not meet entrance criteria|3
5188210|NCT01189461|17910705|P1|Overall Study|Adverse Event|2
5188211|NCT01189461|17910705|P1|Overall Study|Protocol Violation|1
5188212|NCT01189461|17910705|P1|Overall Study|Withdrawal by Subject|6
5188213|NCT01189461|17910705|P1|Overall Study|Lost to Follow-up|1
5188214|NCT01189461|17910705|P1|Overall Study|Lack of Efficacy|13
5188215|NCT01189435|17910712|P1|Overall Study|Physician Decision|1
5188216|NCT01189435|17910712|P1|Overall Study|Withdrawal by Subject|1
5188217|NCT01189266|17910792|P3|Overall Study|No treatment|1
5188218|NCT01189266|17910793|P2|Overall Study|No treatment|0
5188219|NCT01189266|17910794|P1|Overall Study|No treatment|0
5188220|NCT01189266|17910792|P3|Overall Study|Patient refuses further therapy|7
5188221|NCT01189266|17910793|P2|Overall Study|Patient refuses further therapy|0
5188222|NCT01189266|17910794|P1|Overall Study|Patient refuses further therapy|1
5188223|NCT01189266|17910792|P3|Overall Study|Withdrawal by Subject|1
5188224|NCT01189266|17910793|P2|Overall Study|Withdrawal by Subject|0
5188225|NCT01189266|17910794|P1|Overall Study|Withdrawal by Subject|0
5188226|NCT01189266|17910792|P3|Overall Study|Protocol Violation|1
5188227|NCT01189266|17910793|P2|Overall Study|Protocol Violation|1
5188228|NCT01189266|17910794|P1|Overall Study|Protocol Violation|0
5188229|NCT01189266|17910792|P3|Overall Study|Physician Decision|1
5188230|NCT01189266|17910793|P2|Overall Study|Physician Decision|0
5188231|NCT01189266|17910794|P1|Overall Study|Physician Decision|0
5188232|NCT01189266|17910792|P3|Overall Study|Lack of Efficacy|44
5188233|NCT01189266|17910793|P2|Overall Study|Lack of Efficacy|5
5188234|NCT01189266|17910794|P1|Overall Study|Lack of Efficacy|4
5188235|NCT01189266|17910792|P3|Overall Study|Death|5
5188236|NCT01189266|17910793|P2|Overall Study|Death|0
5188237|NCT01189266|17910794|P1|Overall Study|Death|0
5188238|NCT01189266|17910792|P3|Overall Study|Adverse Event|5
5188239|NCT01189266|17910793|P2|Overall Study|Adverse Event|0
5188240|NCT01189266|17910794|P1|Overall Study|Adverse Event|1
5188241|NCT01189227|17910844|P2|Overall Study|Study terminated due to low accrual|3
5188242|NCT01189227|17910845|P1|Overall Study|Study terminated due to low accrual|6
5188243|NCT01189201|17910851|P1|Overall Study|Adverse Event|1
5188244|NCT01189032|17910954|P3|Overall Study|Protocol Violation|1
5188245|NCT01189032|17910955|P2|Overall Study|Protocol Violation|1
5188246|NCT01189032|17910956|P1|Overall Study|Protocol Violation|1
5188247|NCT01189032|17910954|P3|Overall Study|Withdrawal by Subject|1
5188248|NCT01189032|17910955|P2|Overall Study|Withdrawal by Subject|0
5188249|NCT01189032|17910956|P1|Overall Study|Withdrawal by Subject|1
5188250|NCT01189032|17910954|P3|Overall Study|Lack of Efficacy|0
5188251|NCT01189032|17910955|P2|Overall Study|Lack of Efficacy|3
5188252|NCT01189032|17910956|P1|Overall Study|Lack of Efficacy|2
5188253|NCT01189032|17910954|P3|Overall Study|Adverse Event|4
5188254|NCT01189032|17910955|P2|Overall Study|Adverse Event|3
5188255|NCT01189032|17910956|P1|Overall Study|Adverse Event|1
5188256|NCT01188967|17910966|P2|Overall Study|Lost to Follow-up|2
5188257|NCT01188967|17910967|P1|Overall Study|Lost to Follow-up|3
5188258|NCT01188967|17910966|P2|Overall Study|Physician Decision|1
5188259|NCT01188967|17910967|P1|Overall Study|Physician Decision|1
5188260|NCT01188967|17910966|P2|Overall Study|Withdrawal by Subject|1
5188261|NCT01188967|17910967|P1|Overall Study|Withdrawal by Subject|1
5188262|NCT01188811|17911020|P2|Overall Study|Adverse Event|0
5188263|NCT01188811|17911021|P1|Overall Study|Adverse Event|6
5188264|NCT01188811|17911020|P2|Overall Study|Withdrawal by Subject|2
5188265|NCT01188811|17911021|P1|Overall Study|Withdrawal by Subject|0
5188266|NCT01188798|17911033|P2|Overall Study|Protocol closure|1
5188267|NCT01188798|17911034|P1|Overall Study|Protocol closure|1
5188268|NCT01188798|17911033|P2|Overall Study|Required additional transplant|1
5188269|NCT01188798|17911034|P1|Overall Study|Required additional transplant|1
5188270|NCT01188798|17911033|P2|Overall Study|Death|1
5188271|NCT01188798|17911034|P1|Overall Study|Death|0
5188272|NCT01188772|17911046|P4|Overall Study|Withdrawal by Subject|0
5188273|NCT01188772|17911047|P3|Overall Study|Withdrawal by Subject|2
5188274|NCT01188772|17911048|P2|Overall Study|Withdrawal by Subject|0
5188275|NCT01188772|17911049|P1|Overall Study|Withdrawal by Subject|0
5188276|NCT01188772|17911046|P4|Overall Study|Virologic Failure|0
5188277|NCT01188772|17911047|P3|Overall Study|Virologic Failure|0
5188278|NCT01188772|17911048|P2|Overall Study|Virologic Failure|0
5188279|NCT01188772|17911049|P1|Overall Study|Virologic Failure|1
5188280|NCT01188772|17911046|P4|Overall Study|Treatment Failure|0
5188281|NCT01188772|17911047|P3|Overall Study|Treatment Failure|1
5188282|NCT01188772|17911048|P2|Overall Study|Treatment Failure|0
5188283|NCT01188772|17911049|P1|Overall Study|Treatment Failure|0
5188284|NCT01188772|17911046|P4|Overall Study|Terminated by Sponsor|0
5188285|NCT01188772|17911047|P3|Overall Study|Terminated by Sponsor|1
5188286|NCT01188772|17911048|P2|Overall Study|Terminated by Sponsor|0
5188287|NCT01188772|17911049|P1|Overall Study|Terminated by Sponsor|0
5188288|NCT01188772|17911046|P4|Overall Study|Physician Decision|0
5188289|NCT01188772|17911047|P3|Overall Study|Physician Decision|1
5188290|NCT01188772|17911048|P2|Overall Study|Physician Decision|0
5188291|NCT01188772|17911049|P1|Overall Study|Physician Decision|0
5188292|NCT01188772|17911046|P4|Overall Study|Non-responder|0
5188293|NCT01188772|17911047|P3|Overall Study|Non-responder|3
5188294|NCT01188772|17911048|P2|Overall Study|Non-responder|0
5188295|NCT01188772|17911049|P1|Overall Study|Non-responder|0
5188296|NCT01188772|17911046|P4|Overall Study|Lost to Follow-up|1
5188297|NCT01188772|17911047|P3|Overall Study|Lost to Follow-up|1
5188298|NCT01188772|17911048|P2|Overall Study|Lost to Follow-up|1
5188299|NCT01188772|17911049|P1|Overall Study|Lost to Follow-up|4
5188300|NCT01188772|17911046|P4|Overall Study|Adverse Event|0
5188301|NCT01188772|17911047|P3|Overall Study|Adverse Event|2
5188302|NCT01188772|17911048|P2|Overall Study|Adverse Event|1
5188303|NCT01188772|17911049|P1|Overall Study|Adverse Event|0
5188304|NCT01188772|17911046|P4|Overall Study|Randomized but Not Treated|0
5188305|NCT01188772|17911047|P3|Overall Study|Randomized but Not Treated|0
5188306|NCT01188772|17911048|P2|Overall Study|Randomized but Not Treated|1
5188307|NCT01188772|17911049|P1|Overall Study|Randomized but Not Treated|0
5188308|NCT01188681|17911121|P4|Overall Study|Withdrawal by Subject|1
5188309|NCT01188681|17911122|P3|Overall Study|Withdrawal by Subject|0
5188310|NCT01188681|17911123|P2|Overall Study|Withdrawal by Subject|0
5188311|NCT01188681|17911124|P1|Overall Study|Withdrawal by Subject|0
5188312|NCT01188681|17911121|P4|Overall Study|bladder cancer|0
5188313|NCT01188681|17911122|P3|Overall Study|bladder cancer|1
5188314|NCT01188681|17911123|P2|Overall Study|bladder cancer|0
5188315|NCT01188681|17911124|P1|Overall Study|bladder cancer|0
5188316|NCT01188668|17911138|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
5188317|NCT01188668|17911138|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
5188318|NCT01188668|17911138|P1|Period 1: ARIP Alone|Protocol Violation|2
5188319|NCT01188655|17911171|P1|Overall Study|Other|11
5188320|NCT01188655|17911171|P1|Overall Study|Lost to Follow-up|1
5188321|NCT01188655|17911171|P1|Overall Study|Lack of Efficacy|1
5188322|NCT01188564|17911215|P2|Double-blind Phase|randomized not treated|0
5188323|NCT01188564|17911216|P1|Double-blind Phase|randomized not treated|1
5188324|NCT01188551|17911228|P4|Overall Study|Pharmacy issues|0
5188325|NCT01188551|17911229|P3|Overall Study|Pharmacy issues|0
5188326|NCT01188551|17911230|P2|Overall Study|Pharmacy issues|0
5188327|NCT01188551|17911231|P1|Overall Study|Pharmacy issues|1
5188328|NCT01188538|17911247|P2|Overall Study|Lost to Follow-up|1
5188329|NCT01188538|17911248|P1|Overall Study|Lost to Follow-up|0
5188330|NCT01188343|17911344|P3|Overall Study|Withdrawal by Subject|0
5188331|NCT01188343|17911345|P2|Overall Study|Withdrawal by Subject|24
5188332|NCT01188343|17911346|P1|Overall Study|Withdrawal by Subject|1
5188333|NCT01188343|17911344|P3|Overall Study|Not vaccinated|1
5188334|NCT01188343|17911345|P2|Overall Study|Not vaccinated|2
5188335|NCT01188343|17911346|P1|Overall Study|Not vaccinated|0
5188336|NCT01188226|17911372|P1|Overall Study|Withdrawal by Subject|4
5188337|NCT01187953|17911418|P2|Overall Study|Withdrawal by Subject|3
5188338|NCT01187953|17911419|P1|Overall Study|Withdrawal by Subject|3
5188339|NCT01187953|17911418|P2|Overall Study|Lost to Follow-up|3
5188340|NCT01187953|17911419|P1|Overall Study|Lost to Follow-up|0
5188341|NCT01187953|17911418|P2|Overall Study|Adverse Event|2
5188342|NCT01187953|17911419|P1|Overall Study|Adverse Event|1
5188343|NCT01187953|17911418|P2|Overall Study|Death|13
5188344|NCT01187953|17911419|P1|Overall Study|Death|11
5188345|NCT01187901|17911433|P2|Overall Study|Pregnancy|2
5188346|NCT01187901|17911434|P1|Overall Study|Pregnancy|0
5188347|NCT01187901|17911433|P2|Overall Study|No Endpoint due to Early Study Halt|3
5188348|NCT01187901|17911434|P1|Overall Study|No Endpoint due to Early Study Halt|2
5188349|NCT01187901|17911433|P2|Overall Study|Adverse Event|0
5188350|NCT01187901|17911434|P1|Overall Study|Adverse Event|3
5188351|NCT01187901|17911433|P2|Overall Study|Suspected Allergic Reaction|1
5188352|NCT01187901|17911434|P1|Overall Study|Suspected Allergic Reaction|1
5188353|NCT01187901|17911433|P2|Overall Study|Unrelated Health Reasons|2
5188354|NCT01187901|17911434|P1|Overall Study|Unrelated Health Reasons|1
5188355|NCT01187901|17911433|P2|Overall Study|Lost to Follow-up|2
5188356|NCT01187901|17911434|P1|Overall Study|Lost to Follow-up|1
5188357|NCT01187901|17911433|P2|Overall Study|Protocol Violation|0
5188358|NCT01187901|17911434|P1|Overall Study|Protocol Violation|1
5188359|NCT01187550|17911475|P2|Overall Study|Randomized but not treated|0
5188360|NCT01187550|17911476|P1|Overall Study|Randomized but not treated|8
5188361|NCT01187550|17911475|P2|Overall Study|Other|0
5188362|NCT01187550|17911476|P1|Overall Study|Other|3
5188363|NCT01187550|17911475|P2|Overall Study|Protocol Violation|1
5188364|NCT01187550|17911476|P1|Overall Study|Protocol Violation|3
5188365|NCT01187446|17911632|P2|Overall Study|Patient started non-protocol therapy|1
5188366|NCT01187446|17911633|P1|Overall Study|Patient started non-protocol therapy|0
5188367|NCT01187433|17911649|P2|Overall Study|Withdrawal by Subject|2
5188368|NCT01187433|17911650|P1|Overall Study|Withdrawal by Subject|5
5188369|NCT01187433|17911649|P2|Overall Study|Protocol Violation|2
5188370|NCT01187433|17911650|P1|Overall Study|Protocol Violation|6
5188371|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
5188372|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5188373|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5188374|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5188375|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5188376|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
5188377|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
5188378|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5188379|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5188380|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5188381|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
5188382|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
5188383|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5188384|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
5188385|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5188386|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5188387|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5188388|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5188389|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5188390|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5188391|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
5188392|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
5188393|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
5188394|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
5188395|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5188396|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
5188397|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
5188398|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
5188399|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
5188400|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5188401|NCT01187407|17911680|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
5188402|NCT01187407|17911681|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
5188403|NCT01187407|17911682|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
5188404|NCT01187407|17911683|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5188405|NCT01187407|17911684|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5188406|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188407|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188408|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188409|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188410|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
5188411|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188412|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188413|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188414|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188415|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
5188416|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188417|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188418|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188419|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188420|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
5188421|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188422|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188423|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188424|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188425|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
5188426|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188427|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188428|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188429|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188430|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
5188431|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188432|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188433|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188434|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188435|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
5188436|NCT01187407|17911680|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188437|NCT01187407|17911681|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188438|NCT01187407|17911682|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188439|NCT01187407|17911683|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188440|NCT01187407|17911684|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
5188441|NCT01187043|17911797|P5|Overall Study|Unable to make scheduled visits|1
5188442|NCT01187043|17911798|P4|Overall Study|Unable to make scheduled visits|0
5188443|NCT01187043|17911799|P3|Overall Study|Unable to make scheduled visits|4
5188444|NCT01187043|17911800|P2|Overall Study|Unable to make scheduled visits|0
5188445|NCT01187043|17911801|P1|Overall Study|Unable to make scheduled visits|1
5188446|NCT01187043|17911797|P5|Overall Study|Adverse Event|1
5188447|NCT01187043|17911798|P4|Overall Study|Adverse Event|0
5188448|NCT01187043|17911799|P3|Overall Study|Adverse Event|0
5188449|NCT01187043|17911800|P2|Overall Study|Adverse Event|0
5188450|NCT01187043|17911801|P1|Overall Study|Adverse Event|0
5188451|NCT01186978|17911827|P1|Overall Study|Withdrawal by Subject|1
5188452|NCT01186939|17911834|P1|Overall Study|Transformation to AML|1
5188453|NCT01186939|17911834|P1|Overall Study|Bone marrow transplant|1
5188454|NCT01186939|17911834|P1|Overall Study|Myocardial infarction|1
5188455|NCT01186939|17911834|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
5188456|NCT01186939|17911834|P1|Overall Study|Started additional treatment|1
5188457|NCT01186939|17911834|P1|Overall Study|Sponsor decision|4
5188458|NCT01186939|17911834|P1|Overall Study|Program closed|5
5188459|NCT01186939|17911834|P1|Overall Study|No longer receiving clinical benefit|17
5188460|NCT01186939|17911834|P1|Overall Study|Withdrawal by Subject|2
5188461|NCT01186939|17911834|P1|Overall Study|Death|7
5188462|NCT01186848|17911838|P1|Overall Study|Adverse Event|2
5188463|NCT01186848|17911838|P1|Overall Study|Withdrawal by Subject|2
5188464|NCT01186848|17911838|P1|Overall Study|Lost to Follow-up|4
5188465|NCT01186809|17911844|P1|Overall Study|Death|30
5188466|NCT01186796|17911850|P2|Overall Study|Protocol Violation|1
5188467|NCT01186796|17911851|P1|Overall Study|Protocol Violation|0
5188468|NCT01186796|17911850|P2|Overall Study|Withdrawal by Subject|1
5188469|NCT01186796|17911851|P1|Overall Study|Withdrawal by Subject|1
5188470|NCT01186796|17911850|P2|Overall Study|Adverse Event|0
5188471|NCT01186796|17911851|P1|Overall Study|Adverse Event|3
5188472|NCT01186770|17911869|P4|Overall Study|Other than specified|2
5188473|NCT01186770|17911870|P3|Overall Study|Other than specified|1
5188474|NCT01186770|17911871|P2|Overall Study|Other than specified|1
5188475|NCT01186770|17911872|P1|Overall Study|Other than specified|0
5188476|NCT01186770|17911869|P4|Overall Study|Insufficient response to treatment|7
5188477|NCT01186770|17911870|P3|Overall Study|Insufficient response to treatment|5
5188478|NCT01186770|17911871|P2|Overall Study|Insufficient response to treatment|8
5188479|NCT01186770|17911872|P1|Overall Study|Insufficient response to treatment|7
5188480|NCT01186770|17911869|P4|Overall Study|Lost to Follow-up|9
5188481|NCT01186770|17911870|P3|Overall Study|Lost to Follow-up|14
5188482|NCT01186770|17911871|P2|Overall Study|Lost to Follow-up|6
5188483|NCT01186770|17911872|P1|Overall Study|Lost to Follow-up|10
5188484|NCT01186770|17911869|P4|Overall Study|Withdrawal by Subject|17
5188485|NCT01186770|17911870|P3|Overall Study|Withdrawal by Subject|11
5188486|NCT01186770|17911871|P2|Overall Study|Withdrawal by Subject|13
5188487|NCT01186770|17911872|P1|Overall Study|Withdrawal by Subject|15
5188488|NCT01186770|17911869|P4|Overall Study|Adverse Event|9
5188489|NCT01186770|17911870|P3|Overall Study|Adverse Event|7
5188490|NCT01186770|17911871|P2|Overall Study|Adverse Event|9
5188491|NCT01186770|17911872|P1|Overall Study|Adverse Event|2
5188492|NCT01186770|17911869|P4|Overall Study|Protocol Violation|14
5188493|NCT01186770|17911870|P3|Overall Study|Protocol Violation|12
5188494|NCT01186770|17911871|P2|Overall Study|Protocol Violation|9
5188495|NCT01186770|17911872|P1|Overall Study|Protocol Violation|7
5188496|NCT01186770|17911869|P4|Overall Study|Ineligibility|0
5188497|NCT01186770|17911870|P3|Overall Study|Ineligibility|2
5188498|NCT01186770|17911871|P2|Overall Study|Ineligibility|0
5188499|NCT01186770|17911872|P1|Overall Study|Ineligibility|0
5188500|NCT01186744|17911896|P6|Overall Study|Death|0
5188501|NCT01186744|17911897|P5|Overall Study|Death|0
5188502|NCT01186744|17911898|P4|Overall Study|Death|0
5188503|NCT01186744|17911899|P3|Overall Study|Death|0
5188504|NCT01186744|17911900|P2|Overall Study|Death|0
5188505|NCT01186744|17911901|P1|Overall Study|Death|1
5188506|NCT01186744|17911896|P6|Overall Study|Adverse Event|4
5188507|NCT01186744|17911897|P5|Overall Study|Adverse Event|1
5188508|NCT01186744|17911898|P4|Overall Study|Adverse Event|0
5188509|NCT01186744|17911899|P3|Overall Study|Adverse Event|1
5188510|NCT01186744|17911900|P2|Overall Study|Adverse Event|14
5188511|NCT01186744|17911901|P1|Overall Study|Adverse Event|10
5188512|NCT01186744|17911896|P6|Overall Study|Other|5
5188513|NCT01186744|17911897|P5|Overall Study|Other|1
5188514|NCT01186744|17911898|P4|Overall Study|Other|2
5188515|NCT01186744|17911899|P3|Overall Study|Other|1
5188516|NCT01186744|17911900|P2|Overall Study|Other|10
5188517|NCT01186744|17911901|P1|Overall Study|Other|9
5188518|NCT01186744|17911896|P6|Overall Study|Study terminated by Sponsor|0
5188519|NCT01186744|17911897|P5|Overall Study|Study terminated by Sponsor|0
5188520|NCT01186744|17911898|P4|Overall Study|Study terminated by Sponsor|0
5188521|NCT01186744|17911899|P3|Overall Study|Study terminated by Sponsor|0
5188522|NCT01186744|17911900|P2|Overall Study|Study terminated by Sponsor|0
5188523|NCT01186744|17911901|P1|Overall Study|Study terminated by Sponsor|1
5188524|NCT01186744|17911896|P6|Overall Study|Withdrawal by Subject|6
5188525|NCT01186744|17911897|P5|Overall Study|Withdrawal by Subject|0
5188526|NCT01186744|17911898|P4|Overall Study|Withdrawal by Subject|5
5188527|NCT01186744|17911899|P3|Overall Study|Withdrawal by Subject|2
5188528|NCT01186744|17911900|P2|Overall Study|Withdrawal by Subject|10
5188529|NCT01186744|17911901|P1|Overall Study|Withdrawal by Subject|14
5188530|NCT01186744|17911896|P6|Overall Study|Screen failure|0
5188531|NCT01186744|17911897|P5|Overall Study|Screen failure|0
5188532|NCT01186744|17911898|P4|Overall Study|Screen failure|1
5188533|NCT01186744|17911899|P3|Overall Study|Screen failure|0
5188534|NCT01186744|17911900|P2|Overall Study|Screen failure|1
5188535|NCT01186744|17911901|P1|Overall Study|Screen failure|1
5188536|NCT01186744|17911896|P6|Overall Study|Lost to Follow-up|4
5188537|NCT01186744|17911897|P5|Overall Study|Lost to Follow-up|1
5188538|NCT01186744|17911898|P4|Overall Study|Lost to Follow-up|1
5188539|NCT01186744|17911899|P3|Overall Study|Lost to Follow-up|2
5188540|NCT01186744|17911900|P2|Overall Study|Lost to Follow-up|16
5188541|NCT01186744|17911901|P1|Overall Study|Lost to Follow-up|15
5188542|NCT01186744|17911896|P6|Overall Study|Protocol Violation|2
5188543|NCT01186744|17911897|P5|Overall Study|Protocol Violation|1
5188544|NCT01186744|17911898|P4|Overall Study|Protocol Violation|1
5188545|NCT01186744|17911899|P3|Overall Study|Protocol Violation|0
5188546|NCT01186744|17911900|P2|Overall Study|Protocol Violation|2
5188547|NCT01186744|17911901|P1|Overall Study|Protocol Violation|1
5188548|NCT01186744|17911896|P6|Overall Study|Lack of Efficacy|5
5188549|NCT01186744|17911897|P5|Overall Study|Lack of Efficacy|2
5188550|NCT01186744|17911898|P4|Overall Study|Lack of Efficacy|2
5188551|NCT01186744|17911899|P3|Overall Study|Lack of Efficacy|0
5188552|NCT01186744|17911900|P2|Overall Study|Lack of Efficacy|99
5188553|NCT01186744|17911901|P1|Overall Study|Lack of Efficacy|156
5188554|NCT01186692|17912321|P1|Overall Study|Adverse Event|2
5188555|NCT01186692|17912321|P1|Overall Study|Futher testing contraindicated implant|19
5188556|NCT01186692|17912321|P1|Overall Study|Not Catheterized|11
5188557|NCT01186458|17912348|P1|Overall Study|Adverse Event|1
5188558|NCT01186419|17912357|P2|Overall Study|Other|1
5188559|NCT01186419|17912358|P1|Overall Study|Other|1
5188560|NCT01186419|17912357|P2|Overall Study|Physician Decision|3
5188561|NCT01186419|17912358|P1|Overall Study|Physician Decision|0
5188562|NCT01186419|17912357|P2|Overall Study|Adverse Event|2
5188563|NCT01186419|17912358|P1|Overall Study|Adverse Event|1
5188564|NCT01186419|17912357|P2|Overall Study|Withdrawal by Subject|3
5188565|NCT01186419|17912358|P1|Overall Study|Withdrawal by Subject|5
5188566|NCT01186328|17912372|P3|Overall Study|Death|0
5188567|NCT01186328|17912373|P2|Overall Study|Death|0
5188568|NCT01186328|17912374|P1|Overall Study|Death|1
5188569|NCT01185964|17912404|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
5188570|NCT01185964|17912405|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5188571|NCT01185964|17912406|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5188572|NCT01185964|17912407|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5188573|NCT01185964|17912404|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
5188574|NCT01185964|17912405|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5188575|NCT01185964|17912406|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5188576|NCT01185964|17912407|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5188577|NCT01185964|17912404|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
5188578|NCT01185964|17912405|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5188579|NCT01185964|17912406|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5188580|NCT01185964|17912407|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5188581|NCT01185964|17912404|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
5188582|NCT01185964|17912405|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
5188583|NCT01185964|17912406|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
5188584|NCT01185964|17912407|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
5188585|NCT01185964|17912404|P4|Phase 1b and Phase 2|Adverse Event|0
5188586|NCT01185964|17912405|P3|Phase 1b and Phase 2|Adverse Event|2
5188587|NCT01185964|17912406|P2|Phase 1b and Phase 2|Adverse Event|0
5188588|NCT01185964|17912407|P1|Phase 1b and Phase 2|Adverse Event|1
5188589|NCT01185964|17912404|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5188590|NCT01185964|17912405|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
5188591|NCT01185964|17912406|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5188592|NCT01185964|17912407|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5188593|NCT01185964|17912404|P4|Phase 1b and Phase 2|Other Therapy Started|0
5188594|NCT01185964|17912405|P3|Phase 1b and Phase 2|Other Therapy Started|3
5188595|NCT01185964|17912406|P2|Phase 1b and Phase 2|Other Therapy Started|3
5188596|NCT01185964|17912407|P1|Phase 1b and Phase 2|Other Therapy Started|0
5188597|NCT01185964|17912404|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
5188598|NCT01185964|17912405|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
5188599|NCT01185964|17912406|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
5188600|NCT01185964|17912407|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
5188601|NCT01185834|17912433|P1|Overall Study|Early exit - Site error|2
5188602|NCT01185834|17912433|P1|Overall Study|Time/Job Conflict|2
5188603|NCT01185834|17912433|P1|Overall Study|Biomicroscopy|4
5188604|NCT01185834|17912433|P1|Overall Study|Discomfort|4
5188605|NCT01185834|17912433|P1|Overall Study|Lost to Follow-up|2
5188606|NCT01185821|17912443|P5|Overall Study|Administrative problems|2
5188607|NCT01185821|17912444|P4|Overall Study|Administrative problems|1
5188608|NCT01185821|17912445|P3|Overall Study|Administrative problems|1
5188609|NCT01185821|17912446|P2|Overall Study|Administrative problems|0
5188610|NCT01185821|17912447|P1|Overall Study|Administrative problems|0
5188611|NCT01185821|17912443|P5|Overall Study|Lost to Follow-up|2
5188612|NCT01185821|17912444|P4|Overall Study|Lost to Follow-up|1
5188613|NCT01185821|17912445|P3|Overall Study|Lost to Follow-up|2
5188614|NCT01185821|17912446|P2|Overall Study|Lost to Follow-up|1
5188615|NCT01185821|17912447|P1|Overall Study|Lost to Follow-up|1
5188616|NCT01185821|17912443|P5|Overall Study|Withdrawal by Subject|3
5188617|NCT01185821|17912444|P4|Overall Study|Withdrawal by Subject|1
5188618|NCT01185821|17912445|P3|Overall Study|Withdrawal by Subject|2
5188619|NCT01185821|17912446|P2|Overall Study|Withdrawal by Subject|2
5188620|NCT01185821|17912447|P1|Overall Study|Withdrawal by Subject|3
5188621|NCT01185821|17912443|P5|Overall Study|Lack of Efficacy|9
5188622|NCT01185821|17912444|P4|Overall Study|Lack of Efficacy|0
5188623|NCT01185821|17912445|P3|Overall Study|Lack of Efficacy|3
5188624|NCT01185821|17912446|P2|Overall Study|Lack of Efficacy|0
5188625|NCT01185821|17912447|P1|Overall Study|Lack of Efficacy|0
5188626|NCT01185821|17912443|P5|Overall Study|Adverse Event|5
5188627|NCT01185821|17912444|P4|Overall Study|Adverse Event|2
5188628|NCT01185821|17912445|P3|Overall Study|Adverse Event|1
5188629|NCT01185821|17912446|P2|Overall Study|Adverse Event|3
5188630|NCT01185821|17912447|P1|Overall Study|Adverse Event|2
5188631|NCT01185821|17912443|P5|Overall Study|Condition no longer required study drug|1
5188632|NCT01185821|17912444|P4|Overall Study|Condition no longer required study drug|0
5188633|NCT01185821|17912445|P3|Overall Study|Condition no longer required study drug|0
5188634|NCT01185821|17912446|P2|Overall Study|Condition no longer required study drug|0
5188635|NCT01185821|17912447|P1|Overall Study|Condition no longer required study drug|0
5188636|NCT01185821|17912443|P5|Overall Study|Death|0
5188637|NCT01185821|17912444|P4|Overall Study|Death|0
5188638|NCT01185821|17912445|P3|Overall Study|Death|0
5188639|NCT01185821|17912446|P2|Overall Study|Death|1
5188640|NCT01185821|17912447|P1|Overall Study|Death|0
5188641|NCT01185821|17912443|P5|Overall Study|Abnormal test procedure result|1
5188642|NCT01185821|17912444|P4|Overall Study|Abnormal test procedure result|0
5188643|NCT01185821|17912445|P3|Overall Study|Abnormal test procedure result|0
5188644|NCT01185821|17912446|P2|Overall Study|Abnormal test procedure result|0
5188645|NCT01185821|17912447|P1|Overall Study|Abnormal test procedure result|0
5188646|NCT01185821|17912443|P5|Overall Study|Protocol Violation|1
5188647|NCT01185821|17912444|P4|Overall Study|Protocol Violation|1
5188648|NCT01185821|17912445|P3|Overall Study|Protocol Violation|0
5188649|NCT01185821|17912446|P2|Overall Study|Protocol Violation|0
5188650|NCT01185821|17912447|P1|Overall Study|Protocol Violation|0
5188651|NCT01185821|17912443|P5|Overall Study|Abnormal laboratory value(s)|0
5188652|NCT01185821|17912444|P4|Overall Study|Abnormal laboratory value(s)|0
5188653|NCT01185821|17912445|P3|Overall Study|Abnormal laboratory value(s)|1
5188654|NCT01185821|17912446|P2|Overall Study|Abnormal laboratory value(s)|2
5188655|NCT01185821|17912447|P1|Overall Study|Abnormal laboratory value(s)|1
5188656|NCT01185782|17912498|P2|Overall Study|Randomized but not treated|4
5188657|NCT01185782|17912499|P1|Overall Study|Randomized but not treated|0
5188658|NCT01185782|17912498|P2|Overall Study|Other|5
5188659|NCT01185782|17912499|P1|Overall Study|Other|2
5188660|NCT01185782|17912498|P2|Overall Study|Poor Response to Treatment|1
5188661|NCT01185782|17912499|P1|Overall Study|Poor Response to Treatment|3
5188662|NCT01185782|17912498|P2|Overall Study|Protocol Violation|0
5188663|NCT01185782|17912499|P1|Overall Study|Protocol Violation|1
5188664|NCT01185782|17912498|P2|Overall Study|Adverse Event|1
5188665|NCT01185782|17912499|P1|Overall Study|Adverse Event|0
5188666|NCT01185704|17912527|P2|Overall Study|Ectopic pregnancy|1
5188667|NCT01185704|17912528|P1|Overall Study|Ectopic pregnancy|0
5188668|NCT01185704|17912527|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
5188669|NCT01185704|17912528|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
5188670|NCT01185704|17912527|P2|Overall Study|Lack of ovarian response|1
5188671|NCT01185704|17912528|P1|Overall Study|Lack of ovarian response|5
5188672|NCT01185704|17912527|P2|Overall Study|Randomized but not treated|3
5188673|NCT01185704|17912528|P1|Overall Study|Randomized but not treated|3
5188674|NCT01185639|17912562|P1|Overall Study|Progressed and didn't receive therapy|2
5188675|NCT01185600|17912572|P2|Overall Study|Hold by DSMB|2
5188676|NCT01185600|17912573|P1|Overall Study|Hold by DSMB|1
5188677|NCT01185600|17912572|P2|Overall Study|Withdrawal by Subject|1
5188678|NCT01185600|17912573|P1|Overall Study|Withdrawal by Subject|1
5188679|NCT01185600|17912572|P2|Overall Study|Physician Decision|35
5188680|NCT01185600|17912573|P1|Overall Study|Physician Decision|29
5188681|NCT01185600|17912572|P2|Overall Study|Lost to Follow-up|5
5188682|NCT01185600|17912573|P1|Overall Study|Lost to Follow-up|0
5188683|NCT01185600|17912572|P2|Overall Study|Death|1
5188684|NCT01185600|17912573|P1|Overall Study|Death|0
5188685|NCT01185600|17912572|P2|Overall Study|Adverse Event|1
5188686|NCT01185600|17912573|P1|Overall Study|Adverse Event|1
5188687|NCT01185561|17912595|P2|Overall Study|Withdrawal by Subject|8
5188688|NCT01185561|17912596|P1|Overall Study|Withdrawal by Subject|2
5188689|NCT01185561|17912595|P2|Overall Study|Lost to Follow-up|4
5188690|NCT01185561|17912596|P1|Overall Study|Lost to Follow-up|0
5188691|NCT01185548|17912608|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
5188692|NCT01185522|17912621|P1|Overall Study|Other reasons|12
5188693|NCT01185522|17912621|P1|Overall Study|Poor tolerance|39
5188694|NCT01185522|17912621|P1|Overall Study|Withdrawal by Subject|10
5188695|NCT01185522|17912621|P1|Overall Study|Lost to Follow-up|19
5188696|NCT01185522|17912621|P1|Overall Study|Lack of Efficacy|28
5188697|NCT01185509|17912647|P2|Overall Study|Intercurrent Illness|1
5188698|NCT01185509|17912648|P1|Overall Study|Intercurrent Illness|0
5188699|NCT01185509|17912647|P2|Overall Study|Death|1
5188700|NCT01185509|17912648|P1|Overall Study|Death|0
5188701|NCT01185509|17912647|P2|Overall Study|Withdrawal by Subject|1
5188702|NCT01185509|17912648|P1|Overall Study|Withdrawal by Subject|0
5188703|NCT01185509|17912647|P2|Overall Study|Physician Decision|2
5188704|NCT01185509|17912648|P1|Overall Study|Physician Decision|2
5188705|NCT01185509|17912647|P2|Overall Study|Progression/Relapse|15
5188706|NCT01185509|17912648|P1|Overall Study|Progression/Relapse|9
5188707|NCT01185353|17912664|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
5188708|NCT01185353|17912665|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
5188709|NCT01185353|17912666|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
5188710|NCT01185353|17912667|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
5188711|NCT01185353|17912668|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
5188712|NCT01185353|17912669|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
5188713|NCT01185353|17912670|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
5188714|NCT01185353|17912671|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
5188715|NCT01185353|17912672|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
5188716|NCT01185353|17912673|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
5188717|NCT01185353|17912664|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
5188718|NCT01185353|17912665|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
5188719|NCT01185353|17912666|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
5188720|NCT01185353|17912667|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188721|NCT01185353|17912668|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188722|NCT01185353|17912669|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188723|NCT01185353|17912670|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188724|NCT01185353|17912671|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188725|NCT01185353|17912672|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188726|NCT01185353|17912673|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5188727|NCT01185353|17912664|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188728|NCT01185353|17912665|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
5188729|NCT01185353|17912666|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
5188730|NCT01185353|17912667|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188731|NCT01185353|17912668|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188732|NCT01185353|17912669|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188733|NCT01185353|17912670|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188734|NCT01185353|17912671|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188735|NCT01185353|17912672|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188736|NCT01185353|17912673|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5188737|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Reason missing|0
5188738|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Reason missing|1
5188739|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Reason missing|0
5188740|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Reason missing|0
5188741|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Reason missing|0
5188742|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Reason missing|0
5188743|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Reason missing|0
5188744|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Reason missing|0
5188745|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Reason missing|0
5188746|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Reason missing|0
5188747|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
5188748|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
5188749|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
5188750|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
5188751|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
5188752|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
5188753|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
5188754|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
5188755|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
5188756|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
5188757|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
5188758|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188759|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188760|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188761|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188762|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188763|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188764|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188765|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188766|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5188767|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Death|1
5188768|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Death|0
5188769|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Death|0
5188770|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Death|0
5188771|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Death|0
5188772|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Death|0
5188773|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Death|0
5188774|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Death|0
5188775|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Death|0
5188776|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Death|0
5188777|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188778|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
5188779|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188780|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188781|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188782|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188783|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188784|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188785|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188786|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5188787|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
5188788|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
5188789|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
5188790|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188791|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188792|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188793|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188794|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188795|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188796|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5188797|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
5188798|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
5188799|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
5188800|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188801|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188802|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188803|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188804|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188805|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188806|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5188807|NCT01185353|17912664|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
5188808|NCT01185353|17912665|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
5188809|NCT01185353|17912666|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
5188810|NCT01185353|17912667|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
5188811|NCT01185353|17912668|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
5188812|NCT01185353|17912669|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
5188813|NCT01185353|17912670|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
5188814|NCT01185353|17912671|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
5188815|NCT01185353|17912672|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
5188816|NCT01185353|17912673|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
5188817|NCT01185353|17912664|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188818|NCT01185353|17912665|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188819|NCT01185353|17912666|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188820|NCT01185353|17912667|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
5188821|NCT01185353|17912668|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188822|NCT01185353|17912669|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188823|NCT01185353|17912670|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188824|NCT01185353|17912671|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188825|NCT01185353|17912672|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188826|NCT01185353|17912673|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5188827|NCT01185353|17912664|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5188828|NCT01185353|17912665|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5188829|NCT01185353|17912666|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5188830|NCT01185353|17912667|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
5188831|NCT01185353|17912668|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
5188832|NCT01185353|17912669|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5188833|NCT01185353|17912670|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
5188834|NCT01185353|17912671|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
5188835|NCT01185353|17912672|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5188836|NCT01185353|17912673|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5188837|NCT01185353|17912664|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188838|NCT01185353|17912665|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188839|NCT01185353|17912666|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188840|NCT01185353|17912667|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
5188841|NCT01185353|17912668|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188842|NCT01185353|17912669|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188843|NCT01185353|17912670|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
5188844|NCT01185353|17912671|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188845|NCT01185353|17912672|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188846|NCT01185353|17912673|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5188847|NCT01185353|17912664|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188848|NCT01185353|17912665|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188849|NCT01185353|17912666|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188850|NCT01185353|17912667|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188851|NCT01185353|17912668|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188852|NCT01185353|17912669|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188853|NCT01185353|17912670|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
5188854|NCT01185353|17912671|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188855|NCT01185353|17912672|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
5188856|NCT01185353|17912673|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5188857|NCT01185353|17912664|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
5188858|NCT01185353|17912665|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
5188859|NCT01185353|17912666|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
5188860|NCT01185353|17912667|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
5188861|NCT01185353|17912668|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
5188862|NCT01185353|17912669|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
5188863|NCT01185353|17912670|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
5188864|NCT01185353|17912671|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
5188865|NCT01185353|17912672|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
5188866|NCT01185353|17912673|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
5188867|NCT01185353|17912664|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188868|NCT01185353|17912665|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188869|NCT01185353|17912666|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188870|NCT01185353|17912667|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188871|NCT01185353|17912668|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188872|NCT01185353|17912669|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
5188873|NCT01185353|17912670|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188874|NCT01185353|17912671|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188875|NCT01185353|17912672|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5188876|NCT01185353|17912673|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
5188877|NCT01185353|17912664|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188878|NCT01185353|17912665|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188879|NCT01185353|17912666|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188880|NCT01185353|17912667|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188881|NCT01185353|17912668|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188882|NCT01185353|17912669|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
5188883|NCT01185353|17912670|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188884|NCT01185353|17912671|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188885|NCT01185353|17912672|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188886|NCT01185353|17912673|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
5188887|NCT01185353|17912664|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
5188888|NCT01185353|17912665|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
5188889|NCT01185353|17912666|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
5188890|NCT01185353|17912667|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
5188891|NCT01185353|17912668|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
5188892|NCT01185353|17912669|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
5188893|NCT01185353|17912670|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
5188894|NCT01185353|17912671|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
5188895|NCT01185353|17912672|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
5188896|NCT01185353|17912673|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
5188897|NCT01185353|17912664|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188898|NCT01185353|17912665|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188899|NCT01185353|17912666|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188900|NCT01185353|17912667|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188901|NCT01185353|17912668|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188902|NCT01185353|17912669|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
5188903|NCT01185353|17912670|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188904|NCT01185353|17912671|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188905|NCT01185353|17912672|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5188906|NCT01185353|17912673|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
5188907|NCT01185353|17912664|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188908|NCT01185353|17912665|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188909|NCT01185353|17912666|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188910|NCT01185353|17912667|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188911|NCT01185353|17912668|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188912|NCT01185353|17912669|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
5188913|NCT01185353|17912670|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188914|NCT01185353|17912671|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188915|NCT01185353|17912672|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188916|NCT01185353|17912673|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5188917|NCT01185353|17912664|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
5188918|NCT01185353|17912665|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
5188919|NCT01185353|17912666|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
5188920|NCT01185353|17912667|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
5188921|NCT01185353|17912668|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
5188922|NCT01185353|17912669|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
5188923|NCT01185353|17912670|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
5188924|NCT01185353|17912671|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
5188925|NCT01185353|17912672|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
5188926|NCT01185353|17912673|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
5188927|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
5188928|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
5188929|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5188930|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5188931|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
5188932|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
5188933|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
5188934|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5188935|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5188936|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
5188937|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5188938|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5188939|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5188940|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5188941|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5188942|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5188943|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
5188944|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
5188945|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
5188946|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5188947|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
5188948|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
5188949|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
5188950|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5188951|NCT01185340|17912834|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5188952|NCT01185340|17912835|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
5188953|NCT01185340|17912836|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5188954|NCT01185340|17912837|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5188955|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188956|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188957|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5188958|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
5188959|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188960|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188961|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5188962|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
5188963|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188964|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188965|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5188966|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
5188967|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188968|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188969|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5188970|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
5188971|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188972|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188973|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5188974|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
5188975|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188976|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188977|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5188978|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
5188979|NCT01185340|17912834|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188980|NCT01185340|17912835|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188981|NCT01185340|17912836|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5188982|NCT01185340|17912837|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
5188983|NCT01185301|17912889|P4|Overall Study|Other Reason|2
5188984|NCT01185301|17912890|P3|Overall Study|Other Reason|2
5188985|NCT01185301|17912891|P2|Overall Study|Other Reason|2
5188986|NCT01185301|17912892|P1|Overall Study|Other Reason|3
5188987|NCT01185301|17912889|P4|Overall Study|Lost to Follow-up|1
5188988|NCT01185301|17912890|P3|Overall Study|Lost to Follow-up|0
5188989|NCT01185301|17912891|P2|Overall Study|Lost to Follow-up|0
5188990|NCT01185301|17912892|P1|Overall Study|Lost to Follow-up|2
5188991|NCT01185301|17912889|P4|Overall Study|Withdrawal by Subject|3
5188992|NCT01185301|17912890|P3|Overall Study|Withdrawal by Subject|2
5188993|NCT01185301|17912891|P2|Overall Study|Withdrawal by Subject|5
5188994|NCT01185301|17912892|P1|Overall Study|Withdrawal by Subject|7
5188995|NCT01185301|17912889|P4|Overall Study|Adverse Event|3
5188996|NCT01185301|17912890|P3|Overall Study|Adverse Event|2
5188997|NCT01185301|17912891|P2|Overall Study|Adverse Event|0
5188998|NCT01185301|17912892|P1|Overall Study|Adverse Event|3
5188999|NCT01185288|17912952|P2|Overall Study|Noncompliance|1
5189000|NCT01185288|17912953|P1|Overall Study|Noncompliance|0
5189001|NCT01185288|17912952|P2|Overall Study|Did not meet inclusion criteria|0
5189002|NCT01185288|17912953|P1|Overall Study|Did not meet inclusion criteria|1
5189003|NCT01185288|17912952|P2|Overall Study|Investigator discretion|0
5189004|NCT01185288|17912953|P1|Overall Study|Investigator discretion|1
5189005|NCT01185288|17912952|P2|Overall Study|Lack of Efficacy|0
5189006|NCT01185288|17912953|P1|Overall Study|Lack of Efficacy|2
5189007|NCT01185288|17912952|P2|Overall Study|Lost to Follow-up|5
5189008|NCT01185288|17912953|P1|Overall Study|Lost to Follow-up|2
5189009|NCT01185288|17912952|P2|Overall Study|Withdrawal by Subject|4
5189010|NCT01185288|17912953|P1|Overall Study|Withdrawal by Subject|6
5189011|NCT01185288|17912952|P2|Overall Study|Adverse Event|6
5189012|NCT01185288|17912953|P1|Overall Study|Adverse Event|7
5189013|NCT01185249|17912971|P1|Overall Study|Patients discharged or change in status|42
5189014|NCT01185171|17912976|P1|Maintenance|Disease Recurrence|1
5189015|NCT01185171|17912976|P1|Maintenance|Withdrawal by Subject|1
5189016|NCT01185171|17912976|P1|Maintenance|Comorbid Illness|2
5189017|NCT01185171|17912976|P1|Maintenance|Nausea|1
5189018|NCT01185171|17912976|P1|Maintenance|Xerostomia|1
5189019|NCT01185171|17912976|P1|Maintenance|Diarrhea|1
5189020|NCT01185171|17912976|P1|Maintenance|Rush|2
5189021|NCT01185171|17912976|P1|Maintenance|Elevated liver transaminases|3
5189022|NCT01185171|17912976|P1|Concurrent Chemo and Radiation Treatment|Death|3
5189023|NCT01185171|17912976|P1|Induction Chemotherapy|Duodenal Ulcer|1
5189024|NCT01185171|17912976|P1|Induction Chemotherapy|Withdrawal by Subject|1
5189025|NCT01185080|17912986|P3|Overall Study|Personal reasons|1
5189026|NCT01185080|17912987|P2|Overall Study|Personal reasons|0
5189027|NCT01185080|17912988|P1|Overall Study|Personal reasons|0
5189028|NCT01185080|17912986|P3|Overall Study|Adverse Event|0
5189029|NCT01185080|17912987|P2|Overall Study|Adverse Event|1
5189030|NCT01185080|17912988|P1|Overall Study|Adverse Event|1
5189031|NCT01184989|17913040|P1|Overall Study|Withdrawal by Subject|1
5189032|NCT01184989|17913040|P1|Overall Study|Adverse Event|11
5189033|NCT01184872|17913060|P2|Overall Study|Protocol deviation|0
5189034|NCT01184872|17913061|P1|Overall Study|Protocol deviation|1
5189035|NCT01184872|17913060|P2|Overall Study|Administrative problems|1
5189036|NCT01184872|17913061|P1|Overall Study|Administrative problems|1
5189037|NCT01184872|17913060|P2|Overall Study|Lost to Follow-up|1
5189038|NCT01184872|17913061|P1|Overall Study|Lost to Follow-up|0
5189039|NCT01184872|17913060|P2|Overall Study|Withdrawal by Subject|0
5189040|NCT01184872|17913061|P1|Overall Study|Withdrawal by Subject|2
5189041|NCT01184872|17913060|P2|Overall Study|Unsatisfactory therapeutic effect|2
5189042|NCT01184872|17913061|P1|Overall Study|Unsatisfactory therapeutic effect|3
5189043|NCT01184872|17913060|P2|Overall Study|Adverse Event|4
5189044|NCT01184872|17913061|P1|Overall Study|Adverse Event|3
5189045|NCT01184859|17913080|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
5189046|NCT01184859|17913081|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
5189047|NCT01184859|17913082|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
5189048|NCT01184859|17913083|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
5189049|NCT01184859|17913084|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
5189050|NCT01184859|17913080|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
5189051|NCT01184859|17913081|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5189052|NCT01184859|17913082|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5189053|NCT01184859|17913083|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5189054|NCT01184859|17913084|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5189055|NCT01184859|17913080|P5|Period 1: Single Dose|Adverse Event|1
5189056|NCT01184859|17913081|P4|Period 1: Single Dose|Adverse Event|0
5189057|NCT01184859|17913082|P3|Period 1: Single Dose|Adverse Event|0
5189058|NCT01184859|17913083|P2|Period 1: Single Dose|Adverse Event|0
5189059|NCT01184859|17913084|P1|Period 1: Single Dose|Adverse Event|0
5189060|NCT01184859|17913080|P5|Period 1: Single Dose|Protocol Violation|0
5189061|NCT01184859|17913081|P4|Period 1: Single Dose|Protocol Violation|0
5189062|NCT01184859|17913082|P3|Period 1: Single Dose|Protocol Violation|0
5189063|NCT01184859|17913083|P2|Period 1: Single Dose|Protocol Violation|1
5189064|NCT01184859|17913084|P1|Period 1: Single Dose|Protocol Violation|0
5189065|NCT01184859|17913080|P5|Period 1: Single Dose|Insufficient urine production|0
5189066|NCT01184859|17913081|P4|Period 1: Single Dose|Insufficient urine production|0
5189067|NCT01184859|17913082|P3|Period 1: Single Dose|Insufficient urine production|0
5189068|NCT01184859|17913083|P2|Period 1: Single Dose|Insufficient urine production|1
5189069|NCT01184859|17913084|P1|Period 1: Single Dose|Insufficient urine production|0
5189070|NCT01184846|17913176|P1|Overall Study|Insufficient response|1
5189071|NCT01184846|17913176|P1|Overall Study|Adverse Event|2
5189072|NCT01184508|17913209|P2|Overall Study|Randomized, Not Treated|1
5189073|NCT01184508|17913210|P1|Overall Study|Randomized, Not Treated|0
5189074|NCT01184508|17913209|P2|Overall Study|Withdrawal by Subject|3
5189075|NCT01184508|17913210|P1|Overall Study|Withdrawal by Subject|1
5189076|NCT01184508|17913209|P2|Overall Study|Sponsor Decision|2
5189077|NCT01184508|17913210|P1|Overall Study|Sponsor Decision|5
5189078|NCT01184508|17913209|P2|Overall Study|Protocol Violation|1
5189079|NCT01184508|17913210|P1|Overall Study|Protocol Violation|3
5189080|NCT01184508|17913209|P2|Overall Study|Physician Decision|0
5189081|NCT01184508|17913210|P1|Overall Study|Physician Decision|1
5189082|NCT01184508|17913209|P2|Overall Study|Lost to Follow-up|1
5189083|NCT01184508|17913210|P1|Overall Study|Lost to Follow-up|1
5189084|NCT01184508|17913209|P2|Overall Study|Lack of Efficacy|1
5189085|NCT01184508|17913210|P1|Overall Study|Lack of Efficacy|1
5189086|NCT01184508|17913209|P2|Overall Study|Adverse Event|6
5189087|NCT01184508|17913210|P1|Overall Study|Adverse Event|4
5189088|NCT01184326|17913270|P3|Overall Study|Disease Progression|12
5189089|NCT01184326|17913271|P2|Overall Study|Disease Progression|3
5189090|NCT01184326|17913272|P1|Overall Study|Disease Progression|1
5189091|NCT01184326|17913270|P3|Overall Study|Physician Decision|0
5189092|NCT01184326|17913271|P2|Overall Study|Physician Decision|1
5189093|NCT01184326|17913272|P1|Overall Study|Physician Decision|1
5189094|NCT01184326|17913270|P3|Overall Study|Withdrawal by Subject|1
5189095|NCT01184326|17913271|P2|Overall Study|Withdrawal by Subject|0
5189096|NCT01184326|17913272|P1|Overall Study|Withdrawal by Subject|0
5189097|NCT01184326|17913270|P3|Overall Study|Death|1
5189098|NCT01184326|17913271|P2|Overall Study|Death|0
5189099|NCT01184326|17913272|P1|Overall Study|Death|0
5189100|NCT01184326|17913270|P3|Overall Study|Adverse Event|0
5189101|NCT01184326|17913271|P2|Overall Study|Adverse Event|2
5189102|NCT01184326|17913272|P1|Overall Study|Adverse Event|1
5189103|NCT01184118|17913286|P1|Overall Study|Withdrawal by Subject|5
5189104|NCT01184118|17913286|P1|Overall Study|Exclusionary medical condition|2
5189105|NCT01184118|17913286|P1|Overall Study|FEV1 <60% predicted|2
5189106|NCT01184118|17913286|P1|Overall Study|No physiologic confirmation of asthma|8
5189107|NCT01184118|17913286|P1|Overall Study|Only asthma step 1 - screen fail|1
5189108|NCT01184079|17913294|P2|Overall Study|Lost to Follow-up|2
5189109|NCT01184079|17913295|P1|Overall Study|Lost to Follow-up|14
5189110|NCT01184053|17913305|P1|Overall Study|progression while on treatment|3
5189111|NCT01183975|17913321|P1|Overall Study|Lost to Follow-up|73
5189112|NCT01183884|17913338|P1|Overall Study|Other|4
5189113|NCT01183884|17913338|P1|Overall Study|Not Treated|1
5189114|NCT01183884|17913338|P1|Overall Study|Other Complicating Disease|3
5189115|NCT01183884|17913338|P1|Overall Study|Withdrawal by Subject|1
5189116|NCT01183884|17913338|P1|Overall Study|Adverse Event|3
5189117|NCT01183884|17913338|P1|Overall Study|Progressive Disease|26
5189118|NCT01183858|17913346|P2|Overall Study|Lost to Follow-up|1
5189119|NCT01183858|17913347|P1|Overall Study|Lost to Follow-up|1
5189120|NCT01183858|17913346|P2|Overall Study|Death related to Progressive Disease|5
5189121|NCT01183858|17913347|P1|Overall Study|Death related to Progressive Disease|4
5189122|NCT01183858|17913346|P2|Overall Study|Progressive Disease|115
5189123|NCT01183858|17913347|P1|Overall Study|Progressive Disease|112
5189124|NCT01183858|17913346|P2|Overall Study|Administrative/Other|6
5189125|NCT01183858|17913347|P1|Overall Study|Administrative/Other|6
5189126|NCT01183858|17913346|P2|Overall Study|Protocol Violation|0
5189127|NCT01183858|17913347|P1|Overall Study|Protocol Violation|1
5189128|NCT01183858|17913346|P2|Overall Study|Discontinued Smoking|1
5189129|NCT01183858|17913347|P1|Overall Study|Discontinued Smoking|3
5189130|NCT01183858|17913346|P2|Overall Study|Withdrew Consent|4
5189131|NCT01183858|17913347|P1|Overall Study|Withdrew Consent|4
5189132|NCT01183858|17913346|P2|Overall Study|Refused Treatment|4
5189133|NCT01183858|17913347|P1|Overall Study|Refused Treatment|1
5189134|NCT01183858|17913346|P2|Overall Study|Insufficient Therapeutic Response|0
5189135|NCT01183858|17913347|P1|Overall Study|Insufficient Therapeutic Response|2
5189136|NCT01183858|17913346|P2|Overall Study|Investigator's Decision|3
5189137|NCT01183858|17913347|P1|Overall Study|Investigator's Decision|0
5189138|NCT01183858|17913346|P2|Overall Study|Adverse Event|11
5189139|NCT01183858|17913347|P1|Overall Study|Adverse Event|14
5189140|NCT01183858|17913346|P2|Overall Study|Death not related to Progressive Disease|6
5189141|NCT01183858|17913347|P1|Overall Study|Death not related to Progressive Disease|5
5189142|NCT01183780|17913369|P2|Overall Study|Lost to Follow-up|11
5189143|NCT01183780|17913370|P1|Overall Study|Lost to Follow-up|6
5189144|NCT01183780|17913369|P2|Overall Study|Withdrawal by Subject|14
5189145|NCT01183780|17913370|P1|Overall Study|Withdrawal by Subject|25
5189146|NCT01183468|17913503|P4|Overall Study|Withdrawal by Subject|0
5189147|NCT01183468|17913504|P3|Overall Study|Withdrawal by Subject|0
5189148|NCT01183468|17913505|P2|Overall Study|Withdrawal by Subject|1
5189149|NCT01183468|17913506|P1|Overall Study|Withdrawal by Subject|0
5189150|NCT01183468|17913503|P4|Overall Study|Physician Decision|0
5189151|NCT01183468|17913504|P3|Overall Study|Physician Decision|0
5189152|NCT01183468|17913505|P2|Overall Study|Physician Decision|0
5189153|NCT01183468|17913506|P1|Overall Study|Physician Decision|1
5189154|NCT01183468|17913503|P4|Overall Study|Lost to Follow-up|0
5189155|NCT01183468|17913504|P3|Overall Study|Lost to Follow-up|0
5189156|NCT01183468|17913505|P2|Overall Study|Lost to Follow-up|1
5189157|NCT01183468|17913506|P1|Overall Study|Lost to Follow-up|2
5189158|NCT01183390|17913528|P2|First Intervention|Adverse Event|1
5189159|NCT01183390|17913529|P1|First Intervention|Adverse Event|0
5189160|NCT01183260|17913562|P2|Overall Study|Death|0
5189161|NCT01183260|17913563|P1|Overall Study|Death|1
5189162|NCT01183260|17913562|P2|Overall Study|Revised within 30 days|1
5189163|NCT01183260|17913563|P1|Overall Study|Revised within 30 days|0
5189164|NCT01183260|17913562|P2|Overall Study|Withdrawal by Subject|1
5189165|NCT01183260|17913563|P1|Overall Study|Withdrawal by Subject|1
5189166|NCT01183260|17913562|P2|Overall Study|Intraop screen failure|0
5189167|NCT01183260|17913563|P1|Overall Study|Intraop screen failure|2
5189168|NCT01183234|17913573|P2|First Intervention|Adverse Event|0
5189169|NCT01183234|17913574|P1|First Intervention|Adverse Event|1
5189170|NCT01183143|17913666|P1|Overall Study|Subjects enrolled, but not treated|11
5189171|NCT01183143|17913666|P1|Overall Study|Subject Questionnaires not returned|5
5189172|NCT01183143|17913666|P1|Overall Study|Withdrawal by Subject|19
5189173|NCT01183143|17913666|P1|Overall Study|Protocol Violation|115
5189174|NCT01183104|17913682|P2|Overall Study|Did not receive study drug|9
5189175|NCT01183104|17913683|P1|Overall Study|Did not receive study drug|5
5189176|NCT01183104|17913682|P2|Overall Study|Nonparticipation in Extension Study|50
5189177|NCT01183104|17913683|P1|Overall Study|Nonparticipation in Extension Study|39
5189178|NCT01183104|17913682|P2|Overall Study|Withdrawal by Subject|11
5189179|NCT01183104|17913683|P1|Overall Study|Withdrawal by Subject|6
5189180|NCT01183104|17913682|P2|Overall Study|Physician Decision|8
5189181|NCT01183104|17913683|P1|Overall Study|Physician Decision|5
5189182|NCT01183104|17913682|P2|Overall Study|Lost to Follow-up|7
5189183|NCT01183104|17913683|P1|Overall Study|Lost to Follow-up|14
5189184|NCT01183104|17913682|P2|Overall Study|Death|1
5189185|NCT01183104|17913683|P1|Overall Study|Death|0
5189186|NCT01183104|17913682|P2|Overall Study|Adverse Event|6
5189187|NCT01183104|17913683|P1|Overall Study|Adverse Event|8
5189188|NCT01183065|17913699|P1|Overall Study|Patient no longer fits eligibility crite|1
5189189|NCT01183013|17913710|P7|Overall Study|Reasons other than stated above|13
5189190|NCT01183013|17913711|P6|Overall Study|Reasons other than stated above|15
5189191|NCT01183013|17913712|P5|Overall Study|Reasons other than stated above|12
5189192|NCT01183013|17913713|P4|Overall Study|Reasons other than stated above|12
5189193|NCT01183013|17913714|P3|Overall Study|Reasons other than stated above|17
5189194|NCT01183013|17913715|P2|Overall Study|Reasons other than stated above|11
5189195|NCT01183013|17913716|P1|Overall Study|Reasons other than stated above|15
5189196|NCT01183013|17913710|P7|Overall Study|Withdrawal by Subject|10
5189197|NCT01183013|17913711|P6|Overall Study|Withdrawal by Subject|9
5189198|NCT01183013|17913712|P5|Overall Study|Withdrawal by Subject|7
5189199|NCT01183013|17913713|P4|Overall Study|Withdrawal by Subject|8
5189200|NCT01183013|17913714|P3|Overall Study|Withdrawal by Subject|10
5189201|NCT01183013|17913715|P2|Overall Study|Withdrawal by Subject|13
5189202|NCT01183013|17913716|P1|Overall Study|Withdrawal by Subject|9
5189203|NCT01183013|17913710|P7|Overall Study|Lost to Follow-up|5
5189204|NCT01183013|17913711|P6|Overall Study|Lost to Follow-up|6
5189205|NCT01183013|17913712|P5|Overall Study|Lost to Follow-up|2
5189206|NCT01183013|17913713|P4|Overall Study|Lost to Follow-up|3
5189207|NCT01183013|17913714|P3|Overall Study|Lost to Follow-up|4
5189208|NCT01183013|17913715|P2|Overall Study|Lost to Follow-up|3
5189209|NCT01183013|17913716|P1|Overall Study|Lost to Follow-up|7
5189210|NCT01183013|17913710|P7|Overall Study|Protocol Violation|3
5189211|NCT01183013|17913711|P6|Overall Study|Protocol Violation|3
5189212|NCT01183013|17913712|P5|Overall Study|Protocol Violation|4
5189213|NCT01183013|17913713|P4|Overall Study|Protocol Violation|0
5189214|NCT01183013|17913714|P3|Overall Study|Protocol Violation|4
5189215|NCT01183013|17913715|P2|Overall Study|Protocol Violation|2
5189216|NCT01183013|17913716|P1|Overall Study|Protocol Violation|5
5189217|NCT01183013|17913710|P7|Overall Study|Lack of Efficacy|0
5189218|NCT01183013|17913711|P6|Overall Study|Lack of Efficacy|2
5189219|NCT01183013|17913712|P5|Overall Study|Lack of Efficacy|1
5189220|NCT01183013|17913713|P4|Overall Study|Lack of Efficacy|2
5189221|NCT01183013|17913714|P3|Overall Study|Lack of Efficacy|1
5189222|NCT01183013|17913715|P2|Overall Study|Lack of Efficacy|2
5189223|NCT01183013|17913716|P1|Overall Study|Lack of Efficacy|3
5189224|NCT01183013|17913710|P7|Overall Study|Adverse Event|6
5189225|NCT01183013|17913711|P6|Overall Study|Adverse Event|10
5189226|NCT01183013|17913712|P5|Overall Study|Adverse Event|10
5189227|NCT01183013|17913713|P4|Overall Study|Adverse Event|5
5189228|NCT01183013|17913714|P3|Overall Study|Adverse Event|5
5189229|NCT01183013|17913715|P2|Overall Study|Adverse Event|8
5189230|NCT01183013|17913716|P1|Overall Study|Adverse Event|6
5189231|NCT01182844|17913797|P2|Overall Study|Withdrawal by Subject|2
5189232|NCT01182844|17913798|P1|Overall Study|Withdrawal by Subject|0
5189233|NCT01182441|17913883|P2|Overall Study|Physician Decision|1
5189234|NCT01182441|17913884|P1|Overall Study|Physician Decision|1
5189235|NCT01182441|17913883|P2|Overall Study|Adverse Event|0
5189236|NCT01182441|17913884|P1|Overall Study|Adverse Event|2
5189237|NCT01182441|17913883|P2|Overall Study|Implant Not Attempted|0
5189238|NCT01182441|17913884|P1|Overall Study|Implant Not Attempted|4
5189239|NCT01182441|17913883|P2|Overall Study|Withdrawal by Subject|13
5189240|NCT01182441|17913884|P1|Overall Study|Withdrawal by Subject|6
5189241|NCT01182441|17913883|P2|Overall Study|Lost to Follow-up|8
5189242|NCT01182441|17913884|P1|Overall Study|Lost to Follow-up|5
5189243|NCT01182441|17913883|P2|Overall Study|Implant Attempt Unsuccessful|0
5189244|NCT01182441|17913884|P1|Overall Study|Implant Attempt Unsuccessful|13
5189245|NCT01182441|17913883|P2|Overall Study|Death|25
5189246|NCT01182441|17913884|P1|Overall Study|Death|37
5189247|NCT01182441|17913883|P2|Overall Study|Patient Still in Follow-up|72
5189248|NCT01182441|17913884|P1|Overall Study|Patient Still in Follow-up|152
5189249|NCT01182428|17913895|P2|Overall Study|Withdrawal by Subject|0
5189250|NCT01182428|17913896|P1|Overall Study|Withdrawal by Subject|1
5189251|NCT01182428|17913895|P2|Overall Study|Lost to Follow-up|1
5189252|NCT01182428|17913896|P1|Overall Study|Lost to Follow-up|9
5189253|NCT01182428|17913895|P2|Overall Study|Physician Decision|0
5189254|NCT01182428|17913896|P1|Overall Study|Physician Decision|1
5189255|NCT01182415|17913960|P1|Overall Study|Lost to Follow-up|1
5189256|NCT01182350|17913976|P5|Overall Study|Unevaluable for Biopsy|3
5189257|NCT01182350|17913977|P4|Overall Study|Unevaluable for Biopsy|0
5189258|NCT01182350|17913978|P3|Overall Study|Unevaluable for Biopsy|0
5189259|NCT01182350|17913979|P2|Overall Study|Unevaluable for Biopsy|0
5189260|NCT01182350|17913980|P1|Overall Study|Unevaluable for Biopsy|0
5189261|NCT01182350|17913976|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
5189262|NCT01182350|17913977|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
5189263|NCT01182350|17913978|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
5189264|NCT01182350|17913979|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
5189265|NCT01182350|17913980|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
5189266|NCT01182350|17913976|P5|Overall Study|Alternative Therapy|0
5189267|NCT01182350|17913977|P4|Overall Study|Alternative Therapy|0
5189268|NCT01182350|17913978|P3|Overall Study|Alternative Therapy|1
5189269|NCT01182350|17913979|P2|Overall Study|Alternative Therapy|0
5189270|NCT01182350|17913980|P1|Overall Study|Alternative Therapy|2
5189271|NCT01182350|17913976|P5|Overall Study|Withdrawal by Subject|0
5189272|NCT01182350|17913977|P4|Overall Study|Withdrawal by Subject|1
5189273|NCT01182350|17913978|P3|Overall Study|Withdrawal by Subject|0
5189274|NCT01182350|17913979|P2|Overall Study|Withdrawal by Subject|1
5189275|NCT01182350|17913980|P1|Overall Study|Withdrawal by Subject|3
5189276|NCT01182350|17913976|P5|Overall Study|Death|0
5189277|NCT01182350|17913977|P4|Overall Study|Death|0
5189278|NCT01182350|17913978|P3|Overall Study|Death|1
5189279|NCT01182350|17913979|P2|Overall Study|Death|1
5189280|NCT01182350|17913980|P1|Overall Study|Death|0
5189281|NCT01182350|17913976|P5|Overall Study|Disease Progression|0
5189282|NCT01182350|17913977|P4|Overall Study|Disease Progression|1
5189283|NCT01182350|17913978|P3|Overall Study|Disease Progression|0
5189284|NCT01182350|17913979|P2|Overall Study|Disease Progression|12
5189285|NCT01182350|17913980|P1|Overall Study|Disease Progression|15
5189286|NCT01182350|17913976|P5|Overall Study|Adverse Event|0
5189287|NCT01182350|17913977|P4|Overall Study|Adverse Event|0
5189288|NCT01182350|17913978|P3|Overall Study|Adverse Event|0
5189289|NCT01182350|17913979|P2|Overall Study|Adverse Event|0
5189290|NCT01182350|17913980|P1|Overall Study|Adverse Event|5
5189291|NCT01182337|17914002|P2|Overall Study|Lost to Follow-up|1
5189292|NCT01182337|17914003|P1|Overall Study|Lost to Follow-up|0
5189293|NCT01182337|17914002|P2|Overall Study|Withdrawal by Subject|1
5189294|NCT01182337|17914003|P1|Overall Study|Withdrawal by Subject|3
5189295|NCT01182298|17914021|P1|Overall Study|Withdrawal by Subject|2
5189296|NCT01182298|17914021|P1|Overall Study|Lack of Efficacy|4
5189297|NCT01182285|17914025|P3|Third Intervention Week 11-52|Other|2
5189298|NCT01182285|17914026|P2|Third Intervention Week 11-52|Other|0
5189299|NCT01182285|17914027|P1|Third Intervention Week 11-52|Other|0
5189300|NCT01182285|17914025|P3|Third Intervention Week 11-52|Disease Progression|6
5189301|NCT01182285|17914026|P2|Third Intervention Week 11-52|Disease Progression|0
5189302|NCT01182285|17914027|P1|Third Intervention Week 11-52|Disease Progression|0
5189303|NCT01182285|17914025|P3|First Intervention Week 1-10|Non-compliance|0
5189304|NCT01182285|17914026|P2|First Intervention Week 1-10|Non-compliance|0
5189305|NCT01182285|17914027|P1|First Intervention Week 1-10|Non-compliance|1
5189306|NCT01182285|17914025|P3|First Intervention Week 1-10|Adverse Event|0
5189307|NCT01182285|17914026|P2|First Intervention Week 1-10|Adverse Event|0
5189308|NCT01182285|17914027|P1|First Intervention Week 1-10|Adverse Event|1
5189309|NCT01182285|17914025|P3|First Intervention Week 1-10|Disease progression|0
5189310|NCT01182285|17914026|P2|First Intervention Week 1-10|Disease progression|0
5189311|NCT01182285|17914027|P1|First Intervention Week 1-10|Disease progression|1
5189312|NCT01182207|17914037|P2|Second Intervention|Emeses within 1 hour of dosing|0
5189313|NCT01182207|17914038|P1|Second Intervention|Emeses within 1 hour of dosing|1
5189314|NCT01182207|17914037|P2|First Intervention|Positive Hepatitis Results|1
5189315|NCT01182207|17914038|P1|First Intervention|Positive Hepatitis Results|0
5189316|NCT01182194|17914056|P2|Washout of 28 Days|Withdrawal by Subject|0
5189317|NCT01182194|17914057|P1|Washout of 28 Days|Withdrawal by Subject|1
5189318|NCT01182181|17914075|P2|Washout of 21 Days|Withdrawal by Subject|1
5189319|NCT01182181|17914076|P1|Washout of 21 Days|Withdrawal by Subject|0
5189320|NCT01182181|17914075|P2|First Intervention|Adverse Event|0
5189321|NCT01182181|17914076|P1|First Intervention|Adverse Event|1
5189322|NCT01181986|17914101|P3|Phase 2|Medical condition|0
5189323|NCT01181986|17914102|P2|Phase 2|Medical condition|1
5189324|NCT01181986|17914103|P1|Phase 2|Medical condition|0
5189325|NCT01181986|17914101|P3|Phase 2|Adverse Event|0
5189326|NCT01181986|17914102|P2|Phase 2|Adverse Event|3
5189327|NCT01181986|17914103|P1|Phase 2|Adverse Event|0
5189328|NCT01181986|17914101|P3|Phase 1|Protocol Violation|0
5189329|NCT01181986|17914102|P2|Phase 1|Protocol Violation|0
5189330|NCT01181986|17914103|P1|Phase 1|Protocol Violation|1
5189331|NCT01181986|17914101|P3|Phase 1|Adverse Event|1
5189332|NCT01181986|17914102|P2|Phase 1|Adverse Event|0
5189333|NCT01181986|17914103|P1|Phase 1|Adverse Event|0
5189334|NCT01181986|17914101|P3|Phase 1|Lost to Follow-up|1
5189335|NCT01181986|17914102|P2|Phase 1|Lost to Follow-up|1
5189336|NCT01181986|17914103|P1|Phase 1|Lost to Follow-up|0
5189337|NCT01181921|17914124|P1|Overall Study|Lost to Follow-up|1
5189338|NCT01181895|17914131|P3|Overall Study|Withdrawal by Subject|5
5189339|NCT01181895|17914132|P2|Overall Study|Withdrawal by Subject|0
5189340|NCT01181895|17914133|P1|Overall Study|Withdrawal by Subject|3
5189341|NCT01181895|17914131|P3|Overall Study|Investigator Discretion|1
5189342|NCT01181895|17914132|P2|Overall Study|Investigator Discretion|2
5189343|NCT01181895|17914133|P1|Overall Study|Investigator Discretion|1
5189344|NCT01181895|17914131|P3|Overall Study|Lost to Follow-up|2
5189345|NCT01181895|17914132|P2|Overall Study|Lost to Follow-up|1
5189346|NCT01181895|17914133|P1|Overall Study|Lost to Follow-up|0
5189347|NCT01181895|17914131|P3|Overall Study|Protocol Violation|0
5189348|NCT01181895|17914132|P2|Overall Study|Protocol Violation|1
5189349|NCT01181895|17914133|P1|Overall Study|Protocol Violation|2
5189350|NCT01181895|17914131|P3|Overall Study|Lack of Efficacy|9
5189351|NCT01181895|17914132|P2|Overall Study|Lack of Efficacy|9
5189352|NCT01181895|17914133|P1|Overall Study|Lack of Efficacy|8
5189353|NCT01181895|17914131|P3|Overall Study|Adverse Event|1
5189354|NCT01181895|17914132|P2|Overall Study|Adverse Event|1
5189355|NCT01181895|17914133|P1|Overall Study|Adverse Event|3
5189356|NCT01181778|17914191|P1|Overall Study|Physician Decision|48
5189357|NCT01181726|17914199|P2|First Intervention|Adverse Event|0
5189358|NCT01181726|17914200|P1|First Intervention|Adverse Event|1
5189359|NCT01181609|17914280|P1|Overall Study|Death|50
5189360|NCT01181609|17914280|P1|Overall Study|Lost to Follow-up|1
5189361|NCT01181609|17914280|P1|Overall Study|Withdrawal by Subject|1
5189362|NCT01181609|17914280|P1|Overall Study|Adverse Event|1
5189363|NCT01181531|17914298|P2|Overall Study|Adverse Event|1
5189364|NCT01181531|17914299|P1|Overall Study|Adverse Event|0
5189365|NCT01181531|17914298|P2|Overall Study|Death|12
5189366|NCT01181531|17914299|P1|Overall Study|Death|9
5189367|NCT01181531|17914298|P2|Overall Study|Protocol Violation|6
5189368|NCT01181531|17914299|P1|Overall Study|Protocol Violation|6
5189369|NCT01181531|17914298|P2|Overall Study|Withdrawal by Subject|7
5189370|NCT01181531|17914299|P1|Overall Study|Withdrawal by Subject|8
5189371|NCT01181531|17914298|P2|Overall Study|Pregnancy|1
5189372|NCT01181531|17914299|P1|Overall Study|Pregnancy|0
5189373|NCT01181531|17914298|P2|Overall Study|Protocol Specified Criteria|8
5189374|NCT01181531|17914299|P1|Overall Study|Protocol Specified Criteria|15
5189375|NCT01181531|17914298|P2|Overall Study|Ineligibility determined|2
5189376|NCT01181531|17914299|P1|Overall Study|Ineligibility determined|1
5189377|NCT01181531|17914298|P2|Overall Study|Noncompliance|2
5189378|NCT01181531|17914299|P1|Overall Study|Noncompliance|2
5189379|NCT01181531|17914298|P2|Overall Study|Physician Decision|1
5189380|NCT01181531|17914299|P1|Overall Study|Physician Decision|3
5189381|NCT01181531|17914298|P2|Overall Study|Partial consent by subject withdrawn|1
5189382|NCT01181531|17914299|P1|Overall Study|Partial consent by subject withdrawn|0
5189383|NCT01181531|17914298|P2|Overall Study|Other|12
5189384|NCT01181531|17914299|P1|Overall Study|Other|17
5189385|NCT01181271|17914441|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
5189386|NCT01181271|17914441|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
5189387|NCT01181271|17914441|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
5189388|NCT01181271|17914441|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
5189389|NCT01181167|17914465|P2|Overall Study|Withdrawal by Subject|8
5189390|NCT01181167|17914466|P1|Overall Study|Withdrawal by Subject|6
5189391|NCT01181167|17914465|P2|Overall Study|Protocol Violation|0
5189392|NCT01181167|17914466|P1|Overall Study|Protocol Violation|3
5189393|NCT01181167|17914465|P2|Overall Study|Physician Decision|3
5189394|NCT01181167|17914466|P1|Overall Study|Physician Decision|2
5189395|NCT01181167|17914465|P2|Overall Study|Lost to Follow-up|0
5189396|NCT01181167|17914466|P1|Overall Study|Lost to Follow-up|1
5189397|NCT01181167|17914465|P2|Overall Study|Adverse Event|21
5189398|NCT01181167|17914466|P1|Overall Study|Adverse Event|11
5189399|NCT01181141|17914476|P2|Overall Study|Withdrawal by Subject|1
5189400|NCT01181141|17914477|P1|Overall Study|Withdrawal by Subject|3
5189401|NCT01181141|17914476|P2|Overall Study|Protocol Violation|1
5189402|NCT01181141|17914477|P1|Overall Study|Protocol Violation|3
5189403|NCT01181141|17914476|P2|Overall Study|Physician Decision|0
5189404|NCT01181141|17914477|P1|Overall Study|Physician Decision|2
5189405|NCT01181141|17914476|P2|Overall Study|Lost to Follow-up|1
5189406|NCT01181141|17914477|P1|Overall Study|Lost to Follow-up|1
5189407|NCT01181141|17914476|P2|Overall Study|Lack of Efficacy|0
5189408|NCT01181141|17914477|P1|Overall Study|Lack of Efficacy|1
5189409|NCT01181141|17914476|P2|Overall Study|Adverse Event|1
5189410|NCT01181141|17914477|P1|Overall Study|Adverse Event|2
5189411|NCT01181128|17914486|P3|Overall Study|Other|1
5189412|NCT01181128|17914487|P2|Overall Study|Other|1
5189413|NCT01181128|17914488|P1|Overall Study|Other|1
5189414|NCT01181128|17914486|P3|Overall Study|Adverse Event|0
5189415|NCT01181128|17914487|P2|Overall Study|Adverse Event|2
5189416|NCT01181128|17914488|P1|Overall Study|Adverse Event|0
5189417|NCT01181128|17914486|P3|Overall Study|Physician Decision|0
5189418|NCT01181128|17914487|P2|Overall Study|Physician Decision|0
5189419|NCT01181128|17914488|P1|Overall Study|Physician Decision|2
5189420|NCT01181128|17914486|P3|Overall Study|Death|0
5189421|NCT01181128|17914487|P2|Overall Study|Death|0
5189422|NCT01181128|17914488|P1|Overall Study|Death|1
5189423|NCT01181128|17914486|P3|Overall Study|Withdrawal by Subject|0
5189424|NCT01181128|17914487|P2|Overall Study|Withdrawal by Subject|2
5189425|NCT01181128|17914488|P1|Overall Study|Withdrawal by Subject|2
5189426|NCT01181102|17914576|P2|Overall Study|Withdrawal by Subject|12
5189427|NCT01181102|17914577|P1|Overall Study|Withdrawal by Subject|10
5189428|NCT01181102|17914576|P2|Overall Study|Protocol Violation|6
5189429|NCT01181102|17914577|P1|Overall Study|Protocol Violation|5
5189430|NCT01181102|17914576|P2|Overall Study|Physician Decision|1
5189431|NCT01181102|17914577|P1|Overall Study|Physician Decision|3
5189432|NCT01181102|17914576|P2|Overall Study|Lost to Follow-up|0
5189433|NCT01181102|17914577|P1|Overall Study|Lost to Follow-up|2
5189434|NCT01181102|17914576|P2|Overall Study|Lack of Efficacy|1
5189435|NCT01181102|17914577|P1|Overall Study|Lack of Efficacy|3
5189436|NCT01181102|17914576|P2|Overall Study|Adverse Event|26
5189437|NCT01181102|17914577|P1|Overall Study|Adverse Event|28
5189438|NCT01181011|17914621|P1|Overall Study|Lost to Follow-up|1
5189439|NCT01181011|17914621|P1|Overall Study|Adverse Event|2
5189440|NCT01180998|17914671|P3|Overall Study|Poor lens handling|2
5189441|NCT01180998|17914672|P2|Overall Study|Poor lens handling|0
5189442|NCT01180998|17914673|P1|Overall Study|Poor lens handling|0
5189443|NCT01180998|17914671|P3|Overall Study|Poor comfort|4
5189444|NCT01180998|17914672|P2|Overall Study|Poor comfort|0
5189445|NCT01180998|17914673|P1|Overall Study|Poor comfort|3
5189446|NCT01180998|17914671|P3|Overall Study|Withdrawal by Subject|1
5189447|NCT01180998|17914672|P2|Overall Study|Withdrawal by Subject|0
5189448|NCT01180998|17914673|P1|Overall Study|Withdrawal by Subject|0
5189449|NCT01180998|17914671|P3|Overall Study|Protocol Violation|0
5189450|NCT01180998|17914672|P2|Overall Study|Protocol Violation|2
5189451|NCT01180998|17914673|P1|Overall Study|Protocol Violation|1
5189452|NCT01180998|17914671|P3|Overall Study|Lost to Follow-up|1
5189453|NCT01180998|17914672|P2|Overall Study|Lost to Follow-up|0
5189454|NCT01180998|17914673|P1|Overall Study|Lost to Follow-up|0
5189455|NCT01180998|17914671|P3|Overall Study|Poor Vision|2
5189456|NCT01180998|17914672|P2|Overall Study|Poor Vision|2
5189457|NCT01180998|17914673|P1|Overall Study|Poor Vision|0
5189458|NCT01180985|17914687|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
5189459|NCT01180985|17914688|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
5189460|NCT01180790|17914727|P7|Overall Study|Severe coronary atherosclerosis (death)|0
5189461|NCT01180790|17914728|P6|Overall Study|Severe coronary atherosclerosis (death)|0
5189462|NCT01180790|17914729|P5|Overall Study|Severe coronary atherosclerosis (death)|0
5189551|NCT01180049|17914965|P2|Overall Study|Lost to Follow-up|6
5189463|NCT01180790|17914730|P4|Overall Study|Severe coronary atherosclerosis (death)|0
5189464|NCT01180790|17914731|P3|Overall Study|Severe coronary atherosclerosis (death)|1
5189465|NCT01180790|17914732|P2|Overall Study|Severe coronary atherosclerosis (death)|0
5189466|NCT01180790|17914733|P1|Overall Study|Severe coronary atherosclerosis (death)|0
5189467|NCT01180790|17914727|P7|Overall Study|compliance|0
5189468|NCT01180790|17914728|P6|Overall Study|compliance|0
5189469|NCT01180790|17914729|P5|Overall Study|compliance|0
5189470|NCT01180790|17914730|P4|Overall Study|compliance|0
5189471|NCT01180790|17914731|P3|Overall Study|compliance|0
5189472|NCT01180790|17914732|P2|Overall Study|compliance|1
5189473|NCT01180790|17914733|P1|Overall Study|compliance|0
5189474|NCT01180790|17914727|P7|Overall Study|Lack of Efficacy|0
5189475|NCT01180790|17914728|P6|Overall Study|Lack of Efficacy|3
5189476|NCT01180790|17914729|P5|Overall Study|Lack of Efficacy|1
5189477|NCT01180790|17914730|P4|Overall Study|Lack of Efficacy|6
5189478|NCT01180790|17914731|P3|Overall Study|Lack of Efficacy|5
5189479|NCT01180790|17914732|P2|Overall Study|Lack of Efficacy|2
5189480|NCT01180790|17914733|P1|Overall Study|Lack of Efficacy|1
5189481|NCT01180790|17914727|P7|Overall Study|Physician Decision|0
5189482|NCT01180790|17914728|P6|Overall Study|Physician Decision|0
5189483|NCT01180790|17914729|P5|Overall Study|Physician Decision|0
5189484|NCT01180790|17914730|P4|Overall Study|Physician Decision|1
5189485|NCT01180790|17914731|P3|Overall Study|Physician Decision|0
5189486|NCT01180790|17914732|P2|Overall Study|Physician Decision|0
5189487|NCT01180790|17914733|P1|Overall Study|Physician Decision|1
5189488|NCT01180790|17914727|P7|Overall Study|Lost to Follow-up|1
5189489|NCT01180790|17914728|P6|Overall Study|Lost to Follow-up|0
5189490|NCT01180790|17914729|P5|Overall Study|Lost to Follow-up|1
5189491|NCT01180790|17914730|P4|Overall Study|Lost to Follow-up|2
5189492|NCT01180790|17914731|P3|Overall Study|Lost to Follow-up|0
5189493|NCT01180790|17914732|P2|Overall Study|Lost to Follow-up|1
5189494|NCT01180790|17914733|P1|Overall Study|Lost to Follow-up|3
5189495|NCT01180790|17914727|P7|Overall Study|Withdrawal by Subject|0
5189496|NCT01180790|17914728|P6|Overall Study|Withdrawal by Subject|1
5189497|NCT01180790|17914729|P5|Overall Study|Withdrawal by Subject|2
5189498|NCT01180790|17914730|P4|Overall Study|Withdrawal by Subject|0
5189499|NCT01180790|17914731|P3|Overall Study|Withdrawal by Subject|5
5189500|NCT01180790|17914732|P2|Overall Study|Withdrawal by Subject|0
5189501|NCT01180790|17914733|P1|Overall Study|Withdrawal by Subject|3
5189502|NCT01180790|17914727|P7|Overall Study|Adverse Event|0
5189503|NCT01180790|17914728|P6|Overall Study|Adverse Event|3
5189504|NCT01180790|17914729|P5|Overall Study|Adverse Event|1
5189505|NCT01180790|17914730|P4|Overall Study|Adverse Event|0
5189506|NCT01180790|17914731|P3|Overall Study|Adverse Event|2
5189507|NCT01180790|17914732|P2|Overall Study|Adverse Event|1
5189508|NCT01180790|17914733|P1|Overall Study|Adverse Event|1
5189509|NCT01180777|17914798|P1|Overall Study|Adverse Event|1
5189510|NCT01180777|17914798|P1|Overall Study|Lost to Follow-up|1
5189511|NCT01180777|17914798|P1|Overall Study|Poor lens fit|4
5189512|NCT01180777|17914798|P1|Overall Study|Protocol Violation|6
5189513|NCT01180660|17914812|P2|Overall Study|Changed to open surgery|0
5189514|NCT01180660|17914813|P1|Overall Study|Changed to open surgery|1
5189515|NCT01180647|17914823|P2|Overall Study|Lost to Follow-up|6
5189516|NCT01180647|17914824|P1|Overall Study|Lost to Follow-up|5
5189517|NCT01180400|17914859|P2|Overall Study|Other|1
5189518|NCT01180400|17914860|P1|Overall Study|Other|0
5189519|NCT01180400|17914859|P2|Overall Study|Lost to Follow-up|3
5189520|NCT01180400|17914860|P1|Overall Study|Lost to Follow-up|2
5189521|NCT01180400|17914859|P2|Overall Study|Study-specific withdrawal criteria|2
5189522|NCT01180400|17914860|P1|Overall Study|Study-specific withdrawal criteria|1
5189523|NCT01180400|17914859|P2|Overall Study|Lack of Efficacy|0
5189524|NCT01180400|17914860|P1|Overall Study|Lack of Efficacy|2
5189525|NCT01180400|17914859|P2|Overall Study|Condition under investigation worsened|1
5189526|NCT01180400|17914860|P1|Overall Study|Condition under investigation worsened|2
5189527|NCT01180400|17914859|P2|Overall Study|Severe non-compliance to protocol|2
5189528|NCT01180400|17914860|P1|Overall Study|Severe non-compliance to protocol|1
5189529|NCT01180400|17914859|P2|Overall Study|Adverse Event|10
5189530|NCT01180400|17914860|P1|Overall Study|Adverse Event|12
5189531|NCT01180400|17914859|P2|Overall Study|Eligibility criteria not fulfilled|2
5189532|NCT01180400|17914860|P1|Overall Study|Eligibility criteria not fulfilled|0
5189533|NCT01180400|17914859|P2|Overall Study|Withdrawal by Subject|6
5189534|NCT01180400|17914860|P1|Overall Study|Withdrawal by Subject|5
5189535|NCT01180296|17914908|P2|Overall Study|Protocol Violation|2
5189536|NCT01180296|17914909|P1|Overall Study|Protocol Violation|1
5189537|NCT01180244|17914919|P2|Overall Study|Lost to Follow-up|0
5189538|NCT01180244|17914920|P1|Overall Study|Lost to Follow-up|1
5189539|NCT01180244|17914919|P2|Overall Study|Protocol Violation|0
5189540|NCT01180244|17914920|P1|Overall Study|Protocol Violation|1
5189541|NCT01180244|17914919|P2|Overall Study|Withdrawal by Subject|1
5189542|NCT01180244|17914920|P1|Overall Study|Withdrawal by Subject|0
5189543|NCT01180244|17914919|P2|Overall Study|Adverse Event|0
5189544|NCT01180244|17914920|P1|Overall Study|Adverse Event|1
5189545|NCT01180244|17914919|P2|Overall Study|Physician Decision|0
5189546|NCT01180244|17914920|P1|Overall Study|Physician Decision|3
5189547|NCT01180244|17914919|P2|Overall Study|Lack of Efficacy|7
5189548|NCT01180244|17914920|P1|Overall Study|Lack of Efficacy|0
5189549|NCT01180049|17914965|P2|Overall Study|Death|35
5189550|NCT01180049|17914966|P1|Overall Study|Death|36
5189552|NCT01180049|17914966|P1|Overall Study|Lost to Follow-up|8
5189553|NCT01180049|17914965|P2|Overall Study|Other|7
5189554|NCT01180049|17914966|P1|Overall Study|Other|9
5189555|NCT01179919|17915003|P1|Overall Study|Adverse Event|1
5189556|NCT01179919|17915003|P1|Overall Study|Protocol Violation|1
5189557|NCT01179737|17915012|P4|Extension|The study was terminated|0
5189558|NCT01179737|17915013|P3|Extension|The study was terminated|0
5189559|NCT01179737|17915014|P2|Extension|The study was terminated|0
5189560|NCT01179737|17915015|P1|Extension|The study was terminated|3
5189561|NCT01179737|17915012|P4|Cohort 1 & Cohort 2 Expansion|Death|0
5189562|NCT01179737|17915013|P3|Cohort 1 & Cohort 2 Expansion|Death|0
5189563|NCT01179737|17915014|P2|Cohort 1 & Cohort 2 Expansion|Death|0
5189564|NCT01179737|17915015|P1|Cohort 1 & Cohort 2 Expansion|Death|1
5189565|NCT01179737|17915012|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5189566|NCT01179737|17915013|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5189567|NCT01179737|17915014|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
5189568|NCT01179737|17915015|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5189569|NCT01179737|17915012|P4|Cohort 1 & Cohort 2|Death|0
5189570|NCT01179737|17915013|P3|Cohort 1 & Cohort 2|Death|1
5189571|NCT01179737|17915014|P2|Cohort 1 & Cohort 2|Death|0
5189572|NCT01179737|17915015|P1|Cohort 1 & Cohort 2|Death|0
5189573|NCT01179737|17915012|P4|Cohort 1 & Cohort 2|Administrative problems|4
5189574|NCT01179737|17915013|P3|Cohort 1 & Cohort 2|Administrative problems|2
5189575|NCT01179737|17915014|P2|Cohort 1 & Cohort 2|Administrative problems|0
5189576|NCT01179737|17915015|P1|Cohort 1 & Cohort 2|Administrative problems|0
5189577|NCT01179737|17915012|P4|Cohort 1 & Cohort 2|Withdrew consent|0
5189578|NCT01179737|17915013|P3|Cohort 1 & Cohort 2|Withdrew consent|0
5189579|NCT01179737|17915014|P2|Cohort 1 & Cohort 2|Withdrew consent|0
5189580|NCT01179737|17915015|P1|Cohort 1 & Cohort 2|Withdrew consent|2
5189581|NCT01179737|17915012|P4|Cohort 1 & Cohort 2|Adverse Event|0
5189582|NCT01179737|17915013|P3|Cohort 1 & Cohort 2|Adverse Event|1
5189583|NCT01179737|17915014|P2|Cohort 1 & Cohort 2|Adverse Event|1
5189584|NCT01179737|17915015|P1|Cohort 1 & Cohort 2|Adverse Event|3
5189585|NCT01179672|17915026|P2|Overall Study|Physician Decision|1
5189586|NCT01179672|17915027|P1|Overall Study|Physician Decision|1
5189587|NCT01179672|17915026|P2|Overall Study|Protocol Violation|2
5189588|NCT01179672|17915027|P1|Overall Study|Protocol Violation|2
5189589|NCT01179672|17915026|P2|Overall Study|Lost to Follow-up|1
5189590|NCT01179672|17915027|P1|Overall Study|Lost to Follow-up|0
5189591|NCT01179672|17915026|P2|Overall Study|Entry Criteria Not Met|2
5189592|NCT01179672|17915027|P1|Overall Study|Entry Criteria Not Met|0
5189593|NCT01179672|17915026|P2|Overall Study|Withdrawal by Subject|12
5189594|NCT01179672|17915027|P1|Overall Study|Withdrawal by Subject|10
5189595|NCT01179672|17915026|P2|Overall Study|Adverse Event|8
5189596|NCT01179672|17915027|P1|Overall Study|Adverse Event|17
5189597|NCT01179516|17915083|P3|Overall Study|Other|2
5189598|NCT01179516|17915084|P2|Overall Study|Other|0
5189599|NCT01179516|17915085|P1|Overall Study|Other|2
5189600|NCT01179516|17915083|P3|Overall Study|Lost to Follow-up|3
5189601|NCT01179516|17915084|P2|Overall Study|Lost to Follow-up|7
5189602|NCT01179516|17915085|P1|Overall Study|Lost to Follow-up|7
5189603|NCT01179516|17915083|P3|Overall Study|Withdrawal of Consent|10
5189604|NCT01179516|17915084|P2|Overall Study|Withdrawal of Consent|6
5189605|NCT01179516|17915085|P1|Overall Study|Withdrawal of Consent|2
5189606|NCT01179516|17915083|P3|Overall Study|Protocol Deviations|3
5189607|NCT01179516|17915084|P2|Overall Study|Protocol Deviations|3
5189608|NCT01179516|17915085|P1|Overall Study|Protocol Deviations|4
5189609|NCT01179516|17915083|P3|Overall Study|Noncompliance with Study Drug|1
5189610|NCT01179516|17915084|P2|Overall Study|Noncompliance with Study Drug|0
5189611|NCT01179516|17915085|P1|Overall Study|Noncompliance with Study Drug|2
5189612|NCT01179516|17915083|P3|Overall Study|Lack of Efficacy|0
5189613|NCT01179516|17915084|P2|Overall Study|Lack of Efficacy|2
5189614|NCT01179516|17915085|P1|Overall Study|Lack of Efficacy|4
5189615|NCT01179516|17915083|P3|Overall Study|Pretreatment Event or Adverse Event|12
5189616|NCT01179516|17915084|P2|Overall Study|Pretreatment Event or Adverse Event|8
5189617|NCT01179516|17915085|P1|Overall Study|Pretreatment Event or Adverse Event|6
5189618|NCT01179477|17915129|P1|Overall Study|Did not complete final visit|27
5189619|NCT01179477|17915129|P1|Overall Study|Non-death withdrawal|438
5189620|NCT01179477|17915129|P1|Overall Study|Unsuccessful implant|80
5189621|NCT01179477|17915129|P1|Overall Study|Death|542
5189622|NCT01179399|17915134|P1|Overall Study|Withdrawal by Subject|1
5189623|NCT01179399|17915134|P1|Overall Study|Lack of Efficacy|30
5189624|NCT01179399|17915134|P1|Overall Study|Adverse Event|1
5189625|NCT01179347|17915140|P2|Open-label Period (12 Weeks)|Other|4
5189626|NCT01179347|17915141|P1|Open-label Period (12 Weeks)|Other|7
5189627|NCT01179347|17915140|P2|Open-label Period (12 Weeks)|Protocol Violation|0
5189628|NCT01179347|17915141|P1|Open-label Period (12 Weeks)|Protocol Violation|1
5189629|NCT01179347|17915140|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
5189630|NCT01179347|17915141|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
5189631|NCT01179347|17915140|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
5189632|NCT01179347|17915141|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
5189633|NCT01179347|17915140|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
5189634|NCT01179347|17915141|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
5189635|NCT01179347|17915140|P2|Open-label Period (12 Weeks)|Adverse Event|9
5189636|NCT01179347|17915141|P1|Open-label Period (12 Weeks)|Adverse Event|5
5189637|NCT01179347|17915140|P2|Double-blind Period (12 Weeks)|Other|4
5189638|NCT01179347|17915141|P1|Double-blind Period (12 Weeks)|Other|2
5189639|NCT01179347|17915140|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
5189640|NCT01179347|17915141|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
5189641|NCT01179347|17915140|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
5189642|NCT01179347|17915141|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
5189643|NCT01179347|17915140|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
5189644|NCT01179347|17915141|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
5189645|NCT01179347|17915140|P2|Double-blind Period (12 Weeks)|Adverse Event|6
5189646|NCT01179347|17915141|P1|Double-blind Period (12 Weeks)|Adverse Event|2
5189647|NCT01179334|17915163|P2|Long-term Extension (LTE) Period|Adverse Event|4
5189648|NCT01179334|17915164|P1|Long-term Extension (LTE) Period|Adverse Event|2
5189649|NCT01179334|17915163|P2|Long-term Extension (LTE) Period|Death|0
5189650|NCT01179334|17915164|P1|Long-term Extension (LTE) Period|Death|3
5189651|NCT01179334|17915163|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
5189652|NCT01179334|17915164|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
5189653|NCT01179334|17915163|P2|Treatment Period|Adverse Event|0
5189654|NCT01179334|17915164|P1|Treatment Period|Adverse Event|1
5189655|NCT01179191|17915219|P1|Maintenance Phase (8 Weeks)|Other|66
5189656|NCT01179191|17915219|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
5189657|NCT01179191|17915219|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
5189658|NCT01179191|17915219|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
5189659|NCT01179191|17915219|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
5189660|NCT01179191|17915219|P1|Titration Phase (up to 6 Weeks)|Other|62
5189661|NCT01179191|17915219|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
5189662|NCT01179191|17915219|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
5189663|NCT01179191|17915219|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
5189664|NCT01179191|17915219|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
5189665|NCT01179191|17915219|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
5189666|NCT01179048|17915251|P2|Overall Study|Alive|142
5189667|NCT01179048|17915252|P1|Overall Study|Alive|127
5189668|NCT01179048|17915251|P2|Overall Study|Lost to Follow-up|9
5189669|NCT01179048|17915252|P1|Overall Study|Lost to Follow-up|8
5189670|NCT01179048|17915251|P2|Overall Study|Withdrawn - does not allow contact|8
5189671|NCT01179048|17915252|P1|Overall Study|Withdrawn - does not allow contact|4
5189672|NCT01178853|17915279|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
5189673|NCT01178853|17915280|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
5189674|NCT01178853|17915279|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
5189675|NCT01178853|17915280|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
5189676|NCT01178853|17915279|P2|Period 3 (Warfarin Titration)|Adverse Event|0
5189677|NCT01178853|17915280|P1|Period 3 (Warfarin Titration)|Adverse Event|1
5189678|NCT01178853|17915279|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
5189679|NCT01178853|17915280|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
5189680|NCT01178853|17915279|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
5189681|NCT01178853|17915280|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
5189682|NCT01178762|17915320|P1|Overall Study|Lost to Follow-up|15
5189683|NCT01178671|17915326|P2|Overall Study|Physician Decision|6
5189684|NCT01178671|17915327|P1|Overall Study|Physician Decision|4
5189685|NCT01178671|17915326|P2|Overall Study|Lost to Follow-up|1
5189686|NCT01178671|17915327|P1|Overall Study|Lost to Follow-up|3
5189687|NCT01178671|17915326|P2|Overall Study|Lack of Efficacy|1
5189688|NCT01178671|17915327|P1|Overall Study|Lack of Efficacy|0
5189689|NCT01178671|17915326|P2|Overall Study|Protocol Violation|1
5189690|NCT01178671|17915327|P1|Overall Study|Protocol Violation|1
5189691|NCT01178671|17915326|P2|Overall Study|Adverse Event|6
5189692|NCT01178671|17915327|P1|Overall Study|Adverse Event|4
5189693|NCT01178385|17915375|P2|Overall Study|Withdrawal by Subject|0
5189694|NCT01178385|17915376|P1|Overall Study|Withdrawal by Subject|2
5189695|NCT01178294|17915445|P1|Overall Study|Completion status could not be verified|1
5189696|NCT01178294|17915445|P1|Overall Study|Subject status is terminal|1
5189697|NCT01178294|17915445|P1|Overall Study|Development of inhibitors to OBI-1|1
5189698|NCT01178294|17915445|P1|Overall Study|Death|1
5189699|NCT01178294|17915445|P1|Overall Study|Lack of Efficacy|1
5189700|NCT01178294|17915445|P1|Overall Study|Lost to Follow-up|2
5189701|NCT01178294|17915445|P1|Overall Study|Adverse Event|4
5189702|NCT01178138|17915725|P1|Overall Study|Physician Decision|8
5189703|NCT01178138|17915725|P1|Overall Study|Withdrawal by Subject|7
5189704|NCT01178138|17915725|P1|Overall Study|Lost to Follow-up|8
5189705|NCT01178125|17915746|P1|Overall Study|Investigator Decision|5
5189706|NCT01178125|17915746|P1|Overall Study|Protocol Violation|17
5189707|NCT01178125|17915746|P1|Overall Study|Sponsor Decision|28
5189708|NCT01178125|17915746|P1|Overall Study|Other Reason|39
5189709|NCT01178125|17915746|P1|Overall Study|Pregnancy|55
5189710|NCT01178125|17915746|P1|Overall Study|Noncompliance|184
5189711|NCT01178125|17915746|P1|Overall Study|Withdrawal by Subject|209
5189712|NCT01178125|17915746|P1|Overall Study|Adverse Event|244
5189713|NCT01178125|17915746|P1|Overall Study|Lost to Follow-up|397
5189714|NCT01178099|17915777|P2|Overall Study|Physician Decision|1
5189715|NCT01178099|17915778|P1|Overall Study|Physician Decision|0
5189716|NCT01178086|17915818|P1|Overall Study|Excluded from EAS|20
5189717|NCT01178086|17915818|P1|Overall Study|Other unspecified|89
5189718|NCT01178086|17915818|P1|Overall Study|Death|59
5189719|NCT01178086|17915818|P1|Overall Study|Switch to other CLL therapy|113
5189720|NCT01178086|17915818|P1|Overall Study|Physician Decision|44
5189721|NCT01178086|17915818|P1|Overall Study|Participant refusal|7
5189722|NCT01178073|17915845|P3|Overall Study|Missing Completion Status|0
5189723|NCT01178073|17915846|P2|Overall Study|Missing Completion Status|0
5189724|NCT01178073|17915847|P1|Overall Study|Missing Completion Status|1
5189725|NCT01178073|17915845|P3|Overall Study|Withdrawal by Subject|8
5189726|NCT01178073|17915846|P2|Overall Study|Withdrawal by Subject|6
5189727|NCT01178073|17915847|P1|Overall Study|Withdrawal by Subject|10
5189728|NCT01178073|17915845|P3|Overall Study|Physician Decision|10
5189729|NCT01178073|17915846|P2|Overall Study|Physician Decision|10
5189730|NCT01178073|17915847|P1|Overall Study|Physician Decision|14
5189731|NCT01178073|17915845|P3|Overall Study|Lost to Follow-up|3
5189732|NCT01178073|17915846|P2|Overall Study|Lost to Follow-up|0
5189733|NCT01178073|17915847|P1|Overall Study|Lost to Follow-up|2
5189734|NCT01178073|17915845|P3|Overall Study|Protocol Violation|1
5189735|NCT01178073|17915846|P2|Overall Study|Protocol Violation|1
5189736|NCT01178073|17915847|P1|Overall Study|Protocol Violation|1
5189737|NCT01178073|17915845|P3|Overall Study|Adverse Event|24
5189738|NCT01178073|17915846|P2|Overall Study|Adverse Event|27
5189739|NCT01178073|17915847|P1|Overall Study|Adverse Event|34
5189740|NCT01177969|17915878|P2|Overall Study|Withdrawal by Subject|2
5189741|NCT01177969|17915879|P1|Overall Study|Withdrawal by Subject|1
5189742|NCT01177969|17915878|P2|Overall Study|Protocol Violation|1
5189743|NCT01177969|17915879|P1|Overall Study|Protocol Violation|2
5189744|NCT01177943|17915902|P2|First Intervention|Withdrawal by Subject|0
5189745|NCT01177943|17915903|P1|First Intervention|Withdrawal by Subject|2
5189746|NCT01177813|17915916|P5|Overall Study|Other reason not defined above|2
5189747|NCT01177813|17915917|P4|Overall Study|Other reason not defined above|3
5189748|NCT01177813|17915918|P3|Overall Study|Other reason not defined above|2
5189749|NCT01177813|17915919|P2|Overall Study|Other reason not defined above|2
5189750|NCT01177813|17915920|P1|Overall Study|Other reason not defined above|5
5189751|NCT01177813|17915916|P5|Overall Study|Withdrawal by Subject|3
5189752|NCT01177813|17915917|P4|Overall Study|Withdrawal by Subject|5
5189753|NCT01177813|17915918|P3|Overall Study|Withdrawal by Subject|6
5189754|NCT01177813|17915919|P2|Overall Study|Withdrawal by Subject|7
5189755|NCT01177813|17915920|P1|Overall Study|Withdrawal by Subject|12
5189756|NCT01177813|17915916|P5|Overall Study|Lost to Follow-up|0
5189757|NCT01177813|17915917|P4|Overall Study|Lost to Follow-up|3
5189758|NCT01177813|17915918|P3|Overall Study|Lost to Follow-up|6
5189759|NCT01177813|17915919|P2|Overall Study|Lost to Follow-up|5
5189760|NCT01177813|17915920|P1|Overall Study|Lost to Follow-up|12
5189761|NCT01177813|17915916|P5|Overall Study|Protocol Violation|1
5189762|NCT01177813|17915917|P4|Overall Study|Protocol Violation|0
5189763|NCT01177813|17915918|P3|Overall Study|Protocol Violation|2
5189764|NCT01177813|17915919|P2|Overall Study|Protocol Violation|2
5189765|NCT01177813|17915920|P1|Overall Study|Protocol Violation|3
5189766|NCT01177813|17915916|P5|Overall Study|Lack of Efficacy|0
5189767|NCT01177813|17915917|P4|Overall Study|Lack of Efficacy|0
5189768|NCT01177813|17915918|P3|Overall Study|Lack of Efficacy|0
5189769|NCT01177813|17915919|P2|Overall Study|Lack of Efficacy|0
5189770|NCT01177813|17915920|P1|Overall Study|Lack of Efficacy|1
5189771|NCT01177813|17915916|P5|Overall Study|Adverse Event|3
5189772|NCT01177813|17915917|P4|Overall Study|Adverse Event|6
5189773|NCT01177813|17915918|P3|Overall Study|Adverse Event|4
5189774|NCT01177813|17915919|P2|Overall Study|Adverse Event|2
5189775|NCT01177813|17915920|P1|Overall Study|Adverse Event|8
5189776|NCT01177800|17915949|P2|Overall Study|Withdrawal of informed consent|1
5189777|NCT01177800|17915950|P1|Overall Study|Withdrawal of informed consent|0
5189778|NCT01177800|17915949|P2|Overall Study|Physician Decision|0
5189779|NCT01177800|17915950|P1|Overall Study|Physician Decision|1
5189780|NCT01177800|17915949|P2|Overall Study|Protocol Violation|1
5189781|NCT01177800|17915950|P1|Overall Study|Protocol Violation|0
5189782|NCT01177800|17915949|P2|Overall Study|Adverse Event|3
5189783|NCT01177800|17915950|P1|Overall Study|Adverse Event|9
5189784|NCT01177722|17915972|P4|Overall Study|Withdrawal by Subject|6
5189785|NCT01177722|17915973|P3|Overall Study|Withdrawal by Subject|4
5189786|NCT01177722|17915974|P2|Overall Study|Withdrawal by Subject|6
5189787|NCT01177722|17915975|P1|Overall Study|Withdrawal by Subject|10
5189788|NCT01177722|17915972|P4|Overall Study|Lost to Follow-up|1
5189789|NCT01177722|17915973|P3|Overall Study|Lost to Follow-up|3
5189790|NCT01177722|17915974|P2|Overall Study|Lost to Follow-up|4
5189791|NCT01177722|17915975|P1|Overall Study|Lost to Follow-up|3
5189792|NCT01177722|17915972|P4|Overall Study|Protocol Violation|0
5189793|NCT01177722|17915973|P3|Overall Study|Protocol Violation|1
5189794|NCT01177722|17915974|P2|Overall Study|Protocol Violation|0
5189795|NCT01177722|17915975|P1|Overall Study|Protocol Violation|0
5189796|NCT01177722|17915972|P4|Overall Study|Serious Adverse Event|0
5189797|NCT01177722|17915973|P3|Overall Study|Serious Adverse Event|1
5189798|NCT01177722|17915974|P2|Overall Study|Serious Adverse Event|0
5189799|NCT01177722|17915975|P1|Overall Study|Serious Adverse Event|0
5189800|NCT01177670|17916007|P1|Overall Study|Withdrawal by Subject|4
5189801|NCT01177670|17916007|P1|Overall Study|Physician Decision|50
5189802|NCT01177670|17916007|P1|Overall Study|Study Terminated|115
5189803|NCT01177553|17916014|P2|Overall Study|babies not yet 6 months of age|0
5189804|NCT01177553|17916015|P1|Overall Study|babies not yet 6 months of age|1
5189805|NCT01177410|17916024|P3|Overall Study|Lost to Follow-up|0
5189806|NCT01177410|17916025|P2|Overall Study|Lost to Follow-up|1
5189807|NCT01177410|17916026|P1|Overall Study|Lost to Follow-up|0
5189808|NCT01177410|17916024|P3|Overall Study|Withdrawal by Subject|3
5189809|NCT01177410|17916025|P2|Overall Study|Withdrawal by Subject|4
5189810|NCT01177410|17916026|P1|Overall Study|Withdrawal by Subject|1
5189811|NCT01177410|17916024|P3|Overall Study|Adverse Event|2
5189812|NCT01177410|17916025|P2|Overall Study|Adverse Event|2
5189813|NCT01177410|17916026|P1|Overall Study|Adverse Event|0
5189814|NCT01177384|17916039|P2|Overall Study|Withdrawal by Subject|12
5189815|NCT01177384|17916040|P1|Overall Study|Withdrawal by Subject|5
5189816|NCT01177384|17916039|P2|Overall Study|Protocol Violation|2
5189817|NCT01177384|17916040|P1|Overall Study|Protocol Violation|0
5189818|NCT01177384|17916039|P2|Overall Study|Physician Decision|3
5189819|NCT01177384|17916040|P1|Overall Study|Physician Decision|0
5189820|NCT01177384|17916039|P2|Overall Study|Lost to Follow-up|4
5189821|NCT01177384|17916040|P1|Overall Study|Lost to Follow-up|3
5189822|NCT01177384|17916039|P2|Overall Study|Lack of Efficacy|1
5189823|NCT01177384|17916040|P1|Overall Study|Lack of Efficacy|0
5189824|NCT01177384|17916039|P2|Overall Study|Adverse Event|4
5189825|NCT01177384|17916040|P1|Overall Study|Adverse Event|6
5189826|NCT01177293|17916052|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
5189827|NCT01177293|17916053|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
5189828|NCT01177228|17916071|P4|Overall Study|Withdrawal by Subject|0
5189829|NCT01177228|17916072|P3|Overall Study|Withdrawal by Subject|0
5189830|NCT01177228|17916073|P2|Overall Study|Withdrawal by Subject|1
5189831|NCT01177228|17916074|P1|Overall Study|Withdrawal by Subject|0
5189832|NCT01177228|17916071|P4|Overall Study|Worsening disease activity|0
5189833|NCT01177228|17916072|P3|Overall Study|Worsening disease activity|0
5189834|NCT01177228|17916073|P2|Overall Study|Worsening disease activity|0
5189835|NCT01177228|17916074|P1|Overall Study|Worsening disease activity|1
5189836|NCT01177228|17916071|P4|Overall Study|Positive tuberculosis test|0
5189837|NCT01177228|17916072|P3|Overall Study|Positive tuberculosis test|0
5189838|NCT01177228|17916073|P2|Overall Study|Positive tuberculosis test|1
5189839|NCT01177228|17916074|P1|Overall Study|Positive tuberculosis test|0
5189840|NCT01177137|17916128|P3|Overall Study|Withdrawal by Subject|2
5189841|NCT01177137|17916129|P2|Overall Study|Withdrawal by Subject|10
5189842|NCT01177137|17916130|P1|Overall Study|Withdrawal by Subject|10
5189843|NCT01177059|17916214|P1|Overall Study|Lost to Follow-up|18
5189844|NCT01177059|17916214|P1|Overall Study|Withdrew consent|2
5189845|NCT01177059|17916214|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
5189846|NCT01177007|17916220|P1|Overall Study|Change in treatment modality|21
5189847|NCT01177007|17916220|P1|Overall Study|Required additional Y90 treatment|6
5189848|NCT01177007|17916220|P1|Overall Study|Entered hospice care|5
5189849|NCT01177007|17916220|P1|Overall Study|Death|4
5189850|NCT01177007|17916220|P1|Overall Study|Lost to Follow-up|2
5189851|NCT01176968|17916234|P2|Overall Study|Reason not defined|3
5189852|NCT01176968|17916235|P1|Overall Study|Reason not defined|5
5189853|NCT01176968|17916234|P2|Overall Study|Study terminated by sponsor|1
5189854|NCT01176968|17916235|P1|Overall Study|Study terminated by sponsor|0
5189855|NCT01176968|17916234|P2|Overall Study|Did Not Meet Entrance Criteria|0
5189856|NCT01176968|17916235|P1|Overall Study|Did Not Meet Entrance Criteria|1
5189857|NCT01176968|17916234|P2|Overall Study|Protocol Violation|1
5189858|NCT01176968|17916235|P1|Overall Study|Protocol Violation|2
5189859|NCT01176968|17916234|P2|Overall Study|Withdrawal by Subject|48
5189860|NCT01176968|17916235|P1|Overall Study|Withdrawal by Subject|48
5189861|NCT01176968|17916234|P2|Overall Study|Lost to Follow-up|14
5189862|NCT01176968|17916235|P1|Overall Study|Lost to Follow-up|16
5189863|NCT01176968|17916234|P2|Overall Study|Lack of Efficacy|1
5189864|NCT01176968|17916235|P1|Overall Study|Lack of Efficacy|0
5189865|NCT01176968|17916234|P2|Overall Study|Death|3
5189866|NCT01176968|17916235|P1|Overall Study|Death|2
5189867|NCT01176968|17916234|P2|Overall Study|Adverse Event|11
5189868|NCT01176968|17916235|P1|Overall Study|Adverse Event|10
5189869|NCT01176916|17916281|P1|Overall Study|Withdrawal prior to Treatment|6
5189870|NCT01176916|17916281|P1|Overall Study|Other|6
5189871|NCT01176916|17916281|P1|Overall Study|Withdrawal by Subject|37
5189872|NCT01176916|17916281|P1|Overall Study|Protocol Violation|24
5189873|NCT01176916|17916281|P1|Overall Study|Objective progression or relapse|17
5189874|NCT01176916|17916281|P1|Overall Study|Lost to Follow-up|15
5189875|NCT01176916|17916281|P1|Overall Study|Death|1
5189876|NCT01176916|17916281|P1|Overall Study|Adverse Event|61
5189877|NCT01176773|17916296|P1|Overall Study|Withdrew consent|1
5189878|NCT01176773|17916296|P1|Overall Study|Screen Failure|2
5189879|NCT01176565|17916339|P2|Overall Study|Not Analyzed (any other reason)|2
5189880|NCT01176565|17916340|P1|Overall Study|Not Analyzed (any other reason)|1
5189881|NCT01176565|17916339|P2|Overall Study|Withdrawal by Subject|1
5189882|NCT01176565|17916340|P1|Overall Study|Withdrawal by Subject|7
5189883|NCT01176565|17916339|P2|Overall Study|Lost to Follow-up|16
5189884|NCT01176565|17916340|P1|Overall Study|Lost to Follow-up|12
5189885|NCT01176513|17916358|P1|Overall Study|Withdrew subjects prior to dosing|3
5189886|NCT01176292|17916386|P2|Overall Study|Has not scheduled one-year visit yet|2
5189887|NCT01176292|17916387|P1|Overall Study|Has not scheduled one-year visit yet|2
5189888|NCT01176292|17916386|P2|Overall Study|Physician Decision|2
5189889|NCT01176292|17916387|P1|Overall Study|Physician Decision|0
5189890|NCT01176292|17916386|P2|Overall Study|Adverse Event|1
5189891|NCT01176292|17916387|P1|Overall Study|Adverse Event|1
5189892|NCT01176292|17916386|P2|Overall Study|Lost to Follow-up|4
5189893|NCT01176292|17916387|P1|Overall Study|Lost to Follow-up|2
5189894|NCT01176266|17916405|P1|Overall Study|Withdrawal by Subject|3
5189895|NCT01176266|17916405|P1|Overall Study|Death|6
5189896|NCT01176240|17916429|P2|Study 306B|withdrew prior to dosing|1
5189897|NCT01176240|17916430|P1|Study 306B|withdrew prior to dosing|2
5189898|NCT01176240|17916429|P2|Study 306B|Lost to Follow-up|1
5189899|NCT01176240|17916430|P1|Study 306B|Lost to Follow-up|0
5189900|NCT01176240|17916429|P2|Study 306B|Supine Hypertension|2
5189901|NCT01176240|17916430|P1|Study 306B|Supine Hypertension|1
5189902|NCT01176240|17916429|P2|Study 306B|Physician Decision|1
5189903|NCT01176240|17916430|P1|Study 306B|Physician Decision|2
5189904|NCT01176240|17916429|P2|Study 306B|Withdrawal by Subject|1
5189905|NCT01176240|17916430|P1|Study 306B|Withdrawal by Subject|4
5189906|NCT01176240|17916429|P2|Study 306B|Protocol Violation|3
5189907|NCT01176240|17916430|P1|Study 306B|Protocol Violation|2
5189908|NCT01176240|17916429|P2|Study 306B|Adverse Event|5
5189909|NCT01176240|17916430|P1|Study 306B|Adverse Event|10
5189910|NCT01176240|17916429|P2|Study 306B|Lack of Efficacy|3
5189911|NCT01176240|17916430|P1|Study 306B|Lack of Efficacy|5
5189912|NCT01176240|17916429|P2|Study 306A|Stop due to diverse problems|0
5189913|NCT01176240|17916430|P1|Study 306A|Stop due to diverse problems|1
5189914|NCT01176240|17916429|P2|Study 306A|Withdrawal by Subject|1
5189915|NCT01176240|17916430|P1|Study 306A|Withdrawal by Subject|0
5189916|NCT01176240|17916429|P2|Study 306A|Protocol Violation|1
5189917|NCT01176240|17916430|P1|Study 306A|Protocol Violation|0
5189918|NCT01176240|17916429|P2|Study 306A|Lack of Efficacy|1
5189919|NCT01176240|17916430|P1|Study 306A|Lack of Efficacy|2
5189920|NCT01176058|17916456|P2|Overall Study|Withdrawal by Subject|0
5189921|NCT01176058|17916457|P1|Overall Study|Withdrawal by Subject|1
5189922|NCT01176058|17916456|P2|Overall Study|Insufficient mycological response|1
5189923|NCT01176058|17916457|P1|Overall Study|Insufficient mycological response|0
5189924|NCT01176058|17916456|P2|Overall Study|Insufficient clinical response|2
5189925|NCT01176058|17916457|P1|Overall Study|Insufficient clinical response|2
5189926|NCT01176058|17916456|P2|Overall Study|Adverse Event|0
5189927|NCT01176058|17916457|P1|Overall Study|Adverse Event|1
5189928|NCT01176032|17916481|P2|Overall Study|Other|0
5189929|NCT01176032|17916482|P1|Overall Study|Other|1
5189930|NCT01176032|17916481|P2|Overall Study|Informed consent withdrawn|0
5189931|NCT01176032|17916482|P1|Overall Study|Informed consent withdrawn|3
5189932|NCT01176032|17916481|P2|Overall Study|Protocol Violation|0
5189933|NCT01176032|17916482|P1|Overall Study|Protocol Violation|1
5189934|NCT01176032|17916481|P2|Overall Study|Unsatisfactory therapeutic effect|1
5189935|NCT01176032|17916482|P1|Overall Study|Unsatisfactory therapeutic effect|0
5189936|NCT01176032|17916481|P2|Overall Study|Adverse Event|0
5189937|NCT01176032|17916482|P1|Overall Study|Adverse Event|1
5189938|NCT01175824|17916623|P2|Overall Study|Entry Criteria Not Met|4
5189939|NCT01175824|17916624|P1|Overall Study|Entry Criteria Not Met|6
5189940|NCT01175824|17916623|P2|Overall Study|Sponsor Decision|0
5189941|NCT01175824|17916624|P1|Overall Study|Sponsor Decision|1
5189942|NCT01175824|17916623|P2|Overall Study|Withdrawal by Subject|7
5189943|NCT01175824|17916624|P1|Overall Study|Withdrawal by Subject|3
5189944|NCT01175824|17916623|P2|Overall Study|Protocol Violation|5
5189945|NCT01175824|17916624|P1|Overall Study|Protocol Violation|2
5189946|NCT01175824|17916623|P2|Overall Study|Physician Decision|4
5189947|NCT01175824|17916624|P1|Overall Study|Physician Decision|0
5189948|NCT01175824|17916623|P2|Overall Study|Lost to Follow-up|1
5189949|NCT01175824|17916624|P1|Overall Study|Lost to Follow-up|0
5189950|NCT01175824|17916623|P2|Overall Study|Lack of Efficacy|0
5189951|NCT01175824|17916624|P1|Overall Study|Lack of Efficacy|2
5189952|NCT01175824|17916623|P2|Overall Study|Adverse Event|1
5189953|NCT01175824|17916624|P1|Overall Study|Adverse Event|2
5189954|NCT01175811|17916658|P2|Overall Study|Withdrawal by Subject|7
5189955|NCT01175811|17916659|P1|Overall Study|Withdrawal by Subject|6
5189956|NCT01175811|17916658|P2|Overall Study|Protocol Violation|2
5189957|NCT01175811|17916659|P1|Overall Study|Protocol Violation|1
5189958|NCT01175811|17916658|P2|Overall Study|Physician Decision|1
5189959|NCT01175811|17916659|P1|Overall Study|Physician Decision|1
5189960|NCT01175811|17916658|P2|Overall Study|Lost to Follow-up|2
5189961|NCT01175811|17916659|P1|Overall Study|Lost to Follow-up|3
5189962|NCT01175811|17916658|P2|Overall Study|Lack of Efficacy|0
5189963|NCT01175811|17916659|P1|Overall Study|Lack of Efficacy|1
5189964|NCT01175811|17916658|P2|Overall Study|Entry criteria not met|1
5189965|NCT01175811|17916659|P1|Overall Study|Entry criteria not met|3
5189966|NCT01175811|17916658|P2|Overall Study|Adverse Event|1
5189967|NCT01175811|17916659|P1|Overall Study|Adverse Event|1
5189968|NCT01175707|17916694|P2|Overall Study|Adverse Event|6
5189969|NCT01175707|17916695|P1|Overall Study|Adverse Event|4
5189970|NCT01175668|17916731|P2|Overall Study|Withdrawal by Subject|0
5189971|NCT01175668|17916732|P1|Overall Study|Withdrawal by Subject|2
5189972|NCT01175590|17916742|P2|Overall Study|Protocol Violation|1
5189973|NCT01175590|17916743|P1|Overall Study|Protocol Violation|0
5189974|NCT01175590|17916742|P2|Overall Study|Herpes Simplex Dermatitis|0
5189975|NCT01175590|17916743|P1|Overall Study|Herpes Simplex Dermatitis|1
5189976|NCT01175590|17916742|P2|Overall Study|Treated not as randomized|2
5189977|NCT01175590|17916743|P1|Overall Study|Treated not as randomized|3
5189978|NCT01175590|17916742|P2|Overall Study|Residual Bacterial Conjunctivitis|0
5189979|NCT01175590|17916743|P1|Overall Study|Residual Bacterial Conjunctivitis|1
5189980|NCT01175590|17916742|P2|Overall Study|Lack of Efficacy|1
5189981|NCT01175590|17916743|P1|Overall Study|Lack of Efficacy|1
5189982|NCT01175590|17916742|P2|Overall Study|Physician Decision|4
5189983|NCT01175590|17916743|P1|Overall Study|Physician Decision|1
5189984|NCT01175590|17916742|P2|Overall Study|Adverse Event|0
5189985|NCT01175590|17916743|P1|Overall Study|Adverse Event|4
5189986|NCT01175590|17916742|P2|Overall Study|Withdrawal by Subject|2
5189987|NCT01175590|17916743|P1|Overall Study|Withdrawal by Subject|0
5189988|NCT01175590|17916742|P2|Overall Study|Lost to Follow-up|0
5189989|NCT01175590|17916743|P1|Overall Study|Lost to Follow-up|1
5189990|NCT01175473|17916777|P2|Overall Study|Adverse Event|2
5189991|NCT01175473|17916778|P1|Overall Study|Adverse Event|2
5189992|NCT01175382|17916819|P3|Overall Study|Unable to tolerate study meds|1
5189993|NCT01175382|17916820|P2|Overall Study|Unable to tolerate study meds|1
5189994|NCT01175382|17916821|P1|Overall Study|Unable to tolerate study meds|0
5189995|NCT01175382|17916819|P3|Overall Study|Unwilling to follow protocol|0
5189996|NCT01175382|17916820|P2|Overall Study|Unwilling to follow protocol|1
5189997|NCT01175382|17916821|P1|Overall Study|Unwilling to follow protocol|0
5189998|NCT01175382|17916819|P3|Overall Study|Unable/unwilling to attend visits|2
5189999|NCT01175382|17916820|P2|Overall Study|Unable/unwilling to attend visits|1
5190000|NCT01175382|17916821|P1|Overall Study|Unable/unwilling to attend visits|3
5190001|NCT01175382|17916819|P3|Overall Study|No longer having problem|1
5190002|NCT01175382|17916820|P2|Overall Study|No longer having problem|0
5190003|NCT01175382|17916821|P1|Overall Study|No longer having problem|1
5190004|NCT01175382|17916819|P3|Overall Study|Withdrawal by Subject|1
5190005|NCT01175382|17916820|P2|Overall Study|Withdrawal by Subject|0
5190006|NCT01175382|17916821|P1|Overall Study|Withdrawal by Subject|0
5190007|NCT01175382|17916819|P3|Overall Study|Physician Decision|0
5190008|NCT01175382|17916820|P2|Overall Study|Physician Decision|1
5190009|NCT01175382|17916821|P1|Overall Study|Physician Decision|0
5190010|NCT01175382|17916819|P3|Overall Study|Lost to Follow-up|1
5190011|NCT01175382|17916820|P2|Overall Study|Lost to Follow-up|3
5190012|NCT01175382|17916821|P1|Overall Study|Lost to Follow-up|4
5190013|NCT01175356|17916907|P1|Overall Study|Initiation other tx prior to completion|9
5190014|NCT01175356|17916907|P1|Overall Study|Inadequate stem cell for transplant|1
5190015|NCT01175356|17916907|P1|Overall Study|On other COG study w/tumor tx intent|7
5190016|NCT01175356|17916907|P1|Overall Study|Pts MIBG non-avid after enrollment|2
5190017|NCT01175356|17916907|P1|Overall Study|Refusal by patient/parent/guardian|6
5190018|NCT01175356|17916907|P1|Overall Study|Treatment Slot Not Available|18
5190019|NCT01175356|17916907|P1|Overall Study|Ineligible|1
5190020|NCT01175356|17916907|P1|Overall Study|Physician Decision|23
5190021|NCT01175356|17916907|P1|Overall Study|Lost to Follow-up|1
5190022|NCT01175356|17916907|P1|Overall Study|Lack of Efficacy|12
5190023|NCT01175356|17916907|P1|Overall Study|Death|1
5190024|NCT01175213|17916947|P2|Safety Follow-up|Adverse Event|0
5190025|NCT01175213|17916948|P1|Safety Follow-up|Adverse Event|1
5190026|NCT01175213|17916947|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
5190027|NCT01175213|17916948|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
5190028|NCT01175213|17916947|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
5190029|NCT01175213|17916948|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
5190030|NCT01175213|17916947|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
5190031|NCT01175213|17916948|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
5190032|NCT01175213|17916947|P2|IGSC, 10%/rHuPH20|Death|0
5190033|NCT01175213|17916948|P1|IGSC, 10%/rHuPH20|Death|1
5190034|NCT01175213|17916947|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
5190035|NCT01175213|17916948|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
5190036|NCT01175135|17917005|P4|Overall Study|Randomized But Not Treated|0
5190037|NCT01175135|17917006|P3|Overall Study|Randomized But Not Treated|1
5190038|NCT01175135|17917007|P2|Overall Study|Randomized But Not Treated|0
5190039|NCT01175135|17917008|P1|Overall Study|Randomized But Not Treated|0
5190040|NCT01175135|17917005|P4|Overall Study|Other|0
5190041|NCT01175135|17917006|P3|Overall Study|Other|3
5190042|NCT01175135|17917007|P2|Overall Study|Other|1
5190043|NCT01175135|17917008|P1|Overall Study|Other|3
5190044|NCT01175135|17917005|P4|Overall Study|Withdrawal by Subject|5
5190045|NCT01175135|17917006|P3|Overall Study|Withdrawal by Subject|5
5190046|NCT01175135|17917007|P2|Overall Study|Withdrawal by Subject|8
5190047|NCT01175135|17917008|P1|Overall Study|Withdrawal by Subject|4
5190048|NCT01175135|17917005|P4|Overall Study|Protocol Violation|0
5190049|NCT01175135|17917006|P3|Overall Study|Protocol Violation|0
5190050|NCT01175135|17917007|P2|Overall Study|Protocol Violation|1
5190051|NCT01175135|17917008|P1|Overall Study|Protocol Violation|1
5190052|NCT01175135|17917005|P4|Overall Study|Lost to Follow-up|0
5190053|NCT01175135|17917006|P3|Overall Study|Lost to Follow-up|0
5190054|NCT01175135|17917007|P2|Overall Study|Lost to Follow-up|2
5190055|NCT01175135|17917008|P1|Overall Study|Lost to Follow-up|1
5190056|NCT01175135|17917005|P4|Overall Study|Lack of Efficacy|5
5190057|NCT01175135|17917006|P3|Overall Study|Lack of Efficacy|0
5190058|NCT01175135|17917007|P2|Overall Study|Lack of Efficacy|5
5190059|NCT01175135|17917008|P1|Overall Study|Lack of Efficacy|4
5190060|NCT01175135|17917005|P4|Overall Study|Death|0
5190061|NCT01175135|17917006|P3|Overall Study|Death|0
5190062|NCT01175135|17917007|P2|Overall Study|Death|0
5190063|NCT01175135|17917008|P1|Overall Study|Death|1
5190064|NCT01175135|17917005|P4|Overall Study|Adverse Event|4
5190065|NCT01175135|17917006|P3|Overall Study|Adverse Event|3
5190066|NCT01175135|17917007|P2|Overall Study|Adverse Event|5
5190067|NCT01175135|17917008|P1|Overall Study|Adverse Event|2
5190068|NCT01175083|17917096|P6|Booster Epoch|Withdrawal by Subject|0
5190069|NCT01175083|17917097|P5|Booster Epoch|Withdrawal by Subject|0
5190070|NCT01175083|17917098|P4|Booster Epoch|Withdrawal by Subject|1
5190071|NCT01175083|17917099|P3|Booster Epoch|Withdrawal by Subject|0
5190072|NCT01175083|17917100|P2|Booster Epoch|Withdrawal by Subject|0
5190073|NCT01175083|17917101|P1|Booster Epoch|Withdrawal by Subject|0
5190074|NCT01175083|17917096|P6|Booster Epoch|Death|0
5190075|NCT01175083|17917097|P5|Booster Epoch|Death|0
5190076|NCT01175083|17917098|P4|Booster Epoch|Death|0
5190077|NCT01175083|17917099|P3|Booster Epoch|Death|1
5190078|NCT01175083|17917100|P2|Booster Epoch|Death|0
5190079|NCT01175083|17917101|P1|Booster Epoch|Death|0
5190080|NCT01175083|17917096|P6|Primary Epoch|Lost to Follow-up|1
5190081|NCT01175083|17917097|P5|Primary Epoch|Lost to Follow-up|0
5190082|NCT01175083|17917098|P4|Primary Epoch|Lost to Follow-up|0
5190083|NCT01175083|17917099|P3|Primary Epoch|Lost to Follow-up|0
5190084|NCT01175083|17917100|P2|Primary Epoch|Lost to Follow-up|0
5190085|NCT01175083|17917101|P1|Primary Epoch|Lost to Follow-up|0
5190086|NCT01175083|17917096|P6|Primary Epoch|Withdrawal by Subject|2
5190087|NCT01175083|17917097|P5|Primary Epoch|Withdrawal by Subject|0
5190088|NCT01175083|17917098|P4|Primary Epoch|Withdrawal by Subject|0
5190089|NCT01175083|17917099|P3|Primary Epoch|Withdrawal by Subject|0
5190090|NCT01175083|17917100|P2|Primary Epoch|Withdrawal by Subject|0
5190091|NCT01175083|17917101|P1|Primary Epoch|Withdrawal by Subject|0
5190092|NCT01175018|17917193|P2|Overall Study|Adverse Event|1
5190093|NCT01175018|17917194|P1|Overall Study|Adverse Event|3
5190094|NCT01174784|17917256|P1|Overall Study|Screen fails|4
5190095|NCT01174563|17917302|P1|Overall Study|Sponsor's decision|1
5190096|NCT01174563|17917302|P1|Overall Study|Rash Adverse Event|1
5190097|NCT01174563|17917302|P1|Overall Study|Participant Withdrew Consent|3
5190098|NCT01174563|17917302|P1|Overall Study|Investigator's Discretion|5
5190099|NCT01174563|17917302|P1|Overall Study|Death|5
5190100|NCT01174563|17917302|P1|Overall Study|Progressive Disease|45
5190101|NCT01174550|17917310|P2|Overall Study|Withdrawal by Subject|289
5190102|NCT01174550|17917311|P1|Overall Study|Withdrawal by Subject|543
5190103|NCT01174550|17917310|P2|Overall Study|Lost to Follow-up|510
5190104|NCT01174550|17917311|P1|Overall Study|Lost to Follow-up|652
5190105|NCT01174550|17917310|P2|Overall Study|Death|74
5190106|NCT01174550|17917311|P1|Overall Study|Death|75
5190107|NCT01174459|17917339|P1|Overall Study|case report form (CRF) not collected|5
5190108|NCT01174446|17917344|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5190109|NCT01174446|17917345|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5190110|NCT01174446|17917346|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
5190111|NCT01174446|17917347|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5190112|NCT01174446|17917344|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5190113|NCT01174446|17917345|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5190114|NCT01174446|17917346|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5190115|NCT01174446|17917347|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
5190116|NCT01174446|17917344|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5190117|NCT01174446|17917345|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
5190118|NCT01174446|17917346|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5190119|NCT01174446|17917347|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5190120|NCT01174446|17917344|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5190121|NCT01174446|17917345|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
5190122|NCT01174446|17917346|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5190123|NCT01174446|17917347|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5190124|NCT01174368|17917534|P1|Overall Study|Withdrawal by Subject|1
5190125|NCT01174342|17917540|P1|Overall Study|Conversion to cesarean section|4
5190126|NCT01174264|17917547|P3|Steady-state Pharmacokinetics|Not evaluable|2
5190127|NCT01174264|17917548|P2|Steady-state Pharmacokinetics|Not evaluable|0
5190128|NCT01174264|17917549|P1|Steady-state Pharmacokinetics|Not evaluable|6
5190129|NCT01174264|17917547|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
5190130|NCT01174264|17917548|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
5190131|NCT01174264|17917549|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
5190132|NCT01174264|17917547|P3|Single Dose Pharmacokinetics|Early progressive disease|1
5190133|NCT01174264|17917548|P2|Single Dose Pharmacokinetics|Early progressive disease|0
5190134|NCT01174264|17917549|P1|Single Dose Pharmacokinetics|Early progressive disease|1
5190135|NCT01174238|17917581|P1|Overall Study|Lost to Follow-up|2
5190136|NCT01174186|17917592|P2|Overall Study|Withdrawal by Subject|2
5190137|NCT01174186|17917593|P1|Overall Study|Withdrawal by Subject|0
5190138|NCT01174186|17917592|P2|Overall Study|Lost to Follow-up|1
5190139|NCT01174186|17917593|P1|Overall Study|Lost to Follow-up|0
5190140|NCT01174173|17917600|P1|Overall Study|drug-drug interaction|1
5190141|NCT01174160|17917611|P2|Overall Study|Withdrawal by Subject|0
5190142|NCT01174160|17917612|P1|Overall Study|Withdrawal by Subject|1
5190143|NCT01174160|17917611|P2|Overall Study|Protocol Violation|6
5190144|NCT01174160|17917612|P1|Overall Study|Protocol Violation|4
5190145|NCT01174160|17917611|P2|Overall Study|Physician Decision|0
5190146|NCT01174160|17917612|P1|Overall Study|Physician Decision|1
5190147|NCT01174160|17917611|P2|Overall Study|Lost to Follow-up|0
5190148|NCT01174160|17917612|P1|Overall Study|Lost to Follow-up|1
5190149|NCT01174160|17917611|P2|Overall Study|Adverse Event|0
5190150|NCT01174160|17917612|P1|Overall Study|Adverse Event|1
5190151|NCT01174043|17917627|P1|Overall Study|Withdrawal by Subject|2
5190152|NCT01174043|17917627|P1|Overall Study|Death|1
5190153|NCT01174043|17917627|P1|Overall Study|Adverse Event|3
5190154|NCT01174043|17917627|P1|Overall Study|Disease progression|5
5190155|NCT01174004|17917666|P2|Overall Study|Physician Decision|0
5190156|NCT01174004|17917667|P1|Overall Study|Physician Decision|1
5190157|NCT01174004|17917666|P2|Overall Study|Protocol Violation|1
5190158|NCT01174004|17917667|P1|Overall Study|Protocol Violation|0
5190159|NCT01174004|17917666|P2|Overall Study|At Discretion of Sponsor|2
5190160|NCT01174004|17917667|P1|Overall Study|At Discretion of Sponsor|2
5190161|NCT01174004|17917666|P2|Overall Study|Withdrawal by Subject|3
5190162|NCT01174004|17917667|P1|Overall Study|Withdrawal by Subject|2
5190163|NCT01174004|17917666|P2|Overall Study|Adverse Event|10
5190164|NCT01174004|17917667|P1|Overall Study|Adverse Event|2
5190165|NCT01173718|17917698|P1|Overall Study|Abandonment of study graft|27
5190166|NCT01173718|17917698|P1|Overall Study|Death|17
5190167|NCT01173679|17917707|P1|Overall Study|Death|1
5190168|NCT01173653|17917715|P2|Overall Study|Pts unwilling to provide follow-up|41
5190169|NCT01173653|17917716|P1|Overall Study|Pts unwilling to provide follow-up|53
5190170|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
5190171|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5190172|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5190173|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5190174|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5190175|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
5190176|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
5190177|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
5190178|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5190179|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5190180|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5190181|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
5190182|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5190183|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
5190184|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5190185|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5190186|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5190187|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5190188|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5190189|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5190190|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
5190191|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
5190192|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5190193|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
5190194|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5190195|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
5190196|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
5190197|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
5190198|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
5190199|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5190200|NCT01173601|17917726|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
5190201|NCT01173601|17917727|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
5190202|NCT01173601|17917728|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
5190203|NCT01173601|17917729|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
5190204|NCT01173601|17917730|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5190205|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5190206|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5190207|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5190208|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5190209|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
5190210|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5190211|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5190212|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5190213|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5190214|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
5190215|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5190216|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5190217|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5190218|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5190219|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
5190220|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5190221|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5190222|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5190223|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5190224|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
5190225|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5190226|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5190227|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5190228|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5190229|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
5190230|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5190231|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5190232|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5190233|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5190234|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
5190235|NCT01173601|17917726|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5190236|NCT01173601|17917727|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5190237|NCT01173601|17917728|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5190238|NCT01173601|17917729|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5190239|NCT01173601|17917730|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
5190240|NCT01173523|17917807|P2|Overall Study|Other|3
5190241|NCT01173523|17917808|P1|Overall Study|Other|2
5190242|NCT01173523|17917807|P2|Overall Study|Progressive Disease|8
5190243|NCT01173523|17917808|P1|Overall Study|Progressive Disease|10
5190244|NCT01173523|17917807|P2|Overall Study|Clinical Progression|1
5190245|NCT01173523|17917808|P1|Overall Study|Clinical Progression|1
5190246|NCT01173471|17917824|P4|Overall Study|Reason given as Other|0
5190247|NCT01173471|17917825|P3|Overall Study|Reason given as Other|1
5190248|NCT01173471|17917826|P2|Overall Study|Reason given as Other|0
5190249|NCT01173471|17917827|P1|Overall Study|Reason given as Other|0
5190250|NCT01173471|17917824|P4|Overall Study|Lost to Follow-up|0
5190251|NCT01173471|17917825|P3|Overall Study|Lost to Follow-up|1
5190252|NCT01173471|17917826|P2|Overall Study|Lost to Follow-up|0
5190253|NCT01173471|17917827|P1|Overall Study|Lost to Follow-up|0
5190254|NCT01173471|17917824|P4|Overall Study|Condition under investigation worsened|0
5190255|NCT01173471|17917825|P3|Overall Study|Condition under investigation worsened|0
5190256|NCT01173471|17917826|P2|Overall Study|Condition under investigation worsened|0
5190257|NCT01173471|17917827|P1|Overall Study|Condition under investigation worsened|2
5190258|NCT01173471|17917824|P4|Overall Study|Eligibility criteria not fulfilled|1
5190259|NCT01173471|17917825|P3|Overall Study|Eligibility criteria not fulfilled|1
5190260|NCT01173471|17917826|P2|Overall Study|Eligibility criteria not fulfilled|0
5190261|NCT01173471|17917827|P1|Overall Study|Eligibility criteria not fulfilled|0
5190262|NCT01173120|17917967|P1|Overall Study|Switch-Difficulty With Device|12
5190263|NCT01173120|17917967|P1|Overall Study|Switch-Participant Decision|12
5190264|NCT01173120|17917967|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
5190265|NCT01173120|17917967|P1|Overall Study|Participant Decision|2
5190266|NCT01173120|17917967|P1|Overall Study|Lost to Follow-up|1
5190267|NCT01173120|17917967|P1|Overall Study|Lack of Efficacy|2
5190268|NCT01173055|17917985|P2|Period 2 - Day 64 to 112|Adverse Event|1
5190269|NCT01173055|17917986|P1|Period 2 - Day 64 to 112|Adverse Event|0
5190270|NCT01173055|17917985|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
5190271|NCT01173055|17917986|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
5190272|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
5190273|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190274|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190275|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190276|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190277|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190278|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190279|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190280|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5190281|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190282|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190283|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190284|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190285|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190286|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190287|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
5190288|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190289|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5190290|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
5190291|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
5190292|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
5190293|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
5190294|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
5190295|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
5190296|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
5190297|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
5190298|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
5190299|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5190300|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
5190301|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5190302|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5190303|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5190304|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5190305|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
5190306|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
5190307|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5190308|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190309|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
5190310|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190311|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190312|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190313|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190314|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190315|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
5190316|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5190317|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190318|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190319|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190320|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190321|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190322|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190323|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
5190324|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190325|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5190326|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5190327|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5190328|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5190329|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5190330|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5190331|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5190332|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5190333|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5190334|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5190335|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190336|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
5190337|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190338|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190339|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190340|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190341|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190342|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190343|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5190344|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
5190345|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190346|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190347|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190348|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190349|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190350|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
5190351|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190352|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5190353|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
5190354|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
5190355|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5190356|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5190357|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5190358|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5190359|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
5190360|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
5190361|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5190362|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
5190363|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
5190364|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5190365|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5190366|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5190367|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5190368|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
5190369|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
5190370|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5190371|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5190372|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
5190373|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5190374|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5190375|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5190376|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5190377|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
5190378|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
5190379|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5190380|NCT01172938|17918037|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190381|NCT01172938|17918038|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190382|NCT01172938|17918039|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190383|NCT01172938|17918040|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190384|NCT01172938|17918041|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190385|NCT01172938|17918042|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190386|NCT01172938|17918043|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
5190387|NCT01172938|17918044|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190388|NCT01172938|17918045|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5190389|NCT01172938|17918037|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190390|NCT01172938|17918038|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190391|NCT01172938|17918039|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190392|NCT01172938|17918040|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190393|NCT01172938|17918041|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190394|NCT01172938|17918042|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190395|NCT01172938|17918043|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190396|NCT01172938|17918044|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
5190397|NCT01172938|17918045|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5190398|NCT01172938|17918037|P9|Active-Treatment Phase Weeks (104-156)|Death|0
5190399|NCT01172938|17918038|P8|Active-Treatment Phase Weeks (104-156)|Death|1
5190400|NCT01172938|17918039|P7|Active-Treatment Phase Weeks (104-156)|Death|0
5190401|NCT01172938|17918040|P6|Active-Treatment Phase Weeks (104-156)|Death|0
5190402|NCT01172938|17918041|P5|Active-Treatment Phase Weeks (104-156)|Death|0
5190403|NCT01172938|17918042|P4|Active-Treatment Phase Weeks (104-156)|Death|0
5190404|NCT01172938|17918043|P3|Active-Treatment Phase Weeks (104-156)|Death|0
5190405|NCT01172938|17918044|P2|Active-Treatment Phase Weeks (104-156)|Death|0
5190406|NCT01172938|17918045|P1|Active-Treatment Phase Weeks (104-156)|Death|0
5190407|NCT01172938|17918037|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
5190408|NCT01172938|17918038|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
5190409|NCT01172938|17918039|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5190410|NCT01172938|17918040|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5190411|NCT01172938|17918041|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5190412|NCT01172938|17918042|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5190413|NCT01172938|17918043|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
5190414|NCT01172938|17918044|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
5190415|NCT01172938|17918045|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5190416|NCT01172938|17918037|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5190417|NCT01172938|17918038|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5190418|NCT01172938|17918039|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5190419|NCT01172938|17918040|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5190420|NCT01172938|17918041|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5190421|NCT01172938|17918042|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5190422|NCT01172938|17918043|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5190423|NCT01172938|17918044|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
5190424|NCT01172938|17918045|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5190425|NCT01172938|17918037|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
5190426|NCT01172938|17918038|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190427|NCT01172938|17918039|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190428|NCT01172938|17918040|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190429|NCT01172938|17918041|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190430|NCT01172938|17918042|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190431|NCT01172938|17918043|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190432|NCT01172938|17918044|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190433|NCT01172938|17918045|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5190434|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190435|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190436|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190437|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190438|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190439|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190440|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190441|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
5190442|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
5190443|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
5190444|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190445|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190446|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190447|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190448|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190449|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190450|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
5190451|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5190452|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5190453|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
5190454|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5190455|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5190456|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5190457|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5190458|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
5190459|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
5190460|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5190461|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
5190462|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
5190463|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
5190464|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
5190465|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
5190466|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
5190467|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
5190468|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
5190469|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
5190470|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
5190471|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
5190472|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5190473|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5190474|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5190475|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5190476|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
5190477|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
5190478|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5190479|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190480|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190481|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190482|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190483|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190484|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190485|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
5190486|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190487|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5190488|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5190489|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
5190490|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5190491|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5190492|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5190493|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5190494|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
5190495|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
5190496|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5190497|NCT01172938|17918037|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
5190498|NCT01172938|17918038|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
5190499|NCT01172938|17918039|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5190500|NCT01172938|17918040|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5190501|NCT01172938|17918041|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5190502|NCT01172938|17918042|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5190503|NCT01172938|17918043|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
5190504|NCT01172938|17918044|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
5190505|NCT01172938|17918045|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5190506|NCT01172938|17918037|P9|Active Treatment Phase (Weeks 25-52)|Other|0
5190507|NCT01172938|17918038|P8|Active Treatment Phase (Weeks 25-52)|Other|0
5190508|NCT01172938|17918039|P7|Active Treatment Phase (Weeks 25-52)|Other|1
5190509|NCT01172938|17918040|P6|Active Treatment Phase (Weeks 25-52)|Other|1
5190510|NCT01172938|17918041|P5|Active Treatment Phase (Weeks 25-52)|Other|0
5190511|NCT01172938|17918042|P4|Active Treatment Phase (Weeks 25-52)|Other|0
5190512|NCT01172938|17918043|P3|Active Treatment Phase (Weeks 25-52)|Other|0
5190513|NCT01172938|17918044|P2|Active Treatment Phase (Weeks 25-52)|Other|0
5190514|NCT01172938|17918045|P1|Active Treatment Phase (Weeks 25-52)|Other|0
5190515|NCT01172938|17918037|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5190516|NCT01172938|17918038|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5190517|NCT01172938|17918039|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5190518|NCT01172938|17918040|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5190519|NCT01172938|17918041|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5190520|NCT01172938|17918042|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5190521|NCT01172938|17918043|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5190522|NCT01172938|17918044|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5190523|NCT01172938|17918045|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5190524|NCT01172938|17918037|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5190525|NCT01172938|17918038|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5190526|NCT01172938|17918039|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
5190527|NCT01172938|17918040|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
5190528|NCT01172938|17918041|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
5190529|NCT01172938|17918042|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
5190530|NCT01172938|17918043|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
5190531|NCT01172938|17918044|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
5190532|NCT01172938|17918045|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5190533|NCT01172938|17918037|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190534|NCT01172938|17918038|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190535|NCT01172938|17918039|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190536|NCT01172938|17918040|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190537|NCT01172938|17918041|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190538|NCT01172938|17918042|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190539|NCT01172938|17918043|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
5190540|NCT01172938|17918044|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190541|NCT01172938|17918045|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5190542|NCT01172938|17918037|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5190543|NCT01172938|17918038|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5190544|NCT01172938|17918039|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5190545|NCT01172938|17918040|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
5190546|NCT01172938|17918041|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
5190547|NCT01172938|17918042|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
5190548|NCT01172938|17918043|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
5190549|NCT01172938|17918044|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
5190550|NCT01172938|17918045|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5190551|NCT01172938|17918037|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5190552|NCT01172938|17918038|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5190553|NCT01172938|17918039|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5190554|NCT01172938|17918040|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
5190555|NCT01172938|17918041|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
5190556|NCT01172938|17918042|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
5190557|NCT01172938|17918043|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
5190558|NCT01172938|17918044|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
5190559|NCT01172938|17918045|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5190560|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Other|0
5190561|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Other|0
5190562|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Other|0
5190563|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Other|0
5190564|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Other|0
5190565|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Other|0
5190566|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Other|1
5190567|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Other|2
5190568|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Other|0
5190569|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190570|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190571|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190572|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190573|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190574|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190575|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190576|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5190577|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
5190578|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Death|0
5190579|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Death|0
5190580|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Death|0
5190581|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Death|0
5190582|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Death|0
5190583|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Death|0
5190584|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Death|0
5190585|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Death|1
5190586|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Death|0
5190587|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5190588|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5190589|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5190590|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5190591|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5190592|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5190676|NCT01172639|17918459|P4|Overall Study|Lost to Follow-up|6
5190593|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
5190594|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
5190595|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
5190596|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190597|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190598|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190599|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190600|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190601|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190602|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
5190603|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5190604|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5190605|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5190606|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5190607|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5190608|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5190609|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5190610|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5190611|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
5190612|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
5190613|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
5190614|NCT01172938|17918037|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5190615|NCT01172938|17918038|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5190616|NCT01172938|17918039|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5190617|NCT01172938|17918040|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5190618|NCT01172938|17918041|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5190619|NCT01172938|17918042|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5190620|NCT01172938|17918043|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
5190621|NCT01172938|17918044|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
5190622|NCT01172938|17918045|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
5190623|NCT01172873|17918231|P2|Overall Study|Withdrawal by Subject|2
5190624|NCT01172873|17918232|P1|Overall Study|Withdrawal by Subject|3
5190625|NCT01172847|17918242|P1|Overall Study|Withdrawal by Subject|3
5190626|NCT01172821|17918271|P4|Overall Study|Other|3
5190627|NCT01172821|17918272|P3|Overall Study|Other|5
5190628|NCT01172821|17918273|P2|Overall Study|Other|4
5190629|NCT01172821|17918274|P1|Overall Study|Other|3
5190630|NCT01172821|17918271|P4|Overall Study|Withdrawal by Subject|3
5190631|NCT01172821|17918272|P3|Overall Study|Withdrawal by Subject|3
5190632|NCT01172821|17918273|P2|Overall Study|Withdrawal by Subject|3
5190633|NCT01172821|17918274|P1|Overall Study|Withdrawal by Subject|2
5190634|NCT01172821|17918271|P4|Overall Study|Lost to Follow-up|2
5190635|NCT01172821|17918272|P3|Overall Study|Lost to Follow-up|2
5190636|NCT01172821|17918273|P2|Overall Study|Lost to Follow-up|1
5190637|NCT01172821|17918274|P1|Overall Study|Lost to Follow-up|4
5190638|NCT01172821|17918271|P4|Overall Study|Protocol Violation|2
5190639|NCT01172821|17918272|P3|Overall Study|Protocol Violation|1
5190640|NCT01172821|17918273|P2|Overall Study|Protocol Violation|2
5190641|NCT01172821|17918274|P1|Overall Study|Protocol Violation|0
5190642|NCT01172821|17918271|P4|Overall Study|Adverse Event|7
5190643|NCT01172821|17918272|P3|Overall Study|Adverse Event|2
5190644|NCT01172821|17918273|P2|Overall Study|Adverse Event|2
5190645|NCT01172821|17918274|P1|Overall Study|Adverse Event|5
5190646|NCT01172808|17918364|P4|Overall Study|Other|7
5190647|NCT01172808|17918365|P3|Overall Study|Other|9
5190648|NCT01172808|17918366|P2|Overall Study|Other|5
5190649|NCT01172808|17918367|P1|Overall Study|Other|6
5190650|NCT01172808|17918364|P4|Overall Study|Withdrawal by Subject|2
5190651|NCT01172808|17918365|P3|Overall Study|Withdrawal by Subject|3
5190652|NCT01172808|17918366|P2|Overall Study|Withdrawal by Subject|1
5190653|NCT01172808|17918367|P1|Overall Study|Withdrawal by Subject|4
5190654|NCT01172808|17918364|P4|Overall Study|Lost to Follow-up|3
5190655|NCT01172808|17918365|P3|Overall Study|Lost to Follow-up|1
5190656|NCT01172808|17918366|P2|Overall Study|Lost to Follow-up|1
5190657|NCT01172808|17918367|P1|Overall Study|Lost to Follow-up|0
5190658|NCT01172808|17918364|P4|Overall Study|Protocol Violation|0
5190659|NCT01172808|17918365|P3|Overall Study|Protocol Violation|2
5190660|NCT01172808|17918366|P2|Overall Study|Protocol Violation|2
5190661|NCT01172808|17918367|P1|Overall Study|Protocol Violation|2
5190662|NCT01172808|17918364|P4|Overall Study|Lack of Efficacy|0
5190663|NCT01172808|17918365|P3|Overall Study|Lack of Efficacy|0
5190664|NCT01172808|17918366|P2|Overall Study|Lack of Efficacy|0
5190665|NCT01172808|17918367|P1|Overall Study|Lack of Efficacy|1
5190666|NCT01172808|17918364|P4|Overall Study|Adverse Event|3
5190667|NCT01172808|17918365|P3|Overall Study|Adverse Event|8
5190668|NCT01172808|17918366|P2|Overall Study|Adverse Event|4
5190669|NCT01172808|17918367|P1|Overall Study|Adverse Event|8
5190670|NCT01172639|17918458|P5|Overall Study|Withdrawal by Subject|0
5190671|NCT01172639|17918459|P4|Overall Study|Withdrawal by Subject|5
5190672|NCT01172639|17918460|P3|Overall Study|Withdrawal by Subject|5
5190673|NCT01172639|17918461|P2|Overall Study|Withdrawal by Subject|3
5190674|NCT01172639|17918462|P1|Overall Study|Withdrawal by Subject|3
5190675|NCT01172639|17918458|P5|Overall Study|Lost to Follow-up|6
5190677|NCT01172639|17918460|P3|Overall Study|Lost to Follow-up|11
5190678|NCT01172639|17918461|P2|Overall Study|Lost to Follow-up|7
5190679|NCT01172639|17918462|P1|Overall Study|Lost to Follow-up|9
5190680|NCT01172639|17918458|P5|Overall Study|Death|0
5190681|NCT01172639|17918459|P4|Overall Study|Death|0
5190682|NCT01172639|17918460|P3|Overall Study|Death|0
5190683|NCT01172639|17918461|P2|Overall Study|Death|1
5190684|NCT01172639|17918462|P1|Overall Study|Death|1
5190685|NCT01172535|17918537|P1|Overall Study|Unwilling to adhere to study requirement|1
5190686|NCT01172535|17918537|P1|Overall Study|Ineligible at study entry|1
5190687|NCT01172535|17918537|P1|Overall Study|Lost to Follow-up|1
5190688|NCT01172535|17918537|P1|Overall Study|Withdrawal by Subject|2
5190689|NCT01172535|17918537|P1|Overall Study|Death|3
5190690|NCT01172288|17918590|P2|Overall Study|Protocol Violation|1
5190691|NCT01172288|17918591|P1|Overall Study|Protocol Violation|0
5190692|NCT01172288|17918590|P2|Overall Study|Adverse Event|0
5190693|NCT01172288|17918591|P1|Overall Study|Adverse Event|1
5190694|NCT01172275|17918607|P2|Overall Study|Protocol Violation|0
5190695|NCT01172275|17918608|P1|Overall Study|Protocol Violation|1
5190696|NCT01172275|17918607|P2|Overall Study|Lost to Follow-up|0
5190697|NCT01172275|17918608|P1|Overall Study|Lost to Follow-up|1
5190698|NCT01171989|17918666|P3|Overall Study|Lost to Follow-up|1
5190699|NCT01171989|17918667|P2|Overall Study|Lost to Follow-up|0
5190700|NCT01171989|17918668|P1|Overall Study|Lost to Follow-up|0
5190701|NCT01171976|17918742|P3|Overall Study|Adverse Event|5
5190702|NCT01171976|17918743|P2|Overall Study|Adverse Event|2
5190703|NCT01171976|17918744|P1|Overall Study|Adverse Event|6
5190704|NCT01171976|17918742|P3|Overall Study|Abnormal test result|0
5190705|NCT01171976|17918743|P2|Overall Study|Abnormal test result|0
5190706|NCT01171976|17918744|P1|Overall Study|Abnormal test result|1
5190707|NCT01171976|17918742|P3|Overall Study|Withdrawal by Subject|6
5190708|NCT01171976|17918743|P2|Overall Study|Withdrawal by Subject|5
5190709|NCT01171976|17918744|P1|Overall Study|Withdrawal by Subject|1
5190710|NCT01171976|17918742|P3|Overall Study|Lost to Follow-up|2
5190711|NCT01171976|17918743|P2|Overall Study|Lost to Follow-up|0
5190712|NCT01171976|17918744|P1|Overall Study|Lost to Follow-up|4
5190713|NCT01171976|17918742|P3|Overall Study|Death|1
5190714|NCT01171976|17918743|P2|Overall Study|Death|4
5190715|NCT01171976|17918744|P1|Overall Study|Death|2
5190716|NCT01171976|17918742|P3|Overall Study|Protocol Violation|1
5190717|NCT01171976|17918743|P2|Overall Study|Protocol Violation|0
5190718|NCT01171976|17918744|P1|Overall Study|Protocol Violation|0
5190719|NCT01171963|17918781|P2|Overall Study|Withdrawal by Subject|129
5190720|NCT01171963|17918782|P1|Overall Study|Withdrawal by Subject|114
5190721|NCT01171963|17918781|P2|Overall Study|Other - diarrhoea|0
5190722|NCT01171963|17918782|P1|Overall Study|Other - diarrhoea|1
5190723|NCT01171963|17918781|P2|Overall Study|Lost to Follow-up|24
5190724|NCT01171963|17918782|P1|Overall Study|Lost to Follow-up|23
5190725|NCT01171963|17918781|P2|Overall Study|Adverse Event|15
5190726|NCT01171963|17918782|P1|Overall Study|Adverse Event|10
5190727|NCT01171898|17918851|P4|Overall Study|Other|2
5190728|NCT01171898|17918852|P3|Overall Study|Other|0
5190729|NCT01171898|17918853|P2|Overall Study|Other|5
5190730|NCT01171898|17918854|P1|Overall Study|Other|1
5190731|NCT01171898|17918851|P4|Overall Study|Ongoing|0
5190732|NCT01171898|17918852|P3|Overall Study|Ongoing|3
5190733|NCT01171898|17918853|P2|Overall Study|Ongoing|9
5190734|NCT01171898|17918854|P1|Overall Study|Ongoing|1
5190735|NCT01171898|17918851|P4|Overall Study|Terminated by Sponsor|0
5190736|NCT01171898|17918852|P3|Overall Study|Terminated by Sponsor|0
5190737|NCT01171898|17918853|P2|Overall Study|Terminated by Sponsor|0
5190738|NCT01171898|17918854|P1|Overall Study|Terminated by Sponsor|1
5190739|NCT01171898|17918851|P4|Overall Study|Withdrawal by Subject|3
5190740|NCT01171898|17918852|P3|Overall Study|Withdrawal by Subject|6
5190741|NCT01171898|17918853|P2|Overall Study|Withdrawal by Subject|4
5190742|NCT01171898|17918854|P1|Overall Study|Withdrawal by Subject|1
5190743|NCT01171898|17918851|P4|Overall Study|Lost to Follow-up|1
5190744|NCT01171898|17918852|P3|Overall Study|Lost to Follow-up|1
5190745|NCT01171898|17918853|P2|Overall Study|Lost to Follow-up|1
5190746|NCT01171898|17918854|P1|Overall Study|Lost to Follow-up|0
5190747|NCT01171898|17918851|P4|Overall Study|Death|0
5190748|NCT01171898|17918852|P3|Overall Study|Death|2
5190749|NCT01171898|17918853|P2|Overall Study|Death|0
5190750|NCT01171898|17918854|P1|Overall Study|Death|0
5190751|NCT01171820|17918878|P2|Overall Study|1-Year Missed Visit|1
5190752|NCT01171820|17918879|P1|Overall Study|1-Year Missed Visit|1
5190753|NCT01171820|17918878|P2|Overall Study|Physician Decision|1
5190754|NCT01171820|17918879|P1|Overall Study|Physician Decision|0
5190755|NCT01171820|17918878|P2|Overall Study|Withdrawal by Subject|0
5190756|NCT01171820|17918879|P1|Overall Study|Withdrawal by Subject|2
5190757|NCT01171820|17918878|P2|Overall Study|Lost to Follow-up|1
5190758|NCT01171820|17918879|P1|Overall Study|Lost to Follow-up|0
5190759|NCT01171820|17918878|P2|Overall Study|Death|3
5190760|NCT01171820|17918879|P1|Overall Study|Death|3
5190761|NCT01171677|17918957|P2|Overall Study|completed <70% IntenSati classes|0
5190762|NCT01171677|17918958|P1|Overall Study|completed <70% IntenSati classes|5
5190763|NCT01171677|17918957|P2|Overall Study|Adverse Event|0
5190764|NCT01171677|17918958|P1|Overall Study|Adverse Event|1
5190765|NCT01171677|17918957|P2|Overall Study|Withdrawal by Subject|3
5190766|NCT01171677|17918958|P1|Overall Study|Withdrawal by Subject|0
5190767|NCT01171625|17918990|P1|Overall Study|Consented but did not receive device|25
5190768|NCT01171625|17918990|P1|Overall Study|Other|1
5190769|NCT01171625|17918990|P1|Overall Study|Patient received valve-in-valve|3
5190770|NCT01171625|17918990|P1|Overall Study|Lost to Follow-up|5
5190771|NCT01171625|17918990|P1|Overall Study|Explanted|10
5190772|NCT01171625|17918990|P1|Overall Study|Withdrawal by Subject|31
5190773|NCT01171625|17918990|P1|Overall Study|Death|38
5190774|NCT01171625|17918990|P1|Overall Study|On-Protocol|67
5190775|NCT01171612|17919023|P1|Overall Study|Lost to Follow-up|51
5190776|NCT01171534|17919033|P2|Overall Study|screen failure|1
5190777|NCT01171534|17919034|P1|Overall Study|screen failure|0
5190778|NCT01171534|17919033|P2|Overall Study|Lost to Follow-up|2
5190779|NCT01171534|17919034|P1|Overall Study|Lost to Follow-up|0
5190780|NCT01171521|17919046|P1|Overall Study|screen failure|1
5190781|NCT01171521|17919046|P1|Overall Study|Lost to Follow-up|5
5190782|NCT01171183|17919053|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
5190783|NCT01171183|17919054|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
5190784|NCT01171183|17919053|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
5190785|NCT01171183|17919054|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
5190786|NCT01171183|17919053|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
5190787|NCT01171183|17919054|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
5190788|NCT01171183|17919053|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
5190789|NCT01171183|17919054|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
5190790|NCT01171183|17919053|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
5190791|NCT01171183|17919054|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
5190792|NCT01171183|17919053|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
5190793|NCT01171183|17919054|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
5190794|NCT01170962|17919075|P3|Follow up Period|Others|3
5190795|NCT01170962|17919076|P2|Follow up Period|Others|7
5190796|NCT01170962|17919077|P1|Follow up Period|Others|10
5190797|NCT01170962|17919075|P3|Follow up Period|Death|0
5190798|NCT01170962|17919076|P2|Follow up Period|Death|2
5190799|NCT01170962|17919077|P1|Follow up Period|Death|2
5190800|NCT01170962|17919075|P3|Follow up Period|Lost to Follow-up|1
5190801|NCT01170962|17919076|P2|Follow up Period|Lost to Follow-up|8
5190802|NCT01170962|17919077|P1|Follow up Period|Lost to Follow-up|13
5190803|NCT01170962|17919075|P3|Follow up Period|Withdrawal by Subject|2
5190804|NCT01170962|17919076|P2|Follow up Period|Withdrawal by Subject|10
5190805|NCT01170962|17919077|P1|Follow up Period|Withdrawal by Subject|14
5190806|NCT01170962|17919075|P3|Treatment Period|Completed 24 Week treatment period only|0
5190807|NCT01170962|17919076|P2|Treatment Period|Completed 24 Week treatment period only|2
5190808|NCT01170962|17919077|P1|Treatment Period|Completed 24 Week treatment period only|10
5190809|NCT01170962|17919075|P3|Treatment Period|Request to discontinue treatment|1
5190810|NCT01170962|17919076|P2|Treatment Period|Request to discontinue treatment|3
5190811|NCT01170962|17919077|P1|Treatment Period|Request to discontinue treatment|7
5190812|NCT01170962|17919075|P3|Treatment Period|Participant no longer meets criteria|0
5190813|NCT01170962|17919076|P2|Treatment Period|Participant no longer meets criteria|1
5190814|NCT01170962|17919077|P1|Treatment Period|Participant no longer meets criteria|0
5190815|NCT01170962|17919075|P3|Treatment Period|Lost to Follow-up|1
5190816|NCT01170962|17919076|P2|Treatment Period|Lost to Follow-up|1
5190817|NCT01170962|17919077|P1|Treatment Period|Lost to Follow-up|1
5190818|NCT01170962|17919075|P3|Treatment Period|Withdrawal by Subject|0
5190819|NCT01170962|17919076|P2|Treatment Period|Withdrawal by Subject|1
5190820|NCT01170962|17919077|P1|Treatment Period|Withdrawal by Subject|2
5190821|NCT01170962|17919075|P3|Treatment Period|Adverse Event|3
5190822|NCT01170962|17919076|P2|Treatment Period|Adverse Event|12
5190823|NCT01170962|17919077|P1|Treatment Period|Adverse Event|11
5190824|NCT01170962|17919075|P3|Treatment Period|Lack of Efficacy|7
5190825|NCT01170962|17919076|P2|Treatment Period|Lack of Efficacy|91
5190826|NCT01170962|17919077|P1|Treatment Period|Lack of Efficacy|96
5190827|NCT01170663|17919172|P2|Overall Study|Withdrawal of consent without follow-up|11
5190828|NCT01170663|17919173|P1|Overall Study|Withdrawal of consent without follow-up|11
5190829|NCT01170663|17919172|P2|Overall Study|Lost to Follow-up|9
5190830|NCT01170663|17919173|P1|Overall Study|Lost to Follow-up|3
5190831|NCT01170598|17919201|P1|Overall Study|Refused|1
5190832|NCT01170598|17919201|P1|Overall Study|Lost to Follow-up|1
5190833|NCT01170598|17919201|P1|Overall Study|Death|3
5190834|NCT01170598|17919201|P1|Overall Study|Withdrawal by Subject|1
5190835|NCT01170364|17919264|P2|Overall Study|Protocol Violation|1
5190836|NCT01170364|17919265|P1|Overall Study|Protocol Violation|4
5190837|NCT01170273|17919273|P2|Overall Study|Adverse Event|1
5190838|NCT01170273|17919274|P1|Overall Study|Adverse Event|0
5190839|NCT01170273|17919273|P2|Overall Study|Death|0
5190840|NCT01170273|17919274|P1|Overall Study|Death|1
5190841|NCT01170273|17919273|P2|Overall Study|Protocol Violation|0
5190842|NCT01170273|17919274|P1|Overall Study|Protocol Violation|1
5190843|NCT01170273|17919273|P2|Overall Study|Lost to Follow-up|8
5190844|NCT01170273|17919274|P1|Overall Study|Lost to Follow-up|6
5190845|NCT01170221|17919291|P2|Overall Study|Randomized but not treated|0
5190846|NCT01170221|17919292|P1|Overall Study|Randomized but not treated|1
5190847|NCT01170221|17919291|P2|Overall Study|Subject completed only screening and LFU|0
5190848|NCT01170221|17919292|P1|Overall Study|Subject completed only screening and LFU|1
5190849|NCT01170221|17919291|P2|Overall Study|Withdrawal by Subject|7
5190850|NCT01170221|17919292|P1|Overall Study|Withdrawal by Subject|9
5190851|NCT01170221|17919291|P2|Overall Study|Lost to Follow-up|21
5190852|NCT01170221|17919292|P1|Overall Study|Lost to Follow-up|22
5190853|NCT01170208|17919315|P3|Overall Study|Protocol Violation|1
5190854|NCT01170208|17919316|P2|Overall Study|Protocol Violation|0
5190855|NCT01170208|17919317|P1|Overall Study|Protocol Violation|1
5190856|NCT01170208|17919315|P3|Overall Study|Withdrawal by Subject|1
5190857|NCT01170208|17919316|P2|Overall Study|Withdrawal by Subject|0
5190858|NCT01170208|17919317|P1|Overall Study|Withdrawal by Subject|5
5190859|NCT01170091|17919345|P1|Overall Study|Treatment duration is less than 4 weeks|21
5190860|NCT01170091|17919345|P1|Overall Study|Missing efficacy evaluation|3
5190861|NCT01170065|17919355|P3|Overall Study|Ongoing after planned observation time|10
5190862|NCT01170065|17919356|P2|Overall Study|Ongoing after planned observation time|26
5190863|NCT01170065|17919357|P1|Overall Study|Ongoing after planned observation time|5
5190864|NCT01170065|17919355|P3|Overall Study|Reason other than specified|3
5190865|NCT01170065|17919356|P2|Overall Study|Reason other than specified|8
5190866|NCT01170065|17919357|P1|Overall Study|Reason other than specified|3
5190867|NCT01170065|17919355|P3|Overall Study|Consent withdrawn, not due to AE|2
5190868|NCT01170065|17919356|P2|Overall Study|Consent withdrawn, not due to AE|4
5190869|NCT01170065|17919357|P1|Overall Study|Consent withdrawn, not due to AE|2
5190870|NCT01170065|17919355|P3|Overall Study|Lost to Follow-up|1
5190871|NCT01170065|17919356|P2|Overall Study|Lost to Follow-up|4
5190872|NCT01170065|17919357|P1|Overall Study|Lost to Follow-up|1
5190873|NCT01170065|17919355|P3|Overall Study|Adverse Event|10
5190874|NCT01170065|17919356|P2|Overall Study|Adverse Event|50
5190875|NCT01170065|17919357|P1|Overall Study|Adverse Event|17
5190876|NCT01170039|17919388|P2|Overall Study|Lack of funding, drug not available|3
5190877|NCT01170039|17919389|P1|Overall Study|Lack of funding, drug not available|3
5190878|NCT01170039|17919388|P2|Overall Study|Withdrawal by Subject|3
5190879|NCT01170039|17919389|P1|Overall Study|Withdrawal by Subject|5
5190880|NCT01169987|17919401|P1|Overall Study|Other|4
5190881|NCT01169987|17919401|P1|Overall Study|Lost to Follow-up|24
5190882|NCT01169987|17919401|P1|Overall Study|Withdrawal by Subject|3
5190883|NCT01169779|17919467|P2|Overall Study|Familial and personal reasons|3
5190884|NCT01169779|17919468|P1|Overall Study|Familial and personal reasons|3
5190885|NCT01169779|17919467|P2|Overall Study|Withdrawal by Subject|2
5190886|NCT01169779|17919468|P1|Overall Study|Withdrawal by Subject|3
5190887|NCT01169779|17919467|P2|Overall Study|Protocol Violation|1
5190888|NCT01169779|17919468|P1|Overall Study|Protocol Violation|1
5190889|NCT01169779|17919467|P2|Overall Study|Lack of Efficacy|0
5190890|NCT01169779|17919468|P1|Overall Study|Lack of Efficacy|1
5190891|NCT01169779|17919467|P2|Overall Study|Adverse Event|11
5190892|NCT01169779|17919468|P1|Overall Study|Adverse Event|3
5190893|NCT01169701|17919503|P2|Overall Study|Sponsor decision|1
5190894|NCT01169701|17919504|P1|Overall Study|Sponsor decision|0
5190895|NCT01169701|17919503|P2|Overall Study|Serious adverse event|1
5190896|NCT01169701|17919504|P1|Overall Study|Serious adverse event|0
5190897|NCT01169701|17919503|P2|Overall Study|Administrative problems|1
5190898|NCT01169701|17919504|P1|Overall Study|Administrative problems|0
5190899|NCT01169701|17919503|P2|Overall Study|Death|1
5190900|NCT01169701|17919504|P1|Overall Study|Death|0
5190901|NCT01169701|17919503|P2|Overall Study|Exclusion criteria|0
5190902|NCT01169701|17919504|P1|Overall Study|Exclusion criteria|2
5190903|NCT01169701|17919503|P2|Overall Study|Adverse Event|2
5190904|NCT01169701|17919504|P1|Overall Study|Adverse Event|1
5190905|NCT01169701|17919503|P2|Overall Study|Withdrawal by Subject|3
5190906|NCT01169701|17919504|P1|Overall Study|Withdrawal by Subject|1
5190907|NCT01169701|17919503|P2|Overall Study|Lost to Follow-up|1
5190908|NCT01169701|17919504|P1|Overall Study|Lost to Follow-up|1
5190909|NCT01169675|17919541|P5|Overall Study|Other Reason Not Defined Above|1
5190910|NCT01169675|17919542|P4|Overall Study|Other Reason Not Defined Above|1
5190911|NCT01169675|17919543|P3|Overall Study|Other Reason Not Defined Above|0
5190912|NCT01169675|17919544|P2|Overall Study|Other Reason Not Defined Above|0
5190913|NCT01169675|17919545|P1|Overall Study|Other Reason Not Defined Above|0
5190914|NCT01169675|17919541|P5|Overall Study|Withdrawal by Subject|2
5190915|NCT01169675|17919542|P4|Overall Study|Withdrawal by Subject|1
5190916|NCT01169675|17919543|P3|Overall Study|Withdrawal by Subject|0
5190917|NCT01169675|17919544|P2|Overall Study|Withdrawal by Subject|0
5190918|NCT01169675|17919545|P1|Overall Study|Withdrawal by Subject|1
5190919|NCT01169675|17919541|P5|Overall Study|Adverse Event|0
5190920|NCT01169675|17919542|P4|Overall Study|Adverse Event|0
5190921|NCT01169675|17919543|P3|Overall Study|Adverse Event|2
5190922|NCT01169675|17919544|P2|Overall Study|Adverse Event|1
5190923|NCT01169675|17919545|P1|Overall Study|Adverse Event|5
5190924|NCT01169675|17919541|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
5190925|NCT01169675|17919542|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5190926|NCT01169675|17919543|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
5190927|NCT01169675|17919544|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5190928|NCT01169675|17919545|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
5190929|NCT01169675|17919541|P5|Overall Study|Progressive disease|1
5190930|NCT01169675|17919542|P4|Overall Study|Progressive disease|15
5190931|NCT01169675|17919543|P3|Overall Study|Progressive disease|5
5190932|NCT01169675|17919544|P2|Overall Study|Progressive disease|2
5190933|NCT01169675|17919545|P1|Overall Study|Progressive disease|13
5190934|NCT01169649|17919582|P1|Overall Study|Patient Not Treated|3
5190935|NCT01169558|17919594|P1|Overall Study|Partial response|2
5190936|NCT01169558|17919594|P1|Overall Study|Protocol Violation|2
5190937|NCT01169558|17919594|P1|Overall Study|Non-compliance|2
5190938|NCT01169558|17919594|P1|Overall Study|Need for Surgery|4
5190939|NCT01169558|17919594|P1|Overall Study|Lost to Follow-up|4
5190940|NCT01169558|17919594|P1|Overall Study|Stable Disease|4
5190941|NCT01169558|17919594|P1|Overall Study|Medical Decision|7
5190942|NCT01169558|17919594|P1|Overall Study|Withdrawal of Consent|8
5190943|NCT01169558|17919594|P1|Overall Study|Adverse Event|25
5190944|NCT01169558|17919594|P1|Overall Study|Disease progression|98
5190945|NCT01169493|17919619|P6|Period 3 (6 Months)|Physician Decision|0
5190946|NCT01169493|17919620|P5|Period 3 (6 Months)|Physician Decision|0
5190947|NCT01169493|17919621|P4|Period 3 (6 Months)|Physician Decision|0
5190948|NCT01169493|17919622|P3|Period 3 (6 Months)|Physician Decision|1
5190949|NCT01169493|17919623|P2|Period 3 (6 Months)|Physician Decision|1
5190950|NCT01169493|17919624|P1|Period 3 (6 Months)|Physician Decision|0
5190951|NCT01169493|17919619|P6|Period 3 (6 Months)|Adverse Event|0
5190952|NCT01169493|17919620|P5|Period 3 (6 Months)|Adverse Event|0
5190953|NCT01169493|17919621|P4|Period 3 (6 Months)|Adverse Event|0
5190954|NCT01169493|17919622|P3|Period 3 (6 Months)|Adverse Event|0
5190955|NCT01169493|17919623|P2|Period 3 (6 Months)|Adverse Event|1
5190956|NCT01169493|17919624|P1|Period 3 (6 Months)|Adverse Event|0
5190957|NCT01169493|17919619|P6|Period 1 (6 Months)|Withdrawal by Subject|3
5190958|NCT01169493|17919620|P5|Period 1 (6 Months)|Withdrawal by Subject|0
5190959|NCT01169493|17919621|P4|Period 1 (6 Months)|Withdrawal by Subject|0
5190960|NCT01169493|17919622|P3|Period 1 (6 Months)|Withdrawal by Subject|2
5190961|NCT01169493|17919623|P2|Period 1 (6 Months)|Withdrawal by Subject|1
5190962|NCT01169493|17919624|P1|Period 1 (6 Months)|Withdrawal by Subject|0
5190963|NCT01169350|17919670|P1|Overall Study|Lost to Follow-up|2
5190964|NCT01169350|17919670|P1|Overall Study|Physician Decision|3
5190965|NCT01169103|17919808|P2|Overall Study|Withdrawal by Subject|1
5190966|NCT01169103|17919809|P1|Overall Study|Withdrawal by Subject|3
5190967|NCT01169103|17919808|P2|Overall Study|Lost to Follow-up|3
5190968|NCT01169103|17919809|P1|Overall Study|Lost to Follow-up|3
5190969|NCT01169038|17919836|P1|Overall Study|Required antibiotic administration|1
5190970|NCT01169038|17919836|P1|Overall Study|Adverse Event|5
5190971|NCT01169038|17919836|P1|Overall Study|Death|1
5190972|NCT01168999|17919844|P4|Overall Study|Lost to Follow-up|0
5190973|NCT01168999|17919845|P3|Overall Study|Lost to Follow-up|0
5190974|NCT01168999|17919846|P2|Overall Study|Lost to Follow-up|1
5190975|NCT01168999|17919847|P1|Overall Study|Lost to Follow-up|2
5190976|NCT01168973|17919913|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
5190977|NCT01168973|17919914|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
5190978|NCT01168973|17919913|P2|Overall Study|Sponsor Decision|1
5190979|NCT01168973|17919914|P1|Overall Study|Sponsor Decision|2
5190980|NCT01168973|17919913|P2|Overall Study|Physician Decision|19
5190981|NCT01168973|17919914|P1|Overall Study|Physician Decision|37
5190982|NCT01168973|17919913|P2|Overall Study|Death|45
5190983|NCT01168973|17919914|P1|Overall Study|Death|42
5190984|NCT01168973|17919913|P2|Overall Study|Withdrawal by Subject|53
5190985|NCT01168973|17919914|P1|Overall Study|Withdrawal by Subject|90
5190986|NCT01168973|17919913|P2|Overall Study|Adverse Event|55
5190987|NCT01168973|17919914|P1|Overall Study|Adverse Event|94
5190988|NCT01168973|17919913|P2|Overall Study|Progressive Disease|429
5190989|NCT01168973|17919914|P1|Overall Study|Progressive Disease|341
5190990|NCT01168856|17919989|P2|Overall Study|Protocol Violation|6
5190991|NCT01168856|17919990|P1|Overall Study|Protocol Violation|4
5190992|NCT01168856|17919989|P2|Overall Study|Other|291
5190993|NCT01168856|17919990|P1|Overall Study|Other|1
5190994|NCT01168856|17919989|P2|Overall Study|Death|2
5190995|NCT01168856|17919990|P1|Overall Study|Death|0
5190996|NCT01168856|17919989|P2|Overall Study|Participant received anti-HCV treatment|0
5190997|NCT01168856|17919990|P1|Overall Study|Participant received anti-HCV treatment|1
5190998|NCT01168856|17919989|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
5190999|NCT01168856|17919990|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
5191000|NCT01168856|17919989|P2|Overall Study|Physician Decision|1
5191001|NCT01168856|17919990|P1|Overall Study|Physician Decision|2
5191002|NCT01168856|17919989|P2|Overall Study|Withdrawal by Subject|8
5191003|NCT01168856|17919990|P1|Overall Study|Withdrawal by Subject|6
5191004|NCT01168856|17919989|P2|Overall Study|Lost to Follow-up|34
5191005|NCT01168856|17919990|P1|Overall Study|Lost to Follow-up|4
5191006|NCT01168596|17920088|P2|Overall Study|Withdrawal by Subject|1
5191007|NCT01168596|17920089|P1|Overall Study|Withdrawal by Subject|3
5191008|NCT01168427|17920133|P1|Overall Study|Patient exited prior to implant|1
5191009|NCT01168401|17920149|P11|Overall Study|Withdrawal by Subject|0
5191010|NCT01168401|17920150|P10|Overall Study|Withdrawal by Subject|0
5191011|NCT01168401|17920151|P9|Overall Study|Withdrawal by Subject|0
5191012|NCT01168401|17920152|P8|Overall Study|Withdrawal by Subject|0
5191013|NCT01168401|17920153|P7|Overall Study|Withdrawal by Subject|0
5191014|NCT01168401|17920154|P6|Overall Study|Withdrawal by Subject|0
5191015|NCT01168401|17920155|P5|Overall Study|Withdrawal by Subject|0
5191016|NCT01168401|17920156|P4|Overall Study|Withdrawal by Subject|1
5191017|NCT01168401|17920157|P3|Overall Study|Withdrawal by Subject|0
5191018|NCT01168401|17920158|P2|Overall Study|Withdrawal by Subject|0
5191019|NCT01168401|17920159|P1|Overall Study|Withdrawal by Subject|0
5191020|NCT01168401|17920149|P11|Overall Study|Lost to Follow-up|0
5191021|NCT01168401|17920150|P10|Overall Study|Lost to Follow-up|0
5191022|NCT01168401|17920151|P9|Overall Study|Lost to Follow-up|0
5191023|NCT01168401|17920152|P8|Overall Study|Lost to Follow-up|0
5191024|NCT01168401|17920153|P7|Overall Study|Lost to Follow-up|0
5191025|NCT01168401|17920154|P6|Overall Study|Lost to Follow-up|0
5191026|NCT01168401|17920155|P5|Overall Study|Lost to Follow-up|0
5191027|NCT01168401|17920156|P4|Overall Study|Lost to Follow-up|1
5191028|NCT01168401|17920157|P3|Overall Study|Lost to Follow-up|2
5191029|NCT01168401|17920158|P2|Overall Study|Lost to Follow-up|1
5191030|NCT01168401|17920159|P1|Overall Study|Lost to Follow-up|1
5191031|NCT01168349|17920392|P1|Overall Study|Protocol Violation|76
5191032|NCT01168349|17920392|P1|Overall Study|Other|22
5191033|NCT01168349|17920392|P1|Overall Study|Kidney transplantation|3
5191034|NCT01168349|17920392|P1|Overall Study|Withdrawal by Subject|9
5191035|NCT01168349|17920392|P1|Overall Study|Lost to Follow-up|34
5191036|NCT01168349|17920392|P1|Overall Study|Death|157
5191037|NCT01168232|17920498|P1|Overall Study|Ineligible-Inadequate pathology|1
5191038|NCT01168232|17920498|P1|Overall Study|Ineligible- Wrong cell type|6
5191039|NCT01168232|17920498|P1|Overall Study|Ineligible-Second primary cancer site|1
5191040|NCT01168219|17920505|P1|Overall Study|ineligible due to CML|2
5191041|NCT01168219|17920505|P1|Overall Study|withdrew before transplant|1
5191042|NCT01168219|17920505|P1|Overall Study|off study before starting treatment|2
5191043|NCT01167907|17920528|P2|Overall Study|saphenous catheter dislodged before comp|1
5191044|NCT01167907|17920529|P1|Overall Study|saphenous catheter dislodged before comp|1
5191045|NCT01167907|17920528|P2|Overall Study|Protocol Violation|0
5191046|NCT01167907|17920529|P1|Overall Study|Protocol Violation|1
5191047|NCT01167881|17920547|P2|Overall Study|Other not defined above|55
5191048|NCT01167881|17920548|P1|Overall Study|Other not defined above|31
5191049|NCT01167881|17920547|P2|Overall Study|Not treated|0
5191050|NCT01167881|17920548|P1|Overall Study|Not treated|4
5191051|NCT01167881|17920547|P2|Overall Study|Patient refusal to cont., not due to AE|40
5191052|NCT01167881|17920548|P1|Overall Study|Patient refusal to cont., not due to AE|45
5191053|NCT01167881|17920547|P2|Overall Study|Lost to Follow-up|20
5191054|NCT01167881|17920548|P1|Overall Study|Lost to Follow-up|19
5191055|NCT01167881|17920547|P2|Overall Study|Non compliant with protocol|18
5191056|NCT01167881|17920548|P1|Overall Study|Non compliant with protocol|9
5191057|NCT01167881|17920547|P2|Overall Study|Lack of Efficacy|7
5191058|NCT01167881|17920548|P1|Overall Study|Lack of Efficacy|4
5191059|NCT01167881|17920547|P2|Overall Study|Adverse Event|51
5191060|NCT01167881|17920548|P1|Overall Study|Adverse Event|47
5191061|NCT01167634|17920602|P4|Overall Study|Withdrawal by Subject|0
5191062|NCT01167634|17920603|P3|Overall Study|Withdrawal by Subject|0
5191063|NCT01167634|17920604|P2|Overall Study|Withdrawal by Subject|1
5191064|NCT01167634|17920605|P1|Overall Study|Withdrawal by Subject|1
5191065|NCT01167634|17920602|P4|Overall Study|Lost to Follow-up|4
5191066|NCT01167634|17920603|P3|Overall Study|Lost to Follow-up|3
5191067|NCT01167634|17920604|P2|Overall Study|Lost to Follow-up|3
5191068|NCT01167634|17920605|P1|Overall Study|Lost to Follow-up|1
5191069|NCT01167582|17920626|P2|Overall Study|Lost to Follow-up|1
5191070|NCT01167582|17920627|P1|Overall Study|Lost to Follow-up|0
5191071|NCT01167426|17920678|P1|Overall Study|Sponsor Decision|1
5191072|NCT01167426|17920678|P1|Overall Study|Withdrawal by Subject|2
5191073|NCT01167426|17920678|P1|Overall Study|Protocol Violation|1
5191074|NCT01167426|17920678|P1|Overall Study|Lost to Follow-up|6
5191075|NCT01167257|17920686|P2|Overall Study|Withdrew consent|1
5191076|NCT01167257|17920687|P1|Overall Study|Withdrew consent|1
5191077|NCT01167257|17920686|P2|Overall Study|Lost to Follow-up|2
5191078|NCT01167257|17920687|P1|Overall Study|Lost to Follow-up|2
5191079|NCT01167192|17920709|P1|Overall Study|Insurance denial|1
5191080|NCT01167192|17920709|P1|Overall Study|Withdrawal by Subject|1
5191081|NCT01167192|17920709|P1|Overall Study|Death|1
5191082|NCT01167192|17920709|P1|Overall Study|Adverse Event|1
5191083|NCT01167179|17920726|P2|Overall Study|diverse|5
5191084|NCT01167179|17920727|P1|Overall Study|diverse|6
5191085|NCT01167179|17920726|P2|Overall Study|Withdrawal by Subject|2
5191086|NCT01167179|17920727|P1|Overall Study|Withdrawal by Subject|1
5191087|NCT01167179|17920726|P2|Overall Study|Death|10
5191088|NCT01167179|17920727|P1|Overall Study|Death|4
5191089|NCT01167179|17920726|P2|Overall Study|disease recurrence|4
5191090|NCT01167179|17920727|P1|Overall Study|disease recurrence|4
5191091|NCT01167153|17920737|P2|Overall Study|Subject initiation withdrawal, Other|8
5191092|NCT01167153|17920738|P1|Overall Study|Subject initiation withdrawal, Other|5
5191093|NCT01167153|17920737|P2|Overall Study|Withdrawal consent|1
5191094|NCT01167153|17920738|P1|Overall Study|Withdrawal consent|1
5191095|NCT01167153|17920737|P2|Overall Study|Investigator initiation withdrawal,Other|1
5191096|NCT01167153|17920738|P1|Overall Study|Investigator initiation withdrawal,Other|1
5191097|NCT01167153|17920737|P2|Overall Study|Non-compliance to concomitant medication|2
5191098|NCT01167153|17920738|P1|Overall Study|Non-compliance to concomitant medication|0
5191099|NCT01167153|17920737|P2|Overall Study|Lost to Follow-up|9
5191100|NCT01167153|17920738|P1|Overall Study|Lost to Follow-up|7
5191101|NCT01167153|17920737|P2|Overall Study|Hypotension|0
5191102|NCT01167153|17920738|P1|Overall Study|Hypotension|1
5191103|NCT01167153|17920737|P2|Overall Study|AE including clinical laboratory AE|8
5191104|NCT01167153|17920738|P1|Overall Study|AE including clinical laboratory AE|2
5191105|NCT01167153|17920737|P2|Overall Study|Non-effective therapy|4
5191106|NCT01167153|17920738|P1|Overall Study|Non-effective therapy|1
5191107|NCT01167140|17920756|P1|Overall Study|Withdrawal by Subject|1
5191108|NCT01167023|17920764|P3|Overall Study|Withdrawal by Subject|1
5191109|NCT01167023|17920765|P2|Overall Study|Withdrawal by Subject|0
5191110|NCT01167023|17920766|P1|Overall Study|Withdrawal by Subject|0
5191111|NCT01167023|17920764|P3|Overall Study|Sponsor Decision|0
5191112|NCT01167023|17920765|P2|Overall Study|Sponsor Decision|1
5191113|NCT01167023|17920766|P1|Overall Study|Sponsor Decision|0
5191114|NCT01167023|17920764|P3|Overall Study|Screen Failure|0
5191115|NCT01167023|17920765|P2|Overall Study|Screen Failure|1
5191116|NCT01167023|17920766|P1|Overall Study|Screen Failure|0
5191117|NCT01167023|17920764|P3|Overall Study|Lost to Follow-up|1
5191118|NCT01167023|17920765|P2|Overall Study|Lost to Follow-up|1
5191119|NCT01167023|17920766|P1|Overall Study|Lost to Follow-up|0
5191120|NCT01166958|17920806|P2|Overall Study|Withdrawal by Subject|0
5191121|NCT01166958|17920807|P1|Overall Study|Withdrawal by Subject|1
5191122|NCT01166945|17920823|P2|Day 30|Lost to Follow-up|3
5191123|NCT01166945|17920824|P1|Day 30|Lost to Follow-up|4
5191124|NCT01166945|17920823|P2|Day 15|NonCompliance/Lost to Follow Up|1
5191125|NCT01166945|17920824|P1|Day 15|NonCompliance/Lost to Follow Up|2
5191126|NCT01166945|17920823|P2|Day 10|NonCompliance/Lost to Follow Up|2
5191127|NCT01166945|17920824|P1|Day 10|NonCompliance/Lost to Follow Up|3
5191128|NCT01166945|17920823|P2|Randomized|diagnosed with Group A strep|4
5191129|NCT01166945|17920824|P1|Randomized|diagnosed with Group A strep|4
5191130|NCT01166763|17920832|P1|Overall Study|Withdrawal by Subject|3
5191131|NCT01166750|17920840|P2|Overall Study|Lost to Follow-up|0
5191132|NCT01166750|17920841|P1|Overall Study|Lost to Follow-up|1
5191133|NCT01166659|17920858|P1|Overall Study|Study Closed at Site|1
5191134|NCT01166659|17920858|P1|Overall Study|Lost to Follow-up|1
5191135|NCT01166659|17920858|P1|Overall Study|Death|1
5191136|NCT01166659|17920858|P1|Overall Study|Investigator Decision|2
5191137|NCT01166659|17920858|P1|Overall Study|Subject Decision|8
5191138|NCT01166646|17920867|P2|Overall Study|Adverse Event|0
5191139|NCT01166646|17920868|P1|Overall Study|Adverse Event|1
5191140|NCT01166646|17920867|P2|Overall Study|Protocol Violation|1
5191141|NCT01166646|17920868|P1|Overall Study|Protocol Violation|0
5191142|NCT01166568|17920887|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
5191143|NCT01166568|17920888|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5191144|NCT01166568|17920889|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
5191145|NCT01166568|17920887|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
5191146|NCT01166568|17920888|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
5191147|NCT01166568|17920889|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
5191148|NCT01166568|17920887|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
5191149|NCT01166568|17920888|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
5191150|NCT01166568|17920889|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
5191151|NCT01166438|17920902|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
5191152|NCT01166438|17920903|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
5191153|NCT01166438|17920902|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
5191154|NCT01166438|17920903|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
5191155|NCT01166438|17920902|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
5191156|NCT01166438|17920903|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
5191157|NCT01166438|17920902|P2|Double-blind Phase: 1st 6 Months|Not treated|1
5191158|NCT01166438|17920903|P1|Double-blind Phase: 1st 6 Months|Not treated|1
5191159|NCT01166438|17920902|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
5191160|NCT01166438|17920903|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
5191161|NCT01166438|17920902|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
5191162|NCT01166438|17920903|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
5191163|NCT01166373|17920921|P4|Overall Study|Physician Decision|0
5191164|NCT01166373|17920922|P3|Overall Study|Physician Decision|0
5191165|NCT01166373|17920923|P2|Overall Study|Physician Decision|0
5191166|NCT01166373|17920924|P1|Overall Study|Physician Decision|1
5191167|NCT01166373|17920921|P4|Overall Study|Withdrawal by Subject|3
5191168|NCT01166373|17920922|P3|Overall Study|Withdrawal by Subject|2
5191169|NCT01166373|17920923|P2|Overall Study|Withdrawal by Subject|2
5191170|NCT01166373|17920924|P1|Overall Study|Withdrawal by Subject|1
5191171|NCT01166373|17920921|P4|Overall Study|Lost to Follow-up|2
5191172|NCT01166373|17920922|P3|Overall Study|Lost to Follow-up|2
5191173|NCT01166373|17920923|P2|Overall Study|Lost to Follow-up|2
5191174|NCT01166373|17920924|P1|Overall Study|Lost to Follow-up|3
5191175|NCT01166282|17921057|P3|Open-label Period|Irregular Compliance|1
5191176|NCT01166282|17921058|P2|Open-label Period|Irregular Compliance|0
5191177|NCT01166282|17921059|P1|Open-label Period|Irregular Compliance|0
5191178|NCT01166282|17921057|P3|Open-label Period|Remission|4
5191179|NCT01166282|17921058|P2|Open-label Period|Remission|0
5191180|NCT01166282|17921059|P1|Open-label Period|Remission|0
5191181|NCT01166282|17921057|P3|Open-label Period|Lack of Efficacy|2
5191182|NCT01166282|17921058|P2|Open-label Period|Lack of Efficacy|0
5191183|NCT01166282|17921059|P1|Open-label Period|Lack of Efficacy|0
5191184|NCT01166282|17921057|P3|Open-label Period|Withdrawal by Subject|4
5191185|NCT01166282|17921058|P2|Open-label Period|Withdrawal by Subject|0
5191186|NCT01166282|17921059|P1|Open-label Period|Withdrawal by Subject|0
5191187|NCT01166282|17921057|P3|Open-label Period|Adverse Event|6
5191188|NCT01166282|17921058|P2|Open-label Period|Adverse Event|0
5191189|NCT01166282|17921059|P1|Open-label Period|Adverse Event|0
5191190|NCT01166178|17921098|P2|Overall Study|Study was terminated|8
5191191|NCT01166178|17921099|P1|Overall Study|Study was terminated|20
5191192|NCT01166178|17921098|P2|Overall Study|Withdrawal by Subject|0
5191193|NCT01166178|17921099|P1|Overall Study|Withdrawal by Subject|1
5191194|NCT01165996|17921138|P1|Overall Study|Physician Decision|1
5191195|NCT01165996|17921138|P1|Overall Study|Death|1
5191196|NCT01165684|17921209|P2|Overall Study|Unclassified|22
5191197|NCT01165684|17921210|P1|Overall Study|Unclassified|16
5191198|NCT01165684|17921209|P2|Overall Study|Withdrawal Criteria|13
5191199|NCT01165684|17921210|P1|Overall Study|Withdrawal Criteria|2
5191200|NCT01165684|17921209|P2|Overall Study|Protocol Violation|15
5191201|NCT01165684|17921210|P1|Overall Study|Protocol Violation|7
5191202|NCT01165684|17921209|P2|Overall Study|Lack of Efficacy|1
5191203|NCT01165684|17921210|P1|Overall Study|Lack of Efficacy|2
5191204|NCT01165684|17921209|P2|Overall Study|Adverse Event|1
5191205|NCT01165684|17921210|P1|Overall Study|Adverse Event|1
5191206|NCT01165554|17921244|P1|Overall Study|Withdrawal by Subject|23
5191207|NCT01165424|17921267|P1|Overall Study|Participant moved (relocated)|1
5191208|NCT01165424|17921267|P1|Overall Study|Did not meet entry criteria|1
5191209|NCT01165424|17921267|P1|Overall Study|Laboratory adverse experiences|1
5191210|NCT01165424|17921267|P1|Overall Study|Clinical adverse experiences|1
5191211|NCT01165320|17921274|P3|Overall Study|Reason unknown|0
5191212|NCT01165320|17921275|P2|Overall Study|Reason unknown|1
5191213|NCT01165320|17921276|P1|Overall Study|Reason unknown|0
5191214|NCT01165320|17921274|P3|Overall Study|Lack of Efficacy|0
5191215|NCT01165320|17921275|P2|Overall Study|Lack of Efficacy|2
5191216|NCT01165320|17921276|P1|Overall Study|Lack of Efficacy|0
5191217|NCT01165320|17921274|P3|Overall Study|Laboratory adverse experience|0
5191218|NCT01165320|17921275|P2|Overall Study|Laboratory adverse experience|0
5191219|NCT01165320|17921276|P1|Overall Study|Laboratory adverse experience|1
5191220|NCT01165320|17921274|P3|Overall Study|Clinical adverse experience|0
5191221|NCT01165320|17921275|P2|Overall Study|Clinical adverse experience|1
5191222|NCT01165320|17921276|P1|Overall Study|Clinical adverse experience|2
5191223|NCT01165307|17921286|P2|Overall Study|Subject not available for contact|0
5191224|NCT01165307|17921287|P1|Overall Study|Subject not available for contact|1
5191225|NCT01165307|17921286|P2|Overall Study|Withdrawal by Subject|0
5191226|NCT01165307|17921287|P1|Overall Study|Withdrawal by Subject|2
5191227|NCT01165307|17921286|P2|Overall Study|Lost to Follow-up|3
5191228|NCT01165307|17921287|P1|Overall Study|Lost to Follow-up|11
5191229|NCT01165281|17921317|P2|Overall Study|Other|0
5191230|NCT01165281|17921318|P1|Overall Study|Other|6
5191231|NCT01165281|17921317|P2|Overall Study|Progressive Disease|14
5191232|NCT01165281|17921318|P1|Overall Study|Progressive Disease|10
5191233|NCT01165281|17921317|P2|Overall Study|Noncompliance with Study Drug|4
5191234|NCT01165281|17921318|P1|Overall Study|Noncompliance with Study Drug|1
5191235|NCT01165281|17921317|P2|Overall Study|Withdrawal by Subject|7
5191236|NCT01165281|17921318|P1|Overall Study|Withdrawal by Subject|8
5191237|NCT01165281|17921317|P2|Overall Study|Protocol Violation|5
5191238|NCT01165281|17921318|P1|Overall Study|Protocol Violation|6
5191239|NCT01165281|17921317|P2|Overall Study|Physician Decision|1
5191240|NCT01165281|17921318|P1|Overall Study|Physician Decision|8
5191241|NCT01165281|17921317|P2|Overall Study|Lost to Follow-up|1
5191242|NCT01165281|17921318|P1|Overall Study|Lost to Follow-up|0
5191243|NCT01165281|17921317|P2|Overall Study|Lack of Efficacy|1
5191244|NCT01165281|17921318|P1|Overall Study|Lack of Efficacy|4
5191245|NCT01165281|17921317|P2|Overall Study|Death|4
5191246|NCT01165281|17921318|P1|Overall Study|Death|3
5191247|NCT01165281|17921317|P2|Overall Study|Adverse Event|14
5191248|NCT01165281|17921318|P1|Overall Study|Adverse Event|12
5191249|NCT01165242|17921339|P3|Overall Study|Lost to Follow-up|10
5191250|NCT01165242|17921340|P2|Overall Study|Lost to Follow-up|7
5191251|NCT01165242|17921341|P1|Overall Study|Lost to Follow-up|9
5191252|NCT01165242|17921339|P3|Overall Study|Extended Holiday|1
5191253|NCT01165242|17921340|P2|Overall Study|Extended Holiday|0
5191254|NCT01165242|17921341|P1|Overall Study|Extended Holiday|0
5191255|NCT01165242|17921339|P3|Overall Study|Withdrawal by Subject|2
5191256|NCT01165242|17921340|P2|Overall Study|Withdrawal by Subject|2
5191257|NCT01165242|17921341|P1|Overall Study|Withdrawal by Subject|0
5191258|NCT01165242|17921339|P3|Overall Study|Visit 2 Declined by Subject|1
5191259|NCT01165242|17921340|P2|Overall Study|Visit 2 Declined by Subject|0
5191260|NCT01165242|17921341|P1|Overall Study|Visit 2 Declined by Subject|0
5191261|NCT01165242|17921339|P3|Overall Study|Incarcerated Subjects|0
5191262|NCT01165242|17921340|P2|Overall Study|Incarcerated Subjects|1
5191263|NCT01165242|17921341|P1|Overall Study|Incarcerated Subjects|0
5191264|NCT01165242|17921339|P3|Overall Study|Unreachable Subjects|0
5191265|NCT01165242|17921340|P2|Overall Study|Unreachable Subjects|0
5191266|NCT01165242|17921341|P1|Overall Study|Unreachable Subjects|1
5191267|NCT01165229|17921375|P2|Overall Study|Unknown completion status|1
5191268|NCT01165229|17921376|P1|Overall Study|Unknown completion status|0
5191269|NCT01165229|17921375|P2|Overall Study|No reason from the subject|102
5191270|NCT01165229|17921376|P1|Overall Study|No reason from the subject|108
5191271|NCT01165229|17921375|P2|Overall Study|Suspected HZ Episode|2
5191272|NCT01165229|17921376|P1|Overall Study|Suspected HZ Episode|2
5191273|NCT01165229|17921375|P2|Overall Study|Lost to Follow-up|133
5191274|NCT01165229|17921376|P1|Overall Study|Lost to Follow-up|123
5191275|NCT01165229|17921375|P2|Overall Study|Migrated/moved from study area|46
5191276|NCT01165229|17921376|P1|Overall Study|Migrated/moved from study area|51
5191277|NCT01165229|17921375|P2|Overall Study|Withdrawal by Subject|396
5191278|NCT01165229|17921376|P1|Overall Study|Withdrawal by Subject|387
5191279|NCT01165229|17921375|P2|Overall Study|Protocol Violation|8
5191280|NCT01165229|17921376|P1|Overall Study|Protocol Violation|6
5191281|NCT01165229|17921375|P2|Overall Study|Non-Serious Adverse Event|15
5191282|NCT01165229|17921376|P1|Overall Study|Non-Serious Adverse Event|47
5191283|NCT01165229|17921375|P2|Overall Study|Serious Adverse Event|487
5191284|NCT01165229|17921376|P1|Overall Study|Serious Adverse Event|456
5191285|NCT01165216|17921510|P2|Overall Study|Disease progression|3
5191286|NCT01165216|17921511|P1|Overall Study|Disease progression|1
5191287|NCT01165216|17921510|P2|Overall Study|Withdrawal by Subject|1
5191288|NCT01165216|17921511|P1|Overall Study|Withdrawal by Subject|1
5191289|NCT01165216|17921510|P2|Overall Study|Adverse Event|3
5191290|NCT01165216|17921511|P1|Overall Study|Adverse Event|6
5191291|NCT01165203|17921533|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
5191292|NCT01165203|17921534|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
5191293|NCT01165203|17921533|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
5191294|NCT01165203|17921534|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
5191295|NCT01165203|17921533|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
5191296|NCT01165203|17921534|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
5191297|NCT01165203|17921533|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
5191298|NCT01165203|17921534|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
5191299|NCT01165203|17921533|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
5191300|NCT01165203|17921534|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
5191301|NCT01165203|17921533|P2|Active Phase|Lost to Follow-up|0
5191302|NCT01165203|17921534|P1|Active Phase|Lost to Follow-up|2
5191303|NCT01165203|17921533|P2|Active Phase|Migrated/moved from study area|1
5191304|NCT01165203|17921534|P1|Active Phase|Migrated/moved from study area|0
5191305|NCT01165203|17921533|P2|Active Phase|Withdrawal by Subject|1
5191306|NCT01165203|17921534|P1|Active Phase|Withdrawal by Subject|2
5191307|NCT01165203|17921533|P2|Active Phase|Serious Adverse Event|0
5191308|NCT01165203|17921534|P1|Active Phase|Serious Adverse Event|1
5191309|NCT01165177|17921624|P2|Overall Study|Migrated/ moved from study area|43
5191310|NCT01165177|17921625|P1|Overall Study|Migrated/ moved from study area|48
5191311|NCT01165177|17921624|P2|Overall Study|Lost to Follow-up|194
5191312|NCT01165177|17921625|P1|Overall Study|Lost to Follow-up|183
5191313|NCT01165177|17921624|P2|Overall Study|Suspected HZ episode|2
5191314|NCT01165177|17921625|P1|Overall Study|Suspected HZ episode|0
5191315|NCT01165177|17921624|P2|Overall Study|Other unspecified reasons|35
5191316|NCT01165177|17921625|P1|Overall Study|Other unspecified reasons|47
5191317|NCT01165177|17921624|P2|Overall Study|Non-serious adverse event|18
5191318|NCT01165177|17921625|P1|Overall Study|Non-serious adverse event|30
5191319|NCT01165177|17921624|P2|Overall Study|Protocol Violation|21
5191320|NCT01165177|17921625|P1|Overall Study|Protocol Violation|19
5191321|NCT01165177|17921624|P2|Overall Study|Withdrawal by Subject|354
5191322|NCT01165177|17921625|P1|Overall Study|Withdrawal by Subject|368
5191323|NCT01165177|17921624|P2|Overall Study|Serious Adverse Event|235
5191324|NCT01165177|17921625|P1|Overall Study|Serious Adverse Event|227
5191325|NCT01165138|17921754|P4|Overall Study|Withdrawal by Subject|3
5191326|NCT01165138|17921755|P3|Overall Study|Withdrawal by Subject|6
5191327|NCT01165138|17921756|P2|Overall Study|Withdrawal by Subject|6
5191328|NCT01165138|17921757|P1|Overall Study|Withdrawal by Subject|0
5191329|NCT01165138|17921754|P4|Overall Study|Physician Decision|6
5191330|NCT01165138|17921755|P3|Overall Study|Physician Decision|7
5191331|NCT01165138|17921756|P2|Overall Study|Physician Decision|6
5191332|NCT01165138|17921757|P1|Overall Study|Physician Decision|0
5191333|NCT01165138|17921754|P4|Overall Study|Lost to Follow-up|2
5191334|NCT01165138|17921755|P3|Overall Study|Lost to Follow-up|1
5191335|NCT01165138|17921756|P2|Overall Study|Lost to Follow-up|0
5191336|NCT01165138|17921757|P1|Overall Study|Lost to Follow-up|0
5191337|NCT01165138|17921754|P4|Overall Study|Protocol Violation|2
5191338|NCT01165138|17921755|P3|Overall Study|Protocol Violation|0
5191339|NCT01165138|17921756|P2|Overall Study|Protocol Violation|7
5191340|NCT01165138|17921757|P1|Overall Study|Protocol Violation|0
5191341|NCT01165138|17921754|P4|Overall Study|Lack of Efficacy|7
5191342|NCT01165138|17921755|P3|Overall Study|Lack of Efficacy|6
5191343|NCT01165138|17921756|P2|Overall Study|Lack of Efficacy|32
5191344|NCT01165138|17921757|P1|Overall Study|Lack of Efficacy|0
5191345|NCT01165138|17921754|P4|Overall Study|Adverse Event|2
5191346|NCT01165138|17921755|P3|Overall Study|Adverse Event|0
5191347|NCT01165138|17921756|P2|Overall Study|Adverse Event|1
5191348|NCT01165138|17921757|P1|Overall Study|Adverse Event|0
5191349|NCT01165021|17921827|P1|Overall Study|Death|1
5191350|NCT01164956|17921835|P3|Overall Study|Side Effects|1
5191351|NCT01164956|17921836|P2|Overall Study|Side Effects|0
5191352|NCT01164956|17921837|P1|Overall Study|Side Effects|1
5191353|NCT01164891|17921845|P1|Overall Study|Adverse Event|1
5191354|NCT01164891|17921845|P1|Overall Study|Disease Progression|5
5191355|NCT01164865|17921865|P2|Overall Study|Lost to Follow-up|1
5191356|NCT01164865|17921866|P1|Overall Study|Lost to Follow-up|2
5191357|NCT01164722|17921876|P2|Overall Study|enrolled on other study, concomitant med|3
5191358|NCT01164722|17921877|P1|Overall Study|enrolled on other study, concomitant med|1
5191359|NCT01164722|17921876|P2|Overall Study|met protocol criteria for non-treatment|1
5191360|NCT01164722|17921877|P1|Overall Study|met protocol criteria for non-treatment|11
5191361|NCT01164722|17921876|P2|Overall Study|Lost to Follow-up|6
5191362|NCT01164722|17921877|P1|Overall Study|Lost to Follow-up|3
5191363|NCT01164722|17921876|P2|Overall Study|Withdrawal by Subject|4
5191364|NCT01164722|17921877|P1|Overall Study|Withdrawal by Subject|3
5191365|NCT01164722|17921876|P2|Overall Study|Adverse Event|1
5191366|NCT01164722|17921877|P1|Overall Study|Adverse Event|0
5191367|NCT01164579|17921907|P3|Overall Study|Reason not specified|0
5191368|NCT01164579|17921908|P2|Overall Study|Reason not specified|0
5191369|NCT01164579|17921909|P1|Overall Study|Reason not specified|1
5191370|NCT01164579|17921907|P3|Overall Study|Adverse Event|5
5191371|NCT01164579|17921908|P2|Overall Study|Adverse Event|2
5191372|NCT01164579|17921909|P1|Overall Study|Adverse Event|4
5191373|NCT01164579|17921907|P3|Overall Study|Protocol Violation|2
5191374|NCT01164579|17921908|P2|Overall Study|Protocol Violation|1
5191375|NCT01164579|17921909|P1|Overall Study|Protocol Violation|0
5191376|NCT01164579|17921907|P3|Overall Study|Withdrawal by Subject|3
5191377|NCT01164579|17921908|P2|Overall Study|Withdrawal by Subject|5
5191378|NCT01164579|17921909|P1|Overall Study|Withdrawal by Subject|2
5191379|NCT01164579|17921907|P3|Overall Study|Lost to Follow-up|0
5191380|NCT01164579|17921908|P2|Overall Study|Lost to Follow-up|1
5191381|NCT01164579|17921909|P1|Overall Study|Lost to Follow-up|1
5191382|NCT01164579|17921907|P3|Overall Study|Lack of Efficacy|6
5191383|NCT01164579|17921908|P2|Overall Study|Lack of Efficacy|0
5191384|NCT01164579|17921909|P1|Overall Study|Lack of Efficacy|0
5191385|NCT01164501|17921989|P3|Overall Study|Other reason not defined above|4
5191386|NCT01164501|17921990|P2|Overall Study|Other reason not defined above|1
5191387|NCT01164501|17921991|P1|Overall Study|Other reason not defined above|9
5191388|NCT01164501|17921989|P3|Overall Study|Patient refusal to continue,not due toAE|8
5191389|NCT01164501|17921990|P2|Overall Study|Patient refusal to continue,not due toAE|4
5191390|NCT01164501|17921991|P1|Overall Study|Patient refusal to continue,not due toAE|10
5191391|NCT01164501|17921989|P3|Overall Study|Lost to Follow-up|3
5191392|NCT01164501|17921990|P2|Overall Study|Lost to Follow-up|0
5191393|NCT01164501|17921991|P1|Overall Study|Lost to Follow-up|3
5191394|NCT01164501|17921989|P3|Overall Study|Non compliant with protocol|4
5191395|NCT01164501|17921990|P2|Overall Study|Non compliant with protocol|1
5191396|NCT01164501|17921991|P1|Overall Study|Non compliant with protocol|1
5191397|NCT01164501|17921989|P3|Overall Study|Lack of Efficacy|1
5191398|NCT01164501|17921990|P2|Overall Study|Lack of Efficacy|0
5191399|NCT01164501|17921991|P1|Overall Study|Lack of Efficacy|0
5191400|NCT01164501|17921989|P3|Overall Study|Adverse Event|21
5191401|NCT01164501|17921990|P2|Overall Study|Adverse Event|4
5191402|NCT01164501|17921991|P1|Overall Study|Adverse Event|18
5191403|NCT01164501|17921989|P3|Overall Study|Not treated|1
5191404|NCT01164501|17921990|P2|Overall Study|Not treated|0
5191405|NCT01164501|17921991|P1|Overall Study|Not treated|2
5191406|NCT01164475|17922008|P2|Overall Study|Protocol Violation|0
5191407|NCT01164475|17922009|P1|Overall Study|Protocol Violation|1
5191408|NCT01164475|17922008|P2|Overall Study|Progressive disease|1
5191409|NCT01164475|17922009|P1|Overall Study|Progressive disease|0
5191410|NCT01164475|17922008|P2|Overall Study|Other|1
5191411|NCT01164475|17922009|P1|Overall Study|Other|0
5191412|NCT01164475|17922008|P2|Overall Study|Lack of Efficacy|0
5191413|NCT01164475|17922009|P1|Overall Study|Lack of Efficacy|1
5191414|NCT01164007|17922063|P1|Overall Study|Medical Decision|3
5191415|NCT01164007|17922063|P1|Overall Study|Withdrawal by Subject|1
5191416|NCT01164007|17922063|P1|Overall Study|Protocol Violation|1
5191417|NCT01164007|17922063|P1|Overall Study|Progression of Disease|30
5191418|NCT01164007|17922063|P1|Overall Study|Adverse Event|5
5191419|NCT01163916|17922089|P3|Overall Study|Other|16
5191420|NCT01163916|17922090|P2|Overall Study|Other|4
5191421|NCT01163916|17922091|P1|Overall Study|Other|24
5191422|NCT01163916|17922089|P3|Overall Study|Lack of Efficacy|1
5191423|NCT01163916|17922090|P2|Overall Study|Lack of Efficacy|0
5191424|NCT01163916|17922091|P1|Overall Study|Lack of Efficacy|2
5191425|NCT01163916|17922089|P3|Overall Study|Adverse Event|1
5191426|NCT01163916|17922090|P2|Overall Study|Adverse Event|0
5191427|NCT01163916|17922091|P1|Overall Study|Adverse Event|2
5191428|NCT01163916|17922089|P3|Overall Study|Withdrawal by Subject|2
5191429|NCT01163916|17922090|P2|Overall Study|Withdrawal by Subject|0
5191430|NCT01163916|17922091|P1|Overall Study|Withdrawal by Subject|2
5191431|NCT01163851|17922129|P2|Overall Study|Enrolled but not treated|0
5191432|NCT01163851|17922130|P1|Overall Study|Enrolled but not treated|1
5191433|NCT01163851|17922129|P2|Overall Study|Site Closure|1
5191434|NCT01163851|17922130|P1|Overall Study|Site Closure|0
5191435|NCT01163786|17922208|P1|Completed Follow up (Visit 9 and 10)|Other|1
5191436|NCT01163786|17922208|P1|Treatment With Bortezomib|Adverse Event|2
5191437|NCT01163786|17922208|P1|Treatment With Bortezomib|Withdrawal by Subject|1
5191438|NCT01163747|17922231|P2|Overall Study|Refused Treatment|4
5191439|NCT01163747|17922232|P1|Overall Study|Refused Treatment|6
5191440|NCT01163747|17922231|P2|Overall Study|Protocol Violation|1
5191441|NCT01163747|17922232|P1|Overall Study|Protocol Violation|0
5191442|NCT01163747|17922231|P2|Overall Study|Insufficient Therapeutic Response|1
5191443|NCT01163747|17922232|P1|Overall Study|Insufficient Therapeutic Response|0
5191444|NCT01163747|17922231|P2|Overall Study|Adverse Event|5
5191445|NCT01163747|17922232|P1|Overall Study|Adverse Event|0
5191446|NCT01163721|17922252|P2|Overall Study|Physician Decision|1
5191447|NCT01163721|17922253|P1|Overall Study|Physician Decision|0
5191448|NCT01163721|17922252|P2|Overall Study|Lost to Follow-up|1
5191449|NCT01163721|17922253|P1|Overall Study|Lost to Follow-up|0
5191450|NCT01163721|17922252|P2|Overall Study|Withdrawal by Subject|4
5191451|NCT01163721|17922253|P1|Overall Study|Withdrawal by Subject|3
5191452|NCT01163721|17922252|P2|Overall Study|Adverse Event|6
5191453|NCT01163721|17922253|P1|Overall Study|Adverse Event|5
5191454|NCT01163617|17922303|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191455|NCT01163617|17922304|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191456|NCT01163617|17922305|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191457|NCT01163617|17922306|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191458|NCT01163617|17922307|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191459|NCT01163617|17922308|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
5191460|NCT01163617|17922309|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191461|NCT01163617|17922310|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5191462|NCT01163617|17922303|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191463|NCT01163617|17922304|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191464|NCT01163617|17922305|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191465|NCT01163617|17922306|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191466|NCT01163617|17922307|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191467|NCT01163617|17922308|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191468|NCT01163617|17922309|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
5191469|NCT01163617|17922310|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5191470|NCT01163617|17922303|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191471|NCT01163617|17922304|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191472|NCT01163617|17922305|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191473|NCT01163617|17922306|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191474|NCT01163617|17922307|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191475|NCT01163617|17922308|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191476|NCT01163617|17922309|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
5191477|NCT01163617|17922310|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5191478|NCT01163474|17922339|P1|Overall Study|Lost to Follow-up|3
5191479|NCT01163474|17922339|P1|Overall Study|Tech barriers to videoteleconference vis|12
5191480|NCT01163474|17922339|P1|Overall Study|Withdrawal by Subject|1
5191481|NCT01163318|17922351|P1|Overall Study|Multiple Reasons Per Participant|224
5191482|NCT01163318|17922351|P1|Overall Study|Participants Without Case Report Form|7
5191483|NCT01163318|17922351|P1|Overall Study|History/comorbidity of malignant tumor|3
5191484|NCT01163318|17922351|P1|Overall Study|Did Not Continue Use of Adalimumab|26
5191485|NCT01163318|17922351|P1|Overall Study|Off-Label Use of Adalimumab|8
5191486|NCT01163292|17922360|P2|Overall Study|No further visits|7
5191487|NCT01163292|17922361|P1|Overall Study|No further visits|5
5191488|NCT01163292|17922360|P2|Overall Study|Economic reasons|0
5191489|NCT01163292|17922361|P1|Overall Study|Economic reasons|6
5191490|NCT01163292|17922360|P2|Overall Study|Refusal to receive adalimumab|0
5191491|NCT01163292|17922361|P1|Overall Study|Refusal to receive adalimumab|7
5191492|NCT01163292|17922360|P2|Overall Study|Sufficient response to adalimumab|0
5191493|NCT01163292|17922361|P1|Overall Study|Sufficient response to adalimumab|8
5191494|NCT01163292|17922360|P2|Overall Study|Initiation of biological therapy|15
5191495|NCT01163292|17922361|P1|Overall Study|Initiation of biological therapy|0
5191496|NCT01163292|17922360|P2|Overall Study|Adverse Event|0
5191497|NCT01163292|17922361|P1|Overall Study|Adverse Event|6
5191498|NCT01163292|17922360|P2|Overall Study|Lack of Efficacy|0
5191499|NCT01163292|17922361|P1|Overall Study|Lack of Efficacy|9
5191500|NCT01163279|17922377|P2|Overall Study|Withdrawal by Subject|0
5191501|NCT01163279|17922378|P1|Overall Study|Withdrawal by Subject|2
5191502|NCT01163266|17922407|P3|Overall Study|Other|2
5191503|NCT01163266|17922408|P2|Overall Study|Other|1
5191504|NCT01163266|17922409|P1|Overall Study|Other|1
5191505|NCT01163266|17922407|P3|Overall Study|Lost to Follow-up|10
5191506|NCT01163266|17922408|P2|Overall Study|Lost to Follow-up|7
5191507|NCT01163266|17922409|P1|Overall Study|Lost to Follow-up|7
5191508|NCT01163266|17922407|P3|Overall Study|Withdrawal of Consent|3
5191509|NCT01163266|17922408|P2|Overall Study|Withdrawal of Consent|7
5191510|NCT01163266|17922409|P1|Overall Study|Withdrawal of Consent|5
5191511|NCT01163266|17922407|P3|Overall Study|Protocol Deviations|5
5191512|NCT01163266|17922408|P2|Overall Study|Protocol Deviations|2
5191513|NCT01163266|17922409|P1|Overall Study|Protocol Deviations|2
5191514|NCT01163266|17922407|P3|Overall Study|Noncompliance with Study Drug|0
5191515|NCT01163266|17922408|P2|Overall Study|Noncompliance with Study Drug|2
5191516|NCT01163266|17922409|P1|Overall Study|Noncompliance with Study Drug|0
5191517|NCT01163266|17922407|P3|Overall Study|Lack of Efficacy|1
5191518|NCT01163266|17922408|P2|Overall Study|Lack of Efficacy|3
5191519|NCT01163266|17922409|P1|Overall Study|Lack of Efficacy|1
5191520|NCT01163266|17922407|P3|Overall Study|Pretreatment Event or Adverse Event|7
5191521|NCT01163266|17922408|P2|Overall Study|Pretreatment Event or Adverse Event|9
5191522|NCT01163266|17922409|P1|Overall Study|Pretreatment Event or Adverse Event|2
5191523|NCT01163253|17922434|P2|Overall Study|Other Unspecified|34
5191524|NCT01163253|17922435|P1|Overall Study|Other Unspecified|170
5191525|NCT01163253|17922434|P2|Overall Study|Ongoing|4
5191526|NCT01163253|17922435|P1|Overall Study|Ongoing|13
5191527|NCT01163253|17922434|P2|Overall Study|Death|5
5191528|NCT01163253|17922435|P1|Overall Study|Death|17
5191529|NCT01163253|17922434|P2|Overall Study|Adverse Event|78
5191530|NCT01163253|17922435|P1|Overall Study|Adverse Event|300
5191531|NCT01163253|17922434|P2|Overall Study|Insufficient Clinical Response|29
5191532|NCT01163253|17922435|P1|Overall Study|Insufficient Clinical Response|423
5191533|NCT01163253|17922434|P2|Overall Study|Lost to Follow-up|23
5191534|NCT01163253|17922435|P1|Overall Study|Lost to Follow-up|125
5191535|NCT01163253|17922434|P2|Overall Study|Medication Error|0
5191536|NCT01163253|17922435|P1|Overall Study|Medication Error|1
5191537|NCT01163253|17922434|P2|Overall Study|Withdrawal by Subject|50
5191538|NCT01163253|17922435|P1|Overall Study|Withdrawal by Subject|199
5191539|NCT01163253|17922434|P2|Overall Study|Protocol Violation|12
5191540|NCT01163253|17922435|P1|Overall Study|Protocol Violation|43
5191541|NCT01163253|17922434|P2|Overall Study|Study Terminated by Sponsor|349
5191542|NCT01163253|17922435|P1|Overall Study|Study Terminated by Sponsor|978
5191543|NCT01163253|17922434|P2|Overall Study|Withdrawn Due to Pregnancy|2
5191544|NCT01163253|17922435|P1|Overall Study|Withdrawn Due to Pregnancy|12
5191545|NCT01163149|17922623|P3|Extension Treatment Period|Noncompliance|1
5191546|NCT01163149|17922624|P2|Extension Treatment Period|Noncompliance|0
5191547|NCT01163149|17922625|P1|Extension Treatment Period|Noncompliance|0
5191548|NCT01163149|17922623|P3|Extension Treatment Period|Adverse Event|0
5191549|NCT01163149|17922624|P2|Extension Treatment Period|Adverse Event|1
5191550|NCT01163149|17922625|P1|Extension Treatment Period|Adverse Event|0
5191551|NCT01163149|17922623|P3|Extension Treatment Period|Withdrawal by Subject|1
5191552|NCT01163149|17922624|P2|Extension Treatment Period|Withdrawal by Subject|0
5191553|NCT01163149|17922625|P1|Extension Treatment Period|Withdrawal by Subject|2
5191554|NCT01163032|17922734|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
5191555|NCT01163032|17922735|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
5191556|NCT01163032|17922736|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
5191557|NCT01163032|17922734|P3|Open Label Extension Phase|Study Termination|7
5191558|NCT01163032|17922735|P2|Open Label Extension Phase|Study Termination|0
5191559|NCT01163032|17922736|P1|Open Label Extension Phase|Study Termination|0
5191560|NCT01163032|17922734|P3|Open Label Extension Phase|Protocol Violation|1
5191561|NCT01163032|17922735|P2|Open Label Extension Phase|Protocol Violation|0
5191562|NCT01163032|17922736|P1|Open Label Extension Phase|Protocol Violation|0
5191563|NCT01163032|17922734|P3|Open Label Extension Phase|Withdrawal by Subject|3
5191564|NCT01163032|17922735|P2|Open Label Extension Phase|Withdrawal by Subject|0
5191565|NCT01163032|17922736|P1|Open Label Extension Phase|Withdrawal by Subject|0
5191566|NCT01163032|17922734|P3|Open Label Extension Phase|Adverse Event|3
5191567|NCT01163032|17922735|P2|Open Label Extension Phase|Adverse Event|0
5191568|NCT01163032|17922736|P1|Open Label Extension Phase|Adverse Event|0
5191569|NCT01163032|17922734|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
5191570|NCT01163032|17922735|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
5191571|NCT01163032|17922736|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
5191572|NCT01163032|17922734|P3|Randomization Phase|Various*|0
5191573|NCT01163032|17922735|P2|Randomization Phase|Various*|4
5191574|NCT01163032|17922736|P1|Randomization Phase|Various*|5
5191575|NCT01163032|17922734|P3|Randomization Phase|Protocol Violation|0
5191576|NCT01163032|17922735|P2|Randomization Phase|Protocol Violation|1
5191577|NCT01163032|17922736|P1|Randomization Phase|Protocol Violation|0
5191578|NCT01163032|17922734|P3|Randomization Phase|Adverse Event|0
5191579|NCT01163032|17922735|P2|Randomization Phase|Adverse Event|3
5191580|NCT01163032|17922736|P1|Randomization Phase|Adverse Event|3
5191581|NCT01163032|17922734|P3|Randomization Phase|Withdrawal by Subject|0
5191582|NCT01163032|17922735|P2|Randomization Phase|Withdrawal by Subject|3
5191583|NCT01163032|17922736|P1|Randomization Phase|Withdrawal by Subject|2
5191584|NCT01162863|17922769|P3|Overall Study|Adverse Event|0
5191585|NCT01162863|17922770|P2|Overall Study|Adverse Event|1
5191586|NCT01162863|17922771|P1|Overall Study|Adverse Event|0
5191587|NCT01162863|17922769|P3|Overall Study|Lack of Efficacy|0
5191588|NCT01162863|17922770|P2|Overall Study|Lack of Efficacy|0
5191589|NCT01162863|17922771|P1|Overall Study|Lack of Efficacy|1
5191590|NCT01162499|17922801|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
5191591|NCT01162499|17922802|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
5191592|NCT01162486|17922827|P5|Overall Study|Pregnancy|0
5191593|NCT01162486|17922828|P4|Overall Study|Pregnancy|1
5191594|NCT01162486|17922829|P3|Overall Study|Pregnancy|0
5191595|NCT01162486|17922830|P2|Overall Study|Pregnancy|0
5191596|NCT01162486|17922831|P1|Overall Study|Pregnancy|0
5191597|NCT01162486|17922827|P5|Overall Study|elevated LFTs|0
5191598|NCT01162486|17922828|P4|Overall Study|elevated LFTs|0
5191599|NCT01162486|17922829|P3|Overall Study|elevated LFTs|1
5191600|NCT01162486|17922830|P2|Overall Study|elevated LFTs|0
5191601|NCT01162486|17922831|P1|Overall Study|elevated LFTs|0
5191602|NCT01162486|17922827|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
5191603|NCT01162486|17922828|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
5191604|NCT01162486|17922829|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
5191605|NCT01162486|17922830|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
5191606|NCT01162486|17922831|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
5191607|NCT01162486|17922827|P5|Overall Study|low ANC|0
5191608|NCT01162486|17922828|P4|Overall Study|low ANC|0
5191609|NCT01162486|17922829|P3|Overall Study|low ANC|0
5191610|NCT01162486|17922830|P2|Overall Study|low ANC|0
5191611|NCT01162486|17922831|P1|Overall Study|low ANC|1
5191612|NCT01162473|17922864|P2|Overall Study|Withdrawal by Subject|4
5191613|NCT01162473|17922865|P1|Overall Study|Withdrawal by Subject|0
5191614|NCT01162473|17922864|P2|Overall Study|Adverse Event|1
5191615|NCT01162473|17922865|P1|Overall Study|Adverse Event|2
5191616|NCT01162421|17922873|P2|Overall Study|Other|3
5191617|NCT01162421|17922874|P1|Overall Study|Other|2
5191618|NCT01162421|17922873|P2|Overall Study|Lack of Efficacy|2
5191619|NCT01162421|17922874|P1|Overall Study|Lack of Efficacy|2
5191620|NCT01162421|17922873|P2|Overall Study|Lost to Follow-up|2
5191621|NCT01162421|17922874|P1|Overall Study|Lost to Follow-up|0
5191622|NCT01162421|17922873|P2|Overall Study|Adverse Event|5
5191623|NCT01162421|17922874|P1|Overall Study|Adverse Event|2
5191624|NCT01162421|17922873|P2|Overall Study|Did not receive study drug|1
5191625|NCT01162421|17922874|P1|Overall Study|Did not receive study drug|2
5191626|NCT01162343|17922957|P1|Overall Study|Refused psychiatrist assessment|12
5191627|NCT01162343|17922957|P1|Overall Study|Left ED prior to psychiatrist assessment|80
5191628|NCT01162304|17922972|P1|Overall Study|Beck scale to high|11
5191629|NCT01162239|17922990|P4|Extended Follow-up|Lost to Follow-up|6
5191630|NCT01162239|17922991|P3|Extended Follow-up|Lost to Follow-up|8
5191631|NCT01162239|17922992|P2|Extended Follow-up|Lost to Follow-up|13
5191632|NCT01162239|17922993|P1|Extended Follow-up|Lost to Follow-up|8
5191633|NCT01162239|17922990|P4|Treatment Phase|Lost to Follow-up|1
5191634|NCT01162239|17922991|P3|Treatment Phase|Lost to Follow-up|2
5191635|NCT01162239|17922992|P2|Treatment Phase|Lost to Follow-up|4
5191636|NCT01162239|17922993|P1|Treatment Phase|Lost to Follow-up|5
5191637|NCT01162239|17922990|P4|Treatment Phase|Death|1
5191638|NCT01162239|17922991|P3|Treatment Phase|Death|0
5191639|NCT01162239|17922992|P2|Treatment Phase|Death|0
5191640|NCT01162239|17922993|P1|Treatment Phase|Death|0
5191641|NCT01162239|17922990|P4|Treatment Phase|Withdrawal by Subject|3
5191642|NCT01162239|17922991|P3|Treatment Phase|Withdrawal by Subject|2
5191643|NCT01162239|17922992|P2|Treatment Phase|Withdrawal by Subject|3
5191644|NCT01162239|17922993|P1|Treatment Phase|Withdrawal by Subject|1
5191645|NCT01162135|17923023|P1|Overall Study|Ineligible|1
5191646|NCT01162135|17923023|P1|Overall Study|Severe back pain|1
5191647|NCT01162135|17923023|P1|Overall Study|Withdrawal by Subject|1
5191648|NCT01162122|17923029|P2|Overall Study|Missing primary reason|0
5191649|NCT01162122|17923030|P1|Overall Study|Missing primary reason|1
5191650|NCT01162122|17923029|P2|Overall Study|Unable to classify|7
5191651|NCT01162122|17923030|P1|Overall Study|Unable to classify|3
5191652|NCT01162122|17923029|P2|Overall Study|Administrative reason|1
5191653|NCT01162122|17923030|P1|Overall Study|Administrative reason|1
5191654|NCT01162122|17923029|P2|Overall Study|Inappropriate enrollment|4
5191655|NCT01162122|17923030|P1|Overall Study|Inappropriate enrollment|5
5191656|NCT01162122|17923029|P2|Overall Study|Protocol Violation|2
5191657|NCT01162122|17923030|P1|Overall Study|Protocol Violation|2
5191658|NCT01162122|17923029|P2|Overall Study|Death|46
5191659|NCT01162122|17923030|P1|Overall Study|Death|51
5191660|NCT01162122|17923029|P2|Overall Study|Adverse Event|2
5191661|NCT01162122|17923030|P1|Overall Study|Adverse Event|3
5191662|NCT01162122|17923029|P2|Overall Study|Lost to Follow-up|91
5191663|NCT01162122|17923030|P1|Overall Study|Lost to Follow-up|73
5191664|NCT01162122|17923029|P2|Overall Study|Withdrawal by Subject|43
5191665|NCT01162122|17923030|P1|Overall Study|Withdrawal by Subject|52
5191666|NCT01161628|17923136|P1|Overall Study|Lack of Efficacy|2
5191667|NCT01161628|17923136|P1|Overall Study|Death|6
5191668|NCT01161537|17923159|P1|Part B|Withdrawal by Subject|2
5191669|NCT01161524|17923177|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
5191670|NCT01161524|17923178|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
5191671|NCT01161524|17923179|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
5191672|NCT01161524|17923177|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
5191673|NCT01161524|17923178|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
5191674|NCT01161524|17923179|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
5191675|NCT01161524|17923177|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
5191676|NCT01161524|17923178|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
5191677|NCT01161524|17923179|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
5191678|NCT01161524|17923177|P3|Extension Phase (Approximately 83 Weeks)|Other|6
5191679|NCT01161524|17923178|P2|Extension Phase (Approximately 83 Weeks)|Other|0
5191680|NCT01161524|17923179|P1|Extension Phase (Approximately 83 Weeks)|Other|0
5191681|NCT01161524|17923177|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
5191682|NCT01161524|17923178|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
5191683|NCT01161524|17923179|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
5191684|NCT01161524|17923177|P3|Core Study (23 Weeks)|Subject Choice|0
5191685|NCT01161524|17923178|P2|Core Study (23 Weeks)|Subject Choice|2
5191686|NCT01161524|17923179|P1|Core Study (23 Weeks)|Subject Choice|3
5191687|NCT01161524|17923177|P3|Core Study (23 Weeks)|Lost to Follow-up|0
5191688|NCT01161524|17923178|P2|Core Study (23 Weeks)|Lost to Follow-up|2
5191689|NCT01161524|17923179|P1|Core Study (23 Weeks)|Lost to Follow-up|1
5191690|NCT01161524|17923177|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
5191691|NCT01161524|17923178|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
5191692|NCT01161524|17923179|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
5191693|NCT01161524|17923177|P3|Core Study (23 Weeks)|Other|0
5191694|NCT01161524|17923178|P2|Core Study (23 Weeks)|Other|0
5191695|NCT01161524|17923179|P1|Core Study (23 Weeks)|Other|1
5191696|NCT01161524|17923177|P3|Core Study (23 Weeks)|Adverse Event|0
5191697|NCT01161524|17923178|P2|Core Study (23 Weeks)|Adverse Event|0
5191698|NCT01161524|17923179|P1|Core Study (23 Weeks)|Adverse Event|3
5191699|NCT01161498|17923218|P2|Overall Study|Disease Progression|1
5191700|NCT01161498|17923219|P1|Overall Study|Disease Progression|0
5191701|NCT01161472|17923243|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5191702|NCT01161472|17923244|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5191703|NCT01161472|17923245|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5191704|NCT01161472|17923246|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
5191705|NCT01161446|17923302|P2|Overall Study|Withdrawal by Subject|1
5191706|NCT01161446|17923303|P1|Overall Study|Withdrawal by Subject|0
5191707|NCT01161446|17923302|P2|Overall Study|Lost to Follow-up|14
5191708|NCT01161446|17923303|P1|Overall Study|Lost to Follow-up|18
5191709|NCT01161407|17923329|P2|Overall Study|Protocol Violation|1
5191710|NCT01161407|17923330|P1|Overall Study|Protocol Violation|3
5191711|NCT01161173|17923385|P1|Overall Study|Reasons Not Specified|23
5191712|NCT01161173|17923385|P1|Overall Study|End of Study|2
5191713|NCT01161173|17923385|P1|Overall Study|Death|194
5191714|NCT01161173|17923385|P1|Overall Study|Unacceptable Toxicity|21
5191715|NCT01161173|17923385|P1|Overall Study|Withdrawal of Consent|5
5191716|NCT01161173|17923385|P1|Overall Study|Progressive Disease|82
5191717|NCT01161173|17923385|P1|Overall Study|Lost to Follow-up|7
5191718|NCT01161173|17923385|P1|Overall Study|Protocol Violation|13
5191719|NCT01161043|17923480|P1|Overall Study|Withdrawal by Subject|3
5191720|NCT01160822|17923517|P7|Overall Study|Protocol deviation|0
5191721|NCT01160822|17923518|P6|Overall Study|Protocol deviation|0
5191722|NCT01160822|17923519|P5|Overall Study|Protocol deviation|2
5191723|NCT01160822|17923520|P4|Overall Study|Protocol deviation|0
5191724|NCT01160822|17923521|P3|Overall Study|Protocol deviation|0
5191725|NCT01160822|17923522|P2|Overall Study|Protocol deviation|0
5191726|NCT01160822|17923523|P1|Overall Study|Protocol deviation|0
5191727|NCT01160822|17923517|P7|Overall Study|Administrative problems|0
5191728|NCT01160822|17923518|P6|Overall Study|Administrative problems|0
5191729|NCT01160822|17923519|P5|Overall Study|Administrative problems|1
5191730|NCT01160822|17923520|P4|Overall Study|Administrative problems|0
5191731|NCT01160822|17923521|P3|Overall Study|Administrative problems|0
5191732|NCT01160822|17923522|P2|Overall Study|Administrative problems|0
5191733|NCT01160822|17923523|P1|Overall Study|Administrative problems|0
5191734|NCT01160822|17923517|P7|Overall Study|Lost to Follow-up|0
5191735|NCT01160822|17923518|P6|Overall Study|Lost to Follow-up|0
5191736|NCT01160822|17923519|P5|Overall Study|Lost to Follow-up|1
5191737|NCT01160822|17923520|P4|Overall Study|Lost to Follow-up|0
5191738|NCT01160822|17923521|P3|Overall Study|Lost to Follow-up|0
5191739|NCT01160822|17923522|P2|Overall Study|Lost to Follow-up|0
5191740|NCT01160822|17923523|P1|Overall Study|Lost to Follow-up|0
5191741|NCT01160822|17923517|P7|Overall Study|Withdrawal by Subject|1
5191742|NCT01160822|17923518|P6|Overall Study|Withdrawal by Subject|0
5191743|NCT01160822|17923519|P5|Overall Study|Withdrawal by Subject|0
5191744|NCT01160822|17923520|P4|Overall Study|Withdrawal by Subject|0
5191745|NCT01160822|17923521|P3|Overall Study|Withdrawal by Subject|0
5191746|NCT01160822|17923522|P2|Overall Study|Withdrawal by Subject|0
5191747|NCT01160822|17923523|P1|Overall Study|Withdrawal by Subject|0
5191748|NCT01160822|17923517|P7|Overall Study|Unsatisfactory therapeutic effect|3
5191749|NCT01160822|17923518|P6|Overall Study|Unsatisfactory therapeutic effect|5
5191750|NCT01160822|17923519|P5|Overall Study|Unsatisfactory therapeutic effect|4
5191751|NCT01160822|17923520|P4|Overall Study|Unsatisfactory therapeutic effect|0
5191752|NCT01160822|17923521|P3|Overall Study|Unsatisfactory therapeutic effect|0
5191753|NCT01160822|17923522|P2|Overall Study|Unsatisfactory therapeutic effect|0
5191754|NCT01160822|17923523|P1|Overall Study|Unsatisfactory therapeutic effect|0
5191755|NCT01160822|17923517|P7|Overall Study|Adverse Event|5
5191756|NCT01160822|17923518|P6|Overall Study|Adverse Event|2
5191757|NCT01160822|17923519|P5|Overall Study|Adverse Event|1
5191758|NCT01160822|17923520|P4|Overall Study|Adverse Event|0
5191759|NCT01160822|17923521|P3|Overall Study|Adverse Event|0
5191760|NCT01160822|17923522|P2|Overall Study|Adverse Event|0
5191761|NCT01160822|17923523|P1|Overall Study|Adverse Event|0
5191762|NCT01160770|17923612|P1|Overall Study|Other Reasons|1
5191763|NCT01160770|17923612|P1|Overall Study|Lack of Efficacy|15
5191764|NCT01160770|17923612|P1|Overall Study|Death|9
5191765|NCT01160770|17923612|P1|Overall Study|Study termination or sponsor request|1
5191766|NCT01160770|17923612|P1|Overall Study|Lost to Follow-up|7
5191767|NCT01160770|17923612|P1|Overall Study|Physician Decision|1
5191768|NCT01160770|17923612|P1|Overall Study|Subject/parent/caregiver request|33
5191769|NCT01160770|17923612|P1|Overall Study|Protocol Violation|2
5191770|NCT01160770|17923612|P1|Overall Study|Adverse Event|10
5191771|NCT01160744|17923625|P4|Overall Study|Not meet inclusion/exclusion criteria|0
5191772|NCT01160744|17923626|P3|Overall Study|Not meet inclusion/exclusion criteria|1
5191773|NCT01160744|17923627|P2|Overall Study|Not meet inclusion/exclusion criteria|0
5191774|NCT01160744|17923628|P1|Overall Study|Not meet inclusion/exclusion criteria|0
5191775|NCT01160744|17923625|P4|Overall Study|Withdrawal by Subject|4
5191776|NCT01160744|17923626|P3|Overall Study|Withdrawal by Subject|6
5191777|NCT01160744|17923627|P2|Overall Study|Withdrawal by Subject|5
5191778|NCT01160744|17923628|P1|Overall Study|Withdrawal by Subject|11
5191779|NCT01160640|17923664|P2|Overall Study|Withdrawal by Subject|3
5191780|NCT01160640|17923665|P1|Overall Study|Withdrawal by Subject|0
5191781|NCT01160640|17923664|P2|Overall Study|Incarceration|0
5191782|NCT01160640|17923665|P1|Overall Study|Incarceration|1
5191783|NCT01160640|17923664|P2|Overall Study|Physician Decision|3
5191784|NCT01160640|17923665|P1|Overall Study|Physician Decision|3
5191785|NCT01160614|17923681|P2|Overall Study|Withdrawal by Subject|2
5191786|NCT01160614|17923682|P1|Overall Study|Withdrawal by Subject|0
5191787|NCT01160484|17923730|P1|Overall Study|inclusion/exclusion criteria failure|1
5191788|NCT01160484|17923730|P1|Overall Study|Withdrawal by Subject|2
5191789|NCT01160484|17923730|P1|Overall Study|Adverse Event|6
5191790|NCT01160484|17923730|P1|Overall Study|Lack of Efficacy|9
5191791|NCT01160354|17923783|P3|Overall Study|Death|1
5191792|NCT01160354|17923784|P2|Overall Study|Death|1
5191793|NCT01160354|17923785|P1|Overall Study|Death|0
5191794|NCT01160289|17923804|P6|Post-Randomization Period|Sponsor Decision|0
5191795|NCT01160289|17923805|P5|Post-Randomization Period|Sponsor Decision|0
5191796|NCT01160289|17923806|P4|Post-Randomization Period|Sponsor Decision|0
5191797|NCT01160289|17923807|P3|Post-Randomization Period|Sponsor Decision|0
5191798|NCT01160289|17923808|P2|Post-Randomization Period|Sponsor Decision|1
5191799|NCT01160289|17923809|P1|Post-Randomization Period|Sponsor Decision|0
5191800|NCT01160289|17923804|P6|Post-Randomization Period|Entry Criteria Not Met|0
5191801|NCT01160289|17923805|P5|Post-Randomization Period|Entry Criteria Not Met|0
5191802|NCT01160289|17923806|P4|Post-Randomization Period|Entry Criteria Not Met|2
5191803|NCT01160289|17923807|P3|Post-Randomization Period|Entry Criteria Not Met|2
5191804|NCT01160289|17923808|P2|Post-Randomization Period|Entry Criteria Not Met|2
5191805|NCT01160289|17923809|P1|Post-Randomization Period|Entry Criteria Not Met|0
5191806|NCT01160289|17923804|P6|Post-Randomization Period|Withdrawal by Subject|7
5191807|NCT01160289|17923805|P5|Post-Randomization Period|Withdrawal by Subject|5
5191808|NCT01160289|17923806|P4|Post-Randomization Period|Withdrawal by Subject|8
5191809|NCT01160289|17923807|P3|Post-Randomization Period|Withdrawal by Subject|13
5191810|NCT01160289|17923808|P2|Post-Randomization Period|Withdrawal by Subject|5
5191811|NCT01160289|17923809|P1|Post-Randomization Period|Withdrawal by Subject|0
5191812|NCT01160289|17923804|P6|Post-Randomization Period|Protocol Violation|3
5191813|NCT01160289|17923805|P5|Post-Randomization Period|Protocol Violation|1
5191814|NCT01160289|17923806|P4|Post-Randomization Period|Protocol Violation|0
5191815|NCT01160289|17923807|P3|Post-Randomization Period|Protocol Violation|2
5191816|NCT01160289|17923808|P2|Post-Randomization Period|Protocol Violation|4
5191817|NCT01160289|17923809|P1|Post-Randomization Period|Protocol Violation|0
5191818|NCT01160289|17923804|P6|Post-Randomization Period|Physician Decision|0
5191819|NCT01160289|17923805|P5|Post-Randomization Period|Physician Decision|0
5191820|NCT01160289|17923806|P4|Post-Randomization Period|Physician Decision|0
5191821|NCT01160289|17923807|P3|Post-Randomization Period|Physician Decision|1
5191822|NCT01160289|17923808|P2|Post-Randomization Period|Physician Decision|0
5191823|NCT01160289|17923809|P1|Post-Randomization Period|Physician Decision|0
5191824|NCT01160289|17923804|P6|Post-Randomization Period|Lost to Follow-up|4
5191825|NCT01160289|17923805|P5|Post-Randomization Period|Lost to Follow-up|3
5191826|NCT01160289|17923806|P4|Post-Randomization Period|Lost to Follow-up|5
5191827|NCT01160289|17923807|P3|Post-Randomization Period|Lost to Follow-up|2
5191828|NCT01160289|17923808|P2|Post-Randomization Period|Lost to Follow-up|3
5191829|NCT01160289|17923809|P1|Post-Randomization Period|Lost to Follow-up|0
5191830|NCT01160289|17923804|P6|Post-Randomization Period|Lack of Efficacy|0
5191831|NCT01160289|17923805|P5|Post-Randomization Period|Lack of Efficacy|0
5191832|NCT01160289|17923806|P4|Post-Randomization Period|Lack of Efficacy|3
5191833|NCT01160289|17923807|P3|Post-Randomization Period|Lack of Efficacy|0
5191834|NCT01160289|17923808|P2|Post-Randomization Period|Lack of Efficacy|1
5191835|NCT01160289|17923809|P1|Post-Randomization Period|Lack of Efficacy|0
5191836|NCT01160289|17923804|P6|Post-Randomization Period|Death|0
5191837|NCT01160289|17923805|P5|Post-Randomization Period|Death|0
5191838|NCT01160289|17923806|P4|Post-Randomization Period|Death|1
5191839|NCT01160289|17923807|P3|Post-Randomization Period|Death|0
5191840|NCT01160289|17923808|P2|Post-Randomization Period|Death|0
5191841|NCT01160289|17923809|P1|Post-Randomization Period|Death|0
5191842|NCT01160289|17923804|P6|Post-Randomization Period|Adverse Event|0
5191843|NCT01160289|17923805|P5|Post-Randomization Period|Adverse Event|0
5191844|NCT01160289|17923806|P4|Post-Randomization Period|Adverse Event|2
5191845|NCT01160289|17923807|P3|Post-Randomization Period|Adverse Event|4
5191846|NCT01160289|17923808|P2|Post-Randomization Period|Adverse Event|4
5191847|NCT01160289|17923809|P1|Post-Randomization Period|Adverse Event|0
5191848|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5191849|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5191850|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5191851|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5191852|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5191853|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
5191854|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5191855|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5191856|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5191857|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5191858|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5191859|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
5191860|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
5191861|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
5191862|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
5191863|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
5191864|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
5191865|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
5191866|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
5191867|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
5191868|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
5191869|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
5191870|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
5191871|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
5191872|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5191873|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5191874|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5191875|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5191876|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5191877|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
5191878|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5191879|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5191880|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5191881|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5191882|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5191883|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
5191884|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5191885|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5191886|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5191887|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5191888|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5191889|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
5191890|NCT01160289|17923804|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
5191891|NCT01160289|17923805|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
5191892|NCT01160289|17923806|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
5191893|NCT01160289|17923807|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
5191894|NCT01160289|17923808|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
5191895|NCT01160289|17923809|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
5191896|NCT01160211|17923898|P3|Overall Study|Lost to Follow-up|5
5191897|NCT01160211|17923899|P2|Overall Study|Lost to Follow-up|7
5191898|NCT01160211|17923900|P1|Overall Study|Lost to Follow-up|4
5191899|NCT01160211|17923898|P3|Overall Study|Physician Decision|0
5191900|NCT01160211|17923899|P2|Overall Study|Physician Decision|0
5191901|NCT01160211|17923900|P1|Overall Study|Physician Decision|2
5191902|NCT01160211|17923898|P3|Overall Study|Withdrawal by Subject|3
5191903|NCT01160211|17923899|P2|Overall Study|Withdrawal by Subject|5
5191904|NCT01160211|17923900|P1|Overall Study|Withdrawal by Subject|3
5191905|NCT01160211|17923898|P3|Overall Study|ongoing|79
5191906|NCT01160211|17923899|P2|Overall Study|ongoing|75
5191907|NCT01160211|17923900|P1|Overall Study|ongoing|90
5191908|NCT01160198|17923933|P3|Overall Study|Participant lost drug; withdrew consent|1
5191909|NCT01160198|17923934|P2|Overall Study|Participant lost drug; withdrew consent|0
5191910|NCT01160198|17923935|P1|Overall Study|Participant lost drug; withdrew consent|0
5191911|NCT01160198|17923933|P3|Overall Study|Lost to Follow-up|0
5191912|NCT01160198|17923934|P2|Overall Study|Lost to Follow-up|1
5191913|NCT01160198|17923935|P1|Overall Study|Lost to Follow-up|0
5191914|NCT01160198|17923933|P3|Overall Study|Adverse Event|0
5191915|NCT01160198|17923934|P2|Overall Study|Adverse Event|1
5191916|NCT01160198|17923935|P1|Overall Study|Adverse Event|0
5191917|NCT01160198|17923933|P3|Overall Study|Withdrawal by Subject|0
5191918|NCT01160198|17923934|P2|Overall Study|Withdrawal by Subject|1
5191919|NCT01160198|17923935|P1|Overall Study|Withdrawal by Subject|2
5191920|NCT01159938|17923957|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
5191921|NCT01159938|17923958|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
5191922|NCT01159938|17923959|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
5191923|NCT01159938|17923960|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
5191924|NCT01159938|17923961|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
5191925|NCT01159912|17924024|P3|Overall Study|Withdrawal by Subject|3
5191926|NCT01159912|17924025|P2|Overall Study|Withdrawal by Subject|3
5191927|NCT01159912|17924026|P1|Overall Study|Withdrawal by Subject|10
5191928|NCT01159912|17924024|P3|Overall Study|Physician Decision|3
5191929|NCT01159912|17924025|P2|Overall Study|Physician Decision|0
5191930|NCT01159912|17924026|P1|Overall Study|Physician Decision|0
5191931|NCT01159912|17924024|P3|Overall Study|Lost to Follow-up|0
5191932|NCT01159912|17924025|P2|Overall Study|Lost to Follow-up|0
5191933|NCT01159912|17924026|P1|Overall Study|Lost to Follow-up|4
5191934|NCT01159912|17924024|P3|Overall Study|Protocol Violation|3
5191935|NCT01159912|17924025|P2|Overall Study|Protocol Violation|2
5191936|NCT01159912|17924026|P1|Overall Study|Protocol Violation|1
5191937|NCT01159912|17924024|P3|Overall Study|Lack of Efficacy|14
5191938|NCT01159912|17924025|P2|Overall Study|Lack of Efficacy|15
5191939|NCT01159912|17924026|P1|Overall Study|Lack of Efficacy|23
5191940|NCT01159912|17924024|P3|Overall Study|Adverse Event|3
5191941|NCT01159912|17924025|P2|Overall Study|Adverse Event|2
5191942|NCT01159912|17924026|P1|Overall Study|Adverse Event|2
5191943|NCT01159769|17924049|P1|Overall Study|Adverse Event|1
5191944|NCT01159691|17924069|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
5191945|NCT01159691|17924069|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
5191946|NCT01159691|17924069|P1|Overall Study|Disc. Neupro other & unknown reasons|7
5191947|NCT01159691|17924069|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
5191948|NCT01159691|17924069|P1|Overall Study|Discontinued Neupro due to other reasons|1
5191949|NCT01159691|17924069|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
5191950|NCT01159691|17924069|P1|Overall Study|Unknown reasons|1
5191951|NCT01159691|17924069|P1|Overall Study|Lost to Follow-up|2
5191952|NCT01159665|17924082|P6|Overall Study|Withdrawal by Subject|0
5191953|NCT01159665|17924083|P5|Overall Study|Withdrawal by Subject|0
5191954|NCT01159665|17924084|P4|Overall Study|Withdrawal by Subject|0
5191955|NCT01159665|17924085|P3|Overall Study|Withdrawal by Subject|0
5191956|NCT01159665|17924086|P2|Overall Study|Withdrawal by Subject|1
5191957|NCT01159665|17924087|P1|Overall Study|Withdrawal by Subject|0
5191958|NCT01159600|17924115|P8|Overall Study|Other reason not defined above|3
5191959|NCT01159600|17924116|P7|Overall Study|Other reason not defined above|3
5191960|NCT01159600|17924117|P6|Overall Study|Other reason not defined above|7
5191961|NCT01159600|17924118|P5|Overall Study|Other reason not defined above|5
5191962|NCT01159600|17924119|P4|Overall Study|Other reason not defined above|2
5191963|NCT01159600|17924120|P3|Overall Study|Other reason not defined above|4
5191964|NCT01159600|17924121|P2|Overall Study|Other reason not defined above|0
5191965|NCT01159600|17924122|P1|Overall Study|Other reason not defined above|3
5191966|NCT01159600|17924115|P8|Overall Study|Patient refusal to continue,not due toAE|5
5191967|NCT01159600|17924116|P7|Overall Study|Patient refusal to continue,not due toAE|2
5191968|NCT01159600|17924117|P6|Overall Study|Patient refusal to continue,not due toAE|4
5191969|NCT01159600|17924118|P5|Overall Study|Patient refusal to continue,not due toAE|4
5191970|NCT01159600|17924119|P4|Overall Study|Patient refusal to continue,not due toAE|5
5191971|NCT01159600|17924120|P3|Overall Study|Patient refusal to continue,not due toAE|4
5191972|NCT01159600|17924121|P2|Overall Study|Patient refusal to continue,not due toAE|2
5191973|NCT01159600|17924122|P1|Overall Study|Patient refusal to continue,not due toAE|7
5191974|NCT01159600|17924115|P8|Overall Study|Lost to Follow-up|2
5191975|NCT01159600|17924116|P7|Overall Study|Lost to Follow-up|3
5191976|NCT01159600|17924117|P6|Overall Study|Lost to Follow-up|0
5191977|NCT01159600|17924118|P5|Overall Study|Lost to Follow-up|3
5191978|NCT01159600|17924119|P4|Overall Study|Lost to Follow-up|3
5191979|NCT01159600|17924120|P3|Overall Study|Lost to Follow-up|4
5191980|NCT01159600|17924121|P2|Overall Study|Lost to Follow-up|3
5191981|NCT01159600|17924122|P1|Overall Study|Lost to Follow-up|2
5191982|NCT01159600|17924115|P8|Overall Study|Non compliant with protocol|0
5191983|NCT01159600|17924116|P7|Overall Study|Non compliant with protocol|2
5191984|NCT01159600|17924117|P6|Overall Study|Non compliant with protocol|0
5191985|NCT01159600|17924118|P5|Overall Study|Non compliant with protocol|2
5191986|NCT01159600|17924119|P4|Overall Study|Non compliant with protocol|0
5191987|NCT01159600|17924120|P3|Overall Study|Non compliant with protocol|0
5191988|NCT01159600|17924121|P2|Overall Study|Non compliant with protocol|1
5191989|NCT01159600|17924122|P1|Overall Study|Non compliant with protocol|2
5191990|NCT01159600|17924115|P8|Overall Study|Lack of Efficacy|1
5191991|NCT01159600|17924116|P7|Overall Study|Lack of Efficacy|0
5191992|NCT01159600|17924117|P6|Overall Study|Lack of Efficacy|0
5191993|NCT01159600|17924118|P5|Overall Study|Lack of Efficacy|2
5191994|NCT01159600|17924119|P4|Overall Study|Lack of Efficacy|0
5191995|NCT01159600|17924120|P3|Overall Study|Lack of Efficacy|0
5191996|NCT01159600|17924121|P2|Overall Study|Lack of Efficacy|0
5191997|NCT01159600|17924122|P1|Overall Study|Lack of Efficacy|0
5191998|NCT01159600|17924115|P8|Overall Study|Adverse Event|5
5191999|NCT01159600|17924116|P7|Overall Study|Adverse Event|7
5192000|NCT01159600|17924117|P6|Overall Study|Adverse Event|6
5192001|NCT01159600|17924118|P5|Overall Study|Adverse Event|8
5192002|NCT01159600|17924119|P4|Overall Study|Adverse Event|1
5192003|NCT01159600|17924120|P3|Overall Study|Adverse Event|5
5192004|NCT01159600|17924121|P2|Overall Study|Adverse Event|2
5192005|NCT01159600|17924122|P1|Overall Study|Adverse Event|7
5192006|NCT01159600|17924115|P8|Overall Study|Not treated|2
5192007|NCT01159600|17924116|P7|Overall Study|Not treated|2
5192008|NCT01159600|17924117|P6|Overall Study|Not treated|1
5192009|NCT01159600|17924118|P5|Overall Study|Not treated|0
5192010|NCT01159600|17924119|P4|Overall Study|Not treated|0
5192011|NCT01159600|17924120|P3|Overall Study|Not treated|1
5192012|NCT01159600|17924121|P2|Overall Study|Not treated|0
5192013|NCT01159600|17924122|P1|Overall Study|Not treated|0
5192014|NCT01159574|17924164|P1|Follow Up Phase|still being followed for overall surviva|18
5192015|NCT01159574|17924164|P1|Follow Up Phase|Lost to Follow-up|2
5192016|NCT01159574|17924164|P1|Treatment Phase|still on treatment|2
5192017|NCT01159574|17924164|P1|Treatment Phase|Withdrawal by Subject|7
5192018|NCT01159574|17924164|P1|Treatment Phase|Physician Decision|2
5192019|NCT01159574|17924164|P1|Treatment Phase|Death|6
5192020|NCT01159574|17924164|P1|Treatment Phase|Adverse Event|3
5192021|NCT01159574|17924164|P1|Treatment Phase|non-evaluable/not included in analysis|1
5192022|NCT01159431|17924185|P2|Overall Study|Lack of Efficacy|3
5192023|NCT01159431|17924186|P1|Overall Study|Lack of Efficacy|0
5192024|NCT01159431|17924185|P2|Overall Study|non-compliance|1
5192025|NCT01159431|17924186|P1|Overall Study|non-compliance|1
5192026|NCT01159431|17924185|P2|Overall Study|Adverse Event|2
5192027|NCT01159431|17924186|P1|Overall Study|Adverse Event|1
5192028|NCT01159171|17924239|P1|Overall Study|Death|1
5192029|NCT01159171|17924239|P1|Overall Study|Medical Decision|4
5192030|NCT01159171|17924239|P1|Overall Study|Need for Surgery|5
5192031|NCT01159171|17924239|P1|Overall Study|Protocol Violation|1
5192032|NCT01159171|17924239|P1|Overall Study|Progression of Disease|28
5192033|NCT01159171|17924239|P1|Overall Study|Adverse Event|11
5192034|NCT01158950|17924327|P2|1st Intervention (1 Day)|Physician Decision|2
5192035|NCT01158950|17924328|P1|1st Intervention (1 Day)|Physician Decision|1
5192036|NCT01158924|17924336|P2|Overall Study|Lost to Follow-up|1
5192037|NCT01158924|17924337|P1|Overall Study|Lost to Follow-up|0
5192038|NCT01158924|17924336|P2|Overall Study|Withdrawal by Subject|2
5192039|NCT01158924|17924337|P1|Overall Study|Withdrawal by Subject|1
5192040|NCT01158534|17924442|P1|Overall Study|Other|1
5192041|NCT01158534|17924442|P1|Overall Study|Death|1
5192042|NCT01158534|17924442|P1|Overall Study|Withdrawal by Subject|1
5192043|NCT01158404|17924467|P8|Overall Study|Progressive Disease|0
5192044|NCT01158404|17924468|P7|Overall Study|Progressive Disease|1
5192045|NCT01158404|17924469|P6|Overall Study|Progressive Disease|0
5192046|NCT01158404|17924470|P5|Overall Study|Progressive Disease|0
5192047|NCT01158404|17924471|P4|Overall Study|Progressive Disease|0
5192048|NCT01158404|17924472|P3|Overall Study|Progressive Disease|0
5192049|NCT01158404|17924473|P2|Overall Study|Progressive Disease|0
5192050|NCT01158404|17924474|P1|Overall Study|Progressive Disease|0
5192051|NCT01158404|17924467|P8|Overall Study|Physician Decision|1
5192052|NCT01158404|17924468|P7|Overall Study|Physician Decision|0
5192053|NCT01158404|17924469|P6|Overall Study|Physician Decision|0
5192054|NCT01158404|17924470|P5|Overall Study|Physician Decision|0
5192055|NCT01158404|17924471|P4|Overall Study|Physician Decision|0
5192056|NCT01158404|17924472|P3|Overall Study|Physician Decision|0
5192057|NCT01158404|17924473|P2|Overall Study|Physician Decision|0
5192058|NCT01158404|17924474|P1|Overall Study|Physician Decision|0
5192059|NCT01158404|17924467|P8|Overall Study|Withdrawal by Subject|1
5192060|NCT01158404|17924468|P7|Overall Study|Withdrawal by Subject|0
5192061|NCT01158404|17924469|P6|Overall Study|Withdrawal by Subject|1
5192062|NCT01158404|17924470|P5|Overall Study|Withdrawal by Subject|3
5192063|NCT01158404|17924471|P4|Overall Study|Withdrawal by Subject|0
5192064|NCT01158404|17924472|P3|Overall Study|Withdrawal by Subject|0
5192065|NCT01158404|17924473|P2|Overall Study|Withdrawal by Subject|1
5192066|NCT01158404|17924474|P1|Overall Study|Withdrawal by Subject|0
5192067|NCT01158378|17924516|P2|Overall Study|Withdrawal by Subject|0
5192068|NCT01158378|17924517|P1|Overall Study|Withdrawal by Subject|4
5192069|NCT01158378|17924516|P2|Overall Study|Lost to Follow-up|4
5192070|NCT01158378|17924517|P1|Overall Study|Lost to Follow-up|2
5192071|NCT01158378|17924516|P2|Overall Study|Death|5
5192072|NCT01158378|17924517|P1|Overall Study|Death|4
5192073|NCT01158261|17924529|P1|Overall Study|Withdrawal by Subject|1
5192074|NCT01158261|17924529|P1|Overall Study|Death|7
5192075|NCT01158261|17924529|P1|Overall Study|Lost to Follow-up|9
5192076|NCT01158222|17924533|P1|Overall Study|Not eligible for intermediate phase|17
5192077|NCT01158118|17924545|P2|Overall Study|Death|1
5192078|NCT01158118|17924546|P1|Overall Study|Death|0
5192079|NCT01158118|17924545|P2|Overall Study|Suffered stroke prior to transplant|1
5192080|NCT01158118|17924546|P1|Overall Study|Suffered stroke prior to transplant|0
5192081|NCT01158118|17924545|P2|Overall Study|Donor match was a screen failure|1
5192082|NCT01158118|17924546|P1|Overall Study|Donor match was a screen failure|0
5192083|NCT01158118|17924545|P2|Overall Study|Screen failure|0
5192084|NCT01158118|17924546|P1|Overall Study|Screen failure|1
5192085|NCT01157897|17924566|P4|Overall Study|Relocated|0
5192086|NCT01157897|17924567|P3|Overall Study|Relocated|0
5192087|NCT01157897|17924568|P2|Overall Study|Relocated|2
5192088|NCT01157897|17924569|P1|Overall Study|Relocated|0
5192089|NCT01157897|17924566|P4|Overall Study|Lost to Follow-up|1
5192090|NCT01157897|17924567|P3|Overall Study|Lost to Follow-up|0
5192091|NCT01157897|17924568|P2|Overall Study|Lost to Follow-up|0
5192092|NCT01157897|17924569|P1|Overall Study|Lost to Follow-up|2
5192093|NCT01157845|17924594|P1|Overall Study|Device malfunction|1
5192094|NCT01157845|17924594|P1|Overall Study|Study was ended|1
5192095|NCT01157845|17924594|P1|Overall Study|Protocol Violation|13
5192096|NCT01157845|17924594|P1|Overall Study|Physician Decision|3
5192097|NCT01157845|17924594|P1|Overall Study|Withdrawal by Subject|12
5192098|NCT01157845|17924594|P1|Overall Study|Lost to Follow-up|5
5192099|NCT01157676|17924601|P2|Surgery|underwent robotic cystectomy|0
5192100|NCT01157676|17924602|P1|Surgery|underwent robotic cystectomy|1
5192101|NCT01157676|17924601|P2|Surgery|converted to open procedure|5
5192102|NCT01157676|17924602|P1|Surgery|converted to open procedure|0
5192103|NCT01157676|17924601|P2|Surgery|underwent open cystectomy|4
5192104|NCT01157676|17924602|P1|Surgery|underwent open cystectomy|0
5192105|NCT01157676|17924601|P2|Randomization|Physician Decision|0
5192106|NCT01157676|17924602|P1|Randomization|Physician Decision|1
5192107|NCT01157676|17924601|P2|Randomization|Withdrawal by Subject|13
5192108|NCT01157676|17924602|P1|Randomization|Withdrawal by Subject|17
5192109|NCT01157676|17924601|P2|Randomization|unresectable|3
5192110|NCT01157676|17924602|P1|Randomization|unresectable|2
5192111|NCT01157676|17924601|P2|Randomization|Death|1
5192112|NCT01157676|17924602|P1|Randomization|Death|1
5192113|NCT01157377|17924677|P7|Overall Study|Other Miscellaneous Reasons|1
5192114|NCT01157377|17924678|P6|Overall Study|Other Miscellaneous Reasons|1
5192115|NCT01157377|17924679|P5|Overall Study|Other Miscellaneous Reasons|1
5192116|NCT01157377|17924680|P4|Overall Study|Other Miscellaneous Reasons|0
5192117|NCT01157377|17924681|P3|Overall Study|Other Miscellaneous Reasons|0
5192118|NCT01157377|17924682|P2|Overall Study|Other Miscellaneous Reasons|2
5192119|NCT01157377|17924683|P1|Overall Study|Other Miscellaneous Reasons|0
5192120|NCT01157377|17924677|P7|Overall Study|Lack of Efficacy|1
5192121|NCT01157377|17924678|P6|Overall Study|Lack of Efficacy|0
5192122|NCT01157377|17924679|P5|Overall Study|Lack of Efficacy|0
5192123|NCT01157377|17924680|P4|Overall Study|Lack of Efficacy|0
5192124|NCT01157377|17924681|P3|Overall Study|Lack of Efficacy|0
5192125|NCT01157377|17924682|P2|Overall Study|Lack of Efficacy|0
5192126|NCT01157377|17924683|P1|Overall Study|Lack of Efficacy|0
5192127|NCT01157377|17924677|P7|Overall Study|Protocol Violation|0
5192128|NCT01157377|17924678|P6|Overall Study|Protocol Violation|1
5192129|NCT01157377|17924679|P5|Overall Study|Protocol Violation|0
5192130|NCT01157377|17924680|P4|Overall Study|Protocol Violation|0
5192131|NCT01157377|17924681|P3|Overall Study|Protocol Violation|0
5192132|NCT01157377|17924682|P2|Overall Study|Protocol Violation|0
5192133|NCT01157377|17924683|P1|Overall Study|Protocol Violation|0
5192134|NCT01157377|17924677|P7|Overall Study|Personal Reasons|0
5192135|NCT01157377|17924678|P6|Overall Study|Personal Reasons|0
5192136|NCT01157377|17924679|P5|Overall Study|Personal Reasons|0
5192137|NCT01157377|17924680|P4|Overall Study|Personal Reasons|1
5192138|NCT01157377|17924681|P3|Overall Study|Personal Reasons|0
5192139|NCT01157377|17924682|P2|Overall Study|Personal Reasons|1
5192140|NCT01157377|17924683|P1|Overall Study|Personal Reasons|2
5192141|NCT01157377|17924677|P7|Overall Study|Lost to Follow-up|0
5192142|NCT01157377|17924678|P6|Overall Study|Lost to Follow-up|1
5192143|NCT01157377|17924679|P5|Overall Study|Lost to Follow-up|1
5192144|NCT01157377|17924680|P4|Overall Study|Lost to Follow-up|0
5192145|NCT01157377|17924681|P3|Overall Study|Lost to Follow-up|1
5192146|NCT01157377|17924682|P2|Overall Study|Lost to Follow-up|0
5192147|NCT01157377|17924683|P1|Overall Study|Lost to Follow-up|0
5192148|NCT01157364|17924705|P6|Overall Study|Adverse Event|0
5192149|NCT01157364|17924706|P5|Overall Study|Adverse Event|1
5192150|NCT01157364|17924707|P4|Overall Study|Adverse Event|0
5192151|NCT01157364|17924708|P3|Overall Study|Adverse Event|1
5192152|NCT01157364|17924709|P2|Overall Study|Adverse Event|1
5192153|NCT01157364|17924710|P1|Overall Study|Adverse Event|0
5192154|NCT01157364|17924705|P6|Overall Study|Lack of Efficacy|0
5192155|NCT01157364|17924706|P5|Overall Study|Lack of Efficacy|0
5192156|NCT01157364|17924707|P4|Overall Study|Lack of Efficacy|1
5192157|NCT01157364|17924708|P3|Overall Study|Lack of Efficacy|0
5192158|NCT01157364|17924709|P2|Overall Study|Lack of Efficacy|0
5192159|NCT01157364|17924710|P1|Overall Study|Lack of Efficacy|0
5192160|NCT01157364|17924705|P6|Overall Study|Lost to Follow-up|0
5192161|NCT01157364|17924706|P5|Overall Study|Lost to Follow-up|0
5192162|NCT01157364|17924707|P4|Overall Study|Lost to Follow-up|0
5192163|NCT01157364|17924708|P3|Overall Study|Lost to Follow-up|1
5192164|NCT01157364|17924709|P2|Overall Study|Lost to Follow-up|0
5192165|NCT01157364|17924710|P1|Overall Study|Lost to Follow-up|1
5192166|NCT01157364|17924705|P6|Overall Study|Personal Reasons|1
5192167|NCT01157364|17924706|P5|Overall Study|Personal Reasons|1
5192168|NCT01157364|17924707|P4|Overall Study|Personal Reasons|0
5192169|NCT01157364|17924708|P3|Overall Study|Personal Reasons|0
5192170|NCT01157364|17924709|P2|Overall Study|Personal Reasons|2
5192171|NCT01157364|17924710|P1|Overall Study|Personal Reasons|0
5192172|NCT01157364|17924705|P6|Overall Study|Other Reasons|0
5192173|NCT01157364|17924706|P5|Overall Study|Other Reasons|0
5192174|NCT01157364|17924707|P4|Overall Study|Other Reasons|1
5192175|NCT01157364|17924708|P3|Overall Study|Other Reasons|2
5192176|NCT01157364|17924709|P2|Overall Study|Other Reasons|1
5192177|NCT01157364|17924710|P1|Overall Study|Other Reasons|1
5192178|NCT01157351|17924744|P2|Overall Study|Randomized but not Treated|2
5192179|NCT01157351|17924745|P1|Overall Study|Randomized but not Treated|4
5192180|NCT01157351|17924744|P2|Overall Study|Noncompliance with Study Drug|3
5192181|NCT01157351|17924745|P1|Overall Study|Noncompliance with Study Drug|0
5192182|NCT01157351|17924744|P2|Overall Study|Other|36
5192183|NCT01157351|17924745|P1|Overall Study|Other|32
5192184|NCT01157351|17924744|P2|Overall Study|Protocol Violation|1
5192185|NCT01157351|17924745|P1|Overall Study|Protocol Violation|0
5192186|NCT01157351|17924744|P2|Overall Study|Physician Decision|4
5192187|NCT01157351|17924745|P1|Overall Study|Physician Decision|5
5192188|NCT01157351|17924744|P2|Overall Study|Withdrawal by Subject|27
5192189|NCT01157351|17924745|P1|Overall Study|Withdrawal by Subject|37
5192190|NCT01157351|17924744|P2|Overall Study|Lost to Follow-up|55
5192191|NCT01157351|17924745|P1|Overall Study|Lost to Follow-up|53
5192192|NCT01157351|17924744|P2|Overall Study|Death|0
5192193|NCT01157351|17924745|P1|Overall Study|Death|1
5192194|NCT01157351|17924744|P2|Overall Study|Adverse Event|4
5192195|NCT01157351|17924745|P1|Overall Study|Adverse Event|5
5192196|NCT01157234|17924763|P2|Overall Study|Withdrawal by Subject|0
5192197|NCT01157234|17924764|P1|Overall Study|Withdrawal by Subject|1
5192198|NCT01157182|17924796|P2|Washout of 28 Days|Adverse Event|0
5192199|NCT01157182|17924797|P1|Washout of 28 Days|Adverse Event|2
5192200|NCT01157169|17924845|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
5192201|NCT01157169|17924846|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
5192202|NCT01157169|17924845|P2|First Intervention|Emesis Within 4 hrs of Administration|2
5192203|NCT01157169|17924846|P1|First Intervention|Emesis Within 4 hrs of Administration|4
5192204|NCT01157117|17924865|P3|Overall Study|Unknown (Pending Final Form Submission)|13
5192205|NCT01157117|17924866|P2|Overall Study|Unknown (Pending Final Form Submission)|5
5192206|NCT01157117|17924867|P1|Overall Study|Unknown (Pending Final Form Submission)|4
5192207|NCT01157117|17924865|P3|Overall Study|Lost to Follow-up|1
5192208|NCT01157117|17924866|P2|Overall Study|Lost to Follow-up|0
5192209|NCT01157117|17924867|P1|Overall Study|Lost to Follow-up|0
5192210|NCT01157117|17924865|P3|Overall Study|Lack of Efficacy|0
5192211|NCT01157117|17924866|P2|Overall Study|Lack of Efficacy|1
5192212|NCT01157117|17924867|P1|Overall Study|Lack of Efficacy|1
5192213|NCT01157117|17924865|P3|Overall Study|Withdrawal by Subject|1
5192214|NCT01157117|17924866|P2|Overall Study|Withdrawal by Subject|1
5192215|NCT01157117|17924867|P1|Overall Study|Withdrawal by Subject|4
5192216|NCT01157117|17924865|P3|Overall Study|Dosing Symptoms|0
5192217|NCT01157117|17924866|P2|Overall Study|Dosing Symptoms|4
5192218|NCT01157117|17924867|P1|Overall Study|Dosing Symptoms|0
5192219|NCT01157078|17924908|P2|Overall Study|Other|4
5192220|NCT01157078|17924909|P1|Overall Study|Other|2
5192221|NCT01157078|17924908|P2|Overall Study|Lost to Follow-up|5
5192222|NCT01157078|17924909|P1|Overall Study|Lost to Follow-up|7
5192223|NCT01157078|17924908|P2|Overall Study|Study-specific withdrawal criteria|2
5192224|NCT01157078|17924909|P1|Overall Study|Study-specific withdrawal criteria|2
5192225|NCT01157078|17924908|P2|Overall Study|Lack of Efficacy|0
5192226|NCT01157078|17924909|P1|Overall Study|Lack of Efficacy|2
5192227|NCT01157078|17924908|P2|Overall Study|Condition under investigation worsened|1
5192228|NCT01157078|17924909|P1|Overall Study|Condition under investigation worsened|0
5192229|NCT01157078|17924908|P2|Overall Study|Severe non-compliance to protocol|4
5192230|NCT01157078|17924909|P1|Overall Study|Severe non-compliance to protocol|2
5192231|NCT01157078|17924908|P2|Overall Study|Adverse Event|6
5192232|NCT01157078|17924909|P1|Overall Study|Adverse Event|6
5192233|NCT01157078|17924908|P2|Overall Study|Eligibility criteria not fulfilled|0
5192234|NCT01157078|17924909|P1|Overall Study|Eligibility criteria not fulfilled|2
5192235|NCT01157078|17924908|P2|Overall Study|Withdrawal by Subject|14
5192236|NCT01157078|17924909|P1|Overall Study|Withdrawal by Subject|12
5192237|NCT01157065|17924959|P2|Overall Study|Death|1
5192238|NCT01157065|17924960|P1|Overall Study|Death|0
5192239|NCT01156844|17924981|P4|Overall Study|Protocol deviation|0
5192240|NCT01156844|17924982|P3|Overall Study|Protocol deviation|0
5192241|NCT01156844|17924983|P2|Overall Study|Protocol deviation|0
5192242|NCT01156844|17924984|P1|Overall Study|Protocol deviation|2
5192243|NCT01156844|17924981|P4|Overall Study|Administrative problems|1
5192244|NCT01156844|17924982|P3|Overall Study|Administrative problems|0
5192245|NCT01156844|17924983|P2|Overall Study|Administrative problems|1
5192246|NCT01156844|17924984|P1|Overall Study|Administrative problems|0
5192247|NCT01156844|17924981|P4|Overall Study|Lost to Follow-up|0
5192248|NCT01156844|17924982|P3|Overall Study|Lost to Follow-up|1
5192249|NCT01156844|17924983|P2|Overall Study|Lost to Follow-up|0
5192250|NCT01156844|17924984|P1|Overall Study|Lost to Follow-up|0
5192251|NCT01156844|17924981|P4|Overall Study|Withdrawal by Subject|2
5192252|NCT01156844|17924982|P3|Overall Study|Withdrawal by Subject|2
5192253|NCT01156844|17924983|P2|Overall Study|Withdrawal by Subject|0
5192254|NCT01156844|17924984|P1|Overall Study|Withdrawal by Subject|0
5192255|NCT01156844|17924981|P4|Overall Study|Abnormal test procedure result(s)|2
5192256|NCT01156844|17924982|P3|Overall Study|Abnormal test procedure result(s)|2
5192257|NCT01156844|17924983|P2|Overall Study|Abnormal test procedure result(s)|1
5192258|NCT01156844|17924984|P1|Overall Study|Abnormal test procedure result(s)|0
5192259|NCT01156844|17924981|P4|Overall Study|Adverse Event|1
5192260|NCT01156844|17924982|P3|Overall Study|Adverse Event|1
5192261|NCT01156844|17924983|P2|Overall Study|Adverse Event|0
5192262|NCT01156844|17924984|P1|Overall Study|Adverse Event|0
5192263|NCT01156792|17925018|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
5192264|NCT01156792|17925018|P1|Overall Study|Withdrawal by Subject|9
5192265|NCT01156792|17925018|P1|Overall Study|Physician Decision|3
5192266|NCT01156792|17925018|P1|Overall Study|Lost to Follow-up|3
5192267|NCT01156792|17925018|P1|Overall Study|Protocol Violation|6
5192268|NCT01156792|17925018|P1|Overall Study|Lack of Efficacy|36
5192269|NCT01156792|17925018|P1|Overall Study|Adverse Event|1
5192270|NCT01156714|17925086|P3|Overall Study|Withdrawal by Subject|3
5192271|NCT01156714|17925087|P2|Overall Study|Withdrawal by Subject|4
5192272|NCT01156714|17925088|P1|Overall Study|Withdrawal by Subject|9
5192273|NCT01156675|17925151|P3|Overall Study|No data|2
5192274|NCT01156675|17925152|P2|Overall Study|No data|22
5192275|NCT01156675|17925153|P1|Overall Study|No data|29
5192276|NCT01156675|17925151|P3|Overall Study|Death|0
5192277|NCT01156675|17925152|P2|Overall Study|Death|3
5192278|NCT01156675|17925153|P1|Overall Study|Death|5
5192279|NCT01156532|17925211|P1|Overall Study|Lost to Follow-up|1
5192280|NCT01156532|17925211|P1|Overall Study|Family Reasons|1
5192281|NCT01156480|17925223|P2|Overall Study|change in diagnosis|1
5192282|NCT01156480|17925224|P1|Overall Study|change in diagnosis|0
5192283|NCT01156376|17925253|P3|Overall Study|Withdrawal by Subject|3
5192284|NCT01156376|17925254|P2|Overall Study|Withdrawal by Subject|0
5192285|NCT01156376|17925255|P1|Overall Study|Withdrawal by Subject|0
5192286|NCT01156376|17925253|P3|Overall Study|Adverse Event|1
5192287|NCT01156376|17925254|P2|Overall Study|Adverse Event|0
5192288|NCT01156376|17925255|P1|Overall Study|Adverse Event|1
5192289|NCT01156363|17925476|P1|Overall Study|Other|6
5192290|NCT01156363|17925476|P1|Overall Study|Refused Treatment|4
5192291|NCT01156363|17925476|P1|Overall Study|Failure to Return|1
5192292|NCT01156363|17925476|P1|Overall Study|Insufficient Therapeutic Response|5
5192293|NCT01156363|17925476|P1|Overall Study|Adverse Event|6
5192294|NCT01156311|17925498|P4|6-month Add-on Therapy Period|Other|2
5192295|NCT01156311|17925499|P3|6-month Add-on Therapy Period|Other|1
5192296|NCT01156311|17925500|P2|6-month Add-on Therapy Period|Other|0
5192297|NCT01156311|17925501|P1|6-month Add-on Therapy Period|Other|0
5192298|NCT01156311|17925498|P4|6-month Add-on Therapy Period|Physician Decision|0
5192299|NCT01156311|17925499|P3|6-month Add-on Therapy Period|Physician Decision|1
5192300|NCT01156311|17925500|P2|6-month Add-on Therapy Period|Physician Decision|0
5192301|NCT01156311|17925501|P1|6-month Add-on Therapy Period|Physician Decision|0
5192302|NCT01156311|17925498|P4|6-month Add-on Therapy Period|Disease Activity|2
5192303|NCT01156311|17925499|P3|6-month Add-on Therapy Period|Disease Activity|1
5192304|NCT01156311|17925500|P2|6-month Add-on Therapy Period|Disease Activity|0
5192305|NCT01156311|17925501|P1|6-month Add-on Therapy Period|Disease Activity|0
5192306|NCT01156311|17925498|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
5192307|NCT01156311|17925499|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
5192308|NCT01156311|17925500|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
5192309|NCT01156311|17925501|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
5192310|NCT01156311|17925498|P4|6-month Add-on Therapy Period|Adverse Event|6
5192311|NCT01156311|17925499|P3|6-month Add-on Therapy Period|Adverse Event|7
5192312|NCT01156311|17925500|P2|6-month Add-on Therapy Period|Adverse Event|0
5192313|NCT01156311|17925501|P1|6-month Add-on Therapy Period|Adverse Event|0
5192314|NCT01156311|17925498|P4|2-Month Monotherapy Period|Other|0
5192315|NCT01156311|17925499|P3|2-Month Monotherapy Period|Other|0
5192316|NCT01156311|17925500|P2|2-Month Monotherapy Period|Other|0
5192317|NCT01156311|17925501|P1|2-Month Monotherapy Period|Other|1
5192318|NCT01156311|17925498|P4|2-Month Monotherapy Period|Physician Decision|0
5192319|NCT01156311|17925499|P3|2-Month Monotherapy Period|Physician Decision|0
5192320|NCT01156311|17925500|P2|2-Month Monotherapy Period|Physician Decision|1
5192321|NCT01156311|17925501|P1|2-Month Monotherapy Period|Physician Decision|0
5192322|NCT01156311|17925498|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
5192323|NCT01156311|17925499|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
5192324|NCT01156311|17925500|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
5192325|NCT01156311|17925501|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
5192326|NCT01156142|17925525|P2|Overall Study|Ineligible|1
5192327|NCT01156142|17925526|P1|Overall Study|Ineligible|0
5192328|NCT01156142|17925525|P2|Overall Study|Withdrawal by Subject|6
5192329|NCT01156142|17925526|P1|Overall Study|Withdrawal by Subject|8
5192330|NCT01156116|17925544|P2|Overall Study|CPAP intolerance|0
5192331|NCT01156116|17925545|P1|Overall Study|CPAP intolerance|2
5192332|NCT01156116|17925544|P2|Overall Study|Withdrawal by Subject|1
5192333|NCT01156116|17925545|P1|Overall Study|Withdrawal by Subject|3
5192334|NCT01156051|17925559|P2|Overall Study|patient not compliant with protocol|1
5192335|NCT01156051|17925560|P1|Overall Study|patient not compliant with protocol|0
5192336|NCT01156051|17925559|P2|Overall Study|Lost to Follow-up|0
5192337|NCT01156051|17925560|P1|Overall Study|Lost to Follow-up|1
5192338|NCT01156012|17925574|P2|Overall Study|Non respect of one of inclusion criteria|1
5192339|NCT01156012|17925575|P1|Overall Study|Non respect of one of inclusion criteria|2
5192340|NCT01156012|17925574|P2|Overall Study|use of commercial drug instead of study|1
5192341|NCT01156012|17925575|P1|Overall Study|use of commercial drug instead of study|0
5192342|NCT01156012|17925574|P2|Overall Study|Withdrawal by Subject|0
5192343|NCT01156012|17925575|P1|Overall Study|Withdrawal by Subject|1
5192344|NCT01156012|17925574|P2|Overall Study|Lost to Follow-up|0
5192345|NCT01156012|17925575|P1|Overall Study|Lost to Follow-up|1
5192346|NCT01156012|17925574|P2|Overall Study|Adverse Event|1
5192347|NCT01156012|17925575|P1|Overall Study|Adverse Event|3
5192348|NCT01155869|17925592|P2|Overall Study|Lost to Follow-up|1
5192349|NCT01155869|17925593|P1|Overall Study|Lost to Follow-up|3
5192350|NCT01155726|17925702|P4|Period 1, 3 Days (Masked)|Inconvenience|0
5192351|NCT01155726|17925703|P3|Period 1, 3 Days (Masked)|Inconvenience|2
5192352|NCT01155726|17925704|P2|Period 1, 3 Days (Masked)|Inconvenience|0
5192353|NCT01155726|17925705|P1|Period 1, 3 Days (Masked)|Inconvenience|1
5192354|NCT01155661|17925727|P1|Overall Study|Sponsor Decision|13
5192355|NCT01155661|17925727|P1|Overall Study|Withdrawal by Subject|73
5192356|NCT01155661|17925727|P1|Overall Study|Protocol Violation|35
5192357|NCT01155661|17925727|P1|Overall Study|Physician Decision|3
5192358|NCT01155661|17925727|P1|Overall Study|Lost to Follow-up|22
5192359|NCT01155661|17925727|P1|Overall Study|Lack of Efficacy|32
5192360|NCT01155661|17925727|P1|Overall Study|Death|1
5192361|NCT01155661|17925727|P1|Overall Study|Adverse Event|101
5192362|NCT01155583|17925762|P9|Phase I|Withdrawal by Subject|0
5192363|NCT01155583|17925763|P8|Phase I|Withdrawal by Subject|1
5192364|NCT01155583|17925764|P7|Phase I|Withdrawal by Subject|0
5192365|NCT01155583|17925765|P6|Phase I|Withdrawal by Subject|0
5192366|NCT01155583|17925766|P5|Phase I|Withdrawal by Subject|0
5192367|NCT01155583|17925767|P4|Phase I|Withdrawal by Subject|0
5192368|NCT01155583|17925768|P3|Phase I|Withdrawal by Subject|0
5192369|NCT01155583|17925769|P2|Phase I|Withdrawal by Subject|0
5192370|NCT01155583|17925770|P1|Phase I|Withdrawal by Subject|0
5192371|NCT01155583|17925762|P9|Phase I|Screen failure - did not start treatment|0
5192372|NCT01155583|17925763|P8|Phase I|Screen failure - did not start treatment|2
5192373|NCT01155583|17925764|P7|Phase I|Screen failure - did not start treatment|0
5192374|NCT01155583|17925765|P6|Phase I|Screen failure - did not start treatment|0
5192375|NCT01155583|17925766|P5|Phase I|Screen failure - did not start treatment|1
5192376|NCT01155583|17925767|P4|Phase I|Screen failure - did not start treatment|0
5192377|NCT01155583|17925768|P3|Phase I|Screen failure - did not start treatment|0
5192378|NCT01155583|17925769|P2|Phase I|Screen failure - did not start treatment|0
5192379|NCT01155583|17925770|P1|Phase I|Screen failure - did not start treatment|0
5192380|NCT01155570|17925789|P1|Overall Study|Other Reasons|23
5192381|NCT01155570|17925789|P1|Overall Study|Participant's Economic Reasons + Other|1
5192382|NCT01155570|17925789|P1|Overall Study|Adverse Event + Other Reasons|7
5192383|NCT01155570|17925789|P1|Overall Study|Adverse Event + Lack of Efficacy|2
5192384|NCT01155570|17925789|P1|Overall Study|No Hospital Visits|7
5192385|NCT01155570|17925789|P1|Overall Study|Participant's Economic Reasons|17
5192386|NCT01155570|17925789|P1|Overall Study|Lack of Efficacy|46
5192387|NCT01155570|17925789|P1|Overall Study|Adverse Event|39
5192388|NCT01155531|17925823|P4|Overall Study|Withdrawal by Subject|0
5192389|NCT01155531|17925824|P3|Overall Study|Withdrawal by Subject|1
5192390|NCT01155531|17925825|P2|Overall Study|Withdrawal by Subject|0
5192391|NCT01155531|17925826|P1|Overall Study|Withdrawal by Subject|1
5192392|NCT01155531|17925823|P4|Overall Study|Lost to Follow-up|1
5192393|NCT01155531|17925824|P3|Overall Study|Lost to Follow-up|0
5192394|NCT01155531|17925825|P2|Overall Study|Lost to Follow-up|0
5192395|NCT01155531|17925826|P1|Overall Study|Lost to Follow-up|0
5192396|NCT01155531|17925823|P4|Overall Study|Adverse Event|0
5192397|NCT01155531|17925824|P3|Overall Study|Adverse Event|1
5192398|NCT01155531|17925825|P2|Overall Study|Adverse Event|0
5192399|NCT01155531|17925826|P1|Overall Study|Adverse Event|0
5192400|NCT01155479|17925874|P5|Part II|Non-Compliance with Protocol|0
5192401|NCT01155479|17925875|P4|Part II|Non-Compliance with Protocol|2
5192402|NCT01155479|17925876|P3|Part II|Non-Compliance with Protocol|0
5192403|NCT01155479|17925877|P2|Part II|Non-Compliance with Protocol|1
5192404|NCT01155479|17925878|P1|Part II|Non-Compliance with Protocol|0
5192405|NCT01155479|17925874|P5|Part II|Treatment Failure|1
5192406|NCT01155479|17925875|P4|Part II|Treatment Failure|0
5192407|NCT01155479|17925876|P3|Part II|Treatment Failure|2
5192408|NCT01155479|17925877|P2|Part II|Treatment Failure|1
5192409|NCT01155479|17925878|P1|Part II|Treatment Failure|0
5192410|NCT01155479|17925874|P5|Part II|Lost to Follow-up|1
5192411|NCT01155479|17925875|P4|Part II|Lost to Follow-up|0
5192412|NCT01155479|17925876|P3|Part II|Lost to Follow-up|0
5192413|NCT01155479|17925877|P2|Part II|Lost to Follow-up|0
5192414|NCT01155479|17925878|P1|Part II|Lost to Follow-up|1
5192415|NCT01155479|17925874|P5|Part II|Withdrawal by Subject|3
5192416|NCT01155479|17925875|P4|Part II|Withdrawal by Subject|7
5192417|NCT01155479|17925876|P3|Part II|Withdrawal by Subject|12
5192418|NCT01155479|17925877|P2|Part II|Withdrawal by Subject|4
5192419|NCT01155479|17925878|P1|Part II|Withdrawal by Subject|8
5192420|NCT01155479|17925874|P5|Part II|Administrative|46
5192421|NCT01155479|17925875|P4|Part II|Administrative|38
5192422|NCT01155479|17925876|P3|Part II|Administrative|36
5192423|NCT01155479|17925877|P2|Part II|Administrative|49
5192424|NCT01155479|17925878|P1|Part II|Administrative|43
5192425|NCT01155479|17925874|P5|Part II|Adverse Event|4
5192426|NCT01155479|17925875|P4|Part II|Adverse Event|3
5192427|NCT01155479|17925876|P3|Part II|Adverse Event|8
5192428|NCT01155479|17925877|P2|Part II|Adverse Event|6
5192429|NCT01155479|17925878|P1|Part II|Adverse Event|7
5192430|NCT01155479|17925874|P5|Part I|Non-Compliance with Protocol|2
5192431|NCT01155479|17925875|P4|Part I|Non-Compliance with Protocol|3
5192432|NCT01155479|17925876|P3|Part I|Non-Compliance with Protocol|3
5192433|NCT01155479|17925877|P2|Part I|Non-Compliance with Protocol|1
5192434|NCT01155479|17925878|P1|Part I|Non-Compliance with Protocol|2
5192435|NCT01155479|17925874|P5|Part I|Did Not Receive Treatment|1
5192436|NCT01155479|17925875|P4|Part I|Did Not Receive Treatment|6
5192437|NCT01155479|17925876|P3|Part I|Did Not Receive Treatment|2
5192438|NCT01155479|17925877|P2|Part I|Did Not Receive Treatment|2
5192439|NCT01155479|17925878|P1|Part I|Did Not Receive Treatment|4
5192440|NCT01155479|17925874|P5|Part I|Treatment Failure|2
5192441|NCT01155479|17925875|P4|Part I|Treatment Failure|1
5192442|NCT01155479|17925876|P3|Part I|Treatment Failure|3
5192443|NCT01155479|17925877|P2|Part I|Treatment Failure|0
5192444|NCT01155479|17925878|P1|Part I|Treatment Failure|3
5192445|NCT01155479|17925874|P5|Part I|Lost to Follow-up|0
5192446|NCT01155479|17925875|P4|Part I|Lost to Follow-up|1
5192447|NCT01155479|17925876|P3|Part I|Lost to Follow-up|1
5192448|NCT01155479|17925877|P2|Part I|Lost to Follow-up|0
5192449|NCT01155479|17925878|P1|Part I|Lost to Follow-up|0
5192450|NCT01155479|17925874|P5|Part I|Withdrawal by Subject|9
5192451|NCT01155479|17925875|P4|Part I|Withdrawal by Subject|8
5192452|NCT01155479|17925876|P3|Part I|Withdrawal by Subject|8
5192453|NCT01155479|17925877|P2|Part I|Withdrawal by Subject|13
5192454|NCT01155479|17925878|P1|Part I|Withdrawal by Subject|11
5192455|NCT01155479|17925874|P5|Part I|Did Not Meet Protocol Eligibility|3
5192456|NCT01155479|17925875|P4|Part I|Did Not Meet Protocol Eligibility|1
5192457|NCT01155479|17925876|P3|Part I|Did Not Meet Protocol Eligibility|2
5192458|NCT01155479|17925877|P2|Part I|Did Not Meet Protocol Eligibility|1
5192459|NCT01155479|17925878|P1|Part I|Did Not Meet Protocol Eligibility|3
5192460|NCT01155479|17925874|P5|Part I|Administrative|0
5192461|NCT01155479|17925875|P4|Part I|Administrative|0
5192462|NCT01155479|17925876|P3|Part I|Administrative|2
5192463|NCT01155479|17925877|P2|Part I|Administrative|2
5192464|NCT01155479|17925878|P1|Part I|Administrative|2
5192465|NCT01155479|17925874|P5|Part I|Adverse Event|6
5192466|NCT01155479|17925875|P4|Part I|Adverse Event|7
5192467|NCT01155479|17925876|P3|Part I|Adverse Event|18
5192468|NCT01155479|17925877|P2|Part I|Adverse Event|8
5192469|NCT01155479|17925878|P1|Part I|Adverse Event|13
5192470|NCT01155466|17925930|P5|Overall Study|Randomized not treated|2
5192471|NCT01155466|17925931|P4|Overall Study|Randomized not treated|0
5192472|NCT01155466|17925932|P3|Overall Study|Randomized not treated|3
5192473|NCT01155466|17925933|P2|Overall Study|Randomized not treated|2
5192474|NCT01155466|17925934|P1|Overall Study|Randomized not treated|2
5192475|NCT01155466|17925930|P5|Overall Study|Administrative|0
5192476|NCT01155466|17925931|P4|Overall Study|Administrative|0
5192477|NCT01155466|17925932|P3|Overall Study|Administrative|0
5192478|NCT01155466|17925933|P2|Overall Study|Administrative|3
5192479|NCT01155466|17925934|P1|Overall Study|Administrative|0
5192480|NCT01155466|17925930|P5|Overall Study|Protocol Violation|1
5192481|NCT01155466|17925931|P4|Overall Study|Protocol Violation|0
5192482|NCT01155466|17925932|P3|Overall Study|Protocol Violation|2
5192483|NCT01155466|17925933|P2|Overall Study|Protocol Violation|0
5192484|NCT01155466|17925934|P1|Overall Study|Protocol Violation|0
5192485|NCT01155466|17925930|P5|Overall Study|Withdrawal by Subject|4
5192486|NCT01155466|17925931|P4|Overall Study|Withdrawal by Subject|4
5192487|NCT01155466|17925932|P3|Overall Study|Withdrawal by Subject|9
5192488|NCT01155466|17925933|P2|Overall Study|Withdrawal by Subject|5
5192489|NCT01155466|17925934|P1|Overall Study|Withdrawal by Subject|7
5192490|NCT01155466|17925930|P5|Overall Study|Lost to Follow-up|2
5192491|NCT01155466|17925931|P4|Overall Study|Lost to Follow-up|0
5192492|NCT01155466|17925932|P3|Overall Study|Lost to Follow-up|0
5192493|NCT01155466|17925933|P2|Overall Study|Lost to Follow-up|0
5192494|NCT01155466|17925934|P1|Overall Study|Lost to Follow-up|0
5192495|NCT01155466|17925930|P5|Overall Study|Adverse Event|18
5192496|NCT01155466|17925931|P4|Overall Study|Adverse Event|17
5192497|NCT01155466|17925932|P3|Overall Study|Adverse Event|6
5192498|NCT01155466|17925933|P2|Overall Study|Adverse Event|15
5192499|NCT01155466|17925934|P1|Overall Study|Adverse Event|13
5192500|NCT01155388|17925988|P2|Overall Study|Adverse Event|0
5192501|NCT01155388|17925989|P1|Overall Study|Adverse Event|1
5192502|NCT01155375|17925999|P2|Overall Study|Adverse Event|0
5192503|NCT01155375|17926000|P1|Overall Study|Adverse Event|1
5192504|NCT01155323|17926019|P2|Second Intervention|Lost to Follow-up|1
5192505|NCT01155323|17926020|P1|Second Intervention|Lost to Follow-up|1
5192506|NCT01155323|17926019|P2|First Intervention|exclusion criteria|1
5192507|NCT01155323|17926020|P1|First Intervention|exclusion criteria|1
5192508|NCT01155284|17926038|P2|Overall Study|Adverse Event|0
5192509|NCT01155284|17926039|P1|Overall Study|Adverse Event|1
5192510|NCT01155284|17926038|P2|Overall Study|Physician Decision|0
5192511|NCT01155284|17926039|P1|Overall Study|Physician Decision|1
5192512|NCT01155284|17926038|P2|Overall Study|Lost to Follow-up|2
5192513|NCT01155284|17926039|P1|Overall Study|Lost to Follow-up|1
5192514|NCT01155284|17926038|P2|Overall Study|Withdrawal by Subject|3
5192515|NCT01155284|17926039|P1|Overall Study|Withdrawal by Subject|4
5192516|NCT01155219|17926049|P2|Overall Study|non-medical reason|2
5192517|NCT01155219|17926050|P1|Overall Study|non-medical reason|1
5192518|NCT01155219|17926049|P2|Overall Study|Adverse Event|1
5192519|NCT01155219|17926050|P1|Overall Study|Adverse Event|3
5192520|NCT01155167|17926099|P2|Overall Study|Access site changed to femoral artery|0
5192521|NCT01155167|17926100|P1|Overall Study|Access site changed to femoral artery|1
5192522|NCT01155167|17926099|P2|Overall Study|Insufficient ultrasound data|0
5192523|NCT01155167|17926100|P1|Overall Study|Insufficient ultrasound data|2
5192524|NCT01155141|17926123|P1|Overall Study|Screen Failure|1
5192525|NCT01155141|17926123|P1|Overall Study|Withdrawal by Subject|1
5192526|NCT01155063|17926135|P1|Overall Study|Study terminated by sponsor|87
5192527|NCT01155063|17926135|P1|Overall Study|Withdrawal by Subject|1
5192528|NCT01155063|17926135|P1|Overall Study|Adverse Event|1
5192529|NCT01155024|17926145|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
5192530|NCT01155024|17926146|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
5192531|NCT01155024|17926145|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
5192532|NCT01155024|17926146|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
5192533|NCT01155024|17926145|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
5192534|NCT01155024|17926146|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
5192535|NCT01155011|17926156|P2|6 to 12 Months|Death|5
5192536|NCT01155011|17926157|P1|6 to 12 Months|Death|1
5192537|NCT01155011|17926156|P2|6 to 12 Months|Withdrawal by Subject|5
5192538|NCT01155011|17926157|P1|6 to 12 Months|Withdrawal by Subject|8
5192539|NCT01155011|17926156|P2|Baseline to 6 Months|Death|1
5192540|NCT01155011|17926157|P1|Baseline to 6 Months|Death|0
5192541|NCT01155011|17926156|P2|Baseline to 6 Months|investigator decision, moved|5
5192542|NCT01155011|17926157|P1|Baseline to 6 Months|investigator decision, moved|4
5192543|NCT01155011|17926156|P2|Baseline to 6 Months|Withdrawal by Subject|19
5192544|NCT01155011|17926157|P1|Baseline to 6 Months|Withdrawal by Subject|18
5192545|NCT01154816|17926198|P12|Overall Study|Adverse Event|0
5192546|NCT01154816|17926199|P11|Overall Study|Adverse Event|0
5192547|NCT01154816|17926200|P10|Overall Study|Adverse Event|0
5192548|NCT01154816|17926201|P9|Overall Study|Adverse Event|0
5192549|NCT01154816|17926202|P8|Overall Study|Adverse Event|1
5192550|NCT01154816|17926203|P7|Overall Study|Adverse Event|1
5192551|NCT01154816|17926204|P6|Overall Study|Adverse Event|0
5192552|NCT01154816|17926205|P5|Overall Study|Adverse Event|0
5192553|NCT01154816|17926206|P4|Overall Study|Adverse Event|0
5192554|NCT01154816|17926207|P3|Overall Study|Adverse Event|0
5192555|NCT01154816|17926208|P2|Overall Study|Adverse Event|2
5192556|NCT01154816|17926209|P1|Overall Study|Adverse Event|5
5192557|NCT01154816|17926198|P12|Overall Study|Physician Decision|1
5192558|NCT01154816|17926199|P11|Overall Study|Physician Decision|1
5192559|NCT01154816|17926200|P10|Overall Study|Physician Decision|1
5192560|NCT01154816|17926201|P9|Overall Study|Physician Decision|0
5192561|NCT01154816|17926202|P8|Overall Study|Physician Decision|0
5192562|NCT01154816|17926203|P7|Overall Study|Physician Decision|0
5192563|NCT01154816|17926204|P6|Overall Study|Physician Decision|0
5192564|NCT01154816|17926205|P5|Overall Study|Physician Decision|2
5192565|NCT01154816|17926206|P4|Overall Study|Physician Decision|0
5192566|NCT01154816|17926207|P3|Overall Study|Physician Decision|1
5192567|NCT01154816|17926208|P2|Overall Study|Physician Decision|0
5192568|NCT01154816|17926209|P1|Overall Study|Physician Decision|1
5192569|NCT01154816|17926198|P12|Overall Study|Progressive Disease|3
5192570|NCT01154816|17926199|P11|Overall Study|Progressive Disease|10
5192571|NCT01154816|17926200|P10|Overall Study|Progressive Disease|6
5192572|NCT01154816|17926201|P9|Overall Study|Progressive Disease|8
5192573|NCT01154816|17926202|P8|Overall Study|Progressive Disease|6
5192574|NCT01154816|17926203|P7|Overall Study|Progressive Disease|5
5192575|NCT01154816|17926204|P6|Overall Study|Progressive Disease|8
5192576|NCT01154816|17926205|P5|Overall Study|Progressive Disease|8
5192577|NCT01154816|17926206|P4|Overall Study|Progressive Disease|9
5192578|NCT01154816|17926207|P3|Overall Study|Progressive Disease|9
5192579|NCT01154816|17926208|P2|Overall Study|Progressive Disease|8
5192580|NCT01154816|17926209|P1|Overall Study|Progressive Disease|13
5192581|NCT01154816|17926198|P12|Overall Study|Withdrawal by Subject|0
5192582|NCT01154816|17926199|P11|Overall Study|Withdrawal by Subject|0
5192583|NCT01154816|17926200|P10|Overall Study|Withdrawal by Subject|3
5192584|NCT01154816|17926201|P9|Overall Study|Withdrawal by Subject|1
5192585|NCT01154816|17926202|P8|Overall Study|Withdrawal by Subject|0
5192586|NCT01154816|17926203|P7|Overall Study|Withdrawal by Subject|0
5192587|NCT01154816|17926204|P6|Overall Study|Withdrawal by Subject|0
5192588|NCT01154816|17926205|P5|Overall Study|Withdrawal by Subject|0
5192589|NCT01154816|17926206|P4|Overall Study|Withdrawal by Subject|1
5192590|NCT01154816|17926207|P3|Overall Study|Withdrawal by Subject|0
5192591|NCT01154816|17926208|P2|Overall Study|Withdrawal by Subject|0
5192592|NCT01154816|17926209|P1|Overall Study|Withdrawal by Subject|1
5192593|NCT01154673|17926286|P2|Overall Study|moved out of province|0
5192594|NCT01154673|17926287|P1|Overall Study|moved out of province|1
5192595|NCT01154673|17926286|P2|Overall Study|Lost to Follow-up|0
5192596|NCT01154673|17926287|P1|Overall Study|Lost to Follow-up|1
5192597|NCT01154452|17926342|P4|Phase II|Adverse Event|4
5192598|NCT01154452|17926343|P3|Phase II|Adverse Event|4
5192599|NCT01154452|17926344|P2|Phase II|Adverse Event|0
5192600|NCT01154452|17926345|P1|Phase II|Adverse Event|0
5192601|NCT01154452|17926342|P4|Phase II|Withdrawal by Subject|2
5192602|NCT01154452|17926343|P3|Phase II|Withdrawal by Subject|1
5192603|NCT01154452|17926344|P2|Phase II|Withdrawal by Subject|0
5192604|NCT01154452|17926345|P1|Phase II|Withdrawal by Subject|0
5192605|NCT01154452|17926342|P4|Phase Ib|Adverse Event|0
5192606|NCT01154452|17926343|P3|Phase Ib|Adverse Event|0
5192607|NCT01154452|17926344|P2|Phase Ib|Adverse Event|1
5192608|NCT01154452|17926345|P1|Phase Ib|Adverse Event|2
5192609|NCT01154452|17926342|P4|Phase Ib|Not Treated|0
5192610|NCT01154452|17926343|P3|Phase Ib|Not Treated|0
5192611|NCT01154452|17926344|P2|Phase Ib|Not Treated|0
5192612|NCT01154452|17926345|P1|Phase Ib|Not Treated|1
5192613|NCT01154296|17926377|P2|6-month Follow-up|Declined by Study Coordinator|4
5192614|NCT01154296|17926378|P1|6-month Follow-up|Declined by Study Coordinator|5
5192615|NCT01154296|17926377|P2|6-month Follow-up|Death|2
5192616|NCT01154296|17926378|P1|6-month Follow-up|Death|3
5192617|NCT01154296|17926377|P2|6-month Follow-up|Withdrew consent|15
5192618|NCT01154296|17926378|P1|6-month Follow-up|Withdrew consent|14
5192619|NCT01154296|17926377|P2|6-month Follow-up|Incarcerated|32
5192620|NCT01154296|17926378|P1|6-month Follow-up|Incarcerated|37
5192621|NCT01154296|17926377|P2|6-month Follow-up|Lost contact|275
5192622|NCT01154296|17926378|P1|6-month Follow-up|Lost contact|269
5192623|NCT01154296|17926377|P2|Randomization and Intervention|Left clinic early|0
5192624|NCT01154296|17926378|P1|Randomization and Intervention|Left clinic early|2
5192625|NCT01154296|17926377|P2|Randomization and Intervention|Left before test|1
5192626|NCT01154296|17926378|P1|Randomization and Intervention|Left before test|0
5192627|NCT01154296|17926377|P2|Randomization and Intervention|Did not return|0
5192628|NCT01154296|17926378|P1|Randomization and Intervention|Did not return|1
5192629|NCT01154296|17926377|P2|Randomization and Intervention|Declined by staff|0
5192630|NCT01154296|17926378|P1|Randomization and Intervention|Declined by staff|1
5192631|NCT01154296|17926377|P2|Randomization and Intervention|Decided to decline|1
5192632|NCT01154296|17926378|P1|Randomization and Intervention|Decided to decline|1
5192633|NCT01154283|17926396|P2|7-12 Weeks|Withdrawal by Subject|1
5192634|NCT01154283|17926397|P1|7-12 Weeks|Withdrawal by Subject|0
5192635|NCT01154283|17926396|P2|7-12 Weeks|Death|0
5192636|NCT01154283|17926397|P1|7-12 Weeks|Death|1
5192637|NCT01154283|17926396|P2|0-6 Weeks|Death|1
5192638|NCT01154283|17926397|P1|0-6 Weeks|Death|0
5192639|NCT01154283|17926396|P2|0-6 Weeks|Withdrawal by Subject|2
5192640|NCT01154283|17926397|P1|0-6 Weeks|Withdrawal by Subject|7
5192641|NCT01154231|17926409|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
5192642|NCT01154231|17926409|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
5192643|NCT01154218|17926415|P4|Fourth Intervention Period|Withdrawal by Subject|0
5192644|NCT01154218|17926416|P3|Fourth Intervention Period|Withdrawal by Subject|0
5192645|NCT01154218|17926417|P2|Fourth Intervention Period|Withdrawal by Subject|0
5192646|NCT01154218|17926418|P1|Fourth Intervention Period|Withdrawal by Subject|1
5192647|NCT01154218|17926415|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
5192648|NCT01154218|17926416|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5192649|NCT01154218|17926417|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5192650|NCT01154218|17926418|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5192651|NCT01154218|17926415|P4|Third Intervention Period|Adverse Event|0
5192652|NCT01154218|17926416|P3|Third Intervention Period|Adverse Event|0
5192653|NCT01154218|17926417|P2|Third Intervention Period|Adverse Event|1
5192654|NCT01154218|17926418|P1|Third Intervention Period|Adverse Event|0
5192655|NCT01154166|17926492|P2|Overall Study|Poor Compliance|0
5192656|NCT01154166|17926493|P1|Overall Study|Poor Compliance|1
5192657|NCT01154166|17926492|P2|Overall Study|Disease Progression|0
5192658|NCT01154166|17926493|P1|Overall Study|Disease Progression|1
5192659|NCT01154166|17926492|P2|Overall Study|Lack of Efficacy|0
5192660|NCT01154166|17926493|P1|Overall Study|Lack of Efficacy|3
5192661|NCT01154166|17926492|P2|Overall Study|Withdrawal by Subject|1
5192662|NCT01154166|17926493|P1|Overall Study|Withdrawal by Subject|10
5192663|NCT01154166|17926492|P2|Overall Study|Protocol Violation|1
5192664|NCT01154166|17926493|P1|Overall Study|Protocol Violation|4
5192665|NCT01154166|17926492|P2|Overall Study|Lost to Follow-up|1
5192666|NCT01154166|17926493|P1|Overall Study|Lost to Follow-up|1
5192667|NCT01154166|17926492|P2|Overall Study|Adverse Event|9
5192668|NCT01154166|17926493|P1|Overall Study|Adverse Event|14
5192669|NCT01154153|17926525|P2|Overall Study|Withdrew consent|0
5192670|NCT01154153|17926526|P1|Overall Study|Withdrew consent|1
5192671|NCT01154153|17926525|P2|Overall Study|Unable to use labs|3
5192672|NCT01154153|17926526|P1|Overall Study|Unable to use labs|2
5192673|NCT01154153|17926525|P2|Overall Study|Poor compliance to protocol|0
5192674|NCT01154153|17926526|P1|Overall Study|Poor compliance to protocol|2
5192675|NCT01154140|17926544|P2|Overall Study|Randomized but not treated|2
5192676|NCT01154140|17926545|P1|Overall Study|Randomized but not treated|1
5192677|NCT01154140|17926544|P2|Overall Study|Other|1
5192678|NCT01154140|17926545|P1|Overall Study|Other|3
5192679|NCT01154140|17926544|P2|Overall Study|Withdrawal by Subject|13
5192680|NCT01154140|17926545|P1|Overall Study|Withdrawal by Subject|12
5192681|NCT01154140|17926544|P2|Overall Study|Lost to Follow-up|5
5192682|NCT01154140|17926545|P1|Overall Study|Lost to Follow-up|4
5192683|NCT01154140|17926544|P2|Overall Study|Death|81
5192684|NCT01154140|17926545|P1|Overall Study|Death|71
5192685|NCT01154127|17926598|P2|Period 2 (21 Days)|Protocol Deviation|1
5192686|NCT01154127|17926599|P1|Period 2 (21 Days)|Protocol Deviation|0
5192687|NCT01154127|17926598|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
5192688|NCT01154127|17926599|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
5192689|NCT01154127|17926598|P2|Washout (14 - 28 Days)|Adverse Event|0
5192690|NCT01154127|17926599|P1|Washout (14 - 28 Days)|Adverse Event|2
5192691|NCT01154127|17926598|P2|Period 1 (21 Days)|Withdrawal by Subject|2
5192692|NCT01154127|17926599|P1|Period 1 (21 Days)|Withdrawal by Subject|0
5192693|NCT01154127|17926598|P2|Period 1 (21 Days)|Adverse Event|4
5192694|NCT01154127|17926599|P1|Period 1 (21 Days)|Adverse Event|3
5192695|NCT01154101|17926626|P5|Overall Study|Withdrawal by Subject|1
5192696|NCT01154101|17926627|P4|Overall Study|Withdrawal by Subject|0
5192697|NCT01154101|17926628|P3|Overall Study|Withdrawal by Subject|2
5192698|NCT01154101|17926629|P2|Overall Study|Withdrawal by Subject|1
5192699|NCT01154101|17926630|P1|Overall Study|Withdrawal by Subject|0
5192700|NCT01154101|17926626|P5|Overall Study|Lost to Follow-up|0
5192701|NCT01154101|17926627|P4|Overall Study|Lost to Follow-up|1
5192702|NCT01154101|17926628|P3|Overall Study|Lost to Follow-up|0
5192703|NCT01154101|17926629|P2|Overall Study|Lost to Follow-up|1
5192704|NCT01154101|17926630|P1|Overall Study|Lost to Follow-up|0
5192705|NCT01154101|17926626|P5|Overall Study|Adverse Event|0
5192706|NCT01154101|17926627|P4|Overall Study|Adverse Event|1
5192707|NCT01154101|17926628|P3|Overall Study|Adverse Event|1
5192708|NCT01154101|17926629|P2|Overall Study|Adverse Event|2
5192709|NCT01154101|17926630|P1|Overall Study|Adverse Event|0
5192710|NCT01154088|17926685|P3|Overall Study|Lost to Follow-up|7
5192711|NCT01154088|17926686|P2|Overall Study|Lost to Follow-up|6
5192712|NCT01154088|17926687|P1|Overall Study|Lost to Follow-up|4
5192713|NCT01154036|17926727|P8|Phase II|Withdrawal by Subject|4
5192714|NCT01154036|17926728|P7|Phase II|Withdrawal by Subject|5
5192715|NCT01154036|17926729|P6|Phase II|Withdrawal by Subject|2
5192716|NCT01154036|17926730|P5|Phase II|Withdrawal by Subject|4
5192717|NCT01154036|17926731|P4|Phase II|Withdrawal by Subject|0
5192718|NCT01154036|17926732|P3|Phase II|Withdrawal by Subject|0
5192719|NCT01154036|17926733|P2|Phase II|Withdrawal by Subject|0
5192720|NCT01154036|17926734|P1|Phase II|Withdrawal by Subject|0
5192721|NCT01154036|17926727|P8|Phase II|Protocol Violation|0
5192722|NCT01154036|17926728|P7|Phase II|Protocol Violation|0
5192723|NCT01154036|17926729|P6|Phase II|Protocol Violation|2
5192724|NCT01154036|17926730|P5|Phase II|Protocol Violation|1
5192725|NCT01154036|17926731|P4|Phase II|Protocol Violation|0
5192726|NCT01154036|17926732|P3|Phase II|Protocol Violation|0
5192727|NCT01154036|17926733|P2|Phase II|Protocol Violation|0
5192728|NCT01154036|17926734|P1|Phase II|Protocol Violation|0
5192729|NCT01154036|17926727|P8|Phase II|Lost to Follow-up|1
5192730|NCT01154036|17926728|P7|Phase II|Lost to Follow-up|2
5192731|NCT01154036|17926729|P6|Phase II|Lost to Follow-up|0
5192732|NCT01154036|17926730|P5|Phase II|Lost to Follow-up|2
5192733|NCT01154036|17926731|P4|Phase II|Lost to Follow-up|1
5192734|NCT01154036|17926732|P3|Phase II|Lost to Follow-up|0
5192735|NCT01154036|17926733|P2|Phase II|Lost to Follow-up|0
5192736|NCT01154036|17926734|P1|Phase II|Lost to Follow-up|0
5192737|NCT01154036|17926727|P8|Phase II|Physician Decision|0
5192738|NCT01154036|17926728|P7|Phase II|Physician Decision|1
5192739|NCT01154036|17926729|P6|Phase II|Physician Decision|0
5192740|NCT01154036|17926730|P5|Phase II|Physician Decision|0
5192741|NCT01154036|17926731|P4|Phase II|Physician Decision|0
5192742|NCT01154036|17926732|P3|Phase II|Physician Decision|0
5192743|NCT01154036|17926733|P2|Phase II|Physician Decision|0
5192744|NCT01154036|17926734|P1|Phase II|Physician Decision|0
5192745|NCT01154036|17926727|P8|Phase II|Adverse Event|1
5192746|NCT01154036|17926728|P7|Phase II|Adverse Event|1
5192747|NCT01154036|17926729|P6|Phase II|Adverse Event|1
5192748|NCT01154036|17926730|P5|Phase II|Adverse Event|1
5192749|NCT01154036|17926731|P4|Phase II|Adverse Event|0
5192750|NCT01154036|17926732|P3|Phase II|Adverse Event|0
5192751|NCT01154036|17926733|P2|Phase II|Adverse Event|0
5192752|NCT01154036|17926734|P1|Phase II|Adverse Event|0
5192753|NCT01154036|17926727|P8|Phase I|Adverse Event|0
5192754|NCT01154036|17926728|P7|Phase I|Adverse Event|0
5192755|NCT01154036|17926729|P6|Phase I|Adverse Event|0
5192756|NCT01154036|17926730|P5|Phase I|Adverse Event|0
5192757|NCT01154036|17926731|P4|Phase I|Adverse Event|0
5192758|NCT01154036|17926732|P3|Phase I|Adverse Event|12
5192759|NCT01154036|17926733|P2|Phase I|Adverse Event|11
5192760|NCT01154036|17926734|P1|Phase I|Adverse Event|1
5192761|NCT01154036|17926727|P8|Phase I|Withdrawal by Subject|0
5192762|NCT01154036|17926728|P7|Phase I|Withdrawal by Subject|0
5192763|NCT01154036|17926729|P6|Phase I|Withdrawal by Subject|0
5192764|NCT01154036|17926730|P5|Phase I|Withdrawal by Subject|0
5192765|NCT01154036|17926731|P4|Phase I|Withdrawal by Subject|0
5192766|NCT01154036|17926732|P3|Phase I|Withdrawal by Subject|29
5192767|NCT01154036|17926733|P2|Phase I|Withdrawal by Subject|10
5192768|NCT01154036|17926734|P1|Phase I|Withdrawal by Subject|2
5192769|NCT01154036|17926727|P8|Phase I|Protocol Violation|0
5192770|NCT01154036|17926728|P7|Phase I|Protocol Violation|0
5192771|NCT01154036|17926729|P6|Phase I|Protocol Violation|0
5192772|NCT01154036|17926730|P5|Phase I|Protocol Violation|0
5192773|NCT01154036|17926731|P4|Phase I|Protocol Violation|0
5192774|NCT01154036|17926732|P3|Phase I|Protocol Violation|9
5192775|NCT01154036|17926733|P2|Phase I|Protocol Violation|3
5192776|NCT01154036|17926734|P1|Phase I|Protocol Violation|0
5192777|NCT01154036|17926727|P8|Phase I|Lost to Follow-up|0
5192778|NCT01154036|17926728|P7|Phase I|Lost to Follow-up|0
5192779|NCT01154036|17926729|P6|Phase I|Lost to Follow-up|0
5192780|NCT01154036|17926730|P5|Phase I|Lost to Follow-up|0
5192781|NCT01154036|17926731|P4|Phase I|Lost to Follow-up|0
5192782|NCT01154036|17926732|P3|Phase I|Lost to Follow-up|6
5192783|NCT01154036|17926733|P2|Phase I|Lost to Follow-up|3
5192784|NCT01154036|17926734|P1|Phase I|Lost to Follow-up|0
5192785|NCT01154036|17926727|P8|Phase I|Physician Decision|0
5192786|NCT01154036|17926728|P7|Phase I|Physician Decision|0
5192787|NCT01154036|17926729|P6|Phase I|Physician Decision|0
5192788|NCT01154036|17926730|P5|Phase I|Physician Decision|0
5192789|NCT01154036|17926731|P4|Phase I|Physician Decision|0
5192790|NCT01154036|17926732|P3|Phase I|Physician Decision|0
5192791|NCT01154036|17926733|P2|Phase I|Physician Decision|1
5192792|NCT01154036|17926734|P1|Phase I|Physician Decision|0
5192793|NCT01154010|17926858|P2|Overall Study|Lost to Follow-up|1
5192794|NCT01154010|17926859|P1|Overall Study|Lost to Follow-up|0
5192795|NCT01153984|17926865|P1|Overall Study|Adverse Event|1
5192796|NCT01153984|17926865|P1|Overall Study|Withdrawal by Subject|1
5192797|NCT01153971|17926876|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
5192798|NCT01153971|17926876|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
5192799|NCT01153971|17926876|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
5192800|NCT01153971|17926876|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
5192801|NCT01153971|17926876|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
5192802|NCT01153971|17926876|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
5192803|NCT01153971|17926876|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
5192804|NCT01153958|17926899|P2|Overall Study|Study Terminated|32
5192805|NCT01153958|17926900|P1|Overall Study|Study Terminated|36
5192806|NCT01153893|17926918|P2|Overall Study|Adverse Event|0
5192807|NCT01153893|17926919|P1|Overall Study|Adverse Event|1
5192808|NCT01153841|17926945|P2|Overall Study|Lost to Follow-up|0
5192809|NCT01153841|17926946|P1|Overall Study|Lost to Follow-up|2
5192810|NCT01153841|17926945|P2|Overall Study|Protocol Violation|0
5192811|NCT01153841|17926946|P1|Overall Study|Protocol Violation|2
5192812|NCT01153841|17926945|P2|Overall Study|Withdrawal by Subject|0
5192813|NCT01153841|17926946|P1|Overall Study|Withdrawal by Subject|1
5192814|NCT01153841|17926945|P2|Overall Study|Adverse Event|0
5192815|NCT01153841|17926946|P1|Overall Study|Adverse Event|1
5192816|NCT01153815|17926962|P2|Overall Study|Withdrawal by Subject|4
5192817|NCT01153815|17926963|P1|Overall Study|Withdrawal by Subject|6
5192818|NCT01153815|17926962|P2|Overall Study|Adverse Event|1
5192819|NCT01153815|17926963|P1|Overall Study|Adverse Event|3
5192820|NCT01153763|17926985|P1|Overall Study|Withdrawal by Subject|2
5192821|NCT01153763|17926985|P1|Overall Study|Physician Decision|2
5192822|NCT01153763|17926985|P1|Overall Study|Lost to Follow-up|1
5192823|NCT01153763|17926985|P1|Overall Study|Study Closed|16
5192824|NCT01153724|17927001|P1|Treatment Period 2|Other reason not defined above|1
5192825|NCT01153724|17927001|P1|Treatment Period 2|Adverse Event|1
5192826|NCT01153724|17927001|P1|Treatment Period 1|Withdrawal by Subject|1
5192827|NCT01153698|17927041|P1|Overall Study|Not treated with Pradaxa|5
5192828|NCT01153698|17927041|P1|Overall Study|Other|2
5192829|NCT01153698|17927041|P1|Overall Study|Switch to other anticoagulants|4
5192830|NCT01153698|17927041|P1|Overall Study|Withdrawal by Subject|2
5192831|NCT01153698|17927041|P1|Overall Study|Lost to Follow-up|4
5192832|NCT01153698|17927041|P1|Overall Study|Adverse Event|12
5192833|NCT01153633|17927092|P2|Overall Study|Therapeutic failure|3
5192834|NCT01153633|17927093|P1|Overall Study|Therapeutic failure|3
5192835|NCT01153633|17927092|P2|Overall Study|Protocol Violation|1
5192836|NCT01153633|17927093|P1|Overall Study|Protocol Violation|1
5192837|NCT01153516|17927130|P2|Overall Study|Both subjects refused surgery|0
5192838|NCT01153516|17927131|P1|Overall Study|Both subjects refused surgery|2
5192839|NCT01153425|17927156|P2|Overall Study|Withdrawal by Subject|3
5192840|NCT01153425|17927157|P1|Overall Study|Withdrawal by Subject|3
5192841|NCT01153347|17927169|P4|Overall Study|Death|0
5192842|NCT01153347|17927170|P3|Overall Study|Death|0
5192843|NCT01153347|17927171|P2|Overall Study|Death|0
5192844|NCT01153347|17927172|P1|Overall Study|Death|1
5192845|NCT01153347|17927169|P4|Overall Study|Other|0
5192846|NCT01153347|17927170|P3|Overall Study|Other|4
5192847|NCT01153347|17927171|P2|Overall Study|Other|5
5192848|NCT01153347|17927172|P1|Overall Study|Other|5
5192849|NCT01153347|17927169|P4|Overall Study|Lost to Follow-up|8
5192850|NCT01153347|17927170|P3|Overall Study|Lost to Follow-up|11
5192851|NCT01153347|17927171|P2|Overall Study|Lost to Follow-up|9
5192852|NCT01153347|17927172|P1|Overall Study|Lost to Follow-up|4
5192853|NCT01153347|17927169|P4|Overall Study|Study-specific withdrawal criteria|2
5192854|NCT01153347|17927170|P3|Overall Study|Study-specific withdrawal criteria|1
5192855|NCT01153347|17927171|P2|Overall Study|Study-specific withdrawal criteria|3
5192856|NCT01153347|17927172|P1|Overall Study|Study-specific withdrawal criteria|4
5192857|NCT01153347|17927169|P4|Overall Study|Lack of Efficacy|4
5192858|NCT01153347|17927170|P3|Overall Study|Lack of Efficacy|0
5192859|NCT01153347|17927171|P2|Overall Study|Lack of Efficacy|2
5192860|NCT01153347|17927172|P1|Overall Study|Lack of Efficacy|2
5192861|NCT01153347|17927169|P4|Overall Study|Condition under investigation worsened|0
5192862|NCT01153347|17927170|P3|Overall Study|Condition under investigation worsened|0
5192863|NCT01153347|17927171|P2|Overall Study|Condition under investigation worsened|1
5192864|NCT01153347|17927172|P1|Overall Study|Condition under investigation worsened|1
5192865|NCT01153347|17927169|P4|Overall Study|Severe non-compliance to protocol|3
5192866|NCT01153347|17927170|P3|Overall Study|Severe non-compliance to protocol|4
5192867|NCT01153347|17927171|P2|Overall Study|Severe non-compliance to protocol|7
5192868|NCT01153347|17927172|P1|Overall Study|Severe non-compliance to protocol|6
5192869|NCT01153347|17927169|P4|Overall Study|Adverse Event|7
5192870|NCT01153347|17927170|P3|Overall Study|Adverse Event|21
5192871|NCT01153347|17927171|P2|Overall Study|Adverse Event|9
5192872|NCT01153347|17927172|P1|Overall Study|Adverse Event|3
5192873|NCT01153347|17927169|P4|Overall Study|Eligibility criteria not fulfilled|1
5192874|NCT01153347|17927170|P3|Overall Study|Eligibility criteria not fulfilled|2
5192875|NCT01153347|17927171|P2|Overall Study|Eligibility criteria not fulfilled|1
5192876|NCT01153347|17927172|P1|Overall Study|Eligibility criteria not fulfilled|0
5192877|NCT01153347|17927169|P4|Overall Study|Withdrawal by Subject|7
5192878|NCT01153347|17927170|P3|Overall Study|Withdrawal by Subject|7
5192879|NCT01153347|17927171|P2|Overall Study|Withdrawal by Subject|7
5192880|NCT01153347|17927172|P1|Overall Study|Withdrawal by Subject|7
5192881|NCT01153321|17927272|P2|Overall Study|Adverse Event|1
5192882|NCT01153321|17927273|P1|Overall Study|Adverse Event|1
5192883|NCT01153321|17927272|P2|Overall Study|Withdrawal by Subject|1
5192884|NCT01153321|17927273|P1|Overall Study|Withdrawal by Subject|0
5192885|NCT01153321|17927272|P2|Overall Study|Development of study withdrawal criteria|1
5192886|NCT01153321|17927273|P1|Overall Study|Development of study withdrawal criteria|0
5192887|NCT01153269|17927385|P1|Overall Study|Antiretroviral therapy break|1
5192888|NCT01153269|17927385|P1|Overall Study|Withdrawal by Subject|1
5192889|NCT01153009|17927448|P4|Overall Study|Other|2
5192890|NCT01153009|17927449|P3|Overall Study|Other|3
5192891|NCT01153009|17927450|P2|Overall Study|Other|1
5192892|NCT01153009|17927451|P1|Overall Study|Other|1
5192893|NCT01153009|17927448|P4|Overall Study|Lost to Follow-up|15
5192894|NCT01153009|17927449|P3|Overall Study|Lost to Follow-up|11
5192895|NCT01153009|17927450|P2|Overall Study|Lost to Follow-up|8
5192896|NCT01153009|17927451|P1|Overall Study|Lost to Follow-up|8
5192897|NCT01153009|17927448|P4|Overall Study|Withdrawal of Consent|6
5192898|NCT01153009|17927449|P3|Overall Study|Withdrawal of Consent|4
5192899|NCT01153009|17927450|P2|Overall Study|Withdrawal of Consent|5
5192900|NCT01153009|17927451|P1|Overall Study|Withdrawal of Consent|5
5192901|NCT01153009|17927448|P4|Overall Study|Protocol Deviations|2
5192902|NCT01153009|17927449|P3|Overall Study|Protocol Deviations|3
5192903|NCT01153009|17927450|P2|Overall Study|Protocol Deviations|3
5192904|NCT01153009|17927451|P1|Overall Study|Protocol Deviations|4
5192905|NCT01153009|17927448|P4|Overall Study|Noncompliance with Study Medication|1
5192906|NCT01153009|17927449|P3|Overall Study|Noncompliance with Study Medication|4
5192907|NCT01153009|17927450|P2|Overall Study|Noncompliance with Study Medication|3
5192908|NCT01153009|17927451|P1|Overall Study|Noncompliance with Study Medication|1
5192909|NCT01153009|17927448|P4|Overall Study|Lack of Efficacy|1
5192910|NCT01153009|17927449|P3|Overall Study|Lack of Efficacy|2
5192911|NCT01153009|17927450|P2|Overall Study|Lack of Efficacy|0
5192912|NCT01153009|17927451|P1|Overall Study|Lack of Efficacy|9
5192913|NCT01153009|17927448|P4|Overall Study|Adverse Event|10
5192914|NCT01153009|17927449|P3|Overall Study|Adverse Event|14
5192915|NCT01153009|17927450|P2|Overall Study|Adverse Event|14
5192916|NCT01153009|17927451|P1|Overall Study|Adverse Event|4
5192917|NCT01152996|17927481|P1|Overall Study|Elevated liver enzymes|1
5192918|NCT01152996|17927481|P1|Overall Study|Protocol Violation|22
5192919|NCT01152996|17927481|P1|Overall Study|Other|36
5192920|NCT01152996|17927481|P1|Overall Study|Noncompliance|41
5192921|NCT01152996|17927481|P1|Overall Study|Lack of Efficacy|68
5192922|NCT01152996|17927481|P1|Overall Study|Lost to Follow-up|112
5192923|NCT01152996|17927481|P1|Overall Study|Adverse Event|115
5192924|NCT01152996|17927481|P1|Overall Study|Withdrawal by Subject|142
5192925|NCT01152814|17927494|P1|Overall Study|Lost to Follow-up|2
5192926|NCT01152788|17927503|P2|Overall Study|No treatment|1
5192927|NCT01152788|17927504|P1|Overall Study|No treatment|0
5192928|NCT01152788|17927503|P2|Overall Study|Withdrawal by Subject|3
5192929|NCT01152788|17927504|P1|Overall Study|Withdrawal by Subject|0
5192930|NCT01152580|17927541|P2|Overall Study|Withdrawal by Subject|1
5192931|NCT01152580|17927542|P1|Overall Study|Withdrawal by Subject|0
5192932|NCT01152554|17927564|P2|Overall Study|Death|1
5192933|NCT01152554|17927565|P1|Overall Study|Death|1
5192934|NCT01152554|17927564|P2|Overall Study|Other|8
5192935|NCT01152554|17927565|P1|Overall Study|Other|28
5192936|NCT01152554|17927564|P2|Overall Study|Lost to Follow-up|32
5192937|NCT01152554|17927565|P1|Overall Study|Lost to Follow-up|87
5192938|NCT01152554|17927564|P2|Overall Study|Study-specific withdrawal criteria|8
5192939|NCT01152554|17927565|P1|Overall Study|Study-specific withdrawal criteria|17
5192940|NCT01152554|17927564|P2|Overall Study|Lack of Efficacy|3
5192941|NCT01152554|17927565|P1|Overall Study|Lack of Efficacy|20
5192942|NCT01152554|17927564|P2|Overall Study|Condition under investigation worsened|2
5192943|NCT01152554|17927565|P1|Overall Study|Condition under investigation worsened|5
5192944|NCT01152554|17927564|P2|Overall Study|Severe non-compliance to protocol|14
5192945|NCT01152554|17927565|P1|Overall Study|Severe non-compliance to protocol|36
5192946|NCT01152554|17927564|P2|Overall Study|Adverse Event|14
5192947|NCT01152554|17927565|P1|Overall Study|Adverse Event|67
5192948|NCT01152554|17927564|P2|Overall Study|Eligiblity criteria not fulfilled|1
5192949|NCT01152554|17927565|P1|Overall Study|Eligiblity criteria not fulfilled|0
5192950|NCT01152554|17927564|P2|Overall Study|Withdrawal by Subject|28
5192951|NCT01152554|17927565|P1|Overall Study|Withdrawal by Subject|73
5192952|NCT01152450|17927604|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
5192953|NCT01152450|17927605|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
5192954|NCT01152450|17927606|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
5192955|NCT01152450|17927607|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
5192956|NCT01152450|17927608|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
5192957|NCT01152450|17927609|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
5192958|NCT01152450|17927604|P6|Period 1 (4 Weeks)|Protocol Violation|0
5192959|NCT01152450|17927605|P5|Period 1 (4 Weeks)|Protocol Violation|1
5192960|NCT01152450|17927606|P4|Period 1 (4 Weeks)|Protocol Violation|0
5192961|NCT01152450|17927607|P3|Period 1 (4 Weeks)|Protocol Violation|0
5192962|NCT01152450|17927608|P2|Period 1 (4 Weeks)|Protocol Violation|0
5192963|NCT01152450|17927609|P1|Period 1 (4 Weeks)|Protocol Violation|0
5192964|NCT01152450|17927604|P6|Period 1 (4 Weeks)|Adverse Event|1
5192965|NCT01152450|17927605|P5|Period 1 (4 Weeks)|Adverse Event|1
5192966|NCT01152450|17927606|P4|Period 1 (4 Weeks)|Adverse Event|0
5192967|NCT01152450|17927607|P3|Period 1 (4 Weeks)|Adverse Event|0
5192968|NCT01152450|17927608|P2|Period 1 (4 Weeks)|Adverse Event|0
5192969|NCT01152450|17927609|P1|Period 1 (4 Weeks)|Adverse Event|0
5192970|NCT01152437|17927680|P3|Overall Study|Refusal to continue taking trial medicat|2
5192971|NCT01152437|17927681|P2|Overall Study|Refusal to continue taking trial medicat|0
5192972|NCT01152437|17927682|P1|Overall Study|Refusal to continue taking trial medicat|1
5192973|NCT01152437|17927680|P3|Overall Study|Progressive disease|32
5192974|NCT01152437|17927681|P2|Overall Study|Progressive disease|13
5192975|NCT01152437|17927682|P1|Overall Study|Progressive disease|27
5192976|NCT01152437|17927680|P3|Overall Study|Not treated|2
5192977|NCT01152437|17927681|P2|Overall Study|Not treated|1
5192978|NCT01152437|17927682|P1|Overall Study|Not treated|0
5192979|NCT01152437|17927680|P3|Overall Study|Other Adverse Event|7
5192980|NCT01152437|17927681|P2|Overall Study|Other Adverse Event|1
5192981|NCT01152437|17927682|P1|Overall Study|Other Adverse Event|8
5192982|NCT01152385|17927702|P4|Overall Study|Other|3
5192983|NCT01152385|17927703|P3|Overall Study|Other|2
5192984|NCT01152385|17927704|P2|Overall Study|Other|3
5192985|NCT01152385|17927705|P1|Overall Study|Other|4
5192986|NCT01152385|17927702|P4|Overall Study|Study-specific withdrawal criteria|0
5192987|NCT01152385|17927703|P3|Overall Study|Study-specific withdrawal criteria|2
5192988|NCT01152385|17927704|P2|Overall Study|Study-specific withdrawal criteria|1
5192989|NCT01152385|17927705|P1|Overall Study|Study-specific withdrawal criteria|1
5192990|NCT01152385|17927702|P4|Overall Study|Adverse Event|0
5192991|NCT01152385|17927703|P3|Overall Study|Adverse Event|0
5192992|NCT01152385|17927704|P2|Overall Study|Adverse Event|1
5192993|NCT01152385|17927705|P1|Overall Study|Adverse Event|1
5192994|NCT01152385|17927702|P4|Overall Study|Protocol Violation|1
5192995|NCT01152385|17927703|P3|Overall Study|Protocol Violation|0
5192996|NCT01152385|17927704|P2|Overall Study|Protocol Violation|0
5192997|NCT01152385|17927705|P1|Overall Study|Protocol Violation|0
5192998|NCT01152385|17927702|P4|Overall Study|Withdrawal by Subject|1
5192999|NCT01152385|17927703|P3|Overall Study|Withdrawal by Subject|1
5193000|NCT01152385|17927704|P2|Overall Study|Withdrawal by Subject|1
5193001|NCT01152385|17927705|P1|Overall Study|Withdrawal by Subject|3
5193002|NCT01152190|17927776|P2|Overall Study|Withdrawal by Subject|3
5193003|NCT01152190|17927777|P1|Overall Study|Withdrawal by Subject|1
5193004|NCT01152190|17927776|P2|Overall Study|Protocol Violation|1
5193005|NCT01152190|17927777|P1|Overall Study|Protocol Violation|1
5193006|NCT01152190|17927776|P2|Overall Study|Death|0
5193007|NCT01152190|17927777|P1|Overall Study|Death|1
5193008|NCT01152190|17927776|P2|Overall Study|Adverse Event|4
5193009|NCT01152190|17927777|P1|Overall Study|Adverse Event|2
5193010|NCT01152021|17927800|P2|Overall Study|No access to study drug in Pharmacy|1
5193011|NCT01152021|17927801|P1|Overall Study|No access to study drug in Pharmacy|0
5193012|NCT01152021|17927800|P2|Overall Study|Physician Decision|1
5193013|NCT01152021|17927801|P1|Overall Study|Physician Decision|1
5193014|NCT01152021|17927800|P2|Overall Study|Study drug had expired|0
5193015|NCT01152021|17927801|P1|Overall Study|Study drug had expired|1
5193016|NCT01152021|17927800|P2|Overall Study|Adverse Event|4
5193017|NCT01152021|17927801|P1|Overall Study|Adverse Event|4
5193018|NCT01151618|17927858|P1|Overall Study|Withdrawal by Subject|7
5193019|NCT01151618|17927858|P1|Overall Study|Adverse Event|2
5193020|NCT01151579|17927866|P2|Overall Study|Not meet inclusion criteria|4
5193021|NCT01151579|17927867|P1|Overall Study|Not meet inclusion criteria|6
5193022|NCT01151579|17927866|P2|Overall Study|Withdrawal by Subject|2
5193023|NCT01151579|17927867|P1|Overall Study|Withdrawal by Subject|3
5193024|NCT01151579|17927866|P2|Overall Study|Physician Decision|1
5193025|NCT01151579|17927867|P1|Overall Study|Physician Decision|3
5193026|NCT01151540|17927881|P1|Overall Study|Withdrawal by Subject|7
5193027|NCT01151540|17927881|P1|Overall Study|Adverse event, non-fatal|4
5193028|NCT01151540|17927881|P1|Overall Study|Other|2
5193029|NCT01151423|17927930|P2|Overall Study|Participated in other clinical trial|0
5193030|NCT01151423|17927931|P1|Overall Study|Participated in other clinical trial|1
5193031|NCT01151423|17927930|P2|Overall Study|Diagnosed as non-TTP patient|1
5193032|NCT01151423|17927931|P1|Overall Study|Diagnosed as non-TTP patient|0
5193033|NCT01151423|17927930|P2|Overall Study|Lost to Follow-up|0
5193034|NCT01151423|17927931|P1|Overall Study|Lost to Follow-up|1
5193035|NCT01151423|17927930|P2|Overall Study|Withdrawal by Subject|3
5193036|NCT01151423|17927931|P1|Overall Study|Withdrawal by Subject|1
5193037|NCT01151423|17927930|P2|Overall Study|Adverse Event|0
5193038|NCT01151423|17927931|P1|Overall Study|Adverse Event|3
5193039|NCT01151423|17927930|P2|Overall Study|Death|1
5193040|NCT01151423|17927931|P1|Overall Study|Death|0
5193041|NCT01151423|17927930|P2|Overall Study|Pregnancy|1
5193042|NCT01151423|17927931|P1|Overall Study|Pregnancy|0
5193043|NCT01151423|17927930|P2|Overall Study|Physician Decision|1
5193044|NCT01151423|17927931|P1|Overall Study|Physician Decision|1
5193045|NCT01151423|17927930|P2|Overall Study|Protocol Violation|1
5193046|NCT01151423|17927931|P1|Overall Study|Protocol Violation|0
5193047|NCT01151423|17927930|P2|Overall Study|Study terminated by Sponsor|10
5193048|NCT01151423|17927931|P1|Overall Study|Study terminated by Sponsor|9
5193049|NCT01151410|17927979|P2|Overall Study|Abnormal laboratory value(s)|1
5193050|NCT01151410|17927980|P1|Overall Study|Abnormal laboratory value(s)|0
5193051|NCT01151410|17927979|P2|Overall Study|Unsatisfactory therapeutic effect|1
5193052|NCT01151410|17927980|P1|Overall Study|Unsatisfactory therapeutic effect|1
5193053|NCT01151410|17927979|P2|Overall Study|Administrative problems|1
5193054|NCT01151410|17927980|P1|Overall Study|Administrative problems|1
5193055|NCT01151410|17927979|P2|Overall Study|Protocol deviation|1
5193056|NCT01151410|17927980|P1|Overall Study|Protocol deviation|2
5193057|NCT01151410|17927979|P2|Overall Study|Adverse Event|2
5193058|NCT01151410|17927980|P1|Overall Study|Adverse Event|1
5193059|NCT01151410|17927979|P2|Overall Study|Lost to Follow-up|4
5193060|NCT01151410|17927980|P1|Overall Study|Lost to Follow-up|3
5193061|NCT01151410|17927979|P2|Overall Study|Withdrawal by Subject|5
5193062|NCT01151410|17927980|P1|Overall Study|Withdrawal by Subject|3
5193063|NCT01151345|17928024|P2|First Intervention Period|Protocol Violation|1
5193064|NCT01151345|17928025|P1|First Intervention Period|Protocol Violation|0
5193065|NCT01151280|17928039|P1|Overall Study|Lack of Efficacy|3
5193066|NCT01151280|17928039|P1|Overall Study|Adverse Event|1
5193067|NCT01151215|17928052|P3|Overall Study|Safety as judged by the investigator|1
5193068|NCT01151215|17928053|P2|Overall Study|Safety as judged by the investigator|0
5193069|NCT01151215|17928054|P1|Overall Study|Safety as judged by the investigator|0
5193070|NCT01151215|17928052|P3|Overall Study|Disease progression|1
5193071|NCT01151215|17928053|P2|Overall Study|Disease progression|1
5193072|NCT01151215|17928054|P1|Overall Study|Disease progression|0
5193073|NCT01151215|17928052|P3|Overall Study|Withdrawal by Subject|2
5193074|NCT01151215|17928053|P2|Overall Study|Withdrawal by Subject|1
5193075|NCT01151215|17928054|P1|Overall Study|Withdrawal by Subject|3
5193076|NCT01151215|17928052|P3|Overall Study|Lost to Follow-up|3
5193077|NCT01151215|17928053|P2|Overall Study|Lost to Follow-up|0
5193078|NCT01151215|17928054|P1|Overall Study|Lost to Follow-up|0
5193079|NCT01151215|17928052|P3|Overall Study|Death|11
5193080|NCT01151215|17928053|P2|Overall Study|Death|20
5193081|NCT01151215|17928054|P1|Overall Study|Death|16
5193082|NCT01151215|17928052|P3|Overall Study|Worsening of condition under study|1
5193083|NCT01151215|17928053|P2|Overall Study|Worsening of condition under study|1
5193084|NCT01151215|17928054|P1|Overall Study|Worsening of condition under study|1
5193085|NCT01151137|17928092|P2|Overall Study|Lost to Follow-up|1
5193086|NCT01151137|17928093|P1|Overall Study|Lost to Follow-up|1
5193087|NCT01151137|17928092|P2|Overall Study|Death|27
5193088|NCT01151137|17928093|P1|Overall Study|Death|15
5193089|NCT01151098|17928111|P1|Overall Study|Miscellaneous|13
5193090|NCT01151098|17928111|P1|Overall Study|Protocol Violation|1
5193091|NCT01151098|17928111|P1|Overall Study|Lack of Efficacy|15
5193092|NCT01151098|17928111|P1|Overall Study|Lost to Follow-up|6
5193093|NCT01151098|17928111|P1|Overall Study|Adverse Event|82
5193094|NCT01151085|17928115|P1|Overall Study|Protocol Violation|25
5193095|NCT01151085|17928115|P1|Overall Study|Lost to Follow-up|31
5193096|NCT01151020|17928146|P1|Overall Study|Still be eligible for follow-up|79
5193097|NCT01151020|17928146|P1|Overall Study|Patients did not receive the device|2
5193098|NCT01151020|17928146|P1|Overall Study|Withdrawal by Subject|12
5193099|NCT01151020|17928146|P1|Overall Study|Lost to Follow-up|1
5193100|NCT01151020|17928146|P1|Overall Study|Conversion to open repair|1
5193101|NCT01151020|17928146|P1|Overall Study|Death|15
5193102|NCT01150474|17928225|P2|Overall Study|Surgery Changed|0
5193103|NCT01150474|17928226|P1|Overall Study|Surgery Changed|1
5193104|NCT01150474|17928225|P2|Overall Study|Drug not administered|0
5193105|NCT01150474|17928226|P1|Overall Study|Drug not administered|1
5193106|NCT01150474|17928225|P2|Overall Study|Drug did not arrive in time|0
5193107|NCT01150474|17928226|P1|Overall Study|Drug did not arrive in time|1
5193108|NCT01150474|17928225|P2|Overall Study|Rectotomy|0
5193109|NCT01150474|17928226|P1|Overall Study|Rectotomy|1
5193110|NCT01150474|17928225|P2|Overall Study|Multiple Studies|1
5193111|NCT01150474|17928226|P1|Overall Study|Multiple Studies|0
5193112|NCT01150474|17928225|P2|Overall Study|Cancer found|0
5193113|NCT01150474|17928226|P1|Overall Study|Cancer found|1
5193114|NCT01150474|17928225|P2|Overall Study|Withdrawal by Subject|2
5193115|NCT01150474|17928226|P1|Overall Study|Withdrawal by Subject|5
5193116|NCT01150357|17928271|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
5193117|NCT01150357|17928272|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
5193118|NCT01150357|17928273|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
5193119|NCT01150357|17928271|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
5193120|NCT01150357|17928272|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
5193121|NCT01150357|17928273|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
5193122|NCT01150357|17928271|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
5193123|NCT01150357|17928272|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
5193124|NCT01150357|17928273|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
5193125|NCT01150357|17928271|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
5193126|NCT01150357|17928272|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
5193127|NCT01150357|17928273|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
5193128|NCT01150357|17928271|P3|Dose Response Phase (Phase 1)|Adverse Event|1
5193129|NCT01150357|17928272|P2|Dose Response Phase (Phase 1)|Adverse Event|0
5193130|NCT01150357|17928273|P1|Dose Response Phase (Phase 1)|Adverse Event|0
5193131|NCT01150357|17928271|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
5193132|NCT01150357|17928272|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
5193133|NCT01150357|17928273|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
5193134|NCT01150357|17928271|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
5193135|NCT01150357|17928272|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
5193136|NCT01150357|17928273|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
5193137|NCT01150123|17928353|P18|Overall Study|Lost to Follow-up|0
5193138|NCT01150123|17928354|P17|Overall Study|Lost to Follow-up|0
5193139|NCT01150123|17928355|P16|Overall Study|Lost to Follow-up|0
5193140|NCT01150123|17928356|P15|Overall Study|Lost to Follow-up|0
5193141|NCT01150123|17928357|P14|Overall Study|Lost to Follow-up|0
5193142|NCT01150123|17928358|P13|Overall Study|Lost to Follow-up|2
5193143|NCT01150123|17928359|P12|Overall Study|Lost to Follow-up|1
5193144|NCT01150123|17928360|P11|Overall Study|Lost to Follow-up|1
5193145|NCT01150123|17928361|P10|Overall Study|Lost to Follow-up|1
5193146|NCT01150123|17928362|P9|Overall Study|Lost to Follow-up|3
5193147|NCT01150123|17928363|P8|Overall Study|Lost to Follow-up|0
5193148|NCT01150123|17928364|P7|Overall Study|Lost to Follow-up|0
5193149|NCT01150123|17928365|P6|Overall Study|Lost to Follow-up|5
5193150|NCT01150123|17928366|P5|Overall Study|Lost to Follow-up|2
5193151|NCT01150123|17928367|P4|Overall Study|Lost to Follow-up|2
5193152|NCT01150123|17928368|P3|Overall Study|Lost to Follow-up|2
5193153|NCT01150123|17928369|P2|Overall Study|Lost to Follow-up|1
5193154|NCT01150123|17928370|P1|Overall Study|Lost to Follow-up|2
5193155|NCT01150123|17928353|P18|Overall Study|Withdrawal by Subject|1
5193156|NCT01150123|17928354|P17|Overall Study|Withdrawal by Subject|0
5193157|NCT01150123|17928355|P16|Overall Study|Withdrawal by Subject|1
5193158|NCT01150123|17928356|P15|Overall Study|Withdrawal by Subject|0
5193159|NCT01150123|17928357|P14|Overall Study|Withdrawal by Subject|0
5193160|NCT01150123|17928358|P13|Overall Study|Withdrawal by Subject|1
5193161|NCT01150123|17928359|P12|Overall Study|Withdrawal by Subject|0
5193162|NCT01150123|17928360|P11|Overall Study|Withdrawal by Subject|1
5193163|NCT01150123|17928361|P10|Overall Study|Withdrawal by Subject|0
5193164|NCT01150123|17928362|P9|Overall Study|Withdrawal by Subject|2
5193165|NCT01150123|17928363|P8|Overall Study|Withdrawal by Subject|3
5193166|NCT01150123|17928364|P7|Overall Study|Withdrawal by Subject|0
5193167|NCT01150123|17928365|P6|Overall Study|Withdrawal by Subject|1
5193168|NCT01150123|17928366|P5|Overall Study|Withdrawal by Subject|1
5193169|NCT01150123|17928367|P4|Overall Study|Withdrawal by Subject|1
5193170|NCT01150123|17928368|P3|Overall Study|Withdrawal by Subject|2
5193171|NCT01150123|17928369|P2|Overall Study|Withdrawal by Subject|1
5193172|NCT01150123|17928370|P1|Overall Study|Withdrawal by Subject|1
5193173|NCT01150097|17928546|P3|Months 24 to 48 Post-transplantation|Death|0
5193174|NCT01150097|17928547|P2|Months 24 to 48 Post-transplantation|Death|0
5193175|NCT01150097|17928548|P1|Months 24 to 48 Post-transplantation|Death|2
5193176|NCT01150097|17928546|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
5193177|NCT01150097|17928547|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
5193178|NCT01150097|17928548|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
5193179|NCT01150097|17928546|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
5193180|NCT01150097|17928547|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
5193181|NCT01150097|17928548|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
5193182|NCT01150097|17928546|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
5193183|NCT01150097|17928547|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
5193184|NCT01150097|17928548|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
5193185|NCT01150097|17928546|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
5193186|NCT01150097|17928547|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
5193187|NCT01150097|17928548|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
5193188|NCT01150097|17928546|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
5193189|NCT01150097|17928547|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
5193190|NCT01150097|17928548|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
5193191|NCT01150097|17928546|P3|Months 24 to 36 Post-transplantation|Death|0
5193192|NCT01150097|17928547|P2|Months 24 to 36 Post-transplantation|Death|0
5193193|NCT01150097|17928548|P1|Months 24 to 36 Post-transplantation|Death|2
5193194|NCT01149863|17928592|P1|Overall Study|Missing data or Not receiveing studydrug|3
5193195|NCT01149681|17928667|P1|Overall Study|adverse events nonrelated study drug|2
5193196|NCT01149681|17928667|P1|Overall Study|Physician Decision|2
5193197|NCT01149681|17928667|P1|Overall Study|Progressive disease|1
5193198|NCT01149681|17928667|P1|Overall Study|Withdrawal by Subject|7
5193199|NCT01149655|17928675|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
5193200|NCT01149655|17928676|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
5193201|NCT01149655|17928677|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
5193202|NCT01149655|17928678|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
5193203|NCT01149655|17928675|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
5193204|NCT01149655|17928676|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
5193205|NCT01149655|17928677|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
5193206|NCT01149655|17928678|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
5193207|NCT01149655|17928675|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
5193208|NCT01149655|17928676|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
5193209|NCT01149655|17928677|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
5193210|NCT01149655|17928678|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
5193211|NCT01149655|17928675|P4|Period 3-DB Maintenance Phase|Physician Decision|0
5193212|NCT01149655|17928676|P3|Period 3-DB Maintenance Phase|Physician Decision|1
5193213|NCT01149655|17928677|P2|Period 3-DB Maintenance Phase|Physician Decision|0
5193214|NCT01149655|17928678|P1|Period 3-DB Maintenance Phase|Physician Decision|0
5193215|NCT01149655|17928675|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
5193216|NCT01149655|17928676|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
5193217|NCT01149655|17928677|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
5193218|NCT01149655|17928678|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
5193219|NCT01149655|17928675|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5193220|NCT01149655|17928676|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5193221|NCT01149655|17928677|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
5193222|NCT01149655|17928678|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5193223|NCT01149655|17928675|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
5193224|NCT01149655|17928676|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
5193225|NCT01149655|17928677|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
5193226|NCT01149655|17928678|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
5193227|NCT01149655|17928675|P4|Period 2-Stabilization Phase|Physician Decision|0
5193228|NCT01149655|17928676|P3|Period 2-Stabilization Phase|Physician Decision|0
5193229|NCT01149655|17928677|P2|Period 2-Stabilization Phase|Physician Decision|3
5193230|NCT01149655|17928678|P1|Period 2-Stabilization Phase|Physician Decision|0
5193231|NCT01149655|17928675|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5193232|NCT01149655|17928676|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5193233|NCT01149655|17928677|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
5193234|NCT01149655|17928678|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5193235|NCT01149655|17928675|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5193236|NCT01149655|17928676|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5193237|NCT01149655|17928677|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
5193238|NCT01149655|17928678|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5193239|NCT01149655|17928675|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5193240|NCT01149655|17928676|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5193241|NCT01149655|17928677|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5193242|NCT01149655|17928678|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
5193243|NCT01149655|17928675|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
5193244|NCT01149655|17928676|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
5193245|NCT01149655|17928677|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
5193246|NCT01149655|17928678|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
5193247|NCT01149655|17928675|P4|Period 1 - Conversion Phase|Physician Decision|0
5193248|NCT01149655|17928676|P3|Period 1 - Conversion Phase|Physician Decision|0
5193249|NCT01149655|17928677|P2|Period 1 - Conversion Phase|Physician Decision|0
5193250|NCT01149655|17928678|P1|Period 1 - Conversion Phase|Physician Decision|2
5193251|NCT01149655|17928675|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5193252|NCT01149655|17928676|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5193253|NCT01149655|17928677|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5193254|NCT01149655|17928678|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
5193255|NCT01149655|17928675|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5193256|NCT01149655|17928676|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5193257|NCT01149655|17928677|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5193258|NCT01149655|17928678|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
5193259|NCT01149655|17928675|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
5193260|NCT01149655|17928676|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
5193261|NCT01149655|17928677|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
5193262|NCT01149655|17928678|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
5193263|NCT01149538|17928721|P2|Overall Study|Withdrawal by Subject|3
5193264|NCT01149538|17928722|P1|Overall Study|Withdrawal by Subject|5
5193265|NCT01149538|17928721|P2|Overall Study|Lost to Follow-up|1
5193266|NCT01149538|17928722|P1|Overall Study|Lost to Follow-up|0
5193267|NCT01149486|17928743|P2|First Intervention|Adverse Event|1
5193268|NCT01149486|17928744|P1|First Intervention|Adverse Event|0
5193269|NCT01149473|17928768|P2|Washout of 7 Days|Withdrawal by Subject|1
5193270|NCT01149473|17928769|P1|Washout of 7 Days|Withdrawal by Subject|1
5193271|NCT01149473|17928768|P2|First Intervention|Adverse Event|1
5193272|NCT01149473|17928769|P1|First Intervention|Adverse Event|1
5193273|NCT01149460|17928787|P2|Overall Study|Withdrawal by Subject|2
5193274|NCT01149460|17928788|P1|Overall Study|Withdrawal by Subject|0
5193275|NCT01149421|17928821|P3|Overall Study|Protocol Violation|6
5193276|NCT01149421|17928822|P2|Overall Study|Protocol Violation|2
5193277|NCT01149421|17928823|P1|Overall Study|Protocol Violation|2
5193278|NCT01149421|17928821|P3|Overall Study|Entry Criteria Not Met|2
5193279|NCT01149421|17928822|P2|Overall Study|Entry Criteria Not Met|1
5193280|NCT01149421|17928823|P1|Overall Study|Entry Criteria Not Met|1
5193281|NCT01149421|17928821|P3|Overall Study|Physician Decision|6
5193282|NCT01149421|17928822|P2|Overall Study|Physician Decision|3
5193283|NCT01149421|17928823|P1|Overall Study|Physician Decision|5
5193284|NCT01149421|17928821|P3|Overall Study|Lost to Follow-up|5
5193285|NCT01149421|17928822|P2|Overall Study|Lost to Follow-up|4
5193286|NCT01149421|17928823|P1|Overall Study|Lost to Follow-up|2
5193287|NCT01149421|17928821|P3|Overall Study|Sponsor Decision|1
5193288|NCT01149421|17928822|P2|Overall Study|Sponsor Decision|1
5193289|NCT01149421|17928823|P1|Overall Study|Sponsor Decision|0
5193290|NCT01149421|17928821|P3|Overall Study|Withdrawal by Subject|13
5193291|NCT01149421|17928822|P2|Overall Study|Withdrawal by Subject|12
5193292|NCT01149421|17928823|P1|Overall Study|Withdrawal by Subject|20
5193293|NCT01149421|17928821|P3|Overall Study|Adverse Event|11
5193294|NCT01149421|17928822|P2|Overall Study|Adverse Event|6
5193295|NCT01149421|17928823|P1|Overall Study|Adverse Event|22
5193296|NCT01149369|17928904|P2|Overall Study|Adverse Event|3
5193297|NCT01149369|17928905|P1|Overall Study|Adverse Event|6
5193298|NCT01149343|17929073|P4|Overall Study|Recurrence / Progressive disease|0
5193299|NCT01149343|17929074|P3|Overall Study|Recurrence / Progressive disease|1
5193300|NCT01149343|17929075|P2|Overall Study|Recurrence / Progressive disease|0
5193301|NCT01149343|17929076|P1|Overall Study|Recurrence / Progressive disease|0
5193302|NCT01149343|17929073|P4|Overall Study|Sponsor study termination|2
5193303|NCT01149343|17929074|P3|Overall Study|Sponsor study termination|0
5193304|NCT01149343|17929075|P2|Overall Study|Sponsor study termination|0
5193305|NCT01149343|17929076|P1|Overall Study|Sponsor study termination|0
5193306|NCT01149343|17929073|P4|Overall Study|Other|14
5193307|NCT01149343|17929074|P3|Overall Study|Other|2
5193308|NCT01149343|17929075|P2|Overall Study|Other|10
5193309|NCT01149343|17929076|P1|Overall Study|Other|8
5193310|NCT01149343|17929073|P4|Overall Study|Lost to Follow-up|1
5193311|NCT01149343|17929074|P3|Overall Study|Lost to Follow-up|0
5193312|NCT01149343|17929075|P2|Overall Study|Lost to Follow-up|0
5193313|NCT01149343|17929076|P1|Overall Study|Lost to Follow-up|1
5193314|NCT01149343|17929073|P4|Overall Study|Death|18
5193315|NCT01149343|17929074|P3|Overall Study|Death|18
5193316|NCT01149343|17929075|P2|Overall Study|Death|13
5193317|NCT01149343|17929076|P1|Overall Study|Death|10
5193318|NCT01149343|17929073|P4|Overall Study|Withdrawal by Subject|5
5193319|NCT01149343|17929074|P3|Overall Study|Withdrawal by Subject|1
5193320|NCT01149343|17929075|P2|Overall Study|Withdrawal by Subject|1
5193321|NCT01149343|17929076|P1|Overall Study|Withdrawal by Subject|1
5193322|NCT01149148|17929161|P2|Overall Study|Death|0
5193323|NCT01149148|17929162|P1|Overall Study|Death|1
5193324|NCT01149148|17929161|P2|Overall Study|Lost to Follow-up|2
5193325|NCT01149148|17929162|P1|Overall Study|Lost to Follow-up|1
5193326|NCT01149096|17929172|P2|Overall Study|Lost to Follow-up|1
5193327|NCT01149096|17929173|P1|Overall Study|Lost to Follow-up|0
5193328|NCT01149057|17929197|P1|Overall Study|Other|6
5193329|NCT01149057|17929197|P1|Overall Study|High Parathyroid Hormone Value|1
5193330|NCT01149057|17929197|P1|Overall Study|Lost to Follow-up|1
5193331|NCT01149057|17929197|P1|Overall Study|Participant Non-Compliance|2
5193332|NCT01149057|17929197|P1|Overall Study|B Cell Depletion|4
5193333|NCT01149057|17929197|P1|Overall Study|Positive Hepatitis B Core Antibody|5
5193334|NCT01149057|17929197|P1|Overall Study|Withdrawal by Subject|9
5193335|NCT01149057|17929197|P1|Overall Study|Adverse Event|13
5193336|NCT01149057|17929197|P1|Overall Study|Lack of Efficacy|16
5193337|NCT01148979|17929224|P2|Overall Study|Lost to Follow-up|1
5193338|NCT01148979|17929225|P1|Overall Study|Lost to Follow-up|0
5193339|NCT01148862|17929243|P2|Second Intervention|Withdrawal by Subject|2
5193340|NCT01148862|17929244|P1|Second Intervention|Withdrawal by Subject|0
5193341|NCT01148810|17929276|P2|Overall Study|Protocol Violation|0
5193342|NCT01148810|17929277|P1|Overall Study|Protocol Violation|1
5193343|NCT01148810|17929276|P2|Overall Study|Withdrawal by Subject|2
5193344|NCT01148810|17929277|P1|Overall Study|Withdrawal by Subject|0
5193345|NCT01148810|17929276|P2|Overall Study|Lack of Efficacy|1
5193346|NCT01148810|17929277|P1|Overall Study|Lack of Efficacy|0
5193347|NCT01148810|17929276|P2|Overall Study|Adverse Event|2
5193348|NCT01148810|17929277|P1|Overall Study|Adverse Event|0
5193349|NCT01148771|17929304|P2|Washout Period|Withdrawal by Subject|1
5193350|NCT01148771|17929305|P1|Washout Period|Withdrawal by Subject|0
5193351|NCT01148693|17929325|P2|Overall Study|Attempts for cannulation were failed|10
5193352|NCT01148693|17929326|P1|Overall Study|Attempts for cannulation were failed|13
5193353|NCT01148537|17929346|P3|Overall Study|Adverse Event|1
5193354|NCT01148537|17929347|P2|Overall Study|Adverse Event|0
5193355|NCT01148537|17929348|P1|Overall Study|Adverse Event|2
5193356|NCT01148537|17929346|P3|Overall Study|Withdrawal by Subject|2
5193357|NCT01148537|17929347|P2|Overall Study|Withdrawal by Subject|0
5193358|NCT01148537|17929348|P1|Overall Study|Withdrawal by Subject|1
5193359|NCT01148511|17929434|P3|Randomized|Other|1
5193360|NCT01148511|17929435|P2|Randomized|Other|1
5193361|NCT01148511|17929436|P1|Randomized|Other|0
5193362|NCT01148511|17929434|P3|Randomized|Consent withdrawal|3
5193363|NCT01148511|17929435|P2|Randomized|Consent withdrawal|5
5193364|NCT01148511|17929436|P1|Randomized|Consent withdrawal|0
5193365|NCT01148511|17929434|P3|Randomized|Lost to Follow-up|1
5193366|NCT01148511|17929435|P2|Randomized|Lost to Follow-up|1
5193367|NCT01148511|17929436|P1|Randomized|Lost to Follow-up|0
5193368|NCT01148511|17929434|P3|Randomized|Protocol Violation|1
5193369|NCT01148511|17929435|P2|Randomized|Protocol Violation|2
5193370|NCT01148511|17929436|P1|Randomized|Protocol Violation|0
5193371|NCT01148511|17929434|P3|Randomized|Adverse Event|0
5193372|NCT01148511|17929435|P2|Randomized|Adverse Event|1
5193373|NCT01148511|17929436|P1|Randomized|Adverse Event|0
5193374|NCT01148511|17929434|P3|Exposed to Study Drug|Lost to Follow-up|0
5193375|NCT01148511|17929435|P2|Exposed to Study Drug|Lost to Follow-up|0
5193376|NCT01148511|17929436|P1|Exposed to Study Drug|Lost to Follow-up|4
5193377|NCT01148511|17929434|P3|Exposed to Study Drug|Protocol Violation|0
5193378|NCT01148511|17929435|P2|Exposed to Study Drug|Protocol Violation|0
5193379|NCT01148511|17929436|P1|Exposed to Study Drug|Protocol Violation|2
5193380|NCT01148459|17929457|P2|Overall Study|Failure to comply with study procedures|1
5193381|NCT01148459|17929458|P1|Overall Study|Failure to comply with study procedures|0
5193382|NCT01148459|17929457|P2|Overall Study|Refusal|0
5193383|NCT01148459|17929458|P1|Overall Study|Refusal|1
5193384|NCT01148459|17929457|P2|Overall Study|Lost to Follow-up|0
5193385|NCT01148459|17929458|P1|Overall Study|Lost to Follow-up|2
5193386|NCT01148459|17929457|P2|Overall Study|Migrated/moved from study area|6
5193387|NCT01148459|17929458|P1|Overall Study|Migrated/moved from study area|3
5193388|NCT01148459|17929457|P2|Overall Study|Withdrawal by Subject|0
5193389|NCT01148459|17929458|P1|Overall Study|Withdrawal by Subject|1
5193390|NCT01148459|17929457|P2|Overall Study|Serious Adverse Event|4
5193391|NCT01148459|17929458|P1|Overall Study|Serious Adverse Event|5
5193392|NCT01148225|17929506|P1|Overall Study|Other|185
5193393|NCT01148017|17929557|P4|Overall Study|Unable to classify|0
5193394|NCT01148017|17929558|P3|Overall Study|Unable to classify|0
5193395|NCT01148017|17929559|P2|Overall Study|Unable to classify|1
5193396|NCT01148017|17929560|P1|Overall Study|Unable to classify|3
5193397|NCT01148017|17929557|P4|Overall Study|Administrative reason|0
5193398|NCT01148017|17929558|P3|Overall Study|Administrative reason|0
5193399|NCT01148017|17929559|P2|Overall Study|Administrative reason|9
5193400|NCT01148017|17929560|P1|Overall Study|Administrative reason|22
5193401|NCT01148017|17929557|P4|Overall Study|Inappropriate enrollment|0
5193402|NCT01148017|17929558|P3|Overall Study|Inappropriate enrollment|0
5193403|NCT01148017|17929559|P2|Overall Study|Inappropriate enrollment|0
5193404|NCT01148017|17929560|P1|Overall Study|Inappropriate enrollment|1
5193405|NCT01148017|17929557|P4|Overall Study|Lost to Follow-up|0
5193406|NCT01148017|17929558|P3|Overall Study|Lost to Follow-up|0
5193407|NCT01148017|17929559|P2|Overall Study|Lost to Follow-up|10
5193408|NCT01148017|17929560|P1|Overall Study|Lost to Follow-up|23
5193409|NCT01148017|17929557|P4|Overall Study|Withdrawal by Subject|0
5193410|NCT01148017|17929558|P3|Overall Study|Withdrawal by Subject|0
5193411|NCT01148017|17929559|P2|Overall Study|Withdrawal by Subject|14
5193412|NCT01148017|17929560|P1|Overall Study|Withdrawal by Subject|31
5193413|NCT01147926|17929599|P2|Overall Study|Colonoscopy result|1
5193414|NCT01147926|17929600|P1|Overall Study|Colonoscopy result|0
5193415|NCT01147926|17929599|P2|Overall Study|Went on holiday|1
5193416|NCT01147926|17929600|P1|Overall Study|Went on holiday|0
5193417|NCT01147926|17929599|P2|Overall Study|Too busy, no time for study|0
5193418|NCT01147926|17929600|P1|Overall Study|Too busy, no time for study|1
5193419|NCT01147926|17929599|P2|Overall Study|Lack of Efficacy|0
5193420|NCT01147926|17929600|P1|Overall Study|Lack of Efficacy|1
5193421|NCT01147926|17929599|P2|Overall Study|Sponsor's Decision|1
5193422|NCT01147926|17929600|P1|Overall Study|Sponsor's Decision|0
5193423|NCT01147926|17929599|P2|Overall Study|Lost to Follow-up|2
5193424|NCT01147926|17929600|P1|Overall Study|Lost to Follow-up|0
5193425|NCT01147926|17929599|P2|Overall Study|Selection criteria not met|1
5193426|NCT01147926|17929600|P1|Overall Study|Selection criteria not met|3
5193427|NCT01147926|17929599|P2|Overall Study|Principal investigator left hospital|3
5193428|NCT01147926|17929600|P1|Overall Study|Principal investigator left hospital|1
5193429|NCT01147926|17929599|P2|Overall Study|Subject Non-Compliant|4
5193430|NCT01147926|17929600|P1|Overall Study|Subject Non-Compliant|5
5193431|NCT01147926|17929599|P2|Overall Study|Adverse Event|6
5193432|NCT01147926|17929600|P1|Overall Study|Adverse Event|7
5193433|NCT01147926|17929599|P2|Overall Study|Subject Withdrew Consent|10
5193434|NCT01147926|17929600|P1|Overall Study|Subject Withdrew Consent|9
5193435|NCT01147900|17929635|P3|At Year 10|Lost to Follow-up|0
5193436|NCT01147900|17929636|P2|At Year 10|Lost to Follow-up|1
5193437|NCT01147900|17929637|P1|At Year 10|Lost to Follow-up|0
5193438|NCT01147874|17929696|P1|Overall Study|Withdrawal by Subject|24
5193439|NCT01147874|17929696|P1|Overall Study|Sponsor's Decision|2
5193440|NCT01147874|17929696|P1|Overall Study|Protocol Violation|5
5193441|NCT01147874|17929696|P1|Overall Study|Other|5
5193442|NCT01147874|17929696|P1|Overall Study|Lost to Follow-up|25
5193443|NCT01147874|17929696|P1|Overall Study|Investigator's Request|1
5193444|NCT01147874|17929696|P1|Overall Study|Adverse Event|5
5193445|NCT01147848|17929704|P3|Randomized Phase|Withdrawal by Subject|9
5193446|NCT01147848|17929705|P2|Randomized Phase|Withdrawal by Subject|7
5193447|NCT01147848|17929706|P1|Randomized Phase|Withdrawal by Subject|0
5193448|NCT01147848|17929704|P3|Randomized Phase|Physician Decision|1
5193449|NCT01147848|17929705|P2|Randomized Phase|Physician Decision|0
5193450|NCT01147848|17929706|P1|Randomized Phase|Physician Decision|0
5193451|NCT01147848|17929704|P3|Randomized Phase|Lost to Follow-up|7
5193452|NCT01147848|17929705|P2|Randomized Phase|Lost to Follow-up|5
5193453|NCT01147848|17929706|P1|Randomized Phase|Lost to Follow-up|0
5193454|NCT01147848|17929704|P3|Randomized Phase|Protocol Violation|10
5193455|NCT01147848|17929705|P2|Randomized Phase|Protocol Violation|7
5193456|NCT01147848|17929706|P1|Randomized Phase|Protocol Violation|0
5193457|NCT01147848|17929704|P3|Randomized Phase|Lack of Efficacy|11
5193458|NCT01147848|17929705|P2|Randomized Phase|Lack of Efficacy|20
5193459|NCT01147848|17929706|P1|Randomized Phase|Lack of Efficacy|0
5193460|NCT01147848|17929704|P3|Randomized Phase|Adverse Event|8
5193461|NCT01147848|17929705|P2|Randomized Phase|Adverse Event|6
5193462|NCT01147848|17929706|P1|Randomized Phase|Adverse Event|0
5193463|NCT01147848|17929704|P3|Run-in Period|Run-in Failure|0
5193464|NCT01147848|17929705|P2|Run-in Period|Run-in Failure|0
5193465|NCT01147848|17929706|P1|Run-in Period|Run-in Failure|135
5193466|NCT01147848|17929704|P3|Run-in Period|Screen Failure|0
5193467|NCT01147848|17929705|P2|Run-in Period|Screen Failure|0
5193468|NCT01147848|17929706|P1|Run-in Period|Screen Failure|623
5193469|NCT01147822|17929738|P2|Overall Study|Not Completed/Ongoing|102
5193470|NCT01147822|17929739|P1|Overall Study|Not Completed/Ongoing|111
5193471|NCT01147822|17929738|P2|Overall Study|Withdrawal by Subject|13
5193472|NCT01147822|17929739|P1|Overall Study|Withdrawal by Subject|8
5193473|NCT01147822|17929738|P2|Overall Study|Physician Decision|2
5193474|NCT01147822|17929739|P1|Overall Study|Physician Decision|0
5193475|NCT01147822|17929738|P2|Overall Study|Lost to Follow-up|2
5193476|NCT01147822|17929739|P1|Overall Study|Lost to Follow-up|3
5193477|NCT01147822|17929738|P2|Overall Study|Protocol Violation|1
5193478|NCT01147822|17929739|P1|Overall Study|Protocol Violation|0
5193479|NCT01147822|17929738|P2|Overall Study|Death|59
5193480|NCT01147822|17929739|P1|Overall Study|Death|66
5193481|NCT01147809|17929759|P6|Phase II (168 Days)|Ongoing|0
5193482|NCT01147809|17929760|P5|Phase II (168 Days)|Ongoing|1
5193483|NCT01147809|17929761|P4|Phase II (168 Days)|Ongoing|0
5193484|NCT01147809|17929762|P3|Phase II (168 Days)|Ongoing|0
5193485|NCT01147809|17929763|P2|Phase II (168 Days)|Ongoing|0
5193486|NCT01147809|17929764|P1|Phase II (168 Days)|Ongoing|0
5193487|NCT01147809|17929759|P6|Phase II (168 Days)|Withdrawal by Subject|15
5193488|NCT01147809|17929760|P5|Phase II (168 Days)|Withdrawal by Subject|7
5193489|NCT01147809|17929761|P4|Phase II (168 Days)|Withdrawal by Subject|0
5193490|NCT01147809|17929762|P3|Phase II (168 Days)|Withdrawal by Subject|0
5193491|NCT01147809|17929763|P2|Phase II (168 Days)|Withdrawal by Subject|0
5193492|NCT01147809|17929764|P1|Phase II (168 Days)|Withdrawal by Subject|0
5193493|NCT01147809|17929759|P6|Phase II (168 Days)|Physician Decision|11
5193494|NCT01147809|17929760|P5|Phase II (168 Days)|Physician Decision|5
5193495|NCT01147809|17929761|P4|Phase II (168 Days)|Physician Decision|0
5193496|NCT01147809|17929762|P3|Phase II (168 Days)|Physician Decision|0
5193497|NCT01147809|17929763|P2|Phase II (168 Days)|Physician Decision|0
5193498|NCT01147809|17929764|P1|Phase II (168 Days)|Physician Decision|0
5193499|NCT01147809|17929759|P6|Phase II (168 Days)|Protocol Violation|1
5193500|NCT01147809|17929760|P5|Phase II (168 Days)|Protocol Violation|0
5193501|NCT01147809|17929761|P4|Phase II (168 Days)|Protocol Violation|0
5193502|NCT01147809|17929762|P3|Phase II (168 Days)|Protocol Violation|0
5193503|NCT01147809|17929763|P2|Phase II (168 Days)|Protocol Violation|0
5193504|NCT01147809|17929764|P1|Phase II (168 Days)|Protocol Violation|0
5193505|NCT01147809|17929759|P6|Phase II (168 Days)|Adverse Event|6
5193506|NCT01147809|17929760|P5|Phase II (168 Days)|Adverse Event|3
5193507|NCT01147809|17929761|P4|Phase II (168 Days)|Adverse Event|0
5193508|NCT01147809|17929762|P3|Phase II (168 Days)|Adverse Event|0
5193509|NCT01147809|17929763|P2|Phase II (168 Days)|Adverse Event|0
5193510|NCT01147809|17929764|P1|Phase II (168 Days)|Adverse Event|0
5193511|NCT01147809|17929759|P6|Phase I (168 Days)|Withdrawal by Subject|0
5193512|NCT01147809|17929760|P5|Phase I (168 Days)|Withdrawal by Subject|0
5193513|NCT01147809|17929761|P4|Phase I (168 Days)|Withdrawal by Subject|3
5193514|NCT01147809|17929762|P3|Phase I (168 Days)|Withdrawal by Subject|0
5193515|NCT01147809|17929763|P2|Phase I (168 Days)|Withdrawal by Subject|0
5193516|NCT01147809|17929764|P1|Phase I (168 Days)|Withdrawal by Subject|0
5193517|NCT01147809|17929759|P6|Phase I (168 Days)|Physician Decision|0
5193518|NCT01147809|17929760|P5|Phase I (168 Days)|Physician Decision|0
5193519|NCT01147809|17929761|P4|Phase I (168 Days)|Physician Decision|0
5193520|NCT01147809|17929762|P3|Phase I (168 Days)|Physician Decision|2
5193521|NCT01147809|17929763|P2|Phase I (168 Days)|Physician Decision|1
5193522|NCT01147809|17929764|P1|Phase I (168 Days)|Physician Decision|0
5193523|NCT01147809|17929759|P6|Phase I (168 Days)|Lost to Follow-up|0
5193524|NCT01147809|17929760|P5|Phase I (168 Days)|Lost to Follow-up|0
5193525|NCT01147809|17929761|P4|Phase I (168 Days)|Lost to Follow-up|1
5193526|NCT01147809|17929762|P3|Phase I (168 Days)|Lost to Follow-up|0
5193527|NCT01147809|17929763|P2|Phase I (168 Days)|Lost to Follow-up|0
5193528|NCT01147809|17929764|P1|Phase I (168 Days)|Lost to Follow-up|1
5193529|NCT01147809|17929759|P6|Phase I (168 Days)|Adverse Event|0
5193530|NCT01147809|17929760|P5|Phase I (168 Days)|Adverse Event|0
5193531|NCT01147809|17929761|P4|Phase I (168 Days)|Adverse Event|1
5193532|NCT01147809|17929762|P3|Phase I (168 Days)|Adverse Event|0
5193533|NCT01147809|17929763|P2|Phase I (168 Days)|Adverse Event|0
5193534|NCT01147809|17929764|P1|Phase I (168 Days)|Adverse Event|0
5193535|NCT01147744|17929885|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
5193536|NCT01147744|17929886|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
5193537|NCT01147744|17929887|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
5193538|NCT01147744|17929888|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
5193539|NCT01147744|17929889|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
5193540|NCT01147744|17929890|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
5193541|NCT01147744|17929891|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5193542|NCT01147744|17929885|P7|Overall Study|Sponsor decision to amend protocol|6
5193543|NCT01147744|17929886|P6|Overall Study|Sponsor decision to amend protocol|2
5193544|NCT01147744|17929887|P5|Overall Study|Sponsor decision to amend protocol|7
5193545|NCT01147744|17929888|P4|Overall Study|Sponsor decision to amend protocol|5
5193546|NCT01147744|17929889|P3|Overall Study|Sponsor decision to amend protocol|2
5193547|NCT01147744|17929890|P2|Overall Study|Sponsor decision to amend protocol|4
5193548|NCT01147744|17929891|P1|Overall Study|Sponsor decision to amend protocol|7
5193549|NCT01147744|17929885|P7|Overall Study|Lost to Follow-up|0
5193550|NCT01147744|17929886|P6|Overall Study|Lost to Follow-up|0
5193551|NCT01147744|17929887|P5|Overall Study|Lost to Follow-up|0
5193552|NCT01147744|17929888|P4|Overall Study|Lost to Follow-up|0
5193553|NCT01147744|17929889|P3|Overall Study|Lost to Follow-up|0
5193554|NCT01147744|17929890|P2|Overall Study|Lost to Follow-up|1
5193555|NCT01147744|17929891|P1|Overall Study|Lost to Follow-up|0
5193556|NCT01147744|17929885|P7|Overall Study|Withdrawal by Subject|2
5193557|NCT01147744|17929886|P6|Overall Study|Withdrawal by Subject|5
5193558|NCT01147744|17929887|P5|Overall Study|Withdrawal by Subject|2
5193559|NCT01147744|17929888|P4|Overall Study|Withdrawal by Subject|2
5193560|NCT01147744|17929889|P3|Overall Study|Withdrawal by Subject|2
5193561|NCT01147744|17929890|P2|Overall Study|Withdrawal by Subject|4
5193562|NCT01147744|17929891|P1|Overall Study|Withdrawal by Subject|8
5193563|NCT01147744|17929885|P7|Overall Study|Adverse Event|2
5193564|NCT01147744|17929886|P6|Overall Study|Adverse Event|1
5193565|NCT01147744|17929887|P5|Overall Study|Adverse Event|2
5193566|NCT01147744|17929888|P4|Overall Study|Adverse Event|0
5193567|NCT01147744|17929889|P3|Overall Study|Adverse Event|3
5193568|NCT01147744|17929890|P2|Overall Study|Adverse Event|2
5193569|NCT01147744|17929891|P1|Overall Study|Adverse Event|1
5193570|NCT01147744|17929885|P7|Overall Study|Lack of Efficacy|7
5193571|NCT01147744|17929886|P6|Overall Study|Lack of Efficacy|8
5193572|NCT01147744|17929887|P5|Overall Study|Lack of Efficacy|13
5193573|NCT01147744|17929888|P4|Overall Study|Lack of Efficacy|11
5193574|NCT01147744|17929889|P3|Overall Study|Lack of Efficacy|9
5193575|NCT01147744|17929890|P2|Overall Study|Lack of Efficacy|11
5193576|NCT01147744|17929891|P1|Overall Study|Lack of Efficacy|11
5193577|NCT01147744|17929885|P7|Overall Study|Physician Decision|1
5193578|NCT01147744|17929886|P6|Overall Study|Physician Decision|0
5193579|NCT01147744|17929887|P5|Overall Study|Physician Decision|0
5193580|NCT01147744|17929888|P4|Overall Study|Physician Decision|0
5193581|NCT01147744|17929889|P3|Overall Study|Physician Decision|1
5193582|NCT01147744|17929890|P2|Overall Study|Physician Decision|1
5193583|NCT01147744|17929891|P1|Overall Study|Physician Decision|0
5193584|NCT01147744|17929885|P7|Overall Study|Protocol Violation|1
5193585|NCT01147744|17929886|P6|Overall Study|Protocol Violation|3
5193586|NCT01147744|17929887|P5|Overall Study|Protocol Violation|1
5193587|NCT01147744|17929888|P4|Overall Study|Protocol Violation|0
5193588|NCT01147744|17929889|P3|Overall Study|Protocol Violation|1
5193589|NCT01147744|17929890|P2|Overall Study|Protocol Violation|0
5193590|NCT01147744|17929891|P1|Overall Study|Protocol Violation|1
5193591|NCT01147653|17929986|P2|Year 2|Withdrawal by Subject|3
5193592|NCT01147653|17929987|P1|Year 2|Withdrawal by Subject|2
5193593|NCT01147640|17930048|P2|Overall Study|Didn't meet eligibility criteria|0
5193594|NCT01147640|17930049|P1|Overall Study|Didn't meet eligibility criteria|1
5193595|NCT01147640|17930048|P2|Overall Study|Lost to Follow-up|1
5193596|NCT01147640|17930049|P1|Overall Study|Lost to Follow-up|0
5193597|NCT01147640|17930048|P2|Overall Study|Withdrawal by Subject|0
5193598|NCT01147640|17930049|P1|Overall Study|Withdrawal by Subject|1
5193599|NCT01147640|17930048|P2|Overall Study|Physician Decision|0
5193600|NCT01147640|17930049|P1|Overall Study|Physician Decision|1
5193601|NCT01147640|17930048|P2|Overall Study|Adverse Event|0
5193602|NCT01147640|17930049|P1|Overall Study|Adverse Event|2
5193603|NCT01147497|17930081|P2|Overall Study|failed insertion|0
5193604|NCT01147497|17930082|P1|Overall Study|failed insertion|2
5193605|NCT01147471|17930102|P2|6 Month Follow Up|Lost to Follow-up|2
5193606|NCT01147471|17930103|P1|6 Month Follow Up|Lost to Follow-up|4
5193607|NCT01147471|17930102|P2|3 Month Follow Up|Physician Decision|1
5193608|NCT01147471|17930103|P1|3 Month Follow Up|Physician Decision|0
5193609|NCT01147471|17930102|P2|3 Month Follow Up|Lost to Follow-up|1
5193610|NCT01147471|17930103|P1|3 Month Follow Up|Lost to Follow-up|1
5193611|NCT01147471|17930102|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
5193612|NCT01147471|17930103|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
5193613|NCT01147471|17930102|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
5193614|NCT01147471|17930103|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
5193615|NCT01147471|17930102|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
5193616|NCT01147471|17930103|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
5193617|NCT01147458|17930117|P4|Second Intervention|Other|0
5193618|NCT01147458|17930118|P3|Second Intervention|Other|1
5193619|NCT01147458|17930119|P2|Second Intervention|Other|0
5193620|NCT01147458|17930120|P1|Second Intervention|Other|0
5193621|NCT01147458|17930117|P4|Second Intervention|Adverse Event|1
5193622|NCT01147458|17930118|P3|Second Intervention|Adverse Event|1
5193623|NCT01147458|17930119|P2|Second Intervention|Adverse Event|0
5193624|NCT01147458|17930120|P1|Second Intervention|Adverse Event|2
5193625|NCT01147458|17930117|P4|Second Intervention|Withdrawal by Subject|0
5193626|NCT01147458|17930118|P3|Second Intervention|Withdrawal by Subject|0
5193627|NCT01147458|17930119|P2|Second Intervention|Withdrawal by Subject|1
5193628|NCT01147458|17930120|P1|Second Intervention|Withdrawal by Subject|0
5193629|NCT01147458|17930117|P4|Second Intervention|Protocol Violation|0
5193630|NCT01147458|17930118|P3|Second Intervention|Protocol Violation|1
5193631|NCT01147458|17930119|P2|Second Intervention|Protocol Violation|1
5193632|NCT01147458|17930120|P1|Second Intervention|Protocol Violation|0
5193633|NCT01147458|17930117|P4|Second Intervention|Study terminated by sponsor|3
5193634|NCT01147458|17930118|P3|Second Intervention|Study terminated by sponsor|5
5193635|NCT01147458|17930119|P2|Second Intervention|Study terminated by sponsor|5
5193636|NCT01147458|17930120|P1|Second Intervention|Study terminated by sponsor|7
5193637|NCT01147458|17930117|P4|First Intervention|Other|0
5193638|NCT01147458|17930118|P3|First Intervention|Other|0
5193639|NCT01147458|17930119|P2|First Intervention|Other|2
5193640|NCT01147458|17930120|P1|First Intervention|Other|1
5193641|NCT01147458|17930117|P4|First Intervention|Adverse Event|3
5193642|NCT01147458|17930118|P3|First Intervention|Adverse Event|2
5193643|NCT01147458|17930119|P2|First Intervention|Adverse Event|3
5193644|NCT01147458|17930120|P1|First Intervention|Adverse Event|0
5193645|NCT01147458|17930117|P4|First Intervention|Withdrawal by Subject|0
5193646|NCT01147458|17930118|P3|First Intervention|Withdrawal by Subject|1
5193647|NCT01147458|17930119|P2|First Intervention|Withdrawal by Subject|0
5193648|NCT01147458|17930120|P1|First Intervention|Withdrawal by Subject|3
5193649|NCT01147458|17930117|P4|First Intervention|Protocol Violation|3
5193650|NCT01147458|17930118|P3|First Intervention|Protocol Violation|2
5193651|NCT01147458|17930119|P2|First Intervention|Protocol Violation|3
5193652|NCT01147458|17930120|P1|First Intervention|Protocol Violation|2
5193653|NCT01147458|17930117|P4|First Intervention|Study terminated by sponsor|8
5193654|NCT01147458|17930118|P3|First Intervention|Study terminated by sponsor|7
5193655|NCT01147458|17930119|P2|First Intervention|Study terminated by sponsor|8
5193656|NCT01147458|17930120|P1|First Intervention|Study terminated by sponsor|8
5193657|NCT01147393|17930199|P1|Dose Level -1|Dose Limited Toxicity|1
5193658|NCT01147393|17930199|P1|Dose Level 1|Dose limiting Toxicity|2
5193659|NCT01147341|17930220|P2|Open Label Period|Subject moved|0
5193660|NCT01147341|17930221|P1|Open Label Period|Subject moved|1
5193661|NCT01147341|17930220|P2|Open Label Period|Lack of Efficacy|0
5193662|NCT01147341|17930221|P1|Open Label Period|Lack of Efficacy|3
5193663|NCT01147341|17930220|P2|Double Blind Period|Withdrawal by Subject|1
5193664|NCT01147341|17930221|P1|Double Blind Period|Withdrawal by Subject|0
5193665|NCT01147341|17930220|P2|Double Blind Period|Lack of Efficacy|1
5193666|NCT01147341|17930221|P1|Double Blind Period|Lack of Efficacy|1
5193667|NCT01147250|17930284|P2|Overall Study|Other than specified|1
5193668|NCT01147250|17930285|P1|Overall Study|Other than specified|0
5193669|NCT01147250|17930284|P2|Overall Study|Site termination by sponsor|5
5193670|NCT01147250|17930285|P1|Overall Study|Site termination by sponsor|13
5193671|NCT01147250|17930284|P2|Overall Study|Withdrawal by Subject|88
5193672|NCT01147250|17930285|P1|Overall Study|Withdrawal by Subject|83
5193673|NCT01147250|17930284|P2|Overall Study|Lost to Follow-up|11
5193674|NCT01147250|17930285|P1|Overall Study|Lost to Follow-up|14
5193675|NCT01147172|17930297|P1|Overall Study|Lost to Follow-up|2
5193676|NCT01147172|17930297|P1|Overall Study|Withdrawal by Subject|2
5193677|NCT01147068|17930315|P7|Subjects That Completed Safety Follow-up|Ineligible|0
5193678|NCT01147068|17930316|P6|Subjects That Completed Safety Follow-up|Ineligible|0
5193679|NCT01147068|17930317|P5|Subjects That Completed Safety Follow-up|Ineligible|0
5193680|NCT01147068|17930318|P4|Subjects That Completed Safety Follow-up|Ineligible|0
5193681|NCT01147068|17930319|P3|Subjects That Completed Safety Follow-up|Ineligible|0
5193682|NCT01147068|17930320|P2|Subjects That Completed Safety Follow-up|Ineligible|1
5193683|NCT01147068|17930321|P1|Subjects That Completed Safety Follow-up|Ineligible|0
5193684|NCT01147068|17930315|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5193685|NCT01147068|17930316|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5193686|NCT01147068|17930317|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5193687|NCT01147068|17930318|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
5193688|NCT01147068|17930319|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5193689|NCT01147068|17930320|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5193690|NCT01147068|17930321|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5193691|NCT01147068|17930315|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5193692|NCT01147068|17930316|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5193693|NCT01147068|17930317|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5193694|NCT01147068|17930318|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5193695|NCT01147068|17930319|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5193696|NCT01147068|17930320|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5193697|NCT01147068|17930321|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5193698|NCT01147068|17930315|P7|Subjects That Received 2nd Dose|Other|0
5193699|NCT01147068|17930316|P6|Subjects That Received 2nd Dose|Other|0
5193700|NCT01147068|17930317|P5|Subjects That Received 2nd Dose|Other|1
5193701|NCT01147068|17930318|P4|Subjects That Received 2nd Dose|Other|0
5193702|NCT01147068|17930319|P3|Subjects That Received 2nd Dose|Other|3
5193703|NCT01147068|17930320|P2|Subjects That Received 2nd Dose|Other|3
5193704|NCT01147068|17930321|P1|Subjects That Received 2nd Dose|Other|0
5193705|NCT01147068|17930315|P7|Subjects That Received 2nd Dose|Did not complete the study|0
5193706|NCT01147068|17930316|P6|Subjects That Received 2nd Dose|Did not complete the study|1
5193707|NCT01147068|17930317|P5|Subjects That Received 2nd Dose|Did not complete the study|0
5193708|NCT01147068|17930318|P4|Subjects That Received 2nd Dose|Did not complete the study|0
5193709|NCT01147068|17930319|P3|Subjects That Received 2nd Dose|Did not complete the study|0
5193710|NCT01147068|17930320|P2|Subjects That Received 2nd Dose|Did not complete the study|1
5193711|NCT01147068|17930321|P1|Subjects That Received 2nd Dose|Did not complete the study|0
5193712|NCT01147068|17930315|P7|Subjects That Received 2nd Dose|Ineligible|0
5193713|NCT01147068|17930316|P6|Subjects That Received 2nd Dose|Ineligible|0
5193714|NCT01147068|17930317|P5|Subjects That Received 2nd Dose|Ineligible|0
5193715|NCT01147068|17930318|P4|Subjects That Received 2nd Dose|Ineligible|0
5193716|NCT01147068|17930319|P3|Subjects That Received 2nd Dose|Ineligible|0
5193717|NCT01147068|17930320|P2|Subjects That Received 2nd Dose|Ineligible|1
5193718|NCT01147068|17930321|P1|Subjects That Received 2nd Dose|Ineligible|0
5193719|NCT01147068|17930315|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
5193720|NCT01147068|17930316|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
5193721|NCT01147068|17930317|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
5193722|NCT01147068|17930318|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
5193723|NCT01147068|17930319|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
5193724|NCT01147068|17930320|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
5193725|NCT01147068|17930321|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
5193726|NCT01147055|17930351|P2|First Intervention Period|Lost to Follow-up|0
5193727|NCT01147055|17930352|P1|First Intervention Period|Lost to Follow-up|1
5193728|NCT01146951|17930394|P2|Overall Study|Adverse Event|1
5193729|NCT01146951|17930395|P1|Overall Study|Adverse Event|4
5193730|NCT01146912|17930416|P8|Overall Study|Duplicate patient|0
5193731|NCT01146912|17930417|P7|Overall Study|Duplicate patient|0
5193732|NCT01146912|17930418|P6|Overall Study|Duplicate patient|0
5193733|NCT01146912|17930419|P5|Overall Study|Duplicate patient|0
5193734|NCT01146912|17930420|P4|Overall Study|Duplicate patient|0
5193735|NCT01146912|17930421|P3|Overall Study|Duplicate patient|1
5193736|NCT01146912|17930422|P2|Overall Study|Duplicate patient|0
5193737|NCT01146912|17930423|P1|Overall Study|Duplicate patient|0
5193738|NCT01146912|17930416|P8|Overall Study|< 14 weeks gestational age|0
5193739|NCT01146912|17930417|P7|Overall Study|< 14 weeks gestational age|0
5193740|NCT01146912|17930418|P6|Overall Study|< 14 weeks gestational age|0
5193741|NCT01146912|17930419|P5|Overall Study|< 14 weeks gestational age|0
5193742|NCT01146912|17930420|P4|Overall Study|< 14 weeks gestational age|2
5193743|NCT01146912|17930421|P3|Overall Study|< 14 weeks gestational age|3
5193744|NCT01146912|17930422|P2|Overall Study|< 14 weeks gestational age|0
5193745|NCT01146912|17930423|P1|Overall Study|< 14 weeks gestational age|0
5193746|NCT01146912|17930416|P8|Overall Study|Already received influenza vaccination|0
5193747|NCT01146912|17930417|P7|Overall Study|Already received influenza vaccination|56
5193748|NCT01146912|17930418|P6|Overall Study|Already received influenza vaccination|61
5193749|NCT01146912|17930419|P5|Overall Study|Already received influenza vaccination|41
5193750|NCT01146912|17930420|P4|Overall Study|Already received influenza vaccination|15
5193751|NCT01146912|17930421|P3|Overall Study|Already received influenza vaccination|13
5193752|NCT01146912|17930422|P2|Overall Study|Already received influenza vaccination|822
5194082|NCT01144299|17931584|P1|Overall Study|Withdrawal by Subject|1
5193753|NCT01146912|17930423|P1|Overall Study|Already received influenza vaccination|817
5193754|NCT01146873|17930445|P2|Overall Study|Transfer out|6
5193755|NCT01146873|17930446|P1|Overall Study|Transfer out|0
5193756|NCT01146860|17930462|P2|Overall Study|Withdrawal by Subject|1
5193757|NCT01146860|17930463|P1|Overall Study|Withdrawal by Subject|0
5193758|NCT01146782|17930514|P1|Primary Endpoint Cohort|Physician Decision|1
5193759|NCT01146782|17930514|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
5193760|NCT01146782|17930514|P1|Safety Cohort|TST <4 hrs|14
5193761|NCT01146782|17930514|P1|Safety Cohort|Control AHI <5|4
5193762|NCT01146782|17930514|P1|Safety Cohort|Withdrawal by Subject|4
5193763|NCT01146782|17930514|P1|Safety Cohort|Screen Failure|61
5193764|NCT01146782|17930514|P1|Screening Cohort|Withdrawal by Subject|29
5193765|NCT01146782|17930514|P1|Screening Cohort|Physician Decision|1
5193766|NCT01146782|17930514|P1|Screening Cohort|Lost to Follow-up|4
5193767|NCT01146782|17930514|P1|Screening Cohort|Screen Failure|187
5193768|NCT01146665|17930532|P2|Overall Study|Withdrawal by Subject|16
5193769|NCT01146665|17930533|P1|Overall Study|Withdrawal by Subject|10
5193770|NCT01146613|17930565|P2|Overall Study|Outpatient detox|0
5193771|NCT01146613|17930566|P1|Overall Study|Outpatient detox|1
5193772|NCT01146613|17930565|P2|Overall Study|schedule conflict|0
5193773|NCT01146613|17930566|P1|Overall Study|schedule conflict|1
5193774|NCT01146613|17930565|P2|Overall Study|Withdrawal by Subject|3
5193775|NCT01146613|17930566|P1|Overall Study|Withdrawal by Subject|0
5193776|NCT01146613|17930565|P2|Overall Study|Physician Decision|0
5193777|NCT01146613|17930566|P1|Overall Study|Physician Decision|1
5193778|NCT01146613|17930565|P2|Overall Study|Death|0
5193779|NCT01146613|17930566|P1|Overall Study|Death|1
5193780|NCT01146613|17930565|P2|Overall Study|Lack of Efficacy|1
5193781|NCT01146613|17930566|P1|Overall Study|Lack of Efficacy|0
5193782|NCT01146613|17930565|P2|Overall Study|Lost to Follow-up|8
5193783|NCT01146613|17930566|P1|Overall Study|Lost to Follow-up|3
5193784|NCT01146288|17930676|P2|First Intervention(1 Day)|Adverse Event|1
5193785|NCT01146288|17930677|P1|First Intervention(1 Day)|Adverse Event|0
5193786|NCT01146054|17930691|P1|Overall Study|Lost to Follow-up|1
5193787|NCT01146054|17930691|P1|Overall Study|Other illness precluded treatment|2
5193788|NCT01146054|17930691|P1|Overall Study|Rapid tumor progression|2
5193789|NCT01146054|17930691|P1|Overall Study|Did not meet dose constraints for SBRT|5
5193790|NCT01145898|17930701|P2|3-year Treatment|medication change by treating physician|16
5193791|NCT01145898|17930702|P1|3-year Treatment|medication change by treating physician|3
5193792|NCT01145885|17930733|P1|Overall Study|Progressive Disease|7
5193793|NCT01145755|17930779|P3|Overall Study|Positive urine ethanol|0
5193794|NCT01145755|17930780|P2|Overall Study|Positive urine ethanol|1
5193795|NCT01145755|17930781|P1|Overall Study|Positive urine ethanol|0
5193796|NCT01145755|17930779|P3|Overall Study|Withdrawal by Subject|1
5193797|NCT01145755|17930780|P2|Overall Study|Withdrawal by Subject|0
5193798|NCT01145755|17930781|P1|Overall Study|Withdrawal by Subject|0
5193799|NCT01145755|17930779|P3|Overall Study|Patient could not swollow medication|1
5193800|NCT01145755|17930780|P2|Overall Study|Patient could not swollow medication|0
5193801|NCT01145755|17930781|P1|Overall Study|Patient could not swollow medication|0
5193802|NCT01145755|17930779|P3|Overall Study|Lack of Efficacy|0
5193803|NCT01145755|17930780|P2|Overall Study|Lack of Efficacy|1
5193804|NCT01145755|17930781|P1|Overall Study|Lack of Efficacy|0
5193805|NCT01145755|17930779|P3|Overall Study|Study Closure|17
5193806|NCT01145755|17930780|P2|Overall Study|Study Closure|14
5193807|NCT01145755|17930781|P1|Overall Study|Study Closure|14
5193808|NCT01145755|17930779|P3|Overall Study|Protocol Violation|1
5193809|NCT01145755|17930780|P2|Overall Study|Protocol Violation|3
5193810|NCT01145755|17930781|P1|Overall Study|Protocol Violation|0
5193811|NCT01145755|17930779|P3|Overall Study|Lost to Follow-up|1
5193812|NCT01145755|17930780|P2|Overall Study|Lost to Follow-up|3
5193813|NCT01145755|17930781|P1|Overall Study|Lost to Follow-up|2
5193814|NCT01145755|17930779|P3|Overall Study|Withdrawal by Subject|2
5193815|NCT01145755|17930780|P2|Overall Study|Withdrawal by Subject|2
5193816|NCT01145755|17930781|P1|Overall Study|Withdrawal by Subject|2
5193817|NCT01145755|17930779|P3|Overall Study|Adverse Event|2
5193818|NCT01145755|17930780|P2|Overall Study|Adverse Event|4
5193819|NCT01145755|17930781|P1|Overall Study|Adverse Event|2
5193820|NCT01145625|17930808|P2|Overall Study|Pregnancy|1
5193821|NCT01145625|17930809|P1|Overall Study|Pregnancy|0
5193822|NCT01145625|17930808|P2|Overall Study|Withdrawal by Subject|16
5193823|NCT01145625|17930809|P1|Overall Study|Withdrawal by Subject|7
5193824|NCT01145625|17930808|P2|Overall Study|Protocol Violation|1
5193825|NCT01145625|17930809|P1|Overall Study|Protocol Violation|3
5193826|NCT01145625|17930808|P2|Overall Study|Adverse Event|4
5193827|NCT01145625|17930809|P1|Overall Study|Adverse Event|6
5193828|NCT01145625|17930808|P2|Overall Study|Lost to Follow-up|9
5193829|NCT01145625|17930809|P1|Overall Study|Lost to Follow-up|8
5193830|NCT01145560|17930822|P3|Overall Study|Withdrawal of therapy|1
5193831|NCT01145560|17930823|P2|Overall Study|Withdrawal of therapy|0
5193832|NCT01145560|17930824|P1|Overall Study|Withdrawal of therapy|0
5193833|NCT01145560|17930822|P3|Overall Study|False insurance information|0
5193834|NCT01145560|17930823|P2|Overall Study|False insurance information|1
5193835|NCT01145560|17930824|P1|Overall Study|False insurance information|0
5193836|NCT01145560|17930822|P3|Overall Study|Accidental unblinding of study treatment|0
5193837|NCT01145560|17930823|P2|Overall Study|Accidental unblinding of study treatment|1
5193838|NCT01145560|17930824|P1|Overall Study|Accidental unblinding of study treatment|0
5194083|NCT01144299|17931583|P2|Overall Study|Lost to Follow-up|0
5193839|NCT01145560|17930822|P3|Overall Study|No study drug by 24h after organ failure|0
5193840|NCT01145560|17930823|P2|Overall Study|No study drug by 24h after organ failure|0
5193841|NCT01145560|17930824|P1|Overall Study|No study drug by 24h after organ failure|1
5193842|NCT01145560|17930822|P3|Overall Study|Lost to Follow-up|1
5193843|NCT01145560|17930823|P2|Overall Study|Lost to Follow-up|1
5193844|NCT01145560|17930824|P1|Overall Study|Lost to Follow-up|1
5193845|NCT01145560|17930822|P3|Overall Study|Withdrawal by Subject|0
5193846|NCT01145560|17930823|P2|Overall Study|Withdrawal by Subject|1
5193847|NCT01145560|17930824|P1|Overall Study|Withdrawal by Subject|2
5193848|NCT01145508|17930850|P2|Overall Study|Never started treatment|1
5193849|NCT01145508|17930851|P1|Overall Study|Never started treatment|1
5193850|NCT01145508|17930850|P2|Overall Study|Physician Decision|1
5193851|NCT01145508|17930851|P1|Overall Study|Physician Decision|2
5193852|NCT01145508|17930850|P2|Overall Study|Death|0
5193853|NCT01145508|17930851|P1|Overall Study|Death|1
5193854|NCT01145508|17930850|P2|Overall Study|Adverse Event|0
5193855|NCT01145508|17930851|P1|Overall Study|Adverse Event|1
5193856|NCT01145495|17930857|P1|Overall Study|Disease progression after respone|1
5193857|NCT01145495|17930857|P1|Overall Study|Withdrawal by Subject|5
5193858|NCT01145495|17930857|P1|Overall Study|Adverse Event|6
5193859|NCT01145482|17930863|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5193860|NCT01145482|17930864|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5193861|NCT01145417|17930874|P2|Overall Study|Other|0
5193862|NCT01145417|17930875|P1|Overall Study|Other|1
5193863|NCT01145417|17930874|P2|Overall Study|Study terminated by sponsor|43
5193864|NCT01145417|17930875|P1|Overall Study|Study terminated by sponsor|35
5193865|NCT01145417|17930874|P2|Overall Study|Adverse Event|1
5193866|NCT01145417|17930875|P1|Overall Study|Adverse Event|0
5193867|NCT01145417|17930874|P2|Overall Study|Pregnancy|0
5193868|NCT01145417|17930875|P1|Overall Study|Pregnancy|1
5193869|NCT01145417|17930874|P2|Overall Study|Withdrawal by Subject|2
5193870|NCT01145417|17930875|P1|Overall Study|Withdrawal by Subject|1
5193871|NCT01145417|17930874|P2|Overall Study|Lost to Follow-up|1
5193872|NCT01145417|17930875|P1|Overall Study|Lost to Follow-up|2
5193873|NCT01145417|17930874|P2|Overall Study|Death|0
5193874|NCT01145417|17930875|P1|Overall Study|Death|1
5193875|NCT01145352|17930908|P1|Overall Study|Syringe formulation was used|1
5193876|NCT01145352|17930908|P1|Overall Study|Treated before marketing approval|4
5193877|NCT01145352|17930908|P1|Overall Study|Found to have been registered twice|6
5193878|NCT01145222|17930920|P4|Overall Study|Poor bowel preparation|1
5193879|NCT01145222|17930921|P3|Overall Study|Poor bowel preparation|0
5193880|NCT01145222|17930922|P2|Overall Study|Poor bowel preparation|0
5193881|NCT01145222|17930923|P1|Overall Study|Poor bowel preparation|0
5193882|NCT01145222|17930920|P4|Overall Study|Procedure not done (no anesthesiologist)|0
5193883|NCT01145222|17930921|P3|Overall Study|Procedure not done (no anesthesiologist)|1
5193884|NCT01145222|17930922|P2|Overall Study|Procedure not done (no anesthesiologist)|0
5193885|NCT01145222|17930923|P1|Overall Study|Procedure not done (no anesthesiologist)|0
5193886|NCT01145066|17930970|P3|Overall Study|Low platelet count|0
5193887|NCT01145066|17930971|P2|Overall Study|Low platelet count|1
5193888|NCT01145066|17930972|P1|Overall Study|Low platelet count|0
5193889|NCT01145066|17930970|P3|Overall Study|Abdominal discomfort|0
5193890|NCT01145066|17930971|P2|Overall Study|Abdominal discomfort|1
5193891|NCT01145066|17930972|P1|Overall Study|Abdominal discomfort|0
5193892|NCT01145066|17930970|P3|Overall Study|problems swallowing capsule|0
5193893|NCT01145066|17930971|P2|Overall Study|problems swallowing capsule|0
5193894|NCT01145066|17930972|P1|Overall Study|problems swallowing capsule|1
5193895|NCT01145066|17930970|P3|Overall Study|To start new med|0
5193896|NCT01145066|17930971|P2|Overall Study|To start new med|0
5193897|NCT01145066|17930972|P1|Overall Study|To start new med|1
5193898|NCT01145066|17930970|P3|Overall Study|Withdrawal by Subject|2
5193899|NCT01145066|17930971|P2|Overall Study|Withdrawal by Subject|0
5193900|NCT01145066|17930972|P1|Overall Study|Withdrawal by Subject|0
5193901|NCT01145066|17930970|P3|Overall Study|Non-related surgery|1
5193902|NCT01145066|17930971|P2|Overall Study|Non-related surgery|0
5193903|NCT01145066|17930972|P1|Overall Study|Non-related surgery|0
5193904|NCT01145066|17930970|P3|Overall Study|To resume NSAIDs|1
5193905|NCT01145066|17930971|P2|Overall Study|To resume NSAIDs|2
5193906|NCT01145066|17930972|P1|Overall Study|To resume NSAIDs|2
5193907|NCT01145053|17931040|P1|Overall Study|Other|18
5193908|NCT01145053|17931040|P1|Overall Study|Withdrawal by Subject|25
5193909|NCT01145053|17931040|P1|Overall Study|Lost to Follow-up|28
5193910|NCT01145053|17931040|P1|Overall Study|Adverse Event|22
5193911|NCT01144715|17931092|P2|Overall Study|Adverse Event|1
5193912|NCT01144715|17931093|P1|Overall Study|Adverse Event|0
5193913|NCT01144715|17931092|P2|Overall Study|Withdrawal by Subject|1
5193914|NCT01144715|17931093|P1|Overall Study|Withdrawal by Subject|2
5193915|NCT01144715|17931092|P2|Overall Study|Lost to Follow-up|1
5193916|NCT01144715|17931093|P1|Overall Study|Lost to Follow-up|2
5193917|NCT01144663|17931109|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
5193918|NCT01144663|17931110|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
5193919|NCT01144663|17931111|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
5193920|NCT01144663|17931112|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
5193921|NCT01144663|17931109|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
5193922|NCT01144663|17931110|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
5193923|NCT01144663|17931111|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
5193924|NCT01144663|17931112|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
5193925|NCT01144663|17931109|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
5193926|NCT01144663|17931110|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
5193927|NCT01144663|17931111|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
5193928|NCT01144663|17931112|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
5193929|NCT01144663|17931109|P4|Booster Vaccination Phase|Lost to Follow-up|0
5193930|NCT01144663|17931110|P3|Booster Vaccination Phase|Lost to Follow-up|3
5193931|NCT01144663|17931111|P2|Booster Vaccination Phase|Lost to Follow-up|1
5193932|NCT01144663|17931112|P1|Booster Vaccination Phase|Lost to Follow-up|2
5193933|NCT01144663|17931109|P4|Booster Vaccination Phase|Migrated/moved from study area|0
5193934|NCT01144663|17931110|P3|Booster Vaccination Phase|Migrated/moved from study area|1
5193935|NCT01144663|17931111|P2|Booster Vaccination Phase|Migrated/moved from study area|1
5193936|NCT01144663|17931112|P1|Booster Vaccination Phase|Migrated/moved from study area|1
5193937|NCT01144663|17931109|P4|Booster Vaccination Phase|Withdrawal by Subject|1
5193938|NCT01144663|17931110|P3|Booster Vaccination Phase|Withdrawal by Subject|1
5193939|NCT01144663|17931111|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5193940|NCT01144663|17931112|P1|Booster Vaccination Phase|Withdrawal by Subject|0
5193941|NCT01144663|17931109|P4|Primary Vaccination Phase|Other|2
5193942|NCT01144663|17931110|P3|Primary Vaccination Phase|Other|0
5193943|NCT01144663|17931111|P2|Primary Vaccination Phase|Other|1
5193944|NCT01144663|17931112|P1|Primary Vaccination Phase|Other|0
5193945|NCT01144663|17931109|P4|Primary Vaccination Phase|Lost to Follow-up|2
5193946|NCT01144663|17931110|P3|Primary Vaccination Phase|Lost to Follow-up|1
5193947|NCT01144663|17931111|P2|Primary Vaccination Phase|Lost to Follow-up|0
5193948|NCT01144663|17931112|P1|Primary Vaccination Phase|Lost to Follow-up|2
5193949|NCT01144663|17931109|P4|Primary Vaccination Phase|Migrated/moved from study area|3
5193950|NCT01144663|17931110|P3|Primary Vaccination Phase|Migrated/moved from study area|2
5193951|NCT01144663|17931111|P2|Primary Vaccination Phase|Migrated/moved from study area|1
5193952|NCT01144663|17931112|P1|Primary Vaccination Phase|Migrated/moved from study area|4
5193953|NCT01144663|17931109|P4|Primary Vaccination Phase|Withdrawal by Subject|10
5193954|NCT01144663|17931110|P3|Primary Vaccination Phase|Withdrawal by Subject|3
5193955|NCT01144663|17931111|P2|Primary Vaccination Phase|Withdrawal by Subject|5
5193956|NCT01144663|17931112|P1|Primary Vaccination Phase|Withdrawal by Subject|9
5193957|NCT01144663|17931109|P4|Primary Vaccination Phase|Protocol Violation|0
5193958|NCT01144663|17931110|P3|Primary Vaccination Phase|Protocol Violation|1
5193959|NCT01144663|17931111|P2|Primary Vaccination Phase|Protocol Violation|0
5193960|NCT01144663|17931112|P1|Primary Vaccination Phase|Protocol Violation|2
5193961|NCT01144663|17931109|P4|Primary Vaccination Phase|Adverse Event|1
5193962|NCT01144663|17931110|P3|Primary Vaccination Phase|Adverse Event|0
5193963|NCT01144663|17931111|P2|Primary Vaccination Phase|Adverse Event|0
5193964|NCT01144663|17931112|P1|Primary Vaccination Phase|Adverse Event|1
5193965|NCT01144663|17931109|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
5193966|NCT01144663|17931110|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
5193967|NCT01144663|17931111|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
5193968|NCT01144663|17931112|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
5193969|NCT01144416|17931450|P2|Intervention Period|Other|5
5193970|NCT01144416|17931451|P1|Intervention Period|Other|7
5193971|NCT01144416|17931450|P2|Intervention Period|No/too few/bad quality embryos|3
5193972|NCT01144416|17931451|P1|Intervention Period|No/too few/bad quality embryos|3
5193973|NCT01144416|17931450|P2|Intervention Period|No or abnormal fertilization|10
5193974|NCT01144416|17931451|P1|Intervention Period|No or abnormal fertilization|25
5193975|NCT01144416|17931450|P2|Intervention Period|No/too few/bad oocytes|5
5193976|NCT01144416|17931451|P1|Intervention Period|No/too few/bad oocytes|7
5193977|NCT01144416|17931450|P2|Intervention Period|Too high ovarian response|2
5193978|NCT01144416|17931451|P1|Intervention Period|Too high ovarian response|4
5193979|NCT01144416|17931450|P2|Intervention Period|Risk of OHSS|1
5193980|NCT01144416|17931451|P1|Intervention Period|Risk of OHSS|0
5193981|NCT01144416|17931450|P2|Intervention Period|Insufficient ovarian response|17
5193982|NCT01144416|17931451|P1|Intervention Period|Insufficient ovarian response|11
5193983|NCT01144416|17931450|P2|Intervention Period|Adverse Event|6
5193984|NCT01144416|17931451|P1|Intervention Period|Adverse Event|5
5193985|NCT01144403|17931467|P1|Overall Study|Adverse Event|1
5193986|NCT01144403|17931467|P1|Overall Study|Death|1
5193987|NCT01144403|17931467|P1|Overall Study|Lost to Follow-up|3
5193988|NCT01144377|17931479|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5193989|NCT01144377|17931480|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5193990|NCT01144377|17931481|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5193991|NCT01144377|17931482|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5193992|NCT01144377|17931483|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
5193993|NCT01144377|17931479|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
5193994|NCT01144377|17931480|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5193995|NCT01144377|17931481|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5193996|NCT01144377|17931482|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5193997|NCT01144377|17931483|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5193998|NCT01144377|17931479|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
5193999|NCT01144377|17931480|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5194084|NCT01144299|17931584|P1|Overall Study|Lost to Follow-up|1
5194000|NCT01144377|17931481|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5194001|NCT01144377|17931482|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
5194002|NCT01144377|17931483|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5194003|NCT01144377|17931479|P5|52 Week Treatment Period|Sponsor Decision|1
5194004|NCT01144377|17931480|P4|52 Week Treatment Period|Sponsor Decision|0
5194005|NCT01144377|17931481|P3|52 Week Treatment Period|Sponsor Decision|0
5194006|NCT01144377|17931482|P2|52 Week Treatment Period|Sponsor Decision|0
5194007|NCT01144377|17931483|P1|52 Week Treatment Period|Sponsor Decision|0
5194008|NCT01144377|17931479|P5|52 Week Treatment Period|Withdrawal by Subject|0
5194009|NCT01144377|17931480|P4|52 Week Treatment Period|Withdrawal by Subject|1
5194010|NCT01144377|17931481|P3|52 Week Treatment Period|Withdrawal by Subject|1
5194011|NCT01144377|17931482|P2|52 Week Treatment Period|Withdrawal by Subject|1
5194012|NCT01144377|17931483|P1|52 Week Treatment Period|Withdrawal by Subject|4
5194013|NCT01144377|17931479|P5|52 Week Treatment Period|Lost to Follow-up|0
5194014|NCT01144377|17931480|P4|52 Week Treatment Period|Lost to Follow-up|0
5194015|NCT01144377|17931481|P3|52 Week Treatment Period|Lost to Follow-up|0
5194016|NCT01144377|17931482|P2|52 Week Treatment Period|Lost to Follow-up|0
5194017|NCT01144377|17931483|P1|52 Week Treatment Period|Lost to Follow-up|1
5194018|NCT01144377|17931479|P5|52 Week Treatment Period|Protocol Violation|1
5194019|NCT01144377|17931480|P4|52 Week Treatment Period|Protocol Violation|0
5194020|NCT01144377|17931481|P3|52 Week Treatment Period|Protocol Violation|0
5194021|NCT01144377|17931482|P2|52 Week Treatment Period|Protocol Violation|0
5194022|NCT01144377|17931483|P1|52 Week Treatment Period|Protocol Violation|0
5194023|NCT01144377|17931479|P5|52 Week Treatment Period|Entry Criteria Not Met|0
5194024|NCT01144377|17931480|P4|52 Week Treatment Period|Entry Criteria Not Met|1
5194025|NCT01144377|17931481|P3|52 Week Treatment Period|Entry Criteria Not Met|1
5194026|NCT01144377|17931482|P2|52 Week Treatment Period|Entry Criteria Not Met|0
5194027|NCT01144377|17931483|P1|52 Week Treatment Period|Entry Criteria Not Met|0
5194028|NCT01144377|17931479|P5|52 Week Treatment Period|Adverse Event|1
5194029|NCT01144377|17931480|P4|52 Week Treatment Period|Adverse Event|2
5194030|NCT01144377|17931481|P3|52 Week Treatment Period|Adverse Event|3
5194031|NCT01144377|17931482|P2|52 Week Treatment Period|Adverse Event|0
5194032|NCT01144377|17931483|P1|52 Week Treatment Period|Adverse Event|0
5194033|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Physician Decision|1
5194034|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Physician Decision|0
5194035|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Physician Decision|0
5194036|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Relapse|5
5194037|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Relapse|5
5194038|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Relapse|0
5194039|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
5194040|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
5194041|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
5194042|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
5194043|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
5194044|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
5194045|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Death|0
5194046|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Death|2
5194047|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Death|0
5194048|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Adverse Event|1
5194049|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Adverse Event|3
5194050|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Adverse Event|0
5194051|NCT01144364|17931532|P3|Follow-Up/Maintenance Phase|Disease progression|29
5194052|NCT01144364|17931533|P2|Follow-Up/Maintenance Phase|Disease progression|23
5194053|NCT01144364|17931534|P1|Follow-Up/Maintenance Phase|Disease progression|0
5194054|NCT01144364|17931532|P3|Induction Phase|Protocol Violation|0
5194055|NCT01144364|17931533|P2|Induction Phase|Protocol Violation|0
5194056|NCT01144364|17931534|P1|Induction Phase|Protocol Violation|1
5194057|NCT01144364|17931532|P3|Induction Phase|Secondary neoplasia|0
5194058|NCT01144364|17931533|P2|Induction Phase|Secondary neoplasia|0
5194059|NCT01144364|17931534|P1|Induction Phase|Secondary neoplasia|1
5194060|NCT01144364|17931532|P3|Induction Phase|Stable disease|0
5194061|NCT01144364|17931533|P2|Induction Phase|Stable disease|0
5194062|NCT01144364|17931534|P1|Induction Phase|Stable disease|2
5194063|NCT01144364|17931532|P3|Induction Phase|Physician Decision|0
5194064|NCT01144364|17931533|P2|Induction Phase|Physician Decision|0
5194065|NCT01144364|17931534|P1|Induction Phase|Physician Decision|1
5194066|NCT01144364|17931532|P3|Induction Phase|Lost to Follow-up|0
5194067|NCT01144364|17931533|P2|Induction Phase|Lost to Follow-up|0
5194068|NCT01144364|17931534|P1|Induction Phase|Lost to Follow-up|2
5194069|NCT01144364|17931532|P3|Induction Phase|Withdrawal by Subject|0
5194070|NCT01144364|17931533|P2|Induction Phase|Withdrawal by Subject|0
5194071|NCT01144364|17931534|P1|Induction Phase|Withdrawal by Subject|1
5194072|NCT01144364|17931532|P3|Induction Phase|Death|0
5194073|NCT01144364|17931533|P2|Induction Phase|Death|0
5194074|NCT01144364|17931534|P1|Induction Phase|Death|1
5194075|NCT01144364|17931532|P3|Induction Phase|Adverse Event|0
5194076|NCT01144364|17931533|P2|Induction Phase|Adverse Event|0
5194077|NCT01144364|17931534|P1|Induction Phase|Adverse Event|9
5194078|NCT01144364|17931532|P3|Induction Phase|Disease progression|0
5194079|NCT01144364|17931533|P2|Induction Phase|Disease progression|0
5194080|NCT01144364|17931534|P1|Induction Phase|Disease progression|14
5194081|NCT01144299|17931583|P2|Overall Study|Withdrawal by Subject|0
5194085|NCT01144182|17931629|P2|Overall Study|Lost to Follow-up|9
5194086|NCT01144182|17931630|P1|Overall Study|Lost to Follow-up|9
5194087|NCT01144182|17931629|P2|Overall Study|Withdrawal by Subject|6
5194088|NCT01144182|17931630|P1|Overall Study|Withdrawal by Subject|3
5194089|NCT01144182|17931629|P2|Overall Study|Death|6
5194090|NCT01144182|17931630|P1|Overall Study|Death|5
5194091|NCT01144052|17931690|P2|Overall Study|Withdrawal by Subject|1
5194092|NCT01144052|17931691|P1|Overall Study|Withdrawal by Subject|1
5194093|NCT01143896|17931722|P2|Overall Study|Death|3
5194094|NCT01143896|17931723|P1|Overall Study|Death|6
5194095|NCT01143896|17931722|P2|Overall Study|Withdrawal by Subject|5
5194096|NCT01143896|17931723|P1|Overall Study|Withdrawal by Subject|13
5194097|NCT01143896|17931722|P2|Overall Study|Lost to Follow-up|13
5194098|NCT01143896|17931723|P1|Overall Study|Lost to Follow-up|18
5194099|NCT01143896|17931722|P2|Overall Study|Did not complete Baseline Interview|4
5194100|NCT01143896|17931723|P1|Overall Study|Did not complete Baseline Interview|5
5194101|NCT01143714|17931835|P2|Overall Study|wound size increased|0
5194102|NCT01143714|17931836|P1|Overall Study|wound size increased|1
5194103|NCT01143714|17931835|P2|Overall Study|wound closed = deemed healed|0
5194104|NCT01143714|17931836|P1|Overall Study|wound closed = deemed healed|1
5194105|NCT01143714|17931835|P2|Overall Study|Subject non-compliance|1
5194106|NCT01143714|17931836|P1|Overall Study|Subject non-compliance|0
5194107|NCT01143714|17931835|P2|Overall Study|Withdrawal by Subject|0
5194108|NCT01143714|17931836|P1|Overall Study|Withdrawal by Subject|1
5194109|NCT01143714|17931835|P2|Overall Study|Adverse Event|2
5194110|NCT01143714|17931836|P1|Overall Study|Adverse Event|4
5194111|NCT01143402|17931941|P3|Overall Study|Not Treated|1
5194112|NCT01143402|17931942|P2|Overall Study|Not Treated|0
5194113|NCT01143402|17931943|P1|Overall Study|Not Treated|0
5194114|NCT01143402|17931941|P3|Overall Study|Rapid clinical decline|0
5194115|NCT01143402|17931942|P2|Overall Study|Rapid clinical decline|1
5194116|NCT01143402|17931943|P1|Overall Study|Rapid clinical decline|1
5194117|NCT01143389|17931954|P2|Overall Study|Lost to Follow-up|25
5194118|NCT01143389|17931955|P1|Overall Study|Lost to Follow-up|26
5194119|NCT01143337|17931969|P3|Overall Study|Other reason|5
5194120|NCT01143337|17931970|P2|Overall Study|Other reason|0
5194121|NCT01143337|17931971|P1|Overall Study|Other reason|0
5194122|NCT01143337|17931969|P3|Overall Study|Withdrawal by Subject|1
5194123|NCT01143337|17931970|P2|Overall Study|Withdrawal by Subject|0
5194124|NCT01143337|17931971|P1|Overall Study|Withdrawal by Subject|0
5194125|NCT01143337|17931969|P3|Overall Study|Protocol Violation|0
5194126|NCT01143337|17931970|P2|Overall Study|Protocol Violation|0
5194127|NCT01143337|17931971|P1|Overall Study|Protocol Violation|1
5194128|NCT01143337|17931969|P3|Overall Study|Lack of Efficacy|1
5194129|NCT01143337|17931970|P2|Overall Study|Lack of Efficacy|2
5194130|NCT01143337|17931971|P1|Overall Study|Lack of Efficacy|6
5194131|NCT01143337|17931969|P3|Overall Study|Adverse Event|5
5194132|NCT01143337|17931970|P2|Overall Study|Adverse Event|9
5194133|NCT01143337|17931971|P1|Overall Study|Adverse Event|3
5194134|NCT01143324|17931985|P1|Overall Study|Explant of the device|4
5194135|NCT01143324|17931985|P1|Overall Study|Withdrawal by Subject|4
5194136|NCT01143324|17931985|P1|Overall Study|Lost to Follow-up|11
5194137|NCT01143259|17932024|P2|Overall Study|Screen Failure|9
5194138|NCT01143259|17932025|P1|Overall Study|Screen Failure|7
5194139|NCT01143259|17932024|P2|Overall Study|Protocol Violation|9
5194140|NCT01143259|17932025|P1|Overall Study|Protocol Violation|13
5194141|NCT01143259|17932024|P2|Overall Study|Withdrawal by Subject|2
5194142|NCT01143259|17932025|P1|Overall Study|Withdrawal by Subject|3
5194143|NCT01143207|17932033|P1|Overall Study|Lost to Follow-up|2
5194144|NCT01143090|17932053|P1|Overall Study|Administrative|1
5194145|NCT01143090|17932053|P1|Overall Study|Failure to meet eligibility criteria|1
5194146|NCT01143090|17932053|P1|Overall Study|Non-compliance with study drug|1
5194147|NCT01143090|17932053|P1|Overall Study|Withdrawal by Subject|18
5194148|NCT01143090|17932053|P1|Overall Study|Protocol Violation|2
5194149|NCT01143090|17932053|P1|Overall Study|Lost to Follow-up|9
5194150|NCT01143090|17932053|P1|Overall Study|Adverse Event|17
5194151|NCT01143090|17932053|P1|Overall Study|Lack of Efficacy|2
5194152|NCT01143077|17932060|P3|Overall Study|Principal Investigator Decision|1
5194153|NCT01143077|17932061|P2|Overall Study|Principal Investigator Decision|0
5194154|NCT01143077|17932062|P1|Overall Study|Principal Investigator Decision|2
5194155|NCT01143077|17932060|P3|Overall Study|Administrative|0
5194156|NCT01143077|17932061|P2|Overall Study|Administrative|0
5194157|NCT01143077|17932062|P1|Overall Study|Administrative|1
5194158|NCT01143077|17932060|P3|Overall Study|Non-compliance with study drug|1
5194159|NCT01143077|17932061|P2|Overall Study|Non-compliance with study drug|1
5194160|NCT01143077|17932062|P1|Overall Study|Non-compliance with study drug|0
5194161|NCT01143077|17932060|P3|Overall Study|Withdrawal by Subject|3
5194162|NCT01143077|17932061|P2|Overall Study|Withdrawal by Subject|3
5194163|NCT01143077|17932062|P1|Overall Study|Withdrawal by Subject|4
5194164|NCT01143077|17932060|P3|Overall Study|Protocol Violation|0
5194165|NCT01143077|17932061|P2|Overall Study|Protocol Violation|0
5194166|NCT01143077|17932062|P1|Overall Study|Protocol Violation|2
5194167|NCT01143077|17932060|P3|Overall Study|Lost to Follow-up|4
5194168|NCT01143077|17932061|P2|Overall Study|Lost to Follow-up|3
5194169|NCT01143077|17932062|P1|Overall Study|Lost to Follow-up|2
5194170|NCT01143077|17932060|P3|Overall Study|Adverse Event|5
5194171|NCT01143077|17932061|P2|Overall Study|Adverse Event|6
5194172|NCT01143077|17932062|P1|Overall Study|Adverse Event|5
5194173|NCT01143077|17932060|P3|Overall Study|Lack of Efficacy|1
5194174|NCT01143077|17932061|P2|Overall Study|Lack of Efficacy|2
5194175|NCT01143077|17932062|P1|Overall Study|Lack of Efficacy|0
5194176|NCT01143051|17932079|P6|3-14 Day Washout|Withdrawal by Subject|1
5194177|NCT01143051|17932080|P5|3-14 Day Washout|Withdrawal by Subject|0
5194178|NCT01143051|17932081|P4|3-14 Day Washout|Withdrawal by Subject|0
5194179|NCT01143051|17932082|P3|3-14 Day Washout|Withdrawal by Subject|0
5194180|NCT01143051|17932083|P2|3-14 Day Washout|Withdrawal by Subject|0
5194181|NCT01143051|17932084|P1|3-14 Day Washout|Withdrawal by Subject|0
5194182|NCT01143051|17932079|P6|3-14 Day Washout|Withdrawal by Subject|0
5194183|NCT01143051|17932080|P5|3-14 Day Washout|Withdrawal by Subject|0
5194184|NCT01143051|17932081|P4|3-14 Day Washout|Withdrawal by Subject|0
5194185|NCT01143051|17932082|P3|3-14 Day Washout|Withdrawal by Subject|1
5194186|NCT01143051|17932083|P2|3-14 Day Washout|Withdrawal by Subject|0
5194187|NCT01143051|17932084|P1|3-14 Day Washout|Withdrawal by Subject|0
5194188|NCT01143038|17932133|P1|Overall Study|Death|1
5194189|NCT01143038|17932133|P1|Overall Study|Protocol Deviation|1
5194190|NCT01143038|17932133|P1|Overall Study|Lost to Follow-up|2
5194191|NCT01143038|17932133|P1|Overall Study|Adverse Event|3
5194192|NCT01143038|17932133|P1|Overall Study|Requirement for alternative therapy|5
5194193|NCT01143038|17932133|P1|Overall Study|Withdrawal by Subject|4
5194194|NCT01142908|17932147|P2|Overall Study|Withdrawal by Subject|0
5194195|NCT01142908|17932148|P1|Overall Study|Withdrawal by Subject|3
5194196|NCT01142908|17932147|P2|Overall Study|Excluded - did not meet criteria|5
5194197|NCT01142908|17932148|P1|Overall Study|Excluded - did not meet criteria|9
5194198|NCT01142908|17932147|P2|Overall Study|Death|4
5194199|NCT01142908|17932148|P1|Overall Study|Death|1
5194200|NCT01142908|17932147|P2|Overall Study|Lost to Follow-up|13
5194201|NCT01142908|17932148|P1|Overall Study|Lost to Follow-up|19
5194202|NCT01142791|17932194|P2|Overall Study|Received only 1 sonication|6
5194203|NCT01142791|17932195|P1|Overall Study|Received only 1 sonication|0
5194204|NCT01142791|17932194|P2|Overall Study|Withdrawal by Subject|0
5194205|NCT01142791|17932195|P1|Overall Study|Withdrawal by Subject|5
5194206|NCT01142791|17932194|P2|Overall Study|Lost to Follow-up|0
5194207|NCT01142791|17932195|P1|Overall Study|Lost to Follow-up|1
5194208|NCT01142791|17932194|P2|Overall Study|Alternative Treatment|0
5194209|NCT01142791|17932195|P1|Overall Study|Alternative Treatment|1
5194210|NCT01142726|17932202|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
5194211|NCT01142726|17932203|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
5194212|NCT01142726|17932204|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
5194213|NCT01142726|17932202|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
5194214|NCT01142726|17932203|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
5194215|NCT01142726|17932204|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
5194216|NCT01142726|17932202|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5194217|NCT01142726|17932203|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5194218|NCT01142726|17932204|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5194219|NCT01142726|17932202|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
5194220|NCT01142726|17932203|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
5194221|NCT01142726|17932204|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
5194222|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
5194223|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
5194224|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
5194225|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
5194226|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
5194227|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
5194228|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
5194229|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
5194230|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
5194231|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
5194232|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
5194233|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
5194234|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
5194235|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
5194236|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
5194237|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
5194238|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
5194239|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
5194240|NCT01142726|17932202|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
5194241|NCT01142726|17932203|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
5194242|NCT01142726|17932204|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
5194243|NCT01142726|17932202|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
5194244|NCT01142726|17932203|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
5194245|NCT01142726|17932204|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
5194246|NCT01142726|17932202|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
5194247|NCT01142726|17932203|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
5194248|NCT01142726|17932204|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
5194249|NCT01142726|17932202|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
5194250|NCT01142726|17932203|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
5194251|NCT01142726|17932204|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
5194252|NCT01142726|17932202|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
5194253|NCT01142726|17932203|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
5194254|NCT01142726|17932204|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
5194255|NCT01142726|17932202|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
5194256|NCT01142726|17932203|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
5194257|NCT01142726|17932204|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
5194258|NCT01142661|17932267|P1|Overall Study|Physician Decision|1
5194259|NCT01142661|17932267|P1|Overall Study|Withdrawal by Subject|1
5194260|NCT01142661|17932267|P1|Overall Study|Adverse Event|2
5194261|NCT01142596|17932274|P2|Overall Study|Other reason (not specified)|4
5194262|NCT01142596|17932275|P1|Overall Study|Other reason (not specified)|5
5194263|NCT01142596|17932274|P2|Overall Study|Lost to Follow-up|3
5194264|NCT01142596|17932275|P1|Overall Study|Lost to Follow-up|2
5194265|NCT01142596|17932274|P2|Overall Study|Lack of Efficacy|9
5194266|NCT01142596|17932275|P1|Overall Study|Lack of Efficacy|5
5194267|NCT01142596|17932274|P2|Overall Study|Adverse Event|35
5194268|NCT01142596|17932275|P1|Overall Study|Adverse Event|8
5194269|NCT01142596|17932274|P2|Overall Study|Withdrawal by Subject|35
5194270|NCT01142596|17932275|P1|Overall Study|Withdrawal by Subject|9
5194271|NCT01142466|17932327|P2|Overall Study|Withdrawal by Subject|1
5194272|NCT01142466|17932328|P1|Overall Study|Withdrawal by Subject|1
5194273|NCT01142466|17932327|P2|Overall Study|Adverse Event|1
5194274|NCT01142466|17932328|P1|Overall Study|Adverse Event|2
5194275|NCT01142388|17932348|P2|Overall Study|Never started therapy|3
5194276|NCT01142388|17932349|P1|Overall Study|Never started therapy|7
5194277|NCT01142388|17932348|P2|Overall Study|Other|1
5194278|NCT01142388|17932349|P1|Overall Study|Other|1
5194279|NCT01142388|17932348|P2|Overall Study|Other complications|2
5194280|NCT01142388|17932349|P1|Overall Study|Other complications|0
5194281|NCT01142388|17932348|P2|Overall Study|Alternative therapy|0
5194282|NCT01142388|17932349|P1|Overall Study|Alternative therapy|1
5194283|NCT01142388|17932348|P2|Overall Study|Withdrawal by Subject|3
5194284|NCT01142388|17932349|P1|Overall Study|Withdrawal by Subject|5
5194285|NCT01142388|17932348|P2|Overall Study|Death|2
5194286|NCT01142388|17932349|P1|Overall Study|Death|3
5194287|NCT01142388|17932348|P2|Overall Study|Adverse Event|5
5194288|NCT01142388|17932349|P1|Overall Study|Adverse Event|9
5194289|NCT01142388|17932348|P2|Overall Study|Lack of Efficacy|31
5194290|NCT01142388|17932349|P1|Overall Study|Lack of Efficacy|21
5194291|NCT01142336|17932361|P2|Overall Study|Lost to Follow-up|1
5194292|NCT01142336|17932362|P1|Overall Study|Lost to Follow-up|0
5194293|NCT01142336|17932361|P2|Overall Study|Adverse Event|1
5194294|NCT01142336|17932362|P1|Overall Study|Adverse Event|1
5194295|NCT01142232|17932399|P5|Overall Study|Noncompliance|2
5194296|NCT01142232|17932400|P4|Overall Study|Noncompliance|0
5194297|NCT01142232|17932401|P3|Overall Study|Noncompliance|0
5194298|NCT01142232|17932402|P2|Overall Study|Noncompliance|0
5194299|NCT01142232|17932403|P1|Overall Study|Noncompliance|0
5194300|NCT01142232|17932399|P5|Overall Study|Off Trt for other complicating disease|1
5194301|NCT01142232|17932400|P4|Overall Study|Off Trt for other complicating disease|0
5194302|NCT01142232|17932401|P3|Overall Study|Off Trt for other complicating disease|0
5194303|NCT01142232|17932402|P2|Overall Study|Off Trt for other complicating disease|0
5194304|NCT01142232|17932403|P1|Overall Study|Off Trt for other complicating disease|0
5194305|NCT01142232|17932399|P5|Overall Study|Alternative Therapy|1
5194306|NCT01142232|17932400|P4|Overall Study|Alternative Therapy|0
5194307|NCT01142232|17932401|P3|Overall Study|Alternative Therapy|1
5194308|NCT01142232|17932402|P2|Overall Study|Alternative Therapy|1
5194309|NCT01142232|17932403|P1|Overall Study|Alternative Therapy|0
5194310|NCT01142232|17932399|P5|Overall Study|Physician Decision|10
5194311|NCT01142232|17932400|P4|Overall Study|Physician Decision|2
5194312|NCT01142232|17932401|P3|Overall Study|Physician Decision|0
5194313|NCT01142232|17932402|P2|Overall Study|Physician Decision|1
5194314|NCT01142232|17932403|P1|Overall Study|Physician Decision|0
5194315|NCT01142232|17932399|P5|Overall Study|Withdrawal by Subject|3
5194316|NCT01142232|17932400|P4|Overall Study|Withdrawal by Subject|1
5194317|NCT01142232|17932401|P3|Overall Study|Withdrawal by Subject|0
5194318|NCT01142232|17932402|P2|Overall Study|Withdrawal by Subject|0
5194319|NCT01142232|17932403|P1|Overall Study|Withdrawal by Subject|0
5194320|NCT01142232|17932399|P5|Overall Study|Disease Progression|12
5194321|NCT01142232|17932400|P4|Overall Study|Disease Progression|2
5194322|NCT01142232|17932401|P3|Overall Study|Disease Progression|1
5194323|NCT01142232|17932402|P2|Overall Study|Disease Progression|0
5194324|NCT01142232|17932403|P1|Overall Study|Disease Progression|2
5194325|NCT01142232|17932399|P5|Overall Study|Death|1
5194326|NCT01142232|17932400|P4|Overall Study|Death|0
5194327|NCT01142232|17932401|P3|Overall Study|Death|0
5194328|NCT01142232|17932402|P2|Overall Study|Death|0
5194329|NCT01142232|17932403|P1|Overall Study|Death|0
5194330|NCT01142232|17932399|P5|Overall Study|Adverse Event|4
5194331|NCT01142232|17932400|P4|Overall Study|Adverse Event|0
5194332|NCT01142232|17932401|P3|Overall Study|Adverse Event|1
5194333|NCT01142232|17932402|P2|Overall Study|Adverse Event|2
5194334|NCT01142232|17932403|P1|Overall Study|Adverse Event|1
5194335|NCT01142193|17932418|P2|Overall Study|Other|2
5194336|NCT01142193|17932419|P1|Overall Study|Other|1
5194337|NCT01142193|17932418|P2|Overall Study|Protocol Discontinuation Criterion Met|0
5194338|NCT01142193|17932419|P1|Overall Study|Protocol Discontinuation Criterion Met|1
5194339|NCT01142193|17932418|P2|Overall Study|Withdrawal by Subject|3
5194340|NCT01142193|17932419|P1|Overall Study|Withdrawal by Subject|4
5194341|NCT01142193|17932418|P2|Overall Study|Physician Decision|1
5194342|NCT01142193|17932419|P1|Overall Study|Physician Decision|1
5194343|NCT01142193|17932418|P2|Overall Study|Lack of Efficacy|1
5194344|NCT01142193|17932419|P1|Overall Study|Lack of Efficacy|2
5194345|NCT01142193|17932418|P2|Overall Study|Adverse Event|4
5194346|NCT01142193|17932419|P1|Overall Study|Adverse Event|12
5194347|NCT01142128|17932447|P1|Overall Study|Withdrawal by Subject|2
5194348|NCT01142128|17932447|P1|Overall Study|Lost to Follow-up|1
5194349|NCT01142128|17932447|P1|Overall Study|Physician Decision|1
5194350|NCT01142115|17932457|P2|First Intervention|Adverse Event|0
5194351|NCT01142115|17932458|P1|First Intervention|Adverse Event|1
5194352|NCT01142115|17932457|P2|First Intervention|Lack of Efficacy|1
5194353|NCT01142115|17932458|P1|First Intervention|Lack of Efficacy|1
5194354|NCT01142089|17932475|P2|Overall Study|Patient required rescue medication|17
5194355|NCT01142089|17932476|P1|Overall Study|Patient required rescue medication|8
5194356|NCT01142089|17932475|P2|Overall Study|Noncompliance with study procedures|1
5194357|NCT01142089|17932476|P1|Overall Study|Noncompliance with study procedures|2
5194358|NCT01142089|17932475|P2|Overall Study|Use of prohibited medications|1
5194359|NCT01142089|17932476|P1|Overall Study|Use of prohibited medications|0
5194360|NCT01142089|17932475|P2|Overall Study|Withdrawal by Subject|2
5194361|NCT01142089|17932476|P1|Overall Study|Withdrawal by Subject|1
5194362|NCT01142089|17932475|P2|Overall Study|Physician Decision|0
5194363|NCT01142089|17932476|P1|Overall Study|Physician Decision|1
5194364|NCT01141712|17932507|P1|Overall Study|Disease progression|3
5194365|NCT01141660|17932528|P2|Overall Study|Physician Decision|12
5194366|NCT01141660|17932529|P1|Overall Study|Physician Decision|0
5194367|NCT01141283|17932597|P1|Overall Study|Lack of Efficacy|10
5194368|NCT01141283|17932597|P1|Overall Study|Administrative|4
5194369|NCT01141283|17932597|P1|Overall Study|Withdrawal by Subject|14
5194370|NCT01141283|17932597|P1|Overall Study|Lost to Follow-up|4
5194371|NCT01141283|17932597|P1|Overall Study|Adverse Event|56
5194372|NCT01141205|17932603|P2|Overall Study|Withdrawal by Subject|1
5194373|NCT01141205|17932604|P1|Overall Study|Withdrawal by Subject|1
5194374|NCT01141205|17932603|P2|Overall Study|Lost to Follow-up|0
5194375|NCT01141205|17932604|P1|Overall Study|Lost to Follow-up|1
5194376|NCT01141205|17932603|P2|Overall Study|Physician Decision|1
5194377|NCT01141205|17932604|P1|Overall Study|Physician Decision|1
5194378|NCT01140906|17932643|P4|Overall Study|Administrative or other reason|2
5194379|NCT01140906|17932644|P3|Overall Study|Administrative or other reason|3
5194380|NCT01140906|17932645|P2|Overall Study|Administrative or other reason|5
5194381|NCT01140906|17932646|P1|Overall Study|Administrative or other reason|0
5194382|NCT01140906|17932643|P4|Overall Study|Lost to Follow-up|2
5194383|NCT01140906|17932644|P3|Overall Study|Lost to Follow-up|0
5194384|NCT01140906|17932645|P2|Overall Study|Lost to Follow-up|1
5194385|NCT01140906|17932646|P1|Overall Study|Lost to Follow-up|1
5194386|NCT01140906|17932643|P4|Overall Study|Withdrawal of consent|2
5194387|NCT01140906|17932644|P3|Overall Study|Withdrawal of consent|2
5194388|NCT01140906|17932645|P2|Overall Study|Withdrawal of consent|6
5194389|NCT01140906|17932646|P1|Overall Study|Withdrawal of consent|6
5194390|NCT01140906|17932643|P4|Overall Study|Protocol Violation|1
5194391|NCT01140906|17932644|P3|Overall Study|Protocol Violation|2
5194392|NCT01140906|17932645|P2|Overall Study|Protocol Violation|3
5194393|NCT01140906|17932646|P1|Overall Study|Protocol Violation|5
5194394|NCT01140906|17932643|P4|Overall Study|Non-compliance|1
5194395|NCT01140906|17932644|P3|Overall Study|Non-compliance|0
5194396|NCT01140906|17932645|P2|Overall Study|Non-compliance|1
5194397|NCT01140906|17932646|P1|Overall Study|Non-compliance|0
5194398|NCT01140906|17932643|P4|Overall Study|Lack of Efficacy|1
5194399|NCT01140906|17932644|P3|Overall Study|Lack of Efficacy|2
5194400|NCT01140906|17932645|P2|Overall Study|Lack of Efficacy|8
5194401|NCT01140906|17932646|P1|Overall Study|Lack of Efficacy|6
5194402|NCT01140906|17932643|P4|Overall Study|Adverse Event|7
5194403|NCT01140906|17932644|P3|Overall Study|Adverse Event|17
5194404|NCT01140906|17932645|P2|Overall Study|Adverse Event|10
5194405|NCT01140906|17932646|P1|Overall Study|Adverse Event|7
5194406|NCT01140880|17932686|P2|Overall Study|Protocol Violation|30
5194407|NCT01140880|17932687|P1|Overall Study|Protocol Violation|0
5194408|NCT01140880|17932686|P2|Overall Study|Lost to Follow-up|10
5194409|NCT01140880|17932687|P1|Overall Study|Lost to Follow-up|8
5194410|NCT01140880|17932686|P2|Overall Study|Withdrawal by Subject|3
5194411|NCT01140880|17932687|P1|Overall Study|Withdrawal by Subject|6
5194412|NCT01140880|17932686|P2|Overall Study|Death|1
5194413|NCT01140880|17932687|P1|Overall Study|Death|0
5194414|NCT01140867|17932699|P1|Overall Study|Medication Noncompliance|2
5194415|NCT01140867|17932699|P1|Overall Study|Uncooperative patient|2
5194416|NCT01140867|17932699|P1|Overall Study|Protocol Violation|1
5194417|NCT01140867|17932699|P1|Overall Study|Withdrawal by Subject|1
5194418|NCT01140867|17932699|P1|Overall Study|Lost to Follow-up|2
5194419|NCT01140867|17932699|P1|Overall Study|Lack of Efficacy|3
5194420|NCT01140867|17932699|P1|Overall Study|Adverse Event|22
5194421|NCT01140646|17932739|P1|Overall Study|Refused Further Treatment|5
5194422|NCT01140646|17932739|P1|Overall Study|Adverse Event|4
5194423|NCT01140568|17932747|P1|Overall Study|Screen Fail|4
5194424|NCT01140568|17932747|P1|Overall Study|Withdrawal by Subject|1
5194425|NCT01140568|17932747|P1|Overall Study|disease progression|31
5194426|NCT01140503|17932752|P1|Overall Study|Withdrawal by Subject|1
5194427|NCT01140477|17932760|P2|Overall Study|Subject explanted|1
5194428|NCT01140477|17932761|P1|Overall Study|Subject explanted|0
5194429|NCT01140477|17932760|P2|Overall Study|Death|1
5194430|NCT01140477|17932761|P1|Overall Study|Death|1
5194431|NCT01140477|17932760|P2|Overall Study|Surgical complication preventing implant|0
5194432|NCT01140477|17932761|P1|Overall Study|Surgical complication preventing implant|2
5194433|NCT01140477|17932760|P2|Overall Study|Withdrawal by Subject|4
5194434|NCT01140477|17932761|P1|Overall Study|Withdrawal by Subject|1
5194435|NCT01140477|17932760|P2|Overall Study|Lost to Follow-up|0
5194436|NCT01140477|17932761|P1|Overall Study|Lost to Follow-up|4
5194437|NCT01140451|17932772|P2|Overall Study|Participants Planning Pregnancy|0
5194438|NCT01140451|17932773|P1|Overall Study|Participants Planning Pregnancy|3
5194439|NCT01140451|17932772|P2|Overall Study|Lost to Follow-up|0
5194440|NCT01140451|17932773|P1|Overall Study|Lost to Follow-up|2
5194441|NCT01140451|17932772|P2|Overall Study|Physician Decision|3
5194442|NCT01140451|17932773|P1|Overall Study|Physician Decision|5
5194443|NCT01140451|17932772|P2|Overall Study|Adverse Event|6
5194444|NCT01140451|17932773|P1|Overall Study|Adverse Event|2
5194445|NCT01140451|17932772|P2|Overall Study|Withdrawal by Subject|33
5194446|NCT01140451|17932773|P1|Overall Study|Withdrawal by Subject|26
5194447|NCT01140347|17932838|P2|Overall Study|Withdrawal by Subject|8
5194448|NCT01140347|17932839|P1|Overall Study|Withdrawal by Subject|13
5194449|NCT01140347|17932838|P2|Overall Study|Lost to Follow-up|6
5194450|NCT01140347|17932839|P1|Overall Study|Lost to Follow-up|5
5194451|NCT01140061|17932892|P10|Extension|Laboratory Adverse Event|1
5194452|NCT01140061|17932893|P9|Extension|Laboratory Adverse Event|0
5194453|NCT01140061|17932894|P8|Extension|Laboratory Adverse Event|0
5194454|NCT01140061|17932895|P7|Extension|Laboratory Adverse Event|0
5194455|NCT01140061|17932896|P6|Extension|Laboratory Adverse Event|0
5194456|NCT01140061|17932897|P5|Extension|Laboratory Adverse Event|0
5194457|NCT01140061|17932898|P4|Extension|Laboratory Adverse Event|0
5194458|NCT01140061|17932899|P3|Extension|Laboratory Adverse Event|0
5194459|NCT01140061|17932900|P2|Extension|Laboratory Adverse Event|0
5194460|NCT01140061|17932901|P1|Extension|Laboratory Adverse Event|0
5194461|NCT01140061|17932892|P10|Part I|Adverse Event|0
5194462|NCT01140061|17932893|P9|Part I|Adverse Event|0
5194463|NCT01140061|17932894|P8|Part I|Adverse Event|0
5194464|NCT01140061|17932895|P7|Part I|Adverse Event|0
5194465|NCT01140061|17932896|P6|Part I|Adverse Event|0
5194466|NCT01140061|17932897|P5|Part I|Adverse Event|0
5194467|NCT01140061|17932898|P4|Part I|Adverse Event|0
5194468|NCT01140061|17932899|P3|Part I|Adverse Event|0
5194469|NCT01140061|17932900|P2|Part I|Adverse Event|0
5194470|NCT01140061|17932901|P1|Part I|Adverse Event|1
5194471|NCT01140048|17932928|P1|Overall Study|Lost to Follow-up|31
5194472|NCT01140048|17932928|P1|Overall Study|Withdrawal by Subject|13
5194473|NCT01140048|17932928|P1|Overall Study|Physician Decision|1
5194474|NCT01139775|17932968|P3|Overall Study|Physician Decision|2
5194475|NCT01139775|17932969|P2|Overall Study|Physician Decision|2
5194476|NCT01139775|17932970|P1|Overall Study|Physician Decision|0
5194477|NCT01139775|17932968|P3|Overall Study|Withdrawal by Subject|2
5194478|NCT01139775|17932969|P2|Overall Study|Withdrawal by Subject|0
5194479|NCT01139775|17932970|P1|Overall Study|Withdrawal by Subject|1
5194480|NCT01139775|17932968|P3|Overall Study|Protocol Violation|0
5194481|NCT01139775|17932969|P2|Overall Study|Protocol Violation|5
5194482|NCT01139775|17932970|P1|Overall Study|Protocol Violation|0
5194483|NCT01139775|17932968|P3|Overall Study|Adverse Event|2
5194484|NCT01139775|17932969|P2|Overall Study|Adverse Event|6
5194485|NCT01139775|17932970|P1|Overall Study|Adverse Event|0
5194486|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
5194487|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
5194488|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
5194489|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
5194490|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
5194491|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
5194492|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
5194493|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
5194494|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
5194495|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
5194496|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
5194497|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
5194498|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
5194499|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
5194500|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
5194501|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
5194502|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
5194503|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
5194504|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
5194505|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
5194506|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
5194507|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Death|1
5194508|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Death|1
5194509|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Death|0
5194510|NCT01139762|17933002|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
5194511|NCT01139762|17933003|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
5194512|NCT01139762|17933004|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
5194513|NCT01139762|17933002|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
5194514|NCT01139762|17933003|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
5194515|NCT01139762|17933004|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
5194516|NCT01139762|17933002|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
5194517|NCT01139762|17933003|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
5194518|NCT01139762|17933004|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
5194519|NCT01139762|17933002|P3|Washout and Placebo Lead-In Period|Physician Decision|0
5194520|NCT01139762|17933003|P2|Washout and Placebo Lead-In Period|Physician Decision|0
5194521|NCT01139762|17933004|P1|Washout and Placebo Lead-In Period|Physician Decision|12
5194522|NCT01139762|17933002|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
5194523|NCT01139762|17933003|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
5194524|NCT01139762|17933004|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
5194525|NCT01139762|17933002|P3|Washout and Placebo Lead-In Period|Adverse Event|0
5194526|NCT01139762|17933003|P2|Washout and Placebo Lead-In Period|Adverse Event|0
5194527|NCT01139762|17933004|P1|Washout and Placebo Lead-In Period|Adverse Event|1
5194528|NCT01139762|17933002|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
5194529|NCT01139762|17933003|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
5194530|NCT01139762|17933004|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
5194531|NCT01139658|17933039|P2|Overall Study|Other|75
5194532|NCT01139658|17933040|P1|Overall Study|Other|28
5194533|NCT01139658|17933039|P2|Overall Study|No documentation of treatment|0
5194534|NCT01139658|17933040|P1|Overall Study|No documentation of treatment|1
5194535|NCT01139658|17933039|P2|Overall Study|Withdrawal by Subject|4
5194536|NCT01139658|17933040|P1|Overall Study|Withdrawal by Subject|2
5194537|NCT01139658|17933039|P2|Overall Study|Lack of Efficacy|7
5194538|NCT01139658|17933040|P1|Overall Study|Lack of Efficacy|15
5194539|NCT01139658|17933039|P2|Overall Study|Adverse Event|27
5194540|NCT01139658|17933040|P1|Overall Study|Adverse Event|10
5194541|NCT01139580|17933078|P2|Overall Study|Participant Randomization in Error|1
5194542|NCT01139580|17933079|P1|Overall Study|Participant Randomization in Error|0
5194543|NCT01139580|17933078|P2|Overall Study|Beginning Study Exclusion Treatment|1
5194544|NCT01139580|17933079|P1|Overall Study|Beginning Study Exclusion Treatment|0
5194545|NCT01139580|17933078|P2|Overall Study|Misrandomized|0
5194546|NCT01139580|17933079|P1|Overall Study|Misrandomized|1
5194547|NCT01139580|17933078|P2|Overall Study|Did Not Meet Exclusion Criteria|0
5194548|NCT01139580|17933079|P1|Overall Study|Did Not Meet Exclusion Criteria|1
5194549|NCT01139580|17933078|P2|Overall Study|Used Excluded Medicine After Enrollment|0
5194550|NCT01139580|17933079|P1|Overall Study|Used Excluded Medicine After Enrollment|1
5194551|NCT01139580|17933078|P2|Overall Study|Withdrawal by Subject|9
5194552|NCT01139580|17933079|P1|Overall Study|Withdrawal by Subject|6
5194553|NCT01139580|17933078|P2|Overall Study|Lack of Efficacy|2
5194554|NCT01139580|17933079|P1|Overall Study|Lack of Efficacy|0
5194555|NCT01139580|17933078|P2|Overall Study|Lost to Follow-up|1
5194556|NCT01139580|17933079|P1|Overall Study|Lost to Follow-up|9
5194557|NCT01139580|17933078|P2|Overall Study|Adverse Event|4
5194558|NCT01139580|17933079|P1|Overall Study|Adverse Event|5
5194559|NCT01139450|17933127|P3|Overall Study|Adverse Event|3
5194560|NCT01139450|17933128|P2|Overall Study|Adverse Event|2
5194561|NCT01139450|17933129|P1|Overall Study|Adverse Event|2
5194562|NCT01139450|17933127|P3|Overall Study|Administrative|1
5194563|NCT01139450|17933128|P2|Overall Study|Administrative|0
5194564|NCT01139450|17933129|P1|Overall Study|Administrative|0
5194565|NCT01139450|17933127|P3|Overall Study|Lost to Follow-up|11
5194566|NCT01139450|17933128|P2|Overall Study|Lost to Follow-up|7
5194567|NCT01139450|17933129|P1|Overall Study|Lost to Follow-up|9
5194568|NCT01139450|17933127|P3|Overall Study|Protocol Violation|2
5194569|NCT01139450|17933128|P2|Overall Study|Protocol Violation|5
5194570|NCT01139450|17933129|P1|Overall Study|Protocol Violation|6
5194571|NCT01139450|17933127|P3|Overall Study|Lack of Efficacy|8
5194572|NCT01139450|17933128|P2|Overall Study|Lack of Efficacy|1
5194573|NCT01139450|17933129|P1|Overall Study|Lack of Efficacy|3
5194574|NCT01139450|17933127|P3|Overall Study|Withdrawal by Subject|13
5194575|NCT01139450|17933128|P2|Overall Study|Withdrawal by Subject|10
5194576|NCT01139450|17933129|P1|Overall Study|Withdrawal by Subject|7
5194577|NCT01139164|17933181|P3|Overall Study|Withdrawn prior to study start|0
5194578|NCT01139164|17933182|P2|Overall Study|Withdrawn prior to study start|2
5194579|NCT01139164|17933183|P1|Overall Study|Withdrawn prior to study start|0
5194580|NCT01139125|17933197|P1|Overall Study|Withdrawal by Subject|1
5194581|NCT01139047|17933201|P1|Overall Study|Withdrawal by Subject|1
5194582|NCT01139021|17933216|P6|Overall Study|Withdrawal by Subject|0
5194583|NCT01139021|17933217|P5|Overall Study|Withdrawal by Subject|4
5194584|NCT01139021|17933218|P4|Overall Study|Withdrawal by Subject|1
5194585|NCT01139021|17933219|P3|Overall Study|Withdrawal by Subject|0
5194586|NCT01139021|17933220|P2|Overall Study|Withdrawal by Subject|0
5194587|NCT01139021|17933221|P1|Overall Study|Withdrawal by Subject|0
5194588|NCT01139021|17933216|P6|Overall Study|Protocol Violation|0
5194589|NCT01139021|17933217|P5|Overall Study|Protocol Violation|2
5194590|NCT01139021|17933218|P4|Overall Study|Protocol Violation|0
5194591|NCT01139021|17933219|P3|Overall Study|Protocol Violation|0
5194592|NCT01139021|17933220|P2|Overall Study|Protocol Violation|0
5194593|NCT01139021|17933221|P1|Overall Study|Protocol Violation|1
5194594|NCT01139021|17933216|P6|Overall Study|Lost to Follow-up|0
5194595|NCT01139021|17933217|P5|Overall Study|Lost to Follow-up|2
5194596|NCT01139021|17933218|P4|Overall Study|Lost to Follow-up|0
5194597|NCT01139021|17933219|P3|Overall Study|Lost to Follow-up|0
5194598|NCT01139021|17933220|P2|Overall Study|Lost to Follow-up|0
5194599|NCT01139021|17933221|P1|Overall Study|Lost to Follow-up|0
5194600|NCT01139021|17933216|P6|Overall Study|Adverse Event|0
5194601|NCT01139021|17933217|P5|Overall Study|Adverse Event|1
5194602|NCT01139021|17933218|P4|Overall Study|Adverse Event|0
5194603|NCT01139021|17933219|P3|Overall Study|Adverse Event|0
5194604|NCT01139021|17933220|P2|Overall Study|Adverse Event|0
5194605|NCT01139021|17933221|P1|Overall Study|Adverse Event|0
5194606|NCT01139008|17933257|P1|Overall Study|Non-compliant, lost product|1
5194607|NCT01139008|17933257|P1|Overall Study|Withdrawal by Subject|5
5194608|NCT01138826|17933304|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
5194609|NCT01138826|17933305|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
5194610|NCT01138826|17933306|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
5194611|NCT01138826|17933307|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
5194612|NCT01138826|17933308|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
5194613|NCT01138826|17933309|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
5194614|NCT01138657|17933346|P2|Overall Study|Miscellaneous Reasons|4
5194615|NCT01138657|17933347|P1|Overall Study|Miscellaneous Reasons|3
5194616|NCT01138657|17933346|P2|Overall Study|Lost to Follow-up|3
5194617|NCT01138657|17933347|P1|Overall Study|Lost to Follow-up|0
5194618|NCT01138657|17933346|P2|Overall Study|Lack of Efficacy|1
5194619|NCT01138657|17933347|P1|Overall Study|Lack of Efficacy|2
5194620|NCT01138657|17933346|P2|Overall Study|Adverse Event|10
5194621|NCT01138657|17933347|P1|Overall Study|Adverse Event|3
5194622|NCT01138501|17933410|P1|Overall Study|Withdrawal by Subject|3
5194623|NCT01138501|17933410|P1|Overall Study|Protocol Violation|2
5194624|NCT01138150|17933454|P2|Overall Study|Physician Decision|0
5194625|NCT01138150|17933455|P1|Overall Study|Physician Decision|1
5194626|NCT01138150|17933454|P2|Overall Study|blood unable to be processed|1
5194627|NCT01138150|17933455|P1|Overall Study|blood unable to be processed|0
5194628|NCT01138111|17933536|P1|Overall Study|Lost to Follow-up|2
5194629|NCT01138111|17933536|P1|Overall Study|Death|1
5194630|NCT01138111|17933536|P1|Overall Study|Adverse Event|1
5194631|NCT01138111|17933536|P1|Overall Study|Withdrawal by Subject|5
5194632|NCT01138046|17933590|P1|Overall Study|Withdrawal due to death|6
5194633|NCT01138007|17933610|P3|Overall Study|Withdrawal by Subject|15
5194634|NCT01138007|17933611|P2|Overall Study|Withdrawal by Subject|6
5194635|NCT01138007|17933612|P1|Overall Study|Withdrawal by Subject|5
5194636|NCT01138007|17933610|P3|Overall Study|Physician Decision|3
5194637|NCT01138007|17933611|P2|Overall Study|Physician Decision|5
5194638|NCT01138007|17933612|P1|Overall Study|Physician Decision|0
5194639|NCT01138007|17933610|P3|Overall Study|Lost to Follow-up|5
5194640|NCT01138007|17933611|P2|Overall Study|Lost to Follow-up|3
5194641|NCT01138007|17933612|P1|Overall Study|Lost to Follow-up|3
5194642|NCT01138007|17933610|P3|Overall Study|Protocol-Defined Stopping Criteria|8
5194643|NCT01138007|17933611|P2|Overall Study|Protocol-Defined Stopping Criteria|1
5194644|NCT01138007|17933612|P1|Overall Study|Protocol-Defined Stopping Criteria|6
5194645|NCT01138007|17933610|P3|Overall Study|Protocol Violation|2
5194646|NCT01138007|17933611|P2|Overall Study|Protocol Violation|3
5194647|NCT01138007|17933612|P1|Overall Study|Protocol Violation|2
5194648|NCT01138007|17933610|P3|Overall Study|Lack of Efficacy|6
5194649|NCT01138007|17933611|P2|Overall Study|Lack of Efficacy|0
5194650|NCT01138007|17933612|P1|Overall Study|Lack of Efficacy|2
5194651|NCT01138007|17933610|P3|Overall Study|Adverse Event|9
5194652|NCT01138007|17933611|P2|Overall Study|Adverse Event|12
5194653|NCT01138007|17933612|P1|Overall Study|Adverse Event|4
5194654|NCT01137812|17933719|P2|Overall Study|Other|27
5194655|NCT01137812|17933720|P1|Overall Study|Other|19
5194656|NCT01137812|17933719|P2|Overall Study|Patient met glycemic withdrawal criteria|85
5194657|NCT01137812|17933720|P1|Overall Study|Patient met glycemic withdrawal criteria|40
5194658|NCT01137812|17933719|P2|Overall Study|Death|0
5194659|NCT01137812|17933720|P1|Overall Study|Death|2
5194660|NCT01137812|17933719|P2|Overall Study|Withdrawal by Subject|13
5194661|NCT01137812|17933720|P1|Overall Study|Withdrawal by Subject|5
5194662|NCT01137812|17933719|P2|Overall Study|Protocol Violation|4
5194663|NCT01137812|17933720|P1|Overall Study|Protocol Violation|5
5194664|NCT01137812|17933719|P2|Overall Study|Physician Decision|17
5194665|NCT01137812|17933720|P1|Overall Study|Physician Decision|25
5194666|NCT01137812|17933719|P2|Overall Study|Lost to Follow-up|8
5194667|NCT01137812|17933720|P1|Overall Study|Lost to Follow-up|6
5194668|NCT01137812|17933719|P2|Overall Study|Adverse Event|14
5194669|NCT01137812|17933720|P1|Overall Study|Adverse Event|21
5194670|NCT01137786|17933740|P2|Overall Study|Withdrawal by Subject|1
5194671|NCT01137786|17933741|P1|Overall Study|Withdrawal by Subject|1
5194672|NCT01137786|17933740|P2|Overall Study|Lost to Follow-up|2
5194673|NCT01137786|17933741|P1|Overall Study|Lost to Follow-up|0
5194674|NCT01137773|17933751|P2|Overall Study|Lost to Follow-up|0
5194675|NCT01137773|17933752|P1|Overall Study|Lost to Follow-up|6
5194676|NCT01137773|17933751|P2|Overall Study|Death|3
5194677|NCT01137773|17933752|P1|Overall Study|Death|3
5194678|NCT01137682|17933763|P3|Overall Study|Did not receive treatment in extension|1
5194679|NCT01137682|17933764|P2|Overall Study|Did not receive treatment in extension|0
5194680|NCT01137682|17933765|P1|Overall Study|Did not receive treatment in extension|0
5194681|NCT01137682|17933763|P3|Overall Study|Did not enter extension|2
5194682|NCT01137682|17933764|P2|Overall Study|Did not enter extension|3
5194683|NCT01137682|17933765|P1|Overall Study|Did not enter extension|2
5194684|NCT01137682|17933763|P3|Overall Study|Protocol Violation-Extension|0
5194685|NCT01137682|17933764|P2|Overall Study|Protocol Violation-Extension|1
5194686|NCT01137682|17933765|P1|Overall Study|Protocol Violation-Extension|2
5194687|NCT01137682|17933763|P3|Overall Study|Death-Extension|0
5194688|NCT01137682|17933764|P2|Overall Study|Death-Extension|0
5194689|NCT01137682|17933765|P1|Overall Study|Death-Extension|2
5194690|NCT01137682|17933763|P3|Overall Study|Administrative problems-Extension|0
5194691|NCT01137682|17933764|P2|Overall Study|Administrative problems-Extension|2
5194692|NCT01137682|17933765|P1|Overall Study|Administrative problems-Extension|0
5194693|NCT01137682|17933763|P3|Overall Study|Lost to Follow Up-Extension|0
5194694|NCT01137682|17933764|P2|Overall Study|Lost to Follow Up-Extension|1
5194695|NCT01137682|17933765|P1|Overall Study|Lost to Follow Up-Extension|0
5194696|NCT01137682|17933763|P3|Overall Study|Withdrawal by Subject-Extension|8
5194697|NCT01137682|17933764|P2|Overall Study|Withdrawal by Subject-Extension|8
5194698|NCT01137682|17933765|P1|Overall Study|Withdrawal by Subject-Extension|6
5194699|NCT01137682|17933763|P3|Overall Study|Lack of Efficacy-Extension|13
5194700|NCT01137682|17933764|P2|Overall Study|Lack of Efficacy-Extension|9
5194701|NCT01137682|17933765|P1|Overall Study|Lack of Efficacy-Extension|15
5194702|NCT01137682|17933763|P3|Overall Study|Adverse Event-Extension|7
5194703|NCT01137682|17933764|P2|Overall Study|Adverse Event-Extension|8
5194704|NCT01137682|17933765|P1|Overall Study|Adverse Event-Extension|4
5194705|NCT01137682|17933763|P3|Overall Study|Protocol Violation-CORE|1
5194706|NCT01137682|17933764|P2|Overall Study|Protocol Violation-CORE|1
5194707|NCT01137682|17933765|P1|Overall Study|Protocol Violation-CORE|0
5194708|NCT01137682|17933763|P3|Overall Study|Administrative problems-CORE|0
5194709|NCT01137682|17933764|P2|Overall Study|Administrative problems-CORE|1
5194710|NCT01137682|17933765|P1|Overall Study|Administrative problems-CORE|2
5194711|NCT01137682|17933763|P3|Overall Study|Withdrawal by Subject-CORE|2
5194712|NCT01137682|17933764|P2|Overall Study|Withdrawal by Subject-CORE|2
5194713|NCT01137682|17933765|P1|Overall Study|Withdrawal by Subject-CORE|2
5194714|NCT01137682|17933763|P3|Overall Study|Adverse Event-CORE|0
5194715|NCT01137682|17933764|P2|Overall Study|Adverse Event-CORE|4
5194716|NCT01137682|17933765|P1|Overall Study|Adverse Event-CORE|2
5194717|NCT01137604|17933815|P4|Overall Study|Clinical Decline|1
5194718|NCT01137604|17933816|P3|Overall Study|Clinical Decline|1
5194719|NCT01137604|17933817|P2|Overall Study|Clinical Decline|0
5194720|NCT01137604|17933818|P1|Overall Study|Clinical Decline|0
5194721|NCT01137604|17933815|P4|Overall Study|Participant's Decision|0
5194722|NCT01137604|17933816|P3|Overall Study|Participant's Decision|0
5194723|NCT01137604|17933817|P2|Overall Study|Participant's Decision|0
5194724|NCT01137604|17933818|P1|Overall Study|Participant's Decision|1
5194725|NCT01137604|17933815|P4|Overall Study|Clinical Progression|0
5194726|NCT01137604|17933816|P3|Overall Study|Clinical Progression|1
5194727|NCT01137604|17933817|P2|Overall Study|Clinical Progression|2
5194728|NCT01137604|17933818|P1|Overall Study|Clinical Progression|0
5194729|NCT01137604|17933815|P4|Overall Study|Withdrawal by Subject|1
5194730|NCT01137604|17933816|P3|Overall Study|Withdrawal by Subject|2
5194731|NCT01137604|17933817|P2|Overall Study|Withdrawal by Subject|2
5194732|NCT01137604|17933818|P1|Overall Study|Withdrawal by Subject|0
5194733|NCT01137604|17933815|P4|Overall Study|Adverse Event|9
5194734|NCT01137604|17933816|P3|Overall Study|Adverse Event|9
5194735|NCT01137604|17933817|P2|Overall Study|Adverse Event|6
5194736|NCT01137604|17933818|P1|Overall Study|Adverse Event|1
5194737|NCT01137578|17933852|P3|Overall Study|Other|6
5194738|NCT01137578|17933853|P2|Overall Study|Other|2
5194739|NCT01137578|17933854|P1|Overall Study|Other|12
5194740|NCT01137578|17933852|P3|Overall Study|Withdrawal by Subject|0
5194741|NCT01137578|17933853|P2|Overall Study|Withdrawal by Subject|0
5194742|NCT01137578|17933854|P1|Overall Study|Withdrawal by Subject|1
5194743|NCT01137578|17933852|P3|Overall Study|Participant requested to Discontinue|0
5194744|NCT01137578|17933853|P2|Overall Study|Participant requested to Discontinue|0
5194745|NCT01137578|17933854|P1|Overall Study|Participant requested to Discontinue|3
5194746|NCT01137474|17933903|P4|Overall Study|Administrative reason by sponsor|0
5194747|NCT01137474|17933904|P3|Overall Study|Administrative reason by sponsor|0
5194748|NCT01137474|17933905|P2|Overall Study|Administrative reason by sponsor|1
5194749|NCT01137474|17933906|P1|Overall Study|Administrative reason by sponsor|0
5194750|NCT01137474|17933903|P4|Overall Study|Pregnancy|0
5194751|NCT01137474|17933904|P3|Overall Study|Pregnancy|0
5194752|NCT01137474|17933905|P2|Overall Study|Pregnancy|1
5194753|NCT01137474|17933906|P1|Overall Study|Pregnancy|0
5194754|NCT01137474|17933903|P4|Overall Study|Other|0
5194755|NCT01137474|17933904|P3|Overall Study|Other|0
5194756|NCT01137474|17933905|P2|Overall Study|Other|1
5194757|NCT01137474|17933906|P1|Overall Study|Other|3
5194758|NCT01137474|17933903|P4|Overall Study|Lack of Efficacy|2
5194759|NCT01137474|17933904|P3|Overall Study|Lack of Efficacy|0
5194760|NCT01137474|17933905|P2|Overall Study|Lack of Efficacy|0
5194761|NCT01137474|17933906|P1|Overall Study|Lack of Efficacy|0
5194762|NCT01137474|17933903|P4|Overall Study|Lost to Follow-up|2
5194763|NCT01137474|17933904|P3|Overall Study|Lost to Follow-up|0
5194764|NCT01137474|17933905|P2|Overall Study|Lost to Follow-up|1
5194765|NCT01137474|17933906|P1|Overall Study|Lost to Follow-up|5
5194766|NCT01137474|17933903|P4|Overall Study|No longer met study criteria|5
5194767|NCT01137474|17933904|P3|Overall Study|No longer met study criteria|0
5194768|NCT01137474|17933905|P2|Overall Study|No longer met study criteria|1
5194769|NCT01137474|17933906|P1|Overall Study|No longer met study criteria|6
5194770|NCT01137474|17933903|P4|Overall Study|Withdrawal by Subject|9
5194771|NCT01137474|17933904|P3|Overall Study|Withdrawal by Subject|6
5194772|NCT01137474|17933905|P2|Overall Study|Withdrawal by Subject|2
5194773|NCT01137474|17933906|P1|Overall Study|Withdrawal by Subject|7
5194774|NCT01137474|17933903|P4|Overall Study|Adverse Event|3
5194775|NCT01137474|17933904|P3|Overall Study|Adverse Event|1
5194776|NCT01137474|17933905|P2|Overall Study|Adverse Event|5
5194777|NCT01137474|17933906|P1|Overall Study|Adverse Event|3
5194778|NCT01137435|17933924|P1|Overall Study|Off label usage|4
5194779|NCT01137435|17933924|P1|Overall Study|Lost to Follow-up|24
5194780|NCT01137292|17933951|P1|Overall Study|Other|7
5194781|NCT01137292|17933951|P1|Overall Study|Lost to Follow-up|1
5194782|NCT01137292|17933951|P1|Overall Study|Lack of Efficacy|13
5194783|NCT01137292|17933951|P1|Overall Study|Adverse Event|3
5194784|NCT01137292|17933951|P1|Overall Study|Death|30
5194785|NCT01137110|17933960|P2|Overall Study|Protocol Violation|0
5194786|NCT01137110|17933961|P1|Overall Study|Protocol Violation|1
5194787|NCT01137071|17933967|P1|Overall Study|Wrongly Included|1
5194788|NCT01137071|17933967|P1|Overall Study|Withdrawal by Subject|2
5194789|NCT01137071|17933967|P1|Overall Study|Disease Progression|11
5194790|NCT01136967|17934123|P2|Overall Study|Diagnosis of Second Primary Cancer|1
5194791|NCT01136967|17934124|P1|Overall Study|Diagnosis of Second Primary Cancer|0
5194792|NCT01136967|17934123|P2|Overall Study|Increase in Lesion Size|2
5194793|NCT01136967|17934124|P1|Overall Study|Increase in Lesion Size|0
5194794|NCT01136967|17934123|P2|Overall Study|Investigator's Choice|1
5194795|NCT01136967|17934124|P1|Overall Study|Investigator's Choice|1
5194796|NCT01136967|17934123|P2|Overall Study|Non-compliance|0
5194797|NCT01136967|17934124|P1|Overall Study|Non-compliance|1
5194798|NCT01136967|17934123|P2|Overall Study|Radiation|0
5194799|NCT01136967|17934124|P1|Overall Study|Radiation|1
5194800|NCT01136967|17934123|P2|Overall Study|Clinical Progression|5
5194801|NCT01136967|17934124|P1|Overall Study|Clinical Progression|3
5194802|NCT01136967|17934123|P2|Overall Study|Withdrawal by Subject|2
5194803|NCT01136967|17934124|P1|Overall Study|Withdrawal by Subject|1
5194804|NCT01136967|17934123|P2|Overall Study|Lost to Follow-up|1
5194805|NCT01136967|17934124|P1|Overall Study|Lost to Follow-up|0
5194806|NCT01136967|17934123|P2|Overall Study|Participant Choice|3
5194807|NCT01136967|17934124|P1|Overall Study|Participant Choice|8
5194808|NCT01136967|17934123|P2|Overall Study|Adverse Event|12
5194809|NCT01136967|17934124|P1|Overall Study|Adverse Event|9
5194810|NCT01136954|17934146|P2|Overall Study|Other|3
5194811|NCT01136954|17934147|P1|Overall Study|Other|1
5194812|NCT01136954|17934146|P2|Overall Study|Physician Decision|1
5194813|NCT01136954|17934147|P1|Overall Study|Physician Decision|0
5194814|NCT01136954|17934146|P2|Overall Study|Lack of Efficacy|13
5194815|NCT01136954|17934147|P1|Overall Study|Lack of Efficacy|14
5194816|NCT01136954|17934146|P2|Overall Study|Withdrawal by Subject|2
5194817|NCT01136954|17934147|P1|Overall Study|Withdrawal by Subject|6
5194818|NCT01136954|17934146|P2|Overall Study|Adverse Event|2
5194819|NCT01136954|17934147|P1|Overall Study|Adverse Event|3
5194820|NCT01136915|17934161|P2|Overall Study|Exclusion criterion met|1
5194821|NCT01136915|17934162|P1|Overall Study|Exclusion criterion met|0
5194822|NCT01136915|17934161|P2|Overall Study|Lost to Follow-up|0
5194823|NCT01136915|17934162|P1|Overall Study|Lost to Follow-up|2
5194824|NCT01136876|17934172|P2|Overall Study|Missing NGAL measurement|5
5194825|NCT01136876|17934173|P1|Overall Study|Missing NGAL measurement|2
5194826|NCT01136876|17934172|P2|Overall Study|Physician Decision|5
5194827|NCT01136876|17934173|P1|Overall Study|Physician Decision|3
5194828|NCT01136876|17934172|P2|Overall Study|Lost to Follow-up|1
5194829|NCT01136876|17934173|P1|Overall Study|Lost to Follow-up|0
5194830|NCT01136785|17934202|P2|Overall Study|Protocol Violation|1
5194831|NCT01136785|17934203|P1|Overall Study|Protocol Violation|2
5194832|NCT01136772|17934218|P2|Overall Study|Did not follow up after first injection|2
5194833|NCT01136772|17934219|P1|Overall Study|Did not follow up after first injection|2
5194834|NCT01136772|17934218|P2|Overall Study|Did not receive injection|7
5194835|NCT01136772|17934219|P1|Overall Study|Did not receive injection|10
5194836|NCT01136772|17934218|P2|Overall Study|Withdrawal by Subject|36
5194837|NCT01136772|17934219|P1|Overall Study|Withdrawal by Subject|33
5194838|NCT01136772|17934218|P2|Overall Study|Administrative|12
5194839|NCT01136772|17934219|P1|Overall Study|Administrative|14
5194840|NCT01136772|17934218|P2|Overall Study|Lack of Efficacy|39
5194841|NCT01136772|17934219|P1|Overall Study|Lack of Efficacy|42
5194842|NCT01136772|17934218|P2|Overall Study|Adverse Event|14
5194843|NCT01136772|17934219|P1|Overall Study|Adverse Event|15
5194844|NCT01136746|17934229|P2|Overall Study|Death|0
5194845|NCT01136746|17934230|P1|Overall Study|Death|1
5194846|NCT01136746|17934229|P2|Overall Study|Protocol Violation|1
5194847|NCT01136746|17934230|P1|Overall Study|Protocol Violation|2
5194848|NCT01136746|17934229|P2|Overall Study|Lost to Follow-up|2
5194849|NCT01136746|17934230|P1|Overall Study|Lost to Follow-up|0
5194850|NCT01136733|17934297|P7|Phase 2|Other|6
5194851|NCT01136733|17934298|P6|Phase 2|Other|7
5194852|NCT01136733|17934299|P5|Phase 2|Other|6
5194853|NCT01136733|17934300|P4|Phase 2|Other|0
5194854|NCT01136733|17934301|P3|Phase 2|Other|0
5194855|NCT01136733|17934302|P2|Phase 2|Other|0
5194856|NCT01136733|17934303|P1|Phase 2|Other|0
5194857|NCT01136733|17934297|P7|Phase 2|Administrative-Withdrew Consent|0
5194858|NCT01136733|17934298|P6|Phase 2|Administrative-Withdrew Consent|0
5194859|NCT01136733|17934299|P5|Phase 2|Administrative-Withdrew Consent|1
5194860|NCT01136733|17934300|P4|Phase 2|Administrative-Withdrew Consent|0
5194861|NCT01136733|17934301|P3|Phase 2|Administrative-Withdrew Consent|0
5194862|NCT01136733|17934302|P2|Phase 2|Administrative-Withdrew Consent|0
5194863|NCT01136733|17934303|P1|Phase 2|Administrative-Withdrew Consent|0
5194864|NCT01136733|17934297|P7|Phase 2|Participant Choice|1
5194865|NCT01136733|17934298|P6|Phase 2|Participant Choice|0
5194866|NCT01136733|17934299|P5|Phase 2|Participant Choice|3
5194867|NCT01136733|17934300|P4|Phase 2|Participant Choice|0
5194868|NCT01136733|17934301|P3|Phase 2|Participant Choice|0
5194869|NCT01136733|17934302|P2|Phase 2|Participant Choice|0
5194870|NCT01136733|17934303|P1|Phase 2|Participant Choice|0
5194871|NCT01136733|17934297|P7|Phase 2|Adverse Event|5
5194872|NCT01136733|17934298|P6|Phase 2|Adverse Event|13
5194873|NCT01136733|17934299|P5|Phase 2|Adverse Event|11
5194874|NCT01136733|17934300|P4|Phase 2|Adverse Event|0
5194875|NCT01136733|17934301|P3|Phase 2|Adverse Event|0
5194876|NCT01136733|17934302|P2|Phase 2|Adverse Event|0
5194877|NCT01136733|17934303|P1|Phase 2|Adverse Event|0
5194878|NCT01136733|17934297|P7|Phase 2|Disease Progression|38
5194879|NCT01136733|17934298|P6|Phase 2|Disease Progression|32
5194880|NCT01136733|17934299|P5|Phase 2|Disease Progression|30
5194881|NCT01136733|17934300|P4|Phase 2|Disease Progression|0
5194882|NCT01136733|17934301|P3|Phase 2|Disease Progression|0
5194883|NCT01136733|17934302|P2|Phase 2|Disease Progression|0
5194884|NCT01136733|17934303|P1|Phase 2|Disease Progression|0
5194885|NCT01136733|17934297|P7|Phase 1b|Clinical Progression|0
5194886|NCT01136733|17934298|P6|Phase 1b|Clinical Progression|0
5194887|NCT01136733|17934299|P5|Phase 1b|Clinical Progression|0
5194888|NCT01136733|17934300|P4|Phase 1b|Clinical Progression|0
5194889|NCT01136733|17934301|P3|Phase 1b|Clinical Progression|0
5194890|NCT01136733|17934302|P2|Phase 1b|Clinical Progression|1
5194891|NCT01136733|17934303|P1|Phase 1b|Clinical Progression|1
5194892|NCT01136733|17934297|P7|Phase 1b|Administrative-Withdrew Consent|0
5194893|NCT01136733|17934298|P6|Phase 1b|Administrative-Withdrew Consent|0
5194894|NCT01136733|17934299|P5|Phase 1b|Administrative-Withdrew Consent|0
5194895|NCT01136733|17934300|P4|Phase 1b|Administrative-Withdrew Consent|0
5194896|NCT01136733|17934301|P3|Phase 1b|Administrative-Withdrew Consent|0
5194897|NCT01136733|17934302|P2|Phase 1b|Administrative-Withdrew Consent|1
5194898|NCT01136733|17934303|P1|Phase 1b|Administrative-Withdrew Consent|0
5194899|NCT01136733|17934297|P7|Phase 1b|Participant Choice|0
5194900|NCT01136733|17934298|P6|Phase 1b|Participant Choice|0
5194901|NCT01136733|17934299|P5|Phase 1b|Participant Choice|0
5194902|NCT01136733|17934300|P4|Phase 1b|Participant Choice|0
5194903|NCT01136733|17934301|P3|Phase 1b|Participant Choice|1
5194904|NCT01136733|17934302|P2|Phase 1b|Participant Choice|0
5194905|NCT01136733|17934303|P1|Phase 1b|Participant Choice|0
5194906|NCT01136733|17934297|P7|Phase 1b|Adverse Event|0
5194907|NCT01136733|17934298|P6|Phase 1b|Adverse Event|0
5194908|NCT01136733|17934299|P5|Phase 1b|Adverse Event|0
5194909|NCT01136733|17934300|P4|Phase 1b|Adverse Event|0
5194910|NCT01136733|17934301|P3|Phase 1b|Adverse Event|1
5194911|NCT01136733|17934302|P2|Phase 1b|Adverse Event|3
5194912|NCT01136733|17934303|P1|Phase 1b|Adverse Event|0
5194913|NCT01136655|17934386|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
5194914|NCT01136655|17934386|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
5194915|NCT01136655|17934386|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
5194916|NCT01136655|17934386|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
5194917|NCT01136408|17934419|P3|Overall Study|Protocol Violation|1
5194918|NCT01136408|17934420|P2|Overall Study|Protocol Violation|1
5194919|NCT01136408|17934421|P1|Overall Study|Protocol Violation|1
5194920|NCT01136408|17934419|P3|Overall Study|Adverse Event|4
5194921|NCT01136408|17934420|P2|Overall Study|Adverse Event|8
5194922|NCT01136408|17934421|P1|Overall Study|Adverse Event|4
5194923|NCT01136382|17934478|P2|Overall Study|Withdrawal by Subject|1
5194924|NCT01136382|17934479|P1|Overall Study|Withdrawal by Subject|4
5194925|NCT01136382|17934478|P2|Overall Study|Severe Non-Compliance to Protocol|2
5194926|NCT01136382|17934479|P1|Overall Study|Severe Non-Compliance to Protocol|0
5194927|NCT01136382|17934478|P2|Overall Study|Study-Specific Withdrawal Criteria|25
5194928|NCT01136382|17934479|P1|Overall Study|Study-Specific Withdrawal Criteria|48
5194929|NCT01136382|17934478|P2|Overall Study|Other|3
5194930|NCT01136382|17934479|P1|Overall Study|Other|8
5194931|NCT01136356|17934505|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
5194932|NCT01136356|17934506|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
5194933|NCT01136356|17934505|P2|First 18-day Withdrawal|Physician Decision|0
5194934|NCT01136356|17934506|P1|First 18-day Withdrawal|Physician Decision|1
5194935|NCT01136356|17934505|P2|First 18-day Withdrawal|Withdrawal by Subject|0
5194936|NCT01136356|17934506|P1|First 18-day Withdrawal|Withdrawal by Subject|3
5194937|NCT01136291|17934517|P2|Overall Study|Lost to Follow-up|1
5194938|NCT01136291|17934518|P1|Overall Study|Lost to Follow-up|1
5194939|NCT01136174|17934537|P4|Overall Study|Adverse Event|4
5194940|NCT01136174|17934538|P3|Overall Study|Adverse Event|0
5194941|NCT01136174|17934539|P2|Overall Study|Adverse Event|0
5194942|NCT01136174|17934540|P1|Overall Study|Adverse Event|0
5194943|NCT01135992|17934620|P1|Overall Study|Unclassified|7
5194944|NCT01135992|17934620|P1|Overall Study|Withdrawal criteria|10
5194945|NCT01135992|17934620|P1|Overall Study|Protocol Violation|2
5194946|NCT01135992|17934620|P1|Overall Study|Lack of Efficacy|1
5194947|NCT01135992|17934620|P1|Overall Study|Adverse Event|1
5194948|NCT01135914|17934632|P3|Overall Study|Adverse Event|2
5194949|NCT01135914|17934633|P2|Overall Study|Adverse Event|1
5194950|NCT01135914|17934634|P1|Overall Study|Adverse Event|0
5194951|NCT01135914|17934632|P3|Overall Study|Lack of Efficacy|10
5194952|NCT01135914|17934633|P2|Overall Study|Lack of Efficacy|1
5194953|NCT01135914|17934634|P1|Overall Study|Lack of Efficacy|2
5194954|NCT01135914|17934632|P3|Overall Study|Protocol Violation|3
5194955|NCT01135914|17934633|P2|Overall Study|Protocol Violation|0
5194956|NCT01135914|17934634|P1|Overall Study|Protocol Violation|0
5194957|NCT01135914|17934632|P3|Overall Study|Lost to Follow-up|1
5194958|NCT01135914|17934633|P2|Overall Study|Lost to Follow-up|0
5194959|NCT01135914|17934634|P1|Overall Study|Lost to Follow-up|1
5194960|NCT01135914|17934632|P3|Overall Study|Withdrawal by Subject|6
5194961|NCT01135914|17934633|P2|Overall Study|Withdrawal by Subject|3
5194962|NCT01135914|17934634|P1|Overall Study|Withdrawal by Subject|1
5194963|NCT01135524|17934667|P1|Overall Study|Lack of Efficacy|8
5194964|NCT01135524|17934667|P1|Overall Study|Administrative|151
5194965|NCT01135524|17934667|P1|Overall Study|Lost to Follow-up|3
5194966|NCT01135524|17934667|P1|Overall Study|Adverse Event|20
5194967|NCT01135524|17934667|P1|Overall Study|Withdrawal by Subject|14
5194968|NCT01135511|17934680|P9|Overall Study|Withdrawal by Subject|1
5194969|NCT01135511|17934681|P8|Overall Study|Withdrawal by Subject|0
5194970|NCT01135511|17934682|P7|Overall Study|Withdrawal by Subject|1
5194971|NCT01135511|17934683|P6|Overall Study|Withdrawal by Subject|0
5194972|NCT01135511|17934684|P5|Overall Study|Withdrawal by Subject|0
5194973|NCT01135511|17934685|P4|Overall Study|Withdrawal by Subject|0
5194974|NCT01135511|17934686|P3|Overall Study|Withdrawal by Subject|0
5194975|NCT01135511|17934687|P2|Overall Study|Withdrawal by Subject|0
5194976|NCT01135511|17934688|P1|Overall Study|Withdrawal by Subject|0
5194977|NCT01135511|17934680|P9|Overall Study|noncompliance with study drug taken|0
5194978|NCT01135511|17934681|P8|Overall Study|noncompliance with study drug taken|0
5194979|NCT01135511|17934682|P7|Overall Study|noncompliance with study drug taken|0
5194980|NCT01135511|17934683|P6|Overall Study|noncompliance with study drug taken|0
5194981|NCT01135511|17934684|P5|Overall Study|noncompliance with study drug taken|1
5194982|NCT01135511|17934685|P4|Overall Study|noncompliance with study drug taken|0
5194983|NCT01135511|17934686|P3|Overall Study|noncompliance with study drug taken|0
5194984|NCT01135511|17934687|P2|Overall Study|noncompliance with study drug taken|0
5194985|NCT01135511|17934688|P1|Overall Study|noncompliance with study drug taken|0
5194986|NCT01135511|17934680|P9|Overall Study|could not visit the clinic|0
5194987|NCT01135511|17934681|P8|Overall Study|could not visit the clinic|0
5194988|NCT01135511|17934682|P7|Overall Study|could not visit the clinic|0
5194989|NCT01135511|17934683|P6|Overall Study|could not visit the clinic|0
5194990|NCT01135511|17934684|P5|Overall Study|could not visit the clinic|0
5194991|NCT01135511|17934685|P4|Overall Study|could not visit the clinic|0
5194992|NCT01135511|17934686|P3|Overall Study|could not visit the clinic|2
5194993|NCT01135511|17934687|P2|Overall Study|could not visit the clinic|1
5194994|NCT01135511|17934688|P1|Overall Study|could not visit the clinic|0
5194995|NCT01135511|17934680|P9|Overall Study|Pregnancy|0
5194996|NCT01135511|17934681|P8|Overall Study|Pregnancy|0
5194997|NCT01135511|17934682|P7|Overall Study|Pregnancy|0
5194998|NCT01135511|17934683|P6|Overall Study|Pregnancy|0
5194999|NCT01135511|17934684|P5|Overall Study|Pregnancy|0
5195000|NCT01135511|17934685|P4|Overall Study|Pregnancy|1
5195001|NCT01135511|17934686|P3|Overall Study|Pregnancy|0
5195002|NCT01135511|17934687|P2|Overall Study|Pregnancy|0
5195003|NCT01135511|17934688|P1|Overall Study|Pregnancy|0
5195004|NCT01135511|17934680|P9|Overall Study|Protocol Violation|0
5195005|NCT01135511|17934681|P8|Overall Study|Protocol Violation|0
5195006|NCT01135511|17934682|P7|Overall Study|Protocol Violation|0
5195007|NCT01135511|17934683|P6|Overall Study|Protocol Violation|0
5195008|NCT01135511|17934684|P5|Overall Study|Protocol Violation|0
5195009|NCT01135511|17934685|P4|Overall Study|Protocol Violation|0
5195010|NCT01135511|17934686|P3|Overall Study|Protocol Violation|3
5195011|NCT01135511|17934687|P2|Overall Study|Protocol Violation|0
5195012|NCT01135511|17934688|P1|Overall Study|Protocol Violation|0
5195013|NCT01135511|17934680|P9|Overall Study|Lack of Efficacy|0
5195014|NCT01135511|17934681|P8|Overall Study|Lack of Efficacy|0
5195015|NCT01135511|17934682|P7|Overall Study|Lack of Efficacy|0
5195016|NCT01135511|17934683|P6|Overall Study|Lack of Efficacy|0
5195017|NCT01135511|17934684|P5|Overall Study|Lack of Efficacy|0
5195018|NCT01135511|17934685|P4|Overall Study|Lack of Efficacy|2
5195019|NCT01135511|17934686|P3|Overall Study|Lack of Efficacy|1
5195020|NCT01135511|17934687|P2|Overall Study|Lack of Efficacy|1
5195021|NCT01135511|17934688|P1|Overall Study|Lack of Efficacy|0
5195022|NCT01135511|17934680|P9|Overall Study|Adverse Event|0
5195023|NCT01135511|17934681|P8|Overall Study|Adverse Event|1
5195024|NCT01135511|17934682|P7|Overall Study|Adverse Event|0
5195025|NCT01135511|17934683|P6|Overall Study|Adverse Event|1
5195026|NCT01135511|17934684|P5|Overall Study|Adverse Event|0
5195027|NCT01135511|17934685|P4|Overall Study|Adverse Event|0
5195028|NCT01135511|17934686|P3|Overall Study|Adverse Event|2
5195029|NCT01135511|17934687|P2|Overall Study|Adverse Event|1
5195030|NCT01135511|17934688|P1|Overall Study|Adverse Event|0
5195031|NCT01135498|17934970|P1|Overall Study|Ongoing at time of analysis|2
5195032|NCT01135498|17934970|P1|Overall Study|Death|1
5195033|NCT01135498|17934970|P1|Overall Study|Withdrawal by Subject|4
5195034|NCT01135498|17934970|P1|Overall Study|Investigator judgement|25
5195035|NCT01135498|17934970|P1|Overall Study|Progressive disease|38
5195036|NCT01135498|17934970|P1|Overall Study|Adverse Event|20
5195037|NCT01135134|17935149|P2|Overall Study|Did not meet protocol eligibility|0
5195038|NCT01135134|17935150|P1|Overall Study|Did not meet protocol eligibility|1
5195039|NCT01135134|17935149|P2|Overall Study|Adverse Event|1
5195040|NCT01135134|17935150|P1|Overall Study|Adverse Event|1
5195041|NCT01135017|17935173|P2|Overall Study|Other than above|4
5195042|NCT01135017|17935174|P1|Overall Study|Other than above|3
5195043|NCT01135017|17935173|P2|Overall Study|Adverse Event|8
5195044|NCT01135017|17935174|P1|Overall Study|Adverse Event|3
5195045|NCT01134939|17935212|P8|Overall Study|Termination page not available|0
5195046|NCT01134939|17935213|P7|Overall Study|Termination page not available|7
5195047|NCT01134939|17935214|P6|Overall Study|Termination page not available|3
5195048|NCT01134939|17935215|P5|Overall Study|Termination page not available|0
5195049|NCT01134939|17935216|P4|Overall Study|Termination page not available|8
5195050|NCT01134939|17935217|P3|Overall Study|Termination page not available|5
5195051|NCT01134939|17935218|P2|Overall Study|Termination page not available|6
5195052|NCT01134939|17935219|P1|Overall Study|Termination page not available|4
5195053|NCT01134939|17935212|P8|Overall Study|Death|0
5195054|NCT01134939|17935213|P7|Overall Study|Death|0
5195055|NCT01134939|17935214|P6|Overall Study|Death|0
5195056|NCT01134939|17935215|P5|Overall Study|Death|0
5195057|NCT01134939|17935216|P4|Overall Study|Death|0
5195058|NCT01134939|17935217|P3|Overall Study|Death|0
5195059|NCT01134939|17935218|P2|Overall Study|Death|1
5195060|NCT01134939|17935219|P1|Overall Study|Death|0
5195061|NCT01134939|17935212|P8|Overall Study|Lost to Follow-up|0
5195062|NCT01134939|17935213|P7|Overall Study|Lost to Follow-up|0
5195063|NCT01134939|17935214|P6|Overall Study|Lost to Follow-up|1
5195064|NCT01134939|17935215|P5|Overall Study|Lost to Follow-up|2
5195065|NCT01134939|17935216|P4|Overall Study|Lost to Follow-up|1
5195066|NCT01134939|17935217|P3|Overall Study|Lost to Follow-up|0
5195067|NCT01134939|17935218|P2|Overall Study|Lost to Follow-up|3
5195068|NCT01134939|17935219|P1|Overall Study|Lost to Follow-up|2
5195069|NCT01134939|17935212|P8|Overall Study|Lack of Efficacy|0
5195070|NCT01134939|17935213|P7|Overall Study|Lack of Efficacy|1
5195071|NCT01134939|17935214|P6|Overall Study|Lack of Efficacy|0
5195072|NCT01134939|17935215|P5|Overall Study|Lack of Efficacy|3
5195073|NCT01134939|17935216|P4|Overall Study|Lack of Efficacy|0
5195074|NCT01134939|17935217|P3|Overall Study|Lack of Efficacy|1
5195075|NCT01134939|17935218|P2|Overall Study|Lack of Efficacy|5
5195076|NCT01134939|17935219|P1|Overall Study|Lack of Efficacy|2
5195077|NCT01134939|17935212|P8|Overall Study|Adverse Event|0
5195078|NCT01134939|17935213|P7|Overall Study|Adverse Event|1
5195079|NCT01134939|17935214|P6|Overall Study|Adverse Event|5
5195080|NCT01134939|17935215|P5|Overall Study|Adverse Event|5
5195081|NCT01134939|17935216|P4|Overall Study|Adverse Event|5
5195082|NCT01134939|17935217|P3|Overall Study|Adverse Event|4
5195083|NCT01134939|17935218|P2|Overall Study|Adverse Event|3
5195084|NCT01134939|17935219|P1|Overall Study|Adverse Event|9
5195085|NCT01134783|17935357|P2|Overall Study|Lost to Follow-up|20
5195086|NCT01134783|17935358|P1|Overall Study|Lost to Follow-up|5
5195087|NCT01134783|17935357|P2|Overall Study|Withdrawal by Subject|9
5195088|NCT01134783|17935358|P1|Overall Study|Withdrawal by Subject|15
5195089|NCT01134783|17935357|P2|Overall Study|Pregnancy|8
5195090|NCT01134783|17935358|P1|Overall Study|Pregnancy|16
5195091|NCT01134731|17935377|P3|Overall Study|Lost to Follow-up|3
5195092|NCT01134731|17935378|P2|Overall Study|Lost to Follow-up|4
5195093|NCT01134731|17935379|P1|Overall Study|Lost to Follow-up|5
5195094|NCT01134731|17935377|P3|Overall Study|Withdrawal by Subject|1
5195095|NCT01134731|17935378|P2|Overall Study|Withdrawal by Subject|3
5195096|NCT01134731|17935379|P1|Overall Study|Withdrawal by Subject|3
5195097|NCT01134731|17935377|P3|Overall Study|Lack of Efficacy|1
5195098|NCT01134731|17935378|P2|Overall Study|Lack of Efficacy|0
5195099|NCT01134731|17935379|P1|Overall Study|Lack of Efficacy|0
5195100|NCT01134731|17935377|P3|Overall Study|Physician Decision|2
5195101|NCT01134731|17935378|P2|Overall Study|Physician Decision|2
5195102|NCT01134731|17935379|P1|Overall Study|Physician Decision|2
5195103|NCT01134731|17935377|P3|Overall Study|Adverse Event|1
5195104|NCT01134731|17935378|P2|Overall Study|Adverse Event|2
5195105|NCT01134731|17935379|P1|Overall Study|Adverse Event|3
5195106|NCT01134705|17935392|P2|Overall Study|Other|6
5195107|NCT01134705|17935393|P1|Overall Study|Other|1
5195108|NCT01134705|17935392|P2|Overall Study|Protocol Violation|1
5195109|NCT01134705|17935393|P1|Overall Study|Protocol Violation|1
5195110|NCT01134705|17935392|P2|Overall Study|Lost to Follow-up|2
5195111|NCT01134705|17935393|P1|Overall Study|Lost to Follow-up|5
5195112|NCT01134705|17935392|P2|Overall Study|Pregnancy|0
5195113|NCT01134705|17935393|P1|Overall Study|Pregnancy|1
5195114|NCT01134705|17935392|P2|Overall Study|Withdrawal by Subject|6
5195115|NCT01134705|17935393|P1|Overall Study|Withdrawal by Subject|6
5195116|NCT01134705|17935392|P2|Overall Study|Adverse Event|7
5195117|NCT01134705|17935393|P1|Overall Study|Adverse Event|1
5195118|NCT01134627|17935405|P2|Overall Study|Other|14
5195119|NCT01134627|17935406|P1|Overall Study|Other|11
5195120|NCT01134627|17935405|P2|Overall Study|Planning to become pregnant/pregnancy|0
5195121|NCT01134627|17935406|P1|Overall Study|Planning to become pregnant/pregnancy|1
5195122|NCT01134627|17935405|P2|Overall Study|Withdrawal by Subject|3
5195123|NCT01134627|17935406|P1|Overall Study|Withdrawal by Subject|4
5195124|NCT01134627|17935405|P2|Overall Study|Lack of Efficacy|12
5195125|NCT01134627|17935406|P1|Overall Study|Lack of Efficacy|2
5195126|NCT01134627|17935405|P2|Overall Study|Protocol Violation|5
5195127|NCT01134627|17935406|P1|Overall Study|Protocol Violation|3
5195128|NCT01134627|17935405|P2|Overall Study|Lost to Follow-up|2
5195129|NCT01134627|17935406|P1|Overall Study|Lost to Follow-up|1
5195130|NCT01134627|17935405|P2|Overall Study|Adverse Event|31
5195131|NCT01134627|17935406|P1|Overall Study|Adverse Event|47
5195132|NCT01134614|17935436|P2|Overall Study|Patient in hospice care|1
5195133|NCT01134614|17935437|P1|Overall Study|Patient in hospice care|0
5195134|NCT01134614|17935436|P2|Overall Study|Symptomatic deterioration|1
5195135|NCT01134614|17935437|P1|Overall Study|Symptomatic deterioration|0
5195136|NCT01134614|17935436|P2|Overall Study|Pt received tx not allowed on study|1
5195137|NCT01134614|17935437|P1|Overall Study|Pt received tx not allowed on study|0
5195138|NCT01134614|17935436|P2|Overall Study|Never started treatment|1
5195139|NCT01134614|17935437|P1|Overall Study|Never started treatment|4
5195140|NCT01134614|17935436|P2|Overall Study|Physician's decision|1
5195141|NCT01134614|17935437|P1|Overall Study|Physician's decision|0
5195142|NCT01134614|17935436|P2|Overall Study|Complicating disease|1
5195143|NCT01134614|17935437|P1|Overall Study|Complicating disease|2
5195144|NCT01134614|17935436|P2|Overall Study|Alternative therapy|0
5195145|NCT01134614|17935437|P1|Overall Study|Alternative therapy|2
5195146|NCT01134614|17935436|P2|Overall Study|Withdrawal by Subject|2
5195147|NCT01134614|17935437|P1|Overall Study|Withdrawal by Subject|3
5195148|NCT01134614|17935436|P2|Overall Study|Death|8
5195149|NCT01134614|17935437|P1|Overall Study|Death|5
5195150|NCT01134614|17935436|P2|Overall Study|Adverse Event|39
5195151|NCT01134614|17935437|P1|Overall Study|Adverse Event|26
5195152|NCT01134614|17935436|P2|Overall Study|Progressive disease|54
5195153|NCT01134614|17935437|P1|Overall Study|Progressive disease|60
5195154|NCT01134614|17935436|P2|Overall Study|Still on treatment as of March 2013|13
5195155|NCT01134614|17935437|P1|Overall Study|Still on treatment as of March 2013|21
5195156|NCT01134562|17935465|P5|Overall Study|Adverse Event|0
5195157|NCT01134562|17935466|P4|Overall Study|Adverse Event|0
5195158|NCT01134562|17935467|P3|Overall Study|Adverse Event|0
5195159|NCT01134562|17935468|P2|Overall Study|Adverse Event|1
5195160|NCT01134562|17935469|P1|Overall Study|Adverse Event|0
5195161|NCT01134393|17935641|P1|Overall Study|Other|6
5195162|NCT01134393|17935641|P1|Overall Study|Withdrawal by Subject|11
5195163|NCT01134393|17935641|P1|Overall Study|Lost to Follow-up|3
5195164|NCT01134393|17935641|P1|Overall Study|Protocol Violation|12
5195165|NCT01134393|17935641|P1|Overall Study|Lack of Efficacy|2
5195166|NCT01134393|17935641|P1|Overall Study|Adverse Event|18
5195167|NCT01134315|17935762|P2|Overall Study|Other Reason|17
5195168|NCT01134315|17935763|P1|Overall Study|Other Reason|8
5195169|NCT01134315|17935762|P2|Overall Study|Adverse Event|2
5195170|NCT01134315|17935763|P1|Overall Study|Adverse Event|1
5195171|NCT01134263|17935801|P5|Overall Study|Enrolled, but not treated|0
5195172|NCT01134263|17935802|P4|Overall Study|Enrolled, but not treated|1
5195173|NCT01134263|17935803|P3|Overall Study|Enrolled, but not treated|0
5195174|NCT01134263|17935804|P2|Overall Study|Enrolled, but not treated|1
5195175|NCT01134263|17935805|P1|Overall Study|Enrolled, but not treated|1
5195176|NCT01134263|17935801|P5|Overall Study|Withdrawal by Subject|5
5195177|NCT01134263|17935802|P4|Overall Study|Withdrawal by Subject|7
5195178|NCT01134263|17935803|P3|Overall Study|Withdrawal by Subject|16
5195179|NCT01134263|17935804|P2|Overall Study|Withdrawal by Subject|6
5195180|NCT01134263|17935805|P1|Overall Study|Withdrawal by Subject|8
5195181|NCT01134263|17935801|P5|Overall Study|Lost to Follow-up|1
5195182|NCT01134263|17935802|P4|Overall Study|Lost to Follow-up|3
5195183|NCT01134263|17935803|P3|Overall Study|Lost to Follow-up|5
5195184|NCT01134263|17935804|P2|Overall Study|Lost to Follow-up|3
5195185|NCT01134263|17935805|P1|Overall Study|Lost to Follow-up|4
5195186|NCT01134263|17935801|P5|Overall Study|Protocol Violation|2
5195187|NCT01134263|17935802|P4|Overall Study|Protocol Violation|4
5195188|NCT01134263|17935803|P3|Overall Study|Protocol Violation|2
5195189|NCT01134263|17935804|P2|Overall Study|Protocol Violation|7
5195190|NCT01134263|17935805|P1|Overall Study|Protocol Violation|8
5195191|NCT01134263|17935801|P5|Overall Study|Other adverse event|0
5195192|NCT01134263|17935802|P4|Overall Study|Other adverse event|3
5195193|NCT01134263|17935803|P3|Overall Study|Other adverse event|5
5195194|NCT01134263|17935804|P2|Overall Study|Other adverse event|2
5195195|NCT01134263|17935805|P1|Overall Study|Other adverse event|1
5195196|NCT01134263|17935801|P5|Overall Study|Serious adverse event|1
5195197|NCT01134263|17935802|P4|Overall Study|Serious adverse event|1
5195198|NCT01134263|17935803|P3|Overall Study|Serious adverse event|1
5195199|NCT01134263|17935804|P2|Overall Study|Serious adverse event|1
5195200|NCT01134263|17935805|P1|Overall Study|Serious adverse event|2
5195201|NCT01134107|17935838|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
5195202|NCT01134107|17935839|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
5195203|NCT01134107|17935838|P2|Period 2-Second Treatment Intervention|Physician Decision|0
5195204|NCT01134107|17935839|P1|Period 2-Second Treatment Intervention|Physician Decision|1
5195205|NCT01134107|17935838|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
5195206|NCT01134107|17935839|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
5195207|NCT01134107|17935838|P2|Period 1-First Treatment Intervention|Physician Decision|0
5195208|NCT01134107|17935839|P1|Period 1-First Treatment Intervention|Physician Decision|1
5195209|NCT01134107|17935838|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
5195210|NCT01134107|17935839|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
5195211|NCT01134107|17935838|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
5195212|NCT01134107|17935839|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
5195213|NCT01134107|17935838|P2|Period 1-First Treatment Intervention|Adverse Event|0
5195214|NCT01134107|17935839|P1|Period 1-First Treatment Intervention|Adverse Event|1
5195215|NCT01134055|17935886|P7|Overall Study|Physician Decision|1
5195216|NCT01134055|17935887|P6|Overall Study|Physician Decision|0
5195217|NCT01134055|17935888|P5|Overall Study|Physician Decision|0
5195218|NCT01134055|17935889|P4|Overall Study|Physician Decision|0
5195219|NCT01134055|17935890|P3|Overall Study|Physician Decision|0
5195220|NCT01134055|17935891|P2|Overall Study|Physician Decision|0
5195221|NCT01134055|17935892|P1|Overall Study|Physician Decision|0
5195222|NCT01134055|17935886|P7|Overall Study|Protocol Violation|0
5195223|NCT01134055|17935887|P6|Overall Study|Protocol Violation|0
5195224|NCT01134055|17935888|P5|Overall Study|Protocol Violation|1
5195225|NCT01134055|17935889|P4|Overall Study|Protocol Violation|1
5195226|NCT01134055|17935890|P3|Overall Study|Protocol Violation|0
5195227|NCT01134055|17935891|P2|Overall Study|Protocol Violation|0
5195228|NCT01134055|17935892|P1|Overall Study|Protocol Violation|0
5195229|NCT01134055|17935886|P7|Overall Study|Withdrawal by Subject|8
5195230|NCT01134055|17935887|P6|Overall Study|Withdrawal by Subject|0
5195231|NCT01134055|17935888|P5|Overall Study|Withdrawal by Subject|0
5195232|NCT01134055|17935889|P4|Overall Study|Withdrawal by Subject|2
5195233|NCT01134055|17935890|P3|Overall Study|Withdrawal by Subject|1
5195234|NCT01134055|17935891|P2|Overall Study|Withdrawal by Subject|3
5195235|NCT01134055|17935892|P1|Overall Study|Withdrawal by Subject|3
5195236|NCT01134055|17935886|P7|Overall Study|Lost to Follow-up|0
5195237|NCT01134055|17935887|P6|Overall Study|Lost to Follow-up|0
5195238|NCT01134055|17935888|P5|Overall Study|Lost to Follow-up|0
5195239|NCT01134055|17935889|P4|Overall Study|Lost to Follow-up|1
5195240|NCT01134055|17935890|P3|Overall Study|Lost to Follow-up|0
5195241|NCT01134055|17935891|P2|Overall Study|Lost to Follow-up|1
5195242|NCT01134055|17935892|P1|Overall Study|Lost to Follow-up|0
5195243|NCT01134055|17935886|P7|Overall Study|Adverse Event|2
5195244|NCT01134055|17935887|P6|Overall Study|Adverse Event|7
5195245|NCT01134055|17935888|P5|Overall Study|Adverse Event|5
5195246|NCT01134055|17935889|P4|Overall Study|Adverse Event|2
5195247|NCT01134055|17935890|P3|Overall Study|Adverse Event|2
5195248|NCT01134055|17935891|P2|Overall Study|Adverse Event|2
5195249|NCT01134055|17935892|P1|Overall Study|Adverse Event|5
5195250|NCT01134042|17936026|P3|Overall Study|Withdrawal by Subject|7
5195251|NCT01134042|17936027|P2|Overall Study|Withdrawal by Subject|4
5195252|NCT01134042|17936028|P1|Overall Study|Withdrawal by Subject|13
5195253|NCT01134042|17936026|P3|Overall Study|Physician Decision|1
5195254|NCT01134042|17936027|P2|Overall Study|Physician Decision|8
5195255|NCT01134042|17936028|P1|Overall Study|Physician Decision|4
5195256|NCT01134042|17936026|P3|Overall Study|Lost to Follow-up|1
5195257|NCT01134042|17936027|P2|Overall Study|Lost to Follow-up|0
5195258|NCT01134042|17936028|P1|Overall Study|Lost to Follow-up|2
5195259|NCT01134042|17936026|P3|Overall Study|Protocol Violation|5
5195260|NCT01134042|17936027|P2|Overall Study|Protocol Violation|3
5195261|NCT01134042|17936028|P1|Overall Study|Protocol Violation|5
5195262|NCT01134042|17936026|P3|Overall Study|Lack of Efficacy|18
5195263|NCT01134042|17936027|P2|Overall Study|Lack of Efficacy|6
5195264|NCT01134042|17936028|P1|Overall Study|Lack of Efficacy|21
5195265|NCT01134042|17936026|P3|Overall Study|Adverse Event|2
5195266|NCT01134042|17936027|P2|Overall Study|Adverse Event|7
5195267|NCT01134042|17936028|P1|Overall Study|Adverse Event|3
5195268|NCT01133977|17936104|P5|Overall Study|Withdrawal by Subject|1
5195269|NCT01133977|17936105|P4|Overall Study|Withdrawal by Subject|5
5195270|NCT01133977|17936106|P3|Overall Study|Withdrawal by Subject|0
5195271|NCT01133977|17936107|P2|Overall Study|Withdrawal by Subject|0
5195272|NCT01133977|17936108|P1|Overall Study|Withdrawal by Subject|0
5195273|NCT01133977|17936104|P5|Overall Study|Lost to Follow-up|1
5195274|NCT01133977|17936105|P4|Overall Study|Lost to Follow-up|2
5195275|NCT01133977|17936106|P3|Overall Study|Lost to Follow-up|0
5195276|NCT01133977|17936107|P2|Overall Study|Lost to Follow-up|0
5195277|NCT01133977|17936108|P1|Overall Study|Lost to Follow-up|0
5195278|NCT01133977|17936104|P5|Overall Study|Started a New Line of Therapy|33
5195279|NCT01133977|17936105|P4|Overall Study|Started a New Line of Therapy|25
5195280|NCT01133977|17936106|P3|Overall Study|Started a New Line of Therapy|4
5195281|NCT01133977|17936107|P2|Overall Study|Started a New Line of Therapy|6
5195282|NCT01133977|17936108|P1|Overall Study|Started a New Line of Therapy|2
5195283|NCT01133977|17936104|P5|Overall Study|Death|3
5195284|NCT01133977|17936105|P4|Overall Study|Death|7
5195285|NCT01133977|17936106|P3|Overall Study|Death|1
5195286|NCT01133977|17936107|P2|Overall Study|Death|1
5195287|NCT01133977|17936108|P1|Overall Study|Death|1
5195288|NCT01133977|17936104|P5|Overall Study|Adverse Event|0
5195289|NCT01133977|17936105|P4|Overall Study|Adverse Event|0
5195290|NCT01133977|17936106|P3|Overall Study|Adverse Event|1
5195291|NCT01133977|17936107|P2|Overall Study|Adverse Event|0
5195292|NCT01133977|17936108|P1|Overall Study|Adverse Event|0
5195293|NCT01133847|17936135|P3|Follow-Up Phase|Lost to Follow-up|7
5195294|NCT01133847|17936136|P2|Follow-Up Phase|Lost to Follow-up|3
5195295|NCT01133847|17936137|P1|Follow-Up Phase|Lost to Follow-up|1
5195296|NCT01133847|17936135|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
5195297|NCT01133847|17936136|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
5195298|NCT01133847|17936137|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
5195299|NCT01133821|17936177|P2|Overall Study|Refused participation|3
5195300|NCT01133821|17936178|P1|Overall Study|Refused participation|1
5195301|NCT01133821|17936177|P2|Overall Study|Protocol Violation|1
5195302|NCT01133821|17936178|P1|Overall Study|Protocol Violation|0
5195303|NCT01133821|17936177|P2|Overall Study|preferred other treatment|1
5195304|NCT01133821|17936178|P1|Overall Study|preferred other treatment|1
5195305|NCT01133821|17936177|P2|Overall Study|Withdrawal by Subject|3
5195306|NCT01133821|17936178|P1|Overall Study|Withdrawal by Subject|8
5195307|NCT01133821|17936177|P2|Overall Study|Lost to Follow-up|11
5195308|NCT01133821|17936178|P1|Overall Study|Lost to Follow-up|8
5195309|NCT01133756|17936189|P3|Overall Study|Progression of Disease|1
5195310|NCT01133756|17936190|P2|Overall Study|Progression of Disease|0
5195311|NCT01133756|17936191|P1|Overall Study|Progression of Disease|0
5195312|NCT01133756|17936189|P3|Overall Study|Withdrawal by Subject|0
5195313|NCT01133756|17936190|P2|Overall Study|Withdrawal by Subject|1
5195314|NCT01133756|17936191|P1|Overall Study|Withdrawal by Subject|0
5195315|NCT01133756|17936189|P3|Overall Study|Investigator Decision|0
5195316|NCT01133756|17936190|P2|Overall Study|Investigator Decision|0
5195317|NCT01133756|17936191|P1|Overall Study|Investigator Decision|1
5195318|NCT01133756|17936189|P3|Overall Study|Adverse Event|1
5195319|NCT01133756|17936190|P2|Overall Study|Adverse Event|2
5195320|NCT01133756|17936191|P1|Overall Study|Adverse Event|1
5195321|NCT01133704|17936207|P2|Overall Study|Study Closure|0
5195322|NCT01133704|17936208|P1|Overall Study|Study Closure|1
5195323|NCT01133704|17936207|P2|Overall Study|Patient refused to continue|0
5195324|NCT01133704|17936208|P1|Overall Study|Patient refused to continue|4
5195325|NCT01133704|17936207|P2|Overall Study|Death|26
5195326|NCT01133704|17936208|P1|Overall Study|Death|44
5195327|NCT01133678|17936218|P2|Overall Study|Death|1
5195328|NCT01133678|17936219|P1|Overall Study|Death|1
5195329|NCT01133665|17936225|P1|Overall Study|Physician Decision|2
5195330|NCT01133626|17936285|P3|Overall Study|Other|0
5195331|NCT01133626|17936286|P2|Overall Study|Other|2
5195332|NCT01133626|17936287|P1|Overall Study|Other|0
5195333|NCT01133626|17936285|P3|Overall Study|Withdrawal by Subject|2
5195334|NCT01133626|17936286|P2|Overall Study|Withdrawal by Subject|2
5195335|NCT01133626|17936287|P1|Overall Study|Withdrawal by Subject|1
5195336|NCT01133626|17936285|P3|Overall Study|Adverse Event|0
5195337|NCT01133626|17936286|P2|Overall Study|Adverse Event|1
5195338|NCT01133626|17936287|P1|Overall Study|Adverse Event|0
5195339|NCT01133522|17936305|P10|Overall Study|Physician Decision|0
5195340|NCT01133522|17936306|P9|Overall Study|Physician Decision|0
5195341|NCT01133522|17936307|P8|Overall Study|Physician Decision|0
5195342|NCT01133522|17936308|P7|Overall Study|Physician Decision|0
5195343|NCT01133522|17936309|P6|Overall Study|Physician Decision|0
5195344|NCT01133522|17936310|P5|Overall Study|Physician Decision|1
5195345|NCT01133522|17936311|P4|Overall Study|Physician Decision|0
5195346|NCT01133522|17936312|P3|Overall Study|Physician Decision|0
5195347|NCT01133522|17936313|P2|Overall Study|Physician Decision|0
5195348|NCT01133522|17936314|P1|Overall Study|Physician Decision|0
5195349|NCT01133522|17936305|P10|Overall Study|Withdrawal by Subject|0
5195350|NCT01133522|17936306|P9|Overall Study|Withdrawal by Subject|0
5195351|NCT01133522|17936307|P8|Overall Study|Withdrawal by Subject|0
5195352|NCT01133522|17936308|P7|Overall Study|Withdrawal by Subject|0
5195353|NCT01133522|17936309|P6|Overall Study|Withdrawal by Subject|0
5195354|NCT01133522|17936310|P5|Overall Study|Withdrawal by Subject|0
5195355|NCT01133522|17936311|P4|Overall Study|Withdrawal by Subject|1
5195356|NCT01133522|17936312|P3|Overall Study|Withdrawal by Subject|0
5195357|NCT01133522|17936313|P2|Overall Study|Withdrawal by Subject|1
5195358|NCT01133522|17936314|P1|Overall Study|Withdrawal by Subject|0
5195359|NCT01133418|17936382|P2|Overall Study|Lost to Follow-up|6
5195360|NCT01133418|17936383|P1|Overall Study|Lost to Follow-up|5
5195361|NCT01133405|17936405|P10|Period 2|Physician Decision|0
5195362|NCT01133405|17936406|P9|Period 2|Physician Decision|0
5195363|NCT01133405|17936407|P8|Period 2|Physician Decision|0
5195364|NCT01133405|17936408|P7|Period 2|Physician Decision|0
5195365|NCT01133405|17936409|P6|Period 2|Physician Decision|1
5195366|NCT01133405|17936410|P5|Period 2|Physician Decision|0
5195367|NCT01133405|17936411|P4|Period 2|Physician Decision|0
5195368|NCT01133405|17936412|P3|Period 2|Physician Decision|0
5195369|NCT01133405|17936413|P2|Period 2|Physician Decision|0
5195370|NCT01133405|17936414|P1|Period 2|Physician Decision|0
5195371|NCT01133405|17936405|P10|Period 2|Entry Criteria Not Met|0
5195372|NCT01133405|17936406|P9|Period 2|Entry Criteria Not Met|0
5195373|NCT01133405|17936407|P8|Period 2|Entry Criteria Not Met|0
5195374|NCT01133405|17936408|P7|Period 2|Entry Criteria Not Met|0
5195375|NCT01133405|17936409|P6|Period 2|Entry Criteria Not Met|0
5195376|NCT01133405|17936410|P5|Period 2|Entry Criteria Not Met|0
5195377|NCT01133405|17936411|P4|Period 2|Entry Criteria Not Met|0
5195378|NCT01133405|17936412|P3|Period 2|Entry Criteria Not Met|0
5195379|NCT01133405|17936413|P2|Period 2|Entry Criteria Not Met|1
5195380|NCT01133405|17936414|P1|Period 2|Entry Criteria Not Met|0
5195381|NCT01133405|17936405|P10|Period 2|Withdrawal by Subject|0
5195382|NCT01133405|17936406|P9|Period 2|Withdrawal by Subject|0
5195383|NCT01133405|17936407|P8|Period 2|Withdrawal by Subject|0
5195384|NCT01133405|17936408|P7|Period 2|Withdrawal by Subject|0
5195385|NCT01133405|17936409|P6|Period 2|Withdrawal by Subject|1
5195386|NCT01133405|17936410|P5|Period 2|Withdrawal by Subject|0
5195387|NCT01133405|17936411|P4|Period 2|Withdrawal by Subject|1
5195388|NCT01133405|17936412|P3|Period 2|Withdrawal by Subject|0
5195389|NCT01133405|17936413|P2|Period 2|Withdrawal by Subject|0
5195390|NCT01133405|17936414|P1|Period 2|Withdrawal by Subject|0
5195391|NCT01133405|17936405|P10|Period 2|Adverse Event|0
5195392|NCT01133405|17936406|P9|Period 2|Adverse Event|0
5195393|NCT01133405|17936407|P8|Period 2|Adverse Event|0
5195394|NCT01133405|17936408|P7|Period 2|Adverse Event|0
5195395|NCT01133405|17936409|P6|Period 2|Adverse Event|0
5195396|NCT01133405|17936410|P5|Period 2|Adverse Event|0
5195397|NCT01133405|17936411|P4|Period 2|Adverse Event|0
5195398|NCT01133405|17936412|P3|Period 2|Adverse Event|1
5195399|NCT01133405|17936413|P2|Period 2|Adverse Event|0
5195400|NCT01133405|17936414|P1|Period 2|Adverse Event|0
5195401|NCT01133405|17936405|P10|Period 1|Received drug only in period 3|0
5195402|NCT01133405|17936406|P9|Period 1|Received drug only in period 3|0
5195403|NCT01133405|17936407|P8|Period 1|Received drug only in period 3|0
5195404|NCT01133405|17936408|P7|Period 1|Received drug only in period 3|0
5195405|NCT01133405|17936409|P6|Period 1|Received drug only in period 3|0
5195406|NCT01133405|17936410|P5|Period 1|Received drug only in period 3|0
5195407|NCT01133405|17936411|P4|Period 1|Received drug only in period 3|0
5195408|NCT01133405|17936412|P3|Period 1|Received drug only in period 3|1
5195409|NCT01133405|17936413|P2|Period 1|Received drug only in period 3|1
5195410|NCT01133405|17936414|P1|Period 1|Received drug only in period 3|0
5195411|NCT01133405|17936405|P10|Period 1|Received drug only in period 2|0
5195412|NCT01133405|17936406|P9|Period 1|Received drug only in period 2|0
5195413|NCT01133405|17936407|P8|Period 1|Received drug only in period 2|0
5195414|NCT01133405|17936408|P7|Period 1|Received drug only in period 2|0
5195415|NCT01133405|17936409|P6|Period 1|Received drug only in period 2|1
5195416|NCT01133405|17936410|P5|Period 1|Received drug only in period 2|0
5195417|NCT01133405|17936411|P4|Period 1|Received drug only in period 2|2
5195418|NCT01133405|17936412|P3|Period 1|Received drug only in period 2|0
5195419|NCT01133405|17936413|P2|Period 1|Received drug only in period 2|1
5195420|NCT01133405|17936414|P1|Period 1|Received drug only in period 2|0
5195421|NCT01133405|17936405|P10|Period 1|Discontinued after randomization|0
5195422|NCT01133405|17936406|P9|Period 1|Discontinued after randomization|0
5195423|NCT01133405|17936407|P8|Period 1|Discontinued after randomization|0
5195424|NCT01133405|17936408|P7|Period 1|Discontinued after randomization|1
5195425|NCT01133405|17936409|P6|Period 1|Discontinued after randomization|0
5195426|NCT01133405|17936410|P5|Period 1|Discontinued after randomization|0
5195427|NCT01133405|17936411|P4|Period 1|Discontinued after randomization|0
5195428|NCT01133405|17936412|P3|Period 1|Discontinued after randomization|0
5195429|NCT01133405|17936413|P2|Period 1|Discontinued after randomization|0
5195430|NCT01133405|17936414|P1|Period 1|Discontinued after randomization|1
5195431|NCT01133405|17936405|P10|Period 1|Physician Decision|0
5195432|NCT01133405|17936406|P9|Period 1|Physician Decision|0
5195433|NCT01133405|17936407|P8|Period 1|Physician Decision|0
5195434|NCT01133405|17936408|P7|Period 1|Physician Decision|0
5195435|NCT01133405|17936409|P6|Period 1|Physician Decision|0
5195436|NCT01133405|17936410|P5|Period 1|Physician Decision|0
5195437|NCT01133405|17936411|P4|Period 1|Physician Decision|1
5195438|NCT01133405|17936412|P3|Period 1|Physician Decision|0
5195439|NCT01133405|17936413|P2|Period 1|Physician Decision|0
5195440|NCT01133405|17936414|P1|Period 1|Physician Decision|0
5195441|NCT01133405|17936405|P10|Period 1|Withdrawal by Subject|0
5195442|NCT01133405|17936406|P9|Period 1|Withdrawal by Subject|0
5195443|NCT01133405|17936407|P8|Period 1|Withdrawal by Subject|0
5195444|NCT01133405|17936408|P7|Period 1|Withdrawal by Subject|0
5195445|NCT01133405|17936409|P6|Period 1|Withdrawal by Subject|1
5195446|NCT01133405|17936410|P5|Period 1|Withdrawal by Subject|0
5195447|NCT01133405|17936411|P4|Period 1|Withdrawal by Subject|1
5195448|NCT01133405|17936412|P3|Period 1|Withdrawal by Subject|0
5195449|NCT01133405|17936413|P2|Period 1|Withdrawal by Subject|1
5195450|NCT01133405|17936414|P1|Period 1|Withdrawal by Subject|0
5195451|NCT01133392|17936465|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
5195452|NCT01133392|17936466|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
5195453|NCT01133392|17936465|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
5195454|NCT01133392|17936466|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
5195455|NCT01133379|17936483|P3|Overall Study|Lost to Follow-up|1
5195456|NCT01133379|17936484|P2|Overall Study|Lost to Follow-up|1
5195457|NCT01133379|17936485|P1|Overall Study|Lost to Follow-up|1
5195458|NCT01133379|17936483|P3|Overall Study|Withdrawal by Subject|1
5195459|NCT01133379|17936484|P2|Overall Study|Withdrawal by Subject|1
5195460|NCT01133379|17936485|P1|Overall Study|Withdrawal by Subject|0
5195461|NCT01133288|17936538|P1|Intervention Allocation|study terminated|2
5195462|NCT01133288|17936538|P1|Eligibility Assessment|met exclusion criteria|5
5195463|NCT01133275|17936543|P1|Overall Study|Cerebrovascular accident (CVA)|1
5195464|NCT01133275|17936543|P1|Overall Study|Withdrawal by Subject|1
5195465|NCT01133171|17936551|P3|Overall Study|Withdrawal by Subject|0
5195466|NCT01133171|17936552|P2|Overall Study|Withdrawal by Subject|2
5195467|NCT01133171|17936553|P1|Overall Study|Withdrawal by Subject|1
5195468|NCT01133067|17936569|P1|Overall Study|Lost to Follow-up|3
5195469|NCT01133067|17936569|P1|Overall Study|Death|136
5195470|NCT01132820|17936629|P1|Overall Study|Inadequate data|1
5195471|NCT01132820|17936629|P1|Overall Study|Never treated|1
5195472|NCT01132820|17936629|P1|Overall Study|Ineligible:Inadequate pathology|1
5195473|NCT01132820|17936629|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
5195474|NCT01132820|17936629|P1|Overall Study|Ineligible: wrong cell type|1
5195475|NCT01132755|17936638|P1|Overall Study|Withdrawal by Subject|4
5195476|NCT01132755|17936638|P1|Overall Study|Protocol Violation|15
5195569|NCT01132326|17936846|P1|Overall Study|Lost to Follow-up|16
5195477|NCT01132755|17936638|P1|Overall Study|Procedure not done due to medical reason|23
5195478|NCT01132664|17936667|P5|BM Cohort|Withdrawal by Subject|1
5195479|NCT01132664|17936668|P4|BM Cohort|Withdrawal by Subject|0
5195480|NCT01132664|17936669|P3|BM Cohort|Withdrawal by Subject|0
5195481|NCT01132664|17936670|P2|BM Cohort|Withdrawal by Subject|0
5195482|NCT01132664|17936671|P1|BM Cohort|Withdrawal by Subject|0
5195483|NCT01132664|17936667|P5|BM Cohort|Adverse Event|1
5195484|NCT01132664|17936668|P4|BM Cohort|Adverse Event|0
5195485|NCT01132664|17936669|P3|BM Cohort|Adverse Event|0
5195486|NCT01132664|17936670|P2|BM Cohort|Adverse Event|0
5195487|NCT01132664|17936671|P1|BM Cohort|Adverse Event|0
5195488|NCT01132664|17936667|P5|BM Cohort|Disease progression|4
5195489|NCT01132664|17936668|P4|BM Cohort|Disease progression|3
5195490|NCT01132664|17936669|P3|BM Cohort|Disease progression|0
5195491|NCT01132664|17936670|P2|BM Cohort|Disease progression|0
5195492|NCT01132664|17936671|P1|BM Cohort|Disease progression|0
5195493|NCT01132664|17936667|P5|Phase ll|Disease progression|0
5195494|NCT01132664|17936668|P4|Phase ll|Disease progression|0
5195495|NCT01132664|17936669|P3|Phase ll|Disease progression|35
5195496|NCT01132664|17936670|P2|Phase ll|Disease progression|0
5195497|NCT01132664|17936671|P1|Phase ll|Disease progression|0
5195498|NCT01132664|17936667|P5|Phase ll|Withdrawal by Subject|0
5195499|NCT01132664|17936668|P4|Phase ll|Withdrawal by Subject|0
5195500|NCT01132664|17936669|P3|Phase ll|Withdrawal by Subject|3
5195501|NCT01132664|17936670|P2|Phase ll|Withdrawal by Subject|0
5195502|NCT01132664|17936671|P1|Phase ll|Withdrawal by Subject|0
5195503|NCT01132664|17936667|P5|Phase ll|Adverse Event|0
5195504|NCT01132664|17936668|P4|Phase ll|Adverse Event|0
5195505|NCT01132664|17936669|P3|Phase ll|Adverse Event|10
5195506|NCT01132664|17936670|P2|Phase ll|Adverse Event|0
5195507|NCT01132664|17936671|P1|Phase ll|Adverse Event|0
5195508|NCT01132664|17936667|P5|Phase ll|Death|0
5195509|NCT01132664|17936668|P4|Phase ll|Death|0
5195510|NCT01132664|17936669|P3|Phase ll|Death|2
5195511|NCT01132664|17936670|P2|Phase ll|Death|0
5195512|NCT01132664|17936671|P1|Phase ll|Death|0
5195513|NCT01132664|17936667|P5|Phase lb|Disease Progression|0
5195514|NCT01132664|17936668|P4|Phase lb|Disease Progression|0
5195515|NCT01132664|17936669|P3|Phase lb|Disease Progression|0
5195516|NCT01132664|17936670|P2|Phase lb|Disease Progression|9
5195517|NCT01132664|17936671|P1|Phase lb|Disease Progression|4
5195518|NCT01132664|17936667|P5|Phase lb|Withdrawal by Subject|0
5195519|NCT01132664|17936668|P4|Phase lb|Withdrawal by Subject|0
5195520|NCT01132664|17936669|P3|Phase lb|Withdrawal by Subject|0
5195521|NCT01132664|17936670|P2|Phase lb|Withdrawal by Subject|2
5195522|NCT01132664|17936671|P1|Phase lb|Withdrawal by Subject|1
5195523|NCT01132664|17936667|P5|Phase lb|Adverse Event|0
5195524|NCT01132664|17936668|P4|Phase lb|Adverse Event|0
5195525|NCT01132664|17936669|P3|Phase lb|Adverse Event|0
5195526|NCT01132664|17936670|P2|Phase lb|Adverse Event|1
5195527|NCT01132664|17936671|P1|Phase lb|Adverse Event|0
5195528|NCT01132651|17936705|P2|Overall Study|Lost to Follow-up|1
5195529|NCT01132651|17936706|P1|Overall Study|Lost to Follow-up|1
5195530|NCT01132612|17936717|P3|Overall Study|Lack of Efficacy|73
5195531|NCT01132612|17936718|P2|Overall Study|Lack of Efficacy|22
5195532|NCT01132612|17936719|P1|Overall Study|Lack of Efficacy|23
5195533|NCT01132612|17936717|P3|Overall Study|Administrative problems|52
5195534|NCT01132612|17936718|P2|Overall Study|Administrative problems|1
5195535|NCT01132612|17936719|P1|Overall Study|Administrative problems|5
5195536|NCT01132612|17936717|P3|Overall Study|Withdrawal by Subject|19
5195537|NCT01132612|17936718|P2|Overall Study|Withdrawal by Subject|8
5195538|NCT01132612|17936719|P1|Overall Study|Withdrawal by Subject|5
5195539|NCT01132612|17936717|P3|Overall Study|Adverse Event|15
5195540|NCT01132612|17936718|P2|Overall Study|Adverse Event|2
5195541|NCT01132612|17936719|P1|Overall Study|Adverse Event|5
5195542|NCT01132612|17936717|P3|Overall Study|Lost to Follow-up|7
5195543|NCT01132612|17936718|P2|Overall Study|Lost to Follow-up|2
5195544|NCT01132612|17936719|P1|Overall Study|Lost to Follow-up|2
5195545|NCT01132612|17936717|P3|Overall Study|Protocol deviation|3
5195546|NCT01132612|17936718|P2|Overall Study|Protocol deviation|0
5195547|NCT01132612|17936719|P1|Overall Study|Protocol deviation|0
5195548|NCT01132612|17936717|P3|Overall Study|Death|1
5195549|NCT01132612|17936718|P2|Overall Study|Death|0
5195550|NCT01132612|17936719|P1|Overall Study|Death|0
5195551|NCT01132547|17936735|P2|Overall Study|Death|0
5195552|NCT01132547|17936736|P1|Overall Study|Death|1
5195553|NCT01132547|17936735|P2|Overall Study|Withdrawal by Subject|1
5195554|NCT01132547|17936736|P1|Overall Study|Withdrawal by Subject|3
5195555|NCT01132495|17936806|P4|Overall Study|Various reasons|12
5195556|NCT01132495|17936807|P3|Overall Study|Various reasons|20
5195557|NCT01132495|17936808|P2|Overall Study|Various reasons|38
5195558|NCT01132495|17936809|P1|Overall Study|Various reasons|40
5195559|NCT01132482|17936822|P2|Overall Study|Adverse Event|0
5195560|NCT01132482|17936823|P1|Overall Study|Adverse Event|1
5195561|NCT01132326|17936846|P1|Overall Study|Subject Unable to Come To Visits|1
5195562|NCT01132326|17936846|P1|Overall Study|Death|5
5195563|NCT01132326|17936846|P1|Overall Study|Caregiver Withdrew Consent|1
5195564|NCT01132326|17936846|P1|Overall Study|Pregnancy|1
5195565|NCT01132326|17936846|P1|Overall Study|Declining Health|1
5195566|NCT01132326|17936846|P1|Overall Study|Study Termination|80
5195567|NCT01132326|17936846|P1|Overall Study|Physician Decision|10
5195568|NCT01132326|17936846|P1|Overall Study|Withdrawal by Subject|40
5195570|NCT01132326|17936846|P1|Overall Study|Protocol Violation|1
5195571|NCT01132326|17936846|P1|Overall Study|Adverse Event|37
5195572|NCT01132326|17936846|P1|Overall Study|Lack of Efficacy|25
5195573|NCT01132313|17936862|P12|Overall Study|Other reason not defined above|0
5195574|NCT01132313|17936863|P11|Overall Study|Other reason not defined above|0
5195575|NCT01132313|17936864|P10|Overall Study|Other reason not defined above|0
5195576|NCT01132313|17936865|P9|Overall Study|Other reason not defined above|0
5195577|NCT01132313|17936866|P8|Overall Study|Other reason not defined above|1
5195578|NCT01132313|17936867|P7|Overall Study|Other reason not defined above|0
5195579|NCT01132313|17936868|P6|Overall Study|Other reason not defined above|0
5195580|NCT01132313|17936869|P5|Overall Study|Other reason not defined above|0
5195581|NCT01132313|17936870|P4|Overall Study|Other reason not defined above|0
5195582|NCT01132313|17936871|P3|Overall Study|Other reason not defined above|0
5195583|NCT01132313|17936872|P2|Overall Study|Other reason not defined above|0
5195584|NCT01132313|17936873|P1|Overall Study|Other reason not defined above|0
5195585|NCT01132313|17936862|P12|Overall Study|Lack of antiviral response|0
5195586|NCT01132313|17936863|P11|Overall Study|Lack of antiviral response|1
5195587|NCT01132313|17936864|P10|Overall Study|Lack of antiviral response|0
5195588|NCT01132313|17936865|P9|Overall Study|Lack of antiviral response|0
5195589|NCT01132313|17936866|P8|Overall Study|Lack of antiviral response|0
5195590|NCT01132313|17936867|P7|Overall Study|Lack of antiviral response|21
5195591|NCT01132313|17936868|P6|Overall Study|Lack of antiviral response|18
5195592|NCT01132313|17936869|P5|Overall Study|Lack of antiviral response|18
5195593|NCT01132313|17936870|P4|Overall Study|Lack of antiviral response|18
5195594|NCT01132313|17936871|P3|Overall Study|Lack of antiviral response|12
5195595|NCT01132313|17936872|P2|Overall Study|Lack of antiviral response|0
5195596|NCT01132313|17936873|P1|Overall Study|Lack of antiviral response|0
5195597|NCT01132313|17936862|P12|Overall Study|Withdrawal by Subject|0
5195598|NCT01132313|17936863|P11|Overall Study|Withdrawal by Subject|0
5195599|NCT01132313|17936864|P10|Overall Study|Withdrawal by Subject|2
5195600|NCT01132313|17936865|P9|Overall Study|Withdrawal by Subject|0
5195601|NCT01132313|17936866|P8|Overall Study|Withdrawal by Subject|0
5195602|NCT01132313|17936867|P7|Overall Study|Withdrawal by Subject|1
5195603|NCT01132313|17936868|P6|Overall Study|Withdrawal by Subject|0
5195604|NCT01132313|17936869|P5|Overall Study|Withdrawal by Subject|6
5195605|NCT01132313|17936870|P4|Overall Study|Withdrawal by Subject|3
5195606|NCT01132313|17936871|P3|Overall Study|Withdrawal by Subject|3
5195607|NCT01132313|17936872|P2|Overall Study|Withdrawal by Subject|0
5195608|NCT01132313|17936873|P1|Overall Study|Withdrawal by Subject|0
5195609|NCT01132313|17936862|P12|Overall Study|Lost to Follow-up|0
5195610|NCT01132313|17936863|P11|Overall Study|Lost to Follow-up|0
5195611|NCT01132313|17936864|P10|Overall Study|Lost to Follow-up|0
5195612|NCT01132313|17936865|P9|Overall Study|Lost to Follow-up|0
5195613|NCT01132313|17936866|P8|Overall Study|Lost to Follow-up|1
5195614|NCT01132313|17936867|P7|Overall Study|Lost to Follow-up|0
5195615|NCT01132313|17936868|P6|Overall Study|Lost to Follow-up|0
5195616|NCT01132313|17936869|P5|Overall Study|Lost to Follow-up|0
5195617|NCT01132313|17936870|P4|Overall Study|Lost to Follow-up|0
5195618|NCT01132313|17936871|P3|Overall Study|Lost to Follow-up|1
5195619|NCT01132313|17936872|P2|Overall Study|Lost to Follow-up|0
5195620|NCT01132313|17936873|P1|Overall Study|Lost to Follow-up|0
5195621|NCT01132313|17936862|P12|Overall Study|Protocol Violation|0
5195622|NCT01132313|17936863|P11|Overall Study|Protocol Violation|0
5195623|NCT01132313|17936864|P10|Overall Study|Protocol Violation|0
5195624|NCT01132313|17936865|P9|Overall Study|Protocol Violation|0
5195625|NCT01132313|17936866|P8|Overall Study|Protocol Violation|0
5195626|NCT01132313|17936867|P7|Overall Study|Protocol Violation|0
5195627|NCT01132313|17936868|P6|Overall Study|Protocol Violation|0
5195628|NCT01132313|17936869|P5|Overall Study|Protocol Violation|0
5195629|NCT01132313|17936870|P4|Overall Study|Protocol Violation|1
5195630|NCT01132313|17936871|P3|Overall Study|Protocol Violation|0
5195631|NCT01132313|17936872|P2|Overall Study|Protocol Violation|0
5195632|NCT01132313|17936873|P1|Overall Study|Protocol Violation|0
5195633|NCT01132313|17936862|P12|Overall Study|Adverse Event|0
5195634|NCT01132313|17936863|P11|Overall Study|Adverse Event|0
5195635|NCT01132313|17936864|P10|Overall Study|Adverse Event|2
5195636|NCT01132313|17936865|P9|Overall Study|Adverse Event|7
5195637|NCT01132313|17936866|P8|Overall Study|Adverse Event|3
5195638|NCT01132313|17936867|P7|Overall Study|Adverse Event|5
5195639|NCT01132313|17936868|P6|Overall Study|Adverse Event|6
5195640|NCT01132313|17936869|P5|Overall Study|Adverse Event|19
5195641|NCT01132313|17936870|P4|Overall Study|Adverse Event|10
5195642|NCT01132313|17936871|P3|Overall Study|Adverse Event|4
5195643|NCT01132313|17936872|P2|Overall Study|Adverse Event|0
5195644|NCT01132313|17936873|P1|Overall Study|Adverse Event|0
5195645|NCT01132313|17936862|P12|Overall Study|Not treated|0
5195646|NCT01132313|17936863|P11|Overall Study|Not treated|0
5195647|NCT01132313|17936864|P10|Overall Study|Not treated|0
5195648|NCT01132313|17936865|P9|Overall Study|Not treated|0
5195649|NCT01132313|17936866|P8|Overall Study|Not treated|0
5195650|NCT01132313|17936867|P7|Overall Study|Not treated|3
5195651|NCT01132313|17936868|P6|Overall Study|Not treated|1
5195652|NCT01132313|17936869|P5|Overall Study|Not treated|2
5195653|NCT01132313|17936870|P4|Overall Study|Not treated|0
5195654|NCT01132313|17936871|P3|Overall Study|Not treated|0
5195655|NCT01132313|17936872|P2|Overall Study|Not treated|0
5195656|NCT01132313|17936873|P1|Overall Study|Not treated|2
5195657|NCT01132313|17936862|P12|Overall Study|Lack of Efficacy|0
5195658|NCT01132313|17936863|P11|Overall Study|Lack of Efficacy|0
5195659|NCT01132313|17936864|P10|Overall Study|Lack of Efficacy|16
5195660|NCT01132313|17936865|P9|Overall Study|Lack of Efficacy|14
5195661|NCT01132313|17936866|P8|Overall Study|Lack of Efficacy|3
5195662|NCT01132313|17936867|P7|Overall Study|Lack of Efficacy|0
5195663|NCT01132313|17936868|P6|Overall Study|Lack of Efficacy|0
5195664|NCT01132313|17936869|P5|Overall Study|Lack of Efficacy|0
5195665|NCT01132313|17936870|P4|Overall Study|Lack of Efficacy|0
5195666|NCT01132313|17936871|P3|Overall Study|Lack of Efficacy|0
5195667|NCT01132313|17936872|P2|Overall Study|Lack of Efficacy|0
5195668|NCT01132313|17936873|P1|Overall Study|Lack of Efficacy|1
5195669|NCT01132118|17936953|P2|Second Intervention (8 Weeks)|Adverse Event|1
5195670|NCT01132118|17936954|P1|Second Intervention (8 Weeks)|Adverse Event|0
5195671|NCT01132118|17936953|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
5195672|NCT01132118|17936954|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5195673|NCT01132118|17936953|P2|First Intervention (8 Weeks)|Adverse Event|0
5195674|NCT01132118|17936954|P1|First Intervention (8 Weeks)|Adverse Event|1
5195675|NCT01131676|17936984|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
5195676|NCT01131676|17936985|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
5195677|NCT01131676|17936986|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
5195678|NCT01131676|17936984|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
5195679|NCT01131676|17936985|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
5195680|NCT01131676|17936986|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
5195681|NCT01131676|17936984|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
5195682|NCT01131676|17936985|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
5195683|NCT01131676|17936986|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
5195684|NCT01131676|17936984|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
5195685|NCT01131676|17936985|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
5195686|NCT01131676|17936986|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
5195687|NCT01131676|17936984|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
5195688|NCT01131676|17936985|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
5195689|NCT01131676|17936986|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
5195690|NCT01131676|17936984|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
5195691|NCT01131676|17936985|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
5195692|NCT01131676|17936986|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
5195693|NCT01131676|17936984|P3|Discontinuation From Treatment|Adverse Event|273
5195694|NCT01131676|17936985|P2|Discontinuation From Treatment|Adverse Event|267
5195695|NCT01131676|17936986|P1|Discontinuation From Treatment|Adverse Event|303
5195696|NCT01131676|17936984|P3|Discontinuation From Treatment|Other than those specified|125
5195697|NCT01131676|17936985|P2|Discontinuation From Treatment|Other than those specified|142
5195698|NCT01131676|17936986|P1|Discontinuation From Treatment|Other than those specified|162
5195699|NCT01131676|17936984|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
5195700|NCT01131676|17936985|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
5195701|NCT01131676|17936986|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
5195702|NCT01131676|17936984|P3|Discontinuation From Treatment|Lost to Follow-up|6
5195703|NCT01131676|17936985|P2|Discontinuation From Treatment|Lost to Follow-up|9
5195704|NCT01131676|17936986|P1|Discontinuation From Treatment|Lost to Follow-up|15
5195705|NCT01131676|17936984|P3|Discontinuation From Treatment|Non compliant with protocol|12
5195706|NCT01131676|17936985|P2|Discontinuation From Treatment|Non compliant with protocol|15
5195707|NCT01131676|17936986|P1|Discontinuation From Treatment|Non compliant with protocol|15
5195708|NCT01131676|17936984|P3|Discontinuation From Treatment|Lack of Efficacy|0
5195709|NCT01131676|17936985|P2|Discontinuation From Treatment|Lack of Efficacy|1
5195710|NCT01131676|17936986|P1|Discontinuation From Treatment|Lack of Efficacy|11
5195711|NCT01131676|17936984|P3|Discontinuation From Treatment|Not treated|2
5195712|NCT01131676|17936985|P2|Discontinuation From Treatment|Not treated|2
5195713|NCT01131676|17936986|P1|Discontinuation From Treatment|Not treated|4
5195714|NCT01131676|17936984|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
5195715|NCT01131676|17936985|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
5195716|NCT01131676|17936986|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
5195717|NCT01131585|17937021|P2|Overall Study|Study termination|32
5195718|NCT01131585|17937022|P1|Overall Study|Study termination|78
5195719|NCT01131585|17937021|P2|Overall Study|Administrative problems|1
5195720|NCT01131585|17937022|P1|Overall Study|Administrative problems|1
5195721|NCT01131585|17937021|P2|Overall Study|Lost to Follow-up|1
5195722|NCT01131585|17937022|P1|Overall Study|Lost to Follow-up|0
5195723|NCT01131585|17937021|P2|Overall Study|Withdrawal by Subject|3
5195724|NCT01131585|17937022|P1|Overall Study|Withdrawal by Subject|3
5195725|NCT01131585|17937021|P2|Overall Study|Protocol Violation|1
5195726|NCT01131585|17937022|P1|Overall Study|Protocol Violation|2
5195727|NCT01131585|17937021|P2|Overall Study|Unsatisfactory therapeutic effect|3
5195728|NCT01131585|17937022|P1|Overall Study|Unsatisfactory therapeutic effect|0
5195729|NCT01131585|17937021|P2|Overall Study|Abnormal laboratory value|0
5195730|NCT01131585|17937022|P1|Overall Study|Abnormal laboratory value|1
5195731|NCT01131585|17937021|P2|Overall Study|Adverse Event|2
5195732|NCT01131585|17937022|P1|Overall Study|Adverse Event|0
5195733|NCT01131520|17937030|P2|Overall Study|Subject changed history after enrollment|1
5195734|NCT01131520|17937031|P1|Overall Study|Subject changed history after enrollment|0
5195735|NCT01131520|17937030|P2|Overall Study|Counselor not available|3
5195736|NCT01131520|17937031|P1|Overall Study|Counselor not available|0
5195737|NCT01131520|17937030|P2|Overall Study|Computer problem|0
5195738|NCT01131520|17937031|P1|Overall Study|Computer problem|1
5195739|NCT01131507|17937053|P1|Overall Study|Withdrawal by Subject|1
5195740|NCT01131507|17937053|P1|Overall Study|Lost to Follow-up|1
5195741|NCT01131507|17937053|P1|Overall Study|Adverse Event|1
5195742|NCT01131494|17937058|P1|Overall Study|Withdrawal by Subject|2
5195743|NCT01131455|17937068|P3|Overall Study|Death of PI|0
5195744|NCT01131455|17937069|P2|Overall Study|Death of PI|4
5195745|NCT01131455|17937070|P1|Overall Study|Death of PI|6
5195746|NCT01131312|17937081|P3|Overall Study|Lost to Follow-up|351
5195747|NCT01131312|17937082|P2|Overall Study|Lost to Follow-up|229
5195748|NCT01131312|17937083|P1|Overall Study|Lost to Follow-up|425
5195749|NCT01131299|17937094|P2|Overall Study|Withdrawal by Subject|7
5195750|NCT01131299|17937095|P1|Overall Study|Withdrawal by Subject|4
5195751|NCT01131260|17937108|P2|Overall Study|Ineligible|2
5195752|NCT01131260|17937109|P1|Overall Study|Ineligible|0
5195753|NCT01131260|17937108|P2|Overall Study|Staff error|1
5195754|NCT01131260|17937109|P1|Overall Study|Staff error|2
5195755|NCT01131260|17937108|P2|Overall Study|Technical problems|6
5195756|NCT01131260|17937109|P1|Overall Study|Technical problems|7
5195757|NCT01131260|17937108|P2|Overall Study|Physician Decision|24
5195758|NCT01131260|17937109|P1|Overall Study|Physician Decision|22
5195759|NCT01131260|17937108|P2|Overall Study|Declined to continue participation|13
5195760|NCT01131260|17937109|P1|Overall Study|Declined to continue participation|8
5195761|NCT01131260|17937108|P2|Overall Study|Randomization error|1
5195762|NCT01131260|17937109|P1|Overall Study|Randomization error|5
5195763|NCT01131182|17937157|P2|Overall Study|Other Reason|0
5195764|NCT01131182|17937158|P1|Overall Study|Other Reason|1
5195765|NCT01131182|17937157|P2|Overall Study|Lost to Follow-up|15
5195766|NCT01131182|17937158|P1|Overall Study|Lost to Follow-up|14
5195767|NCT01131182|17937157|P2|Overall Study|Withdrawal by Subject|1
5195768|NCT01131182|17937158|P1|Overall Study|Withdrawal by Subject|1
5195769|NCT01131130|17937166|P1|Period 3- Crossover|+ Slit lamp finding|1
5195770|NCT01131130|17937166|P1|Period 1 - Baseline|Pregnancy|1
5195771|NCT01131104|17937179|P1|Overall Study|No Information on Index Date of Onset|1
5195772|NCT01131104|17937179|P1|Overall Study|Information Not Available|5
5195773|NCT01131104|17937179|P1|Overall Study|Physician Decision|4
5195774|NCT01131104|17937179|P1|Overall Study|Withdrawal by Subject|3
5195775|NCT01131078|17937186|P3|Overall Study|Other|0
5195776|NCT01131078|17937187|P2|Overall Study|Other|1
5195777|NCT01131078|17937188|P1|Overall Study|Other|0
5195778|NCT01131078|17937186|P3|Overall Study|Death|2
5195779|NCT01131078|17937187|P2|Overall Study|Death|0
5195780|NCT01131078|17937188|P1|Overall Study|Death|4
5195781|NCT01131078|17937186|P3|Overall Study|Physician Decision|8
5195782|NCT01131078|17937187|P2|Overall Study|Physician Decision|6
5195783|NCT01131078|17937188|P1|Overall Study|Physician Decision|10
5195784|NCT01131078|17937186|P3|Overall Study|Non-compliance|0
5195785|NCT01131078|17937187|P2|Overall Study|Non-compliance|0
5195786|NCT01131078|17937188|P1|Overall Study|Non-compliance|3
5195787|NCT01131078|17937186|P3|Overall Study|Withdrawal by Subject|3
5195788|NCT01131078|17937187|P2|Overall Study|Withdrawal by Subject|4
5195789|NCT01131078|17937188|P1|Overall Study|Withdrawal by Subject|2
5195790|NCT01131078|17937186|P3|Overall Study|Lost to Follow-up|1
5195791|NCT01131078|17937187|P2|Overall Study|Lost to Follow-up|1
5195792|NCT01131078|17937188|P1|Overall Study|Lost to Follow-up|1
5195793|NCT01131078|17937186|P3|Overall Study|Protocol Violation|0
5195794|NCT01131078|17937187|P2|Overall Study|Protocol Violation|0
5195795|NCT01131078|17937188|P1|Overall Study|Protocol Violation|1
5195796|NCT01131078|17937186|P3|Overall Study|Progressive Disease|71
5195797|NCT01131078|17937187|P2|Overall Study|Progressive Disease|77
5195798|NCT01131078|17937188|P1|Overall Study|Progressive Disease|58
5195799|NCT01131078|17937186|P3|Overall Study|Adverse Event|17
5195800|NCT01131078|17937187|P2|Overall Study|Adverse Event|12
5195801|NCT01131078|17937188|P1|Overall Study|Adverse Event|22
5195802|NCT01130974|17937275|P2|Overall Study|Ineligibility criteria|2
5195803|NCT01130974|17937276|P1|Overall Study|Ineligibility criteria|5
5195804|NCT01130974|17937275|P2|Overall Study|Withdrawal by Subject|1
5195805|NCT01130974|17937276|P1|Overall Study|Withdrawal by Subject|0
5195806|NCT01130974|17937275|P2|Overall Study|Protocol Violation|10
5195807|NCT01130974|17937276|P1|Overall Study|Protocol Violation|10
5195808|NCT01130883|17937302|P1|Overall Study|Adverse Event|3
5195809|NCT01130883|17937302|P1|Overall Study|Reason Unknown|1
5195810|NCT01130883|17937302|P1|Overall Study|Patient Noncompliance|6
5195811|NCT01130831|17937359|P1|Overall Study|Information was missing|3
5195812|NCT01130831|17937359|P1|Overall Study|Death|4
5195813|NCT01130831|17937359|P1|Overall Study|Withdrawal by Subject|7
5195814|NCT01130597|17937398|P1|Overall Study|Protocol Violation|1
5195815|NCT01130597|17937398|P1|Overall Study|Death|1
5195816|NCT01130597|17937398|P1|Overall Study|Adverse Event|4
5195817|NCT01130597|17937398|P1|Overall Study|Protocol-specified (High K+)|1
5195818|NCT01130532|17937423|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
5195819|NCT01130532|17937424|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5195979|NCT01130168|17937545|P4|Period 1|Withdrawal by Subject|1
5195820|NCT01130532|17937425|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5195821|NCT01130532|17937426|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5195822|NCT01130532|17937423|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
5195823|NCT01130532|17937424|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
5195824|NCT01130532|17937425|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
5195825|NCT01130532|17937426|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
5195826|NCT01130532|17937423|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
5195827|NCT01130532|17937424|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5195828|NCT01130532|17937425|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5195829|NCT01130532|17937426|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5195830|NCT01130532|17937423|P4|Period IV (Weeks 13-16)|Adverse Event|1
5195831|NCT01130532|17937424|P3|Period IV (Weeks 13-16)|Adverse Event|0
5195832|NCT01130532|17937425|P2|Period IV (Weeks 13-16)|Adverse Event|0
5195833|NCT01130532|17937426|P1|Period IV (Weeks 13-16)|Adverse Event|0
5195834|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
5195835|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
5195836|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
5195837|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
5195838|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Sponsor Decision|0
5195839|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Sponsor Decision|2
5195840|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Sponsor Decision|4
5195841|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Sponsor Decision|3
5195842|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Protocol Violation|0
5195843|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Protocol Violation|1
5195844|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Protocol Violation|0
5195845|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Protocol Violation|0
5195846|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
5195847|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
5195848|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
5195849|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
5195850|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
5195851|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
5195852|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
5195853|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
5195854|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
5195855|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
5195856|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
5195857|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
5195858|NCT01130532|17937423|P4|Period III (Weeks 0-12)|Adverse Event|0
5195859|NCT01130532|17937424|P3|Period III (Weeks 0-12)|Adverse Event|2
5195860|NCT01130532|17937425|P2|Period III (Weeks 0-12)|Adverse Event|3
5195861|NCT01130532|17937426|P1|Period III (Weeks 0-12)|Adverse Event|3
5195862|NCT01130493|17937471|P3|Part 2: OLE|Withdrawal by Subject|4
5195863|NCT01130493|17937472|P2|Part 2: OLE|Withdrawal by Subject|1
5195864|NCT01130493|17937473|P1|Part 2: OLE|Withdrawal by Subject|0
5195865|NCT01130493|17937471|P3|Part 2: OLE|Adverse Event|1
5195866|NCT01130493|17937472|P2|Part 2: OLE|Adverse Event|2
5195867|NCT01130493|17937473|P1|Part 2: OLE|Adverse Event|0
5195868|NCT01130493|17937471|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
5195869|NCT01130493|17937472|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
5195870|NCT01130493|17937473|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
5195871|NCT01130493|17937471|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
5195872|NCT01130493|17937472|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
5195873|NCT01130493|17937473|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
5195874|NCT01130493|17937471|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
5195875|NCT01130493|17937472|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
5195876|NCT01130493|17937473|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
5195877|NCT01130493|17937471|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
5195878|NCT01130493|17937472|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
5195879|NCT01130493|17937473|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
5195880|NCT01130493|17937471|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
5195881|NCT01130493|17937472|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
5195882|NCT01130493|17937473|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
5195883|NCT01130493|17937471|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
5195884|NCT01130493|17937472|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
5195885|NCT01130493|17937473|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
5195886|NCT01130493|17937471|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
5195887|NCT01130493|17937472|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
5195888|NCT01130493|17937473|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
5195889|NCT01130493|17937471|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
5195890|NCT01130493|17937472|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
5195891|NCT01130493|17937473|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
5195892|NCT01130493|17937471|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
5195893|NCT01130493|17937472|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
5195894|NCT01130493|17937473|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
5195895|NCT01130493|17937471|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
5195980|NCT01130168|17937546|P3|Period 1|Withdrawal by Subject|0
5195896|NCT01130493|17937472|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
5195897|NCT01130493|17937473|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
5195898|NCT01130493|17937471|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
5195899|NCT01130493|17937472|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
5195900|NCT01130493|17937473|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
5195901|NCT01130493|17937471|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
5195902|NCT01130493|17937472|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
5195903|NCT01130493|17937473|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
5195904|NCT01130337|17937490|P1|Overall Study|Surgical resection (R2)|1
5195905|NCT01130337|17937490|P1|Overall Study|Toxicity, AE/intercurrent disease|7
5195906|NCT01130337|17937490|P1|Overall Study|Disease progression|1
5195907|NCT01130337|17937490|P1|Overall Study|Death|1
5195908|NCT01130337|17937490|P1|Overall Study|Principal investigator decision|1
5195909|NCT01130337|17937490|P1|Overall Study|Withdrawal by Subject|3
5195910|NCT01130272|17937502|P5|Overall Study|Study arm discontinued|0
5195911|NCT01130272|17937503|P4|Overall Study|Study arm discontinued|0
5195912|NCT01130272|17937504|P3|Overall Study|Study arm discontinued|0
5195913|NCT01130272|17937505|P2|Overall Study|Study arm discontinued|0
5195914|NCT01130272|17937506|P1|Overall Study|Study arm discontinued|38
5195915|NCT01130272|17937502|P5|Overall Study|Sponsor decision|16
5195916|NCT01130272|17937503|P4|Overall Study|Sponsor decision|13
5195917|NCT01130272|17937504|P3|Overall Study|Sponsor decision|16
5195918|NCT01130272|17937505|P2|Overall Study|Sponsor decision|15
5195919|NCT01130272|17937506|P1|Overall Study|Sponsor decision|6
5195920|NCT01130272|17937502|P5|Overall Study|Physician Decision|2
5195921|NCT01130272|17937503|P4|Overall Study|Physician Decision|1
5195922|NCT01130272|17937504|P3|Overall Study|Physician Decision|0
5195923|NCT01130272|17937505|P2|Overall Study|Physician Decision|1
5195924|NCT01130272|17937506|P1|Overall Study|Physician Decision|1
5195925|NCT01130272|17937502|P5|Overall Study|Withdrawal by Subject|8
5195926|NCT01130272|17937503|P4|Overall Study|Withdrawal by Subject|9
5195927|NCT01130272|17937504|P3|Overall Study|Withdrawal by Subject|10
5195928|NCT01130272|17937505|P2|Overall Study|Withdrawal by Subject|11
5195929|NCT01130272|17937506|P1|Overall Study|Withdrawal by Subject|4
5195930|NCT01130272|17937502|P5|Overall Study|Lost to Follow-up|6
5195931|NCT01130272|17937503|P4|Overall Study|Lost to Follow-up|7
5195932|NCT01130272|17937504|P3|Overall Study|Lost to Follow-up|4
5195933|NCT01130272|17937505|P2|Overall Study|Lost to Follow-up|3
5195934|NCT01130272|17937506|P1|Overall Study|Lost to Follow-up|4
5195935|NCT01130272|17937502|P5|Overall Study|Protocol Violation|5
5195936|NCT01130272|17937503|P4|Overall Study|Protocol Violation|5
5195937|NCT01130272|17937504|P3|Overall Study|Protocol Violation|3
5195938|NCT01130272|17937505|P2|Overall Study|Protocol Violation|0
5195939|NCT01130272|17937506|P1|Overall Study|Protocol Violation|0
5195940|NCT01130272|17937502|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5195941|NCT01130272|17937503|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
5195942|NCT01130272|17937504|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5195943|NCT01130272|17937505|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5195944|NCT01130272|17937506|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5195945|NCT01130272|17937502|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
5195946|NCT01130272|17937503|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
5195947|NCT01130272|17937504|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
5195948|NCT01130272|17937505|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
5195949|NCT01130272|17937506|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
5195950|NCT01130272|17937502|P5|Overall Study|Rescue medications due to diarrhea|6
5195951|NCT01130272|17937503|P4|Overall Study|Rescue medications due to diarrhea|8
5195952|NCT01130272|17937504|P3|Overall Study|Rescue medications due to diarrhea|8
5195953|NCT01130272|17937505|P2|Overall Study|Rescue medications due to diarrhea|5
5195954|NCT01130272|17937506|P1|Overall Study|Rescue medications due to diarrhea|3
5195955|NCT01130272|17937502|P5|Overall Study|IVRS-confirmed constipation|0
5195956|NCT01130272|17937503|P4|Overall Study|IVRS-confirmed constipation|2
5195957|NCT01130272|17937504|P3|Overall Study|IVRS-confirmed constipation|1
5195958|NCT01130272|17937505|P2|Overall Study|IVRS-confirmed constipation|1
5195959|NCT01130272|17937506|P1|Overall Study|IVRS-confirmed constipation|0
5195960|NCT01130272|17937502|P5|Overall Study|Adverse Event|7
5195961|NCT01130272|17937503|P4|Overall Study|Adverse Event|22
5195962|NCT01130272|17937504|P3|Overall Study|Adverse Event|6
5195963|NCT01130272|17937505|P2|Overall Study|Adverse Event|5
5195964|NCT01130272|17937506|P1|Overall Study|Adverse Event|2
5195965|NCT01130168|17937543|P6|Period 1|Adverse Event|0
5195966|NCT01130168|17937544|P5|Period 1|Adverse Event|0
5195967|NCT01130168|17937545|P4|Period 1|Adverse Event|1
5195968|NCT01130168|17937546|P3|Period 1|Adverse Event|0
5195969|NCT01130168|17937547|P2|Period 1|Adverse Event|0
5195970|NCT01130168|17937548|P1|Period 1|Adverse Event|0
5195971|NCT01130168|17937543|P6|Period 1|Discontinued For Other Reason|0
5195972|NCT01130168|17937544|P5|Period 1|Discontinued For Other Reason|0
5195973|NCT01130168|17937545|P4|Period 1|Discontinued For Other Reason|1
5195974|NCT01130168|17937546|P3|Period 1|Discontinued For Other Reason|1
5195975|NCT01130168|17937547|P2|Period 1|Discontinued For Other Reason|0
5195976|NCT01130168|17937548|P1|Period 1|Discontinued For Other Reason|0
5195977|NCT01130168|17937543|P6|Period 1|Withdrawal by Subject|0
5195978|NCT01130168|17937544|P5|Period 1|Withdrawal by Subject|0
5195981|NCT01130168|17937547|P2|Period 1|Withdrawal by Subject|1
5195982|NCT01130168|17937548|P1|Period 1|Withdrawal by Subject|0
5195983|NCT01130103|17937585|P2|Maintenance Treatment|Withdrawal by Subject|0
5195984|NCT01130103|17937586|P1|Maintenance Treatment|Withdrawal by Subject|1
5195985|NCT01130103|17937585|P2|Maintenance Treatment|Lost to Follow-up|1
5195986|NCT01130103|17937586|P1|Maintenance Treatment|Lost to Follow-up|1
5195987|NCT01130103|17937585|P2|Maintenance Treatment|Lack of Efficacy|1
5195988|NCT01130103|17937586|P1|Maintenance Treatment|Lack of Efficacy|0
5195989|NCT01130103|17937585|P2|Randomized Treatment|Withdrawal by Subject|2
5195990|NCT01130103|17937586|P1|Randomized Treatment|Withdrawal by Subject|1
5195991|NCT01130103|17937585|P2|Randomized Treatment|Protocol Violation|2
5195992|NCT01130103|17937586|P1|Randomized Treatment|Protocol Violation|3
5195993|NCT01130103|17937585|P2|Randomized Treatment|Lost to Follow-up|0
5195994|NCT01130103|17937586|P1|Randomized Treatment|Lost to Follow-up|1
5195995|NCT01130103|17937585|P2|Randomized Treatment|Adverse Event|1
5195996|NCT01130103|17937586|P1|Randomized Treatment|Adverse Event|1
5195997|NCT01130051|17937600|P2|Washout Period of 14 Days|Protocol Violation|1
5195998|NCT01130051|17937601|P1|Washout Period of 14 Days|Protocol Violation|1
5195999|NCT01130051|17937600|P2|Washout Period of 14 Days|Withdrawal by Subject|1
5196000|NCT01130051|17937601|P1|Washout Period of 14 Days|Withdrawal by Subject|0
5196001|NCT01129960|17937615|P4|Overall Study|Pregnancy|0
5196002|NCT01129960|17937616|P3|Overall Study|Pregnancy|0
5196003|NCT01129960|17937617|P2|Overall Study|Pregnancy|0
5196004|NCT01129960|17937618|P1|Overall Study|Pregnancy|1
5196005|NCT01129960|17937615|P4|Overall Study|Physician Decision|0
5196006|NCT01129960|17937616|P3|Overall Study|Physician Decision|0
5196007|NCT01129960|17937617|P2|Overall Study|Physician Decision|0
5196008|NCT01129960|17937618|P1|Overall Study|Physician Decision|1
5196009|NCT01129960|17937615|P4|Overall Study|Discontinuation of the study by Sponsor|0
5196010|NCT01129960|17937616|P3|Overall Study|Discontinuation of the study by Sponsor|0
5196011|NCT01129960|17937617|P2|Overall Study|Discontinuation of the study by Sponsor|1
5196012|NCT01129960|17937618|P1|Overall Study|Discontinuation of the study by Sponsor|0
5196013|NCT01129960|17937615|P4|Overall Study|Lost to Follow-up|3
5196014|NCT01129960|17937616|P3|Overall Study|Lost to Follow-up|3
5196015|NCT01129960|17937617|P2|Overall Study|Lost to Follow-up|2
5196016|NCT01129960|17937618|P1|Overall Study|Lost to Follow-up|0
5196017|NCT01129960|17937615|P4|Overall Study|Protocol Violation|0
5196018|NCT01129960|17937616|P3|Overall Study|Protocol Violation|3
5196019|NCT01129960|17937617|P2|Overall Study|Protocol Violation|2
5196020|NCT01129960|17937618|P1|Overall Study|Protocol Violation|1
5196021|NCT01129960|17937615|P4|Overall Study|Adverse Event|7
5196022|NCT01129960|17937616|P3|Overall Study|Adverse Event|16
5196023|NCT01129960|17937617|P2|Overall Study|Adverse Event|16
5196024|NCT01129960|17937618|P1|Overall Study|Adverse Event|23
5196025|NCT01129960|17937615|P4|Overall Study|Lack of Efficacy|1
5196026|NCT01129960|17937616|P3|Overall Study|Lack of Efficacy|1
5196027|NCT01129960|17937617|P2|Overall Study|Lack of Efficacy|1
5196028|NCT01129960|17937618|P1|Overall Study|Lack of Efficacy|1
5196029|NCT01129960|17937615|P4|Overall Study|Withdrawal by Subject|2
5196030|NCT01129960|17937616|P3|Overall Study|Withdrawal by Subject|3
5196031|NCT01129960|17937617|P2|Overall Study|Withdrawal by Subject|0
5196032|NCT01129960|17937618|P1|Overall Study|Withdrawal by Subject|3
5196033|NCT01129921|17937630|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
5196034|NCT01129921|17937631|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
5196035|NCT01129921|17937630|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
5196036|NCT01129921|17937631|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
5196037|NCT01129921|17937630|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
5196038|NCT01129921|17937631|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
5196039|NCT01129921|17937630|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
5196040|NCT01129921|17937631|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
5196041|NCT01129882|17937641|P1|Overall Study|Withdrawal by Subject|160
5196042|NCT01129882|17937641|P1|Overall Study|Trial Termination by Sponsor|6
5196043|NCT01129882|17937641|P1|Overall Study|Withdrawal Criteria Met|19
5196044|NCT01129882|17937641|P1|Overall Study|Protocol Deviation|3
5196045|NCT01129882|17937641|P1|Overall Study|Physician Decision|27
5196046|NCT01129882|17937641|P1|Overall Study|Lost to Follow-up|13
5196047|NCT01129882|17937641|P1|Overall Study|Lack of Efficacy|5
5196048|NCT01129882|17937641|P1|Overall Study|Death|6
5196049|NCT01129882|17937641|P1|Overall Study|Adverse Event|39
5196050|NCT01129622|17937660|P1|Overall Study|Withdrawal by Subject|2
5196051|NCT01129583|17937671|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
5196052|NCT01129583|17937672|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
5196053|NCT01129583|17937671|P2|Overall Study|Lost to Follow-up|1
5196054|NCT01129583|17937672|P1|Overall Study|Lost to Follow-up|1
5196055|NCT01129583|17937671|P2|Overall Study|Death|0
5196056|NCT01129583|17937672|P1|Overall Study|Death|1
5196057|NCT01129557|17937685|P3|Overall Study|Novartis terminated study early|2
5196058|NCT01129557|17937686|P2|Overall Study|Novartis terminated study early|3
5196059|NCT01129557|17937687|P1|Overall Study|Novartis terminated study early|3
5196060|NCT01129557|17937685|P3|Overall Study|Adverse Event|2
5196061|NCT01129557|17937686|P2|Overall Study|Adverse Event|2
5196062|NCT01129557|17937687|P1|Overall Study|Adverse Event|1
5196063|NCT01129336|17937800|P2|Overall Study|Death|4
5196064|NCT01129336|17937801|P1|Overall Study|Death|0
5196065|NCT01129336|17937800|P2|Overall Study|Missing Study Completion Status|3
5196066|NCT01129336|17937801|P1|Overall Study|Missing Study Completion Status|2
5196067|NCT01129336|17937800|P2|Overall Study|Adverse Event|1
5196068|NCT01129336|17937801|P1|Overall Study|Adverse Event|0
5196069|NCT01129336|17937800|P2|Overall Study|Withdrawal by Subject|4
5196070|NCT01129336|17937801|P1|Overall Study|Withdrawal by Subject|7
5196071|NCT01129336|17937800|P2|Overall Study|Lost to Follow-up|0
5196072|NCT01129336|17937801|P1|Overall Study|Lost to Follow-up|1
5196073|NCT01129336|17937800|P2|Overall Study|Disease Progression|4
5196074|NCT01129336|17937801|P1|Overall Study|Disease Progression|1
5196075|NCT01129336|17937800|P2|Overall Study|Protocol Violation|0
5196076|NCT01129336|17937801|P1|Overall Study|Protocol Violation|1
5196077|NCT01129284|17937816|P3|Overall Study|Adverse Event|1
5196078|NCT01129284|17937817|P2|Overall Study|Adverse Event|0
5196079|NCT01129284|17937818|P1|Overall Study|Adverse Event|2
5196080|NCT01129128|17937866|P3|Overall Study|Physician Decision|0
5196081|NCT01129128|17937867|P2|Overall Study|Physician Decision|0
5196082|NCT01129128|17937868|P1|Overall Study|Physician Decision|1
5196083|NCT01129128|17937866|P3|Overall Study|Withdrawal by Subject|3
5196084|NCT01129128|17937867|P2|Overall Study|Withdrawal by Subject|1
5196085|NCT01129128|17937868|P1|Overall Study|Withdrawal by Subject|0
5196086|NCT01129128|17937866|P3|Overall Study|Protocol Violation|0
5196087|NCT01129128|17937867|P2|Overall Study|Protocol Violation|1
5196088|NCT01129128|17937868|P1|Overall Study|Protocol Violation|0
5196089|NCT01129128|17937866|P3|Overall Study|Lost to Follow-up|1
5196090|NCT01129128|17937867|P2|Overall Study|Lost to Follow-up|2
5196091|NCT01129128|17937868|P1|Overall Study|Lost to Follow-up|2
5196092|NCT01129115|17937892|P4|Overall Study|Protocol Violation|2
5196093|NCT01129115|17937893|P3|Overall Study|Protocol Violation|2
5196094|NCT01129115|17937894|P2|Overall Study|Protocol Violation|2
5196095|NCT01129115|17937895|P1|Overall Study|Protocol Violation|0
5196096|NCT01129115|17937892|P4|Overall Study|Withdrawal by Subject|4
5196097|NCT01129115|17937893|P3|Overall Study|Withdrawal by Subject|1
5196098|NCT01129115|17937894|P2|Overall Study|Withdrawal by Subject|3
5196099|NCT01129115|17937895|P1|Overall Study|Withdrawal by Subject|1
5196100|NCT01129115|17937892|P4|Overall Study|Adverse Event|3
5196101|NCT01129115|17937893|P3|Overall Study|Adverse Event|3
5196102|NCT01129115|17937894|P2|Overall Study|Adverse Event|2
5196103|NCT01129115|17937895|P1|Overall Study|Adverse Event|1
5196104|NCT01129102|17937932|P3|Overall Study|Lost to Follow-up|0
5196105|NCT01129102|17937933|P2|Overall Study|Lost to Follow-up|0
5196106|NCT01129102|17937934|P1|Overall Study|Lost to Follow-up|2
5196107|NCT01129102|17937932|P3|Overall Study|Adverse Event|1
5196108|NCT01129102|17937933|P2|Overall Study|Adverse Event|2
5196109|NCT01129102|17937934|P1|Overall Study|Adverse Event|2
5196110|NCT01129102|17937932|P3|Overall Study|Pregnancy|1
5196111|NCT01129102|17937933|P2|Overall Study|Pregnancy|0
5196112|NCT01129102|17937934|P1|Overall Study|Pregnancy|0
5196113|NCT01129102|17937932|P3|Overall Study|Protocol Violation|1
5196114|NCT01129102|17937933|P2|Overall Study|Protocol Violation|1
5196115|NCT01129102|17937934|P1|Overall Study|Protocol Violation|0
5196116|NCT01129102|17937932|P3|Overall Study|Withdrawal by Subject|3
5196117|NCT01129102|17937933|P2|Overall Study|Withdrawal by Subject|0
5196118|NCT01129102|17937934|P1|Overall Study|Withdrawal by Subject|2
5196119|NCT01129102|17937932|P3|Overall Study|No study drug treatment|1
5196120|NCT01129102|17937933|P2|Overall Study|No study drug treatment|3
5196121|NCT01129102|17937934|P1|Overall Study|No study drug treatment|2
5196122|NCT01129011|17937945|P2|Overall Study|misc|4
5196123|NCT01129011|17937946|P1|Overall Study|misc|7
5196124|NCT01129011|17937945|P2|Overall Study|Duodenal Ulcer|8
5196125|NCT01129011|17937946|P1|Overall Study|Duodenal Ulcer|2
5196126|NCT01129011|17937945|P2|Overall Study|Lost to Follow-up|7
5196127|NCT01129011|17937946|P1|Overall Study|Lost to Follow-up|6
5196128|NCT01129011|17937945|P2|Overall Study|Withdrawal by Subject|8
5196129|NCT01129011|17937946|P1|Overall Study|Withdrawal by Subject|24
5196130|NCT01129011|17937945|P2|Overall Study|Adverse Event|30
5196131|NCT01129011|17937946|P1|Overall Study|Adverse Event|20
5196132|NCT01128959|17938001|P1|Treatment Period|Withdrawal by Subject|1
5196133|NCT01128959|17938001|P1|Treatment Period|Adverse Event|3
5196134|NCT01128959|17938001|P1|Lead in Period|Adverse Event|3
5196135|NCT01128946|17938007|P4|Period III|Protocol Violation|0
5196136|NCT01128946|17938008|P3|Period III|Protocol Violation|0
5196137|NCT01128946|17938009|P2|Period III|Protocol Violation|0
5196138|NCT01128946|17938010|P1|Period III|Protocol Violation|1
5196139|NCT01128946|17938007|P4|Period II|Withdrawal by Subject|1
5196140|NCT01128946|17938008|P3|Period II|Withdrawal by Subject|0
5196141|NCT01128946|17938009|P2|Period II|Withdrawal by Subject|0
5196142|NCT01128946|17938010|P1|Period II|Withdrawal by Subject|0
5196143|NCT01128946|17938007|P4|Period II|Protocol Violation|0
5196144|NCT01128946|17938008|P3|Period II|Protocol Violation|0
5196145|NCT01128946|17938009|P2|Period II|Protocol Violation|1
5196146|NCT01128946|17938010|P1|Period II|Protocol Violation|0
5196147|NCT01128946|17938007|P4|Period I|Withdrawal by Subject|1
5196148|NCT01128946|17938008|P3|Period I|Withdrawal by Subject|1
5196149|NCT01128946|17938009|P2|Period I|Withdrawal by Subject|0
5196150|NCT01128946|17938010|P1|Period I|Withdrawal by Subject|0
5196151|NCT01128946|17938007|P4|Period I|Protocol Violation|0
5196152|NCT01128946|17938008|P3|Period I|Protocol Violation|0
5196153|NCT01128946|17938009|P2|Period I|Protocol Violation|1
5196154|NCT01128946|17938010|P1|Period I|Protocol Violation|0
5196155|NCT01128894|17938028|P2|Overall Study|Conflicting HbA1c Results at Screening|0
5196156|NCT01128894|17938029|P1|Overall Study|Conflicting HbA1c Results at Screening|1
5196157|NCT01128894|17938028|P2|Overall Study|Physician Decision|1
5196158|NCT01128894|17938029|P1|Overall Study|Physician Decision|2
5196159|NCT01128894|17938028|P2|Overall Study|Withdrawal by Subject|12
5196160|NCT01128894|17938029|P1|Overall Study|Withdrawal by Subject|10
5196161|NCT01128894|17938028|P2|Overall Study|Lost to Follow-up|8
5196162|NCT01128894|17938029|P1|Overall Study|Lost to Follow-up|8
5196163|NCT01128894|17938028|P2|Overall Study|Noncompliance|5
5196164|NCT01128894|17938029|P1|Overall Study|Noncompliance|4
5196165|NCT01128894|17938028|P2|Overall Study|Protocol Violation|1
5196166|NCT01128894|17938029|P1|Overall Study|Protocol Violation|2
5196167|NCT01128894|17938028|P2|Overall Study|Adverse Event|41
5196168|NCT01128894|17938029|P1|Overall Study|Adverse Event|31
5196169|NCT01128842|17938047|P1|Overall Study|Disease Progression|6
5196170|NCT01128842|17938047|P1|Overall Study|Adverse Event|1
5196171|NCT01128738|17938064|P2|Second TP|Withdrawal by Subject|2
5196172|NCT01128738|17938065|P1|Second TP|Withdrawal by Subject|0
5196173|NCT01128738|17938064|P2|Second TP|Lost to Follow-up|1
5196174|NCT01128738|17938065|P1|Second TP|Lost to Follow-up|0
5196175|NCT01128738|17938064|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
5196176|NCT01128738|17938065|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
5196177|NCT01128738|17938064|P2|First Treatment Phase (TP)|Lost to Follow-up|0
5196178|NCT01128738|17938065|P1|First Treatment Phase (TP)|Lost to Follow-up|1
5196179|NCT01128621|17938190|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
5196180|NCT01128621|17938191|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
5196181|NCT01128595|17938312|P4|Treatment Period 3|Withdrawal by Subject|0
5196182|NCT01128595|17938313|P3|Treatment Period 3|Withdrawal by Subject|0
5196183|NCT01128595|17938314|P2|Treatment Period 3|Withdrawal by Subject|1
5196184|NCT01128595|17938315|P1|Treatment Period 3|Withdrawal by Subject|0
5196185|NCT01128569|17938345|P6|Treatment Period 2|Withdrawal by Subject|0
5196186|NCT01128569|17938346|P5|Treatment Period 2|Withdrawal by Subject|0
5196187|NCT01128569|17938347|P4|Treatment Period 2|Withdrawal by Subject|0
5196188|NCT01128569|17938348|P3|Treatment Period 2|Withdrawal by Subject|0
5196189|NCT01128569|17938349|P2|Treatment Period 2|Withdrawal by Subject|1
5196190|NCT01128569|17938350|P1|Treatment Period 2|Withdrawal by Subject|0
5196191|NCT01128569|17938345|P6|Washout Period 1|Adverse Event|0
5196192|NCT01128569|17938346|P5|Washout Period 1|Adverse Event|0
5196193|NCT01128569|17938347|P4|Washout Period 1|Adverse Event|0
5196194|NCT01128569|17938348|P3|Washout Period 1|Adverse Event|1
5196195|NCT01128569|17938349|P2|Washout Period 1|Adverse Event|0
5196196|NCT01128569|17938350|P1|Washout Period 1|Adverse Event|0
5196197|NCT01128543|17938367|P1|Overall Study|Protocol Violation|1
5196198|NCT01128543|17938367|P1|Overall Study|Withdrawal by Subject|3
5196199|NCT01128413|17938393|P2|Overall Study|Pt made DNR|0
5196200|NCT01128413|17938394|P1|Overall Study|Pt made DNR|1
5196201|NCT01128413|17938393|P2|Overall Study|NICOM Monitor Problems|1
5196202|NCT01128413|17938394|P1|Overall Study|NICOM Monitor Problems|2
5196203|NCT01128413|17938393|P2|Overall Study|Withdrawal by Subject|0
5196204|NCT01128413|17938394|P1|Overall Study|Withdrawal by Subject|1
5196205|NCT01128400|17938403|P3|Overall Study|Excluded due to sinus problems|0
5196206|NCT01128400|17938404|P2|Overall Study|Excluded due to sinus problems|1
5196207|NCT01128400|17938405|P1|Overall Study|Excluded due to sinus problems|0
5196208|NCT01128400|17938403|P3|Overall Study|were not invited to participate on taste|15
5196209|NCT01128400|17938404|P2|Overall Study|were not invited to participate on taste|0
5196210|NCT01128400|17938405|P1|Overall Study|were not invited to participate on taste|0
5196211|NCT01128400|17938403|P3|Overall Study|Screening failure|0
5196212|NCT01128400|17938404|P2|Overall Study|Screening failure|0
5196213|NCT01128400|17938405|P1|Overall Study|Screening failure|1
5196214|NCT01128400|17938403|P3|Overall Study|Lost to Follow-up|1
5196215|NCT01128400|17938404|P2|Overall Study|Lost to Follow-up|0
5196216|NCT01128400|17938405|P1|Overall Study|Lost to Follow-up|1
5196217|NCT01128387|17938418|P2|Overall Study|Physician Decision|1
5196218|NCT01128387|17938419|P1|Overall Study|Physician Decision|0
5196219|NCT01128361|17938429|P2|Overall Study|Withdrawal by Subject|2
5196220|NCT01128361|17938430|P1|Overall Study|Withdrawal by Subject|5
5196221|NCT01128361|17938429|P2|Overall Study|Lost to Follow-up|1
5196222|NCT01128361|17938430|P1|Overall Study|Lost to Follow-up|0
5196223|NCT01128296|17938442|P6|Overall Study|Withdrawal by Subject|2
5196224|NCT01128296|17938443|P5|Overall Study|Withdrawal by Subject|0
5196225|NCT01128296|17938444|P4|Overall Study|Withdrawal by Subject|0
5196226|NCT01128296|17938445|P3|Overall Study|Withdrawal by Subject|0
5196227|NCT01128296|17938446|P2|Overall Study|Withdrawal by Subject|0
5196228|NCT01128296|17938447|P1|Overall Study|Withdrawal by Subject|0
5196229|NCT01128296|17938442|P6|Overall Study|Physician Decision|3
5196230|NCT01128296|17938443|P5|Overall Study|Physician Decision|0
5196231|NCT01128296|17938444|P4|Overall Study|Physician Decision|0
5196232|NCT01128296|17938445|P3|Overall Study|Physician Decision|0
5196233|NCT01128296|17938446|P2|Overall Study|Physician Decision|0
5196234|NCT01128296|17938447|P1|Overall Study|Physician Decision|0
5196235|NCT01128244|17938478|P1|Overall Study|Scheduling conflict|2
5196236|NCT01128244|17938478|P1|Overall Study|Adverse Event|1
5196237|NCT01128179|17938519|P2|Overall Study|Protocol Violation|0
5196238|NCT01128179|17938520|P1|Overall Study|Protocol Violation|1
5196239|NCT01128179|17938519|P2|Overall Study|Death|0
5196240|NCT01128179|17938520|P1|Overall Study|Death|1
5196241|NCT01128153|17938540|P2|Overall Study|Developed discontinuation criteria|1
5196242|NCT01128153|17938541|P1|Overall Study|Developed discontinuation criteria|1
5196243|NCT01128153|17938540|P2|Overall Study|Protocol Violation|0
5196244|NCT01128153|17938541|P1|Overall Study|Protocol Violation|2
5196245|NCT01128153|17938540|P2|Overall Study|Incorrect enrolment to study|1
5196246|NCT01128153|17938541|P1|Overall Study|Incorrect enrolment to study|2
5196247|NCT01128153|17938540|P2|Overall Study|Withdrawal by Subject|3
5196248|NCT01128153|17938541|P1|Overall Study|Withdrawal by Subject|2
5196249|NCT01128153|17938540|P2|Overall Study|Condition under investigation worsened|7
5196250|NCT01128153|17938541|P1|Overall Study|Condition under investigation worsened|8
5196251|NCT01128153|17938540|P2|Overall Study|Adverse Event|3
5196252|NCT01128153|17938541|P1|Overall Study|Adverse Event|1
5196253|NCT01128114|17938557|P1|Overall Study|Screening Failed|2
5196254|NCT01128114|17938557|P1|Overall Study|Treatment Withdrawn|6
5196255|NCT01127763|17938574|P1|Overall Study|Physician Decision|2
5196256|NCT01127763|17938574|P1|Overall Study|Withdrawal by Subject|1
5196257|NCT01127763|17938574|P1|Overall Study|Adverse Event|2
5196258|NCT01127646|17938619|P2|Overall Study|Protocol Violation|1
5196259|NCT01127646|17938620|P1|Overall Study|Protocol Violation|0
5196260|NCT01127646|17938619|P2|Overall Study|Entry Criteria Not Met|0
5196261|NCT01127646|17938620|P1|Overall Study|Entry Criteria Not Met|1
5196262|NCT01127633|17938654|P2|Overall Study|Not treated|0
5196263|NCT01127633|17938655|P1|Overall Study|Not treated|1
5196264|NCT01127633|17938654|P2|Overall Study|Abnormal Lab/ECG Result|1
5196265|NCT01127633|17938655|P1|Overall Study|Abnormal Lab/ECG Result|0
5196266|NCT01127633|17938654|P2|Overall Study|Protocol Violation|16
5196267|NCT01127633|17938655|P1|Overall Study|Protocol Violation|8
5196268|NCT01127633|17938654|P2|Overall Study|Sponsor Decision|195
5196269|NCT01127633|17938655|P1|Overall Study|Sponsor Decision|163
5196270|NCT01127633|17938654|P2|Overall Study|Withdrawal by Subject|72
5196271|NCT01127633|17938655|P1|Overall Study|Withdrawal by Subject|57
5196272|NCT01127633|17938654|P2|Overall Study|Physician Decision|45
5196273|NCT01127633|17938655|P1|Overall Study|Physician Decision|60
5196274|NCT01127633|17938654|P2|Overall Study|Parent/Caregiver Decision|228
5196275|NCT01127633|17938655|P1|Overall Study|Parent/Caregiver Decision|246
5196276|NCT01127633|17938654|P2|Overall Study|Lost to Follow-up|0
5196277|NCT01127633|17938655|P1|Overall Study|Lost to Follow-up|4
5196278|NCT01127633|17938654|P2|Overall Study|Death|43
5196279|NCT01127633|17938655|P1|Overall Study|Death|40
5196280|NCT01127633|17938654|P2|Overall Study|Adverse Event|73
5196281|NCT01127633|17938655|P1|Overall Study|Adverse Event|74
5196282|NCT01127607|17938687|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
5196283|NCT01127607|17938688|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
5196284|NCT01127607|17938687|P2|Phase II (Between Subjects)|Lost to Follow-up|2
5196285|NCT01127607|17938688|P1|Phase II (Between Subjects)|Lost to Follow-up|0
5196286|NCT01127256|17938865|P2|Overall Study|Protocol Violation|0
5196287|NCT01127256|17938866|P1|Overall Study|Protocol Violation|1
5196288|NCT01127256|17938865|P2|Overall Study|Withdrawal by Subject|9
5196289|NCT01127256|17938866|P1|Overall Study|Withdrawal by Subject|5
5196290|NCT01127256|17938865|P2|Overall Study|Lost to Follow-up|17
5196291|NCT01127256|17938866|P1|Overall Study|Lost to Follow-up|16
5196292|NCT01127256|17938865|P2|Overall Study|Lack of Efficacy|0
5196293|NCT01127256|17938866|P1|Overall Study|Lack of Efficacy|4
5196294|NCT01127256|17938865|P2|Overall Study|Adverse Event|13
5196295|NCT01127256|17938866|P1|Overall Study|Adverse Event|13
5196296|NCT01127165|17938878|P2|Overall Study|Protocol Violation|1
5196297|NCT01127165|17938879|P1|Overall Study|Protocol Violation|0
5196298|NCT01127165|17938878|P2|Overall Study|Withdrawal by Subject|3
5196299|NCT01127165|17938879|P1|Overall Study|Withdrawal by Subject|1
5196300|NCT01127165|17938878|P2|Overall Study|Lost to Follow-up|5
5196301|NCT01127165|17938879|P1|Overall Study|Lost to Follow-up|3
5196302|NCT01127165|17938878|P2|Overall Study|Lack of Efficacy|8
5196303|NCT01127165|17938879|P1|Overall Study|Lack of Efficacy|10
5196304|NCT01127165|17938878|P2|Overall Study|Adverse Event|2
5196305|NCT01127165|17938879|P1|Overall Study|Adverse Event|2
5196306|NCT01127139|17938891|P1|Overall Study|Reason not specified|1
5196307|NCT01127139|17938891|P1|Overall Study|Lack of Efficacy|4
5196308|NCT01127139|17938891|P1|Overall Study|Incompliance|12
5196309|NCT01127139|17938891|P1|Overall Study|Adverse Event|40
5196310|NCT01127061|17938919|P2|Overall Study|Physician Decision|3
5196311|NCT01127061|17938920|P1|Overall Study|Physician Decision|3
5196312|NCT01127061|17938919|P2|Overall Study|Lost to Follow-up|10
5196313|NCT01127061|17938920|P1|Overall Study|Lost to Follow-up|7
5196314|NCT01126879|17938957|P2|Overall Study|Physician Decision|0
5196315|NCT01126879|17938958|P1|Overall Study|Physician Decision|1
5196316|NCT01126879|17938957|P2|Overall Study|Adverse Event|1
5196317|NCT01126879|17938958|P1|Overall Study|Adverse Event|0
5196318|NCT01126879|17938957|P2|Overall Study|Withdrawal by Subject|0
5196319|NCT01126879|17938958|P1|Overall Study|Withdrawal by Subject|1
5196320|NCT01126879|17938957|P2|Overall Study|Progressive Disease|1
5196321|NCT01126879|17938958|P1|Overall Study|Progressive Disease|3
5196322|NCT01126619|17939005|P1|Overall Study|Non-compliance|1
5196323|NCT01126619|17939005|P1|Overall Study|Withdrawal by Subject|9
5196324|NCT01126619|17939005|P1|Overall Study|Serious adverse event|1
5196325|NCT01126619|17939005|P1|Overall Study|Investigator decision|4
5196326|NCT01126619|17939005|P1|Overall Study|Not eligible for the study|2
5196327|NCT01126580|17939033|P3|Overall Study|Treatment Non-compliance|3
5196328|NCT01126580|17939034|P2|Overall Study|Treatment Non-compliance|2
5196329|NCT01126580|17939035|P1|Overall Study|Treatment Non-compliance|0
5196330|NCT01126580|17939033|P3|Overall Study|Lost to Follow-up|9
5196331|NCT01126580|17939034|P2|Overall Study|Lost to Follow-up|13
5196332|NCT01126580|17939035|P1|Overall Study|Lost to Follow-up|15
5196333|NCT01126580|17939033|P3|Overall Study|Protocol Violation|2
5196334|NCT01126580|17939034|P2|Overall Study|Protocol Violation|1
5196335|NCT01126580|17939035|P1|Overall Study|Protocol Violation|0
5196336|NCT01126580|17939033|P3|Overall Study|Lack of Efficacy|4
5196337|NCT01126580|17939034|P2|Overall Study|Lack of Efficacy|3
5196338|NCT01126580|17939035|P1|Overall Study|Lack of Efficacy|2
5196339|NCT01126580|17939033|P3|Overall Study|Entry Criteria Not Met|2
5196340|NCT01126580|17939034|P2|Overall Study|Entry Criteria Not Met|1
5196341|NCT01126580|17939035|P1|Overall Study|Entry Criteria Not Met|1
5196342|NCT01126580|17939033|P3|Overall Study|Physician Decision|2
5196343|NCT01126580|17939034|P2|Overall Study|Physician Decision|1
5196344|NCT01126580|17939035|P1|Overall Study|Physician Decision|1
5196345|NCT01126580|17939033|P3|Overall Study|Sponsor Decision|7
5196346|NCT01126580|17939034|P2|Overall Study|Sponsor Decision|4
5196347|NCT01126580|17939035|P1|Overall Study|Sponsor Decision|5
5196348|NCT01126580|17939033|P3|Overall Study|Withdrawal by Subject|14
5196349|NCT01126580|17939034|P2|Overall Study|Withdrawal by Subject|19
5196350|NCT01126580|17939035|P1|Overall Study|Withdrawal by Subject|11
5196351|NCT01126580|17939033|P3|Overall Study|Adverse Event|12
5196352|NCT01126580|17939034|P2|Overall Study|Adverse Event|8
5196353|NCT01126580|17939035|P1|Overall Study|Adverse Event|14
5196354|NCT01126541|17939130|P3|Overall Study|Administrative reason or other|2
5196355|NCT01126541|17939131|P2|Overall Study|Administrative reason or other|1
5196356|NCT01126541|17939132|P1|Overall Study|Administrative reason or other|1
5196357|NCT01126541|17939130|P3|Overall Study|Protocol Violation|1
5196358|NCT01126541|17939131|P2|Overall Study|Protocol Violation|0
5196359|NCT01126541|17939132|P1|Overall Study|Protocol Violation|0
5196360|NCT01126541|17939130|P3|Overall Study|Withdrawal by Subject|6
5196361|NCT01126541|17939131|P2|Overall Study|Withdrawal by Subject|5
5196362|NCT01126541|17939132|P1|Overall Study|Withdrawal by Subject|2
5196363|NCT01126541|17939130|P3|Overall Study|Lost to Follow-up|2
5196364|NCT01126541|17939131|P2|Overall Study|Lost to Follow-up|2
5196365|NCT01126541|17939132|P1|Overall Study|Lost to Follow-up|1
5196366|NCT01126541|17939130|P3|Overall Study|Lack of Efficacy|11
5196367|NCT01126541|17939131|P2|Overall Study|Lack of Efficacy|1
5196368|NCT01126541|17939132|P1|Overall Study|Lack of Efficacy|6
5196369|NCT01126541|17939130|P3|Overall Study|Death|0
5196370|NCT01126541|17939131|P2|Overall Study|Death|1
5196371|NCT01126541|17939132|P1|Overall Study|Death|0
5196372|NCT01126541|17939130|P3|Overall Study|Adverse Event|4
5196373|NCT01126541|17939131|P2|Overall Study|Adverse Event|2
5196374|NCT01126541|17939132|P1|Overall Study|Adverse Event|0
5196375|NCT01126437|17939216|P3|Overall Study|Other reason not specified|178
5196376|NCT01126437|17939217|P2|Overall Study|Other reason not specified|176
5196377|NCT01126437|17939218|P1|Overall Study|Other reason not specified|210
5196378|NCT01126437|17939216|P3|Overall Study|Withdrawal by Subject|319
5196379|NCT01126437|17939217|P2|Overall Study|Withdrawal by Subject|335
5196380|NCT01126437|17939218|P1|Overall Study|Withdrawal by Subject|331
5196381|NCT01126437|17939216|P3|Overall Study|Lost to Follow-up|55
5196382|NCT01126437|17939217|P2|Overall Study|Lost to Follow-up|63
5196383|NCT01126437|17939218|P1|Overall Study|Lost to Follow-up|52
5196384|NCT01126437|17939216|P3|Overall Study|Protocol Violation|41
5196385|NCT01126437|17939217|P2|Overall Study|Protocol Violation|66
5196386|NCT01126437|17939218|P1|Overall Study|Protocol Violation|64
5196387|NCT01126437|17939216|P3|Overall Study|Lack of Efficacy|59
5196388|NCT01126437|17939217|P2|Overall Study|Lack of Efficacy|60
5196389|NCT01126437|17939218|P1|Overall Study|Lack of Efficacy|65
5196390|NCT01126437|17939216|P3|Overall Study|Adverse Event|635
5196391|NCT01126437|17939217|P2|Overall Study|Adverse Event|606
5196392|NCT01126437|17939218|P1|Overall Study|Adverse Event|602
5196393|NCT01126437|17939216|P3|Overall Study|Sites with data irregularities/fraud|7
5196394|NCT01126437|17939217|P2|Overall Study|Sites with data irregularities/fraud|6
5196395|NCT01126437|17939218|P1|Overall Study|Sites with data irregularities/fraud|6
5196396|NCT01126437|17939216|P3|Overall Study|Not treated|19
5196397|NCT01126437|17939217|P2|Overall Study|Not treated|18
5196398|NCT01126437|17939218|P1|Overall Study|Not treated|11
5196399|NCT01126424|17939256|P6|Overall Study|Withdrawal by Subject|0
5196400|NCT01126424|17939257|P5|Overall Study|Withdrawal by Subject|1
5196401|NCT01126424|17939258|P4|Overall Study|Withdrawal by Subject|3
5196402|NCT01126424|17939259|P3|Overall Study|Withdrawal by Subject|1
5196403|NCT01126424|17939260|P2|Overall Study|Withdrawal by Subject|0
5196404|NCT01126424|17939261|P1|Overall Study|Withdrawal by Subject|0
5196405|NCT01126424|17939256|P6|Overall Study|Adverse Event|0
5196406|NCT01126424|17939257|P5|Overall Study|Adverse Event|1
5196407|NCT01126424|17939258|P4|Overall Study|Adverse Event|0
5196408|NCT01126424|17939259|P3|Overall Study|Adverse Event|0
5196409|NCT01126424|17939260|P2|Overall Study|Adverse Event|0
5196410|NCT01126424|17939261|P1|Overall Study|Adverse Event|0
5196411|NCT01126359|17939284|P2|First Intervention (20-minutes)|Physician Decision|1
5196412|NCT01126359|17939285|P1|First Intervention (20-minutes)|Physician Decision|0
5196413|NCT01126268|17939297|P1|Overall Study|Adverse Event|1
5196414|NCT01126060|17939336|P2|Overall Study|Protocol Violation|2
5196415|NCT01126060|17939337|P1|Overall Study|Protocol Violation|0
5196416|NCT01125930|17939345|P2|Overall Study|Lost to Follow-up|2
5196417|NCT01125930|17939346|P1|Overall Study|Lost to Follow-up|0
5196418|NCT01125930|17939345|P2|Overall Study|Protocol Violation|1
5196419|NCT01125930|17939346|P1|Overall Study|Protocol Violation|0
5196420|NCT01125930|17939345|P2|Overall Study|Withdrawal by Subject|6
5196421|NCT01125930|17939346|P1|Overall Study|Withdrawal by Subject|1
5196422|NCT01125930|17939345|P2|Overall Study|Adverse Event|1
5196423|NCT01125930|17939346|P1|Overall Study|Adverse Event|0
5196424|NCT01125917|17939500|P1|Overall Study|Lack of Efficacy|19
5196425|NCT01125917|17939500|P1|Overall Study|Administrative|223
5196426|NCT01125917|17939500|P1|Overall Study|Withdrawal by Subject|31
5196427|NCT01125917|17939500|P1|Overall Study|Lost to Follow-up|23
5196428|NCT01125917|17939500|P1|Overall Study|Adverse Event|43
5196429|NCT01125813|17939504|P1|Overall Study|Screen Failures|4
5196430|NCT01125813|17939504|P1|Overall Study|Withdrawal by Subject|1
5196431|NCT01125813|17939504|P1|Overall Study|Death|1
5196432|NCT01125800|17939514|P5|Phase II|Disease progression|8
5196433|NCT01125800|17939515|P4|Phase II|Disease progression|1
5196434|NCT01125800|17939516|P3|Phase II|Disease progression|0
5196435|NCT01125800|17939517|P2|Phase II|Disease progression|0
5196436|NCT01125800|17939518|P1|Phase II|Disease progression|0
5196437|NCT01125800|17939514|P5|Phase II|Adverse Event|2
5196438|NCT01125800|17939515|P4|Phase II|Adverse Event|0
5196439|NCT01125800|17939516|P3|Phase II|Adverse Event|0
5196440|NCT01125800|17939517|P2|Phase II|Adverse Event|0
5196441|NCT01125800|17939518|P1|Phase II|Adverse Event|0
5196442|NCT01125800|17939514|P5|Phase II|Protocol Violation|1
5196443|NCT01125800|17939515|P4|Phase II|Protocol Violation|0
5196444|NCT01125800|17939516|P3|Phase II|Protocol Violation|0
5196445|NCT01125800|17939517|P2|Phase II|Protocol Violation|0
5196446|NCT01125800|17939518|P1|Phase II|Protocol Violation|0
5196447|NCT01125800|17939514|P5|Phase I|Disease progression|0
5196448|NCT01125800|17939515|P4|Phase I|Disease progression|3
5196449|NCT01125800|17939516|P3|Phase I|Disease progression|1
5196450|NCT01125800|17939517|P2|Phase I|Disease progression|4
5196451|NCT01125800|17939518|P1|Phase I|Disease progression|5
5196452|NCT01125800|17939514|P5|Phase I|Withdrawal by Subject|0
5196453|NCT01125800|17939515|P4|Phase I|Withdrawal by Subject|0
5196454|NCT01125800|17939516|P3|Phase I|Withdrawal by Subject|1
5196455|NCT01125800|17939517|P2|Phase I|Withdrawal by Subject|0
5196456|NCT01125800|17939518|P1|Phase I|Withdrawal by Subject|0
5196457|NCT01125800|17939514|P5|Phase I|Administrative problems|0
5196458|NCT01125800|17939515|P4|Phase I|Administrative problems|0
5196459|NCT01125800|17939516|P3|Phase I|Administrative problems|0
5196460|NCT01125800|17939517|P2|Phase I|Administrative problems|0
5196461|NCT01125800|17939518|P1|Phase I|Administrative problems|1
5196462|NCT01125800|17939514|P5|Phase I|Adverse Event|0
5196463|NCT01125800|17939515|P4|Phase I|Adverse Event|7
5196464|NCT01125800|17939516|P3|Phase I|Adverse Event|1
5196465|NCT01125800|17939517|P2|Phase I|Adverse Event|2
5196466|NCT01125800|17939518|P1|Phase I|Adverse Event|2
5196467|NCT01125800|17939514|P5|Phase I|Protocol Violation|0
5196468|NCT01125800|17939515|P4|Phase I|Protocol Violation|1
5196469|NCT01125800|17939516|P3|Phase I|Protocol Violation|1
5196470|NCT01125800|17939517|P2|Phase I|Protocol Violation|3
5196471|NCT01125800|17939518|P1|Phase I|Protocol Violation|0
5196472|NCT01125748|17939584|P2|Overall Study|Patient Decision to Withdraw|4
5196473|NCT01125748|17939585|P1|Overall Study|Patient Decision to Withdraw|2
5196474|NCT01125748|17939584|P2|Overall Study|Physician Decision|7
5196475|NCT01125748|17939585|P1|Overall Study|Physician Decision|8
5196476|NCT01125748|17939584|P2|Overall Study|Lost to Follow-up|1
5196477|NCT01125748|17939585|P1|Overall Study|Lost to Follow-up|0
5196478|NCT01125748|17939584|P2|Overall Study|Adverse Event|2
5196479|NCT01125748|17939585|P1|Overall Study|Adverse Event|0
5196480|NCT01125722|17939595|P2|Overall Study|Lost to Follow-up|0
5196481|NCT01125722|17939596|P1|Overall Study|Lost to Follow-up|1
5196482|NCT01125722|17939595|P2|Overall Study|Withdrawal by Subject|1
5196483|NCT01125722|17939596|P1|Overall Study|Withdrawal by Subject|2
5196484|NCT01125566|17939643|P3|Patients Who Switched From AV to TV|Other than listed above|4
5196485|NCT01125566|17939644|P2|Patients Who Switched From AV to TV|Other than listed above|0
5196486|NCT01125566|17939645|P1|Patients Who Switched From AV to TV|Other than listed above|0
5196487|NCT01125566|17939643|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
5196488|NCT01125566|17939644|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
5196489|NCT01125566|17939645|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
5196490|NCT01125566|17939643|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
5196491|NCT01125566|17939644|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
5196492|NCT01125566|17939645|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
5196493|NCT01125566|17939643|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
5196494|NCT01125566|17939644|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
5196495|NCT01125566|17939645|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
5196496|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
5196497|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
5196498|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
5196499|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
5196500|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
5196501|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
5196502|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Not treated|0
5196503|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Not treated|0
5196504|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Not treated|2
5196505|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
5196506|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
5196507|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
5196508|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
5196509|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
5196510|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
5196511|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
5196512|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
5196513|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
5196514|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
5196515|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
5196516|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
5196517|NCT01125566|17939643|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
5196518|NCT01125566|17939644|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
5196519|NCT01125566|17939645|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
5196520|NCT01125514|17939658|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
5196521|NCT01125514|17939658|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
5196522|NCT01125514|17939658|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
5196523|NCT01125514|17939658|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
5196524|NCT01125514|17939658|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
5196525|NCT01125514|17939658|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
5196526|NCT01125189|17939758|P3|Follow up Period|Other reasons|5
5196527|NCT01125189|17939759|P2|Follow up Period|Other reasons|4
5196528|NCT01125189|17939760|P1|Follow up Period|Other reasons|4
5196529|NCT01125189|17939758|P3|Follow up Period|Lost to Follow-up|6
5196530|NCT01125189|17939759|P2|Follow up Period|Lost to Follow-up|9
5196531|NCT01125189|17939760|P1|Follow up Period|Lost to Follow-up|12
5196532|NCT01125189|17939758|P3|Follow up Period|Death|0
5196533|NCT01125189|17939759|P2|Follow up Period|Death|0
5196534|NCT01125189|17939760|P1|Follow up Period|Death|1
5196535|NCT01125189|17939758|P3|Follow up Period|Withdrawal by Subject|5
5196536|NCT01125189|17939759|P2|Follow up Period|Withdrawal by Subject|2
5196537|NCT01125189|17939760|P1|Follow up Period|Withdrawal by Subject|3
5196538|NCT01125189|17939758|P3|Treatment Period|Completed 24 week treatment period only|2
5196539|NCT01125189|17939759|P2|Treatment Period|Completed 24 week treatment period only|1
5196540|NCT01125189|17939760|P1|Treatment Period|Completed 24 week treatment period only|2
5196541|NCT01125189|17939758|P3|Treatment Period|Other reasons|0
5196542|NCT01125189|17939759|P2|Treatment Period|Other reasons|1
5196543|NCT01125189|17939760|P1|Treatment Period|Other reasons|1
5196544|NCT01125189|17939758|P3|Treatment Period|Participants requested to discontinue|4
5196545|NCT01125189|17939759|P2|Treatment Period|Participants requested to discontinue|3
5196546|NCT01125189|17939760|P1|Treatment Period|Participants requested to discontinue|1
5196547|NCT01125189|17939758|P3|Treatment Period|Poor compliance/noncompliance|0
5196548|NCT01125189|17939759|P2|Treatment Period|Poor compliance/noncompliance|1
5196549|NCT01125189|17939760|P1|Treatment Period|Poor compliance/noncompliance|0
5196550|NCT01125189|17939758|P3|Treatment Period|Lost to Follow-up|1
5196551|NCT01125189|17939759|P2|Treatment Period|Lost to Follow-up|2
5196552|NCT01125189|17939760|P1|Treatment Period|Lost to Follow-up|1
5196553|NCT01125189|17939758|P3|Treatment Period|Death|0
5196554|NCT01125189|17939759|P2|Treatment Period|Death|0
5196555|NCT01125189|17939760|P1|Treatment Period|Death|1
5196556|NCT01125189|17939758|P3|Treatment Period|Withdrawal by Subject|1
5196557|NCT01125189|17939759|P2|Treatment Period|Withdrawal by Subject|1
5196558|NCT01125189|17939760|P1|Treatment Period|Withdrawal by Subject|3
5196559|NCT01125189|17939758|P3|Treatment Period|Adverse Event|8
5196560|NCT01125189|17939759|P2|Treatment Period|Adverse Event|8
5196561|NCT01125189|17939760|P1|Treatment Period|Adverse Event|7
5196562|NCT01125189|17939758|P3|Treatment Period|Lack of Efficacy|25
5196563|NCT01125189|17939759|P2|Treatment Period|Lack of Efficacy|18
5196564|NCT01125189|17939760|P1|Treatment Period|Lack of Efficacy|15
5196565|NCT01124916|17939829|P2|Overall Study|Lost to Follow-up|2
5196566|NCT01124916|17939830|P1|Overall Study|Lost to Follow-up|3
5196567|NCT01124864|17939844|P6|Overall Study|Protocol Violation|0
5196568|NCT01124864|17939845|P5|Overall Study|Protocol Violation|1
5196569|NCT01124864|17939846|P4|Overall Study|Protocol Violation|0
5196570|NCT01124864|17939847|P3|Overall Study|Protocol Violation|0
5196571|NCT01124864|17939848|P2|Overall Study|Protocol Violation|0
5196572|NCT01124864|17939849|P1|Overall Study|Protocol Violation|1
5196573|NCT01124864|17939844|P6|Overall Study|Lost to Follow-up|0
5196574|NCT01124864|17939845|P5|Overall Study|Lost to Follow-up|0
5196575|NCT01124864|17939846|P4|Overall Study|Lost to Follow-up|1
5196576|NCT01124864|17939847|P3|Overall Study|Lost to Follow-up|0
5196577|NCT01124864|17939848|P2|Overall Study|Lost to Follow-up|1
5196578|NCT01124864|17939849|P1|Overall Study|Lost to Follow-up|1
5196579|NCT01124864|17939844|P6|Overall Study|Withdrawal by Subject|1
5196580|NCT01124864|17939845|P5|Overall Study|Withdrawal by Subject|2
5196581|NCT01124864|17939846|P4|Overall Study|Withdrawal by Subject|0
5196582|NCT01124864|17939847|P3|Overall Study|Withdrawal by Subject|4
5196583|NCT01124864|17939848|P2|Overall Study|Withdrawal by Subject|3
5196584|NCT01124864|17939849|P1|Overall Study|Withdrawal by Subject|2
5196585|NCT01124864|17939844|P6|Overall Study|Death|0
5196586|NCT01124864|17939845|P5|Overall Study|Death|1
5196587|NCT01124864|17939846|P4|Overall Study|Death|2
5196588|NCT01124864|17939847|P3|Overall Study|Death|6
5196589|NCT01124864|17939848|P2|Overall Study|Death|9
5196590|NCT01124864|17939849|P1|Overall Study|Death|6
5196591|NCT01124864|17939844|P6|Overall Study|Follow up phase competed as per protocol|2
5196592|NCT01124864|17939845|P5|Overall Study|Follow up phase competed as per protocol|26
5196593|NCT01124864|17939846|P4|Overall Study|Follow up phase competed as per protocol|18
5196594|NCT01124864|17939847|P3|Overall Study|Follow up phase competed as per protocol|24
5196595|NCT01124864|17939848|P2|Overall Study|Follow up phase competed as per protocol|22
5196596|NCT01124864|17939849|P1|Overall Study|Follow up phase competed as per protocol|18
5196597|NCT01124838|17939883|P2|Overall Study|Lost to Follow-up|0
5196598|NCT01124838|17939884|P1|Overall Study|Lost to Follow-up|2
5196599|NCT01124838|17939883|P2|Overall Study|Withdrawal by Subject|2
5196600|NCT01124838|17939884|P1|Overall Study|Withdrawal by Subject|3
5196601|NCT01124838|17939883|P2|Overall Study|Lack of Efficacy|0
5196602|NCT01124838|17939884|P1|Overall Study|Lack of Efficacy|2
5196603|NCT01124838|17939883|P2|Overall Study|Adverse Event|11
5196604|NCT01124838|17939884|P1|Overall Study|Adverse Event|7
5196605|NCT01124838|17939883|P2|Overall Study|Miscellaneous|2
5196606|NCT01124838|17939884|P1|Overall Study|Miscellaneous|4
5196607|NCT01124734|17939951|P1|Overall Study|Elected for alternative treatment|2
5196608|NCT01124734|17939951|P1|Overall Study|Withdrawal by Subject|1
5196609|NCT01124734|17939951|P1|Overall Study|Adverse Event|1
5196610|NCT01124734|17939951|P1|Overall Study|Disease progression|13
5196611|NCT01124643|17939962|P1|Overall Study|Death|1
5196612|NCT01124617|17939976|P2|Overall Study|Other|1
5196613|NCT01124617|17939977|P1|Overall Study|Other|2
5196614|NCT01124617|17939976|P2|Overall Study|Withdrawal by Subject|1
5196615|NCT01124617|17939977|P1|Overall Study|Withdrawal by Subject|9
5196616|NCT01124617|17939976|P2|Overall Study|Protocol Violation|1
5196617|NCT01124617|17939977|P1|Overall Study|Protocol Violation|1
5196618|NCT01124617|17939976|P2|Overall Study|Lack of Efficacy|1
5196619|NCT01124617|17939977|P1|Overall Study|Lack of Efficacy|2
5196620|NCT01124617|17939976|P2|Overall Study|Adverse Event|2
5196621|NCT01124617|17939977|P1|Overall Study|Adverse Event|5
5196622|NCT01124604|17940009|P2|Overall Study|Disease Progression|1
5196623|NCT01124604|17940010|P1|Overall Study|Disease Progression|0
5196624|NCT01124604|17940009|P2|Overall Study|Withdrawal by Subject|0
5196625|NCT01124604|17940010|P1|Overall Study|Withdrawal by Subject|4
5196626|NCT01124604|17940009|P2|Overall Study|Lack of Efficacy|0
5196627|NCT01124604|17940010|P1|Overall Study|Lack of Efficacy|1
5196628|NCT01124604|17940009|P2|Overall Study|Adverse Event|1
5196629|NCT01124604|17940010|P1|Overall Study|Adverse Event|10
5196630|NCT01124448|17940049|P2|Overall Study|Protocol Violation|0
5196631|NCT01124448|17940050|P1|Overall Study|Protocol Violation|2
5196632|NCT01124448|17940049|P2|Overall Study|Lost to Follow-up|3
5196633|NCT01124448|17940050|P1|Overall Study|Lost to Follow-up|0
5196634|NCT01124422|17940058|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
5196635|NCT01124422|17940059|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
5196636|NCT01124422|17940060|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
5196637|NCT01124422|17940058|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
5196638|NCT01124422|17940059|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
5196639|NCT01124422|17940060|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
5196640|NCT01124422|17940058|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
5196641|NCT01124422|17940059|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
5196642|NCT01124422|17940060|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
5196643|NCT01124422|17940058|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
5196644|NCT01124422|17940059|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
5196645|NCT01124422|17940060|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
5196646|NCT01124422|17940058|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
5196647|NCT01124422|17940059|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
5196648|NCT01124422|17940060|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
5196649|NCT01124422|17940058|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
5196650|NCT01124422|17940059|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
5196651|NCT01124422|17940060|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
5196652|NCT01124422|17940058|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
5196653|NCT01124422|17940059|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
5196654|NCT01124422|17940060|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
5196655|NCT01124422|17940058|P3|4-Week Open-label Run-in Phase|Physician Decision|0
5196656|NCT01124422|17940059|P2|4-Week Open-label Run-in Phase|Physician Decision|0
5196657|NCT01124422|17940060|P1|4-Week Open-label Run-in Phase|Physician Decision|4
5196658|NCT01124422|17940058|P3|4-Week Open-label Run-in Phase|Adverse Event|0
5196659|NCT01124422|17940059|P2|4-Week Open-label Run-in Phase|Adverse Event|0
5196660|NCT01124422|17940060|P1|4-Week Open-label Run-in Phase|Adverse Event|7
5196661|NCT01124422|17940058|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
5196662|NCT01124422|17940059|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
5196663|NCT01124422|17940060|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
5196664|NCT01124292|17940130|P3|Overall Study|piercing track closed|1
5196665|NCT01124292|17940131|P2|Overall Study|piercing track closed|2
5196666|NCT01124292|17940132|P1|Overall Study|piercing track closed|0
5196667|NCT01124292|17940130|P3|Overall Study|medical issue unrelated to the study|2
5196668|NCT01124292|17940131|P2|Overall Study|medical issue unrelated to the study|0
5196669|NCT01124292|17940132|P1|Overall Study|medical issue unrelated to the study|0
5196670|NCT01124292|17940130|P3|Overall Study|Withdrawal by Subject|2
5196671|NCT01124292|17940131|P2|Overall Study|Withdrawal by Subject|6
5196672|NCT01124292|17940132|P1|Overall Study|Withdrawal by Subject|0
5196673|NCT01124292|17940130|P3|Overall Study|Physician Decision|2
5196674|NCT01124292|17940131|P2|Overall Study|Physician Decision|3
5196675|NCT01124292|17940132|P1|Overall Study|Physician Decision|0
5196676|NCT01124292|17940130|P3|Overall Study|Lost to Follow-up|3
5196677|NCT01124292|17940131|P2|Overall Study|Lost to Follow-up|4
5196678|NCT01124292|17940132|P1|Overall Study|Lost to Follow-up|2
5196679|NCT01124175|17940203|P2|Washout of 7 Days|Withdrawal by Subject|2
5196680|NCT01124175|17940204|P1|Washout of 7 Days|Withdrawal by Subject|0
5196681|NCT01124162|17940222|P2|Washout of 7 Days|Withdrawal by Subject|0
5196682|NCT01124162|17940223|P1|Washout of 7 Days|Withdrawal by Subject|1
5196683|NCT01124162|17940222|P2|First Intervention|Adverse Event|0
5196684|NCT01124162|17940223|P1|First Intervention|Adverse Event|2
5196685|NCT01124149|17940239|P1|Maintenance Phase|Non-compliance|1
5196686|NCT01124149|17940239|P1|Maintenance Phase|Coordinator error|1
5196687|NCT01124149|17940239|P1|Maintenance Phase|Protocol Violation|5
5196688|NCT01124149|17940239|P1|Maintenance Phase|Withdrawal by Subject|10
5196689|NCT01124149|17940239|P1|Maintenance Phase|Lost to Follow-up|15
5196690|NCT01124149|17940239|P1|Maintenance Phase|Adverse Event|24
5196691|NCT01124149|17940239|P1|Maintenance Phase|Lack of Efficacy|40
5196692|NCT01124149|17940239|P1|Acute Phase|Sponsor decision|1
5196693|NCT01124149|17940239|P1|Acute Phase|Travelling to another country|1
5196694|NCT01124149|17940239|P1|Acute Phase|Low hemoglobin|1
5196695|NCT01124149|17940239|P1|Acute Phase|Non-compliance|1
5196696|NCT01124149|17940239|P1|Acute Phase|UC symptoms not ameliorated|1
5196697|NCT01124149|17940239|P1|Acute Phase|Sponsor request|1
5196698|NCT01124149|17940239|P1|Acute Phase|Prolonged antibiotic therapy|1
5196699|NCT01124149|17940239|P1|Acute Phase|Lost to Follow-up|2
5196700|NCT01124149|17940239|P1|Acute Phase|Protocol Violation|14
5196701|NCT01124149|17940239|P1|Acute Phase|Lack of Efficacy|17
5196702|NCT01124149|17940239|P1|Acute Phase|Adverse Event|21
5196703|NCT01124149|17940239|P1|Acute Phase|Withdrawal by Subject|22
5196704|NCT01124097|17940259|P4|Overall Study|Physician Decision|0
5196705|NCT01124097|17940260|P3|Overall Study|Physician Decision|0
5196706|NCT01124097|17940261|P2|Overall Study|Physician Decision|1
5196707|NCT01124097|17940262|P1|Overall Study|Physician Decision|2
5196708|NCT01124097|17940259|P4|Overall Study|Protocol Violation|1
5196709|NCT01124097|17940260|P3|Overall Study|Protocol Violation|2
5196710|NCT01124097|17940261|P2|Overall Study|Protocol Violation|0
5196711|NCT01124097|17940262|P1|Overall Study|Protocol Violation|2
5196712|NCT01124097|17940259|P4|Overall Study|Adverse Event|7
5196713|NCT01124097|17940260|P3|Overall Study|Adverse Event|15
5196714|NCT01124097|17940261|P2|Overall Study|Adverse Event|15
5196715|NCT01124097|17940262|P1|Overall Study|Adverse Event|24
5196716|NCT01124097|17940259|P4|Overall Study|Lack of Efficacy|3
5196717|NCT01124097|17940260|P3|Overall Study|Lack of Efficacy|1
5196718|NCT01124097|17940261|P2|Overall Study|Lack of Efficacy|3
5196719|NCT01124097|17940262|P1|Overall Study|Lack of Efficacy|2
5196720|NCT01124097|17940259|P4|Overall Study|Withdrawal by Subject|3
5196721|NCT01124097|17940260|P3|Overall Study|Withdrawal by Subject|2
5196722|NCT01124097|17940261|P2|Overall Study|Withdrawal by Subject|3
5196723|NCT01124097|17940262|P1|Overall Study|Withdrawal by Subject|4
5196724|NCT01124045|17940274|P2|Overall Study|Physician Decision|2
5196725|NCT01124045|17940275|P1|Overall Study|Physician Decision|0
5196726|NCT01124045|17940274|P2|Overall Study|Lost to Follow-up|1
5196727|NCT01124045|17940275|P1|Overall Study|Lost to Follow-up|0
5196728|NCT01124006|17940308|P3|Overall Study|Other|1
5196729|NCT01124006|17940309|P2|Overall Study|Other|0
5196730|NCT01124006|17940310|P1|Overall Study|Other|0
5196731|NCT01124006|17940308|P3|Overall Study|Lost to Follow-up|1
5196732|NCT01124006|17940309|P2|Overall Study|Lost to Follow-up|0
5196733|NCT01124006|17940310|P1|Overall Study|Lost to Follow-up|1
5196734|NCT01124006|17940308|P3|Overall Study|Withdrawal by Subject|0
5196735|NCT01124006|17940309|P2|Overall Study|Withdrawal by Subject|2
5196736|NCT01124006|17940310|P1|Overall Study|Withdrawal by Subject|2
5196737|NCT01123980|17940338|P2|Overall Study|Unclassified|7
5196738|NCT01123980|17940339|P1|Overall Study|Unclassified|6
5196739|NCT01123980|17940338|P2|Overall Study|Withdrawal by Subject|3
5196740|NCT01123980|17940339|P1|Overall Study|Withdrawal by Subject|5
5196741|NCT01123980|17940338|P2|Overall Study|Protocol Violation|6
5196742|NCT01123980|17940339|P1|Overall Study|Protocol Violation|6
5196743|NCT01123980|17940338|P2|Overall Study|Lost to Follow-up|6
5196744|NCT01123980|17940339|P1|Overall Study|Lost to Follow-up|0
5196745|NCT01123980|17940338|P2|Overall Study|Physician Decision|1
5196746|NCT01123980|17940339|P1|Overall Study|Physician Decision|0
5196747|NCT01123980|17940338|P2|Overall Study|Lack of Efficacy|0
5196748|NCT01123980|17940339|P1|Overall Study|Lack of Efficacy|1
5196749|NCT01123980|17940338|P2|Overall Study|Adverse Event|1
5196750|NCT01123980|17940339|P1|Overall Study|Adverse Event|1
5196751|NCT01123941|17940359|P2|Overall Study|Lost to Follow-up|1
5196752|NCT01123941|17940360|P1|Overall Study|Lost to Follow-up|2
5196753|NCT01123889|17940395|P2|Overall Study|Lost to Follow-up|1
5196754|NCT01123889|17940396|P1|Overall Study|Lost to Follow-up|3
5196755|NCT01123850|17940406|P1|Overall Study|Slow enrollment|45
5196756|NCT01123655|17940413|P3|Overall Study|began prohibitive drug|1
5196757|NCT01123655|17940414|P2|Overall Study|began prohibitive drug|0
5196758|NCT01123655|17940415|P1|Overall Study|began prohibitive drug|0
5196759|NCT01123655|17940413|P3|Overall Study|new illness|0
5196760|NCT01123655|17940414|P2|Overall Study|new illness|1
5196761|NCT01123655|17940415|P1|Overall Study|new illness|0
5196762|NCT01123655|17940413|P3|Overall Study|Medication for RA had to be changed|0
5196763|NCT01123655|17940414|P2|Overall Study|Medication for RA had to be changed|0
5196764|NCT01123655|17940415|P1|Overall Study|Medication for RA had to be changed|1
5196765|NCT01123642|17940487|P1|Overall Study|ineligible at baseline assessment|36
5196766|NCT01123642|17940487|P1|Overall Study|Withdrawal by Subject|9
5196767|NCT01123642|17940487|P1|Overall Study|Lost to Follow-up|23
5196768|NCT01123395|17940503|P2|Washout Period of 14 Days|Withdrawal by Subject|1
5196769|NCT01123395|17940504|P1|Washout Period of 14 Days|Withdrawal by Subject|0
5196770|NCT01123382|17940516|P2|Overall Study|Lost to Follow-up|2
5196771|NCT01123382|17940517|P1|Overall Study|Lost to Follow-up|1
5196772|NCT01123382|17940516|P2|Overall Study|Withdrawal by Subject|4
5196773|NCT01123382|17940517|P1|Overall Study|Withdrawal by Subject|1
5196774|NCT01123356|17940539|P1|Overall Study|Withdrawal by Subject|1
5196775|NCT01123356|17940539|P1|Overall Study|Lack of Efficacy|4
5196776|NCT01123356|17940539|P1|Overall Study|Adverse Event|2
5196777|NCT01123200|17940547|P1|Overall Study|Withdrawal by Subject|1
5196778|NCT01123161|17940554|P2|Overall Study|Withdrawal by Subject|0
5196779|NCT01123161|17940555|P1|Overall Study|Withdrawal by Subject|1
5196780|NCT01123161|17940554|P2|Overall Study|Lost to Follow-up|0
5196781|NCT01123161|17940555|P1|Overall Study|Lost to Follow-up|1
5196782|NCT01123148|17940573|P1|Overall Study|Didn't meet milestone criteria|1
5196783|NCT01123148|17940573|P1|Overall Study|Coughing caused unacceptable EEG quality|1
5196784|NCT01123083|17940579|P2|Overall Study|Participant/legal representative request|3
5196785|NCT01123083|17940580|P1|Overall Study|Participant/legal representative request|7
5196786|NCT01123083|17940579|P2|Overall Study|Withdrew for another reason not covered|1
5196787|NCT01123083|17940580|P1|Overall Study|Withdrew for another reason not covered|0
5196788|NCT01123083|17940579|P2|Overall Study|Adverse Event|0
5196789|NCT01123083|17940580|P1|Overall Study|Adverse Event|1
5196790|NCT01123083|17940579|P2|Overall Study|Lost to Follow-up|6
5196791|NCT01123083|17940580|P1|Overall Study|Lost to Follow-up|2
5196792|NCT01123083|17940579|P2|Overall Study|Administrative reasons|4
5196793|NCT01123083|17940580|P1|Overall Study|Administrative reasons|0
5196794|NCT01123083|17940579|P2|Overall Study|Investigator recommendation|1
5196795|NCT01123083|17940580|P1|Overall Study|Investigator recommendation|1
5196796|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
5196797|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
5196798|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
5196799|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
5196800|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
5196801|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
5196802|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
5196803|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
5196804|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
5196805|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
5196806|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
5196807|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
5196808|NCT01122927|17940604|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
5196809|NCT01122927|17940605|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
5196810|NCT01122927|17940604|P2|Period 1 - Conversion Phase|Protocol Deviation|0
5196811|NCT01122927|17940605|P1|Period 1 - Conversion Phase|Protocol Deviation|1
5196812|NCT01122927|17940604|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
5196813|NCT01122927|17940605|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
5196814|NCT01122927|17940604|P2|Period 1 - Conversion Phase|Physician Decision|0
5196815|NCT01122927|17940605|P1|Period 1 - Conversion Phase|Physician Decision|2
5196816|NCT01122927|17940604|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5196817|NCT01122927|17940605|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
5196818|NCT01122927|17940604|P2|Period 1 - Conversion Phase|Adverse Event|0
5196819|NCT01122927|17940605|P1|Period 1 - Conversion Phase|Adverse Event|3
5196820|NCT01122862|17940657|P3|Period 2|Adverse Event|1
5196821|NCT01122862|17940658|P2|Period 2|Adverse Event|0
5196822|NCT01122862|17940659|P1|Period 2|Adverse Event|0
5196823|NCT01122862|17940657|P3|Period 1|Protocol Violation|0
5196824|NCT01122862|17940658|P2|Period 1|Protocol Violation|1
5196825|NCT01122862|17940659|P1|Period 1|Protocol Violation|0
5196826|NCT01122680|17940765|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
5196827|NCT01122680|17940766|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
5196828|NCT01122680|17940767|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
5196829|NCT01122680|17940768|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
5196830|NCT01122680|17940765|P4|Period 3 (4 Weeks)|Adverse Event|0
5196831|NCT01122680|17940766|P3|Period 3 (4 Weeks)|Adverse Event|0
5196832|NCT01122680|17940767|P2|Period 3 (4 Weeks)|Adverse Event|0
5196833|NCT01122680|17940768|P1|Period 3 (4 Weeks)|Adverse Event|1
5196834|NCT01122680|17940765|P4|Period 2 (4 Weeks)|Other|0
5196835|NCT01122680|17940766|P3|Period 2 (4 Weeks)|Other|0
5196836|NCT01122680|17940767|P2|Period 2 (4 Weeks)|Other|0
5196837|NCT01122680|17940768|P1|Period 2 (4 Weeks)|Other|1
5196838|NCT01122680|17940765|P4|Period 2 (4 Weeks)|Protocol Violation|1
5196839|NCT01122680|17940766|P3|Period 2 (4 Weeks)|Protocol Violation|0
5196840|NCT01122680|17940767|P2|Period 2 (4 Weeks)|Protocol Violation|0
5196841|NCT01122680|17940768|P1|Period 2 (4 Weeks)|Protocol Violation|0
5196842|NCT01122680|17940765|P4|Period 1 (4 Weeks)|Other|0
5196843|NCT01122680|17940766|P3|Period 1 (4 Weeks)|Other|0
5196844|NCT01122680|17940767|P2|Period 1 (4 Weeks)|Other|1
5196845|NCT01122680|17940768|P1|Period 1 (4 Weeks)|Other|1
5196846|NCT01122680|17940765|P4|Period 1 (4 Weeks)|Protocol Violation|0
5196847|NCT01122680|17940766|P3|Period 1 (4 Weeks)|Protocol Violation|0
5196848|NCT01122680|17940767|P2|Period 1 (4 Weeks)|Protocol Violation|0
5196849|NCT01122680|17940768|P1|Period 1 (4 Weeks)|Protocol Violation|1
5196850|NCT01122680|17940765|P4|Period 1 (4 Weeks)|Adverse Event|0
5196851|NCT01122680|17940766|P3|Period 1 (4 Weeks)|Adverse Event|0
5196852|NCT01122680|17940767|P2|Period 1 (4 Weeks)|Adverse Event|0
5196853|NCT01122680|17940768|P1|Period 1 (4 Weeks)|Adverse Event|1
5196854|NCT01122576|17940833|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
5196855|NCT01122576|17940834|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
5196856|NCT01122576|17940835|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
5196857|NCT01122576|17940833|P3|Post-Cataract Surgery|Central Macular Edema|1
5196858|NCT01122576|17940834|P2|Post-Cataract Surgery|Central Macular Edema|0
5196859|NCT01122576|17940835|P1|Post-Cataract Surgery|Central Macular Edema|0
5196860|NCT01122576|17940833|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
5196861|NCT01122576|17940834|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
5196862|NCT01122576|17940835|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
5196863|NCT01122394|17941016|P2|Overall Study|Adverse Event|1
5196864|NCT01122394|17941017|P1|Overall Study|Adverse Event|0
5196865|NCT01122394|17941016|P2|Overall Study|Lost to Follow-up|2
5196866|NCT01122394|17941017|P1|Overall Study|Lost to Follow-up|2
5196867|NCT01122394|17941016|P2|Overall Study|Withdrawal by Subject|1
5196868|NCT01122394|17941017|P1|Overall Study|Withdrawal by Subject|1
5196869|NCT01122381|17941033|P2|Overall Study|study terminated early|1
5196870|NCT01122381|17941034|P1|Overall Study|study terminated early|0
5196871|NCT01122264|17941050|P3|Overall Study|Lack of Efficacy|1
5196872|NCT01122264|17941051|P2|Overall Study|Lack of Efficacy|1
5196873|NCT01122264|17941052|P1|Overall Study|Lack of Efficacy|3
5196874|NCT01122264|17941050|P3|Overall Study|Physician Decision|1
5196875|NCT01122264|17941051|P2|Overall Study|Physician Decision|1
5196876|NCT01122264|17941052|P1|Overall Study|Physician Decision|3
5196877|NCT01122264|17941050|P3|Overall Study|Withdrawal by Subject|16
5196878|NCT01122264|17941051|P2|Overall Study|Withdrawal by Subject|6
5196879|NCT01122264|17941052|P1|Overall Study|Withdrawal by Subject|6
5196880|NCT01122264|17941050|P3|Overall Study|Protocol Violation|9
5196881|NCT01122264|17941051|P2|Overall Study|Protocol Violation|7
5196882|NCT01122264|17941052|P1|Overall Study|Protocol Violation|7
5196883|NCT01122264|17941050|P3|Overall Study|Entry Criteria Not Met|0
5196884|NCT01122264|17941051|P2|Overall Study|Entry Criteria Not Met|0
5196885|NCT01122264|17941052|P1|Overall Study|Entry Criteria Not Met|1
5196886|NCT01122264|17941050|P3|Overall Study|Lost to Follow-up|13
5196887|NCT01122264|17941051|P2|Overall Study|Lost to Follow-up|9
5196888|NCT01122264|17941052|P1|Overall Study|Lost to Follow-up|5
5196889|NCT01122264|17941050|P3|Overall Study|Death|0
5196890|NCT01122264|17941051|P2|Overall Study|Death|0
5196891|NCT01122264|17941052|P1|Overall Study|Death|1
5196892|NCT01122264|17941050|P3|Overall Study|Adverse Event|7
5196893|NCT01122264|17941051|P2|Overall Study|Adverse Event|5
5196894|NCT01122264|17941052|P1|Overall Study|Adverse Event|6
5196895|NCT01122173|17941162|P1|Overall Study|Left study for other reasons|3
5196896|NCT01122173|17941162|P1|Overall Study|Withdrawal by Subject|3
5196897|NCT01122173|17941162|P1|Overall Study|Lost to Follow-up|3
5196898|NCT01121991|17941385|P1|Overall Study|No Fertilization|1
5196899|NCT01121991|17941385|P1|Overall Study|No Oocytes Retrieved|3
5196900|NCT01121991|17941385|P1|Overall Study|Lack of Ovarian Response|2
5196901|NCT01121926|17941410|P2|Washout Period|Positive pregnancy test|1
5196902|NCT01121926|17941411|P1|Washout Period|Positive pregnancy test|0
5196903|NCT01121926|17941410|P2|Washout Period|Adverse Event|1
5196904|NCT01121926|17941411|P1|Washout Period|Adverse Event|0
5196905|NCT01121926|17941410|P2|First Intervention Period|Adverse Event|0
5196906|NCT01121926|17941411|P1|First Intervention Period|Adverse Event|1
5196907|NCT01121913|17941429|P4|Third Washout Period|Adverse Event|0
5196908|NCT01121913|17941430|P3|Third Washout Period|Adverse Event|0
5196909|NCT01121913|17941431|P2|Third Washout Period|Adverse Event|0
5196910|NCT01121913|17941432|P1|Third Washout Period|Adverse Event|1
5196911|NCT01121913|17941429|P4|Second Washout Period|Withdrawal by Subject|0
5196912|NCT01121913|17941430|P3|Second Washout Period|Withdrawal by Subject|1
5196913|NCT01121913|17941431|P2|Second Washout Period|Withdrawal by Subject|0
5196914|NCT01121913|17941432|P1|Second Washout Period|Withdrawal by Subject|0
5196915|NCT01121913|17941429|P4|Second Intervention Period|Adverse Event|0
5196916|NCT01121913|17941430|P3|Second Intervention Period|Adverse Event|1
5196917|NCT01121913|17941431|P2|Second Intervention Period|Adverse Event|0
5196918|NCT01121913|17941432|P1|Second Intervention Period|Adverse Event|0
5196919|NCT01121913|17941429|P4|First Washout Period|Withdrawal by Subject|0
5196920|NCT01121913|17941430|P3|First Washout Period|Withdrawal by Subject|0
5196921|NCT01121913|17941431|P2|First Washout Period|Withdrawal by Subject|0
5196922|NCT01121913|17941432|P1|First Washout Period|Withdrawal by Subject|1
5196923|NCT01121913|17941429|P4|First Intervention Period|Adverse Event|0
5196924|NCT01121913|17941430|P3|First Intervention Period|Adverse Event|1
5196925|NCT01121913|17941431|P2|First Intervention Period|Adverse Event|0
5196926|NCT01121913|17941432|P1|First Intervention Period|Adverse Event|0
5196927|NCT01121900|17941462|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5196928|NCT01121900|17941463|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5196929|NCT01121900|17941462|P2|First Intervention Period|Adverse Event|1
5196930|NCT01121900|17941463|P1|First Intervention Period|Adverse Event|1
5196931|NCT01121757|17941483|P2|Combination|Disease Progression|0
5196932|NCT01121757|17941484|P1|Combination|Disease Progression|2
5196933|NCT01121757|17941483|P2|Combination|Physician Decision|1
5196934|NCT01121757|17941484|P1|Combination|Physician Decision|0
5196935|NCT01121757|17941483|P2|First Drug|Disease Progression|2
5196936|NCT01121757|17941484|P1|First Drug|Disease Progression|0
5196937|NCT01121757|17941483|P2|First Drug|Death|0
5196938|NCT01121757|17941484|P1|First Drug|Death|1
5196939|NCT01121666|17941500|P2|Overall Study|Protocol Violation|10
5196940|NCT01121666|17941501|P1|Overall Study|Protocol Violation|29
5196941|NCT01121575|17941557|P6|Overall Study|Death|1
5196942|NCT01121575|17941558|P5|Overall Study|Death|7
5196943|NCT01121575|17941559|P4|Overall Study|Death|1
5196944|NCT01121575|17941560|P3|Overall Study|Death|0
5196945|NCT01121575|17941561|P2|Overall Study|Death|0
5196946|NCT01121575|17941562|P1|Overall Study|Death|6
5196947|NCT01121575|17941557|P6|Overall Study|Unspecified Reasons|10
5196948|NCT01121575|17941558|P5|Overall Study|Unspecified Reasons|13
5196949|NCT01121575|17941559|P4|Overall Study|Unspecified Reasons|5
5196950|NCT01121575|17941560|P3|Overall Study|Unspecified Reasons|7
5196951|NCT01121575|17941561|P2|Overall Study|Unspecified Reasons|6
5196952|NCT01121575|17941562|P1|Overall Study|Unspecified Reasons|8
5196953|NCT01121575|17941557|P6|Overall Study|Participant Refused Further Follow-Up|1
5196954|NCT01121575|17941558|P5|Overall Study|Participant Refused Further Follow-Up|5
5196955|NCT01121575|17941559|P4|Overall Study|Participant Refused Further Follow-Up|0
5196956|NCT01121575|17941560|P3|Overall Study|Participant Refused Further Follow-Up|0
5196957|NCT01121575|17941561|P2|Overall Study|Participant Refused Further Follow-Up|0
5196958|NCT01121575|17941562|P1|Overall Study|Participant Refused Further Follow-Up|0
5196959|NCT01121562|17941686|P1|Overall Study|Met study discontinuation criteria|1
5196960|NCT01121562|17941686|P1|Overall Study|Sponsor Decision|1
5196961|NCT01121562|17941686|P1|Overall Study|Adverse Event|1
5196962|NCT01121562|17941686|P1|Overall Study|Withdrawal by Subject|1
5196963|NCT01121562|17941686|P1|Overall Study|Objective progression or relapse|8
5196964|NCT01121549|17941695|P1|Overall Study|Other|58
5196965|NCT01121549|17941695|P1|Overall Study|Withdrawal by Subject|16
5196966|NCT01121549|17941695|P1|Overall Study|Protocol Violation|33
5196967|NCT01121549|17941695|P1|Overall Study|Pregnancy|1
5196968|NCT01121549|17941695|P1|Overall Study|Study terminated by sponsor|197
5196969|NCT01121549|17941695|P1|Overall Study|Did not meet entrance criteria|9
5196970|NCT01121549|17941695|P1|Overall Study|Lost to Follow-up|12
5196971|NCT01121549|17941695|P1|Overall Study|Lack of Efficacy|11
5196972|NCT01121549|17941695|P1|Overall Study|Adverse Event|10
5196973|NCT01121536|17941706|P1|Overall Study|Other|118
5196974|NCT01121536|17941706|P1|Overall Study|Lost to Follow-up|39
5196975|NCT01121536|17941706|P1|Overall Study|Noncompliance with study procedures|9
5196976|NCT01121536|17941706|P1|Overall Study|Noncompliance with study medication|12
5196977|NCT01121536|17941706|P1|Overall Study|Protocol Violation|20
5196978|NCT01121536|17941706|P1|Overall Study|Withdrawal by Subject|65
5196979|NCT01121536|17941706|P1|Overall Study|Lack of Efficacy|35
5196980|NCT01121536|17941706|P1|Overall Study|Adverse Event|63
5196981|NCT01121484|17941727|P2|Overall Study|Randomized, not treated|4
5196982|NCT01121484|17941728|P1|Overall Study|Randomized, not treated|1
5196983|NCT01121484|17941727|P2|Overall Study|Other|3
5196984|NCT01121484|17941728|P1|Overall Study|Other|3
5196985|NCT01121484|17941727|P2|Overall Study|Discontinuation of study by sponsor|1
5196986|NCT01121484|17941728|P1|Overall Study|Discontinuation of study by sponsor|0
5196987|NCT01121484|17941727|P2|Overall Study|Withdrawal by Subject|7
5196988|NCT01121484|17941728|P1|Overall Study|Withdrawal by Subject|8
5196989|NCT01121484|17941727|P2|Overall Study|Protocol Violation|0
5196990|NCT01121484|17941728|P1|Overall Study|Protocol Violation|1
5196991|NCT01121484|17941727|P2|Overall Study|Physician Decision|3
5196992|NCT01121484|17941728|P1|Overall Study|Physician Decision|0
5196993|NCT01121484|17941727|P2|Overall Study|Lost to Follow-up|9
5196994|NCT01121484|17941728|P1|Overall Study|Lost to Follow-up|5
5196995|NCT01121484|17941727|P2|Overall Study|Lack of Efficacy|11
5196996|NCT01121484|17941728|P1|Overall Study|Lack of Efficacy|3
5196997|NCT01121484|17941727|P2|Overall Study|Adverse Event|5
5196998|NCT01121484|17941728|P1|Overall Study|Adverse Event|12
5196999|NCT01121406|17941746|P2|Overall Study|Not treated|0
5197000|NCT01121406|17941747|P1|Overall Study|Not treated|1
5197001|NCT01121406|17941746|P2|Overall Study|Reason other than specified above|6
5197002|NCT01121406|17941747|P1|Overall Study|Reason other than specified above|2
5197003|NCT01121406|17941746|P2|Overall Study|Refused continuation of study med.|2
5197004|NCT01121406|17941747|P1|Overall Study|Refused continuation of study med.|1
5197005|NCT01121406|17941746|P2|Overall Study|Lost to Follow-up|1
5197006|NCT01121406|17941747|P1|Overall Study|Lost to Follow-up|0
5197007|NCT01121406|17941746|P2|Overall Study|Non-compliant with protocol|2
5197008|NCT01121406|17941747|P1|Overall Study|Non-compliant with protocol|0
5197009|NCT01121406|17941746|P2|Overall Study|Other AE|10
5197010|NCT01121406|17941747|P1|Overall Study|Other AE|3
5197011|NCT01121406|17941746|P2|Overall Study|Wors. or AE of underlying cancer disease|6
5197012|NCT01121406|17941747|P1|Overall Study|Wors. or AE of underlying cancer disease|4
5197013|NCT01121406|17941746|P2|Overall Study|Progressive disease RECIST|28
5197014|NCT01121406|17941747|P1|Overall Study|Progressive disease RECIST|44
5197015|NCT01121393|17941797|P2|Overall Study|Other than listed|0
5197016|NCT01121393|17941798|P1|Overall Study|Other than listed|6
5197017|NCT01121393|17941797|P2|Overall Study|Not treated|9
5197018|NCT01121393|17941798|P1|Overall Study|Not treated|3
5197019|NCT01121393|17941797|P2|Overall Study|Refused cont. medication|7
5197020|NCT01121393|17941798|P1|Overall Study|Refused cont. medication|7
5197021|NCT01121393|17941797|P2|Overall Study|Lost to Follow-up|0
5197022|NCT01121393|17941798|P1|Overall Study|Lost to Follow-up|1
5197023|NCT01121393|17941797|P2|Overall Study|Non-compliant with protocol|3
5197024|NCT01121393|17941798|P1|Overall Study|Non-compliant with protocol|0
5197025|NCT01121393|17941797|P2|Overall Study|Other Adverse events|45
5197026|NCT01121393|17941798|P1|Overall Study|Other Adverse events|24
5197027|NCT01121393|17941797|P2|Overall Study|Progressive disease|20
5197028|NCT01121393|17941798|P1|Overall Study|Progressive disease|201
5197029|NCT01121263|17941843|P2|Overall Study|Withdrawal by Subject|1
5197030|NCT01121263|17941844|P1|Overall Study|Withdrawal by Subject|0
5197031|NCT01121263|17941843|P2|Overall Study|Lost to Follow-up|12
5197032|NCT01121263|17941844|P1|Overall Study|Lost to Follow-up|22
5197033|NCT01121263|17941843|P2|Overall Study|Death|2
5197034|NCT01121263|17941844|P1|Overall Study|Death|3
5197035|NCT01121185|17941935|P2|Overall Study|Not transplanted|0
5197036|NCT01121185|17941936|P1|Overall Study|Not transplanted|1
5197037|NCT01121185|17941935|P2|Overall Study|Not infused|1
5197038|NCT01121185|17941936|P1|Overall Study|Not infused|0
5197039|NCT01121146|17941970|P2|Overall Study|Lost to Follow-up|16
5197040|NCT01121146|17941971|P1|Overall Study|Lost to Follow-up|7
5197041|NCT01121146|17941970|P2|Overall Study|Adverse Event|11
5197042|NCT01121146|17941971|P1|Overall Study|Adverse Event|2
5197043|NCT01121146|17941970|P2|Overall Study|Death|15
5197044|NCT01121146|17941971|P1|Overall Study|Death|17
5197045|NCT01120899|17941992|P1|Overall Study|Withdrawal by Subject|3
5197046|NCT01120782|17942020|P1|Overall Study|Test article shipping error|11
5197047|NCT01120756|17942026|P2|Overall Study|Withdrawal by Subject|1
5197048|NCT01120756|17942027|P1|Overall Study|Withdrawal by Subject|1
5197049|NCT01120717|17942037|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5197050|NCT01120717|17942038|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5197051|NCT01120717|17942037|P2|Overall Study|Death|1
5197052|NCT01120717|17942038|P1|Overall Study|Death|3
5197053|NCT01120717|17942037|P2|Overall Study|Lost to Follow-up|3
5197054|NCT01120717|17942038|P1|Overall Study|Lost to Follow-up|2
5197055|NCT01120717|17942037|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
5197056|NCT01120717|17942038|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
5197057|NCT01120717|17942037|P2|Overall Study|Protocol Deviation|5
5197058|NCT01120717|17942038|P1|Overall Study|Protocol Deviation|2
5197059|NCT01120717|17942037|P2|Overall Study|Adverse Event|6
5197060|NCT01120717|17942038|P1|Overall Study|Adverse Event|10
5197061|NCT01120717|17942037|P2|Overall Study|Withdrawal by Subject|6
5197062|NCT01120717|17942038|P1|Overall Study|Withdrawal by Subject|11
5197063|NCT01120691|17942144|P3|Overall Study|Abnormal laboratory value(s)|4
5197064|NCT01120691|17942145|P2|Overall Study|Abnormal laboratory value(s)|3
5197065|NCT01120691|17942146|P1|Overall Study|Abnormal laboratory value(s)|1
5197066|NCT01120691|17942144|P3|Overall Study|Patient's inability to use the device|0
5197067|NCT01120691|17942145|P2|Overall Study|Patient's inability to use the device|1
5197068|NCT01120691|17942146|P1|Overall Study|Patient's inability to use the device|3
5197069|NCT01120691|17942144|P3|Overall Study|Abnormal test procedure result(s)|1
5197070|NCT01120691|17942145|P2|Overall Study|Abnormal test procedure result(s)|2
5197071|NCT01120691|17942146|P1|Overall Study|Abnormal test procedure result(s)|3
5197072|NCT01120691|17942144|P3|Overall Study|Lost to Follow-up|4
5197073|NCT01120691|17942145|P2|Overall Study|Lost to Follow-up|6
5197074|NCT01120691|17942146|P1|Overall Study|Lost to Follow-up|5
5197075|NCT01120691|17942144|P3|Overall Study|Protocol deviation|12
5197076|NCT01120691|17942145|P2|Overall Study|Protocol deviation|12
5197077|NCT01120691|17942146|P1|Overall Study|Protocol deviation|13
5197078|NCT01120691|17942144|P3|Overall Study|Administrative problems|9
5197079|NCT01120691|17942145|P2|Overall Study|Administrative problems|8
5197080|NCT01120691|17942146|P1|Overall Study|Administrative problems|15
5197081|NCT01120691|17942144|P3|Overall Study|Unsatisfactory therapeutic effect|38
5197082|NCT01120691|17942145|P2|Overall Study|Unsatisfactory therapeutic effect|32
5197083|NCT01120691|17942146|P1|Overall Study|Unsatisfactory therapeutic effect|18
5197084|NCT01120691|17942144|P3|Overall Study|Death|24
5197085|NCT01120691|17942145|P2|Overall Study|Death|22
5197086|NCT01120691|17942146|P1|Overall Study|Death|21
5197087|NCT01120691|17942144|P3|Overall Study|Subject withdrew consent|44
5197088|NCT01120691|17942145|P2|Overall Study|Subject withdrew consent|50
5197089|NCT01120691|17942146|P1|Overall Study|Subject withdrew consent|33
5197090|NCT01120691|17942144|P3|Overall Study|Adverse Event|47
5197091|NCT01120691|17942145|P2|Overall Study|Adverse Event|67
5197092|NCT01120691|17942146|P1|Overall Study|Adverse Event|59
5197093|NCT01120626|17942243|P2|Overall Study|Withdrawal by Subject|0
5197094|NCT01120626|17942244|P1|Overall Study|Withdrawal by Subject|1
5197095|NCT01120600|17942254|P2|Overall Study|Withdrawal by Subject|11
5197096|NCT01120600|17942255|P1|Overall Study|Withdrawal by Subject|10
5197097|NCT01120600|17942254|P2|Overall Study|Protocol Violation|4
5197098|NCT01120600|17942255|P1|Overall Study|Protocol Violation|0
5197099|NCT01120600|17942254|P2|Overall Study|Physician Decision|3
5197100|NCT01120600|17942255|P1|Overall Study|Physician Decision|1
5197101|NCT01120600|17942254|P2|Overall Study|Lost to Follow-up|3
5197102|NCT01120600|17942255|P1|Overall Study|Lost to Follow-up|1
5197103|NCT01120600|17942254|P2|Overall Study|Excessive Bone Loss|4
5197104|NCT01120600|17942255|P1|Overall Study|Excessive Bone Loss|0
5197105|NCT01120600|17942254|P2|Overall Study|Adverse Event|7
5197106|NCT01120600|17942255|P1|Overall Study|Adverse Event|7
5197107|NCT01120379|17942310|P1|Four Year Timepoint|Any other reason for early termination|217
5197108|NCT01120379|17942310|P1|Four Year Timepoint|Physician Decision|5
5197109|NCT01120379|17942310|P1|Four Year Timepoint|Death|131
5197110|NCT01120379|17942310|P1|Four Year Timepoint|Lost to Follow-up|10
5197111|NCT01120379|17942310|P1|Four Year Timepoint|Withdrawal by Subject|5
5197112|NCT01120379|17942310|P1|Three Year Timepoint|Any other reason for early termination|17
5197113|NCT01120379|17942310|P1|Three Year Timepoint|Physician Decision|9
5197114|NCT01120379|17942310|P1|Three Year Timepoint|Death|120
5197115|NCT01120379|17942310|P1|Three Year Timepoint|Lost to Follow-up|43
5197116|NCT01120379|17942310|P1|Three Year Timepoint|Withdrawal by Subject|25
5197117|NCT01120379|17942310|P1|Two Year Timepoint|Any other reason for early termination|4
5197118|NCT01120379|17942310|P1|Two Year Timepoint|Physician Decision|12
5197119|NCT01120379|17942310|P1|Two Year Timepoint|Death|123
5197120|NCT01120379|17942310|P1|Two Year Timepoint|Lost to Follow-up|87
5197121|NCT01120379|17942310|P1|Two Year Timepoint|Withdrawal by Subject|11
5197122|NCT01120379|17942310|P1|One Year Timepoint|Any other reason for early termination|5
5197123|NCT01120379|17942310|P1|One Year Timepoint|Physician Decision|9
5197124|NCT01120379|17942310|P1|One Year Timepoint|Death|108
5197125|NCT01120379|17942310|P1|One Year Timepoint|Lost to Follow-up|115
5197126|NCT01120379|17942310|P1|One Year Timepoint|Withdrawal by Subject|41
5197127|NCT01120275|17942346|P1|Overall Study|Not specific|1
5197128|NCT01120275|17942346|P1|Overall Study|Refusal|1
5197129|NCT01120275|17942346|P1|Overall Study|Withdrawal by Subject|1
5197130|NCT01120275|17942346|P1|Overall Study|Ineligible|3
5197131|NCT01120275|17942346|P1|Overall Study|Progression|27
5197132|NCT01120275|17942346|P1|Overall Study|Adverse Event|3
5197133|NCT01120210|17942413|P2|MAIN INFUSION|Withdrawal by Subject|1
5197134|NCT01120210|17942414|P1|MAIN INFUSION|Withdrawal by Subject|0
5197135|NCT01120210|17942413|P2|MAIN INFUSION|Adverse Event|0
5197136|NCT01120210|17942414|P1|MAIN INFUSION|Adverse Event|1
5197137|NCT01120184|17942464|P3|Overall Study|Death|169
5197138|NCT01120184|17942465|P2|Overall Study|Death|176
5197139|NCT01120184|17942466|P1|Overall Study|Death|170
5197140|NCT01120184|17942464|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
5197141|NCT01120184|17942465|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
5197142|NCT01120184|17942466|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
5197143|NCT01120184|17942464|P3|Overall Study|Sponsor Decision to Terminate Study|143
5197144|NCT01120184|17942465|P2|Overall Study|Sponsor Decision to Terminate Study|144
5197145|NCT01120184|17942466|P1|Overall Study|Sponsor Decision to Terminate Study|133
5197146|NCT01120184|17942464|P3|Overall Study|Reason not Specified|12
5197147|NCT01120184|17942465|P2|Overall Study|Reason not Specified|3
5197148|NCT01120184|17942466|P1|Overall Study|Reason not Specified|8
5197149|NCT01120184|17942464|P3|Overall Study|Physician Decision|3
5197150|NCT01120184|17942465|P2|Overall Study|Physician Decision|1
5197151|NCT01120184|17942466|P1|Overall Study|Physician Decision|9
5197152|NCT01120184|17942464|P3|Overall Study|Lost to Follow-up|11
5197153|NCT01120184|17942465|P2|Overall Study|Lost to Follow-up|13
5197154|NCT01120184|17942466|P1|Overall Study|Lost to Follow-up|13
5197155|NCT01120184|17942464|P3|Overall Study|Adverse Event|0
5197156|NCT01120184|17942465|P2|Overall Study|Adverse Event|1
5197157|NCT01120184|17942466|P1|Overall Study|Adverse Event|0
5197158|NCT01120093|17942588|P5|Treatment Period 5|Adverse Event|0
5197159|NCT01120093|17942589|P4|Treatment Period 5|Adverse Event|1
5197160|NCT01120093|17942590|P3|Treatment Period 5|Adverse Event|0
5197161|NCT01120093|17942591|P2|Treatment Period 5|Adverse Event|1
5197162|NCT01120093|17942592|P1|Treatment Period 5|Adverse Event|0
5197163|NCT01120093|17942588|P5|Treatment Period 4|Adverse Event|0
5197164|NCT01120093|17942589|P4|Treatment Period 4|Adverse Event|0
5197165|NCT01120093|17942590|P3|Treatment Period 4|Adverse Event|0
5197166|NCT01120093|17942591|P2|Treatment Period 4|Adverse Event|0
5197167|NCT01120093|17942592|P1|Treatment Period 4|Adverse Event|1
5197168|NCT01120093|17942588|P5|Treatment Period 3|Withdrawal by Subject|0
5197169|NCT01120093|17942589|P4|Treatment Period 3|Withdrawal by Subject|0
5197170|NCT01120093|17942590|P3|Treatment Period 3|Withdrawal by Subject|1
5197171|NCT01120093|17942591|P2|Treatment Period 3|Withdrawal by Subject|0
5197172|NCT01120093|17942592|P1|Treatment Period 3|Withdrawal by Subject|0
5197173|NCT01120093|17942588|P5|Treatment Period 3|Adverse Event|1
5197174|NCT01120093|17942589|P4|Treatment Period 3|Adverse Event|0
5197175|NCT01120093|17942590|P3|Treatment Period 3|Adverse Event|0
5197176|NCT01120093|17942591|P2|Treatment Period 3|Adverse Event|0
5197177|NCT01120093|17942592|P1|Treatment Period 3|Adverse Event|0
5197178|NCT01120093|17942588|P5|Treatment Period 3|Lack of Efficacy|0
5197179|NCT01120093|17942589|P4|Treatment Period 3|Lack of Efficacy|1
5197180|NCT01120093|17942590|P3|Treatment Period 3|Lack of Efficacy|0
5197181|NCT01120093|17942591|P2|Treatment Period 3|Lack of Efficacy|0
5197182|NCT01120093|17942592|P1|Treatment Period 3|Lack of Efficacy|0
5197183|NCT01120093|17942588|P5|Treatment Period 2|Withdrawal by Subject|1
5197184|NCT01120093|17942589|P4|Treatment Period 2|Withdrawal by Subject|0
5197185|NCT01120093|17942590|P3|Treatment Period 2|Withdrawal by Subject|0
5197186|NCT01120093|17942591|P2|Treatment Period 2|Withdrawal by Subject|0
5197187|NCT01120093|17942592|P1|Treatment Period 2|Withdrawal by Subject|0
5197188|NCT01120093|17942588|P5|Treatment Period 2|Adverse Event|0
5197189|NCT01120093|17942589|P4|Treatment Period 2|Adverse Event|1
5197190|NCT01120093|17942590|P3|Treatment Period 2|Adverse Event|0
5197191|NCT01120093|17942591|P2|Treatment Period 2|Adverse Event|0
5197192|NCT01120093|17942592|P1|Treatment Period 2|Adverse Event|0
5197193|NCT01120093|17942588|P5|Treatment Period 1|Withdrawal by Subject|0
5197194|NCT01120093|17942589|P4|Treatment Period 1|Withdrawal by Subject|0
5197195|NCT01120093|17942590|P3|Treatment Period 1|Withdrawal by Subject|0
5197196|NCT01120093|17942591|P2|Treatment Period 1|Withdrawal by Subject|1
5197197|NCT01120093|17942592|P1|Treatment Period 1|Withdrawal by Subject|0
5197198|NCT01120093|17942588|P5|Treatment Period 1|Adverse Event|1
5197199|NCT01120093|17942589|P4|Treatment Period 1|Adverse Event|0
5197200|NCT01120093|17942590|P3|Treatment Period 1|Adverse Event|1
5197201|NCT01120093|17942591|P2|Treatment Period 1|Adverse Event|0
5197202|NCT01120093|17942592|P1|Treatment Period 1|Adverse Event|0
5197203|NCT01120067|17942621|P2|Overall Study|fail to engage >3 sessions|0
5197204|NCT01120067|17942622|P1|Overall Study|fail to engage >3 sessions|2
5197205|NCT01120067|17942621|P2|Overall Study|Lost to Follow-up|1
5197206|NCT01120067|17942622|P1|Overall Study|Lost to Follow-up|3
5197207|NCT01120028|17942632|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
5197208|NCT01120028|17942633|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
5197209|NCT01120028|17942634|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
5197210|NCT01120028|17942635|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
5197211|NCT01120028|17942632|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5197212|NCT01120028|17942633|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5197213|NCT01120028|17942634|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
5197214|NCT01120028|17942635|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5197215|NCT01119963|17942659|P2|Overall Study|Lost to Follow-up|1
5197216|NCT01119963|17942660|P1|Overall Study|Lost to Follow-up|1
5197217|NCT01119950|17942670|P1|Overall Study|Death|1
5197218|NCT01119950|17942670|P1|Overall Study|Abnormal lab value|1
5197219|NCT01119950|17942670|P1|Overall Study|Administrative|2
5197220|NCT01119950|17942670|P1|Overall Study|Lost to Follow-up|4
5197221|NCT01119950|17942670|P1|Overall Study|Protocol Violation|5
5197222|NCT01119950|17942670|P1|Overall Study|Withdrawal by Subject|9
5197223|NCT01119950|17942670|P1|Overall Study|Adverse Event|25
5197224|NCT01119937|17942917|P2|Overall Study|Withdrawal by Subject|1
5197225|NCT01119937|17942918|P1|Overall Study|Withdrawal by Subject|2
5197226|NCT01119937|17942917|P2|Overall Study|Unsatisfactory therapeutic effect|0
5197227|NCT01119937|17942918|P1|Overall Study|Unsatisfactory therapeutic effect|3
5197228|NCT01119937|17942917|P2|Overall Study|Protocol deviation|1
5197229|NCT01119937|17942918|P1|Overall Study|Protocol deviation|3
5197230|NCT01119937|17942917|P2|Overall Study|Adverse Event|5
5197231|NCT01119937|17942918|P1|Overall Study|Adverse Event|11
5197232|NCT01119898|17942946|P2|Overall Study|Randomized in error did not participate|0
5197233|NCT01119898|17942947|P1|Overall Study|Randomized in error did not participate|1
5197234|NCT01119898|17942946|P2|Overall Study|Medical procedure|0
5197235|NCT01119898|17942947|P1|Overall Study|Medical procedure|1
5197236|NCT01119898|17942946|P2|Overall Study|Protocol Violation|1
5197237|NCT01119898|17942947|P1|Overall Study|Protocol Violation|1
5197238|NCT01119898|17942946|P2|Overall Study|Lack of Efficacy|2
5197239|NCT01119898|17942947|P1|Overall Study|Lack of Efficacy|0
5197240|NCT01119898|17942946|P2|Overall Study|Withdrawal by Subject|4
5197241|NCT01119898|17942947|P1|Overall Study|Withdrawal by Subject|1
5197242|NCT01119898|17942946|P2|Overall Study|Adverse Event|5
5197243|NCT01119898|17942947|P1|Overall Study|Adverse Event|4
5197244|NCT01119859|17942973|P2|Overall Study|Failure to return|0
5197245|NCT01119859|17942974|P1|Overall Study|Failure to return|3
5197246|NCT01119859|17942973|P2|Overall Study|Refused treatment|6
5197247|NCT01119859|17942974|P1|Overall Study|Refused treatment|3
5197248|NCT01119859|17942973|P2|Overall Study|Insufficient therapeutic response|14
5197249|NCT01119859|17942974|P1|Overall Study|Insufficient therapeutic response|7
5197250|NCT01119859|17942973|P2|Overall Study|Death|0
5197251|NCT01119859|17942974|P1|Overall Study|Death|2
5197252|NCT01119859|17942973|P2|Overall Study|Adverse Event|10
5197253|NCT01119859|17942974|P1|Overall Study|Adverse Event|9
5197254|NCT01119846|17942993|P3|Overall Study|Withdrawal by Subject|4
5197255|NCT01119846|17942994|P2|Overall Study|Withdrawal by Subject|0
5197256|NCT01119846|17942995|P1|Overall Study|Withdrawal by Subject|0
5197257|NCT01119846|17942993|P3|Overall Study|Protocol Violation|1
5197258|NCT01119846|17942994|P2|Overall Study|Protocol Violation|0
5197259|NCT01119846|17942995|P1|Overall Study|Protocol Violation|0
5197260|NCT01119846|17942993|P3|Overall Study|Physician Decision|0
5197261|NCT01119846|17942994|P2|Overall Study|Physician Decision|0
5197262|NCT01119846|17942995|P1|Overall Study|Physician Decision|1
5197263|NCT01119846|17942993|P3|Overall Study|Adverse Event|6
5197264|NCT01119846|17942994|P2|Overall Study|Adverse Event|0
5197265|NCT01119846|17942995|P1|Overall Study|Adverse Event|1
5197266|NCT01119768|17943209|P2|Treatment Period|Lack of Efficacy|25
5197267|NCT01119768|17943210|P1|Treatment Period|Lack of Efficacy|18
5197268|NCT01119703|17943266|P2|Overall Study|Adverse Event|1
5197269|NCT01119703|17943267|P1|Overall Study|Adverse Event|0
5197270|NCT01119625|17943281|P2|Overall Study|Other|1
5197271|NCT01119625|17943282|P1|Overall Study|Other|0
5197272|NCT01119625|17943281|P2|Overall Study|Withdrawal by Subject|1
5197273|NCT01119625|17943282|P1|Overall Study|Withdrawal by Subject|2
5197274|NCT01119625|17943281|P2|Overall Study|Lost to Follow-up|2
5197275|NCT01119625|17943282|P1|Overall Study|Lost to Follow-up|1
5197276|NCT01119508|17943322|P1|Overall Study|Died before tumor response evaluation|1
5197277|NCT01119508|17943322|P1|Overall Study|Withdrawal by Subject|2
5197278|NCT01119508|17943322|P1|Overall Study|Adverse Event|56
5197279|NCT01119443|17943402|P2|Crossover Period 1 (5 Days)|Adverse Event|1
5197280|NCT01119443|17943403|P1|Crossover Period 1 (5 Days)|Adverse Event|0
5197281|NCT01119287|17943446|P6|Overall Study|Patient Decision, not related to AE|0
5197282|NCT01119287|17943447|P5|Overall Study|Patient Decision, not related to AE|1
5197283|NCT01119287|17943448|P4|Overall Study|Patient Decision, not related to AE|2
5197284|NCT01119287|17943449|P3|Overall Study|Patient Decision, not related to AE|2
5197285|NCT01119287|17943450|P2|Overall Study|Patient Decision, not related to AE|0
5197286|NCT01119287|17943451|P1|Overall Study|Patient Decision, not related to AE|0
5197287|NCT01119248|17943464|P1|Overall Study|Physician Decision|5
5197288|NCT01119131|17943514|P3|Overall Study|Physician Decision|1
5197289|NCT01119131|17943515|P2|Overall Study|Physician Decision|0
5197290|NCT01119131|17943516|P1|Overall Study|Physician Decision|0
5197291|NCT01119131|17943514|P3|Overall Study|Non-Compliance|4
5197292|NCT01119131|17943515|P2|Overall Study|Non-Compliance|0
5197293|NCT01119131|17943516|P1|Overall Study|Non-Compliance|1
5197294|NCT01119131|17943514|P3|Overall Study|Adverse Event|1
5197295|NCT01119131|17943515|P2|Overall Study|Adverse Event|1
5197296|NCT01119131|17943516|P1|Overall Study|Adverse Event|1
5197297|NCT01119118|17943545|P1|Overall Study|Adverse Event|1
5197298|NCT01119105|17943556|P3|Overall Study|Other|0
5197299|NCT01119105|17943557|P2|Overall Study|Other|1
5197300|NCT01119105|17943558|P1|Overall Study|Other|1
5197301|NCT01119105|17943556|P3|Overall Study|study drug missed on 2 consecutive days|1
5197302|NCT01119105|17943557|P2|Overall Study|study drug missed on 2 consecutive days|2
5197303|NCT01119105|17943558|P1|Overall Study|study drug missed on 2 consecutive days|1
5197304|NCT01119105|17943556|P3|Overall Study|Adverse Event|1
5197305|NCT01119105|17943557|P2|Overall Study|Adverse Event|0
5197306|NCT01119105|17943558|P1|Overall Study|Adverse Event|1
5197307|NCT01119105|17943556|P3|Overall Study|Lost to Follow-up|5
5197308|NCT01119105|17943557|P2|Overall Study|Lost to Follow-up|2
5197309|NCT01119105|17943558|P1|Overall Study|Lost to Follow-up|0
5197310|NCT01119105|17943556|P3|Overall Study|Withdrawal by Subject|1
5197311|NCT01119105|17943557|P2|Overall Study|Withdrawal by Subject|1
5197312|NCT01119105|17943558|P1|Overall Study|Withdrawal by Subject|1
5197313|NCT01119001|17943573|P1|Overall Study|Withdrawal by Subject|2
5197314|NCT01118975|17943617|P2|Overall Study|Adverse Event|1
5197315|NCT01118975|17943618|P1|Overall Study|Adverse Event|0
5197316|NCT01118962|17943624|P1|Overall Study|Non-compliance with Medicinal Product|1
5197317|NCT01118962|17943624|P1|Overall Study|Pregnancy|1
5197318|NCT01118962|17943624|P1|Overall Study|Withdrawal by Subject|4
5197319|NCT01118962|17943624|P1|Overall Study|Protocol Violation|1
5197320|NCT01118962|17943624|P1|Overall Study|Lack of Efficacy|1
5197321|NCT01118962|17943624|P1|Overall Study|Adverse Event|2
5197322|NCT01118949|17943629|P1|Overall Study|Withdrawal by Subject|4
5197323|NCT01118949|17943629|P1|Overall Study|Adverse Event|5
5197324|NCT01118780|17943659|P2|Overall Study|Withdrawal by Subject|8
5197325|NCT01118780|17943660|P1|Overall Study|Withdrawal by Subject|13
5197326|NCT01118780|17943659|P2|Overall Study|Protocol Violation|6
5197327|NCT01118780|17943660|P1|Overall Study|Protocol Violation|3
5197328|NCT01118780|17943659|P2|Overall Study|Physician Decision|0
5197329|NCT01118780|17943660|P1|Overall Study|Physician Decision|2
5197330|NCT01118780|17943659|P2|Overall Study|Lack of Efficacy|6
5197331|NCT01118780|17943660|P1|Overall Study|Lack of Efficacy|2
5197332|NCT01118780|17943659|P2|Overall Study|Death|0
5197333|NCT01118780|17943660|P1|Overall Study|Death|1
5197334|NCT01118780|17943659|P2|Overall Study|Adverse Event|15
5197335|NCT01118780|17943660|P1|Overall Study|Adverse Event|15
5197336|NCT01118728|17943718|P1|Overall Study|Lost to Follow-up|4
5197337|NCT01118728|17943718|P1|Overall Study|Withdrawal by Subject|3
5197338|NCT01118728|17943718|P1|Overall Study|Sponsor's decision to discontinue study|172
5197339|NCT01118728|17943718|P1|Overall Study|Lack of Efficacy|27
5197340|NCT01118728|17943718|P1|Overall Study|Adverse Event|17
5197341|NCT01118663|17943755|P2|Overall Study|Withdrawal by Subject|1
5197342|NCT01118663|17943756|P1|Overall Study|Withdrawal by Subject|0
5197343|NCT01118663|17943755|P2|Overall Study|Adverse Event|1
5197344|NCT01118663|17943756|P1|Overall Study|Adverse Event|2
5197345|NCT01118455|17943779|P2|Baseline [Visits 1 & 2]|Adverse Event|0
5197346|NCT01118455|17943780|P1|Baseline [Visits 1 & 2]|Adverse Event|1
5197347|NCT01118377|17943808|P1|Overall Study|Failure to Return|3
5197348|NCT01118377|17943808|P1|Overall Study|Death|38
5197349|NCT01118377|17943808|P1|Overall Study|Did Not Receive Study Medication|1
5197350|NCT01118351|17943814|P1|Overall Study|Withdrawal by Subject|1
5197351|NCT01118351|17943814|P1|Overall Study|Adverse Event|3
5197352|NCT01118325|17943838|P3|Overall Study|Adverse Event|1
5197353|NCT01118325|17943839|P2|Overall Study|Adverse Event|0
5197354|NCT01118325|17943840|P1|Overall Study|Adverse Event|1
5197355|NCT01118312|17943886|P2|Overall Study|Withdrawal by Subject|3
5197356|NCT01118312|17943887|P1|Overall Study|Withdrawal by Subject|1
5197357|NCT01118312|17943886|P2|Overall Study|Lost to Follow-up|32
5197358|NCT01118312|17943887|P1|Overall Study|Lost to Follow-up|33
5197359|NCT01118299|17943897|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
5197360|NCT01118299|17943898|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
5197361|NCT01118299|17943897|P2|Overall Study|Lost to Follow-up|1
5197362|NCT01118299|17943898|P1|Overall Study|Lost to Follow-up|2
5197363|NCT01118299|17943897|P2|Overall Study|Withdrawal by Subject|8
5197364|NCT01118299|17943898|P1|Overall Study|Withdrawal by Subject|8
5197365|NCT01118299|17943897|P2|Overall Study|Death|5
5197366|NCT01118299|17943898|P1|Overall Study|Death|7
5197367|NCT01118143|17944095|P2|Overall Study|Withdrawal by Subject|5
5197368|NCT01118143|17944096|P1|Overall Study|Withdrawal by Subject|2
5197369|NCT01118117|17944106|P2|Overall Study|Missed 12 Month Visit|0
5197370|NCT01118117|17944107|P1|Overall Study|Missed 12 Month Visit|7
5197371|NCT01118117|17944106|P2|Overall Study|Lost to Follow-up|0
5197372|NCT01118117|17944107|P1|Overall Study|Lost to Follow-up|6
5197373|NCT01118117|17944106|P2|Overall Study|Death|0
5197374|NCT01118117|17944107|P1|Overall Study|Death|8
5197375|NCT01118052|17944139|P1|Overall Study|Never treated|2
5197376|NCT01117987|17944162|P2|Overall Study|Administrative problems|22
5197377|NCT01117987|17944163|P1|Overall Study|Administrative problems|25
5197378|NCT01117987|17944162|P2|Overall Study|Adverse Event|26
5197379|NCT01117987|17944163|P1|Overall Study|Adverse Event|19
5197380|NCT01117987|17944162|P2|Overall Study|Withdrawal by Subject|10
5197381|NCT01117987|17944163|P1|Overall Study|Withdrawal by Subject|5
5197382|NCT01117987|17944162|P2|Overall Study|Death|10
5197383|NCT01117987|17944163|P1|Overall Study|Death|5
5197384|NCT01117987|17944162|P2|Overall Study|Lack of Efficacy|4
5197385|NCT01117987|17944163|P1|Overall Study|Lack of Efficacy|3
5197386|NCT01117987|17944162|P2|Overall Study|Abnormal test procedure result|0
5197387|NCT01117987|17944163|P1|Overall Study|Abnormal test procedure result|2
5197388|NCT01117987|17944162|P2|Overall Study|Lost to Follow-up|1
5197389|NCT01117987|17944163|P1|Overall Study|Lost to Follow-up|1
5197390|NCT01117987|17944162|P2|Overall Study|Subject no longer requires study drug|0
5197391|NCT01117987|17944163|P1|Overall Study|Subject no longer requires study drug|1
5197392|NCT01117987|17944162|P2|Overall Study|Protocol deviation|1
5197393|NCT01117987|17944163|P1|Overall Study|Protocol deviation|0
5197394|NCT01117870|17944184|P2|Overall Study|Inability to place needle|0
5197395|NCT01117870|17944185|P1|Overall Study|Inability to place needle|1
5197396|NCT01117857|17944199|P1|Overall Study|Physician Decision|1
5197397|NCT01117857|17944199|P1|Overall Study|Withdrawal by Subject|4
5197398|NCT01117857|17944199|P1|Overall Study|Lost to Follow-up|4
5197399|NCT01117766|17944207|P2|Second Intervention|Withdrawal by Subject|1
5197400|NCT01117766|17944208|P1|Second Intervention|Withdrawal by Subject|0
5197401|NCT01117766|17944207|P2|Second Intervention|Adverse Event|2
5197402|NCT01117766|17944208|P1|Second Intervention|Adverse Event|0
5197403|NCT01117766|17944207|P2|Second Intervention|Other|2
5197404|NCT01117766|17944208|P1|Second Intervention|Other|1
5197405|NCT01117766|17944207|P2|Second Intervention|Lost to Follow-up|0
5197406|NCT01117766|17944208|P1|Second Intervention|Lost to Follow-up|1
5197407|NCT01117766|17944207|P2|Washout Period|Protocol Violation|2
5197408|NCT01117766|17944208|P1|Washout Period|Protocol Violation|0
5197409|NCT01117766|17944207|P2|First Intervention|Protocol Violation|0
5197410|NCT01117766|17944208|P1|First Intervention|Protocol Violation|1
5197411|NCT01117766|17944207|P2|First Intervention|Adverse Event|1
5197412|NCT01117766|17944208|P1|First Intervention|Adverse Event|0
5197413|NCT01117623|17944245|P8|Overall Study|Invest. text: completed all planned txs|0
5197414|NCT01117623|17944246|P7|Overall Study|Invest. text: completed all planned txs|0
5197415|NCT01117623|17944247|P6|Overall Study|Invest. text: completed all planned txs|1
5197416|NCT01117623|17944248|P5|Overall Study|Invest. text: completed all planned txs|0
5197417|NCT01117623|17944249|P4|Overall Study|Invest. text: completed all planned txs|0
5197418|NCT01117623|17944250|P3|Overall Study|Invest. text: completed all planned txs|0
5197419|NCT01117623|17944251|P2|Overall Study|Invest. text: completed all planned txs|0
5197420|NCT01117623|17944252|P1|Overall Study|Invest. text: completed all planned txs|0
5197421|NCT01117623|17944245|P8|Overall Study|Non-compliance with study medication|1
5197422|NCT01117623|17944246|P7|Overall Study|Non-compliance with study medication|0
5197423|NCT01117623|17944247|P6|Overall Study|Non-compliance with study medication|0
5197424|NCT01117623|17944248|P5|Overall Study|Non-compliance with study medication|0
5197425|NCT01117623|17944249|P4|Overall Study|Non-compliance with study medication|0
5197426|NCT01117623|17944250|P3|Overall Study|Non-compliance with study medication|0
5197427|NCT01117623|17944251|P2|Overall Study|Non-compliance with study medication|0
5197428|NCT01117623|17944252|P1|Overall Study|Non-compliance with study medication|0
5197429|NCT01117623|17944245|P8|Overall Study|Withdrawal by Subject|1
5197430|NCT01117623|17944246|P7|Overall Study|Withdrawal by Subject|1
5197431|NCT01117623|17944247|P6|Overall Study|Withdrawal by Subject|1
5197432|NCT01117623|17944248|P5|Overall Study|Withdrawal by Subject|0
5197433|NCT01117623|17944249|P4|Overall Study|Withdrawal by Subject|0
5197434|NCT01117623|17944250|P3|Overall Study|Withdrawal by Subject|2
5197435|NCT01117623|17944251|P2|Overall Study|Withdrawal by Subject|0
5197436|NCT01117623|17944252|P1|Overall Study|Withdrawal by Subject|0
5197437|NCT01117623|17944245|P8|Overall Study|Disease progression, recurrence, relapse|22
5197438|NCT01117623|17944246|P7|Overall Study|Disease progression, recurrence, relapse|5
5197439|NCT01117623|17944247|P6|Overall Study|Disease progression, recurrence, relapse|14
5197440|NCT01117623|17944248|P5|Overall Study|Disease progression, recurrence, relapse|8
5197441|NCT01117623|17944249|P4|Overall Study|Disease progression, recurrence, relapse|6
5197442|NCT01117623|17944250|P3|Overall Study|Disease progression, recurrence, relapse|5
5197443|NCT01117623|17944251|P2|Overall Study|Disease progression, recurrence, relapse|6
5197444|NCT01117623|17944252|P1|Overall Study|Disease progression, recurrence, relapse|3
5197445|NCT01117623|17944245|P8|Overall Study|Adverse Event|2
5197446|NCT01117623|17944246|P7|Overall Study|Adverse Event|0
5197447|NCT01117623|17944247|P6|Overall Study|Adverse Event|0
5197448|NCT01117623|17944248|P5|Overall Study|Adverse Event|2
5197449|NCT01117623|17944249|P4|Overall Study|Adverse Event|0
5197450|NCT01117623|17944250|P3|Overall Study|Adverse Event|4
5197451|NCT01117623|17944251|P2|Overall Study|Adverse Event|2
5197452|NCT01117623|17944252|P1|Overall Study|Adverse Event|0
5197453|NCT01117480|17944404|P1|Overall Study|Did Not Start Adalimumab Therapy|20
5197454|NCT01117480|17944404|P1|Overall Study|Protocol Violation|8
5197455|NCT01117454|17944412|P2|Overall Study|Pregnancy|1
5197456|NCT01117454|17944413|P1|Overall Study|Pregnancy|0
5197457|NCT01117428|17944425|P6|Overall Study|Progressive disease|17
5197458|NCT01117428|17944426|P5|Overall Study|Progressive disease|16
5197459|NCT01117428|17944427|P4|Overall Study|Progressive disease|12
5197460|NCT01117428|17944428|P3|Overall Study|Progressive disease|10
5197461|NCT01117428|17944429|P2|Overall Study|Progressive disease|27
5197462|NCT01117428|17944430|P1|Overall Study|Progressive disease|15
5197463|NCT01117428|17944425|P6|Overall Study|Withdrawal by Subject|0
5197464|NCT01117428|17944426|P5|Overall Study|Withdrawal by Subject|0
5197465|NCT01117428|17944427|P4|Overall Study|Withdrawal by Subject|0
5197466|NCT01117428|17944428|P3|Overall Study|Withdrawal by Subject|1
5197467|NCT01117428|17944429|P2|Overall Study|Withdrawal by Subject|0
5197468|NCT01117428|17944430|P1|Overall Study|Withdrawal by Subject|0
5197469|NCT01117428|17944425|P6|Overall Study|Physician Decision|0
5197470|NCT01117428|17944426|P5|Overall Study|Physician Decision|0
5197471|NCT01117428|17944427|P4|Overall Study|Physician Decision|0
5197472|NCT01117428|17944428|P3|Overall Study|Physician Decision|0
5197473|NCT01117428|17944429|P2|Overall Study|Physician Decision|1
5197474|NCT01117428|17944430|P1|Overall Study|Physician Decision|0
5197475|NCT01117428|17944425|P6|Overall Study|Death|1
5197476|NCT01117428|17944426|P5|Overall Study|Death|0
5197477|NCT01117428|17944427|P4|Overall Study|Death|0
5197478|NCT01117428|17944428|P3|Overall Study|Death|2
5197479|NCT01117428|17944429|P2|Overall Study|Death|1
5197480|NCT01117428|17944430|P1|Overall Study|Death|0
5197481|NCT01117428|17944425|P6|Overall Study|Adverse Event|2
5197482|NCT01117428|17944426|P5|Overall Study|Adverse Event|1
5197483|NCT01117428|17944427|P4|Overall Study|Adverse Event|0
5197484|NCT01117428|17944428|P3|Overall Study|Adverse Event|0
5197485|NCT01117428|17944429|P2|Overall Study|Adverse Event|0
5197486|NCT01117428|17944430|P1|Overall Study|Adverse Event|4
5197487|NCT01117428|17944425|P6|Overall Study|Lack of Efficacy|0
5197488|NCT01117428|17944426|P5|Overall Study|Lack of Efficacy|0
5197489|NCT01117428|17944427|P4|Overall Study|Lack of Efficacy|0
5197490|NCT01117428|17944428|P3|Overall Study|Lack of Efficacy|0
5197491|NCT01117428|17944429|P2|Overall Study|Lack of Efficacy|0
5197492|NCT01117428|17944430|P1|Overall Study|Lack of Efficacy|1
5197493|NCT01117350|17944464|P2|Extension Period|Prohibited medication|1
5197494|NCT01117350|17944465|P1|Extension Period|Prohibited medication|0
5197495|NCT01117350|17944464|P2|Extension Period|Inclusion criteria not respected|1
5197496|NCT01117350|17944465|P1|Extension Period|Inclusion criteria not respected|0
5197497|NCT01117350|17944464|P2|Extension Period|Lack of Efficacy|2
5197498|NCT01117350|17944465|P1|Extension Period|Lack of Efficacy|0
5197499|NCT01117350|17944464|P2|Extension Period|Withdrawal by Subject|3
5197500|NCT01117350|17944465|P1|Extension Period|Withdrawal by Subject|0
5197501|NCT01117350|17944464|P2|Extension Period|Lost to Follow-up|2
5197502|NCT01117350|17944465|P1|Extension Period|Lost to Follow-up|0
5197503|NCT01117350|17944464|P2|Extension Period|Protocol Violation|2
5197504|NCT01117350|17944465|P1|Extension Period|Protocol Violation|0
5197505|NCT01117350|17944464|P2|Extension Period|Adverse Event|2
5197506|NCT01117350|17944465|P1|Extension Period|Adverse Event|0
5197507|NCT01117350|17944464|P2|Extension Period|Not included in extension, not treated|50
5197508|NCT01117350|17944465|P1|Extension Period|Not included in extension, not treated|0
5197509|NCT01117350|17944464|P2|Comparative Period|Move to another city/country|1
5197510|NCT01117350|17944465|P1|Comparative Period|Move to another city/country|2
5197511|NCT01117350|17944464|P2|Comparative Period|Physician Decision|1
5197512|NCT01117350|17944465|P1|Comparative Period|Physician Decision|0
5197513|NCT01117350|17944464|P2|Comparative Period|Lack of Efficacy|0
5197514|NCT01117350|17944465|P1|Comparative Period|Lack of Efficacy|1
5197515|NCT01117350|17944464|P2|Comparative Period|Protocol Violation|12
5197516|NCT01117350|17944465|P1|Comparative Period|Protocol Violation|8
5197517|NCT01117350|17944464|P2|Comparative Period|Withdrawal by Subject|13
5197518|NCT01117350|17944465|P1|Comparative Period|Withdrawal by Subject|9
5197519|NCT01117350|17944464|P2|Comparative Period|Lost to Follow-up|7
5197520|NCT01117350|17944465|P1|Comparative Period|Lost to Follow-up|11
5197521|NCT01117350|17944464|P2|Comparative Period|Adverse Event|33
5197522|NCT01117350|17944465|P1|Comparative Period|Adverse Event|6
5197523|NCT01117350|17944464|P2|Comparative Period|Not Treated|8
5197524|NCT01117350|17944465|P1|Comparative Period|Not Treated|5
5197525|NCT01117337|17944497|P2|Overall Study|Lost to Follow-up|0
5197526|NCT01117337|17944498|P1|Overall Study|Lost to Follow-up|4
5197527|NCT01117181|17944519|P2|Overall Study|Withdrawal by Subject|2
5197528|NCT01117181|17944520|P1|Overall Study|Withdrawal by Subject|0
5197529|NCT01117181|17944519|P2|Overall Study|Lost to Follow-up|0
5197530|NCT01117181|17944520|P1|Overall Study|Lost to Follow-up|1
5197531|NCT01117051|17944553|P2|Overall Study|Convenience issue|0
5197532|NCT01117051|17944554|P1|Overall Study|Convenience issue|1
5197533|NCT01117051|17944553|P2|Overall Study|Randomized by mistake|1
5197534|NCT01117051|17944554|P1|Overall Study|Randomized by mistake|0
5197535|NCT01117051|17944553|P2|Overall Study|Surgical procedure|1
5197536|NCT01117051|17944554|P1|Overall Study|Surgical procedure|0
5197537|NCT01117051|17944553|P2|Overall Study|Sponsor's decision|1
5197538|NCT01117051|17944554|P1|Overall Study|Sponsor's decision|3
5197539|NCT01117051|17944553|P2|Overall Study|Did not meet in-/exclusion criteria|1
5197540|NCT01117051|17944554|P1|Overall Study|Did not meet in-/exclusion criteria|0
5197541|NCT01117051|17944553|P2|Overall Study|Lost to Follow-up|1
5197542|NCT01117051|17944554|P1|Overall Study|Lost to Follow-up|0
5197543|NCT01117051|17944553|P2|Overall Study|Adverse Event|3
5197544|NCT01117051|17944554|P1|Overall Study|Adverse Event|4
5197545|NCT01117051|17944553|P2|Overall Study|Withdrawal by Subject|3
5197546|NCT01117051|17944554|P1|Overall Study|Withdrawal by Subject|5
5197547|NCT01117012|17944564|P2|Overall Study|Undefined|3
5197548|NCT01117012|17944565|P1|Overall Study|Undefined|4
5197549|NCT01117012|17944564|P2|Overall Study|Withdrawal by Subject|0
5197550|NCT01117012|17944565|P1|Overall Study|Withdrawal by Subject|3
5197551|NCT01117012|17944564|P2|Overall Study|Death|1
5197552|NCT01117012|17944565|P1|Overall Study|Death|1
5197553|NCT01117012|17944564|P2|Overall Study|Adverse Event|1
5197554|NCT01117012|17944565|P1|Overall Study|Adverse Event|0
5197555|NCT01116882|17944739|P2|12-month|Withdrawal by Subject|8
5197556|NCT01116882|17944740|P1|12-month|Withdrawal by Subject|5
5197557|NCT01116882|17944739|P2|12-month|Other Reasons|49
5197558|NCT01116882|17944740|P1|12-month|Other Reasons|151
5197559|NCT01116882|17944739|P2|12-month|Lost to Follow-up|42
5197560|NCT01116882|17944740|P1|12-month|Lost to Follow-up|111
5197561|NCT01116882|17944739|P2|30-day|Other Reasons|6
5197562|NCT01116882|17944740|P1|30-day|Other Reasons|16
5197563|NCT01116882|17944739|P2|30-day|Withdrawal by Subject|4
5197564|NCT01116882|17944740|P1|30-day|Withdrawal by Subject|2
5197565|NCT01116882|17944739|P2|30-day|Lost to Follow-up|21
5197566|NCT01116882|17944740|P1|30-day|Lost to Follow-up|50
5197567|NCT01116687|17944778|P1|Overall Study|Withdrawal by Subject|4
5197568|NCT01116648|17944805|P15|Phase 1 Dose Level 3|Adverse Event|0
5197569|NCT01116648|17944806|P14|Phase 1 Dose Level 3|Adverse Event|0
5197570|NCT01116648|17944807|P13|Phase 1 Dose Level 3|Adverse Event|0
5197571|NCT01116648|17944808|P12|Phase 1 Dose Level 3|Adverse Event|0
5197572|NCT01116648|17944809|P11|Phase 1 Dose Level 3|Adverse Event|0
5197573|NCT01116648|17944810|P10|Phase 1 Dose Level 3|Adverse Event|0
5197574|NCT01116648|17944811|P9|Phase 1 Dose Level 3|Adverse Event|0
5197575|NCT01116648|17944812|P8|Phase 1 Dose Level 3|Adverse Event|0
5197576|NCT01116648|17944813|P7|Phase 1 Dose Level 3|Adverse Event|0
5197577|NCT01116648|17944814|P6|Phase 1 Dose Level 3|Adverse Event|0
5197578|NCT01116648|17944815|P5|Phase 1 Dose Level 3|Adverse Event|0
5197579|NCT01116648|17944816|P4|Phase 1 Dose Level 3|Adverse Event|2
5197580|NCT01116648|17944817|P3|Phase 1 Dose Level 3|Adverse Event|0
5197581|NCT01116648|17944818|P2|Phase 1 Dose Level 3|Adverse Event|0
5197582|NCT01116648|17944819|P1|Phase 1 Dose Level 3|Adverse Event|0
5197583|NCT01116544|17944846|P2|Overall Study|Withdrawal by Subject|1
5197584|NCT01116544|17944847|P1|Overall Study|Withdrawal by Subject|1
5197585|NCT01116544|17944846|P2|Overall Study|Protocol Violation|0
5197586|NCT01116544|17944847|P1|Overall Study|Protocol Violation|1
5197587|NCT01116440|17944873|P2|Follow-up|Withdrawal by Subject|1
5197588|NCT01116440|17944874|P1|Follow-up|Withdrawal by Subject|0
5197589|NCT01116440|17944873|P2|Follow-up|Lost to Follow-up|1
5197590|NCT01116440|17944874|P1|Follow-up|Lost to Follow-up|0
5197591|NCT01116440|17944873|P2|Withdrawal|Lost to Follow-up|1
5197592|NCT01116440|17944874|P1|Withdrawal|Lost to Follow-up|0
5197593|NCT01116440|17944873|P2|Withdrawal|Withdrawal by Subject|1
5197594|NCT01116440|17944874|P1|Withdrawal|Withdrawal by Subject|0
5197595|NCT01116440|17944873|P2|Treatment|Adverse Event|1
5197596|NCT01116440|17944874|P1|Treatment|Adverse Event|0
5197597|NCT01116440|17944873|P2|Treatment|Lack of Efficacy|1
5197598|NCT01116440|17944874|P1|Treatment|Lack of Efficacy|0
5197599|NCT01116440|17944873|P2|Treatment|Protocol Violation|2
5197600|NCT01116440|17944874|P1|Treatment|Protocol Violation|0
5197601|NCT01116440|17944873|P2|Treatment|Lost to Follow-up|1
5197602|NCT01116440|17944874|P1|Treatment|Lost to Follow-up|1
5197603|NCT01116440|17944873|P2|Treatment|Withdrawal by Subject|2
5197604|NCT01116440|17944874|P1|Treatment|Withdrawal by Subject|2
5197605|NCT01116427|17944890|P2|Extension Phase|Not using appropriate birth control|0
5197606|NCT01116427|17944891|P1|Extension Phase|Not using appropriate birth control|1
5197607|NCT01116427|17944890|P2|Extension Phase|Withdrawal by Subject|1
5197608|NCT01116427|17944891|P1|Extension Phase|Withdrawal by Subject|5
5197609|NCT01116427|17944890|P2|Extension Phase|Lost to Follow-up|0
5197610|NCT01116427|17944891|P1|Extension Phase|Lost to Follow-up|2
5197611|NCT01116427|17944890|P2|Extension Phase|Adverse Event|1
5197612|NCT01116427|17944891|P1|Extension Phase|Adverse Event|1
5197613|NCT01116427|17944890|P2|Core Phase|Worsening Multiple Sclerosis|0
5197614|NCT01116427|17944891|P1|Core Phase|Worsening Multiple Sclerosis|1
5197615|NCT01116427|17944890|P2|Core Phase|Withdrawal by Subject|0
5197616|NCT01116427|17944891|P1|Core Phase|Withdrawal by Subject|3
5197617|NCT01116427|17944890|P2|Core Phase|Lost to Follow-up|0
5197618|NCT01116427|17944891|P1|Core Phase|Lost to Follow-up|1
5197619|NCT01116427|17944890|P2|Core Phase|Adverse Event|1
5197620|NCT01116427|17944891|P1|Core Phase|Adverse Event|0
5197621|NCT01116232|17944932|P1|Overall Study|Progressive diease|4
5197622|NCT01115998|17945046|P2|Overall Study|Lost to Follow-up|6
5197623|NCT01115998|17945047|P1|Overall Study|Lost to Follow-up|6
5197624|NCT01115933|17945057|P1|Overall Study|Did not receive XIENCE PRIME SV|1
5197625|NCT01115855|17945154|P2|Overall Study|Other|6
5197626|NCT01115855|17945155|P1|Overall Study|Other|8
5197627|NCT01115855|17945154|P2|Overall Study|Withdrawal by Subject|5
5197628|NCT01115855|17945155|P1|Overall Study|Withdrawal by Subject|5
5197629|NCT01115855|17945154|P2|Overall Study|Protocol Violation|1
5197630|NCT01115855|17945155|P1|Overall Study|Protocol Violation|0
5197631|NCT01115855|17945154|P2|Overall Study|Lab Abnormality|1
5197632|NCT01115855|17945155|P1|Overall Study|Lab Abnormality|1
5197633|NCT01115855|17945154|P2|Overall Study|Death|5
5197634|NCT01115855|17945155|P1|Overall Study|Death|6
5197635|NCT01115855|17945154|P2|Overall Study|Adverse Event|18
5197636|NCT01115855|17945155|P1|Overall Study|Adverse Event|16
5197637|NCT01115803|17945210|P7|Overall Study|Progressive Disease during Cycle1|1
5197638|NCT01115803|17945211|P6|Overall Study|Progressive Disease during Cycle1|0
5197639|NCT01115803|17945212|P5|Overall Study|Progressive Disease during Cycle1|0
5197640|NCT01115803|17945213|P4|Overall Study|Progressive Disease during Cycle1|0
5197641|NCT01115803|17945214|P3|Overall Study|Progressive Disease during Cycle1|0
5197642|NCT01115803|17945215|P2|Overall Study|Progressive Disease during Cycle1|0
5197643|NCT01115803|17945216|P1|Overall Study|Progressive Disease during Cycle1|0
5197644|NCT01115803|17945210|P7|Overall Study|Lost to Follow-up|0
5197645|NCT01115803|17945211|P6|Overall Study|Lost to Follow-up|0
5197646|NCT01115803|17945212|P5|Overall Study|Lost to Follow-up|0
5197647|NCT01115803|17945213|P4|Overall Study|Lost to Follow-up|0
5197648|NCT01115803|17945214|P3|Overall Study|Lost to Follow-up|1
5197649|NCT01115803|17945215|P2|Overall Study|Lost to Follow-up|0
5197650|NCT01115803|17945216|P1|Overall Study|Lost to Follow-up|0
5197651|NCT01115803|17945210|P7|Overall Study|Withdrawal by Subject|1
5197652|NCT01115803|17945211|P6|Overall Study|Withdrawal by Subject|0
5197653|NCT01115803|17945212|P5|Overall Study|Withdrawal by Subject|0
5197654|NCT01115803|17945213|P4|Overall Study|Withdrawal by Subject|0
5197655|NCT01115803|17945214|P3|Overall Study|Withdrawal by Subject|0
5197656|NCT01115803|17945215|P2|Overall Study|Withdrawal by Subject|0
5197657|NCT01115803|17945216|P1|Overall Study|Withdrawal by Subject|0
5197658|NCT01115738|17945279|P3|Overall Study|Withdrawal by Subject|9
5197659|NCT01115738|17945280|P2|Overall Study|Withdrawal by Subject|6
5197660|NCT01115738|17945281|P1|Overall Study|Withdrawal by Subject|6
5197661|NCT01115738|17945279|P3|Overall Study|Physician Decision|17
5197662|NCT01115738|17945280|P2|Overall Study|Physician Decision|15
5197663|NCT01115738|17945281|P1|Overall Study|Physician Decision|18
5197664|NCT01115738|17945279|P3|Overall Study|Lost to Follow-up|1
5197665|NCT01115738|17945280|P2|Overall Study|Lost to Follow-up|0
5197666|NCT01115738|17945281|P1|Overall Study|Lost to Follow-up|0
5197667|NCT01115738|17945279|P3|Overall Study|Death|0
5197668|NCT01115738|17945280|P2|Overall Study|Death|0
5197669|NCT01115738|17945281|P1|Overall Study|Death|1
5197670|NCT01115569|17945479|P2|Maintenance Phase|Administrative|1
5197671|NCT01115569|17945480|P1|Maintenance Phase|Administrative|0
5197672|NCT01115569|17945479|P2|Maintenance Phase|Non-Compliance with Study Drug|48
5197673|NCT01115569|17945480|P1|Maintenance Phase|Non-Compliance with Study Drug|0
5197674|NCT01115569|17945479|P2|Maintenance Phase|Withdrawal by Subject|27
5197675|NCT01115569|17945480|P1|Maintenance Phase|Withdrawal by Subject|0
5197676|NCT01115569|17945479|P2|Maintenance Phase|Protocol Violation|9
5197677|NCT01115569|17945480|P1|Maintenance Phase|Protocol Violation|0
5197678|NCT01115569|17945479|P2|Maintenance Phase|Physician Decision|3
5197679|NCT01115569|17945480|P1|Maintenance Phase|Physician Decision|0
5197680|NCT01115569|17945479|P2|Maintenance Phase|Lost to Follow-up|8
5197681|NCT01115569|17945480|P1|Maintenance Phase|Lost to Follow-up|0
5197682|NCT01115569|17945479|P2|Maintenance Phase|Adverse Event|43
5197683|NCT01115569|17945480|P1|Maintenance Phase|Adverse Event|0
5197684|NCT01115569|17945479|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
5197685|NCT01115569|17945480|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
5197686|NCT01115569|17945479|P2|Conversion/Titration Phase|Withdrawal by Subject|0
5197687|NCT01115569|17945480|P1|Conversion/Titration Phase|Withdrawal by Subject|26
5197688|NCT01115569|17945479|P2|Conversion/Titration Phase|Protocol Violation|0
5197689|NCT01115569|17945480|P1|Conversion/Titration Phase|Protocol Violation|68
5197690|NCT01115569|17945479|P2|Conversion/Titration Phase|Physician Decision|0
5197691|NCT01115569|17945480|P1|Conversion/Titration Phase|Physician Decision|5
5197692|NCT01115569|17945479|P2|Conversion/Titration Phase|Lost to Follow-up|0
5197693|NCT01115569|17945480|P1|Conversion/Titration Phase|Lost to Follow-up|3
5197694|NCT01115569|17945479|P2|Conversion/Titration Phase|Adverse Event|0
5197695|NCT01115569|17945480|P1|Conversion/Titration Phase|Adverse Event|59
5197696|NCT01115491|17945509|P1|Overall Study|Physician Decision|1
5197697|NCT01115491|17945509|P1|Overall Study|Withdrawal by Subject|1
5197698|NCT01115491|17945509|P1|Overall Study|Lost to Follow-up|3
5197699|NCT01115491|17945509|P1|Overall Study|Adverse Event|3
5197700|NCT01115491|17945509|P1|Overall Study|Death|22
5197701|NCT01115309|17945568|P1|Long-term Follow-up|Lost to Follow-up|6
5197702|NCT01115309|17945568|P1|Procedure Safety (1-Month)|Withdrawal by Subject|1
5197703|NCT01115309|17945568|P1|Procedure Safety (1-Month)|Lost to Follow-up|2
5197704|NCT01114880|17945735|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
5197705|NCT01114880|17945736|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
5197706|NCT01114880|17945735|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
5197707|NCT01114880|17945736|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
5197708|NCT01114880|17945735|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
5197709|NCT01114880|17945736|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
5197710|NCT01114880|17945735|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
5197711|NCT01114880|17945736|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
5197712|NCT01114880|17945735|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
5197713|NCT01114880|17945736|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
5197714|NCT01114880|17945735|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
5197715|NCT01114880|17945736|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
5197716|NCT01114828|17945788|P2|Overall Study|Withdrawal by Subject|1
5197717|NCT01114828|17945789|P1|Overall Study|Withdrawal by Subject|0
5197718|NCT01114828|17945788|P2|Overall Study|Protocol Violation|0
5197719|NCT01114828|17945789|P1|Overall Study|Protocol Violation|2
5197720|NCT01114828|17945788|P2|Overall Study|Lack of Efficacy|2
5197721|NCT01114828|17945789|P1|Overall Study|Lack of Efficacy|0
5197722|NCT01114828|17945788|P2|Overall Study|Adverse Event|1
5197723|NCT01114828|17945789|P1|Overall Study|Adverse Event|1
5197724|NCT01114737|17945799|P2|Open-Label Treatment Period|Difficult Personal Events|0
5197725|NCT01114737|17945800|P1|Open-Label Treatment Period|Difficult Personal Events|1
5197726|NCT01114737|17945799|P2|Open-Label Treatment Period|Lost to Follow-up|1
5197727|NCT01114737|17945800|P1|Open-Label Treatment Period|Lost to Follow-up|3
5197728|NCT01114737|17945799|P2|Open-Label Treatment Period|Withdrawal by Subject|1
5197729|NCT01114737|17945800|P1|Open-Label Treatment Period|Withdrawal by Subject|1
5197730|NCT01114737|17945799|P2|Randomized Treatment Period|Pregnancy|0
5197731|NCT01114737|17945800|P1|Randomized Treatment Period|Pregnancy|1
5197732|NCT01114737|17945799|P2|Randomized Treatment Period|Lost to Follow-up|1
5197733|NCT01114737|17945800|P1|Randomized Treatment Period|Lost to Follow-up|1
5197734|NCT01114737|17945799|P2|Randomized Treatment Period|Withdrawal by Subject|0
5197735|NCT01114737|17945800|P1|Randomized Treatment Period|Withdrawal by Subject|1
5197736|NCT01114724|17945848|P1|Overall Study|Withdrawal by Subject|1
5197737|NCT01114724|17945848|P1|Overall Study|Lost to Follow-up|1
5197738|NCT01114724|17945848|P1|Overall Study|Death|8
5197739|NCT01114672|17945868|P2|Overall Study|transplanted|0
5197740|NCT01114672|17945869|P1|Overall Study|transplanted|1
5197741|NCT01114672|17945868|P2|Overall Study|Lost to Follow-up|0
5197742|NCT01114672|17945869|P1|Overall Study|Lost to Follow-up|1
5197743|NCT01114672|17945868|P2|Overall Study|Withdrawal by Subject|1
5197744|NCT01114672|17945869|P1|Overall Study|Withdrawal by Subject|2
5197745|NCT01114672|17945868|P2|Overall Study|Death|1
5197746|NCT01114672|17945869|P1|Overall Study|Death|0
5197747|NCT01114646|17945877|P2|Overall Study|Withdrawal by Subject|2
5197748|NCT01114646|17945878|P1|Overall Study|Withdrawal by Subject|3
5197749|NCT01114529|17945938|P3|Completed Study Phase at Month 24|Missing|0
5197750|NCT01114529|17945939|P2|Completed Study Phase at Month 24|Missing|0
5197751|NCT01114529|17945940|P1|Completed Study Phase at Month 24|Missing|2
5197752|NCT01114529|17945938|P3|Completed Study Phase at Month 24|Other|0
5197753|NCT01114529|17945939|P2|Completed Study Phase at Month 24|Other|0
5197754|NCT01114529|17945940|P1|Completed Study Phase at Month 24|Other|2
5197755|NCT01114529|17945938|P3|Completed Study Phase at Month 24|Death|4
5197756|NCT01114529|17945939|P2|Completed Study Phase at Month 24|Death|5
5197757|NCT01114529|17945940|P1|Completed Study Phase at Month 24|Death|8
5197758|NCT01114529|17945938|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
5197759|NCT01114529|17945939|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
5197760|NCT01114529|17945940|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
5197761|NCT01114529|17945938|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
5197762|NCT01114529|17945939|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
5197763|NCT01114529|17945940|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
5197764|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Missing|0
5197765|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Missing|0
5197766|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Missing|2
5197767|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Protocol Violation|2
5197768|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Protocol Violation|5
5197769|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Protocol Violation|0
5197770|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Graft loss|0
5197771|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Graft loss|2
5197772|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Graft loss|0
5197773|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Death|2
5197774|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Death|1
5197775|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Death|2
5197776|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Administrative problems|2
5197777|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Administrative problems|1
5197778|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Administrative problems|2
5197779|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
5197780|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
5197781|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
5197782|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
5197783|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
5197784|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
5197785|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
5197786|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
5197787|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
5197788|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
5197789|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
5197790|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
5197791|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
5197792|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
5197793|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
5197794|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
5197795|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
5197796|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
5197797|NCT01114529|17945938|P3|Completed Study Medication at Month 24|Adverse Event|17
5197798|NCT01114529|17945939|P2|Completed Study Medication at Month 24|Adverse Event|18
5197799|NCT01114529|17945940|P1|Completed Study Medication at Month 24|Adverse Event|87
5197800|NCT01114516|17945959|P2|Overall Study|Lost to Follow-up|1
5197801|NCT01114516|17945960|P1|Overall Study|Lost to Follow-up|2
5197802|NCT01114438|17945995|P1|Overall Study|Withdrawal by Subject|2
5197803|NCT01114438|17945995|P1|Overall Study|Physician Decision|1
5197804|NCT01114438|17945995|P1|Overall Study|concomitant medication|1
5197805|NCT01114438|17945995|P1|Overall Study|Adverse Event|10
5197806|NCT01114373|17946005|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
5197807|NCT01114373|17946006|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
5197808|NCT01114373|17946005|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
5197809|NCT01114373|17946006|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
5197810|NCT01114373|17946005|P2|Intervention 1 (4 Weeks)|Incarceration|0
5197811|NCT01114373|17946006|P1|Intervention 1 (4 Weeks)|Incarceration|1
5197812|NCT01114373|17946005|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
5197813|NCT01114373|17946006|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
5197814|NCT01114360|17946038|P2|Intervention 1 (4 Weeks)|Physician Decision|1
5197815|NCT01114360|17946039|P1|Intervention 1 (4 Weeks)|Physician Decision|0
5197816|NCT01114217|17946090|P2|Overall Study|Other-Withdrawal by Subject|1
5197817|NCT01114217|17946091|P1|Overall Study|Other-Withdrawal by Subject|1
5197818|NCT01114217|17946090|P2|Overall Study|Other-Lost to Follow-up|0
5197819|NCT01114217|17946091|P1|Overall Study|Other-Lost to Follow-up|1
5197820|NCT01114217|17946090|P2|Overall Study|Other-Site Stopped Communicating|0
5197821|NCT01114217|17946091|P1|Overall Study|Other-Site Stopped Communicating|2
5197822|NCT01114217|17946090|P2|Overall Study|Other-Study Withdrawn|1
5197823|NCT01114217|17946091|P1|Overall Study|Other-Study Withdrawn|1
5197824|NCT01114217|17946090|P2|Overall Study|Other-Study Termination|1
5197825|NCT01114217|17946091|P1|Overall Study|Other-Study Termination|0
5197826|NCT01114217|17946090|P2|Overall Study|Other-Sponsor Decision|12
5197827|NCT01114217|17946091|P1|Overall Study|Other-Sponsor Decision|10
5197828|NCT01114217|17946090|P2|Overall Study|Other-Physician Decision|1
5197829|NCT01114217|17946091|P1|Overall Study|Other-Physician Decision|1
5197830|NCT01114217|17946090|P2|Overall Study|Other-Non Compliance|0
5197831|NCT01114217|17946091|P1|Overall Study|Other-Non Compliance|2
5197832|NCT01114217|17946090|P2|Overall Study|Other-Lack of Efficacy|0
5197833|NCT01114217|17946091|P1|Overall Study|Other-Lack of Efficacy|1
5197834|NCT01114217|17946090|P2|Overall Study|Other-Protocol Violation|3
5197835|NCT01114217|17946091|P1|Overall Study|Other-Protocol Violation|1
5197836|NCT01114217|17946090|P2|Overall Study|Other-Pregnancy|4
5197837|NCT01114217|17946091|P1|Overall Study|Other-Pregnancy|2
5197838|NCT01114217|17946090|P2|Overall Study|Other-Procedure|1
5197839|NCT01114217|17946091|P1|Overall Study|Other-Procedure|1
5197840|NCT01114217|17946090|P2|Overall Study|Other-Early termination|10
5197841|NCT01114217|17946091|P1|Overall Study|Other-Early termination|6
5197842|NCT01114217|17946090|P2|Overall Study|Other-Clerical Error|0
5197843|NCT01114217|17946091|P1|Overall Study|Other-Clerical Error|3
5197844|NCT01114217|17946090|P2|Overall Study|Withdrawal by Subject|28
5197845|NCT01114217|17946091|P1|Overall Study|Withdrawal by Subject|21
5197846|NCT01114217|17946090|P2|Overall Study|Lost to Follow-up|33
5197847|NCT01114217|17946091|P1|Overall Study|Lost to Follow-up|17
5197848|NCT01114217|17946090|P2|Overall Study|Adverse Event|3
5197849|NCT01114217|17946091|P1|Overall Study|Adverse Event|5
5197850|NCT01114204|17946103|P2|Overall Study|Other-Protocol Violation|0
5197851|NCT01114204|17946104|P1|Overall Study|Other-Protocol Violation|1
5197852|NCT01114204|17946103|P2|Overall Study|Other-Participant request|0
5197853|NCT01114204|17946104|P1|Overall Study|Other-Participant request|2
5197854|NCT01114204|17946103|P2|Overall Study|Other-Medical monitor request|0
5197855|NCT01114204|17946104|P1|Overall Study|Other-Medical monitor request|1
5197856|NCT01114204|17946103|P2|Overall Study|Other-Personal reasons|0
5197857|NCT01114204|17946104|P1|Overall Study|Other-Personal reasons|2
5197858|NCT01114204|17946103|P2|Overall Study|Death|0
5197859|NCT01114204|17946104|P1|Overall Study|Death|1
5197860|NCT01114204|17946103|P2|Overall Study|Withdrawal by Subject|6
5197861|NCT01114204|17946104|P1|Overall Study|Withdrawal by Subject|10
5197862|NCT01114204|17946103|P2|Overall Study|Lost to Follow-up|0
5197863|NCT01114204|17946104|P1|Overall Study|Lost to Follow-up|1
5197864|NCT01114204|17946103|P2|Overall Study|Adverse Event|2
5197865|NCT01114204|17946104|P1|Overall Study|Adverse Event|3
5197866|NCT01114139|17946122|P2|Overall Study|Other-Withdrew prior to receiving dose|3
5197867|NCT01114139|17946123|P1|Overall Study|Other-Withdrew prior to receiving dose|1
5197868|NCT01114139|17946122|P2|Overall Study|Other-Physician changed treatment|0
5197869|NCT01114139|17946123|P1|Overall Study|Other-Physician changed treatment|1
5197870|NCT01114139|17946122|P2|Overall Study|Other-Participant went on hospice|1
5197871|NCT01114139|17946123|P1|Overall Study|Other-Participant went on hospice|0
5197872|NCT01114139|17946122|P2|Overall Study|Other-Participant falsified records|1
5197873|NCT01114139|17946123|P1|Overall Study|Other-Participant falsified records|0
5197874|NCT01114139|17946122|P2|Overall Study|Other-Out of window for study drug dose|0
5197875|NCT01114139|17946123|P1|Overall Study|Other-Out of window for study drug dose|1
5197876|NCT01114139|17946122|P2|Overall Study|Other-Protocol Violation|0
5197877|NCT01114139|17946123|P1|Overall Study|Other-Protocol Violation|1
5197878|NCT01114139|17946122|P2|Overall Study|Other-Missed 1 visit|0
5197879|NCT01114139|17946123|P1|Overall Study|Other-Missed 1 visit|1
5197880|NCT01114139|17946122|P2|Overall Study|Withdrawal by Subject|6
5197881|NCT01114139|17946123|P1|Overall Study|Withdrawal by Subject|17
5197882|NCT01114139|17946122|P2|Overall Study|Lost to Follow-up|3
5197883|NCT01114139|17946123|P1|Overall Study|Lost to Follow-up|15
5197884|NCT01114139|17946122|P2|Overall Study|Adverse Event|2
5197885|NCT01114139|17946123|P1|Overall Study|Adverse Event|3
5197886|NCT01113931|17946152|P2|Overall Study|Withdrawal by Subject|0
5197887|NCT01113931|17946153|P1|Overall Study|Withdrawal by Subject|3
5197888|NCT01113931|17946152|P2|Overall Study|Various|4
5197889|NCT01113931|17946153|P1|Overall Study|Various|2
5197890|NCT01113931|17946152|P2|Overall Study|Lost to Follow-up|9
5197891|NCT01113931|17946153|P1|Overall Study|Lost to Follow-up|12
5197892|NCT01113931|17946152|P2|Overall Study|Physician Decision|2
5197893|NCT01113931|17946153|P1|Overall Study|Physician Decision|0
5197894|NCT01113931|17946152|P2|Overall Study|Adverse Event|2
5197895|NCT01113931|17946153|P1|Overall Study|Adverse Event|2
5197896|NCT01113892|17946167|P2|Overall Study|Graft no longer evaluable|9
5197897|NCT01113892|17946168|P1|Overall Study|Graft no longer evaluable|9
5197898|NCT01113892|17946167|P2|Overall Study|Death|4
5197899|NCT01113892|17946168|P1|Overall Study|Death|2
5197900|NCT01113892|17946167|P2|Overall Study|Withdrawal by Subject|1
5197901|NCT01113892|17946168|P1|Overall Study|Withdrawal by Subject|1
5197902|NCT01113892|17946167|P2|Overall Study|Lost to Follow-up|2
5197903|NCT01113892|17946168|P1|Overall Study|Lost to Follow-up|2
5197904|NCT01113879|17946196|P2|Period 1: Block 1|Withdrawal by Subject|0
5197905|NCT01113879|17946197|P1|Period 1: Block 1|Withdrawal by Subject|2
5197906|NCT01113801|17946209|P4|Overall Study|Clinical Endpoint (ESRD)|5
5197907|NCT01113801|17946210|P3|Overall Study|Clinical Endpoint (ESRD)|2
5197908|NCT01113801|17946211|P2|Overall Study|Clinical Endpoint (ESRD)|4
5197909|NCT01113801|17946212|P1|Overall Study|Clinical Endpoint (ESRD)|7
5197910|NCT01113801|17946209|P4|Overall Study|Sponsor Decision|15
5197911|NCT01113801|17946210|P3|Overall Study|Sponsor Decision|20
5197912|NCT01113801|17946211|P2|Overall Study|Sponsor Decision|21
5197913|NCT01113801|17946212|P1|Overall Study|Sponsor Decision|15
5197914|NCT01113801|17946209|P4|Overall Study|Physician Decision|3
5197915|NCT01113801|17946210|P3|Overall Study|Physician Decision|3
5197916|NCT01113801|17946211|P2|Overall Study|Physician Decision|2
5197917|NCT01113801|17946212|P1|Overall Study|Physician Decision|2
5197918|NCT01113801|17946209|P4|Overall Study|Withdrawal by Subject|8
5197919|NCT01113801|17946210|P3|Overall Study|Withdrawal by Subject|7
5197920|NCT01113801|17946211|P2|Overall Study|Withdrawal by Subject|7
5197921|NCT01113801|17946212|P1|Overall Study|Withdrawal by Subject|9
5197922|NCT01113801|17946209|P4|Overall Study|Protocol Violation|0
5197923|NCT01113801|17946210|P3|Overall Study|Protocol Violation|0
5197924|NCT01113801|17946211|P2|Overall Study|Protocol Violation|1
5197925|NCT01113801|17946212|P1|Overall Study|Protocol Violation|0
5197926|NCT01113801|17946209|P4|Overall Study|Death|4
5197927|NCT01113801|17946210|P3|Overall Study|Death|3
5197928|NCT01113801|17946211|P2|Overall Study|Death|5
5197929|NCT01113801|17946212|P1|Overall Study|Death|4
5197930|NCT01113801|17946209|P4|Overall Study|Adverse Event|6
5197931|NCT01113801|17946210|P3|Overall Study|Adverse Event|2
5197932|NCT01113801|17946211|P2|Overall Study|Adverse Event|0
5197933|NCT01113801|17946212|P1|Overall Study|Adverse Event|4
5197934|NCT01113749|17946240|P2|Overall Study|Lost to Follow-up|2
5197935|NCT01113749|17946241|P1|Overall Study|Lost to Follow-up|1
5197936|NCT01113710|17946264|P1|Overall Study|Subject Did Not Receive Neupro|3
5197937|NCT01113710|17946264|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
5197938|NCT01113710|17946264|P1|Overall Study|Lack of Patient's Compliance/Other|1
5197939|NCT01113710|17946264|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
5197940|NCT01113710|17946264|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
5197941|NCT01113710|17946264|P1|Overall Study|Compliance/Efficacy/AE/Other|1
5197942|NCT01113710|17946264|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
5197943|NCT01113710|17946264|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
5197944|NCT01113710|17946264|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
5197945|NCT01113710|17946264|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
5197946|NCT01113710|17946264|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
5197947|NCT01113710|17946264|P1|Overall Study|Lack of Efficacy/Adverse Event|3
5198036|NCT01111526|17946695|P3|Overall Study|GVHD Disease Progression|2
5197948|NCT01113710|17946264|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
5197949|NCT01113710|17946264|P1|Overall Study|Lack of Efficacy/Other|4
5197950|NCT01113710|17946264|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
5197951|NCT01113710|17946264|P1|Overall Study|Adverse Event/Other|5
5197952|NCT01113710|17946264|P1|Overall Study|Other|7
5197953|NCT01113710|17946264|P1|Overall Study|Lack of Patient's Compliance|8
5197954|NCT01113710|17946264|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
5197955|NCT01113710|17946264|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
5197956|NCT01113710|17946264|P1|Overall Study|Lost to Follow-up|20
5197957|NCT01113710|17946264|P1|Overall Study|Withdrawal by Subject|28
5197958|NCT01113710|17946264|P1|Overall Study|No Information Available|40
5197959|NCT01113710|17946264|P1|Overall Study|Lack of Efficacy|41
5197960|NCT01113710|17946264|P1|Overall Study|Adverse Event|64
5197961|NCT01113580|17946292|P2|Overall Study|Protocol Violation|0
5197962|NCT01113580|17946293|P1|Overall Study|Protocol Violation|1
5197963|NCT01113541|17946307|P1|Overall Study|Adverse Event|4
5197964|NCT01113541|17946307|P1|Overall Study|Study Terminated by Sponsor|7
5197965|NCT01113541|17946307|P1|Overall Study|Protocol Violation|1
5197966|NCT01113541|17946307|P1|Overall Study|Withdrawal by Subject|1
5197967|NCT01113463|17946340|P1|Overall Study|Physician Decision|5
5197968|NCT01112982|17946370|P1|Overall Study|exceeded weight limit to complete MRI|1
5197969|NCT01112982|17946370|P1|Overall Study|Withdrawal by Subject|1
5197970|NCT01112917|17946382|P2|Overall Study|Unable to Convert Filter|0
5197971|NCT01112917|17946383|P1|Overall Study|Unable to Convert Filter|3
5197972|NCT01112917|17946382|P2|Overall Study|Withdrawal by Subject|3
5197973|NCT01112917|17946383|P1|Overall Study|Withdrawal by Subject|1
5197974|NCT01112917|17946382|P2|Overall Study|Lost to Follow-up|1
5197975|NCT01112917|17946383|P1|Overall Study|Lost to Follow-up|1
5197976|NCT01112917|17946382|P2|Overall Study|Death|11
5197977|NCT01112917|17946383|P1|Overall Study|Death|2
5197978|NCT01112579|17946487|P2|Overall Study|Death|2
5197979|NCT01112579|17946488|P1|Overall Study|Death|0
5197980|NCT01112579|17946487|P2|Overall Study|Missed Visit|1
5197981|NCT01112579|17946488|P1|Overall Study|Missed Visit|1
5197982|NCT01112514|17946498|P1|Overall Study|Lost to Follow-up|1
5197983|NCT01112267|17946554|P2|Overall Study|Participants not receive any study drug|2
5197984|NCT01112267|17946555|P1|Overall Study|Participants not receive any study drug|1
5197985|NCT01112267|17946554|P2|Overall Study|Participants not compliant|2
5197986|NCT01112267|17946555|P1|Overall Study|Participants not compliant|1
5197987|NCT01112267|17946554|P2|Overall Study|Protocol Violation|3
5197988|NCT01112267|17946555|P1|Overall Study|Protocol Violation|5
5197989|NCT01112267|17946554|P2|Overall Study|Withdrawal by Subject|5
5197990|NCT01112267|17946555|P1|Overall Study|Withdrawal by Subject|3
5197991|NCT01112267|17946554|P2|Overall Study|Adverse Event|6
5197992|NCT01112267|17946555|P1|Overall Study|Adverse Event|24
5197993|NCT01112059|17946594|P2|Overall Study|Withdrawal by Subject|0
5197994|NCT01112059|17946595|P1|Overall Study|Withdrawal by Subject|1
5197995|NCT01111851|17946609|P2|Overall Study|All planned PET scans were not obtained.|0
5197996|NCT01111851|17946610|P1|Overall Study|All planned PET scans were not obtained.|2
5197997|NCT01111838|17946622|P1|Overall Study|Other Complicating Disease|1
5197998|NCT01111838|17946622|P1|Overall Study|Clinical deterioration|1
5197999|NCT01111838|17946622|P1|Overall Study|Not Treated|3
5198000|NCT01111838|17946622|P1|Overall Study|Patient Ineligible|2
5198001|NCT01111825|17946630|P4|Overall Study|Discontinuation by Sponsor|20
5198002|NCT01111825|17946631|P3|Overall Study|Discontinuation by Sponsor|0
5198003|NCT01111825|17946632|P2|Overall Study|Discontinuation by Sponsor|0
5198004|NCT01111825|17946633|P1|Overall Study|Discontinuation by Sponsor|0
5198005|NCT01111825|17946630|P4|Overall Study|Disease Progression|0
5198006|NCT01111825|17946631|P3|Overall Study|Disease Progression|0
5198007|NCT01111825|17946632|P2|Overall Study|Disease Progression|0
5198008|NCT01111825|17946633|P1|Overall Study|Disease Progression|1
5198009|NCT01111825|17946630|P4|Overall Study|Adverse Event|0
5198010|NCT01111825|17946631|P3|Overall Study|Adverse Event|4
5198011|NCT01111825|17946632|P2|Overall Study|Adverse Event|1
5198012|NCT01111825|17946633|P1|Overall Study|Adverse Event|2
5198013|NCT01111825|17946630|P4|Overall Study|Lost to Follow-up|1
5198014|NCT01111825|17946631|P3|Overall Study|Lost to Follow-up|3
5198015|NCT01111825|17946632|P2|Overall Study|Lost to Follow-up|0
5198016|NCT01111825|17946633|P1|Overall Study|Lost to Follow-up|0
5198017|NCT01111825|17946630|P4|Overall Study|Withdrawal by Subject|0
5198018|NCT01111825|17946631|P3|Overall Study|Withdrawal by Subject|1
5198019|NCT01111825|17946632|P2|Overall Study|Withdrawal by Subject|0
5198020|NCT01111825|17946633|P1|Overall Study|Withdrawal by Subject|0
5198021|NCT01111604|17946655|P3|Overall Study|Met Exclusion Criteria|0
5198022|NCT01111604|17946656|P2|Overall Study|Met Exclusion Criteria|0
5198023|NCT01111604|17946657|P1|Overall Study|Met Exclusion Criteria|2
5198024|NCT01111604|17946655|P3|Overall Study|Death|0
5198025|NCT01111604|17946656|P2|Overall Study|Death|0
5198026|NCT01111604|17946657|P1|Overall Study|Death|1
5198027|NCT01111604|17946655|P3|Overall Study|Withdrawal by Subject|0
5198028|NCT01111604|17946656|P2|Overall Study|Withdrawal by Subject|0
5198029|NCT01111604|17946657|P1|Overall Study|Withdrawal by Subject|2
5198030|NCT01111604|17946655|P3|Overall Study|Withdrew Consent|2
5198031|NCT01111604|17946656|P2|Overall Study|Withdrew Consent|0
5198032|NCT01111604|17946657|P1|Overall Study|Withdrew Consent|3
5198033|NCT01111604|17946655|P3|Overall Study|Lost to Follow-up|1
5198034|NCT01111604|17946656|P2|Overall Study|Lost to Follow-up|0
5198035|NCT01111604|17946657|P1|Overall Study|Lost to Follow-up|0
5198037|NCT01111526|17946696|P2|Overall Study|GVHD Disease Progression|1
5198038|NCT01111526|17946697|P1|Overall Study|GVHD Disease Progression|0
5198039|NCT01111474|17946709|P1|Overall Study|Lost to Follow-up|12
5198040|NCT01111461|17946717|P1|Overall Study|Other|6
5198041|NCT01111461|17946717|P1|Overall Study|Withdrawal by Subject|1
5198042|NCT01111461|17946717|P1|Overall Study|Lost to Follow-up|1
5198043|NCT01111461|17946717|P1|Overall Study|Participant choice|11
5198044|NCT01111461|17946717|P1|Overall Study|Adverse Event|32
5198045|NCT01111292|17946897|P2|Treatment|Physician Decision|1
5198046|NCT01111292|17946898|P1|Treatment|Physician Decision|1
5198047|NCT01111240|17946904|P1|Overall Study|Other|312
5198048|NCT01111240|17946904|P1|Overall Study|Lack of Efficacy and Adverse Event|19
5198049|NCT01111240|17946904|P1|Overall Study|Lack of Efficacy|545
5198050|NCT01111240|17946904|P1|Overall Study|Adverse Event|190
5198051|NCT01111149|17946934|P3|Overall Study|Withdrawal by Subject|2
5198052|NCT01111149|17946935|P2|Overall Study|Withdrawal by Subject|0
5198053|NCT01111149|17946936|P1|Overall Study|Withdrawal by Subject|1
5198054|NCT01111149|17946934|P3|Overall Study|Protocol Violation|2
5198055|NCT01111149|17946935|P2|Overall Study|Protocol Violation|1
5198056|NCT01111149|17946936|P1|Overall Study|Protocol Violation|1
5198057|NCT01111123|17947012|P2|Maintenance Phase|Lost to Follow-up|2
5198058|NCT01111123|17947013|P1|Maintenance Phase|Lost to Follow-up|0
5198059|NCT01111123|17947012|P2|Open- Label Phase|Failed to be clear or almost cleared|0
5198060|NCT01111123|17947013|P1|Open- Label Phase|Failed to be clear or almost cleared|14
5198061|NCT01111019|17947059|P1|Overall Study|Other|1
5198062|NCT01111019|17947059|P1|Overall Study|Withdrew Prematurely|2
5198063|NCT01110915|17947091|P2|Overall Study|Withdrawal by Subject|1
5198064|NCT01110915|17947092|P1|Overall Study|Withdrawal by Subject|7
5198065|NCT01110915|17947091|P2|Overall Study|Lost to Follow-up|0
5198066|NCT01110915|17947092|P1|Overall Study|Lost to Follow-up|1
5198067|NCT01110915|17947091|P2|Overall Study|Death|1
5198068|NCT01110915|17947092|P1|Overall Study|Death|2
5198069|NCT01110707|17947109|P2|Overall Study|Protocol Violation|3
5198070|NCT01110707|17947110|P1|Overall Study|Protocol Violation|0
5198071|NCT01110408|17947211|P2|Overall Study|Protocol Violation|0
5198072|NCT01110408|17947212|P1|Overall Study|Protocol Violation|1
5198073|NCT01110382|17947236|P2|Overall Study|Protocol Violation|1
5198074|NCT01110382|17947237|P1|Overall Study|Protocol Violation|0
5198075|NCT01110382|17947236|P2|Overall Study|Withdrawal by Subject|1
5198076|NCT01110382|17947237|P1|Overall Study|Withdrawal by Subject|0
5198077|NCT01110330|17947258|P3|Overall Study|Other|1
5198078|NCT01110330|17947259|P2|Overall Study|Other|1
5198079|NCT01110330|17947260|P1|Overall Study|Other|1
5198080|NCT01110330|17947258|P3|Overall Study|Withdrawal by Subject|2
5198081|NCT01110330|17947259|P2|Overall Study|Withdrawal by Subject|6
5198082|NCT01110330|17947260|P1|Overall Study|Withdrawal by Subject|0
5198083|NCT01110330|17947258|P3|Overall Study|Protocol Violation|4
5198084|NCT01110330|17947259|P2|Overall Study|Protocol Violation|0
5198085|NCT01110330|17947260|P1|Overall Study|Protocol Violation|2
5198086|NCT01110330|17947258|P3|Overall Study|Physician Decision|0
5198087|NCT01110330|17947259|P2|Overall Study|Physician Decision|1
5198088|NCT01110330|17947260|P1|Overall Study|Physician Decision|0
5198089|NCT01110330|17947258|P3|Overall Study|Lost to Follow-up|15
5198090|NCT01110330|17947259|P2|Overall Study|Lost to Follow-up|10
5198091|NCT01110330|17947260|P1|Overall Study|Lost to Follow-up|9
5198092|NCT01110330|17947258|P3|Overall Study|Lack of Efficacy|1
5198093|NCT01110330|17947259|P2|Overall Study|Lack of Efficacy|1
5198094|NCT01110330|17947260|P1|Overall Study|Lack of Efficacy|3
5198095|NCT01110330|17947258|P3|Overall Study|Adverse Event|3
5198096|NCT01110330|17947259|P2|Overall Study|Adverse Event|4
5198097|NCT01110330|17947260|P1|Overall Study|Adverse Event|0
5198098|NCT01110239|17947288|P4|7.5 Min Ischemia|Withdrawal by Subject|0
5198099|NCT01110239|17947289|P3|7.5 Min Ischemia|Withdrawal by Subject|1
5198100|NCT01110239|17947290|P2|7.5 Min Ischemia|Withdrawal by Subject|0
5198101|NCT01110239|17947291|P1|7.5 Min Ischemia|Withdrawal by Subject|0
5198102|NCT01110239|17947288|P4|Sham Preconditioning|Withdrawal by Subject|0
5198103|NCT01110239|17947289|P3|Sham Preconditioning|Withdrawal by Subject|1
5198104|NCT01110239|17947290|P2|Sham Preconditioning|Withdrawal by Subject|0
5198105|NCT01110239|17947291|P1|Sham Preconditioning|Withdrawal by Subject|0
5198106|NCT01110200|17947307|P2|Overall Study|Lost to Follow-up|7
5198107|NCT01110200|17947308|P1|Overall Study|Lost to Follow-up|10
5198108|NCT01110200|17947307|P2|Overall Study|Physician Decision|17
5198109|NCT01110200|17947308|P1|Overall Study|Physician Decision|13
5198110|NCT01110200|17947307|P2|Overall Study|Protocol Violation|12
5198111|NCT01110200|17947308|P1|Overall Study|Protocol Violation|14
5198112|NCT01110200|17947307|P2|Overall Study|Lack of Efficacy|25
5198113|NCT01110200|17947308|P1|Overall Study|Lack of Efficacy|16
5198114|NCT01110200|17947307|P2|Overall Study|Withdrawal by Subject|32
5198115|NCT01110200|17947308|P1|Overall Study|Withdrawal by Subject|25
5198116|NCT01110200|17947307|P2|Overall Study|Adverse Event|28
5198117|NCT01110200|17947308|P1|Overall Study|Adverse Event|28
5198118|NCT01110005|17947344|P2|Overall Study|Withdrawal by Subject|1
5198119|NCT01110005|17947345|P1|Overall Study|Withdrawal by Subject|0
5198120|NCT01110005|17947344|P2|Overall Study|missing consent|2
5198121|NCT01110005|17947345|P1|Overall Study|missing consent|3
5198122|NCT01110005|17947344|P2|Overall Study|ineligible|2
5198123|NCT01110005|17947345|P1|Overall Study|ineligible|1
5198124|NCT01109992|17947357|P2|Overall Study|Movement during rest scan.|1
5198125|NCT01109992|17947358|P1|Overall Study|Movement during rest scan.|0
5198126|NCT01109992|17947357|P2|Overall Study|Withdrawal by Subject|1
5198127|NCT01109992|17947358|P1|Overall Study|Withdrawal by Subject|0
5198128|NCT01109979|17947372|P2|Overall Study|Withdrawal by Subject|1
5198129|NCT01109979|17947373|P1|Overall Study|Withdrawal by Subject|0
5198130|NCT01109979|17947372|P2|Overall Study|Physician Decision|0
5198131|NCT01109979|17947373|P1|Overall Study|Physician Decision|2
5198132|NCT01109849|17947381|P5|Adaptive Randomization: Weight Recovery|moved away|0
5198133|NCT01109849|17947382|P4|Adaptive Randomization: Weight Recovery|moved away|2
5198134|NCT01109849|17947383|P3|Adaptive Randomization: Weight Recovery|moved away|0
5198135|NCT01109849|17947384|P2|Adaptive Randomization: Weight Recovery|moved away|0
5198136|NCT01109849|17947385|P1|Adaptive Randomization: Weight Recovery|moved away|0
5198137|NCT01109849|17947381|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5198138|NCT01109849|17947382|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5198139|NCT01109849|17947383|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5198140|NCT01109849|17947384|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
5198141|NCT01109849|17947385|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
5198142|NCT01109849|17947381|P5|Initial Randomization: ADHD Treatment|move away|0
5198143|NCT01109849|17947382|P4|Initial Randomization: ADHD Treatment|move away|0
5198144|NCT01109849|17947383|P3|Initial Randomization: ADHD Treatment|move away|0
5198145|NCT01109849|17947384|P2|Initial Randomization: ADHD Treatment|move away|7
5198146|NCT01109849|17947385|P1|Initial Randomization: ADHD Treatment|move away|2
5198147|NCT01109849|17947381|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5198148|NCT01109849|17947382|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5198149|NCT01109849|17947383|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5198150|NCT01109849|17947384|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
5198151|NCT01109849|17947385|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
5198152|NCT01109849|17947381|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
5198153|NCT01109849|17947382|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
5198154|NCT01109849|17947383|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
5198155|NCT01109849|17947384|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
5198156|NCT01109849|17947385|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
5198157|NCT01109849|17947381|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5198158|NCT01109849|17947382|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5198159|NCT01109849|17947383|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5198160|NCT01109849|17947384|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
5198161|NCT01109849|17947385|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
5198162|NCT01109524|17947454|P1|Overall Study|Other|5
5198163|NCT01109524|17947454|P1|Overall Study|Participant requested to end treatment|4
5198164|NCT01109524|17947454|P1|Overall Study|No longer meets criteria|2
5198165|NCT01109524|17947454|P1|Overall Study|Death|2
5198166|NCT01109524|17947454|P1|Overall Study|Maximum clinical benefit|3
5198167|NCT01109524|17947454|P1|Overall Study|Withdrawal by Subject|2
5198168|NCT01109524|17947454|P1|Overall Study|Adverse Event|4
5198169|NCT01109524|17947454|P1|Overall Study|Study Drug toxicity|6
5198170|NCT01109524|17947454|P1|Overall Study|Disease Progression|29
5198171|NCT01109316|17947476|P6|Study Period 3|Withdrawal by Subject|0
5198172|NCT01109316|17947477|P5|Study Period 3|Withdrawal by Subject|1
5198173|NCT01109316|17947478|P4|Study Period 3|Withdrawal by Subject|0
5198174|NCT01109316|17947479|P3|Study Period 3|Withdrawal by Subject|0
5198175|NCT01109316|17947480|P2|Study Period 3|Withdrawal by Subject|0
5198176|NCT01109316|17947481|P1|Study Period 3|Withdrawal by Subject|1
5198177|NCT01109316|17947476|P6|Study Period 3|Lost to Follow-up|0
5198178|NCT01109316|17947477|P5|Study Period 3|Lost to Follow-up|1
5198179|NCT01109316|17947478|P4|Study Period 3|Lost to Follow-up|0
5198180|NCT01109316|17947479|P3|Study Period 3|Lost to Follow-up|0
5198181|NCT01109316|17947480|P2|Study Period 3|Lost to Follow-up|0
5198182|NCT01109316|17947481|P1|Study Period 3|Lost to Follow-up|0
5198183|NCT01109316|17947476|P6|Study Period 2|Withdrawal by Subject|1
5198184|NCT01109316|17947477|P5|Study Period 2|Withdrawal by Subject|0
5198185|NCT01109316|17947478|P4|Study Period 2|Withdrawal by Subject|0
5198186|NCT01109316|17947479|P3|Study Period 2|Withdrawal by Subject|1
5198187|NCT01109316|17947480|P2|Study Period 2|Withdrawal by Subject|0
5198188|NCT01109316|17947481|P1|Study Period 2|Withdrawal by Subject|0
5198189|NCT01109316|17947476|P6|Study Period 2|Protocol Violation|0
5198190|NCT01109316|17947477|P5|Study Period 2|Protocol Violation|0
5198191|NCT01109316|17947478|P4|Study Period 2|Protocol Violation|0
5198192|NCT01109316|17947479|P3|Study Period 2|Protocol Violation|0
5198193|NCT01109316|17947480|P2|Study Period 2|Protocol Violation|0
5198194|NCT01109316|17947481|P1|Study Period 2|Protocol Violation|1
5198195|NCT01109316|17947476|P6|Study Period 2|Physician Decision|0
5198196|NCT01109316|17947477|P5|Study Period 2|Physician Decision|0
5198197|NCT01109316|17947478|P4|Study Period 2|Physician Decision|1
5198198|NCT01109316|17947479|P3|Study Period 2|Physician Decision|0
5198199|NCT01109316|17947480|P2|Study Period 2|Physician Decision|0
5198200|NCT01109316|17947481|P1|Study Period 2|Physician Decision|0
5198201|NCT01109316|17947476|P6|Study Period 2|Entry Criteria Not Met|0
5198202|NCT01109316|17947477|P5|Study Period 2|Entry Criteria Not Met|0
5198203|NCT01109316|17947478|P4|Study Period 2|Entry Criteria Not Met|0
5198204|NCT01109316|17947479|P3|Study Period 2|Entry Criteria Not Met|0
5198205|NCT01109316|17947480|P2|Study Period 2|Entry Criteria Not Met|1
5198206|NCT01109316|17947481|P1|Study Period 2|Entry Criteria Not Met|0
5198207|NCT01109316|17947476|P6|Study Period 1|Sponsor Decision|2
5198208|NCT01109316|17947477|P5|Study Period 1|Sponsor Decision|0
5198209|NCT01109316|17947478|P4|Study Period 1|Sponsor Decision|0
5198210|NCT01109316|17947479|P3|Study Period 1|Sponsor Decision|0
5198211|NCT01109316|17947480|P2|Study Period 1|Sponsor Decision|0
5198212|NCT01109316|17947481|P1|Study Period 1|Sponsor Decision|0
5198213|NCT01109316|17947476|P6|Study Period 1|Withdrawal by Subject|0
5198214|NCT01109316|17947477|P5|Study Period 1|Withdrawal by Subject|2
5198215|NCT01109316|17947478|P4|Study Period 1|Withdrawal by Subject|0
5198216|NCT01109316|17947479|P3|Study Period 1|Withdrawal by Subject|1
5198217|NCT01109316|17947480|P2|Study Period 1|Withdrawal by Subject|0
5198218|NCT01109316|17947481|P1|Study Period 1|Withdrawal by Subject|0
5198219|NCT01109316|17947476|P6|Study Period 1|Lost to Follow-up|0
5198220|NCT01109316|17947477|P5|Study Period 1|Lost to Follow-up|0
5198221|NCT01109316|17947478|P4|Study Period 1|Lost to Follow-up|1
5198222|NCT01109316|17947479|P3|Study Period 1|Lost to Follow-up|1
5198223|NCT01109316|17947480|P2|Study Period 1|Lost to Follow-up|0
5198224|NCT01109316|17947481|P1|Study Period 1|Lost to Follow-up|0
5198225|NCT01109316|17947476|P6|Study Period 1|Adverse Event|0
5198226|NCT01109316|17947477|P5|Study Period 1|Adverse Event|0
5198227|NCT01109316|17947478|P4|Study Period 1|Adverse Event|0
5198228|NCT01109316|17947479|P3|Study Period 1|Adverse Event|1
5198229|NCT01109316|17947480|P2|Study Period 1|Adverse Event|0
5198230|NCT01109316|17947481|P1|Study Period 1|Adverse Event|0
5198231|NCT01109173|17947529|P4|Overall Study|Not Specifiied|14
5198232|NCT01109173|17947530|P3|Overall Study|Not Specifiied|9
5198233|NCT01109173|17947531|P2|Overall Study|Not Specifiied|4
5198234|NCT01109173|17947532|P1|Overall Study|Not Specifiied|5
5198235|NCT01109173|17947529|P4|Overall Study|Patient Did Not Use Study Medication|7
5198236|NCT01109173|17947530|P3|Overall Study|Patient Did Not Use Study Medication|11
5198237|NCT01109173|17947531|P2|Overall Study|Patient Did Not Use Study Medication|26
5198238|NCT01109173|17947532|P1|Overall Study|Patient Did Not Use Study Medication|34
5198239|NCT01109173|17947529|P4|Overall Study|Protocol Violation|2
5198240|NCT01109173|17947530|P3|Overall Study|Protocol Violation|1
5198241|NCT01109173|17947531|P2|Overall Study|Protocol Violation|5
5198242|NCT01109173|17947532|P1|Overall Study|Protocol Violation|4
5198243|NCT01109173|17947529|P4|Overall Study|Treatment Failure|64
5198244|NCT01109173|17947530|P3|Overall Study|Treatment Failure|69
5198245|NCT01109173|17947531|P2|Overall Study|Treatment Failure|32
5198246|NCT01109173|17947532|P1|Overall Study|Treatment Failure|25
5198247|NCT01109173|17947529|P4|Overall Study|Noncompliance|0
5198248|NCT01109173|17947530|P3|Overall Study|Noncompliance|0
5198249|NCT01109173|17947531|P2|Overall Study|Noncompliance|1
5198250|NCT01109173|17947532|P1|Overall Study|Noncompliance|0
5198251|NCT01109173|17947529|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
5198252|NCT01109173|17947530|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
5198253|NCT01109173|17947531|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
5198254|NCT01109173|17947532|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
5198255|NCT01109173|17947529|P4|Overall Study|Lost to Follow-up|0
5198256|NCT01109173|17947530|P3|Overall Study|Lost to Follow-up|0
5198257|NCT01109173|17947531|P2|Overall Study|Lost to Follow-up|1
5198258|NCT01109173|17947532|P1|Overall Study|Lost to Follow-up|0
5198259|NCT01109173|17947529|P4|Overall Study|Adverse Event|6
5198260|NCT01109173|17947530|P3|Overall Study|Adverse Event|9
5198261|NCT01109173|17947531|P2|Overall Study|Adverse Event|17
5198262|NCT01109173|17947532|P1|Overall Study|Adverse Event|15
5198263|NCT01108809|17947645|P1|Overall Study|Lost to Follow-up|1
5198264|NCT01108809|17947645|P1|Overall Study|Adverse Event|3
5198265|NCT01108796|17947662|P2|Overall Study|Lost to Follow-up|6
5198266|NCT01108796|17947663|P1|Overall Study|Lost to Follow-up|7
5198267|NCT01108796|17947662|P2|Overall Study|Adverse Event|1
5198268|NCT01108796|17947663|P1|Overall Study|Adverse Event|0
5198269|NCT01108731|17947706|P2|Overall Study|Adverse Event|3
5198270|NCT01108731|17947707|P1|Overall Study|Adverse Event|3
5198271|NCT01108731|17947706|P2|Overall Study|Withdrawal by Subject|1
5198272|NCT01108731|17947707|P1|Overall Study|Withdrawal by Subject|1
5198273|NCT01108718|17947719|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
5198274|NCT01108718|17947720|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
5198275|NCT01108523|17947732|P1|Overall Study|Protocol Violation|4
5198276|NCT01108510|17947739|P2|Overall Study|Death|1
5198277|NCT01108510|17947740|P1|Overall Study|Death|1
5198278|NCT01108510|17947739|P2|Overall Study|Pregnancy|3
5198279|NCT01108510|17947740|P1|Overall Study|Pregnancy|0
5198280|NCT01108510|17947739|P2|Overall Study|Lack of Efficacy|0
5198281|NCT01108510|17947740|P1|Overall Study|Lack of Efficacy|3
5198282|NCT01108510|17947739|P2|Overall Study|Participant Noncompliance|7
5198283|NCT01108510|17947740|P1|Overall Study|Participant Noncompliance|5
5198284|NCT01108510|17947739|P2|Overall Study|Investigator's Discretion|10
5198285|NCT01108510|17947740|P1|Overall Study|Investigator's Discretion|12
5198286|NCT01108510|17947739|P2|Overall Study|Withdrew Consent|15
5198287|NCT01108510|17947740|P1|Overall Study|Withdrew Consent|21
5198288|NCT01108510|17947739|P2|Overall Study|Lost to Follow-up|17
5198289|NCT01108510|17947740|P1|Overall Study|Lost to Follow-up|20
5198290|NCT01108510|17947739|P2|Overall Study|Adverse Event|19
5198291|NCT01108510|17947740|P1|Overall Study|Adverse Event|26
5198292|NCT01108510|17947739|P2|Overall Study|Joined Another Gilead-sponsored Study|195
5198293|NCT01108510|17947740|P1|Overall Study|Joined Another Gilead-sponsored Study|186
5198294|NCT01108510|17947739|P2|Overall Study|Randomized but Not Treated|1
5198295|NCT01108510|17947740|P1|Overall Study|Randomized but Not Treated|5
5198296|NCT01108458|17947760|P1|Overall Study|Withdrawal by Subject|1
5198297|NCT01108341|17947812|P1|Overall Study|Other|1
5198298|NCT01108341|17947812|P1|Overall Study|Lost to Follow-up|1
5198299|NCT01108341|17947812|P1|Overall Study|Withdrawal by Subject|1
5198300|NCT01108341|17947812|P1|Overall Study|Death|2
5198301|NCT01108263|17947819|P2|Overall Study|Adverse Event|1
5198302|NCT01108263|17947820|P1|Overall Study|Adverse Event|0
5198303|NCT01108237|17947830|P2|Overall Study|Did not meet criteria for analysis|0
5198304|NCT01108237|17947831|P1|Overall Study|Did not meet criteria for analysis|7
5198305|NCT01108237|17947830|P2|Overall Study|No alignment data|17
5198306|NCT01108237|17947831|P1|Overall Study|No alignment data|2
5198307|NCT01108185|17947837|P1|Overall Study|Lost to Follow-up|12
5198308|NCT01108185|17947837|P1|Overall Study|Non-compliance|15
5198309|NCT01108094|17947854|P4|Overall Study|Withdrawal by Subject|0
5198310|NCT01108094|17947855|P3|Overall Study|Withdrawal by Subject|0
5198311|NCT01108094|17947856|P2|Overall Study|Withdrawal by Subject|0
5198312|NCT01108094|17947857|P1|Overall Study|Withdrawal by Subject|1
5198313|NCT01108094|17947854|P4|Overall Study|Adverse Event|0
5198314|NCT01108094|17947855|P3|Overall Study|Adverse Event|0
5198315|NCT01108094|17947856|P2|Overall Study|Adverse Event|0
5198316|NCT01108094|17947857|P1|Overall Study|Adverse Event|2
5198317|NCT01108068|17947901|P2|Overall Study|5 not started, 1 stop due to side effect|0
5198318|NCT01108068|17947902|P1|Overall Study|5 not started, 1 stop due to side effect|6
5198319|NCT01108055|17947909|P1|Overall Study|Not evaluable- didn't complete treatment|4
5198320|NCT01108055|17947909|P1|Overall Study|Ineligible|11
5198321|NCT01107925|17947947|P6|Period 2|Withdrawal by Subject|1
5198322|NCT01107925|17947948|P5|Period 2|Withdrawal by Subject|0
5198323|NCT01107925|17947949|P4|Period 2|Withdrawal by Subject|0
5198324|NCT01107925|17947950|P3|Period 2|Withdrawal by Subject|0
5198325|NCT01107925|17947951|P2|Period 2|Withdrawal by Subject|1
5198326|NCT01107925|17947952|P1|Period 2|Withdrawal by Subject|0
5198327|NCT01107925|17947947|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5198328|NCT01107925|17947948|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
5198329|NCT01107925|17947949|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5198330|NCT01107925|17947950|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5198331|NCT01107925|17947951|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5198332|NCT01107925|17947952|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
5198333|NCT01107912|17947990|P6|Period 3|Withdrawal by Subject|0
5198334|NCT01107912|17947991|P5|Period 3|Withdrawal by Subject|0
5198335|NCT01107912|17947992|P4|Period 3|Withdrawal by Subject|1
5198336|NCT01107912|17947993|P3|Period 3|Withdrawal by Subject|0
5198337|NCT01107912|17947994|P2|Period 3|Withdrawal by Subject|0
5198338|NCT01107912|17947995|P1|Period 3|Withdrawal by Subject|0
5198339|NCT01107912|17947990|P6|Period 3|Adverse Event|0
5198340|NCT01107912|17947991|P5|Period 3|Adverse Event|0
5198341|NCT01107912|17947992|P4|Period 3|Adverse Event|0
5198342|NCT01107912|17947993|P3|Period 3|Adverse Event|1
5198343|NCT01107912|17947994|P2|Period 3|Adverse Event|1
5198344|NCT01107912|17947995|P1|Period 3|Adverse Event|0
5198345|NCT01107912|17947990|P6|Period 2|Physician Decision|0
5198346|NCT01107912|17947991|P5|Period 2|Physician Decision|0
5198347|NCT01107912|17947992|P4|Period 2|Physician Decision|0
5198348|NCT01107912|17947993|P3|Period 2|Physician Decision|1
5198349|NCT01107912|17947994|P2|Period 2|Physician Decision|0
5198350|NCT01107912|17947995|P1|Period 2|Physician Decision|0
5198351|NCT01107912|17947990|P6|Period 1|Withdrawal by Subject|0
5198352|NCT01107912|17947991|P5|Period 1|Withdrawal by Subject|0
5198353|NCT01107912|17947992|P4|Period 1|Withdrawal by Subject|0
5198354|NCT01107912|17947993|P3|Period 1|Withdrawal by Subject|0
5198355|NCT01107912|17947994|P2|Period 1|Withdrawal by Subject|0
5198356|NCT01107912|17947995|P1|Period 1|Withdrawal by Subject|1
5198357|NCT01107912|17947990|P6|Period 1|Physician Decision|0
5198358|NCT01107912|17947991|P5|Period 1|Physician Decision|1
5198359|NCT01107912|17947992|P4|Period 1|Physician Decision|0
5198360|NCT01107912|17947993|P3|Period 1|Physician Decision|0
5198361|NCT01107912|17947994|P2|Period 1|Physician Decision|0
5198362|NCT01107912|17947995|P1|Period 1|Physician Decision|0
5198363|NCT01107912|17947990|P6|Period 1|Adverse Event|0
5198364|NCT01107912|17947991|P5|Period 1|Adverse Event|2
5198365|NCT01107912|17947992|P4|Period 1|Adverse Event|0
5198366|NCT01107912|17947993|P3|Period 1|Adverse Event|0
5198367|NCT01107912|17947994|P2|Period 1|Adverse Event|0
5198368|NCT01107912|17947995|P1|Period 1|Adverse Event|0
5198369|NCT01107899|17948032|P3|Overall Study|Withdrawal by Subject|1
5198370|NCT01107899|17948033|P2|Overall Study|Withdrawal by Subject|0
5198371|NCT01107899|17948034|P1|Overall Study|Withdrawal by Subject|0
5198372|NCT01107899|17948032|P3|Overall Study|Physician Decision|3
5198373|NCT01107899|17948033|P2|Overall Study|Physician Decision|0
5198374|NCT01107899|17948034|P1|Overall Study|Physician Decision|5
5198375|NCT01107886|17948080|P2|Overall Study|Administrative withdrawal of consent|5
5198376|NCT01107886|17948081|P1|Overall Study|Administrative withdrawal of consent|7
5198377|NCT01107886|17948080|P2|Overall Study|Withdrawal by Subject|196
5198378|NCT01107886|17948081|P1|Overall Study|Withdrawal by Subject|180
5198379|NCT01107886|17948080|P2|Overall Study|Lost to Follow-up|13
5198380|NCT01107886|17948081|P1|Overall Study|Lost to Follow-up|15
5198381|NCT01107743|17948114|P1|Overall Study|Protocol Violation|46
5198382|NCT01107535|17948228|P1|Overall Study|Death|5
5198383|NCT01107457|17948241|P6|Part B and C|Clinical Relapse|4
5198384|NCT01107457|17948242|P5|Part B and C|Clinical Relapse|0
5198385|NCT01107457|17948243|P4|Part B and C|Clinical Relapse|0
5198386|NCT01107457|17948244|P3|Part B and C|Clinical Relapse|0
5198387|NCT01107457|17948245|P2|Part B and C|Clinical Relapse|0
5198388|NCT01107457|17948246|P1|Part B and C|Clinical Relapse|0
5198389|NCT01107457|17948241|P6|Part B and C|Withdrawal by Subject|16
5198390|NCT01107457|17948242|P5|Part B and C|Withdrawal by Subject|0
5198391|NCT01107457|17948243|P4|Part B and C|Withdrawal by Subject|0
5198392|NCT01107457|17948244|P3|Part B and C|Withdrawal by Subject|0
5198393|NCT01107457|17948245|P2|Part B and C|Withdrawal by Subject|0
5198394|NCT01107457|17948246|P1|Part B and C|Withdrawal by Subject|0
5198395|NCT01107457|17948241|P6|Part B and C|Sponsor Decision|66
5198396|NCT01107457|17948242|P5|Part B and C|Sponsor Decision|0
5198397|NCT01107457|17948243|P4|Part B and C|Sponsor Decision|0
5198398|NCT01107457|17948244|P3|Part B and C|Sponsor Decision|0
5198399|NCT01107457|17948245|P2|Part B and C|Sponsor Decision|0
5198400|NCT01107457|17948246|P1|Part B and C|Sponsor Decision|0
5198401|NCT01107457|17948241|P6|Part B and C|Protocol Violation|1
5198402|NCT01107457|17948242|P5|Part B and C|Protocol Violation|0
5198403|NCT01107457|17948243|P4|Part B and C|Protocol Violation|0
5198404|NCT01107457|17948244|P3|Part B and C|Protocol Violation|0
5198405|NCT01107457|17948245|P2|Part B and C|Protocol Violation|0
5198406|NCT01107457|17948246|P1|Part B and C|Protocol Violation|0
5198407|NCT01107457|17948241|P6|Part B and C|Lost to Follow-up|10
5198408|NCT01107457|17948242|P5|Part B and C|Lost to Follow-up|0
5198409|NCT01107457|17948243|P4|Part B and C|Lost to Follow-up|0
5198410|NCT01107457|17948244|P3|Part B and C|Lost to Follow-up|0
5198411|NCT01107457|17948245|P2|Part B and C|Lost to Follow-up|0
5198412|NCT01107457|17948246|P1|Part B and C|Lost to Follow-up|0
5198413|NCT01107457|17948241|P6|Part B and C|Lack of Efficacy|7
5198414|NCT01107457|17948242|P5|Part B and C|Lack of Efficacy|0
5198415|NCT01107457|17948243|P4|Part B and C|Lack of Efficacy|0
5198416|NCT01107457|17948244|P3|Part B and C|Lack of Efficacy|0
5198417|NCT01107457|17948245|P2|Part B and C|Lack of Efficacy|0
5198418|NCT01107457|17948246|P1|Part B and C|Lack of Efficacy|0
5198419|NCT01107457|17948241|P6|Part B and C|Physician Decision|3
5198420|NCT01107457|17948242|P5|Part B and C|Physician Decision|0
5198421|NCT01107457|17948243|P4|Part B and C|Physician Decision|0
5198422|NCT01107457|17948244|P3|Part B and C|Physician Decision|0
5198423|NCT01107457|17948245|P2|Part B and C|Physician Decision|0
5198424|NCT01107457|17948246|P1|Part B and C|Physician Decision|0
5198425|NCT01107457|17948241|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
5198426|NCT01107457|17948242|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5198427|NCT01107457|17948243|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5198428|NCT01107457|17948244|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5198429|NCT01107457|17948245|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5198430|NCT01107457|17948246|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5198431|NCT01107457|17948241|P6|Part B and C|Adverse Event|12
5198432|NCT01107457|17948242|P5|Part B and C|Adverse Event|0
5198433|NCT01107457|17948243|P4|Part B and C|Adverse Event|0
5198434|NCT01107457|17948244|P3|Part B and C|Adverse Event|0
5198435|NCT01107457|17948245|P2|Part B and C|Adverse Event|0
5198436|NCT01107457|17948246|P1|Part B and C|Adverse Event|0
5198437|NCT01107457|17948241|P6|Part A|Protocol Violation|0
5198438|NCT01107457|17948242|P5|Part A|Protocol Violation|0
5198439|NCT01107457|17948243|P4|Part A|Protocol Violation|0
5198440|NCT01107457|17948244|P3|Part A|Protocol Violation|0
5198441|NCT01107457|17948245|P2|Part A|Protocol Violation|1
5198442|NCT01107457|17948246|P1|Part A|Protocol Violation|0
5198443|NCT01107457|17948241|P6|Part A|Lack of Efficacy|0
5198444|NCT01107457|17948242|P5|Part A|Lack of Efficacy|0
5198445|NCT01107457|17948243|P4|Part A|Lack of Efficacy|0
5198446|NCT01107457|17948244|P3|Part A|Lack of Efficacy|0
5198447|NCT01107457|17948245|P2|Part A|Lack of Efficacy|0
5198448|NCT01107457|17948246|P1|Part A|Lack of Efficacy|1
5198449|NCT01107457|17948241|P6|Part A|Lost to Follow-up|0
5198450|NCT01107457|17948242|P5|Part A|Lost to Follow-up|0
5198451|NCT01107457|17948243|P4|Part A|Lost to Follow-up|0
5198452|NCT01107457|17948244|P3|Part A|Lost to Follow-up|0
5198453|NCT01107457|17948245|P2|Part A|Lost to Follow-up|1
5198454|NCT01107457|17948246|P1|Part A|Lost to Follow-up|0
5198455|NCT01107457|17948241|P6|Part A|Withdrawal by Subject|0
5198456|NCT01107457|17948242|P5|Part A|Withdrawal by Subject|1
5198457|NCT01107457|17948243|P4|Part A|Withdrawal by Subject|3
5198458|NCT01107457|17948244|P3|Part A|Withdrawal by Subject|0
5198459|NCT01107457|17948245|P2|Part A|Withdrawal by Subject|3
5198460|NCT01107457|17948246|P1|Part A|Withdrawal by Subject|3
5198461|NCT01107457|17948241|P6|Part A|Adverse Event|0
5198462|NCT01107457|17948242|P5|Part A|Adverse Event|0
5198463|NCT01107457|17948243|P4|Part A|Adverse Event|0
5198464|NCT01107457|17948244|P3|Part A|Adverse Event|1
5198465|NCT01107457|17948245|P2|Part A|Adverse Event|2
5198466|NCT01107457|17948246|P1|Part A|Adverse Event|1
5198467|NCT01107444|17948374|P2|Overall Study|Protocol Entry Criteria Not Met|1
5198468|NCT01107444|17948375|P1|Overall Study|Protocol Entry Criteria Not Met|0
5198469|NCT01107444|17948374|P2|Overall Study|Withdrawal by Subject|12
5198470|NCT01107444|17948375|P1|Overall Study|Withdrawal by Subject|8
5198471|NCT01107418|17948409|P1|Overall Study|Entered Extension Study|1
5198472|NCT01107418|17948409|P1|Overall Study|Started Other Therapy|1
5198473|NCT01107418|17948409|P1|Overall Study|Study Closing|1
5198474|NCT01107418|17948409|P1|Overall Study|Withdrawal by Subject|1
5198475|NCT01107418|17948409|P1|Overall Study|Adverse Event|3
5198476|NCT01107418|17948409|P1|Overall Study|Disease Progression|45
5198477|NCT01107405|17948482|P5|Overall Study|Protocol Violation|0
5198478|NCT01107405|17948483|P4|Overall Study|Protocol Violation|1
5198479|NCT01107405|17948484|P3|Overall Study|Protocol Violation|1
5198480|NCT01107405|17948485|P2|Overall Study|Protocol Violation|0
5198481|NCT01107405|17948486|P1|Overall Study|Protocol Violation|0
5198482|NCT01107405|17948482|P5|Overall Study|Withdrawal by Subject|1
5198483|NCT01107405|17948483|P4|Overall Study|Withdrawal by Subject|2
5198484|NCT01107405|17948484|P3|Overall Study|Withdrawal by Subject|1
5198485|NCT01107405|17948485|P2|Overall Study|Withdrawal by Subject|0
5198486|NCT01107405|17948486|P1|Overall Study|Withdrawal by Subject|1
5198487|NCT01107405|17948482|P5|Overall Study|Adverse Event|2
5198488|NCT01107405|17948483|P4|Overall Study|Adverse Event|0
5198489|NCT01107405|17948484|P3|Overall Study|Adverse Event|0
5198490|NCT01107405|17948485|P2|Overall Study|Adverse Event|1
5198491|NCT01107405|17948486|P1|Overall Study|Adverse Event|1
5198492|NCT01107392|17948525|P2|Overall Study|Administrative decision|0
5198493|NCT01107392|17948526|P1|Overall Study|Administrative decision|1
5198494|NCT01107392|17948525|P2|Overall Study|Personal Reasons|3
5198495|NCT01107392|17948526|P1|Overall Study|Personal Reasons|2
5198496|NCT01107392|17948525|P2|Overall Study|Adverse Event|0
5198497|NCT01107392|17948526|P1|Overall Study|Adverse Event|2
5198498|NCT01107379|17948538|P1|Overall Study|Lost to Follow-up|3
5198499|NCT01107379|17948538|P1|Overall Study|Withdrawal by Subject|18
5198500|NCT01107353|17948549|P2|Overall Study|Positive Drug Screen|0
5198501|NCT01107353|17948550|P1|Overall Study|Positive Drug Screen|1
5198502|NCT01107197|17948558|P2|Overall Study|Withdrawal by Subject|5
5198503|NCT01107197|17948559|P1|Overall Study|Withdrawal by Subject|3
5198504|NCT01107197|17948558|P2|Overall Study|Lost to Follow-up|8
5198505|NCT01107197|17948559|P1|Overall Study|Lost to Follow-up|5
5198506|NCT01107197|17948558|P2|Overall Study|Death|10
5198507|NCT01107197|17948559|P1|Overall Study|Death|12
5198508|NCT01106976|17948594|P1|Overall Study|Lost to Follow-up|8
5198509|NCT01106911|17948608|P1|Overall Study|deemed ineligible after screening|3
5198510|NCT01106911|17948608|P1|Overall Study|Physician Decision|2
5198511|NCT01106898|17948612|P1|Overall Study|Adverse Event|6
5198512|NCT01106846|17948657|P2|Overall Study|Change in surgical procedure|1
5198513|NCT01106846|17948658|P1|Overall Study|Change in surgical procedure|0
5198514|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5198515|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5198516|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5198517|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Other|4
5198518|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Other|3
5198519|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Other|8
5198520|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5198521|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5198522|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5198523|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
5198524|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5198525|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5198526|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
5198527|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
5198528|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
5198529|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5198530|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5198531|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5198532|NCT01106690|17948708|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
5198533|NCT01106690|17948709|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5198534|NCT01106690|17948710|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5198535|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Other|6
5198536|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Other|2
5198537|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Other|10
5198538|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5198539|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5198540|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
5198541|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5198542|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5198543|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5198544|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5198545|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5198546|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5198547|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
5198548|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
5198549|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
5198550|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
5198551|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
5198552|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
5198553|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5198554|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Protocol Violation|0
5198555|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Protocol Violation|1
5198556|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
5198557|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
5198558|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
5198559|NCT01106690|17948708|P3|Core Period: Baseline to Week 26|Adverse Event|4
5198560|NCT01106690|17948709|P2|Core Period: Baseline to Week 26|Adverse Event|1
5198561|NCT01106690|17948710|P1|Core Period: Baseline to Week 26|Adverse Event|6
5198562|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Other|5
5198563|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Other|8
5198564|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Other|5
5198565|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Other|6
5198566|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5198567|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5198568|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5198569|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5198570|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5198571|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
5198572|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
5198573|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5198574|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5198575|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
5198576|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
5198577|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5198578|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
5198579|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5198580|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
5198581|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
5198582|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
5198583|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
5198584|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
5198585|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
5198586|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5198587|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5198588|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5198589|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5198590|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
5198591|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
5198592|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
5198593|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
5198594|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Death|1
5198595|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Death|0
5198596|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Death|0
5198597|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Death|0
5198598|NCT01106677|17948746|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
5198599|NCT01106677|17948747|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
5198600|NCT01106677|17948748|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5198601|NCT01106677|17948749|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5198602|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Pregnancy|0
5198603|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Pregnancy|0
5198604|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Pregnancy|1
5198605|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Pregnancy|0
5198606|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Other|23
5198607|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Other|8
5198608|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Other|14
5198609|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Other|8
5198610|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Product quality complaint|0
5198611|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Product quality complaint|1
5198612|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Product quality complaint|1
5198613|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Product quality complaint|0
5198614|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
5198615|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
5198616|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
5198617|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
5198618|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5198619|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5198620|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
5198621|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5198622|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
5198623|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
5198624|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
5198625|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
5198626|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
5198627|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
5198628|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5198629|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
5198630|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Protocol Violation|3
5198631|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5198632|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Protocol Violation|1
5198633|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Protocol Violation|0
5198634|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Physician Decision|1
5198635|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Physician Decision|3
5198636|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Physician Decision|1
5198637|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Physician Decision|2
5198638|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
5198639|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
5198640|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
5198641|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
5198642|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
5198643|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
5198644|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
5198645|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
5198646|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Death|0
5198647|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Death|1
5198648|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Death|0
5198649|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Death|0
5198650|NCT01106677|17948746|P4|Core Period: Baseline to Week 26|Adverse Event|8
5198651|NCT01106677|17948747|P3|Core Period: Baseline to Week 26|Adverse Event|6
5198652|NCT01106677|17948748|P2|Core Period: Baseline to Week 26|Adverse Event|18
5198653|NCT01106677|17948749|P1|Core Period: Baseline to Week 26|Adverse Event|7
5198654|NCT01106651|17948812|P3|Overall Study|Death|0
5198655|NCT01106651|17948813|P2|Overall Study|Death|3
5198656|NCT01106651|17948814|P1|Overall Study|Death|0
5198657|NCT01106651|17948812|P3|Overall Study|Other|21
5198658|NCT01106651|17948813|P2|Overall Study|Other|31
5198659|NCT01106651|17948814|P1|Overall Study|Other|34
5198660|NCT01106651|17948812|P3|Overall Study|Noncompliance with study drug|2
5198661|NCT01106651|17948813|P2|Overall Study|Noncompliance with study drug|0
5198662|NCT01106651|17948814|P1|Overall Study|Noncompliance with study drug|1
5198663|NCT01106651|17948812|P3|Overall Study|Withdrawal by Subject|4
5198664|NCT01106651|17948813|P2|Overall Study|Withdrawal by Subject|7
5198665|NCT01106651|17948814|P1|Overall Study|Withdrawal by Subject|14
5198666|NCT01106651|17948812|P3|Overall Study|Protocol Violation|1
5198667|NCT01106651|17948813|P2|Overall Study|Protocol Violation|2
5198668|NCT01106651|17948814|P1|Overall Study|Protocol Violation|1
5198669|NCT01106651|17948812|P3|Overall Study|Physician Decision|1
5198670|NCT01106651|17948813|P2|Overall Study|Physician Decision|3
5198671|NCT01106651|17948814|P1|Overall Study|Physician Decision|4
5198672|NCT01106651|17948812|P3|Overall Study|Lost to Follow-up|6
5198673|NCT01106651|17948813|P2|Overall Study|Lost to Follow-up|2
5198674|NCT01106651|17948814|P1|Overall Study|Lost to Follow-up|8
5198675|NCT01106651|17948812|P3|Overall Study|Adverse Event|23
5198676|NCT01106651|17948813|P2|Overall Study|Adverse Event|9
5198677|NCT01106651|17948814|P1|Overall Study|Adverse Event|17
5198678|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Other|4
5198679|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Other|5
5198680|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Other|5
5198681|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5198682|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5198683|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5198684|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
5198685|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
5198686|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
5198687|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5198688|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5198689|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
5198690|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5198691|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5198692|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
5198693|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
5198694|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
5198695|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
5198696|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5198697|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
5198698|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5198699|NCT01106625|17948867|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
5198700|NCT01106625|17948868|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
5198701|NCT01106625|17948869|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
5198702|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Other|4
5198703|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Other|7
5198704|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Other|8
5198705|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5198706|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5198707|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5198708|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
5198709|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
5198710|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
5198711|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5198712|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5198713|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
5198714|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
5198715|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
5198716|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
5198717|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Protocol Violation|3
5198718|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Protocol Violation|1
5198719|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Protocol Violation|2
5198720|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Physician Decision|0
5198721|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Physician Decision|0
5198722|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Physician Decision|1
5198723|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
5198724|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
5198725|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
5198726|NCT01106625|17948867|P3|Core Period: Baseline to Week 26|Adverse Event|8
5198727|NCT01106625|17948868|P2|Core Period: Baseline to Week 26|Adverse Event|8
5198728|NCT01106625|17948869|P1|Core Period: Baseline to Week 26|Adverse Event|6
5198729|NCT01106586|17948900|P2|Overall Study|Participant Transferred to Another Study|197
5198730|NCT01106586|17948901|P1|Overall Study|Participant Transferred to Another Study|212
5198731|NCT01106586|17948900|P2|Overall Study|Protocol Violation|0
5198732|NCT01106586|17948901|P1|Overall Study|Protocol Violation|1
5198733|NCT01106586|17948900|P2|Overall Study|Participant Noncompliance|10
5198734|NCT01106586|17948901|P1|Overall Study|Participant Noncompliance|12
5198735|NCT01106586|17948900|P2|Overall Study|Lost to Follow-up|20
5198736|NCT01106586|17948901|P1|Overall Study|Lost to Follow-up|24
5198737|NCT01106586|17948900|P2|Overall Study|Withdrew Consent|30
5198738|NCT01106586|17948901|P1|Overall Study|Withdrew Consent|18
5198739|NCT01106586|17948900|P2|Overall Study|Investigator's Discretion|8
5198740|NCT01106586|17948901|P1|Overall Study|Investigator's Discretion|5
5198741|NCT01106586|17948900|P2|Overall Study|Lack of Efficacy|0
5198742|NCT01106586|17948901|P1|Overall Study|Lack of Efficacy|1
5198743|NCT01106586|17948900|P2|Overall Study|Pregnancy|2
5198744|NCT01106586|17948901|P1|Overall Study|Pregnancy|2
5198745|NCT01106586|17948900|P2|Overall Study|Death|3
5198746|NCT01106586|17948901|P1|Overall Study|Death|1
5198747|NCT01106586|17948900|P2|Overall Study|Adverse Event|15
5198748|NCT01106586|17948901|P1|Overall Study|Adverse Event|9
5198749|NCT01106534|17948919|P1|Overall Study|Physician Decision|1
5198750|NCT01106534|17948919|P1|Overall Study|Death|16
5198751|NCT01106534|17948919|P1|Overall Study|Lost to Follow-up|2
5198752|NCT01106534|17948919|P1|Overall Study|Withdrawal by Subject|18
5198753|NCT01106430|17948951|P2|Overall Study|Withdrawal by Subject|4
5198754|NCT01106430|17948952|P1|Overall Study|Withdrawal by Subject|8
5198755|NCT01106430|17948951|P2|Overall Study|Protocol Violation|2
5198756|NCT01106430|17948952|P1|Overall Study|Protocol Violation|7
5198757|NCT01106430|17948951|P2|Overall Study|Previous Use Of Marijuana|0
5198758|NCT01106430|17948952|P1|Overall Study|Previous Use Of Marijuana|1
5198759|NCT01106430|17948951|P2|Overall Study|Hard Time Swallowing The Pills|0
5198760|NCT01106430|17948952|P1|Overall Study|Hard Time Swallowing The Pills|1
5198761|NCT01106430|17948951|P2|Overall Study|Noncompliance|1
5198762|NCT01106430|17948952|P1|Overall Study|Noncompliance|0
5198763|NCT01106430|17948951|P2|Overall Study|Refused To Take Medication|1
5198764|NCT01106430|17948952|P1|Overall Study|Refused To Take Medication|0
5198765|NCT01106430|17948951|P2|Overall Study|Moved Out Of State|1
5198766|NCT01106430|17948952|P1|Overall Study|Moved Out Of State|0
5198767|NCT01106430|17948951|P2|Overall Study|Early Termination Requested By Sponsor|0
5198768|NCT01106430|17948952|P1|Overall Study|Early Termination Requested By Sponsor|1
5198769|NCT01106430|17948951|P2|Overall Study|Lost to Follow-up|1
5198770|NCT01106430|17948952|P1|Overall Study|Lost to Follow-up|5
5198771|NCT01106430|17948951|P2|Overall Study|Lack of Efficacy|13
5198772|NCT01106430|17948952|P1|Overall Study|Lack of Efficacy|2
5198773|NCT01106430|17948951|P2|Overall Study|Adverse Event|10
5198774|NCT01106430|17948952|P1|Overall Study|Adverse Event|8
5198775|NCT01106404|17948974|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
5198776|NCT01106404|17948975|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
5198777|NCT01106404|17948974|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
5198778|NCT01106404|17948975|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
5198779|NCT01106404|17948974|P2|Period I (First 6 Weeks)|Physician Decision|0
5198780|NCT01106404|17948975|P1|Period I (First 6 Weeks)|Physician Decision|1
5198781|NCT01106404|17948974|P2|Period I (First 6 Weeks)|Adverse Event|0
5198782|NCT01106404|17948975|P1|Period I (First 6 Weeks)|Adverse Event|2
5198783|NCT01106352|17948998|P5|Overall Study|Home hospice since July 2013|0
5198784|NCT01106352|17948999|P4|Overall Study|Home hospice since July 2013|1
5198785|NCT01106352|17949000|P3|Overall Study|Home hospice since July 2013|0
5198786|NCT01106352|17949001|P2|Overall Study|Home hospice since July 2013|0
5198787|NCT01106352|17949002|P1|Overall Study|Home hospice since July 2013|0
5198788|NCT01106352|17948998|P5|Overall Study|Subject entered hospice|0
5198789|NCT01106352|17948999|P4|Overall Study|Subject entered hospice|1
5198790|NCT01106352|17949000|P3|Overall Study|Subject entered hospice|0
5198791|NCT01106352|17949001|P2|Overall Study|Subject entered hospice|0
5198792|NCT01106352|17949002|P1|Overall Study|Subject entered hospice|0
5198793|NCT01106352|17948998|P5|Overall Study|Went on hospice|0
5198794|NCT01106352|17948999|P4|Overall Study|Went on hospice|1
5198795|NCT01106352|17949000|P3|Overall Study|Went on hospice|0
5198796|NCT01106352|17949001|P2|Overall Study|Went on hospice|0
5198797|NCT01106352|17949002|P1|Overall Study|Went on hospice|0
5198798|NCT01106352|17948998|P5|Overall Study|Withdrawal by Subject|2
5198799|NCT01106352|17948999|P4|Overall Study|Withdrawal by Subject|3
5198800|NCT01106352|17949000|P3|Overall Study|Withdrawal by Subject|0
5198801|NCT01106352|17949001|P2|Overall Study|Withdrawal by Subject|0
5198802|NCT01106352|17949002|P1|Overall Study|Withdrawal by Subject|0
5198803|NCT01106352|17948998|P5|Overall Study|Disease progression|0
5198804|NCT01106352|17948999|P4|Overall Study|Disease progression|1
5198805|NCT01106352|17949000|P3|Overall Study|Disease progression|0
5198806|NCT01106352|17949001|P2|Overall Study|Disease progression|0
5198807|NCT01106352|17949002|P1|Overall Study|Disease progression|0
5198808|NCT01106352|17948998|P5|Overall Study|Death|1
5198809|NCT01106352|17948999|P4|Overall Study|Death|3
5198810|NCT01106352|17949000|P3|Overall Study|Death|1
5198811|NCT01106352|17949001|P2|Overall Study|Death|0
5198812|NCT01106352|17949002|P1|Overall Study|Death|0
5198813|NCT01106352|17948998|P5|Overall Study|Lost to Follow-up|1
5198814|NCT01106352|17948999|P4|Overall Study|Lost to Follow-up|0
5198815|NCT01106352|17949000|P3|Overall Study|Lost to Follow-up|0
5198816|NCT01106352|17949001|P2|Overall Study|Lost to Follow-up|0
5198817|NCT01106352|17949002|P1|Overall Study|Lost to Follow-up|0
5198818|NCT01106352|17948998|P5|Overall Study|Too ill to come in for the visit|0
5198819|NCT01106352|17948999|P4|Overall Study|Too ill to come in for the visit|0
5198820|NCT01106352|17949000|P3|Overall Study|Too ill to come in for the visit|1
5198821|NCT01106352|17949001|P2|Overall Study|Too ill to come in for the visit|0
5198822|NCT01106352|17949002|P1|Overall Study|Too ill to come in for the visit|0
5198823|NCT01106352|17948998|P5|Overall Study|Sponsor Decision|0
5198824|NCT01106352|17948999|P4|Overall Study|Sponsor Decision|0
5198825|NCT01106352|17949000|P3|Overall Study|Sponsor Decision|0
5198826|NCT01106352|17949001|P2|Overall Study|Sponsor Decision|0
5198827|NCT01106352|17949002|P1|Overall Study|Sponsor Decision|1
5198828|NCT01106352|17948998|P5|Overall Study|Subjects untreated|4
5198829|NCT01106352|17948999|P4|Overall Study|Subjects untreated|3
5198830|NCT01106352|17949000|P3|Overall Study|Subjects untreated|0
5198831|NCT01106352|17949001|P2|Overall Study|Subjects untreated|0
5198832|NCT01106352|17949002|P1|Overall Study|Subjects untreated|0
5198833|NCT01106287|17949098|P4|Overall Study|Adverse Event|0
5198834|NCT01106287|17949099|P3|Overall Study|Adverse Event|0
5198835|NCT01106287|17949100|P2|Overall Study|Adverse Event|0
5198836|NCT01106287|17949101|P1|Overall Study|Adverse Event|1
5198837|NCT01106248|17949121|P1|Overall Study|Administrative|2
5198838|NCT01106248|17949121|P1|Overall Study|Adverse Event|1
5198839|NCT01106157|17949129|P2|Overall Study|Withdrawal by Subject|0
5198840|NCT01106157|17949130|P1|Overall Study|Withdrawal by Subject|1
5198841|NCT01106092|17949158|P4|Overall Study|Withdrawal by Subject|1
5198842|NCT01106092|17949159|P3|Overall Study|Withdrawal by Subject|0
5198843|NCT01106092|17949160|P2|Overall Study|Withdrawal by Subject|0
5198844|NCT01106092|17949161|P1|Overall Study|Withdrawal by Subject|0
5198845|NCT01106027|17949244|P1|Overall Study|Lost graft early, discontinued|1
5198846|NCT01106014|17949250|P2|Overall Study|Lost to Follow-up|3
5198847|NCT01106014|17949251|P1|Overall Study|Lost to Follow-up|2
5198848|NCT01106014|17949250|P2|Overall Study|Administrative reason|6
5198849|NCT01106014|17949251|P1|Overall Study|Administrative reason|7
5198850|NCT01106014|17949250|P2|Overall Study|Withdrawal by Subject|37
5198851|NCT01106014|17949251|P1|Overall Study|Withdrawal by Subject|43
5198852|NCT01106014|17949250|P2|Overall Study|Adverse Event|42
5198853|NCT01106014|17949251|P1|Overall Study|Adverse Event|78
5198854|NCT01106014|17949250|P2|Overall Study|Morbidity or Mortality primary endpoint|242
5198855|NCT01106014|17949251|P1|Overall Study|Morbidity or Mortality primary endpoint|155
5198856|NCT01105975|17949271|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5198857|NCT01105975|17949272|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
5198858|NCT01105975|17949273|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5198859|NCT01105975|17949274|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5198860|NCT01105975|17949275|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
5198861|NCT01105975|17949276|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5198862|NCT01105975|17949277|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5198863|NCT01105975|17949278|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5198864|NCT01105975|17949279|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5198865|NCT01105975|17949280|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5198866|NCT01105975|17949271|P10|Overall Study|Protocol Violation|2
5198867|NCT01105975|17949272|P9|Overall Study|Protocol Violation|2
5198868|NCT01105975|17949273|P8|Overall Study|Protocol Violation|1
5198869|NCT01105975|17949274|P7|Overall Study|Protocol Violation|1
5198870|NCT01105975|17949275|P6|Overall Study|Protocol Violation|1
5198871|NCT01105975|17949276|P5|Overall Study|Protocol Violation|1
5198872|NCT01105975|17949277|P4|Overall Study|Protocol Violation|0
5198873|NCT01105975|17949278|P3|Overall Study|Protocol Violation|2
5198874|NCT01105975|17949279|P2|Overall Study|Protocol Violation|2
5198875|NCT01105975|17949280|P1|Overall Study|Protocol Violation|0
5198876|NCT01105975|17949271|P10|Overall Study|Physician Decision|0
5198877|NCT01105975|17949272|P9|Overall Study|Physician Decision|0
5198878|NCT01105975|17949273|P8|Overall Study|Physician Decision|0
5198879|NCT01105975|17949274|P7|Overall Study|Physician Decision|2
5198880|NCT01105975|17949275|P6|Overall Study|Physician Decision|0
5198881|NCT01105975|17949276|P5|Overall Study|Physician Decision|0
5198882|NCT01105975|17949277|P4|Overall Study|Physician Decision|0
5198883|NCT01105975|17949278|P3|Overall Study|Physician Decision|0
5198884|NCT01105975|17949279|P2|Overall Study|Physician Decision|0
5198885|NCT01105975|17949280|P1|Overall Study|Physician Decision|0
5198886|NCT01105975|17949271|P10|Overall Study|Lost to Follow-up|0
5198887|NCT01105975|17949272|P9|Overall Study|Lost to Follow-up|1
5198888|NCT01105975|17949273|P8|Overall Study|Lost to Follow-up|0
5198889|NCT01105975|17949274|P7|Overall Study|Lost to Follow-up|0
5198890|NCT01105975|17949275|P6|Overall Study|Lost to Follow-up|0
5198891|NCT01105975|17949276|P5|Overall Study|Lost to Follow-up|1
5198892|NCT01105975|17949277|P4|Overall Study|Lost to Follow-up|1
5198893|NCT01105975|17949278|P3|Overall Study|Lost to Follow-up|0
5198894|NCT01105975|17949279|P2|Overall Study|Lost to Follow-up|0
5198895|NCT01105975|17949280|P1|Overall Study|Lost to Follow-up|1
5198896|NCT01105975|17949271|P10|Overall Study|Withdrawal by Subject|3
5198897|NCT01105975|17949272|P9|Overall Study|Withdrawal by Subject|0
5198898|NCT01105975|17949273|P8|Overall Study|Withdrawal by Subject|1
5198899|NCT01105975|17949274|P7|Overall Study|Withdrawal by Subject|2
5198900|NCT01105975|17949275|P6|Overall Study|Withdrawal by Subject|1
5198901|NCT01105975|17949276|P5|Overall Study|Withdrawal by Subject|4
5198902|NCT01105975|17949277|P4|Overall Study|Withdrawal by Subject|0
5198903|NCT01105975|17949278|P3|Overall Study|Withdrawal by Subject|2
5198904|NCT01105975|17949279|P2|Overall Study|Withdrawal by Subject|2
5198905|NCT01105975|17949280|P1|Overall Study|Withdrawal by Subject|2
5198906|NCT01105975|17949271|P10|Overall Study|Adverse Event|4
5198907|NCT01105975|17949272|P9|Overall Study|Adverse Event|1
5198908|NCT01105975|17949273|P8|Overall Study|Adverse Event|4
5198909|NCT01105975|17949274|P7|Overall Study|Adverse Event|2
5198910|NCT01105975|17949275|P6|Overall Study|Adverse Event|1
5198911|NCT01105975|17949276|P5|Overall Study|Adverse Event|0
5198912|NCT01105975|17949277|P4|Overall Study|Adverse Event|1
5198913|NCT01105975|17949278|P3|Overall Study|Adverse Event|5
5198914|NCT01105975|17949279|P2|Overall Study|Adverse Event|1
5198915|NCT01105975|17949280|P1|Overall Study|Adverse Event|2
5198916|NCT01105936|17949428|P4|Period 3|Protocol Violation|0
5198917|NCT01105936|17949429|P3|Period 3|Protocol Violation|0
5198918|NCT01105936|17949430|P2|Period 3|Protocol Violation|2
5198919|NCT01105936|17949431|P1|Period 3|Protocol Violation|0
5198920|NCT01105936|17949428|P4|Period 2|Adverse Event|0
5198921|NCT01105936|17949429|P3|Period 2|Adverse Event|0
5198922|NCT01105936|17949430|P2|Period 2|Adverse Event|0
5198923|NCT01105936|17949431|P1|Period 2|Adverse Event|1
5198924|NCT01105936|17949428|P4|Period 1|Adverse Event|1
5198925|NCT01105936|17949429|P3|Period 1|Adverse Event|0
5198926|NCT01105936|17949430|P2|Period 1|Adverse Event|0
5198927|NCT01105936|17949431|P1|Period 1|Adverse Event|0
5198928|NCT01105767|17949460|P3|Overall Study|Lost to Follow-up|1184
5198929|NCT01105767|17949461|P2|Overall Study|Lost to Follow-up|1614
5198930|NCT01105767|17949462|P1|Overall Study|Lost to Follow-up|1160
5198931|NCT01105533|17949514|P9|Overall Study|Physician Decision|0
5198932|NCT01105533|17949515|P8|Overall Study|Physician Decision|1
5198933|NCT01105533|17949516|P7|Overall Study|Physician Decision|0
5198934|NCT01105533|17949517|P6|Overall Study|Physician Decision|0
5198935|NCT01105533|17949518|P5|Overall Study|Physician Decision|0
5198936|NCT01105533|17949519|P4|Overall Study|Physician Decision|0
5198937|NCT01105533|17949520|P3|Overall Study|Physician Decision|0
5198938|NCT01105533|17949521|P2|Overall Study|Physician Decision|0
5198939|NCT01105533|17949522|P1|Overall Study|Physician Decision|0
5198940|NCT01105533|17949514|P9|Overall Study|Other|2
5198941|NCT01105533|17949515|P8|Overall Study|Other|1
5198942|NCT01105533|17949516|P7|Overall Study|Other|3
5198943|NCT01105533|17949517|P6|Overall Study|Other|0
5198944|NCT01105533|17949518|P5|Overall Study|Other|1
5198945|NCT01105533|17949519|P4|Overall Study|Other|0
5198946|NCT01105533|17949520|P3|Overall Study|Other|0
5198947|NCT01105533|17949521|P2|Overall Study|Other|0
5198948|NCT01105533|17949522|P1|Overall Study|Other|0
5198949|NCT01105533|17949514|P9|Overall Study|Adverse Event|1
5198950|NCT01105533|17949515|P8|Overall Study|Adverse Event|0
5198951|NCT01105533|17949516|P7|Overall Study|Adverse Event|2
5198952|NCT01105533|17949517|P6|Overall Study|Adverse Event|2
5198953|NCT01105533|17949518|P5|Overall Study|Adverse Event|1
5198954|NCT01105533|17949519|P4|Overall Study|Adverse Event|0
5198955|NCT01105533|17949520|P3|Overall Study|Adverse Event|0
5198956|NCT01105533|17949521|P2|Overall Study|Adverse Event|0
5198957|NCT01105533|17949522|P1|Overall Study|Adverse Event|0
5198958|NCT01105533|17949514|P9|Overall Study|Lack of Efficacy|9
5198959|NCT01105533|17949515|P8|Overall Study|Lack of Efficacy|2
5198960|NCT01105533|17949516|P7|Overall Study|Lack of Efficacy|3
5198961|NCT01105533|17949517|P6|Overall Study|Lack of Efficacy|5
5198962|NCT01105533|17949518|P5|Overall Study|Lack of Efficacy|4
5198963|NCT01105533|17949519|P4|Overall Study|Lack of Efficacy|3
5198964|NCT01105533|17949520|P3|Overall Study|Lack of Efficacy|3
5198965|NCT01105533|17949521|P2|Overall Study|Lack of Efficacy|1
5198966|NCT01105533|17949522|P1|Overall Study|Lack of Efficacy|1
5198967|NCT01105533|17949514|P9|Overall Study|Death|0
5198968|NCT01105533|17949515|P8|Overall Study|Death|0
5198969|NCT01105533|17949516|P7|Overall Study|Death|0
5198970|NCT01105533|17949517|P6|Overall Study|Death|0
5198971|NCT01105533|17949518|P5|Overall Study|Death|1
5198972|NCT01105533|17949519|P4|Overall Study|Death|0
5198973|NCT01105533|17949520|P3|Overall Study|Death|0
5198974|NCT01105533|17949521|P2|Overall Study|Death|0
5198975|NCT01105533|17949522|P1|Overall Study|Death|0
5198976|NCT01105377|17949612|P2|Overall Study|Withdrawal by Subject|1
5198977|NCT01105377|17949613|P1|Overall Study|Withdrawal by Subject|0
5198978|NCT01105130|17949661|P3|Overall Study|Multiple Reasons|2
5198979|NCT01105130|17949662|P2|Overall Study|Multiple Reasons|0
5198980|NCT01105130|17949663|P1|Overall Study|Multiple Reasons|3
5198981|NCT01105130|17949661|P3|Overall Study|Toxicity|2
5198982|NCT01105130|17949662|P2|Overall Study|Toxicity|3
5198983|NCT01105130|17949663|P1|Overall Study|Toxicity|1
5198984|NCT01105130|17949661|P3|Overall Study|Never Started|4
5198985|NCT01105130|17949662|P2|Overall Study|Never Started|2
5198986|NCT01105130|17949663|P1|Overall Study|Never Started|2
5198987|NCT01105130|17949661|P3|Overall Study|Withdrawal by Subject|2
5198988|NCT01105130|17949662|P2|Overall Study|Withdrawal by Subject|6
5198989|NCT01105130|17949663|P1|Overall Study|Withdrawal by Subject|4
5198990|NCT01105091|17949693|P2|Overall Study|Death|0
5198991|NCT01105091|17949694|P1|Overall Study|Death|2
5198992|NCT01105065|17949718|P1|Overall Study|Technical Problems|1
5198993|NCT01105065|17949718|P1|Overall Study|Adverse Event|5
5198994|NCT01104870|17949727|P3|Overall Study|Withdrawal by Subject|1
5198995|NCT01104870|17949728|P2|Overall Study|Withdrawal by Subject|0
5198996|NCT01104870|17949729|P1|Overall Study|Withdrawal by Subject|0
5198997|NCT01104870|17949727|P3|Overall Study|Death|1
5198998|NCT01104870|17949728|P2|Overall Study|Death|0
5198999|NCT01104870|17949729|P1|Overall Study|Death|0
5199000|NCT01104870|17949727|P3|Overall Study|Adverse Event|0
5199001|NCT01104870|17949728|P2|Overall Study|Adverse Event|1
5199002|NCT01104870|17949729|P1|Overall Study|Adverse Event|1
5199003|NCT01104792|17949758|P1|Overall Study|Did Not Meet Eligibility Criteria|133
5199004|NCT01104792|17949758|P1|Overall Study|Reasons Not Specified|27
5199005|NCT01104792|17949758|P1|Overall Study|Lost to Follow-up|43
5199006|NCT01104792|17949758|P1|Overall Study|Withdrawal of Consent|179
5199007|NCT01104792|17949758|P1|Overall Study|Protocol Violation|45
5199008|NCT01104792|17949758|P1|Overall Study|Insufficient Therapeutic Response|22
5199009|NCT01104792|17949758|P1|Overall Study|Adverse Event|77
5199010|NCT01104779|17949766|P3|Overall Study|Withdrawal by Subject|32
5199011|NCT01104779|17949767|P2|Overall Study|Withdrawal by Subject|25
5199012|NCT01104779|17949768|P1|Overall Study|Withdrawal by Subject|16
5199013|NCT01104779|17949766|P3|Overall Study|Lost to Follow-up|1
5199014|NCT01104779|17949767|P2|Overall Study|Lost to Follow-up|0
5199015|NCT01104779|17949768|P1|Overall Study|Lost to Follow-up|2
5199016|NCT01104779|17949766|P3|Overall Study|Other reasons|0
5199017|NCT01104779|17949767|P2|Overall Study|Other reasons|1
5199018|NCT01104779|17949768|P1|Overall Study|Other reasons|0
5199019|NCT01104779|17949766|P3|Overall Study|Did not meet inc/exc criteria|1
5199020|NCT01104779|17949767|P2|Overall Study|Did not meet inc/exc criteria|1
5199021|NCT01104779|17949768|P1|Overall Study|Did not meet inc/exc criteria|1
5199022|NCT01104779|17949766|P3|Overall Study|Adverse Event|13
5199023|NCT01104779|17949767|P2|Overall Study|Adverse Event|14
5199024|NCT01104779|17949768|P1|Overall Study|Adverse Event|13
5199025|NCT01104779|17949766|P3|Overall Study|Lack of Efficacy|13
5199026|NCT01104779|17949767|P2|Overall Study|Lack of Efficacy|12
5199027|NCT01104779|17949768|P1|Overall Study|Lack of Efficacy|26
5199028|NCT01104779|17949766|P3|Overall Study|Protocol Violation|2
5199029|NCT01104779|17949767|P2|Overall Study|Protocol Violation|2
5199030|NCT01104779|17949768|P1|Overall Study|Protocol Violation|1
5199031|NCT01104766|17949783|P4|Overall Study|Lost to Follow-up|1
5199032|NCT01104766|17949784|P3|Overall Study|Lost to Follow-up|1
5199033|NCT01104766|17949785|P2|Overall Study|Lost to Follow-up|2
5199034|NCT01104766|17949786|P1|Overall Study|Lost to Follow-up|1
5199035|NCT01104766|17949783|P4|Overall Study|Withdrawal by Subject|15
5199036|NCT01104766|17949784|P3|Overall Study|Withdrawal by Subject|25
5199037|NCT01104766|17949785|P2|Overall Study|Withdrawal by Subject|19
5199038|NCT01104766|17949786|P1|Overall Study|Withdrawal by Subject|17
5199039|NCT01104766|17949783|P4|Overall Study|Protocol Violation|0
5199040|NCT01104766|17949784|P3|Overall Study|Protocol Violation|0
5199041|NCT01104766|17949785|P2|Overall Study|Protocol Violation|0
5199042|NCT01104766|17949786|P1|Overall Study|Protocol Violation|2
5199043|NCT01104766|17949783|P4|Overall Study|Lack of Efficacy|8
5199044|NCT01104766|17949784|P3|Overall Study|Lack of Efficacy|14
5199045|NCT01104766|17949785|P2|Overall Study|Lack of Efficacy|15
5199046|NCT01104766|17949786|P1|Overall Study|Lack of Efficacy|20
5199047|NCT01104766|17949783|P4|Overall Study|Adverse Event|14
5199048|NCT01104766|17949784|P3|Overall Study|Adverse Event|20
5199049|NCT01104766|17949785|P2|Overall Study|Adverse Event|15
5199050|NCT01104766|17949786|P1|Overall Study|Adverse Event|17
5199051|NCT01104766|17949783|P4|Overall Study|Did not meet inc/exc criteria|0
5199052|NCT01104766|17949784|P3|Overall Study|Did not meet inc/exc criteria|0
5199053|NCT01104766|17949785|P2|Overall Study|Did not meet inc/exc criteria|0
5199054|NCT01104766|17949786|P1|Overall Study|Did not meet inc/exc criteria|1
5199055|NCT01104701|17949804|P4|Overall Study|Physician Decision|0
5199056|NCT01104701|17949805|P3|Overall Study|Physician Decision|0
5199057|NCT01104701|17949806|P2|Overall Study|Physician Decision|2
5199058|NCT01104701|17949807|P1|Overall Study|Physician Decision|0
5199059|NCT01104701|17949804|P4|Overall Study|Adverse Event|1
5199060|NCT01104701|17949805|P3|Overall Study|Adverse Event|0
5199061|NCT01104701|17949806|P2|Overall Study|Adverse Event|0
5199062|NCT01104701|17949807|P1|Overall Study|Adverse Event|0
5199063|NCT01104701|17949804|P4|Overall Study|Withdrawal by Subject|1
5199064|NCT01104701|17949805|P3|Overall Study|Withdrawal by Subject|2
5199065|NCT01104701|17949806|P2|Overall Study|Withdrawal by Subject|1
5199066|NCT01104701|17949807|P1|Overall Study|Withdrawal by Subject|0
5199067|NCT01104662|17949869|P8|Overall Study|Randomized but not treated|0
5199068|NCT01104662|17949870|P7|Overall Study|Randomized but not treated|0
5199069|NCT01104662|17949871|P6|Overall Study|Randomized but not treated|1
5199070|NCT01104662|17949872|P5|Overall Study|Randomized but not treated|0
5199071|NCT01104662|17949873|P4|Overall Study|Randomized but not treated|0
5199072|NCT01104662|17949874|P3|Overall Study|Randomized but not treated|1
5199073|NCT01104662|17949875|P2|Overall Study|Randomized but not treated|4
5199074|NCT01104662|17949876|P1|Overall Study|Randomized but not treated|3
5199075|NCT01104662|17949869|P8|Overall Study|Reason not specified|0
5199076|NCT01104662|17949870|P7|Overall Study|Reason not specified|0
5199077|NCT01104662|17949871|P6|Overall Study|Reason not specified|1
5199078|NCT01104662|17949872|P5|Overall Study|Reason not specified|0
5199079|NCT01104662|17949873|P4|Overall Study|Reason not specified|0
5199080|NCT01104662|17949874|P3|Overall Study|Reason not specified|0
5199081|NCT01104662|17949875|P2|Overall Study|Reason not specified|3
5199082|NCT01104662|17949876|P1|Overall Study|Reason not specified|3
5199083|NCT01104662|17949869|P8|Overall Study|Participant left investigator's care|0
5199084|NCT01104662|17949870|P7|Overall Study|Participant left investigator's care|0
5199085|NCT01104662|17949871|P6|Overall Study|Participant left investigator's care|0
5199086|NCT01104662|17949872|P5|Overall Study|Participant left investigator's care|0
5199087|NCT01104662|17949873|P4|Overall Study|Participant left investigator's care|0
5199088|NCT01104662|17949874|P3|Overall Study|Participant left investigator's care|0
5199089|NCT01104662|17949875|P2|Overall Study|Participant left investigator's care|1
5199090|NCT01104662|17949876|P1|Overall Study|Participant left investigator's care|1
5199091|NCT01104662|17949869|P8|Overall Study|Clinical Failure|0
5199092|NCT01104662|17949870|P7|Overall Study|Clinical Failure|0
5199093|NCT01104662|17949871|P6|Overall Study|Clinical Failure|1
5199094|NCT01104662|17949872|P5|Overall Study|Clinical Failure|0
5199095|NCT01104662|17949873|P4|Overall Study|Clinical Failure|0
5199096|NCT01104662|17949874|P3|Overall Study|Clinical Failure|0
5199097|NCT01104662|17949875|P2|Overall Study|Clinical Failure|0
5199098|NCT01104662|17949876|P1|Overall Study|Clinical Failure|1
5199099|NCT01104662|17949869|P8|Overall Study|Adverse Event|0
5199100|NCT01104662|17949870|P7|Overall Study|Adverse Event|0
5199101|NCT01104662|17949871|P6|Overall Study|Adverse Event|1
5199102|NCT01104662|17949872|P5|Overall Study|Adverse Event|1
5199103|NCT01104662|17949873|P4|Overall Study|Adverse Event|1
5199104|NCT01104662|17949874|P3|Overall Study|Adverse Event|0
5199105|NCT01104662|17949875|P2|Overall Study|Adverse Event|2
5199106|NCT01104662|17949876|P1|Overall Study|Adverse Event|2
5199107|NCT01104636|17949902|P1|Overall Study|Ongoing|21
5199108|NCT01104636|17949902|P1|Overall Study|Adverse Event|40
5199109|NCT01104636|17949902|P1|Overall Study|Pregnancy|2
5199110|NCT01104636|17949902|P1|Overall Study|Study terminated by sponsor|1
5199111|NCT01104636|17949902|P1|Overall Study|Other|43
5199112|NCT01104636|17949902|P1|Overall Study|Withdrawal by Subject|4
5199113|NCT01104636|17949902|P1|Overall Study|Lost to Follow-up|24
5199114|NCT01104636|17949902|P1|Overall Study|Lack of Efficacy|43
5199115|NCT01104584|17949907|P1|Overall Study|Study prematurely discontinued|2
5199116|NCT01104584|17949907|P1|Overall Study|Study drug never administered|21
5199117|NCT01104558|17949977|P1|Overall Study|Missing of genetic analysis results|1
5199118|NCT01104558|17949977|P1|Overall Study|Missing of primary efficacy assessment|10
5199119|NCT01104558|17949977|P1|Overall Study|Protocol Violation|6
5199120|NCT01104545|17950021|P3|Overall Study|Adverse Event|2
5199121|NCT01104545|17950022|P2|Overall Study|Adverse Event|1
5199122|NCT01104545|17950023|P1|Overall Study|Adverse Event|0
5199123|NCT01104493|17950180|P2|Overall Study|Lost to Follow-up|2
5199124|NCT01104493|17950181|P1|Overall Study|Lost to Follow-up|0
5199125|NCT01104415|17950199|P2|Extension Period|Heart surgery/feeling miserable|1
5199126|NCT01104415|17950200|P1|Extension Period|Heart surgery/feeling miserable|0
5199127|NCT01104415|17950199|P2|Extension Period|Transition to Study LX1606.302|4
5199128|NCT01104415|17950200|P1|Extension Period|Transition to Study LX1606.302|0
5199129|NCT01104415|17950199|P2|Extension Period|Physician Decision|1
5199130|NCT01104415|17950200|P1|Extension Period|Physician Decision|0
5199131|NCT01104415|17950199|P2|Extension Period|Death|1
5199132|NCT01104415|17950200|P1|Extension Period|Death|0
5199133|NCT01104415|17950199|P2|Extension Period|Progressive disease|4
5199134|NCT01104415|17950200|P1|Extension Period|Progressive disease|0
5199135|NCT01104415|17950199|P2|Core Phase|Consent withdrawn by subjects|0
5199136|NCT01104415|17950200|P1|Core Phase|Consent withdrawn by subjects|1
5199137|NCT01104376|17950244|P1|Overall Study|Consented but excluded after labs|13
5199138|NCT01104376|17950244|P1|Overall Study|Withdrawal by Subject|15
5199139|NCT01104311|17950250|P2|Overall Study|Adverse Event|2
5199140|NCT01104311|17950251|P1|Overall Study|Adverse Event|1
5199141|NCT01104311|17950250|P2|Overall Study|low compliance|1
5199142|NCT01104311|17950251|P1|Overall Study|low compliance|1
5199143|NCT01104311|17950250|P2|Overall Study|Physician Decision|2
5199144|NCT01104311|17950251|P1|Overall Study|Physician Decision|2
5199145|NCT01104311|17950250|P2|Overall Study|Protocol Violation|1
5199146|NCT01104311|17950251|P1|Overall Study|Protocol Violation|0
5199147|NCT01104311|17950250|P2|Overall Study|Withdrawal by Subject|6
5199148|NCT01104311|17950251|P1|Overall Study|Withdrawal by Subject|6
5199149|NCT01104246|17950278|P1|Overall Study|did not meet inclusion criteria|4
5199150|NCT01104246|17950278|P1|Overall Study|Withdrawal by Subject|1
5199151|NCT01104155|17950293|P2|Overall Study|Other|4
5199152|NCT01104155|17950294|P1|Overall Study|Other|3
5199153|NCT01104155|17950293|P2|Overall Study|Withdrawal of consent|1
5199154|NCT01104155|17950294|P1|Overall Study|Withdrawal of consent|1
5199155|NCT01104155|17950293|P2|Overall Study|Participant choice|5
5199156|NCT01104155|17950294|P1|Overall Study|Participant choice|6
5199157|NCT01104155|17950293|P2|Overall Study|Adverse Event|8
5199158|NCT01104155|17950294|P1|Overall Study|Adverse Event|15
5199159|NCT01103960|17950346|P2|Overall Study|Other|0
5199160|NCT01103960|17950347|P1|Overall Study|Other|1
5199161|NCT01103960|17950346|P2|Overall Study|Withdrawal by Subject|1
5199162|NCT01103960|17950347|P1|Overall Study|Withdrawal by Subject|2
5199163|NCT01103960|17950346|P2|Overall Study|Adverse Event|1
5199164|NCT01103960|17950347|P1|Overall Study|Adverse Event|2
5199165|NCT01103778|17950382|P1|Overall Study|Screen failure|1
5199166|NCT01103778|17950382|P1|Overall Study|Proteinuria improved prior to enrollment|1
5199167|NCT01103778|17950382|P1|Overall Study|Lost to Follow-up|1
5199168|NCT01103713|17950389|P1|Overall Study|Other|1
5199169|NCT01103713|17950389|P1|Overall Study|Study terminated by sponsor|2
5199170|NCT01103713|17950389|P1|Overall Study|Withdrawal by Subject|8
5199171|NCT01103713|17950389|P1|Overall Study|Lost to Follow-up|2
5199172|NCT01103479|17950439|P3|Overall Study|Saw non-study physician|0
5199173|NCT01103479|17950440|P2|Overall Study|Saw non-study physician|0
5199174|NCT01103479|17950441|P1|Overall Study|Saw non-study physician|2
5199175|NCT01103479|17950439|P3|Overall Study|Active cancer|0
5199176|NCT01103479|17950440|P2|Overall Study|Active cancer|0
5199177|NCT01103479|17950441|P1|Overall Study|Active cancer|1
5199178|NCT01103479|17950439|P3|Overall Study|Family history of CRC|2
5199179|NCT01103479|17950440|P2|Overall Study|Family history of CRC|0
5199180|NCT01103479|17950441|P1|Overall Study|Family history of CRC|1
5199181|NCT01103479|17950439|P3|Overall Study|Up to date with CRC screening|12
5199182|NCT01103479|17950440|P2|Overall Study|Up to date with CRC screening|9
5199183|NCT01103479|17950441|P1|Overall Study|Up to date with CRC screening|1
5199184|NCT01103466|17950454|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
5199185|NCT01103466|17950455|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
5199186|NCT01103466|17950456|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
5199187|NCT01103466|17950454|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
5199188|NCT01103466|17950455|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
5199189|NCT01103466|17950456|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
5199190|NCT01103466|17950454|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
5199191|NCT01103466|17950455|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
5199192|NCT01103466|17950456|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
5199193|NCT01103466|17950454|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
5199194|NCT01103466|17950455|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
5199195|NCT01103466|17950456|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
5199196|NCT01103466|17950454|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
5199197|NCT01103466|17950455|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
5199198|NCT01103466|17950456|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
5199199|NCT01103466|17950454|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
5199200|NCT01103466|17950455|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
5199201|NCT01103466|17950456|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
5199202|NCT01103362|17950546|P1|Overall Study|study terminated|596
5199203|NCT01103323|17950552|P2|Switched From Placebo to Regorafenib|Adverse Event|1
5199204|NCT01103323|17950553|P1|Switched From Placebo to Regorafenib|Adverse Event|0
5199205|NCT01103323|17950552|P2|Without/Before Drug Switch|Switch to Regorafenib|4
5199206|NCT01103323|17950553|P1|Without/Before Drug Switch|Switch to Regorafenib|0
5199207|NCT01103323|17950552|P2|Without/Before Drug Switch|did not receive study treatment|2
5199208|NCT01103323|17950553|P1|Without/Before Drug Switch|did not receive study treatment|5
5199209|NCT01103323|17950552|P2|Without/Before Drug Switch|Physician Decision|0
5199210|NCT01103323|17950553|P1|Without/Before Drug Switch|Physician Decision|2
5199211|NCT01103323|17950552|P2|Without/Before Drug Switch|Protocol Violation|0
5199212|NCT01103323|17950553|P1|Without/Before Drug Switch|Protocol Violation|2
5199213|NCT01103323|17950552|P2|Without/Before Drug Switch|Withdrawal by Subject|5
5199214|NCT01103323|17950553|P1|Without/Before Drug Switch|Withdrawal by Subject|17
5199215|NCT01103323|17950552|P2|Without/Before Drug Switch|Adverse Event|7
5199216|NCT01103323|17950553|P1|Without/Before Drug Switch|Adverse Event|50
5199217|NCT01103284|17950570|P2|Overall Study|Missing CRF entries for study completion|2
5199218|NCT01103284|17950571|P1|Overall Study|Missing CRF entries for study completion|0
5199219|NCT01103284|17950570|P2|Overall Study|Not described|1
5199220|NCT01103284|17950571|P1|Overall Study|Not described|2
5199221|NCT01103284|17950570|P2|Overall Study|Termination by the Sponsor|1
5199222|NCT01103284|17950571|P1|Overall Study|Termination by the Sponsor|0
5199223|NCT01103284|17950570|P2|Overall Study|Dermal Hypersensitivity|1
5199224|NCT01103284|17950571|P1|Overall Study|Dermal Hypersensitivity|0
5199225|NCT01103284|17950570|P2|Overall Study|Withdrawal by Subject|18
5199226|NCT01103284|17950571|P1|Overall Study|Withdrawal by Subject|14
5199227|NCT01103284|17950570|P2|Overall Study|Adverse Event|5
5199228|NCT01103284|17950571|P1|Overall Study|Adverse Event|0
5199229|NCT01103284|17950570|P2|Overall Study|Protocol Violation|5
5199230|NCT01103284|17950571|P1|Overall Study|Protocol Violation|12
5199231|NCT01103284|17950570|P2|Overall Study|Pregnancy|1
5199232|NCT01103284|17950571|P1|Overall Study|Pregnancy|3
5199233|NCT01103284|17950570|P2|Overall Study|Lost to Follow-up|10
5199234|NCT01103284|17950571|P1|Overall Study|Lost to Follow-up|9
5199235|NCT01103284|17950570|P2|Overall Study|Death|0
5199236|NCT01103284|17950571|P1|Overall Study|Death|2
5199237|NCT01103245|17950599|P4|Overall Study|Physician Decision|0
5199238|NCT01103245|17950600|P3|Overall Study|Physician Decision|0
5199239|NCT01103245|17950601|P2|Overall Study|Physician Decision|0
5199240|NCT01103245|17950602|P1|Overall Study|Physician Decision|1
5199241|NCT01103245|17950599|P4|Overall Study|Adverse Event|0
5199242|NCT01103245|17950600|P3|Overall Study|Adverse Event|1
5199243|NCT01103245|17950601|P2|Overall Study|Adverse Event|2
5199244|NCT01103245|17950602|P1|Overall Study|Adverse Event|0
5199245|NCT01103245|17950599|P4|Overall Study|Inadequate IV access|0
5199246|NCT01103245|17950600|P3|Overall Study|Inadequate IV access|0
5199247|NCT01103245|17950601|P2|Overall Study|Inadequate IV access|0
5199248|NCT01103245|17950602|P1|Overall Study|Inadequate IV access|1
5199249|NCT01103245|17950599|P4|Overall Study|Withdrawal by Subject|0
5199250|NCT01103245|17950600|P3|Overall Study|Withdrawal by Subject|3
5199251|NCT01103245|17950601|P2|Overall Study|Withdrawal by Subject|0
5199252|NCT01103245|17950602|P1|Overall Study|Withdrawal by Subject|1
5199253|NCT01103232|17950618|P2|Overall Study|Protocol Violation|1
5199254|NCT01103232|17950619|P1|Overall Study|Protocol Violation|0
5199255|NCT01103232|17950618|P2|Overall Study|Withdrawal by Subject|1
5199256|NCT01103232|17950619|P1|Overall Study|Withdrawal by Subject|1
5199257|NCT01103180|17950627|P2|Overall Study|Protocol Violation|1
5199258|NCT01103180|17950628|P1|Overall Study|Protocol Violation|0
5199259|NCT01103180|17950627|P2|Overall Study|Physician Decision|0
5199260|NCT01103180|17950628|P1|Overall Study|Physician Decision|1
5199261|NCT01103180|17950627|P2|Overall Study|Lost to Follow-up|7
5199262|NCT01103180|17950628|P1|Overall Study|Lost to Follow-up|13
5199263|NCT01103180|17950627|P2|Overall Study|Withdrawal by Subject|13
5199264|NCT01103180|17950628|P1|Overall Study|Withdrawal by Subject|8
5199265|NCT01103141|17950638|P2|Overall Study|Lost to Follow-up|1
5199266|NCT01103141|17950639|P1|Overall Study|Lost to Follow-up|2
5199267|NCT01103141|17950638|P2|Overall Study|Death|1
5199268|NCT01103141|17950639|P1|Overall Study|Death|0
5199269|NCT01103063|17950647|P2|Overall Study|Death|1
5199270|NCT01103063|17950648|P1|Overall Study|Death|3
5199271|NCT01103063|17950647|P2|Overall Study|Study terminated by Sponsor|342
5199272|NCT01103063|17950648|P1|Overall Study|Study terminated by Sponsor|326
5199273|NCT01103063|17950647|P2|Overall Study|Protocol Violation|0
5199274|NCT01103063|17950648|P1|Overall Study|Protocol Violation|1
5199275|NCT01103063|17950647|P2|Overall Study|Other|11
5199276|NCT01103063|17950648|P1|Overall Study|Other|16
5199277|NCT01103063|17950647|P2|Overall Study|Withdrawal by Subject|15
5199278|NCT01103063|17950648|P1|Overall Study|Withdrawal by Subject|60
5199279|NCT01103063|17950647|P2|Overall Study|Lost to Follow-up|51
5199280|NCT01103063|17950648|P1|Overall Study|Lost to Follow-up|68
5199281|NCT01103063|17950647|P2|Overall Study|Adverse Event|1
5199282|NCT01103063|17950648|P1|Overall Study|Adverse Event|3
5199283|NCT01102972|17950716|P2|Overall Study|Withdrawal by Subject|6
5199284|NCT01102972|17950717|P1|Overall Study|Withdrawal by Subject|6
5199285|NCT01102972|17950716|P2|Overall Study|Investigator Discretion|0
5199286|NCT01102972|17950717|P1|Overall Study|Investigator Discretion|2
5199287|NCT01102972|17950716|P2|Overall Study|Lost to Follow-up|5
5199288|NCT01102972|17950717|P1|Overall Study|Lost to Follow-up|10
5199289|NCT01102972|17950716|P2|Overall Study|Protocol Violation|0
5199290|NCT01102972|17950717|P1|Overall Study|Protocol Violation|1
5199291|NCT01102972|17950716|P2|Overall Study|Lack of Efficacy|1
5199292|NCT01102972|17950717|P1|Overall Study|Lack of Efficacy|2
5199293|NCT01102972|17950716|P2|Overall Study|Adverse Event|2
5199294|NCT01102972|17950717|P1|Overall Study|Adverse Event|8
5199295|NCT01102803|17950781|P2|Post to Follow-Up|Lost to Follow-up|3
5199296|NCT01102803|17950782|P1|Post to Follow-Up|Lost to Follow-up|1
5199297|NCT01102803|17950781|P2|Baseline to Post-Treatment|Lost to Follow-up|0
5199298|NCT01102803|17950782|P1|Baseline to Post-Treatment|Lost to Follow-up|3
5199299|NCT01102777|17950796|P2|Overall Study|Lost to Follow-up|10
5199300|NCT01102777|17950797|P1|Overall Study|Lost to Follow-up|7
5199301|NCT01102777|17950796|P2|Overall Study|Death|6
5199302|NCT01102777|17950797|P1|Overall Study|Death|2
5199303|NCT01102491|17950856|P2|Overall Study|Protocol Violation|12
5199304|NCT01102491|17950857|P1|Overall Study|Protocol Violation|11
5199305|NCT01102426|17950865|P2|Overall Study|Death (non-related to the study|8
5199306|NCT01102426|17950866|P1|Overall Study|Death (non-related to the study|19
5199307|NCT01102426|17950865|P2|Overall Study|Death (due to adverse events|1
5199308|NCT01102426|17950866|P1|Overall Study|Death (due to adverse events|0
5199309|NCT01102426|17950865|P2|Overall Study|Patient Refusal|12
5199310|NCT01102426|17950866|P1|Overall Study|Patient Refusal|24
5199311|NCT01102426|17950865|P2|Overall Study|Adverse Events (unrelated to|1
5199312|NCT01102426|17950866|P1|Overall Study|Adverse Events (unrelated to|9
5199313|NCT01102426|17950865|P2|Overall Study|Progressive Disease|44
5199314|NCT01102426|17950866|P1|Overall Study|Progressive Disease|85
5199315|NCT01102426|17950865|P2|Overall Study|Physician Decision|6
5199316|NCT01102426|17950866|P1|Overall Study|Physician Decision|9
5199317|NCT01102426|17950865|P2|Overall Study|Adverse Events (treatment-related)|8
5199318|NCT01102426|17950866|P1|Overall Study|Adverse Events (treatment-related)|15
5199319|NCT01102426|17950865|P2|Overall Study|Randomized but not treated|1
5199320|NCT01102426|17950866|P1|Overall Study|Randomized but not treated|4
5199321|NCT01102374|17950917|P2|Overall Study|Lost to Follow-up|6
5199322|NCT01102374|17950918|P1|Overall Study|Lost to Follow-up|7
5199323|NCT01102374|17950917|P2|Overall Study|Death|13
5199324|NCT01102374|17950918|P1|Overall Study|Death|9
5199325|NCT01102257|17950967|P2|Overall Study|Adverse Event|0
5199326|NCT01102257|17950968|P1|Overall Study|Adverse Event|1
5199327|NCT01102257|17950967|P2|Overall Study|Adverse Event|0
5199328|NCT01102257|17950968|P1|Overall Study|Adverse Event|1
5199329|NCT01102140|17950985|P2|Overall Study|Investigator terminated study|2
5199330|NCT01102140|17950986|P1|Overall Study|Investigator terminated study|2
5199331|NCT01102140|17950985|P2|Overall Study|Lost to Follow-up|0
5199332|NCT01102140|17950986|P1|Overall Study|Lost to Follow-up|1
5199333|NCT01101841|17951041|P2|Overall Study|Eligibility Criteria|2
5199334|NCT01101841|17951042|P1|Overall Study|Eligibility Criteria|1
5199335|NCT01101841|17951041|P2|Overall Study|Suicidality Tracking Scale|1
5199336|NCT01101841|17951042|P1|Overall Study|Suicidality Tracking Scale|3
5199337|NCT01101841|17951041|P2|Overall Study|Other|1
5199338|NCT01101841|17951042|P1|Overall Study|Other|0
5199339|NCT01101841|17951041|P2|Overall Study|Lack of Efficacy|2
5199340|NCT01101841|17951042|P1|Overall Study|Lack of Efficacy|0
5199341|NCT01101841|17951041|P2|Overall Study|Physician Decision|2
5199342|NCT01101841|17951042|P1|Overall Study|Physician Decision|0
5199343|NCT01101841|17951041|P2|Overall Study|Protocol Violation|1
5199344|NCT01101841|17951042|P1|Overall Study|Protocol Violation|1
5199345|NCT01101841|17951041|P2|Overall Study|Withdrawal by Subject|40
5199346|NCT01101841|17951042|P1|Overall Study|Withdrawal by Subject|21
5199347|NCT01101841|17951041|P2|Overall Study|Lost to Follow-up|3
5199348|NCT01101841|17951042|P1|Overall Study|Lost to Follow-up|9
5199349|NCT01101841|17951041|P2|Overall Study|Adverse Event|15
5199350|NCT01101841|17951042|P1|Overall Study|Adverse Event|15
5199351|NCT01101542|17951080|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
5199352|NCT01101542|17951080|P1|Year 6 Surveillance Period|Pregnancy|1
5199353|NCT01101542|17951080|P1|Year 6 Surveillance Period|Lost to Follow-up|986
5199354|NCT01101542|17951080|P1|Year 5 Surveillance Period|Pregnancy|1
5199355|NCT01101542|17951080|P1|Year 5 Surveillance Period|Lost to Follow-up|140
5199356|NCT01101542|17951080|P1|Year 4 Surveillance Period|Other|287
5199357|NCT01101542|17951080|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
5199358|NCT01101542|17951080|P1|Year 3 Surveillance Period|Lost to Follow-up|7
5199359|NCT01101477|17951096|P3|Overall Study|Protocol Violation|1
5199360|NCT01101477|17951097|P2|Overall Study|Protocol Violation|3
5199361|NCT01101477|17951098|P1|Overall Study|Protocol Violation|5
5199362|NCT01101334|17951121|P2|Overall Study|Other|1
5199363|NCT01101334|17951122|P1|Overall Study|Other|2
5199364|NCT01101334|17951121|P2|Overall Study|Progressive Disease|35
5199365|NCT01101334|17951122|P1|Overall Study|Progressive Disease|22
5199366|NCT01101334|17951121|P2|Overall Study|Withdrawal by Sponsor|1
5199367|NCT01101334|17951122|P1|Overall Study|Withdrawal by Sponsor|1
5199368|NCT01101334|17951121|P2|Overall Study|Withdrawal by Subject|3
5199369|NCT01101334|17951122|P1|Overall Study|Withdrawal by Subject|4
5199370|NCT01101334|17951121|P2|Overall Study|Death|1
5199371|NCT01101334|17951122|P1|Overall Study|Death|7
5199372|NCT01101334|17951121|P2|Overall Study|Adverse Event|4
5199373|NCT01101334|17951122|P1|Overall Study|Adverse Event|9
5199374|NCT01101321|17951134|P2|Period 1|Adverse Event|3
5199375|NCT01101321|17951135|P1|Period 1|Adverse Event|3
5199376|NCT01101321|17951134|P2|Period 1|Withdrawal by Subject|1
5199377|NCT01101321|17951135|P1|Period 1|Withdrawal by Subject|1
5199378|NCT01101308|17951145|P2|Period 1|Positive for cotinine|0
5199379|NCT01101308|17951146|P1|Period 1|Positive for cotinine|1
5199380|NCT01101308|17951145|P2|Period 1|Adverse Event|1
5199381|NCT01101308|17951146|P1|Period 1|Adverse Event|2
5199382|NCT01101191|17951157|P2|Period 1|Adverse Event|2
5199383|NCT01101191|17951158|P1|Period 1|Adverse Event|1
5199384|NCT01101191|17951157|P2|Period 1|Withdrawal by Subject|0
5199385|NCT01101191|17951158|P1|Period 1|Withdrawal by Subject|1
5199386|NCT01101178|17951169|P2|Period 2|Withdrawal by Subject|1
5199387|NCT01101178|17951170|P1|Period 2|Withdrawal by Subject|0
5199388|NCT01101178|17951169|P2|Period 1|Adverse Event|1
5199389|NCT01101178|17951170|P1|Period 1|Adverse Event|2
5199390|NCT01101178|17951169|P2|Period 1|Positive drug screen|1
5199391|NCT01101178|17951170|P1|Period 1|Positive drug screen|1
5199392|NCT01101178|17951169|P2|Period 1|Withdrawal by Subject|2
5199393|NCT01101178|17951170|P1|Period 1|Withdrawal by Subject|1
5199394|NCT01101165|17951181|P2|Period 2|Adverse Event|0
5199395|NCT01101165|17951182|P1|Period 2|Adverse Event|1
5199396|NCT01101165|17951181|P2|Period 2|Withdrawal by Subject|1
5199397|NCT01101165|17951182|P1|Period 2|Withdrawal by Subject|3
5199398|NCT01101165|17951181|P2|Period 1|Lost to Follow-up|0
5199399|NCT01101165|17951182|P1|Period 1|Lost to Follow-up|1
5199400|NCT01101165|17951181|P2|Period 1|Positive Drug Screen|1
5199401|NCT01101165|17951182|P1|Period 1|Positive Drug Screen|0
5199402|NCT01101165|17951181|P2|Period 1|Withdrawal by Subject|2
5199403|NCT01101165|17951182|P1|Period 1|Withdrawal by Subject|0
5199404|NCT01101165|17951181|P2|Period 1|Adverse Event|2
5199405|NCT01101165|17951182|P1|Period 1|Adverse Event|1
5199406|NCT01101061|17951203|P6|Overall Study|Adverse Event|0
5199407|NCT01101061|17951204|P5|Overall Study|Adverse Event|0
5199408|NCT01101061|17951205|P4|Overall Study|Adverse Event|0
5199409|NCT01101061|17951206|P3|Overall Study|Adverse Event|1
5199410|NCT01101061|17951207|P2|Overall Study|Adverse Event|0
5199411|NCT01101061|17951208|P1|Overall Study|Adverse Event|0
5199412|NCT01101035|17951288|P2|Overall Study|Reason not Specified|363
5199413|NCT01101035|17951289|P1|Overall Study|Reason not Specified|333
5199414|NCT01101035|17951288|P2|Overall Study|Voluntary Withdrawal|587
5199415|NCT01101035|17951289|P1|Overall Study|Voluntary Withdrawal|595
5199416|NCT01101035|17951288|P2|Overall Study|Lost to Follow-up|223
5199417|NCT01101035|17951289|P1|Overall Study|Lost to Follow-up|226
5199418|NCT01101035|17951288|P2|Overall Study|Major Protocol Deviation|46
5199419|NCT01101035|17951289|P1|Overall Study|Major Protocol Deviation|52
5199420|NCT01101035|17951288|P2|Overall Study|Adverse Event|172
5199421|NCT01101035|17951289|P1|Overall Study|Adverse Event|191
5199422|NCT01101022|17951309|P2|Overall Study|Vacation|1
5199423|NCT01101022|17951310|P1|Overall Study|Vacation|0
5199424|NCT01101022|17951309|P2|Overall Study|Work schedule|1
5199425|NCT01101022|17951310|P1|Overall Study|Work schedule|1
5199426|NCT01101022|17951309|P2|Overall Study|Non-compliance|0
5199427|NCT01101022|17951310|P1|Overall Study|Non-compliance|1
5199428|NCT01101022|17951309|P2|Overall Study|Sponsor decision|1
5199429|NCT01101022|17951310|P1|Overall Study|Sponsor decision|1
5199430|NCT01101022|17951309|P2|Overall Study|Lack of Efficacy|7
5199431|NCT01101022|17951310|P1|Overall Study|Lack of Efficacy|0
5199432|NCT01101022|17951309|P2|Overall Study|Lost to Follow-up|4
5199433|NCT01101022|17951310|P1|Overall Study|Lost to Follow-up|1
5199434|NCT01101022|17951309|P2|Overall Study|Withdrawal by Subject|8
5199435|NCT01101022|17951310|P1|Overall Study|Withdrawal by Subject|3
5199436|NCT01101022|17951309|P2|Overall Study|Protocol Violation|3
5199437|NCT01101022|17951310|P1|Overall Study|Protocol Violation|4
5199438|NCT01101022|17951309|P2|Overall Study|Adverse Event|2
5199439|NCT01101022|17951310|P1|Overall Study|Adverse Event|6
5199440|NCT01100944|17951344|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
5199441|NCT01100944|17951345|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
5199442|NCT01100944|17951346|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
5199443|NCT01100944|17951344|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
5199444|NCT01100944|17951345|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
5199445|NCT01100944|17951346|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
5199446|NCT01100944|17951344|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
5199447|NCT01100944|17951345|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
5199448|NCT01100944|17951346|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
5199449|NCT01100944|17951344|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
5199450|NCT01100944|17951345|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
5199451|NCT01100944|17951346|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
5199452|NCT01100853|17951404|P2|Overall Study|Withdrawal by Subject|4
5199453|NCT01100853|17951405|P1|Overall Study|Withdrawal by Subject|6
5199454|NCT01100853|17951404|P2|Overall Study|Received <4 study injections|13
5199455|NCT01100853|17951405|P1|Overall Study|Received <4 study injections|10
5199456|NCT01100853|17951404|P2|Overall Study|Lost to Follow-up|6
5199457|NCT01100853|17951405|P1|Overall Study|Lost to Follow-up|11
5199458|NCT01100658|17951451|P1|Overall Study|Withdrawal by Subject|1
5199459|NCT01100567|17951483|P2|Overall Study|Deemed ineligible after consent|1
5199460|NCT01100567|17951484|P1|Overall Study|Deemed ineligible after consent|0
5199461|NCT01100567|17951483|P2|Overall Study|Physician Decision|1
5199462|NCT01100567|17951484|P1|Overall Study|Physician Decision|0
5199463|NCT01100567|17951483|P2|Overall Study|Lost to Follow-up|2
5199464|NCT01100567|17951484|P1|Overall Study|Lost to Follow-up|1
5199465|NCT01100567|17951483|P2|Overall Study|Early Hospital Discharge|4
5199466|NCT01100567|17951484|P1|Overall Study|Early Hospital Discharge|6
5199467|NCT01100567|17951483|P2|Overall Study|Withdrawal by Subject|8
5199468|NCT01100567|17951484|P1|Overall Study|Withdrawal by Subject|5
5199469|NCT01100528|17951492|P1|Overall Study|Withdrawal by Subject|2
5199470|NCT01100528|17951492|P1|Overall Study|Death|1
5199471|NCT01100502|17951500|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
5199472|NCT01100502|17951501|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
5199473|NCT01100502|17951500|P2|Long-Term Follow-up|Lost to Follow-up|2
5199474|NCT01100502|17951501|P1|Long-Term Follow-up|Lost to Follow-up|5
5199475|NCT01100502|17951500|P2|Long-Term Follow-up|Withdrawal by Subject|8
5199476|NCT01100502|17951501|P1|Long-Term Follow-up|Withdrawal by Subject|10
5199477|NCT01100502|17951500|P2|Treatment Period|Progressive Disease|69
5199478|NCT01100502|17951501|P1|Treatment Period|Progressive Disease|24
5199479|NCT01100502|17951500|P2|Treatment Period|Withdrawal by Subject|4
5199480|NCT01100502|17951501|P1|Treatment Period|Withdrawal by Subject|9
5199481|NCT01100502|17951500|P2|Treatment Period|Adverse Event|10
5199482|NCT01100502|17951501|P1|Treatment Period|Adverse Event|54
5199483|NCT01100437|17951511|P3|Maintenance|Sponsor termination of study|1
5199484|NCT01100437|17951512|P2|Maintenance|Sponsor termination of study|0
5199485|NCT01100437|17951513|P1|Maintenance|Sponsor termination of study|0
5199486|NCT01100437|17951511|P3|Maintenance|Withdrawal by Subject|1
5199487|NCT01100437|17951512|P2|Maintenance|Withdrawal by Subject|0
5199488|NCT01100437|17951513|P1|Maintenance|Withdrawal by Subject|0
5199489|NCT01100437|17951511|P3|Titration/Stabilization|Sponsor canceled study|1
5199490|NCT01100437|17951512|P2|Titration/Stabilization|Sponsor canceled study|0
5199491|NCT01100437|17951513|P1|Titration/Stabilization|Sponsor canceled study|0
5199492|NCT01100437|17951511|P3|Titration/Stabilization|Non-compliance|1
5199493|NCT01100437|17951512|P2|Titration/Stabilization|Non-compliance|0
5199494|NCT01100437|17951513|P1|Titration/Stabilization|Non-compliance|0
5199495|NCT01100437|17951511|P3|Titration/Stabilization|Adverse Event|4
5199496|NCT01100437|17951512|P2|Titration/Stabilization|Adverse Event|0
5199497|NCT01100437|17951513|P1|Titration/Stabilization|Adverse Event|0
5199498|NCT01100320|17951550|P2|Period 2|Withdrawal by Subject|1
5199499|NCT01100320|17951551|P1|Period 2|Withdrawal by Subject|1
5199500|NCT01100320|17951550|P2|Period 1|Adverse Event|2
5199501|NCT01100320|17951551|P1|Period 1|Adverse Event|2
5199502|NCT01100320|17951550|P2|Period 1|Positive Drug Screen|1
5199503|NCT01100320|17951551|P1|Period 1|Positive Drug Screen|1
5199504|NCT01100320|17951550|P2|Period 1|Withdrawal by Subject|4
5199505|NCT01100320|17951551|P1|Period 1|Withdrawal by Subject|2
5199506|NCT01100307|17951563|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
5199507|NCT01100307|17951564|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
5199508|NCT01100307|17951563|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
5199509|NCT01100307|17951564|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
5199510|NCT01100307|17951563|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
5199511|NCT01100307|17951564|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
5199512|NCT01100307|17951563|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
5199513|NCT01100307|17951564|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
5199514|NCT01100307|17951563|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
5199515|NCT01100307|17951564|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
5199516|NCT01100307|17951563|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
5199517|NCT01100307|17951564|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
5199518|NCT01100086|17951633|P2|Period 1|Withdrawal by Subject|0
5199519|NCT01100086|17951634|P1|Period 1|Withdrawal by Subject|1
5199520|NCT01100073|17951644|P1|Overall Study|Missing|5
5199521|NCT01100073|17951644|P1|Overall Study|Other|8
5199522|NCT01100073|17951644|P1|Overall Study|Insufficient tolerability +patients wish|8
5199523|NCT01100073|17951644|P1|Overall Study|Lack of effect + patient's wish|2
5199524|NCT01100073|17951644|P1|Overall Study|Lost to Follow-up|39
5199525|NCT01100073|17951644|P1|Overall Study|Withdrawal by Subject|13
5199526|NCT01100073|17951644|P1|Overall Study|Insufficient Tolerability|21
5199527|NCT01100073|17951644|P1|Overall Study|Lack of Efficacy|4
5199528|NCT01100034|17951659|P1|Overall Study|Site closed due to non-responsiveness|1
5199529|NCT01100034|17951659|P1|Overall Study|Participants moved to another hospital|4
5199530|NCT01100034|17951659|P1|Overall Study|Participated in another clinical trial|1
5199531|NCT01100034|17951659|P1|Overall Study|Sponsor decision|21
5199532|NCT01100034|17951659|P1|Overall Study|Withdrawal by Subject|4
5199533|NCT01100034|17951659|P1|Overall Study|Withdrawal of parent/guardian consent|1
5199534|NCT01100034|17951659|P1|Overall Study|Lost to Follow-up|11
5199535|NCT01099917|17951697|P1|Overall Study|Not Treated|24
5199536|NCT01099917|17951697|P1|Overall Study|Adverse Event|3
5199537|NCT01099709|17951759|P2|Period 1|Adverse Event|0
5199538|NCT01099709|17951760|P1|Period 1|Adverse Event|1
5199539|NCT01099709|17951759|P2|Period 1|Positive cotinine test|1
5199540|NCT01099709|17951760|P1|Period 1|Positive cotinine test|0
5199541|NCT01099709|17951759|P2|Period 1|Withdrawal by Subject|1
5199542|NCT01099709|17951760|P1|Period 1|Withdrawal by Subject|0
5199543|NCT01099579|17951829|P3|Stage 2 (ATV Capsule)|Adverse Event|0
5199544|NCT01099579|17951830|P2|Stage 2 (ATV Capsule)|Adverse Event|1
5199545|NCT01099579|17951831|P1|Stage 2 (ATV Capsule)|Adverse Event|0
5199546|NCT01099579|17951829|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
5199547|NCT01099579|17951830|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
5199548|NCT01099579|17951831|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
5199549|NCT01099579|17951829|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5199550|NCT01099579|17951830|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5199551|NCT01099579|17951831|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5199552|NCT01099579|17951829|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
5199553|NCT01099579|17951830|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
5199554|NCT01099579|17951831|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
5199555|NCT01099579|17951829|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5199556|NCT01099579|17951830|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5199557|NCT01099579|17951831|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5199558|NCT01099579|17951829|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
5199559|NCT01099579|17951830|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
5199560|NCT01099579|17951831|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
5199561|NCT01099579|17951829|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
5199562|NCT01099579|17951830|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
5199563|NCT01099579|17951831|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
5199564|NCT01099579|17951829|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
5199565|NCT01099579|17951830|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
5199566|NCT01099579|17951831|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
5199567|NCT01099579|17951829|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
5199568|NCT01099579|17951830|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
5199569|NCT01099579|17951831|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
5199570|NCT01099579|17951829|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
5199571|NCT01099579|17951830|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
5199572|NCT01099579|17951831|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
5199573|NCT01099397|17951940|P1|Overall Study|Withdrawal by Subject|5
5199574|NCT01099397|17951940|P1|Overall Study|Protocol Violation|4
5199575|NCT01099397|17951940|P1|Overall Study|Lost to Follow-up|4
5199576|NCT01099267|17951967|P1|MDS-003 Study|Secondary Malign Disease|1
5199577|NCT01099267|17951967|P1|MDS-003 Study|Loss of Response|1
5199578|NCT01099267|17951967|P1|MDS-003 Study|Non-Compliance|2
5199579|NCT01099267|17951967|P1|MDS-003 Study|Investigator Decision|2
5199580|NCT01099267|17951967|P1|MDS-003 Study|Disease Progression|7
5199581|NCT01099267|17951967|P1|MDS-003 Study|Study Closed by Sponsor|2
5199582|NCT01099267|17951967|P1|MDS-003 Study|Death|11
5199583|NCT01099267|17951967|P1|MDS-003 Study|Lost to Follow-up|1
5199584|NCT01099267|17951967|P1|MDS-003 Study|Withdrawal by Subject|8
5199585|NCT01099267|17951967|P1|MDS-003 Study|Lack of Efficacy|52
5199586|NCT01099267|17951967|P1|MDS-003 Study|Adverse Event|37
5199587|NCT01099215|17951977|P2|Overall Study|Adverse Event|1
5199588|NCT01099215|17951978|P1|Overall Study|Adverse Event|0
5199589|NCT01099215|17951977|P2|Overall Study|Withdrawal by Subject|0
5199590|NCT01099215|17951978|P1|Overall Study|Withdrawal by Subject|1
5199591|NCT01098851|17952048|P2|Overall Study|Equipment failure|0
5199592|NCT01098851|17952049|P1|Overall Study|Equipment failure|1
5199593|NCT01098812|17952060|P3|Overall Study|Lost to Follow-up|0
5199594|NCT01098812|17952061|P2|Overall Study|Lost to Follow-up|1
5199595|NCT01098812|17952062|P1|Overall Study|Lost to Follow-up|0
5199596|NCT01098812|17952060|P3|Overall Study|Death|1
5199597|NCT01098812|17952061|P2|Overall Study|Death|0
5199598|NCT01098812|17952062|P1|Overall Study|Death|2
5199599|NCT01098539|17952138|P2|Overall Study|Physician Decision|3
5199600|NCT01098539|17952139|P1|Overall Study|Physician Decision|5
5199601|NCT01098539|17952138|P2|Overall Study|Withdrawal by Subject|26
5199602|NCT01098539|17952139|P1|Overall Study|Withdrawal by Subject|12
5199603|NCT01098539|17952138|P2|Overall Study|Lost to Follow-up|4
5199604|NCT01098539|17952139|P1|Overall Study|Lost to Follow-up|4
5199605|NCT01098539|17952138|P2|Overall Study|Noncompliance|5
5199606|NCT01098539|17952139|P1|Overall Study|Noncompliance|3
5199607|NCT01098539|17952138|P2|Overall Study|Protocol Violation|4
5199608|NCT01098539|17952139|P1|Overall Study|Protocol Violation|1
5199609|NCT01098539|17952138|P2|Overall Study|Adverse Event|26
5199610|NCT01098539|17952139|P1|Overall Study|Adverse Event|26
5199611|NCT01098487|17952190|P1|Overall Study|Physician Decision|1
5199612|NCT01098487|17952190|P1|Overall Study|Lost to Follow-up|3
5199613|NCT01098487|17952190|P1|Overall Study|Withdrawal by Subject|7
5199614|NCT01098487|17952190|P1|Overall Study|Lack of Efficacy|11
5199615|NCT01098487|17952190|P1|Overall Study|Adverse Event|22
5199616|NCT01098474|17952208|P6|Follow Up Phase|Lost to Follow-up|0
5199617|NCT01098474|17952209|P5|Follow Up Phase|Lost to Follow-up|1
5199618|NCT01098474|17952210|P4|Follow Up Phase|Lost to Follow-up|0
5199619|NCT01098474|17952211|P3|Follow Up Phase|Lost to Follow-up|0
5199620|NCT01098474|17952212|P2|Follow Up Phase|Lost to Follow-up|0
5199621|NCT01098474|17952213|P1|Follow Up Phase|Lost to Follow-up|0
5199622|NCT01098474|17952208|P6|Follow Up Phase|Withdrawal by Subject|1
5199623|NCT01098474|17952209|P5|Follow Up Phase|Withdrawal by Subject|0
5199624|NCT01098474|17952210|P4|Follow Up Phase|Withdrawal by Subject|2
5199625|NCT01098474|17952211|P3|Follow Up Phase|Withdrawal by Subject|0
5199626|NCT01098474|17952212|P2|Follow Up Phase|Withdrawal by Subject|0
5199627|NCT01098474|17952213|P1|Follow Up Phase|Withdrawal by Subject|0
5199628|NCT01098474|17952208|P6|Follow Up Phase|Other|4
5199629|NCT01098474|17952209|P5|Follow Up Phase|Other|0
5199630|NCT01098474|17952210|P4|Follow Up Phase|Other|0
5199631|NCT01098474|17952211|P3|Follow Up Phase|Other|0
5199632|NCT01098474|17952212|P2|Follow Up Phase|Other|0
5199633|NCT01098474|17952213|P1|Follow Up Phase|Other|0
5199634|NCT01098474|17952208|P6|Follow Up Phase|Travelled out of study area|0
5199635|NCT01098474|17952209|P5|Follow Up Phase|Travelled out of study area|1
5199636|NCT01098474|17952210|P4|Follow Up Phase|Travelled out of study area|0
5199637|NCT01098474|17952211|P3|Follow Up Phase|Travelled out of study area|0
5199638|NCT01098474|17952212|P2|Follow Up Phase|Travelled out of study area|0
5199639|NCT01098474|17952213|P1|Follow Up Phase|Travelled out of study area|0
5199640|NCT01098474|17952208|P6|Active Phase|Lost to Follow-up|0
5199641|NCT01098474|17952209|P5|Active Phase|Lost to Follow-up|0
5199642|NCT01098474|17952210|P4|Active Phase|Lost to Follow-up|0
5199643|NCT01098474|17952211|P3|Active Phase|Lost to Follow-up|0
5199644|NCT01098474|17952212|P2|Active Phase|Lost to Follow-up|0
5199645|NCT01098474|17952213|P1|Active Phase|Lost to Follow-up|1
5199646|NCT01098474|17952208|P6|Active Phase|Withdrawal by Subject|0
5199647|NCT01098474|17952209|P5|Active Phase|Withdrawal by Subject|0
5199648|NCT01098474|17952210|P4|Active Phase|Withdrawal by Subject|0
5199649|NCT01098474|17952211|P3|Active Phase|Withdrawal by Subject|2
5199650|NCT01098474|17952212|P2|Active Phase|Withdrawal by Subject|1
5199651|NCT01098474|17952213|P1|Active Phase|Withdrawal by Subject|1
5199652|NCT01098474|17952208|P6|Active Phase|Other|0
5199653|NCT01098474|17952209|P5|Active Phase|Other|0
5199654|NCT01098474|17952210|P4|Active Phase|Other|0
5199655|NCT01098474|17952211|P3|Active Phase|Other|3
5199656|NCT01098474|17952212|P2|Active Phase|Other|0
5199657|NCT01098474|17952213|P1|Active Phase|Other|0
5199658|NCT01098461|17952447|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
5199659|NCT01098461|17952448|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
5199660|NCT01098461|17952449|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
5199661|NCT01098461|17952450|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
5199662|NCT01098461|17952447|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5199663|NCT01098461|17952448|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5199664|NCT01098461|17952449|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
5199665|NCT01098461|17952450|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5199666|NCT01098461|17952447|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5199667|NCT01098461|17952448|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5199668|NCT01098461|17952449|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
5199669|NCT01098461|17952450|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5199670|NCT01098461|17952447|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5199671|NCT01098461|17952448|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5199672|NCT01098461|17952449|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
5199673|NCT01098461|17952450|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5199674|NCT01098461|17952447|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
5199675|NCT01098461|17952448|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
5199676|NCT01098461|17952449|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
5199677|NCT01098461|17952450|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
5199678|NCT01098461|17952447|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
5199679|NCT01098461|17952448|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
5199680|NCT01098461|17952449|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
5199681|NCT01098461|17952450|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
5199682|NCT01098461|17952447|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
5199683|NCT01098461|17952448|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
5199684|NCT01098461|17952449|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
5199685|NCT01098461|17952450|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
5199686|NCT01098305|17952510|P2|Overall Study|Lost to Follow-up|33
5199687|NCT01098305|17952511|P1|Overall Study|Lost to Follow-up|31
5199688|NCT01098266|17952521|P2|Overall Study|Withdrawal by Subject|5
5199689|NCT01098266|17952522|P1|Overall Study|Withdrawal by Subject|3
5199690|NCT01098266|17952521|P2|Overall Study|Death|2
5199691|NCT01098266|17952522|P1|Overall Study|Death|3
5199692|NCT01098266|17952521|P2|Overall Study|Physician Decision|0
5199693|NCT01098266|17952522|P1|Overall Study|Physician Decision|1
5199694|NCT01098240|17952551|P3|Double-Blind Phase|Adverse Event|3
5199695|NCT01098240|17952552|P2|Double-Blind Phase|Adverse Event|3
5199696|NCT01098240|17952553|P1|Double-Blind Phase|Adverse Event|0
5199697|NCT01098240|17952551|P3|Double-Blind Phase|Withdrawal by Subject|3
5199698|NCT01098240|17952552|P2|Double-Blind Phase|Withdrawal by Subject|1
5199699|NCT01098240|17952553|P1|Double-Blind Phase|Withdrawal by Subject|0
5199700|NCT01098240|17952551|P3|Double-Blind Phase|Insufficient Clinical Response|2
5199701|NCT01098240|17952552|P2|Double-Blind Phase|Insufficient Clinical Response|1
5199702|NCT01098240|17952553|P1|Double-Blind Phase|Insufficient Clinical Response|0
5199703|NCT01098240|17952551|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
5199704|NCT01098240|17952552|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
5199705|NCT01098240|17952553|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
5199706|NCT01098240|17952551|P3|Double-Blind Phase|Other|2
5199707|NCT01098240|17952552|P2|Double-Blind Phase|Other|2
5199708|NCT01098240|17952553|P1|Double-Blind Phase|Other|0
5199709|NCT01098240|17952551|P3|Double-Blind Phase|Lost to Follow-up|0
5199710|NCT01098240|17952552|P2|Double-Blind Phase|Lost to Follow-up|2
5199711|NCT01098240|17952553|P1|Double-Blind Phase|Lost to Follow-up|0
5199712|NCT01098240|17952551|P3|Double-Blind Phase|Protocol Violation|4
5199713|NCT01098240|17952552|P2|Double-Blind Phase|Protocol Violation|2
5199714|NCT01098240|17952553|P1|Double-Blind Phase|Protocol Violation|0
5199715|NCT01098240|17952551|P3|Double-Blind Phase|Study Terminated by Sponsor|8
5199716|NCT01098240|17952552|P2|Double-Blind Phase|Study Terminated by Sponsor|5
5199717|NCT01098240|17952553|P1|Double-Blind Phase|Study Terminated by Sponsor|0
5199718|NCT01098240|17952551|P3|Open-Label Phase|Adverse Event|0
5199719|NCT01098240|17952552|P2|Open-Label Phase|Adverse Event|0
5199720|NCT01098240|17952553|P1|Open-Label Phase|Adverse Event|12
5199721|NCT01098240|17952551|P3|Open-Label Phase|Withdrawal by Subject|0
5199722|NCT01098240|17952552|P2|Open-Label Phase|Withdrawal by Subject|0
5199723|NCT01098240|17952553|P1|Open-Label Phase|Withdrawal by Subject|9
5199724|NCT01098240|17952551|P3|Open-Label Phase|Pregnancy|0
5199725|NCT01098240|17952552|P2|Open-Label Phase|Pregnancy|0
5199726|NCT01098240|17952553|P1|Open-Label Phase|Pregnancy|1
5199727|NCT01098240|17952551|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
5199728|NCT01098240|17952552|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
5199729|NCT01098240|17952553|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
5199730|NCT01098240|17952551|P3|Open-Label Phase|Other|0
5199731|NCT01098240|17952552|P2|Open-Label Phase|Other|0
5199732|NCT01098240|17952553|P1|Open-Label Phase|Other|19
5199733|NCT01098240|17952551|P3|Open-Label Phase|Lost to Follow-up|0
5199734|NCT01098240|17952552|P2|Open-Label Phase|Lost to Follow-up|0
5199735|NCT01098240|17952553|P1|Open-Label Phase|Lost to Follow-up|13
5199736|NCT01098240|17952551|P3|Open-Label Phase|Protocol Violation|0
5199737|NCT01098240|17952552|P2|Open-Label Phase|Protocol Violation|0
5199738|NCT01098240|17952553|P1|Open-Label Phase|Protocol Violation|4
5199739|NCT01098240|17952551|P3|Open-Label Phase|Study Terminated by Sponsor|0
5199740|NCT01098240|17952552|P2|Open-Label Phase|Study Terminated by Sponsor|0
5199741|NCT01098240|17952553|P1|Open-Label Phase|Study Terminated by Sponsor|27
5199742|NCT01098162|17952583|P1|Overall Study|Reason Unknown|26
5199743|NCT01098162|17952583|P1|Overall Study|Other Reason|1
5199744|NCT01098162|17952583|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
5199745|NCT01098162|17952583|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
5199746|NCT01098162|17952583|P1|Overall Study|Adverse Event & Lost to Follow-up|2
5199747|NCT01098162|17952583|P1|Overall Study|Adverse Event & Wish of Patient|13
5199748|NCT01098162|17952583|P1|Overall Study|Adverse Event & Lack of Efficacy|6
5199749|NCT01098162|17952583|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
5199750|NCT01098162|17952583|P1|Overall Study|Lost to Follow-up|9
5199751|NCT01098162|17952583|P1|Overall Study|Wish of Patient|7
5199752|NCT01098162|17952583|P1|Overall Study|Lack of Efficacy|4
5199753|NCT01098162|17952583|P1|Overall Study|Adverse Event|37
5199754|NCT01098110|17952595|P3|Overall Study|Untreated|0
5199755|NCT01098110|17952596|P2|Overall Study|Untreated|1
5199756|NCT01098110|17952597|P1|Overall Study|Untreated|1
5199757|NCT01098110|17952595|P3|Overall Study|Other|5
5199758|NCT01098110|17952596|P2|Overall Study|Other|7
5199759|NCT01098110|17952597|P1|Overall Study|Other|4
5199760|NCT01098110|17952595|P3|Overall Study|Lack of Efficacy|27
5199761|NCT01098110|17952596|P2|Overall Study|Lack of Efficacy|9
5199762|NCT01098110|17952597|P1|Overall Study|Lack of Efficacy|13
5199763|NCT01098110|17952595|P3|Overall Study|Adverse Event|43
5199764|NCT01098110|17952596|P2|Overall Study|Adverse Event|32
5199765|NCT01098110|17952597|P1|Overall Study|Adverse Event|30
5199766|NCT01098110|17952595|P3|Overall Study|Withdrawal by Subject|19
5199767|NCT01098110|17952596|P2|Overall Study|Withdrawal by Subject|24
5199768|NCT01098110|17952597|P1|Overall Study|Withdrawal by Subject|14
5199769|NCT01098097|17952638|P1|Overall Study|No reason reported|31
5199770|NCT01098097|17952638|P1|Overall Study|Status unknown|16
5199771|NCT01098097|17952638|P1|Overall Study|Lost to Follow-up|18
5199772|NCT01098097|17952638|P1|Overall Study|Adverse Event|17
5199773|NCT01098071|17952647|P1|Overall Study|Lost to Follow-up|13
5199774|NCT01098071|17952647|P1|Overall Study|Surgery (adenoidectomy)|2
5199775|NCT01098032|17952660|P2|Overall Study|Withdrawal by Subject|1
5199776|NCT01098032|17952661|P1|Overall Study|Withdrawal by Subject|1
5199777|NCT01097863|17952778|P3|Overall Study|Did not return for final visit|1
5199778|NCT01097863|17952779|P2|Overall Study|Did not return for final visit|0
5199779|NCT01097863|17952780|P1|Overall Study|Did not return for final visit|0
5199780|NCT01097863|17952778|P3|Overall Study|Discomfort|1
5199781|NCT01097863|17952779|P2|Overall Study|Discomfort|0
5199782|NCT01097863|17952780|P1|Overall Study|Discomfort|1
5199783|NCT01097707|17952804|P5|Overall Study|Reason unknown|1
5199784|NCT01097707|17952805|P4|Overall Study|Reason unknown|0
5199785|NCT01097707|17952806|P3|Overall Study|Reason unknown|0
5199786|NCT01097707|17952807|P2|Overall Study|Reason unknown|0
5199787|NCT01097707|17952808|P1|Overall Study|Reason unknown|0
5199788|NCT01097707|17952804|P5|Overall Study|Withdrawal by Subject|3
5199789|NCT01097707|17952805|P4|Overall Study|Withdrawal by Subject|4
5199790|NCT01097707|17952806|P3|Overall Study|Withdrawal by Subject|1
5199791|NCT01097707|17952807|P2|Overall Study|Withdrawal by Subject|6
5199792|NCT01097707|17952808|P1|Overall Study|Withdrawal by Subject|3
5199793|NCT01097707|17952804|P5|Overall Study|Sponsor Decision|36
5199794|NCT01097707|17952805|P4|Overall Study|Sponsor Decision|35
5199795|NCT01097707|17952806|P3|Overall Study|Sponsor Decision|34
5199796|NCT01097707|17952807|P2|Overall Study|Sponsor Decision|31
5199797|NCT01097707|17952808|P1|Overall Study|Sponsor Decision|31
5199798|NCT01097707|17952804|P5|Overall Study|Protocol Violation|2
5199799|NCT01097707|17952805|P4|Overall Study|Protocol Violation|2
5199800|NCT01097707|17952806|P3|Overall Study|Protocol Violation|3
5199801|NCT01097707|17952807|P2|Overall Study|Protocol Violation|2
5199802|NCT01097707|17952808|P1|Overall Study|Protocol Violation|2
5199803|NCT01097707|17952804|P5|Overall Study|Lost to Follow-up|3
5199804|NCT01097707|17952805|P4|Overall Study|Lost to Follow-up|0
5199805|NCT01097707|17952806|P3|Overall Study|Lost to Follow-up|2
5199806|NCT01097707|17952807|P2|Overall Study|Lost to Follow-up|1
5199807|NCT01097707|17952808|P1|Overall Study|Lost to Follow-up|1
5199808|NCT01097707|17952804|P5|Overall Study|Lack of Efficacy|0
5199809|NCT01097707|17952805|P4|Overall Study|Lack of Efficacy|1
5199810|NCT01097707|17952806|P3|Overall Study|Lack of Efficacy|0
5199811|NCT01097707|17952807|P2|Overall Study|Lack of Efficacy|0
5199812|NCT01097707|17952808|P1|Overall Study|Lack of Efficacy|1
5199813|NCT01097707|17952804|P5|Overall Study|Entry Criteria Not Met|1
5199814|NCT01097707|17952805|P4|Overall Study|Entry Criteria Not Met|0
5199815|NCT01097707|17952806|P3|Overall Study|Entry Criteria Not Met|1
5199816|NCT01097707|17952807|P2|Overall Study|Entry Criteria Not Met|1
5199817|NCT01097707|17952808|P1|Overall Study|Entry Criteria Not Met|2
5199818|NCT01097707|17952804|P5|Overall Study|Adverse Event|3
5199819|NCT01097707|17952805|P4|Overall Study|Adverse Event|1
5199820|NCT01097707|17952806|P3|Overall Study|Adverse Event|3
5199821|NCT01097707|17952807|P2|Overall Study|Adverse Event|2
5199822|NCT01097707|17952808|P1|Overall Study|Adverse Event|4
5199823|NCT01097707|17952804|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5199824|NCT01097707|17952805|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5199825|NCT01097707|17952806|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5199826|NCT01097707|17952807|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5199827|NCT01097707|17952808|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5199828|NCT01097694|17952857|P2|Overall Study|Withdrawal by Subject|1
5199829|NCT01097694|17952858|P1|Overall Study|Withdrawal by Subject|3
5199830|NCT01097694|17952857|P2|Overall Study|Lost to Follow-up|3
5199831|NCT01097694|17952858|P1|Overall Study|Lost to Follow-up|0
5199832|NCT01097694|17952857|P2|Overall Study|Adverse Event|0
5199833|NCT01097694|17952858|P1|Overall Study|Adverse Event|5
5199834|NCT01097668|17952920|P2|Overall Study|Lost to Follow-up|0
5199835|NCT01097668|17952921|P1|Overall Study|Lost to Follow-up|1
5199836|NCT01097668|17952920|P2|Overall Study|Withdrawal by Subject|2
5199837|NCT01097668|17952921|P1|Overall Study|Withdrawal by Subject|1
5199838|NCT01097655|17952931|P1|Overall Study|Did Not Meet Inclusion Criteria|8
5199839|NCT01097655|17952931|P1|Overall Study|Subject Documented Twice|1
5199840|NCT01097655|17952931|P1|Overall Study|Withdrawal by Subject|1
5199841|NCT01097629|17952941|P8|DB RO Phase|Lost to Follow-up|0
5199842|NCT01097629|17952942|P7|DB RO Phase|Lost to Follow-up|2
5199843|NCT01097629|17952943|P6|DB RO Phase|Lost to Follow-up|0
5199844|NCT01097629|17952944|P5|DB RO Phase|Lost to Follow-up|0
5199845|NCT01097629|17952945|P4|DB RO Phase|Lost to Follow-up|0
5199846|NCT01097629|17952946|P3|DB RO Phase|Lost to Follow-up|0
5199847|NCT01097629|17952947|P2|DB RO Phase|Lost to Follow-up|0
5199848|NCT01097629|17952948|P1|DB RO Phase|Lost to Follow-up|0
5199849|NCT01097629|17952941|P8|DB RO Phase|Protocol Violation|0
5199850|NCT01097629|17952942|P7|DB RO Phase|Protocol Violation|1
5199851|NCT01097629|17952943|P6|DB RO Phase|Protocol Violation|1
5199852|NCT01097629|17952944|P5|DB RO Phase|Protocol Violation|0
5199853|NCT01097629|17952945|P4|DB RO Phase|Protocol Violation|1
5199854|NCT01097629|17952946|P3|DB RO Phase|Protocol Violation|0
5199855|NCT01097629|17952947|P2|DB RO Phase|Protocol Violation|0
5199856|NCT01097629|17952948|P1|DB RO Phase|Protocol Violation|0
5199857|NCT01097629|17952941|P8|DB RO Phase|Withdrawal by Subject|1
5199858|NCT01097629|17952942|P7|DB RO Phase|Withdrawal by Subject|0
5199859|NCT01097629|17952943|P6|DB RO Phase|Withdrawal by Subject|0
5199860|NCT01097629|17952944|P5|DB RO Phase|Withdrawal by Subject|0
5199861|NCT01097629|17952945|P4|DB RO Phase|Withdrawal by Subject|0
5199862|NCT01097629|17952946|P3|DB RO Phase|Withdrawal by Subject|0
5199863|NCT01097629|17952947|P2|DB RO Phase|Withdrawal by Subject|0
5199864|NCT01097629|17952948|P1|DB RO Phase|Withdrawal by Subject|0
5199865|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5199866|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5199867|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5199868|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5199869|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5199870|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
5199871|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
5199872|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
5199873|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5199874|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5199875|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5199876|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5199877|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5199878|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5199879|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
5199880|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
5199881|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5199882|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5199883|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5199884|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5199885|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5199886|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
5199887|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
5199888|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
5199889|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5199890|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5199891|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5199892|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5199893|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5199894|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5199895|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
5199896|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
5199897|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5199898|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5199899|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5199900|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5199982|NCT01097616|17953004|P3|Optional DB EXT Phase|Protocol Violation|3
5199901|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5199902|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
5199903|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
5199904|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
5199905|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5199906|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5199907|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5199908|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5199909|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5199910|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
5199911|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
5199912|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
5199913|NCT01097629|17952941|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5199914|NCT01097629|17952942|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5199915|NCT01097629|17952943|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5199916|NCT01097629|17952944|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5199917|NCT01097629|17952945|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5199918|NCT01097629|17952946|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
5199919|NCT01097629|17952947|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
5199920|NCT01097629|17952948|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
5199921|NCT01097616|17952999|P8|DB RO Phase|Not Treated in RO|0
5199922|NCT01097616|17953000|P7|DB RO Phase|Not Treated in RO|0
5199923|NCT01097616|17953001|P6|DB RO Phase|Not Treated in RO|1
5199924|NCT01097616|17953002|P5|DB RO Phase|Not Treated in RO|0
5199925|NCT01097616|17953003|P4|DB RO Phase|Not Treated in RO|0
5199926|NCT01097616|17953004|P3|DB RO Phase|Not Treated in RO|0
5199927|NCT01097616|17953005|P2|DB RO Phase|Not Treated in RO|0
5199928|NCT01097616|17953006|P1|DB RO Phase|Not Treated in RO|0
5199929|NCT01097616|17952999|P8|DB RO Phase|Lost to Follow-up|1
5199930|NCT01097616|17953000|P7|DB RO Phase|Lost to Follow-up|0
5199931|NCT01097616|17953001|P6|DB RO Phase|Lost to Follow-up|0
5199932|NCT01097616|17953002|P5|DB RO Phase|Lost to Follow-up|1
5199933|NCT01097616|17953003|P4|DB RO Phase|Lost to Follow-up|1
5199934|NCT01097616|17953004|P3|DB RO Phase|Lost to Follow-up|0
5199935|NCT01097616|17953005|P2|DB RO Phase|Lost to Follow-up|0
5199936|NCT01097616|17953006|P1|DB RO Phase|Lost to Follow-up|0
5199937|NCT01097616|17952999|P8|DB RO Phase|Withdrawal by Subject|0
5199938|NCT01097616|17953000|P7|DB RO Phase|Withdrawal by Subject|0
5199939|NCT01097616|17953001|P6|DB RO Phase|Withdrawal by Subject|1
5199940|NCT01097616|17953002|P5|DB RO Phase|Withdrawal by Subject|0
5199941|NCT01097616|17953003|P4|DB RO Phase|Withdrawal by Subject|0
5199942|NCT01097616|17953004|P3|DB RO Phase|Withdrawal by Subject|0
5199943|NCT01097616|17953005|P2|DB RO Phase|Withdrawal by Subject|0
5199944|NCT01097616|17953006|P1|DB RO Phase|Withdrawal by Subject|0
5199945|NCT01097616|17952999|P8|DB RO Phase|Adverse Event|0
5199946|NCT01097616|17953000|P7|DB RO Phase|Adverse Event|1
5199947|NCT01097616|17953001|P6|DB RO Phase|Adverse Event|0
5199948|NCT01097616|17953002|P5|DB RO Phase|Adverse Event|0
5199949|NCT01097616|17953003|P4|DB RO Phase|Adverse Event|0
5199950|NCT01097616|17953004|P3|DB RO Phase|Adverse Event|0
5199951|NCT01097616|17953005|P2|DB RO Phase|Adverse Event|0
5199952|NCT01097616|17953006|P1|DB RO Phase|Adverse Event|0
5199953|NCT01097616|17952999|P8|Optional DB EXT Phase|Physician Decision|0
5199954|NCT01097616|17953000|P7|Optional DB EXT Phase|Physician Decision|0
5199955|NCT01097616|17953001|P6|Optional DB EXT Phase|Physician Decision|0
5199956|NCT01097616|17953002|P5|Optional DB EXT Phase|Physician Decision|0
5199957|NCT01097616|17953003|P4|Optional DB EXT Phase|Physician Decision|0
5199958|NCT01097616|17953004|P3|Optional DB EXT Phase|Physician Decision|0
5199959|NCT01097616|17953005|P2|Optional DB EXT Phase|Physician Decision|0
5199960|NCT01097616|17953006|P1|Optional DB EXT Phase|Physician Decision|1
5199961|NCT01097616|17952999|P8|Optional DB EXT Phase|Lack of Efficacy|0
5199962|NCT01097616|17953000|P7|Optional DB EXT Phase|Lack of Efficacy|0
5199963|NCT01097616|17953001|P6|Optional DB EXT Phase|Lack of Efficacy|0
5199964|NCT01097616|17953002|P5|Optional DB EXT Phase|Lack of Efficacy|0
5199965|NCT01097616|17953003|P4|Optional DB EXT Phase|Lack of Efficacy|0
5199966|NCT01097616|17953004|P3|Optional DB EXT Phase|Lack of Efficacy|1
5199967|NCT01097616|17953005|P2|Optional DB EXT Phase|Lack of Efficacy|1
5199968|NCT01097616|17953006|P1|Optional DB EXT Phase|Lack of Efficacy|1
5199969|NCT01097616|17952999|P8|Optional DB EXT Phase|Lost to Follow-up|0
5199970|NCT01097616|17953000|P7|Optional DB EXT Phase|Lost to Follow-up|0
5199971|NCT01097616|17953001|P6|Optional DB EXT Phase|Lost to Follow-up|0
5199972|NCT01097616|17953002|P5|Optional DB EXT Phase|Lost to Follow-up|0
5199973|NCT01097616|17953003|P4|Optional DB EXT Phase|Lost to Follow-up|0
5199974|NCT01097616|17953004|P3|Optional DB EXT Phase|Lost to Follow-up|1
5199975|NCT01097616|17953005|P2|Optional DB EXT Phase|Lost to Follow-up|5
5199976|NCT01097616|17953006|P1|Optional DB EXT Phase|Lost to Follow-up|1
5199977|NCT01097616|17952999|P8|Optional DB EXT Phase|Protocol Violation|0
5199978|NCT01097616|17953000|P7|Optional DB EXT Phase|Protocol Violation|0
5199979|NCT01097616|17953001|P6|Optional DB EXT Phase|Protocol Violation|0
5199980|NCT01097616|17953002|P5|Optional DB EXT Phase|Protocol Violation|0
5199981|NCT01097616|17953003|P4|Optional DB EXT Phase|Protocol Violation|0
5199983|NCT01097616|17953005|P2|Optional DB EXT Phase|Protocol Violation|2
5199984|NCT01097616|17953006|P1|Optional DB EXT Phase|Protocol Violation|0
5199985|NCT01097616|17952999|P8|Optional DB EXT Phase|Withdrawal by Subject|0
5199986|NCT01097616|17953000|P7|Optional DB EXT Phase|Withdrawal by Subject|0
5199987|NCT01097616|17953001|P6|Optional DB EXT Phase|Withdrawal by Subject|0
5199988|NCT01097616|17953002|P5|Optional DB EXT Phase|Withdrawal by Subject|0
5199989|NCT01097616|17953003|P4|Optional DB EXT Phase|Withdrawal by Subject|0
5199990|NCT01097616|17953004|P3|Optional DB EXT Phase|Withdrawal by Subject|3
5199991|NCT01097616|17953005|P2|Optional DB EXT Phase|Withdrawal by Subject|6
5199992|NCT01097616|17953006|P1|Optional DB EXT Phase|Withdrawal by Subject|12
5199993|NCT01097616|17952999|P8|Optional DB EXT Phase|Adverse Event|0
5199994|NCT01097616|17953000|P7|Optional DB EXT Phase|Adverse Event|0
5199995|NCT01097616|17953001|P6|Optional DB EXT Phase|Adverse Event|0
5199996|NCT01097616|17953002|P5|Optional DB EXT Phase|Adverse Event|0
5199997|NCT01097616|17953003|P4|Optional DB EXT Phase|Adverse Event|0
5199998|NCT01097616|17953004|P3|Optional DB EXT Phase|Adverse Event|2
5199999|NCT01097616|17953005|P2|Optional DB EXT Phase|Adverse Event|7
5200000|NCT01097616|17953006|P1|Optional DB EXT Phase|Adverse Event|0
5200001|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200002|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200003|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200004|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200005|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200006|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
5200007|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200008|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5200009|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5200010|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5200011|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5200012|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5200013|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5200014|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5200015|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
5200016|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
5200017|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5200018|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5200019|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5200020|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5200021|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5200022|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5200023|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
5200024|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
5200025|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5200026|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5200027|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5200028|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5200029|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5200030|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
5200031|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
5200032|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
5200033|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5200034|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5200035|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5200036|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5200037|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5200038|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5200039|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5200040|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5200041|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5200042|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5200043|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5200044|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5200045|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5200046|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
5200047|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
5200048|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
5200049|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5200050|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5200051|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5200052|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5200053|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5200054|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
5200055|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
5200056|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
5200057|NCT01097616|17952999|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5200058|NCT01097616|17953000|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5200059|NCT01097616|17953001|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5200060|NCT01097616|17953002|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5200061|NCT01097616|17953003|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5200062|NCT01097616|17953004|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
5200063|NCT01097616|17953005|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
5200064|NCT01097616|17953006|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
5200065|NCT01097577|17953079|P2|Overall Study|Adverse Event|1
5200066|NCT01097577|17953080|P1|Overall Study|Adverse Event|0
5200067|NCT01097421|17953100|P1|Overall Study|Withdrawal by Subject|3
5200068|NCT01097421|17953100|P1|Overall Study|Lost to Follow-up|1
5200069|NCT01097421|17953100|P1|Overall Study|Protocol Violation|2
5200070|NCT01097421|17953100|P1|Overall Study|Adverse Event|8
5200071|NCT01097330|17953119|P2|Overall Study|Study terminated early|5
5200072|NCT01097330|17953120|P1|Overall Study|Study terminated early|7
5200073|NCT01097057|17953137|P1|Overall Study|Physician Decision|3
5200074|NCT01097044|17953146|P2|Overall Study|Withdrawal by Sponsor|1
5200075|NCT01097044|17953147|P1|Overall Study|Withdrawal by Sponsor|0
5200076|NCT01097044|17953146|P2|Overall Study|Lost to Follow-up|0
5200077|NCT01097044|17953147|P1|Overall Study|Lost to Follow-up|1
5200078|NCT01097044|17953146|P2|Overall Study|Withdrawal by Subject|4
5200079|NCT01097044|17953147|P1|Overall Study|Withdrawal by Subject|4
5200080|NCT01097005|17953165|P1|Overall Study|Discontinuance by complication|50
5200081|NCT01097005|17953165|P1|Overall Study|Adverse Event|14
5200082|NCT01097005|17953165|P1|Overall Study|Deviation from exclusion criteria|37
5200083|NCT01097005|17953165|P1|Overall Study|No examination data available|244
5200084|NCT01097005|17953165|P1|Overall Study|Poor medication compliance|1
5200085|NCT01097005|17953165|P1|Overall Study|Subjects cannot visit the hospital|1
5200086|NCT01097005|17953165|P1|Overall Study|Case Report Form not collected|18
5200087|NCT01096849|17953211|P3|Overall Study|Lost to Follow-up|1
5200088|NCT01096849|17953212|P2|Overall Study|Lost to Follow-up|3
5200089|NCT01096849|17953213|P1|Overall Study|Lost to Follow-up|1
5200090|NCT01096849|17953211|P3|Overall Study|Administrative Reasons|2
5200091|NCT01096849|17953212|P2|Overall Study|Administrative Reasons|1
5200092|NCT01096849|17953213|P1|Overall Study|Administrative Reasons|0
5200093|NCT01096849|17953211|P3|Overall Study|Investigator or Medical Monitor Decision|0
5200094|NCT01096849|17953212|P2|Overall Study|Investigator or Medical Monitor Decision|1
5200095|NCT01096849|17953213|P1|Overall Study|Investigator or Medical Monitor Decision|0
5200096|NCT01096849|17953211|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
5200097|NCT01096849|17953212|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
5200098|NCT01096849|17953213|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
5200099|NCT01096849|17953211|P3|Overall Study|Lack of Efficacy|0
5200100|NCT01096849|17953212|P2|Overall Study|Lack of Efficacy|2
5200101|NCT01096849|17953213|P1|Overall Study|Lack of Efficacy|0
5200102|NCT01096849|17953211|P3|Overall Study|Consent Withdrawn|2
5200103|NCT01096849|17953212|P2|Overall Study|Consent Withdrawn|4
5200104|NCT01096849|17953213|P1|Overall Study|Consent Withdrawn|1
5200105|NCT01096784|17953289|P2|Overall Study|Other Unspecified|1
5200106|NCT01096784|17953290|P1|Overall Study|Other Unspecified|0
5200107|NCT01096784|17953289|P2|Overall Study|Administrative Decision|1
5200108|NCT01096784|17953290|P1|Overall Study|Administrative Decision|0
5200109|NCT01096784|17953289|P2|Overall Study|Protocol Deviation|2
5200110|NCT01096784|17953290|P1|Overall Study|Protocol Deviation|2
5200111|NCT01096784|17953289|P2|Overall Study|Adverse Event|9
5200112|NCT01096784|17953290|P1|Overall Study|Adverse Event|11
5200113|NCT01096784|17953289|P2|Overall Study|Withdrawal by Subject|1
5200114|NCT01096784|17953290|P1|Overall Study|Withdrawal by Subject|2
5200115|NCT01096667|17953395|P5|Overall Study|Not treated|0
5200116|NCT01096667|17953396|P4|Overall Study|Not treated|0
5200117|NCT01096667|17953397|P3|Overall Study|Not treated|0
5200118|NCT01096667|17953398|P2|Overall Study|Not treated|0
5200119|NCT01096667|17953399|P1|Overall Study|Not treated|1
5200120|NCT01096667|17953395|P5|Overall Study|Protocol Violation|0
5200121|NCT01096667|17953396|P4|Overall Study|Protocol Violation|1
5200122|NCT01096667|17953397|P3|Overall Study|Protocol Violation|0
5200123|NCT01096667|17953398|P2|Overall Study|Protocol Violation|0
5200124|NCT01096667|17953399|P1|Overall Study|Protocol Violation|0
5200125|NCT01096667|17953395|P5|Overall Study|Reason not available|0
5200126|NCT01096667|17953396|P4|Overall Study|Reason not available|1
5200127|NCT01096667|17953397|P3|Overall Study|Reason not available|1
5200128|NCT01096667|17953398|P2|Overall Study|Reason not available|1
5200129|NCT01096667|17953399|P1|Overall Study|Reason not available|0
5200130|NCT01096667|17953395|P5|Overall Study|Withdrawal by Subject|0
5200131|NCT01096667|17953396|P4|Overall Study|Withdrawal by Subject|1
5200132|NCT01096667|17953397|P3|Overall Study|Withdrawal by Subject|0
5200133|NCT01096667|17953398|P2|Overall Study|Withdrawal by Subject|0
5200134|NCT01096667|17953399|P1|Overall Study|Withdrawal by Subject|1
5200135|NCT01096667|17953395|P5|Overall Study|Lost to Follow-up|0
5200136|NCT01096667|17953396|P4|Overall Study|Lost to Follow-up|0
5200137|NCT01096667|17953397|P3|Overall Study|Lost to Follow-up|1
5200138|NCT01096667|17953398|P2|Overall Study|Lost to Follow-up|1
5200139|NCT01096667|17953399|P1|Overall Study|Lost to Follow-up|1
5200140|NCT01096589|17953541|P4|Overall Study|found treatment exhausting|1
5200141|NCT01096589|17953542|P3|Overall Study|found treatment exhausting|0
5200142|NCT01096589|17953543|P2|Overall Study|found treatment exhausting|0
5200143|NCT01096589|17953544|P1|Overall Study|found treatment exhausting|0
5200144|NCT01096589|17953541|P4|Overall Study|Compliance with protocol|0
5200145|NCT01096589|17953542|P3|Overall Study|Compliance with protocol|1
5200146|NCT01096589|17953543|P2|Overall Study|Compliance with protocol|0
5200147|NCT01096589|17953544|P1|Overall Study|Compliance with protocol|0
5200148|NCT01096589|17953541|P4|Overall Study|Withdrawal by Subject|1
5200149|NCT01096589|17953542|P3|Overall Study|Withdrawal by Subject|1
5200150|NCT01096589|17953543|P2|Overall Study|Withdrawal by Subject|1
5200151|NCT01096589|17953544|P1|Overall Study|Withdrawal by Subject|2
5200152|NCT01096589|17953541|P4|Overall Study|Adverse Event|1
5200153|NCT01096589|17953542|P3|Overall Study|Adverse Event|2
5200154|NCT01096589|17953543|P2|Overall Study|Adverse Event|1
5200155|NCT01096589|17953544|P1|Overall Study|Adverse Event|2
5200156|NCT01096550|17953560|P2|Overall Study|Lost to Follow-up|9
5200157|NCT01096550|17953561|P1|Overall Study|Lost to Follow-up|12
5200158|NCT01096550|17953560|P2|Overall Study|non-African American participant|6
5200159|NCT01096550|17953561|P1|Overall Study|non-African American participant|13
5200160|NCT01096550|17953560|P2|Overall Study|Withdrawal by Subject|1
5200161|NCT01096550|17953561|P1|Overall Study|Withdrawal by Subject|0
5200162|NCT01096550|17953560|P2|Overall Study|clinic readmission|1
5200163|NCT01096550|17953561|P1|Overall Study|clinic readmission|1
5200164|NCT01096550|17953560|P2|Overall Study|non-regular treatment track at clinic|1
5200165|NCT01096550|17953561|P1|Overall Study|non-regular treatment track at clinic|1
5200166|NCT01096550|17953560|P2|Overall Study|discontinued site|11
5200167|NCT01096550|17953561|P1|Overall Study|discontinued site|10
5200168|NCT01096446|17953569|P2|Overall Study|Protocol Violation|0
5200169|NCT01096446|17953570|P1|Overall Study|Protocol Violation|2
5200170|NCT01096446|17953569|P2|Overall Study|Death|0
5200171|NCT01096446|17953570|P1|Overall Study|Death|1
5200172|NCT01096342|17953575|P1|Overall Study|Protocol Violation|1
5200173|NCT01096316|17953583|P2|Overall Study|Lost to Follow-up|9
5200174|NCT01096316|17953584|P1|Overall Study|Lost to Follow-up|15
5200175|NCT01096186|17953605|P1|Overall Study|Noncompliance with study drug|1
5200176|NCT01096186|17953605|P1|Overall Study|Physician Decision|1
5200177|NCT01096186|17953605|P1|Overall Study|Withdrawal by Subject|22
5200178|NCT01096186|17953605|P1|Overall Study|Lost to Follow-up|2
5200179|NCT01096186|17953605|P1|Overall Study|Lack of Efficacy|4
5200180|NCT01096186|17953605|P1|Overall Study|Death|4
5200181|NCT01096186|17953605|P1|Overall Study|Adverse Event|16
5200182|NCT01096160|17953621|P10|Overall Study|Met stopping criteria per protocol|0
5200183|NCT01096160|17953622|P9|Overall Study|Met stopping criteria per protocol|2
5200184|NCT01096160|17953623|P8|Overall Study|Met stopping criteria per protocol|0
5200185|NCT01096160|17953624|P7|Overall Study|Met stopping criteria per protocol|2
5200186|NCT01096160|17953625|P6|Overall Study|Met stopping criteria per protocol|0
5200187|NCT01096160|17953626|P5|Overall Study|Met stopping criteria per protocol|1
5200188|NCT01096160|17953627|P4|Overall Study|Met stopping criteria per protocol|0
5200189|NCT01096160|17953628|P3|Overall Study|Met stopping criteria per protocol|0
5200190|NCT01096160|17953629|P2|Overall Study|Met stopping criteria per protocol|0
5200191|NCT01096160|17953630|P1|Overall Study|Met stopping criteria per protocol|0
5200192|NCT01096160|17953621|P10|Overall Study|Adverse Event|1
5200193|NCT01096160|17953622|P9|Overall Study|Adverse Event|0
5200194|NCT01096160|17953623|P8|Overall Study|Adverse Event|0
5200195|NCT01096160|17953624|P7|Overall Study|Adverse Event|0
5200196|NCT01096160|17953625|P6|Overall Study|Adverse Event|0
5200197|NCT01096160|17953626|P5|Overall Study|Adverse Event|0
5200198|NCT01096160|17953627|P4|Overall Study|Adverse Event|0
5200199|NCT01096160|17953628|P3|Overall Study|Adverse Event|1
5200200|NCT01096160|17953629|P2|Overall Study|Adverse Event|0
5200201|NCT01096160|17953630|P1|Overall Study|Adverse Event|0
5200202|NCT01096056|17953688|P2|Overall Study|Lost to Follow-up|1
5200203|NCT01096056|17953689|P1|Overall Study|Lost to Follow-up|0
5200204|NCT01096017|17953721|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
5200205|NCT01096017|17953722|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
5200206|NCT01095978|17953750|P1|Overall Study|Adverse Event|1
5200207|NCT01095978|17953750|P1|Overall Study|Did not take Klacid SR|2
5200208|NCT01095835|17953784|P3|Overall Study|Protocol Violation|0
5200209|NCT01095835|17953785|P2|Overall Study|Protocol Violation|2
5200210|NCT01095835|17953786|P1|Overall Study|Protocol Violation|1
5200211|NCT01095835|17953784|P3|Overall Study|Non study compliance|1
5200212|NCT01095835|17953785|P2|Overall Study|Non study compliance|0
5200213|NCT01095835|17953786|P1|Overall Study|Non study compliance|0
5200214|NCT01095835|17953784|P3|Overall Study|Withdrawal by Subject|0
5200215|NCT01095835|17953785|P2|Overall Study|Withdrawal by Subject|3
5200216|NCT01095835|17953786|P1|Overall Study|Withdrawal by Subject|1
5200217|NCT01095835|17953784|P3|Overall Study|Physician Decision|1
5200218|NCT01095835|17953785|P2|Overall Study|Physician Decision|0
5200219|NCT01095835|17953786|P1|Overall Study|Physician Decision|0
5200220|NCT01095835|17953784|P3|Overall Study|Lack of Efficacy|0
5200221|NCT01095835|17953785|P2|Overall Study|Lack of Efficacy|1
5200222|NCT01095835|17953786|P1|Overall Study|Lack of Efficacy|0
5200223|NCT01095835|17953784|P3|Overall Study|Adverse Event|6
5200224|NCT01095835|17953785|P2|Overall Study|Adverse Event|6
5200225|NCT01095835|17953786|P1|Overall Study|Adverse Event|8
5200226|NCT01095796|17953824|P2|Overall Study|Participant Transferred to Another Study|200
5200227|NCT01095796|17953825|P1|Overall Study|Participant Transferred to Another Study|215
5200228|NCT01095796|17953824|P2|Overall Study|Protocol Violation|0
5200229|NCT01095796|17953825|P1|Overall Study|Protocol Violation|1
5200230|NCT01095796|17953824|P2|Overall Study|Participant Noncompliance|10
5200231|NCT01095796|17953825|P1|Overall Study|Participant Noncompliance|5
5200232|NCT01095796|17953824|P2|Overall Study|Lost to Follow-up|29
5200233|NCT01095796|17953825|P1|Overall Study|Lost to Follow-up|27
5200234|NCT01095796|17953824|P2|Overall Study|Withdrew Consent|22
5200235|NCT01095796|17953825|P1|Overall Study|Withdrew Consent|16
5200236|NCT01095796|17953824|P2|Overall Study|Investigator's Discretion|2
5200237|NCT01095796|17953825|P1|Overall Study|Investigator's Discretion|7
5200238|NCT01095796|17953824|P2|Overall Study|Lack of Efficacy|3
5200239|NCT01095796|17953825|P1|Overall Study|Lack of Efficacy|5
5200240|NCT01095796|17953824|P2|Overall Study|Pregnancy|0
5200241|NCT01095796|17953825|P1|Overall Study|Pregnancy|2
5200242|NCT01095796|17953824|P2|Overall Study|Death|2
5200243|NCT01095796|17953825|P1|Overall Study|Death|3
5200244|NCT01095796|17953824|P2|Overall Study|Adverse Event|19
5200245|NCT01095796|17953825|P1|Overall Study|Adverse Event|9
5200246|NCT01095796|17953824|P2|Overall Study|Randomized but Not Treated|2
5200247|NCT01095796|17953825|P1|Overall Study|Randomized but Not Treated|5
5200248|NCT01095666|17953855|P3|Overall Study|Non-compliance, not met criteria etc.|2
5200249|NCT01095666|17953856|P2|Overall Study|Non-compliance, not met criteria etc.|2
5200250|NCT01095666|17953857|P1|Overall Study|Non-compliance, not met criteria etc.|7
5200251|NCT01095666|17953855|P3|Overall Study|Withdrawal by Subject|1
5200252|NCT01095666|17953856|P2|Overall Study|Withdrawal by Subject|6
5200253|NCT01095666|17953857|P1|Overall Study|Withdrawal by Subject|6
5200254|NCT01095666|17953855|P3|Overall Study|Lost to Follow-up|0
5200255|NCT01095666|17953856|P2|Overall Study|Lost to Follow-up|2
5200256|NCT01095666|17953857|P1|Overall Study|Lost to Follow-up|2
5200257|NCT01095666|17953855|P3|Overall Study|Adverse Event|3
5200258|NCT01095666|17953856|P2|Overall Study|Adverse Event|1
5200259|NCT01095666|17953857|P1|Overall Study|Adverse Event|2
5200260|NCT01095666|17953855|P3|Overall Study|Lack of Efficacy|1
5200261|NCT01095666|17953856|P2|Overall Study|Lack of Efficacy|0
5200262|NCT01095666|17953857|P1|Overall Study|Lack of Efficacy|0
5200263|NCT01095653|17953880|P3|Overall Study|non-compliance, not met criteria, etc.|5
5200264|NCT01095653|17953881|P2|Overall Study|non-compliance, not met criteria, etc.|6
5200265|NCT01095653|17953882|P1|Overall Study|non-compliance, not met criteria, etc.|10
5200266|NCT01095653|17953880|P3|Overall Study|Withdrawal by Subject|3
5200267|NCT01095653|17953881|P2|Overall Study|Withdrawal by Subject|5
5200268|NCT01095653|17953882|P1|Overall Study|Withdrawal by Subject|4
5200269|NCT01095653|17953880|P3|Overall Study|Lost to Follow-up|4
5200270|NCT01095653|17953881|P2|Overall Study|Lost to Follow-up|0
5200271|NCT01095653|17953882|P1|Overall Study|Lost to Follow-up|1
5200272|NCT01095653|17953880|P3|Overall Study|Adverse Event|4
5200273|NCT01095653|17953881|P2|Overall Study|Adverse Event|4
5200274|NCT01095653|17953882|P1|Overall Study|Adverse Event|1
5200275|NCT01095653|17953880|P3|Overall Study|Lack of Efficacy|0
5200276|NCT01095653|17953881|P2|Overall Study|Lack of Efficacy|0
5200277|NCT01095653|17953882|P1|Overall Study|Lack of Efficacy|3
5200278|NCT01095250|17953940|P4|Overall Study|Withdrawal by Subject|0
5200279|NCT01095250|17953941|P3|Overall Study|Withdrawal by Subject|1
5200280|NCT01095250|17953942|P2|Overall Study|Withdrawal by Subject|0
5200281|NCT01095250|17953943|P1|Overall Study|Withdrawal by Subject|0
5200282|NCT01095250|17953940|P4|Overall Study|administrative reasons|5
5200283|NCT01095250|17953941|P3|Overall Study|administrative reasons|7
5200284|NCT01095250|17953942|P2|Overall Study|administrative reasons|10
5200285|NCT01095250|17953943|P1|Overall Study|administrative reasons|8
5200286|NCT01095094|17953973|P1|Overall Study|Physician Decision|1
5200287|NCT01095094|17953973|P1|Overall Study|Death|1
5200288|NCT01095094|17953973|P1|Overall Study|Withdrawal by Subject|1
5200289|NCT01094886|17953995|P1|Overall Study|Withdrawal by Subject|5
5200290|NCT01094886|17953995|P1|Overall Study|Adverse Event|2
5200291|NCT01094808|17954005|P3|Overall Study|Withdrawal by Subject|0
5200292|NCT01094808|17954006|P2|Overall Study|Withdrawal by Subject|1
5200293|NCT01094808|17954007|P1|Overall Study|Withdrawal by Subject|1
5200294|NCT01094782|17954048|P6|Overall Study|Noncompliance With Study Schedule|0
5200295|NCT01094782|17954049|P5|Overall Study|Noncompliance With Study Schedule|0
5200296|NCT01094782|17954050|P4|Overall Study|Noncompliance With Study Schedule|1
5200297|NCT01094782|17954051|P3|Overall Study|Noncompliance With Study Schedule|0
5200298|NCT01094782|17954052|P2|Overall Study|Noncompliance With Study Schedule|0
5200299|NCT01094782|17954053|P1|Overall Study|Noncompliance With Study Schedule|0
5200300|NCT01094782|17954048|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
5200301|NCT01094782|17954049|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
5200302|NCT01094782|17954050|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
5200303|NCT01094782|17954051|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
5200304|NCT01094782|17954052|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
5200305|NCT01094782|17954053|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
5200306|NCT01094782|17954048|P6|Overall Study|Recent Interventional Injection|1
5200307|NCT01094782|17954049|P5|Overall Study|Recent Interventional Injection|0
5200308|NCT01094782|17954050|P4|Overall Study|Recent Interventional Injection|0
5200309|NCT01094782|17954051|P3|Overall Study|Recent Interventional Injection|0
5200310|NCT01094782|17954052|P2|Overall Study|Recent Interventional Injection|0
5200311|NCT01094782|17954053|P1|Overall Study|Recent Interventional Injection|0
5200312|NCT01094782|17954048|P6|Overall Study|Wrong Pain Condition|1
5200313|NCT01094782|17954049|P5|Overall Study|Wrong Pain Condition|1
5200314|NCT01094782|17954050|P4|Overall Study|Wrong Pain Condition|2
5200315|NCT01094782|17954051|P3|Overall Study|Wrong Pain Condition|0
5200316|NCT01094782|17954052|P2|Overall Study|Wrong Pain Condition|0
5200317|NCT01094782|17954053|P1|Overall Study|Wrong Pain Condition|0
5200318|NCT01094782|17954048|P6|Overall Study|Hypertension|0
5200319|NCT01094782|17954049|P5|Overall Study|Hypertension|0
5200320|NCT01094782|17954050|P4|Overall Study|Hypertension|0
5200321|NCT01094782|17954051|P3|Overall Study|Hypertension|1
5200322|NCT01094782|17954052|P2|Overall Study|Hypertension|0
5200323|NCT01094782|17954053|P1|Overall Study|Hypertension|0
5200324|NCT01094782|17954048|P6|Overall Study|Healthy Subject Had Pain|0
5200325|NCT01094782|17954049|P5|Overall Study|Healthy Subject Had Pain|0
5200326|NCT01094782|17954050|P4|Overall Study|Healthy Subject Had Pain|0
5200327|NCT01094782|17954051|P3|Overall Study|Healthy Subject Had Pain|0
5200328|NCT01094782|17954052|P2|Overall Study|Healthy Subject Had Pain|1
5200329|NCT01094782|17954053|P1|Overall Study|Healthy Subject Had Pain|0
5200330|NCT01094782|17954048|P6|Overall Study|Unable to Complete Questionnaires|0
5200331|NCT01094782|17954049|P5|Overall Study|Unable to Complete Questionnaires|0
5200332|NCT01094782|17954050|P4|Overall Study|Unable to Complete Questionnaires|0
5200333|NCT01094782|17954051|P3|Overall Study|Unable to Complete Questionnaires|0
5200334|NCT01094782|17954052|P2|Overall Study|Unable to Complete Questionnaires|1
5200335|NCT01094782|17954053|P1|Overall Study|Unable to Complete Questionnaires|0
5200336|NCT01094782|17954048|P6|Overall Study|Sensory Deficit at Site of QST|0
5200337|NCT01094782|17954049|P5|Overall Study|Sensory Deficit at Site of QST|0
5200338|NCT01094782|17954050|P4|Overall Study|Sensory Deficit at Site of QST|0
5200339|NCT01094782|17954051|P3|Overall Study|Sensory Deficit at Site of QST|0
5200340|NCT01094782|17954052|P2|Overall Study|Sensory Deficit at Site of QST|1
5200341|NCT01094782|17954053|P1|Overall Study|Sensory Deficit at Site of QST|0
5200342|NCT01094782|17954048|P6|Overall Study|Positive Drug Screen|2
5200343|NCT01094782|17954049|P5|Overall Study|Positive Drug Screen|3
5200344|NCT01094782|17954050|P4|Overall Study|Positive Drug Screen|1
5200345|NCT01094782|17954051|P3|Overall Study|Positive Drug Screen|1
5200346|NCT01094782|17954052|P2|Overall Study|Positive Drug Screen|2
5200347|NCT01094782|17954053|P1|Overall Study|Positive Drug Screen|2
5200348|NCT01094782|17954048|P6|Overall Study|Lost to Follow-up|4
5200349|NCT01094782|17954049|P5|Overall Study|Lost to Follow-up|1
5200350|NCT01094782|17954050|P4|Overall Study|Lost to Follow-up|2
5200351|NCT01094782|17954051|P3|Overall Study|Lost to Follow-up|0
5200352|NCT01094782|17954052|P2|Overall Study|Lost to Follow-up|0
5200353|NCT01094782|17954053|P1|Overall Study|Lost to Follow-up|1
5200354|NCT01094782|17954048|P6|Overall Study|Withdrawal by Subject|0
5200355|NCT01094782|17954049|P5|Overall Study|Withdrawal by Subject|5
5200356|NCT01094782|17954050|P4|Overall Study|Withdrawal by Subject|5
5200357|NCT01094782|17954051|P3|Overall Study|Withdrawal by Subject|1
5200358|NCT01094782|17954052|P2|Overall Study|Withdrawal by Subject|5
5200359|NCT01094782|17954053|P1|Overall Study|Withdrawal by Subject|5
5200360|NCT01094743|17954097|P1|Period 1|Unsatisfactory comfort at lens fitting|2
5200361|NCT01094730|17954114|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
5200362|NCT01094730|17954115|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
5200363|NCT01094730|17954114|P2|Period 2 (14 Days)|Adverse Event|1
5200364|NCT01094730|17954115|P1|Period 2 (14 Days)|Adverse Event|0
5200365|NCT01094730|17954114|P2|Period 2 (14 Days)|No time for the follow-up visit|0
5200366|NCT01094730|17954115|P1|Period 2 (14 Days)|No time for the follow-up visit|1
5200367|NCT01094730|17954114|P2|Period 2 (14 Days)|Protocol Violation|0
5200368|NCT01094730|17954115|P1|Period 2 (14 Days)|Protocol Violation|2
5200369|NCT01094730|17954114|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
5200370|NCT01094730|17954115|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
5200371|NCT01094730|17954114|P2|Period 1 (14 Days)|No time for the follow-up visit|0
5200372|NCT01094730|17954115|P1|Period 1 (14 Days)|No time for the follow-up visit|1
5200373|NCT01094730|17954114|P2|Period 1 (14 Days)|Withdrawal by Subject|1
5200374|NCT01094730|17954115|P1|Period 1 (14 Days)|Withdrawal by Subject|0
5200375|NCT01094730|17954114|P2|Period 1 (14 Days)|Lost to Follow-up|1
5200376|NCT01094730|17954115|P1|Period 1 (14 Days)|Lost to Follow-up|0
5200377|NCT01094301|17954251|P1|Implant Stage|No return of pain|4
5200378|NCT01094301|17954251|P1|Implant Stage|Withdrawal by Subject|2
5200379|NCT01094301|17954251|P1|Implant Stage|Protocol Violation|1
5200380|NCT01094301|17954251|P1|Implant Stage|Adverse Event|1
5200381|NCT01094301|17954251|P1|Trial Stage|Withdrawal by Subject|1
5200382|NCT01094288|17954281|P8|Overall Study|Ongoing Participants|0
5200383|NCT01094288|17954282|P7|Overall Study|Ongoing Participants|0
5200384|NCT01094288|17954283|P6|Overall Study|Ongoing Participants|0
5200385|NCT01094288|17954284|P5|Overall Study|Ongoing Participants|0
5200386|NCT01094288|17954285|P4|Overall Study|Ongoing Participants|0
5200387|NCT01094288|17954286|P3|Overall Study|Ongoing Participants|0
5200388|NCT01094288|17954287|P2|Overall Study|Ongoing Participants|3
5200389|NCT01094288|17954288|P1|Overall Study|Ongoing Participants|0
5200390|NCT01094288|17954281|P8|Overall Study|Reason not Specified|0
5200391|NCT01094288|17954282|P7|Overall Study|Reason not Specified|0
5200392|NCT01094288|17954283|P6|Overall Study|Reason not Specified|0
5200393|NCT01094288|17954284|P5|Overall Study|Reason not Specified|0
5200394|NCT01094288|17954285|P4|Overall Study|Reason not Specified|1
5200395|NCT01094288|17954286|P3|Overall Study|Reason not Specified|0
5200396|NCT01094288|17954287|P2|Overall Study|Reason not Specified|3
5200397|NCT01094288|17954288|P1|Overall Study|Reason not Specified|2
5200398|NCT01094288|17954281|P8|Overall Study|Initiation of Alternative Therapy|0
5200399|NCT01094288|17954282|P7|Overall Study|Initiation of Alternative Therapy|0
5200400|NCT01094288|17954283|P6|Overall Study|Initiation of Alternative Therapy|0
5200401|NCT01094288|17954284|P5|Overall Study|Initiation of Alternative Therapy|0
5200402|NCT01094288|17954285|P4|Overall Study|Initiation of Alternative Therapy|0
5200403|NCT01094288|17954286|P3|Overall Study|Initiation of Alternative Therapy|1
5200404|NCT01094288|17954287|P2|Overall Study|Initiation of Alternative Therapy|0
5200405|NCT01094288|17954288|P1|Overall Study|Initiation of Alternative Therapy|0
5200406|NCT01094288|17954281|P8|Overall Study|Withdrawal by Subject|2
5200407|NCT01094288|17954282|P7|Overall Study|Withdrawal by Subject|0
5200408|NCT01094288|17954283|P6|Overall Study|Withdrawal by Subject|0
5200409|NCT01094288|17954284|P5|Overall Study|Withdrawal by Subject|0
5200410|NCT01094288|17954285|P4|Overall Study|Withdrawal by Subject|0
5200411|NCT01094288|17954286|P3|Overall Study|Withdrawal by Subject|2
5200412|NCT01094288|17954287|P2|Overall Study|Withdrawal by Subject|1
5200413|NCT01094288|17954288|P1|Overall Study|Withdrawal by Subject|0
5200414|NCT01094288|17954281|P8|Overall Study|Adverse Event|0
5200415|NCT01094288|17954282|P7|Overall Study|Adverse Event|0
5200416|NCT01094288|17954283|P6|Overall Study|Adverse Event|0
5200417|NCT01094288|17954284|P5|Overall Study|Adverse Event|0
5200418|NCT01094288|17954285|P4|Overall Study|Adverse Event|1
5200419|NCT01094288|17954286|P3|Overall Study|Adverse Event|1
5200420|NCT01094288|17954287|P2|Overall Study|Adverse Event|3
5200421|NCT01094288|17954288|P1|Overall Study|Adverse Event|0
5200422|NCT01094184|17954400|P2|Overall Study|Death|11
5200423|NCT01094184|17954401|P1|Overall Study|Death|35
5200424|NCT01094171|17954635|P1|Overall Study|Other|1
5200425|NCT01094171|17954635|P1|Overall Study|Migration from the study area|3
5200426|NCT01094171|17954635|P1|Overall Study|Informed consent withdrawal|4
5200427|NCT01094171|17954635|P1|Overall Study|Lost to Follow-up|2
5200428|NCT01094119|17954644|P2|Overall Study|Lack of Efficacy|4
5200429|NCT01094119|17954645|P1|Overall Study|Lack of Efficacy|2
5200430|NCT01093885|17954670|P1|Overall Study|Lost to Follow-up|1
5200431|NCT01093885|17954670|P1|Overall Study|Adverse Event|4
5200432|NCT01093846|17954678|P3|Overall Study|Administrative Problems|15
5200433|NCT01093846|17954679|P2|Overall Study|Administrative Problems|17
5200434|NCT01093846|17954680|P1|Overall Study|Administrative Problems|18
5200435|NCT01093846|17954678|P3|Overall Study|Condition no longer required study drug|1
5200436|NCT01093846|17954679|P2|Overall Study|Condition no longer required study drug|1
5200437|NCT01093846|17954680|P1|Overall Study|Condition no longer required study drug|1
5200438|NCT01093846|17954678|P3|Overall Study|Lack of Efficacy|4
5200439|NCT01093846|17954679|P2|Overall Study|Lack of Efficacy|0
5200440|NCT01093846|17954680|P1|Overall Study|Lack of Efficacy|0
5200441|NCT01093846|17954678|P3|Overall Study|Adverse Event|1
5200442|NCT01093846|17954679|P2|Overall Study|Adverse Event|0
5200443|NCT01093846|17954680|P1|Overall Study|Adverse Event|0
5200444|NCT01093755|17954705|P2|Overall Study|Withdrawal by Subject|4
5200445|NCT01093755|17954706|P1|Overall Study|Withdrawal by Subject|3
5200446|NCT01093625|17954746|P2|1-Year Visit|Lost to Follow-up|3
5200447|NCT01093625|17954747|P1|1-Year Visit|Lost to Follow-up|5
5200448|NCT01093625|17954746|P2|6-Month Visit|Lost to Follow-up|2
5200449|NCT01093625|17954747|P1|6-Month Visit|Lost to Follow-up|2
5200450|NCT01093625|17954746|P2|6-Month Visit|Withdrawal by Subject|7
5200451|NCT01093625|17954747|P1|6-Month Visit|Withdrawal by Subject|6
5200452|NCT01093625|17954746|P2|3-Month Visit|Lost to Follow-up|0
5200453|NCT01093625|17954747|P1|3-Month Visit|Lost to Follow-up|2
5200454|NCT01093625|17954746|P2|1-Month Visit|Lost to Follow-up|0
5200455|NCT01093625|17954747|P1|1-Month Visit|Lost to Follow-up|2
5200456|NCT01093625|17954746|P2|2-Week Visit|Withdrawal by Subject|0
5200457|NCT01093625|17954747|P1|2-Week Visit|Withdrawal by Subject|1
5200458|NCT01093625|17954746|P2|Baseline and Dispensed|Withdrawal by Subject|0
5200459|NCT01093625|17954747|P1|Baseline and Dispensed|Withdrawal by Subject|2
5200460|NCT01093599|17954767|P2|Overall Study|Lost to Follow-up|46
5200461|NCT01093599|17954768|P1|Overall Study|Lost to Follow-up|32
5200462|NCT01093586|17954774|P1|Overall Study|Failed to engraft|3
5200463|NCT01093573|17954795|P3|Overall Study|Insurance Denied|1
5200464|NCT01093573|17954796|P2|Overall Study|Insurance Denied|0
5200465|NCT01093573|17954797|P1|Overall Study|Insurance Denied|0
5200466|NCT01093573|17954795|P3|Overall Study|Physician Decision|1
5200467|NCT01093573|17954796|P2|Overall Study|Physician Decision|0
5200468|NCT01093573|17954797|P1|Overall Study|Physician Decision|0
5200469|NCT01093534|17954814|P3|Overall Study|Other|4
5200470|NCT01093534|17954815|P2|Overall Study|Other|3
5200471|NCT01093534|17954816|P1|Overall Study|Other|1
5200472|NCT01093534|17954814|P3|Overall Study|Withdrawal by Subject|2
5200473|NCT01093534|17954815|P2|Overall Study|Withdrawal by Subject|7
5200474|NCT01093534|17954816|P1|Overall Study|Withdrawal by Subject|5
5200475|NCT01093534|17954814|P3|Overall Study|Lack of Efficacy|1
5200476|NCT01093534|17954815|P2|Overall Study|Lack of Efficacy|1
5200477|NCT01093534|17954816|P1|Overall Study|Lack of Efficacy|2
5200478|NCT01093534|17954814|P3|Overall Study|Adverse Event|2
5200479|NCT01093534|17954815|P2|Overall Study|Adverse Event|5
5200480|NCT01093534|17954816|P1|Overall Study|Adverse Event|2
5200481|NCT01093222|17954964|P1|Overall Study|Not protocol specified|1
5200482|NCT01093222|17954964|P1|Overall Study|Death|2
5200483|NCT01093222|17954964|P1|Overall Study|Progression/relapse|24
5200484|NCT01093222|17954964|P1|Overall Study|Adverse Event|7
5200485|NCT01093222|17954964|P1|Overall Study|Ineligible|6
5200486|NCT01092832|17955040|P2|Overall Study|Other|0
5200487|NCT01092832|17955041|P1|Overall Study|Other|1
5200488|NCT01092780|17955053|P4|Washout Period 2|Adverse Event|0
5200489|NCT01092780|17955054|P3|Washout Period 2|Adverse Event|1
5200490|NCT01092780|17955055|P2|Washout Period 2|Adverse Event|1
5200491|NCT01092780|17955056|P1|Washout Period 2|Adverse Event|0
5200492|NCT01092780|17955053|P4|Washout Period 1|Noncompliance with nCPAP|0
5200493|NCT01092780|17955054|P3|Washout Period 1|Noncompliance with nCPAP|0
5200494|NCT01092780|17955055|P2|Washout Period 1|Noncompliance with nCPAP|0
5200495|NCT01092780|17955056|P1|Washout Period 1|Noncompliance with nCPAP|1
5200496|NCT01092780|17955053|P4|Washout Period 1|Adverse Event|0
5200497|NCT01092780|17955054|P3|Washout Period 1|Adverse Event|0
5200498|NCT01092780|17955055|P2|Washout Period 1|Adverse Event|1
5200499|NCT01092780|17955056|P1|Washout Period 1|Adverse Event|0
5200500|NCT01092728|17955092|P2|Overall Study|Prohibited Concomitant Medications|0
5200501|NCT01092728|17955093|P1|Overall Study|Prohibited Concomitant Medications|1
5200502|NCT01092728|17955092|P2|Overall Study|Disease Progression|13
5200503|NCT01092728|17955093|P1|Overall Study|Disease Progression|1
5200504|NCT01092728|17955092|P2|Overall Study|Adverse Event|1
5200505|NCT01092728|17955093|P1|Overall Study|Adverse Event|0
5200506|NCT01092728|17955092|P2|Overall Study|Withdrawal by Subject|0
5200507|NCT01092728|17955093|P1|Overall Study|Withdrawal by Subject|2
5200508|NCT01092702|17955101|P1|Overall Study|Lost to Follow-up|2
5200509|NCT01092702|17955101|P1|Overall Study|Withdrawal by Subject|7
5200510|NCT01092663|17955118|P2|Overall Study|Protocol Violation|1
5200511|NCT01092663|17955119|P1|Overall Study|Protocol Violation|0
5200512|NCT01092663|17955118|P2|Overall Study|Adverse Event|1
5200513|NCT01092663|17955119|P1|Overall Study|Adverse Event|1
5200514|NCT01092663|17955118|P2|Overall Study|High fasting triglyceride|0
5200515|NCT01092663|17955119|P1|Overall Study|High fasting triglyceride|2
5200516|NCT01092663|17955118|P2|Overall Study|Glucose >300mg/dL|0
5200517|NCT01092663|17955119|P1|Overall Study|Glucose >300mg/dL|1
5200518|NCT01092663|17955118|P2|Overall Study|Withdrawal by Subject|2
5200519|NCT01092663|17955119|P1|Overall Study|Withdrawal by Subject|3
5200520|NCT01092637|17955167|P2|Overall Study|Death|49
5200521|NCT01092637|17955168|P1|Overall Study|Death|47
5200522|NCT01092546|17955183|P1|Overall Study|Subjects withdrawn prior to dosing|4
5200523|NCT01092507|17955190|P2|Overall Study|Withdrawal by Subject|0
5200524|NCT01092507|17955191|P1|Overall Study|Withdrawal by Subject|2
5200525|NCT01092416|17955226|P1|12-Month Follow-up|Data collected after close of 1Y window|2
5200526|NCT01092416|17955226|P1|12-Month Follow-up|Missed 1-year follow-up|1
5200527|NCT01092416|17955226|P1|12-Month Follow-up|Withdrawal by Subject|2
5200528|NCT01092416|17955226|P1|12-Month Follow-up|Lost to Follow-up|4
5200529|NCT01092416|17955226|P1|12-Month Follow-up|Death|16
5200530|NCT01092416|17955226|P1|30-Day Follow-up|Data collected after close of 30D window|5
5200531|NCT01092416|17955226|P1|30-Day Follow-up|Missed 30-day follow-up|3
5200532|NCT01092416|17955226|P1|30-Day Follow-up|Death|2
5200533|NCT01092416|17955226|P1|Enrollment|Atherectomy device not inserted|3
5200534|NCT01091974|17955276|P4|Overall Study|side-effects|2
5200535|NCT01091974|17955277|P3|Overall Study|side-effects|0
5200536|NCT01091974|17955278|P2|Overall Study|side-effects|1
5200537|NCT01091974|17955279|P1|Overall Study|side-effects|1
5200538|NCT01091974|17955276|P4|Overall Study|Withdrawal by Subject|2
5200539|NCT01091974|17955277|P3|Overall Study|Withdrawal by Subject|2
5200540|NCT01091974|17955278|P2|Overall Study|Withdrawal by Subject|3
5200541|NCT01091974|17955279|P1|Overall Study|Withdrawal by Subject|1
5200542|NCT01091974|17955276|P4|Overall Study|resumed sleep medication|2
5200543|NCT01091974|17955277|P3|Overall Study|resumed sleep medication|1
5200544|NCT01091974|17955278|P2|Overall Study|resumed sleep medication|0
5200545|NCT01091974|17955279|P1|Overall Study|resumed sleep medication|0
5200546|NCT01091974|17955276|P4|Overall Study|Did not start intervention|1
5200547|NCT01091974|17955277|P3|Overall Study|Did not start intervention|3
5200548|NCT01091974|17955278|P2|Overall Study|Did not start intervention|1
5200549|NCT01091974|17955279|P1|Overall Study|Did not start intervention|3
5200550|NCT01091675|17955314|P1|Overall Study|Lack of Efficacy|27
5200551|NCT01091675|17955314|P1|Overall Study|Adverse Event|7
5200552|NCT01091662|17955320|P2|Overall Study|unable to swallow capsule|1
5200553|NCT01091662|17955321|P1|Overall Study|unable to swallow capsule|0
5200554|NCT01091662|17955320|P2|Overall Study|Protocol Violation|2
5200555|NCT01091662|17955321|P1|Overall Study|Protocol Violation|0
5200556|NCT01091662|17955320|P2|Overall Study|Pregnancy|1
5200557|NCT01091662|17955321|P1|Overall Study|Pregnancy|0
5200558|NCT01091662|17955320|P2|Overall Study|Lost to Follow-up|1
5200559|NCT01091662|17955321|P1|Overall Study|Lost to Follow-up|0
5200560|NCT01091662|17955320|P2|Overall Study|met exclusion criteria|0
5200561|NCT01091662|17955321|P1|Overall Study|met exclusion criteria|1
5200562|NCT01091662|17955320|P2|Overall Study|met exit criteria|13
5200563|NCT01091662|17955321|P1|Overall Study|met exit criteria|7
5200564|NCT01091662|17955320|P2|Overall Study|Withdrawal by Subject|6
5200565|NCT01091662|17955321|P1|Overall Study|Withdrawal by Subject|7
5200566|NCT01091662|17955320|P2|Overall Study|Physician Decision|1
5200567|NCT01091662|17955321|P1|Overall Study|Physician Decision|1
5200568|NCT01091662|17955320|P2|Overall Study|Adverse Event|9
5200569|NCT01091662|17955321|P1|Overall Study|Adverse Event|1
5200570|NCT01091519|17955359|P2|Overall Study|Randomized not treated|4
5200571|NCT01091519|17955360|P1|Overall Study|Randomized not treated|4
5200572|NCT01091519|17955359|P2|Overall Study|Other|8
5200573|NCT01091519|17955360|P1|Overall Study|Other|6
5200574|NCT01091519|17955359|P2|Overall Study|Withdrawal by Subject|2
5200575|NCT01091519|17955360|P1|Overall Study|Withdrawal by Subject|2
5200576|NCT01091519|17955359|P2|Overall Study|Lost to Follow-up|24
5200577|NCT01091519|17955360|P1|Overall Study|Lost to Follow-up|14
5200578|NCT01091519|17955359|P2|Overall Study|Lack of Efficacy|19
5200579|NCT01091519|17955360|P1|Overall Study|Lack of Efficacy|16
5200580|NCT01091519|17955359|P2|Overall Study|Death|0
5200581|NCT01091519|17955360|P1|Overall Study|Death|1
5200582|NCT01091519|17955359|P2|Overall Study|Adverse Event|16
5200583|NCT01091519|17955360|P1|Overall Study|Adverse Event|12
5200584|NCT01091454|17955372|P1|Overall Study|Ineligible|1
5200585|NCT01091428|17955385|P4|Phase 2|Physician Decision|0
5200586|NCT01091428|17955386|P3|Phase 2|Physician Decision|2
5200587|NCT01091428|17955387|P2|Phase 2|Physician Decision|0
5200588|NCT01091428|17955388|P1|Phase 2|Physician Decision|0
5200589|NCT01091428|17955385|P4|Phase 2|Reason not specified|3
5200590|NCT01091428|17955386|P3|Phase 2|Reason not specified|4
5200591|NCT01091428|17955387|P2|Phase 2|Reason not specified|0
5200592|NCT01091428|17955388|P1|Phase 2|Reason not specified|0
5200593|NCT01091428|17955385|P4|Phase 2|Unsatisfactory Therapeutic Response|1
5200594|NCT01091428|17955386|P3|Phase 2|Unsatisfactory Therapeutic Response|1
5200595|NCT01091428|17955387|P2|Phase 2|Unsatisfactory Therapeutic Response|0
5200596|NCT01091428|17955388|P1|Phase 2|Unsatisfactory Therapeutic Response|0
5200597|NCT01091428|17955385|P4|Phase 2|Withdrawal by Subject|8
5200598|NCT01091428|17955386|P3|Phase 2|Withdrawal by Subject|9
5200599|NCT01091428|17955387|P2|Phase 2|Withdrawal by Subject|0
5200600|NCT01091428|17955388|P1|Phase 2|Withdrawal by Subject|0
5200601|NCT01091428|17955385|P4|Phase 2|Adverse Event|5
5200602|NCT01091428|17955386|P3|Phase 2|Adverse Event|12
5200603|NCT01091428|17955387|P2|Phase 2|Adverse Event|0
5200604|NCT01091428|17955388|P1|Phase 2|Adverse Event|0
5200605|NCT01091428|17955385|P4|Phase 2|Symptomatic Deterioration|6
5200606|NCT01091428|17955386|P3|Phase 2|Symptomatic Deterioration|1
5200607|NCT01091428|17955387|P2|Phase 2|Symptomatic Deterioration|0
5200608|NCT01091428|17955388|P1|Phase 2|Symptomatic Deterioration|0
5200609|NCT01091428|17955385|P4|Phase 2|Progressive Disease|46
5200610|NCT01091428|17955386|P3|Phase 2|Progressive Disease|44
5200611|NCT01091428|17955387|P2|Phase 2|Progressive Disease|0
5200612|NCT01091428|17955388|P1|Phase 2|Progressive Disease|0
5200613|NCT01091428|17955385|P4|Phase 1|Single-Patient IND|0
5200614|NCT01091428|17955386|P3|Phase 1|Single-Patient IND|0
5200615|NCT01091428|17955387|P2|Phase 1|Single-Patient IND|0
5200616|NCT01091428|17955388|P1|Phase 1|Single-Patient IND|2
5200617|NCT01091428|17955385|P4|Phase 1|Reason not specified|0
5200618|NCT01091428|17955386|P3|Phase 1|Reason not specified|0
5200619|NCT01091428|17955387|P2|Phase 1|Reason not specified|1
5200620|NCT01091428|17955388|P1|Phase 1|Reason not specified|0
5200621|NCT01091428|17955385|P4|Phase 1|Withdrawal by Subject|0
5200622|NCT01091428|17955386|P3|Phase 1|Withdrawal by Subject|0
5200623|NCT01091428|17955387|P2|Phase 1|Withdrawal by Subject|0
5200624|NCT01091428|17955388|P1|Phase 1|Withdrawal by Subject|7
5200625|NCT01091428|17955385|P4|Phase 1|Adverse Event|0
5200626|NCT01091428|17955386|P3|Phase 1|Adverse Event|0
5200627|NCT01091428|17955387|P2|Phase 1|Adverse Event|0
5200628|NCT01091428|17955388|P1|Phase 1|Adverse Event|2
5200629|NCT01091428|17955385|P4|Phase 1|Symptomatic Deterioration|0
5200630|NCT01091428|17955386|P3|Phase 1|Symptomatic Deterioration|0
5200631|NCT01091428|17955387|P2|Phase 1|Symptomatic Deterioration|2
5200632|NCT01091428|17955388|P1|Phase 1|Symptomatic Deterioration|3
5200633|NCT01091428|17955385|P4|Phase 1|Progressive Disease|0
5200634|NCT01091428|17955386|P3|Phase 1|Progressive Disease|0
5200635|NCT01091428|17955387|P2|Phase 1|Progressive Disease|8
5200636|NCT01091428|17955388|P1|Phase 1|Progressive Disease|24
5200637|NCT01091363|17955491|P2|Overall Study|Lost to Follow-up|2
5200638|NCT01091363|17955492|P1|Overall Study|Lost to Follow-up|2
5200639|NCT01091363|17955491|P2|Overall Study|Withdrawal by Subject|15
5200640|NCT01091363|17955492|P1|Overall Study|Withdrawal by Subject|11
5200641|NCT01091259|17955502|P1|Overall Study|Lack of Efficacy|2
5200642|NCT01091259|17955502|P1|Overall Study|Adverse Event|3
5200643|NCT01091246|17955513|P3|Overall Study|Subject not dosed|1
5200644|NCT01091246|17955514|P2|Overall Study|Subject not dosed|0
5200645|NCT01091246|17955515|P1|Overall Study|Subject not dosed|2
5200646|NCT01091246|17955513|P3|Overall Study|Withdrawal by Subject|4
5200647|NCT01091246|17955514|P2|Overall Study|Withdrawal by Subject|5
5200648|NCT01091246|17955515|P1|Overall Study|Withdrawal by Subject|9
5200649|NCT01091246|17955513|P3|Overall Study|Adverse Event|1
5200650|NCT01091246|17955514|P2|Overall Study|Adverse Event|0
5200651|NCT01091246|17955515|P1|Overall Study|Adverse Event|1
5200652|NCT01091246|17955513|P3|Overall Study|Lost to Follow-up|7
5200653|NCT01091246|17955514|P2|Overall Study|Lost to Follow-up|11
5200654|NCT01091246|17955515|P1|Overall Study|Lost to Follow-up|23
5200655|NCT01091168|17955591|P2|Overall Study|Physician, patient's decision, other|37
5200656|NCT01091168|17955592|P1|Overall Study|Physician, patient's decision, other|27
5200657|NCT01091168|17955591|P2|Overall Study|Lost to Follow-up|1
5200658|NCT01091168|17955592|P1|Overall Study|Lost to Follow-up|0
5200659|NCT01091168|17955591|P2|Overall Study|Adverse Event|24
5200660|NCT01091168|17955592|P1|Overall Study|Adverse Event|21
5200661|NCT01091168|17955591|P2|Overall Study|Progressive disease|234
5200662|NCT01091168|17955592|P1|Overall Study|Progressive disease|250
5200663|NCT01091103|17955667|P1|Overall Study|Progressive Disease|3
5200664|NCT01091103|17955667|P1|Overall Study|Adverse Event|1
5200665|NCT01090973|17955687|P1|Overall Study|Disease progression|1
5200666|NCT01090765|17955708|P6|Overall Study|Vasovagal reaction with first infusion|0
5200667|NCT01090765|17955709|P5|Overall Study|Vasovagal reaction with first infusion|1
5200668|NCT01090765|17955710|P4|Overall Study|Vasovagal reaction with first infusion|0
5200669|NCT01090765|17955711|P3|Overall Study|Vasovagal reaction with first infusion|0
5200670|NCT01090765|17955712|P2|Overall Study|Vasovagal reaction with first infusion|0
5200671|NCT01090765|17955713|P1|Overall Study|Vasovagal reaction with first infusion|0
5200672|NCT01090765|17955708|P6|Overall Study|Developed a DVT, needed anticoagulation|0
5200673|NCT01090765|17955709|P5|Overall Study|Developed a DVT, needed anticoagulation|0
5200674|NCT01090765|17955710|P4|Overall Study|Developed a DVT, needed anticoagulation|1
5200675|NCT01090765|17955711|P3|Overall Study|Developed a DVT, needed anticoagulation|0
5200676|NCT01090765|17955712|P2|Overall Study|Developed a DVT, needed anticoagulation|0
5200677|NCT01090765|17955713|P1|Overall Study|Developed a DVT, needed anticoagulation|0
5200678|NCT01090765|17955708|P6|Overall Study|Patient withdrew consent|1
5200679|NCT01090765|17955709|P5|Overall Study|Patient withdrew consent|1
5200680|NCT01090765|17955710|P4|Overall Study|Patient withdrew consent|0
5200681|NCT01090765|17955711|P3|Overall Study|Patient withdrew consent|0
5200682|NCT01090765|17955712|P2|Overall Study|Patient withdrew consent|0
5200683|NCT01090765|17955713|P1|Overall Study|Patient withdrew consent|0
5200684|NCT01090739|17955759|P1|36 Month Follow-up|Visit still pending|17
5200685|NCT01090739|17955759|P1|36 Month Follow-up|Withdrawal by Subject|6
5200686|NCT01090739|17955759|P1|24 Month Follow-up|Death|1
5200687|NCT01090739|17955759|P1|24 Month Follow-up|Lost to Follow-up|1
5200688|NCT01090739|17955759|P1|24 Month Follow-up|Withdrawal by Subject|7
5200689|NCT01090739|17955759|P1|12 Month Follow-up|Death|1
5200690|NCT01090739|17955759|P1|12 Month Follow-up|Physician Decision|1
5200691|NCT01090739|17955759|P1|12 Month Follow-up|Lost to Follow-up|1
5200692|NCT01090739|17955759|P1|12 Month Follow-up|Withdrawal by Subject|2
5200693|NCT01090739|17955759|P1|Enrollment|Adverse Event|1
5200694|NCT01090739|17955759|P1|Enrollment|Study implant limit reached|2
5200695|NCT01090739|17955759|P1|Enrollment|Sponsor termination of site|4
5200696|NCT01090739|17955759|P1|Enrollment|Physician Decision|5
5200697|NCT01090739|17955759|P1|Enrollment|Lost to Follow-up|5
5200698|NCT01090739|17955759|P1|Enrollment|Protocol Violation|14
5200699|NCT01090739|17955759|P1|Enrollment|Withdrawal by Subject|24
5200700|NCT01090492|17955784|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200701|NCT01090492|17955785|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
5200702|NCT01090492|17955786|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200703|NCT01090492|17955787|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200704|NCT01090492|17955788|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200705|NCT01090492|17955789|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200706|NCT01090492|17955790|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200707|NCT01090492|17955791|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5200708|NCT01090492|17955784|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
5200709|NCT01090492|17955785|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
5200710|NCT01090492|17955786|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
5200711|NCT01090492|17955787|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
5200712|NCT01090492|17955788|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
5200713|NCT01090492|17955789|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
5200714|NCT01090492|17955790|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
5200715|NCT01090492|17955791|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
5200716|NCT01090492|17955784|P8|Second Intervention Period (4 Weeks)|Other|0
5200717|NCT01090492|17955785|P7|Second Intervention Period (4 Weeks)|Other|0
5200718|NCT01090492|17955786|P6|Second Intervention Period (4 Weeks)|Other|0
5200719|NCT01090492|17955787|P5|Second Intervention Period (4 Weeks)|Other|0
5200720|NCT01090492|17955788|P4|Second Intervention Period (4 Weeks)|Other|0
5200721|NCT01090492|17955789|P3|Second Intervention Period (4 Weeks)|Other|1
5200722|NCT01090492|17955790|P2|Second Intervention Period (4 Weeks)|Other|1
5200723|NCT01090492|17955791|P1|Second Intervention Period (4 Weeks)|Other|0
5200724|NCT01090492|17955784|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
5200725|NCT01090492|17955785|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
5200726|NCT01090492|17955786|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
5200727|NCT01090492|17955787|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
5200728|NCT01090492|17955788|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
5200729|NCT01090492|17955789|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
5200730|NCT01090492|17955790|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
5200731|NCT01090492|17955791|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
5200732|NCT01090492|17955784|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
5200733|NCT01090492|17955785|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
5200734|NCT01090492|17955786|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
5200735|NCT01090492|17955787|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
5200736|NCT01090492|17955788|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
5200737|NCT01090492|17955789|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
5200738|NCT01090492|17955790|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
5200739|NCT01090492|17955791|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
5200740|NCT01090492|17955784|P8|First Intervention Period (4 Weeks)|Adverse Event|5
5200741|NCT01090492|17955785|P7|First Intervention Period (4 Weeks)|Adverse Event|0
5200742|NCT01090492|17955786|P6|First Intervention Period (4 Weeks)|Adverse Event|2
5200743|NCT01090492|17955787|P5|First Intervention Period (4 Weeks)|Adverse Event|1
5200744|NCT01090492|17955788|P4|First Intervention Period (4 Weeks)|Adverse Event|3
5200745|NCT01090492|17955789|P3|First Intervention Period (4 Weeks)|Adverse Event|0
5200746|NCT01090492|17955790|P2|First Intervention Period (4 Weeks)|Adverse Event|2
5200747|NCT01090492|17955791|P1|First Intervention Period (4 Weeks)|Adverse Event|0
5200748|NCT01090492|17955784|P8|First Intervention Period (4 Weeks)|Pregnancy|0
5200749|NCT01090492|17955785|P7|First Intervention Period (4 Weeks)|Pregnancy|0
5200750|NCT01090492|17955786|P6|First Intervention Period (4 Weeks)|Pregnancy|0
5200751|NCT01090492|17955787|P5|First Intervention Period (4 Weeks)|Pregnancy|1
5200752|NCT01090492|17955788|P4|First Intervention Period (4 Weeks)|Pregnancy|0
5200753|NCT01090492|17955789|P3|First Intervention Period (4 Weeks)|Pregnancy|0
5200754|NCT01090492|17955790|P2|First Intervention Period (4 Weeks)|Pregnancy|0
5200755|NCT01090492|17955791|P1|First Intervention Period (4 Weeks)|Pregnancy|0
5200756|NCT01090492|17955784|P8|First Intervention Period (4 Weeks)|Other|0
5200757|NCT01090492|17955785|P7|First Intervention Period (4 Weeks)|Other|0
5200758|NCT01090492|17955786|P6|First Intervention Period (4 Weeks)|Other|0
5200759|NCT01090492|17955787|P5|First Intervention Period (4 Weeks)|Other|2
5200760|NCT01090492|17955788|P4|First Intervention Period (4 Weeks)|Other|1
5200761|NCT01090492|17955789|P3|First Intervention Period (4 Weeks)|Other|1
5200762|NCT01090492|17955790|P2|First Intervention Period (4 Weeks)|Other|0
5200763|NCT01090492|17955791|P1|First Intervention Period (4 Weeks)|Other|0
5200764|NCT01090492|17955784|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200765|NCT01090492|17955785|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200766|NCT01090492|17955786|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200767|NCT01090492|17955787|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200768|NCT01090492|17955788|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200769|NCT01090492|17955789|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
5200770|NCT01090492|17955790|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200771|NCT01090492|17955791|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5200772|NCT01090492|17955784|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
5200773|NCT01090492|17955785|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5200774|NCT01090492|17955786|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5200775|NCT01090492|17955787|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5200776|NCT01090492|17955788|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5200777|NCT01090492|17955789|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5200778|NCT01090492|17955790|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
5200779|NCT01090492|17955791|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5200780|NCT01090492|17955784|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
5200781|NCT01090492|17955785|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
5200782|NCT01090492|17955786|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
5200783|NCT01090492|17955787|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
5200784|NCT01090492|17955788|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
5200785|NCT01090492|17955789|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
5200786|NCT01090492|17955790|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
5200787|NCT01090492|17955791|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
5200788|NCT01090453|17955859|P2|Overall Study|Eligibility Criteria|1
5200789|NCT01090453|17955860|P1|Overall Study|Eligibility Criteria|0
5200790|NCT01090453|17955859|P2|Overall Study|Other|4
5200791|NCT01090453|17955860|P1|Overall Study|Other|2
5200792|NCT01090453|17955859|P2|Overall Study|Protocol Violation|0
5200793|NCT01090453|17955860|P1|Overall Study|Protocol Violation|2
5200794|NCT01090453|17955859|P2|Overall Study|Non serious AEs|0
5200795|NCT01090453|17955860|P1|Overall Study|Non serious AEs|1
5200796|NCT01090453|17955859|P2|Overall Study|Lost to Follow-up|7
5200797|NCT01090453|17955860|P1|Overall Study|Lost to Follow-up|7
5200798|NCT01090453|17955859|P2|Overall Study|Withdrawal by Subject|2
5200799|NCT01090453|17955860|P1|Overall Study|Withdrawal by Subject|1
5200800|NCT01090427|17955911|P7|After Controlled Period|Adverse Event|0
5200801|NCT01090427|17955912|P6|After Controlled Period|Adverse Event|1
5200802|NCT01090427|17955913|P5|After Controlled Period|Adverse Event|0
5200803|NCT01090427|17955914|P4|After Controlled Period|Adverse Event|2
5200804|NCT01090427|17955915|P3|After Controlled Period|Adverse Event|0
5200805|NCT01090427|17955916|P2|After Controlled Period|Adverse Event|0
5200806|NCT01090427|17955917|P1|After Controlled Period|Adverse Event|0
5200807|NCT01090427|17955911|P7|After Controlled Period|Lack of Efficacy|2
5200808|NCT01090427|17955912|P6|After Controlled Period|Lack of Efficacy|3
5200809|NCT01090427|17955913|P5|After Controlled Period|Lack of Efficacy|0
5200810|NCT01090427|17955914|P4|After Controlled Period|Lack of Efficacy|0
5200811|NCT01090427|17955915|P3|After Controlled Period|Lack of Efficacy|0
5200812|NCT01090427|17955916|P2|After Controlled Period|Lack of Efficacy|0
5200813|NCT01090427|17955917|P1|After Controlled Period|Lack of Efficacy|0
5200814|NCT01090427|17955911|P7|After Controlled Period|Death|0
5200815|NCT01090427|17955912|P6|After Controlled Period|Death|1
5200816|NCT01090427|17955913|P5|After Controlled Period|Death|0
5200817|NCT01090427|17955914|P4|After Controlled Period|Death|0
5200818|NCT01090427|17955915|P3|After Controlled Period|Death|0
5200819|NCT01090427|17955916|P2|After Controlled Period|Death|0
5200820|NCT01090427|17955917|P1|After Controlled Period|Death|0
5200821|NCT01090414|17955954|P4|Study 101-99|Participant Request|0
5200822|NCT01090414|17955955|P3|Study 101-99|Participant Request|0
5200823|NCT01090414|17955956|P2|Study 101-99|Participant Request|1
5200824|NCT01090414|17955957|P1|Study 101-99|Participant Request|3
5200825|NCT01090414|17955954|P4|Study 101-99|Withdrew Consent|1
5200826|NCT01090414|17955955|P3|Study 101-99|Withdrew Consent|3
5200827|NCT01090414|17955956|P2|Study 101-99|Withdrew Consent|2
5200828|NCT01090414|17955957|P1|Study 101-99|Withdrew Consent|0
5200829|NCT01090414|17955954|P4|Study 101-99|Other (Unknown Reasons)|0
5200830|NCT01090414|17955955|P3|Study 101-99|Other (Unknown Reasons)|0
5200831|NCT01090414|17955956|P2|Study 101-99|Other (Unknown Reasons)|3
5200832|NCT01090414|17955957|P1|Study 101-99|Other (Unknown Reasons)|3
5200833|NCT01090414|17955954|P4|Study 101-99|Sponsor Discontinued Study|0
5200834|NCT01090414|17955955|P3|Study 101-99|Sponsor Discontinued Study|5
5200835|NCT01090414|17955956|P2|Study 101-99|Sponsor Discontinued Study|7
5200836|NCT01090414|17955957|P1|Study 101-99|Sponsor Discontinued Study|0
5200837|NCT01090414|17955954|P4|Study 101-99|Death|0
5200838|NCT01090414|17955955|P3|Study 101-99|Death|1
5200839|NCT01090414|17955956|P2|Study 101-99|Death|8
5200840|NCT01090414|17955957|P1|Study 101-99|Death|3
5200841|NCT01090414|17955954|P4|Study 101-99|Investigator Request|0
5200842|NCT01090414|17955955|P3|Study 101-99|Investigator Request|4
5200843|NCT01090414|17955956|P2|Study 101-99|Investigator Request|11
5200844|NCT01090414|17955957|P1|Study 101-99|Investigator Request|1
5200845|NCT01090414|17955954|P4|Study 101-99|Adverse Event|0
5200846|NCT01090414|17955955|P3|Study 101-99|Adverse Event|18
5200847|NCT01090414|17955956|P2|Study 101-99|Adverse Event|28
5200848|NCT01090414|17955957|P1|Study 101-99|Adverse Event|10
5200849|NCT01090414|17955954|P4|Study 101-99|Progressive Disease|4
5200850|NCT01090414|17955955|P3|Study 101-99|Progressive Disease|10
5200851|NCT01090414|17955956|P2|Study 101-99|Progressive Disease|48
5200852|NCT01090414|17955957|P1|Study 101-99|Progressive Disease|28
5200853|NCT01090323|17956024|P2|Overall Study|Stopped end of extension 1#|1
5200854|NCT01090323|17956025|P1|Overall Study|Stopped end of extension 1#|3
5200855|NCT01090323|17956024|P2|Overall Study|Stopped end of core|0
5200856|NCT01090323|17956025|P1|Overall Study|Stopped end of core|7
5200857|NCT01090323|17956024|P2|Overall Study|Death|2
5200858|NCT01090323|17956025|P1|Overall Study|Death|1
5200859|NCT01090323|17956024|P2|Overall Study|Administrative problems|4
5200860|NCT01090323|17956025|P1|Overall Study|Administrative problems|6
5200861|NCT01090323|17956024|P2|Overall Study|Lost to Follow-up|6
5200862|NCT01090323|17956025|P1|Overall Study|Lost to Follow-up|11
5200863|NCT01090323|17956024|P2|Overall Study|Withdrew consent|11
5200864|NCT01090323|17956025|P1|Overall Study|Withdrew consent|33
5200865|NCT01090323|17956024|P2|Overall Study|Protocol Violation|1
5200866|NCT01090323|17956025|P1|Overall Study|Protocol Violation|2
5200867|NCT01090323|17956024|P2|Overall Study|Condition no longer requires drug|4
5200868|NCT01090323|17956025|P1|Overall Study|Condition no longer requires drug|5
5200869|NCT01090323|17956024|P2|Overall Study|Unsatisfactory therapeutic effect|2
5200870|NCT01090323|17956025|P1|Overall Study|Unsatisfactory therapeutic effect|4
5200871|NCT01090323|17956024|P2|Overall Study|Abnormal Test Procedure Results|0
5200872|NCT01090323|17956025|P1|Overall Study|Abnormal Test Procedure Results|2
5200873|NCT01090323|17956024|P2|Overall Study|Abnormal Lab Values|1
5200874|NCT01090323|17956025|P1|Overall Study|Abnormal Lab Values|3
5200875|NCT01090323|17956024|P2|Overall Study|Adverse Event|2
5200876|NCT01090323|17956025|P1|Overall Study|Adverse Event|12
5200877|NCT01090310|17956037|P4|Extension Study|Subject withdrew consent|0
5200878|NCT01090310|17956038|P3|Extension Study|Subject withdrew consent|0
5200879|NCT01090310|17956039|P2|Extension Study|Subject withdrew consent|1
5200880|NCT01090310|17956040|P1|Extension Study|Subject withdrew consent|0
5200881|NCT01090310|17956037|P4|Extension Study|Unsatisfactory therapeutic effect|1
5200882|NCT01090310|17956038|P3|Extension Study|Unsatisfactory therapeutic effect|1
5200883|NCT01090310|17956039|P2|Extension Study|Unsatisfactory therapeutic effect|0
5200884|NCT01090310|17956040|P1|Extension Study|Unsatisfactory therapeutic effect|1
5200885|NCT01090310|17956037|P4|Extension Study|Adverse Event|1
5200886|NCT01090310|17956038|P3|Extension Study|Adverse Event|0
5200887|NCT01090310|17956039|P2|Extension Study|Adverse Event|0
5200888|NCT01090310|17956040|P1|Extension Study|Adverse Event|0
5200889|NCT01090310|17956037|P4|Extension Study|Aministrative problems|18
5200890|NCT01090310|17956038|P3|Extension Study|Aministrative problems|14
5200891|NCT01090310|17956039|P2|Extension Study|Aministrative problems|15
5200892|NCT01090310|17956040|P1|Extension Study|Aministrative problems|13
5200893|NCT01090310|17956037|P4|Core Study|Protocol deviation|1
5200894|NCT01090310|17956038|P3|Core Study|Protocol deviation|0
5200895|NCT01090310|17956039|P2|Core Study|Protocol deviation|0
5200896|NCT01090310|17956040|P1|Core Study|Protocol deviation|1
5200897|NCT01090310|17956037|P4|Core Study|Administrative reasons|4
5200898|NCT01090310|17956038|P3|Core Study|Administrative reasons|4
5200899|NCT01090310|17956039|P2|Core Study|Administrative reasons|6
5200900|NCT01090310|17956040|P1|Core Study|Administrative reasons|5
5200901|NCT01090310|17956037|P4|Core Study|Abnormal test procedure result|0
5200902|NCT01090310|17956038|P3|Core Study|Abnormal test procedure result|1
5200903|NCT01090310|17956039|P2|Core Study|Abnormal test procedure result|0
5200904|NCT01090310|17956040|P1|Core Study|Abnormal test procedure result|0
5200905|NCT01090310|17956037|P4|Core Study|Subject withdrew consent|1
5200906|NCT01090310|17956038|P3|Core Study|Subject withdrew consent|1
5200907|NCT01090310|17956039|P2|Core Study|Subject withdrew consent|3
5200908|NCT01090310|17956040|P1|Core Study|Subject withdrew consent|0
5200909|NCT01090310|17956037|P4|Core Study|Adverse Event|1
5200910|NCT01090310|17956038|P3|Core Study|Adverse Event|1
5200911|NCT01090310|17956039|P2|Core Study|Adverse Event|2
5200912|NCT01090310|17956040|P1|Core Study|Adverse Event|2
5200913|NCT01090102|17956088|P2|Second 12 Weeks|Withdrawal by Subject|1
5200914|NCT01090102|17956089|P1|Second 12 Weeks|Withdrawal by Subject|0
5200915|NCT01090102|17956088|P2|First 12 Weeks|Death|1
5200916|NCT01090102|17956089|P1|First 12 Weeks|Death|1
5200917|NCT01090102|17956088|P2|First 12 Weeks|Adverse Event|0
5200918|NCT01090102|17956089|P1|First 12 Weeks|Adverse Event|2
5200919|NCT01090102|17956088|P2|First 12 Weeks|Withdrawal by Subject|1
5200920|NCT01090102|17956089|P1|First 12 Weeks|Withdrawal by Subject|1
5200921|NCT01090076|17956099|P2|Overall Study|Withdrawal by Subject|1
5200922|NCT01090076|17956100|P1|Overall Study|Withdrawal by Subject|0
5200923|NCT01090076|17956099|P2|Overall Study|Death|1
5200924|NCT01090076|17956100|P1|Overall Study|Death|1
5200925|NCT01090063|17956110|P1|Treatment|Withdrawal by Subject|4
5200926|NCT01090063|17956110|P1|Screen|Screen Failed|4
5200927|NCT01090050|17956126|P2|Overall Study|Physician Decision|1
5200928|NCT01090050|17956127|P1|Overall Study|Physician Decision|0
5200929|NCT01090050|17956126|P2|Overall Study|Lack of Efficacy|5
5200930|NCT01090050|17956127|P1|Overall Study|Lack of Efficacy|1
5200931|NCT01090050|17956126|P2|Overall Study|Lost to Follow-up|1
5200932|NCT01090050|17956127|P1|Overall Study|Lost to Follow-up|0
5200933|NCT01090011|17956147|P1|Overall Study|Other reason not defined above|5
5200934|NCT01090011|17956147|P1|Overall Study|Refusal to start/continue medication|5
5200935|NCT01090011|17956147|P1|Overall Study|Protocol Violation|1
5200936|NCT01090011|17956147|P1|Overall Study|Adverse Event|32
5200937|NCT01090011|17956147|P1|Overall Study|Progressive disease|128
5200938|NCT01089647|17956240|P2|Overall Study|Adverse Event|1
5200939|NCT01089647|17956241|P1|Overall Study|Adverse Event|0
5200940|NCT01089647|17956240|P2|Overall Study|Withdrawal by Subject|1
5200941|NCT01089647|17956241|P1|Overall Study|Withdrawal by Subject|2
5200942|NCT01089647|17956240|P2|Overall Study|Lost to Follow-up|2
5200943|NCT01089647|17956241|P1|Overall Study|Lost to Follow-up|2
5200944|NCT01089608|17956249|P2|Overall Study|Lost to Follow-up|2
5200945|NCT01089608|17956250|P1|Overall Study|Lost to Follow-up|0
5200946|NCT01089608|17956249|P2|Overall Study|Adverse Event|4
5200947|NCT01089608|17956250|P1|Overall Study|Adverse Event|0
5200948|NCT01089582|17956267|P1|Overall Study|Withdrawal by Subject|1
5200949|NCT01089582|17956267|P1|Overall Study|Other|4
5200950|NCT01089582|17956267|P1|Overall Study|Lost to Follow-up|8
5200951|NCT01089582|17956267|P1|Overall Study|Adverse Event|15
5200952|NCT01089582|17956267|P1|Overall Study|Death|2
5200953|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
5200954|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
5200955|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5200956|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
5200957|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5200958|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5200959|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
5200960|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
5200961|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
5200962|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
5200963|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
5200964|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
5200965|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
5200966|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
5200967|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
5200968|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
5200969|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
5200970|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
5200971|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5200972|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5200973|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5200974|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
5200975|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5200976|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5200977|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5200978|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
5200979|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
5200980|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5200981|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5200982|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5200983|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5200984|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5200985|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5200986|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5200987|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
5200988|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
5200989|NCT01089556|17956310|P6|Study Period III (Weeks 9-16)|Adverse Event|3
5200990|NCT01089556|17956311|P5|Study Period III (Weeks 9-16)|Adverse Event|4
5200991|NCT01089556|17956312|P4|Study Period III (Weeks 9-16)|Adverse Event|2
5200992|NCT01089556|17956313|P3|Study Period III (Weeks 9-16)|Adverse Event|4
5200993|NCT01089556|17956314|P2|Study Period III (Weeks 9-16)|Adverse Event|0
5200994|NCT01089556|17956315|P1|Study Period III (Weeks 9-16)|Adverse Event|0
5200995|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
5200996|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
5200997|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
5200998|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
5200999|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
5201000|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
5201001|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5201002|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5201003|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5201004|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5201005|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
5201006|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
5201007|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
5201008|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
5201009|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
5201010|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
5201011|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
5201012|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
5201013|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Physician Decision|0
5201014|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Physician Decision|0
5201015|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Physician Decision|0
5201016|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Physician Decision|0
5201017|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Physician Decision|0
5201018|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Physician Decision|4
5201019|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5201020|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5201021|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5201022|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5201023|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
5201024|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5201025|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5201026|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5201027|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5201028|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5201029|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
5201030|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
5201031|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5201032|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5201033|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5201034|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5201035|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
5201036|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
5201037|NCT01089556|17956310|P6|Study Period II (Weeks 1-8)|Adverse Event|0
5201038|NCT01089556|17956311|P5|Study Period II (Weeks 1-8)|Adverse Event|0
5201039|NCT01089556|17956312|P4|Study Period II (Weeks 1-8)|Adverse Event|0
5201040|NCT01089556|17956313|P3|Study Period II (Weeks 1-8)|Adverse Event|0
5201041|NCT01089556|17956314|P2|Study Period II (Weeks 1-8)|Adverse Event|39
5201042|NCT01089556|17956315|P1|Study Period II (Weeks 1-8)|Adverse Event|35
5201043|NCT01089543|17956389|P4|Overall Study|Adverse Event|0
5201044|NCT01089543|17956390|P3|Overall Study|Adverse Event|0
5201045|NCT01089543|17956391|P2|Overall Study|Adverse Event|1
5201046|NCT01089543|17956392|P1|Overall Study|Adverse Event|0
5201047|NCT01089543|17956389|P4|Overall Study|Physician Decision|1
5201048|NCT01089543|17956390|P3|Overall Study|Physician Decision|0
5201049|NCT01089543|17956391|P2|Overall Study|Physician Decision|0
5201050|NCT01089543|17956392|P1|Overall Study|Physician Decision|1
5201051|NCT01089543|17956389|P4|Overall Study|Withdrawal by Subject|1
5201052|NCT01089543|17956390|P3|Overall Study|Withdrawal by Subject|3
5201053|NCT01089543|17956391|P2|Overall Study|Withdrawal by Subject|3
5201054|NCT01089543|17956392|P1|Overall Study|Withdrawal by Subject|2
5201055|NCT01089504|17956427|P2|Overall Study|Withdrawal by Subject|0
5201056|NCT01089504|17956428|P1|Overall Study|Withdrawal by Subject|2
5201057|NCT01089504|17956427|P2|Overall Study|Lost to Follow-up|1
5201058|NCT01089504|17956428|P1|Overall Study|Lost to Follow-up|1
5201059|NCT01089413|17956441|P1|Overall Study|Other|71
5201060|NCT01089413|17956441|P1|Overall Study|Metastasectomy|13
5201061|NCT01089413|17956441|P1|Overall Study|Death|10
5201062|NCT01089413|17956441|P1|Overall Study|Unacceptable Toxicity|12
5201063|NCT01089413|17956441|P1|Overall Study|Participant Withdrew Consent|1
5201064|NCT01089413|17956441|P1|Overall Study|Progressive Disease|93
5201065|NCT01089413|17956441|P1|Overall Study|Lost to Follow-up|1
5201066|NCT01089361|17956460|P2|Overall Study|Death|0
5201067|NCT01089361|17956461|P1|Overall Study|Death|1
5201068|NCT01089127|17956510|P6|Overall Study|Protocol deviation|0
5201069|NCT01089127|17956511|P5|Overall Study|Protocol deviation|1
5201070|NCT01089127|17956512|P4|Overall Study|Protocol deviation|0
5201071|NCT01089127|17956513|P3|Overall Study|Protocol deviation|0
5201072|NCT01089127|17956514|P2|Overall Study|Protocol deviation|1
5201073|NCT01089127|17956515|P1|Overall Study|Protocol deviation|0
5201074|NCT01089127|17956510|P6|Overall Study|Lost to Follow-up|0
5201075|NCT01089127|17956511|P5|Overall Study|Lost to Follow-up|1
5201076|NCT01089127|17956512|P4|Overall Study|Lost to Follow-up|0
5201077|NCT01089127|17956513|P3|Overall Study|Lost to Follow-up|0
5201078|NCT01089127|17956514|P2|Overall Study|Lost to Follow-up|1
5201079|NCT01089127|17956515|P1|Overall Study|Lost to Follow-up|1
5201080|NCT01089127|17956510|P6|Overall Study|Abnormal test procedure result(s)|0
5201081|NCT01089127|17956511|P5|Overall Study|Abnormal test procedure result(s)|0
5201082|NCT01089127|17956512|P4|Overall Study|Abnormal test procedure result(s)|0
5201083|NCT01089127|17956513|P3|Overall Study|Abnormal test procedure result(s)|0
5201084|NCT01089127|17956514|P2|Overall Study|Abnormal test procedure result(s)|1
5201085|NCT01089127|17956515|P1|Overall Study|Abnormal test procedure result(s)|2
5201086|NCT01089127|17956510|P6|Overall Study|Subject withdrew consent|2
5201087|NCT01089127|17956511|P5|Overall Study|Subject withdrew consent|0
5201088|NCT01089127|17956512|P4|Overall Study|Subject withdrew consent|1
5201089|NCT01089127|17956513|P3|Overall Study|Subject withdrew consent|1
5201090|NCT01089127|17956514|P2|Overall Study|Subject withdrew consent|1
5201091|NCT01089127|17956515|P1|Overall Study|Subject withdrew consent|0
5201092|NCT01089127|17956510|P6|Overall Study|Adverse Event|1
5201093|NCT01089127|17956511|P5|Overall Study|Adverse Event|0
5201094|NCT01089127|17956512|P4|Overall Study|Adverse Event|0
5201095|NCT01089127|17956513|P3|Overall Study|Adverse Event|1
5201096|NCT01089127|17956514|P2|Overall Study|Adverse Event|1
5201097|NCT01089127|17956515|P1|Overall Study|Adverse Event|5
5201098|NCT01089023|17956569|P1|Overall Study|Lack of Efficacy|1
5201099|NCT01089023|17956569|P1|Overall Study|Protocol Violation|1
5201100|NCT01089023|17956569|P1|Overall Study|Withdrawal by Subject|1
5201101|NCT01089023|17956569|P1|Overall Study|Adverse Event|1
5201102|NCT01089023|17956569|P1|Overall Study|Lost to Follow-up|3
5201103|NCT01088997|17956583|P2|Overall Study|Excluded prior to receiving drug|1
5201104|NCT01088997|17956584|P1|Overall Study|Excluded prior to receiving drug|1
5201105|NCT01088997|17956583|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
5201106|NCT01088997|17956584|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
5201107|NCT01088997|17956583|P2|Overall Study|Physician Decision|1
5201108|NCT01088997|17956584|P1|Overall Study|Physician Decision|1
5201109|NCT01088984|17956595|P2|Phase 2|Other|1
5201110|NCT01088984|17956596|P1|Phase 2|Other|0
5201111|NCT01088984|17956595|P2|Phase 2|DIsease Progression|25
5201112|NCT01088984|17956596|P1|Phase 2|DIsease Progression|0
5201113|NCT01088984|17956595|P2|Phase 2|Withdrawal by Subject|1
5201114|NCT01088984|17956596|P1|Phase 2|Withdrawal by Subject|0
5201115|NCT01088984|17956595|P2|Phase 2|Death|5
5201116|NCT01088984|17956596|P1|Phase 2|Death|0
5201117|NCT01088984|17956595|P2|Phase 1|Other|1
5201118|NCT01088984|17956596|P1|Phase 1|Other|1
5201119|NCT01088984|17956595|P2|Phase 1|Disease Progression|4
5201120|NCT01088984|17956596|P1|Phase 1|Disease Progression|2
5201121|NCT01088984|17956595|P2|Phase 1|Death|1
5201122|NCT01088984|17956596|P1|Phase 1|Death|2
5201123|NCT01088529|17956667|P2|Overall Study|Did not receive study treatment|1
5201124|NCT01088529|17956668|P1|Overall Study|Did not receive study treatment|0
5201125|NCT01088503|17956681|P3|Overall Study|Death|7
5201126|NCT01088503|17956682|P2|Overall Study|Death|358
5201127|NCT01088503|17956683|P1|Overall Study|Death|64
5201128|NCT01088503|17956681|P3|Overall Study|Withdrawal by Subject|10
5201129|NCT01088503|17956682|P2|Overall Study|Withdrawal by Subject|327
5201130|NCT01088503|17956683|P1|Overall Study|Withdrawal by Subject|118
5201131|NCT01088438|17956761|P2|Overall Study|Lost to Follow-up|30
5201132|NCT01088438|17956762|P1|Overall Study|Lost to Follow-up|18
5201133|NCT01088438|17956761|P2|Overall Study|Withdrawal by Subject|6
5201134|NCT01088438|17956762|P1|Overall Study|Withdrawal by Subject|11
5201135|NCT01088412|17956775|P3|Overall Study|Study Summary Not Completed|22
5201136|NCT01088412|17956776|P2|Overall Study|Study Summary Not Completed|64
5201137|NCT01088412|17956777|P1|Overall Study|Study Summary Not Completed|4360
5201138|NCT01088412|17956775|P3|Overall Study|Lost to Follow-up|11
5201139|NCT01088412|17956776|P2|Overall Study|Lost to Follow-up|130
5201140|NCT01088412|17956777|P1|Overall Study|Lost to Follow-up|3052
5201141|NCT01088412|17956775|P3|Overall Study|Third Party Required to Change Brand|0
5201142|NCT01088412|17956776|P2|Overall Study|Third Party Required to Change Brand|0
5201143|NCT01088412|17956777|P1|Overall Study|Third Party Required to Change Brand|487
5201144|NCT01088412|17956775|P3|Overall Study|Sponsor Decision|23
5201145|NCT01088412|17956776|P2|Overall Study|Sponsor Decision|79
5201146|NCT01088412|17956777|P1|Overall Study|Sponsor Decision|4467
5201147|NCT01088412|17956775|P3|Overall Study|Physician Decision|4
5201148|NCT01088412|17956776|P2|Overall Study|Physician Decision|8
5201149|NCT01088412|17956777|P1|Overall Study|Physician Decision|1041
5201150|NCT01088412|17956775|P3|Overall Study|Participant Moved|2
5201151|NCT01088412|17956776|P2|Overall Study|Participant Moved|21
5201152|NCT01088412|17956777|P1|Overall Study|Participant Moved|601
5201153|NCT01088412|17956775|P3|Overall Study|Received Another GH Product|0
5201154|NCT01088412|17956776|P2|Overall Study|Received Another GH Product|0
5201155|NCT01088412|17956777|P1|Overall Study|Received Another GH Product|79
5201156|NCT01088412|17956775|P3|Overall Study|Withdrawal by Subject|1
5201157|NCT01088412|17956776|P2|Overall Study|Withdrawal by Subject|25
5201158|NCT01088412|17956777|P1|Overall Study|Withdrawal by Subject|1761
5201159|NCT01088412|17956775|P3|Overall Study|Other Reason per Case Report Form|9
5201160|NCT01088412|17956776|P2|Overall Study|Other Reason per Case Report Form|103
5201161|NCT01088412|17956777|P1|Overall Study|Other Reason per Case Report Form|2089
5201162|NCT01088412|17956775|P3|Overall Study|Death|0
5201163|NCT01088412|17956776|P2|Overall Study|Death|6
5201164|NCT01088412|17956777|P1|Overall Study|Death|42
5201165|NCT01088412|17956775|P3|Overall Study|Adverse Event|0
5201166|NCT01088412|17956776|P2|Overall Study|Adverse Event|0
5201167|NCT01088412|17956777|P1|Overall Study|Adverse Event|38
5201168|NCT01088399|17956796|P3|Overall Study|Study summary visit not completed|80
5201169|NCT01088399|17956797|P2|Overall Study|Study summary visit not completed|283
5201170|NCT01088399|17956798|P1|Overall Study|Study summary visit not completed|2398
5201171|NCT01088399|17956796|P3|Overall Study|Enrollment criteria not met|70
5201172|NCT01088399|17956797|P2|Overall Study|Enrollment criteria not met|119
5201173|NCT01088399|17956798|P1|Overall Study|Enrollment criteria not met|48
5201174|NCT01088399|17956796|P3|Overall Study|Protocol Violation|0
5201175|NCT01088399|17956797|P2|Overall Study|Protocol Violation|1
5201176|NCT01088399|17956798|P1|Overall Study|Protocol Violation|10
5201177|NCT01088399|17956796|P3|Overall Study|Sponsor decision|7
5201178|NCT01088399|17956797|P2|Overall Study|Sponsor decision|298
5201179|NCT01088399|17956798|P1|Overall Study|Sponsor decision|1573
5201180|NCT01088399|17956796|P3|Overall Study|Change to or start of somatropin therapy|12
5201181|NCT01088399|17956797|P2|Overall Study|Change to or start of somatropin therapy|17
5201182|NCT01088399|17956798|P1|Overall Study|Change to or start of somatropin therapy|234
5201183|NCT01088399|17956796|P3|Overall Study|Withdrawal by Subject|33
5201184|NCT01088399|17956797|P2|Overall Study|Withdrawal by Subject|195
5201185|NCT01088399|17956798|P1|Overall Study|Withdrawal by Subject|544
5201186|NCT01088399|17956796|P3|Overall Study|Physician Decision|16
5201187|NCT01088399|17956797|P2|Overall Study|Physician Decision|88
5201188|NCT01088399|17956798|P1|Overall Study|Physician Decision|531
5201189|NCT01088399|17956796|P3|Overall Study|Lost to Follow-up|58
5201190|NCT01088399|17956797|P2|Overall Study|Lost to Follow-up|278
5201191|NCT01088399|17956798|P1|Overall Study|Lost to Follow-up|1070
5201192|NCT01088399|17956796|P3|Overall Study|Lack of Efficacy|5
5201193|NCT01088399|17956797|P2|Overall Study|Lack of Efficacy|7
5201194|NCT01088399|17956798|P1|Overall Study|Lack of Efficacy|298
5201195|NCT01088399|17956796|P3|Overall Study|Death|0
5201196|NCT01088399|17956797|P2|Overall Study|Death|45
5201197|NCT01088399|17956798|P1|Overall Study|Death|204
5201198|NCT01088399|17956796|P3|Overall Study|Adverse Event|0
5201199|NCT01088399|17956797|P2|Overall Study|Adverse Event|16
5201200|NCT01088399|17956798|P1|Overall Study|Adverse Event|211
5201201|NCT01088243|17956827|P2|Overall Study|Adverse Event|0
5201202|NCT01088243|17956828|P1|Overall Study|Adverse Event|1
5201203|NCT01087970|17956869|P1|Overall Study|Protocol Violation|2
5201204|NCT01087957|17956881|P2|Overall Study|Physician Decision|9
5201205|NCT01087957|17956882|P1|Overall Study|Physician Decision|5
5201206|NCT01087957|17956881|P2|Overall Study|Withdrawal by Subject|15
5201207|NCT01087957|17956882|P1|Overall Study|Withdrawal by Subject|18
5201208|NCT01087957|17956881|P2|Overall Study|Protocol Violation|25
5201209|NCT01087957|17956882|P1|Overall Study|Protocol Violation|13
5201210|NCT01087957|17956881|P2|Overall Study|Lost to Follow-up|4
5201211|NCT01087957|17956882|P1|Overall Study|Lost to Follow-up|3
5201212|NCT01087957|17956881|P2|Overall Study|Death|2
5201213|NCT01087957|17956882|P1|Overall Study|Death|2
5201214|NCT01087944|17956908|P2|Period 2 (Week 4-6)|Adverse Event|2
5201215|NCT01087944|17956909|P1|Period 2 (Week 4-6)|Adverse Event|0
5201216|NCT01087944|17956908|P2|Period 1 (Week 1-3)|Adverse Event|0
5201217|NCT01087944|17956909|P1|Period 1 (Week 1-3)|Adverse Event|1
5201218|NCT01087905|17956989|P8|Overall Study|Withdrawal by Subject|5
5201219|NCT01087905|17956990|P7|Overall Study|Withdrawal by Subject|3
5201220|NCT01087905|17956991|P6|Overall Study|Withdrawal by Subject|3
5201221|NCT01087905|17956992|P5|Overall Study|Withdrawal by Subject|4
5201222|NCT01087905|17956993|P4|Overall Study|Withdrawal by Subject|5
5201223|NCT01087905|17956994|P3|Overall Study|Withdrawal by Subject|4
5201224|NCT01087905|17956995|P2|Overall Study|Withdrawal by Subject|4
5201225|NCT01087905|17956996|P1|Overall Study|Withdrawal by Subject|5
5201226|NCT01087905|17956989|P8|Overall Study|Lost to Follow-up|24
5201227|NCT01087905|17956990|P7|Overall Study|Lost to Follow-up|20
5201228|NCT01087905|17956991|P6|Overall Study|Lost to Follow-up|25
5201229|NCT01087905|17956992|P5|Overall Study|Lost to Follow-up|27
5201230|NCT01087905|17956993|P4|Overall Study|Lost to Follow-up|31
5201231|NCT01087905|17956994|P3|Overall Study|Lost to Follow-up|18
5201232|NCT01087905|17956995|P2|Overall Study|Lost to Follow-up|28
5201233|NCT01087905|17956996|P1|Overall Study|Lost to Follow-up|24
5201234|NCT01087814|17957018|P2|Second Intervention (5 Days)|Physician Decision|0
5201235|NCT01087814|17957019|P1|Second Intervention (5 Days)|Physician Decision|1
5201236|NCT01087814|17957018|P2|First Intervention (5 Days)|Withdrawal by Subject|1
5201237|NCT01087814|17957019|P1|First Intervention (5 Days)|Withdrawal by Subject|3
5201238|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Personal reasons|1
5201239|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Personal reasons|0
5201240|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Personal reasons|0
5201241|NCT01087788|17957037|P3|Open-Label Period (OL-P)|No participation in study extension|1
5201242|NCT01087788|17957038|P2|Open-Label Period (OL-P)|No participation in study extension|0
5201243|NCT01087788|17957039|P1|Open-Label Period (OL-P)|No participation in study extension|0
5201244|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Principal investigator decision|2
5201245|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Principal investigator decision|1
5201246|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Principal investigator decision|0
5201247|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Sponsor request|0
5201248|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Sponsor request|0
5201249|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Sponsor request|1
5201250|NCT01087788|17957037|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
5201251|NCT01087788|17957038|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
5201252|NCT01087788|17957039|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
5201253|NCT01087788|17957037|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
5201254|NCT01087788|17957038|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
5201255|NCT01087788|17957039|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
5201256|NCT01087788|17957037|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
5201257|NCT01087788|17957038|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
5201258|NCT01087788|17957039|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
5201259|NCT01087788|17957037|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
5201260|NCT01087788|17957038|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
5201261|NCT01087788|17957039|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
5201262|NCT01087788|17957037|P3|Open-Label Period (OL-P)|AE, serious fatal|1
5201263|NCT01087788|17957038|P2|Open-Label Period (OL-P)|AE, serious fatal|0
5201264|NCT01087788|17957039|P1|Open-Label Period (OL-P)|AE, serious fatal|2
5201265|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
5201266|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
5201267|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
5201268|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
5201269|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
5201270|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
5201271|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Protocol Violation|0
5201272|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Protocol Violation|1
5201273|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Protocol Violation|2
5201274|NCT01087788|17957037|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
5201275|NCT01087788|17957038|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
5201276|NCT01087788|17957039|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
5201277|NCT01087788|17957037|P3|24-weeks Dose-blind Period|Patient moved|1
5201278|NCT01087788|17957038|P2|24-weeks Dose-blind Period|Patient moved|0
5201279|NCT01087788|17957039|P1|24-weeks Dose-blind Period|Patient moved|0
5201280|NCT01087788|17957037|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
5201281|NCT01087788|17957038|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
5201282|NCT01087788|17957039|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
5201283|NCT01087788|17957037|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
5201284|NCT01087788|17957038|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
5201285|NCT01087788|17957039|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
5201286|NCT01087788|17957037|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
5201287|NCT01087788|17957038|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
5201288|NCT01087788|17957039|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
5201289|NCT01087788|17957037|P3|24-weeks Dose-blind Period|AE, serious fatal|0
5201290|NCT01087788|17957038|P2|24-weeks Dose-blind Period|AE, serious fatal|1
5201291|NCT01087788|17957039|P1|24-weeks Dose-blind Period|AE, serious fatal|0
5201292|NCT01087788|17957037|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
5201293|NCT01087788|17957038|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
5201294|NCT01087788|17957039|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
5201295|NCT01087788|17957037|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
5201296|NCT01087788|17957038|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
5201297|NCT01087788|17957039|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
5201298|NCT01087788|17957037|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
5201299|NCT01087788|17957038|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
5201300|NCT01087788|17957039|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
5201301|NCT01087788|17957037|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
5201302|NCT01087788|17957038|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
5201303|NCT01087788|17957039|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
5201304|NCT01087788|17957037|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
5201305|NCT01087788|17957038|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
5201306|NCT01087788|17957039|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
5201307|NCT01087788|17957037|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
5201308|NCT01087788|17957038|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
5201309|NCT01087788|17957039|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
5201310|NCT01087788|17957037|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
5201311|NCT01087788|17957038|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
5201312|NCT01087788|17957039|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
5201313|NCT01087788|17957037|P3|24-weeks Double-blind Period|AE, unknown type|1
5201314|NCT01087788|17957038|P2|24-weeks Double-blind Period|AE, unknown type|0
5201315|NCT01087788|17957039|P1|24-weeks Double-blind Period|AE, unknown type|0
5201316|NCT01087788|17957037|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
5201317|NCT01087788|17957038|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
5201318|NCT01087788|17957039|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
5201319|NCT01087788|17957037|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
5201320|NCT01087788|17957038|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
5201321|NCT01087788|17957039|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
5201322|NCT01087788|17957037|P3|24-weeks Double-blind Period|AE, serious fatal|1
5201323|NCT01087788|17957038|P2|24-weeks Double-blind Period|AE, serious fatal|1
5201324|NCT01087788|17957039|P1|24-weeks Double-blind Period|AE, serious fatal|0
5201325|NCT01087788|17957037|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
5201326|NCT01087788|17957038|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
5201327|NCT01087788|17957039|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
5201328|NCT01087788|17957037|P3|24-weeks Double-blind Period|Lost to Follow-up|1
5201329|NCT01087788|17957038|P2|24-weeks Double-blind Period|Lost to Follow-up|1
5201330|NCT01087788|17957039|P1|24-weeks Double-blind Period|Lost to Follow-up|4
5201331|NCT01087788|17957037|P3|24-weeks Double-blind Period|Protocol Violation|0
5201332|NCT01087788|17957038|P2|24-weeks Double-blind Period|Protocol Violation|1
5201333|NCT01087788|17957039|P1|24-weeks Double-blind Period|Protocol Violation|0
5201334|NCT01087788|17957037|P3|24-weeks Double-blind Period|Lack of Efficacy|1
5201335|NCT01087788|17957038|P2|24-weeks Double-blind Period|Lack of Efficacy|0
5201336|NCT01087788|17957039|P1|24-weeks Double-blind Period|Lack of Efficacy|2
5201337|NCT01087775|17957066|P1|Overall Study|failed inclusion criteria|2
5201338|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
5201339|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
5201340|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5201341|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5201342|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5201343|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
5201344|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
5201345|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5201346|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5201347|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5201348|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
5201349|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
5201350|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5201351|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5201352|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5201353|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|Other|4
5201354|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|Other|2
5201355|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|Other|0
5201356|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|Other|0
5201357|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|Other|0
5201358|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
5201359|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
5201360|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5201361|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5201362|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5201363|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
5201364|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
5201365|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5201366|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5201367|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5201368|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
5201369|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
5201370|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5201371|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5201372|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5201373|NCT01087762|17957074|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
5201374|NCT01087762|17957075|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
5201375|NCT01087762|17957076|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5201376|NCT01087762|17957077|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5201377|NCT01087762|17957078|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5201378|NCT01087762|17957074|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
5201379|NCT01087762|17957075|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
5201380|NCT01087762|17957076|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
5201381|NCT01087762|17957077|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
5201382|NCT01087762|17957078|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
5201383|NCT01087762|17957074|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
5201384|NCT01087762|17957075|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
5201385|NCT01087762|17957076|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
5201386|NCT01087762|17957077|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
5201387|NCT01087762|17957078|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
5201388|NCT01087762|17957074|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
5201389|NCT01087762|17957075|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
5201390|NCT01087762|17957076|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
5201391|NCT01087762|17957077|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
5201392|NCT01087762|17957078|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
5201393|NCT01087762|17957074|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5201394|NCT01087762|17957075|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5201395|NCT01087762|17957076|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
5201396|NCT01087762|17957077|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5201397|NCT01087762|17957078|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
5201398|NCT01087762|17957074|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5201399|NCT01087762|17957075|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5201400|NCT01087762|17957076|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
5201401|NCT01087762|17957077|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5201402|NCT01087762|17957078|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
5201403|NCT01087736|17957126|P2|Overall Study|Withdrawal by Subject|1
5201404|NCT01087736|17957127|P1|Overall Study|Withdrawal by Subject|0
5201405|NCT01087736|17957126|P2|Overall Study|Death|1
5201406|NCT01087736|17957127|P1|Overall Study|Death|0
5201407|NCT01087736|17957126|P2|Overall Study|Lost to Follow-up|0
5201408|NCT01087736|17957127|P1|Overall Study|Lost to Follow-up|1
5201409|NCT01087723|17957137|P2|Overall Study|Reason Not Specified|2
5201410|NCT01087723|17957138|P1|Overall Study|Reason Not Specified|1
5201411|NCT01087723|17957137|P2|Overall Study|Lost to Follow-up|4
5201412|NCT01087723|17957138|P1|Overall Study|Lost to Follow-up|1
5201413|NCT01087723|17957137|P2|Overall Study|Physician Decision|0
5201414|NCT01087723|17957138|P1|Overall Study|Physician Decision|2
5201415|NCT01087723|17957137|P2|Overall Study|Withdrawal by Subject|13
5201416|NCT01087723|17957138|P1|Overall Study|Withdrawal by Subject|10
5201417|NCT01087723|17957137|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
5201418|NCT01087723|17957138|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
5201419|NCT01087528|17957179|P1|Overall Study|Incomplete CE procedure|6
5201420|NCT01087528|17957179|P1|Overall Study|Withdrawal by Subject|1
5201421|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
5201422|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
5201423|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
5201424|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
5201425|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
5201426|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
5201427|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
5201428|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
5201429|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
5201430|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
5201431|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
5201432|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
5201433|NCT01087502|17957191|P2|Up to Final Analysis (Week 52)|Adverse Event|10
5201434|NCT01087502|17957192|P1|Up to Final Analysis (Week 52)|Adverse Event|17
5201435|NCT01087502|17957191|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
5201436|NCT01087502|17957192|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
5201437|NCT01087502|17957191|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
5201438|NCT01087502|17957192|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
5201439|NCT01087502|17957191|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
5201440|NCT01087502|17957192|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
5201441|NCT01087502|17957191|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
5201442|NCT01087502|17957192|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
5201443|NCT01087502|17957191|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
5201444|NCT01087502|17957192|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
5201445|NCT01087489|17957211|P2|Overall Study|unable to survey by telephone|1
5201446|NCT01087489|17957212|P1|Overall Study|unable to survey by telephone|0
5201447|NCT01087489|17957211|P2|Overall Study|Death|1
5201448|NCT01087489|17957212|P1|Overall Study|Death|0
5201449|NCT01087489|17957211|P2|Overall Study|enrolled in another VA study|1
5201450|NCT01087489|17957212|P1|Overall Study|enrolled in another VA study|0
5201451|NCT01086969|17957225|P3|Overall Study|Withdrawal by Subject|0
5201452|NCT01086969|17957226|P2|Overall Study|Withdrawal by Subject|2
5201453|NCT01086969|17957227|P1|Overall Study|Withdrawal by Subject|1
5201454|NCT01086540|17957323|P2|Overall Study|Addition of new therapy for PAH|0
5201455|NCT01086540|17957324|P1|Overall Study|Addition of new therapy for PAH|1
5201456|NCT01086540|17957323|P2|Overall Study|Physician Decision|1
5201457|NCT01086540|17957324|P1|Overall Study|Physician Decision|2
5201458|NCT01086540|17957323|P2|Overall Study|Death|1
5201459|NCT01086540|17957324|P1|Overall Study|Death|3
5201460|NCT01086423|17957382|P3|Overall Study|Lost to Follow-up|1
5201461|NCT01086423|17957383|P2|Overall Study|Lost to Follow-up|0
5201462|NCT01086423|17957384|P1|Overall Study|Lost to Follow-up|0
5201463|NCT01086423|17957382|P3|Overall Study|Withdrawal by Subject|3
5201464|NCT01086423|17957383|P2|Overall Study|Withdrawal by Subject|1
5201465|NCT01086423|17957384|P1|Overall Study|Withdrawal by Subject|5
5201466|NCT01086423|17957382|P3|Overall Study|Adverse event, non-fatal|0
5201467|NCT01086423|17957383|P2|Overall Study|Adverse event, non-fatal|1
5201468|NCT01086423|17957384|P1|Overall Study|Adverse event, non-fatal|2
5201469|NCT01086423|17957382|P3|Overall Study|Adverse event, fatal|0
5201470|NCT01086423|17957383|P2|Overall Study|Adverse event, fatal|1
5201471|NCT01086423|17957384|P1|Overall Study|Adverse event, fatal|1
5201472|NCT01086423|17957382|P3|Overall Study|Migrated/moved from study area|4
5201473|NCT01086423|17957383|P2|Overall Study|Migrated/moved from study area|0
5201474|NCT01086423|17957384|P1|Overall Study|Migrated/moved from study area|2
5201475|NCT01086423|17957382|P3|Overall Study|Protocol Violation|1
5201476|NCT01086423|17957383|P2|Overall Study|Protocol Violation|0
5201477|NCT01086423|17957384|P1|Overall Study|Protocol Violation|0
5201478|NCT01086410|17957429|P4|Overall Study|Lost to Follow-up|0
5201479|NCT01086410|17957430|P3|Overall Study|Lost to Follow-up|1
5201480|NCT01086410|17957431|P2|Overall Study|Lost to Follow-up|0
5201481|NCT01086410|17957432|P1|Overall Study|Lost to Follow-up|0
5201482|NCT01086410|17957429|P4|Overall Study|Protocol Violation|0
5201483|NCT01086410|17957430|P3|Overall Study|Protocol Violation|0
5201484|NCT01086410|17957431|P2|Overall Study|Protocol Violation|1
5201485|NCT01086410|17957432|P1|Overall Study|Protocol Violation|1
5201486|NCT01086410|17957429|P4|Overall Study|Lack of Efficacy|0
5201487|NCT01086410|17957430|P3|Overall Study|Lack of Efficacy|0
5201488|NCT01086410|17957431|P2|Overall Study|Lack of Efficacy|1
5201489|NCT01086410|17957432|P1|Overall Study|Lack of Efficacy|1
5201490|NCT01086410|17957429|P4|Overall Study|Adverse Event|2
5201491|NCT01086410|17957430|P3|Overall Study|Adverse Event|0
5201492|NCT01086410|17957431|P2|Overall Study|Adverse Event|0
5201493|NCT01086410|17957432|P1|Overall Study|Adverse Event|1
5201494|NCT01086384|17957528|P3|Treatment Period|Received Treatment in Error|0
5201495|NCT01086384|17957529|P2|Treatment Period|Received Treatment in Error|1
5201496|NCT01086384|17957530|P1|Treatment Period|Received Treatment in Error|0
5201497|NCT01086384|17957528|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
5201498|NCT01086384|17957529|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
5201499|NCT01086384|17957530|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
5201500|NCT01086384|17957528|P3|Treatment Period|Study Closed/Terminated|8
5201501|NCT01086384|17957529|P2|Treatment Period|Study Closed/Terminated|7
5201502|NCT01086384|17957530|P1|Treatment Period|Study Closed/Terminated|0
5201503|NCT01086384|17957528|P3|Treatment Period|Physician Decision|6
5201504|NCT01086384|17957529|P2|Treatment Period|Physician Decision|9
5201505|NCT01086384|17957530|P1|Treatment Period|Physician Decision|0
5201506|NCT01086384|17957528|P3|Treatment Period|Lost to Follow-up|9
5201507|NCT01086384|17957529|P2|Treatment Period|Lost to Follow-up|11
5201508|NCT01086384|17957530|P1|Treatment Period|Lost to Follow-up|0
5201509|NCT01086384|17957528|P3|Treatment Period|Adverse Event|15
5201510|NCT01086384|17957529|P2|Treatment Period|Adverse Event|19
5201511|NCT01086384|17957530|P1|Treatment Period|Adverse Event|0
5201512|NCT01086384|17957528|P3|Treatment Period|Lack of Efficacy|13
5201513|NCT01086384|17957529|P2|Treatment Period|Lack of Efficacy|22
5201514|NCT01086384|17957530|P1|Treatment Period|Lack of Efficacy|0
5201515|NCT01086384|17957528|P3|Treatment Period|Protocol Violation|17
5201516|NCT01086384|17957529|P2|Treatment Period|Protocol Violation|26
5201517|NCT01086384|17957530|P1|Treatment Period|Protocol Violation|0
5201518|NCT01086384|17957528|P3|Treatment Period|Withdrawal by Subject|55
5201519|NCT01086384|17957529|P2|Treatment Period|Withdrawal by Subject|53
5201520|NCT01086384|17957530|P1|Treatment Period|Withdrawal by Subject|0
5201521|NCT01086384|17957528|P3|2-week Run-in Period|Randomized in Error|0
5201522|NCT01086384|17957529|P2|2-week Run-in Period|Randomized in Error|0
5201523|NCT01086384|17957530|P1|2-week Run-in Period|Randomized in Error|1
5201524|NCT01086384|17957528|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5201525|NCT01086384|17957529|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5201526|NCT01086384|17957530|P1|2-week Run-in Period|Continuation Criteria Not Met|92
5201527|NCT01086384|17957528|P3|2-week Run-in Period|Study Closed/Terminated|0
5201528|NCT01086384|17957529|P2|2-week Run-in Period|Study Closed/Terminated|0
5201529|NCT01086384|17957530|P1|2-week Run-in Period|Study Closed/Terminated|42
5201530|NCT01086384|17957528|P3|2-week Run-in Period|Withdrawal by Subject|0
5201531|NCT01086384|17957529|P2|2-week Run-in Period|Withdrawal by Subject|0
5201532|NCT01086384|17957530|P1|2-week Run-in Period|Withdrawal by Subject|19
5201533|NCT01086384|17957528|P3|2-week Run-in Period|Physician Decision|0
5201534|NCT01086384|17957529|P2|2-week Run-in Period|Physician Decision|0
5201535|NCT01086384|17957530|P1|2-week Run-in Period|Physician Decision|6
5201536|NCT01086384|17957528|P3|2-week Run-in Period|Lost to Follow-up|0
5201537|NCT01086384|17957529|P2|2-week Run-in Period|Lost to Follow-up|0
5201538|NCT01086384|17957530|P1|2-week Run-in Period|Lost to Follow-up|1
5201539|NCT01086384|17957528|P3|2-week Run-in Period|Protocol Violation|0
5201540|NCT01086384|17957529|P2|2-week Run-in Period|Protocol Violation|0
5201541|NCT01086384|17957530|P1|2-week Run-in Period|Protocol Violation|1
5201542|NCT01086384|17957528|P3|2-week Run-in Period|Adverse Event|0
5201543|NCT01086384|17957529|P2|2-week Run-in Period|Adverse Event|0
5201544|NCT01086384|17957530|P1|2-week Run-in Period|Adverse Event|1
5201545|NCT01086358|17957540|P2|Second Intervention|Lost to Follow-up|4
5201546|NCT01086358|17957541|P1|Second Intervention|Lost to Follow-up|4
5201547|NCT01086358|17957540|P2|First Intervention|Withdrawal by Subject|1
5201548|NCT01086358|17957541|P1|First Intervention|Withdrawal by Subject|0
5201549|NCT01086358|17957540|P2|First Intervention|Lost to Follow-up|4
5201550|NCT01086358|17957541|P1|First Intervention|Lost to Follow-up|9
5201551|NCT01086215|17957611|P4|Overall Study|Lost to Follow-up|2
5201552|NCT01086215|17957612|P3|Overall Study|Lost to Follow-up|18
5201553|NCT01086215|17957613|P2|Overall Study|Lost to Follow-up|39
5201554|NCT01086215|17957614|P1|Overall Study|Lost to Follow-up|22
5201555|NCT01086215|17957611|P4|Overall Study|Death|1
5201556|NCT01086215|17957612|P3|Overall Study|Death|8
5201557|NCT01086215|17957613|P2|Overall Study|Death|8
5201558|NCT01086215|17957614|P1|Overall Study|Death|14
5201559|NCT01086150|17957635|P3|Overall Study|Screen Failure|0
5201560|NCT01086150|17957636|P2|Overall Study|Screen Failure|1
5201561|NCT01086150|17957637|P1|Overall Study|Screen Failure|0
5201562|NCT01086150|17957635|P3|Overall Study|Lost to Follow-up|0
5201563|NCT01086150|17957636|P2|Overall Study|Lost to Follow-up|1
5201564|NCT01086150|17957637|P1|Overall Study|Lost to Follow-up|0
5201565|NCT01086150|17957635|P3|Overall Study|Withdrawal by Subject|1
5201566|NCT01086150|17957636|P2|Overall Study|Withdrawal by Subject|4
5201567|NCT01086150|17957637|P1|Overall Study|Withdrawal by Subject|0
5201568|NCT01086033|17957648|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
5201569|NCT01086033|17957648|P1|Overall Study|AE and Other Reason|1
5201570|NCT01086033|17957648|P1|Overall Study|AE and Lost to Follow-up|1
5201571|NCT01086033|17957648|P1|Overall Study|Death|1
5201572|NCT01086033|17957648|P1|Overall Study|AE and Lack of Efficacy|4
5201573|NCT01086033|17957648|P1|Overall Study|Withdrew consent and Other Reason|4
5201574|NCT01086033|17957648|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
5201575|NCT01086033|17957648|P1|Overall Study|AE and Withdrew Consent|5
5201576|NCT01086033|17957648|P1|Overall Study|Other|13
5201577|NCT01086033|17957648|P1|Overall Study|Other|14
5201578|NCT01086033|17957648|P1|Overall Study|Withdrawal by Subject|41
5201579|NCT01086033|17957648|P1|Overall Study|Adverse Event|42
5201580|NCT01086033|17957648|P1|Overall Study|Lost to Follow-up|86
5201581|NCT01086033|17957648|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
5201582|NCT01085812|17957714|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
5201583|NCT01085812|17957715|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
5201584|NCT01085812|17957714|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
5201585|NCT01085812|17957715|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
5201586|NCT01085812|17957714|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
5201587|NCT01085812|17957715|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
5201588|NCT01085812|17957714|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
5201589|NCT01085812|17957715|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
5201590|NCT01085812|17957714|P2|Double-blind Intent-to-treat Population|Adverse Event|8
5201591|NCT01085812|17957715|P1|Double-blind Intent-to-treat Population|Adverse Event|3
5201592|NCT01085812|17957714|P2|Double-Blind Period|Other Reasons|2
5201593|NCT01085812|17957715|P1|Double-Blind Period|Other Reasons|0
5201594|NCT01085812|17957714|P2|Double-Blind Period|Lost to Follow-up|17
5201595|NCT01085812|17957715|P1|Double-Blind Period|Lost to Follow-up|5
5201596|NCT01085812|17957714|P2|Double-Blind Period|Withdrawal by Subject|24
5201597|NCT01085812|17957715|P1|Double-Blind Period|Withdrawal by Subject|11
5201598|NCT01085812|17957714|P2|Double-Blind Period|Protocol Violation|7
5201599|NCT01085812|17957715|P1|Double-Blind Period|Protocol Violation|2
5201600|NCT01085812|17957714|P2|Double-Blind Period|Adverse Event|8
5201601|NCT01085812|17957715|P1|Double-Blind Period|Adverse Event|3
5201602|NCT01085812|17957714|P2|Open-Label Period|Lost to Follow-up|42
5201603|NCT01085812|17957715|P1|Open-Label Period|Lost to Follow-up|0
5201604|NCT01085812|17957714|P2|Open-Label Period|Withdrawal by Subject|53
5201605|NCT01085812|17957715|P1|Open-Label Period|Withdrawal by Subject|0
5201606|NCT01085812|17957714|P2|Open-Label Period|Protocol Violation|39
5201607|NCT01085812|17957715|P1|Open-Label Period|Protocol Violation|0
5201608|NCT01085812|17957714|P2|Open-Label Period|Lack of Efficacy|26
5201609|NCT01085812|17957715|P1|Open-Label Period|Lack of Efficacy|0
5201610|NCT01085812|17957714|P2|Open-Label Period|Adverse Event|80
5201611|NCT01085812|17957715|P1|Open-Label Period|Adverse Event|0
5201612|NCT01085734|17957762|P2|Overall Study|Withdrawal by Subject|1
5201613|NCT01085734|17957763|P1|Overall Study|Withdrawal by Subject|0
5201614|NCT01085734|17957762|P2|Overall Study|Lost to Follow-up|1
5201615|NCT01085734|17957763|P1|Overall Study|Lost to Follow-up|0
5201616|NCT01085734|17957762|P2|Overall Study|Death|0
5201617|NCT01085734|17957763|P1|Overall Study|Death|1
5201618|NCT01085734|17957762|P2|Overall Study|Adverse Event|2
5201619|NCT01085734|17957763|P1|Overall Study|Adverse Event|0
5201620|NCT01085682|17957775|P2|Overall Study|Withdrawal by Subject|25
5201621|NCT01085682|17957776|P1|Overall Study|Withdrawal by Subject|25
5201622|NCT01085630|17957793|P2|Overall Study|Ineligible|0
5201623|NCT01085630|17957794|P1|Overall Study|Ineligible|3
5201624|NCT01085630|17957793|P2|Overall Study|Insufficient data|0
5201625|NCT01085630|17957794|P1|Overall Study|Insufficient data|1
5201626|NCT01085591|17957807|P3|Overall Study|Not Properly Consented|0
5201627|NCT01085591|17957808|P2|Overall Study|Not Properly Consented|0
5201628|NCT01085591|17957809|P1|Overall Study|Not Properly Consented|1
5201629|NCT01085591|17957807|P3|Overall Study|Other|0
5201630|NCT01085591|17957808|P2|Overall Study|Other|1
5201631|NCT01085591|17957809|P1|Overall Study|Other|0
5201632|NCT01085591|17957807|P3|Overall Study|Protocol Violation|1
5201633|NCT01085591|17957808|P2|Overall Study|Protocol Violation|1
5201634|NCT01085591|17957809|P1|Overall Study|Protocol Violation|1
5201635|NCT01085591|17957807|P3|Overall Study|Lost to Follow-up|1
5201636|NCT01085591|17957808|P2|Overall Study|Lost to Follow-up|1
5201637|NCT01085591|17957809|P1|Overall Study|Lost to Follow-up|0
5201638|NCT01085591|17957807|P3|Overall Study|Withdrawal by Subject|1
5201639|NCT01085591|17957808|P2|Overall Study|Withdrawal by Subject|2
5201640|NCT01085591|17957809|P1|Overall Study|Withdrawal by Subject|0
5201641|NCT01085591|17957807|P3|Overall Study|Physician Decision|1
5201642|NCT01085591|17957808|P2|Overall Study|Physician Decision|0
5201643|NCT01085591|17957809|P1|Overall Study|Physician Decision|1
5201644|NCT01085591|17957807|P3|Overall Study|Adverse Event|3
5201645|NCT01085591|17957808|P2|Overall Study|Adverse Event|1
5201646|NCT01085591|17957809|P1|Overall Study|Adverse Event|0
5201647|NCT01085357|17957862|P2|Overall Study|Lost to Follow-up|0
5201648|NCT01085357|17957863|P1|Overall Study|Lost to Follow-up|2
5201649|NCT01085357|17957862|P2|Overall Study|Death|1
5201650|NCT01085357|17957863|P1|Overall Study|Death|11
5201651|NCT01085357|17957862|P2|Overall Study|Investigator Decision|1
5201652|NCT01085357|17957863|P1|Overall Study|Investigator Decision|1
5201653|NCT01085357|17957862|P2|Overall Study|Subject Decision|3
5201654|NCT01085357|17957863|P1|Overall Study|Subject Decision|4
5201655|NCT01085357|17957862|P2|Overall Study|Adverse Event|1
5201656|NCT01085357|17957863|P1|Overall Study|Adverse Event|1
5201657|NCT01085214|17957936|P1|Overall Study|Alternate treatment required|1
5201658|NCT01085201|17957948|P5|Overall Study|Fond ineligible after consent|0
5201659|NCT01085201|17957949|P4|Overall Study|Fond ineligible after consent|0
5201660|NCT01085201|17957950|P3|Overall Study|Fond ineligible after consent|1
5201661|NCT01085201|17957951|P2|Overall Study|Fond ineligible after consent|1
5201662|NCT01085201|17957952|P1|Overall Study|Fond ineligible after consent|0
5201663|NCT01085201|17957948|P5|Overall Study|Unknown- no study drug|0
5201664|NCT01085201|17957949|P4|Overall Study|Unknown- no study drug|0
5201665|NCT01085201|17957950|P3|Overall Study|Unknown- no study drug|0
5201666|NCT01085201|17957951|P2|Overall Study|Unknown- no study drug|0
5201667|NCT01085201|17957952|P1|Overall Study|Unknown- no study drug|2
5201668|NCT01085201|17957948|P5|Overall Study|Scheduling conflict|0
5201669|NCT01085201|17957949|P4|Overall Study|Scheduling conflict|0
5201670|NCT01085201|17957950|P3|Overall Study|Scheduling conflict|1
5201671|NCT01085201|17957951|P2|Overall Study|Scheduling conflict|0
5201672|NCT01085201|17957952|P1|Overall Study|Scheduling conflict|1
5201673|NCT01085136|17957974|P3|Part B|Other reason not defined above|3
5201674|NCT01085136|17957975|P2|Part B|Other reason not defined above|6
5201675|NCT01085136|17957976|P1|Part B|Other reason not defined above|0
5201676|NCT01085136|17957974|P3|Part B|Not treated|8
5201677|NCT01085136|17957975|P2|Part B|Not treated|4
5201678|NCT01085136|17957976|P1|Part B|Not treated|0
5201679|NCT01085136|17957974|P3|Part B|Refusal to continue trial medication|7
5201680|NCT01085136|17957975|P2|Part B|Refusal to continue trial medication|12
5201681|NCT01085136|17957976|P1|Part B|Refusal to continue trial medication|0
5201682|NCT01085136|17957974|P3|Part B|Other AE|8
5201683|NCT01085136|17957975|P2|Part B|Other AE|29
5201684|NCT01085136|17957976|P1|Part B|Other AE|0
5201685|NCT01085136|17957974|P3|Part A|Other reason not defined above|0
5201686|NCT01085136|17957975|P2|Part A|Other reason not defined above|0
5201687|NCT01085136|17957976|P1|Part A|Other reason not defined above|30
5201688|NCT01085136|17957974|P3|Part A|Refusal to continue trial medication|0
5201689|NCT01085136|17957975|P2|Part A|Refusal to continue trial medication|0
5201690|NCT01085136|17957976|P1|Part A|Refusal to continue trial medication|64
5201691|NCT01085136|17957974|P3|Part A|Lost to Follow-up|0
5201692|NCT01085136|17957975|P2|Part A|Lost to Follow-up|0
5201693|NCT01085136|17957976|P1|Part A|Lost to Follow-up|3
5201694|NCT01085136|17957974|P3|Part A|Protocol Violation|0
5201695|NCT01085136|17957975|P2|Part A|Protocol Violation|0
5201696|NCT01085136|17957976|P1|Part A|Protocol Violation|3
5201697|NCT01085136|17957974|P3|Part A|Other Adverse event|0
5201698|NCT01085136|17957975|P2|Part A|Other Adverse event|0
5201699|NCT01085136|17957976|P1|Part A|Other Adverse event|223
5201700|NCT01085045|17957992|P1|Part B|Adverse Event|6
5201701|NCT01085045|17957992|P1|Part B|Lost to Follow-up|1
5201702|NCT01085045|17957992|P1|Part B|Protocol Specified Criteria|6
5201703|NCT01085045|17957992|P1|Part B|Withdrawal by Subject|2
5201704|NCT01085045|17957992|P1|Part A|Protocol Specified Criteria|7
5201705|NCT01085045|17957992|P1|Part A|Protocol Violation|1
5201706|NCT01085045|17957992|P1|Part A|Adverse Event|6
5201707|NCT01085045|17957992|P1|Part A|Withdrawal by Subject|4
5201708|NCT01084772|17958103|P2|2 Years|Study Termination|2
5201709|NCT01084772|17958104|P1|2 Years|Study Termination|3
5201710|NCT01084772|17958103|P2|2 Years|Lost to Follow-up|2
5201711|NCT01084772|17958104|P1|2 Years|Lost to Follow-up|5
5201712|NCT01084772|17958103|P2|2 Years|Withdrawal by Subject|0
5201713|NCT01084772|17958104|P1|2 Years|Withdrawal by Subject|1
5201714|NCT01084772|17958103|P2|1 Year|Study Termination|7
5201715|NCT01084772|17958104|P1|1 Year|Study Termination|0
5201716|NCT01084772|17958103|P2|1 Year|Lost to Follow-up|0
5201717|NCT01084772|17958104|P1|1 Year|Lost to Follow-up|3
5201718|NCT01084772|17958103|P2|1 Year|Withdrawal by Subject|1
5201719|NCT01084772|17958104|P1|1 Year|Withdrawal by Subject|0
5201720|NCT01084772|17958103|P2|3 Months|Study Termination|2
5201721|NCT01084772|17958104|P1|3 Months|Study Termination|2
5201722|NCT01084772|17958103|P2|3 Months|Death|0
5201723|NCT01084772|17958104|P1|3 Months|Death|1
5201724|NCT01084772|17958103|P2|Baseline|Withdrawal by Subject|6
5201725|NCT01084772|17958104|P1|Baseline|Withdrawal by Subject|7
5201726|NCT01084707|17958140|P1|Overall Study|Withdrawal by Subject|6
5201727|NCT01084694|17958176|P2|Overall Study|eligibility not maintained|7
5201728|NCT01084694|17958177|P1|Overall Study|eligibility not maintained|2
5201729|NCT01084694|17958176|P2|Overall Study|Death|12
5201730|NCT01084694|17958177|P1|Overall Study|Death|2
5201731|NCT01084694|17958176|P2|Overall Study|Withdrawal by Subject|1
5201732|NCT01084694|17958177|P1|Overall Study|Withdrawal by Subject|2
5201733|NCT01084668|17958193|P1|Overall Study|Non-compliance|1
5201734|NCT01084668|17958193|P1|Overall Study|Pregnancy|1
5201735|NCT01084668|17958193|P1|Overall Study|Withdrawal by Subject|2
5201736|NCT01084668|17958193|P1|Overall Study|Lack of Efficacy|5
5201737|NCT01084655|17958205|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
5201738|NCT01084655|17958206|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
5201739|NCT01084655|17958207|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
5201740|NCT01084655|17958205|P3|Overall Study|Symptomatic deterioration|2
5201741|NCT01084655|17958206|P2|Overall Study|Symptomatic deterioration|0
5201742|NCT01084655|17958207|P1|Overall Study|Symptomatic deterioration|0
5201743|NCT01084655|17958205|P3|Overall Study|Other|2
5201744|NCT01084655|17958206|P2|Overall Study|Other|3
5201745|NCT01084655|17958207|P1|Overall Study|Other|0
5201746|NCT01084655|17958205|P3|Overall Study|Adverse Event|2
5201747|NCT01084655|17958206|P2|Overall Study|Adverse Event|1
5201748|NCT01084655|17958207|P1|Overall Study|Adverse Event|2
5201749|NCT01084655|17958205|P3|Overall Study|Withdrawal by Subject|4
5201750|NCT01084655|17958206|P2|Overall Study|Withdrawal by Subject|0
5201751|NCT01084655|17958207|P1|Overall Study|Withdrawal by Subject|1
5201752|NCT01084655|17958205|P3|Overall Study|Radiographic disease progression|8
5201753|NCT01084655|17958206|P2|Overall Study|Radiographic disease progression|2
5201754|NCT01084655|17958207|P1|Overall Study|Radiographic disease progression|3
5201755|NCT01084603|17958242|P1|Washout Period 4|Adverse Event|1
5201756|NCT01084603|17958242|P1|Oral Nicotine 1|Withdrawal by Subject|1
5201757|NCT01084603|17958242|P1|Nicorette® Gum|Withdrawal by Subject|1
5201758|NCT01084603|17958242|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
5201759|NCT01084603|17958242|P1|Baseline|Withdrawal by Subject|2
5201760|NCT01084551|17958278|P3|Overall Study|Physician Decision|0
5201761|NCT01084551|17958279|P2|Overall Study|Physician Decision|0
5201762|NCT01084551|17958280|P1|Overall Study|Physician Decision|1
5201763|NCT01084551|17958278|P3|Overall Study|Lost to Follow-up|3
5201764|NCT01084551|17958279|P2|Overall Study|Lost to Follow-up|0
5201765|NCT01084551|17958280|P1|Overall Study|Lost to Follow-up|0
5201766|NCT01084551|17958278|P3|Overall Study|Protocol Violation|0
5201767|NCT01084551|17958279|P2|Overall Study|Protocol Violation|4
5201768|NCT01084551|17958280|P1|Overall Study|Protocol Violation|2
5201769|NCT01084551|17958278|P3|Overall Study|Withdrawal by Subject|0
5201770|NCT01084551|17958279|P2|Overall Study|Withdrawal by Subject|1
5201771|NCT01084551|17958280|P1|Overall Study|Withdrawal by Subject|2
5201772|NCT01084551|17958278|P3|Overall Study|Lack of Efficacy|1
5201773|NCT01084551|17958279|P2|Overall Study|Lack of Efficacy|0
5201774|NCT01084551|17958280|P1|Overall Study|Lack of Efficacy|2
5201775|NCT01084551|17958278|P3|Overall Study|Adverse Event|4
5201776|NCT01084551|17958279|P2|Overall Study|Adverse Event|9
5201777|NCT01084551|17958280|P1|Overall Study|Adverse Event|2
5201778|NCT01084538|17958318|P1|Overall Study|Reason unknown|8
5201779|NCT01084538|17958318|P1|Overall Study|Over-suppression of parathyroid gland|2
5201780|NCT01084538|17958318|P1|Overall Study|Change of residence|2
5201781|NCT01084538|17958318|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
5201782|NCT01084538|17958318|P1|Overall Study|Hyperphosphatemia|2
5201783|NCT01084538|17958318|P1|Overall Study|Patient noncompliance|2
5201784|NCT01084538|17958318|P1|Overall Study|Lack of effectiveness|2
5201785|NCT01084538|17958318|P1|Overall Study|Serious Adverse Event|3
5201786|NCT01084538|17958318|P1|Overall Study|Kidney transplant|6
5201787|NCT01084538|17958318|P1|Overall Study|Adverse Event|9
5201788|NCT01084538|17958318|P1|Overall Study|Drug not available|30
5201789|NCT01084252|17958452|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201790|NCT01084252|17958453|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
5201791|NCT01084252|17958454|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201792|NCT01084252|17958455|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201793|NCT01084252|17958456|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201794|NCT01084252|17958457|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201795|NCT01084252|17958458|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201796|NCT01084252|17958459|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201797|NCT01084252|17958460|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201798|NCT01084252|17958461|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201799|NCT01084252|17958462|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201800|NCT01084252|17958463|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201801|NCT01084252|17958464|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201802|NCT01084252|17958465|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5201803|NCT01084252|17958452|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
5201804|NCT01084252|17958453|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
5201805|NCT01084252|17958454|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201806|NCT01084252|17958455|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201807|NCT01084252|17958456|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201808|NCT01084252|17958457|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201809|NCT01084252|17958458|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201810|NCT01084252|17958459|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201811|NCT01084252|17958460|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201812|NCT01084252|17958461|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201813|NCT01084252|17958462|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201814|NCT01084252|17958463|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201815|NCT01084252|17958464|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201816|NCT01084252|17958465|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5201817|NCT01084252|17958452|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
5201818|NCT01084252|17958453|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
5201819|NCT01084252|17958454|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201820|NCT01084252|17958455|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201821|NCT01084252|17958456|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201822|NCT01084252|17958457|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201823|NCT01084252|17958458|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201824|NCT01084252|17958459|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201825|NCT01084252|17958460|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201826|NCT01084252|17958461|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201827|NCT01084252|17958462|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201828|NCT01084252|17958463|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201829|NCT01084252|17958464|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201830|NCT01084252|17958465|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5201831|NCT01084252|17958452|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201832|NCT01084252|17958453|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
5201833|NCT01084252|17958454|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201834|NCT01084252|17958455|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201835|NCT01084252|17958456|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201836|NCT01084252|17958457|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201837|NCT01084252|17958458|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201838|NCT01084252|17958459|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201839|NCT01084252|17958460|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201840|NCT01084252|17958461|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201841|NCT01084252|17958462|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201842|NCT01084252|17958463|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201843|NCT01084252|17958464|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201844|NCT01084252|17958465|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5201845|NCT01084252|17958452|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
5201846|NCT01084252|17958453|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
5201847|NCT01084252|17958454|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201848|NCT01084252|17958455|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201849|NCT01084252|17958456|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201850|NCT01084252|17958457|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201851|NCT01084252|17958458|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201852|NCT01084252|17958459|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201853|NCT01084252|17958460|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201854|NCT01084252|17958461|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201855|NCT01084252|17958462|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201856|NCT01084252|17958463|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201857|NCT01084252|17958464|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201858|NCT01084252|17958465|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5201859|NCT01084252|17958452|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
5201860|NCT01084252|17958453|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
5201861|NCT01084252|17958454|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201862|NCT01084252|17958455|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201863|NCT01084252|17958456|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201864|NCT01084252|17958457|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201865|NCT01084252|17958458|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201866|NCT01084252|17958459|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201867|NCT01084252|17958460|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201868|NCT01084252|17958461|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201869|NCT01084252|17958462|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201870|NCT01084252|17958463|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201871|NCT01084252|17958464|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201872|NCT01084252|17958465|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5201873|NCT01084252|17958452|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201874|NCT01084252|17958453|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201875|NCT01084252|17958454|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
5201876|NCT01084252|17958455|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
5201877|NCT01084252|17958456|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
5201878|NCT01084252|17958457|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
5201879|NCT01084252|17958458|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201880|NCT01084252|17958459|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201881|NCT01084252|17958460|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201882|NCT01084252|17958461|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201883|NCT01084252|17958462|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201884|NCT01084252|17958463|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201885|NCT01084252|17958464|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201886|NCT01084252|17958465|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5201887|NCT01084252|17958452|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201888|NCT01084252|17958453|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201889|NCT01084252|17958454|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
5201890|NCT01084252|17958455|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
5201891|NCT01084252|17958456|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201892|NCT01084252|17958457|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
5201893|NCT01084252|17958458|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201894|NCT01084252|17958459|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201895|NCT01084252|17958460|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201896|NCT01084252|17958461|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201897|NCT01084252|17958462|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201898|NCT01084252|17958463|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201899|NCT01084252|17958464|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201900|NCT01084252|17958465|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5201901|NCT01084252|17958452|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201902|NCT01084252|17958453|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201903|NCT01084252|17958454|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
5201904|NCT01084252|17958455|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
5201905|NCT01084252|17958456|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
5201906|NCT01084252|17958457|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
5201907|NCT01084252|17958458|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201908|NCT01084252|17958459|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201909|NCT01084252|17958460|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201910|NCT01084252|17958461|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201911|NCT01084252|17958462|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201912|NCT01084252|17958463|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201913|NCT01084252|17958464|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201914|NCT01084252|17958465|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5201915|NCT01084252|17958452|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201916|NCT01084252|17958453|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201917|NCT01084252|17958454|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
5201918|NCT01084252|17958455|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
5201919|NCT01084252|17958456|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
5201920|NCT01084252|17958457|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201921|NCT01084252|17958458|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201922|NCT01084252|17958459|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201923|NCT01084252|17958460|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201924|NCT01084252|17958461|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201925|NCT01084252|17958462|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201926|NCT01084252|17958463|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201927|NCT01084252|17958464|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201928|NCT01084252|17958465|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5201929|NCT01084252|17958452|P14|Phase 1 (120 Weeks)|Other than specified above|0
5201930|NCT01084252|17958453|P13|Phase 1 (120 Weeks)|Other than specified above|0
5201931|NCT01084252|17958454|P12|Phase 1 (120 Weeks)|Other than specified above|0
5201932|NCT01084252|17958455|P11|Phase 1 (120 Weeks)|Other than specified above|0
5201933|NCT01084252|17958456|P10|Phase 1 (120 Weeks)|Other than specified above|0
5201934|NCT01084252|17958457|P9|Phase 1 (120 Weeks)|Other than specified above|0
5201935|NCT01084252|17958458|P8|Phase 1 (120 Weeks)|Other than specified above|1
5201936|NCT01084252|17958459|P7|Phase 1 (120 Weeks)|Other than specified above|1
5201937|NCT01084252|17958460|P6|Phase 1 (120 Weeks)|Other than specified above|0
5201938|NCT01084252|17958461|P5|Phase 1 (120 Weeks)|Other than specified above|1
5201939|NCT01084252|17958462|P4|Phase 1 (120 Weeks)|Other than specified above|3
5201940|NCT01084252|17958463|P3|Phase 1 (120 Weeks)|Other than specified above|0
5201941|NCT01084252|17958464|P2|Phase 1 (120 Weeks)|Other than specified above|1
5201942|NCT01084252|17958465|P1|Phase 1 (120 Weeks)|Other than specified above|1
5201943|NCT01084252|17958452|P14|Phase 1 (120 Weeks)|Progressive disease|0
5201944|NCT01084252|17958453|P13|Phase 1 (120 Weeks)|Progressive disease|0
5201945|NCT01084252|17958454|P12|Phase 1 (120 Weeks)|Progressive disease|0
5201946|NCT01084252|17958455|P11|Phase 1 (120 Weeks)|Progressive disease|0
5201947|NCT01084252|17958456|P10|Phase 1 (120 Weeks)|Progressive disease|0
5201948|NCT01084252|17958457|P9|Phase 1 (120 Weeks)|Progressive disease|0
5201949|NCT01084252|17958458|P8|Phase 1 (120 Weeks)|Progressive disease|6
5201950|NCT01084252|17958459|P7|Phase 1 (120 Weeks)|Progressive disease|5
5201951|NCT01084252|17958460|P6|Phase 1 (120 Weeks)|Progressive disease|6
5201952|NCT01084252|17958461|P5|Phase 1 (120 Weeks)|Progressive disease|16
5201953|NCT01084252|17958462|P4|Phase 1 (120 Weeks)|Progressive disease|22
5201954|NCT01084252|17958463|P3|Phase 1 (120 Weeks)|Progressive disease|2
5201955|NCT01084252|17958464|P2|Phase 1 (120 Weeks)|Progressive disease|5
5201956|NCT01084252|17958465|P1|Phase 1 (120 Weeks)|Progressive disease|15
5201957|NCT01084252|17958452|P14|Phase 1 (120 Weeks)|Adverse Event|0
5201958|NCT01084252|17958453|P13|Phase 1 (120 Weeks)|Adverse Event|0
5201959|NCT01084252|17958454|P12|Phase 1 (120 Weeks)|Adverse Event|0
5201960|NCT01084252|17958455|P11|Phase 1 (120 Weeks)|Adverse Event|0
5201961|NCT01084252|17958456|P10|Phase 1 (120 Weeks)|Adverse Event|0
5201962|NCT01084252|17958457|P9|Phase 1 (120 Weeks)|Adverse Event|0
5201963|NCT01084252|17958458|P8|Phase 1 (120 Weeks)|Adverse Event|0
5201964|NCT01084252|17958459|P7|Phase 1 (120 Weeks)|Adverse Event|1
5201965|NCT01084252|17958460|P6|Phase 1 (120 Weeks)|Adverse Event|0
5201966|NCT01084252|17958461|P5|Phase 1 (120 Weeks)|Adverse Event|1
5201967|NCT01084252|17958462|P4|Phase 1 (120 Weeks)|Adverse Event|1
5201968|NCT01084252|17958463|P3|Phase 1 (120 Weeks)|Adverse Event|1
5201969|NCT01084252|17958464|P2|Phase 1 (120 Weeks)|Adverse Event|0
5201970|NCT01084252|17958465|P1|Phase 1 (120 Weeks)|Adverse Event|0
5201971|NCT01084239|17958649|P2|28-Day Follow-up|Lost to Follow-up|9
5201972|NCT01084239|17958650|P1|28-Day Follow-up|Lost to Follow-up|4
5201973|NCT01084174|17958668|P2|Overall Study|Participant noncompliance|1
5201974|NCT01084174|17958669|P1|Overall Study|Participant noncompliance|0
5201975|NCT01084174|17958668|P2|Overall Study|Anaphylaxis|1
5201976|NCT01084174|17958669|P1|Overall Study|Anaphylaxis|0
5201977|NCT01084174|17958668|P2|Overall Study|Eosinophilic esophagitis|1
5201978|NCT01084174|17958669|P1|Overall Study|Eosinophilic esophagitis|0
5201979|NCT01084174|17958668|P2|Overall Study|gastrointestinal symptoms|1
5201980|NCT01084174|17958669|P1|Overall Study|gastrointestinal symptoms|1
5201981|NCT01084135|17958702|P2|20 Week|Physician Decision|1
5201982|NCT01084135|17958703|P1|20 Week|Physician Decision|0
5201983|NCT01084083|17958713|P1|Overall Study|Never started assigned therapy|1
5201984|NCT01084083|17958713|P1|Overall Study|Other|2
5201985|NCT01084083|17958713|P1|Overall Study|Complicating disease|1
5201986|NCT01084083|17958713|P1|Overall Study|Withdrawal by Subject|2
5201987|NCT01084083|17958713|P1|Overall Study|Death|1
5201988|NCT01084083|17958713|P1|Overall Study|Adverse Event|5
5201989|NCT01084005|17958721|P2|Overall Study|Withdrawal by Subject|1
5201990|NCT01084005|17958722|P1|Overall Study|Withdrawal by Subject|1
5201991|NCT01084005|17958721|P2|Overall Study|Protocol Violation|7
5201992|NCT01084005|17958722|P1|Overall Study|Protocol Violation|3
5201993|NCT01084005|17958721|P2|Overall Study|Adverse Event|8
5201994|NCT01084005|17958722|P1|Overall Study|Adverse Event|1
5201995|NCT01083810|17958803|P3|Overall Study|Virologic failure|0
5201996|NCT01083810|17958804|P2|Overall Study|Virologic failure|8
5201997|NCT01083810|17958805|P1|Overall Study|Virologic failure|1
5201998|NCT01083810|17958803|P3|Overall Study|Therapy break|2
5201999|NCT01083810|17958804|P2|Overall Study|Therapy break|2
5202000|NCT01083810|17958805|P1|Overall Study|Therapy break|1
5202001|NCT01083810|17958803|P3|Overall Study|Participation in study|0
5202002|NCT01083810|17958804|P2|Overall Study|Participation in study|0
5202003|NCT01083810|17958805|P1|Overall Study|Participation in study|1
5202004|NCT01083810|17958803|P3|Overall Study|Co-morbidities|0
5202005|NCT01083810|17958804|P2|Overall Study|Co-morbidities|0
5202006|NCT01083810|17958805|P1|Overall Study|Co-morbidities|1
5202007|NCT01083810|17958803|P3|Overall Study|Death|3
5202008|NCT01083810|17958804|P2|Overall Study|Death|2
5202009|NCT01083810|17958805|P1|Overall Study|Death|2
5202010|NCT01083810|17958803|P3|Overall Study|Simplification|0
5202011|NCT01083810|17958804|P2|Overall Study|Simplification|1
5202012|NCT01083810|17958805|P1|Overall Study|Simplification|4
5202013|NCT01083810|17958803|P3|Overall Study|Non-compliance|2
5202014|NCT01083810|17958804|P2|Overall Study|Non-compliance|7
5202015|NCT01083810|17958805|P1|Overall Study|Non-compliance|4
5202016|NCT01083810|17958803|P3|Overall Study|Reason not reported|1
5202017|NCT01083810|17958804|P2|Overall Study|Reason not reported|1
5202018|NCT01083810|17958805|P1|Overall Study|Reason not reported|6
5202019|NCT01083810|17958803|P3|Overall Study|Withdrawal by Subject|4
5202020|NCT01083810|17958804|P2|Overall Study|Withdrawal by Subject|2
5202021|NCT01083810|17958805|P1|Overall Study|Withdrawal by Subject|7
5202022|NCT01083810|17958803|P3|Overall Study|Adverse Event|4
5202023|NCT01083810|17958804|P2|Overall Study|Adverse Event|11
5202024|NCT01083810|17958805|P1|Overall Study|Adverse Event|15
5202025|NCT01083810|17958803|P3|Overall Study|Lost to Follow-up|4
5202026|NCT01083810|17958804|P2|Overall Study|Lost to Follow-up|11
5202027|NCT01083810|17958805|P1|Overall Study|Lost to Follow-up|23
5202028|NCT01083771|17958826|P1|Overall Study|Withdrawal by Subject|3
5202029|NCT01083771|17958826|P1|Overall Study|non-compliant|2
5202030|NCT01083693|17958927|P3|Overall Study|Reason unknown|1
5202031|NCT01083693|17958928|P2|Overall Study|Reason unknown|0
5202032|NCT01083693|17958929|P1|Overall Study|Reason unknown|0
5202033|NCT01083693|17958927|P3|Overall Study|Withdrawal by Subject|2
5202034|NCT01083693|17958928|P2|Overall Study|Withdrawal by Subject|0
5202035|NCT01083693|17958929|P1|Overall Study|Withdrawal by Subject|3
5202036|NCT01083693|17958927|P3|Overall Study|Other medical condition/surgery|0
5202037|NCT01083693|17958928|P2|Overall Study|Other medical condition/surgery|1
5202038|NCT01083693|17958929|P1|Overall Study|Other medical condition/surgery|1
5202039|NCT01083693|17958927|P3|Overall Study|Complete remission|0
5202040|NCT01083693|17958928|P2|Overall Study|Complete remission|1
5202041|NCT01083693|17958929|P1|Overall Study|Complete remission|0
5202042|NCT01083693|17958927|P3|Overall Study|Patient Moved|0
5202043|NCT01083693|17958928|P2|Overall Study|Patient Moved|1
5202044|NCT01083693|17958929|P1|Overall Study|Patient Moved|0
5202045|NCT01083693|17958927|P3|Overall Study|Lack of effectiveness|2
5202046|NCT01083693|17958928|P2|Overall Study|Lack of effectiveness|2
5202047|NCT01083693|17958929|P1|Overall Study|Lack of effectiveness|13
5202048|NCT01083693|17958927|P3|Overall Study|Lost to Follow-up|2
5202049|NCT01083693|17958928|P2|Overall Study|Lost to Follow-up|0
5202050|NCT01083693|17958929|P1|Overall Study|Lost to Follow-up|2
5202051|NCT01083693|17958927|P3|Overall Study|Adverse Event|0
5202052|NCT01083693|17958928|P2|Overall Study|Adverse Event|1
5202053|NCT01083693|17958929|P1|Overall Study|Adverse Event|1
5202054|NCT01083680|17958964|P1|Overall Study|Withdrawal by Subject|1086
5202055|NCT01083680|17958964|P1|Overall Study|Lost to Follow-up|2758
5202056|NCT01083641|17958987|P1|Overall Study|Withdrawal by Subject|2
5202057|NCT01083602|17959007|P1|Overall Study|Lack of Efficacy|36
5202058|NCT01083602|17959007|P1|Overall Study|Withdrawal by Subject|5
5202059|NCT01083602|17959007|P1|Overall Study|Death|1
5202060|NCT01083602|17959007|P1|Overall Study|New Cancer Therapy|2
5202061|NCT01083602|17959007|P1|Overall Study|Adverse Event|11
5202062|NCT01083576|17959018|P2|Overall Study|Treatment Failure|1
5202063|NCT01083576|17959019|P1|Overall Study|Treatment Failure|6
5202064|NCT01083485|17959049|P2|Overall Study|Other|0
5202065|NCT01083485|17959050|P1|Overall Study|Other|1
5202066|NCT01083485|17959049|P2|Overall Study|Withdrawal by Subject|2
5202067|NCT01083485|17959050|P1|Overall Study|Withdrawal by Subject|5
5202068|NCT01083485|17959049|P2|Overall Study|Protocol Violation|0
5202069|NCT01083485|17959050|P1|Overall Study|Protocol Violation|1
5202070|NCT01083485|17959049|P2|Overall Study|Adverse Event|1
5202071|NCT01083485|17959050|P1|Overall Study|Adverse Event|0
5202072|NCT01083316|17959082|P1|Overall Study|Withdrawal by Subject|1
5202073|NCT01083316|17959082|P1|Overall Study|Adverse Event|2
5202074|NCT01083186|17959094|P1|Overall Study|Non-compliance to Study Treatment|1
5202075|NCT01083186|17959094|P1|Overall Study|Administrative Reasons|2
5202076|NCT01083186|17959094|P1|Overall Study|Hemodialysis Initiation|28
5202077|NCT01083186|17959094|P1|Overall Study|Lack of Efficacy|2
5202078|NCT01083186|17959094|P1|Overall Study|Adverse Event|3
5202079|NCT01083186|17959094|P1|Overall Study|Death|3
5202080|NCT01083186|17959094|P1|Overall Study|Consent Withdrawal|7
5202081|NCT01083186|17959094|P1|Overall Study|Lost to Follow-up|48
5202082|NCT01083173|17959135|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
5202083|NCT01083173|17959136|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
5202084|NCT01083173|17959135|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
5202085|NCT01083173|17959136|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
5202086|NCT01083173|17959135|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
5202087|NCT01083173|17959136|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
5202088|NCT01083173|17959135|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
5202089|NCT01083173|17959136|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
5202090|NCT01083173|17959135|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
5202091|NCT01083173|17959136|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
5202092|NCT01083173|17959135|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
5202093|NCT01083173|17959136|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
5202094|NCT01083173|17959135|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
5202095|NCT01083173|17959136|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
5202096|NCT01083173|17959135|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
5202097|NCT01083173|17959136|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
5202098|NCT01083173|17959135|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
5202099|NCT01083173|17959136|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
5202100|NCT01083173|17959135|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
5202101|NCT01083173|17959136|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
5202102|NCT01083173|17959135|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
5202103|NCT01083173|17959136|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
5202104|NCT01083160|17959154|P1|Overall Study|Adverse Event|1
5202105|NCT01083121|17959161|P1|Overall Study|Use of Humira outside the approved label|81
5202106|NCT01082965|17959171|P2|Overall Study|Other|1
5202107|NCT01082965|17959172|P1|Overall Study|Other|1
5202108|NCT01082965|17959171|P2|Overall Study|Protocol Violation|1
5202109|NCT01082965|17959172|P1|Overall Study|Protocol Violation|0
5202110|NCT01082874|17959209|P4|Overall Study|Withdrawal by Subject|3
5202111|NCT01082874|17959210|P3|Overall Study|Withdrawal by Subject|5
5202112|NCT01082874|17959211|P2|Overall Study|Withdrawal by Subject|2
5202113|NCT01082874|17959212|P1|Overall Study|Withdrawal by Subject|1
5202114|NCT01082874|17959209|P4|Overall Study|Lost to Follow-up|10
5202115|NCT01082874|17959210|P3|Overall Study|Lost to Follow-up|6
5202116|NCT01082874|17959211|P2|Overall Study|Lost to Follow-up|10
5202117|NCT01082874|17959212|P1|Overall Study|Lost to Follow-up|10
5202118|NCT01082640|17959225|P3|Overall Study|Other|3
5202119|NCT01082640|17959226|P2|Overall Study|Other|1
5202120|NCT01082640|17959227|P1|Overall Study|Other|2
5202121|NCT01082640|17959225|P3|Overall Study|Lost to Follow-up|0
5202122|NCT01082640|17959226|P2|Overall Study|Lost to Follow-up|3
5202123|NCT01082640|17959227|P1|Overall Study|Lost to Follow-up|0
5202124|NCT01082640|17959225|P3|Overall Study|Major protocol deviation|0
5202125|NCT01082640|17959226|P2|Overall Study|Major protocol deviation|3
5202126|NCT01082640|17959227|P1|Overall Study|Major protocol deviation|3
5202127|NCT01082640|17959225|P3|Overall Study|Withdrawal by Subject|2
5202128|NCT01082640|17959226|P2|Overall Study|Withdrawal by Subject|3
5202129|NCT01082640|17959227|P1|Overall Study|Withdrawal by Subject|3
5202130|NCT01082640|17959225|P3|Overall Study|Adverse Event|3
5202131|NCT01082640|17959226|P2|Overall Study|Adverse Event|5
5202132|NCT01082640|17959227|P1|Overall Study|Adverse Event|9
5202133|NCT01082614|17959249|P2|Overall Study|Physician Decision|0
5202134|NCT01082614|17959250|P1|Overall Study|Physician Decision|2
5202135|NCT01082614|17959249|P2|Overall Study|Equipment Malfunction|1
5202136|NCT01082614|17959250|P1|Overall Study|Equipment Malfunction|0
5202137|NCT01082614|17959249|P2|Overall Study|Adverse Event|4
5202138|NCT01082614|17959250|P1|Overall Study|Adverse Event|1
5202139|NCT01082367|17959321|P2|Follow-up (F-U) Period|Adverse Event|1
5202140|NCT01082367|17959322|P1|Follow-up (F-U) Period|Adverse Event|0
5202141|NCT01082367|17959321|P2|Follow-up (F-U) Period|Abnormal lab values|0
5202142|NCT01082367|17959322|P1|Follow-up (F-U) Period|Abnormal lab values|1
5202143|NCT01082367|17959321|P2|Follow-up (F-U) Period|Administrative problems|0
5202144|NCT01082367|17959322|P1|Follow-up (F-U) Period|Administrative problems|1
5202145|NCT01082367|17959321|P2|Double-blind Period|Adverse Event|1
5202146|NCT01082367|17959322|P1|Double-blind Period|Adverse Event|0
5202147|NCT01082367|17959321|P2|Double-blind Period|Lack of Efficacy|11
5202148|NCT01082367|17959322|P1|Double-blind Period|Lack of Efficacy|5
5202149|NCT01082367|17959321|P2|Double-blind Period|Administrative problems|1
5202150|NCT01082367|17959322|P1|Double-blind Period|Administrative problems|0
5202151|NCT01082328|17959336|P1|Overall Study|Adverse Event|1
5202152|NCT01082211|17959345|P1|Overall Study|No protocol treatment received|3
5202153|NCT01082211|17959345|P1|Overall Study|Protocol Violation|4
5202154|NCT01082081|17959372|P3|Overall Study|Other Reason|0
5202155|NCT01082081|17959373|P2|Overall Study|Other Reason|1
5202156|NCT01082081|17959374|P1|Overall Study|Other Reason|0
5202157|NCT01082081|17959372|P3|Overall Study|Withdrawal by Subject|1
5202158|NCT01082081|17959373|P2|Overall Study|Withdrawal by Subject|0
5202159|NCT01082081|17959374|P1|Overall Study|Withdrawal by Subject|0
5202160|NCT01082081|17959372|P3|Overall Study|Lost to Follow-up|1
5202161|NCT01082081|17959373|P2|Overall Study|Lost to Follow-up|0
5202162|NCT01082081|17959374|P1|Overall Study|Lost to Follow-up|0
5202163|NCT01081951|17959426|P2|Overall Study|Lost to Follow-up|1
5202164|NCT01081951|17959427|P1|Overall Study|Lost to Follow-up|0
5202165|NCT01081951|17959426|P2|Overall Study|Allocated treatment but did not take it|1
5202166|NCT01081951|17959427|P1|Overall Study|Allocated treatment but did not take it|0
5202167|NCT01081951|17959426|P2|Overall Study|Withdrawal by Subject|6
5202168|NCT01081951|17959427|P1|Overall Study|Withdrawal by Subject|2
5202169|NCT01081951|17959426|P2|Overall Study|Death|47
5202170|NCT01081951|17959427|P1|Overall Study|Death|54
5202171|NCT01081912|17959437|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
5202172|NCT01081912|17959438|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
5202173|NCT01081912|17959439|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
5202174|NCT01081912|17959437|P3|Maintenance Treatment|Non-Compliance|7
5202175|NCT01081912|17959438|P2|Maintenance Treatment|Non-Compliance|4
5202176|NCT01081912|17959439|P1|Maintenance Treatment|Non-Compliance|0
5202177|NCT01081912|17959437|P3|Maintenance Treatment|Withdrawal by Subject|5
5202178|NCT01081912|17959438|P2|Maintenance Treatment|Withdrawal by Subject|5
5202179|NCT01081912|17959439|P1|Maintenance Treatment|Withdrawal by Subject|0
5202180|NCT01081912|17959437|P3|Maintenance Treatment|Protocol Violation|2
5202181|NCT01081912|17959438|P2|Maintenance Treatment|Protocol Violation|1
5202182|NCT01081912|17959439|P1|Maintenance Treatment|Protocol Violation|0
5202183|NCT01081912|17959437|P3|Maintenance Treatment|Physician Decision|1
5202184|NCT01081912|17959438|P2|Maintenance Treatment|Physician Decision|0
5202185|NCT01081912|17959439|P1|Maintenance Treatment|Physician Decision|0
5202186|NCT01081912|17959437|P3|Maintenance Treatment|Lost to Follow-up|0
5202187|NCT01081912|17959438|P2|Maintenance Treatment|Lost to Follow-up|1
5202188|NCT01081912|17959439|P1|Maintenance Treatment|Lost to Follow-up|0
5202189|NCT01081912|17959437|P3|Maintenance Treatment|Lack of Efficacy|64
5202190|NCT01081912|17959438|P2|Maintenance Treatment|Lack of Efficacy|14
5202191|NCT01081912|17959439|P1|Maintenance Treatment|Lack of Efficacy|0
5202192|NCT01081912|17959437|P3|Maintenance Treatment|Adverse Event|12
5202193|NCT01081912|17959438|P2|Maintenance Treatment|Adverse Event|2
5202194|NCT01081912|17959439|P1|Maintenance Treatment|Adverse Event|0
5202195|NCT01081912|17959437|P3|Conversion/Titration|Non-Compliance|0
5202196|NCT01081912|17959438|P2|Conversion/Titration|Non-Compliance|0
5202197|NCT01081912|17959439|P1|Conversion/Titration|Non-Compliance|47
5202198|NCT01081912|17959437|P3|Conversion/Titration|Withdrawal by Subject|0
5202199|NCT01081912|17959438|P2|Conversion/Titration|Withdrawal by Subject|0
5202200|NCT01081912|17959439|P1|Conversion/Titration|Withdrawal by Subject|23
5202201|NCT01081912|17959437|P3|Conversion/Titration|Protocol Violation|0
5202202|NCT01081912|17959438|P2|Conversion/Titration|Protocol Violation|0
5202203|NCT01081912|17959439|P1|Conversion/Titration|Protocol Violation|67
5202204|NCT01081912|17959437|P3|Conversion/Titration|Physician Decision|0
5202205|NCT01081912|17959438|P2|Conversion/Titration|Physician Decision|0
5202206|NCT01081912|17959439|P1|Conversion/Titration|Physician Decision|2
5202207|NCT01081912|17959437|P3|Conversion/Titration|Lost to Follow-up|0
5202208|NCT01081912|17959438|P2|Conversion/Titration|Lost to Follow-up|0
5202209|NCT01081912|17959439|P1|Conversion/Titration|Lost to Follow-up|5
5202210|NCT01081912|17959437|P3|Conversion/Titration|Lack of Efficacy|0
5202211|NCT01081912|17959438|P2|Conversion/Titration|Lack of Efficacy|0
5202212|NCT01081912|17959439|P1|Conversion/Titration|Lack of Efficacy|17
5202213|NCT01081912|17959437|P3|Conversion/Titration|Adverse Event|0
5202214|NCT01081912|17959438|P2|Conversion/Titration|Adverse Event|0
5202215|NCT01081912|17959439|P1|Conversion/Titration|Adverse Event|47
5202216|NCT01081886|17959448|P2|Overall Study|Study termination|13
5202217|NCT01081886|17959449|P1|Overall Study|Study termination|11
5202218|NCT01081873|17959457|P1|Overall Study|Other|47
5202219|NCT01081873|17959457|P1|Overall Study|Progression of prostate cancer|13
5202220|NCT01081873|17959457|P1|Overall Study|Lost to Follow-up|142
5202221|NCT01081873|17959457|P1|Overall Study|Withdrawal by Subject|10
5202222|NCT01081873|17959457|P1|Overall Study|Death|86
5202223|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
5202224|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
5202225|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
5202226|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
5202227|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
5202228|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5202229|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5202230|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5202231|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
5202232|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
5202233|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Other|0
5202234|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Other|0
5202235|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Other|4
5202236|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Other|5
5202237|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Other|4
5202238|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5202239|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5202240|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5202241|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
5202242|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5202243|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5202244|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5202245|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5202246|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5202247|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5202248|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5202249|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5202250|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5202251|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
5202252|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5202253|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
5202254|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
5202255|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5202256|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5202257|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
5202258|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5202259|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5202260|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5202261|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
5202262|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
5202263|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Death|0
5202264|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Death|0
5202265|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Death|0
5202266|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Death|0
5202267|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Death|1
5202268|NCT01081834|17959529|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
5202269|NCT01081834|17959530|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
5202270|NCT01081834|17959531|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
5202271|NCT01081834|17959532|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
5202272|NCT01081834|17959533|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5202273|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5202274|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5202275|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5202276|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
5202277|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
5202278|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Other|0
5202279|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Other|1
5202280|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Other|3
5202281|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Other|4
5202282|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Other|4
5202283|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5202284|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5202285|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5202286|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5202287|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5202288|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5202289|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
5202290|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
5202291|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
5202292|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
5202293|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
5202294|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5202295|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
5202296|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5202297|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
5202298|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Protocol Violation|2
5202299|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Protocol Violation|0
5202300|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5202301|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Protocol Violation|4
5202302|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Protocol Violation|0
5202303|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
5202304|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
5202305|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
5202306|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
5202307|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
5202308|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Death|0
5202309|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Death|0
5202310|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Death|0
5202311|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Death|0
5202312|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Death|1
5202313|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Adverse Event|1
5202314|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Adverse Event|1
5202315|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Adverse Event|3
5202316|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Adverse Event|5
5202317|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Adverse Event|2
5202318|NCT01081834|17959529|P5|Core Period: Baseline to Week 26|Pregnancy|0
5202319|NCT01081834|17959530|P4|Core Period: Baseline to Week 26|Pregnancy|0
5202320|NCT01081834|17959531|P3|Core Period: Baseline to Week 26|Pregnancy|0
5202321|NCT01081834|17959532|P2|Core Period: Baseline to Week 26|Pregnancy|0
5202322|NCT01081834|17959533|P1|Core Period: Baseline to Week 26|Pregnancy|1
5202323|NCT01081795|17959594|P3|Overall Study|Other|0
5202324|NCT01081795|17959595|P2|Overall Study|Other|2
5202325|NCT01081795|17959596|P1|Overall Study|Other|1
5202326|NCT01081795|17959594|P3|Overall Study|Using drug with restricted days of use|2
5202327|NCT01081795|17959595|P2|Overall Study|Using drug with restricted days of use|3
5202328|NCT01081795|17959596|P1|Overall Study|Using drug with restricted days of use|2
5202329|NCT01081795|17959594|P3|Overall Study|Use of a prohibited concomitant drug|1
5202330|NCT01081795|17959595|P2|Overall Study|Use of a prohibited concomitant drug|1
5202331|NCT01081795|17959596|P1|Overall Study|Use of a prohibited concomitant drug|1
5202332|NCT01081795|17959594|P3|Overall Study|Ineligible for participation|0
5202333|NCT01081795|17959595|P2|Overall Study|Ineligible for participation|0
5202334|NCT01081795|17959596|P1|Overall Study|Ineligible for participation|1
5202335|NCT01081795|17959594|P3|Overall Study|Revocation of informed consent|0
5202336|NCT01081795|17959595|P2|Overall Study|Revocation of informed consent|0
5202337|NCT01081795|17959596|P1|Overall Study|Revocation of informed consent|2
5202338|NCT01081795|17959594|P3|Overall Study|Subject's schedule|2
5202339|NCT01081795|17959595|P2|Overall Study|Subject's schedule|1
5202340|NCT01081795|17959596|P1|Overall Study|Subject's schedule|1
5202341|NCT01081795|17959594|P3|Overall Study|Lack of Efficacy|19
5202342|NCT01081795|17959595|P2|Overall Study|Lack of Efficacy|5
5202343|NCT01081795|17959596|P1|Overall Study|Lack of Efficacy|7
5202344|NCT01081795|17959594|P3|Overall Study|Adverse Event|6
5202345|NCT01081795|17959595|P2|Overall Study|Adverse Event|23
5202346|NCT01081795|17959596|P1|Overall Study|Adverse Event|18
5202347|NCT01081769|17959633|P2|CORE Intent-To-Treat|Patient Moved|2
5202348|NCT01081769|17959634|P1|CORE Intent-To-Treat|Patient Moved|2
5202349|NCT01081769|17959633|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
5202350|NCT01081769|17959634|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
5202351|NCT01081769|17959633|P2|CORE Intent-To-Treat|Ineligibility|4
5202352|NCT01081769|17959634|P1|CORE Intent-To-Treat|Ineligibility|3
5202353|NCT01081769|17959633|P2|CORE Intent-To-Treat|Other|1
5202354|NCT01081769|17959634|P1|CORE Intent-To-Treat|Other|0
5202355|NCT01081769|17959633|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
5202356|NCT01081769|17959634|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
5202357|NCT01081769|17959633|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
5202358|NCT01081769|17959634|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
5202359|NCT01081769|17959633|P2|CORE Intent-To-Treat|Pregnancy|0
5202360|NCT01081769|17959634|P1|CORE Intent-To-Treat|Pregnancy|1
5202361|NCT01081769|17959633|P2|CORE Intent-To-Treat|Lost to Follow-up|5
5202362|NCT01081769|17959634|P1|CORE Intent-To-Treat|Lost to Follow-up|4
5202363|NCT01081769|17959633|P2|CORE Intent-To-Treat|Lack of Efficacy|6
5202364|NCT01081769|17959634|P1|CORE Intent-To-Treat|Lack of Efficacy|2
5202365|NCT01081769|17959633|P2|CORE Intent-To-Treat|Death|1
5202366|NCT01081769|17959634|P1|CORE Intent-To-Treat|Death|1
5202367|NCT01081769|17959633|P2|CORE Intent-To-Treat|Adverse Event|11
5202368|NCT01081769|17959634|P1|CORE Intent-To-Treat|Adverse Event|14
5202369|NCT01081769|17959633|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
5202370|NCT01081769|17959634|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
5202371|NCT01081769|17959633|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
5202372|NCT01081769|17959634|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
5202373|NCT01081769|17959633|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
5202374|NCT01081769|17959634|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
5202375|NCT01081769|17959633|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
5202376|NCT01081769|17959634|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
5202377|NCT01081678|17959672|P4|Overall Study|Other|0
5202378|NCT01081678|17959673|P3|Overall Study|Other|0
5202379|NCT01081678|17959674|P2|Overall Study|Other|1
5202380|NCT01081678|17959675|P1|Overall Study|Other|0
5202381|NCT01081678|17959672|P4|Overall Study|Death|6
5202382|NCT01081678|17959673|P3|Overall Study|Death|2
5202383|NCT01081678|17959674|P2|Overall Study|Death|2
5202384|NCT01081678|17959675|P1|Overall Study|Death|2
5202385|NCT01081678|17959672|P4|Overall Study|Lost to Follow-up|3
5202386|NCT01081678|17959673|P3|Overall Study|Lost to Follow-up|4
5202387|NCT01081678|17959674|P2|Overall Study|Lost to Follow-up|1
5202388|NCT01081678|17959675|P1|Overall Study|Lost to Follow-up|4
5202389|NCT01081678|17959672|P4|Overall Study|Administrative Decision|1
5202390|NCT01081678|17959673|P3|Overall Study|Administrative Decision|0
5202391|NCT01081678|17959674|P2|Overall Study|Administrative Decision|0
5202392|NCT01081678|17959675|P1|Overall Study|Administrative Decision|1
5202393|NCT01081678|17959672|P4|Overall Study|Withdrawal by Subject|14
5202394|NCT01081678|17959673|P3|Overall Study|Withdrawal by Subject|17
5202395|NCT01081678|17959674|P2|Overall Study|Withdrawal by Subject|7
5202396|NCT01081678|17959675|P1|Overall Study|Withdrawal by Subject|15
5202397|NCT01081678|17959672|P4|Overall Study|Adverse Event|2
5202398|NCT01081678|17959673|P3|Overall Study|Adverse Event|2
5202399|NCT01081678|17959674|P2|Overall Study|Adverse Event|1
5202400|NCT01081678|17959675|P1|Overall Study|Adverse Event|2
5202401|NCT01081678|17959672|P4|Overall Study|Noncompliance|2
5202402|NCT01081678|17959673|P3|Overall Study|Noncompliance|5
5202403|NCT01081678|17959674|P2|Overall Study|Noncompliance|4
5202404|NCT01081678|17959675|P1|Overall Study|Noncompliance|3
5202405|NCT01081678|17959672|P4|Overall Study|Ineligibility Determined|1
5202406|NCT01081678|17959673|P3|Overall Study|Ineligibility Determined|1
5202407|NCT01081678|17959674|P2|Overall Study|Ineligibility Determined|0
5202408|NCT01081678|17959675|P1|Overall Study|Ineligibility Determined|0
5202409|NCT01081665|17959705|P1|Overall Study|Lack of Efficacy|1
5202410|NCT01081665|17959705|P1|Overall Study|Adverse Event|1
5202411|NCT01081665|17959705|P1|Overall Study|Change in renal replacement therapy|2
5202412|NCT01081665|17959705|P1|Overall Study|Regulation of iPTH|5
5202413|NCT01081665|17959705|P1|Overall Study|Change of dialysis unit|10
5202414|NCT01081665|17959705|P1|Overall Study|Withdrawal by Subject|17
5202415|NCT01081665|17959705|P1|Overall Study|Lost to Follow-up|18
5202416|NCT01081665|17959705|P1|Overall Study|Death|41
5202417|NCT01081626|17959717|P2|Overall Study|Other|30
5202418|NCT01081626|17959718|P1|Overall Study|Other|33
5202419|NCT01081626|17959717|P2|Overall Study|Lost to Follow-up|1
5202420|NCT01081626|17959718|P1|Overall Study|Lost to Follow-up|0
5202421|NCT01081626|17959717|P2|Overall Study|Overstimulation|1
5202422|NCT01081626|17959718|P1|Overall Study|Overstimulation|0
5202423|NCT01081626|17959717|P2|Overall Study|Low antral follicle count|0
5202424|NCT01081626|17959718|P1|Overall Study|Low antral follicle count|1
5202425|NCT01081626|17959717|P2|Overall Study|Missing Estradiol|28
5202426|NCT01081626|17959718|P1|Overall Study|Missing Estradiol|25
5202427|NCT01081626|17959717|P2|Overall Study|Dosing error|1
5202428|NCT01081626|17959718|P1|Overall Study|Dosing error|1
5202429|NCT01081301|17959744|P1|Overall Study|Lost to Follow-up|4
5202430|NCT01081301|17959744|P1|Overall Study|Patient too ill|2
5202431|NCT01081301|17959744|P1|Overall Study|Too busy|5
5202432|NCT01081301|17959744|P1|Overall Study|Bereaved|3
5202433|NCT01081249|17959819|P2|Overall Study|Diagnosed with Bipolar Disorder|1
5202434|NCT01081249|17959820|P1|Overall Study|Diagnosed with Bipolar Disorder|0
5202435|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
5202436|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
5202437|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
5202438|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
5202439|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
5202440|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
5202441|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
5202442|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
5202443|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
5202444|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
5202445|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
5202446|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
5202447|NCT01081145|17959826|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
5202448|NCT01081145|17959827|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
5202449|NCT01081145|17959826|P2|Open-Label Phase|Protocol Violation|0
5202450|NCT01081145|17959827|P1|Open-Label Phase|Protocol Violation|4
5202451|NCT01081145|17959826|P2|Open-Label Phase|Lost to Follow-up|0
5202452|NCT01081145|17959827|P1|Open-Label Phase|Lost to Follow-up|11
5202453|NCT01081145|17959826|P2|Open-Label Phase|Other|0
5202454|NCT01081145|17959827|P1|Open-Label Phase|Other|12
5202455|NCT01081145|17959826|P2|Open-Label Phase|Withdrawal by Subject|0
5202456|NCT01081145|17959827|P1|Open-Label Phase|Withdrawal by Subject|41
5202457|NCT01081145|17959826|P2|Open-Label Phase|Adverse Event|0
5202458|NCT01081145|17959827|P1|Open-Label Phase|Adverse Event|42
5202459|NCT01081145|17959826|P2|Open-Label Phase|Response criteria not met|0
5202460|NCT01081145|17959827|P1|Open-Label Phase|Response criteria not met|46
5202461|NCT01081145|17959826|P2|Open-Label Phase|Lack of Efficacy|0
5202462|NCT01081145|17959827|P1|Open-Label Phase|Lack of Efficacy|56
5202463|NCT01081132|17959855|P2|Overall Study|Protocol Violation|1
5202464|NCT01081132|17959856|P1|Overall Study|Protocol Violation|3
5202465|NCT01081132|17959855|P2|Overall Study|Declined Taper Phase|1
5202466|NCT01081132|17959856|P1|Overall Study|Declined Taper Phase|0
5202467|NCT01081132|17959855|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
5202468|NCT01081132|17959856|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
5202469|NCT01081132|17959855|P2|Overall Study|Stopped Taking Meds|0
5202470|NCT01081132|17959856|P1|Overall Study|Stopped Taking Meds|2
5202471|NCT01081132|17959855|P2|Overall Study|Missed Visits|1
5202472|NCT01081132|17959856|P1|Overall Study|Missed Visits|1
5202473|NCT01081132|17959855|P2|Overall Study|Lack Of Compliance|1
5202474|NCT01081132|17959856|P1|Overall Study|Lack Of Compliance|0
5202475|NCT01081132|17959855|P2|Overall Study|Non Compliance|2
5202476|NCT01081132|17959856|P1|Overall Study|Non Compliance|4
5202477|NCT01081132|17959855|P2|Overall Study|Adverse Event|9
5202478|NCT01081132|17959856|P1|Overall Study|Adverse Event|3
5202479|NCT01081132|17959855|P2|Overall Study|Lost to Follow-up|11
5202480|NCT01081132|17959856|P1|Overall Study|Lost to Follow-up|4
5202481|NCT01081132|17959855|P2|Overall Study|Withdrawal by Subject|16
5202482|NCT01081132|17959856|P1|Overall Study|Withdrawal by Subject|13
5202483|NCT01081132|17959855|P2|Overall Study|Lack of Efficacy|9
5202484|NCT01081132|17959856|P1|Overall Study|Lack of Efficacy|25
5202485|NCT01080807|17959940|P2|Overall Study|Moved away without notifying center|0
5202486|NCT01080807|17959941|P1|Overall Study|Moved away without notifying center|1
5202487|NCT01080807|17959940|P2|Overall Study|Switched to first shift|0
5202488|NCT01080807|17959941|P1|Overall Study|Switched to first shift|1
5202489|NCT01080807|17959940|P2|Overall Study|Work schedule and travel|1
5202490|NCT01080807|17959941|P1|Overall Study|Work schedule and travel|0
5202491|NCT01080807|17959940|P2|Overall Study|Work schedule changing|1
5202492|NCT01080807|17959941|P1|Overall Study|Work schedule changing|1
5202493|NCT01080807|17959940|P2|Overall Study|Stopped working consistent night shifts|1
5202494|NCT01080807|17959941|P1|Overall Study|Stopped working consistent night shifts|0
5202495|NCT01080807|17959940|P2|Overall Study|Laid off or terminated from job|2
5202496|NCT01080807|17959941|P1|Overall Study|Laid off or terminated from job|1
5202497|NCT01080807|17959940|P2|Overall Study|Began working day shift|2
5202498|NCT01080807|17959941|P1|Overall Study|Began working day shift|0
5202499|NCT01080807|17959940|P2|Overall Study|Noncompliance to study procedures|1
5202500|NCT01080807|17959941|P1|Overall Study|Noncompliance to study procedures|1
5202501|NCT01080807|17959940|P2|Overall Study|Noncompliance with drug administration|1
5202502|NCT01080807|17959941|P1|Overall Study|Noncompliance with drug administration|1
5202503|NCT01080807|17959940|P2|Overall Study|Lost to Follow-up|4
5202504|NCT01080807|17959941|P1|Overall Study|Lost to Follow-up|6
5202505|NCT01080807|17959940|P2|Overall Study|Protocol Violation|6
5202506|NCT01080807|17959941|P1|Overall Study|Protocol Violation|7
5202507|NCT01080807|17959940|P2|Overall Study|Withdrawal by Subject|2
5202508|NCT01080807|17959941|P1|Overall Study|Withdrawal by Subject|7
5202509|NCT01080807|17959940|P2|Overall Study|Lack of Efficacy|1
5202510|NCT01080807|17959941|P1|Overall Study|Lack of Efficacy|0
5202511|NCT01080807|17959940|P2|Overall Study|Adverse Event|1
5202512|NCT01080807|17959941|P1|Overall Study|Adverse Event|9
5202513|NCT01080768|17960050|P2|Overall Study|Protocol Deviation|1
5202514|NCT01080768|17960051|P1|Overall Study|Protocol Deviation|2
5202515|NCT01080716|17960061|P4|Part 1|Physician Decision|0
5202516|NCT01080716|17960062|P3|Part 1|Physician Decision|0
5202517|NCT01080716|17960063|P2|Part 1|Physician Decision|0
5202518|NCT01080716|17960064|P1|Part 1|Physician Decision|1
5202519|NCT01080625|17960103|P3|Overall Study|Physician Decision|1
5202520|NCT01080625|17960104|P2|Overall Study|Physician Decision|2
5202521|NCT01080625|17960105|P1|Overall Study|Physician Decision|0
5202522|NCT01080391|17960115|P2|Overall Study|Randomized but not treated|4
5202523|NCT01080391|17960116|P1|Overall Study|Randomized but not treated|7
5202524|NCT01080326|17960134|P1|Overall Study|Surgeon decision|1
5202525|NCT01080326|17960134|P1|Overall Study|Patient deterioration prior to procedure|3
5202526|NCT01080300|17960140|P2|Overall Study|Reasons not specified|6
5202527|NCT01080300|17960141|P1|Overall Study|Reasons not specified|4
5202528|NCT01080300|17960140|P2|Overall Study|Withdrawal by Subject|28
5202529|NCT01080300|17960141|P1|Overall Study|Withdrawal by Subject|12
5202530|NCT01080300|17960140|P2|Overall Study|Death|1
5202531|NCT01080300|17960141|P1|Overall Study|Death|0
5202532|NCT01080300|17960140|P2|Overall Study|Lost to Follow-up|6
5202533|NCT01080300|17960141|P1|Overall Study|Lost to Follow-up|10
5202534|NCT01080300|17960140|P2|Overall Study|Protocol Violation|13
5202535|NCT01080300|17960141|P1|Overall Study|Protocol Violation|7
5202536|NCT01080300|17960140|P2|Overall Study|Lack of Efficacy|15
5202537|NCT01080300|17960141|P1|Overall Study|Lack of Efficacy|12
5202538|NCT01080300|17960140|P2|Overall Study|Adverse Event|35
5202539|NCT01080300|17960141|P1|Overall Study|Adverse Event|49
5202540|NCT01080131|17960246|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
5202541|NCT01080131|17960247|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
5202542|NCT01080131|17960246|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
5202543|NCT01080131|17960247|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
5202544|NCT01080131|17960246|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
5202545|NCT01080131|17960247|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
5202546|NCT01080131|17960246|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
5202547|NCT01080131|17960247|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
5202548|NCT01080131|17960246|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
5202549|NCT01080131|17960247|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
5202550|NCT01080131|17960246|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
5202551|NCT01080131|17960247|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
5202552|NCT01080131|17960246|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
5202553|NCT01080131|17960247|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
5202554|NCT01080131|17960246|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
5202555|NCT01080131|17960247|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
5202556|NCT01080131|17960246|P2|Core Study (0- 12 Weeks)|Death|0
5202557|NCT01080131|17960247|P1|Core Study (0- 12 Weeks)|Death|1
5202558|NCT01080131|17960246|P2|Core Study (0- 12 Weeks)|Administrative problems|1
5202559|NCT01080131|17960247|P1|Core Study (0- 12 Weeks)|Administrative problems|0
5202560|NCT01080131|17960246|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
5202561|NCT01080131|17960247|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
5202562|NCT01080131|17960246|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
5202563|NCT01080131|17960247|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
5202564|NCT01080131|17960246|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
5202565|NCT01080131|17960247|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
5202566|NCT01079988|17960342|P5|Overall Study|Other|1
5202567|NCT01079988|17960343|P4|Overall Study|Other|2
5202568|NCT01079988|17960344|P3|Overall Study|Other|0
5202569|NCT01079988|17960345|P2|Overall Study|Other|0
5202570|NCT01079988|17960346|P1|Overall Study|Other|0
5202571|NCT01079988|17960342|P5|Overall Study|Lack of Efficacy|0
5202572|NCT01079988|17960343|P4|Overall Study|Lack of Efficacy|0
5202573|NCT01079988|17960344|P3|Overall Study|Lack of Efficacy|0
5202574|NCT01079988|17960345|P2|Overall Study|Lack of Efficacy|0
5202575|NCT01079988|17960346|P1|Overall Study|Lack of Efficacy|1
5202576|NCT01079988|17960342|P5|Overall Study|Lost to Follow-up|0
5202577|NCT01079988|17960343|P4|Overall Study|Lost to Follow-up|1
5202578|NCT01079988|17960344|P3|Overall Study|Lost to Follow-up|0
5202579|NCT01079988|17960345|P2|Overall Study|Lost to Follow-up|0
5202580|NCT01079988|17960346|P1|Overall Study|Lost to Follow-up|0
5202581|NCT01079962|17960365|P2|Overall Study|Due to arrhythmia/bradycardia|1
5202582|NCT01079962|17960366|P1|Overall Study|Due to arrhythmia/bradycardia|1
5202583|NCT01079962|17960365|P2|Overall Study|Participant not returning for next visit|0
5202584|NCT01079962|17960366|P1|Overall Study|Participant not returning for next visit|1
5202585|NCT01079962|17960365|P2|Overall Study|Inclusion/exclusion criteria|3
5202586|NCT01079962|17960366|P1|Overall Study|Inclusion/exclusion criteria|1
5202587|NCT01079962|17960365|P2|Overall Study|No blood pressure (BP) control|0
5202588|NCT01079962|17960366|P1|Overall Study|No blood pressure (BP) control|3
5202589|NCT01079962|17960365|P2|Overall Study|Protocol Violation|2
5202590|NCT01079962|17960366|P1|Overall Study|Protocol Violation|2
5202591|NCT01079962|17960365|P2|Overall Study|Withdrawal by Subject|7
5202592|NCT01079962|17960366|P1|Overall Study|Withdrawal by Subject|5
5202593|NCT01079962|17960365|P2|Overall Study|Adverse Event|2
5202594|NCT01079962|17960366|P1|Overall Study|Adverse Event|2
5202595|NCT01079949|17960394|P2|Overall Study|Randomized but not treated|0
5202596|NCT01079949|17960395|P1|Overall Study|Randomized but not treated|1
5202597|NCT01079949|17960394|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
5202598|NCT01079949|17960395|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
5202599|NCT01079949|17960394|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
5202600|NCT01079949|17960395|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
5202601|NCT01079949|17960394|P2|Overall Study|Withdrawal before r-hCG administration|3
5202602|NCT01079949|17960395|P1|Overall Study|Withdrawal before r-hCG administration|2
5202603|NCT01079936|17960441|P5|Phase II|Insurance Issue|1
5202604|NCT01079936|17960442|P4|Phase II|Insurance Issue|0
5202605|NCT01079936|17960443|P3|Phase II|Insurance Issue|0
5202606|NCT01079936|17960444|P2|Phase II|Insurance Issue|0
5202607|NCT01079936|17960445|P1|Phase II|Insurance Issue|0
5202608|NCT01079936|17960441|P5|Phase II|Adverse Event|0
5202609|NCT01079936|17960442|P4|Phase II|Adverse Event|0
5202610|NCT01079936|17960443|P3|Phase II|Adverse Event|1
5202611|NCT01079936|17960444|P2|Phase II|Adverse Event|0
5202612|NCT01079936|17960445|P1|Phase II|Adverse Event|0
5202613|NCT01079936|17960441|P5|Phase I: MTD|No Stem Cell Transplantation|0
5202614|NCT01079936|17960442|P4|Phase I: MTD|No Stem Cell Transplantation|0
5202615|NCT01079936|17960443|P3|Phase I: MTD|No Stem Cell Transplantation|0
5202616|NCT01079936|17960444|P2|Phase I: MTD|No Stem Cell Transplantation|0
5202617|NCT01079936|17960445|P1|Phase I: MTD|No Stem Cell Transplantation|2
5202618|NCT01079936|17960441|P5|Phase I: MTD|First Remission Status|0
5202619|NCT01079936|17960442|P4|Phase I: MTD|First Remission Status|0
5202620|NCT01079936|17960443|P3|Phase I: MTD|First Remission Status|0
5202621|NCT01079936|17960444|P2|Phase I: MTD|First Remission Status|0
5202622|NCT01079936|17960445|P1|Phase I: MTD|First Remission Status|2
5202623|NCT01079832|17960464|P1|Overall Study|Withdrawal by Subject|1
5202624|NCT01079806|17960474|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
5202625|NCT01079806|17960475|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
5202626|NCT01079806|17960474|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
5202627|NCT01079806|17960475|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
5202628|NCT01079806|17960474|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
5202629|NCT01079806|17960475|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
5202630|NCT01079806|17960474|P2|Day 1 to Week 96|Removal by Medical Monitor|1
5202631|NCT01079806|17960475|P1|Day 1 to Week 96|Removal by Medical Monitor|0
5202632|NCT01079806|17960474|P2|Day 1 to Week 96|Subject request to stop study treatment|0
5202633|NCT01079806|17960475|P1|Day 1 to Week 96|Subject request to stop study treatment|1
5202634|NCT01079806|17960474|P2|Day 1 to Week 96|Lost to Follow-up|0
5202635|NCT01079806|17960475|P1|Day 1 to Week 96|Lost to Follow-up|1
5202636|NCT01079806|17960474|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
5202637|NCT01079806|17960475|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
5202638|NCT01079806|17960474|P2|Day 1 to Week 96|Pregnancy|1
5202639|NCT01079806|17960475|P1|Day 1 to Week 96|Pregnancy|0
5202640|NCT01079806|17960474|P2|Day 1 to Week 96|Withdrawal by Subject|2
5202641|NCT01079806|17960475|P1|Day 1 to Week 96|Withdrawal by Subject|3
5202642|NCT01079806|17960474|P2|Day 1 to Week 96|Adverse Event|3
5202643|NCT01079806|17960475|P1|Day 1 to Week 96|Adverse Event|0
5202644|NCT01079741|17960510|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
5202645|NCT01079741|17960511|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5202646|NCT01079741|17960512|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5202647|NCT01079741|17960513|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5202648|NCT01079741|17960514|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5202649|NCT01079741|17960510|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5202650|NCT01079741|17960511|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5202651|NCT01079741|17960512|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5202652|NCT01079741|17960513|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
5202653|NCT01079741|17960514|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5202654|NCT01079234|17960562|P4|Extension: Week 27 to 52|Unclassified|7
5202655|NCT01079234|17960563|P3|Extension: Week 27 to 52|Unclassified|4
5202656|NCT01079234|17960564|P2|Extension: Week 27 to 52|Unclassified|0
5202657|NCT01079234|17960565|P1|Extension: Week 27 to 52|Unclassified|0
5202658|NCT01079234|17960562|P4|Extension: Week 27 to 52|Withdrawal criteria|2
5202659|NCT01079234|17960563|P3|Extension: Week 27 to 52|Withdrawal criteria|4
5202660|NCT01079234|17960564|P2|Extension: Week 27 to 52|Withdrawal criteria|0
5202661|NCT01079234|17960565|P1|Extension: Week 27 to 52|Withdrawal criteria|0
5202662|NCT01079234|17960562|P4|Extension: Week 27 to 52|Protocol Violation|5
5202663|NCT01079234|17960563|P3|Extension: Week 27 to 52|Protocol Violation|2
5202664|NCT01079234|17960564|P2|Extension: Week 27 to 52|Protocol Violation|0
5202665|NCT01079234|17960565|P1|Extension: Week 27 to 52|Protocol Violation|0
5202666|NCT01079234|17960562|P4|Extension: Week 27 to 52|Lack of Efficacy|2
5202667|NCT01079234|17960563|P3|Extension: Week 27 to 52|Lack of Efficacy|0
5202668|NCT01079234|17960564|P2|Extension: Week 27 to 52|Lack of Efficacy|0
5202669|NCT01079234|17960565|P1|Extension: Week 27 to 52|Lack of Efficacy|0
5202670|NCT01079234|17960562|P4|Extension: Week 27 to 52|Adverse Event|0
5202671|NCT01079234|17960563|P3|Extension: Week 27 to 52|Adverse Event|1
5202672|NCT01079234|17960564|P2|Extension: Week 27 to 52|Adverse Event|0
5202673|NCT01079234|17960565|P1|Extension: Week 27 to 52|Adverse Event|0
5202674|NCT01079234|17960562|P4|Main: Week 0 to 26|Unclassified|0
5202675|NCT01079234|17960563|P3|Main: Week 0 to 26|Unclassified|4
5202676|NCT01079234|17960564|P2|Main: Week 0 to 26|Unclassified|13
5202677|NCT01079234|17960565|P1|Main: Week 0 to 26|Unclassified|7
5202678|NCT01079234|17960562|P4|Main: Week 0 to 26|Withdrawal criteria|0
5202679|NCT01079234|17960563|P3|Main: Week 0 to 26|Withdrawal criteria|2
5202680|NCT01079234|17960564|P2|Main: Week 0 to 26|Withdrawal criteria|6
5202681|NCT01079234|17960565|P1|Main: Week 0 to 26|Withdrawal criteria|6
5202682|NCT01079234|17960562|P4|Main: Week 0 to 26|Protocol Violation|0
5202683|NCT01079234|17960563|P3|Main: Week 0 to 26|Protocol Violation|4
5202684|NCT01079234|17960564|P2|Main: Week 0 to 26|Protocol Violation|2
5202685|NCT01079234|17960565|P1|Main: Week 0 to 26|Protocol Violation|6
5202686|NCT01079234|17960562|P4|Main: Week 0 to 26|Lack of Efficacy|0
5202687|NCT01079234|17960563|P3|Main: Week 0 to 26|Lack of Efficacy|1
5202688|NCT01079234|17960564|P2|Main: Week 0 to 26|Lack of Efficacy|1
5202689|NCT01079234|17960565|P1|Main: Week 0 to 26|Lack of Efficacy|2
5202690|NCT01079234|17960562|P4|Main: Week 0 to 26|Adverse Event|0
5202691|NCT01079234|17960563|P3|Main: Week 0 to 26|Adverse Event|1
5202692|NCT01079234|17960564|P2|Main: Week 0 to 26|Adverse Event|4
5202693|NCT01079234|17960565|P1|Main: Week 0 to 26|Adverse Event|5
5202694|NCT01079195|17960583|P1|Overall Study|Non-compliance|2
5202695|NCT01079195|17960583|P1|Overall Study|No Follow-up Documentation Available|4
5202696|NCT01079195|17960583|P1|Overall Study|Improved Status of Participant|4
5202697|NCT01079195|17960583|P1|Overall Study|Physician Decision|4
5202698|NCT01079195|17960583|P1|Overall Study|Lack of Effectiveness|12
5202699|NCT01079195|17960583|P1|Overall Study|Financial Reasons|15
5202700|NCT01079195|17960583|P1|Overall Study|Withdrawal by Subject|18
5202701|NCT01079195|17960583|P1|Overall Study|Reason Unknown|39
5202702|NCT01079195|17960583|P1|Overall Study|Adverse Event|157
5202703|NCT01079195|17960583|P1|Overall Study|No Documentation Available|437
5202704|NCT01079195|17960583|P1|Overall Study|No Documentation of Tarka Therapy|739
5202705|NCT01079182|17960589|P1|Overall Study|Reasons not Evaluated|271
5202706|NCT01079182|17960589|P1|Overall Study|ADR and Lack of Effectiveness|39
5202707|NCT01079182|17960589|P1|Overall Study|Lack of Efficacy|514
5202708|NCT01079182|17960589|P1|Overall Study|Adverse Drug Reaction (ADR)|261
5202709|NCT01079182|17960589|P1|Overall Study|Lost to Follow-up|1634
5202710|NCT01079130|17960697|P6|Overall Study|Lost to Follow-up|0
5202711|NCT01079130|17960698|P5|Overall Study|Lost to Follow-up|1
5202712|NCT01079130|17960699|P4|Overall Study|Lost to Follow-up|0
5202713|NCT01079130|17960700|P3|Overall Study|Lost to Follow-up|0
5202714|NCT01079130|17960701|P2|Overall Study|Lost to Follow-up|0
5202715|NCT01079130|17960702|P1|Overall Study|Lost to Follow-up|0
5202716|NCT01079130|17960697|P6|Overall Study|Unsatisfactory therapeutic effect|0
5202717|NCT01079130|17960698|P5|Overall Study|Unsatisfactory therapeutic effect|0
5202718|NCT01079130|17960699|P4|Overall Study|Unsatisfactory therapeutic effect|2
5202719|NCT01079130|17960700|P3|Overall Study|Unsatisfactory therapeutic effect|0
5202720|NCT01079130|17960701|P2|Overall Study|Unsatisfactory therapeutic effect|0
5202721|NCT01079130|17960702|P1|Overall Study|Unsatisfactory therapeutic effect|0
5202722|NCT01079130|17960697|P6|Overall Study|Abnormal test procedure result(s)|0
5202723|NCT01079130|17960698|P5|Overall Study|Abnormal test procedure result(s)|1
5202724|NCT01079130|17960699|P4|Overall Study|Abnormal test procedure result(s)|0
5202725|NCT01079130|17960700|P3|Overall Study|Abnormal test procedure result(s)|0
5202726|NCT01079130|17960701|P2|Overall Study|Abnormal test procedure result(s)|0
5202727|NCT01079130|17960702|P1|Overall Study|Abnormal test procedure result(s)|0
5202728|NCT01079130|17960697|P6|Overall Study|Protocol deviation|0
5202729|NCT01079130|17960698|P5|Overall Study|Protocol deviation|0
5202730|NCT01079130|17960699|P4|Overall Study|Protocol deviation|2
5202731|NCT01079130|17960700|P3|Overall Study|Protocol deviation|1
5202732|NCT01079130|17960701|P2|Overall Study|Protocol deviation|2
5202733|NCT01079130|17960702|P1|Overall Study|Protocol deviation|0
5202734|NCT01079130|17960697|P6|Overall Study|Withdrawal by Subject|3
5202735|NCT01079130|17960698|P5|Overall Study|Withdrawal by Subject|1
5202736|NCT01079130|17960699|P4|Overall Study|Withdrawal by Subject|0
5202737|NCT01079130|17960700|P3|Overall Study|Withdrawal by Subject|0
5202738|NCT01079130|17960701|P2|Overall Study|Withdrawal by Subject|1
5202739|NCT01079130|17960702|P1|Overall Study|Withdrawal by Subject|0
5202740|NCT01079130|17960697|P6|Overall Study|Administrative problems|1
5202741|NCT01079130|17960698|P5|Overall Study|Administrative problems|0
5202742|NCT01079130|17960699|P4|Overall Study|Administrative problems|0
5202743|NCT01079130|17960700|P3|Overall Study|Administrative problems|0
5202744|NCT01079130|17960701|P2|Overall Study|Administrative problems|3
5202745|NCT01079130|17960702|P1|Overall Study|Administrative problems|1
5202746|NCT01079130|17960697|P6|Overall Study|Adverse Event|1
5202747|NCT01079130|17960698|P5|Overall Study|Adverse Event|5
5202748|NCT01079130|17960699|P4|Overall Study|Adverse Event|1
5202749|NCT01079130|17960700|P3|Overall Study|Adverse Event|0
5202750|NCT01079130|17960701|P2|Overall Study|Adverse Event|1
5202751|NCT01079130|17960702|P1|Overall Study|Adverse Event|1
5202752|NCT01078974|17960722|P1|Overall Study|Adverse Event|3
5202753|NCT01078922|17960727|P1|Overall Study|Adverse Event|1
5202754|NCT01078805|17960768|P1|Overall Study|Didn't take study drug|82
5202755|NCT01078805|17960768|P1|Overall Study|Other|173
5202756|NCT01078805|17960768|P1|Overall Study|Withdrawal by Subject|739
5202757|NCT01078805|17960768|P1|Overall Study|Sponsor decision|46
5202758|NCT01078805|17960768|P1|Overall Study|Serious adverse event|26
5202759|NCT01078805|17960768|P1|Overall Study|Physician Decision|169
5202760|NCT01078805|17960768|P1|Overall Study|Lost to Follow-up|676
5202761|NCT01078805|17960768|P1|Overall Study|Death|134
5202762|NCT01078805|17960768|P1|Overall Study|Clinically significant abnormal lab|5
5202763|NCT01078675|17960795|P2|Overall Study|Adverse Event|0
5202764|NCT01078675|17960796|P1|Overall Study|Adverse Event|3
5202765|NCT01078675|17960795|P2|Overall Study|Provided in CRF for specific reasons|3
5202766|NCT01078675|17960796|P1|Overall Study|Provided in CRF for specific reasons|2
5202767|NCT01078675|17960795|P2|Overall Study|Protocol Violation|0
5202768|NCT01078675|17960796|P1|Overall Study|Protocol Violation|56
5202769|NCT01078675|17960795|P2|Overall Study|Withdrawal by Subject|3
5202770|NCT01078675|17960796|P1|Overall Study|Withdrawal by Subject|7
5202771|NCT01078662|17960818|P5|Overall Study|Lost to Follow-up|0
5202772|NCT01078662|17960819|P4|Overall Study|Lost to Follow-up|0
5202773|NCT01078662|17960820|P3|Overall Study|Lost to Follow-up|0
5202774|NCT01078662|17960821|P2|Overall Study|Lost to Follow-up|0
5202775|NCT01078662|17960822|P1|Overall Study|Lost to Follow-up|1
5202776|NCT01078662|17960818|P5|Overall Study|Protocol Violation|0
5202777|NCT01078662|17960819|P4|Overall Study|Protocol Violation|0
5202778|NCT01078662|17960820|P3|Overall Study|Protocol Violation|0
5202779|NCT01078662|17960821|P2|Overall Study|Protocol Violation|1
5202780|NCT01078662|17960822|P1|Overall Study|Protocol Violation|0
5202781|NCT01078662|17960818|P5|Overall Study|Withdrawal by Subject|0
5202782|NCT01078662|17960819|P4|Overall Study|Withdrawal by Subject|0
5202783|NCT01078662|17960820|P3|Overall Study|Withdrawal by Subject|1
5202784|NCT01078662|17960821|P2|Overall Study|Withdrawal by Subject|11
5202785|NCT01078662|17960822|P1|Overall Study|Withdrawal by Subject|4
5202786|NCT01078662|17960818|P5|Overall Study|Patients reached data cut-off|3
5202787|NCT01078662|17960819|P4|Overall Study|Patients reached data cut-off|2
5202788|NCT01078662|17960820|P3|Overall Study|Patients reached data cut-off|2
5202789|NCT01078662|17960821|P2|Overall Study|Patients reached data cut-off|53
5202790|NCT01078662|17960822|P1|Overall Study|Patients reached data cut-off|12
5202791|NCT01078662|17960818|P5|Overall Study|Death|8
5202792|NCT01078662|17960819|P4|Overall Study|Death|5
5202793|NCT01078662|17960820|P3|Overall Study|Death|18
5202794|NCT01078662|17960821|P2|Overall Study|Death|103
5202795|NCT01078662|17960822|P1|Overall Study|Death|41
5202796|NCT01078623|17960861|P20|Treatment Period 4|Withdrawal by Subject|0
5202797|NCT01078623|17960862|P19|Treatment Period 4|Withdrawal by Subject|0
5202798|NCT01078623|17960863|P18|Treatment Period 4|Withdrawal by Subject|0
5202799|NCT01078623|17960864|P17|Treatment Period 4|Withdrawal by Subject|0
5202800|NCT01078623|17960865|P16|Treatment Period 4|Withdrawal by Subject|1
5202801|NCT01078623|17960866|P15|Treatment Period 4|Withdrawal by Subject|0
5202802|NCT01078623|17960867|P14|Treatment Period 4|Withdrawal by Subject|0
5202803|NCT01078623|17960868|P13|Treatment Period 4|Withdrawal by Subject|0
5202804|NCT01078623|17960869|P12|Treatment Period 4|Withdrawal by Subject|0
5202805|NCT01078623|17960870|P11|Treatment Period 4|Withdrawal by Subject|0
5202806|NCT01078623|17960871|P10|Treatment Period 4|Withdrawal by Subject|0
5202807|NCT01078623|17960872|P9|Treatment Period 4|Withdrawal by Subject|0
5202808|NCT01078623|17960873|P8|Treatment Period 4|Withdrawal by Subject|0
5202809|NCT01078623|17960874|P7|Treatment Period 4|Withdrawal by Subject|0
5202810|NCT01078623|17960875|P6|Treatment Period 4|Withdrawal by Subject|0
5202811|NCT01078623|17960876|P5|Treatment Period 4|Withdrawal by Subject|0
5202812|NCT01078623|17960877|P4|Treatment Period 4|Withdrawal by Subject|0
5202813|NCT01078623|17960878|P3|Treatment Period 4|Withdrawal by Subject|0
5202814|NCT01078623|17960879|P2|Treatment Period 4|Withdrawal by Subject|0
5202815|NCT01078623|17960880|P1|Treatment Period 4|Withdrawal by Subject|0
5202816|NCT01078623|17960861|P20|Treatment Period 4|Adverse Event|0
5202817|NCT01078623|17960862|P19|Treatment Period 4|Adverse Event|0
5202818|NCT01078623|17960863|P18|Treatment Period 4|Adverse Event|0
5202819|NCT01078623|17960864|P17|Treatment Period 4|Adverse Event|0
5202820|NCT01078623|17960865|P16|Treatment Period 4|Adverse Event|0
5202821|NCT01078623|17960866|P15|Treatment Period 4|Adverse Event|0
5202822|NCT01078623|17960867|P14|Treatment Period 4|Adverse Event|0
5202823|NCT01078623|17960868|P13|Treatment Period 4|Adverse Event|0
5202824|NCT01078623|17960869|P12|Treatment Period 4|Adverse Event|0
5202825|NCT01078623|17960870|P11|Treatment Period 4|Adverse Event|0
5202826|NCT01078623|17960871|P10|Treatment Period 4|Adverse Event|0
5202827|NCT01078623|17960872|P9|Treatment Period 4|Adverse Event|0
5202828|NCT01078623|17960873|P8|Treatment Period 4|Adverse Event|0
5202829|NCT01078623|17960874|P7|Treatment Period 4|Adverse Event|0
5202830|NCT01078623|17960875|P6|Treatment Period 4|Adverse Event|0
5202831|NCT01078623|17960876|P5|Treatment Period 4|Adverse Event|0
5202832|NCT01078623|17960877|P4|Treatment Period 4|Adverse Event|0
5202833|NCT01078623|17960878|P3|Treatment Period 4|Adverse Event|1
5202834|NCT01078623|17960879|P2|Treatment Period 4|Adverse Event|0
5202835|NCT01078623|17960880|P1|Treatment Period 4|Adverse Event|0
5202836|NCT01078623|17960861|P20|Treatment Period 3|Adverse Event|0
5202837|NCT01078623|17960862|P19|Treatment Period 3|Adverse Event|0
5202838|NCT01078623|17960863|P18|Treatment Period 3|Adverse Event|0
5202839|NCT01078623|17960864|P17|Treatment Period 3|Adverse Event|0
5202840|NCT01078623|17960865|P16|Treatment Period 3|Adverse Event|0
5202841|NCT01078623|17960866|P15|Treatment Period 3|Adverse Event|0
5202842|NCT01078623|17960867|P14|Treatment Period 3|Adverse Event|1
5202843|NCT01078623|17960868|P13|Treatment Period 3|Adverse Event|0
5202844|NCT01078623|17960869|P12|Treatment Period 3|Adverse Event|0
5202845|NCT01078623|17960870|P11|Treatment Period 3|Adverse Event|0
5202846|NCT01078623|17960871|P10|Treatment Period 3|Adverse Event|0
5202847|NCT01078623|17960872|P9|Treatment Period 3|Adverse Event|0
5202848|NCT01078623|17960873|P8|Treatment Period 3|Adverse Event|0
5202849|NCT01078623|17960874|P7|Treatment Period 3|Adverse Event|0
5202850|NCT01078623|17960875|P6|Treatment Period 3|Adverse Event|0
5202851|NCT01078623|17960876|P5|Treatment Period 3|Adverse Event|1
5202852|NCT01078623|17960877|P4|Treatment Period 3|Adverse Event|0
5202853|NCT01078623|17960878|P3|Treatment Period 3|Adverse Event|0
5202854|NCT01078623|17960879|P2|Treatment Period 3|Adverse Event|0
5202855|NCT01078623|17960880|P1|Treatment Period 3|Adverse Event|0
5202856|NCT01078623|17960861|P20|Treatment Period 2|Withdrawal by Subject|0
5202857|NCT01078623|17960862|P19|Treatment Period 2|Withdrawal by Subject|0
5202858|NCT01078623|17960863|P18|Treatment Period 2|Withdrawal by Subject|0
5202859|NCT01078623|17960864|P17|Treatment Period 2|Withdrawal by Subject|0
5202860|NCT01078623|17960865|P16|Treatment Period 2|Withdrawal by Subject|0
5202861|NCT01078623|17960866|P15|Treatment Period 2|Withdrawal by Subject|0
5202862|NCT01078623|17960867|P14|Treatment Period 2|Withdrawal by Subject|0
5202863|NCT01078623|17960868|P13|Treatment Period 2|Withdrawal by Subject|0
5202864|NCT01078623|17960869|P12|Treatment Period 2|Withdrawal by Subject|0
5202865|NCT01078623|17960870|P11|Treatment Period 2|Withdrawal by Subject|0
5202866|NCT01078623|17960871|P10|Treatment Period 2|Withdrawal by Subject|0
5202867|NCT01078623|17960872|P9|Treatment Period 2|Withdrawal by Subject|0
5202868|NCT01078623|17960873|P8|Treatment Period 2|Withdrawal by Subject|0
5202869|NCT01078623|17960874|P7|Treatment Period 2|Withdrawal by Subject|0
5202870|NCT01078623|17960875|P6|Treatment Period 2|Withdrawal by Subject|1
5202871|NCT01078623|17960876|P5|Treatment Period 2|Withdrawal by Subject|0
5202872|NCT01078623|17960877|P4|Treatment Period 2|Withdrawal by Subject|0
5202873|NCT01078623|17960878|P3|Treatment Period 2|Withdrawal by Subject|0
5202874|NCT01078623|17960879|P2|Treatment Period 2|Withdrawal by Subject|0
5202875|NCT01078623|17960880|P1|Treatment Period 2|Withdrawal by Subject|0
5202876|NCT01078623|17960861|P20|Treatment Period 2|Adverse Event|0
5202877|NCT01078623|17960862|P19|Treatment Period 2|Adverse Event|1
5202878|NCT01078623|17960863|P18|Treatment Period 2|Adverse Event|0
5202879|NCT01078623|17960864|P17|Treatment Period 2|Adverse Event|0
5202880|NCT01078623|17960865|P16|Treatment Period 2|Adverse Event|0
5202881|NCT01078623|17960866|P15|Treatment Period 2|Adverse Event|0
5202882|NCT01078623|17960867|P14|Treatment Period 2|Adverse Event|0
5202883|NCT01078623|17960868|P13|Treatment Period 2|Adverse Event|0
5202884|NCT01078623|17960869|P12|Treatment Period 2|Adverse Event|0
5202885|NCT01078623|17960870|P11|Treatment Period 2|Adverse Event|0
5202886|NCT01078623|17960871|P10|Treatment Period 2|Adverse Event|0
5202887|NCT01078623|17960872|P9|Treatment Period 2|Adverse Event|0
5202888|NCT01078623|17960873|P8|Treatment Period 2|Adverse Event|0
5202889|NCT01078623|17960874|P7|Treatment Period 2|Adverse Event|1
5202890|NCT01078623|17960875|P6|Treatment Period 2|Adverse Event|0
5202891|NCT01078623|17960876|P5|Treatment Period 2|Adverse Event|0
5202892|NCT01078623|17960877|P4|Treatment Period 2|Adverse Event|0
5202893|NCT01078623|17960878|P3|Treatment Period 2|Adverse Event|0
5202894|NCT01078623|17960879|P2|Treatment Period 2|Adverse Event|0
5202895|NCT01078623|17960880|P1|Treatment Period 2|Adverse Event|0
5202896|NCT01078623|17960861|P20|Treatment Period 1|Protocol Violation|0
5202897|NCT01078623|17960862|P19|Treatment Period 1|Protocol Violation|0
5202898|NCT01078623|17960863|P18|Treatment Period 1|Protocol Violation|0
5202899|NCT01078623|17960864|P17|Treatment Period 1|Protocol Violation|0
5202900|NCT01078623|17960865|P16|Treatment Period 1|Protocol Violation|0
5202901|NCT01078623|17960866|P15|Treatment Period 1|Protocol Violation|0
5202902|NCT01078623|17960867|P14|Treatment Period 1|Protocol Violation|0
5202903|NCT01078623|17960868|P13|Treatment Period 1|Protocol Violation|0
5202904|NCT01078623|17960869|P12|Treatment Period 1|Protocol Violation|0
5202905|NCT01078623|17960870|P11|Treatment Period 1|Protocol Violation|0
5202906|NCT01078623|17960871|P10|Treatment Period 1|Protocol Violation|0
5202907|NCT01078623|17960872|P9|Treatment Period 1|Protocol Violation|0
5202908|NCT01078623|17960873|P8|Treatment Period 1|Protocol Violation|0
5202909|NCT01078623|17960874|P7|Treatment Period 1|Protocol Violation|0
5202910|NCT01078623|17960875|P6|Treatment Period 1|Protocol Violation|1
5202911|NCT01078623|17960876|P5|Treatment Period 1|Protocol Violation|0
5202912|NCT01078623|17960877|P4|Treatment Period 1|Protocol Violation|0
5202913|NCT01078623|17960878|P3|Treatment Period 1|Protocol Violation|0
5202914|NCT01078623|17960879|P2|Treatment Period 1|Protocol Violation|0
5202915|NCT01078623|17960880|P1|Treatment Period 1|Protocol Violation|0
5202916|NCT01078623|17960861|P20|Treatment Period 1|Withdrawal by Subject|0
5202917|NCT01078623|17960862|P19|Treatment Period 1|Withdrawal by Subject|0
5202918|NCT01078623|17960863|P18|Treatment Period 1|Withdrawal by Subject|0
5202919|NCT01078623|17960864|P17|Treatment Period 1|Withdrawal by Subject|0
5202920|NCT01078623|17960865|P16|Treatment Period 1|Withdrawal by Subject|0
5202921|NCT01078623|17960866|P15|Treatment Period 1|Withdrawal by Subject|0
5202922|NCT01078623|17960867|P14|Treatment Period 1|Withdrawal by Subject|0
5202923|NCT01078623|17960868|P13|Treatment Period 1|Withdrawal by Subject|0
5202924|NCT01078623|17960869|P12|Treatment Period 1|Withdrawal by Subject|0
5202925|NCT01078623|17960870|P11|Treatment Period 1|Withdrawal by Subject|1
5202926|NCT01078623|17960871|P10|Treatment Period 1|Withdrawal by Subject|0
5202927|NCT01078623|17960872|P9|Treatment Period 1|Withdrawal by Subject|0
5202928|NCT01078623|17960873|P8|Treatment Period 1|Withdrawal by Subject|1
5202929|NCT01078623|17960874|P7|Treatment Period 1|Withdrawal by Subject|0
5202930|NCT01078623|17960875|P6|Treatment Period 1|Withdrawal by Subject|0
5202931|NCT01078623|17960876|P5|Treatment Period 1|Withdrawal by Subject|0
5202932|NCT01078623|17960877|P4|Treatment Period 1|Withdrawal by Subject|0
5202933|NCT01078623|17960878|P3|Treatment Period 1|Withdrawal by Subject|0
5202934|NCT01078623|17960879|P2|Treatment Period 1|Withdrawal by Subject|0
5202935|NCT01078623|17960880|P1|Treatment Period 1|Withdrawal by Subject|0
5202936|NCT01078623|17960861|P20|Treatment Period 1|Adverse Event|0
5202937|NCT01078623|17960862|P19|Treatment Period 1|Adverse Event|0
5202938|NCT01078623|17960863|P18|Treatment Period 1|Adverse Event|0
5202939|NCT01078623|17960864|P17|Treatment Period 1|Adverse Event|0
5202940|NCT01078623|17960865|P16|Treatment Period 1|Adverse Event|0
5202941|NCT01078623|17960866|P15|Treatment Period 1|Adverse Event|0
5202942|NCT01078623|17960867|P14|Treatment Period 1|Adverse Event|0
5202943|NCT01078623|17960868|P13|Treatment Period 1|Adverse Event|0
5202944|NCT01078623|17960869|P12|Treatment Period 1|Adverse Event|0
5202945|NCT01078623|17960870|P11|Treatment Period 1|Adverse Event|0
5202946|NCT01078623|17960871|P10|Treatment Period 1|Adverse Event|1
5202947|NCT01078623|17960872|P9|Treatment Period 1|Adverse Event|1
5202948|NCT01078623|17960873|P8|Treatment Period 1|Adverse Event|0
5202949|NCT01078623|17960874|P7|Treatment Period 1|Adverse Event|1
5202950|NCT01078623|17960875|P6|Treatment Period 1|Adverse Event|0
5202951|NCT01078623|17960876|P5|Treatment Period 1|Adverse Event|0
5202952|NCT01078623|17960877|P4|Treatment Period 1|Adverse Event|0
5202953|NCT01078623|17960878|P3|Treatment Period 1|Adverse Event|1
5202954|NCT01078623|17960879|P2|Treatment Period 1|Adverse Event|1
5202955|NCT01078623|17960880|P1|Treatment Period 1|Adverse Event|1
5202956|NCT01078584|17960902|P1|Overall Study|Multiple Reasons|2
5202957|NCT01078584|17960902|P1|Overall Study|Serious Adverse Event|27
5202958|NCT01078584|17960902|P1|Overall Study|Protocol Violation|75
5202959|NCT01078584|17960902|P1|Overall Study|Lack of Efficacy|98
5202960|NCT01078584|17960902|P1|Overall Study|Physician Discontinued Patient|12
5202961|NCT01078584|17960902|P1|Overall Study|Physician Switched Medication|26
5202962|NCT01078584|17960902|P1|Overall Study|Blood Pressure Controlled|49
5202963|NCT01078584|17960902|P1|Overall Study|Non-compliance|67
5202964|NCT01078584|17960902|P1|Overall Study|Physician Withdrew from Study|90
5202965|NCT01078584|17960902|P1|Overall Study|Withdrawal of Consent|244
5202966|NCT01078584|17960902|P1|Overall Study|Non-serious Adverse Event|577
5202967|NCT01078584|17960902|P1|Overall Study|Lost to Follow-up|670
5202968|NCT01078584|17960902|P1|Overall Study|Final Status Unknown|1073
5202969|NCT01078571|17960983|P1|Overall Study|Protocol Violation|2
5202970|NCT01078571|17960983|P1|Overall Study|Lost to Follow-up|8
5202971|NCT01078571|17960983|P1|Overall Study|Withdrawal by Subject|12
5202972|NCT01078571|17960983|P1|Overall Study|Reason not reported|21
5202973|NCT01078571|17960983|P1|Overall Study|Lack of effectiveness|36
5202974|NCT01078571|17960983|P1|Overall Study|Adverse Event|36
5202975|NCT01078545|17961034|P1|Overall Study|Participant moved to another physician|1
5202976|NCT01078545|17961034|P1|Overall Study|Death|3
5202977|NCT01078545|17961034|P1|Overall Study|Withdrawal by Subject|3
5202978|NCT01078545|17961034|P1|Overall Study|Physician Decision|6
5202979|NCT01078545|17961034|P1|Overall Study|Lost to Follow-up|13
5202980|NCT01078454|17961044|P2|Overall Study|Death|1
5202981|NCT01078454|17961045|P1|Overall Study|Death|0
5202982|NCT01078454|17961044|P2|Overall Study|Adverse Event|1
5202983|NCT01078454|17961045|P1|Overall Study|Adverse Event|1
5202984|NCT01078441|17961051|P1|Overall Study|Withdrawal by Subject|1
5202985|NCT01078389|17961091|P2|Overall Study|Other|2
5202986|NCT01078389|17961092|P1|Overall Study|Other|9
5202987|NCT01078389|17961091|P2|Overall Study|Voluntary Withdrawal|36
5202988|NCT01078389|17961092|P1|Overall Study|Voluntary Withdrawal|20
5202989|NCT01078389|17961091|P2|Overall Study|Lost to Follow-up|23
5202990|NCT01078389|17961092|P1|Overall Study|Lost to Follow-up|23
5202991|NCT01078389|17961091|P2|Overall Study|Major Protocol Deviation|0
5202992|NCT01078389|17961092|P1|Overall Study|Major Protocol Deviation|2
5202993|NCT01078389|17961091|P2|Overall Study|Adverse Event|6
5202994|NCT01078389|17961092|P1|Overall Study|Adverse Event|10
5202995|NCT01078298|17961253|P2|Overall Study|Other|32
5202996|NCT01078298|17961254|P1|Overall Study|Other|24
5202997|NCT01078298|17961253|P2|Overall Study|Did not meet entrance criteria|1
5202998|NCT01078298|17961254|P1|Overall Study|Did not meet entrance criteria|0
5202999|NCT01078298|17961253|P2|Overall Study|Death|0
5203000|NCT01078298|17961254|P1|Overall Study|Death|2
5203001|NCT01078298|17961253|P2|Overall Study|Adverse Event|5
5203002|NCT01078298|17961254|P1|Overall Study|Adverse Event|6
5203003|NCT01078298|17961253|P2|Overall Study|Protocol Violation|6
5203004|NCT01078298|17961254|P1|Overall Study|Protocol Violation|6
5203005|NCT01078298|17961253|P2|Overall Study|Withdrawal by Subject|33
5203006|NCT01078298|17961254|P1|Overall Study|Withdrawal by Subject|31
5203007|NCT01078298|17961253|P2|Overall Study|Lost to Follow-up|13
5203008|NCT01078298|17961254|P1|Overall Study|Lost to Follow-up|12
5203009|NCT01078168|17961364|P2|Overall Study|Physician Decision|1
5203010|NCT01078168|17961365|P1|Overall Study|Physician Decision|0
5203011|NCT01078155|17961371|P1|Overall Study|Lost to Follow-up|15
5203012|NCT01078155|17961371|P1|Overall Study|Participant's Decision|6
5203013|NCT01078155|17961371|P1|Overall Study|Lack of Efficacy|16
5203014|NCT01078155|17961371|P1|Overall Study|Adverse Event|7
5203015|NCT01078116|17961387|P1|Overall Study|Case report form not completed|3
5203016|NCT01078116|17961387|P1|Overall Study|Lack of effectiveness|15
5203017|NCT01078116|17961387|P1|Overall Study|Withdrawal by Subject|8
5203018|NCT01078116|17961387|P1|Overall Study|Adverse Event|5
5203019|NCT01078116|17961387|P1|Overall Study|Lost to Follow-up|17
5203020|NCT01078090|17961395|P1|Overall Study|Other|523
5203021|NCT01078090|17961395|P1|Overall Study|ADR and lack of efficacy|61
5203022|NCT01078090|17961395|P1|Overall Study|Lack of Efficacy|1193
5203023|NCT01078090|17961395|P1|Overall Study|Adverse drug reaction (ADR)|453
5203024|NCT01078090|17961395|P1|Overall Study|Lost to Follow-up|2363
5203025|NCT01077960|17961489|P1|Overall Study|Reason unspecified|1
5203026|NCT01077960|17961489|P1|Overall Study|Subject decision|1
5203027|NCT01077960|17961489|P1|Overall Study|Lost to Follow-up|5
5203028|NCT01077960|17961489|P1|Overall Study|Protocol Violation|3
5203029|NCT01077960|17961489|P1|Overall Study|Adverse Event|6
5203030|NCT01077804|17961739|P1|Overall Study|Other|18
5203031|NCT01077804|17961739|P1|Overall Study|Refused to continue|79
5203032|NCT01077804|17961739|P1|Overall Study|Unreachable|102
5203033|NCT01077739|17961748|P2|Overall Study|Other|2
5203034|NCT01077739|17961749|P1|Overall Study|Other|2
5203035|NCT01077739|17961748|P2|Overall Study|Unacceptable toxicity|2
5203036|NCT01077739|17961749|P1|Overall Study|Unacceptable toxicity|1
5203037|NCT01077739|17961748|P2|Overall Study|Death|3
5203038|NCT01077739|17961749|P1|Overall Study|Death|0
5203039|NCT01077739|17961748|P2|Overall Study|Withdrawal by Subject|0
5203040|NCT01077739|17961749|P1|Overall Study|Withdrawal by Subject|1
5203041|NCT01077739|17961748|P2|Overall Study|Premature withdrawal|3
5203042|NCT01077739|17961749|P1|Overall Study|Premature withdrawal|1
5203043|NCT01077713|17961763|P2|Overall Study|Other|2
5203044|NCT01077713|17961764|P1|Overall Study|Other|4
5203045|NCT01077713|17961763|P2|Overall Study|Adverse Event|1
5203046|NCT01077713|17961764|P1|Overall Study|Adverse Event|2
5203047|NCT01077713|17961763|P2|Overall Study|Lost to Follow-up|1
5203048|NCT01077713|17961764|P1|Overall Study|Lost to Follow-up|1
5203049|NCT01077713|17961763|P2|Overall Study|Death|29
5203050|NCT01077713|17961764|P1|Overall Study|Death|28
5203051|NCT01077713|17961763|P2|Overall Study|Progressive Disease (PD)|1
5203052|NCT01077713|17961764|P1|Overall Study|Progressive Disease (PD)|0
5203053|NCT01077713|17961763|P2|Overall Study|Withdrawal by Subject|2
5203054|NCT01077713|17961764|P1|Overall Study|Withdrawal by Subject|1
5203055|NCT01077622|17961788|P1|Overall Study|Withdrawal by Subject|1
5203056|NCT01077622|17961788|P1|Overall Study|Physician Decision|2
5203057|NCT01077544|17961908|P2|Overall Study|Disease Progression|1
5203058|NCT01077544|17961909|P1|Overall Study|Disease Progression|0
5203059|NCT01077544|17961908|P2|Overall Study|Adverse Event|1
5203060|NCT01077544|17961909|P1|Overall Study|Adverse Event|0
5203061|NCT01077544|17961908|P2|Overall Study|New Cancer Therapy|3
5203062|NCT01077544|17961909|P1|Overall Study|New Cancer Therapy|3
5203063|NCT01077518|17961937|P3|Optional Ofa Phase|Withdrawal by Subject|3
5203064|NCT01077518|17961938|P2|Optional Ofa Phase|Withdrawal by Subject|0
5203065|NCT01077518|17961939|P1|Optional Ofa Phase|Withdrawal by Subject|0
5203066|NCT01077518|17961937|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
5203067|NCT01077518|17961938|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
5203068|NCT01077518|17961939|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
5203069|NCT01077518|17961937|P3|Optional Ofa Phase|Physician Decision|1
5203070|NCT01077518|17961938|P2|Optional Ofa Phase|Physician Decision|0
5203071|NCT01077518|17961939|P1|Optional Ofa Phase|Physician Decision|0
5203072|NCT01077518|17961937|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
5203073|NCT01077518|17961938|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
5203074|NCT01077518|17961939|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
5203075|NCT01077518|17961937|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
5203076|NCT01077518|17961938|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
5203077|NCT01077518|17961939|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
5203078|NCT01077518|17961937|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
5203079|NCT01077518|17961938|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
5203080|NCT01077518|17961939|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
5203081|NCT01077518|17961937|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
5203082|NCT01077518|17961938|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
5203083|NCT01077518|17961939|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
5203084|NCT01077375|17962012|P2|Overall Study|Other Reason|1
5203085|NCT01077375|17962013|P1|Overall Study|Other Reason|0
5203086|NCT01077375|17962012|P2|Overall Study|Lost to Follow-up|5
5203087|NCT01077375|17962013|P1|Overall Study|Lost to Follow-up|2
5203088|NCT01077375|17962012|P2|Overall Study|Withdrawal by Subject|6
5203089|NCT01077375|17962013|P1|Overall Study|Withdrawal by Subject|0
5203090|NCT01077375|17962012|P2|Overall Study|Lack of Efficacy|8
5203091|NCT01077375|17962013|P1|Overall Study|Lack of Efficacy|6
5203092|NCT01077375|17962012|P2|Overall Study|Adverse Event|15
5203093|NCT01077375|17962013|P1|Overall Study|Adverse Event|2
5203094|NCT01077362|17962024|P3|Overall Study|Other|2
5203095|NCT01077362|17962025|P2|Overall Study|Other|1
5203096|NCT01077362|17962026|P1|Overall Study|Other|0
5203097|NCT01077362|17962024|P3|Overall Study|Withdrawal by Subject|5
5203098|NCT01077362|17962025|P2|Overall Study|Withdrawal by Subject|3
5203099|NCT01077362|17962026|P1|Overall Study|Withdrawal by Subject|5
5203100|NCT01077362|17962024|P3|Overall Study|Adverse Event|4
5203101|NCT01077362|17962025|P2|Overall Study|Adverse Event|7
5203102|NCT01077362|17962026|P1|Overall Study|Adverse Event|12
5203103|NCT01077362|17962024|P3|Overall Study|Lost to Follow-up|3
5203104|NCT01077362|17962025|P2|Overall Study|Lost to Follow-up|0
5203105|NCT01077362|17962026|P1|Overall Study|Lost to Follow-up|1
5203106|NCT01077362|17962024|P3|Overall Study|Lack of Efficacy|10
5203107|NCT01077362|17962025|P2|Overall Study|Lack of Efficacy|8
5203108|NCT01077362|17962026|P1|Overall Study|Lack of Efficacy|13
5203109|NCT01077323|17962062|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
5203110|NCT01077323|17962063|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
5203111|NCT01077323|17962064|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
5203112|NCT01077323|17962062|P3|Overall Study|Dispensing of drug in baseline period|256446
5203113|NCT01077323|17962063|P2|Overall Study|Dispensing of drug in baseline period|120229
5203114|NCT01077323|17962064|P1|Overall Study|Dispensing of drug in baseline period|0
5203115|NCT01077323|17962062|P3|Overall Study|<9 months enroll before drug dispensed|11655523
5203116|NCT01077323|17962063|P2|Overall Study|<9 months enroll before drug dispensed|263954
5203117|NCT01077323|17962064|P1|Overall Study|<9 months enroll before drug dispensed|11226
5203118|NCT01077284|17962107|P3|Overall Study|Other|1
5203119|NCT01077284|17962108|P2|Overall Study|Other|0
5203120|NCT01077284|17962109|P1|Overall Study|Other|0
5203121|NCT01077284|17962107|P3|Overall Study|Withdrawal by Subject|1
5203122|NCT01077284|17962108|P2|Overall Study|Withdrawal by Subject|3
5203123|NCT01077284|17962109|P1|Overall Study|Withdrawal by Subject|2
5203124|NCT01077284|17962107|P3|Overall Study|Lost to Follow-up|0
5203125|NCT01077284|17962108|P2|Overall Study|Lost to Follow-up|2
5203126|NCT01077284|17962109|P1|Overall Study|Lost to Follow-up|1
5203127|NCT01077284|17962107|P3|Overall Study|Adverse Event|1
5203128|NCT01077284|17962108|P2|Overall Study|Adverse Event|0
5203129|NCT01077284|17962109|P1|Overall Study|Adverse Event|2
5203130|NCT01077271|17962130|P1|Overall Study|Mother unconvinced of the necessity|1
5203131|NCT01077271|17962130|P1|Overall Study|End of RSV season nearly reached|1
5203132|NCT01077271|17962130|P1|Overall Study|Parents thought too many injections|2
5203133|NCT01077271|17962130|P1|Overall Study|Changed doctors|2
5203134|NCT01077271|17962130|P1|Overall Study|Quota used up (insurance reimb issue)|2
5203135|NCT01077271|17962130|P1|Overall Study|Noncompliance|2
5203136|NCT01077271|17962130|P1|Overall Study|Screen failure, did not take palivizumab|4
5203137|NCT01077271|17962130|P1|Overall Study|Parental desire|8
5203138|NCT01077258|17962168|P1|Overall Study|Other reasons|260
5203139|NCT01077258|17962168|P1|Overall Study|Clinical remission|37
5203140|NCT01077258|17962168|P1|Overall Study|Lack of Efficacy|663
5203141|NCT01077258|17962168|P1|Overall Study|Adverse drug reaction|218
5203142|NCT01077258|17962168|P1|Overall Study|Lost to Follow-up|1390
5203143|NCT01077193|17962204|P1|Overall Study|Study Terminated by Sponsor|40
5203144|NCT01077193|17962204|P1|Overall Study|Lack of Efficacy|1
5203145|NCT01077193|17962204|P1|Overall Study|Withdrawal by Subject|2
5203146|NCT01077193|17962204|P1|Overall Study|Lost to Follow-up|1
5203147|NCT01077154|17962210|P2|Overall Study|Protocol Deviation|0
5203148|NCT01077154|17962211|P1|Overall Study|Protocol Deviation|1
5203149|NCT01077154|17962210|P2|Overall Study|Administrative Decision|6
5203150|NCT01077154|17962211|P1|Overall Study|Administrative Decision|1
5203151|NCT01077154|17962210|P2|Overall Study|Adverse Event|9
5203152|NCT01077154|17962211|P1|Overall Study|Adverse Event|9
5203153|NCT01077154|17962210|P2|Overall Study|Other|11
5203154|NCT01077154|17962211|P1|Overall Study|Other|14
5203155|NCT01077154|17962210|P2|Overall Study|Ineligibility Determined|14
5203156|NCT01077154|17962211|P1|Overall Study|Ineligibility Determined|10
5203157|NCT01077154|17962210|P2|Overall Study|Disease Progression|20
5203158|NCT01077154|17962211|P1|Overall Study|Disease Progression|18
5203159|NCT01077154|17962210|P2|Overall Study|Noncompliance|20
5203160|NCT01077154|17962211|P1|Overall Study|Noncompliance|22
5203161|NCT01077154|17962210|P2|Overall Study|Lost to Follow-up|35
5203162|NCT01077154|17962211|P1|Overall Study|Lost to Follow-up|43
5203163|NCT01077154|17962210|P2|Overall Study|Death|214
5203164|NCT01077154|17962211|P1|Overall Study|Death|215
5203165|NCT01077154|17962210|P2|Overall Study|Withdrawal by Subject|385
5203166|NCT01077154|17962211|P1|Overall Study|Withdrawal by Subject|369
5203167|NCT01077154|17962210|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
5203168|NCT01077154|17962211|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
5203169|NCT01077128|17962225|P1|Overall Study|Other|54
5203170|NCT01077128|17962225|P1|Overall Study|Lack of efficacy/disease exacerbation|1
5203171|NCT01077128|17962225|P1|Overall Study|Adverse event and disease exacerbation|1
5203172|NCT01077128|17962225|P1|Overall Study|Adverse event and consent withdrawal|1
5203173|NCT01077128|17962225|P1|Overall Study|Disease exacerbation|1
5203174|NCT01077128|17962225|P1|Overall Study|Lack of Efficacy|1
5203175|NCT01077128|17962225|P1|Overall Study|Adverse Event|8
5203176|NCT01077076|17962283|P6|Third Intervention|Death in the participant's family|1
5203177|NCT01077076|17962284|P5|Third Intervention|Death in the participant's family|0
5203178|NCT01077076|17962285|P4|Third Intervention|Death in the participant's family|0
5203179|NCT01077076|17962286|P3|Third Intervention|Death in the participant's family|0
5203180|NCT01077076|17962287|P2|Third Intervention|Death in the participant's family|0
5203181|NCT01077076|17962288|P1|Third Intervention|Death in the participant's family|0
5203182|NCT01077076|17962283|P6|First Intervention|Withdrawal by Subject|0
5203183|NCT01077076|17962284|P5|First Intervention|Withdrawal by Subject|0
5203184|NCT01077076|17962285|P4|First Intervention|Withdrawal by Subject|0
5203185|NCT01077076|17962286|P3|First Intervention|Withdrawal by Subject|0
5203186|NCT01077076|17962287|P2|First Intervention|Withdrawal by Subject|0
5203187|NCT01077076|17962288|P1|First Intervention|Withdrawal by Subject|1
5203188|NCT01077063|17962298|P2|Overall Study|Withdrawal by Subject|2
5203189|NCT01077063|17962299|P1|Overall Study|Withdrawal by Subject|0
5203190|NCT01077063|17962298|P2|Overall Study|Death|1
5203191|NCT01077063|17962299|P1|Overall Study|Death|1
5203192|NCT01077063|17962298|P2|Overall Study|Adverse Event|0
5203193|NCT01077063|17962299|P1|Overall Study|Adverse Event|3
5203194|NCT01077050|17962305|P1|Overall Study|Screen failure|8
5203195|NCT01077050|17962305|P1|Overall Study|Subjects signed ICF could not be located|1
5203196|NCT01077024|17962311|P2|Overall Study|Other|4
5203197|NCT01077024|17962312|P1|Overall Study|Other|4
5203198|NCT01077024|17962311|P2|Overall Study|Incarcerated|8
5203199|NCT01077024|17962312|P1|Overall Study|Incarcerated|7
5203200|NCT01077024|17962311|P2|Overall Study|Withdrawal by Subject|2
5203201|NCT01077024|17962312|P1|Overall Study|Withdrawal by Subject|0
5203202|NCT01077024|17962311|P2|Overall Study|Lost to Follow-up|14
5203203|NCT01077024|17962312|P1|Overall Study|Lost to Follow-up|20
5203204|NCT01076959|17962351|P1|Overall Study|Other|119
5203205|NCT01076959|17962351|P1|Overall Study|Lost to Follow-up|241
5203206|NCT01076959|17962351|P1|Overall Study|Non-compliance|274
5203207|NCT01076959|17962351|P1|Overall Study|Lack of Efficacy|849
5203208|NCT01076959|17962351|P1|Overall Study|Adverse Event|767
5203209|NCT01076647|17962387|P2|Overall Study|Unclassified|12
5203210|NCT01076647|17962388|P1|Overall Study|Unclassified|12
5203211|NCT01076647|17962387|P2|Overall Study|Withdrawal criteria|2
5203212|NCT01076647|17962388|P1|Overall Study|Withdrawal criteria|2
5203213|NCT01076647|17962387|P2|Overall Study|Protocol Violation|9
5203214|NCT01076647|17962388|P1|Overall Study|Protocol Violation|7
5203215|NCT01076647|17962387|P2|Overall Study|Lack of Efficacy|1
5203216|NCT01076647|17962388|P1|Overall Study|Lack of Efficacy|0
5203217|NCT01076647|17962387|P2|Overall Study|Adverse Event|1
5203218|NCT01076647|17962388|P1|Overall Study|Adverse Event|4
5203219|NCT01076543|17962402|P6|Overall Study|Withdrawal by Subject|0
5203220|NCT01076543|17962403|P5|Overall Study|Withdrawal by Subject|0
5203221|NCT01076543|17962404|P4|Overall Study|Withdrawal by Subject|0
5203222|NCT01076543|17962405|P3|Overall Study|Withdrawal by Subject|0
5203223|NCT01076543|17962406|P2|Overall Study|Withdrawal by Subject|0
5203224|NCT01076543|17962407|P1|Overall Study|Withdrawal by Subject|2
5203225|NCT01076400|17962468|P3|Overall Study|Progressive Disease|0
5203226|NCT01076400|17962469|P2|Overall Study|Progressive Disease|0
5203227|NCT01076400|17962470|P1|Overall Study|Progressive Disease|5
5203228|NCT01076400|17962468|P3|Overall Study|Adverse Event|0
5203229|NCT01076400|17962469|P2|Overall Study|Adverse Event|0
5203230|NCT01076400|17962470|P1|Overall Study|Adverse Event|2
5203231|NCT01076361|17962476|P1|Overall Study|22 leads were excluded from analysis|21
5203232|NCT01076335|17962484|P1|Overall Study|Withdrawal without treatment|1
5203233|NCT01076335|17962484|P1|Overall Study|Withdrawal by Subject|3
5203234|NCT01076205|17962536|P1|Overall Study|Lost to Follow-up|3151
5203235|NCT01076205|17962536|P1|Overall Study|Unknown Reason|71
5203236|NCT01076205|17962536|P1|Overall Study|Other Reason|1075
5203237|NCT01076205|17962536|P1|Overall Study|Lack of Effectiveness|1423
5203238|NCT01076205|17962536|P1|Overall Study|Adverse Drug Reaction|299
5203239|NCT01076192|17962589|P1|Overall Study|Other|197
5203240|NCT01076179|17962604|P1|Overall Study|Withdrawal by Subject|1
5203241|NCT01076166|17962627|P1|Overall Study|Symptoms improved/resolved|6
5203242|NCT01076166|17962627|P1|Overall Study|Adverse Event|3
5203243|NCT01076153|17962634|P1|Overall Study|Adverse Event|1
5203244|NCT01076153|17962634|P1|Overall Study|Symptoms improved/resolved|10
5203245|NCT01076088|17962648|P6|Overall Study|Other protocol specified criteria|1
5203246|NCT01076088|17962649|P5|Overall Study|Other protocol specified criteria|0
5203247|NCT01076088|17962650|P4|Overall Study|Other protocol specified criteria|0
5203248|NCT01076088|17962651|P3|Overall Study|Other protocol specified criteria|0
5203249|NCT01076088|17962652|P2|Overall Study|Other protocol specified criteria|0
5203250|NCT01076088|17962653|P1|Overall Study|Other protocol specified criteria|0
5203251|NCT01076088|17962648|P6|Overall Study|Withdrawal by Subject|17
5203252|NCT01076088|17962649|P5|Overall Study|Withdrawal by Subject|11
5203253|NCT01076088|17962650|P4|Overall Study|Withdrawal by Subject|10
5203254|NCT01076088|17962651|P3|Overall Study|Withdrawal by Subject|14
5203255|NCT01076088|17962652|P2|Overall Study|Withdrawal by Subject|8
5203256|NCT01076088|17962653|P1|Overall Study|Withdrawal by Subject|8
5203257|NCT01076088|17962648|P6|Overall Study|Physician Decision|0
5203258|NCT01076088|17962649|P5|Overall Study|Physician Decision|1
5203259|NCT01076088|17962650|P4|Overall Study|Physician Decision|1
5203260|NCT01076088|17962651|P3|Overall Study|Physician Decision|0
5203261|NCT01076088|17962652|P2|Overall Study|Physician Decision|3
5203262|NCT01076088|17962653|P1|Overall Study|Physician Decision|1
5203263|NCT01076088|17962648|P6|Overall Study|Non-compliance with study drug|0
5203264|NCT01076088|17962649|P5|Overall Study|Non-compliance with study drug|0
5203265|NCT01076088|17962650|P4|Overall Study|Non-compliance with study drug|1
5203266|NCT01076088|17962651|P3|Overall Study|Non-compliance with study drug|0
5203267|NCT01076088|17962652|P2|Overall Study|Non-compliance with study drug|0
5203268|NCT01076088|17962653|P1|Overall Study|Non-compliance with study drug|0
5203269|NCT01076088|17962648|P6|Overall Study|Lost to Follow-up|2
5203270|NCT01076088|17962649|P5|Overall Study|Lost to Follow-up|1
5203271|NCT01076088|17962650|P4|Overall Study|Lost to Follow-up|1
5203272|NCT01076088|17962651|P3|Overall Study|Lost to Follow-up|0
5203273|NCT01076088|17962652|P2|Overall Study|Lost to Follow-up|1
5203274|NCT01076088|17962653|P1|Overall Study|Lost to Follow-up|1
5203275|NCT01076088|17962648|P6|Overall Study|Adverse Event|3
5203276|NCT01076088|17962649|P5|Overall Study|Adverse Event|3
5203277|NCT01076088|17962650|P4|Overall Study|Adverse Event|2
5203278|NCT01076088|17962651|P3|Overall Study|Adverse Event|3
5203279|NCT01076088|17962652|P2|Overall Study|Adverse Event|6
5203280|NCT01076088|17962653|P1|Overall Study|Adverse Event|1
5203281|NCT01076075|17962681|P2|Overall Study|Withdrawal by Subject|19
5203282|NCT01076075|17962682|P1|Overall Study|Withdrawal by Subject|8
5203283|NCT01076075|17962681|P2|Overall Study|Protocol Violation|1
5203284|NCT01076075|17962682|P1|Overall Study|Protocol Violation|0
5203285|NCT01076075|17962681|P2|Overall Study|other|9
5203286|NCT01076075|17962682|P1|Overall Study|other|19
5203287|NCT01076075|17962681|P2|Overall Study|Lost to Follow-up|5
5203288|NCT01076075|17962682|P1|Overall Study|Lost to Follow-up|6
5203289|NCT01076075|17962681|P2|Overall Study|Lack of Efficacy|4
5203290|NCT01076075|17962682|P1|Overall Study|Lack of Efficacy|5
5203291|NCT01076075|17962681|P2|Overall Study|Adverse Event|9
5203292|NCT01076075|17962682|P1|Overall Study|Adverse Event|3
5203293|NCT01076036|17962696|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
5203294|NCT01076010|17962704|P3|Overall Study|Other|0
5203295|NCT01076010|17962705|P2|Overall Study|Other|2
5203296|NCT01076010|17962706|P1|Overall Study|Other|5
5203297|NCT01076010|17962704|P3|Overall Study|Withdrawal by Subject|1
5203298|NCT01076010|17962705|P2|Overall Study|Withdrawal by Subject|0
5203299|NCT01076010|17962706|P1|Overall Study|Withdrawal by Subject|3
5203300|NCT01076010|17962704|P3|Overall Study|Noncompliance|0
5203301|NCT01076010|17962705|P2|Overall Study|Noncompliance|1
5203302|NCT01076010|17962706|P1|Overall Study|Noncompliance|1
5203303|NCT01076010|17962704|P3|Overall Study|Protocol Violation|0
5203304|NCT01076010|17962705|P2|Overall Study|Protocol Violation|1
5203305|NCT01076010|17962706|P1|Overall Study|Protocol Violation|0
5203306|NCT01076010|17962704|P3|Overall Study|Significant Surgical Procedure|0
5203307|NCT01076010|17962705|P2|Overall Study|Significant Surgical Procedure|1
5203308|NCT01076010|17962706|P1|Overall Study|Significant Surgical Procedure|0
5203309|NCT01076010|17962704|P3|Overall Study|Treatment Interruption for > 2 Weeks|0
5203310|NCT01076010|17962705|P2|Overall Study|Treatment Interruption for > 2 Weeks|1
5203311|NCT01076010|17962706|P1|Overall Study|Treatment Interruption for > 2 Weeks|0
5203312|NCT01076010|17962704|P3|Overall Study|Lack of Efficacy|0
5203313|NCT01076010|17962705|P2|Overall Study|Lack of Efficacy|0
5203314|NCT01076010|17962706|P1|Overall Study|Lack of Efficacy|4
5203315|NCT01076010|17962704|P3|Overall Study|Progressive disease|1
5203316|NCT01076010|17962705|P2|Overall Study|Progressive disease|30
5203317|NCT01076010|17962706|P1|Overall Study|Progressive disease|90
5203318|NCT01076010|17962704|P3|Overall Study|Adverse Event|0
5203319|NCT01076010|17962705|P2|Overall Study|Adverse Event|2
5203320|NCT01076010|17962706|P1|Overall Study|Adverse Event|7
5203321|NCT01076010|17962704|P3|Overall Study|Death|0
5203322|NCT01076010|17962705|P2|Overall Study|Death|1
5203323|NCT01076010|17962706|P1|Overall Study|Death|15
5203324|NCT01075984|17962746|P5|Follow-up Phase|Treatment failure|4
5203325|NCT01075984|17962747|P4|Follow-up Phase|Treatment failure|0
5203326|NCT01075984|17962748|P3|Follow-up Phase|Treatment failure|0
5203327|NCT01075984|17962749|P2|Follow-up Phase|Treatment failure|0
5203328|NCT01075984|17962750|P1|Follow-up Phase|Treatment failure|0
5203329|NCT01075984|17962746|P5|Follow-up Phase|Progression of disease|2
5203330|NCT01075984|17962747|P4|Follow-up Phase|Progression of disease|0
5203331|NCT01075984|17962748|P3|Follow-up Phase|Progression of disease|0
5203332|NCT01075984|17962749|P2|Follow-up Phase|Progression of disease|0
5203333|NCT01075984|17962750|P1|Follow-up Phase|Progression of disease|0
5203334|NCT01075984|17962746|P5|Follow-up Phase|Withdrawal by Subject|10
5203335|NCT01075984|17962747|P4|Follow-up Phase|Withdrawal by Subject|0
5203336|NCT01075984|17962748|P3|Follow-up Phase|Withdrawal by Subject|0
5203337|NCT01075984|17962749|P2|Follow-up Phase|Withdrawal by Subject|0
5203338|NCT01075984|17962750|P1|Follow-up Phase|Withdrawal by Subject|0
5203339|NCT01075984|17962746|P5|Follow-up Phase|Administrative|1
5203340|NCT01075984|17962747|P4|Follow-up Phase|Administrative|0
5203341|NCT01075984|17962748|P3|Follow-up Phase|Administrative|0
5203342|NCT01075984|17962749|P2|Follow-up Phase|Administrative|0
5203343|NCT01075984|17962750|P1|Follow-up Phase|Administrative|0
5203344|NCT01075984|17962746|P5|Follow-up Phase|Adverse Event|27
5203345|NCT01075984|17962747|P4|Follow-up Phase|Adverse Event|2
5203346|NCT01075984|17962748|P3|Follow-up Phase|Adverse Event|0
5203347|NCT01075984|17962749|P2|Follow-up Phase|Adverse Event|0
5203348|NCT01075984|17962750|P1|Follow-up Phase|Adverse Event|0
5203349|NCT01075984|17962746|P5|Follow-up Phase|Protocol Violation|3
5203350|NCT01075984|17962747|P4|Follow-up Phase|Protocol Violation|0
5203351|NCT01075984|17962748|P3|Follow-up Phase|Protocol Violation|1
5203352|NCT01075984|17962749|P2|Follow-up Phase|Protocol Violation|0
5203353|NCT01075984|17962750|P1|Follow-up Phase|Protocol Violation|0
5203354|NCT01075984|17962746|P5|Treatment Phase|Progression of disease|2
5203355|NCT01075984|17962747|P4|Treatment Phase|Progression of disease|0
5203356|NCT01075984|17962748|P3|Treatment Phase|Progression of disease|0
5203357|NCT01075984|17962749|P2|Treatment Phase|Progression of disease|0
5203358|NCT01075984|17962750|P1|Treatment Phase|Progression of disease|0
5203359|NCT01075984|17962746|P5|Treatment Phase|Treatment Failure|5
5203360|NCT01075984|17962747|P4|Treatment Phase|Treatment Failure|0
5203361|NCT01075984|17962748|P3|Treatment Phase|Treatment Failure|1
5203362|NCT01075984|17962749|P2|Treatment Phase|Treatment Failure|0
5203363|NCT01075984|17962750|P1|Treatment Phase|Treatment Failure|0
5203364|NCT01075984|17962746|P5|Treatment Phase|Withdrawal by Subject|15
5203365|NCT01075984|17962747|P4|Treatment Phase|Withdrawal by Subject|0
5203366|NCT01075984|17962748|P3|Treatment Phase|Withdrawal by Subject|2
5203367|NCT01075984|17962749|P2|Treatment Phase|Withdrawal by Subject|0
5203368|NCT01075984|17962750|P1|Treatment Phase|Withdrawal by Subject|0
5203369|NCT01075984|17962746|P5|Treatment Phase|Protocol Violation|3
5203370|NCT01075984|17962747|P4|Treatment Phase|Protocol Violation|0
5203371|NCT01075984|17962748|P3|Treatment Phase|Protocol Violation|1
5203372|NCT01075984|17962749|P2|Treatment Phase|Protocol Violation|0
5203373|NCT01075984|17962750|P1|Treatment Phase|Protocol Violation|0
5203374|NCT01075984|17962746|P5|Treatment Phase|Adverse Event|35
5203375|NCT01075984|17962747|P4|Treatment Phase|Adverse Event|7
5203376|NCT01075984|17962748|P3|Treatment Phase|Adverse Event|3
5203377|NCT01075984|17962749|P2|Treatment Phase|Adverse Event|1
5203378|NCT01075984|17962750|P1|Treatment Phase|Adverse Event|0
5203379|NCT01075958|17962808|P1|Overall Study|Blood sample could not be obtained|44
5203380|NCT01075815|17962824|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
5203381|NCT01075815|17962825|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
5203382|NCT01075815|17962824|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
5203383|NCT01075815|17962825|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
5203384|NCT01075815|17962824|P2|Overall Study|Withdrawal before r-hCG administration|1
5203385|NCT01075815|17962825|P1|Overall Study|Withdrawal before r-hCG administration|6
5203386|NCT01075763|17962863|P2|Overall Study|Withdrawal by Subject|2
5203387|NCT01075763|17962864|P1|Overall Study|Withdrawal by Subject|2
5203388|NCT01075763|17962863|P2|Overall Study|Lack of Efficacy|1
5203389|NCT01075763|17962864|P1|Overall Study|Lack of Efficacy|0
5203390|NCT01075763|17962863|P2|Overall Study|Lost to Follow-up|1
5203391|NCT01075763|17962864|P1|Overall Study|Lost to Follow-up|2
5203392|NCT01075685|17962888|P2|Overall Study|Lost to Follow-up|220
5203393|NCT01075685|17962889|P1|Overall Study|Lost to Follow-up|563
5203394|NCT01075685|17962888|P2|Overall Study|Withdrawal by Subject|5
5203395|NCT01075685|17962889|P1|Overall Study|Withdrawal by Subject|20
5203396|NCT01075685|17962888|P2|Overall Study|Protocol Violation|1
5203397|NCT01075685|17962889|P1|Overall Study|Protocol Violation|9
5203398|NCT01075646|17962905|P4|Overall Study|Lost to Follow-up|2
5203399|NCT01075646|17962906|P3|Overall Study|Lost to Follow-up|1
5203400|NCT01075646|17962907|P2|Overall Study|Lost to Follow-up|3
5203401|NCT01075646|17962908|P1|Overall Study|Lost to Follow-up|4
5203402|NCT01075412|17962940|P2|Overall Study|Withdrawal by Subject|1
5203403|NCT01075412|17962941|P1|Overall Study|Withdrawal by Subject|0
5203404|NCT01075321|17962966|P4|Overall Study|Ineligible (miscalculated lab value)|1
5203405|NCT01075321|17962967|P3|Overall Study|Ineligible (miscalculated lab value)|0
5203406|NCT01075321|17962968|P2|Overall Study|Ineligible (miscalculated lab value)|0
5203407|NCT01075321|17962969|P1|Overall Study|Ineligible (miscalculated lab value)|0
5203408|NCT01075321|17962966|P4|Overall Study|Treatment Incomplete due to progression|0
5203409|NCT01075321|17962967|P3|Overall Study|Treatment Incomplete due to progression|0
5203410|NCT01075321|17962968|P2|Overall Study|Treatment Incomplete due to progression|0
5203411|NCT01075321|17962969|P1|Overall Study|Treatment Incomplete due to progression|1
5203412|NCT01075321|17962966|P4|Overall Study|Protocol Violation|0
5203413|NCT01075321|17962967|P3|Overall Study|Protocol Violation|1
5203414|NCT01075321|17962968|P2|Overall Study|Protocol Violation|0
5203415|NCT01075321|17962969|P1|Overall Study|Protocol Violation|0
5203416|NCT01075321|17962966|P4|Overall Study|Withdrawal by Subject|1
5203417|NCT01075321|17962967|P3|Overall Study|Withdrawal by Subject|1
5203418|NCT01075321|17962968|P2|Overall Study|Withdrawal by Subject|0
5203419|NCT01075321|17962969|P1|Overall Study|Withdrawal by Subject|0
5203420|NCT01075282|17962987|P3|Overall Study|Death|2
5203421|NCT01075282|17962988|P2|Overall Study|Death|1
5203422|NCT01075282|17962989|P1|Overall Study|Death|0
5203423|NCT01075282|17962987|P3|Overall Study|Protocol Violation|1
5203424|NCT01075282|17962988|P2|Overall Study|Protocol Violation|2
5203425|NCT01075282|17962989|P1|Overall Study|Protocol Violation|0
5203426|NCT01075282|17962987|P3|Overall Study|Treatment Non-compliance|2
5203427|NCT01075282|17962988|P2|Overall Study|Treatment Non-compliance|2
5203428|NCT01075282|17962989|P1|Overall Study|Treatment Non-compliance|1
5203429|NCT01075282|17962987|P3|Overall Study|Lack of Efficacy|0
5203430|NCT01075282|17962988|P2|Overall Study|Lack of Efficacy|1
5203431|NCT01075282|17962989|P1|Overall Study|Lack of Efficacy|1
5203432|NCT01075282|17962987|P3|Overall Study|Physician Decision|3
5203433|NCT01075282|17962988|P2|Overall Study|Physician Decision|3
5203434|NCT01075282|17962989|P1|Overall Study|Physician Decision|3
5203435|NCT01075282|17962987|P3|Overall Study|Lost to Follow-up|3
5203436|NCT01075282|17962988|P2|Overall Study|Lost to Follow-up|3
5203437|NCT01075282|17962989|P1|Overall Study|Lost to Follow-up|3
5203438|NCT01075282|17962987|P3|Overall Study|Entry Criteria Not Met|0
5203439|NCT01075282|17962988|P2|Overall Study|Entry Criteria Not Met|2
5203440|NCT01075282|17962989|P1|Overall Study|Entry Criteria Not Met|3
5203441|NCT01075282|17962987|P3|Overall Study|Adverse Event|5
5203442|NCT01075282|17962988|P2|Overall Study|Adverse Event|8
5203443|NCT01075282|17962989|P1|Overall Study|Adverse Event|9
5203444|NCT01075282|17962987|P3|Overall Study|Withdrawal by Subject|11
5203445|NCT01075282|17962988|P2|Overall Study|Withdrawal by Subject|7
5203446|NCT01075282|17962989|P1|Overall Study|Withdrawal by Subject|11
5203447|NCT01075256|17963072|P3|Overall Study|Withdrawal by Subject|0
5203448|NCT01075256|17963073|P2|Overall Study|Withdrawal by Subject|0
5203449|NCT01075256|17963074|P1|Overall Study|Withdrawal by Subject|1
5203450|NCT01075243|17963106|P3|Overall Study|Withdrawal by Subject|0
5203451|NCT01075243|17963107|P2|Overall Study|Withdrawal by Subject|1
5203452|NCT01075243|17963108|P1|Overall Study|Withdrawal by Subject|1
5203453|NCT01075243|17963106|P3|Overall Study|Lost to Follow-up|0
5203454|NCT01075243|17963107|P2|Overall Study|Lost to Follow-up|2
5203455|NCT01075243|17963108|P1|Overall Study|Lost to Follow-up|5
5203456|NCT01075217|17963160|P2|Overall Study|Physician Decision|0
5203457|NCT01075217|17963161|P1|Overall Study|Physician Decision|1
5203458|NCT01075217|17963160|P2|Overall Study|Adverse Event|1
5203459|NCT01075217|17963161|P1|Overall Study|Adverse Event|1
5203460|NCT01075191|17963194|P1|Overall Study|Unknown Reasons|1
5203461|NCT01075191|17963194|P1|Overall Study|Patient's Wish|2
5203462|NCT01075191|17963194|P1|Overall Study|Therapy Break|3
5203463|NCT01075191|17963194|P1|Overall Study|Noncompliance|3
5203464|NCT01075191|17963194|P1|Overall Study|Adverse Event|4
5203465|NCT01075191|17963194|P1|Overall Study|Co-morbidities|1
5203466|NCT01075191|17963194|P1|Overall Study|Intensification|3
5203467|NCT01075191|17963194|P1|Overall Study|Death|1
5203468|NCT01075178|17963205|P2|Subject Chart Review|matched partner excluded (reasons above)|3
5203469|NCT01075178|17963206|P1|Subject Chart Review|matched partner excluded (reasons above)|6
5203470|NCT01075178|17963205|P2|Subject Chart Review|no data collected due to site closure|4
5203471|NCT01075178|17963206|P1|Subject Chart Review|no data collected due to site closure|3
5203472|NCT01075178|17963205|P2|Subject Chart Review|died before chart review period|2
5203473|NCT01075178|17963206|P1|Subject Chart Review|died before chart review period|0
5203474|NCT01075178|17963205|P2|Subject Matching|eligible but not matched|403
5203475|NCT01075178|17963206|P1|Subject Matching|eligible but not matched|130
5203476|NCT01075152|17963220|P2|Overall Study|Withdrawal by Subject|0
5203477|NCT01075152|17963221|P1|Overall Study|Withdrawal by Subject|1
5203478|NCT01075100|17963247|P2|Overall Study|Other|1
5203479|NCT01075100|17963248|P1|Overall Study|Other|3
5203480|NCT01075100|17963247|P2|Overall Study|Disease Progression|29
5203481|NCT01075100|17963248|P1|Overall Study|Disease Progression|25
5203482|NCT01075100|17963247|P2|Overall Study|Investigator Request|1
5203483|NCT01075100|17963248|P1|Overall Study|Investigator Request|2
5203484|NCT01075100|17963247|P2|Overall Study|Patient Request|4
5203485|NCT01075100|17963248|P1|Overall Study|Patient Request|4
5203486|NCT01075100|17963247|P2|Overall Study|Adverse Event|18
5203487|NCT01075100|17963248|P1|Overall Study|Adverse Event|15
5203488|NCT01075074|17963278|P3|Overall Study|Surgeon changed to open incisional case|2
5203489|NCT01075074|17963279|P2|Overall Study|Surgeon changed to open incisional case|2
5203490|NCT01075074|17963280|P1|Overall Study|Surgeon changed to open incisional case|1
5203491|NCT01075048|17963300|P3|Overall Study|Lost to Follow-up|1
5203492|NCT01075048|17963301|P2|Overall Study|Lost to Follow-up|1
5203493|NCT01075048|17963302|P1|Overall Study|Lost to Follow-up|0
5203494|NCT01075048|17963300|P3|Overall Study|Withdrawal by Subject|3
5203495|NCT01075048|17963301|P2|Overall Study|Withdrawal by Subject|6
5203496|NCT01075048|17963302|P1|Overall Study|Withdrawal by Subject|1
5203497|NCT01075048|17963300|P3|Overall Study|Start of other or new therapy|46
5203498|NCT01075048|17963301|P2|Overall Study|Start of other or new therapy|36
5203499|NCT01075048|17963302|P1|Overall Study|Start of other or new therapy|4
5203500|NCT01075048|17963300|P3|Overall Study|Death|12
5203501|NCT01075048|17963301|P2|Overall Study|Death|17
5203502|NCT01075048|17963302|P1|Overall Study|Death|4
5203503|NCT01074944|17963325|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
5203504|NCT01074944|17963326|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5203505|NCT01074944|17963327|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5203506|NCT01074944|17963328|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5203507|NCT01074944|17963329|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5203508|NCT01074944|17963325|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
5203509|NCT01074944|17963326|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
5203510|NCT01074944|17963327|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
5203511|NCT01074944|17963328|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
5203512|NCT01074944|17963329|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
5203513|NCT01074944|17963325|P5|Long Term Treatment|Withdrawal by Subject|0
5203514|NCT01074944|17963326|P4|Long Term Treatment|Withdrawal by Subject|2
5203515|NCT01074944|17963327|P3|Long Term Treatment|Withdrawal by Subject|0
5203516|NCT01074944|17963328|P2|Long Term Treatment|Withdrawal by Subject|0
5203517|NCT01074944|17963329|P1|Long Term Treatment|Withdrawal by Subject|0
5203518|NCT01074944|17963325|P5|Long Term Treatment|Entered in Period, But Not Treated|0
5203519|NCT01074944|17963326|P4|Long Term Treatment|Entered in Period, But Not Treated|1
5203520|NCT01074944|17963327|P3|Long Term Treatment|Entered in Period, But Not Treated|0
5203521|NCT01074944|17963328|P2|Long Term Treatment|Entered in Period, But Not Treated|0
5203522|NCT01074944|17963329|P1|Long Term Treatment|Entered in Period, But Not Treated|0
5203523|NCT01074944|17963325|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5203524|NCT01074944|17963326|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
5203525|NCT01074944|17963327|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5203526|NCT01074944|17963328|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5203527|NCT01074944|17963329|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5203528|NCT01074944|17963325|P5|Long Term Treatment|Lost to Follow-up|0
5203529|NCT01074944|17963326|P4|Long Term Treatment|Lost to Follow-up|2
5203530|NCT01074944|17963327|P3|Long Term Treatment|Lost to Follow-up|0
5203531|NCT01074944|17963328|P2|Long Term Treatment|Lost to Follow-up|0
5203532|NCT01074944|17963329|P1|Long Term Treatment|Lost to Follow-up|0
5203533|NCT01074944|17963325|P5|Long Term Treatment|Adverse Event|0
5203534|NCT01074944|17963326|P4|Long Term Treatment|Adverse Event|3
5203535|NCT01074944|17963327|P3|Long Term Treatment|Adverse Event|0
5203536|NCT01074944|17963328|P2|Long Term Treatment|Adverse Event|0
5203537|NCT01074944|17963329|P1|Long Term Treatment|Adverse Event|0
5203538|NCT01074944|17963325|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5203539|NCT01074944|17963326|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5203540|NCT01074944|17963327|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
5203541|NCT01074944|17963328|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
5203542|NCT01074944|17963329|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5203543|NCT01074944|17963325|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5203544|NCT01074944|17963326|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5203545|NCT01074944|17963327|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5203546|NCT01074944|17963328|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
5203547|NCT01074944|17963329|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5203548|NCT01074944|17963325|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5203549|NCT01074944|17963326|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5203550|NCT01074944|17963327|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
5203551|NCT01074944|17963328|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
5203552|NCT01074944|17963329|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5203553|NCT01074944|17963325|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5203554|NCT01074944|17963326|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5203555|NCT01074944|17963327|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
5203556|NCT01074944|17963328|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
5203557|NCT01074944|17963329|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5203558|NCT01074944|17963325|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5203559|NCT01074944|17963326|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5203560|NCT01074944|17963327|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
5203561|NCT01074944|17963328|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
5203562|NCT01074944|17963329|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5203563|NCT01074944|17963325|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5203564|NCT01074944|17963326|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5203565|NCT01074944|17963327|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5203566|NCT01074944|17963328|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5203567|NCT01074944|17963329|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
5203568|NCT01074944|17963325|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5203569|NCT01074944|17963326|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5203570|NCT01074944|17963327|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5203571|NCT01074944|17963328|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5203572|NCT01074944|17963329|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
5203573|NCT01074944|17963325|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5203574|NCT01074944|17963326|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5203575|NCT01074944|17963327|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5203576|NCT01074944|17963328|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5203577|NCT01074944|17963329|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
5203578|NCT01074944|17963325|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5203579|NCT01074944|17963326|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5203580|NCT01074944|17963327|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5203581|NCT01074944|17963328|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5203582|NCT01074944|17963329|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
5203583|NCT01074931|17963383|P1|Overall Study|Death|5
5203584|NCT01074931|17963383|P1|Overall Study|Economic reasons|1
5203585|NCT01074658|17963395|P1|Overall Study|No implant attempted|19
5203586|NCT01074554|17963403|P2|Overall Study|Lost to Follow-up|1
5203587|NCT01074554|17963404|P1|Overall Study|Lost to Follow-up|0
5203588|NCT01074554|17963403|P2|Overall Study|Adverse Event|3
5203589|NCT01074554|17963404|P1|Overall Study|Adverse Event|3
5203590|NCT01074502|17963414|P1|Overall Study|Withdrawal by Subject|1
5203591|NCT01074450|17963438|P2|Second Intervention|Physician Decision|1
5203592|NCT01074450|17963439|P1|Second Intervention|Physician Decision|0
5203593|NCT01074450|17963438|P2|Second Intervention|Protocol Violation|0
5203594|NCT01074450|17963439|P1|Second Intervention|Protocol Violation|1
5203595|NCT01074450|17963438|P2|First Intervention|Emesis in Dosing Interval|2
5203596|NCT01074450|17963439|P1|First Intervention|Emesis in Dosing Interval|0
5203597|NCT01074307|17963468|P2|Overall Study|Protocol Violation|5
5203598|NCT01074307|17963469|P1|Overall Study|Protocol Violation|8
5203599|NCT01074307|17963468|P2|Overall Study|Exclusion criterion|1
5203600|NCT01074307|17963469|P1|Overall Study|Exclusion criterion|0
5203601|NCT01074307|17963468|P2|Overall Study|No primary endpoint evaluation|6
5203602|NCT01074307|17963469|P1|Overall Study|No primary endpoint evaluation|14
5203603|NCT01074268|17963491|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
5203604|NCT01074268|17963492|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
5203605|NCT01074268|17963491|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
5203606|NCT01074268|17963492|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
5203607|NCT01074268|17963491|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
5203608|NCT01074268|17963492|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
5203609|NCT01074268|17963491|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
5203610|NCT01074268|17963492|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
5203611|NCT01074268|17963491|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
5203612|NCT01074268|17963492|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
5203613|NCT01074268|17963491|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
5203614|NCT01074268|17963492|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
5203615|NCT01074268|17963491|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
5203616|NCT01074268|17963492|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
5203617|NCT01074268|17963491|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
5203618|NCT01074268|17963492|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
5203619|NCT01074268|17963491|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
5203620|NCT01074268|17963492|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
5203621|NCT01074255|17963518|P1|Overall Study|Did not receive EMEND|2
5203622|NCT01074242|17963522|P1|Overall Study|Duplicate Case Report Form|5
5203623|NCT01074242|17963522|P1|Overall Study|Violation of vaccine dose or dosage|351
5203624|NCT01074242|17963522|P1|Overall Study|Case report unclear|6
5203625|NCT01074242|17963522|P1|Overall Study|Lost to Follow-up|1
5203626|NCT01074242|17963522|P1|Overall Study|Case report before date of contract|40
5203627|NCT01074229|17963530|P3|Overall Study|Change to open surgical procedure|4
5203628|NCT01074229|17963531|P2|Overall Study|Change to open surgical procedure|3
5203629|NCT01074229|17963532|P1|Overall Study|Change to open surgical procedure|1
5203630|NCT01074229|17963530|P3|Overall Study|Lost to Follow-up|0
5203631|NCT01074229|17963531|P2|Overall Study|Lost to Follow-up|0
5203632|NCT01074229|17963532|P1|Overall Study|Lost to Follow-up|1
5203633|NCT01074216|17963543|P1|Overall Study|Not Treated|12
5203634|NCT01074216|17963543|P1|Overall Study|Physician Decision|1
5203635|NCT01074047|17963607|P2|Extension Phase|Death|0
5203636|NCT01074047|17963608|P1|Extension Phase|Death|5
5203637|NCT01074047|17963607|P2|Extension Phase|Withdrawal by Subject|0
5203638|NCT01074047|17963608|P1|Extension Phase|Withdrawal by Subject|2
5203639|NCT01074047|17963607|P2|Extension Phase|Disease Progression|0
5203640|NCT01074047|17963608|P1|Extension Phase|Disease Progression|9
5203641|NCT01074047|17963607|P2|Extension Phase|Adverse Event|0
5203642|NCT01074047|17963608|P1|Extension Phase|Adverse Event|5
5203643|NCT01074047|17963607|P2|Extension Phase|Physician Decision|0
5203644|NCT01074047|17963608|P1|Extension Phase|Physician Decision|1
5203645|NCT01074047|17963607|P2|Survival Follow-Up Phase|Alive at study closure|3
5203646|NCT01074047|17963608|P1|Survival Follow-Up Phase|Alive at study closure|1
5203647|NCT01074047|17963607|P2|Survival Follow-Up Phase|Death|124
5203648|NCT01074047|17963608|P1|Survival Follow-Up Phase|Death|116
5203649|NCT01074047|17963607|P2|Survival Follow-Up Phase|Lost to Follow-up|1
5203650|NCT01074047|17963608|P1|Survival Follow-Up Phase|Lost to Follow-up|2
5203651|NCT01074047|17963607|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
5203652|NCT01074047|17963608|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
5203653|NCT01074047|17963607|P2|Treatment Phase|Miscellaneous|39
5203654|NCT01074047|17963608|P1|Treatment Phase|Miscellaneous|32
5203655|NCT01074047|17963607|P2|Treatment Phase|Protocol Violation|1
5203656|NCT01074047|17963608|P1|Treatment Phase|Protocol Violation|0
5203657|NCT01074047|17963607|P2|Treatment Phase|Lost to Follow-up|1
5203658|NCT01074047|17963608|P1|Treatment Phase|Lost to Follow-up|0
5203659|NCT01074047|17963607|P2|Treatment Phase|Death|58
5203660|NCT01074047|17963608|P1|Treatment Phase|Death|53
5203661|NCT01074047|17963607|P2|Treatment Phase|Withdrawal by Subject|48
5203662|NCT01074047|17963608|P1|Treatment Phase|Withdrawal by Subject|27
5203663|NCT01074047|17963607|P2|Treatment Phase|Disease Progression|21
5203664|NCT01074047|17963608|P1|Treatment Phase|Disease Progression|16
5203665|NCT01074047|17963607|P2|Treatment Phase|Adverse Event|66
5203666|NCT01074047|17963608|P1|Treatment Phase|Adverse Event|89
5203667|NCT01074008|17963696|P9|Overall Study|Lost to Follow-up|4
5203668|NCT01074008|17963697|P8|Overall Study|Lost to Follow-up|0
5203669|NCT01074008|17963698|P7|Overall Study|Lost to Follow-up|1
5203670|NCT01074008|17963699|P6|Overall Study|Lost to Follow-up|0
5203671|NCT01074008|17963700|P5|Overall Study|Lost to Follow-up|1
5203672|NCT01074008|17963701|P4|Overall Study|Lost to Follow-up|1
5203673|NCT01074008|17963702|P3|Overall Study|Lost to Follow-up|1
5203674|NCT01074008|17963703|P2|Overall Study|Lost to Follow-up|1
5203675|NCT01074008|17963704|P1|Overall Study|Lost to Follow-up|0
5203676|NCT01074008|17963696|P9|Overall Study|Withdrawal by Subject|0
5203677|NCT01074008|17963697|P8|Overall Study|Withdrawal by Subject|0
5203678|NCT01074008|17963698|P7|Overall Study|Withdrawal by Subject|0
5203679|NCT01074008|17963699|P6|Overall Study|Withdrawal by Subject|0
5203680|NCT01074008|17963700|P5|Overall Study|Withdrawal by Subject|1
5203681|NCT01074008|17963701|P4|Overall Study|Withdrawal by Subject|0
5203682|NCT01074008|17963702|P3|Overall Study|Withdrawal by Subject|1
5203683|NCT01074008|17963703|P2|Overall Study|Withdrawal by Subject|1
5203684|NCT01074008|17963704|P1|Overall Study|Withdrawal by Subject|1
5203685|NCT01074008|17963696|P9|Overall Study|Adverse Event|0
5203686|NCT01074008|17963697|P8|Overall Study|Adverse Event|0
5203687|NCT01074008|17963698|P7|Overall Study|Adverse Event|0
5203688|NCT01074008|17963699|P6|Overall Study|Adverse Event|0
5203689|NCT01074008|17963700|P5|Overall Study|Adverse Event|0
5203690|NCT01074008|17963701|P4|Overall Study|Adverse Event|0
5203691|NCT01074008|17963702|P3|Overall Study|Adverse Event|0
5203692|NCT01074008|17963703|P2|Overall Study|Adverse Event|1
5203693|NCT01074008|17963704|P1|Overall Study|Adverse Event|0
5203694|NCT01073943|17963814|P2|Overall Study|Could not tolerate prep|0
5203695|NCT01073943|17963815|P1|Overall Study|Could not tolerate prep|1
5203696|NCT01073943|17963814|P2|Overall Study|Unable to return for follow-up|1
5203697|NCT01073943|17963815|P1|Overall Study|Unable to return for follow-up|0
5203698|NCT01073943|17963814|P2|Overall Study|Subject forgot|1
5203699|NCT01073943|17963815|P1|Overall Study|Subject forgot|0
5203700|NCT01073943|17963814|P2|Overall Study|Power outage; colonoscopy not done|0
5203701|NCT01073943|17963815|P1|Overall Study|Power outage; colonoscopy not done|1
5203702|NCT01073943|17963814|P2|Overall Study|Lost to Follow-up|2
5203703|NCT01073943|17963815|P1|Overall Study|Lost to Follow-up|0
5203704|NCT01073943|17963814|P2|Overall Study|Adverse Event|1
5203705|NCT01073943|17963815|P1|Overall Study|Adverse Event|1
5203706|NCT01073943|17963814|P2|Overall Study|Protocol Violation|1
5203707|NCT01073943|17963815|P1|Overall Study|Protocol Violation|2
5203708|NCT01073943|17963814|P2|Overall Study|Withdrawal by Subject|2
5203709|NCT01073943|17963815|P1|Overall Study|Withdrawal by Subject|8
5203710|NCT01073930|17963841|P2|Overall Study|Inadequate prep; unable to do procedure|1
5203711|NCT01073930|17963842|P1|Overall Study|Inadequate prep; unable to do procedure|0
5203712|NCT01073930|17963841|P2|Overall Study|Noncompliance with study drug|1
5203713|NCT01073930|17963842|P1|Overall Study|Noncompliance with study drug|0
5203714|NCT01073930|17963841|P2|Overall Study|Adverse Event|1
5203715|NCT01073930|17963842|P1|Overall Study|Adverse Event|0
5203716|NCT01073930|17963841|P2|Overall Study|Lost to Follow-up|1
5203717|NCT01073930|17963842|P1|Overall Study|Lost to Follow-up|0
5203718|NCT01073930|17963841|P2|Overall Study|Withdrawal by Subject|2
5203719|NCT01073930|17963842|P1|Overall Study|Withdrawal by Subject|3
5203720|NCT01073865|17963866|P2|Overall Study|Withdrawal by Subject|5
5203721|NCT01073865|17963867|P1|Overall Study|Withdrawal by Subject|5
5203722|NCT01073865|17963866|P2|Overall Study|Death|2
5203723|NCT01073865|17963867|P1|Overall Study|Death|3
5203724|NCT01073865|17963866|P2|Overall Study|Lost to Follow-up|1
5203725|NCT01073865|17963867|P1|Overall Study|Lost to Follow-up|1
5203726|NCT01073865|17963866|P2|Overall Study|Reasons other than below|31
5203727|NCT01073865|17963867|P1|Overall Study|Reasons other than below|19
5203728|NCT01073631|17963886|P1|Overall Study|Other|63
5203729|NCT01073631|17963886|P1|Overall Study|Adverse Event|24
5203730|NCT01073631|17963886|P1|Overall Study|Death|82
5203731|NCT01073618|17963891|P1|Overall Study|Other|80
5203732|NCT01073618|17963891|P1|Overall Study|Adverse Event|19
5203733|NCT01073618|17963891|P1|Overall Study|Death|208
5203734|NCT01073605|17963899|P3|Overall Study|Randomized But Not Treated|1
5203735|NCT01073605|17963900|P2|Overall Study|Randomized But Not Treated|1
5203736|NCT01073605|17963901|P1|Overall Study|Randomized But Not Treated|0
5203737|NCT01073605|17963899|P3|Overall Study|Withdrawal by Subject|22
5203738|NCT01073605|17963900|P2|Overall Study|Withdrawal by Subject|39
5203739|NCT01073605|17963901|P1|Overall Study|Withdrawal by Subject|31
5203740|NCT01073605|17963899|P3|Overall Study|Other|29
5203741|NCT01073605|17963900|P2|Overall Study|Other|21
5203742|NCT01073605|17963901|P1|Overall Study|Other|25
5203743|NCT01073605|17963899|P3|Overall Study|Lost to Follow-up|9
5203744|NCT01073605|17963900|P2|Overall Study|Lost to Follow-up|4
5203745|NCT01073605|17963901|P1|Overall Study|Lost to Follow-up|3
5203746|NCT01073605|17963899|P3|Overall Study|Adverse Event|0
5203747|NCT01073605|17963900|P2|Overall Study|Adverse Event|1
5203748|NCT01073605|17963901|P1|Overall Study|Adverse Event|2
5203749|NCT01073605|17963899|P3|Overall Study|Ongoing at Cutoff Date|0
5203750|NCT01073605|17963900|P2|Overall Study|Ongoing at Cutoff Date|1
5203751|NCT01073605|17963901|P1|Overall Study|Ongoing at Cutoff Date|1
5203752|NCT01073566|17963947|P2|Period 2 (6 Weeks)|Adverse Event|0
5203753|NCT01073566|17963948|P1|Period 2 (6 Weeks)|Adverse Event|1
5203754|NCT01073462|17963960|P1|Overall Study|Lost to Follow-up|7
5203755|NCT01073462|17963960|P1|Overall Study|Serious adverse event|2
5203756|NCT01073462|17963960|P1|Overall Study|Low parathyroid hormone levels|8
5203757|NCT01073462|17963960|P1|Overall Study|Kidney transplant|10
5203758|NCT01073462|17963960|P1|Overall Study|Death|14
5203759|NCT01073293|17963979|P2|Overall Study|Withdrawal by Subject|10
5203760|NCT01073293|17963980|P1|Overall Study|Withdrawal by Subject|5
5203761|NCT01073293|17963979|P2|Overall Study|Lost to Follow-up|1
5203762|NCT01073293|17963980|P1|Overall Study|Lost to Follow-up|0
5203763|NCT01073267|17964002|P1|Overall Study|Disease Progression|3
5203764|NCT01073163|17964006|P1|Overall Study|Early termination|1
5203765|NCT01073163|17964006|P1|Overall Study|Disease Progression|1
5203766|NCT01073163|17964006|P1|Overall Study|Adverse Event|1
5203767|NCT01072929|17964029|P3|Overall Study|Other|0
5203768|NCT01072929|17964030|P2|Overall Study|Other|3
5203769|NCT01072929|17964031|P1|Overall Study|Other|0
5203770|NCT01072929|17964029|P3|Overall Study|Noncompliance with study procedures|1
5203771|NCT01072929|17964030|P2|Overall Study|Noncompliance with study procedures|0
5203772|NCT01072929|17964031|P1|Overall Study|Noncompliance with study procedures|1
5203773|NCT01072929|17964029|P3|Overall Study|Noncompliance with study medication|0
5203774|NCT01072929|17964030|P2|Overall Study|Noncompliance with study medication|3
5203775|NCT01072929|17964031|P1|Overall Study|Noncompliance with study medication|0
5203776|NCT01072929|17964029|P3|Overall Study|Lost to Follow-up|1
5203777|NCT01072929|17964030|P2|Overall Study|Lost to Follow-up|4
5203778|NCT01072929|17964031|P1|Overall Study|Lost to Follow-up|8
5203779|NCT01072929|17964029|P3|Overall Study|Protocol Violation|2
5203780|NCT01072929|17964030|P2|Overall Study|Protocol Violation|11
5203781|NCT01072929|17964031|P1|Overall Study|Protocol Violation|13
5203782|NCT01072929|17964029|P3|Overall Study|Withdrawal by Subject|3
5203783|NCT01072929|17964030|P2|Overall Study|Withdrawal by Subject|15
5203784|NCT01072929|17964031|P1|Overall Study|Withdrawal by Subject|7
5203785|NCT01072929|17964029|P3|Overall Study|Lack of Efficacy|0
5203786|NCT01072929|17964030|P2|Overall Study|Lack of Efficacy|4
5203787|NCT01072929|17964031|P1|Overall Study|Lack of Efficacy|7
5203788|NCT01072929|17964029|P3|Overall Study|Adverse Event|2
5203789|NCT01072929|17964030|P2|Overall Study|Adverse Event|11
5203790|NCT01072929|17964031|P1|Overall Study|Adverse Event|8
5203791|NCT01072877|17964110|P5|Overall Study|Lost to Follow-up|0
5203792|NCT01072877|17964111|P4|Overall Study|Lost to Follow-up|2
5203793|NCT01072877|17964112|P3|Overall Study|Lost to Follow-up|0
5203794|NCT01072877|17964113|P2|Overall Study|Lost to Follow-up|1
5203795|NCT01072877|17964114|P1|Overall Study|Lost to Follow-up|1
5203796|NCT01072630|17964193|P3|Overall Study|Other|1
5203797|NCT01072630|17964194|P2|Overall Study|Other|2
5203798|NCT01072630|17964195|P1|Overall Study|Other|3
5203799|NCT01072630|17964193|P3|Overall Study|Noncompliance with study procedures|1
5203800|NCT01072630|17964194|P2|Overall Study|Noncompliance with study procedures|2
5203801|NCT01072630|17964195|P1|Overall Study|Noncompliance with study procedures|1
5203802|NCT01072630|17964193|P3|Overall Study|Noncompliance with study medication|1
5203803|NCT01072630|17964194|P2|Overall Study|Noncompliance with study medication|1
5203804|NCT01072630|17964195|P1|Overall Study|Noncompliance with study medication|1
5203805|NCT01072630|17964193|P3|Overall Study|Lost to Follow-up|1
5203806|NCT01072630|17964194|P2|Overall Study|Lost to Follow-up|11
5203807|NCT01072630|17964195|P1|Overall Study|Lost to Follow-up|11
5203808|NCT01072630|17964193|P3|Overall Study|Protocol Violation|4
5203809|NCT01072630|17964194|P2|Overall Study|Protocol Violation|8
5203810|NCT01072630|17964195|P1|Overall Study|Protocol Violation|10
5203811|NCT01072630|17964193|P3|Overall Study|Withdrawal by Subject|2
5203812|NCT01072630|17964194|P2|Overall Study|Withdrawal by Subject|7
5203813|NCT01072630|17964195|P1|Overall Study|Withdrawal by Subject|8
5203814|NCT01072630|17964193|P3|Overall Study|Lack of Efficacy|1
5203815|NCT01072630|17964194|P2|Overall Study|Lack of Efficacy|10
5203816|NCT01072630|17964195|P1|Overall Study|Lack of Efficacy|10
5203817|NCT01072630|17964193|P3|Overall Study|Adverse Event|2
5203818|NCT01072630|17964194|P2|Overall Study|Adverse Event|19
5203819|NCT01072630|17964195|P1|Overall Study|Adverse Event|11
5203820|NCT01072539|17964276|P1|Overall Study|Protocol Violation|2
5203821|NCT01072539|17964276|P1|Overall Study|Treated prior to the Site Initiation|1
5203822|NCT01072500|17964300|P2|Overall Study|Withdrawal by Subject|10
5203823|NCT01072500|17964301|P1|Overall Study|Withdrawal by Subject|17
5203824|NCT01072500|17964300|P2|Overall Study|Lost to Follow-up|2
5203825|NCT01072500|17964301|P1|Overall Study|Lost to Follow-up|5
5203826|NCT01072500|17964300|P2|Overall Study|Death|2
5203827|NCT01072500|17964301|P1|Overall Study|Death|2
5203828|NCT01072448|17964311|P2|Overall Study|Death|2
5203829|NCT01072448|17964312|P1|Overall Study|Death|0
5203830|NCT01072448|17964311|P2|Overall Study|Abnormal laboratory value(s)|1
5203831|NCT01072448|17964312|P1|Overall Study|Abnormal laboratory value(s)|0
5203832|NCT01072448|17964311|P2|Overall Study|Lost to Follow-up|1
5203833|NCT01072448|17964312|P1|Overall Study|Lost to Follow-up|1
5203834|NCT01072448|17964311|P2|Overall Study|Unsatisfactory therapeutic effect|3
5203835|NCT01072448|17964312|P1|Overall Study|Unsatisfactory therapeutic effect|1
5203836|NCT01072448|17964311|P2|Overall Study|Abnormal test procedure result(s)|0
5203837|NCT01072448|17964312|P1|Overall Study|Abnormal test procedure result(s)|1
5203838|NCT01072448|17964311|P2|Overall Study|Protocol deviation|4
5203839|NCT01072448|17964312|P1|Overall Study|Protocol deviation|3
5203840|NCT01072448|17964311|P2|Overall Study|Subject withdrew consent|9
5203841|NCT01072448|17964312|P1|Overall Study|Subject withdrew consent|4
5203842|NCT01072448|17964311|P2|Overall Study|Adverse Event|10
5203843|NCT01072448|17964312|P1|Overall Study|Adverse Event|9
5203844|NCT01072396|17964326|P2|Period Two|Lost to Follow-up|0
5203845|NCT01072396|17964327|P1|Period Two|Lost to Follow-up|1
5203846|NCT01072396|17964326|P2|Period Two|Adverse Event|3
5203847|NCT01072396|17964327|P1|Period Two|Adverse Event|0
5203848|NCT01072396|17964326|P2|Washout Period|Missing termination information|1
5203849|NCT01072396|17964327|P1|Washout Period|Missing termination information|0
5203850|NCT01072396|17964326|P2|Period One|Withdrawal by Subject|0
5203851|NCT01072396|17964327|P1|Period One|Withdrawal by Subject|2
5203852|NCT01072396|17964326|P2|Period One|Protocol Violation|1
5203853|NCT01072396|17964327|P1|Period One|Protocol Violation|2
5203854|NCT01072396|17964326|P2|Period One|Adverse Event|1
5203855|NCT01072396|17964327|P1|Period One|Adverse Event|1
5203856|NCT01072357|17964339|P2|Overall Study|Lost to Follow-up|1
5203857|NCT01072357|17964340|P1|Overall Study|Lost to Follow-up|0
5203858|NCT01072344|17964350|P2|Overall Study|Lost to Follow-up|4
5203859|NCT01072344|17964351|P1|Overall Study|Lost to Follow-up|3
5203860|NCT01072344|17964350|P2|Overall Study|Protocol Violation|2
5203861|NCT01072344|17964351|P1|Overall Study|Protocol Violation|1
5203862|NCT01072344|17964350|P2|Overall Study|Relasped-reached end point|12
5203863|NCT01072344|17964351|P1|Overall Study|Relasped-reached end point|7
5203864|NCT01072201|17964389|P2|Overall Study|Lost to Follow-up|1
5203865|NCT01072201|17964390|P1|Overall Study|Lost to Follow-up|0
5203866|NCT01072175|17964423|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203867|NCT01072175|17964424|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
5203868|NCT01072175|17964425|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
5203869|NCT01072175|17964426|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203870|NCT01072175|17964427|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203871|NCT01072175|17964428|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203872|NCT01072175|17964429|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203873|NCT01072175|17964430|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203874|NCT01072175|17964431|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203875|NCT01072175|17964432|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203876|NCT01072175|17964433|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203877|NCT01072175|17964434|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203878|NCT01072175|17964435|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
5203879|NCT01072175|17964423|P13|Part D (HPMC Capsules)|Study closed/terminated|9
5203880|NCT01072175|17964424|P12|Part D (HPMC Capsules)|Study closed/terminated|10
5203881|NCT01072175|17964425|P11|Part D (HPMC Capsules)|Study closed/terminated|1
5203882|NCT01072175|17964426|P10|Part D (HPMC Capsules)|Study closed/terminated|2
5203883|NCT01072175|17964427|P9|Part D (HPMC Capsules)|Study closed/terminated|0
5203884|NCT01072175|17964428|P8|Part D (HPMC Capsules)|Study closed/terminated|0
5203885|NCT01072175|17964429|P7|Part D (HPMC Capsules)|Study closed/terminated|0
5203886|NCT01072175|17964430|P6|Part D (HPMC Capsules)|Study closed/terminated|0
5203887|NCT01072175|17964431|P5|Part D (HPMC Capsules)|Study closed/terminated|0
5203888|NCT01072175|17964432|P4|Part D (HPMC Capsules)|Study closed/terminated|0
5203889|NCT01072175|17964433|P3|Part D (HPMC Capsules)|Study closed/terminated|0
5203890|NCT01072175|17964434|P2|Part D (HPMC Capsules)|Study closed/terminated|0
5203891|NCT01072175|17964435|P1|Part D (HPMC Capsules)|Study closed/terminated|0
5203892|NCT01072175|17964423|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
5203893|NCT01072175|17964424|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
5203894|NCT01072175|17964425|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
5203895|NCT01072175|17964426|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
5203896|NCT01072175|17964427|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
5203897|NCT01072175|17964428|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
5203898|NCT01072175|17964429|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
5203899|NCT01072175|17964430|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
5203900|NCT01072175|17964431|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
5203901|NCT01072175|17964432|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
5203902|NCT01072175|17964433|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
5203903|NCT01072175|17964434|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
5203904|NCT01072175|17964435|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
5203905|NCT01072175|17964423|P13|Part D (HPMC Capsules)|Physician Decision|1
5203906|NCT01072175|17964424|P12|Part D (HPMC Capsules)|Physician Decision|1
5203907|NCT01072175|17964425|P11|Part D (HPMC Capsules)|Physician Decision|1
5203908|NCT01072175|17964426|P10|Part D (HPMC Capsules)|Physician Decision|0
5203909|NCT01072175|17964427|P9|Part D (HPMC Capsules)|Physician Decision|0
5203910|NCT01072175|17964428|P8|Part D (HPMC Capsules)|Physician Decision|0
5203911|NCT01072175|17964429|P7|Part D (HPMC Capsules)|Physician Decision|0
5203912|NCT01072175|17964430|P6|Part D (HPMC Capsules)|Physician Decision|0
5203913|NCT01072175|17964431|P5|Part D (HPMC Capsules)|Physician Decision|0
5203914|NCT01072175|17964432|P4|Part D (HPMC Capsules)|Physician Decision|0
5203915|NCT01072175|17964433|P3|Part D (HPMC Capsules)|Physician Decision|0
5203916|NCT01072175|17964434|P2|Part D (HPMC Capsules)|Physician Decision|0
5203917|NCT01072175|17964435|P1|Part D (HPMC Capsules)|Physician Decision|0
5203918|NCT01072175|17964423|P13|Part D (HPMC Capsules)|Death|26
5203919|NCT01072175|17964424|P12|Part D (HPMC Capsules)|Death|28
5203920|NCT01072175|17964425|P11|Part D (HPMC Capsules)|Death|12
5203921|NCT01072175|17964426|P10|Part D (HPMC Capsules)|Death|10
5203922|NCT01072175|17964427|P9|Part D (HPMC Capsules)|Death|0
5203923|NCT01072175|17964428|P8|Part D (HPMC Capsules)|Death|0
5203924|NCT01072175|17964429|P7|Part D (HPMC Capsules)|Death|0
5203925|NCT01072175|17964430|P6|Part D (HPMC Capsules)|Death|0
5203926|NCT01072175|17964431|P5|Part D (HPMC Capsules)|Death|0
5203927|NCT01072175|17964432|P4|Part D (HPMC Capsules)|Death|0
5203928|NCT01072175|17964433|P3|Part D (HPMC Capsules)|Death|0
5203929|NCT01072175|17964434|P2|Part D (HPMC Capsules)|Death|0
5203930|NCT01072175|17964435|P1|Part D (HPMC Capsules)|Death|0
5203931|NCT01072175|17964423|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203932|NCT01072175|17964424|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203933|NCT01072175|17964425|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203934|NCT01072175|17964426|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203935|NCT01072175|17964427|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
5203936|NCT01072175|17964428|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203937|NCT01072175|17964429|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203938|NCT01072175|17964430|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203939|NCT01072175|17964431|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203940|NCT01072175|17964432|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203941|NCT01072175|17964433|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203942|NCT01072175|17964434|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203943|NCT01072175|17964435|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5203944|NCT01072175|17964423|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203945|NCT01072175|17964424|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203946|NCT01072175|17964425|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203947|NCT01072175|17964426|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203948|NCT01072175|17964427|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
5203949|NCT01072175|17964428|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203950|NCT01072175|17964429|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203951|NCT01072175|17964430|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203952|NCT01072175|17964431|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203953|NCT01072175|17964432|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203954|NCT01072175|17964433|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203955|NCT01072175|17964434|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203956|NCT01072175|17964435|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5203957|NCT01072175|17964423|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203958|NCT01072175|17964424|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203959|NCT01072175|17964425|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203960|NCT01072175|17964426|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203961|NCT01072175|17964427|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
5203962|NCT01072175|17964428|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203963|NCT01072175|17964429|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203964|NCT01072175|17964430|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203965|NCT01072175|17964431|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203966|NCT01072175|17964432|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203967|NCT01072175|17964433|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203968|NCT01072175|17964434|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203969|NCT01072175|17964435|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5203970|NCT01072175|17964423|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
5203971|NCT01072175|17964424|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
5203972|NCT01072175|17964425|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
5203973|NCT01072175|17964426|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
5203974|NCT01072175|17964427|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
5203975|NCT01072175|17964428|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
5203976|NCT01072175|17964429|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
5203977|NCT01072175|17964430|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
5203978|NCT01072175|17964431|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
5203979|NCT01072175|17964432|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
5203980|NCT01072175|17964433|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
5203981|NCT01072175|17964434|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
5203982|NCT01072175|17964435|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
5203983|NCT01072175|17964423|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203984|NCT01072175|17964424|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203985|NCT01072175|17964425|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203986|NCT01072175|17964426|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203987|NCT01072175|17964427|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203988|NCT01072175|17964428|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203989|NCT01072175|17964429|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
5203990|NCT01072175|17964430|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
5203991|NCT01072175|17964431|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203992|NCT01072175|17964432|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203993|NCT01072175|17964433|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203994|NCT01072175|17964434|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203995|NCT01072175|17964435|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5203996|NCT01072175|17964423|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5203997|NCT01072175|17964424|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5203998|NCT01072175|17964425|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5203999|NCT01072175|17964426|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204000|NCT01072175|17964427|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204001|NCT01072175|17964428|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
5204002|NCT01072175|17964429|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
5204003|NCT01072175|17964430|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
5204004|NCT01072175|17964431|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204005|NCT01072175|17964432|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204006|NCT01072175|17964433|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204007|NCT01072175|17964434|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204008|NCT01072175|17964435|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5204009|NCT01072175|17964423|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204010|NCT01072175|17964424|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204011|NCT01072175|17964425|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204012|NCT01072175|17964426|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204013|NCT01072175|17964427|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204014|NCT01072175|17964428|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
5204015|NCT01072175|17964429|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
5204016|NCT01072175|17964430|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204017|NCT01072175|17964431|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204018|NCT01072175|17964432|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204019|NCT01072175|17964433|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204020|NCT01072175|17964434|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204021|NCT01072175|17964435|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5204022|NCT01072175|17964423|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204023|NCT01072175|17964424|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204024|NCT01072175|17964425|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204025|NCT01072175|17964426|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204026|NCT01072175|17964427|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204027|NCT01072175|17964428|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
5204028|NCT01072175|17964429|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
5204029|NCT01072175|17964430|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
5204030|NCT01072175|17964431|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204031|NCT01072175|17964432|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204032|NCT01072175|17964433|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204033|NCT01072175|17964434|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204034|NCT01072175|17964435|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
5204035|NCT01072175|17964423|P13|Part C (Phase II: Randomized Phase)|Death|0
5204036|NCT01072175|17964424|P12|Part C (Phase II: Randomized Phase)|Death|0
5204037|NCT01072175|17964425|P11|Part C (Phase II: Randomized Phase)|Death|0
5204038|NCT01072175|17964426|P10|Part C (Phase II: Randomized Phase)|Death|0
5204039|NCT01072175|17964427|P9|Part C (Phase II: Randomized Phase)|Death|0
5204040|NCT01072175|17964428|P8|Part C (Phase II: Randomized Phase)|Death|39
5204041|NCT01072175|17964429|P7|Part C (Phase II: Randomized Phase)|Death|34
5204042|NCT01072175|17964430|P6|Part C (Phase II: Randomized Phase)|Death|44
5204043|NCT01072175|17964431|P5|Part C (Phase II: Randomized Phase)|Death|0
5204044|NCT01072175|17964432|P4|Part C (Phase II: Randomized Phase)|Death|0
5204045|NCT01072175|17964433|P3|Part C (Phase II: Randomized Phase)|Death|0
5204046|NCT01072175|17964434|P2|Part C (Phase II: Randomized Phase)|Death|0
5204047|NCT01072175|17964435|P1|Part C (Phase II: Randomized Phase)|Death|0
5204048|NCT01072175|17964423|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204049|NCT01072175|17964424|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204050|NCT01072175|17964425|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204051|NCT01072175|17964426|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204052|NCT01072175|17964427|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204053|NCT01072175|17964428|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204054|NCT01072175|17964429|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204055|NCT01072175|17964430|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204056|NCT01072175|17964431|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
5204057|NCT01072175|17964432|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
5204058|NCT01072175|17964433|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204059|NCT01072175|17964434|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
5204060|NCT01072175|17964435|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5204061|NCT01072175|17964423|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204062|NCT01072175|17964424|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204063|NCT01072175|17964425|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204064|NCT01072175|17964426|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204065|NCT01072175|17964427|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204066|NCT01072175|17964428|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204067|NCT01072175|17964429|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204068|NCT01072175|17964430|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204069|NCT01072175|17964431|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
5204070|NCT01072175|17964432|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
5204071|NCT01072175|17964433|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
5204072|NCT01072175|17964434|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204073|NCT01072175|17964435|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5204074|NCT01072175|17964423|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204075|NCT01072175|17964424|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204076|NCT01072175|17964425|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204077|NCT01072175|17964426|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204078|NCT01072175|17964427|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204079|NCT01072175|17964428|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204080|NCT01072175|17964429|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204081|NCT01072175|17964430|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204082|NCT01072175|17964431|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
5204083|NCT01072175|17964432|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
5204084|NCT01072175|17964433|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204085|NCT01072175|17964434|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
5204086|NCT01072175|17964435|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5204087|NCT01072175|17964423|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204088|NCT01072175|17964424|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204089|NCT01072175|17964425|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204090|NCT01072175|17964426|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204091|NCT01072175|17964427|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204092|NCT01072175|17964428|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204093|NCT01072175|17964429|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204094|NCT01072175|17964430|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204095|NCT01072175|17964431|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
5204096|NCT01072175|17964432|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204097|NCT01072175|17964433|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
5204098|NCT01072175|17964434|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204099|NCT01072175|17964435|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
5204100|NCT01072175|17964423|P13|Part B (Dose Escalation and Expansion)|Death|0
5204101|NCT01072175|17964424|P12|Part B (Dose Escalation and Expansion)|Death|0
5204102|NCT01072175|17964425|P11|Part B (Dose Escalation and Expansion)|Death|0
5204103|NCT01072175|17964426|P10|Part B (Dose Escalation and Expansion)|Death|0
5204104|NCT01072175|17964427|P9|Part B (Dose Escalation and Expansion)|Death|0
5204105|NCT01072175|17964428|P8|Part B (Dose Escalation and Expansion)|Death|0
5204106|NCT01072175|17964429|P7|Part B (Dose Escalation and Expansion)|Death|0
5204107|NCT01072175|17964430|P6|Part B (Dose Escalation and Expansion)|Death|0
5204108|NCT01072175|17964431|P5|Part B (Dose Escalation and Expansion)|Death|68
5204109|NCT01072175|17964432|P4|Part B (Dose Escalation and Expansion)|Death|21
5204110|NCT01072175|17964433|P3|Part B (Dose Escalation and Expansion)|Death|18
5204111|NCT01072175|17964434|P2|Part B (Dose Escalation and Expansion)|Death|4
5204112|NCT01072175|17964435|P1|Part B (Dose Escalation and Expansion)|Death|0
5204113|NCT01072175|17964423|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204114|NCT01072175|17964424|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204115|NCT01072175|17964425|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204116|NCT01072175|17964426|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204117|NCT01072175|17964427|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204118|NCT01072175|17964428|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204119|NCT01072175|17964429|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204120|NCT01072175|17964430|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204121|NCT01072175|17964431|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204122|NCT01072175|17964432|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204123|NCT01072175|17964433|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204124|NCT01072175|17964434|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5204125|NCT01072175|17964435|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
5204126|NCT01072175|17964423|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
5204127|NCT01072175|17964424|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
5204128|NCT01072175|17964425|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
5204129|NCT01072175|17964426|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
5204130|NCT01072175|17964427|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
5204131|NCT01072175|17964428|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
5204132|NCT01072175|17964429|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
5204133|NCT01072175|17964430|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
5204134|NCT01072175|17964431|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
5204135|NCT01072175|17964432|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
5204136|NCT01072175|17964433|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
5204137|NCT01072175|17964434|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
5204138|NCT01072175|17964435|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
5204139|NCT01072175|17964423|P13|Part A (Drug-Drug Interaction)|Death|0
5204140|NCT01072175|17964424|P12|Part A (Drug-Drug Interaction)|Death|0
5204141|NCT01072175|17964425|P11|Part A (Drug-Drug Interaction)|Death|0
5204142|NCT01072175|17964426|P10|Part A (Drug-Drug Interaction)|Death|0
5204143|NCT01072175|17964427|P9|Part A (Drug-Drug Interaction)|Death|0
5204144|NCT01072175|17964428|P8|Part A (Drug-Drug Interaction)|Death|0
5204145|NCT01072175|17964429|P7|Part A (Drug-Drug Interaction)|Death|0
5204146|NCT01072175|17964430|P6|Part A (Drug-Drug Interaction)|Death|0
5204147|NCT01072175|17964431|P5|Part A (Drug-Drug Interaction)|Death|0
5204148|NCT01072175|17964432|P4|Part A (Drug-Drug Interaction)|Death|0
5204149|NCT01072175|17964433|P3|Part A (Drug-Drug Interaction)|Death|0
5204150|NCT01072175|17964434|P2|Part A (Drug-Drug Interaction)|Death|0
5204151|NCT01072175|17964435|P1|Part A (Drug-Drug Interaction)|Death|1
5204152|NCT01072149|17964644|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204153|NCT01072149|17964645|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204154|NCT01072149|17964646|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204155|NCT01072149|17964647|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204156|NCT01072149|17964648|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
5204157|NCT01072149|17964649|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204158|NCT01072149|17964650|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204159|NCT01072149|17964651|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204160|NCT01072149|17964652|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204161|NCT01072149|17964653|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204162|NCT01072149|17964654|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204163|NCT01072149|17964655|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204164|NCT01072149|17964656|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204165|NCT01072149|17964657|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204166|NCT01072149|17964658|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204167|NCT01072149|17964659|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
5204168|NCT01072149|17964660|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204169|NCT01072149|17964661|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5204170|NCT01072149|17964644|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204171|NCT01072149|17964645|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204172|NCT01072149|17964646|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204173|NCT01072149|17964647|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204174|NCT01072149|17964648|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204175|NCT01072149|17964649|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
5204176|NCT01072149|17964650|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204177|NCT01072149|17964651|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204178|NCT01072149|17964652|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204179|NCT01072149|17964653|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204180|NCT01072149|17964654|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204181|NCT01072149|17964655|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204182|NCT01072149|17964656|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204183|NCT01072149|17964657|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204184|NCT01072149|17964658|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204185|NCT01072149|17964659|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204186|NCT01072149|17964660|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204187|NCT01072149|17964661|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
5204188|NCT01072149|17964644|P18|Washout Period 2 (14 Days)|Adverse Event|0
5204189|NCT01072149|17964645|P17|Washout Period 2 (14 Days)|Adverse Event|0
5204190|NCT01072149|17964646|P16|Washout Period 2 (14 Days)|Adverse Event|1
5204191|NCT01072149|17964647|P15|Washout Period 2 (14 Days)|Adverse Event|0
5204192|NCT01072149|17964648|P14|Washout Period 2 (14 Days)|Adverse Event|0
5204193|NCT01072149|17964649|P13|Washout Period 2 (14 Days)|Adverse Event|0
5204194|NCT01072149|17964650|P12|Washout Period 2 (14 Days)|Adverse Event|0
5204195|NCT01072149|17964651|P11|Washout Period 2 (14 Days)|Adverse Event|0
5204196|NCT01072149|17964652|P10|Washout Period 2 (14 Days)|Adverse Event|0
5204197|NCT01072149|17964653|P9|Washout Period 2 (14 Days)|Adverse Event|0
5204198|NCT01072149|17964654|P8|Washout Period 2 (14 Days)|Adverse Event|0
5204199|NCT01072149|17964655|P7|Washout Period 2 (14 Days)|Adverse Event|0
5204200|NCT01072149|17964656|P6|Washout Period 2 (14 Days)|Adverse Event|0
5204201|NCT01072149|17964657|P5|Washout Period 2 (14 Days)|Adverse Event|0
5204202|NCT01072149|17964658|P4|Washout Period 2 (14 Days)|Adverse Event|0
5204203|NCT01072149|17964659|P3|Washout Period 2 (14 Days)|Adverse Event|0
5204204|NCT01072149|17964660|P2|Washout Period 2 (14 Days)|Adverse Event|0
5204205|NCT01072149|17964661|P1|Washout Period 2 (14 Days)|Adverse Event|0
5204206|NCT01072149|17964644|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204207|NCT01072149|17964645|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204208|NCT01072149|17964646|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
5204209|NCT01072149|17964647|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204210|NCT01072149|17964648|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204211|NCT01072149|17964649|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204212|NCT01072149|17964650|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204213|NCT01072149|17964651|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204214|NCT01072149|17964652|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204215|NCT01072149|17964653|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204216|NCT01072149|17964654|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204217|NCT01072149|17964655|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204218|NCT01072149|17964656|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204219|NCT01072149|17964657|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204220|NCT01072149|17964658|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204221|NCT01072149|17964659|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204222|NCT01072149|17964660|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204223|NCT01072149|17964661|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5204224|NCT01072149|17964644|P18|Washout Period 2 (14 Days)|Physician Decision|0
5204225|NCT01072149|17964645|P17|Washout Period 2 (14 Days)|Physician Decision|0
5204226|NCT01072149|17964646|P16|Washout Period 2 (14 Days)|Physician Decision|0
5204227|NCT01072149|17964647|P15|Washout Period 2 (14 Days)|Physician Decision|0
5204228|NCT01072149|17964648|P14|Washout Period 2 (14 Days)|Physician Decision|0
5204229|NCT01072149|17964649|P13|Washout Period 2 (14 Days)|Physician Decision|0
5204230|NCT01072149|17964650|P12|Washout Period 2 (14 Days)|Physician Decision|0
5204231|NCT01072149|17964651|P11|Washout Period 2 (14 Days)|Physician Decision|0
5204232|NCT01072149|17964652|P10|Washout Period 2 (14 Days)|Physician Decision|0
5204233|NCT01072149|17964653|P9|Washout Period 2 (14 Days)|Physician Decision|0
5204234|NCT01072149|17964654|P8|Washout Period 2 (14 Days)|Physician Decision|0
5204235|NCT01072149|17964655|P7|Washout Period 2 (14 Days)|Physician Decision|0
5204236|NCT01072149|17964656|P6|Washout Period 2 (14 Days)|Physician Decision|0
5204237|NCT01072149|17964657|P5|Washout Period 2 (14 Days)|Physician Decision|0
5204238|NCT01072149|17964658|P4|Washout Period 2 (14 Days)|Physician Decision|0
5204239|NCT01072149|17964659|P3|Washout Period 2 (14 Days)|Physician Decision|0
5204240|NCT01072149|17964660|P2|Washout Period 2 (14 Days)|Physician Decision|0
5204241|NCT01072149|17964661|P1|Washout Period 2 (14 Days)|Physician Decision|1
5204242|NCT01072149|17964644|P18|Treatment Period 2 (28 Days)|Physician Decision|0
5204243|NCT01072149|17964645|P17|Treatment Period 2 (28 Days)|Physician Decision|0
5204244|NCT01072149|17964646|P16|Treatment Period 2 (28 Days)|Physician Decision|0
5204245|NCT01072149|17964647|P15|Treatment Period 2 (28 Days)|Physician Decision|0
5204246|NCT01072149|17964648|P14|Treatment Period 2 (28 Days)|Physician Decision|0
5204247|NCT01072149|17964649|P13|Treatment Period 2 (28 Days)|Physician Decision|0
5204248|NCT01072149|17964650|P12|Treatment Period 2 (28 Days)|Physician Decision|0
5204249|NCT01072149|17964651|P11|Treatment Period 2 (28 Days)|Physician Decision|0
5204250|NCT01072149|17964652|P10|Treatment Period 2 (28 Days)|Physician Decision|0
5204251|NCT01072149|17964653|P9|Treatment Period 2 (28 Days)|Physician Decision|0
5204252|NCT01072149|17964654|P8|Treatment Period 2 (28 Days)|Physician Decision|1
5204253|NCT01072149|17964655|P7|Treatment Period 2 (28 Days)|Physician Decision|0
5204254|NCT01072149|17964656|P6|Treatment Period 2 (28 Days)|Physician Decision|0
5204255|NCT01072149|17964657|P5|Treatment Period 2 (28 Days)|Physician Decision|0
5204256|NCT01072149|17964658|P4|Treatment Period 2 (28 Days)|Physician Decision|0
5204257|NCT01072149|17964659|P3|Treatment Period 2 (28 Days)|Physician Decision|0
5204258|NCT01072149|17964660|P2|Treatment Period 2 (28 Days)|Physician Decision|0
5204259|NCT01072149|17964661|P1|Treatment Period 2 (28 Days)|Physician Decision|0
5204260|NCT01072149|17964644|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204261|NCT01072149|17964645|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204262|NCT01072149|17964646|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204263|NCT01072149|17964647|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204264|NCT01072149|17964648|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204265|NCT01072149|17964649|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204266|NCT01072149|17964650|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204267|NCT01072149|17964651|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204268|NCT01072149|17964652|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204269|NCT01072149|17964653|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204270|NCT01072149|17964654|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204271|NCT01072149|17964655|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204272|NCT01072149|17964656|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204273|NCT01072149|17964657|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204274|NCT01072149|17964658|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204275|NCT01072149|17964659|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5204276|NCT01072149|17964660|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204277|NCT01072149|17964661|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5204278|NCT01072149|17964644|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204279|NCT01072149|17964645|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204280|NCT01072149|17964646|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204281|NCT01072149|17964647|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204282|NCT01072149|17964648|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204283|NCT01072149|17964649|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204284|NCT01072149|17964650|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204285|NCT01072149|17964651|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204286|NCT01072149|17964652|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204287|NCT01072149|17964653|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204288|NCT01072149|17964654|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204289|NCT01072149|17964655|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204290|NCT01072149|17964656|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204291|NCT01072149|17964657|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204292|NCT01072149|17964658|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204293|NCT01072149|17964659|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204294|NCT01072149|17964660|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
5204295|NCT01072149|17964661|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5204296|NCT01072149|17964644|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204297|NCT01072149|17964645|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204298|NCT01072149|17964646|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204299|NCT01072149|17964647|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204300|NCT01072149|17964648|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204301|NCT01072149|17964649|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204302|NCT01072149|17964650|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204303|NCT01072149|17964651|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
5204304|NCT01072149|17964652|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204305|NCT01072149|17964653|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204306|NCT01072149|17964654|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204307|NCT01072149|17964655|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204308|NCT01072149|17964656|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204309|NCT01072149|17964657|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204310|NCT01072149|17964658|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204311|NCT01072149|17964659|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204312|NCT01072149|17964660|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204313|NCT01072149|17964661|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5204314|NCT01072149|17964644|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
5204315|NCT01072149|17964645|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
5204316|NCT01072149|17964646|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
5204317|NCT01072149|17964647|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
5204318|NCT01072149|17964648|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
5204319|NCT01072149|17964649|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
5204320|NCT01072149|17964650|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
5204321|NCT01072149|17964651|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
5204322|NCT01072149|17964652|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
5204323|NCT01072149|17964653|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
5204324|NCT01072149|17964654|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
5204325|NCT01072149|17964655|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
5204326|NCT01072149|17964656|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
5204327|NCT01072149|17964657|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
5204328|NCT01072149|17964658|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
5204329|NCT01072149|17964659|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
5204330|NCT01072149|17964660|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
5204331|NCT01072149|17964661|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
5204332|NCT01072149|17964644|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204333|NCT01072149|17964645|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204334|NCT01072149|17964646|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204335|NCT01072149|17964647|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204336|NCT01072149|17964648|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204337|NCT01072149|17964649|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204338|NCT01072149|17964650|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204339|NCT01072149|17964651|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204340|NCT01072149|17964652|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204341|NCT01072149|17964653|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204342|NCT01072149|17964654|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204343|NCT01072149|17964655|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204344|NCT01072149|17964656|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204345|NCT01072149|17964657|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204346|NCT01072149|17964658|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204347|NCT01072149|17964659|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5204348|NCT01072149|17964660|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204349|NCT01072149|17964661|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5204350|NCT01071954|17964750|P1|Overall Study|Protocol Specified Criteria|1
5204351|NCT01071954|17964750|P1|Overall Study|Administrative Decision|5
5204352|NCT01071954|17964750|P1|Overall Study|Requirement for Alternative Therapy|5
5204353|NCT01071954|17964750|P1|Overall Study|Withdrawal by Subject|11
5204354|NCT01071954|17964750|P1|Overall Study|Adverse Event|1
5204355|NCT01071954|17964750|P1|Overall Study|Noncompliance|4
5204356|NCT01071915|17964759|P1|Overall Study|Miscellaneous Reasons|2
5204357|NCT01071915|17964759|P1|Overall Study|Withdrawal by Subject|2
5204358|NCT01071915|17964759|P1|Overall Study|Physician Decision|2
5204359|NCT01071915|17964759|P1|Overall Study|Adverse Event|3
5204360|NCT01071798|17964769|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
5204361|NCT01071798|17964769|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
5204362|NCT01071798|17964769|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
5204363|NCT01071798|17964769|P1|Subpopulation Who Received Two Cycles|Remission|1
5204364|NCT01071798|17964769|P1|Participants Who Received One Cycle|Severe concomitant disease|2
5204365|NCT01071798|17964769|P1|Participants Who Received One Cycle|Change of therapy|6
5204366|NCT01071798|17964769|P1|Participants Who Received One Cycle|Death|5
5204367|NCT01071798|17964769|P1|Participants Who Received One Cycle|Patient requirement|20
5204368|NCT01071798|17964769|P1|Participants Who Received One Cycle|Lack of tolerability|14
5204369|NCT01071798|17964769|P1|Participants Who Received One Cycle|Lack of Efficacy|18
5204370|NCT01071512|17964799|P1|Overall Study|positive anti-JC virus antibody test|2
5204371|NCT01071512|17964799|P1|Overall Study|Development of antibodies to drug|2
5204372|NCT01071512|17964799|P1|Overall Study|Adverse Event|1
5204373|NCT01071395|17964809|P2|Overall Study|Adverse Event|1
5204374|NCT01071395|17964810|P1|Overall Study|Adverse Event|3
5204375|NCT01071395|17964809|P2|Overall Study|Withdrawal by Subject|1
5204376|NCT01071395|17964810|P1|Overall Study|Withdrawal by Subject|2
5204377|NCT01071317|17964829|P2|Overall Study|Lost to Follow-up|2
5204378|NCT01071317|17964830|P1|Overall Study|Lost to Follow-up|2
5204379|NCT01071278|17964842|P1|Overall Study|Completion Status Unknown|459
5204380|NCT01071278|17964842|P1|Overall Study|Premature Discontinuation|254
5204381|NCT01071252|17964853|P5|Overall Study|Death|1
5204382|NCT01071252|17964854|P4|Overall Study|Death|0
5204383|NCT01071252|17964855|P3|Overall Study|Death|0
5204384|NCT01071252|17964856|P2|Overall Study|Death|0
5204385|NCT01071252|17964857|P1|Overall Study|Death|0
5204386|NCT01071252|17964853|P5|Overall Study|Adverse Event|0
5204387|NCT01071252|17964854|P4|Overall Study|Adverse Event|1
5204388|NCT01071252|17964855|P3|Overall Study|Adverse Event|0
5204389|NCT01071252|17964856|P2|Overall Study|Adverse Event|1
5204390|NCT01071252|17964857|P1|Overall Study|Adverse Event|1
5204391|NCT01071252|17964853|P5|Overall Study|Lost to Follow-up|0
5204392|NCT01071252|17964854|P4|Overall Study|Lost to Follow-up|2
5204393|NCT01071252|17964855|P3|Overall Study|Lost to Follow-up|1
5204394|NCT01071252|17964856|P2|Overall Study|Lost to Follow-up|0
5204395|NCT01071252|17964857|P1|Overall Study|Lost to Follow-up|1
5204396|NCT01071252|17964853|P5|Overall Study|administrative problems|1
5204397|NCT01071252|17964854|P4|Overall Study|administrative problems|2
5204398|NCT01071252|17964855|P3|Overall Study|administrative problems|0
5204399|NCT01071252|17964856|P2|Overall Study|administrative problems|1
5204400|NCT01071252|17964857|P1|Overall Study|administrative problems|1
5204401|NCT01071252|17964853|P5|Overall Study|Withdrawal by Subject|3
5204402|NCT01071252|17964854|P4|Overall Study|Withdrawal by Subject|2
5204403|NCT01071252|17964855|P3|Overall Study|Withdrawal by Subject|1
5204404|NCT01071252|17964856|P2|Overall Study|Withdrawal by Subject|2
5204405|NCT01071252|17964857|P1|Overall Study|Withdrawal by Subject|8
5204406|NCT01071252|17964853|P5|Overall Study|unsatisfactory therapeutic effect|6
5204407|NCT01071252|17964854|P4|Overall Study|unsatisfactory therapeutic effect|0
5204408|NCT01071252|17964855|P3|Overall Study|unsatisfactory therapeutic effect|2
5204409|NCT01071252|17964856|P2|Overall Study|unsatisfactory therapeutic effect|6
5204410|NCT01071252|17964857|P1|Overall Study|unsatisfactory therapeutic effect|4
5204411|NCT01071200|17964885|P2|Overall Study|No viable embryos|1
5204412|NCT01071200|17964886|P1|Overall Study|No viable embryos|0
5204413|NCT01071200|17964885|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
5204414|NCT01071200|17964886|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
5204415|NCT01071200|17964885|P2|Overall Study|No oocytes retrieved|1
5204416|NCT01071200|17964886|P1|Overall Study|No oocytes retrieved|1
5204417|NCT01071200|17964885|P2|Overall Study|No fertilization|0
5204418|NCT01071200|17964886|P1|Overall Study|No fertilization|4
5204419|NCT01071200|17964885|P2|Overall Study|Lack of ovarian response|1
5204420|NCT01071200|17964886|P1|Overall Study|Lack of ovarian response|1
5204421|NCT01071096|17964918|P2|First Intervention (90 Days)|Lost to Follow-up|0
5204422|NCT01071096|17964919|P1|First Intervention (90 Days)|Lost to Follow-up|1
5204423|NCT01071083|17964943|P5|Overall Study|Subject Refused to Continue|0
5204424|NCT01071083|17964944|P4|Overall Study|Subject Refused to Continue|0
5204425|NCT01071083|17964945|P3|Overall Study|Subject Refused to Continue|0
5204426|NCT01071083|17964946|P2|Overall Study|Subject Refused to Continue|0
5204427|NCT01071083|17964947|P1|Overall Study|Subject Refused to Continue|1
5204428|NCT01071083|17964943|P5|Overall Study|Did Not Want Per Protocol Treatment|1
5204429|NCT01071083|17964944|P4|Overall Study|Did Not Want Per Protocol Treatment|0
5204430|NCT01071083|17964945|P3|Overall Study|Did Not Want Per Protocol Treatment|1
5204431|NCT01071083|17964946|P2|Overall Study|Did Not Want Per Protocol Treatment|0
5204432|NCT01071083|17964947|P1|Overall Study|Did Not Want Per Protocol Treatment|0
5204433|NCT01071083|17964943|P5|Overall Study|Did Not Meet Eligibility Criteria|1
5204434|NCT01071083|17964944|P4|Overall Study|Did Not Meet Eligibility Criteria|1
5204435|NCT01071083|17964945|P3|Overall Study|Did Not Meet Eligibility Criteria|1
5204436|NCT01071083|17964946|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5204437|NCT01071083|17964947|P1|Overall Study|Did Not Meet Eligibility Criteria|0
5204438|NCT01071083|17964943|P5|Overall Study|Images Not Usable (Motion)|0
5204439|NCT01071083|17964944|P4|Overall Study|Images Not Usable (Motion)|0
5204440|NCT01071083|17964945|P3|Overall Study|Images Not Usable (Motion)|0
5204441|NCT01071083|17964946|P2|Overall Study|Images Not Usable (Motion)|1
5204442|NCT01071083|17964947|P1|Overall Study|Images Not Usable (Motion)|0
5204443|NCT01071083|17964943|P5|Overall Study|Subject Moved|0
5204444|NCT01071083|17964944|P4|Overall Study|Subject Moved|0
5204445|NCT01071083|17964945|P3|Overall Study|Subject Moved|0
5204446|NCT01071083|17964946|P2|Overall Study|Subject Moved|1
5204447|NCT01071083|17964947|P1|Overall Study|Subject Moved|0
5204448|NCT01071083|17964943|P5|Overall Study|Early Rescue|1
5204449|NCT01071083|17964944|P4|Overall Study|Early Rescue|0
5204450|NCT01071083|17964945|P3|Overall Study|Early Rescue|0
5204451|NCT01071083|17964946|P2|Overall Study|Early Rescue|0
5204452|NCT01071083|17964947|P1|Overall Study|Early Rescue|1
5204453|NCT01071083|17964943|P5|Overall Study|Physician Decision|1
5204454|NCT01071083|17964944|P4|Overall Study|Physician Decision|1
5204455|NCT01071083|17964945|P3|Overall Study|Physician Decision|0
5204456|NCT01071083|17964946|P2|Overall Study|Physician Decision|0
5204457|NCT01071083|17964947|P1|Overall Study|Physician Decision|1
5204458|NCT01071083|17964943|P5|Overall Study|Withdrawal by Subject|3
5204459|NCT01071083|17964944|P4|Overall Study|Withdrawal by Subject|0
5204460|NCT01071083|17964945|P3|Overall Study|Withdrawal by Subject|2
5204461|NCT01071083|17964946|P2|Overall Study|Withdrawal by Subject|0
5204462|NCT01071083|17964947|P1|Overall Study|Withdrawal by Subject|3
5204463|NCT01071083|17964943|P5|Overall Study|Adverse Event|1
5204464|NCT01071083|17964944|P4|Overall Study|Adverse Event|0
5204465|NCT01071083|17964945|P3|Overall Study|Adverse Event|1
5204466|NCT01071083|17964946|P2|Overall Study|Adverse Event|0
5204467|NCT01071083|17964947|P1|Overall Study|Adverse Event|1
5204468|NCT01071070|17964966|P2|Overall Study|Hypercalcemia|0
5204469|NCT01071070|17964967|P1|Overall Study|Hypercalcemia|1
5204470|NCT01071070|17964966|P2|Overall Study|Missed 3 consecutive doses of study drug|0
5204471|NCT01071070|17964967|P1|Overall Study|Missed 3 consecutive doses of study drug|2
5204472|NCT01071070|17964966|P2|Overall Study|Withdrawal by Subject|0
5204473|NCT01071070|17964967|P1|Overall Study|Withdrawal by Subject|1
5204474|NCT01071070|17964966|P2|Overall Study|Adverse Event|3
5204475|NCT01071070|17964967|P1|Overall Study|Adverse Event|0
5204476|NCT01070979|17965013|P3|Overall Study|No study drug taken|0
5204477|NCT01070979|17965014|P2|Overall Study|No study drug taken|1
5204478|NCT01070979|17965015|P1|Overall Study|No study drug taken|0
5204479|NCT01070979|17965013|P3|Overall Study|Withdrawal by Subject|1
5204480|NCT01070979|17965014|P2|Overall Study|Withdrawal by Subject|1
5204481|NCT01070979|17965015|P1|Overall Study|Withdrawal by Subject|3
5204482|NCT01070979|17965013|P3|Overall Study|Surgery, moving, personal, abn. labs|2
5204483|NCT01070979|17965014|P2|Overall Study|Surgery, moving, personal, abn. labs|4
5204484|NCT01070979|17965015|P1|Overall Study|Surgery, moving, personal, abn. labs|4
5204485|NCT01070979|17965013|P3|Overall Study|Protocol Violation|6
5204486|NCT01070979|17965014|P2|Overall Study|Protocol Violation|2
5204487|NCT01070979|17965015|P1|Overall Study|Protocol Violation|0
5204488|NCT01070979|17965013|P3|Overall Study|Lost to Follow-up|1
5204489|NCT01070979|17965014|P2|Overall Study|Lost to Follow-up|1
5204490|NCT01070979|17965015|P1|Overall Study|Lost to Follow-up|2
5204491|NCT01070979|17965013|P3|Overall Study|Adverse Event|3
5204492|NCT01070979|17965014|P2|Overall Study|Adverse Event|3
5204493|NCT01070979|17965015|P1|Overall Study|Adverse Event|2
5204494|NCT01070966|17965041|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
5204495|NCT01070966|17965041|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
5204496|NCT01070966|17965041|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
5204497|NCT01070966|17965041|P1|Participants for Safety Evaluation|TMT given before date of contract|3
5204498|NCT01070966|17965041|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
5204499|NCT01070966|17965041|P1|Participants for Safety Evaluation|Duplicate Participants|4
5204500|NCT01070966|17965041|P1|Participants for Safety Evaluation|Off-label use|9
5204501|NCT01070966|17965041|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
5204502|NCT01070953|17965052|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
5204503|NCT01070953|17965052|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
5204504|NCT01070953|17965052|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
5204505|NCT01070953|17965052|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
5204506|NCT01070953|17965052|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
5204507|NCT01070953|17965052|P1|Participants for Safety Evaluation|Uncontracted participants|4
5204508|NCT01070953|17965052|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
5204509|NCT01070953|17965052|P1|Participants for Safety Evaluation|Duplicated participants|22
5204510|NCT01070953|17965052|P1|Participants for Safety Evaluation|Off-label use|283
5204511|NCT01070953|17965052|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
5204512|NCT01070888|17965065|P2|Washout (14 Days)|Physician Decision|0
5204513|NCT01070888|17965066|P1|Washout (14 Days)|Physician Decision|1
5204514|NCT01070888|17965065|P2|First Intervention (14 Days)|Lost to Follow-up|1
5204515|NCT01070888|17965066|P1|First Intervention (14 Days)|Lost to Follow-up|0
5204516|NCT01070888|17965065|P2|First Intervention (14 Days)|Adverse Event|1
5204517|NCT01070888|17965066|P1|First Intervention (14 Days)|Adverse Event|0
5204518|NCT01070784|17965091|P2|Overall Study|Adverse Event|9
5204519|NCT01070784|17965092|P1|Overall Study|Adverse Event|14
5204520|NCT01070784|17965091|P2|Overall Study|Withdrawal by Subject|9
5204521|NCT01070784|17965092|P1|Overall Study|Withdrawal by Subject|6
5204522|NCT01070771|17965180|P1|Overall Study|Protocol Violation|1
5204523|NCT01070771|17965180|P1|Overall Study|Adverse Event|2
5204524|NCT01070550|17965200|P6|Overall Study|Withdrawal by Subject|0
5204525|NCT01070550|17965201|P5|Overall Study|Withdrawal by Subject|0
5204526|NCT01070550|17965202|P4|Overall Study|Withdrawal by Subject|0
5204527|NCT01070550|17965203|P3|Overall Study|Withdrawal by Subject|3
5204528|NCT01070550|17965204|P2|Overall Study|Withdrawal by Subject|0
5204529|NCT01070550|17965205|P1|Overall Study|Withdrawal by Subject|35
5204530|NCT01070550|17965200|P6|Overall Study|Other|0
5204531|NCT01070550|17965201|P5|Overall Study|Other|0
5204532|NCT01070550|17965202|P4|Overall Study|Other|1
5204533|NCT01070550|17965203|P3|Overall Study|Other|0
5204534|NCT01070550|17965204|P2|Overall Study|Other|0
5204535|NCT01070550|17965205|P1|Overall Study|Other|5
5204536|NCT01070550|17965200|P6|Overall Study|Treatment was stopped early|0
5204537|NCT01070550|17965201|P5|Overall Study|Treatment was stopped early|0
5204538|NCT01070550|17965202|P4|Overall Study|Treatment was stopped early|0
5204539|NCT01070550|17965203|P3|Overall Study|Treatment was stopped early|0
5204540|NCT01070550|17965204|P2|Overall Study|Treatment was stopped early|0
5204541|NCT01070550|17965205|P1|Overall Study|Treatment was stopped early|7
5204542|NCT01070550|17965200|P6|Overall Study|Treatment unavailable|0
5204543|NCT01070550|17965201|P5|Overall Study|Treatment unavailable|0
5204544|NCT01070550|17965202|P4|Overall Study|Treatment unavailable|0
5204545|NCT01070550|17965203|P3|Overall Study|Treatment unavailable|0
5204546|NCT01070550|17965204|P2|Overall Study|Treatment unavailable|0
5204547|NCT01070550|17965205|P1|Overall Study|Treatment unavailable|1
5204548|NCT01070550|17965200|P6|Overall Study|Treatment stopped|0
5204549|NCT01070550|17965201|P5|Overall Study|Treatment stopped|0
5204550|NCT01070550|17965202|P4|Overall Study|Treatment stopped|0
5204551|NCT01070550|17965203|P3|Overall Study|Treatment stopped|0
5204552|NCT01070550|17965204|P2|Overall Study|Treatment stopped|0
5204553|NCT01070550|17965205|P1|Overall Study|Treatment stopped|3
5204554|NCT01070550|17965200|P6|Overall Study|Treatment restarted|0
5204555|NCT01070550|17965201|P5|Overall Study|Treatment restarted|0
5204556|NCT01070550|17965202|P4|Overall Study|Treatment restarted|0
5204557|NCT01070550|17965203|P3|Overall Study|Treatment restarted|0
5204558|NCT01070550|17965204|P2|Overall Study|Treatment restarted|1
5204559|NCT01070550|17965205|P1|Overall Study|Treatment restarted|0
5204560|NCT01070550|17965200|P6|Overall Study|Treatment not started|0
5204561|NCT01070550|17965201|P5|Overall Study|Treatment not started|0
5204562|NCT01070550|17965202|P4|Overall Study|Treatment not started|0
5204563|NCT01070550|17965203|P3|Overall Study|Treatment not started|4
5204564|NCT01070550|17965204|P2|Overall Study|Treatment not started|2
5204565|NCT01070550|17965205|P1|Overall Study|Treatment not started|14
5204566|NCT01070550|17965200|P6|Overall Study|Treatment interrupted|0
5204567|NCT01070550|17965201|P5|Overall Study|Treatment interrupted|0
5204568|NCT01070550|17965202|P4|Overall Study|Treatment interrupted|1
5204569|NCT01070550|17965203|P3|Overall Study|Treatment interrupted|1
5204570|NCT01070550|17965204|P2|Overall Study|Treatment interrupted|0
5204571|NCT01070550|17965205|P1|Overall Study|Treatment interrupted|7
5204572|NCT01070550|17965200|P6|Overall Study|Treatment duration shortened|0
5204573|NCT01070550|17965201|P5|Overall Study|Treatment duration shortened|0
5204574|NCT01070550|17965202|P4|Overall Study|Treatment duration shortened|0
5204575|NCT01070550|17965203|P3|Overall Study|Treatment duration shortened|0
5204576|NCT01070550|17965204|P2|Overall Study|Treatment duration shortened|0
5204577|NCT01070550|17965205|P1|Overall Study|Treatment duration shortened|1
5204578|NCT01070550|17965200|P6|Overall Study|Sponsor decision|0
5204579|NCT01070550|17965201|P5|Overall Study|Sponsor decision|0
5204580|NCT01070550|17965202|P4|Overall Study|Sponsor decision|0
5204581|NCT01070550|17965203|P3|Overall Study|Sponsor decision|0
5204582|NCT01070550|17965204|P2|Overall Study|Sponsor decision|0
5204583|NCT01070550|17965205|P1|Overall Study|Sponsor decision|1
5204584|NCT01070550|17965200|P6|Overall Study|Screen failure|0
5204585|NCT01070550|17965201|P5|Overall Study|Screen failure|0
5204586|NCT01070550|17965202|P4|Overall Study|Screen failure|0
5204587|NCT01070550|17965203|P3|Overall Study|Screen failure|0
5204588|NCT01070550|17965204|P2|Overall Study|Screen failure|0
5204589|NCT01070550|17965205|P1|Overall Study|Screen failure|1
5204590|NCT01070550|17965200|P6|Overall Study|Result not available|0
5204591|NCT01070550|17965201|P5|Overall Study|Result not available|0
5204592|NCT01070550|17965202|P4|Overall Study|Result not available|0
5204593|NCT01070550|17965203|P3|Overall Study|Result not available|3
5204594|NCT01070550|17965204|P2|Overall Study|Result not available|1
5204595|NCT01070550|17965205|P1|Overall Study|Result not available|3
5204596|NCT01070550|17965200|P6|Overall Study|Relapse|0
5204597|NCT01070550|17965201|P5|Overall Study|Relapse|0
5204598|NCT01070550|17965202|P4|Overall Study|Relapse|4
5204599|NCT01070550|17965203|P3|Overall Study|Relapse|14
5204600|NCT01070550|17965204|P2|Overall Study|Relapse|5
5204601|NCT01070550|17965205|P1|Overall Study|Relapse|44
5204602|NCT01070550|17965200|P6|Overall Study|Protocol Violation|0
5204603|NCT01070550|17965201|P5|Overall Study|Protocol Violation|0
5204604|NCT01070550|17965202|P4|Overall Study|Protocol Violation|1
5204605|NCT01070550|17965203|P3|Overall Study|Protocol Violation|1
5204606|NCT01070550|17965204|P2|Overall Study|Protocol Violation|1
5204607|NCT01070550|17965205|P1|Overall Study|Protocol Violation|15
5204608|NCT01070550|17965200|P6|Overall Study|Not categorized|1
5204609|NCT01070550|17965201|P5|Overall Study|Not categorized|0
5204610|NCT01070550|17965202|P4|Overall Study|Not categorized|1
5204611|NCT01070550|17965203|P3|Overall Study|Not categorized|6
5204612|NCT01070550|17965204|P2|Overall Study|Not categorized|2
5204613|NCT01070550|17965205|P1|Overall Study|Not categorized|33
5204614|NCT01070550|17965200|P6|Overall Study|Non-responders|2
5204615|NCT01070550|17965201|P5|Overall Study|Non-responders|0
5204616|NCT01070550|17965202|P4|Overall Study|Non-responders|20
5204617|NCT01070550|17965203|P3|Overall Study|Non-responders|21
5204618|NCT01070550|17965204|P2|Overall Study|Non-responders|4
5204619|NCT01070550|17965205|P1|Overall Study|Non-responders|493
5204620|NCT01070550|17965200|P6|Overall Study|New treatment started|0
5204621|NCT01070550|17965201|P5|Overall Study|New treatment started|0
5204622|NCT01070550|17965202|P4|Overall Study|New treatment started|2
5204623|NCT01070550|17965203|P3|Overall Study|New treatment started|0
5204624|NCT01070550|17965204|P2|Overall Study|New treatment started|1
5204625|NCT01070550|17965205|P1|Overall Study|New treatment started|3
5204626|NCT01070550|17965200|P6|Overall Study|Miscellaneous|0
5204627|NCT01070550|17965201|P5|Overall Study|Miscellaneous|0
5204628|NCT01070550|17965202|P4|Overall Study|Miscellaneous|1
5204629|NCT01070550|17965203|P3|Overall Study|Miscellaneous|3
5204630|NCT01070550|17965204|P2|Overall Study|Miscellaneous|2
5204631|NCT01070550|17965205|P1|Overall Study|Miscellaneous|12
5204632|NCT01070550|17965200|P6|Overall Study|Lack of Efficacy|1
5204633|NCT01070550|17965201|P5|Overall Study|Lack of Efficacy|0
5204634|NCT01070550|17965202|P4|Overall Study|Lack of Efficacy|5
5204635|NCT01070550|17965203|P3|Overall Study|Lack of Efficacy|5
5204636|NCT01070550|17965204|P2|Overall Study|Lack of Efficacy|1
5204637|NCT01070550|17965205|P1|Overall Study|Lack of Efficacy|65
5204638|NCT01070550|17965200|P6|Overall Study|Lab test not done|1
5204639|NCT01070550|17965201|P5|Overall Study|Lab test not done|0
5204640|NCT01070550|17965202|P4|Overall Study|Lab test not done|1
5204641|NCT01070550|17965203|P3|Overall Study|Lab test not done|4
5204642|NCT01070550|17965204|P2|Overall Study|Lab test not done|3
5204643|NCT01070550|17965205|P1|Overall Study|Lab test not done|22
5204644|NCT01070550|17965200|P6|Overall Study|Incomplete treatment|0
5204645|NCT01070550|17965201|P5|Overall Study|Incomplete treatment|0
5204646|NCT01070550|17965202|P4|Overall Study|Incomplete treatment|0
5204647|NCT01070550|17965203|P3|Overall Study|Incomplete treatment|0
5204648|NCT01070550|17965204|P2|Overall Study|Incomplete treatment|0
5204649|NCT01070550|17965205|P1|Overall Study|Incomplete treatment|2
5204650|NCT01070550|17965200|P6|Overall Study|Failed to return|2
5204651|NCT01070550|17965201|P5|Overall Study|Failed to return|1
5204652|NCT01070550|17965202|P4|Overall Study|Failed to return|40
5204653|NCT01070550|17965203|P3|Overall Study|Failed to return|144
5204654|NCT01070550|17965204|P2|Overall Study|Failed to return|33
5204655|NCT01070550|17965205|P1|Overall Study|Failed to return|450
5204656|NCT01070550|17965200|P6|Overall Study|Early termination|0
5204657|NCT01070550|17965201|P5|Overall Study|Early termination|0
5204658|NCT01070550|17965202|P4|Overall Study|Early termination|0
5204659|NCT01070550|17965203|P3|Overall Study|Early termination|0
5204660|NCT01070550|17965204|P2|Overall Study|Early termination|0
5204661|NCT01070550|17965205|P1|Overall Study|Early termination|3
5204662|NCT01070550|17965200|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
5204663|NCT01070550|17965201|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
5204664|NCT01070550|17965202|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
5204665|NCT01070550|17965203|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
5204666|NCT01070550|17965204|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5204667|NCT01070550|17965205|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
5204668|NCT01070550|17965200|P6|Overall Study|Death|0
5204669|NCT01070550|17965201|P5|Overall Study|Death|0
5204670|NCT01070550|17965202|P4|Overall Study|Death|0
5204671|NCT01070550|17965203|P3|Overall Study|Death|3
5204672|NCT01070550|17965204|P2|Overall Study|Death|4
5204673|NCT01070550|17965205|P1|Overall Study|Death|20
5204674|NCT01070550|17965200|P6|Overall Study|Adverse Event|0
5204675|NCT01070550|17965201|P5|Overall Study|Adverse Event|0
5204676|NCT01070550|17965202|P4|Overall Study|Adverse Event|0
5204677|NCT01070550|17965203|P3|Overall Study|Adverse Event|3
5204678|NCT01070550|17965204|P2|Overall Study|Adverse Event|1
5204679|NCT01070550|17965205|P1|Overall Study|Adverse Event|43
5204680|NCT01070394|17965345|P1|Overall Study|Withdrawal by Subject|1
5204681|NCT01070394|17965345|P1|Overall Study|Adverse Event|6
5204682|NCT01070381|17965356|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
5204683|NCT01070381|17965357|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
5204684|NCT01070381|17965356|P2|Period 2, 1 Week of Wear|Handling|1
5204685|NCT01070381|17965357|P1|Period 2, 1 Week of Wear|Handling|0
5204686|NCT01070329|17965365|P2|Overall Study|Sponsor Decision|1
5204687|NCT01070329|17965366|P1|Overall Study|Sponsor Decision|0
5204688|NCT01070329|17965365|P2|Overall Study|Entry Criteria Not Met|0
5204689|NCT01070329|17965366|P1|Overall Study|Entry Criteria Not Met|1
5204690|NCT01070329|17965365|P2|Overall Study|Physician Decision|1
5204691|NCT01070329|17965366|P1|Overall Study|Physician Decision|2
5204692|NCT01070329|17965365|P2|Overall Study|Lack of Efficacy|6
5204693|NCT01070329|17965366|P1|Overall Study|Lack of Efficacy|2
5204694|NCT01070329|17965365|P2|Overall Study|Protocol Violation|8
5204695|NCT01070329|17965366|P1|Overall Study|Protocol Violation|3
5204696|NCT01070329|17965365|P2|Overall Study|Withdrawal by Subject|11
5204697|NCT01070329|17965366|P1|Overall Study|Withdrawal by Subject|9
5204698|NCT01070329|17965365|P2|Overall Study|Lost to Follow-up|12
5204699|NCT01070329|17965366|P1|Overall Study|Lost to Follow-up|22
5204700|NCT01070329|17965365|P2|Overall Study|Adverse Event|10
5204701|NCT01070329|17965366|P1|Overall Study|Adverse Event|13
5204702|NCT01070316|17965398|P1|Extension Phase|Withdrawal by Subject|1
5204703|NCT01070316|17965398|P1|Extension Phase|Lack of Efficacy|3
5204704|NCT01070303|17965405|P1|Overall Study|Other|18
5204705|NCT01070303|17965405|P1|Overall Study|Administrative Reason|1
5204706|NCT01070303|17965405|P1|Overall Study|Lack of Efficacy|2
5204707|NCT01070303|17965405|P1|Overall Study|Protocol Violation|0
5204708|NCT01070303|17965405|P1|Overall Study|Lost to Follow-up|9
5204709|NCT01070303|17965405|P1|Overall Study|Withdrawal by Subject|20
5204710|NCT01070303|17965405|P1|Overall Study|Adverse Event|39
5204711|NCT01070043|17965500|P3|Double-Blind Treatment|Adverse Event|2
5204712|NCT01070043|17965501|P2|Double-Blind Treatment|Adverse Event|0
5204713|NCT01070043|17965502|P1|Double-Blind Treatment|Adverse Event|0
5204714|NCT01070043|17965500|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
5204715|NCT01070043|17965501|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
5204716|NCT01070043|17965502|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
5204717|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Removal|0
5204718|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Removal|1
5204719|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Physician Decision|2
5204720|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Physician Decision|0
5204721|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
5204722|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
5204723|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
5204724|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
5204725|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
5204726|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
5204727|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
5204728|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
5204729|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Protocol Violation|1
5204730|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Protocol Violation|0
5204731|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
5204732|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
5204733|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
5204734|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
5204735|NCT01069939|17965518|P2|Randomised and Included in the Analyses|Adverse Event|22
5204736|NCT01069939|17965519|P1|Randomised and Included in the Analyses|Adverse Event|17
5204737|NCT01069900|17965545|P2|Overall Study|Insufficient Therapeutic effect|0
5204738|NCT01069900|17965546|P1|Overall Study|Insufficient Therapeutic effect|1
5204739|NCT01069900|17965545|P2|Overall Study|Protocol Violation|1
5204740|NCT01069900|17965546|P1|Overall Study|Protocol Violation|4
5204741|NCT01069900|17965545|P2|Overall Study|Withdrawal by Subject|1
5204742|NCT01069900|17965546|P1|Overall Study|Withdrawal by Subject|6
5204743|NCT01069900|17965545|P2|Overall Study|Lost to Follow-up|1
5204744|NCT01069900|17965546|P1|Overall Study|Lost to Follow-up|7
5204745|NCT01069900|17965545|P2|Overall Study|Technical problems|1
5204746|NCT01069900|17965546|P1|Overall Study|Technical problems|0
5204747|NCT01069861|17965590|P1|Overall Study|Did not meet entrance criteria|1
5204748|NCT01069861|17965590|P1|Overall Study|Adverse Event|1
5204749|NCT01069861|17965590|P1|Overall Study|Death|1
5204750|NCT01069627|17965603|P1|Overall Study|Protocol Violation|1
5204751|NCT01069627|17965603|P1|Overall Study|Adverse Event|12
5204752|NCT01069627|17965603|P1|Overall Study|Disease progression|7
5204753|NCT01069523|17965653|P2|Overall Study|Withdrawal by Subject|7
5204754|NCT01069523|17965654|P1|Overall Study|Withdrawal by Subject|4
5204755|NCT01069484|17965677|P2|Overall Study|Illness mother or child|1
5204756|NCT01069484|17965678|P1|Overall Study|Illness mother or child|3
5204757|NCT01069484|17965677|P2|Overall Study|No specific reason|2
5204758|NCT01069484|17965678|P1|Overall Study|No specific reason|8
5204759|NCT01069484|17965677|P2|Overall Study|Death-in-near-family|0
5204760|NCT01069484|17965678|P1|Overall Study|Death-in-near-family|1
5204761|NCT01069419|17965686|P1|Overall Study|Missing termination information|13
5204762|NCT01069419|17965686|P1|Overall Study|Other Reason|43
5204763|NCT01069419|17965686|P1|Overall Study|Withdrawal by Subject|34
5204764|NCT01069419|17965686|P1|Overall Study|Remission of disease|11
5204765|NCT01069419|17965686|P1|Overall Study|Lost to Follow-up|49
5204766|NCT01069419|17965686|P1|Overall Study|Lack of Efficacy|332
5204767|NCT01069419|17965686|P1|Overall Study|Adverse Event|233
5204768|NCT01069341|17965715|P1|Overall Study|Lost to Follow-up|1
5204769|NCT01069289|17965757|P2|Overall Study|Due to deteriorating health condition|0
5204770|NCT01069289|17965758|P1|Overall Study|Due to deteriorating health condition|1
5204771|NCT01069289|17965757|P2|Overall Study|Severe non-compliance to protocol|2
5204772|NCT01069289|17965758|P1|Overall Study|Severe non-compliance to protocol|3
5204773|NCT01069289|17965757|P2|Overall Study|Eligibility criteria not fulfilled|0
5204774|NCT01069289|17965758|P1|Overall Study|Eligibility criteria not fulfilled|2
5204775|NCT01069289|17965757|P2|Overall Study|Adverse Event|28
5204776|NCT01069289|17965758|P1|Overall Study|Adverse Event|21
5204777|NCT01069289|17965757|P2|Overall Study|Withdrawal by Subject|26
5204778|NCT01069289|17965758|P1|Overall Study|Withdrawal by Subject|15
5204779|NCT01069172|17965807|P2|Overall Study|Withdrawal by Subject|0
5204780|NCT01069172|17965808|P1|Overall Study|Withdrawal by Subject|1
5204781|NCT01069120|17965818|P1|Overall Study|Study prematurely terminated|27
5204782|NCT01068912|17965855|P3|Overall Study|other underlying illness|3
5204783|NCT01068912|17965856|P2|Overall Study|other underlying illness|3
5204784|NCT01068912|17965857|P1|Overall Study|other underlying illness|0
5204785|NCT01068912|17965855|P3|Overall Study|aggravation influenza|1
5204786|NCT01068912|17965856|P2|Overall Study|aggravation influenza|1
5204787|NCT01068912|17965857|P1|Overall Study|aggravation influenza|1
5204788|NCT01068912|17965855|P3|Overall Study|Protocol Violation|0
5204789|NCT01068912|17965856|P2|Overall Study|Protocol Violation|2
5204790|NCT01068912|17965857|P1|Overall Study|Protocol Violation|0
5204791|NCT01068912|17965855|P3|Overall Study|Lost to Follow-up|3
5204792|NCT01068912|17965856|P2|Overall Study|Lost to Follow-up|7
5204793|NCT01068912|17965857|P1|Overall Study|Lost to Follow-up|3
5204794|NCT01068912|17965855|P3|Overall Study|Withdrawal by Subject|6
5204795|NCT01068912|17965856|P2|Overall Study|Withdrawal by Subject|6
5204796|NCT01068912|17965857|P1|Overall Study|Withdrawal by Subject|5
5204797|NCT01068912|17965855|P3|Overall Study|Adverse Event|2
5204798|NCT01068912|17965856|P2|Overall Study|Adverse Event|3
5204799|NCT01068912|17965857|P1|Overall Study|Adverse Event|2
5204800|NCT01068860|17965885|P10|Overall Study|Lost to Follow-up|0
5204801|NCT01068860|17965886|P9|Overall Study|Lost to Follow-up|0
5204802|NCT01068860|17965887|P8|Overall Study|Lost to Follow-up|0
5204803|NCT01068860|17965888|P7|Overall Study|Lost to Follow-up|0
5204804|NCT01068860|17965889|P6|Overall Study|Lost to Follow-up|0
5204805|NCT01068860|17965890|P5|Overall Study|Lost to Follow-up|0
5204806|NCT01068860|17965891|P4|Overall Study|Lost to Follow-up|0
5204807|NCT01068860|17965892|P3|Overall Study|Lost to Follow-up|0
5204808|NCT01068860|17965893|P2|Overall Study|Lost to Follow-up|1
5204809|NCT01068860|17965894|P1|Overall Study|Lost to Follow-up|0
5204810|NCT01068860|17965885|P10|Overall Study|Administrative problems; misrandomized|1
5204811|NCT01068860|17965886|P9|Overall Study|Administrative problems; misrandomized|0
5204812|NCT01068860|17965887|P8|Overall Study|Administrative problems; misrandomized|0
5204813|NCT01068860|17965888|P7|Overall Study|Administrative problems; misrandomized|0
5204814|NCT01068860|17965889|P6|Overall Study|Administrative problems; misrandomized|0
5204815|NCT01068860|17965890|P5|Overall Study|Administrative problems; misrandomized|0
5204816|NCT01068860|17965891|P4|Overall Study|Administrative problems; misrandomized|1
5204817|NCT01068860|17965892|P3|Overall Study|Administrative problems; misrandomized|0
5204818|NCT01068860|17965893|P2|Overall Study|Administrative problems; misrandomized|0
5204819|NCT01068860|17965894|P1|Overall Study|Administrative problems; misrandomized|0
5204820|NCT01068860|17965885|P10|Overall Study|Withdrawal by Subject|3
5204821|NCT01068860|17965886|P9|Overall Study|Withdrawal by Subject|0
5204822|NCT01068860|17965887|P8|Overall Study|Withdrawal by Subject|0
5204823|NCT01068860|17965888|P7|Overall Study|Withdrawal by Subject|0
5204824|NCT01068860|17965889|P6|Overall Study|Withdrawal by Subject|2
5204825|NCT01068860|17965890|P5|Overall Study|Withdrawal by Subject|0
5204826|NCT01068860|17965891|P4|Overall Study|Withdrawal by Subject|0
5204827|NCT01068860|17965892|P3|Overall Study|Withdrawal by Subject|0
5204828|NCT01068860|17965893|P2|Overall Study|Withdrawal by Subject|0
5204829|NCT01068860|17965894|P1|Overall Study|Withdrawal by Subject|0
5204830|NCT01068769|17966077|P1|Overall Study|Ineligible|1
5204831|NCT01068743|17966082|P4|Period 3|Adverse Event|0
5204832|NCT01068743|17966083|P3|Period 3|Adverse Event|0
5204833|NCT01068743|17966084|P2|Period 3|Adverse Event|1
5204834|NCT01068743|17966085|P1|Period 3|Adverse Event|0
5204835|NCT01068730|17966159|P4|Period 4|Family emergency|0
5204836|NCT01068730|17966160|P3|Period 4|Family emergency|0
5204837|NCT01068730|17966161|P2|Period 4|Family emergency|1
5204838|NCT01068730|17966162|P1|Period 4|Family emergency|0
5204839|NCT01068730|17966159|P4|Period 3|Personal reason|0
5204840|NCT01068730|17966160|P3|Period 3|Personal reason|0
5204841|NCT01068730|17966161|P2|Period 3|Personal reason|0
5204842|NCT01068730|17966162|P1|Period 3|Personal reason|1
5204843|NCT01068717|17966216|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5204844|NCT01068717|17966217|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5204845|NCT01068717|17966218|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5204846|NCT01068717|17966219|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
5204847|NCT01068678|17966275|P2|Overall Study|Unclassified|15
5204848|NCT01068678|17966276|P1|Overall Study|Unclassified|18
5204849|NCT01068678|17966275|P2|Overall Study|Withdrawal criteria|6
5204850|NCT01068678|17966276|P1|Overall Study|Withdrawal criteria|12
5204851|NCT01068678|17966275|P2|Overall Study|Protocol Violation|1
5204852|NCT01068678|17966276|P1|Overall Study|Protocol Violation|5
5204853|NCT01068678|17966275|P2|Overall Study|Lack of Efficacy|2
5204854|NCT01068678|17966276|P1|Overall Study|Lack of Efficacy|3
5204855|NCT01068665|17966286|P2|Overall Study|Other|12
5204856|NCT01068665|17966287|P1|Overall Study|Other|17
5204857|NCT01068665|17966286|P2|Overall Study|Withdrawal Criteria|9
5204858|NCT01068665|17966287|P1|Overall Study|Withdrawal Criteria|3
5204859|NCT01068665|17966286|P2|Overall Study|Protocol Violation|2
5204860|NCT01068665|17966287|P1|Overall Study|Protocol Violation|5
5204861|NCT01068665|17966286|P2|Overall Study|Lack of Efficacy|2
5204862|NCT01068665|17966287|P1|Overall Study|Lack of Efficacy|0
5204863|NCT01068665|17966286|P2|Overall Study|Adverse Event|4
5204864|NCT01068665|17966287|P1|Overall Study|Adverse Event|5
5204865|NCT01068652|17966297|P2|Overall Study|Unclassified|4
5204866|NCT01068652|17966298|P1|Overall Study|Unclassified|7
5204867|NCT01068652|17966297|P2|Overall Study|Patient was not eligible|0
5204868|NCT01068652|17966298|P1|Overall Study|Patient was not eligible|1
5204869|NCT01068652|17966297|P2|Overall Study|Withdrawal criteria|2
5204870|NCT01068652|17966298|P1|Overall Study|Withdrawal criteria|1
5204871|NCT01068652|17966297|P2|Overall Study|Protocol Violation|6
5204872|NCT01068652|17966298|P1|Overall Study|Protocol Violation|3
5204873|NCT01068652|17966297|P2|Overall Study|Lost to Follow-up|1
5204874|NCT01068652|17966298|P1|Overall Study|Lost to Follow-up|2
5204875|NCT01068652|17966297|P2|Overall Study|Lack of Efficacy|2
5204876|NCT01068652|17966298|P1|Overall Study|Lack of Efficacy|0
5204877|NCT01068652|17966297|P2|Overall Study|Adverse Event|0
5204878|NCT01068652|17966298|P1|Overall Study|Adverse Event|4
5204879|NCT01068626|17966338|P2|Overall Study|Withdrawal by Subject|2
5204880|NCT01068626|17966339|P1|Overall Study|Withdrawal by Subject|0
5204881|NCT01068626|17966338|P2|Overall Study|Adverse Event|0
5204882|NCT01068626|17966339|P1|Overall Study|Adverse Event|3
5204883|NCT01068600|17966357|P2|Overall Study|Administrative problems|1
5204884|NCT01068600|17966358|P1|Overall Study|Administrative problems|0
5204885|NCT01068600|17966357|P2|Overall Study|Unsatisfactory therapeutic effect|4
5204886|NCT01068600|17966358|P1|Overall Study|Unsatisfactory therapeutic effect|0
5204887|NCT01068600|17966357|P2|Overall Study|Protocol deviation|1
5204888|NCT01068600|17966358|P1|Overall Study|Protocol deviation|1
5204889|NCT01068600|17966357|P2|Overall Study|Lost to Follow-up|2
5204890|NCT01068600|17966358|P1|Overall Study|Lost to Follow-up|1
5204891|NCT01068600|17966357|P2|Overall Study|Abnormal laboratory value(s)|0
5204892|NCT01068600|17966358|P1|Overall Study|Abnormal laboratory value(s)|1
5204893|NCT01068600|17966357|P2|Overall Study|Adverse Event|3
5204894|NCT01068600|17966358|P1|Overall Study|Adverse Event|3
5204895|NCT01068600|17966357|P2|Overall Study|Withdrawal by Subject|6
5204896|NCT01068600|17966358|P1|Overall Study|Withdrawal by Subject|5
5204897|NCT01068509|17966380|P3|Overall Study|Reason Not Specified|0
5204898|NCT01068509|17966381|P2|Overall Study|Reason Not Specified|1
5204899|NCT01068509|17966382|P1|Overall Study|Reason Not Specified|0
5204900|NCT01068509|17966380|P3|Overall Study|Withdrew Consent|2
5204901|NCT01068509|17966381|P2|Overall Study|Withdrew Consent|1
5204902|NCT01068509|17966382|P1|Overall Study|Withdrew Consent|0
5204903|NCT01068509|17966380|P3|Overall Study|Lost to Follow-up|0
5204904|NCT01068509|17966381|P2|Overall Study|Lost to Follow-up|0
5204905|NCT01068509|17966382|P1|Overall Study|Lost to Follow-up|1
5204906|NCT01068509|17966380|P3|Overall Study|Disease Progression|18
5204907|NCT01068509|17966381|P2|Overall Study|Disease Progression|20
5204908|NCT01068509|17966382|P1|Overall Study|Disease Progression|5
5204909|NCT01068509|17966380|P3|Overall Study|Death|1
5204910|NCT01068509|17966381|P2|Overall Study|Death|0
5204911|NCT01068509|17966382|P1|Overall Study|Death|0
5204912|NCT01068418|17966395|P1|Overall Study|Physician Decision|12
5204913|NCT01068262|17966404|P4|Overall Study|Withdrawal by Subject|0
5204914|NCT01068262|17966405|P3|Overall Study|Withdrawal by Subject|0
5204915|NCT01068262|17966406|P2|Overall Study|Withdrawal by Subject|1
5204916|NCT01068262|17966407|P1|Overall Study|Withdrawal by Subject|0
5204917|NCT01068262|17966404|P4|Overall Study|Protocol Violation|0
5204918|NCT01068262|17966405|P3|Overall Study|Protocol Violation|0
5204919|NCT01068262|17966406|P2|Overall Study|Protocol Violation|0
5204920|NCT01068262|17966407|P1|Overall Study|Protocol Violation|1
5204921|NCT01068262|17966404|P4|Overall Study|Adverse Event|0
5204922|NCT01068262|17966405|P3|Overall Study|Adverse Event|1
5204923|NCT01068262|17966406|P2|Overall Study|Adverse Event|0
5204924|NCT01068262|17966407|P1|Overall Study|Adverse Event|2
5204925|NCT01068158|17966437|P2|Overall Study|Protocol Violation|2
5204926|NCT01068158|17966438|P1|Overall Study|Protocol Violation|0
5204927|NCT01068158|17966437|P2|Overall Study|Lost to Follow-up|0
5204928|NCT01068158|17966438|P1|Overall Study|Lost to Follow-up|7
5204929|NCT01068158|17966437|P2|Overall Study|Withdrawal by Subject|2
5204930|NCT01068158|17966438|P1|Overall Study|Withdrawal by Subject|1
5204931|NCT01067976|17966450|P1|Overall Study|Study prematurely discontinued|2
5204932|NCT01067976|17966450|P1|Overall Study|Study drug never administered|20
5204933|NCT01067846|17966511|P2|Overall Study|participation in other tx study|0
5204934|NCT01067846|17966512|P1|Overall Study|participation in other tx study|1
5204935|NCT01067846|17966511|P2|Overall Study|Withdrawal by Subject|0
5204936|NCT01067846|17966512|P1|Overall Study|Withdrawal by Subject|1
5204937|NCT01067846|17966511|P2|Overall Study|Lost to Follow-up|19
5204938|NCT01067846|17966512|P1|Overall Study|Lost to Follow-up|17
5204939|NCT01067521|17966582|P2|Open-Label Period|Lost to Follow-up|20
5204940|NCT01067521|17966583|P1|Open-Label Period|Lost to Follow-up|21
5204941|NCT01067521|17966582|P2|Open-Label Period|Teva requested subject to be withdrawn|2
5204942|NCT01067521|17966583|P1|Open-Label Period|Teva requested subject to be withdrawn|5
5204943|NCT01067521|17966582|P2|Open-Label Period|Pregnancy|8
5204944|NCT01067521|17966583|P1|Open-Label Period|Pregnancy|14
5204945|NCT01067521|17966582|P2|Open-Label Period|Protocol Violation|0
5204946|NCT01067521|17966583|P1|Open-Label Period|Protocol Violation|3
5204947|NCT01067521|17966582|P2|Open-Label Period|Non-compliance with study drug|0
5204948|NCT01067521|17966583|P1|Open-Label Period|Non-compliance with study drug|5
5204949|NCT01067521|17966582|P2|Open-Label Period|Physician Decision|11
5204950|NCT01067521|17966583|P1|Open-Label Period|Physician Decision|13
5204951|NCT01067521|17966582|P2|Open-Label Period|Withdrawal by Subject|88
5204952|NCT01067521|17966583|P1|Open-Label Period|Withdrawal by Subject|160
5204953|NCT01067521|17966582|P2|Open-Label Period|Adverse Event|28
5204954|NCT01067521|17966583|P1|Open-Label Period|Adverse Event|30
5204955|NCT01067521|17966582|P2|Open-Label Period|Death|1
5204956|NCT01067521|17966583|P1|Open-Label Period|Death|3
5204957|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
5204958|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
5204959|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
5204960|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
5204961|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
5204962|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
5204963|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
5204964|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
5204965|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
5204966|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
5204967|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
5204968|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
5204969|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
5204970|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
5204971|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
5204972|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
5204973|NCT01067521|17966582|P2|Double-Blind Placebo-Controlled Period|Death|1
5204974|NCT01067521|17966583|P1|Double-Blind Placebo-Controlled Period|Death|0
5204975|NCT01067508|17966609|P2|Overall Study|Withdrawal by Subject|1
5204976|NCT01067508|17966610|P1|Overall Study|Withdrawal by Subject|0
5204977|NCT01067508|17966609|P2|Overall Study|Physician Decision|1
5204978|NCT01067508|17966610|P1|Overall Study|Physician Decision|0
5204979|NCT01067469|17966618|P2|Overall Study|Disease Progression|1
5204980|NCT01067469|17966619|P1|Overall Study|Disease Progression|0
5204981|NCT01067469|17966618|P2|Overall Study|Withdrawal by Subject|1
5204982|NCT01067469|17966619|P1|Overall Study|Withdrawal by Subject|0
5204983|NCT01067352|17966651|P3|Overall Study|Physician Decision|0
5204984|NCT01067352|17966652|P2|Overall Study|Physician Decision|1
5204985|NCT01067352|17966653|P1|Overall Study|Physician Decision|0
5204986|NCT01067352|17966651|P3|Overall Study|Withdrawal by Subject|1
5204987|NCT01067352|17966652|P2|Overall Study|Withdrawal by Subject|2
5204988|NCT01067352|17966653|P1|Overall Study|Withdrawal by Subject|1
5204989|NCT01067339|17966669|P2|Overall Study|Withdrawal by Subject|5
5204990|NCT01067339|17966670|P1|Overall Study|Withdrawal by Subject|6
5204991|NCT01067326|17966680|P2|Overall Study|Early Study Termination|1
5204992|NCT01067326|17966681|P1|Overall Study|Early Study Termination|1
5204993|NCT01067326|17966680|P2|Overall Study|Withdrawal by Subject|0
5204994|NCT01067326|17966681|P1|Overall Study|Withdrawal by Subject|1
5204995|NCT01067326|17966680|P2|Overall Study|Adverse Event|2
5204996|NCT01067326|17966681|P1|Overall Study|Adverse Event|0
5204997|NCT01067144|17966695|P2|Follow-up|Death|1
5204998|NCT01067144|17966696|P1|Follow-up|Death|0
5204999|NCT01067144|17966695|P2|Follow-up|Surgery cancelled|1
5205000|NCT01067144|17966696|P1|Follow-up|Surgery cancelled|0
5205001|NCT01067144|17966695|P2|Follow-up|Withdrawal by Subject|14
5205002|NCT01067144|17966696|P1|Follow-up|Withdrawal by Subject|18
5205003|NCT01067144|17966695|P2|Follow-up|Censored owing to second surgery|28
5205004|NCT01067144|17966696|P1|Follow-up|Censored owing to second surgery|19
5205005|NCT01067144|17966695|P2|Follow-up|Lost to Follow-up|12
5205006|NCT01067144|17966696|P1|Follow-up|Lost to Follow-up|22
5205007|NCT01067144|17966695|P2|Treatment|Did not receive allocated intervention|7
5205008|NCT01067144|17966696|P1|Treatment|Did not receive allocated intervention|4
5205009|NCT01067105|17966712|P1|Overall Study|Other|31
5205010|NCT01067105|17966712|P1|Overall Study|Physician Decision|6
5205011|NCT01067105|17966712|P1|Overall Study|Lost to Follow-up|6
5205012|NCT01067105|17966712|P1|Overall Study|Withdrawal by Subject|36
5205013|NCT01067105|17966712|P1|Overall Study|Protocol Violation|48
5205014|NCT01067105|17966712|P1|Overall Study|Adverse Event|14
5205015|NCT01066936|17966729|P1|Overall Study|Withdrawal by Subject|4
5205016|NCT01066936|17966729|P1|Overall Study|Lost to Follow-up|3
5205017|NCT01066936|17966729|P1|Overall Study|Device revised/removed|1
5205018|NCT01066936|17966729|P1|Overall Study|Death|2
5205019|NCT01066923|17966765|P4|Overall Study|Withdrawal by Subject|8
5205020|NCT01066923|17966766|P3|Overall Study|Withdrawal by Subject|8
5205021|NCT01066923|17966767|P2|Overall Study|Withdrawal by Subject|3
5205022|NCT01066923|17966768|P1|Overall Study|Withdrawal by Subject|3
5205023|NCT01066897|17966792|P2|Overall Study|stopped study after developing the flu.|0
5205024|NCT01066897|17966793|P1|Overall Study|stopped study after developing the flu.|1
5205025|NCT01066897|17966792|P2|Overall Study|Withdrawal by Subject|0
5205026|NCT01066897|17966793|P1|Overall Study|Withdrawal by Subject|1
5205027|NCT01066871|17966807|P4|Overall Study|Other|2
5205028|NCT01066871|17966808|P3|Overall Study|Other|1
5205029|NCT01066871|17966809|P2|Overall Study|Other|2
5205030|NCT01066871|17966810|P1|Overall Study|Other|0
5205031|NCT01066871|17966807|P4|Overall Study|Withdrawal by Subject|0
5205032|NCT01066871|17966808|P3|Overall Study|Withdrawal by Subject|0
5205033|NCT01066871|17966809|P2|Overall Study|Withdrawal by Subject|1
5205034|NCT01066871|17966810|P1|Overall Study|Withdrawal by Subject|3
5205035|NCT01066871|17966807|P4|Overall Study|Lack of Efficacy|1
5205036|NCT01066871|17966808|P3|Overall Study|Lack of Efficacy|0
5205037|NCT01066871|17966809|P2|Overall Study|Lack of Efficacy|0
5205038|NCT01066871|17966810|P1|Overall Study|Lack of Efficacy|0
5205039|NCT01066871|17966807|P4|Overall Study|Protocol Violation|2
5205040|NCT01066871|17966808|P3|Overall Study|Protocol Violation|3
5205041|NCT01066871|17966809|P2|Overall Study|Protocol Violation|0
5205042|NCT01066871|17966810|P1|Overall Study|Protocol Violation|1
5205043|NCT01066871|17966807|P4|Overall Study|Lost to Follow-up|0
5205044|NCT01066871|17966808|P3|Overall Study|Lost to Follow-up|2
5205045|NCT01066871|17966809|P2|Overall Study|Lost to Follow-up|2
5205046|NCT01066871|17966810|P1|Overall Study|Lost to Follow-up|0
5205047|NCT01066819|17966874|P6|Overall Study|Other|0
5205048|NCT01066819|17966875|P5|Overall Study|Other|0
5205049|NCT01066819|17966876|P4|Overall Study|Other|0
5205050|NCT01066819|17966877|P3|Overall Study|Other|1
5205051|NCT01066819|17966878|P2|Overall Study|Other|1
5205052|NCT01066819|17966879|P1|Overall Study|Other|5
5205053|NCT01066819|17966874|P6|Overall Study|Treatment stopped|0
5205054|NCT01066819|17966875|P5|Overall Study|Treatment stopped|0
5205055|NCT01066819|17966876|P4|Overall Study|Treatment stopped|1
5205056|NCT01066819|17966877|P3|Overall Study|Treatment stopped|2
5205057|NCT01066819|17966878|P2|Overall Study|Treatment stopped|1
5205058|NCT01066819|17966879|P1|Overall Study|Treatment stopped|12
5205059|NCT01066819|17966874|P6|Overall Study|Treatment never started|2
5205060|NCT01066819|17966875|P5|Overall Study|Treatment never started|2
5205061|NCT01066819|17966876|P4|Overall Study|Treatment never started|3
5205062|NCT01066819|17966877|P3|Overall Study|Treatment never started|19
5205063|NCT01066819|17966878|P2|Overall Study|Treatment never started|19
5205064|NCT01066819|17966879|P1|Overall Study|Treatment never started|85
5205065|NCT01066819|17966874|P6|Overall Study|Spontaneous cure|0
5205066|NCT01066819|17966875|P5|Overall Study|Spontaneous cure|0
5205067|NCT01066819|17966876|P4|Overall Study|Spontaneous cure|0
5205068|NCT01066819|17966877|P3|Overall Study|Spontaneous cure|0
5205069|NCT01066819|17966878|P2|Overall Study|Spontaneous cure|0
5205070|NCT01066819|17966879|P1|Overall Study|Spontaneous cure|1
5205071|NCT01066819|17966874|P6|Overall Study|Screen failure|0
5205072|NCT01066819|17966875|P5|Overall Study|Screen failure|0
5205073|NCT01066819|17966876|P4|Overall Study|Screen failure|0
5205074|NCT01066819|17966877|P3|Overall Study|Screen failure|0
5205075|NCT01066819|17966878|P2|Overall Study|Screen failure|0
5205076|NCT01066819|17966879|P1|Overall Study|Screen failure|1
5205077|NCT01066819|17966874|P6|Overall Study|Results not available|0
5205078|NCT01066819|17966875|P5|Overall Study|Results not available|0
5205079|NCT01066819|17966876|P4|Overall Study|Results not available|0
5205080|NCT01066819|17966877|P3|Overall Study|Results not available|0
5205081|NCT01066819|17966878|P2|Overall Study|Results not available|0
5205082|NCT01066819|17966879|P1|Overall Study|Results not available|1
5205083|NCT01066819|17966874|P6|Overall Study|Relapse|0
5205084|NCT01066819|17966875|P5|Overall Study|Relapse|0
5205085|NCT01066819|17966876|P4|Overall Study|Relapse|0
5205086|NCT01066819|17966877|P3|Overall Study|Relapse|3
5205087|NCT01066819|17966878|P2|Overall Study|Relapse|4
5205088|NCT01066819|17966879|P1|Overall Study|Relapse|16
5205089|NCT01066819|17966874|P6|Overall Study|Not categorised|0
5205090|NCT01066819|17966875|P5|Overall Study|Not categorised|0
5205091|NCT01066819|17966876|P4|Overall Study|Not categorised|1
5205092|NCT01066819|17966877|P3|Overall Study|Not categorised|6
5205093|NCT01066819|17966878|P2|Overall Study|Not categorised|2
5205094|NCT01066819|17966879|P1|Overall Study|Not categorised|9
5205095|NCT01066819|17966874|P6|Overall Study|Non responders|1
5205096|NCT01066819|17966875|P5|Overall Study|Non responders|0
5205097|NCT01066819|17966876|P4|Overall Study|Non responders|2
5205098|NCT01066819|17966877|P3|Overall Study|Non responders|7
5205099|NCT01066819|17966878|P2|Overall Study|Non responders|2
5205100|NCT01066819|17966879|P1|Overall Study|Non responders|123
5205101|NCT01066819|17966874|P6|Overall Study|Miscellaneous|0
5205102|NCT01066819|17966875|P5|Overall Study|Miscellaneous|0
5205103|NCT01066819|17966876|P4|Overall Study|Miscellaneous|1
5205104|NCT01066819|17966877|P3|Overall Study|Miscellaneous|18
5205105|NCT01066819|17966878|P2|Overall Study|Miscellaneous|10
5205106|NCT01066819|17966879|P1|Overall Study|Miscellaneous|28
5205107|NCT01066819|17966874|P6|Overall Study|Lab test not done|0
5205108|NCT01066819|17966875|P5|Overall Study|Lab test not done|0
5205109|NCT01066819|17966876|P4|Overall Study|Lab test not done|1
5205110|NCT01066819|17966877|P3|Overall Study|Lab test not done|2
5205111|NCT01066819|17966878|P2|Overall Study|Lab test not done|0
5205112|NCT01066819|17966879|P1|Overall Study|Lab test not done|9
5205113|NCT01066819|17966874|P6|Overall Study|Failed to return|3
5205114|NCT01066819|17966875|P5|Overall Study|Failed to return|2
5205115|NCT01066819|17966876|P4|Overall Study|Failed to return|7
5205116|NCT01066819|17966877|P3|Overall Study|Failed to return|68
5205117|NCT01066819|17966878|P2|Overall Study|Failed to return|107
5205118|NCT01066819|17966879|P1|Overall Study|Failed to return|298
5205119|NCT01066819|17966874|P6|Overall Study|Early termination|0
5205120|NCT01066819|17966875|P5|Overall Study|Early termination|0
5205121|NCT01066819|17966876|P4|Overall Study|Early termination|0
5205122|NCT01066819|17966877|P3|Overall Study|Early termination|0
5205123|NCT01066819|17966878|P2|Overall Study|Early termination|0
5205124|NCT01066819|17966879|P1|Overall Study|Early termination|2
5205125|NCT01066819|17966874|P6|Overall Study|Not met inclusion/exclusion criteria|0
5205126|NCT01066819|17966875|P5|Overall Study|Not met inclusion/exclusion criteria|0
5205127|NCT01066819|17966876|P4|Overall Study|Not met inclusion/exclusion criteria|0
5205128|NCT01066819|17966877|P3|Overall Study|Not met inclusion/exclusion criteria|0
5205129|NCT01066819|17966878|P2|Overall Study|Not met inclusion/exclusion criteria|0
5205130|NCT01066819|17966879|P1|Overall Study|Not met inclusion/exclusion criteria|1
5205131|NCT01066819|17966874|P6|Overall Study|Administrative|0
5205132|NCT01066819|17966875|P5|Overall Study|Administrative|0
5205133|NCT01066819|17966876|P4|Overall Study|Administrative|0
5205134|NCT01066819|17966877|P3|Overall Study|Administrative|2
5205135|NCT01066819|17966878|P2|Overall Study|Administrative|4
5205136|NCT01066819|17966879|P1|Overall Study|Administrative|6
5205137|NCT01066819|17966874|P6|Overall Study|Withdrawal by Subject|0
5205138|NCT01066819|17966875|P5|Overall Study|Withdrawal by Subject|0
5205139|NCT01066819|17966876|P4|Overall Study|Withdrawal by Subject|0
5205140|NCT01066819|17966877|P3|Overall Study|Withdrawal by Subject|6
5205141|NCT01066819|17966878|P2|Overall Study|Withdrawal by Subject|11
5205142|NCT01066819|17966879|P1|Overall Study|Withdrawal by Subject|29
5205143|NCT01066819|17966874|P6|Overall Study|Protocol Violation|0
5205144|NCT01066819|17966875|P5|Overall Study|Protocol Violation|0
5205145|NCT01066819|17966876|P4|Overall Study|Protocol Violation|0
5205146|NCT01066819|17966877|P3|Overall Study|Protocol Violation|0
5205147|NCT01066819|17966878|P2|Overall Study|Protocol Violation|6
5205148|NCT01066819|17966879|P1|Overall Study|Protocol Violation|12
5205149|NCT01066819|17966874|P6|Overall Study|Physician Decision|0
5205150|NCT01066819|17966875|P5|Overall Study|Physician Decision|0
5205151|NCT01066819|17966876|P4|Overall Study|Physician Decision|0
5205152|NCT01066819|17966877|P3|Overall Study|Physician Decision|3
5205153|NCT01066819|17966878|P2|Overall Study|Physician Decision|2
5205154|NCT01066819|17966879|P1|Overall Study|Physician Decision|6
5205155|NCT01066819|17966874|P6|Overall Study|Lack of Efficacy|0
5205156|NCT01066819|17966875|P5|Overall Study|Lack of Efficacy|0
5205157|NCT01066819|17966876|P4|Overall Study|Lack of Efficacy|1
5205158|NCT01066819|17966877|P3|Overall Study|Lack of Efficacy|2
5205159|NCT01066819|17966878|P2|Overall Study|Lack of Efficacy|1
5205160|NCT01066819|17966879|P1|Overall Study|Lack of Efficacy|22
5205161|NCT01066819|17966874|P6|Overall Study|Death|0
5205162|NCT01066819|17966875|P5|Overall Study|Death|0
5205163|NCT01066819|17966876|P4|Overall Study|Death|0
5205164|NCT01066819|17966877|P3|Overall Study|Death|1
5205165|NCT01066819|17966878|P2|Overall Study|Death|0
5205166|NCT01066819|17966879|P1|Overall Study|Death|5
5205167|NCT01066819|17966874|P6|Overall Study|Adverse Event|0
5205168|NCT01066819|17966875|P5|Overall Study|Adverse Event|0
5205169|NCT01066819|17966876|P4|Overall Study|Adverse Event|0
5205170|NCT01066819|17966877|P3|Overall Study|Adverse Event|6
5205171|NCT01066819|17966878|P2|Overall Study|Adverse Event|1
5205172|NCT01066819|17966879|P1|Overall Study|Adverse Event|18
5205173|NCT01066793|17967020|P6|Overall Study|Treatment Stopped|0
5205174|NCT01066793|17967021|P5|Overall Study|Treatment Stopped|0
5205175|NCT01066793|17967022|P4|Overall Study|Treatment Stopped|1
5205176|NCT01066793|17967023|P3|Overall Study|Treatment Stopped|0
5205177|NCT01066793|17967024|P2|Overall Study|Treatment Stopped|1
5205178|NCT01066793|17967025|P1|Overall Study|Treatment Stopped|2
5205179|NCT01066793|17967020|P6|Overall Study|Treatment Never Started|0
5205180|NCT01066793|17967021|P5|Overall Study|Treatment Never Started|0
5205181|NCT01066793|17967022|P4|Overall Study|Treatment Never Started|1
5205182|NCT01066793|17967023|P3|Overall Study|Treatment Never Started|4
5205183|NCT01066793|17967024|P2|Overall Study|Treatment Never Started|5
5205184|NCT01066793|17967025|P1|Overall Study|Treatment Never Started|18
5205185|NCT01066793|17967020|P6|Overall Study|Treatment Interrupted|0
5205186|NCT01066793|17967021|P5|Overall Study|Treatment Interrupted|0
5205187|NCT01066793|17967022|P4|Overall Study|Treatment Interrupted|0
5205188|NCT01066793|17967023|P3|Overall Study|Treatment Interrupted|0
5205189|NCT01066793|17967024|P2|Overall Study|Treatment Interrupted|1
5205190|NCT01066793|17967025|P1|Overall Study|Treatment Interrupted|1
5205191|NCT01066793|17967020|P6|Overall Study|Result Not Available|0
5205192|NCT01066793|17967021|P5|Overall Study|Result Not Available|0
5205193|NCT01066793|17967022|P4|Overall Study|Result Not Available|0
5205194|NCT01066793|17967023|P3|Overall Study|Result Not Available|0
5205195|NCT01066793|17967024|P2|Overall Study|Result Not Available|0
5205196|NCT01066793|17967025|P1|Overall Study|Result Not Available|1
5205197|NCT01066793|17967020|P6|Overall Study|Relapse|0
5205198|NCT01066793|17967021|P5|Overall Study|Relapse|0
5205199|NCT01066793|17967022|P4|Overall Study|Relapse|3
5205200|NCT01066793|17967023|P3|Overall Study|Relapse|2
5205201|NCT01066793|17967024|P2|Overall Study|Relapse|8
5205202|NCT01066793|17967025|P1|Overall Study|Relapse|20
5205203|NCT01066793|17967020|P6|Overall Study|Other|0
5205204|NCT01066793|17967021|P5|Overall Study|Other|0
5205205|NCT01066793|17967022|P4|Overall Study|Other|2
5205206|NCT01066793|17967023|P3|Overall Study|Other|6
5205207|NCT01066793|17967024|P2|Overall Study|Other|5
5205208|NCT01066793|17967025|P1|Overall Study|Other|15
5205209|NCT01066793|17967020|P6|Overall Study|Non-responders|0
5205210|NCT01066793|17967021|P5|Overall Study|Non-responders|0
5205211|NCT01066793|17967022|P4|Overall Study|Non-responders|25
5205212|NCT01066793|17967023|P3|Overall Study|Non-responders|11
5205213|NCT01066793|17967024|P2|Overall Study|Non-responders|5
5205214|NCT01066793|17967025|P1|Overall Study|Non-responders|104
5205215|NCT01066793|17967020|P6|Overall Study|Miscellaneous|0
5205216|NCT01066793|17967021|P5|Overall Study|Miscellaneous|0
5205217|NCT01066793|17967022|P4|Overall Study|Miscellaneous|0
5205218|NCT01066793|17967023|P3|Overall Study|Miscellaneous|6
5205219|NCT01066793|17967024|P2|Overall Study|Miscellaneous|5
5205220|NCT01066793|17967025|P1|Overall Study|Miscellaneous|4
5205221|NCT01066793|17967020|P6|Overall Study|Lab test not done|0
5205222|NCT01066793|17967021|P5|Overall Study|Lab test not done|0
5205223|NCT01066793|17967022|P4|Overall Study|Lab test not done|1
5205224|NCT01066793|17967023|P3|Overall Study|Lab test not done|0
5205225|NCT01066793|17967024|P2|Overall Study|Lab test not done|0
5205226|NCT01066793|17967025|P1|Overall Study|Lab test not done|7
5205227|NCT01066793|17967020|P6|Overall Study|Early Termination|0
5205228|NCT01066793|17967021|P5|Overall Study|Early Termination|0
5205229|NCT01066793|17967022|P4|Overall Study|Early Termination|0
5205230|NCT01066793|17967023|P3|Overall Study|Early Termination|0
5205231|NCT01066793|17967024|P2|Overall Study|Early Termination|0
5205232|NCT01066793|17967025|P1|Overall Study|Early Termination|3
5205233|NCT01066793|17967020|P6|Overall Study|Withdrawal by Subject|0
5205234|NCT01066793|17967021|P5|Overall Study|Withdrawal by Subject|0
5205235|NCT01066793|17967022|P4|Overall Study|Withdrawal by Subject|0
5205236|NCT01066793|17967023|P3|Overall Study|Withdrawal by Subject|1
5205237|NCT01066793|17967024|P2|Overall Study|Withdrawal by Subject|4
5205238|NCT01066793|17967025|P1|Overall Study|Withdrawal by Subject|7
5205239|NCT01066793|17967020|P6|Overall Study|Protocol Violation|0
5205240|NCT01066793|17967021|P5|Overall Study|Protocol Violation|0
5205241|NCT01066793|17967022|P4|Overall Study|Protocol Violation|0
5205242|NCT01066793|17967023|P3|Overall Study|Protocol Violation|2
5205243|NCT01066793|17967024|P2|Overall Study|Protocol Violation|2
5205244|NCT01066793|17967025|P1|Overall Study|Protocol Violation|3
5205245|NCT01066793|17967020|P6|Overall Study|Physician Decision|0
5205246|NCT01066793|17967021|P5|Overall Study|Physician Decision|0
5205247|NCT01066793|17967022|P4|Overall Study|Physician Decision|0
5205248|NCT01066793|17967023|P3|Overall Study|Physician Decision|0
5205249|NCT01066793|17967024|P2|Overall Study|Physician Decision|0
5205250|NCT01066793|17967025|P1|Overall Study|Physician Decision|3
5205251|NCT01066793|17967020|P6|Overall Study|Lost to Follow-up|1
5205252|NCT01066793|17967021|P5|Overall Study|Lost to Follow-up|0
5205253|NCT01066793|17967022|P4|Overall Study|Lost to Follow-up|16
5205254|NCT01066793|17967023|P3|Overall Study|Lost to Follow-up|82
5205255|NCT01066793|17967024|P2|Overall Study|Lost to Follow-up|39
5205256|NCT01066793|17967025|P1|Overall Study|Lost to Follow-up|180
5205257|NCT01066793|17967020|P6|Overall Study|Lack of Efficacy|0
5205258|NCT01066793|17967021|P5|Overall Study|Lack of Efficacy|0
5205259|NCT01066793|17967022|P4|Overall Study|Lack of Efficacy|0
5205260|NCT01066793|17967023|P3|Overall Study|Lack of Efficacy|0
5205261|NCT01066793|17967024|P2|Overall Study|Lack of Efficacy|1
5205262|NCT01066793|17967025|P1|Overall Study|Lack of Efficacy|2
5205263|NCT01066793|17967020|P6|Overall Study|Death|0
5205264|NCT01066793|17967021|P5|Overall Study|Death|0
5205265|NCT01066793|17967022|P4|Overall Study|Death|0
5205266|NCT01066793|17967023|P3|Overall Study|Death|1
5205267|NCT01066793|17967024|P2|Overall Study|Death|1
5205268|NCT01066793|17967025|P1|Overall Study|Death|4
5205269|NCT01066780|17967165|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
5205270|NCT01066780|17967166|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
5205271|NCT01066585|17967196|P2|Overall Study|Withdrawal by Subject|3
5205272|NCT01066585|17967197|P1|Overall Study|Withdrawal by Subject|0
5205273|NCT01066585|17967196|P2|Overall Study|Protocol Violation|0
5205274|NCT01066585|17967197|P1|Overall Study|Protocol Violation|1
5205275|NCT01066546|17967209|P1|Overall Study|Study terminated by sponsor|5
5205276|NCT01066156|17967254|P1|Overall Study|Withdrawal by Subject|1
5205277|NCT01066156|17967254|P1|Overall Study|Lost to Follow-up|7
5205278|NCT01066156|17967254|P1|Overall Study|ineligible|2
5205279|NCT01066143|17967258|P1|Overall Study|ineligible for the study|8
5205280|NCT01066104|17967264|P2|Overall Study|Protocol Violation|0
5205281|NCT01066104|17967265|P1|Overall Study|Protocol Violation|1
5205282|NCT01066104|17967264|P2|Overall Study|Adverse Event|1
5205283|NCT01066104|17967265|P1|Overall Study|Adverse Event|1
5205284|NCT01066052|17967275|P2|Overall Study|Enrolled But Not Treated|0
5205285|NCT01066052|17967276|P1|Overall Study|Enrolled But Not Treated|3
5205286|NCT01066039|17967287|P1|Overall Study|Drug/Dose Adjustment Required|1
5205287|NCT01066039|17967287|P1|Overall Study|Failure to Control Blood Pressure|1
5205288|NCT01066039|17967287|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
5205289|NCT01066039|17967287|P1|Overall Study|Additional Antihypertensive Required|4
5205290|NCT01066039|17967287|P1|Overall Study|Dropout due to Insulin Administration|1
5205291|NCT01066039|17967287|P1|Overall Study|Investigator's Request|1
5205292|NCT01066039|17967287|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
5205293|NCT01066039|17967287|P1|Overall Study|Protocol Violation|2
5205294|NCT01066039|17967287|P1|Overall Study|Withdrawal by Subject|17
5205295|NCT01066039|17967287|P1|Overall Study|Adverse Event|6
5205296|NCT01066000|17967312|P1|Overall Study|Adverse Event|1
5205297|NCT01066000|17967312|P1|Overall Study|Withdrawal by Subject|1
5205298|NCT01066000|17967312|P1|Overall Study|Death|3
5205299|NCT01066000|17967312|P1|Overall Study|Protocol Violation|4
5205300|NCT01065844|17967323|P1|Overall Study|Adverse Event|5
5205301|NCT01065818|17967327|P1|Overall Study|Not a candidate for surgery|1
5205302|NCT01065818|17967327|P1|Overall Study|Withdrawal by Subject|1
5205303|NCT01065779|17967331|P1|Overall Study|Inclusion Criteria Violation|7
5205304|NCT01065779|17967331|P1|Overall Study|Failed to Follow-up|10
5205305|NCT01065779|17967331|P1|Overall Study|Not Administered With Study Drug|17
5205306|NCT01065779|17967331|P1|Overall Study|Non-enrollment Period Administration|10
5205307|NCT01065779|17967331|P1|Overall Study|Investigation Before Contract Date|37
5205308|NCT01065779|17967331|P1|Overall Study|Duplicate Investigation|1
5205309|NCT01065766|17967342|P1|Overall Study|Violated dosage/administration|25
5205310|NCT01065766|17967342|P1|Overall Study|Contraindication to administration|6
5205311|NCT01065766|17967342|P1|Overall Study|Assessed before the contracted date|1
5205312|NCT01065597|17967361|P1|Overall Study|Adverse Event|1
5205313|NCT01065454|17967408|P4|Follow up|study ongoing|41
5205314|NCT01065454|17967409|P3|Follow up|study ongoing|15
5205315|NCT01065454|17967410|P2|Follow up|study ongoing|22
5205316|NCT01065454|17967411|P1|Follow up|study ongoing|37
5205317|NCT01065454|17967408|P4|Follow up|Withdrawal by Subject|0
5205318|NCT01065454|17967409|P3|Follow up|Withdrawal by Subject|1
5205319|NCT01065454|17967410|P2|Follow up|Withdrawal by Subject|1
5205320|NCT01065454|17967411|P1|Follow up|Withdrawal by Subject|1
5205321|NCT01065454|17967408|P4|Follow up|Progressive disease|1
5205322|NCT01065454|17967409|P3|Follow up|Progressive disease|0
5205323|NCT01065454|17967410|P2|Follow up|Progressive disease|0
5205324|NCT01065454|17967411|P1|Follow up|Progressive disease|0
5205325|NCT01065454|17967408|P4|Follow up|Lost to Follow-up|1
5205326|NCT01065454|17967409|P3|Follow up|Lost to Follow-up|0
5205327|NCT01065454|17967410|P2|Follow up|Lost to Follow-up|0
5205328|NCT01065454|17967411|P1|Follow up|Lost to Follow-up|0
5205329|NCT01065454|17967408|P4|Follow up|Death|0
5205330|NCT01065454|17967409|P3|Follow up|Death|1
5205331|NCT01065454|17967410|P2|Follow up|Death|1
5205332|NCT01065454|17967411|P1|Follow up|Death|0
5205333|NCT01065454|17967408|P4|Follow up|Adverse Event|1
5205334|NCT01065454|17967409|P3|Follow up|Adverse Event|0
5205335|NCT01065454|17967410|P2|Follow up|Adverse Event|0
5205336|NCT01065454|17967411|P1|Follow up|Adverse Event|1
5205337|NCT01065454|17967408|P4|Treatment|Withdrawal by Subject|3
5205338|NCT01065454|17967409|P3|Treatment|Withdrawal by Subject|2
5205339|NCT01065454|17967410|P2|Treatment|Withdrawal by Subject|1
5205340|NCT01065454|17967411|P1|Treatment|Withdrawal by Subject|3
5205341|NCT01065454|17967408|P4|Treatment|Protocol Violation|0
5205342|NCT01065454|17967409|P3|Treatment|Protocol Violation|1
5205343|NCT01065454|17967410|P2|Treatment|Protocol Violation|0
5205344|NCT01065454|17967411|P1|Treatment|Protocol Violation|1
5205345|NCT01065454|17967408|P4|Treatment|Protocol Decision|2
5205346|NCT01065454|17967409|P3|Treatment|Protocol Decision|3
5205347|NCT01065454|17967410|P2|Treatment|Protocol Decision|0
5205348|NCT01065454|17967411|P1|Treatment|Protocol Decision|0
5205349|NCT01065454|17967408|P4|Treatment|Non-compliance|1
5205350|NCT01065454|17967409|P3|Treatment|Non-compliance|0
5205351|NCT01065454|17967410|P2|Treatment|Non-compliance|0
5205352|NCT01065454|17967411|P1|Treatment|Non-compliance|1
5205353|NCT01065454|17967408|P4|Treatment|Death|0
5205354|NCT01065454|17967409|P3|Treatment|Death|0
5205355|NCT01065454|17967410|P2|Treatment|Death|0
5205356|NCT01065454|17967411|P1|Treatment|Death|1
5205357|NCT01065454|17967408|P4|Treatment|Adverse Event|6
5205358|NCT01065454|17967409|P3|Treatment|Adverse Event|3
5205359|NCT01065454|17967410|P2|Treatment|Adverse Event|4
5205360|NCT01065454|17967411|P1|Treatment|Adverse Event|7
5205361|NCT01065350|17967534|P2|Overall Study|Received incorrect drug allocation|1
5205362|NCT01065350|17967535|P1|Overall Study|Received incorrect drug allocation|0
5205363|NCT01064947|17967596|P1|Overall Study|negative culture|41
5205364|NCT01064856|17967637|P4|Open-label (OL) Period|Other|7
5205365|NCT01064856|17967638|P3|Open-label (OL) Period|Other|7
5205366|NCT01064856|17967639|P2|Open-label (OL) Period|Other|0
5205367|NCT01064856|17967640|P1|Open-label (OL) Period|Other|0
5205368|NCT01064856|17967637|P4|Open-label (OL) Period|Lost to Follow-up|1
5205369|NCT01064856|17967638|P3|Open-label (OL) Period|Lost to Follow-up|2
5205370|NCT01064856|17967639|P2|Open-label (OL) Period|Lost to Follow-up|0
5205371|NCT01064856|17967640|P1|Open-label (OL) Period|Lost to Follow-up|0
5205372|NCT01064856|17967637|P4|Open-label (OL) Period|Consent withdrawn by participant|6
5205373|NCT01064856|17967638|P3|Open-label (OL) Period|Consent withdrawn by participant|5
5205374|NCT01064856|17967639|P2|Open-label (OL) Period|Consent withdrawn by participant|0
5205375|NCT01064856|17967640|P1|Open-label (OL) Period|Consent withdrawn by participant|0
5205376|NCT01064856|17967637|P4|Open-label (OL) Period|Adverse Event|6
5205377|NCT01064856|17967638|P3|Open-label (OL) Period|Adverse Event|12
5205378|NCT01064856|17967639|P2|Open-label (OL) Period|Adverse Event|0
5205379|NCT01064856|17967640|P1|Open-label (OL) Period|Adverse Event|0
5205380|NCT01064856|17967637|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
5205381|NCT01064856|17967638|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
5205382|NCT01064856|17967639|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
5205383|NCT01064856|17967640|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
5205384|NCT01064856|17967637|P4|Double-blind (DB) Period|Adverse Event|0
5205385|NCT01064856|17967638|P3|Double-blind (DB) Period|Adverse Event|0
5205386|NCT01064856|17967639|P2|Double-blind (DB) Period|Adverse Event|0
5205387|NCT01064856|17967640|P1|Double-blind (DB) Period|Adverse Event|1
5205388|NCT01064817|17967684|P2|Study Completion|Withdrawal by Subject|0
5205389|NCT01064817|17967685|P1|Study Completion|Withdrawal by Subject|1
5205390|NCT01064817|17967684|P2|Study Completion|Physician Decision|0
5205391|NCT01064817|17967685|P1|Study Completion|Physician Decision|1
5205392|NCT01064739|17967697|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
5205393|NCT01064687|17967768|P4|Overall Study|Treatment Noncompliance|0
5205394|NCT01064687|17967769|P3|Overall Study|Treatment Noncompliance|1
5205395|NCT01064687|17967770|P2|Overall Study|Treatment Noncompliance|1
5205396|NCT01064687|17967771|P1|Overall Study|Treatment Noncompliance|1
5205397|NCT01064687|17967768|P4|Overall Study|Withdrawal by Subject|5
5205398|NCT01064687|17967769|P3|Overall Study|Withdrawal by Subject|12
5205399|NCT01064687|17967770|P2|Overall Study|Withdrawal by Subject|7
5205400|NCT01064687|17967771|P1|Overall Study|Withdrawal by Subject|9
5205401|NCT01064687|17967768|P4|Overall Study|Sponsor Decision|0
5205402|NCT01064687|17967769|P3|Overall Study|Sponsor Decision|3
5205403|NCT01064687|17967770|P2|Overall Study|Sponsor Decision|0
5205404|NCT01064687|17967771|P1|Overall Study|Sponsor Decision|0
5205405|NCT01064687|17967768|P4|Overall Study|Protocol Violation|1
5205406|NCT01064687|17967769|P3|Overall Study|Protocol Violation|0
5205407|NCT01064687|17967770|P2|Overall Study|Protocol Violation|1
5205408|NCT01064687|17967771|P1|Overall Study|Protocol Violation|1
5205409|NCT01064687|17967768|P4|Overall Study|Physician Decision|0
5205410|NCT01064687|17967769|P3|Overall Study|Physician Decision|0
5205411|NCT01064687|17967770|P2|Overall Study|Physician Decision|2
5205412|NCT01064687|17967771|P1|Overall Study|Physician Decision|2
5205413|NCT01064687|17967768|P4|Overall Study|Lost to Follow-up|5
5205414|NCT01064687|17967769|P3|Overall Study|Lost to Follow-up|13
5205415|NCT01064687|17967770|P2|Overall Study|Lost to Follow-up|10
5205416|NCT01064687|17967771|P1|Overall Study|Lost to Follow-up|7
5205417|NCT01064687|17967768|P4|Overall Study|Lack of Efficacy|3
5205418|NCT01064687|17967769|P3|Overall Study|Lack of Efficacy|2
5205419|NCT01064687|17967770|P2|Overall Study|Lack of Efficacy|0
5205420|NCT01064687|17967771|P1|Overall Study|Lack of Efficacy|1
5205421|NCT01064687|17967768|P4|Overall Study|Entry Criteria Not Met|0
5205422|NCT01064687|17967769|P3|Overall Study|Entry Criteria Not Met|0
5205423|NCT01064687|17967770|P2|Overall Study|Entry Criteria Not Met|0
5205424|NCT01064687|17967771|P1|Overall Study|Entry Criteria Not Met|3
5205425|NCT01064687|17967768|P4|Overall Study|Death|0
5205426|NCT01064687|17967769|P3|Overall Study|Death|0
5205427|NCT01064687|17967770|P2|Overall Study|Death|1
5205428|NCT01064687|17967771|P1|Overall Study|Death|1
5205429|NCT01064687|17967768|P4|Overall Study|Adverse Event|3
5205430|NCT01064687|17967769|P3|Overall Study|Adverse Event|10
5205431|NCT01064687|17967770|P2|Overall Study|Adverse Event|4
5205432|NCT01064687|17967771|P1|Overall Study|Adverse Event|9
5205433|NCT01064648|17967951|P4|Phase II|Under Review|0
5205434|NCT01064648|17967952|P3|Phase II|Under Review|2
5205435|NCT01064648|17967953|P2|Phase II|Under Review|0
5205436|NCT01064648|17967954|P1|Phase II|Under Review|0
5205437|NCT01064648|17967951|P4|Phase II|Non-protocol specified|3
5205438|NCT01064648|17967952|P3|Phase II|Non-protocol specified|5
5205439|NCT01064648|17967953|P2|Phase II|Non-protocol specified|0
5205440|NCT01064648|17967954|P1|Phase II|Non-protocol specified|0
5205441|NCT01064648|17967951|P4|Phase II|Progression|27
5205442|NCT01064648|17967952|P3|Phase II|Progression|21
5205443|NCT01064648|17967953|P2|Phase II|Progression|0
5205444|NCT01064648|17967954|P1|Phase II|Progression|0
5205445|NCT01064648|17967951|P4|Phase II|Withdrawal by Subject|5
5205446|NCT01064648|17967952|P3|Phase II|Withdrawal by Subject|2
5205447|NCT01064648|17967953|P2|Phase II|Withdrawal by Subject|0
5205448|NCT01064648|17967954|P1|Phase II|Withdrawal by Subject|0
5205449|NCT01064648|17967951|P4|Phase II|Death|5
5205450|NCT01064648|17967952|P3|Phase II|Death|4
5205451|NCT01064648|17967953|P2|Phase II|Death|0
5205452|NCT01064648|17967954|P1|Phase II|Death|0
5205453|NCT01064648|17967951|P4|Phase II|Adverse Event|8
5205454|NCT01064648|17967952|P3|Phase II|Adverse Event|15
5205455|NCT01064648|17967953|P2|Phase II|Adverse Event|0
5205456|NCT01064648|17967954|P1|Phase II|Adverse Event|0
5205457|NCT01064648|17967951|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
5205458|NCT01064648|17967952|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
5205459|NCT01064648|17967953|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
5205460|NCT01064648|17967954|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
5205461|NCT01064648|17967951|P4|Phase I Cohort 2: Dose Level 2|Progression|0
5205462|NCT01064648|17967952|P3|Phase I Cohort 2: Dose Level 2|Progression|0
5205463|NCT01064648|17967953|P2|Phase I Cohort 2: Dose Level 2|Progression|5
5205464|NCT01064648|17967954|P1|Phase I Cohort 2: Dose Level 2|Progression|0
5205465|NCT01064648|17967951|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
5205466|NCT01064648|17967952|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
5205467|NCT01064648|17967953|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
5205468|NCT01064648|17967954|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
5205469|NCT01064648|17967951|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
5205470|NCT01064648|17967952|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
5205471|NCT01064648|17967953|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
5205472|NCT01064648|17967954|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
5205473|NCT01064648|17967951|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
5205474|NCT01064648|17967952|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
5205475|NCT01064648|17967953|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
5205476|NCT01064648|17967954|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
5205477|NCT01064648|17967951|P4|Phase I Cohort1: Dose Level 1|Progression|0
5205478|NCT01064648|17967952|P3|Phase I Cohort1: Dose Level 1|Progression|0
5205479|NCT01064648|17967953|P2|Phase I Cohort1: Dose Level 1|Progression|0
5205480|NCT01064648|17967954|P1|Phase I Cohort1: Dose Level 1|Progression|5
5205481|NCT01064622|17967980|P2|Randomized Phase II|Protocol Violation|1
5205482|NCT01064622|17967981|P1|Randomized Phase II|Protocol Violation|0
5205483|NCT01064622|17967980|P2|Randomized Phase II|Withdrawal by Subject|2
5205484|NCT01064622|17967981|P1|Randomized Phase II|Withdrawal by Subject|2
5205485|NCT01064531|17968004|P2|Overall Study|Death|1
5205486|NCT01064531|17968005|P1|Overall Study|Death|0
5205487|NCT01064531|17968004|P2|Overall Study|Revision due to dislocation|1
5205488|NCT01064531|17968005|P1|Overall Study|Revision due to dislocation|0
5205489|NCT01064531|17968004|P2|Overall Study|Revision due to femoral stem loosening|0
5205490|NCT01064531|17968005|P1|Overall Study|Revision due to femoral stem loosening|1
5205491|NCT01064531|17968004|P2|Overall Study|Withdrawal by Subject|2
5205492|NCT01064531|17968005|P1|Overall Study|Withdrawal by Subject|2
5205493|NCT01064531|17968004|P2|Overall Study|Physician Decision|1
5205494|NCT01064531|17968005|P1|Overall Study|Physician Decision|0
5205495|NCT01064531|17968004|P2|Overall Study|Lost to Follow-up|2
5205496|NCT01064531|17968005|P1|Overall Study|Lost to Follow-up|0
5205497|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Other|1
5205498|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Other|2
5205499|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Other|5
5205500|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
5205501|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5205502|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
5205503|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5205504|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5205505|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
5205506|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5205507|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5205508|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5205509|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
5205510|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
5205511|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
5205512|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5205513|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5205514|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5205515|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Death|0
5205516|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Death|1
5205517|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Death|0
5205518|NCT01064414|17968052|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
5205519|NCT01064414|17968053|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5205520|NCT01064414|17968054|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
5205521|NCT01064414|17968052|P3|Core Period: Baseline to Week 26|Other|2
5205522|NCT01064414|17968053|P2|Core Period: Baseline to Week 26|Other|7
5205523|NCT01064414|17968054|P1|Core Period: Baseline to Week 26|Other|4
5205524|NCT01064414|17968052|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5205525|NCT01064414|17968053|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5205526|NCT01064414|17968054|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5205527|NCT01064414|17968052|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
5205528|NCT01064414|17968053|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
5205529|NCT01064414|17968054|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
5205530|NCT01064414|17968052|P3|Core Period: Baseline to Week 26|Protocol Violation|1
5205531|NCT01064414|17968053|P2|Core Period: Baseline to Week 26|Protocol Violation|0
5205532|NCT01064414|17968054|P1|Core Period: Baseline to Week 26|Protocol Violation|1
5205533|NCT01064414|17968052|P3|Core Period: Baseline to Week 26|Death|0
5205534|NCT01064414|17968053|P2|Core Period: Baseline to Week 26|Death|1
5205535|NCT01064414|17968054|P1|Core Period: Baseline to Week 26|Death|0
5205536|NCT01064414|17968052|P3|Core Period: Baseline to Week 26|Adverse Event|2
5205537|NCT01064414|17968053|P2|Core Period: Baseline to Week 26|Adverse Event|4
5205538|NCT01064414|17968054|P1|Core Period: Baseline to Week 26|Adverse Event|4
5205539|NCT01064401|17968073|P2|Overall Study|Other|1
5205540|NCT01064401|17968074|P1|Overall Study|Other|2
5205541|NCT01064401|17968073|P2|Overall Study|Site Closure|5
5205542|NCT01064401|17968074|P1|Overall Study|Site Closure|4
5205543|NCT01064401|17968073|P2|Overall Study|Noncompliance|8
5205544|NCT01064401|17968074|P1|Overall Study|Noncompliance|7
5205545|NCT01064401|17968073|P2|Overall Study|Pregnancy|7
5205546|NCT01064401|17968074|P1|Overall Study|Pregnancy|4
5205547|NCT01064401|17968073|P2|Overall Study|Death|0
5205548|NCT01064401|17968074|P1|Overall Study|Death|4
5205549|NCT01064401|17968073|P2|Overall Study|Investigator Decision|6
5205550|NCT01064401|17968074|P1|Overall Study|Investigator Decision|4
5205551|NCT01064401|17968073|P2|Overall Study|Consent Withdrawn|80
5205552|NCT01064401|17968074|P1|Overall Study|Consent Withdrawn|98
5205553|NCT01064401|17968073|P2|Overall Study|Lost to Follow-up|9
5205554|NCT01064401|17968074|P1|Overall Study|Lost to Follow-up|12
5205555|NCT01064401|17968073|P2|Overall Study|Lack of Efficacy|23
5205556|NCT01064401|17968074|P1|Overall Study|Lack of Efficacy|46
5205557|NCT01064401|17968073|P2|Overall Study|Adverse Event|56
5205558|NCT01064401|17968074|P1|Overall Study|Adverse Event|47
5205559|NCT01064310|17968123|P3|Open Label Pazopinib|Physician Decision|20
5205560|NCT01064310|17968124|P2|Open Label Pazopinib|Physician Decision|0
5205561|NCT01064310|17968125|P1|Open Label Pazopinib|Physician Decision|0
5205562|NCT01064310|17968123|P3|Open Label Pazopinib|Lack of Efficacy|51
5205563|NCT01064310|17968124|P2|Open Label Pazopinib|Lack of Efficacy|0
5205564|NCT01064310|17968125|P1|Open Label Pazopinib|Lack of Efficacy|0
5205565|NCT01064310|17968123|P3|Open Label Pazopinib|Adverse Event|12
5205566|NCT01064310|17968124|P2|Open Label Pazopinib|Adverse Event|0
5205567|NCT01064310|17968125|P1|Open Label Pazopinib|Adverse Event|0
5205568|NCT01064310|17968123|P3|Open Label Pazopinib|Withdrawal by Subject|1
5205569|NCT01064310|17968124|P2|Open Label Pazopinib|Withdrawal by Subject|0
5205570|NCT01064310|17968125|P1|Open Label Pazopinib|Withdrawal by Subject|0
5205571|NCT01064310|17968123|P3|Period 2|Lack of Efficacy|0
5205572|NCT01064310|17968124|P2|Period 2|Lack of Efficacy|4
5205573|NCT01064310|17968125|P1|Period 2|Lack of Efficacy|1
5205574|NCT01064310|17968123|P3|Period 2|Entered Open-label Period|0
5205575|NCT01064310|17968124|P2|Period 2|Entered Open-label Period|0
5205576|NCT01064310|17968125|P1|Period 2|Entered Open-label Period|1
5205577|NCT01064310|17968123|P3|Period 2|Physician Decision|0
5205578|NCT01064310|17968124|P2|Period 2|Physician Decision|1
5205579|NCT01064310|17968125|P1|Period 2|Physician Decision|0
5205580|NCT01064310|17968123|P3|Period 2|Adverse Event|0
5205581|NCT01064310|17968124|P2|Period 2|Adverse Event|1
5205582|NCT01064310|17968125|P1|Period 2|Adverse Event|2
5205583|NCT01064310|17968123|P3|Period 1|Entered Open-label Period|0
5205584|NCT01064310|17968124|P2|Period 1|Entered Open-label Period|1
5205585|NCT01064310|17968125|P1|Period 1|Entered Open-label Period|1
5205586|NCT01064310|17968123|P3|Period 1|Lack of Efficacy|0
5205587|NCT01064310|17968124|P2|Period 1|Lack of Efficacy|5
5205588|NCT01064310|17968125|P1|Period 1|Lack of Efficacy|3
5205589|NCT01064310|17968123|P3|Period 1|Withdrawal by Subject|0
5205590|NCT01064310|17968124|P2|Period 1|Withdrawal by Subject|2
5205591|NCT01064310|17968125|P1|Period 1|Withdrawal by Subject|2
5205592|NCT01064310|17968123|P3|Period 1|Physician Decision|0
5205593|NCT01064310|17968124|P2|Period 1|Physician Decision|0
5205594|NCT01064310|17968125|P1|Period 1|Physician Decision|1
5205595|NCT01064310|17968123|P3|Period 1|Adverse Event|0
5205596|NCT01064310|17968124|P2|Period 1|Adverse Event|10
5205597|NCT01064310|17968125|P1|Period 1|Adverse Event|7
5205598|NCT01064297|17968155|P3|Overall Study|Lost to Follow-up|133
5205599|NCT01064297|17968156|P2|Overall Study|Lost to Follow-up|48
5205600|NCT01064297|17968157|P1|Overall Study|Lost to Follow-up|791
5205601|NCT01064167|17968226|P2|Overall Study|Protocol Violation|15
5205602|NCT01064167|17968227|P1|Overall Study|Protocol Violation|14
5205603|NCT01063972|17968242|P2|Overall Study|Incarcerated|1
5205604|NCT01063972|17968243|P1|Overall Study|Incarcerated|2
5205605|NCT01063972|17968242|P2|Overall Study|Death|11
5205606|NCT01063972|17968243|P1|Overall Study|Death|12
5205607|NCT01063881|17968293|P3|Overall Study|Reason for not completed not specified|0
5205608|NCT01063881|17968294|P2|Overall Study|Reason for not completed not specified|1
5205609|NCT01063881|17968295|P1|Overall Study|Reason for not completed not specified|5
5205610|NCT01063881|17968293|P3|Overall Study|Withdrawal by Subject|0
5205611|NCT01063881|17968294|P2|Overall Study|Withdrawal by Subject|1
5205612|NCT01063881|17968295|P1|Overall Study|Withdrawal by Subject|25
5205613|NCT01063881|17968293|P3|Overall Study|Lost to Follow-up|1
5205614|NCT01063881|17968294|P2|Overall Study|Lost to Follow-up|7
5205615|NCT01063881|17968295|P1|Overall Study|Lost to Follow-up|13
5205616|NCT01063881|17968293|P3|Overall Study|Adverse Event|0
5205617|NCT01063881|17968294|P2|Overall Study|Adverse Event|2
5205618|NCT01063881|17968295|P1|Overall Study|Adverse Event|12
5205619|NCT01063868|17968319|P2|Overall Study|Study Terminated By Sponsor|4
5205620|NCT01063868|17968320|P1|Overall Study|Study Terminated By Sponsor|23
5205621|NCT01063868|17968319|P2|Overall Study|Withdrawal by Subject|1
5205622|NCT01063868|17968320|P1|Overall Study|Withdrawal by Subject|3
5205623|NCT01063868|17968319|P2|Overall Study|Adverse Event|7
5205624|NCT01063868|17968320|P1|Overall Study|Adverse Event|9
5205625|NCT01063855|17968328|P2|Overall Study|Reason not specified|11
5205626|NCT01063855|17968329|P1|Overall Study|Reason not specified|13
5205627|NCT01063855|17968328|P2|Overall Study|Withdrawal by Subject|8
5205628|NCT01063855|17968329|P1|Overall Study|Withdrawal by Subject|11
5205629|NCT01063855|17968328|P2|Overall Study|Lack of Efficacy|1
5205630|NCT01063855|17968329|P1|Overall Study|Lack of Efficacy|0
5205631|NCT01063855|17968328|P2|Overall Study|Pregnancy|0
5205632|NCT01063855|17968329|P1|Overall Study|Pregnancy|1
5205633|NCT01063855|17968328|P2|Overall Study|Lost to Follow-up|4
5205634|NCT01063855|17968329|P1|Overall Study|Lost to Follow-up|8
5205635|NCT01063855|17968328|P2|Overall Study|Death|1
5205636|NCT01063855|17968329|P1|Overall Study|Death|0
5205637|NCT01063855|17968328|P2|Overall Study|Adverse Event|4
5205638|NCT01063855|17968329|P1|Overall Study|Adverse Event|4
5205639|NCT01063764|17968376|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
5205640|NCT01063764|17968376|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
5205641|NCT01063764|17968376|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
5205642|NCT01063764|17968376|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
5205643|NCT01063764|17968376|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
5205644|NCT01063764|17968376|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
5205645|NCT01063764|17968376|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
5205646|NCT01063595|17968395|P2|First Intervention|Reason not Specified|1
5205647|NCT01063595|17968396|P1|First Intervention|Reason not Specified|0
5205648|NCT01063595|17968395|P2|First Intervention|Withdrawal by Subject|0
5205649|NCT01063595|17968396|P1|First Intervention|Withdrawal by Subject|1
5205650|NCT01063595|17968395|P2|First Intervention|Adverse Event|4
5205651|NCT01063595|17968396|P1|First Intervention|Adverse Event|1
5205652|NCT01063595|17968395|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
5205653|NCT01063595|17968396|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
5205654|NCT01063595|17968395|P2|Enrolled in Study and Randomized|Adverse Event|1
5205655|NCT01063595|17968396|P1|Enrolled in Study and Randomized|Adverse Event|0
5205656|NCT01063595|17968395|P2|Enrolled in Study and Randomized|Reason not Specified|0
5205657|NCT01063595|17968396|P1|Enrolled in Study and Randomized|Reason not Specified|1
5205658|NCT01063517|17968408|P2|Overall Study|Death|48
5205659|NCT01063517|17968409|P1|Overall Study|Death|33
5205660|NCT01063517|17968408|P2|Overall Study|Withdrawal by Subject|2
5205661|NCT01063517|17968409|P1|Overall Study|Withdrawal by Subject|1
5205662|NCT01063517|17968408|P2|Overall Study|Lost to Follow-up|3
5205663|NCT01063517|17968409|P1|Overall Study|Lost to Follow-up|4
5205664|NCT01063517|17968408|P2|Overall Study|Study reached data cut-off|7
5205665|NCT01063517|17968409|P1|Overall Study|Study reached data cut-off|19
5205666|NCT01063517|17968408|P2|Overall Study|Consent withdrawal|0
5205667|NCT01063517|17968409|P1|Overall Study|Consent withdrawal|1
5205668|NCT01063348|17968449|P2|Overall Study|Lost to Follow-up|10
5205669|NCT01063348|17968450|P1|Overall Study|Lost to Follow-up|3
5205670|NCT01063283|17968460|P3|Cycle 1|Technical failure in data collection|0
5205671|NCT01063283|17968461|P2|Cycle 1|Technical failure in data collection|0
5205672|NCT01063283|17968462|P1|Cycle 1|Technical failure in data collection|1
5205673|NCT01063283|17968460|P3|Cycle 1|Adverse Event|0
5205674|NCT01063283|17968461|P2|Cycle 1|Adverse Event|0
5205675|NCT01063283|17968462|P1|Cycle 1|Adverse Event|2
5205676|NCT01063153|17968476|P2|Overall Study|Physician Decision|4
5205677|NCT01063153|17968477|P1|Overall Study|Physician Decision|0
5205678|NCT01063153|17968476|P2|Overall Study|Withdrawal by Subject|1
5205679|NCT01063153|17968477|P1|Overall Study|Withdrawal by Subject|0
5205680|NCT01063153|17968476|P2|Overall Study|Lost to Follow-up|7
5205681|NCT01063153|17968477|P1|Overall Study|Lost to Follow-up|0
5205682|NCT01063153|17968476|P2|Overall Study|Found Ineligible During Screening|0
5205683|NCT01063153|17968477|P1|Overall Study|Found Ineligible During Screening|2
5205684|NCT01063062|17968508|P2|Overall Study|Miscellaneous reason|1
5205685|NCT01063062|17968509|P1|Overall Study|Miscellaneous reason|0
5205686|NCT01063062|17968508|P2|Overall Study|Lost to Follow-up|2
5205687|NCT01063062|17968509|P1|Overall Study|Lost to Follow-up|0
5205688|NCT01063062|17968508|P2|Overall Study|Investigator's request|0
5205689|NCT01063062|17968509|P1|Overall Study|Investigator's request|1
5205690|NCT01063062|17968508|P2|Overall Study|Protocol Violation|4
5205691|NCT01063062|17968509|P1|Overall Study|Protocol Violation|5
5205692|NCT01063062|17968508|P2|Overall Study|Adverse Event|4
5205693|NCT01063062|17968509|P1|Overall Study|Adverse Event|2
5205694|NCT01063062|17968508|P2|Overall Study|Patient withdrew consent|1
5205695|NCT01063062|17968509|P1|Overall Study|Patient withdrew consent|0
5205696|NCT01063036|17968563|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
5205697|NCT01063036|17968563|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
5205698|NCT01063036|17968563|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
5205699|NCT01063036|17968563|P1|Participants Treated With Study Drug|Pregnancy|1
5205700|NCT01063036|17968563|P1|Participants Treated With Study Drug|Lost to Follow-up|1
5205701|NCT01063036|17968563|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
5205702|NCT01063036|17968563|P1|Participants Treated With Study Drug|Protocol Violation|1
5205703|NCT01063036|17968563|P1|Participants Treated With Study Drug|Adverse Event|1
5205704|NCT01062971|17968579|P2|Overall Study|Lost to Follow-up|4
5205705|NCT01062971|17968580|P1|Overall Study|Lost to Follow-up|3
5205706|NCT01062971|17968579|P2|Overall Study|Protocol Violation|3
5205707|NCT01062971|17968580|P1|Overall Study|Protocol Violation|1
5205708|NCT01062841|17968619|P2|Overall Study|Withdrawal by Study|0
5205709|NCT01062841|17968620|P1|Overall Study|Withdrawal by Study|3
5205710|NCT01062841|17968619|P2|Overall Study|Withdrawal by Subject|0
5205711|NCT01062841|17968620|P1|Overall Study|Withdrawal by Subject|2
5205712|NCT01062841|17968619|P2|Overall Study|Death|5
5205713|NCT01062841|17968620|P1|Overall Study|Death|3
5205714|NCT01062841|17968619|P2|Overall Study|Indwelling Device Removed|48
5205715|NCT01062841|17968620|P1|Overall Study|Indwelling Device Removed|41
5205716|NCT01062763|17968650|P2|Overall Study|Adverse Event|4
5205717|NCT01062763|17968651|P1|Overall Study|Adverse Event|3
5205718|NCT01062425|17968677|P2|Overall Study|Protocol Violation|6
5205719|NCT01062425|17968678|P1|Overall Study|Protocol Violation|3
5205720|NCT01062399|17968695|P5|Overall Study|Protocol Violation|4
5205721|NCT01062399|17968696|P4|Overall Study|Protocol Violation|6
5205722|NCT01062399|17968697|P3|Overall Study|Protocol Violation|0
5205723|NCT01062399|17968698|P2|Overall Study|Protocol Violation|1
5205724|NCT01062399|17968699|P1|Overall Study|Protocol Violation|0
5205725|NCT01062256|17968743|P3|Overall Study|Administrative|0
5205726|NCT01062256|17968744|P2|Overall Study|Administrative|2
5205727|NCT01062256|17968745|P1|Overall Study|Administrative|0
5205728|NCT01062256|17968743|P3|Overall Study|Ineligible|3
5205729|NCT01062256|17968744|P2|Overall Study|Ineligible|4
5205730|NCT01062256|17968745|P1|Overall Study|Ineligible|1
5205731|NCT01062256|17968743|P3|Overall Study|Withdrawal by Subject|1
5205732|NCT01062256|17968744|P2|Overall Study|Withdrawal by Subject|1
5205733|NCT01062256|17968745|P1|Overall Study|Withdrawal by Subject|1
5205734|NCT01062256|17968743|P3|Overall Study|Adverse Event|0
5205735|NCT01062256|17968744|P2|Overall Study|Adverse Event|0
5205736|NCT01062256|17968745|P1|Overall Study|Adverse Event|1
5205737|NCT01062126|17968776|P1|Overall Study|All Withdrawals|324
5205738|NCT01062126|17968776|P1|Overall Study|Death|209
5205739|NCT01062113|17968783|P3|Overall Study|Withdrawal by Subject|0
5205740|NCT01062113|17968784|P2|Overall Study|Withdrawal by Subject|0
5205741|NCT01062113|17968785|P1|Overall Study|Withdrawal by Subject|1
5205742|NCT01062113|17968783|P3|Overall Study|Lack of Efficacy|31
5205743|NCT01062113|17968784|P2|Overall Study|Lack of Efficacy|22
5205744|NCT01062113|17968785|P1|Overall Study|Lack of Efficacy|38
5205745|NCT01062113|17968783|P3|Overall Study|Adverse Event|0
5205746|NCT01062113|17968784|P2|Overall Study|Adverse Event|0
5205747|NCT01062113|17968785|P1|Overall Study|Adverse Event|1
5205748|NCT01062061|17968803|P1|Overall Study|Failed to meet inclusion criteria|2
5205749|NCT01062061|17968803|P1|Overall Study|Outside chief indications|10
5205750|NCT01062061|17968803|P1|Overall Study|Investigated before study start|13
5205751|NCT01062061|17968803|P1|Overall Study|Enrolled more than once|2
5205752|NCT01061866|17968842|P1|Overall Study|Adverse Event|2
5205753|NCT01061775|17968846|P1|Overall Study|Lost to Follow-up|1
5205754|NCT01061775|17968846|P1|Overall Study|Physician Decision|2
5205755|NCT01061736|17968863|P10|Overall Study|Other than specified above|21
5205756|NCT01061736|17968864|P9|Overall Study|Other than specified above|15
5205757|NCT01061736|17968865|P8|Overall Study|Other than specified above|18
5205758|NCT01061736|17968866|P7|Overall Study|Other than specified above|0
5205759|NCT01061736|17968867|P6|Overall Study|Other than specified above|0
5205760|NCT01061736|17968868|P5|Overall Study|Other than specified above|1
5205761|NCT01061736|17968869|P4|Overall Study|Other than specified above|0
5205762|NCT01061736|17968870|P3|Overall Study|Other than specified above|2
5205763|NCT01061736|17968871|P2|Overall Study|Other than specified above|1
5205764|NCT01061736|17968872|P1|Overall Study|Other than specified above|0
5205765|NCT01061736|17968863|P10|Overall Study|Not treated|0
5205766|NCT01061736|17968864|P9|Overall Study|Not treated|1
5205767|NCT01061736|17968865|P8|Overall Study|Not treated|2
5205768|NCT01061736|17968866|P7|Overall Study|Not treated|0
5205769|NCT01061736|17968867|P6|Overall Study|Not treated|0
5205770|NCT01061736|17968868|P5|Overall Study|Not treated|1
5205771|NCT01061736|17968869|P4|Overall Study|Not treated|0
5205772|NCT01061736|17968870|P3|Overall Study|Not treated|0
5205773|NCT01061736|17968871|P2|Overall Study|Not treated|0
5205774|NCT01061736|17968872|P1|Overall Study|Not treated|0
5205775|NCT01061736|17968863|P10|Overall Study|Poor compliance to protocol|9
5205776|NCT01061736|17968864|P9|Overall Study|Poor compliance to protocol|5
5205777|NCT01061736|17968865|P8|Overall Study|Poor compliance to protocol|2
5205778|NCT01061736|17968866|P7|Overall Study|Poor compliance to protocol|0
5205779|NCT01061736|17968867|P6|Overall Study|Poor compliance to protocol|0
5205780|NCT01061736|17968868|P5|Overall Study|Poor compliance to protocol|0
5205781|NCT01061736|17968869|P4|Overall Study|Poor compliance to protocol|0
5205782|NCT01061736|17968870|P3|Overall Study|Poor compliance to protocol|0
5205783|NCT01061736|17968871|P2|Overall Study|Poor compliance to protocol|0
5205784|NCT01061736|17968872|P1|Overall Study|Poor compliance to protocol|0
5205785|NCT01061736|17968863|P10|Overall Study|Lack of Efficacy|10
5205786|NCT01061736|17968864|P9|Overall Study|Lack of Efficacy|9
5205787|NCT01061736|17968865|P8|Overall Study|Lack of Efficacy|9
5205788|NCT01061736|17968866|P7|Overall Study|Lack of Efficacy|1
5205789|NCT01061736|17968867|P6|Overall Study|Lack of Efficacy|2
5205790|NCT01061736|17968868|P5|Overall Study|Lack of Efficacy|1
5205791|NCT01061736|17968869|P4|Overall Study|Lack of Efficacy|1
5205792|NCT01061736|17968870|P3|Overall Study|Lack of Efficacy|1
5205793|NCT01061736|17968871|P2|Overall Study|Lack of Efficacy|2
5205794|NCT01061736|17968872|P1|Overall Study|Lack of Efficacy|0
5205795|NCT01061736|17968863|P10|Overall Study|Adverse Event|34
5205796|NCT01061736|17968864|P9|Overall Study|Adverse Event|67
5205797|NCT01061736|17968865|P8|Overall Study|Adverse Event|63
5205798|NCT01061736|17968866|P7|Overall Study|Adverse Event|4
5205799|NCT01061736|17968867|P6|Overall Study|Adverse Event|1
5205800|NCT01061736|17968868|P5|Overall Study|Adverse Event|4
5205801|NCT01061736|17968869|P4|Overall Study|Adverse Event|2
5205802|NCT01061736|17968870|P3|Overall Study|Adverse Event|3
5205803|NCT01061736|17968871|P2|Overall Study|Adverse Event|1
5205804|NCT01061736|17968872|P1|Overall Study|Adverse Event|13
5205805|NCT01061736|17968863|P10|Overall Study|Dose regimen not selected|0
5205806|NCT01061736|17968864|P9|Overall Study|Dose regimen not selected|0
5205807|NCT01061736|17968865|P8|Overall Study|Dose regimen not selected|0
5205808|NCT01061736|17968866|P7|Overall Study|Dose regimen not selected|79
5205809|NCT01061736|17968867|P6|Overall Study|Dose regimen not selected|0
5205810|NCT01061736|17968868|P5|Overall Study|Dose regimen not selected|0
5205811|NCT01061736|17968869|P4|Overall Study|Dose regimen not selected|0
5205812|NCT01061736|17968870|P3|Overall Study|Dose regimen not selected|0
5205813|NCT01061736|17968871|P2|Overall Study|Dose regimen not selected|0
5205814|NCT01061736|17968872|P1|Overall Study|Dose regimen not selected|0
5205815|NCT01061723|17968911|P6|Overall Study|Other than specified above|1
5205816|NCT01061723|17968912|P5|Overall Study|Other than specified above|0
5205817|NCT01061723|17968913|P4|Overall Study|Other than specified above|1
5205818|NCT01061723|17968914|P3|Overall Study|Other than specified above|1
5205819|NCT01061723|17968915|P2|Overall Study|Other than specified above|1
5205820|NCT01061723|17968916|P1|Overall Study|Other than specified above|2
5205821|NCT01061723|17968911|P6|Overall Study|Randomized but not treated|1
5205822|NCT01061723|17968912|P5|Overall Study|Randomized but not treated|0
5205823|NCT01061723|17968913|P4|Overall Study|Randomized but not treated|0
5205824|NCT01061723|17968914|P3|Overall Study|Randomized but not treated|0
5205825|NCT01061723|17968915|P2|Overall Study|Randomized but not treated|0
5205826|NCT01061723|17968916|P1|Overall Study|Randomized but not treated|0
5205827|NCT01061723|17968911|P6|Overall Study|Lack of Efficacy|1
5205828|NCT01061723|17968912|P5|Overall Study|Lack of Efficacy|1
5205829|NCT01061723|17968913|P4|Overall Study|Lack of Efficacy|2
5205830|NCT01061723|17968914|P3|Overall Study|Lack of Efficacy|4
5205831|NCT01061723|17968915|P2|Overall Study|Lack of Efficacy|3
5205832|NCT01061723|17968916|P1|Overall Study|Lack of Efficacy|2
5205833|NCT01061723|17968911|P6|Overall Study|Adverse Event|6
5205834|NCT01061723|17968912|P5|Overall Study|Adverse Event|2
5205835|NCT01061723|17968913|P4|Overall Study|Adverse Event|5
5205836|NCT01061723|17968914|P3|Overall Study|Adverse Event|5
5205837|NCT01061723|17968915|P2|Overall Study|Adverse Event|2
5205838|NCT01061723|17968916|P1|Overall Study|Adverse Event|0
5205839|NCT01061710|17968996|P1|Overall Study|Protocol Violation|14
5205840|NCT01061671|17969006|P2|Overall Study|Death|30
5205841|NCT01061671|17969007|P1|Overall Study|Death|28
5205842|NCT01061671|17969006|P2|Overall Study|Lost to Follow-up|5
5205843|NCT01061671|17969007|P1|Overall Study|Lost to Follow-up|3
5205844|NCT01061671|17969006|P2|Overall Study|Withdrawal by Subject|20
5205845|NCT01061671|17969007|P1|Overall Study|Withdrawal by Subject|16
5205846|NCT01061606|17969019|P1|Overall Study|alternative therapy|2
5205847|NCT01061606|17969019|P1|Overall Study|Disease Progression|4
5205848|NCT01061606|17969019|P1|Overall Study|Death|1
5205849|NCT01061606|17969019|P1|Overall Study|Adverse Event|1
5205850|NCT01061567|17969028|P1|Overall Study|Other reason than stated above|3
5205851|NCT01061567|17969028|P1|Overall Study|Withdrawal by Subject|11
5205852|NCT01061567|17969028|P1|Overall Study|Protocol Violation|1
5205853|NCT01061567|17969028|P1|Overall Study|Lost to Follow-up|24
5205854|NCT01061567|17969028|P1|Overall Study|Lack of Efficacy|3
5205855|NCT01061567|17969028|P1|Overall Study|Death|2
5205856|NCT01061567|17969028|P1|Overall Study|Adverse Event|32
5205857|NCT01061385|17969052|P2|Overall Study|subject decision not related to AE|1
5205858|NCT01061385|17969053|P1|Overall Study|subject decision not related to AE|0
5205859|NCT01061385|17969052|P2|Overall Study|Lost to Follow-up|0
5205860|NCT01061385|17969053|P1|Overall Study|Lost to Follow-up|1
5205861|NCT01061359|17969061|P1|Overall Study|Secondary neoplasm|11
5205862|NCT01061359|17969061|P1|Overall Study|Relapse|187
5205863|NCT01061359|17969061|P1|Overall Study|Lost to Follow-up|1072
5205864|NCT01061359|17969061|P1|Overall Study|Death|32
5205865|NCT01061333|17969067|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
5205866|NCT01061333|17969068|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
5205867|NCT01061177|17969106|P1|Overall Study|Death|4
5205868|NCT01061177|17969106|P1|Overall Study|Administratie problems|4
5205869|NCT01061177|17969106|P1|Overall Study|Abnormal test procedure results|4
5205870|NCT01061177|17969106|P1|Overall Study|Abnormal laboratory values|6
5205871|NCT01061177|17969106|P1|Overall Study|New cancer therapy|9
5205872|NCT01061177|17969106|P1|Overall Study|Lost to Follow-up|9
5205873|NCT01061177|17969106|P1|Overall Study|Protocol Violation|11
5205874|NCT01061177|17969106|P1|Overall Study|Disease progression|17
5205875|NCT01061177|17969106|P1|Overall Study|Withdrawal by Subject|27
5205876|NCT01061177|17969106|P1|Overall Study|Adverse Event|117
5205877|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
5205878|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
5205879|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
5205880|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
5205881|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
5205882|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
5205883|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
5205884|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
5205885|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
5205886|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
5205887|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
5205888|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
5205889|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
5205890|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
5205891|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
5205892|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
5205893|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
5205894|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
5205895|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
5205896|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
5205897|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
5205898|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
5205899|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
5205900|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
5205901|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5205902|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5205903|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5205904|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
5205905|NCT01061151|17969129|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
5205906|NCT01061151|17969130|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
5205907|NCT01061151|17969131|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
5205908|NCT01061151|17969132|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
5205909|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
5205910|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
5205911|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
5205912|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
5205913|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
5205914|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
5205915|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
5205916|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
5205917|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
5205918|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
5205919|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
5205920|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
5205921|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
5205922|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
5205923|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
5205924|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
5205925|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
5205926|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
5205927|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
5205928|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
5205929|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
5205930|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
5205931|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
5205932|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
5205933|NCT01061151|17969129|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
5205934|NCT01061151|17969130|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
5205935|NCT01061151|17969131|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
5205936|NCT01061151|17969132|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
5205937|NCT01061008|17969191|P2|Overall Study|Adverse Event|1
5205938|NCT01061008|17969192|P1|Overall Study|Adverse Event|0
5205939|NCT01061008|17969191|P2|Overall Study|Unable to exercise following surgery|0
5205940|NCT01061008|17969192|P1|Overall Study|Unable to exercise following surgery|1
5205941|NCT01061008|17969191|P2|Overall Study|Withdrawal by Subject|3
5205942|NCT01061008|17969192|P1|Overall Study|Withdrawal by Subject|1
5205943|NCT01061008|17969191|P2|Overall Study|Death|0
5205944|NCT01061008|17969192|P1|Overall Study|Death|1
5205945|NCT01061008|17969191|P2|Overall Study|Badiocephalic fistula failed|2
5205946|NCT01061008|17969192|P1|Overall Study|Badiocephalic fistula failed|3
5205947|NCT01060670|17969200|P2|Run In|screen failure|238
5205948|NCT01060670|17969201|P1|Run In|screen failure|0
5205949|NCT01060553|17969236|P2|Overall Study|Lack of Efficacy|0
5205950|NCT01060553|17969237|P1|Overall Study|Lack of Efficacy|1
5205951|NCT01060553|17969236|P2|Overall Study|Withdrawal by Subject|5
5205952|NCT01060553|17969237|P1|Overall Study|Withdrawal by Subject|5
5205953|NCT01060553|17969236|P2|Overall Study|Lost to Follow-up|5
5205954|NCT01060553|17969237|P1|Overall Study|Lost to Follow-up|3
5205955|NCT01060540|17969244|P2|Overall Study|Physician Decision|1
5205956|NCT01060540|17969245|P1|Overall Study|Physician Decision|0
5205957|NCT01060540|17969244|P2|Overall Study|Death|1
5205958|NCT01060540|17969245|P1|Overall Study|Death|2
5205959|NCT01060540|17969244|P2|Overall Study|Lost to Follow-up|43
5205960|NCT01060540|17969245|P1|Overall Study|Lost to Follow-up|52
5205961|NCT01060540|17969244|P2|Overall Study|Withdrawal by Subject|20
5205962|NCT01060540|17969245|P1|Overall Study|Withdrawal by Subject|10
5205963|NCT01060384|17969259|P5|Overall Study|Intercurrent illness|1
5205964|NCT01060384|17969260|P4|Overall Study|Intercurrent illness|0
5205965|NCT01060384|17969261|P3|Overall Study|Intercurrent illness|0
5205966|NCT01060384|17969262|P2|Overall Study|Intercurrent illness|0
5205967|NCT01060384|17969263|P1|Overall Study|Intercurrent illness|0
5205968|NCT01060384|17969259|P5|Overall Study|Death|1
5205969|NCT01060384|17969260|P4|Overall Study|Death|0
5205970|NCT01060384|17969261|P3|Overall Study|Death|0
5205971|NCT01060384|17969262|P2|Overall Study|Death|0
5205972|NCT01060384|17969263|P1|Overall Study|Death|0
5205973|NCT01060384|17969259|P5|Overall Study|Withdrawal by Subject|0
5205974|NCT01060384|17969260|P4|Overall Study|Withdrawal by Subject|0
5205975|NCT01060384|17969261|P3|Overall Study|Withdrawal by Subject|0
5205976|NCT01060384|17969262|P2|Overall Study|Withdrawal by Subject|1
5205977|NCT01060384|17969263|P1|Overall Study|Withdrawal by Subject|0
5205978|NCT01060150|17969282|P1|Overall Study|Enrolled, but not treated|2
5205979|NCT01060150|17969282|P1|Overall Study|Withdrawal by Subject|8
5205980|NCT01060150|17969282|P1|Overall Study|Protocol Violation|6
5205981|NCT01060150|17969282|P1|Overall Study|Lost to Follow-up|1
5205982|NCT01060150|17969282|P1|Overall Study|Adverse Event|6
5205983|NCT01060124|17969297|P1|Overall Study|Withdrawal by Subject|7
5205984|NCT01060124|17969297|P1|Overall Study|Adverse Event|14
5205985|NCT01060124|17969297|P1|Overall Study|Other|16
5205986|NCT01060111|17969308|P3|Overall Study|Other|4
5205987|NCT01060111|17969309|P2|Overall Study|Other|3
5205988|NCT01060111|17969310|P1|Overall Study|Other|2
5205989|NCT01060111|17969308|P3|Overall Study|Participants' non-cooperation|0
5205990|NCT01060111|17969309|P2|Overall Study|Participants' non-cooperation|0
5205991|NCT01060111|17969310|P1|Overall Study|Participants' non-cooperation|1
5205992|NCT01060111|17969308|P3|Overall Study|Adverse event and insufficient effect|0
5205993|NCT01060111|17969309|P2|Overall Study|Adverse event and insufficient effect|1
5205994|NCT01060111|17969310|P1|Overall Study|Adverse event and insufficient effect|0
5205995|NCT01060111|17969308|P3|Overall Study|Participants' non-cooperation|6
5205996|NCT01060111|17969309|P2|Overall Study|Participants' non-cooperation|6
5205997|NCT01060111|17969310|P1|Overall Study|Participants' non-cooperation|8
5205998|NCT01060111|17969308|P3|Overall Study|Participants' evasion for hospital visit|2
5205999|NCT01060111|17969309|P2|Overall Study|Participants' evasion for hospital visit|3
5206000|NCT01060111|17969310|P1|Overall Study|Participants' evasion for hospital visit|0
5206001|NCT01060111|17969308|P3|Overall Study|Inappropriate participant|5
5206002|NCT01060111|17969309|P2|Overall Study|Inappropriate participant|4
5206003|NCT01060111|17969310|P1|Overall Study|Inappropriate participant|5
5206004|NCT01060111|17969308|P3|Overall Study|Lack of Efficacy|0
5206005|NCT01060111|17969309|P2|Overall Study|Lack of Efficacy|1
5206006|NCT01060111|17969310|P1|Overall Study|Lack of Efficacy|2
5206007|NCT01060111|17969308|P3|Overall Study|Adverse Event|18
5206008|NCT01060111|17969309|P2|Overall Study|Adverse Event|5
5206009|NCT01060111|17969310|P1|Overall Study|Adverse Event|9
5206010|NCT01060072|17969342|P2|Overall Study|Excluded Medications|1
5206011|NCT01060072|17969343|P1|Overall Study|Excluded Medications|0
5206012|NCT01060072|17969342|P2|Overall Study|Acute cholecystitis|0
5206013|NCT01060072|17969343|P1|Overall Study|Acute cholecystitis|1
5206014|NCT01060072|17969342|P2|Overall Study|Protocol Violation|1
5206015|NCT01060072|17969343|P1|Overall Study|Protocol Violation|0
5206016|NCT01060072|17969342|P2|Overall Study|Physician Decision|2
5206017|NCT01060072|17969343|P1|Overall Study|Physician Decision|0
5206018|NCT01060072|17969342|P2|Overall Study|Adverse Event|1
5206019|NCT01060072|17969343|P1|Overall Study|Adverse Event|1
5206020|NCT01060059|17969359|P2|Overall Study|lack of compliance|2
5206021|NCT01060059|17969360|P1|Overall Study|lack of compliance|5
5206022|NCT01060059|17969359|P2|Overall Study|lack of glycemic control|1
5206023|NCT01060059|17969360|P1|Overall Study|lack of glycemic control|2
5206024|NCT01060059|17969359|P2|Overall Study|Withdrawal by Subject|23
5206025|NCT01060059|17969360|P1|Overall Study|Withdrawal by Subject|35
5206026|NCT01060059|17969359|P2|Overall Study|entry criteria not met|3
5206027|NCT01060059|17969360|P1|Overall Study|entry criteria not met|4
5206028|NCT01060059|17969359|P2|Overall Study|Lost to Follow-up|34
5206029|NCT01060059|17969360|P1|Overall Study|Lost to Follow-up|18
5206030|NCT01060059|17969359|P2|Overall Study|Death|3
5206031|NCT01060059|17969360|P1|Overall Study|Death|2
5206032|NCT01060059|17969359|P2|Overall Study|Adverse Event|1
5206033|NCT01060059|17969360|P1|Overall Study|Adverse Event|1
5206034|NCT01060007|17969418|P1|Overall Study|Inevaluable for response at surgery|3
5206035|NCT01060007|17969418|P1|Overall Study|Withdrawal by Subject|1
5206036|NCT01059903|17969486|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
5206037|NCT01059903|17969487|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
5206038|NCT01059864|17969530|P3|Double-Blind Treatment Phase|Adverse Event|3
5206039|NCT01059864|17969531|P2|Double-Blind Treatment Phase|Adverse Event|3
5206040|NCT01059864|17969532|P1|Double-Blind Treatment Phase|Adverse Event|0
5206041|NCT01059864|17969530|P3|Open-Label Run-In Phase|Protocol Violation|0
5206042|NCT01059864|17969531|P2|Open-Label Run-In Phase|Protocol Violation|0
5206043|NCT01059864|17969532|P1|Open-Label Run-In Phase|Protocol Violation|2
5206044|NCT01059864|17969530|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
5206045|NCT01059864|17969531|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
5206046|NCT01059864|17969532|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
5206047|NCT01059864|17969530|P3|Open-Label Run-In Phase|Lost to Follow-up|0
5206048|NCT01059864|17969531|P2|Open-Label Run-In Phase|Lost to Follow-up|0
5206049|NCT01059864|17969532|P1|Open-Label Run-In Phase|Lost to Follow-up|2
5206050|NCT01059864|17969530|P3|Open-Label Run-In Phase|Lack of Efficacy|0
5206051|NCT01059864|17969531|P2|Open-Label Run-In Phase|Lack of Efficacy|0
5206052|NCT01059864|17969532|P1|Open-Label Run-In Phase|Lack of Efficacy|1
5206053|NCT01059864|17969530|P3|Open-Label Run-In Phase|Adverse Event|0
5206054|NCT01059864|17969531|P2|Open-Label Run-In Phase|Adverse Event|0
5206055|NCT01059864|17969532|P1|Open-Label Run-In Phase|Adverse Event|7
5206056|NCT01059825|17969606|P7|Treatment Period|Adverse event not related to study drug|0
5206057|NCT01059825|17969607|P6|Treatment Period|Adverse event not related to study drug|1
5206058|NCT01059825|17969608|P5|Treatment Period|Adverse event not related to study drug|1
5206059|NCT01059825|17969609|P4|Treatment Period|Adverse event not related to study drug|1
5206060|NCT01059825|17969610|P3|Treatment Period|Adverse event not related to study drug|2
5206061|NCT01059825|17969611|P2|Treatment Period|Adverse event not related to study drug|1
5206062|NCT01059825|17969612|P1|Treatment Period|Adverse event not related to study drug|0
5206063|NCT01059825|17969606|P7|Treatment Period|Insufficient clinical response|0
5206064|NCT01059825|17969607|P6|Treatment Period|Insufficient clinical response|0
5206065|NCT01059825|17969608|P5|Treatment Period|Insufficient clinical response|0
5206066|NCT01059825|17969609|P4|Treatment Period|Insufficient clinical response|0
5206067|NCT01059825|17969610|P3|Treatment Period|Insufficient clinical response|0
5206068|NCT01059825|17969611|P2|Treatment Period|Insufficient clinical response|0
5206069|NCT01059825|17969612|P1|Treatment Period|Insufficient clinical response|3
5206070|NCT01059825|17969606|P7|Treatment Period|Adverse event related to study drug|0
5206071|NCT01059825|17969607|P6|Treatment Period|Adverse event related to study drug|0
5206072|NCT01059825|17969608|P5|Treatment Period|Adverse event related to study drug|0
5206073|NCT01059825|17969609|P4|Treatment Period|Adverse event related to study drug|1
5206074|NCT01059825|17969610|P3|Treatment Period|Adverse event related to study drug|1
5206075|NCT01059825|17969611|P2|Treatment Period|Adverse event related to study drug|0
5206076|NCT01059825|17969612|P1|Treatment Period|Adverse event related to study drug|1
5206077|NCT01059825|17969606|P7|Treatment Period|Protocol Violation|0
5206078|NCT01059825|17969607|P6|Treatment Period|Protocol Violation|1
5206079|NCT01059825|17969608|P5|Treatment Period|Protocol Violation|1
5206080|NCT01059825|17969609|P4|Treatment Period|Protocol Violation|1
5206081|NCT01059825|17969610|P3|Treatment Period|Protocol Violation|1
5206082|NCT01059825|17969611|P2|Treatment Period|Protocol Violation|0
5206083|NCT01059825|17969612|P1|Treatment Period|Protocol Violation|0
5206084|NCT01059825|17969606|P7|Treatment Period|Other reason not specified|0
5206085|NCT01059825|17969607|P6|Treatment Period|Other reason not specified|0
5206086|NCT01059825|17969608|P5|Treatment Period|Other reason not specified|0
5206087|NCT01059825|17969609|P4|Treatment Period|Other reason not specified|2
5206088|NCT01059825|17969610|P3|Treatment Period|Other reason not specified|1
5206089|NCT01059825|17969611|P2|Treatment Period|Other reason not specified|2
5206090|NCT01059825|17969612|P1|Treatment Period|Other reason not specified|1
5206091|NCT01059825|17969606|P7|Treatment Period|Withdrawal by Subject|0
5206092|NCT01059825|17969607|P6|Treatment Period|Withdrawal by Subject|1
5206093|NCT01059825|17969608|P5|Treatment Period|Withdrawal by Subject|4
5206094|NCT01059825|17969609|P4|Treatment Period|Withdrawal by Subject|5
5206095|NCT01059825|17969610|P3|Treatment Period|Withdrawal by Subject|1
5206096|NCT01059825|17969611|P2|Treatment Period|Withdrawal by Subject|0
5206097|NCT01059825|17969612|P1|Treatment Period|Withdrawal by Subject|3
5206098|NCT01059825|17969606|P7|Treatment Period|Lost to Follow-up|0
5206099|NCT01059825|17969607|P6|Treatment Period|Lost to Follow-up|0
5206100|NCT01059825|17969608|P5|Treatment Period|Lost to Follow-up|2
5206101|NCT01059825|17969609|P4|Treatment Period|Lost to Follow-up|1
5206102|NCT01059825|17969610|P3|Treatment Period|Lost to Follow-up|0
5206103|NCT01059825|17969611|P2|Treatment Period|Lost to Follow-up|1
5206104|NCT01059825|17969612|P1|Treatment Period|Lost to Follow-up|2
5206105|NCT01059825|17969606|P7|Enrolled, Run-in Period|Protocol Violation|5
5206106|NCT01059825|17969607|P6|Enrolled, Run-in Period|Protocol Violation|0
5206107|NCT01059825|17969608|P5|Enrolled, Run-in Period|Protocol Violation|0
5206108|NCT01059825|17969609|P4|Enrolled, Run-in Period|Protocol Violation|0
5206109|NCT01059825|17969610|P3|Enrolled, Run-in Period|Protocol Violation|0
5206110|NCT01059825|17969611|P2|Enrolled, Run-in Period|Protocol Violation|0
5206111|NCT01059825|17969612|P1|Enrolled, Run-in Period|Protocol Violation|0
5206112|NCT01059825|17969606|P7|Enrolled, Run-in Period|Other reason not specified|7
5206113|NCT01059825|17969607|P6|Enrolled, Run-in Period|Other reason not specified|0
5206114|NCT01059825|17969608|P5|Enrolled, Run-in Period|Other reason not specified|0
5206115|NCT01059825|17969609|P4|Enrolled, Run-in Period|Other reason not specified|0
5206116|NCT01059825|17969610|P3|Enrolled, Run-in Period|Other reason not specified|0
5206117|NCT01059825|17969611|P2|Enrolled, Run-in Period|Other reason not specified|0
5206118|NCT01059825|17969612|P1|Enrolled, Run-in Period|Other reason not specified|0
5206119|NCT01059825|17969606|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
5206120|NCT01059825|17969607|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
5206121|NCT01059825|17969608|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
5206122|NCT01059825|17969609|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
5206123|NCT01059825|17969610|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
5206124|NCT01059825|17969611|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
5206125|NCT01059825|17969612|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
5206126|NCT01059825|17969606|P7|Enrolled, Run-in Period|Lost to Follow-up|5
5206127|NCT01059825|17969607|P6|Enrolled, Run-in Period|Lost to Follow-up|0
5206128|NCT01059825|17969608|P5|Enrolled, Run-in Period|Lost to Follow-up|0
5206129|NCT01059825|17969609|P4|Enrolled, Run-in Period|Lost to Follow-up|0
5206130|NCT01059825|17969610|P3|Enrolled, Run-in Period|Lost to Follow-up|0
5206131|NCT01059825|17969611|P2|Enrolled, Run-in Period|Lost to Follow-up|0
5206132|NCT01059825|17969612|P1|Enrolled, Run-in Period|Lost to Follow-up|0
5206133|NCT01059825|17969606|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
5206134|NCT01059825|17969607|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
5206135|NCT01059825|17969608|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
5206136|NCT01059825|17969609|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
5206137|NCT01059825|17969610|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
5206138|NCT01059825|17969611|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
5206139|NCT01059825|17969612|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
5206140|NCT01059825|17969606|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
5206141|NCT01059825|17969607|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
5206142|NCT01059825|17969608|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
5206143|NCT01059825|17969609|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
5206144|NCT01059825|17969610|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
5206145|NCT01059825|17969611|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
5206146|NCT01059825|17969612|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
5206147|NCT01059812|17969799|P2|Overall Study|Unclassified|4
5206148|NCT01059812|17969800|P1|Overall Study|Unclassified|14
5206149|NCT01059812|17969799|P2|Overall Study|Withdrawal Criteria|4
5206150|NCT01059812|17969800|P1|Overall Study|Withdrawal Criteria|9
5206151|NCT01059812|17969799|P2|Overall Study|Protocol Violation|1
5206152|NCT01059812|17969800|P1|Overall Study|Protocol Violation|3
5206153|NCT01059812|17969799|P2|Overall Study|Lack of Efficacy|2
5206154|NCT01059812|17969800|P1|Overall Study|Lack of Efficacy|2
5206155|NCT01059812|17969799|P2|Overall Study|Adverse Event|5
5206156|NCT01059812|17969800|P1|Overall Study|Adverse Event|9
5206157|NCT01059799|17969816|P2|Overall Study|Other|3
5206158|NCT01059799|17969817|P1|Overall Study|Other|12
5206159|NCT01059799|17969816|P2|Overall Study|Withdrawal criteria|2
5206160|NCT01059799|17969817|P1|Overall Study|Withdrawal criteria|13
5206161|NCT01059799|17969816|P2|Overall Study|Protocol Violation|2
5206162|NCT01059799|17969817|P1|Overall Study|Protocol Violation|3
5206163|NCT01059799|17969816|P2|Overall Study|Lack of Efficacy|0
5206164|NCT01059799|17969817|P1|Overall Study|Lack of Efficacy|1
5206165|NCT01059799|17969816|P2|Overall Study|Adverse Event|3
5206166|NCT01059799|17969817|P1|Overall Study|Adverse Event|2
5206167|NCT01059773|17969831|P2|Overall Study|Other|3
5206168|NCT01059773|17969832|P1|Overall Study|Other|1
5206169|NCT01059773|17969831|P2|Overall Study|Ineligible follow TB screening criteria|1
5206170|NCT01059773|17969832|P1|Overall Study|Ineligible follow TB screening criteria|0
5206171|NCT01059773|17969831|P2|Overall Study|Malignancy including squamous cell skin|1
5206172|NCT01059773|17969832|P1|Overall Study|Malignancy including squamous cell skin|0
5206173|NCT01059773|17969831|P2|Overall Study|Death|1
5206174|NCT01059773|17969832|P1|Overall Study|Death|0
5206175|NCT01059773|17969831|P2|Overall Study|Lack of Efficacy|3
5206176|NCT01059773|17969832|P1|Overall Study|Lack of Efficacy|3
5206177|NCT01059773|17969831|P2|Overall Study|Physician Decision|4
5206178|NCT01059773|17969832|P1|Overall Study|Physician Decision|5
5206179|NCT01059773|17969831|P2|Overall Study|Protocol Violation|2
5206180|NCT01059773|17969832|P1|Overall Study|Protocol Violation|6
5206181|NCT01059773|17969831|P2|Overall Study|Pregnancy|1
5206182|NCT01059773|17969832|P1|Overall Study|Pregnancy|1
5206183|NCT01059773|17969831|P2|Overall Study|Lost to Follow-up|1
5206184|NCT01059773|17969832|P1|Overall Study|Lost to Follow-up|1
5206185|NCT01059773|17969831|P2|Overall Study|Withdrawal by Subject|5
5206186|NCT01059773|17969832|P1|Overall Study|Withdrawal by Subject|1
5206187|NCT01059773|17969831|P2|Overall Study|Adverse Event|2
5206188|NCT01059773|17969832|P1|Overall Study|Adverse Event|2
5206189|NCT01059643|17969988|P1|Overall Study|Physician Decision|1
5206190|NCT01059643|17969988|P1|Overall Study|Withdrawal by Subject|2
5206191|NCT01059643|17969988|P1|Overall Study|Adverse Event|3
5206192|NCT01059630|17970003|P2|Overall Study|Withdrawal by Subject|14
5206193|NCT01059630|17970004|P1|Overall Study|Withdrawal by Subject|21
5206194|NCT01059630|17970003|P2|Overall Study|Physician Decision|4
5206195|NCT01059630|17970004|P1|Overall Study|Physician Decision|2
5206196|NCT01059630|17970003|P2|Overall Study|Lost to Follow-up|1
5206197|NCT01059630|17970004|P1|Overall Study|Lost to Follow-up|4
5206198|NCT01059630|17970003|P2|Overall Study|Death|84
5206199|NCT01059630|17970004|P1|Overall Study|Death|100
5206200|NCT01059617|17970078|P4|Overall Study|Other|6
5206201|NCT01059617|17970079|P3|Overall Study|Other|8
5206202|NCT01059617|17970080|P2|Overall Study|Other|1
5206203|NCT01059617|17970081|P1|Overall Study|Other|7
5206204|NCT01059565|17970251|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
5206205|NCT01059565|17970252|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
5206206|NCT01059565|17970251|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
5206207|NCT01059565|17970252|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
5206208|NCT01059565|17970251|P2|24-Week Open-Label Phase|Subject noncompliance|0
5206209|NCT01059565|17970252|P1|24-Week Open-Label Phase|Subject noncompliance|1
5206210|NCT01059565|17970251|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
5206211|NCT01059565|17970252|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
5206212|NCT01059565|17970251|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
5206213|NCT01059565|17970252|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
5206214|NCT01059565|17970251|P2|24-Week Open-Label Phase|Adverse Event|0
5206215|NCT01059565|17970252|P1|24-Week Open-Label Phase|Adverse Event|2
5206216|NCT01059565|17970251|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
5206217|NCT01059565|17970252|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
5206218|NCT01059565|17970251|P2|24-Week Randomized Phase|Lost to Follow-up|1
5206219|NCT01059565|17970252|P1|24-Week Randomized Phase|Lost to Follow-up|0
5206220|NCT01059565|17970251|P2|24-Week Randomized Phase|Withdrawal by Subject|1
5206221|NCT01059565|17970252|P1|24-Week Randomized Phase|Withdrawal by Subject|3
5206222|NCT01059565|17970251|P2|24-Week Randomized Phase|Adverse Event|0
5206223|NCT01059565|17970252|P1|24-Week Randomized Phase|Adverse Event|5
5206224|NCT01059565|17970251|P2|24-Week Randomized Phase|Randomized but not treated|0
5206225|NCT01059565|17970252|P1|24-Week Randomized Phase|Randomized but not treated|1
5206226|NCT01059539|17970286|P1|Overall Study|Reason Not Specified|2
5206227|NCT01059539|17970286|P1|Overall Study|Lost to Follow-up|42
5206228|NCT01059539|17970286|P1|Overall Study|Withdrawal of Consent|80
5206229|NCT01059539|17970286|P1|Overall Study|Protocol Violation|55
5206230|NCT01059539|17970286|P1|Overall Study|Insufficient Therapeutic Response|26
5206231|NCT01059539|17970286|P1|Overall Study|Adverse Event|66
5206232|NCT01059526|17970293|P2|Overall Study|Patient found to be dermatographic|0
5206233|NCT01059526|17970294|P1|Overall Study|Patient found to be dermatographic|1
5206234|NCT01059526|17970293|P2|Overall Study|Lost to Follow-up|1
5206235|NCT01059526|17970294|P1|Overall Study|Lost to Follow-up|4
5206236|NCT01059526|17970293|P2|Overall Study|Withdrawal by Subject|1
5206237|NCT01059526|17970294|P1|Overall Study|Withdrawal by Subject|3
5206238|NCT01059526|17970293|P2|Overall Study|Protocol Violation|1
5206239|NCT01059526|17970294|P1|Overall Study|Protocol Violation|0
5206240|NCT01059526|17970293|P2|Overall Study|Adverse Event|2
5206241|NCT01059526|17970294|P1|Overall Study|Adverse Event|2
5206242|NCT01059526|17970293|P2|Overall Study|Patient enrolled but not treated|17
5206243|NCT01059526|17970294|P1|Overall Study|Patient enrolled but not treated|20
5206244|NCT01059344|17970640|P2|Overall Study|Other|6
5206245|NCT01059344|17970641|P1|Overall Study|Other|3
5206246|NCT01059344|17970640|P2|Overall Study|Lost to Follow-up|1
5206247|NCT01059344|17970641|P1|Overall Study|Lost to Follow-up|1
5206248|NCT01059344|17970640|P2|Overall Study|Withdrawal by Subject|9
5206249|NCT01059344|17970641|P1|Overall Study|Withdrawal by Subject|6
5206250|NCT01059344|17970640|P2|Overall Study|Adverse Event|30
5206251|NCT01059344|17970641|P1|Overall Study|Adverse Event|12
5206252|NCT01059318|17970659|P1|Extension (36 Week)|Adverse Event|3
5206253|NCT01059318|17970659|P1|Core Study (26 Week)|Withdrawal by Subject|1
5206254|NCT01059318|17970659|P1|Core Study (26 Week)|Adverse Event|3
5206255|NCT01059175|17970680|P2|Overall Study|Lost to Follow-up|1
5206256|NCT01059175|17970681|P1|Overall Study|Lost to Follow-up|0
5206257|NCT01059175|17970680|P2|Overall Study|Adverse Event|2
5206258|NCT01059175|17970681|P1|Overall Study|Adverse Event|4
5206259|NCT01059175|17970680|P2|Overall Study|Death|17
5206260|NCT01059175|17970681|P1|Overall Study|Death|17
5206261|NCT01059071|17970703|P4|Overall Study|Physician Decision|1
5206262|NCT01059071|17970704|P3|Overall Study|Physician Decision|0
5206263|NCT01059071|17970705|P2|Overall Study|Physician Decision|0
5206264|NCT01059071|17970706|P1|Overall Study|Physician Decision|0
5206265|NCT01059071|17970703|P4|Overall Study|Withdrawal by Subject|2
5206266|NCT01059071|17970704|P3|Overall Study|Withdrawal by Subject|0
5206267|NCT01059071|17970705|P2|Overall Study|Withdrawal by Subject|0
5206268|NCT01059071|17970706|P1|Overall Study|Withdrawal by Subject|1
5206269|NCT01059071|17970703|P4|Overall Study|Lack of Efficacy|3
5206270|NCT01059071|17970704|P3|Overall Study|Lack of Efficacy|2
5206271|NCT01059071|17970705|P2|Overall Study|Lack of Efficacy|4
5206272|NCT01059071|17970706|P1|Overall Study|Lack of Efficacy|1
5206273|NCT01058863|17970733|P1|Overall Study|Randomized in error|1
5206274|NCT01058863|17970733|P1|Overall Study|Sponsor requested withdrawal|1
5206275|NCT01058863|17970733|P1|Overall Study|Withdrawal by Subject|1
5206276|NCT01058863|17970733|P1|Overall Study|Lost to Follow-up|1
5206277|NCT01058707|17970758|P7|Overall Study|Reason Not Specified|7
5206278|NCT01058707|17970759|P6|Overall Study|Reason Not Specified|1
5206279|NCT01058707|17970760|P5|Overall Study|Reason Not Specified|7
5206280|NCT01058707|17970761|P4|Overall Study|Reason Not Specified|0
5206281|NCT01058707|17970762|P3|Overall Study|Reason Not Specified|2
5206282|NCT01058707|17970763|P2|Overall Study|Reason Not Specified|3
5206283|NCT01058707|17970764|P1|Overall Study|Reason Not Specified|0
5206284|NCT01058707|17970758|P7|Overall Study|Lost to Follow-up|0
5206285|NCT01058707|17970759|P6|Overall Study|Lost to Follow-up|0
5206286|NCT01058707|17970760|P5|Overall Study|Lost to Follow-up|0
5206287|NCT01058707|17970761|P4|Overall Study|Lost to Follow-up|0
5206288|NCT01058707|17970762|P3|Overall Study|Lost to Follow-up|1
5206289|NCT01058707|17970763|P2|Overall Study|Lost to Follow-up|0
5206290|NCT01058707|17970764|P1|Overall Study|Lost to Follow-up|0
5206291|NCT01058707|17970758|P7|Overall Study|Subject Decision|6
5206292|NCT01058707|17970759|P6|Overall Study|Subject Decision|3
5206293|NCT01058707|17970760|P5|Overall Study|Subject Decision|2
5206294|NCT01058707|17970761|P4|Overall Study|Subject Decision|1
5206295|NCT01058707|17970762|P3|Overall Study|Subject Decision|3
5206296|NCT01058707|17970763|P2|Overall Study|Subject Decision|3
5206297|NCT01058707|17970764|P1|Overall Study|Subject Decision|5
5206298|NCT01058707|17970758|P7|Overall Study|Adverse Event|1
5206299|NCT01058707|17970759|P6|Overall Study|Adverse Event|3
5206300|NCT01058707|17970760|P5|Overall Study|Adverse Event|7
5206301|NCT01058707|17970761|P4|Overall Study|Adverse Event|6
5206302|NCT01058707|17970762|P3|Overall Study|Adverse Event|7
5206303|NCT01058707|17970763|P2|Overall Study|Adverse Event|4
5206304|NCT01058707|17970764|P1|Overall Study|Adverse Event|11
5206305|NCT01058707|17970758|P7|Overall Study|Disease Progression|12
5206306|NCT01058707|17970759|P6|Overall Study|Disease Progression|10
5206307|NCT01058707|17970760|P5|Overall Study|Disease Progression|23
5206308|NCT01058707|17970761|P4|Overall Study|Disease Progression|15
5206309|NCT01058707|17970762|P3|Overall Study|Disease Progression|20
5206310|NCT01058707|17970763|P2|Overall Study|Disease Progression|20
5206311|NCT01058707|17970764|P1|Overall Study|Disease Progression|15
5206312|NCT01058668|17970930|P3|Double-blind Treatment Phase|Other Unspecified|0
5206313|NCT01058668|17970931|P2|Double-blind Treatment Phase|Other Unspecified|1
5206314|NCT01058668|17970932|P1|Double-blind Treatment Phase|Other Unspecified|1
5206398|NCT01058421|17970981|P2|1 Month Outcomes|Remained in Hospital|12
5206315|NCT01058668|17970930|P3|Double-blind Treatment Phase|Lost to Follow-up|1
5206316|NCT01058668|17970931|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5206317|NCT01058668|17970932|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5206318|NCT01058668|17970930|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
5206319|NCT01058668|17970931|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
5206320|NCT01058668|17970932|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
5206321|NCT01058668|17970930|P3|Double-blind Treatment Phase|Protocol Violation|2
5206322|NCT01058668|17970931|P2|Double-blind Treatment Phase|Protocol Violation|1
5206323|NCT01058668|17970932|P1|Double-blind Treatment Phase|Protocol Violation|1
5206324|NCT01058668|17970930|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
5206325|NCT01058668|17970931|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
5206326|NCT01058668|17970932|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
5206327|NCT01058668|17970930|P3|Double-blind Treatment Phase|Adverse Event|25
5206328|NCT01058668|17970931|P2|Double-blind Treatment Phase|Adverse Event|15
5206329|NCT01058668|17970932|P1|Double-blind Treatment Phase|Adverse Event|8
5206330|NCT01058655|17970947|P4|Overall Study|Other|4
5206331|NCT01058655|17970948|P3|Overall Study|Other|0
5206332|NCT01058655|17970949|P2|Overall Study|Other|0
5206333|NCT01058655|17970950|P1|Overall Study|Other|0
5206334|NCT01058655|17970947|P4|Overall Study|Disease Progression|24
5206335|NCT01058655|17970948|P3|Overall Study|Disease Progression|4
5206336|NCT01058655|17970949|P2|Overall Study|Disease Progression|2
5206337|NCT01058655|17970950|P1|Overall Study|Disease Progression|1
5206338|NCT01058655|17970947|P4|Overall Study|Death|0
5206339|NCT01058655|17970948|P3|Overall Study|Death|1
5206340|NCT01058655|17970949|P2|Overall Study|Death|1
5206341|NCT01058655|17970950|P1|Overall Study|Death|0
5206342|NCT01058655|17970947|P4|Overall Study|Clinical Progression (non-RECIST)|7
5206343|NCT01058655|17970948|P3|Overall Study|Clinical Progression (non-RECIST)|0
5206344|NCT01058655|17970949|P2|Overall Study|Clinical Progression (non-RECIST)|0
5206345|NCT01058655|17970950|P1|Overall Study|Clinical Progression (non-RECIST)|1
5206346|NCT01058655|17970947|P4|Overall Study|Symptomatic Deterioration|1
5206347|NCT01058655|17970948|P3|Overall Study|Symptomatic Deterioration|0
5206348|NCT01058655|17970949|P2|Overall Study|Symptomatic Deterioration|0
5206349|NCT01058655|17970950|P1|Overall Study|Symptomatic Deterioration|0
5206350|NCT01058655|17970947|P4|Overall Study|Prolonged Treatment Delay|2
5206351|NCT01058655|17970948|P3|Overall Study|Prolonged Treatment Delay|0
5206352|NCT01058655|17970949|P2|Overall Study|Prolonged Treatment Delay|0
5206353|NCT01058655|17970950|P1|Overall Study|Prolonged Treatment Delay|0
5206354|NCT01058655|17970947|P4|Overall Study|Withdrawal by Subject|4
5206355|NCT01058655|17970948|P3|Overall Study|Withdrawal by Subject|3
5206356|NCT01058655|17970949|P2|Overall Study|Withdrawal by Subject|0
5206357|NCT01058655|17970950|P1|Overall Study|Withdrawal by Subject|1
5206358|NCT01058642|17970968|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
5206359|NCT01058642|17970969|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
5206360|NCT01058642|17970970|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
5206361|NCT01058642|17970971|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
5206362|NCT01058642|17970968|P4|Treatment Period 1|Protocol Violation|1
5206363|NCT01058642|17970969|P3|Treatment Period 1|Protocol Violation|0
5206364|NCT01058642|17970970|P2|Treatment Period 1|Protocol Violation|0
5206365|NCT01058642|17970971|P1|Treatment Period 1|Protocol Violation|0
5206366|NCT01058642|17970968|P4|Treatment Period 1|Lack of Efficacy|1
5206367|NCT01058642|17970969|P3|Treatment Period 1|Lack of Efficacy|0
5206368|NCT01058642|17970970|P2|Treatment Period 1|Lack of Efficacy|0
5206369|NCT01058642|17970971|P1|Treatment Period 1|Lack of Efficacy|0
5206370|NCT01058642|17970968|P4|Treatment Period 1|Withdrawal by Subject|0
5206371|NCT01058642|17970969|P3|Treatment Period 1|Withdrawal by Subject|0
5206372|NCT01058642|17970970|P2|Treatment Period 1|Withdrawal by Subject|0
5206373|NCT01058642|17970971|P1|Treatment Period 1|Withdrawal by Subject|1
5206374|NCT01058642|17970968|P4|Treatment Period 1|Physician Decision|0
5206375|NCT01058642|17970969|P3|Treatment Period 1|Physician Decision|1
5206376|NCT01058642|17970970|P2|Treatment Period 1|Physician Decision|0
5206377|NCT01058642|17970971|P1|Treatment Period 1|Physician Decision|0
5206378|NCT01058642|17970968|P4|Treatment Period 1|Adverse Event|0
5206379|NCT01058642|17970969|P3|Treatment Period 1|Adverse Event|1
5206380|NCT01058642|17970970|P2|Treatment Period 1|Adverse Event|1
5206381|NCT01058642|17970971|P1|Treatment Period 1|Adverse Event|0
5206382|NCT01058421|17970981|P2|6 Month Outcomes|Remained in Other Facility|3
5206383|NCT01058421|17970982|P1|6 Month Outcomes|Remained in Other Facility|1
5206384|NCT01058421|17970981|P2|6 Month Outcomes|Lost to Follow-up|21
5206385|NCT01058421|17970982|P1|6 Month Outcomes|Lost to Follow-up|16
5206386|NCT01058421|17970981|P2|6 Month Outcomes|Death|2
5206387|NCT01058421|17970982|P1|6 Month Outcomes|Death|2
5206388|NCT01058421|17970981|P2|3 Month Outcomes|Remained in Other Facility|8
5206389|NCT01058421|17970982|P1|3 Month Outcomes|Remained in Other Facility|5
5206390|NCT01058421|17970981|P2|3 Month Outcomes|Remained in Hospital|2
5206391|NCT01058421|17970982|P1|3 Month Outcomes|Remained in Hospital|0
5206392|NCT01058421|17970981|P2|3 Month Outcomes|Lost to Follow-up|11
5206393|NCT01058421|17970982|P1|3 Month Outcomes|Lost to Follow-up|12
5206394|NCT01058421|17970981|P2|3 Month Outcomes|Death|5
5206395|NCT01058421|17970982|P1|3 Month Outcomes|Death|3
5206396|NCT01058421|17970981|P2|1 Month Outcomes|Remained in Other Facility|17
5206397|NCT01058421|17970982|P1|1 Month Outcomes|Remained in Other Facility|16
5206399|NCT01058421|17970982|P1|1 Month Outcomes|Remained in Hospital|5
5206400|NCT01058421|17970981|P2|1 Month Outcomes|Lost to Follow-up|7
5206401|NCT01058421|17970982|P1|1 Month Outcomes|Lost to Follow-up|8
5206402|NCT01058421|17970981|P2|1 Month Outcomes|Death|6
5206403|NCT01058421|17970982|P1|1 Month Outcomes|Death|10
5206404|NCT01058395|17971006|P2|Overall Study|Lost to Follow-up|0
5206405|NCT01058395|17971007|P1|Overall Study|Lost to Follow-up|1
5206406|NCT01058395|17971006|P2|Overall Study|Death|1
5206407|NCT01058395|17971007|P1|Overall Study|Death|2
5206408|NCT01058369|17971016|P1|Overall Study|Early termination study|1
5206409|NCT01058369|17971016|P1|Overall Study|Adverse Event|1
5206410|NCT01058356|17971020|P1|Overall Study|Lost to Follow-up|4
5206411|NCT01058356|17971020|P1|Overall Study|Withdrawal by Subject|21
5206412|NCT01058356|17971020|P1|Overall Study|Administration of contraindicated drugs|12
5206413|NCT01058356|17971020|P1|Overall Study|Adverse Event|5
5206414|NCT01058304|17971027|P2|Overall Study|Developed exclusion criterion|12
5206415|NCT01058304|17971028|P1|Overall Study|Developed exclusion criterion|6
5206416|NCT01058304|17971027|P2|Overall Study|Lost to Follow-up|16
5206417|NCT01058304|17971028|P1|Overall Study|Lost to Follow-up|13
5206418|NCT01058304|17971027|P2|Overall Study|Withdrawal by Subject|5
5206419|NCT01058304|17971028|P1|Overall Study|Withdrawal by Subject|8
5206420|NCT01058265|17971038|P2|Overall Study|Lost to Follow-up|12
5206421|NCT01058265|17971039|P1|Overall Study|Lost to Follow-up|11
5206422|NCT01058096|17971058|P2|Double-blind Treatment Phase|Other Unspecified|0
5206423|NCT01058096|17971059|P1|Double-blind Treatment Phase|Other Unspecified|2
5206424|NCT01058096|17971058|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5206425|NCT01058096|17971059|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5206426|NCT01058096|17971058|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
5206427|NCT01058096|17971059|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
5206428|NCT01058096|17971058|P2|Double-blind Treatment Phase|Protocol Violation|1
5206429|NCT01058096|17971059|P1|Double-blind Treatment Phase|Protocol Violation|2
5206430|NCT01058096|17971058|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
5206431|NCT01058096|17971059|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
5206432|NCT01058096|17971058|P2|Double-blind Treatment Phase|Adverse Event|15
5206433|NCT01058096|17971059|P1|Double-blind Treatment Phase|Adverse Event|11
5206434|NCT01058005|17971075|P3|Overall Study|Reason Missing|1
5206435|NCT01058005|17971076|P2|Overall Study|Reason Missing|3
5206436|NCT01058005|17971077|P1|Overall Study|Reason Missing|5
5206437|NCT01058005|17971075|P3|Overall Study|Withdrawn Due to Study Termination|7
5206438|NCT01058005|17971076|P2|Overall Study|Withdrawn Due to Study Termination|13
5206439|NCT01058005|17971077|P1|Overall Study|Withdrawn Due to Study Termination|27
5206440|NCT01058005|17971075|P3|Overall Study|Withdrawal by Subject|11
5206441|NCT01058005|17971076|P2|Overall Study|Withdrawal by Subject|5
5206442|NCT01058005|17971077|P1|Overall Study|Withdrawal by Subject|4
5206443|NCT01058005|17971075|P3|Overall Study|Physician Decision|0
5206444|NCT01058005|17971076|P2|Overall Study|Physician Decision|2
5206445|NCT01058005|17971077|P1|Overall Study|Physician Decision|2
5206446|NCT01058005|17971075|P3|Overall Study|Adverse Event|1
5206447|NCT01058005|17971076|P2|Overall Study|Adverse Event|2
5206448|NCT01058005|17971077|P1|Overall Study|Adverse Event|0
5206449|NCT01057862|17971112|P2|Overall Study|Withdrawal by Subject|2
5206450|NCT01057862|17971113|P1|Overall Study|Withdrawal by Subject|1
5206451|NCT01057810|17971123|P2|Overall Study|Other|14
5206452|NCT01057810|17971124|P1|Overall Study|Other|7
5206453|NCT01057810|17971123|P2|Overall Study|No longer met study criteria|1
5206454|NCT01057810|17971124|P1|Overall Study|No longer met study criteria|0
5206455|NCT01057810|17971123|P2|Overall Study|Poor/non-compliance|1
5206456|NCT01057810|17971124|P1|Overall Study|Poor/non-compliance|0
5206457|NCT01057810|17971123|P2|Overall Study|Maximum clinical benefit|5
5206458|NCT01057810|17971124|P1|Overall Study|Maximum clinical benefit|5
5206459|NCT01057810|17971123|P2|Overall Study|Death|12
5206460|NCT01057810|17971124|P1|Overall Study|Death|2
5206461|NCT01057810|17971123|P2|Overall Study|Withdrawal by Subject|25
5206462|NCT01057810|17971124|P1|Overall Study|Withdrawal by Subject|10
5206463|NCT01057810|17971123|P2|Overall Study|Adverse event unrelated to study drug|29
5206464|NCT01057810|17971124|P1|Overall Study|Adverse event unrelated to study drug|13
5206465|NCT01057810|17971123|P2|Overall Study|Study drug toxicity|114
5206466|NCT01057810|17971124|P1|Overall Study|Study drug toxicity|5
5206467|NCT01057810|17971123|P2|Overall Study|Disease progression|197
5206468|NCT01057810|17971124|P1|Overall Study|Disease progression|156
5206469|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
5206470|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
5206471|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
5206472|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
5206473|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
5206474|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
5206475|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
5206476|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
5206477|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
5206478|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
5206479|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
5206480|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
5206481|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
5206482|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
5206483|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
5206484|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
5206485|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
5206486|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
5206487|NCT01057693|17971140|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
5206488|NCT01057693|17971141|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
5206489|NCT01057693|17971142|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
5206490|NCT01057693|17971140|P3|Between Single-Blind and Double-Blind|Other|0
5206491|NCT01057693|17971141|P2|Between Single-Blind and Double-Blind|Other|0
5206492|NCT01057693|17971142|P1|Between Single-Blind and Double-Blind|Other|6
5206493|NCT01057693|17971140|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
5206494|NCT01057693|17971141|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
5206495|NCT01057693|17971142|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
5206496|NCT01057693|17971140|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
5206497|NCT01057693|17971141|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
5206498|NCT01057693|17971142|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
5206499|NCT01057693|17971140|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
5206500|NCT01057693|17971141|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
5206501|NCT01057693|17971142|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
5206502|NCT01057693|17971140|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
5206503|NCT01057693|17971141|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
5206504|NCT01057693|17971142|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
5206505|NCT01057693|17971140|P3|Between Single-Blind and Double-Blind|Adverse Event|0
5206506|NCT01057693|17971141|P2|Between Single-Blind and Double-Blind|Adverse Event|0
5206507|NCT01057693|17971142|P1|Between Single-Blind and Double-Blind|Adverse Event|5
5206508|NCT01057693|17971140|P3|Single-Blind Phase (Up to Week 6)|Other|0
5206509|NCT01057693|17971141|P2|Single-Blind Phase (Up to Week 6)|Other|0
5206510|NCT01057693|17971142|P1|Single-Blind Phase (Up to Week 6)|Other|2
5206511|NCT01057693|17971140|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
5206512|NCT01057693|17971141|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
5206513|NCT01057693|17971142|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
5206514|NCT01057693|17971140|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
5206515|NCT01057693|17971141|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
5206516|NCT01057693|17971142|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
5206517|NCT01057693|17971140|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
5206518|NCT01057693|17971141|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
5206519|NCT01057693|17971142|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
5206520|NCT01057693|17971140|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
5206521|NCT01057693|17971141|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
5206522|NCT01057693|17971142|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
5206523|NCT01057693|17971140|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
5206524|NCT01057693|17971141|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
5206525|NCT01057693|17971142|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
5206526|NCT01057589|17971188|P1|Overall Study|Lost to Follow-up|1
5206527|NCT01057589|17971188|P1|Overall Study|Death|8
5206528|NCT01057589|17971188|P1|Overall Study|Sponsor Decision|1
5206529|NCT01057589|17971188|P1|Overall Study|Withdrawal by Subject|3
5206530|NCT01057589|17971188|P1|Overall Study|Physician Decision|8
5206531|NCT01057589|17971188|P1|Overall Study|Adverse Event|10
5206532|NCT01057589|17971188|P1|Overall Study|Disease Progression|35
5206533|NCT01057433|17971197|P1|Overall Study|Adverse Event|1
5206534|NCT01057394|17971201|P2|Overall Study|Not eligible|2
5206535|NCT01057394|17971202|P1|Overall Study|Not eligible|0
5206536|NCT01057251|17971212|P2|Overall Study|Other Reason|1
5206537|NCT01057251|17971213|P1|Overall Study|Other Reason|1
5206538|NCT01057251|17971212|P2|Overall Study|Lost to Follow-up|6
5206539|NCT01057251|17971213|P1|Overall Study|Lost to Follow-up|7
5206540|NCT01057251|17971212|P2|Overall Study|Withdrawal by Subject|5
5206541|NCT01057251|17971213|P1|Overall Study|Withdrawal by Subject|4
5206542|NCT01057251|17971212|P2|Overall Study|Protocol Violation|2
5206543|NCT01057251|17971213|P1|Overall Study|Protocol Violation|6
5206544|NCT01057251|17971212|P2|Overall Study|Lack of Efficacy|11
5206545|NCT01057251|17971213|P1|Overall Study|Lack of Efficacy|2
5206546|NCT01057251|17971212|P2|Overall Study|Adverse Event|2
5206547|NCT01057251|17971213|P1|Overall Study|Adverse Event|4
5206548|NCT01057251|17971212|P2|Overall Study|Did not meet InclusionExclusion criteria|2
5206549|NCT01057251|17971213|P1|Overall Study|Did not meet InclusionExclusion criteria|4
5206550|NCT01056822|17971291|P2|Overall Study|Lost to Follow-up|0
5206551|NCT01056822|17971292|P1|Overall Study|Lost to Follow-up|1
5206552|NCT01056822|17971291|P2|Overall Study|Withdrawal by Subject|1
5206553|NCT01056822|17971292|P1|Overall Study|Withdrawal by Subject|1
5206554|NCT01056822|17971291|P2|Overall Study|Protocol Violation|5
5206555|NCT01056822|17971292|P1|Overall Study|Protocol Violation|6
5206556|NCT01056822|17971291|P2|Overall Study|Adverse Event|1
5206557|NCT01056822|17971292|P1|Overall Study|Adverse Event|0
5206558|NCT01056718|17971341|P1|Overall Study|Ischemia on baseline stress test|1
5206559|NCT01056718|17971341|P1|Overall Study|Withdrawal by Subject|2
5206560|NCT01056653|17971374|P3|Overall Study|Lost to Follow-up|2
5206561|NCT01056653|17971375|P2|Overall Study|Lost to Follow-up|0
5206562|NCT01056653|17971376|P1|Overall Study|Lost to Follow-up|0
5206563|NCT01056640|17971392|P2|Overall Study|Death|4
5206564|NCT01056640|17971393|P1|Overall Study|Death|15
5206565|NCT01056640|17971392|P2|Overall Study|Withdrawal by Subject|8
5206566|NCT01056640|17971393|P1|Overall Study|Withdrawal by Subject|11
5206567|NCT01056536|17971408|P3|Overall Study|Lost to Follow-up|248
5206568|NCT01056536|17971409|P2|Overall Study|Lost to Follow-up|116
5206569|NCT01056536|17971410|P1|Overall Study|Lost to Follow-up|202
5206570|NCT01056523|17971421|P7|Overall Study|Death|1
5206571|NCT01056523|17971422|P6|Overall Study|Death|0
5206572|NCT01056523|17971423|P5|Overall Study|Death|0
5206573|NCT01056523|17971424|P4|Overall Study|Death|3
5206574|NCT01056523|17971425|P3|Overall Study|Death|2
5206575|NCT01056523|17971426|P2|Overall Study|Death|0
5206576|NCT01056523|17971427|P1|Overall Study|Death|1
5206577|NCT01056510|17971437|P2|Overall Study|Missing|1
5206578|NCT01056510|17971438|P1|Overall Study|Missing|0
5206579|NCT01056510|17971437|P2|Overall Study|Other|12
5206580|NCT01056510|17971438|P1|Overall Study|Other|10
5206581|NCT01056510|17971437|P2|Overall Study|Lost to Follow-up|6
5206582|NCT01056510|17971438|P1|Overall Study|Lost to Follow-up|5
5206583|NCT01056510|17971437|P2|Overall Study|Physician Decision|5
5206584|NCT01056510|17971438|P1|Overall Study|Physician Decision|4
5206585|NCT01056510|17971437|P2|Overall Study|Noncompliance|3
5206586|NCT01056510|17971438|P1|Overall Study|Noncompliance|1
5206587|NCT01056510|17971437|P2|Overall Study|Death|34
5206588|NCT01056510|17971438|P1|Overall Study|Death|29
5206589|NCT01056510|17971437|P2|Overall Study|Withdrawal by Subject|2
5206590|NCT01056510|17971438|P1|Overall Study|Withdrawal by Subject|4
5206591|NCT01056510|17971437|P2|Overall Study|Dropout Before Start of Treatment|1
5206592|NCT01056510|17971438|P1|Overall Study|Dropout Before Start of Treatment|1
5206593|NCT01056484|17971484|P2|Follow up - Non-randomized|Withdrawal by Subject|2
5206594|NCT01056484|17971485|P1|Follow up - Non-randomized|Withdrawal by Subject|0
5206595|NCT01056484|17971484|P2|Randomized Controlled Trial|Physician Decision|0
5206596|NCT01056484|17971485|P1|Randomized Controlled Trial|Physician Decision|1
5206597|NCT01056484|17971484|P2|Randomized Controlled Trial|Withdrawal by Subject|1
5206598|NCT01056484|17971485|P1|Randomized Controlled Trial|Withdrawal by Subject|6
5206599|NCT01056380|17971501|P2|Overall Study|Lost to Follow-up|3
5206600|NCT01056380|17971502|P1|Overall Study|Lost to Follow-up|2
5206601|NCT01056341|17971529|P5|Overall Study|Other reasons|5
5206602|NCT01056341|17971530|P4|Overall Study|Other reasons|9
5206603|NCT01056341|17971531|P3|Overall Study|Other reasons|8
5206604|NCT01056341|17971532|P2|Overall Study|Other reasons|4
5206605|NCT01056341|17971533|P1|Overall Study|Other reasons|4
5206606|NCT01056341|17971529|P5|Overall Study|Lack of Efficacy|9
5206607|NCT01056341|17971530|P4|Overall Study|Lack of Efficacy|25
5206608|NCT01056341|17971531|P3|Overall Study|Lack of Efficacy|7
5206609|NCT01056341|17971532|P2|Overall Study|Lack of Efficacy|30
5206610|NCT01056341|17971533|P1|Overall Study|Lack of Efficacy|32
5206611|NCT01056341|17971529|P5|Overall Study|Treatment Intolerance|0
5206612|NCT01056341|17971530|P4|Overall Study|Treatment Intolerance|2
5206613|NCT01056341|17971531|P3|Overall Study|Treatment Intolerance|0
5206614|NCT01056341|17971532|P2|Overall Study|Treatment Intolerance|2
5206615|NCT01056341|17971533|P1|Overall Study|Treatment Intolerance|0
5206616|NCT01056289|17971612|P4|Double-blind Phase|Physician Decision|0
5206617|NCT01056289|17971613|P3|Double-blind Phase|Physician Decision|1
5206618|NCT01056289|17971614|P2|Double-blind Phase|Physician Decision|0
5206619|NCT01056289|17971615|P1|Double-blind Phase|Physician Decision|0
5206620|NCT01056289|17971612|P4|Double-blind Phase|Discontinuation symptom|2
5206621|NCT01056289|17971613|P3|Double-blind Phase|Discontinuation symptom|2
5206622|NCT01056289|17971614|P2|Double-blind Phase|Discontinuation symptom|1
5206623|NCT01056289|17971615|P1|Double-blind Phase|Discontinuation symptom|0
5206624|NCT01056289|17971612|P4|Double-blind Phase|Withdrawal by Subject|2
5206625|NCT01056289|17971613|P3|Double-blind Phase|Withdrawal by Subject|4
5206626|NCT01056289|17971614|P2|Double-blind Phase|Withdrawal by Subject|0
5206627|NCT01056289|17971615|P1|Double-blind Phase|Withdrawal by Subject|0
5206628|NCT01056289|17971612|P4|Double-blind Phase|Protocol Violation|1
5206629|NCT01056289|17971613|P3|Double-blind Phase|Protocol Violation|1
5206630|NCT01056289|17971614|P2|Double-blind Phase|Protocol Violation|0
5206631|NCT01056289|17971615|P1|Double-blind Phase|Protocol Violation|0
5206632|NCT01056289|17971612|P4|Double-blind Phase|Other|2
5206633|NCT01056289|17971613|P3|Double-blind Phase|Other|1
5206634|NCT01056289|17971614|P2|Double-blind Phase|Other|0
5206635|NCT01056289|17971615|P1|Double-blind Phase|Other|0
5206636|NCT01056289|17971612|P4|Double-blind Phase|Lost to Follow-up|2
5206637|NCT01056289|17971613|P3|Double-blind Phase|Lost to Follow-up|2
5206638|NCT01056289|17971614|P2|Double-blind Phase|Lost to Follow-up|2
5206639|NCT01056289|17971615|P1|Double-blind Phase|Lost to Follow-up|0
5206640|NCT01056289|17971612|P4|Double-blind Phase|Adverse Event|1
5206641|NCT01056289|17971613|P3|Double-blind Phase|Adverse Event|2
5206642|NCT01056289|17971614|P2|Double-blind Phase|Adverse Event|1
5206643|NCT01056289|17971615|P1|Double-blind Phase|Adverse Event|0
5206644|NCT01056289|17971612|P4|Open-label Phase|Not randomized to Double-blind phase|0
5206645|NCT01056289|17971613|P3|Open-label Phase|Not randomized to Double-blind phase|0
5206646|NCT01056289|17971614|P2|Open-label Phase|Not randomized to Double-blind phase|0
5206647|NCT01056289|17971615|P1|Open-label Phase|Not randomized to Double-blind phase|1
5206648|NCT01056289|17971612|P4|Open-label Phase|Lack of Efficacy|0
5206649|NCT01056289|17971613|P3|Open-label Phase|Lack of Efficacy|0
5206650|NCT01056289|17971614|P2|Open-label Phase|Lack of Efficacy|0
5206651|NCT01056289|17971615|P1|Open-label Phase|Lack of Efficacy|18
5206652|NCT01056289|17971612|P4|Open-label Phase|Withdrawal by Subject|0
5206653|NCT01056289|17971613|P3|Open-label Phase|Withdrawal by Subject|0
5206654|NCT01056289|17971614|P2|Open-label Phase|Withdrawal by Subject|0
5206655|NCT01056289|17971615|P1|Open-label Phase|Withdrawal by Subject|26
5206656|NCT01056289|17971612|P4|Open-label Phase|Protocol Violation|0
5206657|NCT01056289|17971613|P3|Open-label Phase|Protocol Violation|0
5206658|NCT01056289|17971614|P2|Open-label Phase|Protocol Violation|0
5206659|NCT01056289|17971615|P1|Open-label Phase|Protocol Violation|6
5206660|NCT01056289|17971612|P4|Open-label Phase|Other|0
5206661|NCT01056289|17971613|P3|Open-label Phase|Other|0
5206662|NCT01056289|17971614|P2|Open-label Phase|Other|0
5206663|NCT01056289|17971615|P1|Open-label Phase|Other|9
5206664|NCT01056289|17971612|P4|Open-label Phase|Lost to Follow-up|0
5206665|NCT01056289|17971613|P3|Open-label Phase|Lost to Follow-up|0
5206666|NCT01056289|17971614|P2|Open-label Phase|Lost to Follow-up|0
5206667|NCT01056289|17971615|P1|Open-label Phase|Lost to Follow-up|30
5206668|NCT01056289|17971612|P4|Open-label Phase|Adverse Event|0
5206669|NCT01056289|17971613|P3|Open-label Phase|Adverse Event|0
5206670|NCT01056289|17971614|P2|Open-label Phase|Adverse Event|0
5206671|NCT01056289|17971615|P1|Open-label Phase|Adverse Event|29
5206672|NCT01056276|17971632|P2|Maintenance Therapy|Continuing maintenance therapy|14
5206673|NCT01056276|17971633|P1|Maintenance Therapy|Continuing maintenance therapy|0
5206674|NCT01056276|17971632|P2|Maintenance Therapy|Intercurrent Illness|1
5206675|NCT01056276|17971633|P1|Maintenance Therapy|Intercurrent Illness|0
5206676|NCT01056276|17971632|P2|Maintenance Therapy|Withdrawal by Subject|1
5206677|NCT01056276|17971633|P1|Maintenance Therapy|Withdrawal by Subject|0
5206678|NCT01056276|17971632|P2|Maintenance Therapy|Physician Decision|1
5206679|NCT01056276|17971633|P1|Maintenance Therapy|Physician Decision|0
5206680|NCT01056276|17971632|P2|Maintenance Therapy|Progressive Disease|9
5206681|NCT01056276|17971633|P1|Maintenance Therapy|Progressive Disease|0
5206682|NCT01056276|17971632|P2|Maintenance Therapy|Toxicity|2
5206683|NCT01056276|17971633|P1|Maintenance Therapy|Toxicity|0
5206684|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
5206685|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
5206686|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Death|1
5206687|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Death|3
5206688|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Physician Decision|0
5206689|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Physician Decision|3
5206690|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
5206691|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
5206692|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Disease Progression|2
5206693|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Disease Progression|2
5206694|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
5206695|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
5206696|NCT01056276|17971632|P2|Treatment Period-Cycles 1-8|Toxicity|1
5206697|NCT01056276|17971633|P1|Treatment Period-Cycles 1-8|Toxicity|2
5206698|NCT01056263|17971647|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
5206699|NCT01056263|17971647|P1|Overall Study|Objective progression or relapse|1
5206700|NCT01056263|17971647|P1|Overall Study|Neoplasm progression|1
5206701|NCT01056263|17971647|P1|Overall Study|Progressive disease|2
5206702|NCT01056263|17971647|P1|Overall Study|Lack of Efficacy|29
5206703|NCT01056263|17971647|P1|Overall Study|Withdrawal by Subject|1
5206704|NCT01056263|17971647|P1|Overall Study|Death|1
5206705|NCT01056263|17971647|P1|Overall Study|Adverse Event|12
5206706|NCT01056107|17971670|P4|Overall Study|Withdrawal by Subject|0
5206707|NCT01056107|17971671|P3|Overall Study|Withdrawal by Subject|3
5206708|NCT01056107|17971672|P2|Overall Study|Withdrawal by Subject|1
5206709|NCT01056107|17971673|P1|Overall Study|Withdrawal by Subject|0
5206710|NCT01055886|17971730|P2|Overall Study|Withdrawal by PI|1
5206711|NCT01055886|17971731|P1|Overall Study|Withdrawal by PI|0
5206712|NCT01055886|17971730|P2|Overall Study|Lost to Follow-up|1
5206713|NCT01055886|17971731|P1|Overall Study|Lost to Follow-up|1
5206714|NCT01055886|17971730|P2|Overall Study|Withdrawal by Subject|9
5206715|NCT01055886|17971731|P1|Overall Study|Withdrawal by Subject|4
5206716|NCT01055834|17971743|P2|Treatment Period I|Adverse Event|0
5206717|NCT01055834|17971744|P1|Treatment Period I|Adverse Event|1
5206718|NCT01055639|17971829|P2|Overall Study|Withdrawal by Subject|11
5206719|NCT01055639|17971830|P1|Overall Study|Withdrawal by Subject|8
5206720|NCT01055639|17971829|P2|Overall Study|Protocol Violation|5
5206721|NCT01055639|17971830|P1|Overall Study|Protocol Violation|5
5206722|NCT01055639|17971829|P2|Overall Study|Lost to Follow-up|11
5206723|NCT01055639|17971830|P1|Overall Study|Lost to Follow-up|8
5206724|NCT01055639|17971829|P2|Overall Study|Lack of Efficacy|1
5206725|NCT01055639|17971830|P1|Overall Study|Lack of Efficacy|0
5206726|NCT01055639|17971829|P2|Overall Study|Adverse Event|1
5206727|NCT01055639|17971830|P1|Overall Study|Adverse Event|0
5206728|NCT01055613|17971854|P2|Overall Study|Subject Disinterest|1
5206729|NCT01055613|17971855|P1|Overall Study|Subject Disinterest|1
5206730|NCT01055613|17971854|P2|Overall Study|Protocol Violation|1
5206731|NCT01055613|17971855|P1|Overall Study|Protocol Violation|1
5206732|NCT01055613|17971854|P2|Overall Study|Lost to Follow-up|1
5206733|NCT01055613|17971855|P1|Overall Study|Lost to Follow-up|1
5206734|NCT01055613|17971854|P2|Overall Study|Discomfort|1
5206735|NCT01055613|17971855|P1|Overall Study|Discomfort|2
5206736|NCT01055613|17971854|P2|Overall Study|Unacceptable lens fit|0
5206737|NCT01055613|17971855|P1|Overall Study|Unacceptable lens fit|1
5206738|NCT01055613|17971854|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5206739|NCT01055613|17971855|P1|Overall Study|No Longer Meets Eligibility Criteria|3
5206740|NCT01055496|17971865|P2|Overall Study|Other - Unspecified|1
5206741|NCT01055496|17971866|P1|Overall Study|Other - Unspecified|0
5206742|NCT01055496|17971865|P2|Overall Study|Lost to Follow-up|2
5206743|NCT01055496|17971866|P1|Overall Study|Lost to Follow-up|0
5206744|NCT01055496|17971865|P2|Overall Study|Death|23
5206745|NCT01055496|17971866|P1|Overall Study|Death|13
5206746|NCT01055496|17971865|P2|Overall Study|Withdrawal by Subject|4
5206747|NCT01055496|17971866|P1|Overall Study|Withdrawal by Subject|2
5206748|NCT01055457|17971923|P10|Overall Study|Adverse Event|0
5206749|NCT01055457|17971924|P9|Overall Study|Adverse Event|0
5206750|NCT01055457|17971925|P8|Overall Study|Adverse Event|0
5206751|NCT01055457|17971926|P7|Overall Study|Adverse Event|0
5206752|NCT01055457|17971927|P6|Overall Study|Adverse Event|0
5206753|NCT01055457|17971928|P5|Overall Study|Adverse Event|0
5206754|NCT01055457|17971929|P4|Overall Study|Adverse Event|1
5206755|NCT01055457|17971930|P3|Overall Study|Adverse Event|0
5206756|NCT01055457|17971931|P2|Overall Study|Adverse Event|0
5206757|NCT01055457|17971932|P1|Overall Study|Adverse Event|0
5206758|NCT01055457|17971923|P10|Overall Study|Pregnancy|0
5206759|NCT01055457|17971924|P9|Overall Study|Pregnancy|0
5206760|NCT01055457|17971925|P8|Overall Study|Pregnancy|0
5206761|NCT01055457|17971926|P7|Overall Study|Pregnancy|0
5206762|NCT01055457|17971927|P6|Overall Study|Pregnancy|0
5206763|NCT01055457|17971928|P5|Overall Study|Pregnancy|0
5206764|NCT01055457|17971929|P4|Overall Study|Pregnancy|1
5206765|NCT01055457|17971930|P3|Overall Study|Pregnancy|0
5206766|NCT01055457|17971931|P2|Overall Study|Pregnancy|0
5206767|NCT01055457|17971932|P1|Overall Study|Pregnancy|0
5206768|NCT01055457|17971923|P10|Overall Study|Discomfort|0
5206769|NCT01055457|17971924|P9|Overall Study|Discomfort|0
5206770|NCT01055457|17971925|P8|Overall Study|Discomfort|0
5206771|NCT01055457|17971926|P7|Overall Study|Discomfort|0
5206772|NCT01055457|17971927|P6|Overall Study|Discomfort|0
5206773|NCT01055457|17971928|P5|Overall Study|Discomfort|1
5206774|NCT01055457|17971929|P4|Overall Study|Discomfort|0
5206775|NCT01055457|17971930|P3|Overall Study|Discomfort|0
5206776|NCT01055457|17971931|P2|Overall Study|Discomfort|0
5206777|NCT01055457|17971932|P1|Overall Study|Discomfort|0
5206778|NCT01055457|17971923|P10|Overall Study|Subject Ineligible|0
5206779|NCT01055457|17971924|P9|Overall Study|Subject Ineligible|0
5206780|NCT01055457|17971925|P8|Overall Study|Subject Ineligible|0
5206781|NCT01055457|17971926|P7|Overall Study|Subject Ineligible|0
5206782|NCT01055457|17971927|P6|Overall Study|Subject Ineligible|0
5206783|NCT01055457|17971928|P5|Overall Study|Subject Ineligible|1
5206784|NCT01055457|17971929|P4|Overall Study|Subject Ineligible|0
5206785|NCT01055457|17971930|P3|Overall Study|Subject Ineligible|1
5206786|NCT01055457|17971931|P2|Overall Study|Subject Ineligible|0
5206787|NCT01055457|17971932|P1|Overall Study|Subject Ineligible|1
5206788|NCT01055457|17971923|P10|Overall Study|Subject Disinterest|0
5206789|NCT01055457|17971924|P9|Overall Study|Subject Disinterest|0
5206790|NCT01055457|17971925|P8|Overall Study|Subject Disinterest|1
5206791|NCT01055457|17971926|P7|Overall Study|Subject Disinterest|0
5206792|NCT01055457|17971927|P6|Overall Study|Subject Disinterest|0
5206793|NCT01055457|17971928|P5|Overall Study|Subject Disinterest|0
5206794|NCT01055457|17971929|P4|Overall Study|Subject Disinterest|0
5206795|NCT01055457|17971930|P3|Overall Study|Subject Disinterest|0
5206796|NCT01055457|17971931|P2|Overall Study|Subject Disinterest|0
5206797|NCT01055457|17971932|P1|Overall Study|Subject Disinterest|0
5206798|NCT01055457|17971923|P10|Overall Study|Protocol Violation|1
5206799|NCT01055457|17971924|P9|Overall Study|Protocol Violation|0
5206800|NCT01055457|17971925|P8|Overall Study|Protocol Violation|0
5206801|NCT01055457|17971926|P7|Overall Study|Protocol Violation|1
5206802|NCT01055457|17971927|P6|Overall Study|Protocol Violation|2
5206803|NCT01055457|17971928|P5|Overall Study|Protocol Violation|1
5206804|NCT01055457|17971929|P4|Overall Study|Protocol Violation|1
5206805|NCT01055457|17971930|P3|Overall Study|Protocol Violation|1
5206806|NCT01055457|17971931|P2|Overall Study|Protocol Violation|0
5206807|NCT01055457|17971932|P1|Overall Study|Protocol Violation|0
5206808|NCT01055457|17971923|P10|Overall Study|Lost to Follow-up|0
5206809|NCT01055457|17971924|P9|Overall Study|Lost to Follow-up|0
5206810|NCT01055457|17971925|P8|Overall Study|Lost to Follow-up|0
5206811|NCT01055457|17971926|P7|Overall Study|Lost to Follow-up|0
5206812|NCT01055457|17971927|P6|Overall Study|Lost to Follow-up|1
5206813|NCT01055457|17971928|P5|Overall Study|Lost to Follow-up|0
5206814|NCT01055457|17971929|P4|Overall Study|Lost to Follow-up|0
5206815|NCT01055457|17971930|P3|Overall Study|Lost to Follow-up|0
5206816|NCT01055457|17971931|P2|Overall Study|Lost to Follow-up|1
5206817|NCT01055457|17971932|P1|Overall Study|Lost to Follow-up|0
5206818|NCT01055314|17971966|P2|Overall Study|No treatment|0
5206819|NCT01055314|17971967|P1|Overall Study|No treatment|1
5206820|NCT01055314|17971966|P2|Overall Study|Refusal of further protocol therapy|4
5206821|NCT01055314|17971967|P1|Overall Study|Refusal of further protocol therapy|10
5206822|NCT01055314|17971966|P2|Overall Study|Ineligible|5
5206823|NCT01055314|17971967|P1|Overall Study|Ineligible|3
5206824|NCT01055314|17971966|P2|Overall Study|Withdrawal by Subject|0
5206825|NCT01055314|17971967|P1|Overall Study|Withdrawal by Subject|1
5206826|NCT01055314|17971966|P2|Overall Study|Physician Decision|5
5206827|NCT01055314|17971967|P1|Overall Study|Physician Decision|10
5206828|NCT01055314|17971966|P2|Overall Study|Lack of Efficacy|19
5206829|NCT01055314|17971967|P1|Overall Study|Lack of Efficacy|11
5206830|NCT01055314|17971966|P2|Overall Study|Death|1
5206831|NCT01055314|17971967|P1|Overall Study|Death|2
5206832|NCT01055314|17971966|P2|Overall Study|Adverse Event|4
5206833|NCT01055314|17971967|P1|Overall Study|Adverse Event|7
5206834|NCT01055262|17971979|P1|Overall Study|Uncooperativeness|1
5206835|NCT01055262|17971979|P1|Overall Study|Protocol Violation|3
5206836|NCT01055262|17971979|P1|Overall Study|Adverse Event|5
5206837|NCT01055197|17972020|P2|Overall Study|Withdrawal by Subject|0
5206838|NCT01055197|17972021|P1|Overall Study|Withdrawal by Subject|2
5206839|NCT01055197|17972020|P2|Overall Study|Protocol Violation|2
5206840|NCT01055197|17972021|P1|Overall Study|Protocol Violation|7
5206841|NCT01055132|17972056|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
5206842|NCT01055132|17972057|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
5206843|NCT01055132|17972056|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
5206844|NCT01055132|17972057|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
5206845|NCT01055028|17972082|P2|Inter-treatment Period|Did not start Cycle 4|3
5206846|NCT01055028|17972083|P1|Inter-treatment Period|Did not start Cycle 4|0
5206847|NCT01055028|17972082|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
5206848|NCT01055028|17972083|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
5206849|NCT01055028|17972082|P2|Treatment Cycles 1 to 3|Adverse Event|1
5206850|NCT01055028|17972083|P1|Treatment Cycles 1 to 3|Adverse Event|0
5206851|NCT01055028|17972082|P2|Screening|Screen Failure|1
5206852|NCT01055028|17972083|P1|Screening|Screen Failure|1
5206853|NCT01054976|17972097|P1|Overall Study|Other|8
5206854|NCT01054976|17972097|P1|Overall Study|Withdrawal by Subject|4
5206855|NCT01054976|17972097|P1|Overall Study|Uncooperative participations to study|7
5206856|NCT01054976|17972097|P1|Overall Study|Adverse Event|16
5206857|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
5206858|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5206859|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
5206860|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5206861|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5206862|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
5206863|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5206864|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Physician Decision|1
5206865|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Physician Decision|1
5206866|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Physician Decision|3
5206867|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Physician Decision|6
5206868|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5206869|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Physician Decision|4
5206870|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5206871|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5206872|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5206873|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5206874|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5206875|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5206876|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5206877|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5206878|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
5206879|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5206880|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5206881|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5206882|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
5206883|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5206884|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5206885|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
5206886|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
5206887|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5206888|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5206889|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
5206890|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5206891|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
5206892|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
5206893|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
5206894|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
5206895|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5206896|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
5206897|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
5206898|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5206899|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
5206970|NCT01054729|17972195|P3|Overall Study|Subject moved|1
5206900|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
5206901|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
5206902|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
5206903|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
5206904|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
5206905|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5206906|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5206907|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
5206908|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5206909|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
5206910|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5206911|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5206912|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5206913|NCT01054885|17972118|P7|24-week, Double-blind Treatment Period|Adverse Event|19
5206914|NCT01054885|17972119|P6|24-week, Double-blind Treatment Period|Adverse Event|17
5206915|NCT01054885|17972120|P5|24-week, Double-blind Treatment Period|Adverse Event|15
5206916|NCT01054885|17972121|P4|24-week, Double-blind Treatment Period|Adverse Event|15
5206917|NCT01054885|17972122|P3|24-week, Double-blind Treatment Period|Adverse Event|12
5206918|NCT01054885|17972123|P2|24-week, Double-blind Treatment Period|Adverse Event|18
5206919|NCT01054885|17972124|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5206920|NCT01054885|17972118|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5206921|NCT01054885|17972119|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5206922|NCT01054885|17972120|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5206923|NCT01054885|17972121|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5206924|NCT01054885|17972122|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5206925|NCT01054885|17972123|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5206926|NCT01054885|17972124|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
5206927|NCT01054885|17972118|P7|2-week, Single-blind Run-In Period|Adverse Event|0
5206928|NCT01054885|17972119|P6|2-week, Single-blind Run-In Period|Adverse Event|0
5206929|NCT01054885|17972120|P5|2-week, Single-blind Run-In Period|Adverse Event|0
5206930|NCT01054885|17972121|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5206931|NCT01054885|17972122|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5206932|NCT01054885|17972123|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5206933|NCT01054885|17972124|P1|2-week, Single-blind Run-In Period|Adverse Event|7
5206934|NCT01054885|17972118|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5206935|NCT01054885|17972119|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5206936|NCT01054885|17972120|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5206937|NCT01054885|17972121|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5206938|NCT01054885|17972122|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5206939|NCT01054885|17972123|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5206940|NCT01054885|17972124|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
5206941|NCT01054885|17972118|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5206942|NCT01054885|17972119|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5206943|NCT01054885|17972120|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5206944|NCT01054885|17972121|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5206945|NCT01054885|17972122|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5206946|NCT01054885|17972123|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5206947|NCT01054885|17972124|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
5206948|NCT01054885|17972118|P7|2-week, Single-blind Run-In Period|Physician Decision|0
5206949|NCT01054885|17972119|P6|2-week, Single-blind Run-In Period|Physician Decision|0
5206950|NCT01054885|17972120|P5|2-week, Single-blind Run-In Period|Physician Decision|0
5206951|NCT01054885|17972121|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5206952|NCT01054885|17972122|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5206953|NCT01054885|17972123|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5206954|NCT01054885|17972124|P1|2-week, Single-blind Run-In Period|Physician Decision|6
5206955|NCT01054885|17972118|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5206956|NCT01054885|17972119|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5206957|NCT01054885|17972120|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5206958|NCT01054885|17972121|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5206959|NCT01054885|17972122|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5206960|NCT01054885|17972123|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5206961|NCT01054885|17972124|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
5206962|NCT01054846|17972164|P2|Overall Study|Lost to Follow-up|17
5206963|NCT01054846|17972165|P1|Overall Study|Lost to Follow-up|76
5206964|NCT01054820|17972172|P1|Overall Study|Withdrawal by Subject|2
5206965|NCT01054729|17972194|P4|Overall Study|Lack of Efficacy|1
5206966|NCT01054729|17972195|P3|Overall Study|Lack of Efficacy|0
5206967|NCT01054729|17972196|P2|Overall Study|Lack of Efficacy|0
5206968|NCT01054729|17972197|P1|Overall Study|Lack of Efficacy|0
5206969|NCT01054729|17972194|P4|Overall Study|Subject moved|0
5206971|NCT01054729|17972196|P2|Overall Study|Subject moved|0
5206972|NCT01054729|17972197|P1|Overall Study|Subject moved|0
5206973|NCT01054729|17972194|P4|Overall Study|Personal/Obligations|0
5206974|NCT01054729|17972195|P3|Overall Study|Personal/Obligations|0
5206975|NCT01054729|17972196|P2|Overall Study|Personal/Obligations|1
5206976|NCT01054729|17972197|P1|Overall Study|Personal/Obligations|0
5206977|NCT01054729|17972194|P4|Overall Study|PEG/RBV Non-responder|0
5206978|NCT01054729|17972195|P3|Overall Study|PEG/RBV Non-responder|1
5206979|NCT01054729|17972196|P2|Overall Study|PEG/RBV Non-responder|0
5206980|NCT01054729|17972197|P1|Overall Study|PEG/RBV Non-responder|1
5206981|NCT01054729|17972194|P4|Overall Study|Non-responder|1
5206982|NCT01054729|17972195|P3|Overall Study|Non-responder|1
5206983|NCT01054729|17972196|P2|Overall Study|Non-responder|0
5206984|NCT01054729|17972197|P1|Overall Study|Non-responder|1
5206985|NCT01054729|17972194|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
5206986|NCT01054729|17972195|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
5206987|NCT01054729|17972196|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
5206988|NCT01054729|17972197|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
5206989|NCT01054729|17972194|P4|Overall Study|Lost to Follow-up|0
5206990|NCT01054729|17972195|P3|Overall Study|Lost to Follow-up|0
5206991|NCT01054729|17972196|P2|Overall Study|Lost to Follow-up|1
5206992|NCT01054729|17972197|P1|Overall Study|Lost to Follow-up|0
5206993|NCT01054729|17972194|P4|Overall Study|Withdrawal by Subject|0
5206994|NCT01054729|17972195|P3|Overall Study|Withdrawal by Subject|1
5206995|NCT01054729|17972196|P2|Overall Study|Withdrawal by Subject|0
5206996|NCT01054729|17972197|P1|Overall Study|Withdrawal by Subject|1
5206997|NCT01054729|17972194|P4|Overall Study|Adverse Event|1
5206998|NCT01054729|17972195|P3|Overall Study|Adverse Event|2
5206999|NCT01054729|17972196|P2|Overall Study|Adverse Event|1
5207000|NCT01054729|17972197|P1|Overall Study|Adverse Event|1
5207001|NCT01054729|17972194|P4|Overall Study|Randomized but Not Treated|0
5207002|NCT01054729|17972195|P3|Overall Study|Randomized but Not Treated|0
5207003|NCT01054729|17972196|P2|Overall Study|Randomized but Not Treated|1
5207004|NCT01054729|17972197|P1|Overall Study|Randomized but Not Treated|0
5207005|NCT01054599|17972295|P2|Overall Study|Withdrawal by Subject|1
5207006|NCT01054599|17972296|P1|Overall Study|Withdrawal by Subject|0
5207007|NCT01054599|17972295|P2|Overall Study|Adverse Event|1
5207008|NCT01054599|17972296|P1|Overall Study|Adverse Event|0
5207009|NCT01054599|17972295|P2|Overall Study|Lost to Follow-up|2
5207010|NCT01054599|17972296|P1|Overall Study|Lost to Follow-up|0
5207011|NCT01054599|17972295|P2|Overall Study|Visual impairment, WTAR <80|1
5207012|NCT01054599|17972296|P1|Overall Study|Visual impairment, WTAR <80|0
5207013|NCT01054599|17972295|P2|Overall Study|Timing/scheduling difficulties|1
5207014|NCT01054599|17972296|P1|Overall Study|Timing/scheduling difficulties|1
5207015|NCT01054599|17972295|P2|Overall Study|Spells/seizure-like episodes|1
5207016|NCT01054599|17972296|P1|Overall Study|Spells/seizure-like episodes|1
5207017|NCT01054599|17972295|P2|Overall Study|Protocol Violation|0
5207018|NCT01054599|17972296|P1|Overall Study|Protocol Violation|1
5207019|NCT01054599|17972295|P2|Overall Study|Dizziness due to phenytoin toxicity|0
5207020|NCT01054599|17972296|P1|Overall Study|Dizziness due to phenytoin toxicity|1
5207021|NCT01054573|17972403|P4|Overall Study|Withdrawal by Subject|1
5207022|NCT01054573|17972404|P3|Overall Study|Withdrawal by Subject|2
5207023|NCT01054573|17972405|P2|Overall Study|Withdrawal by Subject|2
5207024|NCT01054573|17972406|P1|Overall Study|Withdrawal by Subject|0
5207025|NCT01054573|17972403|P4|Overall Study|Lost to Follow-up|0
5207026|NCT01054573|17972404|P3|Overall Study|Lost to Follow-up|0
5207027|NCT01054573|17972405|P2|Overall Study|Lost to Follow-up|2
5207028|NCT01054573|17972406|P1|Overall Study|Lost to Follow-up|0
5207029|NCT01054573|17972403|P4|Overall Study|Adverse Event|1
5207030|NCT01054573|17972404|P3|Overall Study|Adverse Event|1
5207031|NCT01054573|17972405|P2|Overall Study|Adverse Event|0
5207032|NCT01054573|17972406|P1|Overall Study|Adverse Event|1
5207033|NCT01054560|17972452|P2|Overall Study|Physician Decision|0
5207034|NCT01054560|17972453|P1|Overall Study|Physician Decision|1
5207035|NCT01054560|17972452|P2|Overall Study|Withdrawal by Subject|2
5207036|NCT01054560|17972453|P1|Overall Study|Withdrawal by Subject|0
5207037|NCT01054560|17972452|P2|Overall Study|Lost to Follow-up|5
5207038|NCT01054560|17972453|P1|Overall Study|Lost to Follow-up|2
5207039|NCT01054560|17972452|P2|Overall Study|Death|21
5207040|NCT01054560|17972453|P1|Overall Study|Death|10
5207041|NCT01054300|17972505|P4|Period 2|Withdrawal by Subject|0
5207042|NCT01054300|17972506|P3|Period 2|Withdrawal by Subject|1
5207043|NCT01054300|17972507|P2|Period 2|Withdrawal by Subject|0
5207044|NCT01054300|17972508|P1|Period 2|Withdrawal by Subject|0
5207045|NCT01054300|17972505|P4|Period 1|Adverse Event|0
5207046|NCT01054300|17972506|P3|Period 1|Adverse Event|0
5207047|NCT01054300|17972507|P2|Period 1|Adverse Event|0
5207048|NCT01054300|17972508|P1|Period 1|Adverse Event|1
5207049|NCT01054222|17972558|P1|Overall Study|Withdrawal by Subject|6
5207050|NCT01054222|17972558|P1|Overall Study|Lost to Follow-up|4
5207051|NCT01054222|17972558|P1|Overall Study|Lack of Efficacy|1
5207052|NCT01054170|17972599|P2|Overall Study|Adverse Event|4
5207053|NCT01054170|17972600|P1|Overall Study|Adverse Event|0
5207054|NCT01054170|17972599|P2|Overall Study|Withdrawal by Subject|2
5207055|NCT01054170|17972600|P1|Overall Study|Withdrawal by Subject|3
5207056|NCT01054170|17972599|P2|Overall Study|Protocol Violation|0
5207057|NCT01054170|17972600|P1|Overall Study|Protocol Violation|1
5207058|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5207059|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
5207060|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5207061|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5207062|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
5207063|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5207064|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Physician Decision|4
5207065|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Physician Decision|5
5207066|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Physician Decision|5
5207067|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Physician Decision|2
5207068|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Physician Decision|5
5207069|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5207070|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5207071|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5207072|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5207073|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5207074|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
5207075|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5207076|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
5207077|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5207078|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
5207079|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
5207080|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
5207081|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5207082|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
5207083|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
5207084|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5207085|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
5207086|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
5207087|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5207088|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
5207089|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
5207090|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5207091|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
5207092|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
5207093|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5207094|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5207095|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5207096|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5207097|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5207098|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5207099|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5207100|NCT01053988|17972665|P6|24-week, Double-blind Treatment Period|Adverse Event|14
5207101|NCT01053988|17972666|P5|24-week, Double-blind Treatment Period|Adverse Event|17
5207102|NCT01053988|17972667|P4|24-week, Double-blind Treatment Period|Adverse Event|24
5207103|NCT01053988|17972668|P3|24-week, Double-blind Treatment Period|Adverse Event|23
5207104|NCT01053988|17972669|P2|24-week, Double-blind Treatment Period|Adverse Event|15
5207105|NCT01053988|17972670|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5207106|NCT01053988|17972665|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5207107|NCT01053988|17972666|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5207108|NCT01053988|17972667|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5207109|NCT01053988|17972668|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5207110|NCT01053988|17972669|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5207111|NCT01053988|17972670|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
5207112|NCT01053988|17972665|P6|2-week, Single-blind Run-In Period|Physician Decision|0
5207113|NCT01053988|17972666|P5|2-week, Single-blind Run-In Period|Physician Decision|0
5207114|NCT01053988|17972667|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5207115|NCT01053988|17972668|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5207116|NCT01053988|17972669|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5207117|NCT01053988|17972670|P1|2-week, Single-blind Run-In Period|Physician Decision|5
5207118|NCT01053988|17972665|P6|2-week, Single-blind Run-In Period|Adverse Event|0
5207119|NCT01053988|17972666|P5|2-week, Single-blind Run-In Period|Adverse Event|0
5207120|NCT01053988|17972667|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5207121|NCT01053988|17972668|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5207122|NCT01053988|17972669|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5207123|NCT01053988|17972670|P1|2-week, Single-blind Run-In Period|Adverse Event|6
5207124|NCT01053988|17972665|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5207125|NCT01053988|17972666|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5207126|NCT01053988|17972667|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5207127|NCT01053988|17972668|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5207128|NCT01053988|17972669|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5207129|NCT01053988|17972670|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
5207130|NCT01053988|17972665|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5207131|NCT01053988|17972666|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5207132|NCT01053988|17972667|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5207133|NCT01053988|17972668|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5207134|NCT01053988|17972669|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5207135|NCT01053988|17972670|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
5207136|NCT01053988|17972665|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5207137|NCT01053988|17972666|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5207138|NCT01053988|17972667|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5207139|NCT01053988|17972668|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5207140|NCT01053988|17972669|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5207141|NCT01053988|17972670|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
5207142|NCT01053962|17972707|P5|Treatment Period|Noncompliance with protocol|0
5207143|NCT01053962|17972708|P4|Treatment Period|Noncompliance with protocol|0
5207144|NCT01053962|17972709|P3|Treatment Period|Noncompliance with protocol|0
5207145|NCT01053962|17972710|P2|Treatment Period|Noncompliance with protocol|0
5207146|NCT01053962|17972711|P1|Treatment Period|Noncompliance with protocol|1
5207147|NCT01053962|17972707|P5|Treatment Period|Withdrawal by Subject|1
5207148|NCT01053962|17972708|P4|Treatment Period|Withdrawal by Subject|0
5207149|NCT01053962|17972709|P3|Treatment Period|Withdrawal by Subject|0
5207150|NCT01053962|17972710|P2|Treatment Period|Withdrawal by Subject|0
5207151|NCT01053962|17972711|P1|Treatment Period|Withdrawal by Subject|0
5207152|NCT01053962|17972707|P5|Treatment Period|Adverse Event|1
5207153|NCT01053962|17972708|P4|Treatment Period|Adverse Event|0
5207154|NCT01053962|17972709|P3|Treatment Period|Adverse Event|0
5207155|NCT01053962|17972710|P2|Treatment Period|Adverse Event|0
5207156|NCT01053962|17972711|P1|Treatment Period|Adverse Event|0
5207157|NCT01053962|17972707|P5|Treatment Period|Lack of Efficacy|1
5207158|NCT01053962|17972708|P4|Treatment Period|Lack of Efficacy|0
5207159|NCT01053962|17972709|P3|Treatment Period|Lack of Efficacy|0
5207160|NCT01053962|17972710|P2|Treatment Period|Lack of Efficacy|0
5207161|NCT01053962|17972711|P1|Treatment Period|Lack of Efficacy|0
5207162|NCT01053962|17972707|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
5207163|NCT01053962|17972708|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
5207164|NCT01053962|17972709|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
5207165|NCT01053962|17972710|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
5207166|NCT01053962|17972711|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
5207167|NCT01053962|17972707|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
5207168|NCT01053962|17972708|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
5207169|NCT01053962|17972709|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
5207170|NCT01053962|17972710|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
5207171|NCT01053962|17972711|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
5207172|NCT01053962|17972707|P5|Pretreatment Period|Venipuncture Failure|0
5207173|NCT01053962|17972708|P4|Pretreatment Period|Venipuncture Failure|0
5207174|NCT01053962|17972709|P3|Pretreatment Period|Venipuncture Failure|1
5207175|NCT01053962|17972710|P2|Pretreatment Period|Venipuncture Failure|0
5207176|NCT01053962|17972711|P1|Pretreatment Period|Venipuncture Failure|0
5207177|NCT01053962|17972707|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
5207178|NCT01053962|17972708|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
5207179|NCT01053962|17972709|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5207180|NCT01053962|17972710|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5207181|NCT01053962|17972711|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5207182|NCT01053741|17972762|P2|2nd Study Intervention|Physician Decision|1
5207183|NCT01053741|17972763|P1|2nd Study Intervention|Physician Decision|0
5207184|NCT01053663|17972772|P1|Overall Study|Negative Influenza Diagnosis|1
5207185|NCT01053663|17972772|P1|Overall Study|Transferred to Another Hospital|1
5207186|NCT01053663|17972772|P1|Overall Study|Poor IV Access|1
5207187|NCT01053663|17972772|P1|Overall Study|Lost to Follow-up|1
5207188|NCT01053663|17972772|P1|Overall Study|Death|2
5207189|NCT01053429|17972830|P1|Overall Study|Other|309
5207190|NCT01053429|17972830|P1|Overall Study|Adverse Event|64
5207191|NCT01053247|17972860|P3|Overall Study|Adverse Event|3
5207192|NCT01053247|17972861|P2|Overall Study|Adverse Event|9
5207193|NCT01053247|17972862|P1|Overall Study|Adverse Event|0
5207194|NCT01053247|17972860|P3|Overall Study|Lost to Follow-up|7
5207195|NCT01053247|17972861|P2|Overall Study|Lost to Follow-up|5
5207196|NCT01053247|17972862|P1|Overall Study|Lost to Follow-up|8
5207197|NCT01053247|17972860|P3|Overall Study|Protocol Violation|2
5207198|NCT01053247|17972861|P2|Overall Study|Protocol Violation|1
5207199|NCT01053247|17972862|P1|Overall Study|Protocol Violation|2
5207200|NCT01053247|17972860|P3|Overall Study|Lack of Efficacy|1
5207201|NCT01053247|17972861|P2|Overall Study|Lack of Efficacy|0
5207202|NCT01053247|17972862|P1|Overall Study|Lack of Efficacy|1
5207203|NCT01053247|17972860|P3|Overall Study|Withdrawal by Subject|15
5207204|NCT01053247|17972861|P2|Overall Study|Withdrawal by Subject|4
5207205|NCT01053247|17972862|P1|Overall Study|Withdrawal by Subject|9
5207206|NCT01053221|17972872|P2|Overall Study|The study was closed prematurely|9
5207207|NCT01053221|17972873|P1|Overall Study|The study was closed prematurely|5
5207208|NCT01052844|17972975|P2|Overall Study|Adverse Event|1
5207209|NCT01052844|17972976|P1|Overall Study|Adverse Event|0
5207210|NCT01052779|17972997|P2|Overall Study|Other-Missed Week 5 Visit|0
5207211|NCT01052779|17972998|P1|Overall Study|Other-Missed Week 5 Visit|2
5207212|NCT01052779|17972997|P2|Overall Study|Other-Surgery|2
5207213|NCT01052779|17972998|P1|Overall Study|Other-Surgery|0
5207214|NCT01052779|17972997|P2|Overall Study|Other-Protocol Violation|1
5207215|NCT01052779|17972998|P1|Overall Study|Other-Protocol Violation|1
5207216|NCT01052779|17972997|P2|Overall Study|Withdrawal by Subject|2
5207217|NCT01052779|17972998|P1|Overall Study|Withdrawal by Subject|1
5207218|NCT01052779|17972997|P2|Overall Study|Adverse Event|4
5207219|NCT01052779|17972998|P1|Overall Study|Adverse Event|1
5207220|NCT01052714|17973008|P3|Overall Study|Withdrawal by Subject|1
5207221|NCT01052714|17973009|P2|Overall Study|Withdrawal by Subject|12
5207222|NCT01052714|17973010|P1|Overall Study|Withdrawal by Subject|7
5207223|NCT01052714|17973008|P3|Overall Study|Physician Decision|1
5207224|NCT01052714|17973009|P2|Overall Study|Physician Decision|9
5207225|NCT01052714|17973010|P1|Overall Study|Physician Decision|9
5207226|NCT01052714|17973008|P3|Overall Study|Lost to Follow-up|0
5207227|NCT01052714|17973009|P2|Overall Study|Lost to Follow-up|3
5207228|NCT01052714|17973010|P1|Overall Study|Lost to Follow-up|2
5207229|NCT01052714|17973008|P3|Overall Study|Death|0
5207230|NCT01052714|17973009|P2|Overall Study|Death|2
5207231|NCT01052714|17973010|P1|Overall Study|Death|1
5207232|NCT01052714|17973008|P3|Overall Study|Adverse Event|0
5207233|NCT01052714|17973009|P2|Overall Study|Adverse Event|3
5207234|NCT01052714|17973010|P1|Overall Study|Adverse Event|6
5207235|NCT01052662|17973064|P3|Overall Study|Administrative|0
5207236|NCT01052662|17973065|P2|Overall Study|Administrative|3
5207237|NCT01052662|17973066|P1|Overall Study|Administrative|0
5207238|NCT01052662|17973064|P3|Overall Study|Legal Problem|0
5207239|NCT01052662|17973065|P2|Overall Study|Legal Problem|0
5207240|NCT01052662|17973066|P1|Overall Study|Legal Problem|2
5207241|NCT01052662|17973064|P3|Overall Study|Adverse Event|0
5207242|NCT01052662|17973065|P2|Overall Study|Adverse Event|1
5207243|NCT01052662|17973066|P1|Overall Study|Adverse Event|1
5207244|NCT01052662|17973064|P3|Overall Study|Pharmacy issue|3
5207245|NCT01052662|17973065|P2|Overall Study|Pharmacy issue|3
5207246|NCT01052662|17973066|P1|Overall Study|Pharmacy issue|1
5207247|NCT01052662|17973064|P3|Overall Study|Withdrawal by Subject|1
5207248|NCT01052662|17973065|P2|Overall Study|Withdrawal by Subject|2
5207249|NCT01052662|17973066|P1|Overall Study|Withdrawal by Subject|3
5207250|NCT01052662|17973064|P3|Overall Study|Lost to Follow-up|18
5207251|NCT01052662|17973065|P2|Overall Study|Lost to Follow-up|13
5207252|NCT01052662|17973066|P1|Overall Study|Lost to Follow-up|15
5207253|NCT01052480|17973107|P2|Overall Study|Death|5
5207254|NCT01052480|17973108|P1|Overall Study|Death|1
5207255|NCT01052480|17973107|P2|Overall Study|Physician Decision|2
5207256|NCT01052480|17973108|P1|Overall Study|Physician Decision|0
5207257|NCT01052480|17973107|P2|Overall Study|Withdrawal by Subject|7
5207258|NCT01052480|17973108|P1|Overall Study|Withdrawal by Subject|3
5207259|NCT01052480|17973107|P2|Overall Study|Protocol Violation|0
5207260|NCT01052480|17973108|P1|Overall Study|Protocol Violation|1
5207261|NCT01052480|17973107|P2|Overall Study|Lost to Follow-up|3
5207262|NCT01052480|17973108|P1|Overall Study|Lost to Follow-up|3
5207263|NCT01052428|17973158|P2|Overall Study|Withdrawal by Subject|1
5207264|NCT01052428|17973159|P1|Overall Study|Withdrawal by Subject|0
5207265|NCT01052428|17973158|P2|Overall Study|Death|0
5207266|NCT01052428|17973159|P1|Overall Study|Death|1
5207267|NCT01052272|17973181|P4|Overall Study|decline in health|0
5207268|NCT01052272|17973182|P3|Overall Study|decline in health|1
5207269|NCT01052272|17973183|P2|Overall Study|decline in health|0
5207270|NCT01052272|17973184|P1|Overall Study|decline in health|0
5207271|NCT01052272|17973181|P4|Overall Study|placed in long-term care|0
5207272|NCT01052272|17973182|P3|Overall Study|placed in long-term care|1
5207273|NCT01052272|17973183|P2|Overall Study|placed in long-term care|0
5207274|NCT01052272|17973184|P1|Overall Study|placed in long-term care|0
5207275|NCT01052272|17973181|P4|Overall Study|Withdrawal by Subject|2
5207276|NCT01052272|17973182|P3|Overall Study|Withdrawal by Subject|3
5207277|NCT01052272|17973183|P2|Overall Study|Withdrawal by Subject|2
5207278|NCT01052272|17973184|P1|Overall Study|Withdrawal by Subject|0
5207279|NCT01052272|17973181|P4|Overall Study|patient refuses follow-up|4
5207280|NCT01052272|17973182|P3|Overall Study|patient refuses follow-up|2
5207281|NCT01052272|17973183|P2|Overall Study|patient refuses follow-up|4
5207282|NCT01052272|17973184|P1|Overall Study|patient refuses follow-up|5
5207283|NCT01052272|17973181|P4|Overall Study|Physician Decision|0
5207284|NCT01052272|17973182|P3|Overall Study|Physician Decision|0
5207285|NCT01052272|17973183|P2|Overall Study|Physician Decision|1
5207286|NCT01052272|17973184|P1|Overall Study|Physician Decision|0
5207287|NCT01052272|17973181|P4|Overall Study|Death|1
5207288|NCT01052272|17973182|P3|Overall Study|Death|1
5207289|NCT01052272|17973183|P2|Overall Study|Death|0
5207290|NCT01052272|17973184|P1|Overall Study|Death|0
5207291|NCT01052116|17973229|P2|Overall Study|Spirometry not performed|4
5207292|NCT01052116|17973230|P1|Overall Study|Spirometry not performed|0
5207293|NCT01052116|17973229|P2|Overall Study|Withdrawal by Subject|6
5207294|NCT01052116|17973230|P1|Overall Study|Withdrawal by Subject|3
5207295|NCT01052116|17973229|P2|Overall Study|Lost to Follow-up|17
5207296|NCT01052116|17973230|P1|Overall Study|Lost to Follow-up|11
5207297|NCT01052077|17973238|P4|Phase A+|Withdrawal by Subject|7
5207298|NCT01052077|17973239|P3|Phase A+|Withdrawal by Subject|0
5207299|NCT01052077|17973240|P2|Phase A+|Withdrawal by Subject|0
5207300|NCT01052077|17973241|P1|Phase A+|Withdrawal by Subject|0
5207301|NCT01052077|17973238|P4|Phase A+|Met Withdrawal Criteria|2
5207302|NCT01052077|17973239|P3|Phase A+|Met Withdrawal Criteria|0
5207303|NCT01052077|17973240|P2|Phase A+|Met Withdrawal Criteria|0
5207304|NCT01052077|17973241|P1|Phase A+|Met Withdrawal Criteria|0
5207305|NCT01052077|17973238|P4|Phase A+|Adverse Event|4
5207306|NCT01052077|17973239|P3|Phase A+|Adverse Event|0
5207307|NCT01052077|17973240|P2|Phase A+|Adverse Event|0
5207308|NCT01052077|17973241|P1|Phase A+|Adverse Event|0
5207309|NCT01052077|17973238|P4|Phase A+|Lost to Follow-up|8
5207310|NCT01052077|17973239|P3|Phase A+|Lost to Follow-up|0
5207311|NCT01052077|17973240|P2|Phase A+|Lost to Follow-up|0
5207312|NCT01052077|17973241|P1|Phase A+|Lost to Follow-up|0
5207313|NCT01052077|17973238|P4|Phase B|Lack of Efficacy|0
5207314|NCT01052077|17973239|P3|Phase B|Lack of Efficacy|0
5207315|NCT01052077|17973240|P2|Phase B|Lack of Efficacy|1
5207316|NCT01052077|17973241|P1|Phase B|Lack of Efficacy|0
5207317|NCT01052077|17973238|P4|Phase B|Protocol Deviation|0
5207318|NCT01052077|17973239|P3|Phase B|Protocol Deviation|4
5207319|NCT01052077|17973240|P2|Phase B|Protocol Deviation|3
5207320|NCT01052077|17973241|P1|Phase B|Protocol Deviation|0
5207321|NCT01052077|17973238|P4|Phase B|Withdrawal by Subject|0
5207322|NCT01052077|17973239|P3|Phase B|Withdrawal by Subject|5
5207323|NCT01052077|17973240|P2|Phase B|Withdrawal by Subject|0
5207324|NCT01052077|17973241|P1|Phase B|Withdrawal by Subject|0
5207325|NCT01052077|17973238|P4|Phase B|Physician Decision|0
5207326|NCT01052077|17973239|P3|Phase B|Physician Decision|1
5207327|NCT01052077|17973240|P2|Phase B|Physician Decision|1
5207328|NCT01052077|17973241|P1|Phase B|Physician Decision|0
5207329|NCT01052077|17973238|P4|Phase B|Met Withdrawal Criteria|0
5207330|NCT01052077|17973239|P3|Phase B|Met Withdrawal Criteria|1
5207331|NCT01052077|17973240|P2|Phase B|Met Withdrawal Criteria|2
5207332|NCT01052077|17973241|P1|Phase B|Met Withdrawal Criteria|0
5207333|NCT01052077|17973238|P4|Phase B|Adverse Event|0
5207334|NCT01052077|17973239|P3|Phase B|Adverse Event|2
5207335|NCT01052077|17973240|P2|Phase B|Adverse Event|9
5207336|NCT01052077|17973241|P1|Phase B|Adverse Event|0
5207337|NCT01052077|17973238|P4|Phase B|Lost to Follow-up|0
5207338|NCT01052077|17973239|P3|Phase B|Lost to Follow-up|3
5207339|NCT01052077|17973240|P2|Phase B|Lost to Follow-up|2
5207340|NCT01052077|17973241|P1|Phase B|Lost to Follow-up|0
5207341|NCT01052077|17973238|P4|Phase A|Protocol Deviation|0
5207342|NCT01052077|17973239|P3|Phase A|Protocol Deviation|0
5207343|NCT01052077|17973240|P2|Phase A|Protocol Deviation|0
5207344|NCT01052077|17973241|P1|Phase A|Protocol Deviation|27
5207345|NCT01052077|17973238|P4|Phase A|Withdrawal by Subject|0
5207346|NCT01052077|17973239|P3|Phase A|Withdrawal by Subject|0
5207347|NCT01052077|17973240|P2|Phase A|Withdrawal by Subject|0
5207348|NCT01052077|17973241|P1|Phase A|Withdrawal by Subject|29
5207349|NCT01052077|17973238|P4|Phase A|Physician Decision|0
5207350|NCT01052077|17973239|P3|Phase A|Physician Decision|0
5207351|NCT01052077|17973240|P2|Phase A|Physician Decision|0
5207352|NCT01052077|17973241|P1|Phase A|Physician Decision|10
5207353|NCT01052077|17973238|P4|Phase A|Met Withdrawal Criteria|0
5207354|NCT01052077|17973239|P3|Phase A|Met Withdrawal Criteria|0
5207355|NCT01052077|17973240|P2|Phase A|Met Withdrawal Criteria|0
5207356|NCT01052077|17973241|P1|Phase A|Met Withdrawal Criteria|26
5207357|NCT01052077|17973238|P4|Phase A|Adverse Event|0
5207358|NCT01052077|17973239|P3|Phase A|Adverse Event|0
5207359|NCT01052077|17973240|P2|Phase A|Adverse Event|0
5207360|NCT01052077|17973241|P1|Phase A|Adverse Event|32
5207361|NCT01052077|17973238|P4|Phase A|Lost to Follow-up|0
5207362|NCT01052077|17973239|P3|Phase A|Lost to Follow-up|0
5207363|NCT01052077|17973240|P2|Phase A|Lost to Follow-up|0
5207364|NCT01052077|17973241|P1|Phase A|Lost to Follow-up|22
5207365|NCT01052038|17973268|P3|Overall Study|Protocol Violation|3
5207366|NCT01052038|17973269|P2|Overall Study|Protocol Violation|3
5207367|NCT01052038|17973270|P1|Overall Study|Protocol Violation|2
5207368|NCT01052038|17973268|P3|Overall Study|Lost to Follow-up|1
5207369|NCT01052038|17973269|P2|Overall Study|Lost to Follow-up|3
5207370|NCT01052038|17973270|P1|Overall Study|Lost to Follow-up|2
5207371|NCT01051986|17973292|P2|Overall Study|Protocol Violation|3
5207372|NCT01051986|17973293|P1|Overall Study|Protocol Violation|2
5207373|NCT01051986|17973292|P2|Overall Study|Withdrawal by Subject|1
5207374|NCT01051986|17973293|P1|Overall Study|Withdrawal by Subject|2
5207375|NCT01051986|17973292|P2|Overall Study|Death|0
5207376|NCT01051986|17973293|P1|Overall Study|Death|1
5207377|NCT01051960|17973307|P1|Overall Study|Adverse Event|1
5207378|NCT01051921|17973315|P1|Overall Study|patient moved|1
5207379|NCT01051921|17973315|P1|Overall Study|virological failure|1
5207380|NCT01051921|17973315|P1|Overall Study|Lost to Follow-up|4
5207381|NCT01051921|17973315|P1|Overall Study|Withdrawal by Subject|7
5207382|NCT01051921|17973315|P1|Overall Study|Adverse Event|8
5207383|NCT01051921|17973315|P1|Overall Study|Physician Decision|9
5207384|NCT01051856|17973322|P2|Overall Study|Withdrawal by Subject|0
5207385|NCT01051856|17973323|P1|Overall Study|Withdrawal by Subject|1
5207386|NCT01051817|17973333|P2|Overall Study|Protocol Violation|1
5207387|NCT01051817|17973334|P1|Overall Study|Protocol Violation|0
5207388|NCT01051817|17973333|P2|Overall Study|Withdrawal by Subject|5
5207389|NCT01051817|17973334|P1|Overall Study|Withdrawal by Subject|3
5207390|NCT01051817|17973333|P2|Overall Study|Abnormal Test Proceedure reults|1
5207391|NCT01051817|17973334|P1|Overall Study|Abnormal Test Proceedure reults|0
5207392|NCT01051817|17973333|P2|Overall Study|Adverse Event|2
5207393|NCT01051817|17973334|P1|Overall Study|Adverse Event|0
5207394|NCT01051791|17973344|P1|Overall Study|Withdrawal by Subject|1
5207395|NCT01051791|17973344|P1|Overall Study|Failed screening|3
5207396|NCT01051739|17973362|P2|Overall Study|Withdrawal by Subject|10
5207397|NCT01051739|17973363|P1|Overall Study|Withdrawal by Subject|25
5207398|NCT01051739|17973362|P2|Overall Study|Death|3
5207399|NCT01051739|17973363|P1|Overall Study|Death|3
5207400|NCT01051661|17973375|P6|Overall Study|Withdrawal by Subject|34
5207401|NCT01051661|17973376|P5|Overall Study|Withdrawal by Subject|12
5207402|NCT01051661|17973377|P4|Overall Study|Withdrawal by Subject|28
5207403|NCT01051661|17973378|P3|Overall Study|Withdrawal by Subject|13
5207404|NCT01051661|17973379|P2|Overall Study|Withdrawal by Subject|30
5207405|NCT01051661|17973380|P1|Overall Study|Withdrawal by Subject|16
5207406|NCT01051661|17973375|P6|Overall Study|Protocol Violation|1
5207407|NCT01051661|17973376|P5|Overall Study|Protocol Violation|2
5207408|NCT01051661|17973377|P4|Overall Study|Protocol Violation|1
5207409|NCT01051661|17973378|P3|Overall Study|Protocol Violation|0
5207410|NCT01051661|17973379|P2|Overall Study|Protocol Violation|0
5207411|NCT01051661|17973380|P1|Overall Study|Protocol Violation|0
5207412|NCT01051661|17973375|P6|Overall Study|Subject lost legal representation|0
5207413|NCT01051661|17973376|P5|Overall Study|Subject lost legal representation|1
5207414|NCT01051661|17973377|P4|Overall Study|Subject lost legal representation|0
5207415|NCT01051661|17973378|P3|Overall Study|Subject lost legal representation|0
5207416|NCT01051661|17973379|P2|Overall Study|Subject lost legal representation|0
5207417|NCT01051661|17973380|P1|Overall Study|Subject lost legal representation|0
5207418|NCT01051661|17973375|P6|Overall Study|Failure to comply with protocol|0
5207419|NCT01051661|17973376|P5|Overall Study|Failure to comply with protocol|0
5207420|NCT01051661|17973377|P4|Overall Study|Failure to comply with protocol|0
5207421|NCT01051661|17973378|P3|Overall Study|Failure to comply with protocol|2
5207422|NCT01051661|17973379|P2|Overall Study|Failure to comply with protocol|0
5207423|NCT01051661|17973380|P1|Overall Study|Failure to comply with protocol|0
5207424|NCT01051661|17973375|P6|Overall Study|Consent not received from both parents|1
5207425|NCT01051661|17973376|P5|Overall Study|Consent not received from both parents|0
5207426|NCT01051661|17973377|P4|Overall Study|Consent not received from both parents|0
5207427|NCT01051661|17973378|P3|Overall Study|Consent not received from both parents|0
5207428|NCT01051661|17973379|P2|Overall Study|Consent not received from both parents|0
5207429|NCT01051661|17973380|P1|Overall Study|Consent not received from both parents|0
5207430|NCT01051661|17973375|P6|Overall Study|Unable to attend visit(s)|2
5207431|NCT01051661|17973376|P5|Overall Study|Unable to attend visit(s)|3
5207432|NCT01051661|17973377|P4|Overall Study|Unable to attend visit(s)|1
5207433|NCT01051661|17973378|P3|Overall Study|Unable to attend visit(s)|2
5207434|NCT01051661|17973379|P2|Overall Study|Unable to attend visit(s)|4
5207435|NCT01051661|17973380|P1|Overall Study|Unable to attend visit(s)|2
5207436|NCT01051661|17973375|P6|Overall Study|Data not reliable|1
5207437|NCT01051661|17973376|P5|Overall Study|Data not reliable|0
5207438|NCT01051661|17973377|P4|Overall Study|Data not reliable|0
5207439|NCT01051661|17973378|P3|Overall Study|Data not reliable|0
5207440|NCT01051661|17973379|P2|Overall Study|Data not reliable|0
5207441|NCT01051661|17973380|P1|Overall Study|Data not reliable|1
5207442|NCT01051661|17973375|P6|Overall Study|Refused blood sampling|1
5207443|NCT01051661|17973376|P5|Overall Study|Refused blood sampling|0
5207444|NCT01051661|17973377|P4|Overall Study|Refused blood sampling|0
5207445|NCT01051661|17973378|P3|Overall Study|Refused blood sampling|0
5207446|NCT01051661|17973379|P2|Overall Study|Refused blood sampling|0
5207447|NCT01051661|17973380|P1|Overall Study|Refused blood sampling|0
5207448|NCT01051661|17973375|P6|Overall Study|Migrated/moved from study area|3
5207449|NCT01051661|17973376|P5|Overall Study|Migrated/moved from study area|7
5207450|NCT01051661|17973377|P4|Overall Study|Migrated/moved from study area|8
5207451|NCT01051661|17973378|P3|Overall Study|Migrated/moved from study area|6
5207452|NCT01051661|17973379|P2|Overall Study|Migrated/moved from study area|6
5207453|NCT01051661|17973380|P1|Overall Study|Migrated/moved from study area|1
5207454|NCT01051661|17973375|P6|Overall Study|Lost to Follow-up|24
5207455|NCT01051661|17973376|P5|Overall Study|Lost to Follow-up|10
5207456|NCT01051661|17973377|P4|Overall Study|Lost to Follow-up|17
5207457|NCT01051661|17973378|P3|Overall Study|Lost to Follow-up|15
5207458|NCT01051661|17973379|P2|Overall Study|Lost to Follow-up|22
5207459|NCT01051661|17973380|P1|Overall Study|Lost to Follow-up|13
5207460|NCT01051661|17973375|P6|Overall Study|Adverse Event|0
5207461|NCT01051661|17973376|P5|Overall Study|Adverse Event|0
5207462|NCT01051661|17973377|P4|Overall Study|Adverse Event|1
5207463|NCT01051661|17973378|P3|Overall Study|Adverse Event|1
5207464|NCT01051661|17973379|P2|Overall Study|Adverse Event|1
5207465|NCT01051661|17973380|P1|Overall Study|Adverse Event|1
5207466|NCT01051557|17973577|P7|Overall Study|Adverse Event|4
5207467|NCT01051557|17973578|P6|Overall Study|Adverse Event|3
5207468|NCT01051557|17973579|P5|Overall Study|Adverse Event|1
5207469|NCT01051557|17973580|P4|Overall Study|Adverse Event|1
5207470|NCT01051557|17973581|P3|Overall Study|Adverse Event|0
5207471|NCT01051557|17973582|P2|Overall Study|Adverse Event|0
5207472|NCT01051557|17973583|P1|Overall Study|Adverse Event|0
5207473|NCT01051557|17973577|P7|Overall Study|Withdrawal by Subject|1
5207474|NCT01051557|17973578|P6|Overall Study|Withdrawal by Subject|0
5207475|NCT01051557|17973579|P5|Overall Study|Withdrawal by Subject|2
5207476|NCT01051557|17973580|P4|Overall Study|Withdrawal by Subject|0
5207477|NCT01051557|17973581|P3|Overall Study|Withdrawal by Subject|1
5207478|NCT01051557|17973582|P2|Overall Study|Withdrawal by Subject|0
5207479|NCT01051557|17973583|P1|Overall Study|Withdrawal by Subject|0
5207480|NCT01051557|17973577|P7|Overall Study|disease progression|1
5207481|NCT01051557|17973578|P6|Overall Study|disease progression|3
5207482|NCT01051557|17973579|P5|Overall Study|disease progression|4
5207483|NCT01051557|17973580|P4|Overall Study|disease progression|2
5207484|NCT01051557|17973581|P3|Overall Study|disease progression|5
5207485|NCT01051557|17973582|P2|Overall Study|disease progression|3
5207486|NCT01051557|17973583|P1|Overall Study|disease progression|3
5207487|NCT01051557|17973577|P7|Overall Study|Physician Decision|0
5207488|NCT01051557|17973578|P6|Overall Study|Physician Decision|0
5207489|NCT01051557|17973579|P5|Overall Study|Physician Decision|0
5207490|NCT01051557|17973580|P4|Overall Study|Physician Decision|0
5207491|NCT01051557|17973581|P3|Overall Study|Physician Decision|0
5207492|NCT01051557|17973582|P2|Overall Study|Physician Decision|0
5207493|NCT01051557|17973583|P1|Overall Study|Physician Decision|1
5207494|NCT01051466|17973614|P2|Overall Study|Physician Decision|0
5207495|NCT01051466|17973615|P1|Overall Study|Physician Decision|1
5207496|NCT01051466|17973614|P2|Overall Study|Entry Criteria Not Met|3
5207497|NCT01051466|17973615|P1|Overall Study|Entry Criteria Not Met|0
5207498|NCT01051466|17973614|P2|Overall Study|Withdrawal by Subject|1
5207499|NCT01051466|17973615|P1|Overall Study|Withdrawal by Subject|5
5207500|NCT01051466|17973614|P2|Overall Study|Lost to Follow-up|1
5207501|NCT01051466|17973615|P1|Overall Study|Lost to Follow-up|1
5207502|NCT01051466|17973614|P2|Overall Study|Adverse Event|0
5207503|NCT01051466|17973615|P1|Overall Study|Adverse Event|1
5207504|NCT01051349|17973660|P1|Overall Study|Reason not Specified|12
5207505|NCT01051349|17973660|P1|Overall Study|Subject non-compliance|7
5207506|NCT01051349|17973660|P1|Overall Study|Lost to Follow-up|6
5207507|NCT01051349|17973660|P1|Overall Study|Investigator Decision|6
5207508|NCT01051349|17973660|P1|Overall Study|Consent Withdrawn|54
5207509|NCT01051349|17973660|P1|Overall Study|Adverse Event|88
5207510|NCT01051323|17973689|P1|Overall Study|Missing|37
5207511|NCT01051323|17973689|P1|Overall Study|Other|148
5207512|NCT01051323|17973689|P1|Overall Study|Hospitalization|28
5207513|NCT01051323|17973689|P1|Overall Study|Death|129
5207514|NCT01051323|17973689|P1|Overall Study|Lost to Follow-up|31
5207515|NCT01051323|17973689|P1|Overall Study|Withdrawal by Subject|13
5207516|NCT01051323|17973689|P1|Overall Study|Dialysis dependency|22
5207517|NCT01051323|17973689|P1|Overall Study|Transplantation|28
5207518|NCT01051323|17973689|P1|Overall Study|Discontinuation of treatment|103
5207519|NCT01051063|17973718|P2|Overall Study|Lost to Follow-up|1
5207520|NCT01051063|17973719|P1|Overall Study|Lost to Follow-up|0
5207521|NCT01051063|17973718|P2|Overall Study|Other|0
5207522|NCT01051063|17973719|P1|Overall Study|Other|1
5207523|NCT01051063|17973718|P2|Overall Study|Moved from the study site area|0
5207524|NCT01051063|17973719|P1|Overall Study|Moved from the study site area|1
5207525|NCT01051063|17973718|P2|Overall Study|Termination of the study|0
5207526|NCT01051063|17973719|P1|Overall Study|Termination of the study|5
5207527|NCT01051063|17973718|P2|Overall Study|Withdrawal by Subject|1
5207528|NCT01051063|17973719|P1|Overall Study|Withdrawal by Subject|1
5207529|NCT01051063|17973718|P2|Overall Study|Death|2
5207530|NCT01051063|17973719|P1|Overall Study|Death|2
5207531|NCT01050998|17973739|P5|Overall Study|Data integrity issues|4
5207532|NCT01050998|17973740|P4|Overall Study|Data integrity issues|1
5207533|NCT01050998|17973741|P3|Overall Study|Data integrity issues|1
5207534|NCT01050998|17973742|P2|Overall Study|Data integrity issues|0
5207535|NCT01050998|17973743|P1|Overall Study|Data integrity issues|0
5207536|NCT01050998|17973739|P5|Overall Study|Other|5
5207537|NCT01050998|17973740|P4|Overall Study|Other|1
5207538|NCT01050998|17973741|P3|Overall Study|Other|1
5207539|NCT01050998|17973742|P2|Overall Study|Other|2
5207540|NCT01050998|17973743|P1|Overall Study|Other|3
5207541|NCT01050998|17973739|P5|Overall Study|Withdrawal by Subject|3
5207542|NCT01050998|17973740|P4|Overall Study|Withdrawal by Subject|1
5207543|NCT01050998|17973741|P3|Overall Study|Withdrawal by Subject|0
5207544|NCT01050998|17973742|P2|Overall Study|Withdrawal by Subject|0
5207545|NCT01050998|17973743|P1|Overall Study|Withdrawal by Subject|0
5207546|NCT01050998|17973739|P5|Overall Study|Adverse Event|2
5207547|NCT01050998|17973740|P4|Overall Study|Adverse Event|0
5207548|NCT01050998|17973741|P3|Overall Study|Adverse Event|1
5207549|NCT01050998|17973742|P2|Overall Study|Adverse Event|0
5207550|NCT01050998|17973743|P1|Overall Study|Adverse Event|1
5207551|NCT01050816|17974082|P1|Overall Study|patient's refusal|2
5207552|NCT01050816|17974082|P1|Overall Study|Lost to Follow-up|2
5207553|NCT01050790|17974088|P1|Overall Study|Adverse Event|1
5207554|NCT01050764|17974098|P1|Overall Study|Death after HSCT, before T-cell infusion|1
5207555|NCT01050764|17974098|P1|Overall Study|Donor mobilization failure, death|1
5207556|NCT01050764|17974098|P1|Overall Study|Death, before HSCT|1
5207557|NCT01050673|17974109|P2|Overall Study|Physician Decision|5
5207558|NCT01050673|17974110|P1|Overall Study|Physician Decision|4
5207559|NCT01050634|17974178|P1|Overall Study|Ongoing at Date of Cut-Off|5
5207560|NCT01050634|17974178|P1|Overall Study|Other|21
5207561|NCT01050634|17974178|P1|Overall Study|Lost to Follow-up|2
5207562|NCT01050634|17974178|P1|Overall Study|Adverse Event|42
5207563|NCT01050634|17974178|P1|Overall Study|Death|2
5207564|NCT01050634|17974178|P1|Overall Study|Enrolled, but Not Treated|56
5207565|NCT01050569|17974202|P3|Overall Study|Physician Decision|3
5207566|NCT01050569|17974203|P2|Overall Study|Physician Decision|3
5207567|NCT01050569|17974204|P1|Overall Study|Physician Decision|3
5207568|NCT01050569|17974202|P3|Overall Study|Adverse Event|0
5207569|NCT01050569|17974203|P2|Overall Study|Adverse Event|0
5207570|NCT01050569|17974204|P1|Overall Study|Adverse Event|1
5207571|NCT01050569|17974202|P3|Overall Study|Lack of Efficacy|3
5207572|NCT01050569|17974203|P2|Overall Study|Lack of Efficacy|4
5207573|NCT01050569|17974204|P1|Overall Study|Lack of Efficacy|5
5207574|NCT01050569|17974202|P3|Overall Study|Withdrawal by Subject|11
5207575|NCT01050569|17974203|P2|Overall Study|Withdrawal by Subject|3
5207576|NCT01050569|17974204|P1|Overall Study|Withdrawal by Subject|9
5207577|NCT01050569|17974202|P3|Overall Study|Lost to Follow-up|16
5207578|NCT01050569|17974203|P2|Overall Study|Lost to Follow-up|14
5207579|NCT01050569|17974204|P1|Overall Study|Lost to Follow-up|20
5207580|NCT01050543|17974223|P2|Overall Study|Administrative|1
5207581|NCT01050543|17974224|P1|Overall Study|Administrative|4
5207582|NCT01050543|17974223|P2|Overall Study|Protocol Violation|1
5207583|NCT01050543|17974224|P1|Overall Study|Protocol Violation|0
5207584|NCT01050543|17974223|P2|Overall Study|Withdrawal by Subject|2
5207585|NCT01050543|17974224|P1|Overall Study|Withdrawal by Subject|0
5207586|NCT01050530|17974232|P2|Overall Study|Protocol Violation|0
5207587|NCT01050530|17974233|P1|Overall Study|Protocol Violation|1
5207588|NCT01050530|17974232|P2|Overall Study|Withdrawal by Subject|3
5207589|NCT01050530|17974233|P1|Overall Study|Withdrawal by Subject|0
5207590|NCT01050530|17974232|P2|Overall Study|Lack of Efficacy|4
5207591|NCT01050530|17974233|P1|Overall Study|Lack of Efficacy|1
5207592|NCT01050530|17974232|P2|Overall Study|Adverse Event|3
5207593|NCT01050530|17974233|P1|Overall Study|Adverse Event|6
5207594|NCT01050257|17974244|P3|Overall Study|Death|1
5207595|NCT01050257|17974245|P2|Overall Study|Death|0
5207596|NCT01050257|17974246|P1|Overall Study|Death|0
5207597|NCT01050257|17974244|P3|Overall Study|Failure to return|0
5207598|NCT01050257|17974245|P2|Overall Study|Failure to return|2
5207599|NCT01050257|17974246|P1|Overall Study|Failure to return|0
5207600|NCT01050257|17974244|P3|Overall Study|Violation criteria|0
5207601|NCT01050257|17974245|P2|Overall Study|Violation criteria|1
5207602|NCT01050257|17974246|P1|Overall Study|Violation criteria|0
5207603|NCT01050257|17974244|P3|Overall Study|Refused treatment/ Did not Cooperate|0
5207604|NCT01050257|17974245|P2|Overall Study|Refused treatment/ Did not Cooperate|1
5207605|NCT01050257|17974246|P1|Overall Study|Refused treatment/ Did not Cooperate|1
5207606|NCT01050257|17974244|P3|Overall Study|No reason specified|2
5207607|NCT01050257|17974245|P2|Overall Study|No reason specified|0
5207608|NCT01050257|17974246|P1|Overall Study|No reason specified|0
5207609|NCT01050257|17974244|P3|Overall Study|Withdrawal by Subject|0
5207610|NCT01050257|17974245|P2|Overall Study|Withdrawal by Subject|3
5207611|NCT01050257|17974246|P1|Overall Study|Withdrawal by Subject|0
5207612|NCT01050257|17974244|P3|Overall Study|Admin/Other (did not switch to oral)|2
5207613|NCT01050257|17974245|P2|Overall Study|Admin/Other (did not switch to oral)|2
5207614|NCT01050257|17974246|P1|Overall Study|Admin/Other (did not switch to oral)|6
5207615|NCT01050257|17974244|P3|Overall Study|Adverse Event|2
5207616|NCT01050257|17974245|P2|Overall Study|Adverse Event|4
5207617|NCT01050257|17974246|P1|Overall Study|Adverse Event|4
5207618|NCT01050218|17974281|P1|Overall Study|Family emergency|1
5207619|NCT01050218|17974281|P1|Overall Study|Serious Adverse Event|1
5207620|NCT01050218|17974281|P1|Overall Study|Failed to return|7
5207621|NCT01050218|17974281|P1|Overall Study|Compliance|2
5207622|NCT01050218|17974281|P1|Overall Study|Discontinued by sponsor|18
5207623|NCT01050218|17974281|P1|Overall Study|Withdrawal by Subject|18
5207624|NCT01050218|17974281|P1|Overall Study|Protocol Violation|3
5207625|NCT01050218|17974281|P1|Overall Study|Lack of Efficacy|8
5207626|NCT01050218|17974281|P1|Overall Study|Adverse Event|37
5207627|NCT01050205|17974287|P2|Overall Study|Discontinued Intervention|0
5207628|NCT01050205|17974288|P1|Overall Study|Discontinued Intervention|2
5207629|NCT01050205|17974287|P2|Overall Study|Relocated from area|2
5207630|NCT01050205|17974288|P1|Overall Study|Relocated from area|1
5207631|NCT01050205|17974287|P2|Overall Study|Withdrawal by Subject|1
5207632|NCT01050205|17974288|P1|Overall Study|Withdrawal by Subject|1
5207633|NCT01050205|17974287|P2|Overall Study|Lost to Follow-up|1
5207634|NCT01050205|17974288|P1|Overall Study|Lost to Follow-up|7
5207635|NCT01050062|17974345|P2|Overall Study|Others|11
5207636|NCT01050062|17974346|P1|Overall Study|Others|17
5207637|NCT01050062|17974345|P2|Overall Study|Physician Decision|9
5207638|NCT01050062|17974346|P1|Overall Study|Physician Decision|74
5207639|NCT01050062|17974345|P2|Overall Study|Lack of Efficacy|35
5207640|NCT01050062|17974346|P1|Overall Study|Lack of Efficacy|22
5207641|NCT01050062|17974345|P2|Overall Study|Lost to Follow-up|35
5207642|NCT01050062|17974346|P1|Overall Study|Lost to Follow-up|83
5207643|NCT01050062|17974345|P2|Overall Study|Adverse Event|22
5207644|NCT01050062|17974346|P1|Overall Study|Adverse Event|75
5207645|NCT01049984|17974368|P2|Overall Study|Treatment failure|2
5207646|NCT01049984|17974369|P1|Overall Study|Treatment failure|0
5207647|NCT01049984|17974368|P2|Overall Study|Adverse Event|7
5207648|NCT01049984|17974369|P1|Overall Study|Adverse Event|13
5207649|NCT01049984|17974368|P2|Overall Study|Lost to Follow-up|1
5207650|NCT01049984|17974369|P1|Overall Study|Lost to Follow-up|2
5207651|NCT01049984|17974368|P2|Overall Study|Protocol Violation|4
5207652|NCT01049984|17974369|P1|Overall Study|Protocol Violation|3
5207653|NCT01049984|17974368|P2|Overall Study|Withdrawal by Subject|5
5207654|NCT01049984|17974369|P1|Overall Study|Withdrawal by Subject|1
5207655|NCT01049581|17974433|P2|Overall Study|Lost to Follow-up|1
5207656|NCT01049581|17974434|P1|Overall Study|Lost to Follow-up|2
5207657|NCT01049503|17974449|P6|Overall Study|Lost to Follow-up|8
5207658|NCT01049503|17974450|P5|Overall Study|Lost to Follow-up|27
5207659|NCT01049503|17974451|P4|Overall Study|Lost to Follow-up|26
5207660|NCT01049503|17974452|P3|Overall Study|Lost to Follow-up|24
5207661|NCT01049503|17974453|P2|Overall Study|Lost to Follow-up|12
5207662|NCT01049503|17974454|P1|Overall Study|Lost to Follow-up|11
5207663|NCT01049412|17974485|P2|Period II|Lost to Follow-up|0
5207664|NCT01049412|17974486|P1|Period II|Lost to Follow-up|1
5207665|NCT01049412|17974485|P2|Period II|Adverse Event|0
5207666|NCT01049412|17974486|P1|Period II|Adverse Event|1
5207667|NCT01049412|17974485|P2|Period II|Withdrawal by Subject|3
5207668|NCT01049412|17974486|P1|Period II|Withdrawal by Subject|2
5207669|NCT01049412|17974485|P2|Period I|Adverse Event|0
5207670|NCT01049412|17974486|P1|Period I|Adverse Event|1
5207671|NCT01049412|17974485|P2|Period I|Protocol Violation|2
5207672|NCT01049412|17974486|P1|Period I|Protocol Violation|1
5207673|NCT01049412|17974485|P2|Period I|Physician Decision|3
5207674|NCT01049412|17974486|P1|Period I|Physician Decision|0
5207675|NCT01049412|17974485|P2|Period I|Lost to Follow-up|2
5207676|NCT01049412|17974486|P1|Period I|Lost to Follow-up|2
5207677|NCT01049412|17974485|P2|Period I|Withdrawal by Subject|6
5207678|NCT01049412|17974486|P1|Period I|Withdrawal by Subject|4
5207679|NCT01049373|17974515|P2|Overall Study|Non-cooperation|1
5207680|NCT01049373|17974516|P1|Overall Study|Non-cooperation|0
5207681|NCT01049373|17974515|P2|Overall Study|Other|1
5207682|NCT01049373|17974516|P1|Overall Study|Other|1
5207683|NCT01049373|17974515|P2|Overall Study|no evaluable study values|21
5207684|NCT01049373|17974516|P1|Overall Study|no evaluable study values|9
5207685|NCT01049373|17974515|P2|Overall Study|Lost to Follow-up|4
5207686|NCT01049373|17974516|P1|Overall Study|Lost to Follow-up|9
5207687|NCT01049373|17974515|P2|Overall Study|Adverse Event|3
5207688|NCT01049373|17974516|P1|Overall Study|Adverse Event|3
5207689|NCT01049373|17974515|P2|Overall Study|Withdrawal by Subject|5
5207690|NCT01049373|17974516|P1|Overall Study|Withdrawal by Subject|8
5207691|NCT01049373|17974515|P2|Overall Study|Protocol Violation|9
5207692|NCT01049373|17974516|P1|Overall Study|Protocol Violation|9
5207693|NCT01049360|17974530|P20|Period 4|Withdrawal by Subject|0
5207694|NCT01049360|17974531|P19|Period 4|Withdrawal by Subject|0
5207695|NCT01049360|17974532|P18|Period 4|Withdrawal by Subject|0
5207696|NCT01049360|17974533|P17|Period 4|Withdrawal by Subject|0
5207697|NCT01049360|17974534|P16|Period 4|Withdrawal by Subject|0
5207698|NCT01049360|17974535|P15|Period 4|Withdrawal by Subject|0
5207699|NCT01049360|17974536|P14|Period 4|Withdrawal by Subject|0
5207700|NCT01049360|17974537|P13|Period 4|Withdrawal by Subject|0
5207701|NCT01049360|17974538|P12|Period 4|Withdrawal by Subject|0
5207702|NCT01049360|17974539|P11|Period 4|Withdrawal by Subject|0
5207703|NCT01049360|17974540|P10|Period 4|Withdrawal by Subject|0
5207704|NCT01049360|17974541|P9|Period 4|Withdrawal by Subject|0
5207705|NCT01049360|17974542|P8|Period 4|Withdrawal by Subject|0
5207706|NCT01049360|17974543|P7|Period 4|Withdrawal by Subject|0
5207707|NCT01049360|17974544|P6|Period 4|Withdrawal by Subject|0
5207708|NCT01049360|17974545|P5|Period 4|Withdrawal by Subject|0
5207709|NCT01049360|17974546|P4|Period 4|Withdrawal by Subject|1
5207710|NCT01049360|17974547|P3|Period 4|Withdrawal by Subject|0
5207711|NCT01049360|17974548|P2|Period 4|Withdrawal by Subject|0
5207712|NCT01049360|17974549|P1|Period 4|Withdrawal by Subject|0
5207713|NCT01049360|17974530|P20|Period 4|Protocol Violation|0
5207714|NCT01049360|17974531|P19|Period 4|Protocol Violation|0
5207715|NCT01049360|17974532|P18|Period 4|Protocol Violation|1
5207716|NCT01049360|17974533|P17|Period 4|Protocol Violation|0
5207717|NCT01049360|17974534|P16|Period 4|Protocol Violation|0
5207718|NCT01049360|17974535|P15|Period 4|Protocol Violation|0
5207719|NCT01049360|17974536|P14|Period 4|Protocol Violation|0
5207720|NCT01049360|17974537|P13|Period 4|Protocol Violation|0
5207721|NCT01049360|17974538|P12|Period 4|Protocol Violation|0
5207722|NCT01049360|17974539|P11|Period 4|Protocol Violation|0
5207723|NCT01049360|17974540|P10|Period 4|Protocol Violation|0
5207724|NCT01049360|17974541|P9|Period 4|Protocol Violation|0
5207725|NCT01049360|17974542|P8|Period 4|Protocol Violation|0
5207726|NCT01049360|17974543|P7|Period 4|Protocol Violation|0
5207727|NCT01049360|17974544|P6|Period 4|Protocol Violation|0
5207728|NCT01049360|17974545|P5|Period 4|Protocol Violation|0
5207729|NCT01049360|17974546|P4|Period 4|Protocol Violation|0
5207730|NCT01049360|17974547|P3|Period 4|Protocol Violation|0
5207731|NCT01049360|17974548|P2|Period 4|Protocol Violation|0
5207732|NCT01049360|17974549|P1|Period 4|Protocol Violation|0
5207733|NCT01049360|17974530|P20|Period 2|Lack of Efficacy|0
5207734|NCT01049360|17974531|P19|Period 2|Lack of Efficacy|0
5207735|NCT01049360|17974532|P18|Period 2|Lack of Efficacy|0
5207736|NCT01049360|17974533|P17|Period 2|Lack of Efficacy|0
5207737|NCT01049360|17974534|P16|Period 2|Lack of Efficacy|0
5207738|NCT01049360|17974535|P15|Period 2|Lack of Efficacy|0
5207739|NCT01049360|17974536|P14|Period 2|Lack of Efficacy|0
5207740|NCT01049360|17974537|P13|Period 2|Lack of Efficacy|0
5207741|NCT01049360|17974538|P12|Period 2|Lack of Efficacy|0
5207742|NCT01049360|17974539|P11|Period 2|Lack of Efficacy|0
5207743|NCT01049360|17974540|P10|Period 2|Lack of Efficacy|0
5207744|NCT01049360|17974541|P9|Period 2|Lack of Efficacy|0
5207745|NCT01049360|17974542|P8|Period 2|Lack of Efficacy|0
5207746|NCT01049360|17974543|P7|Period 2|Lack of Efficacy|0
5207747|NCT01049360|17974544|P6|Period 2|Lack of Efficacy|1
5207748|NCT01049360|17974545|P5|Period 2|Lack of Efficacy|0
5207749|NCT01049360|17974546|P4|Period 2|Lack of Efficacy|0
5207750|NCT01049360|17974547|P3|Period 2|Lack of Efficacy|0
5207751|NCT01049360|17974548|P2|Period 2|Lack of Efficacy|0
5207752|NCT01049360|17974549|P1|Period 2|Lack of Efficacy|0
5207753|NCT01049360|17974530|P20|Period 2|Withdrawal by Subject|1
5207754|NCT01049360|17974531|P19|Period 2|Withdrawal by Subject|0
5207755|NCT01049360|17974532|P18|Period 2|Withdrawal by Subject|0
5207756|NCT01049360|17974533|P17|Period 2|Withdrawal by Subject|0
5207757|NCT01049360|17974534|P16|Period 2|Withdrawal by Subject|0
5207758|NCT01049360|17974535|P15|Period 2|Withdrawal by Subject|1
5207759|NCT01049360|17974536|P14|Period 2|Withdrawal by Subject|0
5207760|NCT01049360|17974537|P13|Period 2|Withdrawal by Subject|0
5207761|NCT01049360|17974538|P12|Period 2|Withdrawal by Subject|0
5207762|NCT01049360|17974539|P11|Period 2|Withdrawal by Subject|0
5207763|NCT01049360|17974540|P10|Period 2|Withdrawal by Subject|0
5207764|NCT01049360|17974541|P9|Period 2|Withdrawal by Subject|0
5207765|NCT01049360|17974542|P8|Period 2|Withdrawal by Subject|0
5207766|NCT01049360|17974543|P7|Period 2|Withdrawal by Subject|0
5207767|NCT01049360|17974544|P6|Period 2|Withdrawal by Subject|0
5207768|NCT01049360|17974545|P5|Period 2|Withdrawal by Subject|0
5207769|NCT01049360|17974546|P4|Period 2|Withdrawal by Subject|1
5207770|NCT01049360|17974547|P3|Period 2|Withdrawal by Subject|0
5207771|NCT01049360|17974548|P2|Period 2|Withdrawal by Subject|0
5207772|NCT01049360|17974549|P1|Period 2|Withdrawal by Subject|0
5207773|NCT01049360|17974530|P20|Period 2|Adverse Event|1
5207774|NCT01049360|17974531|P19|Period 2|Adverse Event|0
5207775|NCT01049360|17974532|P18|Period 2|Adverse Event|0
5207776|NCT01049360|17974533|P17|Period 2|Adverse Event|0
5207777|NCT01049360|17974534|P16|Period 2|Adverse Event|0
5207778|NCT01049360|17974535|P15|Period 2|Adverse Event|0
5207779|NCT01049360|17974536|P14|Period 2|Adverse Event|0
5207780|NCT01049360|17974537|P13|Period 2|Adverse Event|0
5207781|NCT01049360|17974538|P12|Period 2|Adverse Event|0
5207782|NCT01049360|17974539|P11|Period 2|Adverse Event|0
5207783|NCT01049360|17974540|P10|Period 2|Adverse Event|0
5207784|NCT01049360|17974541|P9|Period 2|Adverse Event|1
5207785|NCT01049360|17974542|P8|Period 2|Adverse Event|0
5207786|NCT01049360|17974543|P7|Period 2|Adverse Event|0
5207787|NCT01049360|17974544|P6|Period 2|Adverse Event|0
5207788|NCT01049360|17974545|P5|Period 2|Adverse Event|0
5207789|NCT01049360|17974546|P4|Period 2|Adverse Event|0
5207790|NCT01049360|17974547|P3|Period 2|Adverse Event|0
5207791|NCT01049360|17974548|P2|Period 2|Adverse Event|1
5207792|NCT01049360|17974549|P1|Period 2|Adverse Event|0
5207793|NCT01049360|17974530|P20|Period 2|Protocol Violation|0
5207794|NCT01049360|17974531|P19|Period 2|Protocol Violation|0
5207795|NCT01049360|17974532|P18|Period 2|Protocol Violation|0
5207796|NCT01049360|17974533|P17|Period 2|Protocol Violation|0
5207797|NCT01049360|17974534|P16|Period 2|Protocol Violation|1
5207798|NCT01049360|17974535|P15|Period 2|Protocol Violation|1
5207799|NCT01049360|17974536|P14|Period 2|Protocol Violation|0
5207800|NCT01049360|17974537|P13|Period 2|Protocol Violation|0
5207801|NCT01049360|17974538|P12|Period 2|Protocol Violation|0
5207802|NCT01049360|17974539|P11|Period 2|Protocol Violation|0
5207803|NCT01049360|17974540|P10|Period 2|Protocol Violation|0
5207804|NCT01049360|17974541|P9|Period 2|Protocol Violation|0
5207805|NCT01049360|17974542|P8|Period 2|Protocol Violation|0
5207806|NCT01049360|17974543|P7|Period 2|Protocol Violation|0
5207807|NCT01049360|17974544|P6|Period 2|Protocol Violation|0
5207808|NCT01049360|17974545|P5|Period 2|Protocol Violation|0
5207809|NCT01049360|17974546|P4|Period 2|Protocol Violation|1
5207810|NCT01049360|17974547|P3|Period 2|Protocol Violation|0
5207811|NCT01049360|17974548|P2|Period 2|Protocol Violation|0
5207812|NCT01049360|17974549|P1|Period 2|Protocol Violation|0
5207813|NCT01049360|17974530|P20|Period 1|Withdrawal by Subject|0
5207814|NCT01049360|17974531|P19|Period 1|Withdrawal by Subject|0
5207815|NCT01049360|17974532|P18|Period 1|Withdrawal by Subject|0
5207816|NCT01049360|17974533|P17|Period 1|Withdrawal by Subject|0
5207817|NCT01049360|17974534|P16|Period 1|Withdrawal by Subject|0
5207818|NCT01049360|17974535|P15|Period 1|Withdrawal by Subject|0
5207819|NCT01049360|17974536|P14|Period 1|Withdrawal by Subject|0
5207820|NCT01049360|17974537|P13|Period 1|Withdrawal by Subject|1
5207821|NCT01049360|17974538|P12|Period 1|Withdrawal by Subject|0
5207822|NCT01049360|17974539|P11|Period 1|Withdrawal by Subject|1
5207823|NCT01049360|17974540|P10|Period 1|Withdrawal by Subject|0
5207824|NCT01049360|17974541|P9|Period 1|Withdrawal by Subject|1
5207825|NCT01049360|17974542|P8|Period 1|Withdrawal by Subject|0
5207826|NCT01049360|17974543|P7|Period 1|Withdrawal by Subject|0
5207827|NCT01049360|17974544|P6|Period 1|Withdrawal by Subject|0
5207828|NCT01049360|17974545|P5|Period 1|Withdrawal by Subject|0
5207829|NCT01049360|17974546|P4|Period 1|Withdrawal by Subject|0
5207830|NCT01049360|17974547|P3|Period 1|Withdrawal by Subject|0
5207831|NCT01049360|17974548|P2|Period 1|Withdrawal by Subject|0
5207832|NCT01049360|17974549|P1|Period 1|Withdrawal by Subject|0
5207833|NCT01049360|17974530|P20|Period 1|Did not meet inc/exc criteria|0
5207834|NCT01049360|17974531|P19|Period 1|Did not meet inc/exc criteria|0
5207835|NCT01049360|17974532|P18|Period 1|Did not meet inc/exc criteria|0
5207836|NCT01049360|17974533|P17|Period 1|Did not meet inc/exc criteria|0
5207837|NCT01049360|17974534|P16|Period 1|Did not meet inc/exc criteria|0
5207838|NCT01049360|17974535|P15|Period 1|Did not meet inc/exc criteria|0
5207839|NCT01049360|17974536|P14|Period 1|Did not meet inc/exc criteria|0
5207840|NCT01049360|17974537|P13|Period 1|Did not meet inc/exc criteria|0
5207841|NCT01049360|17974538|P12|Period 1|Did not meet inc/exc criteria|0
5207842|NCT01049360|17974539|P11|Period 1|Did not meet inc/exc criteria|0
5207843|NCT01049360|17974540|P10|Period 1|Did not meet inc/exc criteria|0
5207844|NCT01049360|17974541|P9|Period 1|Did not meet inc/exc criteria|1
5207845|NCT01049360|17974542|P8|Period 1|Did not meet inc/exc criteria|1
5207846|NCT01049360|17974543|P7|Period 1|Did not meet inc/exc criteria|0
5207847|NCT01049360|17974544|P6|Period 1|Did not meet inc/exc criteria|0
5207848|NCT01049360|17974545|P5|Period 1|Did not meet inc/exc criteria|0
5207849|NCT01049360|17974546|P4|Period 1|Did not meet inc/exc criteria|0
5207850|NCT01049360|17974547|P3|Period 1|Did not meet inc/exc criteria|0
5207851|NCT01049360|17974548|P2|Period 1|Did not meet inc/exc criteria|0
5207852|NCT01049360|17974549|P1|Period 1|Did not meet inc/exc criteria|0
5207853|NCT01049360|17974530|P20|Period 1|Adverse Event|0
5207854|NCT01049360|17974531|P19|Period 1|Adverse Event|1
5207855|NCT01049360|17974532|P18|Period 1|Adverse Event|0
5207856|NCT01049360|17974533|P17|Period 1|Adverse Event|1
5207857|NCT01049360|17974534|P16|Period 1|Adverse Event|0
5207858|NCT01049360|17974535|P15|Period 1|Adverse Event|0
5207859|NCT01049360|17974536|P14|Period 1|Adverse Event|1
5207860|NCT01049360|17974537|P13|Period 1|Adverse Event|1
5207861|NCT01049360|17974538|P12|Period 1|Adverse Event|0
5207862|NCT01049360|17974539|P11|Period 1|Adverse Event|0
5207863|NCT01049360|17974540|P10|Period 1|Adverse Event|0
5207864|NCT01049360|17974541|P9|Period 1|Adverse Event|0
5207865|NCT01049360|17974542|P8|Period 1|Adverse Event|1
5207866|NCT01049360|17974543|P7|Period 1|Adverse Event|0
5207867|NCT01049360|17974544|P6|Period 1|Adverse Event|0
5207868|NCT01049360|17974545|P5|Period 1|Adverse Event|0
5207869|NCT01049360|17974546|P4|Period 1|Adverse Event|1
5207870|NCT01049360|17974547|P3|Period 1|Adverse Event|0
5207871|NCT01049360|17974548|P2|Period 1|Adverse Event|1
5207872|NCT01049360|17974549|P1|Period 1|Adverse Event|0
5207873|NCT01049334|17974573|P2|Overall Study|Protocol Violation|1
5207874|NCT01049334|17974574|P1|Overall Study|Protocol Violation|0
5207875|NCT01049334|17974573|P2|Overall Study|Physician Decision|0
5207876|NCT01049334|17974574|P1|Overall Study|Physician Decision|2
5207877|NCT01049334|17974573|P2|Overall Study|Adverse Event|3
5207878|NCT01049334|17974574|P1|Overall Study|Adverse Event|2
5207879|NCT01049334|17974573|P2|Overall Study|Withdrawal by Subject|3
5207880|NCT01049334|17974574|P1|Overall Study|Withdrawal by Subject|5
5207881|NCT01049308|17974610|P1|Pill Counts|Withdrawal by Subject|83
5207882|NCT01049217|17974624|P2|Overall Study|Randomized but not Treated|2
5207883|NCT01049217|17974625|P1|Overall Study|Randomized but not Treated|0
5207884|NCT01049217|17974624|P2|Overall Study|Other|2
5207885|NCT01049217|17974625|P1|Overall Study|Other|1
5207886|NCT01049217|17974624|P2|Overall Study|Study Terminated by Sponsor|43
5207887|NCT01049217|17974625|P1|Overall Study|Study Terminated by Sponsor|43
5207888|NCT01049217|17974624|P2|Overall Study|Pregnancy|0
5207889|NCT01049217|17974625|P1|Overall Study|Pregnancy|1
5207890|NCT01049217|17974624|P2|Overall Study|Protocol Violation|3
5207891|NCT01049217|17974625|P1|Overall Study|Protocol Violation|1
5207892|NCT01049217|17974624|P2|Overall Study|Withdrawal by Subject|3
5207893|NCT01049217|17974625|P1|Overall Study|Withdrawal by Subject|4
5207894|NCT01049217|17974624|P2|Overall Study|Lost to Follow-up|8
5207895|NCT01049217|17974625|P1|Overall Study|Lost to Follow-up|3
5207896|NCT01049217|17974624|P2|Overall Study|Lack of Efficacy|1
5207897|NCT01049217|17974625|P1|Overall Study|Lack of Efficacy|1
5207898|NCT01049217|17974624|P2|Overall Study|Adverse Event|1
5207899|NCT01049217|17974625|P1|Overall Study|Adverse Event|2
5207900|NCT01049035|17974702|P7|Overall Study|Voluntary withdrawal not due to an AE|2
5207901|NCT01049035|17974703|P6|Overall Study|Voluntary withdrawal not due to an AE|5
5207902|NCT01049035|17974704|P5|Overall Study|Voluntary withdrawal not due to an AE|1
5207903|NCT01049035|17974705|P4|Overall Study|Voluntary withdrawal not due to an AE|2
5207904|NCT01049035|17974706|P3|Overall Study|Voluntary withdrawal not due to an AE|8
5207905|NCT01049035|17974707|P2|Overall Study|Voluntary withdrawal not due to an AE|10
5207906|NCT01049035|17974708|P1|Overall Study|Voluntary withdrawal not due to an AE|16
5207907|NCT01049035|17974702|P7|Overall Study|Lost to Follow-up|3
5207908|NCT01049035|17974703|P6|Overall Study|Lost to Follow-up|3
5207909|NCT01049035|17974704|P5|Overall Study|Lost to Follow-up|0
5207910|NCT01049035|17974705|P4|Overall Study|Lost to Follow-up|1
5207911|NCT01049035|17974706|P3|Overall Study|Lost to Follow-up|4
5207912|NCT01049035|17974707|P2|Overall Study|Lost to Follow-up|4
5207913|NCT01049035|17974708|P1|Overall Study|Lost to Follow-up|5
5207914|NCT01049035|17974702|P7|Overall Study|Non-compliance with the protocol|10
5207915|NCT01049035|17974703|P6|Overall Study|Non-compliance with the protocol|4
5207916|NCT01049035|17974704|P5|Overall Study|Non-compliance with the protocol|3
5207917|NCT01049035|17974705|P4|Overall Study|Non-compliance with the protocol|5
5207918|NCT01049035|17974706|P3|Overall Study|Non-compliance with the protocol|14
5207919|NCT01049035|17974707|P2|Overall Study|Non-compliance with the protocol|6
5207920|NCT01049035|17974708|P1|Overall Study|Non-compliance with the protocol|12
5207921|NCT01049035|17974702|P7|Overall Study|Other adverse event (AE)|0
5207922|NCT01049035|17974703|P6|Overall Study|Other adverse event (AE)|0
5207923|NCT01049035|17974704|P5|Overall Study|Other adverse event (AE)|0
5207924|NCT01049035|17974705|P4|Overall Study|Other adverse event (AE)|1
5207925|NCT01049035|17974706|P3|Overall Study|Other adverse event (AE)|0
5207926|NCT01049035|17974707|P2|Overall Study|Other adverse event (AE)|0
5207927|NCT01049035|17974708|P1|Overall Study|Other adverse event (AE)|0
5207928|NCT01049035|17974702|P7|Overall Study|Serious adverse event|0
5207929|NCT01049035|17974703|P6|Overall Study|Serious adverse event|0
5207930|NCT01049035|17974704|P5|Overall Study|Serious adverse event|0
5207931|NCT01049035|17974705|P4|Overall Study|Serious adverse event|2
5207932|NCT01049035|17974706|P3|Overall Study|Serious adverse event|1
5207933|NCT01049035|17974707|P2|Overall Study|Serious adverse event|1
5207934|NCT01049035|17974708|P1|Overall Study|Serious adverse event|0
5207935|NCT01049009|17974867|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
5207936|NCT01049009|17974868|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
5207937|NCT01049009|17974867|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
5207938|NCT01049009|17974868|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
5207939|NCT01049009|17974867|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5207940|NCT01049009|17974868|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5207941|NCT01049009|17974867|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5207942|NCT01049009|17974868|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5207943|NCT01048944|17974880|P4|Overall Study|Protocol Violation|2
5207944|NCT01048944|17974881|P3|Overall Study|Protocol Violation|10
5207945|NCT01048944|17974882|P2|Overall Study|Protocol Violation|10
5207946|NCT01048944|17974883|P1|Overall Study|Protocol Violation|8
5207947|NCT01048866|17974915|P2|Overall Study|Other|1
5207948|NCT01048866|17974916|P1|Overall Study|Other|1
5207949|NCT01048866|17974915|P2|Overall Study|Lost to Follow-up|2
5207950|NCT01048866|17974916|P1|Overall Study|Lost to Follow-up|0
5207951|NCT01048866|17974915|P2|Overall Study|Withdrawal by Subject|2
5207952|NCT01048866|17974916|P1|Overall Study|Withdrawal by Subject|0
5207953|NCT01048866|17974915|P2|Overall Study|Physician Decision|0
5207954|NCT01048866|17974916|P1|Overall Study|Physician Decision|1
5207955|NCT01048866|17974915|P2|Overall Study|Protocol Violation|0
5207956|NCT01048866|17974916|P1|Overall Study|Protocol Violation|1
5207957|NCT01048866|17974915|P2|Overall Study|Adverse Event|0
5207958|NCT01048866|17974916|P1|Overall Study|Adverse Event|1
5207959|NCT01048788|17974961|P3|Overall Study|Withdrawal by Subject|0
5207960|NCT01048788|17974962|P2|Overall Study|Withdrawal by Subject|1
5207961|NCT01048788|17974963|P1|Overall Study|Withdrawal by Subject|0
5207962|NCT01048788|17974961|P3|Overall Study|Lack of Efficacy|1
5207963|NCT01048788|17974962|P2|Overall Study|Lack of Efficacy|0
5207964|NCT01048788|17974963|P1|Overall Study|Lack of Efficacy|0
5207965|NCT01048788|17974961|P3|Overall Study|Adverse Event|1
5207966|NCT01048788|17974962|P2|Overall Study|Adverse Event|1
5207967|NCT01048788|17974963|P1|Overall Study|Adverse Event|5
5207968|NCT01048671|17974985|P3|Overall Study|Protocol Violation|1
5207969|NCT01048671|17974986|P2|Overall Study|Protocol Violation|1
5207970|NCT01048671|17974987|P1|Overall Study|Protocol Violation|0
5207971|NCT01048541|17975067|P2|Overall Study|Withdrawal by Subject|0
5207972|NCT01048541|17975068|P1|Overall Study|Withdrawal by Subject|1
5207973|NCT01048502|17975078|P4|Overall Study|Physician Decision|1
5207974|NCT01048502|17975079|P3|Overall Study|Physician Decision|0
5207975|NCT01048502|17975080|P2|Overall Study|Physician Decision|3
5207976|NCT01048502|17975081|P1|Overall Study|Physician Decision|0
5207977|NCT01048502|17975078|P4|Overall Study|Withdrawal by Subject|3
5207978|NCT01048502|17975079|P3|Overall Study|Withdrawal by Subject|5
5207979|NCT01048502|17975080|P2|Overall Study|Withdrawal by Subject|4
5207980|NCT01048502|17975081|P1|Overall Study|Withdrawal by Subject|1
5207981|NCT01048502|17975078|P4|Overall Study|Adverse Event|0
5207982|NCT01048502|17975079|P3|Overall Study|Adverse Event|0
5207983|NCT01048502|17975080|P2|Overall Study|Adverse Event|0
5207984|NCT01048502|17975081|P1|Overall Study|Adverse Event|1
5207985|NCT01048502|17975078|P4|Overall Study|Lost to Follow-up|0
5207986|NCT01048502|17975079|P3|Overall Study|Lost to Follow-up|0
5207987|NCT01048502|17975080|P2|Overall Study|Lost to Follow-up|0
5207988|NCT01048502|17975081|P1|Overall Study|Lost to Follow-up|2
5207989|NCT01048333|17975117|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5207990|NCT01048333|17975118|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5207991|NCT01048333|17975119|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5207992|NCT01048333|17975120|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5207993|NCT01048333|17975121|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
5207994|NCT01048333|17975122|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5207995|NCT01048242|17975144|P2|Overall Study|See study flow chart|2
5207996|NCT01048242|17975145|P1|Overall Study|See study flow chart|4
5207997|NCT01048099|17975160|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
5207998|NCT01048099|17975160|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
5207999|NCT01047553|17975208|P2|Overall Study|PI's decision|1
5208000|NCT01047553|17975209|P1|Overall Study|PI's decision|0
5208001|NCT01047553|17975208|P2|Overall Study|Sever Non-Compliance to Protocol|0
5208002|NCT01047553|17975209|P1|Overall Study|Sever Non-Compliance to Protocol|1
5208003|NCT01047553|17975208|P2|Overall Study|Lost to Follow-up|0
5208004|NCT01047553|17975209|P1|Overall Study|Lost to Follow-up|1
5208005|NCT01047553|17975208|P2|Overall Study|Development of Study-Specific Withdrawal|1
5208006|NCT01047553|17975209|P1|Overall Study|Development of Study-Specific Withdrawal|1
5208007|NCT01047553|17975208|P2|Overall Study|Withdrawal by Subject|2
5208008|NCT01047553|17975209|P1|Overall Study|Withdrawal by Subject|4
5208009|NCT01047553|17975208|P2|Overall Study|Adverse Event|5
5208010|NCT01047553|17975209|P1|Overall Study|Adverse Event|10
5208011|NCT01047436|17975316|P2|Overall Study|Protocol Violation|0
5208012|NCT01047436|17975317|P1|Overall Study|Protocol Violation|1
5208013|NCT01047345|17975342|P3|Extension|Lost to Follow-up|5
5208014|NCT01047345|17975343|P2|Extension|Lost to Follow-up|0
5208015|NCT01047345|17975344|P1|Extension|Lost to Follow-up|0
5208016|NCT01047345|17975342|P3|Extension|Withdrawal by Subject|1
5208017|NCT01047345|17975343|P2|Extension|Withdrawal by Subject|0
5208018|NCT01047345|17975344|P1|Extension|Withdrawal by Subject|0
5208019|NCT01047345|17975342|P3|Base Study|Withdrawal by Subject|0
5208020|NCT01047345|17975343|P2|Base Study|Withdrawal by Subject|4
5208021|NCT01047345|17975344|P1|Base Study|Withdrawal by Subject|12
5208022|NCT01047345|17975342|P3|Base Study|Protocol Violation|0
5208023|NCT01047345|17975343|P2|Base Study|Protocol Violation|1
5208024|NCT01047345|17975344|P1|Base Study|Protocol Violation|3
5208025|NCT01047345|17975342|P3|Base Study|Lost to Follow-up|0
5208026|NCT01047345|17975343|P2|Base Study|Lost to Follow-up|1
5208027|NCT01047345|17975344|P1|Base Study|Lost to Follow-up|4
5208028|NCT01047345|17975342|P3|Base Study|Adverse Event|0
5208029|NCT01047345|17975343|P2|Base Study|Adverse Event|0
5208030|NCT01047345|17975344|P1|Base Study|Adverse Event|3
5208031|NCT01047332|17975366|P2|Overall Study|Lost to Follow-up|3
5208032|NCT01047332|17975367|P1|Overall Study|Lost to Follow-up|8
5208033|NCT01047332|17975366|P2|Overall Study|Died Unobstructed|41
5208034|NCT01047332|17975367|P1|Overall Study|Died Unobstructed|38
5208035|NCT01047332|17975366|P2|Overall Study|SEMS Obstruction|20
5208036|NCT01047332|17975367|P1|Overall Study|SEMS Obstruction|11
5208037|NCT01047319|17975382|P3|Overall Study|Study terminated by Sponsor|203
5208038|NCT01047319|17975383|P2|Overall Study|Study terminated by Sponsor|215
5208039|NCT01047319|17975384|P1|Overall Study|Study terminated by Sponsor|198
5208040|NCT01047319|17975382|P3|Overall Study|Withdrawal by Subject|87
5208041|NCT01047319|17975383|P2|Overall Study|Withdrawal by Subject|75
5208042|NCT01047319|17975384|P1|Overall Study|Withdrawal by Subject|77
5208043|NCT01047319|17975382|P3|Overall Study|Adverse Event|21
5208044|NCT01047319|17975383|P2|Overall Study|Adverse Event|27
5208045|NCT01047319|17975384|P1|Overall Study|Adverse Event|16
5208046|NCT01047319|17975382|P3|Overall Study|Lost to Follow-up|10
5208047|NCT01047319|17975383|P2|Overall Study|Lost to Follow-up|10
5208048|NCT01047319|17975384|P1|Overall Study|Lost to Follow-up|14
5208049|NCT01047319|17975382|P3|Overall Study|Physician Decision|10
5208050|NCT01047319|17975383|P2|Overall Study|Physician Decision|9
5208051|NCT01047319|17975384|P1|Overall Study|Physician Decision|12
5208052|NCT01047319|17975382|P3|Overall Study|Pregnancy|8
5208053|NCT01047319|17975383|P2|Overall Study|Pregnancy|8
5208054|NCT01047319|17975384|P1|Overall Study|Pregnancy|13
5208055|NCT01047319|17975382|P3|Overall Study|Death|5
5208056|NCT01047319|17975383|P2|Overall Study|Death|1
5208057|NCT01047319|17975384|P1|Overall Study|Death|5
5208058|NCT01047319|17975382|P3|Overall Study|Lack of Efficacy|3
5208059|NCT01047319|17975383|P2|Overall Study|Lack of Efficacy|3
5208060|NCT01047319|17975384|P1|Overall Study|Lack of Efficacy|4
5208061|NCT01047319|17975382|P3|Overall Study|Protocol Violation|4
5208062|NCT01047319|17975383|P2|Overall Study|Protocol Violation|2
5208063|NCT01047319|17975384|P1|Overall Study|Protocol Violation|3
5208064|NCT01047319|17975382|P3|Overall Study|Teva requested participant withdrawal|1
5208065|NCT01047319|17975383|P2|Overall Study|Teva requested participant withdrawal|0
5208066|NCT01047319|17975384|P1|Overall Study|Teva requested participant withdrawal|3
5208067|NCT01047306|17975406|P2|Overall Study|Lost to Follow-up|0
5208068|NCT01047306|17975407|P1|Overall Study|Lost to Follow-up|1
5208069|NCT01047306|17975406|P2|Overall Study|Withdrawal by Subject|0
5208070|NCT01047306|17975407|P1|Overall Study|Withdrawal by Subject|2
5208071|NCT01047293|17975481|P4|Overall Study|DLT criteria not fulfilled|0
5208072|NCT01047293|17975482|P3|Overall Study|DLT criteria not fulfilled|0
5208073|NCT01047293|17975483|P2|Overall Study|DLT criteria not fulfilled|1
5208074|NCT01047293|17975484|P1|Overall Study|DLT criteria not fulfilled|1
5208075|NCT01047007|17975515|P4|Overall Study|Progressive Disease|0
5208076|NCT01047007|17975516|P3|Overall Study|Progressive Disease|1
5208077|NCT01047007|17975517|P2|Overall Study|Progressive Disease|4
5208078|NCT01047007|17975518|P1|Overall Study|Progressive Disease|2
5208079|NCT01047007|17975515|P4|Overall Study|Adverse Event|0
5208080|NCT01047007|17975516|P3|Overall Study|Adverse Event|1
5208081|NCT01047007|17975517|P2|Overall Study|Adverse Event|2
5208082|NCT01047007|17975518|P1|Overall Study|Adverse Event|0
5208083|NCT01046903|17975529|P1|Overall Study|Other|5
5208084|NCT01046903|17975529|P1|Overall Study|Withdrawal by Subject|3
5208085|NCT01046903|17975529|P1|Overall Study|Adverse Event|4
5208086|NCT01046903|17975529|P1|Overall Study|Lost to Follow-up|16
5208087|NCT01046877|17975542|P1|Overall Study|Exited voluntarily after tube extrusion|11
5208088|NCT01046877|17975542|P1|Overall Study|Exited voluntarily before tube extrusion|7
5208089|NCT01046695|17975558|P2|Overall Study|TENS interfered with the cardiac monitor|1
5208090|NCT01046695|17975559|P1|Overall Study|TENS interfered with the cardiac monitor|0
5208091|NCT01046695|17975558|P2|Overall Study|Subject had a pacemaker|1
5208092|NCT01046695|17975559|P1|Overall Study|Subject had a pacemaker|0
5208093|NCT01046682|17975571|P2|Overall Study|Adverse Event|0
5208094|NCT01046682|17975572|P1|Overall Study|Adverse Event|2
5208095|NCT01046643|17975589|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
5208096|NCT01046643|17975590|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
5208097|NCT01046643|17975591|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
5208098|NCT01046643|17975592|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
5208099|NCT01046565|17975614|P1|Overall Study|Withdrawal by Subject|7
5208100|NCT01046565|17975614|P1|Overall Study|Adverse Event|2
5208101|NCT01046396|17975623|P1|Overall Study|Withdrawal by Subject|5
5208102|NCT01046253|17975634|P2|Second Intervention|Protocol Violation|1
5208103|NCT01046253|17975635|P1|Second Intervention|Protocol Violation|0
5208104|NCT01046253|17975634|P2|Second Intervention|Adverse Event|1
5208105|NCT01046253|17975635|P1|Second Intervention|Adverse Event|0
5208106|NCT01046136|17975647|P2|Overall Study|Lost to Follow-up|3
5208107|NCT01046136|17975648|P1|Overall Study|Lost to Follow-up|3
5208108|NCT01046136|17975647|P2|Overall Study|Physician Decision|1
5208109|NCT01046136|17975648|P1|Overall Study|Physician Decision|1
5208110|NCT01046136|17975647|P2|Overall Study|Withdrawal by Subject|4
5208111|NCT01046136|17975648|P1|Overall Study|Withdrawal by Subject|0
5208112|NCT01046110|17975660|P2|Overall Study|Unclassified|35
5208113|NCT01046110|17975661|P1|Overall Study|Unclassified|36
5208114|NCT01046110|17975660|P2|Overall Study|Withdrawal Criteria|5
5208115|NCT01046110|17975661|P1|Overall Study|Withdrawal Criteria|3
5208116|NCT01046110|17975660|P2|Overall Study|Protocol Violation|12
5208117|NCT01046110|17975661|P1|Overall Study|Protocol Violation|7
5208118|NCT01046110|17975660|P2|Overall Study|Lack of Efficacy|1
5208119|NCT01046110|17975661|P1|Overall Study|Lack of Efficacy|0
5208120|NCT01046110|17975660|P2|Overall Study|Adverse Event|2
5208121|NCT01046110|17975661|P1|Overall Study|Adverse Event|9
5208122|NCT01046084|17975671|P2|Third Washout of 7 Days|Withdrawal by Subject|0
5208123|NCT01046084|17975672|P1|Third Washout of 7 Days|Withdrawal by Subject|2
5208124|NCT01045993|17975686|P4|Overall Study|Treated-later found eligibility not met|0
5208125|NCT01045993|17975687|P3|Overall Study|Treated-later found eligibility not met|0
5208126|NCT01045993|17975688|P2|Overall Study|Treated-later found eligibility not met|1
5208127|NCT01045993|17975689|P1|Overall Study|Treated-later found eligibility not met|0
5208128|NCT01045967|17975765|P2|Second Intervention|Protocol Violation|1
5208129|NCT01045967|17975766|P1|Second Intervention|Protocol Violation|0
5208130|NCT01045798|17975778|P2|Overall Study|Received Systemic Antifungal Prestudy|1
5208131|NCT01045798|17975779|P1|Overall Study|Received Systemic Antifungal Prestudy|0
5208132|NCT01045798|17975778|P2|Overall Study|Changed to Other Antifungal Therapy|2
5208133|NCT01045798|17975779|P1|Overall Study|Changed to Other Antifungal Therapy|1
5208134|NCT01045798|17975778|P2|Overall Study|Invasive Fungal Infection at Baseline|1
5208135|NCT01045798|17975779|P1|Overall Study|Invasive Fungal Infection at Baseline|0
5208136|NCT01045798|17975778|P2|Overall Study|Changed to Open-Label Caspofungin|0
5208137|NCT01045798|17975779|P1|Overall Study|Changed to Open-Label Caspofungin|1
5208138|NCT01045707|17975787|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
5208139|NCT01045707|17975788|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
5208140|NCT01045707|17975787|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
5208141|NCT01045707|17975788|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
5208142|NCT01045707|17975787|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
5208143|NCT01045707|17975788|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
5208144|NCT01045707|17975787|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
5208145|NCT01045707|17975788|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
5208146|NCT01045707|17975787|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
5208147|NCT01045707|17975788|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
5208148|NCT01045707|17975787|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
5208149|NCT01045707|17975788|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
5208150|NCT01045707|17975787|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
5208151|NCT01045707|17975788|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
5208152|NCT01045707|17975787|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
5208153|NCT01045707|17975788|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
5208154|NCT01045707|17975787|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
5208155|NCT01045707|17975788|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
5208156|NCT01045694|17975804|P1|Overall Study|Withdrawal by Subject|2
5208157|NCT01045460|17975825|P2|Overall Study|Lack of Efficacy|0
5208158|NCT01045460|17975826|P1|Overall Study|Lack of Efficacy|3
5208159|NCT01045460|17975825|P2|Overall Study|Lost to Follow-up|1
5208160|NCT01045460|17975826|P1|Overall Study|Lost to Follow-up|0
5208161|NCT01045460|17975825|P2|Overall Study|Physician Decision|2
5208162|NCT01045460|17975826|P1|Overall Study|Physician Decision|3
5208163|NCT01045447|17975838|P2|Overall Study|Unclassified|13
5208164|NCT01045447|17975839|P1|Overall Study|Unclassified|17
5208165|NCT01045447|17975838|P2|Overall Study|Withdrawal Criteria|10
5208166|NCT01045447|17975839|P1|Overall Study|Withdrawal Criteria|10
5208167|NCT01045447|17975838|P2|Overall Study|Protocol Violation|3
5208168|NCT01045447|17975839|P1|Overall Study|Protocol Violation|6
5208169|NCT01045447|17975838|P2|Overall Study|Lack of Efficacy|1
5208170|NCT01045447|17975839|P1|Overall Study|Lack of Efficacy|3
5208171|NCT01045447|17975838|P2|Overall Study|Adverse Event|1
5208172|NCT01045447|17975839|P1|Overall Study|Adverse Event|0
5208173|NCT01045421|17975853|P11|Phase 2|Other|1
5208174|NCT01045421|17975854|P10|Phase 2|Other|0
5208175|NCT01045421|17975855|P9|Phase 2|Other|0
5208176|NCT01045421|17975856|P8|Phase 2|Other|3
5208177|NCT01045421|17975857|P7|Phase 2|Other|0
5208178|NCT01045421|17975858|P6|Phase 2|Other|0
5208179|NCT01045421|17975859|P5|Phase 2|Other|0
5208180|NCT01045421|17975860|P4|Phase 2|Other|0
5208181|NCT01045421|17975861|P3|Phase 2|Other|0
5208182|NCT01045421|17975862|P2|Phase 2|Other|0
5208183|NCT01045421|17975863|P1|Phase 2|Other|0
5208184|NCT01045421|17975853|P11|Phase 2|Death|0
5208185|NCT01045421|17975854|P10|Phase 2|Death|2
5208186|NCT01045421|17975855|P9|Phase 2|Death|1
5208187|NCT01045421|17975856|P8|Phase 2|Death|1
5208188|NCT01045421|17975857|P7|Phase 2|Death|0
5208189|NCT01045421|17975858|P6|Phase 2|Death|0
5208190|NCT01045421|17975859|P5|Phase 2|Death|0
5208191|NCT01045421|17975860|P4|Phase 2|Death|0
5208192|NCT01045421|17975861|P3|Phase 2|Death|0
5208193|NCT01045421|17975862|P2|Phase 2|Death|0
5208194|NCT01045421|17975863|P1|Phase 2|Death|0
5208195|NCT01045421|17975853|P11|Phase 2|Progressive Disease|1
5208196|NCT01045421|17975854|P10|Phase 2|Progressive Disease|1
5208197|NCT01045421|17975855|P9|Phase 2|Progressive Disease|1
5208198|NCT01045421|17975856|P8|Phase 2|Progressive Disease|1
5208199|NCT01045421|17975857|P7|Phase 2|Progressive Disease|0
5208200|NCT01045421|17975858|P6|Phase 2|Progressive Disease|0
5208201|NCT01045421|17975859|P5|Phase 2|Progressive Disease|0
5208202|NCT01045421|17975860|P4|Phase 2|Progressive Disease|0
5208203|NCT01045421|17975861|P3|Phase 2|Progressive Disease|0
5208204|NCT01045421|17975862|P2|Phase 2|Progressive Disease|0
5208205|NCT01045421|17975863|P1|Phase 2|Progressive Disease|0
5208206|NCT01045421|17975853|P11|Phase 1|Withdrawal by Subject|0
5208207|NCT01045421|17975854|P10|Phase 1|Withdrawal by Subject|0
5208208|NCT01045421|17975855|P9|Phase 1|Withdrawal by Subject|0
5208209|NCT01045421|17975856|P8|Phase 1|Withdrawal by Subject|0
5208210|NCT01045421|17975857|P7|Phase 1|Withdrawal by Subject|0
5208211|NCT01045421|17975858|P6|Phase 1|Withdrawal by Subject|0
5208212|NCT01045421|17975859|P5|Phase 1|Withdrawal by Subject|0
5208213|NCT01045421|17975860|P4|Phase 1|Withdrawal by Subject|1
5208214|NCT01045421|17975861|P3|Phase 1|Withdrawal by Subject|0
5208215|NCT01045421|17975862|P2|Phase 1|Withdrawal by Subject|0
5208216|NCT01045421|17975863|P1|Phase 1|Withdrawal by Subject|0
5208217|NCT01045421|17975853|P11|Phase 1|Progressive Disease|0
5208218|NCT01045421|17975854|P10|Phase 1|Progressive Disease|0
5208219|NCT01045421|17975855|P9|Phase 1|Progressive Disease|0
5208220|NCT01045421|17975856|P8|Phase 1|Progressive Disease|0
5208221|NCT01045421|17975857|P7|Phase 1|Progressive Disease|0
5208222|NCT01045421|17975858|P6|Phase 1|Progressive Disease|0
5208223|NCT01045421|17975859|P5|Phase 1|Progressive Disease|1
5208224|NCT01045421|17975860|P4|Phase 1|Progressive Disease|0
5208225|NCT01045421|17975861|P3|Phase 1|Progressive Disease|0
5208226|NCT01045421|17975862|P2|Phase 1|Progressive Disease|0
5208227|NCT01045421|17975863|P1|Phase 1|Progressive Disease|0
5208228|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
5208229|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
5208230|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
5208231|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
5208232|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
5208233|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
5208234|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
5208235|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
5208236|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
5208237|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
5208238|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
5208239|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
5208240|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
5208241|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
5208242|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
5208243|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
5208244|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
5208245|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
5208246|NCT01045161|17975972|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
5208247|NCT01045161|17975973|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
5208248|NCT01045161|17975974|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
5208249|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
5208250|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
5208251|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
5208252|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
5208253|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
5208254|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
5208255|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5208256|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5208257|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5208258|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
5208259|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
5208260|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
5208261|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
5208262|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
5208263|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
5208264|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
5208355|NCT01043705|17976517|P1|Overall Study|Multiple Reasons|4
5208265|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
5208266|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
5208267|NCT01045161|17975972|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
5208268|NCT01045161|17975973|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
5208269|NCT01045161|17975974|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
5208270|NCT01045096|17976011|P3|Overall Study|Other|0
5208271|NCT01045096|17976012|P2|Overall Study|Other|0
5208272|NCT01045096|17976013|P1|Overall Study|Other|1
5208273|NCT01045096|17976011|P3|Overall Study|Withdrawal by Subject|0
5208274|NCT01045096|17976012|P2|Overall Study|Withdrawal by Subject|0
5208275|NCT01045096|17976013|P1|Overall Study|Withdrawal by Subject|2
5208276|NCT01044745|17976130|P1|Overall Study|Ineiligible|2
5208277|NCT01044732|17976139|P2|Overall Study|Technical error or malfunction|14
5208278|NCT01044732|17976140|P1|Overall Study|Technical error or malfunction|15
5208279|NCT01044732|17976139|P2|Overall Study|Inability to reach cecum|2
5208280|NCT01044732|17976140|P1|Overall Study|Inability to reach cecum|5
5208281|NCT01044732|17976139|P2|Overall Study|Inadequate bowel preparation|17
5208282|NCT01044732|17976140|P1|Overall Study|Inadequate bowel preparation|11
5208283|NCT01044732|17976139|P2|Overall Study|Withdrawal by Subject|1
5208284|NCT01044732|17976140|P1|Overall Study|Withdrawal by Subject|0
5208285|NCT01044732|17976139|P2|Overall Study|Protocol Violation|12
5208286|NCT01044732|17976140|P1|Overall Study|Protocol Violation|11
5208287|NCT01044732|17976139|P2|Overall Study|Physician Decision|3
5208288|NCT01044732|17976140|P1|Overall Study|Physician Decision|5
5208289|NCT01044732|17976139|P2|Overall Study|Lost to Follow-up|1
5208290|NCT01044732|17976140|P1|Overall Study|Lost to Follow-up|2
5208291|NCT01044498|17976329|P2|Overall Study|Other|0
5208292|NCT01044498|17976330|P1|Overall Study|Other|1
5208293|NCT01044498|17976329|P2|Overall Study|Adverse Event|1
5208294|NCT01044498|17976330|P1|Overall Study|Adverse Event|1
5208295|NCT01044498|17976329|P2|Overall Study|Withdrew consent|1
5208296|NCT01044498|17976330|P1|Overall Study|Withdrew consent|1
5208297|NCT01044459|17976356|P2|Overall Study|Lost to Follow-up|12
5208298|NCT01044459|17976357|P1|Overall Study|Lost to Follow-up|18
5208299|NCT01044459|17976356|P2|Overall Study|COPD exacerbation|8
5208300|NCT01044459|17976357|P1|Overall Study|COPD exacerbation|9
5208301|NCT01044459|17976356|P2|Overall Study|Other Reason|14
5208302|NCT01044459|17976357|P1|Overall Study|Other Reason|7
5208303|NCT01044459|17976356|P2|Overall Study|Protocol Violation|16
5208304|NCT01044459|17976357|P1|Overall Study|Protocol Violation|11
5208305|NCT01044459|17976356|P2|Overall Study|Lack of Efficacy|12
5208306|NCT01044459|17976357|P1|Overall Study|Lack of Efficacy|23
5208307|NCT01044459|17976356|P2|Overall Study|Adverse Event|20
5208308|NCT01044459|17976357|P1|Overall Study|Adverse Event|22
5208309|NCT01044459|17976356|P2|Overall Study|Terminated by Sponsor|21
5208310|NCT01044459|17976357|P1|Overall Study|Terminated by Sponsor|22
5208311|NCT01044459|17976356|P2|Overall Study|Withdrawal by Subject|28
5208312|NCT01044459|17976357|P1|Overall Study|Withdrawal by Subject|21
5208313|NCT01044433|17976365|P1|Overall Study|Withdrawal by Subject|3
5208314|NCT01044433|17976365|P1|Overall Study|Lost to Follow-up|3
5208315|NCT01044303|17976373|P1|Overall Study|Lost to Follow-up|2
5208316|NCT01044290|17976383|P3|Follow-Up 2|Withdrawal by Subject|1
5208317|NCT01044290|17976384|P2|Follow-Up 2|Withdrawal by Subject|1
5208318|NCT01044290|17976385|P1|Follow-Up 2|Withdrawal by Subject|0
5208319|NCT01044290|17976383|P3|Follow-Up 2|Death|1
5208320|NCT01044290|17976384|P2|Follow-Up 2|Death|1
5208321|NCT01044290|17976385|P1|Follow-Up 2|Death|0
5208322|NCT01044290|17976383|P3|Follow-up 1|Withdrawal by Subject|0
5208323|NCT01044290|17976384|P2|Follow-up 1|Withdrawal by Subject|2
5208324|NCT01044290|17976385|P1|Follow-up 1|Withdrawal by Subject|2
5208325|NCT01044290|17976383|P3|Follow-up 1|Death|1
5208326|NCT01044290|17976384|P2|Follow-up 1|Death|3
5208327|NCT01044290|17976385|P1|Follow-up 1|Death|3
5208328|NCT01043874|17976505|P1|Overall Study|Administrative Problems|1
5208329|NCT01043874|17976505|P1|Overall Study|Lack of Efficacy|1
5208330|NCT01043874|17976505|P1|Overall Study|Withdrawal by Subject|1
5208331|NCT01043874|17976505|P1|Overall Study|Adverse Event|3
5208332|NCT01043705|17976515|P3|Overall Study|Other|25
5208333|NCT01043705|17976516|P2|Overall Study|Other|19
5208334|NCT01043705|17976517|P1|Overall Study|Other|0
5208335|NCT01043705|17976515|P3|Overall Study|Screen Fail|0
5208336|NCT01043705|17976516|P2|Overall Study|Screen Fail|0
5208337|NCT01043705|17976517|P1|Overall Study|Screen Fail|21
5208338|NCT01043705|17976515|P3|Overall Study|Adverse Event|0
5208339|NCT01043705|17976516|P2|Overall Study|Adverse Event|2
5208340|NCT01043705|17976517|P1|Overall Study|Adverse Event|0
5208341|NCT01043705|17976515|P3|Overall Study|Subsequent Procedure|29
5208342|NCT01043705|17976516|P2|Overall Study|Subsequent Procedure|24
5208343|NCT01043705|17976517|P1|Overall Study|Subsequent Procedure|9
5208344|NCT01043705|17976515|P3|Overall Study|Site Closure|0
5208345|NCT01043705|17976516|P2|Overall Study|Site Closure|0
5208346|NCT01043705|17976517|P1|Overall Study|Site Closure|8
5208347|NCT01043705|17976515|P3|Overall Study|Withdrawal by Subject|0
5208348|NCT01043705|17976516|P2|Overall Study|Withdrawal by Subject|6
5208349|NCT01043705|17976517|P1|Overall Study|Withdrawal by Subject|8
5208350|NCT01043705|17976515|P3|Overall Study|Protocol Violation|0
5208351|NCT01043705|17976516|P2|Overall Study|Protocol Violation|1
5208352|NCT01043705|17976517|P1|Overall Study|Protocol Violation|2
5208353|NCT01043705|17976515|P3|Overall Study|Multiple Reasons|0
5208354|NCT01043705|17976516|P2|Overall Study|Multiple Reasons|7
5208356|NCT01043705|17976515|P3|Overall Study|Lost to Follow-up|0
5208357|NCT01043705|17976516|P2|Overall Study|Lost to Follow-up|12
5208358|NCT01043705|17976517|P1|Overall Study|Lost to Follow-up|27
5208359|NCT01043705|17976515|P3|Overall Study|Death|26
5208360|NCT01043705|17976516|P2|Overall Study|Death|60
5208361|NCT01043705|17976517|P1|Overall Study|Death|28
5208362|NCT01043185|17976606|P10|Period 6 - Third Washout Period|Protocol Violation|0
5208363|NCT01043185|17976607|P9|Period 6 - Third Washout Period|Protocol Violation|1
5208364|NCT01043185|17976608|P8|Period 6 - Third Washout Period|Protocol Violation|0
5208365|NCT01043185|17976609|P7|Period 6 - Third Washout Period|Protocol Violation|0
5208366|NCT01043185|17976610|P6|Period 6 - Third Washout Period|Protocol Violation|0
5208367|NCT01043185|17976611|P5|Period 6 - Third Washout Period|Protocol Violation|0
5208368|NCT01043185|17976612|P4|Period 6 - Third Washout Period|Protocol Violation|0
5208369|NCT01043185|17976613|P3|Period 6 - Third Washout Period|Protocol Violation|0
5208370|NCT01043185|17976614|P2|Period 6 - Third Washout Period|Protocol Violation|0
5208371|NCT01043185|17976615|P1|Period 6 - Third Washout Period|Protocol Violation|0
5208372|NCT01042977|17976691|P2|Overall Study|Various|0
5208373|NCT01042977|17976692|P1|Overall Study|Various|3
5208374|NCT01042977|17976691|P2|Overall Study|Administrative reason by sponsor|1
5208375|NCT01042977|17976692|P1|Overall Study|Administrative reason by sponsor|0
5208376|NCT01042977|17976691|P2|Overall Study|Safety|2
5208377|NCT01042977|17976692|P1|Overall Study|Safety|0
5208378|NCT01042977|17976691|P2|Overall Study|Incorrect enrollment|4
5208379|NCT01042977|17976692|P1|Overall Study|Incorrect enrollment|6
5208380|NCT01042977|17976691|P2|Overall Study|Subject no longer meets study criteria|13
5208381|NCT01042977|17976692|P1|Overall Study|Subject no longer meets study criteria|15
5208382|NCT01042977|17976691|P2|Overall Study|Poor/non-compliance|4
5208383|NCT01042977|17976692|P1|Overall Study|Poor/non-compliance|3
5208384|NCT01042977|17976691|P2|Overall Study|Lost to Follow-up|2
5208385|NCT01042977|17976692|P1|Overall Study|Lost to Follow-up|0
5208386|NCT01042977|17976691|P2|Overall Study|Withdrawal by Subject|16
5208387|NCT01042977|17976692|P1|Overall Study|Withdrawal by Subject|8
5208388|NCT01042977|17976691|P2|Overall Study|Death|1
5208389|NCT01042977|17976692|P1|Overall Study|Death|2
5208390|NCT01042977|17976691|P2|Overall Study|Adverse Event|12
5208391|NCT01042977|17976692|P1|Overall Study|Adverse Event|4
5208392|NCT01042938|17976712|P2|Overall Study|Ineligible: RTOG study conflict|0
5208393|NCT01042938|17976713|P1|Overall Study|Ineligible: RTOG study conflict|1
5208394|NCT01042938|17976712|P2|Overall Study|Protocol Violation|1
5208395|NCT01042938|17976713|P1|Overall Study|Protocol Violation|1
5208396|NCT01042938|17976712|P2|Overall Study|Withdrawal by Subject|1
5208397|NCT01042938|17976713|P1|Overall Study|Withdrawal by Subject|1
5208398|NCT01042678|17976732|P6|Overall Study|Physician Decision|0
5208399|NCT01042678|17976733|P5|Overall Study|Physician Decision|0
5208400|NCT01042678|17976734|P4|Overall Study|Physician Decision|0
5208401|NCT01042678|17976735|P3|Overall Study|Physician Decision|0
5208402|NCT01042678|17976736|P2|Overall Study|Physician Decision|0
5208403|NCT01042678|17976737|P1|Overall Study|Physician Decision|1
5208404|NCT01042600|17976775|P2|Overall Study|Ineligible|0
5208405|NCT01042600|17976776|P1|Overall Study|Ineligible|1
5208406|NCT01042535|17976796|P1|Overall Study|complications from other disease|2
5208407|NCT01042535|17976796|P1|Overall Study|disease progression during treatment|3
5208408|NCT01042535|17976796|P1|Overall Study|disease progression prior to treatment|3
5208409|NCT01042392|17976830|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5208410|NCT01042392|17976831|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5208411|NCT01042392|17976832|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5208412|NCT01042392|17976833|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
5208413|NCT01042392|17976830|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5208414|NCT01042392|17976831|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
5208415|NCT01042392|17976832|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5208416|NCT01042392|17976833|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5208417|NCT01042392|17976830|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5208418|NCT01042392|17976831|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5208419|NCT01042392|17976832|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5208420|NCT01042392|17976833|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
5208421|NCT01042392|17976830|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5208422|NCT01042392|17976831|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
5208423|NCT01042392|17976832|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5208424|NCT01042392|17976833|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5208425|NCT01042392|17976830|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5208426|NCT01042392|17976831|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5208427|NCT01042392|17976832|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5208428|NCT01042392|17976833|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
5208429|NCT01042392|17976830|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5208430|NCT01042392|17976831|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
5208431|NCT01042392|17976832|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5208432|NCT01042392|17976833|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5208433|NCT01042392|17976830|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
5208434|NCT01042392|17976831|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
5208435|NCT01042392|17976832|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
5208436|NCT01042392|17976833|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
5208437|NCT01042392|17976830|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5208438|NCT01042392|17976831|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5208439|NCT01042392|17976832|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5208440|NCT01042392|17976833|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
5208441|NCT01042392|17976830|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
5208442|NCT01042392|17976831|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
5208443|NCT01042392|17976832|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
5208444|NCT01042392|17976833|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
5208445|NCT01042236|17976881|P6|Treatment Period 3|Protocol Violation|0
5208446|NCT01042236|17976882|P5|Treatment Period 3|Protocol Violation|0
5208447|NCT01042236|17976883|P4|Treatment Period 3|Protocol Violation|1
5208448|NCT01042236|17976884|P3|Treatment Period 3|Protocol Violation|0
5208449|NCT01042236|17976885|P2|Treatment Period 3|Protocol Violation|0
5208450|NCT01042236|17976886|P1|Treatment Period 3|Protocol Violation|0
5208451|NCT01042236|17976881|P6|Treatment Period 3|Adverse Event|0
5208452|NCT01042236|17976882|P5|Treatment Period 3|Adverse Event|0
5208453|NCT01042236|17976883|P4|Treatment Period 3|Adverse Event|1
5208454|NCT01042236|17976884|P3|Treatment Period 3|Adverse Event|0
5208455|NCT01042236|17976885|P2|Treatment Period 3|Adverse Event|0
5208456|NCT01042236|17976886|P1|Treatment Period 3|Adverse Event|0
5208457|NCT01042236|17976881|P6|Treatment Period 1|Adverse Event|0
5208458|NCT01042236|17976882|P5|Treatment Period 1|Adverse Event|1
5208459|NCT01042236|17976883|P4|Treatment Period 1|Adverse Event|0
5208460|NCT01042236|17976884|P3|Treatment Period 1|Adverse Event|0
5208461|NCT01042236|17976885|P2|Treatment Period 1|Adverse Event|1
5208462|NCT01042236|17976886|P1|Treatment Period 1|Adverse Event|0
5208463|NCT01042158|17976923|P1|Overall Study|Physician Decision|1
5208464|NCT01042093|17976953|P4|Overall Study|Withdrawal by Subject|1
5208465|NCT01042093|17976954|P3|Overall Study|Withdrawal by Subject|0
5208466|NCT01042093|17976955|P2|Overall Study|Withdrawal by Subject|0
5208467|NCT01042093|17976956|P1|Overall Study|Withdrawal by Subject|0
5208468|NCT01042093|17976953|P4|Overall Study|Protocol Violation|3
5208469|NCT01042093|17976954|P3|Overall Study|Protocol Violation|2
5208470|NCT01042093|17976955|P2|Overall Study|Protocol Violation|2
5208471|NCT01042093|17976956|P1|Overall Study|Protocol Violation|2
5208472|NCT01041976|17976976|P2|Overall Study|Death|4
5208473|NCT01041976|17976977|P1|Overall Study|Death|0
5208474|NCT01041976|17976976|P2|Overall Study|Incarceration|0
5208475|NCT01041976|17976977|P1|Overall Study|Incarceration|2
5208476|NCT01041976|17976976|P2|Overall Study|Withdrawal by Subject|0
5208477|NCT01041976|17976977|P1|Overall Study|Withdrawal by Subject|3
5208478|NCT01041859|17976987|P3|Double-Blind Maintenance|Withdrawal by Subject|9
5208479|NCT01041859|17976988|P2|Double-Blind Maintenance|Withdrawal by Subject|8
5208480|NCT01041859|17976989|P1|Double-Blind Maintenance|Withdrawal by Subject|0
5208481|NCT01041859|17976987|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
5208482|NCT01041859|17976988|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
5208483|NCT01041859|17976989|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
5208484|NCT01041859|17976987|P3|Double-Blind Maintenance|Other|2
5208485|NCT01041859|17976988|P2|Double-Blind Maintenance|Other|6
5208486|NCT01041859|17976989|P1|Double-Blind Maintenance|Other|0
5208487|NCT01041859|17976987|P3|Double-Blind Maintenance|Protocol Violation|3
5208488|NCT01041859|17976988|P2|Double-Blind Maintenance|Protocol Violation|1
5208489|NCT01041859|17976989|P1|Double-Blind Maintenance|Protocol Violation|0
5208490|NCT01041859|17976987|P3|Double-Blind Maintenance|Physician Decision|1
5208491|NCT01041859|17976988|P2|Double-Blind Maintenance|Physician Decision|2
5208492|NCT01041859|17976989|P1|Double-Blind Maintenance|Physician Decision|0
5208493|NCT01041859|17976987|P3|Double-Blind Maintenance|Lost to Follow-up|0
5208494|NCT01041859|17976988|P2|Double-Blind Maintenance|Lost to Follow-up|1
5208495|NCT01041859|17976989|P1|Double-Blind Maintenance|Lost to Follow-up|0
5208496|NCT01041859|17976987|P3|Double-Blind Maintenance|Lack of Efficacy|11
5208497|NCT01041859|17976988|P2|Double-Blind Maintenance|Lack of Efficacy|3
5208498|NCT01041859|17976989|P1|Double-Blind Maintenance|Lack of Efficacy|0
5208499|NCT01041859|17976987|P3|Double-Blind Maintenance|Adverse Event|13
5208500|NCT01041859|17976988|P2|Double-Blind Maintenance|Adverse Event|23
5208501|NCT01041859|17976989|P1|Double-Blind Maintenance|Adverse Event|0
5208502|NCT01041859|17976987|P3|Open-Label Titration|Withdrawal by Subject|0
5208503|NCT01041859|17976988|P2|Open-Label Titration|Withdrawal by Subject|0
5208504|NCT01041859|17976989|P1|Open-Label Titration|Withdrawal by Subject|11
5208505|NCT01041859|17976987|P3|Open-Label Titration|Noncompliance With Study Drug|0
5208506|NCT01041859|17976988|P2|Open-Label Titration|Noncompliance With Study Drug|0
5208507|NCT01041859|17976989|P1|Open-Label Titration|Noncompliance With Study Drug|8
5208508|NCT01041859|17976987|P3|Open-Label Titration|Other|0
5208509|NCT01041859|17976988|P2|Open-Label Titration|Other|0
5208510|NCT01041859|17976989|P1|Open-Label Titration|Other|7
5208511|NCT01041859|17976987|P3|Open-Label Titration|Protocol Violation|0
5208512|NCT01041859|17976988|P2|Open-Label Titration|Protocol Violation|0
5208513|NCT01041859|17976989|P1|Open-Label Titration|Protocol Violation|1
5208514|NCT01041859|17976987|P3|Open-Label Titration|Physician Decision|0
5208515|NCT01041859|17976988|P2|Open-Label Titration|Physician Decision|0
5208516|NCT01041859|17976989|P1|Open-Label Titration|Physician Decision|1
5208517|NCT01041859|17976987|P3|Open-Label Titration|Lost to Follow-up|0
5208518|NCT01041859|17976988|P2|Open-Label Titration|Lost to Follow-up|0
5208519|NCT01041859|17976989|P1|Open-Label Titration|Lost to Follow-up|1
5208520|NCT01041859|17976987|P3|Open-Label Titration|Lack of Efficacy|0
5208521|NCT01041859|17976988|P2|Open-Label Titration|Lack of Efficacy|0
5208522|NCT01041859|17976989|P1|Open-Label Titration|Lack of Efficacy|3
5208523|NCT01041859|17976987|P3|Open-Label Titration|Adverse Event|0
5208524|NCT01041859|17976988|P2|Open-Label Titration|Adverse Event|0
5208525|NCT01041859|17976989|P1|Open-Label Titration|Adverse Event|69
5208526|NCT01041638|17977025|P1|Overall Study|Withdrawal by Subject|11
5208527|NCT01041638|17977025|P1|Overall Study|Physician Decision|4
5208528|NCT01041638|17977025|P1|Overall Study|Lack of Efficacy|7
5208529|NCT01041638|17977025|P1|Overall Study|Death|1
5208530|NCT01041638|17977025|P1|Overall Study|Adverse Event|4
5208531|NCT01041573|17977035|P4|Overall Study|positive to anti-HCV|0
5208532|NCT01041573|17977036|P3|Overall Study|positive to anti-HCV|0
5208533|NCT01041573|17977037|P2|Overall Study|positive to anti-HCV|0
5208534|NCT01041573|17977038|P1|Overall Study|positive to anti-HCV|1
5208535|NCT01041573|17977035|P4|Overall Study|further blood extraction|0
5208536|NCT01041573|17977036|P3|Overall Study|further blood extraction|0
5208537|NCT01041573|17977037|P2|Overall Study|further blood extraction|1
5208538|NCT01041573|17977038|P1|Overall Study|further blood extraction|0
5208539|NCT01041573|17977035|P4|Overall Study|relocation|1
5208540|NCT01041573|17977036|P3|Overall Study|relocation|3
5208541|NCT01041573|17977037|P2|Overall Study|relocation|4
5208542|NCT01041573|17977038|P1|Overall Study|relocation|1
5208543|NCT01041573|17977035|P4|Overall Study|Adverse Event|0
5208544|NCT01041573|17977036|P3|Overall Study|Adverse Event|0
5208545|NCT01041573|17977037|P2|Overall Study|Adverse Event|2
5208546|NCT01041573|17977038|P1|Overall Study|Adverse Event|0
5208547|NCT01041573|17977035|P4|Overall Study|Lost to Follow-up|1
5208548|NCT01041573|17977036|P3|Overall Study|Lost to Follow-up|2
5208549|NCT01041573|17977037|P2|Overall Study|Lost to Follow-up|1
5208550|NCT01041573|17977038|P1|Overall Study|Lost to Follow-up|0
5208551|NCT01041573|17977035|P4|Overall Study|Death|0
5208552|NCT01041573|17977036|P3|Overall Study|Death|0
5208553|NCT01041573|17977037|P2|Overall Study|Death|0
5208554|NCT01041573|17977038|P1|Overall Study|Death|1
5208555|NCT01041573|17977035|P4|Overall Study|Withdrawal by Subject|0
5208556|NCT01041573|17977036|P3|Overall Study|Withdrawal by Subject|2
5208557|NCT01041573|17977037|P2|Overall Study|Withdrawal by Subject|5
5208558|NCT01041573|17977038|P1|Overall Study|Withdrawal by Subject|2
5208559|NCT01041417|17977061|P2|Overall Study|Death|0
5208560|NCT01041417|17977062|P1|Overall Study|Death|1
5208561|NCT01041417|17977061|P2|Overall Study|Lost to Follow-up|1
5208562|NCT01041417|17977062|P1|Overall Study|Lost to Follow-up|1
5208563|NCT01041417|17977061|P2|Overall Study|Adverse Event|2
5208564|NCT01041417|17977062|P1|Overall Study|Adverse Event|5
5208565|NCT01041404|17977100|P2|Overall Study|Other|23
5208566|NCT01041404|17977101|P1|Overall Study|Other|11
5208567|NCT01041404|17977100|P2|Overall Study|Failure to Return|2
5208568|NCT01041404|17977101|P1|Overall Study|Failure to Return|1
5208569|NCT01041404|17977100|P2|Overall Study|Withdrawal by Subject|23
5208570|NCT01041404|17977101|P1|Overall Study|Withdrawal by Subject|29
5208571|NCT01041404|17977100|P2|Overall Study|Protocol Violation|0
5208572|NCT01041404|17977101|P1|Overall Study|Protocol Violation|4
5208573|NCT01041404|17977100|P2|Overall Study|Violation of Selection Criteria|1
5208574|NCT01041404|17977101|P1|Overall Study|Violation of Selection Criteria|0
5208575|NCT01041404|17977100|P2|Overall Study|Lack of Efficacy|210
5208576|NCT01041404|17977101|P1|Overall Study|Lack of Efficacy|200
5208577|NCT01041404|17977100|P2|Overall Study|Adverse Event|35
5208578|NCT01041404|17977101|P1|Overall Study|Adverse Event|45
5208579|NCT01041287|17977142|P2|Treatment Period 2 (3 Months)|Adverse Event|2
5208580|NCT01041287|17977143|P1|Treatment Period 2 (3 Months)|Adverse Event|0
5208581|NCT01041287|17977142|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
5208582|NCT01041287|17977143|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
5208583|NCT01040871|17977183|P2|Overall Study|Randomized and Not Treated|1
5208584|NCT01040871|17977184|P1|Overall Study|Randomized and Not Treated|2
5208585|NCT01040871|17977183|P2|Overall Study|drug supply issue|0
5208586|NCT01040871|17977184|P1|Overall Study|drug supply issue|1
5208587|NCT01040871|17977183|P2|Overall Study|Lack of Efficacy|1
5208588|NCT01040871|17977184|P1|Overall Study|Lack of Efficacy|1
5208589|NCT01040871|17977183|P2|Overall Study|Death|3
5208590|NCT01040871|17977184|P1|Overall Study|Death|1
5208591|NCT01040871|17977183|P2|Overall Study|Withdrawal by Subject|0
5208592|NCT01040871|17977184|P1|Overall Study|Withdrawal by Subject|2
5208593|NCT01040871|17977183|P2|Overall Study|Adverse Event|2
5208594|NCT01040871|17977184|P1|Overall Study|Adverse Event|6
5208595|NCT01040845|17977235|P2|Overall Study|Physician Decision|0
5208596|NCT01040845|17977236|P1|Overall Study|Physician Decision|1
5208597|NCT01040845|17977235|P2|Overall Study|Withdrawal by Subject|1
5208598|NCT01040845|17977236|P1|Overall Study|Withdrawal by Subject|1
5208599|NCT01040832|17977251|P2|Overall Study|Other|1
5208600|NCT01040832|17977252|P1|Overall Study|Other|2
5208601|NCT01040832|17977251|P2|Overall Study|Symptomatic deterioration|5
5208602|NCT01040832|17977252|P1|Overall Study|Symptomatic deterioration|2
5208603|NCT01040832|17977251|P2|Overall Study|Progressive disease|17
5208604|NCT01040832|17977252|P1|Overall Study|Progressive disease|32
5208605|NCT01040832|17977251|P2|Overall Study|Withdrawal by Subject|3
5208606|NCT01040832|17977252|P1|Overall Study|Withdrawal by Subject|2
5208607|NCT01040832|17977251|P2|Overall Study|Death|6
5208608|NCT01040832|17977252|P1|Overall Study|Death|4
5208609|NCT01040832|17977251|P2|Overall Study|Adverse Event|5
5208610|NCT01040832|17977252|P1|Overall Study|Adverse Event|4
5208611|NCT01040793|17977275|P6|Overall Study|Other reasons not listed above|0
5208612|NCT01040793|17977276|P5|Overall Study|Other reasons not listed above|1
5208613|NCT01040793|17977277|P4|Overall Study|Other reasons not listed above|0
5208614|NCT01040793|17977278|P3|Overall Study|Other reasons not listed above|1
5208615|NCT01040793|17977279|P2|Overall Study|Other reasons not listed above|0
5208616|NCT01040793|17977280|P1|Overall Study|Other reasons not listed above|0
5208617|NCT01040793|17977275|P6|Overall Study|Withdrawal by Subject|0
5208618|NCT01040793|17977276|P5|Overall Study|Withdrawal by Subject|0
5208619|NCT01040793|17977277|P4|Overall Study|Withdrawal by Subject|2
5208620|NCT01040793|17977278|P3|Overall Study|Withdrawal by Subject|0
5208621|NCT01040793|17977279|P2|Overall Study|Withdrawal by Subject|0
5208622|NCT01040793|17977280|P1|Overall Study|Withdrawal by Subject|0
5208623|NCT01040793|17977275|P6|Overall Study|Lost to Follow-up|0
5208624|NCT01040793|17977276|P5|Overall Study|Lost to Follow-up|0
5208625|NCT01040793|17977277|P4|Overall Study|Lost to Follow-up|0
5208626|NCT01040793|17977278|P3|Overall Study|Lost to Follow-up|1
5208627|NCT01040793|17977279|P2|Overall Study|Lost to Follow-up|1
5208628|NCT01040793|17977280|P1|Overall Study|Lost to Follow-up|0
5208629|NCT01040793|17977275|P6|Overall Study|Protocol Violation|0
5208630|NCT01040793|17977276|P5|Overall Study|Protocol Violation|1
5208631|NCT01040793|17977277|P4|Overall Study|Protocol Violation|0
5208632|NCT01040793|17977278|P3|Overall Study|Protocol Violation|1
5208633|NCT01040793|17977279|P2|Overall Study|Protocol Violation|1
5208634|NCT01040793|17977280|P1|Overall Study|Protocol Violation|1
5208635|NCT01040793|17977275|P6|Overall Study|Adverse Event|1
5208636|NCT01040793|17977276|P5|Overall Study|Adverse Event|2
5208637|NCT01040793|17977277|P4|Overall Study|Adverse Event|2
5208638|NCT01040793|17977278|P3|Overall Study|Adverse Event|0
5208639|NCT01040793|17977279|P2|Overall Study|Adverse Event|3
5208640|NCT01040793|17977280|P1|Overall Study|Adverse Event|5
5208641|NCT01040780|17977359|P2|Overall Study|Protocol Violation|3
5208642|NCT01040780|17977360|P1|Overall Study|Protocol Violation|1
5208643|NCT01040728|17977374|P4|Overall Study|Other reasons not listed above|0
5208644|NCT01040728|17977375|P3|Overall Study|Other reasons not listed above|0
5208645|NCT01040728|17977376|P2|Overall Study|Other reasons not listed above|1
5208646|NCT01040728|17977377|P1|Overall Study|Other reasons not listed above|0
5208647|NCT01040728|17977374|P4|Overall Study|Lack of Efficacy|1
5208648|NCT01040728|17977375|P3|Overall Study|Lack of Efficacy|0
5208649|NCT01040728|17977376|P2|Overall Study|Lack of Efficacy|1
5208650|NCT01040728|17977377|P1|Overall Study|Lack of Efficacy|0
5208651|NCT01040728|17977374|P4|Overall Study|Protocol Violation|1
5208652|NCT01040728|17977375|P3|Overall Study|Protocol Violation|0
5208653|NCT01040728|17977376|P2|Overall Study|Protocol Violation|0
5208654|NCT01040728|17977377|P1|Overall Study|Protocol Violation|0
5208655|NCT01040728|17977374|P4|Overall Study|Withdrawal by Subject|0
5208656|NCT01040728|17977375|P3|Overall Study|Withdrawal by Subject|1
5208657|NCT01040728|17977376|P2|Overall Study|Withdrawal by Subject|1
5208658|NCT01040728|17977377|P1|Overall Study|Withdrawal by Subject|0
5208659|NCT01040728|17977374|P4|Overall Study|Adverse Event|4
5208660|NCT01040728|17977375|P3|Overall Study|Adverse Event|0
5208661|NCT01040728|17977376|P2|Overall Study|Adverse Event|8
5208662|NCT01040728|17977377|P1|Overall Study|Adverse Event|4
5208663|NCT01040689|17977447|P4|Overall Study|Other reasons not listed above|0
5208664|NCT01040689|17977448|P3|Overall Study|Other reasons not listed above|0
5208665|NCT01040689|17977449|P2|Overall Study|Other reasons not listed above|1
5208666|NCT01040689|17977450|P1|Overall Study|Other reasons not listed above|0
5208667|NCT01040689|17977447|P4|Overall Study|Withdrawal by Subject|0
5208668|NCT01040689|17977448|P3|Overall Study|Withdrawal by Subject|1
5208669|NCT01040689|17977449|P2|Overall Study|Withdrawal by Subject|1
5208670|NCT01040689|17977450|P1|Overall Study|Withdrawal by Subject|2
5208671|NCT01040689|17977447|P4|Overall Study|Lost to Follow-up|0
5208672|NCT01040689|17977448|P3|Overall Study|Lost to Follow-up|0
5208673|NCT01040689|17977449|P2|Overall Study|Lost to Follow-up|0
5208674|NCT01040689|17977450|P1|Overall Study|Lost to Follow-up|1
5208675|NCT01040689|17977447|P4|Overall Study|Lack of Efficacy|0
5208676|NCT01040689|17977448|P3|Overall Study|Lack of Efficacy|1
5208677|NCT01040689|17977449|P2|Overall Study|Lack of Efficacy|0
5208678|NCT01040689|17977450|P1|Overall Study|Lack of Efficacy|0
5208679|NCT01040689|17977447|P4|Overall Study|Adverse Event|4
5208680|NCT01040689|17977448|P3|Overall Study|Adverse Event|2
5208681|NCT01040689|17977449|P2|Overall Study|Adverse Event|0
5208682|NCT01040689|17977450|P1|Overall Study|Adverse Event|0
5208683|NCT01040403|17977529|P1|Overall Study|Other reason not defined above|6
5208684|NCT01040403|17977529|P1|Overall Study|Not treated|1
5208685|NCT01040403|17977529|P1|Overall Study|Lost to Follow-up|1
5208686|NCT01040403|17977529|P1|Overall Study|Protocol Violation|2
5208687|NCT01040403|17977529|P1|Overall Study|Adverse Event|10
5208688|NCT01040351|17977717|P2|Overall Study|poor ovarian response|2
5208689|NCT01040351|17977718|P1|Overall Study|poor ovarian response|1
5208690|NCT01040260|17977728|P2|Overall Study|Lost to Follow-up|5
5208691|NCT01040260|17977729|P1|Overall Study|Lost to Follow-up|3
5208692|NCT01040260|17977728|P2|Overall Study|Withdrawal by Subject|6
5208693|NCT01040260|17977729|P1|Overall Study|Withdrawal by Subject|12
5208694|NCT01040169|17977756|P2|Overall Study|Lost to Follow-up|8
5208695|NCT01040169|17977757|P1|Overall Study|Lost to Follow-up|3
5208696|NCT01040130|17977765|P6|Overall Study|Other reasons not listed above|0
5208697|NCT01040130|17977766|P5|Overall Study|Other reasons not listed above|0
5208698|NCT01040130|17977767|P4|Overall Study|Other reasons not listed above|0
5208699|NCT01040130|17977768|P3|Overall Study|Other reasons not listed above|0
5208700|NCT01040130|17977769|P2|Overall Study|Other reasons not listed above|0
5208701|NCT01040130|17977770|P1|Overall Study|Other reasons not listed above|2
5208702|NCT01040130|17977765|P6|Overall Study|Withdrawal by Subject|1
5208703|NCT01040130|17977766|P5|Overall Study|Withdrawal by Subject|0
5208704|NCT01040130|17977767|P4|Overall Study|Withdrawal by Subject|0
5208705|NCT01040130|17977768|P3|Overall Study|Withdrawal by Subject|0
5208706|NCT01040130|17977769|P2|Overall Study|Withdrawal by Subject|2
5208707|NCT01040130|17977770|P1|Overall Study|Withdrawal by Subject|0
5208708|NCT01040130|17977765|P6|Overall Study|Protocol Violation|0
5208709|NCT01040130|17977766|P5|Overall Study|Protocol Violation|0
5208710|NCT01040130|17977767|P4|Overall Study|Protocol Violation|0
5208711|NCT01040130|17977768|P3|Overall Study|Protocol Violation|2
5208712|NCT01040130|17977769|P2|Overall Study|Protocol Violation|0
5208713|NCT01040130|17977770|P1|Overall Study|Protocol Violation|0
5208714|NCT01040130|17977765|P6|Overall Study|Adverse Event|3
5208715|NCT01040130|17977766|P5|Overall Study|Adverse Event|0
5208716|NCT01040130|17977767|P4|Overall Study|Adverse Event|5
5208717|NCT01040130|17977768|P3|Overall Study|Adverse Event|0
5208718|NCT01040130|17977769|P2|Overall Study|Adverse Event|1
5208719|NCT01040130|17977770|P1|Overall Study|Adverse Event|1
5208720|NCT01039688|17977863|P3|Overall Study|Death|0
5208721|NCT01039688|17977864|P2|Overall Study|Death|0
5208722|NCT01039688|17977865|P1|Overall Study|Death|2
5208723|NCT01039688|17977863|P3|Overall Study|Withdrawal by Subject|13
5208724|NCT01039688|17977864|P2|Overall Study|Withdrawal by Subject|27
5208725|NCT01039688|17977865|P1|Overall Study|Withdrawal by Subject|23
5208726|NCT01039688|17977863|P3|Overall Study|Other|12
5208727|NCT01039688|17977864|P2|Overall Study|Other|25
5208728|NCT01039688|17977865|P1|Overall Study|Other|13
5208729|NCT01039688|17977863|P3|Overall Study|Lost to Follow-up|5
5208730|NCT01039688|17977864|P2|Overall Study|Lost to Follow-up|9
5208731|NCT01039688|17977865|P1|Overall Study|Lost to Follow-up|11
5208732|NCT01039688|17977863|P3|Overall Study|Lack of Efficacy|26
5208733|NCT01039688|17977864|P2|Overall Study|Lack of Efficacy|11
5208734|NCT01039688|17977865|P1|Overall Study|Lack of Efficacy|20
5208735|NCT01039688|17977863|P3|Overall Study|Adverse Event|24
5208736|NCT01039688|17977864|P2|Overall Study|Adverse Event|39
5208737|NCT01039688|17977865|P1|Overall Study|Adverse Event|38
5208738|NCT01039675|17978136|P2|Overall Study|Physician Decision|1
5208739|NCT01039675|17978137|P1|Overall Study|Physician Decision|0
5208740|NCT01039675|17978136|P2|Overall Study|Lost to Follow-up|1
5208741|NCT01039675|17978137|P1|Overall Study|Lost to Follow-up|0
5208742|NCT01039675|17978136|P2|Overall Study|Withdrawal by Subject|1
5208743|NCT01039675|17978137|P1|Overall Study|Withdrawal by Subject|0
5208744|NCT01039675|17978136|P2|Overall Study|Lack of Efficacy|2
5208745|NCT01039675|17978137|P1|Overall Study|Lack of Efficacy|0
5208746|NCT01039675|17978136|P2|Overall Study|Adverse Event|2
5208747|NCT01039675|17978137|P1|Overall Study|Adverse Event|0
5208748|NCT01039584|17978150|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
5208749|NCT01039584|17978151|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
5208750|NCT01039584|17978152|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
5208751|NCT01039584|17978150|P3|Overall Study|Pap smear with significant pathology|3
5208752|NCT01039584|17978151|P2|Overall Study|Pap smear with significant pathology|10
5208753|NCT01039584|17978152|P1|Overall Study|Pap smear with significant pathology|10
5208754|NCT01039584|17978150|P3|Overall Study|other|1
5208755|NCT01039584|17978151|P2|Overall Study|other|3
5208756|NCT01039584|17978152|P1|Overall Study|other|1
5208757|NCT01039584|17978150|P3|Overall Study|Lack of Efficacy|10
5208758|NCT01039584|17978151|P2|Overall Study|Lack of Efficacy|6
5208759|NCT01039584|17978152|P1|Overall Study|Lack of Efficacy|7
5208760|NCT01039584|17978150|P3|Overall Study|Negative Baseline culture for Candida|24
5208761|NCT01039584|17978151|P2|Overall Study|Negative Baseline culture for Candida|59
5208762|NCT01039584|17978152|P1|Overall Study|Negative Baseline culture for Candida|59
5208763|NCT01039584|17978150|P3|Overall Study|Lost to Follow-up|4
5208764|NCT01039584|17978151|P2|Overall Study|Lost to Follow-up|3
5208765|NCT01039584|17978152|P1|Overall Study|Lost to Follow-up|5
5208766|NCT01039584|17978150|P3|Overall Study|Protocol Violation|6
5208767|NCT01039584|17978151|P2|Overall Study|Protocol Violation|4
5208768|NCT01039584|17978152|P1|Overall Study|Protocol Violation|10
5208769|NCT01039584|17978150|P3|Overall Study|Withdrawal by Subject|1
5208770|NCT01039584|17978151|P2|Overall Study|Withdrawal by Subject|2
5208771|NCT01039584|17978152|P1|Overall Study|Withdrawal by Subject|4
5208772|NCT01039519|17978166|P1|Survival Follow-up|Sponsor decision|4
5208773|NCT01039519|17978166|P1|Survival Follow-up|Death|23
5208774|NCT01039519|17978166|P1|Treatment|Physician Decision|2
5208775|NCT01039519|17978166|P1|Treatment|Adverse Event|3
5208776|NCT01039519|17978166|P1|Treatment|Treatment failure|2
5208777|NCT01039519|17978166|P1|Treatment|Progressive disease|20
5208778|NCT01039428|17978202|P2|Overall Study|Withdrawal by Subject|0
5208779|NCT01039428|17978203|P1|Overall Study|Withdrawal by Subject|1
5208780|NCT01039428|17978202|P2|Overall Study|Protocol Violation|0
5208781|NCT01039428|17978203|P1|Overall Study|Protocol Violation|1
5208782|NCT01039376|17978227|P2|Overall Study|Study terminated by Sponsor|72
5208783|NCT01039376|17978228|P1|Overall Study|Study terminated by Sponsor|90
5208784|NCT01039376|17978227|P2|Overall Study|Withdrawal by Subject|32
5208785|NCT01039376|17978228|P1|Overall Study|Withdrawal by Subject|20
5208786|NCT01039376|17978227|P2|Overall Study|Physician Decision|10
5208787|NCT01039376|17978228|P1|Overall Study|Physician Decision|15
5208788|NCT01039376|17978227|P2|Overall Study|Lost to Follow-up|12
5208789|NCT01039376|17978228|P1|Overall Study|Lost to Follow-up|5
5208790|NCT01038921|17978297|P2|Overall Study|Physician Decision|0
5208791|NCT01038921|17978298|P1|Overall Study|Physician Decision|1
5208792|NCT01038921|17978297|P2|Overall Study|Withdrawal by Subject|0
5208793|NCT01038921|17978298|P1|Overall Study|Withdrawal by Subject|1
5208794|NCT01038869|17978304|P1|Overall Study|Lost to Follow-up|6
5208795|NCT01038869|17978304|P1|Overall Study|Withdrawal by Subject|1
5208796|NCT01038856|17978312|P1|Overall Study|Adverse Event|2
5208797|NCT01038752|17978321|P2|Overall Study|Lost to Follow-up|3
5208798|NCT01038752|17978322|P1|Overall Study|Lost to Follow-up|3
5208799|NCT01038752|17978321|P2|Overall Study|Tumor Progression|2
5208800|NCT01038752|17978322|P1|Overall Study|Tumor Progression|2
5208801|NCT01038713|17978345|P3|Overall Study|Autoimmune Pancreatitis|0
5208802|NCT01038713|17978346|P2|Overall Study|Autoimmune Pancreatitis|0
5208803|NCT01038713|17978347|P1|Overall Study|Autoimmune Pancreatitis|1
5208804|NCT01038713|17978345|P3|Overall Study|died from PEP|0
5208805|NCT01038713|17978346|P2|Overall Study|died from PEP|1
5208806|NCT01038713|17978347|P1|Overall Study|died from PEP|0
5208807|NCT01038713|17978345|P3|Overall Study|Neuroendocrine Tumor|0
5208808|NCT01038713|17978346|P2|Overall Study|Neuroendocrine Tumor|1
5208809|NCT01038713|17978347|P1|Overall Study|Neuroendocrine Tumor|0
5208810|NCT01038713|17978345|P3|Overall Study|Lost to Follow-up|0
5208811|NCT01038713|17978346|P2|Overall Study|Lost to Follow-up|0
5208812|NCT01038713|17978347|P1|Overall Study|Lost to Follow-up|3
5208813|NCT01038713|17978345|P3|Overall Study|Patient to hospice|1
5208814|NCT01038713|17978346|P2|Overall Study|Patient to hospice|1
5208815|NCT01038713|17978347|P1|Overall Study|Patient to hospice|1
5208816|NCT01038687|17978370|P3|Overall Study|Adverse Event|1
5208817|NCT01038687|17978371|P2|Overall Study|Adverse Event|2
5208818|NCT01038687|17978372|P1|Overall Study|Adverse Event|0
5208819|NCT01038635|17978413|P9|Overall Study|Death|2
5208820|NCT01038635|17978414|P8|Overall Study|Death|1
5208821|NCT01038635|17978415|P7|Overall Study|Death|1
5208822|NCT01038635|17978416|P6|Overall Study|Death|0
5208823|NCT01038635|17978417|P5|Overall Study|Death|1
5208824|NCT01038635|17978418|P4|Overall Study|Death|0
5208825|NCT01038635|17978419|P3|Overall Study|Death|0
5208826|NCT01038635|17978420|P2|Overall Study|Death|0
5208827|NCT01038635|17978421|P1|Overall Study|Death|0
5208828|NCT01038635|17978413|P9|Overall Study|Disease Progression|0
5208829|NCT01038635|17978414|P8|Overall Study|Disease Progression|4
5208830|NCT01038635|17978415|P7|Overall Study|Disease Progression|1
5208831|NCT01038635|17978416|P6|Overall Study|Disease Progression|0
5208832|NCT01038635|17978417|P5|Overall Study|Disease Progression|0
5208833|NCT01038635|17978418|P4|Overall Study|Disease Progression|0
5208834|NCT01038635|17978419|P3|Overall Study|Disease Progression|0
5208835|NCT01038635|17978420|P2|Overall Study|Disease Progression|0
5208836|NCT01038635|17978421|P1|Overall Study|Disease Progression|2
5208837|NCT01038609|17978447|P5|Overall Study|Refusal of Blood Draws|0
5208838|NCT01038609|17978448|P4|Overall Study|Refusal of Blood Draws|0
5208839|NCT01038609|17978449|P3|Overall Study|Refusal of Blood Draws|0
5208840|NCT01038609|17978450|P2|Overall Study|Refusal of Blood Draws|1
5208841|NCT01038609|17978451|P1|Overall Study|Refusal of Blood Draws|0
5208842|NCT01038609|17978447|P5|Overall Study|Death in the Family|0
5208843|NCT01038609|17978448|P4|Overall Study|Death in the Family|0
5208844|NCT01038609|17978449|P3|Overall Study|Death in the Family|0
5208845|NCT01038609|17978450|P2|Overall Study|Death in the Family|0
5208846|NCT01038609|17978451|P1|Overall Study|Death in the Family|1
5208847|NCT01038609|17978447|P5|Overall Study|Dosing Error|1
5208848|NCT01038609|17978448|P4|Overall Study|Dosing Error|1
5208849|NCT01038609|17978449|P3|Overall Study|Dosing Error|0
5208850|NCT01038609|17978450|P2|Overall Study|Dosing Error|0
5208851|NCT01038609|17978451|P1|Overall Study|Dosing Error|0
5208852|NCT01038609|17978447|P5|Overall Study|Adverse Event|0
5208853|NCT01038609|17978448|P4|Overall Study|Adverse Event|0
5208854|NCT01038609|17978449|P3|Overall Study|Adverse Event|1
5208855|NCT01038609|17978450|P2|Overall Study|Adverse Event|0
5208856|NCT01038609|17978451|P1|Overall Study|Adverse Event|0
5208857|NCT01038323|17978570|P3|Overall Study|Withdrawal by Subject|4
5208858|NCT01038323|17978571|P2|Overall Study|Withdrawal by Subject|2
5208859|NCT01038323|17978572|P1|Overall Study|Withdrawal by Subject|3
5208860|NCT01038128|17978586|P1|Overall Study|Withdrawal by Subject|2
5208861|NCT01038128|17978586|P1|Overall Study|Lost to Follow-up|1
5208862|NCT01038128|17978586|P1|Overall Study|Lack of Efficacy|1
5208863|NCT01037244|17978750|P4|Overall Study|Various|1
5208864|NCT01037244|17978751|P3|Overall Study|Various|1
5208865|NCT01037244|17978752|P2|Overall Study|Various|2
5208866|NCT01037244|17978753|P1|Overall Study|Various|3
5208867|NCT01037244|17978750|P4|Overall Study|Partner Withdrew Consent|0
5208868|NCT01037244|17978751|P3|Overall Study|Partner Withdrew Consent|0
5208869|NCT01037244|17978752|P2|Overall Study|Partner Withdrew Consent|1
5208870|NCT01037244|17978753|P1|Overall Study|Partner Withdrew Consent|2
5208871|NCT01037244|17978750|P4|Overall Study|Withdrawal by Subject|5
5208872|NCT01037244|17978751|P3|Overall Study|Withdrawal by Subject|3
5208873|NCT01037244|17978752|P2|Overall Study|Withdrawal by Subject|5
5208874|NCT01037244|17978753|P1|Overall Study|Withdrawal by Subject|1
5208875|NCT01037244|17978750|P4|Overall Study|Lost to Follow-up|4
5208876|NCT01037244|17978751|P3|Overall Study|Lost to Follow-up|4
5208877|NCT01037244|17978752|P2|Overall Study|Lost to Follow-up|3
5208878|NCT01037244|17978753|P1|Overall Study|Lost to Follow-up|3
5208879|NCT01037244|17978750|P4|Overall Study|Lack of Efficacy|1
5208880|NCT01037244|17978751|P3|Overall Study|Lack of Efficacy|0
5208881|NCT01037244|17978752|P2|Overall Study|Lack of Efficacy|1
5208882|NCT01037244|17978753|P1|Overall Study|Lack of Efficacy|1
5208883|NCT01037244|17978750|P4|Overall Study|Adverse Event|3
5208884|NCT01037244|17978751|P3|Overall Study|Adverse Event|6
5208885|NCT01037244|17978752|P2|Overall Study|Adverse Event|2
5208886|NCT01037244|17978753|P1|Overall Study|Adverse Event|3
5208887|NCT01037218|17978815|P4|Overall Study|Various|1
5208888|NCT01037218|17978816|P3|Overall Study|Various|3
5208889|NCT01037218|17978817|P2|Overall Study|Various|2
5208890|NCT01037218|17978818|P1|Overall Study|Various|3
5208891|NCT01037218|17978815|P4|Overall Study|Protocol Violation|2
5208892|NCT01037218|17978816|P3|Overall Study|Protocol Violation|2
5208893|NCT01037218|17978817|P2|Overall Study|Protocol Violation|0
5208894|NCT01037218|17978818|P1|Overall Study|Protocol Violation|0
5208895|NCT01037218|17978815|P4|Overall Study|Partner Withdrew Consent|1
5208896|NCT01037218|17978816|P3|Overall Study|Partner Withdrew Consent|2
5208897|NCT01037218|17978817|P2|Overall Study|Partner Withdrew Consent|3
5208898|NCT01037218|17978818|P1|Overall Study|Partner Withdrew Consent|0
5208899|NCT01037218|17978815|P4|Overall Study|Withdrawal by Subject|4
5208900|NCT01037218|17978816|P3|Overall Study|Withdrawal by Subject|7
5208901|NCT01037218|17978817|P2|Overall Study|Withdrawal by Subject|7
5208902|NCT01037218|17978818|P1|Overall Study|Withdrawal by Subject|6
5208903|NCT01037218|17978815|P4|Overall Study|Lost to Follow-up|2
5208904|NCT01037218|17978816|P3|Overall Study|Lost to Follow-up|4
5208905|NCT01037218|17978817|P2|Overall Study|Lost to Follow-up|5
5208906|NCT01037218|17978818|P1|Overall Study|Lost to Follow-up|3
5208907|NCT01037218|17978815|P4|Overall Study|Lack of Efficacy|5
5208908|NCT01037218|17978816|P3|Overall Study|Lack of Efficacy|1
5208909|NCT01037218|17978817|P2|Overall Study|Lack of Efficacy|2
5208910|NCT01037218|17978818|P1|Overall Study|Lack of Efficacy|0
5208911|NCT01037218|17978815|P4|Overall Study|Adverse Event|1
5208912|NCT01037218|17978816|P3|Overall Study|Adverse Event|2
5208913|NCT01037218|17978817|P2|Overall Study|Adverse Event|2
5208914|NCT01037218|17978818|P1|Overall Study|Adverse Event|4
5208915|NCT01037127|17978889|P2|Overall Study|Study Closed Terminated|17
5208916|NCT01037127|17978890|P1|Overall Study|Study Closed Terminated|2
5208917|NCT01037127|17978889|P2|Overall Study|Physician Decision|0
5208918|NCT01037127|17978890|P1|Overall Study|Physician Decision|1
5208919|NCT01037127|17978889|P2|Overall Study|Lost to Follow-up|4
5208920|NCT01037127|17978890|P1|Overall Study|Lost to Follow-up|2
5208921|NCT01037114|17978922|P1|Year 20|Others|1
5208922|NCT01037088|17978935|P1|Overall Study|Withdrawal by Subject|3
5208923|NCT01036763|17978967|P1|Overall Study|Other reason (not specified)|40
5208924|NCT01036763|17978967|P1|Overall Study|Lost to Follow-up|28
5208925|NCT01036763|17978967|P1|Overall Study|Adverse Event|25
5208926|NCT01036724|17978979|P2|Overall Study|Protocol Violation|5
5208927|NCT01036724|17978980|P1|Overall Study|Protocol Violation|4
5208928|NCT01036724|17978979|P2|Overall Study|Lack of Efficacy|1
5208929|NCT01036724|17978980|P1|Overall Study|Lack of Efficacy|1
5208930|NCT01036724|17978979|P2|Overall Study|Adverse Event|2
5208931|NCT01036724|17978980|P1|Overall Study|Adverse Event|1
5208932|NCT01036594|17978988|P2|Treatment Regiments Post Week 12|Lack of Efficacy|1
5208933|NCT01036594|17978989|P1|Treatment Regiments Post Week 12|Lack of Efficacy|0
5208934|NCT01036594|17978988|P2|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
5208935|NCT01036594|17978989|P1|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
5208936|NCT01036594|17978988|P2|Treatment Regiments Post Week 12|Adverse Event|1
5208937|NCT01036594|17978989|P1|Treatment Regiments Post Week 12|Adverse Event|0
5208938|NCT01036594|17978988|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
5208939|NCT01036594|17978989|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|1
5208940|NCT01036594|17978988|P2|Treatment Regiments Post Week 12|Physician Decision|1
5208941|NCT01036594|17978989|P1|Treatment Regiments Post Week 12|Physician Decision|1
5208942|NCT01036594|17978988|P2|Week 12 Evaluation|Physician Decision|0
5208943|NCT01036594|17978989|P1|Week 12 Evaluation|Physician Decision|1
5208944|NCT01036594|17978988|P2|Week 12 Evaluation|Adverse Event|0
5208945|NCT01036594|17978989|P1|Week 12 Evaluation|Adverse Event|5
5208946|NCT01036594|17978988|P2|First Treatment Regimen|Withdrawal by Subject|0
5208947|NCT01036594|17978989|P1|First Treatment Regimen|Withdrawal by Subject|1
5208948|NCT01036594|17978988|P2|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
5208949|NCT01036594|17978989|P1|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
5208950|NCT01036529|17979013|P2|Overall Study|Sponsor study termination|12
5208951|NCT01036529|17979014|P1|Overall Study|Sponsor study termination|11
5208952|NCT01036529|17979013|P2|Overall Study|Withdrawal by Subject|1
5208953|NCT01036529|17979014|P1|Overall Study|Withdrawal by Subject|1
5208954|NCT01036529|17979013|P2|Overall Study|Physician Decision|0
5208955|NCT01036529|17979014|P1|Overall Study|Physician Decision|1
5208956|NCT01036529|17979013|P2|Overall Study|Lost to Follow-up|1
5208957|NCT01036529|17979014|P1|Overall Study|Lost to Follow-up|0
5208958|NCT01036529|17979013|P2|Overall Study|Adverse Event|1
5208959|NCT01036529|17979014|P1|Overall Study|Adverse Event|0
5208960|NCT01036438|17979041|P2|Overall Study|No effect of study treatment|1
5208961|NCT01036438|17979042|P1|Overall Study|No effect of study treatment|3
5208962|NCT01036438|17979041|P2|Overall Study|Death|1
5208963|NCT01036438|17979042|P1|Overall Study|Death|0
5208964|NCT01036438|17979041|P2|Overall Study|Adverse Event|8
5208965|NCT01036438|17979042|P1|Overall Study|Adverse Event|7
5208966|NCT01036321|17979050|P2|Overall Study|Adverse Event|1
5208967|NCT01036321|17979051|P1|Overall Study|Adverse Event|2
5208968|NCT01036321|17979050|P2|Overall Study|Withdrawal by Subject|2
5208969|NCT01036321|17979051|P1|Overall Study|Withdrawal by Subject|3
5208970|NCT01036321|17979050|P2|Overall Study|Ineligible after randomization|1
5208971|NCT01036321|17979051|P1|Overall Study|Ineligible after randomization|0
5208972|NCT01036165|17979075|P1|Overall Study|Problems finding proper area to inject|1
5208973|NCT01036165|17979075|P1|Overall Study|Device Related Issues|3
5208974|NCT01036165|17979075|P1|Overall Study|Withdrawal by Subject|3
5208975|NCT01036165|17979075|P1|Overall Study|Lost to Follow-up|2
5208976|NCT01036165|17979075|P1|Overall Study|Adverse Event|6
5208977|NCT01036022|17979086|P6|Overall Study|Withdrawal by Subject|0
5208978|NCT01036022|17979087|P5|Overall Study|Withdrawal by Subject|2
5208979|NCT01036022|17979088|P4|Overall Study|Withdrawal by Subject|1
5208980|NCT01036022|17979089|P3|Overall Study|Withdrawal by Subject|0
5208981|NCT01036022|17979090|P2|Overall Study|Withdrawal by Subject|0
5208982|NCT01036022|17979091|P1|Overall Study|Withdrawal by Subject|0
5208983|NCT01036022|17979086|P6|Overall Study|Physician Decision|0
5208984|NCT01036022|17979087|P5|Overall Study|Physician Decision|0
5208985|NCT01036022|17979088|P4|Overall Study|Physician Decision|0
5208986|NCT01036022|17979089|P3|Overall Study|Physician Decision|1
5208987|NCT01036022|17979090|P2|Overall Study|Physician Decision|0
5208988|NCT01036022|17979091|P1|Overall Study|Physician Decision|0
5208989|NCT01036022|17979086|P6|Overall Study|Lack of Efficacy|1
5208990|NCT01036022|17979087|P5|Overall Study|Lack of Efficacy|1
5208991|NCT01036022|17979088|P4|Overall Study|Lack of Efficacy|0
5208992|NCT01036022|17979089|P3|Overall Study|Lack of Efficacy|1
5208993|NCT01036022|17979090|P2|Overall Study|Lack of Efficacy|1
5208994|NCT01036022|17979091|P1|Overall Study|Lack of Efficacy|1
5208995|NCT01036022|17979086|P6|Overall Study|Adverse Event|2
5208996|NCT01036022|17979087|P5|Overall Study|Adverse Event|0
5208997|NCT01036022|17979088|P4|Overall Study|Adverse Event|1
5208998|NCT01036022|17979089|P3|Overall Study|Adverse Event|2
5208999|NCT01036022|17979090|P2|Overall Study|Adverse Event|3
5209000|NCT01036022|17979091|P1|Overall Study|Adverse Event|1
5209001|NCT01035905|17979227|P2|Overall Study|Lack of Efficacy|1
5209002|NCT01035905|17979228|P1|Overall Study|Lack of Efficacy|1
5209003|NCT01035606|17979401|P3|Overall Study|change in health, job demands,family|4
5209004|NCT01035606|17979402|P2|Overall Study|change in health, job demands,family|3
5209005|NCT01035606|17979403|P1|Overall Study|change in health, job demands,family|3
5209006|NCT01035463|17979419|P6|Overall Study|Other|2
5209007|NCT01035463|17979420|P5|Overall Study|Other|0
5209008|NCT01035463|17979421|P4|Overall Study|Other|1
5209009|NCT01035463|17979422|P3|Overall Study|Other|0
5209010|NCT01035463|17979423|P2|Overall Study|Other|0
5209011|NCT01035463|17979424|P1|Overall Study|Other|0
5209012|NCT01035463|17979419|P6|Overall Study|Other Malignancy|2
5209013|NCT01035463|17979420|P5|Overall Study|Other Malignancy|0
5209014|NCT01035463|17979421|P4|Overall Study|Other Malignancy|0
5209015|NCT01035463|17979422|P3|Overall Study|Other Malignancy|0
5209016|NCT01035463|17979423|P2|Overall Study|Other Malignancy|0
5209017|NCT01035463|17979424|P1|Overall Study|Other Malignancy|0
5209018|NCT01035463|17979419|P6|Overall Study|Disease progression|3
5209019|NCT01035463|17979420|P5|Overall Study|Disease progression|0
5209020|NCT01035463|17979421|P4|Overall Study|Disease progression|0
5209021|NCT01035463|17979422|P3|Overall Study|Disease progression|0
5209022|NCT01035463|17979423|P2|Overall Study|Disease progression|0
5209023|NCT01035463|17979424|P1|Overall Study|Disease progression|0
5209024|NCT01035463|17979419|P6|Overall Study|Withdrawal by Subject|4
5209025|NCT01035463|17979420|P5|Overall Study|Withdrawal by Subject|1
5209026|NCT01035463|17979421|P4|Overall Study|Withdrawal by Subject|0
5209027|NCT01035463|17979422|P3|Overall Study|Withdrawal by Subject|1
5209028|NCT01035463|17979423|P2|Overall Study|Withdrawal by Subject|2
5209029|NCT01035463|17979424|P1|Overall Study|Withdrawal by Subject|0
5209030|NCT01035463|17979419|P6|Overall Study|Adverse Event|7
5209031|NCT01035463|17979420|P5|Overall Study|Adverse Event|5
5209032|NCT01035463|17979421|P4|Overall Study|Adverse Event|1
5209033|NCT01035463|17979422|P3|Overall Study|Adverse Event|4
5209034|NCT01035463|17979423|P2|Overall Study|Adverse Event|0
5209035|NCT01035463|17979424|P1|Overall Study|Adverse Event|0
5209036|NCT01035255|17979461|P2|Overall Study|patient's request|13
5209037|NCT01035255|17979462|P1|Overall Study|patient's request|15
5209038|NCT01035255|17979461|P2|Overall Study|Lost to Follow-up|5
5209039|NCT01035255|17979462|P1|Overall Study|Lost to Follow-up|2
5209040|NCT01035255|17979461|P2|Overall Study|Death|844
5209041|NCT01035255|17979462|P1|Overall Study|Death|724
5209042|NCT01035229|17979480|P2|Overall Study|Disease Progression|152
5209043|NCT01035229|17979481|P1|Overall Study|Disease Progression|261
5209044|NCT01035229|17979480|P2|Overall Study|Sponsor's decision to end study|3
5209045|NCT01035229|17979481|P1|Overall Study|Sponsor's decision to end study|3
5209046|NCT01035229|17979480|P2|Overall Study|Protocol Violation|2
5209047|NCT01035229|17979481|P1|Overall Study|Protocol Violation|0
5209048|NCT01035229|17979480|P2|Overall Study|New cancer therapy|0
5209049|NCT01035229|17979481|P1|Overall Study|New cancer therapy|2
5209050|NCT01035229|17979480|P2|Overall Study|Death|5
5209051|NCT01035229|17979481|P1|Overall Study|Death|13
5209052|NCT01035229|17979480|P2|Overall Study|Administrative problems|1
5209053|NCT01035229|17979481|P1|Overall Study|Administrative problems|1
5209054|NCT01035229|17979480|P2|Overall Study|Lost to Follow-up|0
5209055|NCT01035229|17979481|P1|Overall Study|Lost to Follow-up|1
5209056|NCT01035229|17979480|P2|Overall Study|Withdrawal by Subject|7
5209057|NCT01035229|17979481|P1|Overall Study|Withdrawal by Subject|20
5209058|NCT01035229|17979480|P2|Overall Study|Adverse Event|14
5209059|NCT01035229|17979481|P1|Overall Study|Adverse Event|61
5209060|NCT01035138|17979511|P3|Overall Study|Lost to Follow-up|1
5209061|NCT01035138|17979512|P2|Overall Study|Lost to Follow-up|0
5209062|NCT01035138|17979513|P1|Overall Study|Lost to Follow-up|0
5209063|NCT01035138|17979511|P3|Overall Study|Sponsor Decision|42
5209064|NCT01035138|17979512|P2|Overall Study|Sponsor Decision|60
5209065|NCT01035138|17979513|P1|Overall Study|Sponsor Decision|66
5209066|NCT01035138|17979511|P3|Overall Study|Physician Decision|1
5209067|NCT01035138|17979512|P2|Overall Study|Physician Decision|0
5209068|NCT01035138|17979513|P1|Overall Study|Physician Decision|0
5209069|NCT01035138|17979511|P3|Overall Study|Withdrawal by Subject|0
5209070|NCT01035138|17979512|P2|Overall Study|Withdrawal by Subject|0
5209071|NCT01035138|17979513|P1|Overall Study|Withdrawal by Subject|1
5209072|NCT01035138|17979511|P3|Overall Study|Caregiver Decision|1
5209073|NCT01035138|17979512|P2|Overall Study|Caregiver Decision|0
5209074|NCT01035138|17979513|P1|Overall Study|Caregiver Decision|2
5209075|NCT01035138|17979511|P3|Overall Study|Adverse Event|2
5209076|NCT01035138|17979512|P2|Overall Study|Adverse Event|0
5209077|NCT01035138|17979513|P1|Overall Study|Adverse Event|4
5209078|NCT01035060|17979613|P2|Overall Study|Physician Decision|0
5209079|NCT01035060|17979614|P1|Overall Study|Physician Decision|2
5209080|NCT01035060|17979613|P2|Overall Study|Withdrawal by Subject|6
5209081|NCT01035060|17979614|P1|Overall Study|Withdrawal by Subject|8
5209082|NCT01035060|17979613|P2|Overall Study|Did not quality after 2nd screening|1
5209083|NCT01035060|17979614|P1|Overall Study|Did not quality after 2nd screening|14
5209084|NCT01035060|17979613|P2|Overall Study|Lost to Follow-up|7
5209085|NCT01035060|17979614|P1|Overall Study|Lost to Follow-up|0
5209086|NCT01034709|17979639|P2|Overall Study|Protocol Violation|16
5209087|NCT01034709|17979640|P1|Overall Study|Protocol Violation|9
5209088|NCT01034657|17979646|P3|Randomized Phase|Adverse Event|1
5209089|NCT01034657|17979647|P2|Randomized Phase|Adverse Event|2
5209090|NCT01034657|17979648|P1|Randomized Phase|Adverse Event|0
5209091|NCT01034657|17979646|P3|Randomized Phase|Abnormal laboratory value|0
5209092|NCT01034657|17979647|P2|Randomized Phase|Abnormal laboratory value|1
5209093|NCT01034657|17979648|P1|Randomized Phase|Abnormal laboratory value|0
5209094|NCT01034657|17979646|P3|Randomized Phase|Lack of Efficacy|0
5209095|NCT01034657|17979647|P2|Randomized Phase|Lack of Efficacy|1
5209096|NCT01034657|17979648|P1|Randomized Phase|Lack of Efficacy|5
5209097|NCT01034657|17979646|P3|Randomized Phase|Withdrawal by Subject|0
5209098|NCT01034657|17979647|P2|Randomized Phase|Withdrawal by Subject|2
5209099|NCT01034657|17979648|P1|Randomized Phase|Withdrawal by Subject|0
5209100|NCT01034657|17979646|P3|Core Phase|Protocol Violation|0
5209101|NCT01034657|17979647|P2|Core Phase|Protocol Violation|0
5209102|NCT01034657|17979648|P1|Core Phase|Protocol Violation|2
5209103|NCT01034657|17979646|P3|Core Phase|Adverse Event|0
5209104|NCT01034657|17979647|P2|Core Phase|Adverse Event|0
5209105|NCT01034657|17979648|P1|Core Phase|Adverse Event|8
5209106|NCT01034657|17979646|P3|Core Phase|Abnormal laboratory value|0
5209107|NCT01034657|17979647|P2|Core Phase|Abnormal laboratory value|0
5209108|NCT01034657|17979648|P1|Core Phase|Abnormal laboratory value|1
5209109|NCT01034657|17979646|P3|Core Phase|Lack of Efficacy|0
5209110|NCT01034657|17979647|P2|Core Phase|Lack of Efficacy|0
5209111|NCT01034657|17979648|P1|Core Phase|Lack of Efficacy|2
5209112|NCT01034657|17979646|P3|Core Phase|Withdrawal by Subject|0
5209113|NCT01034657|17979647|P2|Core Phase|Withdrawal by Subject|0
5209114|NCT01034657|17979648|P1|Core Phase|Withdrawal by Subject|1
5209115|NCT01034631|17979689|P3|Phase II|Determined Ineligible per protocol|0
5209116|NCT01034631|17979690|P2|Phase II|Determined Ineligible per protocol|1
5209117|NCT01034631|17979691|P1|Phase II|Determined Ineligible per protocol|0
5209118|NCT01034631|17979689|P3|Phase II|Not Evaluable per protocol|2
5209119|NCT01034631|17979690|P2|Phase II|Not Evaluable per protocol|0
5209120|NCT01034631|17979691|P1|Phase II|Not Evaluable per protocol|0
5209121|NCT01034631|17979689|P3|Phase I|Symptomatic Deterioration before Treatme|0
5209122|NCT01034631|17979690|P2|Phase I|Symptomatic Deterioration before Treatme|0
5209123|NCT01034631|17979691|P1|Phase I|Symptomatic Deterioration before Treatme|3
5209124|NCT01034540|17979758|P2|Overall Study|Adverse Event|1
5209125|NCT01034540|17979759|P1|Overall Study|Adverse Event|0
5209126|NCT01034462|17979778|P2|Overall Study|Other reasons|2
5209127|NCT01034462|17979779|P1|Overall Study|Other reasons|1
5209128|NCT01034462|17979778|P2|Overall Study|Lost to Follow-up|16
5209129|NCT01034462|17979779|P1|Overall Study|Lost to Follow-up|14
5209130|NCT01034462|17979778|P2|Overall Study|Withdrawal by Subject|8
5209131|NCT01034462|17979779|P1|Overall Study|Withdrawal by Subject|9
5209132|NCT01034462|17979778|P2|Overall Study|Protocol Violation|7
5209133|NCT01034462|17979779|P1|Overall Study|Protocol Violation|10
5209134|NCT01034462|17979778|P2|Overall Study|Lack of Efficacy|4
5209135|NCT01034462|17979779|P1|Overall Study|Lack of Efficacy|4
5209136|NCT01034462|17979778|P2|Overall Study|Adverse Event|17
5209137|NCT01034462|17979779|P1|Overall Study|Adverse Event|7
5209138|NCT01034397|17979789|P2|Overall Study|Other|1
5209139|NCT01034397|17979790|P1|Overall Study|Other|0
5209140|NCT01034397|17979789|P2|Overall Study|Adverse Event|0
5209141|NCT01034397|17979790|P1|Overall Study|Adverse Event|4
5209142|NCT01034397|17979789|P2|Overall Study|Lack of Efficacy|0
5209143|NCT01034397|17979790|P1|Overall Study|Lack of Efficacy|3
5209144|NCT01034397|17979789|P2|Overall Study|Lack of compliance|1
5209145|NCT01034397|17979790|P1|Overall Study|Lack of compliance|0
5209146|NCT01034358|17979939|P1|Overall Study|Protocol Violation|1
5209147|NCT01034358|17979939|P1|Overall Study|Withdrawal by Subject|1
5209148|NCT01034306|17979945|P2|Overall Study|Noncomplience|0
5209149|NCT01034306|17979946|P1|Overall Study|Noncomplience|1
5209150|NCT01034306|17979945|P2|Overall Study|hospitalized and decided to stop|0
5209151|NCT01034306|17979946|P1|Overall Study|hospitalized and decided to stop|1
5209152|NCT01034306|17979945|P2|Overall Study|Withdrawal by Subject|2
5209153|NCT01034306|17979946|P1|Overall Study|Withdrawal by Subject|2
5209154|NCT01034306|17979945|P2|Overall Study|Lost to Follow-up|1
5209155|NCT01034306|17979946|P1|Overall Study|Lost to Follow-up|0
5209156|NCT01034306|17979945|P2|Overall Study|Adverse Event|0
5209157|NCT01034306|17979946|P1|Overall Study|Adverse Event|1
5209158|NCT01034176|17979954|P2|Overall Study|Lost to Follow-up|1
5209159|NCT01034176|17979955|P1|Overall Study|Lost to Follow-up|0
5209160|NCT01034176|17979954|P2|Overall Study|Withdrawal by Subject|1
5209161|NCT01034176|17979955|P1|Overall Study|Withdrawal by Subject|0
5209162|NCT01034176|17979954|P2|Overall Study|Physician Decision|0
5209163|NCT01034176|17979955|P1|Overall Study|Physician Decision|2
5209164|NCT01034163|17979965|P2|Overall Study|Abnormal laboratory value|0
5209165|NCT01034163|17979966|P1|Overall Study|Abnormal laboratory value|1
5209166|NCT01034163|17979965|P2|Overall Study|Administrative problems|1
5209167|NCT01034163|17979966|P1|Overall Study|Administrative problems|0
5209168|NCT01034163|17979965|P2|Overall Study|Adverse Event|0
5209169|NCT01034163|17979966|P1|Overall Study|Adverse Event|6
5209170|NCT01034163|17979965|P2|Overall Study|Disease progression|4
5209171|NCT01034163|17979966|P1|Overall Study|Disease progression|3
5209172|NCT01034163|17979965|P2|Overall Study|Protocol deviation|0
5209173|NCT01034163|17979966|P1|Overall Study|Protocol deviation|1
5209174|NCT01034163|17979965|P2|Overall Study|Withdrawal by Subject|2
5209175|NCT01034163|17979966|P1|Overall Study|Withdrawal by Subject|8
5209176|NCT01034163|17979965|P2|Overall Study|Treatment completed as per protocol|7
5209177|NCT01034163|17979966|P1|Overall Study|Treatment completed as per protocol|8
5209178|NCT01034137|17979975|P3|Overall Study|Administrative or other|4
5209179|NCT01034137|17979976|P2|Overall Study|Administrative or other|3
5209180|NCT01034137|17979977|P1|Overall Study|Administrative or other|2
5209181|NCT01034137|17979975|P3|Overall Study|Refused treatment or did not cooperate|1
5209182|NCT01034137|17979976|P2|Overall Study|Refused treatment or did not cooperate|0
5209183|NCT01034137|17979977|P1|Overall Study|Refused treatment or did not cooperate|2
5209184|NCT01034137|17979975|P3|Overall Study|Protocol Violation|1
5209185|NCT01034137|17979976|P2|Overall Study|Protocol Violation|2
5209186|NCT01034137|17979977|P1|Overall Study|Protocol Violation|2
5209187|NCT01034137|17979975|P3|Overall Study|Lack of Efficacy|13
5209188|NCT01034137|17979976|P2|Overall Study|Lack of Efficacy|4
5209189|NCT01034137|17979977|P1|Overall Study|Lack of Efficacy|9
5209190|NCT01034137|17979975|P3|Overall Study|Withdrawal by Subject|3
5209191|NCT01034137|17979976|P2|Overall Study|Withdrawal by Subject|3
5209192|NCT01034137|17979977|P1|Overall Study|Withdrawal by Subject|4
5209193|NCT01034137|17979975|P3|Overall Study|Adverse Event|8
5209194|NCT01034137|17979976|P2|Overall Study|Adverse Event|10
5209195|NCT01034137|17979977|P1|Overall Study|Adverse Event|9
5209196|NCT01033942|17980116|P3|Overall Study|Enrolled in Extension Study|0
5209197|NCT01033942|17980117|P2|Overall Study|Enrolled in Extension Study|3
5209198|NCT01033942|17980118|P1|Overall Study|Enrolled in Extension Study|0
5209199|NCT01033942|17980116|P3|Overall Study|Lost to Follow-up|0
5209200|NCT01033942|17980117|P2|Overall Study|Lost to Follow-up|0
5209201|NCT01033942|17980118|P1|Overall Study|Lost to Follow-up|1
5209202|NCT01033942|17980116|P3|Overall Study|Withdrawal by Subject|1
5209203|NCT01033942|17980117|P2|Overall Study|Withdrawal by Subject|1
5209204|NCT01033942|17980118|P1|Overall Study|Withdrawal by Subject|1
5209205|NCT01033851|17980416|P2|Overall Study|Withdrawal by Subject|7
5209206|NCT01033851|17980417|P1|Overall Study|Withdrawal by Subject|3
5209207|NCT01033825|17980432|P7|Overall Study|Other|0
5209208|NCT01033825|17980433|P6|Overall Study|Other|0
5209209|NCT01033825|17980434|P5|Overall Study|Other|1
5209210|NCT01033825|17980435|P4|Overall Study|Other|0
5209211|NCT01033825|17980436|P3|Overall Study|Other|0
5209212|NCT01033825|17980437|P2|Overall Study|Other|0
5209213|NCT01033825|17980438|P1|Overall Study|Other|0
5209214|NCT01033825|17980432|P7|Overall Study|Protocol Violation|0
5209215|NCT01033825|17980433|P6|Overall Study|Protocol Violation|0
5209216|NCT01033825|17980434|P5|Overall Study|Protocol Violation|0
5209217|NCT01033825|17980435|P4|Overall Study|Protocol Violation|0
5209218|NCT01033825|17980436|P3|Overall Study|Protocol Violation|0
5209219|NCT01033825|17980437|P2|Overall Study|Protocol Violation|0
5209220|NCT01033825|17980438|P1|Overall Study|Protocol Violation|1
5209221|NCT01033825|17980432|P7|Overall Study|Adverse Event|0
5209222|NCT01033825|17980433|P6|Overall Study|Adverse Event|0
5209223|NCT01033825|17980434|P5|Overall Study|Adverse Event|0
5209224|NCT01033825|17980435|P4|Overall Study|Adverse Event|1
5209225|NCT01033825|17980436|P3|Overall Study|Adverse Event|0
5209226|NCT01033825|17980437|P2|Overall Study|Adverse Event|0
5209227|NCT01033825|17980438|P1|Overall Study|Adverse Event|0
5209228|NCT01033825|17980432|P7|Overall Study|Withdrawal by Subject|0
5209229|NCT01033825|17980433|P6|Overall Study|Withdrawal by Subject|0
5209230|NCT01033825|17980434|P5|Overall Study|Withdrawal by Subject|1
5209231|NCT01033825|17980435|P4|Overall Study|Withdrawal by Subject|1
5209232|NCT01033825|17980436|P3|Overall Study|Withdrawal by Subject|2
5209233|NCT01033825|17980437|P2|Overall Study|Withdrawal by Subject|3
5209234|NCT01033825|17980438|P1|Overall Study|Withdrawal by Subject|2
5209235|NCT01033747|17980665|P2|Overall Study|Stopped at end of Extension 1|0
5209236|NCT01033747|17980666|P1|Overall Study|Stopped at end of Extension 1|2
5209237|NCT01033747|17980665|P2|Overall Study|Stopped at end of prolongation visit 1|0
5209238|NCT01033747|17980666|P1|Overall Study|Stopped at end of prolongation visit 1|1
5209239|NCT01033747|17980665|P2|Overall Study|Withdrawal by Subject|6
5209240|NCT01033747|17980666|P1|Overall Study|Withdrawal by Subject|9
5209241|NCT01033747|17980665|P2|Overall Study|Protocol Violation|0
5209242|NCT01033747|17980666|P1|Overall Study|Protocol Violation|1
5209243|NCT01033747|17980665|P2|Overall Study|Unsatisfactory therapeutic effect|4
5209244|NCT01033747|17980666|P1|Overall Study|Unsatisfactory therapeutic effect|14
5209245|NCT01033747|17980665|P2|Overall Study|Abnormal test procedure|1
5209246|NCT01033747|17980666|P1|Overall Study|Abnormal test procedure|0
5209247|NCT01033747|17980665|P2|Overall Study|Abnormal Laboratory Value|0
5209248|NCT01033747|17980666|P1|Overall Study|Abnormal Laboratory Value|1
5209249|NCT01033747|17980665|P2|Overall Study|Adverse Event|4
5209250|NCT01033747|17980666|P1|Overall Study|Adverse Event|9
5209251|NCT01033734|17980674|P1|Overall Study|Withdrawal by Subject|1
5209252|NCT01033487|17980730|P10|Fourth Intervention Period|Adverse Event|0
5209253|NCT01033487|17980731|P9|Fourth Intervention Period|Adverse Event|1
5209254|NCT01033487|17980732|P8|Fourth Intervention Period|Adverse Event|0
5209255|NCT01033487|17980733|P7|Fourth Intervention Period|Adverse Event|0
5209256|NCT01033487|17980734|P6|Fourth Intervention Period|Adverse Event|0
5209257|NCT01033487|17980735|P5|Fourth Intervention Period|Adverse Event|0
5209258|NCT01033487|17980736|P4|Fourth Intervention Period|Adverse Event|0
5209259|NCT01033487|17980737|P3|Fourth Intervention Period|Adverse Event|0
5209260|NCT01033487|17980738|P2|Fourth Intervention Period|Adverse Event|0
5209261|NCT01033487|17980739|P1|Fourth Intervention Period|Adverse Event|0
5209262|NCT01033448|17980793|P1|Overall Study|Unknown disposition|1
5209263|NCT01033448|17980793|P1|Overall Study|Withdrew due to other reasons|3
5209264|NCT01033448|17980793|P1|Overall Study|Lost to Follow-up|3
5209265|NCT01033448|17980793|P1|Overall Study|Positive HCV-RNA at week 48|1
5209266|NCT01033448|17980793|P1|Overall Study|Withdrawal by Subject|4
5209267|NCT01033136|17980852|P2|Follow-Up (3 Month)|Lost to Follow-up|2
5209268|NCT01033136|17980853|P1|Follow-Up (3 Month)|Lost to Follow-up|2
5209269|NCT01033071|17980864|P3|Overall Study|Other|3
5209270|NCT01033071|17980865|P2|Overall Study|Other|4
5209271|NCT01033071|17980866|P1|Overall Study|Other|6
5209272|NCT01033071|17980864|P3|Overall Study|Lack of Efficacy|1
5209273|NCT01033071|17980865|P2|Overall Study|Lack of Efficacy|1
5209274|NCT01033071|17980866|P1|Overall Study|Lack of Efficacy|0
5209275|NCT01033071|17980864|P3|Overall Study|Withdrawal by Subject|11
5209276|NCT01033071|17980865|P2|Overall Study|Withdrawal by Subject|14
5209277|NCT01033071|17980866|P1|Overall Study|Withdrawal by Subject|17
5209278|NCT01033071|17980864|P3|Overall Study|Lost to Follow-up|5
5209279|NCT01033071|17980865|P2|Overall Study|Lost to Follow-up|5
5209280|NCT01033071|17980866|P1|Overall Study|Lost to Follow-up|4
5209281|NCT01033071|17980864|P3|Overall Study|Protocol Violation|1
5209282|NCT01033071|17980865|P2|Overall Study|Protocol Violation|2
5209283|NCT01033071|17980866|P1|Overall Study|Protocol Violation|0
5209284|NCT01033071|17980864|P3|Overall Study|Adverse Event|26
5209285|NCT01033071|17980865|P2|Overall Study|Adverse Event|51
5209286|NCT01033071|17980866|P1|Overall Study|Adverse Event|28
5209287|NCT01033019|17980937|P2|Overall Study|Withdrawal by Subject|0
5209288|NCT01033019|17980938|P1|Overall Study|Withdrawal by Subject|1
5209289|NCT01032915|17980995|P4|Overall Study|Protocol Violation|1
5209290|NCT01032915|17980996|P3|Overall Study|Protocol Violation|0
5209291|NCT01032915|17980997|P2|Overall Study|Protocol Violation|0
5209292|NCT01032915|17980998|P1|Overall Study|Protocol Violation|1
5209293|NCT01032915|17980995|P4|Overall Study|Administrative reasons|4
5209294|NCT01032915|17980996|P3|Overall Study|Administrative reasons|4
5209295|NCT01032915|17980997|P2|Overall Study|Administrative reasons|6
5209296|NCT01032915|17980998|P1|Overall Study|Administrative reasons|5
5209297|NCT01032915|17980995|P4|Overall Study|Withdrawal by Subject|1
5209298|NCT01032915|17980996|P3|Overall Study|Withdrawal by Subject|1
5209299|NCT01032915|17980997|P2|Overall Study|Withdrawal by Subject|3
5209300|NCT01032915|17980998|P1|Overall Study|Withdrawal by Subject|0
5209301|NCT01032915|17980995|P4|Overall Study|Abnormal test procedure result|0
5209302|NCT01032915|17980996|P3|Overall Study|Abnormal test procedure result|1
5209303|NCT01032915|17980997|P2|Overall Study|Abnormal test procedure result|0
5209304|NCT01032915|17980998|P1|Overall Study|Abnormal test procedure result|0
5209305|NCT01032915|17980995|P4|Overall Study|Adverse Event|1
5209306|NCT01032915|17980996|P3|Overall Study|Adverse Event|1
5209307|NCT01032915|17980997|P2|Overall Study|Adverse Event|2
5209308|NCT01032915|17980998|P1|Overall Study|Adverse Event|2
5209309|NCT01032889|17981023|P3|Overall Study|Miscellaneous Reasons|1
5209310|NCT01032889|17981024|P2|Overall Study|Miscellaneous Reasons|1
5209311|NCT01032889|17981025|P1|Overall Study|Miscellaneous Reasons|2
5209312|NCT01032889|17981023|P3|Overall Study|Lack of Submental Fat|1
5209313|NCT01032889|17981024|P2|Overall Study|Lack of Submental Fat|8
5209314|NCT01032889|17981025|P1|Overall Study|Lack of Submental Fat|2
5209315|NCT01032889|17981023|P3|Overall Study|Lost to Follow-up|0
5209316|NCT01032889|17981024|P2|Overall Study|Lost to Follow-up|1
5209317|NCT01032889|17981025|P1|Overall Study|Lost to Follow-up|1
5209318|NCT01032889|17981023|P3|Overall Study|Patient Request|0
5209319|NCT01032889|17981024|P2|Overall Study|Patient Request|1
5209320|NCT01032889|17981025|P1|Overall Study|Patient Request|0
5209321|NCT01032889|17981023|P3|Overall Study|Withdrawal of Consent|1
5209322|NCT01032889|17981024|P2|Overall Study|Withdrawal of Consent|2
5209323|NCT01032889|17981025|P1|Overall Study|Withdrawal of Consent|1
5209324|NCT01032889|17981023|P3|Overall Study|Adverse Event|0
5209325|NCT01032889|17981024|P2|Overall Study|Adverse Event|2
5209326|NCT01032889|17981025|P1|Overall Study|Adverse Event|2
5209327|NCT01032837|17981056|P4|Overall Study|Refused treatment|1
5209328|NCT01032837|17981057|P3|Overall Study|Refused treatment|0
5209329|NCT01032837|17981058|P2|Overall Study|Refused treatment|0
5209330|NCT01032837|17981059|P1|Overall Study|Refused treatment|0
5209331|NCT01032837|17981056|P4|Overall Study|Failed to return|0
5209332|NCT01032837|17981057|P3|Overall Study|Failed to return|1
5209333|NCT01032837|17981058|P2|Overall Study|Failed to return|0
5209334|NCT01032837|17981059|P1|Overall Study|Failed to return|0
5209335|NCT01032837|17981056|P4|Overall Study|Withdrew consent|1
5209336|NCT01032837|17981057|P3|Overall Study|Withdrew consent|0
5209337|NCT01032837|17981058|P2|Overall Study|Withdrew consent|2
5209338|NCT01032837|17981059|P1|Overall Study|Withdrew consent|0
5209339|NCT01032837|17981056|P4|Overall Study|Adverse event/internal illness|1
5209340|NCT01032837|17981057|P3|Overall Study|Adverse event/internal illness|0
5209341|NCT01032837|17981058|P2|Overall Study|Adverse event/internal illness|1
5209342|NCT01032837|17981059|P1|Overall Study|Adverse event/internal illness|0
5209343|NCT01032629|17981159|P3|Overall Study|Lost to Follow-up|37
5209344|NCT01032629|17981160|P2|Overall Study|Lost to Follow-up|47
5209345|NCT01032629|17981161|P1|Overall Study|Lost to Follow-up|74
5209346|NCT01032629|17981159|P3|Overall Study|Withdrawal by Subject|35
5209347|NCT01032629|17981160|P2|Overall Study|Withdrawal by Subject|36
5209348|NCT01032629|17981161|P1|Overall Study|Withdrawal by Subject|50
5209349|NCT01032629|17981159|P3|Overall Study|Closed Site|16
5209350|NCT01032629|17981160|P2|Overall Study|Closed Site|18
5209351|NCT01032629|17981161|P1|Overall Study|Closed Site|21
5209352|NCT01032382|17981273|P2|Overall Study|Index lesion relapse|3
5209353|NCT01032382|17981274|P1|Overall Study|Index lesion relapse|1
5209354|NCT01032382|17981273|P2|Overall Study|Treatment failure|1
5209355|NCT01032382|17981274|P1|Overall Study|Treatment failure|3
5209356|NCT01032382|17981273|P2|Overall Study|Disease dissemination|1
5209357|NCT01032382|17981274|P1|Overall Study|Disease dissemination|1
5209358|NCT01032291|17981362|P3|Proof of Concept|Never Received Study Drug|0
5209359|NCT01032291|17981363|P2|Proof of Concept|Never Received Study Drug|1
5209360|NCT01032291|17981364|P1|Proof of Concept|Never Received Study Drug|0
5209361|NCT01032291|17981362|P3|Proof of Concept|Lack of Efficacy|0
5209362|NCT01032291|17981363|P2|Proof of Concept|Lack of Efficacy|1
5209363|NCT01032291|17981364|P1|Proof of Concept|Lack of Efficacy|0
5209364|NCT01032291|17981362|P3|Proof of Concept|Death|2
5209365|NCT01032291|17981363|P2|Proof of Concept|Death|1
5209366|NCT01032291|17981364|P1|Proof of Concept|Death|0
5209367|NCT01032291|17981362|P3|Proof of Concept|Adverse Event|1
5209368|NCT01032291|17981363|P2|Proof of Concept|Adverse Event|5
5209369|NCT01032291|17981364|P1|Proof of Concept|Adverse Event|0
5209370|NCT01032291|17981362|P3|Safety Lead-in|Death|0
5209371|NCT01032291|17981363|P2|Safety Lead-in|Death|0
5209372|NCT01032291|17981364|P1|Safety Lead-in|Death|1
5209373|NCT01032291|17981362|P3|Safety Lead-in|Adverse Event|0
5209374|NCT01032291|17981363|P2|Safety Lead-in|Adverse Event|0
5209375|NCT01032291|17981364|P1|Safety Lead-in|Adverse Event|1
5209376|NCT01032239|17981411|P2|Overall Study|Protocol Violation|0
5209377|NCT01032239|17981412|P1|Overall Study|Protocol Violation|1
5209378|NCT01032239|17981411|P2|Overall Study|Death|0
5209379|NCT01032239|17981412|P1|Overall Study|Death|1
5209380|NCT01032239|17981411|P2|Overall Study|Withdrawal by Subject|3
5209381|NCT01032239|17981412|P1|Overall Study|Withdrawal by Subject|2
5209382|NCT01032239|17981411|P2|Overall Study|Lost to Follow-up|2
5209383|NCT01032239|17981412|P1|Overall Study|Lost to Follow-up|3
5209384|NCT01032200|17981442|P2|Overall Study|Multiple|1
5209385|NCT01032200|17981443|P1|Overall Study|Multiple|1
5209386|NCT01032200|17981442|P2|Overall Study|Progression|0
5209387|NCT01032200|17981443|P1|Overall Study|Progression|1
5209388|NCT01032200|17981442|P2|Overall Study|Toxicity|2
5209389|NCT01032200|17981443|P1|Overall Study|Toxicity|0
5209390|NCT01032200|17981442|P2|Overall Study|Withdrawal by Subject|3
5209391|NCT01032200|17981443|P1|Overall Study|Withdrawal by Subject|1
5209392|NCT01032200|17981442|P2|Overall Study|Death|1
5209393|NCT01032200|17981443|P1|Overall Study|Death|1
5209394|NCT01032174|17981459|P2|Overall Study|Adverse Event|1
5209395|NCT01032174|17981460|P1|Overall Study|Adverse Event|0
5209396|NCT01032070|17981700|P2|Overall Study|Withdrawal by Subject|2
5209397|NCT01032070|17981701|P1|Overall Study|Withdrawal by Subject|0
5209398|NCT01032070|17981700|P2|Overall Study|Medical or ethical reasons|2
5209399|NCT01032070|17981701|P1|Overall Study|Medical or ethical reasons|0
5209400|NCT01032070|17981700|P2|Overall Study|Disease progression|8
5209401|NCT01032070|17981701|P1|Overall Study|Disease progression|13
5209402|NCT01032044|17981730|P2|Overall Study|Lost to Follow-up|11
5209403|NCT01032044|17981731|P1|Overall Study|Lost to Follow-up|11
5209404|NCT01032044|17981730|P2|Overall Study|Adverse Event|1
5209405|NCT01032044|17981731|P1|Overall Study|Adverse Event|0
5209406|NCT01032044|17981730|P2|Overall Study|Protocol Violation|8
5209407|NCT01032044|17981731|P1|Overall Study|Protocol Violation|14
5209408|NCT01032018|17981739|P2|Overall Study|Death|1
5209409|NCT01032018|17981740|P1|Overall Study|Death|0
5209410|NCT01032018|17981739|P2|Overall Study|Lost to Follow-up|5
5209411|NCT01032018|17981740|P1|Overall Study|Lost to Follow-up|6
5209412|NCT01031979|17981750|P2|Overall Study|Lost to Follow-up|4
5209413|NCT01031979|17981751|P1|Overall Study|Lost to Follow-up|5
5209414|NCT01031836|17981784|P6|Stage II|Other|0
5209415|NCT01031836|17981785|P5|Stage II|Other|1
5209416|NCT01031836|17981786|P4|Stage II|Other|1
5209417|NCT01031836|17981787|P3|Stage II|Other|0
5209418|NCT01031836|17981788|P2|Stage II|Other|0
5209419|NCT01031836|17981789|P1|Stage II|Other|2
5209420|NCT01031836|17981784|P6|Stage II|Adverse Event|1
5209421|NCT01031836|17981785|P5|Stage II|Adverse Event|1
5209422|NCT01031836|17981786|P4|Stage II|Adverse Event|2
5209423|NCT01031836|17981787|P3|Stage II|Adverse Event|2
5209424|NCT01031836|17981788|P2|Stage II|Adverse Event|0
5209425|NCT01031836|17981789|P1|Stage II|Adverse Event|0
5209426|NCT01031836|17981784|P6|Stage I|Other|1
5209427|NCT01031836|17981785|P5|Stage I|Other|0
5209428|NCT01031836|17981786|P4|Stage I|Other|0
5209429|NCT01031836|17981787|P3|Stage I|Other|0
5209430|NCT01031836|17981788|P2|Stage I|Other|1
5209431|NCT01031836|17981789|P1|Stage I|Other|0
5209432|NCT01031836|17981784|P6|Stage I|Adverse Event|0
5209433|NCT01031836|17981785|P5|Stage I|Adverse Event|0
5209434|NCT01031836|17981786|P4|Stage I|Adverse Event|0
5209435|NCT01031836|17981787|P3|Stage I|Adverse Event|0
5209436|NCT01031836|17981788|P2|Stage I|Adverse Event|1
5209437|NCT01031836|17981789|P1|Stage I|Adverse Event|1
5209438|NCT01031706|17981850|P2|Overall Study|Withdrawal by Subject|1
5209439|NCT01031706|17981851|P1|Overall Study|Withdrawal by Subject|1
5209440|NCT01031706|17981850|P2|Overall Study|Adverse Event|0
5209441|NCT01031706|17981851|P1|Overall Study|Adverse Event|1
5209442|NCT01031680|17981861|P2|Overall Study|Various|2
5209443|NCT01031680|17981862|P1|Overall Study|Various|0
5209444|NCT01031680|17981861|P2|Overall Study|Administrative Reason by Sponsor|1
5209445|NCT01031680|17981862|P1|Overall Study|Administrative Reason by Sponsor|0
5209446|NCT01031680|17981861|P2|Overall Study|Incorrect Enrolment|2
5209447|NCT01031680|17981862|P1|Overall Study|Incorrect Enrolment|1
5209448|NCT01031680|17981861|P2|Overall Study|Safety|0
5209449|NCT01031680|17981862|P1|Overall Study|Safety|1
5209450|NCT01031680|17981861|P2|Overall Study|Poor/Non-compliance|6
5209451|NCT01031680|17981862|P1|Overall Study|Poor/Non-compliance|5
5209452|NCT01031680|17981861|P2|Overall Study|Subject No Longer Meets Study Criteria|17
5209453|NCT01031680|17981862|P1|Overall Study|Subject No Longer Meets Study Criteria|26
5209454|NCT01031680|17981861|P2|Overall Study|Death|1
5209455|NCT01031680|17981862|P1|Overall Study|Death|2
5209456|NCT01031680|17981861|P2|Overall Study|Withdrawal by Subject|16
5209457|NCT01031680|17981862|P1|Overall Study|Withdrawal by Subject|12
5209458|NCT01031680|17981861|P2|Overall Study|Lost to Follow-up|10
5209459|NCT01031680|17981862|P1|Overall Study|Lost to Follow-up|2
5209460|NCT01031680|17981861|P2|Overall Study|Adverse Event|3
5209461|NCT01031680|17981862|P1|Overall Study|Adverse Event|8
5209462|NCT01031628|17981882|P4|Overall Study|Study terminated early|0
5209463|NCT01031628|17981883|P3|Overall Study|Study terminated early|3
5209464|NCT01031628|17981884|P2|Overall Study|Study terminated early|1
5209465|NCT01031628|17981885|P1|Overall Study|Study terminated early|0
5209466|NCT01031537|17981910|P1|Overall Study|PI removal, no longer met eligibility|12
5209467|NCT01031537|17981910|P1|Overall Study|Withdrawal by Subject|5
5209468|NCT01031537|17981910|P1|Overall Study|moved, met exclusion criteria|10
5209469|NCT01031537|17981910|P1|Overall Study|retired from NIH, met exclusion criteria|1
5209470|NCT01031537|17981910|P1|Overall Study|Lack of Efficacy|1
5209471|NCT01031537|17981910|P1|Overall Study|medical reasons not related to study|3
5209472|NCT01031446|17981928|P1|Overall Study|Still on treatment|1
5209473|NCT01031446|17981928|P1|Overall Study|Withdrawal by Subject|3
5209474|NCT01031446|17981928|P1|Overall Study|Physician Decision|4
5209475|NCT01031446|17981928|P1|Overall Study|Adverse Event|9
5209476|NCT01031446|17981928|P1|Overall Study|Disease Progression|38
5209477|NCT01031381|17981942|P1|Overall Study|Withdrawal by Subject|6
5209478|NCT01031381|17981942|P1|Overall Study|Physician Decision|3
5209479|NCT01031069|17981971|P4|Overall Study|Other|0
5209480|NCT01031069|17981972|P3|Overall Study|Other|1
5209481|NCT01031069|17981973|P2|Overall Study|Other|0
5209482|NCT01031069|17981974|P1|Overall Study|Other|0
5209483|NCT01031069|17981971|P4|Overall Study|Lost to Follow-up|15
5209484|NCT01031069|17981972|P3|Overall Study|Lost to Follow-up|21
5209485|NCT01031069|17981973|P2|Overall Study|Lost to Follow-up|5
5209486|NCT01031069|17981974|P1|Overall Study|Lost to Follow-up|9
5209487|NCT01031069|17981971|P4|Overall Study|Migrated/moved from study area|1
5209488|NCT01031069|17981972|P3|Overall Study|Migrated/moved from study area|1
5209489|NCT01031069|17981973|P2|Overall Study|Migrated/moved from study area|2
5209490|NCT01031069|17981974|P1|Overall Study|Migrated/moved from study area|1
5209491|NCT01031069|17981971|P4|Overall Study|Withdrawal by Subject|18
5209492|NCT01031069|17981972|P3|Overall Study|Withdrawal by Subject|18
5209493|NCT01031069|17981973|P2|Overall Study|Withdrawal by Subject|3
5209494|NCT01031069|17981974|P1|Overall Study|Withdrawal by Subject|2
5209495|NCT01031069|17981971|P4|Overall Study|Serious Adverse Event|0
5209496|NCT01031069|17981972|P3|Overall Study|Serious Adverse Event|0
5209497|NCT01031069|17981973|P2|Overall Study|Serious Adverse Event|1
5209498|NCT01031069|17981974|P1|Overall Study|Serious Adverse Event|0
5209499|NCT01031004|17982076|P2|Overall Study|Lost to Follow-up|0
5209500|NCT01031004|17982077|P1|Overall Study|Lost to Follow-up|1
5209501|NCT01031004|17982076|P2|Overall Study|Protocol Violation|1
5209502|NCT01031004|17982077|P1|Overall Study|Protocol Violation|0
5209503|NCT01030965|17982121|P4|Overall Study|Withdrawal by Subject|2
5209504|NCT01030965|17982122|P3|Overall Study|Withdrawal by Subject|0
5209505|NCT01030965|17982123|P2|Overall Study|Withdrawal by Subject|1
5209506|NCT01030965|17982124|P1|Overall Study|Withdrawal by Subject|0
5209507|NCT01030965|17982121|P4|Overall Study|Protocol-defined Stopping Criteria|0
5209508|NCT01030965|17982122|P3|Overall Study|Protocol-defined Stopping Criteria|1
5209509|NCT01030965|17982123|P2|Overall Study|Protocol-defined Stopping Criteria|1
5209510|NCT01030965|17982124|P1|Overall Study|Protocol-defined Stopping Criteria|0
5209511|NCT01030965|17982121|P4|Overall Study|Adverse Event|1
5209512|NCT01030965|17982122|P3|Overall Study|Adverse Event|2
5209513|NCT01030965|17982123|P2|Overall Study|Adverse Event|1
5209514|NCT01030965|17982124|P1|Overall Study|Adverse Event|0
5209515|NCT01030965|17982121|P4|Overall Study|Protocol Violation|1
5209516|NCT01030965|17982122|P3|Overall Study|Protocol Violation|1
5209517|NCT01030965|17982123|P2|Overall Study|Protocol Violation|1
5209518|NCT01030965|17982124|P1|Overall Study|Protocol Violation|1
5209519|NCT01030965|17982121|P4|Overall Study|Lack of Efficacy|3
5209520|NCT01030965|17982122|P3|Overall Study|Lack of Efficacy|0
5209521|NCT01030965|17982123|P2|Overall Study|Lack of Efficacy|2
5209522|NCT01030965|17982124|P1|Overall Study|Lack of Efficacy|3
5209523|NCT01030952|17982144|P2|Overall Study|Unexplained|1
5209524|NCT01030952|17982145|P1|Overall Study|Unexplained|1
5209525|NCT01030952|17982144|P2|Overall Study|Lost to Follow-up|1
5209526|NCT01030952|17982145|P1|Overall Study|Lost to Follow-up|0
5209527|NCT01030952|17982144|P2|Overall Study|Informed consent withdrawal|0
5209528|NCT01030952|17982145|P1|Overall Study|Informed consent withdrawal|1
5209529|NCT01030952|17982144|P2|Overall Study|Protocol Violation|1
5209530|NCT01030952|17982145|P1|Overall Study|Protocol Violation|0
5209531|NCT01030822|17982193|P3|Overall Study|Lost to Follow-up|7
5209532|NCT01030822|17982194|P2|Overall Study|Lost to Follow-up|4
5209533|NCT01030822|17982195|P1|Overall Study|Lost to Follow-up|9
5209534|NCT01030822|17982193|P3|Overall Study|Withdrawal by Subject|16
5209535|NCT01030822|17982194|P2|Overall Study|Withdrawal by Subject|13
5209536|NCT01030822|17982195|P1|Overall Study|Withdrawal by Subject|16
5209537|NCT01030822|17982193|P3|Overall Study|Moved/migrated from study area|3
5209538|NCT01030822|17982194|P2|Overall Study|Moved/migrated from study area|7
5209539|NCT01030822|17982195|P1|Overall Study|Moved/migrated from study area|6
5209540|NCT01030718|17982270|P3|Study CA180-036 Only|Other Reasons|0
5209541|NCT01030718|17982271|P2|Study CA180-036 Only|Other Reasons|2
5209542|NCT01030718|17982272|P1|Study CA180-036 Only|Other Reasons|0
5209543|NCT01030718|17982270|P3|Study CA180-036 Only|Death|0
5209544|NCT01030718|17982271|P2|Study CA180-036 Only|Death|1
5209545|NCT01030718|17982272|P1|Study CA180-036 Only|Death|0
5209546|NCT01030718|17982270|P3|Study CA180-036 Only|Adverse Event|0
5209547|NCT01030718|17982271|P2|Study CA180-036 Only|Adverse Event|3
5209548|NCT01030718|17982272|P1|Study CA180-036 Only|Adverse Event|2
5209549|NCT01030718|17982270|P3|Study CA180-036 Only|insufficient effect|5
5209550|NCT01030718|17982271|P2|Study CA180-036 Only|insufficient effect|1
5209551|NCT01030718|17982272|P1|Study CA180-036 Only|insufficient effect|1
5209552|NCT01030718|17982270|P3|Studies CA180-031 and -036 Combined|other reasons|0
5209553|NCT01030718|17982271|P2|Studies CA180-031 and -036 Combined|other reasons|2
5209554|NCT01030718|17982272|P1|Studies CA180-031 and -036 Combined|other reasons|0
5209555|NCT01030718|17982270|P3|Studies CA180-031 and -036 Combined|Death|0
5209556|NCT01030718|17982271|P2|Studies CA180-031 and -036 Combined|Death|1
5209557|NCT01030718|17982272|P1|Studies CA180-031 and -036 Combined|Death|0
5209558|NCT01030718|17982270|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
5209559|NCT01030718|17982271|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
5209560|NCT01030718|17982272|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
5209561|NCT01030718|17982270|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
5209562|NCT01030718|17982271|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
5209563|NCT01030718|17982272|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
5209564|NCT01030666|17982333|P2|Overall Study|Lost to Follow-up|2
5209565|NCT01030666|17982334|P1|Overall Study|Lost to Follow-up|3
5209566|NCT01030536|17982359|P5|Overall Study|Death|0
5209567|NCT01030536|17982360|P4|Overall Study|Death|0
5209568|NCT01030536|17982361|P3|Overall Study|Death|0
5209569|NCT01030536|17982362|P2|Overall Study|Death|1
5209570|NCT01030536|17982363|P1|Overall Study|Death|0
5209571|NCT01030536|17982359|P5|Overall Study|Progressive disease|0
5209572|NCT01030536|17982360|P4|Overall Study|Progressive disease|2
5209573|NCT01030536|17982361|P3|Overall Study|Progressive disease|3
5209574|NCT01030536|17982362|P2|Overall Study|Progressive disease|2
5209575|NCT01030536|17982363|P1|Overall Study|Progressive disease|6
5209576|NCT01030536|17982359|P5|Overall Study|Adverse Event|1
5209577|NCT01030536|17982360|P4|Overall Study|Adverse Event|0
5209578|NCT01030536|17982361|P3|Overall Study|Adverse Event|1
5209579|NCT01030536|17982362|P2|Overall Study|Adverse Event|3
5209580|NCT01030536|17982363|P1|Overall Study|Adverse Event|0
5209581|NCT01030536|17982359|P5|Overall Study|undefined|0
5209582|NCT01030536|17982360|P4|Overall Study|undefined|1
5209583|NCT01030536|17982361|P3|Overall Study|undefined|1
5209584|NCT01030536|17982362|P2|Overall Study|undefined|0
5209585|NCT01030536|17982363|P1|Overall Study|undefined|1
5209586|NCT01030536|17982359|P5|Overall Study|Withdrawal by Subject|0
5209587|NCT01030536|17982360|P4|Overall Study|Withdrawal by Subject|0
5209588|NCT01030536|17982361|P3|Overall Study|Withdrawal by Subject|1
5209589|NCT01030536|17982362|P2|Overall Study|Withdrawal by Subject|0
5209590|NCT01030536|17982363|P1|Overall Study|Withdrawal by Subject|0
5209591|NCT01030523|17982468|P2|Overall Study|Withdrawal by Subject|1
5209592|NCT01030523|17982469|P1|Overall Study|Withdrawal by Subject|0
5209593|NCT01030523|17982468|P2|Overall Study|Implant failure|0
5209594|NCT01030523|17982469|P1|Overall Study|Implant failure|1
5209595|NCT01030523|17982468|P2|Overall Study|Lost to Follow-up|4
5209596|NCT01030523|17982469|P1|Overall Study|Lost to Follow-up|4
5209597|NCT01030523|17982468|P2|Overall Study|Death|0
5209598|NCT01030523|17982469|P1|Overall Study|Death|1
5209599|NCT01030458|17982483|P2|Overall Study|Side effect of medication|1
5209600|NCT01030458|17982484|P1|Overall Study|Side effect of medication|1
5209601|NCT01030458|17982483|P2|Overall Study|Moved or changed job|13
5209602|NCT01030458|17982484|P1|Overall Study|Moved or changed job|6
5209603|NCT01030458|17982483|P2|Overall Study|Logistical reasons|5
5209604|NCT01030458|17982484|P1|Overall Study|Logistical reasons|9
5209605|NCT01030458|17982483|P2|Overall Study|Withdrawal by Subject|3
5209606|NCT01030458|17982484|P1|Overall Study|Withdrawal by Subject|2
5209607|NCT01030458|17982483|P2|Overall Study|Lost to Follow-up|10
5209608|NCT01030458|17982484|P1|Overall Study|Lost to Follow-up|9
5209609|NCT01030341|17982517|P1|Overall Study|Lost to Follow-up|2
5209610|NCT01030341|17982517|P1|Overall Study|Withdrawal by Subject|1
5209611|NCT01030198|17982540|P2|Overall Study|Could not measure efficacy accurately|7
5209612|NCT01030198|17982541|P1|Overall Study|Could not measure efficacy accurately|0
5209613|NCT01030133|17982549|P2|Overall Study|failed to experience pain at level 7/10|2
5209614|NCT01030133|17982550|P1|Overall Study|failed to experience pain at level 7/10|2
5209615|NCT01029925|17982562|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
5209616|NCT01029925|17982562|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
5209617|NCT01029925|17982562|P1|Completion of Cycle 1 (28 Days)|Death|2
5209618|NCT01029886|17982581|P2|Overall Study|Loss Glucose Control|1
5209619|NCT01029886|17982582|P1|Overall Study|Loss Glucose Control|7
5209620|NCT01029886|17982581|P2|Overall Study|Sponsor Decision|0
5209621|NCT01029886|17982582|P1|Overall Study|Sponsor Decision|1
5209622|NCT01029886|17982581|P2|Overall Study|Entry Criteria Not Met|5
5209623|NCT01029886|17982582|P1|Overall Study|Entry Criteria Not Met|13
5209624|NCT01029886|17982581|P2|Overall Study|Withdrawal by Subject|18
5209625|NCT01029886|17982582|P1|Overall Study|Withdrawal by Subject|8
5209626|NCT01029886|17982581|P2|Overall Study|Protocol Violation|5
5209627|NCT01029886|17982582|P1|Overall Study|Protocol Violation|17
5209628|NCT01029886|17982581|P2|Overall Study|Physician Decision|6
5209629|NCT01029886|17982582|P1|Overall Study|Physician Decision|2
5209630|NCT01029886|17982581|P2|Overall Study|Lost to Follow-up|0
5209631|NCT01029886|17982582|P1|Overall Study|Lost to Follow-up|1
5209632|NCT01029886|17982581|P2|Overall Study|Adverse Event|25
5209633|NCT01029886|17982582|P1|Overall Study|Adverse Event|12
5209634|NCT01029795|17982610|P2|Overall Study|Withdrawal by Subject|3
5209635|NCT01029795|17982611|P1|Overall Study|Withdrawal by Subject|1
5209636|NCT01029795|17982610|P2|Overall Study|Sponsor Decision|17
5209637|NCT01029795|17982611|P1|Overall Study|Sponsor Decision|11
5209638|NCT01029795|17982610|P2|Overall Study|Physician Decision|1
5209639|NCT01029795|17982611|P1|Overall Study|Physician Decision|2
5209640|NCT01029795|17982610|P2|Overall Study|Entry Criteria Not Met|1
5209641|NCT01029795|17982611|P1|Overall Study|Entry Criteria Not Met|2
5209642|NCT01029782|17982665|P2|Overall Study|Withdrawal by Subject|1
5209643|NCT01029782|17982666|P1|Overall Study|Withdrawal by Subject|0
5209644|NCT01029782|17982665|P2|Overall Study|Protocol Violation|2
5209645|NCT01029782|17982666|P1|Overall Study|Protocol Violation|0
5209646|NCT01029782|17982665|P2|Overall Study|Physician Decision|1
5209647|NCT01029782|17982666|P1|Overall Study|Physician Decision|0
5209648|NCT01029782|17982665|P2|Overall Study|Adverse Event|1
5209649|NCT01029782|17982666|P1|Overall Study|Adverse Event|0
5209650|NCT01029782|17982665|P2|Overall Study|Diagnosis changed|1
5209651|NCT01029782|17982666|P1|Overall Study|Diagnosis changed|1
5209652|NCT01029782|17982665|P2|Overall Study|Lost to Follow-up|2
5209653|NCT01029782|17982666|P1|Overall Study|Lost to Follow-up|2
5209654|NCT01029691|17982718|P3|Continued APAP to Delivery|Death|1
5209655|NCT01029691|17982719|P2|Continued APAP to Delivery|Death|0
5209656|NCT01029691|17982720|P1|Continued APAP to Delivery|Death|0
5209657|NCT01029652|17982745|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
5209658|NCT01029652|17982746|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
5209659|NCT01029652|17982745|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
5209660|NCT01029652|17982746|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
5209661|NCT01029652|17982745|P2|Extension Study 2 (25-72 Weeks)|Death|1
5209662|NCT01029652|17982746|P1|Extension Study 2 (25-72 Weeks)|Death|1
5209663|NCT01029652|17982745|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
5209664|NCT01029652|17982746|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
5209665|NCT01029652|17982745|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
5209666|NCT01029652|17982746|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
5209667|NCT01029652|17982745|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
5209668|NCT01029652|17982746|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
5209669|NCT01029652|17982745|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
5209670|NCT01029652|17982746|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
5209671|NCT01029652|17982745|P2|Core Study (0-12 Weeks)|Death|1
5209672|NCT01029652|17982746|P1|Core Study (0-12 Weeks)|Death|0
5209673|NCT01029652|17982745|P2|Core Study (0-12 Weeks)|Administrative problems|1
5209674|NCT01029652|17982746|P1|Core Study (0-12 Weeks)|Administrative problems|2
5209675|NCT01029652|17982745|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
5209676|NCT01029652|17982746|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
5209677|NCT01029652|17982745|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
5209678|NCT01029652|17982746|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
5209679|NCT01029652|17982745|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
5209680|NCT01029652|17982746|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
5209681|NCT01029535|17982830|P1|Overall Study|Death|1
5209682|NCT01029535|17982830|P1|Overall Study|Use of Another Treatment|1
5209683|NCT01029535|17982830|P1|Overall Study|Adverse Event|1
5209684|NCT01029535|17982830|P1|Overall Study|Participant Withdrew Consent|2
5209685|NCT01029535|17982830|P1|Overall Study|Protocol Violation|2
5209686|NCT01029535|17982830|P1|Overall Study|Lost to Follow-up|24
5209687|NCT01029405|17982859|P4|Overall Study|Other|1
5209688|NCT01029405|17982860|P3|Overall Study|Other|0
5209689|NCT01029405|17982861|P2|Overall Study|Other|1
5209690|NCT01029405|17982862|P1|Overall Study|Other|0
5209691|NCT01029405|17982859|P4|Overall Study|Lost to Follow-up|2
5209692|NCT01029405|17982860|P3|Overall Study|Lost to Follow-up|1
5209693|NCT01029405|17982861|P2|Overall Study|Lost to Follow-up|1
5209694|NCT01029405|17982862|P1|Overall Study|Lost to Follow-up|2
5209695|NCT01029405|17982859|P4|Overall Study|Adverse Event|1
5209696|NCT01029405|17982860|P3|Overall Study|Adverse Event|1
5209697|NCT01029405|17982861|P2|Overall Study|Adverse Event|0
5209698|NCT01029405|17982862|P1|Overall Study|Adverse Event|0
5209699|NCT01029405|17982859|P4|Overall Study|Protocol Violation|1
5209700|NCT01029405|17982860|P3|Overall Study|Protocol Violation|0
5209701|NCT01029405|17982861|P2|Overall Study|Protocol Violation|0
5209702|NCT01029405|17982862|P1|Overall Study|Protocol Violation|0
5209703|NCT01029405|17982859|P4|Overall Study|Withdrawal by Subject|0
5209704|NCT01029405|17982860|P3|Overall Study|Withdrawal by Subject|2
5209705|NCT01029405|17982861|P2|Overall Study|Withdrawal by Subject|1
5209706|NCT01029405|17982862|P1|Overall Study|Withdrawal by Subject|0
5209707|NCT01029392|17982874|P2|Overall Study|Physician Decision|0
5209708|NCT01029392|17982875|P1|Overall Study|Physician Decision|2
5209709|NCT01029392|17982874|P2|Overall Study|Withdrawal by Subject|11
5209710|NCT01029392|17982875|P1|Overall Study|Withdrawal by Subject|18
5209711|NCT01029366|17982885|P2|Overall Study|manufacturing failure|1
5209712|NCT01029366|17982886|P1|Overall Study|manufacturing failure|0
5209713|NCT01029366|17982885|P2|Overall Study|disease progression|0
5209714|NCT01029366|17982886|P1|Overall Study|disease progression|2
5209715|NCT01029366|17982885|P2|Overall Study|Death|1
5209716|NCT01029366|17982886|P1|Overall Study|Death|1
5209717|NCT01029366|17982885|P2|Overall Study|Withdrawal by Subject|0
5209718|NCT01029366|17982886|P1|Overall Study|Withdrawal by Subject|1
5209719|NCT01029340|17982898|P6|Extension Period|Physician Decision|1
5209720|NCT01029340|17982899|P5|Extension Period|Physician Decision|0
5209721|NCT01029340|17982900|P4|Extension Period|Physician Decision|0
5209722|NCT01029340|17982901|P3|Extension Period|Physician Decision|0
5209723|NCT01029340|17982902|P2|Extension Period|Physician Decision|0
5209724|NCT01029340|17982903|P1|Extension Period|Physician Decision|0
5209725|NCT01029340|17982898|P6|Extension Period|Withdrawal by Subject|1
5209726|NCT01029340|17982899|P5|Extension Period|Withdrawal by Subject|0
5209727|NCT01029340|17982900|P4|Extension Period|Withdrawal by Subject|0
5209728|NCT01029340|17982901|P3|Extension Period|Withdrawal by Subject|0
5209729|NCT01029340|17982902|P2|Extension Period|Withdrawal by Subject|0
5209730|NCT01029340|17982903|P1|Extension Period|Withdrawal by Subject|0
5209731|NCT01029340|17982898|P6|Extension Period|non-compliance|1
5209732|NCT01029340|17982899|P5|Extension Period|non-compliance|0
5209733|NCT01029340|17982900|P4|Extension Period|non-compliance|0
5209734|NCT01029340|17982901|P3|Extension Period|non-compliance|0
5209735|NCT01029340|17982902|P2|Extension Period|non-compliance|0
5209736|NCT01029340|17982903|P1|Extension Period|non-compliance|0
5209737|NCT01029340|17982898|P6|Extension Period|starting another study|8
5209738|NCT01029340|17982899|P5|Extension Period|starting another study|0
5209739|NCT01029340|17982900|P4|Extension Period|starting another study|0
5209740|NCT01029340|17982901|P3|Extension Period|starting another study|0
5209741|NCT01029340|17982902|P2|Extension Period|starting another study|0
5209742|NCT01029340|17982903|P1|Extension Period|starting another study|0
5209743|NCT01029340|17982898|P6|Extension Period|Adverse Event|1
5209744|NCT01029340|17982899|P5|Extension Period|Adverse Event|0
5209745|NCT01029340|17982900|P4|Extension Period|Adverse Event|0
5209746|NCT01029340|17982901|P3|Extension Period|Adverse Event|0
5209747|NCT01029340|17982902|P2|Extension Period|Adverse Event|0
5209748|NCT01029340|17982903|P1|Extension Period|Adverse Event|0
5209749|NCT01029340|17982898|P6|Part B Treatment Period|Protocol Violation|0
5209750|NCT01029340|17982899|P5|Part B Treatment Period|Protocol Violation|0
5209751|NCT01029340|17982900|P4|Part B Treatment Period|Protocol Violation|0
5209752|NCT01029340|17982901|P3|Part B Treatment Period|Protocol Violation|1
5209753|NCT01029340|17982902|P2|Part B Treatment Period|Protocol Violation|0
5209754|NCT01029340|17982903|P1|Part B Treatment Period|Protocol Violation|0
5209755|NCT01029340|17982898|P6|Part B Treatment Period|Withdrawal by Subject|0
5209756|NCT01029340|17982899|P5|Part B Treatment Period|Withdrawal by Subject|0
5209757|NCT01029340|17982900|P4|Part B Treatment Period|Withdrawal by Subject|0
5209758|NCT01029340|17982901|P3|Part B Treatment Period|Withdrawal by Subject|1
5209759|NCT01029340|17982902|P2|Part B Treatment Period|Withdrawal by Subject|0
5209760|NCT01029340|17982903|P1|Part B Treatment Period|Withdrawal by Subject|0
5209761|NCT01029262|17982934|P2|Overall Study|Death|3
5209762|NCT01029262|17982935|P1|Overall Study|Death|0
5209763|NCT01029262|17982934|P2|Overall Study|Miscellaneous|9
5209764|NCT01029262|17982935|P1|Overall Study|Miscellaneous|1
5209765|NCT01029262|17982934|P2|Overall Study|Protocol Violation|3
5209766|NCT01029262|17982935|P1|Overall Study|Protocol Violation|2
5209767|NCT01029262|17982934|P2|Overall Study|Withdrawal by Subject|17
5209768|NCT01029262|17982935|P1|Overall Study|Withdrawal by Subject|10
5209769|NCT01029262|17982934|P2|Overall Study|Lack of therapeutic effect|76
5209770|NCT01029262|17982935|P1|Overall Study|Lack of therapeutic effect|57
5209771|NCT01029262|17982934|P2|Overall Study|Adverse Event|52
5209772|NCT01029262|17982935|P1|Overall Study|Adverse Event|9
5209773|NCT01028651|17983104|P1|Overall Study|Adverse Event|1
5209774|NCT01028651|17983104|P1|Overall Study|Death|2
5209775|NCT01028560|17983127|P2|Overall Study|Withdrawal by Subject|12
5209776|NCT01028560|17983128|P1|Overall Study|Withdrawal by Subject|7
5209777|NCT01028560|17983127|P2|Overall Study|Lack of Efficacy|6
5209778|NCT01028560|17983128|P1|Overall Study|Lack of Efficacy|3
5209779|NCT01028391|17983142|P2|Overall Study|Needed excluded medication|1
5209780|NCT01028391|17983143|P1|Overall Study|Needed excluded medication|1
5209781|NCT01028391|17983142|P2|Overall Study|Withdrawal by Subject|3
5209782|NCT01028391|17983143|P1|Overall Study|Withdrawal by Subject|6
5209783|NCT01028391|17983142|P2|Overall Study|Physician Decision|1
5209784|NCT01028391|17983143|P1|Overall Study|Physician Decision|0
5209785|NCT01028391|17983142|P2|Overall Study|Lost to Follow-up|4
5209786|NCT01028391|17983143|P1|Overall Study|Lost to Follow-up|3
5209787|NCT01028391|17983142|P2|Overall Study|Lack of Efficacy|2
5209788|NCT01028391|17983143|P1|Overall Study|Lack of Efficacy|0
5209789|NCT01028391|17983142|P2|Overall Study|Adverse Event|0
5209790|NCT01028391|17983143|P1|Overall Study|Adverse Event|4
5209791|NCT01028378|17983151|P1|Overall Study|Adminstrative Reasons|4
5209792|NCT01028378|17983151|P1|Overall Study|Withdrawal by Subject|1
5209793|NCT01028378|17983151|P1|Overall Study|Lost to Follow-up|12
5209794|NCT01028352|17983163|P1|Overall Study|Withdrawal by Subject|1
5209795|NCT01028352|17983163|P1|Overall Study|Ineligible due to baseline average pain|5
5209796|NCT01028300|17983168|P1|Overall Study|Study Terminated|4
5209797|NCT01028222|17983177|P2|Overall Study|Adverse Event|0
5209798|NCT01028222|17983178|P1|Overall Study|Adverse Event|2
5209799|NCT01028222|17983177|P2|Overall Study|Crossover to nilotinib w/out progression|2
5209800|NCT01028222|17983178|P1|Overall Study|Crossover to nilotinib w/out progression|0
5209801|NCT01028222|17983177|P2|Overall Study|Withdrawal by Subject|0
5209802|NCT01028222|17983178|P1|Overall Study|Withdrawal by Subject|1
5209803|NCT01028222|17983177|P2|Overall Study|Lost to Follow-up|1
5209804|NCT01028222|17983178|P1|Overall Study|Lost to Follow-up|0
5209805|NCT01028222|17983177|P2|Overall Study|Administrative problems|1
5209806|NCT01028222|17983178|P1|Overall Study|Administrative problems|1
5209807|NCT01028222|17983177|P2|Overall Study|Disease progression|9
5209808|NCT01028222|17983178|P1|Overall Study|Disease progression|33
5209809|NCT01028222|17983177|P2|Overall Study|Protocol deviation|0
5209810|NCT01028222|17983178|P1|Overall Study|Protocol deviation|1
5209811|NCT01028053|17983220|P1|Overall Study|Various reasons|4
5209812|NCT01028053|17983220|P1|Overall Study|Terminated by Sponsor|1
5209813|NCT01028053|17983220|P1|Overall Study|Technical Problem|1
5209814|NCT01028053|17983220|P1|Overall Study|Physician Decision|2
5209815|NCT01028053|17983220|P1|Overall Study|Protocol Violation|1
5209816|NCT01028053|17983220|P1|Overall Study|Patient Request|11
5209817|NCT01028053|17983220|P1|Overall Study|Screen Failure|113
5209818|NCT01028027|17983228|P2|Overall Study|Lack of Efficacy|1
5209819|NCT01028027|17983229|P1|Overall Study|Lack of Efficacy|0
5209820|NCT01028027|17983228|P2|Overall Study|Protocol Violation|1
5209821|NCT01028027|17983229|P1|Overall Study|Protocol Violation|3
5209822|NCT01028027|17983228|P2|Overall Study|Adverse Event|7
5209823|NCT01028027|17983229|P1|Overall Study|Adverse Event|4
5209824|NCT01028027|17983228|P2|Overall Study|Withdrawal by Subject|3
5209825|NCT01028027|17983229|P1|Overall Study|Withdrawal by Subject|5
5209826|NCT01028027|17983228|P2|Overall Study|Lost to Follow-up|1
5209827|NCT01028027|17983229|P1|Overall Study|Lost to Follow-up|4
5209828|NCT01028014|17983251|P6|Overall Study|Lost to Follow-up|2
5209829|NCT01028014|17983252|P5|Overall Study|Lost to Follow-up|1
5209830|NCT01028014|17983253|P4|Overall Study|Lost to Follow-up|1
5209831|NCT01028014|17983254|P3|Overall Study|Lost to Follow-up|0
5209832|NCT01028014|17983255|P2|Overall Study|Lost to Follow-up|2
5209833|NCT01028014|17983256|P1|Overall Study|Lost to Follow-up|1
5209834|NCT01027897|17983297|P1|Overall Study|Withdrawal by Subject|1
5209835|NCT01027897|17983297|P1|Overall Study|Protocol Violation|1
5209836|NCT01027884|17983305|P2|Overall Study|Spinal fixation surgery|3
5209837|NCT01027884|17983306|P1|Overall Study|Spinal fixation surgery|0
5209838|NCT01027884|17983305|P2|Overall Study|Lost to Follow-up|1
5209839|NCT01027884|17983306|P1|Overall Study|Lost to Follow-up|0
5209840|NCT01027884|17983305|P2|Overall Study|Withdrawal by Subject|1
5209841|NCT01027884|17983306|P1|Overall Study|Withdrawal by Subject|0
5209842|NCT01027884|17983305|P2|Overall Study|Non-compliance|1
5209843|NCT01027884|17983306|P1|Overall Study|Non-compliance|1
5209844|NCT01027884|17983305|P2|Overall Study|Protocol Violation|0
5209845|NCT01027884|17983306|P1|Overall Study|Protocol Violation|1
5209846|NCT01027884|17983305|P2|Overall Study|Adverse Event|1
5209847|NCT01027884|17983306|P1|Overall Study|Adverse Event|2
5209848|NCT01027871|17983323|P3|Overall Study|Discontinued Prior to Treatment|1
5209849|NCT01027871|17983324|P2|Overall Study|Discontinued Prior to Treatment|0
5209850|NCT01027871|17983325|P1|Overall Study|Discontinued Prior to Treatment|0
5209851|NCT01027871|17983323|P3|Overall Study|Sponsor Decision|0
5209852|NCT01027871|17983324|P2|Overall Study|Sponsor Decision|2
5209853|NCT01027871|17983325|P1|Overall Study|Sponsor Decision|0
5209854|NCT01027871|17983323|P3|Overall Study|Adverse Event|2
5209855|NCT01027871|17983324|P2|Overall Study|Adverse Event|2
5209856|NCT01027871|17983325|P1|Overall Study|Adverse Event|0
5209857|NCT01027871|17983323|P3|Overall Study|Withdrawal by Subject|2
5209858|NCT01027871|17983324|P2|Overall Study|Withdrawal by Subject|2
5209859|NCT01027871|17983325|P1|Overall Study|Withdrawal by Subject|1
5209860|NCT01027871|17983323|P3|Overall Study|Protocol Violation|2
5209861|NCT01027871|17983324|P2|Overall Study|Protocol Violation|2
5209862|NCT01027871|17983325|P1|Overall Study|Protocol Violation|0
5209863|NCT01027871|17983323|P3|Overall Study|Physician Decision|0
5209864|NCT01027871|17983324|P2|Overall Study|Physician Decision|5
5209865|NCT01027871|17983325|P1|Overall Study|Physician Decision|1
5209866|NCT01027845|17983384|P4|Booster Vaccination Phase|Migrated/moved from study area|0
5209867|NCT01027845|17983385|P3|Booster Vaccination Phase|Migrated/moved from study area|0
5209868|NCT01027845|17983386|P2|Booster Vaccination Phase|Migrated/moved from study area|0
5209869|NCT01027845|17983387|P1|Booster Vaccination Phase|Migrated/moved from study area|1
5209870|NCT01027845|17983384|P4|Booster Vaccination Phase|Withdrawal by Subject|0
5209871|NCT01027845|17983385|P3|Booster Vaccination Phase|Withdrawal by Subject|0
5209872|NCT01027845|17983386|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5209873|NCT01027845|17983387|P1|Booster Vaccination Phase|Withdrawal by Subject|1
5209874|NCT01027845|17983384|P4|Primary Vaccination Phase|Migrated/moved from study area|0
5209875|NCT01027845|17983385|P3|Primary Vaccination Phase|Migrated/moved from study area|0
5209876|NCT01027845|17983386|P2|Primary Vaccination Phase|Migrated/moved from study area|1
5209877|NCT01027845|17983387|P1|Primary Vaccination Phase|Migrated/moved from study area|0
5209878|NCT01027845|17983384|P4|Primary Vaccination Phase|Protocol Violation|0
5209879|NCT01027845|17983385|P3|Primary Vaccination Phase|Protocol Violation|0
5209880|NCT01027845|17983386|P2|Primary Vaccination Phase|Protocol Violation|0
5209881|NCT01027845|17983387|P1|Primary Vaccination Phase|Protocol Violation|1
5209882|NCT01027845|17983384|P4|Primary Vaccination Phase|Adverse Event|0
5209883|NCT01027845|17983385|P3|Primary Vaccination Phase|Adverse Event|0
5209884|NCT01027845|17983386|P2|Primary Vaccination Phase|Adverse Event|0
5209885|NCT01027845|17983387|P1|Primary Vaccination Phase|Adverse Event|1
5209886|NCT01027845|17983384|P4|Primary Vaccination Phase|Serious Adverse Event|0
5209887|NCT01027845|17983385|P3|Primary Vaccination Phase|Serious Adverse Event|0
5209888|NCT01027845|17983386|P2|Primary Vaccination Phase|Serious Adverse Event|0
5209889|NCT01027845|17983387|P1|Primary Vaccination Phase|Serious Adverse Event|2
5209890|NCT01027754|17983470|P2|Overall Study|Withdrawal by Subject|5
5209891|NCT01027754|17983471|P1|Overall Study|Withdrawal by Subject|0
5209892|NCT01027754|17983470|P2|Overall Study|withdrew/lost to follow-up after interve|3
5209893|NCT01027754|17983471|P1|Overall Study|withdrew/lost to follow-up after interve|2
5209894|NCT01027702|17983505|P7|Overall Study|Death|0
5209895|NCT01027702|17983506|P6|Overall Study|Death|0
5209896|NCT01027702|17983507|P5|Overall Study|Death|0
5209897|NCT01027702|17983508|P4|Overall Study|Death|0
5209898|NCT01027702|17983509|P3|Overall Study|Death|1
5209899|NCT01027702|17983510|P2|Overall Study|Death|0
5209900|NCT01027702|17983511|P1|Overall Study|Death|0
5209901|NCT01027702|17983505|P7|Overall Study|Received subsequent therapy|1
5209902|NCT01027702|17983506|P6|Overall Study|Received subsequent therapy|0
5209903|NCT01027702|17983507|P5|Overall Study|Received subsequent therapy|1
5209904|NCT01027702|17983508|P4|Overall Study|Received subsequent therapy|4
5209905|NCT01027702|17983509|P3|Overall Study|Received subsequent therapy|0
5209906|NCT01027702|17983510|P2|Overall Study|Received subsequent therapy|2
5209907|NCT01027702|17983511|P1|Overall Study|Received subsequent therapy|1
5209908|NCT01027650|17983537|P8|Overall Study|Lack of Efficacy|0
5209909|NCT01027650|17983538|P7|Overall Study|Lack of Efficacy|0
5209910|NCT01027650|17983539|P6|Overall Study|Lack of Efficacy|1
5209911|NCT01027650|17983540|P5|Overall Study|Lack of Efficacy|0
5209912|NCT01027650|17983541|P4|Overall Study|Lack of Efficacy|0
5209913|NCT01027650|17983542|P3|Overall Study|Lack of Efficacy|0
5209914|NCT01027650|17983543|P2|Overall Study|Lack of Efficacy|0
5209915|NCT01027650|17983544|P1|Overall Study|Lack of Efficacy|0
5209916|NCT01027650|17983537|P8|Overall Study|Lost to Follow-up|0
5209917|NCT01027650|17983538|P7|Overall Study|Lost to Follow-up|1
5209918|NCT01027650|17983539|P6|Overall Study|Lost to Follow-up|0
5209919|NCT01027650|17983540|P5|Overall Study|Lost to Follow-up|0
5209920|NCT01027650|17983541|P4|Overall Study|Lost to Follow-up|0
5209921|NCT01027650|17983542|P3|Overall Study|Lost to Follow-up|0
5209922|NCT01027650|17983543|P2|Overall Study|Lost to Follow-up|0
5209923|NCT01027650|17983544|P1|Overall Study|Lost to Follow-up|0
5209924|NCT01027650|17983537|P8|Overall Study|Personal Reasons|0
5209925|NCT01027650|17983538|P7|Overall Study|Personal Reasons|0
5209926|NCT01027650|17983539|P6|Overall Study|Personal Reasons|1
5209927|NCT01027650|17983540|P5|Overall Study|Personal Reasons|2
5209928|NCT01027650|17983541|P4|Overall Study|Personal Reasons|0
5209929|NCT01027650|17983542|P3|Overall Study|Personal Reasons|0
5209930|NCT01027650|17983543|P2|Overall Study|Personal Reasons|0
5209931|NCT01027650|17983544|P1|Overall Study|Personal Reasons|0
5209932|NCT01027416|17983622|P2|Overall Study|Physician Decision|4
5209933|NCT01027416|17983623|P1|Overall Study|Physician Decision|1
5209934|NCT01027416|17983622|P2|Overall Study|Withdrawal by Subject|1
5209935|NCT01027416|17983623|P1|Overall Study|Withdrawal by Subject|0
5209936|NCT01027364|17983635|P4|Overall Study|Withdrawal by Subject|0
5209937|NCT01027364|17983636|P3|Overall Study|Withdrawal by Subject|0
5209938|NCT01027364|17983637|P2|Overall Study|Withdrawal by Subject|2
5209939|NCT01027364|17983638|P1|Overall Study|Withdrawal by Subject|1
5209940|NCT01027364|17983635|P4|Overall Study|Protocol Violation|1
5209941|NCT01027364|17983636|P3|Overall Study|Protocol Violation|0
5209942|NCT01027364|17983637|P2|Overall Study|Protocol Violation|0
5209943|NCT01027364|17983638|P1|Overall Study|Protocol Violation|1
5209944|NCT01027364|17983635|P4|Overall Study|Lost to Follow-up|0
5209945|NCT01027364|17983636|P3|Overall Study|Lost to Follow-up|0
5209946|NCT01027364|17983637|P2|Overall Study|Lost to Follow-up|0
5209947|NCT01027364|17983638|P1|Overall Study|Lost to Follow-up|1
5209948|NCT01027364|17983635|P4|Overall Study|Adverse Event|0
5209949|NCT01027364|17983636|P3|Overall Study|Adverse Event|1
5209950|NCT01027364|17983637|P2|Overall Study|Adverse Event|0
5209951|NCT01027364|17983638|P1|Overall Study|Adverse Event|1
5209952|NCT01027351|17983733|P6|Overall Study|Protocol Violation|0
5209953|NCT01027351|17983734|P5|Overall Study|Protocol Violation|1
5209954|NCT01027351|17983735|P4|Overall Study|Protocol Violation|1
5209955|NCT01027351|17983736|P3|Overall Study|Protocol Violation|0
5209956|NCT01027351|17983737|P2|Overall Study|Protocol Violation|0
5209957|NCT01027351|17983738|P1|Overall Study|Protocol Violation|1
5209958|NCT01027351|17983733|P6|Overall Study|Inappropriate enrollment|0
5209959|NCT01027351|17983734|P5|Overall Study|Inappropriate enrollment|1
5209960|NCT01027351|17983735|P4|Overall Study|Inappropriate enrollment|0
5209961|NCT01027351|17983736|P3|Overall Study|Inappropriate enrollment|0
5209962|NCT01027351|17983737|P2|Overall Study|Inappropriate enrollment|0
5209963|NCT01027351|17983738|P1|Overall Study|Inappropriate enrollment|0
5209964|NCT01027351|17983733|P6|Overall Study|Lost to Follow-up|0
5209965|NCT01027351|17983734|P5|Overall Study|Lost to Follow-up|6
5209966|NCT01027351|17983735|P4|Overall Study|Lost to Follow-up|1
5209967|NCT01027351|17983736|P3|Overall Study|Lost to Follow-up|0
5209968|NCT01027351|17983737|P2|Overall Study|Lost to Follow-up|1
5209969|NCT01027351|17983738|P1|Overall Study|Lost to Follow-up|1
5209970|NCT01027351|17983733|P6|Overall Study|Withdrawal by Subject|5
5209971|NCT01027351|17983734|P5|Overall Study|Withdrawal by Subject|3
5209972|NCT01027351|17983735|P4|Overall Study|Withdrawal by Subject|0
5209973|NCT01027351|17983736|P3|Overall Study|Withdrawal by Subject|1
5209974|NCT01027351|17983737|P2|Overall Study|Withdrawal by Subject|0
5209975|NCT01027351|17983738|P1|Overall Study|Withdrawal by Subject|1
5209976|NCT01027286|17983822|P2|Overall Study|Lost to Follow-up|1
5209977|NCT01027286|17983823|P1|Overall Study|Lost to Follow-up|0
5209978|NCT01027286|17983822|P2|Overall Study|Unable to Obtain Required Blood Volume|0
5209979|NCT01027286|17983823|P1|Overall Study|Unable to Obtain Required Blood Volume|1
5209980|NCT01027273|17983843|P2|Overall Study|Death|2
5209981|NCT01027273|17983844|P1|Overall Study|Death|2
5209982|NCT01027273|17983843|P2|Overall Study|Lost to Follow-up|31
5209983|NCT01027273|17983844|P1|Overall Study|Lost to Follow-up|57
5209984|NCT01026974|17983891|P4|Overall Study|Inappropriate enrollment|0
5209985|NCT01026974|17983892|P3|Overall Study|Inappropriate enrollment|1
5209986|NCT01026974|17983893|P2|Overall Study|Inappropriate enrollment|0
5209987|NCT01026974|17983894|P1|Overall Study|Inappropriate enrollment|0
5209988|NCT01026974|17983891|P4|Overall Study|Adverse Event|1
5209989|NCT01026974|17983892|P3|Overall Study|Adverse Event|0
5209990|NCT01026974|17983893|P2|Overall Study|Adverse Event|0
5209991|NCT01026974|17983894|P1|Overall Study|Adverse Event|0
5209992|NCT01026974|17983891|P4|Overall Study|Lost to Follow-up|0
5209993|NCT01026974|17983892|P3|Overall Study|Lost to Follow-up|4
5209994|NCT01026974|17983893|P2|Overall Study|Lost to Follow-up|1
5209995|NCT01026974|17983894|P1|Overall Study|Lost to Follow-up|1
5209996|NCT01026974|17983891|P4|Overall Study|Withdrawal by Subject|2
5209997|NCT01026974|17983892|P3|Overall Study|Withdrawal by Subject|7
5209998|NCT01026974|17983893|P2|Overall Study|Withdrawal by Subject|1
5209999|NCT01026974|17983894|P1|Overall Study|Withdrawal by Subject|0
5210000|NCT01026948|17983951|P1|Overall Study|Physician Decision|8
5210001|NCT01026831|17983984|P2|Overall Study|Withdrawal by Subject|5
5210002|NCT01026831|17983985|P1|Overall Study|Withdrawal by Subject|7
5210003|NCT01026831|17983984|P2|Overall Study|Protocol Violation|2
5210004|NCT01026831|17983985|P1|Overall Study|Protocol Violation|0
5210005|NCT01026831|17983984|P2|Overall Study|Physician Decision|1
5210006|NCT01026831|17983985|P1|Overall Study|Physician Decision|1
5210007|NCT01026831|17983984|P2|Overall Study|Lost to Follow-up|0
5210008|NCT01026831|17983985|P1|Overall Study|Lost to Follow-up|2
5210009|NCT01026831|17983984|P2|Overall Study|Adverse Event|3
5210010|NCT01026831|17983985|P1|Overall Study|Adverse Event|4
5210011|NCT01026818|17983996|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
5210012|NCT01026818|17983997|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
5210013|NCT01026818|17983998|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
5210014|NCT01026818|17983999|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
5210087|NCT01026818|17983996|P4|Screening Period|Physician Decision|0
5210015|NCT01026818|17983996|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
5210016|NCT01026818|17983997|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
5210017|NCT01026818|17983998|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
5210018|NCT01026818|17983999|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
5210019|NCT01026818|17983996|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
5210020|NCT01026818|17983997|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
5210021|NCT01026818|17983998|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
5210022|NCT01026818|17983999|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
5210023|NCT01026818|17983996|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5210024|NCT01026818|17983997|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5210025|NCT01026818|17983998|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
5210026|NCT01026818|17983999|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5210027|NCT01026818|17983996|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5210028|NCT01026818|17983997|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5210029|NCT01026818|17983998|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
5210030|NCT01026818|17983999|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5210031|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
5210032|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
5210033|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
5210034|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
5210035|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
5210036|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
5210037|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
5210038|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
5210039|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5210040|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5210041|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
5210042|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5210043|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
5210044|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
5210045|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
5210046|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
5210047|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
5210048|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
5210049|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
5210050|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
5210051|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5210052|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5210053|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
5210054|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5210055|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
5210056|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
5210057|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
5210058|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
5210059|NCT01026818|17983996|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
5210060|NCT01026818|17983997|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
5210061|NCT01026818|17983998|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
5210062|NCT01026818|17983999|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
5210063|NCT01026818|17983996|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
5210064|NCT01026818|17983997|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
5210065|NCT01026818|17983998|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
5210066|NCT01026818|17983999|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
5210067|NCT01026818|17983996|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
5210068|NCT01026818|17983997|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
5210069|NCT01026818|17983998|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
5210070|NCT01026818|17983999|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
5210071|NCT01026818|17983996|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
5210072|NCT01026818|17983997|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
5210073|NCT01026818|17983998|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
5210074|NCT01026818|17983999|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
5210075|NCT01026818|17983996|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
5210076|NCT01026818|17983997|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
5210077|NCT01026818|17983998|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
5210078|NCT01026818|17983999|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
5210079|NCT01026818|17983996|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
5210080|NCT01026818|17983997|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
5210081|NCT01026818|17983998|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
5210082|NCT01026818|17983999|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
5210083|NCT01026818|17983996|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
5210084|NCT01026818|17983997|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
5210085|NCT01026818|17983998|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
5210086|NCT01026818|17983999|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
5210088|NCT01026818|17983997|P3|Screening Period|Physician Decision|0
5210089|NCT01026818|17983998|P2|Screening Period|Physician Decision|0
5210090|NCT01026818|17983999|P1|Screening Period|Physician Decision|1
5210091|NCT01026818|17983996|P4|Screening Period|Adverse Event|0
5210092|NCT01026818|17983997|P3|Screening Period|Adverse Event|0
5210093|NCT01026818|17983998|P2|Screening Period|Adverse Event|0
5210094|NCT01026818|17983999|P1|Screening Period|Adverse Event|2
5210095|NCT01026818|17983996|P4|Screening Period|Protocol Deviation|0
5210096|NCT01026818|17983997|P3|Screening Period|Protocol Deviation|0
5210097|NCT01026818|17983998|P2|Screening Period|Protocol Deviation|0
5210098|NCT01026818|17983999|P1|Screening Period|Protocol Deviation|3
5210099|NCT01026818|17983996|P4|Screening Period|Withdrawal by Subject|0
5210100|NCT01026818|17983997|P3|Screening Period|Withdrawal by Subject|0
5210101|NCT01026818|17983998|P2|Screening Period|Withdrawal by Subject|0
5210102|NCT01026818|17983999|P1|Screening Period|Withdrawal by Subject|49
5210103|NCT01026818|17983996|P4|Screening Period|Entry Criteria Not Met|0
5210104|NCT01026818|17983997|P3|Screening Period|Entry Criteria Not Met|0
5210105|NCT01026818|17983998|P2|Screening Period|Entry Criteria Not Met|0
5210106|NCT01026818|17983999|P1|Screening Period|Entry Criteria Not Met|105
5210107|NCT01026792|17984087|P1|Overall Study|Protocol Violation|1
5210108|NCT01026493|17984130|P8|Overall Study|Protocol Violation|1
5210109|NCT01026493|17984131|P7|Overall Study|Protocol Violation|4
5210110|NCT01026493|17984132|P6|Overall Study|Protocol Violation|3
5210111|NCT01026493|17984133|P5|Overall Study|Protocol Violation|2
5210112|NCT01026493|17984134|P4|Overall Study|Protocol Violation|0
5210113|NCT01026493|17984135|P3|Overall Study|Protocol Violation|0
5210114|NCT01026493|17984136|P2|Overall Study|Protocol Violation|1
5210115|NCT01026493|17984137|P1|Overall Study|Protocol Violation|0
5210116|NCT01026454|17984165|P2|Second Intervention|Pregnancy|1
5210117|NCT01026454|17984166|P1|Second Intervention|Pregnancy|1
5210118|NCT01026389|17984515|P2|Overall Study|change of treatment, patient moved|2
5210119|NCT01026389|17984516|P1|Overall Study|change of treatment, patient moved|4
5210120|NCT01026389|17984515|P2|Overall Study|Withdrawal by Subject|3
5210121|NCT01026389|17984516|P1|Overall Study|Withdrawal by Subject|1
5210122|NCT01026324|17984531|P3|Follow up/Survival|Withdrawal by Subject|0
5210123|NCT01026324|17984532|P2|Follow up/Survival|Withdrawal by Subject|0
5210124|NCT01026324|17984533|P1|Follow up/Survival|Withdrawal by Subject|1
5210125|NCT01026220|17984543|P3|Consolidation Maintenance|Withdrawal by Subject|6
5210126|NCT01026220|17984544|P2|Consolidation Maintenance|Withdrawal by Subject|2
5210127|NCT01026220|17984545|P1|Consolidation Maintenance|Withdrawal by Subject|0
5210128|NCT01026220|17984543|P3|Consolidation Maintenance|Physician Decision|7
5210129|NCT01026220|17984544|P2|Consolidation Maintenance|Physician Decision|2
5210130|NCT01026220|17984545|P1|Consolidation Maintenance|Physician Decision|0
5210131|NCT01026220|17984543|P3|Consolidation Maintenance|Lack of Efficacy|1
5210132|NCT01026220|17984544|P2|Consolidation Maintenance|Lack of Efficacy|1
5210133|NCT01026220|17984545|P1|Consolidation Maintenance|Lack of Efficacy|0
5210134|NCT01026220|17984543|P3|Consolidation Maintenance|Death|0
5210135|NCT01026220|17984544|P2|Consolidation Maintenance|Death|1
5210136|NCT01026220|17984545|P1|Consolidation Maintenance|Death|0
5210137|NCT01026220|17984543|P3|Induction|Ineligible|0
5210138|NCT01026220|17984544|P2|Induction|Ineligible|0
5210139|NCT01026220|17984545|P1|Induction|Ineligible|1
5210140|NCT01026220|17984543|P3|Induction|Withdrawal by Subject|0
5210141|NCT01026220|17984544|P2|Induction|Withdrawal by Subject|0
5210142|NCT01026220|17984545|P1|Induction|Withdrawal by Subject|9
5210143|NCT01026220|17984543|P3|Induction|Physician Decision|0
5210144|NCT01026220|17984544|P2|Induction|Physician Decision|0
5210145|NCT01026220|17984545|P1|Induction|Physician Decision|12
5210146|NCT01026220|17984543|P3|Induction|Lack of Efficacy|0
5210147|NCT01026220|17984544|P2|Induction|Lack of Efficacy|0
5210148|NCT01026220|17984545|P1|Induction|Lack of Efficacy|2
5210149|NCT01026220|17984543|P3|Induction|Death|0
5210150|NCT01026220|17984544|P2|Induction|Death|0
5210151|NCT01026220|17984545|P1|Induction|Death|1
5210152|NCT01026194|17984569|P2|Period 2：Open-label Period|Withdrawal by Subject|4
5210153|NCT01026194|17984570|P1|Period 2：Open-label Period|Withdrawal by Subject|0
5210154|NCT01026194|17984569|P2|Period 2：Open-label Period|Physician Decision|1
5210155|NCT01026194|17984570|P1|Period 2：Open-label Period|Physician Decision|3
5210156|NCT01026194|17984569|P2|Period 2：Open-label Period|Adverse Event|5
5210157|NCT01026194|17984570|P1|Period 2：Open-label Period|Adverse Event|4
5210158|NCT01026194|17984569|P2|Period 1：Double Blind Period|Physician Decision|4
5210159|NCT01026194|17984570|P1|Period 1：Double Blind Period|Physician Decision|0
5210160|NCT01026194|17984569|P2|Period 1：Double Blind Period|Lack of Efficacy|0
5210161|NCT01026194|17984570|P1|Period 1：Double Blind Period|Lack of Efficacy|1
5210162|NCT01026194|17984569|P2|Period 1：Double Blind Period|Adverse Event|1
5210163|NCT01026194|17984570|P1|Period 1：Double Blind Period|Adverse Event|2
5210164|NCT01026142|17984602|P2|Overall Study|Withdrew consent or lost to follow-up|29
5210165|NCT01026142|17984603|P1|Overall Study|Withdrew consent or lost to follow-up|36
5210166|NCT01026142|17984602|P2|Overall Study|Death|134
5210167|NCT01026142|17984603|P1|Overall Study|Death|136
5210168|NCT01026103|17984625|P1|Overall Study|did not receive study device bc of error|1
5210169|NCT01026103|17984625|P1|Overall Study|Physician Decision|1
5210170|NCT01026038|17984635|P3|Overall Study|Lost to Follow-up|0
5210171|NCT01026038|17984636|P2|Overall Study|Lost to Follow-up|1
5210172|NCT01026038|17984637|P1|Overall Study|Lost to Follow-up|1
5210173|NCT01025843|17984686|P10|Washout 4|Withdrawal by Subject|0
5210174|NCT01025843|17984687|P9|Washout 4|Withdrawal by Subject|0
5210175|NCT01025843|17984688|P8|Washout 4|Withdrawal by Subject|0
5210176|NCT01025843|17984689|P7|Washout 4|Withdrawal by Subject|0
5210177|NCT01025843|17984690|P6|Washout 4|Withdrawal by Subject|0
5210178|NCT01025843|17984691|P5|Washout 4|Withdrawal by Subject|0
5210179|NCT01025843|17984692|P4|Washout 4|Withdrawal by Subject|1
5210180|NCT01025843|17984693|P3|Washout 4|Withdrawal by Subject|1
5210181|NCT01025843|17984694|P2|Washout 4|Withdrawal by Subject|0
5210182|NCT01025843|17984695|P1|Washout 4|Withdrawal by Subject|0
5210183|NCT01025817|17984789|P2|Completed Study|Lost to Follow-up|1
5210184|NCT01025817|17984790|P1|Completed Study|Lost to Follow-up|0
5210185|NCT01025817|17984789|P2|Completed Study|Missing|0
5210186|NCT01025817|17984790|P1|Completed Study|Missing|2
5210187|NCT01025817|17984789|P2|Completed Study|Death|5
5210188|NCT01025817|17984790|P1|Completed Study|Death|6
5210189|NCT01025817|17984789|P2|Completed Study|Withdrawal by Subject|16
5210190|NCT01025817|17984790|P1|Completed Study|Withdrawal by Subject|8
5210191|NCT01025817|17984789|P2|Completed Study Medication|Lost to Follow-up|1
5210192|NCT01025817|17984790|P1|Completed Study Medication|Lost to Follow-up|0
5210193|NCT01025817|17984789|P2|Completed Study Medication|Subject no longer required study drug|1
5210194|NCT01025817|17984790|P1|Completed Study Medication|Subject no longer required study drug|0
5210195|NCT01025817|17984789|P2|Completed Study Medication|Abnormal lab values|2
5210196|NCT01025817|17984790|P1|Completed Study Medication|Abnormal lab values|0
5210197|NCT01025817|17984789|P2|Completed Study Medication|Death|2
5210198|NCT01025817|17984790|P1|Completed Study Medication|Death|2
5210199|NCT01025817|17984789|P2|Completed Study Medication|Graft loss|5
5210200|NCT01025817|17984790|P1|Completed Study Medication|Graft loss|2
5210201|NCT01025817|17984789|P2|Completed Study Medication|Abnormal test procedure|0
5210202|NCT01025817|17984790|P1|Completed Study Medication|Abnormal test procedure|4
5210203|NCT01025817|17984789|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
5210204|NCT01025817|17984790|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
5210205|NCT01025817|17984789|P2|Completed Study Medication|Administrative problems|5
5210206|NCT01025817|17984790|P1|Completed Study Medication|Administrative problems|7
5210207|NCT01025817|17984789|P2|Completed Study Medication|Withdrawal by Subject|9
5210208|NCT01025817|17984790|P1|Completed Study Medication|Withdrawal by Subject|8
5210209|NCT01025817|17984789|P2|Completed Study Medication|Protocol Deviation|8
5210210|NCT01025817|17984790|P1|Completed Study Medication|Protocol Deviation|9
5210211|NCT01025817|17984789|P2|Completed Study Medication|Adverse Event|39
5210212|NCT01025817|17984790|P1|Completed Study Medication|Adverse Event|66
5210213|NCT01025752|17984956|P2|Overall Study|Physician Decision|3
5210214|NCT01025752|17984957|P1|Overall Study|Physician Decision|1
5210215|NCT01025752|17984956|P2|Overall Study|Lost to Follow-up|10
5210216|NCT01025752|17984957|P1|Overall Study|Lost to Follow-up|7
5210217|NCT01025635|17984977|P2|Overall Study|Reason not known|2
5210218|NCT01025635|17984978|P1|Overall Study|Reason not known|4
5210219|NCT01025635|17984977|P2|Overall Study|Lost to Follow-up|13
5210220|NCT01025635|17984978|P1|Overall Study|Lost to Follow-up|9
5210221|NCT01025635|17984977|P2|Overall Study|Lack of Efficacy|1
5210222|NCT01025635|17984978|P1|Overall Study|Lack of Efficacy|0
5210223|NCT01025635|17984977|P2|Overall Study|Protocol Violation|2
5210224|NCT01025635|17984978|P1|Overall Study|Protocol Violation|4
5210225|NCT01025635|17984977|P2|Overall Study|Withdrawal by Subject|7
5210226|NCT01025635|17984978|P1|Overall Study|Withdrawal by Subject|6
5210227|NCT01025336|17985010|P5|Overall Study|Protocol Violation|0
5210228|NCT01025336|17985011|P4|Overall Study|Protocol Violation|2
5210229|NCT01025336|17985012|P3|Overall Study|Protocol Violation|0
5210230|NCT01025336|17985013|P2|Overall Study|Protocol Violation|0
5210231|NCT01025336|17985014|P1|Overall Study|Protocol Violation|0
5210232|NCT01025284|17985069|P3|Overall Study|Withdrawal by Subject|0
5210233|NCT01025284|17985070|P2|Overall Study|Withdrawal by Subject|1
5210234|NCT01025284|17985071|P1|Overall Study|Withdrawal by Subject|0
5210235|NCT01025284|17985069|P3|Overall Study|Investigator Decision|0
5210236|NCT01025284|17985070|P2|Overall Study|Investigator Decision|1
5210237|NCT01025284|17985071|P1|Overall Study|Investigator Decision|0
5210238|NCT01025232|17985096|P2|Overall Study|Study drug no longer available|6
5210239|NCT01025232|17985097|P1|Overall Study|Study drug no longer available|3
5210240|NCT01025193|17985115|P1|Overall Study|Adverse Event|3
5210241|NCT01025193|17985115|P1|Overall Study|Protocol Violation|1
5210242|NCT01025154|17985125|P1|Overall Study|Withdrawal by Subject|1
5210243|NCT01025154|17985125|P1|Overall Study|Lost to Follow-up|1
5210244|NCT01025037|17985134|P1|Overall Study|Withdrawal by Subject|1
5210245|NCT01025037|17985134|P1|Overall Study|Lost to Follow-up|7
5210246|NCT01025037|17985134|P1|Overall Study|Adverse Event|3
5210247|NCT01024959|17985156|P1|Overall Study|missing results required for analysis|17
5210248|NCT01024959|17985156|P1|Overall Study|results not evaluable|12
5210249|NCT01024959|17985156|P1|Overall Study|ineligible|12
5210250|NCT01024946|17985165|P1|Overall Study|Adverse Event|1
5210251|NCT01024946|17985165|P1|Overall Study|Withdrawal by Subject|1
5210252|NCT01024946|17985165|P1|Overall Study|Screen Failure|3
5210253|NCT01024920|17985171|P2|Overall Study|Not treated|0
5210254|NCT01024920|17985172|P1|Overall Study|Not treated|3
5210255|NCT01024920|17985171|P2|Overall Study|Other reason|13
5210256|NCT01024920|17985172|P1|Overall Study|Other reason|21
5210257|NCT01024920|17985171|P2|Overall Study|Withdrawal by Subject|0
5210258|NCT01024920|17985172|P1|Overall Study|Withdrawal by Subject|2
5210259|NCT01024920|17985171|P2|Overall Study|Lost to Follow-up|4
5210260|NCT01024920|17985172|P1|Overall Study|Lost to Follow-up|4
5210261|NCT01024920|17985171|P2|Overall Study|Adverse Event|2
5210262|NCT01024920|17985172|P1|Overall Study|Adverse Event|4
5210263|NCT01024920|17985171|P2|Overall Study|Progressive disease|3
5210264|NCT01024920|17985172|P1|Overall Study|Progressive disease|11
5210265|NCT01024855|17985190|P1|Overall Study|Inclusion/exclusion criteria|1
5210266|NCT01024751|17985197|P2|Eligible Participants|Ineligible|1
5210267|NCT01024751|17985198|P1|Eligible Participants|Ineligible|0
5210268|NCT01024751|17985197|P2|Eligible Participants|Lost to Follow-up|1
5210269|NCT01024751|17985198|P1|Eligible Participants|Lost to Follow-up|0
5210270|NCT01024751|17985197|P2|Eligible Participants|Withdrawal by Subject|1
5210271|NCT01024751|17985198|P1|Eligible Participants|Withdrawal by Subject|0
5210272|NCT01024751|17985197|P2|Enrolled Participants|Ineligible at baseline|4
5210273|NCT01024751|17985198|P1|Enrolled Participants|Ineligible at baseline|3
5210274|NCT01024608|17985255|P2|Overall Study|Never received study treatment|0
5210275|NCT01024608|17985256|P1|Overall Study|Never received study treatment|2
5210276|NCT01024608|17985255|P2|Overall Study|Protocol Violation|3
5210277|NCT01024608|17985256|P1|Overall Study|Protocol Violation|0
5210278|NCT01024608|17985255|P2|Overall Study|Lost to Follow-up|1
5210279|NCT01024608|17985256|P1|Overall Study|Lost to Follow-up|0
5210280|NCT01024608|17985255|P2|Overall Study|Withdrawal by Subject|0
5210281|NCT01024608|17985256|P1|Overall Study|Withdrawal by Subject|1
5210282|NCT01024608|17985255|P2|Overall Study|Adverse Event|0
5210283|NCT01024608|17985256|P1|Overall Study|Adverse Event|1
5210284|NCT01024465|17985285|P1|Overall Study|Physician Decision|1
5210285|NCT01024465|17985285|P1|Overall Study|Adverse Event|2
5210286|NCT01024387|17985289|P1|Overall Study|Other|5
5210287|NCT01024387|17985289|P1|Overall Study|Adverse Event|3
5210288|NCT01024387|17985289|P1|Overall Study|Prolonged Treatment Delay|1
5210289|NCT01024387|17985289|P1|Overall Study|Death|2
5210290|NCT01024387|17985289|P1|Overall Study|Withdrawal by Subject|5
5210291|NCT01024387|17985289|P1|Overall Study|Physician Decision|5
5210292|NCT01024387|17985289|P1|Overall Study|Symptomatic Progression|10
5210293|NCT01024387|17985289|P1|Overall Study|Radiographic Progression|29
5210294|NCT01024309|17985310|P2|Overall Study|Withdrawal by Subject|4
5210295|NCT01024309|17985311|P1|Overall Study|Withdrawal by Subject|4
5210296|NCT01024309|17985310|P2|Overall Study|Physician Decision|0
5210297|NCT01024309|17985311|P1|Overall Study|Physician Decision|4
5210298|NCT01024244|17985343|P5|Overall Study|Withdrawal by Subject|0
5210299|NCT01024244|17985344|P4|Overall Study|Withdrawal by Subject|0
5210300|NCT01024244|17985345|P3|Overall Study|Withdrawal by Subject|0
5210301|NCT01024244|17985346|P2|Overall Study|Withdrawal by Subject|1
5210302|NCT01024244|17985347|P1|Overall Study|Withdrawal by Subject|0
5210303|NCT01024244|17985343|P5|Overall Study|Sponsor Decision|10
5210304|NCT01024244|17985344|P4|Overall Study|Sponsor Decision|12
5210305|NCT01024244|17985345|P3|Overall Study|Sponsor Decision|14
5210306|NCT01024244|17985346|P2|Overall Study|Sponsor Decision|7
5210307|NCT01024244|17985347|P1|Overall Study|Sponsor Decision|14
5210308|NCT01024244|17985343|P5|Overall Study|Protocol Violation|2
5210309|NCT01024244|17985344|P4|Overall Study|Protocol Violation|0
5210310|NCT01024244|17985345|P3|Overall Study|Protocol Violation|0
5210311|NCT01024244|17985346|P2|Overall Study|Protocol Violation|0
5210312|NCT01024244|17985347|P1|Overall Study|Protocol Violation|1
5210313|NCT01024244|17985343|P5|Overall Study|Lack of Efficacy|0
5210314|NCT01024244|17985344|P4|Overall Study|Lack of Efficacy|0
5210315|NCT01024244|17985345|P3|Overall Study|Lack of Efficacy|0
5210316|NCT01024244|17985346|P2|Overall Study|Lack of Efficacy|0
5210317|NCT01024244|17985347|P1|Overall Study|Lack of Efficacy|1
5210318|NCT01024244|17985343|P5|Overall Study|Entry Criteria Not Met|0
5210319|NCT01024244|17985344|P4|Overall Study|Entry Criteria Not Met|0
5210320|NCT01024244|17985345|P3|Overall Study|Entry Criteria Not Met|0
5210321|NCT01024244|17985346|P2|Overall Study|Entry Criteria Not Met|1
5210322|NCT01024244|17985347|P1|Overall Study|Entry Criteria Not Met|0
5210323|NCT01024244|17985343|P5|Overall Study|Adverse Event|2
5210324|NCT01024244|17985344|P4|Overall Study|Adverse Event|1
5210325|NCT01024244|17985345|P3|Overall Study|Adverse Event|0
5210326|NCT01024244|17985346|P2|Overall Study|Adverse Event|2
5210327|NCT01024244|17985347|P1|Overall Study|Adverse Event|1
5210328|NCT01024036|17985461|P2|Follow-Up Period|Adverse Event|1
5210329|NCT01024036|17985462|P1|Follow-Up Period|Adverse Event|4
5210330|NCT01024036|17985461|P2|Follow-Up Period|Withdrawal by Subject|1
5210331|NCT01024036|17985462|P1|Follow-Up Period|Withdrawal by Subject|0
5210332|NCT01024036|17985461|P2|Follow-Up Period|Lost to Follow-up|1
5210333|NCT01024036|17985462|P1|Follow-Up Period|Lost to Follow-up|1
5210334|NCT01024036|17985461|P2|Unblinded Treatment|Lack of Efficacy|2
5210335|NCT01024036|17985462|P1|Unblinded Treatment|Lack of Efficacy|0
5210336|NCT01024036|17985461|P2|Unblinded Treatment|Adverse Event|1
5210337|NCT01024036|17985462|P1|Unblinded Treatment|Adverse Event|0
5210338|NCT01024036|17985461|P2|Blinded Treatment|Withdrawal by Subject|3
5210339|NCT01024036|17985462|P1|Blinded Treatment|Withdrawal by Subject|4
5210340|NCT01024036|17985461|P2|Blinded Treatment|Death|2
5210341|NCT01024036|17985462|P1|Blinded Treatment|Death|0
5210342|NCT01024036|17985461|P2|Blinded Treatment|Physician Decision|0
5210343|NCT01024036|17985462|P1|Blinded Treatment|Physician Decision|1
5210344|NCT01024036|17985461|P2|Blinded Treatment|Lack of Efficacy|14
5210345|NCT01024036|17985462|P1|Blinded Treatment|Lack of Efficacy|16
5210346|NCT01024036|17985461|P2|Blinded Treatment|Adverse Event|1
5210347|NCT01024036|17985462|P1|Blinded Treatment|Adverse Event|1
5210348|NCT01023958|17985509|P1|Overall Study|Refused to continue medication|1
5210349|NCT01023958|17985509|P1|Overall Study|Other adverse event|1
5210350|NCT01023958|17985509|P1|Overall Study|Progressive disease|48
5210351|NCT01023815|17985557|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5210352|NCT01023815|17985558|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5210353|NCT01023815|17985559|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
5210354|NCT01023815|17985560|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5210355|NCT01023815|17985557|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
5210356|NCT01023815|17985558|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
5210357|NCT01023815|17985559|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
5210358|NCT01023815|17985560|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
5210359|NCT01023815|17985557|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
5210360|NCT01023815|17985558|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
5210361|NCT01023815|17985559|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
5210362|NCT01023815|17985560|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
5210363|NCT01023815|17985557|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
5210364|NCT01023815|17985558|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
5210365|NCT01023815|17985559|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
5210366|NCT01023815|17985560|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
5210367|NCT01023815|17985557|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5210368|NCT01023815|17985558|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5210369|NCT01023815|17985559|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5210370|NCT01023815|17985560|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
5210371|NCT01023789|17985579|P1|3 - Year Visit|Lost to Follow-up|13
5210372|NCT01023789|17985579|P1|3 - Year Visit|Withdrawal of consent|1
5210373|NCT01023789|17985579|P1|3 - Year Visit|Death|29
5210374|NCT01023672|17985665|P1|Overall Study|Death|1
5210375|NCT01023672|17985665|P1|Overall Study|Worsening disease|2
5210376|NCT01023659|17985672|P3|Overall Study|Lost to Follow-up|99
5210377|NCT01023659|17985673|P2|Overall Study|Lost to Follow-up|228
5210378|NCT01023659|17985674|P1|Overall Study|Lost to Follow-up|73
5210379|NCT01023581|17985701|P7|Overall Study|Other|0
5210380|NCT01023581|17985702|P6|Overall Study|Other|0
5210381|NCT01023581|17985703|P5|Overall Study|Other|1
5210382|NCT01023581|17985704|P4|Overall Study|Other|0
5210383|NCT01023581|17985705|P3|Overall Study|Other|1
5210384|NCT01023581|17985706|P2|Overall Study|Other|0
5210385|NCT01023581|17985707|P1|Overall Study|Other|1
5210386|NCT01023581|17985701|P7|Overall Study|Physician Decision|1
5210387|NCT01023581|17985702|P6|Overall Study|Physician Decision|1
5210388|NCT01023581|17985703|P5|Overall Study|Physician Decision|1
5210389|NCT01023581|17985704|P4|Overall Study|Physician Decision|1
5210390|NCT01023581|17985705|P3|Overall Study|Physician Decision|2
5210391|NCT01023581|17985706|P2|Overall Study|Physician Decision|0
5210392|NCT01023581|17985707|P1|Overall Study|Physician Decision|2
5210393|NCT01023581|17985701|P7|Overall Study|Lack of Efficacy|1
5210394|NCT01023581|17985702|P6|Overall Study|Lack of Efficacy|2
5210395|NCT01023581|17985703|P5|Overall Study|Lack of Efficacy|1
5210396|NCT01023581|17985704|P4|Overall Study|Lack of Efficacy|2
5210397|NCT01023581|17985705|P3|Overall Study|Lack of Efficacy|6
5210398|NCT01023581|17985706|P2|Overall Study|Lack of Efficacy|3
5210399|NCT01023581|17985707|P1|Overall Study|Lack of Efficacy|9
5210400|NCT01023581|17985701|P7|Overall Study|Pregnancy|0
5210401|NCT01023581|17985702|P6|Overall Study|Pregnancy|1
5210402|NCT01023581|17985703|P5|Overall Study|Pregnancy|0
5210403|NCT01023581|17985704|P4|Overall Study|Pregnancy|2
5210404|NCT01023581|17985705|P3|Overall Study|Pregnancy|0
5210405|NCT01023581|17985706|P2|Overall Study|Pregnancy|0
5210406|NCT01023581|17985707|P1|Overall Study|Pregnancy|0
5210407|NCT01023581|17985701|P7|Overall Study|Withdrawal by Subject|5
5210408|NCT01023581|17985702|P6|Overall Study|Withdrawal by Subject|8
5210409|NCT01023581|17985703|P5|Overall Study|Withdrawal by Subject|6
5210410|NCT01023581|17985704|P4|Overall Study|Withdrawal by Subject|10
5210411|NCT01023581|17985705|P3|Overall Study|Withdrawal by Subject|16
5210412|NCT01023581|17985706|P2|Overall Study|Withdrawal by Subject|8
5210413|NCT01023581|17985707|P1|Overall Study|Withdrawal by Subject|13
5210414|NCT01023581|17985701|P7|Overall Study|Lost to Follow-up|2
5210415|NCT01023581|17985702|P6|Overall Study|Lost to Follow-up|2
5210416|NCT01023581|17985703|P5|Overall Study|Lost to Follow-up|5
5210417|NCT01023581|17985704|P4|Overall Study|Lost to Follow-up|2
5210418|NCT01023581|17985705|P3|Overall Study|Lost to Follow-up|7
5210419|NCT01023581|17985706|P2|Overall Study|Lost to Follow-up|8
5210420|NCT01023581|17985707|P1|Overall Study|Lost to Follow-up|4
5210421|NCT01023581|17985701|P7|Overall Study|Major protocol deviation|0
5210422|NCT01023581|17985702|P6|Overall Study|Major protocol deviation|0
5210423|NCT01023581|17985703|P5|Overall Study|Major protocol deviation|0
5210424|NCT01023581|17985704|P4|Overall Study|Major protocol deviation|0
5210425|NCT01023581|17985705|P3|Overall Study|Major protocol deviation|3
5210426|NCT01023581|17985706|P2|Overall Study|Major protocol deviation|0
5210427|NCT01023581|17985707|P1|Overall Study|Major protocol deviation|2
5210428|NCT01023581|17985701|P7|Overall Study|Adverse Event|11
5210429|NCT01023581|17985702|P6|Overall Study|Adverse Event|5
5210430|NCT01023581|17985703|P5|Overall Study|Adverse Event|2
5210431|NCT01023581|17985704|P4|Overall Study|Adverse Event|3
5210432|NCT01023581|17985705|P3|Overall Study|Adverse Event|7
5210433|NCT01023581|17985706|P2|Overall Study|Adverse Event|4
5210434|NCT01023581|17985707|P1|Overall Study|Adverse Event|4
5210435|NCT01023516|17985764|P2|Overall Study|Incorrect enrolment|2
5210436|NCT01023516|17985765|P1|Overall Study|Incorrect enrolment|4
5210437|NCT01023516|17985764|P2|Overall Study|Study-specific criteria|2
5210438|NCT01023516|17985765|P1|Overall Study|Study-specific criteria|4
5210439|NCT01023516|17985764|P2|Overall Study|Safety reason|3
5210440|NCT01023516|17985765|P1|Overall Study|Safety reason|0
5210441|NCT01023516|17985764|P2|Overall Study|Adverse Event|6
5210442|NCT01023516|17985765|P1|Overall Study|Adverse Event|9
5210443|NCT01023516|17985764|P2|Overall Study|Voluntary discontinuation|5
5210444|NCT01023516|17985765|P1|Overall Study|Voluntary discontinuation|7
5210445|NCT01023308|17985847|P2|Overall Study|Withdrawal by Subject|18
5210446|NCT01023308|17985848|P1|Overall Study|Withdrawal by Subject|34
5210447|NCT01023308|17985847|P2|Overall Study|Lost to Follow-up|0
5210448|NCT01023308|17985848|P1|Overall Study|Lost to Follow-up|1
5210449|NCT01023308|17985847|P2|Overall Study|Untreated|5
5210450|NCT01023308|17985848|P1|Overall Study|Untreated|5
5210451|NCT01023308|17985847|P2|Overall Study|Protocol Violation|4
5210452|NCT01023308|17985848|P1|Overall Study|Protocol Violation|3
5210453|NCT01023308|17985847|P2|Overall Study|New Cancer therapy|7
5210454|NCT01023308|17985848|P1|Overall Study|New Cancer therapy|4
5210455|NCT01023308|17985847|P2|Overall Study|Disease progression|153
5210456|NCT01023308|17985848|P1|Overall Study|Disease progression|82
5210457|NCT01023308|17985847|P2|Overall Study|Death|17
5210458|NCT01023308|17985848|P1|Overall Study|Death|21
5210459|NCT01023308|17985847|P2|Overall Study|Adverse Event|66
5210460|NCT01023308|17985848|P1|Overall Study|Adverse Event|130
5210461|NCT01023308|17985847|P2|Overall Study|Administrative problems|1
5210462|NCT01023308|17985848|P1|Overall Study|Administrative problems|2
5210463|NCT01023308|17985847|P2|Overall Study|Abnormal test proceedure results|8
5210464|NCT01023308|17985848|P1|Overall Study|Abnormal test proceedure results|3
5210465|NCT01023269|17985874|P2|Overall Study|early termination of the study|0
5210466|NCT01023269|17985875|P1|Overall Study|early termination of the study|2
5210467|NCT01023256|17985883|P4|Overall Study|Withdrawal by Subject|2
5210468|NCT01023256|17985884|P3|Overall Study|Withdrawal by Subject|0
5210469|NCT01023256|17985885|P2|Overall Study|Withdrawal by Subject|0
5210470|NCT01023256|17985886|P1|Overall Study|Withdrawal by Subject|0
5210471|NCT01023256|17985883|P4|Overall Study|Adverse Event|1
5210472|NCT01023256|17985884|P3|Overall Study|Adverse Event|0
5210473|NCT01023256|17985885|P2|Overall Study|Adverse Event|0
5210474|NCT01023256|17985886|P1|Overall Study|Adverse Event|0
5210475|NCT01023256|17985883|P4|Overall Study|Other|2
5210476|NCT01023256|17985884|P3|Overall Study|Other|0
5210477|NCT01023256|17985885|P2|Overall Study|Other|0
5210478|NCT01023256|17985886|P1|Overall Study|Other|1
5210479|NCT01023256|17985883|P4|Overall Study|Randomized but not treated|0
5210480|NCT01023256|17985884|P3|Overall Study|Randomized but not treated|1
5210481|NCT01023256|17985885|P2|Overall Study|Randomized but not treated|0
5210482|NCT01023256|17985886|P1|Overall Study|Randomized but not treated|1
5210483|NCT01023256|17985883|P4|Overall Study|Protocol Violation|0
5210484|NCT01023256|17985884|P3|Overall Study|Protocol Violation|0
5210485|NCT01023256|17985885|P2|Overall Study|Protocol Violation|3
5210486|NCT01023256|17985886|P1|Overall Study|Protocol Violation|2
5210487|NCT01023217|17985928|P2|Overall Study|Withdrawal by Subject|0
5210488|NCT01023217|17985929|P1|Overall Study|Withdrawal by Subject|1
5210489|NCT01023061|17985967|P1|Overall Study|Withdrawal prior to treatment|2
5210490|NCT01023035|17985976|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
5210491|NCT01023035|17985977|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
5210492|NCT01023035|17985978|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
5210493|NCT01023035|17985976|P3|Follow-up Period (up to Week 72)|Adverse Event|1
5210494|NCT01023035|17985977|P2|Follow-up Period (up to Week 72)|Adverse Event|0
5210495|NCT01023035|17985978|P1|Follow-up Period (up to Week 72)|Adverse Event|2
5210496|NCT01023035|17985976|P3|Treatment Period|Treatment Failure|24
5210497|NCT01023035|17985977|P2|Treatment Period|Treatment Failure|31
5210498|NCT01023035|17985978|P1|Treatment Period|Treatment Failure|26
5210499|NCT01023035|17985976|P3|Treatment Period|Non-Medical Reasons|44
5210500|NCT01023035|17985977|P2|Treatment Period|Non-Medical Reasons|22
5210501|NCT01023035|17985978|P1|Treatment Period|Non-Medical Reasons|19
5210502|NCT01023035|17985976|P3|Treatment Period|Adverse Event|50
5210503|NCT01023035|17985977|P2|Treatment Period|Adverse Event|32
5210504|NCT01023035|17985978|P1|Treatment Period|Adverse Event|27
5210505|NCT01023022|17985988|P1|Overall Study|due to technical issues|2
5210506|NCT01023022|17985988|P1|Overall Study|Lost to Follow-up|7
5210507|NCT01023022|17985988|P1|Overall Study|Death|5
5210508|NCT01022996|17985994|P1|Overall Study|Protocol Violation|1
5210509|NCT01022996|17985994|P1|Overall Study|Disease Progression|32
5210510|NCT01022996|17985994|P1|Overall Study|Administrative problems|6
5210511|NCT01022996|17985994|P1|Overall Study|Lost to Follow-up|1
5210512|NCT01022996|17985994|P1|Overall Study|Withdrawal by Subject|3
5210513|NCT01022996|17985994|P1|Overall Study|Adverse Event|14
5210514|NCT01022853|17986008|P5|Overall Study|Other not stated above|0
5210515|NCT01022853|17986009|P4|Overall Study|Other not stated above|0
5210516|NCT01022853|17986010|P3|Overall Study|Other not stated above|1
5210517|NCT01022853|17986011|P2|Overall Study|Other not stated above|0
5210518|NCT01022853|17986012|P1|Overall Study|Other not stated above|1
5210519|NCT01022853|17986008|P5|Overall Study|Withdrawal by Subject|0
5210520|NCT01022853|17986009|P4|Overall Study|Withdrawal by Subject|1
5210521|NCT01022853|17986010|P3|Overall Study|Withdrawal by Subject|1
5210522|NCT01022853|17986011|P2|Overall Study|Withdrawal by Subject|1
5210523|NCT01022853|17986012|P1|Overall Study|Withdrawal by Subject|0
5210524|NCT01022853|17986008|P5|Overall Study|Dose-limiting toxicity|1
5210525|NCT01022853|17986009|P4|Overall Study|Dose-limiting toxicity|0
5210526|NCT01022853|17986010|P3|Overall Study|Dose-limiting toxicity|0
5210527|NCT01022853|17986011|P2|Overall Study|Dose-limiting toxicity|0
5210528|NCT01022853|17986012|P1|Overall Study|Dose-limiting toxicity|0
5210529|NCT01022853|17986008|P5|Overall Study|Progressive disease|1
5210530|NCT01022853|17986009|P4|Overall Study|Progressive disease|7
5210531|NCT01022853|17986010|P3|Overall Study|Progressive disease|11
5210532|NCT01022853|17986011|P2|Overall Study|Progressive disease|3
5210533|NCT01022853|17986012|P1|Overall Study|Progressive disease|2
5210534|NCT01022762|17986091|P2|Overall Study|Unclassified|20
5210535|NCT01022762|17986092|P1|Overall Study|Unclassified|12
5210536|NCT01022762|17986091|P2|Overall Study|Protocol Violation|6
5210537|NCT01022762|17986092|P1|Overall Study|Protocol Violation|7
5210538|NCT01022762|17986091|P2|Overall Study|Lack of Efficacy|1
5210539|NCT01022762|17986092|P1|Overall Study|Lack of Efficacy|0
5210540|NCT01022762|17986091|P2|Overall Study|Adverse Event|1
5210541|NCT01022762|17986092|P1|Overall Study|Adverse Event|3
5210542|NCT01022502|17986127|P1|Overall Study|Withdrawal by Subject|1
5210543|NCT01022502|17986127|P1|Overall Study|employment related reasons|1
5210544|NCT01022502|17986127|P1|Overall Study|Adverse Event|1
5210545|NCT01022424|17986141|P1|Overall Study|eGFR under the withdrawal criteria|2
5210546|NCT01022424|17986141|P1|Overall Study|Physician Decision|1
5210547|NCT01022424|17986141|P1|Overall Study|Adverse Event|1
5210548|NCT01022398|17986156|P2|Overall Study|Study terminated|2
5210549|NCT01022398|17986157|P1|Overall Study|Study terminated|2
5210550|NCT01022203|17986182|P2|Follow-Up Assessment|Lost to Follow-up|2
5210551|NCT01022203|17986183|P1|Follow-Up Assessment|Lost to Follow-up|2
5210552|NCT01022203|17986182|P2|Post Treatment Assessment|Adverse Event|2
5210553|NCT01022203|17986183|P1|Post Treatment Assessment|Adverse Event|0
5210554|NCT01022203|17986182|P2|Post Treatment Assessment|Physician Decision|0
5210555|NCT01022203|17986183|P1|Post Treatment Assessment|Physician Decision|2
5210556|NCT01022203|17986182|P2|Post Treatment Assessment|Withdrawal by Subject|12
5210557|NCT01022203|17986183|P1|Post Treatment Assessment|Withdrawal by Subject|12
5210558|NCT01022112|17986202|P5|Overall Study|Fasting plasma glucose level increased|7
5210559|NCT01022112|17986203|P4|Overall Study|Fasting plasma glucose level increased|0
5210560|NCT01022112|17986204|P3|Overall Study|Fasting plasma glucose level increased|0
5210561|NCT01022112|17986205|P2|Overall Study|Fasting plasma glucose level increased|0
5210562|NCT01022112|17986206|P1|Overall Study|Fasting plasma glucose level increased|1
5210563|NCT01022112|17986202|P5|Overall Study|Withdrawal by Subject|1
5210564|NCT01022112|17986203|P4|Overall Study|Withdrawal by Subject|2
5210565|NCT01022112|17986204|P3|Overall Study|Withdrawal by Subject|2
5210566|NCT01022112|17986205|P2|Overall Study|Withdrawal by Subject|1
5210567|NCT01022112|17986206|P1|Overall Study|Withdrawal by Subject|0
5210568|NCT01022112|17986202|P5|Overall Study|Physician Decision|1
5210569|NCT01022112|17986203|P4|Overall Study|Physician Decision|0
5210570|NCT01022112|17986204|P3|Overall Study|Physician Decision|1
5210571|NCT01022112|17986205|P2|Overall Study|Physician Decision|0
5210572|NCT01022112|17986206|P1|Overall Study|Physician Decision|0
5210573|NCT01022112|17986202|P5|Overall Study|Lack of Efficacy|1
5210574|NCT01022112|17986203|P4|Overall Study|Lack of Efficacy|0
5210575|NCT01022112|17986204|P3|Overall Study|Lack of Efficacy|0
5210576|NCT01022112|17986205|P2|Overall Study|Lack of Efficacy|0
5210577|NCT01022112|17986206|P1|Overall Study|Lack of Efficacy|1
5210578|NCT01022112|17986202|P5|Overall Study|Adverse Event|0
5210579|NCT01022112|17986203|P4|Overall Study|Adverse Event|1
5210580|NCT01022112|17986204|P3|Overall Study|Adverse Event|0
5210581|NCT01022112|17986205|P2|Overall Study|Adverse Event|2
5210582|NCT01022112|17986206|P1|Overall Study|Adverse Event|1
5210583|NCT01021878|17986255|P2|Overall Study|Transplantation|1
5210584|NCT01021878|17986256|P1|Overall Study|Transplantation|6
5210585|NCT01021878|17986255|P2|Overall Study|Adverse Event|5
5210586|NCT01021878|17986256|P1|Overall Study|Adverse Event|6
5210587|NCT01021878|17986255|P2|Overall Study|Death|1
5210588|NCT01021878|17986256|P1|Overall Study|Death|0
5210589|NCT01021878|17986255|P2|Overall Study|Lost to Follow-up|3
5210590|NCT01021878|17986256|P1|Overall Study|Lost to Follow-up|4
5210591|NCT01021852|17986278|P8|Treatment Period 2|Withdrawal by Subject|2
5210592|NCT01021852|17986279|P7|Treatment Period 2|Withdrawal by Subject|1
5210593|NCT01021852|17986280|P6|Treatment Period 2|Withdrawal by Subject|0
5210594|NCT01021852|17986281|P5|Treatment Period 2|Withdrawal by Subject|0
5210595|NCT01021852|17986282|P4|Treatment Period 2|Withdrawal by Subject|0
5210596|NCT01021852|17986283|P3|Treatment Period 2|Withdrawal by Subject|0
5210597|NCT01021852|17986284|P2|Treatment Period 2|Withdrawal by Subject|0
5210598|NCT01021852|17986285|P1|Treatment Period 2|Withdrawal by Subject|0
5210599|NCT01021852|17986278|P8|Treatment Period 2|Protocol Violation|0
5210600|NCT01021852|17986279|P7|Treatment Period 2|Protocol Violation|1
5210601|NCT01021852|17986280|P6|Treatment Period 2|Protocol Violation|0
5210602|NCT01021852|17986281|P5|Treatment Period 2|Protocol Violation|1
5210603|NCT01021852|17986282|P4|Treatment Period 2|Protocol Violation|0
5210604|NCT01021852|17986283|P3|Treatment Period 2|Protocol Violation|0
5210605|NCT01021852|17986284|P2|Treatment Period 2|Protocol Violation|0
5210606|NCT01021852|17986285|P1|Treatment Period 2|Protocol Violation|0
5210607|NCT01021852|17986278|P8|Treatment Period 2|Physician Decision|0
5210608|NCT01021852|17986279|P7|Treatment Period 2|Physician Decision|0
5210609|NCT01021852|17986280|P6|Treatment Period 2|Physician Decision|0
5210610|NCT01021852|17986281|P5|Treatment Period 2|Physician Decision|0
5210611|NCT01021852|17986282|P4|Treatment Period 2|Physician Decision|0
5210612|NCT01021852|17986283|P3|Treatment Period 2|Physician Decision|1
5210613|NCT01021852|17986284|P2|Treatment Period 2|Physician Decision|0
5210614|NCT01021852|17986285|P1|Treatment Period 2|Physician Decision|0
5210615|NCT01021852|17986278|P8|Treatment Period 2|Lack of Efficacy|0
5210616|NCT01021852|17986279|P7|Treatment Period 2|Lack of Efficacy|0
5210617|NCT01021852|17986280|P6|Treatment Period 2|Lack of Efficacy|1
5210618|NCT01021852|17986281|P5|Treatment Period 2|Lack of Efficacy|0
5210619|NCT01021852|17986282|P4|Treatment Period 2|Lack of Efficacy|0
5210620|NCT01021852|17986283|P3|Treatment Period 2|Lack of Efficacy|0
5210621|NCT01021852|17986284|P2|Treatment Period 2|Lack of Efficacy|0
5210622|NCT01021852|17986285|P1|Treatment Period 2|Lack of Efficacy|0
5210623|NCT01021852|17986278|P8|Treatment Period 2|Adverse Event|0
5210624|NCT01021852|17986279|P7|Treatment Period 2|Adverse Event|1
5210625|NCT01021852|17986280|P6|Treatment Period 2|Adverse Event|0
5210626|NCT01021852|17986281|P5|Treatment Period 2|Adverse Event|1
5210627|NCT01021852|17986282|P4|Treatment Period 2|Adverse Event|0
5210628|NCT01021852|17986283|P3|Treatment Period 2|Adverse Event|0
5210629|NCT01021852|17986284|P2|Treatment Period 2|Adverse Event|1
5210630|NCT01021852|17986285|P1|Treatment Period 2|Adverse Event|0
5210631|NCT01021852|17986278|P8|Washout Period-No Drug|Adverse Event|0
5210632|NCT01021852|17986279|P7|Washout Period-No Drug|Adverse Event|0
5210633|NCT01021852|17986280|P6|Washout Period-No Drug|Adverse Event|1
5210634|NCT01021852|17986281|P5|Washout Period-No Drug|Adverse Event|0
5210635|NCT01021852|17986282|P4|Washout Period-No Drug|Adverse Event|0
5210636|NCT01021852|17986283|P3|Washout Period-No Drug|Adverse Event|0
5210637|NCT01021852|17986284|P2|Washout Period-No Drug|Adverse Event|0
5210638|NCT01021852|17986285|P1|Washout Period-No Drug|Adverse Event|1
5210639|NCT01021852|17986278|P8|Washout Period-Placebo|Protocol Violation|0
5210640|NCT01021852|17986279|P7|Washout Period-Placebo|Protocol Violation|1
5210641|NCT01021852|17986280|P6|Washout Period-Placebo|Protocol Violation|0
5210642|NCT01021852|17986281|P5|Washout Period-Placebo|Protocol Violation|0
5210643|NCT01021852|17986282|P4|Washout Period-Placebo|Protocol Violation|0
5210644|NCT01021852|17986283|P3|Washout Period-Placebo|Protocol Violation|0
5210645|NCT01021852|17986284|P2|Washout Period-Placebo|Protocol Violation|0
5210646|NCT01021852|17986285|P1|Washout Period-Placebo|Protocol Violation|0
5210647|NCT01021852|17986278|P8|Washout Period-Placebo|Lost to Follow-up|0
5210648|NCT01021852|17986279|P7|Washout Period-Placebo|Lost to Follow-up|0
5210649|NCT01021852|17986280|P6|Washout Period-Placebo|Lost to Follow-up|0
5210650|NCT01021852|17986281|P5|Washout Period-Placebo|Lost to Follow-up|1
5210651|NCT01021852|17986282|P4|Washout Period-Placebo|Lost to Follow-up|0
5210652|NCT01021852|17986283|P3|Washout Period-Placebo|Lost to Follow-up|0
5210653|NCT01021852|17986284|P2|Washout Period-Placebo|Lost to Follow-up|0
5210654|NCT01021852|17986285|P1|Washout Period-Placebo|Lost to Follow-up|0
5210655|NCT01021852|17986278|P8|Washout Period-Placebo|Adverse Event|0
5210656|NCT01021852|17986279|P7|Washout Period-Placebo|Adverse Event|0
5210657|NCT01021852|17986280|P6|Washout Period-Placebo|Adverse Event|1
5210658|NCT01021852|17986281|P5|Washout Period-Placebo|Adverse Event|0
5210659|NCT01021852|17986282|P4|Washout Period-Placebo|Adverse Event|1
5210660|NCT01021852|17986283|P3|Washout Period-Placebo|Adverse Event|0
5210661|NCT01021852|17986284|P2|Washout Period-Placebo|Adverse Event|0
5210662|NCT01021852|17986285|P1|Washout Period-Placebo|Adverse Event|0
5210663|NCT01021852|17986278|P8|Treatment Period 1|Not Treated|0
5210664|NCT01021852|17986279|P7|Treatment Period 1|Not Treated|0
5210665|NCT01021852|17986280|P6|Treatment Period 1|Not Treated|0
5210666|NCT01021852|17986281|P5|Treatment Period 1|Not Treated|0
5210667|NCT01021852|17986282|P4|Treatment Period 1|Not Treated|2
5210668|NCT01021852|17986283|P3|Treatment Period 1|Not Treated|0
5210669|NCT01021852|17986284|P2|Treatment Period 1|Not Treated|0
5210670|NCT01021852|17986285|P1|Treatment Period 1|Not Treated|0
5210671|NCT01021852|17986278|P8|Treatment Period 1|Withdrawal by Subject|1
5210672|NCT01021852|17986279|P7|Treatment Period 1|Withdrawal by Subject|0
5210673|NCT01021852|17986280|P6|Treatment Period 1|Withdrawal by Subject|0
5210674|NCT01021852|17986281|P5|Treatment Period 1|Withdrawal by Subject|1
5210675|NCT01021852|17986282|P4|Treatment Period 1|Withdrawal by Subject|0
5210676|NCT01021852|17986283|P3|Treatment Period 1|Withdrawal by Subject|0
5210677|NCT01021852|17986284|P2|Treatment Period 1|Withdrawal by Subject|0
5210678|NCT01021852|17986285|P1|Treatment Period 1|Withdrawal by Subject|0
5210679|NCT01021852|17986278|P8|Treatment Period 1|Pregnancy|0
5210680|NCT01021852|17986279|P7|Treatment Period 1|Pregnancy|0
5210681|NCT01021852|17986280|P6|Treatment Period 1|Pregnancy|0
5210682|NCT01021852|17986281|P5|Treatment Period 1|Pregnancy|0
5210683|NCT01021852|17986282|P4|Treatment Period 1|Pregnancy|0
5210684|NCT01021852|17986283|P3|Treatment Period 1|Pregnancy|1
5210685|NCT01021852|17986284|P2|Treatment Period 1|Pregnancy|0
5210686|NCT01021852|17986285|P1|Treatment Period 1|Pregnancy|0
5210687|NCT01021852|17986278|P8|Treatment Period 1|Adverse Event|0
5210688|NCT01021852|17986279|P7|Treatment Period 1|Adverse Event|0
5210689|NCT01021852|17986280|P6|Treatment Period 1|Adverse Event|2
5210690|NCT01021852|17986281|P5|Treatment Period 1|Adverse Event|2
5210691|NCT01021852|17986282|P4|Treatment Period 1|Adverse Event|0
5210692|NCT01021852|17986283|P3|Treatment Period 1|Adverse Event|1
5210693|NCT01021852|17986284|P2|Treatment Period 1|Adverse Event|1
5210694|NCT01021852|17986285|P1|Treatment Period 1|Adverse Event|3
5210695|NCT01021813|17986321|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
5210696|NCT01021813|17986322|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
5210697|NCT01021813|17986323|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
5210698|NCT01021813|17986324|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
5210699|NCT01021813|17986325|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
5210700|NCT01021813|17986321|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
5210701|NCT01021813|17986322|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
5210702|NCT01021813|17986323|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
5210703|NCT01021813|17986324|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
5210704|NCT01021813|17986325|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
5210705|NCT01021813|17986321|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
5210706|NCT01021813|17986322|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5210707|NCT01021813|17986323|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5210708|NCT01021813|17986324|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5210709|NCT01021813|17986325|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5210710|NCT01021813|17986321|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5210711|NCT01021813|17986322|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
5210712|NCT01021813|17986323|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5210713|NCT01021813|17986324|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5210714|NCT01021813|17986325|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5210715|NCT01021813|17986321|P5|DB Randomized Discontinuation Phase|Adverse Event|1
5210716|NCT01021813|17986322|P4|DB Randomized Discontinuation Phase|Adverse Event|3
5210717|NCT01021813|17986323|P3|DB Randomized Discontinuation Phase|Adverse Event|0
5210718|NCT01021813|17986324|P2|DB Randomized Discontinuation Phase|Adverse Event|0
5210719|NCT01021813|17986325|P1|DB Randomized Discontinuation Phase|Adverse Event|0
5210720|NCT01021813|17986321|P5|DB Treatment Phase|Withdrawal by Subject|0
5210721|NCT01021813|17986322|P4|DB Treatment Phase|Withdrawal by Subject|0
5210722|NCT01021813|17986323|P3|DB Treatment Phase|Withdrawal by Subject|0
5210723|NCT01021813|17986324|P2|DB Treatment Phase|Withdrawal by Subject|24
5210724|NCT01021813|17986325|P1|DB Treatment Phase|Withdrawal by Subject|60
5210725|NCT01021813|17986321|P5|DB Treatment Phase|Protocol Violation|0
5210726|NCT01021813|17986322|P4|DB Treatment Phase|Protocol Violation|0
5210727|NCT01021813|17986323|P3|DB Treatment Phase|Protocol Violation|0
5210728|NCT01021813|17986324|P2|DB Treatment Phase|Protocol Violation|3
5210729|NCT01021813|17986325|P1|DB Treatment Phase|Protocol Violation|4
5210730|NCT01021813|17986321|P5|DB Treatment Phase|Pregnancy|0
5210731|NCT01021813|17986322|P4|DB Treatment Phase|Pregnancy|0
5210732|NCT01021813|17986323|P3|DB Treatment Phase|Pregnancy|0
5210733|NCT01021813|17986324|P2|DB Treatment Phase|Pregnancy|0
5210734|NCT01021813|17986325|P1|DB Treatment Phase|Pregnancy|1
5210735|NCT01021813|17986321|P5|DB Treatment Phase|Physician Decision|0
5210736|NCT01021813|17986322|P4|DB Treatment Phase|Physician Decision|0
5210737|NCT01021813|17986323|P3|DB Treatment Phase|Physician Decision|0
5210738|NCT01021813|17986324|P2|DB Treatment Phase|Physician Decision|8
5210739|NCT01021813|17986325|P1|DB Treatment Phase|Physician Decision|17
5210740|NCT01021813|17986321|P5|DB Treatment Phase|Lost to Follow-up|0
5210741|NCT01021813|17986322|P4|DB Treatment Phase|Lost to Follow-up|0
5210742|NCT01021813|17986323|P3|DB Treatment Phase|Lost to Follow-up|0
5210743|NCT01021813|17986324|P2|DB Treatment Phase|Lost to Follow-up|12
5210744|NCT01021813|17986325|P1|DB Treatment Phase|Lost to Follow-up|14
5210745|NCT01021813|17986321|P5|DB Treatment Phase|Lack of Efficacy|0
5210746|NCT01021813|17986322|P4|DB Treatment Phase|Lack of Efficacy|0
5210747|NCT01021813|17986323|P3|DB Treatment Phase|Lack of Efficacy|0
5210748|NCT01021813|17986324|P2|DB Treatment Phase|Lack of Efficacy|28
5210749|NCT01021813|17986325|P1|DB Treatment Phase|Lack of Efficacy|44
5210750|NCT01021813|17986321|P5|DB Treatment Phase|Adverse Event|0
5210751|NCT01021813|17986322|P4|DB Treatment Phase|Adverse Event|0
5210752|NCT01021813|17986323|P3|DB Treatment Phase|Adverse Event|0
5210753|NCT01021813|17986324|P2|DB Treatment Phase|Adverse Event|22
5210754|NCT01021813|17986325|P1|DB Treatment Phase|Adverse Event|60
5210755|NCT01021748|17986386|P9|Overall Study|Not Treated|0
5210756|NCT01021748|17986387|P8|Overall Study|Not Treated|0
5210757|NCT01021748|17986388|P7|Overall Study|Not Treated|0
5210758|NCT01021748|17986389|P6|Overall Study|Not Treated|0
5210759|NCT01021748|17986390|P5|Overall Study|Not Treated|0
5210760|NCT01021748|17986391|P4|Overall Study|Not Treated|0
5210761|NCT01021748|17986392|P3|Overall Study|Not Treated|0
5210762|NCT01021748|17986393|P2|Overall Study|Not Treated|1
5210763|NCT01021748|17986394|P1|Overall Study|Not Treated|0
5210764|NCT01021748|17986386|P9|Overall Study|Withdrawal by Subject|1
5210765|NCT01021748|17986387|P8|Overall Study|Withdrawal by Subject|0
5210766|NCT01021748|17986388|P7|Overall Study|Withdrawal by Subject|1
5210767|NCT01021748|17986389|P6|Overall Study|Withdrawal by Subject|0
5210768|NCT01021748|17986390|P5|Overall Study|Withdrawal by Subject|0
5210769|NCT01021748|17986391|P4|Overall Study|Withdrawal by Subject|0
5210770|NCT01021748|17986392|P3|Overall Study|Withdrawal by Subject|0
5210771|NCT01021748|17986393|P2|Overall Study|Withdrawal by Subject|0
5210772|NCT01021748|17986394|P1|Overall Study|Withdrawal by Subject|0
5210773|NCT01021748|17986386|P9|Overall Study|Progressive Disease|6
5210774|NCT01021748|17986387|P8|Overall Study|Progressive Disease|5
5210775|NCT01021748|17986388|P7|Overall Study|Progressive Disease|0
5210776|NCT01021748|17986389|P6|Overall Study|Progressive Disease|3
5210777|NCT01021748|17986390|P5|Overall Study|Progressive Disease|7
5210778|NCT01021748|17986391|P4|Overall Study|Progressive Disease|6
5210779|NCT01021748|17986392|P3|Overall Study|Progressive Disease|4
5210780|NCT01021748|17986393|P2|Overall Study|Progressive Disease|3
5210781|NCT01021748|17986394|P1|Overall Study|Progressive Disease|3
5210782|NCT01021748|17986386|P9|Overall Study|Physician Decision|2
5210783|NCT01021748|17986387|P8|Overall Study|Physician Decision|1
5210784|NCT01021748|17986388|P7|Overall Study|Physician Decision|1
5210785|NCT01021748|17986389|P6|Overall Study|Physician Decision|0
5210786|NCT01021748|17986390|P5|Overall Study|Physician Decision|0
5210787|NCT01021748|17986391|P4|Overall Study|Physician Decision|1
5210788|NCT01021748|17986392|P3|Overall Study|Physician Decision|1
5210789|NCT01021748|17986393|P2|Overall Study|Physician Decision|0
5210790|NCT01021748|17986394|P1|Overall Study|Physician Decision|1
5210791|NCT01021748|17986386|P9|Overall Study|Adverse Event|7
5210792|NCT01021748|17986387|P8|Overall Study|Adverse Event|0
5210793|NCT01021748|17986388|P7|Overall Study|Adverse Event|1
5210794|NCT01021748|17986389|P6|Overall Study|Adverse Event|0
5210795|NCT01021748|17986390|P5|Overall Study|Adverse Event|2
5210796|NCT01021748|17986391|P4|Overall Study|Adverse Event|0
5210797|NCT01021748|17986392|P3|Overall Study|Adverse Event|2
5210798|NCT01021748|17986393|P2|Overall Study|Adverse Event|1
5210799|NCT01021748|17986394|P1|Overall Study|Adverse Event|2
5210800|NCT01021683|17986441|P1|Overall Study|Other|8
5210801|NCT01021683|17986441|P1|Overall Study|Recovery of neutrophil count|51
5210802|NCT01021683|17986441|P1|Overall Study|Lack of Efficacy|12
5210803|NCT01021553|17986467|P3|Overall Study|Withdrawal by Subject|0
5210804|NCT01021553|17986468|P2|Overall Study|Withdrawal by Subject|1
5210805|NCT01021553|17986469|P1|Overall Study|Withdrawal by Subject|1
5210806|NCT01021553|17986467|P3|Overall Study|Lost to Follow-up|1
5210807|NCT01021553|17986468|P2|Overall Study|Lost to Follow-up|0
5210808|NCT01021553|17986469|P1|Overall Study|Lost to Follow-up|0
5210809|NCT01021553|17986467|P3|Overall Study|Protocol Violation|2
5210810|NCT01021553|17986468|P2|Overall Study|Protocol Violation|2
5210811|NCT01021553|17986469|P1|Overall Study|Protocol Violation|0
5210812|NCT01021553|17986467|P3|Overall Study|Lack of Efficacy|0
5210813|NCT01021553|17986468|P2|Overall Study|Lack of Efficacy|2
5210814|NCT01021553|17986469|P1|Overall Study|Lack of Efficacy|2
5210815|NCT01021553|17986467|P3|Overall Study|Adverse Event|0
5210816|NCT01021553|17986468|P2|Overall Study|Adverse Event|0
5210817|NCT01021553|17986469|P1|Overall Study|Adverse Event|1
5210818|NCT01021423|17986523|P2|Overall Study|Study terminated|5
5210819|NCT01021423|17986524|P1|Overall Study|Study terminated|4
5210820|NCT01021332|17986540|P1|Overall Study|Miscellaneous|3
5210821|NCT01021332|17986540|P1|Overall Study|Protocol Violation|9
5210822|NCT01021332|17986540|P1|Overall Study|Lost to Follow-up|4
5210823|NCT01021332|17986540|P1|Overall Study|Withdrawal of Consent|23
5210824|NCT01021332|17986540|P1|Overall Study|Lack of Efficacy|19
5210825|NCT01021332|17986540|P1|Overall Study|Adverse Event|43
5210826|NCT01021332|17986540|P1|Overall Study|Not fulfilling incl./excl.criteria|5
5210827|NCT01021293|17986601|P2|Overall Study|Lost to Follow-up|1
5210828|NCT01021293|17986602|P1|Overall Study|Lost to Follow-up|1
5210829|NCT01021293|17986601|P2|Overall Study|Migrated/moved from study area|18
5210830|NCT01021293|17986602|P1|Overall Study|Migrated/moved from study area|6
5210831|NCT01021293|17986601|P2|Overall Study|Withdrawal by Subject|3
5210832|NCT01021293|17986602|P1|Overall Study|Withdrawal by Subject|1
5210833|NCT01021293|17986601|P2|Overall Study|Adverse Event|1
5210834|NCT01021293|17986602|P1|Overall Study|Adverse Event|2
5210835|NCT01021293|17986601|P2|Overall Study|Serious Adverse Event|1
5210836|NCT01021293|17986602|P1|Overall Study|Serious Adverse Event|2
5210837|NCT01021215|17986621|P2|Overall Study|Lost to Follow-up|0
5210838|NCT01021215|17986622|P1|Overall Study|Lost to Follow-up|3
5210839|NCT01021137|17986636|P4|Overall Study|Withdrawal by Subject|3
5210840|NCT01021137|17986637|P3|Overall Study|Withdrawal by Subject|0
5210841|NCT01021137|17986638|P2|Overall Study|Withdrawal by Subject|0
5210842|NCT01021137|17986639|P1|Overall Study|Withdrawal by Subject|1
5210843|NCT01021137|17986636|P4|Overall Study|Lost to Follow-up|6
5210844|NCT01021137|17986637|P3|Overall Study|Lost to Follow-up|2
5210845|NCT01021137|17986638|P2|Overall Study|Lost to Follow-up|4
5210846|NCT01021137|17986639|P1|Overall Study|Lost to Follow-up|9
5210847|NCT01021020|17986682|P1|14 Day Washout Period A|Physician Decision|1
5210848|NCT01021020|17986682|P1|Period I|Withdrawal by Subject|1
5210849|NCT01021020|17986682|P1|Period I|Protocol Violation|1
5210850|NCT01021007|17986698|P2|Overall Study|Adverse Event|3
5210851|NCT01021007|17986699|P1|Overall Study|Adverse Event|1
5210852|NCT01021007|17986698|P2|Overall Study|Lost to Follow-up|1
5210853|NCT01021007|17986699|P1|Overall Study|Lost to Follow-up|1
5210854|NCT01020981|17986711|P2|Overall Study|Participant declined to complete survey|0
5210855|NCT01020981|17986712|P1|Overall Study|Participant declined to complete survey|2
5210856|NCT01020981|17986711|P2|Overall Study|Survey returned undeliverable|32
5210857|NCT01020981|17986712|P1|Overall Study|Survey returned undeliverable|8
5210858|NCT01020981|17986711|P2|Overall Study|Did not return mailed survey|58
5210859|NCT01020981|17986712|P1|Overall Study|Did not return mailed survey|74
5210860|NCT01020877|17986733|P2|Second Intervention|Withdrawal by Subject|0
5210861|NCT01020877|17986734|P1|Second Intervention|Withdrawal by Subject|1
5210862|NCT01020838|17986744|P1|Overall Study|Most common: Study ended by sponsor|77
5210863|NCT01020838|17986744|P1|Overall Study|Lost to Follow-up|6
5210864|NCT01020838|17986744|P1|Overall Study|Withdrawal by Subject|9
5210865|NCT01020838|17986744|P1|Overall Study|Adverse Event|1
5210866|NCT01020838|17986744|P1|Overall Study|Death|90
5210867|NCT01020812|17986759|P1|Overall Study|Protocol Violation|1
5210868|NCT01020812|17986759|P1|Overall Study|Withdrawal by Subject|1
5210869|NCT01020812|17986759|P1|Overall Study|Physician Decision|1
5210870|NCT01020799|17986769|P3|Overall Study|Lost to Follow-up|2
5210871|NCT01020799|17986770|P2|Overall Study|Lost to Follow-up|4
5210872|NCT01020799|17986771|P1|Overall Study|Lost to Follow-up|6
5210873|NCT01020799|17986769|P3|Overall Study|Withdrawal by Subject|3
5210874|NCT01020799|17986770|P2|Overall Study|Withdrawal by Subject|2
5210875|NCT01020799|17986771|P1|Overall Study|Withdrawal by Subject|2
5210876|NCT01020799|17986769|P3|Overall Study|Protocol Violation|0
5210877|NCT01020799|17986770|P2|Overall Study|Protocol Violation|2
5210878|NCT01020799|17986771|P1|Overall Study|Protocol Violation|3
5210879|NCT01020799|17986769|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
5210880|NCT01020799|17986770|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
5210881|NCT01020799|17986771|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
5210882|NCT01020799|17986769|P3|Overall Study|Adverse Event|2
5210883|NCT01020799|17986770|P2|Overall Study|Adverse Event|3
5210884|NCT01020799|17986771|P1|Overall Study|Adverse Event|4
5210885|NCT01020786|17986794|P1|Maintenance Period|Sponsor Decision|1
5210886|NCT01020786|17986794|P1|Maintenance Period|Withdrawal by Subject|8
5210887|NCT01020786|17986794|P1|Maintenance Period|Progressive Disease|43
5210888|NCT01020786|17986794|P1|Maintenance Period|Adverse Event|8
5210889|NCT01020786|17986794|P1|Induction Period|Withdrawal by Subject|3
5210890|NCT01020786|17986794|P1|Induction Period|Investigator Decision|3
5210891|NCT01020786|17986794|P1|Induction Period|Progressive Disease|31
5210892|NCT01020786|17986794|P1|Induction Period|Adverse Event|10
5210893|NCT01020786|17986794|P1|Induction Period|Entry Criteria Not Met|2
5210894|NCT01020773|17986808|P2|Overall Study|Withdrawal by Subject|3
5210895|NCT01020773|17986809|P1|Overall Study|Withdrawal by Subject|4
5210896|NCT01020747|17986815|P1|Overall Study|Withdrawal by Subject|1
5210897|NCT01020526|17986831|P1|Overall Study|Adverse Event|2
5210898|NCT01020526|17986831|P1|Overall Study|Lost to Follow-up|1
5210899|NCT01020526|17986831|P1|Overall Study|Insufficient clinical response|3
5210900|NCT01020526|17986831|P1|Overall Study|Other reasons|3
5210901|NCT01020526|17986831|P1|Overall Study|Withdrawal by Subject|5
5210902|NCT01020474|17986837|P2|Overall Study|Insufficient Clinical Response|3
5210903|NCT01020474|17986838|P1|Overall Study|Insufficient Clinical Response|0
5210904|NCT01020474|17986837|P2|Overall Study|Other Reasons|1
5210905|NCT01020474|17986838|P1|Overall Study|Other Reasons|1
5210906|NCT01020474|17986837|P2|Overall Study|Withdrawal by Subject|7
5210907|NCT01020474|17986838|P1|Overall Study|Withdrawal by Subject|5
5210908|NCT01020474|17986837|P2|Overall Study|Protocol Violation|2
5210909|NCT01020474|17986838|P1|Overall Study|Protocol Violation|0
5210910|NCT01020474|17986837|P2|Overall Study|Adverse Event|4
5210911|NCT01020474|17986838|P1|Overall Study|Adverse Event|4
5210912|NCT01020448|17986858|P1|Treatment|Lost to Follow-up|2
5210913|NCT01020448|17986858|P1|Treatment|Lack of Efficacy|8
5210914|NCT01020448|17986858|P1|Treatment|Disease Progression|2
5210915|NCT01020448|17986858|P1|Treatment|Consent Withdrawn|3
5210916|NCT01020448|17986858|P1|Treatment|Adverse Event|11
5210917|NCT01020448|17986858|P1|Pre-assignment|Does Not Meet Entry Criteria|2
5210918|NCT01020448|17986858|P1|Pre-assignment|Withdrawal by Subject|5
5210919|NCT01020448|17986858|P1|Pre-assignment|Adverse Event|6
5210920|NCT01020435|17986869|P2|Overall Study|Lost to Follow-up|1
5210921|NCT01020435|17986870|P1|Overall Study|Lost to Follow-up|0
5210922|NCT01020305|17986878|P1|Overall Study|Adverse Event|2
5210923|NCT01020123|17986889|P7|Extention Period|Lost to Follow-up|0
5210924|NCT01020123|17986890|P6|Extention Period|Lost to Follow-up|2
5210925|NCT01020123|17986891|P5|Extention Period|Lost to Follow-up|0
5210926|NCT01020123|17986892|P4|Extention Period|Lost to Follow-up|0
5210927|NCT01020123|17986893|P3|Extention Period|Lost to Follow-up|0
5210928|NCT01020123|17986894|P2|Extention Period|Lost to Follow-up|0
5210929|NCT01020123|17986895|P1|Extention Period|Lost to Follow-up|0
5210930|NCT01020123|17986889|P7|Extention Period|Protocol Violation|1
5210931|NCT01020123|17986890|P6|Extention Period|Protocol Violation|0
5210932|NCT01020123|17986891|P5|Extention Period|Protocol Violation|0
5210933|NCT01020123|17986892|P4|Extention Period|Protocol Violation|0
5210934|NCT01020123|17986893|P3|Extention Period|Protocol Violation|1
5210935|NCT01020123|17986894|P2|Extention Period|Protocol Violation|1
5210936|NCT01020123|17986895|P1|Extention Period|Protocol Violation|1
5210937|NCT01020123|17986889|P7|Extention Period|Adverse Event|0
5210938|NCT01020123|17986890|P6|Extention Period|Adverse Event|0
5210939|NCT01020123|17986891|P5|Extention Period|Adverse Event|0
5210940|NCT01020123|17986892|P4|Extention Period|Adverse Event|1
5210941|NCT01020123|17986893|P3|Extention Period|Adverse Event|0
5210942|NCT01020123|17986894|P2|Extention Period|Adverse Event|0
5210943|NCT01020123|17986895|P1|Extention Period|Adverse Event|0
5210944|NCT01020123|17986889|P7|Extention Period|Withdrawal by Subject|0
5210945|NCT01020123|17986890|P6|Extention Period|Withdrawal by Subject|0
5210946|NCT01020123|17986891|P5|Extention Period|Withdrawal by Subject|0
5210947|NCT01020123|17986892|P4|Extention Period|Withdrawal by Subject|0
5210948|NCT01020123|17986893|P3|Extention Period|Withdrawal by Subject|1
5210949|NCT01020123|17986894|P2|Extention Period|Withdrawal by Subject|1
5210950|NCT01020123|17986895|P1|Extention Period|Withdrawal by Subject|2
5210951|NCT01020123|17986889|P7|Main Period|Unclasified|6
5210952|NCT01020123|17986890|P6|Main Period|Unclasified|3
5210953|NCT01020123|17986891|P5|Main Period|Unclasified|1
5210954|NCT01020123|17986892|P4|Main Period|Unclasified|0
5210955|NCT01020123|17986893|P3|Main Period|Unclasified|1
5210956|NCT01020123|17986894|P2|Main Period|Unclasified|0
5210957|NCT01020123|17986895|P1|Main Period|Unclasified|2
5210958|NCT01020123|17986889|P7|Main Period|Lost to Follow-up|0
5210959|NCT01020123|17986890|P6|Main Period|Lost to Follow-up|0
5210960|NCT01020123|17986891|P5|Main Period|Lost to Follow-up|0
5210961|NCT01020123|17986892|P4|Main Period|Lost to Follow-up|0
5210962|NCT01020123|17986893|P3|Main Period|Lost to Follow-up|0
5210963|NCT01020123|17986894|P2|Main Period|Lost to Follow-up|2
5210964|NCT01020123|17986895|P1|Main Period|Lost to Follow-up|0
5210965|NCT01020123|17986889|P7|Main Period|Protocol Violation|2
5210966|NCT01020123|17986890|P6|Main Period|Protocol Violation|3
5210967|NCT01020123|17986891|P5|Main Period|Protocol Violation|2
5210968|NCT01020123|17986892|P4|Main Period|Protocol Violation|5
5210969|NCT01020123|17986893|P3|Main Period|Protocol Violation|2
5210970|NCT01020123|17986894|P2|Main Period|Protocol Violation|4
5210971|NCT01020123|17986895|P1|Main Period|Protocol Violation|4
5210972|NCT01020123|17986889|P7|Main Period|Adverse Event|1
5210973|NCT01020123|17986890|P6|Main Period|Adverse Event|2
5210974|NCT01020123|17986891|P5|Main Period|Adverse Event|1
5210975|NCT01020123|17986892|P4|Main Period|Adverse Event|1
5210976|NCT01020123|17986893|P3|Main Period|Adverse Event|2
5210977|NCT01020123|17986894|P2|Main Period|Adverse Event|2
5210978|NCT01020123|17986895|P1|Main Period|Adverse Event|5
5210979|NCT01020123|17986889|P7|Main Period|Eligibility Criteria not fullfilled|0
5210980|NCT01020123|17986890|P6|Main Period|Eligibility Criteria not fullfilled|0
5210981|NCT01020123|17986891|P5|Main Period|Eligibility Criteria not fullfilled|1
5210982|NCT01020123|17986892|P4|Main Period|Eligibility Criteria not fullfilled|0
5210983|NCT01020123|17986893|P3|Main Period|Eligibility Criteria not fullfilled|0
5210984|NCT01020123|17986894|P2|Main Period|Eligibility Criteria not fullfilled|1
5210985|NCT01020123|17986895|P1|Main Period|Eligibility Criteria not fullfilled|0
5210986|NCT01020123|17986889|P7|Main Period|Withdrawal by Subject|2
5210987|NCT01020123|17986890|P6|Main Period|Withdrawal by Subject|3
5210988|NCT01020123|17986891|P5|Main Period|Withdrawal by Subject|6
5210989|NCT01020123|17986892|P4|Main Period|Withdrawal by Subject|1
5210990|NCT01020123|17986893|P3|Main Period|Withdrawal by Subject|3
5210991|NCT01020123|17986894|P2|Main Period|Withdrawal by Subject|5
5210992|NCT01020123|17986895|P1|Main Period|Withdrawal by Subject|6
5210993|NCT01020019|17987090|P2|Overall Study|moving|2
5210994|NCT01020019|17987091|P1|Overall Study|moving|0
5210995|NCT01020019|17987090|P2|Overall Study|not interested in treatment|4
5210996|NCT01020019|17987091|P1|Overall Study|not interested in treatment|4
5210997|NCT01020019|17987090|P2|Overall Study|Adverse Event|5
5210998|NCT01020019|17987091|P1|Overall Study|Adverse Event|1
5210999|NCT01020019|17987090|P2|Overall Study|Lost to Follow-up|18
5211000|NCT01020019|17987091|P1|Overall Study|Lost to Follow-up|21
5211001|NCT01019980|17987112|P2|Overall Study|Drug not available.|0
5211002|NCT01019980|17987113|P1|Overall Study|Drug not available.|2
5211003|NCT01019694|17987176|P3|Overall Study|Other reason (not specified)|6
5211004|NCT01019694|17987177|P2|Overall Study|Other reason (not specified)|5
5211005|NCT01019694|17987178|P1|Overall Study|Other reason (not specified)|1
5211006|NCT01019694|17987176|P3|Overall Study|Not treated|3
5211007|NCT01019694|17987177|P2|Overall Study|Not treated|2
5211008|NCT01019694|17987178|P1|Overall Study|Not treated|0
5211009|NCT01019694|17987176|P3|Overall Study|Withdrawal by Subject|12
5211010|NCT01019694|17987177|P2|Overall Study|Withdrawal by Subject|6
5211011|NCT01019694|17987178|P1|Overall Study|Withdrawal by Subject|4
5211012|NCT01019694|17987176|P3|Overall Study|Lost to Follow-up|3
5211013|NCT01019694|17987177|P2|Overall Study|Lost to Follow-up|3
5211014|NCT01019694|17987178|P1|Overall Study|Lost to Follow-up|5
5211015|NCT01019694|17987176|P3|Overall Study|Protocol Violation|4
5211016|NCT01019694|17987177|P2|Overall Study|Protocol Violation|6
5211017|NCT01019694|17987178|P1|Overall Study|Protocol Violation|2
5211018|NCT01019694|17987176|P3|Overall Study|Adverse Event|19
5211019|NCT01019694|17987177|P2|Overall Study|Adverse Event|16
5211020|NCT01019694|17987178|P1|Overall Study|Adverse Event|12
5211021|NCT01019486|17987303|P3|Overall Study|Withdrawal by Subject|1
5211022|NCT01019486|17987304|P2|Overall Study|Withdrawal by Subject|1
5211023|NCT01019486|17987305|P1|Overall Study|Withdrawal by Subject|1
5211024|NCT01019369|17987319|P2|Overall Study|Withdrawal by Subject|1
5211025|NCT01019369|17987320|P1|Overall Study|Withdrawal by Subject|0
5211026|NCT01019369|17987319|P2|Overall Study|Lost to Follow-up|6
5211027|NCT01019369|17987320|P1|Overall Study|Lost to Follow-up|10
5211028|NCT01019317|17987336|P1|Overall Study|Not Eligible|4
5211029|NCT01019252|17987342|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
5211030|NCT01019252|17987343|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
5211031|NCT01019252|17987342|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
5211032|NCT01019252|17987343|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
5211033|NCT01019252|17987342|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
5211034|NCT01019252|17987343|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
5211035|NCT01019252|17987342|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
5211036|NCT01019252|17987343|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
5211037|NCT01019135|17987356|P3|Overall Study|Did not attend CR|6
5211038|NCT01019135|17987357|P2|Overall Study|Did not attend CR|13
5211039|NCT01019135|17987358|P1|Overall Study|Did not attend CR|8
5211040|NCT01019135|17987356|P3|Overall Study|Did not receive allocated intervention|25
5211041|NCT01019135|17987357|P2|Overall Study|Did not receive allocated intervention|6
5211042|NCT01019135|17987358|P1|Overall Study|Did not receive allocated intervention|12
5211043|NCT01018992|17987386|P2|Overall Study|Lost to Follow-up|1
5211044|NCT01018992|17987387|P1|Overall Study|Lost to Follow-up|5
5211045|NCT01018992|17987386|P2|Overall Study|Protocol Violation|4
5211046|NCT01018992|17987387|P1|Overall Study|Protocol Violation|0
5211047|NCT01018992|17987386|P2|Overall Study|Withdrawal by Subject|8
5211048|NCT01018992|17987387|P1|Overall Study|Withdrawal by Subject|3
5211049|NCT01018992|17987386|P2|Overall Study|Adverse Event|3
5211050|NCT01018992|17987387|P1|Overall Study|Adverse Event|8
5211051|NCT01018979|17987401|P2|Overall Study|Not received at least one dose|1
5211052|NCT01018979|17987402|P1|Overall Study|Not received at least one dose|0
5211053|NCT01018979|17987401|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
5211054|NCT01018979|17987402|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
5211055|NCT01018953|17987432|P1|Overall Study|Study termination by sponsor|5
5211056|NCT01018953|17987432|P1|Overall Study|Withdrawal by Subject|1
5211057|NCT01018953|17987432|P1|Overall Study|Adverse Event|2
5211058|NCT01018862|17987445|P3|Overall Study|administrative problems|4
5211059|NCT01018862|17987446|P2|Overall Study|administrative problems|4
5211060|NCT01018862|17987447|P1|Overall Study|administrative problems|5
5211061|NCT01018862|17987445|P3|Overall Study|Withdrawal by Subject|1
5211062|NCT01018862|17987446|P2|Overall Study|Withdrawal by Subject|2
5211063|NCT01018862|17987447|P1|Overall Study|Withdrawal by Subject|1
5211064|NCT01018862|17987445|P3|Overall Study|Protocol Violation|3
5211065|NCT01018862|17987446|P2|Overall Study|Protocol Violation|3
5211066|NCT01018862|17987447|P1|Overall Study|Protocol Violation|1
5211067|NCT01018862|17987445|P3|Overall Study|Lost to Follow-up|0
5211068|NCT01018862|17987446|P2|Overall Study|Lost to Follow-up|1
5211069|NCT01018862|17987447|P1|Overall Study|Lost to Follow-up|3
5211070|NCT01018862|17987445|P3|Overall Study|Lack of Efficacy|2
5211071|NCT01018862|17987446|P2|Overall Study|Lack of Efficacy|0
5211072|NCT01018862|17987447|P1|Overall Study|Lack of Efficacy|1
5211073|NCT01018862|17987445|P3|Overall Study|Adverse Event|6
5211074|NCT01018862|17987446|P2|Overall Study|Adverse Event|0
5211075|NCT01018862|17987447|P1|Overall Study|Adverse Event|2
5211076|NCT01018810|17987469|P5|Overall Study|Sponsor Decision|1
5211077|NCT01018810|17987470|P4|Overall Study|Sponsor Decision|1
5211078|NCT01018810|17987471|P3|Overall Study|Sponsor Decision|1
5211079|NCT01018810|17987472|P2|Overall Study|Sponsor Decision|0
5211080|NCT01018810|17987473|P1|Overall Study|Sponsor Decision|2
5211081|NCT01018810|17987469|P5|Overall Study|Withdrawal by Subject|0
5211082|NCT01018810|17987470|P4|Overall Study|Withdrawal by Subject|0
5211083|NCT01018810|17987471|P3|Overall Study|Withdrawal by Subject|0
5211084|NCT01018810|17987472|P2|Overall Study|Withdrawal by Subject|1
5211085|NCT01018810|17987473|P1|Overall Study|Withdrawal by Subject|0
5211086|NCT01018732|17987533|P3|Overall Study|Unable to Classify|1
5211087|NCT01018732|17987534|P2|Overall Study|Unable to Classify|0
5211088|NCT01018732|17987535|P1|Overall Study|Unable to Classify|0
5211089|NCT01018732|17987533|P3|Overall Study|Inappropriate Enrollment|0
5211090|NCT01018732|17987534|P2|Overall Study|Inappropriate Enrollment|1
5211091|NCT01018732|17987535|P1|Overall Study|Inappropriate Enrollment|0
5211092|NCT01018732|17987533|P3|Overall Study|Protocol Violation|0
5211093|NCT01018732|17987534|P2|Overall Study|Protocol Violation|1
5211094|NCT01018732|17987535|P1|Overall Study|Protocol Violation|1
5211095|NCT01018732|17987533|P3|Overall Study|Lost to Follow-up|3
5211096|NCT01018732|17987534|P2|Overall Study|Lost to Follow-up|0
5211097|NCT01018732|17987535|P1|Overall Study|Lost to Follow-up|0
5211098|NCT01018680|17987569|P2|Overall Study|Physician Decision|1
5211099|NCT01018680|17987570|P1|Overall Study|Physician Decision|3
5211100|NCT01018680|17987569|P2|Overall Study|Entry Criteria Not Met|4
5211101|NCT01018680|17987570|P1|Overall Study|Entry Criteria Not Met|1
5211102|NCT01018680|17987569|P2|Overall Study|Lost to Follow-up|3
5211103|NCT01018680|17987570|P1|Overall Study|Lost to Follow-up|5
5211104|NCT01018680|17987569|P2|Overall Study|Lack of Efficacy|2
5211105|NCT01018680|17987570|P1|Overall Study|Lack of Efficacy|8
5211106|NCT01018680|17987569|P2|Overall Study|Sponsor Decision|7
5211107|NCT01018680|17987570|P1|Overall Study|Sponsor Decision|6
5211108|NCT01018680|17987569|P2|Overall Study|Protocol Violation|8
5211109|NCT01018680|17987570|P1|Overall Study|Protocol Violation|5
5211110|NCT01018680|17987569|P2|Overall Study|Withdrawal by Subject|10
5211111|NCT01018680|17987570|P1|Overall Study|Withdrawal by Subject|10
5211112|NCT01018680|17987569|P2|Overall Study|Adverse Event|40
5211113|NCT01018680|17987570|P1|Overall Study|Adverse Event|23
5211114|NCT01020487|17987613|P3|Part 2 Open-label Period|Adverse Event|1
5211115|NCT01020487|17987614|P2|Part 2 Open-label Period|Adverse Event|4
5211116|NCT01020487|17987615|P1|Part 2 Open-label Period|Adverse Event|0
5211117|NCT01020487|17987613|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
5211118|NCT01020487|17987614|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
5211119|NCT01020487|17987615|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
5211120|NCT01020487|17987613|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
5211121|NCT01020487|17987614|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
5211122|NCT01020487|17987615|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
5211123|NCT01020487|17987613|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
5211124|NCT01020487|17987614|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
5211125|NCT01020487|17987615|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
5211126|NCT01020487|17987613|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
5211127|NCT01020487|17987614|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
5211128|NCT01020487|17987615|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
5211129|NCT01018511|17987640|P4|Overall Study|Miscellaneous|0
5211130|NCT01018511|17987641|P3|Overall Study|Miscellaneous|0
5211131|NCT01018511|17987642|P2|Overall Study|Miscellaneous|2
5211132|NCT01018511|17987643|P1|Overall Study|Miscellaneous|0
5211133|NCT01018511|17987640|P4|Overall Study|Protocol Violation|9
5211134|NCT01018511|17987641|P3|Overall Study|Protocol Violation|7
5211135|NCT01018511|17987642|P2|Overall Study|Protocol Violation|8
5211136|NCT01018511|17987643|P1|Overall Study|Protocol Violation|5
5211137|NCT01018511|17987640|P4|Overall Study|Lost to Follow-up|0
5211138|NCT01018511|17987641|P3|Overall Study|Lost to Follow-up|1
5211139|NCT01018511|17987642|P2|Overall Study|Lost to Follow-up|0
5211140|NCT01018511|17987643|P1|Overall Study|Lost to Follow-up|0
5211141|NCT01018511|17987640|P4|Overall Study|Withdrawal by Subject|9
5211142|NCT01018511|17987641|P3|Overall Study|Withdrawal by Subject|11
5211143|NCT01018511|17987642|P2|Overall Study|Withdrawal by Subject|5
5211144|NCT01018511|17987643|P1|Overall Study|Withdrawal by Subject|6
5211145|NCT01018511|17987640|P4|Overall Study|Lack of Efficacy|2
5211146|NCT01018511|17987641|P3|Overall Study|Lack of Efficacy|1
5211147|NCT01018511|17987642|P2|Overall Study|Lack of Efficacy|1
5211148|NCT01018511|17987643|P1|Overall Study|Lack of Efficacy|4
5211149|NCT01018511|17987640|P4|Overall Study|Adverse Event|10
5211150|NCT01018511|17987641|P3|Overall Study|Adverse Event|13
5211151|NCT01018511|17987642|P2|Overall Study|Adverse Event|9
5211152|NCT01018511|17987643|P1|Overall Study|Adverse Event|5
5211153|NCT01018511|17987640|P4|Overall Study|Not fulfilling eligibility criteria|3
5211154|NCT01018511|17987641|P3|Overall Study|Not fulfilling eligibility criteria|7
5211155|NCT01018511|17987642|P2|Overall Study|Not fulfilling eligibility criteria|7
5211156|NCT01018511|17987643|P1|Overall Study|Not fulfilling eligibility criteria|6
5211157|NCT01018394|17987840|P2|Overall Study|Lost to Follow-up|3
5211158|NCT01018394|17987841|P1|Overall Study|Lost to Follow-up|4
5211159|NCT01018394|17987840|P2|Overall Study|Withdrawal by Subject|5
5211160|NCT01018394|17987841|P1|Overall Study|Withdrawal by Subject|5
5211161|NCT01018264|17987851|P2|Overall Study|Lost to Follow-up|1
5211162|NCT01018264|17987852|P1|Overall Study|Lost to Follow-up|0
5211163|NCT01018264|17987851|P2|Overall Study|Withdrawal by Subject|0
5211164|NCT01018264|17987852|P1|Overall Study|Withdrawal by Subject|1
5211165|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
5211166|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
5211167|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
5211168|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
5211169|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Physician Decision|3
5211170|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Physician Decision|0
5211171|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Physician Decision|1
5211172|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Physician Decision|0
5211173|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
5211174|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
5211175|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
5211176|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
5211177|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
5211178|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
5211179|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
5211180|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
5211181|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Protocol Violation|2
5211182|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Protocol Violation|8
5211183|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Protocol Violation|8
5211184|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Protocol Violation|0
5211185|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
5211186|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
5211187|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
5211188|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
5211189|NCT01018186|17987869|P4|52-week Double-blind Treatment Period|Adverse Event|6
5211190|NCT01018186|17987870|P3|52-week Double-blind Treatment Period|Adverse Event|3
5211191|NCT01018186|17987871|P2|52-week Double-blind Treatment Period|Adverse Event|5
5211192|NCT01018186|17987872|P1|52-week Double-blind Treatment Period|Adverse Event|0
5211193|NCT01018186|17987869|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5211194|NCT01018186|17987870|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5211195|NCT01018186|17987871|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5211196|NCT01018186|17987872|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
5211197|NCT01018186|17987869|P4|2-week Run-in Period|Withdrawal by Subject|0
5211198|NCT01018186|17987870|P3|2-week Run-in Period|Withdrawal by Subject|0
5211199|NCT01018186|17987871|P2|2-week Run-in Period|Withdrawal by Subject|0
5211200|NCT01018186|17987872|P1|2-week Run-in Period|Withdrawal by Subject|11
5211201|NCT01018186|17987869|P4|2-week Run-in Period|Physician Decision|0
5211202|NCT01018186|17987870|P3|2-week Run-in Period|Physician Decision|0
5211203|NCT01018186|17987871|P2|2-week Run-in Period|Physician Decision|0
5211204|NCT01018186|17987872|P1|2-week Run-in Period|Physician Decision|3
5211205|NCT01018186|17987869|P4|2-week Run-in Period|Lost to Follow-up|0
5211206|NCT01018186|17987870|P3|2-week Run-in Period|Lost to Follow-up|0
5211207|NCT01018186|17987871|P2|2-week Run-in Period|Lost to Follow-up|0
5211208|NCT01018186|17987872|P1|2-week Run-in Period|Lost to Follow-up|2
5211209|NCT01018186|17987869|P4|2-week Run-in Period|Protocol Violation|0
5211210|NCT01018186|17987870|P3|2-week Run-in Period|Protocol Violation|0
5211211|NCT01018186|17987871|P2|2-week Run-in Period|Protocol Violation|0
5211212|NCT01018186|17987872|P1|2-week Run-in Period|Protocol Violation|1
5211213|NCT01018030|17988073|P3|Overall Study|Did Not Receive Study Drug|0
5211214|NCT01018030|17988074|P2|Overall Study|Did Not Receive Study Drug|3
5211215|NCT01018030|17988075|P1|Overall Study|Did Not Receive Study Drug|1
5211216|NCT01018030|17988073|P3|Overall Study|Lack of Efficacy|0
5211217|NCT01018030|17988074|P2|Overall Study|Lack of Efficacy|0
5211218|NCT01018030|17988075|P1|Overall Study|Lack of Efficacy|1
5211219|NCT01018030|17988073|P3|Overall Study|Physician Decision|1
5211220|NCT01018030|17988074|P2|Overall Study|Physician Decision|0
5211221|NCT01018030|17988075|P1|Overall Study|Physician Decision|1
5211222|NCT01018030|17988073|P3|Overall Study|Protocol Violation|0
5211223|NCT01018030|17988074|P2|Overall Study|Protocol Violation|1
5211224|NCT01018030|17988075|P1|Overall Study|Protocol Violation|2
5211225|NCT01018030|17988073|P3|Overall Study|Lost to Follow-up|3
5211226|NCT01018030|17988074|P2|Overall Study|Lost to Follow-up|0
5211227|NCT01018030|17988075|P1|Overall Study|Lost to Follow-up|2
5211228|NCT01018030|17988073|P3|Overall Study|Withdrawal by Subject|4
5211229|NCT01018030|17988074|P2|Overall Study|Withdrawal by Subject|2
5211230|NCT01018030|17988075|P1|Overall Study|Withdrawal by Subject|2
5211231|NCT01018030|17988073|P3|Overall Study|Adverse Event|5
5211232|NCT01018030|17988074|P2|Overall Study|Adverse Event|5
5211233|NCT01018030|17988075|P1|Overall Study|Adverse Event|10
5211234|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Physician Decision|7
5211235|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Physician Decision|9
5211236|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Physician Decision|8
5211237|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Physician Decision|10
5211238|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Physician Decision|0
5211239|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
5211240|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5211241|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
5211242|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5211243|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
5211244|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5211245|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5211246|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5211247|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5211248|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5211249|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
5211250|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
5211251|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5211252|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
5211253|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5211254|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
5211255|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
5211256|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
5211257|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
5211258|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
5211259|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
5211260|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
5211261|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
5211262|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
5211263|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
5211264|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
5211265|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
5211266|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
5211267|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
5211268|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
5211269|NCT01017952|17988126|P5|52-week, Double-blind Treatment Period|Adverse Event|30
5211270|NCT01017952|17988127|P4|52-week, Double-blind Treatment Period|Adverse Event|35
5211271|NCT01017952|17988128|P3|52-week, Double-blind Treatment Period|Adverse Event|32
5211272|NCT01017952|17988129|P2|52-week, Double-blind Treatment Period|Adverse Event|25
5211273|NCT01017952|17988130|P1|52-week, Double-blind Treatment Period|Adverse Event|0
5211274|NCT01017952|17988126|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5211275|NCT01017952|17988127|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5211276|NCT01017952|17988128|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5211277|NCT01017952|17988129|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5211278|NCT01017952|17988130|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
5211279|NCT01017952|17988126|P5|4-week, Open-label Run-In Period|Physician Decision|0
5211280|NCT01017952|17988127|P4|4-week, Open-label Run-In Period|Physician Decision|0
5211281|NCT01017952|17988128|P3|4-week, Open-label Run-In Period|Physician Decision|0
5211282|NCT01017952|17988129|P2|4-week, Open-label Run-In Period|Physician Decision|0
5211283|NCT01017952|17988130|P1|4-week, Open-label Run-In Period|Physician Decision|10
5211284|NCT01017952|17988126|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
5211285|NCT01017952|17988127|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
5211286|NCT01017952|17988128|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
5211287|NCT01017952|17988129|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
5211288|NCT01017952|17988130|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
5211289|NCT01017952|17988126|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5211290|NCT01017952|17988127|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5211291|NCT01017952|17988128|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5211292|NCT01017952|17988129|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5211293|NCT01017952|17988130|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
5211294|NCT01017952|17988126|P5|4-week, Open-label Run-In Period|Adverse Event|0
5211295|NCT01017952|17988127|P4|4-week, Open-label Run-In Period|Adverse Event|0
5211296|NCT01017952|17988128|P3|4-week, Open-label Run-In Period|Adverse Event|0
5211297|NCT01017952|17988129|P2|4-week, Open-label Run-In Period|Adverse Event|0
5211298|NCT01017952|17988130|P1|4-week, Open-label Run-In Period|Adverse Event|23
5211299|NCT01017952|17988126|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5211300|NCT01017952|17988127|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5211301|NCT01017952|17988128|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5211302|NCT01017952|17988129|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5211303|NCT01017952|17988130|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
5211304|NCT01017874|17988154|P2|Overall Study|Physician Decision|3
5211305|NCT01017874|17988155|P1|Overall Study|Physician Decision|1
5211306|NCT01017874|17988154|P2|Overall Study|Lost to Follow-up|2
5211307|NCT01017874|17988155|P1|Overall Study|Lost to Follow-up|3
5211308|NCT01017874|17988154|P2|Overall Study|Sponsor decision|1
5211309|NCT01017874|17988155|P1|Overall Study|Sponsor decision|3
5211310|NCT01017874|17988154|P2|Overall Study|Withdrawal by Subject|20
5211311|NCT01017874|17988155|P1|Overall Study|Withdrawal by Subject|23
5211312|NCT01017731|17988173|P1|Overall Study|Adverse Event|1
5211313|NCT01017731|17988173|P1|Overall Study|Physician Decision|2
5211314|NCT01017731|17988173|P1|Overall Study|Withdrawal by Subject|3
5211315|NCT01017731|17988173|P1|Overall Study|Lost to Follow-up|2
5211316|NCT01017601|17988202|P2|Overall Study|Withdrawal by Subject|1
5211317|NCT01017601|17988203|P1|Overall Study|Withdrawal by Subject|0
5211318|NCT01017601|17988202|P2|Overall Study|Disease Progression|12
5211319|NCT01017601|17988203|P1|Overall Study|Disease Progression|12
5211320|NCT01017575|17988230|P5|Overall Study|Withdrawal by Subject|0
5211321|NCT01017575|17988231|P4|Overall Study|Withdrawal by Subject|0
5211322|NCT01017575|17988232|P3|Overall Study|Withdrawal by Subject|0
5211323|NCT01017575|17988233|P2|Overall Study|Withdrawal by Subject|0
5211324|NCT01017575|17988234|P1|Overall Study|Withdrawal by Subject|1
5211325|NCT01017575|17988230|P5|Overall Study|Adverse Event|2
5211326|NCT01017575|17988231|P4|Overall Study|Adverse Event|0
5211327|NCT01017575|17988232|P3|Overall Study|Adverse Event|0
5211328|NCT01017575|17988233|P2|Overall Study|Adverse Event|1
5211329|NCT01017575|17988234|P1|Overall Study|Adverse Event|0
5211330|NCT01017575|17988230|P5|Overall Study|Lack of Efficacy|1
5211331|NCT01017575|17988231|P4|Overall Study|Lack of Efficacy|1
5211332|NCT01017575|17988232|P3|Overall Study|Lack of Efficacy|0
5211333|NCT01017575|17988233|P2|Overall Study|Lack of Efficacy|1
5211334|NCT01017575|17988234|P1|Overall Study|Lack of Efficacy|0
5211335|NCT01017549|17988271|P1|5 Year Follow-up|Mastectomy|3
5211336|NCT01017549|17988271|P1|5 Year Follow-up|Lost to Follow-up|9
5211337|NCT01017549|17988271|P1|One-year Follow-up|Withdrawal by Subject|5
5211338|NCT01017549|17988271|P1|One-year Follow-up|Lost to Follow-up|2
5211339|NCT01017549|17988271|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
5211340|NCT01017263|17988302|P1|Overall Study|not eligible|12
5211341|NCT01017146|17988383|P2|Overall Study|Change in Work Situation|0
5211342|NCT01017146|17988384|P1|Overall Study|Change in Work Situation|1
5211343|NCT01017146|17988383|P2|Overall Study|Did Not Meet Eligibility Criteria|2
5211344|NCT01017146|17988384|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5211345|NCT01017146|17988383|P2|Overall Study|Took Excluded Medication|0
5211346|NCT01017146|17988384|P1|Overall Study|Took Excluded Medication|2
5211347|NCT01017146|17988383|P2|Overall Study|Protocol Violation|0
5211348|NCT01017146|17988384|P1|Overall Study|Protocol Violation|2
5211349|NCT01017146|17988383|P2|Overall Study|Pregnancy|1
5211350|NCT01017146|17988384|P1|Overall Study|Pregnancy|2
5211351|NCT01017146|17988383|P2|Overall Study|Relocation|4
5211352|NCT01017146|17988384|P1|Overall Study|Relocation|0
5211353|NCT01017146|17988383|P2|Overall Study|Withdrawal by Subject|16
5211354|NCT01017146|17988384|P1|Overall Study|Withdrawal by Subject|32
5211355|NCT01017146|17988383|P2|Overall Study|Noncompliance with Study Product|1
5211356|NCT01017146|17988384|P1|Overall Study|Noncompliance with Study Product|1
5211357|NCT01017146|17988383|P2|Overall Study|Lost to Follow-up|14
5211358|NCT01017146|17988384|P1|Overall Study|Lost to Follow-up|14
5211359|NCT01017146|17988383|P2|Overall Study|Adverse Event|1
5211360|NCT01017146|17988384|P1|Overall Study|Adverse Event|11
5211361|NCT01017120|17988422|P2|Overall Study|Parent Unable to Provide Transportation|0
5211362|NCT01017120|17988423|P1|Overall Study|Parent Unable to Provide Transportation|1
5211363|NCT01017120|17988422|P2|Overall Study|Protocol Violation|0
5211364|NCT01017120|17988423|P1|Overall Study|Protocol Violation|1
5211365|NCT01017120|17988422|P2|Overall Study|Relocated Out of Town|2
5211366|NCT01017120|17988423|P1|Overall Study|Relocated Out of Town|0
5211367|NCT01017120|17988422|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5211368|NCT01017120|17988423|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5211369|NCT01017120|17988422|P2|Overall Study|Pregnancy|1
5211370|NCT01017120|17988423|P1|Overall Study|Pregnancy|1
5211371|NCT01017120|17988422|P2|Overall Study|Withdrawal by Subject|21
5211372|NCT01017120|17988423|P1|Overall Study|Withdrawal by Subject|39
5211373|NCT01017120|17988422|P2|Overall Study|Lack of Efficacy|0
5211374|NCT01017120|17988423|P1|Overall Study|Lack of Efficacy|1
5211375|NCT01017120|17988422|P2|Overall Study|Lost to Follow-up|11
5211376|NCT01017120|17988423|P1|Overall Study|Lost to Follow-up|13
5211377|NCT01017120|17988422|P2|Overall Study|Adverse Event|0
5211378|NCT01017120|17988423|P1|Overall Study|Adverse Event|9
5211379|NCT01017029|17988484|P2|Overall Study|Death|1
5211380|NCT01017029|17988485|P1|Overall Study|Death|3
5211381|NCT01017029|17988484|P2|Overall Study|Administrative problem|1
5211382|NCT01017029|17988485|P1|Overall Study|Administrative problem|0
5211383|NCT01017029|17988484|P2|Overall Study|Lost to Follow-up|0
5211384|NCT01017029|17988485|P1|Overall Study|Lost to Follow-up|1
5211385|NCT01016977|17988513|P2|Overall Study|Withdrawal by Subject|2
5211386|NCT01016977|17988514|P1|Overall Study|Withdrawal by Subject|2
5211387|NCT01016977|17988513|P2|Overall Study|Lost to Follow-up|0
5211388|NCT01016977|17988514|P1|Overall Study|Lost to Follow-up|1
5211389|NCT01016964|17988550|P2|Overall Study|Lost to Follow-up|3
5211390|NCT01016964|17988551|P1|Overall Study|Lost to Follow-up|3
5211391|NCT01016912|17988567|P5|Follow-up Period|Other reason|0
5211392|NCT01016912|17988568|P4|Follow-up Period|Other reason|1
5211393|NCT01016912|17988569|P3|Follow-up Period|Other reason|1
5211394|NCT01016912|17988570|P2|Follow-up Period|Other reason|0
5211395|NCT01016912|17988571|P1|Follow-up Period|Other reason|0
5211396|NCT01016912|17988567|P5|End of Treatment Period|Completed double-blind period only|0
5211397|NCT01016912|17988568|P4|End of Treatment Period|Completed double-blind period only|0
5211398|NCT01016912|17988569|P3|End of Treatment Period|Completed double-blind period only|0
5211399|NCT01016912|17988570|P2|End of Treatment Period|Completed double-blind period only|1
5211400|NCT01016912|17988571|P1|End of Treatment Period|Completed double-blind period only|0
5211401|NCT01016912|17988567|P5|End of Treatment Period|Adverse Event|0
5211402|NCT01016912|17988568|P4|End of Treatment Period|Adverse Event|0
5211403|NCT01016912|17988569|P3|End of Treatment Period|Adverse Event|1
5211404|NCT01016912|17988570|P2|End of Treatment Period|Adverse Event|1
5211405|NCT01016912|17988571|P1|End of Treatment Period|Adverse Event|0
5211406|NCT01016912|17988567|P5|End of Treatment Period|Lack of Efficacy|4
5211407|NCT01016912|17988568|P4|End of Treatment Period|Lack of Efficacy|4
5211408|NCT01016912|17988569|P3|End of Treatment Period|Lack of Efficacy|0
5211409|NCT01016912|17988570|P2|End of Treatment Period|Lack of Efficacy|1
5211410|NCT01016912|17988571|P1|End of Treatment Period|Lack of Efficacy|0
5211411|NCT01016600|17988750|P4|Overall Study|Did not start treatment|0
5211412|NCT01016600|17988751|P3|Overall Study|Did not start treatment|0
5211413|NCT01016600|17988752|P2|Overall Study|Did not start treatment|0
5211414|NCT01016600|17988753|P1|Overall Study|Did not start treatment|1
5211415|NCT01016262|17988941|P6|Open-Label Phase|Withdrawal of Informed Consent|0
5211416|NCT01016262|17988942|P5|Open-Label Phase|Withdrawal of Informed Consent|1
5211417|NCT01016262|17988943|P4|Open-Label Phase|Withdrawal of Informed Consent|0
5211418|NCT01016262|17988944|P3|Open-Label Phase|Withdrawal of Informed Consent|0
5211419|NCT01016262|17988945|P2|Open-Label Phase|Withdrawal of Informed Consent|0
5211420|NCT01016262|17988946|P1|Open-Label Phase|Withdrawal of Informed Consent|0
5211421|NCT01016262|17988941|P6|Open-Label Phase|Lack of Efficacy|0
5211422|NCT01016262|17988942|P5|Open-Label Phase|Lack of Efficacy|0
5211423|NCT01016262|17988943|P4|Open-Label Phase|Lack of Efficacy|1
5211424|NCT01016262|17988944|P3|Open-Label Phase|Lack of Efficacy|0
5211425|NCT01016262|17988945|P2|Open-Label Phase|Lack of Efficacy|0
5211426|NCT01016262|17988946|P1|Open-Label Phase|Lack of Efficacy|0
5211427|NCT01016262|17988941|P6|Open-Label Phase|Lost to Follow-up|0
5211428|NCT01016262|17988942|P5|Open-Label Phase|Lost to Follow-up|1
5211429|NCT01016262|17988943|P4|Open-Label Phase|Lost to Follow-up|0
5211430|NCT01016262|17988944|P3|Open-Label Phase|Lost to Follow-up|0
5211431|NCT01016262|17988945|P2|Open-Label Phase|Lost to Follow-up|0
5211432|NCT01016262|17988946|P1|Open-Label Phase|Lost to Follow-up|0
5211433|NCT01016262|17988941|P6|Open-Label Phase|Adverse Event|0
5211434|NCT01016262|17988942|P5|Open-Label Phase|Adverse Event|0
5211435|NCT01016262|17988943|P4|Open-Label Phase|Adverse Event|1
5211436|NCT01016262|17988944|P3|Open-Label Phase|Adverse Event|0
5211437|NCT01016262|17988945|P2|Open-Label Phase|Adverse Event|0
5211438|NCT01016262|17988946|P1|Open-Label Phase|Adverse Event|0
5211439|NCT01016262|17988941|P6|Double-blind Phase|Withdrawal of Informed Consent|0
5211440|NCT01016262|17988942|P5|Double-blind Phase|Withdrawal of Informed Consent|0
5211441|NCT01016262|17988943|P4|Double-blind Phase|Withdrawal of Informed Consent|0
5211442|NCT01016262|17988944|P3|Double-blind Phase|Withdrawal of Informed Consent|1
5211443|NCT01016262|17988945|P2|Double-blind Phase|Withdrawal of Informed Consent|0
5211444|NCT01016262|17988946|P1|Double-blind Phase|Withdrawal of Informed Consent|0
5211445|NCT01016262|17988941|P6|Double-blind Phase|Disease Progression|0
5211446|NCT01016262|17988942|P5|Double-blind Phase|Disease Progression|0
5211447|NCT01016262|17988943|P4|Double-blind Phase|Disease Progression|0
5211448|NCT01016262|17988944|P3|Double-blind Phase|Disease Progression|2
5211449|NCT01016262|17988945|P2|Double-blind Phase|Disease Progression|1
5211450|NCT01016262|17988946|P1|Double-blind Phase|Disease Progression|0
5211451|NCT01016262|17988941|P6|Double-blind Phase|Lack of Efficacy|0
5211452|NCT01016262|17988942|P5|Double-blind Phase|Lack of Efficacy|0
5211453|NCT01016262|17988943|P4|Double-blind Phase|Lack of Efficacy|0
5211454|NCT01016262|17988944|P3|Double-blind Phase|Lack of Efficacy|5
5211455|NCT01016262|17988945|P2|Double-blind Phase|Lack of Efficacy|0
5211456|NCT01016262|17988946|P1|Double-blind Phase|Lack of Efficacy|1
5211457|NCT01016262|17988941|P6|Double-blind Phase|Adverse Event|0
5211458|NCT01016262|17988942|P5|Double-blind Phase|Adverse Event|0
5211459|NCT01016262|17988943|P4|Double-blind Phase|Adverse Event|0
5211460|NCT01016262|17988944|P3|Double-blind Phase|Adverse Event|1
5211461|NCT01016262|17988945|P2|Double-blind Phase|Adverse Event|0
5211462|NCT01016262|17988946|P1|Double-blind Phase|Adverse Event|0
5211463|NCT01016132|17988969|P1|Overall Study|Discomfort|1
5211464|NCT01016067|17988984|P2|Overall Study|Withdrew due to Relocation|1
5211465|NCT01016067|17988985|P1|Overall Study|Withdrew due to Relocation|0
5211466|NCT01016067|17988984|P2|Overall Study|Physician Decision|1
5211467|NCT01016067|17988985|P1|Overall Study|Physician Decision|1
5211468|NCT01016067|17988984|P2|Overall Study|Lost to Follow-up|2
5211469|NCT01016067|17988985|P1|Overall Study|Lost to Follow-up|1
5211470|NCT01016015|17989003|P1|Overall Study|Adverse Event|15
5211471|NCT01016015|17989003|P1|Overall Study|Withdrawal by Subject|1
5211472|NCT01016015|17989003|P1|Overall Study|Not Treated|3
5211473|NCT01015833|17989014|P2|Overall Study|Did not start treatment|0
5211474|NCT01015833|17989015|P1|Overall Study|Did not start treatment|1
5211475|NCT01015833|17989014|P2|Overall Study|Motor Vehicle Accidents|0
5211476|NCT01015833|17989015|P1|Overall Study|Motor Vehicle Accidents|1
5211477|NCT01015833|17989014|P2|Overall Study|Other|1
5211478|NCT01015833|17989015|P1|Overall Study|Other|5
5211479|NCT01015833|17989014|P2|Overall Study|Symptomatic deterioration|1
5211480|NCT01015833|17989015|P1|Overall Study|Symptomatic deterioration|0
5211481|NCT01015833|17989014|P2|Overall Study|Physician Decision|0
5211482|NCT01015833|17989015|P1|Overall Study|Physician Decision|2
5211483|NCT01015833|17989014|P2|Overall Study|Adverse Event|1
5211484|NCT01015833|17989015|P1|Overall Study|Adverse Event|0
5211485|NCT01015833|17989014|P2|Overall Study|Withdrawal by Subject|2
5211486|NCT01015833|17989015|P1|Overall Study|Withdrawal by Subject|3
5211487|NCT01015833|17989014|P2|Overall Study|Death|0
5211488|NCT01015833|17989015|P1|Overall Study|Death|1
5211489|NCT01015820|17989031|P2|Overall Study|Suboptimal measurements|0
5211490|NCT01015820|17989032|P1|Overall Study|Suboptimal measurements|1
5211491|NCT01015768|17989062|P2|Overall Study|Some subject data unuseable|4
5211492|NCT01015768|17989063|P1|Overall Study|Some subject data unuseable|4
5211493|NCT01015703|17989078|P5|Overall Study|Protocol Violation|0
5211494|NCT01015703|17989079|P4|Overall Study|Protocol Violation|0
5211495|NCT01015703|17989080|P3|Overall Study|Protocol Violation|0
5211496|NCT01015703|17989081|P2|Overall Study|Protocol Violation|0
5211497|NCT01015703|17989082|P1|Overall Study|Protocol Violation|1
5211498|NCT01015703|17989078|P5|Overall Study|Adverse Event|0
5211499|NCT01015703|17989079|P4|Overall Study|Adverse Event|0
5211500|NCT01015703|17989080|P3|Overall Study|Adverse Event|0
5211501|NCT01015703|17989081|P2|Overall Study|Adverse Event|0
5211502|NCT01015703|17989082|P1|Overall Study|Adverse Event|1
5211503|NCT01015703|17989078|P5|Overall Study|Withdrawal by Subject|0
5211504|NCT01015703|17989079|P4|Overall Study|Withdrawal by Subject|0
5211505|NCT01015703|17989080|P3|Overall Study|Withdrawal by Subject|0
5211506|NCT01015703|17989081|P2|Overall Study|Withdrawal by Subject|1
5211507|NCT01015703|17989082|P1|Overall Study|Withdrawal by Subject|0
5211508|NCT01015677|17989097|P3|Overall Study|Withdrawal by Subject|0
5211509|NCT01015677|17989098|P2|Overall Study|Withdrawal by Subject|1
5211510|NCT01015677|17989099|P1|Overall Study|Withdrawal by Subject|1
5211511|NCT01015677|17989097|P3|Overall Study|Protocol Violation|0
5211512|NCT01015677|17989098|P2|Overall Study|Protocol Violation|1
5211513|NCT01015677|17989099|P1|Overall Study|Protocol Violation|0
5211514|NCT01015677|17989097|P3|Overall Study|Lack of Efficacy|0
5211515|NCT01015677|17989098|P2|Overall Study|Lack of Efficacy|1
5211516|NCT01015677|17989099|P1|Overall Study|Lack of Efficacy|0
5211517|NCT01015677|17989097|P3|Overall Study|Adverse Event|0
5211518|NCT01015677|17989098|P2|Overall Study|Adverse Event|1
5211519|NCT01015677|17989099|P1|Overall Study|Adverse Event|0
5211520|NCT01015638|17989121|P2|Overall Study|Withdrawal by Subject|0
5211521|NCT01015638|17989122|P1|Overall Study|Withdrawal by Subject|1
5211522|NCT01015612|17989150|P1|Overall Study|Withdrawal by Subject|40
5211523|NCT01015612|17989150|P1|Overall Study|Death|113
5211524|NCT01015560|17989181|P1|Overall Study|Withdrawal by Subject|1
5211525|NCT01015560|17989181|P1|Overall Study|Not protocol specified|1
5211526|NCT01015560|17989181|P1|Overall Study|Adverse Event|1
5211527|NCT01015287|17989230|P2|Overall Study|Protocol Violation|1
5211528|NCT01015287|17989231|P1|Overall Study|Protocol Violation|1
5211529|NCT01015287|17989230|P2|Overall Study|Lost to Follow-up|1
5211530|NCT01015287|17989231|P1|Overall Study|Lost to Follow-up|2
5211531|NCT01015287|17989230|P2|Overall Study|Entry Criteria not Met|14
5211532|NCT01015287|17989231|P1|Overall Study|Entry Criteria not Met|11
5211533|NCT01015287|17989230|P2|Overall Study|Withdrawal by Subject|19
5211534|NCT01015287|17989231|P1|Overall Study|Withdrawal by Subject|14
5211535|NCT01015287|17989230|P2|Overall Study|Physician Decision|21
5211536|NCT01015287|17989231|P1|Overall Study|Physician Decision|19
5211537|NCT01015287|17989230|P2|Overall Study|Sponsor Decision|7
5211538|NCT01015287|17989231|P1|Overall Study|Sponsor Decision|3
5211539|NCT01015287|17989230|P2|Overall Study|Adverse Event|0
5211540|NCT01015287|17989231|P1|Overall Study|Adverse Event|1
5211541|NCT01015287|17989230|P2|Overall Study|Death|16
5211542|NCT01015287|17989231|P1|Overall Study|Death|21
5211543|NCT01015131|17989263|P1|Overall Study|Other Protocol Specified Criteria|4
5211544|NCT01015131|17989263|P1|Overall Study|Withdrawal by Subject|2
5211545|NCT01015131|17989263|P1|Overall Study|Protocol Violation|1
5211546|NCT01015131|17989263|P1|Overall Study|Physician Decision|1
5211547|NCT01015118|17989279|P2|Overall Study|Other than stated above|23
5211548|NCT01015118|17989280|P1|Overall Study|Other than stated above|42
5211549|NCT01015118|17989279|P2|Overall Study|Not treated|5
5211550|NCT01015118|17989280|P1|Overall Study|Not treated|9
5211551|NCT01015118|17989279|P2|Overall Study|Progressive disease|229
5211552|NCT01015118|17989280|P1|Overall Study|Progressive disease|364
5211553|NCT01015118|17989279|P2|Overall Study|Worsening or AE of underlying disease|4
5211554|NCT01015118|17989280|P1|Overall Study|Worsening or AE of underlying disease|5
5211555|NCT01015118|17989279|P2|Overall Study|Other Adverse Event (AE)|33
5211556|NCT01015118|17989280|P1|Overall Study|Other Adverse Event (AE)|141
5211557|NCT01015118|17989279|P2|Overall Study|Withdrawal by Subject|27
5211558|NCT01015118|17989280|P1|Overall Study|Withdrawal by Subject|103
5211559|NCT01015118|17989279|P2|Overall Study|Protocol Violation|6
5211560|NCT01015118|17989280|P1|Overall Study|Protocol Violation|5
5211561|NCT01014988|17989308|P6|Overall Study|Withdrawal by Subject|0
5211562|NCT01014988|17989309|P5|Overall Study|Withdrawal by Subject|0
5211563|NCT01014988|17989310|P4|Overall Study|Withdrawal by Subject|0
5211564|NCT01014988|17989311|P3|Overall Study|Withdrawal by Subject|0
5211565|NCT01014988|17989312|P2|Overall Study|Withdrawal by Subject|0
5211566|NCT01014988|17989313|P1|Overall Study|Withdrawal by Subject|1
5211567|NCT01014988|17989308|P6|Overall Study|Physician Decision|0
5211568|NCT01014988|17989309|P5|Overall Study|Physician Decision|0
5211569|NCT01014988|17989310|P4|Overall Study|Physician Decision|0
5211570|NCT01014988|17989311|P3|Overall Study|Physician Decision|0
5211571|NCT01014988|17989312|P2|Overall Study|Physician Decision|0
5211572|NCT01014988|17989313|P1|Overall Study|Physician Decision|1
5211573|NCT01014988|17989308|P6|Overall Study|Lost to Follow-up|0
5211574|NCT01014988|17989309|P5|Overall Study|Lost to Follow-up|0
5211575|NCT01014988|17989310|P4|Overall Study|Lost to Follow-up|0
5211576|NCT01014988|17989311|P3|Overall Study|Lost to Follow-up|1
5211577|NCT01014988|17989312|P2|Overall Study|Lost to Follow-up|0
5211578|NCT01014988|17989313|P1|Overall Study|Lost to Follow-up|1
5211579|NCT01014988|17989308|P6|Overall Study|Adverse Event|3
5211580|NCT01014988|17989309|P5|Overall Study|Adverse Event|1
5211581|NCT01014988|17989310|P4|Overall Study|Adverse Event|0
5211582|NCT01014988|17989311|P3|Overall Study|Adverse Event|1
5211583|NCT01014988|17989312|P2|Overall Study|Adverse Event|0
5211584|NCT01014988|17989313|P1|Overall Study|Adverse Event|20
5211585|NCT01014975|17989485|P3|Overall Study|Lost to Follow-up|1
5211586|NCT01014975|17989486|P2|Overall Study|Lost to Follow-up|0
5211587|NCT01014975|17989487|P1|Overall Study|Lost to Follow-up|0
5211588|NCT01014975|17989485|P3|Overall Study|Death|4
5211589|NCT01014975|17989486|P2|Overall Study|Death|3
5211590|NCT01014975|17989487|P1|Overall Study|Death|3
5211591|NCT01014975|17989485|P3|Overall Study|Withdrawal by Subject|1
5211592|NCT01014975|17989486|P2|Overall Study|Withdrawal by Subject|0
5211593|NCT01014975|17989487|P1|Overall Study|Withdrawal by Subject|1
5211594|NCT01014910|17989992|P2|Overall Study|Withdrawal by Subject|2
5211595|NCT01014910|17989993|P1|Overall Study|Withdrawal by Subject|0
5211596|NCT01014767|17990011|P4|Overall Study|PI left institution, data unavailable|1
5211597|NCT01014767|17990012|P3|Overall Study|PI left institution, data unavailable|4
5211598|NCT01014767|17990013|P2|Overall Study|PI left institution, data unavailable|1
5211599|NCT01014767|17990014|P1|Overall Study|PI left institution, data unavailable|12
5211600|NCT01014689|17990058|P2|Overall Study|Pregnancy|0
5211601|NCT01014689|17990059|P1|Overall Study|Pregnancy|1
5211602|NCT01014689|17990058|P2|Overall Study|Lost to Follow-up|7
5211603|NCT01014689|17990059|P1|Overall Study|Lost to Follow-up|3
5211604|NCT01014689|17990058|P2|Overall Study|Protocol Violation|1
5211605|NCT01014689|17990059|P1|Overall Study|Protocol Violation|1
5211606|NCT01014689|17990058|P2|Overall Study|Withdrawal by Subject|4
5211607|NCT01014689|17990059|P1|Overall Study|Withdrawal by Subject|5
5211608|NCT01014689|17990058|P2|Overall Study|Adverse Event|0
5211609|NCT01014689|17990059|P1|Overall Study|Adverse Event|3
5211610|NCT01014689|17990058|P2|Overall Study|Lack of Efficacy|1
5211611|NCT01014689|17990059|P1|Overall Study|Lack of Efficacy|0
5211612|NCT01014585|17990094|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
5211613|NCT01014585|17990095|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
5211614|NCT01014585|17990096|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
5211615|NCT01014585|17990097|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
5211616|NCT01014585|17990094|P4|Overall Study|Lost to Follow-up|2
5211617|NCT01014585|17990095|P3|Overall Study|Lost to Follow-up|0
5211618|NCT01014585|17990096|P2|Overall Study|Lost to Follow-up|0
5211619|NCT01014585|17990097|P1|Overall Study|Lost to Follow-up|0
5211620|NCT01014585|17990094|P4|Overall Study|Withdrawal by Subject|3
5211621|NCT01014585|17990095|P3|Overall Study|Withdrawal by Subject|1
5211622|NCT01014585|17990096|P2|Overall Study|Withdrawal by Subject|0
5211623|NCT01014585|17990097|P1|Overall Study|Withdrawal by Subject|2
5211624|NCT01014585|17990094|P4|Overall Study|Adverse Event|3
5211625|NCT01014585|17990095|P3|Overall Study|Adverse Event|0
5211626|NCT01014585|17990096|P2|Overall Study|Adverse Event|2
5211627|NCT01014585|17990097|P1|Overall Study|Adverse Event|0
5211628|NCT01014533|17990117|P2|Overall Study|unable to come to appointment|3
5211629|NCT01014533|17990118|P1|Overall Study|unable to come to appointment|0
5211630|NCT01014533|17990117|P2|Overall Study|Withdrawal by Subject|0
5211631|NCT01014533|17990118|P1|Overall Study|Withdrawal by Subject|2
5211632|NCT01014533|17990117|P2|Overall Study|Protocol Violation|2
5211633|NCT01014533|17990118|P1|Overall Study|Protocol Violation|3
5211634|NCT01014442|17990139|P2|Overall Study|Unspecified Reason|1
5211635|NCT01014442|17990140|P1|Overall Study|Unspecified Reason|1
5211636|NCT01014442|17990139|P2|Overall Study|Lack of Compliance|1
5211637|NCT01014442|17990140|P1|Overall Study|Lack of Compliance|0
5211638|NCT01014442|17990139|P2|Overall Study|Protocol Violation|5
5211639|NCT01014442|17990140|P1|Overall Study|Protocol Violation|2
5211640|NCT01014442|17990139|P2|Overall Study|Withdrawal by Subject|4
5211641|NCT01014442|17990140|P1|Overall Study|Withdrawal by Subject|4
5211642|NCT01014442|17990139|P2|Overall Study|Adverse Event|8
5211643|NCT01014442|17990140|P1|Overall Study|Adverse Event|0
5211644|NCT01014208|17990264|P2|Overall Study|Study Closed/terminated|83
5211645|NCT01014208|17990265|P1|Overall Study|Study Closed/terminated|78
5211646|NCT01014208|17990264|P2|Overall Study|Did Not Receive Study Drug|0
5211647|NCT01014208|17990265|P1|Overall Study|Did Not Receive Study Drug|2
5211648|NCT01014208|17990264|P2|Overall Study|Participant Withdrew Consent|12
5211649|NCT01014208|17990265|P1|Overall Study|Participant Withdrew Consent|12
5211650|NCT01014208|17990264|P2|Overall Study|Lost to Follow-up|5
5211651|NCT01014208|17990265|P1|Overall Study|Lost to Follow-up|2
5211652|NCT01014143|17990307|P3|Second Intervention|Lost to Follow-up|0
5211653|NCT01014143|17990308|P2|Second Intervention|Lost to Follow-up|0
5211654|NCT01014143|17990309|P1|Second Intervention|Lost to Follow-up|2
5211655|NCT01014013|17990404|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
5211656|NCT01014013|17990405|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
5211657|NCT01014013|17990404|P2|Overall Study|Appendectomy|0
5211658|NCT01014013|17990405|P1|Overall Study|Appendectomy|1
5211659|NCT01014013|17990404|P2|Overall Study|Another antibiotic therapy required|1
5211660|NCT01014013|17990405|P1|Overall Study|Another antibiotic therapy required|0
5211661|NCT01014013|17990404|P2|Overall Study|Physician Decision|1
5211662|NCT01014013|17990405|P1|Overall Study|Physician Decision|0
5211663|NCT01014013|17990404|P2|Overall Study|Pathogen resistant|4
5211664|NCT01014013|17990405|P1|Overall Study|Pathogen resistant|7
5211665|NCT01014013|17990404|P2|Overall Study|Negative urine culture|0
5211666|NCT01014013|17990405|P1|Overall Study|Negative urine culture|2
5211667|NCT01014013|17990404|P2|Overall Study|Pathogen culture = no growth|34
5211668|NCT01014013|17990405|P1|Overall Study|Pathogen culture = no growth|26
5211669|NCT01014013|17990404|P2|Overall Study|Clinical/microbiologic failure|2
5211670|NCT01014013|17990405|P1|Overall Study|Clinical/microbiologic failure|1
5211671|NCT01014013|17990404|P2|Overall Study|Withdrawal by Subject|4
5211672|NCT01014013|17990405|P1|Overall Study|Withdrawal by Subject|7
5211673|NCT01014013|17990404|P2|Overall Study|Protocol Violation|3
5211674|NCT01014013|17990405|P1|Overall Study|Protocol Violation|1
5211675|NCT01014013|17990404|P2|Overall Study|Laboratory adverse experience|1
5211676|NCT01014013|17990405|P1|Overall Study|Laboratory adverse experience|1
5211677|NCT01014013|17990404|P2|Overall Study|Clinical adverse experience|2
5211678|NCT01014013|17990405|P1|Overall Study|Clinical adverse experience|4
5211679|NCT01014013|17990404|P2|Overall Study|Inclusion/Exclusion criteria not met|3
5211680|NCT01014013|17990405|P1|Overall Study|Inclusion/Exclusion criteria not met|1
5211681|NCT01013961|17990417|P2|Overall Study|Physician Decision|1
5211682|NCT01013961|17990418|P1|Overall Study|Physician Decision|0
5211683|NCT01013961|17990417|P2|Overall Study|Withdrawal by Subject|0
5211684|NCT01013961|17990418|P1|Overall Study|Withdrawal by Subject|1
5211685|NCT01013961|17990417|P2|Overall Study|Adverse Event|2
5211686|NCT01013961|17990418|P1|Overall Study|Adverse Event|2
5211687|NCT01013883|17990436|P2|Overall Study|Lost to Follow-up|2
5211688|NCT01013883|17990437|P1|Overall Study|Lost to Follow-up|2
5211689|NCT01013870|17990449|P2|Overall Study|Lost to Follow-up|3
5211690|NCT01013870|17990450|P1|Overall Study|Lost to Follow-up|1
5211691|NCT01013792|17990499|P2|Overall Study|Lost to Follow-up|1
5211692|NCT01013792|17990500|P1|Overall Study|Lost to Follow-up|0
5211693|NCT01013792|17990499|P2|Overall Study|Adverse Event|3
5211694|NCT01013792|17990500|P1|Overall Study|Adverse Event|0
5211695|NCT01013792|17990499|P2|Overall Study|Study suspended|1
5211696|NCT01013792|17990500|P1|Overall Study|Study suspended|2
5211697|NCT01013753|17990506|P1|Overall Study|Other|2
5211698|NCT01013753|17990506|P1|Overall Study|Withdrawal by Subject|2
5211699|NCT01013753|17990506|P1|Overall Study|Lost to Follow-up|1
5211700|NCT01013753|17990506|P1|Overall Study|Protocol Violation|3
5211701|NCT01013753|17990506|P1|Overall Study|Adverse Event|8
5211702|NCT01013740|17990702|P2|Overall Study|Ongoing: Study records not completed|2
5211703|NCT01013740|17990703|P1|Overall Study|Ongoing: Study records not completed|0
5211704|NCT01013740|17990702|P2|Overall Study|Missing|1
5211705|NCT01013740|17990703|P1|Overall Study|Missing|2
5211706|NCT01013740|17990702|P2|Overall Study|study close / terminated : done in error|1
5211707|NCT01013740|17990703|P1|Overall Study|study close / terminated : done in error|2
5211708|NCT01013740|17990702|P2|Overall Study|Withdrawal by Subject|10
5211709|NCT01013740|17990703|P1|Overall Study|Withdrawal by Subject|2
5211710|NCT01013740|17990702|P2|Overall Study|Physician Decision|0
5211711|NCT01013740|17990703|P1|Overall Study|Physician Decision|2
5211712|NCT01013740|17990702|P2|Overall Study|Lost to Follow-up|5
5211713|NCT01013740|17990703|P1|Overall Study|Lost to Follow-up|3
5211714|NCT01013701|17990727|P1|Overall Study|study prematurely terminated|7
5211715|NCT01013597|17990734|P1|Overall Study|Withdrawal by Subject|1
5211716|NCT01013350|17990746|P2|Overall Study|Other|25
5211717|NCT01013350|17990747|P1|Overall Study|Other|1
5211718|NCT01013350|17990746|P2|Overall Study|Participant entered interventional study|8
5211719|NCT01013350|17990747|P1|Overall Study|Participant entered interventional study|0
5211720|NCT01013350|17990746|P2|Overall Study|Death|5
5211721|NCT01013350|17990747|P1|Overall Study|Death|3
5211722|NCT01013350|17990746|P2|Overall Study|Withdrawal by Subject|38
5211723|NCT01013350|17990747|P1|Overall Study|Withdrawal by Subject|15
5211724|NCT01013350|17990746|P2|Overall Study|Physician Decision|20
5211725|NCT01013350|17990747|P1|Overall Study|Physician Decision|4
5211726|NCT01013350|17990746|P2|Overall Study|Adverse Event|1
5211727|NCT01013350|17990747|P1|Overall Study|Adverse Event|0
5211728|NCT01013350|17990746|P2|Overall Study|Lost to Follow-up|95
5211729|NCT01013350|17990747|P1|Overall Study|Lost to Follow-up|15
5211730|NCT01013285|17990760|P2|Overall Study|Death|89
5211731|NCT01013285|17990761|P1|Overall Study|Death|48
5211732|NCT01013207|17990774|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
5211733|NCT01012999|17990792|P1|Overall Study|Protocol Violation|1
5211734|NCT01012973|17990798|P2|Overall Study|Withdrawal by Subject|6
5211735|NCT01012973|17990799|P1|Overall Study|Withdrawal by Subject|4
5211736|NCT01012973|17990798|P2|Overall Study|Protocol Violation|2
5211737|NCT01012973|17990799|P1|Overall Study|Protocol Violation|5
5211738|NCT01012973|17990798|P2|Overall Study|Increase in vis. acuity, never injected|1
5211739|NCT01012973|17990799|P1|Overall Study|Increase in vis. acuity, never injected|0
5211740|NCT01012973|17990798|P2|Overall Study|(Overseas travel - indefinite period)|0
5211741|NCT01012973|17990799|P1|Overall Study|(Overseas travel - indefinite period)|1
5211742|NCT01012973|17990798|P2|Overall Study|Lost to Follow-up|0
5211743|NCT01012973|17990799|P1|Overall Study|Lost to Follow-up|1
5211744|NCT01012973|17990798|P2|Overall Study|Lack of Efficacy|5
5211745|NCT01012973|17990799|P1|Overall Study|Lack of Efficacy|0
5211746|NCT01012973|17990798|P2|Overall Study|Adverse Event|5
5211747|NCT01012973|17990799|P1|Overall Study|Adverse Event|5
5211748|NCT01012947|17990824|P5|Overall Study|Lost to Follow-up|142
5211749|NCT01012947|17990825|P4|Overall Study|Lost to Follow-up|118
5211750|NCT01012947|17990826|P3|Overall Study|Lost to Follow-up|130
5211751|NCT01012947|17990827|P2|Overall Study|Lost to Follow-up|135
5211752|NCT01012947|17990828|P1|Overall Study|Lost to Follow-up|131
5211753|NCT01012765|17990849|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
5211754|NCT01012765|17990850|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
5211755|NCT01012765|17990851|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
5211756|NCT01012765|17990852|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
5211757|NCT01012765|17990853|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
5211758|NCT01012765|17990854|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
5211759|NCT01012765|17990849|P6|Treatment Period 2|Adverse Event|0
5211760|NCT01012765|17990850|P5|Treatment Period 2|Adverse Event|0
5211761|NCT01012765|17990851|P4|Treatment Period 2|Adverse Event|0
5211762|NCT01012765|17990852|P3|Treatment Period 2|Adverse Event|1
5211763|NCT01012765|17990853|P2|Treatment Period 2|Adverse Event|1
5211764|NCT01012765|17990854|P1|Treatment Period 2|Adverse Event|0
5211765|NCT01012765|17990849|P6|Treatment Period 2|Abnormal laboratory value(s)|1
5211766|NCT01012765|17990850|P5|Treatment Period 2|Abnormal laboratory value(s)|0
5211767|NCT01012765|17990851|P4|Treatment Period 2|Abnormal laboratory value(s)|0
5211768|NCT01012765|17990852|P3|Treatment Period 2|Abnormal laboratory value(s)|0
5211769|NCT01012765|17990853|P2|Treatment Period 2|Abnormal laboratory value(s)|0
5211770|NCT01012765|17990854|P1|Treatment Period 2|Abnormal laboratory value(s)|0
5211771|NCT01012765|17990849|P6|Treatment Period 2|Withdrawal by Subject|0
5211772|NCT01012765|17990850|P5|Treatment Period 2|Withdrawal by Subject|1
5211773|NCT01012765|17990851|P4|Treatment Period 2|Withdrawal by Subject|0
5211774|NCT01012765|17990852|P3|Treatment Period 2|Withdrawal by Subject|1
5211775|NCT01012765|17990853|P2|Treatment Period 2|Withdrawal by Subject|0
5211776|NCT01012765|17990854|P1|Treatment Period 2|Withdrawal by Subject|1
5211777|NCT01012765|17990849|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
5211778|NCT01012765|17990850|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
5211779|NCT01012765|17990851|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
5211780|NCT01012765|17990852|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
5211781|NCT01012765|17990853|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
5211782|NCT01012765|17990854|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
5211783|NCT01012765|17990849|P6|Treatment Period 1|Protocol Violation|0
5211784|NCT01012765|17990850|P5|Treatment Period 1|Protocol Violation|1
5211785|NCT01012765|17990851|P4|Treatment Period 1|Protocol Violation|2
5211786|NCT01012765|17990852|P3|Treatment Period 1|Protocol Violation|0
5211787|NCT01012765|17990853|P2|Treatment Period 1|Protocol Violation|0
5211788|NCT01012765|17990854|P1|Treatment Period 1|Protocol Violation|0
5211789|NCT01012765|17990849|P6|Treatment Period 1|Administrative problems|0
5211790|NCT01012765|17990850|P5|Treatment Period 1|Administrative problems|1
5211791|NCT01012765|17990851|P4|Treatment Period 1|Administrative problems|1
5211792|NCT01012765|17990852|P3|Treatment Period 1|Administrative problems|1
5211793|NCT01012765|17990853|P2|Treatment Period 1|Administrative problems|0
5211794|NCT01012765|17990854|P1|Treatment Period 1|Administrative problems|0
5211795|NCT01012765|17990849|P6|Treatment Period 1|Withdrawal by Subject|0
5211796|NCT01012765|17990850|P5|Treatment Period 1|Withdrawal by Subject|0
5211797|NCT01012765|17990851|P4|Treatment Period 1|Withdrawal by Subject|0
5211798|NCT01012765|17990852|P3|Treatment Period 1|Withdrawal by Subject|0
5211799|NCT01012765|17990853|P2|Treatment Period 1|Withdrawal by Subject|0
5211800|NCT01012765|17990854|P1|Treatment Period 1|Withdrawal by Subject|2
5211801|NCT01012765|17990849|P6|Treatment Period 1|Adverse Event|0
5211802|NCT01012765|17990850|P5|Treatment Period 1|Adverse Event|0
5211803|NCT01012765|17990851|P4|Treatment Period 1|Adverse Event|0
5211804|NCT01012765|17990852|P3|Treatment Period 1|Adverse Event|1
5211805|NCT01012765|17990853|P2|Treatment Period 1|Adverse Event|0
5211806|NCT01012765|17990854|P1|Treatment Period 1|Adverse Event|1
5211807|NCT01012739|17990883|P4|Treatment Period 2|Abnormal test procedure results|1
5211808|NCT01012739|17990884|P3|Treatment Period 2|Abnormal test procedure results|0
5211809|NCT01012739|17990885|P2|Treatment Period 2|Abnormal test procedure results|0
5211810|NCT01012739|17990886|P1|Treatment Period 2|Abnormal test procedure results|0
5211811|NCT01012739|17990883|P4|Treatment Period 1|Adverse Event|1
5211812|NCT01012739|17990884|P3|Treatment Period 1|Adverse Event|0
5211813|NCT01012739|17990885|P2|Treatment Period 1|Adverse Event|0
5211814|NCT01012739|17990886|P1|Treatment Period 1|Adverse Event|0
5211815|NCT01012713|17990914|P1|Overall Study|Lack of Efficacy|3
5211816|NCT01012622|17990940|P1|Overall Study|withdrawal of consent by a parent|2
5211817|NCT01012622|17990940|P1|Overall Study|screening failure|1
5211818|NCT01012622|17990940|P1|Overall Study|Other|1
5211819|NCT01012622|17990940|P1|Overall Study|non-compliance with the drug|9
5211820|NCT01012622|17990940|P1|Overall Study|Adverse Event|7
5211821|NCT01012622|17990940|P1|Overall Study|Lost to Follow-up|5
5211822|NCT01012622|17990940|P1|Overall Study|Withdrawal by Subject|6
5211823|NCT01012440|17990966|P1|Overall Study|Withdrawal by Subject|2
5211824|NCT01012414|17990970|P1|Overall Study|Trial was stopped before completed|7
5211825|NCT01012414|17990970|P1|Overall Study|Lost to Follow-up|1
5211826|NCT01012414|17990970|P1|Overall Study|Withdrawal by Subject|2
5211827|NCT01012323|17991011|P1|Overall Study|Investigator Judgment|1
5211828|NCT01012258|17991048|P1|Overall Study|Ongoing|29
5211829|NCT01012258|17991048|P1|Overall Study|Another Tumor Discovered|1
5211830|NCT01012258|17991048|P1|Overall Study|Another Anti-cancer Drug Received|1
5211831|NCT01012258|17991048|P1|Overall Study|Symptomatic Deterioration|1
5211832|NCT01012258|17991048|P1|Overall Study|Progressive Disease (PD)|18
5211833|NCT01012258|17991048|P1|Overall Study|Adverse Event|1
5211834|NCT01012258|17991048|P1|Overall Study|Lost to Follow-up|1
5211835|NCT01012258|17991048|P1|Overall Study|Death|14
5211836|NCT01012219|17991095|P1|Period 2|Withdrawal by Subject|1
5211837|NCT01012219|17991095|P1|Period 1|Withdrawal by Subject|1
5211838|NCT01012037|17991386|P3|Overall Study|Other reason (not specified)|1
5211839|NCT01012037|17991387|P2|Overall Study|Other reason (not specified)|1
5211840|NCT01012037|17991388|P1|Overall Study|Other reason (not specified)|1
5211841|NCT01012037|17991386|P3|Overall Study|Withdrawal by Subject|1
5211842|NCT01012037|17991387|P2|Overall Study|Withdrawal by Subject|4
5211843|NCT01012037|17991388|P1|Overall Study|Withdrawal by Subject|0
5211844|NCT01012037|17991386|P3|Overall Study|Protocol Violation|5
5211845|NCT01012037|17991387|P2|Overall Study|Protocol Violation|3
5211846|NCT01012037|17991388|P1|Overall Study|Protocol Violation|0
5211847|NCT01012037|17991386|P3|Overall Study|Adverse Event|3
5211848|NCT01012037|17991387|P2|Overall Study|Adverse Event|8
5211849|NCT01012037|17991388|P1|Overall Study|Adverse Event|0
5211850|NCT01011946|17991423|P1|Overall Study|No pathological lab value|1
5211851|NCT01011946|17991423|P1|Overall Study|Transferred to another hospital|2
5211852|NCT01011933|17991427|P1|Overall Study|Never treated|1
5211853|NCT01011933|17991427|P1|Overall Study|Inadequate pathology|1
5211854|NCT01011933|17991427|P1|Overall Study|Improper pre-protocol Rx|1
5211855|NCT01011933|17991427|P1|Overall Study|Wrong cell type|1
5211856|NCT01011907|17991444|P2|Overall Study|Adverse Event|4
5211857|NCT01011907|17991445|P1|Overall Study|Adverse Event|1
5211858|NCT01011907|17991444|P2|Overall Study|Withdrawal by Subject|11
5211859|NCT01011907|17991445|P1|Overall Study|Withdrawal by Subject|13
5211860|NCT01011868|17991462|P3|After Week 78 Follow-up|Other reason not defined above|16
5211861|NCT01011868|17991463|P2|After Week 78 Follow-up|Other reason not defined above|5
5211862|NCT01011868|17991464|P1|After Week 78 Follow-up|Other reason not defined above|5
5211863|NCT01011868|17991462|P3|After Week 78 Follow-up|Withdrawal by Subject|1
5211864|NCT01011868|17991463|P2|After Week 78 Follow-up|Withdrawal by Subject|8
5211865|NCT01011868|17991464|P1|After Week 78 Follow-up|Withdrawal by Subject|9
5211866|NCT01011868|17991462|P3|After Week 78 Follow-up|Lost to Follow-up|4
5211867|NCT01011868|17991463|P2|After Week 78 Follow-up|Lost to Follow-up|6
5211868|NCT01011868|17991464|P1|After Week 78 Follow-up|Lost to Follow-up|11
5211869|NCT01011868|17991462|P3|After Week 78 Follow-up|Protocol Violation|2
5211870|NCT01011868|17991463|P2|After Week 78 Follow-up|Protocol Violation|1
5211871|NCT01011868|17991464|P1|After Week 78 Follow-up|Protocol Violation|9
5211872|NCT01011868|17991462|P3|After Week 78 Follow-up|Lack of Efficacy|0
5211873|NCT01011868|17991463|P2|After Week 78 Follow-up|Lack of Efficacy|0
5211874|NCT01011868|17991464|P1|After Week 78 Follow-up|Lack of Efficacy|4
5211875|NCT01011868|17991462|P3|After Week 78 Follow-up|Adverse Event|21
5211876|NCT01011868|17991463|P2|After Week 78 Follow-up|Adverse Event|18
5211877|NCT01011868|17991464|P1|After Week 78 Follow-up|Adverse Event|14
5211878|NCT01011868|17991462|P3|After Week 18 Follow-up|Other reason not defined above|12
5211879|NCT01011868|17991463|P2|After Week 18 Follow-up|Other reason not defined above|3
5211880|NCT01011868|17991464|P1|After Week 18 Follow-up|Other reason not defined above|2
5211881|NCT01011868|17991462|P3|After Week 18 Follow-up|Withdrawal by Subject|0
5211882|NCT01011868|17991463|P2|After Week 18 Follow-up|Withdrawal by Subject|3
5211883|NCT01011868|17991464|P1|After Week 18 Follow-up|Withdrawal by Subject|6
5211884|NCT01011868|17991462|P3|After Week 18 Follow-up|Lost to Follow-up|0
5211885|NCT01011868|17991463|P2|After Week 18 Follow-up|Lost to Follow-up|3
5211886|NCT01011868|17991464|P1|After Week 18 Follow-up|Lost to Follow-up|5
5211887|NCT01011868|17991462|P3|After Week 18 Follow-up|Protocol Violation|1
5211888|NCT01011868|17991463|P2|After Week 18 Follow-up|Protocol Violation|1
5211889|NCT01011868|17991464|P1|After Week 18 Follow-up|Protocol Violation|1
5211890|NCT01011868|17991462|P3|After Week 18 Follow-up|Lack of Efficacy|0
5211891|NCT01011868|17991463|P2|After Week 18 Follow-up|Lack of Efficacy|0
5211892|NCT01011868|17991464|P1|After Week 18 Follow-up|Lack of Efficacy|1
5211893|NCT01011868|17991462|P3|After Week 18 Follow-up|Adverse Event|13
5211894|NCT01011868|17991463|P2|After Week 18 Follow-up|Adverse Event|6
5211895|NCT01011868|17991464|P1|After Week 18 Follow-up|Adverse Event|8
5211896|NCT01011738|17991526|P3|Overall Study|Unknown reasons|17
5211897|NCT01011738|17991527|P2|Overall Study|Unknown reasons|291
5211898|NCT01011738|17991528|P1|Overall Study|Unknown reasons|312
5211899|NCT01011738|17991526|P3|Overall Study|Death|0
5211900|NCT01011738|17991527|P2|Overall Study|Death|3
5211901|NCT01011738|17991528|P1|Overall Study|Death|12
5211902|NCT01011673|17991568|P2|24 Hour Follow-up|Lost to Follow-up|3
5211903|NCT01011673|17991569|P1|24 Hour Follow-up|Lost to Follow-up|3
5211904|NCT01011673|17991568|P2|Randomized|Secondary headache|1
5211905|NCT01011673|17991569|P1|Randomized|Secondary headache|2
5211906|NCT01011556|17991592|P4|Overall Study|Inclusion/exclusion criteria not met|5
5211907|NCT01011556|17991593|P3|Overall Study|Inclusion/exclusion criteria not met|3
5211908|NCT01011556|17991594|P2|Overall Study|Inclusion/exclusion criteria not met|1
5211909|NCT01011556|17991595|P1|Overall Study|Inclusion/exclusion criteria not met|2
5211910|NCT01011556|17991592|P4|Overall Study|Sponsor decision|2
5211911|NCT01011556|17991593|P3|Overall Study|Sponsor decision|1
5211912|NCT01011556|17991594|P2|Overall Study|Sponsor decision|1
5211913|NCT01011556|17991595|P1|Overall Study|Sponsor decision|0
5211914|NCT01011556|17991592|P4|Overall Study|Withdrawal by Subject|4
5211915|NCT01011556|17991593|P3|Overall Study|Withdrawal by Subject|4
5211916|NCT01011556|17991594|P2|Overall Study|Withdrawal by Subject|2
5211917|NCT01011556|17991595|P1|Overall Study|Withdrawal by Subject|1
5211918|NCT01011556|17991592|P4|Overall Study|Protocol Violation|0
5211919|NCT01011556|17991593|P3|Overall Study|Protocol Violation|0
5211920|NCT01011556|17991594|P2|Overall Study|Protocol Violation|1
5211921|NCT01011556|17991595|P1|Overall Study|Protocol Violation|0
5211922|NCT01011556|17991592|P4|Overall Study|Physician Decision|1
5211923|NCT01011556|17991593|P3|Overall Study|Physician Decision|0
5211924|NCT01011556|17991594|P2|Overall Study|Physician Decision|0
5211925|NCT01011556|17991595|P1|Overall Study|Physician Decision|1
5211926|NCT01011556|17991592|P4|Overall Study|Lost to Follow-up|0
5211927|NCT01011556|17991593|P3|Overall Study|Lost to Follow-up|0
5211928|NCT01011556|17991594|P2|Overall Study|Lost to Follow-up|0
5211929|NCT01011556|17991595|P1|Overall Study|Lost to Follow-up|1
5211930|NCT01011556|17991592|P4|Overall Study|Adverse Event|1
5211931|NCT01011556|17991593|P3|Overall Study|Adverse Event|2
5211932|NCT01011556|17991594|P2|Overall Study|Adverse Event|3
5211933|NCT01011556|17991595|P1|Overall Study|Adverse Event|1
5211934|NCT01011465|17991673|P8|Overall Study|Withdrawal by Subject|0
5211935|NCT01011465|17991674|P7|Overall Study|Withdrawal by Subject|1
5211936|NCT01011465|17991675|P6|Overall Study|Withdrawal by Subject|0
5211937|NCT01011465|17991676|P5|Overall Study|Withdrawal by Subject|1
5211938|NCT01011465|17991677|P4|Overall Study|Withdrawal by Subject|0
5211939|NCT01011465|17991678|P3|Overall Study|Withdrawal by Subject|0
5211940|NCT01011465|17991679|P2|Overall Study|Withdrawal by Subject|1
5211941|NCT01011465|17991680|P1|Overall Study|Withdrawal by Subject|2
5211942|NCT01011439|17991708|P1|Overall Study|Sponsor's decision|15
5211943|NCT01011439|17991708|P1|Overall Study|Withdrawal by Subject|1
5211944|NCT01011439|17991708|P1|Overall Study|Lost to Follow-up|4
5211945|NCT01011439|17991708|P1|Overall Study|Death|37
5211946|NCT01011387|17991745|P1|Overall Study|Protocol Violation|1
5211947|NCT01011387|17991745|P1|Overall Study|Adverse Event|2
5211948|NCT01011387|17991745|P1|Overall Study|Withdrawal by Subject|3
5211949|NCT01011335|17991753|P13|Overall Study|Adverse Event|1
5211950|NCT01011335|17991754|P12|Overall Study|Adverse Event|0
5211951|NCT01011335|17991755|P11|Overall Study|Adverse Event|4
5211952|NCT01011335|17991756|P10|Overall Study|Adverse Event|0
5211953|NCT01011335|17991757|P9|Overall Study|Adverse Event|0
5211954|NCT01011335|17991758|P8|Overall Study|Adverse Event|0
5211955|NCT01011335|17991759|P7|Overall Study|Adverse Event|0
5211956|NCT01011335|17991760|P6|Overall Study|Adverse Event|0
5211957|NCT01011335|17991761|P5|Overall Study|Adverse Event|0
5211958|NCT01011335|17991762|P4|Overall Study|Adverse Event|0
5211959|NCT01011335|17991763|P3|Overall Study|Adverse Event|0
5211960|NCT01011335|17991764|P2|Overall Study|Adverse Event|0
5211961|NCT01011335|17991765|P1|Overall Study|Adverse Event|0
5211962|NCT01011335|17991753|P13|Overall Study|Moved/deployed or no booster|0
5211963|NCT01011335|17991754|P12|Overall Study|Moved/deployed or no booster|0
5211964|NCT01011335|17991755|P11|Overall Study|Moved/deployed or no booster|2
5211965|NCT01011335|17991756|P10|Overall Study|Moved/deployed or no booster|0
5211966|NCT01011335|17991757|P9|Overall Study|Moved/deployed or no booster|1
5211967|NCT01011335|17991758|P8|Overall Study|Moved/deployed or no booster|0
5211968|NCT01011335|17991759|P7|Overall Study|Moved/deployed or no booster|1
5211969|NCT01011335|17991760|P6|Overall Study|Moved/deployed or no booster|0
5211970|NCT01011335|17991761|P5|Overall Study|Moved/deployed or no booster|0
5211971|NCT01011335|17991762|P4|Overall Study|Moved/deployed or no booster|1
5211972|NCT01011335|17991763|P3|Overall Study|Moved/deployed or no booster|0
5211973|NCT01011335|17991764|P2|Overall Study|Moved/deployed or no booster|0
5211974|NCT01011335|17991765|P1|Overall Study|Moved/deployed or no booster|1
5211975|NCT01011335|17991753|P13|Overall Study|Protocol Violation|0
5211976|NCT01011335|17991754|P12|Overall Study|Protocol Violation|0
5211977|NCT01011335|17991755|P11|Overall Study|Protocol Violation|0
5211978|NCT01011335|17991756|P10|Overall Study|Protocol Violation|0
5211979|NCT01011335|17991757|P9|Overall Study|Protocol Violation|0
5211980|NCT01011335|17991758|P8|Overall Study|Protocol Violation|0
5211981|NCT01011335|17991759|P7|Overall Study|Protocol Violation|0
5211982|NCT01011335|17991760|P6|Overall Study|Protocol Violation|0
5211983|NCT01011335|17991761|P5|Overall Study|Protocol Violation|0
5211984|NCT01011335|17991762|P4|Overall Study|Protocol Violation|0
5211985|NCT01011335|17991763|P3|Overall Study|Protocol Violation|0
5211986|NCT01011335|17991764|P2|Overall Study|Protocol Violation|1
5211987|NCT01011335|17991765|P1|Overall Study|Protocol Violation|0
5211988|NCT01011335|17991753|P13|Overall Study|Lost to Follow-up|2
5211989|NCT01011335|17991754|P12|Overall Study|Lost to Follow-up|1
5211990|NCT01011335|17991755|P11|Overall Study|Lost to Follow-up|0
5211991|NCT01011335|17991756|P10|Overall Study|Lost to Follow-up|0
5211992|NCT01011335|17991757|P9|Overall Study|Lost to Follow-up|1
5211993|NCT01011335|17991758|P8|Overall Study|Lost to Follow-up|2
5211994|NCT01011335|17991759|P7|Overall Study|Lost to Follow-up|2
5211995|NCT01011335|17991760|P6|Overall Study|Lost to Follow-up|1
5211996|NCT01011335|17991761|P5|Overall Study|Lost to Follow-up|1
5211997|NCT01011335|17991762|P4|Overall Study|Lost to Follow-up|1
5211998|NCT01011335|17991763|P3|Overall Study|Lost to Follow-up|1
5211999|NCT01011335|17991764|P2|Overall Study|Lost to Follow-up|0
5212000|NCT01011335|17991765|P1|Overall Study|Lost to Follow-up|0
5212001|NCT01011309|17991805|P3|Overall Study|Protocol Violation|3
5212002|NCT01011309|17991806|P2|Overall Study|Protocol Violation|1
5212003|NCT01011309|17991807|P1|Overall Study|Protocol Violation|0
5212004|NCT01011309|17991805|P3|Overall Study|Lack of Efficacy|0
5212005|NCT01011309|17991806|P2|Overall Study|Lack of Efficacy|1
5212006|NCT01011309|17991807|P1|Overall Study|Lack of Efficacy|0
5212007|NCT01011309|17991805|P3|Overall Study|Adverse Event|2
5212008|NCT01011309|17991806|P2|Overall Study|Adverse Event|1
5212009|NCT01011309|17991807|P1|Overall Study|Adverse Event|2
5212010|NCT01011283|17991823|P2|Overall Study|Other|2
5212011|NCT01011283|17991824|P1|Overall Study|Other|2
5212012|NCT01011283|17991823|P2|Overall Study|Terminated by Sponsor|5
5212013|NCT01011283|17991824|P1|Overall Study|Terminated by Sponsor|5
5212014|NCT01011283|17991823|P2|Overall Study|Progressive Disease|2
5212015|NCT01011283|17991824|P1|Overall Study|Progressive Disease|0
5212016|NCT01011283|17991823|P2|Overall Study|Adverse Event|2
5212017|NCT01011283|17991824|P1|Overall Study|Adverse Event|4
5212018|NCT01011153|17991873|P3|Overall Study|Less than 78 cases completed|9
5212019|NCT01011153|17991874|P2|Overall Study|Less than 78 cases completed|11
5212020|NCT01011153|17991875|P1|Overall Study|Less than 78 cases completed|8
5212021|NCT01011049|17991904|P4|Overall Study|Withdrawal by Subject|0
5212022|NCT01011049|17991905|P3|Overall Study|Withdrawal by Subject|1
5212023|NCT01011049|17991906|P2|Overall Study|Withdrawal by Subject|0
5212024|NCT01011049|17991907|P1|Overall Study|Withdrawal by Subject|0
5212025|NCT01011049|17991904|P4|Overall Study|Lost to Follow-up|0
5212026|NCT01011049|17991905|P3|Overall Study|Lost to Follow-up|1
5212027|NCT01011049|17991906|P2|Overall Study|Lost to Follow-up|2
5212028|NCT01011049|17991907|P1|Overall Study|Lost to Follow-up|1
5212029|NCT01011049|17991904|P4|Overall Study|Protocol Violation|0
5212030|NCT01011049|17991905|P3|Overall Study|Protocol Violation|2
5212031|NCT01011049|17991906|P2|Overall Study|Protocol Violation|0
5212032|NCT01011049|17991907|P1|Overall Study|Protocol Violation|0
5212033|NCT01010971|17991937|P3|Overall Study|Other|2
5212034|NCT01010971|17991938|P2|Overall Study|Other|0
5212035|NCT01010971|17991939|P1|Overall Study|Other|1
5212036|NCT01010971|17991937|P3|Overall Study|Lost to Follow-up|3
5212037|NCT01010971|17991938|P2|Overall Study|Lost to Follow-up|2
5212038|NCT01010971|17991939|P1|Overall Study|Lost to Follow-up|0
5212039|NCT01010971|17991937|P3|Overall Study|Withdrawal by Subject|5
5212040|NCT01010971|17991938|P2|Overall Study|Withdrawal by Subject|2
5212041|NCT01010971|17991939|P1|Overall Study|Withdrawal by Subject|0
5212042|NCT01010971|17991937|P3|Overall Study|Adverse Event|3
5212043|NCT01010971|17991938|P2|Overall Study|Adverse Event|4
5212044|NCT01010971|17991939|P1|Overall Study|Adverse Event|2
5212045|NCT01010867|17992067|P1|Overall Study|< 50% adherence to probiotic|1
5212046|NCT01010776|17992079|P1|Extension Phase|Other|3
5212047|NCT01010776|17992079|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
5212048|NCT01010776|17992079|P1|Main Phase|Did not received study medication|5
5212049|NCT01010776|17992079|P1|Main Phase|Other|1
5212050|NCT01010776|17992079|P1|Main Phase|Inform consent withdrawal|1
5212051|NCT01010776|17992079|P1|Main Phase|Selection failure|2
5212052|NCT01010776|17992079|P1|Main Phase|Non-compliance to study medication|5
5212053|NCT01010776|17992079|P1|Main Phase|Lost to Follow-up|6
5212054|NCT01010776|17992079|P1|Main Phase|Adverse Event|7
5212055|NCT01010776|17992079|P1|Main Phase|Lack of Efficacy|8
5212056|NCT01010776|17992079|P1|Main Phase|Withdrawal by Subject|14
5212057|NCT01010750|17992136|P6|Second Intervention|Adverse Event|0
5212058|NCT01010750|17992137|P5|Second Intervention|Adverse Event|0
5212059|NCT01010750|17992138|P4|Second Intervention|Adverse Event|0
5212060|NCT01010750|17992139|P3|Second Intervention|Adverse Event|0
5212061|NCT01010750|17992140|P2|Second Intervention|Adverse Event|1
5212062|NCT01010750|17992141|P1|Second Intervention|Adverse Event|0
5212063|NCT01010633|17992166|P2|Overall Study|Investigator decision|1
5212064|NCT01010633|17992167|P1|Overall Study|Investigator decision|0
5212065|NCT01010633|17992166|P2|Overall Study|Withdrawal by Subject|1
5212066|NCT01010633|17992167|P1|Overall Study|Withdrawal by Subject|2
5212067|NCT01010633|17992166|P2|Overall Study|Protocol Violation|2
5212068|NCT01010633|17992167|P1|Overall Study|Protocol Violation|1
5212069|NCT01010633|17992166|P2|Overall Study|Adverse Event|1
5212070|NCT01010633|17992167|P1|Overall Study|Adverse Event|1
5212071|NCT01010503|17992194|P1|Overall Study|Death|1
5212072|NCT01010503|17992194|P1|Overall Study|Adverse Event|1
5212073|NCT01010230|17992253|P2|Overall Study|Lost to Follow-up|2
5212074|NCT01010230|17992254|P1|Overall Study|Lost to Follow-up|4
5212075|NCT01010230|17992253|P2|Overall Study|Withdrawal by Subject|5
5212076|NCT01010230|17992254|P1|Overall Study|Withdrawal by Subject|6
5212077|NCT01010217|17992289|P5|Overall Study|Physician Decision|3
5212078|NCT01010217|17992290|P4|Overall Study|Physician Decision|6
5212079|NCT01010217|17992291|P3|Overall Study|Physician Decision|0
5212080|NCT01010217|17992292|P2|Overall Study|Physician Decision|0
5212081|NCT01010217|17992293|P1|Overall Study|Physician Decision|0
5212082|NCT01010217|17992289|P5|Overall Study|Withdrawal by Subject|0
5212083|NCT01010217|17992290|P4|Overall Study|Withdrawal by Subject|0
5212084|NCT01010217|17992291|P3|Overall Study|Withdrawal by Subject|0
5212085|NCT01010217|17992292|P2|Overall Study|Withdrawal by Subject|0
5212086|NCT01010217|17992293|P1|Overall Study|Withdrawal by Subject|1
5212087|NCT01010217|17992289|P5|Overall Study|Lost to Follow-up|0
5212088|NCT01010217|17992290|P4|Overall Study|Lost to Follow-up|0
5212089|NCT01010217|17992291|P3|Overall Study|Lost to Follow-up|1
5212090|NCT01010217|17992292|P2|Overall Study|Lost to Follow-up|5
5212091|NCT01010217|17992293|P1|Overall Study|Lost to Follow-up|4
5212092|NCT01010204|17992332|P2|Overall Study|psychiatric hospitalization|1
5212093|NCT01010204|17992333|P1|Overall Study|psychiatric hospitalization|2
5212094|NCT01010204|17992332|P2|Overall Study|Withdrawal by Subject|3
5212095|NCT01010204|17992333|P1|Overall Study|Withdrawal by Subject|2
5212096|NCT01010204|17992332|P2|Overall Study|Adverse Event|3
5212097|NCT01010204|17992333|P1|Overall Study|Adverse Event|1
5212098|NCT01010204|17992332|P2|Overall Study|Lost to Follow-up|2
5212099|NCT01010204|17992333|P1|Overall Study|Lost to Follow-up|2
5212100|NCT01010126|17992349|P6|Overall Study|Withdrawal by Subject|0
5212101|NCT01010126|17992350|P5|Overall Study|Withdrawal by Subject|3
5212102|NCT01010126|17992351|P4|Overall Study|Withdrawal by Subject|0
5212103|NCT01010126|17992352|P3|Overall Study|Withdrawal by Subject|1
5212104|NCT01010126|17992353|P2|Overall Study|Withdrawal by Subject|0
5212105|NCT01010126|17992354|P1|Overall Study|Withdrawal by Subject|1
5212106|NCT01010061|17992406|P2|Overall Study|Did Not Receive Treatment|2
5212107|NCT01010061|17992407|P1|Overall Study|Did Not Receive Treatment|2
5212108|NCT01010061|17992406|P2|Overall Study|Violation of Selection Criteria|1
5212109|NCT01010061|17992407|P1|Overall Study|Violation of Selection Criteria|0
5212110|NCT01010061|17992406|P2|Overall Study|Insufficient Therapeutic Response|5
5212111|NCT01010061|17992407|P1|Overall Study|Insufficient Therapeutic Response|1
5212112|NCT01010061|17992406|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5212113|NCT01010061|17992407|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
5212114|NCT01010061|17992406|P2|Overall Study|Administrative/Other|1
5212115|NCT01010061|17992407|P1|Overall Study|Administrative/Other|0
5212116|NCT01010061|17992406|P2|Overall Study|Death|6
5212117|NCT01010061|17992407|P1|Overall Study|Death|3
5212118|NCT01010061|17992406|P2|Overall Study|Withdrew Consent|1
5212119|NCT01010061|17992407|P1|Overall Study|Withdrew Consent|5
5212120|NCT01010061|17992406|P2|Overall Study|Disease Progression|8
5212121|NCT01010061|17992407|P1|Overall Study|Disease Progression|2
5212122|NCT01010061|17992406|P2|Overall Study|Adverse Events or Intercurrent Illness|16
5212123|NCT01010061|17992407|P1|Overall Study|Adverse Events or Intercurrent Illness|33
5212124|NCT01009983|17992458|P1|Overall Study|necessary scans not completed|1
5212125|NCT01009840|17992471|P1|Overall Study|Subject Withdrew Consent to Participate|1
5212126|NCT01009840|17992471|P1|Overall Study|Subject was Withdrawn by Investigator|1
5212127|NCT01009840|17992471|P1|Overall Study|Subject Met Withdrawal Criteria|7
5212128|NCT01009840|17992471|P1|Overall Study|Adverse Event|4
5212129|NCT01009840|17992471|P1|Overall Study|Lost to Follow-up|1
5212130|NCT01009814|17992489|P5|Overall Study|No longer met study criteria|0
5212131|NCT01009814|17992490|P4|Overall Study|No longer met study criteria|0
5212132|NCT01009814|17992491|P3|Overall Study|No longer met study criteria|0
5212133|NCT01009814|17992492|P2|Overall Study|No longer met study criteria|1
5212134|NCT01009814|17992493|P1|Overall Study|No longer met study criteria|1
5212135|NCT01009645|17992617|P4|Overall Study|Lost to Follow-up|5
5212136|NCT01009645|17992618|P3|Overall Study|Lost to Follow-up|4
5212137|NCT01009645|17992619|P2|Overall Study|Lost to Follow-up|8
5212138|NCT01009645|17992620|P1|Overall Study|Lost to Follow-up|2
5212139|NCT01009580|17992657|P2|Overall Study|Unclassified|21
5212140|NCT01009580|17992658|P1|Overall Study|Unclassified|17
5212141|NCT01009580|17992657|P2|Overall Study|Withdrawal Criteria|6
5212142|NCT01009580|17992658|P1|Overall Study|Withdrawal Criteria|4
5212143|NCT01009580|17992657|P2|Overall Study|Protocol Violation|3
5212144|NCT01009580|17992658|P1|Overall Study|Protocol Violation|2
5212145|NCT01009580|17992657|P2|Overall Study|Lack of Efficacy|1
5212146|NCT01009580|17992658|P1|Overall Study|Lack of Efficacy|0
5212147|NCT01009580|17992657|P2|Overall Study|Adverse Event|4
5212148|NCT01009580|17992658|P1|Overall Study|Adverse Event|4
5212149|NCT01009554|17992672|P2|Overall Study|Noncompliant with Study Product|3
5212150|NCT01009554|17992673|P1|Overall Study|Noncompliant with Study Product|0
5212151|NCT01009554|17992672|P2|Overall Study|Withdrawal by Subject|3
5212152|NCT01009554|17992673|P1|Overall Study|Withdrawal by Subject|1
5212153|NCT01009554|17992672|P2|Overall Study|Adverse Event|1
5212154|NCT01009554|17992673|P1|Overall Study|Adverse Event|1
5212155|NCT01009515|17992805|P1|Overall Study|Withdrawal by Subject|3
5212156|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Physician Decision|8
5212157|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Physician Decision|6
5212158|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Physician Decision|6
5212159|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Physician Decision|4
5212160|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Physician Decision|0
5212161|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
5212162|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5212163|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
5212164|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
5212165|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
5212166|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5212167|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5212168|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5212169|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
5212170|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5212171|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
5212172|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5212173|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
5212174|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
5212175|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5212176|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
5212177|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
5212178|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
5212179|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
5212180|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
5212181|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
5212182|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
5212183|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
5212184|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
5212185|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
5212186|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
5212187|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
5212188|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
5212189|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
5212190|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
5212191|NCT01009463|17992816|P5|52-week, Double-blind Treatment Period|Adverse Event|31
5212192|NCT01009463|17992817|P4|52-week, Double-blind Treatment Period|Adverse Event|29
5212193|NCT01009463|17992818|P3|52-week, Double-blind Treatment Period|Adverse Event|25
5212194|NCT01009463|17992819|P2|52-week, Double-blind Treatment Period|Adverse Event|22
5212195|NCT01009463|17992820|P1|52-week, Double-blind Treatment Period|Adverse Event|0
5212196|NCT01009463|17992816|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5212197|NCT01009463|17992817|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5212198|NCT01009463|17992818|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5212199|NCT01009463|17992819|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5212200|NCT01009463|17992820|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
5212201|NCT01009463|17992816|P5|4-week, Open-label Run-In Period|Physician Decision|0
5212202|NCT01009463|17992817|P4|4-week, Open-label Run-In Period|Physician Decision|0
5212203|NCT01009463|17992818|P3|4-week, Open-label Run-In Period|Physician Decision|0
5212204|NCT01009463|17992819|P2|4-week, Open-label Run-In Period|Physician Decision|0
5212205|NCT01009463|17992820|P1|4-week, Open-label Run-In Period|Physician Decision|10
5212206|NCT01009463|17992816|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
5212207|NCT01009463|17992817|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
5212208|NCT01009463|17992818|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
5212209|NCT01009463|17992819|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
5212210|NCT01009463|17992820|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
5212211|NCT01009463|17992816|P5|4-week, Open-label Run-In Period|Adverse Event|0
5212212|NCT01009463|17992817|P4|4-week, Open-label Run-In Period|Adverse Event|0
5212213|NCT01009463|17992818|P3|4-week, Open-label Run-In Period|Adverse Event|0
5212214|NCT01009463|17992819|P2|4-week, Open-label Run-In Period|Adverse Event|0
5212215|NCT01009463|17992820|P1|4-week, Open-label Run-In Period|Adverse Event|10
5212216|NCT01009463|17992816|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5212217|NCT01009463|17992817|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5212218|NCT01009463|17992818|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5212219|NCT01009463|17992819|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5212220|NCT01009463|17992820|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
5212221|NCT01009346|17992842|P1|Overall Study|Adverse Event|4
5212222|NCT01009294|17992866|P1|Overall Study|Study discontinued by Sponsor|6
5212223|NCT01009203|17992887|P1|Overall Study|Treatment-unrelated death|1
5212224|NCT01009203|17992887|P1|Overall Study|Adverse Event|5
5212225|NCT01009203|17992887|P1|Overall Study|Withdrawal by Subject|1
5212226|NCT01009099|17992927|P2|Overall Study|Death|1
5212227|NCT01009099|17992928|P1|Overall Study|Death|0
5212228|NCT01009099|17992927|P2|Overall Study|Withdrawal by Subject|1
5212229|NCT01009099|17992928|P1|Overall Study|Withdrawal by Subject|1
5212230|NCT01009099|17992927|P2|Overall Study|Physician Decision|2
5212231|NCT01009099|17992928|P1|Overall Study|Physician Decision|3
5212232|NCT01009099|17992927|P2|Overall Study|Lost to Follow-up|0
5212233|NCT01009099|17992928|P1|Overall Study|Lost to Follow-up|1
5212234|NCT01009086|17992937|P3|Overall Study|Other|1
5212235|NCT01009086|17992938|P2|Overall Study|Other|5
5212236|NCT01009086|17992939|P1|Overall Study|Other|3
5212237|NCT01009086|17992937|P3|Overall Study|Withdrawal by Subject|13
5212238|NCT01009086|17992938|P2|Overall Study|Withdrawal by Subject|11
5212239|NCT01009086|17992939|P1|Overall Study|Withdrawal by Subject|9
5212240|NCT01009086|17992937|P3|Overall Study|Adverse Event|8
5212241|NCT01009086|17992938|P2|Overall Study|Adverse Event|11
5212242|NCT01009086|17992939|P1|Overall Study|Adverse Event|12
5212243|NCT01009086|17992937|P3|Overall Study|Lost to Follow-up|3
5212244|NCT01009086|17992938|P2|Overall Study|Lost to Follow-up|5
5212245|NCT01009086|17992939|P1|Overall Study|Lost to Follow-up|4
5212246|NCT01009086|17992937|P3|Overall Study|Lack of Efficacy|9
5212247|NCT01009086|17992938|P2|Overall Study|Lack of Efficacy|15
5212248|NCT01009086|17992939|P1|Overall Study|Lack of Efficacy|16
5212249|NCT01009060|17992974|P2|Overall Study|Withdrawal by Subject|1
5212250|NCT01009060|17992975|P1|Overall Study|Withdrawal by Subject|1
5212251|NCT01009060|17992974|P2|Overall Study|Physician Decision|1
5212252|NCT01009060|17992975|P1|Overall Study|Physician Decision|1
5212253|NCT01009060|17992974|P2|Overall Study|Lost to Follow-up|0
5212254|NCT01009060|17992975|P1|Overall Study|Lost to Follow-up|1
5212255|NCT01009060|17992974|P2|Overall Study|Protocol Violation|1
5212256|NCT01009060|17992975|P1|Overall Study|Protocol Violation|0
5212257|NCT01009060|17992974|P2|Overall Study|Adverse Event|2
5212258|NCT01009060|17992975|P1|Overall Study|Adverse Event|1
5212259|NCT01009047|17993013|P2|Overall Study|Other|2
5212260|NCT01009047|17993014|P1|Overall Study|Other|3
5212261|NCT01009047|17993013|P2|Overall Study|Withdrawal by consent|11
5212262|NCT01009047|17993014|P1|Overall Study|Withdrawal by consent|16
5212263|NCT01009047|17993013|P2|Overall Study|Lack of Efficacy|11
5212264|NCT01009047|17993014|P1|Overall Study|Lack of Efficacy|4
5212265|NCT01009047|17993013|P2|Overall Study|Lost to Follow-up|2
5212266|NCT01009047|17993014|P1|Overall Study|Lost to Follow-up|0
5212267|NCT01009047|17993013|P2|Overall Study|Adverse Event|0
5212268|NCT01009047|17993014|P1|Overall Study|Adverse Event|5
5212269|NCT01009034|17993036|P1|Overall Study|Withdrawal by Subject|2
5212270|NCT01009034|17993036|P1|Overall Study|Lost to Follow-up|2
5212271|NCT01008995|17993044|P4|After Controlled Period|Other|0
5212272|NCT01008995|17993045|P3|After Controlled Period|Other|1
5212273|NCT01008995|17993046|P2|After Controlled Period|Other|0
5212274|NCT01008995|17993047|P1|After Controlled Period|Other|0
5212275|NCT01008995|17993044|P4|After Controlled Period|Adverse Event|1
5212276|NCT01008995|17993045|P3|After Controlled Period|Adverse Event|1
5212277|NCT01008995|17993046|P2|After Controlled Period|Adverse Event|0
5212278|NCT01008995|17993047|P1|After Controlled Period|Adverse Event|0
5212279|NCT01008995|17993044|P4|Controlled Period|Other|0
5212280|NCT01008995|17993045|P3|Controlled Period|Other|0
5212281|NCT01008995|17993046|P2|Controlled Period|Other|1
5212282|NCT01008995|17993047|P1|Controlled Period|Other|2
5212283|NCT01008995|17993044|P4|Controlled Period|Adverse Event|0
5212284|NCT01008995|17993045|P3|Controlled Period|Adverse Event|0
5212285|NCT01008995|17993046|P2|Controlled Period|Adverse Event|2
5212286|NCT01008995|17993047|P1|Controlled Period|Adverse Event|1
5212287|NCT01008943|17993064|P1|Overall Study|Withdrawal by Subject|1
5212288|NCT01008904|17993071|P1|Overall Study|unexpected unrelated surgery|1
5212289|NCT01008904|17993071|P1|Overall Study|Adverse Event|2
5212290|NCT01008904|17993071|P1|Overall Study|Lost to Follow-up|1
5212291|NCT01008748|17993076|P1|Overall Study|Other|1
5212292|NCT01008748|17993076|P1|Overall Study|Lost to Follow-up|80
5212293|NCT01008696|17993101|P2|Overall Study|Other|2
5212294|NCT01008696|17993102|P1|Overall Study|Other|0
5212295|NCT01008696|17993101|P2|Overall Study|Other|3
5212296|NCT01008696|17993102|P1|Overall Study|Other|2
5212297|NCT01008696|17993101|P2|Overall Study|Participants' non-cooperation|3
5212298|NCT01008696|17993102|P1|Overall Study|Participants' non-cooperation|2
5212299|NCT01008696|17993101|P2|Overall Study|Adverse Event|0
5212300|NCT01008696|17993102|P1|Overall Study|Adverse Event|1
5212301|NCT01008696|17993101|P2|Overall Study|Physician Decision|1
5212302|NCT01008696|17993102|P1|Overall Study|Physician Decision|5
5212303|NCT01008696|17993101|P2|Overall Study|Withdrawal by Subject|4
5212304|NCT01008696|17993102|P1|Overall Study|Withdrawal by Subject|2
5212305|NCT01008696|17993101|P2|Overall Study|Participant's evasion of hospital visit|4
5212306|NCT01008696|17993102|P1|Overall Study|Participant's evasion of hospital visit|5
5212307|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
5212308|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
5212309|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
5212310|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
5212311|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
5212312|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
5212313|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
5212314|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5212315|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5212316|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
5212317|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5212318|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5212319|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|Physician Decision|0
5212320|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|Physician Decision|1
5212321|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|Physician Decision|0
5212322|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5212323|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
5212324|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
5212325|NCT01008618|17993112|P3|Period 2 (Double-Blind Period)|Adverse Event|2
5212326|NCT01008618|17993113|P2|Period 2 (Double-Blind Period)|Adverse Event|11
5212327|NCT01008618|17993114|P1|Period 2 (Double-Blind Period)|Adverse Event|0
5212328|NCT01008618|17993112|P3|Period 1 (Titration Period)|Aggravated symptom|0
5212329|NCT01008618|17993113|P2|Period 1 (Titration Period)|Aggravated symptom|0
5212330|NCT01008618|17993114|P1|Period 1 (Titration Period)|Aggravated symptom|2
5212331|NCT01008618|17993112|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5212332|NCT01008618|17993113|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5212333|NCT01008618|17993114|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
5212334|NCT01008618|17993112|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
5212335|NCT01008618|17993113|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
5212336|NCT01008618|17993114|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
5212337|NCT01008618|17993112|P3|Period 1 (Titration Period)|Adverse Event|0
5212338|NCT01008618|17993113|P2|Period 1 (Titration Period)|Adverse Event|0
5212339|NCT01008618|17993114|P1|Period 1 (Titration Period)|Adverse Event|33
5212340|NCT01008618|17993112|P3|Period 1 (Titration Period)|Physician Decision|0
5212341|NCT01008618|17993113|P2|Period 1 (Titration Period)|Physician Decision|0
5212342|NCT01008618|17993114|P1|Period 1 (Titration Period)|Physician Decision|2
5212343|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
5212344|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
5212345|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
5212346|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
5212347|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5212348|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5212349|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
5212350|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
5212351|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
5212352|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
5212353|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
5212354|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5212355|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
5212356|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
5212357|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
5212358|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5212359|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5212360|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
5212361|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|Adverse Event|4
5212362|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|Adverse Event|14
5212363|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|Adverse Event|0
5212364|NCT01008553|17993163|P3|Period 2 (Double-Blind Period)|Physician Decision|2
5212365|NCT01008553|17993164|P2|Period 2 (Double-Blind Period)|Physician Decision|1
5212366|NCT01008553|17993165|P1|Period 2 (Double-Blind Period)|Physician Decision|0
5212367|NCT01008553|17993163|P3|Period 1 (Titration Period)|Not appropriate for this study|0
5212368|NCT01008553|17993164|P2|Period 1 (Titration Period)|Not appropriate for this study|0
5212369|NCT01008553|17993165|P1|Period 1 (Titration Period)|Not appropriate for this study|1
5212370|NCT01008553|17993163|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5212371|NCT01008553|17993164|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5212372|NCT01008553|17993165|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
5212373|NCT01008553|17993163|P3|Period 1 (Titration Period)|Determined to increase dosage|0
5212374|NCT01008553|17993164|P2|Period 1 (Titration Period)|Determined to increase dosage|0
5212375|NCT01008553|17993165|P1|Period 1 (Titration Period)|Determined to increase dosage|3
5212376|NCT01008553|17993163|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
5212377|NCT01008553|17993164|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
5212378|NCT01008553|17993165|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
5212379|NCT01008553|17993163|P3|Period 1 (Titration Period)|Adverse Event|0
5212380|NCT01008553|17993164|P2|Period 1 (Titration Period)|Adverse Event|0
5212381|NCT01008553|17993165|P1|Period 1 (Titration Period)|Adverse Event|33
5212382|NCT01008553|17993163|P3|Period 1 (Titration Period)|Physician Decision|0
5212383|NCT01008553|17993164|P2|Period 1 (Titration Period)|Physician Decision|0
5212384|NCT01008553|17993165|P1|Period 1 (Titration Period)|Physician Decision|2
5212385|NCT01008475|17993197|P7|Overall Study|Ongoing treatment at data cut-off date|4
5212386|NCT01008475|17993198|P6|Overall Study|Ongoing treatment at data cut-off date|6
5212387|NCT01008475|17993199|P5|Overall Study|Ongoing treatment at data cut-off date|5
5212388|NCT01008475|17993200|P4|Overall Study|Ongoing treatment at data cut-off date|0
5212389|NCT01008475|17993201|P3|Overall Study|Ongoing treatment at data cut-off date|0
5212390|NCT01008475|17993202|P2|Overall Study|Ongoing treatment at data cut-off date|0
5212391|NCT01008475|17993203|P1|Overall Study|Ongoing treatment at data cut-off date|0
5212392|NCT01008449|17993243|P2|Overall Study|Lost to Follow-up|19
5212393|NCT01008449|17993244|P1|Overall Study|Lost to Follow-up|29
5212394|NCT01008423|17993266|P2|Overall Study|Other|1
5212395|NCT01008423|17993267|P1|Overall Study|Other|0
5212396|NCT01008423|17993266|P2|Overall Study|Personal Conflict|0
5212397|NCT01008423|17993267|P1|Overall Study|Personal Conflict|1
5212398|NCT01008423|17993266|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
5212399|NCT01008423|17993267|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
5212400|NCT01008423|17993266|P2|Overall Study|Lack of Efficacy|5
5212401|NCT01008423|17993267|P1|Overall Study|Lack of Efficacy|0
5212402|NCT01008423|17993266|P2|Overall Study|Low Cortisol|1
5212403|NCT01008423|17993267|P1|Overall Study|Low Cortisol|0
5212404|NCT01008423|17993266|P2|Overall Study|Lost to Follow-up|2
5212405|NCT01008423|17993267|P1|Overall Study|Lost to Follow-up|0
5212406|NCT01008423|17993266|P2|Overall Study|Withdrawal by Subject|7
5212407|NCT01008423|17993267|P1|Overall Study|Withdrawal by Subject|4
5212408|NCT01008423|17993266|P2|Overall Study|Adverse Event|6
5212409|NCT01008423|17993267|P1|Overall Study|Adverse Event|13
5212410|NCT01008410|17993293|P2|Overall Study|Met Exclusion Criterion|1
5212411|NCT01008410|17993294|P1|Overall Study|Met Exclusion Criterion|0
5212412|NCT01008410|17993293|P2|Overall Study|Lack of Efficacy|6
5212413|NCT01008410|17993294|P1|Overall Study|Lack of Efficacy|2
5212414|NCT01008410|17993293|P2|Overall Study|Low Cortisol|0
5212415|NCT01008410|17993294|P1|Overall Study|Low Cortisol|2
5212416|NCT01008410|17993293|P2|Overall Study|Noncompliance|0
5212417|NCT01008410|17993294|P1|Overall Study|Noncompliance|1
5212418|NCT01008410|17993293|P2|Overall Study|Lost to Follow-up|0
5212419|NCT01008410|17993294|P1|Overall Study|Lost to Follow-up|1
5212420|NCT01008410|17993293|P2|Overall Study|Withdrawal by Subject|2
5212421|NCT01008410|17993294|P1|Overall Study|Withdrawal by Subject|6
5212422|NCT01008410|17993293|P2|Overall Study|Adverse Event|7
5212423|NCT01008410|17993294|P1|Overall Study|Adverse Event|13
5212424|NCT01008150|17993348|P4|Overall Study|did not receive study drug|0
5212425|NCT01008150|17993349|P3|Overall Study|did not receive study drug|1
5212426|NCT01008150|17993350|P2|Overall Study|did not receive study drug|1
5212427|NCT01008150|17993351|P1|Overall Study|did not receive study drug|1
5212428|NCT01007916|17993399|P2|Period 2, 4 Weeks of Wear|Relocation|0
5212429|NCT01007916|17993400|P1|Period 2, 4 Weeks of Wear|Relocation|1
5212430|NCT01007916|17993399|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
5212431|NCT01007916|17993400|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
5212432|NCT01007942|17993408|P2|Overall Study|Patients untreated|3
5212433|NCT01007942|17993409|P1|Overall Study|Patients untreated|4
5212434|NCT01007942|17993408|P2|Overall Study|Death|2
5212435|NCT01007942|17993409|P1|Overall Study|Death|3
5212436|NCT01007942|17993408|P2|Overall Study|Administrative problems|0
5212437|NCT01007942|17993409|P1|Overall Study|Administrative problems|2
5212438|NCT01007942|17993408|P2|Overall Study|Lost to Follow-up|0
5212439|NCT01007942|17993409|P1|Overall Study|Lost to Follow-up|1
5212440|NCT01007942|17993408|P2|Overall Study|Withdrawal by Subject|14
5212441|NCT01007942|17993409|P1|Overall Study|Withdrawal by Subject|19
5212442|NCT01007942|17993408|P2|Overall Study|Protocol Violation|1
5212443|NCT01007942|17993409|P1|Overall Study|Protocol Violation|1
5212444|NCT01007942|17993408|P2|Overall Study|New cancer therapy|1
5212445|NCT01007942|17993409|P1|Overall Study|New cancer therapy|5
5212446|NCT01007942|17993408|P2|Overall Study|Disease progression|242
5212447|NCT01007942|17993409|P1|Overall Study|Disease progression|217
5212448|NCT01007942|17993408|P2|Overall Study|Abnormal test procedure|1
5212449|NCT01007942|17993409|P1|Overall Study|Abnormal test procedure|0
5212450|NCT01007942|17993408|P2|Overall Study|Adverse Event|14
5212451|NCT01007942|17993409|P1|Overall Study|Adverse Event|29
5212452|NCT01007838|17993435|P4|Overall Study|Started home haemodialysis|0
5212453|NCT01007838|17993436|P3|Overall Study|Started home haemodialysis|0
5212454|NCT01007838|17993437|P2|Overall Study|Started home haemodialysis|0
5212455|NCT01007838|17993438|P1|Overall Study|Started home haemodialysis|1
5212456|NCT01007838|17993435|P4|Overall Study|Physician Decision|0
5212457|NCT01007838|17993436|P3|Overall Study|Physician Decision|0
5212458|NCT01007838|17993437|P2|Overall Study|Physician Decision|0
5212459|NCT01007838|17993438|P1|Overall Study|Physician Decision|1
5212460|NCT01007838|17993435|P4|Overall Study|Withdrawal by Subject|0
5212461|NCT01007838|17993436|P3|Overall Study|Withdrawal by Subject|0
5212462|NCT01007838|17993437|P2|Overall Study|Withdrawal by Subject|0
5212463|NCT01007838|17993438|P1|Overall Study|Withdrawal by Subject|1
5212464|NCT01007812|17993448|P2|Period 1, One Week|Discomfort|0
5212465|NCT01007812|17993449|P1|Period 1, One Week|Discomfort|1
5212466|NCT01007812|17993448|P2|Period 1, One Week|Lost to Follow-up|1
5212467|NCT01007812|17993449|P1|Period 1, One Week|Lost to Follow-up|0
5212468|NCT01007552|17993499|P1|Overall Study|Withdrawal by Subject|1
5212469|NCT01007448|17993515|P2|Overall Study|Adverse Event|4
5212470|NCT01007448|17993516|P1|Overall Study|Adverse Event|1
5212471|NCT01007448|17993515|P2|Overall Study|Withdrawal by Subject|3
5212472|NCT01007448|17993516|P1|Overall Study|Withdrawal by Subject|2
5212473|NCT01007448|17993515|P2|Overall Study|Lack of Efficacy|0
5212474|NCT01007448|17993516|P1|Overall Study|Lack of Efficacy|2
5212475|NCT01007448|17993515|P2|Overall Study|Progressive Disease|2
5212476|NCT01007448|17993516|P1|Overall Study|Progressive Disease|1
5212477|NCT01007448|17993515|P2|Overall Study|Participant Given Prohibited Medication|0
5212478|NCT01007448|17993516|P1|Overall Study|Participant Given Prohibited Medication|1
5212479|NCT01007448|17993515|P2|Overall Study|Participant Leaving the Country|0
5212480|NCT01007448|17993516|P1|Overall Study|Participant Leaving the Country|1
5212481|NCT01007448|17993515|P2|Overall Study|Staph Skin Infection Flare|0
5212482|NCT01007448|17993516|P1|Overall Study|Staph Skin Infection Flare|1
5212483|NCT01007448|17993515|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
5212484|NCT01007448|17993516|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
5212485|NCT01007435|17993548|P4|Overall Study|Reason not Specified|1
5212486|NCT01007435|17993549|P3|Overall Study|Reason not Specified|2
5212487|NCT01007435|17993550|P2|Overall Study|Reason not Specified|1
5212488|NCT01007435|17993551|P1|Overall Study|Reason not Specified|1
5212489|NCT01007435|17993548|P4|Overall Study|Failure to Return|6
5212490|NCT01007435|17993549|P3|Overall Study|Failure to Return|3
5212491|NCT01007435|17993550|P2|Overall Study|Failure to Return|4
5212492|NCT01007435|17993551|P1|Overall Study|Failure to Return|5
5212493|NCT01007435|17993548|P4|Overall Study|Refused Treatment|8
5212494|NCT01007435|17993549|P3|Overall Study|Refused Treatment|5
5212495|NCT01007435|17993550|P2|Overall Study|Refused Treatment|13
5212496|NCT01007435|17993551|P1|Overall Study|Refused Treatment|13
5212497|NCT01007435|17993548|P4|Overall Study|Other Protocol Violation|0
5212498|NCT01007435|17993549|P3|Overall Study|Other Protocol Violation|1
5212499|NCT01007435|17993550|P2|Overall Study|Other Protocol Violation|0
5212500|NCT01007435|17993551|P1|Overall Study|Other Protocol Violation|2
5212501|NCT01007435|17993548|P4|Overall Study|Violation of Selection Criteria at Entry|0
5212502|NCT01007435|17993549|P3|Overall Study|Violation of Selection Criteria at Entry|2
5212503|NCT01007435|17993550|P2|Overall Study|Violation of Selection Criteria at Entry|5
5212504|NCT01007435|17993551|P1|Overall Study|Violation of Selection Criteria at Entry|3
5212505|NCT01007435|17993548|P4|Overall Study|Insufficient Therapeutic Response|9
5212506|NCT01007435|17993549|P3|Overall Study|Insufficient Therapeutic Response|2
5212507|NCT01007435|17993550|P2|Overall Study|Insufficient Therapeutic Response|7
5212508|NCT01007435|17993551|P1|Overall Study|Insufficient Therapeutic Response|21
5212509|NCT01007435|17993548|P4|Overall Study|Death|1
5212510|NCT01007435|17993549|P3|Overall Study|Death|2
5212511|NCT01007435|17993550|P2|Overall Study|Death|4
5212512|NCT01007435|17993551|P1|Overall Study|Death|2
5212513|NCT01007435|17993548|P4|Overall Study|Adverse Event|31
5212514|NCT01007435|17993549|P3|Overall Study|Adverse Event|47
5212515|NCT01007435|17993550|P2|Overall Study|Adverse Event|25
5212516|NCT01007435|17993551|P1|Overall Study|Adverse Event|16
5212517|NCT01007396|17993593|P1|Overall Study|Lost to Follow-up|47
5212518|NCT01007253|17993598|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
5212519|NCT01007253|17993599|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
5212520|NCT01007253|17993600|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
5212521|NCT01007253|17993601|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
5212522|NCT01007149|17993633|P2|Overall Study|Administrative problems|1
5212523|NCT01007149|17993634|P1|Overall Study|Administrative problems|0
5212524|NCT01007123|17993708|P4|Overall Study|Lost to Follow-up|0
5212525|NCT01007123|17993709|P3|Overall Study|Lost to Follow-up|0
5212526|NCT01007123|17993710|P2|Overall Study|Lost to Follow-up|1
5212527|NCT01007123|17993711|P1|Overall Study|Lost to Follow-up|0
5212528|NCT01007123|17993708|P4|Overall Study|Withdrawal by Subject|0
5212529|NCT01007123|17993709|P3|Overall Study|Withdrawal by Subject|1
5212530|NCT01007123|17993710|P2|Overall Study|Withdrawal by Subject|0
5212531|NCT01007123|17993711|P1|Overall Study|Withdrawal by Subject|1
5212532|NCT01007123|17993708|P4|Overall Study|Protocol Violation|1
5212533|NCT01007123|17993709|P3|Overall Study|Protocol Violation|2
5212534|NCT01007123|17993710|P2|Overall Study|Protocol Violation|1
5212535|NCT01007123|17993711|P1|Overall Study|Protocol Violation|1
5212536|NCT01007123|17993708|P4|Overall Study|Lack of Efficacy|4
5212537|NCT01007123|17993709|P3|Overall Study|Lack of Efficacy|1
5212538|NCT01007123|17993710|P2|Overall Study|Lack of Efficacy|0
5212539|NCT01007123|17993711|P1|Overall Study|Lack of Efficacy|1
5212540|NCT01007123|17993708|P4|Overall Study|Adverse Event|1
5212541|NCT01007123|17993709|P3|Overall Study|Adverse Event|7
5212542|NCT01007123|17993710|P2|Overall Study|Adverse Event|4
5212543|NCT01007123|17993711|P1|Overall Study|Adverse Event|3
5212544|NCT01007032|17993772|P4|Overall Study|Withdrawal by Subject|1
5212545|NCT01007032|17993773|P3|Overall Study|Withdrawal by Subject|0
5212546|NCT01007032|17993774|P2|Overall Study|Withdrawal by Subject|0
5212547|NCT01007032|17993775|P1|Overall Study|Withdrawal by Subject|0
5212548|NCT01007032|17993772|P4|Overall Study|On Study Treatment at Cut-off Date|0
5212549|NCT01007032|17993773|P3|Overall Study|On Study Treatment at Cut-off Date|1
5212550|NCT01007032|17993774|P2|Overall Study|On Study Treatment at Cut-off Date|1
5212551|NCT01007032|17993775|P1|Overall Study|On Study Treatment at Cut-off Date|0
5212552|NCT01006980|17993819|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
5212553|NCT01006980|17993820|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
5212554|NCT01006980|17993819|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
5212555|NCT01006980|17993820|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
5212556|NCT01006980|17993819|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
5212557|NCT01006980|17993820|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
5212558|NCT01006980|17993819|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
5212559|NCT01006980|17993820|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
5212560|NCT01006980|17993819|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
5212561|NCT01006980|17993820|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
5212562|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
5212563|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
5212564|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
5212565|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
5212566|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
5212567|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
5212568|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
5212569|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
5212570|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Progression|218
5212571|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Progression|257
5212572|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Death|12
5212573|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Death|13
5212574|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Adverse Event|5
5212575|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Adverse Event|25
5212576|NCT01006980|17993819|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
5212577|NCT01006980|17993820|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
5212578|NCT01006889|17993859|P1|Overall Study|Withdrawal by Subject|3
5212579|NCT01006707|17993870|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
5212580|NCT01006707|17993871|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
5212581|NCT01006707|17993872|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
5212582|NCT01006707|17993870|P3|Study Session 1|Lost to Follow-up|0
5212583|NCT01006707|17993871|P2|Study Session 1|Lost to Follow-up|0
5212584|NCT01006707|17993872|P1|Study Session 1|Lost to Follow-up|2
5212585|NCT01006629|17993892|P1|Overall Study|Parent unable to perform site visit|4
5212586|NCT01006629|17993892|P1|Overall Study|Parent refused to continue participation|1
5212587|NCT01006629|17993892|P1|Overall Study|Adverse Event|1
5212588|NCT01006616|17993907|P4|Period 2 (18 Months)|Study Terminated|70
5212589|NCT01006616|17993908|P3|Period 2 (18 Months)|Study Terminated|44
5212590|NCT01006616|17993909|P2|Period 2 (18 Months)|Study Terminated|46
5212591|NCT01006616|17993910|P1|Period 2 (18 Months)|Study Terminated|63
5212592|NCT01006616|17993907|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
5212593|NCT01006616|17993908|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
5212594|NCT01006616|17993909|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
5212595|NCT01006616|17993910|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
5212596|NCT01006616|17993907|P4|Period 2 (18 Months)|Withdrawal by Subject|1
5212597|NCT01006616|17993908|P3|Period 2 (18 Months)|Withdrawal by Subject|0
5212598|NCT01006616|17993909|P2|Period 2 (18 Months)|Withdrawal by Subject|4
5212599|NCT01006616|17993910|P1|Period 2 (18 Months)|Withdrawal by Subject|1
5212600|NCT01006616|17993907|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
5212601|NCT01006616|17993908|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
5212602|NCT01006616|17993909|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
5212603|NCT01006616|17993910|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
5212604|NCT01006616|17993907|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
5212605|NCT01006616|17993908|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
5212606|NCT01006616|17993909|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
5212607|NCT01006616|17993910|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
5212608|NCT01006616|17993907|P4|Period 2 (18 Months)|Lost to Follow-up|0
5212609|NCT01006616|17993908|P3|Period 2 (18 Months)|Lost to Follow-up|0
5212610|NCT01006616|17993909|P2|Period 2 (18 Months)|Lost to Follow-up|0
5212611|NCT01006616|17993910|P1|Period 2 (18 Months)|Lost to Follow-up|2
5212612|NCT01006616|17993907|P4|Period 2 (18 Months)|Lack of Efficacy|2
5212613|NCT01006616|17993908|P3|Period 2 (18 Months)|Lack of Efficacy|1
5212614|NCT01006616|17993909|P2|Period 2 (18 Months)|Lack of Efficacy|0
5212615|NCT01006616|17993910|P1|Period 2 (18 Months)|Lack of Efficacy|0
5212616|NCT01006616|17993907|P4|Period 2 (18 Months)|Adverse Event|4
5212617|NCT01006616|17993908|P3|Period 2 (18 Months)|Adverse Event|6
5212618|NCT01006616|17993909|P2|Period 2 (18 Months)|Adverse Event|6
5212619|NCT01006616|17993910|P1|Period 2 (18 Months)|Adverse Event|6
5212620|NCT01006616|17993907|P4|Period 1 (6 Months)|Not Treated|1
5212621|NCT01006616|17993908|P3|Period 1 (6 Months)|Not Treated|1
5212622|NCT01006616|17993909|P2|Period 1 (6 Months)|Not Treated|0
5212623|NCT01006616|17993910|P1|Period 1 (6 Months)|Not Treated|0
5212624|NCT01006616|17993907|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
5212625|NCT01006616|17993908|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
5212626|NCT01006616|17993909|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
5212627|NCT01006616|17993910|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
5212628|NCT01006616|17993907|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5212629|NCT01006616|17993908|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5212630|NCT01006616|17993909|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
5212631|NCT01006616|17993910|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5212632|NCT01006616|17993907|P4|Period 1 (6 Months)|Withdrawal by Subject|0
5212633|NCT01006616|17993908|P3|Period 1 (6 Months)|Withdrawal by Subject|2
5212634|NCT01006616|17993909|P2|Period 1 (6 Months)|Withdrawal by Subject|2
5212635|NCT01006616|17993910|P1|Period 1 (6 Months)|Withdrawal by Subject|2
5212636|NCT01006616|17993907|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
5212637|NCT01006616|17993908|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
5212638|NCT01006616|17993909|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
5212639|NCT01006616|17993910|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
5212640|NCT01006616|17993907|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
5212641|NCT01006616|17993908|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
5212642|NCT01006616|17993909|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
5212643|NCT01006616|17993910|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
5212644|NCT01006616|17993907|P4|Period 1 (6 Months)|Lost to Follow-up|0
5212645|NCT01006616|17993908|P3|Period 1 (6 Months)|Lost to Follow-up|1
5212646|NCT01006616|17993909|P2|Period 1 (6 Months)|Lost to Follow-up|0
5212647|NCT01006616|17993910|P1|Period 1 (6 Months)|Lost to Follow-up|0
5212648|NCT01006616|17993907|P4|Period 1 (6 Months)|Lack of Efficacy|4
5212649|NCT01006616|17993908|P3|Period 1 (6 Months)|Lack of Efficacy|0
5212650|NCT01006616|17993909|P2|Period 1 (6 Months)|Lack of Efficacy|4
5212651|NCT01006616|17993910|P1|Period 1 (6 Months)|Lack of Efficacy|3
5212652|NCT01006616|17993907|P4|Period 1 (6 Months)|Adverse Event|9
5212653|NCT01006616|17993908|P3|Period 1 (6 Months)|Adverse Event|37
5212654|NCT01006616|17993909|P2|Period 1 (6 Months)|Adverse Event|31
5212655|NCT01006616|17993910|P1|Period 1 (6 Months)|Adverse Event|10
5212656|NCT01006603|17994046|P2|Overall Study|Other|7
5212657|NCT01006603|17994047|P1|Overall Study|Other|3
5212658|NCT01006603|17994046|P2|Overall Study|Study specific discontinuation criteria|34
5212659|NCT01006603|17994047|P1|Overall Study|Study specific discontinuation criteria|33
5212660|NCT01006603|17994046|P2|Overall Study|Death|1
5212661|NCT01006603|17994047|P1|Overall Study|Death|1
5212662|NCT01006603|17994046|P2|Overall Study|Adverse Event|7
5212663|NCT01006603|17994047|P1|Overall Study|Adverse Event|15
5212664|NCT01006603|17994046|P2|Overall Study|Incorrect enrolment|2
5212665|NCT01006603|17994047|P1|Overall Study|Incorrect enrolment|0
5212666|NCT01006603|17994046|P2|Overall Study|Protocol Violation|3
5212667|NCT01006603|17994047|P1|Overall Study|Protocol Violation|1
5212668|NCT01006603|17994046|P2|Overall Study|Safety reason|1
5212669|NCT01006603|17994047|P1|Overall Study|Safety reason|1
5212670|NCT01006603|17994046|P2|Overall Study|Lost to Follow-up|1
5212671|NCT01006603|17994047|P1|Overall Study|Lost to Follow-up|0
5212672|NCT01006603|17994046|P2|Overall Study|Withdrawal by Subject|19
5212673|NCT01006603|17994047|P1|Overall Study|Withdrawal by Subject|17
5212674|NCT01006590|17994067|P2|Overall Study|Other|2
5212675|NCT01006590|17994068|P1|Overall Study|Other|3
5212676|NCT01006590|17994067|P2|Overall Study|Study specific discontinuation criteria|23
5212677|NCT01006590|17994068|P1|Overall Study|Study specific discontinuation criteria|16
5212678|NCT01006590|17994067|P2|Overall Study|Withdrawal by Subject|2
5212679|NCT01006590|17994068|P1|Overall Study|Withdrawal by Subject|4
5212680|NCT01006590|17994067|P2|Overall Study|Protocol Violation|0
5212681|NCT01006590|17994068|P1|Overall Study|Protocol Violation|1
5212682|NCT01006590|17994067|P2|Overall Study|Lost to Follow-up|1
5212683|NCT01006590|17994068|P1|Overall Study|Lost to Follow-up|1
5212684|NCT01006590|17994067|P2|Overall Study|Death|1
5212685|NCT01006590|17994068|P1|Overall Study|Death|1
5212686|NCT01006590|17994067|P2|Overall Study|Adverse Event|3
5212687|NCT01006590|17994068|P1|Overall Study|Adverse Event|2
5212688|NCT01006356|17994107|P1|Overall Study|Other|23
5212689|NCT01006356|17994107|P1|Overall Study|Protocol Violation|3
5212690|NCT01006356|17994107|P1|Overall Study|Choice by participants|2
5212691|NCT01006356|17994107|P1|Overall Study|Withdrawal by Subject|1
5212692|NCT01006356|17994107|P1|Overall Study|Paticipants did not cooperate|6
5212693|NCT01006356|17994107|P1|Overall Study|Physician Decision|1
5212694|NCT01006356|17994107|P1|Overall Study|Adverse Event|6
5212695|NCT01006291|17994122|P3|Overall Study|Other|17
5212696|NCT01006291|17994123|P2|Overall Study|Other|14
5212697|NCT01006291|17994124|P1|Overall Study|Other|14
5212698|NCT01006291|17994122|P3|Overall Study|Withdrawal criteria|4
5212699|NCT01006291|17994123|P2|Overall Study|Withdrawal criteria|4
5212700|NCT01006291|17994124|P1|Overall Study|Withdrawal criteria|5
5212701|NCT01006291|17994122|P3|Overall Study|Protocol Violation|3
5212702|NCT01006291|17994123|P2|Overall Study|Protocol Violation|3
5212703|NCT01006291|17994124|P1|Overall Study|Protocol Violation|3
5212704|NCT01006291|17994122|P3|Overall Study|Lack of Efficacy|1
5212705|NCT01006291|17994123|P2|Overall Study|Lack of Efficacy|2
5212706|NCT01006291|17994124|P1|Overall Study|Lack of Efficacy|2
5212707|NCT01006291|17994122|P3|Overall Study|Adverse Event|2
5212708|NCT01006291|17994123|P2|Overall Study|Adverse Event|1
5212709|NCT01006291|17994124|P1|Overall Study|Adverse Event|2
5212710|NCT01006135|17994174|P1|Overall Study|Other|72
5212711|NCT01006135|17994174|P1|Overall Study|Lost to Follow-up|32
5212712|NCT01006135|17994174|P1|Overall Study|Protocol Violation|14
5212713|NCT01006135|17994174|P1|Overall Study|Adverse Event|22
5212714|NCT01006122|17994181|P2|Second Double-blind Intervention Period|Death|1
5212715|NCT01006122|17994182|P1|Second Double-blind Intervention Period|Death|0
5212716|NCT01006122|17994181|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
5212717|NCT01006122|17994182|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
5212718|NCT01006122|17994181|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
5212719|NCT01006122|17994182|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
5212720|NCT01006122|17994181|P2|Second Double-blind Intervention Period|Protocol Violation|0
5212721|NCT01006122|17994182|P1|Second Double-blind Intervention Period|Protocol Violation|1
5212722|NCT01006122|17994181|P2|Second Double-blind Intervention Period|Adverse Event|1
5212723|NCT01006122|17994182|P1|Second Double-blind Intervention Period|Adverse Event|1
5212724|NCT01006122|17994181|P2|First Double-blind Intervention Period|Adverse Event|4
5212725|NCT01006122|17994182|P1|First Double-blind Intervention Period|Adverse Event|0
5212726|NCT01006122|17994181|P2|First Double-blind Intervention Period|Other|0
5212727|NCT01006122|17994182|P1|First Double-blind Intervention Period|Other|3
5212728|NCT01006122|17994181|P2|First Double-blind Intervention Period|Lack of Efficacy|1
5212729|NCT01006122|17994182|P1|First Double-blind Intervention Period|Lack of Efficacy|2
5212730|NCT01006122|17994181|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
5212731|NCT01006122|17994182|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
5212732|NCT01006122|17994181|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
5212733|NCT01006122|17994182|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
5212734|NCT01006122|17994181|P2|First Double-blind Intervention Period|Pregnancy|1
5212735|NCT01006122|17994182|P1|First Double-blind Intervention Period|Pregnancy|0
5212736|NCT01006122|17994181|P2|First Double-blind Intervention Period|Protocol Violation|1
5212737|NCT01006122|17994182|P1|First Double-blind Intervention Period|Protocol Violation|1
5212738|NCT01006122|17994181|P2|First Double-blind Intervention Period|Lost to Follow-up|2
5212739|NCT01006122|17994182|P1|First Double-blind Intervention Period|Lost to Follow-up|0
5212740|NCT01005966|17994233|P5|Treatment Period 4 (14 Days)|Other Reason|1
5212741|NCT01005966|17994234|P4|Treatment Period 4 (14 Days)|Other Reason|0
5212742|NCT01005966|17994235|P3|Treatment Period 4 (14 Days)|Other Reason|0
5212743|NCT01005966|17994236|P2|Treatment Period 4 (14 Days)|Other Reason|0
5212744|NCT01005966|17994237|P1|Treatment Period 4 (14 Days)|Other Reason|0
5212745|NCT01005966|17994233|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
5212746|NCT01005966|17994234|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
5212747|NCT01005966|17994235|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
5212748|NCT01005966|17994236|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
5212749|NCT01005966|17994237|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
5212750|NCT01005966|17994233|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
5212751|NCT01005966|17994234|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
5212752|NCT01005966|17994235|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
5212753|NCT01005966|17994236|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
5212754|NCT01005966|17994237|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
5212755|NCT01005966|17994233|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5212756|NCT01005966|17994234|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5212757|NCT01005966|17994235|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5212758|NCT01005966|17994236|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5212759|NCT01005966|17994237|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5212760|NCT01005966|17994233|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5212761|NCT01005966|17994234|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5212762|NCT01005966|17994235|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
5212763|NCT01005966|17994236|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
5212764|NCT01005966|17994237|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
5212765|NCT01005966|17994233|P5|Treatment Period 2 (14 Days)|Adverse Event|0
5212766|NCT01005966|17994234|P4|Treatment Period 2 (14 Days)|Adverse Event|0
5212767|NCT01005966|17994235|P3|Treatment Period 2 (14 Days)|Adverse Event|1
5212768|NCT01005966|17994236|P2|Treatment Period 2 (14 Days)|Adverse Event|1
5212769|NCT01005966|17994237|P1|Treatment Period 2 (14 Days)|Adverse Event|0
5212770|NCT01005966|17994233|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5212771|NCT01005966|17994234|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
5212772|NCT01005966|17994235|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5212773|NCT01005966|17994236|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5212774|NCT01005966|17994237|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5212775|NCT01005966|17994233|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
5212776|NCT01005966|17994234|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
5212777|NCT01005966|17994235|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
5212778|NCT01005966|17994236|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
5212779|NCT01005966|17994237|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
5212780|NCT01005966|17994233|P5|Treatment Period 1 (14 Days)|Adverse Event|0
5212781|NCT01005966|17994234|P4|Treatment Period 1 (14 Days)|Adverse Event|0
5212782|NCT01005966|17994235|P3|Treatment Period 1 (14 Days)|Adverse Event|0
5212783|NCT01005966|17994236|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5212784|NCT01005966|17994237|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5212785|NCT01005914|17994257|P1|Overall Study|Withdrawal by Subject|1
5212786|NCT01005914|17994257|P1|Overall Study|Lack of Efficacy|1
5212787|NCT01005914|17994257|P1|Overall Study|Death|4
5212788|NCT01005914|17994257|P1|Overall Study|Adverse Event|4
5212789|NCT01005901|17994263|P2|Overall Study|No longer requires study drug|1
5212790|NCT01005901|17994264|P1|Overall Study|No longer requires study drug|0
5212791|NCT01005901|17994263|P2|Overall Study|Patient's inability to use the device|1
5212792|NCT01005901|17994264|P1|Overall Study|Patient's inability to use the device|1
5212793|NCT01005901|17994263|P2|Overall Study|Lost to Follow-up|2
5212794|NCT01005901|17994264|P1|Overall Study|Lost to Follow-up|1
5212795|NCT01005901|17994263|P2|Overall Study|Death|3
5212796|NCT01005901|17994264|P1|Overall Study|Death|2
5212797|NCT01005901|17994263|P2|Overall Study|Protocol Violation|3
5212798|NCT01005901|17994264|P1|Overall Study|Protocol Violation|4
5212799|NCT01005901|17994263|P2|Overall Study|Unsatisfactory therapeutic effect|5
5212800|NCT01005901|17994264|P1|Overall Study|Unsatisfactory therapeutic effect|5
5212801|NCT01005901|17994263|P2|Overall Study|Administrative problems|13
5212802|NCT01005901|17994264|P1|Overall Study|Administrative problems|21
5212803|NCT01005901|17994263|P2|Overall Study|Adverse Event|16
5212804|NCT01005901|17994264|P1|Overall Study|Adverse Event|30
5212805|NCT01005901|17994263|P2|Overall Study|Withdrawal by Subject|14
5212806|NCT01005901|17994264|P1|Overall Study|Withdrawal by Subject|38
5212807|NCT01005875|17994327|P1|Overall Study|Death|3
5212808|NCT01005745|17994344|P1|Overall Study|Inappropriate antidiuretic hormone|1
5212809|NCT01005745|17994344|P1|Overall Study|Death prior to treatment|1
5212810|NCT01005745|17994344|P1|Overall Study|Disease progressed during TIL growth|3
5212811|NCT01005745|17994344|P1|Overall Study|No TIL growth|1
5212812|NCT01005732|17994349|P1|Overall Study|Death|1
5212813|NCT01005732|17994349|P1|Overall Study|Lost to Follow-up|10
5212814|NCT01005719|17994365|P6|Period 2|Adverse Event|1
5212815|NCT01005719|17994366|P5|Period 2|Adverse Event|1
5212816|NCT01005719|17994367|P4|Period 2|Adverse Event|0
5212817|NCT01005719|17994368|P3|Period 2|Adverse Event|0
5212818|NCT01005719|17994369|P2|Period 2|Adverse Event|0
5212819|NCT01005719|17994370|P1|Period 2|Adverse Event|0
5212820|NCT01005719|17994365|P6|Period 1|Delay in completing study procedures|1
5212821|NCT01005719|17994366|P5|Period 1|Delay in completing study procedures|0
5212822|NCT01005719|17994367|P4|Period 1|Delay in completing study procedures|0
5212823|NCT01005719|17994368|P3|Period 1|Delay in completing study procedures|0
5212824|NCT01005719|17994369|P2|Period 1|Delay in completing study procedures|0
5212825|NCT01005719|17994370|P1|Period 1|Delay in completing study procedures|0
5212826|NCT01005719|17994365|P6|Period 1|Adverse Event|0
5212827|NCT01005719|17994366|P5|Period 1|Adverse Event|0
5212828|NCT01005719|17994367|P4|Period 1|Adverse Event|1
5212829|NCT01005719|17994368|P3|Period 1|Adverse Event|0
5212830|NCT01005719|17994369|P2|Period 1|Adverse Event|0
5212831|NCT01005719|17994370|P1|Period 1|Adverse Event|0
5212832|NCT01005680|17994437|P2|Overall Study|Physician Decision|1
5212833|NCT01005680|17994438|P1|Overall Study|Physician Decision|1
5212834|NCT01005680|17994437|P2|Overall Study|Withdrawal by Subject|4
5212835|NCT01005680|17994438|P1|Overall Study|Withdrawal by Subject|1
5212836|NCT01005680|17994437|P2|Overall Study|Lost to Follow-up|6
5212837|NCT01005680|17994438|P1|Overall Study|Lost to Follow-up|4
5212838|NCT01005602|17994462|P2|Overall Study|Excluded due to unreliable clinical data|0
5212839|NCT01005602|17994463|P1|Overall Study|Excluded due to unreliable clinical data|1
5212840|NCT01005329|17994551|P1|Overall Study|Ineligible or received no protocol trt.|4
5212841|NCT01005316|17994564|P4|Overall Study|Retransplanted|0
5212842|NCT01005316|17994565|P3|Overall Study|Retransplanted|0
5212843|NCT01005316|17994566|P2|Overall Study|Retransplanted|1
5212844|NCT01005316|17994567|P1|Overall Study|Retransplanted|0
5212845|NCT01005316|17994564|P4|Overall Study|Transferred Care|3
5212846|NCT01005316|17994565|P3|Overall Study|Transferred Care|1
5212847|NCT01005316|17994566|P2|Overall Study|Transferred Care|0
5212848|NCT01005316|17994567|P1|Overall Study|Transferred Care|1
5212849|NCT01005316|17994564|P4|Overall Study|Delisted|0
5212850|NCT01005316|17994565|P3|Overall Study|Delisted|0
5212851|NCT01005316|17994566|P2|Overall Study|Delisted|0
5212852|NCT01005316|17994567|P1|Overall Study|Delisted|8
5212853|NCT01005316|17994564|P4|Overall Study|Consented to Another Study|0
5212854|NCT01005316|17994565|P3|Overall Study|Consented to Another Study|0
5212855|NCT01005316|17994566|P2|Overall Study|Consented to Another Study|0
5212856|NCT01005316|17994567|P1|Overall Study|Consented to Another Study|2
5212857|NCT01005316|17994564|P4|Overall Study|Withdrawal by Subject|2
5212858|NCT01005316|17994565|P3|Overall Study|Withdrawal by Subject|0
5212859|NCT01005316|17994566|P2|Overall Study|Withdrawal by Subject|1
5212860|NCT01005316|17994567|P1|Overall Study|Withdrawal by Subject|1
5212861|NCT01005316|17994564|P4|Overall Study|Sponsor Decision|0
5212862|NCT01005316|17994565|P3|Overall Study|Sponsor Decision|0
5212863|NCT01005316|17994566|P2|Overall Study|Sponsor Decision|3
5212864|NCT01005316|17994567|P1|Overall Study|Sponsor Decision|6
5212865|NCT01005316|17994564|P4|Overall Study|Physician Decision|0
5212866|NCT01005316|17994565|P3|Overall Study|Physician Decision|0
5212867|NCT01005316|17994566|P2|Overall Study|Physician Decision|0
5212868|NCT01005316|17994567|P1|Overall Study|Physician Decision|6
5212869|NCT01005316|17994564|P4|Overall Study|Lost to Follow-up|2
5212870|NCT01005316|17994565|P3|Overall Study|Lost to Follow-up|0
5212871|NCT01005316|17994566|P2|Overall Study|Lost to Follow-up|3
5212872|NCT01005316|17994567|P1|Overall Study|Lost to Follow-up|1
5212873|NCT01005316|17994564|P4|Overall Study|Study Termination|85
5212874|NCT01005316|17994565|P3|Overall Study|Study Termination|9
5212875|NCT01005316|17994566|P2|Overall Study|Study Termination|63
5212876|NCT01005316|17994567|P1|Overall Study|Study Termination|5
5212877|NCT01005316|17994564|P4|Overall Study|Death|15
5212878|NCT01005316|17994565|P3|Overall Study|Death|1
5212879|NCT01005316|17994566|P2|Overall Study|Death|5
5212880|NCT01005316|17994567|P1|Overall Study|Death|20
5212881|NCT01005316|17994564|P4|Overall Study|Adverse Event|1
5212882|NCT01005316|17994565|P3|Overall Study|Adverse Event|0
5212883|NCT01005316|17994566|P2|Overall Study|Adverse Event|0
5212884|NCT01005316|17994567|P1|Overall Study|Adverse Event|0
5212885|NCT01005251|17994634|P5|Overall Study|Lack of Efficacy|0
5212886|NCT01005251|17994635|P4|Overall Study|Lack of Efficacy|1
5212887|NCT01005251|17994636|P3|Overall Study|Lack of Efficacy|1
5212888|NCT01005251|17994637|P2|Overall Study|Lack of Efficacy|0
5212889|NCT01005251|17994638|P1|Overall Study|Lack of Efficacy|0
5212890|NCT01005251|17994634|P5|Overall Study|Randomized in error|0
5212891|NCT01005251|17994635|P4|Overall Study|Randomized in error|1
5212892|NCT01005251|17994636|P3|Overall Study|Randomized in error|1
5212893|NCT01005251|17994637|P2|Overall Study|Randomized in error|0
5212894|NCT01005251|17994638|P1|Overall Study|Randomized in error|0
5212895|NCT01005251|17994634|P5|Overall Study|Wrong drug dispensed|0
5212896|NCT01005251|17994635|P4|Overall Study|Wrong drug dispensed|0
5212897|NCT01005251|17994636|P3|Overall Study|Wrong drug dispensed|0
5212898|NCT01005251|17994637|P2|Overall Study|Wrong drug dispensed|1
5212899|NCT01005251|17994638|P1|Overall Study|Wrong drug dispensed|0
5212900|NCT01005251|17994634|P5|Overall Study|Patient moved|0
5212901|NCT01005251|17994635|P4|Overall Study|Patient moved|0
5212902|NCT01005251|17994636|P3|Overall Study|Patient moved|0
5212903|NCT01005251|17994637|P2|Overall Study|Patient moved|0
5212904|NCT01005251|17994638|P1|Overall Study|Patient moved|1
5212905|NCT01005251|17994634|P5|Overall Study|Physician Decision|2
5212906|NCT01005251|17994635|P4|Overall Study|Physician Decision|0
5212907|NCT01005251|17994636|P3|Overall Study|Physician Decision|0
5212908|NCT01005251|17994637|P2|Overall Study|Physician Decision|0
5212909|NCT01005251|17994638|P1|Overall Study|Physician Decision|0
5212910|NCT01005251|17994634|P5|Overall Study|Lost to Follow-up|0
5212911|NCT01005251|17994635|P4|Overall Study|Lost to Follow-up|0
5212912|NCT01005251|17994636|P3|Overall Study|Lost to Follow-up|2
5212913|NCT01005251|17994637|P2|Overall Study|Lost to Follow-up|4
5212914|NCT01005251|17994638|P1|Overall Study|Lost to Follow-up|1
5212915|NCT01005251|17994634|P5|Overall Study|Developed study-specific withdrawal crit|1
5212916|NCT01005251|17994635|P4|Overall Study|Developed study-specific withdrawal crit|0
5212917|NCT01005251|17994636|P3|Overall Study|Developed study-specific withdrawal crit|3
5212918|NCT01005251|17994637|P2|Overall Study|Developed study-specific withdrawal crit|0
5212919|NCT01005251|17994638|P1|Overall Study|Developed study-specific withdrawal crit|2
5212920|NCT01005251|17994634|P5|Overall Study|Protocol Violation|2
5212921|NCT01005251|17994635|P4|Overall Study|Protocol Violation|0
5212922|NCT01005251|17994636|P3|Overall Study|Protocol Violation|0
5212923|NCT01005251|17994637|P2|Overall Study|Protocol Violation|0
5212924|NCT01005251|17994638|P1|Overall Study|Protocol Violation|1
5212925|NCT01005251|17994634|P5|Overall Study|Adverse Event|4
5212926|NCT01005251|17994635|P4|Overall Study|Adverse Event|5
5212927|NCT01005251|17994636|P3|Overall Study|Adverse Event|8
5212928|NCT01005251|17994637|P2|Overall Study|Adverse Event|6
5212929|NCT01005251|17994638|P1|Overall Study|Adverse Event|2
5212930|NCT01005251|17994634|P5|Overall Study|Eligibility criteria not fulfilled|0
5212931|NCT01005251|17994635|P4|Overall Study|Eligibility criteria not fulfilled|1
5212932|NCT01005251|17994636|P3|Overall Study|Eligibility criteria not fulfilled|4
5212933|NCT01005251|17994637|P2|Overall Study|Eligibility criteria not fulfilled|0
5212934|NCT01005251|17994638|P1|Overall Study|Eligibility criteria not fulfilled|4
5212935|NCT01005251|17994634|P5|Overall Study|Withdrawal by Subject|9
5212936|NCT01005251|17994635|P4|Overall Study|Withdrawal by Subject|4
5212937|NCT01005251|17994636|P3|Overall Study|Withdrawal by Subject|3
5212938|NCT01005251|17994637|P2|Overall Study|Withdrawal by Subject|5
5212939|NCT01005251|17994638|P1|Overall Study|Withdrawal by Subject|2
5212940|NCT01004861|17994722|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212941|NCT01004861|17994723|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212942|NCT01004861|17994724|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212943|NCT01004861|17994725|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212944|NCT01004861|17994726|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
5212945|NCT01004861|17994727|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212946|NCT01004861|17994728|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212947|NCT01004861|17994729|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212948|NCT01004861|17994730|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212949|NCT01004861|17994731|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212950|NCT01004861|17994732|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212951|NCT01004861|17994733|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212952|NCT01004861|17994734|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
5212953|NCT01004861|17994722|P13|Overall Study|Other|3
5212954|NCT01004861|17994723|P12|Overall Study|Other|2
5212955|NCT01004861|17994724|P11|Overall Study|Other|1
5212956|NCT01004861|17994725|P10|Overall Study|Other|2
5212957|NCT01004861|17994726|P9|Overall Study|Other|1
5212958|NCT01004861|17994727|P8|Overall Study|Other|0
5212959|NCT01004861|17994728|P7|Overall Study|Other|0
5212960|NCT01004861|17994729|P6|Overall Study|Other|0
5212961|NCT01004861|17994730|P5|Overall Study|Other|0
5212962|NCT01004861|17994731|P4|Overall Study|Other|0
5212963|NCT01004861|17994732|P3|Overall Study|Other|0
5212964|NCT01004861|17994733|P2|Overall Study|Other|0
5212965|NCT01004861|17994734|P1|Overall Study|Other|0
5212966|NCT01004861|17994722|P13|Overall Study|Non-compliance|1
5212967|NCT01004861|17994723|P12|Overall Study|Non-compliance|0
5212968|NCT01004861|17994724|P11|Overall Study|Non-compliance|0
5212969|NCT01004861|17994725|P10|Overall Study|Non-compliance|0
5212970|NCT01004861|17994726|P9|Overall Study|Non-compliance|5
5212971|NCT01004861|17994727|P8|Overall Study|Non-compliance|0
5212972|NCT01004861|17994728|P7|Overall Study|Non-compliance|0
5212973|NCT01004861|17994729|P6|Overall Study|Non-compliance|0
5212974|NCT01004861|17994730|P5|Overall Study|Non-compliance|0
5212975|NCT01004861|17994731|P4|Overall Study|Non-compliance|0
5212976|NCT01004861|17994732|P3|Overall Study|Non-compliance|0
5212977|NCT01004861|17994733|P2|Overall Study|Non-compliance|0
5212978|NCT01004861|17994734|P1|Overall Study|Non-compliance|0
5212979|NCT01004861|17994722|P13|Overall Study|Lost to Follow-up|0
5212980|NCT01004861|17994723|P12|Overall Study|Lost to Follow-up|1
5212981|NCT01004861|17994724|P11|Overall Study|Lost to Follow-up|0
5212982|NCT01004861|17994725|P10|Overall Study|Lost to Follow-up|0
5212983|NCT01004861|17994726|P9|Overall Study|Lost to Follow-up|1
5212984|NCT01004861|17994727|P8|Overall Study|Lost to Follow-up|1
5212985|NCT01004861|17994728|P7|Overall Study|Lost to Follow-up|0
5212986|NCT01004861|17994729|P6|Overall Study|Lost to Follow-up|0
5212987|NCT01004861|17994730|P5|Overall Study|Lost to Follow-up|0
5212988|NCT01004861|17994731|P4|Overall Study|Lost to Follow-up|0
5212989|NCT01004861|17994732|P3|Overall Study|Lost to Follow-up|0
5212990|NCT01004861|17994733|P2|Overall Study|Lost to Follow-up|0
5212991|NCT01004861|17994734|P1|Overall Study|Lost to Follow-up|0
5212992|NCT01004861|17994722|P13|Overall Study|Withdrawal by Subject|3
5212993|NCT01004861|17994723|P12|Overall Study|Withdrawal by Subject|2
5212994|NCT01004861|17994724|P11|Overall Study|Withdrawal by Subject|1
5212995|NCT01004861|17994725|P10|Overall Study|Withdrawal by Subject|1
5212996|NCT01004861|17994726|P9|Overall Study|Withdrawal by Subject|2
5212997|NCT01004861|17994727|P8|Overall Study|Withdrawal by Subject|0
5212998|NCT01004861|17994728|P7|Overall Study|Withdrawal by Subject|1
5212999|NCT01004861|17994729|P6|Overall Study|Withdrawal by Subject|0
5213000|NCT01004861|17994730|P5|Overall Study|Withdrawal by Subject|1
5213001|NCT01004861|17994731|P4|Overall Study|Withdrawal by Subject|0
5213002|NCT01004861|17994732|P3|Overall Study|Withdrawal by Subject|0
5213003|NCT01004861|17994733|P2|Overall Study|Withdrawal by Subject|0
5213004|NCT01004861|17994734|P1|Overall Study|Withdrawal by Subject|0
5213005|NCT01004861|17994722|P13|Overall Study|Protocol Violation|0
5213006|NCT01004861|17994723|P12|Overall Study|Protocol Violation|0
5213007|NCT01004861|17994724|P11|Overall Study|Protocol Violation|0
5213008|NCT01004861|17994725|P10|Overall Study|Protocol Violation|0
5213009|NCT01004861|17994726|P9|Overall Study|Protocol Violation|0
5213010|NCT01004861|17994727|P8|Overall Study|Protocol Violation|0
5213011|NCT01004861|17994728|P7|Overall Study|Protocol Violation|0
5213012|NCT01004861|17994729|P6|Overall Study|Protocol Violation|0
5213013|NCT01004861|17994730|P5|Overall Study|Protocol Violation|1
5213014|NCT01004861|17994731|P4|Overall Study|Protocol Violation|0
5213015|NCT01004861|17994732|P3|Overall Study|Protocol Violation|0
5213016|NCT01004861|17994733|P2|Overall Study|Protocol Violation|0
5213017|NCT01004861|17994734|P1|Overall Study|Protocol Violation|0
5213018|NCT01004861|17994722|P13|Overall Study|Adverse Event|2
5213019|NCT01004861|17994723|P12|Overall Study|Adverse Event|0
5213020|NCT01004861|17994724|P11|Overall Study|Adverse Event|1
5213021|NCT01004861|17994725|P10|Overall Study|Adverse Event|1
5213022|NCT01004861|17994726|P9|Overall Study|Adverse Event|13
5213023|NCT01004861|17994727|P8|Overall Study|Adverse Event|1
5213024|NCT01004861|17994728|P7|Overall Study|Adverse Event|1
5213025|NCT01004861|17994729|P6|Overall Study|Adverse Event|2
5213026|NCT01004861|17994730|P5|Overall Study|Adverse Event|0
5213027|NCT01004861|17994731|P4|Overall Study|Adverse Event|1
5213028|NCT01004861|17994732|P3|Overall Study|Adverse Event|0
5213029|NCT01004861|17994733|P2|Overall Study|Adverse Event|0
5213030|NCT01004861|17994734|P1|Overall Study|Adverse Event|0
5213031|NCT01004861|17994722|P13|Overall Study|Physician Decision|3
5213032|NCT01004861|17994723|P12|Overall Study|Physician Decision|0
5213033|NCT01004861|17994724|P11|Overall Study|Physician Decision|0
5213034|NCT01004861|17994725|P10|Overall Study|Physician Decision|0
5213035|NCT01004861|17994726|P9|Overall Study|Physician Decision|0
5213036|NCT01004861|17994727|P8|Overall Study|Physician Decision|1
5213037|NCT01004861|17994728|P7|Overall Study|Physician Decision|0
5213038|NCT01004861|17994729|P6|Overall Study|Physician Decision|0
5213039|NCT01004861|17994730|P5|Overall Study|Physician Decision|1
5213040|NCT01004861|17994731|P4|Overall Study|Physician Decision|1
5213041|NCT01004861|17994732|P3|Overall Study|Physician Decision|1
5213042|NCT01004861|17994733|P2|Overall Study|Physician Decision|2
5213043|NCT01004861|17994734|P1|Overall Study|Physician Decision|0
5213044|NCT01004861|17994722|P13|Overall Study|Disease progression|8
5213045|NCT01004861|17994723|P12|Overall Study|Disease progression|3
5213046|NCT01004861|17994724|P11|Overall Study|Disease progression|6
5213047|NCT01004861|17994725|P10|Overall Study|Disease progression|7
5213048|NCT01004861|17994726|P9|Overall Study|Disease progression|4
5213049|NCT01004861|17994727|P8|Overall Study|Disease progression|1
5213050|NCT01004861|17994728|P7|Overall Study|Disease progression|5
5213051|NCT01004861|17994729|P6|Overall Study|Disease progression|4
5213052|NCT01004861|17994730|P5|Overall Study|Disease progression|4
5213053|NCT01004861|17994731|P4|Overall Study|Disease progression|4
5213054|NCT01004861|17994732|P3|Overall Study|Disease progression|5
5213055|NCT01004861|17994733|P2|Overall Study|Disease progression|4
5213056|NCT01004861|17994734|P1|Overall Study|Disease progression|3
5213057|NCT01004848|17994800|P2|Overall Study|Lost to Follow-up|45
5213058|NCT01004848|17994801|P1|Overall Study|Lost to Follow-up|55
5213059|NCT01004822|17994839|P8|Overall Study|Other|0
5213060|NCT01004822|17994840|P7|Overall Study|Other|0
5213061|NCT01004822|17994841|P6|Overall Study|Other|1
5213062|NCT01004822|17994842|P5|Overall Study|Other|0
5213063|NCT01004822|17994843|P4|Overall Study|Other|1
5213064|NCT01004822|17994844|P3|Overall Study|Other|4
5213065|NCT01004822|17994845|P2|Overall Study|Other|0
5213066|NCT01004822|17994846|P1|Overall Study|Other|0
5213067|NCT01004822|17994839|P8|Overall Study|Adverse Event|1
5213068|NCT01004822|17994840|P7|Overall Study|Adverse Event|1
5213069|NCT01004822|17994841|P6|Overall Study|Adverse Event|0
5213070|NCT01004822|17994842|P5|Overall Study|Adverse Event|0
5213071|NCT01004822|17994843|P4|Overall Study|Adverse Event|0
5213072|NCT01004822|17994844|P3|Overall Study|Adverse Event|0
5213073|NCT01004822|17994845|P2|Overall Study|Adverse Event|0
5213074|NCT01004822|17994846|P1|Overall Study|Adverse Event|0
5213075|NCT01004822|17994839|P8|Overall Study|No longer willing to continue|0
5213076|NCT01004822|17994840|P7|Overall Study|No longer willing to continue|1
5213077|NCT01004822|17994841|P6|Overall Study|No longer willing to continue|1
5213078|NCT01004822|17994842|P5|Overall Study|No longer willing to continue|2
5213079|NCT01004822|17994843|P4|Overall Study|No longer willing to continue|1
5213080|NCT01004822|17994844|P3|Overall Study|No longer willing to continue|0
5213081|NCT01004822|17994845|P2|Overall Study|No longer willing to continue|0
5213082|NCT01004822|17994846|P1|Overall Study|No longer willing to continue|0
5213083|NCT01004822|17994839|P8|Overall Study|Global deterioration of health status|0
5213084|NCT01004822|17994840|P7|Overall Study|Global deterioration of health status|1
5213085|NCT01004822|17994841|P6|Overall Study|Global deterioration of health status|0
5213086|NCT01004822|17994842|P5|Overall Study|Global deterioration of health status|0
5213087|NCT01004822|17994843|P4|Overall Study|Global deterioration of health status|1
5213088|NCT01004822|17994844|P3|Overall Study|Global deterioration of health status|0
5213089|NCT01004822|17994845|P2|Overall Study|Global deterioration of health status|0
5213090|NCT01004822|17994846|P1|Overall Study|Global deterioration of health status|0
5213091|NCT01004822|17994839|P8|Overall Study|Objective progression or relapse|4
5213092|NCT01004822|17994840|P7|Overall Study|Objective progression or relapse|1
5213093|NCT01004822|17994841|P6|Overall Study|Objective progression or relapse|2
5213094|NCT01004822|17994842|P5|Overall Study|Objective progression or relapse|2
5213095|NCT01004822|17994843|P4|Overall Study|Objective progression or relapse|1
5213096|NCT01004822|17994844|P3|Overall Study|Objective progression or relapse|0
5213097|NCT01004822|17994845|P2|Overall Study|Objective progression or relapse|3
5213098|NCT01004822|17994846|P1|Overall Study|Objective progression or relapse|3
5213099|NCT01004614|17995011|P4|Washout|Withdrawal by Subject|0
5213100|NCT01004614|17995012|P3|Washout|Withdrawal by Subject|0
5213101|NCT01004614|17995013|P2|Washout|Withdrawal by Subject|1
5213102|NCT01004614|17995014|P1|Washout|Withdrawal by Subject|0
5213103|NCT01004510|17995048|P1|Overall Study|Adverse Event|1
5213104|NCT01004432|17995052|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
5213105|NCT01004432|17995053|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5213106|NCT01004432|17995054|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5213107|NCT01004432|17995055|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5213108|NCT01004432|17995056|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5213109|NCT01004432|17995052|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
5213110|NCT01004432|17995053|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5213111|NCT01004432|17995054|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5213112|NCT01004432|17995055|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5213113|NCT01004432|17995056|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5213114|NCT01004432|17995052|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
5213115|NCT01004432|17995053|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5213116|NCT01004432|17995054|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5213117|NCT01004432|17995055|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5213118|NCT01004432|17995056|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5213119|NCT01004432|17995052|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
5213120|NCT01004432|17995053|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
5213121|NCT01004432|17995054|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
5213122|NCT01004432|17995055|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
5213123|NCT01004432|17995056|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
5213124|NCT01004432|17995052|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
5213125|NCT01004432|17995053|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
5213126|NCT01004432|17995054|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
5213127|NCT01004432|17995055|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
5213128|NCT01004432|17995056|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
5213129|NCT01004432|17995052|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
5213130|NCT01004432|17995053|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
5213131|NCT01004432|17995054|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
5213132|NCT01004432|17995055|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
5213133|NCT01004432|17995056|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
5213134|NCT01004432|17995052|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5213135|NCT01004432|17995053|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
5213136|NCT01004432|17995054|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5213137|NCT01004432|17995055|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5213138|NCT01004432|17995056|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5213139|NCT01004432|17995052|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
5213140|NCT01004432|17995053|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
5213141|NCT01004432|17995054|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
5213142|NCT01004432|17995055|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
5213143|NCT01004432|17995056|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
5213144|NCT01004432|17995052|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
5213145|NCT01004432|17995053|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
5213146|NCT01004432|17995054|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
5213147|NCT01004432|17995055|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
5213148|NCT01004432|17995056|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
5213149|NCT01004432|17995052|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
5213150|NCT01004432|17995053|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
5213151|NCT01004432|17995054|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
5213152|NCT01004432|17995055|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
5213153|NCT01004432|17995056|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
5213154|NCT01004432|17995052|P5|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5213155|NCT01004432|17995053|P4|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5213156|NCT01004432|17995054|P3|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5213157|NCT01004432|17995055|P2|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5213158|NCT01004432|17995056|P1|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
5213159|NCT01004432|17995052|P5|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5213160|NCT01004432|17995053|P4|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5213161|NCT01004432|17995054|P3|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5213162|NCT01004432|17995055|P2|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5213163|NCT01004432|17995056|P1|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
5213164|NCT01004432|17995052|P5|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5213165|NCT01004432|17995053|P4|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5213166|NCT01004432|17995054|P3|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5213167|NCT01004432|17995055|P2|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5213168|NCT01004432|17995056|P1|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
5213169|NCT01004432|17995052|P5|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5213170|NCT01004432|17995053|P4|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5213171|NCT01004432|17995054|P3|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5213172|NCT01004432|17995055|P2|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5213173|NCT01004432|17995056|P1|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
5213174|NCT01004432|17995052|P5|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5213175|NCT01004432|17995053|P4|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5213176|NCT01004432|17995054|P3|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5213177|NCT01004432|17995055|P2|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5213178|NCT01004432|17995056|P1|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
5213179|NCT01004406|17995078|P2|Overall Study|Lost to Follow-up|0
5213180|NCT01004406|17995079|P1|Overall Study|Lost to Follow-up|1
5213181|NCT01004406|17995078|P2|Overall Study|Withdrawal by Subject|0
5213182|NCT01004406|17995079|P1|Overall Study|Withdrawal by Subject|2
5213183|NCT01004263|17995114|P1|Overall Study|Lack of Qualifying Event|2
5213184|NCT01004263|17995114|P1|Overall Study|Physician Decision|15
5213185|NCT01004263|17995114|P1|Overall Study|Pregnancy|2
5213186|NCT01004263|17995114|P1|Overall Study|Lack of Efficacy|13
5213187|NCT01004263|17995114|P1|Overall Study|Lost to Follow-up|64
5213188|NCT01004263|17995114|P1|Overall Study|Protocol Violation|10
5213189|NCT01004263|17995114|P1|Overall Study|Withdrawal by Subject|58
5213190|NCT01004263|17995114|P1|Overall Study|Adverse Event|15
5213191|NCT01004250|17995122|P1|Follow-Up (FU) Period|Lost to Follow-up|1
5213192|NCT01004250|17995122|P1|Maintenance Therapy Period|Physician Decision|4
5213193|NCT01004250|17995122|P1|Maintenance Therapy Period|Withdrawal by Subject|5
5213194|NCT01004250|17995122|P1|Maintenance Therapy Period|Protocol Violation|1
5213195|NCT01004250|17995122|P1|Maintenance Therapy Period|Lost to Follow-up|1
5213196|NCT01004250|17995122|P1|Maintenance Therapy Period|Adverse Event|15
5213197|NCT01004250|17995122|P1|Induction Therapy Period|Physician Decision|2
5213198|NCT01004250|17995122|P1|Induction Therapy Period|Withdrawal by Subject|2
5213199|NCT01004250|17995122|P1|Induction Therapy Period|Entry Criteria Not Met|1
5213200|NCT01004250|17995122|P1|Induction Therapy Period|Adverse Event|10
5213201|NCT01004185|17995134|P2|Overall Study|Withdrawal by Subject|1
5213202|NCT01004185|17995135|P1|Overall Study|Withdrawal by Subject|2
5213203|NCT01004185|17995134|P2|Overall Study|Sponsor Terminated Study|5
5213204|NCT01004185|17995135|P1|Overall Study|Sponsor Terminated Study|4
5213205|NCT01004185|17995134|P2|Overall Study|Lack of Efficacy|1
5213206|NCT01004185|17995135|P1|Overall Study|Lack of Efficacy|2
5213207|NCT01004185|17995134|P2|Overall Study|Lost to Follow-up|1
5213208|NCT01004185|17995135|P1|Overall Study|Lost to Follow-up|0
5213209|NCT01004185|17995134|P2|Overall Study|Adverse Event|1
5213210|NCT01004185|17995135|P1|Overall Study|Adverse Event|1
5213211|NCT01004172|17995143|P1|Overall Study|Symptomatic Deterioration|2
5213212|NCT01004172|17995143|P1|Overall Study|Physician Decision|1
5213213|NCT01004172|17995143|P1|Overall Study|Adverse Event|1
5213214|NCT01004172|17995143|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
5213215|NCT01004172|17995143|P1|Overall Study|Progressive Disease in Non-CNS Only|16
5213216|NCT01004172|17995143|P1|Overall Study|Progressive Disease in CNS Only|16
5213217|NCT01004159|17995151|P1|Overall Study|Disease Progression|18
5213218|NCT01004159|17995151|P1|Overall Study|Adverse Event|2
5213219|NCT01004146|17995158|P2|Overall Study|Withdrawal by Subject|5
5213220|NCT01004146|17995159|P1|Overall Study|Withdrawal by Subject|4
5213221|NCT01004003|17995253|P9|Overall Study|Other|0
5213222|NCT01004003|17995254|P8|Overall Study|Other|0
5213223|NCT01004003|17995255|P7|Overall Study|Other|0
5213224|NCT01004003|17995256|P6|Overall Study|Other|1
5213225|NCT01004003|17995257|P5|Overall Study|Other|0
5213226|NCT01004003|17995258|P4|Overall Study|Other|0
5213227|NCT01004003|17995259|P3|Overall Study|Other|0
5213228|NCT01004003|17995260|P2|Overall Study|Other|0
5213229|NCT01004003|17995261|P1|Overall Study|Other|0
5213230|NCT01004003|17995253|P9|Overall Study|Refused to continue taking trial med.|2
5213231|NCT01004003|17995254|P8|Overall Study|Refused to continue taking trial med.|0
5213232|NCT01004003|17995255|P7|Overall Study|Refused to continue taking trial med.|0
5213233|NCT01004003|17995256|P6|Overall Study|Refused to continue taking trial med.|0
5213234|NCT01004003|17995257|P5|Overall Study|Refused to continue taking trial med.|0
5213235|NCT01004003|17995258|P4|Overall Study|Refused to continue taking trial med.|0
5213236|NCT01004003|17995259|P3|Overall Study|Refused to continue taking trial med.|0
5213237|NCT01004003|17995260|P2|Overall Study|Refused to continue taking trial med.|0
5213238|NCT01004003|17995261|P1|Overall Study|Refused to continue taking trial med.|0
5213239|NCT01004003|17995253|P9|Overall Study|Adverse Event|6
5213240|NCT01004003|17995254|P8|Overall Study|Adverse Event|21
5213241|NCT01004003|17995255|P7|Overall Study|Adverse Event|7
5213242|NCT01004003|17995256|P6|Overall Study|Adverse Event|2
5213243|NCT01004003|17995257|P5|Overall Study|Adverse Event|2
5213244|NCT01004003|17995258|P4|Overall Study|Adverse Event|3
5213245|NCT01004003|17995259|P3|Overall Study|Adverse Event|3
5213246|NCT01004003|17995260|P2|Overall Study|Adverse Event|2
5213247|NCT01004003|17995261|P1|Overall Study|Adverse Event|4
5213248|NCT01004003|17995253|P9|Overall Study|Progressive disease|22
5213249|NCT01004003|17995254|P8|Overall Study|Progressive disease|39
5213250|NCT01004003|17995255|P7|Overall Study|Progressive disease|1
5213251|NCT01004003|17995256|P6|Overall Study|Progressive disease|1
5213252|NCT01004003|17995257|P5|Overall Study|Progressive disease|2
5213253|NCT01004003|17995258|P4|Overall Study|Progressive disease|0
5213254|NCT01004003|17995259|P3|Overall Study|Progressive disease|1
5213255|NCT01004003|17995260|P2|Overall Study|Progressive disease|1
5213256|NCT01004003|17995261|P1|Overall Study|Progressive disease|2
5213257|NCT01003990|17995292|P3|Overall Study|Subject Withdrew Consent|7
5213258|NCT01003990|17995293|P2|Overall Study|Subject Withdrew Consent|5
5213259|NCT01003990|17995294|P1|Overall Study|Subject Withdrew Consent|12
5213260|NCT01003990|17995292|P3|Overall Study|No Longer Met Study Criteria|0
5213261|NCT01003990|17995293|P2|Overall Study|No Longer Met Study Criteria|1
5213262|NCT01003990|17995294|P1|Overall Study|No Longer Met Study Criteria|4
5213263|NCT01003990|17995292|P3|Overall Study|Pregnancy|4
5213264|NCT01003990|17995293|P2|Overall Study|Pregnancy|2
5213265|NCT01003990|17995294|P1|Overall Study|Pregnancy|10
5213266|NCT01003990|17995292|P3|Overall Study|Poor/Non-compliance|2
5213267|NCT01003990|17995293|P2|Overall Study|Poor/Non-compliance|3
5213268|NCT01003990|17995294|P1|Overall Study|Poor/Non-compliance|4
5213269|NCT01003990|17995292|P3|Overall Study|Reasons Not Identified|8
5213270|NCT01003990|17995293|P2|Overall Study|Reasons Not Identified|13
5213271|NCT01003990|17995294|P1|Overall Study|Reasons Not Identified|14
5213272|NCT01003990|17995292|P3|Overall Study|Lost to Follow-up|7
5213273|NCT01003990|17995293|P2|Overall Study|Lost to Follow-up|12
5213274|NCT01003990|17995294|P1|Overall Study|Lost to Follow-up|30
5213275|NCT01003990|17995292|P3|Overall Study|Lack of Efficacy|3
5213276|NCT01003990|17995293|P2|Overall Study|Lack of Efficacy|2
5213277|NCT01003990|17995294|P1|Overall Study|Lack of Efficacy|10
5213278|NCT01003990|17995292|P3|Overall Study|Death|1
5213279|NCT01003990|17995293|P2|Overall Study|Death|8
5213280|NCT01003990|17995294|P1|Overall Study|Death|0
5213281|NCT01003990|17995292|P3|Overall Study|Adverse Event|11
5213282|NCT01003990|17995293|P2|Overall Study|Adverse Event|5
5213283|NCT01003990|17995294|P1|Overall Study|Adverse Event|8
5213284|NCT01003899|17995311|P1|Overall Study|Progressive disease|34
5213285|NCT01003899|17995311|P1|Overall Study|Not treated|1
5213286|NCT01003899|17995311|P1|Overall Study|Not entered|4
5213287|NCT01003899|17995311|P1|Overall Study|Other Adverse Event|8
5213288|NCT01003886|17995320|P1|Overall Study|Adverse Event|3
5213289|NCT01003886|17995320|P1|Overall Study|Other|14
5213290|NCT01003886|17995320|P1|Overall Study|Withdrawal by Subject|39
5213291|NCT01003886|17995320|P1|Overall Study|Lost to Follow-up|169
5213292|NCT01003886|17995320|P1|Overall Study|Lack of Efficacy|5
5213293|NCT01003639|17995341|P2|Overall Study|Physician Decision|0
5213294|NCT01003639|17995342|P1|Overall Study|Physician Decision|1
5213295|NCT01003639|17995341|P2|Overall Study|Protocol Violation|1
5213296|NCT01003639|17995342|P1|Overall Study|Protocol Violation|0
5213297|NCT01003639|17995341|P2|Overall Study|Adverse Event|1
5213298|NCT01003639|17995342|P1|Overall Study|Adverse Event|0
5213299|NCT01003639|17995341|P2|Overall Study|Lack of Efficacy|6
5213300|NCT01003639|17995342|P1|Overall Study|Lack of Efficacy|1
5213301|NCT01003639|17995341|P2|Overall Study|Withdrawal by Subject|5
5213302|NCT01003639|17995342|P1|Overall Study|Withdrawal by Subject|9
5213303|NCT01003639|17995341|P2|Overall Study|Lost to Follow-up|9
5213304|NCT01003639|17995342|P1|Overall Study|Lost to Follow-up|6
5213305|NCT01003249|17995398|P2|Second Intervention (4 Weeks)|Adverse Event|0
5213306|NCT01003249|17995399|P1|Second Intervention (4 Weeks)|Adverse Event|1
5213307|NCT01003249|17995398|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5213308|NCT01003249|17995399|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5213309|NCT01003249|17995398|P2|First Intervention (4 Weeks)|Non-Serious Event|1
5213310|NCT01003249|17995399|P1|First Intervention (4 Weeks)|Non-Serious Event|1
5213311|NCT01003249|17995398|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
5213312|NCT01003249|17995399|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
5213313|NCT01003210|17995417|P2|Overall Study|Lost to Follow-up|3
5213314|NCT01003210|17995418|P1|Overall Study|Lost to Follow-up|1
5213315|NCT01003184|17995430|P2|Overall Study|Physician Decision|0
5213316|NCT01003184|17995431|P1|Overall Study|Physician Decision|1
5213317|NCT01003184|17995430|P2|Overall Study|Withdrawal by Subject|6
5213318|NCT01003184|17995431|P1|Overall Study|Withdrawal by Subject|1
5213319|NCT01003184|17995430|P2|Overall Study|Protocol Violation|0
5213320|NCT01003184|17995431|P1|Overall Study|Protocol Violation|3
5213321|NCT01003184|17995430|P2|Overall Study|Loss of glucose control|1
5213322|NCT01003184|17995431|P1|Overall Study|Loss of glucose control|1
5213323|NCT01003184|17995430|P2|Overall Study|Lost to Follow-up|0
5213324|NCT01003184|17995431|P1|Overall Study|Lost to Follow-up|1
5213325|NCT01003184|17995430|P2|Overall Study|Adverse Event|5
5213326|NCT01003184|17995431|P1|Overall Study|Adverse Event|12
5213327|NCT01002989|17995514|P1|Overall Study|exclusion criteria, no consent|5
5213328|NCT01002742|17995529|P2|Overall Study|Determined to be ineligible|1
5213329|NCT01002742|17995530|P1|Overall Study|Determined to be ineligible|0
5213330|NCT01002573|17995566|P2|Overall Study|Subject did not receive at least 1 dose|7
5213331|NCT01002573|17995567|P1|Overall Study|Subject did not receive at least 1 dose|11
5213332|NCT01002547|17995588|P3|Overall Study|Adverse Event|0
5213333|NCT01002547|17995589|P2|Overall Study|Adverse Event|0
5213334|NCT01002547|17995590|P1|Overall Study|Adverse Event|1
5213335|NCT01002547|17995588|P3|Overall Study|Death|2
5213336|NCT01002547|17995589|P2|Overall Study|Death|2
5213337|NCT01002547|17995590|P1|Overall Study|Death|0
5213338|NCT01002547|17995588|P3|Overall Study|Physician Decision|0
5213339|NCT01002547|17995589|P2|Overall Study|Physician Decision|0
5213340|NCT01002547|17995590|P1|Overall Study|Physician Decision|1
5213341|NCT01002547|17995588|P3|Overall Study|Lost to Follow-up|1
5213342|NCT01002547|17995589|P2|Overall Study|Lost to Follow-up|1
5213343|NCT01002547|17995590|P1|Overall Study|Lost to Follow-up|2
5213344|NCT01002547|17995588|P3|Overall Study|Withdrawal by Subject|5
5213345|NCT01002547|17995589|P2|Overall Study|Withdrawal by Subject|0
5213346|NCT01002547|17995590|P1|Overall Study|Withdrawal by Subject|4
5213347|NCT01002482|17995648|P2|Overall Study|Included twice|0
5213348|NCT01002482|17995649|P1|Overall Study|Included twice|1
5213349|NCT01002482|17995648|P2|Overall Study|Withdrawal by Subject|21
5213350|NCT01002482|17995649|P1|Overall Study|Withdrawal by Subject|14
5213351|NCT01002339|17995683|P3|Overall Study|Randomized. Not transplanted|1
5213352|NCT01002339|17995684|P2|Overall Study|Randomized. Not transplanted|0
5213353|NCT01002339|17995685|P1|Overall Study|Randomized. Not transplanted|0
5213354|NCT01002339|17995683|P3|Overall Study|Lung cancer detected before transplant|1
5213355|NCT01002339|17995684|P2|Overall Study|Lung cancer detected before transplant|0
5213356|NCT01002339|17995685|P1|Overall Study|Lung cancer detected before transplant|0
5213357|NCT01002339|17995683|P3|Overall Study|Protocol Violation|2
5213358|NCT01002339|17995684|P2|Overall Study|Protocol Violation|0
5213359|NCT01002339|17995685|P1|Overall Study|Protocol Violation|0
5213360|NCT01002339|17995683|P3|Overall Study|Incorrect treatment assignment|1
5213361|NCT01002339|17995684|P2|Overall Study|Incorrect treatment assignment|0
5213362|NCT01002339|17995685|P1|Overall Study|Incorrect treatment assignment|0
5213363|NCT01002339|17995683|P3|Overall Study|Withdrawal by Subject|0
5213364|NCT01002339|17995684|P2|Overall Study|Withdrawal by Subject|1
5213365|NCT01002339|17995685|P1|Overall Study|Withdrawal by Subject|0
5213366|NCT01002105|17995761|P2|Overall Study|condition worsened|2
5213367|NCT01002105|17995762|P1|Overall Study|condition worsened|4
5213368|NCT01002105|17995761|P2|Overall Study|non compliance|3
5213369|NCT01002105|17995762|P1|Overall Study|non compliance|5
5213370|NCT01002105|17995761|P2|Overall Study|Lost to Follow-up|16
5213371|NCT01002105|17995762|P1|Overall Study|Lost to Follow-up|10
5213372|NCT01001988|17995778|P1|Overall Study|Lost to Follow-up|15
5213373|NCT01001988|17995778|P1|Overall Study|Withdrawal by Subject|18
5213374|NCT01001988|17995778|P1|Overall Study|Protocol Violation|84
5213375|NCT01001832|17995796|P2|Follow-up Period|Other|1
5213376|NCT01001832|17995797|P1|Follow-up Period|Other|2
5213377|NCT01001832|17995796|P2|Follow-up Period|Follow-up no longer required /protocol|20
5213378|NCT01001832|17995797|P1|Follow-up Period|Follow-up no longer required /protocol|15
5213379|NCT01001832|17995796|P2|Follow-up Period|Withdrawal by Subject|0
5213380|NCT01001832|17995797|P1|Follow-up Period|Withdrawal by Subject|1
5213381|NCT01001832|17995796|P2|Long-term Period|Other|2
5213382|NCT01001832|17995797|P1|Long-term Period|Other|1
5213383|NCT01001832|17995796|P2|Long-term Period|Lack of Efficacy|2
5213384|NCT01001832|17995797|P1|Long-term Period|Lack of Efficacy|0
5213385|NCT01001832|17995796|P2|Long-term Period|Withdrawal by Subject|0
5213386|NCT01001832|17995797|P1|Long-term Period|Withdrawal by Subject|1
5213387|NCT01001832|17995796|P2|Long-term Period|Adverse Event|1
5213388|NCT01001832|17995797|P1|Long-term Period|Adverse Event|2
5213389|NCT01001832|17995796|P2|Short-term Period|Adverse Event|3
5213390|NCT01001832|17995797|P1|Short-term Period|Adverse Event|2
5213391|NCT01001767|17995855|P2|Overall Study|Physician Decision|0
5213392|NCT01001767|17995856|P1|Overall Study|Physician Decision|1
5213393|NCT01001767|17995855|P2|Overall Study|Lost to Follow-up|0
5213394|NCT01001767|17995856|P1|Overall Study|Lost to Follow-up|1
5213395|NCT01001767|17995855|P2|Overall Study|Protocol Violation|0
5213396|NCT01001767|17995856|P1|Overall Study|Protocol Violation|1
5213397|NCT01001767|17995855|P2|Overall Study|no baseline study performed|0
5213398|NCT01001767|17995856|P1|Overall Study|no baseline study performed|1
5213399|NCT01001702|17995862|P1|Overall Study|Lack of Efficacy per Investigator|3
5213400|NCT01001702|17995862|P1|Overall Study|Withdrawal by Subject|19
5213401|NCT01001702|17995862|P1|Overall Study|Investigator withdrew Subject|10
5213402|NCT01001702|17995862|P1|Overall Study|Subject met Withdrawal Criteria|22
5213403|NCT01001702|17995862|P1|Overall Study|Sponsor Discontinued Study|4
5213404|NCT01001702|17995862|P1|Overall Study|Adverse Event|7
5213405|NCT01001702|17995862|P1|Overall Study|Lost to Follow-up|7
5213406|NCT01001598|17995873|P1|Overall Study|Adverse Event|1
5213407|NCT01001598|17995873|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
5213408|NCT01001572|17995881|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
5213409|NCT01001572|17995882|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
5213410|NCT01001572|17995883|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
5213411|NCT01001572|17995881|P3|Double-Blind Treatment Phase|Protocol deviation|1
5213412|NCT01001572|17995882|P2|Double-Blind Treatment Phase|Protocol deviation|0
5213413|NCT01001572|17995883|P1|Double-Blind Treatment Phase|Protocol deviation|0
5213414|NCT01001572|17995881|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
5213415|NCT01001572|17995882|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5213416|NCT01001572|17995883|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5213417|NCT01001572|17995881|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
5213418|NCT01001572|17995882|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
5213419|NCT01001572|17995883|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
5213420|NCT01001572|17995881|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
5213421|NCT01001572|17995882|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
5213422|NCT01001572|17995883|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
5213423|NCT01001572|17995881|P3|Double-Blind Treatment Phase|Adverse Event|2
5213424|NCT01001572|17995882|P2|Double-Blind Treatment Phase|Adverse Event|2
5213425|NCT01001572|17995883|P1|Double-Blind Treatment Phase|Adverse Event|0
5213426|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
5213427|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
5213428|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
5213429|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
5213430|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
5213431|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
5213432|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
5213433|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
5213434|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
5213435|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
5213436|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
5213437|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
5213438|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
5213439|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
5213440|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
5213441|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
5213442|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
5213443|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
5213444|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
5213445|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
5213446|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
5213447|NCT01001572|17995881|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
5213448|NCT01001572|17995882|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
5213449|NCT01001572|17995883|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
5213450|NCT01001520|17995921|P2|Medication Period 2|Withdrawal by Subject|3
5213451|NCT01001520|17995922|P1|Medication Period 2|Withdrawal by Subject|0
5213452|NCT01001520|17995921|P2|Washout Period|Withdrawal by Subject|1
5213453|NCT01001520|17995922|P1|Washout Period|Withdrawal by Subject|2
5213454|NCT01001520|17995921|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
5213455|NCT01001520|17995922|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
5213456|NCT01001520|17995921|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
5213457|NCT01001520|17995922|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
5213458|NCT01001520|17995921|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
5213459|NCT01001520|17995922|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
5213460|NCT01001520|17995921|P2|Medication Period 1|Withdrawal by Subject|2
5213461|NCT01001520|17995922|P1|Medication Period 1|Withdrawal by Subject|2
5213462|NCT01001494|17995949|P3|Overall Study|Other|3
5213463|NCT01001494|17995950|P2|Overall Study|Other|1
5213464|NCT01001494|17995951|P1|Overall Study|Other|0
5213465|NCT01001494|17995949|P3|Overall Study|Lack of Efficacy|8
5213466|NCT01001494|17995950|P2|Overall Study|Lack of Efficacy|0
5213467|NCT01001494|17995951|P1|Overall Study|Lack of Efficacy|2
5213468|NCT01001494|17995949|P3|Overall Study|COPD exacerbation|5
5213469|NCT01001494|17995950|P2|Overall Study|COPD exacerbation|4
5213470|NCT01001494|17995951|P1|Overall Study|COPD exacerbation|3
5213471|NCT01001494|17995949|P3|Overall Study|Withdrawal by Subject|17
5213472|NCT01001494|17995950|P2|Overall Study|Withdrawal by Subject|7
5213473|NCT01001494|17995951|P1|Overall Study|Withdrawal by Subject|9
5213474|NCT01001494|17995949|P3|Overall Study|Lost to Follow-up|1
5213475|NCT01001494|17995950|P2|Overall Study|Lost to Follow-up|0
5213476|NCT01001494|17995951|P1|Overall Study|Lost to Follow-up|2
5213477|NCT01001494|17995949|P3|Overall Study|Protocol Violation|1
5213478|NCT01001494|17995950|P2|Overall Study|Protocol Violation|1
5213479|NCT01001494|17995951|P1|Overall Study|Protocol Violation|0
5213480|NCT01001494|17995949|P3|Overall Study|Adverse Event|6
5213481|NCT01001494|17995950|P2|Overall Study|Adverse Event|4
5213482|NCT01001494|17995951|P1|Overall Study|Adverse Event|8
5213483|NCT01001429|17996036|P2|Overall Study|surgery cancelled|1
5213484|NCT01001429|17996037|P1|Overall Study|surgery cancelled|0
5213485|NCT01001390|17996076|P2|Overall Study|Failure to wear AFO device|0
5213486|NCT01001390|17996077|P1|Overall Study|Failure to wear AFO device|2
5213487|NCT01001377|17996085|P2|Overall Study|Death|384
5213488|NCT01001377|17996086|P1|Overall Study|Death|391
5213489|NCT01001377|17996085|P2|Overall Study|Lost to Follow-up|17
5213490|NCT01001377|17996086|P1|Overall Study|Lost to Follow-up|14
5213491|NCT01001377|17996085|P2|Overall Study|Withdrawal by Subject|20
5213492|NCT01001377|17996086|P1|Overall Study|Withdrawal by Subject|19
5213493|NCT01001377|17996085|P2|Overall Study|Ineligibility determined|0
5213494|NCT01001377|17996086|P1|Overall Study|Ineligibility determined|2
5213495|NCT01001325|17996116|P2|Overall Study|Protocol Violation|0
5213496|NCT01001325|17996117|P1|Overall Study|Protocol Violation|2
5213497|NCT01001325|17996116|P2|Overall Study|Lost to Follow-up|10
5213498|NCT01001325|17996117|P1|Overall Study|Lost to Follow-up|16
5213499|NCT01001299|17996123|P1|Overall Study|Withdrew Consent|1
5213500|NCT01001299|17996123|P1|Overall Study|Began Taking Commercially Available Drug|2
5213501|NCT01001299|17996123|P1|Overall Study|Death|1
5213502|NCT01001299|17996123|P1|Overall Study|Adverse event or Intercurrent Illness|1
5213503|NCT01001299|17996123|P1|Overall Study|Insufficient Therapeutic Response|20
5213504|NCT01001234|17996152|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
5213505|NCT01001234|17996153|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
5213506|NCT01001234|17996154|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
5213507|NCT01001234|17996155|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
5213508|NCT01001234|17996156|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
5213509|NCT01001234|17996152|P5|Overall Study|Not Treated: Physician Decision|0
5213510|NCT01001234|17996153|P4|Overall Study|Not Treated: Physician Decision|0
5213511|NCT01001234|17996154|P3|Overall Study|Not Treated: Physician Decision|0
5213512|NCT01001234|17996155|P2|Overall Study|Not Treated: Physician Decision|4
5213513|NCT01001234|17996156|P1|Overall Study|Not Treated: Physician Decision|37
5213514|NCT01001234|17996152|P5|Overall Study|Not Treated: Pregnancy|0
5213515|NCT01001234|17996153|P4|Overall Study|Not Treated: Pregnancy|0
5213516|NCT01001234|17996154|P3|Overall Study|Not Treated: Pregnancy|0
5213517|NCT01001234|17996155|P2|Overall Study|Not Treated: Pregnancy|0
5213518|NCT01001234|17996156|P1|Overall Study|Not Treated: Pregnancy|3
5213519|NCT01001234|17996152|P5|Overall Study|Not Treated: Lost to Follow-up|0
5213520|NCT01001234|17996153|P4|Overall Study|Not Treated: Lost to Follow-up|5
5213521|NCT01001234|17996154|P3|Overall Study|Not Treated: Lost to Follow-up|7
5213522|NCT01001234|17996155|P2|Overall Study|Not Treated: Lost to Follow-up|4
5213523|NCT01001234|17996156|P1|Overall Study|Not Treated: Lost to Follow-up|53
5213524|NCT01001234|17996152|P5|Overall Study|Not Treated: Protocol Violation|0
5213525|NCT01001234|17996153|P4|Overall Study|Not Treated: Protocol Violation|0
5213526|NCT01001234|17996154|P3|Overall Study|Not Treated: Protocol Violation|0
5213527|NCT01001234|17996155|P2|Overall Study|Not Treated: Protocol Violation|0
5213528|NCT01001234|17996156|P1|Overall Study|Not Treated: Protocol Violation|3
5213529|NCT01001234|17996152|P5|Overall Study|Not Treated: Withdrawal by Subject|0
5213530|NCT01001234|17996153|P4|Overall Study|Not Treated: Withdrawal by Subject|0
5213531|NCT01001234|17996154|P3|Overall Study|Not Treated: Withdrawal by Subject|2
5213532|NCT01001234|17996155|P2|Overall Study|Not Treated: Withdrawal by Subject|2
5213533|NCT01001234|17996156|P1|Overall Study|Not Treated: Withdrawal by Subject|23
5213534|NCT01001234|17996152|P5|Overall Study|Not Treated: Adverse Event|0
5213535|NCT01001234|17996153|P4|Overall Study|Not Treated: Adverse Event|0
5213536|NCT01001234|17996154|P3|Overall Study|Not Treated: Adverse Event|0
5213537|NCT01001234|17996155|P2|Overall Study|Not Treated: Adverse Event|0
5213538|NCT01001234|17996156|P1|Overall Study|Not Treated: Adverse Event|1
5213539|NCT01001234|17996152|P5|Overall Study|Physician Decision|0
5213540|NCT01001234|17996153|P4|Overall Study|Physician Decision|0
5213541|NCT01001234|17996154|P3|Overall Study|Physician Decision|0
5213542|NCT01001234|17996155|P2|Overall Study|Physician Decision|0
5213543|NCT01001234|17996156|P1|Overall Study|Physician Decision|1
5213544|NCT01001234|17996152|P5|Overall Study|Lost to Follow-up|0
5213545|NCT01001234|17996153|P4|Overall Study|Lost to Follow-up|2
5213546|NCT01001234|17996154|P3|Overall Study|Lost to Follow-up|1
5213547|NCT01001234|17996155|P2|Overall Study|Lost to Follow-up|0
5213548|NCT01001234|17996156|P1|Overall Study|Lost to Follow-up|0
5213549|NCT01001234|17996152|P5|Overall Study|Protocol Violation|0
5213550|NCT01001234|17996153|P4|Overall Study|Protocol Violation|18
5213551|NCT01001234|17996154|P3|Overall Study|Protocol Violation|19
5213552|NCT01001234|17996155|P2|Overall Study|Protocol Violation|3
5213553|NCT01001234|17996156|P1|Overall Study|Protocol Violation|34
5213554|NCT01001234|17996152|P5|Overall Study|Withdrawal by Subject|0
5213555|NCT01001234|17996153|P4|Overall Study|Withdrawal by Subject|0
5213556|NCT01001234|17996154|P3|Overall Study|Withdrawal by Subject|3
5213557|NCT01001234|17996155|P2|Overall Study|Withdrawal by Subject|0
5213558|NCT01001234|17996156|P1|Overall Study|Withdrawal by Subject|2
5213559|NCT01001221|17996172|P5|Overall Study|Not treated; protocol exclusion|0
5213560|NCT01001221|17996173|P4|Overall Study|Not treated; protocol exclusion|0
5213561|NCT01001221|17996174|P3|Overall Study|Not treated; protocol exclusion|1
5213562|NCT01001221|17996175|P2|Overall Study|Not treated; protocol exclusion|0
5213563|NCT01001221|17996176|P1|Overall Study|Not treated; protocol exclusion|0
5213564|NCT01001221|17996172|P5|Overall Study|Other|0
5213565|NCT01001221|17996173|P4|Overall Study|Other|0
5213566|NCT01001221|17996174|P3|Overall Study|Other|0
5213567|NCT01001221|17996175|P2|Overall Study|Other|1
5213568|NCT01001221|17996176|P1|Overall Study|Other|1
5213569|NCT01001221|17996172|P5|Overall Study|Disease progression|0
5213570|NCT01001221|17996173|P4|Overall Study|Disease progression|4
5213571|NCT01001221|17996174|P3|Overall Study|Disease progression|2
5213572|NCT01001221|17996175|P2|Overall Study|Disease progression|2
5213573|NCT01001221|17996176|P1|Overall Study|Disease progression|3
5213574|NCT01001221|17996172|P5|Overall Study|Adverse Event|0
5213575|NCT01001221|17996173|P4|Overall Study|Adverse Event|2
5213576|NCT01001221|17996174|P3|Overall Study|Adverse Event|0
5213577|NCT01001221|17996175|P2|Overall Study|Adverse Event|2
5213578|NCT01001221|17996176|P1|Overall Study|Adverse Event|1
5213579|NCT01001208|17996351|P2|Overall Study|Other|2
5213580|NCT01001208|17996352|P1|Overall Study|Other|0
5213581|NCT01001208|17996351|P2|Overall Study|Disease Progression|3
5213582|NCT01001208|17996352|P1|Overall Study|Disease Progression|0
5213583|NCT01001208|17996351|P2|Overall Study|Noncompliance|7
5213584|NCT01001208|17996352|P1|Overall Study|Noncompliance|4
5213585|NCT01001208|17996351|P2|Overall Study|Ineligibility Determined|2
5213586|NCT01001208|17996352|P1|Overall Study|Ineligibility Determined|4
5213587|NCT01001208|17996351|P2|Overall Study|Withdrawal by Subject|5
5213588|NCT01001208|17996352|P1|Overall Study|Withdrawal by Subject|4
5213589|NCT01001208|17996351|P2|Overall Study|Physician Decision|0
5213590|NCT01001208|17996352|P1|Overall Study|Physician Decision|1
5213591|NCT01001208|17996351|P2|Overall Study|Lost to Follow-up|9
5213592|NCT01001208|17996352|P1|Overall Study|Lost to Follow-up|5
5213593|NCT01001208|17996351|P2|Overall Study|Adverse Event|5
5213594|NCT01001208|17996352|P1|Overall Study|Adverse Event|10
5213595|NCT01001169|17996395|P2|Overall Study|Withdrawal by Subject|1
5213596|NCT01001169|17996396|P1|Overall Study|Withdrawal by Subject|2
5213597|NCT01001104|17996504|P4|Overall Study|Withdrawal by Subject|2
5213598|NCT01001104|17996505|P3|Overall Study|Withdrawal by Subject|0
5213599|NCT01001104|17996506|P2|Overall Study|Withdrawal by Subject|0
5213600|NCT01001104|17996507|P1|Overall Study|Withdrawal by Subject|0
5213601|NCT01001104|17996504|P4|Overall Study|Entry Criteria Not Met|1
5213602|NCT01001104|17996505|P3|Overall Study|Entry Criteria Not Met|0
5213603|NCT01001104|17996506|P2|Overall Study|Entry Criteria Not Met|0
5213604|NCT01001104|17996507|P1|Overall Study|Entry Criteria Not Met|0
5213605|NCT01001104|17996504|P4|Overall Study|Lost to Follow-up|0
5213606|NCT01001104|17996505|P3|Overall Study|Lost to Follow-up|1
5213607|NCT01001104|17996506|P2|Overall Study|Lost to Follow-up|0
5213608|NCT01001104|17996507|P1|Overall Study|Lost to Follow-up|0
5213609|NCT01001104|17996504|P4|Overall Study|Adverse Event|0
5213610|NCT01001104|17996505|P3|Overall Study|Adverse Event|0
5213611|NCT01001104|17996506|P2|Overall Study|Adverse Event|1
5213612|NCT01001104|17996507|P1|Overall Study|Adverse Event|2
5213613|NCT01000974|17996598|P3|Booster Vaccination Phase|Other|4
5213614|NCT01000974|17996599|P2|Booster Vaccination Phase|Other|6
5213615|NCT01000974|17996600|P1|Booster Vaccination Phase|Other|24
5213616|NCT01000974|17996598|P3|Booster Vaccination Phase|Lost to Follow-up|7
5213617|NCT01000974|17996599|P2|Booster Vaccination Phase|Lost to Follow-up|5
5213618|NCT01000974|17996600|P1|Booster Vaccination Phase|Lost to Follow-up|40
5213619|NCT01000974|17996598|P3|Booster Vaccination Phase|Withdrawal by Subject|1
5213620|NCT01000974|17996599|P2|Booster Vaccination Phase|Withdrawal by Subject|1
5213621|NCT01000974|17996600|P1|Booster Vaccination Phase|Withdrawal by Subject|3
5213622|NCT01000974|17996598|P3|Booster Vaccination Phase|Protocol Violation|2
5213623|NCT01000974|17996599|P2|Booster Vaccination Phase|Protocol Violation|0
5213624|NCT01000974|17996600|P1|Booster Vaccination Phase|Protocol Violation|0
5213625|NCT01000974|17996598|P3|Primary Vaccination Phase|Other|12
5213626|NCT01000974|17996599|P2|Primary Vaccination Phase|Other|9
5213627|NCT01000974|17996600|P1|Primary Vaccination Phase|Other|4
5213628|NCT01000974|17996598|P3|Primary Vaccination Phase|Adverse Event|2
5213629|NCT01000974|17996599|P2|Primary Vaccination Phase|Adverse Event|2
5213630|NCT01000974|17996600|P1|Primary Vaccination Phase|Adverse Event|14
5213631|NCT01000974|17996598|P3|Primary Vaccination Phase|Protocol Violation|2
5213632|NCT01000974|17996599|P2|Primary Vaccination Phase|Protocol Violation|3
5213633|NCT01000974|17996600|P1|Primary Vaccination Phase|Protocol Violation|40
5213634|NCT01000974|17996598|P3|Primary Vaccination Phase|Lost to Follow-up|26
5213635|NCT01000974|17996599|P2|Primary Vaccination Phase|Lost to Follow-up|19
5213636|NCT01000974|17996600|P1|Primary Vaccination Phase|Lost to Follow-up|171
5213637|NCT01000974|17996598|P3|Primary Vaccination Phase|Withdrawal by Subject|21
5213638|NCT01000974|17996599|P2|Primary Vaccination Phase|Withdrawal by Subject|17
5213639|NCT01000974|17996600|P1|Primary Vaccination Phase|Withdrawal by Subject|109
5213640|NCT01000961|17996707|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
5213641|NCT01000961|17996708|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
5213642|NCT01000961|17996707|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5213643|NCT01000961|17996708|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
5213644|NCT01000805|17996731|P2|Overall Study|Sponsor Decision|1
5213645|NCT01000805|17996732|P1|Overall Study|Sponsor Decision|0
5213646|NCT01000805|17996731|P2|Overall Study|Withdrawal by Subject|6
5213647|NCT01000805|17996732|P1|Overall Study|Withdrawal by Subject|16
5213648|NCT01000805|17996731|P2|Overall Study|Protocol Violation|8
5213649|NCT01000805|17996732|P1|Overall Study|Protocol Violation|12
5213650|NCT01000805|17996731|P2|Overall Study|Physician Decision|1
5213651|NCT01000805|17996732|P1|Overall Study|Physician Decision|0
5213652|NCT01000805|17996731|P2|Overall Study|Lost to Follow-up|21
5213653|NCT01000805|17996732|P1|Overall Study|Lost to Follow-up|16
5213654|NCT01000805|17996731|P2|Overall Study|Lack of Efficacy|16
5213655|NCT01000805|17996732|P1|Overall Study|Lack of Efficacy|5
5213656|NCT01000805|17996731|P2|Overall Study|Adverse Event|9
5213657|NCT01000805|17996732|P1|Overall Study|Adverse Event|21
5213658|NCT01000727|17996766|P2|Overall Study|Study closed/terminated|24
5213659|NCT01000727|17996767|P1|Overall Study|Study closed/terminated|23
5213660|NCT01000727|17996766|P2|Overall Study|Withdrawal by Subject|109
5213661|NCT01000727|17996767|P1|Overall Study|Withdrawal by Subject|111
5213662|NCT01000727|17996766|P2|Overall Study|Lost to Follow-up|43
5213663|NCT01000727|17996767|P1|Overall Study|Lost to Follow-up|41
5213664|NCT01000649|17996832|P4|Overall Study|Lost to Follow-up|2
5213665|NCT01000649|17996833|P3|Overall Study|Lost to Follow-up|0
5213666|NCT01000649|17996834|P2|Overall Study|Lost to Follow-up|2
5213667|NCT01000649|17996835|P1|Overall Study|Lost to Follow-up|0
5213668|NCT01000649|17996832|P4|Overall Study|Adverse Event|4
5213669|NCT01000649|17996833|P3|Overall Study|Adverse Event|2
5213670|NCT01000649|17996834|P2|Overall Study|Adverse Event|1
5213671|NCT01000649|17996835|P1|Overall Study|Adverse Event|5
5213672|NCT01000610|17996916|P1|Overall Study|Treatment failure|1
5213673|NCT01000610|17996916|P1|Overall Study|Lost to Follow-up|4
5213674|NCT01000610|17996916|P1|Overall Study|Adverse Event|1
5213675|NCT01000506|17996927|P4|Overall Study|Withdrawal by Subject|7
5213676|NCT01000506|17996928|P3|Overall Study|Withdrawal by Subject|2
5213677|NCT01000506|17996929|P2|Overall Study|Withdrawal by Subject|8
5213678|NCT01000506|17996930|P1|Overall Study|Withdrawal by Subject|11
5213679|NCT01000506|17996927|P4|Overall Study|Physician Decision|3
5213680|NCT01000506|17996928|P3|Overall Study|Physician Decision|3
5213681|NCT01000506|17996929|P2|Overall Study|Physician Decision|3
5213682|NCT01000506|17996930|P1|Overall Study|Physician Decision|1
5213683|NCT01000506|17996927|P4|Overall Study|Lost to Follow-up|0
5213684|NCT01000506|17996928|P3|Overall Study|Lost to Follow-up|4
5213685|NCT01000506|17996929|P2|Overall Study|Lost to Follow-up|1
5213686|NCT01000506|17996930|P1|Overall Study|Lost to Follow-up|1
5213687|NCT01000506|17996927|P4|Overall Study|Protocol Violation|0
5213688|NCT01000506|17996928|P3|Overall Study|Protocol Violation|0
5213689|NCT01000506|17996929|P2|Overall Study|Protocol Violation|1
5213690|NCT01000506|17996930|P1|Overall Study|Protocol Violation|1
5213691|NCT01000506|17996927|P4|Overall Study|Lack of Efficacy|4
5213692|NCT01000506|17996928|P3|Overall Study|Lack of Efficacy|4
5213693|NCT01000506|17996929|P2|Overall Study|Lack of Efficacy|6
5213694|NCT01000506|17996930|P1|Overall Study|Lack of Efficacy|8
5213695|NCT01000506|17996927|P4|Overall Study|Adverse Event|9
5213696|NCT01000506|17996928|P3|Overall Study|Adverse Event|8
5213697|NCT01000506|17996929|P2|Overall Study|Adverse Event|5
5213698|NCT01000506|17996930|P1|Overall Study|Adverse Event|6
5213699|NCT01000493|17996974|P2|Overall Study|Withdrawal by Subject|7
5213700|NCT01000493|17996975|P1|Overall Study|Withdrawal by Subject|3
5213701|NCT01000493|17996974|P2|Overall Study|Physician Decision|1
5213702|NCT01000493|17996975|P1|Overall Study|Physician Decision|1
5213703|NCT01000493|17996974|P2|Overall Study|Lost to Follow-up|9
5213704|NCT01000493|17996975|P1|Overall Study|Lost to Follow-up|5
5213705|NCT01000493|17996974|P2|Overall Study|Study closed/terminated|23
5213706|NCT01000493|17996975|P1|Overall Study|Study closed/terminated|25
5213707|NCT01000493|17996974|P2|Overall Study|Protocol Violation|8
5213708|NCT01000493|17996975|P1|Overall Study|Protocol Violation|1
5213709|NCT01000493|17996974|P2|Overall Study|Lack of Efficacy|1
5213710|NCT01000493|17996975|P1|Overall Study|Lack of Efficacy|1
5213711|NCT01000493|17996974|P2|Overall Study|Adverse Event|6
5213712|NCT01000493|17996975|P1|Overall Study|Adverse Event|3
5213713|NCT01000480|17997025|P1|Concurrent Therapy Phase|Physician Decision|1
5213714|NCT01000480|17997025|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
5213715|NCT01000480|17997025|P1|Concurrent Therapy Phase|Protocol Violation|2
5213716|NCT01000480|17997025|P1|Concurrent Therapy Phase|Adverse Event|4
5213717|NCT01000480|17997025|P1|Induction Phase|Entry Criteria Not Met|3
5213718|NCT01000480|17997025|P1|Induction Phase|Physician Decision|1
5213719|NCT01000480|17997025|P1|Induction Phase|Lost to Follow-up|1
5213720|NCT01000480|17997025|P1|Induction Phase|Adverse Event|2
5213721|NCT01000376|17997033|P2|Cycle 1 Day 1|Progressive Disease|0
5213722|NCT01000376|17997034|P1|Cycle 1 Day 1|Progressive Disease|1
5213723|NCT01000376|17997033|P2|Cycle 1 Day 1|Adverse Event|0
5213724|NCT01000376|17997034|P1|Cycle 1 Day 1|Adverse Event|1
5213725|NCT01000337|17997044|P2|Overall Study|Lost to Follow-up|3
5213726|NCT01000337|17997045|P1|Overall Study|Lost to Follow-up|4
5213727|NCT01000311|17997063|P2|Overall Study|Administrative reason|15
5213728|NCT01000311|17997064|P1|Overall Study|Administrative reason|9
5213729|NCT01000311|17997063|P2|Overall Study|Inappropriate enrollment|0
5213730|NCT01000311|17997064|P1|Overall Study|Inappropriate enrollment|2
5213731|NCT01000311|17997063|P2|Overall Study|Protocol Violation|2
5213732|NCT01000311|17997064|P1|Overall Study|Protocol Violation|1
5213733|NCT01000311|17997063|P2|Overall Study|Lost to Follow-up|24
5213734|NCT01000311|17997064|P1|Overall Study|Lost to Follow-up|15
5213735|NCT01000311|17997063|P2|Overall Study|Withdrawal by Subject|24
5213736|NCT01000311|17997064|P1|Overall Study|Withdrawal by Subject|16
5213737|NCT01000311|17997063|P2|Overall Study|Adverse Event|5
5213738|NCT01000311|17997064|P1|Overall Study|Adverse Event|2
5213739|NCT01000155|17997114|P1|Overall Study|Adverse Event|1
5213740|NCT01000155|17997114|P1|Overall Study|Withdrawal by Subject|1
5213741|NCT01000064|17997120|P2|Overall Study|Withdrawal by Subject|1
5213742|NCT01000064|17997121|P1|Overall Study|Withdrawal by Subject|1
5213743|NCT01000051|17997144|P2|Overall Study|Serious noncompliance|0
5213744|NCT01000051|17997145|P1|Overall Study|Serious noncompliance|1
5213745|NCT01000051|17997144|P2|Overall Study|Disease Progression|0
5213746|NCT01000051|17997145|P1|Overall Study|Disease Progression|1
5213747|NCT01000051|17997144|P2|Overall Study|Withdrawal by Subject|1
5213748|NCT01000051|17997145|P1|Overall Study|Withdrawal by Subject|1
5213749|NCT01000025|17997153|P2|Overall Study|Intercurrent Illness|7
5213750|NCT01000025|17997154|P1|Overall Study|Intercurrent Illness|26
5213751|NCT01000025|17997153|P2|Overall Study|Lack of Efficacy|208
5213752|NCT01000025|17997154|P1|Overall Study|Lack of Efficacy|363
5213753|NCT01000025|17997153|P2|Overall Study|Death|13
5213754|NCT01000025|17997154|P1|Overall Study|Death|23
5213755|NCT01000025|17997153|P2|Overall Study|Withdrawal by Subject|8
5213756|NCT01000025|17997154|P1|Overall Study|Withdrawal by Subject|13
5213757|NCT01000025|17997153|P2|Overall Study|Adverse Event|2
5213758|NCT01000025|17997154|P1|Overall Study|Adverse Event|43
5213759|NCT00999921|17997172|P2|Overall Study|Lost to Follow-up|19
5213760|NCT00999921|17997173|P1|Overall Study|Lost to Follow-up|10
5213761|NCT00999908|17997183|P3|Treatment Period 2|Protocol Violation|0
5213762|NCT00999908|17997184|P2|Treatment Period 2|Protocol Violation|0
5213763|NCT00999908|17997185|P1|Treatment Period 2|Protocol Violation|1
5213764|NCT00999908|17997183|P3|Treatment Period 1|Subject withdrew consent|0
5213765|NCT00999908|17997184|P2|Treatment Period 1|Subject withdrew consent|0
5213766|NCT00999908|17997185|P1|Treatment Period 1|Subject withdrew consent|2
5213767|NCT00999804|17997214|P2|Overall Study|Ineligible|0
5213768|NCT00999804|17997215|P1|Overall Study|Ineligible|3
5213769|NCT00999804|17997214|P2|Overall Study|Death|0
5213770|NCT00999804|17997215|P1|Overall Study|Death|1
5213771|NCT00999804|17997214|P2|Overall Study|Withdrawal by Subject|0
5213772|NCT00999804|17997215|P1|Overall Study|Withdrawal by Subject|4
5213773|NCT00999804|17997214|P2|Overall Study|Adverse Event|3
5213774|NCT00999804|17997215|P1|Overall Study|Adverse Event|4
5213775|NCT00999804|17997214|P2|Overall Study|Lack of Efficacy|2
5213776|NCT00999804|17997215|P1|Overall Study|Lack of Efficacy|9
5213777|NCT00999713|17997229|P2|Overall Study|Physician Decision|0
5213778|NCT00999713|17997230|P1|Overall Study|Physician Decision|2
5213779|NCT00999687|17997244|P1|Second Intervention|Lack of Efficacy|1
5213780|NCT00999687|17997244|P1|Second Intervention|Withdrawal by Subject|2
5213781|NCT00999687|17997244|P1|First Intervention|Withdrawal by Subject|1
5213782|NCT00999661|17997251|P1|Overall Study|Not meeting eligibility criteria|9
5213783|NCT00999661|17997251|P1|Overall Study|Withdrawal by Subject|1
5213784|NCT00999661|17997251|P1|Overall Study|Adverse Event|1
5213785|NCT00999661|17997251|P1|Overall Study|Lost to Follow-up|59
5213786|NCT00999596|17997272|P1|Overall Study|Statistical population not required|101
5213787|NCT00999544|17997277|P1|Overall Study|Withdrawal by Subject|1
5213788|NCT00999466|17997313|P3|Main Part|Adverse Event|2
5213789|NCT00999466|17997314|P2|Main Part|Adverse Event|4
5213790|NCT00999466|17997315|P1|Main Part|Adverse Event|0
5213791|NCT00999466|17997313|P3|Main Part|Withdrawal by Subject|2
5213792|NCT00999466|17997314|P2|Main Part|Withdrawal by Subject|0
5213793|NCT00999466|17997315|P1|Main Part|Withdrawal by Subject|0
5213794|NCT00999167|17997592|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
5213795|NCT00999167|17997593|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
5213796|NCT00999167|17997594|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
5213797|NCT00999167|17997592|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
5213798|NCT00999167|17997593|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
5213799|NCT00999167|17997594|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
5213800|NCT00999167|17997592|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
5213801|NCT00999167|17997593|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
5213802|NCT00999167|17997594|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
5213803|NCT00999167|17997592|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
5213804|NCT00999167|17997593|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
5213805|NCT00999167|17997594|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
5213806|NCT00999167|17997592|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
5213807|NCT00999167|17997593|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
5213808|NCT00999167|17997594|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
5213809|NCT00999167|17997592|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
5213810|NCT00999167|17997593|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
5213811|NCT00999167|17997594|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
5213812|NCT00999167|17997592|P3|Part A: Open Label Safety run-in|Adverse Event|0
5213813|NCT00999167|17997593|P2|Part A: Open Label Safety run-in|Adverse Event|0
5213814|NCT00999167|17997594|P1|Part A: Open Label Safety run-in|Adverse Event|3
5213815|NCT00999167|17997592|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
5213816|NCT00999167|17997593|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
5213817|NCT00999167|17997594|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
5213818|NCT00998985|17997732|P14|Overall Study|Protocol Violation|0
5213819|NCT00998985|17997733|P13|Overall Study|Protocol Violation|0
5213820|NCT00998985|17997734|P12|Overall Study|Protocol Violation|0
5213821|NCT00998985|17997735|P11|Overall Study|Protocol Violation|0
5213822|NCT00998985|17997736|P10|Overall Study|Protocol Violation|0
5213823|NCT00998985|17997737|P9|Overall Study|Protocol Violation|0
5213824|NCT00998985|17997738|P8|Overall Study|Protocol Violation|0
5213825|NCT00998985|17997739|P7|Overall Study|Protocol Violation|0
5213826|NCT00998985|17997740|P6|Overall Study|Protocol Violation|1
5213827|NCT00998985|17997741|P5|Overall Study|Protocol Violation|0
5213828|NCT00998985|17997742|P4|Overall Study|Protocol Violation|0
5213829|NCT00998985|17997743|P3|Overall Study|Protocol Violation|0
5213830|NCT00998985|17997744|P2|Overall Study|Protocol Violation|0
5213831|NCT00998985|17997745|P1|Overall Study|Protocol Violation|0
5213832|NCT00998985|17997732|P14|Overall Study|Withdrawal by Subject|0
5213833|NCT00998985|17997733|P13|Overall Study|Withdrawal by Subject|0
5213834|NCT00998985|17997734|P12|Overall Study|Withdrawal by Subject|0
5213835|NCT00998985|17997735|P11|Overall Study|Withdrawal by Subject|0
5213836|NCT00998985|17997736|P10|Overall Study|Withdrawal by Subject|0
5213837|NCT00998985|17997737|P9|Overall Study|Withdrawal by Subject|1
5213838|NCT00998985|17997738|P8|Overall Study|Withdrawal by Subject|0
5213839|NCT00998985|17997739|P7|Overall Study|Withdrawal by Subject|0
5213840|NCT00998985|17997740|P6|Overall Study|Withdrawal by Subject|0
5213841|NCT00998985|17997741|P5|Overall Study|Withdrawal by Subject|0
5213842|NCT00998985|17997742|P4|Overall Study|Withdrawal by Subject|0
5213843|NCT00998985|17997743|P3|Overall Study|Withdrawal by Subject|0
5213844|NCT00998985|17997744|P2|Overall Study|Withdrawal by Subject|0
5213845|NCT00998985|17997745|P1|Overall Study|Withdrawal by Subject|0
5213846|NCT00998881|17997813|P2|Overall Study|Personal matter|0
5213847|NCT00998881|17997814|P1|Overall Study|Personal matter|1
5213848|NCT00998881|17997813|P2|Overall Study|Withdrawal by Subject|0
5213849|NCT00998881|17997814|P1|Overall Study|Withdrawal by Subject|1
5213850|NCT00998881|17997813|P2|Overall Study|Physician Decision|0
5213851|NCT00998881|17997814|P1|Overall Study|Physician Decision|3
5213852|NCT00998881|17997813|P2|Overall Study|Lack of Efficacy|0
5213853|NCT00998881|17997814|P1|Overall Study|Lack of Efficacy|1
5213854|NCT00998881|17997813|P2|Overall Study|Adverse Event|2
5213855|NCT00998881|17997814|P1|Overall Study|Adverse Event|2
5213856|NCT00998790|17997833|P1|Overall Study|Withdrawal by Subject|21
5213857|NCT00998764|17997843|P2|Overall Study|Recurrent Episode of vasogenic edema|0
5213858|NCT00998764|17997844|P1|Overall Study|Recurrent Episode of vasogenic edema|1
5213859|NCT00998764|17997843|P2|Overall Study|Other|4
5213860|NCT00998764|17997844|P1|Overall Study|Other|4
5213861|NCT00998764|17997843|P2|Overall Study|Loss of Caregiver|3
5213862|NCT00998764|17997844|P1|Overall Study|Loss of Caregiver|0
5213863|NCT00998764|17997843|P2|Overall Study|Lost to Follow-up|1
5213864|NCT00998764|17997844|P1|Overall Study|Lost to Follow-up|1
5213865|NCT00998764|17997843|P2|Overall Study|Failed to Return|1
5213866|NCT00998764|17997844|P1|Overall Study|Failed to Return|1
5213867|NCT00998764|17997843|P2|Overall Study|Protocol Violation|1
5213868|NCT00998764|17997844|P1|Overall Study|Protocol Violation|0
5213869|NCT00998764|17997843|P2|Overall Study|Discontinuation of Study by Sponsor|217
5213870|NCT00998764|17997844|P1|Overall Study|Discontinuation of Study by Sponsor|164
5213871|NCT00998764|17997843|P2|Overall Study|Death|1
5213872|NCT00998764|17997844|P1|Overall Study|Death|3
5213873|NCT00998764|17997843|P2|Overall Study|Physician Decision|3
5213874|NCT00998764|17997844|P1|Overall Study|Physician Decision|3
5213875|NCT00998764|17997843|P2|Overall Study|Withdrawal by Subject|25
5213876|NCT00998764|17997844|P1|Overall Study|Withdrawal by Subject|19
5213877|NCT00998764|17997843|P2|Overall Study|Adverse Event|12
5213878|NCT00998764|17997844|P1|Overall Study|Adverse Event|17
5213879|NCT00998764|17997843|P2|Overall Study|Lack of Efficacy|6
5213880|NCT00998764|17997844|P1|Overall Study|Lack of Efficacy|3
5213881|NCT00998738|17997866|P1|Overall Study|Uknown|1
5213882|NCT00998400|17997934|P2|Overall Study|Logistical problems|0
5213883|NCT00998400|17997935|P1|Overall Study|Logistical problems|1
5213884|NCT00998400|17997934|P2|Overall Study|Lack of interest/motivation|2
5213885|NCT00998400|17997935|P1|Overall Study|Lack of interest/motivation|1
5213886|NCT00998335|17997980|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
5213887|NCT00998335|17997981|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
5213888|NCT00998309|17998009|P1|Overall Study|Protocol Violation|4
5213889|NCT00998296|17998076|P11|Overall Study|Reason other than those specified above|0
5213890|NCT00998296|17998077|P10|Overall Study|Reason other than those specified above|1
5213891|NCT00998296|17998078|P9|Overall Study|Reason other than those specified above|0
5213892|NCT00998296|17998079|P8|Overall Study|Reason other than those specified above|0
5213893|NCT00998296|17998080|P7|Overall Study|Reason other than those specified above|0
5213894|NCT00998296|17998081|P6|Overall Study|Reason other than those specified above|0
5213895|NCT00998296|17998082|P5|Overall Study|Reason other than those specified above|0
5213896|NCT00998296|17998083|P4|Overall Study|Reason other than those specified above|0
5213897|NCT00998296|17998084|P3|Overall Study|Reason other than those specified above|0
5213898|NCT00998296|17998085|P2|Overall Study|Reason other than those specified above|0
5213899|NCT00998296|17998086|P1|Overall Study|Reason other than those specified above|0
5213900|NCT00998296|17998076|P11|Overall Study|Refused to continue taking trial med.|0
5213901|NCT00998296|17998077|P10|Overall Study|Refused to continue taking trial med.|2
5213902|NCT00998296|17998078|P9|Overall Study|Refused to continue taking trial med.|0
5213903|NCT00998296|17998079|P8|Overall Study|Refused to continue taking trial med.|0
5213904|NCT00998296|17998080|P7|Overall Study|Refused to continue taking trial med.|0
5213905|NCT00998296|17998081|P6|Overall Study|Refused to continue taking trial med.|0
5213906|NCT00998296|17998082|P5|Overall Study|Refused to continue taking trial med.|0
5213907|NCT00998296|17998083|P4|Overall Study|Refused to continue taking trial med.|0
5213908|NCT00998296|17998084|P3|Overall Study|Refused to continue taking trial med.|0
5213909|NCT00998296|17998085|P2|Overall Study|Refused to continue taking trial med.|0
5213910|NCT00998296|17998086|P1|Overall Study|Refused to continue taking trial med.|0
5213911|NCT00998296|17998076|P11|Overall Study|Other adverse event|2
5213912|NCT00998296|17998077|P10|Overall Study|Other adverse event|1
5213913|NCT00998296|17998078|P9|Overall Study|Other adverse event|0
5213914|NCT00998296|17998079|P8|Overall Study|Other adverse event|0
5213915|NCT00998296|17998080|P7|Overall Study|Other adverse event|0
5213916|NCT00998296|17998081|P6|Overall Study|Other adverse event|0
5213917|NCT00998296|17998082|P5|Overall Study|Other adverse event|1
5213918|NCT00998296|17998083|P4|Overall Study|Other adverse event|0
5213919|NCT00998296|17998084|P3|Overall Study|Other adverse event|0
5213920|NCT00998296|17998085|P2|Overall Study|Other adverse event|0
5213921|NCT00998296|17998086|P1|Overall Study|Other adverse event|0
5213922|NCT00998296|17998076|P11|Overall Study|Dose limiting or dose reducing toxicity|0
5213923|NCT00998296|17998077|P10|Overall Study|Dose limiting or dose reducing toxicity|0
5213924|NCT00998296|17998078|P9|Overall Study|Dose limiting or dose reducing toxicity|2
5213925|NCT00998296|17998079|P8|Overall Study|Dose limiting or dose reducing toxicity|2
5213926|NCT00998296|17998080|P7|Overall Study|Dose limiting or dose reducing toxicity|0
5213927|NCT00998296|17998081|P6|Overall Study|Dose limiting or dose reducing toxicity|0
5213928|NCT00998296|17998082|P5|Overall Study|Dose limiting or dose reducing toxicity|1
5213929|NCT00998296|17998083|P4|Overall Study|Dose limiting or dose reducing toxicity|0
5213930|NCT00998296|17998084|P3|Overall Study|Dose limiting or dose reducing toxicity|0
5213931|NCT00998296|17998085|P2|Overall Study|Dose limiting or dose reducing toxicity|0
5213932|NCT00998296|17998086|P1|Overall Study|Dose limiting or dose reducing toxicity|0
5213933|NCT00998296|17998076|P11|Overall Study|Progressive disease|5
5213934|NCT00998296|17998077|P10|Overall Study|Progressive disease|14
5213935|NCT00998296|17998078|P9|Overall Study|Progressive disease|0
5213936|NCT00998296|17998079|P8|Overall Study|Progressive disease|0
5213937|NCT00998296|17998080|P7|Overall Study|Progressive disease|1
5213938|NCT00998296|17998081|P6|Overall Study|Progressive disease|0
5213939|NCT00998296|17998082|P5|Overall Study|Progressive disease|0
5213940|NCT00998296|17998083|P4|Overall Study|Progressive disease|0
5213941|NCT00998296|17998084|P3|Overall Study|Progressive disease|0
5213942|NCT00998296|17998085|P2|Overall Study|Progressive disease|1
5213943|NCT00998296|17998086|P1|Overall Study|Progressive disease|0
5213944|NCT00997984|17998189|P3|Overall Study|Work schedule|2
5213945|NCT00997984|17998190|P2|Overall Study|Work schedule|0
5213946|NCT00997984|17998191|P1|Overall Study|Work schedule|0
5213947|NCT00997984|17998189|P3|Overall Study|Suicidal ideation|1
5213948|NCT00997984|17998190|P2|Overall Study|Suicidal ideation|0
5213949|NCT00997984|17998191|P1|Overall Study|Suicidal ideation|0
5213950|NCT00997984|17998189|P3|Overall Study|Wrong medication dispensed|0
5213951|NCT00997984|17998190|P2|Overall Study|Wrong medication dispensed|1
5213952|NCT00997984|17998191|P1|Overall Study|Wrong medication dispensed|0
5213953|NCT00997984|17998189|P3|Overall Study|non-compliance|3
5213954|NCT00997984|17998190|P2|Overall Study|non-compliance|2
5213955|NCT00997984|17998191|P1|Overall Study|non-compliance|0
5213956|NCT00997984|17998189|P3|Overall Study|Met exclusion criteria|0
5213957|NCT00997984|17998190|P2|Overall Study|Met exclusion criteria|0
5213958|NCT00997984|17998191|P1|Overall Study|Met exclusion criteria|1
5213959|NCT00997984|17998189|P3|Overall Study|Lack of Efficacy|3
5213960|NCT00997984|17998190|P2|Overall Study|Lack of Efficacy|6
5213961|NCT00997984|17998191|P1|Overall Study|Lack of Efficacy|20
5213962|NCT00997984|17998189|P3|Overall Study|Lost to Follow-up|4
5213963|NCT00997984|17998190|P2|Overall Study|Lost to Follow-up|5
5213964|NCT00997984|17998191|P1|Overall Study|Lost to Follow-up|8
5213965|NCT00997984|17998189|P3|Overall Study|Withdrawal by Subject|5
5213966|NCT00997984|17998190|P2|Overall Study|Withdrawal by Subject|9
5213967|NCT00997984|17998191|P1|Overall Study|Withdrawal by Subject|6
5213968|NCT00997984|17998189|P3|Overall Study|Protocol Violation|0
5213969|NCT00997984|17998190|P2|Overall Study|Protocol Violation|3
5213970|NCT00997984|17998191|P1|Overall Study|Protocol Violation|1
5213971|NCT00997984|17998189|P3|Overall Study|Adverse Event|8
5213972|NCT00997984|17998190|P2|Overall Study|Adverse Event|8
5213973|NCT00997984|17998191|P1|Overall Study|Adverse Event|1
5213974|NCT00997503|17998349|P1|Overall Study|Other reason|13
5213975|NCT00997503|17998349|P1|Overall Study|Missed 12-month follow-up|85
5213976|NCT00997503|17998349|P1|Overall Study|Physician Decision|10
5213977|NCT00997503|17998349|P1|Overall Study|Adverse Event|3
5213978|NCT00997503|17998349|P1|Overall Study|Lost to Follow-up|33
5213979|NCT00997503|17998349|P1|Overall Study|Withdrawal by Subject|76
5213980|NCT00997503|17998349|P1|Overall Study|Death|53
5213981|NCT00997438|17998392|P3|Overall Study|Exclusion criteria at visit 1|3
5213982|NCT00997438|17998393|P2|Overall Study|Exclusion criteria at visit 1|2
5213983|NCT00997438|17998394|P1|Overall Study|Exclusion criteria at visit 1|2
5213984|NCT00997438|17998392|P3|Overall Study|Withdrawal by Subject|0
5213985|NCT00997438|17998393|P2|Overall Study|Withdrawal by Subject|1
5213986|NCT00997438|17998394|P1|Overall Study|Withdrawal by Subject|1
5213987|NCT00997438|17998392|P3|Overall Study|Blood draw difficulty|1
5213988|NCT00997438|17998393|P2|Overall Study|Blood draw difficulty|0
5213989|NCT00997438|17998394|P1|Overall Study|Blood draw difficulty|2
5213990|NCT00997386|17998434|P1|Overall Study|Death|7
5213991|NCT00997373|17998443|P2|Overall Study|could not have hysterectomy|0
5213992|NCT00997373|17998444|P1|Overall Study|could not have hysterectomy|6
5213993|NCT00997373|17998443|P2|Overall Study|wrong tumor type|0
5213994|NCT00997373|17998444|P1|Overall Study|wrong tumor type|4
5213995|NCT00997373|17998443|P2|Overall Study|Withdrawal by Subject|0
5213996|NCT00997373|17998444|P1|Overall Study|Withdrawal by Subject|5
5213997|NCT00997334|17998450|P1|Overall Study|Ineligible|1
5213998|NCT00997334|17998450|P1|Overall Study|No lesion amenable|1
5213999|NCT00997334|17998450|P1|Overall Study|Urgent Palliative Care|2
5214000|NCT00997334|17998450|P1|Overall Study|Death|2
5214001|NCT00997334|17998450|P1|Overall Study|Withdrawal by Subject|3
5214002|NCT00997334|17998450|P1|Overall Study|Patient non-compliance|1
5214003|NCT00997334|17998450|P1|Overall Study|Adverse Event|3
5214004|NCT00997334|17998450|P1|Overall Study|still on therapy|12
5214005|NCT00997321|17998459|P2|Overall Study|did not undergo sedation after enrollmen|3
5214006|NCT00997321|17998460|P1|Overall Study|did not undergo sedation after enrollmen|0
5214007|NCT00997243|17998472|P1|Overall Study|Early termination of study by sponsor|7
5214008|NCT00997126|17998504|P2|Overall Study|Physician Decision|11
5214009|NCT00997126|17998505|P1|Overall Study|Physician Decision|7
5214010|NCT00997035|17998534|P2|3-month Follow-up Visit|Lost to Follow-up|6
5214011|NCT00997035|17998535|P1|3-month Follow-up Visit|Lost to Follow-up|12
5214012|NCT00997035|17998534|P2|3-week Followup Visit|Lost to Follow-up|6
5214013|NCT00997035|17998535|P1|3-week Followup Visit|Lost to Follow-up|9
5214014|NCT00996996|17998559|P1|Overall Study|Did Not Receive Study Medications|1
5214015|NCT00996996|17998559|P1|Overall Study|Death|5
5214016|NCT00996996|17998559|P1|Overall Study|Lost to Follow-up|9
5214017|NCT00996996|17998559|P1|Overall Study|Non-compliance|8
5214018|NCT00996996|17998559|P1|Overall Study|Progressive Disease|10
5214019|NCT00996944|17998593|P2|Long-term Treatment Period|Study Closed/Terminated|5
5214020|NCT00996944|17998594|P1|Long-term Treatment Period|Study Closed/Terminated|12
5214021|NCT00996944|17998593|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5214022|NCT00996944|17998594|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5214023|NCT00996944|17998593|P2|Double-blind Treatment Period|Study Closed/Terminated|5
5214024|NCT00996944|17998594|P1|Double-blind Treatment Period|Study Closed/Terminated|6
5214025|NCT00996944|17998593|P2|Double-blind Treatment Period|Protocol Violation|0
5214026|NCT00996944|17998594|P1|Double-blind Treatment Period|Protocol Violation|1
5214027|NCT00996944|17998593|P2|Double-blind Treatment Period|Adverse Event|1
5214028|NCT00996944|17998594|P1|Double-blind Treatment Period|Adverse Event|2
5214029|NCT00996918|17998646|P5|Overall Study|Other|0
5214030|NCT00996918|17998647|P4|Overall Study|Other|0
5214031|NCT00996918|17998648|P3|Overall Study|Other|0
5214032|NCT00996918|17998649|P2|Overall Study|Other|1
5214033|NCT00996918|17998650|P1|Overall Study|Other|3
5214034|NCT00996918|17998646|P5|Overall Study|Loss of Caregiver|0
5214035|NCT00996918|17998647|P4|Overall Study|Loss of Caregiver|0
5214036|NCT00996918|17998648|P3|Overall Study|Loss of Caregiver|0
5214037|NCT00996918|17998649|P2|Overall Study|Loss of Caregiver|1
5214038|NCT00996918|17998650|P1|Overall Study|Loss of Caregiver|0
5214039|NCT00996918|17998646|P5|Overall Study|Discontinuation of Study by Sponsor|2
5214040|NCT00996918|17998647|P4|Overall Study|Discontinuation of Study by Sponsor|45
5214041|NCT00996918|17998648|P3|Overall Study|Discontinuation of Study by Sponsor|30
5214042|NCT00996918|17998649|P2|Overall Study|Discontinuation of Study by Sponsor|54
5214043|NCT00996918|17998650|P1|Overall Study|Discontinuation of Study by Sponsor|31
5214044|NCT00996918|17998646|P5|Overall Study|Physician Decision|0
5214045|NCT00996918|17998647|P4|Overall Study|Physician Decision|0
5214046|NCT00996918|17998648|P3|Overall Study|Physician Decision|0
5214047|NCT00996918|17998649|P2|Overall Study|Physician Decision|0
5214048|NCT00996918|17998650|P1|Overall Study|Physician Decision|1
5214049|NCT00996918|17998646|P5|Overall Study|Withdrawal by Subject|2
5214050|NCT00996918|17998647|P4|Overall Study|Withdrawal by Subject|3
5214051|NCT00996918|17998648|P3|Overall Study|Withdrawal by Subject|3
5214052|NCT00996918|17998649|P2|Overall Study|Withdrawal by Subject|4
5214053|NCT00996918|17998650|P1|Overall Study|Withdrawal by Subject|1
5214054|NCT00996918|17998646|P5|Overall Study|Adverse Event|0
5214055|NCT00996918|17998647|P4|Overall Study|Adverse Event|6
5214056|NCT00996918|17998648|P3|Overall Study|Adverse Event|2
5214057|NCT00996918|17998649|P2|Overall Study|Adverse Event|5
5214058|NCT00996918|17998650|P1|Overall Study|Adverse Event|2
5214059|NCT00996918|17998646|P5|Overall Study|Lack of Efficacy|0
5214060|NCT00996918|17998647|P4|Overall Study|Lack of Efficacy|2
5214061|NCT00996918|17998648|P3|Overall Study|Lack of Efficacy|2
5214062|NCT00996918|17998649|P2|Overall Study|Lack of Efficacy|1
5214063|NCT00996918|17998650|P1|Overall Study|Lack of Efficacy|1
5214064|NCT00996892|17998694|P20|Expansion Stage 2A|Disease Progression|31
5214065|NCT00996892|17998695|P19|Expansion Stage 2A|Disease Progression|0
5214066|NCT00996892|17998696|P18|Expansion Stage 2A|Disease Progression|0
5214067|NCT00996892|17998697|P17|Expansion Stage 2A|Disease Progression|0
5214068|NCT00996892|17998698|P16|Expansion Stage 2A|Disease Progression|0
5214069|NCT00996892|17998699|P15|Expansion Stage 2A|Disease Progression|0
5214070|NCT00996892|17998700|P14|Expansion Stage 2A|Disease Progression|0
5214071|NCT00996892|17998701|P13|Expansion Stage 2A|Disease Progression|0
5214072|NCT00996892|17998702|P12|Expansion Stage 2A|Disease Progression|0
5214073|NCT00996892|17998703|P11|Expansion Stage 2A|Disease Progression|0
5214074|NCT00996892|17998704|P10|Expansion Stage 2A|Disease Progression|0
5214075|NCT00996892|17998705|P9|Expansion Stage 2A|Disease Progression|0
5214076|NCT00996892|17998706|P8|Expansion Stage 2A|Disease Progression|0
5214077|NCT00996892|17998707|P7|Expansion Stage 2A|Disease Progression|0
5214078|NCT00996892|17998708|P6|Expansion Stage 2A|Disease Progression|0
5214079|NCT00996892|17998709|P5|Expansion Stage 2A|Disease Progression|0
5214080|NCT00996892|17998710|P4|Expansion Stage 2A|Disease Progression|0
5214081|NCT00996892|17998711|P3|Expansion Stage 2A|Disease Progression|0
5214082|NCT00996892|17998712|P2|Expansion Stage 2A|Disease Progression|0
5214083|NCT00996892|17998713|P1|Expansion Stage 2A|Disease Progression|0
5214084|NCT00996892|17998694|P20|Expansion Stage 2A|Withdrawal by Subject|4
5214085|NCT00996892|17998695|P19|Expansion Stage 2A|Withdrawal by Subject|0
5214086|NCT00996892|17998696|P18|Expansion Stage 2A|Withdrawal by Subject|0
5214087|NCT00996892|17998697|P17|Expansion Stage 2A|Withdrawal by Subject|0
5214088|NCT00996892|17998698|P16|Expansion Stage 2A|Withdrawal by Subject|0
5214089|NCT00996892|17998699|P15|Expansion Stage 2A|Withdrawal by Subject|0
5214090|NCT00996892|17998700|P14|Expansion Stage 2A|Withdrawal by Subject|0
5214091|NCT00996892|17998701|P13|Expansion Stage 2A|Withdrawal by Subject|0
5214092|NCT00996892|17998702|P12|Expansion Stage 2A|Withdrawal by Subject|0
5214093|NCT00996892|17998703|P11|Expansion Stage 2A|Withdrawal by Subject|0
5214094|NCT00996892|17998704|P10|Expansion Stage 2A|Withdrawal by Subject|0
5214095|NCT00996892|17998705|P9|Expansion Stage 2A|Withdrawal by Subject|0
5214096|NCT00996892|17998706|P8|Expansion Stage 2A|Withdrawal by Subject|0
5214097|NCT00996892|17998707|P7|Expansion Stage 2A|Withdrawal by Subject|0
5214098|NCT00996892|17998708|P6|Expansion Stage 2A|Withdrawal by Subject|0
5214099|NCT00996892|17998709|P5|Expansion Stage 2A|Withdrawal by Subject|0
5214100|NCT00996892|17998710|P4|Expansion Stage 2A|Withdrawal by Subject|0
5214101|NCT00996892|17998711|P3|Expansion Stage 2A|Withdrawal by Subject|0
5214102|NCT00996892|17998712|P2|Expansion Stage 2A|Withdrawal by Subject|0
5214103|NCT00996892|17998713|P1|Expansion Stage 2A|Withdrawal by Subject|0
5214104|NCT00996892|17998694|P20|Expansion Stage 2A|Physician Decision|2
5214105|NCT00996892|17998695|P19|Expansion Stage 2A|Physician Decision|0
5214106|NCT00996892|17998696|P18|Expansion Stage 2A|Physician Decision|0
5214107|NCT00996892|17998697|P17|Expansion Stage 2A|Physician Decision|0
5214108|NCT00996892|17998698|P16|Expansion Stage 2A|Physician Decision|0
5214109|NCT00996892|17998699|P15|Expansion Stage 2A|Physician Decision|0
5214110|NCT00996892|17998700|P14|Expansion Stage 2A|Physician Decision|0
5214111|NCT00996892|17998701|P13|Expansion Stage 2A|Physician Decision|0
5214112|NCT00996892|17998702|P12|Expansion Stage 2A|Physician Decision|0
5214113|NCT00996892|17998703|P11|Expansion Stage 2A|Physician Decision|0
5214114|NCT00996892|17998704|P10|Expansion Stage 2A|Physician Decision|0
5214115|NCT00996892|17998705|P9|Expansion Stage 2A|Physician Decision|0
5214116|NCT00996892|17998706|P8|Expansion Stage 2A|Physician Decision|0
5214117|NCT00996892|17998707|P7|Expansion Stage 2A|Physician Decision|0
5214118|NCT00996892|17998708|P6|Expansion Stage 2A|Physician Decision|0
5214119|NCT00996892|17998709|P5|Expansion Stage 2A|Physician Decision|0
5214120|NCT00996892|17998710|P4|Expansion Stage 2A|Physician Decision|0
5214121|NCT00996892|17998711|P3|Expansion Stage 2A|Physician Decision|0
5214122|NCT00996892|17998712|P2|Expansion Stage 2A|Physician Decision|0
5214123|NCT00996892|17998713|P1|Expansion Stage 2A|Physician Decision|0
5214124|NCT00996892|17998694|P20|Expansion Stage 2A|Adverse Event|8
5214125|NCT00996892|17998695|P19|Expansion Stage 2A|Adverse Event|0
5214126|NCT00996892|17998696|P18|Expansion Stage 2A|Adverse Event|0
5214127|NCT00996892|17998697|P17|Expansion Stage 2A|Adverse Event|0
5214128|NCT00996892|17998698|P16|Expansion Stage 2A|Adverse Event|0
5214129|NCT00996892|17998699|P15|Expansion Stage 2A|Adverse Event|0
5214130|NCT00996892|17998700|P14|Expansion Stage 2A|Adverse Event|0
5214131|NCT00996892|17998701|P13|Expansion Stage 2A|Adverse Event|0
5214132|NCT00996892|17998702|P12|Expansion Stage 2A|Adverse Event|0
5214133|NCT00996892|17998703|P11|Expansion Stage 2A|Adverse Event|0
5214134|NCT00996892|17998704|P10|Expansion Stage 2A|Adverse Event|0
5214135|NCT00996892|17998705|P9|Expansion Stage 2A|Adverse Event|0
5214136|NCT00996892|17998706|P8|Expansion Stage 2A|Adverse Event|0
5214137|NCT00996892|17998707|P7|Expansion Stage 2A|Adverse Event|0
5214138|NCT00996892|17998708|P6|Expansion Stage 2A|Adverse Event|0
5214139|NCT00996892|17998709|P5|Expansion Stage 2A|Adverse Event|0
5214140|NCT00996892|17998710|P4|Expansion Stage 2A|Adverse Event|0
5214141|NCT00996892|17998711|P3|Expansion Stage 2A|Adverse Event|0
5214142|NCT00996892|17998712|P2|Expansion Stage 2A|Adverse Event|0
5214143|NCT00996892|17998713|P1|Expansion Stage 2A|Adverse Event|0
5214144|NCT00996892|17998694|P20|Expansion Stage 2|Disease Progression|0
5214145|NCT00996892|17998695|P19|Expansion Stage 2|Disease Progression|28
5214146|NCT00996892|17998696|P18|Expansion Stage 2|Disease Progression|0
5214147|NCT00996892|17998697|P17|Expansion Stage 2|Disease Progression|0
5214148|NCT00996892|17998698|P16|Expansion Stage 2|Disease Progression|0
5214149|NCT00996892|17998699|P15|Expansion Stage 2|Disease Progression|0
5214150|NCT00996892|17998700|P14|Expansion Stage 2|Disease Progression|0
5214151|NCT00996892|17998701|P13|Expansion Stage 2|Disease Progression|0
5214152|NCT00996892|17998702|P12|Expansion Stage 2|Disease Progression|0
5214153|NCT00996892|17998703|P11|Expansion Stage 2|Disease Progression|0
5214154|NCT00996892|17998704|P10|Expansion Stage 2|Disease Progression|0
5214155|NCT00996892|17998705|P9|Expansion Stage 2|Disease Progression|0
5214156|NCT00996892|17998706|P8|Expansion Stage 2|Disease Progression|0
5214157|NCT00996892|17998707|P7|Expansion Stage 2|Disease Progression|0
5214158|NCT00996892|17998708|P6|Expansion Stage 2|Disease Progression|0
5214159|NCT00996892|17998709|P5|Expansion Stage 2|Disease Progression|0
5214160|NCT00996892|17998710|P4|Expansion Stage 2|Disease Progression|0
5214161|NCT00996892|17998711|P3|Expansion Stage 2|Disease Progression|0
5214162|NCT00996892|17998712|P2|Expansion Stage 2|Disease Progression|0
5214163|NCT00996892|17998713|P1|Expansion Stage 2|Disease Progression|0
5214164|NCT00996892|17998694|P20|Expansion Stage 2|Withdrawal by Subject|0
5214165|NCT00996892|17998695|P19|Expansion Stage 2|Withdrawal by Subject|1
5214166|NCT00996892|17998696|P18|Expansion Stage 2|Withdrawal by Subject|0
5214167|NCT00996892|17998697|P17|Expansion Stage 2|Withdrawal by Subject|0
5214168|NCT00996892|17998698|P16|Expansion Stage 2|Withdrawal by Subject|0
5214169|NCT00996892|17998699|P15|Expansion Stage 2|Withdrawal by Subject|0
5214170|NCT00996892|17998700|P14|Expansion Stage 2|Withdrawal by Subject|0
5214171|NCT00996892|17998701|P13|Expansion Stage 2|Withdrawal by Subject|0
5214172|NCT00996892|17998702|P12|Expansion Stage 2|Withdrawal by Subject|0
5214173|NCT00996892|17998703|P11|Expansion Stage 2|Withdrawal by Subject|0
5214174|NCT00996892|17998704|P10|Expansion Stage 2|Withdrawal by Subject|0
5214175|NCT00996892|17998705|P9|Expansion Stage 2|Withdrawal by Subject|0
5214176|NCT00996892|17998706|P8|Expansion Stage 2|Withdrawal by Subject|0
5214177|NCT00996892|17998707|P7|Expansion Stage 2|Withdrawal by Subject|0
5214178|NCT00996892|17998708|P6|Expansion Stage 2|Withdrawal by Subject|0
5214179|NCT00996892|17998709|P5|Expansion Stage 2|Withdrawal by Subject|0
5214180|NCT00996892|17998710|P4|Expansion Stage 2|Withdrawal by Subject|0
5214181|NCT00996892|17998711|P3|Expansion Stage 2|Withdrawal by Subject|0
5214182|NCT00996892|17998712|P2|Expansion Stage 2|Withdrawal by Subject|0
5214183|NCT00996892|17998713|P1|Expansion Stage 2|Withdrawal by Subject|0
5214184|NCT00996892|17998694|P20|Expansion Stage 2|Physician Decision|0
5214185|NCT00996892|17998695|P19|Expansion Stage 2|Physician Decision|1
5214186|NCT00996892|17998696|P18|Expansion Stage 2|Physician Decision|0
5214187|NCT00996892|17998697|P17|Expansion Stage 2|Physician Decision|0
5214188|NCT00996892|17998698|P16|Expansion Stage 2|Physician Decision|0
5214189|NCT00996892|17998699|P15|Expansion Stage 2|Physician Decision|0
5214190|NCT00996892|17998700|P14|Expansion Stage 2|Physician Decision|0
5214191|NCT00996892|17998701|P13|Expansion Stage 2|Physician Decision|0
5214192|NCT00996892|17998702|P12|Expansion Stage 2|Physician Decision|0
5214193|NCT00996892|17998703|P11|Expansion Stage 2|Physician Decision|0
5214194|NCT00996892|17998704|P10|Expansion Stage 2|Physician Decision|0
5214195|NCT00996892|17998705|P9|Expansion Stage 2|Physician Decision|0
5214196|NCT00996892|17998706|P8|Expansion Stage 2|Physician Decision|0
5214197|NCT00996892|17998707|P7|Expansion Stage 2|Physician Decision|0
5214198|NCT00996892|17998708|P6|Expansion Stage 2|Physician Decision|0
5214199|NCT00996892|17998709|P5|Expansion Stage 2|Physician Decision|0
5214200|NCT00996892|17998710|P4|Expansion Stage 2|Physician Decision|0
5214201|NCT00996892|17998711|P3|Expansion Stage 2|Physician Decision|0
5214202|NCT00996892|17998712|P2|Expansion Stage 2|Physician Decision|0
5214203|NCT00996892|17998713|P1|Expansion Stage 2|Physician Decision|0
5214204|NCT00996892|17998694|P20|Expansion Stage 2|Death|0
5214205|NCT00996892|17998695|P19|Expansion Stage 2|Death|2
5214206|NCT00996892|17998696|P18|Expansion Stage 2|Death|0
5214207|NCT00996892|17998697|P17|Expansion Stage 2|Death|0
5214208|NCT00996892|17998698|P16|Expansion Stage 2|Death|0
5214209|NCT00996892|17998699|P15|Expansion Stage 2|Death|0
5214210|NCT00996892|17998700|P14|Expansion Stage 2|Death|0
5214211|NCT00996892|17998701|P13|Expansion Stage 2|Death|0
5214212|NCT00996892|17998702|P12|Expansion Stage 2|Death|0
5214213|NCT00996892|17998703|P11|Expansion Stage 2|Death|0
5214214|NCT00996892|17998704|P10|Expansion Stage 2|Death|0
5214215|NCT00996892|17998705|P9|Expansion Stage 2|Death|0
5214216|NCT00996892|17998706|P8|Expansion Stage 2|Death|0
5214217|NCT00996892|17998707|P7|Expansion Stage 2|Death|0
5214218|NCT00996892|17998708|P6|Expansion Stage 2|Death|0
5214219|NCT00996892|17998709|P5|Expansion Stage 2|Death|0
5214220|NCT00996892|17998710|P4|Expansion Stage 2|Death|0
5214221|NCT00996892|17998711|P3|Expansion Stage 2|Death|0
5214222|NCT00996892|17998712|P2|Expansion Stage 2|Death|0
5214223|NCT00996892|17998713|P1|Expansion Stage 2|Death|0
5214224|NCT00996892|17998694|P20|Expansion Stage 2|Adverse Event|0
5214225|NCT00996892|17998695|P19|Expansion Stage 2|Adverse Event|3
5214226|NCT00996892|17998696|P18|Expansion Stage 2|Adverse Event|0
5214227|NCT00996892|17998697|P17|Expansion Stage 2|Adverse Event|0
5214228|NCT00996892|17998698|P16|Expansion Stage 2|Adverse Event|0
5214229|NCT00996892|17998699|P15|Expansion Stage 2|Adverse Event|0
5214230|NCT00996892|17998700|P14|Expansion Stage 2|Adverse Event|0
5214231|NCT00996892|17998701|P13|Expansion Stage 2|Adverse Event|0
5214232|NCT00996892|17998702|P12|Expansion Stage 2|Adverse Event|0
5214233|NCT00996892|17998703|P11|Expansion Stage 2|Adverse Event|0
5214234|NCT00996892|17998704|P10|Expansion Stage 2|Adverse Event|0
5214235|NCT00996892|17998705|P9|Expansion Stage 2|Adverse Event|0
5214236|NCT00996892|17998706|P8|Expansion Stage 2|Adverse Event|0
5214237|NCT00996892|17998707|P7|Expansion Stage 2|Adverse Event|0
5214238|NCT00996892|17998708|P6|Expansion Stage 2|Adverse Event|0
5214239|NCT00996892|17998709|P5|Expansion Stage 2|Adverse Event|0
5214240|NCT00996892|17998710|P4|Expansion Stage 2|Adverse Event|0
5214241|NCT00996892|17998711|P3|Expansion Stage 2|Adverse Event|0
5214242|NCT00996892|17998712|P2|Expansion Stage 2|Adverse Event|0
5214243|NCT00996892|17998713|P1|Expansion Stage 2|Adverse Event|0
5214244|NCT00996892|17998694|P20|Dose-Escalation Stage 1B|Disease Progression|0
5214245|NCT00996892|17998695|P19|Dose-Escalation Stage 1B|Disease Progression|0
5214246|NCT00996892|17998696|P18|Dose-Escalation Stage 1B|Disease Progression|3
5214247|NCT00996892|17998697|P17|Dose-Escalation Stage 1B|Disease Progression|3
5214248|NCT00996892|17998698|P16|Dose-Escalation Stage 1B|Disease Progression|3
5214249|NCT00996892|17998699|P15|Dose-Escalation Stage 1B|Disease Progression|4
5214250|NCT00996892|17998700|P14|Dose-Escalation Stage 1B|Disease Progression|0
5214251|NCT00996892|17998701|P13|Dose-Escalation Stage 1B|Disease Progression|0
5214252|NCT00996892|17998702|P12|Dose-Escalation Stage 1B|Disease Progression|0
5214253|NCT00996892|17998703|P11|Dose-Escalation Stage 1B|Disease Progression|0
5214254|NCT00996892|17998704|P10|Dose-Escalation Stage 1B|Disease Progression|0
5214255|NCT00996892|17998705|P9|Dose-Escalation Stage 1B|Disease Progression|0
5214256|NCT00996892|17998706|P8|Dose-Escalation Stage 1B|Disease Progression|0
5214257|NCT00996892|17998707|P7|Dose-Escalation Stage 1B|Disease Progression|0
5214258|NCT00996892|17998708|P6|Dose-Escalation Stage 1B|Disease Progression|0
5214259|NCT00996892|17998709|P5|Dose-Escalation Stage 1B|Disease Progression|0
5214260|NCT00996892|17998710|P4|Dose-Escalation Stage 1B|Disease Progression|0
5214261|NCT00996892|17998711|P3|Dose-Escalation Stage 1B|Disease Progression|0
5214262|NCT00996892|17998712|P2|Dose-Escalation Stage 1B|Disease Progression|0
5214263|NCT00996892|17998713|P1|Dose-Escalation Stage 1B|Disease Progression|0
5214264|NCT00996892|17998694|P20|Dose-Escalation Stage 1B|Physician Decision|0
5214265|NCT00996892|17998695|P19|Dose-Escalation Stage 1B|Physician Decision|0
5214266|NCT00996892|17998696|P18|Dose-Escalation Stage 1B|Physician Decision|2
5214267|NCT00996892|17998697|P17|Dose-Escalation Stage 1B|Physician Decision|0
5214268|NCT00996892|17998698|P16|Dose-Escalation Stage 1B|Physician Decision|0
5214269|NCT00996892|17998699|P15|Dose-Escalation Stage 1B|Physician Decision|0
5214270|NCT00996892|17998700|P14|Dose-Escalation Stage 1B|Physician Decision|0
5214271|NCT00996892|17998701|P13|Dose-Escalation Stage 1B|Physician Decision|0
5214272|NCT00996892|17998702|P12|Dose-Escalation Stage 1B|Physician Decision|0
5214273|NCT00996892|17998703|P11|Dose-Escalation Stage 1B|Physician Decision|0
5214274|NCT00996892|17998704|P10|Dose-Escalation Stage 1B|Physician Decision|0
5214275|NCT00996892|17998705|P9|Dose-Escalation Stage 1B|Physician Decision|0
5214276|NCT00996892|17998706|P8|Dose-Escalation Stage 1B|Physician Decision|0
5214277|NCT00996892|17998707|P7|Dose-Escalation Stage 1B|Physician Decision|0
5214278|NCT00996892|17998708|P6|Dose-Escalation Stage 1B|Physician Decision|0
5214279|NCT00996892|17998709|P5|Dose-Escalation Stage 1B|Physician Decision|0
5214280|NCT00996892|17998710|P4|Dose-Escalation Stage 1B|Physician Decision|0
5214281|NCT00996892|17998711|P3|Dose-Escalation Stage 1B|Physician Decision|0
5214282|NCT00996892|17998712|P2|Dose-Escalation Stage 1B|Physician Decision|0
5214283|NCT00996892|17998713|P1|Dose-Escalation Stage 1B|Physician Decision|0
5214284|NCT00996892|17998694|P20|Dose-Escalation Stage 1A|Disease Progression|0
5214285|NCT00996892|17998695|P19|Dose-Escalation Stage 1A|Disease Progression|0
5214286|NCT00996892|17998696|P18|Dose-Escalation Stage 1A|Disease Progression|0
5214287|NCT00996892|17998697|P17|Dose-Escalation Stage 1A|Disease Progression|0
5214288|NCT00996892|17998698|P16|Dose-Escalation Stage 1A|Disease Progression|0
5214289|NCT00996892|17998699|P15|Dose-Escalation Stage 1A|Disease Progression|0
5214290|NCT00996892|17998700|P14|Dose-Escalation Stage 1A|Disease Progression|4
5214291|NCT00996892|17998701|P13|Dose-Escalation Stage 1A|Disease Progression|6
5214292|NCT00996892|17998702|P12|Dose-Escalation Stage 1A|Disease Progression|7
5214293|NCT00996892|17998703|P11|Dose-Escalation Stage 1A|Disease Progression|5
5214294|NCT00996892|17998704|P10|Dose-Escalation Stage 1A|Disease Progression|1
5214295|NCT00996892|17998705|P9|Dose-Escalation Stage 1A|Disease Progression|3
5214296|NCT00996892|17998706|P8|Dose-Escalation Stage 1A|Disease Progression|2
5214297|NCT00996892|17998707|P7|Dose-Escalation Stage 1A|Disease Progression|0
5214298|NCT00996892|17998708|P6|Dose-Escalation Stage 1A|Disease Progression|0
5214299|NCT00996892|17998709|P5|Dose-Escalation Stage 1A|Disease Progression|0
5214300|NCT00996892|17998710|P4|Dose-Escalation Stage 1A|Disease Progression|0
5214301|NCT00996892|17998711|P3|Dose-Escalation Stage 1A|Disease Progression|0
5214302|NCT00996892|17998712|P2|Dose-Escalation Stage 1A|Disease Progression|0
5214303|NCT00996892|17998713|P1|Dose-Escalation Stage 1A|Disease Progression|0
5214304|NCT00996892|17998694|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214305|NCT00996892|17998695|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214306|NCT00996892|17998696|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214307|NCT00996892|17998697|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214308|NCT00996892|17998698|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214309|NCT00996892|17998699|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214310|NCT00996892|17998700|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214311|NCT00996892|17998701|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5214312|NCT00996892|17998702|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5214313|NCT00996892|17998703|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5214314|NCT00996892|17998704|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5214315|NCT00996892|17998705|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214316|NCT00996892|17998706|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214317|NCT00996892|17998707|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214318|NCT00996892|17998708|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214319|NCT00996892|17998709|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214320|NCT00996892|17998710|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214321|NCT00996892|17998711|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214322|NCT00996892|17998712|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214323|NCT00996892|17998713|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5214324|NCT00996892|17998694|P20|Dose-Escalation Stage 1A|Physician Decision|0
5214325|NCT00996892|17998695|P19|Dose-Escalation Stage 1A|Physician Decision|0
5214326|NCT00996892|17998696|P18|Dose-Escalation Stage 1A|Physician Decision|0
5214327|NCT00996892|17998697|P17|Dose-Escalation Stage 1A|Physician Decision|0
5214328|NCT00996892|17998698|P16|Dose-Escalation Stage 1A|Physician Decision|0
5214329|NCT00996892|17998699|P15|Dose-Escalation Stage 1A|Physician Decision|0
5214330|NCT00996892|17998700|P14|Dose-Escalation Stage 1A|Physician Decision|0
5214331|NCT00996892|17998701|P13|Dose-Escalation Stage 1A|Physician Decision|0
5214332|NCT00996892|17998702|P12|Dose-Escalation Stage 1A|Physician Decision|0
5214333|NCT00996892|17998703|P11|Dose-Escalation Stage 1A|Physician Decision|0
5214334|NCT00996892|17998704|P10|Dose-Escalation Stage 1A|Physician Decision|0
5214335|NCT00996892|17998705|P9|Dose-Escalation Stage 1A|Physician Decision|0
5214336|NCT00996892|17998706|P8|Dose-Escalation Stage 1A|Physician Decision|1
5214337|NCT00996892|17998707|P7|Dose-Escalation Stage 1A|Physician Decision|0
5214338|NCT00996892|17998708|P6|Dose-Escalation Stage 1A|Physician Decision|0
5214339|NCT00996892|17998709|P5|Dose-Escalation Stage 1A|Physician Decision|0
5214340|NCT00996892|17998710|P4|Dose-Escalation Stage 1A|Physician Decision|0
5214341|NCT00996892|17998711|P3|Dose-Escalation Stage 1A|Physician Decision|0
5214342|NCT00996892|17998712|P2|Dose-Escalation Stage 1A|Physician Decision|0
5214343|NCT00996892|17998713|P1|Dose-Escalation Stage 1A|Physician Decision|0
5214344|NCT00996892|17998694|P20|Dose-Escalation Stage 1A|Death|0
5214345|NCT00996892|17998695|P19|Dose-Escalation Stage 1A|Death|0
5214346|NCT00996892|17998696|P18|Dose-Escalation Stage 1A|Death|0
5214347|NCT00996892|17998697|P17|Dose-Escalation Stage 1A|Death|0
5214348|NCT00996892|17998698|P16|Dose-Escalation Stage 1A|Death|0
5214349|NCT00996892|17998699|P15|Dose-Escalation Stage 1A|Death|0
5214350|NCT00996892|17998700|P14|Dose-Escalation Stage 1A|Death|0
5214351|NCT00996892|17998701|P13|Dose-Escalation Stage 1A|Death|1
5214352|NCT00996892|17998702|P12|Dose-Escalation Stage 1A|Death|1
5214353|NCT00996892|17998703|P11|Dose-Escalation Stage 1A|Death|0
5214354|NCT00996892|17998704|P10|Dose-Escalation Stage 1A|Death|2
5214355|NCT00996892|17998705|P9|Dose-Escalation Stage 1A|Death|0
5214356|NCT00996892|17998706|P8|Dose-Escalation Stage 1A|Death|0
5214357|NCT00996892|17998707|P7|Dose-Escalation Stage 1A|Death|0
5214358|NCT00996892|17998708|P6|Dose-Escalation Stage 1A|Death|0
5214359|NCT00996892|17998709|P5|Dose-Escalation Stage 1A|Death|0
5214360|NCT00996892|17998710|P4|Dose-Escalation Stage 1A|Death|0
5214361|NCT00996892|17998711|P3|Dose-Escalation Stage 1A|Death|0
5214362|NCT00996892|17998712|P2|Dose-Escalation Stage 1A|Death|0
5214363|NCT00996892|17998713|P1|Dose-Escalation Stage 1A|Death|0
5214364|NCT00996892|17998694|P20|Dose-Escalation Stage 1A|Adverse Event|0
5214365|NCT00996892|17998695|P19|Dose-Escalation Stage 1A|Adverse Event|0
5214366|NCT00996892|17998696|P18|Dose-Escalation Stage 1A|Adverse Event|0
5214367|NCT00996892|17998697|P17|Dose-Escalation Stage 1A|Adverse Event|0
5214368|NCT00996892|17998698|P16|Dose-Escalation Stage 1A|Adverse Event|0
5214369|NCT00996892|17998699|P15|Dose-Escalation Stage 1A|Adverse Event|0
5214370|NCT00996892|17998700|P14|Dose-Escalation Stage 1A|Adverse Event|1
5214371|NCT00996892|17998701|P13|Dose-Escalation Stage 1A|Adverse Event|0
5214372|NCT00996892|17998702|P12|Dose-Escalation Stage 1A|Adverse Event|0
5214373|NCT00996892|17998703|P11|Dose-Escalation Stage 1A|Adverse Event|1
5214374|NCT00996892|17998704|P10|Dose-Escalation Stage 1A|Adverse Event|0
5214375|NCT00996892|17998705|P9|Dose-Escalation Stage 1A|Adverse Event|0
5214376|NCT00996892|17998706|P8|Dose-Escalation Stage 1A|Adverse Event|0
5214377|NCT00996892|17998707|P7|Dose-Escalation Stage 1A|Adverse Event|0
5214378|NCT00996892|17998708|P6|Dose-Escalation Stage 1A|Adverse Event|0
5214379|NCT00996892|17998709|P5|Dose-Escalation Stage 1A|Adverse Event|0
5214380|NCT00996892|17998710|P4|Dose-Escalation Stage 1A|Adverse Event|0
5214381|NCT00996892|17998711|P3|Dose-Escalation Stage 1A|Adverse Event|0
5214382|NCT00996892|17998712|P2|Dose-Escalation Stage 1A|Adverse Event|0
5214383|NCT00996892|17998713|P1|Dose-Escalation Stage 1A|Adverse Event|0
5214384|NCT00996892|17998694|P20|Dose-Escalation Stage 1|Disease Progression|0
5214385|NCT00996892|17998695|P19|Dose-Escalation Stage 1|Disease Progression|0
5214386|NCT00996892|17998696|P18|Dose-Escalation Stage 1|Disease Progression|0
5214387|NCT00996892|17998697|P17|Dose-Escalation Stage 1|Disease Progression|0
5214388|NCT00996892|17998698|P16|Dose-Escalation Stage 1|Disease Progression|0
5214389|NCT00996892|17998699|P15|Dose-Escalation Stage 1|Disease Progression|0
5214390|NCT00996892|17998700|P14|Dose-Escalation Stage 1|Disease Progression|0
5214391|NCT00996892|17998701|P13|Dose-Escalation Stage 1|Disease Progression|0
5214392|NCT00996892|17998702|P12|Dose-Escalation Stage 1|Disease Progression|0
5214393|NCT00996892|17998703|P11|Dose-Escalation Stage 1|Disease Progression|0
5214394|NCT00996892|17998704|P10|Dose-Escalation Stage 1|Disease Progression|0
5214395|NCT00996892|17998705|P9|Dose-Escalation Stage 1|Disease Progression|0
5214396|NCT00996892|17998706|P8|Dose-Escalation Stage 1|Disease Progression|0
5214397|NCT00996892|17998707|P7|Dose-Escalation Stage 1|Disease Progression|0
5214398|NCT00996892|17998708|P6|Dose-Escalation Stage 1|Disease Progression|7
5214399|NCT00996892|17998709|P5|Dose-Escalation Stage 1|Disease Progression|10
5214400|NCT00996892|17998710|P4|Dose-Escalation Stage 1|Disease Progression|4
5214401|NCT00996892|17998711|P3|Dose-Escalation Stage 1|Disease Progression|3
5214402|NCT00996892|17998712|P2|Dose-Escalation Stage 1|Disease Progression|2
5214403|NCT00996892|17998713|P1|Dose-Escalation Stage 1|Disease Progression|2
5214404|NCT00996892|17998694|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214405|NCT00996892|17998695|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214406|NCT00996892|17998696|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214407|NCT00996892|17998697|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214408|NCT00996892|17998698|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214409|NCT00996892|17998699|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214410|NCT00996892|17998700|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214411|NCT00996892|17998701|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214412|NCT00996892|17998702|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214413|NCT00996892|17998703|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214414|NCT00996892|17998704|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214415|NCT00996892|17998705|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214416|NCT00996892|17998706|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214417|NCT00996892|17998707|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
5214418|NCT00996892|17998708|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
5214419|NCT00996892|17998709|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
5214420|NCT00996892|17998710|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
5214421|NCT00996892|17998711|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214422|NCT00996892|17998712|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
5214423|NCT00996892|17998713|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
5214424|NCT00996892|17998694|P20|Dose-Escalation Stage 1|Physician Decision|0
5214425|NCT00996892|17998695|P19|Dose-Escalation Stage 1|Physician Decision|0
5214426|NCT00996892|17998696|P18|Dose-Escalation Stage 1|Physician Decision|0
5214427|NCT00996892|17998697|P17|Dose-Escalation Stage 1|Physician Decision|0
5214428|NCT00996892|17998698|P16|Dose-Escalation Stage 1|Physician Decision|0
5214429|NCT00996892|17998699|P15|Dose-Escalation Stage 1|Physician Decision|0
5214430|NCT00996892|17998700|P14|Dose-Escalation Stage 1|Physician Decision|0
5214431|NCT00996892|17998701|P13|Dose-Escalation Stage 1|Physician Decision|0
5214432|NCT00996892|17998702|P12|Dose-Escalation Stage 1|Physician Decision|0
5214433|NCT00996892|17998703|P11|Dose-Escalation Stage 1|Physician Decision|0
5214434|NCT00996892|17998704|P10|Dose-Escalation Stage 1|Physician Decision|0
5214435|NCT00996892|17998705|P9|Dose-Escalation Stage 1|Physician Decision|0
5214436|NCT00996892|17998706|P8|Dose-Escalation Stage 1|Physician Decision|0
5214437|NCT00996892|17998707|P7|Dose-Escalation Stage 1|Physician Decision|2
5214438|NCT00996892|17998708|P6|Dose-Escalation Stage 1|Physician Decision|1
5214439|NCT00996892|17998709|P5|Dose-Escalation Stage 1|Physician Decision|0
5214440|NCT00996892|17998710|P4|Dose-Escalation Stage 1|Physician Decision|1
5214441|NCT00996892|17998711|P3|Dose-Escalation Stage 1|Physician Decision|0
5214442|NCT00996892|17998712|P2|Dose-Escalation Stage 1|Physician Decision|0
5214443|NCT00996892|17998713|P1|Dose-Escalation Stage 1|Physician Decision|1
5214444|NCT00996892|17998694|P20|Dose-Escalation Stage 1|Death|0
5214445|NCT00996892|17998695|P19|Dose-Escalation Stage 1|Death|0
5214446|NCT00996892|17998696|P18|Dose-Escalation Stage 1|Death|0
5214447|NCT00996892|17998697|P17|Dose-Escalation Stage 1|Death|0
5214448|NCT00996892|17998698|P16|Dose-Escalation Stage 1|Death|0
5214449|NCT00996892|17998699|P15|Dose-Escalation Stage 1|Death|0
5214450|NCT00996892|17998700|P14|Dose-Escalation Stage 1|Death|0
5214451|NCT00996892|17998701|P13|Dose-Escalation Stage 1|Death|0
5214452|NCT00996892|17998702|P12|Dose-Escalation Stage 1|Death|0
5214453|NCT00996892|17998703|P11|Dose-Escalation Stage 1|Death|0
5214454|NCT00996892|17998704|P10|Dose-Escalation Stage 1|Death|0
5214455|NCT00996892|17998705|P9|Dose-Escalation Stage 1|Death|0
5214456|NCT00996892|17998706|P8|Dose-Escalation Stage 1|Death|0
5214457|NCT00996892|17998707|P7|Dose-Escalation Stage 1|Death|0
5214458|NCT00996892|17998708|P6|Dose-Escalation Stage 1|Death|1
5214459|NCT00996892|17998709|P5|Dose-Escalation Stage 1|Death|0
5214460|NCT00996892|17998710|P4|Dose-Escalation Stage 1|Death|0
5214461|NCT00996892|17998711|P3|Dose-Escalation Stage 1|Death|0
5214462|NCT00996892|17998712|P2|Dose-Escalation Stage 1|Death|0
5214463|NCT00996892|17998713|P1|Dose-Escalation Stage 1|Death|1
5214464|NCT00996892|17998694|P20|Dose-Escalation Stage 1|Adverse Event|0
5214465|NCT00996892|17998695|P19|Dose-Escalation Stage 1|Adverse Event|0
5214466|NCT00996892|17998696|P18|Dose-Escalation Stage 1|Adverse Event|0
5214467|NCT00996892|17998697|P17|Dose-Escalation Stage 1|Adverse Event|0
5214468|NCT00996892|17998698|P16|Dose-Escalation Stage 1|Adverse Event|0
5214469|NCT00996892|17998699|P15|Dose-Escalation Stage 1|Adverse Event|0
5214470|NCT00996892|17998700|P14|Dose-Escalation Stage 1|Adverse Event|0
5214471|NCT00996892|17998701|P13|Dose-Escalation Stage 1|Adverse Event|0
5214472|NCT00996892|17998702|P12|Dose-Escalation Stage 1|Adverse Event|0
5214473|NCT00996892|17998703|P11|Dose-Escalation Stage 1|Adverse Event|0
5214474|NCT00996892|17998704|P10|Dose-Escalation Stage 1|Adverse Event|0
5214475|NCT00996892|17998705|P9|Dose-Escalation Stage 1|Adverse Event|0
5214476|NCT00996892|17998706|P8|Dose-Escalation Stage 1|Adverse Event|0
5214477|NCT00996892|17998707|P7|Dose-Escalation Stage 1|Adverse Event|1
5214478|NCT00996892|17998708|P6|Dose-Escalation Stage 1|Adverse Event|0
5214479|NCT00996892|17998709|P5|Dose-Escalation Stage 1|Adverse Event|0
5214480|NCT00996892|17998710|P4|Dose-Escalation Stage 1|Adverse Event|2
5214481|NCT00996892|17998711|P3|Dose-Escalation Stage 1|Adverse Event|0
5214482|NCT00996892|17998712|P2|Dose-Escalation Stage 1|Adverse Event|0
5214483|NCT00996892|17998713|P1|Dose-Escalation Stage 1|Adverse Event|0
5214484|NCT00996840|17999307|P5|Overall Study|Withdrawal by Subject|0
5214485|NCT00996840|17999308|P4|Overall Study|Withdrawal by Subject|0
5214486|NCT00996840|17999309|P3|Overall Study|Withdrawal by Subject|0
5214487|NCT00996840|17999310|P2|Overall Study|Withdrawal by Subject|1
5214488|NCT00996840|17999311|P1|Overall Study|Withdrawal by Subject|1
5214489|NCT00996840|17999307|P5|Overall Study|Physician Decision|2
5214490|NCT00996840|17999308|P4|Overall Study|Physician Decision|1
5214491|NCT00996840|17999309|P3|Overall Study|Physician Decision|1
5214492|NCT00996840|17999310|P2|Overall Study|Physician Decision|0
5214493|NCT00996840|17999311|P1|Overall Study|Physician Decision|0
5214494|NCT00996840|17999307|P5|Overall Study|Adverse Event|0
5214495|NCT00996840|17999308|P4|Overall Study|Adverse Event|0
5214496|NCT00996840|17999309|P3|Overall Study|Adverse Event|0
5214497|NCT00996840|17999310|P2|Overall Study|Adverse Event|1
5214498|NCT00996840|17999311|P1|Overall Study|Adverse Event|0
5214499|NCT00996801|17999461|P6|Overall Study|Withdrawal by Subject|9
5214500|NCT00996801|17999462|P5|Overall Study|Withdrawal by Subject|5
5214501|NCT00996801|17999463|P4|Overall Study|Withdrawal by Subject|5
5214502|NCT00996801|17999464|P3|Overall Study|Withdrawal by Subject|9
5214503|NCT00996801|17999465|P2|Overall Study|Withdrawal by Subject|6
5214504|NCT00996801|17999466|P1|Overall Study|Withdrawal by Subject|8
5214505|NCT00996801|17999461|P6|Overall Study|Study Terminated by Sponsor|0
5214506|NCT00996801|17999462|P5|Overall Study|Study Terminated by Sponsor|46
5214507|NCT00996801|17999463|P4|Overall Study|Study Terminated by Sponsor|0
5214508|NCT00996801|17999464|P3|Overall Study|Study Terminated by Sponsor|0
5214509|NCT00996801|17999465|P2|Overall Study|Study Terminated by Sponsor|1
5214510|NCT00996801|17999466|P1|Overall Study|Study Terminated by Sponsor|0
5214511|NCT00996801|17999461|P6|Overall Study|Protocol Violation|4
5214512|NCT00996801|17999462|P5|Overall Study|Protocol Violation|3
5214513|NCT00996801|17999463|P4|Overall Study|Protocol Violation|2
5214514|NCT00996801|17999464|P3|Overall Study|Protocol Violation|1
5214515|NCT00996801|17999465|P2|Overall Study|Protocol Violation|4
5214516|NCT00996801|17999466|P1|Overall Study|Protocol Violation|3
5214517|NCT00996801|17999461|P6|Overall Study|Progressive Disease|0
5214518|NCT00996801|17999462|P5|Overall Study|Progressive Disease|0
5214519|NCT00996801|17999463|P4|Overall Study|Progressive Disease|0
5214520|NCT00996801|17999464|P3|Overall Study|Progressive Disease|0
5214521|NCT00996801|17999465|P2|Overall Study|Progressive Disease|1
5214522|NCT00996801|17999466|P1|Overall Study|Progressive Disease|0
5214523|NCT00996801|17999461|P6|Overall Study|Physician Decision|0
5214524|NCT00996801|17999462|P5|Overall Study|Physician Decision|0
5214525|NCT00996801|17999463|P4|Overall Study|Physician Decision|1
5214526|NCT00996801|17999464|P3|Overall Study|Physician Decision|0
5214527|NCT00996801|17999465|P2|Overall Study|Physician Decision|0
5214528|NCT00996801|17999466|P1|Overall Study|Physician Decision|0
5214529|NCT00996801|17999461|P6|Overall Study|Lost to Follow-up|2
5214530|NCT00996801|17999462|P5|Overall Study|Lost to Follow-up|3
5214531|NCT00996801|17999463|P4|Overall Study|Lost to Follow-up|3
5214532|NCT00996801|17999464|P3|Overall Study|Lost to Follow-up|0
5214533|NCT00996801|17999465|P2|Overall Study|Lost to Follow-up|0
5214534|NCT00996801|17999466|P1|Overall Study|Lost to Follow-up|0
5214535|NCT00996801|17999461|P6|Overall Study|Lack of Efficacy|1
5214536|NCT00996801|17999462|P5|Overall Study|Lack of Efficacy|0
5214537|NCT00996801|17999463|P4|Overall Study|Lack of Efficacy|3
5214538|NCT00996801|17999464|P3|Overall Study|Lack of Efficacy|1
5214539|NCT00996801|17999465|P2|Overall Study|Lack of Efficacy|0
5214540|NCT00996801|17999466|P1|Overall Study|Lack of Efficacy|3
5214541|NCT00996801|17999461|P6|Overall Study|Adverse Event|3
5214542|NCT00996801|17999462|P5|Overall Study|Adverse Event|31
5214543|NCT00996801|17999463|P4|Overall Study|Adverse Event|17
5214544|NCT00996801|17999464|P3|Overall Study|Adverse Event|12
5214545|NCT00996801|17999465|P2|Overall Study|Adverse Event|4
5214546|NCT00996801|17999466|P1|Overall Study|Adverse Event|6
5214547|NCT00996736|17999578|P2|Overall Study|Visit not within 3-month window|3
5214548|NCT00996736|17999579|P1|Overall Study|Visit not within 3-month window|5
5214549|NCT00996736|17999578|P2|Overall Study|Lost to Follow-up|14
5214550|NCT00996736|17999579|P1|Overall Study|Lost to Follow-up|15
5214551|NCT00996736|17999578|P2|Overall Study|Death|1
5214552|NCT00996736|17999579|P1|Overall Study|Death|1
5214553|NCT00996658|17999599|P2|Overall Study|Other|7
5214554|NCT00996658|17999600|P1|Overall Study|Other|9
5214555|NCT00996658|17999599|P2|Overall Study|Non-compliance issues|3
5214556|NCT00996658|17999600|P1|Overall Study|Non-compliance issues|3
5214557|NCT00996658|17999599|P2|Overall Study|Lost to Follow-up|5
5214558|NCT00996658|17999600|P1|Overall Study|Lost to Follow-up|2
5214559|NCT00996658|17999599|P2|Overall Study|Protocol Violation|1
5214560|NCT00996658|17999600|P1|Overall Study|Protocol Violation|0
5214561|NCT00996658|17999599|P2|Overall Study|Adverse Event|5
5214562|NCT00996658|17999600|P1|Overall Study|Adverse Event|2
5214563|NCT00996632|17999628|P2|Overall Study|Physician Decision|0
5214564|NCT00996632|17999629|P1|Overall Study|Physician Decision|0
5214565|NCT00996606|17999637|P1|Overall Study|Withdrawal by Subject|3
5214566|NCT00996606|17999637|P1|Overall Study|Protocol Violation|1
5214567|NCT00996606|17999637|P1|Overall Study|Insufficient Therapeutic Response|2
5214568|NCT00996606|17999637|P1|Overall Study|Adverse Event or Intercurrent Illness|2
5214569|NCT00996593|17999731|P1|Long-Term Follow-Up|Site Closed|1
5214570|NCT00996593|17999731|P1|Long-Term Follow-Up|Withdrawal by Subject|2
5214571|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
5214572|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
5214573|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
5214574|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Death|1
5214575|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
5214576|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
5214577|NCT00996593|17999731|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
5214578|NCT00996580|17999759|P1|Overall Study|Other|29
5214579|NCT00996580|17999759|P1|Overall Study|Withdrawal by Subject|217
5214580|NCT00996580|17999759|P1|Overall Study|Sponsor requested participant withdrawal|35
5214581|NCT00996580|17999759|P1|Overall Study|Protocol Violation|16
5214582|NCT00996580|17999759|P1|Overall Study|Pregnancy|68
5214583|NCT00996580|17999759|P1|Overall Study|Physician Decision|5
5214584|NCT00996580|17999759|P1|Overall Study|Noncompliance with the protocol|137
5214585|NCT00996580|17999759|P1|Overall Study|Lost to Follow-up|480
5214586|NCT00996580|17999759|P1|Overall Study|Adverse Event|466
5214587|NCT00996489|17999794|P1|Overall Study|Discontinued|116
5214588|NCT00996489|17999794|P1|Overall Study|Device failure|45
5214589|NCT00996476|17999814|P5|Overall Study|Adverse Event|1
5214590|NCT00996476|17999815|P4|Overall Study|Adverse Event|0
5214591|NCT00996476|17999816|P3|Overall Study|Adverse Event|0
5214592|NCT00996476|17999817|P2|Overall Study|Adverse Event|1
5214593|NCT00996476|17999818|P1|Overall Study|Adverse Event|0
5214594|NCT00996476|17999814|P5|Overall Study|Withdrawal by Subject|1
5214595|NCT00996476|17999815|P4|Overall Study|Withdrawal by Subject|0
5214596|NCT00996476|17999816|P3|Overall Study|Withdrawal by Subject|1
5214597|NCT00996476|17999817|P2|Overall Study|Withdrawal by Subject|2
5214598|NCT00996476|17999818|P1|Overall Study|Withdrawal by Subject|1
5214599|NCT00996437|17999886|P2|Overall Study|Missed|5
5214600|NCT00996437|17999887|P1|Overall Study|Missed|2
5214601|NCT00996437|17999886|P2|Overall Study|Dropped|2
5214602|NCT00996437|17999887|P1|Overall Study|Dropped|2
5214603|NCT00996437|17999886|P2|Overall Study|Death|0
5214604|NCT00996437|17999887|P1|Overall Study|Death|1
5214605|NCT00996333|17999932|P1|Overall Study|Other|5
5214606|NCT00996333|17999932|P1|Overall Study|Physician Decision|1
5214607|NCT00996333|17999932|P1|Overall Study|Adverse Event|1
5214608|NCT00996333|17999932|P1|Overall Study|Death|4
5214609|NCT00996333|17999932|P1|Overall Study|Withdrawal by Subject|1
5214610|NCT00996333|17999932|P1|Overall Study|Screen failure|1
5214611|NCT00996307|17999942|P4|Overall Study|Unable to classify|1
5214612|NCT00996307|17999943|P3|Overall Study|Unable to classify|2
5214613|NCT00996307|17999944|P2|Overall Study|Unable to classify|0
5214614|NCT00996307|17999945|P1|Overall Study|Unable to classify|4
5214615|NCT00996307|17999942|P4|Overall Study|Administrative reason|0
5214616|NCT00996307|17999943|P3|Overall Study|Administrative reason|0
5214617|NCT00996307|17999944|P2|Overall Study|Administrative reason|1
5214618|NCT00996307|17999945|P1|Overall Study|Administrative reason|0
5214619|NCT00996307|17999942|P4|Overall Study|Lost to Follow-up|15
5214620|NCT00996307|17999943|P3|Overall Study|Lost to Follow-up|7
5214621|NCT00996307|17999944|P2|Overall Study|Lost to Follow-up|13
5214622|NCT00996307|17999945|P1|Overall Study|Lost to Follow-up|13
5214623|NCT00996307|17999942|P4|Overall Study|Withdrawal by Subject|5
5214624|NCT00996307|17999943|P3|Overall Study|Withdrawal by Subject|5
5214625|NCT00996307|17999944|P2|Overall Study|Withdrawal by Subject|2
5214626|NCT00996307|17999945|P1|Overall Study|Withdrawal by Subject|3
5214627|NCT00996307|17999942|P4|Overall Study|Adverse Event|0
5214628|NCT00996307|17999943|P3|Overall Study|Adverse Event|0
5214629|NCT00996307|17999944|P2|Overall Study|Adverse Event|1
5214630|NCT00996307|17999945|P1|Overall Study|Adverse Event|0
5214631|NCT00996281|18000005|P2|Overall Study|Other|7
5214632|NCT00996281|18000006|P1|Overall Study|Other|5
5214633|NCT00996281|18000005|P2|Overall Study|Lack of Efficacy|2
5214634|NCT00996281|18000006|P1|Overall Study|Lack of Efficacy|0
5214635|NCT00996281|18000005|P2|Overall Study|Withdrawal by Subject|20
5214636|NCT00996281|18000006|P1|Overall Study|Withdrawal by Subject|31
5214637|NCT00996281|18000005|P2|Overall Study|Lost to Follow-up|16
5214638|NCT00996281|18000006|P1|Overall Study|Lost to Follow-up|14
5214639|NCT00996281|18000005|P2|Overall Study|Major Protocol Deviation|7
5214640|NCT00996281|18000006|P1|Overall Study|Major Protocol Deviation|6
5214641|NCT00996281|18000005|P2|Overall Study|Adverse Event|37
5214642|NCT00996281|18000006|P1|Overall Study|Adverse Event|75
5214643|NCT00996216|18000014|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
5214644|NCT00996216|18000014|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
5214645|NCT00996216|18000014|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
5214646|NCT00996203|18000030|P1|Overall Study|Protocol Violation|2
5214647|NCT00996203|18000030|P1|Overall Study|Lack of Efficacy|1
5214648|NCT00996203|18000030|P1|Overall Study|Lost to Follow-up|1
5214649|NCT00996203|18000030|P1|Overall Study|Adverse Event|3
5214650|NCT00996125|18000062|P2|Overall Study|Withdrawal by Subject|3
5214651|NCT00996125|18000063|P1|Overall Study|Withdrawal by Subject|4
5214652|NCT00996125|18000062|P2|Overall Study|Lost to Follow-up|6
5214653|NCT00996125|18000063|P1|Overall Study|Lost to Follow-up|1
5214654|NCT00996125|18000062|P2|Overall Study|Adverse Event|2
5214655|NCT00996125|18000063|P1|Overall Study|Adverse Event|0
5214656|NCT00996034|18000083|P1|Overall Study|withdrawn by PI|1
5214657|NCT00996034|18000083|P1|Overall Study|Lost to Follow-up|2
5214658|NCT00995930|18000089|P2|Overall Study|Adverse Event|14
5214659|NCT00995930|18000090|P1|Overall Study|Adverse Event|11
5214660|NCT00995930|18000089|P2|Overall Study|Withdrawal by Subject|4
5214661|NCT00995930|18000090|P1|Overall Study|Withdrawal by Subject|3
5214662|NCT00995930|18000089|P2|Overall Study|Lost to Follow-up|2
5214663|NCT00995930|18000090|P1|Overall Study|Lost to Follow-up|1
5214664|NCT00995930|18000089|P2|Overall Study|Administrative problems|2
5214665|NCT00995930|18000090|P1|Overall Study|Administrative problems|4
5214666|NCT00995930|18000089|P2|Overall Study|Death|1
5214667|NCT00995930|18000090|P1|Overall Study|Death|0
5214668|NCT00995930|18000089|P2|Overall Study|Protocol deviation|5
5214669|NCT00995930|18000090|P1|Overall Study|Protocol deviation|2
5214670|NCT00995865|18000141|P3|Overall Study|Lost to Follow-up|1
5214671|NCT00995865|18000142|P2|Overall Study|Lost to Follow-up|0
5214672|NCT00995865|18000143|P1|Overall Study|Lost to Follow-up|0
5214673|NCT00995865|18000141|P3|Overall Study|Protocol Violation|0
5214674|NCT00995865|18000142|P2|Overall Study|Protocol Violation|0
5214675|NCT00995865|18000143|P1|Overall Study|Protocol Violation|2
5214676|NCT00995774|18000165|P2|Training Period 2|Withdrawal by Subject|0
5214677|NCT00995774|18000166|P1|Training Period 2|Withdrawal by Subject|2
5214678|NCT00995709|18000200|P3|Overall Study|Protocol Violation|0
5214679|NCT00995709|18000201|P2|Overall Study|Protocol Violation|1
5214680|NCT00995709|18000202|P1|Overall Study|Protocol Violation|2
5214681|NCT00995709|18000200|P3|Overall Study|Death|0
5214682|NCT00995709|18000201|P2|Overall Study|Death|1
5214683|NCT00995709|18000202|P1|Overall Study|Death|0
5214684|NCT00995709|18000200|P3|Overall Study|Lost to Follow-up|0
5214685|NCT00995709|18000201|P2|Overall Study|Lost to Follow-up|0
5214686|NCT00995709|18000202|P1|Overall Study|Lost to Follow-up|1
5214687|NCT00995709|18000200|P3|Overall Study|Withdrawal by Subject|1
5214688|NCT00995709|18000201|P2|Overall Study|Withdrawal by Subject|4
5214689|NCT00995709|18000202|P1|Overall Study|Withdrawal by Subject|0
5214690|NCT00995709|18000200|P3|Overall Study|Lack of Efficacy|4
5214691|NCT00995709|18000201|P2|Overall Study|Lack of Efficacy|1
5214692|NCT00995709|18000202|P1|Overall Study|Lack of Efficacy|0
5214693|NCT00995709|18000200|P3|Overall Study|Adverse Event|0
5214694|NCT00995709|18000201|P2|Overall Study|Adverse Event|2
5214695|NCT00995709|18000202|P1|Overall Study|Adverse Event|4
5214696|NCT00995670|18000228|P3|Overall Study|Failed arterial cannulation|3
5214697|NCT00995670|18000229|P2|Overall Study|Failed arterial cannulation|0
5214698|NCT00995670|18000230|P1|Overall Study|Failed arterial cannulation|1
5214699|NCT00995566|18000238|P1|Overall Study|Early study termination|52
5214700|NCT00995566|18000238|P1|Overall Study|Adverse Event|2
5214701|NCT00995553|18000252|P2|Overall Study|Withdrawal by Subject|6
5214702|NCT00995553|18000253|P1|Overall Study|Withdrawal by Subject|2
5214703|NCT00995488|18000302|P1|Overall Study|Withdrawal by Subject|1
5214704|NCT00995436|18000336|P3|Overall Study|Withdrawal by Subject|0
5214705|NCT00995436|18000337|P2|Overall Study|Withdrawal by Subject|5
5214706|NCT00995436|18000338|P1|Overall Study|Withdrawal by Subject|2
5214707|NCT00995410|18000346|P1|Overall Study|Misc|28
5214708|NCT00995410|18000346|P1|Overall Study|Lost to Follow-up|2
5214709|NCT00995410|18000346|P1|Overall Study|Withdrawal by Subject|7
5214710|NCT00995410|18000346|P1|Overall Study|Adverse Event|51
5214711|NCT00995371|18000353|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
5214712|NCT00995371|18000354|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
5214713|NCT00995345|18000372|P5|Overall Study|all other reasons combined|3
5214714|NCT00995345|18000373|P4|Overall Study|all other reasons combined|1
5214715|NCT00995345|18000374|P3|Overall Study|all other reasons combined|2
5214716|NCT00995345|18000375|P2|Overall Study|all other reasons combined|2
5214717|NCT00995345|18000376|P1|Overall Study|all other reasons combined|2
5214718|NCT00995345|18000372|P5|Overall Study|Lost to Follow-up|0
5214719|NCT00995345|18000373|P4|Overall Study|Lost to Follow-up|1
5214720|NCT00995345|18000374|P3|Overall Study|Lost to Follow-up|2
5214721|NCT00995345|18000375|P2|Overall Study|Lost to Follow-up|2
5214722|NCT00995345|18000376|P1|Overall Study|Lost to Follow-up|2
5214723|NCT00995345|18000372|P5|Overall Study|Adverse Event|1
5214724|NCT00995345|18000373|P4|Overall Study|Adverse Event|0
5214725|NCT00995345|18000374|P3|Overall Study|Adverse Event|2
5214726|NCT00995345|18000375|P2|Overall Study|Adverse Event|1
5214727|NCT00995345|18000376|P1|Overall Study|Adverse Event|3
5214728|NCT00995345|18000372|P5|Overall Study|Withdrawal by Subject|1
5214729|NCT00995345|18000373|P4|Overall Study|Withdrawal by Subject|3
5214730|NCT00995345|18000374|P3|Overall Study|Withdrawal by Subject|1
5214731|NCT00995345|18000375|P2|Overall Study|Withdrawal by Subject|2
5214732|NCT00995345|18000376|P1|Overall Study|Withdrawal by Subject|4
5214733|NCT00995085|18000408|P1|Overall Study|Withdrawal by Subject|5
5214734|NCT00995020|18000425|P2|Overall Study|specimen fragmentation, thermal damage|2
5214735|NCT00995020|18000426|P1|Overall Study|specimen fragmentation, thermal damage|1
5214736|NCT00995020|18000425|P2|Overall Study|margin analysis not performed|5
5214737|NCT00995020|18000426|P1|Overall Study|margin analysis not performed|2
5214738|NCT00995007|18000436|P2|Overall Study|Toxicity|0
5214739|NCT00995007|18000437|P1|Overall Study|Toxicity|8
5214740|NCT00995007|18000436|P2|Overall Study|Refused further treatment|2
5214741|NCT00995007|18000437|P1|Overall Study|Refused further treatment|8
5214742|NCT00995007|18000436|P2|Overall Study|Withdrew consent|0
5214743|NCT00995007|18000437|P1|Overall Study|Withdrew consent|1
5214744|NCT00994682|18000500|P2|Pioglitazone Open Label|Physician Decision|1
5214745|NCT00994682|18000501|P1|Pioglitazone Open Label|Physician Decision|6
5214746|NCT00994682|18000500|P2|Pioglitazone Open Label|Lost to Follow-up|2
5214747|NCT00994682|18000501|P1|Pioglitazone Open Label|Lost to Follow-up|3
5214748|NCT00994682|18000500|P2|Pioglitazone Open Label|Withdrawal by Subject|4
5214749|NCT00994682|18000501|P1|Pioglitazone Open Label|Withdrawal by Subject|4
5214750|NCT00994682|18000500|P2|Double Bilnd|Adverse Event|0
5214751|NCT00994682|18000501|P1|Double Bilnd|Adverse Event|1
5214752|NCT00994682|18000500|P2|Double Bilnd|Lost to Follow-up|3
5214753|NCT00994682|18000501|P1|Double Bilnd|Lost to Follow-up|3
5214754|NCT00994682|18000500|P2|Double Bilnd|Withdrawal by Subject|6
5214755|NCT00994682|18000501|P1|Double Bilnd|Withdrawal by Subject|5
5214756|NCT00994643|18000545|P1|Overall Study|Withdrawal by Subject|1
5214757|NCT00994461|18000559|P3|Overall Study|Adverse Event|0
5214758|NCT00994461|18000560|P2|Overall Study|Adverse Event|1
5214759|NCT00994461|18000561|P1|Overall Study|Adverse Event|2
5214760|NCT00994448|18000589|P2|Overall Study|Physician Decision|0
5214761|NCT00994448|18000590|P1|Overall Study|Physician Decision|1
5214762|NCT00994448|18000589|P2|Overall Study|Withdrawal by Subject|1
5214763|NCT00994448|18000590|P1|Overall Study|Withdrawal by Subject|1
5214764|NCT00994448|18000589|P2|Overall Study|Lost to Follow-up|1
5214765|NCT00994448|18000590|P1|Overall Study|Lost to Follow-up|5
5214766|NCT00994448|18000589|P2|Overall Study|Adverse Event|0
5214767|NCT00994448|18000590|P1|Overall Study|Adverse Event|1
5214768|NCT00994422|18000598|P2|Overall Study|Lost to Follow-up|1
5214769|NCT00994422|18000599|P1|Overall Study|Lost to Follow-up|7
5214770|NCT00994279|18000624|P2|Overall Study|Multiple reasons|3
5214771|NCT00994279|18000625|P1|Overall Study|Multiple reasons|1
5214772|NCT00994279|18000624|P2|Overall Study|Toxicity|0
5214773|NCT00994279|18000625|P1|Overall Study|Toxicity|1
5214774|NCT00994279|18000624|P2|Overall Study|Withdrawal by Subject|2
5214775|NCT00994279|18000625|P1|Overall Study|Withdrawal by Subject|2
5214776|NCT00994240|18000635|P2|Overall Study|study termination|3
5214777|NCT00994240|18000636|P1|Overall Study|study termination|2
5214778|NCT00994240|18000635|P2|Overall Study|Withdrawal by Subject|0
5214779|NCT00994240|18000636|P1|Overall Study|Withdrawal by Subject|1
5214780|NCT00994240|18000635|P2|Overall Study|Lost to Follow-up|2
5214781|NCT00994240|18000636|P1|Overall Study|Lost to Follow-up|3
5214782|NCT00994214|18000646|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
5214783|NCT00994214|18000647|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
5214784|NCT00994214|18000648|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
5214785|NCT00994214|18000649|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
5214786|NCT00994214|18000646|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
5214787|NCT00994214|18000647|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5214788|NCT00994214|18000648|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5214789|NCT00994214|18000649|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5214790|NCT00994214|18000646|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
5214791|NCT00994214|18000647|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
5214792|NCT00994214|18000648|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
5214793|NCT00994214|18000649|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
5214794|NCT00994214|18000646|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5214795|NCT00994214|18000647|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5214796|NCT00994214|18000648|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5214797|NCT00994214|18000649|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
5214798|NCT00994214|18000646|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
5214799|NCT00994214|18000647|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5214800|NCT00994214|18000648|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5214801|NCT00994214|18000649|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5214802|NCT00994214|18000646|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5214803|NCT00994214|18000647|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5214804|NCT00994214|18000648|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
5214805|NCT00994214|18000649|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5214806|NCT00994110|18000728|P2|Overall Study|Pt not eligible|5
5214807|NCT00994110|18000729|P1|Overall Study|Pt not eligible|10
5214808|NCT00994110|18000728|P2|Overall Study|Patient not resected|52
5214809|NCT00994110|18000729|P1|Overall Study|Patient not resected|41
5214810|NCT00994110|18000728|P2|Overall Study|Adverse Event|0
5214811|NCT00994110|18000729|P1|Overall Study|Adverse Event|1
5214812|NCT00994110|18000728|P2|Overall Study|Not Treated|8
5214813|NCT00994110|18000729|P1|Overall Study|Not Treated|4
5214814|NCT00994110|18000728|P2|Overall Study|Withdrawal by Subject|9
5214815|NCT00994110|18000729|P1|Overall Study|Withdrawal by Subject|9
5214816|NCT00993967|18000735|P1|Overall Study|Protocol Violation|2
5214817|NCT00993967|18000735|P1|Overall Study|Withdrawal by Subject|36
5214818|NCT00993967|18000735|P1|Overall Study|Lost to Follow-up|14
5214819|NCT00993967|18000735|P1|Overall Study|Death|1
5214820|NCT00993967|18000735|P1|Overall Study|Adverse Event|8
5214821|NCT00993954|18000742|P2|Overall Study|Protocol Violation|2
5214822|NCT00993954|18000743|P1|Overall Study|Protocol Violation|21
5214823|NCT00993928|18000756|P2|Overall Study|ineligible|0
5214824|NCT00993928|18000757|P1|Overall Study|ineligible|1
5214825|NCT00993928|18000756|P2|Overall Study|Withdrawal by Subject|7
5214826|NCT00993928|18000757|P1|Overall Study|Withdrawal by Subject|4
5214827|NCT00993915|18000771|P1|Overall Study|Ongoing|3
5214828|NCT00993915|18000771|P1|Overall Study|Other|1
5214829|NCT00993915|18000771|P1|Overall Study|Withdrawal by Subject|2
5214830|NCT00993915|18000771|P1|Overall Study|Insufficient clinical response|3
5214831|NCT00993668|18000797|P2|Open-Label Period|Lost to Follow-up|1
5214832|NCT00993668|18000798|P1|Open-Label Period|Lost to Follow-up|6
5214833|NCT00993668|18000797|P2|Open-Label Period|Withdrawal by Subject|3
5214834|NCT00993668|18000798|P1|Open-Label Period|Withdrawal by Subject|4
5214835|NCT00993668|18000797|P2|Open-Label Period|Lack of Efficacy|3
5214836|NCT00993668|18000798|P1|Open-Label Period|Lack of Efficacy|4
5214837|NCT00993668|18000797|P2|Open-Label Period|Adverse Event|8
5214838|NCT00993668|18000798|P1|Open-Label Period|Adverse Event|9
5214839|NCT00993668|18000797|P2|Single-Blind Period|Lost to Follow-up|1
5214840|NCT00993668|18000798|P1|Single-Blind Period|Lost to Follow-up|3
5214841|NCT00993668|18000797|P2|Single-Blind Period|Lack of Efficacy|1
5214842|NCT00993668|18000798|P1|Single-Blind Period|Lack of Efficacy|0
5214843|NCT00993668|18000797|P2|Single-Blind Period|Adverse Event|1
5214844|NCT00993668|18000798|P1|Single-Blind Period|Adverse Event|1
5214845|NCT00993616|18000842|P1|Overall Study|Never treated|1
5214846|NCT00993616|18000842|P1|Overall Study|No tumor at entry|1
5214847|NCT00993499|18000860|P6|Discontinued After Starting Course 3|Other adverse event|0
5214848|NCT00993499|18000861|P5|Discontinued After Starting Course 3|Other adverse event|0
5214849|NCT00993499|18000862|P4|Discontinued After Starting Course 3|Other adverse event|0
5214850|NCT00993499|18000863|P3|Discontinued After Starting Course 3|Other adverse event|1
5214851|NCT00993499|18000864|P2|Discontinued After Starting Course 3|Other adverse event|0
5214852|NCT00993499|18000865|P1|Discontinued After Starting Course 3|Other adverse event|1
5214853|NCT00993499|18000860|P6|Discontinued After Starting Course 3|DLT|0
5214854|NCT00993499|18000861|P5|Discontinued After Starting Course 3|DLT|0
5214855|NCT00993499|18000862|P4|Discontinued After Starting Course 3|DLT|1
5214856|NCT00993499|18000863|P3|Discontinued After Starting Course 3|DLT|2
5214857|NCT00993499|18000864|P2|Discontinued After Starting Course 3|DLT|0
5214858|NCT00993499|18000865|P1|Discontinued After Starting Course 3|DLT|1
5214859|NCT00993499|18000860|P6|Discontinued After Starting Course 3|Progressive Disease|3
5214860|NCT00993499|18000861|P5|Discontinued After Starting Course 3|Progressive Disease|3
5214861|NCT00993499|18000862|P4|Discontinued After Starting Course 3|Progressive Disease|1
5214862|NCT00993499|18000863|P3|Discontinued After Starting Course 3|Progressive Disease|3
5214863|NCT00993499|18000864|P2|Discontinued After Starting Course 3|Progressive Disease|4
5214864|NCT00993499|18000865|P1|Discontinued After Starting Course 3|Progressive Disease|6
5214865|NCT00993499|18000860|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
5214866|NCT00993499|18000861|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
5214867|NCT00993499|18000862|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
5214868|NCT00993499|18000863|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
5214869|NCT00993499|18000864|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
5214870|NCT00993499|18000865|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
5214871|NCT00993499|18000860|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5214872|NCT00993499|18000861|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5214873|NCT00993499|18000862|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5214874|NCT00993499|18000863|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
5214875|NCT00993499|18000864|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5214876|NCT00993499|18000865|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5214877|NCT00993499|18000860|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5214878|NCT00993499|18000861|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5214879|NCT00993499|18000862|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
5214880|NCT00993499|18000863|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
5214881|NCT00993499|18000864|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5214882|NCT00993499|18000865|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5214883|NCT00993499|18000860|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5214884|NCT00993499|18000861|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5214885|NCT00993499|18000862|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5214886|NCT00993499|18000863|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5214887|NCT00993499|18000864|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
5214888|NCT00993499|18000865|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
5214889|NCT00993499|18000860|P6|Discontinued Before Starting Course 3|Progressive Disease|0
5214890|NCT00993499|18000861|P5|Discontinued Before Starting Course 3|Progressive Disease|0
5214891|NCT00993499|18000862|P4|Discontinued Before Starting Course 3|Progressive Disease|0
5214892|NCT00993499|18000863|P3|Discontinued Before Starting Course 3|Progressive Disease|0
5214893|NCT00993499|18000864|P2|Discontinued Before Starting Course 3|Progressive Disease|2
5214894|NCT00993499|18000865|P1|Discontinued Before Starting Course 3|Progressive Disease|2
5214895|NCT00993499|18000860|P6|Run-in Period (8 Days)|Progressive disease|0
5214896|NCT00993499|18000861|P5|Run-in Period (8 Days)|Progressive disease|0
5214897|NCT00993499|18000862|P4|Run-in Period (8 Days)|Progressive disease|0
5214898|NCT00993499|18000863|P3|Run-in Period (8 Days)|Progressive disease|1
5214899|NCT00993499|18000864|P2|Run-in Period (8 Days)|Progressive disease|1
5214900|NCT00993499|18000865|P1|Run-in Period (8 Days)|Progressive disease|0
5214901|NCT00993499|18000860|P6|Run-in Period (8 Days)|Consent withdrawn|0
5214902|NCT00993499|18000861|P5|Run-in Period (8 Days)|Consent withdrawn|0
5214903|NCT00993499|18000862|P4|Run-in Period (8 Days)|Consent withdrawn|0
5214904|NCT00993499|18000863|P3|Run-in Period (8 Days)|Consent withdrawn|0
5214905|NCT00993499|18000864|P2|Run-in Period (8 Days)|Consent withdrawn|1
5214906|NCT00993499|18000865|P1|Run-in Period (8 Days)|Consent withdrawn|0
5214907|NCT00993499|18000860|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5214908|NCT00993499|18000861|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5214909|NCT00993499|18000862|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5214910|NCT00993499|18000863|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5214911|NCT00993499|18000864|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5214912|NCT00993499|18000865|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
5214913|NCT00993499|18000860|P6|Run-in Period (8 Days)|Adverse Event|0
5214914|NCT00993499|18000861|P5|Run-in Period (8 Days)|Adverse Event|0
5214915|NCT00993499|18000862|P4|Run-in Period (8 Days)|Adverse Event|0
5214916|NCT00993499|18000863|P3|Run-in Period (8 Days)|Adverse Event|0
5214917|NCT00993499|18000864|P2|Run-in Period (8 Days)|Adverse Event|1
5214918|NCT00993499|18000865|P1|Run-in Period (8 Days)|Adverse Event|0
5214919|NCT00993473|18000947|P2|Overall Study|Family event|0
5214920|NCT00993473|18000948|P1|Overall Study|Family event|1
5214921|NCT00993473|18000947|P2|Overall Study|Technical problem with CGM device|1
5214922|NCT00993473|18000948|P1|Overall Study|Technical problem with CGM device|0
5214923|NCT00993473|18000947|P2|Overall Study|Withdrawal by Subject|5
5214924|NCT00993473|18000948|P1|Overall Study|Withdrawal by Subject|1
5214925|NCT00993473|18000947|P2|Overall Study|Lost to Follow-up|0
5214926|NCT00993473|18000948|P1|Overall Study|Lost to Follow-up|1
5214927|NCT00993473|18000947|P2|Overall Study|Protocol Violation|2
5214928|NCT00993473|18000948|P1|Overall Study|Protocol Violation|1
5214929|NCT00993473|18000947|P2|Overall Study|Adverse Event|2
5214930|NCT00993473|18000948|P1|Overall Study|Adverse Event|0
5214931|NCT00993447|18000986|P2|Overall Study|Adverse Event|0
5214932|NCT00993447|18000987|P1|Overall Study|Adverse Event|1
5214933|NCT00993447|18000986|P2|Overall Study|Lost to Follow-up|3
5214934|NCT00993447|18000987|P1|Overall Study|Lost to Follow-up|1
5214935|NCT00993447|18000986|P2|Overall Study|Protocol Violation|8
5214936|NCT00993447|18000987|P1|Overall Study|Protocol Violation|12
5214937|NCT00993447|18000986|P2|Overall Study|Withdrawal by Subject|8
5214938|NCT00993447|18000987|P1|Overall Study|Withdrawal by Subject|23
5214939|NCT00993421|18001024|P7|Overall Study|Protocol Violation|1
5214940|NCT00993421|18001025|P6|Overall Study|Protocol Violation|2
5214941|NCT00993421|18001026|P5|Overall Study|Protocol Violation|0
5214942|NCT00993421|18001027|P4|Overall Study|Protocol Violation|0
5214943|NCT00993421|18001028|P3|Overall Study|Protocol Violation|0
5214944|NCT00993421|18001029|P2|Overall Study|Protocol Violation|0
5214945|NCT00993421|18001030|P1|Overall Study|Protocol Violation|0
5214946|NCT00993421|18001024|P7|Overall Study|Physician Decision|1
5214947|NCT00993421|18001025|P6|Overall Study|Physician Decision|1
5214948|NCT00993421|18001026|P5|Overall Study|Physician Decision|0
5214949|NCT00993421|18001027|P4|Overall Study|Physician Decision|0
5214950|NCT00993421|18001028|P3|Overall Study|Physician Decision|0
5214951|NCT00993421|18001029|P2|Overall Study|Physician Decision|0
5214952|NCT00993421|18001030|P1|Overall Study|Physician Decision|0
5214953|NCT00993421|18001024|P7|Overall Study|Entry Criteria Exclusion|0
5214954|NCT00993421|18001025|P6|Overall Study|Entry Criteria Exclusion|1
5214955|NCT00993421|18001026|P5|Overall Study|Entry Criteria Exclusion|0
5214956|NCT00993421|18001027|P4|Overall Study|Entry Criteria Exclusion|3
5214957|NCT00993421|18001028|P3|Overall Study|Entry Criteria Exclusion|1
5214958|NCT00993421|18001029|P2|Overall Study|Entry Criteria Exclusion|0
5214959|NCT00993421|18001030|P1|Overall Study|Entry Criteria Exclusion|0
5214960|NCT00993421|18001024|P7|Overall Study|Death|1
5214961|NCT00993421|18001025|P6|Overall Study|Death|0
5214962|NCT00993421|18001026|P5|Overall Study|Death|0
5214963|NCT00993421|18001027|P4|Overall Study|Death|0
5214964|NCT00993421|18001028|P3|Overall Study|Death|0
5214965|NCT00993421|18001029|P2|Overall Study|Death|0
5214966|NCT00993421|18001030|P1|Overall Study|Death|0
5214967|NCT00993421|18001024|P7|Overall Study|Withdrawal by Subject|3
5214968|NCT00993421|18001025|P6|Overall Study|Withdrawal by Subject|5
5214969|NCT00993421|18001026|P5|Overall Study|Withdrawal by Subject|3
5214970|NCT00993421|18001027|P4|Overall Study|Withdrawal by Subject|3
5214971|NCT00993421|18001028|P3|Overall Study|Withdrawal by Subject|3
5214972|NCT00993421|18001029|P2|Overall Study|Withdrawal by Subject|2
5214973|NCT00993421|18001030|P1|Overall Study|Withdrawal by Subject|3
5214974|NCT00993421|18001024|P7|Overall Study|Lost to Follow-up|6
5214975|NCT00993421|18001025|P6|Overall Study|Lost to Follow-up|0
5214976|NCT00993421|18001026|P5|Overall Study|Lost to Follow-up|0
5214977|NCT00993421|18001027|P4|Overall Study|Lost to Follow-up|0
5214978|NCT00993421|18001028|P3|Overall Study|Lost to Follow-up|5
5214979|NCT00993421|18001029|P2|Overall Study|Lost to Follow-up|5
5214980|NCT00993421|18001030|P1|Overall Study|Lost to Follow-up|3
5214981|NCT00993421|18001024|P7|Overall Study|Sponsor Decision|29
5214982|NCT00993421|18001025|P6|Overall Study|Sponsor Decision|30
5214983|NCT00993421|18001026|P5|Overall Study|Sponsor Decision|38
5214984|NCT00993421|18001027|P4|Overall Study|Sponsor Decision|30
5214985|NCT00993421|18001028|P3|Overall Study|Sponsor Decision|28
5214986|NCT00993421|18001029|P2|Overall Study|Sponsor Decision|31
5214987|NCT00993421|18001030|P1|Overall Study|Sponsor Decision|36
5214988|NCT00993421|18001024|P7|Overall Study|Adverse Event|1
5214989|NCT00993421|18001025|P6|Overall Study|Adverse Event|7
5214990|NCT00993421|18001026|P5|Overall Study|Adverse Event|5
5214991|NCT00993421|18001027|P4|Overall Study|Adverse Event|9
5214992|NCT00993421|18001028|P3|Overall Study|Adverse Event|6
5214993|NCT00993421|18001029|P2|Overall Study|Adverse Event|7
5214994|NCT00993421|18001030|P1|Overall Study|Adverse Event|2
5214995|NCT00993317|18001181|P2|Overall Study|Early study termination at the site|0
5214996|NCT00993317|18001182|P1|Overall Study|Early study termination at the site|1
5214997|NCT00993317|18001181|P2|Overall Study|Investigator's opinion|1
5214998|NCT00993317|18001182|P1|Overall Study|Investigator's opinion|0
5214999|NCT00993317|18001181|P2|Overall Study|Withdrawal by Subject|2
5215000|NCT00993317|18001182|P1|Overall Study|Withdrawal by Subject|0
5215001|NCT00993317|18001181|P2|Overall Study|Lack of Efficacy|18
5215002|NCT00993317|18001182|P1|Overall Study|Lack of Efficacy|18
5215003|NCT00993317|18001181|P2|Overall Study|Adverse Event|4
5215004|NCT00993317|18001182|P1|Overall Study|Adverse Event|2
5215005|NCT00993291|18001200|P1|Overall Study|Withdrawal by Subject|1
5215006|NCT00993265|18001206|P2|Overall Study|Non-compliant with study medication|0
5215007|NCT00993265|18001207|P1|Overall Study|Non-compliant with study medication|1
5215008|NCT00993265|18001206|P2|Overall Study|Changed dose of concomitant drug|0
5215009|NCT00993265|18001207|P1|Overall Study|Changed dose of concomitant drug|2
5215010|NCT00993265|18001206|P2|Overall Study|Adverse Event|0
5215011|NCT00993265|18001207|P1|Overall Study|Adverse Event|1
5215012|NCT00993148|18001259|P1|Overall Study|never initiated treatment|1
5215013|NCT00993148|18001259|P1|Overall Study|Lost to Follow-up|2
5215014|NCT00993044|18001271|P1|Irinotecan 50 mg|Physician Decision|1
5215015|NCT00993031|18001278|P2|Overall Study|Lost to Follow-up|13
5215016|NCT00993031|18001279|P1|Overall Study|Lost to Follow-up|19
5215017|NCT00993031|18001278|P2|Overall Study|Withdrawal by Subject|3
5215018|NCT00993031|18001279|P1|Overall Study|Withdrawal by Subject|3
5215019|NCT00993031|18001278|P2|Overall Study|Physician Decision|2
5215020|NCT00993031|18001279|P1|Overall Study|Physician Decision|0
5215021|NCT00993031|18001278|P2|Overall Study|Death|1
5215022|NCT00993031|18001279|P1|Overall Study|Death|0
5215023|NCT00992992|18001311|P1|Overall Study|Sponsor Closed the Study|4
5215024|NCT00992992|18001311|P1|Overall Study|GlaxoSmithKline Closed the Study|2
5215025|NCT00992992|18001311|P1|Overall Study|Death|16
5215026|NCT00992992|18001311|P1|Overall Study|Lost to Follow-up|3
5215027|NCT00992836|18001342|P1|Overall Study|Protocol Violation|2
5215028|NCT00992836|18001342|P1|Overall Study|Withdrawal by Subject|2
5215029|NCT00992836|18001342|P1|Overall Study|Lost to Follow-up|1
5215030|NCT00992784|18001357|P3|Overall Study|Withdrawal by Subject|1
5215031|NCT00992784|18001358|P2|Overall Study|Withdrawal by Subject|1
5215032|NCT00992784|18001359|P1|Overall Study|Withdrawal by Subject|1
5215033|NCT00992784|18001357|P3|Overall Study|Adverse Event|0
5215034|NCT00992784|18001358|P2|Overall Study|Adverse Event|1
5215035|NCT00992784|18001359|P1|Overall Study|Adverse Event|2
5215036|NCT00992589|18001471|P4|Double-Blind Phase|Other|3
5215037|NCT00992589|18001472|P3|Double-Blind Phase|Other|6
5215038|NCT00992589|18001473|P2|Double-Blind Phase|Other|1
5215039|NCT00992589|18001474|P1|Double-Blind Phase|Other|0
5215040|NCT00992589|18001471|P4|Double-Blind Phase|Lost to Follow-up|2
5215041|NCT00992589|18001472|P3|Double-Blind Phase|Lost to Follow-up|0
5215042|NCT00992589|18001473|P2|Double-Blind Phase|Lost to Follow-up|0
5215043|NCT00992589|18001474|P1|Double-Blind Phase|Lost to Follow-up|0
5215044|NCT00992589|18001471|P4|Double-Blind Phase|Withdrawal by Subject|2
5215045|NCT00992589|18001472|P3|Double-Blind Phase|Withdrawal by Subject|5
5215046|NCT00992589|18001473|P2|Double-Blind Phase|Withdrawal by Subject|6
5215047|NCT00992589|18001474|P1|Double-Blind Phase|Withdrawal by Subject|0
5215048|NCT00992589|18001471|P4|Double-Blind Phase|Adverse Event|3
5215049|NCT00992589|18001472|P3|Double-Blind Phase|Adverse Event|2
5215050|NCT00992589|18001473|P2|Double-Blind Phase|Adverse Event|6
5215051|NCT00992589|18001474|P1|Double-Blind Phase|Adverse Event|0
5215052|NCT00992589|18001471|P4|Open-Label Phase|Other|0
5215053|NCT00992589|18001472|P3|Open-Label Phase|Other|0
5215054|NCT00992589|18001473|P2|Open-Label Phase|Other|0
5215055|NCT00992589|18001474|P1|Open-Label Phase|Other|45
5215056|NCT00992589|18001471|P4|Open-Label Phase|Physician Decision|0
5215057|NCT00992589|18001472|P3|Open-Label Phase|Physician Decision|0
5215058|NCT00992589|18001473|P2|Open-Label Phase|Physician Decision|0
5215059|NCT00992589|18001474|P1|Open-Label Phase|Physician Decision|4
5215060|NCT00992589|18001471|P4|Open-Label Phase|Protocol Violation|0
5215061|NCT00992589|18001472|P3|Open-Label Phase|Protocol Violation|0
5215062|NCT00992589|18001473|P2|Open-Label Phase|Protocol Violation|0
5215063|NCT00992589|18001474|P1|Open-Label Phase|Protocol Violation|3
5215064|NCT00992589|18001471|P4|Open-Label Phase|Lost to Follow-up|0
5215065|NCT00992589|18001472|P3|Open-Label Phase|Lost to Follow-up|0
5215066|NCT00992589|18001473|P2|Open-Label Phase|Lost to Follow-up|0
5215067|NCT00992589|18001474|P1|Open-Label Phase|Lost to Follow-up|1
5215068|NCT00992589|18001471|P4|Open-Label Phase|Withdrawal by Subject|0
5215069|NCT00992589|18001472|P3|Open-Label Phase|Withdrawal by Subject|0
5215070|NCT00992589|18001473|P2|Open-Label Phase|Withdrawal by Subject|0
5215071|NCT00992589|18001474|P1|Open-Label Phase|Withdrawal by Subject|20
5215072|NCT00992589|18001471|P4|Open-Label Phase|Adverse Event|0
5215073|NCT00992589|18001472|P3|Open-Label Phase|Adverse Event|0
5215074|NCT00992589|18001473|P2|Open-Label Phase|Adverse Event|0
5215075|NCT00992589|18001474|P1|Open-Label Phase|Adverse Event|4
5215076|NCT00992511|18001520|P4|Overall Study|Withdrawal by Subject|1
5215077|NCT00992511|18001521|P3|Overall Study|Withdrawal by Subject|1
5215078|NCT00992511|18001522|P2|Overall Study|Withdrawal by Subject|0
5215079|NCT00992511|18001523|P1|Overall Study|Withdrawal by Subject|0
5215080|NCT00992511|18001520|P4|Overall Study|Lost to Follow-up|2
5215081|NCT00992511|18001521|P3|Overall Study|Lost to Follow-up|0
5215082|NCT00992511|18001522|P2|Overall Study|Lost to Follow-up|0
5215083|NCT00992511|18001523|P1|Overall Study|Lost to Follow-up|1
5215084|NCT00992511|18001520|P4|Overall Study|Migrated/moved from study area|2
5215085|NCT00992511|18001521|P3|Overall Study|Migrated/moved from study area|1
5215086|NCT00992511|18001522|P2|Overall Study|Migrated/moved from study area|0
5215087|NCT00992511|18001523|P1|Overall Study|Migrated/moved from study area|1
5215088|NCT00992459|18001607|P2|Overall Study|Adverse Event|0
5215089|NCT00992459|18001608|P1|Overall Study|Adverse Event|1
5215090|NCT00992459|18001607|P2|Overall Study|Withdrawal by Subject|1
5215091|NCT00992459|18001608|P1|Overall Study|Withdrawal by Subject|0
5215092|NCT00992446|18001632|P1|Overall Study|Maintenance Therapy Screen Fail|5
5215093|NCT00992446|18001632|P1|Overall Study|Withdrawal by Subject|2
5215094|NCT00992446|18001632|P1|Overall Study|Disease Progression|1
5215095|NCT00992407|18001707|P2|Overall Study|Study medication not administered|13
5215096|NCT00992407|18001708|P1|Overall Study|Study medication not administered|17
5215097|NCT00992407|18001707|P2|Overall Study|Loss of follow-up & Adverse events|1
5215098|NCT00992407|18001708|P1|Overall Study|Loss of follow-up & Adverse events|2
5215099|NCT00992407|18001707|P2|Overall Study|Other|0
5215100|NCT00992407|18001708|P1|Overall Study|Other|2
5215101|NCT00992407|18001707|P2|Overall Study|protocol Violation & Adverse events|4
5215102|NCT00992407|18001708|P1|Overall Study|protocol Violation & Adverse events|2
5215103|NCT00992407|18001707|P2|Overall Study|Adverse Event|2
5215104|NCT00992407|18001708|P1|Overall Study|Adverse Event|3
5215105|NCT00992407|18001707|P2|Overall Study|Lost to Follow-up|3
5215106|NCT00992407|18001708|P1|Overall Study|Lost to Follow-up|3
5215107|NCT00992407|18001707|P2|Overall Study|Protocol Violation|1
5215108|NCT00992407|18001708|P1|Overall Study|Protocol Violation|2
5215109|NCT00992394|18001758|P2|Overall Study|Other event|0
5215110|NCT00992394|18001759|P1|Overall Study|Other event|1
5215111|NCT00992394|18001758|P2|Overall Study|Lost to Follow-up|0
5215112|NCT00992394|18001759|P1|Overall Study|Lost to Follow-up|2
5215113|NCT00992394|18001758|P2|Overall Study|Protocol Violation|4
5215114|NCT00992394|18001759|P1|Overall Study|Protocol Violation|2
5215115|NCT00992394|18001758|P2|Overall Study|Physician Decision|0
5215116|NCT00992394|18001759|P1|Overall Study|Physician Decision|1
5215117|NCT00992394|18001758|P2|Overall Study|Withdrawal by Subject|2
5215118|NCT00992394|18001759|P1|Overall Study|Withdrawal by Subject|8
5215119|NCT00992394|18001758|P2|Overall Study|Adverse Event|5
5215120|NCT00992394|18001759|P1|Overall Study|Adverse Event|4
5215121|NCT00992394|18001758|P2|Overall Study|Lack of Efficacy|3
5215122|NCT00992394|18001759|P1|Overall Study|Lack of Efficacy|6
5215123|NCT00992225|18001846|P1|Overall Study|Adverse Event|2
5215124|NCT00992225|18001846|P1|Overall Study|Entry Criteria Not Met|8
5215125|NCT00992186|18001856|P1|Overall Study|Refusal To Receive Study Agent|3
5215126|NCT00992186|18001856|P1|Overall Study|Progressive Disease|30
5215127|NCT00992186|18001856|P1|Overall Study|Adverse Event|9
5215128|NCT00992186|18001856|P1|Overall Study|Physician Decision|1
5215129|NCT00992186|18001856|P1|Overall Study|Protocol Violation|1
5215130|NCT00992186|18001856|P1|Overall Study|Withdrawal by Subject|2
5215131|NCT00992108|18001875|P2|Overall Study|Lost to Follow-up|1
5215132|NCT00992108|18001876|P1|Overall Study|Lost to Follow-up|0
5215133|NCT00992056|18001890|P2|Washout Period (2 Weeks)|Physician Decision|0
5215134|NCT00992056|18001891|P1|Washout Period (2 Weeks)|Physician Decision|1
5215135|NCT00992056|18001890|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
5215136|NCT00992056|18001891|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
5215137|NCT00992017|18001897|P1|Overall Study|Not adhere to study requirements|1
5215138|NCT00992017|18001897|P1|Overall Study|Unable to get to clinic|5
5215139|NCT00992017|18001897|P1|Overall Study|Withdrawal by Subject|2
5215140|NCT00992017|18001897|P1|Overall Study|Lost to Follow-up|2
5215141|NCT00991952|18001912|P2|Overall Study|Adverse Event|1
5215142|NCT00991952|18001913|P1|Overall Study|Adverse Event|0
5215143|NCT00991939|18001921|P2|Overall Study|Entire study terminated|1
5215144|NCT00991939|18001922|P1|Overall Study|Entire study terminated|4
5215145|NCT00991939|18001921|P2|Overall Study|Withdrawal by Subject|0
5215146|NCT00991939|18001922|P1|Overall Study|Withdrawal by Subject|1
5215147|NCT00991939|18001921|P2|Overall Study|Lost to Follow-up|1
5215148|NCT00991939|18001922|P1|Overall Study|Lost to Follow-up|0
5215149|NCT00991887|18001956|P2|Overall Study|Lost to Follow-up|1
5215150|NCT00991887|18001957|P1|Overall Study|Lost to Follow-up|2
5215151|NCT00991510|18001976|P2|Period III (Days 29-112)|Adverse Event|1
5215152|NCT00991510|18001977|P1|Period III (Days 29-112)|Adverse Event|1
5215153|NCT00991510|18001976|P2|Period I (Days 1-14)|Adverse Event|0
5215154|NCT00991510|18001977|P1|Period I (Days 1-14)|Adverse Event|1
5215155|NCT00991406|18002021|P1|Overall Study|One participant did not respond to FES.|1
5215156|NCT00991341|18002030|P2|Overall Study|Withdrawal by Subject|4
5215157|NCT00991341|18002031|P1|Overall Study|Withdrawal by Subject|3
5215158|NCT00991341|18002030|P2|Overall Study|Physician Decision|2
5215159|NCT00991341|18002031|P1|Overall Study|Physician Decision|1
5215160|NCT00991341|18002030|P2|Overall Study|no RBCs received 96hrs after randomized|155
5215161|NCT00991341|18002031|P1|Overall Study|no RBCs received 96hrs after randomized|186
5215162|NCT00991341|18002030|P2|Overall Study|Death|0
5215163|NCT00991341|18002031|P1|Overall Study|Death|3
5215164|NCT00991341|18002030|P2|Overall Study|no surgery w/in 30 days of randomization|18
5215165|NCT00991341|18002031|P1|Overall Study|no surgery w/in 30 days of randomization|11
5215166|NCT00991302|18002069|P2|Overall Study|Lost to Follow-up|12
5215167|NCT00991302|18002070|P1|Overall Study|Lost to Follow-up|14
5215168|NCT00991302|18002069|P2|Overall Study|Death|1
5215169|NCT00991302|18002070|P1|Overall Study|Death|0
5215170|NCT00991289|18002086|P1|Overall Study|Protocol Violation|2
5215171|NCT00991289|18002086|P1|Overall Study|Lost to Follow-up|4
5215172|NCT00991289|18002086|P1|Overall Study|Withdrawal by Subject|3
5215173|NCT00991289|18002086|P1|Overall Study|Physician Decision|2
5215174|NCT00991289|18002086|P1|Overall Study|Adverse Event|1
5215175|NCT00991276|18002106|P6|Third Intervention Period|Withdrawal by Subject|0
5215176|NCT00991276|18002107|P5|Third Intervention Period|Withdrawal by Subject|0
5215177|NCT00991276|18002108|P4|Third Intervention Period|Withdrawal by Subject|1
5215178|NCT00991276|18002109|P3|Third Intervention Period|Withdrawal by Subject|0
5215179|NCT00991276|18002110|P2|Third Intervention Period|Withdrawal by Subject|0
5215180|NCT00991276|18002111|P1|Third Intervention Period|Withdrawal by Subject|0
5215181|NCT00991276|18002106|P6|Third Intervention Period|Adverse Event|0
5215182|NCT00991276|18002107|P5|Third Intervention Period|Adverse Event|0
5215183|NCT00991276|18002108|P4|Third Intervention Period|Adverse Event|0
5215184|NCT00991276|18002109|P3|Third Intervention Period|Adverse Event|1
5215185|NCT00991276|18002110|P2|Third Intervention Period|Adverse Event|0
5215186|NCT00991276|18002111|P1|Third Intervention Period|Adverse Event|0
5215187|NCT00991276|18002106|P6|Third Intervention Period|Other|1
5215188|NCT00991276|18002107|P5|Third Intervention Period|Other|0
5215189|NCT00991276|18002108|P4|Third Intervention Period|Other|0
5215190|NCT00991276|18002109|P3|Third Intervention Period|Other|0
5215191|NCT00991276|18002110|P2|Third Intervention Period|Other|0
5215192|NCT00991276|18002111|P1|Third Intervention Period|Other|0
5215193|NCT00991276|18002106|P6|Third Intervention Period|Protocol Violation|0
5215194|NCT00991276|18002107|P5|Third Intervention Period|Protocol Violation|0
5215195|NCT00991276|18002108|P4|Third Intervention Period|Protocol Violation|0
5215196|NCT00991276|18002109|P3|Third Intervention Period|Protocol Violation|0
5215197|NCT00991276|18002110|P2|Third Intervention Period|Protocol Violation|0
5215198|NCT00991276|18002111|P1|Third Intervention Period|Protocol Violation|1
5215199|NCT00991276|18002106|P6|Second Intervention Period|Other|1
5215200|NCT00991276|18002107|P5|Second Intervention Period|Other|0
5215201|NCT00991276|18002108|P4|Second Intervention Period|Other|1
5215202|NCT00991276|18002109|P3|Second Intervention Period|Other|0
5215203|NCT00991276|18002110|P2|Second Intervention Period|Other|0
5215204|NCT00991276|18002111|P1|Second Intervention Period|Other|0
5215205|NCT00991276|18002106|P6|Second Intervention Period|Protocol Violation|0
5215206|NCT00991276|18002107|P5|Second Intervention Period|Protocol Violation|0
5215207|NCT00991276|18002108|P4|Second Intervention Period|Protocol Violation|0
5215208|NCT00991276|18002109|P3|Second Intervention Period|Protocol Violation|0
5215209|NCT00991276|18002110|P2|Second Intervention Period|Protocol Violation|0
5215210|NCT00991276|18002111|P1|Second Intervention Period|Protocol Violation|1
5215211|NCT00991276|18002106|P6|Second Intervention Period|Adverse Event|0
5215212|NCT00991276|18002107|P5|Second Intervention Period|Adverse Event|1
5215213|NCT00991276|18002108|P4|Second Intervention Period|Adverse Event|1
5215214|NCT00991276|18002109|P3|Second Intervention Period|Adverse Event|0
5215215|NCT00991276|18002110|P2|Second Intervention Period|Adverse Event|2
5215216|NCT00991276|18002111|P1|Second Intervention Period|Adverse Event|0
5215217|NCT00991276|18002106|P6|First Intervention Period|Lost to Follow-up|0
5215218|NCT00991276|18002107|P5|First Intervention Period|Lost to Follow-up|0
5215219|NCT00991276|18002108|P4|First Intervention Period|Lost to Follow-up|1
5215220|NCT00991276|18002109|P3|First Intervention Period|Lost to Follow-up|0
5215221|NCT00991276|18002110|P2|First Intervention Period|Lost to Follow-up|1
5215222|NCT00991276|18002111|P1|First Intervention Period|Lost to Follow-up|0
5215223|NCT00991276|18002106|P6|First Intervention Period|Withdrawal by Subject|1
5215224|NCT00991276|18002107|P5|First Intervention Period|Withdrawal by Subject|0
5215225|NCT00991276|18002108|P4|First Intervention Period|Withdrawal by Subject|1
5215226|NCT00991276|18002109|P3|First Intervention Period|Withdrawal by Subject|0
5215227|NCT00991276|18002110|P2|First Intervention Period|Withdrawal by Subject|1
5215228|NCT00991276|18002111|P1|First Intervention Period|Withdrawal by Subject|0
5215229|NCT00991276|18002106|P6|First Intervention Period|Other|0
5215230|NCT00991276|18002107|P5|First Intervention Period|Other|1
5215231|NCT00991276|18002108|P4|First Intervention Period|Other|1
5215232|NCT00991276|18002109|P3|First Intervention Period|Other|0
5215233|NCT00991276|18002110|P2|First Intervention Period|Other|0
5215234|NCT00991276|18002111|P1|First Intervention Period|Other|0
5215235|NCT00991276|18002106|P6|First Intervention Period|Insufficient clinical response|0
5215236|NCT00991276|18002107|P5|First Intervention Period|Insufficient clinical response|1
5215237|NCT00991276|18002108|P4|First Intervention Period|Insufficient clinical response|0
5215238|NCT00991276|18002109|P3|First Intervention Period|Insufficient clinical response|0
5215239|NCT00991276|18002110|P2|First Intervention Period|Insufficient clinical response|0
5215240|NCT00991276|18002111|P1|First Intervention Period|Insufficient clinical response|0
5215241|NCT00991276|18002106|P6|First Intervention Period|Protocol Violation|0
5215242|NCT00991276|18002107|P5|First Intervention Period|Protocol Violation|2
5215243|NCT00991276|18002108|P4|First Intervention Period|Protocol Violation|0
5215244|NCT00991276|18002109|P3|First Intervention Period|Protocol Violation|0
5215245|NCT00991276|18002110|P2|First Intervention Period|Protocol Violation|0
5215246|NCT00991276|18002111|P1|First Intervention Period|Protocol Violation|0
5215247|NCT00991276|18002106|P6|First Intervention Period|Adverse Event|0
5215248|NCT00991276|18002107|P5|First Intervention Period|Adverse Event|0
5215249|NCT00991276|18002108|P4|First Intervention Period|Adverse Event|1
5215250|NCT00991276|18002109|P3|First Intervention Period|Adverse Event|0
5215251|NCT00991276|18002110|P2|First Intervention Period|Adverse Event|1
5215252|NCT00991276|18002111|P1|First Intervention Period|Adverse Event|0
5215253|NCT00990821|18002326|P14|Overall Study|Withdrawal by Subject|1
5215254|NCT00990821|18002327|P13|Overall Study|Withdrawal by Subject|2
5215255|NCT00990821|18002328|P12|Overall Study|Withdrawal by Subject|5
5215256|NCT00990821|18002329|P11|Overall Study|Withdrawal by Subject|3
5215257|NCT00990821|18002330|P10|Overall Study|Withdrawal by Subject|1
5215258|NCT00990821|18002331|P9|Overall Study|Withdrawal by Subject|0
5215259|NCT00990821|18002332|P8|Overall Study|Withdrawal by Subject|0
5215260|NCT00990821|18002333|P7|Overall Study|Withdrawal by Subject|1
5215261|NCT00990821|18002334|P6|Overall Study|Withdrawal by Subject|3
5215262|NCT00990821|18002335|P5|Overall Study|Withdrawal by Subject|3
5215263|NCT00990821|18002336|P4|Overall Study|Withdrawal by Subject|0
5215264|NCT00990821|18002337|P3|Overall Study|Withdrawal by Subject|0
5215265|NCT00990821|18002338|P2|Overall Study|Withdrawal by Subject|2
5215266|NCT00990821|18002339|P1|Overall Study|Withdrawal by Subject|0
5215267|NCT00990704|18002376|P2|Overall Study|Physician Decision|1
5215268|NCT00990704|18002377|P1|Overall Study|Physician Decision|0
5215269|NCT00990704|18002376|P2|Overall Study|Adverse Event|1
5215270|NCT00990704|18002377|P1|Overall Study|Adverse Event|1
5215271|NCT00990665|18002397|P1|Overall Study|System Explant|3
5215272|NCT00990665|18002397|P1|Overall Study|Lost to Follow-up|1
5215273|NCT00990665|18002397|P1|Overall Study|Withdrawal by Subject|6
5215274|NCT00990665|18002397|P1|Overall Study|Heart Transplant|1
5215275|NCT00990665|18002397|P1|Overall Study|Death|29
5215276|NCT00990665|18002397|P1|Overall Study|Unsuccessful Implant|8
5215277|NCT00990652|18002404|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
5215278|NCT00990652|18002404|P1|Pre-surgical Bortezomib|Adverse Event|1
5215279|NCT00990340|18002438|P2|First 14-day Treatment|Protocol Violation|2
5215280|NCT00990340|18002439|P1|First 14-day Treatment|Protocol Violation|2
5215281|NCT00990340|18002438|P2|First 14-day Treatment|Lost to Follow-up|1
5215282|NCT00990340|18002439|P1|First 14-day Treatment|Lost to Follow-up|2
5215283|NCT00990340|18002438|P2|First 14-day Treatment|Not Compliant|1
5215284|NCT00990340|18002439|P1|First 14-day Treatment|Not Compliant|2
5215285|NCT00990314|18002453|P1|Overall Study|Lack of Efficacy|1
5215286|NCT00990314|18002453|P1|Overall Study|Physician Decision|3
5215287|NCT00990314|18002453|P1|Overall Study|Non-Compliance|1
5215288|NCT00990314|18002453|P1|Overall Study|Withdrawal by Subject|3
5215289|NCT00990314|18002453|P1|Overall Study|Adverse Event|2
5215290|NCT00990314|18002453|P1|Overall Study|Death|2
5215291|NCT00990249|18002495|P1|Overall Study|Not treated|2
5215292|NCT00990249|18002495|P1|Overall Study|Death|2
5215293|NCT00990249|18002495|P1|Overall Study|Non-Compliance|1
5215294|NCT00990249|18002495|P1|Overall Study|Disease Progression|8
5215295|NCT00990184|18002510|P1|Overall Study|Physician Decision|1
5215296|NCT00990106|18002518|P2|Overall Study|scheduling conflicts|2
5215297|NCT00990106|18002519|P1|Overall Study|scheduling conflicts|0
5215298|NCT00990106|18002518|P2|Overall Study|planned major surgery|1
5215299|NCT00990106|18002519|P1|Overall Study|planned major surgery|0
5215300|NCT00990106|18002518|P2|Overall Study|started exclusionary medication|1
5215301|NCT00990106|18002519|P1|Overall Study|started exclusionary medication|0
5215302|NCT00990106|18002518|P2|Overall Study|relocation/deployment|1
5215303|NCT00990106|18002519|P1|Overall Study|relocation/deployment|4
5215304|NCT00990106|18002518|P2|Overall Study|opted for open label prazosin|1
5215305|NCT00990106|18002519|P1|Overall Study|opted for open label prazosin|1
5215306|NCT00990106|18002518|P2|Overall Study|Withdrawal by Subject|1
5215307|NCT00990106|18002519|P1|Overall Study|Withdrawal by Subject|2
5215308|NCT00990106|18002518|P2|Overall Study|Lost to Follow-up|3
5215309|NCT00990106|18002519|P1|Overall Study|Lost to Follow-up|1
5215310|NCT00990106|18002518|P2|Overall Study|"too busy to continue"|2
5215311|NCT00990106|18002519|P1|Overall Study|"too busy to continue"|1
5215312|NCT00990093|18002529|P2|Test Period 2 (15-28 Days)|Other|1
5215313|NCT00990093|18002530|P1|Test Period 2 (15-28 Days)|Other|0
5215314|NCT00990093|18002529|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
5215315|NCT00990093|18002530|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
5215316|NCT00990093|18002529|P2|Test Period 2 (15-28 Days)|Adverse Event|0
5215317|NCT00990093|18002530|P1|Test Period 2 (15-28 Days)|Adverse Event|1
5215318|NCT00990093|18002529|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
5215319|NCT00990093|18002530|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
5215320|NCT00990093|18002529|P2|Test Period 1 (1-14 Days)|Other|0
5215321|NCT00990093|18002530|P1|Test Period 1 (1-14 Days)|Other|1
5215322|NCT00990093|18002529|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
5215323|NCT00990093|18002530|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
5215324|NCT00990093|18002529|P2|Test Period 1 (1-14 Days)|Adverse Event|0
5215325|NCT00990093|18002530|P1|Test Period 1 (1-14 Days)|Adverse Event|1
5215326|NCT00989963|18002582|P3|Overall Study|Adverse Event|1
5215327|NCT00989963|18002583|P2|Overall Study|Adverse Event|1
5215328|NCT00989963|18002584|P1|Overall Study|Adverse Event|1
5215329|NCT00989950|18002620|P4|Randomized Phase|Adverse Event|0
5215330|NCT00989950|18002621|P3|Randomized Phase|Adverse Event|0
5215331|NCT00989950|18002622|P2|Randomized Phase|Adverse Event|1
5215332|NCT00989950|18002623|P1|Randomized Phase|Adverse Event|0
5215333|NCT00989950|18002620|P4|Randomized Phase|Protocol Violation|0
5215334|NCT00989950|18002621|P3|Randomized Phase|Protocol Violation|0
5215335|NCT00989950|18002622|P2|Randomized Phase|Protocol Violation|0
5215336|NCT00989950|18002623|P1|Randomized Phase|Protocol Violation|1
5215337|NCT00989833|18002655|P3|Overall Study|Incorrectly randomized|0
5215338|NCT00989833|18002656|P2|Overall Study|Incorrectly randomized|0
5215339|NCT00989833|18002657|P1|Overall Study|Incorrectly randomized|1
5215340|NCT00989833|18002655|P3|Overall Study|Withdrawal by Subject|1
5215341|NCT00989833|18002656|P2|Overall Study|Withdrawal by Subject|0
5215342|NCT00989833|18002657|P1|Overall Study|Withdrawal by Subject|0
5215343|NCT00989833|18002655|P3|Overall Study|Protocol Violation|1
5215344|NCT00989833|18002656|P2|Overall Study|Protocol Violation|2
5215345|NCT00989833|18002657|P1|Overall Study|Protocol Violation|1
5215346|NCT00989833|18002655|P3|Overall Study|Lost to Follow-up|0
5215347|NCT00989833|18002656|P2|Overall Study|Lost to Follow-up|1
5215348|NCT00989833|18002657|P1|Overall Study|Lost to Follow-up|0
5215349|NCT00989781|18002688|P2|Ovarian Response to hCG|Lost to Follow-up|2
5215350|NCT00989781|18002689|P1|Ovarian Response to hCG|Lost to Follow-up|3
5215351|NCT00989664|18002719|P1|Long-Term Follow-Up|Death|3
5215352|NCT00989664|18002719|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
5215353|NCT00989664|18002719|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
5215354|NCT00989664|18002719|P1|Dosimetric and Therapeutic Treatment|Death|1
5215355|NCT00989664|18002719|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
5215356|NCT00989664|18002719|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
5215357|NCT00989664|18002719|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
5215358|NCT00989287|18002804|P2|Overall Study|Lost to Follow-up|1
5215359|NCT00989287|18002805|P1|Overall Study|Lost to Follow-up|0
5215360|NCT00989287|18002804|P2|Overall Study|Adverse Event|0
5215361|NCT00989287|18002805|P1|Overall Study|Adverse Event|1
5215362|NCT00989261|18002907|P2|Overall Study|Lost to Follow-up|0
5215363|NCT00989261|18002908|P1|Overall Study|Lost to Follow-up|3
5215364|NCT00989261|18002907|P2|Overall Study|Withdrawal by Subject|1
5215365|NCT00989261|18002908|P1|Overall Study|Withdrawal by Subject|0
5215366|NCT00989261|18002907|P2|Overall Study|Still in follow up|21
5215367|NCT00989261|18002908|P1|Overall Study|Still in follow up|12
5215368|NCT00989235|18002938|P2|Overall Study|Lost to Follow-up|1
5215369|NCT00989235|18002939|P1|Overall Study|Lost to Follow-up|0
5215370|NCT00989235|18002938|P2|Overall Study|Randomized by Mistake|2
5215371|NCT00989235|18002939|P1|Overall Study|Randomized by Mistake|0
5215372|NCT00989235|18002938|P2|Overall Study|Desire to Become Pregnant|0
5215373|NCT00989235|18002939|P1|Overall Study|Desire to Become Pregnant|1
5215374|NCT00989235|18002938|P2|Overall Study|Withdrawal of Consent|1
5215375|NCT00989235|18002939|P1|Overall Study|Withdrawal of Consent|1
5215376|NCT00989235|18002938|P2|Overall Study|Lack of Efficacy|0
5215377|NCT00989235|18002939|P1|Overall Study|Lack of Efficacy|1
5215378|NCT00989235|18002938|P2|Overall Study|Adverse Event|1
5215379|NCT00989235|18002939|P1|Overall Study|Adverse Event|0
5215380|NCT00989235|18002938|P2|Overall Study|Death|1
5215381|NCT00989235|18002939|P1|Overall Study|Death|0
5215382|NCT00989196|18002984|P2|Treatment Period|Lost to Follow-up|0
5215383|NCT00989196|18002985|P1|Treatment Period|Lost to Follow-up|1
5215384|NCT00989092|18003023|P2|Overall Study|Did not receive study drug|0
5215385|NCT00989092|18003024|P1|Overall Study|Did not receive study drug|2
5215386|NCT00989092|18003023|P2|Overall Study|Erythropoietin therapy initiated|0
5215387|NCT00989092|18003024|P1|Overall Study|Erythropoietin therapy initiated|2
5215388|NCT00989092|18003023|P2|Overall Study|Protocol deviation|0
5215389|NCT00989092|18003024|P1|Overall Study|Protocol deviation|2
5215390|NCT00989092|18003023|P2|Overall Study|Other|1
5215391|NCT00989092|18003024|P1|Overall Study|Other|3
5215392|NCT00989092|18003023|P2|Overall Study|Lost to Follow-up|2
5215393|NCT00989092|18003024|P1|Overall Study|Lost to Follow-up|6
5215394|NCT00989092|18003023|P2|Overall Study|Ineligibility determined|3
5215395|NCT00989092|18003024|P1|Overall Study|Ineligibility determined|3
5215396|NCT00989092|18003023|P2|Overall Study|Death|2
5215397|NCT00989092|18003024|P1|Overall Study|Death|14
5215398|NCT00989092|18003023|P2|Overall Study|Withdrawal by Subject|9
5215399|NCT00989092|18003024|P1|Overall Study|Withdrawal by Subject|17
5215400|NCT00989092|18003023|P2|Overall Study|Chemotherapy initiated|4
5215401|NCT00989092|18003024|P1|Overall Study|Chemotherapy initiated|12
5215402|NCT00989092|18003023|P2|Overall Study|Adverse Event|1
5215403|NCT00989092|18003024|P1|Overall Study|Adverse Event|20
5215404|NCT00989092|18003023|P2|Overall Study|Physician Decision|6
5215405|NCT00989092|18003024|P1|Overall Study|Physician Decision|9
5215406|NCT00988884|18003076|P2|Overall Study|Withdrawal by Subject|18
5215407|NCT00988884|18003077|P1|Overall Study|Withdrawal by Subject|15
5215408|NCT00988884|18003076|P2|Overall Study|Protocol Violation|1
5215409|NCT00988884|18003077|P1|Overall Study|Protocol Violation|0
5215410|NCT00988884|18003076|P2|Overall Study|Lost to Follow-up|16
5215411|NCT00988884|18003077|P1|Overall Study|Lost to Follow-up|20
5215412|NCT00988884|18003076|P2|Overall Study|Adverse Event|1
5215413|NCT00988884|18003077|P1|Overall Study|Adverse Event|0
5215414|NCT00988858|18003099|P1|Overall Study|Sponsor Decision|1
5215415|NCT00988858|18003099|P1|Overall Study|Physician Decision|1
5215416|NCT00988858|18003099|P1|Overall Study|Death|1
5215417|NCT00988858|18003099|P1|Overall Study|Adverse Event|7
5215418|NCT00988637|18003148|P2|Overall Study|non-compliance with study drug|1
5215419|NCT00988637|18003149|P1|Overall Study|non-compliance with study drug|0
5215420|NCT00988637|18003148|P2|Overall Study|Withdrawal by Subject|1
5215421|NCT00988637|18003149|P1|Overall Study|Withdrawal by Subject|1
5215422|NCT00988637|18003148|P2|Overall Study|Lost to Follow-up|1
5215423|NCT00988637|18003149|P1|Overall Study|Lost to Follow-up|2
5215424|NCT00988598|18003181|P2|Overall Study|Withdrawal by Subject|0
5215425|NCT00988598|18003182|P1|Overall Study|Withdrawal by Subject|2
5215426|NCT00988559|18003210|P4|Overall Study|Lost to Follow-up|0
5215427|NCT00988559|18003211|P3|Overall Study|Lost to Follow-up|1
5215428|NCT00988559|18003212|P2|Overall Study|Lost to Follow-up|0
5215429|NCT00988559|18003213|P1|Overall Study|Lost to Follow-up|0
5215430|NCT00988559|18003210|P4|Overall Study|Pregnancy|0
5215431|NCT00988559|18003211|P3|Overall Study|Pregnancy|1
5215432|NCT00988559|18003212|P2|Overall Study|Pregnancy|1
5215433|NCT00988559|18003213|P1|Overall Study|Pregnancy|0
5215434|NCT00988559|18003210|P4|Overall Study|Withdrawal by Subject|1
5215435|NCT00988559|18003211|P3|Overall Study|Withdrawal by Subject|0
5215436|NCT00988559|18003212|P2|Overall Study|Withdrawal by Subject|1
5215437|NCT00988559|18003213|P1|Overall Study|Withdrawal by Subject|1
5215438|NCT00988533|18003227|P1|Overall Study|Lost to Follow-up|3
5215439|NCT00988442|18003241|P2|Overall Study|Early Study Closure|25
5215440|NCT00988442|18003242|P1|Overall Study|Early Study Closure|29
5215441|NCT00988442|18003241|P2|Overall Study|Lost to Follow-up|1
5215442|NCT00988442|18003242|P1|Overall Study|Lost to Follow-up|0
5215443|NCT00988442|18003241|P2|Overall Study|Death|2
5215444|NCT00988442|18003242|P1|Overall Study|Death|1
5215445|NCT00988429|18003305|P3|Overall Study|other reasons|1
5215446|NCT00988429|18003306|P2|Overall Study|other reasons|8
5215447|NCT00988429|18003307|P1|Overall Study|other reasons|8
5215448|NCT00988429|18003305|P3|Overall Study|Administrative Reasons|1
5215449|NCT00988429|18003306|P2|Overall Study|Administrative Reasons|2
5215450|NCT00988429|18003307|P1|Overall Study|Administrative Reasons|1
5215451|NCT00988429|18003305|P3|Overall Study|Withdrawal by Subject|12
5215452|NCT00988429|18003306|P2|Overall Study|Withdrawal by Subject|7
5215453|NCT00988429|18003307|P1|Overall Study|Withdrawal by Subject|7
5215454|NCT00988429|18003305|P3|Overall Study|Protocol Violation|3
5215455|NCT00988429|18003306|P2|Overall Study|Protocol Violation|3
5215456|NCT00988429|18003307|P1|Overall Study|Protocol Violation|4
5215457|NCT00988429|18003305|P3|Overall Study|Pregnancy|0
5215458|NCT00988429|18003306|P2|Overall Study|Pregnancy|1
5215459|NCT00988429|18003307|P1|Overall Study|Pregnancy|2
5215460|NCT00988429|18003305|P3|Overall Study|Physician Decision|3
5215461|NCT00988429|18003306|P2|Overall Study|Physician Decision|0
5215462|NCT00988429|18003307|P1|Overall Study|Physician Decision|1
5215463|NCT00988429|18003305|P3|Overall Study|Non-Compliance with Study Drug|3
5215464|NCT00988429|18003306|P2|Overall Study|Non-Compliance with Study Drug|1
5215465|NCT00988429|18003307|P1|Overall Study|Non-Compliance with Study Drug|5
5215466|NCT00988429|18003305|P3|Overall Study|Lack of Efficacy|1
5215467|NCT00988429|18003306|P2|Overall Study|Lack of Efficacy|0
5215468|NCT00988429|18003307|P1|Overall Study|Lack of Efficacy|0
5215469|NCT00988429|18003305|P3|Overall Study|Adverse Event|45
5215470|NCT00988429|18003306|P2|Overall Study|Adverse Event|21
5215471|NCT00988429|18003307|P1|Overall Study|Adverse Event|9
5215472|NCT00988351|18003320|P2|Overall Study|not using CPAP|3
5215473|NCT00988351|18003321|P1|Overall Study|not using CPAP|5
5215474|NCT00988351|18003320|P2|Overall Study|Lost to Follow-up|9
5215475|NCT00988351|18003321|P1|Overall Study|Lost to Follow-up|6
5215476|NCT00988351|18003320|P2|Overall Study|Withdrawal by Subject|0
5215477|NCT00988351|18003321|P1|Overall Study|Withdrawal by Subject|8
5215478|NCT00988247|18003398|P2|Overall Study|Other|0
5215479|NCT00988247|18003399|P1|Overall Study|Other|3
5215480|NCT00988247|18003398|P2|Overall Study|Sponsor requested withdrawal|1
5215481|NCT00988247|18003399|P1|Overall Study|Sponsor requested withdrawal|3
5215482|NCT00988247|18003398|P2|Overall Study|Protocol Violation|5
5215483|NCT00988247|18003399|P1|Overall Study|Protocol Violation|4
5215484|NCT00988247|18003398|P2|Overall Study|Lost to Follow-up|2
5215485|NCT00988247|18003399|P1|Overall Study|Lost to Follow-up|11
5215486|NCT00988247|18003398|P2|Overall Study|Pregnancy|2
5215487|NCT00988247|18003399|P1|Overall Study|Pregnancy|1
5215488|NCT00988247|18003398|P2|Overall Study|Withdrawal by Subject|13
5215489|NCT00988247|18003399|P1|Overall Study|Withdrawal by Subject|44
5215490|NCT00988247|18003398|P2|Overall Study|Adverse Event|3
5215491|NCT00988247|18003399|P1|Overall Study|Adverse Event|17
5215492|NCT00988221|18003418|P4|Part III|Refused Treatment|0
5215493|NCT00988221|18003419|P3|Part III|Refused Treatment|1
5215494|NCT00988221|18003420|P2|Part III|Refused Treatment|0
5215495|NCT00988221|18003421|P1|Part III|Refused Treatment|0
5215496|NCT00988221|18003418|P4|Part III|Insufficient Therapeutic Response|0
5215497|NCT00988221|18003419|P3|Part III|Insufficient Therapeutic Response|1
5215498|NCT00988221|18003420|P2|Part III|Insufficient Therapeutic Response|1
5215499|NCT00988221|18003421|P1|Part III|Insufficient Therapeutic Response|0
5215500|NCT00988221|18003418|P4|Part III|Adverse Event|0
5215501|NCT00988221|18003419|P3|Part III|Adverse Event|1
5215502|NCT00988221|18003420|P2|Part III|Adverse Event|0
5215503|NCT00988221|18003421|P1|Part III|Adverse Event|1
5215504|NCT00988221|18003418|P4|Part II|Reason not Specified|0
5215505|NCT00988221|18003419|P3|Part II|Reason not Specified|1
5215506|NCT00988221|18003420|P2|Part II|Reason not Specified|0
5215507|NCT00988221|18003421|P1|Part II|Reason not Specified|0
5215508|NCT00988221|18003418|P4|Part II|Withdrawal by Subject|2
5215509|NCT00988221|18003419|P3|Part II|Withdrawal by Subject|2
5215510|NCT00988221|18003420|P2|Part II|Withdrawal by Subject|0
5215511|NCT00988221|18003421|P1|Part II|Withdrawal by Subject|0
5215512|NCT00988221|18003418|P4|Part II|Adverse Event|1
5215513|NCT00988221|18003419|P3|Part II|Adverse Event|0
5215514|NCT00988221|18003420|P2|Part II|Adverse Event|0
5215515|NCT00988221|18003421|P1|Part II|Adverse Event|1
5215516|NCT00988221|18003418|P4|Part I|Lost to Follow-up|0
5215517|NCT00988221|18003419|P3|Part I|Lost to Follow-up|0
5215518|NCT00988221|18003420|P2|Part I|Lost to Follow-up|1
5215519|NCT00988221|18003421|P1|Part I|Lost to Follow-up|0
5215520|NCT00988221|18003418|P4|Part I|Refused Treatment|0
5215521|NCT00988221|18003419|P3|Part I|Refused Treatment|1
5215522|NCT00988221|18003420|P2|Part I|Refused Treatment|2
5215523|NCT00988221|18003421|P1|Part I|Refused Treatment|0
5215524|NCT00988221|18003418|P4|Part I|Insufficient Therapeutic Response|0
5215525|NCT00988221|18003419|P3|Part I|Insufficient Therapeutic Response|5
5215526|NCT00988221|18003420|P2|Part I|Insufficient Therapeutic Response|6
5215527|NCT00988221|18003421|P1|Part I|Insufficient Therapeutic Response|4
5215528|NCT00988221|18003418|P4|Part I|Adverse Event|0
5215529|NCT00988221|18003419|P3|Part I|Adverse Event|2
5215530|NCT00988221|18003420|P2|Part I|Adverse Event|1
5215531|NCT00988221|18003421|P1|Part I|Adverse Event|0
5215532|NCT00988208|18003594|P2|Overall Study|Other|3
5215533|NCT00988208|18003595|P1|Overall Study|Other|8
5215534|NCT00988208|18003594|P2|Overall Study|Subject Decision/Investigator Discretion|32
5215535|NCT00988208|18003595|P1|Overall Study|Subject Decision/Investigator Discretion|32
5215536|NCT00988208|18003594|P2|Overall Study|Clinical Deterioration|14
5215537|NCT00988208|18003595|P1|Overall Study|Clinical Deterioration|7
5215538|NCT00988208|18003594|P2|Overall Study|Biochemical Progression|7
5215539|NCT00988208|18003595|P1|Overall Study|Biochemical Progression|21
5215540|NCT00988208|18003594|P2|Overall Study|Clinical Progression|16
5215541|NCT00988208|18003595|P1|Overall Study|Clinical Progression|17
5215542|NCT00988208|18003594|P2|Overall Study|Sponsor Decision|78
5215543|NCT00988208|18003595|P1|Overall Study|Sponsor Decision|102
5215544|NCT00988208|18003594|P2|Overall Study|Protocol Violation|2
5215545|NCT00988208|18003595|P1|Overall Study|Protocol Violation|9
5215546|NCT00988208|18003594|P2|Overall Study|Lost to Follow-up|3
5215547|NCT00988208|18003595|P1|Overall Study|Lost to Follow-up|2
5215548|NCT00988208|18003594|P2|Overall Study|Death|15
5215549|NCT00988208|18003595|P1|Overall Study|Death|9
5215550|NCT00988208|18003594|P2|Overall Study|Withdrawal by Subject|57
5215551|NCT00988208|18003595|P1|Overall Study|Withdrawal by Subject|50
5215552|NCT00988208|18003594|P2|Overall Study|Disease Progression|89
5215553|NCT00988208|18003595|P1|Overall Study|Disease Progression|103
5215554|NCT00988208|18003594|P2|Overall Study|Adverse Event|122
5215555|NCT00988208|18003595|P1|Overall Study|Adverse Event|71
5215556|NCT00988169|18003613|P1|Overall Study|Withdrawal by Subject|1
5215557|NCT00988117|18003665|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
5215558|NCT00988117|18003665|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
5215559|NCT00988091|18003674|P2|Open-label Period|Other|3
5215560|NCT00988091|18003675|P1|Open-label Period|Other|2
5215561|NCT00988091|18003674|P2|Open-label Period|Lost to Follow-up|5
5215562|NCT00988091|18003675|P1|Open-label Period|Lost to Follow-up|3
5215563|NCT00988091|18003674|P2|Open-label Period|Withdrawal by Subject|16
5215564|NCT00988091|18003675|P1|Open-label Period|Withdrawal by Subject|10
5215565|NCT00988091|18003674|P2|Open-label Period|Protocol Violation|1
5215566|NCT00988091|18003675|P1|Open-label Period|Protocol Violation|1
5215567|NCT00988091|18003674|P2|Open-label Period|Use of exclusionary medication|1
5215568|NCT00988091|18003675|P1|Open-label Period|Use of exclusionary medication|1
5215569|NCT00988091|18003674|P2|Open-label Period|Adverse Event|7
5215570|NCT00988091|18003675|P1|Open-label Period|Adverse Event|4
5215571|NCT00988091|18003674|P2|Double-blind Period|Use of exclusionary medication|3
5215572|NCT00988091|18003675|P1|Double-blind Period|Use of exclusionary medication|2
5215573|NCT00988091|18003674|P2|Double-blind Period|Adverse Event|9
5215574|NCT00988091|18003675|P1|Double-blind Period|Adverse Event|6
5215575|NCT00988091|18003674|P2|Double-blind Period|Other|8
5215576|NCT00988091|18003675|P1|Double-blind Period|Other|8
5215577|NCT00988091|18003674|P2|Double-blind Period|Lost to Follow-up|14
5215578|NCT00988091|18003675|P1|Double-blind Period|Lost to Follow-up|12
5215579|NCT00988091|18003674|P2|Double-blind Period|Withdrawal by Subject|13
5215580|NCT00988091|18003675|P1|Double-blind Period|Withdrawal by Subject|15
5215581|NCT00988065|18003697|P3|Overall Study|Noncompliance with protocol|9
5215582|NCT00988065|18003698|P2|Overall Study|Noncompliance with protocol|6
5215583|NCT00988065|18003699|P1|Overall Study|Noncompliance with protocol|5
5215584|NCT00988065|18003697|P3|Overall Study|Subject withdrew consent|2
5215585|NCT00988065|18003698|P2|Overall Study|Subject withdrew consent|5
5215586|NCT00988065|18003699|P1|Overall Study|Subject withdrew consent|3
5215587|NCT00988065|18003697|P3|Overall Study|Lost to Follow-up|2
5215588|NCT00988065|18003698|P2|Overall Study|Lost to Follow-up|2
5215589|NCT00988065|18003699|P1|Overall Study|Lost to Follow-up|1
5215590|NCT00988065|18003697|P3|Overall Study|Adverse Event|2
5215591|NCT00988065|18003698|P2|Overall Study|Adverse Event|10
5215592|NCT00988065|18003699|P1|Overall Study|Adverse Event|4
5215593|NCT00988052|18003721|P2|Overall Study|Study terminated by sponsor|236
5215594|NCT00988052|18003722|P1|Overall Study|Study terminated by sponsor|240
5215595|NCT00988052|18003721|P2|Overall Study|Withdrawal by Subject|91
5215596|NCT00988052|18003722|P1|Overall Study|Withdrawal by Subject|90
5215597|NCT00988052|18003721|P2|Overall Study|Adverse Event|28
5215598|NCT00988052|18003722|P1|Overall Study|Adverse Event|35
5215599|NCT00988052|18003721|P2|Overall Study|Physician Decision|28
5215600|NCT00988052|18003722|P1|Overall Study|Physician Decision|27
5215601|NCT00988052|18003721|P2|Overall Study|Lost to Follow-up|11
5215602|NCT00988052|18003722|P1|Overall Study|Lost to Follow-up|6
5215603|NCT00988052|18003721|P2|Overall Study|Lack of Efficacy|7
5215604|NCT00988052|18003722|P1|Overall Study|Lack of Efficacy|8
5215605|NCT00988052|18003721|P2|Overall Study|Pregnancy|6
5215606|NCT00988052|18003722|P1|Overall Study|Pregnancy|6
5215607|NCT00988052|18003721|P2|Overall Study|Protocol Violation|5
5215608|NCT00988052|18003722|P1|Overall Study|Protocol Violation|6
5215609|NCT00988052|18003721|P2|Overall Study|Death|3
5215610|NCT00988052|18003722|P1|Overall Study|Death|1
5215611|NCT00988052|18003721|P2|Overall Study|Teva requested subject withdrawal|1
5215612|NCT00988052|18003722|P1|Overall Study|Teva requested subject withdrawal|3
5215613|NCT00988052|18003721|P2|Overall Study|Missing|0
5215614|NCT00988052|18003722|P1|Overall Study|Missing|1
5215615|NCT00987935|18003766|P9|Overall Study|Reason other than those specified above|1
5215616|NCT00987935|18003767|P8|Overall Study|Reason other than those specified above|0
5215617|NCT00987935|18003768|P7|Overall Study|Reason other than those specified above|0
5215618|NCT00987935|18003769|P6|Overall Study|Reason other than those specified above|0
5215619|NCT00987935|18003770|P5|Overall Study|Reason other than those specified above|0
5215620|NCT00987935|18003771|P4|Overall Study|Reason other than those specified above|0
5215621|NCT00987935|18003772|P3|Overall Study|Reason other than those specified above|0
5215622|NCT00987935|18003773|P2|Overall Study|Reason other than those specified above|0
5215623|NCT00987935|18003774|P1|Overall Study|Reason other than those specified above|0
5215624|NCT00987935|18003766|P9|Overall Study|Refused to continue taking trial med.|2
5215625|NCT00987935|18003767|P8|Overall Study|Refused to continue taking trial med.|4
5215626|NCT00987935|18003768|P7|Overall Study|Refused to continue taking trial med.|4
5215627|NCT00987935|18003769|P6|Overall Study|Refused to continue taking trial med.|0
5215628|NCT00987935|18003770|P5|Overall Study|Refused to continue taking trial med.|1
5215629|NCT00987935|18003771|P4|Overall Study|Refused to continue taking trial med.|0
5215630|NCT00987935|18003772|P3|Overall Study|Refused to continue taking trial med.|0
5215631|NCT00987935|18003773|P2|Overall Study|Refused to continue taking trial med.|0
5215632|NCT00987935|18003774|P1|Overall Study|Refused to continue taking trial med.|1
5215633|NCT00987935|18003766|P9|Overall Study|Adverse Event|6
5215634|NCT00987935|18003767|P8|Overall Study|Adverse Event|10
5215635|NCT00987935|18003768|P7|Overall Study|Adverse Event|2
5215636|NCT00987935|18003769|P6|Overall Study|Adverse Event|0
5215637|NCT00987935|18003770|P5|Overall Study|Adverse Event|1
5215638|NCT00987935|18003771|P4|Overall Study|Adverse Event|1
5215639|NCT00987935|18003772|P3|Overall Study|Adverse Event|0
5215640|NCT00987935|18003773|P2|Overall Study|Adverse Event|1
5215641|NCT00987935|18003774|P1|Overall Study|Adverse Event|0
5215642|NCT00987935|18003766|P9|Overall Study|Progressive disease|23
5215643|NCT00987935|18003767|P8|Overall Study|Progressive disease|48
5215644|NCT00987935|18003768|P7|Overall Study|Progressive disease|9
5215645|NCT00987935|18003769|P6|Overall Study|Progressive disease|3
5215646|NCT00987935|18003770|P5|Overall Study|Progressive disease|5
5215647|NCT00987935|18003771|P4|Overall Study|Progressive disease|2
5215648|NCT00987935|18003772|P3|Overall Study|Progressive disease|3
5215649|NCT00987935|18003773|P2|Overall Study|Progressive disease|2
5215650|NCT00987935|18003774|P1|Overall Study|Progressive disease|3
5215651|NCT00987831|18003830|P3|Overall Study|Lost to Follow-up|0
5215652|NCT00987831|18003831|P2|Overall Study|Lost to Follow-up|3
5215653|NCT00987831|18003832|P1|Overall Study|Lost to Follow-up|0
5215654|NCT00987831|18003830|P3|Overall Study|Never flared in 12 months|0
5215655|NCT00987831|18003831|P2|Overall Study|Never flared in 12 months|0
5215656|NCT00987831|18003832|P1|Overall Study|Never flared in 12 months|1
5215657|NCT00987623|18003854|P2|Overall Study|Influenza|1
5215658|NCT00987623|18003855|P1|Overall Study|Influenza|0
5215659|NCT00987623|18003854|P2|Overall Study|Biomicroscopy|1
5215660|NCT00987623|18003855|P1|Overall Study|Biomicroscopy|0
5215661|NCT00987623|18003854|P2|Overall Study|Discomfort|0
5215662|NCT00987623|18003855|P1|Overall Study|Discomfort|1
5215663|NCT00987623|18003854|P2|Overall Study|Time/job conflict|0
5215664|NCT00987623|18003855|P1|Overall Study|Time/job conflict|2
5215665|NCT00987623|18003854|P2|Overall Study|Lost to Follow-up|1
5215666|NCT00987623|18003855|P1|Overall Study|Lost to Follow-up|2
5215667|NCT00987467|18003884|P1|Overall Study|Lost to Follow-up|2
5215668|NCT00987402|18003908|P2|Overall Study|Insufficient data entry|98
5215669|NCT00987402|18003909|P1|Overall Study|Insufficient data entry|86
5215670|NCT00987389|18003917|P4|Overall Study|Multiple different reasons|1
5215671|NCT00987389|18003918|P3|Overall Study|Multiple different reasons|3
5215672|NCT00987389|18003919|P2|Overall Study|Multiple different reasons|0
5215673|NCT00987389|18003920|P1|Overall Study|Multiple different reasons|1
5215674|NCT00987389|18003917|P4|Overall Study|Withdrawn from Treatment|0
5215675|NCT00987389|18003918|P3|Overall Study|Withdrawn from Treatment|0
5215676|NCT00987389|18003919|P2|Overall Study|Withdrawn from Treatment|1
5215677|NCT00987389|18003920|P1|Overall Study|Withdrawn from Treatment|0
5215678|NCT00987389|18003917|P4|Overall Study|Withdrawal by Subject|1
5215679|NCT00987389|18003918|P3|Overall Study|Withdrawal by Subject|2
5215680|NCT00987389|18003919|P2|Overall Study|Withdrawal by Subject|3
5215681|NCT00987389|18003920|P1|Overall Study|Withdrawal by Subject|4
5215682|NCT00987389|18003917|P4|Overall Study|Lost to Follow-up|1
5215683|NCT00987389|18003918|P3|Overall Study|Lost to Follow-up|3
5215684|NCT00987389|18003919|P2|Overall Study|Lost to Follow-up|1
5215685|NCT00987389|18003920|P1|Overall Study|Lost to Follow-up|4
5215686|NCT00987389|18003917|P4|Overall Study|Ineligible|0
5215687|NCT00987389|18003918|P3|Overall Study|Ineligible|0
5215688|NCT00987389|18003919|P2|Overall Study|Ineligible|3
5215689|NCT00987389|18003920|P1|Overall Study|Ineligible|0
5215690|NCT00987337|18003939|P3|Overall Study|Participant Relapsed|5
5215691|NCT00987337|18003940|P2|Overall Study|Participant Relapsed|20
5215692|NCT00987337|18003941|P1|Overall Study|Participant Relapsed|18
5215693|NCT00987337|18003939|P3|Overall Study|Protocol Violation|2
5215694|NCT00987337|18003940|P2|Overall Study|Protocol Violation|0
5215695|NCT00987337|18003941|P1|Overall Study|Protocol Violation|1
5215696|NCT00987337|18003939|P3|Overall Study|Other|5
5215697|NCT00987337|18003940|P2|Overall Study|Other|2
5215698|NCT00987337|18003941|P1|Overall Study|Other|0
5215699|NCT00987337|18003939|P3|Overall Study|Withdrawal by Subject|9
5215700|NCT00987337|18003940|P2|Overall Study|Withdrawal by Subject|9
5215701|NCT00987337|18003941|P1|Overall Study|Withdrawal by Subject|6
5215702|NCT00987337|18003939|P3|Overall Study|Lost to Follow-up|2
5215703|NCT00987337|18003940|P2|Overall Study|Lost to Follow-up|6
5215704|NCT00987337|18003941|P1|Overall Study|Lost to Follow-up|10
5215705|NCT00987337|18003939|P3|Overall Study|Virologic Breakthrough|8
5215706|NCT00987337|18003940|P2|Overall Study|Virologic Breakthrough|2
5215707|NCT00987337|18003941|P1|Overall Study|Virologic Breakthrough|2
5215708|NCT00987337|18003939|P3|Overall Study|Insufficient Virologic Response|12
5215709|NCT00987337|18003940|P2|Overall Study|Insufficient Virologic Response|7
5215710|NCT00987337|18003941|P1|Overall Study|Insufficient Virologic Response|10
5215711|NCT00987337|18003939|P3|Overall Study|Adverse Event|8
5215712|NCT00987337|18003940|P2|Overall Study|Adverse Event|9
5215713|NCT00987337|18003941|P1|Overall Study|Adverse Event|10
5215714|NCT00986986|18003996|P2|Overall Study|Lost to Follow-up|1
5215715|NCT00986986|18003997|P1|Overall Study|Lost to Follow-up|0
5215716|NCT00986973|18004007|P1|Overall Study|Withdrawn by study team|1
5215717|NCT00986921|18004033|P2|Overall Study|Physician Decision|0
5215718|NCT00986921|18004034|P1|Overall Study|Physician Decision|1
5215719|NCT00986830|18004067|P1|Overall Study|Unable to access sinus with device|5
5215720|NCT00986830|18004067|P1|Overall Study|Lack of Efficacy|1
5215721|NCT00986830|18004067|P1|Overall Study|Lost to Follow-up|1
5215722|NCT00986830|18004067|P1|Overall Study|Death|1
5215723|NCT00986674|18004082|P3|Overall Study|unknown/not specify|9
5215724|NCT00986674|18004083|P2|Overall Study|unknown/not specify|7
5215725|NCT00986674|18004084|P1|Overall Study|unknown/not specify|0
5215726|NCT00986674|18004082|P3|Overall Study|not start protocol therapy|1
5215727|NCT00986674|18004083|P2|Overall Study|not start protocol therapy|3
5215728|NCT00986674|18004084|P1|Overall Study|not start protocol therapy|4
5215729|NCT00986674|18004082|P3|Overall Study|alternative therapy|1
5215730|NCT00986674|18004083|P2|Overall Study|alternative therapy|0
5215731|NCT00986674|18004084|P1|Overall Study|alternative therapy|0
5215732|NCT00986674|18004082|P3|Overall Study|Withdrawal by Subject|1
5215733|NCT00986674|18004083|P2|Overall Study|Withdrawal by Subject|2
5215734|NCT00986674|18004084|P1|Overall Study|Withdrawal by Subject|6
5215735|NCT00986674|18004082|P3|Overall Study|Death|4
5215736|NCT00986674|18004083|P2|Overall Study|Death|0
5215737|NCT00986674|18004084|P1|Overall Study|Death|5
5215738|NCT00986674|18004082|P3|Overall Study|Adverse Event|9
5215739|NCT00986674|18004083|P2|Overall Study|Adverse Event|8
5215740|NCT00986674|18004084|P1|Overall Study|Adverse Event|4
5215741|NCT00986674|18004082|P3|Overall Study|Lack of Efficacy|23
5215742|NCT00986674|18004083|P2|Overall Study|Lack of Efficacy|25
5215743|NCT00986674|18004084|P1|Overall Study|Lack of Efficacy|28
5215744|NCT00986570|18004117|P1|Overall Study|Potential bias for objective assessment|1
5215745|NCT00986570|18004117|P1|Overall Study|Lost to Follow-up|6
5215746|NCT00986479|18004134|P2|Period 1|Administrative reasons|0
5215747|NCT00986479|18004135|P1|Period 1|Administrative reasons|1
5215748|NCT00986479|18004134|P2|Period 1|Improved mood|0
5215749|NCT00986479|18004135|P1|Period 1|Improved mood|1
5215750|NCT00986440|18004181|P2|Overall Study|Screen failure (not dosed)|2
5215751|NCT00986440|18004182|P1|Overall Study|Screen failure (not dosed)|4
5215752|NCT00986440|18004181|P2|Overall Study|Withdrawal by Subject|2
5215753|NCT00986440|18004182|P1|Overall Study|Withdrawal by Subject|1
5215754|NCT00986440|18004181|P2|Overall Study|Serious adverse event or adverse event|2
5215755|NCT00986440|18004182|P1|Overall Study|Serious adverse event or adverse event|9
5215756|NCT00986440|18004181|P2|Overall Study|Progressive disease|37
5215757|NCT00986440|18004182|P1|Overall Study|Progressive disease|27
5215758|NCT00986427|18004200|P2|Overall Study|Withdrawal by Subject|0
5215759|NCT00986427|18004201|P1|Overall Study|Withdrawal by Subject|1
5215760|NCT00986427|18004200|P2|Overall Study|Lack of Efficacy|0
5215761|NCT00986427|18004201|P1|Overall Study|Lack of Efficacy|1
5215762|NCT00986427|18004200|P2|Overall Study|Lost to Follow-up|0
5215763|NCT00986427|18004201|P1|Overall Study|Lost to Follow-up|2
5215764|NCT00986362|18004229|P2|Overall Study|Lost to Follow-up|1
5215765|NCT00986362|18004230|P1|Overall Study|Lost to Follow-up|0
5215766|NCT00986362|18004229|P2|Overall Study|Death|0
5215767|NCT00986362|18004230|P1|Overall Study|Death|2
5215768|NCT00986349|18004236|P1|Overall Study|device migration|1
5215769|NCT00986349|18004236|P1|Overall Study|Physician Decision|1
5215770|NCT00986349|18004236|P1|Overall Study|Adverse Event|2
5215771|NCT00986349|18004236|P1|Overall Study|Unsuccessful implant procedure|3
5215772|NCT00986258|18004260|P1|Maintenance Period|Withdrawal by Subject|2
5215773|NCT00986258|18004260|P1|Maintenance Period|Lack of Efficacy|2
5215774|NCT00986258|18004260|P1|Maintenance Period|Adverse Event|5
5215775|NCT00986258|18004260|P1|Titration and Optimal Dose Period|Other|1
5215776|NCT00986258|18004260|P1|Titration and Optimal Dose Period|Non-Compliance|1
5215777|NCT00986258|18004260|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
5215778|NCT00986258|18004260|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
5215779|NCT00986258|18004260|P1|Titration and Optimal Dose Period|Adverse Event|15
5215780|NCT00986258|18004260|P1|Observation Period|Not eligible to be dosed|11
5215781|NCT00986245|18004288|P2|Second Intervention|Protocol Violation|1
5215782|NCT00986245|18004289|P1|Second Intervention|Protocol Violation|0
5215783|NCT00986245|18004288|P2|Second Intervention|Lost to Follow-up|0
5215784|NCT00986245|18004289|P1|Second Intervention|Lost to Follow-up|1
5215785|NCT00986245|18004288|P2|Second Intervention|Poor compliance|0
5215786|NCT00986245|18004289|P1|Second Intervention|Poor compliance|1
5215787|NCT00986245|18004288|P2|First Intervention|Out of indication|0
5215788|NCT00986245|18004289|P1|First Intervention|Out of indication|1
5215789|NCT00986245|18004288|P2|First Intervention|Protocol Violation|1
5215790|NCT00986245|18004289|P1|First Intervention|Protocol Violation|0
5215791|NCT00986245|18004288|P2|First Intervention|Withdrawal by Subject|1
5215792|NCT00986245|18004289|P1|First Intervention|Withdrawal by Subject|0
5215793|NCT00986245|18004288|P2|First Intervention|Lack of Efficacy|2
5215794|NCT00986245|18004289|P1|First Intervention|Lack of Efficacy|1
5215795|NCT00986245|18004288|P2|First Intervention|Poor compliance|4
5215796|NCT00986245|18004289|P1|First Intervention|Poor compliance|8
5215797|NCT00986232|18004326|P4|Overall Study|Incomplete safety follow-up|2
5215798|NCT00986232|18004327|P3|Overall Study|Incomplete safety follow-up|2
5215799|NCT00986232|18004328|P2|Overall Study|Incomplete safety follow-up|7
5215800|NCT00986232|18004329|P1|Overall Study|Incomplete safety follow-up|3
5215801|NCT00986232|18004326|P4|Overall Study|Missed one or more bleeds|7
5215802|NCT00986232|18004327|P3|Overall Study|Missed one or more bleeds|6
5215803|NCT00986232|18004328|P2|Overall Study|Missed one or more bleeds|10
5215804|NCT00986232|18004329|P1|Overall Study|Missed one or more bleeds|13
5215805|NCT00986232|18004326|P4|Overall Study|Withdrawal by Subject|3
5215806|NCT00986232|18004327|P3|Overall Study|Withdrawal by Subject|12
5215807|NCT00986232|18004328|P2|Overall Study|Withdrawal by Subject|16
5215808|NCT00986232|18004329|P1|Overall Study|Withdrawal by Subject|13
5215809|NCT00986232|18004326|P4|Overall Study|Protocol Violation|1
5215810|NCT00986232|18004327|P3|Overall Study|Protocol Violation|0
5215811|NCT00986232|18004328|P2|Overall Study|Protocol Violation|3
5215812|NCT00986232|18004329|P1|Overall Study|Protocol Violation|2
5215813|NCT00986232|18004326|P4|Overall Study|Lost to Follow-up|7
5215814|NCT00986232|18004327|P3|Overall Study|Lost to Follow-up|12
5215815|NCT00986232|18004328|P2|Overall Study|Lost to Follow-up|12
5215816|NCT00986232|18004329|P1|Overall Study|Lost to Follow-up|19
5215817|NCT00986232|18004326|P4|Overall Study|Adverse Event|0
5215818|NCT00986232|18004327|P3|Overall Study|Adverse Event|3
5215819|NCT00986232|18004328|P2|Overall Study|Adverse Event|2
5215820|NCT00986232|18004329|P1|Overall Study|Adverse Event|1
5215821|NCT00986180|18004403|P2|Overall Study|Miscellanies|11
5215822|NCT00986180|18004404|P1|Overall Study|Miscellanies|10
5215823|NCT00986180|18004403|P2|Overall Study|Withdrawal by Subject|9
5215824|NCT00986180|18004404|P1|Overall Study|Withdrawal by Subject|1
5215825|NCT00986180|18004403|P2|Overall Study|Protocol Violation|0
5215826|NCT00986180|18004404|P1|Overall Study|Protocol Violation|2
5215827|NCT00986180|18004403|P2|Overall Study|Physician Decision|3
5215828|NCT00986180|18004404|P1|Overall Study|Physician Decision|1
5215829|NCT00986180|18004403|P2|Overall Study|Lost to Follow-up|7
5215830|NCT00986180|18004404|P1|Overall Study|Lost to Follow-up|5
5215831|NCT00986180|18004403|P2|Overall Study|Lack of Efficacy|3
5215832|NCT00986180|18004404|P1|Overall Study|Lack of Efficacy|4
5215833|NCT00986180|18004403|P2|Overall Study|Adverse Event|23
5215834|NCT00986180|18004404|P1|Overall Study|Adverse Event|21
5215835|NCT00986154|18004482|P2|Overall Study|never received study drug|27
5215836|NCT00986154|18004483|P1|Overall Study|never received study drug|25
5215837|NCT00986154|18004482|P2|Overall Study|investigator/subject decide not continue|3
5215838|NCT00986154|18004483|P1|Overall Study|investigator/subject decide not continue|6
5215839|NCT00986154|18004482|P2|Overall Study|Withdrawal by Subject|33
5215840|NCT00986154|18004483|P1|Overall Study|Withdrawal by Subject|32
5215841|NCT00986154|18004482|P2|Overall Study|Lost to Follow-up|4
5215842|NCT00986154|18004483|P1|Overall Study|Lost to Follow-up|7
5215843|NCT00986154|18004482|P2|Overall Study|Death|127
5215844|NCT00986154|18004483|P1|Overall Study|Death|136
5215845|NCT00986102|18004497|P4|Overall Study|Withdrawal by Subject|0
5215846|NCT00986102|18004498|P3|Overall Study|Withdrawal by Subject|0
5215847|NCT00986102|18004499|P2|Overall Study|Withdrawal by Subject|1
5215848|NCT00986102|18004500|P1|Overall Study|Withdrawal by Subject|1
5215849|NCT00986102|18004497|P4|Overall Study|Lost to Follow-up|1
5215850|NCT00986102|18004498|P3|Overall Study|Lost to Follow-up|0
5215851|NCT00986102|18004499|P2|Overall Study|Lost to Follow-up|1
5215852|NCT00986102|18004500|P1|Overall Study|Lost to Follow-up|0
5215853|NCT00985985|18004550|P4|Overall Study|Other Reason|2
5215854|NCT00985985|18004551|P3|Overall Study|Other Reason|4
5215855|NCT00985985|18004552|P2|Overall Study|Other Reason|1
5215856|NCT00985985|18004553|P1|Overall Study|Other Reason|6
5215857|NCT00985985|18004550|P4|Overall Study|Withdrawal by Subject|2
5215858|NCT00985985|18004551|P3|Overall Study|Withdrawal by Subject|2
5215859|NCT00985985|18004552|P2|Overall Study|Withdrawal by Subject|2
5215860|NCT00985985|18004553|P1|Overall Study|Withdrawal by Subject|4
5215861|NCT00985985|18004550|P4|Overall Study|Lack of Efficacy|3
5215862|NCT00985985|18004551|P3|Overall Study|Lack of Efficacy|1
5215863|NCT00985985|18004552|P2|Overall Study|Lack of Efficacy|6
5215864|NCT00985985|18004553|P1|Overall Study|Lack of Efficacy|5
5215865|NCT00985985|18004550|P4|Overall Study|Protocol Violation|1
5215866|NCT00985985|18004551|P3|Overall Study|Protocol Violation|0
5215867|NCT00985985|18004552|P2|Overall Study|Protocol Violation|2
5215868|NCT00985985|18004553|P1|Overall Study|Protocol Violation|1
5215869|NCT00985985|18004550|P4|Overall Study|Lost to Follow-up|3
5215870|NCT00985985|18004551|P3|Overall Study|Lost to Follow-up|2
5215871|NCT00985985|18004552|P2|Overall Study|Lost to Follow-up|11
5215872|NCT00985985|18004553|P1|Overall Study|Lost to Follow-up|4
5215873|NCT00985985|18004550|P4|Overall Study|Adverse Event|2
5215874|NCT00985985|18004551|P3|Overall Study|Adverse Event|2
5215875|NCT00985985|18004552|P2|Overall Study|Adverse Event|2
5215876|NCT00985985|18004553|P1|Overall Study|Adverse Event|4
5215877|NCT00985959|18004594|P3|Overall Study|Other|11
5215878|NCT00985959|18004595|P2|Overall Study|Other|0
5215879|NCT00985959|18004596|P1|Overall Study|Other|0
5215880|NCT00985959|18004594|P3|Overall Study|Complete response observed over 2 cycles|4
5215881|NCT00985959|18004595|P2|Overall Study|Complete response observed over 2 cycles|1
5215882|NCT00985959|18004596|P1|Overall Study|Complete response observed over 2 cycles|0
5215883|NCT00985959|18004594|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
5215884|NCT00985959|18004595|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
5215885|NCT00985959|18004596|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
5215886|NCT00985959|18004594|P3|Overall Study|Unrecovered toxicity|7
5215887|NCT00985959|18004595|P2|Overall Study|Unrecovered toxicity|0
5215888|NCT00985959|18004596|P1|Overall Study|Unrecovered toxicity|0
5215889|NCT00985959|18004594|P3|Overall Study|Progressive disease|8
5215890|NCT00985959|18004595|P2|Overall Study|Progressive disease|2
5215891|NCT00985959|18004596|P1|Overall Study|Progressive disease|1
5215892|NCT00985959|18004594|P3|Overall Study|Withdrawal by Subject|8
5215893|NCT00985959|18004595|P2|Overall Study|Withdrawal by Subject|0
5215894|NCT00985959|18004596|P1|Overall Study|Withdrawal by Subject|0
5215895|NCT00985959|18004594|P3|Overall Study|Adverse Event|19
5215896|NCT00985959|18004595|P2|Overall Study|Adverse Event|0
5215897|NCT00985959|18004596|P1|Overall Study|Adverse Event|0
5215898|NCT00985946|18004619|P1|Overall Study|Withdrawal by Subject|1
5215899|NCT00985946|18004619|P1|Overall Study|Lost to Follow-up|6
5215900|NCT00985790|18004648|P2|Overall Study|Lost to Follow-up|7
5215901|NCT00985790|18004649|P1|Overall Study|Lost to Follow-up|6
5215902|NCT00985790|18004648|P2|Overall Study|Withdrawal by Subject|1
5215903|NCT00985790|18004649|P1|Overall Study|Withdrawal by Subject|1
5215904|NCT00985751|18004690|P5|Overall Study|Adverse Event|1
5215905|NCT00985751|18004691|P4|Overall Study|Adverse Event|0
5215906|NCT00985751|18004692|P3|Overall Study|Adverse Event|0
5215907|NCT00985751|18004693|P2|Overall Study|Adverse Event|0
5215908|NCT00985751|18004694|P1|Overall Study|Adverse Event|0
5215909|NCT00985738|18004757|P2|Overall Study|Study closed prematurely|8
5215910|NCT00985738|18004758|P1|Overall Study|Study closed prematurely|8
5215911|NCT00985725|18004766|P2|Overall Study|Out-of-window visits|1
5215912|NCT00985725|18004767|P1|Overall Study|Out-of-window visits|0
5215913|NCT00985725|18004766|P2|Overall Study|Non-compliance|2
5215914|NCT00985725|18004767|P1|Overall Study|Non-compliance|1
5215915|NCT00985725|18004766|P2|Overall Study|Lack of Efficacy|1
5215916|NCT00985725|18004767|P1|Overall Study|Lack of Efficacy|0
5215917|NCT00985725|18004766|P2|Overall Study|Lost to Follow-up|1
5215918|NCT00985725|18004767|P1|Overall Study|Lost to Follow-up|1
5215919|NCT00985725|18004766|P2|Overall Study|Withdrawal by Subject|4
5215920|NCT00985725|18004767|P1|Overall Study|Withdrawal by Subject|4
5215921|NCT00985725|18004766|P2|Overall Study|Protocol Violation|3
5215922|NCT00985725|18004767|P1|Overall Study|Protocol Violation|1
5215923|NCT00985725|18004766|P2|Overall Study|Adverse Event|1
5215924|NCT00985725|18004767|P1|Overall Study|Adverse Event|4
5215925|NCT00985712|18004803|P2|Overall Study|Sponsor decision|2
5215926|NCT00985712|18004804|P1|Overall Study|Sponsor decision|0
5215927|NCT00985712|18004803|P2|Overall Study|Withdrawal by Subject|1
5215928|NCT00985712|18004804|P1|Overall Study|Withdrawal by Subject|4
5215929|NCT00985712|18004803|P2|Overall Study|Protocol Violation|1
5215930|NCT00985712|18004804|P1|Overall Study|Protocol Violation|0
5215931|NCT00985712|18004803|P2|Overall Study|Lost to Follow-up|2
5215932|NCT00985712|18004804|P1|Overall Study|Lost to Follow-up|2
5215933|NCT00985712|18004803|P2|Overall Study|Adverse Event|1
5215934|NCT00985712|18004804|P1|Overall Study|Adverse Event|0
5215935|NCT00985686|18004822|P4|Overall Study|Lost to Follow-up|2
5215936|NCT00985686|18004823|P3|Overall Study|Lost to Follow-up|0
5215937|NCT00985686|18004824|P2|Overall Study|Lost to Follow-up|1
5215938|NCT00985686|18004825|P1|Overall Study|Lost to Follow-up|1
5215939|NCT00985673|18004839|P6|Overall Study|Other|0
5215940|NCT00985673|18004840|P5|Overall Study|Other|1
5215941|NCT00985673|18004841|P4|Overall Study|Other|0
5215942|NCT00985673|18004842|P3|Overall Study|Other|1
5215943|NCT00985673|18004843|P2|Overall Study|Other|0
5215944|NCT00985673|18004844|P1|Overall Study|Other|1
5215945|NCT00985673|18004839|P6|Overall Study|Withdrawal by Subject|3
5215946|NCT00985673|18004840|P5|Overall Study|Withdrawal by Subject|2
5215947|NCT00985673|18004841|P4|Overall Study|Withdrawal by Subject|2
5215948|NCT00985673|18004842|P3|Overall Study|Withdrawal by Subject|5
5215949|NCT00985673|18004843|P2|Overall Study|Withdrawal by Subject|4
5215950|NCT00985673|18004844|P1|Overall Study|Withdrawal by Subject|0
5215951|NCT00985673|18004839|P6|Overall Study|Lost to Follow-up|3
5215952|NCT00985673|18004840|P5|Overall Study|Lost to Follow-up|5
5215953|NCT00985673|18004841|P4|Overall Study|Lost to Follow-up|10
5215954|NCT00985673|18004842|P3|Overall Study|Lost to Follow-up|6
5215955|NCT00985673|18004843|P2|Overall Study|Lost to Follow-up|7
5215956|NCT00985673|18004844|P1|Overall Study|Lost to Follow-up|6
5215957|NCT00985504|18005127|P2|Optimization Period|Withdrawal by Subject|8
5215958|NCT00985504|18005128|P1|Optimization Period|Withdrawal by Subject|10
5215959|NCT00985504|18005127|P2|Optimization Period|Protocol Violation|1
5215960|NCT00985504|18005128|P1|Optimization Period|Protocol Violation|3
5215961|NCT00985504|18005127|P2|Optimization Period|Physician Decision|0
5215962|NCT00985504|18005128|P1|Optimization Period|Physician Decision|1
5215963|NCT00985504|18005127|P2|Optimization Period|Lost to Follow-up|1
5215964|NCT00985504|18005128|P1|Optimization Period|Lost to Follow-up|0
5215965|NCT00985504|18005127|P2|Optimization Period|Lack of Efficacy|3
5215966|NCT00985504|18005128|P1|Optimization Period|Lack of Efficacy|5
5215967|NCT00985504|18005127|P2|Optimization Period|Death|1
5215968|NCT00985504|18005128|P1|Optimization Period|Death|0
5215969|NCT00985504|18005127|P2|Optimization Period|Adverse Event|9
5215970|NCT00985504|18005128|P1|Optimization Period|Adverse Event|7
5215971|NCT00985504|18005127|P2|Acute Treatment Period|Withdrawal by Subject|5
5215972|NCT00985504|18005128|P1|Acute Treatment Period|Withdrawal by Subject|9
5215973|NCT00985504|18005127|P2|Acute Treatment Period|Sponsor Decision|1
5215974|NCT00985504|18005128|P1|Acute Treatment Period|Sponsor Decision|0
5215975|NCT00985504|18005127|P2|Acute Treatment Period|Protocol Violation|0
5215976|NCT00985504|18005128|P1|Acute Treatment Period|Protocol Violation|2
5215977|NCT00985504|18005127|P2|Acute Treatment Period|Entry Criteria Not Met|2
5215978|NCT00985504|18005128|P1|Acute Treatment Period|Entry Criteria Not Met|1
5215979|NCT00985504|18005127|P2|Acute Treatment Period|Adverse Event|4
5215980|NCT00985504|18005128|P1|Acute Treatment Period|Adverse Event|3
5215981|NCT00985491|18005154|P1|Overall Study|implant failure|3
5215982|NCT00985491|18005154|P1|Overall Study|Withdrawal by Subject|1
5215983|NCT00985491|18005154|P1|Overall Study|device migration|7
5215984|NCT00985491|18005154|P1|Overall Study|Adverse Event|8
5215985|NCT00985465|18005161|P2|Overall Study|Considered to be part of the other group|1
5215986|NCT00985465|18005162|P1|Overall Study|Considered to be part of the other group|0
5215987|NCT00985465|18005161|P2|Overall Study|Withdrawal by Subject|2
5215988|NCT00985465|18005162|P1|Overall Study|Withdrawal by Subject|1
5215989|NCT00985439|18005189|P4|Overall Study|Adverse Event|0
5215990|NCT00985439|18005190|P3|Overall Study|Adverse Event|1
5215991|NCT00985439|18005191|P2|Overall Study|Adverse Event|0
5215992|NCT00985439|18005192|P1|Overall Study|Adverse Event|0
5215993|NCT00985231|18005208|P2|Overall Study|Study related symptoms & complaints|2
5215994|NCT00985231|18005209|P1|Overall Study|Study related symptoms & complaints|0
5215995|NCT00985231|18005208|P2|Overall Study|Lost to Follow-up|1
5215996|NCT00985231|18005209|P1|Overall Study|Lost to Follow-up|0
5215997|NCT00985231|18005208|P2|Overall Study|Withdrawal by Subject|0
5215998|NCT00985231|18005209|P1|Overall Study|Withdrawal by Subject|1
5215999|NCT00985231|18005208|P2|Overall Study|Protocol Violation|0
5216000|NCT00985231|18005209|P1|Overall Study|Protocol Violation|1
5216001|NCT00985231|18005208|P2|Overall Study|ineligible|0
5216002|NCT00985231|18005209|P1|Overall Study|ineligible|1
5216003|NCT00985192|18005217|P1|Overall Study|Determined to be Ineligible During Trial|2
5216004|NCT00985192|18005217|P1|Overall Study|Disease Progression|1
5216005|NCT00985192|18005217|P1|Overall Study|Withdrawal by Subject|1
5216006|NCT00985166|18005229|P3|Overall Study|Other|1
5216007|NCT00985166|18005230|P2|Overall Study|Other|0
5216008|NCT00985166|18005231|P1|Overall Study|Other|1
5216009|NCT00985166|18005229|P3|Overall Study|Test not done|4
5216010|NCT00985166|18005230|P2|Overall Study|Test not done|0
5216011|NCT00985166|18005231|P1|Overall Study|Test not done|2
5216012|NCT00985166|18005229|P3|Overall Study|Withdrawal by Subject|0
5216013|NCT00985166|18005230|P2|Overall Study|Withdrawal by Subject|2
5216014|NCT00985166|18005231|P1|Overall Study|Withdrawal by Subject|3
5216015|NCT00985166|18005229|P3|Overall Study|Lost to Follow-up|2
5216016|NCT00985166|18005230|P2|Overall Study|Lost to Follow-up|2
5216017|NCT00985166|18005231|P1|Overall Study|Lost to Follow-up|3
5216018|NCT00985153|18005251|P4|Overall Study|Incomplete Safety Follow-up|4
5216019|NCT00985153|18005252|P3|Overall Study|Incomplete Safety Follow-up|4
5216020|NCT00985153|18005253|P2|Overall Study|Incomplete Safety Follow-up|5
5216021|NCT00985153|18005254|P1|Overall Study|Incomplete Safety Follow-up|3
5216022|NCT00985153|18005251|P4|Overall Study|Missed One or More Bleeds|10
5216023|NCT00985153|18005252|P3|Overall Study|Missed One or More Bleeds|8
5216024|NCT00985153|18005253|P2|Overall Study|Missed One or More Bleeds|7
5216025|NCT00985153|18005254|P1|Overall Study|Missed One or More Bleeds|7
5216026|NCT00985153|18005251|P4|Overall Study|Withdrawal by Subject|10
5216027|NCT00985153|18005252|P3|Overall Study|Withdrawal by Subject|11
5216028|NCT00985153|18005253|P2|Overall Study|Withdrawal by Subject|11
5216029|NCT00985153|18005254|P1|Overall Study|Withdrawal by Subject|6
5216030|NCT00985153|18005251|P4|Overall Study|Protocol Violation|3
5216031|NCT00985153|18005252|P3|Overall Study|Protocol Violation|4
5216032|NCT00985153|18005253|P2|Overall Study|Protocol Violation|2
5216033|NCT00985153|18005254|P1|Overall Study|Protocol Violation|3
5216034|NCT00985153|18005251|P4|Overall Study|Lost to Follow-up|20
5216035|NCT00985153|18005252|P3|Overall Study|Lost to Follow-up|17
5216036|NCT00985153|18005253|P2|Overall Study|Lost to Follow-up|19
5216037|NCT00985153|18005254|P1|Overall Study|Lost to Follow-up|16
5216038|NCT00985114|18005302|P2|Overall Study|Withdrawal by Subject|2
5216039|NCT00985114|18005303|P1|Overall Study|Withdrawal by Subject|0
5216040|NCT00985114|18005302|P2|Overall Study|Adverse Event|0
5216041|NCT00985114|18005303|P1|Overall Study|Adverse Event|1
5216042|NCT00985088|18005317|P8|Overall Study|Lost to Follow-up|2
5216043|NCT00985088|18005318|P7|Overall Study|Lost to Follow-up|3
5216044|NCT00985088|18005319|P6|Overall Study|Lost to Follow-up|5
5216045|NCT00985088|18005320|P5|Overall Study|Lost to Follow-up|6
5216046|NCT00985088|18005321|P4|Overall Study|Lost to Follow-up|6
5216047|NCT00985088|18005322|P3|Overall Study|Lost to Follow-up|2
5216048|NCT00985088|18005323|P2|Overall Study|Lost to Follow-up|1
5216049|NCT00985088|18005324|P1|Overall Study|Lost to Follow-up|6
5216050|NCT00985088|18005317|P8|Overall Study|Migrated/moved from study area|1
5216051|NCT00985088|18005318|P7|Overall Study|Migrated/moved from study area|0
5216052|NCT00985088|18005319|P6|Overall Study|Migrated/moved from study area|0
5216053|NCT00985088|18005320|P5|Overall Study|Migrated/moved from study area|0
5216054|NCT00985088|18005321|P4|Overall Study|Migrated/moved from study area|0
5216055|NCT00985088|18005322|P3|Overall Study|Migrated/moved from study area|1
5216056|NCT00985088|18005323|P2|Overall Study|Migrated/moved from study area|0
5216057|NCT00985088|18005324|P1|Overall Study|Migrated/moved from study area|0
5216058|NCT00985088|18005317|P8|Overall Study|Withdrawal by Subject|2
5216059|NCT00985088|18005318|P7|Overall Study|Withdrawal by Subject|1
5216060|NCT00985088|18005319|P6|Overall Study|Withdrawal by Subject|2
5216061|NCT00985088|18005320|P5|Overall Study|Withdrawal by Subject|3
5216062|NCT00985088|18005321|P4|Overall Study|Withdrawal by Subject|1
5216063|NCT00985088|18005322|P3|Overall Study|Withdrawal by Subject|0
5216064|NCT00985088|18005323|P2|Overall Study|Withdrawal by Subject|0
5216065|NCT00985088|18005324|P1|Overall Study|Withdrawal by Subject|4
5216066|NCT00985088|18005317|P8|Overall Study|Adverse Event|0
5216067|NCT00985088|18005318|P7|Overall Study|Adverse Event|0
5216068|NCT00985088|18005319|P6|Overall Study|Adverse Event|0
5216069|NCT00985088|18005320|P5|Overall Study|Adverse Event|0
5216070|NCT00985088|18005321|P4|Overall Study|Adverse Event|0
5216071|NCT00985088|18005322|P3|Overall Study|Adverse Event|1
5216072|NCT00985088|18005323|P2|Overall Study|Adverse Event|0
5216073|NCT00985088|18005324|P1|Overall Study|Adverse Event|0
5216074|NCT00985088|18005317|P8|Overall Study|Serious Adverse Event|1
5216075|NCT00985088|18005318|P7|Overall Study|Serious Adverse Event|0
5216076|NCT00985088|18005319|P6|Overall Study|Serious Adverse Event|0
5216077|NCT00985088|18005320|P5|Overall Study|Serious Adverse Event|0
5216078|NCT00985088|18005321|P4|Overall Study|Serious Adverse Event|0
5216079|NCT00985088|18005322|P3|Overall Study|Serious Adverse Event|0
5216080|NCT00985088|18005323|P2|Overall Study|Serious Adverse Event|1
5216081|NCT00985088|18005324|P1|Overall Study|Serious Adverse Event|1
5216082|NCT00984867|18005593|P2|Overall Study|lack of efficacy and subject compliance|0
5216083|NCT00984867|18005594|P1|Overall Study|lack of efficacy and subject compliance|1
5216084|NCT00984867|18005593|P2|Overall Study|site closing|0
5216085|NCT00984867|18005594|P1|Overall Study|site closing|1
5216086|NCT00984867|18005593|P2|Overall Study|Subject no longer meets study criteria|1
5216087|NCT00984867|18005594|P1|Overall Study|Subject no longer meets study criteria|1
5216088|NCT00984867|18005593|P2|Overall Study|Poor/non-compliance|1
5216089|NCT00984867|18005594|P1|Overall Study|Poor/non-compliance|0
5216090|NCT00984867|18005593|P2|Overall Study|Lost to Follow-up|4
5216091|NCT00984867|18005594|P1|Overall Study|Lost to Follow-up|3
5216092|NCT00984867|18005593|P2|Overall Study|Withdrawal by Subject|4
5216093|NCT00984867|18005594|P1|Overall Study|Withdrawal by Subject|13
5216094|NCT00984867|18005593|P2|Overall Study|Death|0
5216095|NCT00984867|18005594|P1|Overall Study|Death|1
5216096|NCT00984867|18005593|P2|Overall Study|Adverse Event|7
5216097|NCT00984867|18005594|P1|Overall Study|Adverse Event|3
5216098|NCT00984659|18005634|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
5216099|NCT00984659|18005635|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
5216100|NCT00984659|18005636|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
5216101|NCT00984659|18005637|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
5216102|NCT00984659|18005634|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5216103|NCT00984659|18005635|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
5216104|NCT00984659|18005636|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5216105|NCT00984659|18005637|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5216106|NCT00984659|18005634|P4|6-week Double-blind Treatment Period|Protocol Violation|4
5216107|NCT00984659|18005635|P3|6-week Double-blind Treatment Period|Protocol Violation|0
5216108|NCT00984659|18005636|P2|6-week Double-blind Treatment Period|Protocol Violation|0
5216109|NCT00984659|18005637|P1|6-week Double-blind Treatment Period|Protocol Violation|0
5216110|NCT00984659|18005634|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
5216111|NCT00984659|18005635|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
5216112|NCT00984659|18005636|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
5216113|NCT00984659|18005637|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
5216114|NCT00984659|18005634|P4|6-week Double-blind Treatment Period|Adverse Event|7
5216115|NCT00984659|18005635|P3|6-week Double-blind Treatment Period|Adverse Event|3
5216116|NCT00984659|18005636|P2|6-week Double-blind Treatment Period|Adverse Event|3
5216117|NCT00984659|18005637|P1|6-week Double-blind Treatment Period|Adverse Event|0
5216118|NCT00984659|18005634|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5216119|NCT00984659|18005635|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5216120|NCT00984659|18005636|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5216121|NCT00984659|18005637|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
5216122|NCT00984659|18005634|P4|2-week Run-in Period|Withdrawal by Subject|0
5216123|NCT00984659|18005635|P3|2-week Run-in Period|Withdrawal by Subject|0
5216124|NCT00984659|18005636|P2|2-week Run-in Period|Withdrawal by Subject|0
5216125|NCT00984659|18005637|P1|2-week Run-in Period|Withdrawal by Subject|10
5216126|NCT00984659|18005634|P4|2-week Run-in Period|Physician Decision|0
5216127|NCT00984659|18005635|P3|2-week Run-in Period|Physician Decision|0
5216128|NCT00984659|18005636|P2|2-week Run-in Period|Physician Decision|0
5216129|NCT00984659|18005637|P1|2-week Run-in Period|Physician Decision|10
5216130|NCT00984659|18005634|P4|2-week Run-in Period|Lost to Follow-up|0
5216131|NCT00984659|18005635|P3|2-week Run-in Period|Lost to Follow-up|0
5216132|NCT00984659|18005636|P2|2-week Run-in Period|Lost to Follow-up|0
5216133|NCT00984659|18005637|P1|2-week Run-in Period|Lost to Follow-up|3
5216134|NCT00984659|18005634|P4|2-week Run-in Period|Study Closed/Terminated|0
5216135|NCT00984659|18005635|P3|2-week Run-in Period|Study Closed/Terminated|0
5216136|NCT00984659|18005636|P2|2-week Run-in Period|Study Closed/Terminated|0
5216137|NCT00984659|18005637|P1|2-week Run-in Period|Study Closed/Terminated|2
5216138|NCT00984659|18005634|P4|2-week Run-in Period|Protocol Violation|0
5216139|NCT00984659|18005635|P3|2-week Run-in Period|Protocol Violation|0
5216140|NCT00984659|18005636|P2|2-week Run-in Period|Protocol Violation|0
5216141|NCT00984659|18005637|P1|2-week Run-in Period|Protocol Violation|5
5216142|NCT00984659|18005634|P4|2-week Run-in Period|Adverse Event|0
5216143|NCT00984659|18005635|P3|2-week Run-in Period|Adverse Event|0
5216144|NCT00984659|18005636|P2|2-week Run-in Period|Adverse Event|0
5216145|NCT00984659|18005637|P1|2-week Run-in Period|Adverse Event|8
5216146|NCT00984620|18005664|P2|Overall Study|reason other than listed above|4
5216147|NCT00984620|18005665|P1|Overall Study|reason other than listed above|0
5216148|NCT00984620|18005664|P2|Overall Study|Withdrawal by Subject|2
5216149|NCT00984620|18005665|P1|Overall Study|Withdrawal by Subject|0
5216150|NCT00984620|18005664|P2|Overall Study|Lost to Follow-up|1
5216151|NCT00984620|18005665|P1|Overall Study|Lost to Follow-up|1
5216152|NCT00984620|18005664|P2|Overall Study|Adverse Event|5
5216153|NCT00984620|18005665|P1|Overall Study|Adverse Event|5
5216154|NCT00984594|18005703|P2|Overall Study|Withdrawal by Subject|1
5216155|NCT00984594|18005704|P1|Overall Study|Withdrawal by Subject|0
5216156|NCT00984594|18005703|P2|Overall Study|Lost to Follow-up|0
5216157|NCT00984594|18005704|P1|Overall Study|Lost to Follow-up|1
5216158|NCT00984568|18005720|P2|Overall Study|Unknown Reason|3
5216159|NCT00984568|18005721|P1|Overall Study|Unknown Reason|1
5216160|NCT00984568|18005720|P2|Overall Study|Opportunistic Infection|0
5216161|NCT00984568|18005721|P1|Overall Study|Opportunistic Infection|1
5216162|NCT00984568|18005720|P2|Overall Study|Lost to Follow-up|1
5216163|NCT00984568|18005721|P1|Overall Study|Lost to Follow-up|0
5216164|NCT00984568|18005720|P2|Overall Study|Did Not Meet Randomization Criteria|0
5216165|NCT00984568|18005721|P1|Overall Study|Did Not Meet Randomization Criteria|1
5216166|NCT00984568|18005720|P2|Overall Study|Adverse Event|0
5216167|NCT00984568|18005721|P1|Overall Study|Adverse Event|2
5216168|NCT00984568|18005720|P2|Overall Study|Lack of Efficacy|0
5216169|NCT00984568|18005721|P1|Overall Study|Lack of Efficacy|2
5216170|NCT00984568|18005720|P2|Overall Study|Withdrawal by Subject|2
5216171|NCT00984568|18005721|P1|Overall Study|Withdrawal by Subject|1
5216172|NCT00984542|18005729|P1|Overall Study|clinical deterioration|2
5216173|NCT00984542|18005729|P1|Overall Study|Withdrawal by Subject|3
5216174|NCT00984542|18005729|P1|Overall Study|complicating disease|3
5216175|NCT00984542|18005729|P1|Overall Study|Death|7
5216176|NCT00984542|18005729|P1|Overall Study|toxicity|7
5216177|NCT00984542|18005729|P1|Overall Study|disease progression|19
5216178|NCT00984295|18005779|P3|Overall Study|Incomplete safety follow-up|3
5216179|NCT00984295|18005780|P2|Overall Study|Incomplete safety follow-up|2
5216180|NCT00984295|18005781|P1|Overall Study|Incomplete safety follow-up|11
5216181|NCT00984295|18005779|P3|Overall Study|Missed one or more blood samplings|2
5216182|NCT00984295|18005780|P2|Overall Study|Missed one or more blood samplings|7
5216183|NCT00984295|18005781|P1|Overall Study|Missed one or more blood samplings|3
5216184|NCT00984295|18005779|P3|Overall Study|CAE - discontinued test vaccine|3
5216185|NCT00984295|18005780|P2|Overall Study|CAE - discontinued test vaccine|1
5216186|NCT00984295|18005781|P1|Overall Study|CAE - discontinued test vaccine|0
5216187|NCT00984295|18005779|P3|Overall Study|Withdrawal by Subject|12
5216188|NCT00984295|18005780|P2|Overall Study|Withdrawal by Subject|9
5216189|NCT00984295|18005781|P1|Overall Study|Withdrawal by Subject|18
5216190|NCT00984295|18005779|P3|Overall Study|Protocol Violation|4
5216191|NCT00984295|18005780|P2|Overall Study|Protocol Violation|1
5216192|NCT00984295|18005781|P1|Overall Study|Protocol Violation|2
5216193|NCT00984295|18005779|P3|Overall Study|Lost to Follow-up|13
5216194|NCT00984295|18005780|P2|Overall Study|Lost to Follow-up|12
5216195|NCT00984295|18005781|P1|Overall Study|Lost to Follow-up|31
5216196|NCT00984282|18005848|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
5216197|NCT00984282|18005849|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
5216198|NCT00984282|18005848|P2|Long Term Follow-up|Switched to commercial drug|2
5216199|NCT00984282|18005849|P1|Long Term Follow-up|Switched to commercial drug|4
5216200|NCT00984282|18005848|P2|Long Term Follow-up|Transferred to treat. continuation study|3
5216201|NCT00984282|18005849|P1|Long Term Follow-up|Transferred to treat. continuation study|2
5216202|NCT00984282|18005848|P2|Long Term Follow-up|Protocol driven decision point|26
5216203|NCT00984282|18005849|P1|Long Term Follow-up|Protocol driven decision point|25
5216204|NCT00984282|18005848|P2|Long Term Follow-up|Lost to Follow-up|6
5216205|NCT00984282|18005849|P1|Long Term Follow-up|Lost to Follow-up|3
5216206|NCT00984282|18005848|P2|Long Term Follow-up|Death|68
5216207|NCT00984282|18005849|P1|Long Term Follow-up|Death|27
5216208|NCT00984282|18005848|P2|Long Term Follow-up|Withdrawal by Subject|14
5216209|NCT00984282|18005849|P1|Long Term Follow-up|Withdrawal by Subject|8
5216210|NCT00984282|18005848|P2|Open-label Treatment|Physician Decision|0
5216211|NCT00984282|18005849|P1|Open-label Treatment|Physician Decision|1
5216212|NCT00984282|18005848|P2|Open-label Treatment|Switched to commercial drug|7
5216213|NCT00984282|18005849|P1|Open-label Treatment|Switched to commercial drug|6
5216214|NCT00984282|18005848|P2|Open-label Treatment|Transferred to treat. continuation study|3
5216215|NCT00984282|18005849|P1|Open-label Treatment|Transferred to treat. continuation study|2
5216216|NCT00984282|18005848|P2|Open-label Treatment|Protocol driven decision point|1
5216217|NCT00984282|18005849|P1|Open-label Treatment|Protocol driven decision point|1
5216218|NCT00984282|18005848|P2|Open-label Treatment|Target lesion removed|1
5216219|NCT00984282|18005849|P1|Open-label Treatment|Target lesion removed|0
5216220|NCT00984282|18005848|P2|Open-label Treatment|Non-compliant with study medication|0
5216221|NCT00984282|18005849|P1|Open-label Treatment|Non-compliant with study medication|1
5216222|NCT00984282|18005848|P2|Open-label Treatment|Patient convenience|0
5216223|NCT00984282|18005849|P1|Open-label Treatment|Patient convenience|1
5216224|NCT00984282|18005848|P2|Open-label Treatment|Lost to Follow-up|1
5216225|NCT00984282|18005849|P1|Open-label Treatment|Lost to Follow-up|1
5216226|NCT00984282|18005848|P2|Open-label Treatment|Progression, recurrence or relapse|82
5216227|NCT00984282|18005849|P1|Open-label Treatment|Progression, recurrence or relapse|40
5216228|NCT00984282|18005848|P2|Open-label Treatment|Death|15
5216229|NCT00984282|18005849|P1|Open-label Treatment|Death|7
5216230|NCT00984282|18005848|P2|Open-label Treatment|Withdrawal by Subject|21
5216231|NCT00984282|18005849|P1|Open-label Treatment|Withdrawal by Subject|6
5216232|NCT00984282|18005848|P2|Open-label Treatment|Adverse Event|30
5216233|NCT00984282|18005849|P1|Open-label Treatment|Adverse Event|20
5216234|NCT00984282|18005848|P2|Double Blind Treatment|Transferred to treat. continuation study|1
5216235|NCT00984282|18005849|P1|Double Blind Treatment|Transferred to treat. continuation study|2
5216236|NCT00984282|18005848|P2|Double Blind Treatment|Radiological and clinical progression|1
5216237|NCT00984282|18005849|P1|Double Blind Treatment|Radiological and clinical progression|0
5216238|NCT00984282|18005848|P2|Double Blind Treatment|protocol driven decision point|1
5216239|NCT00984282|18005849|P1|Double Blind Treatment|protocol driven decision point|1
5216240|NCT00984282|18005848|P2|Double Blind Treatment|Switched to commercial drug|1
5216241|NCT00984282|18005849|P1|Double Blind Treatment|Switched to commercial drug|6
5216242|NCT00984282|18005848|P2|Double Blind Treatment|Not treated|1
5216243|NCT00984282|18005849|P1|Double Blind Treatment|Not treated|0
5216244|NCT00984282|18005848|P2|Double Blind Treatment|Death|4
5216245|NCT00984282|18005849|P1|Double Blind Treatment|Death|8
5216246|NCT00984282|18005848|P2|Double Blind Treatment|Lost to Follow-up|0
5216247|NCT00984282|18005849|P1|Double Blind Treatment|Lost to Follow-up|3
5216248|NCT00984282|18005848|P2|Double Blind Treatment|Withdrawal by Subject|18
5216249|NCT00984282|18005849|P1|Double Blind Treatment|Withdrawal by Subject|13
5216250|NCT00984282|18005848|P2|Double Blind Treatment|Progression by clinical judgment|0
5216251|NCT00984282|18005849|P1|Double Blind Treatment|Progression by clinical judgment|2
5216252|NCT00984282|18005848|P2|Double Blind Treatment|Noncompliance with study medication|0
5216253|NCT00984282|18005849|P1|Double Blind Treatment|Noncompliance with study medication|3
5216254|NCT00984282|18005848|P2|Double Blind Treatment|Physician Decision|2
5216255|NCT00984282|18005849|P1|Double Blind Treatment|Physician Decision|1
5216256|NCT00984282|18005848|P2|Double Blind Treatment|Progression, recurrence or relapse|3
5216257|NCT00984282|18005849|P1|Double Blind Treatment|Progression, recurrence or relapse|25
5216258|NCT00984282|18005848|P2|Double Blind Treatment|Adverse Event|6
5216259|NCT00984282|18005849|P1|Double Blind Treatment|Adverse Event|40
5216260|NCT00984256|18005872|P2|Overall Study|Withdrawal by Subject|1
5216261|NCT00984256|18005873|P1|Overall Study|Withdrawal by Subject|0
5216262|NCT00984204|18005893|P1|Overall Study|Lack of Efficacy|10
5216263|NCT00984204|18005893|P1|Overall Study|Lost to Follow-up|4
5216264|NCT00984204|18005893|P1|Overall Study|Death|1
5216265|NCT00984165|18005903|P4|Overall Study|removed with a pair recipient|1
5216266|NCT00984165|18005904|P3|Overall Study|removed with a pair recipient|0
5216267|NCT00984165|18005905|P2|Overall Study|removed with a pair recipient|0
5216268|NCT00984165|18005906|P1|Overall Study|removed with a pair recipient|0
5216269|NCT00984165|18005903|P4|Overall Study|P+/donor pair removed from protocol|1
5216270|NCT00984165|18005904|P3|Overall Study|P+/donor pair removed from protocol|0
5216271|NCT00984165|18005905|P2|Overall Study|P+/donor pair removed from protocol|0
5216272|NCT00984165|18005906|P1|Overall Study|P+/donor pair removed from protocol|0
5216273|NCT00984165|18005903|P4|Overall Study|New protocol|1
5216274|NCT00984165|18005904|P3|Overall Study|New protocol|0
5216275|NCT00984165|18005905|P2|Overall Study|New protocol|0
5216276|NCT00984165|18005906|P1|Overall Study|New protocol|0
5216277|NCT00984165|18005903|P4|Overall Study|Death of recipient|1
5216278|NCT00984165|18005904|P3|Overall Study|Death of recipient|0
5216279|NCT00984165|18005905|P2|Overall Study|Death of recipient|0
5216280|NCT00984165|18005906|P1|Overall Study|Death of recipient|0
5216281|NCT00984165|18005903|P4|Overall Study|Disease progression on study|0
5216282|NCT00984165|18005904|P3|Overall Study|Disease progression on study|0
5216283|NCT00984165|18005905|P2|Overall Study|Disease progression on study|1
5216284|NCT00984165|18005906|P1|Overall Study|Disease progression on study|5
5216285|NCT00984165|18005903|P4|Overall Study|Death on study|0
5216286|NCT00984165|18005904|P3|Overall Study|Death on study|0
5216287|NCT00984165|18005905|P2|Overall Study|Death on study|0
5216288|NCT00984165|18005906|P1|Overall Study|Death on study|2
5216289|NCT00984126|18005935|P4|Overall Study|Withdrawal criteria|9
5216290|NCT00984126|18005936|P3|Overall Study|Withdrawal criteria|3
5216291|NCT00984126|18005937|P2|Overall Study|Withdrawal criteria|1
5216292|NCT00984126|18005938|P1|Overall Study|Withdrawal criteria|0
5216293|NCT00984126|18005935|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
5216294|NCT00984126|18005936|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
5216295|NCT00984126|18005937|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
5216296|NCT00984126|18005938|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
5216297|NCT00984126|18005935|P4|Overall Study|Adverse Event|2
5216298|NCT00984126|18005936|P3|Overall Study|Adverse Event|0
5216299|NCT00984126|18005937|P2|Overall Study|Adverse Event|0
5216300|NCT00984126|18005938|P1|Overall Study|Adverse Event|0
5216301|NCT00984126|18005935|P4|Overall Study|Protocol Violation|2
5216302|NCT00984126|18005936|P3|Overall Study|Protocol Violation|1
5216303|NCT00984126|18005937|P2|Overall Study|Protocol Violation|0
5216304|NCT00984126|18005938|P1|Overall Study|Protocol Violation|0
5216305|NCT00984061|18005963|P1|Clarithromycin Alone|Protocol Violation|1
5216306|NCT00984022|18005976|P2|Overall Study|Lost to Follow-up|14
5216307|NCT00984022|18005977|P1|Overall Study|Lost to Follow-up|10
5216308|NCT00984009|18005987|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
5216309|NCT00983957|18006020|P1|Overall Study|Personal Reasons|1
5216310|NCT00983957|18006020|P1|Overall Study|Adverse Event|1
5216311|NCT00983931|18006054|P1|14 Day Washout Period|Physician Decision|1
5216312|NCT00983918|18006068|P4|Overall Study|conversion to open cholecystectomy|2
5216313|NCT00983918|18006069|P3|Overall Study|conversion to open cholecystectomy|2
5216314|NCT00983918|18006070|P2|Overall Study|conversion to open cholecystectomy|2
5216315|NCT00983918|18006071|P1|Overall Study|conversion to open cholecystectomy|0
5216316|NCT00983905|18006081|P1|Colchicine Alone|Adverse Event|2
5216317|NCT00983905|18006081|P1|Theophylline Alone|Adverse Event|1
5216318|NCT00983892|18006094|P2|Overall Study|Withdrawal by Subject|12
5216319|NCT00983892|18006095|P1|Overall Study|Withdrawal by Subject|10
5216320|NCT00983853|18006107|P6|Overall Study|Unable to come to study follow-up visits|0
5216321|NCT00983853|18006108|P5|Overall Study|Unable to come to study follow-up visits|0
5216322|NCT00983853|18006109|P4|Overall Study|Unable to come to study follow-up visits|0
5216323|NCT00983853|18006110|P3|Overall Study|Unable to come to study follow-up visits|0
5216324|NCT00983853|18006111|P2|Overall Study|Unable to come to study follow-up visits|1
5216325|NCT00983853|18006112|P1|Overall Study|Unable to come to study follow-up visits|0
5216326|NCT00983853|18006107|P6|Overall Study|Withdrawal by Subject|0
5216327|NCT00983853|18006108|P5|Overall Study|Withdrawal by Subject|1
5216328|NCT00983853|18006109|P4|Overall Study|Withdrawal by Subject|0
5216329|NCT00983853|18006110|P3|Overall Study|Withdrawal by Subject|1
5216330|NCT00983853|18006111|P2|Overall Study|Withdrawal by Subject|0
5216331|NCT00983853|18006112|P1|Overall Study|Withdrawal by Subject|0
5216332|NCT00983853|18006107|P6|Overall Study|Lost to Follow-up|1
5216333|NCT00983853|18006108|P5|Overall Study|Lost to Follow-up|2
5216334|NCT00983853|18006109|P4|Overall Study|Lost to Follow-up|2
5216335|NCT00983853|18006110|P3|Overall Study|Lost to Follow-up|2
5216336|NCT00983853|18006111|P2|Overall Study|Lost to Follow-up|1
5216337|NCT00983853|18006112|P1|Overall Study|Lost to Follow-up|1
5216338|NCT00983827|18006140|P1|Overall Study|Withdrawal by Subject|1
5216339|NCT00983749|18006158|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
5216340|NCT00983749|18006159|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
5216341|NCT00983619|18006194|P12|Overall Study|Other|0
5216342|NCT00983619|18006195|P11|Overall Study|Other|1
5216343|NCT00983619|18006196|P10|Overall Study|Other|1
5216344|NCT00983619|18006197|P9|Overall Study|Other|0
5216345|NCT00983619|18006198|P8|Overall Study|Other|2
5216346|NCT00983619|18006199|P7|Overall Study|Other|2
5216347|NCT00983619|18006200|P6|Overall Study|Other|12
5216348|NCT00983619|18006201|P5|Overall Study|Other|0
5216349|NCT00983619|18006202|P4|Overall Study|Other|1
5216350|NCT00983619|18006203|P3|Overall Study|Other|0
5216351|NCT00983619|18006204|P2|Overall Study|Other|0
5216352|NCT00983619|18006205|P1|Overall Study|Other|1
5216353|NCT00983619|18006194|P12|Overall Study|Death|8
5216354|NCT00983619|18006195|P11|Overall Study|Death|9
5216355|NCT00983619|18006196|P10|Overall Study|Death|2
5216356|NCT00983619|18006197|P9|Overall Study|Death|1
5216357|NCT00983619|18006198|P8|Overall Study|Death|0
5216358|NCT00983619|18006199|P7|Overall Study|Death|1
5216359|NCT00983619|18006200|P6|Overall Study|Death|30
5216360|NCT00983619|18006201|P5|Overall Study|Death|2
5216361|NCT00983619|18006202|P4|Overall Study|Death|1
5216362|NCT00983619|18006203|P3|Overall Study|Death|2
5216363|NCT00983619|18006204|P2|Overall Study|Death|2
5216364|NCT00983619|18006205|P1|Overall Study|Death|0
5216365|NCT00983619|18006194|P12|Overall Study|Withdrawal by Subject|1
5216366|NCT00983619|18006195|P11|Overall Study|Withdrawal by Subject|1
5216367|NCT00983619|18006196|P10|Overall Study|Withdrawal by Subject|0
5216368|NCT00983619|18006197|P9|Overall Study|Withdrawal by Subject|0
5216369|NCT00983619|18006198|P8|Overall Study|Withdrawal by Subject|0
5216370|NCT00983619|18006199|P7|Overall Study|Withdrawal by Subject|0
5216371|NCT00983619|18006200|P6|Overall Study|Withdrawal by Subject|23
5216372|NCT00983619|18006201|P5|Overall Study|Withdrawal by Subject|1
5216373|NCT00983619|18006202|P4|Overall Study|Withdrawal by Subject|3
5216374|NCT00983619|18006203|P3|Overall Study|Withdrawal by Subject|1
5216375|NCT00983619|18006204|P2|Overall Study|Withdrawal by Subject|1
5216376|NCT00983619|18006205|P1|Overall Study|Withdrawal by Subject|2
5216377|NCT00983619|18006194|P12|Overall Study|Lost to Follow-up|2
5216378|NCT00983619|18006195|P11|Overall Study|Lost to Follow-up|0
5216379|NCT00983619|18006196|P10|Overall Study|Lost to Follow-up|0
5216380|NCT00983619|18006197|P9|Overall Study|Lost to Follow-up|0
5216381|NCT00983619|18006198|P8|Overall Study|Lost to Follow-up|0
5216382|NCT00983619|18006199|P7|Overall Study|Lost to Follow-up|0
5216383|NCT00983619|18006200|P6|Overall Study|Lost to Follow-up|2
5216384|NCT00983619|18006201|P5|Overall Study|Lost to Follow-up|0
5216385|NCT00983619|18006202|P4|Overall Study|Lost to Follow-up|0
5216386|NCT00983619|18006203|P3|Overall Study|Lost to Follow-up|0
5216387|NCT00983619|18006204|P2|Overall Study|Lost to Follow-up|1
5216388|NCT00983619|18006205|P1|Overall Study|Lost to Follow-up|0
5216389|NCT00983580|18006510|P2|Overall Study|Ineligible|0
5216390|NCT00983580|18006511|P1|Overall Study|Ineligible|3
5216391|NCT00983580|18006510|P2|Overall Study|Protocol Violation|1
5216392|NCT00983580|18006511|P1|Overall Study|Protocol Violation|1
5216393|NCT00983580|18006510|P2|Overall Study|Cancel Prior to treatment|3
5216394|NCT00983580|18006511|P1|Overall Study|Cancel Prior to treatment|1
5216395|NCT00983528|18006537|P1|Overall Study|Study Terminated|1
5216396|NCT00983528|18006537|P1|Overall Study|Lost to Follow-up|1
5216397|NCT00983528|18006537|P1|Overall Study|Death|4
5216398|NCT00983515|18006542|P1|Colchicine With Ritonavir|Lost to Follow-up|1
5216399|NCT00983515|18006542|P1|Ritonavir Alone|liver panel out of range|6
5216400|NCT00983476|18006569|P3|Overall Study|Did not receive intervention|0
5216401|NCT00983476|18006570|P2|Overall Study|Did not receive intervention|22
5216402|NCT00983476|18006571|P1|Overall Study|Did not receive intervention|17
5216403|NCT00983437|18006603|P1|Overall Study|Other Reason|26
5216404|NCT00983437|18006603|P1|Overall Study|Lost to Follow-up|2
5216405|NCT00983437|18006603|P1|Overall Study|Noncompliance to Study Procedures|1
5216406|NCT00983437|18006603|P1|Overall Study|Withdrawal by Subject|8
5216407|NCT00983437|18006603|P1|Overall Study|Lack of Efficacy|1
5216408|NCT00983437|18006603|P1|Overall Study|Adverse Event|9
5216409|NCT00983385|18006622|P1|Observation Period|Not Evaluable due to Non Compliance|12
5216410|NCT00983385|18006622|P1|Observation Period|Not eligible to be dosed|20
5216411|NCT00983372|18006667|P1|Diltiazem ER Alone|Adverse Event|1
5216412|NCT00983372|18006667|P1|Diltiazem ER Alone|missed diltiazem dose|2
5216413|NCT00983372|18006667|P1|14 Day Washout Period|Withdrawal by Subject|1
5216414|NCT00983294|18006694|P1|Colchicine With Azithromycin|Adverse Event|1
5216415|NCT00983294|18006694|P1|14 Day Washout Period|Withdrawal by Subject|2
5216416|NCT00983073|18006736|P1|Maintenance Period|Other Reason|7
5216417|NCT00983073|18006736|P1|Maintenance Period|Lack of Efficacy|2
5216418|NCT00983073|18006736|P1|Maintenance Period|Withdrawal by Subject|2
5216419|NCT00983073|18006736|P1|Maintenance Period|Adverse Event|5
5216420|NCT00983073|18006736|P1|Titration and Optimal Dose Period|Other reason|4
5216421|NCT00983073|18006736|P1|Titration and Optimal Dose Period|Non-Compliance|1
5216422|NCT00983073|18006736|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
5216423|NCT00983073|18006736|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
5216424|NCT00983073|18006736|P1|Titration and Optimal Dose Period|Adverse Event|19
5216425|NCT00982878|18006762|P1|Overall Study|Physician Decision|1
5216426|NCT00982735|18007060|P1|Overall Study|Patient ineligible for trial|224
5216427|NCT00982735|18007060|P1|Overall Study|Lost to Follow-up|6
5216428|NCT00982657|18007070|P4|Overall Study|On going at date of cut-off|1
5216429|NCT00982657|18007071|P3|Overall Study|On going at date of cut-off|0
5216430|NCT00982657|18007072|P2|Overall Study|On going at date of cut-off|0
5216431|NCT00982657|18007073|P1|Overall Study|On going at date of cut-off|0
5216432|NCT00982657|18007070|P4|Overall Study|Other|4
5216433|NCT00982657|18007071|P3|Overall Study|Other|0
5216434|NCT00982657|18007072|P2|Overall Study|Other|0
5216435|NCT00982657|18007073|P1|Overall Study|Other|0
5216436|NCT00982657|18007070|P4|Overall Study|Withdrawal by Subject|3
5216437|NCT00982657|18007071|P3|Overall Study|Withdrawal by Subject|1
5216438|NCT00982657|18007072|P2|Overall Study|Withdrawal by Subject|0
5216439|NCT00982657|18007073|P1|Overall Study|Withdrawal by Subject|0
5216440|NCT00982657|18007070|P4|Overall Study|Death|1
5216441|NCT00982657|18007071|P3|Overall Study|Death|1
5216442|NCT00982657|18007072|P2|Overall Study|Death|0
5216443|NCT00982657|18007073|P1|Overall Study|Death|1
5216444|NCT00982644|18007114|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
5216445|NCT00982644|18007115|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
5216446|NCT00982644|18007114|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
5216447|NCT00982644|18007115|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
5216448|NCT00982644|18007114|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
5216449|NCT00982644|18007115|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
5216450|NCT00982644|18007114|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
5216451|NCT00982644|18007115|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
5216452|NCT00982644|18007114|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
5216453|NCT00982644|18007115|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
5216454|NCT00982644|18007114|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
5216455|NCT00982644|18007115|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
5216456|NCT00982644|18007114|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
5216457|NCT00982644|18007115|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
5216458|NCT00982644|18007114|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
5216459|NCT00982644|18007115|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
5216460|NCT00982644|18007114|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
5216461|NCT00982644|18007115|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
5216462|NCT00982644|18007114|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
5216463|NCT00982644|18007115|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
5216464|NCT00982488|18007170|P5|Overall Study|Withdrawal by Subject|0
5216465|NCT00982488|18007171|P4|Overall Study|Withdrawal by Subject|0
5216466|NCT00982488|18007172|P3|Overall Study|Withdrawal by Subject|1
5216467|NCT00982488|18007173|P2|Overall Study|Withdrawal by Subject|1
5216468|NCT00982488|18007174|P1|Overall Study|Withdrawal by Subject|5
5216469|NCT00982488|18007170|P5|Overall Study|Study drug toxicity|0
5216470|NCT00982488|18007171|P4|Overall Study|Study drug toxicity|0
5216471|NCT00982488|18007172|P3|Overall Study|Study drug toxicity|6
5216472|NCT00982488|18007173|P2|Overall Study|Study drug toxicity|1
5216473|NCT00982488|18007174|P1|Overall Study|Study drug toxicity|34
5216474|NCT00982488|18007170|P5|Overall Study|Stem cell transplant|0
5216475|NCT00982488|18007171|P4|Overall Study|Stem cell transplant|1
5216476|NCT00982488|18007172|P3|Overall Study|Stem cell transplant|0
5216477|NCT00982488|18007173|P2|Overall Study|Stem cell transplant|0
5216478|NCT00982488|18007174|P1|Overall Study|Stem cell transplant|2
5216479|NCT00982488|18007170|P5|Overall Study|Poor compliance/noncompliance|0
5216480|NCT00982488|18007171|P4|Overall Study|Poor compliance/noncompliance|0
5216481|NCT00982488|18007172|P3|Overall Study|Poor compliance/noncompliance|0
5216482|NCT00982488|18007173|P2|Overall Study|Poor compliance/noncompliance|1
5216483|NCT00982488|18007174|P1|Overall Study|Poor compliance/noncompliance|0
5216484|NCT00982488|18007170|P5|Overall Study|Other|0
5216485|NCT00982488|18007171|P4|Overall Study|Other|1
5216486|NCT00982488|18007172|P3|Overall Study|Other|3
5216487|NCT00982488|18007173|P2|Overall Study|Other|1
5216488|NCT00982488|18007174|P1|Overall Study|Other|15
5216489|NCT00982488|18007170|P5|Overall Study|Maximum clinical benefit|0
5216490|NCT00982488|18007171|P4|Overall Study|Maximum clinical benefit|0
5216491|NCT00982488|18007172|P3|Overall Study|Maximum clinical benefit|1
5216492|NCT00982488|18007173|P2|Overall Study|Maximum clinical benefit|1
5216493|NCT00982488|18007174|P1|Overall Study|Maximum clinical benefit|1
5216494|NCT00982488|18007170|P5|Overall Study|Lost to Follow-up|0
5216495|NCT00982488|18007171|P4|Overall Study|Lost to Follow-up|0
5216496|NCT00982488|18007172|P3|Overall Study|Lost to Follow-up|0
5216497|NCT00982488|18007173|P2|Overall Study|Lost to Follow-up|0
5216498|NCT00982488|18007174|P1|Overall Study|Lost to Follow-up|1
5216499|NCT00982488|18007170|P5|Overall Study|Disease progression|1
5216500|NCT00982488|18007171|P4|Overall Study|Disease progression|1
5216501|NCT00982488|18007172|P3|Overall Study|Disease progression|10
5216502|NCT00982488|18007173|P2|Overall Study|Disease progression|5
5216503|NCT00982488|18007174|P1|Overall Study|Disease progression|30
5216504|NCT00982488|18007170|P5|Overall Study|Death|0
5216505|NCT00982488|18007171|P4|Overall Study|Death|0
5216506|NCT00982488|18007172|P3|Overall Study|Death|2
5216507|NCT00982488|18007173|P2|Overall Study|Death|0
5216508|NCT00982488|18007174|P1|Overall Study|Death|11
5216509|NCT00982488|18007170|P5|Overall Study|Adverse event unrelated to study drug|0
5216510|NCT00982488|18007171|P4|Overall Study|Adverse event unrelated to study drug|0
5216511|NCT00982488|18007172|P3|Overall Study|Adverse event unrelated to study drug|0
5216512|NCT00982488|18007173|P2|Overall Study|Adverse event unrelated to study drug|1
5216513|NCT00982488|18007174|P1|Overall Study|Adverse event unrelated to study drug|5
5216514|NCT00982488|18007170|P5|Overall Study|Administrative reason by sponsor|0
5216515|NCT00982488|18007171|P4|Overall Study|Administrative reason by sponsor|0
5216516|NCT00982488|18007172|P3|Overall Study|Administrative reason by sponsor|11
5216517|NCT00982488|18007173|P2|Overall Study|Administrative reason by sponsor|3
5216518|NCT00982488|18007174|P1|Overall Study|Administrative reason by sponsor|81
5216519|NCT00982410|18007207|P2|12-month Follow-up Assessment|scheduled, no-show|0
5216520|NCT00982410|18007208|P1|12-month Follow-up Assessment|scheduled, no-show|1
5216521|NCT00982410|18007207|P2|12-month Follow-up Assessment|incarceration|1
5216522|NCT00982410|18007208|P1|12-month Follow-up Assessment|incarceration|2
5216523|NCT00982410|18007207|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
5216524|NCT00982410|18007208|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
5216525|NCT00982410|18007207|P2|12-month Follow-up Assessment|could not reach to schedule|5
5216526|NCT00982410|18007208|P1|12-month Follow-up Assessment|could not reach to schedule|6
5216527|NCT00982410|18007207|P2|12-month Follow-up Assessment|Death|2
5216528|NCT00982410|18007208|P1|12-month Follow-up Assessment|Death|0
5216529|NCT00982410|18007207|P2|6-month Follow-up Assessment|scheduled, no-show|1
5216530|NCT00982410|18007208|P1|6-month Follow-up Assessment|scheduled, no-show|0
5216531|NCT00982410|18007207|P2|6-month Follow-up Assessment|patent surgery|1
5216532|NCT00982410|18007208|P1|6-month Follow-up Assessment|patent surgery|0
5216533|NCT00982410|18007207|P2|6-month Follow-up Assessment|incarceration|2
5216534|NCT00982410|18007208|P1|6-month Follow-up Assessment|incarceration|0
5216535|NCT00982410|18007207|P2|6-month Follow-up Assessment|participant no transportation|0
5216536|NCT00982410|18007208|P1|6-month Follow-up Assessment|participant no transportation|1
5216537|NCT00982410|18007207|P2|6-month Follow-up Assessment|Could not reach to schedule|7
5216538|NCT00982410|18007208|P1|6-month Follow-up Assessment|Could not reach to schedule|5
5216539|NCT00982410|18007207|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
5216540|NCT00982410|18007208|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
5216541|NCT00982410|18007207|P2|3-month Follow-up Assessment|Scheduled, no-show|2
5216542|NCT00982410|18007208|P1|3-month Follow-up Assessment|Scheduled, no-show|1
5216543|NCT00982410|18007207|P2|3-month Follow-up Assessment|Could not reach to schedule|9
5216544|NCT00982410|18007208|P1|3-month Follow-up Assessment|Could not reach to schedule|8
5216545|NCT00982319|18007249|P2|Overall Study|Pregnancy|1
5216546|NCT00982319|18007250|P1|Overall Study|Pregnancy|0
5216547|NCT00982319|18007249|P2|Overall Study|Preop values out of acceptable range|1
5216548|NCT00982319|18007250|P1|Overall Study|Preop values out of acceptable range|1
5216549|NCT00982319|18007249|P2|Overall Study|Surgery date change|0
5216550|NCT00982319|18007250|P1|Overall Study|Surgery date change|1
5216551|NCT00982280|18007258|P1|Maintenance Period|Adverse Event|1
5216552|NCT00982280|18007258|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
5216553|NCT00982280|18007258|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
5216554|NCT00982280|18007258|P1|Titration and Optimal Dose Period|Adverse Event|5
5216555|NCT00982280|18007258|P1|Observation Period|Not eligible to be dosed|19
5216556|NCT00982228|18007283|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
5216557|NCT00982228|18007284|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
5216558|NCT00982228|18007283|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
5216559|NCT00982228|18007284|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
5216560|NCT00982228|18007283|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
5216561|NCT00982228|18007284|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
5216562|NCT00982228|18007283|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
5216563|NCT00982228|18007284|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
5216564|NCT00982228|18007283|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
5216565|NCT00982228|18007284|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
5216566|NCT00982228|18007283|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
5216567|NCT00982228|18007284|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
5216568|NCT00982228|18007283|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
5216569|NCT00982228|18007284|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
5216570|NCT00982228|18007283|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
5216571|NCT00982228|18007284|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
5216572|NCT00982228|18007283|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
5216573|NCT00982228|18007284|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
5216574|NCT00982228|18007283|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
5216575|NCT00982228|18007284|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
5216576|NCT00982137|18007343|P4|Overall Study|Withdrawal by Subject|0
5216577|NCT00982137|18007344|P3|Overall Study|Withdrawal by Subject|0
5216578|NCT00982137|18007345|P2|Overall Study|Withdrawal by Subject|1
5216579|NCT00982137|18007346|P1|Overall Study|Withdrawal by Subject|0
5216580|NCT00982137|18007343|P4|Overall Study|Lost to Follow-up|1
5216581|NCT00982137|18007344|P3|Overall Study|Lost to Follow-up|0
5216582|NCT00982137|18007345|P2|Overall Study|Lost to Follow-up|0
5216583|NCT00982137|18007346|P1|Overall Study|Lost to Follow-up|0
5216584|NCT00982111|18007378|P2|Overall Study|Withdrawal by Subject|17
5216585|NCT00982111|18007379|P1|Overall Study|Withdrawal by Subject|16
5216586|NCT00982111|18007378|P2|Overall Study|On Study Treatment at Conclusion|0
5216587|NCT00982111|18007379|P1|Overall Study|On Study Treatment at Conclusion|7
5216588|NCT00982111|18007378|P2|Overall Study|New Anti-Cancer Therapy|5
5216589|NCT00982111|18007379|P1|Overall Study|New Anti-Cancer Therapy|5
5216590|NCT00982111|18007378|P2|Overall Study|Lost to Follow-up|6
5216591|NCT00982111|18007379|P1|Overall Study|Lost to Follow-up|9
5216592|NCT00982111|18007378|P2|Overall Study|Progressive Disease|37
5216593|NCT00982111|18007379|P1|Overall Study|Progressive Disease|37
5216594|NCT00982111|18007378|P2|Overall Study|Adverse Event|1
5216595|NCT00982111|18007379|P1|Overall Study|Adverse Event|1
5216596|NCT00982020|18007412|P2|Overall Study|Clinical Relapse|1
5216597|NCT00982020|18007413|P1|Overall Study|Clinical Relapse|0
5216598|NCT00982020|18007412|P2|Overall Study|Protocol Violation|2
5216599|NCT00982020|18007413|P1|Overall Study|Protocol Violation|0
5216600|NCT00982020|18007412|P2|Overall Study|Entry Criteria Not Met|1
5216601|NCT00982020|18007413|P1|Overall Study|Entry Criteria Not Met|2
5216602|NCT00982020|18007412|P2|Overall Study|Physician Decision|5
5216603|NCT00982020|18007413|P1|Overall Study|Physician Decision|2
5216604|NCT00982020|18007412|P2|Overall Study|Treatment Non-compliance|6
5216605|NCT00982020|18007413|P1|Overall Study|Treatment Non-compliance|3
5216606|NCT00982020|18007412|P2|Overall Study|Parent/Caregiver Decision|5
5216607|NCT00982020|18007413|P1|Overall Study|Parent/Caregiver Decision|5
5216608|NCT00982020|18007412|P2|Overall Study|Lack of Efficacy|4
5216609|NCT00982020|18007413|P1|Overall Study|Lack of Efficacy|10
5216610|NCT00982020|18007412|P2|Overall Study|Lost to Follow-up|11
5216611|NCT00982020|18007413|P1|Overall Study|Lost to Follow-up|5
5216612|NCT00982020|18007412|P2|Overall Study|Withdrawal by Subject|14
5216613|NCT00982020|18007413|P1|Overall Study|Withdrawal by Subject|11
5216614|NCT00982020|18007412|P2|Overall Study|Adverse Event|15
5216615|NCT00982020|18007413|P1|Overall Study|Adverse Event|19
5216616|NCT00981799|18007467|P4|Overall Study|Adverse Event|0
5216617|NCT00981799|18007468|P3|Overall Study|Adverse Event|0
5216618|NCT00981799|18007469|P2|Overall Study|Adverse Event|1
5216619|NCT00981799|18007470|P1|Overall Study|Adverse Event|1
5216620|NCT00981747|18007484|P1|Placebo Oral Tablet|Withdrawal by Subject|1
5216621|NCT00981747|18007484|P1|Losartan|Death|1
5216622|NCT00981747|18007484|P1|Losartan|Withdrawal by Subject|1
5216623|NCT00981578|18007550|P1|Overall Study|Withdrawal by Subject|2
5216624|NCT00981578|18007550|P1|Overall Study|Death|1
5216625|NCT00981526|18007558|P2|Overall Study|Physician Decision|4
5216626|NCT00981526|18007559|P1|Overall Study|Physician Decision|4
5216627|NCT00981526|18007558|P2|Overall Study|Withdrawal by Subject|2
5216628|NCT00981526|18007559|P1|Overall Study|Withdrawal by Subject|0
5216629|NCT00981461|18007577|P2|Overall Study|Lost to Follow-up|2
5216630|NCT00981461|18007578|P1|Overall Study|Lost to Follow-up|5
5216631|NCT00981409|18007602|P2|Overall Study|Prostate Cancer Treatment before Trial|0
5216632|NCT00981409|18007603|P1|Overall Study|Prostate Cancer Treatment before Trial|2
5216633|NCT00981409|18007602|P2|Overall Study|Protocol Violation|1
5216634|NCT00981409|18007603|P1|Overall Study|Protocol Violation|0
5216635|NCT00981409|18007602|P2|Overall Study|Adverse Event|0
5216636|NCT00981409|18007603|P1|Overall Study|Adverse Event|4
5216637|NCT00981292|18007642|P6|Day 3|Protocol Violation|1
5216638|NCT00981292|18007643|P5|Day 3|Protocol Violation|0
5216639|NCT00981292|18007644|P4|Day 3|Protocol Violation|0
5216640|NCT00981292|18007645|P3|Day 3|Protocol Violation|0
5216641|NCT00981292|18007646|P2|Day 3|Protocol Violation|0
5216642|NCT00981292|18007647|P1|Day 3|Protocol Violation|0
5216643|NCT00981292|18007642|P6|Day 2|Protocol Violation|0
5216644|NCT00981292|18007643|P5|Day 2|Protocol Violation|0
5216645|NCT00981292|18007644|P4|Day 2|Protocol Violation|0
5216646|NCT00981292|18007645|P3|Day 2|Protocol Violation|0
5216647|NCT00981292|18007646|P2|Day 2|Protocol Violation|0
5216648|NCT00981292|18007647|P1|Day 2|Protocol Violation|2
5216649|NCT00981292|18007642|P6|Day 1|Protocol Violation|2
5216650|NCT00981292|18007643|P5|Day 1|Protocol Violation|0
5216651|NCT00981292|18007644|P4|Day 1|Protocol Violation|0
5216652|NCT00981292|18007645|P3|Day 1|Protocol Violation|0
5216653|NCT00981292|18007646|P2|Day 1|Protocol Violation|0
5216654|NCT00981292|18007647|P1|Day 1|Protocol Violation|1
5216655|NCT00981175|18007731|P2|Booster Dose Vaccination|Lost to Follow-up|3
5216656|NCT00981175|18007732|P1|Booster Dose Vaccination|Lost to Follow-up|2
5216657|NCT00981175|18007731|P2|Primary Dose Vaccination|Lost to Follow-up|1
5216658|NCT00981175|18007732|P1|Primary Dose Vaccination|Lost to Follow-up|2
5216659|NCT00981175|18007731|P2|Primary Dose Vaccination|Protocol Violation|1
5216660|NCT00981175|18007732|P1|Primary Dose Vaccination|Protocol Violation|0
5216661|NCT00981175|18007731|P2|Primary Dose Vaccination|Adverse Event|0
5216662|NCT00981175|18007732|P1|Primary Dose Vaccination|Adverse Event|1
5216663|NCT00981149|18007757|P2|Overall Study|Withdrawal by Subject|1
5216664|NCT00981149|18007758|P1|Overall Study|Withdrawal by Subject|1
5216665|NCT00981149|18007757|P2|Overall Study|Lost to Follow-up|2
5216666|NCT00981149|18007758|P1|Overall Study|Lost to Follow-up|1
5216667|NCT00981084|18007768|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
5216668|NCT00981084|18007769|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
5216669|NCT00981084|18007768|P2|Post Intervention (Data Analysis)|poor effort|1
5216670|NCT00981084|18007769|P1|Post Intervention (Data Analysis)|poor effort|1
5216671|NCT00981058|18007785|P2|Overall Study|On study treatment at conclusion|0
5216672|NCT00981058|18007786|P1|Overall Study|On study treatment at conclusion|9
5216673|NCT00981058|18007785|P2|Overall Study|Withdrawal by Subject|23
5216674|NCT00981058|18007786|P1|Overall Study|Withdrawal by Subject|25
5216675|NCT00981058|18007785|P2|Overall Study|Randomization Error|2
5216676|NCT00981058|18007786|P1|Overall Study|Randomization Error|1
5216677|NCT00981058|18007785|P2|Overall Study|Radiologist Error|1
5216678|NCT00981058|18007786|P1|Overall Study|Radiologist Error|0
5216679|NCT00981058|18007785|P2|Overall Study|Noncompliance|0
5216680|NCT00981058|18007786|P1|Overall Study|Noncompliance|1
5216681|NCT00981058|18007785|P2|Overall Study|New Anticancer Therapy|6
5216682|NCT00981058|18007786|P1|Overall Study|New Anticancer Therapy|6
5216683|NCT00981058|18007785|P2|Overall Study|Lost to Follow-up|15
5216684|NCT00981058|18007786|P1|Overall Study|Lost to Follow-up|16
5216685|NCT00981058|18007785|P2|Overall Study|Progressive Disease|49
5216686|NCT00981058|18007786|P1|Overall Study|Progressive Disease|61
5216687|NCT00981058|18007785|P2|Overall Study|Adverse Event|1
5216688|NCT00981058|18007786|P1|Overall Study|Adverse Event|1
5216689|NCT00981019|18007817|P1|Overall Study|Hit the survey after closure|79
5216690|NCT00981019|18007817|P1|Overall Study|Inadvertent exclusion|239
5216691|NCT00981019|18007817|P1|Overall Study|Did not match target population|94
5216692|NCT00981019|18007817|P1|Overall Study|Did not respond|65
5216693|NCT00980980|18007824|P3|Overall Study|Withdrawal by Hospital|0
5216694|NCT00980980|18007825|P2|Overall Study|Withdrawal by Hospital|1
5216695|NCT00980980|18007826|P1|Overall Study|Withdrawal by Hospital|0
5216696|NCT00980798|18007857|P2|Overall Study|Other|1
5216697|NCT00980798|18007858|P1|Overall Study|Other|0
5216698|NCT00980798|18007857|P2|Overall Study|Withdrawal by Subject|11
5216699|NCT00980798|18007858|P1|Overall Study|Withdrawal by Subject|8
5216700|NCT00980798|18007857|P2|Overall Study|Physician Decision|1
5216701|NCT00980798|18007858|P1|Overall Study|Physician Decision|2
5216702|NCT00980798|18007857|P2|Overall Study|Lost to Follow-up|1
5216703|NCT00980798|18007858|P1|Overall Study|Lost to Follow-up|0
5216704|NCT00980798|18007857|P2|Overall Study|Lack of Efficacy|5
5216705|NCT00980798|18007858|P1|Overall Study|Lack of Efficacy|16
5216706|NCT00980798|18007857|P2|Overall Study|Adverse Event|36
5216707|NCT00980798|18007858|P1|Overall Study|Adverse Event|7
5216708|NCT00980655|18007914|P2|Overall Study|Other|1
5216709|NCT00980655|18007915|P1|Overall Study|Other|0
5216710|NCT00980655|18007914|P2|Overall Study|Parent/legal guardian request|0
5216711|NCT00980655|18007915|P1|Overall Study|Parent/legal guardian request|1
5216712|NCT00980655|18007914|P2|Overall Study|Lost to Follow-up|1
5216713|NCT00980655|18007915|P1|Overall Study|Lost to Follow-up|0
5216714|NCT00980655|18007914|P2|Overall Study|Withdrawal by Subject|4
5216715|NCT00980655|18007915|P1|Overall Study|Withdrawal by Subject|0
5216716|NCT00980655|18007914|P2|Overall Study|Protocol Violation|7
5216717|NCT00980655|18007915|P1|Overall Study|Protocol Violation|2
5216718|NCT00980655|18007914|P2|Overall Study|Death|7
5216719|NCT00980655|18007915|P1|Overall Study|Death|0
5216720|NCT00980655|18007914|P2|Overall Study|Adverse Event|31
5216721|NCT00980655|18007915|P1|Overall Study|Adverse Event|13
5216722|NCT00980343|18007998|P2|Overall Study|no tumor at surgery - treatment effect|3
5216723|NCT00980343|18007999|P1|Overall Study|no tumor at surgery - treatment effect|1
5216724|NCT00980330|18008023|P7|Overall Study|(not specified)|0
5216725|NCT00980330|18008024|P6|Overall Study|(not specified)|1
5216726|NCT00980330|18008025|P5|Overall Study|(not specified)|1
5216727|NCT00980330|18008026|P4|Overall Study|(not specified)|1
5216728|NCT00980330|18008027|P3|Overall Study|(not specified)|0
5216729|NCT00980330|18008028|P2|Overall Study|(not specified)|0
5216730|NCT00980330|18008029|P1|Overall Study|(not specified)|2
5216731|NCT00980330|18008023|P7|Overall Study|Withdrawal by Subject|5
5216732|NCT00980330|18008024|P6|Overall Study|Withdrawal by Subject|2
5216733|NCT00980330|18008025|P5|Overall Study|Withdrawal by Subject|3
5216734|NCT00980330|18008026|P4|Overall Study|Withdrawal by Subject|1
5216735|NCT00980330|18008027|P3|Overall Study|Withdrawal by Subject|4
5216736|NCT00980330|18008028|P2|Overall Study|Withdrawal by Subject|4
5216737|NCT00980330|18008029|P1|Overall Study|Withdrawal by Subject|2
5216738|NCT00980330|18008023|P7|Overall Study|Lost to Follow-up|2
5216739|NCT00980330|18008024|P6|Overall Study|Lost to Follow-up|1
5216740|NCT00980330|18008025|P5|Overall Study|Lost to Follow-up|1
5216741|NCT00980330|18008026|P4|Overall Study|Lost to Follow-up|2
5216742|NCT00980330|18008027|P3|Overall Study|Lost to Follow-up|4
5216743|NCT00980330|18008028|P2|Overall Study|Lost to Follow-up|1
5216744|NCT00980330|18008029|P1|Overall Study|Lost to Follow-up|1
5216745|NCT00980330|18008023|P7|Overall Study|Adverse Event|0
5216746|NCT00980330|18008024|P6|Overall Study|Adverse Event|0
5216747|NCT00980330|18008025|P5|Overall Study|Adverse Event|0
5216748|NCT00980330|18008026|P4|Overall Study|Adverse Event|1
5216749|NCT00980330|18008027|P3|Overall Study|Adverse Event|0
5216750|NCT00980330|18008028|P2|Overall Study|Adverse Event|0
5216751|NCT00980330|18008029|P1|Overall Study|Adverse Event|0
5216752|NCT00980200|18008144|P5|7-day Treatment Period 3|Lack of Efficacy|1
5216753|NCT00980200|18008145|P4|7-day Treatment Period 3|Lack of Efficacy|0
5216754|NCT00980200|18008146|P3|7-day Treatment Period 3|Lack of Efficacy|0
5216755|NCT00980200|18008147|P2|7-day Treatment Period 3|Lack of Efficacy|1
5216756|NCT00980200|18008148|P1|7-day Treatment Period 3|Lack of Efficacy|0
5216757|NCT00980200|18008144|P5|7-day Treatment Period 1|Withdrawal by Subject|0
5216758|NCT00980200|18008145|P4|7-day Treatment Period 1|Withdrawal by Subject|0
5216759|NCT00980200|18008146|P3|7-day Treatment Period 1|Withdrawal by Subject|0
5216760|NCT00980200|18008147|P2|7-day Treatment Period 1|Withdrawal by Subject|1
5216761|NCT00980200|18008148|P1|7-day Treatment Period 1|Withdrawal by Subject|0
5216762|NCT00980174|18008167|P2|Overall Study|Other|1
5216763|NCT00980174|18008168|P1|Overall Study|Other|0
5216764|NCT00980174|18008167|P2|Overall Study|Death|1
5216765|NCT00980174|18008168|P1|Overall Study|Death|1
5216766|NCT00980174|18008167|P2|Overall Study|Ineligibility determined|1
5216767|NCT00980174|18008168|P1|Overall Study|Ineligibility determined|2
5216768|NCT00980174|18008167|P2|Overall Study|Adverse Event|3
5216769|NCT00980174|18008168|P1|Overall Study|Adverse Event|0
5216770|NCT00980174|18008167|P2|Overall Study|Withdrawal by Subject|4
5216771|NCT00980174|18008168|P1|Overall Study|Withdrawal by Subject|1
5216772|NCT00980148|18008186|P2|Overall Study|Various other reasons|9
5216773|NCT00980148|18008187|P1|Overall Study|Various other reasons|8
5216774|NCT00980148|18008186|P2|Overall Study|Negative for chlamydia at enrollment|9
5216775|NCT00980148|18008187|P1|Overall Study|Negative for chlamydia at enrollment|12
5216776|NCT00980148|18008186|P2|Overall Study|Received other antichlamydia treatment|14
5216777|NCT00980148|18008187|P1|Overall Study|Received other antichlamydia treatment|20
5216778|NCT00980148|18008186|P2|Overall Study|Discharged from facility|96
5216779|NCT00980148|18008187|P1|Overall Study|Discharged from facility|89
5216780|NCT00980057|18008195|P2|Overall Study|Withdrawal by Subject|1
5216781|NCT00980057|18008196|P1|Overall Study|Withdrawal by Subject|1
5216782|NCT00980057|18008195|P2|Overall Study|Lost to Follow-up|0
5216783|NCT00980057|18008196|P1|Overall Study|Lost to Follow-up|1
5216784|NCT00980057|18008195|P2|Overall Study|Physician Decision|0
5216785|NCT00980057|18008196|P1|Overall Study|Physician Decision|4
5216786|NCT00980057|18008195|P2|Overall Study|Adverse Event|1
5216787|NCT00980057|18008196|P1|Overall Study|Adverse Event|0
5216788|NCT00980057|18008195|P2|Overall Study|Death|3
5216789|NCT00980057|18008196|P1|Overall Study|Death|13
5216790|NCT00980044|18008219|P3|Overall Study|Protocol Violation|2
5216791|NCT00980044|18008220|P2|Overall Study|Protocol Violation|0
5216792|NCT00980044|18008221|P1|Overall Study|Protocol Violation|0
5216793|NCT00980044|18008219|P3|Overall Study|Withdrawal by Subject|3
5216794|NCT00980044|18008220|P2|Overall Study|Withdrawal by Subject|7
5216795|NCT00980044|18008221|P1|Overall Study|Withdrawal by Subject|5
5216796|NCT00980005|18008240|P2|Overall Study|Other|3
5216797|NCT00980005|18008241|P1|Overall Study|Other|4
5216798|NCT00980005|18008240|P2|Overall Study|Lost to Follow-up|43
5216799|NCT00980005|18008241|P1|Overall Study|Lost to Follow-up|37
5216800|NCT00980005|18008240|P2|Overall Study|Withdrawal by Subject|17
5216801|NCT00980005|18008241|P1|Overall Study|Withdrawal by Subject|6
5216802|NCT00979992|18008281|P1|Overall Study|Refused - Never Treated|2
5216803|NCT00979992|18008281|P1|Overall Study|Ineligible - wrong cell type|2
5216804|NCT00979992|18008281|P1|Overall Study|Ineligible - inadequate pathology|1
5216805|NCT00979953|18008293|P4|Overall Study|Protocol Violation|2
5216806|NCT00979953|18008294|P3|Overall Study|Protocol Violation|2
5216807|NCT00979953|18008295|P2|Overall Study|Protocol Violation|0
5216808|NCT00979953|18008296|P1|Overall Study|Protocol Violation|1
5216809|NCT00979953|18008293|P4|Overall Study|Withdrawal by Subject|1
5216810|NCT00979953|18008294|P3|Overall Study|Withdrawal by Subject|2
5216811|NCT00979953|18008295|P2|Overall Study|Withdrawal by Subject|0
5216812|NCT00979953|18008296|P1|Overall Study|Withdrawal by Subject|0
5216813|NCT00979953|18008293|P4|Overall Study|Lost to Follow-up|0
5216814|NCT00979953|18008294|P3|Overall Study|Lost to Follow-up|1
5216815|NCT00979953|18008295|P2|Overall Study|Lost to Follow-up|1
5216816|NCT00979953|18008296|P1|Overall Study|Lost to Follow-up|1
5216817|NCT00979953|18008293|P4|Overall Study|Lack of Efficacy|0
5216818|NCT00979953|18008294|P3|Overall Study|Lack of Efficacy|0
5216819|NCT00979953|18008295|P2|Overall Study|Lack of Efficacy|2
5216820|NCT00979953|18008296|P1|Overall Study|Lack of Efficacy|1
5216821|NCT00979953|18008293|P4|Overall Study|Adverse Event|4
5216822|NCT00979953|18008294|P3|Overall Study|Adverse Event|17
5216823|NCT00979953|18008295|P2|Overall Study|Adverse Event|2
5216824|NCT00979953|18008296|P1|Overall Study|Adverse Event|5
5216825|NCT00979901|18008319|P4|Overall Study|Treatment Group Terminated by Sponsor|112
5216826|NCT00979901|18008320|P3|Overall Study|Treatment Group Terminated by Sponsor|0
5216827|NCT00979901|18008321|P2|Overall Study|Treatment Group Terminated by Sponsor|0
5216828|NCT00979901|18008322|P1|Overall Study|Treatment Group Terminated by Sponsor|0
5216829|NCT00979901|18008319|P4|Overall Study|Left Country|0
5216830|NCT00979901|18008320|P3|Overall Study|Left Country|1
5216831|NCT00979901|18008321|P2|Overall Study|Left Country|0
5216832|NCT00979901|18008322|P1|Overall Study|Left Country|0
5216833|NCT00979901|18008319|P4|Overall Study|Discontinued in Error|0
5216834|NCT00979901|18008320|P3|Overall Study|Discontinued in Error|0
5216835|NCT00979901|18008321|P2|Overall Study|Discontinued in Error|1
5216836|NCT00979901|18008322|P1|Overall Study|Discontinued in Error|0
5216837|NCT00979901|18008319|P4|Overall Study|elevated lab values pre-randomization|0
5216838|NCT00979901|18008320|P3|Overall Study|elevated lab values pre-randomization|0
5216839|NCT00979901|18008321|P2|Overall Study|elevated lab values pre-randomization|0
5216840|NCT00979901|18008322|P1|Overall Study|elevated lab values pre-randomization|1
5216841|NCT00979901|18008319|P4|Overall Study|vacation|0
5216842|NCT00979901|18008320|P3|Overall Study|vacation|0
5216843|NCT00979901|18008321|P2|Overall Study|vacation|0
5216844|NCT00979901|18008322|P1|Overall Study|vacation|1
5216845|NCT00979901|18008319|P4|Overall Study|out-of-state|0
5216846|NCT00979901|18008320|P3|Overall Study|out-of-state|0
5216847|NCT00979901|18008321|P2|Overall Study|out-of-state|0
5216848|NCT00979901|18008322|P1|Overall Study|out-of-state|1
5216849|NCT00979901|18008319|P4|Overall Study|Noncompliance|0
5216850|NCT00979901|18008320|P3|Overall Study|Noncompliance|0
5216851|NCT00979901|18008321|P2|Overall Study|Noncompliance|0
5216852|NCT00979901|18008322|P1|Overall Study|Noncompliance|1
5216853|NCT00979901|18008319|P4|Overall Study|Withdrawal by Subject|1
5216854|NCT00979901|18008320|P3|Overall Study|Withdrawal by Subject|1
5216855|NCT00979901|18008321|P2|Overall Study|Withdrawal by Subject|1
5216856|NCT00979901|18008322|P1|Overall Study|Withdrawal by Subject|2
5216857|NCT00979901|18008319|P4|Overall Study|Protocol Violation|1
5216858|NCT00979901|18008320|P3|Overall Study|Protocol Violation|7
5216859|NCT00979901|18008321|P2|Overall Study|Protocol Violation|2
5216860|NCT00979901|18008322|P1|Overall Study|Protocol Violation|2
5216861|NCT00979901|18008319|P4|Overall Study|Lost to Follow-up|0
5216862|NCT00979901|18008320|P3|Overall Study|Lost to Follow-up|2
5216863|NCT00979901|18008321|P2|Overall Study|Lost to Follow-up|1
5216864|NCT00979901|18008322|P1|Overall Study|Lost to Follow-up|1
5216865|NCT00979901|18008319|P4|Overall Study|Lack of Efficacy|0
5216866|NCT00979901|18008320|P3|Overall Study|Lack of Efficacy|9
5216867|NCT00979901|18008321|P2|Overall Study|Lack of Efficacy|4
5216868|NCT00979901|18008322|P1|Overall Study|Lack of Efficacy|8
5216869|NCT00979901|18008319|P4|Overall Study|Adverse Event|2
5216870|NCT00979901|18008320|P3|Overall Study|Adverse Event|9
5216871|NCT00979901|18008321|P2|Overall Study|Adverse Event|3
5216872|NCT00979901|18008322|P1|Overall Study|Adverse Event|1
5216873|NCT00979654|18008395|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
5216874|NCT00979654|18008395|P1|Overall Study|Serious Adverse Event|1
5216875|NCT00979654|18008395|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
5216876|NCT00979654|18008395|P1|Overall Study|Per Principal Investigator's Discretion|1
5216877|NCT00979654|18008395|P1|Overall Study|Adverse Event of Diverticulitis|1
5216878|NCT00979654|18008395|P1|Overall Study|Adverse Event|1
5216879|NCT00979654|18008395|P1|Overall Study|Lack of Efficacy|6
5216880|NCT00979654|18008395|P1|Overall Study|Death|1
5216881|NCT00979654|18008395|P1|Overall Study|Withdrawal by Subject|22
5216882|NCT00979654|18008395|P1|Overall Study|Lost to Follow-up|1
5216883|NCT00979628|18008410|P3|Overall Study|transferred to ICU|1
5216884|NCT00979628|18008411|P2|Overall Study|transferred to ICU|2
5216885|NCT00979628|18008412|P1|Overall Study|transferred to ICU|1
5216886|NCT00979628|18008410|P3|Overall Study|received steroids|0
5216887|NCT00979628|18008411|P2|Overall Study|received steroids|1
5216888|NCT00979628|18008412|P1|Overall Study|received steroids|1
5216889|NCT00979628|18008410|P3|Overall Study|received regimen < 24 hours|5
5216890|NCT00979628|18008411|P2|Overall Study|received regimen < 24 hours|6
5216891|NCT00979628|18008412|P1|Overall Study|received regimen < 24 hours|7
5216892|NCT00979602|18008442|P2|Overall Study|Others|3
5216893|NCT00979602|18008443|P1|Overall Study|Others|3
5216894|NCT00979602|18008442|P2|Overall Study|Migrated/moved from study area|6
5216895|NCT00979602|18008443|P1|Overall Study|Migrated/moved from study area|3
5216896|NCT00979602|18008442|P2|Overall Study|Lost to Follow-up|96
5216897|NCT00979602|18008443|P1|Overall Study|Lost to Follow-up|100
5216898|NCT00979602|18008442|P2|Overall Study|Withdrawal by Subject|25
5216899|NCT00979602|18008443|P1|Overall Study|Withdrawal by Subject|31
5216900|NCT00979602|18008442|P2|Overall Study|Protocol Violation|0
5216901|NCT00979602|18008443|P1|Overall Study|Protocol Violation|3
5216902|NCT00979602|18008442|P2|Overall Study|Serious Adverse Event|3
5216903|NCT00979602|18008443|P1|Overall Study|Serious Adverse Event|5
5216904|NCT00979576|18008614|P3|Combination Followed by Monotherapy|Progressive Disease|1
5216905|NCT00979576|18008615|P2|Combination Followed by Monotherapy|Progressive Disease|2
5216906|NCT00979576|18008616|P1|Combination Followed by Monotherapy|Progressive Disease|0
5216907|NCT00979576|18008614|P3|Combination Treatment Phase|Adverse Event|2
5216908|NCT00979576|18008615|P2|Combination Treatment Phase|Adverse Event|2
5216909|NCT00979576|18008616|P1|Combination Treatment Phase|Adverse Event|0
5216910|NCT00979576|18008614|P3|Combination Treatment Phase|Dose limiting toxicity|2
5216911|NCT00979576|18008615|P2|Combination Treatment Phase|Dose limiting toxicity|3
5216912|NCT00979576|18008616|P1|Combination Treatment Phase|Dose limiting toxicity|0
5216913|NCT00979576|18008614|P3|Combination Treatment Phase|Progressive disease|5
5216914|NCT00979576|18008615|P2|Combination Treatment Phase|Progressive disease|1
5216915|NCT00979576|18008616|P1|Combination Treatment Phase|Progressive disease|3
5216916|NCT00979420|18008673|P4|Overall Study|Other reasons not related to Viramune|1
5216917|NCT00979420|18008674|P3|Overall Study|Other reasons not related to Viramune|0
5216918|NCT00979420|18008675|P2|Overall Study|Other reasons not related to Viramune|0
5216919|NCT00979420|18008676|P1|Overall Study|Other reasons not related to Viramune|3
5216920|NCT00979420|18008673|P4|Overall Study|Lack of Efficacy|1
5216921|NCT00979420|18008674|P3|Overall Study|Lack of Efficacy|1
5216922|NCT00979420|18008675|P2|Overall Study|Lack of Efficacy|0
5216923|NCT00979420|18008676|P1|Overall Study|Lack of Efficacy|3
5216924|NCT00979420|18008673|P4|Overall Study|Adverse Event|0
5216925|NCT00979420|18008674|P3|Overall Study|Adverse Event|0
5216926|NCT00979420|18008675|P2|Overall Study|Adverse Event|0
5216927|NCT00979420|18008676|P1|Overall Study|Adverse Event|1
5216928|NCT00979407|18008746|P2|Overall Study|Lost to Follow-up|3
5216929|NCT00979407|18008747|P1|Overall Study|Lost to Follow-up|3
5216930|NCT00979407|18008746|P2|Overall Study|Withdrawal by Subject|4
5216931|NCT00979407|18008747|P1|Overall Study|Withdrawal by Subject|3
5216932|NCT00979212|18008800|P2|Overall Study|No protocol therapy received|0
5216933|NCT00979212|18008801|P1|Overall Study|No protocol therapy received|1
5216934|NCT00979212|18008800|P2|Overall Study|Protocol Violation|8
5216935|NCT00979212|18008801|P1|Overall Study|Protocol Violation|1
5216936|NCT00979134|18008838|P3|Overall Study|Other|5
5216937|NCT00979134|18008839|P2|Overall Study|Other|1
5216938|NCT00979134|18008840|P1|Overall Study|Other|8
5216939|NCT00979134|18008838|P3|Overall Study|Death|26
5216940|NCT00979134|18008839|P2|Overall Study|Death|0
5216941|NCT00979134|18008840|P1|Overall Study|Death|4
5216942|NCT00979134|18008838|P3|Overall Study|Lost to Follow-up|0
5216943|NCT00979134|18008839|P2|Overall Study|Lost to Follow-up|2
5216944|NCT00979134|18008840|P1|Overall Study|Lost to Follow-up|2
5216945|NCT00979134|18008838|P3|Overall Study|Withdrawal by Subject|2
5216946|NCT00979134|18008839|P2|Overall Study|Withdrawal by Subject|1
5216947|NCT00979134|18008840|P1|Overall Study|Withdrawal by Subject|1
5216948|NCT00979134|18008838|P3|Overall Study|Adverse Event|2
5216949|NCT00979134|18008839|P2|Overall Study|Adverse Event|0
5216950|NCT00979134|18008840|P1|Overall Study|Adverse Event|0
5216951|NCT00979134|18008838|P3|Overall Study|Disease progression|5
5216952|NCT00979134|18008839|P2|Overall Study|Disease progression|2
5216953|NCT00979134|18008840|P1|Overall Study|Disease progression|18
5216954|NCT00978757|18008928|P2|Overall Study|Physician Decision|3
5216955|NCT00978757|18008929|P1|Overall Study|Physician Decision|1
5216956|NCT00978731|18008939|P4|Overall Study|No response|0
5216957|NCT00978731|18008940|P3|Overall Study|No response|0
5216958|NCT00978731|18008941|P2|Overall Study|No response|0
5216959|NCT00978731|18008942|P1|Overall Study|No response|1
5216960|NCT00978731|18008939|P4|Overall Study|Study closure|1
5216961|NCT00978731|18008940|P3|Overall Study|Study closure|1
5216962|NCT00978731|18008941|P2|Overall Study|Study closure|4
5216963|NCT00978731|18008942|P1|Overall Study|Study closure|3
5216964|NCT00978731|18008939|P4|Overall Study|Disease progression/relapse|2
5216965|NCT00978731|18008940|P3|Overall Study|Disease progression/relapse|2
5216966|NCT00978731|18008941|P2|Overall Study|Disease progression/relapse|4
5216967|NCT00978731|18008942|P1|Overall Study|Disease progression/relapse|5
5216968|NCT00978731|18008939|P4|Overall Study|Deterioration without progression|0
5216969|NCT00978731|18008940|P3|Overall Study|Deterioration without progression|0
5216970|NCT00978731|18008941|P2|Overall Study|Deterioration without progression|1
5216971|NCT00978731|18008942|P1|Overall Study|Deterioration without progression|0
5216972|NCT00978731|18008939|P4|Overall Study|Administrative reason|0
5216973|NCT00978731|18008940|P3|Overall Study|Administrative reason|1
5216974|NCT00978731|18008941|P2|Overall Study|Administrative reason|3
5216975|NCT00978731|18008942|P1|Overall Study|Administrative reason|3
5216976|NCT00978731|18008939|P4|Overall Study|Participant's request|0
5216977|NCT00978731|18008940|P3|Overall Study|Participant's request|0
5216978|NCT00978731|18008941|P2|Overall Study|Participant's request|0
5216979|NCT00978731|18008942|P1|Overall Study|Participant's request|1
5216980|NCT00978731|18008939|P4|Overall Study|Adverse Event|0
5216981|NCT00978731|18008940|P3|Overall Study|Adverse Event|0
5216982|NCT00978731|18008941|P2|Overall Study|Adverse Event|2
5216983|NCT00978731|18008942|P1|Overall Study|Adverse Event|5
5216984|NCT00978731|18008939|P4|Overall Study|Lost to Follow-up|1
5216985|NCT00978731|18008940|P3|Overall Study|Lost to Follow-up|0
5216986|NCT00978731|18008941|P2|Overall Study|Lost to Follow-up|0
5216987|NCT00978731|18008942|P1|Overall Study|Lost to Follow-up|0
5216988|NCT00978731|18008939|P4|Overall Study|Death|0
5216989|NCT00978731|18008940|P3|Overall Study|Death|1
5216990|NCT00978731|18008941|P2|Overall Study|Death|1
5216991|NCT00978731|18008942|P1|Overall Study|Death|4
5216992|NCT00978627|18008982|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
5216993|NCT00978627|18008983|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
5216994|NCT00978627|18008982|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
5216995|NCT00978627|18008983|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
5216996|NCT00978627|18008982|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
5216997|NCT00978627|18008983|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
5216998|NCT00978627|18008982|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
5216999|NCT00978627|18008983|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
5217000|NCT00978627|18008982|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
5217001|NCT00978627|18008983|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
5217002|NCT00978627|18008982|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
5217003|NCT00978627|18008983|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
5217004|NCT00978627|18008982|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
5217005|NCT00978627|18008983|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
5217006|NCT00978627|18008982|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
5217007|NCT00978627|18008983|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
5217008|NCT00978627|18008982|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
5217009|NCT00978627|18008983|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
5217010|NCT00978432|18009021|P3|Overall Study|Adverse Event|1
5217011|NCT00978432|18009022|P2|Overall Study|Adverse Event|0
5217012|NCT00978432|18009023|P1|Overall Study|Adverse Event|2
5217013|NCT00978432|18009021|P3|Overall Study|Lack of Efficacy|3
5217014|NCT00978432|18009022|P2|Overall Study|Lack of Efficacy|1
5217015|NCT00978432|18009023|P1|Overall Study|Lack of Efficacy|1
5217016|NCT00978432|18009021|P3|Overall Study|Withdrawal by Subject|1
5217017|NCT00978432|18009022|P2|Overall Study|Withdrawal by Subject|0
5217018|NCT00978432|18009023|P1|Overall Study|Withdrawal by Subject|0
5217019|NCT00978380|18009074|P1|Overall Study|Unclassified|8
5217020|NCT00978380|18009074|P1|Overall Study|Withdrawal criteria|9
5217021|NCT00978380|18009074|P1|Overall Study|Protocol Violation|2
5217022|NCT00978341|18009080|P2|Washout Period of 2 Weeks|Adverse Event|0
5217023|NCT00978341|18009081|P1|Washout Period of 2 Weeks|Adverse Event|1
5217024|NCT00978250|18009103|P4|Overall Study|Late determination of ineligibility|1
5217025|NCT00978250|18009104|P3|Overall Study|Late determination of ineligibility|0
5217026|NCT00978250|18009105|P2|Overall Study|Late determination of ineligibility|1
5217027|NCT00978250|18009106|P1|Overall Study|Late determination of ineligibility|0
5217028|NCT00978120|18009122|P4|Overall Study|Moved out of state|1
5217029|NCT00978120|18009123|P3|Overall Study|Moved out of state|0
5217030|NCT00978120|18009124|P2|Overall Study|Moved out of state|0
5217031|NCT00978120|18009125|P1|Overall Study|Moved out of state|0
5217032|NCT00978120|18009122|P4|Overall Study|Withdrawal by Subject|0
5217033|NCT00978120|18009123|P3|Overall Study|Withdrawal by Subject|0
5217034|NCT00978120|18009124|P2|Overall Study|Withdrawal by Subject|0
5217035|NCT00978120|18009125|P1|Overall Study|Withdrawal by Subject|2
5217036|NCT00978120|18009122|P4|Overall Study|Lost to Follow-up|0
5217037|NCT00978120|18009123|P3|Overall Study|Lost to Follow-up|3
5217038|NCT00978120|18009124|P2|Overall Study|Lost to Follow-up|0
5217039|NCT00978120|18009125|P1|Overall Study|Lost to Follow-up|0
5217040|NCT00978120|18009122|P4|Overall Study|Death|1
5217041|NCT00978120|18009123|P3|Overall Study|Death|0
5217042|NCT00978120|18009124|P2|Overall Study|Death|0
5217043|NCT00978120|18009125|P1|Overall Study|Death|0
5217044|NCT00978068|18009177|P2|Overall Study|Unable to Comply with Study|2
5217045|NCT00978068|18009178|P1|Overall Study|Unable to Comply with Study|0
5217046|NCT00978068|18009177|P2|Overall Study|Physician Decision|1
5217047|NCT00978068|18009178|P1|Overall Study|Physician Decision|0
5217048|NCT00978068|18009177|P2|Overall Study|Lost to Follow-up|2
5217049|NCT00978068|18009178|P1|Overall Study|Lost to Follow-up|1
5217050|NCT00978068|18009177|P2|Overall Study|Death|2
5217051|NCT00978068|18009178|P1|Overall Study|Death|1
5217052|NCT00978068|18009177|P2|Overall Study|Were Awaiting Initiation of ART|2
5217053|NCT00978068|18009178|P1|Overall Study|Were Awaiting Initiation of ART|2
5217054|NCT00978042|18009196|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
5217055|NCT00978042|18009197|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
5217056|NCT00978042|18009196|P2|Initial Treatment Period|Consent withdrawn|9
5217057|NCT00978042|18009197|P1|Initial Treatment Period|Consent withdrawn|22
5217058|NCT00978042|18009196|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
5217059|NCT00978042|18009197|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
5217060|NCT00978042|18009196|P2|Initial Treatment Period|Adverse Event|0
5217061|NCT00978042|18009197|P1|Initial Treatment Period|Adverse Event|2
5217062|NCT00978042|18009196|P2|Initial Treatment Period|Lost to Follow-up|3
5217063|NCT00978042|18009197|P1|Initial Treatment Period|Lost to Follow-up|21
5217064|NCT00978042|18009196|P2|Initial Treatment Period|Ineligibility|0
5217065|NCT00978042|18009197|P1|Initial Treatment Period|Ineligibility|1
5217066|NCT00978042|18009196|P2|Initial Treatment Period|Treated in Error|3
5217067|NCT00978042|18009197|P1|Initial Treatment Period|Treated in Error|0
5217068|NCT00978029|18009210|P3|Overall Study|Protocol Violation|0
5217069|NCT00978029|18009211|P2|Overall Study|Protocol Violation|1
5217070|NCT00978029|18009212|P1|Overall Study|Protocol Violation|0
5217071|NCT00978029|18009210|P3|Overall Study|Withdrawal by Subject|1
5217072|NCT00978029|18009211|P2|Overall Study|Withdrawal by Subject|0
5217073|NCT00978029|18009212|P1|Overall Study|Withdrawal by Subject|0
5217074|NCT00978029|18009210|P3|Overall Study|Adverse Event|5
5217075|NCT00978029|18009211|P2|Overall Study|Adverse Event|2
5217076|NCT00978029|18009212|P1|Overall Study|Adverse Event|1
5217077|NCT00977938|18009239|P4|Observation (30-33 mo. Post Procedure)|Other|0
5217078|NCT00977938|18009240|P3|Observation (30-33 mo. Post Procedure)|Other|0
5217079|NCT00977938|18009241|P2|Observation (30-33 mo. Post Procedure)|Other|4
5217080|NCT00977938|18009242|P1|Observation (30-33 mo. Post Procedure)|Other|8
5217081|NCT00977938|18009239|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
5217082|NCT00977938|18009240|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
5217083|NCT00977938|18009241|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
5217084|NCT00977938|18009242|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
5217085|NCT00977938|18009239|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
5217086|NCT00977938|18009240|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
5217087|NCT00977938|18009241|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
5217088|NCT00977938|18009242|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
5217089|NCT00977938|18009239|P4|Treatment (12-30 mo. Post Procedure)|Other|4
5217090|NCT00977938|18009240|P3|Treatment (12-30 mo. Post Procedure)|Other|3
5217091|NCT00977938|18009241|P2|Treatment (12-30 mo. Post Procedure)|Other|18
5217092|NCT00977938|18009242|P1|Treatment (12-30 mo. Post Procedure)|Other|17
5217093|NCT00977938|18009239|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
5217094|NCT00977938|18009240|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
5217095|NCT00977938|18009241|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
5217096|NCT00977938|18009242|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
5217097|NCT00977938|18009239|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
5217098|NCT00977938|18009240|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
5217099|NCT00977938|18009241|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
5217100|NCT00977938|18009242|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
5217101|NCT00977665|18009319|P2|Overall Study|Treatment failure|1
5217102|NCT00977665|18009320|P1|Overall Study|Treatment failure|0
5217103|NCT00977665|18009319|P2|Overall Study|Adverse Event|7
5217104|NCT00977665|18009320|P1|Overall Study|Adverse Event|14
5217105|NCT00977665|18009319|P2|Overall Study|Death|2
5217106|NCT00977665|18009320|P1|Overall Study|Death|3
5217107|NCT00977665|18009319|P2|Overall Study|Lost to Follow-up|0
5217108|NCT00977665|18009320|P1|Overall Study|Lost to Follow-up|1
5217109|NCT00977665|18009319|P2|Overall Study|Sponsor requested withdrawal|1
5217110|NCT00977665|18009320|P1|Overall Study|Sponsor requested withdrawal|0
5217111|NCT00977665|18009319|P2|Overall Study|Physician Decision|1
5217112|NCT00977665|18009320|P1|Overall Study|Physician Decision|2
5217113|NCT00977665|18009319|P2|Overall Study|Withdrawal by Subject|3
5217114|NCT00977665|18009320|P1|Overall Study|Withdrawal by Subject|1
5217115|NCT00977613|18009352|P1|Overall Study|Lost to Follow-up|16
5217116|NCT00977574|18009359|P3|Overall Study|Never Treated|4
5217117|NCT00977574|18009360|P2|Overall Study|Never Treated|2
5217118|NCT00977574|18009361|P1|Overall Study|Never Treated|4
5217119|NCT00977561|18009380|P2|Overall Study|Other|0
5217120|NCT00977561|18009381|P1|Overall Study|Other|2
5217121|NCT00977561|18009380|P2|Overall Study|Study terminated|2
5217122|NCT00977561|18009381|P1|Overall Study|Study terminated|0
5217123|NCT00977561|18009380|P2|Overall Study|Death|2
5217124|NCT00977561|18009381|P1|Overall Study|Death|3
5217125|NCT00977548|18009408|P1|Overall Study|Withdrawal by Subject|1
5217126|NCT00977548|18009408|P1|Overall Study|Adverse Event|8
5217127|NCT00977548|18009408|P1|Overall Study|Ineligible|4
5217128|NCT00977470|18009417|P2|Overall Study|Still on-study|0
5217129|NCT00977470|18009418|P1|Overall Study|Still on-study|2
5217130|NCT00977470|18009417|P2|Overall Study|prolonged recovery post-surgery|1
5217131|NCT00977470|18009418|P1|Overall Study|prolonged recovery post-surgery|0
5217132|NCT00977470|18009417|P2|Overall Study|clinical decline|1
5217133|NCT00977470|18009418|P1|Overall Study|clinical decline|0
5217134|NCT00977470|18009417|P2|Overall Study|Death|2
5217135|NCT00977470|18009418|P1|Overall Study|Death|0
5217136|NCT00977470|18009417|P2|Overall Study|Withdrawal by Subject|2
5217137|NCT00977470|18009418|P1|Overall Study|Withdrawal by Subject|0
5217138|NCT00977470|18009417|P2|Overall Study|Protocol Violation|0
5217139|NCT00977470|18009418|P1|Overall Study|Protocol Violation|1
5217140|NCT00977470|18009417|P2|Overall Study|Adverse Event|2
5217141|NCT00977470|18009418|P1|Overall Study|Adverse Event|1
5217142|NCT00977470|18009417|P2|Overall Study|Physician Decision|0
5217143|NCT00977470|18009418|P1|Overall Study|Physician Decision|2
5217144|NCT00977470|18009417|P2|Overall Study|Lack of Efficacy|30
5217145|NCT00977470|18009418|P1|Overall Study|Lack of Efficacy|32
5217146|NCT00977431|18009441|P5|Overall Study|Progressive disease|5
5217147|NCT00977431|18009442|P4|Overall Study|Progressive disease|3
5217148|NCT00977431|18009443|P3|Overall Study|Progressive disease|1
5217149|NCT00977431|18009444|P2|Overall Study|Progressive disease|6
5217150|NCT00977431|18009445|P1|Overall Study|Progressive disease|2
5217151|NCT00977431|18009441|P5|Overall Study|Dose-limiting toxicity (DLT)|0
5217152|NCT00977431|18009442|P4|Overall Study|Dose-limiting toxicity (DLT)|0
5217153|NCT00977431|18009443|P3|Overall Study|Dose-limiting toxicity (DLT)|1
5217154|NCT00977431|18009444|P2|Overall Study|Dose-limiting toxicity (DLT)|0
5217155|NCT00977431|18009445|P1|Overall Study|Dose-limiting toxicity (DLT)|1
5217156|NCT00977431|18009441|P5|Overall Study|Adverse Event|6
5217157|NCT00977431|18009442|P4|Overall Study|Adverse Event|0
5217158|NCT00977431|18009443|P3|Overall Study|Adverse Event|4
5217159|NCT00977431|18009444|P2|Overall Study|Adverse Event|0
5217160|NCT00977431|18009445|P1|Overall Study|Adverse Event|3
5217161|NCT00977431|18009441|P5|Overall Study|Protocol Violation|0
5217162|NCT00977431|18009442|P4|Overall Study|Protocol Violation|0
5217163|NCT00977431|18009443|P3|Overall Study|Protocol Violation|1
5217164|NCT00977431|18009444|P2|Overall Study|Protocol Violation|0
5217165|NCT00977431|18009445|P1|Overall Study|Protocol Violation|0
5217166|NCT00977431|18009441|P5|Overall Study|Other than listed|2
5217167|NCT00977431|18009442|P4|Overall Study|Other than listed|0
5217168|NCT00977431|18009443|P3|Overall Study|Other than listed|0
5217169|NCT00977431|18009444|P2|Overall Study|Other than listed|0
5217170|NCT00977431|18009445|P1|Overall Study|Other than listed|1
5217171|NCT00977379|18009478|P2|Overall Study|Randomization Error|1
5217172|NCT00977379|18009479|P1|Overall Study|Randomization Error|0
5217173|NCT00977379|18009478|P2|Overall Study|Participant Moving House|1
5217174|NCT00977379|18009479|P1|Overall Study|Participant Moving House|0
5217175|NCT00977379|18009478|P2|Overall Study|Premature Study Termination|0
5217176|NCT00977379|18009479|P1|Overall Study|Premature Study Termination|4
5217177|NCT00977379|18009478|P2|Overall Study|Death|9
5217178|NCT00977379|18009479|P1|Overall Study|Death|7
5217179|NCT00977379|18009478|P2|Overall Study|Withdrawal by Subject|1
5217180|NCT00977379|18009479|P1|Overall Study|Withdrawal by Subject|1
5217181|NCT00977314|18009515|P2|Overall Study|Physician Decision|0
5217182|NCT00977314|18009516|P1|Overall Study|Physician Decision|1
5217183|NCT00977314|18009515|P2|Overall Study|Withdrawal by Subject|0
5217184|NCT00977314|18009516|P1|Overall Study|Withdrawal by Subject|1
5217185|NCT00977197|18009524|P2|Overall Study|Nonadherence|1
5217186|NCT00977197|18009525|P1|Overall Study|Nonadherence|1
5217187|NCT00977197|18009524|P2|Overall Study|Lost to Follow-up|3
5217188|NCT00977197|18009525|P1|Overall Study|Lost to Follow-up|1
5217189|NCT00977197|18009524|P2|Overall Study|Lack of Efficacy|0
5217190|NCT00977197|18009525|P1|Overall Study|Lack of Efficacy|1
5217191|NCT00977197|18009524|P2|Overall Study|Adverse Event|1
5217192|NCT00977197|18009525|P1|Overall Study|Adverse Event|3
5217193|NCT00977197|18009524|P2|Overall Study|Withdrawal by Subject|4
5217194|NCT00977197|18009525|P1|Overall Study|Withdrawal by Subject|3
5217195|NCT00977106|18009588|P2|Overall Study|Other|0
5217196|NCT00977106|18009589|P1|Overall Study|Other|1
5217197|NCT00977106|18009588|P2|Overall Study|Protocol Violation|1
5217198|NCT00977106|18009589|P1|Overall Study|Protocol Violation|0
5217199|NCT00977106|18009588|P2|Overall Study|Lack of Efficacy|2
5217200|NCT00977106|18009589|P1|Overall Study|Lack of Efficacy|2
5217201|NCT00977106|18009588|P2|Overall Study|Withdrawal by Subject|2
5217202|NCT00977106|18009589|P1|Overall Study|Withdrawal by Subject|2
5217203|NCT00977106|18009588|P2|Overall Study|Adverse Event|6
5217204|NCT00977106|18009589|P1|Overall Study|Adverse Event|5
5217205|NCT00977080|18009681|P4|Overall Study|Travel for family reasons|0
5217206|NCT00977080|18009682|P3|Overall Study|Travel for family reasons|0
5217207|NCT00977080|18009683|P2|Overall Study|Travel for family reasons|0
5217208|NCT00977080|18009684|P1|Overall Study|Travel for family reasons|1
5217209|NCT00977080|18009681|P4|Overall Study|Required kidney transplantation|1
5217210|NCT00977080|18009682|P3|Overall Study|Required kidney transplantation|3
5217211|NCT00977080|18009683|P2|Overall Study|Required kidney transplantation|3
5217212|NCT00977080|18009684|P1|Overall Study|Required kidney transplantation|1
5217213|NCT00977080|18009681|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
5217214|NCT00977080|18009682|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5217215|NCT00977080|18009683|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5217216|NCT00977080|18009684|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5217217|NCT00977080|18009681|P4|Overall Study|Noncompliance|0
5217218|NCT00977080|18009682|P3|Overall Study|Noncompliance|1
5217219|NCT00977080|18009683|P2|Overall Study|Noncompliance|2
5217220|NCT00977080|18009684|P1|Overall Study|Noncompliance|0
5217221|NCT00977080|18009681|P4|Overall Study|Protocol Violation|3
5217222|NCT00977080|18009682|P3|Overall Study|Protocol Violation|4
5217223|NCT00977080|18009683|P2|Overall Study|Protocol Violation|3
5217224|NCT00977080|18009684|P1|Overall Study|Protocol Violation|7
5217225|NCT00977080|18009681|P4|Overall Study|Withdrawal by Subject|5
5217226|NCT00977080|18009682|P3|Overall Study|Withdrawal by Subject|1
5217227|NCT00977080|18009683|P2|Overall Study|Withdrawal by Subject|5
5217228|NCT00977080|18009684|P1|Overall Study|Withdrawal by Subject|1
5217229|NCT00977080|18009681|P4|Overall Study|Adverse Event|7
5217230|NCT00977080|18009682|P3|Overall Study|Adverse Event|7
5217231|NCT00977080|18009683|P2|Overall Study|Adverse Event|7
5217232|NCT00977080|18009684|P1|Overall Study|Adverse Event|2
5217233|NCT00976989|18009717|P3|Overall Study|Other|1
5217234|NCT00976989|18009718|P2|Overall Study|Other|0
5217235|NCT00976989|18009719|P1|Overall Study|Other|1
5217236|NCT00976989|18009717|P3|Overall Study|Recurrence of Disease|0
5217237|NCT00976989|18009718|P2|Overall Study|Recurrence of Disease|1
5217238|NCT00976989|18009719|P1|Overall Study|Recurrence of Disease|0
5217239|NCT00976989|18009717|P3|Overall Study|Failure to Return|0
5217240|NCT00976989|18009718|P2|Overall Study|Failure to Return|1
5217241|NCT00976989|18009719|P1|Overall Study|Failure to Return|2
5217242|NCT00976989|18009717|P3|Overall Study|Refused Treatment|5
5217243|NCT00976989|18009718|P2|Overall Study|Refused Treatment|3
5217244|NCT00976989|18009719|P1|Overall Study|Refused Treatment|4
5217245|NCT00976989|18009717|P3|Overall Study|Death|10
5217246|NCT00976989|18009718|P2|Overall Study|Death|7
5217247|NCT00976989|18009719|P1|Overall Study|Death|5
5217248|NCT00976989|18009717|P3|Overall Study|Violation of Selection Criteria at Entry|1
5217249|NCT00976989|18009718|P2|Overall Study|Violation of Selection Criteria at Entry|0
5217250|NCT00976989|18009719|P1|Overall Study|Violation of Selection Criteria at Entry|1
5217251|NCT00976950|18009760|P1|Overall Study|Events with no relationship to Aptivus|3
5217252|NCT00976950|18009760|P1|Overall Study|Adverse Event|3
5217253|NCT00976937|18009768|P2|Overall Study|Personal and Familial Reason|2
5217254|NCT00976937|18009769|P1|Overall Study|Personal and Familial Reason|2
5217255|NCT00976937|18009768|P2|Overall Study|Poor compliance to protocol|0
5217256|NCT00976937|18009769|P1|Overall Study|Poor compliance to protocol|3
5217257|NCT00976937|18009768|P2|Overall Study|Withdrawal by Subject|3
5217258|NCT00976937|18009769|P1|Overall Study|Withdrawal by Subject|5
5217259|NCT00976937|18009768|P2|Overall Study|Lost to Follow-up|1
5217260|NCT00976937|18009769|P1|Overall Study|Lost to Follow-up|2
5217261|NCT00976937|18009768|P2|Overall Study|Adverse Event|5
5217262|NCT00976937|18009769|P1|Overall Study|Adverse Event|4
5217263|NCT00976911|18009811|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
5217264|NCT00976911|18009812|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
5217265|NCT00976911|18009811|P2|Overall Study|Other|9
5217266|NCT00976911|18009812|P1|Overall Study|Other|8
5217267|NCT00976911|18009811|P2|Overall Study|Protocol Violation|0
5217268|NCT00976911|18009812|P1|Overall Study|Protocol Violation|2
5217269|NCT00976911|18009811|P2|Overall Study|Adverse Event|1
5217270|NCT00976911|18009812|P1|Overall Study|Adverse Event|0
5217271|NCT00976911|18009811|P2|Overall Study|Death|126
5217272|NCT00976911|18009812|P1|Overall Study|Death|138
5217273|NCT00976911|18009811|P2|Overall Study|Withdrawal by Subject|6
5217274|NCT00976911|18009812|P1|Overall Study|Withdrawal by Subject|4
5217275|NCT00976898|18009830|P1|Overall Study|Progressive Disease|1
5217276|NCT00976898|18009830|P1|Overall Study|Liver Transplant|1
5217277|NCT00976898|18009830|P1|Overall Study|Physician Decision|1
5217278|NCT00976898|18009830|P1|Overall Study|Adverse Event|1
5217279|NCT00976898|18009830|P1|Overall Study|Protocol Violation|1
5217280|NCT00976820|18009841|P4|Overall Study|Withdrawal by Subject|4
5217281|NCT00976820|18009842|P3|Overall Study|Withdrawal by Subject|1
5217282|NCT00976820|18009843|P2|Overall Study|Withdrawal by Subject|4
5217283|NCT00976820|18009844|P1|Overall Study|Withdrawal by Subject|2
5217284|NCT00976820|18009841|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
5217285|NCT00976820|18009842|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
5217286|NCT00976820|18009843|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
5217287|NCT00976820|18009844|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
5217288|NCT00976820|18009841|P4|Overall Study|Lost to Follow-up|3
5217289|NCT00976820|18009842|P3|Overall Study|Lost to Follow-up|2
5217290|NCT00976820|18009843|P2|Overall Study|Lost to Follow-up|16
5217291|NCT00976820|18009844|P1|Overall Study|Lost to Follow-up|5
5217292|NCT00976716|18010180|P1|Overall Study|Adverse Event|1
5217293|NCT00976703|18010198|P2|Overall Study|ineligible for study|2
5217294|NCT00976703|18010199|P1|Overall Study|ineligible for study|2
5217295|NCT00976703|18010198|P2|Overall Study|Physician Decision|1
5217296|NCT00976703|18010199|P1|Overall Study|Physician Decision|1
5217297|NCT00976677|18010213|P2|Overall Study|Unknown/Missing|0
5217298|NCT00976677|18010214|P1|Overall Study|Unknown/Missing|1
5217299|NCT00976677|18010213|P2|Overall Study|Trial unblinded|2
5217300|NCT00976677|18010214|P1|Overall Study|Trial unblinded|2
5217301|NCT00976677|18010213|P2|Overall Study|Disease progression|1
5217302|NCT00976677|18010214|P1|Overall Study|Disease progression|1
5217303|NCT00976677|18010213|P2|Overall Study|Withdrawal by Subject|2
5217304|NCT00976677|18010214|P1|Overall Study|Withdrawal by Subject|0
5217305|NCT00976677|18010213|P2|Overall Study|Adverse Event|0
5217306|NCT00976677|18010214|P1|Overall Study|Adverse Event|1
5217307|NCT00976573|18010422|P2|Overall Study|Cancel prior to receiving treatment|2
5217308|NCT00976573|18010423|P1|Overall Study|Cancel prior to receiving treatment|4
5217309|NCT00976573|18010422|P2|Overall Study|Ineligible|1
5217310|NCT00976573|18010423|P1|Overall Study|Ineligible|0
5217311|NCT00976560|18010437|P2|Overall Study|Withdrawal by Subject|3
5217312|NCT00976560|18010438|P1|Overall Study|Withdrawal by Subject|2
5217313|NCT00976560|18010437|P2|Overall Study|Physician Decision|0
5217314|NCT00976560|18010438|P1|Overall Study|Physician Decision|2
5217315|NCT00976560|18010437|P2|Overall Study|Lost to Follow-up|0
5217316|NCT00976560|18010438|P1|Overall Study|Lost to Follow-up|1
5217317|NCT00976560|18010437|P2|Overall Study|Protocol Violation|0
5217318|NCT00976560|18010438|P1|Overall Study|Protocol Violation|1
5217319|NCT00976560|18010437|P2|Overall Study|Lack of Efficacy|5
5217320|NCT00976560|18010438|P1|Overall Study|Lack of Efficacy|3
5217321|NCT00976560|18010437|P2|Overall Study|Adverse Event|5
5217322|NCT00976560|18010438|P1|Overall Study|Adverse Event|5
5217323|NCT00976508|18010507|P2|Overall Study|Terminated by the Sponsor|1
5217324|NCT00976508|18010508|P1|Overall Study|Terminated by the Sponsor|0
5217325|NCT00976508|18010507|P2|Overall Study|Subject Enrolled in Hospice|0
5217326|NCT00976508|18010508|P1|Overall Study|Subject Enrolled in Hospice|1
5217327|NCT00976508|18010507|P2|Overall Study|Disease Progression|4
5217328|NCT00976508|18010508|P1|Overall Study|Disease Progression|4
5217329|NCT00976508|18010507|P2|Overall Study|Withdrawal by Subject|0
5217330|NCT00976508|18010508|P1|Overall Study|Withdrawal by Subject|1
5217331|NCT00976508|18010507|P2|Overall Study|Lost to Follow-up|0
5217332|NCT00976508|18010508|P1|Overall Study|Lost to Follow-up|1
5217333|NCT00976508|18010507|P2|Overall Study|Death|1
5217334|NCT00976508|18010508|P1|Overall Study|Death|7
5217335|NCT00976495|18010541|P3|Overall Study|Withdrawal by Subject|0
5217336|NCT00976495|18010542|P2|Overall Study|Withdrawal by Subject|1
5217337|NCT00976495|18010543|P1|Overall Study|Withdrawal by Subject|0
5217338|NCT00976482|18010560|P1|Overall Study|Protocol Violation|5
5217339|NCT00976482|18010560|P1|Overall Study|Center terminated|1
5217340|NCT00976482|18010560|P1|Overall Study|Withdrawal by Subject|45
5217341|NCT00976482|18010560|P1|Overall Study|Death|208
5217342|NCT00976456|18010566|P2|Overall Study|screening failure, unknown|4
5217343|NCT00976456|18010567|P1|Overall Study|screening failure, unknown|11
5217344|NCT00976456|18010566|P2|Overall Study|Withdrawal by Subject|1
5217345|NCT00976456|18010567|P1|Overall Study|Withdrawal by Subject|3
5217346|NCT00976456|18010566|P2|Overall Study|Lack of Efficacy|2
5217347|NCT00976456|18010567|P1|Overall Study|Lack of Efficacy|5
5217348|NCT00976456|18010566|P2|Overall Study|Death|9
5217349|NCT00976456|18010567|P1|Overall Study|Death|7
5217350|NCT00976456|18010566|P2|Overall Study|Adverse Event|22
5217351|NCT00976456|18010567|P1|Overall Study|Adverse Event|17
5217352|NCT00976391|18010594|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5217353|NCT00976391|18010595|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
5217354|NCT00976391|18010594|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
5217355|NCT00976391|18010595|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
5217356|NCT00976391|18010594|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
5217357|NCT00976391|18010595|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
5217358|NCT00976391|18010594|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
5217359|NCT00976391|18010595|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
5217360|NCT00976391|18010594|P2|Follow-up Period (8 Weeks)|Noncompliance|2
5217361|NCT00976391|18010595|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5217362|NCT00976391|18010594|P2|Follow-up Period (8 Weeks)|Adverse Event|1
5217363|NCT00976391|18010595|P1|Follow-up Period (8 Weeks)|Adverse Event|3
5217364|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Pregnancy|0
5217365|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Pregnancy|1
5217366|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
5217367|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
5217368|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Physician Decision|1
5217369|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Physician Decision|1
5217370|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
5217371|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
5217372|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
5217373|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
5217374|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Noncompliance|4
5217375|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Noncompliance|4
5217376|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Protocol Violation|1
5217377|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Protocol Violation|1
5217378|NCT00976391|18010594|P2|Treatment Period (52 Weeks)|Adverse Event|2
5217379|NCT00976391|18010595|P1|Treatment Period (52 Weeks)|Adverse Event|16
5217380|NCT00976274|18010643|P2|Overall Study|Physician Decision|2
5217381|NCT00976274|18010644|P1|Overall Study|Physician Decision|1
5217382|NCT00976274|18010643|P2|Overall Study|Withdrawal by Subject|1
5217383|NCT00976274|18010644|P1|Overall Study|Withdrawal by Subject|1
5217384|NCT00976274|18010643|P2|Overall Study|Lost to Follow-up|5
5217385|NCT00976274|18010644|P1|Overall Study|Lost to Follow-up|5
5217386|NCT00976209|18010660|P2|Treatment Period 2|Lost to Follow-up|1
5217387|NCT00976209|18010661|P1|Treatment Period 2|Lost to Follow-up|0
5217388|NCT00976209|18010660|P2|Treatment Period 2|Withdrawal by Subject|1
5217389|NCT00976209|18010661|P1|Treatment Period 2|Withdrawal by Subject|0
5217390|NCT00976209|18010660|P2|Wash-out Period|Other|0
5217391|NCT00976209|18010661|P1|Wash-out Period|Other|1
5217392|NCT00976209|18010660|P2|Wash-out Period|Protocol Violation|0
5217393|NCT00976209|18010661|P1|Wash-out Period|Protocol Violation|1
5217394|NCT00976209|18010660|P2|Wash-out Period|Lost to Follow-up|0
5217395|NCT00976209|18010661|P1|Wash-out Period|Lost to Follow-up|1
5217396|NCT00976209|18010660|P2|Wash-out Period|Adverse Event|2
5217397|NCT00976209|18010661|P1|Wash-out Period|Adverse Event|1
5217398|NCT00976209|18010660|P2|Treatment Period 1|Other|1
5217399|NCT00976209|18010661|P1|Treatment Period 1|Other|0
5217400|NCT00976209|18010660|P2|Treatment Period 1|Lost to Follow-up|0
5217401|NCT00976209|18010661|P1|Treatment Period 1|Lost to Follow-up|2
5217402|NCT00976209|18010660|P2|Treatment Period 1|Protocol Violation|0
5217403|NCT00976209|18010661|P1|Treatment Period 1|Protocol Violation|1
5217404|NCT00976027|18010674|P2|Overall Study|Withdrawal by Subject|66
5217405|NCT00976027|18010675|P1|Overall Study|Withdrawal by Subject|107
5217406|NCT00976027|18010674|P2|Overall Study|Lost to Follow-up|103
5217407|NCT00976027|18010675|P1|Overall Study|Lost to Follow-up|208
5217408|NCT00976027|18010674|P2|Overall Study|Protocol Violation|27
5217409|NCT00976027|18010675|P1|Overall Study|Protocol Violation|60
5217410|NCT00976027|18010674|P2|Overall Study|Adverse Event|2
5217411|NCT00976027|18010675|P1|Overall Study|Adverse Event|0
5217412|NCT00976027|18010674|P2|Overall Study|Serious Adverse Event|17
5217413|NCT00976027|18010675|P1|Overall Study|Serious Adverse Event|36
5217414|NCT00975975|18010687|P1|Overall Study|Death|6
5217415|NCT00975923|18010695|P2|Overall Study|Withdrawal by Subject|1
5217416|NCT00975923|18010696|P1|Overall Study|Withdrawal by Subject|0
5217417|NCT00975884|18010706|P2|Overall Study|Other|3
5217418|NCT00975884|18010707|P1|Overall Study|Other|1
5217419|NCT00975884|18010706|P2|Overall Study|Withdrawal by Subject|9
5217420|NCT00975884|18010707|P1|Overall Study|Withdrawal by Subject|9
5217421|NCT00975884|18010706|P2|Overall Study|Lost to Follow-up|3
5217422|NCT00975884|18010707|P1|Overall Study|Lost to Follow-up|5
5217423|NCT00975884|18010706|P2|Overall Study|Adverse Event|0
5217424|NCT00975884|18010707|P1|Overall Study|Adverse Event|1
5217425|NCT00975806|18010864|P3|Overall Study|Physician decision and disease related|1
5217426|NCT00975806|18010865|P2|Overall Study|Physician decision and disease related|0
5217427|NCT00975806|18010866|P1|Overall Study|Physician decision and disease related|1
5217428|NCT00975806|18010864|P3|Overall Study|Death|0
5217429|NCT00975806|18010865|P2|Overall Study|Death|1
5217430|NCT00975806|18010866|P1|Overall Study|Death|0
5217431|NCT00975806|18010864|P3|Overall Study|Withdrawal by Subject|0
5217432|NCT00975806|18010865|P2|Overall Study|Withdrawal by Subject|0
5217433|NCT00975806|18010866|P1|Overall Study|Withdrawal by Subject|1
5217434|NCT00975806|18010864|P3|Overall Study|Disease Progression|1
5217435|NCT00975806|18010865|P2|Overall Study|Disease Progression|5
5217436|NCT00975806|18010866|P1|Overall Study|Disease Progression|1
5217437|NCT00975806|18010864|P3|Overall Study|Adverse Event|2
5217438|NCT00975806|18010865|P2|Overall Study|Adverse Event|1
5217439|NCT00975806|18010866|P1|Overall Study|Adverse Event|2
5217440|NCT00975780|18010890|P2|Follow Up|Discharged from Facility|12
5217441|NCT00975780|18010891|P1|Follow Up|Discharged from Facility|7
5217442|NCT00975780|18010890|P2|Follow Up|Facility Withdrawal|23
5217443|NCT00975780|18010891|P1|Follow Up|Facility Withdrawal|7
5217444|NCT00975780|18010890|P2|Follow Up|Death|122
5217445|NCT00975780|18010891|P1|Follow Up|Death|88
5217446|NCT00975715|18010901|P2|Maintenance Period|Adverse Event|1
5217447|NCT00975715|18010902|P1|Maintenance Period|Adverse Event|2
5217448|NCT00975715|18010901|P2|Titration Period|Protocol Violation|0
5217449|NCT00975715|18010902|P1|Titration Period|Protocol Violation|1
5217450|NCT00975715|18010901|P2|Titration Period|Adverse Event|0
5217451|NCT00975715|18010902|P1|Titration Period|Adverse Event|6
5217452|NCT00975689|18010918|P2|Overall Study|Physician Decision|0
5217453|NCT00975689|18010919|P1|Overall Study|Physician Decision|1
5217454|NCT00975689|18010918|P2|Overall Study|Withdrawal by Subject|0
5217455|NCT00975689|18010919|P1|Overall Study|Withdrawal by Subject|1
5217456|NCT00975689|18010918|P2|Overall Study|Adverse Event|3
5217457|NCT00975689|18010919|P1|Overall Study|Adverse Event|0
5217458|NCT00975611|18010988|P1|Overall Study|Physician Decision|1
5217459|NCT00975611|18010988|P1|Overall Study|Screen Fail|16
5217460|NCT00975585|18010994|P2|Overall Study|Lens issue|2
5217461|NCT00975585|18010995|P1|Overall Study|Lens issue|2
5217462|NCT00975585|18010994|P2|Overall Study|Withdrawal by Subject|1
5217463|NCT00975585|18010995|P1|Overall Study|Withdrawal by Subject|2
5217464|NCT00975585|18010994|P2|Overall Study|Lost to Follow-up|5
5217465|NCT00975585|18010995|P1|Overall Study|Lost to Follow-up|3
5217466|NCT00975585|18010994|P2|Overall Study|Adverse Event|4
5217467|NCT00975585|18010995|P1|Overall Study|Adverse Event|0
5217468|NCT00975507|18011015|P2|Overall Study|Withdrawal by Subject|3
5217469|NCT00975507|18011016|P1|Overall Study|Withdrawal by Subject|10
5217470|NCT00975507|18011015|P2|Overall Study|Protocol Violation|0
5217471|NCT00975507|18011016|P1|Overall Study|Protocol Violation|2
5217472|NCT00975507|18011015|P2|Overall Study|Lost to Follow-up|1
5217473|NCT00975507|18011016|P1|Overall Study|Lost to Follow-up|7
5217474|NCT00975507|18011015|P2|Overall Study|Adverse Event|0
5217475|NCT00975507|18011016|P1|Overall Study|Adverse Event|1
5217476|NCT00975481|18011036|P6|Fifth Intervention Period|Withdrawal by Subject|0
5217477|NCT00975481|18011037|P5|Fifth Intervention Period|Withdrawal by Subject|1
5217478|NCT00975481|18011038|P4|Fifth Intervention Period|Withdrawal by Subject|0
5217479|NCT00975481|18011039|P3|Fifth Intervention Period|Withdrawal by Subject|0
5217480|NCT00975481|18011040|P2|Fifth Intervention Period|Withdrawal by Subject|0
5217481|NCT00975481|18011041|P1|Fifth Intervention Period|Withdrawal by Subject|0
5217482|NCT00975481|18011036|P6|Fourth Intervention Period|Withdrawal by Subject|0
5217483|NCT00975481|18011037|P5|Fourth Intervention Period|Withdrawal by Subject|0
5217484|NCT00975481|18011038|P4|Fourth Intervention Period|Withdrawal by Subject|1
5217485|NCT00975481|18011039|P3|Fourth Intervention Period|Withdrawal by Subject|1
5217486|NCT00975481|18011040|P2|Fourth Intervention Period|Withdrawal by Subject|0
5217487|NCT00975481|18011041|P1|Fourth Intervention Period|Withdrawal by Subject|0
5217488|NCT00975481|18011036|P6|Second Intervention Period|Withdrawal by Subject|0
5217489|NCT00975481|18011037|P5|Second Intervention Period|Withdrawal by Subject|0
5217490|NCT00975481|18011038|P4|Second Intervention Period|Withdrawal by Subject|0
5217491|NCT00975481|18011039|P3|Second Intervention Period|Withdrawal by Subject|1
5217492|NCT00975481|18011040|P2|Second Intervention Period|Withdrawal by Subject|0
5217493|NCT00975481|18011041|P1|Second Intervention Period|Withdrawal by Subject|0
5217494|NCT00975481|18011036|P6|Second Intervention Period|Adverse Event|0
5217495|NCT00975481|18011037|P5|Second Intervention Period|Adverse Event|0
5217496|NCT00975481|18011038|P4|Second Intervention Period|Adverse Event|0
5217497|NCT00975481|18011039|P3|Second Intervention Period|Adverse Event|0
5217498|NCT00975481|18011040|P2|Second Intervention Period|Adverse Event|1
5217499|NCT00975481|18011041|P1|Second Intervention Period|Adverse Event|2
5217500|NCT00975416|18011141|P2|Overall Study|early discharge from tx|5
5217501|NCT00975416|18011142|P1|Overall Study|early discharge from tx|3
5217502|NCT00975286|18011151|P2|Overall Study|Sponsor Decision|2
5217503|NCT00975286|18011152|P1|Overall Study|Sponsor Decision|0
5217504|NCT00975286|18011151|P2|Overall Study|Poor Compliance to Protocol|2
5217505|NCT00975286|18011152|P1|Overall Study|Poor Compliance to Protocol|0
5217506|NCT00975286|18011151|P2|Overall Study|Familial and Personal Reasons|2
5217507|NCT00975286|18011152|P1|Overall Study|Familial and Personal Reasons|2
5217508|NCT00975286|18011151|P2|Overall Study|Withdrawal by Subject|2
5217509|NCT00975286|18011152|P1|Overall Study|Withdrawal by Subject|0
5217510|NCT00975286|18011151|P2|Overall Study|Protocol Violation|2
5217511|NCT00975286|18011152|P1|Overall Study|Protocol Violation|1
5217512|NCT00975286|18011151|P2|Overall Study|Adverse Event|19
5217513|NCT00975286|18011152|P1|Overall Study|Adverse Event|9
5217514|NCT00975221|18011184|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
5217515|NCT00975221|18011185|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
5217516|NCT00975221|18011184|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
5217517|NCT00975221|18011185|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
5217518|NCT00975221|18011184|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
5217519|NCT00975221|18011185|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
5217520|NCT00975221|18011184|P2|Titration Phase (Weeks 1-12)|Other|1
5217521|NCT00975221|18011185|P1|Titration Phase (Weeks 1-12)|Other|0
5217522|NCT00975221|18011184|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
5217523|NCT00975221|18011185|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
5217524|NCT00975221|18011184|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
5217525|NCT00975221|18011185|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
5217526|NCT00975195|18011201|P2|Overall Study|Not treated|2
5217527|NCT00975195|18011202|P1|Overall Study|Not treated|1
5217528|NCT00975195|18011201|P2|Overall Study|Other reason not defined above|33
5217529|NCT00975195|18011202|P1|Overall Study|Other reason not defined above|29
5217530|NCT00975195|18011201|P2|Overall Study|Withdrawal by Subject|61
5217531|NCT00975195|18011202|P1|Overall Study|Withdrawal by Subject|48
5217532|NCT00975195|18011201|P2|Overall Study|Lost to Follow-up|7
5217533|NCT00975195|18011202|P1|Overall Study|Lost to Follow-up|9
5217534|NCT00975195|18011201|P2|Overall Study|Protocol Violation|23
5217535|NCT00975195|18011202|P1|Overall Study|Protocol Violation|27
5217536|NCT00975195|18011201|P2|Overall Study|Lack of Efficacy|6
5217537|NCT00975195|18011202|P1|Overall Study|Lack of Efficacy|6
5217538|NCT00975195|18011201|P2|Overall Study|Adverse Event|101
5217539|NCT00975195|18011202|P1|Overall Study|Adverse Event|108
5217540|NCT00975156|18011262|P2|Overall Study|Protocol Violation|1
5217541|NCT00975156|18011263|P1|Overall Study|Protocol Violation|0
5217542|NCT00975143|18011275|P2|Overall Study|Details not available|4
5217543|NCT00975143|18011276|P1|Overall Study|Details not available|10
5217544|NCT00975143|18011275|P2|Overall Study|Physician Decision|2
5217545|NCT00975143|18011276|P1|Overall Study|Physician Decision|1
5217546|NCT00975143|18011275|P2|Overall Study|Non-compliance|8
5217547|NCT00975143|18011276|P1|Overall Study|Non-compliance|5
5217548|NCT00975143|18011275|P2|Overall Study|Lost to Follow-up|16
5217549|NCT00975143|18011276|P1|Overall Study|Lost to Follow-up|20
5217550|NCT00975143|18011275|P2|Overall Study|Withdrawal by Subject|15
5217551|NCT00975143|18011276|P1|Overall Study|Withdrawal by Subject|15
5217552|NCT00975143|18011275|P2|Overall Study|Adverse Event|15
5217553|NCT00975143|18011276|P1|Overall Study|Adverse Event|19
5217554|NCT00975130|18011286|P3|Study Part 2|Protocol Violation|1
5217555|NCT00975130|18011287|P2|Study Part 2|Protocol Violation|0
5217556|NCT00975130|18011288|P1|Study Part 2|Protocol Violation|0
5217557|NCT00975130|18011286|P3|Study Part 2|Administrative|0
5217558|NCT00975130|18011287|P2|Study Part 2|Administrative|1
5217559|NCT00975130|18011288|P1|Study Part 2|Administrative|0
5217560|NCT00975130|18011286|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
5217561|NCT00975130|18011287|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
5217562|NCT00975130|18011288|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
5217563|NCT00975130|18011286|P3|Study Part 2|Withdrew Consent|2
5217564|NCT00975130|18011287|P2|Study Part 2|Withdrew Consent|6
5217565|NCT00975130|18011288|P1|Study Part 2|Withdrew Consent|0
5217566|NCT00975130|18011286|P3|Study Part 2|Withdrawal by Subject|5
5217567|NCT00975130|18011287|P2|Study Part 2|Withdrawal by Subject|13
5217568|NCT00975130|18011288|P1|Study Part 2|Withdrawal by Subject|0
5217569|NCT00975130|18011286|P3|Study Part 2|Lost to Follow-up|1
5217570|NCT00975130|18011287|P2|Study Part 2|Lost to Follow-up|0
5217571|NCT00975130|18011288|P1|Study Part 2|Lost to Follow-up|0
5217572|NCT00975130|18011286|P3|Study Part 2|Adverse Event|7
5217573|NCT00975130|18011287|P2|Study Part 2|Adverse Event|14
5217574|NCT00975130|18011288|P1|Study Part 2|Adverse Event|0
5217575|NCT00975130|18011286|P3|Study Part 1|Withdrew Consent|0
5217576|NCT00975130|18011287|P2|Study Part 1|Withdrew Consent|0
5217577|NCT00975130|18011288|P1|Study Part 1|Withdrew Consent|24
5217578|NCT00975130|18011286|P3|Study Part 1|Administrative|0
5217579|NCT00975130|18011287|P2|Study Part 1|Administrative|0
5217580|NCT00975130|18011288|P1|Study Part 1|Administrative|4
5217581|NCT00975130|18011286|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
5217582|NCT00975130|18011287|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
5217583|NCT00975130|18011288|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
5217584|NCT00975130|18011286|P3|Study Part 1|Protocol Violation|0
5217585|NCT00975130|18011287|P2|Study Part 1|Protocol Violation|0
5217586|NCT00975130|18011288|P1|Study Part 1|Protocol Violation|13
5217587|NCT00975130|18011286|P3|Study Part 1|Withdrawal by Subject|0
5217588|NCT00975130|18011287|P2|Study Part 1|Withdrawal by Subject|0
5217589|NCT00975130|18011288|P1|Study Part 1|Withdrawal by Subject|61
5217590|NCT00975130|18011286|P3|Study Part 1|Lost to Follow-up|0
5217591|NCT00975130|18011287|P2|Study Part 1|Lost to Follow-up|0
5217592|NCT00975130|18011288|P1|Study Part 1|Lost to Follow-up|19
5217593|NCT00975130|18011286|P3|Study Part 1|Adverse Event|0
5217594|NCT00975130|18011287|P2|Study Part 1|Adverse Event|0
5217595|NCT00975130|18011288|P1|Study Part 1|Adverse Event|150
5217596|NCT00975000|18011472|P2|Overall Study|Non-compliance|1
5217597|NCT00975000|18011473|P1|Overall Study|Non-compliance|0
5217598|NCT00975000|18011472|P2|Overall Study|Protocol-specified Criteria|0
5217599|NCT00975000|18011473|P1|Overall Study|Protocol-specified Criteria|1
5217600|NCT00975000|18011472|P2|Overall Study|Lost to Follow-up|1
5217601|NCT00975000|18011473|P1|Overall Study|Lost to Follow-up|0
5217602|NCT00975000|18011472|P2|Overall Study|Withdrawal by Subject|2
5217603|NCT00975000|18011473|P1|Overall Study|Withdrawal by Subject|2
5217604|NCT00975000|18011472|P2|Overall Study|Adverse Event|1
5217605|NCT00975000|18011473|P1|Overall Study|Adverse Event|1
5217606|NCT00975000|18011472|P2|Overall Study|Other|0
5217607|NCT00975000|18011473|P1|Overall Study|Other|1
5217608|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Various|0
5217609|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Various|4
5217610|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
5217611|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
5217612|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
5217613|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
5217614|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
5217615|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
5217616|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
5217617|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
5217618|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
5217619|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
5217620|NCT00974974|18011497|P2|Maintenance - Double Blind Treatment|Adverse Event|3
5217621|NCT00974974|18011498|P1|Maintenance - Double Blind Treatment|Adverse Event|3
5217622|NCT00974974|18011497|P2|IPX066 Dose Conversion|Protocol Violation|0
5217623|NCT00974974|18011498|P1|IPX066 Dose Conversion|Protocol Violation|4
5217624|NCT00974974|18011497|P2|IPX066 Dose Conversion|Various|0
5217625|NCT00974974|18011498|P1|IPX066 Dose Conversion|Various|3
5217626|NCT00974974|18011497|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
5217627|NCT00974974|18011498|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
5217628|NCT00974974|18011497|P2|IPX066 Dose Conversion|Lack of Efficacy|0
5217629|NCT00974974|18011498|P1|IPX066 Dose Conversion|Lack of Efficacy|13
5217630|NCT00974974|18011497|P2|IPX066 Dose Conversion|Death|0
5217631|NCT00974974|18011498|P1|IPX066 Dose Conversion|Death|2
5217632|NCT00974974|18011497|P2|IPX066 Dose Conversion|Adverse Event|0
5217633|NCT00974974|18011498|P1|IPX066 Dose Conversion|Adverse Event|23
5217634|NCT00974974|18011497|P2|IR CD-LD Dose Adjustment|Various|9
5217635|NCT00974974|18011498|P1|IR CD-LD Dose Adjustment|Various|0
5217636|NCT00974974|18011497|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
5217637|NCT00974974|18011498|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
5217638|NCT00974974|18011497|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
5217639|NCT00974974|18011498|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
5217640|NCT00974974|18011497|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
5217641|NCT00974974|18011498|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
5217642|NCT00974974|18011497|P2|IR CD-LD Dose Adjustment|Adverse Event|3
5217643|NCT00974974|18011498|P1|IR CD-LD Dose Adjustment|Adverse Event|0
5217644|NCT00974922|18011508|P1|Overall Study|study terminated|24
5217645|NCT00974675|18011526|P4|Overall Study|Participant on holiday; unable to attend|1
5217646|NCT00974675|18011527|P3|Overall Study|Participant on holiday; unable to attend|0
5217647|NCT00974675|18011528|P2|Overall Study|Participant on holiday; unable to attend|0
5217648|NCT00974675|18011529|P1|Overall Study|Participant on holiday; unable to attend|0
5217649|NCT00974675|18011526|P4|Overall Study|Physician Decision|0
5217650|NCT00974675|18011527|P3|Overall Study|Physician Decision|1
5217651|NCT00974675|18011528|P2|Overall Study|Physician Decision|0
5217652|NCT00974675|18011529|P1|Overall Study|Physician Decision|0
5217653|NCT00974675|18011526|P4|Overall Study|Adverse Event|1
5217654|NCT00974675|18011527|P3|Overall Study|Adverse Event|1
5217655|NCT00974675|18011528|P2|Overall Study|Adverse Event|1
5217656|NCT00974675|18011529|P1|Overall Study|Adverse Event|2
5217657|NCT00974571|18011578|P3|Overall Study|Other|10
5217658|NCT00974571|18011579|P2|Overall Study|Other|0
5217659|NCT00974571|18011580|P1|Overall Study|Other|4
5217660|NCT00974571|18011578|P3|Overall Study|Patient Moved|1
5217661|NCT00974571|18011579|P2|Overall Study|Patient Moved|0
5217662|NCT00974571|18011580|P1|Overall Study|Patient Moved|1
5217663|NCT00974571|18011578|P3|Overall Study|Withdrawal by Subject|16
5217664|NCT00974571|18011579|P2|Overall Study|Withdrawal by Subject|5
5217665|NCT00974571|18011580|P1|Overall Study|Withdrawal by Subject|14
5217666|NCT00974571|18011578|P3|Overall Study|Protocol Violation|18
5217667|NCT00974571|18011579|P2|Overall Study|Protocol Violation|4
5217668|NCT00974571|18011580|P1|Overall Study|Protocol Violation|13
5217669|NCT00974571|18011578|P3|Overall Study|Lost to Follow-up|2
5217670|NCT00974571|18011579|P2|Overall Study|Lost to Follow-up|1
5217671|NCT00974571|18011580|P1|Overall Study|Lost to Follow-up|2
5217672|NCT00974571|18011578|P3|Overall Study|Lack of Efficacy|9
5217673|NCT00974571|18011579|P2|Overall Study|Lack of Efficacy|2
5217674|NCT00974571|18011580|P1|Overall Study|Lack of Efficacy|3
5217675|NCT00974571|18011578|P3|Overall Study|Adverse Event|27
5217676|NCT00974571|18011579|P2|Overall Study|Adverse Event|4
5217677|NCT00974571|18011580|P1|Overall Study|Adverse Event|31
5217678|NCT00974311|18011686|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
5217679|NCT00974311|18011687|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
5217680|NCT00974311|18011686|P2|OLE Phase (up to 77 Months)|Other|2
5217681|NCT00974311|18011687|P1|OLE Phase (up to 77 Months)|Other|15
5217682|NCT00974311|18011686|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
5217683|NCT00974311|18011687|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
5217684|NCT00974311|18011686|P2|OLE Phase (up to 77 Months)|Death|21
5217685|NCT00974311|18011687|P1|OLE Phase (up to 77 Months)|Death|14
5217686|NCT00974311|18011686|P2|DB Phase (up to 24 Months)|Other|0
5217687|NCT00974311|18011687|P1|DB Phase (up to 24 Months)|Other|1
5217688|NCT00974311|18011686|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
5217689|NCT00974311|18011687|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
5217690|NCT00974311|18011686|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
5217691|NCT00974311|18011687|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
5217692|NCT00974311|18011686|P2|DB Phase (up to 24 Months)|Death|298
5217693|NCT00974311|18011687|P1|DB Phase (up to 24 Months)|Death|561
5217694|NCT00974311|18011686|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
5217695|NCT00974311|18011687|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
5217696|NCT00974259|18011725|P2|Overall Study|Technically inadequate PbtO2 recordings|1
5217697|NCT00974259|18011726|P1|Overall Study|Technically inadequate PbtO2 recordings|2
5217698|NCT00974233|18011744|P1|Maintenance Lenalidomide|Adverse Event|8
5217699|NCT00974233|18011744|P1|Maintenance Lenalidomide|Lack of Efficacy|5
5217700|NCT00974233|18011744|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
5217701|NCT00974233|18011744|P1|Induction Chemoimmunotherapy|Adverse Event|7
5217702|NCT00974233|18011744|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
5217703|NCT00974233|18011744|P1|Induction Chemoimmunotherapy|Death|2
5217704|NCT00974220|18011759|P2|Treatment Period 1|noncompliant subjects|1
5217705|NCT00974220|18011760|P1|Treatment Period 1|noncompliant subjects|0
5217706|NCT00974220|18011759|P2|Treatment Period 1|Adverse Event|1
5217707|NCT00974220|18011760|P1|Treatment Period 1|Adverse Event|2
5217708|NCT00974090|18011805|P2|Period 2: Open-label Period|Withdrawal by Subject|0
5217709|NCT00974090|18011806|P1|Period 2: Open-label Period|Withdrawal by Subject|1
5217710|NCT00974090|18011805|P2|Period 2: Open-label Period|Physician Decision|3
5217711|NCT00974090|18011806|P1|Period 2: Open-label Period|Physician Decision|0
5217712|NCT00974090|18011805|P2|Period 2: Open-label Period|Lack of Efficacy|1
5217713|NCT00974090|18011806|P1|Period 2: Open-label Period|Lack of Efficacy|3
5217714|NCT00974090|18011805|P2|Period 2: Open-label Period|Adverse Event|6
5217715|NCT00974090|18011806|P1|Period 2: Open-label Period|Adverse Event|4
5217716|NCT00974090|18011805|P2|Period 1: Double Blind Period|Physician Decision|0
5217717|NCT00974090|18011806|P1|Period 1: Double Blind Period|Physician Decision|1
5217718|NCT00974090|18011805|P2|Period 1: Double Blind Period|Adverse Event|1
5217719|NCT00974090|18011806|P1|Period 1: Double Blind Period|Adverse Event|2
5217720|NCT00973973|18011842|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
5217721|NCT00973973|18011843|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
5217722|NCT00973973|18011842|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
5217723|NCT00973973|18011843|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
5217724|NCT00973973|18011842|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
5217725|NCT00973973|18011843|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
5217726|NCT00973973|18011842|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
5217727|NCT00973973|18011843|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
5217728|NCT00973973|18011842|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
5217729|NCT00973973|18011843|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
5217730|NCT00973973|18011842|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
5217731|NCT00973973|18011843|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
5217732|NCT00973973|18011842|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
5217733|NCT00973973|18011843|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
5217734|NCT00973973|18011842|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
5217735|NCT00973973|18011843|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
5217736|NCT00973973|18011842|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
5217737|NCT00973973|18011843|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
5217738|NCT00973973|18011842|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
5217739|NCT00973973|18011843|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
5217740|NCT00973973|18011842|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
5217741|NCT00973973|18011843|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
5217742|NCT00973973|18011842|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
5217743|NCT00973973|18011843|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
5217744|NCT00973921|18011903|P1|Overall Study|IVUS results were not available|9
5217745|NCT00973765|18011920|P2|Overall Study|Lost to Follow-up|14
5217746|NCT00973765|18011921|P1|Overall Study|Lost to Follow-up|8
5217747|NCT00973700|18011943|P5|Overall Study|Unable to Classify|1
5217748|NCT00973700|18011944|P4|Overall Study|Unable to Classify|2
5217749|NCT00973700|18011945|P3|Overall Study|Unable to Classify|1
5217750|NCT00973700|18011946|P2|Overall Study|Unable to Classify|0
5217751|NCT00973700|18011947|P1|Overall Study|Unable to Classify|0
5217752|NCT00973700|18011943|P5|Overall Study|Inappropriate enrolment|0
5217753|NCT00973700|18011944|P4|Overall Study|Inappropriate enrolment|4
5217754|NCT00973700|18011945|P3|Overall Study|Inappropriate enrolment|0
5217755|NCT00973700|18011946|P2|Overall Study|Inappropriate enrolment|0
5217756|NCT00973700|18011947|P1|Overall Study|Inappropriate enrolment|0
5217757|NCT00973700|18011943|P5|Overall Study|Lost to Follow-up|5
5217758|NCT00973700|18011944|P4|Overall Study|Lost to Follow-up|8
5217759|NCT00973700|18011945|P3|Overall Study|Lost to Follow-up|1
5217760|NCT00973700|18011946|P2|Overall Study|Lost to Follow-up|0
5217761|NCT00973700|18011947|P1|Overall Study|Lost to Follow-up|5
5217762|NCT00973700|18011943|P5|Overall Study|Withdrawal by Subject|4
5217763|NCT00973700|18011944|P4|Overall Study|Withdrawal by Subject|4
5217764|NCT00973700|18011945|P3|Overall Study|Withdrawal by Subject|8
5217765|NCT00973700|18011946|P2|Overall Study|Withdrawal by Subject|2
5217766|NCT00973700|18011947|P1|Overall Study|Withdrawal by Subject|2
5217767|NCT00973674|18011996|P2|Overall Study|Protocol Violation|0
5217768|NCT00973674|18011997|P1|Overall Study|Protocol Violation|2
5217769|NCT00973622|18012011|P2|Overall Study|did not complete rTMS sessions|2
5217770|NCT00973622|18012012|P1|Overall Study|did not complete rTMS sessions|11
5217771|NCT00973622|18012011|P2|Overall Study|did not pass MRI screen|0
5217772|NCT00973622|18012012|P1|Overall Study|did not pass MRI screen|6
5217773|NCT00973622|18012011|P2|Overall Study|did not attend MRI|3
5217774|NCT00973622|18012012|P1|Overall Study|did not attend MRI|14
5217775|NCT00973479|18012020|P2|Overall Study|Other|7
5217776|NCT00973479|18012021|P1|Overall Study|Other|1
5217777|NCT00973479|18012020|P2|Overall Study|Protocol Violation|2
5217778|NCT00973479|18012021|P1|Overall Study|Protocol Violation|2
5217779|NCT00973479|18012020|P2|Overall Study|Adverse Event|32
5217780|NCT00973479|18012021|P1|Overall Study|Adverse Event|12
5217781|NCT00973479|18012020|P2|Overall Study|Lack of Efficacy|7
5217782|NCT00973479|18012021|P1|Overall Study|Lack of Efficacy|5
5217783|NCT00973479|18012020|P2|Overall Study|Withdrawal by Subject|16
5217784|NCT00973479|18012021|P1|Overall Study|Withdrawal by Subject|15
5217785|NCT00973479|18012020|P2|Overall Study|Death|2
5217786|NCT00973479|18012021|P1|Overall Study|Death|2
5217787|NCT00973479|18012020|P2|Overall Study|Lost to Follow-up|3
5217788|NCT00973479|18012021|P1|Overall Study|Lost to Follow-up|0
5217789|NCT00973362|18012039|P2|3-Year Follow-up|Lost to Follow-up|0
5217790|NCT00973362|18012040|P1|3-Year Follow-up|Lost to Follow-up|17
5217791|NCT00973362|18012039|P2|Baseline Evaluation|Inevaluable|223
5217792|NCT00973362|18012040|P1|Baseline Evaluation|Inevaluable|686
5217793|NCT00973362|18012039|P2|Baseline Evaluation|No colposcopy visit|0
5217794|NCT00973362|18012040|P1|Baseline Evaluation|No colposcopy visit|62
5217795|NCT00973362|18012039|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
5217796|NCT00973362|18012040|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
5217797|NCT00973349|18012065|P16|Overall Study|Unable to classify|0
5217798|NCT00973349|18012066|P15|Overall Study|Unable to classify|0
5217799|NCT00973349|18012067|P14|Overall Study|Unable to classify|0
5217800|NCT00973349|18012068|P13|Overall Study|Unable to classify|0
5217801|NCT00973349|18012069|P12|Overall Study|Unable to classify|0
5217802|NCT00973349|18012070|P11|Overall Study|Unable to classify|0
5217803|NCT00973349|18012071|P10|Overall Study|Unable to classify|1
5217804|NCT00973349|18012072|P9|Overall Study|Unable to classify|0
5217805|NCT00973349|18012073|P8|Overall Study|Unable to classify|0
5217806|NCT00973349|18012074|P7|Overall Study|Unable to classify|0
5217807|NCT00973349|18012075|P6|Overall Study|Unable to classify|1
5217808|NCT00973349|18012076|P5|Overall Study|Unable to classify|1
5217809|NCT00973349|18012077|P4|Overall Study|Unable to classify|0
5217810|NCT00973349|18012078|P3|Overall Study|Unable to classify|0
5217811|NCT00973349|18012079|P2|Overall Study|Unable to classify|0
5217812|NCT00973349|18012080|P1|Overall Study|Unable to classify|0
5217813|NCT00973349|18012065|P16|Overall Study|Protocol Violation|0
5217814|NCT00973349|18012066|P15|Overall Study|Protocol Violation|0
5217815|NCT00973349|18012067|P14|Overall Study|Protocol Violation|0
5217816|NCT00973349|18012068|P13|Overall Study|Protocol Violation|0
5217817|NCT00973349|18012069|P12|Overall Study|Protocol Violation|0
5217818|NCT00973349|18012070|P11|Overall Study|Protocol Violation|0
5217819|NCT00973349|18012071|P10|Overall Study|Protocol Violation|0
5217820|NCT00973349|18012072|P9|Overall Study|Protocol Violation|1
5217821|NCT00973349|18012073|P8|Overall Study|Protocol Violation|0
5217822|NCT00973349|18012074|P7|Overall Study|Protocol Violation|0
5217823|NCT00973349|18012075|P6|Overall Study|Protocol Violation|0
5217824|NCT00973349|18012076|P5|Overall Study|Protocol Violation|0
5217825|NCT00973349|18012077|P4|Overall Study|Protocol Violation|0
5217826|NCT00973349|18012078|P3|Overall Study|Protocol Violation|0
5217827|NCT00973349|18012079|P2|Overall Study|Protocol Violation|0
5217828|NCT00973349|18012080|P1|Overall Study|Protocol Violation|0
5217829|NCT00973349|18012065|P16|Overall Study|Inappropriate enrolment|1
5217830|NCT00973349|18012066|P15|Overall Study|Inappropriate enrolment|1
5217831|NCT00973349|18012067|P14|Overall Study|Inappropriate enrolment|0
5217832|NCT00973349|18012068|P13|Overall Study|Inappropriate enrolment|1
5217833|NCT00973349|18012069|P12|Overall Study|Inappropriate enrolment|0
5217834|NCT00973349|18012070|P11|Overall Study|Inappropriate enrolment|0
5217835|NCT00973349|18012071|P10|Overall Study|Inappropriate enrolment|2
5217836|NCT00973349|18012072|P9|Overall Study|Inappropriate enrolment|0
5217837|NCT00973349|18012073|P8|Overall Study|Inappropriate enrolment|0
5217838|NCT00973349|18012074|P7|Overall Study|Inappropriate enrolment|0
5217839|NCT00973349|18012075|P6|Overall Study|Inappropriate enrolment|0
5217840|NCT00973349|18012076|P5|Overall Study|Inappropriate enrolment|0
5217841|NCT00973349|18012077|P4|Overall Study|Inappropriate enrolment|0
5217842|NCT00973349|18012078|P3|Overall Study|Inappropriate enrolment|1
5217843|NCT00973349|18012079|P2|Overall Study|Inappropriate enrolment|0
5217844|NCT00973349|18012080|P1|Overall Study|Inappropriate enrolment|0
5217845|NCT00973349|18012065|P16|Overall Study|Lost to Follow-up|1
5217846|NCT00973349|18012066|P15|Overall Study|Lost to Follow-up|0
5217847|NCT00973349|18012067|P14|Overall Study|Lost to Follow-up|0
5217848|NCT00973349|18012068|P13|Overall Study|Lost to Follow-up|0
5217849|NCT00973349|18012069|P12|Overall Study|Lost to Follow-up|1
5217850|NCT00973349|18012070|P11|Overall Study|Lost to Follow-up|0
5217851|NCT00973349|18012071|P10|Overall Study|Lost to Follow-up|1
5217852|NCT00973349|18012072|P9|Overall Study|Lost to Follow-up|2
5217853|NCT00973349|18012073|P8|Overall Study|Lost to Follow-up|1
5217854|NCT00973349|18012074|P7|Overall Study|Lost to Follow-up|0
5217855|NCT00973349|18012075|P6|Overall Study|Lost to Follow-up|3
5217856|NCT00973349|18012076|P5|Overall Study|Lost to Follow-up|1
5217857|NCT00973349|18012077|P4|Overall Study|Lost to Follow-up|2
5217858|NCT00973349|18012078|P3|Overall Study|Lost to Follow-up|2
5217859|NCT00973349|18012079|P2|Overall Study|Lost to Follow-up|1
5217860|NCT00973349|18012080|P1|Overall Study|Lost to Follow-up|3
5217861|NCT00973349|18012065|P16|Overall Study|Withdrawal by Subject|0
5217862|NCT00973349|18012066|P15|Overall Study|Withdrawal by Subject|0
5217863|NCT00973349|18012067|P14|Overall Study|Withdrawal by Subject|0
5217864|NCT00973349|18012068|P13|Overall Study|Withdrawal by Subject|0
5217865|NCT00973349|18012069|P12|Overall Study|Withdrawal by Subject|1
5217866|NCT00973349|18012070|P11|Overall Study|Withdrawal by Subject|0
5217867|NCT00973349|18012071|P10|Overall Study|Withdrawal by Subject|2
5217868|NCT00973349|18012072|P9|Overall Study|Withdrawal by Subject|0
5217869|NCT00973349|18012073|P8|Overall Study|Withdrawal by Subject|2
5217870|NCT00973349|18012074|P7|Overall Study|Withdrawal by Subject|2
5217871|NCT00973349|18012075|P6|Overall Study|Withdrawal by Subject|0
5217872|NCT00973349|18012076|P5|Overall Study|Withdrawal by Subject|2
5217873|NCT00973349|18012077|P4|Overall Study|Withdrawal by Subject|3
5217874|NCT00973349|18012078|P3|Overall Study|Withdrawal by Subject|2
5217875|NCT00973349|18012079|P2|Overall Study|Withdrawal by Subject|2
5217876|NCT00973349|18012080|P1|Overall Study|Withdrawal by Subject|1
5217877|NCT00973349|18012065|P16|Overall Study|Adverse Event|0
5217878|NCT00973349|18012066|P15|Overall Study|Adverse Event|1
5217879|NCT00973349|18012067|P14|Overall Study|Adverse Event|0
5217880|NCT00973349|18012068|P13|Overall Study|Adverse Event|0
5217881|NCT00973349|18012069|P12|Overall Study|Adverse Event|0
5217882|NCT00973349|18012070|P11|Overall Study|Adverse Event|0
5217883|NCT00973349|18012071|P10|Overall Study|Adverse Event|0
5217884|NCT00973349|18012072|P9|Overall Study|Adverse Event|1
5217885|NCT00973349|18012073|P8|Overall Study|Adverse Event|0
5217886|NCT00973349|18012074|P7|Overall Study|Adverse Event|0
5217887|NCT00973349|18012075|P6|Overall Study|Adverse Event|0
5217888|NCT00973349|18012076|P5|Overall Study|Adverse Event|1
5217889|NCT00973349|18012077|P4|Overall Study|Adverse Event|0
5217890|NCT00973349|18012078|P3|Overall Study|Adverse Event|0
5217891|NCT00973349|18012079|P2|Overall Study|Adverse Event|0
5217892|NCT00973349|18012080|P1|Overall Study|Adverse Event|0
5217893|NCT00973102|18012180|P2|Overall Study|Prisoner|1
5217894|NCT00973102|18012181|P1|Overall Study|Prisoner|0
5217895|NCT00973102|18012180|P2|Overall Study|Protocol Violation|0
5217896|NCT00973102|18012181|P1|Overall Study|Protocol Violation|1
5217897|NCT00972816|18012212|P8|Overall Study|Unable to classify|0
5217898|NCT00972816|18012213|P7|Overall Study|Unable to classify|0
5217899|NCT00972816|18012214|P6|Overall Study|Unable to classify|0
5217900|NCT00972816|18012215|P5|Overall Study|Unable to classify|1
5217901|NCT00972816|18012216|P4|Overall Study|Unable to classify|0
5217902|NCT00972816|18012217|P3|Overall Study|Unable to classify|0
5217903|NCT00972816|18012218|P2|Overall Study|Unable to classify|0
5217904|NCT00972816|18012219|P1|Overall Study|Unable to classify|2
5217905|NCT00972816|18012212|P8|Overall Study|Inappropriate enrolment|0
5217906|NCT00972816|18012213|P7|Overall Study|Inappropriate enrolment|2
5217907|NCT00972816|18012214|P6|Overall Study|Inappropriate enrolment|0
5217908|NCT00972816|18012215|P5|Overall Study|Inappropriate enrolment|0
5217909|NCT00972816|18012216|P4|Overall Study|Inappropriate enrolment|0
5217910|NCT00972816|18012217|P3|Overall Study|Inappropriate enrolment|0
5217911|NCT00972816|18012218|P2|Overall Study|Inappropriate enrolment|0
5217912|NCT00972816|18012219|P1|Overall Study|Inappropriate enrolment|0
5217913|NCT00972816|18012212|P8|Overall Study|Lost to Follow-up|7
5217914|NCT00972816|18012213|P7|Overall Study|Lost to Follow-up|7
5217915|NCT00972816|18012214|P6|Overall Study|Lost to Follow-up|10
5217916|NCT00972816|18012215|P5|Overall Study|Lost to Follow-up|11
5217917|NCT00972816|18012216|P4|Overall Study|Lost to Follow-up|5
5217918|NCT00972816|18012217|P3|Overall Study|Lost to Follow-up|7
5217919|NCT00972816|18012218|P2|Overall Study|Lost to Follow-up|9
5217920|NCT00972816|18012219|P1|Overall Study|Lost to Follow-up|11
5217921|NCT00972816|18012212|P8|Overall Study|Withdrawal by Subject|2
5217922|NCT00972816|18012213|P7|Overall Study|Withdrawal by Subject|1
5217923|NCT00972816|18012214|P6|Overall Study|Withdrawal by Subject|1
5217924|NCT00972816|18012215|P5|Overall Study|Withdrawal by Subject|0
5217925|NCT00972816|18012216|P4|Overall Study|Withdrawal by Subject|3
5217926|NCT00972816|18012217|P3|Overall Study|Withdrawal by Subject|1
5217927|NCT00972816|18012218|P2|Overall Study|Withdrawal by Subject|2
5217928|NCT00972816|18012219|P1|Overall Study|Withdrawal by Subject|4
5217929|NCT00972816|18012212|P8|Overall Study|Adverse Event|0
5217930|NCT00972816|18012213|P7|Overall Study|Adverse Event|0
5217931|NCT00972816|18012214|P6|Overall Study|Adverse Event|0
5217932|NCT00972816|18012215|P5|Overall Study|Adverse Event|0
5217933|NCT00972816|18012216|P4|Overall Study|Adverse Event|0
5217934|NCT00972816|18012217|P3|Overall Study|Adverse Event|1
5217935|NCT00972816|18012218|P2|Overall Study|Adverse Event|0
5217936|NCT00972816|18012219|P1|Overall Study|Adverse Event|0
5217937|NCT00972777|18012303|P2|Overall Study|Missed visit|0
5217938|NCT00972777|18012304|P1|Overall Study|Missed visit|1
5217939|NCT00972777|18012303|P2|Overall Study|Screening Failure|1
5217940|NCT00972777|18012304|P1|Overall Study|Screening Failure|2
5217941|NCT00972777|18012303|P2|Overall Study|Protocol Violation|2
5217942|NCT00972777|18012304|P1|Overall Study|Protocol Violation|0
5217943|NCT00972777|18012303|P2|Overall Study|Physician Decision|0
5217944|NCT00972777|18012304|P1|Overall Study|Physician Decision|4
5217945|NCT00972777|18012303|P2|Overall Study|Withdrawal by Subject|5
5217946|NCT00972777|18012304|P1|Overall Study|Withdrawal by Subject|4
5217947|NCT00972777|18012303|P2|Overall Study|Lost to Follow-up|4
5217948|NCT00972777|18012304|P1|Overall Study|Lost to Follow-up|0
5217949|NCT00972777|18012303|P2|Overall Study|Adverse Event|2
5217950|NCT00972777|18012304|P1|Overall Study|Adverse Event|3
5217951|NCT00972738|18012319|P3|Overall Study|Other|1
5217952|NCT00972738|18012320|P2|Overall Study|Other|2
5217953|NCT00972738|18012321|P1|Overall Study|Other|1
5217954|NCT00972738|18012319|P3|Overall Study|Moved|1
5217955|NCT00972738|18012320|P2|Overall Study|Moved|0
5217956|NCT00972738|18012321|P1|Overall Study|Moved|0
5217957|NCT00972738|18012319|P3|Overall Study|Withdrawal by Subject|4
5217958|NCT00972738|18012320|P2|Overall Study|Withdrawal by Subject|1
5217959|NCT00972738|18012321|P1|Overall Study|Withdrawal by Subject|5
5217960|NCT00972738|18012319|P3|Overall Study|Lack of Efficacy|11
5217961|NCT00972738|18012320|P2|Overall Study|Lack of Efficacy|1
5217962|NCT00972738|18012321|P1|Overall Study|Lack of Efficacy|5
5217963|NCT00972738|18012319|P3|Overall Study|Lost to Follow-up|1
5217964|NCT00972738|18012320|P2|Overall Study|Lost to Follow-up|0
5217965|NCT00972738|18012321|P1|Overall Study|Lost to Follow-up|1
5217966|NCT00972738|18012319|P3|Overall Study|Protocol Violation|3
5217967|NCT00972738|18012320|P2|Overall Study|Protocol Violation|1
5217968|NCT00972738|18012321|P1|Overall Study|Protocol Violation|2
5217969|NCT00972738|18012319|P3|Overall Study|Adverse Event|8
5217970|NCT00972738|18012320|P2|Overall Study|Adverse Event|1
5217971|NCT00972738|18012321|P1|Overall Study|Adverse Event|7
5217972|NCT00972595|18012438|P2|Period 1|Adverse Event|0
5217973|NCT00972595|18012439|P1|Period 1|Adverse Event|1
5217974|NCT00972543|18012449|P2|Overall Study|Early study termination by sponsor|1
5217975|NCT00972543|18012450|P1|Overall Study|Early study termination by sponsor|4
5217976|NCT00972543|18012449|P2|Overall Study|Adverse Event|0
5217977|NCT00972543|18012450|P1|Overall Study|Adverse Event|1
5217978|NCT00972517|18012533|P6|Overall Study|Withdrawal by Subject|0
5217979|NCT00972517|18012534|P5|Overall Study|Withdrawal by Subject|1
5217980|NCT00972517|18012535|P4|Overall Study|Withdrawal by Subject|2
5217981|NCT00972517|18012536|P3|Overall Study|Withdrawal by Subject|0
5217982|NCT00972517|18012537|P2|Overall Study|Withdrawal by Subject|1
5217983|NCT00972517|18012538|P1|Overall Study|Withdrawal by Subject|0
5217984|NCT00972517|18012533|P6|Overall Study|Adverse Event|0
5217985|NCT00972517|18012534|P5|Overall Study|Adverse Event|0
5217986|NCT00972517|18012535|P4|Overall Study|Adverse Event|1
5217987|NCT00972517|18012536|P3|Overall Study|Adverse Event|0
5217988|NCT00972517|18012537|P2|Overall Study|Adverse Event|0
5217989|NCT00972517|18012538|P1|Overall Study|Adverse Event|0
5217990|NCT00972504|18012633|P1|Overall Study|Investigator discretion|1
5217991|NCT00972504|18012633|P1|Overall Study|Adverse Event|2
5217992|NCT00972478|18012665|P2|Overall Study|Not start protocol treatment|2
5217993|NCT00972478|18012666|P1|Overall Study|Not start protocol treatment|1
5217994|NCT00972478|18012665|P2|Overall Study|Ineligible|7
5217995|NCT00972478|18012666|P1|Overall Study|Ineligible|1
5217996|NCT00972478|18012665|P2|Overall Study|Not protocol specified|1
5217997|NCT00972478|18012666|P1|Overall Study|Not protocol specified|1
5217998|NCT00972478|18012665|P2|Overall Study|Death|2
5217999|NCT00972478|18012666|P1|Overall Study|Death|0
5218000|NCT00972478|18012665|P2|Overall Study|Progression/Relapse|2
5218001|NCT00972478|18012666|P1|Overall Study|Progression/Relapse|0
5218002|NCT00972478|18012665|P2|Overall Study|Withdrawal by Subject|8
5218003|NCT00972478|18012666|P1|Overall Study|Withdrawal by Subject|1
5218004|NCT00972478|18012665|P2|Overall Study|Adverse Event|16
5218005|NCT00972478|18012666|P1|Overall Study|Adverse Event|3
5218006|NCT00972322|18012711|P2|Overall Study|Consistently high glucose values|0
5218007|NCT00972322|18012712|P1|Overall Study|Consistently high glucose values|1
5218008|NCT00972322|18012711|P2|Overall Study|Lost to Follow-up|1
5218009|NCT00972322|18012712|P1|Overall Study|Lost to Follow-up|0
5218010|NCT00972322|18012711|P2|Overall Study|Positive drug screen|1
5218011|NCT00972322|18012712|P1|Overall Study|Positive drug screen|0
5218012|NCT00972322|18012711|P2|Overall Study|Adverse Event|1
5218013|NCT00972322|18012712|P1|Overall Study|Adverse Event|2
5218014|NCT00972283|18012724|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
5218015|NCT00972283|18012725|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
5218016|NCT00972283|18012724|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
5218017|NCT00972283|18012725|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
5218018|NCT00972283|18012724|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
5218019|NCT00972283|18012725|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
5218020|NCT00972283|18012724|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
5218021|NCT00972283|18012725|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
5218022|NCT00972283|18012724|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
5218023|NCT00972283|18012725|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
5218024|NCT00972283|18012724|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
5218025|NCT00972283|18012725|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
5218026|NCT00972283|18012724|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
5218027|NCT00972283|18012725|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
5218028|NCT00972283|18012724|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
5218029|NCT00972283|18012725|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
5218030|NCT00972283|18012724|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
5218031|NCT00972283|18012725|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
5218032|NCT00972283|18012724|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
5218033|NCT00972283|18012725|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
5218034|NCT00972244|18012752|P5|Overall Study|Various|2
5218035|NCT00972244|18012753|P4|Overall Study|Various|0
5218036|NCT00972244|18012754|P3|Overall Study|Various|0
5218037|NCT00972244|18012755|P2|Overall Study|Various|0
5218038|NCT00972244|18012756|P1|Overall Study|Various|0
5218039|NCT00972244|18012752|P5|Overall Study|Death|0
5218040|NCT00972244|18012753|P4|Overall Study|Death|0
5218041|NCT00972244|18012754|P3|Overall Study|Death|0
5218042|NCT00972244|18012755|P2|Overall Study|Death|0
5218043|NCT00972244|18012756|P1|Overall Study|Death|1
5218044|NCT00972244|18012752|P5|Overall Study|Safety|1
5218045|NCT00972244|18012753|P4|Overall Study|Safety|0
5218046|NCT00972244|18012754|P3|Overall Study|Safety|0
5218047|NCT00972244|18012755|P2|Overall Study|Safety|0
5218048|NCT00972244|18012756|P1|Overall Study|Safety|0
5218049|NCT00972244|18012752|P5|Overall Study|Withdrawal by Subject|1
5218050|NCT00972244|18012753|P4|Overall Study|Withdrawal by Subject|0
5218051|NCT00972244|18012754|P3|Overall Study|Withdrawal by Subject|1
5218052|NCT00972244|18012755|P2|Overall Study|Withdrawal by Subject|2
5218053|NCT00972244|18012756|P1|Overall Study|Withdrawal by Subject|1
5218054|NCT00972244|18012752|P5|Overall Study|Subject No Longer Meets Study Criteria|5
5218055|NCT00972244|18012753|P4|Overall Study|Subject No Longer Meets Study Criteria|0
5218056|NCT00972244|18012754|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5218057|NCT00972244|18012755|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5218058|NCT00972244|18012756|P1|Overall Study|Subject No Longer Meets Study Criteria|2
5218059|NCT00972244|18012752|P5|Overall Study|Adverse Event|0
5218060|NCT00972244|18012753|P4|Overall Study|Adverse Event|0
5218061|NCT00972244|18012754|P3|Overall Study|Adverse Event|1
5218062|NCT00972244|18012755|P2|Overall Study|Adverse Event|1
5218063|NCT00972244|18012756|P1|Overall Study|Adverse Event|0
5218064|NCT00972244|18012752|P5|Overall Study|Incorrect Enrolment|0
5218065|NCT00972244|18012753|P4|Overall Study|Incorrect Enrolment|0
5218066|NCT00972244|18012754|P3|Overall Study|Incorrect Enrolment|0
5218067|NCT00972244|18012755|P2|Overall Study|Incorrect Enrolment|0
5218068|NCT00972244|18012756|P1|Overall Study|Incorrect Enrolment|1
5218069|NCT00972153|18012788|P3|Overall Study|Equipment malfunction during case|0
5218070|NCT00972153|18012789|P2|Overall Study|Equipment malfunction during case|1
5218071|NCT00972153|18012790|P1|Overall Study|Equipment malfunction during case|0
5218072|NCT00972023|18012805|P1|Overall Study|Withdrawal by Subject|1
5218073|NCT00971997|18012812|P1|Overall Study|Physician Decision|7
5218074|NCT00971997|18012812|P1|Overall Study|Withdrawal by Subject|5
5218075|NCT00971997|18012812|P1|Overall Study|Protocol Violation|4
5218076|NCT00971997|18012812|P1|Overall Study|Death|1
5218077|NCT00971997|18012812|P1|Overall Study|Adverse Event|2
5218078|NCT00971932|18012830|P1|Overall Study|Ongoing|4
5218079|NCT00971932|18012830|P1|Overall Study|Investigator's decision|2
5218080|NCT00971932|18012830|P1|Overall Study|Withdrawal by Subject|1
5218081|NCT00971425|18012931|P2|Overall Study|Withdrawal by Subject|1
5218082|NCT00971425|18012932|P1|Overall Study|Withdrawal by Subject|0
5218083|NCT00971425|18012931|P2|Overall Study|Adverse Event|1
5218084|NCT00971425|18012932|P1|Overall Study|Adverse Event|1
5218085|NCT00971321|18012968|P2|Up to Month 11-12|Lost to Follow-up|0
5218086|NCT00971321|18012969|P1|Up to Month 11-12|Lost to Follow-up|1
5218087|NCT00971321|18012968|P2|Up to Month 11-12|Migrated/moved from study area|2
5218088|NCT00971321|18012969|P1|Up to Month 11-12|Migrated/moved from study area|2
5218089|NCT00971321|18012968|P2|Up to Month 11-12|Withdrawal by Subject|1
5218090|NCT00971321|18012969|P1|Up to Month 11-12|Withdrawal by Subject|2
5218091|NCT00971321|18012968|P2|Up to Month 7|Migrated/moved from study area|2
5218092|NCT00971321|18012969|P1|Up to Month 7|Migrated/moved from study area|3
5218093|NCT00971321|18012968|P2|Up to Month 7|Withdrawal by Subject|0
5218094|NCT00971321|18012969|P1|Up to Month 7|Withdrawal by Subject|1
5218095|NCT00971243|18013049|P5|Open-label Period|Other reason|2
5218096|NCT00971243|18013050|P4|Open-label Period|Other reason|0
5218097|NCT00971243|18013051|P3|Open-label Period|Other reason|0
5218098|NCT00971243|18013052|P2|Open-label Period|Other reason|0
5218099|NCT00971243|18013053|P1|Open-label Period|Other reason|0
5218100|NCT00971243|18013049|P5|Open-label Period|Withdrawal by Subject|1
5218101|NCT00971243|18013050|P4|Open-label Period|Withdrawal by Subject|2
5218102|NCT00971243|18013051|P3|Open-label Period|Withdrawal by Subject|0
5218103|NCT00971243|18013052|P2|Open-label Period|Withdrawal by Subject|0
5218104|NCT00971243|18013053|P1|Open-label Period|Withdrawal by Subject|1
5218105|NCT00971243|18013049|P5|Open-label Period|Protocol Violation|1
5218106|NCT00971243|18013050|P4|Open-label Period|Protocol Violation|0
5218107|NCT00971243|18013051|P3|Open-label Period|Protocol Violation|1
5218108|NCT00971243|18013052|P2|Open-label Period|Protocol Violation|1
5218109|NCT00971243|18013053|P1|Open-label Period|Protocol Violation|1
5218110|NCT00971243|18013049|P5|Open-label Period|Physician Decision|2
5218111|NCT00971243|18013050|P4|Open-label Period|Physician Decision|7
5218112|NCT00971243|18013051|P3|Open-label Period|Physician Decision|3
5218113|NCT00971243|18013052|P2|Open-label Period|Physician Decision|9
5218114|NCT00971243|18013053|P1|Open-label Period|Physician Decision|5
5218115|NCT00971243|18013049|P5|Open-label Period|Adverse Event|0
5218116|NCT00971243|18013050|P4|Open-label Period|Adverse Event|1
5218117|NCT00971243|18013051|P3|Open-label Period|Adverse Event|1
5218118|NCT00971243|18013052|P2|Open-label Period|Adverse Event|0
5218119|NCT00971243|18013053|P1|Open-label Period|Adverse Event|1
5218120|NCT00971243|18013049|P5|Double Blind Period|Other reasons|1
5218121|NCT00971243|18013050|P4|Double Blind Period|Other reasons|0
5218122|NCT00971243|18013051|P3|Double Blind Period|Other reasons|2
5218123|NCT00971243|18013052|P2|Double Blind Period|Other reasons|0
5218124|NCT00971243|18013053|P1|Double Blind Period|Other reasons|1
5218125|NCT00971243|18013049|P5|Double Blind Period|Withdrawal by Subject|4
5218126|NCT00971243|18013050|P4|Double Blind Period|Withdrawal by Subject|4
5218127|NCT00971243|18013051|P3|Double Blind Period|Withdrawal by Subject|4
5218128|NCT00971243|18013052|P2|Double Blind Period|Withdrawal by Subject|1
5218129|NCT00971243|18013053|P1|Double Blind Period|Withdrawal by Subject|4
5218130|NCT00971243|18013049|P5|Double Blind Period|Protocol Violation|2
5218131|NCT00971243|18013050|P4|Double Blind Period|Protocol Violation|2
5218132|NCT00971243|18013051|P3|Double Blind Period|Protocol Violation|3
5218133|NCT00971243|18013052|P2|Double Blind Period|Protocol Violation|0
5218134|NCT00971243|18013053|P1|Double Blind Period|Protocol Violation|2
5218135|NCT00971243|18013049|P5|Double Blind Period|Physician Decision|7
5218136|NCT00971243|18013050|P4|Double Blind Period|Physician Decision|6
5218137|NCT00971243|18013051|P3|Double Blind Period|Physician Decision|7
5218138|NCT00971243|18013052|P2|Double Blind Period|Physician Decision|6
5218139|NCT00971243|18013053|P1|Double Blind Period|Physician Decision|10
5218140|NCT00971243|18013049|P5|Double Blind Period|Lost to Follow-up|1
5218141|NCT00971243|18013050|P4|Double Blind Period|Lost to Follow-up|0
5218142|NCT00971243|18013051|P3|Double Blind Period|Lost to Follow-up|1
5218143|NCT00971243|18013052|P2|Double Blind Period|Lost to Follow-up|1
5218144|NCT00971243|18013053|P1|Double Blind Period|Lost to Follow-up|0
5218145|NCT00971243|18013049|P5|Double Blind Period|Adverse Event|3
5218146|NCT00971243|18013050|P4|Double Blind Period|Adverse Event|2
5218147|NCT00971243|18013051|P3|Double Blind Period|Adverse Event|2
5218148|NCT00971243|18013052|P2|Double Blind Period|Adverse Event|3
5218149|NCT00971243|18013053|P1|Double Blind Period|Adverse Event|2
5218150|NCT00971204|18013070|P1|Overall Study|Lost to Follow-up|10
5218151|NCT00971204|18013070|P1|Overall Study|Did not meet all criteria-not treated|14
5218152|NCT00971048|18013078|P4|Overall Study|Physician Decision|1
5218153|NCT00971048|18013079|P3|Overall Study|Physician Decision|0
5218154|NCT00971048|18013080|P2|Overall Study|Physician Decision|0
5218155|NCT00971048|18013081|P1|Overall Study|Physician Decision|0
5218156|NCT00971048|18013078|P4|Overall Study|Adverse Event|0
5218157|NCT00971048|18013079|P3|Overall Study|Adverse Event|1
5218158|NCT00971048|18013080|P2|Overall Study|Adverse Event|0
5218159|NCT00971048|18013081|P1|Overall Study|Adverse Event|0
5218160|NCT00971048|18013078|P4|Overall Study|Protocol Violation|1
5218161|NCT00971048|18013079|P3|Overall Study|Protocol Violation|0
5218162|NCT00971048|18013080|P2|Overall Study|Protocol Violation|2
5218163|NCT00971048|18013081|P1|Overall Study|Protocol Violation|1
5218164|NCT00970944|18013105|P2|Overall Study|Physician Decision|2
5218165|NCT00970944|18013106|P1|Overall Study|Physician Decision|0
5218166|NCT00970944|18013105|P2|Overall Study|Death|0
5218167|NCT00970944|18013106|P1|Overall Study|Death|1
5218168|NCT00970684|18013158|P1|Overall Study|Withdrawal by Subject|1
5218169|NCT00970684|18013158|P1|Overall Study|Adverse Event|4
5218170|NCT00970684|18013158|P1|Overall Study|Lack of Efficacy|5
5218171|NCT00970632|18013167|P3|Overall Study|Sponsor decision|1
5218172|NCT00970632|18013168|P2|Overall Study|Sponsor decision|0
5218173|NCT00970632|18013169|P1|Overall Study|Sponsor decision|1
5218174|NCT00970632|18013167|P3|Overall Study|Entry criteria not met|2
5218175|NCT00970632|18013168|P2|Overall Study|Entry criteria not met|2
5218176|NCT00970632|18013169|P1|Overall Study|Entry criteria not met|0
5218177|NCT00970632|18013167|P3|Overall Study|Withdrawal by Subject|4
5218178|NCT00970632|18013168|P2|Overall Study|Withdrawal by Subject|6
5218179|NCT00970632|18013169|P1|Overall Study|Withdrawal by Subject|7
5218180|NCT00970632|18013167|P3|Overall Study|Protocol Violation|8
5218181|NCT00970632|18013168|P2|Overall Study|Protocol Violation|5
5218182|NCT00970632|18013169|P1|Overall Study|Protocol Violation|8
5218183|NCT00970632|18013167|P3|Overall Study|Lost to Follow-up|2
5218184|NCT00970632|18013168|P2|Overall Study|Lost to Follow-up|0
5218185|NCT00970632|18013169|P1|Overall Study|Lost to Follow-up|3
5218186|NCT00970632|18013167|P3|Overall Study|Lack of Efficacy|0
5218187|NCT00970632|18013168|P2|Overall Study|Lack of Efficacy|0
5218188|NCT00970632|18013169|P1|Overall Study|Lack of Efficacy|3
5218189|NCT00970632|18013167|P3|Overall Study|Adverse Event|1
5218190|NCT00970632|18013168|P2|Overall Study|Adverse Event|2
5218191|NCT00970632|18013169|P1|Overall Study|Adverse Event|2
5218192|NCT00970593|18013241|P7|Overall Study|Withdrawal by Subject|0
5218193|NCT00970593|18013242|P6|Overall Study|Withdrawal by Subject|0
5218194|NCT00970593|18013243|P5|Overall Study|Withdrawal by Subject|0
5218195|NCT00970593|18013244|P4|Overall Study|Withdrawal by Subject|0
5218196|NCT00970593|18013245|P3|Overall Study|Withdrawal by Subject|1
5218197|NCT00970593|18013246|P2|Overall Study|Withdrawal by Subject|0
5218198|NCT00970593|18013247|P1|Overall Study|Withdrawal by Subject|0
5218199|NCT00970593|18013241|P7|Overall Study|Discontinuation of study by sponsor|2
5218200|NCT00970593|18013242|P6|Overall Study|Discontinuation of study by sponsor|0
5218201|NCT00970593|18013243|P5|Overall Study|Discontinuation of study by sponsor|0
5218202|NCT00970593|18013244|P4|Overall Study|Discontinuation of study by sponsor|0
5218203|NCT00970593|18013245|P3|Overall Study|Discontinuation of study by sponsor|5
5218204|NCT00970593|18013246|P2|Overall Study|Discontinuation of study by sponsor|0
5218205|NCT00970593|18013247|P1|Overall Study|Discontinuation of study by sponsor|0
5218206|NCT00970593|18013241|P7|Overall Study|Adverse Event|0
5218207|NCT00970593|18013242|P6|Overall Study|Adverse Event|0
5218208|NCT00970593|18013243|P5|Overall Study|Adverse Event|0
5218209|NCT00970593|18013244|P4|Overall Study|Adverse Event|0
5218210|NCT00970593|18013245|P3|Overall Study|Adverse Event|0
5218211|NCT00970593|18013246|P2|Overall Study|Adverse Event|1
5218212|NCT00970593|18013247|P1|Overall Study|Adverse Event|1
5218213|NCT00970502|18013329|P1|Overall Study|Withdrawal by Subject|1
5218214|NCT00970489|18013340|P2|Overall Study|Death/Withdrew/Criteria Violation|41
5218215|NCT00970489|18013341|P1|Overall Study|Death/Withdrew/Criteria Violation|54
5218216|NCT00970359|18013353|P1|Overall Study|Not Treated|4
5218217|NCT00970307|18013383|P3|Overall Study|Withdrawal by Subject|2
5218218|NCT00970307|18013384|P2|Overall Study|Withdrawal by Subject|3
5218219|NCT00970307|18013385|P1|Overall Study|Withdrawal by Subject|2
5218220|NCT00970307|18013383|P3|Overall Study|Serious Adverse Event|0
5218221|NCT00970307|18013384|P2|Overall Study|Serious Adverse Event|0
5218222|NCT00970307|18013385|P1|Overall Study|Serious Adverse Event|1
5218223|NCT00970294|18013459|P1|Overall Study|Withdrawal by Subject|1
5218224|NCT00970294|18013459|P1|Overall Study|Physician Decision|4
5218225|NCT00970281|18013467|P2|Overall Study|Physician Decision|1
5218226|NCT00970281|18013468|P1|Overall Study|Physician Decision|1
5218227|NCT00970281|18013467|P2|Overall Study|Withdrawal by Subject|1
5218228|NCT00970281|18013468|P1|Overall Study|Withdrawal by Subject|0
5218229|NCT00970281|18013467|P2|Overall Study|Lack of Efficacy|14
5218230|NCT00970281|18013468|P1|Overall Study|Lack of Efficacy|1
5218231|NCT00970268|18013486|P2|Overall Study|Inclusion/Exclusion Criteria|0
5218232|NCT00970268|18013487|P1|Overall Study|Inclusion/Exclusion Criteria|1
5218233|NCT00970268|18013486|P2|Overall Study|Lost to Follow-up|2
5218234|NCT00970268|18013487|P1|Overall Study|Lost to Follow-up|1
5218235|NCT00970268|18013486|P2|Overall Study|COPD Exacerbation|2
5218236|NCT00970268|18013487|P1|Overall Study|COPD Exacerbation|4
5218237|NCT00970268|18013486|P2|Overall Study|Other Reason|1
5218238|NCT00970268|18013487|P1|Overall Study|Other Reason|3
5218239|NCT00970268|18013486|P2|Overall Study|Protocol Violation|7
5218240|NCT00970268|18013487|P1|Overall Study|Protocol Violation|4
5218241|NCT00970268|18013486|P2|Overall Study|Lack of Efficacy|6
5218242|NCT00970268|18013487|P1|Overall Study|Lack of Efficacy|3
5218243|NCT00970268|18013486|P2|Overall Study|Adverse Event|12
5218244|NCT00970268|18013487|P1|Overall Study|Adverse Event|15
5218245|NCT00970268|18013486|P2|Overall Study|Withdrawal by Subject|19
5218246|NCT00970268|18013487|P1|Overall Study|Withdrawal by Subject|12
5218247|NCT00969761|18013573|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218248|NCT00969761|18013574|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218249|NCT00969761|18013575|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218250|NCT00969761|18013576|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
5218251|NCT00969761|18013577|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218252|NCT00969761|18013578|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218253|NCT00969761|18013579|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218254|NCT00969761|18013580|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
5218255|NCT00969761|18013581|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
5218256|NCT00969761|18013582|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218257|NCT00969761|18013583|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218258|NCT00969761|18013584|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5218259|NCT00969761|18013573|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5218260|NCT00969761|18013574|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5218261|NCT00969761|18013575|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5218262|NCT00969761|18013576|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
5218263|NCT00969761|18013577|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
5218264|NCT00969761|18013578|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5218265|NCT00969761|18013579|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5218266|NCT00969761|18013580|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5218267|NCT00969761|18013581|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5218268|NCT00969761|18013582|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
5218269|NCT00969761|18013583|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5218270|NCT00969761|18013584|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5218271|NCT00969761|18013573|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218272|NCT00969761|18013574|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218273|NCT00969761|18013575|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218274|NCT00969761|18013576|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
5218275|NCT00969761|18013577|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218276|NCT00969761|18013578|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218277|NCT00969761|18013579|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218278|NCT00969761|18013580|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218279|NCT00969761|18013581|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218280|NCT00969761|18013582|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218281|NCT00969761|18013583|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218282|NCT00969761|18013584|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5218283|NCT00969761|18013573|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218284|NCT00969761|18013574|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218285|NCT00969761|18013575|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218286|NCT00969761|18013576|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218287|NCT00969761|18013577|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218288|NCT00969761|18013578|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218289|NCT00969761|18013579|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218290|NCT00969761|18013580|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218291|NCT00969761|18013581|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218292|NCT00969761|18013582|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
5218293|NCT00969761|18013583|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218294|NCT00969761|18013584|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5218295|NCT00969761|18013573|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218296|NCT00969761|18013574|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218297|NCT00969761|18013575|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218298|NCT00969761|18013576|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218299|NCT00969761|18013577|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218300|NCT00969761|18013578|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218301|NCT00969761|18013579|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218302|NCT00969761|18013580|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218303|NCT00969761|18013581|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218304|NCT00969761|18013582|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
5218305|NCT00969761|18013583|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218306|NCT00969761|18013584|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5218307|NCT00969761|18013573|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218308|NCT00969761|18013574|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218393|NCT00969553|18013934|P2|Overall Study|Progressive disease (PD)|2
5218309|NCT00969761|18013575|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5218310|NCT00969761|18013576|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5218311|NCT00969761|18013577|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218312|NCT00969761|18013578|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218313|NCT00969761|18013579|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218314|NCT00969761|18013580|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218315|NCT00969761|18013581|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5218316|NCT00969761|18013582|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218317|NCT00969761|18013583|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5218318|NCT00969761|18013584|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5218319|NCT00969709|18013890|P4|Overall Study|Other reasons|0
5218320|NCT00969709|18013891|P3|Overall Study|Other reasons|3
5218321|NCT00969709|18013892|P2|Overall Study|Other reasons|0
5218322|NCT00969709|18013893|P1|Overall Study|Other reasons|0
5218323|NCT00969709|18013890|P4|Overall Study|Lost to Follow-up|15
5218324|NCT00969709|18013891|P3|Overall Study|Lost to Follow-up|8
5218325|NCT00969709|18013892|P2|Overall Study|Lost to Follow-up|14
5218326|NCT00969709|18013893|P1|Overall Study|Lost to Follow-up|10
5218327|NCT00969709|18013890|P4|Overall Study|Withdrawal by Subject|23
5218328|NCT00969709|18013891|P3|Overall Study|Withdrawal by Subject|11
5218329|NCT00969709|18013892|P2|Overall Study|Withdrawal by Subject|12
5218330|NCT00969709|18013893|P1|Overall Study|Withdrawal by Subject|9
5218331|NCT00969709|18013890|P4|Overall Study|Protocol Violation|10
5218332|NCT00969709|18013891|P3|Overall Study|Protocol Violation|9
5218333|NCT00969709|18013892|P2|Overall Study|Protocol Violation|5
5218334|NCT00969709|18013893|P1|Overall Study|Protocol Violation|9
5218335|NCT00969709|18013890|P4|Overall Study|Lack of Efficacy|3
5218336|NCT00969709|18013891|P3|Overall Study|Lack of Efficacy|1
5218337|NCT00969709|18013892|P2|Overall Study|Lack of Efficacy|4
5218338|NCT00969709|18013893|P1|Overall Study|Lack of Efficacy|7
5218339|NCT00969709|18013890|P4|Overall Study|Adverse Event|12
5218340|NCT00969709|18013891|P3|Overall Study|Adverse Event|26
5218341|NCT00969709|18013892|P2|Overall Study|Adverse Event|13
5218342|NCT00969709|18013893|P1|Overall Study|Adverse Event|3
5218343|NCT00969618|18013907|P1|Overall Study|Withdrawal by Subject|27
5218344|NCT00969618|18013907|P1|Overall Study|Protocol Violation|9
5218345|NCT00969618|18013907|P1|Overall Study|Physician Decision|1
5218346|NCT00969618|18013907|P1|Overall Study|Lost to Follow-up|7
5218347|NCT00969618|18013907|P1|Overall Study|Lack of Efficacy|2
5218348|NCT00969618|18013907|P1|Overall Study|Entry Criteria Not Met|3
5218349|NCT00969618|18013907|P1|Overall Study|Adverse Event|29
5218350|NCT00969553|18013927|P9|Overall Study|Not specified above|0
5218351|NCT00969553|18013928|P8|Overall Study|Not specified above|1
5218352|NCT00969553|18013929|P7|Overall Study|Not specified above|1
5218353|NCT00969553|18013930|P6|Overall Study|Not specified above|0
5218354|NCT00969553|18013931|P5|Overall Study|Not specified above|0
5218355|NCT00969553|18013932|P4|Overall Study|Not specified above|4
5218356|NCT00969553|18013933|P3|Overall Study|Not specified above|0
5218357|NCT00969553|18013934|P2|Overall Study|Not specified above|0
5218358|NCT00969553|18013935|P1|Overall Study|Not specified above|0
5218359|NCT00969553|18013927|P9|Overall Study|Refused cont. medication|0
5218360|NCT00969553|18013928|P8|Overall Study|Refused cont. medication|1
5218361|NCT00969553|18013929|P7|Overall Study|Refused cont. medication|0
5218362|NCT00969553|18013930|P6|Overall Study|Refused cont. medication|0
5218363|NCT00969553|18013931|P5|Overall Study|Refused cont. medication|0
5218364|NCT00969553|18013932|P4|Overall Study|Refused cont. medication|2
5218365|NCT00969553|18013933|P3|Overall Study|Refused cont. medication|0
5218366|NCT00969553|18013934|P2|Overall Study|Refused cont. medication|1
5218367|NCT00969553|18013935|P1|Overall Study|Refused cont. medication|1
5218368|NCT00969553|18013927|P9|Overall Study|Other Adverse Event|0
5218369|NCT00969553|18013928|P8|Overall Study|Other Adverse Event|0
5218370|NCT00969553|18013929|P7|Overall Study|Other Adverse Event|1
5218371|NCT00969553|18013930|P6|Overall Study|Other Adverse Event|0
5218372|NCT00969553|18013931|P5|Overall Study|Other Adverse Event|0
5218373|NCT00969553|18013932|P4|Overall Study|Other Adverse Event|1
5218374|NCT00969553|18013933|P3|Overall Study|Other Adverse Event|0
5218375|NCT00969553|18013934|P2|Overall Study|Other Adverse Event|0
5218376|NCT00969553|18013935|P1|Overall Study|Other Adverse Event|0
5218377|NCT00969553|18013927|P9|Overall Study|Dose limiting Toxicity (DLT)|0
5218378|NCT00969553|18013928|P8|Overall Study|Dose limiting Toxicity (DLT)|0
5218379|NCT00969553|18013929|P7|Overall Study|Dose limiting Toxicity (DLT)|0
5218380|NCT00969553|18013930|P6|Overall Study|Dose limiting Toxicity (DLT)|0
5218381|NCT00969553|18013931|P5|Overall Study|Dose limiting Toxicity (DLT)|1
5218382|NCT00969553|18013932|P4|Overall Study|Dose limiting Toxicity (DLT)|0
5218383|NCT00969553|18013933|P3|Overall Study|Dose limiting Toxicity (DLT)|0
5218384|NCT00969553|18013934|P2|Overall Study|Dose limiting Toxicity (DLT)|0
5218385|NCT00969553|18013935|P1|Overall Study|Dose limiting Toxicity (DLT)|0
5218386|NCT00969553|18013927|P9|Overall Study|Progressive disease (PD)|3
5218387|NCT00969553|18013928|P8|Overall Study|Progressive disease (PD)|12
5218388|NCT00969553|18013929|P7|Overall Study|Progressive disease (PD)|2
5218389|NCT00969553|18013930|P6|Overall Study|Progressive disease (PD)|4
5218390|NCT00969553|18013931|P5|Overall Study|Progressive disease (PD)|2
5218391|NCT00969553|18013932|P4|Overall Study|Progressive disease (PD)|9
5218392|NCT00969553|18013933|P3|Overall Study|Progressive disease (PD)|6
5218394|NCT00969553|18013935|P1|Overall Study|Progressive disease (PD)|2
5218395|NCT00969540|18014078|P2|Overall Study|Lost to Follow-up|1
5218396|NCT00969540|18014079|P1|Overall Study|Lost to Follow-up|1
5218397|NCT00969436|18014104|P3|Overall Study|Lost to Follow-up|5
5218398|NCT00969436|18014105|P2|Overall Study|Lost to Follow-up|8
5218399|NCT00969436|18014106|P1|Overall Study|Lost to Follow-up|8
5218400|NCT00969436|18014104|P3|Overall Study|Withdrawal by Subject|2
5218401|NCT00969436|18014105|P2|Overall Study|Withdrawal by Subject|0
5218402|NCT00969436|18014106|P1|Overall Study|Withdrawal by Subject|3
5218403|NCT00969436|18014104|P3|Overall Study|Subject eliminated (other vaccine)|0
5218404|NCT00969436|18014105|P2|Overall Study|Subject eliminated (other vaccine)|0
5218405|NCT00969436|18014106|P1|Overall Study|Subject eliminated (other vaccine)|1
5218406|NCT00969436|18014104|P3|Overall Study|Parents personal problem|1
5218407|NCT00969436|18014105|P2|Overall Study|Parents personal problem|0
5218408|NCT00969436|18014106|P1|Overall Study|Parents personal problem|0
5218409|NCT00969436|18014104|P3|Overall Study|Father - serious health problem|1
5218410|NCT00969436|18014105|P2|Overall Study|Father - serious health problem|0
5218411|NCT00969436|18014106|P1|Overall Study|Father - serious health problem|0
5218412|NCT00969436|18014104|P3|Overall Study|Migrated/moved from study area|2
5218413|NCT00969436|18014105|P2|Overall Study|Migrated/moved from study area|10
5218414|NCT00969436|18014106|P1|Overall Study|Migrated/moved from study area|12
5218415|NCT00969436|18014104|P3|Overall Study|Protocol Violation|0
5218416|NCT00969436|18014105|P2|Overall Study|Protocol Violation|3
5218417|NCT00969436|18014106|P1|Overall Study|Protocol Violation|1
5218418|NCT00969332|18014138|P1|Overall Study|Withdrawal by Subject|3
5218419|NCT00969332|18014138|P1|Overall Study|Physician Decision|8
5218420|NCT00969280|18014154|P2|Overall Study|infection of influenza A(H1N1)|1
5218421|NCT00969280|18014155|P1|Overall Study|infection of influenza A(H1N1)|0
5218422|NCT00969280|18014154|P2|Overall Study|Withdrawal by Subject|1
5218423|NCT00969280|18014155|P1|Overall Study|Withdrawal by Subject|0
5218424|NCT00969280|18014154|P2|Overall Study|Protocol Violation|1
5218425|NCT00969280|18014155|P1|Overall Study|Protocol Violation|2
5218426|NCT00969228|18014163|P2|Overall Study|Porcine circovirus detection in vaccine|14
5218427|NCT00969228|18014164|P1|Overall Study|Porcine circovirus detection in vaccine|38
5218428|NCT00969228|18014163|P2|Overall Study|Withdrawal by Subject|0
5218429|NCT00969228|18014164|P1|Overall Study|Withdrawal by Subject|4
5218430|NCT00969228|18014163|P2|Overall Study|Adverse Event|0
5218431|NCT00969228|18014164|P1|Overall Study|Adverse Event|1
5218432|NCT00969150|18014182|P2|Overall Study|Other reasons|0
5218433|NCT00969150|18014183|P1|Overall Study|Other reasons|1
5218434|NCT00969150|18014182|P2|Overall Study|Lost to Follow-up|4
5218435|NCT00969150|18014183|P1|Overall Study|Lost to Follow-up|5
5218436|NCT00969150|18014182|P2|Overall Study|Withdrawal by Subject|9
5218437|NCT00969150|18014183|P1|Overall Study|Withdrawal by Subject|13
5218438|NCT00969150|18014182|P2|Overall Study|Protocol Violation|12
5218439|NCT00969150|18014183|P1|Overall Study|Protocol Violation|9
5218440|NCT00969150|18014182|P2|Overall Study|Lack of Efficacy|1
5218441|NCT00969150|18014183|P1|Overall Study|Lack of Efficacy|1
5218442|NCT00969150|18014182|P2|Overall Study|Adverse Event|14
5218443|NCT00969150|18014183|P1|Overall Study|Adverse Event|4
5218444|NCT00969124|18014191|P1|Overall Study|Technical error|1
5218445|NCT00969124|18014191|P1|Overall Study|Previously unrecognized disease|3
5218446|NCT00969124|18014191|P1|Overall Study|Inability to reach cecum|9
5218447|NCT00969124|18014191|P1|Overall Study|Inadequate bowel preparation|15
5218448|NCT00969124|18014191|P1|Overall Study|Protocol Violation|2
5218449|NCT00968981|18014200|P3|Overall Study|Withdrawal by Subject|3
5218450|NCT00968981|18014201|P2|Overall Study|Withdrawal by Subject|3
5218451|NCT00968981|18014202|P1|Overall Study|Withdrawal by Subject|1
5218452|NCT00968981|18014200|P3|Overall Study|Physician Decision|5
5218453|NCT00968981|18014201|P2|Overall Study|Physician Decision|3
5218454|NCT00968981|18014202|P1|Overall Study|Physician Decision|5
5218455|NCT00968981|18014200|P3|Overall Study|Lost to Follow-up|1
5218456|NCT00968981|18014201|P2|Overall Study|Lost to Follow-up|0
5218457|NCT00968981|18014202|P1|Overall Study|Lost to Follow-up|0
5218458|NCT00968981|18014200|P3|Overall Study|Disease Progression|13
5218459|NCT00968981|18014201|P2|Overall Study|Disease Progression|16
5218460|NCT00968981|18014202|P1|Overall Study|Disease Progression|14
5218461|NCT00968981|18014200|P3|Overall Study|Adverse Event|0
5218462|NCT00968981|18014201|P2|Overall Study|Adverse Event|0
5218463|NCT00968981|18014202|P1|Overall Study|Adverse Event|2
5218464|NCT00968968|18014240|P2|Overall Study|Lost to Follow-up|1
5218465|NCT00968968|18014241|P1|Overall Study|Lost to Follow-up|0
5218466|NCT00968968|18014240|P2|Overall Study|Physician Decision|2
5218467|NCT00968968|18014241|P1|Overall Study|Physician Decision|1
5218468|NCT00968968|18014240|P2|Overall Study|Withdrawal by Subject|0
5218469|NCT00968968|18014241|P1|Overall Study|Withdrawal by Subject|2
5218470|NCT00968968|18014240|P2|Overall Study|Protocol defined stopping criteria|1
5218471|NCT00968968|18014241|P1|Overall Study|Protocol defined stopping criteria|3
5218472|NCT00968968|18014240|P2|Overall Study|Study closed/terminated|10
5218473|NCT00968968|18014241|P1|Overall Study|Study closed/terminated|10
5218474|NCT00968864|18014287|P1|Overall Study|Protocol exception/ not evaluable|1
5218475|NCT00968812|18014315|P3|Overall Study|Other|40
5218476|NCT00968812|18014316|P2|Overall Study|Other|37
5218477|NCT00968812|18014317|P1|Overall Study|Other|25
5218478|NCT00968812|18014315|P3|Overall Study|Unable to take rescue therapy|17
5218479|NCT00968812|18014316|P2|Overall Study|Unable to take rescue therapy|12
5218480|NCT00968812|18014317|P1|Overall Study|Unable to take rescue therapy|12
5218481|NCT00968812|18014315|P3|Overall Study|Noncompliance with study drug|6
5218482|NCT00968812|18014316|P2|Overall Study|Noncompliance with study drug|1
5218483|NCT00968812|18014317|P1|Overall Study|Noncompliance with study drug|4
5218484|NCT00968812|18014315|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
5218485|NCT00968812|18014316|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
5218486|NCT00968812|18014317|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
5218487|NCT00968812|18014315|P3|Overall Study|Withdrawal by Subject|25
5218488|NCT00968812|18014316|P2|Overall Study|Withdrawal by Subject|23
5218489|NCT00968812|18014317|P1|Overall Study|Withdrawal by Subject|17
5218490|NCT00968812|18014315|P3|Overall Study|Protocol Violation|3
5218491|NCT00968812|18014316|P2|Overall Study|Protocol Violation|4
5218492|NCT00968812|18014317|P1|Overall Study|Protocol Violation|7
5218493|NCT00968812|18014315|P3|Overall Study|Physician Decision|9
5218494|NCT00968812|18014316|P2|Overall Study|Physician Decision|5
5218495|NCT00968812|18014317|P1|Overall Study|Physician Decision|8
5218496|NCT00968812|18014315|P3|Overall Study|Lost to Follow-up|11
5218497|NCT00968812|18014316|P2|Overall Study|Lost to Follow-up|12
5218498|NCT00968812|18014317|P1|Overall Study|Lost to Follow-up|17
5218499|NCT00968812|18014315|P3|Overall Study|Lack of Efficacy|16
5218500|NCT00968812|18014316|P2|Overall Study|Lack of Efficacy|7
5218501|NCT00968812|18014317|P1|Overall Study|Lack of Efficacy|9
5218502|NCT00968812|18014315|P3|Overall Study|Death|1
5218503|NCT00968812|18014316|P2|Overall Study|Death|2
5218504|NCT00968812|18014317|P1|Overall Study|Death|2
5218505|NCT00968812|18014315|P3|Overall Study|Adverse Event|33
5218506|NCT00968812|18014316|P2|Overall Study|Adverse Event|46
5218507|NCT00968812|18014317|P1|Overall Study|Adverse Event|30
5218508|NCT00968799|18014337|P1|Overall Study|Advanced disease, HIPEC not applicable|2
5218509|NCT00968708|18014347|P2|Overall Study|Other|34
5218510|NCT00968708|18014348|P1|Overall Study|Other|26
5218511|NCT00968708|18014347|P2|Overall Study|Investigator Discretion|1
5218512|NCT00968708|18014348|P1|Overall Study|Investigator Discretion|0
5218513|NCT00968708|18014347|P2|Overall Study|Voluntary Withdrawal|101
5218514|NCT00968708|18014348|P1|Overall Study|Voluntary Withdrawal|104
5218515|NCT00968708|18014347|P2|Overall Study|Lost to Follow-up|11
5218516|NCT00968708|18014348|P1|Overall Study|Lost to Follow-up|19
5218517|NCT00968708|18014347|P2|Overall Study|Major Protocol Deviation|1
5218518|NCT00968708|18014348|P1|Overall Study|Major Protocol Deviation|0
5218519|NCT00968708|18014347|P2|Overall Study|Adverse Event|150
5218520|NCT00968708|18014348|P1|Overall Study|Adverse Event|169
5218521|NCT00968669|18014360|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
5218522|NCT00968669|18014361|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5218523|NCT00968669|18014362|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5218524|NCT00968669|18014363|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5218525|NCT00968669|18014360|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5218526|NCT00968669|18014361|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5218527|NCT00968669|18014362|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
5218528|NCT00968669|18014363|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5218529|NCT00968669|18014360|P4|Overall Study|SUBJECT INCARCERATED|0
5218530|NCT00968669|18014361|P3|Overall Study|SUBJECT INCARCERATED|0
5218531|NCT00968669|18014362|P2|Overall Study|SUBJECT INCARCERATED|1
5218532|NCT00968669|18014363|P1|Overall Study|SUBJECT INCARCERATED|0
5218533|NCT00968669|18014360|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5218534|NCT00968669|18014361|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5218535|NCT00968669|18014362|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
5218536|NCT00968669|18014363|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5218537|NCT00968669|18014360|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5218538|NCT00968669|18014361|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
5218539|NCT00968669|18014362|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5218540|NCT00968669|18014363|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5218541|NCT00968669|18014360|P4|Overall Study|SPONSOR DECISION|0
5218542|NCT00968669|18014361|P3|Overall Study|SPONSOR DECISION|0
5218543|NCT00968669|18014362|P2|Overall Study|SPONSOR DECISION|1
5218544|NCT00968669|18014363|P1|Overall Study|SPONSOR DECISION|0
5218545|NCT00968669|18014360|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5218546|NCT00968669|18014361|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5218547|NCT00968669|18014362|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
5218548|NCT00968669|18014363|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5218549|NCT00968669|18014360|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5218550|NCT00968669|18014361|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5218551|NCT00968669|18014362|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
5218552|NCT00968669|18014363|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5218553|NCT00968669|18014360|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5218554|NCT00968669|18014361|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5218555|NCT00968669|18014362|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
5218556|NCT00968669|18014363|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5218557|NCT00968669|18014360|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5218558|NCT00968669|18014361|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5218559|NCT00968669|18014362|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
5218560|NCT00968669|18014363|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5218561|NCT00968669|18014360|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5218562|NCT00968669|18014361|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5218563|NCT00968669|18014362|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5218564|NCT00968669|18014363|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
5218565|NCT00968669|18014360|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
5218566|NCT00968669|18014361|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
5218567|NCT00968669|18014362|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
5218568|NCT00968669|18014363|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
5218569|NCT00968669|18014360|P4|Overall Study|EARLY WITHDRAWAL|0
5218570|NCT00968669|18014361|P3|Overall Study|EARLY WITHDRAWAL|0
5218571|NCT00968669|18014362|P2|Overall Study|EARLY WITHDRAWAL|1
5218572|NCT00968669|18014363|P1|Overall Study|EARLY WITHDRAWAL|0
5218573|NCT00968669|18014360|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5218574|NCT00968669|18014361|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
5218575|NCT00968669|18014362|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5218576|NCT00968669|18014363|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5218577|NCT00968669|18014360|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5218578|NCT00968669|18014361|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5218579|NCT00968669|18014362|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5218580|NCT00968669|18014363|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
5218581|NCT00968669|18014360|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5218582|NCT00968669|18014361|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5218583|NCT00968669|18014362|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5218584|NCT00968669|18014363|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
5218585|NCT00968669|18014360|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
5218586|NCT00968669|18014361|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5218587|NCT00968669|18014362|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5218588|NCT00968669|18014363|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5218589|NCT00968669|18014360|P4|Overall Study|AE|0
5218590|NCT00968669|18014361|P3|Overall Study|AE|0
5218591|NCT00968669|18014362|P2|Overall Study|AE|0
5218592|NCT00968669|18014363|P1|Overall Study|AE|1
5218593|NCT00968669|18014360|P4|Overall Study|Pregnancy|0
5218594|NCT00968669|18014361|P3|Overall Study|Pregnancy|2
5218595|NCT00968669|18014362|P2|Overall Study|Pregnancy|0
5218596|NCT00968669|18014363|P1|Overall Study|Pregnancy|0
5218597|NCT00968669|18014360|P4|Overall Study|Withdrawal by Subject|3
5218598|NCT00968669|18014361|P3|Overall Study|Withdrawal by Subject|5
5218599|NCT00968669|18014362|P2|Overall Study|Withdrawal by Subject|7
5218600|NCT00968669|18014363|P1|Overall Study|Withdrawal by Subject|9
5218601|NCT00968669|18014360|P4|Overall Study|Lost to Follow-up|4
5218602|NCT00968669|18014361|P3|Overall Study|Lost to Follow-up|1
5218603|NCT00968669|18014362|P2|Overall Study|Lost to Follow-up|2
5218604|NCT00968669|18014363|P1|Overall Study|Lost to Follow-up|5
5218605|NCT00968617|18014453|P1|Overall Study|Study terminated by sponsor|6
5218606|NCT00968539|18014467|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
5218607|NCT00968539|18014468|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
5218608|NCT00968526|18014528|P2|Overall Study|Migrated/moved from study area|0
5218609|NCT00968526|18014529|P1|Overall Study|Migrated/moved from study area|1
5218610|NCT00968526|18014528|P2|Overall Study|Adverse Event|0
5218611|NCT00968526|18014529|P1|Overall Study|Adverse Event|2
5218612|NCT00968253|18014631|P3|Overall Study|Adverse Event|1
5218613|NCT00968253|18014632|P2|Overall Study|Adverse Event|0
5218614|NCT00968253|18014633|P1|Overall Study|Adverse Event|0
5218615|NCT00968253|18014631|P3|Overall Study|Disease Progression|3
5218616|NCT00968253|18014632|P2|Overall Study|Disease Progression|3
5218617|NCT00968253|18014633|P1|Overall Study|Disease Progression|0
5218618|NCT00968253|18014631|P3|Overall Study|Withdrawal by Subject|1
5218619|NCT00968253|18014632|P2|Overall Study|Withdrawal by Subject|0
5218620|NCT00968253|18014633|P1|Overall Study|Withdrawal by Subject|0
5218621|NCT00968253|18014631|P3|Overall Study|Death|2
5218622|NCT00968253|18014632|P2|Overall Study|Death|0
5218623|NCT00968253|18014633|P1|Overall Study|Death|0
5218624|NCT00968201|18014654|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
5218625|NCT00968201|18014655|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
5218626|NCT00968201|18014656|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
5218627|NCT00968201|18014654|P3|Extension Study - (Period III)|Other|2
5218628|NCT00968201|18014655|P2|Extension Study - (Period III)|Other|0
5218629|NCT00968201|18014656|P1|Extension Study - (Period III)|Other|0
5218630|NCT00968201|18014654|P3|Extension Study - (Period III)|Noncompliance|3
5218631|NCT00968201|18014655|P2|Extension Study - (Period III)|Noncompliance|0
5218632|NCT00968201|18014656|P1|Extension Study - (Period III)|Noncompliance|0
5218633|NCT00968201|18014654|P3|Extension Study - (Period III)|Patient Relocated|1
5218634|NCT00968201|18014655|P2|Extension Study - (Period III)|Patient Relocated|1
5218635|NCT00968201|18014656|P1|Extension Study - (Period III)|Patient Relocated|0
5218636|NCT00968201|18014654|P3|Extension Study - (Period III)|Withdrawal by Subject|40
5218637|NCT00968201|18014655|P2|Extension Study - (Period III)|Withdrawal by Subject|20
5218638|NCT00968201|18014656|P1|Extension Study - (Period III)|Withdrawal by Subject|0
5218639|NCT00968201|18014654|P3|Extension Study - (Period III)|Protocol Violation|14
5218640|NCT00968201|18014655|P2|Extension Study - (Period III)|Protocol Violation|17
5218641|NCT00968201|18014656|P1|Extension Study - (Period III)|Protocol Violation|0
5218642|NCT00968201|18014654|P3|Extension Study - (Period III)|Lost to Follow-up|13
5218643|NCT00968201|18014655|P2|Extension Study - (Period III)|Lost to Follow-up|7
5218644|NCT00968201|18014656|P1|Extension Study - (Period III)|Lost to Follow-up|0
5218645|NCT00968201|18014654|P3|Extension Study - (Period III)|Adverse Event|22
5218646|NCT00968201|18014655|P2|Extension Study - (Period III)|Adverse Event|5
5218647|NCT00968201|18014656|P1|Extension Study - (Period III)|Adverse Event|0
5218648|NCT00968201|18014654|P3|Base Study - (Period II)|Site Error|1
5218649|NCT00968201|18014655|P2|Base Study - (Period II)|Site Error|0
5218650|NCT00968201|18014656|P1|Base Study - (Period II)|Site Error|0
5218651|NCT00968201|18014654|P3|Base Study - (Period II)|Withdrawal by Subject|8
5218652|NCT00968201|18014655|P2|Base Study - (Period II)|Withdrawal by Subject|0
5218653|NCT00968201|18014656|P1|Base Study - (Period II)|Withdrawal by Subject|4
5218654|NCT00968201|18014654|P3|Base Study - (Period II)|Protocol Violation|12
5218655|NCT00968201|18014655|P2|Base Study - (Period II)|Protocol Violation|0
5218656|NCT00968201|18014656|P1|Base Study - (Period II)|Protocol Violation|12
5218657|NCT00968201|18014654|P3|Base Study - (Period II)|Lost to Follow-up|7
5218658|NCT00968201|18014655|P2|Base Study - (Period II)|Lost to Follow-up|0
5218659|NCT00968201|18014656|P1|Base Study - (Period II)|Lost to Follow-up|2
5218660|NCT00968201|18014654|P3|Base Study - (Period II)|Lack of Efficacy|1
5218661|NCT00968201|18014655|P2|Base Study - (Period II)|Lack of Efficacy|0
5218662|NCT00968201|18014656|P1|Base Study - (Period II)|Lack of Efficacy|0
5218663|NCT00968201|18014654|P3|Base Study - (Period II)|Adverse Event|16
5218664|NCT00968201|18014655|P2|Base Study - (Period II)|Adverse Event|0
5218665|NCT00968201|18014656|P1|Base Study - (Period II)|Adverse Event|8
5218666|NCT00968149|18014717|P2|Overall Study|Withdrawal by Subject|0
5218667|NCT00968149|18014718|P1|Overall Study|Withdrawal by Subject|2
5218668|NCT00968149|18014717|P2|Overall Study|Protocol Violation|0
5218669|NCT00968149|18014718|P1|Overall Study|Protocol Violation|4
5218670|NCT00968149|18014717|P2|Overall Study|Lost to Follow-up|1
5218671|NCT00968149|18014718|P1|Overall Study|Lost to Follow-up|0
5218672|NCT00968149|18014717|P2|Overall Study|Lack of Efficacy|4
5218673|NCT00968149|18014718|P1|Overall Study|Lack of Efficacy|0
5218674|NCT00968149|18014717|P2|Overall Study|Adverse Event|1
5218675|NCT00968149|18014718|P1|Overall Study|Adverse Event|5
5218676|NCT00967798|18014786|P2|Overall Study|Lost to Follow-up|1
5218677|NCT00967798|18014787|P1|Overall Study|Lost to Follow-up|4
5218678|NCT00967798|18014786|P2|Overall Study|Withdrawal by Subject|2
5218679|NCT00967798|18014787|P1|Overall Study|Withdrawal by Subject|5
5218680|NCT00967694|18014801|P1|Overall Study|Withdrawal by Subject|6
5218681|NCT00967668|18014808|P3|Overall Study|Pregnancy|0
5218682|NCT00967668|18014809|P2|Overall Study|Pregnancy|0
5218683|NCT00967668|18014810|P1|Overall Study|Pregnancy|1
5218684|NCT00967668|18014808|P3|Overall Study|Refused 12-mo assessment|9
5218685|NCT00967668|18014809|P2|Overall Study|Refused 12-mo assessment|1
5218686|NCT00967668|18014810|P1|Overall Study|Refused 12-mo assessment|3
5218687|NCT00967668|18014808|P3|Overall Study|Lost to Follow-up|16
5218688|NCT00967668|18014809|P2|Overall Study|Lost to Follow-up|9
5218689|NCT00967668|18014810|P1|Overall Study|Lost to Follow-up|15
5218690|NCT00967668|18014808|P3|Overall Study|Lost to follow-up at 12-mo|26
5218691|NCT00967668|18014809|P2|Overall Study|Lost to follow-up at 12-mo|29
5218692|NCT00967668|18014810|P1|Overall Study|Lost to follow-up at 12-mo|27
5218693|NCT00967668|18014808|P3|Overall Study|Refused Year 2|4
5218694|NCT00967668|18014809|P2|Overall Study|Refused Year 2|6
5218695|NCT00967668|18014810|P1|Overall Study|Refused Year 2|11
5218696|NCT00967668|18014808|P3|Overall Study|Removed due to behavior|2
5218697|NCT00967668|18014809|P2|Overall Study|Removed due to behavior|1
5218698|NCT00967668|18014810|P1|Overall Study|Removed due to behavior|1
5218699|NCT00967668|18014808|P3|Overall Study|Death|4
5218700|NCT00967668|18014809|P2|Overall Study|Death|2
5218701|NCT00967668|18014810|P1|Overall Study|Death|0
5218702|NCT00967668|18014808|P3|Overall Study|Withdrawal by Subject|8
5218703|NCT00967668|18014809|P2|Overall Study|Withdrawal by Subject|8
5218704|NCT00967668|18014810|P1|Overall Study|Withdrawal by Subject|13
5218705|NCT00967616|18014823|P2|Overall Study|Protocol Violation|0
5218706|NCT00967616|18014824|P1|Overall Study|Protocol Violation|1
5218707|NCT00967616|18014823|P2|Overall Study|Other|8
5218708|NCT00967616|18014824|P1|Overall Study|Other|8
5218709|NCT00967616|18014823|P2|Overall Study|Progressive Disease|18
5218710|NCT00967616|18014824|P1|Overall Study|Progressive Disease|31
5218711|NCT00967616|18014823|P2|Overall Study|Withdrawal by Subject|4
5218712|NCT00967616|18014824|P1|Overall Study|Withdrawal by Subject|8
5218713|NCT00967616|18014823|P2|Overall Study|Death|3
5218714|NCT00967616|18014824|P1|Overall Study|Death|0
5218715|NCT00967616|18014823|P2|Overall Study|Adverse Event or Serious Adverse Event|17
5218716|NCT00967616|18014824|P1|Overall Study|Adverse Event or Serious Adverse Event|2
5218717|NCT00967330|18014892|P2|Overall Study|Severe protocol deviation|1
5218718|NCT00967330|18014893|P1|Overall Study|Severe protocol deviation|0
5218719|NCT00967330|18014892|P2|Overall Study|Death|51
5218720|NCT00967330|18014893|P1|Overall Study|Death|102
5218721|NCT00967330|18014892|P2|Overall Study|Lost to Follow-up|1
5218722|NCT00967330|18014893|P1|Overall Study|Lost to Follow-up|1
5218723|NCT00967330|18014892|P2|Overall Study|Withdrawal by Subject|0
5218724|NCT00967330|18014893|P1|Overall Study|Withdrawal by Subject|6
5218725|NCT00967330|18014892|P2|Overall Study|Regular|3
5218726|NCT00967330|18014893|P1|Overall Study|Regular|10
5218727|NCT00967330|18014892|P2|Overall Study|Protocol Violation|4
5218728|NCT00967330|18014893|P1|Overall Study|Protocol Violation|3
5218729|NCT00967226|18014923|P2|Overall Study|Physician Decision|1
5218730|NCT00967226|18014924|P1|Overall Study|Physician Decision|0
5218731|NCT00967226|18014923|P2|Overall Study|Protocol Violation|0
5218732|NCT00967226|18014924|P1|Overall Study|Protocol Violation|2
5218733|NCT00967226|18014923|P2|Overall Study|Adverse Event|5
5218734|NCT00967226|18014924|P1|Overall Study|Adverse Event|0
5218735|NCT00967018|18014958|P1|Overall Study|Miscellaneous Reasons|9
5218736|NCT00967018|18014958|P1|Overall Study|Withdrawal by Subject|1
5218737|NCT00967018|18014958|P1|Overall Study|Lost to Follow-up|2
5218738|NCT00967018|18014958|P1|Overall Study|Physician Decision|7
5218739|NCT00967018|18014958|P1|Overall Study|Adverse Event|2
5218740|NCT00967005|18014967|P2|Overall Study|Lost to Follow-up|10
5218741|NCT00967005|18014968|P1|Overall Study|Lost to Follow-up|7
5218742|NCT00966940|18015054|P2|Period 1, First 6 Weeks|Protocol Violation|0
5218743|NCT00966940|18015055|P1|Period 1, First 6 Weeks|Protocol Violation|1
5218744|NCT00966940|18015054|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
5218745|NCT00966940|18015055|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
5218746|NCT00966875|18015082|P9|Part B|Entry Criteria|1
5218747|NCT00966875|18015083|P8|Part B|Entry Criteria|0
5218748|NCT00966875|18015084|P7|Part B|Entry Criteria|1
5218749|NCT00966875|18015085|P6|Part B|Entry Criteria|0
5218750|NCT00966875|18015086|P5|Part B|Entry Criteria|0
5218751|NCT00966875|18015087|P4|Part B|Entry Criteria|0
5218752|NCT00966875|18015088|P3|Part B|Entry Criteria|0
5218753|NCT00966875|18015089|P2|Part B|Entry Criteria|0
5218754|NCT00966875|18015090|P1|Part B|Entry Criteria|0
5218755|NCT00966875|18015082|P9|Part B|Withdrawal by Subject|5
5218756|NCT00966875|18015083|P8|Part B|Withdrawal by Subject|5
5218757|NCT00966875|18015084|P7|Part B|Withdrawal by Subject|4
5218758|NCT00966875|18015085|P6|Part B|Withdrawal by Subject|1
5218759|NCT00966875|18015086|P5|Part B|Withdrawal by Subject|2
5218760|NCT00966875|18015087|P4|Part B|Withdrawal by Subject|1
5218761|NCT00966875|18015088|P3|Part B|Withdrawal by Subject|2
5218762|NCT00966875|18015089|P2|Part B|Withdrawal by Subject|1
5218763|NCT00966875|18015090|P1|Part B|Withdrawal by Subject|2
5218764|NCT00966875|18015082|P9|Part B|Sponsor Decision|1
5218765|NCT00966875|18015083|P8|Part B|Sponsor Decision|2
5218766|NCT00966875|18015084|P7|Part B|Sponsor Decision|0
5218767|NCT00966875|18015085|P6|Part B|Sponsor Decision|1
5218768|NCT00966875|18015086|P5|Part B|Sponsor Decision|0
5218769|NCT00966875|18015087|P4|Part B|Sponsor Decision|0
5218770|NCT00966875|18015088|P3|Part B|Sponsor Decision|0
5218771|NCT00966875|18015089|P2|Part B|Sponsor Decision|0
5218772|NCT00966875|18015090|P1|Part B|Sponsor Decision|1
5218773|NCT00966875|18015082|P9|Part B|Physician Decision|2
5218774|NCT00966875|18015083|P8|Part B|Physician Decision|0
5218775|NCT00966875|18015084|P7|Part B|Physician Decision|0
5218776|NCT00966875|18015085|P6|Part B|Physician Decision|1
5218777|NCT00966875|18015086|P5|Part B|Physician Decision|2
5218778|NCT00966875|18015087|P4|Part B|Physician Decision|0
5218779|NCT00966875|18015088|P3|Part B|Physician Decision|1
5218780|NCT00966875|18015089|P2|Part B|Physician Decision|0
5218781|NCT00966875|18015090|P1|Part B|Physician Decision|0
5218782|NCT00966875|18015082|P9|Part B|Lost to Follow-up|1
5218783|NCT00966875|18015083|P8|Part B|Lost to Follow-up|0
5218784|NCT00966875|18015084|P7|Part B|Lost to Follow-up|0
5218785|NCT00966875|18015085|P6|Part B|Lost to Follow-up|0
5218786|NCT00966875|18015086|P5|Part B|Lost to Follow-up|0
5218787|NCT00966875|18015087|P4|Part B|Lost to Follow-up|1
5218788|NCT00966875|18015088|P3|Part B|Lost to Follow-up|0
5218789|NCT00966875|18015089|P2|Part B|Lost to Follow-up|0
5218790|NCT00966875|18015090|P1|Part B|Lost to Follow-up|0
5218791|NCT00966875|18015082|P9|Part B|Lack of Efficacy|6
5218792|NCT00966875|18015083|P8|Part B|Lack of Efficacy|9
5218793|NCT00966875|18015084|P7|Part B|Lack of Efficacy|12
5218794|NCT00966875|18015085|P6|Part B|Lack of Efficacy|3
5218795|NCT00966875|18015086|P5|Part B|Lack of Efficacy|2
5218796|NCT00966875|18015087|P4|Part B|Lack of Efficacy|1
5218797|NCT00966875|18015088|P3|Part B|Lack of Efficacy|1
5218798|NCT00966875|18015089|P2|Part B|Lack of Efficacy|1
5218799|NCT00966875|18015090|P1|Part B|Lack of Efficacy|2
5218800|NCT00966875|18015082|P9|Part B|Death|0
5218801|NCT00966875|18015083|P8|Part B|Death|1
5218802|NCT00966875|18015084|P7|Part B|Death|0
5218803|NCT00966875|18015085|P6|Part B|Death|0
5218804|NCT00966875|18015086|P5|Part B|Death|0
5218805|NCT00966875|18015087|P4|Part B|Death|0
5218806|NCT00966875|18015088|P3|Part B|Death|1
5218807|NCT00966875|18015089|P2|Part B|Death|0
5218808|NCT00966875|18015090|P1|Part B|Death|0
5218809|NCT00966875|18015082|P9|Part B|Adverse Event|2
5218810|NCT00966875|18015083|P8|Part B|Adverse Event|2
5218811|NCT00966875|18015084|P7|Part B|Adverse Event|5
5218812|NCT00966875|18015085|P6|Part B|Adverse Event|0
5218813|NCT00966875|18015086|P5|Part B|Adverse Event|1
5218814|NCT00966875|18015087|P4|Part B|Adverse Event|0
5218815|NCT00966875|18015088|P3|Part B|Adverse Event|1
5218816|NCT00966875|18015089|P2|Part B|Adverse Event|1
5218817|NCT00966875|18015090|P1|Part B|Adverse Event|0
5218818|NCT00966875|18015082|P9|Part A|Protocol Violation|1
5218819|NCT00966875|18015083|P8|Part A|Protocol Violation|1
5218820|NCT00966875|18015084|P7|Part A|Protocol Violation|2
5218821|NCT00966875|18015085|P6|Part A|Protocol Violation|0
5218822|NCT00966875|18015086|P5|Part A|Protocol Violation|0
5218823|NCT00966875|18015087|P4|Part A|Protocol Violation|0
5218824|NCT00966875|18015088|P3|Part A|Protocol Violation|0
5218825|NCT00966875|18015089|P2|Part A|Protocol Violation|0
5218826|NCT00966875|18015090|P1|Part A|Protocol Violation|0
5218827|NCT00966875|18015082|P9|Part A|Withdrawal by Subject|1
5218828|NCT00966875|18015083|P8|Part A|Withdrawal by Subject|1
5218829|NCT00966875|18015084|P7|Part A|Withdrawal by Subject|5
5218830|NCT00966875|18015085|P6|Part A|Withdrawal by Subject|0
5218831|NCT00966875|18015086|P5|Part A|Withdrawal by Subject|3
5218832|NCT00966875|18015087|P4|Part A|Withdrawal by Subject|1
5218833|NCT00966875|18015088|P3|Part A|Withdrawal by Subject|1
5218834|NCT00966875|18015089|P2|Part A|Withdrawal by Subject|2
5218835|NCT00966875|18015090|P1|Part A|Withdrawal by Subject|2
5218836|NCT00966875|18015082|P9|Part A|Sponsor Decision|1
5218837|NCT00966875|18015083|P8|Part A|Sponsor Decision|2
5218838|NCT00966875|18015084|P7|Part A|Sponsor Decision|0
5218839|NCT00966875|18015085|P6|Part A|Sponsor Decision|0
5218840|NCT00966875|18015086|P5|Part A|Sponsor Decision|1
5218841|NCT00966875|18015087|P4|Part A|Sponsor Decision|0
5218842|NCT00966875|18015088|P3|Part A|Sponsor Decision|1
5218843|NCT00966875|18015089|P2|Part A|Sponsor Decision|0
5218844|NCT00966875|18015090|P1|Part A|Sponsor Decision|0
5218845|NCT00966875|18015082|P9|Part A|Physician Decision|2
5218846|NCT00966875|18015083|P8|Part A|Physician Decision|0
5218847|NCT00966875|18015084|P7|Part A|Physician Decision|1
5218848|NCT00966875|18015085|P6|Part A|Physician Decision|0
5218849|NCT00966875|18015086|P5|Part A|Physician Decision|1
5218850|NCT00966875|18015087|P4|Part A|Physician Decision|0
5218851|NCT00966875|18015088|P3|Part A|Physician Decision|0
5218852|NCT00966875|18015089|P2|Part A|Physician Decision|0
5218853|NCT00966875|18015090|P1|Part A|Physician Decision|0
5218854|NCT00966875|18015082|P9|Part A|Parent/Caregiver Decision|0
5218855|NCT00966875|18015083|P8|Part A|Parent/Caregiver Decision|0
5218856|NCT00966875|18015084|P7|Part A|Parent/Caregiver Decision|0
5218857|NCT00966875|18015085|P6|Part A|Parent/Caregiver Decision|0
5218858|NCT00966875|18015086|P5|Part A|Parent/Caregiver Decision|0
5218859|NCT00966875|18015087|P4|Part A|Parent/Caregiver Decision|1
5218860|NCT00966875|18015088|P3|Part A|Parent/Caregiver Decision|0
5218861|NCT00966875|18015089|P2|Part A|Parent/Caregiver Decision|0
5218862|NCT00966875|18015090|P1|Part A|Parent/Caregiver Decision|0
5218863|NCT00966875|18015082|P9|Part A|Lost to Follow-up|0
5218864|NCT00966875|18015083|P8|Part A|Lost to Follow-up|0
5218865|NCT00966875|18015084|P7|Part A|Lost to Follow-up|0
5218866|NCT00966875|18015085|P6|Part A|Lost to Follow-up|1
5218867|NCT00966875|18015086|P5|Part A|Lost to Follow-up|0
5218868|NCT00966875|18015087|P4|Part A|Lost to Follow-up|0
5218869|NCT00966875|18015088|P3|Part A|Lost to Follow-up|0
5218870|NCT00966875|18015089|P2|Part A|Lost to Follow-up|0
5218871|NCT00966875|18015090|P1|Part A|Lost to Follow-up|2
5218872|NCT00966875|18015082|P9|Part A|Lack of Efficacy|0
5218873|NCT00966875|18015083|P8|Part A|Lack of Efficacy|0
5218874|NCT00966875|18015084|P7|Part A|Lack of Efficacy|4
5218875|NCT00966875|18015085|P6|Part A|Lack of Efficacy|0
5218876|NCT00966875|18015086|P5|Part A|Lack of Efficacy|0
5218877|NCT00966875|18015087|P4|Part A|Lack of Efficacy|0
5218878|NCT00966875|18015088|P3|Part A|Lack of Efficacy|0
5218879|NCT00966875|18015089|P2|Part A|Lack of Efficacy|1
5218880|NCT00966875|18015090|P1|Part A|Lack of Efficacy|0
5218881|NCT00966875|18015082|P9|Part A|Entry Criteria|0
5218882|NCT00966875|18015083|P8|Part A|Entry Criteria|0
5218883|NCT00966875|18015084|P7|Part A|Entry Criteria|0
5218884|NCT00966875|18015085|P6|Part A|Entry Criteria|2
5218885|NCT00966875|18015086|P5|Part A|Entry Criteria|0
5218886|NCT00966875|18015087|P4|Part A|Entry Criteria|0
5218887|NCT00966875|18015088|P3|Part A|Entry Criteria|0
5218888|NCT00966875|18015089|P2|Part A|Entry Criteria|0
5218889|NCT00966875|18015090|P1|Part A|Entry Criteria|0
5218890|NCT00966875|18015082|P9|Part A|Adverse Event|3
5218891|NCT00966875|18015083|P8|Part A|Adverse Event|3
5218892|NCT00966875|18015084|P7|Part A|Adverse Event|0
5218893|NCT00966875|18015085|P6|Part A|Adverse Event|1
5218894|NCT00966875|18015086|P5|Part A|Adverse Event|0
5218895|NCT00966875|18015087|P4|Part A|Adverse Event|1
5218896|NCT00966875|18015088|P3|Part A|Adverse Event|0
5218897|NCT00966875|18015089|P2|Part A|Adverse Event|1
5218898|NCT00966875|18015090|P1|Part A|Adverse Event|2
5218899|NCT00966719|18015441|P2|Overall Study|Lost to Follow-up|11
5218900|NCT00966719|18015442|P1|Overall Study|Lost to Follow-up|6
5218901|NCT00966693|18015466|P4|Overall Study|Disease Progression|16
5218902|NCT00966693|18015467|P3|Overall Study|Disease Progression|1
5218903|NCT00966693|18015468|P2|Overall Study|Disease Progression|0
5218904|NCT00966693|18015469|P1|Overall Study|Disease Progression|0
5218905|NCT00966693|18015466|P4|Overall Study|Withdrawal by Subject|5
5218906|NCT00966693|18015467|P3|Overall Study|Withdrawal by Subject|0
5218907|NCT00966693|18015468|P2|Overall Study|Withdrawal by Subject|0
5218908|NCT00966693|18015469|P1|Overall Study|Withdrawal by Subject|1
5218909|NCT00966693|18015466|P4|Overall Study|Death|0
5218910|NCT00966693|18015467|P3|Overall Study|Death|1
5218911|NCT00966693|18015468|P2|Overall Study|Death|0
5218912|NCT00966693|18015469|P1|Overall Study|Death|0
5218913|NCT00966693|18015466|P4|Overall Study|Adverse Event|2
5218914|NCT00966693|18015467|P3|Overall Study|Adverse Event|1
5218915|NCT00966693|18015468|P2|Overall Study|Adverse Event|0
5218916|NCT00966693|18015469|P1|Overall Study|Adverse Event|0
5218917|NCT00966654|18015503|P1|Overall Study|Study was terminated,PI left institution|12
5218918|NCT00966355|18015577|P3|Overall Study|Lost to Follow-up|3
5218919|NCT00966355|18015578|P2|Overall Study|Lost to Follow-up|4
5218920|NCT00966355|18015579|P1|Overall Study|Lost to Follow-up|5
5218921|NCT00966355|18015577|P3|Overall Study|newly diagnosed advanced HCC|10
5218922|NCT00966355|18015578|P2|Overall Study|newly diagnosed advanced HCC|12
5218923|NCT00966355|18015579|P1|Overall Study|newly diagnosed advanced HCC|11
5218924|NCT00966355|18015577|P3|Overall Study|non-variceal bleeding on endoscopy|71
5218925|NCT00966355|18015578|P2|Overall Study|non-variceal bleeding on endoscopy|70
5218926|NCT00966355|18015579|P1|Overall Study|non-variceal bleeding on endoscopy|68
5218927|NCT00966277|18015592|P2|Overall Study|Treatment Plan Changed|1
5218928|NCT00966277|18015593|P1|Overall Study|Treatment Plan Changed|0
5218929|NCT00966277|18015592|P2|Overall Study|Ineligible|3
5218930|NCT00966277|18015593|P1|Overall Study|Ineligible|1
5218931|NCT00966277|18015592|P2|Overall Study|Withdrawal by Subject|0
5218932|NCT00966277|18015593|P1|Overall Study|Withdrawal by Subject|3
5218933|NCT00966264|18015601|P2|Overall Study|Lost to Follow-up|3
5218934|NCT00966264|18015602|P1|Overall Study|Lost to Follow-up|4
5218935|NCT00965848|18015648|P3|Overall Study|Other|1
5218936|NCT00965848|18015649|P2|Overall Study|Other|0
5218937|NCT00965848|18015650|P1|Overall Study|Other|5
5218938|NCT00965848|18015648|P3|Overall Study|Not Clinically Evaluable|1
5218939|NCT00965848|18015649|P2|Overall Study|Not Clinically Evaluable|1
5218940|NCT00965848|18015650|P1|Overall Study|Not Clinically Evaluable|7
5218941|NCT00965848|18015648|P3|Overall Study|Indeterminate Clinical Outcome|1
5218942|NCT00965848|18015649|P2|Overall Study|Indeterminate Clinical Outcome|0
5218943|NCT00965848|18015650|P1|Overall Study|Indeterminate Clinical Outcome|2
5218944|NCT00965848|18015648|P3|Overall Study|Withdrawal by Subject|0
5218945|NCT00965848|18015649|P2|Overall Study|Withdrawal by Subject|0
5218946|NCT00965848|18015650|P1|Overall Study|Withdrawal by Subject|1
5218947|NCT00965848|18015648|P3|Overall Study|Lost to Follow-up|1
5218948|NCT00965848|18015649|P2|Overall Study|Lost to Follow-up|0
5218949|NCT00965848|18015650|P1|Overall Study|Lost to Follow-up|0
5218950|NCT00965848|18015648|P3|Overall Study|Death|5
5218951|NCT00965848|18015649|P2|Overall Study|Death|1
5218952|NCT00965848|18015650|P1|Overall Study|Death|11
5218953|NCT00965848|18015648|P3|Overall Study|Protocol Violation|1
5218954|NCT00965848|18015649|P2|Overall Study|Protocol Violation|0
5218955|NCT00965848|18015650|P1|Overall Study|Protocol Violation|3
5218956|NCT00965757|18015669|P4|Extension Phase|Other|1
5218957|NCT00965757|18015670|P3|Extension Phase|Other|2
5218958|NCT00965757|18015671|P2|Extension Phase|Other|0
5218959|NCT00965757|18015672|P1|Extension Phase|Other|0
5218960|NCT00965757|18015669|P4|Extension Phase|Protocol Violation|1
5218961|NCT00965757|18015670|P3|Extension Phase|Protocol Violation|0
5218962|NCT00965757|18015671|P2|Extension Phase|Protocol Violation|0
5218963|NCT00965757|18015672|P1|Extension Phase|Protocol Violation|0
5218964|NCT00965757|18015669|P4|Extension Phase|Ineligible after Taking Study Drug|3
5218965|NCT00965757|18015670|P3|Extension Phase|Ineligible after Taking Study Drug|3
5218966|NCT00965757|18015671|P2|Extension Phase|Ineligible after Taking Study Drug|0
5218967|NCT00965757|18015672|P1|Extension Phase|Ineligible after Taking Study Drug|0
5218968|NCT00965757|18015669|P4|Extension Phase|Lost to Follow-up|1
5218969|NCT00965757|18015670|P3|Extension Phase|Lost to Follow-up|0
5218970|NCT00965757|18015671|P2|Extension Phase|Lost to Follow-up|0
5218971|NCT00965757|18015672|P1|Extension Phase|Lost to Follow-up|0
5218972|NCT00965757|18015669|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
5218973|NCT00965757|18015670|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
5218974|NCT00965757|18015671|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
5218975|NCT00965757|18015672|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
5218976|NCT00965757|18015669|P4|Extension Phase|Lack of Efficacy|12
5218977|NCT00965757|18015670|P3|Extension Phase|Lack of Efficacy|8
5218978|NCT00965757|18015671|P2|Extension Phase|Lack of Efficacy|0
5218979|NCT00965757|18015672|P1|Extension Phase|Lack of Efficacy|0
5218980|NCT00965757|18015669|P4|Extension Phase|Abnormal Laboratory Value|1
5218981|NCT00965757|18015670|P3|Extension Phase|Abnormal Laboratory Value|6
5218982|NCT00965757|18015671|P2|Extension Phase|Abnormal Laboratory Value|0
5218983|NCT00965757|18015672|P1|Extension Phase|Abnormal Laboratory Value|0
5218984|NCT00965757|18015669|P4|Extension Phase|Adverse drug reaction|3
5218985|NCT00965757|18015670|P3|Extension Phase|Adverse drug reaction|6
5218986|NCT00965757|18015671|P2|Extension Phase|Adverse drug reaction|0
5218987|NCT00965757|18015672|P1|Extension Phase|Adverse drug reaction|0
5218988|NCT00965757|18015669|P4|Extension Phase|Progression of concomitant disease|2
5218989|NCT00965757|18015670|P3|Extension Phase|Progression of concomitant disease|4
5218990|NCT00965757|18015671|P2|Extension Phase|Progression of concomitant disease|0
5218991|NCT00965757|18015672|P1|Extension Phase|Progression of concomitant disease|0
5218992|NCT00965757|18015669|P4|Double-blind Phase|Other|0
5218993|NCT00965757|18015670|P3|Double-blind Phase|Other|0
5218994|NCT00965757|18015671|P2|Double-blind Phase|Other|0
5218995|NCT00965757|18015672|P1|Double-blind Phase|Other|1
5218996|NCT00965757|18015669|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
5218997|NCT00965757|18015670|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
5218998|NCT00965757|18015671|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
5218999|NCT00965757|18015672|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
5219000|NCT00965757|18015669|P4|Double-blind Phase|Lost to Follow-up|0
5219001|NCT00965757|18015670|P3|Double-blind Phase|Lost to Follow-up|0
5219002|NCT00965757|18015671|P2|Double-blind Phase|Lost to Follow-up|1
5219003|NCT00965757|18015672|P1|Double-blind Phase|Lost to Follow-up|0
5219004|NCT00965757|18015669|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5219005|NCT00965757|18015670|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5219006|NCT00965757|18015671|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5219007|NCT00965757|18015672|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
5219008|NCT00965757|18015669|P4|Double-blind Phase|Lack of Efficacy|0
5219009|NCT00965757|18015670|P3|Double-blind Phase|Lack of Efficacy|0
5219010|NCT00965757|18015671|P2|Double-blind Phase|Lack of Efficacy|11
5219011|NCT00965757|18015672|P1|Double-blind Phase|Lack of Efficacy|7
5219012|NCT00965757|18015669|P4|Double-blind Phase|Abnormal Laboratory Value|0
5219013|NCT00965757|18015670|P3|Double-blind Phase|Abnormal Laboratory Value|0
5219014|NCT00965757|18015671|P2|Double-blind Phase|Abnormal Laboratory Value|0
5219015|NCT00965757|18015672|P1|Double-blind Phase|Abnormal Laboratory Value|2
5219016|NCT00965757|18015669|P4|Double-blind Phase|Adverse drug reaction|0
5219017|NCT00965757|18015670|P3|Double-blind Phase|Adverse drug reaction|0
5219018|NCT00965757|18015671|P2|Double-blind Phase|Adverse drug reaction|1
5219019|NCT00965757|18015672|P1|Double-blind Phase|Adverse drug reaction|2
5219020|NCT00965757|18015669|P4|Double-blind Phase|Progression of concomitant disease|0
5219021|NCT00965757|18015670|P3|Double-blind Phase|Progression of concomitant disease|0
5219022|NCT00965757|18015671|P2|Double-blind Phase|Progression of concomitant disease|2
5219023|NCT00965757|18015672|P1|Double-blind Phase|Progression of concomitant disease|1
5219024|NCT00965731|18015706|P2|Overall Study|Other|15
5219025|NCT00965731|18015707|P1|Overall Study|Other|7
5219026|NCT00965731|18015706|P2|Overall Study|Withdrawal by Subject|1
5219027|NCT00965731|18015707|P1|Overall Study|Withdrawal by Subject|0
5219028|NCT00965731|18015706|P2|Overall Study|Death|4
5219029|NCT00965731|18015707|P1|Overall Study|Death|0
5219030|NCT00965718|18015771|P1|Overall Study|Withdrawal by Subject|4
5219031|NCT00965575|18015783|P2|Overall Study|subject unwillingness to swallow study c|0
5219032|NCT00965575|18015784|P1|Overall Study|subject unwillingness to swallow study c|1
5219033|NCT00965562|18015795|P3|Overall Study|Withdrawal by Subject|0
5219034|NCT00965562|18015796|P2|Overall Study|Withdrawal by Subject|2
5219035|NCT00965562|18015797|P1|Overall Study|Withdrawal by Subject|2
5219036|NCT00965562|18015795|P3|Overall Study|Lost to Follow-up|3
5219037|NCT00965562|18015796|P2|Overall Study|Lost to Follow-up|2
5219038|NCT00965562|18015797|P1|Overall Study|Lost to Follow-up|1
5219039|NCT00965523|18015835|P1|Study 224|Physician Decision|1
5219040|NCT00965523|18015835|P1|Study 224|Progressive Disease|5
5219041|NCT00965523|18015835|P1|Study 221|Physician Decision|3
5219042|NCT00965523|18015835|P1|Study 221|Progressive Disease|4
5219043|NCT00965497|18015840|P1|Overall Study|Physician Decision|1
5219044|NCT00965484|18015845|P1|Overall Study|Withdrawal by Subject|1
5219045|NCT00965484|18015845|P1|Overall Study|Protocol Violation|1
5219046|NCT00965458|18015854|P2|Overall Study|Withdrawal by Subject|1
5219047|NCT00965458|18015855|P1|Overall Study|Withdrawal by Subject|0
5219048|NCT00965458|18015854|P2|Overall Study|Lost to Follow-up|3
5219049|NCT00965458|18015855|P1|Overall Study|Lost to Follow-up|1
5219050|NCT00965458|18015854|P2|Overall Study|Adverse Event|0
5219051|NCT00965458|18015855|P1|Overall Study|Adverse Event|1
5219052|NCT00965419|18015871|P1|Follow-up Phase|Lack of Efficacy|28
5219053|NCT00965419|18015871|P1|Follow-up Phase|Parent/Caregiver Decision|9
5219054|NCT00965419|18015871|P1|Follow-up Phase|Physician Decision|4
5219055|NCT00965419|18015871|P1|Follow-up Phase|Withdrawal by Subject|8
5219056|NCT00965419|18015871|P1|Follow-up Phase|Protocol Violation|4
5219057|NCT00965419|18015871|P1|Follow-up Phase|Adverse Event|9
5219058|NCT00965419|18015871|P1|Open Label Treatment for Responders|Lost to Follow-up|46
5219059|NCT00965419|18015871|P1|Open Label Treatment for Responders|Lack of Efficacy|67
5219060|NCT00965419|18015871|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
5219061|NCT00965419|18015871|P1|Open Label Treatment for Responders|Sponsor Decision|5
5219062|NCT00965419|18015871|P1|Open Label Treatment for Responders|Physician Decision|6
5219063|NCT00965419|18015871|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
5219064|NCT00965419|18015871|P1|Open Label Treatment for Responders|Protocol Violation|21
5219065|NCT00965419|18015871|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
5219066|NCT00965419|18015871|P1|Open Label Treatment for Responders|Adverse Event|33
5219067|NCT00965341|18015917|P2|Overall Study|Transportation issues|3
5219068|NCT00965341|18015918|P1|Overall Study|Transportation issues|4
5219069|NCT00965341|18015917|P2|Overall Study|Lost to Follow-up|0
5219070|NCT00965341|18015918|P1|Overall Study|Lost to Follow-up|1
5219071|NCT00965341|18015917|P2|Overall Study|Withdrew consent|5
5219072|NCT00965341|18015918|P1|Overall Study|Withdrew consent|1
5219073|NCT00965263|18015928|P2|Overall Study|Protocol Violation|2
5219074|NCT00965263|18015929|P1|Overall Study|Protocol Violation|0
5219075|NCT00965263|18015928|P2|Overall Study|Family emergency|1
5219076|NCT00965263|18015929|P1|Overall Study|Family emergency|0
5219077|NCT00965263|18015928|P2|Overall Study|Physician Decision|0
5219078|NCT00965263|18015929|P1|Overall Study|Physician Decision|2
5219079|NCT00965185|18015989|P2|Overall Study|Withdrawal by Subject|1
5219080|NCT00965185|18015990|P1|Overall Study|Withdrawal by Subject|0
5219081|NCT00965185|18015989|P2|Overall Study|Lost to Follow-up|0
5219082|NCT00965185|18015990|P1|Overall Study|Lost to Follow-up|2
5219083|NCT00965146|18016010|P1|Overall Study|Overall Study Termination|145
5219084|NCT00965146|18016010|P1|Overall Study|Revision / Removal of Study Implant|6
5219085|NCT00965146|18016010|P1|Overall Study|Intercurrent illness|1
5219086|NCT00965146|18016010|P1|Overall Study|Unwilling to return|11
5219087|NCT00965146|18016010|P1|Overall Study|Unable to return|1
5219088|NCT00965146|18016010|P1|Overall Study|Withdrawal by Subject|17
5219089|NCT00965146|18016010|P1|Overall Study|Lost to Follow-up|22
5219090|NCT00965146|18016010|P1|Overall Study|Death|7
5219091|NCT00965094|18016017|P2|Overall Study|Lost to Follow-up|1
5219092|NCT00965094|18016018|P1|Overall Study|Lost to Follow-up|0
5219093|NCT00965094|18016017|P2|Overall Study|Adverse Event|0
5219094|NCT00965094|18016018|P1|Overall Study|Adverse Event|5
5219095|NCT00965081|18016034|P2|Overall Study|Switched to Rescue Arm|12
5219096|NCT00965081|18016035|P1|Overall Study|Switched to Rescue Arm|5
5219097|NCT00965081|18016034|P2|Overall Study|Withdrawal by Subject|7
5219098|NCT00965081|18016035|P1|Overall Study|Withdrawal by Subject|4
5219099|NCT00965081|18016034|P2|Overall Study|Sponsor Decision|0
5219100|NCT00965081|18016035|P1|Overall Study|Sponsor Decision|1
5219101|NCT00965081|18016034|P2|Overall Study|Protocol Violation|5
5219102|NCT00965081|18016035|P1|Overall Study|Protocol Violation|2
5219103|NCT00965081|18016034|P2|Overall Study|Physician Decision|0
5219104|NCT00965081|18016035|P1|Overall Study|Physician Decision|2
5219105|NCT00965081|18016034|P2|Overall Study|Lost to Follow-up|5
5219106|NCT00965081|18016035|P1|Overall Study|Lost to Follow-up|4
5219107|NCT00965081|18016034|P2|Overall Study|Lack of Efficacy|5
5219108|NCT00965081|18016035|P1|Overall Study|Lack of Efficacy|2
5219109|NCT00965081|18016034|P2|Overall Study|Adverse Event|9
5219110|NCT00965081|18016035|P1|Overall Study|Adverse Event|14
5219111|NCT00964886|18016067|P4|Overall Study|Protocol Violation|0
5219112|NCT00964886|18016068|P3|Overall Study|Protocol Violation|0
5219113|NCT00964886|18016069|P2|Overall Study|Protocol Violation|2
5219114|NCT00964886|18016070|P1|Overall Study|Protocol Violation|0
5219115|NCT00964886|18016067|P4|Overall Study|Adverse Event|2
5219116|NCT00964886|18016068|P3|Overall Study|Adverse Event|5
5219117|NCT00964886|18016069|P2|Overall Study|Adverse Event|1
5219118|NCT00964886|18016070|P1|Overall Study|Adverse Event|3
5219119|NCT00964886|18016067|P4|Overall Study|Withdrawal by Subject|3
5219120|NCT00964886|18016068|P3|Overall Study|Withdrawal by Subject|5
5219121|NCT00964886|18016069|P2|Overall Study|Withdrawal by Subject|2
5219122|NCT00964886|18016070|P1|Overall Study|Withdrawal by Subject|6
5219123|NCT00964886|18016067|P4|Overall Study|Lost to Follow-up|4
5219124|NCT00964886|18016068|P3|Overall Study|Lost to Follow-up|6
5219125|NCT00964886|18016069|P2|Overall Study|Lost to Follow-up|2
5219126|NCT00964886|18016070|P1|Overall Study|Lost to Follow-up|2
5219127|NCT00964860|18016086|P2|Overall Study|Withdrawal by Subject|1
5219128|NCT00964860|18016087|P1|Overall Study|Withdrawal by Subject|0
5219129|NCT00964795|18016095|P1|Overall Study|Other|23
5219130|NCT00964795|18016095|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
5219131|NCT00964795|18016095|P1|Overall Study|Termination of Study by Sponsor|169
5219132|NCT00964795|18016095|P1|Overall Study|Lost to Follow-up|7
5219133|NCT00964795|18016095|P1|Overall Study|Death|14
5219134|NCT00964795|18016095|P1|Overall Study|Adverse Event|12
5219135|NCT00964795|18016095|P1|Overall Study|Withdrawal by Subject|79
5219136|NCT00964782|18016104|P2|Overall Study|Lost to Follow-up|0
5219137|NCT00964782|18016105|P1|Overall Study|Lost to Follow-up|1
5219138|NCT00964743|18016119|P1|Overall Study|Neither patient completed 8 weeks of tre|2
5219139|NCT00964678|18016127|P1|Overall Study|Physician Decision|4
5219140|NCT00964392|18016191|P2|Overall Study|Not completed|168
5219141|NCT00964392|18016192|P1|Overall Study|Not completed|44
5219142|NCT00964392|18016191|P2|Overall Study|Early Termination, non-study arrhythmia|6
5219143|NCT00964392|18016192|P1|Overall Study|Early Termination, non-study arrhythmia|1
5219144|NCT00964392|18016191|P2|Overall Study|Lost to Follow-up|10
5219145|NCT00964392|18016192|P1|Overall Study|Lost to Follow-up|4
5219146|NCT00964392|18016191|P2|Overall Study|Withdrawal by Subject|6
5219147|NCT00964392|18016192|P1|Overall Study|Withdrawal by Subject|4
5219148|NCT00964366|18016202|P2|Overall Study|Withdrawal by Subject|1
5219149|NCT00964366|18016203|P1|Overall Study|Withdrawal by Subject|0
5219150|NCT00964366|18016202|P2|Overall Study|Did not qualify at Day 1|0
5219151|NCT00964366|18016203|P1|Overall Study|Did not qualify at Day 1|1
5219152|NCT00964223|18016228|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
5219153|NCT00964158|18016296|P3|Overall Study|Withdrawal by Subject|6
5219154|NCT00964158|18016297|P2|Overall Study|Withdrawal by Subject|0
5219155|NCT00964158|18016298|P1|Overall Study|Withdrawal by Subject|0
5219156|NCT00964158|18016296|P3|Overall Study|Lost to Follow-up|2
5219157|NCT00964158|18016297|P2|Overall Study|Lost to Follow-up|1
5219158|NCT00964158|18016298|P1|Overall Study|Lost to Follow-up|0
5219159|NCT00964028|18016373|P2|Overall Study|Withdrawal by Subject|1
5219160|NCT00964028|18016374|P1|Overall Study|Withdrawal by Subject|0
5219161|NCT00963937|18016389|P3|Overall Study|Physician Decision|4
5219162|NCT00963937|18016390|P2|Overall Study|Physician Decision|10
5219163|NCT00963937|18016391|P1|Overall Study|Physician Decision|18
5219164|NCT00963937|18016389|P3|Overall Study|Protocol Violation|0
5219165|NCT00963937|18016390|P2|Overall Study|Protocol Violation|1
5219166|NCT00963937|18016391|P1|Overall Study|Protocol Violation|1
5219167|NCT00963924|18016429|P2|Overall Study|Lost to Follow-up|1
5219168|NCT00963924|18016430|P1|Overall Study|Lost to Follow-up|0
5219169|NCT00963924|18016429|P2|Overall Study|Changed antipsychotic|1
5219170|NCT00963924|18016430|P1|Overall Study|Changed antipsychotic|0
5219171|NCT00963924|18016429|P2|Overall Study|Withdrawal by Subject|1
5219172|NCT00963924|18016430|P1|Overall Study|Withdrawal by Subject|0
5219173|NCT00963924|18016429|P2|Overall Study|Adverse Event|0
5219174|NCT00963924|18016430|P1|Overall Study|Adverse Event|1
5219175|NCT00963820|18016504|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
5219176|NCT00963820|18016505|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219177|NCT00963820|18016506|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219178|NCT00963820|18016507|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219179|NCT00963820|18016508|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219180|NCT00963820|18016509|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219181|NCT00963820|18016510|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219182|NCT00963820|18016511|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219183|NCT00963820|18016512|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219184|NCT00963820|18016513|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219185|NCT00963820|18016514|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219186|NCT00963820|18016515|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
5219187|NCT00963820|18016504|P12|Expansion Phase|Withdrawal by Subject|1
5219188|NCT00963820|18016505|P11|Expansion Phase|Withdrawal by Subject|1
5219189|NCT00963820|18016506|P10|Expansion Phase|Withdrawal by Subject|0
5219190|NCT00963820|18016507|P9|Expansion Phase|Withdrawal by Subject|1
5219191|NCT00963820|18016508|P8|Expansion Phase|Withdrawal by Subject|0
5219192|NCT00963820|18016509|P7|Expansion Phase|Withdrawal by Subject|0
5219193|NCT00963820|18016510|P6|Expansion Phase|Withdrawal by Subject|0
5219194|NCT00963820|18016511|P5|Expansion Phase|Withdrawal by Subject|0
5219195|NCT00963820|18016512|P4|Expansion Phase|Withdrawal by Subject|0
5219196|NCT00963820|18016513|P3|Expansion Phase|Withdrawal by Subject|0
5219197|NCT00963820|18016514|P2|Expansion Phase|Withdrawal by Subject|0
5219198|NCT00963820|18016515|P1|Expansion Phase|Withdrawal by Subject|0
5219199|NCT00963820|18016504|P12|Expansion Phase|Adverse Event|0
5219200|NCT00963820|18016505|P11|Expansion Phase|Adverse Event|0
5219201|NCT00963820|18016506|P10|Expansion Phase|Adverse Event|3
5219202|NCT00963820|18016507|P9|Expansion Phase|Adverse Event|1
5219203|NCT00963820|18016508|P8|Expansion Phase|Adverse Event|0
5219204|NCT00963820|18016509|P7|Expansion Phase|Adverse Event|0
5219205|NCT00963820|18016510|P6|Expansion Phase|Adverse Event|0
5219206|NCT00963820|18016511|P5|Expansion Phase|Adverse Event|0
5219207|NCT00963820|18016512|P4|Expansion Phase|Adverse Event|0
5219208|NCT00963820|18016513|P3|Expansion Phase|Adverse Event|0
5219209|NCT00963820|18016514|P2|Expansion Phase|Adverse Event|0
5219210|NCT00963820|18016515|P1|Expansion Phase|Adverse Event|0
5219211|NCT00963820|18016504|P12|Expansion Phase|Progressive Disease|2
5219212|NCT00963820|18016505|P11|Expansion Phase|Progressive Disease|4
5219213|NCT00963820|18016506|P10|Expansion Phase|Progressive Disease|6
5219214|NCT00963820|18016507|P9|Expansion Phase|Progressive Disease|8
5219215|NCT00963820|18016508|P8|Expansion Phase|Progressive Disease|0
5219216|NCT00963820|18016509|P7|Expansion Phase|Progressive Disease|0
5219217|NCT00963820|18016510|P6|Expansion Phase|Progressive Disease|0
5219218|NCT00963820|18016511|P5|Expansion Phase|Progressive Disease|0
5219219|NCT00963820|18016512|P4|Expansion Phase|Progressive Disease|0
5219220|NCT00963820|18016513|P3|Expansion Phase|Progressive Disease|0
5219221|NCT00963820|18016514|P2|Expansion Phase|Progressive Disease|0
5219222|NCT00963820|18016515|P1|Expansion Phase|Progressive Disease|0
5219223|NCT00963820|18016504|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219224|NCT00963820|18016505|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219225|NCT00963820|18016506|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219226|NCT00963820|18016507|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219227|NCT00963820|18016508|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219228|NCT00963820|18016509|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5219229|NCT00963820|18016510|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219230|NCT00963820|18016511|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219231|NCT00963820|18016512|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219232|NCT00963820|18016513|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219233|NCT00963820|18016514|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219234|NCT00963820|18016515|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5219235|NCT00963820|18016504|P12|Dose Escalation Phase|Withdrawal by Subject|0
5219236|NCT00963820|18016505|P11|Dose Escalation Phase|Withdrawal by Subject|0
5219237|NCT00963820|18016506|P10|Dose Escalation Phase|Withdrawal by Subject|0
5219238|NCT00963820|18016507|P9|Dose Escalation Phase|Withdrawal by Subject|0
5219239|NCT00963820|18016508|P8|Dose Escalation Phase|Withdrawal by Subject|2
5219240|NCT00963820|18016509|P7|Dose Escalation Phase|Withdrawal by Subject|1
5219241|NCT00963820|18016510|P6|Dose Escalation Phase|Withdrawal by Subject|0
5219242|NCT00963820|18016511|P5|Dose Escalation Phase|Withdrawal by Subject|0
5219243|NCT00963820|18016512|P4|Dose Escalation Phase|Withdrawal by Subject|0
5219244|NCT00963820|18016513|P3|Dose Escalation Phase|Withdrawal by Subject|0
5219245|NCT00963820|18016514|P2|Dose Escalation Phase|Withdrawal by Subject|0
5219246|NCT00963820|18016515|P1|Dose Escalation Phase|Withdrawal by Subject|0
5219247|NCT00963820|18016504|P12|Dose Escalation Phase|Adverse Event|0
5219248|NCT00963820|18016505|P11|Dose Escalation Phase|Adverse Event|0
5219249|NCT00963820|18016506|P10|Dose Escalation Phase|Adverse Event|0
5219250|NCT00963820|18016507|P9|Dose Escalation Phase|Adverse Event|0
5219251|NCT00963820|18016508|P8|Dose Escalation Phase|Adverse Event|1
5219252|NCT00963820|18016509|P7|Dose Escalation Phase|Adverse Event|3
5219253|NCT00963820|18016510|P6|Dose Escalation Phase|Adverse Event|0
5219254|NCT00963820|18016511|P5|Dose Escalation Phase|Adverse Event|0
5219255|NCT00963820|18016512|P4|Dose Escalation Phase|Adverse Event|0
5219256|NCT00963820|18016513|P3|Dose Escalation Phase|Adverse Event|0
5219257|NCT00963820|18016514|P2|Dose Escalation Phase|Adverse Event|0
5219258|NCT00963820|18016515|P1|Dose Escalation Phase|Adverse Event|0
5219259|NCT00963820|18016504|P12|Dose Escalation Phase|Progressive Disease|0
5219260|NCT00963820|18016505|P11|Dose Escalation Phase|Progressive Disease|0
5219261|NCT00963820|18016506|P10|Dose Escalation Phase|Progressive Disease|0
5219262|NCT00963820|18016507|P9|Dose Escalation Phase|Progressive Disease|0
5219263|NCT00963820|18016508|P8|Dose Escalation Phase|Progressive Disease|2
5219264|NCT00963820|18016509|P7|Dose Escalation Phase|Progressive Disease|3
5219265|NCT00963820|18016510|P6|Dose Escalation Phase|Progressive Disease|3
5219266|NCT00963820|18016511|P5|Dose Escalation Phase|Progressive Disease|4
5219267|NCT00963820|18016512|P4|Dose Escalation Phase|Progressive Disease|3
5219268|NCT00963820|18016513|P3|Dose Escalation Phase|Progressive Disease|3
5219269|NCT00963820|18016514|P2|Dose Escalation Phase|Progressive Disease|3
5219270|NCT00963820|18016515|P1|Dose Escalation Phase|Progressive Disease|3
5219271|NCT00963807|18016651|P1|Overall Study|Disease progression|15
5219272|NCT00963807|18016651|P1|Overall Study|Reaction to study chemotherapy regimen|1
5219273|NCT00963807|18016651|P1|Overall Study|Physician Decision|2
5219274|NCT00963599|18016684|P4|Overall Study|Withdrawal by Subject|3
5219275|NCT00963599|18016685|P3|Overall Study|Withdrawal by Subject|3
5219276|NCT00963599|18016686|P2|Overall Study|Withdrawal by Subject|1
5219277|NCT00963599|18016687|P1|Overall Study|Withdrawal by Subject|2
5219278|NCT00963599|18016684|P4|Overall Study|Protocol Violation|4
5219279|NCT00963599|18016685|P3|Overall Study|Protocol Violation|3
5219280|NCT00963599|18016686|P2|Overall Study|Protocol Violation|2
5219281|NCT00963599|18016687|P1|Overall Study|Protocol Violation|2
5219282|NCT00963599|18016684|P4|Overall Study|Lost to Follow-up|1
5219283|NCT00963599|18016685|P3|Overall Study|Lost to Follow-up|1
5219284|NCT00963599|18016686|P2|Overall Study|Lost to Follow-up|1
5219285|NCT00963599|18016687|P1|Overall Study|Lost to Follow-up|0
5219286|NCT00963599|18016684|P4|Overall Study|Lack of Efficacy|4
5219287|NCT00963599|18016685|P3|Overall Study|Lack of Efficacy|1
5219288|NCT00963599|18016686|P2|Overall Study|Lack of Efficacy|2
5219289|NCT00963599|18016687|P1|Overall Study|Lack of Efficacy|0
5219290|NCT00963599|18016684|P4|Overall Study|Adverse Event|2
5219291|NCT00963599|18016685|P3|Overall Study|Adverse Event|1
5219292|NCT00963599|18016686|P2|Overall Study|Adverse Event|0
5219293|NCT00963599|18016687|P1|Overall Study|Adverse Event|2
5219294|NCT00963547|18016758|P7|Overall Study|Reason Unknown|0
5219295|NCT00963547|18016759|P6|Overall Study|Reason Unknown|0
5219296|NCT00963547|18016760|P5|Overall Study|Reason Unknown|0
5219297|NCT00963547|18016761|P4|Overall Study|Reason Unknown|0
5219298|NCT00963547|18016762|P3|Overall Study|Reason Unknown|0
5219299|NCT00963547|18016763|P2|Overall Study|Reason Unknown|1
5219300|NCT00963547|18016764|P1|Overall Study|Reason Unknown|0
5219301|NCT00963547|18016758|P7|Overall Study|Withdrawal by Subject|0
5219302|NCT00963547|18016759|P6|Overall Study|Withdrawal by Subject|0
5219303|NCT00963547|18016760|P5|Overall Study|Withdrawal by Subject|0
5219304|NCT00963547|18016761|P4|Overall Study|Withdrawal by Subject|0
5219305|NCT00963547|18016762|P3|Overall Study|Withdrawal by Subject|3
5219306|NCT00963547|18016763|P2|Overall Study|Withdrawal by Subject|0
5219307|NCT00963547|18016764|P1|Overall Study|Withdrawal by Subject|0
5219308|NCT00963547|18016758|P7|Overall Study|Progressive Disease|0
5219309|NCT00963547|18016759|P6|Overall Study|Progressive Disease|0
5219310|NCT00963547|18016760|P5|Overall Study|Progressive Disease|0
5219311|NCT00963547|18016761|P4|Overall Study|Progressive Disease|5
5219312|NCT00963547|18016762|P3|Overall Study|Progressive Disease|9
5219313|NCT00963547|18016763|P2|Overall Study|Progressive Disease|8
5219314|NCT00963547|18016764|P1|Overall Study|Progressive Disease|3
5219315|NCT00963547|18016758|P7|Overall Study|Physician Decision|0
5219316|NCT00963547|18016759|P6|Overall Study|Physician Decision|0
5219317|NCT00963547|18016760|P5|Overall Study|Physician Decision|0
5219318|NCT00963547|18016761|P4|Overall Study|Physician Decision|0
5219319|NCT00963547|18016762|P3|Overall Study|Physician Decision|0
5219320|NCT00963547|18016763|P2|Overall Study|Physician Decision|1
5219321|NCT00963547|18016764|P1|Overall Study|Physician Decision|1
5219322|NCT00963547|18016758|P7|Overall Study|Adverse Event|0
5219323|NCT00963547|18016759|P6|Overall Study|Adverse Event|0
5219324|NCT00963547|18016760|P5|Overall Study|Adverse Event|0
5219325|NCT00963547|18016761|P4|Overall Study|Adverse Event|1
5219326|NCT00963547|18016762|P3|Overall Study|Adverse Event|0
5219327|NCT00963547|18016763|P2|Overall Study|Adverse Event|1
5219328|NCT00963547|18016764|P1|Overall Study|Adverse Event|0
5219329|NCT00963469|18016811|P3|Overall Study|Site closed (local pollen Season ended)|3
5219330|NCT00963469|18016812|P2|Overall Study|Site closed (local pollen Season ended)|1
5219331|NCT00963469|18016813|P1|Overall Study|Site closed (local pollen Season ended)|4
5219332|NCT00963469|18016811|P3|Overall Study|Moved|0
5219333|NCT00963469|18016812|P2|Overall Study|Moved|0
5219334|NCT00963469|18016813|P1|Overall Study|Moved|1
5219335|NCT00963469|18016811|P3|Overall Study|Pre-randomization Adverse Event|0
5219336|NCT00963469|18016812|P2|Overall Study|Pre-randomization Adverse Event|2
5219337|NCT00963469|18016813|P1|Overall Study|Pre-randomization Adverse Event|1
5219338|NCT00963469|18016811|P3|Overall Study|Withdrawal by Subject|1
5219339|NCT00963469|18016812|P2|Overall Study|Withdrawal by Subject|1
5219340|NCT00963469|18016813|P1|Overall Study|Withdrawal by Subject|4
5219341|NCT00963469|18016811|P3|Overall Study|Protocol Violation|3
5219342|NCT00963469|18016812|P2|Overall Study|Protocol Violation|5
5219343|NCT00963469|18016813|P1|Overall Study|Protocol Violation|5
5219344|NCT00963469|18016811|P3|Overall Study|Lost to Follow-up|0
5219345|NCT00963469|18016812|P2|Overall Study|Lost to Follow-up|1
5219346|NCT00963469|18016813|P1|Overall Study|Lost to Follow-up|1
5219347|NCT00963469|18016811|P3|Overall Study|Lack of Efficacy|2
5219348|NCT00963469|18016812|P2|Overall Study|Lack of Efficacy|7
5219349|NCT00963469|18016813|P1|Overall Study|Lack of Efficacy|10
5219350|NCT00963469|18016811|P3|Overall Study|Adverse Event|1
5219351|NCT00963469|18016812|P2|Overall Study|Adverse Event|11
5219352|NCT00963469|18016813|P1|Overall Study|Adverse Event|15
5219353|NCT00963235|18016880|P1|Overall Study|Other|1
5219354|NCT00963235|18016880|P1|Overall Study|Physician Decision|2
5219355|NCT00963235|18016880|P1|Overall Study|Adverse Event|5
5219356|NCT00963235|18016880|P1|Overall Study|Protocol Violation|7
5219357|NCT00963235|18016880|P1|Overall Study|Failed to return|9
5219358|NCT00963235|18016880|P1|Overall Study|Lost to Follow-up|14
5219359|NCT00963235|18016880|P1|Overall Study|Withdrawal by Subject|22
5219360|NCT00962780|18017172|P2|Overall Study|Other|1
5219361|NCT00962780|18017173|P1|Overall Study|Other|0
5219362|NCT00962780|18017172|P2|Overall Study|Withdrawal by Subject|8
5219363|NCT00962780|18017173|P1|Overall Study|Withdrawal by Subject|1
5219364|NCT00962780|18017172|P2|Overall Study|Protocol Violation|4
5219365|NCT00962780|18017173|P1|Overall Study|Protocol Violation|9
5219366|NCT00962780|18017172|P2|Overall Study|Death|1
5219367|NCT00962780|18017173|P1|Overall Study|Death|0
5219368|NCT00962741|18017248|P1|Overall Study|drug ineffective+prohibited drug taken|1
5219369|NCT00962741|18017248|P1|Overall Study|Lack of Efficacy|1
5219370|NCT00962741|18017248|P1|Overall Study|Withdrawal by Subject|1
5219371|NCT00962741|18017248|P1|Overall Study|Lost to Follow-up|2
5219372|NCT00962741|18017248|P1|Overall Study|Failed to return|3
5219373|NCT00962650|18017339|P1|Overall Study|Transgastric DP was not completed|2
5219374|NCT00962585|18017358|P4|Overall Study|Withdrew Consent|0
5219375|NCT00962585|18017359|P3|Overall Study|Withdrew Consent|0
5219376|NCT00962585|18017360|P2|Overall Study|Withdrew Consent|0
5219377|NCT00962585|18017361|P1|Overall Study|Withdrew Consent|2
5219378|NCT00962585|18017358|P4|Overall Study|Withdrawal by Subject|0
5219379|NCT00962585|18017359|P3|Overall Study|Withdrawal by Subject|0
5219380|NCT00962585|18017360|P2|Overall Study|Withdrawal by Subject|0
5219381|NCT00962585|18017361|P1|Overall Study|Withdrawal by Subject|1
5219382|NCT00962585|18017358|P4|Overall Study|Protocol Violation|0
5219383|NCT00962585|18017359|P3|Overall Study|Protocol Violation|1
5219384|NCT00962585|18017360|P2|Overall Study|Protocol Violation|0
5219385|NCT00962585|18017361|P1|Overall Study|Protocol Violation|0
5219386|NCT00962585|18017358|P4|Overall Study|Lost to Follow-up|0
5219387|NCT00962585|18017359|P3|Overall Study|Lost to Follow-up|1
5219388|NCT00962585|18017360|P2|Overall Study|Lost to Follow-up|0
5219389|NCT00962585|18017361|P1|Overall Study|Lost to Follow-up|3
5219390|NCT00962585|18017358|P4|Overall Study|Adverse Event|0
5219391|NCT00962585|18017359|P3|Overall Study|Adverse Event|1
5219392|NCT00962585|18017360|P2|Overall Study|Adverse Event|2
5219393|NCT00962585|18017361|P1|Overall Study|Adverse Event|0
5219394|NCT00962390|18017438|P4|Overall Study|Withdrawal by Subject|0
5219395|NCT00962390|18017439|P3|Overall Study|Withdrawal by Subject|1
5219396|NCT00962390|18017440|P2|Overall Study|Withdrawal by Subject|1
5219397|NCT00962390|18017441|P1|Overall Study|Withdrawal by Subject|1
5219398|NCT00962390|18017438|P4|Overall Study|Protocol Violation|0
5219399|NCT00962390|18017439|P3|Overall Study|Protocol Violation|0
5219400|NCT00962390|18017440|P2|Overall Study|Protocol Violation|0
5219401|NCT00962390|18017441|P1|Overall Study|Protocol Violation|1
5219402|NCT00962390|18017438|P4|Overall Study|Lost to Follow-up|0
5219403|NCT00962390|18017439|P3|Overall Study|Lost to Follow-up|0
5219404|NCT00962390|18017440|P2|Overall Study|Lost to Follow-up|2
5219405|NCT00962390|18017441|P1|Overall Study|Lost to Follow-up|2
5219406|NCT00962390|18017438|P4|Overall Study|Adverse Event|1
5219407|NCT00962390|18017439|P3|Overall Study|Adverse Event|3
5219408|NCT00962390|18017440|P2|Overall Study|Adverse Event|0
5219409|NCT00962390|18017441|P1|Overall Study|Adverse Event|0
5219410|NCT00962247|18017503|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
5219411|NCT00962247|18017503|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
5219412|NCT00962208|18017514|P2|Overall Study|Lost to Follow-up|9
5219413|NCT00962208|18017515|P1|Overall Study|Lost to Follow-up|0
5219414|NCT00962208|18017514|P2|Overall Study|Contraindicated to continue study|1
5219415|NCT00962208|18017515|P1|Overall Study|Contraindicated to continue study|5
5219416|NCT00962208|18017514|P2|Overall Study|Could not achieve good vision|0
5219417|NCT00962208|18017515|P1|Overall Study|Could not achieve good vision|9
5219418|NCT00962104|18017523|P2|Overall Study|Other|0
5219419|NCT00962104|18017524|P1|Overall Study|Other|2
5219420|NCT00962104|18017523|P2|Overall Study|Withdrawal by Subject|6
5219421|NCT00962104|18017524|P1|Overall Study|Withdrawal by Subject|10
5219422|NCT00962104|18017523|P2|Overall Study|Sponsor Decision|1
5219423|NCT00962104|18017524|P1|Overall Study|Sponsor Decision|0
5219424|NCT00962104|18017523|P2|Overall Study|Protocol Violation|8
5219425|NCT00962104|18017524|P1|Overall Study|Protocol Violation|6
5219426|NCT00962104|18017523|P2|Overall Study|Physician Decision|0
5219427|NCT00962104|18017524|P1|Overall Study|Physician Decision|1
5219428|NCT00962104|18017523|P2|Overall Study|Lost to Follow-up|4
5219429|NCT00962104|18017524|P1|Overall Study|Lost to Follow-up|10
5219430|NCT00962104|18017523|P2|Overall Study|Lack of Efficacy|1
5219431|NCT00962104|18017524|P1|Overall Study|Lack of Efficacy|0
5219432|NCT00962104|18017523|P2|Overall Study|Entry Criteria Not Met|2
5219433|NCT00962104|18017524|P1|Overall Study|Entry Criteria Not Met|1
5219434|NCT00962104|18017523|P2|Overall Study|Adverse Event|3
5219435|NCT00962104|18017524|P1|Overall Study|Adverse Event|10
5219436|NCT00962091|18017557|P7|Overall Study|Adverse Event|1
5219437|NCT00962091|18017558|P6|Overall Study|Adverse Event|0
5219438|NCT00962091|18017559|P5|Overall Study|Adverse Event|0
5219439|NCT00962091|18017560|P4|Overall Study|Adverse Event|0
5219440|NCT00962091|18017561|P3|Overall Study|Adverse Event|0
5219441|NCT00962091|18017562|P2|Overall Study|Adverse Event|0
5219442|NCT00962091|18017563|P1|Overall Study|Adverse Event|0
5219443|NCT00962091|18017557|P7|Overall Study|Withdrawal by Subject|0
5219444|NCT00962091|18017558|P6|Overall Study|Withdrawal by Subject|1
5219445|NCT00962091|18017559|P5|Overall Study|Withdrawal by Subject|0
5219446|NCT00962091|18017560|P4|Overall Study|Withdrawal by Subject|1
5219447|NCT00962091|18017561|P3|Overall Study|Withdrawal by Subject|1
5219448|NCT00962091|18017562|P2|Overall Study|Withdrawal by Subject|2
5219449|NCT00962091|18017563|P1|Overall Study|Withdrawal by Subject|1
5219450|NCT00962013|18017666|P1|Overall Study|No 5 year evaluation|6
5219451|NCT00962013|18017666|P1|Overall Study|Site Termination|24
5219452|NCT00962013|18017666|P1|Overall Study|Removal of study device|3
5219453|NCT00962013|18017666|P1|Overall Study|Withdrawal by Subject|8
5219454|NCT00962013|18017666|P1|Overall Study|Unable/Unwilling to return|6
5219455|NCT00962013|18017666|P1|Overall Study|Lost to Follow-up|12
5219456|NCT00962013|18017666|P1|Overall Study|Death|8
5219457|NCT00962013|18017666|P1|Overall Study|Did not have surgery|1
5219458|NCT00961961|18017690|P4|Phase II|Withdrawal by Subject|0
5219459|NCT00961961|18017691|P3|Phase II|Withdrawal by Subject|1
5219460|NCT00961961|18017692|P2|Phase II|Withdrawal by Subject|0
5219461|NCT00961961|18017693|P1|Phase II|Withdrawal by Subject|0
5219462|NCT00961961|18017690|P4|Phase II|Physician Decision|0
5219463|NCT00961961|18017691|P3|Phase II|Physician Decision|1
5219464|NCT00961961|18017692|P2|Phase II|Physician Decision|0
5219465|NCT00961961|18017693|P1|Phase II|Physician Decision|0
5219466|NCT00961961|18017690|P4|Phase II|Adverse Event|1
5219467|NCT00961961|18017691|P3|Phase II|Adverse Event|0
5219468|NCT00961961|18017692|P2|Phase II|Adverse Event|0
5219469|NCT00961961|18017693|P1|Phase II|Adverse Event|0
5219470|NCT00961961|18017690|P4|Phase II|Lost to Follow-up|7
5219471|NCT00961961|18017691|P3|Phase II|Lost to Follow-up|10
5219472|NCT00961961|18017692|P2|Phase II|Lost to Follow-up|0
5219473|NCT00961961|18017693|P1|Phase II|Lost to Follow-up|0
5219474|NCT00961961|18017690|P4|Phase I|Physician Decision|0
5219475|NCT00961961|18017691|P3|Phase I|Physician Decision|0
5219476|NCT00961961|18017692|P2|Phase I|Physician Decision|0
5219477|NCT00961961|18017693|P1|Phase I|Physician Decision|8
5219478|NCT00961961|18017690|P4|Phase I|Adverse Event|0
5219479|NCT00961961|18017691|P3|Phase I|Adverse Event|0
5219480|NCT00961961|18017692|P2|Phase I|Adverse Event|0
5219481|NCT00961961|18017693|P1|Phase I|Adverse Event|7
5219482|NCT00961961|18017690|P4|Phase I|Lack of Efficacy|0
5219483|NCT00961961|18017691|P3|Phase I|Lack of Efficacy|0
5219484|NCT00961961|18017692|P2|Phase I|Lack of Efficacy|0
5219485|NCT00961961|18017693|P1|Phase I|Lack of Efficacy|94
5219486|NCT00961961|18017690|P4|Phase I|Lost to Follow-up|0
5219487|NCT00961961|18017691|P3|Phase I|Lost to Follow-up|0
5219488|NCT00961961|18017692|P2|Phase I|Lost to Follow-up|0
5219489|NCT00961961|18017693|P1|Phase I|Lost to Follow-up|10
5219490|NCT00961961|18017690|P4|Phase I|Withdrawal by Subject|0
5219491|NCT00961961|18017691|P3|Phase I|Withdrawal by Subject|0
5219492|NCT00961961|18017692|P2|Phase I|Withdrawal by Subject|0
5219493|NCT00961961|18017693|P1|Phase I|Withdrawal by Subject|7
5219494|NCT00961896|18017718|P3|Overall Study|Abnormal laboratory value|1
5219495|NCT00961896|18017719|P2|Overall Study|Abnormal laboratory value|0
5219496|NCT00961896|18017720|P1|Overall Study|Abnormal laboratory value|0
5219497|NCT00961649|18017787|P4|Overall Study|Study terminated by sponsor|1
5219498|NCT00961649|18017788|P3|Overall Study|Study terminated by sponsor|4
5219499|NCT00961649|18017789|P2|Overall Study|Study terminated by sponsor|4
5219500|NCT00961649|18017790|P1|Overall Study|Study terminated by sponsor|4
5219501|NCT00961649|18017787|P4|Overall Study|Patient left to Mexico-family emergency|0
5219502|NCT00961649|18017788|P3|Overall Study|Patient left to Mexico-family emergency|0
5219503|NCT00961649|18017789|P2|Overall Study|Patient left to Mexico-family emergency|0
5219504|NCT00961649|18017790|P1|Overall Study|Patient left to Mexico-family emergency|1
5219505|NCT00961649|18017787|P4|Overall Study|Patient has travel plans during holidays|0
5219506|NCT00961649|18017788|P3|Overall Study|Patient has travel plans during holidays|1
5219507|NCT00961649|18017789|P2|Overall Study|Patient has travel plans during holidays|0
5219508|NCT00961649|18017790|P1|Overall Study|Patient has travel plans during holidays|0
5219509|NCT00961649|18017787|P4|Overall Study|Inadequate control of IOP|1
5219510|NCT00961649|18017788|P3|Overall Study|Inadequate control of IOP|0
5219511|NCT00961649|18017789|P2|Overall Study|Inadequate control of IOP|0
5219512|NCT00961649|18017790|P1|Overall Study|Inadequate control of IOP|0
5219513|NCT00961649|18017787|P4|Overall Study|Adverse Event|2
5219514|NCT00961649|18017788|P3|Overall Study|Adverse Event|0
5219515|NCT00961649|18017789|P2|Overall Study|Adverse Event|0
5219516|NCT00961649|18017790|P1|Overall Study|Adverse Event|4
5219517|NCT00961636|18017804|P3|Overall Study|Withdrawal by Subject|13
5219518|NCT00961636|18017805|P2|Overall Study|Withdrawal by Subject|22
5219519|NCT00961636|18017806|P1|Overall Study|Withdrawal by Subject|29
5219520|NCT00961636|18017804|P3|Overall Study|Protocol Violation|1
5219521|NCT00961636|18017805|P2|Overall Study|Protocol Violation|5
5219522|NCT00961636|18017806|P1|Overall Study|Protocol Violation|9
5219523|NCT00961636|18017804|P3|Overall Study|Physician Decision|1
5219524|NCT00961636|18017805|P2|Overall Study|Physician Decision|1
5219525|NCT00961636|18017806|P1|Overall Study|Physician Decision|3
5219526|NCT00961636|18017804|P3|Overall Study|Lost to Follow-up|1
5219527|NCT00961636|18017805|P2|Overall Study|Lost to Follow-up|3
5219528|NCT00961636|18017806|P1|Overall Study|Lost to Follow-up|2
5219529|NCT00961636|18017804|P3|Overall Study|Flushing Symptoms|3
5219530|NCT00961636|18017805|P2|Overall Study|Flushing Symptoms|46
5219531|NCT00961636|18017806|P1|Overall Study|Flushing Symptoms|29
5219532|NCT00961636|18017804|P3|Overall Study|Adverse Event|13
5219533|NCT00961636|18017805|P2|Overall Study|Adverse Event|54
5219534|NCT00961636|18017806|P1|Overall Study|Adverse Event|35
5219535|NCT00961571|18017817|P1|Overall Study|Physician Decision|39
5219536|NCT00961415|18017845|P3|Maintenance Treatment Phase|Other reason|3
5219537|NCT00961415|18017846|P2|Maintenance Treatment Phase|Other reason|1
5219538|NCT00961415|18017847|P1|Maintenance Treatment Phase|Other reason|0
5219539|NCT00961415|18017845|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
5219540|NCT00961415|18017846|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
5219541|NCT00961415|18017847|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5219542|NCT00961415|18017845|P3|Maintenance Treatment Phase|Investigators decision|0
5219543|NCT00961415|18017846|P2|Maintenance Treatment Phase|Investigators decision|2
5219544|NCT00961415|18017847|P1|Maintenance Treatment Phase|Investigators decision|0
5219545|NCT00961415|18017845|P3|Maintenance Treatment Phase|Death|34
5219546|NCT00961415|18017846|P2|Maintenance Treatment Phase|Death|42
5219547|NCT00961415|18017847|P1|Maintenance Treatment Phase|Death|0
5219548|NCT00961415|18017845|P3|Induction Treatment Phase|Other Reason|0
5219549|NCT00961415|18017846|P2|Induction Treatment Phase|Other Reason|0
5219550|NCT00961415|18017847|P1|Induction Treatment Phase|Other Reason|5
5219551|NCT00961415|18017845|P3|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
5219552|NCT00961415|18017846|P2|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
5219553|NCT00961415|18017847|P1|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
5219554|NCT00961415|18017845|P3|Induction Treatment Phase|Physician Decision|0
5219555|NCT00961415|18017846|P2|Induction Treatment Phase|Physician Decision|0
5219556|NCT00961415|18017847|P1|Induction Treatment Phase|Physician Decision|2
5219557|NCT00961415|18017845|P3|Induction Treatment Phase|Protocol Violation|0
5219558|NCT00961415|18017846|P2|Induction Treatment Phase|Protocol Violation|0
5219559|NCT00961415|18017847|P1|Induction Treatment Phase|Protocol Violation|1
5219560|NCT00961415|18017845|P3|Induction Treatment Phase|Death|0
5219561|NCT00961415|18017846|P2|Induction Treatment Phase|Death|0
5219562|NCT00961415|18017847|P1|Induction Treatment Phase|Death|77
5219563|NCT00961415|18017845|P3|Induction Treatment Phase|Withdrawal by Subject|0
5219564|NCT00961415|18017846|P2|Induction Treatment Phase|Withdrawal by Subject|0
5219565|NCT00961415|18017847|P1|Induction Treatment Phase|Withdrawal by Subject|11
5219566|NCT00961350|18017887|P2|Overall Study|Misc|21
5219567|NCT00961350|18017888|P1|Overall Study|Misc|16
5219568|NCT00961350|18017887|P2|Overall Study|Lost to Follow-up|3
5219569|NCT00961350|18017888|P1|Overall Study|Lost to Follow-up|3
5219570|NCT00961350|18017887|P2|Overall Study|Withdrawal by Subject|10
5219571|NCT00961350|18017888|P1|Overall Study|Withdrawal by Subject|10
5219572|NCT00961350|18017887|P2|Overall Study|Adverse Event|33
5219573|NCT00961350|18017888|P1|Overall Study|Adverse Event|18
5219574|NCT00961298|18017909|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
5219575|NCT00961298|18017909|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
5219576|NCT00961298|18017909|P1|Two Week Placebo Run in|Withdrawal by Subject|1
5219577|NCT00961259|18017916|P3|Washout Period of 7 Days|due to concomitant medication used|0
5219578|NCT00961259|18017917|P2|Washout Period of 7 Days|due to concomitant medication used|1
5219579|NCT00961259|18017918|P1|Washout Period of 7 Days|due to concomitant medication used|0
5219580|NCT00961220|18017946|P1|Overall Study|Complete Response prior to 12 courses|1
5219581|NCT00961220|18017946|P1|Overall Study|O6BG no longer supplied|1
5219582|NCT00961220|18017946|P1|Overall Study|No IV access for O6BG|1
5219583|NCT00961220|18017946|P1|Overall Study|Lack of Efficacy|1
5219584|NCT00961220|18017946|P1|Overall Study|Adverse Event|3
5219585|NCT00961181|18017962|P1|Overall Study|Lost to Follow-up|1
5219586|NCT00961181|18017962|P1|Overall Study|Withdrawal by Subject|2
5219587|NCT00961181|18017962|P1|Overall Study|Death|2
5219588|NCT00961116|18017975|P2|Washout Period of 7 Days|Protocol Violation|1
5219589|NCT00961116|18017976|P1|Washout Period of 7 Days|Protocol Violation|0
5219590|NCT00961116|18017975|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5219591|NCT00961116|18017976|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5219592|NCT00961116|18017975|P2|Washout Period of 7 Days|Adverse Event|1
5219593|NCT00961116|18017976|P1|Washout Period of 7 Days|Adverse Event|1
5219594|NCT00960999|18018003|P2|Overall Study|RT dose constraints not met|0
5219595|NCT00960999|18018004|P1|Overall Study|RT dose constraints not met|2
5219596|NCT00960999|18018003|P2|Overall Study|Protocol Violation|2
5219597|NCT00960999|18018004|P1|Overall Study|Protocol Violation|5
5219598|NCT00960999|18018003|P2|Overall Study|Withdrawal by Subject|0
5219599|NCT00960999|18018004|P1|Overall Study|Withdrawal by Subject|1
5219600|NCT00960986|18018036|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
5219601|NCT00960986|18018037|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
5219602|NCT00960986|18018038|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
5219603|NCT00960986|18018039|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
5219604|NCT00960986|18018036|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5219605|NCT00960986|18018037|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
5219606|NCT00960986|18018038|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5219607|NCT00960986|18018039|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5219608|NCT00960986|18018036|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
5219609|NCT00960986|18018037|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
5219610|NCT00960986|18018038|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
5219611|NCT00960986|18018039|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
5219697|NCT00960869|18018233|P1|Overall Study|Lost to Follow-up|1
5219612|NCT00960986|18018036|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5219613|NCT00960986|18018037|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
5219614|NCT00960986|18018038|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5219615|NCT00960986|18018039|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5219616|NCT00960986|18018036|P4|Period 3 (7-week Therapy Period)|Death|0
5219617|NCT00960986|18018037|P3|Period 3 (7-week Therapy Period)|Death|1
5219618|NCT00960986|18018038|P2|Period 3 (7-week Therapy Period)|Death|0
5219619|NCT00960986|18018039|P1|Period 3 (7-week Therapy Period)|Death|0
5219620|NCT00960986|18018036|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
5219621|NCT00960986|18018037|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
5219622|NCT00960986|18018038|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
5219623|NCT00960986|18018039|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
5219624|NCT00960986|18018036|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5219625|NCT00960986|18018037|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5219626|NCT00960986|18018038|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
5219627|NCT00960986|18018039|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5219628|NCT00960986|18018036|P4|Period 1 (Screening and Washout)|Protocol Violation|0
5219629|NCT00960986|18018037|P3|Period 1 (Screening and Washout)|Protocol Violation|0
5219630|NCT00960986|18018038|P2|Period 1 (Screening and Washout)|Protocol Violation|0
5219631|NCT00960986|18018039|P1|Period 1 (Screening and Washout)|Protocol Violation|1
5219632|NCT00960986|18018036|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
5219633|NCT00960986|18018037|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
5219634|NCT00960986|18018038|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
5219635|NCT00960986|18018039|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
5219636|NCT00960986|18018036|P4|Period 1 (Screening and Washout)|Adverse Event|1
5219637|NCT00960986|18018037|P3|Period 1 (Screening and Washout)|Adverse Event|1
5219638|NCT00960986|18018038|P2|Period 1 (Screening and Washout)|Adverse Event|2
5219639|NCT00960986|18018039|P1|Period 1 (Screening and Washout)|Adverse Event|1
5219640|NCT00960934|18018115|P6|Overall Study|Study Terminated by Sponsor|49
5219641|NCT00960934|18018116|P5|Overall Study|Study Terminated by Sponsor|49
5219642|NCT00960934|18018117|P4|Overall Study|Study Terminated by Sponsor|50
5219643|NCT00960934|18018118|P3|Overall Study|Study Terminated by Sponsor|52
5219644|NCT00960934|18018119|P2|Overall Study|Study Terminated by Sponsor|46
5219645|NCT00960934|18018120|P1|Overall Study|Study Terminated by Sponsor|50
5219646|NCT00960934|18018115|P6|Overall Study|Withdrawal by Subject|7
5219647|NCT00960934|18018116|P5|Overall Study|Withdrawal by Subject|5
5219648|NCT00960934|18018117|P4|Overall Study|Withdrawal by Subject|5
5219649|NCT00960934|18018118|P3|Overall Study|Withdrawal by Subject|4
5219650|NCT00960934|18018119|P2|Overall Study|Withdrawal by Subject|6
5219651|NCT00960934|18018120|P1|Overall Study|Withdrawal by Subject|5
5219652|NCT00960934|18018115|P6|Overall Study|Protocol Violation|2
5219653|NCT00960934|18018116|P5|Overall Study|Protocol Violation|3
5219654|NCT00960934|18018117|P4|Overall Study|Protocol Violation|3
5219655|NCT00960934|18018118|P3|Overall Study|Protocol Violation|0
5219656|NCT00960934|18018119|P2|Overall Study|Protocol Violation|4
5219657|NCT00960934|18018120|P1|Overall Study|Protocol Violation|3
5219658|NCT00960934|18018115|P6|Overall Study|Progressive Disease|1
5219659|NCT00960934|18018116|P5|Overall Study|Progressive Disease|1
5219660|NCT00960934|18018117|P4|Overall Study|Progressive Disease|0
5219661|NCT00960934|18018118|P3|Overall Study|Progressive Disease|0
5219662|NCT00960934|18018119|P2|Overall Study|Progressive Disease|1
5219663|NCT00960934|18018120|P1|Overall Study|Progressive Disease|1
5219664|NCT00960934|18018115|P6|Overall Study|Physician Decision|0
5219665|NCT00960934|18018116|P5|Overall Study|Physician Decision|0
5219666|NCT00960934|18018117|P4|Overall Study|Physician Decision|0
5219667|NCT00960934|18018118|P3|Overall Study|Physician Decision|0
5219668|NCT00960934|18018119|P2|Overall Study|Physician Decision|1
5219669|NCT00960934|18018120|P1|Overall Study|Physician Decision|0
5219670|NCT00960934|18018115|P6|Overall Study|Other|2
5219671|NCT00960934|18018116|P5|Overall Study|Other|2
5219672|NCT00960934|18018117|P4|Overall Study|Other|4
5219673|NCT00960934|18018118|P3|Overall Study|Other|5
5219674|NCT00960934|18018119|P2|Overall Study|Other|1
5219675|NCT00960934|18018120|P1|Overall Study|Other|2
5219676|NCT00960934|18018115|P6|Overall Study|Lost to Follow-up|0
5219677|NCT00960934|18018116|P5|Overall Study|Lost to Follow-up|0
5219678|NCT00960934|18018117|P4|Overall Study|Lost to Follow-up|0
5219679|NCT00960934|18018118|P3|Overall Study|Lost to Follow-up|0
5219680|NCT00960934|18018119|P2|Overall Study|Lost to Follow-up|1
5219681|NCT00960934|18018120|P1|Overall Study|Lost to Follow-up|0
5219682|NCT00960934|18018115|P6|Overall Study|Lack of Efficacy|0
5219683|NCT00960934|18018116|P5|Overall Study|Lack of Efficacy|0
5219684|NCT00960934|18018117|P4|Overall Study|Lack of Efficacy|0
5219685|NCT00960934|18018118|P3|Overall Study|Lack of Efficacy|0
5219686|NCT00960934|18018119|P2|Overall Study|Lack of Efficacy|0
5219687|NCT00960934|18018120|P1|Overall Study|Lack of Efficacy|1
5219688|NCT00960934|18018115|P6|Overall Study|Adverse Event|3
5219689|NCT00960934|18018116|P5|Overall Study|Adverse Event|4
5219690|NCT00960934|18018117|P4|Overall Study|Adverse Event|2
5219691|NCT00960934|18018118|P3|Overall Study|Adverse Event|3
5219692|NCT00960934|18018119|P2|Overall Study|Adverse Event|3
5219693|NCT00960934|18018120|P1|Overall Study|Adverse Event|2
5219694|NCT00960869|18018232|P2|Overall Study|Misc|18
5219695|NCT00960869|18018233|P1|Overall Study|Misc|19
5219696|NCT00960869|18018232|P2|Overall Study|Lost to Follow-up|4
5219698|NCT00960869|18018232|P2|Overall Study|Withdrawal by Subject|14
5219699|NCT00960869|18018233|P1|Overall Study|Withdrawal by Subject|16
5219700|NCT00960869|18018232|P2|Overall Study|Adverse Event|26
5219701|NCT00960869|18018233|P1|Overall Study|Adverse Event|17
5219702|NCT00960856|18018247|P4|Washout Period of 7 Days|Adverse Event|0
5219703|NCT00960856|18018248|P3|Washout Period of 7 Days|Adverse Event|1
5219704|NCT00960856|18018249|P2|Washout Period of 7 Days|Adverse Event|0
5219705|NCT00960856|18018250|P1|Washout Period of 7 Days|Adverse Event|0
5219706|NCT00960856|18018247|P4|Washout Period of 7 Days|Withdrawal by Subject|0
5219707|NCT00960856|18018248|P3|Washout Period of 7 Days|Withdrawal by Subject|0
5219708|NCT00960856|18018249|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5219709|NCT00960856|18018250|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5219710|NCT00960843|18018270|P2|Overall Study|Repeated needle dislodgment|1
5219711|NCT00960843|18018271|P1|Overall Study|Repeated needle dislodgment|0
5219712|NCT00960843|18018270|P2|Overall Study|Protocol Violation|4
5219713|NCT00960843|18018271|P1|Overall Study|Protocol Violation|0
5219714|NCT00960843|18018270|P2|Overall Study|Lost to Follow-up|0
5219715|NCT00960843|18018271|P1|Overall Study|Lost to Follow-up|2
5219716|NCT00960687|18018292|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5219717|NCT00960687|18018293|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5219718|NCT00960687|18018292|P2|Washout Period of 7 Days|Adverse Event|2
5219719|NCT00960687|18018293|P1|Washout Period of 7 Days|Adverse Event|3
5219720|NCT00960661|18018305|P3|Interventional Phase|Lack of Efficacy|0
5219721|NCT00960661|18018306|P2|Interventional Phase|Lack of Efficacy|2
5219722|NCT00960661|18018307|P1|Interventional Phase|Lack of Efficacy|0
5219723|NCT00960661|18018305|P3|Interventional Phase|sponsor decision|0
5219724|NCT00960661|18018306|P2|Interventional Phase|sponsor decision|1
5219725|NCT00960661|18018307|P1|Interventional Phase|sponsor decision|0
5219726|NCT00960661|18018305|P3|Interventional Phase|Physician Decision|5
5219727|NCT00960661|18018306|P2|Interventional Phase|Physician Decision|3
5219728|NCT00960661|18018307|P1|Interventional Phase|Physician Decision|0
5219729|NCT00960661|18018305|P3|Interventional Phase|Withdrawal by Subject|29
5219730|NCT00960661|18018306|P2|Interventional Phase|Withdrawal by Subject|18
5219731|NCT00960661|18018307|P1|Interventional Phase|Withdrawal by Subject|0
5219732|NCT00960661|18018305|P3|Interventional Phase|Protocol Violation|2
5219733|NCT00960661|18018306|P2|Interventional Phase|Protocol Violation|7
5219734|NCT00960661|18018307|P1|Interventional Phase|Protocol Violation|0
5219735|NCT00960661|18018305|P3|Interventional Phase|entry criteria not met|0
5219736|NCT00960661|18018306|P2|Interventional Phase|entry criteria not met|3
5219737|NCT00960661|18018307|P1|Interventional Phase|entry criteria not met|0
5219738|NCT00960661|18018305|P3|Interventional Phase|Lost to Follow-up|2
5219739|NCT00960661|18018306|P2|Interventional Phase|Lost to Follow-up|0
5219740|NCT00960661|18018307|P1|Interventional Phase|Lost to Follow-up|0
5219741|NCT00960661|18018305|P3|Interventional Phase|Death|0
5219742|NCT00960661|18018306|P2|Interventional Phase|Death|1
5219743|NCT00960661|18018307|P1|Interventional Phase|Death|0
5219744|NCT00960661|18018305|P3|Interventional Phase|Adverse Event|8
5219745|NCT00960661|18018306|P2|Interventional Phase|Adverse Event|17
5219746|NCT00960661|18018307|P1|Interventional Phase|Adverse Event|0
5219747|NCT00960661|18018305|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
5219748|NCT00960661|18018306|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
5219749|NCT00960661|18018307|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
5219750|NCT00960661|18018305|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
5219751|NCT00960661|18018306|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
5219752|NCT00960661|18018307|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
5219753|NCT00960661|18018305|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
5219754|NCT00960661|18018306|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
5219755|NCT00960661|18018307|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
5219756|NCT00960661|18018305|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
5219757|NCT00960661|18018306|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
5219758|NCT00960661|18018307|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
5219759|NCT00960661|18018305|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
5219760|NCT00960661|18018306|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
5219761|NCT00960661|18018307|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
5219762|NCT00960661|18018305|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
5219763|NCT00960661|18018306|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
5219764|NCT00960661|18018307|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
5219765|NCT00960570|18018346|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
5219766|NCT00960570|18018346|P1|1 Day Period Between Dosing|Adverse Event|2
5219767|NCT00960570|18018346|P1|21 Day Washout Period|Withdrawal by Subject|1
5219768|NCT00960570|18018346|P1|21 Day Washout Period|Adverse Event|1
5219769|NCT00960531|18018367|P10|Overall Study|Reason not Specified|1
5219770|NCT00960531|18018368|P9|Overall Study|Reason not Specified|8
5219771|NCT00960531|18018369|P8|Overall Study|Reason not Specified|0
5219772|NCT00960531|18018370|P7|Overall Study|Reason not Specified|16
5219773|NCT00960531|18018371|P6|Overall Study|Reason not Specified|0
5219774|NCT00960531|18018372|P5|Overall Study|Reason not Specified|2
5219775|NCT00960531|18018373|P4|Overall Study|Reason not Specified|1
5219776|NCT00960531|18018374|P3|Overall Study|Reason not Specified|13
5219777|NCT00960531|18018375|P2|Overall Study|Reason not Specified|1
5219778|NCT00960531|18018376|P1|Overall Study|Reason not Specified|2
5219779|NCT00960531|18018367|P10|Overall Study|Adverse Event (AE)|0
5219780|NCT00960531|18018368|P9|Overall Study|Adverse Event (AE)|2
5219781|NCT00960531|18018369|P8|Overall Study|Adverse Event (AE)|0
5219782|NCT00960531|18018370|P7|Overall Study|Adverse Event (AE)|2
5219783|NCT00960531|18018371|P6|Overall Study|Adverse Event (AE)|1
5219784|NCT00960531|18018372|P5|Overall Study|Adverse Event (AE)|0
5219785|NCT00960531|18018373|P4|Overall Study|Adverse Event (AE)|0
5219786|NCT00960531|18018374|P3|Overall Study|Adverse Event (AE)|0
5219787|NCT00960531|18018375|P2|Overall Study|Adverse Event (AE)|0
5219788|NCT00960531|18018376|P1|Overall Study|Adverse Event (AE)|2
5219789|NCT00960531|18018367|P10|Overall Study|Failed to Return|0
5219790|NCT00960531|18018368|P9|Overall Study|Failed to Return|0
5219791|NCT00960531|18018369|P8|Overall Study|Failed to Return|2
5219792|NCT00960531|18018370|P7|Overall Study|Failed to Return|0
5219793|NCT00960531|18018371|P6|Overall Study|Failed to Return|0
5219794|NCT00960531|18018372|P5|Overall Study|Failed to Return|0
5219795|NCT00960531|18018373|P4|Overall Study|Failed to Return|0
5219796|NCT00960531|18018374|P3|Overall Study|Failed to Return|0
5219797|NCT00960531|18018375|P2|Overall Study|Failed to Return|0
5219798|NCT00960531|18018376|P1|Overall Study|Failed to Return|2
5219799|NCT00960531|18018367|P10|Overall Study|Lost to Follow-up|0
5219800|NCT00960531|18018368|P9|Overall Study|Lost to Follow-up|0
5219801|NCT00960531|18018369|P8|Overall Study|Lost to Follow-up|0
5219802|NCT00960531|18018370|P7|Overall Study|Lost to Follow-up|1
5219803|NCT00960531|18018371|P6|Overall Study|Lost to Follow-up|0
5219804|NCT00960531|18018372|P5|Overall Study|Lost to Follow-up|0
5219805|NCT00960531|18018373|P4|Overall Study|Lost to Follow-up|0
5219806|NCT00960531|18018374|P3|Overall Study|Lost to Follow-up|1
5219807|NCT00960531|18018375|P2|Overall Study|Lost to Follow-up|0
5219808|NCT00960531|18018376|P1|Overall Study|Lost to Follow-up|0
5219809|NCT00960531|18018367|P10|Overall Study|Discontinuation of Study by Sponsor|0
5219810|NCT00960531|18018368|P9|Overall Study|Discontinuation of Study by Sponsor|0
5219811|NCT00960531|18018369|P8|Overall Study|Discontinuation of Study by Sponsor|1
5219812|NCT00960531|18018370|P7|Overall Study|Discontinuation of Study by Sponsor|0
5219813|NCT00960531|18018371|P6|Overall Study|Discontinuation of Study by Sponsor|0
5219814|NCT00960531|18018372|P5|Overall Study|Discontinuation of Study by Sponsor|0
5219815|NCT00960531|18018373|P4|Overall Study|Discontinuation of Study by Sponsor|0
5219816|NCT00960531|18018374|P3|Overall Study|Discontinuation of Study by Sponsor|0
5219817|NCT00960531|18018375|P2|Overall Study|Discontinuation of Study by Sponsor|0
5219818|NCT00960531|18018376|P1|Overall Study|Discontinuation of Study by Sponsor|0
5219819|NCT00960531|18018367|P10|Overall Study|Investigator Request|0
5219820|NCT00960531|18018368|P9|Overall Study|Investigator Request|0
5219821|NCT00960531|18018369|P8|Overall Study|Investigator Request|0
5219822|NCT00960531|18018370|P7|Overall Study|Investigator Request|0
5219823|NCT00960531|18018371|P6|Overall Study|Investigator Request|0
5219824|NCT00960531|18018372|P5|Overall Study|Investigator Request|0
5219825|NCT00960531|18018373|P4|Overall Study|Investigator Request|0
5219826|NCT00960531|18018374|P3|Overall Study|Investigator Request|1
5219827|NCT00960531|18018375|P2|Overall Study|Investigator Request|0
5219828|NCT00960531|18018376|P1|Overall Study|Investigator Request|0
5219829|NCT00960531|18018367|P10|Overall Study|Caregiver Request|0
5219830|NCT00960531|18018368|P9|Overall Study|Caregiver Request|3
5219831|NCT00960531|18018369|P8|Overall Study|Caregiver Request|1
5219832|NCT00960531|18018370|P7|Overall Study|Caregiver Request|3
5219833|NCT00960531|18018371|P6|Overall Study|Caregiver Request|2
5219834|NCT00960531|18018372|P5|Overall Study|Caregiver Request|0
5219835|NCT00960531|18018373|P4|Overall Study|Caregiver Request|5
5219836|NCT00960531|18018374|P3|Overall Study|Caregiver Request|6
5219837|NCT00960531|18018375|P2|Overall Study|Caregiver Request|0
5219838|NCT00960531|18018376|P1|Overall Study|Caregiver Request|2
5219839|NCT00960531|18018367|P10|Overall Study|Withdrawal by Subject|0
5219840|NCT00960531|18018368|P9|Overall Study|Withdrawal by Subject|1
5219841|NCT00960531|18018369|P8|Overall Study|Withdrawal by Subject|0
5219842|NCT00960531|18018370|P7|Overall Study|Withdrawal by Subject|2
5219843|NCT00960531|18018371|P6|Overall Study|Withdrawal by Subject|0
5219844|NCT00960531|18018372|P5|Overall Study|Withdrawal by Subject|0
5219845|NCT00960531|18018373|P4|Overall Study|Withdrawal by Subject|2
5219846|NCT00960531|18018374|P3|Overall Study|Withdrawal by Subject|5
5219847|NCT00960531|18018375|P2|Overall Study|Withdrawal by Subject|0
5219848|NCT00960531|18018376|P1|Overall Study|Withdrawal by Subject|1
5219849|NCT00960531|18018367|P10|Overall Study|Lack of Efficacy|0
5219850|NCT00960531|18018368|P9|Overall Study|Lack of Efficacy|0
5219851|NCT00960531|18018369|P8|Overall Study|Lack of Efficacy|0
5219852|NCT00960531|18018370|P7|Overall Study|Lack of Efficacy|0
5219853|NCT00960531|18018371|P6|Overall Study|Lack of Efficacy|0
5219854|NCT00960531|18018372|P5|Overall Study|Lack of Efficacy|0
5219855|NCT00960531|18018373|P4|Overall Study|Lack of Efficacy|0
5219856|NCT00960531|18018374|P3|Overall Study|Lack of Efficacy|0
5219857|NCT00960531|18018375|P2|Overall Study|Lack of Efficacy|0
5219858|NCT00960531|18018376|P1|Overall Study|Lack of Efficacy|1
5219859|NCT00960440|18018458|P4|Overall Study|Other|0
5219860|NCT00960440|18018459|P3|Overall Study|Other|1
5219861|NCT00960440|18018460|P2|Overall Study|Other|1
5219862|NCT00960440|18018461|P1|Overall Study|Other|1
5219863|NCT00960440|18018458|P4|Overall Study|Withdrawal by Subject|1
5219864|NCT00960440|18018459|P3|Overall Study|Withdrawal by Subject|2
5219865|NCT00960440|18018460|P2|Overall Study|Withdrawal by Subject|5
5219866|NCT00960440|18018461|P1|Overall Study|Withdrawal by Subject|9
5219867|NCT00960440|18018458|P4|Overall Study|Protocol Violation|4
5219868|NCT00960440|18018459|P3|Overall Study|Protocol Violation|3
5219869|NCT00960440|18018460|P2|Overall Study|Protocol Violation|8
5219870|NCT00960440|18018461|P1|Overall Study|Protocol Violation|2
5219871|NCT00960440|18018458|P4|Overall Study|Lack of Efficacy|8
5219872|NCT00960440|18018459|P3|Overall Study|Lack of Efficacy|3
5219873|NCT00960440|18018460|P2|Overall Study|Lack of Efficacy|5
5219874|NCT00960440|18018461|P1|Overall Study|Lack of Efficacy|2
5219875|NCT00960440|18018458|P4|Overall Study|Adverse Event|4
5219876|NCT00960440|18018459|P3|Overall Study|Adverse Event|4
5219877|NCT00960440|18018460|P2|Overall Study|Adverse Event|12
5219878|NCT00960440|18018461|P1|Overall Study|Adverse Event|12
5219879|NCT00960440|18018458|P4|Overall Study|Death|1
5219880|NCT00960440|18018459|P3|Overall Study|Death|0
5219881|NCT00960440|18018460|P2|Overall Study|Death|0
5219882|NCT00960440|18018461|P1|Overall Study|Death|0
5219883|NCT00960375|18018633|P2|Overall Study|Lost to Follow-up|22
5219884|NCT00960375|18018634|P1|Overall Study|Lost to Follow-up|20
5219885|NCT00960323|18018642|P1|Atorvastatin Alone|Withdrawal by Subject|1
5219886|NCT00960297|18018653|P1|Overall Study|Disease progression|1
5219887|NCT00960297|18018653|P1|Overall Study|Venous port infection|1
5219888|NCT00960297|18018653|P1|Overall Study|Physician Decision|1
5219889|NCT00960206|18018660|P3|Overall Study|Missing 10 year data|1
5219890|NCT00960206|18018661|P2|Overall Study|Missing 10 year data|1
5219891|NCT00960206|18018662|P1|Overall Study|Missing 10 year data|20
5219892|NCT00960206|18018660|P3|Overall Study|Revision of study component|2
5219893|NCT00960206|18018661|P2|Overall Study|Revision of study component|2
5219894|NCT00960206|18018662|P1|Overall Study|Revision of study component|2
5219895|NCT00960206|18018660|P3|Overall Study|Withdrawal by Subject|0
5219896|NCT00960206|18018661|P2|Overall Study|Withdrawal by Subject|4
5219897|NCT00960206|18018662|P1|Overall Study|Withdrawal by Subject|2
5219898|NCT00960206|18018660|P3|Overall Study|Lost to Follow-up|8
5219899|NCT00960206|18018661|P2|Overall Study|Lost to Follow-up|14
5219900|NCT00960206|18018662|P1|Overall Study|Lost to Follow-up|8
5219901|NCT00960206|18018660|P3|Overall Study|Unwilling/Unable to return|0
5219902|NCT00960206|18018661|P2|Overall Study|Unwilling/Unable to return|2
5219903|NCT00960206|18018662|P1|Overall Study|Unwilling/Unable to return|1
5219904|NCT00960206|18018660|P3|Overall Study|Death|1
5219905|NCT00960206|18018661|P2|Overall Study|Death|4
5219906|NCT00960206|18018662|P1|Overall Study|Death|7
5219907|NCT00960193|18018680|P1|14 Day Washout Period|Withdrawal by Subject|1
5219908|NCT00960154|18018693|P2|Overall Study|Study termination|25
5219909|NCT00960154|18018694|P1|Overall Study|Study termination|25
5219910|NCT00960141|18018705|P3|Overall Study|Withdrawal by Subject|1
5219911|NCT00960141|18018706|P2|Overall Study|Withdrawal by Subject|2
5219912|NCT00960141|18018707|P1|Overall Study|Withdrawal by Subject|1
5219913|NCT00960141|18018705|P3|Overall Study|Protocol Violation|2
5219914|NCT00960141|18018706|P2|Overall Study|Protocol Violation|3
5219915|NCT00960141|18018707|P1|Overall Study|Protocol Violation|1
5219916|NCT00960141|18018705|P3|Overall Study|Lost to Follow-up|0
5219917|NCT00960141|18018706|P2|Overall Study|Lost to Follow-up|0
5219918|NCT00960141|18018707|P1|Overall Study|Lost to Follow-up|1
5219919|NCT00960141|18018705|P3|Overall Study|Lack of Efficacy|2
5219920|NCT00960141|18018706|P2|Overall Study|Lack of Efficacy|4
5219921|NCT00960141|18018707|P1|Overall Study|Lack of Efficacy|3
5219922|NCT00960141|18018705|P3|Overall Study|Adverse Event|2
5219923|NCT00960141|18018706|P2|Overall Study|Adverse Event|8
5219924|NCT00960141|18018707|P1|Overall Study|Adverse Event|4
5219925|NCT00960115|18018732|P2|Overall Study|Ongoing treatment at data cut-off date|15
5219926|NCT00960115|18018733|P1|Overall Study|Ongoing treatment at data cut-off date|19
5219927|NCT00960076|18018747|P2|Overall Study|Did not attend the termination visit|1
5219928|NCT00960076|18018748|P1|Overall Study|Did not attend the termination visit|0
5219929|NCT00960076|18018747|P2|Overall Study|Hyperglycemia|5
5219930|NCT00960076|18018748|P1|Overall Study|Hyperglycemia|1
5219931|NCT00960076|18018747|P2|Overall Study|Severe non-compliance to protocol|2
5219932|NCT00960076|18018748|P1|Overall Study|Severe non-compliance to protocol|1
5219933|NCT00960076|18018747|P2|Overall Study|Lost to Follow-up|3
5219934|NCT00960076|18018748|P1|Overall Study|Lost to Follow-up|3
5219935|NCT00960076|18018747|P2|Overall Study|Withdrawal by Subject|2
5219936|NCT00960076|18018748|P1|Overall Study|Withdrawal by Subject|1
5219937|NCT00960076|18018747|P2|Overall Study|No longer met study criteria|5
5219938|NCT00960076|18018748|P1|Overall Study|No longer met study criteria|1
5219939|NCT00960076|18018747|P2|Overall Study|Adverse Event|7
5219940|NCT00960076|18018748|P1|Overall Study|Adverse Event|1
5219941|NCT00960063|18018763|P3|Overall Study|Progression of Disease|3
5219942|NCT00960063|18018764|P2|Overall Study|Progression of Disease|0
5219943|NCT00960063|18018765|P1|Overall Study|Progression of Disease|0
5219944|NCT00960063|18018763|P3|Overall Study|Adverse Event|0
5219945|NCT00960063|18018764|P2|Overall Study|Adverse Event|0
5219946|NCT00960063|18018765|P1|Overall Study|Adverse Event|1
5219947|NCT00960011|18018805|P2|Overall Study|Lost to Follow-up|2
5219948|NCT00960011|18018806|P1|Overall Study|Lost to Follow-up|6
5219949|NCT00960011|18018805|P2|Overall Study|Death|0
5219950|NCT00960011|18018806|P1|Overall Study|Death|5
5219951|NCT00959946|18018899|P8|Overall Study|Withdrawal by Subject|0
5219952|NCT00959946|18018900|P7|Overall Study|Withdrawal by Subject|0
5219953|NCT00959946|18018901|P6|Overall Study|Withdrawal by Subject|1
5219954|NCT00959946|18018902|P5|Overall Study|Withdrawal by Subject|0
5219955|NCT00959946|18018903|P4|Overall Study|Withdrawal by Subject|0
5219956|NCT00959946|18018904|P3|Overall Study|Withdrawal by Subject|0
5219957|NCT00959946|18018905|P2|Overall Study|Withdrawal by Subject|0
5219958|NCT00959946|18018906|P1|Overall Study|Withdrawal by Subject|0
5219959|NCT00959946|18018899|P8|Overall Study|Disease Progression|2
5219960|NCT00959946|18018900|P7|Overall Study|Disease Progression|2
5219961|NCT00959946|18018901|P6|Overall Study|Disease Progression|6
5219962|NCT00959946|18018902|P5|Overall Study|Disease Progression|4
5219963|NCT00959946|18018903|P4|Overall Study|Disease Progression|4
5219964|NCT00959946|18018904|P3|Overall Study|Disease Progression|2
5219965|NCT00959946|18018905|P2|Overall Study|Disease Progression|4
5219966|NCT00959946|18018906|P1|Overall Study|Disease Progression|2
5219967|NCT00959946|18018899|P8|Overall Study|Death|0
5219968|NCT00959946|18018900|P7|Overall Study|Death|0
5219969|NCT00959946|18018901|P6|Overall Study|Death|1
5219970|NCT00959946|18018902|P5|Overall Study|Death|0
5219971|NCT00959946|18018903|P4|Overall Study|Death|0
5219972|NCT00959946|18018904|P3|Overall Study|Death|0
5219973|NCT00959946|18018905|P2|Overall Study|Death|0
5219974|NCT00959946|18018906|P1|Overall Study|Death|0
5219975|NCT00959946|18018899|P8|Overall Study|Adverse Event|0
5219976|NCT00959946|18018900|P7|Overall Study|Adverse Event|0
5219977|NCT00959946|18018901|P6|Overall Study|Adverse Event|1
5219978|NCT00959946|18018902|P5|Overall Study|Adverse Event|0
5219979|NCT00959946|18018903|P4|Overall Study|Adverse Event|1
5219980|NCT00959946|18018904|P3|Overall Study|Adverse Event|2
5219981|NCT00959946|18018905|P2|Overall Study|Adverse Event|0
5219982|NCT00959946|18018906|P1|Overall Study|Adverse Event|0
5219983|NCT00959907|18018970|P2|Overall Study|Withdrawal by Subject|0
5219984|NCT00959907|18018971|P1|Overall Study|Withdrawal by Subject|2
5219985|NCT00959907|18018970|P2|Overall Study|Adverse Event|0
5219986|NCT00959907|18018971|P1|Overall Study|Adverse Event|1
5219987|NCT00959907|18018970|P2|Overall Study|Protocol Violation|1
5219988|NCT00959907|18018971|P1|Overall Study|Protocol Violation|0
5219989|NCT00959894|18018981|P1|Overall Study|Subject moved out of town|1
5219990|NCT00959894|18018981|P1|Overall Study|Need for contraindicated medication|1
5219991|NCT00959894|18018981|P1|Overall Study|Withdrawal by Subject|1
5219992|NCT00959894|18018981|P1|Overall Study|Adverse Event|3
5219993|NCT00959894|18018981|P1|Overall Study|Lost to Follow-up|10
5219994|NCT00959751|18019030|P2|Overall Study|No migraine headache without aura|7
5219995|NCT00959751|18019031|P1|Overall Study|No migraine headache without aura|7
5219996|NCT00959751|18019030|P2|Overall Study|Non-compliance to Study Procedures|1
5219997|NCT00959751|18019031|P1|Overall Study|Non-compliance to Study Procedures|0
5219998|NCT00959751|18019030|P2|Overall Study|Consent Withdrawn|1
5219999|NCT00959751|18019031|P1|Overall Study|Consent Withdrawn|0
5220000|NCT00959751|18019030|P2|Overall Study|Lost to Follow-up|3
5220001|NCT00959751|18019031|P1|Overall Study|Lost to Follow-up|2
5220002|NCT00959699|18019053|P2|Follow-up Period|Withdrawal by Subject|4
5220003|NCT00959699|18019054|P1|Follow-up Period|Withdrawal by Subject|3
5220004|NCT00959699|18019053|P2|Follow-up Period|Lost to Follow-up|2
5220005|NCT00959699|18019054|P1|Follow-up Period|Lost to Follow-up|3
5220006|NCT00959699|18019053|P2|Treatment Period|Futility/crossover to boceprevir|0
5220007|NCT00959699|18019054|P1|Treatment Period|Futility/crossover to boceprevir|4
5220008|NCT00959699|18019053|P2|Treatment Period|Did not receive treatment|1
5220009|NCT00959699|18019054|P1|Treatment Period|Did not receive treatment|0
5220010|NCT00959699|18019053|P2|Treatment Period|Non-Compliance with Protocol|1
5220011|NCT00959699|18019054|P1|Treatment Period|Non-Compliance with Protocol|0
5220012|NCT00959699|18019053|P2|Treatment Period|Withdrawal by Subject|3
5220013|NCT00959699|18019054|P1|Treatment Period|Withdrawal by Subject|1
5220014|NCT00959699|18019053|P2|Treatment Period|Lost to Follow-up|1
5220015|NCT00959699|18019054|P1|Treatment Period|Lost to Follow-up|0
5220016|NCT00959699|18019053|P2|Treatment Period|Lack of Efficacy|6
5220017|NCT00959699|18019054|P1|Treatment Period|Lack of Efficacy|15
5220018|NCT00959699|18019053|P2|Treatment Period|Adverse Event|13
5220019|NCT00959699|18019054|P1|Treatment Period|Adverse Event|3
5220020|NCT00959647|18019100|P1|Overall Study|Withdrawal by Subject|7
5220021|NCT00959647|18019100|P1|Overall Study|Study terminated by sponsor|4
5220022|NCT00959647|18019100|P1|Overall Study|Progressive disease|6
5220023|NCT00959647|18019100|P1|Overall Study|Adverse Event|2
5220024|NCT00959374|18019105|P1|Overall Study|Physician Decision|1
5220025|NCT00959374|18019105|P1|Overall Study|Implant Removed/Not Replaced|4
5220026|NCT00959374|18019105|P1|Overall Study|Protocol Violation|1
5220027|NCT00959374|18019105|P1|Overall Study|Death|1
5220028|NCT00959374|18019105|P1|Overall Study|Lost to Follow-up|14
5220029|NCT00959374|18019105|P1|Overall Study|Withdrawal by Subject|2
5220030|NCT00959192|18019119|P4|Overall Study|Caregiver Request|1
5220031|NCT00959192|18019120|P3|Overall Study|Caregiver Request|2
5220032|NCT00959192|18019121|P2|Overall Study|Caregiver Request|0
5220033|NCT00959192|18019122|P1|Overall Study|Caregiver Request|0
5220034|NCT00959192|18019119|P4|Overall Study|Investigator Request|0
5220035|NCT00959192|18019120|P3|Overall Study|Investigator Request|0
5220036|NCT00959192|18019121|P2|Overall Study|Investigator Request|0
5220037|NCT00959192|18019122|P1|Overall Study|Investigator Request|1
5220038|NCT00959192|18019119|P4|Overall Study|Adverse Event|0
5220039|NCT00959192|18019120|P3|Overall Study|Adverse Event|1
5220040|NCT00959192|18019121|P2|Overall Study|Adverse Event|1
5220041|NCT00959192|18019122|P1|Overall Study|Adverse Event|1
5220042|NCT00959049|18019181|P6|Overall Study|Withdrawal by Subject|0
5220043|NCT00959049|18019182|P5|Overall Study|Withdrawal by Subject|0
5220044|NCT00959049|18019183|P4|Overall Study|Withdrawal by Subject|0
5220045|NCT00959049|18019184|P3|Overall Study|Withdrawal by Subject|0
5220046|NCT00959049|18019185|P2|Overall Study|Withdrawal by Subject|2
5220047|NCT00959049|18019186|P1|Overall Study|Withdrawal by Subject|0
5220048|NCT00959049|18019181|P6|Overall Study|Contraindicated medication|0
5220049|NCT00959049|18019182|P5|Overall Study|Contraindicated medication|0
5220050|NCT00959049|18019183|P4|Overall Study|Contraindicated medication|1
5220051|NCT00959049|18019184|P3|Overall Study|Contraindicated medication|0
5220052|NCT00959049|18019185|P2|Overall Study|Contraindicated medication|0
5220053|NCT00959049|18019186|P1|Overall Study|Contraindicated medication|0
5220054|NCT00959049|18019181|P6|Overall Study|Lost to Follow-up|1
5220055|NCT00959049|18019182|P5|Overall Study|Lost to Follow-up|9
5220056|NCT00959049|18019183|P4|Overall Study|Lost to Follow-up|10
5220057|NCT00959049|18019184|P3|Overall Study|Lost to Follow-up|1
5220058|NCT00959049|18019185|P2|Overall Study|Lost to Follow-up|5
5220059|NCT00959049|18019186|P1|Overall Study|Lost to Follow-up|17
5220060|NCT00959049|18019181|P6|Overall Study|Adverse Event|0
5220061|NCT00959049|18019182|P5|Overall Study|Adverse Event|0
5220062|NCT00959049|18019183|P4|Overall Study|Adverse Event|0
5220063|NCT00959049|18019184|P3|Overall Study|Adverse Event|0
5220064|NCT00959049|18019185|P2|Overall Study|Adverse Event|0
5220065|NCT00959049|18019186|P1|Overall Study|Adverse Event|1
5220066|NCT00958893|18019251|P1|Overall Study|Study prematurely terminated|4
5220067|NCT00958880|18019257|P2|Overall Study|Lost to Follow-up|2
5220068|NCT00958880|18019258|P1|Overall Study|Lost to Follow-up|2
5220069|NCT00958841|18019266|P1|Overall Study|Discontinued prior to M*|28
5220070|NCT00958841|18019266|P1|Overall Study|Completed M6/did not enter extension|27
5220071|NCT00958841|18019266|P1|Overall Study|Unsatisfactory therapeutic effect|22
5220072|NCT00958841|18019266|P1|Overall Study|Withdrawal by Subject|1
5220073|NCT00958841|18019266|P1|Overall Study|New cancer therapy|5
5220074|NCT00958841|18019266|P1|Overall Study|Adverse Event|8
5220075|NCT00958841|18019266|P1|Overall Study|Administrative problems|1
5220076|NCT00958841|18019266|P1|Overall Study|Abnormal test procedure result(s)|3
5220077|NCT00958841|18019266|P1|Overall Study|Abnormal laboratory value(s)|1
5220078|NCT00958828|18019284|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
5220079|NCT00958828|18019285|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
5220080|NCT00958828|18019284|P2|Period 1, 1 Week of Wear|Randomization break|1
5220081|NCT00958828|18019285|P1|Period 1, 1 Week of Wear|Randomization break|0
5220082|NCT00958789|18019291|P1|Overall Study|Revision|7
5220083|NCT00958789|18019291|P1|Overall Study|Subject terminated|2
5220084|NCT00958789|18019291|P1|Overall Study|2 yr. Knee Society Score not calculable|1
5220085|NCT00958789|18019291|P1|Overall Study|No 2 yr. Knee Society Score data|4
5220086|NCT00958789|18019291|P1|Overall Study|Withdrawal by Subject|17
5220087|NCT00958789|18019291|P1|Overall Study|Lost to Follow-up|14
5220088|NCT00958789|18019291|P1|Overall Study|Death|5
5220089|NCT00958776|18019311|P2|Overall Study|Missing|1
5220090|NCT00958776|18019312|P1|Overall Study|Missing|1
5220091|NCT00958776|18019311|P2|Overall Study|Noncompliance; Protocol Deviations|3
5220092|NCT00958776|18019312|P1|Overall Study|Noncompliance; Protocol Deviations|2
5220093|NCT00958776|18019311|P2|Overall Study|Death|1
5220094|NCT00958776|18019312|P1|Overall Study|Death|2
5220095|NCT00958776|18019311|P2|Overall Study|Protocol Violation|1
5220096|NCT00958776|18019312|P1|Overall Study|Protocol Violation|1
5220097|NCT00958776|18019311|P2|Overall Study|Withdrawal by Subject|16
5220098|NCT00958776|18019312|P1|Overall Study|Withdrawal by Subject|7
5220099|NCT00958776|18019311|P2|Overall Study|Lost to Follow-up|6
5220100|NCT00958776|18019312|P1|Overall Study|Lost to Follow-up|2
5220101|NCT00958776|18019311|P2|Overall Study|Physician Decision|0
5220102|NCT00958776|18019312|P1|Overall Study|Physician Decision|1
5220103|NCT00958776|18019311|P2|Overall Study|Adverse Event|1
5220104|NCT00958776|18019312|P1|Overall Study|Adverse Event|0
5220105|NCT00958724|18019342|P1|Overall Study|Disease Progression|6
5220106|NCT00958711|18019354|P2|Overall Study|Adverse Event|2
5220107|NCT00958711|18019355|P1|Overall Study|Adverse Event|1
5220108|NCT00958711|18019354|P2|Overall Study|Death|2
5220109|NCT00958711|18019355|P1|Overall Study|Death|1
5220110|NCT00958711|18019354|P2|Overall Study|Other|5
5220111|NCT00958711|18019355|P1|Overall Study|Other|2
5220112|NCT00958711|18019354|P2|Overall Study|Lost to Follow-up|1
5220113|NCT00958711|18019355|P1|Overall Study|Lost to Follow-up|4
5220114|NCT00958711|18019354|P2|Overall Study|Physician Decision|7
5220115|NCT00958711|18019355|P1|Overall Study|Physician Decision|5
5220116|NCT00958711|18019354|P2|Overall Study|Withdrawal by Subject|4
5220117|NCT00958711|18019355|P1|Overall Study|Withdrawal by Subject|0
5220118|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5220119|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
5220120|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5220121|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5220122|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5220123|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
5220124|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5220125|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5220126|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
5220127|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
5220128|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
5220129|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
5220130|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
5220131|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
5220132|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
5220133|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
5220134|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
5220135|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
5220136|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
5220137|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
5220138|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
5220139|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
5220140|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
5220141|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
5220142|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
5220143|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
5220144|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
5220145|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
5220146|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
5220147|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
5220148|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
5220149|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
5220150|NCT00958568|18019400|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
5220151|NCT00958568|18019401|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
5220152|NCT00958568|18019402|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
5220153|NCT00958568|18019403|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
5220154|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5220155|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5220156|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
5220157|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5220158|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5220159|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5220160|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
5220161|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5220162|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5220163|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5220164|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
5220165|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5220166|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5220167|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5220168|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
5220169|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5220170|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5220171|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5220172|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
5220173|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5220174|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5220175|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5220176|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
5220177|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5220178|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5220179|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5220180|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
5220181|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5220182|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5220183|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5220184|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
5220185|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5220186|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5220187|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5220188|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
5220189|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5220190|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5220191|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5220192|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
5220193|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5220194|NCT00958568|18019400|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5220195|NCT00958568|18019401|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5220196|NCT00958568|18019402|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
5220197|NCT00958568|18019403|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5220198|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5220199|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5220200|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5220201|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
5220202|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5220203|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5220204|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5220205|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
5220206|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5220207|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5220208|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5220209|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
5220210|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5220211|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5220212|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5220213|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
5220214|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5220215|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5220216|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5220217|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
5220218|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5220219|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5220220|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5220221|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
5220222|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5220223|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5220224|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5220225|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
5220226|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5220227|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5220228|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5220229|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
5220230|NCT00958568|18019400|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5220231|NCT00958568|18019401|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5220232|NCT00958568|18019402|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5220233|NCT00958568|18019403|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
5220234|NCT00958438|18019640|P3|Overall Study|Other than specified above|2
5220235|NCT00958438|18019641|P2|Overall Study|Other than specified above|3
5220236|NCT00958438|18019642|P1|Overall Study|Other than specified above|2
5220237|NCT00958438|18019640|P3|Overall Study|Physician Decision|1
5220238|NCT00958438|18019641|P2|Overall Study|Physician Decision|0
5220239|NCT00958438|18019642|P1|Overall Study|Physician Decision|1
5220240|NCT00958438|18019640|P3|Overall Study|Adverse Event|0
5220241|NCT00958438|18019641|P2|Overall Study|Adverse Event|3
5220242|NCT00958438|18019642|P1|Overall Study|Adverse Event|0
5220243|NCT00958438|18019640|P3|Overall Study|Withdrawal by Subject|1
5220244|NCT00958438|18019641|P2|Overall Study|Withdrawal by Subject|2
5220245|NCT00958438|18019642|P1|Overall Study|Withdrawal by Subject|4
5220246|NCT00958438|18019640|P3|Overall Study|Protocol Violation|2
5220247|NCT00958438|18019641|P2|Overall Study|Protocol Violation|2
5220248|NCT00958438|18019642|P1|Overall Study|Protocol Violation|3
5220249|NCT00958412|18019665|P1|Overall Study|Study prematurely terminated|18
5220250|NCT00958360|18019671|P2|Overall Study|Lost to Follow-up|1
5220251|NCT00958360|18019672|P1|Overall Study|Lost to Follow-up|0
5220252|NCT00958360|18019671|P2|Overall Study|Physician Decision|1
5220253|NCT00958360|18019672|P1|Overall Study|Physician Decision|2
5220254|NCT00958360|18019671|P2|Overall Study|Death|7
5220255|NCT00958360|18019672|P1|Overall Study|Death|6
5220256|NCT00958360|18019671|P2|Overall Study|Withdrawal by Subject|1
5220257|NCT00958360|18019672|P1|Overall Study|Withdrawal by Subject|3
5220258|NCT00958347|18019686|P1|Overall Study|study termination|135
5220259|NCT00958347|18019686|P1|Overall Study|revision/removal|10
5220260|NCT00958347|18019686|P1|Overall Study|Lost to Follow-up|15
5220261|NCT00958347|18019686|P1|Overall Study|Withdrawal by Subject|23
5220262|NCT00958347|18019686|P1|Overall Study|Death|43
5220263|NCT00958256|18019730|P1|Overall Study|Adverse Event|3
5220264|NCT00958243|18019740|P6|Overall Study|Lost to Follow-up|5
5220265|NCT00958243|18019741|P5|Overall Study|Lost to Follow-up|8
5220266|NCT00958243|18019742|P4|Overall Study|Lost to Follow-up|2
5220267|NCT00958243|18019743|P3|Overall Study|Lost to Follow-up|11
5220268|NCT00958243|18019744|P2|Overall Study|Lost to Follow-up|5
5220269|NCT00958243|18019745|P1|Overall Study|Lost to Follow-up|2
5220270|NCT00958243|18019740|P6|Overall Study|Withdrawal by Subject|5
5220271|NCT00958243|18019741|P5|Overall Study|Withdrawal by Subject|1
5220272|NCT00958243|18019742|P4|Overall Study|Withdrawal by Subject|1
5220273|NCT00958243|18019743|P3|Overall Study|Withdrawal by Subject|3
5220274|NCT00958243|18019744|P2|Overall Study|Withdrawal by Subject|1
5220275|NCT00958243|18019745|P1|Overall Study|Withdrawal by Subject|0
5220276|NCT00958217|18019803|P2|Overall Study|Inpatient hospitalization|1
5220277|NCT00958217|18019804|P1|Overall Study|Inpatient hospitalization|0
5220278|NCT00958217|18019803|P2|Overall Study|Moved out of area|1
5220279|NCT00958217|18019804|P1|Overall Study|Moved out of area|1
5220280|NCT00958217|18019803|P2|Overall Study|Lost to Follow-up|19
5220281|NCT00958217|18019804|P1|Overall Study|Lost to Follow-up|17
5220282|NCT00958217|18019803|P2|Overall Study|Withdrawal by Subject|3
5220283|NCT00958217|18019804|P1|Overall Study|Withdrawal by Subject|4
5220284|NCT00958217|18019803|P2|Overall Study|Death|1
5220285|NCT00958217|18019804|P1|Overall Study|Death|2
5220286|NCT00958191|18019815|P1|Overall Study|No 5 yr x-rays|56
5220287|NCT00958191|18019815|P1|Overall Study|Site termination|11
5220288|NCT00958191|18019815|P1|Overall Study|Revision of study device|4
5220289|NCT00958191|18019815|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
5220290|NCT00958191|18019815|P1|Overall Study|Inadequate 5 yr x-ray quality|10
5220291|NCT00958191|18019815|P1|Overall Study|Lost to Follow-up|5
5220292|NCT00958191|18019815|P1|Overall Study|Death|4
5220293|NCT00958165|18019830|P1|Overall Study|Not eligible|9
5220294|NCT00958165|18019830|P1|Overall Study|Lost to Follow-up|5
5220295|NCT00958126|18019842|P8|Overall Study|Other Reason|0
5220296|NCT00958126|18019843|P7|Overall Study|Other Reason|0
5220297|NCT00958126|18019844|P6|Overall Study|Other Reason|1
5220298|NCT00958126|18019845|P5|Overall Study|Other Reason|0
5220299|NCT00958126|18019846|P4|Overall Study|Other Reason|1
5220300|NCT00958126|18019847|P3|Overall Study|Other Reason|0
5220301|NCT00958126|18019848|P2|Overall Study|Other Reason|0
5220302|NCT00958126|18019849|P1|Overall Study|Other Reason|0
5220303|NCT00958126|18019842|P8|Overall Study|Sponsor/Investigator decision|0
5220304|NCT00958126|18019843|P7|Overall Study|Sponsor/Investigator decision|0
5220305|NCT00958126|18019844|P6|Overall Study|Sponsor/Investigator decision|0
5220306|NCT00958126|18019845|P5|Overall Study|Sponsor/Investigator decision|0
5220307|NCT00958126|18019846|P4|Overall Study|Sponsor/Investigator decision|1
5220308|NCT00958126|18019847|P3|Overall Study|Sponsor/Investigator decision|0
5220309|NCT00958126|18019848|P2|Overall Study|Sponsor/Investigator decision|0
5220310|NCT00958126|18019849|P1|Overall Study|Sponsor/Investigator decision|0
5220311|NCT00958126|18019842|P8|Overall Study|Lost to Follow-up|0
5220312|NCT00958126|18019843|P7|Overall Study|Lost to Follow-up|0
5220313|NCT00958126|18019844|P6|Overall Study|Lost to Follow-up|0
5220314|NCT00958126|18019845|P5|Overall Study|Lost to Follow-up|0
5220315|NCT00958126|18019846|P4|Overall Study|Lost to Follow-up|8
5220316|NCT00958126|18019847|P3|Overall Study|Lost to Follow-up|9
5220317|NCT00958126|18019848|P2|Overall Study|Lost to Follow-up|5
5220318|NCT00958126|18019849|P1|Overall Study|Lost to Follow-up|1
5220319|NCT00958126|18019842|P8|Overall Study|Moved away from study area|0
5220320|NCT00958126|18019843|P7|Overall Study|Moved away from study area|0
5220321|NCT00958126|18019844|P6|Overall Study|Moved away from study area|0
5220322|NCT00958126|18019845|P5|Overall Study|Moved away from study area|0
5220323|NCT00958126|18019846|P4|Overall Study|Moved away from study area|1
5220324|NCT00958126|18019847|P3|Overall Study|Moved away from study area|1
5220325|NCT00958126|18019848|P2|Overall Study|Moved away from study area|0
5220326|NCT00958126|18019849|P1|Overall Study|Moved away from study area|0
5220327|NCT00958126|18019842|P8|Overall Study|Withdrawal by Subject|0
5220328|NCT00958126|18019843|P7|Overall Study|Withdrawal by Subject|0
5220329|NCT00958126|18019844|P6|Overall Study|Withdrawal by Subject|0
5220330|NCT00958126|18019845|P5|Overall Study|Withdrawal by Subject|0
5220331|NCT00958126|18019846|P4|Overall Study|Withdrawal by Subject|0
5220332|NCT00958126|18019847|P3|Overall Study|Withdrawal by Subject|0
5220333|NCT00958126|18019848|P2|Overall Study|Withdrawal by Subject|2
5220334|NCT00958126|18019849|P1|Overall Study|Withdrawal by Subject|0
5220335|NCT00958126|18019842|P8|Overall Study|Serious Adverse Event|0
5220336|NCT00958126|18019843|P7|Overall Study|Serious Adverse Event|1
5220337|NCT00958126|18019844|P6|Overall Study|Serious Adverse Event|0
5220338|NCT00958126|18019845|P5|Overall Study|Serious Adverse Event|0
5220339|NCT00958126|18019846|P4|Overall Study|Serious Adverse Event|0
5220340|NCT00958126|18019847|P3|Overall Study|Serious Adverse Event|0
5220341|NCT00958126|18019848|P2|Overall Study|Serious Adverse Event|2
5220342|NCT00958126|18019849|P1|Overall Study|Serious Adverse Event|0
5220343|NCT00958074|18019921|P2|Overall Study|Withdrawal by Subject|1
5220344|NCT00958074|18019922|P1|Overall Study|Withdrawal by Subject|0
5220345|NCT00958009|18019945|P1|Overall Study|Subject found device difficult to use|1
5220346|NCT00958009|18019945|P1|Overall Study|Adverse Event|1
5220347|NCT00957996|18019952|P2|Overall Study|Noncompliance; Protocol Deviations|6
5220348|NCT00957996|18019953|P1|Overall Study|Noncompliance; Protocol Deviations|5
5220349|NCT00957996|18019952|P2|Overall Study|Missing|0
5220350|NCT00957996|18019953|P1|Overall Study|Missing|1
5220351|NCT00957996|18019952|P2|Overall Study|Influenza-related complication|1
5220352|NCT00957996|18019953|P1|Overall Study|Influenza-related complication|0
5220353|NCT00957996|18019952|P2|Overall Study|Physician Decision|1
5220354|NCT00957996|18019953|P1|Overall Study|Physician Decision|1
5220355|NCT00957996|18019952|P2|Overall Study|Adverse Event|1
5220356|NCT00957996|18019953|P1|Overall Study|Adverse Event|2
5220357|NCT00957996|18019952|P2|Overall Study|Withdrawal by Subject|2
5220358|NCT00957996|18019953|P1|Overall Study|Withdrawal by Subject|9
5220359|NCT00957996|18019952|P2|Overall Study|Lost to Follow-up|7
5220360|NCT00957996|18019953|P1|Overall Study|Lost to Follow-up|4
5220361|NCT00957996|18019952|P2|Overall Study|Death|10
5220362|NCT00957996|18019953|P1|Overall Study|Death|4
5220363|NCT00957944|18019985|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
5220364|NCT00957944|18019986|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
5220365|NCT00957931|18020020|P1|Overall Study|Death|4
5220366|NCT00957905|18020030|P2|Part B|Protocol Violation|1
5220367|NCT00957905|18020031|P1|Part B|Protocol Violation|0
5220368|NCT00957905|18020030|P2|Part B|Death|1
5220369|NCT00957905|18020031|P1|Part B|Death|0
5220370|NCT00957905|18020030|P2|Part B|Physician Decision|1
5220371|NCT00957905|18020031|P1|Part B|Physician Decision|0
5220372|NCT00957905|18020030|P2|Part B|Not Treated|1
5220373|NCT00957905|18020031|P1|Part B|Not Treated|0
5220374|NCT00957853|18020040|P3|Overall Study|Withdrawal by Subject|0
5220375|NCT00957853|18020041|P2|Overall Study|Withdrawal by Subject|0
5220376|NCT00957853|18020042|P1|Overall Study|Withdrawal by Subject|1
5220377|NCT00957801|18020066|P4|Overall Study|Withdrawal by Subject|1
5220378|NCT00957801|18020067|P3|Overall Study|Withdrawal by Subject|0
5220379|NCT00957801|18020068|P2|Overall Study|Withdrawal by Subject|0
5220380|NCT00957801|18020069|P1|Overall Study|Withdrawal by Subject|0
5220381|NCT00957723|18020235|P1|Overall Study|2yr ROM Data Not Evaluable|12
5220382|NCT00957723|18020235|P1|Overall Study|Intercurrent Illness|2
5220383|NCT00957723|18020235|P1|Overall Study|Investigative Site Terminated|61
5220384|NCT00957723|18020235|P1|Overall Study|Withdrawal by Subject|24
5220385|NCT00957723|18020235|P1|Overall Study|Lost to Follow-up|8
5220386|NCT00957723|18020235|P1|Overall Study|Revision/ Removal of Study Implant|3
5220387|NCT00957723|18020235|P1|Overall Study|Death|3
5220388|NCT00957658|18020324|P1|Overall Study|Protocol Violation|5
5220389|NCT00957658|18020324|P1|Overall Study|surgery cancelled|2
5220390|NCT00957658|18020324|P1|Overall Study|unwilling/unable to return|2
5220391|NCT00957658|18020324|P1|Overall Study|Site termination|10
5220392|NCT00957658|18020324|P1|Overall Study|Incomplete 2 yr data|28
5220393|NCT00957658|18020324|P1|Overall Study|Revision|1
5220394|NCT00957658|18020324|P1|Overall Study|Withdrawal by Subject|12
5220395|NCT00957658|18020324|P1|Overall Study|Lost to Follow-up|4
5220396|NCT00957658|18020324|P1|Overall Study|Death|1
5220397|NCT00957580|18020351|P3|Overall Study|Enrolled but not treated|0
5220398|NCT00957580|18020352|P2|Overall Study|Enrolled but not treated|1
5220399|NCT00957580|18020353|P1|Overall Study|Enrolled but not treated|0
5220400|NCT00957580|18020351|P3|Overall Study|Ongoing at data cut-off|0
5220401|NCT00957580|18020352|P2|Overall Study|Ongoing at data cut-off|1
5220402|NCT00957580|18020353|P1|Overall Study|Ongoing at data cut-off|0
5220403|NCT00957528|18020500|P3|Overall Study|Withdrawal by Subject|1
5220404|NCT00957528|18020501|P2|Overall Study|Withdrawal by Subject|0
5220405|NCT00957528|18020502|P1|Overall Study|Withdrawal by Subject|0
5220406|NCT00957528|18020500|P3|Overall Study|Protocol Violation|0
5220407|NCT00957528|18020501|P2|Overall Study|Protocol Violation|1
5220408|NCT00957528|18020502|P1|Overall Study|Protocol Violation|0
5220409|NCT00957424|18020525|P1|Overall Study|Withdrawal by Subject|1
5220410|NCT00957424|18020525|P1|Overall Study|Protocol Violation|3
5220411|NCT00957424|18020525|P1|Overall Study|Lost to Follow-up|19
5220412|NCT00957372|18020535|P4|PART II|Patient non-compliance|4
5220413|NCT00957372|18020536|P3|PART II|Patient non-compliance|0
5220414|NCT00957372|18020537|P2|PART II|Patient non-compliance|0
5220415|NCT00957372|18020538|P1|PART II|Patient non-compliance|0
5220416|NCT00957372|18020535|P4|PART II|Adverse Event|10
5220417|NCT00957372|18020536|P3|PART II|Adverse Event|0
5220418|NCT00957372|18020537|P2|PART II|Adverse Event|0
5220419|NCT00957372|18020538|P1|PART II|Adverse Event|0
5220420|NCT00957372|18020535|P4|PART II|Not Know|20
5220421|NCT00957372|18020536|P3|PART II|Not Know|0
5220422|NCT00957372|18020537|P2|PART II|Not Know|0
5220423|NCT00957372|18020538|P1|PART II|Not Know|0
5220424|NCT00957372|18020535|P4|PART II|Pregnancy|1
5220425|NCT00957372|18020536|P3|PART II|Pregnancy|0
5220426|NCT00957372|18020537|P2|PART II|Pregnancy|0
5220427|NCT00957372|18020538|P1|PART II|Pregnancy|0
5220428|NCT00957372|18020535|P4|PART II|Physician Decision|1
5220429|NCT00957372|18020536|P3|PART II|Physician Decision|0
5220430|NCT00957372|18020537|P2|PART II|Physician Decision|0
5220431|NCT00957372|18020538|P1|PART II|Physician Decision|0
5220432|NCT00957372|18020535|P4|PART II|Withdrawal by Subject|8
5220433|NCT00957372|18020536|P3|PART II|Withdrawal by Subject|0
5220434|NCT00957372|18020537|P2|PART II|Withdrawal by Subject|0
5220435|NCT00957372|18020538|P1|PART II|Withdrawal by Subject|0
5220436|NCT00957372|18020535|P4|PART I|Lost to Follow-up|0
5220437|NCT00957372|18020536|P3|PART I|Lost to Follow-up|1
5220438|NCT00957372|18020537|P2|PART I|Lost to Follow-up|0
5220439|NCT00957372|18020538|P1|PART I|Lost to Follow-up|0
5220440|NCT00957268|18020678|P5|Overall Study|Voluntary Withdrawal|0
5220441|NCT00957268|18020679|P4|Overall Study|Voluntary Withdrawal|0
5220442|NCT00957268|18020680|P3|Overall Study|Voluntary Withdrawal|1
5220443|NCT00957268|18020681|P2|Overall Study|Voluntary Withdrawal|0
5220444|NCT00957268|18020682|P1|Overall Study|Voluntary Withdrawal|0
5220445|NCT00957034|18020804|P3|Overall Study|Withdrawal by Subject|0
5220446|NCT00957034|18020805|P2|Overall Study|Withdrawal by Subject|2
5220447|NCT00957034|18020806|P1|Overall Study|Withdrawal by Subject|0
5220448|NCT00957034|18020804|P3|Overall Study|Sponsor Terminated Study|5
5220449|NCT00957034|18020805|P2|Overall Study|Sponsor Terminated Study|1
5220450|NCT00957034|18020806|P1|Overall Study|Sponsor Terminated Study|6
5220451|NCT00957034|18020804|P3|Overall Study|Adverse Event|1
5220452|NCT00957034|18020805|P2|Overall Study|Adverse Event|1
5220453|NCT00957034|18020806|P1|Overall Study|Adverse Event|0
5220454|NCT00957021|18020829|P1|Overall Study|Termination due to language issue|2
5220455|NCT00957021|18020829|P1|Overall Study|Surgery Cancelled|9
5220456|NCT00957021|18020829|P1|Overall Study|Site Termination by the 2 yr visit|16
5220457|NCT00957021|18020829|P1|Overall Study|Revised study component by 2 yr visit|8
5220458|NCT00957021|18020829|P1|Overall Study|No 2 yr ROM data|35
5220459|NCT00957021|18020829|P1|Overall Study|Withdrawal by Subject|34
5220460|NCT00957021|18020829|P1|Overall Study|Lost to Follow-up|8
5220461|NCT00957021|18020829|P1|Overall Study|Death|5
5220462|NCT00957008|18020842|P4|Overall Study|Relocated; Family conflict|3
5220463|NCT00957008|18020843|P3|Overall Study|Relocated; Family conflict|1
5220464|NCT00957008|18020844|P2|Overall Study|Relocated; Family conflict|1
5220465|NCT00957008|18020845|P1|Overall Study|Relocated; Family conflict|4
5220466|NCT00957008|18020842|P4|Overall Study|Physician Decision|1
5220467|NCT00957008|18020843|P3|Overall Study|Physician Decision|1
5220468|NCT00957008|18020844|P2|Overall Study|Physician Decision|0
5220469|NCT00957008|18020845|P1|Overall Study|Physician Decision|1
5220470|NCT00957008|18020842|P4|Overall Study|Lost to Follow-up|4
5220471|NCT00957008|18020843|P3|Overall Study|Lost to Follow-up|3
5220472|NCT00957008|18020844|P2|Overall Study|Lost to Follow-up|1
5220473|NCT00957008|18020845|P1|Overall Study|Lost to Follow-up|3
5220474|NCT00957008|18020842|P4|Overall Study|Withdrawal by Subject|16
5220475|NCT00957008|18020843|P3|Overall Study|Withdrawal by Subject|12
5220476|NCT00957008|18020844|P2|Overall Study|Withdrawal by Subject|10
5220477|NCT00957008|18020845|P1|Overall Study|Withdrawal by Subject|13
5220478|NCT00956943|18020873|P2|Overall Study|Lost to Follow-up|10
5220479|NCT00956943|18020874|P1|Overall Study|Lost to Follow-up|9
5220480|NCT00956839|18020898|P3|Overall Study|Lost to Follow-up|3
5220481|NCT00956839|18020899|P2|Overall Study|Lost to Follow-up|0
5220482|NCT00956839|18020900|P1|Overall Study|Lost to Follow-up|3
5220483|NCT00956813|18020913|P2|Flaxseed and Placebo|Ineligible|1
5220484|NCT00956813|18020914|P1|Flaxseed and Placebo|Ineligible|3
5220485|NCT00956813|18020913|P2|Flaxseed and Placebo|Withdrawal by Subject|4
5220486|NCT00956813|18020914|P1|Flaxseed and Placebo|Withdrawal by Subject|5
5220487|NCT00956592|18020966|P2|Overall Study|Protocol Violation|3
5220488|NCT00956592|18020967|P1|Overall Study|Protocol Violation|1
5220489|NCT00956293|18021002|P3|Follow-up Period|Follow-up period was terminated.|0
5220490|NCT00956293|18021003|P2|Follow-up Period|Follow-up period was terminated.|32
5220491|NCT00956293|18021004|P1|Follow-up Period|Follow-up period was terminated.|20
5220492|NCT00956293|18021002|P3|Main Period (Randomization)|Adverse Event|0
5220493|NCT00956293|18021003|P2|Main Period (Randomization)|Adverse Event|15
5220494|NCT00956293|18021004|P1|Main Period (Randomization)|Adverse Event|0
5220495|NCT00956293|18021002|P3|Main Period (Randomization)|Lack of Efficacy|0
5220496|NCT00956293|18021003|P2|Main Period (Randomization)|Lack of Efficacy|10
5220497|NCT00956293|18021004|P1|Main Period (Randomization)|Lack of Efficacy|1
5220498|NCT00956293|18021002|P3|Main Period (Randomization)|Abnormal laboratory value|0
5220499|NCT00956293|18021003|P2|Main Period (Randomization)|Abnormal laboratory value|2
5220500|NCT00956293|18021004|P1|Main Period (Randomization)|Abnormal laboratory value|0
5220501|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
5220502|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
5220503|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
5220504|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Adverse Event|36
5220505|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Adverse Event|0
5220506|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Adverse Event|0
5220507|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
5220508|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
5220509|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
5220510|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
5220511|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
5220512|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
5220513|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Graft loss|7
5220514|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Graft loss|0
5220515|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Graft loss|0
5220516|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Administrative problems|6
5220517|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Administrative problems|0
5220518|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Administrative problems|0
5220519|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
5220520|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
5220521|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
5220522|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Protocol Violation|1
5220523|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Protocol Violation|0
5220524|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Protocol Violation|0
5220525|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Death|1
5220526|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Death|0
5220527|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Death|0
5220528|NCT00956293|18021002|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
5220529|NCT00956293|18021003|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
5220530|NCT00956293|18021004|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
5220531|NCT00955968|18021059|P2|Overall Study|Site closed|52
5220532|NCT00955968|18021060|P1|Overall Study|Site closed|55
5220533|NCT00955968|18021059|P2|Overall Study|Lost to Follow-up|39
5220534|NCT00955968|18021060|P1|Overall Study|Lost to Follow-up|45
5220535|NCT00955968|18021059|P2|Overall Study|Withdrawal by Subject|31
5220536|NCT00955968|18021060|P1|Overall Study|Withdrawal by Subject|35
5220537|NCT00955968|18021059|P2|Overall Study|Death|4
5220538|NCT00955968|18021060|P1|Overall Study|Death|2
5220539|NCT00955955|18021102|P3|Overall Study|Lost to Follow-up|0
5220540|NCT00955955|18021103|P2|Overall Study|Lost to Follow-up|0
5220541|NCT00955955|18021104|P1|Overall Study|Lost to Follow-up|2
5220542|NCT00955825|18021188|P2|Overall Study|Any other reason not above-mentioned|9
5220543|NCT00955825|18021189|P1|Overall Study|Any other reason not above-mentioned|7
5220544|NCT00955825|18021188|P2|Overall Study|Withdrawal by Subject|6
5220545|NCT00955825|18021189|P1|Overall Study|Withdrawal by Subject|4
5220546|NCT00955825|18021188|P2|Overall Study|Adverse Event|2
5220547|NCT00955825|18021189|P1|Overall Study|Adverse Event|15
5220548|NCT00955721|18021206|P2|Overall Study|Withdrawal by Subject|0
5220549|NCT00955721|18021207|P1|Overall Study|Withdrawal by Subject|1
5220550|NCT00955721|18021206|P2|Overall Study|Death|0
5220551|NCT00955721|18021207|P1|Overall Study|Death|1
5220552|NCT00955721|18021206|P2|Overall Study|Physician Decision|0
5220553|NCT00955721|18021207|P1|Overall Study|Physician Decision|1
5220554|NCT00955708|18021217|P1|Overall Study|Patient changed care provider/moved|91
5220555|NCT00955708|18021217|P1|Overall Study|Closure of study location|60
5220556|NCT00955708|18021217|P1|Overall Study|Patient Refused to participate further|116
5220557|NCT00955708|18021217|P1|Overall Study|Product removed from service|94
5220558|NCT00955708|18021217|P1|Overall Study|Registry Conclusion|186
5220559|NCT00955708|18021217|P1|Overall Study|Protocol Violation|134
5220560|NCT00955708|18021217|P1|Overall Study|Physician Decision|36
5220561|NCT00955708|18021217|P1|Overall Study|Lost to Follow-up|72
5220562|NCT00955708|18021217|P1|Overall Study|Death|269
5220563|NCT00955682|18021223|P2|Booster Period (Month 49)|Lost to Follow-up|1
5220564|NCT00955682|18021224|P1|Booster Period (Month 49)|Lost to Follow-up|1
5220565|NCT00955617|18021334|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
5220566|NCT00955617|18021335|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
5220567|NCT00955617|18021334|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
5220568|NCT00955617|18021335|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
5220569|NCT00955617|18021334|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
5220570|NCT00955617|18021335|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
5220571|NCT00955617|18021334|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
5220572|NCT00955617|18021335|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
5220573|NCT00955474|18021399|P2|Overall Study|Physician Decision|5
5220574|NCT00955474|18021400|P1|Overall Study|Physician Decision|7
5220575|NCT00955357|18021436|P2|Maintenance Phase|Non compliance to study procedures|0
5220576|NCT00955357|18021437|P1|Maintenance Phase|Non compliance to study procedures|1
5220577|NCT00955357|18021436|P2|Maintenance Phase|Patient moving out of area|1
5220578|NCT00955357|18021437|P1|Maintenance Phase|Patient moving out of area|0
5220579|NCT00955357|18021436|P2|Maintenance Phase|Withdrawal by Subject|4
5220580|NCT00955357|18021437|P1|Maintenance Phase|Withdrawal by Subject|4
5220581|NCT00955357|18021436|P2|Maintenance Phase|Lost to Follow-up|7
5220582|NCT00955357|18021437|P1|Maintenance Phase|Lost to Follow-up|2
5220583|NCT00955357|18021436|P2|Maintenance Phase|Protocol Violation|6
5220584|NCT00955357|18021437|P1|Maintenance Phase|Protocol Violation|2
5220585|NCT00955357|18021436|P2|Maintenance Phase|Lack of Efficacy|4
5220586|NCT00955357|18021437|P1|Maintenance Phase|Lack of Efficacy|0
5220587|NCT00955357|18021436|P2|Maintenance Phase|Adverse Event|23
5220588|NCT00955357|18021437|P1|Maintenance Phase|Adverse Event|3
5220589|NCT00955357|18021436|P2|Titration Phase|Non compliance to study procedures|1
5220590|NCT00955357|18021437|P1|Titration Phase|Non compliance to study procedures|0
5220591|NCT00955357|18021436|P2|Titration Phase|Study medication not tolerated|1
5220592|NCT00955357|18021437|P1|Titration Phase|Study medication not tolerated|0
5220593|NCT00955357|18021436|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
5220594|NCT00955357|18021437|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
5220595|NCT00955357|18021436|P2|Titration Phase|Withdrawal by Subject|5
5220596|NCT00955357|18021437|P1|Titration Phase|Withdrawal by Subject|3
5220597|NCT00955357|18021436|P2|Titration Phase|Lost to Follow-up|3
5220598|NCT00955357|18021437|P1|Titration Phase|Lost to Follow-up|1
5220599|NCT00955357|18021436|P2|Titration Phase|Protocol Violation|7
5220600|NCT00955357|18021437|P1|Titration Phase|Protocol Violation|3
5220601|NCT00955357|18021436|P2|Titration Phase|Lack of Efficacy|2
5220602|NCT00955357|18021437|P1|Titration Phase|Lack of Efficacy|0
5220603|NCT00955357|18021436|P2|Titration Phase|Adverse Event|46
5220604|NCT00955357|18021437|P1|Titration Phase|Adverse Event|9
5220605|NCT00955305|18021445|P2|Overall Study|Ineligible|7
5220606|NCT00955305|18021446|P1|Overall Study|Ineligible|5
5220607|NCT00955305|18021445|P2|Overall Study|Never started protocol treatment|5
5220608|NCT00955305|18021446|P1|Overall Study|Never started protocol treatment|5
5220609|NCT00955305|18021445|P2|Overall Study|No off-treatment reason submitted|0
5220610|NCT00955305|18021446|P1|Overall Study|No off-treatment reason submitted|1
5220611|NCT00955305|18021445|P2|Overall Study|Lost to Follow-up|1
5220612|NCT00955305|18021446|P1|Overall Study|Lost to Follow-up|0
5220613|NCT00955305|18021445|P2|Overall Study|Maximum response achieved|1
5220614|NCT00955305|18021446|P1|Overall Study|Maximum response achieved|0
5220615|NCT00955305|18021445|P2|Overall Study|Functional decline|0
5220616|NCT00955305|18021446|P1|Overall Study|Functional decline|2
5220617|NCT00955305|18021445|P2|Overall Study|Continued presence of residual disease|1
5220618|NCT00955305|18021446|P1|Overall Study|Continued presence of residual disease|0
5220619|NCT00955305|18021445|P2|Overall Study|Physician Decision|0
5220620|NCT00955305|18021446|P1|Overall Study|Physician Decision|1
5220621|NCT00955305|18021445|P2|Overall Study|Other complicating disease|4
5220622|NCT00955305|18021446|P1|Overall Study|Other complicating disease|2
5220623|NCT00955305|18021445|P2|Overall Study|Alternative therapy|0
5220624|NCT00955305|18021446|P1|Overall Study|Alternative therapy|4
5220625|NCT00955305|18021445|P2|Overall Study|Withdrawal by Subject|4
5220626|NCT00955305|18021446|P1|Overall Study|Withdrawal by Subject|5
5220627|NCT00955305|18021445|P2|Overall Study|Death|1
5220628|NCT00955305|18021446|P1|Overall Study|Death|2
5220629|NCT00955305|18021445|P2|Overall Study|Adverse Event|22
5220630|NCT00955305|18021446|P1|Overall Study|Adverse Event|22
5220631|NCT00955305|18021445|P2|Overall Study|Disease progression|41
5220632|NCT00955305|18021446|P1|Overall Study|Disease progression|39
5220633|NCT00955279|18021459|P3|Overall Study|Withdrawal by Subject|3
5220634|NCT00955279|18021460|P2|Overall Study|Withdrawal by Subject|0
5220635|NCT00955279|18021461|P1|Overall Study|Withdrawal by Subject|2
5220636|NCT00955279|18021459|P3|Overall Study|Lost to Follow-up|1
5220637|NCT00955279|18021460|P2|Overall Study|Lost to Follow-up|3
5220638|NCT00955279|18021461|P1|Overall Study|Lost to Follow-up|0
5220639|NCT00955279|18021459|P3|Overall Study|Death|1
5220640|NCT00955279|18021460|P2|Overall Study|Death|1
5220641|NCT00955279|18021461|P1|Overall Study|Death|1
5220642|NCT00955279|18021459|P3|Overall Study|Other|3
5220643|NCT00955279|18021460|P2|Overall Study|Other|0
5220644|NCT00955279|18021461|P1|Overall Study|Other|0
5220645|NCT00955110|18021669|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
5220646|NCT00955110|18021669|P1|Treatment Phase|Non-compliance with study restrictions|1
5220647|NCT00955110|18021669|P1|Treatment Phase|Administrative reasons|2
5220648|NCT00955110|18021669|P1|Treatment Phase|Adverse Event|2
5220649|NCT00955110|18021669|P1|Qualification Phase|Did not meet eligibility criteria|24
5220650|NCT00954941|18021716|P2|Overall Study|Adverse Event|1
5220651|NCT00954941|18021717|P1|Overall Study|Adverse Event|0
5220652|NCT00954941|18021716|P2|Overall Study|Ineligible|2
5220653|NCT00954941|18021717|P1|Overall Study|Ineligible|2
5220654|NCT00954941|18021716|P2|Overall Study|Physician Decision|2
5220655|NCT00954941|18021717|P1|Overall Study|Physician Decision|2
5220656|NCT00954941|18021716|P2|Overall Study|Insurance Denial|2
5220657|NCT00954941|18021717|P1|Overall Study|Insurance Denial|2
5220658|NCT00954941|18021716|P2|Overall Study|Withdrawal by Subject|0
5220659|NCT00954941|18021717|P1|Overall Study|Withdrawal by Subject|1
5220660|NCT00954941|18021716|P2|Overall Study|Received treatment at home|0
5220661|NCT00954941|18021717|P1|Overall Study|Received treatment at home|1
5220662|NCT00954733|18021733|P1|Overall Study|blood gas machine did not work|1
5220663|NCT00954707|18021737|P1|Overall Study|Lost to Follow-up|33
5220664|NCT00954707|18021737|P1|Overall Study|Withdrawal by Subject|100
5220665|NCT00954707|18021737|P1|Overall Study|Death|34
5220666|NCT00954538|18021759|P6|Part III|Withdrawal by Subject|0
5220667|NCT00954538|18021760|P5|Part III|Withdrawal by Subject|1
5220668|NCT00954538|18021761|P4|Part III|Withdrawal by Subject|0
5220669|NCT00954538|18021762|P3|Part III|Withdrawal by Subject|0
5220670|NCT00954538|18021763|P2|Part III|Withdrawal by Subject|0
5220671|NCT00954538|18021764|P1|Part III|Withdrawal by Subject|0
5220672|NCT00954512|18021781|P6|Overall Study|Progression of Disease|1
5220673|NCT00954512|18021782|P5|Overall Study|Progression of Disease|1
5220674|NCT00954512|18021783|P4|Overall Study|Progression of Disease|1
5220675|NCT00954512|18021784|P3|Overall Study|Progression of Disease|0
5220676|NCT00954512|18021785|P2|Overall Study|Progression of Disease|1
5220677|NCT00954512|18021786|P1|Overall Study|Progression of Disease|2
5220678|NCT00954512|18021781|P6|Overall Study|Symptomatic Deterioration|0
5220679|NCT00954512|18021782|P5|Overall Study|Symptomatic Deterioration|2
5220680|NCT00954512|18021783|P4|Overall Study|Symptomatic Deterioration|0
5220681|NCT00954512|18021784|P3|Overall Study|Symptomatic Deterioration|0
5220682|NCT00954512|18021785|P2|Overall Study|Symptomatic Deterioration|1
5220683|NCT00954512|18021786|P1|Overall Study|Symptomatic Deterioration|0
5220684|NCT00954512|18021781|P6|Overall Study|Physician Decision|0
5220685|NCT00954512|18021782|P5|Overall Study|Physician Decision|0
5220686|NCT00954512|18021783|P4|Overall Study|Physician Decision|1
5220687|NCT00954512|18021784|P3|Overall Study|Physician Decision|0
5220688|NCT00954512|18021785|P2|Overall Study|Physician Decision|1
5220689|NCT00954512|18021786|P1|Overall Study|Physician Decision|0
5220690|NCT00954512|18021781|P6|Overall Study|Adverse Event|2
5220691|NCT00954512|18021782|P5|Overall Study|Adverse Event|1
5220692|NCT00954512|18021783|P4|Overall Study|Adverse Event|0
5220693|NCT00954512|18021784|P3|Overall Study|Adverse Event|0
5220694|NCT00954512|18021785|P2|Overall Study|Adverse Event|0
5220695|NCT00954512|18021786|P1|Overall Study|Adverse Event|0
5220696|NCT00954512|18021781|P6|Overall Study|Withdrawal by Subject|1
5220697|NCT00954512|18021782|P5|Overall Study|Withdrawal by Subject|0
5220698|NCT00954512|18021783|P4|Overall Study|Withdrawal by Subject|0
5220699|NCT00954512|18021784|P3|Overall Study|Withdrawal by Subject|0
5220700|NCT00954512|18021785|P2|Overall Study|Withdrawal by Subject|0
5220701|NCT00954512|18021786|P1|Overall Study|Withdrawal by Subject|0
5220702|NCT00954447|18021807|P2|Overall Study|Other|18
5220703|NCT00954447|18021808|P1|Overall Study|Other|21
5220704|NCT00954447|18021807|P2|Overall Study|Withdrawal by Subject|21
5220705|NCT00954447|18021808|P1|Overall Study|Withdrawal by Subject|26
5220706|NCT00954447|18021807|P2|Overall Study|Lost to Follow-up|14
5220707|NCT00954447|18021808|P1|Overall Study|Lost to Follow-up|8
5220708|NCT00954447|18021807|P2|Overall Study|Protocol Violation|7
5220709|NCT00954447|18021808|P1|Overall Study|Protocol Violation|5
5220710|NCT00954447|18021807|P2|Overall Study|Lack of Efficacy|3
5220711|NCT00954447|18021808|P1|Overall Study|Lack of Efficacy|17
5220712|NCT00954447|18021807|P2|Overall Study|Adverse Event|25
5220713|NCT00954447|18021808|P1|Overall Study|Adverse Event|33
5220714|NCT00954421|18021844|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
5220715|NCT00954421|18021844|P1|6 Months of DBS|Withdrawal by Subject|1
5220716|NCT00954421|18021844|P1|Screening|screen failures|3
5220717|NCT00954174|18021894|P4|Overall Study|Never Treated|3
5220718|NCT00954174|18021895|P3|Overall Study|Never Treated|0
5220719|NCT00954174|18021896|P2|Overall Study|Never Treated|17
5220720|NCT00954174|18021897|P1|Overall Study|Never Treated|4
5220721|NCT00954174|18021894|P4|Overall Study|Ineligible|4
5220722|NCT00954174|18021895|P3|Overall Study|Ineligible|7
5220723|NCT00954174|18021896|P2|Overall Study|Ineligible|47
5220724|NCT00954174|18021897|P1|Overall Study|Ineligible|40
5220725|NCT00954174|18021894|P4|Overall Study|Medical Reason|0
5220726|NCT00954174|18021895|P3|Overall Study|Medical Reason|1
5220727|NCT00954174|18021896|P2|Overall Study|Medical Reason|2
5220728|NCT00954174|18021897|P1|Overall Study|Medical Reason|4
5220729|NCT00954174|18021894|P4|Overall Study|Withdrawal by Subject|3
5220730|NCT00954174|18021895|P3|Overall Study|Withdrawal by Subject|4
5220731|NCT00954174|18021896|P2|Overall Study|Withdrawal by Subject|10
5220732|NCT00954174|18021897|P1|Overall Study|Withdrawal by Subject|14
5220733|NCT00954174|18021894|P4|Overall Study|Lack of Efficacy|6
5220734|NCT00954174|18021895|P3|Overall Study|Lack of Efficacy|8
5220735|NCT00954174|18021896|P2|Overall Study|Lack of Efficacy|22
5220736|NCT00954174|18021897|P1|Overall Study|Lack of Efficacy|32
5220737|NCT00954174|18021894|P4|Overall Study|Death|0
5220738|NCT00954174|18021895|P3|Overall Study|Death|0
5220739|NCT00954174|18021896|P2|Overall Study|Death|2
5220740|NCT00954174|18021897|P1|Overall Study|Death|4
5220741|NCT00954174|18021894|P4|Overall Study|Adverse Event|9
5220742|NCT00954174|18021895|P3|Overall Study|Adverse Event|4
5220743|NCT00954174|18021896|P2|Overall Study|Adverse Event|23
5220744|NCT00954174|18021897|P1|Overall Study|Adverse Event|28
5220745|NCT00954122|18021917|P1|Overall Study|Safety Reason|1
5220746|NCT00954122|18021917|P1|Overall Study|Adverse Event|1
5220747|NCT00954122|18021917|P1|Overall Study|Withdrawal by Subject|5
5220748|NCT00953927|18021934|P2|Overall Study|Other study discontinuation|1
5220749|NCT00953927|18021935|P1|Overall Study|Other study discontinuation|1
5220750|NCT00953927|18021934|P2|Overall Study|Death|4
5220751|NCT00953927|18021935|P1|Overall Study|Death|7
5220752|NCT00953927|18021934|P2|Overall Study|Withdrawal by Subject|25
5220753|NCT00953927|18021935|P1|Overall Study|Withdrawal by Subject|36
5220754|NCT00953927|18021934|P2|Overall Study|Lost to Follow-up|65
5220755|NCT00953927|18021935|P1|Overall Study|Lost to Follow-up|61
5220756|NCT00953745|18021990|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
5220757|NCT00953745|18021991|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
5220758|NCT00953745|18021990|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
5220759|NCT00953745|18021991|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
5220760|NCT00953745|18021990|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
5220761|NCT00953745|18021991|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
5220762|NCT00953745|18021990|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
5220763|NCT00953745|18021991|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
5220764|NCT00953745|18021990|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
5220765|NCT00953745|18021991|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
5220766|NCT00953745|18021990|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
5220767|NCT00953745|18021991|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
5220768|NCT00953706|18022024|P4|Part B (96-Week Open-Label Extension)|Other|2
5220769|NCT00953706|18022025|P3|Part B (96-Week Open-Label Extension)|Other|0
5220770|NCT00953706|18022026|P2|Part B (96-Week Open-Label Extension)|Other|0
5220771|NCT00953706|18022027|P1|Part B (96-Week Open-Label Extension)|Other|0
5220772|NCT00953706|18022024|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
5220773|NCT00953706|18022025|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
5220774|NCT00953706|18022026|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
5220775|NCT00953706|18022027|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
5220776|NCT00953706|18022024|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
5220777|NCT00953706|18022025|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
5220778|NCT00953706|18022026|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
5220779|NCT00953706|18022027|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
5220780|NCT00953706|18022024|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
5220781|NCT00953706|18022025|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5220782|NCT00953706|18022026|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5220783|NCT00953706|18022027|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5220784|NCT00953706|18022024|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
5220785|NCT00953706|18022025|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5220786|NCT00953706|18022026|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5220787|NCT00953706|18022027|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5220788|NCT00953706|18022024|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
5220789|NCT00953706|18022025|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
5220790|NCT00953706|18022026|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
5220791|NCT00953706|18022027|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
5220792|NCT00953706|18022024|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5220793|NCT00953706|18022025|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5220794|NCT00953706|18022026|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
5220795|NCT00953706|18022027|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5220796|NCT00953706|18022024|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5220797|NCT00953706|18022025|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5220798|NCT00953706|18022026|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
5220799|NCT00953706|18022027|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5220800|NCT00953706|18022024|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5220801|NCT00953706|18022025|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5220802|NCT00953706|18022026|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
5220803|NCT00953706|18022027|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5220804|NCT00953706|18022024|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5220805|NCT00953706|18022025|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5220806|NCT00953706|18022026|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
5220807|NCT00953706|18022027|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5220808|NCT00953706|18022024|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
5220809|NCT00953706|18022025|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
5220810|NCT00953706|18022026|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
5220811|NCT00953706|18022027|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
5220812|NCT00953680|18022059|P2|Period 1|Withdrawal by Subject|1
5220813|NCT00953680|18022060|P1|Period 1|Withdrawal by Subject|0
5220814|NCT00953667|18022072|P1|Overall Study|poor venous access,unable to draw blood|4
5220815|NCT00953667|18022072|P1|Overall Study|Adverse Event|10
5220816|NCT00953667|18022072|P1|Overall Study|Withdrawal by Subject|63
5220817|NCT00953667|18022072|P1|Overall Study|Physician Decision|35
5220818|NCT00953667|18022072|P1|Overall Study|Lost to Follow-up|11
5220819|NCT00953615|18022093|P1|Overall Study|Adverse Event|1
5220820|NCT00953576|18022102|P2|Overall Study|Ineligible after Consent|0
5220821|NCT00953576|18022103|P1|Overall Study|Ineligible after Consent|2
5220822|NCT00953576|18022102|P2|Overall Study|Adverse Event|1
5220823|NCT00953576|18022103|P1|Overall Study|Adverse Event|0
5220824|NCT00953524|18022118|P4|Overall Study|Withdrawal by Subject|0
5220825|NCT00953524|18022119|P3|Overall Study|Withdrawal by Subject|1
5220826|NCT00953524|18022120|P2|Overall Study|Withdrawal by Subject|4
5220827|NCT00953524|18022121|P1|Overall Study|Withdrawal by Subject|2
5220828|NCT00953524|18022118|P4|Overall Study|Lost to Follow-up|0
5220829|NCT00953524|18022119|P3|Overall Study|Lost to Follow-up|1
5220830|NCT00953524|18022120|P2|Overall Study|Lost to Follow-up|1
5220831|NCT00953524|18022121|P1|Overall Study|Lost to Follow-up|0
5220832|NCT00953524|18022118|P4|Overall Study|Protocol Violation|6
5220833|NCT00953524|18022119|P3|Overall Study|Protocol Violation|11
5220834|NCT00953524|18022120|P2|Overall Study|Protocol Violation|10
5220835|NCT00953524|18022121|P1|Overall Study|Protocol Violation|18
5220836|NCT00953524|18022118|P4|Overall Study|Adverse Event|2
5220837|NCT00953524|18022119|P3|Overall Study|Adverse Event|1
5220838|NCT00953524|18022120|P2|Overall Study|Adverse Event|0
5220839|NCT00953524|18022121|P1|Overall Study|Adverse Event|2
5220840|NCT00953407|18022164|P5|Overall Study|Lost to Follow-up|0
5220841|NCT00953407|18022165|P4|Overall Study|Lost to Follow-up|1
5220842|NCT00953407|18022166|P3|Overall Study|Lost to Follow-up|0
5220843|NCT00953407|18022167|P2|Overall Study|Lost to Follow-up|0
5220844|NCT00953407|18022168|P1|Overall Study|Lost to Follow-up|0
5220845|NCT00953407|18022164|P5|Overall Study|Failed inclusion criteria|1
5220846|NCT00953407|18022165|P4|Overall Study|Failed inclusion criteria|1
5220847|NCT00953407|18022166|P3|Overall Study|Failed inclusion criteria|1
5220848|NCT00953407|18022167|P2|Overall Study|Failed inclusion criteria|1
5220849|NCT00953407|18022168|P1|Overall Study|Failed inclusion criteria|1
5220850|NCT00953329|18022180|P1|Overall Study|Lack of Efficacy|1
5220851|NCT00953225|18022193|P2|Overall Study|Withdrawal by Subject|0
5220852|NCT00953225|18022194|P1|Overall Study|Withdrawal by Subject|2
5220853|NCT00953160|18022278|P1|Overall Study|Withdrawal by Subject|4
5220854|NCT00953160|18022278|P1|Overall Study|Lost to Follow-up|23
5220855|NCT00953147|18022287|P3|Overall Study|Other|13
5220856|NCT00953147|18022288|P2|Overall Study|Other|11
5220857|NCT00953147|18022289|P1|Overall Study|Other|4
5220858|NCT00953147|18022287|P3|Overall Study|Physician Decision|3
5220859|NCT00953147|18022288|P2|Overall Study|Physician Decision|7
5220860|NCT00953147|18022289|P1|Overall Study|Physician Decision|2
5220861|NCT00953147|18022287|P3|Overall Study|Lost to Follow-up|4
5220862|NCT00953147|18022288|P2|Overall Study|Lost to Follow-up|9
5220863|NCT00953147|18022289|P1|Overall Study|Lost to Follow-up|8
5220864|NCT00953147|18022287|P3|Overall Study|Withdrawal by Subject|12
5220865|NCT00953147|18022288|P2|Overall Study|Withdrawal by Subject|15
5220866|NCT00953147|18022289|P1|Overall Study|Withdrawal by Subject|13
5220867|NCT00953147|18022287|P3|Overall Study|Protocol Violation|4
5220868|NCT00953147|18022288|P2|Overall Study|Protocol Violation|8
5220869|NCT00953147|18022289|P1|Overall Study|Protocol Violation|2
5220870|NCT00953147|18022287|P3|Overall Study|Adverse Event|6
5220871|NCT00953147|18022288|P2|Overall Study|Adverse Event|16
5220872|NCT00953147|18022289|P1|Overall Study|Adverse Event|8
5220873|NCT00953056|18022367|P6|Overall Study|Serious Adverse Event|1
5220874|NCT00953056|18022368|P5|Overall Study|Serious Adverse Event|0
5220875|NCT00953056|18022369|P4|Overall Study|Serious Adverse Event|0
5220876|NCT00953056|18022370|P3|Overall Study|Serious Adverse Event|0
5220877|NCT00953056|18022371|P2|Overall Study|Serious Adverse Event|0
5220878|NCT00953056|18022372|P1|Overall Study|Serious Adverse Event|0
5220879|NCT00953056|18022367|P6|Overall Study|Withdrew Consent|3
5220880|NCT00953056|18022368|P5|Overall Study|Withdrew Consent|2
5220881|NCT00953056|18022369|P4|Overall Study|Withdrew Consent|0
5220882|NCT00953056|18022370|P3|Overall Study|Withdrew Consent|0
5220883|NCT00953056|18022371|P2|Overall Study|Withdrew Consent|0
5220884|NCT00953056|18022372|P1|Overall Study|Withdrew Consent|0
5220885|NCT00953043|18022396|P2|Overall Study|Physician Decision|2
5220886|NCT00953043|18022397|P1|Overall Study|Physician Decision|0
5220887|NCT00953043|18022396|P2|Overall Study|Withdrawal by Subject|0
5220888|NCT00953043|18022397|P1|Overall Study|Withdrawal by Subject|4
5220889|NCT00953017|18022421|P4|Overall Study|Brown stool prior to procedure|0
5220890|NCT00953017|18022422|P3|Overall Study|Brown stool prior to procedure|1
5220891|NCT00953017|18022423|P2|Overall Study|Brown stool prior to procedure|0
5220892|NCT00953017|18022424|P1|Overall Study|Brown stool prior to procedure|0
5220893|NCT00953017|18022421|P4|Overall Study|Procedure incomplete due to pain/looping|1
5220894|NCT00953017|18022422|P3|Overall Study|Procedure incomplete due to pain/looping|0
5220895|NCT00953017|18022423|P2|Overall Study|Procedure incomplete due to pain/looping|1
5220896|NCT00953017|18022424|P1|Overall Study|Procedure incomplete due to pain/looping|0
5220897|NCT00953017|18022421|P4|Overall Study|Incomplete data|0
5220898|NCT00953017|18022422|P3|Overall Study|Incomplete data|0
5220899|NCT00953017|18022423|P2|Overall Study|Incomplete data|1
5220900|NCT00953017|18022424|P1|Overall Study|Incomplete data|1
5220901|NCT00953017|18022421|P4|Overall Study|DId not show up for colonoscopy|4
5220902|NCT00953017|18022422|P3|Overall Study|DId not show up for colonoscopy|5
5220903|NCT00953017|18022423|P2|Overall Study|DId not show up for colonoscopy|4
5220904|NCT00953017|18022424|P1|Overall Study|DId not show up for colonoscopy|4
5220905|NCT00952848|18022446|P1|Overall Study|Withdrawal by Subject|4
5220906|NCT00952822|18022453|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5220907|NCT00952822|18022454|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
5220908|NCT00952822|18022455|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5220909|NCT00952822|18022456|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5220910|NCT00952822|18022453|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5220911|NCT00952822|18022454|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5220912|NCT00952822|18022455|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
5220913|NCT00952822|18022456|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5220914|NCT00952731|18022488|P2|Overall Study|Drug supply expired|0
5220915|NCT00952731|18022489|P1|Overall Study|Drug supply expired|1
5220916|NCT00952705|18022521|P3|Overall Study|Exclusion criteria not met pre dose|0
5220917|NCT00952705|18022522|P2|Overall Study|Exclusion criteria not met pre dose|1
5220918|NCT00952705|18022523|P1|Overall Study|Exclusion criteria not met pre dose|0
5220919|NCT00952705|18022521|P3|Overall Study|Incarcerated post dose|0
5220920|NCT00952705|18022522|P2|Overall Study|Incarcerated post dose|0
5220921|NCT00952705|18022523|P1|Overall Study|Incarcerated post dose|5
5220922|NCT00952705|18022521|P3|Overall Study|Death|0
5220923|NCT00952705|18022522|P2|Overall Study|Death|0
5220924|NCT00952705|18022523|P1|Overall Study|Death|2
5220925|NCT00952705|18022521|P3|Overall Study|Withdrawal by Subject|1
5220926|NCT00952705|18022522|P2|Overall Study|Withdrawal by Subject|1
5220927|NCT00952705|18022523|P1|Overall Study|Withdrawal by Subject|2
5220928|NCT00952705|18022521|P3|Overall Study|Lost to Follow-up|9
5220929|NCT00952705|18022522|P2|Overall Study|Lost to Follow-up|8
5220930|NCT00952705|18022523|P1|Overall Study|Lost to Follow-up|24
5220931|NCT00952614|18022610|P1|Overall Study|other reason|1
5220932|NCT00952614|18022610|P1|Overall Study|Lost to Follow-up|3
5220933|NCT00952614|18022610|P1|Overall Study|Death|3
5220934|NCT00952588|18022617|P2|Overall Study|Lack of Efficacy|2
5220935|NCT00952588|18022618|P1|Overall Study|Lack of Efficacy|2
5220936|NCT00952588|18022617|P2|Overall Study|Physician Decision|1
5220937|NCT00952588|18022618|P1|Overall Study|Physician Decision|0
5220938|NCT00952588|18022617|P2|Overall Study|Lost to Follow-up|0
5220939|NCT00952588|18022618|P1|Overall Study|Lost to Follow-up|2
5220940|NCT00952588|18022617|P2|Overall Study|Adverse Event|3
5220941|NCT00952588|18022618|P1|Overall Study|Adverse Event|2
5220942|NCT00952588|18022617|P2|Overall Study|Withdrawal by Subject|5
5220943|NCT00952588|18022618|P1|Overall Study|Withdrawal by Subject|2
5220944|NCT00952588|18022617|P2|Overall Study|Death|13
5220945|NCT00952588|18022618|P1|Overall Study|Death|28
5220946|NCT00952523|18022636|P1|Overall Study|Withdrawal by Subject|7
5220947|NCT00952484|18022645|P3|Overall Study|Withdrawal by Subject|0
5220948|NCT00952484|18022646|P2|Overall Study|Withdrawal by Subject|1
5220949|NCT00952484|18022647|P1|Overall Study|Withdrawal by Subject|0
5220950|NCT00952419|18022674|P3|Overall Study|Withdrawal by Subject|0
5220951|NCT00952419|18022675|P2|Overall Study|Withdrawal by Subject|3
5220952|NCT00952419|18022676|P1|Overall Study|Withdrawal by Subject|1
5220953|NCT00952419|18022674|P3|Overall Study|Protocol Violation|0
5220954|NCT00952419|18022675|P2|Overall Study|Protocol Violation|7
5220955|NCT00952419|18022676|P1|Overall Study|Protocol Violation|3
5220956|NCT00952419|18022674|P3|Overall Study|Adverse Event|0
5220957|NCT00952419|18022675|P2|Overall Study|Adverse Event|0
5220958|NCT00952419|18022676|P1|Overall Study|Adverse Event|2
5220959|NCT00952380|18022717|P5|Overall Study|Non-compliant to protocol|0
5220960|NCT00952380|18022718|P4|Overall Study|Non-compliant to protocol|1
5220961|NCT00952380|18022719|P3|Overall Study|Non-compliant to protocol|0
5220962|NCT00952380|18022720|P2|Overall Study|Non-compliant to protocol|0
5220963|NCT00952380|18022721|P1|Overall Study|Non-compliant to protocol|0
5220964|NCT00952380|18022717|P5|Overall Study|Physician Decision|0
5220965|NCT00952380|18022718|P4|Overall Study|Physician Decision|2
5220966|NCT00952380|18022719|P3|Overall Study|Physician Decision|1
5220967|NCT00952380|18022720|P2|Overall Study|Physician Decision|0
5220968|NCT00952380|18022721|P1|Overall Study|Physician Decision|0
5220969|NCT00952380|18022717|P5|Overall Study|Adverse Event|3
5220970|NCT00952380|18022718|P4|Overall Study|Adverse Event|0
5220971|NCT00952380|18022719|P3|Overall Study|Adverse Event|0
5220972|NCT00952380|18022720|P2|Overall Study|Adverse Event|1
5220973|NCT00952380|18022721|P1|Overall Study|Adverse Event|0
5220974|NCT00952380|18022717|P5|Overall Study|Withdrawal by Subject|2
5220975|NCT00952380|18022718|P4|Overall Study|Withdrawal by Subject|0
5220976|NCT00952380|18022719|P3|Overall Study|Withdrawal by Subject|1
5220977|NCT00952380|18022720|P2|Overall Study|Withdrawal by Subject|0
5220978|NCT00952380|18022721|P1|Overall Study|Withdrawal by Subject|0
5220979|NCT00952380|18022717|P5|Overall Study|Other|1
5220980|NCT00952380|18022718|P4|Overall Study|Other|0
5220981|NCT00952380|18022719|P3|Overall Study|Other|0
5220982|NCT00952380|18022720|P2|Overall Study|Other|0
5220983|NCT00952380|18022721|P1|Overall Study|Other|0
5220984|NCT00952367|18022822|P1|Overall Study|Protocol Violation|3
5220985|NCT00952367|18022822|P1|Overall Study|Noncoordination|1
5220986|NCT00952367|18022822|P1|Overall Study|Withdrawal by Subject|2
5220987|NCT00952341|18022837|P2|Cycle 2|Progressive Disease|1
5220988|NCT00952341|18022838|P1|Cycle 2|Progressive Disease|0
5220989|NCT00952341|18022837|P2|Cycle 2|Physician Decision|1
5220990|NCT00952341|18022838|P1|Cycle 2|Physician Decision|1
5220991|NCT00952341|18022837|P2|Cycle 2|Lost to Follow-up|9
5220992|NCT00952341|18022838|P1|Cycle 2|Lost to Follow-up|6
5220993|NCT00952341|18022837|P2|Cycle 2|Protocol Violation|0
5220994|NCT00952341|18022838|P1|Cycle 2|Protocol Violation|1
5220995|NCT00952341|18022837|P2|Cycle 2|Withdrawal by Subject|1
5220996|NCT00952341|18022838|P1|Cycle 2|Withdrawal by Subject|1
5220997|NCT00952341|18022837|P2|Cycle 1|Physician Decision|1
5220998|NCT00952341|18022838|P1|Cycle 1|Physician Decision|0
5220999|NCT00952341|18022837|P2|Cycle 1|Lost to Follow-up|2
5221000|NCT00952341|18022838|P1|Cycle 1|Lost to Follow-up|11
5221001|NCT00952341|18022837|P2|Cycle 1|Protocol Violation|1
5221002|NCT00952341|18022838|P1|Cycle 1|Protocol Violation|2
5221003|NCT00952341|18022837|P2|Cycle 1|Withdrawal by Subject|8
5221004|NCT00952341|18022838|P1|Cycle 1|Withdrawal by Subject|3
5221005|NCT00952341|18022837|P2|Cycle 1|Adverse Event|1
5221006|NCT00952341|18022838|P1|Cycle 1|Adverse Event|4
5221007|NCT00952289|18022900|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
5221008|NCT00952289|18022901|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
5221009|NCT00952289|18022900|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
5221010|NCT00952289|18022901|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
5221011|NCT00952289|18022900|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
5221012|NCT00952289|18022901|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
5221013|NCT00952289|18022900|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
5221014|NCT00952289|18022901|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
5221015|NCT00952289|18022900|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
5221016|NCT00952289|18022901|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
5221017|NCT00952289|18022900|P2|All Participants|Data lost during site relocation|1
5221018|NCT00952289|18022901|P1|All Participants|Data lost during site relocation|0
5221019|NCT00952289|18022900|P2|All Participants|Withdrawal by Subject|10
5221020|NCT00952289|18022901|P1|All Participants|Withdrawal by Subject|1
5221021|NCT00952289|18022900|P2|All Participants|Disease progression|12
5221022|NCT00952289|18022901|P1|All Participants|Disease progression|3
5221023|NCT00952289|18022900|P2|All Participants|Adverse Event|8
5221024|NCT00952289|18022901|P1|All Participants|Adverse Event|8
5221025|NCT00952289|18022900|P2|All Participants|Death|9
5221026|NCT00952289|18022901|P1|All Participants|Death|9
5221027|NCT00952276|18022930|P5|Overall Study|Withdrawal by Subject|0
5221028|NCT00952276|18022931|P4|Overall Study|Withdrawal by Subject|1
5221029|NCT00952276|18022932|P3|Overall Study|Withdrawal by Subject|0
5221030|NCT00952276|18022933|P2|Overall Study|Withdrawal by Subject|0
5221031|NCT00952276|18022934|P1|Overall Study|Withdrawal by Subject|1
5221032|NCT00952068|18023020|P1|Overall Study|Withdrawal by Subject|4
5221033|NCT00952068|18023020|P1|Overall Study|Adverse Event|3
5221034|NCT00951912|18023031|P3|Overall Study|Other: Stroke|0
5221035|NCT00951912|18023032|P2|Overall Study|Other: Stroke|1
5221036|NCT00951912|18023033|P1|Overall Study|Other: Stroke|0
5221037|NCT00951912|18023031|P3|Overall Study|Other: Colon cancer|0
5221038|NCT00951912|18023032|P2|Overall Study|Other: Colon cancer|0
5221039|NCT00951912|18023033|P1|Overall Study|Other: Colon cancer|1
5221040|NCT00951912|18023031|P3|Overall Study|Other:Depression|0
5221041|NCT00951912|18023032|P2|Overall Study|Other:Depression|0
5221042|NCT00951912|18023033|P1|Overall Study|Other:Depression|1
5221043|NCT00951912|18023031|P3|Overall Study|Withdrawal by Subject|0
5221044|NCT00951912|18023032|P2|Overall Study|Withdrawal by Subject|1
5221045|NCT00951912|18023033|P1|Overall Study|Withdrawal by Subject|1
5221046|NCT00951912|18023031|P3|Overall Study|Physician Decision|1
5221047|NCT00951912|18023032|P2|Overall Study|Physician Decision|0
5221048|NCT00951912|18023033|P1|Overall Study|Physician Decision|1
5221049|NCT00951912|18023031|P3|Overall Study|Lost to Follow-up|0
5221050|NCT00951912|18023032|P2|Overall Study|Lost to Follow-up|2
5221051|NCT00951912|18023033|P1|Overall Study|Lost to Follow-up|2
5221052|NCT00951912|18023031|P3|Overall Study|Adverse Event|1
5221053|NCT00951912|18023032|P2|Overall Study|Adverse Event|1
5221054|NCT00951912|18023033|P1|Overall Study|Adverse Event|0
5221055|NCT00951912|18023031|P3|Overall Study|Lack of Efficacy|0
5221056|NCT00951912|18023032|P2|Overall Study|Lack of Efficacy|0
5221057|NCT00951912|18023033|P1|Overall Study|Lack of Efficacy|1
5221058|NCT00951665|18023133|P6|Phase 2a|Disease Progression|5
5221059|NCT00951665|18023134|P5|Phase 2a|Disease Progression|6
5221060|NCT00951665|18023135|P4|Phase 2a|Disease Progression|0
5221061|NCT00951665|18023136|P3|Phase 2a|Disease Progression|0
5221062|NCT00951665|18023137|P2|Phase 2a|Disease Progression|0
5221063|NCT00951665|18023138|P1|Phase 2a|Disease Progression|0
5221064|NCT00951665|18023133|P6|Phase 2a|Withdrawal by Subject|0
5221065|NCT00951665|18023134|P5|Phase 2a|Withdrawal by Subject|2
5221066|NCT00951665|18023135|P4|Phase 2a|Withdrawal by Subject|0
5221067|NCT00951665|18023136|P3|Phase 2a|Withdrawal by Subject|0
5221068|NCT00951665|18023137|P2|Phase 2a|Withdrawal by Subject|0
5221069|NCT00951665|18023138|P1|Phase 2a|Withdrawal by Subject|0
5221070|NCT00951665|18023133|P6|Phase 2a|Physician Decision|1
5221071|NCT00951665|18023134|P5|Phase 2a|Physician Decision|0
5221072|NCT00951665|18023135|P4|Phase 2a|Physician Decision|0
5221073|NCT00951665|18023136|P3|Phase 2a|Physician Decision|0
5221074|NCT00951665|18023137|P2|Phase 2a|Physician Decision|0
5221075|NCT00951665|18023138|P1|Phase 2a|Physician Decision|0
5221076|NCT00951665|18023133|P6|Phase 2a|Lost to Follow-up|0
5221077|NCT00951665|18023134|P5|Phase 2a|Lost to Follow-up|1
5221078|NCT00951665|18023135|P4|Phase 2a|Lost to Follow-up|0
5221079|NCT00951665|18023136|P3|Phase 2a|Lost to Follow-up|0
5221080|NCT00951665|18023137|P2|Phase 2a|Lost to Follow-up|0
5221081|NCT00951665|18023138|P1|Phase 2a|Lost to Follow-up|0
5221082|NCT00951665|18023133|P6|Phase 2a|Death|1
5221083|NCT00951665|18023134|P5|Phase 2a|Death|1
5221084|NCT00951665|18023135|P4|Phase 2a|Death|0
5221085|NCT00951665|18023136|P3|Phase 2a|Death|0
5221086|NCT00951665|18023137|P2|Phase 2a|Death|0
5221087|NCT00951665|18023138|P1|Phase 2a|Death|0
5221088|NCT00951665|18023133|P6|Phase 2a|Adverse Event|0
5221089|NCT00951665|18023134|P5|Phase 2a|Adverse Event|2
5221090|NCT00951665|18023135|P4|Phase 2a|Adverse Event|0
5221091|NCT00951665|18023136|P3|Phase 2a|Adverse Event|0
5221092|NCT00951665|18023137|P2|Phase 2a|Adverse Event|0
5221093|NCT00951665|18023138|P1|Phase 2a|Adverse Event|0
5221094|NCT00951665|18023133|P6|Phase 1b|Protocol Violation|0
5221095|NCT00951665|18023134|P5|Phase 1b|Protocol Violation|0
5221096|NCT00951665|18023135|P4|Phase 1b|Protocol Violation|0
5221097|NCT00951665|18023136|P3|Phase 1b|Protocol Violation|0
5221098|NCT00951665|18023137|P2|Phase 1b|Protocol Violation|0
5221099|NCT00951665|18023138|P1|Phase 1b|Protocol Violation|2
5221100|NCT00951665|18023133|P6|Phase 1b|Disease Progression|0
5221101|NCT00951665|18023134|P5|Phase 1b|Disease Progression|0
5221102|NCT00951665|18023135|P4|Phase 1b|Disease Progression|0
5221103|NCT00951665|18023136|P3|Phase 1b|Disease Progression|14
5221104|NCT00951665|18023137|P2|Phase 1b|Disease Progression|2
5221105|NCT00951665|18023138|P1|Phase 1b|Disease Progression|13
5221106|NCT00951665|18023133|P6|Phase 1b|Withdrawal by Subject|0
5221107|NCT00951665|18023134|P5|Phase 1b|Withdrawal by Subject|0
5221108|NCT00951665|18023135|P4|Phase 1b|Withdrawal by Subject|0
5221109|NCT00951665|18023136|P3|Phase 1b|Withdrawal by Subject|0
5221110|NCT00951665|18023137|P2|Phase 1b|Withdrawal by Subject|1
5221111|NCT00951665|18023138|P1|Phase 1b|Withdrawal by Subject|0
5221112|NCT00951665|18023133|P6|Phase 1b|Physician Decision|0
5221113|NCT00951665|18023134|P5|Phase 1b|Physician Decision|0
5221114|NCT00951665|18023135|P4|Phase 1b|Physician Decision|0
5221115|NCT00951665|18023136|P3|Phase 1b|Physician Decision|1
5221116|NCT00951665|18023137|P2|Phase 1b|Physician Decision|0
5221117|NCT00951665|18023138|P1|Phase 1b|Physician Decision|4
5221118|NCT00951665|18023133|P6|Phase 1b|Death|0
5221119|NCT00951665|18023134|P5|Phase 1b|Death|0
5221120|NCT00951665|18023135|P4|Phase 1b|Death|0
5221121|NCT00951665|18023136|P3|Phase 1b|Death|2
5221122|NCT00951665|18023137|P2|Phase 1b|Death|0
5221123|NCT00951665|18023138|P1|Phase 1b|Death|1
5221124|NCT00951665|18023133|P6|Phase 1b|Adverse Event|0
5221125|NCT00951665|18023134|P5|Phase 1b|Adverse Event|0
5221126|NCT00951665|18023135|P4|Phase 1b|Adverse Event|1
5221127|NCT00951665|18023136|P3|Phase 1b|Adverse Event|0
5221128|NCT00951665|18023137|P2|Phase 1b|Adverse Event|1
5221129|NCT00951665|18023138|P1|Phase 1b|Adverse Event|2
5221130|NCT00951509|18023247|P1|Overall Study|Withdrawal by Subject|2
5221131|NCT00951496|18023258|P3|Overall Study|Did not initiate study treatment|13
5221132|NCT00951496|18023259|P2|Overall Study|Did not initiate study treatment|8
5221133|NCT00951496|18023260|P1|Overall Study|Did not initiate study treatment|10
5221134|NCT00951483|18023288|P2|Overall Study|Withdrawal by Subject|0
5221135|NCT00951483|18023289|P1|Overall Study|Withdrawal by Subject|15
5221136|NCT00951483|18023288|P2|Overall Study|Physician Decision|0
5221137|NCT00951483|18023289|P1|Overall Study|Physician Decision|4
5221138|NCT00951379|18023309|P2|Overall Study|Disease Progression|1
5221139|NCT00951379|18023310|P1|Overall Study|Disease Progression|0
5221140|NCT00951379|18023309|P2|Overall Study|Noncompliance|0
5221141|NCT00951379|18023310|P1|Overall Study|Noncompliance|1
5221142|NCT00951379|18023309|P2|Overall Study|Withdrawal by Subject|0
5221143|NCT00951379|18023310|P1|Overall Study|Withdrawal by Subject|1
5221144|NCT00951379|18023309|P2|Overall Study|Adverse Event|1
5221145|NCT00951379|18023310|P1|Overall Study|Adverse Event|4
5221146|NCT00951275|18023352|P1|Overall Study|Protocol Violation|1
5221147|NCT00951275|18023352|P1|Overall Study|Withdrawal by Subject|4
5221148|NCT00951275|18023352|P1|Overall Study|Adverse Event|7
5221149|NCT00951275|18023352|P1|Overall Study|Administrative Reason|1
5221150|NCT00951171|18023384|P2|Overall Study|Adverse Event|0
5221151|NCT00951171|18023385|P1|Overall Study|Adverse Event|2
5221152|NCT00951080|18023417|P2|Overall Study|Other|22
5221153|NCT00951080|18023418|P1|Overall Study|Other|19
5221154|NCT00951080|18023417|P2|Overall Study|Physician Decision|1
5221155|NCT00951080|18023418|P1|Overall Study|Physician Decision|4
5221156|NCT00951080|18023417|P2|Overall Study|Lost to Follow-up|1
5221157|NCT00951080|18023418|P1|Overall Study|Lost to Follow-up|0
5221158|NCT00951080|18023417|P2|Overall Study|Adverse Event|3
5221159|NCT00951080|18023418|P1|Overall Study|Adverse Event|3
5221160|NCT00951041|18023426|P2|Overall Study|Other|0
5221161|NCT00951041|18023427|P1|Overall Study|Other|3
5221162|NCT00951041|18023426|P2|Overall Study|Lost to Follow-up|0
5221163|NCT00951041|18023427|P1|Overall Study|Lost to Follow-up|1
5221164|NCT00951041|18023426|P2|Overall Study|Withdrawal by Subject|1
5221165|NCT00951041|18023427|P1|Overall Study|Withdrawal by Subject|1
5221166|NCT00951015|18023482|P5|Open-label Phase|Physician Decision|8
5221167|NCT00951015|18023483|P4|Open-label Phase|Physician Decision|0
5221168|NCT00951015|18023484|P3|Open-label Phase|Physician Decision|0
5221169|NCT00951015|18023485|P2|Open-label Phase|Physician Decision|0
5221170|NCT00951015|18023486|P1|Open-label Phase|Physician Decision|0
5221171|NCT00951015|18023482|P5|Open-label Phase|Withdrawal by Subject|14
5221172|NCT00951015|18023483|P4|Open-label Phase|Withdrawal by Subject|0
5221173|NCT00951015|18023484|P3|Open-label Phase|Withdrawal by Subject|0
5221174|NCT00951015|18023485|P2|Open-label Phase|Withdrawal by Subject|0
5221175|NCT00951015|18023486|P1|Open-label Phase|Withdrawal by Subject|0
5221176|NCT00951015|18023482|P5|Open-label Phase|Lost to Follow-up|12
5221177|NCT00951015|18023483|P4|Open-label Phase|Lost to Follow-up|0
5221178|NCT00951015|18023484|P3|Open-label Phase|Lost to Follow-up|0
5221179|NCT00951015|18023485|P2|Open-label Phase|Lost to Follow-up|0
5221180|NCT00951015|18023486|P1|Open-label Phase|Lost to Follow-up|0
5221181|NCT00951015|18023482|P5|Open-label Phase|Protocol Violation|12
5221182|NCT00951015|18023483|P4|Open-label Phase|Protocol Violation|0
5221183|NCT00951015|18023484|P3|Open-label Phase|Protocol Violation|0
5221184|NCT00951015|18023485|P2|Open-label Phase|Protocol Violation|0
5221185|NCT00951015|18023486|P1|Open-label Phase|Protocol Violation|0
5221186|NCT00951015|18023482|P5|Open-label Phase|Lack of Efficacy|1
5221187|NCT00951015|18023483|P4|Open-label Phase|Lack of Efficacy|0
5221188|NCT00951015|18023484|P3|Open-label Phase|Lack of Efficacy|0
5221189|NCT00951015|18023485|P2|Open-label Phase|Lack of Efficacy|0
5221190|NCT00951015|18023486|P1|Open-label Phase|Lack of Efficacy|0
5221191|NCT00951015|18023482|P5|Open-label Phase|Adverse Event|3
5221192|NCT00951015|18023483|P4|Open-label Phase|Adverse Event|0
5221193|NCT00951015|18023484|P3|Open-label Phase|Adverse Event|0
5221194|NCT00951015|18023485|P2|Open-label Phase|Adverse Event|0
5221195|NCT00951015|18023486|P1|Open-label Phase|Adverse Event|0
5221196|NCT00951015|18023482|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
5221197|NCT00951015|18023483|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
5221198|NCT00951015|18023484|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
5221199|NCT00951015|18023485|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
5221200|NCT00951015|18023486|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
5221201|NCT00951015|18023482|P5|Randomization Phase 96 Week|Lost to Follow-up|0
5221202|NCT00951015|18023483|P4|Randomization Phase 96 Week|Lost to Follow-up|2
5221203|NCT00951015|18023484|P3|Randomization Phase 96 Week|Lost to Follow-up|1
5221204|NCT00951015|18023485|P2|Randomization Phase 96 Week|Lost to Follow-up|3
5221205|NCT00951015|18023486|P1|Randomization Phase 96 Week|Lost to Follow-up|0
5221206|NCT00951015|18023482|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5221207|NCT00951015|18023483|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
5221208|NCT00951015|18023484|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5221209|NCT00951015|18023485|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5221210|NCT00951015|18023486|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5221211|NCT00951015|18023482|P5|Randomization Phase 96 Week|Protocol Violation|0
5221212|NCT00951015|18023483|P4|Randomization Phase 96 Week|Protocol Violation|0
5221213|NCT00951015|18023484|P3|Randomization Phase 96 Week|Protocol Violation|1
5221214|NCT00951015|18023485|P2|Randomization Phase 96 Week|Protocol Violation|1
5221215|NCT00951015|18023486|P1|Randomization Phase 96 Week|Protocol Violation|1
5221216|NCT00951015|18023482|P5|Randomization Phase 96 Week|Lack of Efficacy|0
5221217|NCT00951015|18023483|P4|Randomization Phase 96 Week|Lack of Efficacy|0
5221218|NCT00951015|18023484|P3|Randomization Phase 96 Week|Lack of Efficacy|0
5221219|NCT00951015|18023485|P2|Randomization Phase 96 Week|Lack of Efficacy|1
5221220|NCT00951015|18023486|P1|Randomization Phase 96 Week|Lack of Efficacy|1
5221221|NCT00951015|18023482|P5|Randomization Phase 96 Week|Adverse Event|0
5221222|NCT00951015|18023483|P4|Randomization Phase 96 Week|Adverse Event|5
5221223|NCT00951015|18023484|P3|Randomization Phase 96 Week|Adverse Event|2
5221224|NCT00951015|18023485|P2|Randomization Phase 96 Week|Adverse Event|1
5221225|NCT00951015|18023486|P1|Randomization Phase 96 Week|Adverse Event|1
5221226|NCT00950963|18023583|P2|Overall Study|Lost to Follow-up|24
5221227|NCT00950963|18023584|P1|Overall Study|Lost to Follow-up|29
5221228|NCT00950950|18023600|P2|Overall Study|Withdrawal by Subject|1
5221229|NCT00950950|18023601|P1|Overall Study|Withdrawal by Subject|0
5221230|NCT00950950|18023600|P2|Overall Study|Adverse Event|0
5221231|NCT00950950|18023601|P1|Overall Study|Adverse Event|1
5221232|NCT00950911|18023683|P2|Overall Study|Poor performance status|1
5221233|NCT00950911|18023684|P1|Overall Study|Poor performance status|0
5221234|NCT00950911|18023683|P2|Overall Study|Noncompliance|0
5221235|NCT00950911|18023684|P1|Overall Study|Noncompliance|1
5221236|NCT00950911|18023683|P2|Overall Study|Ineligibility determined|0
5221237|NCT00950911|18023684|P1|Overall Study|Ineligibility determined|1
5221238|NCT00950911|18023683|P2|Overall Study|Administrative decision|1
5221239|NCT00950911|18023684|P1|Overall Study|Administrative decision|3
5221240|NCT00950911|18023683|P2|Overall Study|Consent withdrawn|3
5221241|NCT00950911|18023684|P1|Overall Study|Consent withdrawn|1
5221242|NCT00950911|18023683|P2|Overall Study|Disease progression|2
5221243|NCT00950911|18023684|P1|Overall Study|Disease progression|2
5221244|NCT00950911|18023683|P2|Overall Study|Death|6
5221245|NCT00950911|18023684|P1|Overall Study|Death|4
5221246|NCT00950911|18023683|P2|Overall Study|Adverse Event|2
5221247|NCT00950911|18023684|P1|Overall Study|Adverse Event|0
5221248|NCT00950872|18023690|P1|Overall Study|Did not have surgery|2
5221249|NCT00950872|18023690|P1|Overall Study|Withdrawal by Subject|1
5221250|NCT00950859|18023699|P2|Overall Study|Lost to Follow-up|3
5221251|NCT00950859|18023700|P1|Overall Study|Lost to Follow-up|0
5221252|NCT00950859|18023699|P2|Overall Study|Protocol Violation|1
5221253|NCT00950859|18023700|P1|Overall Study|Protocol Violation|1
5221254|NCT00950859|18023699|P2|Overall Study|Insufficient Viral Load Response|3
5221255|NCT00950859|18023700|P1|Overall Study|Insufficient Viral Load Response|12
5221256|NCT00950859|18023699|P2|Overall Study|Adverse Event|3
5221257|NCT00950859|18023700|P1|Overall Study|Adverse Event|3
5221258|NCT00950807|18023799|P10|Treatment Period 3|Adverse Event|0
5221259|NCT00950807|18023800|P9|Treatment Period 3|Adverse Event|0
5221260|NCT00950807|18023801|P8|Treatment Period 3|Adverse Event|0
5221261|NCT00950807|18023802|P7|Treatment Period 3|Adverse Event|1
5221262|NCT00950807|18023803|P6|Treatment Period 3|Adverse Event|0
5221263|NCT00950807|18023804|P5|Treatment Period 3|Adverse Event|0
5221264|NCT00950807|18023805|P4|Treatment Period 3|Adverse Event|0
5221265|NCT00950807|18023806|P3|Treatment Period 3|Adverse Event|0
5221266|NCT00950807|18023807|P2|Treatment Period 3|Adverse Event|0
5221267|NCT00950807|18023808|P1|Treatment Period 3|Adverse Event|0
5221268|NCT00950807|18023799|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221269|NCT00950807|18023800|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221270|NCT00950807|18023801|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
5221271|NCT00950807|18023802|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221272|NCT00950807|18023803|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221273|NCT00950807|18023804|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221274|NCT00950807|18023805|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221275|NCT00950807|18023806|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221276|NCT00950807|18023807|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
5221277|NCT00950807|18023808|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
5221278|NCT00950807|18023799|P10|Treatment Period 3|Withdrawal by Subject|1
5221279|NCT00950807|18023800|P9|Treatment Period 3|Withdrawal by Subject|0
5221280|NCT00950807|18023801|P8|Treatment Period 3|Withdrawal by Subject|0
5221281|NCT00950807|18023802|P7|Treatment Period 3|Withdrawal by Subject|0
5221282|NCT00950807|18023803|P6|Treatment Period 3|Withdrawal by Subject|0
5221283|NCT00950807|18023804|P5|Treatment Period 3|Withdrawal by Subject|0
5221284|NCT00950807|18023805|P4|Treatment Period 3|Withdrawal by Subject|0
5221285|NCT00950807|18023806|P3|Treatment Period 3|Withdrawal by Subject|0
5221286|NCT00950807|18023807|P2|Treatment Period 3|Withdrawal by Subject|0
5221287|NCT00950807|18023808|P1|Treatment Period 3|Withdrawal by Subject|0
5221288|NCT00950807|18023799|P10|Washout Period 2|Adverse Event|0
5221289|NCT00950807|18023800|P9|Washout Period 2|Adverse Event|0
5221290|NCT00950807|18023801|P8|Washout Period 2|Adverse Event|0
5221291|NCT00950807|18023802|P7|Washout Period 2|Adverse Event|0
5221292|NCT00950807|18023803|P6|Washout Period 2|Adverse Event|0
5221293|NCT00950807|18023804|P5|Washout Period 2|Adverse Event|0
5221294|NCT00950807|18023805|P4|Washout Period 2|Adverse Event|1
5221295|NCT00950807|18023806|P3|Washout Period 2|Adverse Event|0
5221296|NCT00950807|18023807|P2|Washout Period 2|Adverse Event|0
5221297|NCT00950807|18023808|P1|Washout Period 2|Adverse Event|3
5221298|NCT00950807|18023799|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
5221299|NCT00950807|18023800|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
5221300|NCT00950807|18023801|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
5221301|NCT00950807|18023802|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
5221302|NCT00950807|18023803|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
5221303|NCT00950807|18023804|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
5221304|NCT00950807|18023805|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
5221305|NCT00950807|18023806|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
5221306|NCT00950807|18023807|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
5221307|NCT00950807|18023808|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
5221308|NCT00950807|18023799|P10|Washout Period 2|Lack of Efficacy|0
5221309|NCT00950807|18023800|P9|Washout Period 2|Lack of Efficacy|0
5221310|NCT00950807|18023801|P8|Washout Period 2|Lack of Efficacy|0
5221311|NCT00950807|18023802|P7|Washout Period 2|Lack of Efficacy|0
5221312|NCT00950807|18023803|P6|Washout Period 2|Lack of Efficacy|0
5221313|NCT00950807|18023804|P5|Washout Period 2|Lack of Efficacy|0
5221314|NCT00950807|18023805|P4|Washout Period 2|Lack of Efficacy|0
5221315|NCT00950807|18023806|P3|Washout Period 2|Lack of Efficacy|0
5221316|NCT00950807|18023807|P2|Washout Period 2|Lack of Efficacy|0
5221317|NCT00950807|18023808|P1|Washout Period 2|Lack of Efficacy|1
5221318|NCT00950807|18023799|P10|Treatment Period 2|Adverse Event|0
5221319|NCT00950807|18023800|P9|Treatment Period 2|Adverse Event|0
5221320|NCT00950807|18023801|P8|Treatment Period 2|Adverse Event|1
5221321|NCT00950807|18023802|P7|Treatment Period 2|Adverse Event|0
5221322|NCT00950807|18023803|P6|Treatment Period 2|Adverse Event|1
5221323|NCT00950807|18023804|P5|Treatment Period 2|Adverse Event|0
5221324|NCT00950807|18023805|P4|Treatment Period 2|Adverse Event|1
5221325|NCT00950807|18023806|P3|Treatment Period 2|Adverse Event|0
5221326|NCT00950807|18023807|P2|Treatment Period 2|Adverse Event|1
5221327|NCT00950807|18023808|P1|Treatment Period 2|Adverse Event|0
5221328|NCT00950807|18023799|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221329|NCT00950807|18023800|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221330|NCT00950807|18023801|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221331|NCT00950807|18023802|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221332|NCT00950807|18023803|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221333|NCT00950807|18023804|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221334|NCT00950807|18023805|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221335|NCT00950807|18023806|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221336|NCT00950807|18023807|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
5221337|NCT00950807|18023808|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
5221338|NCT00950807|18023799|P10|Treatment Period 2|Withdrawal by Subject|0
5221339|NCT00950807|18023800|P9|Treatment Period 2|Withdrawal by Subject|0
5221340|NCT00950807|18023801|P8|Treatment Period 2|Withdrawal by Subject|2
5221341|NCT00950807|18023802|P7|Treatment Period 2|Withdrawal by Subject|1
5221342|NCT00950807|18023803|P6|Treatment Period 2|Withdrawal by Subject|0
5221343|NCT00950807|18023804|P5|Treatment Period 2|Withdrawal by Subject|0
5221344|NCT00950807|18023805|P4|Treatment Period 2|Withdrawal by Subject|0
5221345|NCT00950807|18023806|P3|Treatment Period 2|Withdrawal by Subject|0
5221346|NCT00950807|18023807|P2|Treatment Period 2|Withdrawal by Subject|0
5221347|NCT00950807|18023808|P1|Treatment Period 2|Withdrawal by Subject|0
5221348|NCT00950807|18023799|P10|Treatment Period 2|Lack of Efficacy|0
5221349|NCT00950807|18023800|P9|Treatment Period 2|Lack of Efficacy|0
5221350|NCT00950807|18023801|P8|Treatment Period 2|Lack of Efficacy|0
5221351|NCT00950807|18023802|P7|Treatment Period 2|Lack of Efficacy|0
5221352|NCT00950807|18023803|P6|Treatment Period 2|Lack of Efficacy|0
5221353|NCT00950807|18023804|P5|Treatment Period 2|Lack of Efficacy|0
5221354|NCT00950807|18023805|P4|Treatment Period 2|Lack of Efficacy|0
5221355|NCT00950807|18023806|P3|Treatment Period 2|Lack of Efficacy|0
5221356|NCT00950807|18023807|P2|Treatment Period 2|Lack of Efficacy|0
5221357|NCT00950807|18023808|P1|Treatment Period 2|Lack of Efficacy|1
5221358|NCT00950807|18023799|P10|Washout Period 1|Adverse Event|0
5221359|NCT00950807|18023800|P9|Washout Period 1|Adverse Event|0
5221360|NCT00950807|18023801|P8|Washout Period 1|Adverse Event|0
5221361|NCT00950807|18023802|P7|Washout Period 1|Adverse Event|0
5221362|NCT00950807|18023803|P6|Washout Period 1|Adverse Event|0
5221363|NCT00950807|18023804|P5|Washout Period 1|Adverse Event|1
5221364|NCT00950807|18023805|P4|Washout Period 1|Adverse Event|1
5221365|NCT00950807|18023806|P3|Washout Period 1|Adverse Event|0
5221366|NCT00950807|18023807|P2|Washout Period 1|Adverse Event|0
5221367|NCT00950807|18023808|P1|Washout Period 1|Adverse Event|2
5221368|NCT00950807|18023799|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
5221369|NCT00950807|18023800|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
5221370|NCT00950807|18023801|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
5221371|NCT00950807|18023802|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
5221372|NCT00950807|18023803|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
5221373|NCT00950807|18023804|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
5221374|NCT00950807|18023805|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
5221375|NCT00950807|18023806|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
5221376|NCT00950807|18023807|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
5221377|NCT00950807|18023808|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
5221378|NCT00950807|18023799|P10|Washout Period 1|Withdrawal by Subject|0
5221379|NCT00950807|18023800|P9|Washout Period 1|Withdrawal by Subject|1
5221380|NCT00950807|18023801|P8|Washout Period 1|Withdrawal by Subject|0
5221381|NCT00950807|18023802|P7|Washout Period 1|Withdrawal by Subject|0
5221382|NCT00950807|18023803|P6|Washout Period 1|Withdrawal by Subject|0
5221383|NCT00950807|18023804|P5|Washout Period 1|Withdrawal by Subject|0
5221384|NCT00950807|18023805|P4|Washout Period 1|Withdrawal by Subject|0
5221385|NCT00950807|18023806|P3|Washout Period 1|Withdrawal by Subject|0
5221386|NCT00950807|18023807|P2|Washout Period 1|Withdrawal by Subject|0
5221387|NCT00950807|18023808|P1|Washout Period 1|Withdrawal by Subject|0
5221388|NCT00950807|18023799|P10|Washout Period 1|Lack of Efficacy|0
5221389|NCT00950807|18023800|P9|Washout Period 1|Lack of Efficacy|0
5221390|NCT00950807|18023801|P8|Washout Period 1|Lack of Efficacy|0
5221391|NCT00950807|18023802|P7|Washout Period 1|Lack of Efficacy|1
5221392|NCT00950807|18023803|P6|Washout Period 1|Lack of Efficacy|0
5221393|NCT00950807|18023804|P5|Washout Period 1|Lack of Efficacy|0
5221394|NCT00950807|18023805|P4|Washout Period 1|Lack of Efficacy|0
5221395|NCT00950807|18023806|P3|Washout Period 1|Lack of Efficacy|0
5221396|NCT00950807|18023807|P2|Washout Period 1|Lack of Efficacy|0
5221397|NCT00950807|18023808|P1|Washout Period 1|Lack of Efficacy|0
5221398|NCT00950807|18023799|P10|Treatment Period 1|Adverse Event|0
5221399|NCT00950807|18023800|P9|Treatment Period 1|Adverse Event|0
5221400|NCT00950807|18023801|P8|Treatment Period 1|Adverse Event|0
5221401|NCT00950807|18023802|P7|Treatment Period 1|Adverse Event|0
5221402|NCT00950807|18023803|P6|Treatment Period 1|Adverse Event|1
5221403|NCT00950807|18023804|P5|Treatment Period 1|Adverse Event|0
5221404|NCT00950807|18023805|P4|Treatment Period 1|Adverse Event|0
5221405|NCT00950807|18023806|P3|Treatment Period 1|Adverse Event|0
5221406|NCT00950807|18023807|P2|Treatment Period 1|Adverse Event|0
5221407|NCT00950807|18023808|P1|Treatment Period 1|Adverse Event|0
5221408|NCT00950807|18023799|P10|Treatment Period 1|Withdrawal by Subject|0
5221409|NCT00950807|18023800|P9|Treatment Period 1|Withdrawal by Subject|1
5221410|NCT00950807|18023801|P8|Treatment Period 1|Withdrawal by Subject|0
5221411|NCT00950807|18023802|P7|Treatment Period 1|Withdrawal by Subject|0
5221412|NCT00950807|18023803|P6|Treatment Period 1|Withdrawal by Subject|0
5221413|NCT00950807|18023804|P5|Treatment Period 1|Withdrawal by Subject|1
5221414|NCT00950807|18023805|P4|Treatment Period 1|Withdrawal by Subject|0
5221415|NCT00950807|18023806|P3|Treatment Period 1|Withdrawal by Subject|0
5221416|NCT00950807|18023807|P2|Treatment Period 1|Withdrawal by Subject|0
5221417|NCT00950807|18023808|P1|Treatment Period 1|Withdrawal by Subject|1
5221418|NCT00950807|18023799|P10|Treatment Period 1|Lost to Follow-up|0
5221419|NCT00950807|18023800|P9|Treatment Period 1|Lost to Follow-up|0
5221420|NCT00950807|18023801|P8|Treatment Period 1|Lost to Follow-up|0
5221421|NCT00950807|18023802|P7|Treatment Period 1|Lost to Follow-up|0
5221422|NCT00950807|18023803|P6|Treatment Period 1|Lost to Follow-up|0
5221423|NCT00950807|18023804|P5|Treatment Period 1|Lost to Follow-up|0
5221424|NCT00950807|18023805|P4|Treatment Period 1|Lost to Follow-up|0
5221425|NCT00950807|18023806|P3|Treatment Period 1|Lost to Follow-up|1
5221426|NCT00950807|18023807|P2|Treatment Period 1|Lost to Follow-up|0
5221427|NCT00950807|18023808|P1|Treatment Period 1|Lost to Follow-up|0
5221428|NCT00950807|18023799|P10|Treatment Period 1|Protocol Violation|0
5221429|NCT00950807|18023800|P9|Treatment Period 1|Protocol Violation|0
5221430|NCT00950807|18023801|P8|Treatment Period 1|Protocol Violation|0
5221431|NCT00950807|18023802|P7|Treatment Period 1|Protocol Violation|0
5221432|NCT00950807|18023803|P6|Treatment Period 1|Protocol Violation|0
5221433|NCT00950807|18023804|P5|Treatment Period 1|Protocol Violation|0
5221434|NCT00950807|18023805|P4|Treatment Period 1|Protocol Violation|0
5221435|NCT00950807|18023806|P3|Treatment Period 1|Protocol Violation|0
5221436|NCT00950807|18023807|P2|Treatment Period 1|Protocol Violation|0
5221437|NCT00950807|18023808|P1|Treatment Period 1|Protocol Violation|1
5221438|NCT00950807|18023799|P10|Treatment Period 1|Lack of Efficacy|0
5221439|NCT00950807|18023800|P9|Treatment Period 1|Lack of Efficacy|0
5221440|NCT00950807|18023801|P8|Treatment Period 1|Lack of Efficacy|0
5221441|NCT00950807|18023802|P7|Treatment Period 1|Lack of Efficacy|0
5221442|NCT00950807|18023803|P6|Treatment Period 1|Lack of Efficacy|1
5221443|NCT00950807|18023804|P5|Treatment Period 1|Lack of Efficacy|0
5221444|NCT00950807|18023805|P4|Treatment Period 1|Lack of Efficacy|0
5221445|NCT00950807|18023806|P3|Treatment Period 1|Lack of Efficacy|0
5221446|NCT00950807|18023807|P2|Treatment Period 1|Lack of Efficacy|0
5221447|NCT00950807|18023808|P1|Treatment Period 1|Lack of Efficacy|1
5221448|NCT00950755|18023850|P1|Long-Term Follow-Up|Death|8
5221449|NCT00950755|18023850|P1|Long-Term Follow-Up|Lost to Follow-up|1
5221450|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
5221451|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
5221452|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
5221453|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
5221454|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Death|1
5221455|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
5221456|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
5221457|NCT00950755|18023850|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
5221458|NCT00950742|18023876|P2|Overall Study|Dose limiting toxicity|0
5221459|NCT00950742|18023877|P1|Overall Study|Dose limiting toxicity|6
5221460|NCT00950742|18023876|P2|Overall Study|Progressive Disease|2
5221461|NCT00950742|18023877|P1|Overall Study|Progressive Disease|6
5221462|NCT00950742|18023876|P2|Overall Study|Withdrawal by Subject|0
5221463|NCT00950742|18023877|P1|Overall Study|Withdrawal by Subject|3
5221464|NCT00950742|18023876|P2|Overall Study|Other Adverse Event|0
5221465|NCT00950742|18023877|P1|Overall Study|Other Adverse Event|1
5221466|NCT00950690|18023898|P1|Overall Study|Other|163
5221467|NCT00950690|18023898|P1|Overall Study|Lost to Follow-up|40
5221468|NCT00950690|18023898|P1|Overall Study|Lack of Efficacy|22
5221469|NCT00950690|18023898|P1|Overall Study|Adverse Event|15
5221470|NCT00950690|18023898|P1|Overall Study|Death|4
5221471|NCT00950664|18023905|P2|First Intervention|Withdrawal by Subject|2
5221472|NCT00950664|18023906|P1|First Intervention|Withdrawal by Subject|2
5221473|NCT00950664|18023905|P2|First Intervention|Lost to Follow-up|3
5221474|NCT00950664|18023906|P1|First Intervention|Lost to Follow-up|1
5221475|NCT00950651|18023926|P2|Overall Study|Withdrawal by Subject|9
5221476|NCT00950651|18023927|P1|Overall Study|Withdrawal by Subject|8
5221477|NCT00950651|18023926|P2|Overall Study|Protocol Violation|4
5221478|NCT00950651|18023927|P1|Overall Study|Protocol Violation|3
5221479|NCT00950651|18023926|P2|Overall Study|Lack of Efficacy|2
5221480|NCT00950651|18023927|P1|Overall Study|Lack of Efficacy|2
5221481|NCT00950651|18023926|P2|Overall Study|Death|0
5221482|NCT00950651|18023927|P1|Overall Study|Death|1
5221483|NCT00950651|18023926|P2|Overall Study|Adverse Event|20
5221484|NCT00950651|18023927|P1|Overall Study|Adverse Event|17
5221485|NCT00950599|18024020|P10|Follow-Up Period|Subject withdrew Consent|1
5221486|NCT00950599|18024021|P9|Follow-Up Period|Subject withdrew Consent|2
5221487|NCT00950599|18024022|P8|Follow-Up Period|Subject withdrew Consent|0
5221488|NCT00950599|18024023|P7|Follow-Up Period|Subject withdrew Consent|0
5221489|NCT00950599|18024024|P6|Follow-Up Period|Subject withdrew Consent|0
5221490|NCT00950599|18024025|P5|Follow-Up Period|Subject withdrew Consent|0
5221491|NCT00950599|18024026|P4|Follow-Up Period|Subject withdrew Consent|0
5221492|NCT00950599|18024027|P3|Follow-Up Period|Subject withdrew Consent|0
5221493|NCT00950599|18024028|P2|Follow-Up Period|Subject withdrew Consent|0
5221494|NCT00950599|18024029|P1|Follow-Up Period|Subject withdrew Consent|0
5221495|NCT00950599|18024020|P10|Follow-Up Period|Poor/Noncompliance|0
5221496|NCT00950599|18024021|P9|Follow-Up Period|Poor/Noncompliance|1
5221497|NCT00950599|18024022|P8|Follow-Up Period|Poor/Noncompliance|0
5221498|NCT00950599|18024023|P7|Follow-Up Period|Poor/Noncompliance|0
5221499|NCT00950599|18024024|P6|Follow-Up Period|Poor/Noncompliance|0
5221500|NCT00950599|18024025|P5|Follow-Up Period|Poor/Noncompliance|0
5221501|NCT00950599|18024026|P4|Follow-Up Period|Poor/Noncompliance|0
5221502|NCT00950599|18024027|P3|Follow-Up Period|Poor/Noncompliance|0
5221503|NCT00950599|18024028|P2|Follow-Up Period|Poor/Noncompliance|0
5221504|NCT00950599|18024029|P1|Follow-Up Period|Poor/Noncompliance|0
5221505|NCT00950599|18024020|P10|Follow-Up Period|Physician Decision|0
5221506|NCT00950599|18024021|P9|Follow-Up Period|Physician Decision|1
5221507|NCT00950599|18024022|P8|Follow-Up Period|Physician Decision|0
5221508|NCT00950599|18024023|P7|Follow-Up Period|Physician Decision|0
5221509|NCT00950599|18024024|P6|Follow-Up Period|Physician Decision|0
5221510|NCT00950599|18024025|P5|Follow-Up Period|Physician Decision|0
5221511|NCT00950599|18024026|P4|Follow-Up Period|Physician Decision|0
5221512|NCT00950599|18024027|P3|Follow-Up Period|Physician Decision|0
5221513|NCT00950599|18024028|P2|Follow-Up Period|Physician Decision|0
5221514|NCT00950599|18024029|P1|Follow-Up Period|Physician Decision|0
5221515|NCT00950599|18024020|P10|Follow-Up Period|Lost to Follow-up|1
5221516|NCT00950599|18024021|P9|Follow-Up Period|Lost to Follow-up|5
5221517|NCT00950599|18024022|P8|Follow-Up Period|Lost to Follow-up|0
5221518|NCT00950599|18024023|P7|Follow-Up Period|Lost to Follow-up|0
5221519|NCT00950599|18024024|P6|Follow-Up Period|Lost to Follow-up|0
5221520|NCT00950599|18024025|P5|Follow-Up Period|Lost to Follow-up|0
5221521|NCT00950599|18024026|P4|Follow-Up Period|Lost to Follow-up|0
5221522|NCT00950599|18024027|P3|Follow-Up Period|Lost to Follow-up|0
5221523|NCT00950599|18024028|P2|Follow-Up Period|Lost to Follow-up|0
5221524|NCT00950599|18024029|P1|Follow-Up Period|Lost to Follow-up|0
5221525|NCT00950599|18024020|P10|Follow-Up Period|Lack of Efficacy|0
5221526|NCT00950599|18024021|P9|Follow-Up Period|Lack of Efficacy|3
5221527|NCT00950599|18024022|P8|Follow-Up Period|Lack of Efficacy|0
5221528|NCT00950599|18024023|P7|Follow-Up Period|Lack of Efficacy|0
5221529|NCT00950599|18024024|P6|Follow-Up Period|Lack of Efficacy|0
5221530|NCT00950599|18024025|P5|Follow-Up Period|Lack of Efficacy|0
5221531|NCT00950599|18024026|P4|Follow-Up Period|Lack of Efficacy|0
5221532|NCT00950599|18024027|P3|Follow-Up Period|Lack of Efficacy|0
5221533|NCT00950599|18024028|P2|Follow-Up Period|Lack of Efficacy|0
5221534|NCT00950599|18024029|P1|Follow-Up Period|Lack of Efficacy|0
5221535|NCT00950599|18024020|P10|Follow-Up Period|Adverse Event|0
5221536|NCT00950599|18024021|P9|Follow-Up Period|Adverse Event|1
5221537|NCT00950599|18024022|P8|Follow-Up Period|Adverse Event|0
5221538|NCT00950599|18024023|P7|Follow-Up Period|Adverse Event|0
5221539|NCT00950599|18024024|P6|Follow-Up Period|Adverse Event|0
5221540|NCT00950599|18024025|P5|Follow-Up Period|Adverse Event|0
5221541|NCT00950599|18024026|P4|Follow-Up Period|Adverse Event|0
5221542|NCT00950599|18024027|P3|Follow-Up Period|Adverse Event|0
5221543|NCT00950599|18024028|P2|Follow-Up Period|Adverse Event|0
5221544|NCT00950599|18024029|P1|Follow-Up Period|Adverse Event|0
5221545|NCT00950599|18024020|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
5221546|NCT00950599|18024021|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
5221547|NCT00950599|18024022|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
5221548|NCT00950599|18024023|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
5221549|NCT00950599|18024024|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
5221550|NCT00950599|18024025|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
5221551|NCT00950599|18024026|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
5221552|NCT00950599|18024027|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
5221553|NCT00950599|18024028|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
5221554|NCT00950599|18024029|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
5221555|NCT00950599|18024020|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221556|NCT00950599|18024021|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221557|NCT00950599|18024022|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221558|NCT00950599|18024023|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221559|NCT00950599|18024024|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
5221560|NCT00950599|18024025|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
5221561|NCT00950599|18024026|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221562|NCT00950599|18024027|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221563|NCT00950599|18024028|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221564|NCT00950599|18024029|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5221565|NCT00950599|18024020|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
5221566|NCT00950599|18024021|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
5221567|NCT00950599|18024022|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
5221568|NCT00950599|18024023|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
5221569|NCT00950599|18024024|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
5221570|NCT00950599|18024025|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
5221571|NCT00950599|18024026|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
5221572|NCT00950599|18024027|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
5221573|NCT00950599|18024028|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
5221574|NCT00950599|18024029|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
5221575|NCT00950599|18024020|P10|Double-Blind Treatment Period|Lost to Follow-up|0
5221576|NCT00950599|18024021|P9|Double-Blind Treatment Period|Lost to Follow-up|0
5221577|NCT00950599|18024022|P8|Double-Blind Treatment Period|Lost to Follow-up|1
5221578|NCT00950599|18024023|P7|Double-Blind Treatment Period|Lost to Follow-up|0
5221579|NCT00950599|18024024|P6|Double-Blind Treatment Period|Lost to Follow-up|2
5221580|NCT00950599|18024025|P5|Double-Blind Treatment Period|Lost to Follow-up|1
5221581|NCT00950599|18024026|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5221582|NCT00950599|18024027|P3|Double-Blind Treatment Period|Lost to Follow-up|0
5221583|NCT00950599|18024028|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5221584|NCT00950599|18024029|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5221585|NCT00950599|18024020|P10|Double-Blind Treatment Period|Lack of Efficacy|0
5221586|NCT00950599|18024021|P9|Double-Blind Treatment Period|Lack of Efficacy|0
5221587|NCT00950599|18024022|P8|Double-Blind Treatment Period|Lack of Efficacy|1
5221588|NCT00950599|18024023|P7|Double-Blind Treatment Period|Lack of Efficacy|0
5221589|NCT00950599|18024024|P6|Double-Blind Treatment Period|Lack of Efficacy|6
5221590|NCT00950599|18024025|P5|Double-Blind Treatment Period|Lack of Efficacy|3
5221591|NCT00950599|18024026|P4|Double-Blind Treatment Period|Lack of Efficacy|7
5221592|NCT00950599|18024027|P3|Double-Blind Treatment Period|Lack of Efficacy|5
5221593|NCT00950599|18024028|P2|Double-Blind Treatment Period|Lack of Efficacy|5
5221594|NCT00950599|18024029|P1|Double-Blind Treatment Period|Lack of Efficacy|2
5221595|NCT00950599|18024020|P10|Double-Blind Treatment Period|Adverse Event|0
5221596|NCT00950599|18024021|P9|Double-Blind Treatment Period|Adverse Event|0
5221597|NCT00950599|18024022|P8|Double-Blind Treatment Period|Adverse Event|0
5221598|NCT00950599|18024023|P7|Double-Blind Treatment Period|Adverse Event|0
5221599|NCT00950599|18024024|P6|Double-Blind Treatment Period|Adverse Event|1
5221600|NCT00950599|18024025|P5|Double-Blind Treatment Period|Adverse Event|1
5221601|NCT00950599|18024026|P4|Double-Blind Treatment Period|Adverse Event|1
5221602|NCT00950599|18024027|P3|Double-Blind Treatment Period|Adverse Event|1
5221603|NCT00950599|18024028|P2|Double-Blind Treatment Period|Adverse Event|1
5221604|NCT00950599|18024029|P1|Double-Blind Treatment Period|Adverse Event|0
5221605|NCT00950599|18024020|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221606|NCT00950599|18024021|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221607|NCT00950599|18024022|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221608|NCT00950599|18024023|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221609|NCT00950599|18024024|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221610|NCT00950599|18024025|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221611|NCT00950599|18024026|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
5221612|NCT00950599|18024027|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221613|NCT00950599|18024028|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221614|NCT00950599|18024029|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
5221615|NCT00950300|18024615|P2|SFU Period|Withdrawal by Subject|8
5221616|NCT00950300|18024616|P1|SFU Period|Withdrawal by Subject|4
5221617|NCT00950300|18024615|P2|SFU Period|Lost to Follow-up|28
5221618|NCT00950300|18024616|P1|SFU Period|Lost to Follow-up|30
5221619|NCT00950300|18024615|P2|SFU Period|Death|42
5221620|NCT00950300|18024616|P1|SFU Period|Death|44
5221621|NCT00950300|18024615|P2|TFFU Period|Other|3
5221622|NCT00950300|18024616|P1|TFFU Period|Other|4
5221623|NCT00950300|18024615|P2|TFFU Period|Recurrence of Disease|72
5221624|NCT00950300|18024616|P1|TFFU Period|Recurrence of Disease|63
5221625|NCT00950300|18024615|P2|TFFU Period|Failure to Return|16
5221626|NCT00950300|18024616|P1|TFFU Period|Failure to Return|16
5221627|NCT00950300|18024615|P2|TFFU Period|Refused Treatment|11
5221628|NCT00950300|18024616|P1|TFFU Period|Refused Treatment|10
5221629|NCT00950300|18024615|P2|TFFU Period|Death|1
5221630|NCT00950300|18024616|P1|TFFU Period|Death|4
5221631|NCT00950300|18024615|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
5221632|NCT00950300|18024616|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
5221633|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
5221634|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
5221635|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
5221636|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
5221637|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
5221638|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
5221639|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
5221640|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
5221641|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
5221642|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
5221643|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
5221644|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
5221645|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
5221646|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
5221647|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
5221648|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
5221649|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
5221650|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
5221651|NCT00950300|18024615|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
5221652|NCT00950300|18024616|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
5221653|NCT00950248|18024665|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
5221654|NCT00950248|18024666|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
5221655|NCT00950248|18024667|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
5221656|NCT00950248|18024665|P3|Year 2&3 Treatment Randomization|Death|1
5221657|NCT00950248|18024666|P2|Year 2&3 Treatment Randomization|Death|0
5221658|NCT00950248|18024667|P1|Year 2&3 Treatment Randomization|Death|0
5221659|NCT00950248|18024665|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
5221660|NCT00950248|18024666|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
5221661|NCT00950248|18024667|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
5221662|NCT00950248|18024665|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
5221663|NCT00950248|18024666|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
5221664|NCT00950248|18024667|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
5221665|NCT00950248|18024665|P3|Year 1: Baseline|worsening of symptoms|0
5221666|NCT00950248|18024666|P2|Year 1: Baseline|worsening of symptoms|0
5221667|NCT00950248|18024667|P1|Year 1: Baseline|worsening of symptoms|2
5221668|NCT00950248|18024665|P3|Year 1: Baseline|Withdrawal by Subject|0
5221669|NCT00950248|18024666|P2|Year 1: Baseline|Withdrawal by Subject|0
5221670|NCT00950248|18024667|P1|Year 1: Baseline|Withdrawal by Subject|6
5221671|NCT00950170|18024707|P1|Overall Study|Discontinuation of Study by Sponsor|1
5221672|NCT00950170|18024707|P1|Overall Study|Adverse Event|2
5221673|NCT00950170|18024707|P1|Overall Study|Parent/Legal Guardian Request|1
5221674|NCT00949988|18024758|P1|Overall Study|Withdrawal by Subject|3
5221675|NCT00949975|18024773|P4|Overall Study|Other|0
5221676|NCT00949975|18024774|P3|Overall Study|Other|0
5221677|NCT00949975|18024775|P2|Overall Study|Other|0
5221678|NCT00949975|18024776|P1|Overall Study|Other|1
5221679|NCT00949975|18024773|P4|Overall Study|Lost to Follow-up|3
5221680|NCT00949975|18024774|P3|Overall Study|Lost to Follow-up|1
5221681|NCT00949975|18024775|P2|Overall Study|Lost to Follow-up|0
5221682|NCT00949975|18024776|P1|Overall Study|Lost to Follow-up|1
5221683|NCT00949975|18024773|P4|Overall Study|Severe non-compliance|2
5221684|NCT00949975|18024774|P3|Overall Study|Severe non-compliance|0
5221685|NCT00949975|18024775|P2|Overall Study|Severe non-compliance|1
5221686|NCT00949975|18024776|P1|Overall Study|Severe non-compliance|3
5221687|NCT00949975|18024773|P4|Overall Study|Incorrect enrolment|7
5221688|NCT00949975|18024774|P3|Overall Study|Incorrect enrolment|4
5221689|NCT00949975|18024775|P2|Overall Study|Incorrect enrolment|10
5221690|NCT00949975|18024776|P1|Overall Study|Incorrect enrolment|5
5221691|NCT00949975|18024773|P4|Overall Study|Study-specific criteria|0
5221692|NCT00949975|18024774|P3|Overall Study|Study-specific criteria|1
5221693|NCT00949975|18024775|P2|Overall Study|Study-specific criteria|1
5221694|NCT00949975|18024776|P1|Overall Study|Study-specific criteria|0
5221695|NCT00949975|18024773|P4|Overall Study|Safety reason|0
5221696|NCT00949975|18024774|P3|Overall Study|Safety reason|0
5221697|NCT00949975|18024775|P2|Overall Study|Safety reason|1
5221698|NCT00949975|18024776|P1|Overall Study|Safety reason|0
5221699|NCT00949975|18024773|P4|Overall Study|Adverse Event|10
5221700|NCT00949975|18024774|P3|Overall Study|Adverse Event|10
5221701|NCT00949975|18024775|P2|Overall Study|Adverse Event|11
5221702|NCT00949975|18024776|P1|Overall Study|Adverse Event|11
5221703|NCT00949975|18024773|P4|Overall Study|Voluntary discontinuation|6
5221704|NCT00949975|18024774|P3|Overall Study|Voluntary discontinuation|3
5221705|NCT00949975|18024775|P2|Overall Study|Voluntary discontinuation|5
5221706|NCT00949975|18024776|P1|Overall Study|Voluntary discontinuation|6
5221707|NCT00949910|18024894|P1|Overall Study|No Data|9
5221708|NCT00949910|18024894|P1|Overall Study|Other|4
5221709|NCT00949910|18024894|P1|Overall Study|Physician/Participant Decision|7
5221710|NCT00949910|18024894|P1|Overall Study|Serious Adverse Event|6
5221711|NCT00949910|18024894|P1|Overall Study|Adverse Event|83
5221712|NCT00949910|18024894|P1|Overall Study|Prolonged Dosing Interruption|4
5221713|NCT00949910|18024894|P1|Overall Study|Non-Compliance|10
5221714|NCT00949910|18024894|P1|Overall Study|Logistical Reasons|13
5221715|NCT00949910|18024894|P1|Overall Study|Violation of Eligibility|23
5221716|NCT00949910|18024894|P1|Overall Study|Switched to Commercial Treatment|4
5221717|NCT00949910|18024894|P1|Overall Study|Switched to Compassionate/Other Use|174
5221718|NCT00949910|18024894|P1|Overall Study|Unspecified Progression/Deterioration|13
5221719|NCT00949910|18024894|P1|Overall Study|Death from Unknown Cause|5
5221720|NCT00949910|18024894|P1|Overall Study|Death Due to Toxicity|3
5221721|NCT00949910|18024894|P1|Overall Study|Death Due to Adverse Event|115
5221722|NCT00949910|18024894|P1|Overall Study|Death Due to Progression/Deterioration|4
5221723|NCT00949910|18024894|P1|Overall Study|Death Due to Malignant Disease|456
5221724|NCT00949910|18024894|P1|Overall Study|Participant Refusal|390
5221725|NCT00949910|18024894|P1|Overall Study|Study Drug-Related Adverse Event|315
5221726|NCT00949910|18024894|P1|Overall Study|Lost to Follow-up|100
5221727|NCT00949910|18024894|P1|Overall Study|Symptomatic Deterioration|1088
5221728|NCT00949910|18024894|P1|Overall Study|Progressive Disease|3750
5221729|NCT00949884|18024907|P3|Overall Study|Study terminated by sponsor|1
5221730|NCT00949884|18024908|P2|Overall Study|Study terminated by sponsor|0
5221731|NCT00949884|18024909|P1|Overall Study|Study terminated by sponsor|0
5221732|NCT00949884|18024907|P3|Overall Study|Lack of Efficacy|7
5221733|NCT00949884|18024908|P2|Overall Study|Lack of Efficacy|2
5221734|NCT00949884|18024909|P1|Overall Study|Lack of Efficacy|4
5221735|NCT00949884|18024907|P3|Overall Study|Withdrawal by Subject|16
5221736|NCT00949884|18024908|P2|Overall Study|Withdrawal by Subject|4
5221737|NCT00949884|18024909|P1|Overall Study|Withdrawal by Subject|13
5221738|NCT00949884|18024907|P3|Overall Study|Treatment non-compliance|8
5221739|NCT00949884|18024908|P2|Overall Study|Treatment non-compliance|0
5221740|NCT00949884|18024909|P1|Overall Study|Treatment non-compliance|5
5221741|NCT00949884|18024907|P3|Overall Study|Physician Decision|6
5221742|NCT00949884|18024908|P2|Overall Study|Physician Decision|0
5221743|NCT00949884|18024909|P1|Overall Study|Physician Decision|5
5221744|NCT00949884|18024907|P3|Overall Study|Lost to Follow-up|5
5221745|NCT00949884|18024908|P2|Overall Study|Lost to Follow-up|5
5221746|NCT00949884|18024909|P1|Overall Study|Lost to Follow-up|7
5221747|NCT00949884|18024907|P3|Overall Study|Did not meet inclusion/exclusion|3
5221748|NCT00949884|18024908|P2|Overall Study|Did not meet inclusion/exclusion|1
5221749|NCT00949884|18024909|P1|Overall Study|Did not meet inclusion/exclusion|2
5221750|NCT00949884|18024907|P3|Overall Study|Adverse Event|12
5221751|NCT00949884|18024908|P2|Overall Study|Adverse Event|3
5221752|NCT00949884|18024909|P1|Overall Study|Adverse Event|14
5221753|NCT00949715|18024964|P2|Overall Study|Missing 24 month LVEF measurement|0
5221754|NCT00949715|18024965|P1|Overall Study|Missing 24 month LVEF measurement|2
5221755|NCT00949715|18024964|P2|Overall Study|Lost to Follow-up|0
5221756|NCT00949715|18024965|P1|Overall Study|Lost to Follow-up|1
5221757|NCT00949715|18024964|P2|Overall Study|Physician Decision|0
5221758|NCT00949715|18024965|P1|Overall Study|Physician Decision|1
5221759|NCT00949702|18024976|P1|Overall Study|Withdrawal of consent|1
5221760|NCT00949702|18024976|P1|Overall Study|Disease progression|7
5221761|NCT00949702|18024976|P1|Overall Study|Death|40
5221762|NCT00949650|18024993|P2|Overall Study|Other not specified above|0
5221763|NCT00949650|18024994|P1|Overall Study|Other not specified above|5
5221764|NCT00949650|18024993|P2|Overall Study|Not treated|4
5221765|NCT00949650|18024994|P1|Overall Study|Not treated|1
5221766|NCT00949650|18024993|P2|Overall Study|Refusal to continue medication|11
5221767|NCT00949650|18024994|P1|Overall Study|Refusal to continue medication|7
5221768|NCT00949650|18024993|P2|Overall Study|Protocol Violation|4
5221769|NCT00949650|18024994|P1|Overall Study|Protocol Violation|1
5221770|NCT00949650|18024993|P2|Overall Study|Other Adverse Event (AE)|17
5221771|NCT00949650|18024994|P1|Overall Study|Other Adverse Event (AE)|28
5221772|NCT00949650|18024993|P2|Overall Study|Completed 6 courses of chemotherapy|60
5221773|NCT00949650|18024994|P1|Overall Study|Completed 6 courses of chemotherapy|0
5221774|NCT00949650|18024993|P2|Overall Study|Progressive disease|19
5221775|NCT00949650|18024994|P1|Overall Study|Progressive disease|188
5221776|NCT00949533|18025032|P2|Overall Study|Lost to Follow-up|1
5221777|NCT00949533|18025033|P1|Overall Study|Lost to Follow-up|0
5221778|NCT00949325|18025049|P3|Overall Study|Adverse Event|0
5221779|NCT00949325|18025050|P2|Overall Study|Adverse Event|2
5221780|NCT00949325|18025051|P1|Overall Study|Adverse Event|0
5221781|NCT00949117|18025075|P2|Overall Study|Adverse Event|1
5221782|NCT00949117|18025076|P1|Overall Study|Adverse Event|0
5221783|NCT00949117|18025075|P2|Overall Study|Protocol Violation|1
5221784|NCT00949117|18025076|P1|Overall Study|Protocol Violation|1
5221785|NCT00949117|18025075|P2|Overall Study|Lack of Efficacy|3
5221786|NCT00949117|18025076|P1|Overall Study|Lack of Efficacy|2
5221787|NCT00948974|18025117|P2|Overall Study|Lost to Follow-up|20
5221788|NCT00948974|18025118|P1|Overall Study|Lost to Follow-up|23
5221789|NCT00948922|18025136|P3|Overall Study|Not evaluable at time of analysis|0
5221790|NCT00948922|18025137|P2|Overall Study|Not evaluable at time of analysis|3
5221791|NCT00948922|18025138|P1|Overall Study|Not evaluable at time of analysis|0
5221792|NCT00948922|18025136|P3|Overall Study|Transplant eligibility issues|0
5221793|NCT00948922|18025137|P2|Overall Study|Transplant eligibility issues|3
5221794|NCT00948922|18025138|P1|Overall Study|Transplant eligibility issues|2
5221795|NCT00948922|18025136|P3|Overall Study|Insurance issues|0
5221796|NCT00948922|18025137|P2|Overall Study|Insurance issues|0
5221797|NCT00948922|18025138|P1|Overall Study|Insurance issues|1
5221798|NCT00948922|18025136|P3|Overall Study|Disease progression|0
5221799|NCT00948922|18025137|P2|Overall Study|Disease progression|1
5221800|NCT00948922|18025138|P1|Overall Study|Disease progression|0
5221801|NCT00948922|18025136|P3|Overall Study|Death|0
5221802|NCT00948922|18025137|P2|Overall Study|Death|0
5221803|NCT00948922|18025138|P1|Overall Study|Death|3
5221804|NCT00948922|18025136|P3|Overall Study|Withdrawal by Subject|1
5221805|NCT00948922|18025137|P2|Overall Study|Withdrawal by Subject|2
5221806|NCT00948922|18025138|P1|Overall Study|Withdrawal by Subject|0
5221807|NCT00948922|18025136|P3|Overall Study|Did not start study treatment|0
5221808|NCT00948922|18025137|P2|Overall Study|Did not start study treatment|5
5221809|NCT00948922|18025138|P1|Overall Study|Did not start study treatment|2
5221810|NCT00948896|18025161|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221811|NCT00948896|18025162|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221812|NCT00948896|18025163|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221813|NCT00948896|18025164|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221814|NCT00948896|18025165|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
5221815|NCT00948896|18025166|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221816|NCT00948896|18025167|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221817|NCT00948896|18025168|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5221818|NCT00948896|18025161|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
5221819|NCT00948896|18025162|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
5221820|NCT00948896|18025163|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
5221821|NCT00948896|18025164|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
5221822|NCT00948896|18025165|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
5221823|NCT00948896|18025166|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
5221824|NCT00948896|18025167|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
5221825|NCT00948896|18025168|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
5221826|NCT00948896|18025161|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5221827|NCT00948896|18025162|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5221828|NCT00948896|18025163|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5221829|NCT00948896|18025164|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
5221830|NCT00948896|18025165|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5221831|NCT00948896|18025166|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
5221832|NCT00948896|18025167|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5221833|NCT00948896|18025168|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
5221834|NCT00948896|18025161|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5221835|NCT00948896|18025162|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5221836|NCT00948896|18025163|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5221837|NCT00948896|18025164|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5221838|NCT00948896|18025165|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5221839|NCT00948896|18025166|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5221840|NCT00948896|18025167|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5221841|NCT00948896|18025168|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5221842|NCT00948896|18025161|P8|24 Months of Age to 36 Months of Age|Death|0
5221843|NCT00948896|18025162|P7|24 Months of Age to 36 Months of Age|Death|0
5221844|NCT00948896|18025163|P6|24 Months of Age to 36 Months of Age|Death|1
5221845|NCT00948896|18025164|P5|24 Months of Age to 36 Months of Age|Death|0
5221846|NCT00948896|18025165|P4|24 Months of Age to 36 Months of Age|Death|0
5221847|NCT00948896|18025166|P3|24 Months of Age to 36 Months of Age|Death|2
5221848|NCT00948896|18025167|P2|24 Months of Age to 36 Months of Age|Death|2
5221849|NCT00948896|18025168|P1|24 Months of Age to 36 Months of Age|Death|0
5221850|NCT00948896|18025161|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
5221851|NCT00948896|18025162|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
5221852|NCT00948896|18025163|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
5221853|NCT00948896|18025164|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
5221854|NCT00948896|18025165|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
5221855|NCT00948896|18025166|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
5221856|NCT00948896|18025167|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
5221857|NCT00948896|18025168|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
5221858|NCT00948896|18025161|P8|Randomization to 24 Months of Age|Protocol Violation|1
5221859|NCT00948896|18025162|P7|Randomization to 24 Months of Age|Protocol Violation|1
5221860|NCT00948896|18025163|P6|Randomization to 24 Months of Age|Protocol Violation|0
5221861|NCT00948896|18025164|P5|Randomization to 24 Months of Age|Protocol Violation|0
5221862|NCT00948896|18025165|P4|Randomization to 24 Months of Age|Protocol Violation|1
5221863|NCT00948896|18025166|P3|Randomization to 24 Months of Age|Protocol Violation|0
5221864|NCT00948896|18025167|P2|Randomization to 24 Months of Age|Protocol Violation|1
5221865|NCT00948896|18025168|P1|Randomization to 24 Months of Age|Protocol Violation|0
5221866|NCT00948896|18025161|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
5221867|NCT00948896|18025162|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
5221868|NCT00948896|18025163|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
5221869|NCT00948896|18025164|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
5221870|NCT00948896|18025165|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
5221871|NCT00948896|18025166|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
5221872|NCT00948896|18025167|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
5221873|NCT00948896|18025168|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
5221874|NCT00948896|18025161|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
5221875|NCT00948896|18025162|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
5221876|NCT00948896|18025163|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
5221877|NCT00948896|18025164|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
5221878|NCT00948896|18025165|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
5221879|NCT00948896|18025166|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
5221880|NCT00948896|18025167|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
5221881|NCT00948896|18025168|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
5221882|NCT00948896|18025161|P8|Randomization to 24 Months of Age|Death|1
5221883|NCT00948896|18025162|P7|Randomization to 24 Months of Age|Death|2
5221884|NCT00948896|18025163|P6|Randomization to 24 Months of Age|Death|1
5221885|NCT00948896|18025164|P5|Randomization to 24 Months of Age|Death|2
5221886|NCT00948896|18025165|P4|Randomization to 24 Months of Age|Death|0
5221887|NCT00948896|18025166|P3|Randomization to 24 Months of Age|Death|0
5221888|NCT00948896|18025167|P2|Randomization to 24 Months of Age|Death|0
5221889|NCT00948896|18025168|P1|Randomization to 24 Months of Age|Death|1
5221890|NCT00948857|18025204|P2|Overall Study|Lost to Follow-up|0
5221891|NCT00948857|18025205|P1|Overall Study|Lost to Follow-up|1
5221892|NCT00948818|18025213|P2|Overall Study|Other Reason|5
5221893|NCT00948818|18025214|P1|Overall Study|Other Reason|4
5221894|NCT00948818|18025213|P2|Overall Study|Lack of Efficacy|5
5221895|NCT00948818|18025214|P1|Overall Study|Lack of Efficacy|4
5221896|NCT00948818|18025213|P2|Overall Study|Lost to Follow-up|17
5221897|NCT00948818|18025214|P1|Overall Study|Lost to Follow-up|10
5221898|NCT00948818|18025213|P2|Overall Study|Withdrawal by Subject|25
5221899|NCT00948818|18025214|P1|Overall Study|Withdrawal by Subject|25
5221900|NCT00948818|18025213|P2|Overall Study|Protocol Violation|10
5221901|NCT00948818|18025214|P1|Overall Study|Protocol Violation|9
5221902|NCT00948818|18025213|P2|Overall Study|Adverse Event|32
5221903|NCT00948818|18025214|P1|Overall Study|Adverse Event|10
5221904|NCT00948766|18025261|P2|Extension Study|Death|0
5221905|NCT00948766|18025262|P1|Extension Study|Death|4
5221906|NCT00948766|18025261|P2|Extension Study|Administrative Problems|0
5221907|NCT00948766|18025262|P1|Extension Study|Administrative Problems|1
5221908|NCT00948766|18025261|P2|Extension Study|Lost to Follow-up|0
5221909|NCT00948766|18025262|P1|Extension Study|Lost to Follow-up|8
5221910|NCT00948766|18025261|P2|Extension Study|Patient Withdrew Consent|0
5221911|NCT00948766|18025262|P1|Extension Study|Patient Withdrew Consent|32
5221912|NCT00948766|18025261|P2|Extension Study|Study Drug No Longer Required|0
5221913|NCT00948766|18025262|P1|Extension Study|Study Drug No Longer Required|1
5221914|NCT00948766|18025261|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
5221915|NCT00948766|18025262|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
5221916|NCT00948766|18025261|P2|Extension Study|Adverse Event|0
5221917|NCT00948766|18025262|P1|Extension Study|Adverse Event|43
5221918|NCT00948766|18025261|P2|Core Study|Protocol Deviation|10
5221919|NCT00948766|18025262|P1|Core Study|Protocol Deviation|8
5221920|NCT00948766|18025261|P2|Core Study|Death|1
5221921|NCT00948766|18025262|P1|Core Study|Death|1
5221922|NCT00948766|18025261|P2|Core Study|Administrative Problems|2
5221923|NCT00948766|18025262|P1|Core Study|Administrative Problems|2
5221924|NCT00948766|18025261|P2|Core Study|Lost to Follow-up|2
5221925|NCT00948766|18025262|P1|Core Study|Lost to Follow-up|3
5221926|NCT00948766|18025261|P2|Core Study|Patient Withdrew Consent|46
5221927|NCT00948766|18025262|P1|Core Study|Patient Withdrew Consent|27
5221928|NCT00948766|18025261|P2|Core Study|Unsatisfactory Therapeutic Effect|14
5221929|NCT00948766|18025262|P1|Core Study|Unsatisfactory Therapeutic Effect|13
5221930|NCT00948766|18025261|P2|Core Study|Adverse Event|51
5221931|NCT00948766|18025262|P1|Core Study|Adverse Event|73
5221932|NCT00948688|18025278|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
5221933|NCT00948688|18025279|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
5221934|NCT00948688|18025278|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
5221935|NCT00948688|18025279|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
5221936|NCT00948688|18025278|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
5221937|NCT00948688|18025279|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
5221938|NCT00948675|18025293|P2|Overall Study|Treatment ongoing|4
5221939|NCT00948675|18025294|P1|Overall Study|Treatment ongoing|5
5221940|NCT00948675|18025293|P2|Overall Study|Lost to Follow-up|0
5221941|NCT00948675|18025294|P1|Overall Study|Lost to Follow-up|2
5221942|NCT00948506|18025321|P2|Overall Study|Withdrawal by Subject|1
5221943|NCT00948506|18025322|P1|Overall Study|Withdrawal by Subject|3
5221944|NCT00948441|18025333|P2|Overall Study|no longer meet inclusion criteria|4
5221945|NCT00948441|18025334|P1|Overall Study|no longer meet inclusion criteria|1
5221946|NCT00948428|18025345|P3|Overall Study|Non-compliance|0
5221947|NCT00948428|18025346|P2|Overall Study|Non-compliance|2
5221948|NCT00948428|18025347|P1|Overall Study|Non-compliance|1
5221949|NCT00948428|18025345|P3|Overall Study|Intercurrent Illness|0
5221950|NCT00948428|18025346|P2|Overall Study|Intercurrent Illness|0
5221951|NCT00948428|18025347|P1|Overall Study|Intercurrent Illness|1
5221952|NCT00948428|18025345|P3|Overall Study|Death|0
5221953|NCT00948428|18025346|P2|Overall Study|Death|0
5221954|NCT00948428|18025347|P1|Overall Study|Death|2
5221955|NCT00948428|18025345|P3|Overall Study|Lost to Follow-up|1
5221956|NCT00948428|18025346|P2|Overall Study|Lost to Follow-up|1
5221957|NCT00948428|18025347|P1|Overall Study|Lost to Follow-up|2
5221958|NCT00948428|18025345|P3|Overall Study|Adverse Event|0
5221959|NCT00948428|18025346|P2|Overall Study|Adverse Event|3
5221960|NCT00948428|18025347|P1|Overall Study|Adverse Event|6
5221961|NCT00948428|18025345|P3|Overall Study|Withdrawal by Subject|7
5221962|NCT00948428|18025346|P2|Overall Study|Withdrawal by Subject|12
5221963|NCT00948428|18025347|P1|Overall Study|Withdrawal by Subject|6
5221964|NCT00948389|18025366|P5|Overall Study|Both Progression and Toxicity|0
5221965|NCT00948389|18025367|P4|Overall Study|Both Progression and Toxicity|0
5221966|NCT00948389|18025368|P3|Overall Study|Both Progression and Toxicity|0
5221967|NCT00948389|18025369|P2|Overall Study|Both Progression and Toxicity|0
5221968|NCT00948389|18025370|P1|Overall Study|Both Progression and Toxicity|1
5221969|NCT00948389|18025366|P5|Overall Study|Thrombocytopenia, Grade 4|0
5221970|NCT00948389|18025367|P4|Overall Study|Thrombocytopenia, Grade 4|1
5221971|NCT00948389|18025368|P3|Overall Study|Thrombocytopenia, Grade 4|0
5221972|NCT00948389|18025369|P2|Overall Study|Thrombocytopenia, Grade 4|0
5221973|NCT00948389|18025370|P1|Overall Study|Thrombocytopenia, Grade 4|2
5221974|NCT00948389|18025366|P5|Overall Study|Disease Progression/Relapse/Death|1
5221975|NCT00948389|18025367|P4|Overall Study|Disease Progression/Relapse/Death|8
5221976|NCT00948389|18025368|P3|Overall Study|Disease Progression/Relapse/Death|7
5221977|NCT00948389|18025369|P2|Overall Study|Disease Progression/Relapse/Death|3
5221978|NCT00948389|18025370|P1|Overall Study|Disease Progression/Relapse/Death|3
5221979|NCT00948246|18025418|P1|Overall Study|Withdrawal by Subject|1
5221980|NCT00948246|18025418|P1|Overall Study|Death|1
5221981|NCT00948246|18025418|P1|Overall Study|Adverse Event|11
5221982|NCT00948246|18025418|P1|Overall Study|Lost to Follow-up|11
5221983|NCT00948155|18025427|P2|Washout 14 Days|Lost to Follow-up|2
5221984|NCT00948155|18025428|P1|Washout 14 Days|Lost to Follow-up|1
5221985|NCT00948155|18025427|P2|First Intervention 21 Days|Lost to Follow-up|2
5221986|NCT00948155|18025428|P1|First Intervention 21 Days|Lost to Follow-up|2
5221987|NCT00948064|18025475|P3|Phase II|Withdrawal by Subject|0
5221988|NCT00948064|18025476|P2|Phase II|Withdrawal by Subject|1
5221989|NCT00948064|18025477|P1|Phase II|Withdrawal by Subject|0
5221990|NCT00948064|18025475|P3|Phase II|Physician Decision|1
5221991|NCT00948064|18025476|P2|Phase II|Physician Decision|0
5221992|NCT00948064|18025477|P1|Phase II|Physician Decision|0
5221993|NCT00948064|18025475|P3|Phase I|No treatment received|0
5221994|NCT00948064|18025476|P2|Phase I|No treatment received|0
5221995|NCT00948064|18025477|P1|Phase I|No treatment received|1
5221996|NCT00947882|18025492|P4|Overall Study|Trial Terminated by Sponsor|70
5221997|NCT00947882|18025493|P3|Overall Study|Trial Terminated by Sponsor|62
5221998|NCT00947882|18025494|P2|Overall Study|Trial Terminated by Sponsor|61
5221999|NCT00947882|18025495|P1|Overall Study|Trial Terminated by Sponsor|62
5222000|NCT00947882|18025492|P4|Overall Study|Other/Unknown|6
5222001|NCT00947882|18025493|P3|Overall Study|Other/Unknown|3
5222002|NCT00947882|18025494|P2|Overall Study|Other/Unknown|13
5222003|NCT00947882|18025495|P1|Overall Study|Other/Unknown|10
5222004|NCT00947882|18025492|P4|Overall Study|Lost to Follow-up|0
5222005|NCT00947882|18025493|P3|Overall Study|Lost to Follow-up|1
5222006|NCT00947882|18025494|P2|Overall Study|Lost to Follow-up|2
5222007|NCT00947882|18025495|P1|Overall Study|Lost to Follow-up|0
5222008|NCT00947882|18025492|P4|Overall Study|Protocol Violation|0
5222009|NCT00947882|18025493|P3|Overall Study|Protocol Violation|1
5222010|NCT00947882|18025494|P2|Overall Study|Protocol Violation|0
5222011|NCT00947882|18025495|P1|Overall Study|Protocol Violation|0
5222012|NCT00947882|18025492|P4|Overall Study|Withdrawal by Subject|2
5222013|NCT00947882|18025493|P3|Overall Study|Withdrawal by Subject|8
5222014|NCT00947882|18025494|P2|Overall Study|Withdrawal by Subject|0
5222015|NCT00947882|18025495|P1|Overall Study|Withdrawal by Subject|2
5222016|NCT00947882|18025492|P4|Overall Study|Adverse Event|4
5222017|NCT00947882|18025493|P3|Overall Study|Adverse Event|4
5222018|NCT00947882|18025494|P2|Overall Study|Adverse Event|1
5222019|NCT00947882|18025495|P1|Overall Study|Adverse Event|0
5222020|NCT00947856|18025523|P2|Follow-up Period|Withdrawal by Subject|0
5222021|NCT00947856|18025524|P1|Follow-up Period|Withdrawal by Subject|1
5222022|NCT00947856|18025523|P2|Follow-up Period|Patient unavailable for site visits|0
5222023|NCT00947856|18025524|P1|Follow-up Period|Patient unavailable for site visits|1
5222024|NCT00947856|18025523|P2|Follow-up Period|Lost to Follow-up|0
5222025|NCT00947856|18025524|P1|Follow-up Period|Lost to Follow-up|7
5222026|NCT00947856|18025523|P2|Follow-up Period|Re-enrolled for Retreatment|3
5222027|NCT00947856|18025524|P1|Follow-up Period|Re-enrolled for Retreatment|2
5222028|NCT00947856|18025523|P2|Follow-up Period|Study Stopped by Sponsor|20
5222029|NCT00947856|18025524|P1|Follow-up Period|Study Stopped by Sponsor|40
5222030|NCT00947856|18025523|P2|Treatment Period|Withdrawal by Subject|1
5222031|NCT00947856|18025524|P1|Treatment Period|Withdrawal by Subject|12
5222032|NCT00947856|18025523|P2|Treatment Period|Study Stopped by Sponsor|4
5222033|NCT00947856|18025524|P1|Treatment Period|Study Stopped by Sponsor|4
5222034|NCT00947856|18025523|P2|Treatment Period|Physician Decision|6
5222035|NCT00947856|18025524|P1|Treatment Period|Physician Decision|14
5222036|NCT00947856|18025523|P2|Treatment Period|Adverse Event|9
5222037|NCT00947856|18025524|P1|Treatment Period|Adverse Event|15
5222038|NCT00947856|18025523|P2|Treatment Period|Progressive Disease|12
5222039|NCT00947856|18025524|P1|Treatment Period|Progressive Disease|33
5222040|NCT00947544|18025613|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
5222041|NCT00947544|18025614|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
5222042|NCT00947531|18025640|P2|Overall Study|Other|1
5222043|NCT00947531|18025641|P1|Overall Study|Other|1
5222044|NCT00947531|18025640|P2|Overall Study|Lack of Efficacy|0
5222045|NCT00947531|18025641|P1|Overall Study|Lack of Efficacy|1
5222046|NCT00947531|18025640|P2|Overall Study|Adverse Event|2
5222047|NCT00947531|18025641|P1|Overall Study|Adverse Event|2
5222048|NCT00947531|18025640|P2|Overall Study|Administrative Reason|1
5222049|NCT00947531|18025641|P1|Overall Study|Administrative Reason|0
5222050|NCT00947531|18025640|P2|Overall Study|Withdrawal by Subject|7
5222051|NCT00947531|18025641|P1|Overall Study|Withdrawal by Subject|10
5222052|NCT00947427|18025679|P2|Overall Study|Protocol Violation|1
5222053|NCT00947427|18025680|P1|Overall Study|Protocol Violation|0
5222054|NCT00947427|18025679|P2|Overall Study|Withdrawal by Subject|3
5222055|NCT00947427|18025680|P1|Overall Study|Withdrawal by Subject|1
5222056|NCT00947349|18025690|P4|Overall Study Standard of Care|Other|1
5222057|NCT00947349|18025691|P3|Overall Study Standard of Care|Other|0
5222058|NCT00947349|18025692|P2|Overall Study Standard of Care|Other|0
5222059|NCT00947349|18025693|P1|Overall Study Standard of Care|Other|0
5222060|NCT00947349|18025690|P4|Overall Study Standard of Care|Withdrawal by Subject|0
5222061|NCT00947349|18025691|P3|Overall Study Standard of Care|Withdrawal by Subject|1
5222062|NCT00947349|18025692|P2|Overall Study Standard of Care|Withdrawal by Subject|0
5222063|NCT00947349|18025693|P1|Overall Study Standard of Care|Withdrawal by Subject|0
5222064|NCT00947349|18025690|P4|Overall Study Standard of Care|Lack of Efficacy|1
5222065|NCT00947349|18025691|P3|Overall Study Standard of Care|Lack of Efficacy|1
5222066|NCT00947349|18025692|P2|Overall Study Standard of Care|Lack of Efficacy|0
5222067|NCT00947349|18025693|P1|Overall Study Standard of Care|Lack of Efficacy|0
5222068|NCT00947349|18025690|P4|Triple Treatment Combination Period|Adverse Event|0
5222069|NCT00947349|18025691|P3|Triple Treatment Combination Period|Adverse Event|0
5222070|NCT00947349|18025692|P2|Triple Treatment Combination Period|Adverse Event|1
5222071|NCT00947349|18025693|P1|Triple Treatment Combination Period|Adverse Event|0
5222072|NCT00947193|18025902|P2|Overall Study|Factor VIII >1%|0
5222073|NCT00947193|18025903|P1|Overall Study|Factor VIII >1%|1
5222074|NCT00947193|18025902|P2|Overall Study|Withdrawal by Subject|0
5222075|NCT00947193|18025903|P1|Overall Study|Withdrawal by Subject|1
5222076|NCT00947193|18025902|P2|Overall Study|Lost to Follow-up|0
5222077|NCT00947193|18025903|P1|Overall Study|Lost to Follow-up|1
5222078|NCT00947154|18025918|P1|Overall Study|Lost to Follow-up|1
5222079|NCT00947115|18025928|P3|Overall Study|Lost to Follow-up|8
5222080|NCT00947115|18025929|P2|Overall Study|Lost to Follow-up|12
5222081|NCT00947115|18025930|P1|Overall Study|Lost to Follow-up|11
5222082|NCT00947115|18025928|P3|Overall Study|Withdrawal by Subject|4
5222083|NCT00947115|18025929|P2|Overall Study|Withdrawal by Subject|3
5222084|NCT00947115|18025930|P1|Overall Study|Withdrawal by Subject|1
5222085|NCT00947115|18025928|P3|Overall Study|Migrated from study area|0
5222086|NCT00947115|18025929|P2|Overall Study|Migrated from study area|0
5222087|NCT00947115|18025930|P1|Overall Study|Migrated from study area|2
5222088|NCT00947115|18025928|P3|Overall Study|Death|1
5222089|NCT00947115|18025929|P2|Overall Study|Death|1
5222090|NCT00947115|18025930|P1|Overall Study|Death|0
5222091|NCT00947115|18025928|P3|Overall Study|Physician Decision|0
5222092|NCT00947115|18025929|P2|Overall Study|Physician Decision|2
5222093|NCT00947115|18025930|P1|Overall Study|Physician Decision|0
5222094|NCT00947115|18025928|P3|Overall Study|Missed reporting interval|2
5222095|NCT00947115|18025929|P2|Overall Study|Missed reporting interval|4
5222096|NCT00947115|18025930|P1|Overall Study|Missed reporting interval|3
5222097|NCT00947011|18025992|P1|Overall Study|Study was terminated,PI left institution|12
5222098|NCT00946998|18026002|P2|Overall Study|Exited prior to first outcome assessment|3
5222099|NCT00946998|18026003|P1|Overall Study|Exited prior to first outcome assessment|5
5222100|NCT00946985|18026017|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
5222101|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
5222102|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
5222103|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
5222104|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
5222105|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
5222106|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
5222107|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
5222108|NCT00946985|18026017|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
5222109|NCT00946920|18026023|P2|Overall Study|Miscellaneous reasons|3
5222110|NCT00946920|18026024|P1|Overall Study|Miscellaneous reasons|18
5222111|NCT00946920|18026023|P2|Overall Study|Protocol Violation|8
5222112|NCT00946920|18026024|P1|Overall Study|Protocol Violation|16
5222113|NCT00946920|18026023|P2|Overall Study|Adverse Event|14
5222114|NCT00946920|18026024|P1|Overall Study|Adverse Event|41
5222115|NCT00946920|18026023|P2|Overall Study|Physician Decision|2
5222116|NCT00946920|18026024|P1|Overall Study|Physician Decision|5
5222117|NCT00946920|18026023|P2|Overall Study|Lost to Follow-up|2
5222118|NCT00946920|18026024|P1|Overall Study|Lost to Follow-up|2
5222119|NCT00946920|18026023|P2|Overall Study|Withdrawal by Subject|15
5222120|NCT00946920|18026024|P1|Overall Study|Withdrawal by Subject|28
5222121|NCT00946881|18026039|P1|Retreatment|Withdrawal by Subject|1
5222122|NCT00946881|18026039|P1|First Treatment|Patient relocated to another state|1
5222123|NCT00946881|18026039|P1|First Treatment|Withdrawal by Subject|1
5222124|NCT00946712|18026070|P2|Overall Study|Ineligible|6
5222125|NCT00946712|18026071|P1|Overall Study|Ineligible|14
5222126|NCT00946712|18026070|P2|Overall Study|On Treatment|4
5222127|NCT00946712|18026071|P1|Overall Study|On Treatment|0
5222128|NCT00946712|18026070|P2|Overall Study|Other reasons|73
5222129|NCT00946712|18026071|P1|Overall Study|Other reasons|61
5222130|NCT00946712|18026070|P2|Overall Study|No treatment given|29
5222131|NCT00946712|18026071|P1|Overall Study|No treatment given|25
5222132|NCT00946712|18026070|P2|Overall Study|Death|22
5222133|NCT00946712|18026071|P1|Overall Study|Death|21
5222134|NCT00946712|18026070|P2|Overall Study|Disease progression|404
5222135|NCT00946712|18026071|P1|Overall Study|Disease progression|308
5222136|NCT00946712|18026070|P2|Overall Study|Adverse Event|124
5222137|NCT00946712|18026071|P1|Overall Study|Adverse Event|118
5222138|NCT00946647|18026090|P5|Phase ll Part|Subj cond no longer required study drug|0
5222139|NCT00946647|18026091|P4|Phase ll Part|Subj cond no longer required study drug|2
5222140|NCT00946647|18026092|P3|Phase ll Part|Subj cond no longer required study drug|0
5222141|NCT00946647|18026093|P2|Phase ll Part|Subj cond no longer required study drug|0
5222142|NCT00946647|18026094|P1|Phase ll Part|Subj cond no longer required study drug|0
5222143|NCT00946647|18026090|P5|Phase ll Part|Protocol Violation|2
5222144|NCT00946647|18026091|P4|Phase ll Part|Protocol Violation|4
5222145|NCT00946647|18026092|P3|Phase ll Part|Protocol Violation|0
5222146|NCT00946647|18026093|P2|Phase ll Part|Protocol Violation|0
5222147|NCT00946647|18026094|P1|Phase ll Part|Protocol Violation|0
5222148|NCT00946647|18026090|P5|Phase ll Part|Disease progression|14
5222149|NCT00946647|18026091|P4|Phase ll Part|Disease progression|6
5222150|NCT00946647|18026092|P3|Phase ll Part|Disease progression|0
5222151|NCT00946647|18026093|P2|Phase ll Part|Disease progression|0
5222152|NCT00946647|18026094|P1|Phase ll Part|Disease progression|0
5222153|NCT00946647|18026090|P5|Phase ll Part|Death|4
5222154|NCT00946647|18026091|P4|Phase ll Part|Death|7
5222155|NCT00946647|18026092|P3|Phase ll Part|Death|0
5222156|NCT00946647|18026093|P2|Phase ll Part|Death|0
5222157|NCT00946647|18026094|P1|Phase ll Part|Death|0
5222158|NCT00946647|18026090|P5|Phase ll Part|Administrative problems|8
5222159|NCT00946647|18026091|P4|Phase ll Part|Administrative problems|3
5222160|NCT00946647|18026092|P3|Phase ll Part|Administrative problems|0
5222161|NCT00946647|18026093|P2|Phase ll Part|Administrative problems|0
5222162|NCT00946647|18026094|P1|Phase ll Part|Administrative problems|0
5222163|NCT00946647|18026090|P5|Phase ll Part|Withdrawal by Subject|6
5222164|NCT00946647|18026091|P4|Phase ll Part|Withdrawal by Subject|8
5222165|NCT00946647|18026092|P3|Phase ll Part|Withdrawal by Subject|0
5222166|NCT00946647|18026093|P2|Phase ll Part|Withdrawal by Subject|0
5222167|NCT00946647|18026094|P1|Phase ll Part|Withdrawal by Subject|0
5222168|NCT00946647|18026090|P5|Phase ll Part|Adverse Event|6
5222169|NCT00946647|18026091|P4|Phase ll Part|Adverse Event|10
5222170|NCT00946647|18026092|P3|Phase ll Part|Adverse Event|0
5222171|NCT00946647|18026093|P2|Phase ll Part|Adverse Event|0
5222172|NCT00946647|18026094|P1|Phase ll Part|Adverse Event|0
5222173|NCT00946647|18026090|P5|Phase ll Part|Untreated|2
5222174|NCT00946647|18026091|P4|Phase ll Part|Untreated|0
5222175|NCT00946647|18026092|P3|Phase ll Part|Untreated|0
5222176|NCT00946647|18026093|P2|Phase ll Part|Untreated|0
5222177|NCT00946647|18026094|P1|Phase ll Part|Untreated|0
5222178|NCT00946647|18026090|P5|Phase 1 Part|Reason missing|0
5222179|NCT00946647|18026091|P4|Phase 1 Part|Reason missing|0
5222180|NCT00946647|18026092|P3|Phase 1 Part|Reason missing|0
5222181|NCT00946647|18026093|P2|Phase 1 Part|Reason missing|1
5222182|NCT00946647|18026094|P1|Phase 1 Part|Reason missing|0
5222183|NCT00946647|18026090|P5|Phase 1 Part|Abnormal values|0
5222184|NCT00946647|18026091|P4|Phase 1 Part|Abnormal values|0
5222185|NCT00946647|18026092|P3|Phase 1 Part|Abnormal values|0
5222186|NCT00946647|18026093|P2|Phase 1 Part|Abnormal values|2
5222187|NCT00946647|18026094|P1|Phase 1 Part|Abnormal values|0
5222188|NCT00946647|18026090|P5|Phase 1 Part|Withdrawal by Subject|0
5222189|NCT00946647|18026091|P4|Phase 1 Part|Withdrawal by Subject|0
5222190|NCT00946647|18026092|P3|Phase 1 Part|Withdrawal by Subject|3
5222191|NCT00946647|18026093|P2|Phase 1 Part|Withdrawal by Subject|4
5222192|NCT00946647|18026094|P1|Phase 1 Part|Withdrawal by Subject|1
5222193|NCT00946647|18026090|P5|Phase 1 Part|Disease progression|0
5222194|NCT00946647|18026091|P4|Phase 1 Part|Disease progression|0
5222195|NCT00946647|18026092|P3|Phase 1 Part|Disease progression|1
5222196|NCT00946647|18026093|P2|Phase 1 Part|Disease progression|6
5222197|NCT00946647|18026094|P1|Phase 1 Part|Disease progression|3
5222198|NCT00946647|18026090|P5|Phase 1 Part|Adverse Event|0
5222199|NCT00946647|18026091|P4|Phase 1 Part|Adverse Event|0
5222200|NCT00946647|18026092|P3|Phase 1 Part|Adverse Event|3
5222201|NCT00946647|18026093|P2|Phase 1 Part|Adverse Event|5
5222202|NCT00946647|18026094|P1|Phase 1 Part|Adverse Event|2
5222203|NCT00946530|18026128|P4|Overall Study|Physician Decision|1
5222204|NCT00946530|18026129|P3|Overall Study|Physician Decision|1
5222205|NCT00946530|18026130|P2|Overall Study|Physician Decision|1
5222206|NCT00946530|18026131|P1|Overall Study|Physician Decision|1
5222207|NCT00946530|18026128|P4|Overall Study|Withdrawal by Subject|3
5222208|NCT00946530|18026129|P3|Overall Study|Withdrawal by Subject|0
5222209|NCT00946530|18026130|P2|Overall Study|Withdrawal by Subject|3
5222210|NCT00946530|18026131|P1|Overall Study|Withdrawal by Subject|0
5222211|NCT00946322|18026163|P1|Post-treatment|participant failure to follow up|2
5222212|NCT00946322|18026163|P1|Pre-treatment|participant failure to follow up|1
5222213|NCT00946309|18026176|P2|Overall Study|Procedure cancelled/discontinued|3
5222214|NCT00946309|18026177|P1|Overall Study|Procedure cancelled/discontinued|0
5222215|NCT00946309|18026176|P2|Overall Study|Lost to Follow-up|1
5222216|NCT00946309|18026177|P1|Overall Study|Lost to Follow-up|0
5222217|NCT00946309|18026176|P2|Overall Study|Protocol Violation|0
5222218|NCT00946309|18026177|P1|Overall Study|Protocol Violation|1
5222219|NCT00946296|18026195|P2|Overall Study|Physician Decision|0
5222220|NCT00946296|18026196|P1|Overall Study|Physician Decision|3
5222221|NCT00946192|18026218|P3|Overall Study|Did not start medication|0
5222222|NCT00946192|18026219|P2|Overall Study|Did not start medication|0
5222223|NCT00946192|18026220|P1|Overall Study|Did not start medication|2
5222224|NCT00946192|18026218|P3|Overall Study|Withdrawal by Subject|3
5222225|NCT00946192|18026219|P2|Overall Study|Withdrawal by Subject|7
5222226|NCT00946192|18026220|P1|Overall Study|Withdrawal by Subject|10
5222227|NCT00946192|18026218|P3|Overall Study|Lost to Follow-up|9
5222228|NCT00946192|18026219|P2|Overall Study|Lost to Follow-up|11
5222229|NCT00946192|18026220|P1|Overall Study|Lost to Follow-up|6
5222230|NCT00946153|18026236|P5|Phase 2|14 days washout for recovery due to AE|4
5222231|NCT00946153|18026237|P4|Phase 2|14 days washout for recovery due to AE|0
5222232|NCT00946153|18026238|P3|Phase 2|14 days washout for recovery due to AE|0
5222233|NCT00946153|18026239|P2|Phase 2|14 days washout for recovery due to AE|0
5222234|NCT00946153|18026240|P1|Phase 2|14 days washout for recovery due to AE|0
5222235|NCT00946153|18026236|P5|Phase 2|Physician Decision|1
5222236|NCT00946153|18026237|P4|Phase 2|Physician Decision|0
5222237|NCT00946153|18026238|P3|Phase 2|Physician Decision|0
5222238|NCT00946153|18026239|P2|Phase 2|Physician Decision|0
5222239|NCT00946153|18026240|P1|Phase 2|Physician Decision|0
5222240|NCT00946153|18026236|P5|Phase 2|Need more reduction of dose|2
5222241|NCT00946153|18026237|P4|Phase 2|Need more reduction of dose|0
5222242|NCT00946153|18026238|P3|Phase 2|Need more reduction of dose|0
5222243|NCT00946153|18026239|P2|Phase 2|Need more reduction of dose|0
5222244|NCT00946153|18026240|P1|Phase 2|Need more reduction of dose|0
5222245|NCT00946153|18026236|P5|Phase 2|Adverse Event|6
5222246|NCT00946153|18026237|P4|Phase 2|Adverse Event|0
5222247|NCT00946153|18026238|P3|Phase 2|Adverse Event|0
5222248|NCT00946153|18026239|P2|Phase 2|Adverse Event|0
5222249|NCT00946153|18026240|P1|Phase 2|Adverse Event|0
5222250|NCT00946114|18026268|P2|Overall Study|Withdrawal by Subject|0
5222251|NCT00946114|18026269|P1|Overall Study|Withdrawal by Subject|2
5222252|NCT00946114|18026268|P2|Overall Study|Other|0
5222253|NCT00946114|18026269|P1|Overall Study|Other|1
5222254|NCT00946114|18026268|P2|Overall Study|Death|2
5222255|NCT00946114|18026269|P1|Overall Study|Death|5
5222256|NCT00946101|18026277|P2|Overall Study|Physician Decision|1
5222257|NCT00946101|18026278|P1|Overall Study|Physician Decision|0
5222258|NCT00946101|18026277|P2|Overall Study|Withdrawal of consent|0
5222259|NCT00946101|18026278|P1|Overall Study|Withdrawal of consent|2
5222260|NCT00946101|18026277|P2|Overall Study|Lost to Follow-up|1
5222261|NCT00946101|18026278|P1|Overall Study|Lost to Follow-up|2
5222262|NCT00946088|18026344|P2|Overall Study|Withdrawal by Subject|1
5222263|NCT00946088|18026345|P1|Overall Study|Withdrawal by Subject|0
5222264|NCT00945945|18026389|P2|Overall Study|Entry Criteria Not Met|1
5222265|NCT00945945|18026390|P1|Overall Study|Entry Criteria Not Met|0
5222266|NCT00945945|18026389|P2|Overall Study|Protocol Violation|2
5222267|NCT00945945|18026390|P1|Overall Study|Protocol Violation|4
5222268|NCT00945945|18026389|P2|Overall Study|Lack of Efficacy|2
5222269|NCT00945945|18026390|P1|Overall Study|Lack of Efficacy|6
5222270|NCT00945945|18026389|P2|Overall Study|Lost to Follow-up|5
5222271|NCT00945945|18026390|P1|Overall Study|Lost to Follow-up|4
5222272|NCT00945945|18026389|P2|Overall Study|Withdrawal by Subject|10
5222273|NCT00945945|18026390|P1|Overall Study|Withdrawal by Subject|7
5222274|NCT00945945|18026389|P2|Overall Study|Adverse Event|35
5222275|NCT00945945|18026390|P1|Overall Study|Adverse Event|15
5222276|NCT00945906|18026416|P1|Overall Study|Moved to another country|2
5222277|NCT00945906|18026416|P1|Overall Study|Unable to return for last visit|2
5222278|NCT00945906|18026416|P1|Overall Study|Did not want to return for last visit|2
5222279|NCT00945906|18026416|P1|Overall Study|Withdrawal by Subject|1
5222280|NCT00945893|18026427|P2|Overall Study|Withdrawal of consent|2
5222281|NCT00945893|18026428|P1|Overall Study|Withdrawal of consent|1
5222282|NCT00945893|18026427|P2|Overall Study|Lost to Follow-up|8
5222283|NCT00945893|18026428|P1|Overall Study|Lost to Follow-up|2
5222284|NCT00945815|18026505|P1|Overall Study|Did not begin protocol therapy|1
5222285|NCT00945815|18026505|P1|Overall Study|Ineligible|3
5222286|NCT00945815|18026505|P1|Overall Study|Not protocol specified|1
5222287|NCT00945815|18026505|P1|Overall Study|Death|3
5222288|NCT00945659|18026537|P3|Overall Study|Lost to Follow-up|17
5222289|NCT00945659|18026538|P2|Overall Study|Lost to Follow-up|20
5222290|NCT00945659|18026539|P1|Overall Study|Lost to Follow-up|7
5222291|NCT00945555|18026596|P1|Overall Study|Other|1
5222292|NCT00945555|18026596|P1|Overall Study|Death|18
5222293|NCT00945555|18026596|P1|Overall Study|Participant continued treatment at home|1
5222294|NCT00945555|18026596|P1|Overall Study|Withdrawal by Subject|2
5222295|NCT00945555|18026596|P1|Overall Study|Worsening condition, intensive care unit|1
5222296|NCT00945555|18026596|P1|Overall Study|Referred to another hospital|5
5222297|NCT00945477|18026607|P1|Overall Study|Withdrawal by Subject|1
5222298|NCT00945477|18026607|P1|Overall Study|Lack of Efficacy|2
5222299|NCT00945477|18026607|P1|Overall Study|Adverse Event|3
5222300|NCT00945321|18026623|P6|Period 4|Lost to Follow-up|1
5222301|NCT00945321|18026624|P5|Period 4|Lost to Follow-up|0
5222302|NCT00945321|18026625|P4|Period 4|Lost to Follow-up|0
5222303|NCT00945321|18026626|P3|Period 4|Lost to Follow-up|0
5222304|NCT00945321|18026627|P2|Period 4|Lost to Follow-up|0
5222305|NCT00945321|18026628|P1|Period 4|Lost to Follow-up|0
5222306|NCT00945321|18026623|P6|Period 1|Adverse Event|0
5222307|NCT00945321|18026624|P5|Period 1|Adverse Event|1
5222308|NCT00945321|18026625|P4|Period 1|Adverse Event|0
5222309|NCT00945321|18026626|P3|Period 1|Adverse Event|0
5222310|NCT00945321|18026627|P2|Period 1|Adverse Event|0
5222311|NCT00945321|18026628|P1|Period 1|Adverse Event|0
5222312|NCT00945243|18026761|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
5222313|NCT00945191|18026767|P1|Overall Study|Investigator's discretion|1
5222314|NCT00945191|18026767|P1|Overall Study|Serious adverse event or adverse event|1
5222315|NCT00945191|18026767|P1|Overall Study|Disease progression|3
5222316|NCT00945191|18026767|P1|Overall Study|Participant relocated to another state|1
5222317|NCT00945191|18026767|P1|Overall Study|Did not achieve a complete response|18
5222318|NCT00945009|18026963|P3|Overall Study|Refusal of further protocol|0
5222319|NCT00945009|18026964|P2|Overall Study|Refusal of further protocol|0
5222320|NCT00945009|18026965|P1|Overall Study|Refusal of further protocol|1
5222321|NCT00945009|18026963|P3|Overall Study|Inevaluable|0
5222322|NCT00945009|18026964|P2|Overall Study|Inevaluable|1
5222323|NCT00945009|18026965|P1|Overall Study|Inevaluable|0
5222324|NCT00945009|18026963|P3|Overall Study|Ineligible|0
5222325|NCT00945009|18026964|P2|Overall Study|Ineligible|1
5222326|NCT00945009|18026965|P1|Overall Study|Ineligible|6
5222327|NCT00945009|18026963|P3|Overall Study|Withdrawal by Subject|0
5222328|NCT00945009|18026964|P2|Overall Study|Withdrawal by Subject|0
5222329|NCT00945009|18026965|P1|Overall Study|Withdrawal by Subject|1
5222330|NCT00945009|18026963|P3|Overall Study|Protocol Violation|0
5222331|NCT00945009|18026964|P2|Overall Study|Protocol Violation|1
5222332|NCT00945009|18026965|P1|Overall Study|Protocol Violation|6
5222333|NCT00945009|18026963|P3|Overall Study|Physician Decision|3
5222334|NCT00945009|18026964|P2|Overall Study|Physician Decision|4
5222335|NCT00945009|18026965|P1|Overall Study|Physician Decision|21
5222336|NCT00945009|18026963|P3|Overall Study|Lack of Efficacy|0
5222337|NCT00945009|18026964|P2|Overall Study|Lack of Efficacy|0
5222338|NCT00945009|18026965|P1|Overall Study|Lack of Efficacy|10
5222339|NCT00944697|18027041|P2|Overall Study|Administrative|1
5222340|NCT00944697|18027042|P1|Overall Study|Administrative|1
5222341|NCT00944697|18027041|P2|Overall Study|Adverse Event|3
5222342|NCT00944697|18027042|P1|Overall Study|Adverse Event|0
5222343|NCT00944697|18027041|P2|Overall Study|Withdrawal by Subject|1
5222344|NCT00944697|18027042|P1|Overall Study|Withdrawal by Subject|1
5222345|NCT00944658|18027074|P2|Treatment 12 Weeks|Adverse Event|2
5222346|NCT00944658|18027075|P1|Treatment 12 Weeks|Adverse Event|0
5222347|NCT00944645|18027087|P2|Period 2|Withdrawal by Subject|6
5222348|NCT00944645|18027088|P1|Period 2|Withdrawal by Subject|7
5222349|NCT00944645|18027087|P2|Period 2|Lost to Follow-up|3
5222350|NCT00944645|18027088|P1|Period 2|Lost to Follow-up|0
5222351|NCT00944645|18027087|P2|Period 2|Adverse Event|0
5222352|NCT00944645|18027088|P1|Period 2|Adverse Event|1
5222353|NCT00944229|18027135|P1|Overall Study|Physician Decision|14
5222354|NCT00944229|18027135|P1|Overall Study|Withdrawal by Subject|11
5222355|NCT00944125|18027141|P2|6 Months to Study Completion|Withdrawal by Subject|2
5222356|NCT00944125|18027142|P1|6 Months to Study Completion|Withdrawal by Subject|0
5222357|NCT00944125|18027141|P2|3 to 6 Months|Withdrawal by Subject|2
5222358|NCT00944125|18027142|P1|3 to 6 Months|Withdrawal by Subject|0
5222359|NCT00944034|18027245|P12|Overall Study|Administrative reason|0
5222360|NCT00944034|18027246|P11|Overall Study|Administrative reason|0
5222361|NCT00944034|18027247|P10|Overall Study|Administrative reason|0
5222362|NCT00944034|18027248|P9|Overall Study|Administrative reason|0
5222363|NCT00944034|18027249|P8|Overall Study|Administrative reason|0
5222364|NCT00944034|18027250|P7|Overall Study|Administrative reason|1
5222365|NCT00944034|18027251|P6|Overall Study|Administrative reason|0
5222366|NCT00944034|18027252|P5|Overall Study|Administrative reason|0
5222367|NCT00944034|18027253|P4|Overall Study|Administrative reason|0
5222368|NCT00944034|18027254|P3|Overall Study|Administrative reason|0
5222369|NCT00944034|18027255|P2|Overall Study|Administrative reason|0
5222370|NCT00944034|18027256|P1|Overall Study|Administrative reason|0
5222371|NCT00944034|18027245|P12|Overall Study|Unable to classify|0
5222372|NCT00944034|18027246|P11|Overall Study|Unable to classify|0
5222373|NCT00944034|18027247|P10|Overall Study|Unable to classify|0
5222374|NCT00944034|18027248|P9|Overall Study|Unable to classify|0
5222375|NCT00944034|18027249|P8|Overall Study|Unable to classify|1
5222376|NCT00944034|18027250|P7|Overall Study|Unable to classify|1
5222377|NCT00944034|18027251|P6|Overall Study|Unable to classify|1
5222378|NCT00944034|18027252|P5|Overall Study|Unable to classify|0
5222379|NCT00944034|18027253|P4|Overall Study|Unable to classify|0
5222380|NCT00944034|18027254|P3|Overall Study|Unable to classify|0
5222381|NCT00944034|18027255|P2|Overall Study|Unable to classify|0
5222382|NCT00944034|18027256|P1|Overall Study|Unable to classify|0
5222383|NCT00944034|18027245|P12|Overall Study|Protocol Violation|0
5222384|NCT00944034|18027246|P11|Overall Study|Protocol Violation|0
5222385|NCT00944034|18027247|P10|Overall Study|Protocol Violation|4
5222386|NCT00944034|18027248|P9|Overall Study|Protocol Violation|1
5222387|NCT00944034|18027249|P8|Overall Study|Protocol Violation|1
5222388|NCT00944034|18027250|P7|Overall Study|Protocol Violation|0
5222389|NCT00944034|18027251|P6|Overall Study|Protocol Violation|3
5222390|NCT00944034|18027252|P5|Overall Study|Protocol Violation|2
5222391|NCT00944034|18027253|P4|Overall Study|Protocol Violation|1
5222392|NCT00944034|18027254|P3|Overall Study|Protocol Violation|0
5222393|NCT00944034|18027255|P2|Overall Study|Protocol Violation|0
5222394|NCT00944034|18027256|P1|Overall Study|Protocol Violation|2
5222395|NCT00944034|18027245|P12|Overall Study|Death|0
5222396|NCT00944034|18027246|P11|Overall Study|Death|0
5222397|NCT00944034|18027247|P10|Overall Study|Death|0
5222398|NCT00944034|18027248|P9|Overall Study|Death|0
5222399|NCT00944034|18027249|P8|Overall Study|Death|0
5222400|NCT00944034|18027250|P7|Overall Study|Death|0
5222401|NCT00944034|18027251|P6|Overall Study|Death|0
5222402|NCT00944034|18027252|P5|Overall Study|Death|0
5222403|NCT00944034|18027253|P4|Overall Study|Death|0
5222404|NCT00944034|18027254|P3|Overall Study|Death|1
5222405|NCT00944034|18027255|P2|Overall Study|Death|0
5222406|NCT00944034|18027256|P1|Overall Study|Death|0
5222407|NCT00944034|18027245|P12|Overall Study|Lost to Follow-up|0
5222408|NCT00944034|18027246|P11|Overall Study|Lost to Follow-up|1
5222409|NCT00944034|18027247|P10|Overall Study|Lost to Follow-up|1
5222410|NCT00944034|18027248|P9|Overall Study|Lost to Follow-up|5
5222411|NCT00944034|18027249|P8|Overall Study|Lost to Follow-up|1
5222412|NCT00944034|18027250|P7|Overall Study|Lost to Follow-up|0
5222413|NCT00944034|18027251|P6|Overall Study|Lost to Follow-up|7
5222414|NCT00944034|18027252|P5|Overall Study|Lost to Follow-up|5
5222415|NCT00944034|18027253|P4|Overall Study|Lost to Follow-up|0
5222416|NCT00944034|18027254|P3|Overall Study|Lost to Follow-up|2
5222417|NCT00944034|18027255|P2|Overall Study|Lost to Follow-up|4
5222418|NCT00944034|18027256|P1|Overall Study|Lost to Follow-up|0
5222419|NCT00944034|18027245|P12|Overall Study|Withdrawal by Subject|4
5222420|NCT00944034|18027246|P11|Overall Study|Withdrawal by Subject|0
5222421|NCT00944034|18027247|P10|Overall Study|Withdrawal by Subject|4
5222422|NCT00944034|18027248|P9|Overall Study|Withdrawal by Subject|3
5222423|NCT00944034|18027249|P8|Overall Study|Withdrawal by Subject|2
5222424|NCT00944034|18027250|P7|Overall Study|Withdrawal by Subject|2
5222425|NCT00944034|18027251|P6|Overall Study|Withdrawal by Subject|8
5222426|NCT00944034|18027252|P5|Overall Study|Withdrawal by Subject|5
5222427|NCT00944034|18027253|P4|Overall Study|Withdrawal by Subject|2
5222428|NCT00944034|18027254|P3|Overall Study|Withdrawal by Subject|6
5222429|NCT00944034|18027255|P2|Overall Study|Withdrawal by Subject|2
5222430|NCT00944034|18027256|P1|Overall Study|Withdrawal by Subject|3
5222431|NCT00944034|18027245|P12|Overall Study|Inappropriate enrollment|0
5222432|NCT00944034|18027246|P11|Overall Study|Inappropriate enrollment|0
5222433|NCT00944034|18027247|P10|Overall Study|Inappropriate enrollment|1
5222434|NCT00944034|18027248|P9|Overall Study|Inappropriate enrollment|1
5222435|NCT00944034|18027249|P8|Overall Study|Inappropriate enrollment|0
5222436|NCT00944034|18027250|P7|Overall Study|Inappropriate enrollment|0
5222437|NCT00944034|18027251|P6|Overall Study|Inappropriate enrollment|1
5222438|NCT00944034|18027252|P5|Overall Study|Inappropriate enrollment|2
5222439|NCT00944034|18027253|P4|Overall Study|Inappropriate enrollment|1
5222440|NCT00944034|18027254|P3|Overall Study|Inappropriate enrollment|0
5222441|NCT00944034|18027255|P2|Overall Study|Inappropriate enrollment|1
5222442|NCT00944034|18027256|P1|Overall Study|Inappropriate enrollment|0
5222443|NCT00943917|18027402|P15|Stage II Continuation|A1C elevation|0
5222444|NCT00943917|18027403|P14|Stage II Continuation|A1C elevation|1
5222445|NCT00943917|18027404|P13|Stage II Continuation|A1C elevation|0
5222446|NCT00943917|18027405|P12|Stage II Continuation|A1C elevation|0
5222447|NCT00943917|18027406|P11|Stage II Continuation|A1C elevation|0
5222448|NCT00943917|18027407|P10|Stage II Continuation|A1C elevation|0
5222449|NCT00943917|18027408|P9|Stage II Continuation|A1C elevation|0
5222450|NCT00943917|18027409|P8|Stage II Continuation|A1C elevation|0
5222451|NCT00943917|18027410|P7|Stage II Continuation|A1C elevation|0
5222452|NCT00943917|18027411|P6|Stage II Continuation|A1C elevation|0
5222453|NCT00943917|18027412|P5|Stage II Continuation|A1C elevation|0
5222454|NCT00943917|18027413|P4|Stage II Continuation|A1C elevation|0
5222455|NCT00943917|18027414|P3|Stage II Continuation|A1C elevation|0
5222456|NCT00943917|18027415|P2|Stage II Continuation|A1C elevation|0
5222457|NCT00943917|18027416|P1|Stage II Continuation|A1C elevation|0
5222458|NCT00943917|18027402|P15|Stage II Continuation|hypoglycemia|0
5222459|NCT00943917|18027403|P14|Stage II Continuation|hypoglycemia|0
5222460|NCT00943917|18027404|P13|Stage II Continuation|hypoglycemia|1
5222461|NCT00943917|18027405|P12|Stage II Continuation|hypoglycemia|0
5222462|NCT00943917|18027406|P11|Stage II Continuation|hypoglycemia|0
5222463|NCT00943917|18027407|P10|Stage II Continuation|hypoglycemia|0
5222464|NCT00943917|18027408|P9|Stage II Continuation|hypoglycemia|0
5222465|NCT00943917|18027409|P8|Stage II Continuation|hypoglycemia|0
5222466|NCT00943917|18027410|P7|Stage II Continuation|hypoglycemia|0
5222467|NCT00943917|18027411|P6|Stage II Continuation|hypoglycemia|0
5222468|NCT00943917|18027412|P5|Stage II Continuation|hypoglycemia|0
5222469|NCT00943917|18027413|P4|Stage II Continuation|hypoglycemia|0
5222470|NCT00943917|18027414|P3|Stage II Continuation|hypoglycemia|0
5222471|NCT00943917|18027415|P2|Stage II Continuation|hypoglycemia|0
5222472|NCT00943917|18027416|P1|Stage II Continuation|hypoglycemia|0
5222473|NCT00943917|18027402|P15|Stage II Continuation|Protocol Violation|0
5222474|NCT00943917|18027403|P14|Stage II Continuation|Protocol Violation|0
5222475|NCT00943917|18027404|P13|Stage II Continuation|Protocol Violation|0
5222476|NCT00943917|18027405|P12|Stage II Continuation|Protocol Violation|1
5222477|NCT00943917|18027406|P11|Stage II Continuation|Protocol Violation|0
5222478|NCT00943917|18027407|P10|Stage II Continuation|Protocol Violation|1
5222479|NCT00943917|18027408|P9|Stage II Continuation|Protocol Violation|0
5222480|NCT00943917|18027409|P8|Stage II Continuation|Protocol Violation|0
5222481|NCT00943917|18027410|P7|Stage II Continuation|Protocol Violation|0
5222482|NCT00943917|18027411|P6|Stage II Continuation|Protocol Violation|0
5222483|NCT00943917|18027412|P5|Stage II Continuation|Protocol Violation|0
5222484|NCT00943917|18027413|P4|Stage II Continuation|Protocol Violation|0
5222485|NCT00943917|18027414|P3|Stage II Continuation|Protocol Violation|0
5222486|NCT00943917|18027415|P2|Stage II Continuation|Protocol Violation|0
5222487|NCT00943917|18027416|P1|Stage II Continuation|Protocol Violation|0
5222488|NCT00943917|18027402|P15|Stage II Continuation|Withdrawal by Subject|3
5222489|NCT00943917|18027403|P14|Stage II Continuation|Withdrawal by Subject|1
5222490|NCT00943917|18027404|P13|Stage II Continuation|Withdrawal by Subject|0
5222491|NCT00943917|18027405|P12|Stage II Continuation|Withdrawal by Subject|0
5222492|NCT00943917|18027406|P11|Stage II Continuation|Withdrawal by Subject|0
5222493|NCT00943917|18027407|P10|Stage II Continuation|Withdrawal by Subject|0
5222494|NCT00943917|18027408|P9|Stage II Continuation|Withdrawal by Subject|0
5222495|NCT00943917|18027409|P8|Stage II Continuation|Withdrawal by Subject|0
5222496|NCT00943917|18027410|P7|Stage II Continuation|Withdrawal by Subject|0
5222497|NCT00943917|18027411|P6|Stage II Continuation|Withdrawal by Subject|0
5222498|NCT00943917|18027412|P5|Stage II Continuation|Withdrawal by Subject|0
5222499|NCT00943917|18027413|P4|Stage II Continuation|Withdrawal by Subject|0
5222500|NCT00943917|18027414|P3|Stage II Continuation|Withdrawal by Subject|0
5222501|NCT00943917|18027415|P2|Stage II Continuation|Withdrawal by Subject|0
5222502|NCT00943917|18027416|P1|Stage II Continuation|Withdrawal by Subject|0
5222503|NCT00943917|18027402|P15|Stage II Continuation|Adverse Event|1
5222504|NCT00943917|18027403|P14|Stage II Continuation|Adverse Event|1
5222505|NCT00943917|18027404|P13|Stage II Continuation|Adverse Event|2
5222506|NCT00943917|18027405|P12|Stage II Continuation|Adverse Event|1
5222507|NCT00943917|18027406|P11|Stage II Continuation|Adverse Event|0
5222508|NCT00943917|18027407|P10|Stage II Continuation|Adverse Event|0
5222509|NCT00943917|18027408|P9|Stage II Continuation|Adverse Event|0
5222510|NCT00943917|18027409|P8|Stage II Continuation|Adverse Event|0
5222511|NCT00943917|18027410|P7|Stage II Continuation|Adverse Event|0
5222512|NCT00943917|18027411|P6|Stage II Continuation|Adverse Event|0
5222513|NCT00943917|18027412|P5|Stage II Continuation|Adverse Event|0
5222514|NCT00943917|18027413|P4|Stage II Continuation|Adverse Event|0
5222515|NCT00943917|18027414|P3|Stage II Continuation|Adverse Event|0
5222516|NCT00943917|18027415|P2|Stage II Continuation|Adverse Event|0
5222517|NCT00943917|18027416|P1|Stage II Continuation|Adverse Event|0
5222518|NCT00943917|18027402|P15|Stage II|Pregnancy|0
5222519|NCT00943917|18027403|P14|Stage II|Pregnancy|0
5222520|NCT00943917|18027404|P13|Stage II|Pregnancy|0
5222521|NCT00943917|18027405|P12|Stage II|Pregnancy|0
5222522|NCT00943917|18027406|P11|Stage II|Pregnancy|0
5222523|NCT00943917|18027407|P10|Stage II|Pregnancy|0
5222524|NCT00943917|18027408|P9|Stage II|Pregnancy|0
5222525|NCT00943917|18027409|P8|Stage II|Pregnancy|0
5222526|NCT00943917|18027410|P7|Stage II|Pregnancy|0
5222527|NCT00943917|18027411|P6|Stage II|Pregnancy|1
5222528|NCT00943917|18027412|P5|Stage II|Pregnancy|0
5222529|NCT00943917|18027413|P4|Stage II|Pregnancy|0
5222530|NCT00943917|18027414|P3|Stage II|Pregnancy|0
5222531|NCT00943917|18027415|P2|Stage II|Pregnancy|0
5222532|NCT00943917|18027416|P1|Stage II|Pregnancy|0
5222533|NCT00943917|18027402|P15|Stage II|Withdrawal by Subject|0
5222534|NCT00943917|18027403|P14|Stage II|Withdrawal by Subject|0
5222535|NCT00943917|18027404|P13|Stage II|Withdrawal by Subject|0
5222536|NCT00943917|18027405|P12|Stage II|Withdrawal by Subject|0
5222537|NCT00943917|18027406|P11|Stage II|Withdrawal by Subject|0
5222538|NCT00943917|18027407|P10|Stage II|Withdrawal by Subject|0
5222539|NCT00943917|18027408|P9|Stage II|Withdrawal by Subject|0
5222540|NCT00943917|18027409|P8|Stage II|Withdrawal by Subject|0
5222541|NCT00943917|18027410|P7|Stage II|Withdrawal by Subject|0
5222542|NCT00943917|18027411|P6|Stage II|Withdrawal by Subject|1
5222543|NCT00943917|18027412|P5|Stage II|Withdrawal by Subject|0
5222544|NCT00943917|18027413|P4|Stage II|Withdrawal by Subject|0
5222545|NCT00943917|18027414|P3|Stage II|Withdrawal by Subject|0
5222546|NCT00943917|18027415|P2|Stage II|Withdrawal by Subject|0
5222547|NCT00943917|18027416|P1|Stage II|Withdrawal by Subject|0
5222548|NCT00943917|18027402|P15|Stage II|Adverse Event|0
5222549|NCT00943917|18027403|P14|Stage II|Adverse Event|0
5222550|NCT00943917|18027404|P13|Stage II|Adverse Event|0
5222551|NCT00943917|18027405|P12|Stage II|Adverse Event|0
5222552|NCT00943917|18027406|P11|Stage II|Adverse Event|0
5222553|NCT00943917|18027407|P10|Stage II|Adverse Event|0
5222554|NCT00943917|18027408|P9|Stage II|Adverse Event|1
5222555|NCT00943917|18027409|P8|Stage II|Adverse Event|0
5222556|NCT00943917|18027410|P7|Stage II|Adverse Event|3
5222557|NCT00943917|18027411|P6|Stage II|Adverse Event|1
5222558|NCT00943917|18027412|P5|Stage II|Adverse Event|0
5222559|NCT00943917|18027413|P4|Stage II|Adverse Event|0
5222560|NCT00943917|18027414|P3|Stage II|Adverse Event|0
5222561|NCT00943917|18027415|P2|Stage II|Adverse Event|0
5222562|NCT00943917|18027416|P1|Stage II|Adverse Event|0
5222563|NCT00943917|18027402|P15|Stage I|Withdrawal by Subject|0
5222564|NCT00943917|18027403|P14|Stage I|Withdrawal by Subject|0
5222565|NCT00943917|18027404|P13|Stage I|Withdrawal by Subject|0
5222566|NCT00943917|18027405|P12|Stage I|Withdrawal by Subject|0
5222567|NCT00943917|18027406|P11|Stage I|Withdrawal by Subject|0
5222568|NCT00943917|18027407|P10|Stage I|Withdrawal by Subject|0
5222569|NCT00943917|18027408|P9|Stage I|Withdrawal by Subject|0
5222570|NCT00943917|18027409|P8|Stage I|Withdrawal by Subject|0
5222571|NCT00943917|18027410|P7|Stage I|Withdrawal by Subject|0
5222572|NCT00943917|18027411|P6|Stage I|Withdrawal by Subject|0
5222573|NCT00943917|18027412|P5|Stage I|Withdrawal by Subject|0
5222574|NCT00943917|18027413|P4|Stage I|Withdrawal by Subject|0
5222575|NCT00943917|18027414|P3|Stage I|Withdrawal by Subject|2
5222576|NCT00943917|18027415|P2|Stage I|Withdrawal by Subject|1
5222577|NCT00943917|18027416|P1|Stage I|Withdrawal by Subject|2
5222578|NCT00943917|18027402|P15|Stage I|A1C elevation|0
5222579|NCT00943917|18027403|P14|Stage I|A1C elevation|0
5222580|NCT00943917|18027404|P13|Stage I|A1C elevation|0
5222581|NCT00943917|18027405|P12|Stage I|A1C elevation|0
5222582|NCT00943917|18027406|P11|Stage I|A1C elevation|0
5222583|NCT00943917|18027407|P10|Stage I|A1C elevation|0
5222584|NCT00943917|18027408|P9|Stage I|A1C elevation|0
5222585|NCT00943917|18027409|P8|Stage I|A1C elevation|0
5222586|NCT00943917|18027410|P7|Stage I|A1C elevation|0
5222587|NCT00943917|18027411|P6|Stage I|A1C elevation|0
5222588|NCT00943917|18027412|P5|Stage I|A1C elevation|0
5222589|NCT00943917|18027413|P4|Stage I|A1C elevation|0
5222590|NCT00943917|18027414|P3|Stage I|A1C elevation|0
5222591|NCT00943917|18027415|P2|Stage I|A1C elevation|0
5222592|NCT00943917|18027416|P1|Stage I|A1C elevation|1
5222593|NCT00943917|18027402|P15|Stage I|hyperglycemia|0
5222594|NCT00943917|18027403|P14|Stage I|hyperglycemia|0
5222595|NCT00943917|18027404|P13|Stage I|hyperglycemia|0
5222596|NCT00943917|18027405|P12|Stage I|hyperglycemia|0
5222597|NCT00943917|18027406|P11|Stage I|hyperglycemia|0
5222598|NCT00943917|18027407|P10|Stage I|hyperglycemia|0
5222599|NCT00943917|18027408|P9|Stage I|hyperglycemia|0
5222600|NCT00943917|18027409|P8|Stage I|hyperglycemia|0
5222601|NCT00943917|18027410|P7|Stage I|hyperglycemia|0
5222602|NCT00943917|18027411|P6|Stage I|hyperglycemia|0
5222603|NCT00943917|18027412|P5|Stage I|hyperglycemia|0
5222604|NCT00943917|18027413|P4|Stage I|hyperglycemia|0
5222605|NCT00943917|18027414|P3|Stage I|hyperglycemia|1
5222606|NCT00943917|18027415|P2|Stage I|hyperglycemia|0
5222607|NCT00943917|18027416|P1|Stage I|hyperglycemia|0
5222608|NCT00943917|18027402|P15|Stage I|Lost to Follow-up|0
5222609|NCT00943917|18027403|P14|Stage I|Lost to Follow-up|0
5222610|NCT00943917|18027404|P13|Stage I|Lost to Follow-up|0
5222611|NCT00943917|18027405|P12|Stage I|Lost to Follow-up|0
5222612|NCT00943917|18027406|P11|Stage I|Lost to Follow-up|0
5222613|NCT00943917|18027407|P10|Stage I|Lost to Follow-up|0
5222614|NCT00943917|18027408|P9|Stage I|Lost to Follow-up|0
5222615|NCT00943917|18027409|P8|Stage I|Lost to Follow-up|0
5222616|NCT00943917|18027410|P7|Stage I|Lost to Follow-up|0
5222617|NCT00943917|18027411|P6|Stage I|Lost to Follow-up|0
5222618|NCT00943917|18027412|P5|Stage I|Lost to Follow-up|0
5222619|NCT00943917|18027413|P4|Stage I|Lost to Follow-up|0
5222620|NCT00943917|18027414|P3|Stage I|Lost to Follow-up|1
5222621|NCT00943917|18027415|P2|Stage I|Lost to Follow-up|0
5222622|NCT00943917|18027416|P1|Stage I|Lost to Follow-up|0
5222623|NCT00943917|18027402|P15|Stage I|Adverse Event|0
5222624|NCT00943917|18027403|P14|Stage I|Adverse Event|0
5222625|NCT00943917|18027404|P13|Stage I|Adverse Event|0
5222626|NCT00943917|18027405|P12|Stage I|Adverse Event|0
5222627|NCT00943917|18027406|P11|Stage I|Adverse Event|0
5222628|NCT00943917|18027407|P10|Stage I|Adverse Event|0
5222629|NCT00943917|18027408|P9|Stage I|Adverse Event|0
5222630|NCT00943917|18027409|P8|Stage I|Adverse Event|0
5222631|NCT00943917|18027410|P7|Stage I|Adverse Event|0
5222632|NCT00943917|18027411|P6|Stage I|Adverse Event|0
5222633|NCT00943917|18027412|P5|Stage I|Adverse Event|0
5222634|NCT00943917|18027413|P4|Stage I|Adverse Event|0
5222635|NCT00943917|18027414|P3|Stage I|Adverse Event|2
5222636|NCT00943917|18027415|P2|Stage I|Adverse Event|2
5222637|NCT00943917|18027416|P1|Stage I|Adverse Event|1
5222638|NCT00943852|18027592|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
5222639|NCT00943852|18027593|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
5222640|NCT00943852|18027594|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
5222641|NCT00943852|18027595|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
5222642|NCT00943852|18027596|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
5222643|NCT00943852|18027597|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
5222644|NCT00943852|18027598|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
5222645|NCT00943852|18027599|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
5222646|NCT00943852|18027600|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
5222647|NCT00943852|18027601|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
5222648|NCT00943852|18027592|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222649|NCT00943852|18027593|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222650|NCT00943852|18027594|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
5222651|NCT00943852|18027595|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222652|NCT00943852|18027596|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222653|NCT00943852|18027597|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222654|NCT00943852|18027598|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222655|NCT00943852|18027599|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222656|NCT00943852|18027600|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222657|NCT00943852|18027601|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5222658|NCT00943852|18027592|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222659|NCT00943852|18027593|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222660|NCT00943852|18027594|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222661|NCT00943852|18027595|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
5222662|NCT00943852|18027596|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222663|NCT00943852|18027597|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222664|NCT00943852|18027598|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222665|NCT00943852|18027599|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222666|NCT00943852|18027600|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222667|NCT00943852|18027601|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5222668|NCT00943852|18027592|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
5222669|NCT00943852|18027593|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
5222670|NCT00943852|18027594|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
5222671|NCT00943852|18027595|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
5222672|NCT00943852|18027596|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
5222673|NCT00943852|18027597|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
5222674|NCT00943852|18027598|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
5222675|NCT00943852|18027599|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
5222676|NCT00943852|18027600|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
5222677|NCT00943852|18027601|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
5222678|NCT00943852|18027592|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222679|NCT00943852|18027593|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222680|NCT00943852|18027594|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222681|NCT00943852|18027595|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222682|NCT00943852|18027596|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222683|NCT00943852|18027597|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222684|NCT00943852|18027598|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
5222685|NCT00943852|18027599|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222686|NCT00943852|18027600|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222687|NCT00943852|18027601|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5222688|NCT00943826|18027614|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
5222689|NCT00943826|18027615|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
5222690|NCT00943826|18027614|P2|After Primary Overall Survival Analysis|Progression of Disease|4
5222691|NCT00943826|18027615|P1|After Primary Overall Survival Analysis|Progression of Disease|2
5222692|NCT00943826|18027614|P2|After Primary Overall Survival Analysis|Administrative reasons|16
5222693|NCT00943826|18027615|P1|After Primary Overall Survival Analysis|Administrative reasons|10
5222694|NCT00943826|18027614|P2|After Primary Overall Survival Analysis|Adverse Event|0
5222695|NCT00943826|18027615|P1|After Primary Overall Survival Analysis|Adverse Event|11
5222696|NCT00943826|18027614|P2|Monotherapy Phase|Failure to return|1
5222697|NCT00943826|18027615|P1|Monotherapy Phase|Failure to return|2
5222698|NCT00943826|18027614|P2|Monotherapy Phase|Withdrew Consent|3
5222699|NCT00943826|18027615|P1|Monotherapy Phase|Withdrew Consent|2
5222700|NCT00943826|18027614|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
5222701|NCT00943826|18027615|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
5222702|NCT00943826|18027614|P2|Monotherapy Phase|Administrative reasons|5
5222703|NCT00943826|18027615|P1|Monotherapy Phase|Administrative reasons|11
5222704|NCT00943826|18027614|P2|Monotherapy Phase|Adverse Event|5
5222705|NCT00943826|18027615|P1|Monotherapy Phase|Adverse Event|42
5222706|NCT00943826|18027614|P2|Maintenance Phase|Failure to return|1
5222707|NCT00943826|18027615|P1|Maintenance Phase|Failure to return|0
5222708|NCT00943826|18027614|P2|Maintenance Phase|Administrative reasons|1
5222709|NCT00943826|18027615|P1|Maintenance Phase|Administrative reasons|4
5222710|NCT00943826|18027614|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
5222711|NCT00943826|18027615|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
5222712|NCT00943826|18027614|P2|Maintenance Phase|Withdrew consent|4
5222713|NCT00943826|18027615|P1|Maintenance Phase|Withdrew consent|2
5222714|NCT00943826|18027614|P2|Maintenance Phase|Adverse Event|30
5222715|NCT00943826|18027615|P1|Maintenance Phase|Adverse Event|31
5222716|NCT00943826|18027614|P2|Concurrent Phase|Protocol Violation|0
5222717|NCT00943826|18027615|P1|Concurrent Phase|Protocol Violation|1
5222718|NCT00943826|18027614|P2|Concurrent Phase|Administrative reasons|1
5222719|NCT00943826|18027615|P1|Concurrent Phase|Administrative reasons|2
5222720|NCT00943826|18027614|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
5222721|NCT00943826|18027615|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
5222722|NCT00943826|18027614|P2|Concurrent Phase|Withdrew consent|7
5222723|NCT00943826|18027615|P1|Concurrent Phase|Withdrew consent|3
5222724|NCT00943826|18027614|P2|Concurrent Phase|Adverse Event|27
5222725|NCT00943826|18027615|P1|Concurrent Phase|Adverse Event|50
5222726|NCT00943787|18027639|P1|Overall Study|Withdrawal by Subject|3
5222727|NCT00943787|18027639|P1|Overall Study|Physician Decision|4
5222728|NCT00943761|18027646|P2|Overall Study|Withdrawal by Subject|1
5222729|NCT00943761|18027647|P1|Overall Study|Withdrawal by Subject|2
5222730|NCT00943761|18027646|P2|Overall Study|Lost to Follow-up|0
5222731|NCT00943761|18027647|P1|Overall Study|Lost to Follow-up|2
5222732|NCT00943735|18027659|P1|Overall Study|Other|3
5222733|NCT00943735|18027659|P1|Overall Study|Other|8
5222734|NCT00943735|18027659|P1|Overall Study|Death|1
5222735|NCT00943735|18027659|P1|Overall Study|Withdrawal by Subject|8
5222736|NCT00943735|18027659|P1|Overall Study|Adverse Event|12
5222737|NCT00943722|18027697|P5|Overall Study|Withdrawal by Subject|8
5222738|NCT00943722|18027698|P4|Overall Study|Withdrawal by Subject|13
5222739|NCT00943722|18027699|P3|Overall Study|Withdrawal by Subject|2
5222740|NCT00943722|18027700|P2|Overall Study|Withdrawal by Subject|13
5222741|NCT00943722|18027701|P1|Overall Study|Withdrawal by Subject|12
5222742|NCT00943722|18027697|P5|Overall Study|Protocol Violation|2
5222743|NCT00943722|18027698|P4|Overall Study|Protocol Violation|0
5222744|NCT00943722|18027699|P3|Overall Study|Protocol Violation|0
5222745|NCT00943722|18027700|P2|Overall Study|Protocol Violation|1
5222746|NCT00943722|18027701|P1|Overall Study|Protocol Violation|0
5222747|NCT00943722|18027697|P5|Overall Study|Pregnancy|0
5222748|NCT00943722|18027698|P4|Overall Study|Pregnancy|0
5222749|NCT00943722|18027699|P3|Overall Study|Pregnancy|1
5222750|NCT00943722|18027700|P2|Overall Study|Pregnancy|0
5222751|NCT00943722|18027701|P1|Overall Study|Pregnancy|0
5222752|NCT00943722|18027697|P5|Overall Study|Physician Decision|1
5222753|NCT00943722|18027698|P4|Overall Study|Physician Decision|0
5222754|NCT00943722|18027699|P3|Overall Study|Physician Decision|0
5222755|NCT00943722|18027700|P2|Overall Study|Physician Decision|0
5222756|NCT00943722|18027701|P1|Overall Study|Physician Decision|1
5222757|NCT00943722|18027697|P5|Overall Study|Lost to Follow-up|11
5222758|NCT00943722|18027698|P4|Overall Study|Lost to Follow-up|8
5222759|NCT00943722|18027699|P3|Overall Study|Lost to Follow-up|10
5222760|NCT00943722|18027700|P2|Overall Study|Lost to Follow-up|8
5222761|NCT00943722|18027701|P1|Overall Study|Lost to Follow-up|12
5222762|NCT00943722|18027697|P5|Overall Study|Adverse Event|0
5222763|NCT00943722|18027698|P4|Overall Study|Adverse Event|1
5222764|NCT00943722|18027699|P3|Overall Study|Adverse Event|0
5222765|NCT00943722|18027700|P2|Overall Study|Adverse Event|0
5222766|NCT00943722|18027701|P1|Overall Study|Adverse Event|0
5222767|NCT00943683|18027731|P2|Overall Study|Patient Moved|0
5222768|NCT00943683|18027732|P1|Overall Study|Patient Moved|1
5222769|NCT00943683|18027731|P2|Overall Study|Withdrawal by Subject|0
5222770|NCT00943683|18027732|P1|Overall Study|Withdrawal by Subject|1
5222771|NCT00943683|18027731|P2|Overall Study|Protocol Violation|2
5222772|NCT00943683|18027732|P1|Overall Study|Protocol Violation|1
5222773|NCT00943683|18027731|P2|Overall Study|Lost to Follow-up|1
5222774|NCT00943683|18027732|P1|Overall Study|Lost to Follow-up|1
5222775|NCT00943683|18027731|P2|Overall Study|Adverse Event|3
5222776|NCT00943683|18027732|P1|Overall Study|Adverse Event|3
5222777|NCT00943670|18027738|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
5222778|NCT00943670|18027738|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
5222779|NCT00943670|18027738|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
5222780|NCT00943670|18027738|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
5222781|NCT00943670|18027738|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
5222782|NCT00943670|18027738|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
5222783|NCT00943670|18027738|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
5222784|NCT00943670|18027738|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
5222785|NCT00943670|18027738|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
5222786|NCT00943670|18027738|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
5222787|NCT00943605|18027827|P2|Overall Study|Study termination|30
5222788|NCT00943605|18027828|P1|Overall Study|Study termination|30
5222789|NCT00943592|18027838|P1|Overall Study|Death|3
5222790|NCT00943579|18027851|P2|Overall Study|Lack of Efficacy|2
5222791|NCT00943579|18027852|P1|Overall Study|Lack of Efficacy|2
5222792|NCT00943579|18027851|P2|Overall Study|Adverse Event|3
5222793|NCT00943579|18027852|P1|Overall Study|Adverse Event|4
5222794|NCT00943397|18027953|P2|Overall Study|Site terminated and other|56
5222795|NCT00943397|18027954|P1|Overall Study|Site terminated and other|12
5222796|NCT00943397|18027953|P2|Overall Study|Withdrawal by Subject|1
5222797|NCT00943397|18027954|P1|Overall Study|Withdrawal by Subject|1
5222798|NCT00943397|18027953|P2|Overall Study|Protocol Violation|5
5222799|NCT00943397|18027954|P1|Overall Study|Protocol Violation|2
5222800|NCT00943397|18027953|P2|Overall Study|Lost to Follow-up|4
5222801|NCT00943397|18027954|P1|Overall Study|Lost to Follow-up|0
5222802|NCT00943397|18027953|P2|Overall Study|Adverse Event|6
5222803|NCT00943397|18027954|P1|Overall Study|Adverse Event|0
5222804|NCT00943384|18027960|P1|Overall Study|Withdrawal by Subject|5
5222805|NCT00943384|18027960|P1|Overall Study|Lost to Follow-up|16
5222806|NCT00943384|18027960|P1|Overall Study|Treated off protocol-protocol violation|5
5222807|NCT00943384|18027960|P1|Overall Study|Dispositioned prior to treatment|23
5222808|NCT00943319|18027974|P1|Overall Study|Death|1
5222809|NCT00943306|18027980|P1|Overall Study|Sponsor decision due to non-compliance|1
5222810|NCT00943306|18027980|P1|Overall Study|Death|1
5222811|NCT00943306|18027980|P1|Overall Study|Physician Decision|1
5222812|NCT00943124|18028282|P2|Period 1|Personal Reasons|1
5222813|NCT00943124|18028283|P1|Period 1|Personal Reasons|0
5222814|NCT00943124|18028282|P2|Period 1|Did Not Follow Study Procedures|0
5222815|NCT00943124|18028283|P1|Period 1|Did Not Follow Study Procedures|1
5222816|NCT00943124|18028282|P2|Period 1|Withdrawal by Subject|1
5222817|NCT00943124|18028283|P1|Period 1|Withdrawal by Subject|1
5222818|NCT00943111|18028305|P3|5 Years Long-term Treatment Period|Other than specified above|2
5222819|NCT00943111|18028306|P2|5 Years Long-term Treatment Period|Other than specified above|0
5222991|NCT00941863|18028881|P1|Continued After PCD|Withdrawal by Subject|0
5222820|NCT00943111|18028307|P1|5 Years Long-term Treatment Period|Other than specified above|0
5222821|NCT00943111|18028305|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
5222822|NCT00943111|18028306|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
5222823|NCT00943111|18028307|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
5222824|NCT00943111|18028305|P3|5 Years Long-term Treatment Period|Pregnancy|4
5222825|NCT00943111|18028306|P2|5 Years Long-term Treatment Period|Pregnancy|0
5222826|NCT00943111|18028307|P1|5 Years Long-term Treatment Period|Pregnancy|0
5222827|NCT00943111|18028305|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
5222828|NCT00943111|18028306|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
5222829|NCT00943111|18028307|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
5222830|NCT00943111|18028305|P3|5 Years Long-term Treatment Period|Adverse Event|9
5222831|NCT00943111|18028306|P2|5 Years Long-term Treatment Period|Adverse Event|0
5222832|NCT00943111|18028307|P1|5 Years Long-term Treatment Period|Adverse Event|0
5222833|NCT00943111|18028305|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
5222834|NCT00943111|18028306|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
5222835|NCT00943111|18028307|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
5222836|NCT00943111|18028305|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
5222837|NCT00943111|18028306|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
5222838|NCT00943111|18028307|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
5222839|NCT00943111|18028305|P3|52-Weeks Primary Analysis Period|Adverse Event|0
5222840|NCT00943111|18028306|P2|52-Weeks Primary Analysis Period|Adverse Event|1
5222841|NCT00943111|18028307|P1|52-Weeks Primary Analysis Period|Adverse Event|2
5222842|NCT00943072|18028375|P2|Overall Study|Other|1
5222843|NCT00943072|18028376|P1|Overall Study|Other|1
5222844|NCT00943072|18028375|P2|Overall Study|Lack of Efficacy|4
5222845|NCT00943072|18028376|P1|Overall Study|Lack of Efficacy|0
5222846|NCT00943072|18028375|P2|Overall Study|Lost to Follow-up|2
5222847|NCT00943072|18028376|P1|Overall Study|Lost to Follow-up|1
5222848|NCT00943072|18028375|P2|Overall Study|Protocol Violation|1
5222849|NCT00943072|18028376|P1|Overall Study|Protocol Violation|0
5222850|NCT00943072|18028375|P2|Overall Study|Withdrawal by Subject|1
5222851|NCT00943072|18028376|P1|Overall Study|Withdrawal by Subject|3
5222852|NCT00943072|18028375|P2|Overall Study|Death|2
5222853|NCT00943072|18028376|P1|Overall Study|Death|0
5222854|NCT00943072|18028375|P2|Overall Study|Adverse Event|3
5222855|NCT00943072|18028376|P1|Overall Study|Adverse Event|0
5222856|NCT00942994|18028394|P2|Overall Study|Protocol deviation|2
5222857|NCT00942994|18028395|P1|Overall Study|Protocol deviation|1
5222858|NCT00942994|18028394|P2|Overall Study|Lost to Follow-up|4
5222859|NCT00942994|18028395|P1|Overall Study|Lost to Follow-up|1
5222860|NCT00942994|18028394|P2|Overall Study|Patient withdrew consent|8
5222861|NCT00942994|18028395|P1|Overall Study|Patient withdrew consent|5
5222862|NCT00942994|18028394|P2|Overall Study|Unsatisfactory therapeutic effect|1
5222863|NCT00942994|18028395|P1|Overall Study|Unsatisfactory therapeutic effect|1
5222864|NCT00942994|18028394|P2|Overall Study|Abnormal laboratory value(s)|0
5222865|NCT00942994|18028395|P1|Overall Study|Abnormal laboratory value(s)|1
5222866|NCT00942994|18028394|P2|Overall Study|Adverse Event|4
5222867|NCT00942994|18028395|P1|Overall Study|Adverse Event|7
5222868|NCT00942968|18028411|P1|Overall Study|Deep vein thrombosis (DVT)|2
5222869|NCT00942968|18028411|P1|Overall Study|Participant required pancreatic biopsy|1
5222870|NCT00942968|18028411|P1|Overall Study|Pulmonary embolism (PE)|1
5222871|NCT00942968|18028411|P1|Overall Study|Inferior vena cava filter placement|4
5222872|NCT00942968|18028411|P1|Overall Study|Progression of disease|12
5222873|NCT00942968|18028411|P1|Overall Study|Physician Decision|11
5222874|NCT00942968|18028411|P1|Overall Study|Sponsor request|5
5222875|NCT00942968|18028411|P1|Overall Study|Withdrawal by Subject|44
5222876|NCT00942968|18028411|P1|Overall Study|Lost to Follow-up|4
5222877|NCT00942968|18028411|P1|Overall Study|Protocol Violation|9
5222878|NCT00942968|18028411|P1|Overall Study|Death|76
5222879|NCT00942968|18028411|P1|Overall Study|Adverse Event|60
5222880|NCT00942734|18028489|P1|Overall Study|Physician Decision|1
5222881|NCT00942734|18028489|P1|Overall Study|Disease Progression|2
5222882|NCT00942734|18028489|P1|Overall Study|Protocol Violation|3
5222883|NCT00942734|18028489|P1|Overall Study|Adverse Event|2
5222884|NCT00942708|18028493|P1|Overall Study|Withdrawal by Subject|1
5222885|NCT00942604|18028501|P2|Overall Study|Patient relocation|1
5222886|NCT00942604|18028502|P1|Overall Study|Patient relocation|1
5222887|NCT00942604|18028501|P2|Overall Study|Withdrawal by Subject|1
5222888|NCT00942604|18028502|P1|Overall Study|Withdrawal by Subject|0
5222889|NCT00942604|18028501|P2|Overall Study|Adverse Event|1
5222890|NCT00942604|18028502|P1|Overall Study|Adverse Event|0
5222891|NCT00942604|18028501|P2|Overall Study|Protocol Violation|1
5222892|NCT00942604|18028502|P1|Overall Study|Protocol Violation|1
5222893|NCT00942422|18028610|P1|Overall Study|Progressive diease|1
5222894|NCT00942422|18028610|P1|Overall Study|Death|1
5222895|NCT00942422|18028610|P1|Overall Study|Withdrawal by Subject|1
5222896|NCT00942409|18028614|P1|Overall Study|study drug unavailable|2
5222897|NCT00942409|18028614|P1|Overall Study|Lack of Efficacy|1
5222898|NCT00942357|18028620|P2|Overall Study|Ineligible|40
5222899|NCT00942357|18028621|P1|Overall Study|Ineligible|37
5222900|NCT00942331|18028637|P2|Overall Study|Did not start treatment|22
5222901|NCT00942331|18028638|P1|Overall Study|Did not start treatment|15
5222902|NCT00942266|18028650|P2|Overall Study|medical deterioration (pneumonia)|1
5222903|NCT00942266|18028651|P1|Overall Study|medical deterioration (pneumonia)|0
5222904|NCT00942266|18028650|P2|Overall Study|Physician Decision|0
5222905|NCT00942266|18028651|P1|Overall Study|Physician Decision|2
5222906|NCT00942266|18028650|P2|Overall Study|Intercurrent illness|1
5222907|NCT00942266|18028651|P1|Overall Study|Intercurrent illness|0
5222908|NCT00942266|18028650|P2|Overall Study|Failure to thrive and pt withdrawal|1
5222909|NCT00942266|18028651|P1|Overall Study|Failure to thrive and pt withdrawal|0
5222910|NCT00942266|18028650|P2|Overall Study|Disease Progression|11
5222911|NCT00942266|18028651|P1|Overall Study|Disease Progression|38
5222912|NCT00942266|18028650|P2|Overall Study|Adverse Event|1
5222913|NCT00942266|18028651|P1|Overall Study|Adverse Event|2
5222914|NCT00942266|18028650|P2|Overall Study|Withdrawal by Subject|0
5222915|NCT00942266|18028651|P1|Overall Study|Withdrawal by Subject|1
5222916|NCT00942188|18028673|P4|Overall Study|Sponsor Decision|1
5222917|NCT00942188|18028674|P3|Overall Study|Sponsor Decision|0
5222918|NCT00942188|18028675|P2|Overall Study|Sponsor Decision|2
5222919|NCT00942188|18028676|P1|Overall Study|Sponsor Decision|0
5222920|NCT00942188|18028673|P4|Overall Study|Physician Decision|0
5222921|NCT00942188|18028674|P3|Overall Study|Physician Decision|1
5222922|NCT00942188|18028675|P2|Overall Study|Physician Decision|0
5222923|NCT00942188|18028676|P1|Overall Study|Physician Decision|0
5222924|NCT00942188|18028673|P4|Overall Study|Withdrawal by Subject|2
5222925|NCT00942188|18028674|P3|Overall Study|Withdrawal by Subject|4
5222926|NCT00942188|18028675|P2|Overall Study|Withdrawal by Subject|3
5222927|NCT00942188|18028676|P1|Overall Study|Withdrawal by Subject|1
5222928|NCT00942188|18028673|P4|Overall Study|Lost to Follow-up|0
5222929|NCT00942188|18028674|P3|Overall Study|Lost to Follow-up|2
5222930|NCT00942188|18028675|P2|Overall Study|Lost to Follow-up|1
5222931|NCT00942188|18028676|P1|Overall Study|Lost to Follow-up|2
5222932|NCT00942188|18028673|P4|Overall Study|Protocol Violation|0
5222933|NCT00942188|18028674|P3|Overall Study|Protocol Violation|0
5222934|NCT00942188|18028675|P2|Overall Study|Protocol Violation|1
5222935|NCT00942188|18028676|P1|Overall Study|Protocol Violation|1
5222936|NCT00942188|18028673|P4|Overall Study|Lack of Efficacy|1
5222937|NCT00942188|18028674|P3|Overall Study|Lack of Efficacy|0
5222938|NCT00942188|18028675|P2|Overall Study|Lack of Efficacy|0
5222939|NCT00942188|18028676|P1|Overall Study|Lack of Efficacy|0
5222940|NCT00942188|18028673|P4|Overall Study|Adverse Event|0
5222941|NCT00942188|18028674|P3|Overall Study|Adverse Event|2
5222942|NCT00942188|18028675|P2|Overall Study|Adverse Event|3
5222943|NCT00942188|18028676|P1|Overall Study|Adverse Event|0
5222944|NCT00942175|18028715|P4|Overall Study|Low Platelet Count|0
5222945|NCT00942175|18028716|P3|Overall Study|Low Platelet Count|0
5222946|NCT00942175|18028717|P2|Overall Study|Low Platelet Count|2
5222947|NCT00942175|18028718|P1|Overall Study|Low Platelet Count|0
5222948|NCT00942175|18028715|P4|Overall Study|Elevated Alanine Amino Transferase|1
5222949|NCT00942175|18028716|P3|Overall Study|Elevated Alanine Amino Transferase|0
5222950|NCT00942175|18028717|P2|Overall Study|Elevated Alanine Amino Transferase|0
5222951|NCT00942175|18028718|P1|Overall Study|Elevated Alanine Amino Transferase|0
5222952|NCT00942175|18028715|P4|Overall Study|Pregnancy|1
5222953|NCT00942175|18028716|P3|Overall Study|Pregnancy|0
5222954|NCT00942175|18028717|P2|Overall Study|Pregnancy|0
5222955|NCT00942175|18028718|P1|Overall Study|Pregnancy|0
5222956|NCT00942175|18028715|P4|Overall Study|Protocol Violation|0
5222957|NCT00942175|18028716|P3|Overall Study|Protocol Violation|2
5222958|NCT00942175|18028717|P2|Overall Study|Protocol Violation|1
5222959|NCT00942175|18028718|P1|Overall Study|Protocol Violation|0
5222960|NCT00942175|18028715|P4|Overall Study|Adverse Event|0
5222961|NCT00942175|18028716|P3|Overall Study|Adverse Event|0
5222962|NCT00942175|18028717|P2|Overall Study|Adverse Event|1
5222963|NCT00942175|18028718|P1|Overall Study|Adverse Event|2
5222964|NCT00942162|18028771|P3|Overall Study|Other|0
5222965|NCT00942162|18028772|P2|Overall Study|Other|2
5222966|NCT00942162|18028773|P1|Overall Study|Other|8
5222967|NCT00942162|18028771|P3|Overall Study|Withdrawal by Subject|0
5222968|NCT00942162|18028772|P2|Overall Study|Withdrawal by Subject|2
5222969|NCT00942162|18028773|P1|Overall Study|Withdrawal by Subject|4
5222970|NCT00942162|18028771|P3|Overall Study|Protocol Violation|0
5222971|NCT00942162|18028772|P2|Overall Study|Protocol Violation|0
5222972|NCT00942162|18028773|P1|Overall Study|Protocol Violation|1
5222973|NCT00942162|18028771|P3|Overall Study|Adverse Event|0
5222974|NCT00942162|18028772|P2|Overall Study|Adverse Event|0
5222975|NCT00942162|18028773|P1|Overall Study|Adverse Event|2
5222976|NCT00942162|18028771|P3|Overall Study|Disease progression|1
5222977|NCT00942162|18028772|P2|Overall Study|Disease progression|43
5222978|NCT00942162|18028773|P1|Overall Study|Disease progression|53
5222979|NCT00942084|18028842|P1|Overall Study|Death|2
5222980|NCT00941928|18028859|P1|Overall Study|Disease Progression|1
5222981|NCT00941928|18028859|P1|Overall Study|Withdrawal by Subject|1
5222982|NCT00941863|18028877|P5|Continued After PCD|Disease progression, recurrence, relapse|18
5222983|NCT00941863|18028878|P4|Continued After PCD|Disease progression, recurrence, relapse|0
5222984|NCT00941863|18028879|P3|Continued After PCD|Disease progression, recurrence, relapse|0
5222985|NCT00941863|18028880|P2|Continued After PCD|Disease progression, recurrence, relapse|0
5222986|NCT00941863|18028881|P1|Continued After PCD|Disease progression, recurrence, relapse|0
5222987|NCT00941863|18028877|P5|Continued After PCD|Withdrawal by Subject|1
5222988|NCT00941863|18028878|P4|Continued After PCD|Withdrawal by Subject|0
5222989|NCT00941863|18028879|P3|Continued After PCD|Withdrawal by Subject|0
5222990|NCT00941863|18028880|P2|Continued After PCD|Withdrawal by Subject|0
5222992|NCT00941863|18028877|P5|Until Primary Completion Date (PCD)|Disease progression|73
5222993|NCT00941863|18028878|P4|Until Primary Completion Date (PCD)|Disease progression|14
5222994|NCT00941863|18028879|P3|Until Primary Completion Date (PCD)|Disease progression|8
5222995|NCT00941863|18028880|P2|Until Primary Completion Date (PCD)|Disease progression|1
5222996|NCT00941863|18028881|P1|Until Primary Completion Date (PCD)|Disease progression|6
5222997|NCT00941863|18028877|P5|Until Primary Completion Date (PCD)|Death|7
5222998|NCT00941863|18028878|P4|Until Primary Completion Date (PCD)|Death|2
5222999|NCT00941863|18028879|P3|Until Primary Completion Date (PCD)|Death|1
5223000|NCT00941863|18028880|P2|Until Primary Completion Date (PCD)|Death|0
5223001|NCT00941863|18028881|P1|Until Primary Completion Date (PCD)|Death|0
5223002|NCT00941863|18028877|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
5223003|NCT00941863|18028878|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5223004|NCT00941863|18028879|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
5223005|NCT00941863|18028880|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5223006|NCT00941863|18028881|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5223007|NCT00941863|18028877|P5|Until Primary Completion Date (PCD)|Physician Decision|1
5223008|NCT00941863|18028878|P4|Until Primary Completion Date (PCD)|Physician Decision|0
5223009|NCT00941863|18028879|P3|Until Primary Completion Date (PCD)|Physician Decision|0
5223010|NCT00941863|18028880|P2|Until Primary Completion Date (PCD)|Physician Decision|0
5223011|NCT00941863|18028881|P1|Until Primary Completion Date (PCD)|Physician Decision|0
5223012|NCT00941863|18028877|P5|Until Primary Completion Date (PCD)|Adverse Event|5
5223013|NCT00941863|18028878|P4|Until Primary Completion Date (PCD)|Adverse Event|1
5223014|NCT00941863|18028879|P3|Until Primary Completion Date (PCD)|Adverse Event|2
5223015|NCT00941863|18028880|P2|Until Primary Completion Date (PCD)|Adverse Event|2
5223016|NCT00941863|18028881|P1|Until Primary Completion Date (PCD)|Adverse Event|1
5223017|NCT00941798|18028908|P2|Overall Study|Death|1
5223018|NCT00941798|18028909|P1|Overall Study|Death|0
5223019|NCT00941798|18028908|P2|Overall Study|Abnormal laboratory values|2
5223020|NCT00941798|18028909|P1|Overall Study|Abnormal laboratory values|1
5223021|NCT00941798|18028908|P2|Overall Study|Abnormal test procedure results|1
5223022|NCT00941798|18028909|P1|Overall Study|Abnormal test procedure results|3
5223023|NCT00941798|18028908|P2|Overall Study|Patient's inability to use device|1
5223024|NCT00941798|18028909|P1|Overall Study|Patient's inability to use device|6
5223025|NCT00941798|18028908|P2|Overall Study|Lack of Efficacy|17
5223026|NCT00941798|18028909|P1|Overall Study|Lack of Efficacy|10
5223027|NCT00941798|18028908|P2|Overall Study|Administrative problems|23
5223028|NCT00941798|18028909|P1|Overall Study|Administrative problems|13
5223029|NCT00941798|18028908|P2|Overall Study|Protocol Violation|20
5223030|NCT00941798|18028909|P1|Overall Study|Protocol Violation|17
5223031|NCT00941798|18028908|P2|Overall Study|Lost to Follow-up|23
5223032|NCT00941798|18028909|P1|Overall Study|Lost to Follow-up|29
5223033|NCT00941798|18028908|P2|Overall Study|Adverse Event|23
5223034|NCT00941798|18028909|P1|Overall Study|Adverse Event|43
5223035|NCT00941798|18028908|P2|Overall Study|Withdrawal by Subject|74
5223036|NCT00941798|18028909|P1|Overall Study|Withdrawal by Subject|72
5223037|NCT00941733|18028939|P2|Overall Study|Protocol Violation|6
5223038|NCT00941733|18028940|P1|Overall Study|Protocol Violation|15
5223039|NCT00941733|18028939|P2|Overall Study|Lost to Follow-up|2
5223040|NCT00941733|18028940|P1|Overall Study|Lost to Follow-up|1
5223041|NCT00941733|18028939|P2|Overall Study|Adverse Event|4
5223042|NCT00941733|18028940|P1|Overall Study|Adverse Event|20
5223043|NCT00941733|18028939|P2|Overall Study|Withdrawal by Subject|6
5223044|NCT00941733|18028940|P1|Overall Study|Withdrawal by Subject|14
5223045|NCT00941733|18028939|P2|Overall Study|Death|10
5223046|NCT00941733|18028940|P1|Overall Study|Death|24
5223047|NCT00941720|18028980|P1|Overall Study|ineligible|2
5223048|NCT00941720|18028980|P1|Overall Study|Insurance denied participation|11
5223049|NCT00941720|18028980|P1|Overall Study|Withdrawal by Subject|1
5223050|NCT00941655|18029027|P2|Overall Study|non-compliant|1
5223051|NCT00941655|18029028|P1|Overall Study|non-compliant|0
5223052|NCT00941655|18029027|P2|Overall Study|withdrew consent|1
5223053|NCT00941655|18029028|P1|Overall Study|withdrew consent|0
5223054|NCT00941655|18029027|P2|Overall Study|refused further treatment|1
5223055|NCT00941655|18029028|P1|Overall Study|refused further treatment|0
5223056|NCT00941655|18029027|P2|Overall Study|progressed while on chemo|2
5223057|NCT00941655|18029028|P1|Overall Study|progressed while on chemo|0
5223058|NCT00941655|18029027|P2|Overall Study|not meet criteria for chemo foll surgery|0
5223059|NCT00941655|18029028|P1|Overall Study|not meet criteria for chemo foll surgery|4
5223060|NCT00941655|18029027|P2|Overall Study|received some chemo, 4 and 9 cycles|0
5223061|NCT00941655|18029028|P1|Overall Study|received some chemo, 4 and 9 cycles|1
5223062|NCT00941603|18029053|P6|Overall Study|Did not meet protocol eligibility|0
5223063|NCT00941603|18029054|P5|Overall Study|Did not meet protocol eligibility|0
5223064|NCT00941603|18029055|P4|Overall Study|Did not meet protocol eligibility|0
5223065|NCT00941603|18029056|P3|Overall Study|Did not meet protocol eligibility|0
5223066|NCT00941603|18029057|P2|Overall Study|Did not meet protocol eligibility|0
5223067|NCT00941603|18029058|P1|Overall Study|Did not meet protocol eligibility|1
5223068|NCT00941603|18029053|P6|Overall Study|Protocol Violation|0
5223069|NCT00941603|18029054|P5|Overall Study|Protocol Violation|0
5223070|NCT00941603|18029055|P4|Overall Study|Protocol Violation|0
5223071|NCT00941603|18029056|P3|Overall Study|Protocol Violation|0
5223072|NCT00941603|18029057|P2|Overall Study|Protocol Violation|1
5223073|NCT00941603|18029058|P1|Overall Study|Protocol Violation|0
5223074|NCT00941603|18029053|P6|Overall Study|Withdrawal by Subject|1
5223075|NCT00941603|18029054|P5|Overall Study|Withdrawal by Subject|0
5223076|NCT00941603|18029055|P4|Overall Study|Withdrawal by Subject|2
5223077|NCT00941603|18029056|P3|Overall Study|Withdrawal by Subject|0
5223078|NCT00941603|18029057|P2|Overall Study|Withdrawal by Subject|0
5223079|NCT00941603|18029058|P1|Overall Study|Withdrawal by Subject|0
5223080|NCT00941603|18029053|P6|Overall Study|Lost to Follow-up|2
5223081|NCT00941603|18029054|P5|Overall Study|Lost to Follow-up|0
5223082|NCT00941603|18029055|P4|Overall Study|Lost to Follow-up|1
5223083|NCT00941603|18029056|P3|Overall Study|Lost to Follow-up|0
5223084|NCT00941603|18029057|P2|Overall Study|Lost to Follow-up|0
5223085|NCT00941603|18029058|P1|Overall Study|Lost to Follow-up|0
5223086|NCT00941603|18029053|P6|Overall Study|Adverse Event|0
5223087|NCT00941603|18029054|P5|Overall Study|Adverse Event|4
5223088|NCT00941603|18029055|P4|Overall Study|Adverse Event|1
5223089|NCT00941603|18029056|P3|Overall Study|Adverse Event|5
5223090|NCT00941603|18029057|P2|Overall Study|Adverse Event|15
5223091|NCT00941603|18029058|P1|Overall Study|Adverse Event|10
5223092|NCT00941330|18029080|P2|Overall Study|Physician Decision|2
5223093|NCT00941330|18029081|P1|Overall Study|Physician Decision|0
5223094|NCT00941330|18029080|P2|Overall Study|Other|0
5223095|NCT00941330|18029081|P1|Overall Study|Other|1
5223096|NCT00941304|18029094|P5|Overall Study|Lost to Follow-up|0
5223097|NCT00941304|18029095|P4|Overall Study|Lost to Follow-up|0
5223098|NCT00941304|18029096|P3|Overall Study|Lost to Follow-up|0
5223099|NCT00941304|18029097|P2|Overall Study|Lost to Follow-up|0
5223100|NCT00941304|18029098|P1|Overall Study|Lost to Follow-up|1
5223101|NCT00941070|18029160|P1|Overall Study|Patient non-compliant|1
5223102|NCT00941031|18029180|P7|Maintenance Period|Lack of Efficacy|13
5223103|NCT00941031|18029181|P6|Maintenance Period|Lack of Efficacy|0
5223104|NCT00941031|18029182|P5|Maintenance Period|Lack of Efficacy|0
5223105|NCT00941031|18029183|P4|Maintenance Period|Lack of Efficacy|0
5223106|NCT00941031|18029184|P3|Maintenance Period|Lack of Efficacy|0
5223107|NCT00941031|18029185|P2|Maintenance Period|Lack of Efficacy|0
5223108|NCT00941031|18029186|P1|Maintenance Period|Lack of Efficacy|0
5223109|NCT00941031|18029180|P7|Maintenance Period|Lost to Follow-up|7
5223110|NCT00941031|18029181|P6|Maintenance Period|Lost to Follow-up|2
5223111|NCT00941031|18029182|P5|Maintenance Period|Lost to Follow-up|2
5223112|NCT00941031|18029183|P4|Maintenance Period|Lost to Follow-up|0
5223113|NCT00941031|18029184|P3|Maintenance Period|Lost to Follow-up|0
5223114|NCT00941031|18029185|P2|Maintenance Period|Lost to Follow-up|0
5223115|NCT00941031|18029186|P1|Maintenance Period|Lost to Follow-up|0
5223116|NCT00941031|18029180|P7|Maintenance Period|Adverse Event|8
5223117|NCT00941031|18029181|P6|Maintenance Period|Adverse Event|2
5223118|NCT00941031|18029182|P5|Maintenance Period|Adverse Event|0
5223119|NCT00941031|18029183|P4|Maintenance Period|Adverse Event|0
5223120|NCT00941031|18029184|P3|Maintenance Period|Adverse Event|0
5223121|NCT00941031|18029185|P2|Maintenance Period|Adverse Event|0
5223122|NCT00941031|18029186|P1|Maintenance Period|Adverse Event|0
5223123|NCT00941031|18029180|P7|Maintenance Period|Protocol Violation|1
5223124|NCT00941031|18029181|P6|Maintenance Period|Protocol Violation|0
5223125|NCT00941031|18029182|P5|Maintenance Period|Protocol Violation|0
5223126|NCT00941031|18029183|P4|Maintenance Period|Protocol Violation|0
5223127|NCT00941031|18029184|P3|Maintenance Period|Protocol Violation|0
5223128|NCT00941031|18029185|P2|Maintenance Period|Protocol Violation|0
5223129|NCT00941031|18029186|P1|Maintenance Period|Protocol Violation|0
5223130|NCT00941031|18029180|P7|Maintenance Period|Administrative Problems|1
5223131|NCT00941031|18029181|P6|Maintenance Period|Administrative Problems|0
5223132|NCT00941031|18029182|P5|Maintenance Period|Administrative Problems|1
5223133|NCT00941031|18029183|P4|Maintenance Period|Administrative Problems|0
5223134|NCT00941031|18029184|P3|Maintenance Period|Administrative Problems|0
5223135|NCT00941031|18029185|P2|Maintenance Period|Administrative Problems|0
5223136|NCT00941031|18029186|P1|Maintenance Period|Administrative Problems|0
5223137|NCT00941031|18029180|P7|Maintenance Period|Withdrawal by Subject|13
5223138|NCT00941031|18029181|P6|Maintenance Period|Withdrawal by Subject|2
5223139|NCT00941031|18029182|P5|Maintenance Period|Withdrawal by Subject|6
5223140|NCT00941031|18029183|P4|Maintenance Period|Withdrawal by Subject|0
5223141|NCT00941031|18029184|P3|Maintenance Period|Withdrawal by Subject|0
5223142|NCT00941031|18029185|P2|Maintenance Period|Withdrawal by Subject|0
5223143|NCT00941031|18029186|P1|Maintenance Period|Withdrawal by Subject|0
5223144|NCT00941031|18029180|P7|Induction Period|Adverse Event|0
5223145|NCT00941031|18029181|P6|Induction Period|Adverse Event|0
5223146|NCT00941031|18029182|P5|Induction Period|Adverse Event|0
5223147|NCT00941031|18029183|P4|Induction Period|Adverse Event|2
5223148|NCT00941031|18029184|P3|Induction Period|Adverse Event|3
5223149|NCT00941031|18029185|P2|Induction Period|Adverse Event|0
5223150|NCT00941031|18029186|P1|Induction Period|Adverse Event|1
5223151|NCT00941031|18029180|P7|Induction Period|Adminstative Problems|0
5223152|NCT00941031|18029181|P6|Induction Period|Adminstative Problems|0
5223153|NCT00941031|18029182|P5|Induction Period|Adminstative Problems|0
5223154|NCT00941031|18029183|P4|Induction Period|Adminstative Problems|0
5223155|NCT00941031|18029184|P3|Induction Period|Adminstative Problems|1
5223156|NCT00941031|18029185|P2|Induction Period|Adminstative Problems|1
5223157|NCT00941031|18029186|P1|Induction Period|Adminstative Problems|1
5223158|NCT00941031|18029180|P7|Induction Period|Withdrawal by Subject|0
5223159|NCT00941031|18029181|P6|Induction Period|Withdrawal by Subject|0
5223160|NCT00941031|18029182|P5|Induction Period|Withdrawal by Subject|0
5223161|NCT00941031|18029183|P4|Induction Period|Withdrawal by Subject|2
5223162|NCT00941031|18029184|P3|Induction Period|Withdrawal by Subject|2
5223163|NCT00941031|18029185|P2|Induction Period|Withdrawal by Subject|2
5223164|NCT00941031|18029186|P1|Induction Period|Withdrawal by Subject|1
5223165|NCT00941031|18029180|P7|Induction Period|Lack of Efficacy|0
5223166|NCT00941031|18029181|P6|Induction Period|Lack of Efficacy|0
5223167|NCT00941031|18029182|P5|Induction Period|Lack of Efficacy|0
5223168|NCT00941031|18029183|P4|Induction Period|Lack of Efficacy|5
5223169|NCT00941031|18029184|P3|Induction Period|Lack of Efficacy|0
5223170|NCT00941031|18029185|P2|Induction Period|Lack of Efficacy|1
5223171|NCT00941031|18029186|P1|Induction Period|Lack of Efficacy|2
5223172|NCT00940992|18029233|P3|Overall Study|Lost to Follow-up|1
5223173|NCT00940992|18029234|P2|Overall Study|Lost to Follow-up|1
5223174|NCT00940992|18029235|P1|Overall Study|Lost to Follow-up|0
5223175|NCT00940992|18029233|P3|Overall Study|subject request|0
5223176|NCT00940992|18029234|P2|Overall Study|subject request|1
5223177|NCT00940992|18029235|P1|Overall Study|subject request|2
5223178|NCT00940992|18029233|P3|Overall Study|Adverse Event|1
5223179|NCT00940992|18029234|P2|Overall Study|Adverse Event|0
5223180|NCT00940992|18029235|P1|Overall Study|Adverse Event|2
5223181|NCT00940888|18029264|P1|Overall Study|Lost to Follow-up|6
5223182|NCT00940888|18029264|P1|Overall Study|Withdrawn - Non-Death|364
5223183|NCT00940888|18029264|P1|Overall Study|Death|461
5223184|NCT00940888|18029264|P1|Overall Study|Unsuccessful Implant|4
5223185|NCT00940875|18029271|P2|Post-Study Treatment|Disease Progression|2
5223186|NCT00940875|18029272|P1|Post-Study Treatment|Disease Progression|0
5223187|NCT00940875|18029271|P2|Post-Study Treatment|Death|1
5223188|NCT00940875|18029272|P1|Post-Study Treatment|Death|0
5223189|NCT00940875|18029271|P2|Treatment Phase|Physician Decision|0
5223190|NCT00940875|18029272|P1|Treatment Phase|Physician Decision|1
5223191|NCT00940875|18029271|P2|Treatment Phase|Disease progression|11
5223192|NCT00940875|18029272|P1|Treatment Phase|Disease progression|9
5223193|NCT00940875|18029271|P2|Treatment Phase|Withdrawal by Subject|0
5223194|NCT00940875|18029272|P1|Treatment Phase|Withdrawal by Subject|3
5223195|NCT00940875|18029271|P2|Treatment Phase|Lack of Efficacy|0
5223196|NCT00940875|18029272|P1|Treatment Phase|Lack of Efficacy|1
5223197|NCT00940875|18029271|P2|Treatment Phase|Death|5
5223198|NCT00940875|18029272|P1|Treatment Phase|Death|3
5223199|NCT00940875|18029271|P2|Treatment Phase|Adverse Event|3
5223200|NCT00940875|18029272|P1|Treatment Phase|Adverse Event|9
5223201|NCT00940823|18029292|P2|Overall Study|Lost to Follow-up|20
5223202|NCT00940823|18029293|P1|Overall Study|Lost to Follow-up|27
5223203|NCT00940823|18029292|P2|Overall Study|Death|12
5223204|NCT00940823|18029293|P1|Overall Study|Death|8
5223205|NCT00940602|18029318|P2|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
5223206|NCT00940602|18029319|P1|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
5223207|NCT00940602|18029318|P2|Overall Study|Adverse Event|2
5223208|NCT00940602|18029319|P1|Overall Study|Adverse Event|7
5223209|NCT00940602|18029318|P2|Overall Study|Patient withdrew consent|13
5223210|NCT00940602|18029319|P1|Overall Study|Patient withdrew consent|26
5223211|NCT00940602|18029318|P2|Overall Study|Lost to Follow-up|1
5223212|NCT00940602|18029319|P1|Overall Study|Lost to Follow-up|3
5223213|NCT00940602|18029318|P2|Overall Study|Death|19
5223214|NCT00940602|18029319|P1|Overall Study|Death|38
5223215|NCT00940602|18029318|P2|Overall Study|Disease progression|2
5223216|NCT00940602|18029319|P1|Overall Study|Disease progression|8
5223217|NCT00940602|18029318|P2|Overall Study|Protocol Deviation (untreated)|0
5223218|NCT00940602|18029319|P1|Overall Study|Protocol Deviation (untreated)|1
5223219|NCT00940602|18029318|P2|Overall Study|Pregnancy|0
5223220|NCT00940602|18029319|P1|Overall Study|Pregnancy|1
5223221|NCT00940602|18029318|P2|Overall Study|Physician Decision|5
5223222|NCT00940602|18029319|P1|Overall Study|Physician Decision|8
5223223|NCT00940602|18029318|P2|Overall Study|Patient/guardian decision|28
5223224|NCT00940602|18029319|P1|Overall Study|Patient/guardian decision|13
5223225|NCT00940602|18029318|P2|Overall Study|Administrative problems|1
5223226|NCT00940602|18029319|P1|Overall Study|Administrative problems|1
5223227|NCT00940498|18029397|P8|Overall Study|Not treated due to disease related pain|0
5223228|NCT00940498|18029398|P7|Overall Study|Not treated due to disease related pain|0
5223229|NCT00940498|18029399|P6|Overall Study|Not treated due to disease related pain|0
5223230|NCT00940498|18029400|P5|Overall Study|Not treated due to disease related pain|1
5223231|NCT00940498|18029401|P4|Overall Study|Not treated due to disease related pain|0
5223232|NCT00940498|18029402|P3|Overall Study|Not treated due to disease related pain|0
5223233|NCT00940498|18029403|P2|Overall Study|Not treated due to disease related pain|0
5223234|NCT00940498|18029404|P1|Overall Study|Not treated due to disease related pain|0
5223235|NCT00940498|18029397|P8|Overall Study|Physician Decision|0
5223236|NCT00940498|18029398|P7|Overall Study|Physician Decision|0
5223237|NCT00940498|18029399|P6|Overall Study|Physician Decision|0
5223238|NCT00940498|18029400|P5|Overall Study|Physician Decision|2
5223239|NCT00940498|18029401|P4|Overall Study|Physician Decision|0
5223240|NCT00940498|18029402|P3|Overall Study|Physician Decision|0
5223241|NCT00940498|18029403|P2|Overall Study|Physician Decision|0
5223242|NCT00940498|18029404|P1|Overall Study|Physician Decision|0
5223243|NCT00940498|18029397|P8|Overall Study|Disease Progression|0
5223244|NCT00940498|18029398|P7|Overall Study|Disease Progression|0
5223245|NCT00940498|18029399|P6|Overall Study|Disease Progression|1
5223246|NCT00940498|18029400|P5|Overall Study|Disease Progression|0
5223247|NCT00940498|18029401|P4|Overall Study|Disease Progression|1
5223248|NCT00940498|18029402|P3|Overall Study|Disease Progression|1
5223249|NCT00940498|18029403|P2|Overall Study|Disease Progression|0
5223250|NCT00940498|18029404|P1|Overall Study|Disease Progression|0
5223251|NCT00940498|18029397|P8|Overall Study|Lost to Follow-up|1
5223252|NCT00940498|18029398|P7|Overall Study|Lost to Follow-up|0
5223253|NCT00940498|18029399|P6|Overall Study|Lost to Follow-up|0
5223254|NCT00940498|18029400|P5|Overall Study|Lost to Follow-up|1
5223255|NCT00940498|18029401|P4|Overall Study|Lost to Follow-up|0
5223256|NCT00940498|18029402|P3|Overall Study|Lost to Follow-up|2
5223257|NCT00940498|18029403|P2|Overall Study|Lost to Follow-up|1
5223258|NCT00940498|18029404|P1|Overall Study|Lost to Follow-up|1
5223259|NCT00940498|18029397|P8|Overall Study|Death|0
5223260|NCT00940498|18029398|P7|Overall Study|Death|1
5223261|NCT00940498|18029399|P6|Overall Study|Death|0
5223262|NCT00940498|18029400|P5|Overall Study|Death|5
5223263|NCT00940498|18029401|P4|Overall Study|Death|1
5223264|NCT00940498|18029402|P3|Overall Study|Death|0
5223265|NCT00940498|18029403|P2|Overall Study|Death|0
5223266|NCT00940498|18029404|P1|Overall Study|Death|2
5223267|NCT00940485|18029522|P2|Overall Study|Others|1
5223268|NCT00940485|18029523|P1|Overall Study|Others|1
5223269|NCT00940485|18029522|P2|Overall Study|Withdrawal by Subject|1
5223270|NCT00940485|18029523|P1|Overall Study|Withdrawal by Subject|1
5223271|NCT00940485|18029522|P2|Overall Study|Adverse Event|0
5223272|NCT00940485|18029523|P1|Overall Study|Adverse Event|8
5223273|NCT00940485|18029522|P2|Overall Study|Lost to Follow-up|3
5223274|NCT00940485|18029523|P1|Overall Study|Lost to Follow-up|2
5223275|NCT00940485|18029522|P2|Overall Study|HBeAb positive at Baseline|2
5223276|NCT00940485|18029523|P1|Overall Study|HBeAb positive at Baseline|3
5223277|NCT00940342|18029561|P3|Overall Study|Adverse Event|1
5223278|NCT00940342|18029562|P2|Overall Study|Adverse Event|2
5223279|NCT00940342|18029563|P1|Overall Study|Adverse Event|0
5223280|NCT00940316|18029574|P3|Treated After Cycle 5|Progressive disease|0
5223281|NCT00940316|18029575|P2|Treated After Cycle 5|Progressive disease|1
5223282|NCT00940316|18029576|P1|Treated After Cycle 5|Progressive disease|0
5223283|NCT00940316|18029574|P3|Treated After Cycle 5|Adverse Event|1
5223284|NCT00940316|18029575|P2|Treated After Cycle 5|Adverse Event|0
5223285|NCT00940316|18029576|P1|Treated After Cycle 5|Adverse Event|0
5223286|NCT00940316|18029574|P3|Moved on to be Treated Cycle 5|Adverse Event|0
5223287|NCT00940316|18029575|P2|Moved on to be Treated Cycle 5|Adverse Event|0
5223288|NCT00940316|18029576|P1|Moved on to be Treated Cycle 5|Adverse Event|2
5223289|NCT00940316|18029574|P3|Reached First Response at 8 Weeks|Progressive disease|0
5223290|NCT00940316|18029575|P2|Reached First Response at 8 Weeks|Progressive disease|3
5223291|NCT00940316|18029576|P1|Reached First Response at 8 Weeks|Progressive disease|1
5223292|NCT00940316|18029574|P3|Reached First Response at 8 Weeks|Adverse Event|0
5223293|NCT00940316|18029575|P2|Reached First Response at 8 Weeks|Adverse Event|1
5223294|NCT00940316|18029576|P1|Reached First Response at 8 Weeks|Adverse Event|2
5223295|NCT00940108|18029619|P4|Overall Study|Diagnosed with H1N1|1
5223296|NCT00940108|18029620|P3|Overall Study|Diagnosed with H1N1|0
5223297|NCT00940108|18029621|P2|Overall Study|Diagnosed with H1N1|0
5223298|NCT00940108|18029622|P1|Overall Study|Diagnosed with H1N1|0
5223299|NCT00940108|18029619|P4|Overall Study|Viral illness after Dose 1|0
5223300|NCT00940108|18029620|P3|Overall Study|Viral illness after Dose 1|0
5223301|NCT00940108|18029621|P2|Overall Study|Viral illness after Dose 1|1
5223302|NCT00940108|18029622|P1|Overall Study|Viral illness after Dose 1|0
5223303|NCT00940108|18029619|P4|Overall Study|Refused - pyrexia after Dose 1|0
5223304|NCT00940108|18029620|P3|Overall Study|Refused - pyrexia after Dose 1|0
5223305|NCT00940108|18029621|P2|Overall Study|Refused - pyrexia after Dose 1|1
5223306|NCT00940108|18029622|P1|Overall Study|Refused - pyrexia after Dose 1|0
5223307|NCT00940108|18029619|P4|Overall Study|Declined further vaccination|0
5223308|NCT00940108|18029620|P3|Overall Study|Declined further vaccination|3
5223309|NCT00940108|18029621|P2|Overall Study|Declined further vaccination|1
5223310|NCT00940108|18029622|P1|Overall Study|Declined further vaccination|0
5223311|NCT00940108|18029619|P4|Overall Study|Dose 2 contraindicated|1
5223312|NCT00940108|18029620|P3|Overall Study|Dose 2 contraindicated|0
5223313|NCT00940108|18029621|P2|Overall Study|Dose 2 contraindicated|1
5223314|NCT00940108|18029622|P1|Overall Study|Dose 2 contraindicated|1
5223315|NCT00940108|18029619|P4|Overall Study|Withdrew Consent|1
5223316|NCT00940108|18029620|P3|Overall Study|Withdrew Consent|0
5223317|NCT00940108|18029621|P2|Overall Study|Withdrew Consent|1
5223318|NCT00940108|18029622|P1|Overall Study|Withdrew Consent|2
5223319|NCT00940108|18029619|P4|Overall Study|Adverse Event|2
5223320|NCT00940108|18029620|P3|Overall Study|Adverse Event|0
5223321|NCT00940108|18029621|P2|Overall Study|Adverse Event|4
5223322|NCT00940108|18029622|P1|Overall Study|Adverse Event|2
5223323|NCT00940017|18029672|P1|Overall Study|Adverse Event|1
5223324|NCT00940017|18029672|P1|Overall Study|did not meet entrance criteria|3
5223325|NCT00939822|18029730|P2|Overall Study|Mental health issues|2
5223326|NCT00939822|18029731|P1|Overall Study|Mental health issues|0
5223327|NCT00939822|18029730|P2|Overall Study|withdrew from study due to busy schedule|1
5223328|NCT00939822|18029731|P1|Overall Study|withdrew from study due to busy schedule|1
5223329|NCT00939822|18029730|P2|Overall Study|Lost to Follow-up|0
5223330|NCT00939822|18029731|P1|Overall Study|Lost to Follow-up|1
5223331|NCT00939809|18029743|P1|Overall Study|Death|1
5223332|NCT00939809|18029743|P1|Overall Study|Adverse Event|2
5223333|NCT00939783|18029758|P1|Overall Study|Enrolled but not treated|1
5223334|NCT00939783|18029758|P1|Overall Study|Protocol Violation|3
5223335|NCT00939783|18029758|P1|Overall Study|Lost to Follow-up|8
5223336|NCT00939783|18029758|P1|Overall Study|Other|16
5223337|NCT00939783|18029758|P1|Overall Study|Withdrawal by Subject|78
5223338|NCT00939783|18029758|P1|Overall Study|Study Terminated by Sponsor|498
5223339|NCT00939783|18029758|P1|Overall Study|Adverse Event|39
5223340|NCT00939783|18029758|P1|Overall Study|Death|6
5223341|NCT00939770|18029773|P8|Overall Study|Withdrawal by Subject|2
5223342|NCT00939770|18029774|P7|Overall Study|Withdrawal by Subject|2
5223343|NCT00939770|18029775|P6|Overall Study|Withdrawal by Subject|0
5223344|NCT00939770|18029776|P5|Overall Study|Withdrawal by Subject|6
5223345|NCT00939770|18029777|P4|Overall Study|Withdrawal by Subject|2
5223346|NCT00939770|18029778|P3|Overall Study|Withdrawal by Subject|5
5223347|NCT00939770|18029779|P2|Overall Study|Withdrawal by Subject|1
5223348|NCT00939770|18029780|P1|Overall Study|Withdrawal by Subject|0
5223349|NCT00939770|18029773|P8|Overall Study|Protocol Violation|0
5223350|NCT00939770|18029774|P7|Overall Study|Protocol Violation|0
5223351|NCT00939770|18029775|P6|Overall Study|Protocol Violation|0
5223352|NCT00939770|18029776|P5|Overall Study|Protocol Violation|1
5223353|NCT00939770|18029777|P4|Overall Study|Protocol Violation|0
5223354|NCT00939770|18029778|P3|Overall Study|Protocol Violation|0
5223355|NCT00939770|18029779|P2|Overall Study|Protocol Violation|0
5223356|NCT00939770|18029780|P1|Overall Study|Protocol Violation|0
5223357|NCT00939770|18029773|P8|Overall Study|Physician Decision|6
5223358|NCT00939770|18029774|P7|Overall Study|Physician Decision|0
5223359|NCT00939770|18029775|P6|Overall Study|Physician Decision|1
5223360|NCT00939770|18029776|P5|Overall Study|Physician Decision|7
5223361|NCT00939770|18029777|P4|Overall Study|Physician Decision|0
5223362|NCT00939770|18029778|P3|Overall Study|Physician Decision|2
5223363|NCT00939770|18029779|P2|Overall Study|Physician Decision|0
5223364|NCT00939770|18029780|P1|Overall Study|Physician Decision|0
5223365|NCT00939770|18029773|P8|Overall Study|Lost to Follow-up|0
5223366|NCT00939770|18029774|P7|Overall Study|Lost to Follow-up|0
5223367|NCT00939770|18029775|P6|Overall Study|Lost to Follow-up|0
5223368|NCT00939770|18029776|P5|Overall Study|Lost to Follow-up|1
5223369|NCT00939770|18029777|P4|Overall Study|Lost to Follow-up|0
5223370|NCT00939770|18029778|P3|Overall Study|Lost to Follow-up|0
5223371|NCT00939770|18029779|P2|Overall Study|Lost to Follow-up|0
5223372|NCT00939770|18029780|P1|Overall Study|Lost to Follow-up|0
5223373|NCT00939770|18029773|P8|Overall Study|Lack of Efficacy|1
5223374|NCT00939770|18029774|P7|Overall Study|Lack of Efficacy|11
5223375|NCT00939770|18029775|P6|Overall Study|Lack of Efficacy|8
5223376|NCT00939770|18029776|P5|Overall Study|Lack of Efficacy|16
5223377|NCT00939770|18029777|P4|Overall Study|Lack of Efficacy|9
5223378|NCT00939770|18029778|P3|Overall Study|Lack of Efficacy|13
5223379|NCT00939770|18029779|P2|Overall Study|Lack of Efficacy|6
5223380|NCT00939770|18029780|P1|Overall Study|Lack of Efficacy|4
5223381|NCT00939770|18029773|P8|Overall Study|Adverse Event|1
5223382|NCT00939770|18029774|P7|Overall Study|Adverse Event|1
5223383|NCT00939770|18029775|P6|Overall Study|Adverse Event|2
5223384|NCT00939770|18029776|P5|Overall Study|Adverse Event|6
5223385|NCT00939770|18029777|P4|Overall Study|Adverse Event|0
5223386|NCT00939770|18029778|P3|Overall Study|Adverse Event|0
5223387|NCT00939770|18029779|P2|Overall Study|Adverse Event|1
5223388|NCT00939770|18029780|P1|Overall Study|Adverse Event|1
5223389|NCT00939692|18029865|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
5223390|NCT00939692|18029866|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
5223391|NCT00939692|18029865|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
5223392|NCT00939692|18029866|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
5223393|NCT00939640|18029881|P1|Overall Study|Physician Decision|1
5223394|NCT00939627|18029902|P3|Overall Study|No off-tx reason given|0
5223395|NCT00939627|18029903|P2|Overall Study|No off-tx reason given|2
5223396|NCT00939627|18029904|P1|Overall Study|No off-tx reason given|0
5223397|NCT00939627|18029902|P3|Overall Study|Not compliant|0
5223398|NCT00939627|18029903|P2|Overall Study|Not compliant|0
5223399|NCT00939627|18029904|P1|Overall Study|Not compliant|2
5223400|NCT00939627|18029902|P3|Overall Study|Other complicating disease|0
5223401|NCT00939627|18029903|P2|Overall Study|Other complicating disease|1
5223402|NCT00939627|18029904|P1|Overall Study|Other complicating disease|1
5223403|NCT00939627|18029902|P3|Overall Study|Withdrawal by Subject|0
5223404|NCT00939627|18029903|P2|Overall Study|Withdrawal by Subject|4
5223405|NCT00939627|18029904|P1|Overall Study|Withdrawal by Subject|2
5223406|NCT00939627|18029902|P3|Overall Study|Death|0
5223407|NCT00939627|18029903|P2|Overall Study|Death|2
5223408|NCT00939627|18029904|P1|Overall Study|Death|0
5223409|NCT00939627|18029902|P3|Overall Study|Adverse Event|0
5223410|NCT00939627|18029903|P2|Overall Study|Adverse Event|7
5223411|NCT00939627|18029904|P1|Overall Study|Adverse Event|6
5223412|NCT00939627|18029902|P3|Overall Study|Disease Progression|0
5223413|NCT00939627|18029903|P2|Overall Study|Disease Progression|12
5223414|NCT00939627|18029904|P1|Overall Study|Disease Progression|16
5223415|NCT00939523|18029944|P1|Overall Study|Physician Decision|2
5223416|NCT00939523|18029944|P1|Overall Study|Lack of Efficacy|1
5223417|NCT00939510|18029951|P1|Overall Study|Withdrawal by Subject|1
5223418|NCT00939484|18029960|P3|Overall Study|Progression/Relapse|3
5223419|NCT00939484|18029961|P2|Overall Study|Progression/Relapse|20
5223420|NCT00939484|18029962|P1|Overall Study|Progression/Relapse|8
5223421|NCT00939393|18029988|P2|Overall Study|Lost to Follow-up|0
5223422|NCT00939393|18029989|P1|Overall Study|Lost to Follow-up|3
5223423|NCT00939393|18029988|P2|Overall Study|Withdrawal by Subject|0
5223424|NCT00939393|18029989|P1|Overall Study|Withdrawal by Subject|1
5223425|NCT00939341|18030020|P1|Overall Study|Incorrect enrolment|8
5223426|NCT00939341|18030020|P1|Overall Study|Protocol Violation|6
5223427|NCT00939341|18030020|P1|Overall Study|Withdrawal by Subject|13
5223428|NCT00939341|18030020|P1|Overall Study|Lost to Follow-up|23
5223429|NCT00939341|18030020|P1|Overall Study|Pregnancy|1
5223430|NCT00939341|18030020|P1|Overall Study|Adverse Event|15
5223431|NCT00939185|18030107|P1|Overall Study|Randomized But Did Not Receive Treatment|10
5223432|NCT00939185|18030107|P1|Overall Study|Withdrawal by Subject|2
5223433|NCT00939185|18030107|P1|Overall Study|Other|3
5223434|NCT00939185|18030107|P1|Overall Study|Lost to Follow-up|6
5223435|NCT00939185|18030107|P1|Overall Study|Lack of Efficacy|1
5223436|NCT00939185|18030107|P1|Overall Study|Adverse Event|3
5223437|NCT00939107|18030145|P2|Overall Study|Lost to Follow-up|12
5223438|NCT00939107|18030146|P1|Overall Study|Lost to Follow-up|14
5223439|NCT00939094|18030160|P2|Overall Study|Abnormal ECG findings|0
5223440|NCT00939094|18030161|P1|Overall Study|Abnormal ECG findings|1
5223441|NCT00939094|18030160|P2|Overall Study|Study stopped by sponsor|2
5223442|NCT00939094|18030161|P1|Overall Study|Study stopped by sponsor|0
5223443|NCT00939094|18030160|P2|Overall Study|Severe non-compliance to protocol|1
5223444|NCT00939094|18030161|P1|Overall Study|Severe non-compliance to protocol|0
5223445|NCT00939094|18030160|P2|Overall Study|Eligibility criteria not fulfilled|0
5223446|NCT00939094|18030161|P1|Overall Study|Eligibility criteria not fulfilled|2
5223447|NCT00939094|18030160|P2|Overall Study|Lost to Follow-up|1
5223448|NCT00939094|18030161|P1|Overall Study|Lost to Follow-up|1
5223449|NCT00939094|18030160|P2|Overall Study|Withdrawal by Subject|6
5223450|NCT00939094|18030161|P1|Overall Study|Withdrawal by Subject|1
5223451|NCT00939094|18030160|P2|Overall Study|Adverse Event|0
5223452|NCT00939094|18030161|P1|Overall Study|Adverse Event|9
5223453|NCT00939055|18030183|P2|Overall Study|Discontinuation prior to procedure|0
5223454|NCT00939055|18030184|P1|Overall Study|Discontinuation prior to procedure|4
5223455|NCT00939029|18030194|P2|Overall Study|Adverse Event|1
5223456|NCT00939029|18030195|P1|Overall Study|Adverse Event|0
5223457|NCT00939029|18030194|P2|Overall Study|Lost to Follow-up|4
5223458|NCT00939029|18030195|P1|Overall Study|Lost to Follow-up|3
5223459|NCT00939029|18030194|P2|Overall Study|Withdrawal by Subject|7
5223460|NCT00939029|18030195|P1|Overall Study|Withdrawal by Subject|3
5223461|NCT00939003|18030207|P2|Open-label Treatment Period|Site Closure|4
5223462|NCT00939003|18030208|P1|Open-label Treatment Period|Site Closure|3
5223463|NCT00939003|18030207|P2|Open-label Treatment Period|Exclusion Criteria|0
5223464|NCT00939003|18030208|P1|Open-label Treatment Period|Exclusion Criteria|1
5223465|NCT00939003|18030207|P2|Open-label Treatment Period|Pregnancy|1
5223466|NCT00939003|18030208|P1|Open-label Treatment Period|Pregnancy|1
5223467|NCT00939003|18030207|P2|Open-label Treatment Period|Lack of Efficacy|9
5223468|NCT00939003|18030208|P1|Open-label Treatment Period|Lack of Efficacy|6
5223469|NCT00939003|18030207|P2|Open-label Treatment Period|Withdrawal by Subject|7
5223470|NCT00939003|18030208|P1|Open-label Treatment Period|Withdrawal by Subject|14
5223471|NCT00939003|18030207|P2|Open-label Treatment Period|Adverse Event|8
5223472|NCT00939003|18030208|P1|Open-label Treatment Period|Adverse Event|4
5223473|NCT00939003|18030207|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
5223474|NCT00939003|18030208|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
5223475|NCT00939003|18030207|P2|Double-blind Treatment Period|Pregnancy|1
5223476|NCT00939003|18030208|P1|Double-blind Treatment Period|Pregnancy|0
5223477|NCT00939003|18030207|P2|Double-blind Treatment Period|Lack of Efficacy|1
5223478|NCT00939003|18030208|P1|Double-blind Treatment Period|Lack of Efficacy|0
5223479|NCT00939003|18030207|P2|Double-blind Treatment Period|Adverse Event|1
5223480|NCT00939003|18030208|P1|Double-blind Treatment Period|Adverse Event|1
5223481|NCT00938964|18030245|P2|Overall Study|Found to Meet Exclusion Criteria|4
5223482|NCT00938964|18030246|P1|Overall Study|Found to Meet Exclusion Criteria|3
5223483|NCT00938964|18030245|P2|Overall Study|Withdrawal by Subject|18
5223484|NCT00938964|18030246|P1|Overall Study|Withdrawal by Subject|22
5223485|NCT00938964|18030245|P2|Overall Study|Lost to Follow-up|3
5223486|NCT00938964|18030246|P1|Overall Study|Lost to Follow-up|2
5223487|NCT00938964|18030245|P2|Overall Study|Death|3
5223488|NCT00938964|18030246|P1|Overall Study|Death|3
5223489|NCT00938886|18030310|P2|Overall Study|Lost to Follow-up|2
5223490|NCT00938886|18030311|P1|Overall Study|Lost to Follow-up|3
5223491|NCT00938886|18030310|P2|Overall Study|Withdrawal by Subject|7
5223492|NCT00938886|18030311|P1|Overall Study|Withdrawal by Subject|4
5223493|NCT00938886|18030310|P2|Overall Study|Death|1
5223494|NCT00938886|18030311|P1|Overall Study|Death|0
5223495|NCT00938860|18030321|P2|Overall Study|Protocol Violation|1
5223496|NCT00938860|18030322|P1|Overall Study|Protocol Violation|3
5223497|NCT00938860|18030321|P2|Overall Study|Death|1
5223498|NCT00938860|18030322|P1|Overall Study|Death|1
5223499|NCT00938860|18030321|P2|Overall Study|Administration problems|0
5223500|NCT00938860|18030322|P1|Overall Study|Administration problems|2
5223501|NCT00938860|18030321|P2|Overall Study|Lost to Follow-up|4
5223502|NCT00938860|18030322|P1|Overall Study|Lost to Follow-up|4
5223503|NCT00938860|18030321|P2|Overall Study|Withdrawal by Subject|8
5223504|NCT00938860|18030322|P1|Overall Study|Withdrawal by Subject|11
5223505|NCT00938860|18030321|P2|Overall Study|Abnormal laboratory values|2
5223506|NCT00938860|18030322|P1|Overall Study|Abnormal laboratory values|2
5223507|NCT00938860|18030321|P2|Overall Study|Adverse Event|1
5223508|NCT00938860|18030322|P1|Overall Study|Adverse Event|2
5223509|NCT00938717|18030355|P2|Overall Study|Other reason|2
5223510|NCT00938717|18030356|P1|Overall Study|Other reason|5
5223511|NCT00938717|18030355|P2|Overall Study|Lack of Efficacy|15
5223512|NCT00938717|18030356|P1|Overall Study|Lack of Efficacy|33
5223513|NCT00938717|18030355|P2|Overall Study|Lost to Follow-up|18
5223514|NCT00938717|18030356|P1|Overall Study|Lost to Follow-up|13
5223515|NCT00938717|18030355|P2|Overall Study|Withdrawal by Subject|24
5223516|NCT00938717|18030356|P1|Overall Study|Withdrawal by Subject|26
5223517|NCT00938717|18030355|P2|Overall Study|Protocol Violation|8
5223518|NCT00938717|18030356|P1|Overall Study|Protocol Violation|11
5223519|NCT00938717|18030355|P2|Overall Study|Adverse Event|41
5223520|NCT00938717|18030356|P1|Overall Study|Adverse Event|10
5223521|NCT00938639|18030407|P2|Overall Study|Participant noncompliance|0
5223522|NCT00938639|18030408|P1|Overall Study|Participant noncompliance|1
5223523|NCT00938639|18030407|P2|Overall Study|Family issues|1
5223524|NCT00938639|18030408|P1|Overall Study|Family issues|1
5223525|NCT00938639|18030407|P2|Overall Study|Lost to Follow-up|2
5223526|NCT00938639|18030408|P1|Overall Study|Lost to Follow-up|1
5223527|NCT00938639|18030407|P2|Overall Study|Moved away from study area|1
5223528|NCT00938639|18030408|P1|Overall Study|Moved away from study area|0
5223529|NCT00938470|18030491|P2|Overall Study|Other Reason|1
5223530|NCT00938470|18030492|P1|Overall Study|Other Reason|0
5223531|NCT00938470|18030491|P2|Overall Study|Death|2
5223532|NCT00938470|18030492|P1|Overall Study|Death|3
5223533|NCT00938470|18030491|P2|Overall Study|Alternate Treatment|0
5223534|NCT00938470|18030492|P1|Overall Study|Alternate Treatment|1
5223535|NCT00938470|18030491|P2|Overall Study|Disease Progression|0
5223536|NCT00938470|18030492|P1|Overall Study|Disease Progression|3
5223537|NCT00938431|18030522|P3|Overall Study|Reached maximum dose early|1
5223538|NCT00938431|18030523|P2|Overall Study|Reached maximum dose early|0
5223539|NCT00938431|18030524|P1|Overall Study|Reached maximum dose early|0
5223540|NCT00938431|18030522|P3|Overall Study|Dosing compliance issue|1
5223541|NCT00938431|18030523|P2|Overall Study|Dosing compliance issue|0
5223542|NCT00938431|18030524|P1|Overall Study|Dosing compliance issue|0
5223543|NCT00938431|18030522|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
5223544|NCT00938431|18030523|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
5223545|NCT00938431|18030524|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
5223546|NCT00938431|18030522|P3|Overall Study|Lack of Efficacy|0
5223547|NCT00938431|18030523|P2|Overall Study|Lack of Efficacy|1
5223548|NCT00938431|18030524|P1|Overall Study|Lack of Efficacy|0
5223549|NCT00938431|18030522|P3|Overall Study|Adverse Event|6
5223550|NCT00938431|18030523|P2|Overall Study|Adverse Event|8
5223551|NCT00938431|18030524|P1|Overall Study|Adverse Event|5
5223552|NCT00938392|18030551|P2|Overall Study|Lost to Follow-up|2
5223553|NCT00938392|18030552|P1|Overall Study|Lost to Follow-up|2
5223554|NCT00938392|18030551|P2|Overall Study|Withdrawal by Subject|1
5223555|NCT00938392|18030552|P1|Overall Study|Withdrawal by Subject|0
5223556|NCT00938392|18030551|P2|Overall Study|Adverse Event|1
5223557|NCT00938392|18030552|P1|Overall Study|Adverse Event|0
5223558|NCT00938366|18030578|P2|Overall Study|Withdrawal by Subject|0
5223559|NCT00938366|18030579|P1|Overall Study|Withdrawal by Subject|1
5223560|NCT00938340|18030599|P1|Overall Study|Adverse Event|1
5223561|NCT00938340|18030599|P1|Overall Study|Protocol Violation|1
5223562|NCT00938340|18030599|P1|Overall Study|Withdrawal by Subject|3
5223563|NCT00938327|18030729|P1|Overall Study|Vaccine not received as out of stock|9
5223564|NCT00938327|18030729|P1|Overall Study|2nd dose received outside of the study|7
5223565|NCT00938327|18030729|P1|Overall Study|Lost to Follow-up|37
5223566|NCT00938327|18030729|P1|Overall Study|Withdrawal by Subject|4
5223567|NCT00938327|18030729|P1|Overall Study|Protocol Violation|1
5223568|NCT00938327|18030729|P1|Overall Study|Adverse Event|2
5223569|NCT00938041|18030797|P1|Overall Study|Adrenal Insufficiency|3
5223570|NCT00938041|18030797|P1|Overall Study|Death|12
5223571|NCT00938041|18030797|P1|Overall Study|Progressive Disease|5
5223572|NCT00938041|18030797|P1|Overall Study|Received Alternative Therapy|1
5223573|NCT00938041|18030797|P1|Overall Study|Lost to Follow-up|6
5223574|NCT00938015|18030806|P1|Overall Study|Reason not related to Etanercept|29
5223575|NCT00938015|18030806|P1|Overall Study|Non-responder|52
5223576|NCT00938015|18030806|P1|Overall Study|Adverse Event|32
5223577|NCT00938015|18030806|P1|Overall Study|Lost to Follow-up|32
5223578|NCT00938015|18030806|P1|Overall Study|Death|2
5223579|NCT00937950|18030822|P1|Overall Study|Other|18
5223580|NCT00937950|18030822|P1|Overall Study|Missing confirmed|4
5223581|NCT00937950|18030822|P1|Overall Study|Lost to Follow-up|144
5223582|NCT00937950|18030822|P1|Overall Study|Migrated/moved from study area|27
5223583|NCT00937950|18030822|P1|Overall Study|Withdrawal by Subject|23
5223584|NCT00937937|18030838|P1|Overall Study|Other|2
5223585|NCT00937937|18030838|P1|Overall Study|Death|1
5223586|NCT00937937|18030838|P1|Overall Study|Progression/relapse|61
5223587|NCT00937937|18030838|P1|Overall Study|Withdrawal by Subject|2
5223588|NCT00937937|18030838|P1|Overall Study|Adverse Event|6
5223589|NCT00937833|18030858|P2|Overall Study|Withdrawal by Subject|6
5223590|NCT00937833|18030859|P1|Overall Study|Withdrawal by Subject|4
5223591|NCT00937833|18030858|P2|Overall Study|Lost to Follow-up|8
5223592|NCT00937833|18030859|P1|Overall Study|Lost to Follow-up|10
5223593|NCT00937833|18030858|P2|Overall Study|Procedure delayed; enrollment closed|1
5223594|NCT00937833|18030859|P1|Overall Study|Procedure delayed; enrollment closed|0
5223595|NCT00937833|18030858|P2|Overall Study|Protocol Violation|2
5223596|NCT00937833|18030859|P1|Overall Study|Protocol Violation|1
5223597|NCT00937768|18030872|P2|Overall Study|No Further Funding|4
5223598|NCT00937768|18030873|P1|Overall Study|No Further Funding|4
5223599|NCT00937768|18030872|P2|Overall Study|Alternate Treatment|1
5223600|NCT00937768|18030873|P1|Overall Study|Alternate Treatment|0
5223601|NCT00937768|18030872|P2|Overall Study|Disease Progression|1
5223602|NCT00937768|18030873|P1|Overall Study|Disease Progression|1
5223603|NCT00937768|18030872|P2|Overall Study|Refused Further Treatment|2
5223604|NCT00937768|18030873|P1|Overall Study|Refused Further Treatment|3
5223605|NCT00937560|18030893|P1|Maintenance Treatment|According to protocol|1
5223606|NCT00937560|18030893|P1|Maintenance Treatment|Withdraw consent|5
5223607|NCT00937560|18030893|P1|Maintenance Treatment|Death|12
5223608|NCT00937560|18030893|P1|Initial Treatment|No end of study page|10
5223609|NCT00937560|18030893|P1|Initial Treatment|Lost to Follow-up|1
5223610|NCT00937560|18030893|P1|Initial Treatment|Adverse Event|1
5223611|NCT00937560|18030893|P1|Initial Treatment|Withdraw consent|3
5223612|NCT00937560|18030893|P1|Initial Treatment|Death|6
5223613|NCT00937547|18030904|P3|Overall Study|misdiagnosis|7
5223614|NCT00937547|18030905|P2|Overall Study|misdiagnosis|6
5223615|NCT00937547|18030906|P1|Overall Study|misdiagnosis|1
5223616|NCT00937521|18030943|P8|Booster Phase|Protocol Deviation|0
5223617|NCT00937521|18030944|P7|Booster Phase|Protocol Deviation|1
5223618|NCT00937521|18030945|P6|Booster Phase|Protocol Deviation|0
5223619|NCT00937521|18030946|P5|Booster Phase|Protocol Deviation|0
5223620|NCT00937521|18030947|P4|Booster Phase|Protocol Deviation|0
5223621|NCT00937521|18030948|P3|Booster Phase|Protocol Deviation|0
5223622|NCT00937521|18030949|P2|Booster Phase|Protocol Deviation|0
5223623|NCT00937521|18030950|P1|Booster Phase|Protocol Deviation|0
5223624|NCT00937521|18030943|P8|Booster Phase|Administrative Reason|0
5223625|NCT00937521|18030944|P7|Booster Phase|Administrative Reason|0
5223626|NCT00937521|18030945|P6|Booster Phase|Administrative Reason|1
5223627|NCT00937521|18030946|P5|Booster Phase|Administrative Reason|1
5223628|NCT00937521|18030947|P4|Booster Phase|Administrative Reason|0
5223629|NCT00937521|18030948|P3|Booster Phase|Administrative Reason|1
5223630|NCT00937521|18030949|P2|Booster Phase|Administrative Reason|0
5223631|NCT00937521|18030950|P1|Booster Phase|Administrative Reason|0
5223632|NCT00937521|18030943|P8|Booster Phase|Lost to Follow-up|0
5223633|NCT00937521|18030944|P7|Booster Phase|Lost to Follow-up|3
5223634|NCT00937521|18030945|P6|Booster Phase|Lost to Follow-up|4
5223635|NCT00937521|18030946|P5|Booster Phase|Lost to Follow-up|4
5223636|NCT00937521|18030947|P4|Booster Phase|Lost to Follow-up|2
5223637|NCT00937521|18030948|P3|Booster Phase|Lost to Follow-up|4
5223638|NCT00937521|18030949|P2|Booster Phase|Lost to Follow-up|2
5223639|NCT00937521|18030950|P1|Booster Phase|Lost to Follow-up|2
5223640|NCT00937521|18030943|P8|Booster Phase|Withdrawal by Subject|2
5223641|NCT00937521|18030944|P7|Booster Phase|Withdrawal by Subject|0
5223642|NCT00937521|18030945|P6|Booster Phase|Withdrawal by Subject|0
5223643|NCT00937521|18030946|P5|Booster Phase|Withdrawal by Subject|0
5223644|NCT00937521|18030947|P4|Booster Phase|Withdrawal by Subject|1
5223645|NCT00937521|18030948|P3|Booster Phase|Withdrawal by Subject|0
5223646|NCT00937521|18030949|P2|Booster Phase|Withdrawal by Subject|0
5223647|NCT00937521|18030950|P1|Booster Phase|Withdrawal by Subject|1
5223648|NCT00937521|18030943|P8|Booster Phase|Adverse Event|0
5223649|NCT00937521|18030944|P7|Booster Phase|Adverse Event|1
5223650|NCT00937521|18030945|P6|Booster Phase|Adverse Event|0
5223651|NCT00937521|18030946|P5|Booster Phase|Adverse Event|0
5223652|NCT00937521|18030947|P4|Booster Phase|Adverse Event|0
5223653|NCT00937521|18030948|P3|Booster Phase|Adverse Event|0
5223654|NCT00937521|18030949|P2|Booster Phase|Adverse Event|0
5223655|NCT00937521|18030950|P1|Booster Phase|Adverse Event|0
5223656|NCT00937521|18030943|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5223657|NCT00937521|18030944|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
5223658|NCT00937521|18030945|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5223659|NCT00937521|18030946|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5223660|NCT00937521|18030947|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5223661|NCT00937521|18030948|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5223662|NCT00937521|18030949|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5223663|NCT00937521|18030950|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
5223664|NCT00937521|18030943|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5223665|NCT00937521|18030944|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
5223666|NCT00937521|18030945|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
5223667|NCT00937521|18030946|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
5223668|NCT00937521|18030947|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5223669|NCT00937521|18030948|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5223670|NCT00937521|18030949|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
5223671|NCT00937521|18030950|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5223672|NCT00937521|18030943|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5223673|NCT00937521|18030944|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5223674|NCT00937521|18030945|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5223675|NCT00937521|18030946|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5223676|NCT00937521|18030947|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
5223677|NCT00937521|18030948|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
5223678|NCT00937521|18030949|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5223679|NCT00937521|18030950|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5223680|NCT00937521|18030943|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5223681|NCT00937521|18030944|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
5223682|NCT00937521|18030945|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
5223683|NCT00937521|18030946|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5223684|NCT00937521|18030947|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
5223685|NCT00937521|18030948|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
5223686|NCT00937521|18030949|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5223687|NCT00937521|18030950|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
5223688|NCT00937521|18030943|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
5223689|NCT00937521|18030944|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
5223690|NCT00937521|18030945|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
5223691|NCT00937521|18030946|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
5223692|NCT00937521|18030947|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
5223693|NCT00937521|18030948|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
5223694|NCT00937521|18030949|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
5223695|NCT00937521|18030950|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
5223696|NCT00937495|18031056|P1|Overall Study|Protocol Violation|2
5223697|NCT00937404|18031062|P1|Overall Study|Withdrawal by Subject|1
5223698|NCT00937404|18031062|P1|Overall Study|Protocol Violation|1
5223699|NCT00937391|18031071|P1|Stage 2|Withdrawal by Subject|1
5223700|NCT00937326|18031138|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
5223701|NCT00937326|18031139|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
5223702|NCT00937326|18031140|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
5223703|NCT00937326|18031141|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
5223704|NCT00937326|18031142|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
5223705|NCT00937326|18031138|P5|Overall Study|Withdrawal by Subject|3
5223706|NCT00937326|18031139|P4|Overall Study|Withdrawal by Subject|4
5223707|NCT00937326|18031140|P3|Overall Study|Withdrawal by Subject|1
5223708|NCT00937326|18031141|P2|Overall Study|Withdrawal by Subject|4
5223709|NCT00937326|18031142|P1|Overall Study|Withdrawal by Subject|3
5223710|NCT00937326|18031138|P5|Overall Study|Death|0
5223711|NCT00937326|18031139|P4|Overall Study|Death|0
5223712|NCT00937326|18031140|P3|Overall Study|Death|1
5223713|NCT00937326|18031141|P2|Overall Study|Death|0
5223714|NCT00937326|18031142|P1|Overall Study|Death|0
5223715|NCT00937326|18031138|P5|Overall Study|Adverse Event|2
5223716|NCT00937326|18031139|P4|Overall Study|Adverse Event|1
5223717|NCT00937326|18031140|P3|Overall Study|Adverse Event|1
5223718|NCT00937326|18031141|P2|Overall Study|Adverse Event|3
5223719|NCT00937326|18031142|P1|Overall Study|Adverse Event|0
5223720|NCT00937157|18031391|P1|Overall Study|Lost to Follow-up|3
5223721|NCT00937157|18031391|P1|Overall Study|Pregnancy|1
5223722|NCT00937040|18031422|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
5223723|NCT00937040|18031423|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
5223724|NCT00937040|18031422|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
5223725|NCT00937040|18031423|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
5223726|NCT00937040|18031422|P2|Overall Study|Withdrawal by Subject|7
5223727|NCT00937040|18031423|P1|Overall Study|Withdrawal by Subject|13
5223728|NCT00937040|18031422|P2|Overall Study|Protocol Violation|0
5223729|NCT00937040|18031423|P1|Overall Study|Protocol Violation|3
5223730|NCT00937040|18031422|P2|Overall Study|Lost to Follow-up|12
5223731|NCT00937040|18031423|P1|Overall Study|Lost to Follow-up|12
5223732|NCT00937040|18031422|P2|Overall Study|Adverse Event|8
5223733|NCT00937040|18031423|P1|Overall Study|Adverse Event|5
5223734|NCT00936975|18031465|P1|Overall Study|Post-Tx scan uninterpretable|2
5223735|NCT00936975|18031465|P1|Overall Study|Disease progression|3
5223736|NCT00936975|18031465|P1|Overall Study|Withdrawal by Subject|1
5223737|NCT00936910|18031474|P1|Overall Study|Lack of Efficacy|3
5223738|NCT00936897|18031483|P2|Overall Study|Death|1
5223739|NCT00936897|18031484|P1|Overall Study|Death|0
5223740|NCT00936897|18031483|P2|Overall Study|Noncompliance|2
5223741|NCT00936897|18031484|P1|Overall Study|Noncompliance|0
5223742|NCT00936897|18031483|P2|Overall Study|Ineligibility Determined|3
5223743|NCT00936897|18031484|P1|Overall Study|Ineligibility Determined|0
5223744|NCT00936897|18031483|P2|Overall Study|Protocol Violation|1
5223745|NCT00936897|18031484|P1|Overall Study|Protocol Violation|1
5223746|NCT00936897|18031483|P2|Overall Study|Administrative Decision|2
5223747|NCT00936897|18031484|P1|Overall Study|Administrative Decision|1
5223748|NCT00936897|18031483|P2|Overall Study|Lost to Follow-up|10
5223749|NCT00936897|18031484|P1|Overall Study|Lost to Follow-up|1
5223750|NCT00936897|18031483|P2|Overall Study|Other|9
5223751|NCT00936897|18031484|P1|Overall Study|Other|3
5223752|NCT00936897|18031483|P2|Overall Study|Adverse Event|13
5223753|NCT00936897|18031484|P1|Overall Study|Adverse Event|4
5223754|NCT00936897|18031483|P2|Overall Study|Withdrawal by Subject|19
5223755|NCT00936897|18031484|P1|Overall Study|Withdrawal by Subject|9
5223756|NCT00936884|18031498|P3|Double-blind|Did not receive study drug|0
5223757|NCT00936884|18031499|P2|Double-blind|Did not receive study drug|1
5223758|NCT00936884|18031500|P1|Double-blind|Did not receive study drug|0
5223759|NCT00936884|18031498|P3|Double-blind|No post baseline diary entry|0
5223760|NCT00936884|18031499|P2|Double-blind|No post baseline diary entry|0
5223761|NCT00936884|18031500|P1|Double-blind|No post baseline diary entry|1
5223762|NCT00936884|18031498|P3|Double-blind|Physician Decision|0
5223763|NCT00936884|18031499|P2|Double-blind|Physician Decision|0
5223764|NCT00936884|18031500|P1|Double-blind|Physician Decision|1
5223765|NCT00936884|18031498|P3|Double-blind|Adverse Event|0
5223766|NCT00936884|18031499|P2|Double-blind|Adverse Event|0
5223767|NCT00936884|18031500|P1|Double-blind|Adverse Event|1
5223768|NCT00936884|18031498|P3|Double-blind|Lack of Efficacy|0
5223769|NCT00936884|18031499|P2|Double-blind|Lack of Efficacy|1
5223770|NCT00936884|18031500|P1|Double-blind|Lack of Efficacy|1
5223771|NCT00936884|18031498|P3|Double-blind|Death|0
5223772|NCT00936884|18031499|P2|Double-blind|Death|1
5223773|NCT00936884|18031500|P1|Double-blind|Death|2
5223774|NCT00936884|18031498|P3|Double-blind|Withdrawal by Subject|0
5223775|NCT00936884|18031499|P2|Double-blind|Withdrawal by Subject|4
5223776|NCT00936884|18031500|P1|Double-blind|Withdrawal by Subject|6
5223777|NCT00936715|18031516|P1|Overall Study|Safety or Tolerability Reasons|4
5223778|NCT00936715|18031516|P1|Overall Study|Protocol Violation|1
5223779|NCT00936715|18031516|P1|Overall Study|Investigators Discretion|1
5223780|NCT00936702|18031520|P1|Overall Study|Other|1
5223781|NCT00936702|18031520|P1|Overall Study|Alternative Treatment|1
5223782|NCT00936702|18031520|P1|Overall Study|Withdrawal by Subject|2
5223783|NCT00936702|18031520|P1|Overall Study|Adverse Event|8
5223784|NCT00936702|18031520|P1|Overall Study|Disease progression|34
5223785|NCT00936598|18031553|P2|Overall Study|Ineligible after consent|0
5223786|NCT00936598|18031554|P1|Overall Study|Ineligible after consent|1
5223787|NCT00936598|18031553|P2|Overall Study|Withdrawal by Subject|0
5223788|NCT00936598|18031554|P1|Overall Study|Withdrawal by Subject|1
5223789|NCT00936221|18031656|P2|Overall Study|Withdrawal by Subject|1
5223790|NCT00936221|18031657|P1|Overall Study|Withdrawal by Subject|1
5223791|NCT00936208|18031671|P2|Overall Study|Protocol Violation|22
5223792|NCT00936208|18031672|P1|Overall Study|Protocol Violation|37
5223793|NCT00936117|18031690|P1|Overall Study|Unable to continue oral medication|3
5223794|NCT00936117|18031690|P1|Overall Study|Adverse Event|7
5223795|NCT00936065|18031698|P3|Overall Study|Withdrawal by Subject|4
5223796|NCT00936065|18031699|P2|Overall Study|Withdrawal by Subject|2
5223797|NCT00936065|18031700|P1|Overall Study|Withdrawal by Subject|0
5223798|NCT00936065|18031698|P3|Overall Study|Protocol Violation|1
5223799|NCT00936065|18031699|P2|Overall Study|Protocol Violation|2
5223800|NCT00936065|18031700|P1|Overall Study|Protocol Violation|1
5223801|NCT00936065|18031698|P3|Overall Study|Lost to Follow-up|0
5223802|NCT00936065|18031699|P2|Overall Study|Lost to Follow-up|0
5223803|NCT00936065|18031700|P1|Overall Study|Lost to Follow-up|1
5223804|NCT00936065|18031698|P3|Overall Study|Lack of Efficacy|1
5223805|NCT00936065|18031699|P2|Overall Study|Lack of Efficacy|0
5223806|NCT00936065|18031700|P1|Overall Study|Lack of Efficacy|1
5223807|NCT00936065|18031698|P3|Overall Study|Adverse Event|1
5223808|NCT00936065|18031699|P2|Overall Study|Adverse Event|0
5223809|NCT00936065|18031700|P1|Overall Study|Adverse Event|1
5223810|NCT00935883|18031806|P2|Treatment Period|Withdrawal by Subject|2
5223811|NCT00935883|18031807|P1|Treatment Period|Withdrawal by Subject|0
5223812|NCT00935883|18031806|P2|Treatment Period|Physician Decision|0
5223813|NCT00935883|18031807|P1|Treatment Period|Physician Decision|1
5223814|NCT00935818|18031834|P2|Overall Study|Physician Decision|1
5223815|NCT00935818|18031835|P1|Overall Study|Physician Decision|0
5223816|NCT00935818|18031834|P2|Overall Study|Adverse Event|7
5223817|NCT00935818|18031835|P1|Overall Study|Adverse Event|6
5223818|NCT00935818|18031834|P2|Overall Study|Lost to Follow-up|42
5223819|NCT00935818|18031835|P1|Overall Study|Lost to Follow-up|40
5223820|NCT00935818|18031834|P2|Overall Study|Withdrawal by Subject|50
5223821|NCT00935818|18031835|P1|Overall Study|Withdrawal by Subject|45
5223822|NCT00935701|18031886|P1|Overall Study|Failure to Transition to Acupuncture|1
5223823|NCT00935584|18031903|P2|Overall Study|Provider dropped out of study|4
5223824|NCT00935584|18031904|P1|Overall Study|Provider dropped out of study|14
5223825|NCT00935584|18031903|P2|Overall Study|Patient changed provider|0
5223826|NCT00935584|18031904|P1|Overall Study|Patient changed provider|3
5223827|NCT00935584|18031903|P2|Overall Study|Relocated|0
5223828|NCT00935584|18031904|P1|Overall Study|Relocated|3
5223829|NCT00935584|18031903|P2|Overall Study|No show|0
5223830|NCT00935584|18031904|P1|Overall Study|No show|9
5223831|NCT00935584|18031903|P2|Overall Study|Lost to Follow-up|0
5223832|NCT00935584|18031904|P1|Overall Study|Lost to Follow-up|8
5223833|NCT00935584|18031903|P2|Overall Study|Death|0
5223834|NCT00935584|18031904|P1|Overall Study|Death|3
5223835|NCT00935584|18031903|P2|Overall Study|Withdrawal by Subject|0
5223836|NCT00935584|18031904|P1|Overall Study|Withdrawal by Subject|9
5223837|NCT00935532|18031916|P2|Overall Study|Loss Glucose Control|0
5223838|NCT00935532|18031917|P1|Overall Study|Loss Glucose Control|4
5223839|NCT00935532|18031916|P2|Overall Study|Sponsor Decision|1
5223840|NCT00935532|18031917|P1|Overall Study|Sponsor Decision|0
5223841|NCT00935532|18031916|P2|Overall Study|Subject Decision|1
5223842|NCT00935532|18031917|P1|Overall Study|Subject Decision|2
5223843|NCT00935532|18031916|P2|Overall Study|Protocol Violation|1
5223844|NCT00935532|18031917|P1|Overall Study|Protocol Violation|2
5223845|NCT00935532|18031916|P2|Overall Study|Physician Decision|2
5223846|NCT00935532|18031917|P1|Overall Study|Physician Decision|1
5223847|NCT00935532|18031916|P2|Overall Study|Lost to Follow-up|0
5223848|NCT00935532|18031917|P1|Overall Study|Lost to Follow-up|1
5223849|NCT00935532|18031916|P2|Overall Study|Death|0
5223850|NCT00935532|18031917|P1|Overall Study|Death|1
5223851|NCT00935532|18031916|P2|Overall Study|Adverse Event|6
5223852|NCT00935532|18031917|P1|Overall Study|Adverse Event|11
5223853|NCT00935493|18031946|P3|Overall Study|Treatment Discontinued|0
5223854|NCT00935493|18031947|P2|Overall Study|Treatment Discontinued|1
5223855|NCT00935493|18031948|P1|Overall Study|Treatment Discontinued|0
5223856|NCT00935493|18031946|P3|Overall Study|Lost to Follow-up|1
5223857|NCT00935493|18031947|P2|Overall Study|Lost to Follow-up|1
5223858|NCT00935493|18031948|P1|Overall Study|Lost to Follow-up|1
5223859|NCT00935272|18031997|P2|Overall Study|Protocol Violation|1
5223860|NCT00935272|18031998|P1|Overall Study|Protocol Violation|0
5223861|NCT00935272|18031997|P2|Overall Study|Physician Decision|0
5223862|NCT00935272|18031998|P1|Overall Study|Physician Decision|1
5223863|NCT00935272|18031997|P2|Overall Study|Withdrawal by Subject|2
5223864|NCT00935272|18031998|P1|Overall Study|Withdrawal by Subject|8
5223865|NCT00935272|18031997|P2|Overall Study|Lost to Follow-up|3
5223866|NCT00935272|18031998|P1|Overall Study|Lost to Follow-up|10
5223867|NCT00935259|18032007|P2|Period 1|Administrative (scheduling conflict)|1
5223868|NCT00935259|18032008|P1|Period 1|Administrative (scheduling conflict)|1
5223869|NCT00935220|18032022|P1|Overall Study|Other reason (not specified)|1
5223870|NCT00935220|18032022|P1|Overall Study|Adverse Event|1
5223871|NCT00934947|18032053|P2|Overall Study|Adverse Event|2
5223872|NCT00934947|18032054|P1|Overall Study|Adverse Event|0
5223873|NCT00934856|18032083|P6|Extension Part|Non-compliance with drug|1
5223874|NCT00934856|18032084|P5|Extension Part|Non-compliance with drug|0
5223875|NCT00934856|18032085|P4|Extension Part|Non-compliance with drug|0
5223876|NCT00934856|18032086|P3|Extension Part|Non-compliance with drug|0
5223877|NCT00934856|18032087|P2|Extension Part|Non-compliance with drug|0
5223878|NCT00934856|18032088|P1|Extension Part|Non-compliance with drug|0
5223879|NCT00934856|18032083|P6|Extension Part|Progressive disease|0
5223880|NCT00934856|18032084|P5|Extension Part|Progressive disease|0
5223881|NCT00934856|18032085|P4|Extension Part|Progressive disease|1
5223882|NCT00934856|18032086|P3|Extension Part|Progressive disease|0
5223883|NCT00934856|18032087|P2|Extension Part|Progressive disease|0
5223884|NCT00934856|18032088|P1|Extension Part|Progressive disease|0
5223885|NCT00934856|18032083|P6|Extension Part|Adverse Event|4
5223886|NCT00934856|18032084|P5|Extension Part|Adverse Event|4
5223887|NCT00934856|18032085|P4|Extension Part|Adverse Event|1
5223888|NCT00934856|18032086|P3|Extension Part|Adverse Event|0
5223889|NCT00934856|18032087|P2|Extension Part|Adverse Event|0
5223890|NCT00934856|18032088|P1|Extension Part|Adverse Event|0
5223891|NCT00934856|18032083|P6|Feasibility Part|Withdrawal by Subject|1
5223892|NCT00934856|18032084|P5|Feasibility Part|Withdrawal by Subject|0
5223893|NCT00934856|18032085|P4|Feasibility Part|Withdrawal by Subject|1
5223894|NCT00934856|18032086|P3|Feasibility Part|Withdrawal by Subject|0
5223895|NCT00934856|18032087|P2|Feasibility Part|Withdrawal by Subject|0
5223896|NCT00934856|18032088|P1|Feasibility Part|Withdrawal by Subject|0
5223897|NCT00934856|18032083|P6|Feasibility Part|Adverse Event|2
5223898|NCT00934856|18032084|P5|Feasibility Part|Adverse Event|0
5223899|NCT00934856|18032085|P4|Feasibility Part|Adverse Event|1
5223900|NCT00934856|18032086|P3|Feasibility Part|Adverse Event|0
5223901|NCT00934856|18032087|P2|Feasibility Part|Adverse Event|1
5223902|NCT00934856|18032088|P1|Feasibility Part|Adverse Event|1
5223903|NCT00934856|18032083|P6|Feasibility Part|Physician Decision|0
5223904|NCT00934856|18032084|P5|Feasibility Part|Physician Decision|0
5223905|NCT00934856|18032085|P4|Feasibility Part|Physician Decision|0
5223906|NCT00934856|18032086|P3|Feasibility Part|Physician Decision|1
5223907|NCT00934856|18032087|P2|Feasibility Part|Physician Decision|0
5223908|NCT00934856|18032088|P1|Feasibility Part|Physician Decision|0
5223909|NCT00934856|18032083|P6|Feasibility Part|Progressive disease|0
5223910|NCT00934856|18032084|P5|Feasibility Part|Progressive disease|0
5223911|NCT00934856|18032085|P4|Feasibility Part|Progressive disease|3
5223912|NCT00934856|18032086|P3|Feasibility Part|Progressive disease|2
5223913|NCT00934856|18032087|P2|Feasibility Part|Progressive disease|4
5223914|NCT00934856|18032088|P1|Feasibility Part|Progressive disease|4
5223915|NCT00934843|18032186|P2|Overall Study|Protocol Violation|1
5223916|NCT00934843|18032187|P1|Overall Study|Protocol Violation|0
5223917|NCT00934791|18032203|P2|Overall Study|Withdrawal by Subject|0
5223918|NCT00934791|18032204|P1|Overall Study|Withdrawal by Subject|1
5223919|NCT00934661|18032212|P2|Overall Study|Failure of Combined/Spinal Epidural|0
5223920|NCT00934661|18032213|P1|Overall Study|Failure of Combined/Spinal Epidural|1
5223921|NCT00934648|18032233|P1|Overall Study|Withdrawal by Subject|1
5223922|NCT00934648|18032233|P1|Overall Study|Failure to return|8
5223923|NCT00934622|18032277|P1|Overall Study|2nd Intraoperative exclusion criteria|1
5223924|NCT00934622|18032277|P1|Overall Study|Lost to Follow-up|7
5223925|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
5223926|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
5223927|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
5223928|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
5223929|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
5223930|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
5223931|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
5223932|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
5223933|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
5223934|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
5223935|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
5223936|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
5223937|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
5223938|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
5223939|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
5223940|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
5223941|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
5223942|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
5223943|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
5223944|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
5223945|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
5223946|NCT00934544|18032315|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
5223947|NCT00934544|18032316|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
5223948|NCT00934544|18032317|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
5223949|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
5223950|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
5223951|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
5223952|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
5223953|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
5223954|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
5223955|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
5223956|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
5223957|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
5223958|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
5223959|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
5223960|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
5223961|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
5223962|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
5223963|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
5223964|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
5223965|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
5223966|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
5223967|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
5223968|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
5223969|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
5223970|NCT00934544|18032315|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
5223971|NCT00934544|18032316|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
5223972|NCT00934544|18032317|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
5223973|NCT00934440|18032353|P1|Overall Study|Lost to Follow-up|1
5223974|NCT00934362|18032369|P2|Overall Study|Adverse Event|0
5223975|NCT00934362|18032370|P1|Overall Study|Adverse Event|1
5223976|NCT00934128|18032420|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
5223977|NCT00934128|18032421|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
5223978|NCT00934128|18032420|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
5223979|NCT00934128|18032421|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
5223980|NCT00934128|18032420|P2|Washout Period (1 Hour)|Too tired|0
5223981|NCT00934128|18032421|P1|Washout Period (1 Hour)|Too tired|1
5223982|NCT00934128|18032420|P2|Washout Period (1 Hour)|Pain|0
5223983|NCT00934128|18032421|P1|Washout Period (1 Hour)|Pain|1
5223984|NCT00934128|18032420|P2|Washout Period (1 Hour)|Patient preference|3
5223985|NCT00934128|18032421|P1|Washout Period (1 Hour)|Patient preference|1
5223986|NCT00934128|18032420|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
5223987|NCT00934128|18032421|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
5223988|NCT00934128|18032420|P2|First Intervention (2 Hours)|Adverse Event|1
5223989|NCT00934128|18032421|P1|First Intervention (2 Hours)|Adverse Event|4
5223990|NCT00934128|18032420|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
5223991|NCT00934128|18032421|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
5223992|NCT00934102|18032429|P3|Period 1, One Night of Wear|Personal Reasons|0
5223993|NCT00934102|18032430|P2|Period 1, One Night of Wear|Personal Reasons|0
5223994|NCT00934102|18032431|P1|Period 1, One Night of Wear|Personal Reasons|1
5223995|NCT00934050|18032445|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
5223996|NCT00934050|18032446|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
5223997|NCT00934050|18032447|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5223998|NCT00934050|18032448|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5223999|NCT00934050|18032449|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5224000|NCT00934050|18032450|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5224001|NCT00934050|18032445|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
5224002|NCT00934050|18032446|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5224003|NCT00934050|18032447|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5224004|NCT00934050|18032448|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5224005|NCT00934050|18032449|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5224006|NCT00934050|18032450|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5224007|NCT00934050|18032445|P6|Enrolled After 15 Dec 2009|Death|1
5224008|NCT00934050|18032446|P5|Enrolled After 15 Dec 2009|Death|0
5224009|NCT00934050|18032447|P4|Enrolled After 15 Dec 2009|Death|0
5224010|NCT00934050|18032448|P3|Enrolled After 15 Dec 2009|Death|0
5224011|NCT00934050|18032449|P2|Enrolled After 15 Dec 2009|Death|0
5224012|NCT00934050|18032450|P1|Enrolled After 15 Dec 2009|Death|0
5224013|NCT00934050|18032445|P6|Enrolled After 15 Dec 2009|Adverse Event|0
5224014|NCT00934050|18032446|P5|Enrolled After 15 Dec 2009|Adverse Event|3
5224015|NCT00934050|18032447|P4|Enrolled After 15 Dec 2009|Adverse Event|0
5224016|NCT00934050|18032448|P3|Enrolled After 15 Dec 2009|Adverse Event|0
5224017|NCT00934050|18032449|P2|Enrolled After 15 Dec 2009|Adverse Event|0
5224018|NCT00934050|18032450|P1|Enrolled After 15 Dec 2009|Adverse Event|0
5224019|NCT00934050|18032445|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5224020|NCT00934050|18032446|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5224021|NCT00934050|18032447|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5224022|NCT00934050|18032448|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
5224023|NCT00934050|18032449|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5224024|NCT00934050|18032450|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5224025|NCT00934050|18032445|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
5224026|NCT00934050|18032446|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
5224027|NCT00934050|18032447|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
5224028|NCT00934050|18032448|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
5224029|NCT00934050|18032449|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
5224030|NCT00934050|18032450|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
5224031|NCT00934050|18032445|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5224032|NCT00934050|18032446|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5224033|NCT00934050|18032447|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
5224034|NCT00934050|18032448|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5224035|NCT00934050|18032449|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5224036|NCT00934050|18032450|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
5224037|NCT00933933|18032473|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
5224038|NCT00933933|18032474|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
5224039|NCT00933933|18032475|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
5224040|NCT00933933|18032473|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
5224041|NCT00933933|18032474|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
5224042|NCT00933933|18032475|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
5224043|NCT00933686|18032493|P2|Overall Study|Failure to show up at endpoint visits|2
5224044|NCT00933686|18032494|P1|Overall Study|Failure to show up at endpoint visits|0
5224045|NCT00933686|18032493|P2|Overall Study|Physician Decision|0
5224046|NCT00933686|18032494|P1|Overall Study|Physician Decision|1
5224047|NCT00933686|18032493|P2|Overall Study|Adverse Event|1
5224048|NCT00933686|18032494|P1|Overall Study|Adverse Event|1
5224049|NCT00933686|18032493|P2|Overall Study|Withdrawal by Subject|5
5224050|NCT00933686|18032494|P1|Overall Study|Withdrawal by Subject|6
5224051|NCT00933686|18032493|P2|Overall Study|Lost to Follow-up|2
5224052|NCT00933686|18032494|P1|Overall Study|Lost to Follow-up|2
5224053|NCT00933686|18032493|P2|Overall Study|Protocol Violation|1
5224054|NCT00933686|18032494|P1|Overall Study|Protocol Violation|0
5224055|NCT00933608|18032514|P2|Overall Study|Physician Decision|0
5224056|NCT00933608|18032515|P1|Overall Study|Physician Decision|1
5224057|NCT00933608|18032514|P2|Overall Study|Adverse Event|2
5224058|NCT00933608|18032515|P1|Overall Study|Adverse Event|4
5224059|NCT00933543|18032523|P2|Overall Study|Other|1
5224060|NCT00933543|18032524|P1|Overall Study|Other|1
5224061|NCT00933543|18032523|P2|Overall Study|Lack of Efficacy|3
5224062|NCT00933543|18032524|P1|Overall Study|Lack of Efficacy|0
5224063|NCT00933543|18032523|P2|Overall Study|Withdrawal by Subject|1
5224064|NCT00933543|18032524|P1|Overall Study|Withdrawal by Subject|0
5224065|NCT00933543|18032523|P2|Overall Study|Lost to Follow-up|1
5224066|NCT00933543|18032524|P1|Overall Study|Lost to Follow-up|0
5224067|NCT00933543|18032523|P2|Overall Study|Adverse Event|1
5224068|NCT00933543|18032524|P1|Overall Study|Adverse Event|2
5224069|NCT00933335|18032593|P2|Overall Study|Co-morbid Illness|0
5224070|NCT00933335|18032594|P1|Overall Study|Co-morbid Illness|1
5224071|NCT00933335|18032593|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
5224072|NCT00933335|18032594|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
5224073|NCT00933335|18032593|P2|Overall Study|Progressive Disease|11
5224074|NCT00933335|18032594|P1|Overall Study|Progressive Disease|0
5224075|NCT00933335|18032593|P2|Overall Study|Withdrawal by Subject|1
5224076|NCT00933335|18032594|P1|Overall Study|Withdrawal by Subject|0
5224077|NCT00933335|18032593|P2|Overall Study|Lost to Follow-up|3
5224078|NCT00933335|18032594|P1|Overall Study|Lost to Follow-up|1
5224079|NCT00933270|18032664|P1|Overall Study|Moved or would not return|10
5224080|NCT00933270|18032664|P1|Overall Study|Death|24
5224081|NCT00933270|18032664|P1|Overall Study|Missed Visit|2
5224082|NCT00933270|18032664|P1|Overall Study|Adverse Event|1
5224083|NCT00933270|18032664|P1|Overall Study|Lost to Follow-up|14
5224084|NCT00933270|18032664|P1|Overall Study|Insufficient Follow-up|10
5224085|NCT00933270|18032664|P1|Overall Study|Withdrawal by Subject|26
5224086|NCT00933244|18032758|P3|Overall Study|Withdrawal by Subject|3
5224087|NCT00933244|18032759|P2|Overall Study|Withdrawal by Subject|1
5224088|NCT00933244|18032760|P1|Overall Study|Withdrawal by Subject|5
5224089|NCT00933166|18032777|P1|Overall Study|Withdrawal by Subject|1
5224090|NCT00933166|18032777|P1|Overall Study|Unavailable|4
5224091|NCT00933166|18032777|P1|Overall Study|Lack of Efficacy|9
5224092|NCT00933166|18032777|P1|Overall Study|Lost to Follow-up|4
5224093|NCT00932893|18032783|P2|Overall Study|Other|144
5224094|NCT00932893|18032784|P1|Overall Study|Other|5
5224095|NCT00932893|18032783|P2|Overall Study|Withdrawal by Subject|2
5224096|NCT00932893|18032784|P1|Overall Study|Withdrawal by Subject|5
5224097|NCT00932893|18032783|P2|Overall Study|Lost to Follow-up|0
5224098|NCT00932893|18032784|P1|Overall Study|Lost to Follow-up|8
5224099|NCT00932893|18032783|P2|Overall Study|Death|24
5224100|NCT00932893|18032784|P1|Overall Study|Death|115
5224101|NCT00932698|18032832|P11|Part 2 (Dose Expansion)|Adverse Event|0
5224102|NCT00932698|18032833|P10|Part 2 (Dose Expansion)|Adverse Event|1
5224103|NCT00932698|18032834|P9|Part 2 (Dose Expansion)|Adverse Event|1
5224104|NCT00932698|18032835|P8|Part 2 (Dose Expansion)|Adverse Event|5
5224105|NCT00932698|18032836|P7|Part 2 (Dose Expansion)|Adverse Event|0
5224106|NCT00932698|18032837|P6|Part 2 (Dose Expansion)|Adverse Event|0
5224107|NCT00932698|18032838|P5|Part 2 (Dose Expansion)|Adverse Event|0
5224108|NCT00932698|18032839|P4|Part 2 (Dose Expansion)|Adverse Event|0
5224109|NCT00932698|18032840|P3|Part 2 (Dose Expansion)|Adverse Event|0
5224110|NCT00932698|18032841|P2|Part 2 (Dose Expansion)|Adverse Event|0
5224111|NCT00932698|18032842|P1|Part 2 (Dose Expansion)|Adverse Event|0
5224112|NCT00932698|18032832|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224113|NCT00932698|18032833|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
5224114|NCT00932698|18032834|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
5224115|NCT00932698|18032835|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
5224116|NCT00932698|18032836|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224117|NCT00932698|18032837|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224118|NCT00932698|18032838|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224119|NCT00932698|18032839|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224120|NCT00932698|18032840|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224121|NCT00932698|18032841|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224122|NCT00932698|18032842|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5224123|NCT00932698|18032832|P11|Part 2 (Dose Expansion)|Progressive Disease|2
5224124|NCT00932698|18032833|P10|Part 2 (Dose Expansion)|Progressive Disease|3
5224125|NCT00932698|18032834|P9|Part 2 (Dose Expansion)|Progressive Disease|8
5224126|NCT00932698|18032835|P8|Part 2 (Dose Expansion)|Progressive Disease|14
5224127|NCT00932698|18032836|P7|Part 2 (Dose Expansion)|Progressive Disease|0
5224128|NCT00932698|18032837|P6|Part 2 (Dose Expansion)|Progressive Disease|0
5224129|NCT00932698|18032838|P5|Part 2 (Dose Expansion)|Progressive Disease|0
5224130|NCT00932698|18032839|P4|Part 2 (Dose Expansion)|Progressive Disease|0
5224131|NCT00932698|18032840|P3|Part 2 (Dose Expansion)|Progressive Disease|0
5224132|NCT00932698|18032841|P2|Part 2 (Dose Expansion)|Progressive Disease|0
5224133|NCT00932698|18032842|P1|Part 2 (Dose Expansion)|Progressive Disease|0
5224134|NCT00932698|18032832|P11|Part 1 (Dose Escalation)|Other|0
5224135|NCT00932698|18032833|P10|Part 1 (Dose Escalation)|Other|0
5224136|NCT00932698|18032834|P9|Part 1 (Dose Escalation)|Other|0
5224137|NCT00932698|18032835|P8|Part 1 (Dose Escalation)|Other|0
5224138|NCT00932698|18032836|P7|Part 1 (Dose Escalation)|Other|1
5224139|NCT00932698|18032837|P6|Part 1 (Dose Escalation)|Other|0
5224140|NCT00932698|18032838|P5|Part 1 (Dose Escalation)|Other|0
5224141|NCT00932698|18032839|P4|Part 1 (Dose Escalation)|Other|0
5224142|NCT00932698|18032840|P3|Part 1 (Dose Escalation)|Other|1
5224143|NCT00932698|18032841|P2|Part 1 (Dose Escalation)|Other|0
5224144|NCT00932698|18032842|P1|Part 1 (Dose Escalation)|Other|0
5224145|NCT00932698|18032832|P11|Part 1 (Dose Escalation)|Adverse Event|0
5224146|NCT00932698|18032833|P10|Part 1 (Dose Escalation)|Adverse Event|0
5224147|NCT00932698|18032834|P9|Part 1 (Dose Escalation)|Adverse Event|0
5224148|NCT00932698|18032835|P8|Part 1 (Dose Escalation)|Adverse Event|0
5224149|NCT00932698|18032836|P7|Part 1 (Dose Escalation)|Adverse Event|0
5224150|NCT00932698|18032837|P6|Part 1 (Dose Escalation)|Adverse Event|1
5224151|NCT00932698|18032838|P5|Part 1 (Dose Escalation)|Adverse Event|0
5224152|NCT00932698|18032839|P4|Part 1 (Dose Escalation)|Adverse Event|0
5224153|NCT00932698|18032840|P3|Part 1 (Dose Escalation)|Adverse Event|0
5224154|NCT00932698|18032841|P2|Part 1 (Dose Escalation)|Adverse Event|0
5224155|NCT00932698|18032842|P1|Part 1 (Dose Escalation)|Adverse Event|0
5224156|NCT00932698|18032832|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224157|NCT00932698|18032833|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224158|NCT00932698|18032834|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224159|NCT00932698|18032835|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224160|NCT00932698|18032836|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5224161|NCT00932698|18032837|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5224162|NCT00932698|18032838|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224163|NCT00932698|18032839|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5224164|NCT00932698|18032840|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224165|NCT00932698|18032841|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5224166|NCT00932698|18032842|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5224167|NCT00932698|18032832|P11|Part 1 (Dose Escalation)|Progressive Disease|0
5224168|NCT00932698|18032833|P10|Part 1 (Dose Escalation)|Progressive Disease|0
5224169|NCT00932698|18032834|P9|Part 1 (Dose Escalation)|Progressive Disease|0
5224170|NCT00932698|18032835|P8|Part 1 (Dose Escalation)|Progressive Disease|0
5224171|NCT00932698|18032836|P7|Part 1 (Dose Escalation)|Progressive Disease|2
5224172|NCT00932698|18032837|P6|Part 1 (Dose Escalation)|Progressive Disease|5
5224173|NCT00932698|18032838|P5|Part 1 (Dose Escalation)|Progressive Disease|3
5224174|NCT00932698|18032839|P4|Part 1 (Dose Escalation)|Progressive Disease|2
5224175|NCT00932698|18032840|P3|Part 1 (Dose Escalation)|Progressive Disease|2
5224176|NCT00932698|18032841|P2|Part 1 (Dose Escalation)|Progressive Disease|2
5224177|NCT00932698|18032842|P1|Part 1 (Dose Escalation)|Progressive Disease|3
5224178|NCT00932646|18033016|P4|Overall Study|Withdrawal by Subject|0
5224179|NCT00932646|18033017|P3|Overall Study|Withdrawal by Subject|3
5224180|NCT00932646|18033018|P2|Overall Study|Withdrawal by Subject|1
5224181|NCT00932646|18033019|P1|Overall Study|Withdrawal by Subject|1
5224182|NCT00932646|18033016|P4|Overall Study|Lost to Follow-up|0
5224183|NCT00932646|18033017|P3|Overall Study|Lost to Follow-up|0
5224184|NCT00932646|18033018|P2|Overall Study|Lost to Follow-up|1
5224185|NCT00932646|18033019|P1|Overall Study|Lost to Follow-up|2
5224186|NCT00932646|18033016|P4|Overall Study|Adverse Event|1
5224187|NCT00932646|18033017|P3|Overall Study|Adverse Event|1
5224188|NCT00932646|18033018|P2|Overall Study|Adverse Event|1
5224189|NCT00932646|18033019|P1|Overall Study|Adverse Event|2
5224190|NCT00932451|18033106|P1|Overall Study|Other reasons|5
5224191|NCT00932451|18033106|P1|Overall Study|Death|726
5224192|NCT00932451|18033106|P1|Overall Study|Lost to Follow-up|22
5224193|NCT00932451|18033106|P1|Overall Study|Withdrawal by Subject|69
5224194|NCT00932425|18033130|P2|Overall Study|Withdrawal by Subject|1
5224195|NCT00932425|18033131|P1|Overall Study|Withdrawal by Subject|0
5224196|NCT00932425|18033130|P2|Overall Study|Lost to Follow-up|1
5224197|NCT00932425|18033131|P1|Overall Study|Lost to Follow-up|0
5224198|NCT00932373|18033164|P11|Overall Study|Lack of Efficacy|0
5224199|NCT00932373|18033165|P10|Overall Study|Lack of Efficacy|1
5224200|NCT00932373|18033166|P9|Overall Study|Lack of Efficacy|0
5224201|NCT00932373|18033167|P8|Overall Study|Lack of Efficacy|0
5224202|NCT00932373|18033168|P7|Overall Study|Lack of Efficacy|0
5224203|NCT00932373|18033169|P6|Overall Study|Lack of Efficacy|0
5224204|NCT00932373|18033170|P5|Overall Study|Lack of Efficacy|0
5224205|NCT00932373|18033171|P4|Overall Study|Lack of Efficacy|0
5224206|NCT00932373|18033172|P3|Overall Study|Lack of Efficacy|0
5224207|NCT00932373|18033173|P2|Overall Study|Lack of Efficacy|0
5224208|NCT00932373|18033174|P1|Overall Study|Lack of Efficacy|0
5224209|NCT00932373|18033164|P11|Overall Study|Clinical progression|0
5224210|NCT00932373|18033165|P10|Overall Study|Clinical progression|0
5224211|NCT00932373|18033166|P9|Overall Study|Clinical progression|0
5224212|NCT00932373|18033167|P8|Overall Study|Clinical progression|0
5224213|NCT00932373|18033168|P7|Overall Study|Clinical progression|1
5224214|NCT00932373|18033169|P6|Overall Study|Clinical progression|0
5224215|NCT00932373|18033170|P5|Overall Study|Clinical progression|0
5224216|NCT00932373|18033171|P4|Overall Study|Clinical progression|0
5224217|NCT00932373|18033172|P3|Overall Study|Clinical progression|0
5224218|NCT00932373|18033173|P2|Overall Study|Clinical progression|0
5224219|NCT00932373|18033174|P1|Overall Study|Clinical progression|0
5224220|NCT00932373|18033164|P11|Overall Study|Withdrawal by Subject|0
5224221|NCT00932373|18033165|P10|Overall Study|Withdrawal by Subject|0
5224222|NCT00932373|18033166|P9|Overall Study|Withdrawal by Subject|1
5224223|NCT00932373|18033167|P8|Overall Study|Withdrawal by Subject|0
5224224|NCT00932373|18033168|P7|Overall Study|Withdrawal by Subject|0
5224225|NCT00932373|18033169|P6|Overall Study|Withdrawal by Subject|0
5224226|NCT00932373|18033170|P5|Overall Study|Withdrawal by Subject|0
5224227|NCT00932373|18033171|P4|Overall Study|Withdrawal by Subject|0
5224228|NCT00932373|18033172|P3|Overall Study|Withdrawal by Subject|0
5224229|NCT00932373|18033173|P2|Overall Study|Withdrawal by Subject|0
5224230|NCT00932373|18033174|P1|Overall Study|Withdrawal by Subject|0
5224231|NCT00932373|18033164|P11|Overall Study|Dose limiting toxicity|0
5224232|NCT00932373|18033165|P10|Overall Study|Dose limiting toxicity|0
5224233|NCT00932373|18033166|P9|Overall Study|Dose limiting toxicity|0
5224234|NCT00932373|18033167|P8|Overall Study|Dose limiting toxicity|0
5224235|NCT00932373|18033168|P7|Overall Study|Dose limiting toxicity|0
5224236|NCT00932373|18033169|P6|Overall Study|Dose limiting toxicity|1
5224237|NCT00932373|18033170|P5|Overall Study|Dose limiting toxicity|0
5224238|NCT00932373|18033171|P4|Overall Study|Dose limiting toxicity|0
5224239|NCT00932373|18033172|P3|Overall Study|Dose limiting toxicity|0
5224240|NCT00932373|18033173|P2|Overall Study|Dose limiting toxicity|0
5224241|NCT00932373|18033174|P1|Overall Study|Dose limiting toxicity|0
5224242|NCT00932373|18033164|P11|Overall Study|Physician Decision|0
5224243|NCT00932373|18033165|P10|Overall Study|Physician Decision|1
5224244|NCT00932373|18033166|P9|Overall Study|Physician Decision|0
5224245|NCT00932373|18033167|P8|Overall Study|Physician Decision|0
5224246|NCT00932373|18033168|P7|Overall Study|Physician Decision|0
5224247|NCT00932373|18033169|P6|Overall Study|Physician Decision|0
5224248|NCT00932373|18033170|P5|Overall Study|Physician Decision|2
5224249|NCT00932373|18033171|P4|Overall Study|Physician Decision|0
5224250|NCT00932373|18033172|P3|Overall Study|Physician Decision|1
5224251|NCT00932373|18033173|P2|Overall Study|Physician Decision|0
5224252|NCT00932373|18033174|P1|Overall Study|Physician Decision|0
5224253|NCT00932373|18033164|P11|Overall Study|Adverse Event|1
5224254|NCT00932373|18033165|P10|Overall Study|Adverse Event|2
5224255|NCT00932373|18033166|P9|Overall Study|Adverse Event|0
5224256|NCT00932373|18033167|P8|Overall Study|Adverse Event|1
5224257|NCT00932373|18033168|P7|Overall Study|Adverse Event|0
5224258|NCT00932373|18033169|P6|Overall Study|Adverse Event|1
5224259|NCT00932373|18033170|P5|Overall Study|Adverse Event|2
5224260|NCT00932373|18033171|P4|Overall Study|Adverse Event|0
5224261|NCT00932373|18033172|P3|Overall Study|Adverse Event|0
5224262|NCT00932373|18033173|P2|Overall Study|Adverse Event|0
5224263|NCT00932373|18033174|P1|Overall Study|Adverse Event|0
5224264|NCT00932373|18033164|P11|Overall Study|Progressive disease|2
5224265|NCT00932373|18033165|P10|Overall Study|Progressive disease|9
5224266|NCT00932373|18033166|P9|Overall Study|Progressive disease|1
5224267|NCT00932373|18033167|P8|Overall Study|Progressive disease|2
5224268|NCT00932373|18033168|P7|Overall Study|Progressive disease|0
5224269|NCT00932373|18033169|P6|Overall Study|Progressive disease|1
5224270|NCT00932373|18033170|P5|Overall Study|Progressive disease|10
5224271|NCT00932373|18033171|P4|Overall Study|Progressive disease|0
5224272|NCT00932373|18033172|P3|Overall Study|Progressive disease|0
5224273|NCT00932373|18033173|P2|Overall Study|Progressive disease|1
5224274|NCT00932373|18033174|P1|Overall Study|Progressive disease|3
5224275|NCT00932360|18033274|P6|Washout (One Week)|Withdrawal by Subject|0
5224276|NCT00932360|18033275|P5|Washout (One Week)|Withdrawal by Subject|2
5224277|NCT00932360|18033276|P4|Washout (One Week)|Withdrawal by Subject|0
5224278|NCT00932360|18033277|P3|Washout (One Week)|Withdrawal by Subject|0
5224279|NCT00932360|18033278|P2|Washout (One Week)|Withdrawal by Subject|0
5224280|NCT00932360|18033279|P1|Washout (One Week)|Withdrawal by Subject|0
5224281|NCT00932165|18033336|P1|Overall Study|Lost to Follow-up|1
5224282|NCT00932126|18033360|P8|Overall Study|Other|2
5224283|NCT00932126|18033361|P7|Overall Study|Other|1
5224284|NCT00932126|18033362|P6|Overall Study|Other|0
5224285|NCT00932126|18033363|P5|Overall Study|Other|1
5224286|NCT00932126|18033364|P4|Overall Study|Other|0
5224287|NCT00932126|18033365|P3|Overall Study|Other|0
5224288|NCT00932126|18033366|P2|Overall Study|Other|0
5224289|NCT00932126|18033367|P1|Overall Study|Other|0
5224290|NCT00932126|18033360|P8|Overall Study|Objective progression or relapse|5
5224291|NCT00932126|18033361|P7|Overall Study|Objective progression or relapse|3
5224292|NCT00932126|18033362|P6|Overall Study|Objective progression or relapse|3
5224293|NCT00932126|18033363|P5|Overall Study|Objective progression or relapse|3
5224294|NCT00932126|18033364|P4|Overall Study|Objective progression or relapse|3
5224295|NCT00932126|18033365|P3|Overall Study|Objective progression or relapse|2
5224296|NCT00932126|18033366|P2|Overall Study|Objective progression or relapse|3
5224297|NCT00932126|18033367|P1|Overall Study|Objective progression or relapse|3
5224298|NCT00932126|18033360|P8|Overall Study|Withdrawal by Subject|1
5224299|NCT00932126|18033361|P7|Overall Study|Withdrawal by Subject|0
5224300|NCT00932126|18033362|P6|Overall Study|Withdrawal by Subject|0
5224301|NCT00932126|18033363|P5|Overall Study|Withdrawal by Subject|0
5224302|NCT00932126|18033364|P4|Overall Study|Withdrawal by Subject|0
5224303|NCT00932126|18033365|P3|Overall Study|Withdrawal by Subject|1
5224304|NCT00932126|18033366|P2|Overall Study|Withdrawal by Subject|0
5224305|NCT00932126|18033367|P1|Overall Study|Withdrawal by Subject|0
5224306|NCT00932126|18033360|P8|Overall Study|Protocol Violation|0
5224307|NCT00932126|18033361|P7|Overall Study|Protocol Violation|0
5224308|NCT00932126|18033362|P6|Overall Study|Protocol Violation|0
5224309|NCT00932126|18033363|P5|Overall Study|Protocol Violation|1
5224310|NCT00932126|18033364|P4|Overall Study|Protocol Violation|0
5224311|NCT00932126|18033365|P3|Overall Study|Protocol Violation|0
5224312|NCT00932126|18033366|P2|Overall Study|Protocol Violation|0
5224313|NCT00932126|18033367|P1|Overall Study|Protocol Violation|0
5224314|NCT00932126|18033360|P8|Overall Study|Adverse Event|2
5224315|NCT00932126|18033361|P7|Overall Study|Adverse Event|1
5224316|NCT00932126|18033362|P6|Overall Study|Adverse Event|0
5224317|NCT00932126|18033363|P5|Overall Study|Adverse Event|0
5224318|NCT00932126|18033364|P4|Overall Study|Adverse Event|0
5224319|NCT00932126|18033365|P3|Overall Study|Adverse Event|0
5224320|NCT00932126|18033366|P2|Overall Study|Adverse Event|0
5224321|NCT00932126|18033367|P1|Overall Study|Adverse Event|0
5224322|NCT00932113|18033405|P2|Overall Study|Lost to Follow-up|0
5224323|NCT00932113|18033406|P1|Overall Study|Lost to Follow-up|1
5224324|NCT00931918|18033458|P2|Overall Study|Did not receive study drug|2
5224325|NCT00931918|18033459|P1|Overall Study|Did not receive study drug|3
5224326|NCT00931918|18033458|P2|Overall Study|Other Reason not Specified|4
5224327|NCT00931918|18033459|P1|Overall Study|Other Reason not Specified|4
5224328|NCT00931918|18033458|P2|Overall Study|Withdrawal by Patient|4
5224329|NCT00931918|18033459|P1|Overall Study|Withdrawal by Patient|3
5224330|NCT00931918|18033458|P2|Overall Study|Symptomatic Deterioration|0
5224331|NCT00931918|18033459|P1|Overall Study|Symptomatic Deterioration|1
5224332|NCT00931918|18033458|P2|Overall Study|Progressive Disease|1
5224333|NCT00931918|18033459|P1|Overall Study|Progressive Disease|2
5224334|NCT00931918|18033458|P2|Overall Study|Adverse Event|6
5224335|NCT00931918|18033459|P1|Overall Study|Adverse Event|4
5224336|NCT00931801|18033511|P3|Overall Study|Confirmed Virologic Failure|3
5224337|NCT00931801|18033512|P2|Overall Study|Confirmed Virologic Failure|0
5224338|NCT00931801|18033513|P1|Overall Study|Confirmed Virologic Failure|0
5224339|NCT00931801|18033511|P3|Overall Study|Withdrawal by Subject|0
5224340|NCT00931801|18033512|P2|Overall Study|Withdrawal by Subject|0
5224341|NCT00931801|18033513|P1|Overall Study|Withdrawal by Subject|1
5224342|NCT00931801|18033511|P3|Overall Study|Lost to Follow-up|0
5224343|NCT00931801|18033512|P2|Overall Study|Lost to Follow-up|1
5224344|NCT00931801|18033513|P1|Overall Study|Lost to Follow-up|0
5224345|NCT00931801|18033511|P3|Overall Study|Adverse Event|1
5224346|NCT00931801|18033512|P2|Overall Study|Adverse Event|0
5224347|NCT00931801|18033513|P1|Overall Study|Adverse Event|0
5224348|NCT00931723|18033536|P2|Overall Study|Late hospital discharge|0
5224349|NCT00931723|18033537|P1|Overall Study|Late hospital discharge|1
5224350|NCT00931723|18033536|P2|Overall Study|Sponsor decision|0
5224351|NCT00931723|18033537|P1|Overall Study|Sponsor decision|1
5224352|NCT00931723|18033536|P2|Overall Study|Lack or insufficient theraputic response|5
5224353|NCT00931723|18033537|P1|Overall Study|Lack or insufficient theraputic response|2
5224354|NCT00931723|18033536|P2|Overall Study|Took prohibited concomitant medication|1
5224355|NCT00931723|18033537|P1|Overall Study|Took prohibited concomitant medication|0
5224356|NCT00931723|18033536|P2|Overall Study|Safety reasons|1
5224357|NCT00931723|18033537|P1|Overall Study|Safety reasons|0
5224358|NCT00931723|18033536|P2|Overall Study|Severe non-compliance to protocol|0
5224359|NCT00931723|18033537|P1|Overall Study|Severe non-compliance to protocol|2
5224360|NCT00931723|18033536|P2|Overall Study|Study-specific discontinuation criteria|1
5224361|NCT00931723|18033537|P1|Overall Study|Study-specific discontinuation criteria|1
5224362|NCT00931723|18033536|P2|Overall Study|Lost to Follow-up|2
5224363|NCT00931723|18033537|P1|Overall Study|Lost to Follow-up|1
5224364|NCT00931723|18033536|P2|Overall Study|Condition under investigation worsened|2
5224365|NCT00931723|18033537|P1|Overall Study|Condition under investigation worsened|1
5224366|NCT00931723|18033536|P2|Overall Study|Lithium found in blood|1
5224367|NCT00931723|18033537|P1|Overall Study|Lithium found in blood|0
5224368|NCT00931723|18033536|P2|Overall Study|Adverse Event|13
5224369|NCT00931723|18033537|P1|Overall Study|Adverse Event|6
5224370|NCT00931723|18033536|P2|Overall Study|Withdrawal by Subject|13
5224371|NCT00931723|18033537|P1|Overall Study|Withdrawal by Subject|11
5224372|NCT00931710|18033585|P2|Overall Study|Protocol deviation|2
5224373|NCT00931710|18033586|P1|Overall Study|Protocol deviation|1
5224374|NCT00931710|18033585|P2|Overall Study|Lost to Follow-up|5
5224375|NCT00931710|18033586|P1|Overall Study|Lost to Follow-up|6
5224376|NCT00931710|18033585|P2|Overall Study|Patient withdrew consent|9
5224377|NCT00931710|18033586|P1|Overall Study|Patient withdrew consent|4
5224378|NCT00931710|18033585|P2|Overall Study|Unsatisfactory therapeutic effects|12
5224379|NCT00931710|18033586|P1|Overall Study|Unsatisfactory therapeutic effects|5
5224380|NCT00931710|18033585|P2|Overall Study|Abnormal test procedure results|0
5224381|NCT00931710|18033586|P1|Overall Study|Abnormal test procedure results|2
5224382|NCT00931710|18033585|P2|Overall Study|Adverse Event|10
5224383|NCT00931710|18033586|P1|Overall Study|Adverse Event|16
5224384|NCT00931632|18033604|P2|Overall Study|Adverse Event|15
5224385|NCT00931632|18033605|P1|Overall Study|Adverse Event|19
5224386|NCT00931632|18033604|P2|Overall Study|Withdrawal by Subject|3
5224387|NCT00931632|18033605|P1|Overall Study|Withdrawal by Subject|2
5224388|NCT00931528|18033627|P2|Overall Study|Assessment outside of Time Frame|23
5224389|NCT00931528|18033628|P1|Overall Study|Assessment outside of Time Frame|22
5224390|NCT00931528|18033627|P2|Overall Study|Lost to Follow-up|13
5224391|NCT00931528|18033628|P1|Overall Study|Lost to Follow-up|6
5224392|NCT00931528|18033627|P2|Overall Study|Withdrawal by Subject|12
5224393|NCT00931528|18033628|P1|Overall Study|Withdrawal by Subject|4
5224394|NCT00931528|18033627|P2|Overall Study|Protocol Violation|12
5224395|NCT00931528|18033628|P1|Overall Study|Protocol Violation|9
5224396|NCT00931515|18033648|P2|Overall Study|Lost to Follow-up|5
5224397|NCT00931515|18033649|P1|Overall Study|Lost to Follow-up|2
5224398|NCT00931463|18033679|P2|Overall Study|Lost to Follow-up|1
5224399|NCT00931463|18033680|P1|Overall Study|Lost to Follow-up|4
5224400|NCT00931463|18033679|P2|Overall Study|Withdrawal by Subject|0
5224401|NCT00931463|18033680|P1|Overall Study|Withdrawal by Subject|5
5224402|NCT00931463|18033679|P2|Overall Study|Death|4
5224403|NCT00931463|18033680|P1|Overall Study|Death|8
5224404|NCT00931411|18033696|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
5224405|NCT00931411|18033697|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
5224406|NCT00931411|18033696|P2|First Intervention - 42 Days|Lost to Follow-up|0
5224407|NCT00931411|18033697|P1|First Intervention - 42 Days|Lost to Follow-up|2
5224408|NCT00931411|18033696|P2|First Intervention - 42 Days|Adverse Event|3
5224409|NCT00931411|18033697|P1|First Intervention - 42 Days|Adverse Event|2
5224410|NCT00931385|18033718|P4|Overall Study|Lost to Follow-up|1
5224411|NCT00931385|18033719|P3|Overall Study|Lost to Follow-up|0
5224412|NCT00931385|18033720|P2|Overall Study|Lost to Follow-up|0
5224413|NCT00931385|18033721|P1|Overall Study|Lost to Follow-up|0
5224414|NCT00931385|18033718|P4|Overall Study|Withdrawal by Subject|1
5224415|NCT00931385|18033719|P3|Overall Study|Withdrawal by Subject|0
5224416|NCT00931385|18033720|P2|Overall Study|Withdrawal by Subject|1
5224417|NCT00931385|18033721|P1|Overall Study|Withdrawal by Subject|0
5224418|NCT00931385|18033718|P4|Overall Study|Protocol Violation|0
5224419|NCT00931385|18033719|P3|Overall Study|Protocol Violation|1
5224420|NCT00931385|18033720|P2|Overall Study|Protocol Violation|0
5224421|NCT00931385|18033721|P1|Overall Study|Protocol Violation|0
5224422|NCT00931385|18033718|P4|Overall Study|Adverse Event|3
5224423|NCT00931385|18033719|P3|Overall Study|Adverse Event|0
5224424|NCT00931385|18033720|P2|Overall Study|Adverse Event|1
5224425|NCT00931385|18033721|P1|Overall Study|Adverse Event|2
5224426|NCT00931307|18033790|P1|Overall Study|Biomicroscopy|1
5224427|NCT00931307|18033790|P1|Overall Study|Lack of Efficacy|12
5224428|NCT00931268|18033794|P1|Overall Study|Lost to Follow-up|6
5224429|NCT00931255|18033806|P2|Overall Study|Follow up biopsy not done|3
5224430|NCT00931255|18033807|P1|Overall Study|Follow up biopsy not done|2
5224431|NCT00930982|18033844|P2|Overall Study|Withdrawal by Subject|1
5224432|NCT00930982|18033845|P1|Overall Study|Withdrawal by Subject|1
5224433|NCT00930982|18033844|P2|Overall Study|Protocol Violation|5
5224434|NCT00930982|18033845|P1|Overall Study|Protocol Violation|1
5224435|NCT00930982|18033844|P2|Overall Study|Adverse Event|23
5224436|NCT00930982|18033845|P1|Overall Study|Adverse Event|19
5224437|NCT00930969|18033879|P1|Overall Study|Withdrawal by Subject|19
5224438|NCT00930969|18033879|P1|Overall Study|Physician Decision|13
5224439|NCT00930969|18033879|P1|Overall Study|Lost to Follow-up|1
5224440|NCT00930969|18033879|P1|Overall Study|Death|5
5224441|NCT00930930|18033889|P2|Overall Study|patients not compliant|1
5224442|NCT00930930|18033890|P1|Overall Study|patients not compliant|1
5224443|NCT00930930|18033889|P2|Overall Study|excessive lapse btw txs, not eligible|1
5224444|NCT00930930|18033890|P1|Overall Study|excessive lapse btw txs, not eligible|0
5224445|NCT00930930|18033889|P2|Overall Study|Disease progression|3
5224446|NCT00930930|18033890|P1|Overall Study|Disease progression|2
5224447|NCT00930930|18033889|P2|Overall Study|Withdrawal by Subject|1
5224448|NCT00930930|18033890|P1|Overall Study|Withdrawal by Subject|3
5224449|NCT00930930|18033889|P2|Overall Study|Adverse Event|3
5224450|NCT00930930|18033890|P1|Overall Study|Adverse Event|13
5224451|NCT00930930|18033889|P2|Overall Study|Physician Decision|0
5224452|NCT00930930|18033890|P1|Overall Study|Physician Decision|1
5224453|NCT00930930|18033889|P2|Overall Study|Death|0
5224454|NCT00930930|18033890|P1|Overall Study|Death|1
5224455|NCT00930813|18033904|P2|Overall Study|Lost to Follow-up|4
5224456|NCT00930813|18033905|P1|Overall Study|Lost to Follow-up|2
5224457|NCT00930813|18033904|P2|Overall Study|Withdrawal by Subject|5
5224458|NCT00930813|18033905|P1|Overall Study|Withdrawal by Subject|2
5224459|NCT00930813|18033904|P2|Overall Study|Death|5
5224460|NCT00930813|18033905|P1|Overall Study|Death|4
5224461|NCT00930774|18033926|P4|Overall Study|Withdrawal by Subject|0
5224462|NCT00930774|18033927|P3|Overall Study|Withdrawal by Subject|2
5224463|NCT00930774|18033928|P2|Overall Study|Withdrawal by Subject|9
5224464|NCT00930774|18033929|P1|Overall Study|Withdrawal by Subject|1
5224465|NCT00930761|18033969|P2|Overall Study|less than 3 music therapy sessions|3
5224466|NCT00930761|18033970|P1|Overall Study|less than 3 music therapy sessions|0
5224467|NCT00930761|18033969|P2|Overall Study|3 newborns died; 1 mother quit the study|0
5224468|NCT00930761|18033970|P1|Overall Study|3 newborns died; 1 mother quit the study|4
5224469|NCT00930722|18033982|P1|Overall Study|Study terminated by sponsor|2
5224470|NCT00930722|18033982|P1|Overall Study|No longer willing to participate|9
5224471|NCT00930722|18033982|P1|Overall Study|Lost to Follow-up|16
5224472|NCT00930644|18033997|P1|Overall Study|Adverse Event|16
5224473|NCT00930644|18033997|P1|Overall Study|Death|1
5224474|NCT00930644|18033997|P1|Overall Study|Physician Decision|2
5224475|NCT00930644|18033997|P1|Overall Study|Withdrawal by Subject|4
5224476|NCT00930553|18034010|P1|Overall Study|Other than specified above|28
5224477|NCT00930553|18034010|P1|Overall Study|Study terminated by sponsor|24
5224478|NCT00930553|18034010|P1|Overall Study|Death|9
5224479|NCT00930553|18034010|P1|Overall Study|Lost to Follow-up|25
5224480|NCT00930553|18034010|P1|Overall Study|Withdrawal by Subject|88
5224481|NCT00930553|18034010|P1|Overall Study|Pregnancy|1
5224482|NCT00930553|18034010|P1|Overall Study|Protocol Violation|1
5224483|NCT00930553|18034010|P1|Overall Study|Physician Decision|39
5224484|NCT00930553|18034010|P1|Overall Study|Lack of Efficacy|7
5224485|NCT00930553|18034010|P1|Overall Study|Adverse Event|1
5224486|NCT00930176|18034087|P1|Overall Study|Death|1
5224487|NCT00930059|18034094|P2|Overall Study|Adverse Event|6
5224488|NCT00930059|18034095|P1|Overall Study|Adverse Event|1
5224489|NCT00930059|18034094|P2|Overall Study|1 site terminated by sponsor|1
5224490|NCT00930059|18034095|P1|Overall Study|1 site terminated by sponsor|1
5224491|NCT00930059|18034094|P2|Overall Study|Other|0
5224492|NCT00930059|18034095|P1|Overall Study|Other|1
5224493|NCT00930059|18034094|P2|Overall Study|Withdrawal by Subject|4
5224494|NCT00930059|18034095|P1|Overall Study|Withdrawal by Subject|3
5224495|NCT00930059|18034094|P2|Overall Study|Did not meet entrance criteria|1
5224496|NCT00930059|18034095|P1|Overall Study|Did not meet entrance criteria|1
5224497|NCT00930059|18034094|P2|Overall Study|Death|0
5224498|NCT00930059|18034095|P1|Overall Study|Death|1
5224499|NCT00930046|18034125|P2|Overall Study|Wound catheter malfunctioned|2
5224500|NCT00930046|18034126|P1|Overall Study|Wound catheter malfunctioned|1
5224501|NCT00929994|18034134|P1|Overall Study|employment|1
5224502|NCT00929994|18034134|P1|Overall Study|medical issue unrelated to intervention|4
5224503|NCT00929994|18034134|P1|Overall Study|Withdrawal by Subject|1
5224504|NCT00929864|18034153|P2|Overall Study|Non-specified|7
5224505|NCT00929864|18034154|P1|Overall Study|Non-specified|2
5224506|NCT00929864|18034153|P2|Overall Study|Administrative reason by Sponsor|1
5224507|NCT00929864|18034154|P1|Overall Study|Administrative reason by Sponsor|1
5224508|NCT00929864|18034153|P2|Overall Study|Pregnancy|3
5224509|NCT00929864|18034154|P1|Overall Study|Pregnancy|0
5224510|NCT00929864|18034153|P2|Overall Study|Poor or non-compliance|3
5224511|NCT00929864|18034154|P1|Overall Study|Poor or non-compliance|3
5224512|NCT00929864|18034153|P2|Overall Study|No longer met criteria|1
5224513|NCT00929864|18034154|P1|Overall Study|No longer met criteria|2
5224514|NCT00929864|18034153|P2|Overall Study|Withdrawal by Subject|9
5224515|NCT00929864|18034154|P1|Overall Study|Withdrawal by Subject|20
5224516|NCT00929864|18034153|P2|Overall Study|Lost to Follow-up|12
5224517|NCT00929864|18034154|P1|Overall Study|Lost to Follow-up|7
5224518|NCT00929864|18034153|P2|Overall Study|Lack of Efficacy|16
5224519|NCT00929864|18034154|P1|Overall Study|Lack of Efficacy|19
5224520|NCT00929864|18034153|P2|Overall Study|Adverse Event|30
5224521|NCT00929864|18034154|P1|Overall Study|Adverse Event|11
5224522|NCT00929864|18034153|P2|Overall Study|Death|1
5224523|NCT00929864|18034154|P1|Overall Study|Death|1
5224524|NCT00929734|18034210|P2|Overall Study|Withdrawal by Subject|2
5224525|NCT00929734|18034211|P1|Overall Study|Withdrawal by Subject|0
5224526|NCT00929734|18034210|P2|Overall Study|Lost to Follow-up|1
5224527|NCT00929734|18034211|P1|Overall Study|Lost to Follow-up|2
5224528|NCT00929708|18034228|P5|Overall Study|Lost to Follow-up|0
5224529|NCT00929708|18034229|P4|Overall Study|Lost to Follow-up|1
5224530|NCT00929708|18034230|P3|Overall Study|Lost to Follow-up|0
5224531|NCT00929708|18034231|P2|Overall Study|Lost to Follow-up|0
5224532|NCT00929708|18034232|P1|Overall Study|Lost to Follow-up|0
5224533|NCT00929708|18034228|P5|Overall Study|Physician Decision|1
5224534|NCT00929708|18034229|P4|Overall Study|Physician Decision|2
5224535|NCT00929708|18034230|P3|Overall Study|Physician Decision|2
5224536|NCT00929708|18034231|P2|Overall Study|Physician Decision|2
5224537|NCT00929708|18034232|P1|Overall Study|Physician Decision|0
5224538|NCT00929708|18034228|P5|Overall Study|Adverse Event|3
5224539|NCT00929708|18034229|P4|Overall Study|Adverse Event|0
5224540|NCT00929708|18034230|P3|Overall Study|Adverse Event|0
5224541|NCT00929708|18034231|P2|Overall Study|Adverse Event|0
5224542|NCT00929708|18034232|P1|Overall Study|Adverse Event|0
5224543|NCT00929708|18034228|P5|Overall Study|Withdrawal by Subject|1
5224544|NCT00929708|18034229|P4|Overall Study|Withdrawal by Subject|2
5224545|NCT00929708|18034230|P3|Overall Study|Withdrawal by Subject|0
5224546|NCT00929708|18034231|P2|Overall Study|Withdrawal by Subject|0
5224547|NCT00929708|18034232|P1|Overall Study|Withdrawal by Subject|2
5224548|NCT00929708|18034228|P5|Overall Study|Protocol Violation|1
5224549|NCT00929708|18034229|P4|Overall Study|Protocol Violation|1
5224550|NCT00929708|18034230|P3|Overall Study|Protocol Violation|1
5224551|NCT00929708|18034231|P2|Overall Study|Protocol Violation|1
5224552|NCT00929708|18034232|P1|Overall Study|Protocol Violation|2
5224553|NCT00929695|18034286|P2|Overall Study|incorrect stratification|0
5224554|NCT00929695|18034287|P1|Overall Study|incorrect stratification|2
5224555|NCT00929695|18034286|P2|Overall Study|discharge home|3
5224556|NCT00929695|18034287|P1|Overall Study|discharge home|4
5224557|NCT00929695|18034286|P2|Overall Study|Withdrawal by Subject|2
5224558|NCT00929695|18034287|P1|Overall Study|Withdrawal by Subject|0
5224559|NCT00929695|18034286|P2|Overall Study|Death|1
5224560|NCT00929695|18034287|P1|Overall Study|Death|2
5224561|NCT00929669|18034317|P1|Overall Study|elevated glucose levels|1
5224562|NCT00929656|18034324|P2|Overall Study|Lost to Follow-up|1
5224563|NCT00929656|18034325|P1|Overall Study|Lost to Follow-up|0
5224564|NCT00929643|18034339|P1|Overall Study|Protocol Violation|2
5224565|NCT00929526|18034361|P2|Overall Study|Other|6
5224566|NCT00929526|18034362|P1|Overall Study|Other|8
5224567|NCT00929526|18034361|P2|Overall Study|Lost to Follow-up|12
5224568|NCT00929526|18034362|P1|Overall Study|Lost to Follow-up|8
5224569|NCT00929526|18034361|P2|Overall Study|Withdrawal by Subject|11
5224570|NCT00929526|18034362|P1|Overall Study|Withdrawal by Subject|1
5224571|NCT00929240|18034516|P3|Maintenance Phase|Participant not treated|0
5224572|NCT00929240|18034517|P2|Maintenance Phase|Participant not treated|2
5224573|NCT00929240|18034518|P1|Maintenance Phase|Participant not treated|0
5224574|NCT00929240|18034516|P3|Maintenance Phase|Treatment ongoing at study closure|10
5224575|NCT00929240|18034517|P2|Maintenance Phase|Treatment ongoing at study closure|0
5224576|NCT00929240|18034518|P1|Maintenance Phase|Treatment ongoing at study closure|0
5224577|NCT00929240|18034516|P3|Maintenance Phase|Change of treatment|0
5224578|NCT00929240|18034517|P2|Maintenance Phase|Change of treatment|4
5224579|NCT00929240|18034518|P1|Maintenance Phase|Change of treatment|0
5224580|NCT00929240|18034516|P3|Maintenance Phase|Physician Decision|1
5224581|NCT00929240|18034517|P2|Maintenance Phase|Physician Decision|2
5224582|NCT00929240|18034518|P1|Maintenance Phase|Physician Decision|0
5224583|NCT00929240|18034516|P3|Maintenance Phase|Health authority/Study termination|2
5224584|NCT00929240|18034517|P2|Maintenance Phase|Health authority/Study termination|1
5224585|NCT00929240|18034518|P1|Maintenance Phase|Health authority/Study termination|0
5224586|NCT00929240|18034516|P3|Maintenance Phase|Protocol Violation|0
5224587|NCT00929240|18034517|P2|Maintenance Phase|Protocol Violation|1
5224588|NCT00929240|18034518|P1|Maintenance Phase|Protocol Violation|0
5224589|NCT00929240|18034516|P3|Maintenance Phase|Withdrawal by Subject|6
5224590|NCT00929240|18034517|P2|Maintenance Phase|Withdrawal by Subject|2
5224591|NCT00929240|18034518|P1|Maintenance Phase|Withdrawal by Subject|0
5224592|NCT00929240|18034516|P3|Maintenance Phase|Adverse Event|12
5224593|NCT00929240|18034517|P2|Maintenance Phase|Adverse Event|9
5224594|NCT00929240|18034518|P1|Maintenance Phase|Adverse Event|0
5224595|NCT00929240|18034516|P3|Maintenance Phase|Disease progression|60
5224596|NCT00929240|18034517|P2|Maintenance Phase|Disease progression|73
5224597|NCT00929240|18034518|P1|Maintenance Phase|Disease progression|0
5224598|NCT00929240|18034516|P3|Initial Treatment Phase|Physician Decision|0
5224599|NCT00929240|18034517|P2|Initial Treatment Phase|Physician Decision|0
5224600|NCT00929240|18034518|P1|Initial Treatment Phase|Physician Decision|4
5224601|NCT00929240|18034516|P3|Initial Treatment Phase|Health authority/Study termination|0
5224602|NCT00929240|18034517|P2|Initial Treatment Phase|Health authority/Study termination|0
5224603|NCT00929240|18034518|P1|Initial Treatment Phase|Health authority/Study termination|3
5224604|NCT00929240|18034516|P3|Initial Treatment Phase|Death|0
5224605|NCT00929240|18034517|P2|Initial Treatment Phase|Death|0
5224606|NCT00929240|18034518|P1|Initial Treatment Phase|Death|2
5224607|NCT00929240|18034516|P3|Initial Treatment Phase|Protocol Violation|0
5224608|NCT00929240|18034517|P2|Initial Treatment Phase|Protocol Violation|0
5224609|NCT00929240|18034518|P1|Initial Treatment Phase|Protocol Violation|5
5224610|NCT00929240|18034516|P3|Initial Treatment Phase|Withdrawal by Subject|0
5224611|NCT00929240|18034517|P2|Initial Treatment Phase|Withdrawal by Subject|0
5224612|NCT00929240|18034518|P1|Initial Treatment Phase|Withdrawal by Subject|13
5224613|NCT00929240|18034516|P3|Initial Treatment Phase|Disease progression|0
5224614|NCT00929240|18034517|P2|Initial Treatment Phase|Disease progression|0
5224615|NCT00929240|18034518|P1|Initial Treatment Phase|Disease progression|41
5224616|NCT00929240|18034516|P3|Initial Treatment Phase|Adverse Event|0
5224617|NCT00929240|18034517|P2|Initial Treatment Phase|Adverse Event|0
5224618|NCT00929240|18034518|P1|Initial Treatment Phase|Adverse Event|31
5224619|NCT00929201|18034545|P2|Period 1|Withdrawal by Subject|1
5224620|NCT00929201|18034546|P1|Period 1|Withdrawal by Subject|0
5224621|NCT00929162|18034556|P2|Overall Study|Other termination reason|6
5224622|NCT00929162|18034557|P1|Overall Study|Other termination reason|5
5224623|NCT00929162|18034556|P2|Overall Study|Protocol Violation|30
5224624|NCT00929162|18034557|P1|Overall Study|Protocol Violation|32
5224625|NCT00929162|18034556|P2|Overall Study|Withdrawal by Subject|1
5224626|NCT00929162|18034557|P1|Overall Study|Withdrawal by Subject|3
5224627|NCT00929162|18034556|P2|Overall Study|Adverse Event|5
5224628|NCT00929162|18034557|P1|Overall Study|Adverse Event|8
5224629|NCT00929110|18034570|P3|Overall Study|Patient inability to use the device|0
5224630|NCT00929110|18034571|P2|Overall Study|Patient inability to use the device|1
5224631|NCT00929110|18034572|P1|Overall Study|Patient inability to use the device|0
5224632|NCT00929110|18034570|P3|Overall Study|Abnormal test procedure result(s)|1
5224633|NCT00929110|18034571|P2|Overall Study|Abnormal test procedure result(s)|1
5224634|NCT00929110|18034572|P1|Overall Study|Abnormal test procedure result(s)|0
5224635|NCT00929110|18034570|P3|Overall Study|Abnormal laboratory value(s)|0
5224636|NCT00929110|18034571|P2|Overall Study|Abnormal laboratory value(s)|1
5224637|NCT00929110|18034572|P1|Overall Study|Abnormal laboratory value(s)|0
5224638|NCT00929110|18034570|P3|Overall Study|Death|2
5224639|NCT00929110|18034571|P2|Overall Study|Death|2
5224640|NCT00929110|18034572|P1|Overall Study|Death|2
5224641|NCT00929110|18034570|P3|Overall Study|Administrative problems|2
5224642|NCT00929110|18034571|P2|Overall Study|Administrative problems|1
5224643|NCT00929110|18034572|P1|Overall Study|Administrative problems|4
5224644|NCT00929110|18034570|P3|Overall Study|Protocol deviation|4
5224645|NCT00929110|18034571|P2|Overall Study|Protocol deviation|2
5224646|NCT00929110|18034572|P1|Overall Study|Protocol deviation|5
5224647|NCT00929110|18034570|P3|Overall Study|Lost to Follow-up|3
5224648|NCT00929110|18034571|P2|Overall Study|Lost to Follow-up|7
5224649|NCT00929110|18034572|P1|Overall Study|Lost to Follow-up|7
5224650|NCT00929110|18034570|P3|Overall Study|Unsatisfactory therapeutic effect|6
5224651|NCT00929110|18034571|P2|Overall Study|Unsatisfactory therapeutic effect|9
5224652|NCT00929110|18034572|P1|Overall Study|Unsatisfactory therapeutic effect|20
5224653|NCT00929110|18034570|P3|Overall Study|Subject withdrew consent|26
5224654|NCT00929110|18034571|P2|Overall Study|Subject withdrew consent|23
5224655|NCT00929110|18034572|P1|Overall Study|Subject withdrew consent|40
5224656|NCT00929110|18034570|P3|Overall Study|Adverse Event|18
5224657|NCT00929110|18034571|P2|Overall Study|Adverse Event|29
5224658|NCT00929110|18034572|P1|Overall Study|Adverse Event|40
5224659|NCT00928889|18034655|P2|Overall Study|Other|0
5224660|NCT00928889|18034656|P1|Overall Study|Other|1
5224661|NCT00928889|18034655|P2|Overall Study|Adverse Event|0
5224662|NCT00928889|18034656|P1|Overall Study|Adverse Event|1
5224663|NCT00928889|18034655|P2|Overall Study|Protocol Violation|1
5224664|NCT00928889|18034656|P1|Overall Study|Protocol Violation|0
5224665|NCT00928889|18034655|P2|Overall Study|Lost to Follow-up|1
5224666|NCT00928889|18034656|P1|Overall Study|Lost to Follow-up|3
5224667|NCT00928746|18034702|P1|Overall Study|Other|2
5224668|NCT00928746|18034702|P1|Overall Study|Withdrawal by Subject|1
5224669|NCT00928746|18034702|P1|Overall Study|Protocol Violation|1
5224670|NCT00928746|18034702|P1|Overall Study|Adverse Event|2
5224671|NCT00928707|18034752|P2|Overall Study|Protocol Violation|0
5224672|NCT00928707|18034753|P1|Overall Study|Protocol Violation|1
5224673|NCT00928668|18034774|P5|Overall Study|Other reasons not listed above|0
5224674|NCT00928668|18034775|P4|Overall Study|Other reasons not listed above|1
5224675|NCT00928668|18034776|P3|Overall Study|Other reasons not listed above|0
5224676|NCT00928668|18034777|P2|Overall Study|Other reasons not listed above|0
5224677|NCT00928668|18034778|P1|Overall Study|Other reasons not listed above|0
5224678|NCT00928668|18034774|P5|Overall Study|Withdrawal by Subject|0
5224679|NCT00928668|18034775|P4|Overall Study|Withdrawal by Subject|0
5224680|NCT00928668|18034776|P3|Overall Study|Withdrawal by Subject|1
5224681|NCT00928668|18034777|P2|Overall Study|Withdrawal by Subject|1
5224682|NCT00928668|18034778|P1|Overall Study|Withdrawal by Subject|0
5224683|NCT00928668|18034774|P5|Overall Study|Protocol Violation|1
5224684|NCT00928668|18034775|P4|Overall Study|Protocol Violation|0
5224685|NCT00928668|18034776|P3|Overall Study|Protocol Violation|0
5224686|NCT00928668|18034777|P2|Overall Study|Protocol Violation|0
5224687|NCT00928668|18034778|P1|Overall Study|Protocol Violation|0
5224688|NCT00928668|18034774|P5|Overall Study|Adverse Event|0
5224689|NCT00928668|18034775|P4|Overall Study|Adverse Event|0
5224690|NCT00928668|18034776|P3|Overall Study|Adverse Event|0
5224691|NCT00928668|18034777|P2|Overall Study|Adverse Event|0
5224692|NCT00928668|18034778|P1|Overall Study|Adverse Event|1
5224693|NCT00928512|18034834|P5|Overall Study|Administrative Problems|0
5224694|NCT00928512|18034835|P4|Overall Study|Administrative Problems|0
5224695|NCT00928512|18034836|P3|Overall Study|Administrative Problems|0
5224696|NCT00928512|18034837|P2|Overall Study|Administrative Problems|1
5224697|NCT00928512|18034838|P1|Overall Study|Administrative Problems|0
5224698|NCT00928512|18034834|P5|Overall Study|Lost to Follow-up|3
5224699|NCT00928512|18034835|P4|Overall Study|Lost to Follow-up|1
5224700|NCT00928512|18034836|P3|Overall Study|Lost to Follow-up|2
5224701|NCT00928512|18034837|P2|Overall Study|Lost to Follow-up|1
5224702|NCT00928512|18034838|P1|Overall Study|Lost to Follow-up|1
5224703|NCT00928512|18034834|P5|Overall Study|Withdrawal by Subject|0
5224704|NCT00928512|18034835|P4|Overall Study|Withdrawal by Subject|4
5224705|NCT00928512|18034836|P3|Overall Study|Withdrawal by Subject|3
5224706|NCT00928512|18034837|P2|Overall Study|Withdrawal by Subject|0
5224707|NCT00928512|18034838|P1|Overall Study|Withdrawal by Subject|3
5224708|NCT00928512|18034834|P5|Overall Study|Protocol Violation|3
5224709|NCT00928512|18034835|P4|Overall Study|Protocol Violation|1
5224710|NCT00928512|18034836|P3|Overall Study|Protocol Violation|0
5224711|NCT00928512|18034837|P2|Overall Study|Protocol Violation|1
5224712|NCT00928512|18034838|P1|Overall Study|Protocol Violation|0
5224713|NCT00928512|18034834|P5|Overall Study|Lack of Efficacy|3
5224714|NCT00928512|18034835|P4|Overall Study|Lack of Efficacy|7
5224715|NCT00928512|18034836|P3|Overall Study|Lack of Efficacy|4
5224716|NCT00928512|18034837|P2|Overall Study|Lack of Efficacy|0
5224717|NCT00928512|18034838|P1|Overall Study|Lack of Efficacy|2
5224718|NCT00928512|18034834|P5|Overall Study|Adverse Event|6
5224719|NCT00928512|18034835|P4|Overall Study|Adverse Event|8
5224720|NCT00928512|18034836|P3|Overall Study|Adverse Event|2
5224721|NCT00928512|18034837|P2|Overall Study|Adverse Event|3
5224722|NCT00928512|18034838|P1|Overall Study|Adverse Event|4
5224723|NCT00928486|18034939|P1|Overall Study|Withdrawal by Subject|1
5224724|NCT00928486|18034939|P1|Overall Study|Disease Progression|7
5224725|NCT00928486|18034939|P1|Overall Study|Adverse Event|2
5224726|NCT00928434|18034948|P3|Overall Study|Other (not meeting above criteria)|2
5224727|NCT00928434|18034949|P2|Overall Study|Other (not meeting above criteria)|1
5224728|NCT00928434|18034950|P1|Overall Study|Other (not meeting above criteria)|5
5224729|NCT00928434|18034948|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
5224730|NCT00928434|18034949|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
5224731|NCT00928434|18034950|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
5224732|NCT00928434|18034948|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
5224733|NCT00928434|18034949|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
5224734|NCT00928434|18034950|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
5224735|NCT00928434|18034948|P3|Overall Study|Withdrawal by Subject|2
5224736|NCT00928434|18034949|P2|Overall Study|Withdrawal by Subject|3
5224737|NCT00928434|18034950|P1|Overall Study|Withdrawal by Subject|5
5224738|NCT00928434|18034948|P3|Overall Study|Lost to Follow-up|3
5224739|NCT00928434|18034949|P2|Overall Study|Lost to Follow-up|0
5224740|NCT00928434|18034950|P1|Overall Study|Lost to Follow-up|1
5224741|NCT00928434|18034948|P3|Overall Study|Physician Decision|3
5224742|NCT00928434|18034949|P2|Overall Study|Physician Decision|0
5224743|NCT00928434|18034950|P1|Overall Study|Physician Decision|2
5224744|NCT00928434|18034948|P3|Overall Study|Protocol Violation|8
5224745|NCT00928434|18034949|P2|Overall Study|Protocol Violation|0
5224746|NCT00928434|18034950|P1|Overall Study|Protocol Violation|5
5224747|NCT00928434|18034948|P3|Overall Study|Adverse Event|18
5224748|NCT00928434|18034949|P2|Overall Study|Adverse Event|5
5224749|NCT00928434|18034950|P1|Overall Study|Adverse Event|14
5224750|NCT00928408|18035026|P1|Overall Study|Lost to Follow-up|12
5224751|NCT00928408|18035026|P1|Overall Study|Death|5
5224752|NCT00928408|18035026|P1|Overall Study|Withdrawal by Subject|4
5224753|NCT00928408|18035026|P1|Overall Study|Other|2
5224754|NCT00928252|18035072|P1|Overall Study|Physician Decision|3
5224755|NCT00928187|18035132|P3|Overall Study|Protocol Violation|0
5224756|NCT00928187|18035133|P2|Overall Study|Protocol Violation|1
5224757|NCT00928187|18035134|P1|Overall Study|Protocol Violation|0
5224758|NCT00928187|18035132|P3|Overall Study|Withdrawal by Subject|1
5224759|NCT00928187|18035133|P2|Overall Study|Withdrawal by Subject|1
5224760|NCT00928187|18035134|P1|Overall Study|Withdrawal by Subject|0
5224761|NCT00928187|18035132|P3|Overall Study|Lost to Follow-up|1
5224762|NCT00928187|18035133|P2|Overall Study|Lost to Follow-up|2
5224763|NCT00928187|18035134|P1|Overall Study|Lost to Follow-up|1
5224764|NCT00928187|18035132|P3|Overall Study|Death|3
5224765|NCT00928187|18035133|P2|Overall Study|Death|2
5224766|NCT00928187|18035134|P1|Overall Study|Death|1
5224767|NCT00928070|18035304|P2|Overall Study|Other|5
5224768|NCT00928070|18035305|P1|Overall Study|Other|5
5224769|NCT00928070|18035304|P2|Overall Study|Randomized but not treated|2
5224770|NCT00928070|18035305|P1|Overall Study|Randomized but not treated|2
5224771|NCT00928070|18035304|P2|Overall Study|Protocol Violation|5
5224772|NCT00928070|18035305|P1|Overall Study|Protocol Violation|6
5224773|NCT00928070|18035304|P2|Overall Study|Did not meet entrance criteria|9
5224774|NCT00928070|18035305|P1|Overall Study|Did not meet entrance criteria|16
5224775|NCT00928070|18035304|P2|Overall Study|Lack of Efficacy|5
5224776|NCT00928070|18035305|P1|Overall Study|Lack of Efficacy|9
5224777|NCT00928070|18035304|P2|Overall Study|Adverse Event|26
5224778|NCT00928070|18035305|P1|Overall Study|Adverse Event|14
5224779|NCT00928070|18035304|P2|Overall Study|Withdrawal by Subject|3
5224780|NCT00928070|18035305|P1|Overall Study|Withdrawal by Subject|10
5224781|NCT00928070|18035304|P2|Overall Study|Lost to Follow-up|2
5224782|NCT00928070|18035305|P1|Overall Study|Lost to Follow-up|1
5224783|NCT00928057|18035363|P2|Overall Study|Protocol Violation|1
5224784|NCT00928057|18035364|P1|Overall Study|Protocol Violation|0
5224785|NCT00928057|18035363|P2|Overall Study|Lost to Follow-up|1
5224786|NCT00928057|18035364|P1|Overall Study|Lost to Follow-up|0
5224787|NCT00928057|18035363|P2|Overall Study|Withdrawal by Subject|0
5224788|NCT00928057|18035364|P1|Overall Study|Withdrawal by Subject|1
5224789|NCT00928057|18035363|P2|Overall Study|Adverse Event|2
5224790|NCT00928057|18035364|P1|Overall Study|Adverse Event|1
5224791|NCT00928018|18035389|P2|Overall Study|Withdrawal by Subject|0
5224792|NCT00928018|18035390|P1|Overall Study|Withdrawal by Subject|1
5224793|NCT00927953|18035420|P2|Overall Study|Death|1
5224794|NCT00927953|18035421|P1|Overall Study|Death|2
5224795|NCT00927940|18035435|P1|Overall Study|Death|1
5224796|NCT00927927|18035455|P15|Overall Study|Withdrawal by Subject|0
5224797|NCT00927927|18035456|P14|Overall Study|Withdrawal by Subject|0
5224798|NCT00927927|18035457|P13|Overall Study|Withdrawal by Subject|0
5224799|NCT00927927|18035458|P12|Overall Study|Withdrawal by Subject|2
5224800|NCT00927927|18035459|P11|Overall Study|Withdrawal by Subject|0
5224801|NCT00927927|18035460|P10|Overall Study|Withdrawal by Subject|0
5224802|NCT00927927|18035461|P9|Overall Study|Withdrawal by Subject|0
5224803|NCT00927927|18035462|P8|Overall Study|Withdrawal by Subject|2
5224804|NCT00927927|18035463|P7|Overall Study|Withdrawal by Subject|0
5224805|NCT00927927|18035464|P6|Overall Study|Withdrawal by Subject|0
5224806|NCT00927927|18035465|P5|Overall Study|Withdrawal by Subject|0
5224807|NCT00927927|18035466|P4|Overall Study|Withdrawal by Subject|0
5224808|NCT00927927|18035467|P3|Overall Study|Withdrawal by Subject|0
5224809|NCT00927927|18035468|P2|Overall Study|Withdrawal by Subject|0
5224810|NCT00927927|18035469|P1|Overall Study|Withdrawal by Subject|0
5224811|NCT00927901|18035516|P4|Treatment Period 4|Subject withdrew consent|0
5224812|NCT00927901|18035517|P3|Treatment Period 4|Subject withdrew consent|1
5224813|NCT00927901|18035518|P2|Treatment Period 4|Subject withdrew consent|0
5224814|NCT00927901|18035519|P1|Treatment Period 4|Subject withdrew consent|0
5224815|NCT00927901|18035516|P4|Treatment Period 4|Adverse Event|1
5224816|NCT00927901|18035517|P3|Treatment Period 4|Adverse Event|0
5224817|NCT00927901|18035518|P2|Treatment Period 4|Adverse Event|0
5224818|NCT00927901|18035519|P1|Treatment Period 4|Adverse Event|0
5224819|NCT00927901|18035516|P4|Treatment Period 1|Subject withdrew consent|0
5224820|NCT00927901|18035517|P3|Treatment Period 1|Subject withdrew consent|1
5224821|NCT00927901|18035518|P2|Treatment Period 1|Subject withdrew consent|0
5224822|NCT00927901|18035519|P1|Treatment Period 1|Subject withdrew consent|0
5224823|NCT00927862|18035560|P2|Overall Study|Missing data needed for endpt analyses|45
5224824|NCT00927862|18035561|P1|Overall Study|Missing data needed for endpt analyses|27
5224825|NCT00927823|18035596|P4|Continuous Dosing Period|Other|3
5224826|NCT00927823|18035597|P3|Continuous Dosing Period|Other|9
5224827|NCT00927823|18035598|P2|Continuous Dosing Period|Other|2
5224828|NCT00927823|18035599|P1|Continuous Dosing Period|Other|1
5224829|NCT00927823|18035596|P4|Continuous Dosing Period|Withdrawal by Subject|2
5224830|NCT00927823|18035597|P3|Continuous Dosing Period|Withdrawal by Subject|2
5224831|NCT00927823|18035598|P2|Continuous Dosing Period|Withdrawal by Subject|0
5224832|NCT00927823|18035599|P1|Continuous Dosing Period|Withdrawal by Subject|1
5224833|NCT00927823|18035596|P4|Continuous Dosing Period|Lost to Follow-up|0
5224834|NCT00927823|18035597|P3|Continuous Dosing Period|Lost to Follow-up|9
5224835|NCT00927823|18035598|P2|Continuous Dosing Period|Lost to Follow-up|1
5224836|NCT00927823|18035599|P1|Continuous Dosing Period|Lost to Follow-up|1
5224837|NCT00927823|18035596|P4|Continuous Dosing Period|Death|0
5224838|NCT00927823|18035597|P3|Continuous Dosing Period|Death|6
5224839|NCT00927823|18035598|P2|Continuous Dosing Period|Death|0
5224840|NCT00927823|18035599|P1|Continuous Dosing Period|Death|0
5224841|NCT00927784|18035665|P2|Overall Study|Withdrawal by Subject|0
5224842|NCT00927784|18035666|P1|Overall Study|Withdrawal by Subject|1
5224843|NCT00927784|18035665|P2|Overall Study|Death|0
5224844|NCT00927784|18035666|P1|Overall Study|Death|1
5224845|NCT00927758|18035696|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5224846|NCT00927758|18035697|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5224847|NCT00927758|18035698|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5224848|NCT00927758|18035699|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5224849|NCT00927758|18035700|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5224850|NCT00927758|18035701|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5224851|NCT00927758|18035696|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
5224852|NCT00927758|18035697|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5224853|NCT00927758|18035698|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
5224854|NCT00927758|18035699|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5224855|NCT00927758|18035700|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5224856|NCT00927758|18035701|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5224857|NCT00927589|18035709|P1|Overall Study|Non-compliance|1
5224858|NCT00927589|18035709|P1|Overall Study|Disease Progression|8
5224859|NCT00927589|18035709|P1|Overall Study|Adverse Event|2
5224860|NCT00927589|18035709|P1|Overall Study|Withdrawal by Subject|3
5224861|NCT00927589|18035709|P1|Overall Study|Physician Decision|1
5224862|NCT00927589|18035709|P1|Overall Study|Death|1
5224863|NCT00927563|18035739|P1|Overall Study|Withdrawal by Subject|1
5224864|NCT00927563|18035739|P1|Overall Study|Lost to Follow-up|1
5224865|NCT00927472|18035747|P2|Overall Study|Post treatment Assessment out of window|4
5224866|NCT00927472|18035748|P1|Overall Study|Post treatment Assessment out of window|0
5224867|NCT00927472|18035747|P2|Overall Study|Protocol Violation|1
5224868|NCT00927472|18035748|P1|Overall Study|Protocol Violation|0
5224869|NCT00927472|18035747|P2|Overall Study|Lost to Follow-up|6
5224870|NCT00927472|18035748|P1|Overall Study|Lost to Follow-up|1
5224871|NCT00927472|18035747|P2|Overall Study|Withdrawal by Subject|11
5224872|NCT00927472|18035748|P1|Overall Study|Withdrawal by Subject|10
5224873|NCT00927394|18035774|P2|Overall Study|Randomized in error|1
5224874|NCT00927394|18035775|P1|Overall Study|Randomized in error|0
5224875|NCT00927394|18035774|P2|Overall Study|Protocol deviation|13
5224876|NCT00927394|18035775|P1|Overall Study|Protocol deviation|16
5224877|NCT00927394|18035774|P2|Overall Study|Death|1
5224878|NCT00927394|18035775|P1|Overall Study|Death|1
5224879|NCT00927394|18035774|P2|Overall Study|Administrative Problem|0
5224880|NCT00927394|18035775|P1|Overall Study|Administrative Problem|1
5224881|NCT00927394|18035774|P2|Overall Study|Lost to Follow-up|14
5224882|NCT00927394|18035775|P1|Overall Study|Lost to Follow-up|8
5224883|NCT00927394|18035774|P2|Overall Study|Withdrawal by Subject|24
5224884|NCT00927394|18035775|P1|Overall Study|Withdrawal by Subject|20
5224885|NCT00927394|18035774|P2|Overall Study|Unsatisfactory therapeutic effect|23
5224886|NCT00927394|18035775|P1|Overall Study|Unsatisfactory therapeutic effect|17
5224887|NCT00927394|18035774|P2|Overall Study|Adverse Event|9
5224888|NCT00927394|18035775|P1|Overall Study|Adverse Event|14
5224889|NCT00927368|18035806|P3|Overall Study|cancellation of surgery|2
5224890|NCT00927368|18035807|P2|Overall Study|cancellation of surgery|1
5224891|NCT00927368|18035808|P1|Overall Study|cancellation of surgery|0
5224892|NCT00927368|18035806|P3|Overall Study|ineligible post randomization|1
5224893|NCT00927368|18035807|P2|Overall Study|ineligible post randomization|3
5224894|NCT00927368|18035808|P1|Overall Study|ineligible post randomization|0
5224895|NCT00927368|18035806|P3|Overall Study|equipment failure|0
5224896|NCT00927368|18035807|P2|Overall Study|equipment failure|0
5224897|NCT00927368|18035808|P1|Overall Study|equipment failure|1
5224898|NCT00927368|18035806|P3|Overall Study|Lost to Follow-up|0
5224899|NCT00927368|18035807|P2|Overall Study|Lost to Follow-up|0
5224900|NCT00927368|18035808|P1|Overall Study|Lost to Follow-up|4
5224901|NCT00927368|18035806|P3|Overall Study|enrollment in another study|2
5224902|NCT00927368|18035807|P2|Overall Study|enrollment in another study|1
5224903|NCT00927368|18035808|P1|Overall Study|enrollment in another study|1
5224904|NCT00927355|18035827|P2|Overall Study|Adverse Event|1
5224905|NCT00927355|18035828|P1|Overall Study|Adverse Event|1
5224906|NCT00927251|18035863|P1|Overall Study|Patients not implanted with 4296 lead|8
5224907|NCT00927186|18035869|P2|12 Months Primary Study|Withdrawal by Subject|1
5224908|NCT00927186|18035870|P1|12 Months Primary Study|Withdrawal by Subject|1
5224909|NCT00927186|18035869|P2|12 Months Primary Study|Protocol Violation|1
5224910|NCT00927186|18035870|P1|12 Months Primary Study|Protocol Violation|0
5224911|NCT00927186|18035869|P2|12 Months Primary Study|Lost to Follow-up|0
5224912|NCT00927186|18035870|P1|12 Months Primary Study|Lost to Follow-up|1
5224913|NCT00927186|18035869|P2|12 Months Primary Study|Adverse Event|2
5224914|NCT00927186|18035870|P1|12 Months Primary Study|Adverse Event|5
5224915|NCT00927095|18036000|P3|Overall Study|Physician Decision|1
5224916|NCT00927095|18036001|P2|Overall Study|Physician Decision|2
5224917|NCT00927095|18036002|P1|Overall Study|Physician Decision|1
5224918|NCT00927095|18036000|P3|Overall Study|Withdrawal by Subject|1
5224919|NCT00927095|18036001|P2|Overall Study|Withdrawal by Subject|1
5224920|NCT00927095|18036002|P1|Overall Study|Withdrawal by Subject|2
5224921|NCT00927095|18036000|P3|Overall Study|Adverse Event|0
5224922|NCT00927095|18036001|P2|Overall Study|Adverse Event|1
5224923|NCT00927095|18036002|P1|Overall Study|Adverse Event|3
5224924|NCT00927082|18036014|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
5224925|NCT00927082|18036015|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
5224926|NCT00927082|18036016|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
5224927|NCT00927082|18036017|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
5224928|NCT00927082|18036014|P4|Overall Study|Death|0
5224929|NCT00927082|18036015|P3|Overall Study|Death|1
5224930|NCT00927082|18036016|P2|Overall Study|Death|0
5224931|NCT00927082|18036017|P1|Overall Study|Death|0
5224932|NCT00927082|18036014|P4|Overall Study|Withdrawal by Subject|2
5224933|NCT00927082|18036015|P3|Overall Study|Withdrawal by Subject|7
5224934|NCT00927082|18036016|P2|Overall Study|Withdrawal by Subject|2
5224935|NCT00927082|18036017|P1|Overall Study|Withdrawal by Subject|3
5224936|NCT00927082|18036014|P4|Overall Study|Lost to Follow-up|16
5224937|NCT00927082|18036015|P3|Overall Study|Lost to Follow-up|12
5224938|NCT00927082|18036016|P2|Overall Study|Lost to Follow-up|8
5224939|NCT00927082|18036017|P1|Overall Study|Lost to Follow-up|9
5224940|NCT00927069|18036081|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
5224941|NCT00927069|18036082|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
5224942|NCT00927069|18036083|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
5224943|NCT00927069|18036084|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
5224944|NCT00927069|18036081|P4|Week 12 to Week 24|Withdrawal by Subject|0
5224945|NCT00927069|18036082|P3|Week 12 to Week 24|Withdrawal by Subject|0
5224946|NCT00927069|18036083|P2|Week 12 to Week 24|Withdrawal by Subject|0
5224947|NCT00927069|18036084|P1|Week 12 to Week 24|Withdrawal by Subject|1
5224948|NCT00927069|18036081|P4|Week 12 to Week 24|Lost to Follow-up|0
5224949|NCT00927069|18036082|P3|Week 12 to Week 24|Lost to Follow-up|1
5224950|NCT00927069|18036083|P2|Week 12 to Week 24|Lost to Follow-up|0
5224951|NCT00927069|18036084|P1|Week 12 to Week 24|Lost to Follow-up|0
5224952|NCT00927069|18036081|P4|Week 12 to Week 24|Lack of Efficacy|3
5224953|NCT00927069|18036082|P3|Week 12 to Week 24|Lack of Efficacy|2
5224954|NCT00927069|18036083|P2|Week 12 to Week 24|Lack of Efficacy|0
5224955|NCT00927069|18036084|P1|Week 12 to Week 24|Lack of Efficacy|0
5224956|NCT00927069|18036081|P4|Week 0 to Week 12|Worsening of psoriasis|0
5224957|NCT00927069|18036082|P3|Week 0 to Week 12|Worsening of psoriasis|0
5224958|NCT00927069|18036083|P2|Week 0 to Week 12|Worsening of psoriasis|1
5224959|NCT00927069|18036084|P1|Week 0 to Week 12|Worsening of psoriasis|1
5224960|NCT00926796|18036140|P2|Overall Study|Withdrawal by Subject|0
5224961|NCT00926796|18036141|P1|Overall Study|Withdrawal by Subject|1
5224962|NCT00926796|18036140|P2|Overall Study|Protocol Violation|11
5224963|NCT00926796|18036141|P1|Overall Study|Protocol Violation|15
5224964|NCT00926796|18036140|P2|Overall Study|Lost to Follow-up|13
5224965|NCT00926796|18036141|P1|Overall Study|Lost to Follow-up|22
5224966|NCT00926796|18036140|P2|Overall Study|Adverse Event|14
5224967|NCT00926796|18036141|P1|Overall Study|Adverse Event|7
5224968|NCT00926796|18036140|P2|Overall Study|Ineligible, but positive for gonorrhea|1
5224969|NCT00926796|18036141|P1|Overall Study|Ineligible, but positive for gonorrhea|1
5224970|NCT00926796|18036140|P2|Overall Study|Ineligible, negative for gonorrhea|60
5224971|NCT00926796|18036141|P1|Overall Study|Ineligible, negative for gonorrhea|57
5224972|NCT00926796|18036140|P2|Overall Study|Did not receive randomized treatment|7
5224973|NCT00926796|18036141|P1|Overall Study|Did not receive randomized treatment|4
5224974|NCT00926783|18036162|P2|Overall Study|Incomplete CFAE Procedures|3
5224975|NCT00926783|18036163|P1|Overall Study|Incomplete CFAE Procedures|3
5224976|NCT00926575|18036190|P2|Overall Study|Withdrawal by Subject|9
5224977|NCT00926575|18036191|P1|Overall Study|Withdrawal by Subject|8
5224978|NCT00926575|18036190|P2|Overall Study|Protocol Violation|0
5224979|NCT00926575|18036191|P1|Overall Study|Protocol Violation|1
5224980|NCT00926575|18036190|P2|Overall Study|Physician Decision|2
5224981|NCT00926575|18036191|P1|Overall Study|Physician Decision|1
5224982|NCT00926575|18036190|P2|Overall Study|Lost to Follow-up|1
5224983|NCT00926575|18036191|P1|Overall Study|Lost to Follow-up|1
5224984|NCT00926575|18036190|P2|Overall Study|Death|4
5224985|NCT00926575|18036191|P1|Overall Study|Death|4
5224986|NCT00926575|18036190|P2|Overall Study|Adverse Event|1
5224987|NCT00926575|18036191|P1|Overall Study|Adverse Event|1
5224988|NCT00926536|18036203|P2|Overall Study|Physician Decision|2
5224989|NCT00926536|18036204|P1|Overall Study|Physician Decision|1
5224990|NCT00926393|18036225|P2|Overall Study|Adverse Event|1
5224991|NCT00926393|18036226|P1|Overall Study|Adverse Event|1
5224992|NCT00926393|18036225|P2|Overall Study|Withdrawal by Subject|2
5224993|NCT00926393|18036226|P1|Overall Study|Withdrawal by Subject|1
5224994|NCT00926367|18036271|P2|Overall Study|Skin Irritation|2
5224995|NCT00926367|18036272|P1|Overall Study|Skin Irritation|1
5224996|NCT00926367|18036271|P2|Overall Study|Lost to Follow-up|0
5224997|NCT00926367|18036272|P1|Overall Study|Lost to Follow-up|1
5224998|NCT00926367|18036271|P2|Overall Study|Withdrawal by Subject|1
5224999|NCT00926367|18036272|P1|Overall Study|Withdrawal by Subject|0
5225000|NCT00926328|18036314|P2|Overall Study|Lost to Follow-up|14
5225001|NCT00926328|18036315|P1|Overall Study|Lost to Follow-up|12
5225002|NCT00926289|18036325|P2|Overall Study|Other|3
5225003|NCT00926289|18036326|P1|Overall Study|Other|1
5225004|NCT00926289|18036325|P2|Overall Study|Withdrawal by Subject|4
5225005|NCT00926289|18036326|P1|Overall Study|Withdrawal by Subject|4
5225006|NCT00926289|18036325|P2|Overall Study|Lost to Follow-up|6
5225007|NCT00926289|18036326|P1|Overall Study|Lost to Follow-up|3
5225008|NCT00926289|18036325|P2|Overall Study|Protocol Violation|12
5225009|NCT00926289|18036326|P1|Overall Study|Protocol Violation|8
5225010|NCT00926289|18036325|P2|Overall Study|Adverse Event|11
5225011|NCT00926289|18036326|P1|Overall Study|Adverse Event|9
5225012|NCT00926237|18036394|P2|Overall Study|Withdrawal by Subject|1
5225013|NCT00926237|18036395|P1|Overall Study|Withdrawal by Subject|2
5225014|NCT00926211|18036405|P1|Overall Study|Lost to Follow-up|1
5225015|NCT00926029|18036436|P3|Overall Study|Lost to Follow-up|1
5225016|NCT00926029|18036437|P2|Overall Study|Lost to Follow-up|1
5225017|NCT00926029|18036438|P1|Overall Study|Lost to Follow-up|2
5225018|NCT00926003|18036452|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
5225019|NCT00926003|18036453|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
5225020|NCT00926003|18036454|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
5225021|NCT00926003|18036452|P3|Post-Training Evaluation|Withdrawal by Subject|0
5225022|NCT00926003|18036453|P2|Post-Training Evaluation|Withdrawal by Subject|0
5225023|NCT00926003|18036454|P1|Post-Training Evaluation|Withdrawal by Subject|1
5225024|NCT00925990|18036467|P2|Overall Study|moved out of state, missed medication|2
5225025|NCT00925990|18036468|P1|Overall Study|moved out of state, missed medication|0
5225026|NCT00925990|18036467|P2|Overall Study|Physician Decision|1
5225027|NCT00925990|18036468|P1|Overall Study|Physician Decision|1
5225028|NCT00925990|18036467|P2|Overall Study|Lost to Follow-up|3
5225029|NCT00925990|18036468|P1|Overall Study|Lost to Follow-up|1
5225030|NCT00925990|18036467|P2|Overall Study|Withdrawal by Subject|2
5225031|NCT00925990|18036468|P1|Overall Study|Withdrawal by Subject|2
5225032|NCT00925990|18036467|P2|Overall Study|Adverse Event|3
5225033|NCT00925990|18036468|P1|Overall Study|Adverse Event|1
5225034|NCT00925899|18036503|P2|Part 1|Withdrawal by Subject|9
5225035|NCT00925899|18036504|P1|Part 1|Withdrawal by Subject|10
5225036|NCT00925899|18036503|P2|Part 1|Death|2
5225037|NCT00925899|18036504|P1|Part 1|Death|1
5225038|NCT00925769|18036532|P6|Overall Study|Adverse Event|0
5225039|NCT00925769|18036533|P5|Overall Study|Adverse Event|1
5225040|NCT00925769|18036534|P4|Overall Study|Adverse Event|0
5225041|NCT00925769|18036535|P3|Overall Study|Adverse Event|0
5225042|NCT00925769|18036536|P2|Overall Study|Adverse Event|0
5225043|NCT00925769|18036537|P1|Overall Study|Adverse Event|0
5225044|NCT00925769|18036532|P6|Overall Study|Participant is unable to swallow drug|0
5225045|NCT00925769|18036533|P5|Overall Study|Participant is unable to swallow drug|0
5225046|NCT00925769|18036534|P4|Overall Study|Participant is unable to swallow drug|1
5225047|NCT00925769|18036535|P3|Overall Study|Participant is unable to swallow drug|0
5225048|NCT00925769|18036536|P2|Overall Study|Participant is unable to swallow drug|0
5225049|NCT00925769|18036537|P1|Overall Study|Participant is unable to swallow drug|0
5225050|NCT00925769|18036532|P6|Overall Study|End of study visit not done|0
5225051|NCT00925769|18036533|P5|Overall Study|End of study visit not done|0
5225052|NCT00925769|18036534|P4|Overall Study|End of study visit not done|0
5225053|NCT00925769|18036535|P3|Overall Study|End of study visit not done|1
5225054|NCT00925769|18036536|P2|Overall Study|End of study visit not done|0
5225055|NCT00925769|18036537|P1|Overall Study|End of study visit not done|0
5225056|NCT00925769|18036532|P6|Overall Study|Missing documentation|0
5225057|NCT00925769|18036533|P5|Overall Study|Missing documentation|0
5225058|NCT00925769|18036534|P4|Overall Study|Missing documentation|0
5225059|NCT00925769|18036535|P3|Overall Study|Missing documentation|0
5225060|NCT00925769|18036536|P2|Overall Study|Missing documentation|1
5225061|NCT00925769|18036537|P1|Overall Study|Missing documentation|0
5225062|NCT00925769|18036532|P6|Overall Study|Physician Decision|0
5225063|NCT00925769|18036533|P5|Overall Study|Physician Decision|0
5225064|NCT00925769|18036534|P4|Overall Study|Physician Decision|0
5225065|NCT00925769|18036535|P3|Overall Study|Physician Decision|0
5225066|NCT00925769|18036536|P2|Overall Study|Physician Decision|0
5225067|NCT00925769|18036537|P1|Overall Study|Physician Decision|1
5225068|NCT00925769|18036532|P6|Overall Study|Death|0
5225069|NCT00925769|18036533|P5|Overall Study|Death|0
5225070|NCT00925769|18036534|P4|Overall Study|Death|0
5225071|NCT00925769|18036535|P3|Overall Study|Death|1
5225072|NCT00925769|18036536|P2|Overall Study|Death|0
5225073|NCT00925769|18036537|P1|Overall Study|Death|0
5225074|NCT00925769|18036532|P6|Overall Study|Disease progression|3
5225075|NCT00925769|18036533|P5|Overall Study|Disease progression|2
5225076|NCT00925769|18036534|P4|Overall Study|Disease progression|4
5225077|NCT00925769|18036535|P3|Overall Study|Disease progression|3
5225078|NCT00925769|18036536|P2|Overall Study|Disease progression|5
5225079|NCT00925769|18036537|P1|Overall Study|Disease progression|4
5225080|NCT00925769|18036532|P6|Overall Study|Major toxicity|0
5225081|NCT00925769|18036533|P5|Overall Study|Major toxicity|0
5225082|NCT00925769|18036534|P4|Overall Study|Major toxicity|1
5225083|NCT00925769|18036535|P3|Overall Study|Major toxicity|1
5225084|NCT00925769|18036536|P2|Overall Study|Major toxicity|0
5225085|NCT00925769|18036537|P1|Overall Study|Major toxicity|1
5225086|NCT00925704|18036611|P6|Third Intervention|Withdrew consent|1
5225087|NCT00925704|18036612|P5|Third Intervention|Withdrew consent|0
5225088|NCT00925704|18036613|P4|Third Intervention|Withdrew consent|0
5225089|NCT00925704|18036614|P3|Third Intervention|Withdrew consent|0
5225090|NCT00925704|18036615|P2|Third Intervention|Withdrew consent|0
5225091|NCT00925704|18036616|P1|Third Intervention|Withdrew consent|0
5225092|NCT00925704|18036611|P6|Second Intervention|Withdrawal by Subject|0
5225093|NCT00925704|18036612|P5|Second Intervention|Withdrawal by Subject|1
5225094|NCT00925704|18036613|P4|Second Intervention|Withdrawal by Subject|0
5225095|NCT00925704|18036614|P3|Second Intervention|Withdrawal by Subject|0
5225096|NCT00925704|18036615|P2|Second Intervention|Withdrawal by Subject|0
5225097|NCT00925704|18036616|P1|Second Intervention|Withdrawal by Subject|1
5225098|NCT00925704|18036611|P6|First Intervention|Withdrew consent|0
5225099|NCT00925704|18036612|P5|First Intervention|Withdrew consent|1
5225100|NCT00925704|18036613|P4|First Intervention|Withdrew consent|1
5225101|NCT00925704|18036614|P3|First Intervention|Withdrew consent|0
5225102|NCT00925704|18036615|P2|First Intervention|Withdrew consent|0
5225103|NCT00925704|18036616|P1|First Intervention|Withdrew consent|0
5225104|NCT00925600|18036629|P2|Overall Study|Adverse Event|2
5225105|NCT00925600|18036630|P1|Overall Study|Adverse Event|1
5225106|NCT00925600|18036629|P2|Overall Study|Other|1
5225107|NCT00925600|18036630|P1|Overall Study|Other|3
5225108|NCT00925600|18036629|P2|Overall Study|Requirement for Alternative Therapy|1
5225109|NCT00925600|18036630|P1|Overall Study|Requirement for Alternative Therapy|0
5225110|NCT00925600|18036629|P2|Overall Study|Protocol Deviation|1
5225111|NCT00925600|18036630|P1|Overall Study|Protocol Deviation|0
5225112|NCT00925600|18036629|P2|Overall Study|Ineligibility Determined|0
5225113|NCT00925600|18036630|P1|Overall Study|Ineligibility Determined|2
5225114|NCT00925600|18036629|P2|Overall Study|Noncompliance|0
5225115|NCT00925600|18036630|P1|Overall Study|Noncompliance|2
5225116|NCT00925600|18036629|P2|Overall Study|Administrative Decision|1
5225117|NCT00925600|18036630|P1|Overall Study|Administrative Decision|1
5225118|NCT00925600|18036629|P2|Overall Study|Disease Progression|3
5225119|NCT00925600|18036630|P1|Overall Study|Disease Progression|1
5225120|NCT00925600|18036629|P2|Overall Study|Lost to Follow-up|2
5225121|NCT00925600|18036630|P1|Overall Study|Lost to Follow-up|2
5225122|NCT00925600|18036629|P2|Overall Study|Death|3
5225123|NCT00925600|18036630|P1|Overall Study|Death|4
5225124|NCT00925600|18036629|P2|Overall Study|Withdrawal by Subject|14
5225125|NCT00925600|18036630|P1|Overall Study|Withdrawal by Subject|16
5225126|NCT00925587|18036652|P2|Overall Study|Lost to Follow-up|1
5225127|NCT00925587|18036653|P1|Overall Study|Lost to Follow-up|0
5225128|NCT00925587|18036652|P2|Overall Study|Adverse Event|2
5225129|NCT00925587|18036653|P1|Overall Study|Adverse Event|6
5225130|NCT00925587|18036652|P2|Overall Study|Death|5
5225131|NCT00925587|18036653|P1|Overall Study|Death|5
5225132|NCT00925587|18036652|P2|Overall Study|Withdrawal by Subject|6
5225133|NCT00925587|18036653|P1|Overall Study|Withdrawal by Subject|9
5225134|NCT00925587|18036652|P2|Overall Study|Protocol Violation|4
5225135|NCT00925587|18036653|P1|Overall Study|Protocol Violation|6
5225136|NCT00925587|18036652|P2|Overall Study|Physician Decision|1
5225137|NCT00925587|18036653|P1|Overall Study|Physician Decision|4
5225138|NCT00925587|18036652|P2|Overall Study|Protocol Specified Criteria|6
5225139|NCT00925587|18036653|P1|Overall Study|Protocol Specified Criteria|6
5225140|NCT00925548|18036767|P2|Overall Study|Discontinuation of trial by sponsor|5
5225141|NCT00925548|18036768|P1|Overall Study|Discontinuation of trial by sponsor|10
5225142|NCT00925522|18036794|P1|Overall Study|study closed -- business decision|20
5225143|NCT00925353|18036798|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
5225144|NCT00925301|18036804|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
5225145|NCT00925301|18036805|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5225146|NCT00925301|18036806|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5225147|NCT00925301|18036807|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5225148|NCT00925301|18036804|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
5225149|NCT00925301|18036805|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
5225150|NCT00925301|18036806|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
5225151|NCT00925301|18036807|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
5225152|NCT00925301|18036804|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
5225153|NCT00925301|18036805|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5225154|NCT00925301|18036806|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5225155|NCT00925301|18036807|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5225156|NCT00925301|18036804|P4|6-Month Open-label (Stage 2)|Adverse Event|0
5225157|NCT00925301|18036805|P3|6-Month Open-label (Stage 2)|Adverse Event|2
5225158|NCT00925301|18036806|P2|6-Month Open-label (Stage 2)|Adverse Event|0
5225159|NCT00925301|18036807|P1|6-Month Open-label (Stage 2)|Adverse Event|0
5225160|NCT00925301|18036804|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5225161|NCT00925301|18036805|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
5225162|NCT00925301|18036806|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5225163|NCT00925301|18036807|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5225164|NCT00925301|18036804|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
5225165|NCT00925301|18036805|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
5225166|NCT00925301|18036806|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
5225167|NCT00925301|18036807|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
5225168|NCT00925301|18036804|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5225169|NCT00925301|18036805|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5225170|NCT00925301|18036806|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
5225171|NCT00925301|18036807|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5225172|NCT00925288|18036823|P2|Overall Study|Lost to Follow-up|7
5225173|NCT00925288|18036824|P1|Overall Study|Lost to Follow-up|9
5225174|NCT00925132|18036836|P5|Overall Study|Removed due to disease progression|4
5225175|NCT00925132|18036837|P4|Overall Study|Removed due to disease progression|0
5225176|NCT00925132|18036838|P3|Overall Study|Removed due to disease progression|0
5225177|NCT00925132|18036839|P2|Overall Study|Removed due to disease progression|0
5225178|NCT00925132|18036840|P1|Overall Study|Removed due to disease progression|0
5225179|NCT00925132|18036836|P5|Overall Study|Withdrawal by Subject|1
5225180|NCT00925132|18036837|P4|Overall Study|Withdrawal by Subject|0
5225181|NCT00925132|18036838|P3|Overall Study|Withdrawal by Subject|0
5225182|NCT00925132|18036839|P2|Overall Study|Withdrawal by Subject|0
5225183|NCT00925132|18036840|P1|Overall Study|Withdrawal by Subject|2
5225184|NCT00925015|18036935|P3|Overall Study|Withdrawal by Subject|1
5225185|NCT00925015|18036936|P2|Overall Study|Withdrawal by Subject|0
5225186|NCT00925015|18036937|P1|Overall Study|Withdrawal by Subject|0
5225187|NCT00925015|18036935|P3|Overall Study|Progressive Disease|4
5225188|NCT00925015|18036936|P2|Overall Study|Progressive Disease|3
5225189|NCT00925015|18036937|P1|Overall Study|Progressive Disease|7
5225190|NCT00925015|18036935|P3|Overall Study|Physician Decision|0
5225191|NCT00925015|18036936|P2|Overall Study|Physician Decision|1
5225192|NCT00925015|18036937|P1|Overall Study|Physician Decision|0
5225193|NCT00925015|18036935|P3|Overall Study|Adverse Event|1
5225194|NCT00925015|18036936|P2|Overall Study|Adverse Event|2
5225195|NCT00925015|18036937|P1|Overall Study|Adverse Event|1
5225196|NCT00924950|18036993|P1|Overall Study|Lost to Follow-up|2
5225197|NCT00924898|18037000|P1|Overall Study|Withdrawal by Subject|2
5225198|NCT00924781|18037037|P2|Overall Study|Study terminated by sponsor|10
5225199|NCT00924781|18037038|P1|Overall Study|Study terminated by sponsor|12
5225200|NCT00924729|18037072|P2|Overall Study|Protocol Violation|0
5225201|NCT00924729|18037073|P1|Overall Study|Protocol Violation|1
5225202|NCT00924729|18037072|P2|Overall Study|insufficient volume for analysis|0
5225203|NCT00924729|18037073|P1|Overall Study|insufficient volume for analysis|1
5225204|NCT00924651|18037083|P2|Overall Study|Incomplete Form|1
5225205|NCT00924651|18037084|P1|Overall Study|Incomplete Form|2
5225206|NCT00924651|18037083|P2|Overall Study|Changed Mind|1
5225207|NCT00924651|18037084|P1|Overall Study|Changed Mind|10
5225208|NCT00924651|18037083|P2|Overall Study|Medical|3
5225209|NCT00924651|18037084|P1|Overall Study|Medical|1
5225210|NCT00924651|18037083|P2|Overall Study|Noncompliant|4
5225211|NCT00924651|18037084|P1|Overall Study|Noncompliant|1
5225212|NCT00924651|18037083|P2|Overall Study|Overwhelmed|6
5225213|NCT00924651|18037084|P1|Overall Study|Overwhelmed|6
5225214|NCT00924651|18037083|P2|Overall Study|No Reason|7
5225215|NCT00924651|18037084|P1|Overall Study|No Reason|3
5225216|NCT00924651|18037083|P2|Overall Study|Chemo started too soon|3
5225217|NCT00924651|18037084|P1|Overall Study|Chemo started too soon|2
5225218|NCT00924638|18037092|P2|Overall Study|Physician Decision|3
5225219|NCT00924638|18037093|P1|Overall Study|Physician Decision|3
5225220|NCT00924638|18037092|P2|Overall Study|Withdrawal by Subject|7
5225221|NCT00924638|18037093|P1|Overall Study|Withdrawal by Subject|5
5225222|NCT00924638|18037092|P2|Overall Study|Lost to Follow-up|1
5225223|NCT00924638|18037093|P1|Overall Study|Lost to Follow-up|1
5225224|NCT00924638|18037092|P2|Overall Study|Death|2
5225225|NCT00924638|18037093|P1|Overall Study|Death|3
5225226|NCT00924560|18037115|P3|Overall Study|Miscellaneous Reasons|10
5225227|NCT00924560|18037116|P2|Overall Study|Miscellaneous Reasons|10
5225228|NCT00924560|18037117|P1|Overall Study|Miscellaneous Reasons|13
5225229|NCT00924560|18037115|P3|Overall Study|Lost to Follow-up|45
5225230|NCT00924560|18037116|P2|Overall Study|Lost to Follow-up|94
5225231|NCT00924560|18037117|P1|Overall Study|Lost to Follow-up|78
5225232|NCT00924560|18037115|P3|Overall Study|Pregnancy|1
5225233|NCT00924560|18037116|P2|Overall Study|Pregnancy|7
5225234|NCT00924560|18037117|P1|Overall Study|Pregnancy|5
5225235|NCT00924560|18037115|P3|Overall Study|Adverse Event|0
5225236|NCT00924560|18037116|P2|Overall Study|Adverse Event|33
5225237|NCT00924560|18037117|P1|Overall Study|Adverse Event|39
5225238|NCT00924560|18037115|P3|Overall Study|Withdrawal by Subject|18
5225239|NCT00924560|18037116|P2|Overall Study|Withdrawal by Subject|44
5225240|NCT00924560|18037117|P1|Overall Study|Withdrawal by Subject|50
5225241|NCT00924560|18037115|P3|Overall Study|Physician Decision|4
5225242|NCT00924560|18037116|P2|Overall Study|Physician Decision|3
5225243|NCT00924560|18037117|P1|Overall Study|Physician Decision|2
5225244|NCT00924560|18037115|P3|Overall Study|Non Compliance with the Protocol|4
5225245|NCT00924560|18037116|P2|Overall Study|Non Compliance with the Protocol|15
5225246|NCT00924560|18037117|P1|Overall Study|Non Compliance with the Protocol|20
5225247|NCT00924560|18037115|P3|Overall Study|Did Not Meet Protocol Requirements|1
5225248|NCT00924560|18037116|P2|Overall Study|Did Not Meet Protocol Requirements|2
5225249|NCT00924560|18037117|P1|Overall Study|Did Not Meet Protocol Requirements|4
5225250|NCT00924508|18037161|P1|Overall Study|Withdrawal by Subject|3
5225251|NCT00924469|18037175|P2|Overall Study|Lost to Follow-up|1
5225252|NCT00924469|18037176|P1|Overall Study|Lost to Follow-up|0
5225253|NCT00924469|18037175|P2|Overall Study|Withdrawal by Subject|1
5225254|NCT00924469|18037176|P1|Overall Study|Withdrawal by Subject|0
5225255|NCT00924469|18037175|P2|Overall Study|Adverse Event|0
5225256|NCT00924469|18037176|P1|Overall Study|Adverse Event|2
5225257|NCT00924443|18037198|P1|Overall Study|Protocol Violation|1
5225258|NCT00924443|18037198|P1|Overall Study|Physician Decision|2
5225259|NCT00924404|18037208|P2|Overall Study|Lost to Follow-up|4
5225260|NCT00924404|18037209|P1|Overall Study|Lost to Follow-up|6
5225261|NCT00924313|18037280|P1|Overall Study|not imaged due to failed tracer imaging|1
5225262|NCT00924287|18037292|P1|Overall Study|Death|1
5225263|NCT00924170|18037308|P2|Overall Study|Death|0
5225264|NCT00924170|18037309|P1|Overall Study|Death|1
5225265|NCT00924170|18037308|P2|Overall Study|Stopped due to neutralizing antibodies|0
5225266|NCT00924170|18037309|P1|Overall Study|Stopped due to neutralizing antibodies|3
5225267|NCT00924170|18037308|P2|Overall Study|Progressive disease|6
5225268|NCT00924170|18037309|P1|Overall Study|Progressive disease|3
5225269|NCT00924170|18037308|P2|Overall Study|Physician Decision|1
5225270|NCT00924170|18037309|P1|Overall Study|Physician Decision|0
5225271|NCT00924170|18037308|P2|Overall Study|Refused further treatment|1
5225272|NCT00924170|18037309|P1|Overall Study|Refused further treatment|0
5225273|NCT00923975|18037434|P1|Overall Study|Did not meet inclusion criteria|1
5225274|NCT00923936|18037453|P2|Overall Study|Continuing in follow up period|1
5225275|NCT00923936|18037454|P1|Overall Study|Continuing in follow up period|2
5225276|NCT00923936|18037453|P2|Overall Study|Lost to follow up|0
5225277|NCT00923936|18037454|P1|Overall Study|Lost to follow up|2
5225278|NCT00923936|18037453|P2|Overall Study|Adverse Event|1
5225279|NCT00923936|18037454|P1|Overall Study|Adverse Event|2
5225280|NCT00923936|18037453|P2|Overall Study|progressive disease on study|1
5225281|NCT00923936|18037454|P1|Overall Study|progressive disease on study|2
5225282|NCT00923845|18037483|P2|Induction Therapy|Poor performance status|2
5225283|NCT00923845|18037484|P1|Induction Therapy|Poor performance status|0
5225284|NCT00923364|18037519|P2|Overall Study|Did not go to transplant|0
5225285|NCT00923364|18037520|P1|Overall Study|Did not go to transplant|1
5225286|NCT00923364|18037519|P2|Overall Study|Death|0
5225287|NCT00923364|18037520|P1|Overall Study|Death|3
5225288|NCT00923351|18037532|P3|Overall Study|no apheresis/adequate tumor sample|12
5225289|NCT00923351|18037533|P2|Overall Study|no apheresis/adequate tumor sample|0
5225290|NCT00923351|18037534|P1|Overall Study|no apheresis/adequate tumor sample|0
5225291|NCT00923273|18037549|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5225292|NCT00923273|18037550|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
5225293|NCT00923273|18037551|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5225294|NCT00923273|18037552|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5225295|NCT00923273|18037553|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5225296|NCT00923273|18037549|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5225297|NCT00923273|18037550|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
5225298|NCT00923273|18037551|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5225299|NCT00923273|18037552|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5225300|NCT00923273|18037553|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5225301|NCT00923260|18037578|P2|Overall Study|Lost to Follow-up|1
5225302|NCT00923260|18037579|P1|Overall Study|Lost to Follow-up|1
5225303|NCT00923195|18037742|P2|Overall Study|Death|1
5225304|NCT00923195|18037743|P1|Overall Study|Death|0
5225305|NCT00923156|18037754|P3|Overall Study|Lack of Efficacy|1
5225306|NCT00923156|18037755|P2|Overall Study|Lack of Efficacy|0
5225307|NCT00923156|18037756|P1|Overall Study|Lack of Efficacy|0
5225308|NCT00923156|18037754|P3|Overall Study|Death|0
5225309|NCT00923156|18037755|P2|Overall Study|Death|1
5225310|NCT00923156|18037756|P1|Overall Study|Death|0
5225311|NCT00923156|18037754|P3|Overall Study|Withdrawal by Subject|0
5225312|NCT00923156|18037755|P2|Overall Study|Withdrawal by Subject|1
5225313|NCT00923156|18037756|P1|Overall Study|Withdrawal by Subject|0
5225314|NCT00923156|18037754|P3|Overall Study|Abnormal laboratory values|1
5225315|NCT00923156|18037755|P2|Overall Study|Abnormal laboratory values|0
5225316|NCT00923156|18037756|P1|Overall Study|Abnormal laboratory values|0
5225317|NCT00923156|18037754|P3|Overall Study|Adverse Event|1
5225318|NCT00923156|18037755|P2|Overall Study|Adverse Event|2
5225319|NCT00923156|18037756|P1|Overall Study|Adverse Event|0
5225320|NCT00923130|18037782|P1|Overall Study|Refused further treatment|2
5225321|NCT00923130|18037782|P1|Overall Study|Switched to alternative treatment|2
5225322|NCT00923130|18037782|P1|Overall Study|Discontinued treatment due to toxicities|3
5225323|NCT00923130|18037782|P1|Overall Study|Death|1
5225324|NCT00923130|18037782|P1|Overall Study|Stopped treatment due to progression|17
5225325|NCT00923091|18037817|P13|Period VI (Open-Label)|Other Reason|0
5225326|NCT00923091|18037818|P12|Period VI (Open-Label)|Other Reason|0
5225327|NCT00923091|18037819|P11|Period VI (Open-Label)|Other Reason|0
5225328|NCT00923091|18037820|P10|Period VI (Open-Label)|Other Reason|0
5225329|NCT00923091|18037821|P9|Period VI (Open-Label)|Other Reason|0
5225330|NCT00923091|18037822|P8|Period VI (Open-Label)|Other Reason|0
5225331|NCT00923091|18037823|P7|Period VI (Open-Label)|Other Reason|0
5225332|NCT00923091|18037824|P6|Period VI (Open-Label)|Other Reason|0
5225333|NCT00923091|18037825|P5|Period VI (Open-Label)|Other Reason|1
5225334|NCT00923091|18037826|P4|Period VI (Open-Label)|Other Reason|1
5225335|NCT00923091|18037827|P3|Period VI (Open-Label)|Other Reason|0
5225336|NCT00923091|18037828|P2|Period VI (Open-Label)|Other Reason|0
5225337|NCT00923091|18037829|P1|Period VI (Open-Label)|Other Reason|0
5225338|NCT00923091|18037817|P13|Period VI (Open-Label)|Lost to Follow-up|0
5225339|NCT00923091|18037818|P12|Period VI (Open-Label)|Lost to Follow-up|0
5225340|NCT00923091|18037819|P11|Period VI (Open-Label)|Lost to Follow-up|0
5225341|NCT00923091|18037820|P10|Period VI (Open-Label)|Lost to Follow-up|0
5225342|NCT00923091|18037821|P9|Period VI (Open-Label)|Lost to Follow-up|0
5225343|NCT00923091|18037822|P8|Period VI (Open-Label)|Lost to Follow-up|0
5225344|NCT00923091|18037823|P7|Period VI (Open-Label)|Lost to Follow-up|0
5225345|NCT00923091|18037824|P6|Period VI (Open-Label)|Lost to Follow-up|0
5225346|NCT00923091|18037825|P5|Period VI (Open-Label)|Lost to Follow-up|0
5225347|NCT00923091|18037826|P4|Period VI (Open-Label)|Lost to Follow-up|0
5225348|NCT00923091|18037827|P3|Period VI (Open-Label)|Lost to Follow-up|1
5225349|NCT00923091|18037828|P2|Period VI (Open-Label)|Lost to Follow-up|0
5225350|NCT00923091|18037829|P1|Period VI (Open-Label)|Lost to Follow-up|1
5225351|NCT00923091|18037817|P13|Period VI (Open-Label)|Protocol Violation|0
5225352|NCT00923091|18037818|P12|Period VI (Open-Label)|Protocol Violation|0
5225353|NCT00923091|18037819|P11|Period VI (Open-Label)|Protocol Violation|0
5225354|NCT00923091|18037820|P10|Period VI (Open-Label)|Protocol Violation|0
5225355|NCT00923091|18037821|P9|Period VI (Open-Label)|Protocol Violation|0
5225356|NCT00923091|18037822|P8|Period VI (Open-Label)|Protocol Violation|0
5225357|NCT00923091|18037823|P7|Period VI (Open-Label)|Protocol Violation|0
5225358|NCT00923091|18037824|P6|Period VI (Open-Label)|Protocol Violation|0
5225359|NCT00923091|18037825|P5|Period VI (Open-Label)|Protocol Violation|4
5225360|NCT00923091|18037826|P4|Period VI (Open-Label)|Protocol Violation|1
5225361|NCT00923091|18037827|P3|Period VI (Open-Label)|Protocol Violation|3
5225362|NCT00923091|18037828|P2|Period VI (Open-Label)|Protocol Violation|1
5225363|NCT00923091|18037829|P1|Period VI (Open-Label)|Protocol Violation|6
5225364|NCT00923091|18037817|P13|Period VI (Open-Label)|Withdrawal by Subject|0
5225365|NCT00923091|18037818|P12|Period VI (Open-Label)|Withdrawal by Subject|0
5225366|NCT00923091|18037819|P11|Period VI (Open-Label)|Withdrawal by Subject|0
5225367|NCT00923091|18037820|P10|Period VI (Open-Label)|Withdrawal by Subject|0
5225368|NCT00923091|18037821|P9|Period VI (Open-Label)|Withdrawal by Subject|0
5225369|NCT00923091|18037822|P8|Period VI (Open-Label)|Withdrawal by Subject|0
5225370|NCT00923091|18037823|P7|Period VI (Open-Label)|Withdrawal by Subject|0
5225371|NCT00923091|18037824|P6|Period VI (Open-Label)|Withdrawal by Subject|0
5225372|NCT00923091|18037825|P5|Period VI (Open-Label)|Withdrawal by Subject|1
5225373|NCT00923091|18037826|P4|Period VI (Open-Label)|Withdrawal by Subject|0
5225374|NCT00923091|18037827|P3|Period VI (Open-Label)|Withdrawal by Subject|5
5225375|NCT00923091|18037828|P2|Period VI (Open-Label)|Withdrawal by Subject|7
5225376|NCT00923091|18037829|P1|Period VI (Open-Label)|Withdrawal by Subject|15
5225377|NCT00923091|18037817|P13|Period VI (Open-Label)|Adverse Event|0
5225378|NCT00923091|18037818|P12|Period VI (Open-Label)|Adverse Event|0
5225379|NCT00923091|18037819|P11|Period VI (Open-Label)|Adverse Event|0
5225380|NCT00923091|18037820|P10|Period VI (Open-Label)|Adverse Event|0
5225381|NCT00923091|18037821|P9|Period VI (Open-Label)|Adverse Event|0
5225382|NCT00923091|18037822|P8|Period VI (Open-Label)|Adverse Event|0
5225383|NCT00923091|18037823|P7|Period VI (Open-Label)|Adverse Event|0
5225384|NCT00923091|18037824|P6|Period VI (Open-Label)|Adverse Event|0
5225385|NCT00923091|18037825|P5|Period VI (Open-Label)|Adverse Event|1
5225386|NCT00923091|18037826|P4|Period VI (Open-Label)|Adverse Event|1
5225387|NCT00923091|18037827|P3|Period VI (Open-Label)|Adverse Event|4
5225388|NCT00923091|18037828|P2|Period VI (Open-Label)|Adverse Event|0
5225389|NCT00923091|18037829|P1|Period VI (Open-Label)|Adverse Event|17
5225390|NCT00923091|18037817|P13|Period V (Double -Blind)|Lost to Follow-up|0
5225391|NCT00923091|18037818|P12|Period V (Double -Blind)|Lost to Follow-up|0
5225392|NCT00923091|18037819|P11|Period V (Double -Blind)|Lost to Follow-up|1
5225393|NCT00923091|18037820|P10|Period V (Double -Blind)|Lost to Follow-up|0
5225394|NCT00923091|18037821|P9|Period V (Double -Blind)|Lost to Follow-up|0
5225395|NCT00923091|18037822|P8|Period V (Double -Blind)|Lost to Follow-up|0
5225396|NCT00923091|18037823|P7|Period V (Double -Blind)|Lost to Follow-up|0
5225397|NCT00923091|18037824|P6|Period V (Double -Blind)|Lost to Follow-up|0
5225398|NCT00923091|18037825|P5|Period V (Double -Blind)|Lost to Follow-up|0
5225399|NCT00923091|18037826|P4|Period V (Double -Blind)|Lost to Follow-up|0
5225400|NCT00923091|18037827|P3|Period V (Double -Blind)|Lost to Follow-up|0
5225401|NCT00923091|18037828|P2|Period V (Double -Blind)|Lost to Follow-up|0
5225402|NCT00923091|18037829|P1|Period V (Double -Blind)|Lost to Follow-up|0
5225403|NCT00923091|18037817|P13|Period V (Double -Blind)|Protocol Violation|1
5225404|NCT00923091|18037818|P12|Period V (Double -Blind)|Protocol Violation|0
5225405|NCT00923091|18037819|P11|Period V (Double -Blind)|Protocol Violation|0
5225406|NCT00923091|18037820|P10|Period V (Double -Blind)|Protocol Violation|0
5225407|NCT00923091|18037821|P9|Period V (Double -Blind)|Protocol Violation|0
5225408|NCT00923091|18037822|P8|Period V (Double -Blind)|Protocol Violation|0
5225409|NCT00923091|18037823|P7|Period V (Double -Blind)|Protocol Violation|0
5225410|NCT00923091|18037824|P6|Period V (Double -Blind)|Protocol Violation|0
5225411|NCT00923091|18037825|P5|Period V (Double -Blind)|Protocol Violation|0
5225412|NCT00923091|18037826|P4|Period V (Double -Blind)|Protocol Violation|0
5225413|NCT00923091|18037827|P3|Period V (Double -Blind)|Protocol Violation|0
5225414|NCT00923091|18037828|P2|Period V (Double -Blind)|Protocol Violation|0
5225415|NCT00923091|18037829|P1|Period V (Double -Blind)|Protocol Violation|0
5225416|NCT00923091|18037817|P13|Period V (Double -Blind)|Withdrawal by Subject|1
5225417|NCT00923091|18037818|P12|Period V (Double -Blind)|Withdrawal by Subject|0
5225418|NCT00923091|18037819|P11|Period V (Double -Blind)|Withdrawal by Subject|0
5225419|NCT00923091|18037820|P10|Period V (Double -Blind)|Withdrawal by Subject|0
5225420|NCT00923091|18037821|P9|Period V (Double -Blind)|Withdrawal by Subject|1
5225421|NCT00923091|18037822|P8|Period V (Double -Blind)|Withdrawal by Subject|0
5225422|NCT00923091|18037823|P7|Period V (Double -Blind)|Withdrawal by Subject|0
5225423|NCT00923091|18037824|P6|Period V (Double -Blind)|Withdrawal by Subject|0
5225424|NCT00923091|18037825|P5|Period V (Double -Blind)|Withdrawal by Subject|0
5225425|NCT00923091|18037826|P4|Period V (Double -Blind)|Withdrawal by Subject|0
5225426|NCT00923091|18037827|P3|Period V (Double -Blind)|Withdrawal by Subject|0
5225427|NCT00923091|18037828|P2|Period V (Double -Blind)|Withdrawal by Subject|0
5225428|NCT00923091|18037829|P1|Period V (Double -Blind)|Withdrawal by Subject|0
5225429|NCT00923091|18037817|P13|Period IV (Double-Blind)|Protocol Violation|0
5225430|NCT00923091|18037818|P12|Period IV (Double-Blind)|Protocol Violation|0
5225431|NCT00923091|18037819|P11|Period IV (Double-Blind)|Protocol Violation|0
5225432|NCT00923091|18037820|P10|Period IV (Double-Blind)|Protocol Violation|0
5225433|NCT00923091|18037821|P9|Period IV (Double-Blind)|Protocol Violation|0
5225434|NCT00923091|18037822|P8|Period IV (Double-Blind)|Protocol Violation|0
5225435|NCT00923091|18037823|P7|Period IV (Double-Blind)|Protocol Violation|0
5225436|NCT00923091|18037824|P6|Period IV (Double-Blind)|Protocol Violation|0
5225437|NCT00923091|18037825|P5|Period IV (Double-Blind)|Protocol Violation|0
5225438|NCT00923091|18037826|P4|Period IV (Double-Blind)|Protocol Violation|0
5225439|NCT00923091|18037827|P3|Period IV (Double-Blind)|Protocol Violation|0
5225440|NCT00923091|18037828|P2|Period IV (Double-Blind)|Protocol Violation|1
5225441|NCT00923091|18037829|P1|Period IV (Double-Blind)|Protocol Violation|0
5225442|NCT00923091|18037817|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
5225443|NCT00923091|18037818|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
5225444|NCT00923091|18037819|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
5225445|NCT00923091|18037820|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
5225446|NCT00923091|18037821|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
5225447|NCT00923091|18037822|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
5225448|NCT00923091|18037823|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
5225449|NCT00923091|18037824|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
5225450|NCT00923091|18037825|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
5225451|NCT00923091|18037826|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
5225452|NCT00923091|18037827|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
5225453|NCT00923091|18037828|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
5225454|NCT00923091|18037829|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
5225455|NCT00923091|18037817|P13|Period IV (Double-Blind)|Adverse Event|0
5225456|NCT00923091|18037818|P12|Period IV (Double-Blind)|Adverse Event|0
5225457|NCT00923091|18037819|P11|Period IV (Double-Blind)|Adverse Event|0
5225458|NCT00923091|18037820|P10|Period IV (Double-Blind)|Adverse Event|0
5225459|NCT00923091|18037821|P9|Period IV (Double-Blind)|Adverse Event|0
5225460|NCT00923091|18037822|P8|Period IV (Double-Blind)|Adverse Event|0
5225461|NCT00923091|18037823|P7|Period IV (Double-Blind)|Adverse Event|0
5225462|NCT00923091|18037824|P6|Period IV (Double-Blind)|Adverse Event|0
5225463|NCT00923091|18037825|P5|Period IV (Double-Blind)|Adverse Event|0
5225464|NCT00923091|18037826|P4|Period IV (Double-Blind)|Adverse Event|0
5225465|NCT00923091|18037827|P3|Period IV (Double-Blind)|Adverse Event|0
5225466|NCT00923091|18037828|P2|Period IV (Double-Blind)|Adverse Event|0
5225467|NCT00923091|18037829|P1|Period IV (Double-Blind)|Adverse Event|2
5225468|NCT00923091|18037817|P13|Period III (Single-Blind)|Lost to Follow-up|0
5225469|NCT00923091|18037818|P12|Period III (Single-Blind)|Lost to Follow-up|0
5225470|NCT00923091|18037819|P11|Period III (Single-Blind)|Lost to Follow-up|0
5225471|NCT00923091|18037820|P10|Period III (Single-Blind)|Lost to Follow-up|0
5225472|NCT00923091|18037821|P9|Period III (Single-Blind)|Lost to Follow-up|0
5225473|NCT00923091|18037822|P8|Period III (Single-Blind)|Lost to Follow-up|0
5225474|NCT00923091|18037823|P7|Period III (Single-Blind)|Lost to Follow-up|0
5225475|NCT00923091|18037824|P6|Period III (Single-Blind)|Lost to Follow-up|0
5225476|NCT00923091|18037825|P5|Period III (Single-Blind)|Lost to Follow-up|0
5225477|NCT00923091|18037826|P4|Period III (Single-Blind)|Lost to Follow-up|0
5225478|NCT00923091|18037827|P3|Period III (Single-Blind)|Lost to Follow-up|0
5225479|NCT00923091|18037828|P2|Period III (Single-Blind)|Lost to Follow-up|0
5225480|NCT00923091|18037829|P1|Period III (Single-Blind)|Lost to Follow-up|2
5225481|NCT00923091|18037817|P13|Period III (Single-Blind)|Protocol Violation|0
5225482|NCT00923091|18037818|P12|Period III (Single-Blind)|Protocol Violation|0
5225483|NCT00923091|18037819|P11|Period III (Single-Blind)|Protocol Violation|0
5225484|NCT00923091|18037820|P10|Period III (Single-Blind)|Protocol Violation|0
5225485|NCT00923091|18037821|P9|Period III (Single-Blind)|Protocol Violation|0
5225486|NCT00923091|18037822|P8|Period III (Single-Blind)|Protocol Violation|0
5225487|NCT00923091|18037823|P7|Period III (Single-Blind)|Protocol Violation|0
5225488|NCT00923091|18037824|P6|Period III (Single-Blind)|Protocol Violation|0
5225489|NCT00923091|18037825|P5|Period III (Single-Blind)|Protocol Violation|0
5225490|NCT00923091|18037826|P4|Period III (Single-Blind)|Protocol Violation|0
5225491|NCT00923091|18037827|P3|Period III (Single-Blind)|Protocol Violation|0
5225492|NCT00923091|18037828|P2|Period III (Single-Blind)|Protocol Violation|0
5225493|NCT00923091|18037829|P1|Period III (Single-Blind)|Protocol Violation|3
5225494|NCT00923091|18037817|P13|Period III (Single-Blind)|Withdrawal by Subject|0
5225495|NCT00923091|18037818|P12|Period III (Single-Blind)|Withdrawal by Subject|0
5225496|NCT00923091|18037819|P11|Period III (Single-Blind)|Withdrawal by Subject|0
5225497|NCT00923091|18037820|P10|Period III (Single-Blind)|Withdrawal by Subject|0
5225498|NCT00923091|18037821|P9|Period III (Single-Blind)|Withdrawal by Subject|0
5225499|NCT00923091|18037822|P8|Period III (Single-Blind)|Withdrawal by Subject|0
5225500|NCT00923091|18037823|P7|Period III (Single-Blind)|Withdrawal by Subject|0
5225501|NCT00923091|18037824|P6|Period III (Single-Blind)|Withdrawal by Subject|0
5225502|NCT00923091|18037825|P5|Period III (Single-Blind)|Withdrawal by Subject|0
5225503|NCT00923091|18037826|P4|Period III (Single-Blind)|Withdrawal by Subject|0
5225504|NCT00923091|18037827|P3|Period III (Single-Blind)|Withdrawal by Subject|0
5225505|NCT00923091|18037828|P2|Period III (Single-Blind)|Withdrawal by Subject|0
5225506|NCT00923091|18037829|P1|Period III (Single-Blind)|Withdrawal by Subject|10
5225507|NCT00923091|18037817|P13|Period III (Single-Blind)|Adverse Event|0
5225508|NCT00923091|18037818|P12|Period III (Single-Blind)|Adverse Event|0
5225509|NCT00923091|18037819|P11|Period III (Single-Blind)|Adverse Event|0
5225510|NCT00923091|18037820|P10|Period III (Single-Blind)|Adverse Event|0
5225511|NCT00923091|18037821|P9|Period III (Single-Blind)|Adverse Event|0
5225512|NCT00923091|18037822|P8|Period III (Single-Blind)|Adverse Event|0
5225513|NCT00923091|18037823|P7|Period III (Single-Blind)|Adverse Event|0
5225514|NCT00923091|18037824|P6|Period III (Single-Blind)|Adverse Event|0
5225515|NCT00923091|18037825|P5|Period III (Single-Blind)|Adverse Event|0
5225516|NCT00923091|18037826|P4|Period III (Single-Blind)|Adverse Event|0
5225517|NCT00923091|18037827|P3|Period III (Single-Blind)|Adverse Event|0
5225518|NCT00923091|18037828|P2|Period III (Single-Blind)|Adverse Event|0
5225519|NCT00923091|18037829|P1|Period III (Single-Blind)|Adverse Event|5
5225520|NCT00923091|18037817|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225521|NCT00923091|18037818|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225522|NCT00923091|18037819|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225523|NCT00923091|18037820|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225524|NCT00923091|18037821|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225525|NCT00923091|18037822|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225526|NCT00923091|18037823|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225527|NCT00923091|18037824|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5225528|NCT00923091|18037825|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225529|NCT00923091|18037826|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5225530|NCT00923091|18037827|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225531|NCT00923091|18037828|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5225532|NCT00923091|18037829|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5225533|NCT00923091|18037817|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225534|NCT00923091|18037818|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225535|NCT00923091|18037819|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225536|NCT00923091|18037820|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225537|NCT00923091|18037821|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225538|NCT00923091|18037822|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225539|NCT00923091|18037823|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225540|NCT00923091|18037824|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
5225541|NCT00923091|18037825|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225542|NCT00923091|18037826|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225543|NCT00923091|18037827|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225544|NCT00923091|18037828|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225545|NCT00923091|18037829|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5225546|NCT00923091|18037817|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5225547|NCT00923091|18037818|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5225548|NCT00923091|18037819|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5225549|NCT00923091|18037820|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5225550|NCT00923091|18037821|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5225551|NCT00923091|18037822|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
5225552|NCT00923091|18037823|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
5225553|NCT00923091|18037824|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
5225554|NCT00923091|18037825|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
5225555|NCT00923091|18037826|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
5225556|NCT00923091|18037827|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5225557|NCT00923091|18037828|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5225558|NCT00923091|18037829|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5225559|NCT00923091|18037817|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5225560|NCT00923091|18037818|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5225561|NCT00923091|18037819|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5225562|NCT00923091|18037820|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5225563|NCT00923091|18037821|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5225564|NCT00923091|18037822|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5225565|NCT00923091|18037823|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5225566|NCT00923091|18037824|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
5225567|NCT00923091|18037825|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
5225568|NCT00923091|18037826|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
5225569|NCT00923091|18037827|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5225570|NCT00923091|18037828|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
5225571|NCT00923091|18037829|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
5225572|NCT00923091|18037817|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5225573|NCT00923091|18037818|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5225574|NCT00923091|18037819|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5225575|NCT00923091|18037820|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5225576|NCT00923091|18037821|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5225577|NCT00923091|18037822|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
5225578|NCT00923091|18037823|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
5225579|NCT00923091|18037824|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
5225580|NCT00923091|18037825|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
5225581|NCT00923091|18037826|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
5225582|NCT00923091|18037827|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
5225583|NCT00923091|18037828|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
5225584|NCT00923091|18037829|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
5225585|NCT00923078|18037879|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
5225586|NCT00923078|18037880|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
5225587|NCT00923078|18037881|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
5225588|NCT00923078|18037879|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
5225589|NCT00923078|18037880|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
5225590|NCT00923078|18037881|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
5225591|NCT00922987|18037900|P1|Overall Study|Adverse Event|1
5225592|NCT00922987|18037900|P1|Overall Study|Protocol Violation|2
5225593|NCT00922987|18037900|P1|Overall Study|Insufficient clinical response|1
5225594|NCT00922974|18037915|P2|Phase III Component|Protocol Violation|6
5225595|NCT00922974|18037916|P1|Phase III Component|Protocol Violation|8
5225596|NCT00922974|18037915|P2|Phase II Component|Not evaluable for treatment review|0
5225597|NCT00922974|18037916|P1|Phase II Component|Not evaluable for treatment review|5
5225598|NCT00922974|18037915|P2|Phase II Component|Protocol Violation|0
5225599|NCT00922974|18037916|P1|Phase II Component|Protocol Violation|2
5225600|NCT00922935|18037931|P3|Overall Study|Lost to Follow-up|0
5225601|NCT00922935|18037932|P2|Overall Study|Lost to Follow-up|1
5225602|NCT00922935|18037933|P1|Overall Study|Lost to Follow-up|0
5225603|NCT00922935|18037931|P3|Overall Study|Physician Decision|0
5225604|NCT00922935|18037932|P2|Overall Study|Physician Decision|1
5225605|NCT00922935|18037933|P1|Overall Study|Physician Decision|1
5225606|NCT00922935|18037931|P3|Overall Study|Protocol Violation|0
5225607|NCT00922935|18037932|P2|Overall Study|Protocol Violation|3
5225608|NCT00922935|18037933|P1|Overall Study|Protocol Violation|0
5225609|NCT00922779|18037945|P1|Overall Study|Missing|1874
5225610|NCT00922779|18037945|P1|Overall Study|Other|27
5225611|NCT00922779|18037945|P1|Overall Study|Lost to Follow-up|44
5225612|NCT00922779|18037945|P1|Overall Study|Withdrawal by Subject|308
5225613|NCT00922779|18037945|P1|Overall Study|Pregnancy|7
5225614|NCT00922779|18037945|P1|Overall Study|Adverse Event|67
5225615|NCT00922766|18037952|P1|Overall Study|Adverse Event|1
5225616|NCT00922766|18037952|P1|Overall Study|Other|1
5225617|NCT00922766|18037952|P1|Overall Study|Withdrawal by Subject|2
5225618|NCT00922766|18037952|P1|Overall Study|Death|3
5225619|NCT00922636|18037970|P5|Overall Study|Lost to Follow-up|4
5225620|NCT00922636|18037971|P4|Overall Study|Lost to Follow-up|2
5225621|NCT00922636|18037972|P3|Overall Study|Lost to Follow-up|2
5225622|NCT00922636|18037973|P2|Overall Study|Lost to Follow-up|2
5225623|NCT00922636|18037974|P1|Overall Study|Lost to Follow-up|1
5225624|NCT00922636|18037970|P5|Overall Study|Parent/Caregiver Decision|2
5225625|NCT00922636|18037971|P4|Overall Study|Parent/Caregiver Decision|5
5225626|NCT00922636|18037972|P3|Overall Study|Parent/Caregiver Decision|3
5225627|NCT00922636|18037973|P2|Overall Study|Parent/Caregiver Decision|4
5225628|NCT00922636|18037974|P1|Overall Study|Parent/Caregiver Decision|2
5225629|NCT00922636|18037970|P5|Overall Study|Entry Criteria Not Met|0
5225630|NCT00922636|18037971|P4|Overall Study|Entry Criteria Not Met|1
5225631|NCT00922636|18037972|P3|Overall Study|Entry Criteria Not Met|1
5225632|NCT00922636|18037973|P2|Overall Study|Entry Criteria Not Met|0
5225633|NCT00922636|18037974|P1|Overall Study|Entry Criteria Not Met|0
5225634|NCT00922636|18037970|P5|Overall Study|Protocol Violation|0
5225635|NCT00922636|18037971|P4|Overall Study|Protocol Violation|2
5225636|NCT00922636|18037972|P3|Overall Study|Protocol Violation|2
5225637|NCT00922636|18037973|P2|Overall Study|Protocol Violation|0
5225638|NCT00922636|18037974|P1|Overall Study|Protocol Violation|0
5225639|NCT00922636|18037970|P5|Overall Study|Withdrawal by Subject|4
5225640|NCT00922636|18037971|P4|Overall Study|Withdrawal by Subject|2
5225641|NCT00922636|18037972|P3|Overall Study|Withdrawal by Subject|5
5225642|NCT00922636|18037973|P2|Overall Study|Withdrawal by Subject|0
5225643|NCT00922636|18037974|P1|Overall Study|Withdrawal by Subject|0
5225644|NCT00922636|18037970|P5|Overall Study|Sponsor Decision|0
5225645|NCT00922636|18037971|P4|Overall Study|Sponsor Decision|0
5225646|NCT00922636|18037972|P3|Overall Study|Sponsor Decision|2
5225647|NCT00922636|18037973|P2|Overall Study|Sponsor Decision|0
5225648|NCT00922636|18037974|P1|Overall Study|Sponsor Decision|0
5225649|NCT00922636|18037970|P5|Overall Study|Lack of Efficacy|4
5225650|NCT00922636|18037971|P4|Overall Study|Lack of Efficacy|2
5225651|NCT00922636|18037972|P3|Overall Study|Lack of Efficacy|3
5225652|NCT00922636|18037973|P2|Overall Study|Lack of Efficacy|7
5225653|NCT00922636|18037974|P1|Overall Study|Lack of Efficacy|1
5225654|NCT00922636|18037970|P5|Overall Study|Adverse Event|2
5225655|NCT00922636|18037971|P4|Overall Study|Adverse Event|3
5225656|NCT00922636|18037972|P3|Overall Study|Adverse Event|2
5225657|NCT00922636|18037973|P2|Overall Study|Adverse Event|3
5225658|NCT00922636|18037974|P1|Overall Study|Adverse Event|3
5225659|NCT00922623|18038121|P1|Overall Study|Lost to Follow-up|1
5225660|NCT00922623|18038121|P1|Overall Study|Other|4
5225661|NCT00922480|18038129|P2|Extension Study|Others|1
5225662|NCT00922480|18038130|P1|Extension Study|Others|0
5225663|NCT00922480|18038129|P2|Extension Study|Withdrawal by Subject|1
5225664|NCT00922480|18038130|P1|Extension Study|Withdrawal by Subject|1
5225665|NCT00922480|18038129|P2|Extension Study|Adverse Event|1
5225666|NCT00922480|18038130|P1|Extension Study|Adverse Event|1
5225667|NCT00922480|18038129|P2|Extension Study|Protocol Violation|0
5225668|NCT00922480|18038130|P1|Extension Study|Protocol Violation|3
5225669|NCT00922480|18038129|P2|Main Study|Physician Decision|1
5225670|NCT00922480|18038130|P1|Main Study|Physician Decision|0
5225671|NCT00922480|18038129|P2|Main Study|Lost to Follow-up|0
5225672|NCT00922480|18038130|P1|Main Study|Lost to Follow-up|5
5225673|NCT00922480|18038129|P2|Main Study|Withdrawal by Subject|15
5225674|NCT00922480|18038130|P1|Main Study|Withdrawal by Subject|20
5225675|NCT00922480|18038129|P2|Main Study|Lack of Efficacy|0
5225676|NCT00922480|18038130|P1|Main Study|Lack of Efficacy|3
5225677|NCT00922480|18038129|P2|Main Study|Adverse Event|7
5225678|NCT00922480|18038130|P1|Main Study|Adverse Event|6
5225679|NCT00922480|18038129|P2|Main Study|Protocol Violation|6
5225680|NCT00922480|18038130|P1|Main Study|Protocol Violation|3
5225681|NCT00922441|18038141|P3|Overall Study|Withdrawal by Subject|1
5225682|NCT00922441|18038142|P2|Overall Study|Withdrawal by Subject|0
5225683|NCT00922441|18038143|P1|Overall Study|Withdrawal by Subject|0
5225684|NCT00922441|18038141|P3|Overall Study|Protocol Violation|2
5225685|NCT00922441|18038142|P2|Overall Study|Protocol Violation|0
5225686|NCT00922441|18038143|P1|Overall Study|Protocol Violation|0
5225687|NCT00922428|18038151|P1|Overall Study|no medication use or questionable use|13
5225688|NCT00922428|18038151|P1|Overall Study|retrospective/extremely implausible data|2
5225689|NCT00922272|18038180|P2|Double-blind Phase|Positive urine drug screen|1
5225690|NCT00922272|18038181|P1|Double-blind Phase|Positive urine drug screen|1
5225691|NCT00922272|18038180|P2|Double-blind Phase|Noncompliance|1
5225692|NCT00922272|18038181|P1|Double-blind Phase|Noncompliance|1
5225693|NCT00922272|18038180|P2|Double-blind Phase|Withdrawal criteria met|1
5225694|NCT00922272|18038181|P1|Double-blind Phase|Withdrawal criteria met|1
5225695|NCT00922272|18038180|P2|Double-blind Phase|Lost to Follow-up|1
5225696|NCT00922272|18038181|P1|Double-blind Phase|Lost to Follow-up|2
5225697|NCT00922272|18038180|P2|Double-blind Phase|Withdrawal by Subject|1
5225698|NCT00922272|18038181|P1|Double-blind Phase|Withdrawal by Subject|1
5225699|NCT00922272|18038180|P2|Double-blind Phase|Adverse Event|1
5225700|NCT00922272|18038181|P1|Double-blind Phase|Adverse Event|1
5225701|NCT00922272|18038180|P2|Open-label Phase|Withdrawal criteria met|0
5225702|NCT00922272|18038181|P1|Open-label Phase|Withdrawal criteria met|5
5225703|NCT00922272|18038180|P2|Open-label Phase|Failure to meet randomization criteria|0
5225870|NCT00920621|18038701|P4|Overall Study|Lost to Follow-up|21
5225704|NCT00922272|18038181|P1|Open-label Phase|Failure to meet randomization criteria|1
5225705|NCT00922272|18038180|P2|Open-label Phase|Withdrawal by Subject|0
5225706|NCT00922272|18038181|P1|Open-label Phase|Withdrawal by Subject|11
5225707|NCT00922272|18038180|P2|Open-label Phase|Protocol Violation|0
5225708|NCT00922272|18038181|P1|Open-label Phase|Protocol Violation|1
5225709|NCT00922272|18038180|P2|Open-label Phase|Adverse Event|0
5225710|NCT00922272|18038181|P1|Open-label Phase|Adverse Event|5
5225711|NCT00922207|18038246|P3|Overall Study|Abnormality of Laboratory Test|1
5225712|NCT00922207|18038247|P2|Overall Study|Abnormality of Laboratory Test|1
5225713|NCT00922207|18038248|P1|Overall Study|Abnormality of Laboratory Test|0
5225714|NCT00922207|18038246|P3|Overall Study|Withdrew Consent|2
5225715|NCT00922207|18038247|P2|Overall Study|Withdrew Consent|5
5225716|NCT00922207|18038248|P1|Overall Study|Withdrew Consent|2
5225717|NCT00922207|18038246|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
5225718|NCT00922207|18038247|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5225719|NCT00922207|18038248|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
5225720|NCT00922207|18038246|P3|Overall Study|Violation of Selection Criteria at Entry|0
5225721|NCT00922207|18038247|P2|Overall Study|Violation of Selection Criteria at Entry|1
5225722|NCT00922207|18038248|P1|Overall Study|Violation of Selection Criteria at Entry|0
5225723|NCT00922207|18038246|P3|Overall Study|Insufficient Therapeutic Response|1
5225724|NCT00922207|18038247|P2|Overall Study|Insufficient Therapeutic Response|0
5225725|NCT00922207|18038248|P1|Overall Study|Insufficient Therapeutic Response|0
5225726|NCT00922207|18038246|P3|Overall Study|Adverse Event/Intercurrent Illness|0
5225727|NCT00922207|18038247|P2|Overall Study|Adverse Event/Intercurrent Illness|0
5225728|NCT00922207|18038248|P1|Overall Study|Adverse Event/Intercurrent Illness|3
5225729|NCT00922116|18038284|P1|Overall Study|Other|5
5225730|NCT00922116|18038284|P1|Overall Study|Withdrawal by Subject|4
5225731|NCT00922116|18038284|P1|Overall Study|Lost to Follow-up|1
5225732|NCT00922116|18038284|P1|Overall Study|Death|1
5225733|NCT00922116|18038284|P1|Overall Study|Adverse Event|4
5225734|NCT00921557|18038346|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
5225735|NCT00921557|18038347|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
5225736|NCT00921557|18038348|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
5225737|NCT00921557|18038346|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
5225738|NCT00921557|18038347|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
5225739|NCT00921557|18038348|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
5225740|NCT00921557|18038346|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
5225741|NCT00921557|18038347|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
5225742|NCT00921557|18038348|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
5225743|NCT00921557|18038346|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
5225744|NCT00921557|18038347|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
5225745|NCT00921557|18038348|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
5225746|NCT00921557|18038346|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
5225747|NCT00921557|18038347|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
5225748|NCT00921557|18038348|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
5225749|NCT00921024|18038450|P2|Overall Study|Withdrawal by Subject|3
5225750|NCT00921024|18038451|P1|Overall Study|Withdrawal by Subject|0
5225751|NCT00921024|18038450|P2|Overall Study|Received concomittant therapy|0
5225752|NCT00921024|18038451|P1|Overall Study|Received concomittant therapy|2
5225753|NCT00921024|18038450|P2|Overall Study|Lost to Follow-up|0
5225754|NCT00921024|18038451|P1|Overall Study|Lost to Follow-up|2
5225755|NCT00920907|18038461|P2|Maintenance Period|Adverse Event|1
5225756|NCT00920907|18038462|P1|Maintenance Period|Adverse Event|0
5225757|NCT00920907|18038461|P2|Maintenance Period|Withdrawal by Subject|0
5225758|NCT00920907|18038462|P1|Maintenance Period|Withdrawal by Subject|1
5225759|NCT00920907|18038461|P2|Maintenance Period|Death|1
5225760|NCT00920907|18038462|P1|Maintenance Period|Death|1
5225761|NCT00920907|18038461|P2|Maintenance Period|Study Drug Toxicity|2
5225762|NCT00920907|18038462|P1|Maintenance Period|Study Drug Toxicity|0
5225763|NCT00920907|18038461|P2|Maintenance Period|Administrative (study closure)|2
5225764|NCT00920907|18038462|P1|Maintenance Period|Administrative (study closure)|7
5225765|NCT00920907|18038461|P2|Maintenance Period|Disease Progression|7
5225766|NCT00920907|18038462|P1|Maintenance Period|Disease Progression|3
5225767|NCT00920907|18038461|P2|Induction Period|Withdrawal by Subject|1
5225768|NCT00920907|18038462|P1|Induction Period|Withdrawal by Subject|1
5225769|NCT00920907|18038461|P2|Induction Period|No longer meets study criteria|1
5225770|NCT00920907|18038462|P1|Induction Period|No longer meets study criteria|0
5225771|NCT00920907|18038461|P2|Induction Period|Study Drug Toxicity|6
5225772|NCT00920907|18038462|P1|Induction Period|Study Drug Toxicity|8
5225773|NCT00920907|18038461|P2|Induction Period|Disease Progression|11
5225774|NCT00920907|18038462|P1|Induction Period|Disease Progression|12
5225775|NCT00920907|18038461|P2|Induction Period|Death|1
5225776|NCT00920907|18038462|P1|Induction Period|Death|1
5225777|NCT00920907|18038461|P2|Induction Period|Adverse Event|2
5225778|NCT00920907|18038462|P1|Induction Period|Adverse Event|0
5225779|NCT00920855|18038503|P3|Overall Study|Response plateau; started maintenance|1
5225780|NCT00920855|18038504|P2|Overall Study|Response plateau; started maintenance|0
5225781|NCT00920855|18038505|P1|Overall Study|Response plateau; started maintenance|0
5225782|NCT00920855|18038503|P3|Overall Study|Noncompliance to study medication|1
5225783|NCT00920855|18038504|P2|Overall Study|Noncompliance to study medication|0
5225784|NCT00920855|18038505|P1|Overall Study|Noncompliance to study medication|0
5225785|NCT00920855|18038503|P3|Overall Study|Disease progression|10
5225786|NCT00920855|18038504|P2|Overall Study|Disease progression|1
5225787|NCT00920855|18038505|P1|Overall Study|Disease progression|2
5225788|NCT00920855|18038503|P3|Overall Study|Withdrawal by Subject|6
5225789|NCT00920855|18038504|P2|Overall Study|Withdrawal by Subject|1
5225790|NCT00920855|18038505|P1|Overall Study|Withdrawal by Subject|2
5225791|NCT00920855|18038503|P3|Overall Study|Adverse Event|4
5225792|NCT00920855|18038504|P2|Overall Study|Adverse Event|1
5225793|NCT00920855|18038505|P1|Overall Study|Adverse Event|1
5225794|NCT00920829|18038531|P4|Available for Analysis|Required more treatment|1
5225795|NCT00920829|18038532|P3|Available for Analysis|Required more treatment|0
5225796|NCT00920829|18038533|P2|Available for Analysis|Required more treatment|2
5225797|NCT00920829|18038534|P1|Available for Analysis|Required more treatment|0
5225798|NCT00920829|18038531|P4|Available for Analysis|Protocol Violation|0
5225799|NCT00920829|18038532|P3|Available for Analysis|Protocol Violation|1
5225800|NCT00920829|18038533|P2|Available for Analysis|Protocol Violation|0
5225801|NCT00920829|18038534|P1|Available for Analysis|Protocol Violation|0
5225802|NCT00920829|18038531|P4|Available for Analysis|Death|0
5225803|NCT00920829|18038532|P3|Available for Analysis|Death|0
5225804|NCT00920829|18038533|P2|Available for Analysis|Death|0
5225805|NCT00920829|18038534|P1|Available for Analysis|Death|1
5225806|NCT00920829|18038531|P4|Available for Analysis|Adverse Event|0
5225807|NCT00920829|18038532|P3|Available for Analysis|Adverse Event|1
5225808|NCT00920829|18038533|P2|Available for Analysis|Adverse Event|2
5225809|NCT00920829|18038534|P1|Available for Analysis|Adverse Event|1
5225810|NCT00920829|18038531|P4|Available for Analysis|Required Medical Treatment|0
5225811|NCT00920829|18038532|P3|Available for Analysis|Required Medical Treatment|2
5225812|NCT00920829|18038533|P2|Available for Analysis|Required Medical Treatment|1
5225813|NCT00920829|18038534|P1|Available for Analysis|Required Medical Treatment|0
5225814|NCT00920829|18038531|P4|Available for Analysis|Withdrawal by Subject|10
5225815|NCT00920829|18038532|P3|Available for Analysis|Withdrawal by Subject|6
5225816|NCT00920829|18038533|P2|Available for Analysis|Withdrawal by Subject|6
5225817|NCT00920829|18038534|P1|Available for Analysis|Withdrawal by Subject|6
5225818|NCT00920829|18038531|P4|Allocation|No post randomization data|2
5225819|NCT00920829|18038532|P3|Allocation|No post randomization data|0
5225820|NCT00920829|18038533|P2|Allocation|No post randomization data|1
5225821|NCT00920829|18038534|P1|Allocation|No post randomization data|3
5225822|NCT00920816|18038548|P4|Overall Study|Ongoing|36
5225823|NCT00920816|18038549|P3|Overall Study|Ongoing|70
5225824|NCT00920816|18038550|P2|Overall Study|Ongoing|56
5225825|NCT00920816|18038551|P1|Overall Study|Ongoing|106
5225826|NCT00920816|18038548|P4|Overall Study|Withdrawal by Subject|1
5225827|NCT00920816|18038549|P3|Overall Study|Withdrawal by Subject|1
5225828|NCT00920816|18038550|P2|Overall Study|Withdrawal by Subject|2
5225829|NCT00920816|18038551|P1|Overall Study|Withdrawal by Subject|7
5225830|NCT00920816|18038548|P4|Overall Study|Objective progression or relapse|0
5225831|NCT00920816|18038549|P3|Overall Study|Objective progression or relapse|2
5225832|NCT00920816|18038550|P2|Overall Study|Objective progression or relapse|0
5225833|NCT00920816|18038551|P1|Overall Study|Objective progression or relapse|0
5225834|NCT00920816|18038548|P4|Overall Study|Lost to Follow-up|4
5225835|NCT00920816|18038549|P3|Overall Study|Lost to Follow-up|3
5225836|NCT00920816|18038550|P2|Overall Study|Lost to Follow-up|2
5225837|NCT00920816|18038551|P1|Overall Study|Lost to Follow-up|1
5225838|NCT00920816|18038548|P4|Overall Study|Adverse Event|0
5225839|NCT00920816|18038549|P3|Overall Study|Adverse Event|1
5225840|NCT00920816|18038550|P2|Overall Study|Adverse Event|0
5225841|NCT00920816|18038551|P1|Overall Study|Adverse Event|1
5225842|NCT00920816|18038548|P4|Overall Study|Death|28
5225843|NCT00920816|18038549|P3|Overall Study|Death|58
5225844|NCT00920816|18038550|P2|Overall Study|Death|36
5225845|NCT00920816|18038551|P1|Overall Study|Death|77
5225846|NCT00920790|18038589|P1|Overall Study|aggravation of general condition|14
5225847|NCT00920699|18038601|P3|Overall Study|Lost to Follow-up|2
5225848|NCT00920699|18038602|P2|Overall Study|Lost to Follow-up|0
5225849|NCT00920699|18038603|P1|Overall Study|Lost to Follow-up|0
5225850|NCT00920699|18038601|P3|Overall Study|no longer met eligibility|0
5225851|NCT00920699|18038602|P2|Overall Study|no longer met eligibility|1
5225852|NCT00920699|18038603|P1|Overall Study|no longer met eligibility|0
5225853|NCT00920699|18038601|P3|Overall Study|Withdrawal by Subject|2
5225854|NCT00920699|18038602|P2|Overall Study|Withdrawal by Subject|0
5225855|NCT00920699|18038603|P1|Overall Study|Withdrawal by Subject|2
5225856|NCT00920686|18038620|P3|Overall Study|Study drug dosing criteria not met|12
5225857|NCT00920686|18038621|P2|Overall Study|Study drug dosing criteria not met|19
5225858|NCT00920686|18038622|P1|Overall Study|Study drug dosing criteria not met|17
5225859|NCT00920686|18038620|P3|Overall Study|Lost to Follow-up|1
5225860|NCT00920686|18038621|P2|Overall Study|Lost to Follow-up|3
5225861|NCT00920686|18038622|P1|Overall Study|Lost to Follow-up|2
5225862|NCT00920621|18038701|P4|Overall Study|Blood sample not collected|0
5225863|NCT00920621|18038702|P3|Overall Study|Blood sample not collected|0
5225864|NCT00920621|18038703|P2|Overall Study|Blood sample not collected|14
5225865|NCT00920621|18038704|P1|Overall Study|Blood sample not collected|22
5225866|NCT00920621|18038701|P4|Overall Study|Fetal/neonatal deaths|14
5225867|NCT00920621|18038702|P3|Overall Study|Fetal/neonatal deaths|16
5225868|NCT00920621|18038703|P2|Overall Study|Fetal/neonatal deaths|14
5225869|NCT00920621|18038704|P1|Overall Study|Fetal/neonatal deaths|16
5225871|NCT00920621|18038702|P3|Overall Study|Lost to Follow-up|19
5225872|NCT00920621|18038703|P2|Overall Study|Lost to Follow-up|17
5225873|NCT00920621|18038704|P1|Overall Study|Lost to Follow-up|16
5225874|NCT00920556|18038734|P1|Overall Study|Withdrawal by Subject|1
5225875|NCT00920556|18038734|P1|Overall Study|Physician Decision|7
5225876|NCT00920556|18038734|P1|Overall Study|Adverse Event|16
5225877|NCT00920426|18038783|P4|ITZ111451|Adverse Event|0
5225878|NCT00920426|18038784|P3|ITZ111451|Adverse Event|0
5225879|NCT00920426|18038785|P2|ITZ111451|Adverse Event|0
5225880|NCT00920426|18038786|P1|ITZ111451|Adverse Event|1
5225881|NCT00920218|18038906|P4|Overall Study|Other|0
5225882|NCT00920218|18038907|P3|Overall Study|Other|1
5225883|NCT00920218|18038908|P2|Overall Study|Other|0
5225884|NCT00920218|18038909|P1|Overall Study|Other|0
5225885|NCT00920218|18038906|P4|Overall Study|Transplant failed/malignancy recurrence|3
5225886|NCT00920218|18038907|P3|Overall Study|Transplant failed/malignancy recurrence|2
5225887|NCT00920218|18038908|P2|Overall Study|Transplant failed/malignancy recurrence|1
5225888|NCT00920218|18038909|P1|Overall Study|Transplant failed/malignancy recurrence|0
5225889|NCT00920218|18038906|P4|Overall Study|Lost to Follow-up|3
5225890|NCT00920218|18038907|P3|Overall Study|Lost to Follow-up|0
5225891|NCT00920218|18038908|P2|Overall Study|Lost to Follow-up|1
5225892|NCT00920218|18038909|P1|Overall Study|Lost to Follow-up|0
5225893|NCT00920218|18038906|P4|Overall Study|Migrated/moved from study area|0
5225894|NCT00920218|18038907|P3|Overall Study|Migrated/moved from study area|1
5225895|NCT00920218|18038908|P2|Overall Study|Migrated/moved from study area|0
5225896|NCT00920218|18038909|P1|Overall Study|Migrated/moved from study area|0
5225897|NCT00920218|18038906|P4|Overall Study|Withdrawal by Subject|0
5225898|NCT00920218|18038907|P3|Overall Study|Withdrawal by Subject|2
5225899|NCT00920218|18038908|P2|Overall Study|Withdrawal by Subject|3
5225900|NCT00920218|18038909|P1|Overall Study|Withdrawal by Subject|0
5225901|NCT00920218|18038906|P4|Overall Study|Serious Adverse Event|1
5225902|NCT00920218|18038907|P3|Overall Study|Serious Adverse Event|2
5225903|NCT00920218|18038908|P2|Overall Study|Serious Adverse Event|0
5225904|NCT00920218|18038909|P1|Overall Study|Serious Adverse Event|2
5225905|NCT00920140|18039012|P5|Phase 2|Withdrawal by Subject|1
5225906|NCT00920140|18039013|P4|Phase 2|Withdrawal by Subject|2
5225907|NCT00920140|18039014|P3|Phase 2|Withdrawal by Subject|4
5225908|NCT00920140|18039015|P2|Phase 2|Withdrawal by Subject|0
5225909|NCT00920140|18039016|P1|Phase 2|Withdrawal by Subject|0
5225910|NCT00920140|18039012|P5|Phase 2|Physician Decision|2
5225911|NCT00920140|18039013|P4|Phase 2|Physician Decision|3
5225912|NCT00920140|18039014|P3|Phase 2|Physician Decision|3
5225913|NCT00920140|18039015|P2|Phase 2|Physician Decision|0
5225914|NCT00920140|18039016|P1|Phase 2|Physician Decision|0
5225915|NCT00920140|18039012|P5|Phase 2|Lost to Follow-up|0
5225916|NCT00920140|18039013|P4|Phase 2|Lost to Follow-up|1
5225917|NCT00920140|18039014|P3|Phase 2|Lost to Follow-up|0
5225918|NCT00920140|18039015|P2|Phase 2|Lost to Follow-up|0
5225919|NCT00920140|18039016|P1|Phase 2|Lost to Follow-up|0
5225920|NCT00920140|18039012|P5|Phase 2|Lack of Efficacy|5
5225921|NCT00920140|18039013|P4|Phase 2|Lack of Efficacy|14
5225922|NCT00920140|18039014|P3|Phase 2|Lack of Efficacy|29
5225923|NCT00920140|18039015|P2|Phase 2|Lack of Efficacy|0
5225924|NCT00920140|18039016|P1|Phase 2|Lack of Efficacy|0
5225925|NCT00920140|18039012|P5|Phase 2|Adverse Event|3
5225926|NCT00920140|18039013|P4|Phase 2|Adverse Event|2
5225927|NCT00920140|18039014|P3|Phase 2|Adverse Event|14
5225928|NCT00920140|18039015|P2|Phase 2|Adverse Event|0
5225929|NCT00920140|18039016|P1|Phase 2|Adverse Event|0
5225930|NCT00920140|18039012|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5225931|NCT00920140|18039013|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5225932|NCT00920140|18039014|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5225933|NCT00920140|18039015|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
5225934|NCT00920140|18039016|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5225935|NCT00920140|18039012|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
5225936|NCT00920140|18039013|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
5225937|NCT00920140|18039014|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
5225938|NCT00920140|18039015|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
5225939|NCT00920140|18039016|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
5225940|NCT00920140|18039012|P5|Phase 1 (Dose Escalation)|Adverse Event|0
5225941|NCT00920140|18039013|P4|Phase 1 (Dose Escalation)|Adverse Event|0
5225942|NCT00920140|18039014|P3|Phase 1 (Dose Escalation)|Adverse Event|0
5225943|NCT00920140|18039015|P2|Phase 1 (Dose Escalation)|Adverse Event|3
5225944|NCT00920140|18039016|P1|Phase 1 (Dose Escalation)|Adverse Event|3
5225945|NCT00919893|18039078|P2|Overall Study|Protocol Violation|9
5225946|NCT00919893|18039079|P1|Overall Study|Protocol Violation|19
5225947|NCT00919867|18039091|P6|First Intervention|Physician Decision|1
5225948|NCT00919867|18039092|P5|First Intervention|Physician Decision|0
5225949|NCT00919867|18039093|P4|First Intervention|Physician Decision|0
5225950|NCT00919867|18039094|P3|First Intervention|Physician Decision|0
5225951|NCT00919867|18039095|P2|First Intervention|Physician Decision|0
5225952|NCT00919867|18039096|P1|First Intervention|Physician Decision|0
5225953|NCT00919867|18039091|P6|First Intervention|Withdrawal by Subject|0
5225954|NCT00919867|18039092|P5|First Intervention|Withdrawal by Subject|0
5225955|NCT00919867|18039093|P4|First Intervention|Withdrawal by Subject|0
5225956|NCT00919867|18039094|P3|First Intervention|Withdrawal by Subject|1
5225957|NCT00919867|18039095|P2|First Intervention|Withdrawal by Subject|0
5225958|NCT00919867|18039096|P1|First Intervention|Withdrawal by Subject|0
5225959|NCT00919854|18039117|P1|Overall Study|Adverse Event|1
5225960|NCT00919711|18039155|P2|Overall Study|Noncompliance|0
5225961|NCT00919711|18039156|P1|Overall Study|Noncompliance|1
5225962|NCT00919711|18039155|P2|Overall Study|Death|0
5225963|NCT00919711|18039156|P1|Overall Study|Death|1
5225964|NCT00919711|18039155|P2|Overall Study|Lost to Follow-up|0
5225965|NCT00919711|18039156|P1|Overall Study|Lost to Follow-up|2
5225966|NCT00919711|18039155|P2|Overall Study|Administrative Decision|1
5225967|NCT00919711|18039156|P1|Overall Study|Administrative Decision|0
5225968|NCT00919711|18039155|P2|Overall Study|Other|2
5225969|NCT00919711|18039156|P1|Overall Study|Other|1
5225970|NCT00919711|18039155|P2|Overall Study|Adverse Event|3
5225971|NCT00919711|18039156|P1|Overall Study|Adverse Event|13
5225972|NCT00919711|18039155|P2|Overall Study|Withdrawal by Subject|7
5225973|NCT00919711|18039156|P1|Overall Study|Withdrawal by Subject|15
5225974|NCT00919633|18039172|P4|Overall Study|Viral rebound outside protocol timepoint|0
5225975|NCT00919633|18039173|P3|Overall Study|Viral rebound outside protocol timepoint|1
5225976|NCT00919633|18039174|P2|Overall Study|Viral rebound outside protocol timepoint|0
5225977|NCT00919633|18039175|P1|Overall Study|Viral rebound outside protocol timepoint|0
5225978|NCT00919633|18039172|P4|Overall Study|Request of withdrawal w/o future contact|0
5225979|NCT00919633|18039173|P3|Overall Study|Request of withdrawal w/o future contact|1
5225980|NCT00919633|18039174|P2|Overall Study|Request of withdrawal w/o future contact|0
5225981|NCT00919633|18039175|P1|Overall Study|Request of withdrawal w/o future contact|0
5225982|NCT00919633|18039172|P4|Overall Study|Physician Decision|1
5225983|NCT00919633|18039173|P3|Overall Study|Physician Decision|0
5225984|NCT00919633|18039174|P2|Overall Study|Physician Decision|0
5225985|NCT00919633|18039175|P1|Overall Study|Physician Decision|0
5225986|NCT00919633|18039172|P4|Overall Study|Protocol Violation|1
5225987|NCT00919633|18039173|P3|Overall Study|Protocol Violation|0
5225988|NCT00919633|18039174|P2|Overall Study|Protocol Violation|0
5225989|NCT00919633|18039175|P1|Overall Study|Protocol Violation|0
5225990|NCT00919633|18039172|P4|Overall Study|Withdraw consent post transition to SOC|1
5225991|NCT00919633|18039173|P3|Overall Study|Withdraw consent post transition to SOC|1
5225992|NCT00919633|18039174|P2|Overall Study|Withdraw consent post transition to SOC|0
5225993|NCT00919633|18039175|P1|Overall Study|Withdraw consent post transition to SOC|0
5225994|NCT00919633|18039172|P4|Overall Study|Lost to Follow-up|2
5225995|NCT00919633|18039173|P3|Overall Study|Lost to Follow-up|0
5225996|NCT00919633|18039174|P2|Overall Study|Lost to Follow-up|1
5225997|NCT00919633|18039175|P1|Overall Study|Lost to Follow-up|3
5225998|NCT00919633|18039172|P4|Overall Study|Withdrawal by Subject|3
5225999|NCT00919633|18039173|P3|Overall Study|Withdrawal by Subject|4
5226000|NCT00919633|18039174|P2|Overall Study|Withdrawal by Subject|2
5226001|NCT00919633|18039175|P1|Overall Study|Withdrawal by Subject|1
5226002|NCT00919633|18039172|P4|Overall Study|Lack of Efficacy|3
5226003|NCT00919633|18039173|P3|Overall Study|Lack of Efficacy|2
5226004|NCT00919633|18039174|P2|Overall Study|Lack of Efficacy|3
5226005|NCT00919633|18039175|P1|Overall Study|Lack of Efficacy|17
5226006|NCT00919633|18039172|P4|Overall Study|Death|0
5226007|NCT00919633|18039173|P3|Overall Study|Death|2
5226008|NCT00919633|18039174|P2|Overall Study|Death|0
5226009|NCT00919633|18039175|P1|Overall Study|Death|0
5226010|NCT00919633|18039172|P4|Overall Study|Adverse Event|10
5226011|NCT00919633|18039173|P3|Overall Study|Adverse Event|12
5226012|NCT00919633|18039174|P2|Overall Study|Adverse Event|9
5226013|NCT00919633|18039175|P1|Overall Study|Adverse Event|1
5226014|NCT00919061|18039273|P1|Overall Study|Withdrawal by Subject|1
5226015|NCT00919061|18039273|P1|Overall Study|Adverse Event|1
5226016|NCT00918957|18039286|P2|Overall Study|Withdrawal by Subject|0
5226017|NCT00918957|18039287|P1|Overall Study|Withdrawal by Subject|1
5226018|NCT00918957|18039286|P2|Overall Study|Adverse Event|0
5226019|NCT00918957|18039287|P1|Overall Study|Adverse Event|2
5226020|NCT00918879|18039320|P2|Overall Study|Severe non-compliance to protocol|1
5226021|NCT00918879|18039321|P1|Overall Study|Severe non-compliance to protocol|1
5226022|NCT00918879|18039320|P2|Overall Study|Lost to Follow-up|1
5226023|NCT00918879|18039321|P1|Overall Study|Lost to Follow-up|1
5226024|NCT00918879|18039320|P2|Overall Study|Withdrawal by Subject|4
5226025|NCT00918879|18039321|P1|Overall Study|Withdrawal by Subject|4
5226026|NCT00918749|18039353|P3|Overall Study|No Study Medication Taken|0
5226027|NCT00918749|18039354|P2|Overall Study|No Study Medication Taken|0
5226028|NCT00918749|18039355|P1|Overall Study|No Study Medication Taken|1
5226029|NCT00918749|18039353|P3|Overall Study|Withdrawal by Subject|5
5226030|NCT00918749|18039354|P2|Overall Study|Withdrawal by Subject|3
5226031|NCT00918749|18039355|P1|Overall Study|Withdrawal by Subject|5
5226032|NCT00918749|18039353|P3|Overall Study|Lost to Follow-up|1
5226033|NCT00918749|18039354|P2|Overall Study|Lost to Follow-up|0
5226034|NCT00918749|18039355|P1|Overall Study|Lost to Follow-up|0
5226035|NCT00918749|18039353|P3|Overall Study|Adverse Event|1
5226036|NCT00918749|18039354|P2|Overall Study|Adverse Event|0
5226037|NCT00918749|18039355|P1|Overall Study|Adverse Event|1
5226038|NCT00918736|18039387|P1|Overall Study|Withdrawal by Subject|4
5226039|NCT00918684|18039400|P1|Treatment Phase|Withdrawal by Subject|8
5226040|NCT00918684|18039400|P1|Treatment Phase|Protocol Violation|1
5226041|NCT00918684|18039400|P1|Treatment Phase|Physician Decision|8
5226042|NCT00918684|18039400|P1|Treatment Phase|Lost to Follow-up|2
5226043|NCT00918684|18039400|P1|Treatment Phase|Lack of Efficacy|6
5226044|NCT00918684|18039400|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
5226045|NCT00918645|18039411|P1|Overall Study|Withdrawal by Subject|1
5226046|NCT00918580|18039417|P1|After 6-month FU to 1-year FU|Failed to Return|2
5226047|NCT00918580|18039417|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
5226048|NCT00918580|18039417|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
5226049|NCT00918580|18039417|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
5226050|NCT00918580|18039417|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
5226051|NCT00918580|18039417|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
5226052|NCT00918580|18039417|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
5226053|NCT00918567|18039437|P2|Overall Study|Adverse Event|0
5226054|NCT00918567|18039438|P1|Overall Study|Adverse Event|1
5226055|NCT00918567|18039437|P2|Overall Study|Withdrawal by Subject|1
5226056|NCT00918567|18039438|P1|Overall Study|Withdrawal by Subject|1
5226057|NCT00918567|18039437|P2|Overall Study|Lack of Efficacy|1
5226058|NCT00918567|18039438|P1|Overall Study|Lack of Efficacy|3
5226059|NCT00918463|18039464|P1|Overall Study|Lack of Efficacy|1
5226060|NCT00918463|18039464|P1|Overall Study|Death|1
5226061|NCT00918385|18039472|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
5226062|NCT00918385|18039473|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
5226063|NCT00918385|18039472|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
5226064|NCT00918385|18039473|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
5226065|NCT00918385|18039472|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
5226066|NCT00918385|18039473|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
5226067|NCT00918385|18039472|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
5226068|NCT00918385|18039473|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
5226069|NCT00918385|18039472|P2|Monotherapy|Complicating illness|0
5226070|NCT00918385|18039473|P1|Monotherapy|Complicating illness|1
5226071|NCT00918385|18039472|P2|Monotherapy|Adverse Event|6
5226072|NCT00918385|18039473|P1|Monotherapy|Adverse Event|1
5226073|NCT00918346|18039482|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
5226074|NCT00918346|18039483|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
5226075|NCT00918333|18039499|P2|Overall Study|Withdrawal by Subject|1
5226076|NCT00918333|18039500|P1|Overall Study|Withdrawal by Subject|0
5226077|NCT00918333|18039499|P2|Overall Study|Ineligible|0
5226078|NCT00918333|18039500|P1|Overall Study|Ineligible|1
5226079|NCT00918333|18039499|P2|Overall Study|Inadequate amount of drugs provided|4
5226080|NCT00918333|18039500|P1|Overall Study|Inadequate amount of drugs provided|1
5226081|NCT00918333|18039499|P2|Overall Study|Drug not taken per protocol|0
5226082|NCT00918333|18039500|P1|Overall Study|Drug not taken per protocol|1
5226083|NCT00918281|18039520|P1|Overall Study|Physician Decision|29
5226084|NCT00918255|18039530|P3|Overall Study|Investigator discretion|0
5226085|NCT00918255|18039531|P2|Overall Study|Investigator discretion|0
5226086|NCT00918255|18039532|P1|Overall Study|Investigator discretion|1
5226087|NCT00918255|18039530|P3|Overall Study|Non-compliance|0
5226088|NCT00918255|18039531|P2|Overall Study|Non-compliance|0
5226089|NCT00918255|18039532|P1|Overall Study|Non-compliance|1
5226090|NCT00918255|18039530|P3|Overall Study|Exceeded allowed number of interventions|1
5226091|NCT00918255|18039531|P2|Overall Study|Exceeded allowed number of interventions|0
5226092|NCT00918255|18039532|P1|Overall Study|Exceeded allowed number of interventions|0
5226093|NCT00918255|18039530|P3|Overall Study|Lost to Follow-up|2
5226094|NCT00918255|18039531|P2|Overall Study|Lost to Follow-up|0
5226095|NCT00918255|18039532|P1|Overall Study|Lost to Follow-up|1
5226096|NCT00918255|18039530|P3|Overall Study|Lack of Efficacy|0
5226097|NCT00918255|18039531|P2|Overall Study|Lack of Efficacy|0
5226098|NCT00918255|18039532|P1|Overall Study|Lack of Efficacy|1
5226099|NCT00918255|18039530|P3|Overall Study|Withdrawal by Subject|2
5226100|NCT00918255|18039531|P2|Overall Study|Withdrawal by Subject|0
5226101|NCT00918255|18039532|P1|Overall Study|Withdrawal by Subject|1
5226102|NCT00918255|18039530|P3|Overall Study|Adverse Event|0
5226103|NCT00918255|18039531|P2|Overall Study|Adverse Event|0
5226104|NCT00918255|18039532|P1|Overall Study|Adverse Event|1
5226105|NCT00918203|18039565|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
5226106|NCT00918203|18039566|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
5226107|NCT00918203|18039567|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
5226108|NCT00918203|18039565|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
5226109|NCT00918203|18039566|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
5226110|NCT00918203|18039567|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
5226111|NCT00918203|18039565|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
5226112|NCT00918203|18039566|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
5226113|NCT00918203|18039567|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
5226114|NCT00918203|18039565|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
5226115|NCT00918203|18039566|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
5226116|NCT00918203|18039567|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
5226117|NCT00918138|18039598|P2|Overall Study|Death|0
5226118|NCT00918138|18039599|P1|Overall Study|Death|1
5226119|NCT00918138|18039598|P2|Overall Study|Subject withdrew consent|1
5226120|NCT00918138|18039599|P1|Overall Study|Subject withdrew consent|1
5226121|NCT00917852|18039638|P1|Overall Study|Death|6
5226122|NCT00917644|18039656|P2|Period 2: Second Intervention|family emergency|0
5226123|NCT00917644|18039657|P1|Period 2: Second Intervention|family emergency|1
5226124|NCT00917644|18039656|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
5226125|NCT00917644|18039657|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
5226126|NCT00917644|18039656|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
5226127|NCT00917644|18039657|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
5226128|NCT00917579|18039671|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
5226129|NCT00917579|18039672|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
5226130|NCT00917579|18039671|P2|Washout >= 2 Weeks|Adverse Event|0
5226131|NCT00917579|18039672|P1|Washout >= 2 Weeks|Adverse Event|1
5226132|NCT00917553|18039688|P2|Overall Study|Lost to Follow-up|1
5226133|NCT00917553|18039689|P1|Overall Study|Lost to Follow-up|2
5226134|NCT00917501|18039705|P2|Overall Study|trouble swollowing capsules|1
5226135|NCT00917501|18039706|P1|Overall Study|trouble swollowing capsules|0
5226136|NCT00917501|18039705|P2|Overall Study|Lack of Efficacy|2
5226137|NCT00917501|18039706|P1|Overall Study|Lack of Efficacy|1
5226138|NCT00917501|18039705|P2|Overall Study|Withdrawal by Subject|1
5226139|NCT00917501|18039706|P1|Overall Study|Withdrawal by Subject|3
5226140|NCT00917501|18039705|P2|Overall Study|Lost to Follow-up|1
5226141|NCT00917501|18039706|P1|Overall Study|Lost to Follow-up|4
5226142|NCT00917462|18039712|P1|Overall Study|Clinical Deterioration|1
5226143|NCT00917384|18039722|P2|Overall Study|Withdrawal by Subject|2
5226144|NCT00917384|18039723|P1|Overall Study|Withdrawal by Subject|10
5226145|NCT00917384|18039722|P2|Overall Study|Lost to Follow-up|2
5226146|NCT00917384|18039723|P1|Overall Study|Lost to Follow-up|4
5226147|NCT00917267|18039747|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
5226148|NCT00917267|18039748|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
5226149|NCT00917267|18039747|P2|Overall Study|Sponsor Decision|5
5226150|NCT00917267|18039748|P1|Overall Study|Sponsor Decision|5
5226151|NCT00917267|18039747|P2|Overall Study|Entry Criteria Not Met|0
5226152|NCT00917267|18039748|P1|Overall Study|Entry Criteria Not Met|1
5226153|NCT00917267|18039747|P2|Overall Study|Lost to follow up|2
5226154|NCT00917267|18039748|P1|Overall Study|Lost to follow up|0
5226155|NCT00917267|18039747|P2|Overall Study|Withdrawal by Subject|12
5226156|NCT00917267|18039748|P1|Overall Study|Withdrawal by Subject|5
5226157|NCT00917267|18039747|P2|Overall Study|Protocol Violation|18
5226158|NCT00917267|18039748|P1|Overall Study|Protocol Violation|9
5226159|NCT00917267|18039747|P2|Overall Study|Physician Decision|4
5226160|NCT00917267|18039748|P1|Overall Study|Physician Decision|2
5226161|NCT00917267|18039747|P2|Overall Study|Adverse Event|36
5226162|NCT00917267|18039748|P1|Overall Study|Adverse Event|15
5226163|NCT00917124|18039776|P2|Overall Study|Protocol Violation|6
5226164|NCT00917124|18039777|P1|Overall Study|Protocol Violation|4
5226165|NCT00916929|18039787|P2|Overall Study|Device unable to process impedance data|7
5226166|NCT00916929|18039788|P1|Overall Study|Device unable to process impedance data|0
5226167|NCT00916929|18039787|P2|Overall Study|Moved to another state|1
5226168|NCT00916929|18039788|P1|Overall Study|Moved to another state|0
5226169|NCT00916929|18039787|P2|Overall Study|System explant|0
5226170|NCT00916929|18039788|P1|Overall Study|System explant|1
5226171|NCT00916929|18039787|P2|Overall Study|Transferred to hospice care|1
5226172|NCT00916929|18039788|P1|Overall Study|Transferred to hospice care|1
5226173|NCT00916929|18039787|P2|Overall Study|Left ventricular epicardial lead|2
5226174|NCT00916929|18039788|P1|Overall Study|Left ventricular epicardial lead|1
5226175|NCT00916929|18039787|P2|Overall Study|Withdrawal by Subject|5
5226176|NCT00916929|18039788|P1|Overall Study|Withdrawal by Subject|1
5226177|NCT00916929|18039787|P2|Overall Study|Death|10
5226178|NCT00916929|18039788|P1|Overall Study|Death|5
5226179|NCT00916929|18039787|P2|Overall Study|Lost to Follow-up|3
5226180|NCT00916929|18039788|P1|Overall Study|Lost to Follow-up|1
5226181|NCT00916721|18039798|P2|Overall Study|Protocol Violation|4
5226182|NCT00916721|18039799|P1|Overall Study|Protocol Violation|2
5226183|NCT00916721|18039798|P2|Overall Study|Withdrawal by Subject|2
5226184|NCT00916721|18039799|P1|Overall Study|Withdrawal by Subject|2
5226185|NCT00916721|18039798|P2|Overall Study|Adverse Event|3
5226186|NCT00916721|18039799|P1|Overall Study|Adverse Event|6
5226187|NCT00916721|18039798|P2|Overall Study|Lost to Follow-up|1
5226188|NCT00916721|18039799|P1|Overall Study|Lost to Follow-up|0
5226189|NCT00916617|18039822|P4|Overall Study|Other|2
5226190|NCT00916617|18039823|P3|Overall Study|Other|0
5226191|NCT00916617|18039824|P2|Overall Study|Other|0
5226192|NCT00916617|18039825|P1|Overall Study|Other|2
5226193|NCT00916617|18039822|P4|Overall Study|Lack of Efficacy|0
5226194|NCT00916617|18039823|P3|Overall Study|Lack of Efficacy|0
5226195|NCT00916617|18039824|P2|Overall Study|Lack of Efficacy|0
5226196|NCT00916617|18039825|P1|Overall Study|Lack of Efficacy|1
5226197|NCT00916617|18039822|P4|Overall Study|Lost to Follow-up|0
5226198|NCT00916617|18039823|P3|Overall Study|Lost to Follow-up|0
5226199|NCT00916617|18039824|P2|Overall Study|Lost to Follow-up|1
5226200|NCT00916617|18039825|P1|Overall Study|Lost to Follow-up|2
5226201|NCT00916617|18039822|P4|Overall Study|Discontinuation of Study by Sponsor|1
5226202|NCT00916617|18039823|P3|Overall Study|Discontinuation of Study by Sponsor|3
5226203|NCT00916617|18039824|P2|Overall Study|Discontinuation of Study by Sponsor|13
5226204|NCT00916617|18039825|P1|Overall Study|Discontinuation of Study by Sponsor|8
5226205|NCT00916617|18039822|P4|Overall Study|Physician Decision|0
5226206|NCT00916617|18039823|P3|Overall Study|Physician Decision|0
5226207|NCT00916617|18039824|P2|Overall Study|Physician Decision|1
5226208|NCT00916617|18039825|P1|Overall Study|Physician Decision|1
5226209|NCT00916617|18039822|P4|Overall Study|Caregiver Request|0
5226210|NCT00916617|18039823|P3|Overall Study|Caregiver Request|1
5226211|NCT00916617|18039824|P2|Overall Study|Caregiver Request|2
5226212|NCT00916617|18039825|P1|Overall Study|Caregiver Request|3
5226213|NCT00916617|18039822|P4|Overall Study|Withdrawal by Subject|1
5226214|NCT00916617|18039823|P3|Overall Study|Withdrawal by Subject|0
5226215|NCT00916617|18039824|P2|Overall Study|Withdrawal by Subject|2
5226216|NCT00916617|18039825|P1|Overall Study|Withdrawal by Subject|3
5226217|NCT00916617|18039822|P4|Overall Study|Adverse Event|3
5226218|NCT00916617|18039823|P3|Overall Study|Adverse Event|6
5226219|NCT00916617|18039824|P2|Overall Study|Adverse Event|2
5226220|NCT00916617|18039825|P1|Overall Study|Adverse Event|3
5226221|NCT00916578|18039839|P1|Overall Study|Insurance Denial|2
5226222|NCT00916578|18039839|P1|Overall Study|Withdrawal by Subject|3
5226223|NCT00916578|18039839|P1|Overall Study|Physician Decision|2
5226224|NCT00916383|18039868|P1|Overall Study|Protocol Violation|1
5226225|NCT00916383|18039868|P1|Overall Study|Death|1
5226226|NCT00916383|18039868|P1|Overall Study|Adverse Event|1
5226227|NCT00916370|18039896|P2|Overall Study|Physician Decision|1
5226228|NCT00916370|18039897|P1|Overall Study|Physician Decision|0
5226229|NCT00916370|18039896|P2|Overall Study|Withdrawal by Subject|0
5226230|NCT00916370|18039897|P1|Overall Study|Withdrawal by Subject|2
5226231|NCT00916370|18039896|P2|Overall Study|Death|1
5226232|NCT00916370|18039897|P1|Overall Study|Death|3
5226233|NCT00916357|18040071|P6|Period 2|Weight loss > 3 kilograms (kg)|0
5226234|NCT00916357|18040072|P5|Period 2|Weight loss > 3 kilograms (kg)|0
5226235|NCT00916357|18040073|P4|Period 2|Weight loss > 3 kilograms (kg)|1
5226236|NCT00916357|18040074|P3|Period 2|Weight loss > 3 kilograms (kg)|0
5226237|NCT00916357|18040075|P2|Period 2|Weight loss > 3 kilograms (kg)|0
5226238|NCT00916357|18040076|P1|Period 2|Weight loss > 3 kilograms (kg)|0
5226239|NCT00916357|18040071|P6|Period 1|Withdrawal by Subject|0
5226240|NCT00916357|18040072|P5|Period 1|Withdrawal by Subject|0
5226241|NCT00916357|18040073|P4|Period 1|Withdrawal by Subject|0
5226242|NCT00916357|18040074|P3|Period 1|Withdrawal by Subject|0
5226243|NCT00916357|18040075|P2|Period 1|Withdrawal by Subject|0
5226244|NCT00916357|18040076|P1|Period 1|Withdrawal by Subject|1
5226245|NCT00916344|18040114|P1|Overall Study|Drop-out|5
5226246|NCT00916344|18040114|P1|Overall Study|ICD upgrade|1
5226247|NCT00916344|18040114|P1|Overall Study|Death|2
5226248|NCT00916305|18040121|P2|Overall Study|Withdrawal by Subject|1
5226249|NCT00916305|18040122|P1|Overall Study|Withdrawal by Subject|0
5226250|NCT00916305|18040121|P2|Overall Study|Lost to Follow-up|27
5226251|NCT00916305|18040122|P1|Overall Study|Lost to Follow-up|21
5226252|NCT00916279|18040130|P1|Overall Study|Lost to Follow-up|2
5226253|NCT00916279|18040130|P1|Overall Study|Death|2
5226254|NCT00916149|18040141|P3|Overall Study|Unable to place scalp EEG leads|0
5226255|NCT00916149|18040142|P2|Overall Study|Unable to place scalp EEG leads|0
5226256|NCT00916149|18040143|P1|Overall Study|Unable to place scalp EEG leads|1
5226257|NCT00916149|18040141|P3|Overall Study|Lost to Follow-up|0
5226258|NCT00916149|18040142|P2|Overall Study|Lost to Follow-up|2
5226259|NCT00916149|18040143|P1|Overall Study|Lost to Follow-up|3
5226260|NCT00916058|18040230|P7|Phase 2|Screen Failure|3
5226261|NCT00916058|18040231|P6|Phase 2|Screen Failure|0
5226262|NCT00916058|18040232|P5|Phase 2|Screen Failure|0
5226263|NCT00916058|18040233|P4|Phase 2|Screen Failure|0
5226264|NCT00916058|18040234|P3|Phase 2|Screen Failure|0
5226265|NCT00916058|18040235|P2|Phase 2|Screen Failure|0
5226266|NCT00916058|18040236|P1|Phase 2|Screen Failure|0
5226267|NCT00916058|18040230|P7|Phase 1|Screen Failure|0
5226268|NCT00916058|18040231|P6|Phase 1|Screen Failure|1
5226269|NCT00916058|18040232|P5|Phase 1|Screen Failure|0
5226270|NCT00916058|18040233|P4|Phase 1|Screen Failure|0
5226271|NCT00916058|18040234|P3|Phase 1|Screen Failure|0
5226272|NCT00916058|18040235|P2|Phase 1|Screen Failure|0
5226273|NCT00916058|18040236|P1|Phase 1|Screen Failure|0
5226274|NCT00916006|18040299|P2|Overall Study|Protocol Violation|1
5226275|NCT00916006|18040300|P1|Overall Study|Protocol Violation|0
5226276|NCT00916006|18040299|P2|Overall Study|Withdrawal by Subject|5
5226277|NCT00916006|18040300|P1|Overall Study|Withdrawal by Subject|2
5226278|NCT00916006|18040299|P2|Overall Study|Adverse Event|1
5226279|NCT00916006|18040300|P1|Overall Study|Adverse Event|1
5226280|NCT00915876|18040362|P2|Overall Study|Adverse Event|1
5226281|NCT00915876|18040363|P1|Overall Study|Adverse Event|0
5226282|NCT00915772|18040399|P3|Overall Study|Any other reason|7
5226283|NCT00915772|18040400|P2|Overall Study|Any other reason|7
5226284|NCT00915772|18040401|P1|Overall Study|Any other reason|4
5226285|NCT00915772|18040399|P3|Overall Study|Refused to continue trial medication|4
5226286|NCT00915772|18040400|P2|Overall Study|Refused to continue trial medication|8
5226287|NCT00915772|18040401|P1|Overall Study|Refused to continue trial medication|6
5226288|NCT00915772|18040399|P3|Overall Study|Lack of Efficacy|3
5226289|NCT00915772|18040400|P2|Overall Study|Lack of Efficacy|15
5226290|NCT00915772|18040401|P1|Overall Study|Lack of Efficacy|9
5226291|NCT00915772|18040399|P3|Overall Study|Lost to Follow-up|2
5226292|NCT00915772|18040400|P2|Overall Study|Lost to Follow-up|2
5226293|NCT00915772|18040401|P1|Overall Study|Lost to Follow-up|1
5226294|NCT00915772|18040399|P3|Overall Study|Protocol Violation|2
5226295|NCT00915772|18040400|P2|Overall Study|Protocol Violation|1
5226296|NCT00915772|18040401|P1|Overall Study|Protocol Violation|4
5226297|NCT00915772|18040399|P3|Overall Study|Adverse Event|11
5226298|NCT00915772|18040400|P2|Overall Study|Adverse Event|13
5226299|NCT00915772|18040401|P1|Overall Study|Adverse Event|12
5226300|NCT00915551|18040500|P2|Overall Study|Withdrawal by Subject|1
5226301|NCT00915551|18040501|P1|Overall Study|Withdrawal by Subject|0
5226302|NCT00915525|18040522|P2|Overall Study|Patient Moved|9
5226303|NCT00915525|18040523|P1|Overall Study|Patient Moved|15
5226304|NCT00915525|18040522|P2|Overall Study|Non-Compliance|1
5226305|NCT00915525|18040523|P1|Overall Study|Non-Compliance|3
5226306|NCT00915525|18040522|P2|Overall Study|Study Burden|12
5226307|NCT00915525|18040523|P1|Overall Study|Study Burden|28
5226308|NCT00915525|18040522|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
5226309|NCT00915525|18040523|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
5226310|NCT00915525|18040522|P2|Overall Study|Site Closed|9
5226311|NCT00915525|18040523|P1|Overall Study|Site Closed|27
5226312|NCT00915525|18040522|P2|Overall Study|Other Reason|12
5226313|NCT00915525|18040523|P1|Overall Study|Other Reason|35
5226314|NCT00915525|18040522|P2|Overall Study|Missing|1
5226315|NCT00915525|18040523|P1|Overall Study|Missing|12
5226316|NCT00915525|18040522|P2|Overall Study|Adverse Event|13
5226317|NCT00915525|18040523|P1|Overall Study|Adverse Event|29
5226318|NCT00915525|18040522|P2|Overall Study|Lack of Efficacy|32
5226319|NCT00915525|18040523|P1|Overall Study|Lack of Efficacy|15
5226320|NCT00915525|18040522|P2|Overall Study|Pregnancy|0
5226321|NCT00915525|18040523|P1|Overall Study|Pregnancy|2
5226322|NCT00915525|18040522|P2|Overall Study|Lost to Follow-up|16
5226323|NCT00915525|18040523|P1|Overall Study|Lost to Follow-up|27
5226324|NCT00915525|18040522|P2|Overall Study|Withdrawal by Subject|21
5226325|NCT00915525|18040523|P1|Overall Study|Withdrawal by Subject|59
5226326|NCT00915525|18040522|P2|Overall Study|Protocol Violation|4
5226327|NCT00915525|18040523|P1|Overall Study|Protocol Violation|9
5226328|NCT00915473|18040637|P2|4-week Follow Up|Lost to Follow-up|5
5226329|NCT00915473|18040638|P1|4-week Follow Up|Lost to Follow-up|1
5226330|NCT00915473|18040637|P2|Screening|Withdrawal by Subject|0
5226331|NCT00915473|18040638|P1|Screening|Withdrawal by Subject|1
5226332|NCT00915356|18040655|P5|Overall Study|Withdrawal by Subject|0
5226333|NCT00915356|18040656|P4|Overall Study|Withdrawal by Subject|0
5226334|NCT00915356|18040657|P3|Overall Study|Withdrawal by Subject|0
5226335|NCT00915356|18040658|P2|Overall Study|Withdrawal by Subject|0
5226336|NCT00915356|18040659|P1|Overall Study|Withdrawal by Subject|1
5226337|NCT00915343|18040721|P3|Part B - Open Label Period|Did not attend the last visit|1
5226338|NCT00915343|18040722|P2|Part B - Open Label Period|Did not attend the last visit|0
5226339|NCT00915343|18040723|P1|Part B - Open Label Period|Did not attend the last visit|0
5226340|NCT00915343|18040721|P3|Part B - Open Label Period|Treatment switch|1
5226341|NCT00915343|18040722|P2|Part B - Open Label Period|Treatment switch|0
5226342|NCT00915343|18040723|P1|Part B - Open Label Period|Treatment switch|0
5226343|NCT00915278|18040808|P6|Overall Study|Admission to hospice|0
5226344|NCT00915278|18040809|P5|Overall Study|Admission to hospice|0
5226345|NCT00915278|18040810|P4|Overall Study|Admission to hospice|0
5226346|NCT00915278|18040811|P3|Overall Study|Admission to hospice|1
5226347|NCT00915278|18040812|P2|Overall Study|Admission to hospice|0
5226348|NCT00915278|18040813|P1|Overall Study|Admission to hospice|0
5226349|NCT00915278|18040808|P6|Overall Study|Infusion related AEs|2
5226350|NCT00915278|18040809|P5|Overall Study|Infusion related AEs|0
5226351|NCT00915278|18040810|P4|Overall Study|Infusion related AEs|0
5226352|NCT00915278|18040811|P3|Overall Study|Infusion related AEs|0
5226353|NCT00915278|18040812|P2|Overall Study|Infusion related AEs|0
5226354|NCT00915278|18040813|P1|Overall Study|Infusion related AEs|0
5226355|NCT00915278|18040808|P6|Overall Study|Progressive disease/clinical progression|2
5226356|NCT00915278|18040809|P5|Overall Study|Progressive disease/clinical progression|1
5226357|NCT00915278|18040810|P4|Overall Study|Progressive disease/clinical progression|3
5226358|NCT00915278|18040811|P3|Overall Study|Progressive disease/clinical progression|0
5226359|NCT00915278|18040812|P2|Overall Study|Progressive disease/clinical progression|0
5226360|NCT00915278|18040813|P1|Overall Study|Progressive disease/clinical progression|0
5226361|NCT00915278|18040808|P6|Overall Study|Adverse Event|0
5226362|NCT00915278|18040809|P5|Overall Study|Adverse Event|0
5226363|NCT00915278|18040810|P4|Overall Study|Adverse Event|0
5226364|NCT00915278|18040811|P3|Overall Study|Adverse Event|0
5226365|NCT00915278|18040812|P2|Overall Study|Adverse Event|1
5226366|NCT00915278|18040813|P1|Overall Study|Adverse Event|4
5226367|NCT00915278|18040808|P6|Overall Study|Withdrawal by Subject|4
5226368|NCT00915278|18040809|P5|Overall Study|Withdrawal by Subject|1
5226369|NCT00915278|18040810|P4|Overall Study|Withdrawal by Subject|0
5226370|NCT00915278|18040811|P3|Overall Study|Withdrawal by Subject|0
5226371|NCT00915278|18040812|P2|Overall Study|Withdrawal by Subject|1
5226372|NCT00915278|18040813|P1|Overall Study|Withdrawal by Subject|0
5226373|NCT00915278|18040808|P6|Overall Study|Lost to Follow-up|0
5226374|NCT00915278|18040809|P5|Overall Study|Lost to Follow-up|0
5226375|NCT00915278|18040810|P4|Overall Study|Lost to Follow-up|0
5226376|NCT00915278|18040811|P3|Overall Study|Lost to Follow-up|0
5226377|NCT00915278|18040812|P2|Overall Study|Lost to Follow-up|1
5226378|NCT00915278|18040813|P1|Overall Study|Lost to Follow-up|0
5226379|NCT00915278|18040808|P6|Overall Study|Death|0
5226380|NCT00915278|18040809|P5|Overall Study|Death|0
5226381|NCT00915278|18040810|P4|Overall Study|Death|0
5226382|NCT00915278|18040811|P3|Overall Study|Death|0
5226383|NCT00915278|18040812|P2|Overall Study|Death|0
5226384|NCT00915278|18040813|P1|Overall Study|Death|1
5226385|NCT00915018|18040974|P2|Overall Study|By Sponsor due to Protocol Amendment|105
5226386|NCT00915018|18040975|P1|Overall Study|By Sponsor due to Protocol Amendment|92
5226387|NCT00915018|18040974|P2|Overall Study|Withdrawal by Subject|27
5226388|NCT00915018|18040975|P1|Overall Study|Withdrawal by Subject|38
5226389|NCT00915018|18040974|P2|Overall Study|Lost to Follow-up|5
5226390|NCT00915018|18040975|P1|Overall Study|Lost to Follow-up|10
5226391|NCT00915018|18040974|P2|Overall Study|Death|70
5226392|NCT00915018|18040975|P1|Overall Study|Death|75
5226393|NCT00915005|18040991|P2|Overall Study|Insurance denial|15
5226394|NCT00915005|18040992|P1|Overall Study|Insurance denial|3
5226395|NCT00915005|18040991|P2|Overall Study|Patient preferred protons therapy|0
5226396|NCT00915005|18040992|P1|Overall Study|Patient preferred protons therapy|6
5226397|NCT00915005|18040991|P2|Overall Study|Withdrawal by Subject|4
5226398|NCT00915005|18040992|P1|Overall Study|Withdrawal by Subject|4
5226399|NCT00914966|18041000|P1|Step 2: 2000 Units|Withdrawal by Subject|1
5226400|NCT00914966|18041000|P1|Step 1: 1500 Units|Physician Decision|1
5226401|NCT00914966|18041000|P1|Step 1: 1500 Units|Withdrawal by Subject|1
5226402|NCT00914940|18041012|P1|2 Years to 5 Years Post-transplant|Death|3
5226403|NCT00914940|18041012|P1|D101 to 2 Years Post-transplant|Death|8
5226404|NCT00914940|18041012|P1|D0 to D100 Post-transplant|Death|2
5226405|NCT00914927|18041027|P7|Overall Study|Administrative/Other|0
5226406|NCT00914927|18041028|P6|Overall Study|Administrative/Other|0
5226407|NCT00914927|18041029|P5|Overall Study|Administrative/Other|1
5226408|NCT00914927|18041030|P4|Overall Study|Administrative/Other|0
5226409|NCT00914927|18041031|P3|Overall Study|Administrative/Other|0
5226410|NCT00914927|18041032|P2|Overall Study|Administrative/Other|1
5226411|NCT00914927|18041033|P1|Overall Study|Administrative/Other|2
5226412|NCT00914927|18041027|P7|Overall Study|Lost to Follow-up|0
5226413|NCT00914927|18041028|P6|Overall Study|Lost to Follow-up|0
5226414|NCT00914927|18041029|P5|Overall Study|Lost to Follow-up|0
5226415|NCT00914927|18041030|P4|Overall Study|Lost to Follow-up|1
5226416|NCT00914927|18041031|P3|Overall Study|Lost to Follow-up|0
5226417|NCT00914927|18041032|P2|Overall Study|Lost to Follow-up|0
5226418|NCT00914927|18041033|P1|Overall Study|Lost to Follow-up|0
5226419|NCT00914927|18041027|P7|Overall Study|Withdrawal by Subject|0
5226420|NCT00914927|18041028|P6|Overall Study|Withdrawal by Subject|0
5226421|NCT00914927|18041029|P5|Overall Study|Withdrawal by Subject|0
5226422|NCT00914927|18041030|P4|Overall Study|Withdrawal by Subject|1
5226423|NCT00914927|18041031|P3|Overall Study|Withdrawal by Subject|0
5226424|NCT00914927|18041032|P2|Overall Study|Withdrawal by Subject|1
5226425|NCT00914927|18041033|P1|Overall Study|Withdrawal by Subject|0
5226426|NCT00914927|18041027|P7|Overall Study|Adverse Event|0
5226427|NCT00914927|18041028|P6|Overall Study|Adverse Event|0
5226428|NCT00914927|18041029|P5|Overall Study|Adverse Event|1
5226429|NCT00914927|18041030|P4|Overall Study|Adverse Event|0
5226430|NCT00914927|18041031|P3|Overall Study|Adverse Event|0
5226431|NCT00914927|18041032|P2|Overall Study|Adverse Event|0
5226432|NCT00914927|18041033|P1|Overall Study|Adverse Event|0
5226433|NCT00914849|18041160|P2|Overall Study|Not eligible|1
5226434|NCT00914849|18041161|P1|Overall Study|Not eligible|0
5226435|NCT00914849|18041160|P2|Overall Study|Withdrawal by Subject|0
5226436|NCT00914849|18041161|P1|Overall Study|Withdrawal by Subject|1
5226437|NCT00914810|18041195|P2|Overall Study|Hospitalized and unable to follow up.|1
5226438|NCT00914810|18041196|P1|Overall Study|Hospitalized and unable to follow up.|0
5226439|NCT00914810|18041195|P2|Overall Study|Relocated out of state|0
5226440|NCT00914810|18041196|P1|Overall Study|Relocated out of state|1
5226441|NCT00914810|18041195|P2|Overall Study|Withdrawal by Subject|0
5226442|NCT00914810|18041196|P1|Overall Study|Withdrawal by Subject|1
5226443|NCT00914589|18041207|P3|Overall Study|Death|1
5226444|NCT00914589|18041208|P2|Overall Study|Death|1
5226445|NCT00914589|18041209|P1|Overall Study|Death|0
5226446|NCT00914589|18041207|P3|Overall Study|unclassified|7
5226447|NCT00914589|18041208|P2|Overall Study|unclassified|9
5226448|NCT00914589|18041209|P1|Overall Study|unclassified|16
5226449|NCT00914589|18041207|P3|Overall Study|Protocol Violation|3
5226450|NCT00914589|18041208|P2|Overall Study|Protocol Violation|6
5226451|NCT00914589|18041209|P1|Overall Study|Protocol Violation|8
5226452|NCT00914589|18041207|P3|Overall Study|Adverse Event|1
5226453|NCT00914589|18041208|P2|Overall Study|Adverse Event|0
5226454|NCT00914589|18041209|P1|Overall Study|Adverse Event|1
5226455|NCT00914459|18041235|P2|Overall Study|Parent/Legal guardian request|0
5226456|NCT00914459|18041236|P1|Overall Study|Parent/Legal guardian request|1
5226457|NCT00914459|18041235|P2|Overall Study|Protocol Violation|1
5226458|NCT00914459|18041236|P1|Overall Study|Protocol Violation|0
5226459|NCT00914316|18041266|P4|Phase 2|Withdrawal by Subject|0
5226460|NCT00914316|18041267|P3|Phase 2|Withdrawal by Subject|1
5226461|NCT00914316|18041268|P2|Phase 2|Withdrawal by Subject|0
5226462|NCT00914316|18041269|P1|Phase 2|Withdrawal by Subject|1
5226463|NCT00914316|18041266|P4|Phase 1|Adverse Event|0
5226464|NCT00914316|18041267|P3|Phase 1|Adverse Event|0
5226465|NCT00914316|18041268|P2|Phase 1|Adverse Event|0
5226466|NCT00914316|18041269|P1|Phase 1|Adverse Event|1
5226467|NCT00914316|18041266|P4|Phase 1|Withdrawal by Subject|0
5226468|NCT00914316|18041267|P3|Phase 1|Withdrawal by Subject|4
5226469|NCT00914316|18041268|P2|Phase 1|Withdrawal by Subject|2
5226470|NCT00914316|18041269|P1|Phase 1|Withdrawal by Subject|0
5226471|NCT00914316|18041266|P4|Phase 1|Physician Decision|2
5226472|NCT00914316|18041267|P3|Phase 1|Physician Decision|1
5226473|NCT00914316|18041268|P2|Phase 1|Physician Decision|0
5226474|NCT00914316|18041269|P1|Phase 1|Physician Decision|4
5226475|NCT00913978|18041341|P2|Overall Study|Surgeon choice|3
5226476|NCT00913978|18041342|P1|Overall Study|Surgeon choice|1
5226477|NCT00913835|18041359|P2|Lip Dox: Olaratumab Monotherapy|Other|3
5226478|NCT00913835|18041360|P1|Lip Dox: Olaratumab Monotherapy|Other|0
5226479|NCT00913835|18041359|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
5226480|NCT00913835|18041360|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
5226481|NCT00913835|18041359|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
5226482|NCT00913835|18041360|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
5226483|NCT00913835|18041359|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
5226484|NCT00913835|18041360|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
5226485|NCT00913835|18041359|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
5226486|NCT00913835|18041360|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
5226487|NCT00913770|18041399|P3|Overall Study|Refused|8
5226488|NCT00913770|18041400|P2|Overall Study|Refused|10
5226489|NCT00913770|18041401|P1|Overall Study|Refused|11
5226490|NCT00913770|18041399|P3|Overall Study|Unable to contact|13
5226491|NCT00913770|18041400|P2|Overall Study|Unable to contact|19
5226492|NCT00913770|18041401|P1|Overall Study|Unable to contact|24
5226493|NCT00913744|18041414|P2|Overall Study|Death|0
5226494|NCT00913744|18041415|P1|Overall Study|Death|1
5226495|NCT00913744|18041414|P2|Overall Study|Withdrawal by Subject|1
5226496|NCT00913744|18041415|P1|Overall Study|Withdrawal by Subject|2
5226497|NCT00913744|18041414|P2|Overall Study|Adverse Event|0
5226498|NCT00913744|18041415|P1|Overall Study|Adverse Event|2
5226499|NCT00913692|18041421|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
5226500|NCT00913692|18041421|P1|Screening (4 Months)|Not eligible after screening phase.|6
5226501|NCT00913692|18041421|P1|Screening (4 Months)|Physician Decision|3
5226502|NCT00913523|18041515|P3|Overall Study|Inadequate Number of Tampons Used|3
5226503|NCT00913523|18041516|P2|Overall Study|Inadequate Number of Tampons Used|2
5226504|NCT00913523|18041517|P1|Overall Study|Inadequate Number of Tampons Used|7
5226505|NCT00913523|18041515|P3|Overall Study|Pregnancy|0
5226506|NCT00913523|18041516|P2|Overall Study|Pregnancy|3
5226507|NCT00913523|18041517|P1|Overall Study|Pregnancy|1
5226508|NCT00913523|18041515|P3|Overall Study|Protocol Violation|8
5226509|NCT00913523|18041516|P2|Overall Study|Protocol Violation|8
5226510|NCT00913523|18041517|P1|Overall Study|Protocol Violation|5
5226511|NCT00913523|18041515|P3|Overall Study|Adverse Event|0
5226512|NCT00913523|18041516|P2|Overall Study|Adverse Event|0
5226513|NCT00913523|18041517|P1|Overall Study|Adverse Event|1
5226514|NCT00913523|18041515|P3|Overall Study|Lost to Follow-up|1
5226515|NCT00913523|18041516|P2|Overall Study|Lost to Follow-up|1
5226516|NCT00913523|18041517|P1|Overall Study|Lost to Follow-up|1
5226517|NCT00913523|18041515|P3|Overall Study|Withdrawal by Subject|2
5226518|NCT00913523|18041516|P2|Overall Study|Withdrawal by Subject|2
5226519|NCT00913523|18041517|P1|Overall Study|Withdrawal by Subject|3
5226520|NCT00913458|18041549|P7|Phase 3|Unsatisfactory Response per Investigator|4
5226521|NCT00913458|18041550|P6|Phase 3|Unsatisfactory Response per Investigator|11
5226522|NCT00913458|18041551|P5|Phase 3|Unsatisfactory Response per Investigator|14
5226523|NCT00913458|18041552|P4|Phase 3|Unsatisfactory Response per Investigator|0
5226524|NCT00913458|18041553|P3|Phase 3|Unsatisfactory Response per Investigator|0
5226525|NCT00913458|18041554|P2|Phase 3|Unsatisfactory Response per Investigator|0
5226526|NCT00913458|18041555|P1|Phase 3|Unsatisfactory Response per Investigator|0
5226527|NCT00913458|18041549|P7|Phase 3|Withdrawal by Subject|0
5226528|NCT00913458|18041550|P6|Phase 3|Withdrawal by Subject|2
5226529|NCT00913458|18041551|P5|Phase 3|Withdrawal by Subject|1
5226530|NCT00913458|18041552|P4|Phase 3|Withdrawal by Subject|0
5226531|NCT00913458|18041553|P3|Phase 3|Withdrawal by Subject|0
5226532|NCT00913458|18041554|P2|Phase 3|Withdrawal by Subject|0
5226533|NCT00913458|18041555|P1|Phase 3|Withdrawal by Subject|0
5226534|NCT00913458|18041549|P7|Phase 3|Non-Responder|3
5226535|NCT00913458|18041550|P6|Phase 3|Non-Responder|1
5226536|NCT00913458|18041551|P5|Phase 3|Non-Responder|0
5226537|NCT00913458|18041552|P4|Phase 3|Non-Responder|0
5226538|NCT00913458|18041553|P3|Phase 3|Non-Responder|0
5226539|NCT00913458|18041554|P2|Phase 3|Non-Responder|0
5226540|NCT00913458|18041555|P1|Phase 3|Non-Responder|0
5226541|NCT00913458|18041549|P7|Phase 3|Lost to Follow-up|0
5226542|NCT00913458|18041550|P6|Phase 3|Lost to Follow-up|0
5226543|NCT00913458|18041551|P5|Phase 3|Lost to Follow-up|2
5226544|NCT00913458|18041552|P4|Phase 3|Lost to Follow-up|0
5226545|NCT00913458|18041553|P3|Phase 3|Lost to Follow-up|0
5226546|NCT00913458|18041554|P2|Phase 3|Lost to Follow-up|0
5226547|NCT00913458|18041555|P1|Phase 3|Lost to Follow-up|0
5226548|NCT00913458|18041549|P7|Phase 3|Adverse Event|1
5226549|NCT00913458|18041550|P6|Phase 3|Adverse Event|4
5226550|NCT00913458|18041551|P5|Phase 3|Adverse Event|5
5226551|NCT00913458|18041552|P4|Phase 3|Adverse Event|0
5226552|NCT00913458|18041553|P3|Phase 3|Adverse Event|0
5226553|NCT00913458|18041554|P2|Phase 3|Adverse Event|0
5226554|NCT00913458|18041555|P1|Phase 3|Adverse Event|0
5226555|NCT00913458|18041549|P7|Phase 2|Unsatisfactory Response per Investigator|0
5226556|NCT00913458|18041550|P6|Phase 2|Unsatisfactory Response per Investigator|0
5226557|NCT00913458|18041551|P5|Phase 2|Unsatisfactory Response per Investigator|0
5226558|NCT00913458|18041552|P4|Phase 2|Unsatisfactory Response per Investigator|17
5226559|NCT00913458|18041553|P3|Phase 2|Unsatisfactory Response per Investigator|11
5226560|NCT00913458|18041554|P2|Phase 2|Unsatisfactory Response per Investigator|0
5226561|NCT00913458|18041555|P1|Phase 2|Unsatisfactory Response per Investigator|0
5226562|NCT00913458|18041549|P7|Phase 2|Protocol Violation|0
5226563|NCT00913458|18041550|P6|Phase 2|Protocol Violation|0
5226564|NCT00913458|18041551|P5|Phase 2|Protocol Violation|0
5226565|NCT00913458|18041552|P4|Phase 2|Protocol Violation|0
5226566|NCT00913458|18041553|P3|Phase 2|Protocol Violation|0
5226567|NCT00913458|18041554|P2|Phase 2|Protocol Violation|2
5226568|NCT00913458|18041555|P1|Phase 2|Protocol Violation|0
5226569|NCT00913458|18041549|P7|Phase 2|Lost to Follow-up|0
5226570|NCT00913458|18041550|P6|Phase 2|Lost to Follow-up|0
5226571|NCT00913458|18041551|P5|Phase 2|Lost to Follow-up|0
5226572|NCT00913458|18041552|P4|Phase 2|Lost to Follow-up|1
5226573|NCT00913458|18041553|P3|Phase 2|Lost to Follow-up|0
5226574|NCT00913458|18041554|P2|Phase 2|Lost to Follow-up|0
5226575|NCT00913458|18041555|P1|Phase 2|Lost to Follow-up|0
5226576|NCT00913458|18041549|P7|Phase 2|Adverse Event|0
5226577|NCT00913458|18041550|P6|Phase 2|Adverse Event|0
5226578|NCT00913458|18041551|P5|Phase 2|Adverse Event|0
5226579|NCT00913458|18041552|P4|Phase 2|Adverse Event|1
5226580|NCT00913458|18041553|P3|Phase 2|Adverse Event|0
5226581|NCT00913458|18041554|P2|Phase 2|Adverse Event|3
5226582|NCT00913458|18041555|P1|Phase 2|Adverse Event|0
5226583|NCT00913458|18041549|P7|Phase 2|Subject Request|0
5226584|NCT00913458|18041550|P6|Phase 2|Subject Request|0
5226585|NCT00913458|18041551|P5|Phase 2|Subject Request|0
5226586|NCT00913458|18041552|P4|Phase 2|Subject Request|2
5226587|NCT00913458|18041553|P3|Phase 2|Subject Request|1
5226588|NCT00913458|18041554|P2|Phase 2|Subject Request|0
5226589|NCT00913458|18041555|P1|Phase 2|Subject Request|0
5226590|NCT00913458|18041549|P7|Phase 2|Non-Responder|0
5226591|NCT00913458|18041550|P6|Phase 2|Non-Responder|0
5226592|NCT00913458|18041551|P5|Phase 2|Non-Responder|0
5226593|NCT00913458|18041552|P4|Phase 2|Non-Responder|12
5226594|NCT00913458|18041553|P3|Phase 2|Non-Responder|7
5226595|NCT00913458|18041554|P2|Phase 2|Non-Responder|5
5226596|NCT00913458|18041555|P1|Phase 2|Non-Responder|0
5226597|NCT00913458|18041549|P7|Phase 1|Unsatisfactory Response per Investigator|0
5226598|NCT00913458|18041550|P6|Phase 1|Unsatisfactory Response per Investigator|0
5226599|NCT00913458|18041551|P5|Phase 1|Unsatisfactory Response per Investigator|0
5226600|NCT00913458|18041552|P4|Phase 1|Unsatisfactory Response per Investigator|0
5226601|NCT00913458|18041553|P3|Phase 1|Unsatisfactory Response per Investigator|0
5226602|NCT00913458|18041554|P2|Phase 1|Unsatisfactory Response per Investigator|0
5226603|NCT00913458|18041555|P1|Phase 1|Unsatisfactory Response per Investigator|7
5226604|NCT00913458|18041549|P7|Phase 1|Sponsor|0
5226605|NCT00913458|18041550|P6|Phase 1|Sponsor|0
5226606|NCT00913458|18041551|P5|Phase 1|Sponsor|0
5226607|NCT00913458|18041552|P4|Phase 1|Sponsor|0
5226608|NCT00913458|18041553|P3|Phase 1|Sponsor|0
5226609|NCT00913458|18041554|P2|Phase 1|Sponsor|0
5226610|NCT00913458|18041555|P1|Phase 1|Sponsor|2
5226611|NCT00913458|18041549|P7|Phase 1|Protocol Violation|0
5226612|NCT00913458|18041550|P6|Phase 1|Protocol Violation|0
5226613|NCT00913458|18041551|P5|Phase 1|Protocol Violation|0
5226614|NCT00913458|18041552|P4|Phase 1|Protocol Violation|0
5226615|NCT00913458|18041553|P3|Phase 1|Protocol Violation|0
5226616|NCT00913458|18041554|P2|Phase 1|Protocol Violation|0
5226617|NCT00913458|18041555|P1|Phase 1|Protocol Violation|10
5226618|NCT00913458|18041549|P7|Phase 1|Lost to Follow-up|0
5226619|NCT00913458|18041550|P6|Phase 1|Lost to Follow-up|0
5226620|NCT00913458|18041551|P5|Phase 1|Lost to Follow-up|0
5226621|NCT00913458|18041552|P4|Phase 1|Lost to Follow-up|0
5226622|NCT00913458|18041553|P3|Phase 1|Lost to Follow-up|0
5226623|NCT00913458|18041554|P2|Phase 1|Lost to Follow-up|0
5226624|NCT00913458|18041555|P1|Phase 1|Lost to Follow-up|2
5226625|NCT00913458|18041549|P7|Phase 1|Adverse Event|0
5226626|NCT00913458|18041550|P6|Phase 1|Adverse Event|0
5226627|NCT00913458|18041551|P5|Phase 1|Adverse Event|0
5226628|NCT00913458|18041552|P4|Phase 1|Adverse Event|0
5226629|NCT00913458|18041553|P3|Phase 1|Adverse Event|0
5226630|NCT00913458|18041554|P2|Phase 1|Adverse Event|0
5226631|NCT00913458|18041555|P1|Phase 1|Adverse Event|20
5226632|NCT00913458|18041549|P7|Phase 1|Subject Request|0
5226633|NCT00913458|18041550|P6|Phase 1|Subject Request|0
5226634|NCT00913458|18041551|P5|Phase 1|Subject Request|0
5226635|NCT00913458|18041552|P4|Phase 1|Subject Request|0
5226636|NCT00913458|18041553|P3|Phase 1|Subject Request|0
5226637|NCT00913458|18041554|P2|Phase 1|Subject Request|0
5226638|NCT00913458|18041555|P1|Phase 1|Subject Request|17
5226639|NCT00913458|18041549|P7|Phase 1|Non-Responder|0
5226640|NCT00913458|18041550|P6|Phase 1|Non-Responder|0
5226641|NCT00913458|18041551|P5|Phase 1|Non-Responder|0
5226642|NCT00913458|18041552|P4|Phase 1|Non-Responder|0
5226643|NCT00913458|18041553|P3|Phase 1|Non-Responder|0
5226644|NCT00913458|18041554|P2|Phase 1|Non-Responder|0
5226645|NCT00913458|18041555|P1|Phase 1|Non-Responder|54
5226646|NCT00913380|18041648|P2|Clinical Outcomes|Lost to Follow-up|6
5226647|NCT00913380|18041649|P1|Clinical Outcomes|Lost to Follow-up|6
5226648|NCT00912964|18041728|P3|Overall Study|Randomized but never received study drug|0
5226649|NCT00912964|18041729|P2|Overall Study|Randomized but never received study drug|1
5226650|NCT00912964|18041730|P1|Overall Study|Randomized but never received study drug|0
5226651|NCT00912964|18041728|P3|Overall Study|Violation of exclusion criterion|2
5226652|NCT00912964|18041729|P2|Overall Study|Violation of exclusion criterion|0
5226653|NCT00912964|18041730|P1|Overall Study|Violation of exclusion criterion|0
5226654|NCT00912964|18041728|P3|Overall Study|Non-compliance with study procedures|0
5226655|NCT00912964|18041729|P2|Overall Study|Non-compliance with study procedures|0
5226656|NCT00912964|18041730|P1|Overall Study|Non-compliance with study procedures|2
5226657|NCT00912964|18041728|P3|Overall Study|Medical History|0
5226658|NCT00912964|18041729|P2|Overall Study|Medical History|0
5226659|NCT00912964|18041730|P1|Overall Study|Medical History|1
5226660|NCT00912964|18041728|P3|Overall Study|Taking exclusionary medications|8
5226661|NCT00912964|18041729|P2|Overall Study|Taking exclusionary medications|4
5226662|NCT00912964|18041730|P1|Overall Study|Taking exclusionary medications|7
5226663|NCT00912964|18041728|P3|Overall Study|Protocol Violation|8
5226664|NCT00912964|18041729|P2|Overall Study|Protocol Violation|3
5226665|NCT00912964|18041730|P1|Overall Study|Protocol Violation|5
5226666|NCT00912964|18041728|P3|Overall Study|Lost to Follow-up|3
5226667|NCT00912964|18041729|P2|Overall Study|Lost to Follow-up|3
5226668|NCT00912964|18041730|P1|Overall Study|Lost to Follow-up|4
5226669|NCT00912964|18041728|P3|Overall Study|Withdrawal by Subject|18
5226670|NCT00912964|18041729|P2|Overall Study|Withdrawal by Subject|12
5226671|NCT00912964|18041730|P1|Overall Study|Withdrawal by Subject|20
5226672|NCT00912964|18041728|P3|Overall Study|Lack of Efficacy|3
5226673|NCT00912964|18041729|P2|Overall Study|Lack of Efficacy|4
5226674|NCT00912964|18041730|P1|Overall Study|Lack of Efficacy|11
5226675|NCT00912964|18041728|P3|Overall Study|Adverse Event|12
5226676|NCT00912964|18041729|P2|Overall Study|Adverse Event|18
5226677|NCT00912964|18041730|P1|Overall Study|Adverse Event|15
5226678|NCT00912964|18041728|P3|Overall Study|Eligibility criterion not met|0
5226679|NCT00912964|18041729|P2|Overall Study|Eligibility criterion not met|1
5226680|NCT00912964|18041730|P1|Overall Study|Eligibility criterion not met|1
5226681|NCT00912912|18041873|P1|Overall Study|Disease Progression|3
5226682|NCT00912912|18041873|P1|Overall Study|Withdrawal by Subject|1
5226683|NCT00912808|18041879|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
5226684|NCT00912808|18041880|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
5226685|NCT00912808|18041879|P2|Second Intervention (6 Weeks)|Adverse Event|1
5226686|NCT00912808|18041880|P1|Second Intervention (6 Weeks)|Adverse Event|0
5226687|NCT00912808|18041879|P2|Washout|Withdrawal by Subject|1
5226688|NCT00912808|18041880|P1|Washout|Withdrawal by Subject|0
5226689|NCT00912808|18041879|P2|First Intervention (6 Weeks)|Adverse Event|1
5226690|NCT00912808|18041880|P1|First Intervention (6 Weeks)|Adverse Event|2
5226691|NCT00912782|18041905|P2|Overall Study|Relocated before study completion|1
5226692|NCT00912782|18041906|P1|Overall Study|Relocated before study completion|0
5226693|NCT00912782|18041905|P2|Overall Study|Did not receive vascular access type|2
5226694|NCT00912782|18041906|P1|Overall Study|Did not receive vascular access type|1
5226695|NCT00912782|18041905|P2|Overall Study|Lost to Follow-up|1
5226696|NCT00912782|18041906|P1|Overall Study|Lost to Follow-up|0
5226697|NCT00912782|18041905|P2|Overall Study|Death|1
5226698|NCT00912782|18041906|P1|Overall Study|Death|2
5226699|NCT00912743|18041916|P2|Overall Study|End of treatment form was not collected|0
5226700|NCT00912743|18041917|P1|Overall Study|End of treatment form was not collected|1
5226701|NCT00912743|18041916|P2|Overall Study|Toxicity|1
5226702|NCT00912743|18041917|P1|Overall Study|Toxicity|0
5226703|NCT00912743|18041916|P2|Overall Study|Lack of Efficacy|18
5226704|NCT00912743|18041917|P1|Overall Study|Lack of Efficacy|9
5226705|NCT00912743|18041916|P2|Overall Study|Adverse Event|1
5226706|NCT00912743|18041917|P1|Overall Study|Adverse Event|3
5226707|NCT00912509|18041929|P2|Overall Study|Lack of Efficacy|3
5226708|NCT00912509|18041930|P1|Overall Study|Lack of Efficacy|4
5226709|NCT00912509|18041929|P2|Overall Study|Lost to Follow-up|0
5226710|NCT00912509|18041930|P1|Overall Study|Lost to Follow-up|1
5226711|NCT00912405|18041938|P1|Overall Study|Lost to Follow-up|5
5226712|NCT00912340|18041948|P3|Overall Study|Protocol revised to remove arm|4
5226713|NCT00912340|18041949|P2|Overall Study|Protocol revised to remove arm|0
5226714|NCT00912340|18041950|P1|Overall Study|Protocol revised to remove arm|0
5226715|NCT00912340|18041948|P3|Overall Study|Adverse Event|0
5226716|NCT00912340|18041949|P2|Overall Study|Adverse Event|4
5226717|NCT00912340|18041950|P1|Overall Study|Adverse Event|2
5226718|NCT00912288|18041988|P2|Overall Study|Other|0
5226719|NCT00912288|18041989|P1|Overall Study|Other|1
5226720|NCT00912288|18041988|P2|Overall Study|Study terminated by sponsor|35
5226721|NCT00912288|18041989|P1|Overall Study|Study terminated by sponsor|34
5226722|NCT00912288|18041988|P2|Overall Study|Withdrawal by Subject|3
5226723|NCT00912288|18041989|P1|Overall Study|Withdrawal by Subject|3
5226724|NCT00912288|18041988|P2|Overall Study|Protocol Violation|0
5226725|NCT00912288|18041989|P1|Overall Study|Protocol Violation|1
5226726|NCT00912288|18041988|P2|Overall Study|Lost to Follow-up|0
5226727|NCT00912288|18041989|P1|Overall Study|Lost to Follow-up|1
5226728|NCT00912288|18041988|P2|Overall Study|Adverse Event|1
5226729|NCT00912288|18041989|P1|Overall Study|Adverse Event|1
5226730|NCT00912288|18041988|P2|Overall Study|Death|1
5226731|NCT00912288|18041989|P1|Overall Study|Death|0
5226732|NCT00912223|18042011|P1|Overall Study|Transformed disease|1
5226733|NCT00912223|18042011|P1|Overall Study|Not transplanted|1
5226734|NCT00912223|18042011|P1|Overall Study|Withdrawal by Subject|1
5226735|NCT00912093|18042042|P5|The Controlled Phase|Lost to Follow-up|1
5226736|NCT00912093|18042043|P4|The Controlled Phase|Lost to Follow-up|0
5226737|NCT00912093|18042044|P3|The Controlled Phase|Lost to Follow-up|0
5226738|NCT00912093|18042045|P2|The Controlled Phase|Lost to Follow-up|0
5226739|NCT00912093|18042046|P1|The Controlled Phase|Lost to Follow-up|0
5226740|NCT00912093|18042042|P5|The Controlled Phase|Medical Condition|0
5226741|NCT00912093|18042043|P4|The Controlled Phase|Medical Condition|0
5226742|NCT00912093|18042044|P3|The Controlled Phase|Medical Condition|0
5226743|NCT00912093|18042045|P2|The Controlled Phase|Medical Condition|1
5226744|NCT00912093|18042046|P1|The Controlled Phase|Medical Condition|0
5226745|NCT00912093|18042042|P5|The Controlled Phase|Death|0
5226746|NCT00912093|18042043|P4|The Controlled Phase|Death|0
5226747|NCT00912093|18042044|P3|The Controlled Phase|Death|0
5226748|NCT00912093|18042045|P2|The Controlled Phase|Death|1
5226749|NCT00912093|18042046|P1|The Controlled Phase|Death|0
5226750|NCT00912028|18042065|P5|Overall Study|Withdrawal by Subject|0
5226751|NCT00912028|18042066|P4|Overall Study|Withdrawal by Subject|0
5226752|NCT00912028|18042067|P3|Overall Study|Withdrawal by Subject|0
5226753|NCT00912028|18042068|P2|Overall Study|Withdrawal by Subject|0
5226754|NCT00912028|18042069|P1|Overall Study|Withdrawal by Subject|3
5226755|NCT00912028|18042065|P5|Overall Study|Lost to Follow-up|3
5226756|NCT00912028|18042066|P4|Overall Study|Lost to Follow-up|1
5226757|NCT00912028|18042067|P3|Overall Study|Lost to Follow-up|0
5226758|NCT00912028|18042068|P2|Overall Study|Lost to Follow-up|3
5226759|NCT00912028|18042069|P1|Overall Study|Lost to Follow-up|2
5226760|NCT00912015|18042098|P4|Overall Study|Adverse Event|1
5226761|NCT00912015|18042099|P3|Overall Study|Adverse Event|0
5226762|NCT00912015|18042100|P2|Overall Study|Adverse Event|0
5226763|NCT00912015|18042101|P1|Overall Study|Adverse Event|6
5226764|NCT00912015|18042098|P4|Overall Study|Protocol Violation|1
5226765|NCT00912015|18042099|P3|Overall Study|Protocol Violation|0
5226766|NCT00912015|18042100|P2|Overall Study|Protocol Violation|0
5226767|NCT00912015|18042101|P1|Overall Study|Protocol Violation|1
5226768|NCT00912015|18042098|P4|Overall Study|Withdrawal by Subject|0
5226769|NCT00912015|18042099|P3|Overall Study|Withdrawal by Subject|3
5226770|NCT00912015|18042100|P2|Overall Study|Withdrawal by Subject|8
5226771|NCT00912015|18042101|P1|Overall Study|Withdrawal by Subject|8
5226772|NCT00912015|18042098|P4|Overall Study|Lack of Efficacy|0
5226773|NCT00912015|18042099|P3|Overall Study|Lack of Efficacy|0
5226774|NCT00912015|18042100|P2|Overall Study|Lack of Efficacy|0
5226775|NCT00912015|18042101|P1|Overall Study|Lack of Efficacy|1
5226776|NCT00911989|18042117|P1|Overall Study|Adverse Event|1
5226777|NCT00911937|18042123|P2|Overall Study|Other|5
5226778|NCT00911937|18042124|P1|Overall Study|Other|9
5226779|NCT00911937|18042123|P2|Overall Study|Randomized but not treated|13
5226780|NCT00911937|18042124|P1|Overall Study|Randomized but not treated|13
5226781|NCT00911937|18042123|P2|Overall Study|Protocol Violation|23
5226782|NCT00911937|18042124|P1|Overall Study|Protocol Violation|14
5226783|NCT00911937|18042123|P2|Overall Study|Did not meet inclusion criteria|11
5226784|NCT00911937|18042124|P1|Overall Study|Did not meet inclusion criteria|9
5226785|NCT00911937|18042123|P2|Overall Study|Lack of Efficacy|6
5226786|NCT00911937|18042124|P1|Overall Study|Lack of Efficacy|11
5226787|NCT00911937|18042123|P2|Overall Study|Adverse Event|25
5226788|NCT00911937|18042124|P1|Overall Study|Adverse Event|11
5226789|NCT00911937|18042123|P2|Overall Study|Withdrawn due to pregnancy|0
5226790|NCT00911937|18042124|P1|Overall Study|Withdrawn due to pregnancy|1
5226791|NCT00911937|18042123|P2|Overall Study|Withdrawal by Subject|7
5226792|NCT00911937|18042124|P1|Overall Study|Withdrawal by Subject|10
5226793|NCT00911937|18042123|P2|Overall Study|Lost to Follow-up|5
5226794|NCT00911937|18042124|P1|Overall Study|Lost to Follow-up|8
5226795|NCT00911937|18042123|P2|Overall Study|Death|0
5226796|NCT00911937|18042124|P1|Overall Study|Death|1
5226797|NCT00911859|18042191|P3|Follow-up Period|Study terminated by sponsor|27
5226798|NCT00911859|18042192|P2|Follow-up Period|Study terminated by sponsor|33
5226799|NCT00911859|18042193|P1|Follow-up Period|Study terminated by sponsor|5
5226800|NCT00911859|18042191|P3|Follow-up Period|Withdrawal by Subject|4
5226801|NCT00911859|18042192|P2|Follow-up Period|Withdrawal by Subject|4
5226802|NCT00911859|18042193|P1|Follow-up Period|Withdrawal by Subject|0
5226803|NCT00911859|18042191|P3|Follow-up Period|Lost to Follow-up|0
5226804|NCT00911859|18042192|P2|Follow-up Period|Lost to Follow-up|1
5226805|NCT00911859|18042193|P1|Follow-up Period|Lost to Follow-up|1
5226806|NCT00911859|18042191|P3|Follow-up Period|Death|10
5226807|NCT00911859|18042192|P2|Follow-up Period|Death|8
5226808|NCT00911859|18042193|P1|Follow-up Period|Death|5
5226809|NCT00911859|18042191|P3|Maintainance Period|Withdrawal by Subject|3
5226810|NCT00911859|18042192|P2|Maintainance Period|Withdrawal by Subject|0
5226811|NCT00911859|18042193|P1|Maintainance Period|Withdrawal by Subject|0
5226812|NCT00911859|18042191|P3|Maintainance Period|Physician Decision|9
5226813|NCT00911859|18042192|P2|Maintainance Period|Physician Decision|0
5226814|NCT00911859|18042193|P1|Maintainance Period|Physician Decision|0
5226815|NCT00911859|18042191|P3|Maintainance Period|Lack of Efficacy|9
5226816|NCT00911859|18042192|P2|Maintainance Period|Lack of Efficacy|0
5226817|NCT00911859|18042193|P1|Maintainance Period|Lack of Efficacy|0
5226818|NCT00911859|18042191|P3|Treatment Period|Did not receive study treatment|0
5226819|NCT00911859|18042192|P2|Treatment Period|Did not receive study treatment|1
5226820|NCT00911859|18042193|P1|Treatment Period|Did not receive study treatment|0
5226821|NCT00911859|18042191|P3|Treatment Period|Withdrawal by Subject|5
5226822|NCT00911859|18042192|P2|Treatment Period|Withdrawal by Subject|4
5226823|NCT00911859|18042193|P1|Treatment Period|Withdrawal by Subject|0
5226824|NCT00911859|18042191|P3|Treatment Period|Physician Decision|3
5226825|NCT00911859|18042192|P2|Treatment Period|Physician Decision|3
5226826|NCT00911859|18042193|P1|Treatment Period|Physician Decision|3
5226827|NCT00911859|18042191|P3|Treatment Period|Lack of Efficacy|5
5226828|NCT00911859|18042192|P2|Treatment Period|Lack of Efficacy|7
5226829|NCT00911859|18042193|P1|Treatment Period|Lack of Efficacy|1
5226830|NCT00911859|18042191|P3|Treatment Period|Death|5
5226831|NCT00911859|18042192|P2|Treatment Period|Death|3
5226832|NCT00911859|18042193|P1|Treatment Period|Death|1
5226833|NCT00911859|18042191|P3|Treatment Period|Adverse Event|7
5226834|NCT00911859|18042192|P2|Treatment Period|Adverse Event|3
5226835|NCT00911859|18042193|P1|Treatment Period|Adverse Event|3
5226836|NCT00911820|18042219|P2|Overall Study|Withdraw before Receive Treatment|2
5226837|NCT00911820|18042220|P1|Overall Study|Withdraw before Receive Treatment|0
5226838|NCT00911820|18042219|P2|Overall Study|Pathology Not Confirmed|0
5226839|NCT00911820|18042220|P1|Overall Study|Pathology Not Confirmed|1
5226840|NCT00911820|18042219|P2|Overall Study|Still on Therapy|2
5226841|NCT00911820|18042220|P1|Overall Study|Still on Therapy|2
5226842|NCT00911820|18042219|P2|Overall Study|Pursue Radiation|0
5226843|NCT00911820|18042220|P1|Overall Study|Pursue Radiation|1
5226844|NCT00911820|18042219|P2|Overall Study|Pursue surgery|1
5226845|NCT00911820|18042220|P1|Overall Study|Pursue surgery|1
5226846|NCT00911820|18042219|P2|Overall Study|Death|2
5226847|NCT00911820|18042220|P1|Overall Study|Death|1
5226848|NCT00911820|18042219|P2|Overall Study|Withdrawal by Subject|4
5226849|NCT00911820|18042220|P1|Overall Study|Withdrawal by Subject|3
5226850|NCT00911820|18042219|P2|Overall Study|Decline in Performance Status|2
5226851|NCT00911820|18042220|P1|Overall Study|Decline in Performance Status|4
5226852|NCT00911820|18042219|P2|Overall Study|Physician Decision|9
5226853|NCT00911820|18042220|P1|Overall Study|Physician Decision|5
5226854|NCT00911820|18042219|P2|Overall Study|Clinical Progression|5
5226855|NCT00911820|18042220|P1|Overall Study|Clinical Progression|7
5226856|NCT00911820|18042219|P2|Overall Study|Adverse Event|8
5226857|NCT00911820|18042220|P1|Overall Study|Adverse Event|8
5226858|NCT00911820|18042219|P2|Overall Study|RECIST progression|8
5226859|NCT00911820|18042220|P1|Overall Study|RECIST progression|12
5226860|NCT00911807|18042237|P3|Overall Study|Organizational reasons|1
5226861|NCT00911807|18042238|P2|Overall Study|Organizational reasons|3
5226862|NCT00911807|18042239|P1|Overall Study|Organizational reasons|1
5226863|NCT00911807|18042237|P3|Overall Study|Withdrawal by Subject|7
5226864|NCT00911807|18042238|P2|Overall Study|Withdrawal by Subject|10
5226865|NCT00911807|18042239|P1|Overall Study|Withdrawal by Subject|8
5226866|NCT00911807|18042237|P3|Overall Study|Protocol Violation|9
5226867|NCT00911807|18042238|P2|Overall Study|Protocol Violation|4
5226868|NCT00911807|18042239|P1|Overall Study|Protocol Violation|6
5226869|NCT00911807|18042237|P3|Overall Study|Death|1
5226870|NCT00911807|18042238|P2|Overall Study|Death|0
5226871|NCT00911807|18042239|P1|Overall Study|Death|0
5226872|NCT00911807|18042237|P3|Overall Study|Adverse Event|5
5226873|NCT00911807|18042238|P2|Overall Study|Adverse Event|1
5226874|NCT00911807|18042239|P1|Overall Study|Adverse Event|2
5226875|NCT00911768|18042249|P2|Overall Study|Withdrawal by Subject|0
5226876|NCT00911768|18042250|P1|Overall Study|Withdrawal by Subject|1
5226877|NCT00911768|18042249|P2|Overall Study|Protocol Violation|4
5226878|NCT00911768|18042250|P1|Overall Study|Protocol Violation|5
5226879|NCT00911625|18042279|P2|Overall Study|Lost to Follow-up|0
5226880|NCT00911625|18042280|P1|Overall Study|Lost to Follow-up|7
5226881|NCT00911547|18042309|P4|Overall Study|Withdrawal by Subject|8
5226882|NCT00911547|18042310|P3|Overall Study|Withdrawal by Subject|4
5226883|NCT00911547|18042311|P2|Overall Study|Withdrawal by Subject|10
5226884|NCT00911547|18042312|P1|Overall Study|Withdrawal by Subject|3
5226885|NCT00911547|18042309|P4|Overall Study|Protocol Violation|1
5226886|NCT00911547|18042310|P3|Overall Study|Protocol Violation|5
5226887|NCT00911547|18042311|P2|Overall Study|Protocol Violation|5
5226888|NCT00911547|18042312|P1|Overall Study|Protocol Violation|0
5226889|NCT00911547|18042309|P4|Overall Study|Lost to Follow-up|1
5226890|NCT00911547|18042310|P3|Overall Study|Lost to Follow-up|2
5226891|NCT00911547|18042311|P2|Overall Study|Lost to Follow-up|0
5226892|NCT00911547|18042312|P1|Overall Study|Lost to Follow-up|0
5226893|NCT00911547|18042309|P4|Overall Study|Adverse Event|6
5226894|NCT00911547|18042310|P3|Overall Study|Adverse Event|11
5226895|NCT00911547|18042311|P2|Overall Study|Adverse Event|27
5226896|NCT00911547|18042312|P1|Overall Study|Adverse Event|8
5226897|NCT00911534|18042340|P2|Overall Study|Other|2
5226898|NCT00911534|18042341|P1|Overall Study|Other|2
5226899|NCT00911534|18042340|P2|Overall Study|Withdrawal of consent|4
5226900|NCT00911534|18042341|P1|Overall Study|Withdrawal of consent|1
5226901|NCT00911534|18042340|P2|Overall Study|Lack of Efficacy|1
5226902|NCT00911534|18042341|P1|Overall Study|Lack of Efficacy|4
5226903|NCT00911534|18042340|P2|Overall Study|Withdrawal by Subject|1
5226904|NCT00911534|18042341|P1|Overall Study|Withdrawal by Subject|2
5226905|NCT00911534|18042340|P2|Overall Study|Lost to Follow-up|4
5226906|NCT00911534|18042341|P1|Overall Study|Lost to Follow-up|2
5226907|NCT00911534|18042340|P2|Overall Study|Adverse Event|4
5226908|NCT00911534|18042341|P1|Overall Study|Adverse Event|4
5226909|NCT00911508|18042355|P2|Overall Study|Withdrawal by Subject|112
5226910|NCT00911508|18042356|P1|Overall Study|Withdrawal by Subject|79
5226911|NCT00911508|18042355|P2|Overall Study|Lost to Follow-up|18
5226912|NCT00911508|18042356|P1|Overall Study|Lost to Follow-up|27
5226913|NCT00911300|18042431|P2|Overall Study|Randomized; No Study Medication Received|2
5226914|NCT00911300|18042432|P1|Overall Study|Randomized; No Study Medication Received|0
5226915|NCT00911300|18042431|P2|Overall Study|Treatment Stopped by Mistake|1
5226916|NCT00911300|18042432|P1|Overall Study|Treatment Stopped by Mistake|0
5226917|NCT00911300|18042431|P2|Overall Study|Physician Decision|1
5226918|NCT00911300|18042432|P1|Overall Study|Physician Decision|0
5226919|NCT00911300|18042431|P2|Overall Study|Underlying Disease (Myocarditis)|1
5226920|NCT00911300|18042432|P1|Overall Study|Underlying Disease (Myocarditis)|0
5226921|NCT00911300|18042431|P2|Overall Study|Participant Refused Hospital Consulation|1
5226922|NCT00911300|18042432|P1|Overall Study|Participant Refused Hospital Consulation|0
5226923|NCT00911300|18042431|P2|Overall Study|International Normalized Ratio Too High|1
5226924|NCT00911300|18042432|P1|Overall Study|International Normalized Ratio Too High|0
5226925|NCT00911300|18042431|P2|Overall Study|Investigator's Decision; New AF Episode|1
5226926|NCT00911300|18042432|P1|Overall Study|Investigator's Decision; New AF Episode|0
5226927|NCT00911300|18042431|P2|Overall Study|Participant Could Not Stay in Hospital|1
5226928|NCT00911300|18042432|P1|Overall Study|Participant Could Not Stay in Hospital|0
5226929|NCT00911300|18042431|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
5226930|NCT00911300|18042432|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
5226931|NCT00911300|18042431|P2|Overall Study|Nurse Unavailable in Participant's City|0
5226932|NCT00911300|18042432|P1|Overall Study|Nurse Unavailable in Participant's City|1
5226933|NCT00911300|18042431|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
5226934|NCT00911300|18042432|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
5226935|NCT00911300|18042431|P2|Overall Study|Recurrent Tachyarrhythmia|1
5226936|NCT00911300|18042432|P1|Overall Study|Recurrent Tachyarrhythmia|1
5226937|NCT00911300|18042431|P2|Overall Study|Received Commercial Treatment|0
5226938|NCT00911300|18042432|P1|Overall Study|Received Commercial Treatment|1
5226939|NCT00911300|18042431|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
5226940|NCT00911300|18042432|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
5226941|NCT00911300|18042431|P2|Overall Study|Coronary Angiography Performed|0
5226942|NCT00911300|18042432|P1|Overall Study|Coronary Angiography Performed|1
5226943|NCT00911300|18042431|P2|Overall Study|Consent Withdrawn|12
5226944|NCT00911300|18042432|P1|Overall Study|Consent Withdrawn|4
5226945|NCT00911300|18042431|P2|Overall Study|Protocol Violation|2
5226946|NCT00911300|18042432|P1|Overall Study|Protocol Violation|3
5226947|NCT00911300|18042431|P2|Overall Study|Adverse Event|6
5226948|NCT00911300|18042432|P1|Overall Study|Adverse Event|14
5226949|NCT00911300|18042431|P2|Overall Study|Thrombus Persistant in Second TEE|7
5226950|NCT00911300|18042432|P1|Overall Study|Thrombus Persistant in Second TEE|3
5226951|NCT00911300|18042431|P2|Overall Study|Death|0
5226952|NCT00911300|18042432|P1|Overall Study|Death|1
5226953|NCT00911300|18042431|P2|Overall Study|Primary Endpoint Component Occurred|2
5226954|NCT00911300|18042432|P1|Overall Study|Primary Endpoint Component Occurred|1
5226955|NCT00911170|18042469|P2|Long Term Follow-Up|Death|121
5226956|NCT00911170|18042470|P1|Long Term Follow-Up|Death|116
5226957|NCT00911170|18042469|P2|Long Term Follow-Up|Lost to Follow-up|7
5226958|NCT00911170|18042470|P1|Long Term Follow-Up|Lost to Follow-up|8
5226959|NCT00911170|18042469|P2|Long Term Follow-Up|Physician Decision|4
5226960|NCT00911170|18042470|P1|Long Term Follow-Up|Physician Decision|5
5226961|NCT00911170|18042469|P2|Long Term Follow-Up|Withdrawal by Subject|21
5226962|NCT00911170|18042470|P1|Long Term Follow-Up|Withdrawal by Subject|20
5226963|NCT00911170|18042469|P2|Long Term Follow-Up|Continuing in study|269
5226964|NCT00911170|18042470|P1|Long Term Follow-Up|Continuing in study|274
5226965|NCT00911170|18042469|P2|Treatment Period|Death|9
5226966|NCT00911170|18042470|P1|Treatment Period|Death|6
5226967|NCT00911170|18042469|P2|Treatment Period|Lost to Follow-up|1
5226968|NCT00911170|18042470|P1|Treatment Period|Lost to Follow-up|0
5226969|NCT00911170|18042469|P2|Treatment Period|Physician Decision|5
5226970|NCT00911170|18042470|P1|Treatment Period|Physician Decision|5
5226971|NCT00911170|18042469|P2|Treatment Period|Disease progression|2
5226972|NCT00911170|18042470|P1|Treatment Period|Disease progression|0
5226973|NCT00911170|18042469|P2|Treatment Period|Withdrawal by Subject|4
5226974|NCT00911170|18042470|P1|Treatment Period|Withdrawal by Subject|4
5226975|NCT00911170|18042469|P2|Treatment Period|Adverse Event|10
5226976|NCT00911170|18042470|P1|Treatment Period|Adverse Event|9
5226977|NCT00911170|18042469|P2|Treatment Period|Protocol deviation|2
5226978|NCT00911170|18042470|P1|Treatment Period|Protocol deviation|1
5226979|NCT00911170|18042469|P2|Treatment Period|Ineligibility determined|3
5226980|NCT00911170|18042470|P1|Treatment Period|Ineligibility determined|1
5226981|NCT00911170|18042469|P2|Treatment Period|Randomized in error|1
5226982|NCT00911170|18042470|P1|Treatment Period|Randomized in error|1
5226983|NCT00911157|18042494|P2|Overall Study|Need to treat for lung cancer|0
5226984|NCT00911157|18042495|P1|Overall Study|Need to treat for lung cancer|1
5226985|NCT00911157|18042494|P2|Overall Study|Need for prohibited drug (heparin)|0
5226986|NCT00911157|18042495|P1|Overall Study|Need for prohibited drug (heparin)|1
5226987|NCT00911157|18042494|P2|Overall Study|Withdrawal by Subject|1
5226988|NCT00911157|18042495|P1|Overall Study|Withdrawal by Subject|1
5226989|NCT00911157|18042494|P2|Overall Study|Adverse Event|1
5226990|NCT00911157|18042495|P1|Overall Study|Adverse Event|4
5226991|NCT00911144|18042511|P2|Overall Study|Withdrawal by Subject|5
5226992|NCT00911144|18042512|P1|Overall Study|Withdrawal by Subject|16
5226993|NCT00910988|18042566|P4|Overall Study|Lost to Follow-up|0
5226994|NCT00910988|18042567|P3|Overall Study|Lost to Follow-up|3
5226995|NCT00910988|18042568|P2|Overall Study|Lost to Follow-up|4
5226996|NCT00910988|18042569|P1|Overall Study|Lost to Follow-up|2
5226997|NCT00910962|18042614|P3|Overall Study|Reached defined stopping criteria|17
5226998|NCT00910962|18042615|P2|Overall Study|Reached defined stopping criteria|14
5226999|NCT00910962|18042616|P1|Overall Study|Reached defined stopping criteria|12
5227000|NCT00910962|18042614|P3|Overall Study|Withdrawal by Subject|32
5227001|NCT00910962|18042615|P2|Overall Study|Withdrawal by Subject|32
5227002|NCT00910962|18042616|P1|Overall Study|Withdrawal by Subject|25
5227003|NCT00910962|18042614|P3|Overall Study|Physician Decision|6
5227004|NCT00910962|18042615|P2|Overall Study|Physician Decision|6
5227005|NCT00910962|18042616|P1|Overall Study|Physician Decision|0
5227006|NCT00910962|18042614|P3|Overall Study|Lost to Follow-up|1
5227007|NCT00910962|18042615|P2|Overall Study|Lost to Follow-up|3
5227008|NCT00910962|18042616|P1|Overall Study|Lost to Follow-up|0
5227009|NCT00910962|18042614|P3|Overall Study|Protocol Violation|3
5227010|NCT00910962|18042615|P2|Overall Study|Protocol Violation|3
5227011|NCT00910962|18042616|P1|Overall Study|Protocol Violation|1
5227012|NCT00910962|18042614|P3|Overall Study|Adverse Event|17
5227013|NCT00910962|18042615|P2|Overall Study|Adverse Event|20
5227014|NCT00910962|18042616|P1|Overall Study|Adverse Event|5
5227015|NCT00910910|18042708|P2|Overall Study|Untreated before cycle 1|2
5227016|NCT00910910|18042709|P1|Overall Study|Untreated before cycle 1|1
5227017|NCT00910910|18042708|P2|Overall Study|Other|32
5227018|NCT00910910|18042709|P1|Overall Study|Other|114
5227019|NCT00910910|18042708|P2|Overall Study|Completed 13 cycles of treatment|118
5227020|NCT00910910|18042709|P1|Overall Study|Completed 13 cycles of treatment|0
5227021|NCT00910910|18042708|P2|Overall Study|Protocol Violation|2
5227022|NCT00910910|18042709|P1|Overall Study|Protocol Violation|2
5227023|NCT00910910|18042708|P2|Overall Study|Death|3
5227024|NCT00910910|18042709|P1|Overall Study|Death|9
5227025|NCT00910910|18042708|P2|Overall Study|Lost to Follow-up|2
5227026|NCT00910910|18042709|P1|Overall Study|Lost to Follow-up|2
5227027|NCT00910910|18042708|P2|Overall Study|Withdrawal by Subject|5
5227028|NCT00910910|18042709|P1|Overall Study|Withdrawal by Subject|7
5227029|NCT00910910|18042708|P2|Overall Study|PD with histologic change|2
5227030|NCT00910910|18042709|P1|Overall Study|PD with histologic change|0
5227031|NCT00910910|18042708|P2|Overall Study|PD without histologic change|23
5227032|NCT00910910|18042709|P1|Overall Study|PD without histologic change|27
5227033|NCT00910910|18042708|P2|Overall Study|Adverse Event|35
5227034|NCT00910910|18042709|P1|Overall Study|Adverse Event|63
5227035|NCT00910871|18042745|P1|Overall Study|Undefined|1
5227036|NCT00910871|18042745|P1|Overall Study|Subject didn't meet eligibility criteria|5
5227037|NCT00910871|18042745|P1|Overall Study|Withdrawal by Subject|12
5227038|NCT00910871|18042745|P1|Overall Study|Protocol Violation|11
5227039|NCT00910871|18042745|P1|Overall Study|Lost to Follow-up|8
5227040|NCT00910871|18042745|P1|Overall Study|Death|12
5227041|NCT00910871|18042745|P1|Overall Study|Adverse Event|5
5227042|NCT00910858|18042753|P3|Combined Treatment Phase|Other|1
5227043|NCT00910858|18042754|P2|Combined Treatment Phase|Other|2
5227044|NCT00910858|18042755|P1|Combined Treatment Phase|Other|0
5227045|NCT00910858|18042753|P3|Combined Treatment Phase|Protocol Violation|0
5227046|NCT00910858|18042754|P2|Combined Treatment Phase|Protocol Violation|0
5227047|NCT00910858|18042755|P1|Combined Treatment Phase|Protocol Violation|1
5227048|NCT00910858|18042753|P3|Combined Treatment Phase|Withdrawal by Subject|0
5227049|NCT00910858|18042754|P2|Combined Treatment Phase|Withdrawal by Subject|2
5227050|NCT00910858|18042755|P1|Combined Treatment Phase|Withdrawal by Subject|0
5227051|NCT00910858|18042753|P3|Combined Treatment Phase|Lack of therapeutic effect|3
5227052|NCT00910858|18042754|P2|Combined Treatment Phase|Lack of therapeutic effect|6
5227053|NCT00910858|18042755|P1|Combined Treatment Phase|Lack of therapeutic effect|8
5227054|NCT00910858|18042753|P3|Monotherapy Phase|Other|2
5227055|NCT00910858|18042754|P2|Monotherapy Phase|Other|4
5227056|NCT00910858|18042755|P1|Monotherapy Phase|Other|3
5227057|NCT00910858|18042753|P3|Monotherapy Phase|Protocol Violation|0
5227058|NCT00910858|18042754|P2|Monotherapy Phase|Protocol Violation|0
5227059|NCT00910858|18042755|P1|Monotherapy Phase|Protocol Violation|1
5227060|NCT00910858|18042753|P3|Monotherapy Phase|Withdrawal by Subject|1
5227061|NCT00910858|18042754|P2|Monotherapy Phase|Withdrawal by Subject|3
5227062|NCT00910858|18042755|P1|Monotherapy Phase|Withdrawal by Subject|1
5227063|NCT00910858|18042753|P3|Monotherapy Phase|Lack of therapeutic effect|4
5227064|NCT00910858|18042754|P2|Monotherapy Phase|Lack of therapeutic effect|6
5227065|NCT00910858|18042755|P1|Monotherapy Phase|Lack of therapeutic effect|9
5227066|NCT00910858|18042753|P3|Monotherapy Phase|Adverse Event|0
5227067|NCT00910858|18042754|P2|Monotherapy Phase|Adverse Event|2
5227068|NCT00910858|18042755|P1|Monotherapy Phase|Adverse Event|3
5227069|NCT00910858|18042753|P3|Pharmacokinetic Phase|Adverse Event|0
5227070|NCT00910858|18042754|P2|Pharmacokinetic Phase|Adverse Event|0
5227071|NCT00910858|18042755|P1|Pharmacokinetic Phase|Adverse Event|1
5227072|NCT00910728|18042800|P9|Overall Study|Adverse Event|1
5227073|NCT00910728|18042801|P8|Overall Study|Adverse Event|1
5227074|NCT00910728|18042802|P7|Overall Study|Adverse Event|2
5227075|NCT00910728|18042803|P6|Overall Study|Adverse Event|0
5227076|NCT00910728|18042804|P5|Overall Study|Adverse Event|0
5227077|NCT00910728|18042805|P4|Overall Study|Adverse Event|1
5227078|NCT00910728|18042806|P3|Overall Study|Adverse Event|1
5227079|NCT00910728|18042807|P2|Overall Study|Adverse Event|0
5227080|NCT00910728|18042808|P1|Overall Study|Adverse Event|2
5227081|NCT00910728|18042800|P9|Overall Study|(not specified)|0
5227082|NCT00910728|18042801|P8|Overall Study|(not specified)|0
5227083|NCT00910728|18042802|P7|Overall Study|(not specified)|0
5227084|NCT00910728|18042803|P6|Overall Study|(not specified)|0
5227085|NCT00910728|18042804|P5|Overall Study|(not specified)|1
5227086|NCT00910728|18042805|P4|Overall Study|(not specified)|0
5227087|NCT00910728|18042806|P3|Overall Study|(not specified)|1
5227088|NCT00910728|18042807|P2|Overall Study|(not specified)|0
5227089|NCT00910728|18042808|P1|Overall Study|(not specified)|2
5227090|NCT00910728|18042800|P9|Overall Study|Withdrawal by Subject|0
5227091|NCT00910728|18042801|P8|Overall Study|Withdrawal by Subject|0
5227092|NCT00910728|18042802|P7|Overall Study|Withdrawal by Subject|2
5227093|NCT00910728|18042803|P6|Overall Study|Withdrawal by Subject|1
5227094|NCT00910728|18042804|P5|Overall Study|Withdrawal by Subject|3
5227095|NCT00910728|18042805|P4|Overall Study|Withdrawal by Subject|0
5227096|NCT00910728|18042806|P3|Overall Study|Withdrawal by Subject|0
5227097|NCT00910728|18042807|P2|Overall Study|Withdrawal by Subject|0
5227098|NCT00910728|18042808|P1|Overall Study|Withdrawal by Subject|0
5227099|NCT00910728|18042800|P9|Overall Study|Lack of Efficacy|2
5227100|NCT00910728|18042801|P8|Overall Study|Lack of Efficacy|2
5227101|NCT00910728|18042802|P7|Overall Study|Lack of Efficacy|2
5227102|NCT00910728|18042803|P6|Overall Study|Lack of Efficacy|0
5227103|NCT00910728|18042804|P5|Overall Study|Lack of Efficacy|1
5227104|NCT00910728|18042805|P4|Overall Study|Lack of Efficacy|2
5227105|NCT00910728|18042806|P3|Overall Study|Lack of Efficacy|1
5227106|NCT00910728|18042807|P2|Overall Study|Lack of Efficacy|3
5227107|NCT00910728|18042808|P1|Overall Study|Lack of Efficacy|2
5227108|NCT00910715|18042930|P3|Overall Study|Lost to Follow-up|0
5227109|NCT00910715|18042931|P2|Overall Study|Lost to Follow-up|26
5227110|NCT00910715|18042932|P1|Overall Study|Lost to Follow-up|22
5227111|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
5227112|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
5227113|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
5227114|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
5227115|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
5227116|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
5227117|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
5227118|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
5227119|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Time Demands|0
5227120|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Time Demands|0
5227121|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Time Demands|1
5227122|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Time Demands|2
5227123|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
5227124|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
5227125|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
5227126|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
5227127|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
5227128|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
5227129|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
5227130|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
5227131|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
5227132|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
5227133|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
5227134|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
5227135|NCT00910689|18042946|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
5227136|NCT00910689|18042947|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
5227137|NCT00910689|18042948|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
5227138|NCT00910689|18042949|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
5227139|NCT00910689|18042946|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
5227140|NCT00910689|18042947|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
5227141|NCT00910689|18042948|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
5227142|NCT00910689|18042949|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
5227143|NCT00910689|18042946|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
5227144|NCT00910689|18042947|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
5227145|NCT00910689|18042948|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
5227146|NCT00910689|18042949|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
5227147|NCT00910689|18042946|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
5227148|NCT00910689|18042947|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
5227149|NCT00910689|18042948|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
5227150|NCT00910689|18042949|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
5227151|NCT00910689|18042946|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
5227152|NCT00910689|18042947|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
5227153|NCT00910689|18042948|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
5227154|NCT00910689|18042949|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
5227155|NCT00910689|18042946|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
5227156|NCT00910689|18042947|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
5227157|NCT00910689|18042948|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
5227158|NCT00910689|18042949|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
5227159|NCT00910689|18042946|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
5227160|NCT00910689|18042947|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
5227161|NCT00910689|18042948|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
5227162|NCT00910689|18042949|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
5227163|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Protocol Violation|0
5227164|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Protocol Violation|0
5227165|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Protocol Violation|0
5227166|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Protocol Violation|1
5227167|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Pregnancy|0
5227168|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Pregnancy|0
5227169|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Pregnancy|2
5227170|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Pregnancy|0
5227171|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
5227172|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
5227173|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
5227174|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
5227175|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
5227176|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
5227177|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
5227178|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
5227179|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Time Demands|8
5227180|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Time Demands|4
5227181|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Time Demands|0
5227182|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Time Demands|1
5227183|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Adverse Event|0
5227184|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Adverse Event|2
5227185|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Adverse Event|3
5227186|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Adverse Event|2
5227187|NCT00910689|18042946|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
5227188|NCT00910689|18042947|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
5227189|NCT00910689|18042948|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
5227190|NCT00910689|18042949|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
5227191|NCT00910689|18042946|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
5227192|NCT00910689|18042947|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
5227193|NCT00910689|18042948|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
5227194|NCT00910689|18042949|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
5227195|NCT00910663|18042981|P2|Period 1|Withdrawal by Subject|1
5227196|NCT00910663|18042982|P1|Period 1|Withdrawal by Subject|0
5227197|NCT00910624|18042996|P4|Follow-Up Phase|Administrative|0
5227198|NCT00910624|18042997|P3|Follow-Up Phase|Administrative|1
5227199|NCT00910624|18042998|P2|Follow-Up Phase|Administrative|1
5227200|NCT00910624|18042999|P1|Follow-Up Phase|Administrative|0
5227201|NCT00910624|18042996|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
5227202|NCT00910624|18042997|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
5227203|NCT00910624|18042998|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
5227204|NCT00910624|18042999|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
5227205|NCT00910624|18042996|P4|Follow-Up Phase|Withdrawal by Subject|0
5227206|NCT00910624|18042997|P3|Follow-Up Phase|Withdrawal by Subject|0
5227207|NCT00910624|18042998|P2|Follow-Up Phase|Withdrawal by Subject|0
5227208|NCT00910624|18042999|P1|Follow-Up Phase|Withdrawal by Subject|1
5227209|NCT00910624|18042996|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
5227210|NCT00910624|18042997|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
5227211|NCT00910624|18042998|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
5227212|NCT00910624|18042999|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
5227213|NCT00910624|18042996|P4|Follow-Up Phase|Lost to Follow-up|0
5227214|NCT00910624|18042997|P3|Follow-Up Phase|Lost to Follow-up|2
5227215|NCT00910624|18042998|P2|Follow-Up Phase|Lost to Follow-up|1
5227216|NCT00910624|18042999|P1|Follow-Up Phase|Lost to Follow-up|3
5227217|NCT00910624|18042996|P4|Follow-Up Phase|Adverse Event|0
5227218|NCT00910624|18042997|P3|Follow-Up Phase|Adverse Event|1
5227219|NCT00910624|18042998|P2|Follow-Up Phase|Adverse Event|0
5227220|NCT00910624|18042999|P1|Follow-Up Phase|Adverse Event|0
5227221|NCT00910624|18042996|P4|Treatment Phase|Non-Compliance With Protocol|0
5227222|NCT00910624|18042997|P3|Treatment Phase|Non-Compliance With Protocol|1
5227223|NCT00910624|18042998|P2|Treatment Phase|Non-Compliance With Protocol|1
5227224|NCT00910624|18042999|P1|Treatment Phase|Non-Compliance With Protocol|0
5227225|NCT00910624|18042996|P4|Treatment Phase|Withdrawal by Subject|0
5227226|NCT00910624|18042997|P3|Treatment Phase|Withdrawal by Subject|0
5227227|NCT00910624|18042998|P2|Treatment Phase|Withdrawal by Subject|1
5227228|NCT00910624|18042999|P1|Treatment Phase|Withdrawal by Subject|2
5227229|NCT00910624|18042996|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
5227230|NCT00910624|18042997|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
5227231|NCT00910624|18042998|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
5227232|NCT00910624|18042999|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
5227233|NCT00910624|18042996|P4|Treatment Phase|Lost to Follow-up|0
5227234|NCT00910624|18042997|P3|Treatment Phase|Lost to Follow-up|1
5227235|NCT00910624|18042998|P2|Treatment Phase|Lost to Follow-up|0
5227236|NCT00910624|18042999|P1|Treatment Phase|Lost to Follow-up|0
5227237|NCT00910624|18042996|P4|Treatment Phase|Treatment Failure|0
5227238|NCT00910624|18042997|P3|Treatment Phase|Treatment Failure|0
5227239|NCT00910624|18042998|P2|Treatment Phase|Treatment Failure|10
5227240|NCT00910624|18042999|P1|Treatment Phase|Treatment Failure|23
5227241|NCT00910624|18042996|P4|Treatment Phase|Adverse Event|0
5227242|NCT00910624|18042997|P3|Treatment Phase|Adverse Event|6
5227243|NCT00910624|18042998|P2|Treatment Phase|Adverse Event|6
5227244|NCT00910624|18042999|P1|Treatment Phase|Adverse Event|2
5227245|NCT00910429|18043026|P2|Overall Study|Lack of Efficacy|1
5227246|NCT00910429|18043027|P1|Overall Study|Lack of Efficacy|4
5227247|NCT00910429|18043026|P2|Overall Study|Drug non-compliance|0
5227248|NCT00910429|18043027|P1|Overall Study|Drug non-compliance|1
5227249|NCT00910429|18043026|P2|Overall Study|Adverse Event|5
5227250|NCT00910429|18043027|P1|Overall Study|Adverse Event|10
5227251|NCT00910429|18043026|P2|Overall Study|Lost to Follow-up|1
5227252|NCT00910429|18043027|P1|Overall Study|Lost to Follow-up|2
5227253|NCT00910429|18043026|P2|Overall Study|Protocol Violation|0
5227254|NCT00910429|18043027|P1|Overall Study|Protocol Violation|1
5227255|NCT00910429|18043026|P2|Overall Study|Withdrawal by Subject|2
5227256|NCT00910429|18043027|P1|Overall Study|Withdrawal by Subject|3
5227257|NCT00910429|18043026|P2|Overall Study|Death|12
5227258|NCT00910429|18043027|P1|Overall Study|Death|18
5227259|NCT00910299|18043089|P2|Overall Study|Didn't receive any study drug|1
5227260|NCT00910299|18043090|P1|Overall Study|Didn't receive any study drug|2
5227261|NCT00910299|18043089|P2|Overall Study|Sponsor Decision|60
5227262|NCT00910299|18043090|P1|Overall Study|Sponsor Decision|58
5227263|NCT00910299|18043089|P2|Overall Study|Withdrawal by Subject|13
5227264|NCT00910299|18043090|P1|Overall Study|Withdrawal by Subject|16
5227265|NCT00910273|18043102|P2|Overall Study|Lost to Follow-up|1
5227266|NCT00910273|18043103|P1|Overall Study|Lost to Follow-up|1
5227267|NCT00910273|18043102|P2|Overall Study|Protocol Violation|0
5227268|NCT00910273|18043103|P1|Overall Study|Protocol Violation|1
5227269|NCT00910273|18043102|P2|Overall Study|Discontinuation of study by sponsor|2
5227270|NCT00910273|18043103|P1|Overall Study|Discontinuation of study by sponsor|8
5227271|NCT00910273|18043102|P2|Overall Study|Withdrawal by Subject|0
5227272|NCT00910273|18043103|P1|Overall Study|Withdrawal by Subject|1
5227273|NCT00910273|18043102|P2|Overall Study|Adverse Event|1
5227274|NCT00910273|18043103|P1|Overall Study|Adverse Event|1
5227275|NCT00910273|18043102|P2|Overall Study|Lack of Efficacy|9
5227276|NCT00910273|18043103|P1|Overall Study|Lack of Efficacy|6
5227277|NCT00910247|18043153|P1|Overall Study|Not collected|4
5227278|NCT00910247|18043153|P1|Overall Study|Withdrawal by Subject|25
5227279|NCT00910247|18043153|P1|Overall Study|Protocol Violation|10
5227280|NCT00910247|18043153|P1|Overall Study|Physician Decision|3
5227281|NCT00910247|18043153|P1|Overall Study|Lost to Follow-up|10
5227282|NCT00910247|18043153|P1|Overall Study|Death|2
5227283|NCT00910247|18043153|P1|Overall Study|Adverse Event|15
5227284|NCT00910091|18043203|P2|Treatment and Survival|Adverse Event|0
5227285|NCT00910091|18043204|P1|Treatment and Survival|Adverse Event|1
5227286|NCT00910091|18043203|P2|Treatment and Survival|Withdrawal by Subject|4
5227287|NCT00910091|18043204|P1|Treatment and Survival|Withdrawal by Subject|3
5227288|NCT00910091|18043203|P2|Pre-assignment|Withdrawal by Subject|2
5227289|NCT00910091|18043204|P1|Pre-assignment|Withdrawal by Subject|0
5227290|NCT00910039|18043232|P1|Overall Study|Physician Decision|1
5227291|NCT00910000|18043249|P6|Overall Study|Withdrawal by Subject|0
5227292|NCT00910000|18043250|P5|Overall Study|Withdrawal by Subject|1
5227293|NCT00910000|18043251|P4|Overall Study|Withdrawal by Subject|0
5227294|NCT00910000|18043252|P3|Overall Study|Withdrawal by Subject|1
5227295|NCT00910000|18043253|P2|Overall Study|Withdrawal by Subject|0
5227296|NCT00910000|18043254|P1|Overall Study|Withdrawal by Subject|0
5227297|NCT00910000|18043249|P6|Overall Study|Adverse Event|1
5227298|NCT00910000|18043250|P5|Overall Study|Adverse Event|0
5227299|NCT00910000|18043251|P4|Overall Study|Adverse Event|2
5227300|NCT00910000|18043252|P3|Overall Study|Adverse Event|2
5227301|NCT00910000|18043253|P2|Overall Study|Adverse Event|3
5227302|NCT00910000|18043254|P1|Overall Study|Adverse Event|0
5227303|NCT00909870|18043272|P2|Overall Study|Other|5
5227304|NCT00909870|18043273|P1|Overall Study|Other|1
5227305|NCT00909870|18043272|P2|Overall Study|Physician Decision|2
5227306|NCT00909870|18043273|P1|Overall Study|Physician Decision|0
5227307|NCT00909870|18043272|P2|Overall Study|Lost to Follow-up|3
5227308|NCT00909870|18043273|P1|Overall Study|Lost to Follow-up|3
5227309|NCT00909870|18043272|P2|Overall Study|Withdrawal by Subject|8
5227310|NCT00909870|18043273|P1|Overall Study|Withdrawal by Subject|5
5227311|NCT00909870|18043272|P2|Overall Study|Protocol Violation|2
5227312|NCT00909870|18043273|P1|Overall Study|Protocol Violation|1
5227313|NCT00909870|18043272|P2|Overall Study|Adverse Event|7
5227314|NCT00909870|18043273|P1|Overall Study|Adverse Event|13
5227315|NCT00909857|18043285|P2|Overall Study|Did not receive study medication|24
5227316|NCT00909857|18043286|P1|Overall Study|Did not receive study medication|19
5227317|NCT00909857|18043285|P2|Overall Study|Other|0
5227318|NCT00909857|18043286|P1|Overall Study|Other|1
5227319|NCT00909857|18043285|P2|Overall Study|Pregnancy|0
5227320|NCT00909857|18043286|P1|Overall Study|Pregnancy|1
5227321|NCT00909857|18043285|P2|Overall Study|Protocol Violation|1
5227322|NCT00909857|18043286|P1|Overall Study|Protocol Violation|2
5227323|NCT00909857|18043285|P2|Overall Study|Lost to Follow-up|5
5227324|NCT00909857|18043286|P1|Overall Study|Lost to Follow-up|2
5227325|NCT00909857|18043285|P2|Overall Study|Adverse Event|5
5227326|NCT00909857|18043286|P1|Overall Study|Adverse Event|5
5227327|NCT00909857|18043285|P2|Overall Study|Withdrawal by Subject|10
5227328|NCT00909857|18043286|P1|Overall Study|Withdrawal by Subject|6
5227329|NCT00909844|18043426|P1|Overall Study|Lost to Follow-up|2
5227330|NCT00909844|18043426|P1|Overall Study|Withdrawal by Subject|1
5227331|NCT00909844|18043426|P1|Overall Study|Adverse Event|1
5227332|NCT00909792|18043444|P2|Period 2|Lost to Follow-up|1
5227333|NCT00909792|18043445|P1|Period 2|Lost to Follow-up|0
5227334|NCT00909792|18043444|P2|Period 2|Biomicroscopy|0
5227335|NCT00909792|18043445|P1|Period 2|Biomicroscopy|1
5227336|NCT00909792|18043444|P2|Period 1|Did not meet inclusion criteria|1
5227337|NCT00909792|18043445|P1|Period 1|Did not meet inclusion criteria|0
5227338|NCT00909779|18043453|P2|Overall Study|Randomized in error|1
5227339|NCT00909779|18043454|P1|Overall Study|Randomized in error|1
5227340|NCT00909779|18043453|P2|Overall Study|Noncompliance|1
5227341|NCT00909779|18043454|P1|Overall Study|Noncompliance|1
5227342|NCT00909779|18043453|P2|Overall Study|Medical Monitor Decision|0
5227343|NCT00909779|18043454|P1|Overall Study|Medical Monitor Decision|1
5227344|NCT00909779|18043453|P2|Overall Study|Site Ceasing Operation|2
5227345|NCT00909779|18043454|P1|Overall Study|Site Ceasing Operation|2
5227346|NCT00909779|18043453|P2|Overall Study|Withdrawal by Subject|80
5227347|NCT00909779|18043454|P1|Overall Study|Withdrawal by Subject|116
5227348|NCT00909779|18043453|P2|Overall Study|Protocol Violation|5
5227349|NCT00909779|18043454|P1|Overall Study|Protocol Violation|2
5227350|NCT00909779|18043453|P2|Overall Study|Physician Decision|2
5227351|NCT00909779|18043454|P1|Overall Study|Physician Decision|8
5227352|NCT00909779|18043453|P2|Overall Study|Lost to Follow-up|15
5227353|NCT00909779|18043454|P1|Overall Study|Lost to Follow-up|19
5227354|NCT00909779|18043453|P2|Overall Study|Lack of Efficacy|4
5227355|NCT00909779|18043454|P1|Overall Study|Lack of Efficacy|7
5227356|NCT00909779|18043453|P2|Overall Study|Adverse Event|55
5227357|NCT00909779|18043454|P1|Overall Study|Adverse Event|53
5227358|NCT00909753|18043478|P2|Period: Second Intervention|Protocol Violation|0
5227359|NCT00909753|18043479|P1|Period: Second Intervention|Protocol Violation|1
5227360|NCT00909753|18043478|P2|Period: Washout of 28 Days|Protocol Violation|3
5227361|NCT00909753|18043479|P1|Period: Washout of 28 Days|Protocol Violation|2
5227362|NCT00909727|18043499|P2|Overall Study|Prohibited Medication|0
5227363|NCT00909727|18043500|P1|Overall Study|Prohibited Medication|1
5227364|NCT00909727|18043499|P2|Overall Study|Withdrawal of Consent|0
5227365|NCT00909727|18043500|P1|Overall Study|Withdrawal of Consent|1
5227366|NCT00909727|18043499|P2|Overall Study|Wrong Genotype|0
5227367|NCT00909727|18043500|P1|Overall Study|Wrong Genotype|1
5227368|NCT00909727|18043499|P2|Overall Study|Adverse Event|0
5227369|NCT00909727|18043500|P1|Overall Study|Adverse Event|1
5227370|NCT00909610|18043523|P2|Period: Second Intervention|Adverse Event|0
5227371|NCT00909610|18043524|P1|Period: Second Intervention|Adverse Event|1
5227372|NCT00909610|18043523|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
5227373|NCT00909610|18043524|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
5227374|NCT00909610|18043523|P2|Period: First Intervention|Adverse Event|1
5227375|NCT00909610|18043524|P1|Period: First Intervention|Adverse Event|0
5227376|NCT00909532|18043685|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
5227377|NCT00909532|18043686|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
5227378|NCT00909532|18043685|P2|Overall Study|Wrong Genotype|0
5227379|NCT00909532|18043686|P1|Overall Study|Wrong Genotype|1
5227380|NCT00909532|18043685|P2|Overall Study|Physician Decision|0
5227381|NCT00909532|18043686|P1|Overall Study|Physician Decision|1
5227382|NCT00909532|18043685|P2|Overall Study|Noncompliance with Study Requirements|2
5227383|NCT00909532|18043686|P1|Overall Study|Noncompliance with Study Requirements|0
5227384|NCT00909532|18043685|P2|Overall Study|Withdrawal of Consent|1
5227385|NCT00909532|18043686|P1|Overall Study|Withdrawal of Consent|1
5227386|NCT00909532|18043685|P2|Overall Study|Prohibited Medication|1
5227387|NCT00909532|18043686|P1|Overall Study|Prohibited Medication|2
5227388|NCT00909532|18043685|P2|Overall Study|Pregnancy|1
5227389|NCT00909532|18043686|P1|Overall Study|Pregnancy|0
5227390|NCT00909532|18043685|P2|Overall Study|Adverse Event|1
5227391|NCT00909532|18043686|P1|Overall Study|Adverse Event|4
5227392|NCT00909480|18043704|P2|Overall Study|Unclassified|19
5227393|NCT00909480|18043705|P1|Overall Study|Unclassified|18
5227394|NCT00909480|18043704|P2|Overall Study|Withdrawal criteria|11
5227395|NCT00909480|18043705|P1|Overall Study|Withdrawal criteria|9
5227396|NCT00909480|18043704|P2|Overall Study|Protocol Violation|8
5227397|NCT00909480|18043705|P1|Overall Study|Protocol Violation|6
5227398|NCT00909480|18043704|P2|Overall Study|Adverse Event|3
5227399|NCT00909480|18043705|P1|Overall Study|Adverse Event|5
5227400|NCT00909428|18043740|P3|Overall Study|Lost to Follow-up|9
5227401|NCT00909428|18043741|P2|Overall Study|Lost to Follow-up|10
5227402|NCT00909428|18043742|P1|Overall Study|Lost to Follow-up|13
5227403|NCT00909389|18043749|P1|Overall Study|No Information|103
5227404|NCT00909389|18043749|P1|Overall Study|Lost to Follow-up|4
5227405|NCT00909389|18043749|P1|Overall Study|Poor Compliance|16
5227406|NCT00909389|18043749|P1|Overall Study|Death|4
5227407|NCT00909389|18043749|P1|Overall Study|Adverse Event|6
5227408|NCT00909363|18043756|P3|Overall Study|Lack of Efficacy|0
5227409|NCT00909363|18043757|P2|Overall Study|Lack of Efficacy|0
5227410|NCT00909363|18043758|P1|Overall Study|Lack of Efficacy|1
5227411|NCT00909363|18043756|P3|Overall Study|Withdrawal by Subject|0
5227412|NCT00909363|18043757|P2|Overall Study|Withdrawal by Subject|0
5227413|NCT00909363|18043758|P1|Overall Study|Withdrawal by Subject|1
5227414|NCT00909181|18043805|P3|Overall Study|Lost to Follow-up|33
5227415|NCT00909181|18043806|P2|Overall Study|Lost to Follow-up|18
5227416|NCT00909181|18043807|P1|Overall Study|Lost to Follow-up|39
5227417|NCT00909090|18043833|P2|Overall Study|Lost to Follow-up|17
5227418|NCT00909090|18043834|P1|Overall Study|Lost to Follow-up|17
5227419|NCT00909038|18043852|P1|Overall Study|Non-evaluable Subjects|230
5227420|NCT00909038|18043852|P1|Overall Study|Protocol Violation|187
5227421|NCT00908960|18043864|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
5227422|NCT00908960|18043865|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
5227423|NCT00908960|18043866|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
5227424|NCT00908895|18043910|P2|Overall Study|Adverse Event|1
5227425|NCT00908895|18043911|P1|Overall Study|Adverse Event|1
5227426|NCT00908895|18043910|P2|Overall Study|algodystrophy|2
5227427|NCT00908895|18043911|P1|Overall Study|algodystrophy|2
5227428|NCT00908895|18043910|P2|Overall Study|Lost to Follow-up|3
5227429|NCT00908895|18043911|P1|Overall Study|Lost to Follow-up|1
5227430|NCT00908596|18044012|P4|Overall Study|Withdrawal by Subject|1
5227431|NCT00908596|18044013|P3|Overall Study|Withdrawal by Subject|3
5227432|NCT00908596|18044014|P2|Overall Study|Withdrawal by Subject|1
5227433|NCT00908596|18044015|P1|Overall Study|Withdrawal by Subject|0
5227434|NCT00908596|18044012|P4|Overall Study|Protocol Violation|0
5227435|NCT00908596|18044013|P3|Overall Study|Protocol Violation|0
5227436|NCT00908596|18044014|P2|Overall Study|Protocol Violation|0
5227437|NCT00908596|18044015|P1|Overall Study|Protocol Violation|1
5227438|NCT00908596|18044012|P4|Overall Study|Death|32
5227439|NCT00908596|18044013|P3|Overall Study|Death|57
5227440|NCT00908596|18044014|P2|Overall Study|Death|5
5227441|NCT00908596|18044015|P1|Overall Study|Death|0
5227442|NCT00908596|18044012|P4|Overall Study|Lost to Follow-up|4
5227443|NCT00908596|18044013|P3|Overall Study|Lost to Follow-up|12
5227444|NCT00908596|18044014|P2|Overall Study|Lost to Follow-up|1
5227445|NCT00908596|18044015|P1|Overall Study|Lost to Follow-up|0
5227446|NCT00908596|18044012|P4|Overall Study|Other reasons|0
5227447|NCT00908596|18044013|P3|Overall Study|Other reasons|2
5227448|NCT00908596|18044014|P2|Overall Study|Other reasons|6
5227449|NCT00908596|18044015|P1|Overall Study|Other reasons|46
5227450|NCT00908583|18044045|P1|Phase 5|Adverse Event|3
5227451|NCT00908583|18044045|P1|Phase 4|Physician Decision|1
5227452|NCT00908583|18044045|P1|Phase 4|Adverse Event|1
5227453|NCT00908583|18044045|P1|Phase 3|Adverse Event|2
5227454|NCT00908583|18044045|P1|Phase 2|Adverse Event|1
5227455|NCT00908583|18044045|P1|Phase 2|Physician Decision|1
5227456|NCT00908583|18044045|P1|Phase 1|Adverse Event|4
5227457|NCT00908583|18044045|P1|Phase 1|Withdrawal by Subject|1
5227458|NCT00908544|18044065|P2|Overall Study|Unable to visit sutdy center|0
5227459|NCT00908544|18044066|P1|Overall Study|Unable to visit sutdy center|1
5227460|NCT00908544|18044065|P2|Overall Study|Relocation abroad|1
5227461|NCT00908544|18044066|P1|Overall Study|Relocation abroad|1
5227462|NCT00908544|18044065|P2|Overall Study|Pregnancy|0
5227463|NCT00908544|18044066|P1|Overall Study|Pregnancy|1
5227464|NCT00908544|18044065|P2|Overall Study|Lack of Efficacy|1
5227465|NCT00908544|18044066|P1|Overall Study|Lack of Efficacy|0
5227466|NCT00908544|18044065|P2|Overall Study|Withdrawal by Subject|4
5227467|NCT00908544|18044066|P1|Overall Study|Withdrawal by Subject|2
5227468|NCT00908375|18044125|P2|Overall Study|Lost to Follow-up|6
5227469|NCT00908375|18044126|P1|Overall Study|Lost to Follow-up|8
5227470|NCT00908375|18044125|P2|Overall Study|Withdrawal by Subject|4
5227471|NCT00908375|18044126|P1|Overall Study|Withdrawal by Subject|2
5227472|NCT00908349|18044136|P1|Overall Study|Various|6
5227473|NCT00908349|18044136|P1|Overall Study|Lost to Follow-up|5
5227474|NCT00908349|18044136|P1|Overall Study|Physician Decision|5
5227475|NCT00908349|18044136|P1|Overall Study|Withdrawal by Subject|9
5227476|NCT00908349|18044136|P1|Overall Study|Adverse Event|10
5227477|NCT00908310|18044140|P1|Overall Study|Other reasons|4
5227478|NCT00908310|18044140|P1|Overall Study|Screening failure|5
5227479|NCT00908310|18044140|P1|Overall Study|Lost to Follow-up|7
5227480|NCT00908310|18044140|P1|Overall Study|Withdrawal by Subject|7
5227481|NCT00908310|18044140|P1|Overall Study|Death|37
5227482|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
5227483|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
5227484|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
5227485|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
5227486|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Other|0
5227487|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Other|0
5227488|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Other|1
5227489|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Other|3
5227490|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
5227491|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
5227492|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
5227493|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
5227494|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
5227495|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
5227496|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
5227497|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
5227498|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
5227499|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
5227500|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
5227501|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
5227502|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Death|0
5227503|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Death|0
5227504|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Death|0
5227505|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Death|2
5227506|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
5227507|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
5227508|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
5227509|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
5227510|NCT00908232|18044144|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
5227511|NCT00908232|18044145|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
5227512|NCT00908232|18044146|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
5227513|NCT00908232|18044147|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
5227514|NCT00908232|18044144|P4|Cycle 1 to 4|Other|0
5227515|NCT00908232|18044145|P3|Cycle 1 to 4|Other|0
5227516|NCT00908232|18044146|P2|Cycle 1 to 4|Other|0
5227517|NCT00908232|18044147|P1|Cycle 1 to 4|Other|1
5227518|NCT00908232|18044144|P4|Cycle 1 to 4|Adverse Event|0
5227519|NCT00908232|18044145|P3|Cycle 1 to 4|Adverse Event|0
5227520|NCT00908232|18044146|P2|Cycle 1 to 4|Adverse Event|0
5227521|NCT00908232|18044147|P1|Cycle 1 to 4|Adverse Event|12
5227522|NCT00908232|18044144|P4|Cycle 1 to 4|Progressive Disease|0
5227523|NCT00908232|18044145|P3|Cycle 1 to 4|Progressive Disease|0
5227524|NCT00908232|18044146|P2|Cycle 1 to 4|Progressive Disease|0
5227525|NCT00908232|18044147|P1|Cycle 1 to 4|Progressive Disease|6
5227526|NCT00908232|18044144|P4|Cycle 1 to 4|Withdrawal by Subject|0
5227527|NCT00908232|18044145|P3|Cycle 1 to 4|Withdrawal by Subject|0
5227528|NCT00908232|18044146|P2|Cycle 1 to 4|Withdrawal by Subject|0
5227529|NCT00908232|18044147|P1|Cycle 1 to 4|Withdrawal by Subject|4
5227530|NCT00908232|18044144|P4|Cycle 1 to 4|Death|0
5227531|NCT00908232|18044145|P3|Cycle 1 to 4|Death|0
5227532|NCT00908232|18044146|P2|Cycle 1 to 4|Death|0
5227533|NCT00908232|18044147|P1|Cycle 1 to 4|Death|5
5227534|NCT00908141|18044165|P2|Overall Study|Withdrawal by Subject|1
5227535|NCT00908141|18044166|P1|Overall Study|Withdrawal by Subject|0
5227536|NCT00908115|18044183|P1|Overall Study|Other|14
5227537|NCT00908076|18044191|P2|Overall Study|Lack of Efficacy|1
5227538|NCT00908076|18044192|P1|Overall Study|Lack of Efficacy|1
5227539|NCT00908037|18044205|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227540|NCT00908037|18044206|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
5227541|NCT00908037|18044207|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227542|NCT00908037|18044208|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227543|NCT00908037|18044209|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227544|NCT00908037|18044210|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227545|NCT00908037|18044211|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227546|NCT00908037|18044212|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227547|NCT00908037|18044213|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227548|NCT00908037|18044214|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227549|NCT00908037|18044215|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227550|NCT00908037|18044216|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5227551|NCT00908037|18044205|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227552|NCT00908037|18044206|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227553|NCT00908037|18044207|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
5227554|NCT00908037|18044208|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227555|NCT00908037|18044209|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227556|NCT00908037|18044210|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227557|NCT00908037|18044211|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227558|NCT00908037|18044212|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227559|NCT00908037|18044213|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227560|NCT00908037|18044214|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227561|NCT00908037|18044215|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227562|NCT00908037|18044216|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5227563|NCT00908037|18044205|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227564|NCT00908037|18044206|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
5227565|NCT00908037|18044207|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227566|NCT00908037|18044208|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227567|NCT00908037|18044209|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227568|NCT00908037|18044210|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227569|NCT00908037|18044211|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227570|NCT00908037|18044212|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227571|NCT00908037|18044213|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227572|NCT00908037|18044214|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227573|NCT00908037|18044215|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227574|NCT00908037|18044216|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5227575|NCT00908037|18044205|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227576|NCT00908037|18044206|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227577|NCT00908037|18044207|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
5227578|NCT00908037|18044208|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227579|NCT00908037|18044209|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227580|NCT00908037|18044210|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227581|NCT00908037|18044211|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227582|NCT00908037|18044212|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227583|NCT00908037|18044213|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227656|NCT00907803|18044395|P1|Overall Study|Protocol Violation|0
5227584|NCT00908037|18044214|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227585|NCT00908037|18044215|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227586|NCT00908037|18044216|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5227587|NCT00908037|18044205|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
5227588|NCT00908037|18044206|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227589|NCT00908037|18044207|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
5227590|NCT00908037|18044208|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227591|NCT00908037|18044209|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227592|NCT00908037|18044210|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227593|NCT00908037|18044211|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227594|NCT00908037|18044212|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227595|NCT00908037|18044213|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227596|NCT00908037|18044214|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227597|NCT00908037|18044215|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227598|NCT00908037|18044216|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5227599|NCT00908037|18044205|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
5227600|NCT00908037|18044206|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227601|NCT00908037|18044207|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227602|NCT00908037|18044208|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227603|NCT00908037|18044209|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227604|NCT00908037|18044210|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227605|NCT00908037|18044211|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227606|NCT00908037|18044212|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227607|NCT00908037|18044213|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227608|NCT00908037|18044214|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227609|NCT00908037|18044215|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227610|NCT00908037|18044216|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5227611|NCT00908037|18044205|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227612|NCT00908037|18044206|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227613|NCT00908037|18044207|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227614|NCT00908037|18044208|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227615|NCT00908037|18044209|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227616|NCT00908037|18044210|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
5227617|NCT00908037|18044211|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227618|NCT00908037|18044212|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227619|NCT00908037|18044213|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
5227620|NCT00908037|18044214|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227621|NCT00908037|18044215|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227622|NCT00908037|18044216|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5227623|NCT00908037|18044205|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227624|NCT00908037|18044206|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227625|NCT00908037|18044207|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227626|NCT00908037|18044208|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
5227627|NCT00908037|18044209|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227628|NCT00908037|18044210|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227629|NCT00908037|18044211|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227630|NCT00908037|18044212|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
5227631|NCT00908037|18044213|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227632|NCT00908037|18044214|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227633|NCT00908037|18044215|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227634|NCT00908037|18044216|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5227635|NCT00908037|18044205|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227636|NCT00908037|18044206|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227637|NCT00908037|18044207|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227638|NCT00908037|18044208|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
5227639|NCT00908037|18044209|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227640|NCT00908037|18044210|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
5227641|NCT00908037|18044211|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227642|NCT00908037|18044212|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
5227643|NCT00908037|18044213|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227644|NCT00908037|18044214|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227645|NCT00908037|18044215|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227646|NCT00908037|18044216|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5227647|NCT00908011|18044365|P2|Overall Study|Withdrawal by Subject|2
5227648|NCT00908011|18044366|P1|Overall Study|Withdrawal by Subject|2
5227649|NCT00907881|18044383|P1|Overall Study|Missing discontinuation information|15
5227650|NCT00907881|18044383|P1|Overall Study|Protocol Violation|1
5227651|NCT00907881|18044383|P1|Overall Study|Withdrawal by Subject|5
5227652|NCT00907881|18044383|P1|Overall Study|Noncompliance|5
5227653|NCT00907881|18044383|P1|Overall Study|Lost to Follow-up|59
5227654|NCT00907803|18044393|P3|Overall Study|Protocol Violation|0
5227655|NCT00907803|18044394|P2|Overall Study|Protocol Violation|1
5227657|NCT00907803|18044393|P3|Overall Study|Lost to Follow-up|0
5227658|NCT00907803|18044394|P2|Overall Study|Lost to Follow-up|1
5227659|NCT00907803|18044395|P1|Overall Study|Lost to Follow-up|0
5227660|NCT00907803|18044393|P3|Overall Study|Withdrawal by Subject|0
5227661|NCT00907803|18044394|P2|Overall Study|Withdrawal by Subject|1
5227662|NCT00907803|18044395|P1|Overall Study|Withdrawal by Subject|0
5227663|NCT00907803|18044393|P3|Overall Study|Adverse Event|0
5227664|NCT00907803|18044394|P2|Overall Study|Adverse Event|0
5227665|NCT00907803|18044395|P1|Overall Study|Adverse Event|2
5227666|NCT00907803|18044393|P3|Overall Study|Withdrawal of consent - long commute|0
5227667|NCT00907803|18044394|P2|Overall Study|Withdrawal of consent - long commute|0
5227668|NCT00907803|18044395|P1|Overall Study|Withdrawal of consent - long commute|1
5227669|NCT00907777|18044426|P2|Overall Study|Withdrawal by Subject|1
5227670|NCT00907777|18044427|P1|Overall Study|Withdrawal by Subject|0
5227671|NCT00907738|18044454|P5|Overall Study|Disease progression|2
5227672|NCT00907738|18044455|P4|Overall Study|Disease progression|4
5227673|NCT00907738|18044456|P3|Overall Study|Disease progression|6
5227674|NCT00907738|18044457|P2|Overall Study|Disease progression|1
5227675|NCT00907738|18044458|P1|Overall Study|Disease progression|8
5227676|NCT00907738|18044454|P5|Overall Study|not specified or withdrew consent|0
5227677|NCT00907738|18044455|P4|Overall Study|not specified or withdrew consent|0
5227678|NCT00907738|18044456|P3|Overall Study|not specified or withdrew consent|0
5227679|NCT00907738|18044457|P2|Overall Study|not specified or withdrew consent|0
5227680|NCT00907738|18044458|P1|Overall Study|not specified or withdrew consent|3
5227681|NCT00907738|18044454|P5|Overall Study|Adverse Event|0
5227682|NCT00907738|18044455|P4|Overall Study|Adverse Event|0
5227683|NCT00907738|18044456|P3|Overall Study|Adverse Event|1
5227684|NCT00907738|18044457|P2|Overall Study|Adverse Event|0
5227685|NCT00907738|18044458|P1|Overall Study|Adverse Event|2
5227686|NCT00907621|18044476|P2|Overall Study|intercurrent febrile illness|1
5227687|NCT00907621|18044477|P1|Overall Study|intercurrent febrile illness|1
5227688|NCT00907621|18044476|P2|Overall Study|Lost to Follow-up|3
5227689|NCT00907621|18044477|P1|Overall Study|Lost to Follow-up|6
5227690|NCT00907517|18044490|P5|Overall Study|Symptomatic Deterioration|1
5227691|NCT00907517|18044491|P4|Overall Study|Symptomatic Deterioration|0
5227692|NCT00907517|18044492|P3|Overall Study|Symptomatic Deterioration|0
5227693|NCT00907517|18044493|P2|Overall Study|Symptomatic Deterioration|0
5227694|NCT00907517|18044494|P1|Overall Study|Symptomatic Deterioration|0
5227695|NCT00907517|18044490|P5|Overall Study|Progressive Disease|4
5227696|NCT00907517|18044491|P4|Overall Study|Progressive Disease|4
5227697|NCT00907517|18044492|P3|Overall Study|Progressive Disease|4
5227698|NCT00907517|18044493|P2|Overall Study|Progressive Disease|3
5227699|NCT00907517|18044494|P1|Overall Study|Progressive Disease|3
5227700|NCT00907478|18044519|P3|Overall Study|Other|1
5227701|NCT00907478|18044520|P2|Overall Study|Other|0
5227702|NCT00907478|18044521|P1|Overall Study|Other|3
5227703|NCT00907478|18044519|P3|Overall Study|Lost to Follow-up|0
5227704|NCT00907478|18044520|P2|Overall Study|Lost to Follow-up|0
5227705|NCT00907478|18044521|P1|Overall Study|Lost to Follow-up|1
5227706|NCT00907478|18044519|P3|Overall Study|Pregnancy|1
5227707|NCT00907478|18044520|P2|Overall Study|Pregnancy|1
5227708|NCT00907478|18044521|P1|Overall Study|Pregnancy|0
5227709|NCT00907478|18044519|P3|Overall Study|Protocol-specified criteria|3
5227710|NCT00907478|18044520|P2|Overall Study|Protocol-specified criteria|2
5227711|NCT00907478|18044521|P1|Overall Study|Protocol-specified criteria|5
5227712|NCT00907478|18044519|P3|Overall Study|Death|1
5227713|NCT00907478|18044520|P2|Overall Study|Death|2
5227714|NCT00907478|18044521|P1|Overall Study|Death|4
5227715|NCT00907478|18044519|P3|Overall Study|Physician Decision|3
5227716|NCT00907478|18044520|P2|Overall Study|Physician Decision|0
5227717|NCT00907478|18044521|P1|Overall Study|Physician Decision|2
5227718|NCT00907478|18044519|P3|Overall Study|Requirement for alternative therapy|3
5227719|NCT00907478|18044520|P2|Overall Study|Requirement for alternative therapy|2
5227720|NCT00907478|18044521|P1|Overall Study|Requirement for alternative therapy|1
5227721|NCT00907478|18044519|P3|Overall Study|Withdrawal by Subject|6
5227722|NCT00907478|18044520|P2|Overall Study|Withdrawal by Subject|9
5227723|NCT00907478|18044521|P1|Overall Study|Withdrawal by Subject|8
5227724|NCT00907478|18044519|P3|Overall Study|Adverse Event|2
5227725|NCT00907478|18044520|P2|Overall Study|Adverse Event|1
5227726|NCT00907478|18044521|P1|Overall Study|Adverse Event|3
5227727|NCT00907478|18044519|P3|Overall Study|Noncompliance|1
5227728|NCT00907478|18044520|P2|Overall Study|Noncompliance|0
5227729|NCT00907478|18044521|P1|Overall Study|Noncompliance|0
5227730|NCT00907478|18044519|P3|Overall Study|Ineligibility determined|1
5227731|NCT00907478|18044520|P2|Overall Study|Ineligibility determined|0
5227732|NCT00907478|18044521|P1|Overall Study|Ineligibility determined|0
5227733|NCT00907374|18044571|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
5227734|NCT00907374|18044572|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
5227735|NCT00907335|18044586|P2|Overall Study|Lost to Follow-up|0
5227736|NCT00907335|18044587|P1|Overall Study|Lost to Follow-up|2
5227737|NCT00907335|18044586|P2|Overall Study|Adverse Event|1
5227738|NCT00907335|18044587|P1|Overall Study|Adverse Event|4
5227739|NCT00907335|18044586|P2|Overall Study|Withdrawal by Subject|0
5227740|NCT00907335|18044587|P1|Overall Study|Withdrawal by Subject|2
5227741|NCT00907296|18044613|P10|Overall Study|Lost to Follow-up|4
5227742|NCT00907296|18044614|P9|Overall Study|Lost to Follow-up|0
5227743|NCT00907296|18044615|P8|Overall Study|Lost to Follow-up|2
5227744|NCT00907296|18044616|P7|Overall Study|Lost to Follow-up|2
5227745|NCT00907296|18044617|P6|Overall Study|Lost to Follow-up|3
5227746|NCT00907296|18044618|P5|Overall Study|Lost to Follow-up|0
5227747|NCT00907296|18044619|P4|Overall Study|Lost to Follow-up|2
5227748|NCT00907296|18044620|P3|Overall Study|Lost to Follow-up|0
5227749|NCT00907296|18044621|P2|Overall Study|Lost to Follow-up|1
5227750|NCT00907296|18044622|P1|Overall Study|Lost to Follow-up|9
5227751|NCT00907296|18044613|P10|Overall Study|Withdrawal by Subject|2
5227752|NCT00907296|18044614|P9|Overall Study|Withdrawal by Subject|4
5227753|NCT00907296|18044615|P8|Overall Study|Withdrawal by Subject|2
5227754|NCT00907296|18044616|P7|Overall Study|Withdrawal by Subject|3
5227755|NCT00907296|18044617|P6|Overall Study|Withdrawal by Subject|5
5227756|NCT00907296|18044618|P5|Overall Study|Withdrawal by Subject|1
5227757|NCT00907296|18044619|P4|Overall Study|Withdrawal by Subject|1
5227758|NCT00907296|18044620|P3|Overall Study|Withdrawal by Subject|1
5227759|NCT00907296|18044621|P2|Overall Study|Withdrawal by Subject|2
5227760|NCT00907296|18044622|P1|Overall Study|Withdrawal by Subject|7
5227761|NCT00907296|18044613|P10|Overall Study|Adverse Event|1
5227762|NCT00907296|18044614|P9|Overall Study|Adverse Event|0
5227763|NCT00907296|18044615|P8|Overall Study|Adverse Event|0
5227764|NCT00907296|18044616|P7|Overall Study|Adverse Event|1
5227765|NCT00907296|18044617|P6|Overall Study|Adverse Event|0
5227766|NCT00907296|18044618|P5|Overall Study|Adverse Event|0
5227767|NCT00907296|18044619|P4|Overall Study|Adverse Event|0
5227768|NCT00907296|18044620|P3|Overall Study|Adverse Event|0
5227769|NCT00907296|18044621|P2|Overall Study|Adverse Event|0
5227770|NCT00907296|18044622|P1|Overall Study|Adverse Event|2
5227771|NCT00907296|18044613|P10|Overall Study|Noncompliance|0
5227772|NCT00907296|18044614|P9|Overall Study|Noncompliance|0
5227773|NCT00907296|18044615|P8|Overall Study|Noncompliance|2
5227774|NCT00907296|18044616|P7|Overall Study|Noncompliance|0
5227775|NCT00907296|18044617|P6|Overall Study|Noncompliance|1
5227776|NCT00907296|18044618|P5|Overall Study|Noncompliance|0
5227777|NCT00907296|18044619|P4|Overall Study|Noncompliance|0
5227778|NCT00907296|18044620|P3|Overall Study|Noncompliance|1
5227779|NCT00907296|18044621|P2|Overall Study|Noncompliance|1
5227780|NCT00907296|18044622|P1|Overall Study|Noncompliance|1
5227781|NCT00907296|18044613|P10|Overall Study|Protocol Deviation|0
5227782|NCT00907296|18044614|P9|Overall Study|Protocol Deviation|0
5227783|NCT00907296|18044615|P8|Overall Study|Protocol Deviation|0
5227784|NCT00907296|18044616|P7|Overall Study|Protocol Deviation|0
5227785|NCT00907296|18044617|P6|Overall Study|Protocol Deviation|0
5227786|NCT00907296|18044618|P5|Overall Study|Protocol Deviation|0
5227787|NCT00907296|18044619|P4|Overall Study|Protocol Deviation|0
5227788|NCT00907296|18044620|P3|Overall Study|Protocol Deviation|0
5227789|NCT00907296|18044621|P2|Overall Study|Protocol Deviation|1
5227790|NCT00907296|18044622|P1|Overall Study|Protocol Deviation|0
5227791|NCT00907296|18044613|P10|Overall Study|Ineligibility Determined|0
5227792|NCT00907296|18044614|P9|Overall Study|Ineligibility Determined|0
5227793|NCT00907296|18044615|P8|Overall Study|Ineligibility Determined|1
5227794|NCT00907296|18044616|P7|Overall Study|Ineligibility Determined|0
5227795|NCT00907296|18044617|P6|Overall Study|Ineligibility Determined|0
5227796|NCT00907296|18044618|P5|Overall Study|Ineligibility Determined|0
5227797|NCT00907296|18044619|P4|Overall Study|Ineligibility Determined|1
5227798|NCT00907296|18044620|P3|Overall Study|Ineligibility Determined|0
5227799|NCT00907296|18044621|P2|Overall Study|Ineligibility Determined|0
5227800|NCT00907296|18044622|P1|Overall Study|Ineligibility Determined|1
5227801|NCT00907257|18044676|P2|Overall Study|Personal Reasons|1
5227802|NCT00907257|18044677|P1|Overall Study|Personal Reasons|6
5227803|NCT00907257|18044676|P2|Overall Study|Moved|0
5227804|NCT00907257|18044677|P1|Overall Study|Moved|1
5227805|NCT00907257|18044676|P2|Overall Study|Per IRB-Subject became vulnerable|0
5227806|NCT00907257|18044677|P1|Overall Study|Per IRB-Subject became vulnerable|1
5227807|NCT00907257|18044676|P2|Overall Study|Withdrawal by Subject|2
5227808|NCT00907257|18044677|P1|Overall Study|Withdrawal by Subject|1
5227809|NCT00907257|18044676|P2|Overall Study|Lost to Follow-up|3
5227810|NCT00907257|18044677|P1|Overall Study|Lost to Follow-up|3
5227811|NCT00907257|18044676|P2|Overall Study|Protocol Violation|2
5227812|NCT00907257|18044677|P1|Overall Study|Protocol Violation|1
5227813|NCT00907257|18044676|P2|Overall Study|Adverse Event|4
5227814|NCT00907257|18044677|P1|Overall Study|Adverse Event|0
5227815|NCT00907153|18044699|P2|Overall Study|Withdrawal by Subject|3
5227816|NCT00907153|18044700|P1|Overall Study|Withdrawal by Subject|1
5227817|NCT00907153|18044699|P2|Overall Study|Lost to Follow-up|1
5227818|NCT00907153|18044700|P1|Overall Study|Lost to Follow-up|1
5227819|NCT00906971|18044761|P2|Overall Study|Lost to Follow-up|1
5227820|NCT00906971|18044762|P1|Overall Study|Lost to Follow-up|0
5227821|NCT00906971|18044761|P2|Overall Study|Withdrawal by Subject|2
5227822|NCT00906971|18044762|P1|Overall Study|Withdrawal by Subject|8
5227823|NCT00906945|18044775|P6|Overall Study|Physician Decision|1
5227824|NCT00906945|18044776|P5|Overall Study|Physician Decision|0
5227825|NCT00906945|18044777|P4|Overall Study|Physician Decision|0
5227826|NCT00906945|18044778|P3|Overall Study|Physician Decision|0
5227827|NCT00906945|18044779|P2|Overall Study|Physician Decision|0
5227828|NCT00906945|18044780|P1|Overall Study|Physician Decision|0
5227829|NCT00906945|18044775|P6|Overall Study|Found to be not eligible|1
5227830|NCT00906945|18044776|P5|Overall Study|Found to be not eligible|1
5227831|NCT00906945|18044777|P4|Overall Study|Found to be not eligible|1
5227832|NCT00906945|18044778|P3|Overall Study|Found to be not eligible|0
5227833|NCT00906945|18044779|P2|Overall Study|Found to be not eligible|0
5227834|NCT00906945|18044780|P1|Overall Study|Found to be not eligible|0
5227835|NCT00906698|18044840|P6|Overall Study|incl. non compliance, lost to follow-up|0
5227836|NCT00906698|18044841|P5|Overall Study|incl. non compliance, lost to follow-up|0
5227837|NCT00906698|18044842|P4|Overall Study|incl. non compliance, lost to follow-up|0
5227838|NCT00906698|18044843|P3|Overall Study|incl. non compliance, lost to follow-up|0
5227839|NCT00906698|18044844|P2|Overall Study|incl. non compliance, lost to follow-up|1
5227840|NCT00906698|18044845|P1|Overall Study|incl. non compliance, lost to follow-up|0
5227841|NCT00906698|18044840|P6|Overall Study|Withdrawal by Subject|0
5227842|NCT00906698|18044841|P5|Overall Study|Withdrawal by Subject|1
5227843|NCT00906698|18044842|P4|Overall Study|Withdrawal by Subject|0
5227844|NCT00906698|18044843|P3|Overall Study|Withdrawal by Subject|0
5227845|NCT00906698|18044844|P2|Overall Study|Withdrawal by Subject|0
5227846|NCT00906698|18044845|P1|Overall Study|Withdrawal by Subject|0
5227847|NCT00906698|18044840|P6|Overall Study|Disease progression|4
5227848|NCT00906698|18044841|P5|Overall Study|Disease progression|12
5227849|NCT00906698|18044842|P4|Overall Study|Disease progression|4
5227850|NCT00906698|18044843|P3|Overall Study|Disease progression|4
5227851|NCT00906698|18044844|P2|Overall Study|Disease progression|12
5227852|NCT00906698|18044845|P1|Overall Study|Disease progression|3
5227853|NCT00906698|18044840|P6|Overall Study|Adverse Event|1
5227854|NCT00906698|18044841|P5|Overall Study|Adverse Event|4
5227855|NCT00906698|18044842|P4|Overall Study|Adverse Event|0
5227856|NCT00906698|18044843|P3|Overall Study|Adverse Event|2
5227857|NCT00906698|18044844|P2|Overall Study|Adverse Event|0
5227858|NCT00906698|18044845|P1|Overall Study|Adverse Event|0
5227859|NCT00906698|18044840|P6|Overall Study|Dose-limiting toxicity (DLT)|0
5227860|NCT00906698|18044841|P5|Overall Study|Dose-limiting toxicity (DLT)|1
5227861|NCT00906698|18044842|P4|Overall Study|Dose-limiting toxicity (DLT)|0
5227862|NCT00906698|18044843|P3|Overall Study|Dose-limiting toxicity (DLT)|0
5227863|NCT00906698|18044844|P2|Overall Study|Dose-limiting toxicity (DLT)|6
5227864|NCT00906698|18044845|P1|Overall Study|Dose-limiting toxicity (DLT)|0
5227865|NCT00906399|18044947|P7|Year 2|Other|0
5227866|NCT00906399|18044948|P6|Year 2|Other|1
5227867|NCT00906399|18044949|P5|Year 2|Other|3
5227868|NCT00906399|18044950|P4|Year 2|Other|2
5227869|NCT00906399|18044951|P3|Year 2|Other|0
5227870|NCT00906399|18044952|P2|Year 2|Other|0
5227871|NCT00906399|18044953|P1|Year 2|Other|0
5227872|NCT00906399|18044947|P7|Year 2|Death|3
5227873|NCT00906399|18044948|P6|Year 2|Death|0
5227874|NCT00906399|18044949|P5|Year 2|Death|0
5227875|NCT00906399|18044950|P4|Year 2|Death|1
5227876|NCT00906399|18044951|P3|Year 2|Death|0
5227877|NCT00906399|18044952|P2|Year 2|Death|0
5227878|NCT00906399|18044953|P1|Year 2|Death|0
5227879|NCT00906399|18044947|P7|Year 2|Physician Decision|3
5227880|NCT00906399|18044948|P6|Year 2|Physician Decision|6
5227881|NCT00906399|18044949|P5|Year 2|Physician Decision|2
5227882|NCT00906399|18044950|P4|Year 2|Physician Decision|0
5227883|NCT00906399|18044951|P3|Year 2|Physician Decision|0
5227884|NCT00906399|18044952|P2|Year 2|Physician Decision|0
5227885|NCT00906399|18044953|P1|Year 2|Physician Decision|0
5227886|NCT00906399|18044947|P7|Year 2|Withdrawal by Subject|13
5227887|NCT00906399|18044948|P6|Year 2|Withdrawal by Subject|27
5227888|NCT00906399|18044949|P5|Year 2|Withdrawal by Subject|18
5227889|NCT00906399|18044950|P4|Year 2|Withdrawal by Subject|17
5227890|NCT00906399|18044951|P3|Year 2|Withdrawal by Subject|0
5227891|NCT00906399|18044952|P2|Year 2|Withdrawal by Subject|0
5227892|NCT00906399|18044953|P1|Year 2|Withdrawal by Subject|0
5227893|NCT00906399|18044947|P7|Year 2|Lost to Follow-up|4
5227894|NCT00906399|18044948|P6|Year 2|Lost to Follow-up|2
5227895|NCT00906399|18044949|P5|Year 2|Lost to Follow-up|4
5227896|NCT00906399|18044950|P4|Year 2|Lost to Follow-up|1
5227897|NCT00906399|18044951|P3|Year 2|Lost to Follow-up|0
5227898|NCT00906399|18044952|P2|Year 2|Lost to Follow-up|0
5227899|NCT00906399|18044953|P1|Year 2|Lost to Follow-up|0
5227900|NCT00906399|18044947|P7|Year 2|Adverse Event|6
5227901|NCT00906399|18044948|P6|Year 2|Adverse Event|11
5227902|NCT00906399|18044949|P5|Year 2|Adverse Event|8
5227903|NCT00906399|18044950|P4|Year 2|Adverse Event|9
5227904|NCT00906399|18044951|P3|Year 2|Adverse Event|0
5227905|NCT00906399|18044952|P2|Year 2|Adverse Event|0
5227906|NCT00906399|18044953|P1|Year 2|Adverse Event|0
5227907|NCT00906399|18044947|P7|Year 1|Other|0
5227908|NCT00906399|18044948|P6|Year 1|Other|0
5227909|NCT00906399|18044949|P5|Year 1|Other|0
5227910|NCT00906399|18044950|P4|Year 1|Other|0
5227911|NCT00906399|18044951|P3|Year 1|Other|7
5227912|NCT00906399|18044952|P2|Year 1|Other|2
5227913|NCT00906399|18044953|P1|Year 1|Other|4
5227914|NCT00906399|18044947|P7|Year 1|Death|0
5227915|NCT00906399|18044948|P6|Year 1|Death|0
5227916|NCT00906399|18044949|P5|Year 1|Death|0
5227917|NCT00906399|18044950|P4|Year 1|Death|0
5227918|NCT00906399|18044951|P3|Year 1|Death|1
5227919|NCT00906399|18044952|P2|Year 1|Death|1
5227920|NCT00906399|18044953|P1|Year 1|Death|2
5227921|NCT00906399|18044947|P7|Year 1|Physician Decision|0
5227922|NCT00906399|18044948|P6|Year 1|Physician Decision|0
5227923|NCT00906399|18044949|P5|Year 1|Physician Decision|0
5227924|NCT00906399|18044950|P4|Year 1|Physician Decision|0
5227925|NCT00906399|18044951|P3|Year 1|Physician Decision|3
5227926|NCT00906399|18044952|P2|Year 1|Physician Decision|1
5227927|NCT00906399|18044953|P1|Year 1|Physician Decision|0
5227928|NCT00906399|18044947|P7|Year 1|Withdrawal by Subject|0
5227929|NCT00906399|18044948|P6|Year 1|Withdrawal by Subject|0
5227930|NCT00906399|18044949|P5|Year 1|Withdrawal by Subject|0
5227931|NCT00906399|18044950|P4|Year 1|Withdrawal by Subject|0
5227932|NCT00906399|18044951|P3|Year 1|Withdrawal by Subject|36
5227933|NCT00906399|18044952|P2|Year 1|Withdrawal by Subject|32
5227934|NCT00906399|18044953|P1|Year 1|Withdrawal by Subject|30
5227935|NCT00906399|18044947|P7|Year 1|Lost to Follow-up|0
5227936|NCT00906399|18044948|P6|Year 1|Lost to Follow-up|0
5227937|NCT00906399|18044949|P5|Year 1|Lost to Follow-up|0
5227938|NCT00906399|18044950|P4|Year 1|Lost to Follow-up|0
5227939|NCT00906399|18044951|P3|Year 1|Lost to Follow-up|2
5227940|NCT00906399|18044952|P2|Year 1|Lost to Follow-up|4
5227941|NCT00906399|18044953|P1|Year 1|Lost to Follow-up|4
5227942|NCT00906399|18044947|P7|Year 1|Adverse Event|0
5227943|NCT00906399|18044948|P6|Year 1|Adverse Event|0
5227944|NCT00906399|18044949|P5|Year 1|Adverse Event|0
5227945|NCT00906399|18044950|P4|Year 1|Adverse Event|0
5227946|NCT00906399|18044951|P3|Year 1|Adverse Event|24
5227947|NCT00906399|18044952|P2|Year 1|Adverse Event|22
5227948|NCT00906399|18044953|P1|Year 1|Adverse Event|4
5227949|NCT00906399|18044947|P7|Year 1|Randomized But Not Treated|0
5227950|NCT00906399|18044948|P6|Year 1|Randomized But Not Treated|0
5227951|NCT00906399|18044949|P5|Year 1|Randomized But Not Treated|0
5227952|NCT00906399|18044950|P4|Year 1|Randomized But Not Treated|0
5227953|NCT00906399|18044951|P3|Year 1|Randomized But Not Treated|3
5227954|NCT00906399|18044952|P2|Year 1|Randomized But Not Treated|1
5227955|NCT00906399|18044953|P1|Year 1|Randomized But Not Treated|0
5227956|NCT00906373|18044976|P2|Overall Study|Still on treatment at cutoff date|2
5227957|NCT00906373|18044977|P1|Overall Study|Still on treatment at cutoff date|0
5227958|NCT00906373|18044976|P2|Overall Study|Other|1
5227959|NCT00906373|18044977|P1|Overall Study|Other|0
5227960|NCT00906373|18044976|P2|Overall Study|Withdrawal by Subject|5
5227961|NCT00906373|18044977|P1|Overall Study|Withdrawal by Subject|0
5227962|NCT00906347|18045016|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
5227963|NCT00906347|18045017|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
5227964|NCT00906347|18045016|P2|Received Study Drug|Refused study drug|0
5227965|NCT00906347|18045017|P1|Received Study Drug|Refused study drug|1
5227966|NCT00906347|18045016|P2|Received Study Drug|Nonreassuring fetal heart rate|1
5227967|NCT00906347|18045017|P1|Received Study Drug|Nonreassuring fetal heart rate|13
5227968|NCT00906347|18045016|P2|Received Study Drug|8 cm prior to initiation of study drug|30
5227969|NCT00906347|18045017|P1|Received Study Drug|8 cm prior to initiation of study drug|18
5227970|NCT00906282|18045037|P1|Preoperative Chemotherapy|Toxicity|1
5227971|NCT00906282|18045037|P1|Preoperative Chemotherapy|Progressive disease|6
5227972|NCT00906282|18045037|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
5227973|NCT00906282|18045037|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
5227974|NCT00906204|18045051|P2|Secondary Endpoints (Long-term Safety)|Death|1
5227975|NCT00906204|18045052|P1|Secondary Endpoints (Long-term Safety)|Death|0
5227976|NCT00906204|18045051|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
5227977|NCT00906204|18045052|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
5227978|NCT00906204|18045051|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
5227979|NCT00906204|18045052|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
5227980|NCT00906204|18045051|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
5227981|NCT00906204|18045052|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
5227982|NCT00906204|18045051|P2|Primary Endpoint (Early Safety)|Physician Decision|0
5227983|NCT00906204|18045052|P1|Primary Endpoint (Early Safety)|Physician Decision|1
5227984|NCT00906087|18045106|P1|Initial Washout|Physician Decision|1
5227985|NCT00906087|18045106|P1|Initial Washout|Withdrawal by Subject|1
5227986|NCT00906035|18045143|P3|Overall Study|Withdrawal by Subject|0
5227987|NCT00906035|18045144|P2|Overall Study|Withdrawal by Subject|3
5227988|NCT00906035|18045145|P1|Overall Study|Withdrawal by Subject|2
5227989|NCT00905840|18045159|P1|Overall Study|Adverse Event|1
5227990|NCT00905840|18045159|P1|Overall Study|Withdrawal by Subject|1
5227991|NCT00905840|18045159|P1|Overall Study|Death|3
5227992|NCT00905840|18045159|P1|Overall Study|Lost to Follow-up|11
5227993|NCT00905632|18045190|P7|Overall Study|Adverse Event|4
5227994|NCT00905632|18045191|P6|Overall Study|Adverse Event|1
5227995|NCT00905632|18045192|P5|Overall Study|Adverse Event|0
5227996|NCT00905632|18045193|P4|Overall Study|Adverse Event|0
5227997|NCT00905632|18045194|P3|Overall Study|Adverse Event|0
5227998|NCT00905632|18045195|P2|Overall Study|Adverse Event|0
5227999|NCT00905632|18045196|P1|Overall Study|Adverse Event|0
5228000|NCT00905606|18045334|P2|Washout|Withdrawal by Subject|0
5228001|NCT00905606|18045335|P1|Washout|Withdrawal by Subject|1
5228002|NCT00905606|18045334|P2|Period 1|Adverse Event|1
5228003|NCT00905606|18045335|P1|Period 1|Adverse Event|0
5228004|NCT00905567|18045360|P2|Washout|Withdrawal by Subject|1
5228005|NCT00905567|18045361|P1|Washout|Withdrawal by Subject|0
5228006|NCT00905489|18045393|P1|Optional Extension Phase (OEP)|Adverse Event|1
5228007|NCT00905489|18045393|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
5228008|NCT00905489|18045393|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
5228009|NCT00905437|18045483|P2|Overall Study|Other|6
5228010|NCT00905437|18045484|P1|Overall Study|Other|5
5228011|NCT00905437|18045483|P2|Overall Study|Withdrawal by Subject|1
5228012|NCT00905437|18045484|P1|Overall Study|Withdrawal by Subject|0
5228013|NCT00905437|18045483|P2|Overall Study|Lost to Follow-up|1
5228014|NCT00905437|18045484|P1|Overall Study|Lost to Follow-up|0
5228015|NCT00905437|18045483|P2|Overall Study|Adverse Event|2
5228016|NCT00905437|18045484|P1|Overall Study|Adverse Event|3
5228017|NCT00905424|18045504|P2|Overall Study|Non-adherence to visit schedule|1
5228018|NCT00905424|18045505|P1|Overall Study|Non-adherence to visit schedule|0
5228019|NCT00905424|18045504|P2|Overall Study|Positive urine drug screen|1
5228020|NCT00905424|18045505|P1|Overall Study|Positive urine drug screen|0
5228021|NCT00905424|18045504|P2|Overall Study|Sponsor decision|0
5228022|NCT00905424|18045505|P1|Overall Study|Sponsor decision|1
5228023|NCT00905424|18045504|P2|Overall Study|Non-compliance with study medication|0
5228024|NCT00905424|18045505|P1|Overall Study|Non-compliance with study medication|2
5228025|NCT00905424|18045504|P2|Overall Study|Adverse Event|2
5228026|NCT00905424|18045505|P1|Overall Study|Adverse Event|4
5228027|NCT00905424|18045504|P2|Overall Study|Withdrawal by Subject|2
5228028|NCT00905424|18045505|P1|Overall Study|Withdrawal by Subject|1
5228029|NCT00905424|18045504|P2|Overall Study|Lost to Follow-up|3
5228030|NCT00905424|18045505|P1|Overall Study|Lost to Follow-up|3
5228031|NCT00905359|18045547|P2|Overall Study|Withdrawal consent|6
5228032|NCT00905359|18045548|P1|Overall Study|Withdrawal consent|5
5228033|NCT00905359|18045547|P2|Overall Study|Death|0
5228034|NCT00905359|18045548|P1|Overall Study|Death|2
5228035|NCT00905359|18045547|P2|Overall Study|Lost to Follow-up|10
5228036|NCT00905359|18045548|P1|Overall Study|Lost to Follow-up|17
5228037|NCT00905346|18045584|P2|Period 1|Withdrawal by Subject|0
5228038|NCT00905346|18045585|P1|Period 1|Withdrawal by Subject|1
5228039|NCT00905307|18045599|P6|Overall Study|Lack of Efficacy|8
5228040|NCT00905307|18045600|P5|Overall Study|Lack of Efficacy|4
5228041|NCT00905307|18045601|P4|Overall Study|Lack of Efficacy|4
5228042|NCT00905307|18045602|P3|Overall Study|Lack of Efficacy|5
5228043|NCT00905307|18045603|P2|Overall Study|Lack of Efficacy|3
5228044|NCT00905307|18045604|P1|Overall Study|Lack of Efficacy|6
5228045|NCT00905307|18045599|P6|Overall Study|Protocol Violation|0
5228046|NCT00905307|18045600|P5|Overall Study|Protocol Violation|0
5228047|NCT00905307|18045601|P4|Overall Study|Protocol Violation|0
5228048|NCT00905307|18045602|P3|Overall Study|Protocol Violation|1
5228049|NCT00905307|18045603|P2|Overall Study|Protocol Violation|0
5228050|NCT00905307|18045604|P1|Overall Study|Protocol Violation|1
5228051|NCT00905307|18045599|P6|Overall Study|Withdrawal by Subject|13
5228052|NCT00905307|18045600|P5|Overall Study|Withdrawal by Subject|4
5228053|NCT00905307|18045601|P4|Overall Study|Withdrawal by Subject|11
5228054|NCT00905307|18045602|P3|Overall Study|Withdrawal by Subject|15
5228055|NCT00905307|18045603|P2|Overall Study|Withdrawal by Subject|13
5228056|NCT00905307|18045604|P1|Overall Study|Withdrawal by Subject|5
5228057|NCT00905307|18045599|P6|Overall Study|Adverse Event|5
5228058|NCT00905307|18045600|P5|Overall Study|Adverse Event|3
5228059|NCT00905307|18045601|P4|Overall Study|Adverse Event|11
5228060|NCT00905307|18045602|P3|Overall Study|Adverse Event|5
5228061|NCT00905307|18045603|P2|Overall Study|Adverse Event|4
5228062|NCT00905307|18045604|P1|Overall Study|Adverse Event|3
5228063|NCT00905307|18045599|P6|Overall Study|Lost to Follow-up|1
5228064|NCT00905307|18045600|P5|Overall Study|Lost to Follow-up|1
5228065|NCT00905307|18045601|P4|Overall Study|Lost to Follow-up|0
5228066|NCT00905307|18045602|P3|Overall Study|Lost to Follow-up|0
5228067|NCT00905307|18045603|P2|Overall Study|Lost to Follow-up|0
5228068|NCT00905307|18045604|P1|Overall Study|Lost to Follow-up|0
5228069|NCT00905307|18045599|P6|Overall Study|Switched to Open Label Rescue|15
5228070|NCT00905307|18045600|P5|Overall Study|Switched to Open Label Rescue|4
5228071|NCT00905307|18045601|P4|Overall Study|Switched to Open Label Rescue|11
5228072|NCT00905307|18045602|P3|Overall Study|Switched to Open Label Rescue|11
5228073|NCT00905307|18045603|P2|Overall Study|Switched to Open Label Rescue|17
5228074|NCT00905307|18045604|P1|Overall Study|Switched to Open Label Rescue|7
5228075|NCT00905255|18045699|P2|Overall Study|Familial and Personal Reasons|0
5228076|NCT00905255|18045700|P1|Overall Study|Familial and Personal Reasons|1
5228077|NCT00905255|18045699|P2|Overall Study|Withdrawal by Subject|4
5228078|NCT00905255|18045700|P1|Overall Study|Withdrawal by Subject|5
5228079|NCT00905255|18045699|P2|Overall Study|Adverse Event|5
5228080|NCT00905255|18045700|P1|Overall Study|Adverse Event|7
5228081|NCT00905164|18045718|P2|Period 1|Protocol Violation|1
5228082|NCT00905164|18045719|P1|Period 1|Protocol Violation|0
5228083|NCT00905034|18045766|P1|Overall Study|Withdrawal by Subject|1
5228084|NCT00905021|18045770|P1|Overall Study|Adverse Event|2
5228085|NCT00904982|18045790|P4|Overall Study|Withdrawal by Subject|0
5228086|NCT00904982|18045791|P3|Overall Study|Withdrawal by Subject|0
5228087|NCT00904982|18045792|P2|Overall Study|Withdrawal by Subject|0
5228088|NCT00904982|18045793|P1|Overall Study|Withdrawal by Subject|2
5228089|NCT00904969|18045803|P1|Overall Study|Case Aborted; Subject Exited|1
5228090|NCT00904969|18045803|P1|Overall Study|Additional Treatments|11
5228091|NCT00904969|18045803|P1|Overall Study|Withdrawal by Subject|3
5228092|NCT00904969|18045803|P1|Overall Study|Lost to Follow-up|4
5228093|NCT00904917|18045868|P4|Overall Study|Lost to Follow-up|2
5228094|NCT00904917|18045869|P3|Overall Study|Lost to Follow-up|2
5228095|NCT00904917|18045870|P2|Overall Study|Lost to Follow-up|2
5228096|NCT00904917|18045871|P1|Overall Study|Lost to Follow-up|2
5228097|NCT00904839|18045889|P3|Overall Study|Other than above|7
5228098|NCT00904839|18045890|P2|Overall Study|Other than above|9
5228099|NCT00904839|18045891|P1|Overall Study|Other than above|0
5228100|NCT00904839|18045889|P3|Overall Study|Not treated|1
5228101|NCT00904839|18045890|P2|Overall Study|Not treated|0
5228102|NCT00904839|18045891|P1|Overall Study|Not treated|1
5228103|NCT00904839|18045889|P3|Overall Study|Withdrawal by Subject|0
5228104|NCT00904839|18045890|P2|Overall Study|Withdrawal by Subject|2
5228105|NCT00904839|18045891|P1|Overall Study|Withdrawal by Subject|0
5228106|NCT00904839|18045889|P3|Overall Study|Lost to Follow-up|2
5228107|NCT00904839|18045890|P2|Overall Study|Lost to Follow-up|1
5228108|NCT00904839|18045891|P1|Overall Study|Lost to Follow-up|0
5228109|NCT00904839|18045889|P3|Overall Study|Protocol Violation|1
5228110|NCT00904839|18045890|P2|Overall Study|Protocol Violation|1
5228111|NCT00904839|18045891|P1|Overall Study|Protocol Violation|0
5228112|NCT00904839|18045889|P3|Overall Study|Adverse Event|4
5228113|NCT00904839|18045890|P2|Overall Study|Adverse Event|5
5228114|NCT00904839|18045891|P1|Overall Study|Adverse Event|0
5228115|NCT00904748|18045937|P6|Overall Study|Adverse Event|0
5228116|NCT00904748|18045938|P5|Overall Study|Adverse Event|1
5228117|NCT00904748|18045939|P4|Overall Study|Adverse Event|0
5228118|NCT00904748|18045940|P3|Overall Study|Adverse Event|0
5228119|NCT00904748|18045941|P2|Overall Study|Adverse Event|0
5228120|NCT00904748|18045942|P1|Overall Study|Adverse Event|0
5228121|NCT00904748|18045937|P6|Overall Study|Withdrawal by Subject|0
5228122|NCT00904748|18045938|P5|Overall Study|Withdrawal by Subject|0
5228123|NCT00904748|18045939|P4|Overall Study|Withdrawal by Subject|2
5228124|NCT00904748|18045940|P3|Overall Study|Withdrawal by Subject|1
5228125|NCT00904748|18045941|P2|Overall Study|Withdrawal by Subject|1
5228126|NCT00904748|18045942|P1|Overall Study|Withdrawal by Subject|1
5228127|NCT00904722|18045966|P1|Overall Study|Physician Decision|1
5228128|NCT00904670|18045971|P2|Open Label Phase|Lost to Follow-up|0
5228129|NCT00904670|18045972|P1|Open Label Phase|Lost to Follow-up|1
5228130|NCT00904670|18045971|P2|Open Label Phase|Lack of Efficacy|0
5228131|NCT00904670|18045972|P1|Open Label Phase|Lack of Efficacy|1
5228132|NCT00904670|18045971|P2|Open Label Phase|Adverse Event|0
5228133|NCT00904670|18045972|P1|Open Label Phase|Adverse Event|2
5228134|NCT00904670|18045971|P2|Open Label Phase|Withdrawal by Subject|0
5228135|NCT00904670|18045972|P1|Open Label Phase|Withdrawal by Subject|2
5228136|NCT00904371|18046042|P1|Overall Study|Continued with Tritace|1
5228137|NCT00904371|18046042|P1|Overall Study|Discontinued at target blood pressure|2
5228138|NCT00904371|18046042|P1|Overall Study|Lost to Follow-up|4
5228139|NCT00904371|18046042|P1|Overall Study|Adverse Event|2
5228140|NCT00904215|18046056|P1|Overall Study|Other|28
5228141|NCT00904215|18046056|P1|Overall Study|Withdrawal by Subject|9
5228142|NCT00904215|18046056|P1|Overall Study|Lost to Follow-up|63
5228143|NCT00904215|18046056|P1|Overall Study|Protocol Violation|10
5228144|NCT00904215|18046056|P1|Overall Study|Adverse Event|25
5228145|NCT00904150|18046070|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
5228146|NCT00904150|18046071|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
5228147|NCT00904150|18046070|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
5228148|NCT00904150|18046071|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
5228149|NCT00904033|18046093|P4|Overall Study|Unable to obtain final blood draw|2
5228150|NCT00904033|18046094|P3|Overall Study|Unable to obtain final blood draw|0
5228151|NCT00904033|18046095|P2|Overall Study|Unable to obtain final blood draw|0
5228152|NCT00904033|18046096|P1|Overall Study|Unable to obtain final blood draw|0
5228153|NCT00904033|18046093|P4|Overall Study|Physician Decision|0
5228154|NCT00904033|18046094|P3|Overall Study|Physician Decision|1
5228155|NCT00904033|18046095|P2|Overall Study|Physician Decision|0
5228156|NCT00904033|18046096|P1|Overall Study|Physician Decision|0
5228157|NCT00904033|18046093|P4|Overall Study|Withdrawal by Subject|0
5228158|NCT00904033|18046094|P3|Overall Study|Withdrawal by Subject|0
5228159|NCT00904033|18046095|P2|Overall Study|Withdrawal by Subject|1
5228160|NCT00904033|18046096|P1|Overall Study|Withdrawal by Subject|1
5228161|NCT00903968|18046161|P8|Overall Study|Lack of Efficacy|3
5228162|NCT00903968|18046162|P7|Overall Study|Lack of Efficacy|0
5228163|NCT00903968|18046163|P6|Overall Study|Lack of Efficacy|0
5228164|NCT00903968|18046164|P5|Overall Study|Lack of Efficacy|0
5228165|NCT00903968|18046165|P4|Overall Study|Lack of Efficacy|0
5228166|NCT00903968|18046166|P3|Overall Study|Lack of Efficacy|0
5228167|NCT00903968|18046167|P2|Overall Study|Lack of Efficacy|0
5228168|NCT00903968|18046168|P1|Overall Study|Lack of Efficacy|0
5228169|NCT00903968|18046161|P8|Overall Study|Progressive Disease|18
5228170|NCT00903968|18046162|P7|Overall Study|Progressive Disease|0
5228171|NCT00903968|18046163|P6|Overall Study|Progressive Disease|3
5228172|NCT00903968|18046164|P5|Overall Study|Progressive Disease|3
5228173|NCT00903968|18046165|P4|Overall Study|Progressive Disease|3
5228174|NCT00903968|18046166|P3|Overall Study|Progressive Disease|2
5228175|NCT00903968|18046167|P2|Overall Study|Progressive Disease|3
5228176|NCT00903968|18046168|P1|Overall Study|Progressive Disease|2
5228177|NCT00903968|18046161|P8|Overall Study|Physician Decision|0
5228178|NCT00903968|18046162|P7|Overall Study|Physician Decision|0
5228179|NCT00903968|18046163|P6|Overall Study|Physician Decision|1
5228180|NCT00903968|18046164|P5|Overall Study|Physician Decision|0
5228181|NCT00903968|18046165|P4|Overall Study|Physician Decision|0
5228182|NCT00903968|18046166|P3|Overall Study|Physician Decision|0
5228183|NCT00903968|18046167|P2|Overall Study|Physician Decision|0
5228184|NCT00903968|18046168|P1|Overall Study|Physician Decision|0
5228185|NCT00903968|18046161|P8|Overall Study|Non-Compliance|0
5228186|NCT00903968|18046162|P7|Overall Study|Non-Compliance|0
5228187|NCT00903968|18046163|P6|Overall Study|Non-Compliance|1
5228188|NCT00903968|18046164|P5|Overall Study|Non-Compliance|0
5228189|NCT00903968|18046165|P4|Overall Study|Non-Compliance|0
5228190|NCT00903968|18046166|P3|Overall Study|Non-Compliance|0
5228191|NCT00903968|18046167|P2|Overall Study|Non-Compliance|0
5228192|NCT00903968|18046168|P1|Overall Study|Non-Compliance|0
5228193|NCT00903968|18046161|P8|Overall Study|Withdrawal by Subject|4
5228194|NCT00903968|18046162|P7|Overall Study|Withdrawal by Subject|0
5228195|NCT00903968|18046163|P6|Overall Study|Withdrawal by Subject|1
5228196|NCT00903968|18046164|P5|Overall Study|Withdrawal by Subject|1
5228197|NCT00903968|18046165|P4|Overall Study|Withdrawal by Subject|0
5228198|NCT00903968|18046166|P3|Overall Study|Withdrawal by Subject|1
5228199|NCT00903968|18046167|P2|Overall Study|Withdrawal by Subject|0
5228200|NCT00903968|18046168|P1|Overall Study|Withdrawal by Subject|1
5228201|NCT00903968|18046161|P8|Overall Study|DLT|0
5228202|NCT00903968|18046162|P7|Overall Study|DLT|2
5228203|NCT00903968|18046163|P6|Overall Study|DLT|0
5228204|NCT00903968|18046164|P5|Overall Study|DLT|0
5228205|NCT00903968|18046165|P4|Overall Study|DLT|0
5228206|NCT00903968|18046166|P3|Overall Study|DLT|0
5228207|NCT00903968|18046167|P2|Overall Study|DLT|0
5228208|NCT00903968|18046168|P1|Overall Study|DLT|0
5228209|NCT00903968|18046161|P8|Overall Study|Adverse Event|8
5228210|NCT00903968|18046162|P7|Overall Study|Adverse Event|1
5228211|NCT00903968|18046163|P6|Overall Study|Adverse Event|0
5228212|NCT00903968|18046164|P5|Overall Study|Adverse Event|0
5228213|NCT00903968|18046165|P4|Overall Study|Adverse Event|0
5228214|NCT00903968|18046166|P3|Overall Study|Adverse Event|0
5228215|NCT00903968|18046167|P2|Overall Study|Adverse Event|0
5228216|NCT00903968|18046168|P1|Overall Study|Adverse Event|0
5228217|NCT00903929|18046198|P4|Overall Study|Adverse Event|1
5228218|NCT00903929|18046199|P3|Overall Study|Adverse Event|0
5228219|NCT00903929|18046200|P2|Overall Study|Adverse Event|0
5228220|NCT00903929|18046201|P1|Overall Study|Adverse Event|0
5228221|NCT00903929|18046198|P4|Overall Study|Withdrawal by Subject|2
5228222|NCT00903929|18046199|P3|Overall Study|Withdrawal by Subject|1
5228223|NCT00903929|18046200|P2|Overall Study|Withdrawal by Subject|0
5228224|NCT00903929|18046201|P1|Overall Study|Withdrawal by Subject|0
5228225|NCT00903877|18046207|P1|Overall Study|Participation put on hold|4
5228226|NCT00903877|18046207|P1|Overall Study|Lost to Follow-up|1
5228227|NCT00903877|18046207|P1|Overall Study|Adverse Event|2
5228228|NCT00903877|18046207|P1|Overall Study|Withdrawal by Subject|3
5228229|NCT00903877|18046207|P1|Overall Study|Did not meet study criteria|33
5228230|NCT00903786|18046211|P1|Overall Study|Reason other than lack of efficacy|4
5228231|NCT00903786|18046211|P1|Overall Study|Lack of Efficacy|5
5228232|NCT00903786|18046211|P1|Overall Study|Physician Decision|6
5228233|NCT00903760|18046221|P2|Overall Study|Off treatment for long period|1
5228234|NCT00903760|18046222|P1|Overall Study|Off treatment for long period|0
5228235|NCT00903760|18046221|P2|Overall Study|Withdrawal by Subject|2
5228236|NCT00903760|18046222|P1|Overall Study|Withdrawal by Subject|1
5228237|NCT00903760|18046221|P2|Overall Study|Lost to Follow-up|0
5228238|NCT00903760|18046222|P1|Overall Study|Lost to Follow-up|1
5228239|NCT00903760|18046221|P2|Overall Study|Death|1
5228240|NCT00903760|18046222|P1|Overall Study|Death|0
5228241|NCT00903760|18046221|P2|Overall Study|Physician Decision|2
5228242|NCT00903760|18046222|P1|Overall Study|Physician Decision|1
5228243|NCT00903760|18046221|P2|Overall Study|Stem Cell Transplant|4
5228244|NCT00903760|18046222|P1|Overall Study|Stem Cell Transplant|8
5228245|NCT00903760|18046221|P2|Overall Study|Disease Progression/Death|6
5228246|NCT00903760|18046222|P1|Overall Study|Disease Progression/Death|8
5228247|NCT00903695|18046232|P2|Overall Study|lung cancer|0
5228248|NCT00903695|18046233|P1|Overall Study|lung cancer|1
5228249|NCT00903695|18046232|P2|Overall Study|medical exclusion after 1st testing|0
5228250|NCT00903695|18046233|P1|Overall Study|medical exclusion after 1st testing|1
5228251|NCT00903682|18046255|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
5228252|NCT00903682|18046256|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
5228253|NCT00903682|18046255|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
5228254|NCT00903682|18046256|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
5228255|NCT00903682|18046255|P2|Overall Study|Subject Non-Compliant|0
5228256|NCT00903682|18046256|P1|Overall Study|Subject Non-Compliant|1
5228257|NCT00903682|18046255|P2|Overall Study|Subject Reached A Virologic Endpoint|1
5228258|NCT00903682|18046256|P1|Overall Study|Subject Reached A Virologic Endpoint|1
5228259|NCT00903682|18046255|P2|Overall Study|Pregnancy|1
5228260|NCT00903682|18046256|P1|Overall Study|Pregnancy|0
5228261|NCT00903682|18046255|P2|Overall Study|Withdrawal by Subject|0
5228262|NCT00903682|18046256|P1|Overall Study|Withdrawal by Subject|5
5228263|NCT00903682|18046255|P2|Overall Study|Lost to Follow-up|0
5228264|NCT00903682|18046256|P1|Overall Study|Lost to Follow-up|1
5228265|NCT00903682|18046255|P2|Overall Study|Adverse Event|13
5228266|NCT00903682|18046256|P1|Overall Study|Adverse Event|6
5228267|NCT00903630|18046277|P3|Phase 2|Adverse Event|1
5228268|NCT00903630|18046278|P2|Phase 2|Adverse Event|0
5228269|NCT00903630|18046279|P1|Phase 2|Adverse Event|0
5228270|NCT00903617|18046297|P4|Overall Study|Withdrawal by Subject|0
5228271|NCT00903617|18046298|P3|Overall Study|Withdrawal by Subject|3
5228272|NCT00903617|18046299|P2|Overall Study|Withdrawal by Subject|2
5228273|NCT00903617|18046300|P1|Overall Study|Withdrawal by Subject|1
5228274|NCT00903617|18046297|P4|Overall Study|Lost to Follow-up|1
5228275|NCT00903617|18046298|P3|Overall Study|Lost to Follow-up|1
5228276|NCT00903617|18046299|P2|Overall Study|Lost to Follow-up|0
5228277|NCT00903617|18046300|P1|Overall Study|Lost to Follow-up|2
5228278|NCT00903617|18046297|P4|Overall Study|Protocol-defined stopping criteria|0
5228279|NCT00903617|18046298|P3|Overall Study|Protocol-defined stopping criteria|0
5228280|NCT00903617|18046299|P2|Overall Study|Protocol-defined stopping criteria|2
5228281|NCT00903617|18046300|P1|Overall Study|Protocol-defined stopping criteria|0
5228282|NCT00903617|18046297|P4|Overall Study|Adverse Event|0
5228283|NCT00903617|18046298|P3|Overall Study|Adverse Event|1
5228284|NCT00903617|18046299|P2|Overall Study|Adverse Event|1
5228285|NCT00903617|18046300|P1|Overall Study|Adverse Event|0
5228286|NCT00903409|18046403|P2|Overall Study|Lost to Follow-up|6
5228287|NCT00903409|18046404|P1|Overall Study|Lost to Follow-up|2
5228288|NCT00903409|18046403|P2|Overall Study|Other|3
5228289|NCT00903409|18046404|P1|Overall Study|Other|2
5228290|NCT00903409|18046403|P2|Overall Study|Withdrawal by Subject|8
5228291|NCT00903409|18046404|P1|Overall Study|Withdrawal by Subject|8
5228292|NCT00903409|18046403|P2|Overall Study|Laboratory Abnormality|0
5228293|NCT00903409|18046404|P1|Overall Study|Laboratory Abnormality|2
5228294|NCT00903409|18046403|P2|Overall Study|Non-compliance with Protocol|1
5228295|NCT00903409|18046404|P1|Overall Study|Non-compliance with Protocol|1
5228296|NCT00903409|18046403|P2|Overall Study|Adverse Event|9
5228297|NCT00903409|18046404|P1|Overall Study|Adverse Event|11
5228298|NCT00903383|18046455|P4|Overall Study|Patient Decision|1
5228299|NCT00903383|18046456|P3|Overall Study|Patient Decision|0
5228300|NCT00903383|18046457|P2|Overall Study|Patient Decision|0
5228301|NCT00903383|18046458|P1|Overall Study|Patient Decision|0
5228302|NCT00903383|18046455|P4|Overall Study|Patient Decision - Lack of Efficacy|0
5228303|NCT00903383|18046456|P3|Overall Study|Patient Decision - Lack of Efficacy|0
5228304|NCT00903383|18046457|P2|Overall Study|Patient Decision - Lack of Efficacy|1
5228305|NCT00903383|18046458|P1|Overall Study|Patient Decision - Lack of Efficacy|0
5228306|NCT00903383|18046455|P4|Overall Study|Withdrawal by Subject|2
5228307|NCT00903383|18046456|P3|Overall Study|Withdrawal by Subject|0
5228308|NCT00903383|18046457|P2|Overall Study|Withdrawal by Subject|1
5228309|NCT00903383|18046458|P1|Overall Study|Withdrawal by Subject|4
5228310|NCT00903383|18046455|P4|Overall Study|Decision of Sponsor|0
5228311|NCT00903383|18046456|P3|Overall Study|Decision of Sponsor|0
5228312|NCT00903383|18046457|P2|Overall Study|Decision of Sponsor|0
5228313|NCT00903383|18046458|P1|Overall Study|Decision of Sponsor|1
5228314|NCT00903383|18046455|P4|Overall Study|Lost to Follow-up|1
5228315|NCT00903383|18046456|P3|Overall Study|Lost to Follow-up|0
5228316|NCT00903383|18046457|P2|Overall Study|Lost to Follow-up|0
5228317|NCT00903383|18046458|P1|Overall Study|Lost to Follow-up|0
5228318|NCT00903383|18046455|P4|Overall Study|Physician Decision|0
5228319|NCT00903383|18046456|P3|Overall Study|Physician Decision|0
5228320|NCT00903383|18046457|P2|Overall Study|Physician Decision|2
5228321|NCT00903383|18046458|P1|Overall Study|Physician Decision|1
5228322|NCT00903383|18046455|P4|Overall Study|Adverse Event|1
5228323|NCT00903383|18046456|P3|Overall Study|Adverse Event|3
5228324|NCT00903383|18046457|P2|Overall Study|Adverse Event|2
5228325|NCT00903383|18046458|P1|Overall Study|Adverse Event|1
5228326|NCT00903370|18046490|P2|Overall Study|Lost to Follow-up|8
5228327|NCT00903370|18046491|P1|Overall Study|Lost to Follow-up|6
5228328|NCT00903370|18046490|P2|Overall Study|Withdrawal by Subject|6
5228329|NCT00903370|18046491|P1|Overall Study|Withdrawal by Subject|9
5228330|NCT00903370|18046490|P2|Overall Study|Death|10
5228331|NCT00903370|18046491|P1|Overall Study|Death|13
5228332|NCT00903357|18046499|P2|Second Intervention|Lost to Follow-up|0
5228333|NCT00903357|18046500|P1|Second Intervention|Lost to Follow-up|1
5228334|NCT00903357|18046499|P2|Wash Out Period of 2 Weeks|Flu|1
5228335|NCT00903357|18046500|P1|Wash Out Period of 2 Weeks|Flu|0
5228336|NCT00903357|18046499|P2|First Intervention|Flu|1
5228337|NCT00903357|18046500|P1|First Intervention|Flu|0
5228338|NCT00903357|18046499|P2|First Intervention|Withdrawal by Subject|3
5228339|NCT00903357|18046500|P1|First Intervention|Withdrawal by Subject|5
5228340|NCT00903344|18046512|P2|Overall Study|Lost to Follow-up|0
5228341|NCT00903344|18046513|P1|Overall Study|Lost to Follow-up|3
5228342|NCT00903344|18046512|P2|Overall Study|Pregnancy|3
5228343|NCT00903344|18046513|P1|Overall Study|Pregnancy|2
5228344|NCT00903331|18046531|P2|Overall Study|Lung transplant|2
5228345|NCT00903331|18046532|P1|Overall Study|Lung transplant|0
5228346|NCT00903331|18046531|P2|Overall Study|Withdrawal of consent|8
5228347|NCT00903331|18046532|P1|Overall Study|Withdrawal of consent|1
5228348|NCT00903331|18046531|P2|Overall Study|Death|8
5228349|NCT00903331|18046532|P1|Overall Study|Death|4
5228350|NCT00903201|18046543|P3|Overall Study|Withdrawal by Subject|1
5228351|NCT00903201|18046544|P2|Overall Study|Withdrawal by Subject|0
5228352|NCT00903201|18046545|P1|Overall Study|Withdrawal by Subject|1
5228353|NCT00903201|18046543|P3|Overall Study|Physician Decision|1
5228354|NCT00903201|18046544|P2|Overall Study|Physician Decision|0
5228355|NCT00903201|18046545|P1|Overall Study|Physician Decision|1
5228356|NCT00903201|18046543|P3|Overall Study|Lost to Follow-up|0
5228357|NCT00903201|18046544|P2|Overall Study|Lost to Follow-up|1
5228358|NCT00903201|18046545|P1|Overall Study|Lost to Follow-up|0
5228359|NCT00903201|18046543|P3|Overall Study|Protocol Violation|0
5228360|NCT00903201|18046544|P2|Overall Study|Protocol Violation|1
5228361|NCT00903201|18046545|P1|Overall Study|Protocol Violation|2
5228362|NCT00903201|18046543|P3|Overall Study|Adverse Event|0
5228363|NCT00903201|18046544|P2|Overall Study|Adverse Event|4
5228364|NCT00903201|18046545|P1|Overall Study|Adverse Event|1
5228365|NCT00903175|18046603|P2|Period 2 - Second Line|Death|2
5228366|NCT00903175|18046604|P1|Period 2 - Second Line|Death|5
5228367|NCT00903175|18046603|P2|Period 2 - Second Line|Administrative problems|9
5228368|NCT00903175|18046604|P1|Period 2 - Second Line|Administrative problems|19
5228369|NCT00903175|18046603|P2|Period 2 - Second Line|Lost to Follow-up|0
5228370|NCT00903175|18046604|P1|Period 2 - Second Line|Lost to Follow-up|1
5228371|NCT00903175|18046603|P2|Period 2 - Second Line|Withdrawal by Subject|5
5228372|NCT00903175|18046604|P1|Period 2 - Second Line|Withdrawal by Subject|7
5228373|NCT00903175|18046603|P2|Period 2 - Second Line|Adverse Event|20
5228374|NCT00903175|18046604|P1|Period 2 - Second Line|Adverse Event|16
5228375|NCT00903175|18046603|P2|Period 2 - Second Line|Missing|0
5228376|NCT00903175|18046604|P1|Period 2 - Second Line|Missing|1
5228377|NCT00903175|18046603|P2|Period 1 - First Line|Death|10
5228378|NCT00903175|18046604|P1|Period 1 - First Line|Death|17
5228379|NCT00903175|18046603|P2|Period 1 - First Line|Administrative problems|13
5228380|NCT00903175|18046604|P1|Period 1 - First Line|Administrative problems|12
5228381|NCT00903175|18046603|P2|Period 1 - First Line|Withdrawal by Subject|12
5228382|NCT00903175|18046604|P1|Period 1 - First Line|Withdrawal by Subject|8
5228383|NCT00903175|18046603|P2|Period 1 - First Line|Protocol Violation|3
5228384|NCT00903175|18046604|P1|Period 1 - First Line|Protocol Violation|3
5228385|NCT00903175|18046603|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
5228386|NCT00903175|18046604|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
5228387|NCT00903175|18046603|P2|Period 1 - First Line|Abnormal lab value(s)|1
5228388|NCT00903175|18046604|P1|Period 1 - First Line|Abnormal lab value(s)|0
5228389|NCT00903175|18046603|P2|Period 1 - First Line|Adverse Event|50
5228390|NCT00903175|18046604|P1|Period 1 - First Line|Adverse Event|36
5228391|NCT00903032|18046642|P2|Overall Study|Lost to Follow-up|2
5228392|NCT00903032|18046643|P1|Overall Study|Lost to Follow-up|2
5228393|NCT00903032|18046642|P2|Overall Study|Withdrawal by Subject|3
5228394|NCT00903032|18046643|P1|Overall Study|Withdrawal by Subject|5
5228395|NCT00903006|18046653|P4|Overall Study|Progressive Disease|0
5228396|NCT00903006|18046654|P3|Overall Study|Progressive Disease|1
5228397|NCT00903006|18046655|P2|Overall Study|Progressive Disease|3
5228398|NCT00903006|18046656|P1|Overall Study|Progressive Disease|0
5228399|NCT00903006|18046653|P4|Overall Study|Withdrawal by Subject|0
5228400|NCT00903006|18046654|P3|Overall Study|Withdrawal by Subject|0
5228401|NCT00903006|18046655|P2|Overall Study|Withdrawal by Subject|0
5228402|NCT00903006|18046656|P1|Overall Study|Withdrawal by Subject|2
5228403|NCT00902850|18046668|P2|Overall Study|Physician Decision|2
5228404|NCT00902850|18046669|P1|Overall Study|Physician Decision|2
5228405|NCT00902746|18046675|P1|Overall Study|Physician Decision|2
5228406|NCT00902746|18046675|P1|Overall Study|Lost to Follow-up|3
5228407|NCT00902746|18046675|P1|Overall Study|Adverse Event|8
5228408|NCT00902746|18046675|P1|Overall Study|Withdrawal by Subject|16
5228409|NCT00902746|18046675|P1|Overall Study|Protocol Violation|7
5228410|NCT00902668|18046680|P1|Overall Study|Protocol stopped due to slow accrual.|3
5228411|NCT00902577|18046684|P1|Overall Study|FMISO production failure|2
5228412|NCT00902577|18046684|P1|Overall Study|Withdrawal by Subject|6
5228413|NCT00902564|18046713|P1|Overall Study|Withdrawal by Subject|2
5228414|NCT00902538|18046728|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5228415|NCT00902538|18046729|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5228416|NCT00902538|18046730|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
5228417|NCT00902538|18046731|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5228418|NCT00902538|18046732|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5228419|NCT00902538|18046733|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5228420|NCT00902538|18046728|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5228421|NCT00902538|18046729|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
5228422|NCT00902538|18046730|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
5228423|NCT00902538|18046731|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5228424|NCT00902538|18046732|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5228425|NCT00902538|18046733|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5228426|NCT00902538|18046728|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
5228427|NCT00902538|18046729|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
5228428|NCT00902538|18046730|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
5228429|NCT00902538|18046731|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
5228430|NCT00902538|18046732|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
5228431|NCT00902538|18046733|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
5228432|NCT00902538|18046728|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
5228433|NCT00902538|18046729|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
5228434|NCT00902538|18046730|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
5228435|NCT00902538|18046731|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
5228436|NCT00902538|18046732|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
5228437|NCT00902538|18046733|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
5228438|NCT00902538|18046728|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5228439|NCT00902538|18046729|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5228440|NCT00902538|18046730|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5228441|NCT00902538|18046731|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5228442|NCT00902538|18046732|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
5228443|NCT00902538|18046733|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5228444|NCT00902538|18046728|P6|3-Single-blind, Single Treatment|Protocol Violation|0
5228445|NCT00902538|18046729|P5|3-Single-blind, Single Treatment|Protocol Violation|0
5228446|NCT00902538|18046730|P4|3-Single-blind, Single Treatment|Protocol Violation|0
5228447|NCT00902538|18046731|P3|3-Single-blind, Single Treatment|Protocol Violation|0
5228448|NCT00902538|18046732|P2|3-Single-blind, Single Treatment|Protocol Violation|5
5228449|NCT00902538|18046733|P1|3-Single-blind, Single Treatment|Protocol Violation|0
5228450|NCT00902538|18046728|P6|3-Single-blind, Single Treatment|Adverse Event|0
5228451|NCT00902538|18046729|P5|3-Single-blind, Single Treatment|Adverse Event|0
5228452|NCT00902538|18046730|P4|3-Single-blind, Single Treatment|Adverse Event|0
5228453|NCT00902538|18046731|P3|3-Single-blind, Single Treatment|Adverse Event|0
5228454|NCT00902538|18046732|P2|3-Single-blind, Single Treatment|Adverse Event|5
5228455|NCT00902538|18046733|P1|3-Single-blind, Single Treatment|Adverse Event|0
5228456|NCT00902538|18046728|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
5228457|NCT00902538|18046729|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
5228458|NCT00902538|18046730|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
5228459|NCT00902538|18046731|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
5228460|NCT00902538|18046732|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
5228461|NCT00902538|18046733|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
5228462|NCT00902538|18046728|P6|2-Randomized Double-blind 3 Treatments|Other|0
5228463|NCT00902538|18046729|P5|2-Randomized Double-blind 3 Treatments|Other|0
5228464|NCT00902538|18046730|P4|2-Randomized Double-blind 3 Treatments|Other|0
5228465|NCT00902538|18046731|P3|2-Randomized Double-blind 3 Treatments|Other|0
5228466|NCT00902538|18046732|P2|2-Randomized Double-blind 3 Treatments|Other|1
5228467|NCT00902538|18046733|P1|2-Randomized Double-blind 3 Treatments|Other|2
5228468|NCT00902538|18046728|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5228469|NCT00902538|18046729|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5228470|NCT00902538|18046730|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5228471|NCT00902538|18046731|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
5228472|NCT00902538|18046732|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5228473|NCT00902538|18046733|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
5228474|NCT00902538|18046728|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
5228475|NCT00902538|18046729|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
5228476|NCT00902538|18046730|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
5228477|NCT00902538|18046731|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
5228478|NCT00902538|18046732|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
5228479|NCT00902538|18046733|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
5228480|NCT00902538|18046728|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
5228481|NCT00902538|18046729|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
5228482|NCT00902538|18046730|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
5228483|NCT00902538|18046731|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
5228484|NCT00902538|18046732|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
5228485|NCT00902538|18046733|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
5228486|NCT00902538|18046728|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5228487|NCT00902538|18046729|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5228488|NCT00902538|18046730|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5228489|NCT00902538|18046731|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5228490|NCT00902538|18046732|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5228491|NCT00902538|18046733|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
5228492|NCT00902538|18046728|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5228493|NCT00902538|18046729|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5228494|NCT00902538|18046730|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5228495|NCT00902538|18046731|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5228496|NCT00902538|18046732|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5228497|NCT00902538|18046733|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
5228498|NCT00902538|18046728|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5228499|NCT00902538|18046729|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5228500|NCT00902538|18046730|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5228501|NCT00902538|18046731|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5228502|NCT00902538|18046732|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5228503|NCT00902538|18046733|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
5228504|NCT00902538|18046728|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5228505|NCT00902538|18046729|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5228506|NCT00902538|18046730|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5228507|NCT00902538|18046731|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5228508|NCT00902538|18046732|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5228509|NCT00902538|18046733|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
5228510|NCT00902538|18046728|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5228511|NCT00902538|18046729|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5228512|NCT00902538|18046730|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5228513|NCT00902538|18046731|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5228514|NCT00902538|18046732|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5228515|NCT00902538|18046733|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
5228516|NCT00902486|18046767|P6|Follow-up (After Week 24)|Lost to Follow-up|0
5228517|NCT00902486|18046768|P5|Follow-up (After Week 24)|Lost to Follow-up|0
5228518|NCT00902486|18046769|P4|Follow-up (After Week 24)|Lost to Follow-up|1
5228519|NCT00902486|18046770|P3|Follow-up (After Week 24)|Lost to Follow-up|0
5228520|NCT00902486|18046771|P2|Follow-up (After Week 24)|Lost to Follow-up|0
5228521|NCT00902486|18046772|P1|Follow-up (After Week 24)|Lost to Follow-up|0
5228522|NCT00902486|18046767|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5228523|NCT00902486|18046768|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5228524|NCT00902486|18046769|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5228525|NCT00902486|18046770|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
5228526|NCT00902486|18046771|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5228527|NCT00902486|18046772|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5228528|NCT00902486|18046767|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5228529|NCT00902486|18046768|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5228530|NCT00902486|18046769|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
5228531|NCT00902486|18046770|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5228532|NCT00902486|18046771|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5228533|NCT00902486|18046772|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5228534|NCT00902486|18046767|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
5228535|NCT00902486|18046768|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5228536|NCT00902486|18046769|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5228537|NCT00902486|18046770|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5228538|NCT00902486|18046771|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5228539|NCT00902486|18046772|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5228540|NCT00902486|18046767|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5228541|NCT00902486|18046768|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5228542|NCT00902486|18046769|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
5228543|NCT00902486|18046770|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
5228544|NCT00902486|18046771|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5228545|NCT00902486|18046772|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5228546|NCT00902486|18046767|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
5228547|NCT00902486|18046768|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
5228548|NCT00902486|18046769|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5228549|NCT00902486|18046770|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5228550|NCT00902486|18046771|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5228551|NCT00902486|18046772|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5228552|NCT00902486|18046767|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5228553|NCT00902486|18046768|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5228554|NCT00902486|18046769|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
5228555|NCT00902486|18046770|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5228556|NCT00902486|18046771|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5228557|NCT00902486|18046772|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5228558|NCT00902486|18046767|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5228559|NCT00902486|18046768|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5228560|NCT00902486|18046769|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
5228561|NCT00902486|18046770|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5228562|NCT00902486|18046771|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5228563|NCT00902486|18046772|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5228564|NCT00902486|18046767|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
5228565|NCT00902486|18046768|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
5228566|NCT00902486|18046769|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5228567|NCT00902486|18046770|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5228568|NCT00902486|18046771|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5228569|NCT00902486|18046772|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5228570|NCT00902486|18046767|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
5228571|NCT00902486|18046768|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5228572|NCT00902486|18046769|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5228573|NCT00902486|18046770|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5228574|NCT00902486|18046771|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5228575|NCT00902486|18046772|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
5228576|NCT00902486|18046767|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
5228577|NCT00902486|18046768|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
5228578|NCT00902486|18046769|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
5228579|NCT00902486|18046770|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
5228580|NCT00902486|18046771|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
5228581|NCT00902486|18046772|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
5228582|NCT00902330|18046910|P2|Overall Study|No post baseline data|0
5228583|NCT00902330|18046911|P1|Overall Study|No post baseline data|1
5228584|NCT00902330|18046910|P2|Overall Study|Adverse Event|0
5228585|NCT00902330|18046911|P1|Overall Study|Adverse Event|1
5228586|NCT00902330|18046910|P2|Overall Study|Too overwhelmed by treatment|5
5228587|NCT00902330|18046911|P1|Overall Study|Too overwhelmed by treatment|2
5228588|NCT00902304|18046948|P3|Overall Study|includes pregnancy|2
5228589|NCT00902304|18046949|P2|Overall Study|includes pregnancy|9
5228590|NCT00902304|18046950|P1|Overall Study|includes pregnancy|3
5228591|NCT00902304|18046948|P3|Overall Study|Withdrawal by Subject|43
5228592|NCT00902304|18046949|P2|Overall Study|Withdrawal by Subject|22
5228593|NCT00902304|18046950|P1|Overall Study|Withdrawal by Subject|32
5228594|NCT00902304|18046948|P3|Overall Study|Protocol Violation|20
5228595|NCT00902304|18046949|P2|Overall Study|Protocol Violation|18
5228596|NCT00902304|18046950|P1|Overall Study|Protocol Violation|9
5228597|NCT00902304|18046948|P3|Overall Study|Lost to Follow-up|7
5228598|NCT00902304|18046949|P2|Overall Study|Lost to Follow-up|7
5228599|NCT00902304|18046950|P1|Overall Study|Lost to Follow-up|7
5228600|NCT00902304|18046948|P3|Overall Study|Investigator discretion|13
5228601|NCT00902304|18046949|P2|Overall Study|Investigator discretion|5
5228602|NCT00902304|18046950|P1|Overall Study|Investigator discretion|3
5228603|NCT00902304|18046948|P3|Overall Study|Adverse Event|25
5228604|NCT00902304|18046949|P2|Overall Study|Adverse Event|10
5228605|NCT00902304|18046950|P1|Overall Study|Adverse Event|4
5228606|NCT00902278|18047000|P5|Overall Study|Lost to Follow-up|1
5228607|NCT00902278|18047001|P4|Overall Study|Lost to Follow-up|0
5228608|NCT00902278|18047002|P3|Overall Study|Lost to Follow-up|3
5228609|NCT00902278|18047003|P2|Overall Study|Lost to Follow-up|2
5228610|NCT00902278|18047004|P1|Overall Study|Lost to Follow-up|3
5228611|NCT00902278|18047000|P5|Overall Study|Physician Decision|1
5228612|NCT00902278|18047001|P4|Overall Study|Physician Decision|0
5228613|NCT00902278|18047002|P3|Overall Study|Physician Decision|2
5228614|NCT00902278|18047003|P2|Overall Study|Physician Decision|0
5228615|NCT00902278|18047004|P1|Overall Study|Physician Decision|1
5228616|NCT00902265|18047021|P1|Overall Study|Protocol Violation|1
5228617|NCT00902265|18047021|P1|Overall Study|Lack of Efficacy|2
5228618|NCT00902265|18047021|P1|Overall Study|Adverse Event|2
5228619|NCT00902265|18047021|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
5228620|NCT00902174|18047045|P2|Overall Study|Administration problem|1
5228621|NCT00902174|18047046|P1|Overall Study|Administration problem|0
5228622|NCT00902174|18047045|P2|Overall Study|Protocol Violation|1
5228623|NCT00902174|18047046|P1|Overall Study|Protocol Violation|1
5228624|NCT00902174|18047045|P2|Overall Study|Abnormal labs|1
5228625|NCT00902174|18047046|P1|Overall Study|Abnormal labs|1
5228626|NCT00902174|18047045|P2|Overall Study|Withdrawal by Subject|1
5228627|NCT00902174|18047046|P1|Overall Study|Withdrawal by Subject|2
5228628|NCT00902174|18047045|P2|Overall Study|Death|2
5228629|NCT00902174|18047046|P1|Overall Study|Death|2
5228630|NCT00902174|18047045|P2|Overall Study|Lack of Efficacy|5
5228631|NCT00902174|18047046|P1|Overall Study|Lack of Efficacy|1
5228632|NCT00902174|18047045|P2|Overall Study|Adverse Event|7
5228633|NCT00902174|18047046|P1|Overall Study|Adverse Event|27
5228634|NCT00901927|18047121|P1|Overall Study|Withdrawal by Subject|2
5228635|NCT00901927|18047121|P1|Overall Study|Protocol Violation|3
5228636|NCT00901927|18047121|P1|Overall Study|Lack of Efficacy|1
5228637|NCT00901901|18047129|P2|Follow-up Period|Missing|80
5228638|NCT00901901|18047130|P1|Follow-up Period|Missing|94
5228639|NCT00901901|18047129|P2|Follow-up Period|Lost to Follow-up|8
5228640|NCT00901901|18047130|P1|Follow-up Period|Lost to Follow-up|12
5228641|NCT00901901|18047129|P2|Follow-up Period|Withdrawal by Subject|9
5228642|NCT00901901|18047130|P1|Follow-up Period|Withdrawal by Subject|6
5228643|NCT00901901|18047129|P2|Follow-up Period|Protocol driven decision point|36
5228644|NCT00901901|18047130|P1|Follow-up Period|Protocol driven decision point|47
5228645|NCT00901901|18047129|P2|Follow-up Period|Death|208
5228646|NCT00901901|18047130|P1|Follow-up Period|Death|181
5228647|NCT00901901|18047129|P2|Treatment Period|Transfer to treatment continuation study|2
5228648|NCT00901901|18047130|P1|Treatment Period|Transfer to treatment continuation study|5
5228649|NCT00901901|18047129|P2|Treatment Period|Switch to commercial drug|1
5228650|NCT00901901|18047130|P1|Treatment Period|Switch to commercial drug|1
5228651|NCT00901901|18047129|P2|Treatment Period|Protocol Violation|9
5228652|NCT00901901|18047130|P1|Treatment Period|Protocol Violation|5
5228653|NCT00901901|18047129|P2|Treatment Period|Study terminated by sponsor|0
5228654|NCT00901901|18047130|P1|Treatment Period|Study terminated by sponsor|2
5228655|NCT00901901|18047129|P2|Treatment Period|Protocol driven decision point|2
5228656|NCT00901901|18047130|P1|Treatment Period|Protocol driven decision point|0
5228657|NCT00901901|18047129|P2|Treatment Period|Never treated|3
5228658|NCT00901901|18047130|P1|Treatment Period|Never treated|0
5228659|NCT00901901|18047129|P2|Treatment Period|Missing|0
5228660|NCT00901901|18047130|P1|Treatment Period|Missing|1
5228661|NCT00901901|18047129|P2|Treatment Period|Noncompliance with study medication|1
5228662|NCT00901901|18047130|P1|Treatment Period|Noncompliance with study medication|4
5228663|NCT00901901|18047129|P2|Treatment Period|Lost to Follow-up|5
5228664|NCT00901901|18047130|P1|Treatment Period|Lost to Follow-up|3
5228665|NCT00901901|18047129|P2|Treatment Period|Physician Decision|2
5228666|NCT00901901|18047130|P1|Treatment Period|Physician Decision|2
5228667|NCT00901901|18047129|P2|Treatment Period|Withdrawal by Subject|24
5228668|NCT00901901|18047130|P1|Treatment Period|Withdrawal by Subject|26
5228669|NCT00901901|18047129|P2|Treatment Period|Adverse Event|128
5228670|NCT00901901|18047130|P1|Treatment Period|Adverse Event|120
5228671|NCT00901628|18047152|P2|Overall Study|peroneal nerve palsy|1
5228672|NCT00901628|18047153|P1|Overall Study|peroneal nerve palsy|0
5228673|NCT00901628|18047152|P2|Overall Study|disconnection of drain|1
5228674|NCT00901628|18047153|P1|Overall Study|disconnection of drain|0
5228675|NCT00901628|18047152|P2|Overall Study|disconnection of catheter|8
5228676|NCT00901628|18047153|P1|Overall Study|disconnection of catheter|4
5228677|NCT00901576|18047175|P6|Second Intervention|Physician Decision|0
5228678|NCT00901576|18047176|P5|Second Intervention|Physician Decision|0
5228679|NCT00901576|18047177|P4|Second Intervention|Physician Decision|0
5228680|NCT00901576|18047178|P3|Second Intervention|Physician Decision|0
5228681|NCT00901576|18047179|P2|Second Intervention|Physician Decision|0
5228682|NCT00901576|18047180|P1|Second Intervention|Physician Decision|1
5228683|NCT00901576|18047175|P6|Second Intervention|Withdrawal by Subject|1
5228684|NCT00901576|18047176|P5|Second Intervention|Withdrawal by Subject|0
5228685|NCT00901576|18047177|P4|Second Intervention|Withdrawal by Subject|1
5228686|NCT00901576|18047178|P3|Second Intervention|Withdrawal by Subject|0
5228687|NCT00901576|18047179|P2|Second Intervention|Withdrawal by Subject|0
5228688|NCT00901576|18047180|P1|Second Intervention|Withdrawal by Subject|0
5228689|NCT00901459|18047201|P1|Overall Study|Withdrawal by Subject|6
5228690|NCT00901394|18047215|P3|Overall Study|Physician Decision|2
5228691|NCT00901394|18047216|P2|Overall Study|Physician Decision|1
5228692|NCT00901394|18047217|P1|Overall Study|Physician Decision|1
5228693|NCT00901342|18047225|P1|Overall Study|Withdrawal by Subject|9
5228694|NCT00901342|18047225|P1|Overall Study|Disease progression|1
5228695|NCT00901342|18047225|P1|Overall Study|Death|4
5228696|NCT00901342|18047225|P1|Overall Study|Adverse Event|1
5228697|NCT00901186|18047258|P2|Overall Study|Protocol deviations|4
5228698|NCT00901186|18047259|P1|Overall Study|Protocol deviations|5
5228699|NCT00901186|18047258|P2|Overall Study|Administration problems|1
5228700|NCT00901186|18047259|P1|Overall Study|Administration problems|0
5228701|NCT00901186|18047258|P2|Overall Study|Adverse Event|4
5228702|NCT00901186|18047259|P1|Overall Study|Adverse Event|2
5228703|NCT00901186|18047258|P2|Overall Study|Lost to Follow-up|0
5228704|NCT00901186|18047259|P1|Overall Study|Lost to Follow-up|2
5228705|NCT00901186|18047258|P2|Overall Study|Abnormal laboratory values|1
5228706|NCT00901186|18047259|P1|Overall Study|Abnormal laboratory values|0
5228707|NCT00901186|18047258|P2|Overall Study|Lack of Efficacy|1
5228708|NCT00901186|18047259|P1|Overall Study|Lack of Efficacy|0
5228709|NCT00900796|18047299|P1|Phase 2|Lost to Follow-up|5
5228710|NCT00900796|18047299|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
5228711|NCT00900796|18047299|P1|Phase 1|Missing information at Week 16|7
5228712|NCT00900796|18047299|P1|Phase 1|Lacked sufficient information|4
5228713|NCT00900757|18047309|P1|Overall Study|screen failure|19
5228714|NCT00900731|18047319|P2|Overall Study|Death|2
5228715|NCT00900731|18047320|P1|Overall Study|Death|0
5228716|NCT00900731|18047319|P2|Overall Study|Lack of Efficacy|3
5228717|NCT00900731|18047320|P1|Overall Study|Lack of Efficacy|1
5228718|NCT00900731|18047319|P2|Overall Study|Lost to Follow-up|3
5228719|NCT00900731|18047320|P1|Overall Study|Lost to Follow-up|2
5228720|NCT00900731|18047319|P2|Overall Study|Abnormal Laboratory Value(s)|4
5228721|NCT00900731|18047320|P1|Overall Study|Abnormal Laboratory Value(s)|2
5228722|NCT00900731|18047319|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5228723|NCT00900731|18047320|P1|Overall Study|Abnormal Test Procedure Result(s)|3
5228724|NCT00900731|18047319|P2|Overall Study|Administrative Problems|4
5228725|NCT00900731|18047320|P1|Overall Study|Administrative Problems|5
5228726|NCT00900731|18047319|P2|Overall Study|Protocol Deviation|11
5228727|NCT00900731|18047320|P1|Overall Study|Protocol Deviation|8
5228728|NCT00900731|18047319|P2|Overall Study|Withdrawal by Subject|7
5228729|NCT00900731|18047320|P1|Overall Study|Withdrawal by Subject|8
5228730|NCT00900731|18047319|P2|Overall Study|Adverse Event|27
5228731|NCT00900731|18047320|P1|Overall Study|Adverse Event|31
5228732|NCT00900627|18047357|P6|Overall Study|Death|24
5228733|NCT00900627|18047358|P5|Overall Study|Death|28
5228734|NCT00900627|18047359|P4|Overall Study|Death|0
5228735|NCT00900627|18047360|P3|Overall Study|Death|0
5228736|NCT00900627|18047361|P2|Overall Study|Death|0
5228737|NCT00900627|18047362|P1|Overall Study|Death|0
5228738|NCT00900627|18047357|P6|Overall Study|Adverse Event|0
5228739|NCT00900627|18047358|P5|Overall Study|Adverse Event|0
5228740|NCT00900627|18047359|P4|Overall Study|Adverse Event|3
5228741|NCT00900627|18047360|P3|Overall Study|Adverse Event|0
5228742|NCT00900627|18047361|P2|Overall Study|Adverse Event|2
5228743|NCT00900627|18047362|P1|Overall Study|Adverse Event|1
5228744|NCT00900627|18047357|P6|Overall Study|Withdrawal by Subject|2
5228745|NCT00900627|18047358|P5|Overall Study|Withdrawal by Subject|1
5228746|NCT00900627|18047359|P4|Overall Study|Withdrawal by Subject|0
5228747|NCT00900627|18047360|P3|Overall Study|Withdrawal by Subject|1
5228748|NCT00900627|18047361|P2|Overall Study|Withdrawal by Subject|0
5228749|NCT00900627|18047362|P1|Overall Study|Withdrawal by Subject|1
5228750|NCT00900627|18047357|P6|Overall Study|Condition under investigation worsened|0
5228751|NCT00900627|18047358|P5|Overall Study|Condition under investigation worsened|0
5228752|NCT00900627|18047359|P4|Overall Study|Condition under investigation worsened|3
5228753|NCT00900627|18047360|P3|Overall Study|Condition under investigation worsened|5
5228754|NCT00900627|18047361|P2|Overall Study|Condition under investigation worsened|0
5228755|NCT00900627|18047362|P1|Overall Study|Condition under investigation worsened|4
5228756|NCT00900601|18047380|P1|Overall Study|Physician Decision|1
5228757|NCT00900159|18047399|P2|Second Intervention|disempanelled for inappropriate behavior|0
5228758|NCT00900159|18047400|P1|Second Intervention|disempanelled for inappropriate behavior|1
5228759|NCT00900146|18047419|P5|Intermediate: Period III|Administrative problems|163
5228760|NCT00900146|18047420|P4|Intermediate: Period III|Administrative problems|90
5228761|NCT00900146|18047421|P3|Intermediate: Period III|Administrative problems|84
5228762|NCT00900146|18047422|P2|Intermediate: Period III|Administrative problems|92
5228763|NCT00900146|18047423|P1|Intermediate: Period III|Administrative problems|85
5228764|NCT00900146|18047419|P5|Intermediate: Period III|Lost to Follow-up|1
5228765|NCT00900146|18047420|P4|Intermediate: Period III|Lost to Follow-up|0
5228766|NCT00900146|18047421|P3|Intermediate: Period III|Lost to Follow-up|0
5228767|NCT00900146|18047422|P2|Intermediate: Period III|Lost to Follow-up|0
5228768|NCT00900146|18047423|P1|Intermediate: Period III|Lost to Follow-up|2
5228769|NCT00900146|18047419|P5|Intermediate: Period III|Withdrawal by Subject|3
5228770|NCT00900146|18047420|P4|Intermediate: Period III|Withdrawal by Subject|0
5228771|NCT00900146|18047421|P3|Intermediate: Period III|Withdrawal by Subject|0
5228772|NCT00900146|18047422|P2|Intermediate: Period III|Withdrawal by Subject|1
5228773|NCT00900146|18047423|P1|Intermediate: Period III|Withdrawal by Subject|0
5228774|NCT00900146|18047419|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
5228775|NCT00900146|18047420|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
5228776|NCT00900146|18047421|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
5228777|NCT00900146|18047422|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
5228778|NCT00900146|18047423|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
5228779|NCT00900146|18047419|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
5228780|NCT00900146|18047420|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
5228781|NCT00900146|18047421|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
5228782|NCT00900146|18047422|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
5228783|NCT00900146|18047423|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
5228784|NCT00900146|18047419|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
5228785|NCT00900146|18047420|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
5228786|NCT00900146|18047421|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
5228787|NCT00900146|18047422|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
5228788|NCT00900146|18047423|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
5228789|NCT00900029|18047540|P5|Overall Study|Death|0
5228790|NCT00900029|18047541|P4|Overall Study|Death|1
5228791|NCT00900029|18047542|P3|Overall Study|Death|0
5228792|NCT00900029|18047543|P2|Overall Study|Death|0
5228793|NCT00900029|18047544|P1|Overall Study|Death|1
5228794|NCT00900029|18047540|P5|Overall Study|Adverse Event|1
5228795|NCT00900029|18047541|P4|Overall Study|Adverse Event|1
5228796|NCT00900029|18047542|P3|Overall Study|Adverse Event|1
5228797|NCT00900029|18047543|P2|Overall Study|Adverse Event|0
5228798|NCT00900029|18047544|P1|Overall Study|Adverse Event|0
5228799|NCT00900029|18047540|P5|Overall Study|Withdrawal by Subject|1
5228800|NCT00900029|18047541|P4|Overall Study|Withdrawal by Subject|1
5228801|NCT00900029|18047542|P3|Overall Study|Withdrawal by Subject|1
5228802|NCT00900029|18047543|P2|Overall Study|Withdrawal by Subject|2
5228803|NCT00900029|18047544|P1|Overall Study|Withdrawal by Subject|2
5228804|NCT00900029|18047540|P5|Overall Study|Lost to Follow-up|4
5228805|NCT00900029|18047541|P4|Overall Study|Lost to Follow-up|4
5228806|NCT00900029|18047542|P3|Overall Study|Lost to Follow-up|1
5228807|NCT00900029|18047543|P2|Overall Study|Lost to Follow-up|2
5228808|NCT00900029|18047544|P1|Overall Study|Lost to Follow-up|0
5228809|NCT00899847|18047561|P1|Overall Study|Lack of suitable allogeneic donor|2
5228810|NCT00899678|18047592|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
5228811|NCT00899678|18047593|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
5228812|NCT00899678|18047594|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
5228813|NCT00899678|18047592|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
5228814|NCT00899678|18047593|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
5228815|NCT00899678|18047594|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
5228816|NCT00899678|18047592|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
5228817|NCT00899678|18047593|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
5228818|NCT00899678|18047594|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
5228819|NCT00899678|18047592|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
5228820|NCT00899678|18047593|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
5228821|NCT00899678|18047594|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
5228822|NCT00899678|18047592|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
5228823|NCT00899678|18047593|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
5228824|NCT00899678|18047594|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
5228825|NCT00899678|18047592|P3|Induction Period (Weeks 0 to 6)|Other reason|0
5228826|NCT00899678|18047593|P2|Induction Period (Weeks 0 to 6)|Other reason|0
5228827|NCT00899678|18047594|P1|Induction Period (Weeks 0 to 6)|Other reason|1
5228828|NCT00899678|18047592|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
5228829|NCT00899678|18047593|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
5228830|NCT00899678|18047594|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
5228831|NCT00899678|18047592|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
5228832|NCT00899678|18047593|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
5228833|NCT00899678|18047594|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
5228834|NCT00899678|18047592|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
5228835|NCT00899678|18047593|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
5228836|NCT00899678|18047594|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
5228837|NCT00899548|18047644|P1|Overall Study|Physician Decision|3
5228838|NCT00899431|18047738|P3|Overall Study|Physician Decision|0
5228839|NCT00899431|18047739|P2|Overall Study|Physician Decision|0
5228840|NCT00899431|18047740|P1|Overall Study|Physician Decision|1
5228841|NCT00899392|18047753|P2|Overall Study|Subject didn't finish/partial pilot data|24
5228842|NCT00899392|18047754|P1|Overall Study|Subject didn't finish/partial pilot data|21
5228843|NCT00899379|18047771|P5|Overall Study|Inc/Exc Criteria Not Met|0
5228844|NCT00899379|18047772|P4|Overall Study|Inc/Exc Criteria Not Met|0
5228845|NCT00899379|18047773|P3|Overall Study|Inc/Exc Criteria Not Met|1
5228846|NCT00899379|18047774|P2|Overall Study|Inc/Exc Criteria Not Met|0
5228847|NCT00899379|18047775|P1|Overall Study|Inc/Exc Criteria Not Met|0
5228848|NCT00899379|18047771|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
5228849|NCT00899379|18047772|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
5228850|NCT00899379|18047773|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
5228851|NCT00899379|18047774|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
5228852|NCT00899379|18047775|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
5228853|NCT00899379|18047771|P5|Overall Study|No Attack Pretreatment|4
5228854|NCT00899379|18047772|P4|Overall Study|No Attack Pretreatment|6
5228855|NCT00899379|18047773|P3|Overall Study|No Attack Pretreatment|5
5228856|NCT00899379|18047774|P2|Overall Study|No Attack Pretreatment|5
5228857|NCT00899379|18047775|P1|Overall Study|No Attack Pretreatment|3
5228858|NCT00899379|18047771|P5|Overall Study|Abnormal Baseline ECG|0
5228859|NCT00899379|18047772|P4|Overall Study|Abnormal Baseline ECG|1
5228860|NCT00899379|18047773|P3|Overall Study|Abnormal Baseline ECG|1
5228861|NCT00899379|18047774|P2|Overall Study|Abnormal Baseline ECG|0
5228862|NCT00899379|18047775|P1|Overall Study|Abnormal Baseline ECG|0
5228863|NCT00899379|18047771|P5|Overall Study|Abnormal Prestudy Labs|2
5228864|NCT00899379|18047772|P4|Overall Study|Abnormal Prestudy Labs|0
5228865|NCT00899379|18047773|P3|Overall Study|Abnormal Prestudy Labs|0
5228866|NCT00899379|18047774|P2|Overall Study|Abnormal Prestudy Labs|0
5228867|NCT00899379|18047775|P1|Overall Study|Abnormal Prestudy Labs|0
5228868|NCT00899379|18047771|P5|Overall Study|Patient Uncooperative|0
5228869|NCT00899379|18047772|P4|Overall Study|Patient Uncooperative|1
5228870|NCT00899379|18047773|P3|Overall Study|Patient Uncooperative|0
5228871|NCT00899379|18047774|P2|Overall Study|Patient Uncooperative|0
5228872|NCT00899379|18047775|P1|Overall Study|Patient Uncooperative|0
5228873|NCT00899379|18047771|P5|Overall Study|Pregnancy|0
5228874|NCT00899379|18047772|P4|Overall Study|Pregnancy|0
5228875|NCT00899379|18047773|P3|Overall Study|Pregnancy|0
5228876|NCT00899379|18047774|P2|Overall Study|Pregnancy|0
5228877|NCT00899379|18047775|P1|Overall Study|Pregnancy|1
5228878|NCT00899379|18047771|P5|Overall Study|Withdrawal by Subject|2
5228879|NCT00899379|18047772|P4|Overall Study|Withdrawal by Subject|7
5228880|NCT00899379|18047773|P3|Overall Study|Withdrawal by Subject|4
5228881|NCT00899379|18047774|P2|Overall Study|Withdrawal by Subject|7
5228882|NCT00899379|18047775|P1|Overall Study|Withdrawal by Subject|4
5228883|NCT00899379|18047771|P5|Overall Study|Lost to Follow-up|5
5228884|NCT00899379|18047772|P4|Overall Study|Lost to Follow-up|2
5228885|NCT00899379|18047773|P3|Overall Study|Lost to Follow-up|0
5228886|NCT00899379|18047774|P2|Overall Study|Lost to Follow-up|1
5228887|NCT00899379|18047775|P1|Overall Study|Lost to Follow-up|3
5228888|NCT00899379|18047771|P5|Overall Study|Study Terminated|1
5228889|NCT00899379|18047772|P4|Overall Study|Study Terminated|3
5228890|NCT00899379|18047773|P3|Overall Study|Study Terminated|3
5228891|NCT00899379|18047774|P2|Overall Study|Study Terminated|0
5228892|NCT00899379|18047775|P1|Overall Study|Study Terminated|3
5228893|NCT00899379|18047771|P5|Overall Study|Not Completed/Entered Extn|3
5228894|NCT00899379|18047772|P4|Overall Study|Not Completed/Entered Extn|4
5228895|NCT00899379|18047773|P3|Overall Study|Not Completed/Entered Extn|6
5228896|NCT00899379|18047774|P2|Overall Study|Not Completed/Entered Extn|1
5228897|NCT00899379|18047775|P1|Overall Study|Not Completed/Entered Extn|5
5228898|NCT00899379|18047771|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
5228899|NCT00899379|18047772|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
5228900|NCT00899379|18047773|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
5228901|NCT00899379|18047774|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
5228902|NCT00899379|18047775|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
5228903|NCT00899379|18047771|P5|Overall Study|Abnormal Baseline ECG|0
5228904|NCT00899379|18047772|P4|Overall Study|Abnormal Baseline ECG|1
5228905|NCT00899379|18047773|P3|Overall Study|Abnormal Baseline ECG|0
5228906|NCT00899379|18047774|P2|Overall Study|Abnormal Baseline ECG|0
5228907|NCT00899379|18047775|P1|Overall Study|Abnormal Baseline ECG|0
5228908|NCT00899379|18047771|P5|Overall Study|Patient Uncooperative|2
5228909|NCT00899379|18047772|P4|Overall Study|Patient Uncooperative|1
5228910|NCT00899379|18047773|P3|Overall Study|Patient Uncooperative|0
5228911|NCT00899379|18047774|P2|Overall Study|Patient Uncooperative|1
5228912|NCT00899379|18047775|P1|Overall Study|Patient Uncooperative|0
5228913|NCT00899379|18047771|P5|Overall Study|Pregnancy|1
5228914|NCT00899379|18047772|P4|Overall Study|Pregnancy|0
5228915|NCT00899379|18047773|P3|Overall Study|Pregnancy|1
5228916|NCT00899379|18047774|P2|Overall Study|Pregnancy|0
5228917|NCT00899379|18047775|P1|Overall Study|Pregnancy|0
5228918|NCT00899379|18047771|P5|Overall Study|Withdrawal by Subject|6
5228919|NCT00899379|18047772|P4|Overall Study|Withdrawal by Subject|3
5228920|NCT00899379|18047773|P3|Overall Study|Withdrawal by Subject|2
5228921|NCT00899379|18047774|P2|Overall Study|Withdrawal by Subject|4
5228922|NCT00899379|18047775|P1|Overall Study|Withdrawal by Subject|2
5228923|NCT00899379|18047771|P5|Overall Study|Protocol Violation|0
5228924|NCT00899379|18047772|P4|Overall Study|Protocol Violation|1
5228925|NCT00899379|18047773|P3|Overall Study|Protocol Violation|1
5228926|NCT00899379|18047774|P2|Overall Study|Protocol Violation|0
5228927|NCT00899379|18047775|P1|Overall Study|Protocol Violation|0
5228928|NCT00899379|18047771|P5|Overall Study|Lost to Follow-up|2
5228929|NCT00899379|18047772|P4|Overall Study|Lost to Follow-up|6
5228930|NCT00899379|18047773|P3|Overall Study|Lost to Follow-up|0
5228931|NCT00899379|18047774|P2|Overall Study|Lost to Follow-up|3
5228932|NCT00899379|18047775|P1|Overall Study|Lost to Follow-up|9
5228933|NCT00899379|18047771|P5|Overall Study|Lack of Efficacy|1
5228934|NCT00899379|18047772|P4|Overall Study|Lack of Efficacy|0
5228935|NCT00899379|18047773|P3|Overall Study|Lack of Efficacy|3
5228936|NCT00899379|18047774|P2|Overall Study|Lack of Efficacy|4
5228937|NCT00899379|18047775|P1|Overall Study|Lack of Efficacy|0
5228938|NCT00899379|18047771|P5|Overall Study|Adverse Event|2
5228939|NCT00899379|18047772|P4|Overall Study|Adverse Event|1
5228940|NCT00899379|18047773|P3|Overall Study|Adverse Event|1
5228941|NCT00899379|18047774|P2|Overall Study|Adverse Event|2
5228942|NCT00899379|18047775|P1|Overall Study|Adverse Event|2
5228943|NCT00899353|18047787|P1|Overall Study|Withdrawal by Subject|2
5228944|NCT00899353|18047787|P1|Overall Study|Lost to Follow-up|1
5228945|NCT00899353|18047787|P1|Overall Study|Adverse Event|2
5228946|NCT00898807|18047823|P2|Overall Study|Death|1
5228947|NCT00898807|18047824|P1|Overall Study|Death|0
5228948|NCT00898807|18047823|P2|Overall Study|Lost to Follow-up|3
5228949|NCT00898807|18047824|P1|Overall Study|Lost to Follow-up|1
5228950|NCT00898807|18047823|P2|Overall Study|Family pressure to discontinue|2
5228951|NCT00898807|18047824|P1|Overall Study|Family pressure to discontinue|2
5228952|NCT00898807|18047823|P2|Overall Study|Withdrawal by Subject|3
5228953|NCT00898807|18047824|P1|Overall Study|Withdrawal by Subject|5
5228954|NCT00898677|18047840|P4|Overall Study|Not Treated: Other (Not Specified)|0
5228955|NCT00898677|18047841|P3|Overall Study|Not Treated: Other (Not Specified)|2
5228956|NCT00898677|18047842|P2|Overall Study|Not Treated: Other (Not Specified)|0
5228957|NCT00898677|18047843|P1|Overall Study|Not Treated: Other (Not Specified)|0
5228958|NCT00898677|18047840|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
5228959|NCT00898677|18047841|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
5228960|NCT00898677|18047842|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
5228961|NCT00898677|18047843|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
5228962|NCT00898677|18047840|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
5228963|NCT00898677|18047841|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
5228964|NCT00898677|18047842|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
5228965|NCT00898677|18047843|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
5228966|NCT00898677|18047840|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
5228967|NCT00898677|18047841|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
5228968|NCT00898677|18047842|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
5228969|NCT00898677|18047843|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
5228970|NCT00898677|18047840|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
5228971|NCT00898677|18047841|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
5228972|NCT00898677|18047842|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
5228973|NCT00898677|18047843|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
5228974|NCT00898677|18047840|P4|Overall Study|Not Treated: Patient uncooperative|0
5228975|NCT00898677|18047841|P3|Overall Study|Not Treated: Patient uncooperative|1
5228976|NCT00898677|18047842|P2|Overall Study|Not Treated: Patient uncooperative|3
5228977|NCT00898677|18047843|P1|Overall Study|Not Treated: Patient uncooperative|2
5228978|NCT00898677|18047840|P4|Overall Study|Not Treated: Withdraw by Subject|3
5228979|NCT00898677|18047841|P3|Overall Study|Not Treated: Withdraw by Subject|11
5228980|NCT00898677|18047842|P2|Overall Study|Not Treated: Withdraw by Subject|16
5228981|NCT00898677|18047843|P1|Overall Study|Not Treated: Withdraw by Subject|2
5228982|NCT00898677|18047840|P4|Overall Study|Not Treated: Protocol Violation|0
5228983|NCT00898677|18047841|P3|Overall Study|Not Treated: Protocol Violation|2
5228984|NCT00898677|18047842|P2|Overall Study|Not Treated: Protocol Violation|0
5228985|NCT00898677|18047843|P1|Overall Study|Not Treated: Protocol Violation|2
5228986|NCT00898677|18047840|P4|Overall Study|Not Treated: Pregnancy|0
5228987|NCT00898677|18047841|P3|Overall Study|Not Treated: Pregnancy|1
5228988|NCT00898677|18047842|P2|Overall Study|Not Treated: Pregnancy|0
5228989|NCT00898677|18047843|P1|Overall Study|Not Treated: Pregnancy|0
5228990|NCT00898677|18047840|P4|Overall Study|Not Treated: Lost to Follow-Up|2
5228991|NCT00898677|18047841|P3|Overall Study|Not Treated: Lost to Follow-Up|5
5228992|NCT00898677|18047842|P2|Overall Study|Not Treated: Lost to Follow-Up|5
5228993|NCT00898677|18047843|P1|Overall Study|Not Treated: Lost to Follow-Up|0
5228994|NCT00898677|18047840|P4|Overall Study|Not Treated: Adverse Event|0
5228995|NCT00898677|18047841|P3|Overall Study|Not Treated: Adverse Event|1
5228996|NCT00898677|18047842|P2|Overall Study|Not Treated: Adverse Event|2
5228997|NCT00898677|18047843|P1|Overall Study|Not Treated: Adverse Event|0
5228998|NCT00898677|18047840|P4|Overall Study|Withdrawal by Subject|1
5228999|NCT00898677|18047841|P3|Overall Study|Withdrawal by Subject|0
5229000|NCT00898677|18047842|P2|Overall Study|Withdrawal by Subject|0
5229001|NCT00898677|18047843|P1|Overall Study|Withdrawal by Subject|0
5229002|NCT00898677|18047840|P4|Overall Study|Protocol Violation|0
5229003|NCT00898677|18047841|P3|Overall Study|Protocol Violation|2
5229004|NCT00898677|18047842|P2|Overall Study|Protocol Violation|1
5229005|NCT00898677|18047843|P1|Overall Study|Protocol Violation|1
5229006|NCT00898677|18047840|P4|Overall Study|Lost to Follow-up|0
5229007|NCT00898677|18047841|P3|Overall Study|Lost to Follow-up|2
5229008|NCT00898677|18047842|P2|Overall Study|Lost to Follow-up|0
5229009|NCT00898677|18047843|P1|Overall Study|Lost to Follow-up|0
5229010|NCT00898677|18047840|P4|Overall Study|Adverse Event|0
5229011|NCT00898677|18047841|P3|Overall Study|Adverse Event|1
5229012|NCT00898677|18047842|P2|Overall Study|Adverse Event|0
5229013|NCT00898677|18047843|P1|Overall Study|Adverse Event|0
5229014|NCT00898443|18047881|P2|Overall Study|Withdrawal by Subject|0
5229015|NCT00898443|18047882|P1|Overall Study|Withdrawal by Subject|1
5229016|NCT00897949|18047897|P3|Overall Study|Did not take study drug|4
5229017|NCT00897949|18047898|P2|Overall Study|Did not take study drug|3
5229018|NCT00897949|18047899|P1|Overall Study|Did not take study drug|9
5229019|NCT00897949|18047897|P3|Overall Study|Lack of Migraine Attack|19
5229020|NCT00897949|18047898|P2|Overall Study|Lack of Migraine Attack|30
5229021|NCT00897949|18047899|P1|Overall Study|Lack of Migraine Attack|29
5229022|NCT00897949|18047897|P3|Overall Study|Need for Concom. Med.|1
5229023|NCT00897949|18047898|P2|Overall Study|Need for Concom. Med.|1
5229024|NCT00897949|18047899|P1|Overall Study|Need for Concom. Med.|0
5229025|NCT00897949|18047897|P3|Overall Study|Abnormal Baseline ECG|4
5229026|NCT00897949|18047898|P2|Overall Study|Abnormal Baseline ECG|2
5229027|NCT00897949|18047899|P1|Overall Study|Abnormal Baseline ECG|2
5229028|NCT00897949|18047897|P3|Overall Study|Abnormal Prestudy Labs|4
5229029|NCT00897949|18047898|P2|Overall Study|Abnormal Prestudy Labs|3
5229030|NCT00897949|18047899|P1|Overall Study|Abnormal Prestudy Labs|2
5229031|NCT00897949|18047897|P3|Overall Study|Withdrawal by Subject|17
5229032|NCT00897949|18047898|P2|Overall Study|Withdrawal by Subject|31
5229033|NCT00897949|18047899|P1|Overall Study|Withdrawal by Subject|24
5229034|NCT00897949|18047897|P3|Overall Study|Lost to Follow-up|17
5229035|NCT00897949|18047898|P2|Overall Study|Lost to Follow-up|23
5229036|NCT00897949|18047899|P1|Overall Study|Lost to Follow-up|30
5229037|NCT00897949|18047897|P3|Overall Study|Patient Uncoorperative|1
5229038|NCT00897949|18047898|P2|Overall Study|Patient Uncoorperative|2
5229039|NCT00897949|18047899|P1|Overall Study|Patient Uncoorperative|0
5229040|NCT00897949|18047897|P3|Overall Study|Withdrawal by Subject|0
5229041|NCT00897949|18047898|P2|Overall Study|Withdrawal by Subject|2
5229042|NCT00897949|18047899|P1|Overall Study|Withdrawal by Subject|1
5229043|NCT00897949|18047897|P3|Overall Study|Protocol Violation|1
5229044|NCT00897949|18047898|P2|Overall Study|Protocol Violation|3
5229045|NCT00897949|18047899|P1|Overall Study|Protocol Violation|6
5229046|NCT00897949|18047897|P3|Overall Study|Lost to Follow-up|1
5229047|NCT00897949|18047898|P2|Overall Study|Lost to Follow-up|2
5229048|NCT00897949|18047899|P1|Overall Study|Lost to Follow-up|0
5229049|NCT00897949|18047897|P3|Overall Study|Adverse Event|0
5229050|NCT00897949|18047898|P2|Overall Study|Adverse Event|1
5229051|NCT00897949|18047899|P1|Overall Study|Adverse Event|1
5229052|NCT00897715|18047933|P2|Overall Study|increased risk of infection|0
5229053|NCT00897715|18047934|P1|Overall Study|increased risk of infection|1
5229054|NCT00897715|18047933|P2|Overall Study|Physician Decision|0
5229055|NCT00897715|18047934|P1|Overall Study|Physician Decision|1
5229056|NCT00897715|18047933|P2|Overall Study|Lost to Follow-up|1
5229057|NCT00897715|18047934|P1|Overall Study|Lost to Follow-up|0
5229058|NCT00897390|18047959|P1|Overall Study|Did not Return for the Clinic Visit|2
5229059|NCT00897390|18047959|P1|Overall Study|Personal Reasons|1
5229060|NCT00897390|18047959|P1|Overall Study|No Longer Met Study Criteria|1
5229061|NCT00897390|18047959|P1|Overall Study|Adverse Event|2
5229062|NCT00897104|18048049|P3|Overall Study|Withdrawal by Subject|1
5229063|NCT00897104|18048050|P2|Overall Study|Withdrawal by Subject|0
5229064|NCT00897104|18048051|P1|Overall Study|Withdrawal by Subject|0
5229065|NCT00897104|18048049|P3|Overall Study|Protocol Violation|0
5229066|NCT00897104|18048050|P2|Overall Study|Protocol Violation|0
5229067|NCT00897104|18048051|P1|Overall Study|Protocol Violation|1
5229068|NCT00897104|18048049|P3|Overall Study|Other|0
5229069|NCT00897104|18048050|P2|Overall Study|Other|0
5229070|NCT00897104|18048051|P1|Overall Study|Other|3
5229071|NCT00897104|18048049|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
5229072|NCT00897104|18048050|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
5229073|NCT00897104|18048051|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
5229074|NCT00897104|18048049|P3|Overall Study|Lack of Migraine Attack|1
5229075|NCT00897104|18048050|P2|Overall Study|Lack of Migraine Attack|22
5229076|NCT00897104|18048051|P1|Overall Study|Lack of Migraine Attack|20
5229077|NCT00897104|18048049|P3|Overall Study|Need for Concom. Med.|1
5229078|NCT00897104|18048050|P2|Overall Study|Need for Concom. Med.|1
5229079|NCT00897104|18048051|P1|Overall Study|Need for Concom. Med.|0
5229080|NCT00897104|18048049|P3|Overall Study|Abnormal Baseline ECG|0
5229081|NCT00897104|18048050|P2|Overall Study|Abnormal Baseline ECG|2
5229082|NCT00897104|18048051|P1|Overall Study|Abnormal Baseline ECG|2
5229083|NCT00897104|18048049|P3|Overall Study|Abnormal Prestudy Labs|0
5229084|NCT00897104|18048050|P2|Overall Study|Abnormal Prestudy Labs|0
5229085|NCT00897104|18048051|P1|Overall Study|Abnormal Prestudy Labs|2
5229086|NCT00897104|18048049|P3|Overall Study|Withdrawal by Subject|3
5229087|NCT00897104|18048050|P2|Overall Study|Withdrawal by Subject|27
5229088|NCT00897104|18048051|P1|Overall Study|Withdrawal by Subject|23
5229089|NCT00897104|18048049|P3|Overall Study|Protocol Violation|0
5229090|NCT00897104|18048050|P2|Overall Study|Protocol Violation|1
5229091|NCT00897104|18048051|P1|Overall Study|Protocol Violation|0
5229092|NCT00897104|18048049|P3|Overall Study|Pregnancy|0
5229093|NCT00897104|18048050|P2|Overall Study|Pregnancy|1
5229094|NCT00897104|18048051|P1|Overall Study|Pregnancy|0
5229095|NCT00897104|18048049|P3|Overall Study|Lost to Follow-up|2
5229096|NCT00897104|18048050|P2|Overall Study|Lost to Follow-up|17
5229097|NCT00897104|18048051|P1|Overall Study|Lost to Follow-up|12
5229098|NCT00896649|18048086|P1|Overall Study|technical difficulties|2
5229099|NCT00896649|18048086|P1|Overall Study|missing documentation|1
5229100|NCT00896649|18048086|P1|Overall Study|Pregnancy|1
5229101|NCT00896649|18048086|P1|Overall Study|Physician Decision|1
5229102|NCT00896532|18048099|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229103|NCT00896532|18048100|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
5229104|NCT00896532|18048101|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229105|NCT00896532|18048102|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229106|NCT00896532|18048103|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229107|NCT00896532|18048104|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229108|NCT00896532|18048105|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229109|NCT00896532|18048106|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229110|NCT00896532|18048107|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229111|NCT00896532|18048108|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229112|NCT00896532|18048109|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229113|NCT00896532|18048110|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229114|NCT00896532|18048111|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229115|NCT00896532|18048112|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229116|NCT00896532|18048113|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229117|NCT00896532|18048114|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229118|NCT00896532|18048115|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229119|NCT00896532|18048116|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229120|NCT00896532|18048117|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229121|NCT00896532|18048118|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229122|NCT00896532|18048119|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229123|NCT00896532|18048120|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229124|NCT00896532|18048121|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5229125|NCT00896532|18048099|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229126|NCT00896532|18048100|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
5229127|NCT00896532|18048101|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229128|NCT00896532|18048102|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229129|NCT00896532|18048103|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229130|NCT00896532|18048104|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229131|NCT00896532|18048105|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229132|NCT00896532|18048106|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229133|NCT00896532|18048107|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229134|NCT00896532|18048108|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229135|NCT00896532|18048109|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229136|NCT00896532|18048110|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229137|NCT00896532|18048111|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229138|NCT00896532|18048112|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229139|NCT00896532|18048113|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229140|NCT00896532|18048114|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229141|NCT00896532|18048115|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229142|NCT00896532|18048116|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229143|NCT00896532|18048117|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229144|NCT00896532|18048118|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229145|NCT00896532|18048119|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229146|NCT00896532|18048120|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229147|NCT00896532|18048121|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5229148|NCT00896532|18048099|P23|Months 48-72: Follow-on Phase|Death|0
5229149|NCT00896532|18048100|P22|Months 48-72: Follow-on Phase|Death|0
5229150|NCT00896532|18048101|P21|Months 48-72: Follow-on Phase|Death|0
5229151|NCT00896532|18048102|P20|Months 48-72: Follow-on Phase|Death|0
5229152|NCT00896532|18048103|P19|Months 48-72: Follow-on Phase|Death|1
5229153|NCT00896532|18048104|P18|Months 48-72: Follow-on Phase|Death|0
5229154|NCT00896532|18048105|P17|Months 48-72: Follow-on Phase|Death|0
5229155|NCT00896532|18048106|P16|Months 48-72: Follow-on Phase|Death|0
5229156|NCT00896532|18048107|P15|Months 48-72: Follow-on Phase|Death|0
5229157|NCT00896532|18048108|P14|Months 48-72: Follow-on Phase|Death|0
5229158|NCT00896532|18048109|P13|Months 48-72: Follow-on Phase|Death|0
5229159|NCT00896532|18048110|P12|Months 48-72: Follow-on Phase|Death|0
5229160|NCT00896532|18048111|P11|Months 48-72: Follow-on Phase|Death|0
5229161|NCT00896532|18048112|P10|Months 48-72: Follow-on Phase|Death|0
5229162|NCT00896532|18048113|P9|Months 48-72: Follow-on Phase|Death|0
5229163|NCT00896532|18048114|P8|Months 48-72: Follow-on Phase|Death|0
5229164|NCT00896532|18048115|P7|Months 48-72: Follow-on Phase|Death|0
5229165|NCT00896532|18048116|P6|Months 48-72: Follow-on Phase|Death|0
5229166|NCT00896532|18048117|P5|Months 48-72: Follow-on Phase|Death|0
5229167|NCT00896532|18048118|P4|Months 48-72: Follow-on Phase|Death|0
5229168|NCT00896532|18048119|P3|Months 48-72: Follow-on Phase|Death|0
5229169|NCT00896532|18048120|P2|Months 48-72: Follow-on Phase|Death|0
5229170|NCT00896532|18048121|P1|Months 48-72: Follow-on Phase|Death|0
5229171|NCT00896532|18048099|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229172|NCT00896532|18048100|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229173|NCT00896532|18048101|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229174|NCT00896532|18048102|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229175|NCT00896532|18048103|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229176|NCT00896532|18048104|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229177|NCT00896532|18048105|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
5229178|NCT00896532|18048106|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229179|NCT00896532|18048107|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229180|NCT00896532|18048108|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229181|NCT00896532|18048109|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229182|NCT00896532|18048110|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229183|NCT00896532|18048111|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229184|NCT00896532|18048112|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229185|NCT00896532|18048113|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229186|NCT00896532|18048114|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229187|NCT00896532|18048115|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229188|NCT00896532|18048116|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229189|NCT00896532|18048117|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229190|NCT00896532|18048118|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229191|NCT00896532|18048119|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229192|NCT00896532|18048120|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229193|NCT00896532|18048121|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5229194|NCT00896532|18048099|P23|Months 36-48: Romosozumab Retreatment|Other|0
5229195|NCT00896532|18048100|P22|Months 36-48: Romosozumab Retreatment|Other|0
5229196|NCT00896532|18048101|P21|Months 36-48: Romosozumab Retreatment|Other|0
5229197|NCT00896532|18048102|P20|Months 36-48: Romosozumab Retreatment|Other|0
5229198|NCT00896532|18048103|P19|Months 36-48: Romosozumab Retreatment|Other|0
5229199|NCT00896532|18048104|P18|Months 36-48: Romosozumab Retreatment|Other|1
5229200|NCT00896532|18048105|P17|Months 36-48: Romosozumab Retreatment|Other|0
5229201|NCT00896532|18048106|P16|Months 36-48: Romosozumab Retreatment|Other|0
5229202|NCT00896532|18048107|P15|Months 36-48: Romosozumab Retreatment|Other|0
5229203|NCT00896532|18048108|P14|Months 36-48: Romosozumab Retreatment|Other|0
5229204|NCT00896532|18048109|P13|Months 36-48: Romosozumab Retreatment|Other|0
5229205|NCT00896532|18048110|P12|Months 36-48: Romosozumab Retreatment|Other|0
5229206|NCT00896532|18048111|P11|Months 36-48: Romosozumab Retreatment|Other|0
5229207|NCT00896532|18048112|P10|Months 36-48: Romosozumab Retreatment|Other|0
5229208|NCT00896532|18048113|P9|Months 36-48: Romosozumab Retreatment|Other|0
5229209|NCT00896532|18048114|P8|Months 36-48: Romosozumab Retreatment|Other|0
5229210|NCT00896532|18048115|P7|Months 36-48: Romosozumab Retreatment|Other|0
5229211|NCT00896532|18048116|P6|Months 36-48: Romosozumab Retreatment|Other|0
5229212|NCT00896532|18048117|P5|Months 36-48: Romosozumab Retreatment|Other|0
5229213|NCT00896532|18048118|P4|Months 36-48: Romosozumab Retreatment|Other|0
5229214|NCT00896532|18048119|P3|Months 36-48: Romosozumab Retreatment|Other|0
5229215|NCT00896532|18048120|P2|Months 36-48: Romosozumab Retreatment|Other|0
5229216|NCT00896532|18048121|P1|Months 36-48: Romosozumab Retreatment|Other|0
5229217|NCT00896532|18048099|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229218|NCT00896532|18048100|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229219|NCT00896532|18048101|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229220|NCT00896532|18048102|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229221|NCT00896532|18048103|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229222|NCT00896532|18048104|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229223|NCT00896532|18048105|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
5229224|NCT00896532|18048106|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229225|NCT00896532|18048107|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229226|NCT00896532|18048108|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229227|NCT00896532|18048109|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229228|NCT00896532|18048110|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229229|NCT00896532|18048111|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229230|NCT00896532|18048112|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229231|NCT00896532|18048113|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229232|NCT00896532|18048114|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229233|NCT00896532|18048115|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229234|NCT00896532|18048116|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229235|NCT00896532|18048117|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229236|NCT00896532|18048118|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229237|NCT00896532|18048119|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229238|NCT00896532|18048120|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229239|NCT00896532|18048121|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5229240|NCT00896532|18048099|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229241|NCT00896532|18048100|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229242|NCT00896532|18048101|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229243|NCT00896532|18048102|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229244|NCT00896532|18048103|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229245|NCT00896532|18048104|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
5229246|NCT00896532|18048105|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
5229247|NCT00896532|18048106|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
5229248|NCT00896532|18048107|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229249|NCT00896532|18048108|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229250|NCT00896532|18048109|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229251|NCT00896532|18048110|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229252|NCT00896532|18048111|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229253|NCT00896532|18048112|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229254|NCT00896532|18048113|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229255|NCT00896532|18048114|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229256|NCT00896532|18048115|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229257|NCT00896532|18048116|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229258|NCT00896532|18048117|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229259|NCT00896532|18048118|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229260|NCT00896532|18048119|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229261|NCT00896532|18048120|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229262|NCT00896532|18048121|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5229263|NCT00896532|18048099|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229264|NCT00896532|18048100|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229265|NCT00896532|18048101|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229266|NCT00896532|18048102|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229267|NCT00896532|18048103|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229268|NCT00896532|18048104|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229269|NCT00896532|18048105|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
5229270|NCT00896532|18048106|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
5229271|NCT00896532|18048107|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229272|NCT00896532|18048108|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229273|NCT00896532|18048109|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229274|NCT00896532|18048110|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229275|NCT00896532|18048111|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229276|NCT00896532|18048112|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229277|NCT00896532|18048113|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229278|NCT00896532|18048114|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229279|NCT00896532|18048115|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229280|NCT00896532|18048116|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229281|NCT00896532|18048117|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229282|NCT00896532|18048118|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229283|NCT00896532|18048119|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229284|NCT00896532|18048120|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229285|NCT00896532|18048121|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5229286|NCT00896532|18048099|P23|Months 24-36: Denosumab Extension Phase|Other|0
5229287|NCT00896532|18048100|P22|Months 24-36: Denosumab Extension Phase|Other|0
5229288|NCT00896532|18048101|P21|Months 24-36: Denosumab Extension Phase|Other|0
5229289|NCT00896532|18048102|P20|Months 24-36: Denosumab Extension Phase|Other|0
5229290|NCT00896532|18048103|P19|Months 24-36: Denosumab Extension Phase|Other|0
5229291|NCT00896532|18048104|P18|Months 24-36: Denosumab Extension Phase|Other|0
5229292|NCT00896532|18048105|P17|Months 24-36: Denosumab Extension Phase|Other|0
5229293|NCT00896532|18048106|P16|Months 24-36: Denosumab Extension Phase|Other|0
5229294|NCT00896532|18048107|P15|Months 24-36: Denosumab Extension Phase|Other|0
5229295|NCT00896532|18048108|P14|Months 24-36: Denosumab Extension Phase|Other|1
5229296|NCT00896532|18048109|P13|Months 24-36: Denosumab Extension Phase|Other|2
5229297|NCT00896532|18048110|P12|Months 24-36: Denosumab Extension Phase|Other|2
5229298|NCT00896532|18048111|P11|Months 24-36: Denosumab Extension Phase|Other|1
5229299|NCT00896532|18048112|P10|Months 24-36: Denosumab Extension Phase|Other|0
5229300|NCT00896532|18048113|P9|Months 24-36: Denosumab Extension Phase|Other|0
5229301|NCT00896532|18048114|P8|Months 24-36: Denosumab Extension Phase|Other|0
5229302|NCT00896532|18048115|P7|Months 24-36: Denosumab Extension Phase|Other|0
5229303|NCT00896532|18048116|P6|Months 24-36: Denosumab Extension Phase|Other|0
5229304|NCT00896532|18048117|P5|Months 24-36: Denosumab Extension Phase|Other|0
5229305|NCT00896532|18048118|P4|Months 24-36: Denosumab Extension Phase|Other|0
5229306|NCT00896532|18048119|P3|Months 24-36: Denosumab Extension Phase|Other|0
5229307|NCT00896532|18048120|P2|Months 24-36: Denosumab Extension Phase|Other|0
5229308|NCT00896532|18048121|P1|Months 24-36: Denosumab Extension Phase|Other|0
5229309|NCT00896532|18048099|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229310|NCT00896532|18048100|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229311|NCT00896532|18048101|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229312|NCT00896532|18048102|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229313|NCT00896532|18048103|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229314|NCT00896532|18048104|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229315|NCT00896532|18048105|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229316|NCT00896532|18048106|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229317|NCT00896532|18048107|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229318|NCT00896532|18048108|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
5229319|NCT00896532|18048109|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
5229320|NCT00896532|18048110|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229321|NCT00896532|18048111|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229322|NCT00896532|18048112|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229323|NCT00896532|18048113|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229324|NCT00896532|18048114|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229325|NCT00896532|18048115|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229326|NCT00896532|18048116|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229327|NCT00896532|18048117|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229328|NCT00896532|18048118|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229329|NCT00896532|18048119|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229330|NCT00896532|18048120|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229331|NCT00896532|18048121|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5229332|NCT00896532|18048099|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229333|NCT00896532|18048100|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229334|NCT00896532|18048101|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229335|NCT00896532|18048102|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229336|NCT00896532|18048103|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229337|NCT00896532|18048104|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229338|NCT00896532|18048105|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229339|NCT00896532|18048106|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229340|NCT00896532|18048107|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229341|NCT00896532|18048108|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229342|NCT00896532|18048109|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
5229343|NCT00896532|18048110|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229344|NCT00896532|18048111|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
5229345|NCT00896532|18048112|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229346|NCT00896532|18048113|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229347|NCT00896532|18048114|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229348|NCT00896532|18048115|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229349|NCT00896532|18048116|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229350|NCT00896532|18048117|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229351|NCT00896532|18048118|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229352|NCT00896532|18048119|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229353|NCT00896532|18048120|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229354|NCT00896532|18048121|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5229355|NCT00896532|18048099|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229356|NCT00896532|18048100|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229357|NCT00896532|18048101|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229358|NCT00896532|18048102|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229359|NCT00896532|18048103|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229360|NCT00896532|18048104|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229361|NCT00896532|18048105|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229362|NCT00896532|18048106|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229363|NCT00896532|18048107|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229364|NCT00896532|18048108|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229365|NCT00896532|18048109|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
5229366|NCT00896532|18048110|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229367|NCT00896532|18048111|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229368|NCT00896532|18048112|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229369|NCT00896532|18048113|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229370|NCT00896532|18048114|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229371|NCT00896532|18048115|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229372|NCT00896532|18048116|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229373|NCT00896532|18048117|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229374|NCT00896532|18048118|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229375|NCT00896532|18048119|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229376|NCT00896532|18048120|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229377|NCT00896532|18048121|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5229378|NCT00896532|18048099|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229379|NCT00896532|18048100|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229380|NCT00896532|18048101|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229381|NCT00896532|18048102|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229382|NCT00896532|18048103|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229383|NCT00896532|18048104|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229384|NCT00896532|18048105|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229385|NCT00896532|18048106|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229386|NCT00896532|18048107|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229387|NCT00896532|18048108|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229388|NCT00896532|18048109|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229389|NCT00896532|18048110|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229390|NCT00896532|18048111|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229391|NCT00896532|18048112|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229392|NCT00896532|18048113|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
5229688|NCT00895895|18048697|P2|Period 2|failed to return|0
5229393|NCT00896532|18048114|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229394|NCT00896532|18048115|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229395|NCT00896532|18048116|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229396|NCT00896532|18048117|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229397|NCT00896532|18048118|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229398|NCT00896532|18048119|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229399|NCT00896532|18048120|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229400|NCT00896532|18048121|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5229401|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
5229402|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
5229403|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
5229404|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
5229405|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
5229406|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
5229407|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
5229408|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
5229409|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
5229410|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
5229411|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
5229412|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
5229413|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
5229414|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
5229415|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
5229416|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
5229417|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
5229418|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
5229419|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
5229420|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
5229421|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
5229422|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
5229423|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
5229424|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229425|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229426|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229427|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229428|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229429|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229430|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229431|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229432|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229433|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229434|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229435|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229436|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229437|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229438|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229439|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229440|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229441|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229442|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229443|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
5229444|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229445|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229446|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5229447|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229448|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229449|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229450|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229451|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229452|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229453|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229454|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229455|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229456|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229457|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229458|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229459|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229460|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229461|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229462|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229463|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229464|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229465|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229466|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229467|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
5229468|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229469|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5229470|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229471|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229472|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229473|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229474|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229475|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229476|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229477|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229478|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229479|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229480|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229481|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229482|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229483|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229484|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229485|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229486|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229487|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229488|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229489|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229490|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
5229491|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229492|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5229493|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
5229494|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
5229495|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
5229496|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
5229497|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
5229498|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
5229499|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
5229500|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
5229501|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
5229502|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
5229503|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
5229504|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
5229505|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
5229506|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
5229507|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
5229508|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
5229509|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
5229510|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
5229511|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
5229512|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
5229513|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
5229514|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
5229515|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
5229516|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229517|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229518|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229519|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229520|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229521|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229522|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229523|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229524|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229525|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229526|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229527|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229528|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229529|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229530|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229531|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229532|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229533|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229534|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
5229535|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229536|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
5229537|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229538|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5229539|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229540|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229541|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229542|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229543|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229544|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229545|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229546|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229547|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229548|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229549|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229550|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229551|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229552|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229553|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5229554|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5229555|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5229556|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
5229557|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
5229558|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
5229559|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5229560|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
5229561|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5229562|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229563|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229564|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229565|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229566|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229567|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229568|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229569|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229570|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229571|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229572|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229573|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229574|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229575|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229576|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229577|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5229578|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5229579|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5229580|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5229581|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
5229582|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5229583|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
5229584|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5229585|NCT00896532|18048099|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229586|NCT00896532|18048100|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229587|NCT00896532|18048101|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229588|NCT00896532|18048102|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229589|NCT00896532|18048103|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229590|NCT00896532|18048104|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229591|NCT00896532|18048105|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229592|NCT00896532|18048106|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229593|NCT00896532|18048107|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229594|NCT00896532|18048108|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229595|NCT00896532|18048109|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229596|NCT00896532|18048110|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229597|NCT00896532|18048111|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229598|NCT00896532|18048112|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229599|NCT00896532|18048113|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229600|NCT00896532|18048114|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229601|NCT00896532|18048115|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229602|NCT00896532|18048116|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
5229603|NCT00896532|18048117|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229604|NCT00896532|18048118|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
5229605|NCT00896532|18048119|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229606|NCT00896532|18048120|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229607|NCT00896532|18048121|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5229608|NCT00896480|18048248|P1|Overall Study|Disease progression/recurrence|21
5229609|NCT00896454|18048296|P1|Overall Study|Withdrawal by Subject|1
5229610|NCT00896454|18048296|P1|Overall Study|Ongoing in study|2
5229611|NCT00896454|18048296|P1|Overall Study|Requirement for alternative therapy|3
5229612|NCT00896454|18048296|P1|Overall Study|Other|4
5229613|NCT00896454|18048296|P1|Overall Study|Disease Progression|5
5229614|NCT00896454|18048296|P1|Overall Study|Adverse Event|8
5229615|NCT00896454|18048296|P1|Overall Study|Death|10
5229616|NCT00896363|18048335|P3|Overall Study|Withdrawal by Subject|5
5229617|NCT00896363|18048336|P2|Overall Study|Withdrawal by Subject|5
5229618|NCT00896363|18048337|P1|Overall Study|Withdrawal by Subject|3
5229619|NCT00896363|18048335|P3|Overall Study|Lack of Efficacy|1
5229620|NCT00896363|18048336|P2|Overall Study|Lack of Efficacy|2
5229621|NCT00896363|18048337|P1|Overall Study|Lack of Efficacy|0
5229622|NCT00896363|18048335|P3|Overall Study|Adverse Event|2
5229623|NCT00896363|18048336|P2|Overall Study|Adverse Event|4
5229624|NCT00896363|18048337|P1|Overall Study|Adverse Event|3
5229625|NCT00896337|18048389|P1|Overall Study|Lost to Follow-up|11
5229626|NCT00896337|18048389|P1|Overall Study|Withdrawal by Subject|7
5229627|NCT00896337|18048389|P1|Overall Study|Death|7
5229628|NCT00896233|18048471|P1|Overall Study|Claustrophobia during MRI|1
5229629|NCT00896168|18048484|P2|Overall Study|Other|1
5229630|NCT00896168|18048485|P1|Overall Study|Other|1
5229631|NCT00896168|18048484|P2|Overall Study|Lost to Follow-up|1
5229632|NCT00896168|18048485|P1|Overall Study|Lost to Follow-up|1
5229633|NCT00896168|18048484|P2|Overall Study|Treatment failure|10
5229634|NCT00896168|18048485|P1|Overall Study|Treatment failure|8
5229635|NCT00896168|18048484|P2|Overall Study|Adverse Event|7
5229636|NCT00896168|18048485|P1|Overall Study|Adverse Event|4
5229637|NCT00896051|18048546|P2|Overall Study|Other|1
5229638|NCT00896051|18048547|P1|Overall Study|Other|1
5229639|NCT00896051|18048546|P2|Overall Study|Subject noncompliant|3
5229640|NCT00896051|18048547|P1|Overall Study|Subject noncompliant|1
5229641|NCT00896051|18048546|P2|Overall Study|Withdrawal by Subject|2
5229642|NCT00896051|18048547|P1|Overall Study|Withdrawal by Subject|3
5229643|NCT00896051|18048546|P2|Overall Study|Lost to Follow-up|2
5229644|NCT00896051|18048547|P1|Overall Study|Lost to Follow-up|3
5229645|NCT00896051|18048546|P2|Overall Study|Adverse Event|1
5229646|NCT00896051|18048547|P1|Overall Study|Adverse Event|2
5229647|NCT00895947|18048642|P2|Overall Study|Withdrawal by Subject|0
5229648|NCT00895947|18048643|P1|Overall Study|Withdrawal by Subject|2
5229649|NCT00895947|18048642|P2|Overall Study|Protocol Violation|2
5229650|NCT00895947|18048643|P1|Overall Study|Protocol Violation|4
5229651|NCT00895947|18048642|P2|Overall Study|Lost to Follow-up|4
5229652|NCT00895947|18048643|P1|Overall Study|Lost to Follow-up|3
5229653|NCT00895947|18048642|P2|Overall Study|Adverse Event|4
5229654|NCT00895947|18048643|P1|Overall Study|Adverse Event|3
5229655|NCT00895895|18048694|P5|Period 2|unsatisfactory response-efficacy|0
5229656|NCT00895895|18048695|P4|Period 2|unsatisfactory response-efficacy|0
5229657|NCT00895895|18048696|P3|Period 2|unsatisfactory response-efficacy|0
5229658|NCT00895895|18048697|P2|Period 2|unsatisfactory response-efficacy|1
5229659|NCT00895895|18048698|P1|Period 2|unsatisfactory response-efficacy|2
5229660|NCT00895895|18048694|P5|Period 2|Withdrawal by Subject|5
5229661|NCT00895895|18048695|P4|Period 2|Withdrawal by Subject|3
5229662|NCT00895895|18048696|P3|Period 2|Withdrawal by Subject|0
5229663|NCT00895895|18048697|P2|Period 2|Withdrawal by Subject|2
5229664|NCT00895895|18048698|P1|Period 2|Withdrawal by Subject|0
5229665|NCT00895895|18048694|P5|Period 2|Protocol Violation|1
5229666|NCT00895895|18048695|P4|Period 2|Protocol Violation|1
5229667|NCT00895895|18048696|P3|Period 2|Protocol Violation|1
5229668|NCT00895895|18048697|P2|Period 2|Protocol Violation|0
5229669|NCT00895895|18048698|P1|Period 2|Protocol Violation|1
5229670|NCT00895895|18048694|P5|Period 2|Other|1
5229671|NCT00895895|18048695|P4|Period 2|Other|1
5229672|NCT00895895|18048696|P3|Period 2|Other|3
5229673|NCT00895895|18048697|P2|Period 2|Other|1
5229674|NCT00895895|18048698|P1|Period 2|Other|1
5229675|NCT00895895|18048694|P5|Period 2|Lost to Follow-up|0
5229676|NCT00895895|18048695|P4|Period 2|Lost to Follow-up|1
5229677|NCT00895895|18048696|P3|Period 2|Lost to Follow-up|1
5229678|NCT00895895|18048697|P2|Period 2|Lost to Follow-up|2
5229679|NCT00895895|18048698|P1|Period 2|Lost to Follow-up|1
5229680|NCT00895895|18048694|P5|Period 2|investigator request|0
5229681|NCT00895895|18048695|P4|Period 2|investigator request|0
5229682|NCT00895895|18048696|P3|Period 2|investigator request|0
5229683|NCT00895895|18048697|P2|Period 2|investigator request|0
5229684|NCT00895895|18048698|P1|Period 2|investigator request|2
5229685|NCT00895895|18048694|P5|Period 2|failed to return|0
5229686|NCT00895895|18048695|P4|Period 2|failed to return|0
5229687|NCT00895895|18048696|P3|Period 2|failed to return|0
5229689|NCT00895895|18048698|P1|Period 2|failed to return|2
5229690|NCT00895895|18048694|P5|Period 2|discontinued by sponsor|37
5229691|NCT00895895|18048695|P4|Period 2|discontinued by sponsor|46
5229692|NCT00895895|18048696|P3|Period 2|discontinued by sponsor|38
5229693|NCT00895895|18048697|P2|Period 2|discontinued by sponsor|44
5229694|NCT00895895|18048698|P1|Period 2|discontinued by sponsor|44
5229695|NCT00895895|18048694|P5|Period 2|Death|0
5229696|NCT00895895|18048695|P4|Period 2|Death|0
5229697|NCT00895895|18048696|P3|Period 2|Death|1
5229698|NCT00895895|18048697|P2|Period 2|Death|0
5229699|NCT00895895|18048698|P1|Period 2|Death|0
5229700|NCT00895895|18048694|P5|Period 2|Adverse Event|5
5229701|NCT00895895|18048695|P4|Period 2|Adverse Event|2
5229702|NCT00895895|18048696|P3|Period 2|Adverse Event|5
5229703|NCT00895895|18048697|P2|Period 2|Adverse Event|3
5229704|NCT00895895|18048698|P1|Period 2|Adverse Event|3
5229705|NCT00895895|18048694|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
5229706|NCT00895895|18048695|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5229707|NCT00895895|18048696|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5229708|NCT00895895|18048697|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5229709|NCT00895895|18048698|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5229710|NCT00895895|18048694|P5|After Period 1, Prior to Period 2|Protocol Violation|1
5229711|NCT00895895|18048695|P4|After Period 1, Prior to Period 2|Protocol Violation|0
5229712|NCT00895895|18048696|P3|After Period 1, Prior to Period 2|Protocol Violation|0
5229713|NCT00895895|18048697|P2|After Period 1, Prior to Period 2|Protocol Violation|0
5229714|NCT00895895|18048698|P1|After Period 1, Prior to Period 2|Protocol Violation|0
5229715|NCT00895895|18048694|P5|After Period 1, Prior to Period 2|Other|0
5229716|NCT00895895|18048695|P4|After Period 1, Prior to Period 2|Other|0
5229717|NCT00895895|18048696|P3|After Period 1, Prior to Period 2|Other|1
5229718|NCT00895895|18048697|P2|After Period 1, Prior to Period 2|Other|0
5229719|NCT00895895|18048698|P1|After Period 1, Prior to Period 2|Other|0
5229720|NCT00895895|18048694|P5|After Period 1, Prior to Period 2|Adverse Event|0
5229721|NCT00895895|18048695|P4|After Period 1, Prior to Period 2|Adverse Event|0
5229722|NCT00895895|18048696|P3|After Period 1, Prior to Period 2|Adverse Event|1
5229723|NCT00895895|18048697|P2|After Period 1, Prior to Period 2|Adverse Event|0
5229724|NCT00895895|18048698|P1|After Period 1, Prior to Period 2|Adverse Event|0
5229725|NCT00895895|18048694|P5|Period 1|randomized and not treated|2
5229726|NCT00895895|18048695|P4|Period 1|randomized and not treated|1
5229727|NCT00895895|18048696|P3|Period 1|randomized and not treated|1
5229728|NCT00895895|18048697|P2|Period 1|randomized and not treated|3
5229729|NCT00895895|18048698|P1|Period 1|randomized and not treated|1
5229730|NCT00895895|18048694|P5|Period 1|unsatisfactory response-efficacy|0
5229731|NCT00895895|18048695|P4|Period 1|unsatisfactory response-efficacy|0
5229732|NCT00895895|18048696|P3|Period 1|unsatisfactory response-efficacy|0
5229733|NCT00895895|18048697|P2|Period 1|unsatisfactory response-efficacy|0
5229734|NCT00895895|18048698|P1|Period 1|unsatisfactory response-efficacy|2
5229735|NCT00895895|18048694|P5|Period 1|Withdrawal by Subject|4
5229736|NCT00895895|18048695|P4|Period 1|Withdrawal by Subject|2
5229737|NCT00895895|18048696|P3|Period 1|Withdrawal by Subject|8
5229738|NCT00895895|18048697|P2|Period 1|Withdrawal by Subject|6
5229739|NCT00895895|18048698|P1|Period 1|Withdrawal by Subject|6
5229740|NCT00895895|18048694|P5|Period 1|Protocol Violation|0
5229741|NCT00895895|18048695|P4|Period 1|Protocol Violation|0
5229742|NCT00895895|18048696|P3|Period 1|Protocol Violation|0
5229743|NCT00895895|18048697|P2|Period 1|Protocol Violation|1
5229744|NCT00895895|18048698|P1|Period 1|Protocol Violation|0
5229745|NCT00895895|18048694|P5|Period 1|Other|1
5229746|NCT00895895|18048695|P4|Period 1|Other|1
5229747|NCT00895895|18048696|P3|Period 1|Other|1
5229748|NCT00895895|18048697|P2|Period 1|Other|2
5229749|NCT00895895|18048698|P1|Period 1|Other|1
5229750|NCT00895895|18048694|P5|Period 1|Lost to Follow-up|3
5229751|NCT00895895|18048695|P4|Period 1|Lost to Follow-up|2
5229752|NCT00895895|18048696|P3|Period 1|Lost to Follow-up|3
5229753|NCT00895895|18048697|P2|Period 1|Lost to Follow-up|1
5229754|NCT00895895|18048698|P1|Period 1|Lost to Follow-up|2
5229755|NCT00895895|18048694|P5|Period 1|investigator request|0
5229756|NCT00895895|18048695|P4|Period 1|investigator request|0
5229757|NCT00895895|18048696|P3|Period 1|investigator request|0
5229758|NCT00895895|18048697|P2|Period 1|investigator request|1
5229759|NCT00895895|18048698|P1|Period 1|investigator request|0
5229760|NCT00895895|18048694|P5|Period 1|failed to return|1
5229761|NCT00895895|18048695|P4|Period 1|failed to return|0
5229762|NCT00895895|18048696|P3|Period 1|failed to return|1
5229763|NCT00895895|18048697|P2|Period 1|failed to return|0
5229764|NCT00895895|18048698|P1|Period 1|failed to return|0
5229765|NCT00895895|18048694|P5|Period 1|discontinued by sponsor|1
5229766|NCT00895895|18048695|P4|Period 1|discontinued by sponsor|1
5229767|NCT00895895|18048696|P3|Period 1|discontinued by sponsor|2
5229768|NCT00895895|18048697|P2|Period 1|discontinued by sponsor|1
5229769|NCT00895895|18048698|P1|Period 1|discontinued by sponsor|2
5229770|NCT00895895|18048694|P5|Period 1|Death|1
5229771|NCT00895895|18048695|P4|Period 1|Death|0
5229772|NCT00895895|18048696|P3|Period 1|Death|0
5229773|NCT00895895|18048697|P2|Period 1|Death|0
5229774|NCT00895895|18048698|P1|Period 1|Death|0
5229775|NCT00895895|18048694|P5|Period 1|Adverse Event|7
5229776|NCT00895895|18048695|P4|Period 1|Adverse Event|6
5229777|NCT00895895|18048696|P3|Period 1|Adverse Event|4
5229778|NCT00895895|18048697|P2|Period 1|Adverse Event|6
5229779|NCT00895895|18048698|P1|Period 1|Adverse Event|7
5229780|NCT00895843|18048812|P2|Overall Study|Protocol Violation|12
5229781|NCT00895843|18048813|P1|Overall Study|Protocol Violation|12
5229782|NCT00895661|18048860|P1|Overall Study|reason unknown|2
5229783|NCT00895661|18048860|P1|Overall Study|Death|1
5229784|NCT00895622|18048870|P3|Overall Study|Protocol Violation|4
5229785|NCT00895622|18048871|P2|Overall Study|Protocol Violation|4
5229786|NCT00895622|18048872|P1|Overall Study|Protocol Violation|5
5229787|NCT00895583|18048899|P2|Overall Study|Other|1
5229788|NCT00895583|18048900|P1|Overall Study|Other|0
5229789|NCT00895583|18048899|P2|Overall Study|Lack of Efficacy|0
5229790|NCT00895583|18048900|P1|Overall Study|Lack of Efficacy|5
5229791|NCT00895583|18048899|P2|Overall Study|Withdrawal by Subject|2
5229792|NCT00895583|18048900|P1|Overall Study|Withdrawal by Subject|4
5229793|NCT00895583|18048899|P2|Overall Study|Protocol Violation|0
5229794|NCT00895583|18048900|P1|Overall Study|Protocol Violation|1
5229795|NCT00895583|18048899|P2|Overall Study|Lost to Follow-up|3
5229796|NCT00895583|18048900|P1|Overall Study|Lost to Follow-up|1
5229797|NCT00895583|18048899|P2|Overall Study|Physician Decision|1
5229798|NCT00895583|18048900|P1|Overall Study|Physician Decision|3
5229799|NCT00895583|18048899|P2|Overall Study|Death|1
5229800|NCT00895583|18048900|P1|Overall Study|Death|2
5229801|NCT00895583|18048899|P2|Overall Study|Adverse Event|4
5229802|NCT00895583|18048900|P1|Overall Study|Adverse Event|28
5229803|NCT00895453|18048990|P3|Overall Study|Lost to Follow-up|23
5229804|NCT00895453|18048991|P2|Overall Study|Lost to Follow-up|25
5229805|NCT00895453|18048992|P1|Overall Study|Lost to Follow-up|25
5229806|NCT00895414|18049000|P2|First Intervention (14 Days)|Physician Decision|1
5229807|NCT00895414|18049001|P1|First Intervention (14 Days)|Physician Decision|0
5229808|NCT00895414|18049000|P2|First Intervention (14 Days)|Withdrawal by Subject|0
5229809|NCT00895414|18049001|P1|First Intervention (14 Days)|Withdrawal by Subject|1
5229810|NCT00895310|18049011|P1|Overall Study|Withdrawal by Subject|1
5229811|NCT00895245|18049027|P1|Overall Study|Lack of Efficacy|6
5229812|NCT00895154|18049105|P2|Overall Study|Withdrawal by Subject|1
5229813|NCT00895154|18049106|P1|Overall Study|Withdrawal by Subject|0
5229814|NCT00895154|18049105|P2|Overall Study|Lost to Follow-up|1
5229815|NCT00895154|18049106|P1|Overall Study|Lost to Follow-up|1
5229816|NCT00895037|18049141|P3|Overall Study|Death|1
5229817|NCT00895037|18049142|P2|Overall Study|Death|2
5229818|NCT00895037|18049143|P1|Overall Study|Death|0
5229819|NCT00895011|18049174|P3|Overall Study|schedule conflict|0
5229820|NCT00895011|18049175|P2|Overall Study|schedule conflict|0
5229821|NCT00895011|18049176|P1|Overall Study|schedule conflict|1
5229822|NCT00895011|18049174|P3|Overall Study|Adverse Event|2
5229823|NCT00895011|18049175|P2|Overall Study|Adverse Event|2
5229824|NCT00895011|18049176|P1|Overall Study|Adverse Event|1
5229825|NCT00895011|18049174|P3|Overall Study|Protocol Violation|3
5229826|NCT00895011|18049175|P2|Overall Study|Protocol Violation|1
5229827|NCT00895011|18049176|P1|Overall Study|Protocol Violation|3
5229828|NCT00895011|18049174|P3|Overall Study|Lost to Follow-up|1
5229829|NCT00895011|18049175|P2|Overall Study|Lost to Follow-up|4
5229830|NCT00895011|18049176|P1|Overall Study|Lost to Follow-up|5
5229831|NCT00895011|18049174|P3|Overall Study|Withdrawal by Subject|2
5229832|NCT00895011|18049175|P2|Overall Study|Withdrawal by Subject|7
5229833|NCT00895011|18049176|P1|Overall Study|Withdrawal by Subject|14
5229834|NCT00894933|18049190|P1|Overall Study|Did not meeting incl/excl criteria|1
5229835|NCT00894933|18049190|P1|Overall Study|Cancelled Procedure|1
5229836|NCT00894933|18049190|P1|Overall Study|Lost to Follow-up|2
5229837|NCT00894803|18049208|P2|Overall Study|Lost to Follow-up|1
5229838|NCT00894803|18049209|P1|Overall Study|Lost to Follow-up|0
5229839|NCT00894803|18049208|P2|Overall Study|Death|4
5229840|NCT00894803|18049209|P1|Overall Study|Death|20
5229841|NCT00894790|18049245|P2|Overall Study|Did not meet entrance criteria|0
5229842|NCT00894790|18049246|P1|Overall Study|Did not meet entrance criteria|1
5229843|NCT00894790|18049245|P2|Overall Study|Lost to Follow-up|1
5229844|NCT00894790|18049246|P1|Overall Study|Lost to Follow-up|0
5229845|NCT00894790|18049245|P2|Overall Study|Protocol Violation|1
5229846|NCT00894790|18049246|P1|Overall Study|Protocol Violation|0
5229847|NCT00894686|18049288|P1|Overall Study|Other|5
5229848|NCT00894686|18049288|P1|Overall Study|Physician Decision|1
5229849|NCT00894686|18049288|P1|Overall Study|Withdrawal by Subject|50
5229850|NCT00894647|18049312|P2|Overall Study|Other, not due to AE|2
5229851|NCT00894647|18049313|P1|Overall Study|Other, not due to AE|1
5229852|NCT00894647|18049312|P2|Overall Study|Non-compliance with study procedures|2
5229853|NCT00894647|18049313|P1|Overall Study|Non-compliance with study procedures|0
5229854|NCT00894647|18049312|P2|Overall Study|Lost to Follow-up|2
5229855|NCT00894647|18049313|P1|Overall Study|Lost to Follow-up|0
5229856|NCT00894647|18049312|P2|Overall Study|Withdrawal by Subject|4
5229857|NCT00894647|18049313|P1|Overall Study|Withdrawal by Subject|4
5229858|NCT00894647|18049312|P2|Overall Study|Adverse Event|4
5229859|NCT00894647|18049313|P1|Overall Study|Adverse Event|5
5229860|NCT00894556|18049326|P4|Treatment Phase|Lack of Qualifying Event|0
5229861|NCT00894556|18049327|P3|Treatment Phase|Lack of Qualifying Event|0
5229862|NCT00894556|18049328|P2|Treatment Phase|Lack of Qualifying Event|1
5229863|NCT00894556|18049329|P1|Treatment Phase|Lack of Qualifying Event|2
5229864|NCT00894556|18049326|P4|Treatment Phase|Lost to Follow-up|0
5229865|NCT00894556|18049327|P3|Treatment Phase|Lost to Follow-up|1
5229866|NCT00894556|18049328|P2|Treatment Phase|Lost to Follow-up|3
5229867|NCT00894556|18049329|P1|Treatment Phase|Lost to Follow-up|2
5229868|NCT00894556|18049326|P4|Baseline Phase|Did not meet Randomization Criteria|85
5229869|NCT00894556|18049327|P3|Baseline Phase|Did not meet Randomization Criteria|0
5229870|NCT00894556|18049328|P2|Baseline Phase|Did not meet Randomization Criteria|0
5229871|NCT00894556|18049329|P1|Baseline Phase|Did not meet Randomization Criteria|0
5229872|NCT00894543|18049340|P2|Week 4 to Week 8|No diary or lost or withdrew|2
5229873|NCT00894543|18049341|P1|Week 4 to Week 8|No diary or lost or withdrew|4
5229874|NCT00894543|18049340|P2|Baseline to Week 4|No diary or lost or withdrew|2
5229875|NCT00894543|18049341|P1|Baseline to Week 4|No diary or lost or withdrew|3
5229876|NCT00894413|18049407|P2|Overall Study|Withdrawal by Subject|4
5229877|NCT00894413|18049408|P1|Overall Study|Withdrawal by Subject|0
5229878|NCT00894413|18049407|P2|Overall Study|Adverse Event|2
5229879|NCT00894413|18049408|P1|Overall Study|Adverse Event|0
5229880|NCT00894413|18049407|P2|Overall Study|Physician Decision|2
5229881|NCT00894413|18049408|P1|Overall Study|Physician Decision|0
5229882|NCT00894387|18049416|P2|Overall Study|GCP non-compliance|2
5229883|NCT00894387|18049417|P1|Overall Study|GCP non-compliance|0
5229884|NCT00894387|18049416|P2|Overall Study|Mis-randomized|9
5229885|NCT00894387|18049417|P1|Overall Study|Mis-randomized|13
5229886|NCT00894387|18049416|P2|Overall Study|Other (Missing)|3
5229887|NCT00894387|18049417|P1|Overall Study|Other (Missing)|5
5229888|NCT00894387|18049416|P2|Overall Study|Patient's request|30
5229889|NCT00894387|18049417|P1|Overall Study|Patient's request|25
5229890|NCT00894387|18049416|P2|Overall Study|Protocol Deviation|0
5229891|NCT00894387|18049417|P1|Overall Study|Protocol Deviation|4
5229892|NCT00894387|18049416|P2|Overall Study|Death|76
5229893|NCT00894387|18049417|P1|Overall Study|Death|77
5229894|NCT00894387|18049416|P2|Overall Study|Administrative problems|2
5229895|NCT00894387|18049417|P1|Overall Study|Administrative problems|2
5229896|NCT00894387|18049416|P2|Overall Study|Lost to Follow-up|5
5229897|NCT00894387|18049417|P1|Overall Study|Lost to Follow-up|3
5229898|NCT00894387|18049416|P2|Overall Study|Unsatisfactory therapeutic effect|1
5229899|NCT00894387|18049417|P1|Overall Study|Unsatisfactory therapeutic effect|0
5229900|NCT00894387|18049416|P2|Overall Study|Abnormal Laboratory values|2
5229901|NCT00894387|18049417|P1|Overall Study|Abnormal Laboratory values|2
5229902|NCT00894387|18049416|P2|Overall Study|Adverse Event|45
5229903|NCT00894387|18049417|P1|Overall Study|Adverse Event|44
5229904|NCT00894361|18049437|P2|Overall Study|deaths and less than 2 years followup|64
5229905|NCT00894361|18049438|P1|Overall Study|deaths and less than 2 years followup|24
5229906|NCT00894322|18049449|P3|Overall Study|Withdrawal by Subject|0
5229907|NCT00894322|18049450|P2|Overall Study|Withdrawal by Subject|0
5229908|NCT00894322|18049451|P1|Overall Study|Withdrawal by Subject|1
5229909|NCT00894166|18049502|P8|Overall Study|Death|0
5229910|NCT00894166|18049503|P7|Overall Study|Death|0
5229911|NCT00894166|18049504|P6|Overall Study|Death|0
5229912|NCT00894166|18049505|P5|Overall Study|Death|0
5229913|NCT00894166|18049506|P4|Overall Study|Death|1
5229914|NCT00894166|18049507|P3|Overall Study|Death|0
5229915|NCT00894166|18049508|P2|Overall Study|Death|0
5229916|NCT00894166|18049509|P1|Overall Study|Death|0
5229917|NCT00894166|18049502|P8|Overall Study|Withdrew or Lost to Follow-Up|34
5229918|NCT00894166|18049503|P7|Overall Study|Withdrew or Lost to Follow-Up|16
5229919|NCT00894166|18049504|P6|Overall Study|Withdrew or Lost to Follow-Up|16
5229920|NCT00894166|18049505|P5|Overall Study|Withdrew or Lost to Follow-Up|24
5229921|NCT00894166|18049506|P4|Overall Study|Withdrew or Lost to Follow-Up|68
5229922|NCT00894166|18049507|P3|Overall Study|Withdrew or Lost to Follow-Up|62
5229923|NCT00894166|18049508|P2|Overall Study|Withdrew or Lost to Follow-Up|63
5229924|NCT00894166|18049509|P1|Overall Study|Withdrew or Lost to Follow-Up|61
5229925|NCT00893971|18049555|P1|Overall Study|Physician Decision|3
5229926|NCT00893789|18049673|P4|Overall Study|Lost to Follow-up|1
5229927|NCT00893789|18049674|P3|Overall Study|Lost to Follow-up|0
5229928|NCT00893789|18049675|P2|Overall Study|Lost to Follow-up|0
5229929|NCT00893789|18049676|P1|Overall Study|Lost to Follow-up|0
5229930|NCT00893789|18049673|P4|Overall Study|Protocol Violation|4
5229931|NCT00893789|18049674|P3|Overall Study|Protocol Violation|1
5229932|NCT00893789|18049675|P2|Overall Study|Protocol Violation|1
5229933|NCT00893789|18049676|P1|Overall Study|Protocol Violation|0
5229934|NCT00893789|18049673|P4|Overall Study|Adverse Event|5
5229935|NCT00893789|18049674|P3|Overall Study|Adverse Event|1
5229936|NCT00893789|18049675|P2|Overall Study|Adverse Event|2
5229937|NCT00893789|18049676|P1|Overall Study|Adverse Event|0
5229938|NCT00893789|18049673|P4|Overall Study|Taking Excluded Concomitant Medication|0
5229939|NCT00893789|18049674|P3|Overall Study|Taking Excluded Concomitant Medication|1
5229940|NCT00893789|18049675|P2|Overall Study|Taking Excluded Concomitant Medication|0
5229941|NCT00893789|18049676|P1|Overall Study|Taking Excluded Concomitant Medication|1
5229942|NCT00893789|18049673|P4|Overall Study|Noncompliance With Study Procedures|0
5229943|NCT00893789|18049674|P3|Overall Study|Noncompliance With Study Procedures|0
5229944|NCT00893789|18049675|P2|Overall Study|Noncompliance With Study Procedures|0
5229945|NCT00893789|18049676|P1|Overall Study|Noncompliance With Study Procedures|1
5229946|NCT00893789|18049673|P4|Overall Study|Noncompliance With Study Drug|2
5229947|NCT00893789|18049674|P3|Overall Study|Noncompliance With Study Drug|1
5229948|NCT00893789|18049675|P2|Overall Study|Noncompliance With Study Drug|0
5229949|NCT00893789|18049676|P1|Overall Study|Noncompliance With Study Drug|1
5229950|NCT00893789|18049673|P4|Overall Study|Withdrawal by Subject|1
5229951|NCT00893789|18049674|P3|Overall Study|Withdrawal by Subject|3
5229952|NCT00893789|18049675|P2|Overall Study|Withdrawal by Subject|1
5229953|NCT00893789|18049676|P1|Overall Study|Withdrawal by Subject|3
5229954|NCT00893763|18049760|P2|Overall Study|extubated|110
5229955|NCT00893763|18049761|P1|Overall Study|extubated|110
5229956|NCT00893737|18049769|P1|Overall Study|Lost to Follow-up|6
5229957|NCT00893737|18049769|P1|Overall Study|Withdrawal by Subject|2
5229958|NCT00893737|18049769|P1|Overall Study|Adverse Event|4
5229959|NCT00893464|18049783|P8|Overall Study|Did not complete therapy/experience PD|2
5229960|NCT00893464|18049784|P7|Overall Study|Did not complete therapy/experience PD|2
5229961|NCT00893464|18049785|P6|Overall Study|Did not complete therapy/experience PD|0
5229962|NCT00893464|18049786|P5|Overall Study|Did not complete therapy/experience PD|0
5229963|NCT00893464|18049787|P4|Overall Study|Did not complete therapy/experience PD|0
5229964|NCT00893464|18049788|P3|Overall Study|Did not complete therapy/experience PD|0
5229965|NCT00893464|18049789|P2|Overall Study|Did not complete therapy/experience PD|0
5229966|NCT00893464|18049790|P1|Overall Study|Did not complete therapy/experience PD|0
5229967|NCT00893113|18049917|P2|Overall Study|Withdrew Consent|7
5229968|NCT00893113|18049918|P1|Overall Study|Withdrew Consent|8
5229969|NCT00893113|18049917|P2|Overall Study|Early Termination|1
5229970|NCT00893113|18049918|P1|Overall Study|Early Termination|1
5229971|NCT00893113|18049917|P2|Overall Study|Lost to Follow-up|8
5229972|NCT00893113|18049918|P1|Overall Study|Lost to Follow-up|4
5229973|NCT00892957|18049948|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
5229974|NCT00892957|18049949|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
5229975|NCT00892957|18049948|P2|Between Postoperative Day 1 and Day 14|Death|2
5229976|NCT00892957|18049949|P1|Between Postoperative Day 1 and Day 14|Death|0
5229977|NCT00892775|18050037|P2|Overall Study|Lost to Follow-up|0
5229978|NCT00892775|18050038|P1|Overall Study|Lost to Follow-up|1
5229979|NCT00892775|18050037|P2|Overall Study|Withdrawal by Subject|1
5229980|NCT00892775|18050038|P1|Overall Study|Withdrawal by Subject|0
5229981|NCT00892775|18050037|P2|Overall Study|Migrated/ moved from study area|0
5229982|NCT00892775|18050038|P1|Overall Study|Migrated/ moved from study area|1
5229983|NCT00892775|18050037|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
5229984|NCT00892775|18050038|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
5229985|NCT00892775|18050037|P2|Overall Study|Subject difficulties with blood drawing|0
5229986|NCT00892775|18050038|P1|Overall Study|Subject difficulties with blood drawing|1
5229987|NCT00892775|18050037|P2|Overall Study|Protocol Violation|0
5229988|NCT00892775|18050038|P1|Overall Study|Protocol Violation|1
5229989|NCT00892723|18050065|P3|Overall Study|Withdrawal by Subject|1
5229990|NCT00892723|18050066|P2|Overall Study|Withdrawal by Subject|1
5229991|NCT00892723|18050067|P1|Overall Study|Withdrawal by Subject|1
5229992|NCT00892723|18050065|P3|Overall Study|Lost to Follow-up|1
5229993|NCT00892723|18050066|P2|Overall Study|Lost to Follow-up|3
5229994|NCT00892723|18050067|P1|Overall Study|Lost to Follow-up|1
5229995|NCT00892437|18050156|P2|Open-Label Extension Phase|Withdrew Consent|1
5229996|NCT00892437|18050157|P1|Open-Label Extension Phase|Withdrew Consent|3
5229997|NCT00892437|18050156|P2|Open-Label Extension Phase|Investigator's Discretion|0
5229998|NCT00892437|18050157|P1|Open-Label Extension Phase|Investigator's Discretion|1
5229999|NCT00892437|18050156|P2|Open-Label Extension Phase|Lost to Follow-up|1
5230000|NCT00892437|18050157|P1|Open-Label Extension Phase|Lost to Follow-up|3
5230001|NCT00892437|18050156|P2|Open-Label Extension Phase|Lack of Efficacy|0
5230002|NCT00892437|18050157|P1|Open-Label Extension Phase|Lack of Efficacy|1
5230003|NCT00892437|18050156|P2|Open-Label Extension Phase|Adverse Event|2
5230004|NCT00892437|18050157|P1|Open-Label Extension Phase|Adverse Event|4
5230005|NCT00892437|18050156|P2|Randomized Phase|Withdrew Consent|0
5230006|NCT00892437|18050157|P1|Randomized Phase|Withdrew Consent|1
5230007|NCT00892437|18050156|P2|Randomized Phase|Investigator's Discretion|0
5230008|NCT00892437|18050157|P1|Randomized Phase|Investigator's Discretion|1
5230009|NCT00892437|18050156|P2|Randomized Phase|Lost to Follow-up|3
5230010|NCT00892437|18050157|P1|Randomized Phase|Lost to Follow-up|1
5230011|NCT00892437|18050156|P2|Randomized Phase|Adverse Event|2
5230012|NCT00892437|18050157|P1|Randomized Phase|Adverse Event|2
5230013|NCT00892437|18050156|P2|Randomized Phase|Randomized but not treated|0
5230014|NCT00892437|18050157|P1|Randomized Phase|Randomized but not treated|6
5230015|NCT00892281|18050176|P2|Overall Study|Visit 4 date out of window|0
5230016|NCT00892281|18050177|P1|Overall Study|Visit 4 date out of window|1
5230017|NCT00892281|18050176|P2|Overall Study|Rash on hand|0
5230018|NCT00892281|18050177|P1|Overall Study|Rash on hand|1
5230019|NCT00892281|18050176|P2|Overall Study|Subject had history of drug abuse|0
5230020|NCT00892281|18050177|P1|Overall Study|Subject had history of drug abuse|1
5230021|NCT00892281|18050176|P2|Overall Study|Non-compliant with visits as scheduled|0
5230022|NCT00892281|18050177|P1|Overall Study|Non-compliant with visits as scheduled|1
5230023|NCT00892281|18050176|P2|Overall Study|Missed visits rescheduled out of window|0
5230024|NCT00892281|18050177|P1|Overall Study|Missed visits rescheduled out of window|1
5230025|NCT00892281|18050176|P2|Overall Study|Missed multiple visits|0
5230026|NCT00892281|18050177|P1|Overall Study|Missed multiple visits|1
5230027|NCT00892281|18050176|P2|Overall Study|No show Visit 2; prescription not filled|0
5230028|NCT00892281|18050177|P1|Overall Study|No show Visit 2; prescription not filled|1
5230029|NCT00892281|18050176|P2|Overall Study|Subject not seen by PI at final visit|0
5230030|NCT00892281|18050177|P1|Overall Study|Subject not seen by PI at final visit|1
5230031|NCT00892281|18050176|P2|Overall Study|Lack of efficacy of study product|0
5230032|NCT00892281|18050177|P1|Overall Study|Lack of efficacy of study product|2
5230033|NCT00892281|18050176|P2|Overall Study|Death in family|0
5230034|NCT00892281|18050177|P1|Overall Study|Death in family|1
5230035|NCT00892281|18050176|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
5230036|NCT00892281|18050177|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
5230037|NCT00892281|18050176|P2|Overall Study|Subject lost interest in program|1
5230038|NCT00892281|18050177|P1|Overall Study|Subject lost interest in program|0
5230039|NCT00892281|18050176|P2|Overall Study|PI complained of inadequate compensation|0
5230040|NCT00892281|18050177|P1|Overall Study|PI complained of inadequate compensation|3
5230041|NCT00892281|18050176|P2|Overall Study|Scheduled for knee replacement|1
5230042|NCT00892281|18050177|P1|Overall Study|Scheduled for knee replacement|0
5230043|NCT00892281|18050176|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
5230044|NCT00892281|18050177|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
5230045|NCT00892281|18050176|P2|Overall Study|Subject missed several visits/lost meds|0
5230046|NCT00892281|18050177|P1|Overall Study|Subject missed several visits/lost meds|1
5230047|NCT00892281|18050176|P2|Overall Study|Subject did not return for any visits|0
5230048|NCT00892281|18050177|P1|Overall Study|Subject did not return for any visits|1
5230049|NCT00892281|18050176|P2|Overall Study|Subject not good candidate for study|0
5230050|NCT00892281|18050177|P1|Overall Study|Subject not good candidate for study|1
5230051|NCT00892281|18050176|P2|Overall Study|Unable to redeem the drug voucher|0
5230052|NCT00892281|18050177|P1|Overall Study|Unable to redeem the drug voucher|1
5230053|NCT00892281|18050176|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
5230054|NCT00892281|18050177|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
5230055|NCT00892281|18050176|P2|Overall Study|Did not meet incl/excl criteria|0
5230056|NCT00892281|18050177|P1|Overall Study|Did not meet incl/excl criteria|1
5230057|NCT00892281|18050176|P2|Overall Study|Last visit not done - death in family|0
5230058|NCT00892281|18050177|P1|Overall Study|Last visit not done - death in family|1
5230059|NCT00892281|18050176|P2|Overall Study|Family emergency|0
5230060|NCT00892281|18050177|P1|Overall Study|Family emergency|1
5230061|NCT00892281|18050176|P2|Overall Study|Subject completed day after study closed|0
5230062|NCT00892281|18050177|P1|Overall Study|Subject completed day after study closed|1
5230063|NCT00892281|18050176|P2|Overall Study|Final visit completed 4 weeks late|1
5230064|NCT00892281|18050177|P1|Overall Study|Final visit completed 4 weeks late|0
5230065|NCT00892281|18050176|P2|Overall Study|Subject unable to keep follow-up visits|0
5230066|NCT00892281|18050177|P1|Overall Study|Subject unable to keep follow-up visits|1
5230067|NCT00892281|18050176|P2|Overall Study|Subject failed to return for final visit|0
5230068|NCT00892281|18050177|P1|Overall Study|Subject failed to return for final visit|2
5230069|NCT00892281|18050176|P2|Overall Study|Withdrawal by Subject|14
5230070|NCT00892281|18050177|P1|Overall Study|Withdrawal by Subject|86
5230071|NCT00892281|18050176|P2|Overall Study|Protocol Violation|2
5230072|NCT00892281|18050177|P1|Overall Study|Protocol Violation|7
5230073|NCT00892281|18050176|P2|Overall Study|Pregnancy|0
5230074|NCT00892281|18050177|P1|Overall Study|Pregnancy|1
5230075|NCT00892281|18050176|P2|Overall Study|Lost to Follow-up|8
5230076|NCT00892281|18050177|P1|Overall Study|Lost to Follow-up|81
5230077|NCT00892281|18050176|P2|Overall Study|Adverse Event|8
5230078|NCT00892281|18050177|P1|Overall Study|Adverse Event|65
5230079|NCT00892177|18050190|P6|Phase II|Withdrawal by Subject|1
5230080|NCT00892177|18050191|P5|Phase II|Withdrawal by Subject|4
5230081|NCT00892177|18050192|P4|Phase II|Withdrawal by Subject|0
5230082|NCT00892177|18050193|P3|Phase II|Withdrawal by Subject|0
5230083|NCT00892177|18050194|P2|Phase II|Withdrawal by Subject|0
5230084|NCT00892177|18050195|P1|Phase II|Withdrawal by Subject|0
5230085|NCT00892177|18050190|P6|Phase II|Ineligible|1
5230086|NCT00892177|18050191|P5|Phase II|Ineligible|1
5230087|NCT00892177|18050192|P4|Phase II|Ineligible|0
5230088|NCT00892177|18050193|P3|Phase II|Ineligible|0
5230089|NCT00892177|18050194|P2|Phase II|Ineligible|0
5230090|NCT00892177|18050195|P1|Phase II|Ineligible|0
5230091|NCT00892151|18050220|P1|Overall Study|Protocol Violation|1
5230092|NCT00892099|18050229|P3|Overall Study|Lost to Follow-up|1
5230093|NCT00892099|18050230|P2|Overall Study|Lost to Follow-up|0
5230094|NCT00892099|18050231|P1|Overall Study|Lost to Follow-up|0
5230095|NCT00892099|18050229|P3|Overall Study|investigator decision|1
5230096|NCT00892099|18050230|P2|Overall Study|investigator decision|0
5230097|NCT00892099|18050231|P1|Overall Study|investigator decision|0
5230098|NCT00892099|18050229|P3|Overall Study|kidney function recovered|0
5230099|NCT00892099|18050230|P2|Overall Study|kidney function recovered|1
5230100|NCT00892099|18050231|P1|Overall Study|kidney function recovered|0
5230101|NCT00892099|18050229|P3|Overall Study|no further details|1
5230102|NCT00892099|18050230|P2|Overall Study|no further details|0
5230103|NCT00892099|18050231|P1|Overall Study|no further details|1
5230104|NCT00892099|18050229|P3|Overall Study|Prolonged hospitalization|1
5230105|NCT00892099|18050230|P2|Overall Study|Prolonged hospitalization|0
5230106|NCT00892099|18050231|P1|Overall Study|Prolonged hospitalization|1
5230107|NCT00892099|18050229|P3|Overall Study|replocated|2
5230108|NCT00892099|18050230|P2|Overall Study|replocated|0
5230109|NCT00892099|18050231|P1|Overall Study|replocated|1
5230110|NCT00892099|18050229|P3|Overall Study|Adverse Event|0
5230111|NCT00892099|18050230|P2|Overall Study|Adverse Event|0
5230112|NCT00892099|18050231|P1|Overall Study|Adverse Event|1
5230113|NCT00892099|18050229|P3|Overall Study|Death|1
5230114|NCT00892099|18050230|P2|Overall Study|Death|0
5230115|NCT00892099|18050231|P1|Overall Study|Death|1
5230116|NCT00892047|18050256|P2|Overall Study|Lack of Efficacy|2
5230117|NCT00892047|18050257|P1|Overall Study|Lack of Efficacy|0
5230118|NCT00892047|18050256|P2|Overall Study|subject burden|3
5230119|NCT00892047|18050257|P1|Overall Study|subject burden|2
5230120|NCT00892047|18050256|P2|Overall Study|Adverse Event|2
5230121|NCT00892047|18050257|P1|Overall Study|Adverse Event|2
5230122|NCT00892008|18050273|P1|Overall Study|Adverse Event|37
5230123|NCT00892008|18050273|P1|Overall Study|Other|378
5230124|NCT00892008|18050273|P1|Overall Study|Lost to Follow-up|142
5230125|NCT00892008|18050273|P1|Overall Study|Lack of Efficacy|3
5230126|NCT00892008|18050273|P1|Overall Study|Death|5
5230127|NCT00891930|18050359|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
5230128|NCT00891930|18050359|P1|Part 2: Panitumumab + Ganitumab|Death|30
5230129|NCT00891930|18050359|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
5230130|NCT00891930|18050359|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
5230131|NCT00891930|18050359|P1|Part 1: Panitumumab +Irinotecan|Death|38
5230132|NCT00891904|18050380|P1|Overall Study|Adverse Event|1
5230133|NCT00891904|18050380|P1|Overall Study|Death|1
5230134|NCT00891839|18050406|P1|Overall Study|Disease progression|3
5230135|NCT00891839|18050406|P1|Overall Study|Withdrawal by Subject|2
5230136|NCT00891839|18050406|P1|Overall Study|Adverse Event|2
5230137|NCT00891813|18050415|P1|Overall Study|Protocol Violation|2
5230138|NCT00891813|18050415|P1|Overall Study|Patient Noncompliance|6
5230139|NCT00891813|18050415|P1|Overall Study|Withdrawal by Subject|1
5230140|NCT00891813|18050415|P1|Overall Study|Adverse Event|3
5230141|NCT00891774|18050421|P1|Overall Study|Protocol Violation|4
5230142|NCT00891774|18050421|P1|Overall Study|Withdrawal by Subject|2
5230143|NCT00891774|18050421|P1|Overall Study|Illness (Self/Mother)|3
5230144|NCT00891774|18050421|P1|Overall Study|Lost to Follow-up|5
5230145|NCT00891735|18050432|P4|Overall Study|Patient's decision to withdraw|8
5230146|NCT00891735|18050433|P3|Overall Study|Patient's decision to withdraw|4
5230147|NCT00891735|18050434|P2|Overall Study|Patient's decision to withdraw|9
5230148|NCT00891735|18050435|P1|Overall Study|Patient's decision to withdraw|4
5230149|NCT00891735|18050432|P4|Overall Study|Physician's decision to withdraw patient|0
5230150|NCT00891735|18050433|P3|Overall Study|Physician's decision to withdraw patient|0
5230151|NCT00891735|18050434|P2|Overall Study|Physician's decision to withdraw patient|0
5230152|NCT00891735|18050435|P1|Overall Study|Physician's decision to withdraw patient|1
5230153|NCT00891735|18050432|P4|Overall Study|Lost to Follow-up|2
5230154|NCT00891735|18050433|P3|Overall Study|Lost to Follow-up|2
5230155|NCT00891735|18050434|P2|Overall Study|Lost to Follow-up|2
5230156|NCT00891735|18050435|P1|Overall Study|Lost to Follow-up|2
5230157|NCT00891735|18050432|P4|Overall Study|Death|5
5230158|NCT00891735|18050433|P3|Overall Study|Death|4
5230159|NCT00891735|18050434|P2|Overall Study|Death|5
5230160|NCT00891735|18050435|P1|Overall Study|Death|8
5230161|NCT00891735|18050432|P4|Overall Study|Adverse Event|0
5230162|NCT00891735|18050433|P3|Overall Study|Adverse Event|2
5230163|NCT00891735|18050434|P2|Overall Study|Adverse Event|0
5230164|NCT00891735|18050435|P1|Overall Study|Adverse Event|2
5230165|NCT00891657|18050475|P2|Overall Study|Withdrawal by Subject|1
5230166|NCT00891657|18050476|P1|Overall Study|Withdrawal by Subject|1
5230167|NCT00891618|18050488|P1|Overall Study|Withdrawal by Subject|1
5230168|NCT00891527|18050492|P1|Overall Study|Withdrawal by Subject|2
5230169|NCT00891462|18050501|P3|Overall Study|Lost to Follow-up|0
5230170|NCT00891462|18050502|P2|Overall Study|Lost to Follow-up|2
5230171|NCT00891462|18050503|P1|Overall Study|Lost to Follow-up|0
5230172|NCT00891462|18050501|P3|Overall Study|Inclusion/exclusion criteria|2
5230173|NCT00891462|18050502|P2|Overall Study|Inclusion/exclusion criteria|2
5230174|NCT00891462|18050503|P1|Overall Study|Inclusion/exclusion criteria|0
5230175|NCT00891462|18050501|P3|Overall Study|Protocol Violation|3
5230176|NCT00891462|18050502|P2|Overall Study|Protocol Violation|1
5230177|NCT00891462|18050503|P1|Overall Study|Protocol Violation|2
5230178|NCT00891462|18050501|P3|Overall Study|Other Reason|3
5230179|NCT00891462|18050502|P2|Overall Study|Other Reason|5
5230180|NCT00891462|18050503|P1|Overall Study|Other Reason|2
5230181|NCT00891462|18050501|P3|Overall Study|COPD exacerbation|1
5230182|NCT00891462|18050502|P2|Overall Study|COPD exacerbation|4
5230183|NCT00891462|18050503|P1|Overall Study|COPD exacerbation|7
5230184|NCT00891462|18050501|P3|Overall Study|Lack of Efficacy|1
5230185|NCT00891462|18050502|P2|Overall Study|Lack of Efficacy|5
5230186|NCT00891462|18050503|P1|Overall Study|Lack of Efficacy|10
5230187|NCT00891462|18050501|P3|Overall Study|Adverse Event|7
5230188|NCT00891462|18050502|P2|Overall Study|Adverse Event|8
5230189|NCT00891462|18050503|P1|Overall Study|Adverse Event|7
5230190|NCT00891462|18050501|P3|Overall Study|Withdrawal by Subject|7
5230191|NCT00891462|18050502|P2|Overall Study|Withdrawal by Subject|6
5230192|NCT00891462|18050503|P1|Overall Study|Withdrawal by Subject|9
5230193|NCT00891371|18050525|P1|Treatment|Lost to Follow-up|1
5230194|NCT00891371|18050525|P1|Treatment|Death|1
5230195|NCT00891371|18050525|P1|Treatment|Adverse Event|2
5230196|NCT00891371|18050525|P1|Treatment|Lack of Efficacy|5
5230197|NCT00891371|18050525|P1|Pre-assignment|Consent withdrawal|1
5230198|NCT00891371|18050525|P1|Pre-assignment|Inclusion/exclusion|5
5230199|NCT00891293|18050547|P1|Overall Study|Sponsor termination|62
5230200|NCT00891293|18050547|P1|Overall Study|Subject withdrew consent|7
5230201|NCT00891293|18050547|P1|Overall Study|Lost to Follow-up|7
5230202|NCT00891293|18050547|P1|Overall Study|Laboratory abnormality|4
5230203|NCT00891293|18050547|P1|Overall Study|Protocol Violation|2
5230204|NCT00891293|18050547|P1|Overall Study|Adverse Event|2
5230205|NCT00891228|18050562|P3|Overall Study|Pregnancy|0
5230206|NCT00891228|18050563|P2|Overall Study|Pregnancy|1
5230207|NCT00891228|18050564|P1|Overall Study|Pregnancy|0
5230208|NCT00891228|18050562|P3|Overall Study|Lost to Follow-up|5
5230209|NCT00891228|18050563|P2|Overall Study|Lost to Follow-up|4
5230210|NCT00891228|18050564|P1|Overall Study|Lost to Follow-up|4
5230211|NCT00891228|18050562|P3|Overall Study|Physician Decision|0
5230212|NCT00891228|18050563|P2|Overall Study|Physician Decision|1
5230213|NCT00891228|18050564|P1|Overall Study|Physician Decision|2
5230214|NCT00891228|18050562|P3|Overall Study|Protocol Violation|2
5230215|NCT00891228|18050563|P2|Overall Study|Protocol Violation|1
5230216|NCT00891228|18050564|P1|Overall Study|Protocol Violation|3
5230217|NCT00891228|18050562|P3|Overall Study|Withdrawal by Subject|5
5230218|NCT00891228|18050563|P2|Overall Study|Withdrawal by Subject|4
5230219|NCT00891228|18050564|P1|Overall Study|Withdrawal by Subject|2
5230220|NCT00891228|18050562|P3|Overall Study|Adverse Event|3
5230221|NCT00891228|18050563|P2|Overall Study|Adverse Event|2
5230222|NCT00891228|18050564|P1|Overall Study|Adverse Event|0
5230223|NCT00891202|18050586|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
5230224|NCT00891202|18050587|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
5230225|NCT00891202|18050588|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
5230226|NCT00891202|18050589|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
5230227|NCT00891202|18050586|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
5230228|NCT00891202|18050587|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
5230229|NCT00891202|18050588|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
5230230|NCT00891202|18050589|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
5230231|NCT00891202|18050586|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
5230232|NCT00891202|18050587|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
5230233|NCT00891202|18050588|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
5230234|NCT00891202|18050589|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
5230235|NCT00891202|18050586|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
5230236|NCT00891202|18050587|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
5230237|NCT00891202|18050588|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
5230238|NCT00891202|18050589|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
5230239|NCT00891046|18050765|P5|Overall Study|Lost to Follow-up|1
5230240|NCT00891046|18050766|P4|Overall Study|Lost to Follow-up|0
5230241|NCT00891046|18050767|P3|Overall Study|Lost to Follow-up|0
5230242|NCT00891046|18050768|P2|Overall Study|Lost to Follow-up|0
5230243|NCT00891046|18050769|P1|Overall Study|Lost to Follow-up|0
5230244|NCT00891046|18050765|P5|Overall Study|Withdrawal by Subject|1
5230245|NCT00891046|18050766|P4|Overall Study|Withdrawal by Subject|1
5230246|NCT00891046|18050767|P3|Overall Study|Withdrawal by Subject|2
5230247|NCT00891046|18050768|P2|Overall Study|Withdrawal by Subject|1
5230248|NCT00891046|18050769|P1|Overall Study|Withdrawal by Subject|2
5230249|NCT00891046|18050765|P5|Overall Study|Adverse Event|14
5230250|NCT00891046|18050766|P4|Overall Study|Adverse Event|0
5230251|NCT00891046|18050767|P3|Overall Study|Adverse Event|2
5230252|NCT00891046|18050768|P2|Overall Study|Adverse Event|3
5230253|NCT00891046|18050769|P1|Overall Study|Adverse Event|4
5230254|NCT00891046|18050765|P5|Overall Study|Participant no longer required drug|1
5230255|NCT00891046|18050766|P4|Overall Study|Participant no longer required drug|0
5230256|NCT00891046|18050767|P3|Overall Study|Participant no longer required drug|0
5230257|NCT00891046|18050768|P2|Overall Study|Participant no longer required drug|2
5230258|NCT00891046|18050769|P1|Overall Study|Participant no longer required drug|0
5230259|NCT00891046|18050765|P5|Overall Study|Administrative problems|1
5230260|NCT00891046|18050766|P4|Overall Study|Administrative problems|0
5230261|NCT00891046|18050767|P3|Overall Study|Administrative problems|0
5230262|NCT00891046|18050768|P2|Overall Study|Administrative problems|0
5230263|NCT00891046|18050769|P1|Overall Study|Administrative problems|0
5230264|NCT00891046|18050765|P5|Overall Study|Unsatisfactory therapeutic effect|20
5230265|NCT00891046|18050766|P4|Overall Study|Unsatisfactory therapeutic effect|2
5230266|NCT00891046|18050767|P3|Overall Study|Unsatisfactory therapeutic effect|19
5230267|NCT00891046|18050768|P2|Overall Study|Unsatisfactory therapeutic effect|2
5230268|NCT00891046|18050769|P1|Overall Study|Unsatisfactory therapeutic effect|5
5230269|NCT00891046|18050765|P5|Overall Study|Protocol Violation|1
5230270|NCT00891046|18050766|P4|Overall Study|Protocol Violation|0
5230271|NCT00891046|18050767|P3|Overall Study|Protocol Violation|0
5230272|NCT00891046|18050768|P2|Overall Study|Protocol Violation|1
5230273|NCT00891046|18050769|P1|Overall Study|Protocol Violation|1
5230274|NCT00891020|18050845|P3|Long-term Extension Period|Administrative|2
5230275|NCT00891020|18050846|P2|Long-term Extension Period|Administrative|2
5230276|NCT00891020|18050847|P1|Long-term Extension Period|Administrative|1
5230277|NCT00891020|18050845|P3|Long-term Extension Period|Failure to return|3
5230278|NCT00891020|18050846|P2|Long-term Extension Period|Failure to return|2
5230279|NCT00891020|18050847|P1|Long-term Extension Period|Failure to return|0
5230280|NCT00891020|18050845|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
5230281|NCT00891020|18050846|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
5230282|NCT00891020|18050847|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
5230283|NCT00891020|18050845|P3|Long-term Extension Period|Protocol Violation|1
5230284|NCT00891020|18050846|P2|Long-term Extension Period|Protocol Violation|1
5230285|NCT00891020|18050847|P1|Long-term Extension Period|Protocol Violation|0
5230286|NCT00891020|18050845|P3|Long-term Extension Period|Insufficient therapeutic response|2
5230287|NCT00891020|18050846|P2|Long-term Extension Period|Insufficient therapeutic response|2
5230288|NCT00891020|18050847|P1|Long-term Extension Period|Insufficient therapeutic response|3
5230289|NCT00891020|18050845|P3|Long-term Extension Period|Death|1
5230290|NCT00891020|18050846|P2|Long-term Extension Period|Death|0
5230291|NCT00891020|18050847|P1|Long-term Extension Period|Death|0
5230292|NCT00891020|18050845|P3|Long-term Extension Period|Adverse Event|10
5230293|NCT00891020|18050846|P2|Long-term Extension Period|Adverse Event|11
5230294|NCT00891020|18050847|P1|Long-term Extension Period|Adverse Event|1
5230295|NCT00891020|18050845|P3|24 Week Treatment Period|Administrative/Other|1
5230296|NCT00891020|18050846|P2|24 Week Treatment Period|Administrative/Other|6
5230297|NCT00891020|18050847|P1|24 Week Treatment Period|Administrative/Other|5
5230298|NCT00891020|18050845|P3|24 Week Treatment Period|Withdrew consent|15
5230299|NCT00891020|18050846|P2|24 Week Treatment Period|Withdrew consent|3
5230300|NCT00891020|18050847|P1|24 Week Treatment Period|Withdrew consent|6
5230301|NCT00891020|18050845|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
5230302|NCT00891020|18050846|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
5230303|NCT00891020|18050847|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
5230304|NCT00891020|18050845|P3|24 Week Treatment Period|Other protocol violation|2
5230305|NCT00891020|18050846|P2|24 Week Treatment Period|Other protocol violation|1
5230306|NCT00891020|18050847|P1|24 Week Treatment Period|Other protocol violation|1
5230307|NCT00891020|18050845|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
5230308|NCT00891020|18050846|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
5230309|NCT00891020|18050847|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
5230310|NCT00891020|18050845|P3|24 Week Treatment Period|Failure to return|5
5230311|NCT00891020|18050846|P2|24 Week Treatment Period|Failure to return|5
5230312|NCT00891020|18050847|P1|24 Week Treatment Period|Failure to return|4
5230313|NCT00891020|18050845|P3|24 Week Treatment Period|Insufficient therapeutic response|15
5230314|NCT00891020|18050846|P2|24 Week Treatment Period|Insufficient therapeutic response|9
5230315|NCT00891020|18050847|P1|24 Week Treatment Period|Insufficient therapeutic response|6
5230316|NCT00891020|18050845|P3|24 Week Treatment Period|Death|0
5230317|NCT00891020|18050846|P2|24 Week Treatment Period|Death|2
5230318|NCT00891020|18050847|P1|24 Week Treatment Period|Death|0
5230319|NCT00891020|18050845|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
5230320|NCT00891020|18050846|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
5230321|NCT00891020|18050847|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
5230322|NCT00890929|18050911|P1|Overall Study|Physician Decision|1
5230323|NCT00890929|18050911|P1|Overall Study|Withdrawal by Subject|3
5230324|NCT00890929|18050911|P1|Overall Study|Death before treatment|2
5230325|NCT00890825|18050929|P2|Overall Study|Alive at data cut off (DCO)|14
5230326|NCT00890825|18050930|P1|Overall Study|Alive at data cut off (DCO)|13
5230327|NCT00890825|18050929|P2|Overall Study|Withdrawal by Subject|0
5230328|NCT00890825|18050930|P1|Overall Study|Withdrawal by Subject|1
5230329|NCT00890695|18050959|P2|Overall Study|Protocol Violation|0
5230330|NCT00890695|18050960|P1|Overall Study|Protocol Violation|1
5230331|NCT00890591|18050994|P1|Overall Study|Lack of Efficacy|20
5230332|NCT00890552|18051000|P1|On-treatment|Early prog disease/ death|10
5230333|NCT00890552|18051000|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
5230334|NCT00890409|18051009|P2|Overall Study|Lost to Follow-up|21
5230335|NCT00890409|18051010|P1|Overall Study|Lost to Follow-up|20
5230336|NCT00890201|18051047|P2|Overall Study|Protocol Violation|56
5230337|NCT00890201|18051048|P1|Overall Study|Protocol Violation|5
5230338|NCT00890097|18051066|P3|Overall Study|Protocol Deviation|1
5230339|NCT00890097|18051067|P2|Overall Study|Protocol Deviation|1
5230340|NCT00890097|18051068|P1|Overall Study|Protocol Deviation|1
5230341|NCT00890097|18051066|P3|Overall Study|Subject Moved|0
5230342|NCT00890097|18051067|P2|Overall Study|Subject Moved|4
5230343|NCT00890097|18051068|P1|Overall Study|Subject Moved|0
5230344|NCT00890097|18051066|P3|Overall Study|Transportation|0
5230345|NCT00890097|18051067|P2|Overall Study|Transportation|2
5230346|NCT00890097|18051068|P1|Overall Study|Transportation|0
5230347|NCT00890097|18051066|P3|Overall Study|Failed inclusion criteria|0
5230348|NCT00890097|18051067|P2|Overall Study|Failed inclusion criteria|4
5230349|NCT00890097|18051068|P1|Overall Study|Failed inclusion criteria|3
5230350|NCT00890097|18051066|P3|Overall Study|Randomization Error|0
5230351|NCT00890097|18051067|P2|Overall Study|Randomization Error|0
5230352|NCT00890097|18051068|P1|Overall Study|Randomization Error|2
5230353|NCT00890097|18051066|P3|Overall Study|Subject Decision|6
5230354|NCT00890097|18051067|P2|Overall Study|Subject Decision|2
5230355|NCT00890097|18051068|P1|Overall Study|Subject Decision|3
5230356|NCT00890097|18051066|P3|Overall Study|Did not attend final visit|0
5230357|NCT00890097|18051067|P2|Overall Study|Did not attend final visit|3
5230358|NCT00890097|18051068|P1|Overall Study|Did not attend final visit|2
5230359|NCT00890097|18051066|P3|Overall Study|Sponsor Decision|7
5230360|NCT00890097|18051067|P2|Overall Study|Sponsor Decision|11
5230361|NCT00890097|18051068|P1|Overall Study|Sponsor Decision|7
5230362|NCT00890097|18051066|P3|Overall Study|Noncompliance|4
5230363|NCT00890097|18051067|P2|Overall Study|Noncompliance|4
5230364|NCT00890097|18051068|P1|Overall Study|Noncompliance|0
5230365|NCT00890097|18051066|P3|Overall Study|Lost to Follow-up|5
5230366|NCT00890097|18051067|P2|Overall Study|Lost to Follow-up|5
5230367|NCT00890097|18051068|P1|Overall Study|Lost to Follow-up|5
5230368|NCT00890097|18051066|P3|Overall Study|Withdrew Consent|9
5230369|NCT00890097|18051067|P2|Overall Study|Withdrew Consent|6
5230370|NCT00890097|18051068|P1|Overall Study|Withdrew Consent|9
5230371|NCT00890097|18051066|P3|Overall Study|Decision Unrelated to an Adverse Event|17
5230372|NCT00890097|18051067|P2|Overall Study|Decision Unrelated to an Adverse Event|12
5230373|NCT00890097|18051068|P1|Overall Study|Decision Unrelated to an Adverse Event|15
5230374|NCT00890097|18051066|P3|Overall Study|Adverse Event|28
5230375|NCT00890097|18051067|P2|Overall Study|Adverse Event|32
5230376|NCT00890097|18051068|P1|Overall Study|Adverse Event|21
5230377|NCT00890084|18051076|P1|Overall Study|Lost to Follow-up|126
5230378|NCT00890084|18051076|P1|Overall Study|Adverse Event|16
5230379|NCT00889863|18051116|P2|Part II: Randomized Double Blind|Protocol deviation|1
5230380|NCT00889863|18051117|P1|Part II: Randomized Double Blind|Protocol deviation|0
5230381|NCT00889863|18051116|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
5230382|NCT00889863|18051117|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
5230383|NCT00889863|18051116|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
5230384|NCT00889863|18051117|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
5230385|NCT00889863|18051116|P2|Part II: Randomized Double Blind|Adverse Event|4
5230386|NCT00889863|18051117|P1|Part II: Randomized Double Blind|Adverse Event|0
5230387|NCT00889863|18051116|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
5230388|NCT00889863|18051117|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
5230389|NCT00889863|18051116|P2|Part I: Open Label|Adverse Event|0
5230390|NCT00889863|18051117|P1|Part I: Open Label|Adverse Event|4
5230391|NCT00889863|18051116|P2|Part I: Open Label|Death|0
5230392|NCT00889863|18051117|P1|Part I: Open Label|Death|1
5230393|NCT00889720|18051143|P1|Overall Study|Other|4
5230394|NCT00889720|18051143|P1|Overall Study|Withdrawal by Subject|4
5230395|NCT00889707|18051170|P2|Overall Study|Lack of Efficacy|5
5230396|NCT00889707|18051171|P1|Overall Study|Lack of Efficacy|2
5230397|NCT00889707|18051170|P2|Overall Study|Lost to Follow-up|2
5230398|NCT00889707|18051171|P1|Overall Study|Lost to Follow-up|0
5230399|NCT00889707|18051170|P2|Overall Study|Withdrawal by Subject|3
5230400|NCT00889707|18051171|P1|Overall Study|Withdrawal by Subject|4
5230401|NCT00889707|18051170|P2|Overall Study|Adverse Event|0
5230402|NCT00889707|18051171|P1|Overall Study|Adverse Event|1
5230403|NCT00889681|18051179|P1|Overall Study|Insurance disapproval|1
5230404|NCT00889681|18051179|P1|Overall Study|Not meeting qualification Criteria|2
5230405|NCT00889603|18051186|P1|Overall Study|Other|4
5230406|NCT00889603|18051186|P1|Overall Study|No longer willing to participant in stud|4
5230407|NCT00889603|18051186|P1|Overall Study|Lost to Follow-up|19
5230408|NCT00889603|18051186|P1|Overall Study|Death|3
5230409|NCT00889603|18051186|P1|Overall Study|Adverse Event|7
5230410|NCT00889421|18051208|P1|Overall Study|Lack of Efficacy|3
5230411|NCT00889265|18051249|P1|Overall Study|Protocol Violation|1
5230412|NCT00889265|18051249|P1|Overall Study|Lost to Follow-up|5
5230413|NCT00889265|18051249|P1|Overall Study|Adverse Event|1
5230414|NCT00889252|18051256|P2|Overall Study|Protocol Violation|0
5230415|NCT00889252|18051257|P1|Overall Study|Protocol Violation|2
5230416|NCT00889252|18051256|P2|Overall Study|Withdrawal by Subject|0
5230417|NCT00889252|18051257|P1|Overall Study|Withdrawal by Subject|3
5230418|NCT00889252|18051256|P2|Overall Study|Adverse Event|4
5230419|NCT00889252|18051257|P1|Overall Study|Adverse Event|2
5230420|NCT00889005|18051334|P2|Overall Study|Withdrawal by Subject|0
5230421|NCT00889005|18051335|P1|Overall Study|Withdrawal by Subject|4
5230422|NCT00889005|18051334|P2|Overall Study|Lost to Follow-up|2
5230423|NCT00889005|18051335|P1|Overall Study|Lost to Follow-up|4
5230424|NCT00888940|18051349|P2|Overall Study|Randomized Not Treated|13
5230425|NCT00888940|18051350|P1|Overall Study|Randomized Not Treated|11
5230426|NCT00888940|18051349|P2|Overall Study|Lost to Follow-up|5
5230427|NCT00888940|18051350|P1|Overall Study|Lost to Follow-up|5
5230428|NCT00888940|18051349|P2|Overall Study|Adverse Event|3
5230429|NCT00888940|18051350|P1|Overall Study|Adverse Event|12
5230430|NCT00888849|18051360|P2|Overall Study|Lost to Follow-up|2
5230431|NCT00888849|18051361|P1|Overall Study|Lost to Follow-up|1
5230432|NCT00888849|18051360|P2|Overall Study|Death|7
5230433|NCT00888849|18051361|P1|Overall Study|Death|4
5230434|NCT00888654|18051371|P1|Overall Study|Stopped meds due to headaches|1
5230435|NCT00888654|18051371|P1|Overall Study|Change in surg date|1
5230436|NCT00888654|18051371|P1|Overall Study|Inelig. due to contraindication of med|1
5230437|NCT00888654|18051371|P1|Overall Study|Withdrawal by Subject|1
5230438|NCT00888654|18051371|P1|Overall Study|Surgery aborted|2
5230439|NCT00888654|18051371|P1|Overall Study|Not enough oral meds before surgery|3
5230440|NCT00888654|18051371|P1|Overall Study|Problems swallowing oral meds.|1
5230441|NCT00888615|18051389|P1|Overall Study|No treatment|2
5230442|NCT00888433|18051413|P2|Overall Study|Missed Visit|1
5230443|NCT00888433|18051414|P1|Overall Study|Missed Visit|2
5230444|NCT00888433|18051413|P2|Overall Study|Withdrawal by Subject|2
5230445|NCT00888433|18051414|P1|Overall Study|Withdrawal by Subject|1
5230446|NCT00888381|18051422|P2|Overall Study|Lost to Follow-up|1
5230447|NCT00888381|18051423|P1|Overall Study|Lost to Follow-up|0
5230448|NCT00888355|18051443|P4|Overall Study|Withdrawal by Subject|3
5230449|NCT00888355|18051444|P3|Overall Study|Withdrawal by Subject|1
5230450|NCT00888355|18051445|P2|Overall Study|Withdrawal by Subject|3
5230451|NCT00888355|18051446|P1|Overall Study|Withdrawal by Subject|0
5230452|NCT00888355|18051443|P4|Overall Study|Protocol Violation|2
5230453|NCT00888355|18051444|P3|Overall Study|Protocol Violation|1
5230454|NCT00888355|18051445|P2|Overall Study|Protocol Violation|2
5230455|NCT00888355|18051446|P1|Overall Study|Protocol Violation|3
5230456|NCT00888355|18051443|P4|Overall Study|Lost to Follow-up|0
5230457|NCT00888355|18051444|P3|Overall Study|Lost to Follow-up|2
5230458|NCT00888355|18051445|P2|Overall Study|Lost to Follow-up|2
5230459|NCT00888355|18051446|P1|Overall Study|Lost to Follow-up|0
5230460|NCT00888355|18051443|P4|Overall Study|Lack of Efficacy|2
5230461|NCT00888355|18051444|P3|Overall Study|Lack of Efficacy|5
5230462|NCT00888355|18051445|P2|Overall Study|Lack of Efficacy|2
5230463|NCT00888355|18051446|P1|Overall Study|Lack of Efficacy|9
5230464|NCT00888355|18051443|P4|Overall Study|Adverse Event|3
5230465|NCT00888355|18051444|P3|Overall Study|Adverse Event|3
5230466|NCT00888355|18051445|P2|Overall Study|Adverse Event|0
5230467|NCT00888355|18051446|P1|Overall Study|Adverse Event|10
5230468|NCT00888329|18051502|P2|Overall Study|Physician Decision|9
5230469|NCT00888329|18051503|P1|Overall Study|Physician Decision|6
5230470|NCT00888238|18051509|P3|Washout Period After Period 2|Adverse Event|1
5230471|NCT00888238|18051510|P2|Washout Period After Period 2|Adverse Event|0
5230472|NCT00888238|18051511|P1|Washout Period After Period 2|Adverse Event|0
5230473|NCT00888173|18051519|P1|Overall Study|Ineligible: required test not done|1
5230474|NCT00888173|18051519|P1|Overall Study|Wrong Primary|1
5230475|NCT00888134|18051527|P1|Follow-up|being followed for long-term survival|1
5230476|NCT00888134|18051527|P1|Treatment With Study Drug|Withdrawal by Subject|1
5230477|NCT00887978|18051537|P2|Overall Study|Lost to Follow-up|1
5230478|NCT00887978|18051538|P1|Overall Study|Lost to Follow-up|0
5230479|NCT00887978|18051537|P2|Overall Study|Withdrawal by Subject|2
5230480|NCT00887978|18051538|P1|Overall Study|Withdrawal by Subject|1
5230481|NCT00887978|18051537|P2|Overall Study|Death|3
5230482|NCT00887978|18051538|P1|Overall Study|Death|2
5230483|NCT00887978|18051537|P2|Overall Study|Clinical Worsening|4
5230484|NCT00887978|18051538|P1|Overall Study|Clinical Worsening|4
5230485|NCT00887978|18051537|P2|Overall Study|Adverse Event|5
5230486|NCT00887978|18051538|P1|Overall Study|Adverse Event|18
5230487|NCT00887926|18051608|P4|Overall Study|Withdrawal by Subject|0
5230488|NCT00887926|18051609|P3|Overall Study|Withdrawal by Subject|0
5230489|NCT00887926|18051610|P2|Overall Study|Withdrawal by Subject|1
5230490|NCT00887926|18051611|P1|Overall Study|Withdrawal by Subject|0
5230491|NCT00887913|18051646|P1|Overall Study|Withdrawal by Subject|6
5230492|NCT00887822|18051654|P2|Overall Study|Randomized but not treated|1
5230493|NCT00887822|18051655|P1|Overall Study|Randomized but not treated|0
5230494|NCT00887822|18051654|P2|Overall Study|Protocol Violation|1
5230495|NCT00887822|18051655|P1|Overall Study|Protocol Violation|0
5230496|NCT00887822|18051654|P2|Overall Study|Death|3
5230497|NCT00887822|18051655|P1|Overall Study|Death|2
5230498|NCT00887822|18051654|P2|Overall Study|Administrative/Other than specified|4
5230499|NCT00887822|18051655|P1|Overall Study|Administrative/Other than specified|5
5230500|NCT00887822|18051654|P2|Overall Study|Refused treatment/Did not cooperate|10
5230501|NCT00887822|18051655|P1|Overall Study|Refused treatment/Did not cooperate|12
5230502|NCT00887822|18051654|P2|Overall Study|Failure to return|11
5230503|NCT00887822|18051655|P1|Overall Study|Failure to return|11
5230504|NCT00887822|18051654|P2|Overall Study|Adverse Event|17
5230505|NCT00887822|18051655|P1|Overall Study|Adverse Event|14
5230506|NCT00887822|18051654|P2|Overall Study|Insufficient therapeutic response|55
5230507|NCT00887822|18051655|P1|Overall Study|Insufficient therapeutic response|53
5230508|NCT00887809|18051687|P2|Overall Study|Death|0
5230509|NCT00887809|18051688|P1|Overall Study|Death|1
5230510|NCT00887809|18051687|P2|Overall Study|Patient Not Treated|0
5230511|NCT00887809|18051688|P1|Overall Study|Patient Not Treated|3
5230512|NCT00887744|18051694|P1|Overall Study|Various reasons|9
5230513|NCT00887744|18051694|P1|Overall Study|Withdrawal by Subject|18
5230514|NCT00887744|18051694|P1|Overall Study|Lost to Follow-up|3
5230515|NCT00887744|18051694|P1|Overall Study|Death|1
5230516|NCT00887744|18051694|P1|Overall Study|Adverse Event|3
5230517|NCT00887679|18051703|P1|Overall Study|Physician Decision|5
5230518|NCT00887679|18051703|P1|Overall Study|Lost to Follow-up|4
5230519|NCT00887679|18051703|P1|Overall Study|Withdrawal by Subject|1
5230520|NCT00887588|18051733|P2|Extension Period|Lost to Follow-up|0
5230521|NCT00887588|18051734|P1|Extension Period|Lost to Follow-up|1
5230522|NCT00887588|18051733|P2|Extension Period|Protocol deviation|0
5230523|NCT00887588|18051734|P1|Extension Period|Protocol deviation|1
5230524|NCT00887588|18051733|P2|Extension Period|Death|1
5230525|NCT00887588|18051734|P1|Extension Period|Death|0
5230526|NCT00887588|18051733|P2|Extension Period|Adverse Event|4
5230527|NCT00887588|18051734|P1|Extension Period|Adverse Event|4
5230528|NCT00887588|18051733|P2|Core Period|Adverse Event|11
5230529|NCT00887588|18051734|P1|Core Period|Adverse Event|9
5230530|NCT00887588|18051733|P2|Core Period|Withdrawal by Subject|8
5230531|NCT00887588|18051734|P1|Core Period|Withdrawal by Subject|6
5230532|NCT00887588|18051733|P2|Core Period|Lost to Follow-up|1
5230533|NCT00887588|18051734|P1|Core Period|Lost to Follow-up|3
5230534|NCT00887588|18051733|P2|Core Period|Death|1
5230535|NCT00887588|18051734|P1|Core Period|Death|1
5230536|NCT00887549|18051815|P1|Maintenance Therapy|Death due to adverse event|1
5230537|NCT00887549|18051815|P1|Maintenance Therapy|Progressive Disease|25
5230538|NCT00887549|18051815|P1|Maintenance Therapy|Physician Decision|1
5230539|NCT00887549|18051815|P1|Maintenance Therapy|Adverse Event|16
5230540|NCT00887549|18051815|P1|Induction Therapy|Death due to Study Drug Toxicity|1
5230541|NCT00887549|18051815|P1|Induction Therapy|Death due to Study Disease|4
5230542|NCT00887549|18051815|P1|Induction Therapy|Progressive Disease|13
5230543|NCT00887549|18051815|P1|Induction Therapy|Physician Decision|1
5230544|NCT00887549|18051815|P1|Induction Therapy|Adverse Event|8
5230545|NCT00887484|18051833|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
5230546|NCT00887484|18051833|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
5230547|NCT00887484|18051833|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
5230548|NCT00887354|18051921|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
5230549|NCT00887354|18051922|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
5230550|NCT00887354|18051921|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
5230551|NCT00887354|18051922|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
5230552|NCT00887354|18051921|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
5230553|NCT00887354|18051922|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
5230554|NCT00887354|18051921|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
5230555|NCT00887354|18051922|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
5230556|NCT00887354|18051921|P2|Open Label Phase (Week 26 to Week 78)|Death|2
5230557|NCT00887354|18051922|P1|Open Label Phase (Week 26 to Week 78)|Death|0
5230558|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
5230559|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
5230560|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
5230561|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
5230562|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
5230563|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
5230564|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
5230565|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
5230566|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
5230567|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
5230568|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
5230569|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
5230570|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
5230571|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
5230572|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
5230573|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
5230574|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
5230575|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
5230576|NCT00887354|18051921|P2|Treatment Phase (Week 0 to Week 26)|Death|1
5230577|NCT00887354|18051922|P1|Treatment Phase (Week 0 to Week 26)|Death|0
5230578|NCT00887341|18051942|P2|Overall Study|Lost to Follow-up|1
5230579|NCT00887341|18051943|P1|Overall Study|Lost to Follow-up|0
5230580|NCT00887341|18051942|P2|Overall Study|Adverse Event|1
5230581|NCT00887341|18051943|P1|Overall Study|Adverse Event|0
5230582|NCT00887341|18051942|P2|Overall Study|Withdrawal by Subject|1
5230583|NCT00887341|18051943|P1|Overall Study|Withdrawal by Subject|1
5230584|NCT00887341|18051942|P2|Overall Study|Refused treatment|0
5230585|NCT00887341|18051943|P1|Overall Study|Refused treatment|1
5230586|NCT00887315|18051979|P2|Overall Study|Study termination|4
5230587|NCT00887315|18051980|P1|Overall Study|Study termination|7
5230588|NCT00887289|18051988|P1|Overall Study|Other|20
5230589|NCT00887289|18051988|P1|Overall Study|Lost to Follow-up|8
5230590|NCT00887289|18051988|P1|Overall Study|Withdrawal by Subject|26
5230591|NCT00887289|18051988|P1|Overall Study|Adverse Event|27
5230592|NCT00887289|18051988|P1|Overall Study|Lack of Efficacy|14
5230593|NCT00887250|18052000|P3|Overall Study|Patient uncooperative|1
5230594|NCT00887250|18052001|P2|Overall Study|Patient uncooperative|0
5230595|NCT00887250|18052002|P1|Overall Study|Patient uncooperative|0
5230596|NCT00887250|18052000|P3|Overall Study|Withdrawal by Subject|2
5230597|NCT00887250|18052001|P2|Overall Study|Withdrawal by Subject|1
5230598|NCT00887250|18052002|P1|Overall Study|Withdrawal by Subject|2
5230599|NCT00887250|18052000|P3|Overall Study|Protocol Violation|1
5230600|NCT00887250|18052001|P2|Overall Study|Protocol Violation|2
5230601|NCT00887250|18052002|P1|Overall Study|Protocol Violation|2
5230602|NCT00887250|18052000|P3|Overall Study|Lost to Follow-up|1
5230603|NCT00887250|18052001|P2|Overall Study|Lost to Follow-up|3
5230604|NCT00887250|18052002|P1|Overall Study|Lost to Follow-up|2
5230605|NCT00887250|18052000|P3|Overall Study|Lack of Efficacy|1
5230606|NCT00887250|18052001|P2|Overall Study|Lack of Efficacy|6
5230607|NCT00887250|18052002|P1|Overall Study|Lack of Efficacy|9
5230608|NCT00887250|18052000|P3|Overall Study|Adverse Event|7
5230609|NCT00887250|18052001|P2|Overall Study|Adverse Event|0
5230610|NCT00887250|18052002|P1|Overall Study|Adverse Event|3
5230611|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
5230612|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
5230613|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
5230614|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
5230615|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
5230616|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
5230617|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Other|12
5230618|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Other|11
5230619|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Other|0
5230620|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
5230621|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
5230622|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
5230623|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
5230624|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
5230625|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
5230626|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
5230627|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
5230628|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
5230629|NCT00887224|18052025|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
5230630|NCT00887224|18052026|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
5230631|NCT00887224|18052027|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
5230632|NCT00887224|18052025|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
5230633|NCT00887224|18052026|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
5230634|NCT00887224|18052027|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
5230635|NCT00887224|18052025|P3|Double-blind (DB) Phase|Protocol Violation|5
5230636|NCT00887224|18052026|P2|Double-blind (DB) Phase|Protocol Violation|8
5230637|NCT00887224|18052027|P1|Double-blind (DB) Phase|Protocol Violation|0
5230638|NCT00887224|18052025|P3|Double-blind (DB) Phase|Other|0
5230639|NCT00887224|18052026|P2|Double-blind (DB) Phase|Other|2
5230640|NCT00887224|18052027|P1|Double-blind (DB) Phase|Other|0
5230641|NCT00887224|18052025|P3|Double-blind (DB) Phase|Lost to Follow-up|8
5230642|NCT00887224|18052026|P2|Double-blind (DB) Phase|Lost to Follow-up|8
5230643|NCT00887224|18052027|P1|Double-blind (DB) Phase|Lost to Follow-up|0
5230644|NCT00887224|18052025|P3|Double-blind (DB) Phase|Lack of Efficacy|33
5230645|NCT00887224|18052026|P2|Double-blind (DB) Phase|Lack of Efficacy|67
5230646|NCT00887224|18052027|P1|Double-blind (DB) Phase|Lack of Efficacy|0
5230647|NCT00887224|18052025|P3|Double-blind (DB) Phase|Failed to return|2
5230648|NCT00887224|18052026|P2|Double-blind (DB) Phase|Failed to return|2
5230649|NCT00887224|18052027|P1|Double-blind (DB) Phase|Failed to return|0
5230650|NCT00887224|18052025|P3|Double-blind (DB) Phase|Adverse Event|2
5230651|NCT00887224|18052026|P2|Double-blind (DB) Phase|Adverse Event|7
5230652|NCT00887224|18052027|P1|Double-blind (DB) Phase|Adverse Event|0
5230653|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
5230654|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
5230655|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
5230656|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
5230657|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
5230658|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
5230659|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Other|0
5230660|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Other|0
5230661|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Other|30
5230662|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
5230663|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
5230664|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
5230665|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
5230666|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
5230667|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
5230668|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Failed to return|0
5230669|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Failed to return|0
5230670|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Failed to return|17
5230671|NCT00887224|18052025|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
5230672|NCT00887224|18052026|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
5230673|NCT00887224|18052027|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
5230674|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
5230675|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
5230676|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
5230677|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
5230678|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
5230679|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
5230680|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Other|0
5230681|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Other|0
5230682|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Other|1
5230683|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
5230684|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
5230685|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
5230686|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
5230687|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
5230688|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
5230689|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Failed to return|0
5230690|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Failed to return|0
5230691|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Failed to return|3
5230692|NCT00887224|18052025|P3|Open-label Stability (OLS) Phase|Adverse Event|0
5230693|NCT00887224|18052026|P2|Open-label Stability (OLS) Phase|Adverse Event|0
5230694|NCT00887224|18052027|P1|Open-label Stability (OLS) Phase|Adverse Event|22
5230695|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
5230696|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
5230697|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
5230698|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Protocol Violation|0
5230699|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Protocol Violation|0
5230700|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Protocol Violation|12
5230701|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Other|0
5230702|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Other|0
5230703|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Other|1
5230704|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
5230705|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
5230706|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
5230707|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
5230708|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
5230709|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
5230710|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Failed to return|0
5230711|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Failed to return|0
5230712|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Failed to return|6
5230713|NCT00887224|18052025|P3|Open-label Response (OLR) Phase|Adverse Event|0
5230714|NCT00887224|18052026|P2|Open-label Response (OLR) Phase|Adverse Event|0
5230715|NCT00887224|18052027|P1|Open-label Response (OLR) Phase|Adverse Event|46
5230716|NCT00887198|18052054|P3|Cross Over (Placebo to AA)|Other|19
5230717|NCT00887198|18052055|P2|Cross Over (Placebo to AA)|Other|0
5230718|NCT00887198|18052056|P1|Cross Over (Placebo to AA)|Other|0
5230719|NCT00887198|18052054|P3|Cross Over (Placebo to AA)|Progressive disease|20
5230720|NCT00887198|18052055|P2|Cross Over (Placebo to AA)|Progressive disease|0
5230721|NCT00887198|18052056|P1|Cross Over (Placebo to AA)|Progressive disease|0
5230722|NCT00887198|18052054|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
5230723|NCT00887198|18052055|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
5230724|NCT00887198|18052056|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
5230725|NCT00887198|18052054|P3|Cross Over (Placebo to AA)|Adverse Event|9
5230726|NCT00887198|18052055|P2|Cross Over (Placebo to AA)|Adverse Event|0
5230727|NCT00887198|18052056|P1|Cross Over (Placebo to AA)|Adverse Event|0
5230728|NCT00887198|18052054|P3|Cross Over (Placebo to AA)|Ongoing|35
5230729|NCT00887198|18052055|P2|Cross Over (Placebo to AA)|Ongoing|0
5230730|NCT00887198|18052056|P1|Cross Over (Placebo to AA)|Ongoing|0
5230731|NCT00887198|18052054|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
5230732|NCT00887198|18052055|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
5230733|NCT00887198|18052056|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
5230734|NCT00887198|18052054|P3|Randomized Period|Randomized, Not treated|0
5230735|NCT00887198|18052055|P2|Randomized Period|Randomized, Not treated|2
5230736|NCT00887198|18052056|P1|Randomized Period|Randomized, Not treated|4
5230737|NCT00887198|18052054|P3|Randomized Period|Other|0
5230738|NCT00887198|18052055|P2|Randomized Period|Other|30
5230739|NCT00887198|18052056|P1|Randomized Period|Other|42
5230740|NCT00887198|18052054|P3|Randomized Period|Progressive disease|0
5230741|NCT00887198|18052055|P2|Randomized Period|Progressive disease|370
5230742|NCT00887198|18052056|P1|Randomized Period|Progressive disease|366
5230743|NCT00887198|18052054|P3|Randomized Period|Withdrawal by Subject|0
5230744|NCT00887198|18052055|P2|Randomized Period|Withdrawal by Subject|56
5230745|NCT00887198|18052056|P1|Randomized Period|Withdrawal by Subject|41
5230746|NCT00887198|18052054|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
5230747|NCT00887198|18052055|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
5230748|NCT00887198|18052056|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
5230749|NCT00887198|18052054|P3|Randomized Period|Lost to Follow-up|0
5230750|NCT00887198|18052055|P2|Randomized Period|Lost to Follow-up|0
5230751|NCT00887198|18052056|P1|Randomized Period|Lost to Follow-up|1
5230752|NCT00887198|18052054|P3|Randomized Period|Adverse Event|0
5230753|NCT00887198|18052055|P2|Randomized Period|Adverse Event|33
5230754|NCT00887198|18052056|P1|Randomized Period|Adverse Event|50
5230755|NCT00887198|18052054|P3|Randomized Period|Ongoing|0
5230756|NCT00887198|18052055|P2|Randomized Period|Ongoing|0
5230757|NCT00887198|18052056|P1|Randomized Period|Ongoing|42
5230758|NCT00887159|18052087|P3|Overall Study|Never started assigned therapy|4
5230759|NCT00887159|18052088|P2|Overall Study|Never started assigned therapy|3
5230760|NCT00887159|18052089|P1|Overall Study|Never started assigned therapy|3
5230761|NCT00887159|18052087|P3|Overall Study|Ineligible|0
5230762|NCT00887159|18052088|P2|Overall Study|Ineligible|1
5230763|NCT00887159|18052089|P1|Overall Study|Ineligible|5
5230764|NCT00887159|18052087|P3|Overall Study|Received more tx instead of observation|0
5230765|NCT00887159|18052088|P2|Overall Study|Received more tx instead of observation|0
5230766|NCT00887159|18052089|P1|Overall Study|Received more tx instead of observation|1
5230767|NCT00887159|18052087|P3|Overall Study|Pt had PD but was SD when re-measured|0
5230768|NCT00887159|18052088|P2|Overall Study|Pt had PD but was SD when re-measured|1
5230769|NCT00887159|18052089|P1|Overall Study|Pt had PD but was SD when re-measured|0
5230770|NCT00887159|18052087|P3|Overall Study|Treatment delayed|0
5230771|NCT00887159|18052088|P2|Overall Study|Treatment delayed|1
5230772|NCT00887159|18052089|P1|Overall Study|Treatment delayed|1
5230773|NCT00887159|18052087|P3|Overall Study|Sympomatic deterioration|0
5230774|NCT00887159|18052088|P2|Overall Study|Sympomatic deterioration|0
5230775|NCT00887159|18052089|P1|Overall Study|Sympomatic deterioration|1
5230776|NCT00887159|18052087|P3|Overall Study|Physician Decision|0
5230777|NCT00887159|18052088|P2|Overall Study|Physician Decision|1
5230778|NCT00887159|18052089|P1|Overall Study|Physician Decision|1
5230779|NCT00887159|18052087|P3|Overall Study|Alternative therapy|0
5230780|NCT00887159|18052088|P2|Overall Study|Alternative therapy|0
5230781|NCT00887159|18052089|P1|Overall Study|Alternative therapy|2
5230782|NCT00887159|18052087|P3|Overall Study|Withdrawal by Subject|2
5230783|NCT00887159|18052088|P2|Overall Study|Withdrawal by Subject|4
5230784|NCT00887159|18052089|P1|Overall Study|Withdrawal by Subject|4
5230785|NCT00887159|18052087|P3|Overall Study|Death|0
5230786|NCT00887159|18052088|P2|Overall Study|Death|2
5230787|NCT00887159|18052089|P1|Overall Study|Death|2
5230788|NCT00887159|18052087|P3|Overall Study|Adverse Event|17
5230789|NCT00887159|18052088|P2|Overall Study|Adverse Event|4
5230790|NCT00887159|18052089|P1|Overall Study|Adverse Event|3
5230791|NCT00887159|18052087|P3|Overall Study|Disease progression|33
5230792|NCT00887159|18052088|P2|Overall Study|Disease progression|39
5230793|NCT00887159|18052089|P1|Overall Study|Disease progression|6
5230794|NCT00887068|18052107|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
5230795|NCT00887068|18052108|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
5230796|NCT00887068|18052107|P2|Overall Study|Withdrawal by Subject|0
5230797|NCT00887068|18052108|P1|Overall Study|Withdrawal by Subject|2
5230798|NCT00886938|18052116|P1|Overall Study|Withdrawal by Subject|1
5230799|NCT00886938|18052116|P1|Overall Study|Adverse Event|1
5230800|NCT00886834|18052129|P2|Overall Study|Protocol Violation|3
5230801|NCT00886834|18052130|P1|Overall Study|Protocol Violation|0
5230802|NCT00886821|18052152|P14|Stage 2|Lost to Follow-up|1
5230803|NCT00886821|18052153|P13|Stage 2|Lost to Follow-up|2
5230804|NCT00886821|18052154|P12|Stage 2|Lost to Follow-up|0
5230805|NCT00886821|18052155|P11|Stage 2|Lost to Follow-up|0
5230806|NCT00886821|18052156|P10|Stage 2|Lost to Follow-up|0
5230807|NCT00886821|18052157|P9|Stage 2|Lost to Follow-up|0
5230808|NCT00886821|18052158|P8|Stage 2|Lost to Follow-up|0
5230809|NCT00886821|18052159|P7|Stage 2|Lost to Follow-up|0
5230810|NCT00886821|18052160|P6|Stage 2|Lost to Follow-up|0
5230811|NCT00886821|18052161|P5|Stage 2|Lost to Follow-up|0
5230812|NCT00886821|18052162|P4|Stage 2|Lost to Follow-up|0
5230813|NCT00886821|18052163|P3|Stage 2|Lost to Follow-up|0
5230814|NCT00886821|18052164|P2|Stage 2|Lost to Follow-up|0
5230815|NCT00886821|18052165|P1|Stage 2|Lost to Follow-up|0
5230816|NCT00886821|18052152|P14|Stage 2|Adverse Event|0
5230817|NCT00886821|18052153|P13|Stage 2|Adverse Event|3
5230818|NCT00886821|18052154|P12|Stage 2|Adverse Event|1
5230819|NCT00886821|18052155|P11|Stage 2|Adverse Event|0
5230820|NCT00886821|18052156|P10|Stage 2|Adverse Event|0
5230821|NCT00886821|18052157|P9|Stage 2|Adverse Event|0
5230822|NCT00886821|18052158|P8|Stage 2|Adverse Event|0
5230823|NCT00886821|18052159|P7|Stage 2|Adverse Event|0
5230824|NCT00886821|18052160|P6|Stage 2|Adverse Event|0
5230825|NCT00886821|18052161|P5|Stage 2|Adverse Event|0
5230826|NCT00886821|18052162|P4|Stage 2|Adverse Event|0
5230827|NCT00886821|18052163|P3|Stage 2|Adverse Event|0
5230828|NCT00886821|18052164|P2|Stage 2|Adverse Event|0
5230829|NCT00886821|18052165|P1|Stage 2|Adverse Event|0
5230830|NCT00886795|18052390|P1|Overall Study|Lack of Efficacy|1
5230831|NCT00886769|18052397|P2|Overall Study|Unsatisfactory therapeutic effect|37
5230832|NCT00886769|18052398|P1|Overall Study|Unsatisfactory therapeutic effect|6
5230833|NCT00886743|18052422|P1|Overall Study|Other|1
5230834|NCT00886743|18052422|P1|Overall Study|Adverse Event|3
5230835|NCT00886639|18052460|P1|Overall Study|non-compliance|2
5230836|NCT00886639|18052460|P1|Overall Study|acute exacerbation|14
5230837|NCT00886613|18052474|P3|Overall Study|Subject withdrew consent (Part A)|2
5230838|NCT00886613|18052475|P2|Overall Study|Subject withdrew consent (Part A)|0
5230839|NCT00886613|18052476|P1|Overall Study|Subject withdrew consent (Part A)|0
5230840|NCT00886613|18052474|P3|Overall Study|Lost to follow-up (Part B)|1
5230841|NCT00886613|18052475|P2|Overall Study|Lost to follow-up (Part B)|0
5230842|NCT00886613|18052476|P1|Overall Study|Lost to follow-up (Part B)|1
5230843|NCT00886613|18052474|P3|Overall Study|Protocol deviation (Part B)|0
5230844|NCT00886613|18052475|P2|Overall Study|Protocol deviation (Part B)|0
5230845|NCT00886613|18052476|P1|Overall Study|Protocol deviation (Part B)|1
5230846|NCT00886600|18052498|P4|Combination Therapy Period|Protocol Violation|0
5230847|NCT00886600|18052499|P3|Combination Therapy Period|Protocol Violation|1
5230848|NCT00886600|18052500|P2|Combination Therapy Period|Protocol Violation|0
5230849|NCT00886600|18052501|P1|Combination Therapy Period|Protocol Violation|0
5230850|NCT00886600|18052498|P4|Combination Therapy Period|Adverse Event|0
5230851|NCT00886600|18052499|P3|Combination Therapy Period|Adverse Event|1
5230852|NCT00886600|18052500|P2|Combination Therapy Period|Adverse Event|0
5230853|NCT00886600|18052501|P1|Combination Therapy Period|Adverse Event|0
5230854|NCT00886600|18052498|P4|Double-blind Monotherapy|Withdrawal by Subject|0
5230855|NCT00886600|18052499|P3|Double-blind Monotherapy|Withdrawal by Subject|0
5230856|NCT00886600|18052500|P2|Double-blind Monotherapy|Withdrawal by Subject|0
5230857|NCT00886600|18052501|P1|Double-blind Monotherapy|Withdrawal by Subject|1
5230858|NCT00886600|18052498|P4|Double-blind Monotherapy|Protocol Violation|1
5230859|NCT00886600|18052499|P3|Double-blind Monotherapy|Protocol Violation|0
5230860|NCT00886600|18052500|P2|Double-blind Monotherapy|Protocol Violation|0
5230861|NCT00886600|18052501|P1|Double-blind Monotherapy|Protocol Violation|0
5230862|NCT00886600|18052498|P4|Double-blind Monotherapy|Adverse Event|1
5230863|NCT00886600|18052499|P3|Double-blind Monotherapy|Adverse Event|1
5230864|NCT00886600|18052500|P2|Double-blind Monotherapy|Adverse Event|1
5230865|NCT00886600|18052501|P1|Double-blind Monotherapy|Adverse Event|1
5230866|NCT00886587|18052525|P2|Overall Study|Withdrawal by Subject|1
5230867|NCT00886587|18052526|P1|Overall Study|Withdrawal by Subject|0
5230868|NCT00886587|18052525|P2|Overall Study|Protocol Violation|0
5230869|NCT00886587|18052526|P1|Overall Study|Protocol Violation|2
5230870|NCT00886587|18052525|P2|Overall Study|Adverse Event|1
5230871|NCT00886587|18052526|P1|Overall Study|Adverse Event|2
5230872|NCT00886483|18052540|P2|Overall Study|Distance to center, poor grades|0
5230873|NCT00886483|18052541|P1|Overall Study|Distance to center, poor grades|1
5230874|NCT00886483|18052540|P2|Overall Study|Pursue medications|2
5230875|NCT00886483|18052541|P1|Overall Study|Pursue medications|1
5230876|NCT00886483|18052540|P2|Overall Study|Lost to Follow-up|1
5230877|NCT00886483|18052541|P1|Overall Study|Lost to Follow-up|0
5230878|NCT00886340|18052559|P2|Overall Study|Withdrawal by Subject|7
5230879|NCT00886340|18052560|P1|Overall Study|Withdrawal by Subject|0
5230880|NCT00886288|18052568|P2|Overall Study|Lost to Follow-up|0
5230881|NCT00886288|18052569|P1|Overall Study|Lost to Follow-up|86
5230882|NCT00886288|18052568|P2|Overall Study|no respect of the 12 weeks period|227
5230883|NCT00886288|18052569|P1|Overall Study|no respect of the 12 weeks period|657
5230884|NCT00886119|18052625|P2|Period 1|Did not meet inclusion criteria|0
5230885|NCT00886119|18052626|P1|Period 1|Did not meet inclusion criteria|1
5230886|NCT00886015|18052634|P2|Overall Study|Death|2
5230887|NCT00886015|18052635|P1|Overall Study|Death|0
5230888|NCT00885846|18052654|P3|Overall Study|Withdrawal by Subject|2
5230889|NCT00885846|18052655|P2|Overall Study|Withdrawal by Subject|5
5230890|NCT00885846|18052656|P1|Overall Study|Withdrawal by Subject|2
5230891|NCT00885755|18052671|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
5230892|NCT00885755|18052672|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
5230893|NCT00885755|18052673|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
5230894|NCT00885755|18052671|P3|Part I: Trastuzumab+Taxane|Death|1
5230895|NCT00885755|18052672|P2|Part I: Trastuzumab+Taxane|Death|0
5230896|NCT00885755|18052673|P1|Part I: Trastuzumab+Taxane|Death|0
5230897|NCT00885755|18052671|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
5230898|NCT00885755|18052672|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
5230899|NCT00885755|18052673|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
5230900|NCT00885755|18052671|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
5230901|NCT00885755|18052672|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
5230902|NCT00885755|18052673|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
5230903|NCT00885755|18052671|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
5230904|NCT00885755|18052672|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
5230905|NCT00885755|18052673|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
5230906|NCT00885703|18052716|P7|Overall Study|Ineligible (no CM)|1
5230907|NCT00885703|18052717|P6|Overall Study|Ineligible (no CM)|3
5230908|NCT00885703|18052718|P5|Overall Study|Ineligible (no CM)|2
5230909|NCT00885703|18052719|P4|Overall Study|Ineligible (no CM)|1
5230910|NCT00885703|18052720|P3|Overall Study|Ineligible (no CM)|2
5230911|NCT00885703|18052721|P2|Overall Study|Ineligible (no CM)|3
5230912|NCT00885703|18052722|P1|Overall Study|Ineligible (no CM)|1
5230913|NCT00885703|18052716|P7|Overall Study|Withdrawal by Subject|1
5230914|NCT00885703|18052717|P6|Overall Study|Withdrawal by Subject|1
5230915|NCT00885703|18052718|P5|Overall Study|Withdrawal by Subject|3
5230916|NCT00885703|18052719|P4|Overall Study|Withdrawal by Subject|1
5230917|NCT00885703|18052720|P3|Overall Study|Withdrawal by Subject|0
5230918|NCT00885703|18052721|P2|Overall Study|Withdrawal by Subject|0
5230919|NCT00885703|18052722|P1|Overall Study|Withdrawal by Subject|0
5230920|NCT00885703|18052716|P7|Overall Study|Lost to Follow-up|0
5230921|NCT00885703|18052717|P6|Overall Study|Lost to Follow-up|1
5230922|NCT00885703|18052718|P5|Overall Study|Lost to Follow-up|0
5230923|NCT00885703|18052719|P4|Overall Study|Lost to Follow-up|0
5230924|NCT00885703|18052720|P3|Overall Study|Lost to Follow-up|1
5230925|NCT00885703|18052721|P2|Overall Study|Lost to Follow-up|0
5230926|NCT00885703|18052722|P1|Overall Study|Lost to Follow-up|0
5230927|NCT00885703|18052716|P7|Overall Study|Death|4
5230928|NCT00885703|18052717|P6|Overall Study|Death|8
5230929|NCT00885703|18052718|P5|Overall Study|Death|7
5230930|NCT00885703|18052719|P4|Overall Study|Death|7
5230931|NCT00885703|18052720|P3|Overall Study|Death|8
5230932|NCT00885703|18052721|P2|Overall Study|Death|7
5230933|NCT00885703|18052722|P1|Overall Study|Death|9
5230934|NCT00885677|18052780|P2|Overall Study|Inclusion/exclusion not met|27
5230935|NCT00885677|18052781|P1|Overall Study|Inclusion/exclusion not met|25
5230936|NCT00885677|18052780|P2|Overall Study|Heart transplantation|0
5230937|NCT00885677|18052781|P1|Overall Study|Heart transplantation|1
5230938|NCT00885677|18052780|P2|Overall Study|device/lead revision or replacement|6
5230939|NCT00885677|18052781|P1|Overall Study|device/lead revision or replacement|7
5230940|NCT00885677|18052780|P2|Overall Study|premature study closure|44
5230941|NCT00885677|18052781|P1|Overall Study|premature study closure|41
5230942|NCT00885677|18052780|P2|Overall Study|Protocol Violation|54
5230943|NCT00885677|18052781|P1|Overall Study|Protocol Violation|54
5230944|NCT00885677|18052780|P2|Overall Study|Lost to Follow-up|13
5230945|NCT00885677|18052781|P1|Overall Study|Lost to Follow-up|15
5230946|NCT00885677|18052780|P2|Overall Study|Death|34
5230947|NCT00885677|18052781|P1|Overall Study|Death|40
5230948|NCT00885534|18052797|P1|Overall Study|Patient deemed ineligible|1
5230949|NCT00885482|18052801|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
5230950|NCT00885482|18052801|P1|Overall Study|Death|1
5230951|NCT00885482|18052801|P1|Overall Study|Lack of Efficacy|1
5230952|NCT00885482|18052801|P1|Overall Study|Pregnancy|1
5230953|NCT00885378|18052807|P2|Overall Study|Protocol Violation|0
5230954|NCT00885378|18052808|P1|Overall Study|Protocol Violation|2
5230955|NCT00885378|18052807|P2|Overall Study|Poor/Noncompliance|2
5230956|NCT00885378|18052808|P1|Overall Study|Poor/Noncompliance|2
5230957|NCT00885378|18052807|P2|Overall Study|Lost to Follow-up|2
5230958|NCT00885378|18052808|P1|Overall Study|Lost to Follow-up|1
5230959|NCT00885378|18052807|P2|Overall Study|Withdrawal by Subject|2
5230960|NCT00885378|18052808|P1|Overall Study|Withdrawal by Subject|1
5230961|NCT00885378|18052807|P2|Overall Study|Lack of Efficacy|2
5230962|NCT00885378|18052808|P1|Overall Study|Lack of Efficacy|2
5230963|NCT00885365|18052838|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
5230964|NCT00885365|18052839|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
5230965|NCT00885365|18052838|P2|4 Weeks ON Treatment|Protocol Violation|2
5230966|NCT00885365|18052839|P1|4 Weeks ON Treatment|Protocol Violation|1
5230967|NCT00885365|18052838|P2|4 Weeks ON Treatment|Adverse Event|4
5230968|NCT00885365|18052839|P1|4 Weeks ON Treatment|Adverse Event|2
5230969|NCT00885352|18052875|P2|Overall Study|Lab abnormalities|1
5230970|NCT00885352|18052876|P1|Overall Study|Lab abnormalities|1
5230971|NCT00885352|18052875|P2|Overall Study|Excluded medication|2
5230972|NCT00885352|18052876|P1|Overall Study|Excluded medication|2
5230973|NCT00885352|18052875|P2|Overall Study|Contradiction to study medication|2
5230974|NCT00885352|18052876|P1|Overall Study|Contradiction to study medication|0
5230975|NCT00885352|18052875|P2|Overall Study|Withdrawal by Subject|5
5230976|NCT00885352|18052876|P1|Overall Study|Withdrawal by Subject|1
5230977|NCT00885352|18052875|P2|Overall Study|Protocol Violation|2
5230978|NCT00885352|18052876|P1|Overall Study|Protocol Violation|0
5230979|NCT00885352|18052875|P2|Overall Study|Physician Decision|3
5230980|NCT00885352|18052876|P1|Overall Study|Physician Decision|0
5230981|NCT00885352|18052875|P2|Overall Study|Lost to Follow-up|2
5230982|NCT00885352|18052876|P1|Overall Study|Lost to Follow-up|2
5230983|NCT00885352|18052875|P2|Overall Study|Adverse Event|3
5230984|NCT00885352|18052876|P1|Overall Study|Adverse Event|2
5230985|NCT00885170|18052888|P2|Overall Study|Withdrawal by Subject|13
5230986|NCT00885170|18052889|P1|Overall Study|Withdrawal by Subject|13
5230987|NCT00885170|18052888|P2|Overall Study|Protocol Violation|1
5230988|NCT00885170|18052889|P1|Overall Study|Protocol Violation|3
5230989|NCT00885170|18052888|P2|Overall Study|Physician Decision|1
5230990|NCT00885170|18052889|P1|Overall Study|Physician Decision|2
5230991|NCT00885170|18052888|P2|Overall Study|Lost to Follow-up|1
5230992|NCT00885170|18052889|P1|Overall Study|Lost to Follow-up|2
5230993|NCT00885170|18052888|P2|Overall Study|Excessive bone loss|3
5230994|NCT00885170|18052889|P1|Overall Study|Excessive bone loss|6
5230995|NCT00885170|18052888|P2|Overall Study|Adverse Event|4
5230996|NCT00885170|18052889|P1|Overall Study|Adverse Event|12
5230997|NCT00885118|18052948|P5|Overall Study|Other reason not defined above|0
5230998|NCT00885118|18052949|P4|Overall Study|Other reason not defined above|0
5230999|NCT00885118|18052950|P3|Overall Study|Other reason not defined above|1
5231000|NCT00885118|18052951|P2|Overall Study|Other reason not defined above|0
5231001|NCT00885118|18052952|P1|Overall Study|Other reason not defined above|0
5231002|NCT00885118|18052948|P5|Overall Study|Withdrawal by Subject|1
5231003|NCT00885118|18052949|P4|Overall Study|Withdrawal by Subject|0
5231004|NCT00885118|18052950|P3|Overall Study|Withdrawal by Subject|0
5231005|NCT00885118|18052951|P2|Overall Study|Withdrawal by Subject|0
5231006|NCT00885118|18052952|P1|Overall Study|Withdrawal by Subject|0
5231007|NCT00885118|18052948|P5|Overall Study|Adverse Event|0
5231008|NCT00885118|18052949|P4|Overall Study|Adverse Event|0
5231009|NCT00885118|18052950|P3|Overall Study|Adverse Event|0
5231010|NCT00885118|18052951|P2|Overall Study|Adverse Event|0
5231011|NCT00885118|18052952|P1|Overall Study|Adverse Event|1
5231012|NCT00885105|18053091|P2|Overall Study|Protocol Violation|2
5231013|NCT00885105|18053092|P1|Overall Study|Protocol Violation|0
5231014|NCT00885105|18053091|P2|Overall Study|Adverse Event|0
5231015|NCT00885105|18053092|P1|Overall Study|Adverse Event|1
5231016|NCT00885105|18053091|P2|Overall Study|Withdrawal by Subject|8
5231017|NCT00885105|18053092|P1|Overall Study|Withdrawal by Subject|0
5231018|NCT00884949|18053132|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
5231019|NCT00884949|18053132|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
5231020|NCT00884832|18053167|P2|Overall Study|Withdrawal by Subject|1
5231021|NCT00884832|18053168|P1|Overall Study|Withdrawal by Subject|0
5231022|NCT00884793|18053203|P1|Overall Study|Withdrawal by Subject|1
5231023|NCT00884741|18053222|P4|Randomization|Protocol Violation|8
5231024|NCT00884741|18053223|P3|Randomization|Protocol Violation|8
5231025|NCT00884741|18053224|P2|Randomization|Protocol Violation|0
5231026|NCT00884741|18053225|P1|Randomization|Protocol Violation|0
5231027|NCT00884741|18053222|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
5231028|NCT00884741|18053223|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
5231029|NCT00884741|18053224|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
5231030|NCT00884741|18053225|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
5231031|NCT00884741|18053222|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
5231032|NCT00884741|18053223|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
5231033|NCT00884741|18053224|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
5231034|NCT00884741|18053225|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
5231035|NCT00884741|18053222|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
5231036|NCT00884741|18053223|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
5231037|NCT00884741|18053224|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
5231038|NCT00884741|18053225|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
5231039|NCT00884741|18053222|P4|Step 2 Registration: Tissue Analysis|Death|0
5231040|NCT00884741|18053223|P3|Step 2 Registration: Tissue Analysis|Death|0
5231041|NCT00884741|18053224|P2|Step 2 Registration: Tissue Analysis|Death|1
5231042|NCT00884741|18053225|P1|Step 2 Registration: Tissue Analysis|Death|0
5231043|NCT00884741|18053222|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
5231044|NCT00884741|18053223|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
5231045|NCT00884741|18053224|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
5231046|NCT00884741|18053225|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
5231047|NCT00884741|18053222|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
5231048|NCT00884741|18053223|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
5231049|NCT00884741|18053224|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
5231050|NCT00884741|18053225|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
5231051|NCT00884741|18053222|P4|Step 1 Registration: Tissue Screening|Disease progression|0
5231052|NCT00884741|18053223|P3|Step 1 Registration: Tissue Screening|Disease progression|0
5231053|NCT00884741|18053224|P2|Step 1 Registration: Tissue Screening|Disease progression|0
5231054|NCT00884741|18053225|P1|Step 1 Registration: Tissue Screening|Disease progression|12
5231055|NCT00884741|18053222|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
5231056|NCT00884741|18053223|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
5231057|NCT00884741|18053224|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
5231058|NCT00884741|18053225|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
5231059|NCT00884741|18053222|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
5231060|NCT00884741|18053223|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
5231061|NCT00884741|18053224|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
5231062|NCT00884741|18053225|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
5231063|NCT00884741|18053222|P4|Step 1 Registration: Tissue Screening|Death|0
5231064|NCT00884741|18053223|P3|Step 1 Registration: Tissue Screening|Death|0
5231065|NCT00884741|18053224|P2|Step 1 Registration: Tissue Screening|Death|0
5231066|NCT00884741|18053225|P1|Step 1 Registration: Tissue Screening|Death|3
5231067|NCT00884741|18053222|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
5231068|NCT00884741|18053223|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
5231069|NCT00884741|18053224|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
5231070|NCT00884741|18053225|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
5231071|NCT00884390|18053275|P2|Overall Study|Other|1
5231072|NCT00884390|18053276|P1|Overall Study|Other|11
5231073|NCT00884390|18053275|P2|Overall Study|Discontinuation of Study by Sponsor|2
5231074|NCT00884390|18053276|P1|Overall Study|Discontinuation of Study by Sponsor|2
5231075|NCT00884390|18053275|P2|Overall Study|Withdrawal by Subject|1
5231076|NCT00884390|18053276|P1|Overall Study|Withdrawal by Subject|4
5231077|NCT00884390|18053275|P2|Overall Study|Protocol Violation|1
5231078|NCT00884390|18053276|P1|Overall Study|Protocol Violation|4
5231079|NCT00884390|18053275|P2|Overall Study|Physician Decision|1
5231080|NCT00884390|18053276|P1|Overall Study|Physician Decision|2
5231081|NCT00884390|18053275|P2|Overall Study|Lost to Follow-up|1
5231082|NCT00884390|18053276|P1|Overall Study|Lost to Follow-up|0
5231083|NCT00884390|18053275|P2|Overall Study|Adverse Event|1
5231084|NCT00884390|18053276|P1|Overall Study|Adverse Event|0
5231085|NCT00884377|18053294|P2|Overall Study|Physician Decision|1
5231086|NCT00884377|18053295|P1|Overall Study|Physician Decision|0
5231087|NCT00884377|18053294|P2|Overall Study|Could not confirm diagnosis|0
5231088|NCT00884377|18053295|P1|Overall Study|Could not confirm diagnosis|1
5231089|NCT00884377|18053294|P2|Overall Study|Withdrawal by Subject|0
5231090|NCT00884377|18053295|P1|Overall Study|Withdrawal by Subject|1
5231091|NCT00884325|18053317|P2|Overall Study|Not provided|0
5231092|NCT00884325|18053318|P1|Overall Study|Not provided|1
5231093|NCT00884325|18053317|P2|Overall Study|Withdrawal by Subject|1
5231094|NCT00884325|18053318|P1|Overall Study|Withdrawal by Subject|1
5231095|NCT00884325|18053317|P2|Overall Study|Lack of Efficacy|1
5231096|NCT00884325|18053318|P1|Overall Study|Lack of Efficacy|0
5231097|NCT00884325|18053317|P2|Overall Study|Lost to Follow-up|2
5231098|NCT00884325|18053318|P1|Overall Study|Lost to Follow-up|1
5231099|NCT00884312|18053328|P2|Overall Study|Did Not Receive Study Drug|1
5231100|NCT00884312|18053329|P1|Overall Study|Did Not Receive Study Drug|0
5231101|NCT00884312|18053328|P2|Overall Study|Other|4
5231102|NCT00884312|18053329|P1|Overall Study|Other|0
5231103|NCT00884312|18053328|P2|Overall Study|Physician Decision|1
5231104|NCT00884312|18053329|P1|Overall Study|Physician Decision|0
5231105|NCT00884312|18053328|P2|Overall Study|Withdrawal by Subject|6
5231106|NCT00884312|18053329|P1|Overall Study|Withdrawal by Subject|0
5231107|NCT00884312|18053328|P2|Overall Study|Fatal Adverse Event|4
5231108|NCT00884312|18053329|P1|Overall Study|Fatal Adverse Event|1
5231109|NCT00884312|18053328|P2|Overall Study|Non-fatal Adverse Event|0
5231110|NCT00884312|18053329|P1|Overall Study|Non-fatal Adverse Event|1
5231111|NCT00884312|18053328|P2|Overall Study|Fatal Progressive Disease|1
5231112|NCT00884312|18053329|P1|Overall Study|Fatal Progressive Disease|0
5231113|NCT00884312|18053328|P2|Overall Study|Non-fatal Progressive Disease|8
5231114|NCT00884312|18053329|P1|Overall Study|Non-fatal Progressive Disease|0
5231115|NCT00884286|18053345|P2|Overall Study|Comprised lung carcinoma|1
5231116|NCT00884286|18053346|P1|Overall Study|Comprised lung carcinoma|0
5231117|NCT00884286|18053345|P2|Overall Study|Not treated|1
5231118|NCT00884286|18053346|P1|Overall Study|Not treated|2
5231119|NCT00884286|18053345|P2|Overall Study|Thrombus in right auricle|0
5231120|NCT00884286|18053346|P1|Overall Study|Thrombus in right auricle|1
5231121|NCT00884286|18053345|P2|Overall Study|Septic shock|0
5231122|NCT00884286|18053346|P1|Overall Study|Septic shock|1
5231123|NCT00884286|18053345|P2|Overall Study|Physician Decision|0
5231124|NCT00884286|18053346|P1|Overall Study|Physician Decision|1
5231125|NCT00884286|18053345|P2|Overall Study|Death|2
5231126|NCT00884286|18053346|P1|Overall Study|Death|2
5231127|NCT00884286|18053345|P2|Overall Study|Toxicity|1
5231128|NCT00884286|18053346|P1|Overall Study|Toxicity|4
5231129|NCT00884286|18053345|P2|Overall Study|Progressive disease|28
5231130|NCT00884286|18053346|P1|Overall Study|Progressive disease|21
5231131|NCT00884273|18053360|P2|Overall Study|Practical reasons|0
5231132|NCT00884273|18053361|P1|Overall Study|Practical reasons|1
5231133|NCT00884273|18053360|P2|Overall Study|Protocol Violation|3
5231134|NCT00884273|18053361|P1|Overall Study|Protocol Violation|1
5231135|NCT00884273|18053360|P2|Overall Study|Adverse Event|2
5231136|NCT00884273|18053361|P1|Overall Study|Adverse Event|0
5231137|NCT00884221|18053387|P2|Overall Study|Cancellation of Cycle and Other Reason|13
5231138|NCT00884221|18053388|P1|Overall Study|Cancellation of Cycle and Other Reason|12
5231139|NCT00884221|18053387|P2|Overall Study|Protocol Violation|13
5231140|NCT00884221|18053388|P1|Overall Study|Protocol Violation|16
5231141|NCT00884221|18053387|P2|Overall Study|Adverse Event|3
5231142|NCT00884221|18053388|P1|Overall Study|Adverse Event|6
5231143|NCT00884221|18053387|P2|Overall Study|Withdrawal by Subject|3
5231144|NCT00884221|18053388|P1|Overall Study|Withdrawal by Subject|0
5231145|NCT00884117|18053424|P1|Overall Study|Other|12
5231146|NCT00884117|18053424|P1|Overall Study|Lost to Follow-up|143
5231147|NCT00884117|18053424|P1|Overall Study|Death|3
5231148|NCT00884117|18053424|P1|Overall Study|Withdrawal by Subject|89
5231149|NCT00884117|18053424|P1|Overall Study|Adverse Event|2
5231150|NCT00884039|18053495|P2|Overall Study|Lack of Efficacy|0
5231151|NCT00884039|18053496|P1|Overall Study|Lack of Efficacy|2
5231152|NCT00884039|18053495|P2|Overall Study|Withdrawal by Subject|1
5231153|NCT00884039|18053496|P1|Overall Study|Withdrawal by Subject|0
5231154|NCT00883779|18053504|P2|Off-study Phase|Other|21
5231155|NCT00883779|18053505|P1|Off-study Phase|Other|18
5231156|NCT00883779|18053504|P2|Off-study Phase|Failure to return|6
5231157|NCT00883779|18053505|P1|Off-study Phase|Failure to return|5
5231158|NCT00883779|18053504|P2|Off-study Phase|Refused treatment|1
5231159|NCT00883779|18053505|P1|Off-study Phase|Refused treatment|1
5231160|NCT00883779|18053504|P2|Off-study Phase|Death|174
5231161|NCT00883779|18053505|P1|Off-study Phase|Death|185
5231162|NCT00883779|18053504|P2|Post-Study Treatment Phase|Ongoing in the study|6
5231163|NCT00883779|18053505|P1|Post-Study Treatment Phase|Ongoing in the study|0
5231164|NCT00883779|18053504|P2|Post-Study Treatment Phase|Other|0
5231165|NCT00883779|18053505|P1|Post-Study Treatment Phase|Other|3
5231166|NCT00883779|18053504|P2|Post-Study Treatment Phase|Disease progression|122
5231167|NCT00883779|18053505|P1|Post-Study Treatment Phase|Disease progression|103
5231168|NCT00883779|18053504|P2|Post-Study Treatment Phase|Refused Treatment|0
5231169|NCT00883779|18053505|P1|Post-Study Treatment Phase|Refused Treatment|3
5231170|NCT00883779|18053504|P2|Post-Study Treatment Phase|Protocol Violation|1
5231171|NCT00883779|18053505|P1|Post-Study Treatment Phase|Protocol Violation|0
5231172|NCT00883779|18053504|P2|Post-Study Treatment Phase|Death|3
5231173|NCT00883779|18053505|P1|Post-Study Treatment Phase|Death|1
5231174|NCT00883779|18053504|P2|Post-Study Treatment Phase|Adverse Event|3
5231175|NCT00883779|18053505|P1|Post-Study Treatment Phase|Adverse Event|2
5231176|NCT00883779|18053504|P2|Primary Study Treatment Phase|Other|0
5231177|NCT00883779|18053505|P1|Primary Study Treatment Phase|Other|3
5231178|NCT00883779|18053504|P2|Primary Study Treatment Phase|Refused Treatment|4
5231179|NCT00883779|18053505|P1|Primary Study Treatment Phase|Refused Treatment|5
5231180|NCT00883779|18053504|P2|Primary Study Treatment Phase|Death|3
5231181|NCT00883779|18053505|P1|Primary Study Treatment Phase|Death|2
5231182|NCT00883779|18053504|P2|Primary Study Treatment Phase|Adverse Event|16
5231183|NCT00883779|18053505|P1|Primary Study Treatment Phase|Adverse Event|16
5231184|NCT00883779|18053504|P2|Primary Study Treatment Phase|Disease progression|59
5231185|NCT00883779|18053505|P1|Primary Study Treatment Phase|Disease progression|75
5231186|NCT00883779|18053504|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
5231187|NCT00883779|18053505|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
5231188|NCT00883753|18053541|P1|Overall Study|Administrative/Other|8
5231189|NCT00883753|18053541|P1|Overall Study|Investigator's decision|17
5231190|NCT00883753|18053541|P1|Overall Study|Withdrew consent|10
5231191|NCT00883753|18053541|P1|Overall Study|Refused treatment|4
5231192|NCT00883753|18053541|P1|Overall Study|Protocol Violation|2
5231193|NCT00883753|18053541|P1|Overall Study|Violation of selection criteria at entry|7
5231194|NCT00883753|18053541|P1|Overall Study|Lost to Follow-up|4
5231195|NCT00883753|18053541|P1|Overall Study|Insufficient therapeutic response|16
5231196|NCT00883753|18053541|P1|Overall Study|Death|2
5231197|NCT00883753|18053541|P1|Overall Study|Adverse Event|37
5231198|NCT00883740|18053581|P2|Second Intervention|No longer willing to participate|1
5231199|NCT00883740|18053582|P1|Second Intervention|No longer willing to participate|0
5231200|NCT00883740|18053581|P2|Second Intervention|Protocol Violation|0
5231201|NCT00883740|18053582|P1|Second Intervention|Protocol Violation|1
5231202|NCT00883740|18053581|P2|First Intervention|Adverse Event|2
5231203|NCT00883740|18053582|P1|First Intervention|Adverse Event|1
5231204|NCT00883740|18053581|P2|First Intervention|Protocol Violation|6
5231205|NCT00883740|18053582|P1|First Intervention|Protocol Violation|3
5231206|NCT00883740|18053581|P2|First Intervention|No longer willing to participate|0
5231207|NCT00883740|18053582|P1|First Intervention|No longer willing to participate|2
5231208|NCT00883740|18053581|P2|First Intervention|Lost to Follow-up|0
5231209|NCT00883740|18053582|P1|First Intervention|Lost to Follow-up|1
5231210|NCT00883688|18053622|P1|Overall Study|Ineligible|2
5231211|NCT00883558|18053630|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
5231212|NCT00883558|18053631|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
5231213|NCT00883558|18053632|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
5231214|NCT00883558|18053630|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
5231215|NCT00883558|18053631|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
5231216|NCT00883558|18053632|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
5231217|NCT00883558|18053630|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
5231218|NCT00883558|18053631|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
5231219|NCT00883558|18053632|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
5231220|NCT00883558|18053630|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
5231221|NCT00883558|18053631|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
5231222|NCT00883558|18053632|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
5231223|NCT00883558|18053630|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
5231224|NCT00883558|18053631|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
5231225|NCT00883558|18053632|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
5231226|NCT00883493|18053644|P2|Overall Study|Other|3
5231227|NCT00883493|18053645|P1|Overall Study|Other|5
5231228|NCT00883493|18053644|P2|Overall Study|Study specific disc. criteria|0
5231229|NCT00883493|18053645|P1|Overall Study|Study specific disc. criteria|2
5231230|NCT00883493|18053644|P2|Overall Study|Eligibility Criteria not fullfilled|6
5231231|NCT00883493|18053645|P1|Overall Study|Eligibility Criteria not fullfilled|6
5231232|NCT00883493|18053644|P2|Overall Study|Withdrawal by Subject|20
5231233|NCT00883493|18053645|P1|Overall Study|Withdrawal by Subject|11
5231234|NCT00883493|18053644|P2|Overall Study|Lost to Follow-up|6
5231235|NCT00883493|18053645|P1|Overall Study|Lost to Follow-up|7
5231236|NCT00883493|18053644|P2|Overall Study|Lack of Efficacy|3
5231237|NCT00883493|18053645|P1|Overall Study|Lack of Efficacy|4
5231238|NCT00883493|18053644|P2|Overall Study|Adverse Event|12
5231239|NCT00883493|18053645|P1|Overall Study|Adverse Event|11
5231240|NCT00883337|18053680|P3|Extension Treatment Period|Other than above|5
5231241|NCT00883337|18053681|P2|Extension Treatment Period|Other than above|9
5231242|NCT00883337|18053682|P1|Extension Treatment Period|Other than above|10
5231243|NCT00883337|18053680|P3|Extension Treatment Period|Lost to Follow-up|0
5231244|NCT00883337|18053681|P2|Extension Treatment Period|Lost to Follow-up|0
5231245|NCT00883337|18053682|P1|Extension Treatment Period|Lost to Follow-up|1
5231246|NCT00883337|18053680|P3|Extension Treatment Period|Poor compliance to protocol|1
5231247|NCT00883337|18053681|P2|Extension Treatment Period|Poor compliance to protocol|1
5231248|NCT00883337|18053682|P1|Extension Treatment Period|Poor compliance to protocol|1
5231249|NCT00883337|18053680|P3|Extension Treatment Period|Lack of Efficacy|8
5231250|NCT00883337|18053681|P2|Extension Treatment Period|Lack of Efficacy|8
5231251|NCT00883337|18053682|P1|Extension Treatment Period|Lack of Efficacy|8
5231252|NCT00883337|18053680|P3|Extension Treatment Period|Adverse Event|5
5231253|NCT00883337|18053681|P2|Extension Treatment Period|Adverse Event|5
5231254|NCT00883337|18053682|P1|Extension Treatment Period|Adverse Event|8
5231255|NCT00883337|18053680|P3|Core Treatment Period|Other than above|1
5231256|NCT00883337|18053681|P2|Core Treatment Period|Other than above|1
5231257|NCT00883337|18053682|P1|Core Treatment Period|Other than above|0
5231258|NCT00883337|18053680|P3|Core Treatment Period|Poor compliance to protocol|1
5231259|NCT00883337|18053681|P2|Core Treatment Period|Poor compliance to protocol|0
5231260|NCT00883337|18053682|P1|Core Treatment Period|Poor compliance to protocol|0
5231261|NCT00883337|18053680|P3|Core Treatment Period|Wish to be pregnant|1
5231262|NCT00883337|18053681|P2|Core Treatment Period|Wish to be pregnant|2
5231263|NCT00883337|18053682|P1|Core Treatment Period|Wish to be pregnant|1
5231264|NCT00883337|18053680|P3|Core Treatment Period|Withdrawal by Subject|6
5231265|NCT00883337|18053681|P2|Core Treatment Period|Withdrawal by Subject|2
5231266|NCT00883337|18053682|P1|Core Treatment Period|Withdrawal by Subject|2
5231267|NCT00883337|18053680|P3|Core Treatment Period|Lost to Follow-up|0
5231268|NCT00883337|18053681|P2|Core Treatment Period|Lost to Follow-up|1
5231269|NCT00883337|18053682|P1|Core Treatment Period|Lost to Follow-up|1
5231270|NCT00883337|18053680|P3|Core Treatment Period|Lack of Efficacy|2
5231271|NCT00883337|18053681|P2|Core Treatment Period|Lack of Efficacy|4
5231272|NCT00883337|18053682|P1|Core Treatment Period|Lack of Efficacy|7
5231273|NCT00883337|18053680|P3|Core Treatment Period|Adverse Event|22
5231274|NCT00883337|18053681|P2|Core Treatment Period|Adverse Event|12
5231275|NCT00883337|18053682|P1|Core Treatment Period|Adverse Event|9
5231276|NCT00883181|18053749|P1|Overall Study|Noncompliance|3
5231277|NCT00883181|18053749|P1|Overall Study|Protocol Deviation|3
5231278|NCT00883181|18053749|P1|Overall Study|Other|38
5231279|NCT00883181|18053749|P1|Overall Study|Death|31
5231280|NCT00883181|18053749|P1|Overall Study|Withdrawal by Subject|4
5231281|NCT00883181|18053749|P1|Overall Study|Administrative Reason|24
5231282|NCT00883181|18053749|P1|Overall Study|Disease Progression|94
5231283|NCT00883181|18053749|P1|Overall Study|Non-hematological Adverse Event|55
5231284|NCT00883181|18053749|P1|Overall Study|Hematological Adverse Event|26
5231285|NCT00883129|18053985|P2|Overall Study|Defined Treatment Failure|2
5231286|NCT00883129|18053986|P1|Overall Study|Defined Treatment Failure|0
5231287|NCT00883129|18053985|P2|Overall Study|Death|2
5231288|NCT00883129|18053986|P1|Overall Study|Death|1
5231289|NCT00883129|18053985|P2|Overall Study|Lost to Follow-up|2
5231290|NCT00883129|18053986|P1|Overall Study|Lost to Follow-up|1
5231291|NCT00883129|18053985|P2|Overall Study|Non-compliance|6
5231292|NCT00883129|18053986|P1|Overall Study|Non-compliance|3
5231293|NCT00883129|18053985|P2|Overall Study|Withdrawal by Subject|9
5231294|NCT00883129|18053986|P1|Overall Study|Withdrawal by Subject|8
5231295|NCT00883129|18053985|P2|Overall Study|Adverse Event|15
5231296|NCT00883129|18053986|P1|Overall Study|Adverse Event|7
5231297|NCT00883116|18054010|P2|Overall Study|No longer meets study criteria|2
5231298|NCT00883116|18054011|P1|Overall Study|No longer meets study criteria|2
5231299|NCT00883116|18054010|P2|Overall Study|Withdrawal by Subject|8
5231300|NCT00883116|18054011|P1|Overall Study|Withdrawal by Subject|14
5231301|NCT00883116|18054010|P2|Overall Study|Study drug toxicity|16
5231302|NCT00883116|18054011|P1|Overall Study|Study drug toxicity|36
5231303|NCT00883116|18054010|P2|Overall Study|Not identified|6
5231304|NCT00883116|18054011|P1|Overall Study|Not identified|3
5231305|NCT00883116|18054010|P2|Overall Study|Maximum clinical benefit|46
5231306|NCT00883116|18054011|P1|Overall Study|Maximum clinical benefit|13
5231307|NCT00883116|18054010|P2|Overall Study|Lost to Follow-up|1
5231308|NCT00883116|18054011|P1|Overall Study|Lost to Follow-up|0
5231309|NCT00883116|18054010|P2|Overall Study|Disease progression|128
5231310|NCT00883116|18054011|P1|Overall Study|Disease progression|130
5231311|NCT00883116|18054010|P2|Overall Study|Death|2
5231312|NCT00883116|18054011|P1|Overall Study|Death|6
5231313|NCT00883116|18054010|P2|Overall Study|Adverse event unrelated to study drug|10
5231314|NCT00883116|18054011|P1|Overall Study|Adverse event unrelated to study drug|5
5231315|NCT00883090|18054033|P1|Overall Study|Withdrawal by Subject|1
5231316|NCT00883090|18054033|P1|Overall Study|Sponsor's decision|1
5231317|NCT00883051|18054053|P5|Overall Study|Did not use study medication|17
5231318|NCT00883051|18054054|P4|Overall Study|Did not use study medication|29
5231319|NCT00883051|18054055|P3|Overall Study|Did not use study medication|29
5231320|NCT00883051|18054056|P2|Overall Study|Did not use study medication|22
5231321|NCT00883051|18054057|P1|Overall Study|Did not use study medication|24
5231322|NCT00883051|18054053|P5|Overall Study|Lost to Follow-up|1
5231323|NCT00883051|18054054|P4|Overall Study|Lost to Follow-up|0
5231324|NCT00883051|18054055|P3|Overall Study|Lost to Follow-up|0
5231325|NCT00883051|18054056|P2|Overall Study|Lost to Follow-up|0
5231326|NCT00883051|18054057|P1|Overall Study|Lost to Follow-up|0
5231327|NCT00882999|18054161|P7|Overall Study|Physician Decision|1
5231328|NCT00882999|18054162|P6|Overall Study|Physician Decision|1
5231329|NCT00882999|18054163|P5|Overall Study|Physician Decision|0
5231330|NCT00882999|18054164|P4|Overall Study|Physician Decision|0
5231331|NCT00882999|18054165|P3|Overall Study|Physician Decision|0
5231332|NCT00882999|18054166|P2|Overall Study|Physician Decision|0
5231333|NCT00882999|18054167|P1|Overall Study|Physician Decision|1
5231334|NCT00882999|18054161|P7|Overall Study|Lost to Follow-up|2
5231335|NCT00882999|18054162|P6|Overall Study|Lost to Follow-up|1
5231336|NCT00882999|18054163|P5|Overall Study|Lost to Follow-up|1
5231337|NCT00882999|18054164|P4|Overall Study|Lost to Follow-up|2
5231338|NCT00882999|18054165|P3|Overall Study|Lost to Follow-up|1
5231339|NCT00882999|18054166|P2|Overall Study|Lost to Follow-up|1
5231340|NCT00882999|18054167|P1|Overall Study|Lost to Follow-up|0
5231341|NCT00882999|18054161|P7|Overall Study|Withdrawal by Subject|5
5231342|NCT00882999|18054162|P6|Overall Study|Withdrawal by Subject|5
5231343|NCT00882999|18054163|P5|Overall Study|Withdrawal by Subject|6
5231344|NCT00882999|18054164|P4|Overall Study|Withdrawal by Subject|3
5231345|NCT00882999|18054165|P3|Overall Study|Withdrawal by Subject|3
5231346|NCT00882999|18054166|P2|Overall Study|Withdrawal by Subject|6
5231347|NCT00882999|18054167|P1|Overall Study|Withdrawal by Subject|7
5231348|NCT00882999|18054161|P7|Overall Study|Death|0
5231349|NCT00882999|18054162|P6|Overall Study|Death|0
5231350|NCT00882999|18054163|P5|Overall Study|Death|0
5231351|NCT00882999|18054164|P4|Overall Study|Death|0
5231352|NCT00882999|18054165|P3|Overall Study|Death|0
5231353|NCT00882999|18054166|P2|Overall Study|Death|1
5231354|NCT00882999|18054167|P1|Overall Study|Death|0
5231355|NCT00882999|18054161|P7|Overall Study|Adverse Event|0
5231356|NCT00882999|18054162|P6|Overall Study|Adverse Event|0
5231357|NCT00882999|18054163|P5|Overall Study|Adverse Event|1
5231358|NCT00882999|18054164|P4|Overall Study|Adverse Event|0
5231359|NCT00882999|18054165|P3|Overall Study|Adverse Event|0
5231360|NCT00882999|18054166|P2|Overall Study|Adverse Event|0
5231361|NCT00882999|18054167|P1|Overall Study|Adverse Event|0
5231362|NCT00882921|18054294|P1|Overall Study|Withdrawal Of Consent|1
5231363|NCT00882921|18054294|P1|Overall Study|Termination By Investigator|3
5231364|NCT00882921|18054294|P1|Overall Study|Lost to Follow-up|2
5231365|NCT00882921|18054294|P1|Overall Study|Other|3
5231366|NCT00882921|18054294|P1|Overall Study|Death|2
5231367|NCT00882908|18054304|P5|Overall Study|Study terminated in error|0
5231368|NCT00882908|18054305|P4|Overall Study|Study terminated in error|1
5231369|NCT00882908|18054306|P3|Overall Study|Study terminated in error|0
5231370|NCT00882908|18054307|P2|Overall Study|Study terminated in error|0
5231371|NCT00882908|18054308|P1|Overall Study|Study terminated in error|0
5231372|NCT00882908|18054304|P5|Overall Study|Subject reached a virologic endpoint|1
5231373|NCT00882908|18054305|P4|Overall Study|Subject reached a virologic endpoint|0
5231374|NCT00882908|18054306|P3|Overall Study|Subject reached a virologic endpoint|0
5231375|NCT00882908|18054307|P2|Overall Study|Subject reached a virologic endpoint|0
5231376|NCT00882908|18054308|P1|Overall Study|Subject reached a virologic endpoint|0
5231377|NCT00882908|18054304|P5|Overall Study|Withdrawal by Subject|2
5231378|NCT00882908|18054305|P4|Overall Study|Withdrawal by Subject|5
5231379|NCT00882908|18054306|P3|Overall Study|Withdrawal by Subject|3
5231380|NCT00882908|18054307|P2|Overall Study|Withdrawal by Subject|0
5231381|NCT00882908|18054308|P1|Overall Study|Withdrawal by Subject|0
5231382|NCT00882908|18054304|P5|Overall Study|Protocol Violation|0
5231383|NCT00882908|18054305|P4|Overall Study|Protocol Violation|0
5231384|NCT00882908|18054306|P3|Overall Study|Protocol Violation|0
5231385|NCT00882908|18054307|P2|Overall Study|Protocol Violation|1
5231386|NCT00882908|18054308|P1|Overall Study|Protocol Violation|0
5231387|NCT00882908|18054304|P5|Overall Study|Lost to Follow-up|2
5231388|NCT00882908|18054305|P4|Overall Study|Lost to Follow-up|1
5231389|NCT00882908|18054306|P3|Overall Study|Lost to Follow-up|3
5231390|NCT00882908|18054307|P2|Overall Study|Lost to Follow-up|5
5231391|NCT00882908|18054308|P1|Overall Study|Lost to Follow-up|3
5231392|NCT00882908|18054304|P5|Overall Study|Adverse Event|1
5231393|NCT00882908|18054305|P4|Overall Study|Adverse Event|0
5231394|NCT00882908|18054306|P3|Overall Study|Adverse Event|1
5231395|NCT00882908|18054307|P2|Overall Study|Adverse Event|0
5231396|NCT00882908|18054308|P1|Overall Study|Adverse Event|0
5231397|NCT00882713|18054414|P1|Overall Study|Other - Reasons|2
5231398|NCT00882713|18054414|P1|Overall Study|Failure to return|2
5231399|NCT00882713|18054414|P1|Overall Study|Insufficient therapeutic response|3
5231400|NCT00882713|18054414|P1|Overall Study|Blood transfusion|2
5231401|NCT00882713|18054414|P1|Overall Study|refused treatment/withdrew consent|4
5231402|NCT00882713|18054414|P1|Overall Study|Administrative reasons|4
5231403|NCT00882713|18054414|P1|Overall Study|Death|3
5231404|NCT00882713|18054414|P1|Overall Study|Adverse Event|2
5231405|NCT00882583|18054507|P2|Overall Study|Adverse Event|1
5231406|NCT00882583|18054508|P1|Overall Study|Adverse Event|0
5231407|NCT00882583|18054507|P2|Overall Study|Physician Decision|0
5231408|NCT00882583|18054508|P1|Overall Study|Physician Decision|1
5231409|NCT00882557|18054516|P2|Overall Study|Randomized Not Treated|1
5231410|NCT00882557|18054517|P1|Overall Study|Randomized Not Treated|0
5231411|NCT00882557|18054516|P2|Overall Study|Trouble with Vein Access|0
5231412|NCT00882557|18054517|P1|Overall Study|Trouble with Vein Access|1
5231413|NCT00882557|18054516|P2|Overall Study|Withdrawal by Subject|0
5231414|NCT00882557|18054517|P1|Overall Study|Withdrawal by Subject|1
5231415|NCT00882518|18054537|P2|Overall Study|Allocating random number by mistake|1
5231416|NCT00882518|18054538|P1|Overall Study|Allocating random number by mistake|0
5231417|NCT00882518|18054537|P2|Overall Study|Central lab closure for National day|0
5231418|NCT00882518|18054538|P1|Overall Study|Central lab closure for National day|1
5231419|NCT00882518|18054537|P2|Overall Study|Incorrect enrolment|2
5231420|NCT00882518|18054538|P1|Overall Study|Incorrect enrolment|4
5231421|NCT00882518|18054537|P2|Overall Study|Severe non-compliance to protocol|1
5231422|NCT00882518|18054538|P1|Overall Study|Severe non-compliance to protocol|3
5231423|NCT00882518|18054537|P2|Overall Study|Lack of Efficacy|9
5231424|NCT00882518|18054538|P1|Overall Study|Lack of Efficacy|12
5231425|NCT00882518|18054537|P2|Overall Study|Withdrawal by Subject|13
5231426|NCT00882518|18054538|P1|Overall Study|Withdrawal by Subject|9
5231427|NCT00882518|18054537|P2|Overall Study|Adverse Event|18
5231428|NCT00882518|18054538|P1|Overall Study|Adverse Event|9
5231429|NCT00882440|18054567|P7|Overall Study|Patient Uncooperative|0
5231430|NCT00882440|18054568|P6|Overall Study|Patient Uncooperative|0
5231431|NCT00882440|18054569|P5|Overall Study|Patient Uncooperative|1
5231432|NCT00882440|18054570|P4|Overall Study|Patient Uncooperative|0
5231433|NCT00882440|18054571|P3|Overall Study|Patient Uncooperative|0
5231434|NCT00882440|18054572|P2|Overall Study|Patient Uncooperative|0
5231435|NCT00882440|18054573|P1|Overall Study|Patient Uncooperative|2
5231436|NCT00882440|18054567|P7|Overall Study|Withdrawal by Subject|1
5231437|NCT00882440|18054568|P6|Overall Study|Withdrawal by Subject|0
5231438|NCT00882440|18054569|P5|Overall Study|Withdrawal by Subject|6
5231439|NCT00882440|18054570|P4|Overall Study|Withdrawal by Subject|0
5231440|NCT00882440|18054571|P3|Overall Study|Withdrawal by Subject|1
5231441|NCT00882440|18054572|P2|Overall Study|Withdrawal by Subject|1
5231442|NCT00882440|18054573|P1|Overall Study|Withdrawal by Subject|2
5231443|NCT00882440|18054567|P7|Overall Study|Protocol Violation|0
5231444|NCT00882440|18054568|P6|Overall Study|Protocol Violation|0
5231445|NCT00882440|18054569|P5|Overall Study|Protocol Violation|1
5231446|NCT00882440|18054570|P4|Overall Study|Protocol Violation|1
5231447|NCT00882440|18054571|P3|Overall Study|Protocol Violation|1
5231448|NCT00882440|18054572|P2|Overall Study|Protocol Violation|0
5231449|NCT00882440|18054573|P1|Overall Study|Protocol Violation|0
5231450|NCT00882440|18054567|P7|Overall Study|Lost to Follow-up|1
5231451|NCT00882440|18054568|P6|Overall Study|Lost to Follow-up|0
5231452|NCT00882440|18054569|P5|Overall Study|Lost to Follow-up|1
5231453|NCT00882440|18054570|P4|Overall Study|Lost to Follow-up|1
5231454|NCT00882440|18054571|P3|Overall Study|Lost to Follow-up|1
5231455|NCT00882440|18054572|P2|Overall Study|Lost to Follow-up|0
5231456|NCT00882440|18054573|P1|Overall Study|Lost to Follow-up|2
5231457|NCT00882440|18054567|P7|Overall Study|Lack of Efficacy|0
5231458|NCT00882440|18054568|P6|Overall Study|Lack of Efficacy|3
5231459|NCT00882440|18054569|P5|Overall Study|Lack of Efficacy|0
5231460|NCT00882440|18054570|P4|Overall Study|Lack of Efficacy|0
5231461|NCT00882440|18054571|P3|Overall Study|Lack of Efficacy|2
5231462|NCT00882440|18054572|P2|Overall Study|Lack of Efficacy|5
5231463|NCT00882440|18054573|P1|Overall Study|Lack of Efficacy|3
5231464|NCT00882440|18054567|P7|Overall Study|Adverse Event|2
5231465|NCT00882440|18054568|P6|Overall Study|Adverse Event|4
5231466|NCT00882440|18054569|P5|Overall Study|Adverse Event|1
5231467|NCT00882440|18054570|P4|Overall Study|Adverse Event|1
5231468|NCT00882440|18054571|P3|Overall Study|Adverse Event|2
5231469|NCT00882440|18054572|P2|Overall Study|Adverse Event|2
5231470|NCT00882440|18054573|P1|Overall Study|Adverse Event|2
5231471|NCT00882362|18054598|P2|Overall Study|change of residence or other commitments|0
5231472|NCT00882362|18054599|P1|Overall Study|change of residence or other commitments|5
5231473|NCT00882362|18054598|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
5231474|NCT00882362|18054599|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
5231475|NCT00882362|18054598|P2|Overall Study|Physician Decision|1
5231476|NCT00882362|18054599|P1|Overall Study|Physician Decision|5
5231477|NCT00882362|18054598|P2|Overall Study|Pregnancy|0
5231478|NCT00882362|18054599|P1|Overall Study|Pregnancy|1
5231479|NCT00882362|18054598|P2|Overall Study|Protocol Violation|2
5231480|NCT00882362|18054599|P1|Overall Study|Protocol Violation|7
5231481|NCT00882362|18054598|P2|Overall Study|Lack of Efficacy|0
5231482|NCT00882362|18054599|P1|Overall Study|Lack of Efficacy|3
5231483|NCT00882362|18054598|P2|Overall Study|Withdrawal by Subject|10
5231484|NCT00882362|18054599|P1|Overall Study|Withdrawal by Subject|13
5231485|NCT00882362|18054598|P2|Overall Study|Adverse Event|10
5231486|NCT00882362|18054599|P1|Overall Study|Adverse Event|13
5231487|NCT00882310|18054605|P1|Overall Study|Adverse Event|1
5231488|NCT00882310|18054605|P1|Overall Study|Progression of disease|4
5231489|NCT00882310|18054605|P1|Overall Study|Death|6
5231490|NCT00882310|18054605|P1|Overall Study|Never received treatment|1
5231491|NCT00882310|18054605|P1|Overall Study|Screen Failure|10
5231492|NCT00882115|18054618|P1|Overall Study|did not respond to DEP challe|6
5231493|NCT00882115|18054618|P1|Overall Study|Withdrawal by Subject|3
5231494|NCT00881959|18054628|P2|Overall Study|Lost to Follow-up|4
5231495|NCT00881959|18054629|P1|Overall Study|Lost to Follow-up|2
5231496|NCT00881894|18054637|P2|Overall Study|Other reasons for premature termination|2
5231497|NCT00881894|18054638|P1|Overall Study|Other reasons for premature termination|1
5231498|NCT00881894|18054637|P2|Overall Study|Consent withdrawn|1
5231499|NCT00881894|18054638|P1|Overall Study|Consent withdrawn|0
5231500|NCT00881868|18054670|P2|Overall Study|Protocol Violation|0
5231501|NCT00881868|18054671|P1|Overall Study|Protocol Violation|2
5231502|NCT00881868|18054670|P2|Overall Study|Physician Decision|0
5231503|NCT00881868|18054671|P1|Overall Study|Physician Decision|4
5231504|NCT00881868|18054670|P2|Overall Study|Lost to Follow-up|1
5231505|NCT00881868|18054671|P1|Overall Study|Lost to Follow-up|2
5231506|NCT00881868|18054670|P2|Overall Study|Adverse Event|1
5231507|NCT00881868|18054671|P1|Overall Study|Adverse Event|0
5231508|NCT00881751|18054685|P2|Overall Study|Withdrawal by Subject|2
5231509|NCT00881751|18054686|P1|Overall Study|Withdrawal by Subject|0
5231510|NCT00881751|18054685|P2|Overall Study|Adverse Event|2
5231511|NCT00881751|18054686|P1|Overall Study|Adverse Event|0
5231512|NCT00881751|18054685|P2|Overall Study|Physician Decision|1
5231513|NCT00881751|18054686|P1|Overall Study|Physician Decision|0
5231514|NCT00881712|18054701|P3|Overall Study|Withdrawal by Subject|0
5231515|NCT00881712|18054702|P2|Overall Study|Withdrawal by Subject|0
5231516|NCT00881712|18054703|P1|Overall Study|Withdrawal by Subject|1
5231517|NCT00881712|18054701|P3|Overall Study|Death|0
5231518|NCT00881712|18054702|P2|Overall Study|Death|0
5231519|NCT00881712|18054703|P1|Overall Study|Death|1
5231520|NCT00881621|18054736|P1|Overall Study|Physician Decision|34
5231521|NCT00881608|18054748|P1|Overall Study|Study prematurely terminated|11
5231522|NCT00881569|18054767|P2|Overall Study|Disease progression|1
5231523|NCT00881569|18054768|P1|Overall Study|Disease progression|1
5231524|NCT00881530|18054784|P6|Overall Study|Other reason not defined above|2
5231525|NCT00881530|18054785|P5|Overall Study|Other reason not defined above|0
5231526|NCT00881530|18054786|P4|Overall Study|Other reason not defined above|0
5231527|NCT00881530|18054787|P3|Overall Study|Other reason not defined above|2
5231528|NCT00881530|18054788|P2|Overall Study|Other reason not defined above|1
5231529|NCT00881530|18054789|P1|Overall Study|Other reason not defined above|1
5231530|NCT00881530|18054784|P6|Overall Study|Refused to continue medication|0
5231531|NCT00881530|18054785|P5|Overall Study|Refused to continue medication|0
5231532|NCT00881530|18054786|P4|Overall Study|Refused to continue medication|2
5231533|NCT00881530|18054787|P3|Overall Study|Refused to continue medication|1
5231534|NCT00881530|18054788|P2|Overall Study|Refused to continue medication|2
5231535|NCT00881530|18054789|P1|Overall Study|Refused to continue medication|7
5231536|NCT00881530|18054784|P6|Overall Study|Lost to Follow-up|0
5231537|NCT00881530|18054785|P5|Overall Study|Lost to Follow-up|1
5231538|NCT00881530|18054786|P4|Overall Study|Lost to Follow-up|3
5231539|NCT00881530|18054787|P3|Overall Study|Lost to Follow-up|1
5231540|NCT00881530|18054788|P2|Overall Study|Lost to Follow-up|1
5231541|NCT00881530|18054789|P1|Overall Study|Lost to Follow-up|0
5231542|NCT00881530|18054784|P6|Overall Study|Not compliant with the protocol|0
5231543|NCT00881530|18054785|P5|Overall Study|Not compliant with the protocol|2
5231544|NCT00881530|18054786|P4|Overall Study|Not compliant with the protocol|0
5231545|NCT00881530|18054787|P3|Overall Study|Not compliant with the protocol|0
5231546|NCT00881530|18054788|P2|Overall Study|Not compliant with the protocol|0
5231547|NCT00881530|18054789|P1|Overall Study|Not compliant with the protocol|0
5231548|NCT00881530|18054784|P6|Overall Study|Lack of Efficacy|1
5231549|NCT00881530|18054785|P5|Overall Study|Lack of Efficacy|1
5231550|NCT00881530|18054786|P4|Overall Study|Lack of Efficacy|0
5231551|NCT00881530|18054787|P3|Overall Study|Lack of Efficacy|0
5231552|NCT00881530|18054788|P2|Overall Study|Lack of Efficacy|0
5231553|NCT00881530|18054789|P1|Overall Study|Lack of Efficacy|1
5231554|NCT00881530|18054784|P6|Overall Study|Adverse Event|2
5231555|NCT00881530|18054785|P5|Overall Study|Adverse Event|10
5231556|NCT00881530|18054786|P4|Overall Study|Adverse Event|4
5231557|NCT00881530|18054787|P3|Overall Study|Adverse Event|1
5231558|NCT00881530|18054788|P2|Overall Study|Adverse Event|1
5231559|NCT00881530|18054789|P1|Overall Study|Adverse Event|5
5231560|NCT00881504|18054845|P1|Overall Study|Withdrawal by Subject|1
5231561|NCT00881361|18054865|P3|Overall Study|Ineligible|2
5231562|NCT00881361|18054866|P2|Overall Study|Ineligible|2
5231563|NCT00881361|18054867|P1|Overall Study|Ineligible|17
5231564|NCT00881361|18054865|P3|Overall Study|Terminated prior to surgery|0
5231565|NCT00881361|18054866|P2|Overall Study|Terminated prior to surgery|7
5231566|NCT00881361|18054867|P1|Overall Study|Terminated prior to surgery|27
5231567|NCT00881335|18054882|P2|Overall Study|Lost to Follow-up|2
5231568|NCT00881335|18054883|P1|Overall Study|Lost to Follow-up|3
5231569|NCT00881205|18054903|P2|Overall Study|Condition no longer requires drug|0
5231570|NCT00881205|18054904|P1|Overall Study|Condition no longer requires drug|1
5231571|NCT00881205|18054903|P2|Overall Study|Administrative problems|1
5231572|NCT00881205|18054904|P1|Overall Study|Administrative problems|1
5231573|NCT00881205|18054903|P2|Overall Study|Lost to Follow-up|1
5231574|NCT00881205|18054904|P1|Overall Study|Lost to Follow-up|0
5231575|NCT00881205|18054903|P2|Overall Study|Withdrawal by Subject|2
5231576|NCT00881205|18054904|P1|Overall Study|Withdrawal by Subject|1
5231577|NCT00881205|18054903|P2|Overall Study|Adverse Event|3
5231578|NCT00881205|18054904|P1|Overall Study|Adverse Event|8
5231579|NCT00880906|18054972|P2|Overall Study|Did not meet criteria following patholog|6
5231580|NCT00880906|18054973|P1|Overall Study|Did not meet criteria following patholog|12
5231581|NCT00880906|18054972|P2|Overall Study|Lost to Follow-up|1
5231582|NCT00880906|18054973|P1|Overall Study|Lost to Follow-up|0
5231583|NCT00880893|18054983|P2|Overall Study|Serious adverse event|0
5231584|NCT00880893|18054984|P1|Overall Study|Serious adverse event|3
5231585|NCT00880893|18054983|P2|Overall Study|Lost to Follow-up|33
5231586|NCT00880893|18054984|P1|Overall Study|Lost to Follow-up|76
5231587|NCT00880893|18054983|P2|Overall Study|Withdrawal by Subject|11
5231588|NCT00880893|18054984|P1|Overall Study|Withdrawal by Subject|15
5231589|NCT00880893|18054983|P2|Overall Study|Protocol Violation|1
5231590|NCT00880893|18054984|P1|Overall Study|Protocol Violation|13
5231591|NCT00880763|18055036|P4|Extension Period (Part 2)|Lack of Efficacy|1
5231592|NCT00880763|18055037|P3|Extension Period (Part 2)|Lack of Efficacy|0
5231593|NCT00880763|18055038|P2|Extension Period (Part 2)|Lack of Efficacy|0
5231594|NCT00880763|18055039|P1|Extension Period (Part 2)|Lack of Efficacy|0
5231595|NCT00880763|18055036|P4|Extension Period (Part 2)|Physician Decision|0
5231596|NCT00880763|18055037|P3|Extension Period (Part 2)|Physician Decision|1
5231597|NCT00880763|18055038|P2|Extension Period (Part 2)|Physician Decision|1
5231598|NCT00880763|18055039|P1|Extension Period (Part 2)|Physician Decision|0
5231599|NCT00880763|18055036|P4|Extension Period (Part 2)|Withdrawal by Subject|1
5231600|NCT00880763|18055037|P3|Extension Period (Part 2)|Withdrawal by Subject|1
5231601|NCT00880763|18055038|P2|Extension Period (Part 2)|Withdrawal by Subject|2
5231602|NCT00880763|18055039|P1|Extension Period (Part 2)|Withdrawal by Subject|0
5231603|NCT00880763|18055036|P4|Extension Period (Part 2)|Adverse Event|1
5231604|NCT00880763|18055037|P3|Extension Period (Part 2)|Adverse Event|1
5231605|NCT00880763|18055038|P2|Extension Period (Part 2)|Adverse Event|0
5231606|NCT00880763|18055039|P1|Extension Period (Part 2)|Adverse Event|0
5231607|NCT00880750|18055071|P2|Second Intervention|Unable to collect urine|0
5231608|NCT00880750|18055072|P1|Second Intervention|Unable to collect urine|1
5231609|NCT00880750|18055071|P2|Second Intervention|Protocol Violation|0
5231610|NCT00880750|18055072|P1|Second Intervention|Protocol Violation|1
5231611|NCT00880750|18055071|P2|Second Intervention|Withdrawal by Subject|2
5231612|NCT00880750|18055072|P1|Second Intervention|Withdrawal by Subject|2
5231613|NCT00880750|18055071|P2|First Intervention|Lost to Follow-up|0
5231614|NCT00880750|18055072|P1|First Intervention|Lost to Follow-up|2
5231615|NCT00880750|18055071|P2|First Intervention|Withdrawal by Subject|0
5231616|NCT00880750|18055072|P1|First Intervention|Withdrawal by Subject|2
5231617|NCT00880750|18055071|P2|First Intervention|Non-compliance with meals|1
5231618|NCT00880750|18055072|P1|First Intervention|Non-compliance with meals|0
5231619|NCT00880750|18055071|P2|First Intervention|Unable to collect urine|0
5231620|NCT00880750|18055072|P1|First Intervention|Unable to collect urine|4
5231621|NCT00880750|18055071|P2|First Intervention|Adverse Event|0
5231622|NCT00880750|18055072|P1|First Intervention|Adverse Event|1
5231623|NCT00880698|18055090|P4|Overall Study|Lost to Follow-up|1
5231624|NCT00880698|18055091|P3|Overall Study|Lost to Follow-up|0
5231625|NCT00880698|18055092|P2|Overall Study|Lost to Follow-up|3
5231626|NCT00880698|18055093|P1|Overall Study|Lost to Follow-up|1
5231627|NCT00880698|18055090|P4|Overall Study|Death|2
5231628|NCT00880698|18055091|P3|Overall Study|Death|1
5231629|NCT00880698|18055092|P2|Overall Study|Death|0
5231630|NCT00880698|18055093|P1|Overall Study|Death|0
5231631|NCT00880685|18055119|P1|Memantine 20mg|Withdrawal by Subject|1
5231632|NCT00880685|18055119|P1|Memantine 10mg|Lost to Follow-up|2
5231633|NCT00880620|18055131|P4|Overall Study|Other|2
5231634|NCT00880620|18055132|P3|Overall Study|Other|2
5231635|NCT00880620|18055133|P2|Overall Study|Other|1
5231636|NCT00880620|18055134|P1|Overall Study|Other|1
5231637|NCT00880620|18055131|P4|Overall Study|Noncompliance|1
5231638|NCT00880620|18055132|P3|Overall Study|Noncompliance|1
5231639|NCT00880620|18055133|P2|Overall Study|Noncompliance|0
5231640|NCT00880620|18055134|P1|Overall Study|Noncompliance|0
5231641|NCT00880620|18055131|P4|Overall Study|Withdrawal by Subject|3
5231642|NCT00880620|18055132|P3|Overall Study|Withdrawal by Subject|1
5231643|NCT00880620|18055133|P2|Overall Study|Withdrawal by Subject|3
5231644|NCT00880620|18055134|P1|Overall Study|Withdrawal by Subject|4
5231645|NCT00880620|18055131|P4|Overall Study|Protocol Violation|2
5231646|NCT00880620|18055132|P3|Overall Study|Protocol Violation|0
5231647|NCT00880620|18055133|P2|Overall Study|Protocol Violation|1
5231648|NCT00880620|18055134|P1|Overall Study|Protocol Violation|0
5231649|NCT00880620|18055131|P4|Overall Study|Lost to Follow-up|0
5231650|NCT00880620|18055132|P3|Overall Study|Lost to Follow-up|1
5231651|NCT00880620|18055133|P2|Overall Study|Lost to Follow-up|1
5231652|NCT00880620|18055134|P1|Overall Study|Lost to Follow-up|0
5231653|NCT00880620|18055131|P4|Overall Study|Lack of Efficacy|1
5231654|NCT00880620|18055132|P3|Overall Study|Lack of Efficacy|0
5231655|NCT00880620|18055133|P2|Overall Study|Lack of Efficacy|4
5231656|NCT00880620|18055134|P1|Overall Study|Lack of Efficacy|12
5231657|NCT00880620|18055131|P4|Overall Study|Death|0
5231658|NCT00880620|18055132|P3|Overall Study|Death|1
5231659|NCT00880620|18055133|P2|Overall Study|Death|0
5231660|NCT00880620|18055134|P1|Overall Study|Death|0
5231661|NCT00880620|18055131|P4|Overall Study|Adverse Event|15
5231662|NCT00880620|18055132|P3|Overall Study|Adverse Event|15
5231663|NCT00880620|18055133|P2|Overall Study|Adverse Event|5
5231664|NCT00880620|18055134|P1|Overall Study|Adverse Event|4
5231665|NCT00880607|18055150|P2|Overall Study|surgery did not extend past L1 level|0
5231666|NCT00880607|18055151|P1|Overall Study|surgery did not extend past L1 level|3
5231667|NCT00880607|18055150|P2|Overall Study|Protocol Violation|1
5231668|NCT00880607|18055151|P1|Overall Study|Protocol Violation|2
5231669|NCT00880607|18055150|P2|Overall Study|Physician Decision|2
5231670|NCT00880607|18055151|P1|Overall Study|Physician Decision|2
5231671|NCT00880568|18055183|P9|Overall Study|Withdrawal by Subject|0
5231672|NCT00880568|18055184|P8|Overall Study|Withdrawal by Subject|1
5231673|NCT00880568|18055185|P7|Overall Study|Withdrawal by Subject|0
5231674|NCT00880568|18055186|P6|Overall Study|Withdrawal by Subject|0
5231675|NCT00880568|18055187|P5|Overall Study|Withdrawal by Subject|0
5231676|NCT00880568|18055188|P4|Overall Study|Withdrawal by Subject|0
5231677|NCT00880568|18055189|P3|Overall Study|Withdrawal by Subject|0
5231678|NCT00880568|18055190|P2|Overall Study|Withdrawal by Subject|0
5231679|NCT00880568|18055191|P1|Overall Study|Withdrawal by Subject|0
5231680|NCT00880568|18055183|P9|Overall Study|Adverse Event|0
5231681|NCT00880568|18055184|P8|Overall Study|Adverse Event|1
5231682|NCT00880568|18055185|P7|Overall Study|Adverse Event|1
5231683|NCT00880568|18055186|P6|Overall Study|Adverse Event|0
5231684|NCT00880568|18055187|P5|Overall Study|Adverse Event|0
5231685|NCT00880568|18055188|P4|Overall Study|Adverse Event|0
5231686|NCT00880568|18055189|P3|Overall Study|Adverse Event|0
5231687|NCT00880568|18055190|P2|Overall Study|Adverse Event|0
5231688|NCT00880568|18055191|P1|Overall Study|Adverse Event|0
5231689|NCT00880568|18055183|P9|Overall Study|Disease progression|3
5231690|NCT00880568|18055184|P8|Overall Study|Disease progression|0
5231691|NCT00880568|18055185|P7|Overall Study|Disease progression|5
5231692|NCT00880568|18055186|P6|Overall Study|Disease progression|3
5231693|NCT00880568|18055187|P5|Overall Study|Disease progression|3
5231694|NCT00880568|18055188|P4|Overall Study|Disease progression|1
5231695|NCT00880568|18055189|P3|Overall Study|Disease progression|3
5231696|NCT00880568|18055190|P2|Overall Study|Disease progression|3
5231697|NCT00880568|18055191|P1|Overall Study|Disease progression|3
5231698|NCT00880555|18055237|P6|Overall Study|Lost to Follow-up|0
5231699|NCT00880555|18055238|P5|Overall Study|Lost to Follow-up|0
5231700|NCT00880555|18055239|P4|Overall Study|Lost to Follow-up|0
5231701|NCT00880555|18055240|P3|Overall Study|Lost to Follow-up|0
5231702|NCT00880555|18055241|P2|Overall Study|Lost to Follow-up|1
5231703|NCT00880555|18055242|P1|Overall Study|Lost to Follow-up|0
5231704|NCT00880555|18055237|P6|Overall Study|Death|1
5231705|NCT00880555|18055238|P5|Overall Study|Death|0
5231706|NCT00880555|18055239|P4|Overall Study|Death|0
5231707|NCT00880555|18055240|P3|Overall Study|Death|0
5231708|NCT00880555|18055241|P2|Overall Study|Death|0
5231709|NCT00880555|18055242|P1|Overall Study|Death|0
5231710|NCT00880555|18055237|P6|Overall Study|Lack of resources (hired rater)|0
5231711|NCT00880555|18055238|P5|Overall Study|Lack of resources (hired rater)|0
5231712|NCT00880555|18055239|P4|Overall Study|Lack of resources (hired rater)|0
5231713|NCT00880555|18055240|P3|Overall Study|Lack of resources (hired rater)|5
5231714|NCT00880555|18055241|P2|Overall Study|Lack of resources (hired rater)|7
5231715|NCT00880555|18055242|P1|Overall Study|Lack of resources (hired rater)|9
5231716|NCT00880555|18055237|P6|Overall Study|Withdrawal by Subject|0
5231717|NCT00880555|18055238|P5|Overall Study|Withdrawal by Subject|0
5231718|NCT00880555|18055239|P4|Overall Study|Withdrawal by Subject|0
5231719|NCT00880555|18055240|P3|Overall Study|Withdrawal by Subject|0
5231720|NCT00880555|18055241|P2|Overall Study|Withdrawal by Subject|1
5231721|NCT00880555|18055242|P1|Overall Study|Withdrawal by Subject|1
5231722|NCT00880555|18055237|P6|Overall Study|Physician Decision|0
5231723|NCT00880555|18055238|P5|Overall Study|Physician Decision|1
5231724|NCT00880555|18055239|P4|Overall Study|Physician Decision|2
5231725|NCT00880555|18055240|P3|Overall Study|Physician Decision|0
5231726|NCT00880555|18055241|P2|Overall Study|Physician Decision|8
5231727|NCT00880555|18055242|P1|Overall Study|Physician Decision|0
5231728|NCT00880542|18055253|P1|REP: Surgical Resection|progressive disease|1
5231729|NCT00880542|18055253|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
5231730|NCT00880542|18055253|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
5231731|NCT00880399|18055270|P3|Overall Study|Withdrawal by Subject|3
5231732|NCT00880399|18055271|P2|Overall Study|Withdrawal by Subject|3
5231733|NCT00880399|18055272|P1|Overall Study|Withdrawal by Subject|6
5231734|NCT00880399|18055270|P3|Overall Study|Physician Decision|3
5231735|NCT00880399|18055271|P2|Overall Study|Physician Decision|0
5231736|NCT00880399|18055272|P1|Overall Study|Physician Decision|5
5231737|NCT00880399|18055270|P3|Overall Study|Lost to Follow-up|3
5231738|NCT00880399|18055271|P2|Overall Study|Lost to Follow-up|5
5231739|NCT00880399|18055272|P1|Overall Study|Lost to Follow-up|8
5231740|NCT00880399|18055270|P3|Overall Study|Study closed/terminated|4
5231741|NCT00880399|18055271|P2|Overall Study|Study closed/terminated|7
5231742|NCT00880399|18055272|P1|Overall Study|Study closed/terminated|3
5231743|NCT00880399|18055270|P3|Overall Study|Protocol Violation|6
5231744|NCT00880399|18055271|P2|Overall Study|Protocol Violation|4
5231745|NCT00880399|18055272|P1|Overall Study|Protocol Violation|4
5231746|NCT00880399|18055270|P3|Overall Study|Lack of Efficacy|2
5231747|NCT00880399|18055271|P2|Overall Study|Lack of Efficacy|4
5231748|NCT00880399|18055272|P1|Overall Study|Lack of Efficacy|1
5231749|NCT00880399|18055270|P3|Overall Study|Adverse Event|5
5231750|NCT00880399|18055271|P2|Overall Study|Adverse Event|6
5231751|NCT00880399|18055272|P1|Overall Study|Adverse Event|4
5231752|NCT00880334|18055335|P2|Randomized Phase|Crossover Participants|37
5231753|NCT00880334|18055336|P1|Randomized Phase|Crossover Participants|0
5231754|NCT00880334|18055335|P2|Randomized Phase|Brain Metastasis|1
5231755|NCT00880334|18055336|P1|Randomized Phase|Brain Metastasis|0
5231756|NCT00880334|18055335|P2|Randomized Phase|Inadequate Labs|1
5231757|NCT00880334|18055336|P1|Randomized Phase|Inadequate Labs|1
5231758|NCT00880334|18055335|P2|Randomized Phase|Withdrawal by Subject|1
5231759|NCT00880334|18055336|P1|Randomized Phase|Withdrawal by Subject|2
5231760|NCT00880334|18055335|P2|Randomized Phase|Physician Decision|0
5231761|NCT00880334|18055336|P1|Randomized Phase|Physician Decision|1
5231762|NCT00880269|18055353|P2|Overall Study|Adverse Event|9
5231763|NCT00880269|18055354|P1|Overall Study|Adverse Event|10
5231764|NCT00880269|18055353|P2|Overall Study|Withdrawal by Subject|4
5231765|NCT00880269|18055354|P1|Overall Study|Withdrawal by Subject|3
5231766|NCT00880269|18055353|P2|Overall Study|Lost to Follow-up|1
5231767|NCT00880269|18055354|P1|Overall Study|Lost to Follow-up|0
5231768|NCT00880269|18055353|P2|Overall Study|Death|2
5231769|NCT00880269|18055354|P1|Overall Study|Death|4
5231770|NCT00880269|18055353|P2|Overall Study|New Cancer Therapy|0
5231771|NCT00880269|18055354|P1|Overall Study|New Cancer Therapy|1
5231772|NCT00880269|18055353|P2|Overall Study|Disease Progression|11
5231773|NCT00880269|18055354|P1|Overall Study|Disease Progression|13
5231774|NCT00880269|18055353|P2|Overall Study|Protocol Violation|0
5231775|NCT00880269|18055354|P1|Overall Study|Protocol Violation|1
5231776|NCT00880256|18055370|P1|Overall Study|Lost to Follow-up|28
5231777|NCT00880191|18055397|P2|Overall Study|Hospitalization/efficacy|1
5231778|NCT00880191|18055398|P1|Overall Study|Hospitalization/efficacy|1
5231779|NCT00880191|18055397|P2|Overall Study|Adverse Event|6
5231780|NCT00880191|18055398|P1|Overall Study|Adverse Event|8
5231781|NCT00880191|18055397|P2|Overall Study|Refused further treatment|1
5231782|NCT00880191|18055398|P1|Overall Study|Refused further treatment|4
5231783|NCT00880165|18055418|P2|Overall Study|Lost to follow|15
5231784|NCT00880165|18055419|P1|Overall Study|Lost to follow|9
5231785|NCT00880165|18055418|P2|Overall Study|Required BIPAP or oxygen treatment|4
5231786|NCT00880165|18055419|P1|Overall Study|Required BIPAP or oxygen treatment|12
5231787|NCT00880165|18055418|P2|Overall Study|Not diagnosed with OSA|8
5231788|NCT00880165|18055419|P1|Overall Study|Not diagnosed with OSA|14
5231789|NCT00880165|18055418|P2|Overall Study|Withdrawal by Subject|23
5231790|NCT00880165|18055419|P1|Overall Study|Withdrawal by Subject|27
5231791|NCT00880100|18055429|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
5231792|NCT00880100|18055429|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
5231793|NCT00880100|18055429|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
5231794|NCT00880087|18055442|P2|Overall Study|Lost to Follow-up|2
5231795|NCT00880087|18055443|P1|Overall Study|Lost to Follow-up|0
5231796|NCT00880048|18055458|P3|Overall Study|Study closed/terminated|6
5231797|NCT00880048|18055459|P2|Overall Study|Study closed/terminated|7
5231798|NCT00880048|18055460|P1|Overall Study|Study closed/terminated|9
5231799|NCT00880048|18055458|P3|Overall Study|Withdrawal by Subject|5
5231800|NCT00880048|18055459|P2|Overall Study|Withdrawal by Subject|8
5231801|NCT00880048|18055460|P1|Overall Study|Withdrawal by Subject|5
5231802|NCT00880048|18055458|P3|Overall Study|Physician Decision|7
5231803|NCT00880048|18055459|P2|Overall Study|Physician Decision|1
5231804|NCT00880048|18055460|P1|Overall Study|Physician Decision|1
5231805|NCT00880048|18055458|P3|Overall Study|Lost to Follow-up|5
5231806|NCT00880048|18055459|P2|Overall Study|Lost to Follow-up|6
5231807|NCT00880048|18055460|P1|Overall Study|Lost to Follow-up|6
5231808|NCT00880048|18055458|P3|Overall Study|Protocol Violation|5
5231809|NCT00880048|18055459|P2|Overall Study|Protocol Violation|6
5231810|NCT00880048|18055460|P1|Overall Study|Protocol Violation|4
5231811|NCT00880048|18055458|P3|Overall Study|Lack of Efficacy|2
5231812|NCT00880048|18055459|P2|Overall Study|Lack of Efficacy|2
5231813|NCT00880048|18055460|P1|Overall Study|Lack of Efficacy|1
5231814|NCT00880048|18055458|P3|Overall Study|Adverse Event|5
5231815|NCT00880048|18055459|P2|Overall Study|Adverse Event|3
5231816|NCT00880048|18055460|P1|Overall Study|Adverse Event|2
5231817|NCT00880009|18055527|P1|Overall Study|Protocol Violation|1
5231818|NCT00880009|18055527|P1|Overall Study|Withdrawal by Subject|1
5231819|NCT00880009|18055527|P1|Overall Study|Study terminated by sponsor|14
5231820|NCT00879996|18055551|P2|Overall Study|put on parole|0
5231821|NCT00879996|18055552|P1|Overall Study|put on parole|1
5231822|NCT00879996|18055551|P2|Overall Study|psychiatric problem|1
5231823|NCT00879996|18055552|P1|Overall Study|psychiatric problem|0
5231824|NCT00879996|18055551|P2|Overall Study|Physician Decision|2
5231825|NCT00879996|18055552|P1|Overall Study|Physician Decision|1
5231826|NCT00879996|18055551|P2|Overall Study|non-compliance|4
5231827|NCT00879996|18055552|P1|Overall Study|non-compliance|6
5231828|NCT00879996|18055551|P2|Overall Study|Lost to Follow-up|6
5231829|NCT00879996|18055552|P1|Overall Study|Lost to Follow-up|7
5231830|NCT00879970|18055567|P5|Period 2 Vitamin D Randomization|Death|0
5231831|NCT00879970|18055568|P4|Period 2 Vitamin D Randomization|Death|2
5231832|NCT00879970|18055569|P3|Period 2 Vitamin D Randomization|Death|0
5231833|NCT00879970|18055570|P2|Period 2 Vitamin D Randomization|Death|0
5231834|NCT00879970|18055571|P1|Period 2 Vitamin D Randomization|Death|0
5231835|NCT00879970|18055567|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
5231836|NCT00879970|18055568|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5231837|NCT00879970|18055569|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5231838|NCT00879970|18055570|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5231839|NCT00879970|18055571|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5231840|NCT00879970|18055567|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
5231841|NCT00879970|18055568|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
5231842|NCT00879970|18055569|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
5231843|NCT00879970|18055570|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
5231844|NCT00879970|18055571|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
5231845|NCT00879970|18055567|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
5231846|NCT00879970|18055568|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
5231847|NCT00879970|18055569|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
5231848|NCT00879970|18055570|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
5231849|NCT00879970|18055571|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
5231850|NCT00879970|18055567|P5|Period 1 TZD Randomization|Death|0
5231851|NCT00879970|18055568|P4|Period 1 TZD Randomization|Death|0
5231852|NCT00879970|18055569|P3|Period 1 TZD Randomization|Death|0
5231853|NCT00879970|18055570|P2|Period 1 TZD Randomization|Death|1
5231854|NCT00879970|18055571|P1|Period 1 TZD Randomization|Death|2
5231855|NCT00879970|18055567|P5|Period 1 TZD Randomization|Lost to Follow-up|0
5231856|NCT00879970|18055568|P4|Period 1 TZD Randomization|Lost to Follow-up|0
5231857|NCT00879970|18055569|P3|Period 1 TZD Randomization|Lost to Follow-up|1
5231858|NCT00879970|18055570|P2|Period 1 TZD Randomization|Lost to Follow-up|0
5231859|NCT00879970|18055571|P1|Period 1 TZD Randomization|Lost to Follow-up|1
5231860|NCT00879970|18055567|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
5231861|NCT00879970|18055568|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
5231862|NCT00879970|18055569|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
5231863|NCT00879970|18055570|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
5231864|NCT00879970|18055571|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
5231865|NCT00879879|18055653|P1|Overall Study|Physician Decision|1
5231866|NCT00879879|18055653|P1|Overall Study|Withdrawal by Subject|1
5231867|NCT00879879|18055653|P1|Overall Study|Death|1
5231868|NCT00879814|18055661|P4|Overall Study|Other|0
5231869|NCT00879814|18055662|P3|Overall Study|Other|1
5231870|NCT00879814|18055663|P2|Overall Study|Other|0
5231871|NCT00879814|18055664|P1|Overall Study|Other|0
5231872|NCT00879814|18055661|P4|Overall Study|Physician Decision|0
5231873|NCT00879814|18055662|P3|Overall Study|Physician Decision|1
5231874|NCT00879814|18055663|P2|Overall Study|Physician Decision|0
5231875|NCT00879814|18055664|P1|Overall Study|Physician Decision|0
5231876|NCT00879814|18055661|P4|Overall Study|Withdrawal by Subject|2
5231877|NCT00879814|18055662|P3|Overall Study|Withdrawal by Subject|1
5231878|NCT00879814|18055663|P2|Overall Study|Withdrawal by Subject|1
5231879|NCT00879814|18055664|P1|Overall Study|Withdrawal by Subject|3
5231880|NCT00879814|18055661|P4|Overall Study|Participant Failed to Return|1
5231881|NCT00879814|18055662|P3|Overall Study|Participant Failed to Return|0
5231882|NCT00879814|18055663|P2|Overall Study|Participant Failed to Return|0
5231883|NCT00879814|18055664|P1|Overall Study|Participant Failed to Return|0
5231884|NCT00879814|18055661|P4|Overall Study|Lost to Follow-up|2
5231885|NCT00879814|18055662|P3|Overall Study|Lost to Follow-up|0
5231886|NCT00879814|18055663|P2|Overall Study|Lost to Follow-up|0
5231887|NCT00879814|18055664|P1|Overall Study|Lost to Follow-up|1
5231888|NCT00879814|18055661|P4|Overall Study|Adverse Event|0
5231889|NCT00879814|18055662|P3|Overall Study|Adverse Event|0
5231890|NCT00879814|18055663|P2|Overall Study|Adverse Event|1
5231891|NCT00879814|18055664|P1|Overall Study|Adverse Event|0
5231892|NCT00879775|18055772|P2|Overall Study|Lost to Follow-up|1
5231893|NCT00879775|18055773|P1|Overall Study|Lost to Follow-up|2
5231894|NCT00879710|18055789|P4|Phase 1 - 6 Weeks|Adverse Event|0
5231895|NCT00879710|18055790|P3|Phase 1 - 6 Weeks|Adverse Event|1
5231896|NCT00879710|18055791|P2|Phase 1 - 6 Weeks|Adverse Event|0
5231897|NCT00879710|18055792|P1|Phase 1 - 6 Weeks|Adverse Event|0
5231898|NCT00879710|18055789|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
5231899|NCT00879710|18055790|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
5231900|NCT00879710|18055791|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
5231901|NCT00879710|18055792|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
5231902|NCT00879697|18055802|P2|Overall Study|Physician Decision|2
5231903|NCT00879697|18055803|P1|Overall Study|Physician Decision|2
5231904|NCT00879684|18055809|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
5231905|NCT00879684|18055810|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
5231906|NCT00879684|18055811|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
5231907|NCT00879684|18055812|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
5231908|NCT00879684|18055813|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
5231909|NCT00879684|18055814|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
5231910|NCT00879684|18055815|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
5231911|NCT00879684|18055809|P7|Stage 2: Expanded Cohort|Progressive Disease|11
5231912|NCT00879684|18055810|P6|Stage 2: Expanded Cohort|Progressive Disease|0
5231913|NCT00879684|18055811|P5|Stage 2: Expanded Cohort|Progressive Disease|0
5231914|NCT00879684|18055812|P4|Stage 2: Expanded Cohort|Progressive Disease|0
5231915|NCT00879684|18055813|P3|Stage 2: Expanded Cohort|Progressive Disease|0
5231916|NCT00879684|18055814|P2|Stage 2: Expanded Cohort|Progressive Disease|0
5231917|NCT00879684|18055815|P1|Stage 2: Expanded Cohort|Progressive Disease|0
5231918|NCT00879684|18055809|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
5231919|NCT00879684|18055810|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
5231920|NCT00879684|18055811|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
5231921|NCT00879684|18055812|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
5231922|NCT00879684|18055813|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
5231923|NCT00879684|18055814|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
5231924|NCT00879684|18055815|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
5231925|NCT00879684|18055809|P7|Stage 1: Dose Escalation|Death|0
5231926|NCT00879684|18055810|P6|Stage 1: Dose Escalation|Death|0
5231927|NCT00879684|18055811|P5|Stage 1: Dose Escalation|Death|0
5231928|NCT00879684|18055812|P4|Stage 1: Dose Escalation|Death|0
5231929|NCT00879684|18055813|P3|Stage 1: Dose Escalation|Death|1
5231930|NCT00879684|18055814|P2|Stage 1: Dose Escalation|Death|0
5231931|NCT00879684|18055815|P1|Stage 1: Dose Escalation|Death|0
5231932|NCT00879684|18055809|P7|Stage 1: Dose Escalation|Investigator declined participation|0
5231933|NCT00879684|18055810|P6|Stage 1: Dose Escalation|Investigator declined participation|0
5231934|NCT00879684|18055811|P5|Stage 1: Dose Escalation|Investigator declined participation|0
5231935|NCT00879684|18055812|P4|Stage 1: Dose Escalation|Investigator declined participation|2
5231936|NCT00879684|18055813|P3|Stage 1: Dose Escalation|Investigator declined participation|2
5231937|NCT00879684|18055814|P2|Stage 1: Dose Escalation|Investigator declined participation|0
5231938|NCT00879684|18055815|P1|Stage 1: Dose Escalation|Investigator declined participation|0
5231939|NCT00879684|18055809|P7|Stage 1: Dose Escalation|Progressive Disease|0
5231940|NCT00879684|18055810|P6|Stage 1: Dose Escalation|Progressive Disease|3
5231941|NCT00879684|18055811|P5|Stage 1: Dose Escalation|Progressive Disease|3
5231942|NCT00879684|18055812|P4|Stage 1: Dose Escalation|Progressive Disease|4
5231943|NCT00879684|18055813|P3|Stage 1: Dose Escalation|Progressive Disease|0
5231944|NCT00879684|18055814|P2|Stage 1: Dose Escalation|Progressive Disease|3
5231945|NCT00879684|18055815|P1|Stage 1: Dose Escalation|Progressive Disease|2
5231946|NCT00879684|18055809|P7|Stage 1: Dose Escalation|Adverse Event|0
5231947|NCT00879684|18055810|P6|Stage 1: Dose Escalation|Adverse Event|0
5231948|NCT00879684|18055811|P5|Stage 1: Dose Escalation|Adverse Event|0
5231949|NCT00879684|18055812|P4|Stage 1: Dose Escalation|Adverse Event|0
5231950|NCT00879684|18055813|P3|Stage 1: Dose Escalation|Adverse Event|0
5231951|NCT00879684|18055814|P2|Stage 1: Dose Escalation|Adverse Event|0
5231952|NCT00879684|18055815|P1|Stage 1: Dose Escalation|Adverse Event|1
5231953|NCT00879658|18055884|P7|Overall Study|misrandomized (never received study med)|0
5231954|NCT00879658|18055885|P6|Overall Study|misrandomized (never received study med)|0
5231955|NCT00879658|18055886|P5|Overall Study|misrandomized (never received study med)|0
5231956|NCT00879658|18055887|P4|Overall Study|misrandomized (never received study med)|1
5231957|NCT00879658|18055888|P3|Overall Study|misrandomized (never received study med)|0
5231958|NCT00879658|18055889|P2|Overall Study|misrandomized (never received study med)|0
5231959|NCT00879658|18055890|P1|Overall Study|misrandomized (never received study med)|0
5231960|NCT00879658|18055884|P7|Overall Study|Lack of Efficacy|0
5231961|NCT00879658|18055885|P6|Overall Study|Lack of Efficacy|0
5231962|NCT00879658|18055886|P5|Overall Study|Lack of Efficacy|0
5231963|NCT00879658|18055887|P4|Overall Study|Lack of Efficacy|0
5231964|NCT00879658|18055888|P3|Overall Study|Lack of Efficacy|2
5231965|NCT00879658|18055889|P2|Overall Study|Lack of Efficacy|0
5231966|NCT00879658|18055890|P1|Overall Study|Lack of Efficacy|0
5231967|NCT00879658|18055884|P7|Overall Study|Withdrawal by Subject|0
5231968|NCT00879658|18055885|P6|Overall Study|Withdrawal by Subject|1
5231969|NCT00879658|18055886|P5|Overall Study|Withdrawal by Subject|0
5231970|NCT00879658|18055887|P4|Overall Study|Withdrawal by Subject|0
5231971|NCT00879658|18055888|P3|Overall Study|Withdrawal by Subject|2
5231972|NCT00879658|18055889|P2|Overall Study|Withdrawal by Subject|0
5231973|NCT00879658|18055890|P1|Overall Study|Withdrawal by Subject|3
5231974|NCT00879658|18055884|P7|Overall Study|Protocol Violation|0
5231975|NCT00879658|18055885|P6|Overall Study|Protocol Violation|0
5231976|NCT00879658|18055886|P5|Overall Study|Protocol Violation|0
5231977|NCT00879658|18055887|P4|Overall Study|Protocol Violation|0
5231978|NCT00879658|18055888|P3|Overall Study|Protocol Violation|0
5231979|NCT00879658|18055889|P2|Overall Study|Protocol Violation|0
5231980|NCT00879658|18055890|P1|Overall Study|Protocol Violation|1
5231981|NCT00879658|18055884|P7|Overall Study|Adverse Event|0
5231982|NCT00879658|18055885|P6|Overall Study|Adverse Event|0
5231983|NCT00879658|18055886|P5|Overall Study|Adverse Event|2
5231984|NCT00879658|18055887|P4|Overall Study|Adverse Event|1
5231985|NCT00879658|18055888|P3|Overall Study|Adverse Event|3
5231986|NCT00879658|18055889|P2|Overall Study|Adverse Event|4
5231987|NCT00879658|18055890|P1|Overall Study|Adverse Event|6
5231988|NCT00879658|18055884|P7|Overall Study|Administrative problems|0
5231989|NCT00879658|18055885|P6|Overall Study|Administrative problems|0
5231990|NCT00879658|18055886|P5|Overall Study|Administrative problems|0
5231991|NCT00879658|18055887|P4|Overall Study|Administrative problems|1
5231992|NCT00879658|18055888|P3|Overall Study|Administrative problems|0
5231993|NCT00879658|18055889|P2|Overall Study|Administrative problems|1
5231994|NCT00879658|18055890|P1|Overall Study|Administrative problems|2
5231995|NCT00879658|18055884|P7|Overall Study|Abnormal laboratory value(s)|0
5231996|NCT00879658|18055885|P6|Overall Study|Abnormal laboratory value(s)|0
5231997|NCT00879658|18055886|P5|Overall Study|Abnormal laboratory value(s)|0
5231998|NCT00879658|18055887|P4|Overall Study|Abnormal laboratory value(s)|1
5231999|NCT00879658|18055888|P3|Overall Study|Abnormal laboratory value(s)|0
5232000|NCT00879658|18055889|P2|Overall Study|Abnormal laboratory value(s)|0
5232001|NCT00879658|18055890|P1|Overall Study|Abnormal laboratory value(s)|3
5232002|NCT00879645|18055976|P4|Overall Study|Adverse Event|0
5232003|NCT00879645|18055977|P3|Overall Study|Adverse Event|0
5232004|NCT00879645|18055978|P2|Overall Study|Adverse Event|0
5232005|NCT00879645|18055979|P1|Overall Study|Adverse Event|1
5232006|NCT00879411|18056006|P1|Overall Study|lost to follow-up (non-AE)|162
5232007|NCT00879398|18056012|P1|Overall Study|Other Reasons|171
5232008|NCT00879398|18056012|P1|Overall Study|Adverse Event|41
5232009|NCT00879398|18056012|P1|Overall Study|Lack of Efficacy|64
5232010|NCT00879398|18056012|P1|Overall Study|Visit Stop|399
5232011|NCT00879333|18056030|P2|Overall Study|Protocol Violation|1
5232012|NCT00879333|18056031|P1|Overall Study|Protocol Violation|1
5232013|NCT00879333|18056030|P2|Overall Study|Disease Progression|169
5232014|NCT00879333|18056031|P1|Overall Study|Disease Progression|292
5232015|NCT00879333|18056030|P2|Overall Study|Death|5
5232016|NCT00879333|18056031|P1|Overall Study|Death|16
5232017|NCT00879333|18056030|P2|Overall Study|Administrative Problems|0
5232018|NCT00879333|18056031|P1|Overall Study|Administrative Problems|2
5232019|NCT00879333|18056030|P2|Overall Study|Lost to Follow-up|1
5232020|NCT00879333|18056031|P1|Overall Study|Lost to Follow-up|2
5232021|NCT00879333|18056030|P2|Overall Study|Withdrawal by Subject|7
5232022|NCT00879333|18056031|P1|Overall Study|Withdrawal by Subject|20
5232023|NCT00879333|18056030|P2|Overall Study|Abnormal Laboratory Value|0
5232024|NCT00879333|18056031|P1|Overall Study|Abnormal Laboratory Value|1
5232025|NCT00879333|18056030|P2|Overall Study|Adverse Event|34
5232026|NCT00879333|18056031|P1|Overall Study|Adverse Event|94
5232027|NCT00879229|18056064|P2|Overall Study|Other|0
5232028|NCT00879229|18056065|P1|Overall Study|Other|1
5232029|NCT00879229|18056064|P2|Overall Study|Clinical status did not improve|0
5232030|NCT00879229|18056065|P1|Overall Study|Clinical status did not improve|1
5232031|NCT00879229|18056064|P2|Overall Study|Withdrawal by Subject|0
5232032|NCT00879229|18056065|P1|Overall Study|Withdrawal by Subject|1
5232033|NCT00879229|18056064|P2|Overall Study|Adverse Event|0
5232034|NCT00879229|18056065|P1|Overall Study|Adverse Event|2
5232035|NCT00879229|18056064|P2|Overall Study|Death|2
5232036|NCT00879229|18056065|P1|Overall Study|Death|4
5232037|NCT00879229|18056064|P2|Overall Study|Study terminated by Sponsor|12
5232038|NCT00879229|18056065|P1|Overall Study|Study terminated by Sponsor|13
5232039|NCT00878995|18056113|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
5232040|NCT00878995|18056114|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
5232041|NCT00878969|18056215|P3|Overall Study|Pregnancy|0
5232042|NCT00878969|18056216|P2|Overall Study|Pregnancy|1
5232043|NCT00878969|18056217|P1|Overall Study|Pregnancy|0
5232044|NCT00878969|18056215|P3|Overall Study|Death|2
5232045|NCT00878969|18056216|P2|Overall Study|Death|0
5232046|NCT00878969|18056217|P1|Overall Study|Death|0
5232047|NCT00878969|18056215|P3|Overall Study|Protocol Violation|0
5232048|NCT00878969|18056216|P2|Overall Study|Protocol Violation|0
5232049|NCT00878969|18056217|P1|Overall Study|Protocol Violation|2
5232050|NCT00878969|18056215|P3|Overall Study|Lost to Follow-up|0
5232051|NCT00878969|18056216|P2|Overall Study|Lost to Follow-up|1
5232052|NCT00878969|18056217|P1|Overall Study|Lost to Follow-up|2
5232053|NCT00878969|18056215|P3|Overall Study|Adverse Event|2
5232054|NCT00878969|18056216|P2|Overall Study|Adverse Event|1
5232055|NCT00878969|18056217|P1|Overall Study|Adverse Event|3
5232056|NCT00878969|18056215|P3|Overall Study|kidney transplant|2
5232057|NCT00878969|18056216|P2|Overall Study|kidney transplant|3
5232058|NCT00878969|18056217|P1|Overall Study|kidney transplant|2
5232059|NCT00878969|18056215|P3|Overall Study|Withdrawal by Subject|3
5232060|NCT00878969|18056216|P2|Overall Study|Withdrawal by Subject|6
5232061|NCT00878969|18056217|P1|Overall Study|Withdrawal by Subject|1
5232062|NCT00878969|18056215|P3|Overall Study|Physician Decision|2
5232063|NCT00878969|18056216|P2|Overall Study|Physician Decision|3
5232064|NCT00878969|18056217|P1|Overall Study|Physician Decision|5
5232065|NCT00878800|18056265|P5|Overall Study|Other|1
5232066|NCT00878800|18056266|P4|Overall Study|Other|0
5232067|NCT00878800|18056267|P3|Overall Study|Other|0
5232068|NCT00878800|18056268|P2|Overall Study|Other|1
5232069|NCT00878800|18056269|P1|Overall Study|Other|1
5232070|NCT00878800|18056265|P5|Overall Study|Death|0
5232071|NCT00878800|18056266|P4|Overall Study|Death|0
5232072|NCT00878800|18056267|P3|Overall Study|Death|1
5232073|NCT00878800|18056268|P2|Overall Study|Death|0
5232074|NCT00878800|18056269|P1|Overall Study|Death|0
5232075|NCT00878800|18056265|P5|Overall Study|Withdrew consent|1
5232076|NCT00878800|18056266|P4|Overall Study|Withdrew consent|1
5232077|NCT00878800|18056267|P3|Overall Study|Withdrew consent|0
5232078|NCT00878800|18056268|P2|Overall Study|Withdrew consent|1
5232079|NCT00878800|18056269|P1|Overall Study|Withdrew consent|1
5232080|NCT00878800|18056265|P5|Overall Study|Progressive disease|13
5232081|NCT00878800|18056266|P4|Overall Study|Progressive disease|5
5232082|NCT00878800|18056267|P3|Overall Study|Progressive disease|6
5232083|NCT00878800|18056268|P2|Overall Study|Progressive disease|5
5232084|NCT00878800|18056269|P1|Overall Study|Progressive disease|1
5232085|NCT00878800|18056265|P5|Overall Study|Adverse Event|1
5232086|NCT00878800|18056266|P4|Overall Study|Adverse Event|0
5232087|NCT00878800|18056267|P3|Overall Study|Adverse Event|2
5232088|NCT00878800|18056268|P2|Overall Study|Adverse Event|0
5232089|NCT00878800|18056269|P1|Overall Study|Adverse Event|0
5232090|NCT00878722|18056304|P8|Overall Study|Relapse|0
5232091|NCT00878722|18056305|P7|Overall Study|Relapse|0
5232092|NCT00878722|18056306|P6|Overall Study|Relapse|0
5232093|NCT00878722|18056307|P5|Overall Study|Relapse|0
5232094|NCT00878722|18056308|P4|Overall Study|Relapse|1
5232095|NCT00878722|18056309|P3|Overall Study|Relapse|0
5232096|NCT00878722|18056310|P2|Overall Study|Relapse|0
5232097|NCT00878722|18056311|P1|Overall Study|Relapse|0
5232098|NCT00878722|18056304|P8|Overall Study|Withdrawal by Subject|2
5232099|NCT00878722|18056305|P7|Overall Study|Withdrawal by Subject|0
5232100|NCT00878722|18056306|P6|Overall Study|Withdrawal by Subject|0
5232101|NCT00878722|18056307|P5|Overall Study|Withdrawal by Subject|0
5232102|NCT00878722|18056308|P4|Overall Study|Withdrawal by Subject|0
5232103|NCT00878722|18056309|P3|Overall Study|Withdrawal by Subject|0
5232104|NCT00878722|18056310|P2|Overall Study|Withdrawal by Subject|0
5232105|NCT00878722|18056311|P1|Overall Study|Withdrawal by Subject|0
5232106|NCT00878722|18056304|P8|Overall Study|Adverse Event|0
5232107|NCT00878722|18056305|P7|Overall Study|Adverse Event|2
5232108|NCT00878722|18056306|P6|Overall Study|Adverse Event|0
5232109|NCT00878722|18056307|P5|Overall Study|Adverse Event|0
5232110|NCT00878722|18056308|P4|Overall Study|Adverse Event|0
5232111|NCT00878722|18056309|P3|Overall Study|Adverse Event|0
5232112|NCT00878722|18056310|P2|Overall Study|Adverse Event|0
5232113|NCT00878722|18056311|P1|Overall Study|Adverse Event|0
5232114|NCT00878722|18056304|P8|Overall Study|Death|2
5232115|NCT00878722|18056305|P7|Overall Study|Death|0
5232116|NCT00878722|18056306|P6|Overall Study|Death|1
5232117|NCT00878722|18056307|P5|Overall Study|Death|0
5232118|NCT00878722|18056308|P4|Overall Study|Death|1
5232119|NCT00878722|18056309|P3|Overall Study|Death|0
5232120|NCT00878722|18056310|P2|Overall Study|Death|0
5232121|NCT00878722|18056311|P1|Overall Study|Death|0
5232122|NCT00878722|18056304|P8|Overall Study|Progressive disease|3
5232123|NCT00878722|18056305|P7|Overall Study|Progressive disease|4
5232124|NCT00878722|18056306|P6|Overall Study|Progressive disease|1
5232125|NCT00878722|18056307|P5|Overall Study|Progressive disease|7
5232126|NCT00878722|18056308|P4|Overall Study|Progressive disease|7
5232127|NCT00878722|18056309|P3|Overall Study|Progressive disease|3
5232128|NCT00878722|18056310|P2|Overall Study|Progressive disease|3
5232129|NCT00878722|18056311|P1|Overall Study|Progressive disease|3
5232130|NCT00878709|18056396|P2|Overall Study|Other Reasons|84
5232131|NCT00878709|18056397|P1|Overall Study|Other Reasons|93
5232132|NCT00878709|18056396|P2|Overall Study|Lost to Follow-up|33
5232133|NCT00878709|18056397|P1|Overall Study|Lost to Follow-up|35
5232134|NCT00878709|18056396|P2|Overall Study|Withdrawal by Subject|120
5232135|NCT00878709|18056397|P1|Overall Study|Withdrawal by Subject|197
5232136|NCT00878553|18056471|P5|PK Study|Withdrawal by Subject|0
5232137|NCT00878553|18056472|P4|PK Study|Withdrawal by Subject|1
5232138|NCT00878553|18056473|P3|PK Study|Withdrawal by Subject|0
5232139|NCT00878553|18056474|P2|PK Study|Withdrawal by Subject|0
5232140|NCT00878553|18056475|P1|PK Study|Withdrawal by Subject|0
5232141|NCT00878553|18056471|P5|Sleep Study|family emergency|0
5232142|NCT00878553|18056472|P4|Sleep Study|family emergency|0
5232143|NCT00878553|18056473|P3|Sleep Study|family emergency|0
5232144|NCT00878553|18056474|P2|Sleep Study|family emergency|0
5232145|NCT00878553|18056475|P1|Sleep Study|family emergency|1
5232146|NCT00878553|18056471|P5|Sleep Study|car accident|0
5232147|NCT00878553|18056472|P4|Sleep Study|car accident|0
5232148|NCT00878553|18056473|P3|Sleep Study|car accident|0
5232149|NCT00878553|18056474|P2|Sleep Study|car accident|0
5232150|NCT00878553|18056475|P1|Sleep Study|car accident|1
5232151|NCT00878553|18056471|P5|Sleep Study|Lost to Follow-up|0
5232152|NCT00878553|18056472|P4|Sleep Study|Lost to Follow-up|0
5232153|NCT00878553|18056473|P3|Sleep Study|Lost to Follow-up|0
5232154|NCT00878553|18056474|P2|Sleep Study|Lost to Follow-up|0
5232155|NCT00878553|18056475|P1|Sleep Study|Lost to Follow-up|1
5232156|NCT00878553|18056471|P5|Sleep Study|Withdrawal by Subject|0
5232157|NCT00878553|18056472|P4|Sleep Study|Withdrawal by Subject|0
5232158|NCT00878553|18056473|P3|Sleep Study|Withdrawal by Subject|0
5232159|NCT00878553|18056474|P2|Sleep Study|Withdrawal by Subject|0
5232160|NCT00878553|18056475|P1|Sleep Study|Withdrawal by Subject|2
5232161|NCT00878501|18056534|P3|Overall Study|Administrative|1
5232162|NCT00878501|18056535|P2|Overall Study|Administrative|0
5232163|NCT00878501|18056536|P1|Overall Study|Administrative|0
5232164|NCT00878501|18056534|P3|Overall Study|Mis-randomisation of patient|0
5232165|NCT00878501|18056535|P2|Overall Study|Mis-randomisation of patient|0
5232166|NCT00878501|18056536|P1|Overall Study|Mis-randomisation of patient|1
5232167|NCT00878501|18056534|P3|Overall Study|Intake of prohibited concom. medication|1
5232168|NCT00878501|18056535|P2|Overall Study|Intake of prohibited concom. medication|0
5232169|NCT00878501|18056536|P1|Overall Study|Intake of prohibited concom. medication|0
5232170|NCT00878501|18056534|P3|Overall Study|Incorrect enrolment|0
5232171|NCT00878501|18056535|P2|Overall Study|Incorrect enrolment|2
5232172|NCT00878501|18056536|P1|Overall Study|Incorrect enrolment|1
5232173|NCT00878501|18056534|P3|Overall Study|Protocol Violation|1
5232174|NCT00878501|18056535|P2|Overall Study|Protocol Violation|0
5232175|NCT00878501|18056536|P1|Overall Study|Protocol Violation|0
5232176|NCT00878501|18056534|P3|Overall Study|Withdrawal by Subject|2
5232177|NCT00878501|18056535|P2|Overall Study|Withdrawal by Subject|1
5232178|NCT00878501|18056536|P1|Overall Study|Withdrawal by Subject|2
5232179|NCT00878501|18056534|P3|Overall Study|Lack of Efficacy|0
5232180|NCT00878501|18056535|P2|Overall Study|Lack of Efficacy|1
5232181|NCT00878501|18056536|P1|Overall Study|Lack of Efficacy|2
5232182|NCT00878501|18056534|P3|Overall Study|Adverse Event|3
5232183|NCT00878501|18056535|P2|Overall Study|Adverse Event|3
5232184|NCT00878501|18056536|P1|Overall Study|Adverse Event|11
5232185|NCT00878215|18056585|P4|Overall Study|Determined to be ineligible|0
5232186|NCT00878215|18056586|P3|Overall Study|Determined to be ineligible|0
5232187|NCT00878215|18056587|P2|Overall Study|Determined to be ineligible|10
5232188|NCT00878215|18056588|P1|Overall Study|Determined to be ineligible|0
5232189|NCT00878189|18056600|P9|Overall Study|Objection Progression or Relapse|3
5232190|NCT00878189|18056601|P8|Overall Study|Objection Progression or Relapse|0
5232191|NCT00878189|18056602|P7|Overall Study|Objection Progression or Relapse|0
5232192|NCT00878189|18056603|P6|Overall Study|Objection Progression or Relapse|0
5232193|NCT00878189|18056604|P5|Overall Study|Objection Progression or Relapse|0
5232194|NCT00878189|18056605|P4|Overall Study|Objection Progression or Relapse|0
5232195|NCT00878189|18056606|P3|Overall Study|Objection Progression or Relapse|0
5232196|NCT00878189|18056607|P2|Overall Study|Objection Progression or Relapse|0
5232197|NCT00878189|18056608|P1|Overall Study|Objection Progression or Relapse|0
5232198|NCT00878189|18056600|P9|Overall Study|Lost to Follow-up|0
5232199|NCT00878189|18056601|P8|Overall Study|Lost to Follow-up|0
5232200|NCT00878189|18056602|P7|Overall Study|Lost to Follow-up|1
5232201|NCT00878189|18056603|P6|Overall Study|Lost to Follow-up|1
5232202|NCT00878189|18056604|P5|Overall Study|Lost to Follow-up|0
5232203|NCT00878189|18056605|P4|Overall Study|Lost to Follow-up|0
5232204|NCT00878189|18056606|P3|Overall Study|Lost to Follow-up|0
5232205|NCT00878189|18056607|P2|Overall Study|Lost to Follow-up|0
5232206|NCT00878189|18056608|P1|Overall Study|Lost to Follow-up|0
5232207|NCT00878189|18056600|P9|Overall Study|Other|4
5232208|NCT00878189|18056601|P8|Overall Study|Other|3
5232209|NCT00878189|18056602|P7|Overall Study|Other|15
5232210|NCT00878189|18056603|P6|Overall Study|Other|18
5232211|NCT00878189|18056604|P5|Overall Study|Other|4
5232212|NCT00878189|18056605|P4|Overall Study|Other|7
5232213|NCT00878189|18056606|P3|Overall Study|Other|4
5232214|NCT00878189|18056607|P2|Overall Study|Other|2
5232215|NCT00878189|18056608|P1|Overall Study|Other|3
5232216|NCT00878189|18056600|P9|Overall Study|Participant Refused to Follow-up|0
5232217|NCT00878189|18056601|P8|Overall Study|Participant Refused to Follow-up|0
5232218|NCT00878189|18056602|P7|Overall Study|Participant Refused to Follow-up|0
5232219|NCT00878189|18056603|P6|Overall Study|Participant Refused to Follow-up|4
5232220|NCT00878189|18056604|P5|Overall Study|Participant Refused to Follow-up|0
5232221|NCT00878189|18056605|P4|Overall Study|Participant Refused to Follow-up|0
5232222|NCT00878189|18056606|P3|Overall Study|Participant Refused to Follow-up|0
5232223|NCT00878189|18056607|P2|Overall Study|Participant Refused to Follow-up|0
5232224|NCT00878189|18056608|P1|Overall Study|Participant Refused to Follow-up|0
5232225|NCT00878189|18056600|P9|Overall Study|Death|1
5232226|NCT00878189|18056601|P8|Overall Study|Death|0
5232227|NCT00878189|18056602|P7|Overall Study|Death|0
5232228|NCT00878189|18056603|P6|Overall Study|Death|0
5232229|NCT00878189|18056604|P5|Overall Study|Death|0
5232230|NCT00878189|18056605|P4|Overall Study|Death|1
5232231|NCT00878189|18056606|P3|Overall Study|Death|0
5232232|NCT00878189|18056607|P2|Overall Study|Death|1
5232233|NCT00878189|18056608|P1|Overall Study|Death|0
5232234|NCT00877929|18056876|P2|Overall Study|Other reason (not specified)|6
5232235|NCT00877929|18056877|P1|Overall Study|Other reason (not specified)|2
5232236|NCT00877929|18056876|P2|Overall Study|Lack of Efficacy|1
5232237|NCT00877929|18056877|P1|Overall Study|Lack of Efficacy|0
5232238|NCT00877929|18056876|P2|Overall Study|Withdrawal by Subject|4
5232239|NCT00877929|18056877|P1|Overall Study|Withdrawal by Subject|4
5232240|NCT00877929|18056876|P2|Overall Study|Lost to Follow-up|1
5232241|NCT00877929|18056877|P1|Overall Study|Lost to Follow-up|0
5232242|NCT00877929|18056876|P2|Overall Study|Protocol Violation|3
5232243|NCT00877929|18056877|P1|Overall Study|Protocol Violation|3
5232244|NCT00877929|18056876|P2|Overall Study|Adverse Event|20
5232245|NCT00877929|18056877|P1|Overall Study|Adverse Event|11
5232246|NCT00877890|18056965|P2|Overall Study|Loss of Glucose Control|4
5232247|NCT00877890|18056966|P1|Overall Study|Loss of Glucose Control|3
5232248|NCT00877890|18056965|P2|Overall Study|Investigator Decision|2
5232249|NCT00877890|18056966|P1|Overall Study|Investigator Decision|0
5232250|NCT00877890|18056965|P2|Overall Study|Withdrawal of Consent|12
5232251|NCT00877890|18056966|P1|Overall Study|Withdrawal of Consent|6
5232252|NCT00877890|18056965|P2|Overall Study|Protocol Violation|1
5232253|NCT00877890|18056966|P1|Overall Study|Protocol Violation|0
5232254|NCT00877890|18056965|P2|Overall Study|Lost to Follow-up|5
5232255|NCT00877890|18056966|P1|Overall Study|Lost to Follow-up|5
5232256|NCT00877890|18056965|P2|Overall Study|Adverse Event|6
5232257|NCT00877890|18056966|P1|Overall Study|Adverse Event|6
5232258|NCT00877799|18057031|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
5232259|NCT00877799|18057032|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
5232260|NCT00877799|18057033|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
5232261|NCT00877799|18057034|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
5232262|NCT00877799|18057035|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
5232263|NCT00877799|18057031|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5232264|NCT00877799|18057032|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
5232265|NCT00877799|18057033|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5232266|NCT00877799|18057034|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5232267|NCT00877799|18057035|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5232268|NCT00877799|18057031|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5232269|NCT00877799|18057032|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5232270|NCT00877799|18057033|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5232271|NCT00877799|18057034|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
5232272|NCT00877799|18057035|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5232273|NCT00877799|18057031|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
5232274|NCT00877799|18057032|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
5232275|NCT00877799|18057033|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
5232276|NCT00877799|18057034|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
5232277|NCT00877799|18057035|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
5232278|NCT00877799|18057031|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
5232279|NCT00877799|18057032|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
5232280|NCT00877799|18057033|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
5232281|NCT00877799|18057034|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
5232282|NCT00877799|18057035|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
5232283|NCT00877773|18057050|P1|Overall Study|Disease Progression|44
5232284|NCT00877487|18057063|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
5232285|NCT00877487|18057064|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
5232286|NCT00877487|18057063|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
5232287|NCT00877487|18057064|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
5232288|NCT00877487|18057063|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
5232289|NCT00877487|18057064|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
5232290|NCT00877487|18057063|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
5232291|NCT00877487|18057064|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
5232292|NCT00877487|18057063|P2|Open-label Treatment Phase|Out of country for business|0
5232293|NCT00877487|18057064|P1|Open-label Treatment Phase|Out of country for business|1
5232294|NCT00877487|18057063|P2|Open-label Treatment Phase|Lost to Follow-up|0
5232295|NCT00877487|18057064|P1|Open-label Treatment Phase|Lost to Follow-up|1
5232296|NCT00877487|18057063|P2|Open-label Treatment Phase|Withdrawal by Subject|0
5232297|NCT00877487|18057064|P1|Open-label Treatment Phase|Withdrawal by Subject|1
5232298|NCT00877487|18057063|P2|Open-label Treatment Phase|Protocol Violation|0
5232299|NCT00877487|18057064|P1|Open-label Treatment Phase|Protocol Violation|3
5232300|NCT00877487|18057063|P2|Open-label Treatment Phase|Adverse Event|0
5232301|NCT00877487|18057064|P1|Open-label Treatment Phase|Adverse Event|1
5232302|NCT00877383|18057112|P2|Overall Study|Death|2
5232303|NCT00877383|18057113|P1|Overall Study|Death|1
5232304|NCT00877383|18057112|P2|Overall Study|Unsatisfactory therapeutic effect|0
5232305|NCT00877383|18057113|P1|Overall Study|Unsatisfactory therapeutic effect|1
5232306|NCT00877383|18057112|P2|Overall Study|Protocol deviation|6
5232307|NCT00877383|18057113|P1|Overall Study|Protocol deviation|2
5232308|NCT00877383|18057112|P2|Overall Study|Administrative problems|0
5232309|NCT00877383|18057113|P1|Overall Study|Administrative problems|2
5232310|NCT00877383|18057112|P2|Overall Study|Subject no longer requires study drug|0
5232311|NCT00877383|18057113|P1|Overall Study|Subject no longer requires study drug|2
5232312|NCT00877383|18057112|P2|Overall Study|Subject withdrew consent|12
5232313|NCT00877383|18057113|P1|Overall Study|Subject withdrew consent|3
5232314|NCT00877383|18057112|P2|Overall Study|Lost to Follow-up|3
5232315|NCT00877383|18057113|P1|Overall Study|Lost to Follow-up|5
5232316|NCT00877383|18057112|P2|Overall Study|Adverse Event|14
5232317|NCT00877383|18057113|P1|Overall Study|Adverse Event|13
5232318|NCT00877071|18057133|P1|Overall Study|disease progression|2
5232319|NCT00877032|18057166|P7|Overall Study|Did not meet entrance criteria|2
5232320|NCT00877032|18057167|P6|Overall Study|Did not meet entrance criteria|0
5232321|NCT00877032|18057168|P5|Overall Study|Did not meet entrance criteria|0
5232322|NCT00877032|18057169|P4|Overall Study|Did not meet entrance criteria|1
5232323|NCT00877032|18057170|P3|Overall Study|Did not meet entrance criteria|0
5232324|NCT00877032|18057171|P2|Overall Study|Did not meet entrance criteria|0
5232325|NCT00877032|18057172|P1|Overall Study|Did not meet entrance criteria|0
5232326|NCT00877006|18057273|P2|Long-Term Follow-up Period|Other|9
5232327|NCT00877006|18057274|P1|Long-Term Follow-up Period|Other|7
5232328|NCT00877006|18057273|P2|Long-Term Follow-up Period|Death|18
5232329|NCT00877006|18057274|P1|Long-Term Follow-up Period|Death|26
5232330|NCT00877006|18057273|P2|Long-Term Follow-up Period|Lost to Follow-up|9
5232331|NCT00877006|18057274|P1|Long-Term Follow-up Period|Lost to Follow-up|8
5232332|NCT00877006|18057273|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
5232333|NCT00877006|18057274|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
5232334|NCT00877006|18057273|P2|Treatment Period|Randomized but Not Treated|8
5232335|NCT00877006|18057274|P1|Treatment Period|Randomized but Not Treated|3
5232336|NCT00877006|18057273|P2|Treatment Period|Other|4
5232337|NCT00877006|18057274|P1|Treatment Period|Other|4
5232338|NCT00877006|18057273|P2|Treatment Period|Started New Treatment Regimen|5
5232339|NCT00877006|18057274|P1|Treatment Period|Started New Treatment Regimen|2
5232340|NCT00877006|18057273|P2|Treatment Period|Disease Progression|2
5232341|NCT00877006|18057274|P1|Treatment Period|Disease Progression|1
5232342|NCT00877006|18057273|P2|Treatment Period|Lost to Follow-up|1
5232343|NCT00877006|18057274|P1|Treatment Period|Lost to Follow-up|0
5232344|NCT00877006|18057273|P2|Treatment Period|Protocol Violation|0
5232345|NCT00877006|18057274|P1|Treatment Period|Protocol Violation|1
5232346|NCT00877006|18057273|P2|Treatment Period|Withdrawal by Subject|3
5232347|NCT00877006|18057274|P1|Treatment Period|Withdrawal by Subject|2
5232348|NCT00877006|18057273|P2|Treatment Period|Adverse Event|3
5232349|NCT00877006|18057274|P1|Treatment Period|Adverse Event|10
5232350|NCT00877006|18057273|P2|Treatment Period|Death|1
5232351|NCT00877006|18057274|P1|Treatment Period|Death|2
5232352|NCT00876928|18057350|P2|Overall Study|Hypokalemia-affects insulin secretion|0
5232353|NCT00876928|18057351|P1|Overall Study|Hypokalemia-affects insulin secretion|1
5232354|NCT00876928|18057350|P2|Overall Study|Lost to Follow-up|5
5232355|NCT00876928|18057351|P1|Overall Study|Lost to Follow-up|2
5232356|NCT00876733|18057388|P4|Overall Study|Data not available|1
5232357|NCT00876733|18057389|P3|Overall Study|Data not available|7
5232358|NCT00876733|18057390|P2|Overall Study|Data not available|3
5232359|NCT00876733|18057391|P1|Overall Study|Data not available|14
5232360|NCT00876733|18057388|P4|Overall Study|Lost to Follow-up|2
5232361|NCT00876733|18057389|P3|Overall Study|Lost to Follow-up|3
5232362|NCT00876733|18057390|P2|Overall Study|Lost to Follow-up|10
5232363|NCT00876733|18057391|P1|Overall Study|Lost to Follow-up|26
5232364|NCT00876733|18057388|P4|Overall Study|Lack of Efficacy|1
5232365|NCT00876733|18057389|P3|Overall Study|Lack of Efficacy|10
5232366|NCT00876733|18057390|P2|Overall Study|Lack of Efficacy|9
5232367|NCT00876733|18057391|P1|Overall Study|Lack of Efficacy|17
5232368|NCT00876733|18057388|P4|Overall Study|Adverse Event|3
5232369|NCT00876733|18057389|P3|Overall Study|Adverse Event|10
5232370|NCT00876733|18057390|P2|Overall Study|Adverse Event|20
5232371|NCT00876733|18057391|P1|Overall Study|Adverse Event|34
5232372|NCT00876694|18057499|P2|Overall Study|Death|0
5232373|NCT00876694|18057500|P1|Overall Study|Death|1
5232374|NCT00876694|18057499|P2|Overall Study|Administrative problems|1
5232375|NCT00876694|18057500|P1|Overall Study|Administrative problems|1
5232376|NCT00876694|18057499|P2|Overall Study|Abnormal test procedure result(s)|0
5232377|NCT00876694|18057500|P1|Overall Study|Abnormal test procedure result(s)|1
5232378|NCT00876694|18057499|P2|Overall Study|Unsatisfactory therapeutic effect|0
5232379|NCT00876694|18057500|P1|Overall Study|Unsatisfactory therapeutic effect|2
5232380|NCT00876694|18057499|P2|Overall Study|Subject withdrew consent|4
5232381|NCT00876694|18057500|P1|Overall Study|Subject withdrew consent|6
5232382|NCT00876694|18057499|P2|Overall Study|Adverse Event|7
5232383|NCT00876694|18057500|P1|Overall Study|Adverse Event|10
5232384|NCT00876460|18057526|P8|Mono Therapy Phase|Adverse Event|0
5232385|NCT00876460|18057527|P7|Mono Therapy Phase|Adverse Event|0
5232386|NCT00876460|18057528|P6|Mono Therapy Phase|Adverse Event|0
5232387|NCT00876460|18057529|P5|Mono Therapy Phase|Adverse Event|0
5232388|NCT00876460|18057530|P4|Mono Therapy Phase|Adverse Event|1
5232389|NCT00876460|18057531|P3|Mono Therapy Phase|Adverse Event|0
5232390|NCT00876460|18057532|P2|Mono Therapy Phase|Adverse Event|0
5232391|NCT00876460|18057533|P1|Mono Therapy Phase|Adverse Event|0
5232392|NCT00876460|18057526|P8|Mono Therapy Phase|Withdrawal by Subject|0
5232393|NCT00876460|18057527|P7|Mono Therapy Phase|Withdrawal by Subject|0
5232394|NCT00876460|18057528|P6|Mono Therapy Phase|Withdrawal by Subject|0
5232395|NCT00876460|18057529|P5|Mono Therapy Phase|Withdrawal by Subject|0
5232396|NCT00876460|18057530|P4|Mono Therapy Phase|Withdrawal by Subject|0
5232397|NCT00876460|18057531|P3|Mono Therapy Phase|Withdrawal by Subject|0
5232398|NCT00876460|18057532|P2|Mono Therapy Phase|Withdrawal by Subject|1
5232399|NCT00876460|18057533|P1|Mono Therapy Phase|Withdrawal by Subject|0
5232400|NCT00876460|18057526|P8|Mono Therapy Phase|Progressive disease|3
5232401|NCT00876460|18057527|P7|Mono Therapy Phase|Progressive disease|1
5232402|NCT00876460|18057528|P6|Mono Therapy Phase|Progressive disease|0
5232403|NCT00876460|18057529|P5|Mono Therapy Phase|Progressive disease|2
5232404|NCT00876460|18057530|P4|Mono Therapy Phase|Progressive disease|0
5232405|NCT00876460|18057531|P3|Mono Therapy Phase|Progressive disease|0
5232406|NCT00876460|18057532|P2|Mono Therapy Phase|Progressive disease|0
5232407|NCT00876460|18057533|P1|Mono Therapy Phase|Progressive disease|0
5232408|NCT00876460|18057526|P8|Combination Therapy Phase|Not treated|0
5232409|NCT00876460|18057527|P7|Combination Therapy Phase|Not treated|1
5232410|NCT00876460|18057528|P6|Combination Therapy Phase|Not treated|0
5232411|NCT00876460|18057529|P5|Combination Therapy Phase|Not treated|0
5232412|NCT00876460|18057530|P4|Combination Therapy Phase|Not treated|0
5232413|NCT00876460|18057531|P3|Combination Therapy Phase|Not treated|0
5232414|NCT00876460|18057532|P2|Combination Therapy Phase|Not treated|0
5232415|NCT00876460|18057533|P1|Combination Therapy Phase|Not treated|0
5232416|NCT00876460|18057526|P8|Combination Therapy Phase|Other reason not defined above|2
5232417|NCT00876460|18057527|P7|Combination Therapy Phase|Other reason not defined above|1
5232418|NCT00876460|18057528|P6|Combination Therapy Phase|Other reason not defined above|0
5232419|NCT00876460|18057529|P5|Combination Therapy Phase|Other reason not defined above|0
5232420|NCT00876460|18057530|P4|Combination Therapy Phase|Other reason not defined above|0
5232421|NCT00876460|18057531|P3|Combination Therapy Phase|Other reason not defined above|0
5232422|NCT00876460|18057532|P2|Combination Therapy Phase|Other reason not defined above|0
5232423|NCT00876460|18057533|P1|Combination Therapy Phase|Other reason not defined above|0
5232424|NCT00876460|18057526|P8|Combination Therapy Phase|Withdrawal by Subject|0
5232425|NCT00876460|18057527|P7|Combination Therapy Phase|Withdrawal by Subject|0
5232426|NCT00876460|18057528|P6|Combination Therapy Phase|Withdrawal by Subject|0
5232427|NCT00876460|18057529|P5|Combination Therapy Phase|Withdrawal by Subject|1
5232428|NCT00876460|18057530|P4|Combination Therapy Phase|Withdrawal by Subject|0
5232429|NCT00876460|18057531|P3|Combination Therapy Phase|Withdrawal by Subject|0
5232430|NCT00876460|18057532|P2|Combination Therapy Phase|Withdrawal by Subject|1
5232431|NCT00876460|18057533|P1|Combination Therapy Phase|Withdrawal by Subject|1
5232432|NCT00876460|18057526|P8|Combination Therapy Phase|Adverse Event|2
5232433|NCT00876460|18057527|P7|Combination Therapy Phase|Adverse Event|3
5232434|NCT00876460|18057528|P6|Combination Therapy Phase|Adverse Event|0
5232435|NCT00876460|18057529|P5|Combination Therapy Phase|Adverse Event|2
5232436|NCT00876460|18057530|P4|Combination Therapy Phase|Adverse Event|2
5232437|NCT00876460|18057531|P3|Combination Therapy Phase|Adverse Event|0
5232438|NCT00876460|18057532|P2|Combination Therapy Phase|Adverse Event|2
5232439|NCT00876460|18057533|P1|Combination Therapy Phase|Adverse Event|0
5232440|NCT00876460|18057526|P8|Combination Therapy Phase|Dose limiting toxicity|1
5232441|NCT00876460|18057527|P7|Combination Therapy Phase|Dose limiting toxicity|2
5232442|NCT00876460|18057528|P6|Combination Therapy Phase|Dose limiting toxicity|2
5232443|NCT00876460|18057529|P5|Combination Therapy Phase|Dose limiting toxicity|1
5232444|NCT00876460|18057530|P4|Combination Therapy Phase|Dose limiting toxicity|1
5232445|NCT00876460|18057531|P3|Combination Therapy Phase|Dose limiting toxicity|0
5232446|NCT00876460|18057532|P2|Combination Therapy Phase|Dose limiting toxicity|1
5232447|NCT00876460|18057533|P1|Combination Therapy Phase|Dose limiting toxicity|0
5232448|NCT00876460|18057526|P8|Combination Therapy Phase|Progressive disease|1
5232449|NCT00876460|18057527|P7|Combination Therapy Phase|Progressive disease|1
5232450|NCT00876460|18057528|P6|Combination Therapy Phase|Progressive disease|1
5232451|NCT00876460|18057529|P5|Combination Therapy Phase|Progressive disease|3
5232452|NCT00876460|18057530|P4|Combination Therapy Phase|Progressive disease|3
5232453|NCT00876460|18057531|P3|Combination Therapy Phase|Progressive disease|3
5232454|NCT00876460|18057532|P2|Combination Therapy Phase|Progressive disease|3
5232455|NCT00876460|18057533|P1|Combination Therapy Phase|Progressive disease|2
5232456|NCT00876447|18057605|P2|Overall Study|Adverse Event|8
5232457|NCT00876447|18057606|P1|Overall Study|Adverse Event|4
5232458|NCT00876447|18057605|P2|Overall Study|Lack of Efficacy|3
5232459|NCT00876447|18057606|P1|Overall Study|Lack of Efficacy|5
5232460|NCT00876447|18057605|P2|Overall Study|Pregnancy|2
5232461|NCT00876447|18057606|P1|Overall Study|Pregnancy|4
5232462|NCT00876447|18057605|P2|Overall Study|Lost to Follow-up|15
5232463|NCT00876447|18057606|P1|Overall Study|Lost to Follow-up|6
5232464|NCT00876447|18057605|P2|Overall Study|Personal reasons|28
5232465|NCT00876447|18057606|P1|Overall Study|Personal reasons|30
5232466|NCT00876447|18057605|P2|Overall Study|Protocol Violation|3
5232467|NCT00876447|18057606|P1|Overall Study|Protocol Violation|9
5232468|NCT00876447|18057605|P2|Overall Study|Site closure|14
5232469|NCT00876447|18057606|P1|Overall Study|Site closure|19
5232470|NCT00876447|18057605|P2|Overall Study|Other miscellaneous reasons|8
5232471|NCT00876447|18057606|P1|Overall Study|Other miscellaneous reasons|3
5232472|NCT00876395|18057666|P2|Overall Study|Death|0
5232473|NCT00876395|18057667|P1|Overall Study|Death|12
5232474|NCT00876395|18057666|P2|Overall Study|Administrative problems|23
5232475|NCT00876395|18057667|P1|Overall Study|Administrative problems|39
5232476|NCT00876395|18057666|P2|Overall Study|Lost to Follow-up|0
5232477|NCT00876395|18057667|P1|Overall Study|Lost to Follow-up|2
5232478|NCT00876395|18057666|P2|Overall Study|Withdrawal by Subject|33
5232479|NCT00876395|18057667|P1|Overall Study|Withdrawal by Subject|66
5232480|NCT00876395|18057666|P2|Overall Study|Protocol Violation|2
5232481|NCT00876395|18057667|P1|Overall Study|Protocol Violation|5
5232482|NCT00876395|18057666|P2|Overall Study|New cancer therapy|7
5232483|NCT00876395|18057667|P1|Overall Study|New cancer therapy|25
5232484|NCT00876395|18057666|P2|Overall Study|Disease progression|162
5232485|NCT00876395|18057667|P1|Overall Study|Disease progression|259
5232486|NCT00876395|18057666|P2|Overall Study|Abnormal test procedure result(s)|0
5232487|NCT00876395|18057667|P1|Overall Study|Abnormal test procedure result(s)|1
5232488|NCT00876395|18057666|P2|Overall Study|Adverse Event|11
5232489|NCT00876395|18057667|P1|Overall Study|Adverse Event|63
5232490|NCT00876395|18057666|P2|Overall Study|Untreated|1
5232491|NCT00876395|18057667|P1|Overall Study|Untreated|8
5232492|NCT00876343|18057708|P3|Overall Study|Change of residence or other commitments|3
5232493|NCT00876343|18057709|P2|Overall Study|Change of residence or other commitments|2
5232494|NCT00876343|18057710|P1|Overall Study|Change of residence or other commitments|2
5232495|NCT00876343|18057708|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
5232496|NCT00876343|18057709|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
5232497|NCT00876343|18057710|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
5232498|NCT00876343|18057708|P3|Overall Study|Physician Decision|1
5232499|NCT00876343|18057709|P2|Overall Study|Physician Decision|1
5232500|NCT00876343|18057710|P1|Overall Study|Physician Decision|0
5232501|NCT00876343|18057708|P3|Overall Study|Protocol Violation|1
5232502|NCT00876343|18057709|P2|Overall Study|Protocol Violation|1
5232503|NCT00876343|18057710|P1|Overall Study|Protocol Violation|4
5232504|NCT00876343|18057708|P3|Overall Study|Lack of Efficacy|1
5232505|NCT00876343|18057709|P2|Overall Study|Lack of Efficacy|0
5232506|NCT00876343|18057710|P1|Overall Study|Lack of Efficacy|0
5232507|NCT00876343|18057708|P3|Overall Study|Withdrawal by Subject|3
5232508|NCT00876343|18057709|P2|Overall Study|Withdrawal by Subject|4
5232509|NCT00876343|18057710|P1|Overall Study|Withdrawal by Subject|4
5232510|NCT00876343|18057708|P3|Overall Study|Adverse Event|2
5232511|NCT00876343|18057709|P2|Overall Study|Adverse Event|8
5232512|NCT00876343|18057710|P1|Overall Study|Adverse Event|7
5232513|NCT00876265|18057724|P1|Overall Study|Withdrawal by Subject|2
5232514|NCT00876265|18057724|P1|Overall Study|Lost to Follow-up|6
5232515|NCT00876265|18057724|P1|Overall Study|Miscellaneous reasons|4
5232516|NCT00876018|18057742|P3|Overall Study|Withdrew Consent due to Adverse Event|2
5232517|NCT00876018|18057743|P2|Overall Study|Withdrew Consent due to Adverse Event|4
5232518|NCT00876018|18057744|P1|Overall Study|Withdrew Consent due to Adverse Event|5
5232519|NCT00876018|18057742|P3|Overall Study|Lost to Follow-up|1
5232520|NCT00876018|18057743|P2|Overall Study|Lost to Follow-up|1
5232521|NCT00876018|18057744|P1|Overall Study|Lost to Follow-up|0
5232522|NCT00875979|18057799|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
5232523|NCT00875979|18057800|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
5232524|NCT00875979|18057799|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
5232525|NCT00875979|18057800|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
5232526|NCT00875979|18057799|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
5232527|NCT00875979|18057800|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
5232528|NCT00875979|18057799|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
5232529|NCT00875979|18057800|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
5232530|NCT00875979|18057799|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
5232531|NCT00875979|18057800|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
5232532|NCT00875979|18057799|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
5232533|NCT00875979|18057800|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
5232534|NCT00875979|18057799|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
5232535|NCT00875979|18057800|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
5232536|NCT00875979|18057799|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
5232537|NCT00875979|18057800|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
5232538|NCT00875979|18057799|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
5232539|NCT00875979|18057800|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
5232540|NCT00875810|18057823|P1|Overall Study|Device explanted|1
5232541|NCT00875810|18057823|P1|Overall Study|Patient enroled but not implanted|2
5232542|NCT00875810|18057823|P1|Overall Study|Lost to Follow-up|39
5232543|NCT00875810|18057823|P1|Overall Study|Physician Decision|3
5232544|NCT00875810|18057823|P1|Overall Study|Withdrawal by Subject|1
5232545|NCT00875797|18057832|P2|Overall Study|Protocol Violation|3
5232546|NCT00875797|18057833|P1|Overall Study|Protocol Violation|6
5232547|NCT00875706|18057846|P3|Overall Study|Withdrawal by Subject|0
5232548|NCT00875706|18057847|P2|Overall Study|Withdrawal by Subject|0
5232549|NCT00875706|18057848|P1|Overall Study|Withdrawal by Subject|1
5232550|NCT00875667|18057867|P2|Overall Study|Randomized but no Study Drug Given|1
5232551|NCT00875667|18057868|P1|Overall Study|Randomized but no Study Drug Given|3
5232552|NCT00875667|18057867|P2|Overall Study|Miscellaneous|6
5232553|NCT00875667|18057868|P1|Overall Study|Miscellaneous|12
5232554|NCT00875667|18057867|P2|Overall Study|Disease Progression|49
5232555|NCT00875667|18057868|P1|Overall Study|Disease Progression|100
5232556|NCT00875667|18057867|P2|Overall Study|Protocol Violation|0
5232557|NCT00875667|18057868|P1|Overall Study|Protocol Violation|2
5232558|NCT00875667|18057867|P2|Overall Study|Death|2
5232559|NCT00875667|18057868|P1|Overall Study|Death|7
5232560|NCT00875667|18057867|P2|Overall Study|Withdrawal by Subject|5
5232561|NCT00875667|18057868|P1|Overall Study|Withdrawal by Subject|17
5232562|NCT00875667|18057867|P2|Overall Study|Adverse Event|10
5232563|NCT00875667|18057868|P1|Overall Study|Adverse Event|29
5232564|NCT00875615|18058003|P1|Overall Study|Withdrawal by Subject|1
5232565|NCT00875563|18058017|P1|Overall Study|Still be eligible for follow-up|7
5232566|NCT00875563|18058017|P1|Overall Study|No long-term (3-5 year) consent|6
5232567|NCT00875563|18058017|P1|Overall Study|Withdrawal by Subject|7
5232568|NCT00875563|18058017|P1|Overall Study|Death|4
5232569|NCT00875524|18058042|P2|Overall Study|Withdrawal by Subject|5
5232570|NCT00875524|18058043|P1|Overall Study|Withdrawal by Subject|3
5232571|NCT00875524|18058042|P2|Overall Study|Lost to Follow-up|0
5232572|NCT00875524|18058043|P1|Overall Study|Lost to Follow-up|1
5232573|NCT00875524|18058042|P2|Overall Study|Protocol Violation|0
5232574|NCT00875524|18058043|P1|Overall Study|Protocol Violation|4
5232575|NCT00875524|18058042|P2|Overall Study|Serious adverse event|1
5232576|NCT00875524|18058043|P1|Overall Study|Serious adverse event|0
5232577|NCT00875485|18058061|P2|Challenge Dose Epoch|Pregnancy|0
5232578|NCT00875485|18058062|P1|Challenge Dose Epoch|Pregnancy|1
5232579|NCT00875433|18058102|P1|Overall Study|Other|3
5232580|NCT00875433|18058102|P1|Overall Study|Withdrawal by Subject|2
5232581|NCT00875433|18058102|P1|Overall Study|Other Adverse Event|14
5232582|NCT00875433|18058102|P1|Overall Study|Progressive disease|41
5232583|NCT00875420|18058132|P5|Overall Study|Withdrawal by Subject|0
5232584|NCT00875420|18058133|P4|Overall Study|Withdrawal by Subject|0
5232585|NCT00875420|18058134|P3|Overall Study|Withdrawal by Subject|1
5232586|NCT00875420|18058135|P2|Overall Study|Withdrawal by Subject|0
5232587|NCT00875420|18058136|P1|Overall Study|Withdrawal by Subject|0
5232588|NCT00875420|18058132|P5|Overall Study|Sponsor decision|0
5232589|NCT00875420|18058133|P4|Overall Study|Sponsor decision|0
5232590|NCT00875420|18058134|P3|Overall Study|Sponsor decision|0
5232591|NCT00875420|18058135|P2|Overall Study|Sponsor decision|1
5232592|NCT00875420|18058136|P1|Overall Study|Sponsor decision|0
5232593|NCT00875420|18058132|P5|Overall Study|Prohibited medication|0
5232594|NCT00875420|18058133|P4|Overall Study|Prohibited medication|1
5232595|NCT00875420|18058134|P3|Overall Study|Prohibited medication|0
5232596|NCT00875420|18058135|P2|Overall Study|Prohibited medication|0
5232597|NCT00875420|18058136|P1|Overall Study|Prohibited medication|0
5232598|NCT00875420|18058132|P5|Overall Study|Personal reason|1
5232599|NCT00875420|18058133|P4|Overall Study|Personal reason|0
5232600|NCT00875420|18058134|P3|Overall Study|Personal reason|0
5232601|NCT00875420|18058135|P2|Overall Study|Personal reason|0
5232602|NCT00875420|18058136|P1|Overall Study|Personal reason|0
5232603|NCT00875420|18058132|P5|Overall Study|Lost to Follow-up|0
5232604|NCT00875420|18058133|P4|Overall Study|Lost to Follow-up|0
5232605|NCT00875420|18058134|P3|Overall Study|Lost to Follow-up|0
5232606|NCT00875420|18058135|P2|Overall Study|Lost to Follow-up|0
5232607|NCT00875420|18058136|P1|Overall Study|Lost to Follow-up|1
5232608|NCT00875420|18058132|P5|Overall Study|Inability to complete study procedures|1
5232609|NCT00875420|18058133|P4|Overall Study|Inability to complete study procedures|1
5232610|NCT00875420|18058134|P3|Overall Study|Inability to complete study procedures|1
5232611|NCT00875420|18058135|P2|Overall Study|Inability to complete study procedures|0
5232612|NCT00875420|18058136|P1|Overall Study|Inability to complete study procedures|1
5232613|NCT00875420|18058132|P5|Overall Study|Adverse Event|0
5232614|NCT00875420|18058133|P4|Overall Study|Adverse Event|0
5232615|NCT00875420|18058134|P3|Overall Study|Adverse Event|1
5232616|NCT00875420|18058135|P2|Overall Study|Adverse Event|1
5232617|NCT00875420|18058136|P1|Overall Study|Adverse Event|0
5232618|NCT00875056|18058275|P3|Overall Study|Withdrawal by Subject|1
5232619|NCT00875056|18058276|P2|Overall Study|Withdrawal by Subject|0
5232620|NCT00875056|18058277|P1|Overall Study|Withdrawal by Subject|3
5232621|NCT00875056|18058275|P3|Overall Study|Progressive Disease|3
5232622|NCT00875056|18058276|P2|Overall Study|Progressive Disease|8
5232623|NCT00875056|18058277|P1|Overall Study|Progressive Disease|14
5232624|NCT00875056|18058275|P3|Overall Study|Adverse Event|2
5232625|NCT00875056|18058276|P2|Overall Study|Adverse Event|1
5232626|NCT00875056|18058277|P1|Overall Study|Adverse Event|6
5232627|NCT00875017|18058303|P6|Fourth Intervention|Inability to comply with fasting|1
5232628|NCT00875017|18058304|P5|Fourth Intervention|Inability to comply with fasting|0
5232629|NCT00875017|18058305|P4|Fourth Intervention|Inability to comply with fasting|0
5232630|NCT00875017|18058306|P3|Fourth Intervention|Inability to comply with fasting|0
5232631|NCT00875017|18058307|P2|Fourth Intervention|Inability to comply with fasting|0
5232632|NCT00875017|18058308|P1|Fourth Intervention|Inability to comply with fasting|0
5232633|NCT00875017|18058303|P6|Washout|Withdrawal by Subject|0
5232634|NCT00875017|18058304|P5|Washout|Withdrawal by Subject|1
5232635|NCT00875017|18058305|P4|Washout|Withdrawal by Subject|0
5232636|NCT00875017|18058306|P3|Washout|Withdrawal by Subject|0
5232637|NCT00875017|18058307|P2|Washout|Withdrawal by Subject|0
5232638|NCT00875017|18058308|P1|Washout|Withdrawal by Subject|0
5232639|NCT00875017|18058303|P6|Third Intervention|Adverse Event|0
5232640|NCT00875017|18058304|P5|Third Intervention|Adverse Event|0
5232641|NCT00875017|18058305|P4|Third Intervention|Adverse Event|0
5232642|NCT00875017|18058306|P3|Third Intervention|Adverse Event|1
5232643|NCT00875017|18058307|P2|Third Intervention|Adverse Event|1
5232644|NCT00875017|18058308|P1|Third Intervention|Adverse Event|0
5232645|NCT00875017|18058303|P6|Washout|Problems collecting rectal effluent|0
5232646|NCT00875017|18058304|P5|Washout|Problems collecting rectal effluent|0
5232647|NCT00875017|18058305|P4|Washout|Problems collecting rectal effluent|0
5232648|NCT00875017|18058306|P3|Washout|Problems collecting rectal effluent|0
5232649|NCT00875017|18058307|P2|Washout|Problems collecting rectal effluent|1
5232650|NCT00875017|18058308|P1|Washout|Problems collecting rectal effluent|0
5232651|NCT00875017|18058303|P6|Second Intervention|Adverse Event|0
5232652|NCT00875017|18058304|P5|Second Intervention|Adverse Event|0
5232653|NCT00875017|18058305|P4|Second Intervention|Adverse Event|1
5232654|NCT00875017|18058306|P3|Second Intervention|Adverse Event|0
5232655|NCT00875017|18058307|P2|Second Intervention|Adverse Event|0
5232656|NCT00875017|18058308|P1|Second Intervention|Adverse Event|0
5232657|NCT00875017|18058303|P6|Washout|Problem collecting rectal effluent|0
5232658|NCT00875017|18058304|P5|Washout|Problem collecting rectal effluent|0
5232659|NCT00875017|18058305|P4|Washout|Problem collecting rectal effluent|0
5232660|NCT00875017|18058306|P3|Washout|Problem collecting rectal effluent|1
5232661|NCT00875017|18058307|P2|Washout|Problem collecting rectal effluent|0
5232662|NCT00875017|18058308|P1|Washout|Problem collecting rectal effluent|0
5232663|NCT00875017|18058303|P6|First Intervention|Intolerance to nasogastric tube|0
5232664|NCT00875017|18058304|P5|First Intervention|Intolerance to nasogastric tube|1
5232665|NCT00875017|18058305|P4|First Intervention|Intolerance to nasogastric tube|0
5232666|NCT00875017|18058306|P3|First Intervention|Intolerance to nasogastric tube|0
5232667|NCT00875017|18058307|P2|First Intervention|Intolerance to nasogastric tube|0
5232668|NCT00875017|18058308|P1|First Intervention|Intolerance to nasogastric tube|0
5232669|NCT00875017|18058303|P6|First Intervention|Problems collecting rectal effluent|0
5232670|NCT00875017|18058304|P5|First Intervention|Problems collecting rectal effluent|0
5232671|NCT00875017|18058305|P4|First Intervention|Problems collecting rectal effluent|0
5232672|NCT00875017|18058306|P3|First Intervention|Problems collecting rectal effluent|0
5232673|NCT00875017|18058307|P2|First Intervention|Problems collecting rectal effluent|0
5232674|NCT00875017|18058308|P1|First Intervention|Problems collecting rectal effluent|1
5232675|NCT00875017|18058303|P6|First Intervention|Adverse Event|0
5232676|NCT00875017|18058304|P5|First Intervention|Adverse Event|0
5232677|NCT00875017|18058305|P4|First Intervention|Adverse Event|1
5232678|NCT00875017|18058306|P3|First Intervention|Adverse Event|0
5232679|NCT00875017|18058307|P2|First Intervention|Adverse Event|0
5232680|NCT00875017|18058308|P1|First Intervention|Adverse Event|0
5232681|NCT00875017|18058303|P6|First Intervention|Withdrawal by Subject|0
5232682|NCT00875017|18058304|P5|First Intervention|Withdrawal by Subject|0
5232683|NCT00875017|18058305|P4|First Intervention|Withdrawal by Subject|0
5232684|NCT00875017|18058306|P3|First Intervention|Withdrawal by Subject|1
5232685|NCT00875017|18058307|P2|First Intervention|Withdrawal by Subject|0
5232686|NCT00875017|18058308|P1|First Intervention|Withdrawal by Subject|1
5232687|NCT00874939|18058322|P1|Overall Study|Study terminated|4
5232688|NCT00874848|18058355|P2|Overall Study|Physician Decision|2
5232689|NCT00874848|18058356|P1|Overall Study|Physician Decision|0
5232690|NCT00874848|18058355|P2|Overall Study|Failure to comply with protocol|1
5232691|NCT00874848|18058356|P1|Overall Study|Failure to comply with protocol|0
5232692|NCT00874848|18058355|P2|Overall Study|Noncompliance|1
5232693|NCT00874848|18058356|P1|Overall Study|Noncompliance|1
5232694|NCT00874848|18058355|P2|Overall Study|Withdrawal by Subject|4
5232695|NCT00874848|18058356|P1|Overall Study|Withdrawal by Subject|7
5232696|NCT00874848|18058355|P2|Overall Study|Progressive neoplastic disease|18
5232697|NCT00874848|18058356|P1|Overall Study|Progressive neoplastic disease|38
5232698|NCT00874848|18058355|P2|Overall Study|Adverse Event|2
5232699|NCT00874848|18058356|P1|Overall Study|Adverse Event|13
5232700|NCT00874822|18058372|P1|Overall Study|excluded by criteria|8
5232701|NCT00874770|18058380|P4|Overall Study|Subject no Longer Meets Study Criteria|0
5232702|NCT00874770|18058381|P3|Overall Study|Subject no Longer Meets Study Criteria|0
5232703|NCT00874770|18058382|P2|Overall Study|Subject no Longer Meets Study Criteria|0
5232704|NCT00874770|18058383|P1|Overall Study|Subject no Longer Meets Study Criteria|1
5232705|NCT00874770|18058380|P4|Overall Study|Lost to Follow-up|1
5232706|NCT00874770|18058381|P3|Overall Study|Lost to Follow-up|0
5232707|NCT00874770|18058382|P2|Overall Study|Lost to Follow-up|0
5232708|NCT00874770|18058383|P1|Overall Study|Lost to Follow-up|1
5232709|NCT00874770|18058380|P4|Overall Study|Adverse Event|2
5232710|NCT00874770|18058381|P3|Overall Study|Adverse Event|4
5232711|NCT00874770|18058382|P2|Overall Study|Adverse Event|1
5232712|NCT00874770|18058383|P1|Overall Study|Adverse Event|1
5232713|NCT00874770|18058380|P4|Overall Study|Lack of Efficacy|2
5232714|NCT00874770|18058381|P3|Overall Study|Lack of Efficacy|0
5232715|NCT00874770|18058382|P2|Overall Study|Lack of Efficacy|0
5232716|NCT00874770|18058383|P1|Overall Study|Lack of Efficacy|2
5232717|NCT00874731|18058417|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
5232718|NCT00874731|18058418|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
5232719|NCT00874731|18058419|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
5232720|NCT00874731|18058417|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
5232721|NCT00874731|18058418|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
5232722|NCT00874731|18058419|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
5232723|NCT00874731|18058417|P3|Part 1, Day 1: Placebo|Disease Progression|0
5232724|NCT00874731|18058418|P2|Part 1, Day 1: Placebo|Disease Progression|0
5232725|NCT00874731|18058419|P1|Part 1, Day 1: Placebo|Disease Progression|1
5232726|NCT00874549|18058460|P4|Overall Study|Withdrawal by Subject|1
5232727|NCT00874549|18058461|P3|Overall Study|Withdrawal by Subject|0
5232728|NCT00874549|18058462|P2|Overall Study|Withdrawal by Subject|1
5232729|NCT00874549|18058463|P1|Overall Study|Withdrawal by Subject|0
5232730|NCT00874549|18058460|P4|Overall Study|Lost to Follow-up|0
5232731|NCT00874549|18058461|P3|Overall Study|Lost to Follow-up|1
5232732|NCT00874549|18058462|P2|Overall Study|Lost to Follow-up|0
5232733|NCT00874549|18058463|P1|Overall Study|Lost to Follow-up|0
5232734|NCT00874549|18058460|P4|Overall Study|Protocol Violation|1
5232735|NCT00874549|18058461|P3|Overall Study|Protocol Violation|2
5232736|NCT00874549|18058462|P2|Overall Study|Protocol Violation|0
5232737|NCT00874549|18058463|P1|Overall Study|Protocol Violation|1
5232738|NCT00874549|18058460|P4|Overall Study|Adverse Event|0
5232739|NCT00874549|18058461|P3|Overall Study|Adverse Event|1
5232740|NCT00874549|18058462|P2|Overall Study|Adverse Event|0
5232741|NCT00874549|18058463|P1|Overall Study|Adverse Event|0
5232742|NCT00874497|18058540|P2|Overall Study|Withdrawal by Subject|4
5232743|NCT00874497|18058541|P1|Overall Study|Withdrawal by Subject|5
5232744|NCT00874497|18058540|P2|Overall Study|Physician Decision|1
5232745|NCT00874497|18058541|P1|Overall Study|Physician Decision|1
5232746|NCT00874497|18058540|P2|Overall Study|Met Withdrawal Criteria|2
5232747|NCT00874497|18058541|P1|Overall Study|Met Withdrawal Criteria|4
5232748|NCT00874497|18058540|P2|Overall Study|Sponsor Discontinued Trial|3
5232749|NCT00874497|18058541|P1|Overall Study|Sponsor Discontinued Trial|7
5232750|NCT00874497|18058540|P2|Overall Study|Adverse Event|4
5232751|NCT00874497|18058541|P1|Overall Study|Adverse Event|9
5232752|NCT00874497|18058540|P2|Overall Study|Lost to Follow-up|4
5232753|NCT00874497|18058541|P1|Overall Study|Lost to Follow-up|2
5232754|NCT00874432|18058583|P4|Overall Study|Other|3
5232755|NCT00874432|18058584|P3|Overall Study|Other|8
5232756|NCT00874432|18058585|P2|Overall Study|Other|2
5232757|NCT00874432|18058586|P1|Overall Study|Other|1
5232758|NCT00874432|18058583|P4|Overall Study|Physician Decision|0
5232759|NCT00874432|18058584|P3|Overall Study|Physician Decision|0
5232760|NCT00874432|18058585|P2|Overall Study|Physician Decision|0
5232761|NCT00874432|18058586|P1|Overall Study|Physician Decision|1
5232762|NCT00874432|18058583|P4|Overall Study|Withdrawal by Subject|0
5232763|NCT00874432|18058584|P3|Overall Study|Withdrawal by Subject|0
5232764|NCT00874432|18058585|P2|Overall Study|Withdrawal by Subject|0
5232765|NCT00874432|18058586|P1|Overall Study|Withdrawal by Subject|1
5232766|NCT00874276|18058604|P2|Overall Study|Withdrawal by Subject|1
5232767|NCT00874276|18058605|P1|Overall Study|Withdrawal by Subject|1
5232768|NCT00874237|18058625|P6|Overall Study|Withdrawal by Subject|0
5232769|NCT00874237|18058626|P5|Overall Study|Withdrawal by Subject|0
5232770|NCT00874237|18058627|P4|Overall Study|Withdrawal by Subject|0
5232771|NCT00874237|18058628|P3|Overall Study|Withdrawal by Subject|1
5232772|NCT00874237|18058629|P2|Overall Study|Withdrawal by Subject|0
5232773|NCT00874237|18058630|P1|Overall Study|Withdrawal by Subject|0
5232774|NCT00874237|18058625|P6|Overall Study|Physician Decision|0
5232775|NCT00874237|18058626|P5|Overall Study|Physician Decision|0
5232776|NCT00874237|18058627|P4|Overall Study|Physician Decision|0
5232777|NCT00874237|18058628|P3|Overall Study|Physician Decision|0
5232778|NCT00874237|18058629|P2|Overall Study|Physician Decision|1
5232779|NCT00874237|18058630|P1|Overall Study|Physician Decision|0
5232780|NCT00874120|18058648|P2|Second Intervention|Protocol Violation|0
5232781|NCT00874120|18058649|P1|Second Intervention|Protocol Violation|1
5232782|NCT00874120|18058648|P2|Second Intervention|Withdrawal by Subject|0
5232783|NCT00874120|18058649|P1|Second Intervention|Withdrawal by Subject|1
5232784|NCT00874120|18058648|P2|First Intervention|positive drug test|0
5232785|NCT00874120|18058649|P1|First Intervention|positive drug test|1
5232786|NCT00874120|18058648|P2|First Intervention|Protocol Violation|0
5232787|NCT00874120|18058649|P1|First Intervention|Protocol Violation|3
5232788|NCT00874120|18058648|P2|First Intervention|Lost to Follow-up|1
5232789|NCT00874120|18058649|P1|First Intervention|Lost to Follow-up|0
5232790|NCT00874120|18058648|P2|First Intervention|Withdrawal by Subject|0
5232791|NCT00874120|18058649|P1|First Intervention|Withdrawal by Subject|2
5232792|NCT00874120|18058648|P2|First Intervention|Adverse Event|1
5232793|NCT00874120|18058649|P1|First Intervention|Adverse Event|0
5232794|NCT00874029|18058662|P1|Overall Study|Lost to Follow-up|5
5232795|NCT00874029|18058662|P1|Overall Study|Adverse Event|1
5232796|NCT00874029|18058662|P1|Overall Study|Physician Decision|1
5232797|NCT00874029|18058662|P1|Overall Study|Pregnancy|4
5232798|NCT00874029|18058662|P1|Overall Study|Withdrawal by Subject|10
5232799|NCT00873912|18058678|P2|Overall Study|Lost to Follow-up|0
5232800|NCT00873912|18058679|P1|Overall Study|Lost to Follow-up|2
5232801|NCT00873912|18058678|P2|Overall Study|Withdrawal by Subject|0
5232802|NCT00873912|18058679|P1|Overall Study|Withdrawal by Subject|1
5232803|NCT00873860|18058718|P4|Overall Study|Other|0
5232804|NCT00873860|18058719|P3|Overall Study|Other|1
5232805|NCT00873860|18058720|P2|Overall Study|Other|0
5232806|NCT00873860|18058721|P1|Overall Study|Other|1
5232807|NCT00873860|18058718|P4|Overall Study|Death|0
5232808|NCT00873860|18058719|P3|Overall Study|Death|0
5232809|NCT00873860|18058720|P2|Overall Study|Death|0
5232810|NCT00873860|18058721|P1|Overall Study|Death|1
5232811|NCT00873860|18058718|P4|Overall Study|Withdrawal by Subject|0
5232812|NCT00873860|18058719|P3|Overall Study|Withdrawal by Subject|2
5232813|NCT00873860|18058720|P2|Overall Study|Withdrawal by Subject|0
5232814|NCT00873860|18058721|P1|Overall Study|Withdrawal by Subject|1
5232815|NCT00873860|18058718|P4|Overall Study|Lost to Follow-up|1
5232816|NCT00873860|18058719|P3|Overall Study|Lost to Follow-up|0
5232817|NCT00873860|18058720|P2|Overall Study|Lost to Follow-up|0
5232818|NCT00873860|18058721|P1|Overall Study|Lost to Follow-up|1
5232819|NCT00873730|18058809|P2|Overall Study|Sponsor decision|0
5232820|NCT00873730|18058810|P1|Overall Study|Sponsor decision|1
5232821|NCT00873730|18058809|P2|Overall Study|Withdrawal by Subject|1
5232822|NCT00873730|18058810|P1|Overall Study|Withdrawal by Subject|0
5232823|NCT00873730|18058809|P2|Overall Study|Adverse Event|2
5232824|NCT00873730|18058810|P1|Overall Study|Adverse Event|0
5232825|NCT00873730|18058809|P2|Overall Study|Protocol Deviation|2
5232826|NCT00873730|18058810|P1|Overall Study|Protocol Deviation|5
5232827|NCT00873366|18058853|P1|Overall Study|Refused to continue DM-BT testing|3
5232828|NCT00873366|18058853|P1|Overall Study|Off tamoxifen due to side effects|2
5232829|NCT00873366|18058853|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
5232830|NCT00873119|18058878|P2|Overall Study|Not treated|0
5232831|NCT00873119|18058879|P1|Overall Study|Not treated|2
5232832|NCT00873119|18058878|P2|Overall Study|Other|5
5232833|NCT00873119|18058879|P1|Overall Study|Other|2
5232834|NCT00873119|18058878|P2|Overall Study|Death|1
5232835|NCT00873119|18058879|P1|Overall Study|Death|2
5232836|NCT00873119|18058878|P2|Overall Study|Progressive disease|18
5232837|NCT00873119|18058879|P1|Overall Study|Progressive disease|26
5232838|NCT00873119|18058878|P2|Overall Study|Adverse Event|0
5232839|NCT00873119|18058879|P1|Overall Study|Adverse Event|8
5232840|NCT00873119|18058878|P2|Overall Study|Patient request|2
5232841|NCT00873119|18058879|P1|Overall Study|Patient request|4
5232842|NCT00873093|18058900|P5|Overall Study|Ineligible|0
5232843|NCT00873093|18058901|P4|Overall Study|Ineligible|1
5232844|NCT00873093|18058902|P3|Overall Study|Ineligible|0
5232845|NCT00873093|18058903|P2|Overall Study|Ineligible|1
5232846|NCT00873093|18058904|P1|Overall Study|Ineligible|0
5232847|NCT00873093|18058900|P5|Overall Study|Withdrawal by Subject|0
5232848|NCT00873093|18058901|P4|Overall Study|Withdrawal by Subject|0
5232849|NCT00873093|18058902|P3|Overall Study|Withdrawal by Subject|4
5232850|NCT00873093|18058903|P2|Overall Study|Withdrawal by Subject|4
5232851|NCT00873093|18058904|P1|Overall Study|Withdrawal by Subject|1
5232852|NCT00873093|18058900|P5|Overall Study|Physician Decision|2
5232853|NCT00873093|18058901|P4|Overall Study|Physician Decision|10
5232854|NCT00873093|18058902|P3|Overall Study|Physician Decision|10
5232855|NCT00873093|18058903|P2|Overall Study|Physician Decision|17
5232856|NCT00873093|18058904|P1|Overall Study|Physician Decision|0
5232857|NCT00873093|18058900|P5|Overall Study|Death|0
5232858|NCT00873093|18058901|P4|Overall Study|Death|0
5232859|NCT00873093|18058902|P3|Overall Study|Death|2
5232860|NCT00873093|18058903|P2|Overall Study|Death|3
5232861|NCT00873093|18058904|P1|Overall Study|Death|0
5232862|NCT00873093|18058900|P5|Overall Study|Adverse Event|0
5232863|NCT00873093|18058901|P4|Overall Study|Adverse Event|0
5232864|NCT00873093|18058902|P3|Overall Study|Adverse Event|0
5232865|NCT00873093|18058903|P2|Overall Study|Adverse Event|2
5232866|NCT00873093|18058904|P1|Overall Study|Adverse Event|0
5232867|NCT00873041|18058961|P3|Extension Study|Administrative reasons|1
5232868|NCT00873041|18058962|P2|Extension Study|Administrative reasons|0
5232869|NCT00873041|18058963|P1|Extension Study|Administrative reasons|0
5232870|NCT00873041|18058961|P3|Extension Study|Adverse Event|1
5232871|NCT00873041|18058962|P2|Extension Study|Adverse Event|0
5232872|NCT00873041|18058963|P1|Extension Study|Adverse Event|1
5232873|NCT00873041|18058961|P3|Core Study|Protocol deviation|1
5232874|NCT00873041|18058962|P2|Core Study|Protocol deviation|0
5232875|NCT00873041|18058963|P1|Core Study|Protocol deviation|1
5232876|NCT00873041|18058961|P3|Core Study|Abnormal laboratory value|1
5232877|NCT00873041|18058962|P2|Core Study|Abnormal laboratory value|0
5232878|NCT00873041|18058963|P1|Core Study|Abnormal laboratory value|0
5232879|NCT00873041|18058961|P3|Core Study|Lost to Follow-up|0
5232880|NCT00873041|18058962|P2|Core Study|Lost to Follow-up|1
5232881|NCT00873041|18058963|P1|Core Study|Lost to Follow-up|3
5232882|NCT00873041|18058961|P3|Core Study|Withdrawal by Subject|2
5232883|NCT00873041|18058962|P2|Core Study|Withdrawal by Subject|2
5232884|NCT00873041|18058963|P1|Core Study|Withdrawal by Subject|1
5232885|NCT00873041|18058961|P3|Core Study|Adverse Event|1
5232886|NCT00873041|18058962|P2|Core Study|Adverse Event|3
5232887|NCT00873041|18058963|P1|Core Study|Adverse Event|2
5232888|NCT00873015|18059021|P4|Overall Study|Withdrawal by Subject|0
5232889|NCT00873015|18059022|P3|Overall Study|Withdrawal by Subject|0
5232890|NCT00873015|18059023|P2|Overall Study|Withdrawal by Subject|1
5232891|NCT00873015|18059024|P1|Overall Study|Withdrawal by Subject|0
5232892|NCT00872989|18059041|P2|Overall Study|Not protocol specified|8
5232893|NCT00872989|18059042|P1|Overall Study|Not protocol specified|3
5232894|NCT00872989|18059041|P2|Overall Study|Progression/relapse|35
5232895|NCT00872989|18059042|P1|Overall Study|Progression/relapse|47
5232896|NCT00872989|18059041|P2|Overall Study|Withdrawal by Subject|5
5232897|NCT00872989|18059042|P1|Overall Study|Withdrawal by Subject|8
5232898|NCT00872989|18059041|P2|Overall Study|Adverse Event|15
5232899|NCT00872989|18059042|P1|Overall Study|Adverse Event|7
5232900|NCT00872898|18059061|P2|Part Two - Double Blind|Other reasons|0
5232901|NCT00872898|18059062|P1|Part Two - Double Blind|Other reasons|2
5232902|NCT00872898|18059061|P2|Part Two - Double Blind|Lost to Follow-up|2
5232903|NCT00872898|18059062|P1|Part Two - Double Blind|Lost to Follow-up|0
5232904|NCT00872898|18059061|P2|Part Two - Double Blind|Withdrawal by Subject|1
5232905|NCT00872898|18059062|P1|Part Two - Double Blind|Withdrawal by Subject|3
5232906|NCT00872898|18059061|P2|Part Two - Double Blind|Protocol Violation|0
5232907|NCT00872898|18059062|P1|Part Two - Double Blind|Protocol Violation|1
5232908|NCT00872898|18059061|P2|Part Two - Double Blind|Lack of Efficacy|0
5232909|NCT00872898|18059062|P1|Part Two - Double Blind|Lack of Efficacy|1
5232910|NCT00872898|18059061|P2|Part Two - Double Blind|Adverse Event|3
5232911|NCT00872898|18059062|P1|Part Two - Double Blind|Adverse Event|4
5232912|NCT00872599|18059136|P2|Second Washout Period|Adverse Event|1
5232913|NCT00872599|18059137|P1|Second Washout Period|Adverse Event|1
5232914|NCT00872521|18059157|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
5232915|NCT00872521|18059158|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
5232916|NCT00872521|18059159|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
5232917|NCT00872521|18059157|P3|Completed 3-month Follow up|Physician Decision|0
5232918|NCT00872521|18059158|P2|Completed 3-month Follow up|Physician Decision|1
5232919|NCT00872521|18059159|P1|Completed 3-month Follow up|Physician Decision|0
5232920|NCT00872521|18059157|P3|Completed 3-month Follow up|Other|0
5232921|NCT00872521|18059158|P2|Completed 3-month Follow up|Other|2
5232922|NCT00872521|18059159|P1|Completed 3-month Follow up|Other|0
5232923|NCT00872521|18059157|P3|Primary Endpoint Analysis|Patient response missing|1
5232924|NCT00872521|18059158|P2|Primary Endpoint Analysis|Patient response missing|0
5232925|NCT00872521|18059159|P1|Primary Endpoint Analysis|Patient response missing|0
5232926|NCT00872521|18059157|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
5232927|NCT00872521|18059158|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
5232928|NCT00872521|18059159|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
5232929|NCT00872521|18059157|P3|Primary Endpoint Analysis|Patient choice|0
5232930|NCT00872521|18059158|P2|Primary Endpoint Analysis|Patient choice|1
5232931|NCT00872521|18059159|P1|Primary Endpoint Analysis|Patient choice|0
5232932|NCT00872521|18059157|P3|Primary Endpoint Analysis|Other|0
5232933|NCT00872521|18059158|P2|Primary Endpoint Analysis|Other|2
5232934|NCT00872521|18059159|P1|Primary Endpoint Analysis|Other|1
5232935|NCT00872521|18059157|P3|Completed PAD Induction|Death|0
5232936|NCT00872521|18059158|P2|Completed PAD Induction|Death|1
5232937|NCT00872521|18059159|P1|Completed PAD Induction|Death|1
5232938|NCT00872521|18059157|P3|Completed PAD Induction|Adverse Event|0
5232939|NCT00872521|18059158|P2|Completed PAD Induction|Adverse Event|0
5232940|NCT00872521|18059159|P1|Completed PAD Induction|Adverse Event|4
5232941|NCT00872521|18059157|P3|Completed PAD Induction|Disease progression|0
5232942|NCT00872521|18059158|P2|Completed PAD Induction|Disease progression|2
5232943|NCT00872521|18059159|P1|Completed PAD Induction|Disease progression|0
5232944|NCT00872521|18059157|P3|Completed PAD Induction|Patient choice|0
5232945|NCT00872521|18059158|P2|Completed PAD Induction|Patient choice|1
5232946|NCT00872521|18059159|P1|Completed PAD Induction|Patient choice|0
5232947|NCT00872170|18059230|P2|Overall Study|Adverse Event|0
5232948|NCT00872170|18059231|P1|Overall Study|Adverse Event|1
5232949|NCT00872001|18059261|P2|Overall Study|Administrative|15
5232950|NCT00872001|18059262|P1|Overall Study|Administrative|23
5232951|NCT00872001|18059261|P2|Overall Study|Did Not Meet Protocol Eligibility|36
5232952|NCT00872001|18059262|P1|Overall Study|Did Not Meet Protocol Eligibility|38
5232953|NCT00872001|18059261|P2|Overall Study|Protocol Violation|8
5232954|NCT00872001|18059262|P1|Overall Study|Protocol Violation|5
5232955|NCT00872001|18059261|P2|Overall Study|Withdrawal by Subject|30
5232956|NCT00872001|18059262|P1|Overall Study|Withdrawal by Subject|18
5232957|NCT00872001|18059261|P2|Overall Study|Lost to Follow-up|12
5232958|NCT00872001|18059262|P1|Overall Study|Lost to Follow-up|13
5232959|NCT00872001|18059261|P2|Overall Study|Protocol Defined Clinical Event|7
5232960|NCT00872001|18059262|P1|Overall Study|Protocol Defined Clinical Event|5
5232961|NCT00872001|18059261|P2|Overall Study|Adverse Event|23
5232962|NCT00872001|18059262|P1|Overall Study|Adverse Event|34
5232963|NCT00871975|18059270|P1|Overall Study|Motion artifact, tracing uninterpretable|5
5232964|NCT00871975|18059270|P1|Overall Study|Patient unable to void/insufficient vol|13
5232965|NCT00871975|18059270|P1|Overall Study|Catheters could not be inserted|1
5232966|NCT00871975|18059270|P1|Overall Study|Technical difficulty w155-1ith equipment|3
5232967|NCT00871871|18059276|P4|Part II|Protocol Violation|1
5232968|NCT00871871|18059277|P3|Part II|Protocol Violation|0
5232969|NCT00871871|18059278|P2|Part II|Protocol Violation|0
5232970|NCT00871871|18059279|P1|Part II|Protocol Violation|0
5232971|NCT00871871|18059276|P4|Part II|Adverse Event|2
5232972|NCT00871871|18059277|P3|Part II|Adverse Event|1
5232973|NCT00871871|18059278|P2|Part II|Adverse Event|0
5232974|NCT00871871|18059279|P1|Part II|Adverse Event|0
5232975|NCT00871871|18059276|P4|Part II|Withdrawal by Subject|1
5232976|NCT00871871|18059277|P3|Part II|Withdrawal by Subject|2
5232977|NCT00871871|18059278|P2|Part II|Withdrawal by Subject|0
5232978|NCT00871871|18059279|P1|Part II|Withdrawal by Subject|0
5232979|NCT00871871|18059276|P4|Part II|Lack of Efficacy|0
5232980|NCT00871871|18059277|P3|Part II|Lack of Efficacy|1
5232981|NCT00871871|18059278|P2|Part II|Lack of Efficacy|0
5232982|NCT00871871|18059279|P1|Part II|Lack of Efficacy|0
5232983|NCT00871871|18059276|P4|Part I|Laboratory abnormality|0
5232984|NCT00871871|18059277|P3|Part I|Laboratory abnormality|0
5232985|NCT00871871|18059278|P2|Part I|Laboratory abnormality|1
5232986|NCT00871871|18059279|P1|Part I|Laboratory abnormality|0
5232987|NCT00871871|18059276|P4|Part I|Withdrawal by Subject|0
5232988|NCT00871871|18059277|P3|Part I|Withdrawal by Subject|0
5232989|NCT00871871|18059278|P2|Part I|Withdrawal by Subject|0
5232990|NCT00871871|18059279|P1|Part I|Withdrawal by Subject|3
5232991|NCT00871871|18059276|P4|Part I|Adverse Event|0
5232992|NCT00871871|18059277|P3|Part I|Adverse Event|0
5232993|NCT00871871|18059278|P2|Part I|Adverse Event|2
5232994|NCT00871871|18059279|P1|Part I|Adverse Event|0
5232995|NCT00871780|18059316|P1|Overall Study|Physician Decision|1
5232996|NCT00871780|18059316|P1|Overall Study|Death|1
5232997|NCT00871780|18059316|P1|Overall Study|Voluntary Discontinuation|4
5232998|NCT00871780|18059316|P1|Overall Study|Adverse Event|6
5232999|NCT00871780|18059316|P1|Overall Study|Withdrawal by Subject|9
5233000|NCT00871780|18059316|P1|Overall Study|Enrolled But Not Treated|6
5233001|NCT00871741|18059336|P2|Overall Study|Premature study termination|7
5233002|NCT00871741|18059337|P1|Overall Study|Premature study termination|9
5233003|NCT00871728|18059351|P1|Overall Study|Withdrawal of Informed Consent|5
5233004|NCT00871728|18059351|P1|Overall Study|Participant Non-compliance|1
5233005|NCT00871728|18059351|P1|Overall Study|Failed to Visit Hospital|4
5233006|NCT00871728|18059351|P1|Overall Study|Lost to Follow-up|2
5233007|NCT00871728|18059351|P1|Overall Study|Protocol Violation|7
5233008|NCT00871728|18059351|P1|Overall Study|Adverse Event|1
5233009|NCT00871715|18059364|P3|Overall Study|Lost to Follow-up|9
5233010|NCT00871715|18059365|P2|Overall Study|Lost to Follow-up|6
5233011|NCT00871715|18059366|P1|Overall Study|Lost to Follow-up|3
5233012|NCT00871715|18059364|P3|Overall Study|Physician Decision|2
5233013|NCT00871715|18059365|P2|Overall Study|Physician Decision|0
5233014|NCT00871715|18059366|P1|Overall Study|Physician Decision|6
5233015|NCT00871715|18059364|P3|Overall Study|Withdrawal by Subject|15
5233016|NCT00871715|18059365|P2|Overall Study|Withdrawal by Subject|10
5233017|NCT00871715|18059366|P1|Overall Study|Withdrawal by Subject|6
5233018|NCT00871572|18059443|P4|Overall Study|Withdrawal by Subject|1
5233019|NCT00871572|18059444|P3|Overall Study|Withdrawal by Subject|3
5233020|NCT00871572|18059445|P2|Overall Study|Withdrawal by Subject|2
5233021|NCT00871572|18059446|P1|Overall Study|Withdrawal by Subject|1
5233022|NCT00871572|18059443|P4|Overall Study|Sponsor Decision|0
5233023|NCT00871572|18059444|P3|Overall Study|Sponsor Decision|0
5233024|NCT00871572|18059445|P2|Overall Study|Sponsor Decision|0
5233025|NCT00871572|18059446|P1|Overall Study|Sponsor Decision|1
5233026|NCT00871572|18059443|P4|Overall Study|Protocol Violation|1
5233027|NCT00871572|18059444|P3|Overall Study|Protocol Violation|1
5233028|NCT00871572|18059445|P2|Overall Study|Protocol Violation|0
5233029|NCT00871572|18059446|P1|Overall Study|Protocol Violation|0
5233030|NCT00871572|18059443|P4|Overall Study|Lost to Follow-up|1
5233031|NCT00871572|18059444|P3|Overall Study|Lost to Follow-up|0
5233032|NCT00871572|18059445|P2|Overall Study|Lost to Follow-up|1
5233033|NCT00871572|18059446|P1|Overall Study|Lost to Follow-up|0
5233034|NCT00871572|18059443|P4|Overall Study|Investigator Decision|1
5233035|NCT00871572|18059444|P3|Overall Study|Investigator Decision|0
5233036|NCT00871572|18059445|P2|Overall Study|Investigator Decision|1
5233037|NCT00871572|18059446|P1|Overall Study|Investigator Decision|0
5233038|NCT00871572|18059443|P4|Overall Study|Adverse Event|3
5233039|NCT00871572|18059444|P3|Overall Study|Adverse Event|0
5233040|NCT00871572|18059445|P2|Overall Study|Adverse Event|2
5233041|NCT00871572|18059446|P1|Overall Study|Adverse Event|0
5233042|NCT00871494|18059516|P1|Overall Study|Lost to Follow-up|1
5233043|NCT00871494|18059516|P1|Overall Study|Adverse Event|4
5233044|NCT00871494|18059516|P1|Overall Study|Lack of Efficacy|4
5233045|NCT00871494|18059516|P1|Overall Study|Protocol Violation|5
5233046|NCT00871429|18059523|P1|Overall Study|Questionnaire not completed|1
5233047|NCT00871429|18059523|P1|Overall Study|Withdrawal by Subject|17
5233048|NCT00871429|18059523|P1|Overall Study|Lost to Follow-up|6
5233049|NCT00871403|18059534|P3|Monotherapy Treatment Phase|Adverse Event|0
5233050|NCT00871403|18059535|P2|Monotherapy Treatment Phase|Adverse Event|4
5233051|NCT00871403|18059536|P1|Monotherapy Treatment Phase|Adverse Event|0
5233052|NCT00871403|18059534|P3|Monotherapy Treatment Phase|Disease Progression|1
5233053|NCT00871403|18059535|P2|Monotherapy Treatment Phase|Disease Progression|9
5233054|NCT00871403|18059536|P1|Monotherapy Treatment Phase|Disease Progression|0
5233055|NCT00871403|18059534|P3|Combination Treatment Phase|Physician Decision|3
5233056|NCT00871403|18059535|P2|Combination Treatment Phase|Physician Decision|1
5233057|NCT00871403|18059536|P1|Combination Treatment Phase|Physician Decision|0
5233058|NCT00871403|18059534|P3|Combination Treatment Phase|Withdrawal by Subject|1
5233059|NCT00871403|18059535|P2|Combination Treatment Phase|Withdrawal by Subject|3
5233060|NCT00871403|18059536|P1|Combination Treatment Phase|Withdrawal by Subject|0
5233061|NCT00871403|18059534|P3|Combination Treatment Phase|Disease Progression|5
5233062|NCT00871403|18059535|P2|Combination Treatment Phase|Disease Progression|8
5233063|NCT00871403|18059536|P1|Combination Treatment Phase|Disease Progression|0
5233064|NCT00871403|18059534|P3|Combination Treatment Phase|Adverse Event|2
5233065|NCT00871403|18059535|P2|Combination Treatment Phase|Adverse Event|17
5233066|NCT00871403|18059536|P1|Combination Treatment Phase|Adverse Event|0
5233067|NCT00871403|18059534|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
5233068|NCT00871403|18059535|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
5233069|NCT00871403|18059536|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
5233070|NCT00871403|18059534|P3|Combination Treatment Phase|Randomized but Not Treated|1
5233071|NCT00871403|18059535|P2|Combination Treatment Phase|Randomized but Not Treated|1
5233072|NCT00871403|18059536|P1|Combination Treatment Phase|Randomized but Not Treated|1
5233073|NCT00871377|18059549|P6|Third Intervention (10 Weeks)|Death|0
5233074|NCT00871377|18059550|P5|Third Intervention (10 Weeks)|Death|0
5233075|NCT00871377|18059551|P4|Third Intervention (10 Weeks)|Death|1
5233076|NCT00871377|18059552|P3|Third Intervention (10 Weeks)|Death|0
5233077|NCT00871377|18059553|P2|Third Intervention (10 Weeks)|Death|0
5233078|NCT00871377|18059554|P1|Third Intervention (10 Weeks)|Death|0
5233079|NCT00871377|18059549|P6|Washout (6 Weeks)|Withdrawal by Subject|1
5233080|NCT00871377|18059550|P5|Washout (6 Weeks)|Withdrawal by Subject|0
5233081|NCT00871377|18059551|P4|Washout (6 Weeks)|Withdrawal by Subject|0
5233082|NCT00871377|18059552|P3|Washout (6 Weeks)|Withdrawal by Subject|0
5233083|NCT00871377|18059553|P2|Washout (6 Weeks)|Withdrawal by Subject|0
5233084|NCT00871377|18059554|P1|Washout (6 Weeks)|Withdrawal by Subject|0
5233085|NCT00871377|18059549|P6|Washout (6 Weeks)|Withdrawal by Subject|0
5233086|NCT00871377|18059550|P5|Washout (6 Weeks)|Withdrawal by Subject|0
5233087|NCT00871377|18059551|P4|Washout (6 Weeks)|Withdrawal by Subject|0
5233088|NCT00871377|18059552|P3|Washout (6 Weeks)|Withdrawal by Subject|0
5233089|NCT00871377|18059553|P2|Washout (6 Weeks)|Withdrawal by Subject|0
5233090|NCT00871377|18059554|P1|Washout (6 Weeks)|Withdrawal by Subject|1
5233091|NCT00871377|18059549|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
5233092|NCT00871377|18059550|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
5233093|NCT00871377|18059551|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
5233184|NCT00870233|18060059|P1|Overall Study|Death|1
5233094|NCT00871377|18059552|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
5233095|NCT00871377|18059553|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
5233096|NCT00871377|18059554|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
5233097|NCT00871377|18059549|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
5233098|NCT00871377|18059550|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
5233099|NCT00871377|18059551|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
5233100|NCT00871377|18059552|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
5233101|NCT00871377|18059553|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
5233102|NCT00871377|18059554|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
5233103|NCT00871351|18059565|P3|Overall Study|Adverse Event|0
5233104|NCT00871351|18059566|P2|Overall Study|Adverse Event|1
5233105|NCT00871351|18059567|P1|Overall Study|Adverse Event|3
5233106|NCT00871351|18059565|P3|Overall Study|Withdrawal by Subject|0
5233107|NCT00871351|18059566|P2|Overall Study|Withdrawal by Subject|0
5233108|NCT00871351|18059567|P1|Overall Study|Withdrawal by Subject|1
5233109|NCT00871338|18059589|P2|Prior to Booster|Lost to Follow-up|0
5233110|NCT00871338|18059590|P1|Prior to Booster|Lost to Follow-up|1
5233111|NCT00871338|18059589|P2|Prior to Booster|Withdrawal by Subject|3
5233112|NCT00871338|18059590|P1|Prior to Booster|Withdrawal by Subject|1
5233113|NCT00871234|18059679|P1|Overall Study|Lost to Follow-up|3
5233114|NCT00871234|18059679|P1|Overall Study|Adverse Event|2
5233115|NCT00871169|18059683|P1|Overall Study|Patient did not receive study treatment|2
5233116|NCT00871169|18059683|P1|Overall Study|Protocol Violation|1
5233117|NCT00871117|18059711|P2|Overall Study|Other|4
5233118|NCT00871117|18059712|P1|Overall Study|Other|0
5233119|NCT00871117|18059711|P2|Overall Study|Lost to Follow-up|6
5233120|NCT00871117|18059712|P1|Overall Study|Lost to Follow-up|5
5233121|NCT00871000|18059746|P2|Overall Study|Withdrawal by Subject|0
5233122|NCT00871000|18059747|P1|Overall Study|Withdrawal by Subject|1
5233123|NCT00870870|18059799|P4|Overall Study|Adverse Event|2
5233124|NCT00870870|18059800|P3|Overall Study|Adverse Event|2
5233125|NCT00870870|18059801|P2|Overall Study|Adverse Event|0
5233126|NCT00870870|18059802|P1|Overall Study|Adverse Event|0
5233127|NCT00870870|18059799|P4|Overall Study|Withdrawal by Subject|3
5233128|NCT00870870|18059800|P3|Overall Study|Withdrawal by Subject|1
5233129|NCT00870870|18059801|P2|Overall Study|Withdrawal by Subject|1
5233130|NCT00870870|18059802|P1|Overall Study|Withdrawal by Subject|0
5233131|NCT00870740|18059846|P6|Overall Study|Other|5
5233132|NCT00870740|18059847|P5|Overall Study|Other|3
5233133|NCT00870740|18059848|P4|Overall Study|Other|4
5233134|NCT00870740|18059849|P3|Overall Study|Other|2
5233135|NCT00870740|18059850|P2|Overall Study|Other|5
5233136|NCT00870740|18059851|P1|Overall Study|Other|2
5233137|NCT00870740|18059846|P6|Overall Study|Death|0
5233138|NCT00870740|18059847|P5|Overall Study|Death|1
5233139|NCT00870740|18059848|P4|Overall Study|Death|0
5233140|NCT00870740|18059849|P3|Overall Study|Death|0
5233141|NCT00870740|18059850|P2|Overall Study|Death|0
5233142|NCT00870740|18059851|P1|Overall Study|Death|0
5233143|NCT00870740|18059846|P6|Overall Study|Subject Non-compliance|1
5233144|NCT00870740|18059847|P5|Overall Study|Subject Non-compliance|0
5233145|NCT00870740|18059848|P4|Overall Study|Subject Non-compliance|0
5233146|NCT00870740|18059849|P3|Overall Study|Subject Non-compliance|0
5233147|NCT00870740|18059850|P2|Overall Study|Subject Non-compliance|0
5233148|NCT00870740|18059851|P1|Overall Study|Subject Non-compliance|0
5233149|NCT00870740|18059846|P6|Overall Study|Investigator Decision|0
5233150|NCT00870740|18059847|P5|Overall Study|Investigator Decision|0
5233151|NCT00870740|18059848|P4|Overall Study|Investigator Decision|0
5233152|NCT00870740|18059849|P3|Overall Study|Investigator Decision|1
5233153|NCT00870740|18059850|P2|Overall Study|Investigator Decision|0
5233154|NCT00870740|18059851|P1|Overall Study|Investigator Decision|2
5233155|NCT00870740|18059846|P6|Overall Study|Consent Withdrawn|5
5233156|NCT00870740|18059847|P5|Overall Study|Consent Withdrawn|6
5233157|NCT00870740|18059848|P4|Overall Study|Consent Withdrawn|6
5233158|NCT00870740|18059849|P3|Overall Study|Consent Withdrawn|4
5233159|NCT00870740|18059850|P2|Overall Study|Consent Withdrawn|3
5233160|NCT00870740|18059851|P1|Overall Study|Consent Withdrawn|6
5233161|NCT00870740|18059846|P6|Overall Study|Adverse Event|6
5233162|NCT00870740|18059847|P5|Overall Study|Adverse Event|1
5233163|NCT00870740|18059848|P4|Overall Study|Adverse Event|2
5233164|NCT00870740|18059849|P3|Overall Study|Adverse Event|3
5233165|NCT00870740|18059850|P2|Overall Study|Adverse Event|1
5233166|NCT00870740|18059851|P1|Overall Study|Adverse Event|2
5233167|NCT00870727|18059927|P2|Overall Study|Adverse Event|1
5233168|NCT00870727|18059928|P1|Overall Study|Adverse Event|0
5233169|NCT00870727|18059927|P2|Overall Study|Lack of Efficacy|3
5233170|NCT00870727|18059928|P1|Overall Study|Lack of Efficacy|1
5233171|NCT00870727|18059927|P2|Overall Study|Lost to Follow-up|1
5233172|NCT00870727|18059928|P1|Overall Study|Lost to Follow-up|0
5233173|NCT00870688|18059944|P1|Overall Study|Granules in the Stools|1
5233174|NCT00870688|18059944|P1|Overall Study|Death, Unrelated|1
5233175|NCT00870688|18059944|P1|Overall Study|Lost to Follow-up|2
5233176|NCT00870584|18059949|P2|Overall Study|Protocol Deviation|2
5233177|NCT00870584|18059950|P1|Overall Study|Protocol Deviation|2
5233178|NCT00870584|18059949|P2|Overall Study|Lost to Follow-up|1
5233179|NCT00870584|18059950|P1|Overall Study|Lost to Follow-up|5
5233180|NCT00870584|18059949|P2|Overall Study|Withdrawal by Subject|7
5233181|NCT00870584|18059950|P1|Overall Study|Withdrawal by Subject|6
5233182|NCT00870584|18059949|P2|Overall Study|Adverse Event|3
5233183|NCT00870584|18059950|P1|Overall Study|Adverse Event|3
5233185|NCT00870233|18060059|P1|Overall Study|Incompatible internet browser|2
5233186|NCT00870233|18060059|P1|Overall Study|Did not undergo laparotomy|3
5233187|NCT00870233|18060059|P1|Overall Study|Withdrawal by Subject|18
5233188|NCT00870194|18060068|P2|Overall Study|Subject Decision|2
5233189|NCT00870194|18060069|P1|Overall Study|Subject Decision|7
5233190|NCT00870194|18060068|P2|Overall Study|Entry Criteria Not Met|2
5233191|NCT00870194|18060069|P1|Overall Study|Entry Criteria Not Met|1
5233192|NCT00870194|18060068|P2|Overall Study|Protocol Violation|3
5233193|NCT00870194|18060069|P1|Overall Study|Protocol Violation|3
5233194|NCT00870194|18060068|P2|Overall Study|Physician Decision|1
5233195|NCT00870194|18060069|P1|Overall Study|Physician Decision|3
5233196|NCT00870194|18060068|P2|Overall Study|Lost to Follow-up|0
5233197|NCT00870194|18060069|P1|Overall Study|Lost to Follow-up|2
5233198|NCT00870194|18060068|P2|Overall Study|Lack of Efficacy|1
5233199|NCT00870194|18060069|P1|Overall Study|Lack of Efficacy|0
5233200|NCT00870194|18060068|P2|Overall Study|Adverse Event|5
5233201|NCT00870194|18060069|P1|Overall Study|Adverse Event|10
5233202|NCT00870103|18060107|P1|Overall Study|Lost to Follow-up|2
5233203|NCT00870103|18060107|P1|Overall Study|Physician Decision|2
5233204|NCT00869999|18060112|P1|Overall Study|removed prior to starting therapy|1
5233205|NCT00869999|18060112|P1|Overall Study|Withdrawal by Subject|1
5233206|NCT00869960|18060118|P1|Overall Study|Lost to Follow-up|2
5233207|NCT00869778|18060167|P3|Overall Study|Unblinding|0
5233208|NCT00869778|18060168|P2|Overall Study|Unblinding|0
5233209|NCT00869778|18060169|P1|Overall Study|Unblinding|1
5233210|NCT00869778|18060167|P3|Overall Study|Protocol Violation|5
5233211|NCT00869778|18060168|P2|Overall Study|Protocol Violation|3
5233212|NCT00869778|18060169|P1|Overall Study|Protocol Violation|5
5233213|NCT00869778|18060167|P3|Overall Study|Pregnancy|0
5233214|NCT00869778|18060168|P2|Overall Study|Pregnancy|0
5233215|NCT00869778|18060169|P1|Overall Study|Pregnancy|1
5233216|NCT00869778|18060167|P3|Overall Study|Withdrawal by Subject|5
5233217|NCT00869778|18060168|P2|Overall Study|Withdrawal by Subject|4
5233218|NCT00869778|18060169|P1|Overall Study|Withdrawal by Subject|3
5233219|NCT00869778|18060167|P3|Overall Study|Adverse Event|0
5233220|NCT00869778|18060168|P2|Overall Study|Adverse Event|0
5233221|NCT00869778|18060169|P1|Overall Study|Adverse Event|2
5233222|NCT00869557|18060244|P2|Extension Phase|Withdrew Consent|0
5233223|NCT00869557|18060245|P1|Extension Phase|Withdrew Consent|2
5233224|NCT00869557|18060244|P2|Extension Phase|Investigator's Discretion|0
5233225|NCT00869557|18060245|P1|Extension Phase|Investigator's Discretion|2
5233226|NCT00869557|18060244|P2|Extension Phase|Lost to Follow-up|1
5233227|NCT00869557|18060245|P1|Extension Phase|Lost to Follow-up|3
5233228|NCT00869557|18060244|P2|Extension Phase|Lack of Efficacy|0
5233229|NCT00869557|18060245|P1|Extension Phase|Lack of Efficacy|1
5233230|NCT00869557|18060244|P2|Extension Phase|Adverse Event|2
5233231|NCT00869557|18060245|P1|Extension Phase|Adverse Event|2
5233232|NCT00869557|18060244|P2|Randomized Phase|Withdrew Consent|1
5233233|NCT00869557|18060245|P1|Randomized Phase|Withdrew Consent|0
5233234|NCT00869557|18060244|P2|Randomized Phase|Investigator's Discretion|0
5233235|NCT00869557|18060245|P1|Randomized Phase|Investigator's Discretion|1
5233236|NCT00869557|18060244|P2|Randomized Phase|Lost to Follow-up|1
5233237|NCT00869557|18060245|P1|Randomized Phase|Lost to Follow-up|2
5233238|NCT00869518|18060264|P2|Overall Study|Lost to Follow-up|1
5233239|NCT00869518|18060265|P1|Overall Study|Lost to Follow-up|1
5233240|NCT00869440|18060281|P4|Overall Study|Physician Decision|0
5233241|NCT00869440|18060282|P3|Overall Study|Physician Decision|0
5233242|NCT00869440|18060283|P2|Overall Study|Physician Decision|1
5233243|NCT00869440|18060284|P1|Overall Study|Physician Decision|1
5233244|NCT00869440|18060281|P4|Overall Study|Withdrawal by Subject|0
5233245|NCT00869440|18060282|P3|Overall Study|Withdrawal by Subject|0
5233246|NCT00869440|18060283|P2|Overall Study|Withdrawal by Subject|0
5233247|NCT00869440|18060284|P1|Overall Study|Withdrawal by Subject|1
5233248|NCT00869401|18060318|P5|Overall Study|Withdrawal by Subject|3
5233249|NCT00869401|18060319|P4|Overall Study|Withdrawal by Subject|5
5233250|NCT00869401|18060320|P3|Overall Study|Withdrawal by Subject|0
5233251|NCT00869401|18060321|P2|Overall Study|Withdrawal by Subject|0
5233252|NCT00869401|18060322|P1|Overall Study|Withdrawal by Subject|0
5233253|NCT00869362|18060351|P2|Overall Study|Lost to Follow-up|3
5233254|NCT00869362|18060352|P1|Overall Study|Lost to Follow-up|1
5233255|NCT00869362|18060351|P2|Overall Study|Death|2
5233256|NCT00869362|18060352|P1|Overall Study|Death|0
5233257|NCT00869323|18060373|P1|Maintenance Therapy|concurrent illness|1
5233258|NCT00869258|18060381|P1|Overall Study|Physician Decision|1
5233259|NCT00869128|18060446|P2|Overall Study|lack of Compliance|6
5233260|NCT00869128|18060447|P1|Overall Study|lack of Compliance|6
5233261|NCT00869089|18060451|P1|Overall Study|Screen Fail|1
5233262|NCT00869089|18060451|P1|Overall Study|Withdrawal by Subject|1
5233263|NCT00869089|18060451|P1|Overall Study|Lost to Follow-up|1
5233264|NCT00869050|18060455|P1|Overall Study|Screen Failure|3
5233265|NCT00869024|18060462|P2|Overall Study|Protocol Violation|1
5233266|NCT00869024|18060463|P1|Overall Study|Protocol Violation|0
5233267|NCT00869024|18060462|P2|Overall Study|Lost to Follow-up|1
5233268|NCT00869024|18060463|P1|Overall Study|Lost to Follow-up|0
5233269|NCT00869024|18060462|P2|Overall Study|Death|3
5233270|NCT00869024|18060463|P1|Overall Study|Death|2
5233271|NCT00868998|18060479|P1|Overall Study|Death|1
5233272|NCT00868998|18060479|P1|Overall Study|Progression of disease|2
5233273|NCT00868998|18060479|P1|Overall Study|Withdrawal by Subject|1
5233274|NCT00868998|18060479|P1|Overall Study|Screen Failure|1
5233275|NCT00868790|18060490|P14|Post-study|Excluded Medication|0
5233276|NCT00868790|18060491|P13|Post-study|Excluded Medication|0
5233277|NCT00868790|18060492|P12|Post-study|Excluded Medication|0
5233278|NCT00868790|18060493|P11|Post-study|Excluded Medication|0
5233279|NCT00868790|18060494|P10|Post-study|Excluded Medication|1
5233280|NCT00868790|18060495|P9|Post-study|Excluded Medication|0
5233281|NCT00868790|18060496|P8|Post-study|Excluded Medication|2
5233282|NCT00868790|18060497|P7|Post-study|Excluded Medication|0
5233283|NCT00868790|18060498|P6|Post-study|Excluded Medication|0
5233284|NCT00868790|18060499|P5|Post-study|Excluded Medication|0
5233285|NCT00868790|18060500|P4|Post-study|Excluded Medication|0
5233286|NCT00868790|18060501|P3|Post-study|Excluded Medication|0
5233287|NCT00868790|18060502|P2|Post-study|Excluded Medication|0
5233288|NCT00868790|18060503|P1|Post-study|Excluded Medication|0
5233289|NCT00868790|18060490|P14|Post-study|Withdrawal by Subject|0
5233290|NCT00868790|18060491|P13|Post-study|Withdrawal by Subject|0
5233291|NCT00868790|18060492|P12|Post-study|Withdrawal by Subject|0
5233292|NCT00868790|18060493|P11|Post-study|Withdrawal by Subject|0
5233293|NCT00868790|18060494|P10|Post-study|Withdrawal by Subject|0
5233294|NCT00868790|18060495|P9|Post-study|Withdrawal by Subject|0
5233295|NCT00868790|18060496|P8|Post-study|Withdrawal by Subject|0
5233296|NCT00868790|18060497|P7|Post-study|Withdrawal by Subject|0
5233297|NCT00868790|18060498|P6|Post-study|Withdrawal by Subject|0
5233298|NCT00868790|18060499|P5|Post-study|Withdrawal by Subject|1
5233299|NCT00868790|18060500|P4|Post-study|Withdrawal by Subject|0
5233300|NCT00868790|18060501|P3|Post-study|Withdrawal by Subject|0
5233301|NCT00868790|18060502|P2|Post-study|Withdrawal by Subject|0
5233302|NCT00868790|18060503|P1|Post-study|Withdrawal by Subject|0
5233303|NCT00868790|18060490|P14|Period 4|Abnormal ALT/AST|0
5233304|NCT00868790|18060491|P13|Period 4|Abnormal ALT/AST|0
5233305|NCT00868790|18060492|P12|Period 4|Abnormal ALT/AST|0
5233306|NCT00868790|18060493|P11|Period 4|Abnormal ALT/AST|0
5233307|NCT00868790|18060494|P10|Period 4|Abnormal ALT/AST|0
5233308|NCT00868790|18060495|P9|Period 4|Abnormal ALT/AST|0
5233309|NCT00868790|18060496|P8|Period 4|Abnormal ALT/AST|0
5233310|NCT00868790|18060497|P7|Period 4|Abnormal ALT/AST|0
5233311|NCT00868790|18060498|P6|Period 4|Abnormal ALT/AST|0
5233312|NCT00868790|18060499|P5|Period 4|Abnormal ALT/AST|0
5233313|NCT00868790|18060500|P4|Period 4|Abnormal ALT/AST|0
5233314|NCT00868790|18060501|P3|Period 4|Abnormal ALT/AST|1
5233315|NCT00868790|18060502|P2|Period 4|Abnormal ALT/AST|0
5233316|NCT00868790|18060503|P1|Period 4|Abnormal ALT/AST|0
5233317|NCT00868790|18060490|P14|Period 4|Study Terminated by Sponsor|1
5233318|NCT00868790|18060491|P13|Period 4|Study Terminated by Sponsor|0
5233319|NCT00868790|18060492|P12|Period 4|Study Terminated by Sponsor|1
5233320|NCT00868790|18060493|P11|Period 4|Study Terminated by Sponsor|2
5233321|NCT00868790|18060494|P10|Period 4|Study Terminated by Sponsor|0
5233322|NCT00868790|18060495|P9|Period 4|Study Terminated by Sponsor|2
5233323|NCT00868790|18060496|P8|Period 4|Study Terminated by Sponsor|1
5233324|NCT00868790|18060497|P7|Period 4|Study Terminated by Sponsor|0
5233325|NCT00868790|18060498|P6|Period 4|Study Terminated by Sponsor|0
5233326|NCT00868790|18060499|P5|Period 4|Study Terminated by Sponsor|0
5233327|NCT00868790|18060500|P4|Period 4|Study Terminated by Sponsor|0
5233328|NCT00868790|18060501|P3|Period 4|Study Terminated by Sponsor|0
5233329|NCT00868790|18060502|P2|Period 4|Study Terminated by Sponsor|0
5233330|NCT00868790|18060503|P1|Period 4|Study Terminated by Sponsor|2
5233331|NCT00868790|18060490|P14|Period 4|Lost to Follow-up|0
5233332|NCT00868790|18060491|P13|Period 4|Lost to Follow-up|0
5233333|NCT00868790|18060492|P12|Period 4|Lost to Follow-up|0
5233334|NCT00868790|18060493|P11|Period 4|Lost to Follow-up|0
5233335|NCT00868790|18060494|P10|Period 4|Lost to Follow-up|0
5233336|NCT00868790|18060495|P9|Period 4|Lost to Follow-up|0
5233337|NCT00868790|18060496|P8|Period 4|Lost to Follow-up|1
5233338|NCT00868790|18060497|P7|Period 4|Lost to Follow-up|0
5233339|NCT00868790|18060498|P6|Period 4|Lost to Follow-up|0
5233340|NCT00868790|18060499|P5|Period 4|Lost to Follow-up|0
5233341|NCT00868790|18060500|P4|Period 4|Lost to Follow-up|0
5233342|NCT00868790|18060501|P3|Period 4|Lost to Follow-up|0
5233343|NCT00868790|18060502|P2|Period 4|Lost to Follow-up|0
5233344|NCT00868790|18060503|P1|Period 4|Lost to Follow-up|0
5233345|NCT00868790|18060490|P14|Period 4|Adverse Event|0
5233346|NCT00868790|18060491|P13|Period 4|Adverse Event|1
5233347|NCT00868790|18060492|P12|Period 4|Adverse Event|0
5233348|NCT00868790|18060493|P11|Period 4|Adverse Event|1
5233349|NCT00868790|18060494|P10|Period 4|Adverse Event|0
5233350|NCT00868790|18060495|P9|Period 4|Adverse Event|0
5233351|NCT00868790|18060496|P8|Period 4|Adverse Event|1
5233352|NCT00868790|18060497|P7|Period 4|Adverse Event|0
5233353|NCT00868790|18060498|P6|Period 4|Adverse Event|0
5233354|NCT00868790|18060499|P5|Period 4|Adverse Event|0
5233355|NCT00868790|18060500|P4|Period 4|Adverse Event|0
5233356|NCT00868790|18060501|P3|Period 4|Adverse Event|0
5233357|NCT00868790|18060502|P2|Period 4|Adverse Event|0
5233358|NCT00868790|18060503|P1|Period 4|Adverse Event|0
5233359|NCT00868790|18060490|P14|Period 3|Study Terminated by Sponsor|0
5233360|NCT00868790|18060491|P13|Period 3|Study Terminated by Sponsor|0
5233361|NCT00868790|18060492|P12|Period 3|Study Terminated by Sponsor|0
5233362|NCT00868790|18060493|P11|Period 3|Study Terminated by Sponsor|0
5233363|NCT00868790|18060494|P10|Period 3|Study Terminated by Sponsor|0
5233364|NCT00868790|18060495|P9|Period 3|Study Terminated by Sponsor|0
5233365|NCT00868790|18060496|P8|Period 3|Study Terminated by Sponsor|0
5233366|NCT00868790|18060497|P7|Period 3|Study Terminated by Sponsor|0
5233367|NCT00868790|18060498|P6|Period 3|Study Terminated by Sponsor|0
5233368|NCT00868790|18060499|P5|Period 3|Study Terminated by Sponsor|0
5233369|NCT00868790|18060500|P4|Period 3|Study Terminated by Sponsor|1
5233370|NCT00868790|18060501|P3|Period 3|Study Terminated by Sponsor|0
5233371|NCT00868790|18060502|P2|Period 3|Study Terminated by Sponsor|0
5233372|NCT00868790|18060503|P1|Period 3|Study Terminated by Sponsor|0
5233373|NCT00868790|18060490|P14|Period 3|Protocol Violation|0
5233374|NCT00868790|18060491|P13|Period 3|Protocol Violation|0
5233375|NCT00868790|18060492|P12|Period 3|Protocol Violation|0
5233376|NCT00868790|18060493|P11|Period 3|Protocol Violation|1
5233377|NCT00868790|18060494|P10|Period 3|Protocol Violation|0
5233378|NCT00868790|18060495|P9|Period 3|Protocol Violation|0
5233379|NCT00868790|18060496|P8|Period 3|Protocol Violation|0
5233380|NCT00868790|18060497|P7|Period 3|Protocol Violation|0
5233381|NCT00868790|18060498|P6|Period 3|Protocol Violation|0
5233382|NCT00868790|18060499|P5|Period 3|Protocol Violation|0
5233383|NCT00868790|18060500|P4|Period 3|Protocol Violation|0
5233384|NCT00868790|18060501|P3|Period 3|Protocol Violation|0
5233385|NCT00868790|18060502|P2|Period 3|Protocol Violation|0
5233386|NCT00868790|18060503|P1|Period 3|Protocol Violation|0
5233387|NCT00868790|18060490|P14|Period 3|Adverse Event|0
5233388|NCT00868790|18060491|P13|Period 3|Adverse Event|0
5233389|NCT00868790|18060492|P12|Period 3|Adverse Event|0
5233390|NCT00868790|18060493|P11|Period 3|Adverse Event|0
5233391|NCT00868790|18060494|P10|Period 3|Adverse Event|1
5233392|NCT00868790|18060495|P9|Period 3|Adverse Event|0
5233393|NCT00868790|18060496|P8|Period 3|Adverse Event|0
5233394|NCT00868790|18060497|P7|Period 3|Adverse Event|0
5233395|NCT00868790|18060498|P6|Period 3|Adverse Event|0
5233396|NCT00868790|18060499|P5|Period 3|Adverse Event|0
5233397|NCT00868790|18060500|P4|Period 3|Adverse Event|0
5233398|NCT00868790|18060501|P3|Period 3|Adverse Event|0
5233399|NCT00868790|18060502|P2|Period 3|Adverse Event|0
5233400|NCT00868790|18060503|P1|Period 3|Adverse Event|0
5233401|NCT00868790|18060490|P14|Period 2|Withdrawal by Subject|1
5233402|NCT00868790|18060491|P13|Period 2|Withdrawal by Subject|0
5233403|NCT00868790|18060492|P12|Period 2|Withdrawal by Subject|0
5233404|NCT00868790|18060493|P11|Period 2|Withdrawal by Subject|0
5233405|NCT00868790|18060494|P10|Period 2|Withdrawal by Subject|0
5233406|NCT00868790|18060495|P9|Period 2|Withdrawal by Subject|1
5233407|NCT00868790|18060496|P8|Period 2|Withdrawal by Subject|0
5233408|NCT00868790|18060497|P7|Period 2|Withdrawal by Subject|0
5233409|NCT00868790|18060498|P6|Period 2|Withdrawal by Subject|0
5233410|NCT00868790|18060499|P5|Period 2|Withdrawal by Subject|0
5233411|NCT00868790|18060500|P4|Period 2|Withdrawal by Subject|0
5233412|NCT00868790|18060501|P3|Period 2|Withdrawal by Subject|0
5233413|NCT00868790|18060502|P2|Period 2|Withdrawal by Subject|0
5233414|NCT00868790|18060503|P1|Period 2|Withdrawal by Subject|0
5233415|NCT00868790|18060490|P14|Period 2|Lost to Follow-up|0
5233416|NCT00868790|18060491|P13|Period 2|Lost to Follow-up|0
5233417|NCT00868790|18060492|P12|Period 2|Lost to Follow-up|0
5233418|NCT00868790|18060493|P11|Period 2|Lost to Follow-up|0
5233419|NCT00868790|18060494|P10|Period 2|Lost to Follow-up|0
5233420|NCT00868790|18060495|P9|Period 2|Lost to Follow-up|0
5233421|NCT00868790|18060496|P8|Period 2|Lost to Follow-up|0
5233422|NCT00868790|18060497|P7|Period 2|Lost to Follow-up|0
5233423|NCT00868790|18060498|P6|Period 2|Lost to Follow-up|1
5233424|NCT00868790|18060499|P5|Period 2|Lost to Follow-up|0
5233425|NCT00868790|18060500|P4|Period 2|Lost to Follow-up|0
5233426|NCT00868790|18060501|P3|Period 2|Lost to Follow-up|0
5233427|NCT00868790|18060502|P2|Period 2|Lost to Follow-up|1
5233428|NCT00868790|18060503|P1|Period 2|Lost to Follow-up|0
5233429|NCT00868790|18060490|P14|Period 2|Adverse Event|0
5233430|NCT00868790|18060491|P13|Period 2|Adverse Event|0
5233431|NCT00868790|18060492|P12|Period 2|Adverse Event|0
5233432|NCT00868790|18060493|P11|Period 2|Adverse Event|0
5233433|NCT00868790|18060494|P10|Period 2|Adverse Event|0
5233434|NCT00868790|18060495|P9|Period 2|Adverse Event|1
5233435|NCT00868790|18060496|P8|Period 2|Adverse Event|0
5233436|NCT00868790|18060497|P7|Period 2|Adverse Event|0
5233437|NCT00868790|18060498|P6|Period 2|Adverse Event|0
5233438|NCT00868790|18060499|P5|Period 2|Adverse Event|0
5233439|NCT00868790|18060500|P4|Period 2|Adverse Event|0
5233440|NCT00868790|18060501|P3|Period 2|Adverse Event|0
5233441|NCT00868790|18060502|P2|Period 2|Adverse Event|0
5233442|NCT00868790|18060503|P1|Period 2|Adverse Event|0
5233443|NCT00868790|18060490|P14|Period 1|Lost to Follow-up|0
5233444|NCT00868790|18060491|P13|Period 1|Lost to Follow-up|0
5233445|NCT00868790|18060492|P12|Period 1|Lost to Follow-up|0
5233446|NCT00868790|18060493|P11|Period 1|Lost to Follow-up|0
5233447|NCT00868790|18060494|P10|Period 1|Lost to Follow-up|0
5233448|NCT00868790|18060495|P9|Period 1|Lost to Follow-up|0
5233449|NCT00868790|18060496|P8|Period 1|Lost to Follow-up|0
5233450|NCT00868790|18060497|P7|Period 1|Lost to Follow-up|0
5233451|NCT00868790|18060498|P6|Period 1|Lost to Follow-up|1
5233452|NCT00868790|18060499|P5|Period 1|Lost to Follow-up|0
5233453|NCT00868790|18060500|P4|Period 1|Lost to Follow-up|0
5233454|NCT00868790|18060501|P3|Period 1|Lost to Follow-up|0
5233455|NCT00868790|18060502|P2|Period 1|Lost to Follow-up|0
5233456|NCT00868790|18060503|P1|Period 1|Lost to Follow-up|0
5233457|NCT00868790|18060490|P14|Period 1|Abnormal Triglycerides|0
5233458|NCT00868790|18060491|P13|Period 1|Abnormal Triglycerides|0
5233459|NCT00868790|18060492|P12|Period 1|Abnormal Triglycerides|0
5233460|NCT00868790|18060493|P11|Period 1|Abnormal Triglycerides|0
5233461|NCT00868790|18060494|P10|Period 1|Abnormal Triglycerides|0
5233462|NCT00868790|18060495|P9|Period 1|Abnormal Triglycerides|0
5233463|NCT00868790|18060496|P8|Period 1|Abnormal Triglycerides|0
5233464|NCT00868790|18060497|P7|Period 1|Abnormal Triglycerides|0
5233465|NCT00868790|18060498|P6|Period 1|Abnormal Triglycerides|0
5233466|NCT00868790|18060499|P5|Period 1|Abnormal Triglycerides|1
5233467|NCT00868790|18060500|P4|Period 1|Abnormal Triglycerides|0
5233468|NCT00868790|18060501|P3|Period 1|Abnormal Triglycerides|0
5233469|NCT00868790|18060502|P2|Period 1|Abnormal Triglycerides|0
5233470|NCT00868790|18060503|P1|Period 1|Abnormal Triglycerides|0
5233471|NCT00868790|18060490|P14|Period 1|Withdrawal by Subject|1
5233472|NCT00868790|18060491|P13|Period 1|Withdrawal by Subject|0
5233473|NCT00868790|18060492|P12|Period 1|Withdrawal by Subject|0
5233474|NCT00868790|18060493|P11|Period 1|Withdrawal by Subject|0
5233475|NCT00868790|18060494|P10|Period 1|Withdrawal by Subject|0
5233476|NCT00868790|18060495|P9|Period 1|Withdrawal by Subject|0
5233477|NCT00868790|18060496|P8|Period 1|Withdrawal by Subject|0
5233478|NCT00868790|18060497|P7|Period 1|Withdrawal by Subject|0
5233479|NCT00868790|18060498|P6|Period 1|Withdrawal by Subject|0
5233480|NCT00868790|18060499|P5|Period 1|Withdrawal by Subject|0
5233481|NCT00868790|18060500|P4|Period 1|Withdrawal by Subject|0
5233482|NCT00868790|18060501|P3|Period 1|Withdrawal by Subject|0
5233483|NCT00868790|18060502|P2|Period 1|Withdrawal by Subject|1
5233484|NCT00868790|18060503|P1|Period 1|Withdrawal by Subject|0
5233485|NCT00868790|18060490|P14|Period 1|Protocol Violation|0
5233486|NCT00868790|18060491|P13|Period 1|Protocol Violation|0
5233487|NCT00868790|18060492|P12|Period 1|Protocol Violation|0
5233488|NCT00868790|18060493|P11|Period 1|Protocol Violation|0
5233489|NCT00868790|18060494|P10|Period 1|Protocol Violation|0
5233490|NCT00868790|18060495|P9|Period 1|Protocol Violation|0
5233491|NCT00868790|18060496|P8|Period 1|Protocol Violation|0
5233492|NCT00868790|18060497|P7|Period 1|Protocol Violation|0
5233493|NCT00868790|18060498|P6|Period 1|Protocol Violation|0
5233494|NCT00868790|18060499|P5|Period 1|Protocol Violation|0
5233495|NCT00868790|18060500|P4|Period 1|Protocol Violation|0
5233496|NCT00868790|18060501|P3|Period 1|Protocol Violation|0
5233497|NCT00868790|18060502|P2|Period 1|Protocol Violation|0
5233498|NCT00868790|18060503|P1|Period 1|Protocol Violation|1
5233499|NCT00868790|18060490|P14|Period 1|Adverse Event|1
5233500|NCT00868790|18060491|P13|Period 1|Adverse Event|0
5233501|NCT00868790|18060492|P12|Period 1|Adverse Event|0
5233502|NCT00868790|18060493|P11|Period 1|Adverse Event|0
5233503|NCT00868790|18060494|P10|Period 1|Adverse Event|0
5233504|NCT00868790|18060495|P9|Period 1|Adverse Event|1
5233505|NCT00868790|18060496|P8|Period 1|Adverse Event|3
5233506|NCT00868790|18060497|P7|Period 1|Adverse Event|0
5233507|NCT00868790|18060498|P6|Period 1|Adverse Event|0
5233508|NCT00868790|18060499|P5|Period 1|Adverse Event|0
5233509|NCT00868790|18060500|P4|Period 1|Adverse Event|0
5233510|NCT00868790|18060501|P3|Period 1|Adverse Event|0
5233511|NCT00868790|18060502|P2|Period 1|Adverse Event|0
5233512|NCT00868790|18060503|P1|Period 1|Adverse Event|1
5233513|NCT00868608|18060586|P3|Overall Study|Other - Unspecified|0
5233514|NCT00868608|18060587|P2|Overall Study|Other - Unspecified|0
5233515|NCT00868608|18060588|P1|Overall Study|Other - Unspecified|1
5233516|NCT00868608|18060586|P3|Overall Study|Death|4
5233517|NCT00868608|18060587|P2|Overall Study|Death|2
5233518|NCT00868608|18060588|P1|Overall Study|Death|16
5233519|NCT00868608|18060586|P3|Overall Study|Lost to Follow-up|1
5233520|NCT00868608|18060587|P2|Overall Study|Lost to Follow-up|0
5233521|NCT00868608|18060588|P1|Overall Study|Lost to Follow-up|3
5233522|NCT00868608|18060586|P3|Overall Study|Withdrawal by Subject|0
5233523|NCT00868608|18060587|P2|Overall Study|Withdrawal by Subject|1
5233524|NCT00868608|18060588|P1|Overall Study|Withdrawal by Subject|3
5233525|NCT00868530|18060612|P1|Overall Study|Lost to Follow-up|1
5233526|NCT00868530|18060612|P1|Overall Study|Adverse Event|3
5233527|NCT00868517|18060627|P3|Overall Study|Protocol Violation|0
5233528|NCT00868517|18060628|P2|Overall Study|Protocol Violation|1
5233529|NCT00868517|18060629|P1|Overall Study|Protocol Violation|1
5233530|NCT00868517|18060627|P3|Overall Study|Withdrawal by Subject|2
5233531|NCT00868517|18060628|P2|Overall Study|Withdrawal by Subject|3
5233532|NCT00868517|18060629|P1|Overall Study|Withdrawal by Subject|3
5233533|NCT00868439|18060667|P2|Overall Study|Withdrawal by Subject|1
5233534|NCT00868439|18060668|P1|Overall Study|Withdrawal by Subject|0
5233535|NCT00868439|18060667|P2|Overall Study|Physician Decision|0
5233536|NCT00868439|18060668|P1|Overall Study|Physician Decision|1
5233537|NCT00868439|18060667|P2|Overall Study|Protocol Violation|1
5233538|NCT00868439|18060668|P1|Overall Study|Protocol Violation|1
5233539|NCT00868439|18060667|P2|Overall Study|Death|1
5233540|NCT00868439|18060668|P1|Overall Study|Death|0
5233541|NCT00868439|18060667|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
5233542|NCT00868439|18060668|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
5233543|NCT00868439|18060667|P2|Overall Study|Adverse Event|3
5233544|NCT00868439|18060668|P1|Overall Study|Adverse Event|4
5233545|NCT00868296|18060725|P2|Overall Study|Withdrawal by Subject|1
5233546|NCT00868296|18060726|P1|Overall Study|Withdrawal by Subject|0
5233547|NCT00868296|18060725|P2|Overall Study|Adverse Event|2
5233548|NCT00868296|18060726|P1|Overall Study|Adverse Event|0
5233549|NCT00868231|18060734|P6|Treatment Period 3|Adverse Event|0
5233550|NCT00868231|18060735|P5|Treatment Period 3|Adverse Event|0
5233551|NCT00868231|18060736|P4|Treatment Period 3|Adverse Event|0
5233552|NCT00868231|18060737|P3|Treatment Period 3|Adverse Event|1
5233553|NCT00868231|18060738|P2|Treatment Period 3|Adverse Event|0
5233554|NCT00868231|18060739|P1|Treatment Period 3|Adverse Event|0
5233555|NCT00868231|18060734|P6|Treatment Period 2|Adverse Event|0
5233556|NCT00868231|18060735|P5|Treatment Period 2|Adverse Event|0
5233557|NCT00868231|18060736|P4|Treatment Period 2|Adverse Event|0
5233558|NCT00868231|18060737|P3|Treatment Period 2|Adverse Event|0
5233559|NCT00868231|18060738|P2|Treatment Period 2|Adverse Event|0
5233560|NCT00868231|18060739|P1|Treatment Period 2|Adverse Event|1
5233561|NCT00868231|18060734|P6|Treatment Period 1|Adverse Event|0
5233562|NCT00868231|18060735|P5|Treatment Period 1|Adverse Event|1
5233563|NCT00868231|18060736|P4|Treatment Period 1|Adverse Event|0
5233564|NCT00868231|18060737|P3|Treatment Period 1|Adverse Event|0
5233565|NCT00868231|18060738|P2|Treatment Period 1|Adverse Event|0
5233566|NCT00868231|18060739|P1|Treatment Period 1|Adverse Event|0
5233567|NCT00868192|18060805|P1|Overall Study|Ineligible|4
5233568|NCT00868166|18060822|P2|Overall Study|Non-compliance with IMP|1
5233569|NCT00868166|18060823|P1|Overall Study|Non-compliance with IMP|1
5233570|NCT00868166|18060822|P2|Overall Study|Lack of efficacy, logistics, unwell|10
5233571|NCT00868166|18060823|P1|Overall Study|Lack of efficacy, logistics, unwell|9
5233572|NCT00868166|18060822|P2|Overall Study|Adverse Event|10
5233573|NCT00868166|18060823|P1|Overall Study|Adverse Event|9
5233574|NCT00868166|18060822|P2|Overall Study|Lost to Follow-up|3
5233575|NCT00868166|18060823|P1|Overall Study|Lost to Follow-up|1
5233576|NCT00868166|18060822|P2|Overall Study|Protocol Violation|0
5233577|NCT00868166|18060823|P1|Overall Study|Protocol Violation|1
5233578|NCT00868166|18060822|P2|Overall Study|Withdrawal by Subject|25
5233579|NCT00868166|18060823|P1|Overall Study|Withdrawal by Subject|33
5233580|NCT00868166|18060822|P2|Overall Study|Death|65
5233581|NCT00868166|18060823|P1|Overall Study|Death|58
5233582|NCT00867815|18060885|P1|Overall Study|Lost to Follow-up|1
5233583|NCT00867568|18060896|P1|Overall Study|Withdrawal by Subject|1
5233584|NCT00867568|18060896|P1|Overall Study|Adverse Event|4
5233585|NCT00867568|18060896|P1|Overall Study|Lack of Efficacy|10
5233586|NCT00867503|18060913|P1|Overall Study|Withdrawal by Subject|1
5233587|NCT00867490|18060919|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
5233588|NCT00867490|18060919|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
5233589|NCT00867490|18060919|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
5233590|NCT00867490|18060919|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
5233591|NCT00867490|18060919|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
5233592|NCT00867360|18060961|P2|Overall Study|Physician Decision|1
5233593|NCT00867360|18060962|P1|Overall Study|Physician Decision|0
5233594|NCT00867360|18060961|P2|Overall Study|Withdrawal by Subject|0
5233595|NCT00867360|18060962|P1|Overall Study|Withdrawal by Subject|1
5233596|NCT00867334|18060974|P2|Overall Study|Withdrawal by Subject|0
5233597|NCT00867334|18060975|P1|Overall Study|Withdrawal by Subject|1
5233598|NCT00867334|18060974|P2|Overall Study|Withdrawal by Subject|0
5233599|NCT00867334|18060975|P1|Overall Study|Withdrawal by Subject|1
5233600|NCT00867334|18060974|P2|Overall Study|Withdrawal by Subject|1
5233601|NCT00867334|18060975|P1|Overall Study|Withdrawal by Subject|0
5233602|NCT00867308|18061011|P2|Overall Study|Withdrawal by Subject|2
5233603|NCT00867308|18061012|P1|Overall Study|Withdrawal by Subject|1
5233604|NCT00867308|18061011|P2|Overall Study|Lack of Efficacy|12
5233605|NCT00867308|18061012|P1|Overall Study|Lack of Efficacy|6
5233606|NCT00867308|18061011|P2|Overall Study|Adverse Event|4
5233607|NCT00867308|18061012|P1|Overall Study|Adverse Event|1
5233608|NCT00867308|18061011|P2|Overall Study|Death|0
5233609|NCT00867308|18061012|P1|Overall Study|Death|1
5233610|NCT00867165|18061031|P2|Overall Study|Withdrawal by Subject|0
5233611|NCT00867165|18061032|P1|Overall Study|Withdrawal by Subject|1
5233612|NCT00867165|18061031|P2|Overall Study|Adverse Event|0
5233613|NCT00867165|18061032|P1|Overall Study|Adverse Event|3
5233614|NCT00867113|18061180|P1|Post Treatment After Survival Follow-up|Administrative problems|4
5233615|NCT00867113|18061180|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
5233616|NCT00867113|18061180|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
5233617|NCT00867113|18061180|P1|Post Treatment After Survival Follow-up|Death|1
5233618|NCT00867113|18061180|P1|Treatment Period|Protocol Violation|4
5233619|NCT00867113|18061180|P1|Treatment Period|Disease progression/relapse|1
5233620|NCT00867113|18061180|P1|Treatment Period|Administrative problems|1
5233621|NCT00867113|18061180|P1|Treatment Period|Lost to Follow-up|3
5233622|NCT00867113|18061180|P1|Treatment Period|Withdrawal by Subject|19
5233623|NCT00867113|18061180|P1|Treatment Period|Death|2
5233624|NCT00867113|18061180|P1|Treatment Period|Adverse Event|15
5233625|NCT00867087|18061244|P1|Overall Study|Death|37
5233626|NCT00867087|18061244|P1|Overall Study|Withdrawal by Subject|4
5233627|NCT00867087|18061244|P1|Overall Study|Other|1
5233628|NCT00867035|18061260|P2|Baseline to 1 Week|Withdrawal by Subject|0
5233629|NCT00867035|18061261|P1|Baseline to 1 Week|Withdrawal by Subject|1
5233630|NCT00867035|18061260|P2|Baseline to 1 Hour|Withdrawal by Subject|1
5233631|NCT00867035|18061261|P1|Baseline to 1 Hour|Withdrawal by Subject|1
5233632|NCT00867009|18061287|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
5233633|NCT00867009|18061287|P1|Induction Period|Progressive Disease (PD)|25
5233634|NCT00867009|18061287|P1|Induction Period|Physician Decision|3
5233635|NCT00867009|18061287|P1|Induction Period|Withdrawal by Subject|8
5233636|NCT00867009|18061287|P1|Induction Period|Protocol Violation|1
5233637|NCT00867009|18061287|P1|Induction Period|Death due to Study Disease|4
5233726|NCT00866619|18061524|P2|Overall Study|Withdrawal by Subject|295
5233638|NCT00867009|18061287|P1|Induction Period|Death due to serious adverse event|6
5233639|NCT00867009|18061287|P1|Induction Period|Serious Adverse Event|10
5233640|NCT00867009|18061287|P1|Induction Period|Nonserious Adverse Event|5
5233641|NCT00866918|18061296|P2|Overall Study|Secondary malignancy|0
5233642|NCT00866918|18061297|P1|Overall Study|Secondary malignancy|1
5233643|NCT00866918|18061296|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
5233644|NCT00866918|18061297|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
5233645|NCT00866918|18061296|P2|Overall Study|Ineligible|4
5233646|NCT00866918|18061297|P1|Overall Study|Ineligible|2
5233647|NCT00866918|18061296|P2|Overall Study|Physician Decision|2
5233648|NCT00866918|18061297|P1|Overall Study|Physician Decision|10
5233649|NCT00866918|18061296|P2|Overall Study|Lack of Efficacy|1
5233650|NCT00866918|18061297|P1|Overall Study|Lack of Efficacy|1
5233651|NCT00866918|18061296|P2|Overall Study|Death|5
5233652|NCT00866918|18061297|P1|Overall Study|Death|1
5233653|NCT00866814|18061331|P1|Overall Study|Moved to area without study site|1
5233654|NCT00866814|18061331|P1|Overall Study|Unable to meet follow-up requirements|2
5233655|NCT00866814|18061331|P1|Overall Study|No longer wished to participate|1
5233656|NCT00866814|18061331|P1|Overall Study|Death|1
5233657|NCT00866814|18061331|P1|Overall Study|Physician Decision|1
5233658|NCT00866814|18061331|P1|Overall Study|Adverse Event|2
5233659|NCT00866814|18061331|P1|Overall Study|Lost to Follow-up|12
5233660|NCT00866788|18061344|P4|Overall Study|Physician Decision|1
5233661|NCT00866788|18061345|P3|Overall Study|Physician Decision|1
5233662|NCT00866788|18061346|P2|Overall Study|Physician Decision|0
5233663|NCT00866788|18061347|P1|Overall Study|Physician Decision|0
5233664|NCT00866788|18061344|P4|Overall Study|Disease progression|0
5233665|NCT00866788|18061345|P3|Overall Study|Disease progression|1
5233666|NCT00866788|18061346|P2|Overall Study|Disease progression|1
5233667|NCT00866788|18061347|P1|Overall Study|Disease progression|3
5233668|NCT00866788|18061344|P4|Overall Study|Pregnancy|0
5233669|NCT00866788|18061345|P3|Overall Study|Pregnancy|0
5233670|NCT00866788|18061346|P2|Overall Study|Pregnancy|1
5233671|NCT00866788|18061347|P1|Overall Study|Pregnancy|0
5233672|NCT00866788|18061344|P4|Overall Study|Withdrawal by Subject|1
5233673|NCT00866788|18061345|P3|Overall Study|Withdrawal by Subject|0
5233674|NCT00866788|18061346|P2|Overall Study|Withdrawal by Subject|1
5233675|NCT00866788|18061347|P1|Overall Study|Withdrawal by Subject|2
5233676|NCT00866788|18061344|P4|Overall Study|Lost to Follow-up|2
5233677|NCT00866788|18061345|P3|Overall Study|Lost to Follow-up|0
5233678|NCT00866788|18061346|P2|Overall Study|Lost to Follow-up|1
5233679|NCT00866788|18061347|P1|Overall Study|Lost to Follow-up|1
5233680|NCT00866788|18061344|P4|Overall Study|Adverse Event|1
5233681|NCT00866788|18061345|P3|Overall Study|Adverse Event|0
5233682|NCT00866788|18061346|P2|Overall Study|Adverse Event|2
5233683|NCT00866788|18061347|P1|Overall Study|Adverse Event|0
5233684|NCT00866775|18061395|P2|Overall Study|discontinued due to communication error|1
5233685|NCT00866775|18061396|P1|Overall Study|discontinued due to communication error|0
5233686|NCT00866775|18061395|P2|Overall Study|met exit criteria|17
5233687|NCT00866775|18061396|P1|Overall Study|met exit criteria|23
5233688|NCT00866775|18061395|P2|Overall Study|Withdrawal by Subject|4
5233689|NCT00866775|18061396|P1|Overall Study|Withdrawal by Subject|4
5233690|NCT00866775|18061395|P2|Overall Study|Protocol Violation|4
5233691|NCT00866775|18061396|P1|Overall Study|Protocol Violation|3
5233692|NCT00866775|18061395|P2|Overall Study|Physician Decision|3
5233693|NCT00866775|18061396|P1|Overall Study|Physician Decision|0
5233694|NCT00866775|18061395|P2|Overall Study|Lost to Follow-up|4
5233695|NCT00866775|18061396|P1|Overall Study|Lost to Follow-up|0
5233696|NCT00866775|18061395|P2|Overall Study|Death|0
5233697|NCT00866775|18061396|P1|Overall Study|Death|1
5233698|NCT00866775|18061395|P2|Overall Study|Adverse Event|19
5233699|NCT00866775|18061396|P1|Overall Study|Adverse Event|5
5233700|NCT00866723|18061439|P1|Overall Study|Disease Progression|4
5233701|NCT00866723|18061439|P1|Overall Study|Withdrawal by Subject|1
5233702|NCT00866697|18061446|P2|Overall Study|Withdrawal by Subject|57
5233703|NCT00866697|18061447|P1|Overall Study|Withdrawal by Subject|33
5233704|NCT00866697|18061446|P2|Overall Study|Physician Decision|5
5233705|NCT00866697|18061447|P1|Overall Study|Physician Decision|3
5233706|NCT00866697|18061446|P2|Overall Study|Lost to Follow-up|28
5233707|NCT00866697|18061447|P1|Overall Study|Lost to Follow-up|22
5233708|NCT00866697|18061446|P2|Overall Study|Study closed/terminated|138
5233709|NCT00866697|18061447|P1|Overall Study|Study closed/terminated|156
5233710|NCT00866658|18061489|P2|Overall Study|Familial and Personal Reasons|5
5233711|NCT00866658|18061490|P1|Overall Study|Familial and Personal Reasons|4
5233712|NCT00866658|18061489|P2|Overall Study|Protocol Violation|1
5233713|NCT00866658|18061490|P1|Overall Study|Protocol Violation|1
5233714|NCT00866658|18061489|P2|Overall Study|Withdrawal by Subject|0
5233715|NCT00866658|18061490|P1|Overall Study|Withdrawal by Subject|1
5233716|NCT00866658|18061489|P2|Overall Study|Lack of Efficacy|1
5233717|NCT00866658|18061490|P1|Overall Study|Lack of Efficacy|2
5233718|NCT00866658|18061489|P2|Overall Study|Adverse Event|14
5233719|NCT00866658|18061490|P1|Overall Study|Adverse Event|5
5233720|NCT00866619|18061522|P4|Overall Study|Lost to Follow-up|425
5233721|NCT00866619|18061523|P3|Overall Study|Lost to Follow-up|568
5233722|NCT00866619|18061524|P2|Overall Study|Lost to Follow-up|830
5233723|NCT00866619|18061525|P1|Overall Study|Lost to Follow-up|1145
5233724|NCT00866619|18061522|P4|Overall Study|Withdrawal by Subject|144
5233725|NCT00866619|18061523|P3|Overall Study|Withdrawal by Subject|272
5233727|NCT00866619|18061525|P1|Overall Study|Withdrawal by Subject|587
5233728|NCT00866619|18061522|P4|Overall Study|Protocol Violation|17
5233729|NCT00866619|18061523|P3|Overall Study|Protocol Violation|2
5233730|NCT00866619|18061524|P2|Overall Study|Protocol Violation|39
5233731|NCT00866619|18061525|P1|Overall Study|Protocol Violation|2
5233732|NCT00866619|18061522|P4|Overall Study|Adverse Event|44
5233733|NCT00866619|18061523|P3|Overall Study|Adverse Event|47
5233734|NCT00866619|18061524|P2|Overall Study|Adverse Event|106
5233735|NCT00866619|18061525|P1|Overall Study|Adverse Event|112
5233736|NCT00866606|18061845|P1|Overall Study|Adverse Event|1
5233737|NCT00866606|18061845|P1|Overall Study|Lost to Follow-up|3
5233738|NCT00866359|18061859|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
5233739|NCT00866359|18061860|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
5233740|NCT00866359|18061861|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
5233741|NCT00866359|18061862|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
5233742|NCT00866359|18061859|P4|Treatment Phase (Days 1 to 85)|Other|0
5233743|NCT00866359|18061860|P3|Treatment Phase (Days 1 to 85)|Other|0
5233744|NCT00866359|18061861|P2|Treatment Phase (Days 1 to 85)|Other|0
5233745|NCT00866359|18061862|P1|Treatment Phase (Days 1 to 85)|Other|1
5233746|NCT00866359|18061859|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
5233747|NCT00866359|18061860|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
5233748|NCT00866359|18061861|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
5233749|NCT00866359|18061862|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
5233750|NCT00866359|18061859|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
5233751|NCT00866359|18061860|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
5233752|NCT00866359|18061861|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
5233753|NCT00866359|18061862|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
5233754|NCT00866359|18061859|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
5233755|NCT00866359|18061860|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
5233756|NCT00866359|18061861|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
5233757|NCT00866359|18061862|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
5233758|NCT00866359|18061859|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
5233759|NCT00866359|18061860|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
5233760|NCT00866359|18061861|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
5233761|NCT00866359|18061862|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
5233762|NCT00866333|18061918|P3|Overall Study|Study Terminated by Sponsor|9
5233763|NCT00866333|18061919|P2|Overall Study|Study Terminated by Sponsor|5
5233764|NCT00866333|18061920|P1|Overall Study|Study Terminated by Sponsor|2
5233765|NCT00866333|18061918|P3|Overall Study|Reason not Specified|1
5233766|NCT00866333|18061919|P2|Overall Study|Reason not Specified|1
5233767|NCT00866333|18061920|P1|Overall Study|Reason not Specified|3
5233768|NCT00866333|18061918|P3|Overall Study|Withdrawal of consent|2
5233769|NCT00866333|18061919|P2|Overall Study|Withdrawal of consent|1
5233770|NCT00866333|18061920|P1|Overall Study|Withdrawal of consent|0
5233771|NCT00866320|18061937|P1|Overall Study|Death|2
5233772|NCT00866320|18061937|P1|Overall Study|Withdrawal by Subject|4
5233773|NCT00866307|18061944|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
5233774|NCT00866307|18061945|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
5233775|NCT00866307|18061946|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
5233776|NCT00866307|18061944|P3|Consolidation/Maintenance|Non-compliance|1
5233777|NCT00866307|18061945|P2|Consolidation/Maintenance|Non-compliance|0
5233778|NCT00866307|18061946|P1|Consolidation/Maintenance|Non-compliance|0
5233779|NCT00866307|18061944|P3|Consolidation/Maintenance|Therapy error|0
5233780|NCT00866307|18061945|P2|Consolidation/Maintenance|Therapy error|1
5233781|NCT00866307|18061946|P1|Consolidation/Maintenance|Therapy error|0
5233782|NCT00866307|18061944|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
5233783|NCT00866307|18061945|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
5233784|NCT00866307|18061946|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
5233785|NCT00866307|18061944|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
5233786|NCT00866307|18061945|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
5233787|NCT00866307|18061946|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
5233788|NCT00866307|18061944|P3|Consolidation/Maintenance|Withdrawal by Subject|1
5233789|NCT00866307|18061945|P2|Consolidation/Maintenance|Withdrawal by Subject|1
5233790|NCT00866307|18061946|P1|Consolidation/Maintenance|Withdrawal by Subject|0
5233791|NCT00866307|18061944|P3|Consolidation/Maintenance|Physician Decision|2
5233792|NCT00866307|18061945|P2|Consolidation/Maintenance|Physician Decision|3
5233793|NCT00866307|18061946|P1|Consolidation/Maintenance|Physician Decision|0
5233794|NCT00866307|18061944|P3|Consolidation/Maintenance|Death|1
5233795|NCT00866307|18061945|P2|Consolidation/Maintenance|Death|0
5233796|NCT00866307|18061946|P1|Consolidation/Maintenance|Death|0
5233797|NCT00866307|18061944|P3|Consolidation/Maintenance|Adverse Event|8
5233798|NCT00866307|18061945|P2|Consolidation/Maintenance|Adverse Event|0
5233799|NCT00866307|18061946|P1|Consolidation/Maintenance|Adverse Event|0
5233800|NCT00866307|18061944|P3|Induction|Study was closed at the time|0
5233801|NCT00866307|18061945|P2|Induction|Study was closed at the time|0
5233802|NCT00866307|18061946|P1|Induction|Study was closed at the time|1
5233803|NCT00866307|18061944|P3|Induction|Improper post-induction consent|0
5233804|NCT00866307|18061945|P2|Induction|Improper post-induction consent|0
5233805|NCT00866307|18061946|P1|Induction|Improper post-induction consent|2
5233806|NCT00866307|18061944|P3|Induction|Inadequate cytognetic samples th|0
5233807|NCT00866307|18061945|P2|Induction|Inadequate cytognetic samples th|0
5233808|NCT00866307|18061946|P1|Induction|Inadequate cytognetic samples th|1
5233809|NCT00866307|18061944|P3|Induction|Identification of Patients with Day 29 M|0
5233810|NCT00866307|18061945|P2|Induction|Identification of Patients with Day 29 M|0
5233811|NCT00866307|18061946|P1|Induction|Identification of Patients with Day 29 M|3
5233812|NCT00866307|18061944|P3|Induction|Progressive Disease|0
5233813|NCT00866307|18061945|P2|Induction|Progressive Disease|0
5233814|NCT00866307|18061946|P1|Induction|Progressive Disease|1
5233815|NCT00866307|18061944|P3|Induction|Physician Decision|0
5233816|NCT00866307|18061945|P2|Induction|Physician Decision|0
5233817|NCT00866307|18061946|P1|Induction|Physician Decision|5
5233818|NCT00866307|18061944|P3|Induction|Death|0
5233819|NCT00866307|18061945|P2|Induction|Death|0
5233820|NCT00866307|18061946|P1|Induction|Death|2
5233821|NCT00866307|18061944|P3|Induction|Adverse Event|0
5233822|NCT00866307|18061945|P2|Induction|Adverse Event|0
5233823|NCT00866307|18061946|P1|Induction|Adverse Event|5
5233824|NCT00866294|18061956|P3|Overall Study|Physician Decision|1
5233825|NCT00866294|18061957|P2|Overall Study|Physician Decision|2
5233826|NCT00866294|18061958|P1|Overall Study|Physician Decision|6
5233827|NCT00866294|18061956|P3|Overall Study|Lost to Follow-up|0
5233828|NCT00866294|18061957|P2|Overall Study|Lost to Follow-up|3
5233829|NCT00866294|18061958|P1|Overall Study|Lost to Follow-up|1
5233830|NCT00866294|18061956|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
5233831|NCT00866294|18061957|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5233832|NCT00866294|18061958|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
5233833|NCT00866294|18061956|P3|Overall Study|Protocol Violation|0
5233834|NCT00866294|18061957|P2|Overall Study|Protocol Violation|0
5233835|NCT00866294|18061958|P1|Overall Study|Protocol Violation|2
5233836|NCT00866294|18061956|P3|Overall Study|Lack of Efficacy|0
5233837|NCT00866294|18061957|P2|Overall Study|Lack of Efficacy|1
5233838|NCT00866294|18061958|P1|Overall Study|Lack of Efficacy|7
5233839|NCT00866294|18061956|P3|Overall Study|Adverse Event|9
5233840|NCT00866294|18061957|P2|Overall Study|Adverse Event|13
5233841|NCT00866294|18061958|P1|Overall Study|Adverse Event|12
5233842|NCT00866281|18061987|P2|Overall Study|New cancer therapy|4
5233843|NCT00866281|18061988|P1|Overall Study|New cancer therapy|0
5233844|NCT00866281|18061987|P2|Overall Study|Disease progression|11
5233845|NCT00866281|18061988|P1|Overall Study|Disease progression|3
5233846|NCT00866281|18061987|P2|Overall Study|Withdrawal by participants|0
5233847|NCT00866281|18061988|P1|Overall Study|Withdrawal by participants|3
5233848|NCT00866281|18061987|P2|Overall Study|Adverse Event|0
5233849|NCT00866281|18061988|P1|Overall Study|Adverse Event|1
5233850|NCT00866177|18062004|P1|Overall Study|Not Treated|151
5233851|NCT00866177|18062004|P1|Overall Study|Withdrawal by Subject|1
5233852|NCT00866047|18062008|P1|Follow-up Period|Lost to Follow-up|5
5233853|NCT00866047|18062008|P1|Treatment Period|Withdrawal by Subject|5
5233854|NCT00866047|18062008|P1|Treatment Period|Physician Decision|14
5233855|NCT00866047|18062008|P1|Treatment Period|Adverse Event|16
5233856|NCT00866047|18062008|P1|Treatment Period|Progressive disease|13
5233857|NCT00865904|18062040|P5|Overall Study|Randomized but not Treated|1
5233858|NCT00865904|18062041|P4|Overall Study|Randomized but not Treated|1
5233859|NCT00865904|18062042|P3|Overall Study|Randomized but not Treated|0
5233860|NCT00865904|18062043|P2|Overall Study|Randomized but not Treated|0
5233861|NCT00865904|18062044|P1|Overall Study|Randomized but not Treated|2
5233862|NCT00865709|18062101|P2|Treatment|Surgery|3
5233863|NCT00865709|18062102|P1|Treatment|Surgery|8
5233864|NCT00865709|18062101|P2|Treatment|Physician Decision|2
5233865|NCT00865709|18062102|P1|Treatment|Physician Decision|3
5233866|NCT00865709|18062101|P2|Treatment|Withdrawal by Subject|7
5233867|NCT00865709|18062102|P1|Treatment|Withdrawal by Subject|10
5233868|NCT00865709|18062101|P2|Treatment|Adverse Event|6
5233869|NCT00865709|18062102|P1|Treatment|Adverse Event|9
5233870|NCT00865566|18062120|P2|Overall Study|HIV infection|7
5233871|NCT00865566|18062121|P1|Overall Study|HIV infection|5
5233872|NCT00865566|18062120|P2|Overall Study|Other; N=245 due to early study closure|139
5233873|NCT00865566|18062121|P1|Overall Study|Other; N=245 due to early study closure|154
5233874|NCT00865566|18062120|P2|Overall Study|Participant unable to adhere|42
5233875|NCT00865566|18062121|P1|Overall Study|Participant unable to adhere|27
5233876|NCT00865566|18062120|P2|Overall Study|Participant relocated|107
5233877|NCT00865566|18062121|P1|Overall Study|Participant relocated|78
5233878|NCT00865566|18062120|P2|Overall Study|Physician Decision|1
5233879|NCT00865566|18062121|P1|Overall Study|Physician Decision|0
5233880|NCT00865566|18062120|P2|Overall Study|Withdrawal by Subject|65
5233881|NCT00865566|18062121|P1|Overall Study|Withdrawal by Subject|45
5233882|NCT00865566|18062120|P2|Overall Study|Lost to Follow-up|315
5233883|NCT00865566|18062121|P1|Overall Study|Lost to Follow-up|314
5233884|NCT00865566|18062120|P2|Overall Study|Death|11
5233885|NCT00865566|18062121|P1|Overall Study|Death|1
5233886|NCT00865514|18062141|P1|Overall Study|Infusion cost exceeded funding|2
5233887|NCT00865345|18062146|P1|Overall Study|Withdrawal by Subject|2
5233888|NCT00865306|18062153|P2|Controlled Trial|Withdrawal by Subject|1
5233889|NCT00865306|18062154|P1|Controlled Trial|Withdrawal by Subject|0
5233890|NCT00865306|18062153|P2|Controlled Trial|Sought treatment for conduct disorder|0
5233891|NCT00865306|18062154|P1|Controlled Trial|Sought treatment for conduct disorder|1
5233892|NCT00865306|18062153|P2|Controlled Trial|Improved btw baseline and first session|0
5233893|NCT00865306|18062154|P1|Controlled Trial|Improved btw baseline and first session|1
5233894|NCT00865306|18062153|P2|Controlled Trial|Difficulty commuting|0
5233895|NCT00865306|18062154|P1|Controlled Trial|Difficulty commuting|2
5233896|NCT00865306|18062153|P2|Controlled Trial|Lost to Follow-up|1
5233897|NCT00865306|18062154|P1|Controlled Trial|Lost to Follow-up|1
5233898|NCT00865189|18062183|P2|Overall Study|Withdrawal by Subject|0
5233899|NCT00865189|18062184|P1|Overall Study|Withdrawal by Subject|1
5233900|NCT00865189|18062183|P2|Overall Study|Lost to Follow-up|6
5233901|NCT00865189|18062184|P1|Overall Study|Lost to Follow-up|6
5233902|NCT00865189|18062183|P2|Overall Study|Death|11
5233903|NCT00865189|18062184|P1|Overall Study|Death|4
5233904|NCT00865189|18062183|P2|Overall Study|Other|2
5233905|NCT00865189|18062184|P1|Overall Study|Other|1
5233906|NCT00865124|18062212|P3|Overall Study|Withdrawn consent|0
5233907|NCT00865124|18062213|P2|Overall Study|Withdrawn consent|0
5233908|NCT00865124|18062214|P1|Overall Study|Withdrawn consent|2
5233909|NCT00865124|18062212|P3|Overall Study|Physician Decision|0
5233910|NCT00865124|18062213|P2|Overall Study|Physician Decision|1
5233911|NCT00865124|18062214|P1|Overall Study|Physician Decision|2
5233912|NCT00865098|18062231|P1|Overall Study|Progressive disease|1
5233913|NCT00865046|18062243|P3|Overall Study|Withdrawal by Subject|0
5233914|NCT00865046|18062244|P2|Overall Study|Withdrawal by Subject|0
5233915|NCT00865046|18062245|P1|Overall Study|Withdrawal by Subject|5
5233916|NCT00865046|18062243|P3|Overall Study|Death|1
5233917|NCT00865046|18062244|P2|Overall Study|Death|1
5233918|NCT00865046|18062245|P1|Overall Study|Death|0
5233919|NCT00865046|18062243|P3|Overall Study|Lost to Follow-up|0
5233920|NCT00865046|18062244|P2|Overall Study|Lost to Follow-up|4
5233921|NCT00865046|18062245|P1|Overall Study|Lost to Follow-up|1
5233922|NCT00865020|18062255|P2|Overall Study|Randomized but discontinued|4
5233923|NCT00865020|18062256|P1|Overall Study|Randomized but discontinued|2
5233924|NCT00865020|18062255|P2|Overall Study|Death|1
5233925|NCT00865020|18062256|P1|Overall Study|Death|0
5233926|NCT00865020|18062255|P2|Overall Study|Abnormal laboratory value(s)|1
5233927|NCT00865020|18062256|P1|Overall Study|Abnormal laboratory value(s)|0
5233928|NCT00865020|18062255|P2|Overall Study|Administrative problems|2
5233929|NCT00865020|18062256|P1|Overall Study|Administrative problems|0
5233930|NCT00865020|18062255|P2|Overall Study|Protocol deviation|1
5233931|NCT00865020|18062256|P1|Overall Study|Protocol deviation|4
5233932|NCT00865020|18062255|P2|Overall Study|Lost to Follow-up|4
5233933|NCT00865020|18062256|P1|Overall Study|Lost to Follow-up|6
5233934|NCT00865020|18062255|P2|Overall Study|Abnormal test procedure result(s)|8
5233935|NCT00865020|18062256|P1|Overall Study|Abnormal test procedure result(s)|6
5233936|NCT00865020|18062255|P2|Overall Study|Adverse Event|14
5233937|NCT00865020|18062256|P1|Overall Study|Adverse Event|9
5233938|NCT00865020|18062255|P2|Overall Study|Withdrawal by Subject|16
5233939|NCT00865020|18062256|P1|Overall Study|Withdrawal by Subject|22
5233940|NCT00864916|18062272|P2|Overall Study|Withdrawal by Subject|0
5233941|NCT00864916|18062273|P1|Overall Study|Withdrawal by Subject|1
5233942|NCT00864916|18062272|P2|Overall Study|Protocol Violation|0
5233943|NCT00864916|18062273|P1|Overall Study|Protocol Violation|1
5233944|NCT00864916|18062272|P2|Overall Study|Lost to Follow-up|4
5233945|NCT00864916|18062273|P1|Overall Study|Lost to Follow-up|4
5233946|NCT00864851|18062282|P3|Overall Study|Patient uncooperative|0
5233947|NCT00864851|18062283|P2|Overall Study|Patient uncooperative|0
5233948|NCT00864851|18062284|P1|Overall Study|Patient uncooperative|1
5233949|NCT00864851|18062282|P3|Overall Study|Death|0
5233950|NCT00864851|18062283|P2|Overall Study|Death|0
5233951|NCT00864851|18062284|P1|Overall Study|Death|1
5233952|NCT00864851|18062282|P3|Overall Study|Physician Decision|0
5233953|NCT00864851|18062283|P2|Overall Study|Physician Decision|0
5233954|NCT00864851|18062284|P1|Overall Study|Physician Decision|1
5233955|NCT00864851|18062282|P3|Overall Study|Withdrawal by Subject|0
5233956|NCT00864851|18062283|P2|Overall Study|Withdrawal by Subject|1
5233957|NCT00864851|18062284|P1|Overall Study|Withdrawal by Subject|0
5233958|NCT00864721|18062318|P1|Overall Study|Adverse Event|21
5233959|NCT00864721|18062318|P1|Overall Study|Drug hold/delay more than 4 weeks|1
5233960|NCT00864721|18062318|P1|Overall Study|Hospitalized|1
5233961|NCT00864721|18062318|P1|Overall Study|Patient request|11
5233962|NCT00864682|18062338|P3|Overall Study|Protocol Violation|2
5233963|NCT00864682|18062339|P2|Overall Study|Protocol Violation|1
5233964|NCT00864682|18062340|P1|Overall Study|Protocol Violation|2
5233965|NCT00864513|18062379|P1|Overall Study|Withdrawal by Subject|3
5233966|NCT00864253|18062463|P2|Overall Study|Untreated|7
5233967|NCT00864253|18062464|P1|Overall Study|Untreated|7
5233968|NCT00864253|18062463|P2|Overall Study|Ongoing|3
5233969|NCT00864253|18062464|P1|Overall Study|Ongoing|2
5233970|NCT00864253|18062463|P2|Overall Study|Death|0
5233971|NCT00864253|18062464|P1|Overall Study|Death|1
5233972|NCT00864253|18062463|P2|Overall Study|Withdrawal by Subject|18
5233973|NCT00864253|18062464|P1|Overall Study|Withdrawal by Subject|18
5233974|NCT00864253|18062463|P2|Overall Study|Lost to Follow-up|1
5233975|NCT00864253|18062464|P1|Overall Study|Lost to Follow-up|1
5233976|NCT00864253|18062463|P2|Overall Study|Protocol Violation|2
5233977|NCT00864253|18062464|P1|Overall Study|Protocol Violation|0
5233978|NCT00864253|18062463|P2|Overall Study|Physician Decision|15
5233979|NCT00864253|18062464|P1|Overall Study|Physician Decision|11
5233980|NCT00864253|18062463|P2|Overall Study|Unrelated Adverse Event|1
5233981|NCT00864253|18062464|P1|Overall Study|Unrelated Adverse Event|3
5233982|NCT00864253|18062463|P2|Overall Study|Adverse Event|11
5233983|NCT00864253|18062464|P1|Overall Study|Adverse Event|56
5233984|NCT00864227|18062494|P1|Overall Study|Disease Relapse/Progression|3
5233985|NCT00864227|18062494|P1|Overall Study|Withdrawal by Subject|1
5233986|NCT00863928|18062555|P2|Overall Study|medication allergy|0
5233987|NCT00863928|18062556|P1|Overall Study|medication allergy|3
5233988|NCT00863928|18062555|P2|Overall Study|surgery cancellation|0
5233989|NCT00863928|18062556|P1|Overall Study|surgery cancellation|4
5233990|NCT00863928|18062555|P2|Overall Study|Withdrawal by Subject|0
5233991|NCT00863928|18062556|P1|Overall Study|Withdrawal by Subject|3
5233992|NCT00863928|18062555|P2|Overall Study|Protocol Violation|0
5233993|NCT00863928|18062556|P1|Overall Study|Protocol Violation|26
5233994|NCT00863798|18062565|P3|Overall Study|Randomized not treated|3
5233995|NCT00863798|18062566|P2|Overall Study|Randomized not treated|2
5233996|NCT00863798|18062567|P1|Overall Study|Randomized not treated|4
5233997|NCT00863798|18062565|P3|Overall Study|Withdrawal by Subject|4
5233998|NCT00863798|18062566|P2|Overall Study|Withdrawal by Subject|7
5233999|NCT00863798|18062567|P1|Overall Study|Withdrawal by Subject|8
5234000|NCT00863798|18062565|P3|Overall Study|Protocol Violation|1
5234001|NCT00863798|18062566|P2|Overall Study|Protocol Violation|1
5234002|NCT00863798|18062567|P1|Overall Study|Protocol Violation|0
5234003|NCT00863798|18062565|P3|Overall Study|Other|1
5234004|NCT00863798|18062566|P2|Overall Study|Other|3
5234005|NCT00863798|18062567|P1|Overall Study|Other|2
5234006|NCT00863798|18062565|P3|Overall Study|Lost to Follow-up|5
5234007|NCT00863798|18062566|P2|Overall Study|Lost to Follow-up|9
5234008|NCT00863798|18062567|P1|Overall Study|Lost to Follow-up|6
5234009|NCT00863798|18062565|P3|Overall Study|Lack of Efficacy|6
5234010|NCT00863798|18062566|P2|Overall Study|Lack of Efficacy|3
5234011|NCT00863798|18062567|P1|Overall Study|Lack of Efficacy|4
5234012|NCT00863798|18062565|P3|Overall Study|Investigator request|1
5234013|NCT00863798|18062566|P2|Overall Study|Investigator request|2
5234014|NCT00863798|18062567|P1|Overall Study|Investigator request|1
5234015|NCT00863798|18062565|P3|Overall Study|Participant failed to return|0
5234016|NCT00863798|18062566|P2|Overall Study|Participant failed to return|1
5234017|NCT00863798|18062567|P1|Overall Study|Participant failed to return|2
5234018|NCT00863798|18062565|P3|Overall Study|Adverse Event|4
5234019|NCT00863798|18062566|P2|Overall Study|Adverse Event|2
5234020|NCT00863798|18062567|P1|Overall Study|Adverse Event|5
5234021|NCT00863746|18062619|P2|Survival Follow up|Consent Withdrawn|8
5234022|NCT00863746|18062620|P1|Survival Follow up|Consent Withdrawn|7
5234023|NCT00863746|18062619|P2|Survival Follow up|Lost to Follow-up|1
5234024|NCT00863746|18062620|P1|Survival Follow up|Lost to Follow-up|2
5234025|NCT00863746|18062619|P2|Survival Follow up|Death|271
5234026|NCT00863746|18062620|P1|Survival Follow up|Death|244
5234027|NCT00863746|18062619|P2|Treatment|Other|0
5234028|NCT00863746|18062620|P1|Treatment|Other|1
5234029|NCT00863746|18062619|P2|Treatment|Protocol Violation|3
5234030|NCT00863746|18062620|P1|Treatment|Protocol Violation|5
5234031|NCT00863746|18062619|P2|Treatment|Lost to Follow-up|0
5234032|NCT00863746|18062620|P1|Treatment|Lost to Follow-up|1
5234033|NCT00863746|18062619|P2|Treatment|Consent withdrawn|14
5234034|NCT00863746|18062620|P1|Treatment|Consent withdrawn|15
5234035|NCT00863746|18062619|P2|Treatment|non-compliant with study medication|0
5234036|NCT00863746|18062620|P1|Treatment|non-compliant with study medication|4
5234037|NCT00863746|18062619|P2|Treatment|Adverse Event|16
5234038|NCT00863746|18062620|P1|Treatment|Adverse Event|41
5234039|NCT00863746|18062619|P2|Treatment|Not treated|2
5234040|NCT00863746|18062620|P1|Treatment|Not treated|4
5234041|NCT00863707|18062646|P2|Overall Study|Randomized, but drug not received|3
5234042|NCT00863707|18062647|P1|Overall Study|Randomized, but drug not received|4
5234043|NCT00863681|18062656|P3|Overall Study|Non-compliance with study drug|0
5234044|NCT00863681|18062657|P2|Overall Study|Non-compliance with study drug|3
5234045|NCT00863681|18062658|P1|Overall Study|Non-compliance with study drug|1
5234046|NCT00863681|18062656|P3|Overall Study|Lack of Efficacy|1
5234047|NCT00863681|18062657|P2|Overall Study|Lack of Efficacy|2
5234048|NCT00863681|18062658|P1|Overall Study|Lack of Efficacy|2
5234049|NCT00863681|18062656|P3|Overall Study|Adverse Event|6
5234050|NCT00863681|18062657|P2|Overall Study|Adverse Event|10
5234051|NCT00863681|18062658|P1|Overall Study|Adverse Event|28
5234052|NCT00863681|18062656|P3|Overall Study|Lost to Follow-up|3
5234053|NCT00863681|18062657|P2|Overall Study|Lost to Follow-up|0
5234054|NCT00863681|18062658|P1|Overall Study|Lost to Follow-up|3
5234055|NCT00863681|18062656|P3|Overall Study|Protocol Violation|0
5234056|NCT00863681|18062657|P2|Overall Study|Protocol Violation|0
5234057|NCT00863681|18062658|P1|Overall Study|Protocol Violation|2
5234058|NCT00863681|18062656|P3|Overall Study|Withdrawal by Subject|2
5234059|NCT00863681|18062657|P2|Overall Study|Withdrawal by Subject|5
5234060|NCT00863681|18062658|P1|Overall Study|Withdrawal by Subject|12
5234061|NCT00863681|18062656|P3|Overall Study|Death|6
5234062|NCT00863681|18062657|P2|Overall Study|Death|23
5234063|NCT00863681|18062658|P1|Overall Study|Death|40
5234064|NCT00863681|18062656|P3|Overall Study|Missing|0
5234065|NCT00863681|18062657|P2|Overall Study|Missing|0
5234066|NCT00863681|18062658|P1|Overall Study|Missing|1
5234067|NCT00863681|18062656|P3|Overall Study|Other|0
5234068|NCT00863681|18062657|P2|Overall Study|Other|0
5234069|NCT00863681|18062658|P1|Overall Study|Other|2
5234070|NCT00863655|18062743|P2|Overall Study|Treatment completed as per protocol|1
5234071|NCT00863655|18062744|P1|Overall Study|Treatment completed as per protocol|5
5234072|NCT00863655|18062743|P2|Overall Study|Disease progression|221
5234073|NCT00863655|18062744|P1|Overall Study|Disease progression|364
5234074|NCT00863655|18062743|P2|Overall Study|New cancer therapy|1
5234075|NCT00863655|18062744|P1|Overall Study|New cancer therapy|5
5234076|NCT00863655|18062743|P2|Overall Study|Death|1
5234077|NCT00863655|18062744|P1|Overall Study|Death|7
5234078|NCT00863655|18062743|P2|Overall Study|Administrative problems|0
5234079|NCT00863655|18062744|P1|Overall Study|Administrative problems|1
5234080|NCT00863655|18062743|P2|Overall Study|Withdrawal by Subject|7
5234081|NCT00863655|18062744|P1|Overall Study|Withdrawal by Subject|47
5234082|NCT00863655|18062743|P2|Overall Study|Adverse Event|8
5234083|NCT00863655|18062744|P1|Overall Study|Adverse Event|52
5234084|NCT00863655|18062743|P2|Overall Study|Protocol Violation|0
5234085|NCT00863655|18062744|P1|Overall Study|Protocol Violation|4
5234086|NCT00863512|18062781|P2|Overall Study|Physician Decision|0
5234087|NCT00863512|18062782|P1|Overall Study|Physician Decision|1
5234088|NCT00863512|18062781|P2|Overall Study|Withdrawal by Subject|0
5234089|NCT00863512|18062782|P1|Overall Study|Withdrawal by Subject|11
5234090|NCT00863512|18062781|P2|Overall Study|Adverse Event|0
5234091|NCT00863512|18062782|P1|Overall Study|Adverse Event|2
5234092|NCT00863330|18062813|P1|Overall Study|study terminated early due to administra|6
5234093|NCT00863317|18062819|P2|Overall Study|Lost to Follow-up|9
5234094|NCT00863317|18062820|P1|Overall Study|Lost to Follow-up|8
5234095|NCT00863057|18062876|P4|Period 2 (Weeks 6-10)|Physician Decision|1
5234096|NCT00863057|18062877|P3|Period 2 (Weeks 6-10)|Physician Decision|0
5234097|NCT00863057|18062878|P2|Period 2 (Weeks 6-10)|Physician Decision|0
5234098|NCT00863057|18062879|P1|Period 2 (Weeks 6-10)|Physician Decision|0
5234099|NCT00863057|18062876|P4|Period 2 (Weeks 6-10)|Adverse Event|0
5234100|NCT00863057|18062877|P3|Period 2 (Weeks 6-10)|Adverse Event|1
5234101|NCT00863057|18062878|P2|Period 2 (Weeks 6-10)|Adverse Event|1
5234102|NCT00863057|18062879|P1|Period 2 (Weeks 6-10)|Adverse Event|0
5234103|NCT00863057|18062876|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
5234104|NCT00863057|18062877|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
5234105|NCT00863057|18062878|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
5234106|NCT00863057|18062879|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
5234107|NCT00863057|18062876|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
5234108|NCT00863057|18062877|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
5234109|NCT00863057|18062878|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
5234110|NCT00863057|18062879|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
5234111|NCT00862979|18062937|P2|Overall Study|Death|1
5234112|NCT00862979|18062938|P1|Overall Study|Death|0
5234113|NCT00862979|18062937|P2|Overall Study|Administrative problems|1
5234114|NCT00862979|18062938|P1|Overall Study|Administrative problems|0
5234115|NCT00862979|18062937|P2|Overall Study|Patient withdrew consent|1
5234116|NCT00862979|18062938|P1|Overall Study|Patient withdrew consent|2
5234117|NCT00862979|18062937|P2|Overall Study|Protocol Violation|1
5234118|NCT00862979|18062938|P1|Overall Study|Protocol Violation|0
5234119|NCT00862979|18062937|P2|Overall Study|Adverse Event|3
5234120|NCT00862979|18062938|P1|Overall Study|Adverse Event|6
5234121|NCT00862940|18062956|P2|Overall Study|Administrative or other reason(s)|3
5234122|NCT00862940|18062957|P1|Overall Study|Administrative or other reason(s)|4
5234123|NCT00862940|18062956|P2|Overall Study|Lost to Follow-up|1
5234124|NCT00862940|18062957|P1|Overall Study|Lost to Follow-up|0
5234125|NCT00862940|18062956|P2|Overall Study|Non-compliance|0
5234126|NCT00862940|18062957|P1|Overall Study|Non-compliance|4
5234127|NCT00862940|18062956|P2|Overall Study|Withdrawal by Subject|6
5234128|NCT00862940|18062957|P1|Overall Study|Withdrawal by Subject|4
5234129|NCT00862940|18062956|P2|Overall Study|Protocol Violation|5
5234130|NCT00862940|18062957|P1|Overall Study|Protocol Violation|2
5234131|NCT00862940|18062956|P2|Overall Study|Lack of Efficacy|3
5234132|NCT00862940|18062957|P1|Overall Study|Lack of Efficacy|1
5234133|NCT00862940|18062956|P2|Overall Study|Adverse Event|12
5234134|NCT00862940|18062957|P1|Overall Study|Adverse Event|15
5234135|NCT00862849|18062969|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
5234136|NCT00862849|18062970|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
5234137|NCT00862849|18062971|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
5234138|NCT00862849|18062972|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
5234139|NCT00862849|18062973|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
5234140|NCT00862849|18062974|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
5234141|NCT00862849|18062969|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5234142|NCT00862849|18062970|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5234143|NCT00862849|18062971|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5234144|NCT00862849|18062972|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5234145|NCT00862849|18062973|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
5234146|NCT00862849|18062974|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5234147|NCT00862836|18062997|P1|Overall Study|Withdrawal by Subject|1
5234148|NCT00862823|18063008|P2|First Intervention|Withdrawal by Subject|1
5234149|NCT00862823|18063009|P1|First Intervention|Withdrawal by Subject|1
5234150|NCT00862719|18063058|P4|Overall Study|Veno-Occlusive Disease|0
5234151|NCT00862719|18063059|P3|Overall Study|Veno-Occlusive Disease|1
5234152|NCT00862719|18063060|P2|Overall Study|Veno-Occlusive Disease|0
5234153|NCT00862719|18063061|P1|Overall Study|Veno-Occlusive Disease|0
5234154|NCT00862719|18063058|P4|Overall Study|Engraftment failure|0
5234155|NCT00862719|18063059|P3|Overall Study|Engraftment failure|1
5234156|NCT00862719|18063060|P2|Overall Study|Engraftment failure|0
5234157|NCT00862719|18063061|P1|Overall Study|Engraftment failure|0
5234158|NCT00862719|18063058|P4|Overall Study|Death|1
5234159|NCT00862719|18063059|P3|Overall Study|Death|1
5234160|NCT00862719|18063060|P2|Overall Study|Death|6
5234161|NCT00862719|18063061|P1|Overall Study|Death|5
5234162|NCT00862719|18063058|P4|Overall Study|Disease Progression|0
5234163|NCT00862719|18063059|P3|Overall Study|Disease Progression|1
5234164|NCT00862719|18063060|P2|Overall Study|Disease Progression|0
5234165|NCT00862719|18063061|P1|Overall Study|Disease Progression|5
5234166|NCT00862654|18063084|P4|Overall Study|Included after end of inclusions|0
5234167|NCT00862654|18063085|P3|Overall Study|Included after end of inclusions|1
5234168|NCT00862654|18063086|P2|Overall Study|Included after end of inclusions|0
5234169|NCT00862654|18063087|P1|Overall Study|Included after end of inclusions|0
5234170|NCT00862654|18063084|P4|Overall Study|Never used study drugs|0
5234171|NCT00862654|18063085|P3|Overall Study|Never used study drugs|0
5234172|NCT00862654|18063086|P2|Overall Study|Never used study drugs|0
5234173|NCT00862654|18063087|P1|Overall Study|Never used study drugs|1
5234174|NCT00862654|18063084|P4|Overall Study|Familly constraint|0
5234175|NCT00862654|18063085|P3|Overall Study|Familly constraint|0
5234176|NCT00862654|18063086|P2|Overall Study|Familly constraint|1
5234177|NCT00862654|18063087|P1|Overall Study|Familly constraint|0
5234178|NCT00862654|18063084|P4|Overall Study|Subject mistake|0
5234179|NCT00862654|18063085|P3|Overall Study|Subject mistake|0
5234180|NCT00862654|18063086|P2|Overall Study|Subject mistake|1
5234181|NCT00862654|18063087|P1|Overall Study|Subject mistake|0
5234182|NCT00862654|18063084|P4|Overall Study|Withdrawal by Subject|3
5234183|NCT00862654|18063085|P3|Overall Study|Withdrawal by Subject|2
5234184|NCT00862654|18063086|P2|Overall Study|Withdrawal by Subject|2
5234185|NCT00862654|18063087|P1|Overall Study|Withdrawal by Subject|2
5234186|NCT00862654|18063084|P4|Overall Study|Pregnancy|0
5234187|NCT00862654|18063085|P3|Overall Study|Pregnancy|0
5234188|NCT00862654|18063086|P2|Overall Study|Pregnancy|1
5234189|NCT00862654|18063087|P1|Overall Study|Pregnancy|1
5234190|NCT00862654|18063084|P4|Overall Study|Adverse Event|0
5234191|NCT00862654|18063085|P3|Overall Study|Adverse Event|1
5234192|NCT00862654|18063086|P2|Overall Study|Adverse Event|1
5234193|NCT00862654|18063087|P1|Overall Study|Adverse Event|0
5234194|NCT00862654|18063084|P4|Overall Study|Lost to Follow-up|3
5234195|NCT00862654|18063085|P3|Overall Study|Lost to Follow-up|1
5234196|NCT00862654|18063086|P2|Overall Study|Lost to Follow-up|2
5234197|NCT00862654|18063087|P1|Overall Study|Lost to Follow-up|1
5234198|NCT00862654|18063084|P4|Overall Study|Lack of Efficacy|0
5234199|NCT00862654|18063085|P3|Overall Study|Lack of Efficacy|1
5234200|NCT00862654|18063086|P2|Overall Study|Lack of Efficacy|0
5234201|NCT00862654|18063087|P1|Overall Study|Lack of Efficacy|1
5234202|NCT00862641|18063101|P4|Overall Study|Randomized, but drug not received|4
5234203|NCT00862641|18063102|P3|Overall Study|Randomized, but drug not received|1
5234204|NCT00862641|18063103|P2|Overall Study|Randomized, but drug not received|4
5234205|NCT00862641|18063104|P1|Overall Study|Randomized, but drug not received|1
5234206|NCT00862459|18063198|P3|Overall Study|Administrative problems|0
5234207|NCT00862459|18063199|P2|Overall Study|Administrative problems|1
5234208|NCT00862459|18063200|P1|Overall Study|Administrative problems|0
5234209|NCT00862459|18063198|P3|Overall Study|Inclusion/exclusion criteria not met|0
5234210|NCT00862459|18063199|P2|Overall Study|Inclusion/exclusion criteria not met|1
5234211|NCT00862459|18063200|P1|Overall Study|Inclusion/exclusion criteria not met|0
5234212|NCT00862459|18063198|P3|Overall Study|Unable to hold still for imaging|0
5234213|NCT00862459|18063199|P2|Overall Study|Unable to hold still for imaging|1
5234214|NCT00862459|18063200|P1|Overall Study|Unable to hold still for imaging|0
5234215|NCT00862459|18063198|P3|Overall Study|Intravenous (IV) site problems|1
5234216|NCT00862459|18063199|P2|Overall Study|Intravenous (IV) site problems|0
5234217|NCT00862459|18063200|P1|Overall Study|Intravenous (IV) site problems|1
5234218|NCT00862459|18063198|P3|Overall Study|Operation|0
5234219|NCT00862459|18063199|P2|Overall Study|Operation|1
5234220|NCT00862459|18063200|P1|Overall Study|Operation|1
5234221|NCT00862459|18063198|P3|Overall Study|Personal reasons|0
5234222|NCT00862459|18063199|P2|Overall Study|Personal reasons|0
5234223|NCT00862459|18063200|P1|Overall Study|Personal reasons|1
5234224|NCT00862459|18063198|P3|Overall Study|Adverse Event|0
5234225|NCT00862459|18063199|P2|Overall Study|Adverse Event|1
5234226|NCT00862459|18063200|P1|Overall Study|Adverse Event|0
5234227|NCT00862459|18063198|P3|Overall Study|Withdrawal by Subject|3
5234228|NCT00862459|18063199|P2|Overall Study|Withdrawal by Subject|1
5234229|NCT00862459|18063200|P1|Overall Study|Withdrawal by Subject|1
5234230|NCT00862459|18063198|P3|Overall Study|Protocol Violation|0
5234231|NCT00862459|18063199|P2|Overall Study|Protocol Violation|0
5234232|NCT00862459|18063200|P1|Overall Study|Protocol Violation|1
5234233|NCT00862459|18063198|P3|Overall Study|Lost to Follow-up|2
5234234|NCT00862459|18063199|P2|Overall Study|Lost to Follow-up|2
5234235|NCT00862459|18063200|P1|Overall Study|Lost to Follow-up|1
5234236|NCT00862277|18063347|P3|Overall Study|Protocol Violation|5
5234237|NCT00862277|18063348|P2|Overall Study|Protocol Violation|2
5234238|NCT00862277|18063349|P1|Overall Study|Protocol Violation|1
5234239|NCT00862251|18063363|P3|Overall Study|Withdrawal by Subject|6
5234240|NCT00862251|18063364|P2|Overall Study|Withdrawal by Subject|2
5234241|NCT00862251|18063365|P1|Overall Study|Withdrawal by Subject|9
5234242|NCT00862251|18063363|P3|Overall Study|Protocol Violation|1
5234243|NCT00862251|18063364|P2|Overall Study|Protocol Violation|0
5234244|NCT00862251|18063365|P1|Overall Study|Protocol Violation|2
5234245|NCT00862251|18063363|P3|Overall Study|Lost to Follow-up|1
5234246|NCT00862251|18063364|P2|Overall Study|Lost to Follow-up|0
5234247|NCT00862251|18063365|P1|Overall Study|Lost to Follow-up|0
5234248|NCT00862251|18063363|P3|Overall Study|Adverse Event|1
5234249|NCT00862251|18063364|P2|Overall Study|Adverse Event|3
5234250|NCT00862251|18063365|P1|Overall Study|Adverse Event|8
5234251|NCT00862134|18063425|P2|Overall Study|Withdrew prior to dosing|0
5234252|NCT00862134|18063426|P1|Overall Study|Withdrew prior to dosing|2
5234253|NCT00862134|18063425|P2|Overall Study|Adverse Event|2
5234254|NCT00862134|18063426|P1|Overall Study|Adverse Event|2
5234255|NCT00862134|18063425|P2|Overall Study|Sponsor terminated study|7
5234256|NCT00862134|18063426|P1|Overall Study|Sponsor terminated study|5
5234257|NCT00862134|18063425|P2|Overall Study|Withdrawal by Subject|2
5234258|NCT00862134|18063426|P1|Overall Study|Withdrawal by Subject|1
5234259|NCT00862134|18063425|P2|Overall Study|Physician Decision|1
5234260|NCT00862134|18063426|P1|Overall Study|Physician Decision|0
5234261|NCT00862134|18063425|P2|Overall Study|Death|0
5234262|NCT00862134|18063426|P1|Overall Study|Death|1
5234263|NCT00862121|18063438|P2|Overall Study|Incorrect randomisation|1
5234264|NCT00862121|18063439|P1|Overall Study|Incorrect randomisation|0
5234265|NCT00862121|18063438|P2|Overall Study|Exclusion criterion violation|1
5234266|NCT00862121|18063439|P1|Overall Study|Exclusion criterion violation|0
5234267|NCT00862121|18063438|P2|Overall Study|Protocol Violation|1
5234268|NCT00862121|18063439|P1|Overall Study|Protocol Violation|0
5234269|NCT00862121|18063438|P2|Overall Study|Lack of Efficacy|3
5234270|NCT00862121|18063439|P1|Overall Study|Lack of Efficacy|0
5234271|NCT00862121|18063438|P2|Overall Study|Adverse Event|2
5234272|NCT00862121|18063439|P1|Overall Study|Adverse Event|1
5234273|NCT00862082|18063457|P2|Overall Study|Withdrawal by Subject|1
5234274|NCT00862082|18063458|P1|Overall Study|Withdrawal by Subject|0
5234275|NCT00862082|18063457|P2|Overall Study|Sponsor decision to terminate the study|0
5234276|NCT00862082|18063458|P1|Overall Study|Sponsor decision to terminate the study|5
5234277|NCT00861757|18063513|P4|Overall Study|Withdrawal by Subject|2
5234278|NCT00861757|18063514|P3|Overall Study|Withdrawal by Subject|5
5234279|NCT00861757|18063515|P2|Overall Study|Withdrawal by Subject|5
5234280|NCT00861757|18063516|P1|Overall Study|Withdrawal by Subject|1
5234281|NCT00861757|18063513|P4|Overall Study|Protocol Violation|1
5234282|NCT00861757|18063514|P3|Overall Study|Protocol Violation|4
5234283|NCT00861757|18063515|P2|Overall Study|Protocol Violation|2
5234284|NCT00861757|18063516|P1|Overall Study|Protocol Violation|2
5234285|NCT00861757|18063513|P4|Overall Study|Physician Decision|1
5234286|NCT00861757|18063514|P3|Overall Study|Physician Decision|0
5234287|NCT00861757|18063515|P2|Overall Study|Physician Decision|0
5234288|NCT00861757|18063516|P1|Overall Study|Physician Decision|0
5234289|NCT00861757|18063513|P4|Overall Study|Lost to Follow-up|1
5234290|NCT00861757|18063514|P3|Overall Study|Lost to Follow-up|1
5234291|NCT00861757|18063515|P2|Overall Study|Lost to Follow-up|0
5234292|NCT00861757|18063516|P1|Overall Study|Lost to Follow-up|1
5234293|NCT00861757|18063513|P4|Overall Study|Lack of Efficacy|1
5234294|NCT00861757|18063514|P3|Overall Study|Lack of Efficacy|0
5234295|NCT00861757|18063515|P2|Overall Study|Lack of Efficacy|1
5234296|NCT00861757|18063516|P1|Overall Study|Lack of Efficacy|3
5234297|NCT00861757|18063513|P4|Overall Study|Entry Criteria Not Met|1
5234298|NCT00861757|18063514|P3|Overall Study|Entry Criteria Not Met|1
5234299|NCT00861757|18063515|P2|Overall Study|Entry Criteria Not Met|2
5234300|NCT00861757|18063516|P1|Overall Study|Entry Criteria Not Met|1
5234301|NCT00861757|18063513|P4|Overall Study|Adverse Event|2
5234302|NCT00861757|18063514|P3|Overall Study|Adverse Event|7
5234303|NCT00861757|18063515|P2|Overall Study|Adverse Event|5
5234304|NCT00861757|18063516|P1|Overall Study|Adverse Event|1
5234305|NCT00861744|18063574|P4|Overall Study|Blood draws|1
5234306|NCT00861744|18063575|P3|Overall Study|Blood draws|0
5234307|NCT00861744|18063576|P2|Overall Study|Blood draws|0
5234308|NCT00861744|18063577|P1|Overall Study|Blood draws|0
5234309|NCT00861744|18063574|P4|Overall Study|Migration from study area|0
5234310|NCT00861744|18063575|P3|Overall Study|Migration from study area|1
5234311|NCT00861744|18063576|P2|Overall Study|Migration from study area|3
5234312|NCT00861744|18063577|P1|Overall Study|Migration from study area|0
5234313|NCT00861744|18063574|P4|Overall Study|Protocol Violation|0
5234314|NCT00861744|18063575|P3|Overall Study|Protocol Violation|0
5234315|NCT00861744|18063576|P2|Overall Study|Protocol Violation|1
5234316|NCT00861744|18063577|P1|Overall Study|Protocol Violation|0
5234317|NCT00861744|18063574|P4|Overall Study|Withdrawal by Subject|19
5234318|NCT00861744|18063575|P3|Overall Study|Withdrawal by Subject|6
5234319|NCT00861744|18063576|P2|Overall Study|Withdrawal by Subject|6
5234320|NCT00861744|18063577|P1|Overall Study|Withdrawal by Subject|10
5234321|NCT00861744|18063574|P4|Overall Study|Lost to Follow-up|12
5234322|NCT00861744|18063575|P3|Overall Study|Lost to Follow-up|17
5234323|NCT00861744|18063576|P2|Overall Study|Lost to Follow-up|19
5234324|NCT00861744|18063577|P1|Overall Study|Lost to Follow-up|7
5234325|NCT00861744|18063574|P4|Overall Study|Adverse Event|1
5234326|NCT00861744|18063575|P3|Overall Study|Adverse Event|0
5234327|NCT00861744|18063576|P2|Overall Study|Adverse Event|0
5234328|NCT00861744|18063577|P1|Overall Study|Adverse Event|0
5234329|NCT00861705|18063759|P4|Overall Study|Never Began Treatment|1
5234330|NCT00861705|18063760|P3|Overall Study|Never Began Treatment|0
5234331|NCT00861705|18063761|P2|Overall Study|Never Began Treatment|3
5234332|NCT00861705|18063762|P1|Overall Study|Never Began Treatment|7
5234333|NCT00861692|18063802|P1|Overall Study|Death|6
5234334|NCT00861614|18063814|P2|Overall Study|Other|22
5234335|NCT00861614|18063815|P1|Overall Study|Other|17
5234336|NCT00861614|18063814|P2|Overall Study|Withdrawal by Subject|35
5234337|NCT00861614|18063815|P1|Overall Study|Withdrawal by Subject|34
5234338|NCT00861614|18063814|P2|Overall Study|Adverse Event|23
5234339|NCT00861614|18063815|P1|Overall Study|Adverse Event|27
5234340|NCT00861614|18063814|P2|Overall Study|Death|19
5234341|NCT00861614|18063815|P1|Overall Study|Death|32
5234342|NCT00861614|18063814|P2|Overall Study|Study Drug Toxicity|6
5234343|NCT00861614|18063815|P1|Overall Study|Study Drug Toxicity|79
5234344|NCT00861614|18063814|P2|Overall Study|Disease Progression|263
5234345|NCT00861614|18063815|P1|Overall Study|Disease Progression|182
5234346|NCT00861471|18063900|P1|Overall Study|Physician Decision|2
5234347|NCT00861471|18063900|P1|Overall Study|treatment for lumbar laminectomy|1
5234348|NCT00861471|18063900|P1|Overall Study|Lack of Efficacy|3
5234349|NCT00861471|18063900|P1|Overall Study|Adverse Event|2
5234350|NCT00861471|18063900|P1|Overall Study|Withdrawal by Subject|1
5234351|NCT00861380|18063915|P7|Overall Study|Withdrawal Information not recorded|3020
5234352|NCT00861380|18063916|P6|Overall Study|Withdrawal Information not recorded|6249
5234353|NCT00861380|18063917|P5|Overall Study|Withdrawal Information not recorded|1812
5234354|NCT00861380|18063918|P4|Overall Study|Withdrawal Information not recorded|3689
5234355|NCT00861380|18063919|P3|Overall Study|Withdrawal Information not recorded|8872
5234356|NCT00861380|18063920|P2|Overall Study|Withdrawal Information not recorded|9112
5234357|NCT00861380|18063921|P1|Overall Study|Withdrawal Information not recorded|8427
5234358|NCT00861341|18064005|P1|Overall Study|Withdrawal by Subject|2
5234359|NCT00861198|18064014|P1|Overall Study|SpyGlass Failed|5
5234360|NCT00860951|18064031|P1|Overall Study|Lost to Follow-up|5
5234361|NCT00860951|18064031|P1|Overall Study|Withdrawal by Subject|2
5234362|NCT00860743|18064088|P2|Overall Study|Withdrawal by Subject|0
5234363|NCT00860743|18064089|P1|Overall Study|Withdrawal by Subject|3
5234364|NCT00860470|18064102|P2|Overall Study|Lost to Follow-up|39
5234365|NCT00860470|18064103|P1|Overall Study|Lost to Follow-up|34
5234366|NCT00860470|18064102|P2|Overall Study|Moved away|10
5234367|NCT00860470|18064103|P1|Overall Study|Moved away|8
5234368|NCT00860470|18064102|P2|Overall Study|Death|10
5234369|NCT00860470|18064103|P1|Overall Study|Death|6
5234370|NCT00860405|18064133|P2|Overall Study|Main reason: Follow-up data not complete|4
5234371|NCT00860405|18064134|P1|Overall Study|Main reason: Follow-up data not complete|5
5234372|NCT00860262|18064174|P3|Overall Study|Other|1
5234373|NCT00860262|18064175|P2|Overall Study|Other|3
5234374|NCT00860262|18064176|P1|Overall Study|Other|5
5234375|NCT00860262|18064174|P3|Overall Study|Lack of Efficacy|3
5234376|NCT00860262|18064175|P2|Overall Study|Lack of Efficacy|4
5234377|NCT00860262|18064176|P1|Overall Study|Lack of Efficacy|0
5234378|NCT00860262|18064174|P3|Overall Study|Withdrawal by Subject|6
5234379|NCT00860262|18064175|P2|Overall Study|Withdrawal by Subject|8
5234380|NCT00860262|18064176|P1|Overall Study|Withdrawal by Subject|4
5234381|NCT00860262|18064174|P3|Overall Study|Lost to Follow-up|1
5234382|NCT00860262|18064175|P2|Overall Study|Lost to Follow-up|0
5234383|NCT00860262|18064176|P1|Overall Study|Lost to Follow-up|2
5234384|NCT00860262|18064174|P3|Overall Study|Protocol Violation|0
5234385|NCT00860262|18064175|P2|Overall Study|Protocol Violation|1
5234386|NCT00860262|18064176|P1|Overall Study|Protocol Violation|0
5234387|NCT00860262|18064174|P3|Overall Study|Adverse Event|7
5234388|NCT00860262|18064175|P2|Overall Study|Adverse Event|6
5234389|NCT00860262|18064176|P1|Overall Study|Adverse Event|9
5234390|NCT00860249|18064289|P3|Overall Study|trial was terminated prior to completion|21
5234391|NCT00860249|18064290|P2|Overall Study|trial was terminated prior to completion|18
5234392|NCT00860249|18064291|P1|Overall Study|trial was terminated prior to completion|21
5234393|NCT00860158|18064311|P1|Overall Study|Study Terminated|1
5234394|NCT00860067|18064323|P3|Overall Study|Pregnancy|0
5234395|NCT00860067|18064324|P2|Overall Study|Pregnancy|0
5234396|NCT00860067|18064325|P1|Overall Study|Pregnancy|1
5234397|NCT00860067|18064323|P3|Overall Study|Withdrawal by Subject|0
5234398|NCT00860067|18064324|P2|Overall Study|Withdrawal by Subject|0
5234399|NCT00860067|18064325|P1|Overall Study|Withdrawal by Subject|4
5234400|NCT00860067|18064323|P3|Overall Study|Lost to Follow-up|9
5234401|NCT00860067|18064324|P2|Overall Study|Lost to Follow-up|9
5234402|NCT00860067|18064325|P1|Overall Study|Lost to Follow-up|46
5234403|NCT00860028|18064385|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
5234404|NCT00860028|18064386|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
5234405|NCT00859937|18064428|P2|Overall Study|Protocol Violation|0
5234406|NCT00859937|18064429|P1|Overall Study|Protocol Violation|1
5234407|NCT00859898|18064444|P3|Overall Study|non-specified|1
5234408|NCT00859898|18064445|P2|Overall Study|non-specified|1
5234409|NCT00859898|18064446|P1|Overall Study|non-specified|1
5234410|NCT00859898|18064444|P3|Overall Study|No longer meets criteria|0
5234411|NCT00859898|18064445|P2|Overall Study|No longer meets criteria|1
5234412|NCT00859898|18064446|P1|Overall Study|No longer meets criteria|0
5234413|NCT00859898|18064444|P3|Overall Study|poor/non-compliance|0
5234414|NCT00859898|18064445|P2|Overall Study|poor/non-compliance|0
5234415|NCT00859898|18064446|P1|Overall Study|poor/non-compliance|2
5234416|NCT00859898|18064444|P3|Overall Study|Lost to Follow-up|5
5234417|NCT00859898|18064445|P2|Overall Study|Lost to Follow-up|11
5234418|NCT00859898|18064446|P1|Overall Study|Lost to Follow-up|10
5234419|NCT00859898|18064444|P3|Overall Study|Death|1
5234420|NCT00859898|18064445|P2|Overall Study|Death|0
5234421|NCT00859898|18064446|P1|Overall Study|Death|0
5234422|NCT00859898|18064444|P3|Overall Study|Withdrawal by Subject|11
5234423|NCT00859898|18064445|P2|Overall Study|Withdrawal by Subject|8
5234424|NCT00859898|18064446|P1|Overall Study|Withdrawal by Subject|11
5234425|NCT00859898|18064444|P3|Overall Study|Adverse Event|8
5234426|NCT00859898|18064445|P2|Overall Study|Adverse Event|9
5234427|NCT00859898|18064446|P1|Overall Study|Adverse Event|4
5234428|NCT00859898|18064444|P3|Overall Study|Lack of Efficacy|1
5234429|NCT00859898|18064445|P2|Overall Study|Lack of Efficacy|1
5234430|NCT00859898|18064446|P1|Overall Study|Lack of Efficacy|0
5234431|NCT00859638|18064505|P2|Overall Study|Ill health|1
5234432|NCT00859638|18064506|P1|Overall Study|Ill health|1
5234433|NCT00859638|18064505|P2|Overall Study|Withdrawal by Subject|2
5234434|NCT00859638|18064506|P1|Overall Study|Withdrawal by Subject|3
5234435|NCT00859638|18064505|P2|Overall Study|Lost to Follow-up|1
5234436|NCT00859638|18064506|P1|Overall Study|Lost to Follow-up|6
5234437|NCT00859586|18064512|P1|Overall Study|Donors|4
5234438|NCT00859573|18064528|P2|Overall Study|Physician Decision|1
5234439|NCT00859573|18064529|P1|Overall Study|Physician Decision|1
5234440|NCT00859573|18064528|P2|Overall Study|Withdrawal by Subject|1
5234441|NCT00859573|18064529|P1|Overall Study|Withdrawal by Subject|4
5234442|NCT00859547|18064535|P1|Overall Study|Parent withdrew consent|1
5234443|NCT00859547|18064535|P1|Overall Study|Lost to Follow-up|1
5234444|NCT00859521|18064548|P2|Washout|Withdrawal by Subject|1
5234445|NCT00859521|18064549|P1|Washout|Withdrawal by Subject|0
5234446|NCT00859469|18064570|P1|Overall Study|Death|16
5234447|NCT00859469|18064570|P1|Overall Study|Withdrawal by Subject|1
5234448|NCT00859469|18064570|P1|Overall Study|Lack of Efficacy|9
5234449|NCT00859469|18064570|P1|Overall Study|Adverse Event|2
5234450|NCT00859456|18064576|P1|Overall Study|Non-compliance|3
5234451|NCT00859456|18064576|P1|Overall Study|Progressive disease|2
5234452|NCT00859456|18064576|P1|Overall Study|Adverse Event|3
5234453|NCT00859430|18064582|P2|First Intervention|Withdrawal by Subject|1
5234454|NCT00859430|18064583|P1|First Intervention|Withdrawal by Subject|0
5234455|NCT00859313|18064599|P1|Overall Study|staff error|1
5234456|NCT00859313|18064599|P1|Overall Study|Adverse Event|1
5234457|NCT00859313|18064599|P1|Overall Study|Lack of Efficacy|2
5234458|NCT00859222|18064606|P5|Overall Study|DLT|0
5234459|NCT00859222|18064607|P4|Overall Study|DLT|0
5234460|NCT00859222|18064608|P3|Overall Study|DLT|0
5234461|NCT00859222|18064609|P2|Overall Study|DLT|0
5234462|NCT00859222|18064610|P1|Overall Study|DLT|1
5234463|NCT00859222|18064606|P5|Overall Study|Adverse Event|15
5234464|NCT00859222|18064607|P4|Overall Study|Adverse Event|24
5234465|NCT00859222|18064608|P3|Overall Study|Adverse Event|6
5234466|NCT00859222|18064609|P2|Overall Study|Adverse Event|3
5234467|NCT00859222|18064610|P1|Overall Study|Adverse Event|2
5234468|NCT00859014|18064732|P1|Overall Study|Lost to Follow-up|1
5234469|NCT00859014|18064732|P1|Overall Study|Death|4
5234470|NCT00858988|18064739|P2|Analysis|Lactulose unable to be detected in urine|1
5234471|NCT00858988|18064740|P1|Analysis|Lactulose unable to be detected in urine|2
5234472|NCT00858845|18064756|P2|Overall Study|Patient underwent heart transplant.|1
5234473|NCT00858845|18064757|P1|Overall Study|Patient underwent heart transplant.|0
5234474|NCT00858832|18064769|P2|Overall Study|Adverse Event|1
5234475|NCT00858832|18064770|P1|Overall Study|Adverse Event|0
5234476|NCT00858832|18064769|P2|Overall Study|became ineligible: delivered vaginally|0
5234477|NCT00858832|18064770|P1|Overall Study|became ineligible: delivered vaginally|1
5234478|NCT00858780|18064776|P5|OL Re-Treatment (Failure to Week 48)|Other|1
5234479|NCT00858780|18064777|P4|OL Re-Treatment (Failure to Week 48)|Other|0
5234480|NCT00858780|18064778|P3|OL Re-Treatment (Failure to Week 48)|Other|0
5234481|NCT00858780|18064779|P2|OL Re-Treatment (Failure to Week 48)|Other|0
5234482|NCT00858780|18064780|P1|OL Re-Treatment (Failure to Week 48)|Other|0
5234483|NCT00858780|18064776|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
5234484|NCT00858780|18064777|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5234485|NCT00858780|18064778|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5234486|NCT00858780|18064779|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5234487|NCT00858780|18064780|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5234488|NCT00858780|18064776|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5234489|NCT00858780|18064777|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5234490|NCT00858780|18064778|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5234491|NCT00858780|18064779|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
5234492|NCT00858780|18064780|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5234493|NCT00858780|18064776|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
5234494|NCT00858780|18064777|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
5234495|NCT00858780|18064778|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
5234496|NCT00858780|18064779|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
5234497|NCT00858780|18064780|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
5234498|NCT00858780|18064776|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5234499|NCT00858780|18064777|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5234500|NCT00858780|18064778|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
5234501|NCT00858780|18064779|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5234502|NCT00858780|18064780|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5234503|NCT00858780|18064776|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5234504|NCT00858780|18064777|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5234505|NCT00858780|18064778|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5234506|NCT00858780|18064779|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5234507|NCT00858780|18064780|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
5234508|NCT00858702|18064855|P2|Overall Study|Withdrawal by Subject|0
5234509|NCT00858702|18064856|P1|Overall Study|Withdrawal by Subject|1
5234510|NCT00858702|18064855|P2|Overall Study|Other|1
5234511|NCT00858702|18064856|P1|Overall Study|Other|2
5234512|NCT00858702|18064855|P2|Overall Study|Protocol Violation|1
5234513|NCT00858702|18064856|P1|Overall Study|Protocol Violation|1
5234514|NCT00858702|18064855|P2|Overall Study|Lack of Efficacy|0
5234515|NCT00858702|18064856|P1|Overall Study|Lack of Efficacy|1
5234516|NCT00858637|18064871|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
5234517|NCT00858637|18064872|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5234518|NCT00858637|18064873|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5234519|NCT00858637|18064874|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5234520|NCT00858637|18064875|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5234521|NCT00858637|18064876|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5234522|NCT00858637|18064871|P6|Placebo-controlled Withdrawal Phase|Death|0
5234523|NCT00858637|18064872|P5|Placebo-controlled Withdrawal Phase|Death|1
5234524|NCT00858637|18064873|P4|Placebo-controlled Withdrawal Phase|Death|0
5234525|NCT00858637|18064874|P3|Placebo-controlled Withdrawal Phase|Death|1
5234526|NCT00858637|18064875|P2|Placebo-controlled Withdrawal Phase|Death|0
5234527|NCT00858637|18064876|P1|Placebo-controlled Withdrawal Phase|Death|0
5234528|NCT00858637|18064871|P6|Active Comparison Phase|Other Reasons|0
5234529|NCT00858637|18064872|P5|Active Comparison Phase|Other Reasons|0
5234530|NCT00858637|18064873|P4|Active Comparison Phase|Other Reasons|1
5234531|NCT00858637|18064874|P3|Active Comparison Phase|Other Reasons|0
5234532|NCT00858637|18064875|P2|Active Comparison Phase|Other Reasons|0
5234533|NCT00858637|18064876|P1|Active Comparison Phase|Other Reasons|1
5234534|NCT00858637|18064871|P6|Active Comparison Phase|Withdrawal by Subject|0
5234535|NCT00858637|18064872|P5|Active Comparison Phase|Withdrawal by Subject|0
5234536|NCT00858637|18064873|P4|Active Comparison Phase|Withdrawal by Subject|6
5234537|NCT00858637|18064874|P3|Active Comparison Phase|Withdrawal by Subject|0
5234538|NCT00858637|18064875|P2|Active Comparison Phase|Withdrawal by Subject|0
5234539|NCT00858637|18064876|P1|Active Comparison Phase|Withdrawal by Subject|7
5234540|NCT00858637|18064871|P6|Active Comparison Phase|Physician Decision|0
5234541|NCT00858637|18064872|P5|Active Comparison Phase|Physician Decision|0
5234542|NCT00858637|18064873|P4|Active Comparison Phase|Physician Decision|1
5234543|NCT00858637|18064874|P3|Active Comparison Phase|Physician Decision|0
5234544|NCT00858637|18064875|P2|Active Comparison Phase|Physician Decision|0
5234545|NCT00858637|18064876|P1|Active Comparison Phase|Physician Decision|1
5234546|NCT00858637|18064871|P6|Active Comparison Phase|Death|0
5234547|NCT00858637|18064872|P5|Active Comparison Phase|Death|0
5234548|NCT00858637|18064873|P4|Active Comparison Phase|Death|1
5234549|NCT00858637|18064874|P3|Active Comparison Phase|Death|0
5234550|NCT00858637|18064875|P2|Active Comparison Phase|Death|0
5234551|NCT00858637|18064876|P1|Active Comparison Phase|Death|1
5234552|NCT00858637|18064871|P6|Active Comparison Phase|Adverse Event|0
5234553|NCT00858637|18064872|P5|Active Comparison Phase|Adverse Event|0
5234554|NCT00858637|18064873|P4|Active Comparison Phase|Adverse Event|9
5234555|NCT00858637|18064874|P3|Active Comparison Phase|Adverse Event|0
5234556|NCT00858637|18064875|P2|Active Comparison Phase|Adverse Event|0
5234557|NCT00858637|18064876|P1|Active Comparison Phase|Adverse Event|14
5234558|NCT00858442|18064917|P2|Compression:Start to Finish|Lost to Follow-up|3
5234559|NCT00858442|18064918|P1|Compression:Start to Finish|Lost to Follow-up|1
5234560|NCT00858403|18064928|P1|Overall Study|Disease Progression|1
5234561|NCT00858403|18064928|P1|Overall Study|Death|3
5234562|NCT00858403|18064928|P1|Overall Study|Withdrawal by Subject|1
5234563|NCT00858364|18064949|P2|Overall Study|Still on-study|247
5234564|NCT00858364|18064950|P1|Overall Study|Still on-study|114
5234565|NCT00858364|18064949|P2|Overall Study|Missing|1
5234566|NCT00858364|18064950|P1|Overall Study|Missing|1
5234567|NCT00858364|18064949|P2|Overall Study|Other|17
5234568|NCT00858364|18064950|P1|Overall Study|Other|9
5234569|NCT00858364|18064949|P2|Overall Study|Protocol Deviation|2
5234570|NCT00858364|18064950|P1|Overall Study|Protocol Deviation|0
5234571|NCT00858364|18064949|P2|Overall Study|Noncompliance|4
5234572|NCT00858364|18064950|P1|Overall Study|Noncompliance|3
5234573|NCT00858364|18064949|P2|Overall Study|Lost to Follow-up|54
5234574|NCT00858364|18064950|P1|Overall Study|Lost to Follow-up|24
5234575|NCT00858364|18064949|P2|Overall Study|Ineligibility Determined|10
5234576|NCT00858364|18064950|P1|Overall Study|Ineligibility Determined|1
5234577|NCT00858364|18064949|P2|Overall Study|Withdrawal by Subject|118
5234578|NCT00858364|18064950|P1|Overall Study|Withdrawal by Subject|44
5234579|NCT00858364|18064949|P2|Overall Study|Adverse Event|2
5234580|NCT00858364|18064950|P1|Overall Study|Adverse Event|5
5234581|NCT00858364|18064949|P2|Overall Study|Administrative Decision|2
5234582|NCT00858364|18064950|P1|Overall Study|Administrative Decision|3
5234583|NCT00858247|18064972|P2|Week 12 Follow-up|Withdrawal by Subject|1
5234584|NCT00858247|18064973|P1|Week 12 Follow-up|Withdrawal by Subject|0
5234585|NCT00858247|18064972|P2|Baseline Assessment|Protocol Violation|1
5234586|NCT00858247|18064973|P1|Baseline Assessment|Protocol Violation|0
5234587|NCT00858247|18064972|P2|Baseline Assessment|Poor IV access|0
5234588|NCT00858247|18064973|P1|Baseline Assessment|Poor IV access|1
5234589|NCT00858247|18064972|P2|Baseline Assessment|Withdrawal by Subject|1
5234590|NCT00858247|18064973|P1|Baseline Assessment|Withdrawal by Subject|1
5234591|NCT00858208|18064989|P1|Overall Study|Other|10
5234592|NCT00858208|18064989|P1|Overall Study|Participant refused|40
5234593|NCT00858208|18064989|P1|Overall Study|Lost to Follow-up|26
5234594|NCT00858208|18064989|P1|Overall Study|Adverse Event|3
5234595|NCT00858143|18065006|P1|Overall Study|Other|23
5234596|NCT00858143|18065006|P1|Overall Study|Death|7
5234597|NCT00858143|18065006|P1|Overall Study|Lack of Efficacy|4
5234598|NCT00858143|18065006|P1|Overall Study|Adverse Event|16
5234599|NCT00858117|18065063|P1|Follow up for 5 Years|No further data collected for study|9
5234600|NCT00858117|18065063|P1|Follow up for 5 Years|Death|4
5234601|NCT00858117|18065063|P1|Treatment on Study|Adverse Event|2
5234602|NCT00857948|18065126|P4|Overall Study|Protocol Violation|0
5234603|NCT00857948|18065127|P3|Overall Study|Protocol Violation|1
5234604|NCT00857948|18065128|P2|Overall Study|Protocol Violation|0
5234605|NCT00857948|18065129|P1|Overall Study|Protocol Violation|1
5234606|NCT00857948|18065126|P4|Overall Study|Withdrawal by Subject|0
5234607|NCT00857948|18065127|P3|Overall Study|Withdrawal by Subject|0
5234608|NCT00857948|18065128|P2|Overall Study|Withdrawal by Subject|0
5234609|NCT00857948|18065129|P1|Overall Study|Withdrawal by Subject|2
5234610|NCT00857896|18065151|P1|Baseline to Week 4|Withdrawal by Subject|1
5234611|NCT00857818|18065307|P2|Overall Study|Investigator decision|0
5234612|NCT00857818|18065308|P1|Overall Study|Investigator decision|1
5234613|NCT00857818|18065307|P2|Overall Study|Sponsor terminated study|4
5234614|NCT00857818|18065308|P1|Overall Study|Sponsor terminated study|6
5234615|NCT00857818|18065307|P2|Overall Study|Withdrawal by Subject|4
5234616|NCT00857818|18065308|P1|Overall Study|Withdrawal by Subject|0
5234617|NCT00857818|18065307|P2|Overall Study|Adverse Event|0
5234618|NCT00857818|18065308|P1|Overall Study|Adverse Event|3
5234619|NCT00857818|18065307|P2|Overall Study|Lack of Efficacy|0
5234620|NCT00857818|18065308|P1|Overall Study|Lack of Efficacy|1
5234621|NCT00857792|18065336|P1|Overall Study|inadequate image quality for analysis|12
5234622|NCT00857766|18065342|P2|Overall Study|Participant Withdrew Consent|4
5234623|NCT00857766|18065343|P1|Overall Study|Participant Withdrew Consent|4
5234624|NCT00857766|18065342|P2|Overall Study|Investigator Discretion|3
5234625|NCT00857766|18065343|P1|Overall Study|Investigator Discretion|2
5234626|NCT00857766|18065342|P2|Overall Study|Lost to Follow-up|0
5234627|NCT00857766|18065343|P1|Overall Study|Lost to Follow-up|1
5234628|NCT00857766|18065342|P2|Overall Study|Protocol Violation|11
5234629|NCT00857766|18065343|P1|Overall Study|Protocol Violation|11
5234630|NCT00857766|18065342|P2|Overall Study|Adverse Event|12
5234631|NCT00857766|18065343|P1|Overall Study|Adverse Event|13
5234632|NCT00857649|18065385|P2|Overall Study|Other Reasons|3
5234633|NCT00857649|18065386|P1|Overall Study|Other Reasons|1
5234634|NCT00857649|18065385|P2|Overall Study|Nursing Home Placement|9
5234635|NCT00857649|18065386|P1|Overall Study|Nursing Home Placement|2
5234636|NCT00857649|18065385|P2|Overall Study|Withdrawal of Consent|7
5234637|NCT00857649|18065386|P1|Overall Study|Withdrawal of Consent|10
5234638|NCT00857649|18065385|P2|Overall Study|Protocol Violation|2
5234639|NCT00857649|18065386|P1|Overall Study|Protocol Violation|2
5234640|NCT00857649|18065385|P2|Overall Study|Non-compliance|1
5234641|NCT00857649|18065386|P1|Overall Study|Non-compliance|1
5234642|NCT00857649|18065385|P2|Overall Study|Adverse Event|10
5234643|NCT00857649|18065386|P1|Overall Study|Adverse Event|15
5234644|NCT00857623|18065402|P2|Overall Study|Positive for HEP C|1
5234645|NCT00857623|18065403|P1|Overall Study|Positive for HEP C|0
5234646|NCT00857623|18065402|P2|Overall Study|Intake of prohibited medication|1
5234647|NCT00857623|18065403|P1|Overall Study|Intake of prohibited medication|0
5234648|NCT00857623|18065402|P2|Overall Study|Severe non-compliance to protocol|1
5234649|NCT00857623|18065403|P1|Overall Study|Severe non-compliance to protocol|1
5234650|NCT00857623|18065402|P2|Overall Study|Lack of Efficacy|1
5234651|NCT00857623|18065403|P1|Overall Study|Lack of Efficacy|1
5234652|NCT00857623|18065402|P2|Overall Study|Withdrawal by Subject|1
5234653|NCT00857623|18065403|P1|Overall Study|Withdrawal by Subject|2
5234654|NCT00857623|18065402|P2|Overall Study|Study-specific discontinuation criteria|3
5234655|NCT00857623|18065403|P1|Overall Study|Study-specific discontinuation criteria|5
5234656|NCT00857623|18065402|P2|Overall Study|Adverse Event|2
5234657|NCT00857623|18065403|P1|Overall Study|Adverse Event|5
5234658|NCT00857584|18065427|P2|Overall Study|Physician Decision|1
5234659|NCT00857584|18065428|P1|Overall Study|Physician Decision|1
5234660|NCT00857584|18065427|P2|Overall Study|Adverse Event|2
5234661|NCT00857584|18065428|P1|Overall Study|Adverse Event|2
5234662|NCT00857584|18065427|P2|Overall Study|Lack of Efficacy|2
5234663|NCT00857584|18065428|P1|Overall Study|Lack of Efficacy|1
5234664|NCT00857454|18065555|P1|Overall Study|MTE09 enrollment criteria not met|6
5234665|NCT00857454|18065555|P1|Overall Study|Total Testosterone <300 ng/dL|8
5234666|NCT00857454|18065555|P1|Overall Study|Total Testosterone >1050 ng/dL|1
5234667|NCT00857454|18065555|P1|Overall Study|Adverse Event|2
5234668|NCT00857454|18065555|P1|Overall Study|Lost to Follow-up|1
5234669|NCT00857454|18065555|P1|Overall Study|Withdrawal by Subject|2
5234670|NCT00857415|18065568|P2|Overall Study|Deceased with no autopsy|0
5234671|NCT00857415|18065569|P1|Overall Study|Deceased with no autopsy|2
5234672|NCT00857415|18065568|P2|Overall Study|Subject still living at end of study|0
5234673|NCT00857415|18065569|P1|Overall Study|Subject still living at end of study|110
5234674|NCT00857415|18065568|P2|Overall Study|Invalid image or not imaged|0
5234675|NCT00857415|18065569|P1|Overall Study|Invalid image or not imaged|3
5234676|NCT00857415|18065568|P2|Overall Study|Image acquisition failure|0
5234677|NCT00857415|18065569|P1|Overall Study|Image acquisition failure|2
5234678|NCT00857389|18065576|P1|Overall Study|Did not proceed to transplant|2
5234679|NCT00857311|18065590|P4|Overall Study|Lost to Follow-up|0
5234680|NCT00857311|18065591|P3|Overall Study|Lost to Follow-up|0
5234681|NCT00857311|18065592|P2|Overall Study|Lost to Follow-up|0
5234682|NCT00857311|18065593|P1|Overall Study|Lost to Follow-up|1
5234683|NCT00857285|18065605|P2|Overall Study|Randomization criteria not met|1
5234684|NCT00857285|18065606|P1|Overall Study|Randomization criteria not met|1
5234685|NCT00857285|18065605|P2|Overall Study|Withdrawal by Subject|0
5234686|NCT00857285|18065606|P1|Overall Study|Withdrawal by Subject|4
5234687|NCT00857285|18065605|P2|Overall Study|Protocol Violation|1
5234688|NCT00857285|18065606|P1|Overall Study|Protocol Violation|3
5234689|NCT00857285|18065605|P2|Overall Study|Lack of Efficacy|2
5234690|NCT00857285|18065606|P1|Overall Study|Lack of Efficacy|0
5234691|NCT00857285|18065605|P2|Overall Study|Adverse Event|2
5234692|NCT00857285|18065606|P1|Overall Study|Adverse Event|4
5234693|NCT00857259|18065622|P3|Overall Study|Protocol Violation|1
5234694|NCT00857259|18065623|P2|Overall Study|Protocol Violation|0
5234695|NCT00857259|18065624|P1|Overall Study|Protocol Violation|1
5234696|NCT00857246|18065634|P1|ChemoRT|Adverse Event|2
5234697|NCT00857246|18065634|P1|ChemoRT|Withdrawal by Subject|1
5234698|NCT00857246|18065634|P1|Surgery (Curative)|disease progression|6
5234699|NCT00857246|18065634|P1|Induction Regimen|Withdrawal by Subject|1
5234700|NCT00857246|18065634|P1|Induction Regimen|disease-related complications|1
5234701|NCT00857246|18065634|P1|Induction Regimen|Adverse Event|1
5234702|NCT00857233|18065644|P1|Overall Study|Other Reasons|2
5234703|NCT00857233|18065644|P1|Overall Study|Nursing Home Placement|14
5234704|NCT00857233|18065644|P1|Overall Study|Lost to Follow-up|4
5234705|NCT00857233|18065644|P1|Overall Study|Withdrawal of Consent|9
5234706|NCT00857233|18065644|P1|Overall Study|Non-compliance|1
5234707|NCT00857233|18065644|P1|Overall Study|Lack of Efficacy|1
5234708|NCT00857233|18065644|P1|Overall Study|Adverse Event|24
5234709|NCT00857220|18065653|P1|Overall Study|Miscellaneous|8
5234710|NCT00857220|18065653|P1|Overall Study|Site Closed|5
5234711|NCT00857220|18065653|P1|Overall Study|Clinical Hold|6
5234712|NCT00857220|18065653|P1|Overall Study|Withdrawal by Subject|67
5234713|NCT00857220|18065653|P1|Overall Study|Protocol Violation|16
5234714|NCT00857220|18065653|P1|Overall Study|Physician Decision|4
5234715|NCT00857220|18065653|P1|Overall Study|Lost to Follow-up|30
5234716|NCT00857220|18065653|P1|Overall Study|Lack of Efficacy|11
5234717|NCT00857220|18065653|P1|Overall Study|Death|1
5234718|NCT00857220|18065653|P1|Overall Study|Adverse Event|35
5234719|NCT00856999|18065670|P1|Overall Study|Withdrawal by Subject|5
5234720|NCT00856986|18065680|P5|Extension Period, Weeks 26-52|Unclassified|0
5234721|NCT00856986|18065681|P4|Extension Period, Weeks 26-52|Unclassified|0
5234722|NCT00856986|18065682|P3|Extension Period, Weeks 26-52|Unclassified|11
5234723|NCT00856986|18065683|P2|Extension Period, Weeks 26-52|Unclassified|2
5234724|NCT00856986|18065684|P1|Extension Period, Weeks 26-52|Unclassified|4
5234725|NCT00856986|18065680|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
5234726|NCT00856986|18065681|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
5234727|NCT00856986|18065682|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
5234728|NCT00856986|18065683|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
5234729|NCT00856986|18065684|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
5234730|NCT00856986|18065680|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
5234731|NCT00856986|18065681|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
5234732|NCT00856986|18065682|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
5234733|NCT00856986|18065683|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
5234734|NCT00856986|18065684|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
5234735|NCT00856986|18065680|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
5234736|NCT00856986|18065681|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
5234737|NCT00856986|18065682|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
5234738|NCT00856986|18065683|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
5234739|NCT00856986|18065684|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
5234740|NCT00856986|18065680|P5|Extension Period, Weeks 26-52|Protocol Violation|0
5234741|NCT00856986|18065681|P4|Extension Period, Weeks 26-52|Protocol Violation|0
5234742|NCT00856986|18065682|P3|Extension Period, Weeks 26-52|Protocol Violation|5
5234743|NCT00856986|18065683|P2|Extension Period, Weeks 26-52|Protocol Violation|2
5234744|NCT00856986|18065684|P1|Extension Period, Weeks 26-52|Protocol Violation|6
5234745|NCT00856986|18065680|P5|Extension Period, Weeks 26-52|Adverse Event|0
5234746|NCT00856986|18065681|P4|Extension Period, Weeks 26-52|Adverse Event|0
5234747|NCT00856986|18065682|P3|Extension Period, Weeks 26-52|Adverse Event|10
5234748|NCT00856986|18065683|P2|Extension Period, Weeks 26-52|Adverse Event|3
5234749|NCT00856986|18065684|P1|Extension Period, Weeks 26-52|Adverse Event|3
5234750|NCT00856986|18065680|P5|Main Period, Weeks 0-26|Unclassified|0
5234751|NCT00856986|18065681|P4|Main Period, Weeks 0-26|Unclassified|0
5234752|NCT00856986|18065682|P3|Main Period, Weeks 0-26|Unclassified|7
5234753|NCT00856986|18065683|P2|Main Period, Weeks 0-26|Unclassified|6
5234754|NCT00856986|18065684|P1|Main Period, Weeks 0-26|Unclassified|7
5234755|NCT00856986|18065680|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
5234756|NCT00856986|18065681|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
5234757|NCT00856986|18065682|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
5234758|NCT00856986|18065683|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
5234759|NCT00856986|18065684|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
5234760|NCT00856986|18065680|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
5234761|NCT00856986|18065681|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
5234762|NCT00856986|18065682|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
5234763|NCT00856986|18065683|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
5234764|NCT00856986|18065684|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
5234765|NCT00856986|18065680|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
5234766|NCT00856986|18065681|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
5234767|NCT00856986|18065682|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
5234768|NCT00856986|18065683|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
5234769|NCT00856986|18065684|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
5234770|NCT00856986|18065680|P5|Main Period, Weeks 0-26|Protocol Violation|0
5234771|NCT00856986|18065681|P4|Main Period, Weeks 0-26|Protocol Violation|0
5234772|NCT00856986|18065682|P3|Main Period, Weeks 0-26|Protocol Violation|7
5234773|NCT00856986|18065683|P2|Main Period, Weeks 0-26|Protocol Violation|5
5234774|NCT00856986|18065684|P1|Main Period, Weeks 0-26|Protocol Violation|4
5234775|NCT00856986|18065680|P5|Main Period, Weeks 0-26|Adverse Event|0
5234776|NCT00856986|18065681|P4|Main Period, Weeks 0-26|Adverse Event|0
5234777|NCT00856986|18065682|P3|Main Period, Weeks 0-26|Adverse Event|9
5234778|NCT00856986|18065683|P2|Main Period, Weeks 0-26|Adverse Event|4
5234779|NCT00856986|18065684|P1|Main Period, Weeks 0-26|Adverse Event|6
5234780|NCT00856986|18065680|P5|Run-in Period, Weeks -12-0|Unclassified|0
5234781|NCT00856986|18065681|P4|Run-in Period, Weeks -12-0|Unclassified|24
5234782|NCT00856986|18065682|P3|Run-in Period, Weeks -12-0|Unclassified|0
5234783|NCT00856986|18065683|P2|Run-in Period, Weeks -12-0|Unclassified|0
5234784|NCT00856986|18065684|P1|Run-in Period, Weeks -12-0|Unclassified|0
5234785|NCT00856986|18065680|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5234786|NCT00856986|18065681|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
5234787|NCT00856986|18065682|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5234788|NCT00856986|18065683|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5234789|NCT00856986|18065684|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5234790|NCT00856986|18065680|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5234791|NCT00856986|18065681|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
5234792|NCT00856986|18065682|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5234793|NCT00856986|18065683|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5234794|NCT00856986|18065684|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5234795|NCT00856986|18065680|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5234796|NCT00856986|18065681|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
5234797|NCT00856986|18065682|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5234798|NCT00856986|18065683|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5234799|NCT00856986|18065684|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5234800|NCT00856986|18065680|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
5234801|NCT00856986|18065681|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
5234802|NCT00856986|18065682|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
5234803|NCT00856986|18065683|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
5234804|NCT00856986|18065684|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
5234805|NCT00856986|18065680|P5|Run-in Period, Weeks -12-0|Adverse Event|0
5234806|NCT00856986|18065681|P4|Run-in Period, Weeks -12-0|Adverse Event|92
5234807|NCT00856986|18065682|P3|Run-in Period, Weeks -12-0|Adverse Event|0
5234808|NCT00856986|18065683|P2|Run-in Period, Weeks -12-0|Adverse Event|0
5234809|NCT00856986|18065684|P1|Run-in Period, Weeks -12-0|Adverse Event|0
5234810|NCT00856973|18065854|P3|Overall Study|Other|13
5234811|NCT00856973|18065855|P2|Overall Study|Other|12
5234812|NCT00856973|18065856|P1|Overall Study|Other|11
5234813|NCT00856973|18065854|P3|Overall Study|Withdrawal by Subject|15
5234814|NCT00856973|18065855|P2|Overall Study|Withdrawal by Subject|16
5234815|NCT00856973|18065856|P1|Overall Study|Withdrawal by Subject|13
5234816|NCT00856973|18065854|P3|Overall Study|Protocol Violation|1
5234817|NCT00856973|18065855|P2|Overall Study|Protocol Violation|2
5234818|NCT00856973|18065856|P1|Overall Study|Protocol Violation|1
5234819|NCT00856973|18065854|P3|Overall Study|Physician Decision|1
5234820|NCT00856973|18065855|P2|Overall Study|Physician Decision|3
5234821|NCT00856973|18065856|P1|Overall Study|Physician Decision|0
5234822|NCT00856973|18065854|P3|Overall Study|Lost to Follow-up|5
5234823|NCT00856973|18065855|P2|Overall Study|Lost to Follow-up|3
5234824|NCT00856973|18065856|P1|Overall Study|Lost to Follow-up|6
5234825|NCT00856973|18065854|P3|Overall Study|Adverse Event|3
5234826|NCT00856973|18065855|P2|Overall Study|Adverse Event|5
5234827|NCT00856973|18065856|P1|Overall Study|Adverse Event|5
5234828|NCT00856908|18065936|P2|Overall Study|Lost to Follow-up|0
5234829|NCT00856908|18065937|P1|Overall Study|Lost to Follow-up|1
5234830|NCT00856856|18065962|P1|4-year Clinical Follow-up|Missed visit|1
5234831|NCT00856856|18065962|P1|2-year Clinical Follow-up|Lost to Follow-up|1
5234832|NCT00856843|18066161|P2|Overall Study|Lack of Efficacy|0
5234833|NCT00856843|18066162|P1|Overall Study|Lack of Efficacy|1
5234834|NCT00856843|18066161|P2|Overall Study|Withdrawal by Subject|5
5234835|NCT00856843|18066162|P1|Overall Study|Withdrawal by Subject|1
5234836|NCT00856830|18066198|P4|Irinotecan & Bendamustine|Physician Decision|1
5234837|NCT00856830|18066199|P3|Irinotecan & Bendamustine|Physician Decision|0
5234838|NCT00856830|18066200|P2|Irinotecan & Bendamustine|Physician Decision|0
5234839|NCT00856830|18066201|P1|Irinotecan & Bendamustine|Physician Decision|0
5234840|NCT00856830|18066198|P4|Irinotecan & Bendamustine|Death|2
5234841|NCT00856830|18066199|P3|Irinotecan & Bendamustine|Death|0
5234842|NCT00856830|18066200|P2|Irinotecan & Bendamustine|Death|0
5234843|NCT00856830|18066201|P1|Irinotecan & Bendamustine|Death|0
5234844|NCT00856778|18066212|P1|Overall Study|Lost to Follow-up|5
5234845|NCT00856778|18066212|P1|Overall Study|Study deviation|2
5234846|NCT00856778|18066212|P1|Overall Study|Withdrawal by Subject|10
5234847|NCT00856778|18066212|P1|Overall Study|Adverse Event|7
5234848|NCT00856661|18066255|P2|Overall Study|Physician Judgement|5
5234849|NCT00856661|18066256|P1|Overall Study|Physician Judgement|8
5234850|NCT00856661|18066255|P2|Overall Study|Lost to Follow-up|3
5234851|NCT00856661|18066256|P1|Overall Study|Lost to Follow-up|1
5234852|NCT00856661|18066255|P2|Overall Study|Withdrawal by Subject|2
5234853|NCT00856661|18066256|P1|Overall Study|Withdrawal by Subject|1
5234854|NCT00856661|18066255|P2|Overall Study|Protocol Violation|1
5234855|NCT00856661|18066256|P1|Overall Study|Protocol Violation|2
5234856|NCT00856661|18066255|P2|Overall Study|Death|18
5234857|NCT00856661|18066256|P1|Overall Study|Death|15
5234858|NCT00856635|18066270|P2|Overall Study|Discontinued at Randomization|2
5234859|NCT00856635|18066271|P1|Overall Study|Discontinued at Randomization|2
5234860|NCT00856635|18066270|P2|Overall Study|Other|0
5234861|NCT00856635|18066271|P1|Overall Study|Other|1
5234862|NCT00856635|18066270|P2|Overall Study|Serious Adverse Event|0
5234863|NCT00856635|18066271|P1|Overall Study|Serious Adverse Event|1
5234864|NCT00856635|18066270|P2|Overall Study|Withdrawal by Subject|1
5234865|NCT00856635|18066271|P1|Overall Study|Withdrawal by Subject|3
5234866|NCT00856635|18066270|P2|Overall Study|Pregnancy|0
5234867|NCT00856635|18066271|P1|Overall Study|Pregnancy|1
5234868|NCT00856635|18066270|P2|Overall Study|Lost to Follow-up|5
5234869|NCT00856635|18066271|P1|Overall Study|Lost to Follow-up|2
5234870|NCT00856609|18066281|P2|Overall Study|Adverse Event|0
5234871|NCT00856609|18066282|P1|Overall Study|Adverse Event|1
5234872|NCT00856583|18066294|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
5234873|NCT00856583|18066295|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
5234874|NCT00856583|18066294|P2|Overall Study|Other|104
5234875|NCT00856583|18066295|P1|Overall Study|Other|92
5234876|NCT00856583|18066294|P2|Overall Study|Pregnancy|5
5234877|NCT00856583|18066295|P1|Overall Study|Pregnancy|14
5234878|NCT00856583|18066294|P2|Overall Study|Physician Decision|82
5234879|NCT00856583|18066295|P1|Overall Study|Physician Decision|59
5234880|NCT00856583|18066294|P2|Overall Study|Withdrawal by Subject|919
5234881|NCT00856583|18066295|P1|Overall Study|Withdrawal by Subject|1092
5234882|NCT00856583|18066294|P2|Overall Study|Non-compliance|262
5234883|NCT00856583|18066295|P1|Overall Study|Non-compliance|305
5234884|NCT00856583|18066294|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
5234885|NCT00856583|18066295|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
5234886|NCT00856583|18066294|P2|Overall Study|Serious Adverse Event (SAE)|65
5234887|NCT00856583|18066295|P1|Overall Study|Serious Adverse Event (SAE)|99
5234888|NCT00856583|18066294|P2|Overall Study|Lack of Efficacy|377
5234889|NCT00856583|18066295|P1|Overall Study|Lack of Efficacy|389
5234890|NCT00856557|18066325|P2|Overall Study|No patients with contextual flags|16
5234891|NCT00856557|18066326|P1|Overall Study|No patients with contextual flags|12
5234892|NCT00856544|18066340|P4|Overall Study|Withdrawal by Subject|1
5234893|NCT00856544|18066341|P3|Overall Study|Withdrawal by Subject|0
5234894|NCT00856544|18066342|P2|Overall Study|Withdrawal by Subject|5
5234895|NCT00856544|18066343|P1|Overall Study|Withdrawal by Subject|8
5234896|NCT00856544|18066340|P4|Overall Study|Lost to Follow-up|0
5234897|NCT00856544|18066341|P3|Overall Study|Lost to Follow-up|2
5234898|NCT00856544|18066342|P2|Overall Study|Lost to Follow-up|2
5234899|NCT00856544|18066343|P1|Overall Study|Lost to Follow-up|1
5234900|NCT00856544|18066340|P4|Overall Study|Other|6
5234901|NCT00856544|18066341|P3|Overall Study|Other|1
5234902|NCT00856544|18066342|P2|Overall Study|Other|16
5234903|NCT00856544|18066343|P1|Overall Study|Other|9
5234904|NCT00856544|18066340|P4|Overall Study|Lack of Efficacy|3
5234905|NCT00856544|18066341|P3|Overall Study|Lack of Efficacy|3
5234906|NCT00856544|18066342|P2|Overall Study|Lack of Efficacy|12
5234907|NCT00856544|18066343|P1|Overall Study|Lack of Efficacy|16
5234908|NCT00856544|18066340|P4|Overall Study|Adverse Event|3
5234909|NCT00856544|18066341|P3|Overall Study|Adverse Event|2
5234910|NCT00856544|18066342|P2|Overall Study|Adverse Event|29
5234911|NCT00856544|18066343|P1|Overall Study|Adverse Event|20
5234912|NCT00856544|18066340|P4|Overall Study|Death|0
5234913|NCT00856544|18066341|P3|Overall Study|Death|0
5234914|NCT00856544|18066342|P2|Overall Study|Death|2
5234915|NCT00856544|18066343|P1|Overall Study|Death|0
5234916|NCT00856544|18066340|P4|Overall Study|Randomized but not treated|0
5234917|NCT00856544|18066341|P3|Overall Study|Randomized but not treated|0
5234918|NCT00856544|18066342|P2|Overall Study|Randomized but not treated|0
5234919|NCT00856544|18066343|P1|Overall Study|Randomized but not treated|3
5234920|NCT00856518|18066522|P2|Overall Study|Lost to Follow-up|2
5234921|NCT00856518|18066523|P1|Overall Study|Lost to Follow-up|4
5234922|NCT00856492|18066536|P3|Overall Study|Ineligible or withdrew consent|2
5234923|NCT00856492|18066537|P2|Overall Study|Ineligible or withdrew consent|1
5234924|NCT00856492|18066538|P1|Overall Study|Ineligible or withdrew consent|1
5234925|NCT00856388|18066560|P1|Overall Study|Other|1
5234926|NCT00856349|18066571|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
5234927|NCT00856349|18066571|P1|Overall Study|Site closure|78
5234928|NCT00856349|18066571|P1|Overall Study|Device explant|33
5234929|NCT00856349|18066571|P1|Overall Study|Subject relocation|104
5234930|NCT00856349|18066571|P1|Overall Study|Physician Decision|13
5234931|NCT00856349|18066571|P1|Overall Study|Protocol Violation|38
5234932|NCT00856349|18066571|P1|Overall Study|Lost to Follow-up|91
5234933|NCT00856349|18066571|P1|Overall Study|Withdrawal by Subject|116
5234934|NCT00856349|18066571|P1|Overall Study|Death|418
5234935|NCT00856323|18066580|P1|Overall Study|Withdrawal by Subject|2
5234936|NCT00856297|18066592|P5|Overall Study|Unable to classify|0
5234937|NCT00856297|18066593|P4|Overall Study|Unable to classify|0
5234938|NCT00856297|18066594|P3|Overall Study|Unable to classify|0
5234939|NCT00856297|18066595|P2|Overall Study|Unable to classify|0
5234940|NCT00856297|18066596|P1|Overall Study|Unable to classify|2
5234941|NCT00856284|18066629|P3|Overall Study|Randomized in error|1
5234942|NCT00856284|18066630|P2|Overall Study|Randomized in error|0
5234943|NCT00856284|18066631|P1|Overall Study|Randomized in error|0
5234944|NCT00856284|18066629|P3|Overall Study|Other|14
5234945|NCT00856284|18066630|P2|Overall Study|Other|17
5234946|NCT00856284|18066631|P1|Overall Study|Other|15
5234947|NCT00856284|18066629|P3|Overall Study|Investigator discretion|10
5234948|NCT00856284|18066630|P2|Overall Study|Investigator discretion|8
5234949|NCT00856284|18066631|P1|Overall Study|Investigator discretion|9
5234950|NCT00856284|18066629|P3|Overall Study|Pregnancy|0
5234951|NCT00856284|18066630|P2|Overall Study|Pregnancy|2
5234952|NCT00856284|18066631|P1|Overall Study|Pregnancy|1
5234953|NCT00856284|18066629|P3|Overall Study|Voluntary withdrawal|62
5234954|NCT00856284|18066630|P2|Overall Study|Voluntary withdrawal|52
5234955|NCT00856284|18066631|P1|Overall Study|Voluntary withdrawal|48
5234956|NCT00856284|18066629|P3|Overall Study|Lost to Follow-up|28
5234957|NCT00856284|18066630|P2|Overall Study|Lost to Follow-up|22
5234958|NCT00856284|18066631|P1|Overall Study|Lost to Follow-up|20
5234959|NCT00856284|18066629|P3|Overall Study|Major protocol deviation|15
5234960|NCT00856284|18066630|P2|Overall Study|Major protocol deviation|16
5234961|NCT00856284|18066631|P1|Overall Study|Major protocol deviation|24
5234962|NCT00856284|18066629|P3|Overall Study|Adverse Event|82
5234963|NCT00856284|18066630|P2|Overall Study|Adverse Event|74
5234964|NCT00856284|18066631|P1|Overall Study|Adverse Event|60
5234965|NCT00856284|18066629|P3|Overall Study|Hyperglycemic rescue|235
5234966|NCT00856284|18066630|P2|Overall Study|Hyperglycemic rescue|201
5234967|NCT00856284|18066631|P1|Overall Study|Hyperglycemic rescue|231
5234968|NCT00856245|18066657|P1|Overall Study|Was not transplanted|5
5234969|NCT00856206|18066680|P2|Overall Study|Other than specified above|10
5234970|NCT00856206|18066681|P1|Overall Study|Other than specified above|3
5234971|NCT00856206|18066680|P2|Overall Study|Decision by the Sponsor|8
5234972|NCT00856206|18066681|P1|Overall Study|Decision by the Sponsor|4
5234973|NCT00856206|18066680|P2|Overall Study|Death|2
5234974|NCT00856206|18066681|P1|Overall Study|Death|2
5234975|NCT00856206|18066680|P2|Overall Study|Lost to Follow-up|39
5234976|NCT00856206|18066681|P1|Overall Study|Lost to Follow-up|13
5234977|NCT00856206|18066680|P2|Overall Study|Withdrawal by Subject|36
5234978|NCT00856206|18066681|P1|Overall Study|Withdrawal by Subject|15
5234979|NCT00856206|18066680|P2|Overall Study|Lack of Efficacy|2
5234980|NCT00856206|18066681|P1|Overall Study|Lack of Efficacy|1
5234981|NCT00856206|18066680|P2|Overall Study|Adverse Event|46
5234982|NCT00856206|18066681|P1|Overall Study|Adverse Event|10
5234983|NCT00856206|18066680|P2|Overall Study|Protocol Violation|18
5234984|NCT00856206|18066681|P1|Overall Study|Protocol Violation|6
5234985|NCT00856193|18066695|P2|Period 2|Lost to Follow-up|1
5234986|NCT00856193|18066696|P1|Period 2|Lost to Follow-up|0
5234987|NCT00856193|18066695|P2|Period 2|Abnormal test procedure results|1
5234988|NCT00856193|18066696|P1|Period 2|Abnormal test procedure results|0
5234989|NCT00856180|18066708|P1|Overall Study|Progressive Disease|16
5234990|NCT00856180|18066708|P1|Overall Study|Adverse Event|4
5234991|NCT00855959|18066733|P1|Overall Study|Incorrect enrolment|1
5234992|NCT00855959|18066733|P1|Overall Study|Pregnancy|1
5234993|NCT00855959|18066733|P1|Overall Study|Withdrawal by Subject|3
5234994|NCT00855959|18066733|P1|Overall Study|Lost to Follow-up|2
5234995|NCT00855959|18066733|P1|Overall Study|Adverse Event|2
5234996|NCT00855933|18066750|P2|Overall Study|Withdrawal by Subject|1
5234997|NCT00855933|18066751|P1|Overall Study|Withdrawal by Subject|0
5234998|NCT00855920|18066760|P3|Overall Study|Other than specified above|1
5234999|NCT00855920|18066761|P2|Overall Study|Other than specified above|1
5235000|NCT00855920|18066762|P1|Overall Study|Other than specified above|1
5235001|NCT00855920|18066760|P3|Overall Study|Decision by the sponsor|1
5235002|NCT00855920|18066761|P2|Overall Study|Decision by the sponsor|1
5235003|NCT00855920|18066762|P1|Overall Study|Decision by the sponsor|0
5235004|NCT00855920|18066760|P3|Overall Study|Death|0
5235005|NCT00855920|18066761|P2|Overall Study|Death|1
5235006|NCT00855920|18066762|P1|Overall Study|Death|0
5235007|NCT00855920|18066760|P3|Overall Study|Lost to Follow-up|2
5235008|NCT00855920|18066761|P2|Overall Study|Lost to Follow-up|0
5235009|NCT00855920|18066762|P1|Overall Study|Lost to Follow-up|1
5235010|NCT00855920|18066760|P3|Overall Study|Withdrawal by Subject|2
5235011|NCT00855920|18066761|P2|Overall Study|Withdrawal by Subject|3
5235012|NCT00855920|18066762|P1|Overall Study|Withdrawal by Subject|2
5235013|NCT00855920|18066760|P3|Overall Study|Lack of Efficacy|2
5235014|NCT00855920|18066761|P2|Overall Study|Lack of Efficacy|2
5235015|NCT00855920|18066762|P1|Overall Study|Lack of Efficacy|2
5235016|NCT00855920|18066760|P3|Overall Study|Adverse Event|1
5235017|NCT00855920|18066761|P2|Overall Study|Adverse Event|1
5235018|NCT00855920|18066762|P1|Overall Study|Adverse Event|2
5235019|NCT00855920|18066760|P3|Overall Study|Protocol Violation|2
5235020|NCT00855920|18066761|P2|Overall Study|Protocol Violation|0
5235021|NCT00855920|18066762|P1|Overall Study|Protocol Violation|0
5235022|NCT00855894|18066779|P1|Overall Study|Disease progression|1
5235023|NCT00855894|18066779|P1|Overall Study|Patient's decision|1
5235024|NCT00855894|18066779|P1|Overall Study|Death|31
5235025|NCT00855816|18066802|P2|Overall Study|Became ineligible|1
5235026|NCT00855816|18066803|P1|Overall Study|Became ineligible|0
5235027|NCT00855816|18066802|P2|Overall Study|Death|0
5235028|NCT00855816|18066803|P1|Overall Study|Death|1
5235029|NCT00855816|18066802|P2|Overall Study|Lost to Follow-up|5
5235030|NCT00855816|18066803|P1|Overall Study|Lost to Follow-up|3
5235031|NCT00855816|18066802|P2|Overall Study|Withdrawal by Subject|15
5235032|NCT00855816|18066803|P1|Overall Study|Withdrawal by Subject|22
5235033|NCT00855738|18066809|P1|Overall Study|Death|1
5235034|NCT00855738|18066809|P1|Overall Study|Subject Defaulted|1
5235035|NCT00855738|18066809|P1|Overall Study|Adverse Event|1
5235036|NCT00855738|18066809|P1|Overall Study|Lost to Follow-up|2
5235037|NCT00855595|18066837|P2|Overall Study|patient left country|1
5235038|NCT00855595|18066838|P1|Overall Study|patient left country|0
5235039|NCT00855595|18066837|P2|Overall Study|patient moved out of state|0
5235040|NCT00855595|18066838|P1|Overall Study|patient moved out of state|1
5235041|NCT00855595|18066837|P2|Overall Study|Adverse Event|1
5235042|NCT00855595|18066838|P1|Overall Study|Adverse Event|1
5235043|NCT00855595|18066837|P2|Overall Study|Lost to Follow-up|3
5235044|NCT00855595|18066838|P1|Overall Study|Lost to Follow-up|3
5235045|NCT00855595|18066837|P2|Overall Study|Withdrawal by Subject|2
5235046|NCT00855595|18066838|P1|Overall Study|Withdrawal by Subject|1
5235047|NCT00855582|18066877|P3|Overall Study|Withdrawal by Subject|8
5235048|NCT00855582|18066878|P2|Overall Study|Withdrawal by Subject|4
5235049|NCT00855582|18066879|P1|Overall Study|Withdrawal by Subject|7
5235050|NCT00855582|18066877|P3|Overall Study|Entry Criteria Not Met|3
5235051|NCT00855582|18066878|P2|Overall Study|Entry Criteria Not Met|6
5235052|NCT00855582|18066879|P1|Overall Study|Entry Criteria Not Met|8
5235053|NCT00855582|18066877|P3|Overall Study|Protocol Violation|6
5235054|NCT00855582|18066878|P2|Overall Study|Protocol Violation|2
5235055|NCT00855582|18066879|P1|Overall Study|Protocol Violation|6
5235056|NCT00855582|18066877|P3|Overall Study|Physician Decision|1
5235057|NCT00855582|18066878|P2|Overall Study|Physician Decision|0
5235058|NCT00855582|18066879|P1|Overall Study|Physician Decision|0
5235059|NCT00855582|18066877|P3|Overall Study|Lost to Follow-up|1
5235060|NCT00855582|18066878|P2|Overall Study|Lost to Follow-up|3
5235061|NCT00855582|18066879|P1|Overall Study|Lost to Follow-up|1
5235062|NCT00855582|18066877|P3|Overall Study|Lack of Efficacy|8
5235063|NCT00855582|18066878|P2|Overall Study|Lack of Efficacy|3
5235064|NCT00855582|18066879|P1|Overall Study|Lack of Efficacy|1
5235065|NCT00855582|18066877|P3|Overall Study|Death|0
5235066|NCT00855582|18066878|P2|Overall Study|Death|0
5235067|NCT00855582|18066879|P1|Overall Study|Death|1
5235068|NCT00855582|18066877|P3|Overall Study|Adverse Event|3
5235069|NCT00855582|18066878|P2|Overall Study|Adverse Event|6
5235070|NCT00855582|18066879|P1|Overall Study|Adverse Event|2
5235071|NCT00855465|18066968|P2|Follow-up Period (FUP)|Missing|0
5235072|NCT00855465|18066969|P1|Follow-up Period (FUP)|Missing|1
5235073|NCT00855465|18066968|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
5235074|NCT00855465|18066969|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
5235075|NCT00855465|18066968|P2|Follow-up Period (FUP)|Lost to Follow-up|0
5235076|NCT00855465|18066969|P1|Follow-up Period (FUP)|Lost to Follow-up|3
5235077|NCT00855465|18066968|P2|Follow-up Period (FUP)|Death|1
5235078|NCT00855465|18066969|P1|Follow-up Period (FUP)|Death|0
5235079|NCT00855465|18066968|P2|Follow-up Period (FUP)|Adverse Event|1
5235080|NCT00855465|18066969|P1|Follow-up Period (FUP)|Adverse Event|0
5235081|NCT00855465|18066968|P2|Treatment Period|Not treated|0
5235082|NCT00855465|18066969|P1|Treatment Period|Not treated|1
5235083|NCT00855465|18066968|P2|Treatment Period|Withdrawal by Subject|0
5235084|NCT00855465|18066969|P1|Treatment Period|Withdrawal by Subject|2
5235085|NCT00855465|18066968|P2|Treatment Period|Protocol Violation|0
5235086|NCT00855465|18066969|P1|Treatment Period|Protocol Violation|2
5235087|NCT00855465|18066968|P2|Treatment Period|Non-compliance|0
5235088|NCT00855465|18066969|P1|Treatment Period|Non-compliance|1
5235089|NCT00855465|18066968|P2|Treatment Period|Lack of Efficacy|1
5235090|NCT00855465|18066969|P1|Treatment Period|Lack of Efficacy|2
5235091|NCT00855465|18066968|P2|Treatment Period|Death|2
5235092|NCT00855465|18066969|P1|Treatment Period|Death|2
5235093|NCT00855465|18066968|P2|Treatment Period|Adverse Event|2
5235094|NCT00855465|18066969|P1|Treatment Period|Adverse Event|4
5235095|NCT00855439|18067059|P2|Overall Study|Pregnancy|0
5235096|NCT00855439|18067060|P1|Overall Study|Pregnancy|1
5235097|NCT00855439|18067059|P2|Overall Study|Withdrawal by Subject|0
5235098|NCT00855439|18067060|P1|Overall Study|Withdrawal by Subject|2
5235099|NCT00855335|18067118|P5|Overall Study|Other|1
5235100|NCT00855335|18067119|P4|Overall Study|Other|5
5235101|NCT00855335|18067120|P3|Overall Study|Other|2
5235102|NCT00855335|18067121|P2|Overall Study|Other|1
5235103|NCT00855335|18067122|P1|Overall Study|Other|2
5235104|NCT00855335|18067118|P5|Overall Study|Physician Decision|0
5235105|NCT00855335|18067119|P4|Overall Study|Physician Decision|0
5235106|NCT00855335|18067120|P3|Overall Study|Physician Decision|0
5235107|NCT00855335|18067121|P2|Overall Study|Physician Decision|1
5235108|NCT00855335|18067122|P1|Overall Study|Physician Decision|1
5235109|NCT00855335|18067118|P5|Overall Study|Adverse Event|0
5235110|NCT00855335|18067119|P4|Overall Study|Adverse Event|0
5235111|NCT00855335|18067120|P3|Overall Study|Adverse Event|0
5235112|NCT00855335|18067121|P2|Overall Study|Adverse Event|0
5235113|NCT00855335|18067122|P1|Overall Study|Adverse Event|2
5235114|NCT00855335|18067118|P5|Overall Study|Withdrawal by Subject|0
5235115|NCT00855335|18067119|P4|Overall Study|Withdrawal by Subject|1
5235116|NCT00855335|18067120|P3|Overall Study|Withdrawal by Subject|0
5235117|NCT00855335|18067121|P2|Overall Study|Withdrawal by Subject|0
5235118|NCT00855335|18067122|P1|Overall Study|Withdrawal by Subject|0
5235119|NCT00855335|18067118|P5|Overall Study|Lost to Follow-up|0
5235120|NCT00855335|18067119|P4|Overall Study|Lost to Follow-up|1
5235121|NCT00855335|18067120|P3|Overall Study|Lost to Follow-up|3
5235122|NCT00855335|18067121|P2|Overall Study|Lost to Follow-up|0
5235123|NCT00855335|18067122|P1|Overall Study|Lost to Follow-up|0
5235124|NCT00855309|18067209|P2|Overall Study|patient never recieved drug|0
5235125|NCT00855309|18067210|P1|Overall Study|patient never recieved drug|1
5235126|NCT00855218|18067218|P2|Overall Study|Clinical endpoint reached|13
5235127|NCT00855218|18067219|P1|Overall Study|Clinical endpoint reached|10
5235128|NCT00855218|18067218|P2|Overall Study|Progression measurement proven|15
5235129|NCT00855218|18067219|P1|Overall Study|Progression measurement proven|7
5235130|NCT00855218|18067218|P2|Overall Study|Second malignancy|1
5235131|NCT00855218|18067219|P1|Overall Study|Second malignancy|0
5235132|NCT00855218|18067218|P2|Overall Study|Untreatable disease progression|67
5235133|NCT00855218|18067219|P1|Overall Study|Untreatable disease progression|54
5235134|NCT00855218|18067218|P2|Overall Study|Still treated with study medication|1
5235135|NCT00855218|18067219|P1|Overall Study|Still treated with study medication|0
5235136|NCT00855218|18067218|P2|Overall Study|technical problems|1
5235137|NCT00855218|18067219|P1|Overall Study|technical problems|2
5235138|NCT00855218|18067218|P2|Overall Study|patient convenience|0
5235139|NCT00855218|18067219|P1|Overall Study|patient convenience|2
5235140|NCT00855218|18067218|P2|Overall Study|non-compliant with study drug|1
5235141|NCT00855218|18067219|P1|Overall Study|non-compliant with study drug|3
5235142|NCT00855218|18067218|P2|Overall Study|Protocol Violation|9
5235143|NCT00855218|18067219|P1|Overall Study|Protocol Violation|5
5235144|NCT00855218|18067218|P2|Overall Study|Lost to Follow-up|1
5235145|NCT00855218|18067219|P1|Overall Study|Lost to Follow-up|0
5235146|NCT00855218|18067218|P2|Overall Study|Physician Decision|11
5235147|NCT00855218|18067219|P1|Overall Study|Physician Decision|18
5235148|NCT00855218|18067218|P2|Overall Study|Withdrawal by Subject|6
5235149|NCT00855218|18067219|P1|Overall Study|Withdrawal by Subject|10
5235150|NCT00855218|18067218|P2|Overall Study|Adverse Event|27
5235151|NCT00855218|18067219|P1|Overall Study|Adverse Event|43
5235152|NCT00855166|18067237|P2|Overall Study|Subject no longer meets study criteria|1
5235153|NCT00855166|18067238|P1|Overall Study|Subject no longer meets study criteria|1
5235154|NCT00855166|18067237|P2|Overall Study|Administrative reasons by sponsor|0
5235155|NCT00855166|18067238|P1|Overall Study|Administrative reasons by sponsor|1
5235156|NCT00855166|18067237|P2|Overall Study|Poor/non-compliance|0
5235157|NCT00855166|18067238|P1|Overall Study|Poor/non-compliance|2
5235158|NCT00855166|18067237|P2|Overall Study|Withdrawal by Subject|4
5235159|NCT00855166|18067238|P1|Overall Study|Withdrawal by Subject|1
5235160|NCT00855166|18067237|P2|Overall Study|Death|1
5235161|NCT00855166|18067238|P1|Overall Study|Death|0
5235162|NCT00855166|18067237|P2|Overall Study|Adverse Event|2
5235163|NCT00855166|18067238|P1|Overall Study|Adverse Event|0
5235164|NCT00855062|18067258|P2|Step2|Initiation of antiretroviral therapy/ART|1
5235165|NCT00855062|18067259|P1|Step2|Initiation of antiretroviral therapy/ART|0
5235166|NCT00855062|18067258|P2|Step2|Adverse Event|3
5235167|NCT00855062|18067259|P1|Step2|Adverse Event|0
5235168|NCT00855062|18067258|P2|Step2|Early Study Closure|2
5235169|NCT00855062|18067259|P1|Step2|Early Study Closure|6
5235170|NCT00855062|18067258|P2|Step1|Withdrawal by Subject|3
5235171|NCT00855062|18067259|P1|Step1|Withdrawal by Subject|2
5235172|NCT00855062|18067258|P2|Step1|Pregnancy|0
5235173|NCT00855062|18067259|P1|Step1|Pregnancy|1
5235174|NCT00855062|18067258|P2|Step1|Protocol Violation|0
5235175|NCT00855062|18067259|P1|Step1|Protocol Violation|1
5235176|NCT00855062|18067258|P2|Step1|Adverse Event|1
5235177|NCT00855062|18067259|P1|Step1|Adverse Event|1
5235178|NCT00855062|18067258|P2|Step1|Early Study Closure|7
5235179|NCT00855062|18067259|P1|Step1|Early Study Closure|5
5235180|NCT00854906|18067308|P1|Overall Study|One person had no ocular history|1
5235181|NCT00854724|18067317|P2|Second Intervention|Physician Decision|1
5235182|NCT00854724|18067318|P1|Second Intervention|Physician Decision|0
5235183|NCT00854724|18067317|P2|Second Intervention|Protocol Violation|0
5235184|NCT00854724|18067318|P1|Second Intervention|Protocol Violation|1
5235185|NCT00854724|18067317|P2|Washout|Withdrawal by Subject|1
5235186|NCT00854724|18067318|P1|Washout|Withdrawal by Subject|0
5235187|NCT00854724|18067317|P2|Washout|Protocol Violation|0
5235188|NCT00854724|18067318|P1|Washout|Protocol Violation|1
5235189|NCT00854724|18067317|P2|First Intervention|Withdrawal by Subject|1
5235190|NCT00854724|18067318|P1|First Intervention|Withdrawal by Subject|1
5235191|NCT00854620|18067324|P1|Overall Study|Adverse Event|1
5235192|NCT00854607|18067328|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
5235193|NCT00854581|18067376|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
5235194|NCT00854581|18067376|P1|Induction (Up to Day 21)|Physician Decision|1
5235195|NCT00854581|18067376|P1|Induction (Up to Day 21)|Death|1
5235196|NCT00854581|18067376|P1|Induction (Up to Day 21)|Lack of Efficacy|4
5235197|NCT00854373|18067391|P2|Overall Study|Forgot to take study drug|1
5235198|NCT00854373|18067392|P1|Overall Study|Forgot to take study drug|1
5235199|NCT00854373|18067391|P2|Overall Study|Withdrawal by Subject|3
5235200|NCT00854373|18067392|P1|Overall Study|Withdrawal by Subject|1
5235201|NCT00854360|18067406|P4|Overall Study|Other|3
5235202|NCT00854360|18067407|P3|Overall Study|Other|0
5235203|NCT00854360|18067408|P2|Overall Study|Other|0
5235204|NCT00854360|18067409|P1|Overall Study|Other|0
5235205|NCT00854360|18067406|P4|Overall Study|Lack of Efficacy|0
5235206|NCT00854360|18067407|P3|Overall Study|Lack of Efficacy|0
5235207|NCT00854360|18067408|P2|Overall Study|Lack of Efficacy|1
5235208|NCT00854360|18067409|P1|Overall Study|Lack of Efficacy|2
5235209|NCT00854360|18067406|P4|Overall Study|Pregnancy|0
5235210|NCT00854360|18067407|P3|Overall Study|Pregnancy|0
5235211|NCT00854360|18067408|P2|Overall Study|Pregnancy|1
5235212|NCT00854360|18067409|P1|Overall Study|Pregnancy|0
5235213|NCT00854360|18067406|P4|Overall Study|Withdrawal by Subject|1
5235214|NCT00854360|18067407|P3|Overall Study|Withdrawal by Subject|0
5235215|NCT00854360|18067408|P2|Overall Study|Withdrawal by Subject|0
5235216|NCT00854360|18067409|P1|Overall Study|Withdrawal by Subject|0
5235217|NCT00854360|18067406|P4|Overall Study|Adverse Event|6
5235218|NCT00854360|18067407|P3|Overall Study|Adverse Event|2
5235219|NCT00854360|18067408|P2|Overall Study|Adverse Event|1
5235220|NCT00854360|18067409|P1|Overall Study|Adverse Event|0
5235221|NCT00854308|18067441|P2|Overall Study|Sponsor's decision to terminate study|1
5235222|NCT00854308|18067442|P1|Overall Study|Sponsor's decision to terminate study|0
5235223|NCT00854308|18067441|P2|Overall Study|Withdrawal by Subject|2
5235224|NCT00854308|18067442|P1|Overall Study|Withdrawal by Subject|4
5235225|NCT00854308|18067441|P2|Overall Study|Physician Decision|6
5235226|NCT00854308|18067442|P1|Overall Study|Physician Decision|6
5235227|NCT00854308|18067441|P2|Overall Study|Death|5
5235228|NCT00854308|18067442|P1|Overall Study|Death|2
5235229|NCT00854308|18067441|P2|Overall Study|Adverse Event|3
5235230|NCT00854308|18067442|P1|Overall Study|Adverse Event|8
5235231|NCT00854308|18067441|P2|Overall Study|Disease progression|50
5235232|NCT00854308|18067442|P1|Overall Study|Disease progression|42
5235233|NCT00854113|18067467|P11|Overall Study|Withdrawal by Subject|0
5235234|NCT00854113|18067468|P10|Overall Study|Withdrawal by Subject|0
5235235|NCT00854113|18067469|P9|Overall Study|Withdrawal by Subject|1
5235236|NCT00854113|18067470|P8|Overall Study|Withdrawal by Subject|1
5235237|NCT00854113|18067471|P7|Overall Study|Withdrawal by Subject|0
5235238|NCT00854113|18067472|P6|Overall Study|Withdrawal by Subject|0
5235239|NCT00854113|18067473|P5|Overall Study|Withdrawal by Subject|0
5235240|NCT00854113|18067474|P4|Overall Study|Withdrawal by Subject|0
5235241|NCT00854113|18067475|P3|Overall Study|Withdrawal by Subject|0
5235242|NCT00854113|18067476|P2|Overall Study|Withdrawal by Subject|0
5235243|NCT00854113|18067477|P1|Overall Study|Withdrawal by Subject|0
5235244|NCT00854113|18067467|P11|Overall Study|Adverse Event|0
5235245|NCT00854113|18067468|P10|Overall Study|Adverse Event|0
5235246|NCT00854113|18067469|P9|Overall Study|Adverse Event|0
5235247|NCT00854113|18067470|P8|Overall Study|Adverse Event|2
5235248|NCT00854113|18067471|P7|Overall Study|Adverse Event|0
5235249|NCT00854113|18067472|P6|Overall Study|Adverse Event|0
5235250|NCT00854113|18067473|P5|Overall Study|Adverse Event|0
5235251|NCT00854113|18067474|P4|Overall Study|Adverse Event|0
5235252|NCT00854113|18067475|P3|Overall Study|Adverse Event|0
5235253|NCT00854113|18067476|P2|Overall Study|Adverse Event|0
5235254|NCT00854113|18067477|P1|Overall Study|Adverse Event|0
5235255|NCT00854100|18067581|P3|Overall Study|Adverse Event|2
5235256|NCT00854100|18067582|P2|Overall Study|Adverse Event|1
5235257|NCT00854100|18067583|P1|Overall Study|Adverse Event|2
5235258|NCT00854100|18067581|P3|Overall Study|Protocol Violation|3
5235259|NCT00854100|18067582|P2|Overall Study|Protocol Violation|4
5235260|NCT00854100|18067583|P1|Overall Study|Protocol Violation|2
5235261|NCT00854100|18067581|P3|Overall Study|Withdrawal by Subject|2
5235262|NCT00854100|18067582|P2|Overall Study|Withdrawal by Subject|1
5235263|NCT00854100|18067583|P1|Overall Study|Withdrawal by Subject|3
5235264|NCT00854100|18067581|P3|Overall Study|Lost to Follow-up|3
5235265|NCT00854100|18067582|P2|Overall Study|Lost to Follow-up|0
5235266|NCT00854100|18067583|P1|Overall Study|Lost to Follow-up|2
5235267|NCT00854100|18067581|P3|Overall Study|Inability to complete the study visits|1
5235268|NCT00854100|18067582|P2|Overall Study|Inability to complete the study visits|0
5235269|NCT00854100|18067583|P1|Overall Study|Inability to complete the study visits|0
5235270|NCT00853970|18067622|P2|Overall Study|Cancelled surgery|2
5235271|NCT00853970|18067623|P1|Overall Study|Cancelled surgery|4
5235272|NCT00853970|18067622|P2|Overall Study|Withdrawal by Subject|1
5235273|NCT00853970|18067623|P1|Overall Study|Withdrawal by Subject|2
5235274|NCT00853957|18067633|P2|Overall Study|Protocol deviation|3
5235275|NCT00853957|18067634|P1|Overall Study|Protocol deviation|0
5235276|NCT00853957|18067633|P2|Overall Study|Lost to Follow-up|6
5235277|NCT00853957|18067634|P1|Overall Study|Lost to Follow-up|1
5235278|NCT00853957|18067633|P2|Overall Study|Subject withdrew consent|5
5235279|NCT00853957|18067634|P1|Overall Study|Subject withdrew consent|4
5235280|NCT00853957|18067633|P2|Overall Study|Unsatisfactory therapeutic effect|2
5235281|NCT00853957|18067634|P1|Overall Study|Unsatisfactory therapeutic effect|0
5235282|NCT00853957|18067633|P2|Overall Study|Adverse Event|3
5235283|NCT00853957|18067634|P1|Overall Study|Adverse Event|9
5235284|NCT00853905|18067652|P2|Overall Study|never had surgery|0
5235285|NCT00853905|18067653|P1|Overall Study|never had surgery|1
5235286|NCT00853905|18067652|P2|Overall Study|Withdrawal by Subject|1
5235287|NCT00853905|18067653|P1|Overall Study|Withdrawal by Subject|0
5235288|NCT00853905|18067652|P2|Overall Study|Lost to Follow-up|3
5235289|NCT00853905|18067653|P1|Overall Study|Lost to Follow-up|1
5235290|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Death|6
5235291|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Death|1
5235292|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Administrative problems|56
5235293|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Administrative problems|45
5235294|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
5235295|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
5235296|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
5235297|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
5235298|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
5235299|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
5235300|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
5235301|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
5235302|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
5235303|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
5235304|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
5235305|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
5235306|NCT00853827|18067685|P2|Double Blind Period (103 Weeks)|Adverse Event|14
5235307|NCT00853827|18067686|P1|Double Blind Period (103 Weeks)|Adverse Event|25
5235308|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Protocol Violation|0
5235309|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Protocol Violation|12
5235310|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
5235311|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
5235312|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
5235313|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
5235314|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
5235315|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
5235316|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
5235317|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
5235318|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Adverse Event|0
5235319|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Adverse Event|9
5235320|NCT00853827|18067685|P2|Single Blind Period (1 Week)|Other|0
5235321|NCT00853827|18067686|P1|Single Blind Period (1 Week)|Other|4
5235322|NCT00853762|18067702|P4|Overall Study|Randomised but not Treated|0
5235323|NCT00853762|18067703|P3|Overall Study|Randomised but not Treated|2
5235324|NCT00853762|18067704|P2|Overall Study|Randomised but not Treated|2
5235325|NCT00853762|18067705|P1|Overall Study|Randomised but not Treated|0
5235326|NCT00853762|18067702|P4|Overall Study|Other|0
5235327|NCT00853762|18067703|P3|Overall Study|Other|0
5235328|NCT00853762|18067704|P2|Overall Study|Other|2
5235329|NCT00853762|18067705|P1|Overall Study|Other|0
5235330|NCT00853762|18067702|P4|Overall Study|Withdrawal by Subject|0
5235331|NCT00853762|18067703|P3|Overall Study|Withdrawal by Subject|1
5235332|NCT00853762|18067704|P2|Overall Study|Withdrawal by Subject|0
5235333|NCT00853762|18067705|P1|Overall Study|Withdrawal by Subject|0
5235334|NCT00853762|18067702|P4|Overall Study|Protocol Violation|1
5235335|NCT00853762|18067703|P3|Overall Study|Protocol Violation|0
5235336|NCT00853762|18067704|P2|Overall Study|Protocol Violation|0
5235337|NCT00853762|18067705|P1|Overall Study|Protocol Violation|0
5235338|NCT00853762|18067702|P4|Overall Study|Premature Termination|21
5235339|NCT00853762|18067703|P3|Overall Study|Premature Termination|14
5235340|NCT00853762|18067704|P2|Overall Study|Premature Termination|15
5235341|NCT00853762|18067705|P1|Overall Study|Premature Termination|16
5235342|NCT00853749|18067773|P2|Overall Study|Lost to Follow-up|1
5235343|NCT00853749|18067774|P1|Overall Study|Lost to Follow-up|0
5235344|NCT00853723|18067795|P3|Overall Study|Protocol Violation|1
5235345|NCT00853723|18067796|P2|Overall Study|Protocol Violation|2
5235346|NCT00853723|18067797|P1|Overall Study|Protocol Violation|1
5235347|NCT00853723|18067795|P3|Overall Study|Withdrawal by Subject|0
5235348|NCT00853723|18067796|P2|Overall Study|Withdrawal by Subject|1
5235349|NCT00853723|18067797|P1|Overall Study|Withdrawal by Subject|2
5235350|NCT00853723|18067795|P3|Overall Study|Adverse Event|1
5235351|NCT00853723|18067796|P2|Overall Study|Adverse Event|4
5235352|NCT00853723|18067797|P1|Overall Study|Adverse Event|3
5235353|NCT00853658|18067851|P3|Overall Study|Missing study completion information|6
5235354|NCT00853658|18067852|P2|Overall Study|Missing study completion information|4
5235355|NCT00853658|18067853|P1|Overall Study|Missing study completion information|5
5235356|NCT00853658|18067851|P3|Overall Study|Patient's request|11
5235357|NCT00853658|18067852|P2|Overall Study|Patient's request|17
5235358|NCT00853658|18067853|P1|Overall Study|Patient's request|21
5235359|NCT00853658|18067851|P3|Overall Study|Vital Status at study end N/A|10
5235360|NCT00853658|18067852|P2|Overall Study|Vital Status at study end N/A|10
5235361|NCT00853658|18067853|P1|Overall Study|Vital Status at study end N/A|8
5235362|NCT00853658|18067851|P3|Overall Study|Vital Status unknown at study end|0
5235363|NCT00853658|18067852|P2|Overall Study|Vital Status unknown at study end|1
5235364|NCT00853658|18067853|P1|Overall Study|Vital Status unknown at study end|1
5235365|NCT00853658|18067851|P3|Overall Study|Vital Status known (alive) at study end|3
5235366|NCT00853658|18067852|P2|Overall Study|Vital Status known (alive) at study end|3
5235367|NCT00853658|18067853|P1|Overall Study|Vital Status known (alive) at study end|2
5235368|NCT00853658|18067851|P3|Overall Study|IRB request|2
5235369|NCT00853658|18067852|P2|Overall Study|IRB request|0
5235370|NCT00853658|18067853|P1|Overall Study|IRB request|0
5235371|NCT00853658|18067851|P3|Overall Study|H.A. Request|19
5235372|NCT00853658|18067852|P2|Overall Study|H.A. Request|23
5235373|NCT00853658|18067853|P1|Overall Study|H.A. Request|26
5235374|NCT00853658|18067851|P3|Overall Study|Lost to Follow-up|11
5235375|NCT00853658|18067852|P2|Overall Study|Lost to Follow-up|6
5235376|NCT00853658|18067853|P1|Overall Study|Lost to Follow-up|11
5235377|NCT00853658|18067851|P3|Overall Study|Death|753
5235378|NCT00853658|18067852|P2|Overall Study|Death|768
5235379|NCT00853658|18067853|P1|Overall Study|Death|713
5235380|NCT00853593|18067873|P1|Overall Study|Implant not attempted|4
5235381|NCT00853593|18067873|P1|Overall Study|Model 4396 lead not attempted|29
5235382|NCT00853593|18067873|P1|Overall Study|Subjects did not receive a 4396 lead|12
5235383|NCT00853580|18067900|P2|Overall Study|Commenced contraindicated therapy|2
5235384|NCT00853580|18067901|P1|Overall Study|Commenced contraindicated therapy|0
5235385|NCT00853580|18067900|P2|Overall Study|Withdrawal by Subject|8
5235386|NCT00853580|18067901|P1|Overall Study|Withdrawal by Subject|2
5235387|NCT00853580|18067900|P2|Overall Study|Protocol Violation|1
5235388|NCT00853580|18067901|P1|Overall Study|Protocol Violation|2
5235389|NCT00853580|18067900|P2|Overall Study|Lost to Follow-up|5
5235390|NCT00853580|18067901|P1|Overall Study|Lost to Follow-up|3
5235391|NCT00853567|18067948|P1|Overall Study|Study prematurely terminated|71
5235392|NCT00853489|18067958|P2|Overall Study|Lost to Follow-up|2
5235393|NCT00853489|18067959|P1|Overall Study|Lost to Follow-up|5
5235394|NCT00853385|18067974|P5|Overall Study|Other|12
5235395|NCT00853385|18067975|P4|Overall Study|Other|4
5235396|NCT00853385|18067976|P3|Overall Study|Other|4
5235397|NCT00853385|18067977|P2|Overall Study|Other|9
5235398|NCT00853385|18067978|P1|Overall Study|Other|18
5235399|NCT00853385|18067974|P5|Overall Study|Withdrawal by Subject|1
5235400|NCT00853385|18067975|P4|Overall Study|Withdrawal by Subject|1
5235401|NCT00853385|18067976|P3|Overall Study|Withdrawal by Subject|0
5235402|NCT00853385|18067977|P2|Overall Study|Withdrawal by Subject|2
5235403|NCT00853385|18067978|P1|Overall Study|Withdrawal by Subject|4
5235404|NCT00853385|18067974|P5|Overall Study|Lost to Follow-up|0
5235405|NCT00853385|18067975|P4|Overall Study|Lost to Follow-up|0
5235406|NCT00853385|18067976|P3|Overall Study|Lost to Follow-up|0
5235407|NCT00853385|18067977|P2|Overall Study|Lost to Follow-up|1
5235408|NCT00853385|18067978|P1|Overall Study|Lost to Follow-up|2
5235409|NCT00853385|18067974|P5|Overall Study|Lack of Efficacy|6
5235410|NCT00853385|18067975|P4|Overall Study|Lack of Efficacy|3
5235411|NCT00853385|18067976|P3|Overall Study|Lack of Efficacy|3
5235412|NCT00853385|18067977|P2|Overall Study|Lack of Efficacy|7
5235413|NCT00853385|18067978|P1|Overall Study|Lack of Efficacy|6
5235414|NCT00853385|18067974|P5|Overall Study|Adverse Event|22
5235415|NCT00853385|18067975|P4|Overall Study|Adverse Event|5
5235416|NCT00853385|18067976|P3|Overall Study|Adverse Event|2
5235417|NCT00853385|18067977|P2|Overall Study|Adverse Event|24
5235418|NCT00853385|18067978|P1|Overall Study|Adverse Event|24
5235419|NCT00853385|18067974|P5|Overall Study|Death|1
5235420|NCT00853385|18067975|P4|Overall Study|Death|0
5235421|NCT00853385|18067976|P3|Overall Study|Death|0
5235422|NCT00853385|18067977|P2|Overall Study|Death|0
5235423|NCT00853385|18067978|P1|Overall Study|Death|0
5235424|NCT00853372|18068193|P2|Overall Study|Full Consent Withdrawn|1
5235425|NCT00853372|18068194|P1|Overall Study|Full Consent Withdrawn|1
5235426|NCT00853372|18068193|P2|Overall Study|Lost to Follow-up|2
5235427|NCT00853372|18068194|P1|Overall Study|Lost to Follow-up|1
5235428|NCT00853372|18068193|P2|Overall Study|Death|26
5235429|NCT00853372|18068194|P1|Overall Study|Death|30
5235430|NCT00853307|18068243|P2|Overall Study|Reason Not Specified|1
5235431|NCT00853307|18068244|P1|Overall Study|Reason Not Specified|0
5235432|NCT00853307|18068243|P2|Overall Study|Withdrawal by Subject|2
5235433|NCT00853307|18068244|P1|Overall Study|Withdrawal by Subject|1
5235434|NCT00853307|18068243|P2|Overall Study|Adverse Event|2
5235435|NCT00853307|18068244|P1|Overall Study|Adverse Event|1
5235436|NCT00853242|18068271|P7|Overall Study|Other|2
5235437|NCT00853242|18068272|P6|Overall Study|Other|1
5235438|NCT00853242|18068273|P5|Overall Study|Other|0
5235439|NCT00853242|18068274|P4|Overall Study|Other|0
5235440|NCT00853242|18068275|P3|Overall Study|Other|2
5235441|NCT00853242|18068276|P2|Overall Study|Other|0
5235442|NCT00853242|18068277|P1|Overall Study|Other|2
5235443|NCT00853242|18068271|P7|Overall Study|Withdrawal by Subject|2
5235444|NCT00853242|18068272|P6|Overall Study|Withdrawal by Subject|0
5235445|NCT00853242|18068273|P5|Overall Study|Withdrawal by Subject|0
5235446|NCT00853242|18068274|P4|Overall Study|Withdrawal by Subject|4
5235447|NCT00853242|18068275|P3|Overall Study|Withdrawal by Subject|0
5235448|NCT00853242|18068276|P2|Overall Study|Withdrawal by Subject|2
5235449|NCT00853242|18068277|P1|Overall Study|Withdrawal by Subject|1
5235450|NCT00853242|18068271|P7|Overall Study|Noncompliant|0
5235451|NCT00853242|18068272|P6|Overall Study|Noncompliant|0
5235452|NCT00853242|18068273|P5|Overall Study|Noncompliant|1
5235453|NCT00853242|18068274|P4|Overall Study|Noncompliant|0
5235454|NCT00853242|18068275|P3|Overall Study|Noncompliant|0
5235455|NCT00853242|18068276|P2|Overall Study|Noncompliant|0
5235456|NCT00853242|18068277|P1|Overall Study|Noncompliant|0
5235457|NCT00853242|18068271|P7|Overall Study|Adverse Event|1
5235458|NCT00853242|18068272|P6|Overall Study|Adverse Event|1
5235459|NCT00853242|18068273|P5|Overall Study|Adverse Event|3
5235460|NCT00853242|18068274|P4|Overall Study|Adverse Event|0
5235461|NCT00853242|18068275|P3|Overall Study|Adverse Event|1
5235462|NCT00853242|18068276|P2|Overall Study|Adverse Event|1
5235463|NCT00853242|18068277|P1|Overall Study|Adverse Event|0
5235464|NCT00853229|18068319|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
5235465|NCT00853229|18068320|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
5235466|NCT00853151|18068330|P4|Overall Study|Sponsor Decision|0
5235467|NCT00853151|18068331|P3|Overall Study|Sponsor Decision|0
5235468|NCT00853151|18068332|P2|Overall Study|Sponsor Decision|3
5235469|NCT00853151|18068333|P1|Overall Study|Sponsor Decision|0
5235470|NCT00853151|18068330|P4|Overall Study|Physician Decision|0
5235471|NCT00853151|18068331|P3|Overall Study|Physician Decision|1
5235472|NCT00853151|18068332|P2|Overall Study|Physician Decision|2
5235473|NCT00853151|18068333|P1|Overall Study|Physician Decision|0
5235474|NCT00853151|18068330|P4|Overall Study|Withdrawal by Subject|1
5235475|NCT00853151|18068331|P3|Overall Study|Withdrawal by Subject|2
5235476|NCT00853151|18068332|P2|Overall Study|Withdrawal by Subject|4
5235477|NCT00853151|18068333|P1|Overall Study|Withdrawal by Subject|5
5235478|NCT00853151|18068330|P4|Overall Study|Protocol Violation|1
5235479|NCT00853151|18068331|P3|Overall Study|Protocol Violation|0
5235480|NCT00853151|18068332|P2|Overall Study|Protocol Violation|0
5235481|NCT00853151|18068333|P1|Overall Study|Protocol Violation|0
5235482|NCT00853151|18068330|P4|Overall Study|Death|1
5235483|NCT00853151|18068331|P3|Overall Study|Death|0
5235484|NCT00853151|18068332|P2|Overall Study|Death|0
5235485|NCT00853151|18068333|P1|Overall Study|Death|1
5235486|NCT00853151|18068330|P4|Overall Study|Lost to Follow-up|0
5235487|NCT00853151|18068331|P3|Overall Study|Lost to Follow-up|3
5235488|NCT00853151|18068332|P2|Overall Study|Lost to Follow-up|0
5235489|NCT00853151|18068333|P1|Overall Study|Lost to Follow-up|2
5235490|NCT00853151|18068330|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5235491|NCT00853151|18068331|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5235492|NCT00853151|18068332|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5235493|NCT00853151|18068333|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
5235494|NCT00853151|18068330|P4|Overall Study|Adverse Event|0
5235495|NCT00853151|18068331|P3|Overall Study|Adverse Event|2
5235496|NCT00853151|18068332|P2|Overall Study|Adverse Event|4
5235497|NCT00853151|18068333|P1|Overall Study|Adverse Event|1
5235498|NCT00853125|18068475|P1|Overall Study|Study participant's donor was CMV +|1
5235499|NCT00853112|18068487|P7|Overall Study|Randomized but not treated|1
5235500|NCT00853112|18068488|P6|Overall Study|Randomized but not treated|0
5235501|NCT00853112|18068489|P5|Overall Study|Randomized but not treated|0
5235502|NCT00853112|18068490|P4|Overall Study|Randomized but not treated|2
5235503|NCT00853112|18068491|P3|Overall Study|Randomized but not treated|0
5235504|NCT00853112|18068492|P2|Overall Study|Randomized but not treated|1
5235505|NCT00853112|18068493|P1|Overall Study|Randomized but not treated|0
5235506|NCT00853099|18068603|P4|Double-blind + Open-label Periods|Other|6
5235507|NCT00853099|18068604|P3|Double-blind + Open-label Periods|Other|0
5235508|NCT00853099|18068605|P2|Double-blind + Open-label Periods|Other|0
5235509|NCT00853099|18068606|P1|Double-blind + Open-label Periods|Other|0
5235510|NCT00853099|18068603|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
5235511|NCT00853099|18068604|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
5235512|NCT00853099|18068605|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
5235513|NCT00853099|18068606|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
5235514|NCT00853099|18068603|P4|Double-blind + Open-label Periods|Adverse Event|47
5235515|NCT00853099|18068604|P3|Double-blind + Open-label Periods|Adverse Event|0
5235516|NCT00853099|18068605|P2|Double-blind + Open-label Periods|Adverse Event|0
5235517|NCT00853099|18068606|P1|Double-blind + Open-label Periods|Adverse Event|0
5235518|NCT00853099|18068603|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
5235519|NCT00853099|18068604|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
5235520|NCT00853099|18068605|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
5235521|NCT00853099|18068606|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
5235522|NCT00853099|18068603|P4|Double-blind Period|Mistreated with rescue study drug|0
5235523|NCT00853099|18068604|P3|Double-blind Period|Mistreated with rescue study drug|1
5235524|NCT00853099|18068605|P2|Double-blind Period|Mistreated with rescue study drug|0
5235525|NCT00853099|18068606|P1|Double-blind Period|Mistreated with rescue study drug|0
5235526|NCT00853099|18068603|P4|Double-blind Period|Other|0
5235527|NCT00853099|18068604|P3|Double-blind Period|Other|1
5235528|NCT00853099|18068605|P2|Double-blind Period|Other|0
5235529|NCT00853099|18068606|P1|Double-blind Period|Other|0
5235530|NCT00853099|18068603|P4|Double-blind Period|Lack of Efficacy|0
5235531|NCT00853099|18068604|P3|Double-blind Period|Lack of Efficacy|16
5235532|NCT00853099|18068605|P2|Double-blind Period|Lack of Efficacy|17
5235533|NCT00853099|18068606|P1|Double-blind Period|Lack of Efficacy|14
5235534|NCT00853099|18068603|P4|Double-blind Period|Withdrawal by Subject|0
5235535|NCT00853099|18068604|P3|Double-blind Period|Withdrawal by Subject|0
5235536|NCT00853099|18068605|P2|Double-blind Period|Withdrawal by Subject|3
5235537|NCT00853099|18068606|P1|Double-blind Period|Withdrawal by Subject|2
5235538|NCT00853099|18068603|P4|Double-blind Period|Adverse Event|0
5235539|NCT00853099|18068604|P3|Double-blind Period|Adverse Event|13
5235540|NCT00853099|18068605|P2|Double-blind Period|Adverse Event|9
5235541|NCT00853099|18068606|P1|Double-blind Period|Adverse Event|7
5235542|NCT00853073|18068648|P2|Overall Study|Withdrawal by Subject|2
5235543|NCT00853073|18068649|P1|Overall Study|Withdrawal by Subject|3
5235544|NCT00853047|18068662|P6|Open-Label Extension Phase|Reason Not Specified|6
5235545|NCT00853047|18068663|P5|Open-Label Extension Phase|Reason Not Specified|0
5235546|NCT00853047|18068664|P4|Open-Label Extension Phase|Reason Not Specified|0
5235547|NCT00853047|18068665|P3|Open-Label Extension Phase|Reason Not Specified|0
5235548|NCT00853047|18068666|P2|Open-Label Extension Phase|Reason Not Specified|0
5235549|NCT00853047|18068667|P1|Open-Label Extension Phase|Reason Not Specified|0
5235550|NCT00853047|18068662|P6|Open-Label Extension Phase|Investigator Decision|1
5235551|NCT00853047|18068663|P5|Open-Label Extension Phase|Investigator Decision|0
5235552|NCT00853047|18068664|P4|Open-Label Extension Phase|Investigator Decision|0
5235553|NCT00853047|18068665|P3|Open-Label Extension Phase|Investigator Decision|0
5235554|NCT00853047|18068666|P2|Open-Label Extension Phase|Investigator Decision|0
5235555|NCT00853047|18068667|P1|Open-Label Extension Phase|Investigator Decision|0
5235556|NCT00853047|18068662|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
5235557|NCT00853047|18068663|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
5235558|NCT00853047|18068664|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
5235559|NCT00853047|18068665|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
5235560|NCT00853047|18068666|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
5235561|NCT00853047|18068667|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
5235562|NCT00853047|18068662|P6|Open-Label Extension Phase|Lost to Follow-up|1
5235563|NCT00853047|18068663|P5|Open-Label Extension Phase|Lost to Follow-up|0
5235564|NCT00853047|18068664|P4|Open-Label Extension Phase|Lost to Follow-up|0
5235565|NCT00853047|18068665|P3|Open-Label Extension Phase|Lost to Follow-up|0
5235566|NCT00853047|18068666|P2|Open-Label Extension Phase|Lost to Follow-up|0
5235567|NCT00853047|18068667|P1|Open-Label Extension Phase|Lost to Follow-up|0
5235568|NCT00853047|18068662|P6|Open-Label Extension Phase|Participant Request|7
5235569|NCT00853047|18068663|P5|Open-Label Extension Phase|Participant Request|0
5235570|NCT00853047|18068664|P4|Open-Label Extension Phase|Participant Request|0
5235571|NCT00853047|18068665|P3|Open-Label Extension Phase|Participant Request|0
5235572|NCT00853047|18068666|P2|Open-Label Extension Phase|Participant Request|0
5235573|NCT00853047|18068667|P1|Open-Label Extension Phase|Participant Request|0
5235574|NCT00853047|18068662|P6|Core Phase|Participant Request|0
5235575|NCT00853047|18068663|P5|Core Phase|Participant Request|0
5235576|NCT00853047|18068664|P4|Core Phase|Participant Request|1
5235577|NCT00853047|18068665|P3|Core Phase|Participant Request|0
5235578|NCT00853047|18068666|P2|Core Phase|Participant Request|0
5235579|NCT00853047|18068667|P1|Core Phase|Participant Request|0
5235580|NCT00853021|18068733|P1|Overall Study|Death|1
5235581|NCT00853021|18068733|P1|Overall Study|Withdrawal by Subject|2
5235582|NCT00853021|18068733|P1|Overall Study|Adverse Event|2
5235583|NCT00852995|18068745|P5|Overall Study|Moved Out of Area|0
5235584|NCT00852995|18068746|P4|Overall Study|Moved Out of Area|0
5235585|NCT00852995|18068747|P3|Overall Study|Moved Out of Area|0
5235586|NCT00852995|18068748|P2|Overall Study|Moved Out of Area|0
5235587|NCT00852995|18068749|P1|Overall Study|Moved Out of Area|1
5235588|NCT00852995|18068745|P5|Overall Study|Protocol Violation|1
5235589|NCT00852995|18068746|P4|Overall Study|Protocol Violation|0
5235590|NCT00852995|18068747|P3|Overall Study|Protocol Violation|0
5235591|NCT00852995|18068748|P2|Overall Study|Protocol Violation|0
5235592|NCT00852995|18068749|P1|Overall Study|Protocol Violation|0
5235593|NCT00852995|18068745|P5|Overall Study|Physician Decision|0
5235594|NCT00852995|18068746|P4|Overall Study|Physician Decision|0
5235595|NCT00852995|18068747|P3|Overall Study|Physician Decision|0
5235596|NCT00852995|18068748|P2|Overall Study|Physician Decision|0
5235597|NCT00852995|18068749|P1|Overall Study|Physician Decision|1
5235598|NCT00852995|18068745|P5|Overall Study|Progressive Disease|1
5235599|NCT00852995|18068746|P4|Overall Study|Progressive Disease|2
5235600|NCT00852995|18068747|P3|Overall Study|Progressive Disease|0
5235601|NCT00852995|18068748|P2|Overall Study|Progressive Disease|0
5235602|NCT00852995|18068749|P1|Overall Study|Progressive Disease|1
5235603|NCT00852995|18068745|P5|Overall Study|Non-Compliance|0
5235604|NCT00852995|18068746|P4|Overall Study|Non-Compliance|2
5235605|NCT00852995|18068747|P3|Overall Study|Non-Compliance|0
5235606|NCT00852995|18068748|P2|Overall Study|Non-Compliance|0
5235607|NCT00852995|18068749|P1|Overall Study|Non-Compliance|0
5235608|NCT00852995|18068745|P5|Overall Study|Withdrawal by Subject|2
5235609|NCT00852995|18068746|P4|Overall Study|Withdrawal by Subject|1
5235610|NCT00852995|18068747|P3|Overall Study|Withdrawal by Subject|0
5235611|NCT00852995|18068748|P2|Overall Study|Withdrawal by Subject|0
5235612|NCT00852995|18068749|P1|Overall Study|Withdrawal by Subject|4
5235613|NCT00852995|18068745|P5|Overall Study|Lost to Follow-up|0
5235614|NCT00852995|18068746|P4|Overall Study|Lost to Follow-up|0
5235615|NCT00852995|18068747|P3|Overall Study|Lost to Follow-up|1
5235616|NCT00852995|18068748|P2|Overall Study|Lost to Follow-up|1
5235617|NCT00852995|18068749|P1|Overall Study|Lost to Follow-up|0
5235618|NCT00852995|18068745|P5|Overall Study|Adverse Event|0
5235619|NCT00852995|18068746|P4|Overall Study|Adverse Event|0
5235620|NCT00852995|18068747|P3|Overall Study|Adverse Event|4
5235621|NCT00852995|18068748|P2|Overall Study|Adverse Event|0
5235622|NCT00852995|18068749|P1|Overall Study|Adverse Event|1
5235623|NCT00852969|18068793|P2|Overall Study|Lost to Follow-up|1
5235624|NCT00852969|18068794|P1|Overall Study|Lost to Follow-up|0
5235625|NCT00852969|18068793|P2|Overall Study|Adverse Event|1
5235626|NCT00852969|18068794|P1|Overall Study|Adverse Event|0
5235627|NCT00852930|18068805|P3|Overall Study|Physician Decision|1
5235628|NCT00852930|18068806|P2|Overall Study|Physician Decision|0
5235629|NCT00852930|18068807|P1|Overall Study|Physician Decision|0
5235630|NCT00852930|18068805|P3|Overall Study|Withdrawal by Subject|1
5235631|NCT00852930|18068806|P2|Overall Study|Withdrawal by Subject|1
5235632|NCT00852930|18068807|P1|Overall Study|Withdrawal by Subject|1
5235633|NCT00852917|18068828|P4|Overall Study|Death|1
5235634|NCT00852917|18068829|P3|Overall Study|Death|0
5235635|NCT00852917|18068830|P2|Overall Study|Death|0
5235636|NCT00852917|18068831|P1|Overall Study|Death|0
5235637|NCT00852917|18068828|P4|Overall Study|Physician Decision|19
5235638|NCT00852917|18068829|P3|Overall Study|Physician Decision|2
5235639|NCT00852917|18068830|P2|Overall Study|Physician Decision|7
5235640|NCT00852917|18068831|P1|Overall Study|Physician Decision|6
5235641|NCT00852917|18068828|P4|Overall Study|Withdrawal by Subject|9
5235642|NCT00852917|18068829|P3|Overall Study|Withdrawal by Subject|10
5235643|NCT00852917|18068830|P2|Overall Study|Withdrawal by Subject|8
5235644|NCT00852917|18068831|P1|Overall Study|Withdrawal by Subject|4
5235645|NCT00852917|18068828|P4|Overall Study|Lack of Efficacy|47
5235646|NCT00852917|18068829|P3|Overall Study|Lack of Efficacy|11
5235647|NCT00852917|18068830|P2|Overall Study|Lack of Efficacy|11
5235648|NCT00852917|18068831|P1|Overall Study|Lack of Efficacy|21
5235649|NCT00852917|18068828|P4|Overall Study|Adverse Event|17
5235650|NCT00852917|18068829|P3|Overall Study|Adverse Event|35
5235651|NCT00852917|18068830|P2|Overall Study|Adverse Event|20
5235652|NCT00852917|18068831|P1|Overall Study|Adverse Event|13
5235653|NCT00852540|18068959|P2|Overall Study|Did Not Receive Study Drug|3
5235654|NCT00852540|18068960|P1|Overall Study|Did Not Receive Study Drug|3
5235655|NCT00852540|18068959|P2|Overall Study|Withdrawal by Subject|1
5235656|NCT00852540|18068960|P1|Overall Study|Withdrawal by Subject|3
5235657|NCT00852540|18068959|P2|Overall Study|Investigator Discretion|3
5235658|NCT00852540|18068960|P1|Overall Study|Investigator Discretion|2
5235659|NCT00852540|18068959|P2|Overall Study|Lost to Follow-up|3
5235660|NCT00852540|18068960|P1|Overall Study|Lost to Follow-up|2
5235661|NCT00852540|18068959|P2|Overall Study|Protocol Violation|2
5235662|NCT00852540|18068960|P1|Overall Study|Protocol Violation|1
5235663|NCT00852540|18068959|P2|Overall Study|Lack of Efficacy|3
5235664|NCT00852540|18068960|P1|Overall Study|Lack of Efficacy|15
5235665|NCT00852540|18068959|P2|Overall Study|Adverse Event|3
5235666|NCT00852540|18068960|P1|Overall Study|Adverse Event|10
5235667|NCT00852475|18068994|P2|Overall Study|Lost to Follow-up|4
5235668|NCT00852475|18068995|P1|Overall Study|Lost to Follow-up|3
5235669|NCT00852397|18069006|P3|Overall Study|Protocol Violation|1
5235670|NCT00852397|18069007|P2|Overall Study|Protocol Violation|0
5235671|NCT00852397|18069008|P1|Overall Study|Protocol Violation|0
5235672|NCT00852397|18069006|P3|Overall Study|Difficulty in study site visit|0
5235673|NCT00852397|18069007|P2|Overall Study|Difficulty in study site visit|0
5235674|NCT00852397|18069008|P1|Overall Study|Difficulty in study site visit|1
5235675|NCT00852397|18069006|P3|Overall Study|Study terminated by sponsor|6
5235676|NCT00852397|18069007|P2|Overall Study|Study terminated by sponsor|1
5235677|NCT00852397|18069008|P1|Overall Study|Study terminated by sponsor|2
5235678|NCT00852397|18069006|P3|Overall Study|Withdrawal by Subject|2
5235679|NCT00852397|18069007|P2|Overall Study|Withdrawal by Subject|1
5235680|NCT00852397|18069008|P1|Overall Study|Withdrawal by Subject|4
5235681|NCT00852397|18069006|P3|Overall Study|Death|1
5235682|NCT00852397|18069007|P2|Overall Study|Death|0
5235683|NCT00852397|18069008|P1|Overall Study|Death|0
5235684|NCT00852397|18069006|P3|Overall Study|Adverse Event|4
5235685|NCT00852397|18069007|P2|Overall Study|Adverse Event|6
5235686|NCT00852397|18069008|P1|Overall Study|Adverse Event|4
5235687|NCT00852241|18069037|P1|Overall Study|Physician Decision|18
5235688|NCT00852202|18069044|P3|Overall Study|pregnancy,moving away and surgery|2
5235689|NCT00852202|18069045|P2|Overall Study|pregnancy,moving away and surgery|0
5235690|NCT00852202|18069046|P1|Overall Study|pregnancy,moving away and surgery|1
5235691|NCT00852202|18069044|P3|Overall Study|Lost to Follow-up|6
5235692|NCT00852202|18069045|P2|Overall Study|Lost to Follow-up|5
5235693|NCT00852202|18069046|P1|Overall Study|Lost to Follow-up|5
5235694|NCT00852202|18069044|P3|Overall Study|Withdrawal by Subject|2
5235695|NCT00852202|18069045|P2|Overall Study|Withdrawal by Subject|1
5235696|NCT00852202|18069046|P1|Overall Study|Withdrawal by Subject|3
5235697|NCT00852202|18069044|P3|Overall Study|Protocol Violation|7
5235698|NCT00852202|18069045|P2|Overall Study|Protocol Violation|2
5235699|NCT00852202|18069046|P1|Overall Study|Protocol Violation|2
5235700|NCT00852202|18069044|P3|Overall Study|Lack of Efficacy|2
5235701|NCT00852202|18069045|P2|Overall Study|Lack of Efficacy|1
5235702|NCT00852202|18069046|P1|Overall Study|Lack of Efficacy|4
5235703|NCT00852202|18069044|P3|Overall Study|Adverse Event|7
5235704|NCT00852202|18069045|P2|Overall Study|Adverse Event|3
5235705|NCT00852202|18069046|P1|Overall Study|Adverse Event|2
5235706|NCT00851903|18069088|P1|Overall Study|Withdrawal by Subject|2
5235707|NCT00851890|18069102|P4|Overall Study|Lost to Follow-up|1
5235708|NCT00851890|18069103|P3|Overall Study|Lost to Follow-up|0
5235709|NCT00851890|18069104|P2|Overall Study|Lost to Follow-up|1
5235710|NCT00851890|18069105|P1|Overall Study|Lost to Follow-up|0
5235711|NCT00851877|18069162|P3|Phase II|Withdrawal by Subject|3
5235712|NCT00851877|18069163|P2|Phase II|Withdrawal by Subject|0
5235713|NCT00851877|18069164|P1|Phase II|Withdrawal by Subject|0
5235714|NCT00851877|18069162|P3|Phase I-1|Death|0
5235715|NCT00851877|18069163|P2|Phase I-1|Death|0
5235716|NCT00851877|18069164|P1|Phase I-1|Death|1
5235717|NCT00851799|18069174|P3|Overall Study|Completed protocol due to pregnancy|1
5235718|NCT00851799|18069175|P2|Overall Study|Completed protocol due to pregnancy|0
5235719|NCT00851799|18069176|P1|Overall Study|Completed protocol due to pregnancy|0
5235720|NCT00851799|18069174|P3|Overall Study|Severe Debilitation|0
5235721|NCT00851799|18069175|P2|Overall Study|Severe Debilitation|1
5235722|NCT00851799|18069176|P1|Overall Study|Severe Debilitation|0
5235723|NCT00851799|18069174|P3|Overall Study|Withdrew consent prior study completion|1
5235724|NCT00851799|18069175|P2|Overall Study|Withdrew consent prior study completion|2
5235725|NCT00851799|18069176|P1|Overall Study|Withdrew consent prior study completion|1
5235726|NCT00851799|18069174|P3|Overall Study|Not willing to adhere to requirements|2
5235727|NCT00851799|18069175|P2|Overall Study|Not willing to adhere to requirements|2
5235728|NCT00851799|18069176|P1|Overall Study|Not willing to adhere to requirements|1
5235729|NCT00851799|18069174|P3|Overall Study|Not able to get to clinic|9
5235730|NCT00851799|18069175|P2|Overall Study|Not able to get to clinic|5
5235731|NCT00851799|18069176|P1|Overall Study|Not able to get to clinic|8
5235732|NCT00851799|18069174|P3|Overall Study|Lost to Follow-up|10
5235733|NCT00851799|18069175|P2|Overall Study|Lost to Follow-up|3
5235734|NCT00851799|18069176|P1|Overall Study|Lost to Follow-up|5
5235735|NCT00851799|18069174|P3|Overall Study|Death|1
5235736|NCT00851799|18069175|P2|Overall Study|Death|0
5235737|NCT00851799|18069176|P1|Overall Study|Death|1
5235738|NCT00851786|18069264|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
5235739|NCT00851786|18069265|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
5235740|NCT00851786|18069264|P2|Overall Study|Site Closure|0
5235741|NCT00851786|18069265|P1|Overall Study|Site Closure|1
5235742|NCT00851786|18069264|P2|Overall Study|Incarceration|0
5235743|NCT00851786|18069265|P1|Overall Study|Incarceration|1
5235744|NCT00851786|18069264|P2|Overall Study|Lost to Follow-up|0
5235745|NCT00851786|18069265|P1|Overall Study|Lost to Follow-up|1
5235746|NCT00851786|18069264|P2|Overall Study|Protocol Violation|1
5235747|NCT00851786|18069265|P1|Overall Study|Protocol Violation|0
5235748|NCT00851786|18069264|P2|Overall Study|Withdrawal by Subject|1
5235749|NCT00851786|18069265|P1|Overall Study|Withdrawal by Subject|0
5235750|NCT00851747|18069278|P3|Overall Study|Physician Decision|6
5235751|NCT00851747|18069279|P2|Overall Study|Physician Decision|6
5235752|NCT00851747|18069280|P1|Overall Study|Physician Decision|6
5235753|NCT00851721|18069289|P2|Overall Study|Adverse Event|1
5235754|NCT00851721|18069290|P1|Overall Study|Adverse Event|0
5235755|NCT00851721|18069289|P2|Overall Study|Death|0
5235756|NCT00851721|18069290|P1|Overall Study|Death|1
5235757|NCT00851721|18069289|P2|Overall Study|planned surgery|0
5235758|NCT00851721|18069290|P1|Overall Study|planned surgery|1
5235759|NCT00851682|18069380|P2|Overall Study|screen failure|0
5235760|NCT00851682|18069381|P1|Overall Study|screen failure|5
5235761|NCT00851643|18069395|P6|Extension Study (Up to 36 Months)|Moved|1
5235762|NCT00851643|18069396|P5|Extension Study (Up to 36 Months)|Moved|0
5235763|NCT00851643|18069397|P4|Extension Study (Up to 36 Months)|Moved|1
5235764|NCT00851643|18069398|P3|Extension Study (Up to 36 Months)|Moved|1
5235765|NCT00851643|18069399|P2|Extension Study (Up to 36 Months)|Moved|2
5235766|NCT00851643|18069400|P1|Extension Study (Up to 36 Months)|Moved|0
5235767|NCT00851643|18069395|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
5235768|NCT00851643|18069396|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
5235769|NCT00851643|18069397|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
5235770|NCT00851643|18069398|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
5235771|NCT00851643|18069399|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
5235772|NCT00851643|18069400|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
5235773|NCT00851643|18069395|P6|Base Study (Up to 12 Months)|Other|1
5235774|NCT00851643|18069396|P5|Base Study (Up to 12 Months)|Other|0
5235775|NCT00851643|18069397|P4|Base Study (Up to 12 Months)|Other|0
5235776|NCT00851643|18069398|P3|Base Study (Up to 12 Months)|Other|0
5235777|NCT00851643|18069399|P2|Base Study (Up to 12 Months)|Other|0
5235778|NCT00851643|18069400|P1|Base Study (Up to 12 Months)|Other|0
5235779|NCT00851643|18069395|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5235780|NCT00851643|18069396|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5235781|NCT00851643|18069397|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5235782|NCT00851643|18069398|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5235783|NCT00851643|18069399|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5235784|NCT00851643|18069400|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
5235785|NCT00851630|18069421|P2|Overall Study|Clinical failure|1
5235786|NCT00851630|18069422|P1|Overall Study|Clinical failure|0
5235787|NCT00851630|18069421|P2|Overall Study|Death|1
5235788|NCT00851630|18069422|P1|Overall Study|Death|2
5235789|NCT00851591|18069436|P2|Overall Study|Withdrawal by Subject|0
5235790|NCT00851591|18069437|P1|Overall Study|Withdrawal by Subject|2
5235791|NCT00851552|18069443|P1|Overall Study|Disease Progression|4
5235792|NCT00851552|18069443|P1|Overall Study|Adverse Event|1
5235793|NCT00851552|18069443|P1|Overall Study|Death|2
5235794|NCT00851318|18069473|P4|Overall Study|Physician Decision|1
5235795|NCT00851318|18069474|P3|Overall Study|Physician Decision|1
5235796|NCT00851318|18069475|P2|Overall Study|Physician Decision|0
5235797|NCT00851318|18069476|P1|Overall Study|Physician Decision|0
5235798|NCT00851318|18069473|P4|Overall Study|Non-compliance with Study Procedures|0
5235799|NCT00851318|18069474|P3|Overall Study|Non-compliance with Study Procedures|1
5235800|NCT00851318|18069475|P2|Overall Study|Non-compliance with Study Procedures|0
5235801|NCT00851318|18069476|P1|Overall Study|Non-compliance with Study Procedures|2
5235802|NCT00851318|18069473|P4|Overall Study|Lack of Efficacy|2
5235803|NCT00851318|18069474|P3|Overall Study|Lack of Efficacy|4
5235804|NCT00851318|18069475|P2|Overall Study|Lack of Efficacy|2
5235805|NCT00851318|18069476|P1|Overall Study|Lack of Efficacy|8
5235806|NCT00851318|18069473|P4|Overall Study|Pregnancy|1
5235807|NCT00851318|18069474|P3|Overall Study|Pregnancy|1
5235808|NCT00851318|18069475|P2|Overall Study|Pregnancy|0
5235809|NCT00851318|18069476|P1|Overall Study|Pregnancy|0
5235810|NCT00851318|18069473|P4|Overall Study|Adverse Event|12
5235811|NCT00851318|18069474|P3|Overall Study|Adverse Event|9
5235812|NCT00851318|18069475|P2|Overall Study|Adverse Event|2
5235813|NCT00851318|18069476|P1|Overall Study|Adverse Event|13
5235814|NCT00851318|18069473|P4|Overall Study|Withdrawal by Subject|3
5235815|NCT00851318|18069474|P3|Overall Study|Withdrawal by Subject|5
5235816|NCT00851318|18069475|P2|Overall Study|Withdrawal by Subject|1
5235817|NCT00851318|18069476|P1|Overall Study|Withdrawal by Subject|7
5235818|NCT00851253|18069512|P2|Overall Study|Disease Progression|0
5235819|NCT00851253|18069513|P1|Overall Study|Disease Progression|1
5235820|NCT00851084|18069523|P2|Overall Study|Other|1
5235821|NCT00851084|18069524|P1|Overall Study|Other|7
5235822|NCT00851084|18069523|P2|Overall Study|Metastatic surgery|6
5235823|NCT00851084|18069524|P1|Overall Study|Metastatic surgery|6
5235824|NCT00851084|18069523|P2|Overall Study|Withdrawal by Subject|12
5235825|NCT00851084|18069524|P1|Overall Study|Withdrawal by Subject|11
5235826|NCT00851084|18069523|P2|Overall Study|Consent withdrawn|2
5235827|NCT00851084|18069524|P1|Overall Study|Consent withdrawn|0
5235828|NCT00851084|18069523|P2|Overall Study|Physician Decision|14
5235829|NCT00851084|18069524|P1|Overall Study|Physician Decision|13
5235830|NCT00851084|18069523|P2|Overall Study|Poor compliance to protocol|1
5235831|NCT00851084|18069524|P1|Overall Study|Poor compliance to protocol|1
5235832|NCT00851084|18069523|P2|Overall Study|Disease progression|47
5235833|NCT00851084|18069524|P1|Overall Study|Disease progression|52
5235834|NCT00851084|18069523|P2|Overall Study|Adverse Event|36
5235835|NCT00851084|18069524|P1|Overall Study|Adverse Event|26
5235836|NCT00851084|18069523|P2|Overall Study|Randomized but not treated|0
5235837|NCT00851084|18069524|P1|Overall Study|Randomized but not treated|1
5235838|NCT00850993|18069552|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
5235839|NCT00850993|18069553|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
5235840|NCT00850993|18069554|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
5235841|NCT00850993|18069555|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
5235842|NCT00850759|18069584|P4|Overall Study|Lost to Follow-up|3
5235843|NCT00850759|18069585|P3|Overall Study|Lost to Follow-up|5
5235844|NCT00850759|18069586|P2|Overall Study|Lost to Follow-up|5
5235845|NCT00850759|18069587|P1|Overall Study|Lost to Follow-up|7
5235846|NCT00850564|18069668|P1|Overall Study|Withdrawal by Subject|2
5235847|NCT00850538|18069673|P1|Overall Study|Protocol Violation|2
5235848|NCT00850538|18069673|P1|Overall Study|radiology error|2
5235849|NCT00850538|18069673|P1|Overall Study|Withdrawal by Subject|3
5235850|NCT00850538|18069673|P1|Overall Study|specimen unusable|7
5235851|NCT00850538|18069673|P1|Overall Study|specimen missed due to scheduling error|14
5235852|NCT00850538|18069673|P1|Overall Study|unable/unwilling to complete MRI|13
5235853|NCT00850499|18069679|P2|Overall Study|Lack of Efficacy|1
5235854|NCT00850499|18069680|P1|Overall Study|Lack of Efficacy|0
5235855|NCT00850499|18069679|P2|Overall Study|Adverse Event|1
5235856|NCT00850499|18069680|P1|Overall Study|Adverse Event|3
5235857|NCT00850460|18069694|P2|Overall Study|Lost to Follow-up|4
5235858|NCT00850460|18069695|P1|Overall Study|Lost to Follow-up|4
5235859|NCT00850395|18069709|P1|Overall Study|Other|5
5235860|NCT00850395|18069709|P1|Overall Study|Insufficient clinical response|3
5235861|NCT00850395|18069709|P1|Overall Study|Adverse Event|1
5235862|NCT00850395|18069709|P1|Overall Study|Death|1
5235863|NCT00850343|18069729|P4|Overall Study|Physician Decision|1
5235864|NCT00850343|18069730|P3|Overall Study|Physician Decision|1
5235865|NCT00850343|18069731|P2|Overall Study|Physician Decision|1
5235866|NCT00850343|18069732|P1|Overall Study|Physician Decision|2
5235867|NCT00850343|18069729|P4|Overall Study|Non-compliance with Study Procedures|1
5235868|NCT00850343|18069730|P3|Overall Study|Non-compliance with Study Procedures|1
5235869|NCT00850343|18069731|P2|Overall Study|Non-compliance with Study Procedures|0
5235870|NCT00850343|18069732|P1|Overall Study|Non-compliance with Study Procedures|1
5235871|NCT00850343|18069729|P4|Overall Study|Lack of Efficacy|2
5235872|NCT00850343|18069730|P3|Overall Study|Lack of Efficacy|3
5235873|NCT00850343|18069731|P2|Overall Study|Lack of Efficacy|0
5235874|NCT00850343|18069732|P1|Overall Study|Lack of Efficacy|17
5235875|NCT00850343|18069729|P4|Overall Study|Pregnancy|1
5235876|NCT00850343|18069730|P3|Overall Study|Pregnancy|0
5235877|NCT00850343|18069731|P2|Overall Study|Pregnancy|0
5235878|NCT00850343|18069732|P1|Overall Study|Pregnancy|0
5235879|NCT00850343|18069729|P4|Overall Study|Adverse Event|6
5235880|NCT00850343|18069730|P3|Overall Study|Adverse Event|6
5235881|NCT00850343|18069731|P2|Overall Study|Adverse Event|2
5235882|NCT00850343|18069732|P1|Overall Study|Adverse Event|15
5235883|NCT00850343|18069729|P4|Overall Study|Withdrawal by Subject|2
5235884|NCT00850343|18069730|P3|Overall Study|Withdrawal by Subject|3
5235885|NCT00850343|18069731|P2|Overall Study|Withdrawal by Subject|0
5235886|NCT00850343|18069732|P1|Overall Study|Withdrawal by Subject|11
5235887|NCT00850200|18069762|P1|Overall Study|Withdrawal by Subject|1
5235888|NCT00850200|18069762|P1|Overall Study|Did not recieve treatment|2
5235889|NCT00850200|18069762|P1|Overall Study|Physician Decision|2
5235890|NCT00850174|18069772|P2|Second Intervention|Withdrawal by Subject|0
5235891|NCT00850174|18069773|P1|Second Intervention|Withdrawal by Subject|1
5235892|NCT00850174|18069772|P2|Washout: One Week|Withdrawal by Subject|2
5235893|NCT00850174|18069773|P1|Washout: One Week|Withdrawal by Subject|0
5235894|NCT00850135|18069787|P1|Overall Study|Physician Decision|1
5235895|NCT00850070|18069806|P2|Overall Study|Adverse Event|0
5235896|NCT00850070|18069807|P1|Overall Study|Adverse Event|2
5235897|NCT00850070|18069806|P2|Overall Study|Lack of Efficacy|1
5235898|NCT00850070|18069807|P1|Overall Study|Lack of Efficacy|1
5235899|NCT00849940|18069836|P1|Overall Study|Physician Decision|4
5235900|NCT00849901|18069847|P3|Extension Phase|Lack of Efficacy|1
5235901|NCT00849901|18069848|P2|Extension Phase|Lack of Efficacy|4
5235902|NCT00849901|18069849|P1|Extension Phase|Lack of Efficacy|2
5235903|NCT00849901|18069847|P3|Extension Phase|Physician Decision|0
5235904|NCT00849901|18069848|P2|Extension Phase|Physician Decision|2
5235905|NCT00849901|18069849|P1|Extension Phase|Physician Decision|1
5235906|NCT00849901|18069847|P3|Extension Phase|Parent or Caregiver Decision|4
5235907|NCT00849901|18069848|P2|Extension Phase|Parent or Caregiver Decision|4
5235908|NCT00849901|18069849|P1|Extension Phase|Parent or Caregiver Decision|10
5235909|NCT00849901|18069847|P3|Extension Phase|Withdrawal by Subject|3
5235910|NCT00849901|18069848|P2|Extension Phase|Withdrawal by Subject|6
5235911|NCT00849901|18069849|P1|Extension Phase|Withdrawal by Subject|7
5235912|NCT00849901|18069847|P3|Extension Phase|Protocol Violation|4
5235913|NCT00849901|18069848|P2|Extension Phase|Protocol Violation|2
5235914|NCT00849901|18069849|P1|Extension Phase|Protocol Violation|2
5235915|NCT00849901|18069847|P3|Extension Phase|Lost to Follow-up|1
5235916|NCT00849901|18069848|P2|Extension Phase|Lost to Follow-up|0
5235917|NCT00849901|18069849|P1|Extension Phase|Lost to Follow-up|3
5235918|NCT00849901|18069847|P3|Extension Phase|Adverse Event|4
5235919|NCT00849901|18069848|P2|Extension Phase|Adverse Event|8
5235920|NCT00849901|18069849|P1|Extension Phase|Adverse Event|2
5235921|NCT00849901|18069847|P3|Acute Treatment Phase|Lack of Efficacy|2
5235922|NCT00849901|18069848|P2|Acute Treatment Phase|Lack of Efficacy|3
5235923|NCT00849901|18069849|P1|Acute Treatment Phase|Lack of Efficacy|2
5235924|NCT00849901|18069847|P3|Acute Treatment Phase|Sponsor Decision|0
5235925|NCT00849901|18069848|P2|Acute Treatment Phase|Sponsor Decision|0
5235926|NCT00849901|18069849|P1|Acute Treatment Phase|Sponsor Decision|1
5235927|NCT00849901|18069847|P3|Acute Treatment Phase|Physician Decision|1
5235928|NCT00849901|18069848|P2|Acute Treatment Phase|Physician Decision|1
5235929|NCT00849901|18069849|P1|Acute Treatment Phase|Physician Decision|1
5235930|NCT00849901|18069847|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
5235931|NCT00849901|18069848|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
5235932|NCT00849901|18069849|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
5235933|NCT00849901|18069847|P3|Acute Treatment Phase|Withdrawal by Subject|4
5235934|NCT00849901|18069848|P2|Acute Treatment Phase|Withdrawal by Subject|10
5235935|NCT00849901|18069849|P1|Acute Treatment Phase|Withdrawal by Subject|4
5235936|NCT00849901|18069847|P3|Acute Treatment Phase|Protocol Violation|1
5235937|NCT00849901|18069848|P2|Acute Treatment Phase|Protocol Violation|2
5235938|NCT00849901|18069849|P1|Acute Treatment Phase|Protocol Violation|0
5235939|NCT00849901|18069847|P3|Acute Treatment Phase|Lost to Follow-up|1
5235940|NCT00849901|18069848|P2|Acute Treatment Phase|Lost to Follow-up|4
5235941|NCT00849901|18069849|P1|Acute Treatment Phase|Lost to Follow-up|2
5235942|NCT00849901|18069847|P3|Acute Treatment Phase|Adverse Event|3
5235943|NCT00849901|18069848|P2|Acute Treatment Phase|Adverse Event|1
5235944|NCT00849901|18069849|P1|Acute Treatment Phase|Adverse Event|9
5235945|NCT00849875|18069896|P1|Overall Study|Lost to Follow-up|2
5235946|NCT00849875|18069896|P1|Overall Study|Others|6
5235947|NCT00849875|18069896|P1|Overall Study|Ongoing (unknown completion status)|11
5235948|NCT00849875|18069896|P1|Overall Study|Death|28
5235949|NCT00849797|18069993|P2|Washout: One Week|Withdrawal by Subject|2
5235950|NCT00849797|18069994|P1|Washout: One Week|Withdrawal by Subject|0
5235951|NCT00849797|18069993|P2|First Intervention|Adverse Event|1
5235952|NCT00849797|18069994|P1|First Intervention|Adverse Event|0
5235953|NCT00849797|18069993|P2|First Intervention|bad veins|0
5235954|NCT00849797|18069994|P1|First Intervention|bad veins|1
5235955|NCT00849693|18070012|P4|Extension Phase|Lack of Efficacy|1
5235956|NCT00849693|18070013|P3|Extension Phase|Lack of Efficacy|2
5235957|NCT00849693|18070014|P2|Extension Phase|Lack of Efficacy|2
5235958|NCT00849693|18070015|P1|Extension Phase|Lack of Efficacy|2
5235959|NCT00849693|18070012|P4|Extension Phase|Sponsor decision|1
5235960|NCT00849693|18070013|P3|Extension Phase|Sponsor decision|0
5235961|NCT00849693|18070014|P2|Extension Phase|Sponsor decision|0
5235962|NCT00849693|18070015|P1|Extension Phase|Sponsor decision|1
5235963|NCT00849693|18070012|P4|Extension Phase|Physician Decision|0
5235964|NCT00849693|18070013|P3|Extension Phase|Physician Decision|2
5235965|NCT00849693|18070014|P2|Extension Phase|Physician Decision|1
5235966|NCT00849693|18070015|P1|Extension Phase|Physician Decision|1
5235967|NCT00849693|18070012|P4|Extension Phase|Parent or caregiver decision|5
5235968|NCT00849693|18070013|P3|Extension Phase|Parent or caregiver decision|10
5235969|NCT00849693|18070014|P2|Extension Phase|Parent or caregiver decision|4
5235970|NCT00849693|18070015|P1|Extension Phase|Parent or caregiver decision|9
5235971|NCT00849693|18070012|P4|Extension Phase|Withdrawal by Subject|15
5235972|NCT00849693|18070013|P3|Extension Phase|Withdrawal by Subject|10
5235973|NCT00849693|18070014|P2|Extension Phase|Withdrawal by Subject|9
5235974|NCT00849693|18070015|P1|Extension Phase|Withdrawal by Subject|6
5235975|NCT00849693|18070012|P4|Extension Phase|Protocol Violation|3
5235976|NCT00849693|18070013|P3|Extension Phase|Protocol Violation|2
5235977|NCT00849693|18070014|P2|Extension Phase|Protocol Violation|3
5235978|NCT00849693|18070015|P1|Extension Phase|Protocol Violation|0
5235979|NCT00849693|18070012|P4|Extension Phase|Lost to Follow-up|6
5235980|NCT00849693|18070013|P3|Extension Phase|Lost to Follow-up|6
5235981|NCT00849693|18070014|P2|Extension Phase|Lost to Follow-up|5
5235982|NCT00849693|18070015|P1|Extension Phase|Lost to Follow-up|7
5235983|NCT00849693|18070012|P4|Extension Phase|Adverse Event|7
5235984|NCT00849693|18070013|P3|Extension Phase|Adverse Event|3
5235985|NCT00849693|18070014|P2|Extension Phase|Adverse Event|6
5235986|NCT00849693|18070015|P1|Extension Phase|Adverse Event|4
5235987|NCT00849693|18070012|P4|Acute Treatment Phase|Lack of Efficacy|2
5235988|NCT00849693|18070013|P3|Acute Treatment Phase|Lack of Efficacy|1
5235989|NCT00849693|18070014|P2|Acute Treatment Phase|Lack of Efficacy|3
5235990|NCT00849693|18070015|P1|Acute Treatment Phase|Lack of Efficacy|1
5235991|NCT00849693|18070012|P4|Acute Treatment Phase|Sponsor decision|0
5235992|NCT00849693|18070013|P3|Acute Treatment Phase|Sponsor decision|1
5235993|NCT00849693|18070014|P2|Acute Treatment Phase|Sponsor decision|0
5235994|NCT00849693|18070015|P1|Acute Treatment Phase|Sponsor decision|0
5235995|NCT00849693|18070012|P4|Acute Treatment Phase|Physician Decision|1
5235996|NCT00849693|18070013|P3|Acute Treatment Phase|Physician Decision|2
5235997|NCT00849693|18070014|P2|Acute Treatment Phase|Physician Decision|1
5235998|NCT00849693|18070015|P1|Acute Treatment Phase|Physician Decision|2
5235999|NCT00849693|18070012|P4|Acute Treatment Phase|Parent or caregiver decision|7
5236000|NCT00849693|18070013|P3|Acute Treatment Phase|Parent or caregiver decision|7
5236001|NCT00849693|18070014|P2|Acute Treatment Phase|Parent or caregiver decision|6
5236002|NCT00849693|18070015|P1|Acute Treatment Phase|Parent or caregiver decision|7
5236003|NCT00849693|18070012|P4|Acute Treatment Phase|Withdrawal by Subject|8
5236004|NCT00849693|18070013|P3|Acute Treatment Phase|Withdrawal by Subject|3
5236005|NCT00849693|18070014|P2|Acute Treatment Phase|Withdrawal by Subject|5
5236006|NCT00849693|18070015|P1|Acute Treatment Phase|Withdrawal by Subject|5
5236007|NCT00849693|18070012|P4|Acute Treatment Phase|Protocol Violation|6
5236008|NCT00849693|18070013|P3|Acute Treatment Phase|Protocol Violation|2
5236009|NCT00849693|18070014|P2|Acute Treatment Phase|Protocol Violation|5
5236010|NCT00849693|18070015|P1|Acute Treatment Phase|Protocol Violation|1
5236011|NCT00849693|18070012|P4|Acute Treatment Phase|Lost to Follow-up|9
5236012|NCT00849693|18070013|P3|Acute Treatment Phase|Lost to Follow-up|11
5236013|NCT00849693|18070014|P2|Acute Treatment Phase|Lost to Follow-up|8
5236014|NCT00849693|18070015|P1|Acute Treatment Phase|Lost to Follow-up|5
5236015|NCT00849693|18070012|P4|Acute Treatment Phase|Adverse Event|4
5236016|NCT00849693|18070013|P3|Acute Treatment Phase|Adverse Event|6
5236017|NCT00849693|18070014|P2|Acute Treatment Phase|Adverse Event|7
5236018|NCT00849693|18070015|P1|Acute Treatment Phase|Adverse Event|12
5236019|NCT00849680|18070082|P8|Overall Study|Subject unable to comply with protocol|0
5236020|NCT00849680|18070083|P7|Overall Study|Subject unable to comply with protocol|0
5236021|NCT00849680|18070084|P6|Overall Study|Subject unable to comply with protocol|0
5236022|NCT00849680|18070085|P5|Overall Study|Subject unable to comply with protocol|0
5236023|NCT00849680|18070086|P4|Overall Study|Subject unable to comply with protocol|0
5236024|NCT00849680|18070087|P3|Overall Study|Subject unable to comply with protocol|0
5236025|NCT00849680|18070088|P2|Overall Study|Subject unable to comply with protocol|0
5236026|NCT00849680|18070089|P1|Overall Study|Subject unable to comply with protocol|1
5236027|NCT00849680|18070082|P8|Overall Study|Withdrawal by Subject|1
5236028|NCT00849680|18070083|P7|Overall Study|Withdrawal by Subject|1
5236029|NCT00849680|18070084|P6|Overall Study|Withdrawal by Subject|2
5236030|NCT00849680|18070085|P5|Overall Study|Withdrawal by Subject|2
5236031|NCT00849680|18070086|P4|Overall Study|Withdrawal by Subject|2
5236032|NCT00849680|18070087|P3|Overall Study|Withdrawal by Subject|0
5236033|NCT00849680|18070088|P2|Overall Study|Withdrawal by Subject|0
5236034|NCT00849680|18070089|P1|Overall Study|Withdrawal by Subject|2
5236035|NCT00849680|18070082|P8|Overall Study|Subject moved|2
5236036|NCT00849680|18070083|P7|Overall Study|Subject moved|2
5236037|NCT00849680|18070084|P6|Overall Study|Subject moved|2
5236038|NCT00849680|18070085|P5|Overall Study|Subject moved|0
5236039|NCT00849680|18070086|P4|Overall Study|Subject moved|1
5236040|NCT00849680|18070087|P3|Overall Study|Subject moved|3
5236041|NCT00849680|18070088|P2|Overall Study|Subject moved|0
5236042|NCT00849680|18070089|P1|Overall Study|Subject moved|1
5236043|NCT00849680|18070082|P8|Overall Study|Lost to Follow-up|5
5236044|NCT00849680|18070083|P7|Overall Study|Lost to Follow-up|12
5236045|NCT00849680|18070084|P6|Overall Study|Lost to Follow-up|11
5236046|NCT00849680|18070085|P5|Overall Study|Lost to Follow-up|8
5236047|NCT00849680|18070086|P4|Overall Study|Lost to Follow-up|11
5236048|NCT00849680|18070087|P3|Overall Study|Lost to Follow-up|12
5236049|NCT00849680|18070088|P2|Overall Study|Lost to Follow-up|3
5236050|NCT00849680|18070089|P1|Overall Study|Lost to Follow-up|7
5236051|NCT00849680|18070082|P8|Overall Study|Adverse Event|0
5236052|NCT00849680|18070083|P7|Overall Study|Adverse Event|2
5236053|NCT00849680|18070084|P6|Overall Study|Adverse Event|0
5236054|NCT00849680|18070085|P5|Overall Study|Adverse Event|0
5236055|NCT00849680|18070086|P4|Overall Study|Adverse Event|0
5236056|NCT00849680|18070087|P3|Overall Study|Adverse Event|0
5236057|NCT00849680|18070088|P2|Overall Study|Adverse Event|0
5236058|NCT00849680|18070089|P1|Overall Study|Adverse Event|0
5236059|NCT00849524|18070131|P1|Overall Study|Lack of Efficacy|3
5236060|NCT00849472|18070148|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
5236061|NCT00849472|18070148|P1|Pazopanib Postsurgery Treatment|Moved|1
5236062|NCT00849472|18070148|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
5236063|NCT00849472|18070148|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
5236064|NCT00849472|18070148|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
5236065|NCT00849472|18070148|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
5236066|NCT00849472|18070148|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
5236067|NCT00849472|18070148|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
5236068|NCT00849472|18070148|P1|Weekly Paclitaxel|Physician Decision|3
5236069|NCT00849472|18070148|P1|Weekly Paclitaxel|Withdrawal by Subject|1
5236070|NCT00849472|18070148|P1|Weekly Paclitaxel|Adverse Event|11
5236071|NCT00849472|18070148|P1|Weekly Paclitaxel|Disease Progression|1
5236072|NCT00849472|18070148|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
5236073|NCT00849472|18070148|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
5236074|NCT00849472|18070148|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
5236075|NCT00849472|18070148|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
5236076|NCT00849472|18070148|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
5236077|NCT00849381|18070162|P1|Overall Study|Other|4
5236078|NCT00849381|18070162|P1|Overall Study|Withdrawal by Subject|6
5236079|NCT00849381|18070162|P1|Overall Study|Protocol Violation|5
5236080|NCT00849381|18070162|P1|Overall Study|Lost to Follow-up|129
5236081|NCT00849381|18070162|P1|Overall Study|Adverse Event|1
5236082|NCT00849290|18070168|P1|Overall Study|Disease Progression|20
5236083|NCT00849290|18070168|P1|Overall Study|Protocol Violation|5
5236084|NCT00849290|18070168|P1|Overall Study|Lost to Follow-up|2
5236085|NCT00849290|18070168|P1|Overall Study|Withdrawal by Subject|11
5236086|NCT00849290|18070168|P1|Overall Study|Death|14
5236087|NCT00849290|18070168|P1|Overall Study|Adverse Event|3
5236088|NCT00849212|18070179|P1|Overall Study|Miscellaneous|1
5236089|NCT00849212|18070179|P1|Overall Study|Adverse Event|2
5236090|NCT00849212|18070179|P1|Overall Study|Withdrawal by Subject|3
5236091|NCT00849212|18070179|P1|Overall Study|Lack of Efficacy|1
5236092|NCT00849186|18070184|P1|Overall Study|Other|1
5236093|NCT00849186|18070184|P1|Overall Study|not treated|6
5236094|NCT00849186|18070184|P1|Overall Study|Withdrawal by Subject|1
5236095|NCT00849186|18070184|P1|Overall Study|Adverse Event|2
5236096|NCT00849147|18070190|P1|Overall Study|Disease Relapse/Progression|2
5236097|NCT00849147|18070190|P1|Overall Study|Protocol Violation|2
5236098|NCT00849147|18070190|P1|Overall Study|Withdrawal by Subject|1
5236099|NCT00849108|18070223|P2|Cohort 2 Efficacy|Other|9
5236100|NCT00849108|18070224|P1|Cohort 2 Efficacy|Other|0
5236101|NCT00849108|18070223|P2|Cohort 2 Efficacy|Adverse Event|1
5236102|NCT00849108|18070224|P1|Cohort 2 Efficacy|Adverse Event|0
5236103|NCT00849108|18070223|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
5236104|NCT00849108|18070224|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
5236105|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
5236106|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
5236107|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
5236108|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
5236109|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
5236110|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
5236111|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
5236112|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
5236113|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
5236114|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
5236115|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
5236116|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
5236117|NCT00849056|18070234|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
5236118|NCT00849056|18070235|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
5236119|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
5236120|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
5236121|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
5236122|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
5236123|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
5236124|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
5236125|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
5236126|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
5236127|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
5236128|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
5236129|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
5236130|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
5236131|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
5236132|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
5236133|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
5236134|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
5236135|NCT00849056|18070234|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
5236136|NCT00849056|18070235|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
5236137|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
5236138|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
5236139|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
5236140|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
5236141|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
5236142|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
5236143|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Physician Decision|1
5236144|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Physician Decision|1
5236145|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Physician Decision|0
5236146|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
5236147|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
5236148|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
5236149|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
5236150|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
5236151|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
5236152|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
5236153|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
5236154|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
5236155|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Noncompliance|0
5236156|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Noncompliance|1
5236157|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5236158|NCT00849017|18070260|P3|Follow-up Period (8 Weeks)|Adverse Event|0
5236159|NCT00849017|18070261|P2|Follow-up Period (8 Weeks)|Adverse Event|0
5236160|NCT00849017|18070262|P1|Follow-up Period (8 Weeks)|Adverse Event|1
5236161|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
5236162|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
5236163|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
5236164|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Pregnancy|1
5236165|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Pregnancy|0
5236166|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Pregnancy|1
5236167|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
5236168|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
5236169|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
5236170|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
5236171|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
5236172|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
5236173|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
5236174|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
5236175|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
5236176|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
5236177|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
5236178|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
5236179|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Physician Decision|1
5236180|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Physician Decision|2
5236181|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Physician Decision|0
5236182|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
5236183|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
5236184|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
5236185|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
5236186|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
5236187|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
5236188|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Noncompliance|4
5236189|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Noncompliance|3
5236190|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Noncompliance|3
5236191|NCT00849017|18070260|P3|Treatment Period (156 Weeks)|Adverse Event|15
5236192|NCT00849017|18070261|P2|Treatment Period (156 Weeks)|Adverse Event|6
5236193|NCT00849017|18070262|P1|Treatment Period (156 Weeks)|Adverse Event|5
5236194|NCT00848965|18070305|P1|Overall Study|Withdrawal by Subject|1
5236195|NCT00848965|18070305|P1|Overall Study|Adverse Event|1
5236196|NCT00848926|18070347|P1|Follow-up Period|Other|2
5236197|NCT00848926|18070347|P1|Follow-up Period|Withdrawal by Subject|3
5236198|NCT00848926|18070347|P1|Follow-up Period|Lost to Follow-up|7
5236199|NCT00848926|18070347|P1|Treatment Period|Withdrawal by Subject|7
5236200|NCT00848926|18070347|P1|Treatment Period|Physician Decision|12
5236201|NCT00848926|18070347|P1|Treatment Period|Adverse Event|20
5236202|NCT00848926|18070347|P1|Treatment Period|Progressive disease|45
5236203|NCT00848718|18070397|P13|Overall Study|Progressive disease during treatment|2
5236204|NCT00848718|18070398|P12|Overall Study|Progressive disease during treatment|0
5236205|NCT00848718|18070399|P11|Overall Study|Progressive disease during treatment|0
5236206|NCT00848718|18070400|P10|Overall Study|Progressive disease during treatment|0
5236207|NCT00848718|18070401|P9|Overall Study|Progressive disease during treatment|0
5236208|NCT00848718|18070402|P8|Overall Study|Progressive disease during treatment|2
5236209|NCT00848718|18070403|P7|Overall Study|Progressive disease during treatment|0
5236210|NCT00848718|18070404|P6|Overall Study|Progressive disease during treatment|0
5236211|NCT00848718|18070405|P5|Overall Study|Progressive disease during treatment|0
5236212|NCT00848718|18070406|P4|Overall Study|Progressive disease during treatment|0
5236213|NCT00848718|18070407|P3|Overall Study|Progressive disease during treatment|3
5236214|NCT00848718|18070408|P2|Overall Study|Progressive disease during treatment|0
5236215|NCT00848718|18070409|P1|Overall Study|Progressive disease during treatment|3
5236216|NCT00848718|18070397|P13|Overall Study|Withdrawal by Subject|0
5236217|NCT00848718|18070398|P12|Overall Study|Withdrawal by Subject|0
5236218|NCT00848718|18070399|P11|Overall Study|Withdrawal by Subject|1
5236219|NCT00848718|18070400|P10|Overall Study|Withdrawal by Subject|0
5236220|NCT00848718|18070401|P9|Overall Study|Withdrawal by Subject|0
5236221|NCT00848718|18070402|P8|Overall Study|Withdrawal by Subject|0
5236222|NCT00848718|18070403|P7|Overall Study|Withdrawal by Subject|0
5236223|NCT00848718|18070404|P6|Overall Study|Withdrawal by Subject|0
5236224|NCT00848718|18070405|P5|Overall Study|Withdrawal by Subject|0
5236225|NCT00848718|18070406|P4|Overall Study|Withdrawal by Subject|1
5236226|NCT00848718|18070407|P3|Overall Study|Withdrawal by Subject|0
5236227|NCT00848718|18070408|P2|Overall Study|Withdrawal by Subject|0
5236228|NCT00848718|18070409|P1|Overall Study|Withdrawal by Subject|1
5236229|NCT00848718|18070397|P13|Overall Study|Protocol Violation|1
5236230|NCT00848718|18070398|P12|Overall Study|Protocol Violation|0
5236231|NCT00848718|18070399|P11|Overall Study|Protocol Violation|0
5236232|NCT00848718|18070400|P10|Overall Study|Protocol Violation|0
5236233|NCT00848718|18070401|P9|Overall Study|Protocol Violation|0
5236234|NCT00848718|18070402|P8|Overall Study|Protocol Violation|1
5236235|NCT00848718|18070403|P7|Overall Study|Protocol Violation|0
5236236|NCT00848718|18070404|P6|Overall Study|Protocol Violation|0
5236237|NCT00848718|18070405|P5|Overall Study|Protocol Violation|0
5236238|NCT00848718|18070406|P4|Overall Study|Protocol Violation|0
5236239|NCT00848718|18070407|P3|Overall Study|Protocol Violation|0
5236240|NCT00848718|18070408|P2|Overall Study|Protocol Violation|1
5236241|NCT00848718|18070409|P1|Overall Study|Protocol Violation|0
5236242|NCT00848718|18070397|P13|Overall Study|Progressive disease before treatment|2
5236243|NCT00848718|18070398|P12|Overall Study|Progressive disease before treatment|6
5236244|NCT00848718|18070399|P11|Overall Study|Progressive disease before treatment|3
5236245|NCT00848718|18070400|P10|Overall Study|Progressive disease before treatment|7
5236246|NCT00848718|18070401|P9|Overall Study|Progressive disease before treatment|2
5236247|NCT00848718|18070402|P8|Overall Study|Progressive disease before treatment|1
5236248|NCT00848718|18070403|P7|Overall Study|Progressive disease before treatment|2
5236249|NCT00848718|18070404|P6|Overall Study|Progressive disease before treatment|4
5236250|NCT00848718|18070405|P5|Overall Study|Progressive disease before treatment|4
5236251|NCT00848718|18070406|P4|Overall Study|Progressive disease before treatment|3
5236252|NCT00848718|18070407|P3|Overall Study|Progressive disease before treatment|1
5236253|NCT00848718|18070408|P2|Overall Study|Progressive disease before treatment|5
5236254|NCT00848718|18070409|P1|Overall Study|Progressive disease before treatment|1
5236255|NCT00848718|18070397|P13|Overall Study|Physician Decision|1
5236256|NCT00848718|18070398|P12|Overall Study|Physician Decision|0
5236257|NCT00848718|18070399|P11|Overall Study|Physician Decision|0
5236258|NCT00848718|18070400|P10|Overall Study|Physician Decision|2
5236259|NCT00848718|18070401|P9|Overall Study|Physician Decision|1
5236260|NCT00848718|18070402|P8|Overall Study|Physician Decision|0
5236261|NCT00848718|18070403|P7|Overall Study|Physician Decision|0
5236262|NCT00848718|18070404|P6|Overall Study|Physician Decision|1
5236263|NCT00848718|18070405|P5|Overall Study|Physician Decision|1
5236264|NCT00848718|18070406|P4|Overall Study|Physician Decision|0
5236265|NCT00848718|18070407|P3|Overall Study|Physician Decision|0
5236266|NCT00848718|18070408|P2|Overall Study|Physician Decision|1
5236267|NCT00848718|18070409|P1|Overall Study|Physician Decision|0
5236268|NCT00848718|18070397|P13|Overall Study|Lack of Efficacy|0
5236269|NCT00848718|18070398|P12|Overall Study|Lack of Efficacy|0
5236270|NCT00848718|18070399|P11|Overall Study|Lack of Efficacy|0
5236271|NCT00848718|18070400|P10|Overall Study|Lack of Efficacy|0
5236272|NCT00848718|18070401|P9|Overall Study|Lack of Efficacy|0
5236273|NCT00848718|18070402|P8|Overall Study|Lack of Efficacy|0
5236274|NCT00848718|18070403|P7|Overall Study|Lack of Efficacy|1
5236275|NCT00848718|18070404|P6|Overall Study|Lack of Efficacy|0
5236276|NCT00848718|18070405|P5|Overall Study|Lack of Efficacy|0
5236277|NCT00848718|18070406|P4|Overall Study|Lack of Efficacy|0
5236278|NCT00848718|18070407|P3|Overall Study|Lack of Efficacy|1
5236279|NCT00848718|18070408|P2|Overall Study|Lack of Efficacy|0
5236280|NCT00848718|18070409|P1|Overall Study|Lack of Efficacy|0
5236281|NCT00848718|18070397|P13|Overall Study|Adverse Event|2
5236282|NCT00848718|18070398|P12|Overall Study|Adverse Event|0
5236283|NCT00848718|18070399|P11|Overall Study|Adverse Event|0
5236284|NCT00848718|18070400|P10|Overall Study|Adverse Event|0
5236285|NCT00848718|18070401|P9|Overall Study|Adverse Event|1
5236286|NCT00848718|18070402|P8|Overall Study|Adverse Event|1
5236287|NCT00848718|18070403|P7|Overall Study|Adverse Event|0
5236288|NCT00848718|18070404|P6|Overall Study|Adverse Event|0
5236289|NCT00848718|18070405|P5|Overall Study|Adverse Event|1
5236290|NCT00848718|18070406|P4|Overall Study|Adverse Event|1
5236291|NCT00848718|18070407|P3|Overall Study|Adverse Event|1
5236292|NCT00848718|18070408|P2|Overall Study|Adverse Event|2
5236293|NCT00848718|18070409|P1|Overall Study|Adverse Event|2
5236294|NCT00848549|18070510|P2|E2090-E044-314 (Extension Study)|Other|6
5236295|NCT00848549|18070511|P1|E2090-E044-314 (Extension Study)|Other|5
5236296|NCT00848549|18070510|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
5236297|NCT00848549|18070511|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
5236298|NCT00848549|18070510|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
5236299|NCT00848549|18070511|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
5236300|NCT00848549|18070510|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
5236301|NCT00848549|18070511|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
5236302|NCT00848549|18070510|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
5236303|NCT00848549|18070511|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
5236304|NCT00848549|18070510|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
5236305|NCT00848549|18070511|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
5236306|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
5236307|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
5236308|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Other|3
5236309|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Other|4
5236310|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
5236311|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
5236312|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
5236313|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
5236314|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
5236315|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
5236316|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
5236317|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
5236318|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
5236319|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
5236320|NCT00848549|18070510|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
5236321|NCT00848549|18070511|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
5236322|NCT00848536|18070529|P2|Overall Study|Patient Moved|2
5236323|NCT00848536|18070530|P1|Overall Study|Patient Moved|0
5236324|NCT00848536|18070529|P2|Overall Study|Inadequate Control of IOP|1
5236325|NCT00848536|18070530|P1|Overall Study|Inadequate Control of IOP|1
5236326|NCT00848536|18070529|P2|Overall Study|Noncompliance|0
5236327|NCT00848536|18070530|P1|Overall Study|Noncompliance|1
5236328|NCT00848536|18070529|P2|Overall Study|Protocol Violation|1
5236329|NCT00848536|18070530|P1|Overall Study|Protocol Violation|0
5236330|NCT00848536|18070529|P2|Overall Study|Withdrawal by Subject|1
5236331|NCT00848536|18070530|P1|Overall Study|Withdrawal by Subject|0
5236332|NCT00848536|18070529|P2|Overall Study|Adverse Event|2
5236333|NCT00848536|18070530|P1|Overall Study|Adverse Event|2
5236334|NCT00848497|18070595|P2|Overall Study|Withdrawal by Subject|1
5236335|NCT00848497|18070596|P1|Overall Study|Withdrawal by Subject|0
5236336|NCT00848497|18070595|P2|Overall Study|Screen failure|0
5236337|NCT00848497|18070596|P1|Overall Study|Screen failure|2
5236338|NCT00848484|18070610|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
5236339|NCT00848484|18070611|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
5236340|NCT00848484|18070610|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
5236341|NCT00848484|18070611|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
5236342|NCT00848484|18070610|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
5236343|NCT00848484|18070611|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
5236344|NCT00848484|18070610|P2|First Intervention (Treatment Period 1)|Physician Decision|1
5236345|NCT00848484|18070611|P1|First Intervention (Treatment Period 1)|Physician Decision|0
5236346|NCT00848484|18070610|P2|First Intervention (Treatment Period 1)|Adverse Event|1
5236347|NCT00848484|18070611|P1|First Intervention (Treatment Period 1)|Adverse Event|2
5236348|NCT00848393|18070630|P3|Overall Study|surgical complications unrelated to stud|2
5236349|NCT00848393|18070631|P2|Overall Study|surgical complications unrelated to stud|0
5236350|NCT00848393|18070632|P1|Overall Study|surgical complications unrelated to stud|0
5236351|NCT00848393|18070630|P3|Overall Study|Protocol Violation|1
5236352|NCT00848393|18070631|P2|Overall Study|Protocol Violation|0
5236353|NCT00848393|18070632|P1|Overall Study|Protocol Violation|0
5236354|NCT00848354|18070671|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
5236355|NCT00848354|18070672|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
5236356|NCT00848354|18070671|P2|Phase 2 Year 2|Subject Request|1
5236357|NCT00848354|18070672|P1|Phase 2 Year 2|Subject Request|1
5236358|NCT00848354|18070671|P2|Phase 2 Year 2|Protocol Violation|1
5236359|NCT00848354|18070672|P1|Phase 2 Year 2|Protocol Violation|1
5236360|NCT00848354|18070671|P2|Phase 2 Year 2|Unspecified Reason|0
5236361|NCT00848354|18070672|P1|Phase 2 Year 2|Unspecified Reason|1
5236362|NCT00848354|18070671|P2|Phase 2 Year 2|Lost to Follow-up|3
5236363|NCT00848354|18070672|P1|Phase 2 Year 2|Lost to Follow-up|1
5236364|NCT00848354|18070671|P2|Phase 2 Year 2|Failed to return|0
5236365|NCT00848354|18070672|P1|Phase 2 Year 2|Failed to return|3
5236366|NCT00848354|18070671|P2|Phase 2 Year 2|Death|0
5236367|NCT00848354|18070672|P1|Phase 2 Year 2|Death|2
5236368|NCT00848354|18070671|P2|Phase 2 Year 2|Adverse Event|2
5236369|NCT00848354|18070672|P1|Phase 2 Year 2|Adverse Event|12
5236370|NCT00848354|18070671|P2|Phase 2 Year 1|Subject Request|2
5236371|NCT00848354|18070672|P1|Phase 2 Year 1|Subject Request|1
5236372|NCT00848354|18070671|P2|Phase 2 Year 1|Protocol Violation|1
5236373|NCT00848354|18070672|P1|Phase 2 Year 1|Protocol Violation|4
5236374|NCT00848354|18070671|P2|Phase 2 Year 1|Unspecified Reason|0
5236375|NCT00848354|18070672|P1|Phase 2 Year 1|Unspecified Reason|3
5236376|NCT00848354|18070671|P2|Phase 2 Year 1|Lost to Follow-up|0
5236377|NCT00848354|18070672|P1|Phase 2 Year 1|Lost to Follow-up|1
5236378|NCT00848354|18070671|P2|Phase 2 Year 1|Failed to Return|1
5236379|NCT00848354|18070672|P1|Phase 2 Year 1|Failed to Return|1
5236380|NCT00848354|18070671|P2|Phase 2 Year 1|Death|0
5236381|NCT00848354|18070672|P1|Phase 2 Year 1|Death|1
5236382|NCT00848354|18070671|P2|Phase 2 Year 1|Adverse Event|2
5236383|NCT00848354|18070672|P1|Phase 2 Year 1|Adverse Event|7
5236384|NCT00848354|18070671|P2|Phase 1|Lack of Efficacy|1
5236385|NCT00848354|18070672|P1|Phase 1|Lack of Efficacy|0
5236386|NCT00848354|18070671|P2|Phase 1|Withdrawal by Subject|4
5236387|NCT00848354|18070672|P1|Phase 1|Withdrawal by Subject|2
5236388|NCT00848354|18070671|P2|Phase 1|Protocol Violation|1
5236389|NCT00848354|18070672|P1|Phase 1|Protocol Violation|1
5236390|NCT00848354|18070671|P2|Phase 1|Unspecified Reason|1
5236391|NCT00848354|18070672|P1|Phase 1|Unspecified Reason|1
5236392|NCT00848354|18070671|P2|Phase 1|Lost to Follow-up|1
5236393|NCT00848354|18070672|P1|Phase 1|Lost to Follow-up|1
5236394|NCT00848354|18070671|P2|Phase 1|Failed to return|1
5236395|NCT00848354|18070672|P1|Phase 1|Failed to return|0
5236396|NCT00848354|18070671|P2|Phase 1|Discontinuation of study by sponsor|1
5236397|NCT00848354|18070672|P1|Phase 1|Discontinuation of study by sponsor|2
5236398|NCT00848354|18070671|P2|Phase 1|Adverse Event|4
5236399|NCT00848354|18070672|P1|Phase 1|Adverse Event|5
5236400|NCT00848250|18070824|P2|Overall Study|surgery was completed without cardiopulm|1
5236401|NCT00848250|18070825|P1|Overall Study|surgery was completed without cardiopulm|0
5236402|NCT00848211|18070856|P4|Overall Study|Adverse Event|0
5236403|NCT00848211|18070857|P3|Overall Study|Adverse Event|0
5236404|NCT00848211|18070858|P2|Overall Study|Adverse Event|0
5236405|NCT00848211|18070859|P1|Overall Study|Adverse Event|0
5236406|NCT00848211|18070856|P4|Overall Study|Protocol Violation|0
5236407|NCT00848211|18070857|P3|Overall Study|Protocol Violation|1
5236408|NCT00848211|18070858|P2|Overall Study|Protocol Violation|1
5236409|NCT00848211|18070859|P1|Overall Study|Protocol Violation|0
5236410|NCT00848198|18070877|P1|Overall Study|Incomplete Case Report Forms|15
5236411|NCT00848120|18070942|P1|Overall Study|Adverse Event|1
5236412|NCT00848107|18070954|P1|Overall Study|Pregnancy|1
5236413|NCT00848107|18070954|P1|Overall Study|Death|1
5236414|NCT00848107|18070954|P1|Overall Study|Adverse Event|9
5236415|NCT00848107|18070954|P1|Overall Study|Withdrawal by Subject|8
5236416|NCT00848107|18070954|P1|Overall Study|Lost to Follow-up|2
5236417|NCT00848081|18070964|P2|Overall Study|Withdrawal by Subject|3
5236418|NCT00848081|18070965|P1|Overall Study|Withdrawal by Subject|5
5236419|NCT00848081|18070964|P2|Overall Study|Physician Decision|3
5236420|NCT00848081|18070965|P1|Overall Study|Physician Decision|0
5236421|NCT00848081|18070964|P2|Overall Study|Lost to Follow-up|0
5236422|NCT00848081|18070965|P1|Overall Study|Lost to Follow-up|1
5236423|NCT00848081|18070964|P2|Overall Study|Protocol Violation|5
5236424|NCT00848081|18070965|P1|Overall Study|Protocol Violation|8
5236425|NCT00848081|18070964|P2|Overall Study|Adverse Event|7
5236426|NCT00848081|18070965|P1|Overall Study|Adverse Event|6
5236427|NCT00848042|18070982|P3|Overall Study|Other Therapy|0
5236428|NCT00848042|18070983|P2|Overall Study|Other Therapy|0
5236429|NCT00848042|18070984|P1|Overall Study|Other Therapy|3
5236430|NCT00848042|18070982|P3|Overall Study|Death|0
5236431|NCT00848042|18070983|P2|Overall Study|Death|2
5236432|NCT00848042|18070984|P1|Overall Study|Death|1
5236433|NCT00847912|18071020|P2|Overall Study|Withdrawal by Subject|6
5236434|NCT00847912|18071021|P1|Overall Study|Withdrawal by Subject|3
5236435|NCT00847912|18071020|P2|Overall Study|Protocol Violation|7
5236436|NCT00847912|18071021|P1|Overall Study|Protocol Violation|6
5236437|NCT00847886|18071031|P2|Overall Study|Adverse Event|1
5236438|NCT00847886|18071032|P1|Overall Study|Adverse Event|0
5236439|NCT00847808|18071058|P1|Overall Study|Participant Took Excluded Medication|1
5236440|NCT00847808|18071058|P1|Overall Study|Participant Reported Lack of Efficacy|1
5236441|NCT00847808|18071058|P1|Overall Study|Withdrawal by Subject|4
5236442|NCT00847808|18071058|P1|Overall Study|Lost to Follow-up|1
5236443|NCT00847808|18071058|P1|Overall Study|Protocol Violation|1
5236444|NCT00847808|18071058|P1|Overall Study|Adverse Event|7
5236445|NCT00847730|18071075|P1|Overall Study|Multiple interruptions in therapy|8
5236446|NCT00847704|18071079|P1|Overall Study|Withdrawal by Subject|1
5236447|NCT00847665|18071090|P2|Overall Study|Withdrawal by Subject|0
5236448|NCT00847665|18071091|P1|Overall Study|Withdrawal by Subject|1
5236449|NCT00847626|18071114|P11|Overall Study|Other|3
5236450|NCT00847626|18071115|P10|Overall Study|Other|1
5236451|NCT00847626|18071116|P9|Overall Study|Other|1
5236452|NCT00847626|18071117|P8|Overall Study|Other|3
5236453|NCT00847626|18071118|P7|Overall Study|Other|2
5236454|NCT00847626|18071119|P6|Overall Study|Other|2
5236455|NCT00847626|18071120|P5|Overall Study|Other|2
5236456|NCT00847626|18071121|P4|Overall Study|Other|1
5236457|NCT00847626|18071122|P3|Overall Study|Other|4
5236458|NCT00847626|18071123|P2|Overall Study|Other|5
5236459|NCT00847626|18071124|P1|Overall Study|Other|1
5236460|NCT00847626|18071114|P11|Overall Study|Lack of Efficacy|7
5236461|NCT00847626|18071115|P10|Overall Study|Lack of Efficacy|1
5236462|NCT00847626|18071116|P9|Overall Study|Lack of Efficacy|5
5236463|NCT00847626|18071117|P8|Overall Study|Lack of Efficacy|2
5236464|NCT00847626|18071118|P7|Overall Study|Lack of Efficacy|6
5236465|NCT00847626|18071119|P6|Overall Study|Lack of Efficacy|0
5236466|NCT00847626|18071120|P5|Overall Study|Lack of Efficacy|2
5236467|NCT00847626|18071121|P4|Overall Study|Lack of Efficacy|1
5236468|NCT00847626|18071122|P3|Overall Study|Lack of Efficacy|0
5236469|NCT00847626|18071123|P2|Overall Study|Lack of Efficacy|1
5236470|NCT00847626|18071124|P1|Overall Study|Lack of Efficacy|3
5236471|NCT00847626|18071114|P11|Overall Study|Withdrawal by Subject|2
5236472|NCT00847626|18071115|P10|Overall Study|Withdrawal by Subject|5
5236473|NCT00847626|18071116|P9|Overall Study|Withdrawal by Subject|4
5236474|NCT00847626|18071117|P8|Overall Study|Withdrawal by Subject|4
5236475|NCT00847626|18071118|P7|Overall Study|Withdrawal by Subject|8
5236476|NCT00847626|18071119|P6|Overall Study|Withdrawal by Subject|9
5236477|NCT00847626|18071120|P5|Overall Study|Withdrawal by Subject|12
5236478|NCT00847626|18071121|P4|Overall Study|Withdrawal by Subject|8
5236479|NCT00847626|18071122|P3|Overall Study|Withdrawal by Subject|3
5236480|NCT00847626|18071123|P2|Overall Study|Withdrawal by Subject|5
5236481|NCT00847626|18071124|P1|Overall Study|Withdrawal by Subject|5
5236482|NCT00847626|18071114|P11|Overall Study|Lost to Follow-up|1
5236483|NCT00847626|18071115|P10|Overall Study|Lost to Follow-up|0
5236484|NCT00847626|18071116|P9|Overall Study|Lost to Follow-up|1
5236485|NCT00847626|18071117|P8|Overall Study|Lost to Follow-up|3
5236486|NCT00847626|18071118|P7|Overall Study|Lost to Follow-up|1
5236487|NCT00847626|18071119|P6|Overall Study|Lost to Follow-up|3
5236488|NCT00847626|18071120|P5|Overall Study|Lost to Follow-up|0
5236489|NCT00847626|18071121|P4|Overall Study|Lost to Follow-up|1
5236490|NCT00847626|18071122|P3|Overall Study|Lost to Follow-up|1
5236491|NCT00847626|18071123|P2|Overall Study|Lost to Follow-up|1
5236492|NCT00847626|18071124|P1|Overall Study|Lost to Follow-up|0
5236493|NCT00847626|18071114|P11|Overall Study|Protocol Violation|1
5236494|NCT00847626|18071115|P10|Overall Study|Protocol Violation|1
5236495|NCT00847626|18071116|P9|Overall Study|Protocol Violation|0
5236496|NCT00847626|18071117|P8|Overall Study|Protocol Violation|1
5236497|NCT00847626|18071118|P7|Overall Study|Protocol Violation|1
5236498|NCT00847626|18071119|P6|Overall Study|Protocol Violation|1
5236499|NCT00847626|18071120|P5|Overall Study|Protocol Violation|1
5236500|NCT00847626|18071121|P4|Overall Study|Protocol Violation|1
5236501|NCT00847626|18071122|P3|Overall Study|Protocol Violation|2
5236502|NCT00847626|18071123|P2|Overall Study|Protocol Violation|1
5236503|NCT00847626|18071124|P1|Overall Study|Protocol Violation|2
5236504|NCT00847626|18071114|P11|Overall Study|Adverse Event|6
5236505|NCT00847626|18071115|P10|Overall Study|Adverse Event|6
5236506|NCT00847626|18071116|P9|Overall Study|Adverse Event|3
5236507|NCT00847626|18071117|P8|Overall Study|Adverse Event|6
5236508|NCT00847626|18071118|P7|Overall Study|Adverse Event|4
5236509|NCT00847626|18071119|P6|Overall Study|Adverse Event|22
5236510|NCT00847626|18071120|P5|Overall Study|Adverse Event|11
5236511|NCT00847626|18071121|P4|Overall Study|Adverse Event|19
5236512|NCT00847626|18071122|P3|Overall Study|Adverse Event|6
5236513|NCT00847626|18071123|P2|Overall Study|Adverse Event|10
5236514|NCT00847626|18071124|P1|Overall Study|Adverse Event|10
5236515|NCT00847613|18071323|P4|Overall Study|Other|0
5236516|NCT00847613|18071324|P3|Overall Study|Other|2
5236517|NCT00847613|18071325|P2|Overall Study|Other|1
5236518|NCT00847613|18071326|P1|Overall Study|Other|1
5236519|NCT00847613|18071323|P4|Overall Study|Randomized, but not treated|0
5236520|NCT00847613|18071324|P3|Overall Study|Randomized, but not treated|0
5236521|NCT00847613|18071325|P2|Overall Study|Randomized, but not treated|3
5236522|NCT00847613|18071326|P1|Overall Study|Randomized, but not treated|0
5236523|NCT00847613|18071323|P4|Overall Study|Sponsor request|0
5236524|NCT00847613|18071324|P3|Overall Study|Sponsor request|0
5236525|NCT00847613|18071325|P2|Overall Study|Sponsor request|1
5236526|NCT00847613|18071326|P1|Overall Study|Sponsor request|0
5236527|NCT00847613|18071323|P4|Overall Study|Participant moved|0
5236528|NCT00847613|18071324|P3|Overall Study|Participant moved|0
5236529|NCT00847613|18071325|P2|Overall Study|Participant moved|1
5236530|NCT00847613|18071326|P1|Overall Study|Participant moved|4
5236531|NCT00847613|18071323|P4|Overall Study|Withdrawal by Subject|2
5236532|NCT00847613|18071324|P3|Overall Study|Withdrawal by Subject|2
5236533|NCT00847613|18071325|P2|Overall Study|Withdrawal by Subject|11
5236534|NCT00847613|18071326|P1|Overall Study|Withdrawal by Subject|8
5236535|NCT00847613|18071323|P4|Overall Study|Site closure|1
5236536|NCT00847613|18071324|P3|Overall Study|Site closure|0
5236537|NCT00847613|18071325|P2|Overall Study|Site closure|0
5236538|NCT00847613|18071326|P1|Overall Study|Site closure|1
5236539|NCT00847613|18071323|P4|Overall Study|Pregnancy|0
5236540|NCT00847613|18071324|P3|Overall Study|Pregnancy|0
5236541|NCT00847613|18071325|P2|Overall Study|Pregnancy|1
5236542|NCT00847613|18071326|P1|Overall Study|Pregnancy|1
5236543|NCT00847613|18071323|P4|Overall Study|Protocol Violation|1
5236544|NCT00847613|18071324|P3|Overall Study|Protocol Violation|3
5236545|NCT00847613|18071325|P2|Overall Study|Protocol Violation|6
5236546|NCT00847613|18071326|P1|Overall Study|Protocol Violation|6
5236547|NCT00847613|18071323|P4|Overall Study|Lost to Follow-up|3
5236548|NCT00847613|18071324|P3|Overall Study|Lost to Follow-up|0
5236549|NCT00847613|18071325|P2|Overall Study|Lost to Follow-up|0
5236550|NCT00847613|18071326|P1|Overall Study|Lost to Follow-up|5
5236551|NCT00847613|18071323|P4|Overall Study|Study terminated by Sponsor|1
5236552|NCT00847613|18071324|P3|Overall Study|Study terminated by Sponsor|2
5236553|NCT00847613|18071325|P2|Overall Study|Study terminated by Sponsor|0
5236554|NCT00847613|18071326|P1|Overall Study|Study terminated by Sponsor|1
5236555|NCT00847613|18071323|P4|Overall Study|Lack of Efficacy|1
5236556|NCT00847613|18071324|P3|Overall Study|Lack of Efficacy|3
5236557|NCT00847613|18071325|P2|Overall Study|Lack of Efficacy|3
5236558|NCT00847613|18071326|P1|Overall Study|Lack of Efficacy|7
5236559|NCT00847613|18071323|P4|Overall Study|Adverse Event|6
5236560|NCT00847613|18071324|P3|Overall Study|Adverse Event|5
5236561|NCT00847613|18071325|P2|Overall Study|Adverse Event|26
5236562|NCT00847613|18071326|P1|Overall Study|Adverse Event|36
5236563|NCT00847613|18071323|P4|Overall Study|Death|0
5236564|NCT00847613|18071324|P3|Overall Study|Death|0
5236565|NCT00847613|18071325|P2|Overall Study|Death|1
5236566|NCT00847613|18071326|P1|Overall Study|Death|1
5236567|NCT00847613|18071323|P4|Overall Study|Ongoing at cut-off date|64
5236568|NCT00847613|18071324|P3|Overall Study|Ongoing at cut-off date|64
5236569|NCT00847613|18071325|P2|Overall Study|Ongoing at cut-off date|265
5236570|NCT00847613|18071326|P1|Overall Study|Ongoing at cut-off date|250
5236571|NCT00847561|18071577|P2|Overall Study|Unable to schedule|1
5236572|NCT00847561|18071578|P1|Overall Study|Unable to schedule|9
5236573|NCT00847561|18071577|P2|Overall Study|Withdrawal by Subject|3
5236574|NCT00847561|18071578|P1|Overall Study|Withdrawal by Subject|4
5236575|NCT00847535|18071584|P3|Overall Study|Lost to Follow-up|0
5236576|NCT00847535|18071585|P2|Overall Study|Lost to Follow-up|1
5236577|NCT00847535|18071586|P1|Overall Study|Lost to Follow-up|0
5236578|NCT00847535|18071584|P3|Overall Study|Withdrawal by Subject|1
5236579|NCT00847535|18071585|P2|Overall Study|Withdrawal by Subject|1
5236580|NCT00847535|18071586|P1|Overall Study|Withdrawal by Subject|2
5236581|NCT00847405|18071605|P2|Washout of 7 Days|Withdrawal by Subject|0
5236582|NCT00847405|18071606|P1|Washout of 7 Days|Withdrawal by Subject|1
5236583|NCT00847405|18071605|P2|First Intervention|Adverse Event|1
5236584|NCT00847405|18071606|P1|First Intervention|Adverse Event|0
5236585|NCT00847379|18071617|P3|Overall Study|Study terminated by Sponsor|57
5236586|NCT00847379|18071618|P2|Overall Study|Study terminated by Sponsor|57
5236587|NCT00847379|18071619|P1|Overall Study|Study terminated by Sponsor|59
5236588|NCT00847301|18071717|P1|Overall Study|Other reason not defined above|1
5236589|NCT00847301|18071717|P1|Overall Study|No prescription after hospital discharge|1
5236590|NCT00847301|18071717|P1|Overall Study|Lost to Follow-up|1
5236591|NCT00847301|18071717|P1|Overall Study|Switch to other anticoagulants|16
5236592|NCT00847301|18071717|P1|Overall Study|Adverse Event|35
5236593|NCT00847197|18071765|P2|Overall Study|Withdrawal by Subject|1
5236594|NCT00847197|18071766|P1|Overall Study|Withdrawal by Subject|3
5236595|NCT00847197|18071765|P2|Overall Study|Protocol Violation|1
5236596|NCT00847197|18071766|P1|Overall Study|Protocol Violation|0
5236597|NCT00847197|18071765|P2|Overall Study|Adverse Event|3
5236598|NCT00847197|18071766|P1|Overall Study|Adverse Event|21
5236599|NCT00847145|18071790|P8|Overall Study|Protocol Violation|1
5236600|NCT00847145|18071791|P7|Overall Study|Protocol Violation|0
5236601|NCT00847145|18071792|P6|Overall Study|Protocol Violation|0
5236602|NCT00847145|18071793|P5|Overall Study|Protocol Violation|1
5236603|NCT00847145|18071794|P4|Overall Study|Protocol Violation|0
5236604|NCT00847145|18071795|P3|Overall Study|Protocol Violation|3
5236605|NCT00847145|18071796|P2|Overall Study|Protocol Violation|0
5236606|NCT00847145|18071797|P1|Overall Study|Protocol Violation|0
5236607|NCT00847145|18071790|P8|Overall Study|Inappropriate enrollment|0
5236608|NCT00847145|18071791|P7|Overall Study|Inappropriate enrollment|0
5236609|NCT00847145|18071792|P6|Overall Study|Inappropriate enrollment|0
5236610|NCT00847145|18071793|P5|Overall Study|Inappropriate enrollment|1
5236611|NCT00847145|18071794|P4|Overall Study|Inappropriate enrollment|0
5236612|NCT00847145|18071795|P3|Overall Study|Inappropriate enrollment|0
5236613|NCT00847145|18071796|P2|Overall Study|Inappropriate enrollment|0
5236614|NCT00847145|18071797|P1|Overall Study|Inappropriate enrollment|0
5236615|NCT00847145|18071790|P8|Overall Study|Lost to Follow-up|2
5236616|NCT00847145|18071791|P7|Overall Study|Lost to Follow-up|8
5236617|NCT00847145|18071792|P6|Overall Study|Lost to Follow-up|4
5236618|NCT00847145|18071793|P5|Overall Study|Lost to Follow-up|4
5236619|NCT00847145|18071794|P4|Overall Study|Lost to Follow-up|0
5236620|NCT00847145|18071795|P3|Overall Study|Lost to Follow-up|1
5236621|NCT00847145|18071796|P2|Overall Study|Lost to Follow-up|1
5236622|NCT00847145|18071797|P1|Overall Study|Lost to Follow-up|3
5236623|NCT00847145|18071790|P8|Overall Study|Withdrawal by Subject|1
5236624|NCT00847145|18071791|P7|Overall Study|Withdrawal by Subject|1
5236625|NCT00847145|18071792|P6|Overall Study|Withdrawal by Subject|0
5236626|NCT00847145|18071793|P5|Overall Study|Withdrawal by Subject|0
5236627|NCT00847145|18071794|P4|Overall Study|Withdrawal by Subject|1
5236628|NCT00847145|18071795|P3|Overall Study|Withdrawal by Subject|6
5236629|NCT00847145|18071796|P2|Overall Study|Withdrawal by Subject|4
5236630|NCT00847145|18071797|P1|Overall Study|Withdrawal by Subject|3
5236631|NCT00847145|18071790|P8|Overall Study|AE or Death|0
5236632|NCT00847145|18071791|P7|Overall Study|AE or Death|0
5236633|NCT00847145|18071792|P6|Overall Study|AE or Death|0
5236634|NCT00847145|18071793|P5|Overall Study|AE or Death|0
5236635|NCT00847145|18071794|P4|Overall Study|AE or Death|0
5236636|NCT00847145|18071795|P3|Overall Study|AE or Death|1
5236637|NCT00847145|18071796|P2|Overall Study|AE or Death|1
5236638|NCT00847145|18071797|P1|Overall Study|AE or Death|0
5236639|NCT00847132|18071847|P2|Overall Study|Death|1
5236640|NCT00847132|18071848|P1|Overall Study|Death|1
5236641|NCT00847015|18071856|P1|Overall Study|partial cystectomy vs radical cystectomy|1
5236642|NCT00847015|18071856|P1|Overall Study|declined any surgery|1
5236643|NCT00847015|18071856|P1|Overall Study|Withdrawal by Subject|1
5236644|NCT00846846|18071884|P1|Overall Study|Withdrawal by Subject|19
5236645|NCT00846846|18071884|P1|Overall Study|Death|56
5236646|NCT00846807|18071889|P1|Overall Study|Other|60
5236647|NCT00846807|18071889|P1|Overall Study|No prescription after hospital discharge|56
5236648|NCT00846807|18071889|P1|Overall Study|Switch to other anticoagulants|89
5236649|NCT00846807|18071889|P1|Overall Study|Non compliant with European label|7
5236650|NCT00846807|18071889|P1|Overall Study|Withdrawal by Subject|56
5236651|NCT00846807|18071889|P1|Overall Study|Lost to Follow-up|94
5236652|NCT00846807|18071889|P1|Overall Study|Adverse Event|270
5236653|NCT00846768|18071897|P4|Overall Study|Adverse Event|0
5236654|NCT00846768|18071898|P3|Overall Study|Adverse Event|0
5236655|NCT00846768|18071899|P2|Overall Study|Adverse Event|1
5236656|NCT00846768|18071900|P1|Overall Study|Adverse Event|0
5236657|NCT00846742|18071970|P1|Overall Study|Withdrawal by Subject|1
5236658|NCT00846586|18071997|P2|Overall Study|Unsatisfactory therapeutic effect|1
5236659|NCT00846586|18071998|P1|Overall Study|Unsatisfactory therapeutic effect|0
5236660|NCT00846586|18071997|P2|Overall Study|Lost to Follow-up|4
5236661|NCT00846586|18071998|P1|Overall Study|Lost to Follow-up|1
5236662|NCT00846586|18071997|P2|Overall Study|Abnormal test procedure result(s)|0
5236663|NCT00846586|18071998|P1|Overall Study|Abnormal test procedure result(s)|1
5236664|NCT00846586|18071997|P2|Overall Study|Protocol deviation|6
5236665|NCT00846586|18071998|P1|Overall Study|Protocol deviation|2
5236666|NCT00846586|18071997|P2|Overall Study|Death|0
5236667|NCT00846586|18071998|P1|Overall Study|Death|2
5236668|NCT00846586|18071997|P2|Overall Study|Administrative problems|4
5236669|NCT00846586|18071998|P1|Overall Study|Administrative problems|5
5236670|NCT00846586|18071997|P2|Overall Study|Subject withdrew consent|10
5236671|NCT00846586|18071998|P1|Overall Study|Subject withdrew consent|8
5236672|NCT00846586|18071997|P2|Overall Study|Adverse Event|10
5236673|NCT00846586|18071998|P1|Overall Study|Adverse Event|20
5236674|NCT00846521|18072032|P1|Overall Study|Protocol Violation|1
5236675|NCT00846521|18072032|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
5236676|NCT00846521|18072032|P1|Overall Study|Withdrawal by Subject|5
5236677|NCT00846495|18072039|P2|Overall Study|Physician Decision|0
5236678|NCT00846495|18072040|P1|Overall Study|Physician Decision|1
5236679|NCT00846495|18072039|P2|Overall Study|Lack of Efficacy|2
5236680|NCT00846495|18072040|P1|Overall Study|Lack of Efficacy|1
5236681|NCT00846495|18072039|P2|Overall Study|Adverse Event|1
5236682|NCT00846495|18072040|P1|Overall Study|Adverse Event|5
5236683|NCT00846495|18072039|P2|Overall Study|Lost to Follow-up|0
5236684|NCT00846495|18072040|P1|Overall Study|Lost to Follow-up|1
5236685|NCT00846391|18072068|P3|Overall Study|Study Terminated by Sponsor|2
5236686|NCT00846391|18072069|P2|Overall Study|Study Terminated by Sponsor|2
5236687|NCT00846391|18072070|P1|Overall Study|Study Terminated by Sponsor|1
5236688|NCT00846391|18072068|P3|Overall Study|Physician Decision|1
5236689|NCT00846391|18072069|P2|Overall Study|Physician Decision|0
5236690|NCT00846391|18072070|P1|Overall Study|Physician Decision|0
5236691|NCT00846365|18072081|P3|Overall Study|Other|6
5236692|NCT00846365|18072082|P2|Overall Study|Other|1
5236693|NCT00846365|18072083|P1|Overall Study|Other|9
5236694|NCT00846365|18072081|P3|Overall Study|Lack of Efficacy|2
5236695|NCT00846365|18072082|P2|Overall Study|Lack of Efficacy|1
5236696|NCT00846365|18072083|P1|Overall Study|Lack of Efficacy|1
5236697|NCT00846365|18072081|P3|Overall Study|Pregnancy|0
5236698|NCT00846365|18072082|P2|Overall Study|Pregnancy|0
5236699|NCT00846365|18072083|P1|Overall Study|Pregnancy|1
5236700|NCT00846365|18072081|P3|Overall Study|Withdrawal by Subject|9
5236701|NCT00846365|18072082|P2|Overall Study|Withdrawal by Subject|11
5236702|NCT00846365|18072083|P1|Overall Study|Withdrawal by Subject|11
5236703|NCT00846365|18072081|P3|Overall Study|Lost to Follow-up|5
5236704|NCT00846365|18072082|P2|Overall Study|Lost to Follow-up|2
5236705|NCT00846365|18072083|P1|Overall Study|Lost to Follow-up|8
5236706|NCT00846365|18072081|P3|Overall Study|Protocol Violation|0
5236707|NCT00846365|18072082|P2|Overall Study|Protocol Violation|4
5236708|NCT00846365|18072083|P1|Overall Study|Protocol Violation|5
5236709|NCT00846365|18072081|P3|Overall Study|Adverse Event|11
5236710|NCT00846365|18072082|P2|Overall Study|Adverse Event|30
5236711|NCT00846365|18072083|P1|Overall Study|Adverse Event|20
5236712|NCT00846053|18072164|P2|Overall Study|Physician Decision|0
5236713|NCT00846053|18072165|P1|Overall Study|Physician Decision|3
5236714|NCT00846027|18072173|P1|Overall Study|Subject Not Treated|7
5236715|NCT00846027|18072173|P1|Overall Study|Protocol Violation|2
5236716|NCT00846027|18072173|P1|Overall Study|Investigator Discretion|29
5236717|NCT00846027|18072173|P1|Overall Study|Patient Decision|7
5236718|NCT00846027|18072173|P1|Overall Study|Toxicity|12
5236719|NCT00846027|18072173|P1|Overall Study|Disease Progression|30
5236720|NCT00846027|18072173|P1|Overall Study|Death|3
5236721|NCT00845897|18072196|P3|Overall Study|Too ill to participate|0
5236722|NCT00845897|18072197|P2|Overall Study|Too ill to participate|1
5236723|NCT00845897|18072198|P1|Overall Study|Too ill to participate|0
5236724|NCT00845897|18072196|P3|Overall Study|Ulcer did not heal|1
5236725|NCT00845897|18072197|P2|Overall Study|Ulcer did not heal|0
5236726|NCT00845897|18072198|P1|Overall Study|Ulcer did not heal|1
5236727|NCT00845897|18072196|P3|Overall Study|Withdrawal by Subject|2
5236728|NCT00845897|18072197|P2|Overall Study|Withdrawal by Subject|3
5236729|NCT00845897|18072198|P1|Overall Study|Withdrawal by Subject|0
5236730|NCT00845897|18072196|P3|Overall Study|Lost to Follow-up|0
5236731|NCT00845897|18072197|P2|Overall Study|Lost to Follow-up|1
5236732|NCT00845897|18072198|P1|Overall Study|Lost to Follow-up|1
5236733|NCT00845858|18072212|P3|Overall Study|not eligible|2
5236734|NCT00845858|18072213|P2|Overall Study|not eligible|3
5236735|NCT00845858|18072214|P1|Overall Study|not eligible|0
5236736|NCT00845858|18072212|P3|Overall Study|Protocol Violation|1
5236737|NCT00845858|18072213|P2|Overall Study|Protocol Violation|0
5236738|NCT00845858|18072214|P1|Overall Study|Protocol Violation|0
5236739|NCT00845858|18072212|P3|Overall Study|Adverse Event|4
5236740|NCT00845858|18072213|P2|Overall Study|Adverse Event|8
5236741|NCT00845858|18072214|P1|Overall Study|Adverse Event|3
5236742|NCT00845858|18072212|P3|Overall Study|Withdrawal by Subject|1
5236743|NCT00845858|18072213|P2|Overall Study|Withdrawal by Subject|1
5236744|NCT00845858|18072214|P1|Overall Study|Withdrawal by Subject|5
5236745|NCT00845845|18072227|P2|Overall Study|Lost to Follow-up|4
5236746|NCT00845845|18072228|P1|Overall Study|Lost to Follow-up|0
5236747|NCT00845832|18072239|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
5236748|NCT00845832|18072240|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
5236749|NCT00845832|18072241|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
5236750|NCT00845832|18072239|P3|Safety Follow-Up|Withdrawal by Subject|0
5236751|NCT00845832|18072240|P2|Safety Follow-Up|Withdrawal by Subject|0
5236752|NCT00845832|18072241|P1|Safety Follow-Up|Withdrawal by Subject|1
5236753|NCT00845832|18072239|P3|Treatment Period|Protocol Violation|0
5236754|NCT00845832|18072240|P2|Treatment Period|Protocol Violation|1
5236755|NCT00845832|18072241|P1|Treatment Period|Protocol Violation|1
5236756|NCT00845832|18072239|P3|Treatment Period|Adverse Event|0
5236757|NCT00845832|18072240|P2|Treatment Period|Adverse Event|2
5236758|NCT00845832|18072241|P1|Treatment Period|Adverse Event|0
5236759|NCT00845728|18072287|P2|Overall Study|Withdrawal by Subject|108
5236760|NCT00845728|18072288|P1|Overall Study|Withdrawal by Subject|105
5236761|NCT00845728|18072287|P2|Overall Study|Adverse Event|96
5236762|NCT00845728|18072288|P1|Overall Study|Adverse Event|101
5236763|NCT00845728|18072287|P2|Overall Study|Lack of Efficacy|39
5236764|NCT00845728|18072288|P1|Overall Study|Lack of Efficacy|51
5236765|NCT00845728|18072287|P2|Overall Study|Protocol Violation|24
5236766|NCT00845728|18072288|P1|Overall Study|Protocol Violation|36
5236767|NCT00845728|18072287|P2|Overall Study|Administrative Problems|26
5236768|NCT00845728|18072288|P1|Overall Study|Administrative Problems|34
5236769|NCT00845728|18072287|P2|Overall Study|Death|26
5236770|NCT00845728|18072288|P1|Overall Study|Death|24
5236771|NCT00845728|18072287|P2|Overall Study|Lost to Follow-up|13
5236772|NCT00845728|18072288|P1|Overall Study|Lost to Follow-up|22
5236773|NCT00845728|18072287|P2|Overall Study|Abnormal test procedure result (s)|2
5236774|NCT00845728|18072288|P1|Overall Study|Abnormal test procedure result (s)|7
5236775|NCT00845728|18072287|P2|Overall Study|Patient's inability to use the device|6
5236776|NCT00845728|18072288|P1|Overall Study|Patient's inability to use the device|4
5236777|NCT00845728|18072287|P2|Overall Study|Abnormal laboratory value (s)|2
5236778|NCT00845728|18072288|P1|Overall Study|Abnormal laboratory value (s)|2
5236779|NCT00845676|18072302|P1|Overall Study|Adverse Event|1
5236780|NCT00845676|18072302|P1|Overall Study|Virologic breakthrough at week 20|1
5236781|NCT00845650|18072365|P6|Overall Study|Unable to access IV line|0
5236782|NCT00845650|18072366|P5|Overall Study|Unable to access IV line|0
5236783|NCT00845650|18072367|P4|Overall Study|Unable to access IV line|0
5236784|NCT00845650|18072368|P3|Overall Study|Unable to access IV line|0
5236785|NCT00845650|18072369|P2|Overall Study|Unable to access IV line|0
5236786|NCT00845650|18072370|P1|Overall Study|Unable to access IV line|1
5236787|NCT00845650|18072365|P6|Overall Study|Sponsor hold on dosing|1
5236788|NCT00845650|18072366|P5|Overall Study|Sponsor hold on dosing|1
5236789|NCT00845650|18072367|P4|Overall Study|Sponsor hold on dosing|0
5236790|NCT00845650|18072368|P3|Overall Study|Sponsor hold on dosing|0
5236791|NCT00845650|18072369|P2|Overall Study|Sponsor hold on dosing|0
5236792|NCT00845650|18072370|P1|Overall Study|Sponsor hold on dosing|0
5236793|NCT00845650|18072365|P6|Overall Study|Lost to Follow-up|1
5236794|NCT00845650|18072366|P5|Overall Study|Lost to Follow-up|0
5236795|NCT00845650|18072367|P4|Overall Study|Lost to Follow-up|1
5236796|NCT00845650|18072368|P3|Overall Study|Lost to Follow-up|3
5236797|NCT00845650|18072369|P2|Overall Study|Lost to Follow-up|0
5236798|NCT00845650|18072370|P1|Overall Study|Lost to Follow-up|0
5236799|NCT00845650|18072365|P6|Overall Study|Withdrawal by Subject|0
5236800|NCT00845650|18072366|P5|Overall Study|Withdrawal by Subject|2
5236801|NCT00845650|18072367|P4|Overall Study|Withdrawal by Subject|0
5236802|NCT00845650|18072368|P3|Overall Study|Withdrawal by Subject|0
5236803|NCT00845650|18072369|P2|Overall Study|Withdrawal by Subject|0
5236804|NCT00845650|18072370|P1|Overall Study|Withdrawal by Subject|0
5236805|NCT00845520|18072408|P3|Overall Study|Adverse Event|1
5236806|NCT00845520|18072409|P2|Overall Study|Adverse Event|0
5236807|NCT00845520|18072410|P1|Overall Study|Adverse Event|0
5236808|NCT00845520|18072408|P3|Overall Study|Lost to Follow-up|0
5236809|NCT00845520|18072409|P2|Overall Study|Lost to Follow-up|0
5236810|NCT00845520|18072410|P1|Overall Study|Lost to Follow-up|1
5236811|NCT00845520|18072408|P3|Overall Study|Death|0
5236812|NCT00845520|18072409|P2|Overall Study|Death|2
5236813|NCT00845520|18072410|P1|Overall Study|Death|1
5236814|NCT00845429|18072447|P3|Overall Study|Serious adverse event|1
5236815|NCT00845429|18072448|P2|Overall Study|Serious adverse event|0
5236816|NCT00845429|18072449|P1|Overall Study|Serious adverse event|0
5236817|NCT00845429|18072447|P3|Overall Study|Withdrawal by Subject|2
5236818|NCT00845429|18072448|P2|Overall Study|Withdrawal by Subject|2
5236819|NCT00845429|18072449|P1|Overall Study|Withdrawal by Subject|2
5236820|NCT00845429|18072447|P3|Overall Study|Lost to Follow-up|10
5236821|NCT00845429|18072448|P2|Overall Study|Lost to Follow-up|9
5236822|NCT00845429|18072449|P1|Overall Study|Lost to Follow-up|7
5236823|NCT00845429|18072447|P3|Overall Study|Protocol Violation|7
5236824|NCT00845429|18072448|P2|Overall Study|Protocol Violation|4
5236825|NCT00845429|18072449|P1|Overall Study|Protocol Violation|5
5236826|NCT00845182|18072484|P3|Overall Study|Physician Decision|1
5236827|NCT00845182|18072485|P2|Overall Study|Physician Decision|0
5236828|NCT00845182|18072486|P1|Overall Study|Physician Decision|0
5236829|NCT00845182|18072484|P3|Overall Study|Adverse Event|1
5236830|NCT00845182|18072485|P2|Overall Study|Adverse Event|1
5236831|NCT00845182|18072486|P1|Overall Study|Adverse Event|0
5236832|NCT00845182|18072484|P3|Overall Study|Lost to Follow-up|4
5236833|NCT00845182|18072485|P2|Overall Study|Lost to Follow-up|3
5236834|NCT00845182|18072486|P1|Overall Study|Lost to Follow-up|3
5236835|NCT00845065|18072511|P2|Overall Study|Non-Medical Reasons|11
5236836|NCT00845065|18072512|P1|Overall Study|Non-Medical Reasons|1
5236837|NCT00845065|18072511|P2|Overall Study|Lack of Efficacy|21
5236838|NCT00845065|18072512|P1|Overall Study|Lack of Efficacy|43
5236839|NCT00845065|18072511|P2|Overall Study|Adverse Event|23
5236840|NCT00845065|18072512|P1|Overall Study|Adverse Event|3
5236841|NCT00844896|18072580|P2|Overall Study|Parents did not have time to complete|1
5236842|NCT00844896|18072581|P1|Overall Study|Parents did not have time to complete|0
5236843|NCT00844896|18072580|P2|Overall Study|Lost to Follow-up|16
5236844|NCT00844896|18072581|P1|Overall Study|Lost to Follow-up|12
5236845|NCT00844883|18072603|P1|Overall Study|Bridged to resection|1
5236846|NCT00844883|18072603|P1|Overall Study|Bridged to liver transplant|3
5236847|NCT00844857|18072615|P2|Overall Study|Good Clinical Practice Violations|11
5236848|NCT00844857|18072616|P1|Overall Study|Good Clinical Practice Violations|21
5236849|NCT00844857|18072615|P2|Overall Study|Did Not Take Study Drug|1
5236850|NCT00844857|18072616|P1|Overall Study|Did Not Take Study Drug|3
5236851|NCT00844857|18072615|P2|Overall Study|Lost to Follow-up|3
5236852|NCT00844857|18072616|P1|Overall Study|Lost to Follow-up|2
5236853|NCT00844857|18072615|P2|Overall Study|Entry Criteria Not Met|1
5236854|NCT00844857|18072616|P1|Overall Study|Entry Criteria Not Met|0
5236855|NCT00844857|18072615|P2|Overall Study|Clinical Relapse|1
5236856|NCT00844857|18072616|P1|Overall Study|Clinical Relapse|0
5236857|NCT00844857|18072615|P2|Overall Study|Lack of Efficacy|5
5236858|NCT00844857|18072616|P1|Overall Study|Lack of Efficacy|5
5236859|NCT00844857|18072615|P2|Overall Study|Protocol Violation|0
5236860|NCT00844857|18072616|P1|Overall Study|Protocol Violation|6
5236861|NCT00844857|18072615|P2|Overall Study|Withdrawal by Subject|7
5236862|NCT00844857|18072616|P1|Overall Study|Withdrawal by Subject|8
5236863|NCT00844857|18072615|P2|Overall Study|Parent/Caregiver Decision|2
5236864|NCT00844857|18072616|P1|Overall Study|Parent/Caregiver Decision|6
5236865|NCT00844857|18072615|P2|Overall Study|Physician Decision|0
5236866|NCT00844857|18072616|P1|Overall Study|Physician Decision|2
5236867|NCT00844857|18072615|P2|Overall Study|Sponsor Decision|1
5236868|NCT00844857|18072616|P1|Overall Study|Sponsor Decision|1
5236869|NCT00844857|18072615|P2|Overall Study|Adverse Event|5
5236870|NCT00844857|18072616|P1|Overall Study|Adverse Event|24
5236871|NCT00844844|18072660|P1|Post Treatment Period|Withdrawal by Subject|1
5236872|NCT00844844|18072660|P1|Extension Treatment Period|Adverse Event|2
5236873|NCT00844844|18072660|P1|Treatment Period (26 Weeks)|Protocol Violation|1
5236874|NCT00844844|18072660|P1|Treatment Period (26 Weeks)|Adverse Event|1
5236875|NCT00844831|18072674|P1|Overall Study|Physician Decision|1
5236876|NCT00844831|18072674|P1|Overall Study|Adverse Event|1
5236877|NCT00844831|18072674|P1|Overall Study|Withdrawal by Subject|4
5236878|NCT00844805|18072684|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
5236879|NCT00844805|18072685|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
5236880|NCT00844805|18072686|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
5236881|NCT00844805|18072687|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
5236882|NCT00844805|18072684|P4|Follow-Up Phase|Relapse/Recurrence|4
5236883|NCT00844805|18072685|P3|Follow-Up Phase|Relapse/Recurrence|2
5236884|NCT00844805|18072686|P2|Follow-Up Phase|Relapse/Recurrence|0
5236885|NCT00844805|18072687|P1|Follow-Up Phase|Relapse/Recurrence|0
5236886|NCT00844805|18072684|P4|Follow-Up Phase|Noncompliance With Protocol|1
5236887|NCT00844805|18072685|P3|Follow-Up Phase|Noncompliance With Protocol|0
5236888|NCT00844805|18072686|P2|Follow-Up Phase|Noncompliance With Protocol|0
5236889|NCT00844805|18072687|P1|Follow-Up Phase|Noncompliance With Protocol|0
5236890|NCT00844805|18072684|P4|Follow-Up Phase|Withdrawal by Subject|3
5236891|NCT00844805|18072685|P3|Follow-Up Phase|Withdrawal by Subject|6
5236892|NCT00844805|18072686|P2|Follow-Up Phase|Withdrawal by Subject|0
5236893|NCT00844805|18072687|P1|Follow-Up Phase|Withdrawal by Subject|0
5236894|NCT00844805|18072684|P4|Follow-Up Phase|Adverse Event|0
5236895|NCT00844805|18072685|P3|Follow-Up Phase|Adverse Event|1
5236896|NCT00844805|18072686|P2|Follow-Up Phase|Adverse Event|0
5236897|NCT00844805|18072687|P1|Follow-Up Phase|Adverse Event|0
5236898|NCT00844805|18072684|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
5236899|NCT00844805|18072685|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
5236900|NCT00844805|18072686|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
5236901|NCT00844805|18072687|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
5236902|NCT00844805|18072684|P4|Treatment Phase|Noncompliance With Protocol|0
5236903|NCT00844805|18072685|P3|Treatment Phase|Noncompliance With Protocol|0
5236904|NCT00844805|18072686|P2|Treatment Phase|Noncompliance With Protocol|0
5236905|NCT00844805|18072687|P1|Treatment Phase|Noncompliance With Protocol|1
5236906|NCT00844805|18072684|P4|Treatment Phase|Withdrawal by Subject|0
5236907|NCT00844805|18072685|P3|Treatment Phase|Withdrawal by Subject|0
5236908|NCT00844805|18072686|P2|Treatment Phase|Withdrawal by Subject|4
5236909|NCT00844805|18072687|P1|Treatment Phase|Withdrawal by Subject|3
5236910|NCT00844805|18072684|P4|Treatment Phase|Adverse Event|0
5236911|NCT00844805|18072685|P3|Treatment Phase|Adverse Event|0
5236912|NCT00844805|18072686|P2|Treatment Phase|Adverse Event|1
5236913|NCT00844805|18072687|P1|Treatment Phase|Adverse Event|5
5236914|NCT00844753|18072731|P4|Overall Study|Withdrawal by Subject|3
5236915|NCT00844753|18072732|P3|Overall Study|Withdrawal by Subject|0
5236916|NCT00844753|18072733|P2|Overall Study|Withdrawal by Subject|0
5236917|NCT00844753|18072734|P1|Overall Study|Withdrawal by Subject|1
5236918|NCT00844753|18072731|P4|Overall Study|could not swallow medication|0
5236919|NCT00844753|18072732|P3|Overall Study|could not swallow medication|0
5236920|NCT00844753|18072733|P2|Overall Study|could not swallow medication|0
5236921|NCT00844753|18072734|P1|Overall Study|could not swallow medication|2
5236922|NCT00844753|18072731|P4|Overall Study|Lost to Follow-up|1
5236923|NCT00844753|18072732|P3|Overall Study|Lost to Follow-up|0
5236924|NCT00844753|18072733|P2|Overall Study|Lost to Follow-up|1
5236925|NCT00844753|18072734|P1|Overall Study|Lost to Follow-up|1
5236926|NCT00844753|18072731|P4|Overall Study|Adverse Event|5
5236927|NCT00844753|18072732|P3|Overall Study|Adverse Event|5
5236928|NCT00844753|18072733|P2|Overall Study|Adverse Event|2
5236929|NCT00844753|18072734|P1|Overall Study|Adverse Event|3
5236930|NCT00844753|18072731|P4|Overall Study|Lack of Efficacy|2
5236931|NCT00844753|18072732|P3|Overall Study|Lack of Efficacy|2
5236932|NCT00844753|18072733|P2|Overall Study|Lack of Efficacy|0
5236933|NCT00844753|18072734|P1|Overall Study|Lack of Efficacy|1
5236934|NCT00844649|18072752|P2|Overall Study|Withdrew prior to starting treatment|27
5236935|NCT00844649|18072753|P1|Overall Study|Withdrew prior to starting treatment|11
5236936|NCT00844649|18072752|P2|Overall Study|Other|10
5236937|NCT00844649|18072753|P1|Overall Study|Other|7
5236938|NCT00844649|18072752|P2|Overall Study|Withdrawal by Subject|39
5236939|NCT00844649|18072753|P1|Overall Study|Withdrawal by Subject|28
5236940|NCT00844649|18072752|P2|Overall Study|Protocol Violation|6
5236941|NCT00844649|18072753|P1|Overall Study|Protocol Violation|10
5236942|NCT00844649|18072752|P2|Overall Study|Physician Decision|18
5236943|NCT00844649|18072753|P1|Overall Study|Physician Decision|25
5236944|NCT00844649|18072752|P2|Overall Study|Adverse Event|73
5236945|NCT00844649|18072753|P1|Overall Study|Adverse Event|128
5236946|NCT00844649|18072752|P2|Overall Study|Progressive Disease|245
5236947|NCT00844649|18072753|P1|Overall Study|Progressive Disease|196
5236948|NCT00844597|18072777|P6|Overall Study|Adverse Event|0
5236949|NCT00844597|18072778|P5|Overall Study|Adverse Event|0
5236950|NCT00844597|18072779|P4|Overall Study|Adverse Event|1
5236951|NCT00844597|18072780|P3|Overall Study|Adverse Event|0
5236952|NCT00844597|18072781|P2|Overall Study|Adverse Event|0
5236953|NCT00844597|18072782|P1|Overall Study|Adverse Event|0
5236954|NCT00844558|18072802|P2|Overall Study|Physician Decision|0
5236955|NCT00844558|18072803|P1|Overall Study|Physician Decision|1
5236956|NCT00844558|18072802|P2|Overall Study|Lost to Follow-up|1
5236957|NCT00844558|18072803|P1|Overall Study|Lost to Follow-up|0
5236958|NCT00844558|18072802|P2|Overall Study|Protocol Violation|1
5236959|NCT00844558|18072803|P1|Overall Study|Protocol Violation|1
5236960|NCT00844558|18072802|P2|Overall Study|Death|0
5236961|NCT00844558|18072803|P1|Overall Study|Death|1
5236962|NCT00844558|18072802|P2|Overall Study|Withdrawal by Subject|2
5236963|NCT00844558|18072803|P1|Overall Study|Withdrawal by Subject|9
5236964|NCT00844545|18072819|P1|Post Treatment Period|Withdrawal by Subject|1
5236965|NCT00844545|18072819|P1|Extension Treatment Period|Adverse Event|2
5236966|NCT00844545|18072819|P1|Treatment Period (26 Weeks)|Protocol Violation|1
5236967|NCT00844545|18072819|P1|Treatment Period (26 Weeks)|Adverse Event|1
5236968|NCT00844532|18072833|P1|Overall Study|Lost to Follow-up|7
5236969|NCT00844532|18072833|P1|Overall Study|Withdrawal by Subject|16
5236970|NCT00844532|18072833|P1|Overall Study|Death|16
5236971|NCT00844519|18072919|P2|Overall Study|Adverse Event|0
5236972|NCT00844519|18072920|P1|Overall Study|Adverse Event|1
5236973|NCT00844519|18072919|P2|Overall Study|Withdrawal by Subject|1
5236974|NCT00844519|18072920|P1|Overall Study|Withdrawal by Subject|1
5236975|NCT00844480|18072928|P2|Overall Study|Withdrawal by Subject|3
5236976|NCT00844480|18072929|P1|Overall Study|Withdrawal by Subject|2
5236977|NCT00844428|18072937|P1|Post Treatment Period (Patients Who Disc|Death|1
5236978|NCT00844428|18072937|P1|Extension Treatment Period|Death|1
5236979|NCT00844428|18072937|P1|Screening Period|Screen Failure|3
5236980|NCT00844415|18072953|P1|Overall Study|Withdrawal by Subject|1
5236981|NCT00844376|18072967|P2|Period 1: First Intervention|Withdrawal by Subject|0
5236982|NCT00844376|18072968|P1|Period 1: First Intervention|Withdrawal by Subject|1
5236983|NCT00844194|18072992|P2|Overall Study|Other reason (not specified)|0
5236984|NCT00844194|18072993|P1|Overall Study|Other reason (not specified)|1
5236985|NCT00844194|18072992|P2|Overall Study|Lack of Efficacy|0
5236986|NCT00844194|18072993|P1|Overall Study|Lack of Efficacy|3
5236987|NCT00844194|18072992|P2|Overall Study|Withdrawal by Subject|1
5236988|NCT00844194|18072993|P1|Overall Study|Withdrawal by Subject|2
5236989|NCT00844194|18072992|P2|Overall Study|Lost to Follow-up|1
5236990|NCT00844194|18072993|P1|Overall Study|Lost to Follow-up|1
5236991|NCT00844194|18072992|P2|Overall Study|Protocol Violation|1
5236992|NCT00844194|18072993|P1|Overall Study|Protocol Violation|1
5236993|NCT00844194|18072992|P2|Overall Study|Adverse Event|5
5236994|NCT00844194|18072993|P1|Overall Study|Adverse Event|17
5236995|NCT00843856|18073248|P2|Overall Study|Lost to Follow-up|2
5236996|NCT00843856|18073249|P1|Overall Study|Lost to Follow-up|1
5236997|NCT00843843|18073259|P2|Overall Study|Protocol Violation|1
5236998|NCT00843843|18073260|P1|Overall Study|Protocol Violation|1
5236999|NCT00843843|18073259|P2|Overall Study|Physician Decision|1
5237000|NCT00843843|18073260|P1|Overall Study|Physician Decision|1
5237001|NCT00843778|18073273|P1|Overall Study|Withdrawal by Subject|4
5237002|NCT00843778|18073273|P1|Overall Study|Loss of efficacy|2
5237003|NCT00843778|18073273|P1|Overall Study|Lack of Efficacy|14
5237004|NCT00843778|18073273|P1|Overall Study|Adverse Event|15
5237005|NCT00843635|18073318|P3|Overall Study|Adverse Event|0
5237006|NCT00843635|18073319|P2|Overall Study|Adverse Event|2
5237007|NCT00843635|18073320|P1|Overall Study|Adverse Event|2
5237008|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
5237009|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
5237010|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
5237011|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
5237012|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
5237013|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
5237014|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
5237015|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
5237016|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
5237017|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
5237018|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Death|1
5237019|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Death|0
5237020|NCT00843518|18073359|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
5237021|NCT00843518|18073360|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
5237022|NCT00843492|18073390|P2|Overall Study|Deep-vein Thrombosis|0
5237023|NCT00843492|18073391|P1|Overall Study|Deep-vein Thrombosis|1
5237024|NCT00843492|18073390|P2|Overall Study|Visit Not Performed|0
5237025|NCT00843492|18073391|P1|Overall Study|Visit Not Performed|1
5237026|NCT00843492|18073390|P2|Overall Study|Orthopedic Surgery|2
5237027|NCT00843492|18073391|P1|Overall Study|Orthopedic Surgery|0
5237028|NCT00843492|18073390|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
5237029|NCT00843492|18073391|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
5237030|NCT00843492|18073390|P2|Overall Study|Immobilization Stopped|0
5237031|NCT00843492|18073391|P1|Overall Study|Immobilization Stopped|1
5237032|NCT00843492|18073390|P2|Overall Study|Withdrawal by Subject|4
5237033|NCT00843492|18073391|P1|Overall Study|Withdrawal by Subject|0
5237034|NCT00843492|18073390|P2|Overall Study|Lost to Follow-up|4
5237035|NCT00843492|18073391|P1|Overall Study|Lost to Follow-up|4
5237036|NCT00843492|18073390|P2|Overall Study|Adverse Event|3
5237037|NCT00843492|18073391|P1|Overall Study|Adverse Event|0
5237038|NCT00843284|18073462|P1|Overall Study|Death|3
5237039|NCT00843284|18073462|P1|Overall Study|Withdrawal by Subject|4
5237040|NCT00843284|18073462|P1|Overall Study|Other|10
5237041|NCT00843284|18073462|P1|Overall Study|Lost to Follow-up|11
5237042|NCT00843284|18073462|P1|Overall Study|Lack of Efficacy|5
5237043|NCT00843284|18073462|P1|Overall Study|Adverse Event|39
5237044|NCT00843193|18073472|P2|Overall Study|Withdrawal by Subject|3
5237045|NCT00843193|18073473|P1|Overall Study|Withdrawal by Subject|3
5237046|NCT00843193|18073472|P2|Overall Study|Physician Decision|1
5237047|NCT00843193|18073473|P1|Overall Study|Physician Decision|0
5237048|NCT00843193|18073472|P2|Overall Study|Lost to Follow-up|0
5237049|NCT00843193|18073473|P1|Overall Study|Lost to Follow-up|1
5237050|NCT00843193|18073472|P2|Overall Study|Protocol Violation|2
5237051|NCT00843193|18073473|P1|Overall Study|Protocol Violation|1
5237052|NCT00843193|18073472|P2|Overall Study|Lack of Efficacy|1
5237053|NCT00843193|18073473|P1|Overall Study|Lack of Efficacy|1
5237054|NCT00843193|18073472|P2|Overall Study|Adverse Event|4
5237055|NCT00843193|18073473|P1|Overall Study|Adverse Event|2
5237056|NCT00843167|18073524|P2|Treatment Period|Withdrawal by Subject|3
5237057|NCT00843167|18073525|P1|Treatment Period|Withdrawal by Subject|2
5237058|NCT00843167|18073524|P2|Treatment Period|Adverse Event|5
5237059|NCT00843167|18073525|P1|Treatment Period|Adverse Event|1
5237060|NCT00843115|18073538|P1|Overall Study|Syndrome De Glissement|1
5237061|NCT00843115|18073538|P1|Overall Study|week 12 not done|1
5237062|NCT00843115|18073538|P1|Overall Study|hospitalized due to deterioration|1
5237063|NCT00843115|18073538|P1|Overall Study|patient never took the medication|1
5237064|NCT00843115|18073538|P1|Overall Study|patient took for 2 days then stopped|1
5237065|NCT00843115|18073538|P1|Overall Study|Family discontinued meds|1
5237066|NCT00843115|18073538|P1|Overall Study|Physician Decision|1
5237067|NCT00843115|18073538|P1|Overall Study|Does not meet entrance criteria|1
5237068|NCT00843115|18073538|P1|Overall Study|Patient forgot to take meds|1
5237069|NCT00843115|18073538|P1|Overall Study|Family does not want continuation|1
5237070|NCT00843115|18073538|P1|Overall Study|Family wanted meds stopped|1
5237071|NCT00843115|18073538|P1|Overall Study|Withdrawal by Subject|17
5237072|NCT00843115|18073538|P1|Overall Study|Lost to Follow-up|4
5237073|NCT00843115|18073538|P1|Overall Study|Adverse Event|30
5237074|NCT00843115|18073538|P1|Overall Study|Death|4
5237075|NCT00843024|18073594|P6|Double-blind Treatment Phase|Lack of Efficacy|0
5237076|NCT00843024|18073595|P5|Double-blind Treatment Phase|Lack of Efficacy|1
5237077|NCT00843024|18073596|P4|Double-blind Treatment Phase|Lack of Efficacy|0
5237078|NCT00843024|18073597|P3|Double-blind Treatment Phase|Lack of Efficacy|0
5237079|NCT00843024|18073598|P2|Double-blind Treatment Phase|Lack of Efficacy|0
5237080|NCT00843024|18073599|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5237081|NCT00843024|18073594|P6|Double-blind Treatment Phase|Adverse Event|1
5237082|NCT00843024|18073595|P5|Double-blind Treatment Phase|Adverse Event|1
5237083|NCT00843024|18073596|P4|Double-blind Treatment Phase|Adverse Event|0
5237084|NCT00843024|18073597|P3|Double-blind Treatment Phase|Adverse Event|0
5237085|NCT00843024|18073598|P2|Double-blind Treatment Phase|Adverse Event|0
5237086|NCT00843024|18073599|P1|Double-blind Treatment Phase|Adverse Event|0
5237087|NCT00843024|18073594|P6|Double-blind Treatment Phase|Physician Decision|1
5237088|NCT00843024|18073595|P5|Double-blind Treatment Phase|Physician Decision|1
5237089|NCT00843024|18073596|P4|Double-blind Treatment Phase|Physician Decision|3
5237090|NCT00843024|18073597|P3|Double-blind Treatment Phase|Physician Decision|0
5237091|NCT00843024|18073598|P2|Double-blind Treatment Phase|Physician Decision|0
5237092|NCT00843024|18073599|P1|Double-blind Treatment Phase|Physician Decision|0
5237093|NCT00843024|18073594|P6|Double-blind Treatment Phase|Protocol Violation|3
5237094|NCT00843024|18073595|P5|Double-blind Treatment Phase|Protocol Violation|0
5237095|NCT00843024|18073596|P4|Double-blind Treatment Phase|Protocol Violation|0
5237096|NCT00843024|18073597|P3|Double-blind Treatment Phase|Protocol Violation|3
5237097|NCT00843024|18073598|P2|Double-blind Treatment Phase|Protocol Violation|0
5237098|NCT00843024|18073599|P1|Double-blind Treatment Phase|Protocol Violation|0
5237099|NCT00843024|18073594|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
5237100|NCT00843024|18073595|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
5237101|NCT00843024|18073596|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
5237102|NCT00843024|18073597|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
5237103|NCT00843024|18073598|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
5237104|NCT00843024|18073599|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5237105|NCT00843024|18073594|P6|Double-blind Treatment Phase|Lost to Follow-up|4
5237106|NCT00843024|18073595|P5|Double-blind Treatment Phase|Lost to Follow-up|4
5237107|NCT00843024|18073596|P4|Double-blind Treatment Phase|Lost to Follow-up|4
5237108|NCT00843024|18073597|P3|Double-blind Treatment Phase|Lost to Follow-up|8
5237109|NCT00843024|18073598|P2|Double-blind Treatment Phase|Lost to Follow-up|0
5237110|NCT00843024|18073599|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5237111|NCT00843024|18073594|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
5237112|NCT00843024|18073595|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
5237113|NCT00843024|18073596|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
5237114|NCT00843024|18073597|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
5237115|NCT00843024|18073598|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
5237116|NCT00843024|18073599|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
5237117|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Other|0
5237118|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Other|0
5237119|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Other|0
5237120|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Other|0
5237121|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Other|1
5237122|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Other|0
5237123|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
5237124|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
5237125|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
5237126|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
5237127|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
5237128|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
5237129|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
5237130|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
5237131|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
5237132|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
5237133|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
5237134|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
5237135|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
5237136|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
5237137|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
5237138|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
5237139|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
5237140|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
5237141|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5237142|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5237143|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5237144|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5237145|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
5237146|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
5237147|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5237148|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5237149|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5237150|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5237151|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
5237152|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
5237153|NCT00843024|18073594|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5237154|NCT00843024|18073595|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5237155|NCT00843024|18073596|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5237156|NCT00843024|18073597|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5237157|NCT00843024|18073598|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
5237158|NCT00843024|18073599|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
5237159|NCT00842985|18073664|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
5237160|NCT00842985|18073664|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
5237161|NCT00842985|18073664|P1|First Intervention|Protocol Violation|3
5237162|NCT00842985|18073664|P1|First Intervention|Withdrawal by Subject|3
5237163|NCT00842985|18073664|P1|Screening|Did not meet entrance requirements|27
5237164|NCT00842829|18073682|P3|Continuation Period|Non-compliance to study drug|1
5237165|NCT00842829|18073683|P2|Continuation Period|Non-compliance to study drug|0
5237166|NCT00842829|18073684|P1|Continuation Period|Non-compliance to study drug|0
5237167|NCT00842829|18073682|P3|Continuation Period|Non-compliance to study procedures|2
5237168|NCT00842829|18073683|P2|Continuation Period|Non-compliance to study procedures|0
5237169|NCT00842829|18073684|P1|Continuation Period|Non-compliance to study procedures|0
5237170|NCT00842829|18073682|P3|Continuation Period|Other|7
5237171|NCT00842829|18073683|P2|Continuation Period|Other|0
5237172|NCT00842829|18073684|P1|Continuation Period|Other|0
5237173|NCT00842829|18073682|P3|Continuation Period|Withdrawal by Subject|10
5237174|NCT00842829|18073683|P2|Continuation Period|Withdrawal by Subject|0
5237175|NCT00842829|18073684|P1|Continuation Period|Withdrawal by Subject|0
5237176|NCT00842829|18073682|P3|Continuation Period|Unstable persistent cancer pain|3
5237177|NCT00842829|18073683|P2|Continuation Period|Unstable persistent cancer pain|0
5237178|NCT00842829|18073684|P1|Continuation Period|Unstable persistent cancer pain|0
5237179|NCT00842829|18073682|P3|Continuation Period|Lack of Efficacy|6
5237180|NCT00842829|18073683|P2|Continuation Period|Lack of Efficacy|0
5237181|NCT00842829|18073684|P1|Continuation Period|Lack of Efficacy|0
5237182|NCT00842829|18073682|P3|Continuation Period|Adverse Event|32
5237183|NCT00842829|18073683|P2|Continuation Period|Adverse Event|0
5237184|NCT00842829|18073684|P1|Continuation Period|Adverse Event|0
5237185|NCT00842829|18073682|P3|Treatment Period|Unclear completion status|1
5237186|NCT00842829|18073683|P2|Treatment Period|Unclear completion status|0
5237187|NCT00842829|18073684|P1|Treatment Period|Unclear completion status|0
5237188|NCT00842829|18073682|P3|Treatment Period|Non-compliance to study procedures|4
5237189|NCT00842829|18073683|P2|Treatment Period|Non-compliance to study procedures|0
5237190|NCT00842829|18073684|P1|Treatment Period|Non-compliance to study procedures|0
5237191|NCT00842829|18073682|P3|Treatment Period|Other|18
5237192|NCT00842829|18073683|P2|Treatment Period|Other|0
5237193|NCT00842829|18073684|P1|Treatment Period|Other|0
5237194|NCT00842829|18073682|P3|Treatment Period|Protocol Violation|2
5237195|NCT00842829|18073683|P2|Treatment Period|Protocol Violation|0
5237196|NCT00842829|18073684|P1|Treatment Period|Protocol Violation|0
5237197|NCT00842829|18073682|P3|Treatment Period|Consistently >4 BTP episodes daily|1
5237198|NCT00842829|18073683|P2|Treatment Period|Consistently >4 BTP episodes daily|0
5237199|NCT00842829|18073684|P1|Treatment Period|Consistently >4 BTP episodes daily|0
5237200|NCT00842829|18073682|P3|Treatment Period|Withdrawal by Subject|11
5237201|NCT00842829|18073683|P2|Treatment Period|Withdrawal by Subject|0
5237202|NCT00842829|18073684|P1|Treatment Period|Withdrawal by Subject|0
5237203|NCT00842829|18073682|P3|Treatment Period|Unstable persistent cancer pain|5
5237204|NCT00842829|18073683|P2|Treatment Period|Unstable persistent cancer pain|0
5237205|NCT00842829|18073684|P1|Treatment Period|Unstable persistent cancer pain|0
5237206|NCT00842829|18073682|P3|Treatment Period|Lack of Efficacy|6
5237207|NCT00842829|18073683|P2|Treatment Period|Lack of Efficacy|0
5237208|NCT00842829|18073684|P1|Treatment Period|Lack of Efficacy|0
5237209|NCT00842829|18073682|P3|Treatment Period|Adverse Event|15
5237210|NCT00842829|18073683|P2|Treatment Period|Adverse Event|0
5237211|NCT00842829|18073684|P1|Treatment Period|Adverse Event|0
5237212|NCT00842829|18073682|P3|Dose Titration Period|Non-compliance to study drug|0
5237213|NCT00842829|18073683|P2|Dose Titration Period|Non-compliance to study drug|1
5237214|NCT00842829|18073684|P1|Dose Titration Period|Non-compliance to study drug|2
5237215|NCT00842829|18073682|P3|Dose Titration Period|Non-compliance to study procedures|0
5237216|NCT00842829|18073683|P2|Dose Titration Period|Non-compliance to study procedures|1
5237217|NCT00842829|18073684|P1|Dose Titration Period|Non-compliance to study procedures|1
5237218|NCT00842829|18073682|P3|Dose Titration Period|Other|0
5237219|NCT00842829|18073683|P2|Dose Titration Period|Other|4
5237220|NCT00842829|18073684|P1|Dose Titration Period|Other|5
5237221|NCT00842829|18073682|P3|Dose Titration Period|Withdrawal by Subject|0
5237222|NCT00842829|18073683|P2|Dose Titration Period|Withdrawal by Subject|6
5237223|NCT00842829|18073684|P1|Dose Titration Period|Withdrawal by Subject|2
5237224|NCT00842829|18073682|P3|Dose Titration Period|Unstable persistent cancer pain|0
5237225|NCT00842829|18073683|P2|Dose Titration Period|Unstable persistent cancer pain|0
5237226|NCT00842829|18073684|P1|Dose Titration Period|Unstable persistent cancer pain|1
5237227|NCT00842829|18073682|P3|Dose Titration Period|Lack of Efficacy|0
5237228|NCT00842829|18073683|P2|Dose Titration Period|Lack of Efficacy|1
5237229|NCT00842829|18073684|P1|Dose Titration Period|Lack of Efficacy|4
5237230|NCT00842829|18073682|P3|Dose Titration Period|Adverse Event|0
5237231|NCT00842829|18073683|P2|Dose Titration Period|Adverse Event|10
5237232|NCT00842829|18073684|P1|Dose Titration Period|Adverse Event|11
5237233|NCT00842712|18073743|P7|Randomized Part|Ongoing at cut-off date|2
5237234|NCT00842712|18073744|P6|Randomized Part|Ongoing at cut-off date|0
5237235|NCT00842712|18073745|P5|Randomized Part|Ongoing at cut-off date|0
5237236|NCT00842712|18073746|P4|Randomized Part|Ongoing at cut-off date|0
5237237|NCT00842712|18073747|P3|Randomized Part|Ongoing at cut-off date|0
5237238|NCT00842712|18073748|P2|Randomized Part|Ongoing at cut-off date|0
5237239|NCT00842712|18073749|P1|Randomized Part|Ongoing at cut-off date|0
5237240|NCT00842712|18073743|P7|Randomized Part|Randomized but not treated|4
5237241|NCT00842712|18073744|P6|Randomized Part|Randomized but not treated|1
5237242|NCT00842712|18073745|P5|Randomized Part|Randomized but not treated|0
5237243|NCT00842712|18073746|P4|Randomized Part|Randomized but not treated|0
5237244|NCT00842712|18073747|P3|Randomized Part|Randomized but not treated|0
5237245|NCT00842712|18073748|P2|Randomized Part|Randomized but not treated|0
5237246|NCT00842712|18073749|P1|Randomized Part|Randomized but not treated|0
5237247|NCT00842712|18073743|P7|Safety Run-in Part|Progressive disease|0
5237248|NCT00842712|18073744|P6|Safety Run-in Part|Progressive disease|0
5237249|NCT00842712|18073745|P5|Safety Run-in Part|Progressive disease|0
5237250|NCT00842712|18073746|P4|Safety Run-in Part|Progressive disease|1
5237251|NCT00842712|18073747|P3|Safety Run-in Part|Progressive disease|0
5237252|NCT00842712|18073748|P2|Safety Run-in Part|Progressive disease|1
5237253|NCT00842712|18073749|P1|Safety Run-in Part|Progressive disease|3
5237254|NCT00842712|18073743|P7|Safety Run-in Part|Adverse Event|0
5237255|NCT00842712|18073744|P6|Safety Run-in Part|Adverse Event|0
5237256|NCT00842712|18073745|P5|Safety Run-in Part|Adverse Event|0
5237257|NCT00842712|18073746|P4|Safety Run-in Part|Adverse Event|0
5237258|NCT00842712|18073747|P3|Safety Run-in Part|Adverse Event|0
5237259|NCT00842712|18073748|P2|Safety Run-in Part|Adverse Event|1
5237260|NCT00842712|18073749|P1|Safety Run-in Part|Adverse Event|0
5237261|NCT00842543|18073806|P4|Overall Study|Withdrawal by Subject|4
5237262|NCT00842543|18073807|P3|Overall Study|Withdrawal by Subject|3
5237263|NCT00842543|18073808|P2|Overall Study|Withdrawal by Subject|0
5237264|NCT00842543|18073809|P1|Overall Study|Withdrawal by Subject|2
5237265|NCT00842530|18073823|P2|Overall Study|Withdrawal by Subject|28
5237266|NCT00842530|18073824|P1|Overall Study|Withdrawal by Subject|73
5237267|NCT00842530|18073823|P2|Overall Study|Lost to Follow-up|8
5237268|NCT00842530|18073824|P1|Overall Study|Lost to Follow-up|6
5237269|NCT00842530|18073823|P2|Overall Study|Protocol Violation|14
5237270|NCT00842530|18073824|P1|Overall Study|Protocol Violation|32
5237271|NCT00842530|18073823|P2|Overall Study|Other adverse event|1
5237272|NCT00842530|18073824|P1|Overall Study|Other adverse event|6
5237273|NCT00842530|18073823|P2|Overall Study|Serious adverse event|6
5237274|NCT00842530|18073824|P1|Overall Study|Serious adverse event|0
5237275|NCT00842361|18073854|P2|Overall Study|Unclassified|2
5237276|NCT00842361|18073855|P1|Overall Study|Unclassified|0
5237277|NCT00842361|18073854|P2|Overall Study|Protocol Violation|0
5237278|NCT00842361|18073855|P1|Overall Study|Protocol Violation|1
5237279|NCT00842348|18073875|P2|Study 729|Surgical resection|0
5237280|NCT00842348|18073876|P1|Study 729|Surgical resection|1
5237281|NCT00842348|18073875|P2|Study 729|Sponsor's decision|0
5237282|NCT00842348|18073876|P1|Study 729|Sponsor's decision|1
5237283|NCT00842348|18073875|P2|Study 729|Due to non-availability of IP|1
5237284|NCT00842348|18073876|P1|Study 729|Due to non-availability of IP|0
5237285|NCT00842348|18073875|P2|Study 729|Due to Sponsor stopping the study|1
5237286|NCT00842348|18073876|P1|Study 729|Due to Sponsor stopping the study|1
5237287|NCT00842348|18073875|P2|Study 729|Withdrawal by Subject|4
5237288|NCT00842348|18073876|P1|Study 729|Withdrawal by Subject|2
5237289|NCT00842348|18073875|P2|Study 729|Protocol Violation|1
5237290|NCT00842348|18073876|P1|Study 729|Protocol Violation|1
5237291|NCT00842348|18073875|P2|Study 729|Adverse Event|1
5237292|NCT00842348|18073876|P1|Study 729|Adverse Event|1
5237293|NCT00842348|18073875|P2|Study 729|Disease progression/death|30
5237294|NCT00842348|18073876|P1|Study 729|Disease progression/death|19
5237295|NCT00842348|18073875|P2|Patients Randomised in Study 726|Did not enter Study 729|56
5237296|NCT00842348|18073876|P1|Patients Randomised in Study 726|Did not enter Study 729|59
5237297|NCT00842309|18073895|P2|Overall Study|Withdrawal by Subject|1
5237298|NCT00842309|18073896|P1|Overall Study|Withdrawal by Subject|3
5237299|NCT00842257|18073930|P1|Overall Study|Adverse Event|1
5237300|NCT00842244|18073937|P1|Overall Study|Other|17
5237301|NCT00842244|18073937|P1|Overall Study|Withdrawal by Subject|1
5237302|NCT00842244|18073937|P1|Overall Study|Death|3
5237303|NCT00842153|18073964|P2|Overall Study|Lost to Follow-up|2
5237304|NCT00842153|18073965|P1|Overall Study|Lost to Follow-up|1
5237305|NCT00842153|18073964|P2|Overall Study|Adverse Event|1
5237306|NCT00842153|18073965|P1|Overall Study|Adverse Event|0
5237307|NCT00841906|18074040|P2|Overall Study|Withdrawal by Subject|0
5237308|NCT00841906|18074041|P1|Overall Study|Withdrawal by Subject|2
5237309|NCT00841815|18074066|P2|Washout|Withdrawal by Subject|1
5237310|NCT00841815|18074067|P1|Washout|Withdrawal by Subject|0
5237311|NCT00841776|18074077|P2|Overall Study|Withdrawal by Subject|1
5237312|NCT00841776|18074078|P1|Overall Study|Withdrawal by Subject|0
5237313|NCT00841776|18074077|P2|Overall Study|Lost to Follow-up|1
5237314|NCT00841776|18074078|P1|Overall Study|Lost to Follow-up|2
5237315|NCT00841776|18074077|P2|Overall Study|Lack of Efficacy|1
5237316|NCT00841776|18074078|P1|Overall Study|Lack of Efficacy|0
5237317|NCT00841763|18074096|P4|Overall Study|Unable to Classify|0
5237318|NCT00841763|18074097|P3|Overall Study|Unable to Classify|0
5237319|NCT00841763|18074098|P2|Overall Study|Unable to Classify|1
5237320|NCT00841763|18074099|P1|Overall Study|Unable to Classify|7
5237321|NCT00841763|18074096|P4|Overall Study|Administrative Reasons|0
5237322|NCT00841763|18074097|P3|Overall Study|Administrative Reasons|0
5237323|NCT00841763|18074098|P2|Overall Study|Administrative Reasons|1
5237324|NCT00841763|18074099|P1|Overall Study|Administrative Reasons|3
5237325|NCT00841763|18074096|P4|Overall Study|Protocol Violation|0
5237326|NCT00841763|18074097|P3|Overall Study|Protocol Violation|1
5237327|NCT00841763|18074098|P2|Overall Study|Protocol Violation|3
5237328|NCT00841763|18074099|P1|Overall Study|Protocol Violation|20
5237329|NCT00841763|18074096|P4|Overall Study|Lost to Follow-up|0
5237330|NCT00841763|18074097|P3|Overall Study|Lost to Follow-up|0
5237331|NCT00841763|18074098|P2|Overall Study|Lost to Follow-up|25
5237332|NCT00841763|18074099|P1|Overall Study|Lost to Follow-up|63
5237333|NCT00841763|18074096|P4|Overall Study|Adverse Event|2
5237334|NCT00841763|18074097|P3|Overall Study|Adverse Event|3
5237335|NCT00841763|18074098|P2|Overall Study|Adverse Event|10
5237336|NCT00841763|18074099|P1|Overall Study|Adverse Event|9
5237337|NCT00841763|18074096|P4|Overall Study|Withdrawal by Subject|1
5237338|NCT00841763|18074097|P3|Overall Study|Withdrawal by Subject|4
5237339|NCT00841763|18074098|P2|Overall Study|Withdrawal by Subject|17
5237340|NCT00841763|18074099|P1|Overall Study|Withdrawal by Subject|60
5237341|NCT00841698|18074161|P2|First Intervention|Withdrawal by Subject|0
5237342|NCT00841698|18074162|P1|First Intervention|Withdrawal by Subject|1
5237343|NCT00841672|18074172|P2|Overall Study|Protocol Deviation|1
5237344|NCT00841672|18074173|P1|Overall Study|Protocol Deviation|0
5237345|NCT00841672|18074172|P2|Overall Study|Misrandomized|0
5237346|NCT00841672|18074173|P1|Overall Study|Misrandomized|1
5237347|NCT00841672|18074172|P2|Overall Study|Administrative problems|9
5237348|NCT00841672|18074173|P1|Overall Study|Administrative problems|9
5237349|NCT00841672|18074172|P2|Overall Study|Lost to Follow-up|1
5237350|NCT00841672|18074173|P1|Overall Study|Lost to Follow-up|1
5237351|NCT00841672|18074172|P2|Overall Study|Subject withdrew consent|4
5237352|NCT00841672|18074173|P1|Overall Study|Subject withdrew consent|2
5237353|NCT00841672|18074172|P2|Overall Study|Abnormal test procedure result(s)|1
5237354|NCT00841672|18074173|P1|Overall Study|Abnormal test procedure result(s)|0
5237355|NCT00841672|18074172|P2|Overall Study|Adverse Event|16
5237356|NCT00841672|18074173|P1|Overall Study|Adverse Event|7
5237357|NCT00841659|18074189|P2|Washout: 2 Weeks|Protocol Violation|0
5237358|NCT00841659|18074190|P1|Washout: 2 Weeks|Protocol Violation|1
5237359|NCT00841568|18074198|P1|Overall Study|Creatinine over the withdrawal criteria|1
5237360|NCT00841568|18074198|P1|Overall Study|Withdrawal by Subject|2
5237361|NCT00841568|18074198|P1|Overall Study|Death|1
5237362|NCT00841568|18074198|P1|Overall Study|Adverse Event|1
5237363|NCT00841542|18074226|P2|Period 1|Adverse Event|0
5237364|NCT00841542|18074227|P1|Period 1|Adverse Event|1
5237365|NCT00841321|18074242|P2|Overall Study|Adverse Event|2
5237366|NCT00841321|18074243|P1|Overall Study|Adverse Event|0
5237367|NCT00841321|18074242|P2|Overall Study|Lost to Follow-up|1
5237368|NCT00841321|18074243|P1|Overall Study|Lost to Follow-up|1
5237369|NCT00841100|18074290|P1|Phase 1 (28 Days)|Participant non-compliance|2
5237370|NCT00841100|18074290|P1|Phase 1 (28 Days)|Adverse Event|1
5237371|NCT00841035|18074315|P1|Phase 1 Overall Study|Physician Decision|13
5237372|NCT00840996|18074322|P2|Overall Study|Withdrawal by Subject|0
5237373|NCT00840996|18074323|P1|Overall Study|Withdrawal by Subject|1
5237374|NCT00840970|18074341|P3|Overall Study|Adverse Event|1
5237375|NCT00840970|18074342|P2|Overall Study|Adverse Event|0
5237376|NCT00840970|18074343|P1|Overall Study|Adverse Event|0
5237377|NCT00840879|18074363|P2|Second Intervention|Withdrawal by Subject|0
5237378|NCT00840879|18074364|P1|Second Intervention|Withdrawal by Subject|1
5237379|NCT00840827|18074400|P1|Overall Study|Physician Decision|1
5237380|NCT00840827|18074400|P1|Overall Study|Lack of Efficacy|4
5237381|NCT00840827|18074400|P1|Overall Study|Adverse Event|1
5237382|NCT00840749|18074415|P2|Overall Study|study closed|14
5237383|NCT00840749|18074416|P1|Overall Study|study closed|19
5237384|NCT00840749|18074415|P2|Overall Study|not treated on study arm|11
5237385|NCT00840749|18074416|P1|Overall Study|not treated on study arm|11
5237386|NCT00840749|18074415|P2|Overall Study|Death|2
5237387|NCT00840749|18074416|P1|Overall Study|Death|1
5237388|NCT00840658|18074428|P4|Overall Study|Lost to Follow-up|1
5237389|NCT00840658|18074429|P3|Overall Study|Lost to Follow-up|2
5237390|NCT00840658|18074430|P2|Overall Study|Lost to Follow-up|1
5237391|NCT00840658|18074431|P1|Overall Study|Lost to Follow-up|3
5237392|NCT00840658|18074428|P4|Overall Study|Death|3
5237393|NCT00840658|18074429|P3|Overall Study|Death|3
5237394|NCT00840658|18074430|P2|Overall Study|Death|2
5237395|NCT00840658|18074431|P1|Overall Study|Death|2
5237396|NCT00840632|18074449|P2|Washout|Withdrawal by Subject|1
5237397|NCT00840632|18074450|P1|Washout|Withdrawal by Subject|1
5237398|NCT00840632|18074449|P2|First Intervention|Withdrawal by Subject|1
5237399|NCT00840632|18074450|P1|First Intervention|Withdrawal by Subject|0
5237400|NCT00840463|18074477|P2|Overall Study|Adverse Event|0
5237401|NCT00840463|18074478|P1|Overall Study|Adverse Event|1
5237402|NCT00840450|18074492|P1|Overall Study|Lack of Efficacy|2
5237403|NCT00840450|18074492|P1|Overall Study|Adverse Event|1
5237404|NCT00840411|18074500|P2|Washout|Withdrawal by Subject|0
5237405|NCT00840411|18074501|P1|Washout|Withdrawal by Subject|1
5237406|NCT00840411|18074500|P2|First Intervention|Adverse Event|0
5237407|NCT00840411|18074501|P1|First Intervention|Adverse Event|1
5237408|NCT00840294|18074515|P2|Overall Study|Illness|1
5237409|NCT00840294|18074516|P1|Overall Study|Illness|0
5237410|NCT00840294|18074515|P2|Overall Study|Protocol Violation|3
5237411|NCT00840294|18074516|P1|Overall Study|Protocol Violation|1
5237412|NCT00840294|18074515|P2|Overall Study|Withdrawal by Subject|1
5237413|NCT00840294|18074516|P1|Overall Study|Withdrawal by Subject|2
5237414|NCT00840216|18074537|P2|Washout: 7 Days|Withdrawal by Subject|0
5237415|NCT00840216|18074538|P1|Washout: 7 Days|Withdrawal by Subject|1
5237416|NCT00840203|18074548|P2|Washout|Protocol Violation|0
5237417|NCT00840203|18074549|P1|Washout|Protocol Violation|1
5237418|NCT00840203|18074548|P2|First Intervention|Protocol Violation|1
5237419|NCT00840203|18074549|P1|First Intervention|Protocol Violation|1
5237420|NCT00840177|18074566|P3|Overall Study|Did not start treatment|1
5237421|NCT00840177|18074567|P2|Overall Study|Did not start treatment|0
5237422|NCT00840177|18074568|P1|Overall Study|Did not start treatment|0
5237423|NCT00840177|18074566|P3|Overall Study|Ineligible|3
5237424|NCT00840177|18074567|P2|Overall Study|Ineligible|0
5237425|NCT00840177|18074568|P1|Overall Study|Ineligible|0
5237426|NCT00840177|18074566|P3|Overall Study|not protocol specified|0
5237427|NCT00840177|18074567|P2|Overall Study|not protocol specified|3
5237428|NCT00840177|18074568|P1|Overall Study|not protocol specified|6
5237429|NCT00840177|18074566|P3|Overall Study|Death|5
5237430|NCT00840177|18074567|P2|Overall Study|Death|5
5237431|NCT00840177|18074568|P1|Overall Study|Death|4
5237432|NCT00840177|18074566|P3|Overall Study|Progression/relapse|0
5237433|NCT00840177|18074567|P2|Overall Study|Progression/relapse|0
5237434|NCT00840177|18074568|P1|Overall Study|Progression/relapse|2
5237435|NCT00840177|18074566|P3|Overall Study|Refusal unrelated to adverse events|1
5237436|NCT00840177|18074567|P2|Overall Study|Refusal unrelated to adverse events|0
5237437|NCT00840177|18074568|P1|Overall Study|Refusal unrelated to adverse events|1
5237438|NCT00840177|18074566|P3|Overall Study|Adverse Event|1
5237439|NCT00840177|18074567|P2|Overall Study|Adverse Event|1
5237440|NCT00840177|18074568|P1|Overall Study|Adverse Event|5
5237441|NCT00840086|18074602|P1|Overall Study|Lost to Follow-up|1
5237442|NCT00840086|18074602|P1|Overall Study|Protocol Violation|2
5237443|NCT00840086|18074602|P1|Overall Study|Adverse Event|1
5237444|NCT00840073|18074611|P2|Second Intervention|Missed 72 hour blood draw|1
5237445|NCT00840073|18074612|P1|Second Intervention|Missed 72 hour blood draw|1
5237446|NCT00840060|18074626|P2|Overall Study|Change in emotional/behavioral status|1
5237447|NCT00840060|18074627|P1|Overall Study|Change in emotional/behavioral status|0
5237448|NCT00840060|18074626|P2|Overall Study|Withdrawal by Subject|0
5237449|NCT00840060|18074627|P1|Overall Study|Withdrawal by Subject|1
5237450|NCT00840034|18074637|P2|Taper Phase|Withdrawal by Subject|1
5237451|NCT00840034|18074638|P1|Taper Phase|Withdrawal by Subject|1
5237452|NCT00840034|18074637|P2|Taper Phase|Lost to Follow-up|1
5237453|NCT00840034|18074638|P1|Taper Phase|Lost to Follow-up|1
5237454|NCT00840034|18074637|P2|Taper Phase|Adverse Event|0
5237455|NCT00840034|18074638|P1|Taper Phase|Adverse Event|1
5237456|NCT00840034|18074637|P2|Acute Treatment Phase|Withdrawal by Subject|11
5237457|NCT00840034|18074638|P1|Acute Treatment Phase|Withdrawal by Subject|6
5237458|NCT00840034|18074637|P2|Acute Treatment Phase|Protocol Violation|4
5237459|NCT00840034|18074638|P1|Acute Treatment Phase|Protocol Violation|2
5237460|NCT00840034|18074637|P2|Acute Treatment Phase|Physician Decision|1
5237461|NCT00840034|18074638|P1|Acute Treatment Phase|Physician Decision|0
5237462|NCT00840034|18074637|P2|Acute Treatment Phase|Lost to Follow-up|12
5237463|NCT00840034|18074638|P1|Acute Treatment Phase|Lost to Follow-up|5
5237464|NCT00840034|18074637|P2|Acute Treatment Phase|Lack of Efficacy|0
5237465|NCT00840034|18074638|P1|Acute Treatment Phase|Lack of Efficacy|2
5237466|NCT00840034|18074637|P2|Acute Treatment Phase|Adverse Event|8
5237467|NCT00840034|18074638|P1|Acute Treatment Phase|Adverse Event|6
5237468|NCT00839956|18074691|P1|Overall Study|Withdrawal by Subject|3
5237469|NCT00839956|18074691|P1|Overall Study|Physician Decision|1
5237470|NCT00839956|18074691|P1|Overall Study|Lack of Efficacy|6
5237471|NCT00839956|18074691|P1|Overall Study|Adverse Event|2
5237472|NCT00839917|18074711|P2|Overall Study|Did not receive vaccine|1
5237473|NCT00839917|18074712|P1|Overall Study|Did not receive vaccine|0
5237474|NCT00839917|18074711|P2|Overall Study|Lost to Follow-up|0
5237475|NCT00839917|18074712|P1|Overall Study|Lost to Follow-up|1
5237476|NCT00839852|18074748|P1|Overall Study|Pregnancy|1
5237477|NCT00839852|18074748|P1|Overall Study|Lack of Compliance While in Jail|1
5237478|NCT00839852|18074748|P1|Overall Study|Lost to Follow-up|7
5237479|NCT00839852|18074748|P1|Overall Study|Withdrawal of Consent|16
5237480|NCT00839852|18074748|P1|Overall Study|Protocol Violation|9
5237481|NCT00839852|18074748|P1|Overall Study|Insufficient Therapeutic Response|3
5237482|NCT00839852|18074748|P1|Overall Study|Adverse Event|10
5237483|NCT00839800|18074755|P2|Overall Study|Severe Non-Compliance to Protocol|7
5237484|NCT00839800|18074756|P1|Overall Study|Severe Non-Compliance to Protocol|7
5237485|NCT00839800|18074755|P2|Overall Study|Other|14
5237486|NCT00839800|18074756|P1|Overall Study|Other|8
5237487|NCT00839800|18074755|P2|Overall Study|Safety Reasons|1
5237488|NCT00839800|18074756|P1|Overall Study|Safety Reasons|2
5237489|NCT00839800|18074755|P2|Overall Study|Study-Specific Discontinuation Criteria|13
5237490|NCT00839800|18074756|P1|Overall Study|Study-Specific Discontinuation Criteria|6
5237491|NCT00839800|18074755|P2|Overall Study|Incorrect Enrolment|3
5237492|NCT00839800|18074756|P1|Overall Study|Incorrect Enrolment|3
5237493|NCT00839800|18074755|P2|Overall Study|Withdrawal by Subject|34
5237494|NCT00839800|18074756|P1|Overall Study|Withdrawal by Subject|28
5237495|NCT00839800|18074755|P2|Overall Study|Lost to Follow-up|26
5237496|NCT00839800|18074756|P1|Overall Study|Lost to Follow-up|31
5237497|NCT00839800|18074755|P2|Overall Study|Adverse Event|12
5237498|NCT00839800|18074756|P1|Overall Study|Adverse Event|8
5237499|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
5237500|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
5237501|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
5237502|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
5237503|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
5237504|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
5237505|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
5237506|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
5237507|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
5237508|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
5237509|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
5237510|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
5237511|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
5237512|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
5237513|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
5237514|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
5237515|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
5237516|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
5237517|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
5237518|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
5237519|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
5237520|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
5237521|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
5237522|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
5237523|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
5237524|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
5237525|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
5237526|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
5237527|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
5237528|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
5237529|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
5237530|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
5237531|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
5237532|NCT00839527|18074802|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
5237533|NCT00839527|18074803|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
5237534|NCT00839527|18074804|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
5237535|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
5237536|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
5237537|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
5237538|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
5237539|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
5237540|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
5237541|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
5237542|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
5237543|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
5237544|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
5237545|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
5237546|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
5237547|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Missing|0
5237548|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Missing|1
5237549|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Missing|0
5237550|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
5237551|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
5237552|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
5237553|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
5237554|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
5237555|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
5237556|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
5237557|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
5237558|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
5237559|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
5237560|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
5237561|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
5237562|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
5237563|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
5237564|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
5237565|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
5237566|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
5237567|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
5237568|NCT00839527|18074802|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
5237569|NCT00839527|18074803|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
5237570|NCT00839527|18074804|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
5237571|NCT00839436|18074839|P3|Overall Study|Study drug no longer available|1
5237572|NCT00839436|18074840|P2|Overall Study|Study drug no longer available|0
5237573|NCT00839436|18074841|P1|Overall Study|Study drug no longer available|0
5237574|NCT00839436|18074839|P3|Overall Study|Withdrawal by Subject|0
5237575|NCT00839436|18074840|P2|Overall Study|Withdrawal by Subject|1
5237576|NCT00839436|18074841|P1|Overall Study|Withdrawal by Subject|0
5237577|NCT00839436|18074839|P3|Overall Study|Developed exclusionary condition|0
5237578|NCT00839436|18074840|P2|Overall Study|Developed exclusionary condition|0
5237579|NCT00839436|18074841|P1|Overall Study|Developed exclusionary condition|1
5237580|NCT00839423|18074853|P4|Overall Study|Administrative or other reasons|0
5237581|NCT00839423|18074854|P3|Overall Study|Administrative or other reasons|1
5237582|NCT00839423|18074855|P2|Overall Study|Administrative or other reasons|0
5237583|NCT00839423|18074856|P1|Overall Study|Administrative or other reasons|3
5237584|NCT00839423|18074853|P4|Overall Study|Lost to Follow-up|0
5237585|NCT00839423|18074854|P3|Overall Study|Lost to Follow-up|1
5237586|NCT00839423|18074855|P2|Overall Study|Lost to Follow-up|0
5237587|NCT00839423|18074856|P1|Overall Study|Lost to Follow-up|1
5237588|NCT00839423|18074853|P4|Overall Study|Withdrawal of consent|1
5237589|NCT00839423|18074854|P3|Overall Study|Withdrawal of consent|4
5237590|NCT00839423|18074855|P2|Overall Study|Withdrawal of consent|0
5237591|NCT00839423|18074856|P1|Overall Study|Withdrawal of consent|4
5237592|NCT00839423|18074853|P4|Overall Study|Protocol Violation|0
5237593|NCT00839423|18074854|P3|Overall Study|Protocol Violation|2
5237594|NCT00839423|18074855|P2|Overall Study|Protocol Violation|1
5237595|NCT00839423|18074856|P1|Overall Study|Protocol Violation|0
5237596|NCT00839423|18074853|P4|Overall Study|Non-compliance|1
5237597|NCT00839423|18074854|P3|Overall Study|Non-compliance|0
5237598|NCT00839423|18074855|P2|Overall Study|Non-compliance|0
5237599|NCT00839423|18074856|P1|Overall Study|Non-compliance|0
5237600|NCT00839423|18074853|P4|Overall Study|Lack of Efficacy|2
5237601|NCT00839423|18074854|P3|Overall Study|Lack of Efficacy|3
5237602|NCT00839423|18074855|P2|Overall Study|Lack of Efficacy|6
5237603|NCT00839423|18074856|P1|Overall Study|Lack of Efficacy|6
5237604|NCT00839423|18074853|P4|Overall Study|Adverse Event|16
5237605|NCT00839423|18074854|P3|Overall Study|Adverse Event|7
5237606|NCT00839423|18074855|P2|Overall Study|Adverse Event|3
5237607|NCT00839423|18074856|P1|Overall Study|Adverse Event|4
5237608|NCT00839332|18074897|P3|Phase 2|Lost to Follow-up|1
5237609|NCT00839332|18074898|P2|Phase 2|Lost to Follow-up|0
5237610|NCT00839332|18074899|P1|Phase 2|Lost to Follow-up|0
5237611|NCT00839332|18074897|P3|Phase 2|Physician Decision|1
5237612|NCT00839332|18074898|P2|Phase 2|Physician Decision|4
5237613|NCT00839332|18074899|P1|Phase 2|Physician Decision|0
5237614|NCT00839332|18074897|P3|Phase 2|Withdrawal by Subject|8
5237615|NCT00839332|18074898|P2|Phase 2|Withdrawal by Subject|5
5237616|NCT00839332|18074899|P1|Phase 2|Withdrawal by Subject|0
5237617|NCT00839332|18074897|P3|Phase 2|Death|2
5237618|NCT00839332|18074898|P2|Phase 2|Death|4
5237619|NCT00839332|18074899|P1|Phase 2|Death|0
5237620|NCT00839332|18074897|P3|Phase 2|Adverse Event|6
5237621|NCT00839332|18074898|P2|Phase 2|Adverse Event|8
5237622|NCT00839332|18074899|P1|Phase 2|Adverse Event|0
5237623|NCT00839332|18074897|P3|Phase 2|Disease Progression|21
5237624|NCT00839332|18074898|P2|Phase 2|Disease Progression|46
5237625|NCT00839332|18074899|P1|Phase 2|Disease Progression|0
5237626|NCT00839332|18074897|P3|Phase 2|Protocol Violation|0
5237627|NCT00839332|18074898|P2|Phase 2|Protocol Violation|1
5237628|NCT00839332|18074899|P1|Phase 2|Protocol Violation|0
5237629|NCT00839332|18074897|P3|Phase 1|Physician Decision|0
5237630|NCT00839332|18074898|P2|Phase 1|Physician Decision|0
5237631|NCT00839332|18074899|P1|Phase 1|Physician Decision|2
5237632|NCT00839332|18074897|P3|Phase 1|Withdrawal by Subject|0
5237633|NCT00839332|18074898|P2|Phase 1|Withdrawal by Subject|0
5237634|NCT00839332|18074899|P1|Phase 1|Withdrawal by Subject|4
5237635|NCT00839332|18074897|P3|Phase 1|Adverse Event|0
5237636|NCT00839332|18074898|P2|Phase 1|Adverse Event|0
5237637|NCT00839332|18074899|P1|Phase 1|Adverse Event|6
5237638|NCT00839332|18074897|P3|Phase 1|Disease Progression|0
5237639|NCT00839332|18074898|P2|Phase 1|Disease Progression|0
5237640|NCT00839332|18074899|P1|Phase 1|Disease Progression|38
5237641|NCT00839306|18074960|P2|Overall Study|Other|18
5237642|NCT00839306|18074961|P1|Overall Study|Other|6
5237643|NCT00839306|18074960|P2|Overall Study|Lack of Efficacy|4
5237644|NCT00839306|18074961|P1|Overall Study|Lack of Efficacy|5
5237645|NCT00839306|18074960|P2|Overall Study|Withdrawal by Subject|7
5237646|NCT00839306|18074961|P1|Overall Study|Withdrawal by Subject|5
5237647|NCT00839306|18074960|P2|Overall Study|Lost to Follow-up|9
5237648|NCT00839306|18074961|P1|Overall Study|Lost to Follow-up|6
5237649|NCT00839306|18074960|P2|Overall Study|Adverse Event|5
5237650|NCT00839306|18074961|P1|Overall Study|Adverse Event|3
5237651|NCT00839254|18074977|P8|Overall Study|Lost to Follow-up|2
5237652|NCT00839254|18074978|P7|Overall Study|Lost to Follow-up|4
5237653|NCT00839254|18074979|P6|Overall Study|Lost to Follow-up|8
5237654|NCT00839254|18074980|P5|Overall Study|Lost to Follow-up|8
5237655|NCT00839254|18074981|P4|Overall Study|Lost to Follow-up|24
5237656|NCT00839254|18074982|P3|Overall Study|Lost to Follow-up|32
5237657|NCT00839254|18074983|P2|Overall Study|Lost to Follow-up|30
5237658|NCT00839254|18074984|P1|Overall Study|Lost to Follow-up|51
5237659|NCT00839254|18074977|P8|Overall Study|Withdrawn due to non-compliance|0
5237660|NCT00839254|18074978|P7|Overall Study|Withdrawn due to non-compliance|0
5237661|NCT00839254|18074979|P6|Overall Study|Withdrawn due to non-compliance|0
5237662|NCT00839254|18074980|P5|Overall Study|Withdrawn due to non-compliance|0
5237663|NCT00839254|18074981|P4|Overall Study|Withdrawn due to non-compliance|0
5237664|NCT00839254|18074982|P3|Overall Study|Withdrawn due to non-compliance|0
5237665|NCT00839254|18074983|P2|Overall Study|Withdrawn due to non-compliance|0
5237666|NCT00839254|18074984|P1|Overall Study|Withdrawn due to non-compliance|2
5237667|NCT00839254|18074977|P8|Overall Study|Parents wanted pneumococcal vaccine|0
5237668|NCT00839254|18074978|P7|Overall Study|Parents wanted pneumococcal vaccine|0
5237669|NCT00839254|18074979|P6|Overall Study|Parents wanted pneumococcal vaccine|1
5237670|NCT00839254|18074980|P5|Overall Study|Parents wanted pneumococcal vaccine|0
5237671|NCT00839254|18074981|P4|Overall Study|Parents wanted pneumococcal vaccine|0
5237672|NCT00839254|18074982|P3|Overall Study|Parents wanted pneumococcal vaccine|0
5237673|NCT00839254|18074983|P2|Overall Study|Parents wanted pneumococcal vaccine|0
5237674|NCT00839254|18074984|P1|Overall Study|Parents wanted pneumococcal vaccine|1
5237675|NCT00839254|18074977|P8|Overall Study|Wrong group allocation|0
5237676|NCT00839254|18074978|P7|Overall Study|Wrong group allocation|1
5237677|NCT00839254|18074979|P6|Overall Study|Wrong group allocation|0
5237678|NCT00839254|18074980|P5|Overall Study|Wrong group allocation|0
5237679|NCT00839254|18074981|P4|Overall Study|Wrong group allocation|0
5237680|NCT00839254|18074982|P3|Overall Study|Wrong group allocation|0
5237681|NCT00839254|18074983|P2|Overall Study|Wrong group allocation|0
5237682|NCT00839254|18074984|P1|Overall Study|Wrong group allocation|0
5237683|NCT00839254|18074977|P8|Overall Study|Withdrawal by Subject|9
5237684|NCT00839254|18074978|P7|Overall Study|Withdrawal by Subject|22
5237685|NCT00839254|18074979|P6|Overall Study|Withdrawal by Subject|15
5237686|NCT00839254|18074980|P5|Overall Study|Withdrawal by Subject|27
5237687|NCT00839254|18074981|P4|Overall Study|Withdrawal by Subject|32
5237688|NCT00839254|18074982|P3|Overall Study|Withdrawal by Subject|54
5237689|NCT00839254|18074983|P2|Overall Study|Withdrawal by Subject|53
5237690|NCT00839254|18074984|P1|Overall Study|Withdrawal by Subject|87
5237691|NCT00839254|18074977|P8|Overall Study|Adverse Event|1
5237692|NCT00839254|18074978|P7|Overall Study|Adverse Event|0
5237693|NCT00839254|18074979|P6|Overall Study|Adverse Event|1
5237694|NCT00839254|18074980|P5|Overall Study|Adverse Event|2
5237695|NCT00839254|18074981|P4|Overall Study|Adverse Event|5
5237696|NCT00839254|18074982|P3|Overall Study|Adverse Event|3
5237697|NCT00839254|18074983|P2|Overall Study|Adverse Event|6
5237698|NCT00839254|18074984|P1|Overall Study|Adverse Event|12
5237699|NCT00839254|18074977|P8|Overall Study|Wrong treatment number allocation|0
5237700|NCT00839254|18074978|P7|Overall Study|Wrong treatment number allocation|0
5237701|NCT00839254|18074979|P6|Overall Study|Wrong treatment number allocation|1
5237702|NCT00839254|18074980|P5|Overall Study|Wrong treatment number allocation|0
5237703|NCT00839254|18074981|P4|Overall Study|Wrong treatment number allocation|0
5237704|NCT00839254|18074982|P3|Overall Study|Wrong treatment number allocation|0
5237705|NCT00839254|18074983|P2|Overall Study|Wrong treatment number allocation|1
5237706|NCT00839254|18074984|P1|Overall Study|Wrong treatment number allocation|0
5237707|NCT00839254|18074977|P8|Overall Study|Physician Decision|1
5237708|NCT00839254|18074978|P7|Overall Study|Physician Decision|0
5237709|NCT00839254|18074979|P6|Overall Study|Physician Decision|0
5237710|NCT00839254|18074980|P5|Overall Study|Physician Decision|0
5237711|NCT00839254|18074981|P4|Overall Study|Physician Decision|0
5237712|NCT00839254|18074982|P3|Overall Study|Physician Decision|0
5237713|NCT00839254|18074983|P2|Overall Study|Physician Decision|1
5237714|NCT00839254|18074984|P1|Overall Study|Physician Decision|0
5237715|NCT00839254|18074977|P8|Overall Study|Protocol Violation|2
5237716|NCT00839254|18074978|P7|Overall Study|Protocol Violation|1
5237717|NCT00839254|18074979|P6|Overall Study|Protocol Violation|0
5237718|NCT00839254|18074980|P5|Overall Study|Protocol Violation|0
5237719|NCT00839254|18074981|P4|Overall Study|Protocol Violation|1
5237720|NCT00839254|18074982|P3|Overall Study|Protocol Violation|1
5237721|NCT00839254|18074983|P2|Overall Study|Protocol Violation|1
5237722|NCT00839254|18074984|P1|Overall Study|Protocol Violation|0
5237723|NCT00839098|18075296|P3|Overall Study|Withdrawal by Subject|7
5237724|NCT00839098|18075297|P2|Overall Study|Withdrawal by Subject|1
5237725|NCT00839098|18075298|P1|Overall Study|Withdrawal by Subject|2
5237726|NCT00839072|18075324|P2|Second Intervention Period|Withdrawal by Subject|0
5237727|NCT00839072|18075325|P1|Second Intervention Period|Withdrawal by Subject|1
5237728|NCT00839072|18075324|P2|First Intervention Period|Adverse Event|1
5237729|NCT00839072|18075325|P1|First Intervention Period|Adverse Event|1
5237730|NCT00839072|18075324|P2|First Intervention Period|Withdrawal by Subject|0
5237731|NCT00839072|18075325|P1|First Intervention Period|Withdrawal by Subject|1
5237732|NCT00838929|18075369|P3|Overall Study|Disease progression|1
5237733|NCT00838929|18075370|P2|Overall Study|Disease progression|2
5237734|NCT00838929|18075371|P1|Overall Study|Disease progression|0
5237735|NCT00838929|18075369|P3|Overall Study|Protocol Violation|0
5237736|NCT00838929|18075370|P2|Overall Study|Protocol Violation|1
5237737|NCT00838929|18075371|P1|Overall Study|Protocol Violation|0
5237738|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Missing|0
5237739|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Missing|3
5237740|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
5237741|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
5237742|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
5237743|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
5237744|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Physician Decision|0
5237745|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Physician Decision|2
5237746|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
5237747|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
5237748|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
5237749|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
5237750|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
5237751|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
5237752|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Noncompliance|5
5237753|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Noncompliance|6
5237754|NCT00838916|18075379|P2|Follow-up Period (8 Weeks)|Adverse Event|5
5237755|NCT00838916|18075380|P1|Follow-up Period (8 Weeks)|Adverse Event|10
5237756|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Pregnancy|0
5237757|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Pregnancy|2
5237758|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Missing|1
5237759|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Missing|3
5237760|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
5237761|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
5237762|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Physician Decision|1
5237763|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Physician Decision|6
5237764|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
5237765|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
5237766|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
5237767|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
5237768|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5237769|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
5237770|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Noncompliance|14
5237771|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Noncompliance|21
5237772|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Protocol Violation|3
5237773|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Protocol Violation|12
5237774|NCT00838916|18075379|P2|Treatment Period (156 Weeks)|Adverse Event|11
5237775|NCT00838916|18075380|P1|Treatment Period (156 Weeks)|Adverse Event|50
5237776|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Missing|1
5237777|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Missing|1
5237778|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Missing|2
5237779|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Missing|1
5237780|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
5237781|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
5237782|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
5237783|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
5237784|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
5237785|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
5237786|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
5237787|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
5237788|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
5237789|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
5237790|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
5237791|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
5237792|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5237793|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
5237794|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5237795|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
5237796|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Physician Decision|1
5237797|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Physician Decision|1
5237798|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Physician Decision|1
5237799|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Physician Decision|1
5237800|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
5237801|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
5237802|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
5237803|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
5237804|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
5237805|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
5237806|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
5237807|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
5237808|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
5237809|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
5237810|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
5237811|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
5237812|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Noncompliance|5
5237813|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Noncompliance|5
5237814|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Noncompliance|8
5237815|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5237816|NCT00838903|18075409|P4|Follow-up Period (8 Weeks)|Adverse Event|1
5237817|NCT00838903|18075410|P3|Follow-up Period (8 Weeks)|Adverse Event|3
5237818|NCT00838903|18075411|P2|Follow-up Period (8 Weeks)|Adverse Event|0
5237819|NCT00838903|18075412|P1|Follow-up Period (8 Weeks)|Adverse Event|0
5237820|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
5237821|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
5237822|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
5237823|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
5237824|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
5237825|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
5237826|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
5237827|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
5237828|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
5237904|NCT00838565|18075512|P3|Overall Study|Randomized but not Treated|0
5237829|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
5237830|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
5237831|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
5237832|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Site closed|0
5237833|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Site closed|1
5237834|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Site closed|0
5237835|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Site closed|0
5237836|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
5237837|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
5237838|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
5237839|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
5237840|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Pregnancy|0
5237841|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Pregnancy|1
5237842|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Pregnancy|0
5237843|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Pregnancy|0
5237844|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
5237845|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
5237846|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
5237847|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
5237848|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
5237849|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
5237850|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
5237851|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
5237852|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
5237853|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
5237854|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
5237855|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
5237856|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
5237857|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
5237858|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
5237859|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
5237860|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Physician Decision|2
5237861|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Physician Decision|1
5237862|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Physician Decision|2
5237863|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Physician Decision|1
5237864|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
5237865|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
5237866|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
5237867|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
5237868|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
5237869|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
5237870|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
5237871|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
5237872|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5237873|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
5237874|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5237875|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5237876|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Noncompliance|6
5237877|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Noncompliance|12
5237878|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Noncompliance|13
5237879|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Noncompliance|9
5237880|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Protocol Violation|5
5237881|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Protocol Violation|6
5237882|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Protocol Violation|6
5237883|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Protocol Violation|1
5237884|NCT00838903|18075409|P4|Treatment Period (156 Weeks)|Adverse Event|25
5237885|NCT00838903|18075410|P3|Treatment Period (156 Weeks)|Adverse Event|17
5237886|NCT00838903|18075411|P2|Treatment Period (156 Weeks)|Adverse Event|13
5237887|NCT00838903|18075412|P1|Treatment Period (156 Weeks)|Adverse Event|5
5237888|NCT00838682|18075467|P2|Overall Study|Withdrawal by Subject|1
5237889|NCT00838682|18075468|P1|Overall Study|Withdrawal by Subject|0
5237890|NCT00838682|18075467|P2|Overall Study|Protocol Violation|1
5237891|NCT00838682|18075468|P1|Overall Study|Protocol Violation|0
5237892|NCT00838682|18075467|P2|Overall Study|detection of exclusion criteria|3
5237893|NCT00838682|18075468|P1|Overall Study|detection of exclusion criteria|4
5237894|NCT00838682|18075467|P2|Overall Study|Lost to Follow-up|14
5237895|NCT00838682|18075468|P1|Overall Study|Lost to Follow-up|21
5237896|NCT00838630|18075486|P2|Washout: 7 Days|Protocol Violation|0
5237897|NCT00838630|18075487|P1|Washout: 7 Days|Protocol Violation|1
5237898|NCT00838630|18075486|P2|First Intervention|Adverse Event|0
5237899|NCT00838630|18075487|P1|First Intervention|Adverse Event|1
5237900|NCT00838578|18075495|P1|Overall Study|Protocol Violation|2
5237901|NCT00838565|18075509|P6|Overall Study|Randomized but not Treated|0
5237902|NCT00838565|18075510|P5|Overall Study|Randomized but not Treated|0
5237903|NCT00838565|18075511|P4|Overall Study|Randomized but not Treated|0
5237905|NCT00838565|18075513|P2|Overall Study|Randomized but not Treated|1
5237906|NCT00838565|18075514|P1|Overall Study|Randomized but not Treated|0
5237907|NCT00838565|18075509|P6|Overall Study|Other|0
5237908|NCT00838565|18075510|P5|Overall Study|Other|0
5237909|NCT00838565|18075511|P4|Overall Study|Other|0
5237910|NCT00838565|18075512|P3|Overall Study|Other|0
5237911|NCT00838565|18075513|P2|Overall Study|Other|2
5237912|NCT00838565|18075514|P1|Overall Study|Other|0
5237913|NCT00838565|18075509|P6|Overall Study|Withdrawal by Subject|2
5237914|NCT00838565|18075510|P5|Overall Study|Withdrawal by Subject|0
5237915|NCT00838565|18075511|P4|Overall Study|Withdrawal by Subject|0
5237916|NCT00838565|18075512|P3|Overall Study|Withdrawal by Subject|1
5237917|NCT00838565|18075513|P2|Overall Study|Withdrawal by Subject|0
5237918|NCT00838565|18075514|P1|Overall Study|Withdrawal by Subject|0
5237919|NCT00838539|18075619|P12|Overall Study|Symptomatic Deterioration|0
5237920|NCT00838539|18075620|P11|Overall Study|Symptomatic Deterioration|0
5237921|NCT00838539|18075621|P10|Overall Study|Symptomatic Deterioration|1
5237922|NCT00838539|18075622|P9|Overall Study|Symptomatic Deterioration|0
5237923|NCT00838539|18075623|P8|Overall Study|Symptomatic Deterioration|0
5237924|NCT00838539|18075624|P7|Overall Study|Symptomatic Deterioration|0
5237925|NCT00838539|18075625|P6|Overall Study|Symptomatic Deterioration|1
5237926|NCT00838539|18075626|P5|Overall Study|Symptomatic Deterioration|0
5237927|NCT00838539|18075627|P4|Overall Study|Symptomatic Deterioration|1
5237928|NCT00838539|18075628|P3|Overall Study|Symptomatic Deterioration|1
5237929|NCT00838539|18075629|P2|Overall Study|Symptomatic Deterioration|0
5237930|NCT00838539|18075630|P1|Overall Study|Symptomatic Deterioration|0
5237931|NCT00838539|18075619|P12|Overall Study|Clinical Progression|0
5237932|NCT00838539|18075620|P11|Overall Study|Clinical Progression|0
5237933|NCT00838539|18075621|P10|Overall Study|Clinical Progression|0
5237934|NCT00838539|18075622|P9|Overall Study|Clinical Progression|0
5237935|NCT00838539|18075623|P8|Overall Study|Clinical Progression|0
5237936|NCT00838539|18075624|P7|Overall Study|Clinical Progression|1
5237937|NCT00838539|18075625|P6|Overall Study|Clinical Progression|0
5237938|NCT00838539|18075626|P5|Overall Study|Clinical Progression|0
5237939|NCT00838539|18075627|P4|Overall Study|Clinical Progression|0
5237940|NCT00838539|18075628|P3|Overall Study|Clinical Progression|0
5237941|NCT00838539|18075629|P2|Overall Study|Clinical Progression|0
5237942|NCT00838539|18075630|P1|Overall Study|Clinical Progression|0
5237943|NCT00838539|18075619|P12|Overall Study|Physician Decision|0
5237944|NCT00838539|18075620|P11|Overall Study|Physician Decision|0
5237945|NCT00838539|18075621|P10|Overall Study|Physician Decision|0
5237946|NCT00838539|18075622|P9|Overall Study|Physician Decision|1
5237947|NCT00838539|18075623|P8|Overall Study|Physician Decision|0
5237948|NCT00838539|18075624|P7|Overall Study|Physician Decision|0
5237949|NCT00838539|18075625|P6|Overall Study|Physician Decision|0
5237950|NCT00838539|18075626|P5|Overall Study|Physician Decision|0
5237951|NCT00838539|18075627|P4|Overall Study|Physician Decision|0
5237952|NCT00838539|18075628|P3|Overall Study|Physician Decision|0
5237953|NCT00838539|18075629|P2|Overall Study|Physician Decision|0
5237954|NCT00838539|18075630|P1|Overall Study|Physician Decision|0
5237955|NCT00838539|18075619|P12|Overall Study|Death|0
5237956|NCT00838539|18075620|P11|Overall Study|Death|0
5237957|NCT00838539|18075621|P10|Overall Study|Death|0
5237958|NCT00838539|18075622|P9|Overall Study|Death|0
5237959|NCT00838539|18075623|P8|Overall Study|Death|0
5237960|NCT00838539|18075624|P7|Overall Study|Death|1
5237961|NCT00838539|18075625|P6|Overall Study|Death|0
5237962|NCT00838539|18075626|P5|Overall Study|Death|0
5237963|NCT00838539|18075627|P4|Overall Study|Death|0
5237964|NCT00838539|18075628|P3|Overall Study|Death|0
5237965|NCT00838539|18075629|P2|Overall Study|Death|0
5237966|NCT00838539|18075630|P1|Overall Study|Death|0
5237967|NCT00838539|18075619|P12|Overall Study|Withdrawal by Subject|0
5237968|NCT00838539|18075620|P11|Overall Study|Withdrawal by Subject|2
5237969|NCT00838539|18075621|P10|Overall Study|Withdrawal by Subject|1
5237970|NCT00838539|18075622|P9|Overall Study|Withdrawal by Subject|0
5237971|NCT00838539|18075623|P8|Overall Study|Withdrawal by Subject|0
5237972|NCT00838539|18075624|P7|Overall Study|Withdrawal by Subject|0
5237973|NCT00838539|18075625|P6|Overall Study|Withdrawal by Subject|0
5237974|NCT00838539|18075626|P5|Overall Study|Withdrawal by Subject|0
5237975|NCT00838539|18075627|P4|Overall Study|Withdrawal by Subject|0
5237976|NCT00838539|18075628|P3|Overall Study|Withdrawal by Subject|0
5237977|NCT00838539|18075629|P2|Overall Study|Withdrawal by Subject|1
5237978|NCT00838539|18075630|P1|Overall Study|Withdrawal by Subject|0
5237979|NCT00838539|18075619|P12|Overall Study|Adverse Event|0
5237980|NCT00838539|18075620|P11|Overall Study|Adverse Event|2
5237981|NCT00838539|18075621|P10|Overall Study|Adverse Event|1
5237982|NCT00838539|18075622|P9|Overall Study|Adverse Event|0
5237983|NCT00838539|18075623|P8|Overall Study|Adverse Event|2
5237984|NCT00838539|18075624|P7|Overall Study|Adverse Event|0
5237985|NCT00838539|18075625|P6|Overall Study|Adverse Event|1
5237986|NCT00838539|18075626|P5|Overall Study|Adverse Event|2
5237987|NCT00838539|18075627|P4|Overall Study|Adverse Event|1
5237988|NCT00838539|18075628|P3|Overall Study|Adverse Event|1
5237989|NCT00838539|18075629|P2|Overall Study|Adverse Event|1
5237990|NCT00838539|18075630|P1|Overall Study|Adverse Event|1
5237991|NCT00838539|18075619|P12|Overall Study|Disease Progression|4
5237992|NCT00838539|18075620|P11|Overall Study|Disease Progression|1
5237993|NCT00838539|18075621|P10|Overall Study|Disease Progression|5
5237994|NCT00838539|18075622|P9|Overall Study|Disease Progression|4
5237995|NCT00838539|18075623|P8|Overall Study|Disease Progression|4
5237996|NCT00838539|18075624|P7|Overall Study|Disease Progression|3
5237997|NCT00838539|18075625|P6|Overall Study|Disease Progression|2
5237998|NCT00838539|18075626|P5|Overall Study|Disease Progression|4
5237999|NCT00838539|18075627|P4|Overall Study|Disease Progression|2
5238000|NCT00838539|18075628|P3|Overall Study|Disease Progression|3
5238001|NCT00838539|18075629|P2|Overall Study|Disease Progression|4
5238002|NCT00838539|18075630|P1|Overall Study|Disease Progression|2
5238003|NCT00838526|18075680|P2|Overall Study|Other|7
5238004|NCT00838526|18075681|P1|Overall Study|Other|11
5238005|NCT00838526|18075680|P2|Overall Study|Lack of Efficacy|3
5238006|NCT00838526|18075681|P1|Overall Study|Lack of Efficacy|2
5238007|NCT00838526|18075680|P2|Overall Study|Withdrawal by Subject|5
5238008|NCT00838526|18075681|P1|Overall Study|Withdrawal by Subject|4
5238009|NCT00838526|18075680|P2|Overall Study|Lost to Follow-up|12
5238010|NCT00838526|18075681|P1|Overall Study|Lost to Follow-up|4
5238011|NCT00838526|18075680|P2|Overall Study|Adverse Event|12
5238012|NCT00838526|18075681|P1|Overall Study|Adverse Event|3
5238013|NCT00838513|18075689|P1|Post Treatment Period (Patients Who Disc|Death|1
5238014|NCT00838513|18075689|P1|Extension Treatment Period|Death|1
5238015|NCT00838513|18075689|P1|Screening Period|Screen Failure|3
5238016|NCT00838331|18075705|P1|Aged Blood Transfusion|Withdrawal by Subject|9
5238017|NCT00838279|18075711|P2|Washout|Withdrawal by Subject|1
5238018|NCT00838279|18075712|P1|Washout|Withdrawal by Subject|0
5238019|NCT00838279|18075711|P2|Washout|Protocol Violation|0
5238020|NCT00838279|18075712|P1|Washout|Protocol Violation|1
5238021|NCT00838201|18075722|P2|Overall Study|Death|13
5238022|NCT00838201|18075723|P1|Overall Study|Death|11
5238023|NCT00838201|18075722|P2|Overall Study|Adverse Event|9
5238024|NCT00838201|18075723|P1|Overall Study|Adverse Event|5
5238025|NCT00838201|18075722|P2|Overall Study|Lost to Follow-up|3
5238026|NCT00838201|18075723|P1|Overall Study|Lost to Follow-up|4
5238027|NCT00838201|18075722|P2|Overall Study|Consent withdrawn|19
5238028|NCT00838201|18075723|P1|Overall Study|Consent withdrawn|16
5238029|NCT00838201|18075722|P2|Overall Study|Disease progression|3
5238030|NCT00838201|18075723|P1|Overall Study|Disease progression|3
5238031|NCT00838201|18075722|P2|Overall Study|Administrative decision|2
5238032|NCT00838201|18075723|P1|Overall Study|Administrative decision|1
5238033|NCT00838201|18075722|P2|Overall Study|Noncompliance|1
5238034|NCT00838201|18075723|P1|Overall Study|Noncompliance|0
5238035|NCT00838201|18075722|P2|Overall Study|Investigator decision, or other reasons|3
5238036|NCT00838201|18075723|P1|Overall Study|Investigator decision, or other reasons|2
5238037|NCT00838110|18075791|P4|Overall Study|Randomized but not treated|0
5238038|NCT00838110|18075792|P3|Overall Study|Randomized but not treated|0
5238039|NCT00838110|18075793|P2|Overall Study|Randomized but not treated|1
5238040|NCT00838110|18075794|P1|Overall Study|Randomized but not treated|0
5238041|NCT00838110|18075791|P4|Overall Study|Did not meet eligibility criteria|2
5238042|NCT00838110|18075792|P3|Overall Study|Did not meet eligibility criteria|1
5238043|NCT00838110|18075793|P2|Overall Study|Did not meet eligibility criteria|0
5238044|NCT00838110|18075794|P1|Overall Study|Did not meet eligibility criteria|0
5238045|NCT00838110|18075791|P4|Overall Study|Lost to Follow-up|0
5238046|NCT00838110|18075792|P3|Overall Study|Lost to Follow-up|0
5238047|NCT00838110|18075793|P2|Overall Study|Lost to Follow-up|0
5238048|NCT00838110|18075794|P1|Overall Study|Lost to Follow-up|3
5238049|NCT00838110|18075791|P4|Overall Study|Protocol Violation|1
5238050|NCT00838110|18075792|P3|Overall Study|Protocol Violation|1
5238051|NCT00838110|18075793|P2|Overall Study|Protocol Violation|2
5238052|NCT00838110|18075794|P1|Overall Study|Protocol Violation|0
5238053|NCT00838110|18075791|P4|Overall Study|Other|2
5238054|NCT00838110|18075792|P3|Overall Study|Other|3
5238055|NCT00838110|18075793|P2|Overall Study|Other|3
5238056|NCT00838110|18075794|P1|Overall Study|Other|3
5238057|NCT00838110|18075791|P4|Overall Study|Withdrawal by Subject|4
5238058|NCT00838110|18075792|P3|Overall Study|Withdrawal by Subject|3
5238059|NCT00838110|18075793|P2|Overall Study|Withdrawal by Subject|6
5238060|NCT00838110|18075794|P1|Overall Study|Withdrawal by Subject|5
5238061|NCT00838110|18075791|P4|Overall Study|Adverse Event|7
5238062|NCT00838110|18075792|P3|Overall Study|Adverse Event|8
5238063|NCT00838110|18075793|P2|Overall Study|Adverse Event|10
5238064|NCT00838110|18075794|P1|Overall Study|Adverse Event|11
5238065|NCT00838110|18075791|P4|Overall Study|Death|2
5238066|NCT00838110|18075792|P3|Overall Study|Death|1
5238067|NCT00838110|18075793|P2|Overall Study|Death|0
5238068|NCT00838110|18075794|P1|Overall Study|Death|0
5238069|NCT00838097|18075814|P1|Overall Study|Protocol-specified criteria|142
5238070|NCT00838097|18075814|P1|Overall Study|Death|6
5238071|NCT00838097|18075814|P1|Overall Study|Lost to Follow-up|11
5238072|NCT00838097|18075814|P1|Overall Study|Physician Decision|4
5238073|NCT00838097|18075814|P1|Overall Study|Requirement for alternative therapy|2
5238074|NCT00838097|18075814|P1|Overall Study|Withdrawal by Subject|3
5238075|NCT00838097|18075814|P1|Overall Study|Adverse Event|2
5238076|NCT00838097|18075814|P1|Overall Study|Ineligibility determined|6
5238077|NCT00837967|18075838|P2|Washout Period of 7 - 14 Days|Adverse Event|0
5238078|NCT00837967|18075839|P1|Washout Period of 7 - 14 Days|Adverse Event|2
5238079|NCT00837876|18075865|P1|Overall Study|disease progression|24
5238080|NCT00837876|18075865|P1|Overall Study|Withdrawal by Subject|3
5238081|NCT00837876|18075865|P1|Overall Study|Physician Decision|1
5238082|NCT00837876|18075865|P1|Overall Study|Adverse Event|7
5238083|NCT00837876|18075865|P1|Overall Study|Death|2
5238084|NCT00837811|18075887|P3|Overall Study|Sponsor Decision|0
5238085|NCT00837811|18075888|P2|Overall Study|Sponsor Decision|2
5238086|NCT00837811|18075889|P1|Overall Study|Sponsor Decision|0
5238087|NCT00837811|18075887|P3|Overall Study|Withdrawal by Subject|0
5238088|NCT00837811|18075888|P2|Overall Study|Withdrawal by Subject|9
5238089|NCT00837811|18075889|P1|Overall Study|Withdrawal by Subject|1
5238090|NCT00837811|18075887|P3|Overall Study|Physician Decision|1
5238091|NCT00837811|18075888|P2|Overall Study|Physician Decision|2
5238092|NCT00837811|18075889|P1|Overall Study|Physician Decision|0
5238093|NCT00837811|18075887|P3|Overall Study|Lost to Follow-up|0
5238094|NCT00837811|18075888|P2|Overall Study|Lost to Follow-up|3
5238095|NCT00837811|18075889|P1|Overall Study|Lost to Follow-up|1
5238096|NCT00837811|18075887|P3|Overall Study|Lack of Efficacy|0
5238097|NCT00837811|18075888|P2|Overall Study|Lack of Efficacy|11
5238098|NCT00837811|18075889|P1|Overall Study|Lack of Efficacy|0
5238099|NCT00837811|18075887|P3|Overall Study|Death|0
5238100|NCT00837811|18075888|P2|Overall Study|Death|1
5238101|NCT00837811|18075889|P1|Overall Study|Death|1
5238102|NCT00837811|18075887|P3|Overall Study|Adverse Event|0
5238103|NCT00837811|18075888|P2|Overall Study|Adverse Event|6
5238104|NCT00837811|18075889|P1|Overall Study|Adverse Event|4
5238105|NCT00837759|18075974|P1|Overall Study|Lost to Follow-up|1
5238106|NCT00837759|18075974|P1|Overall Study|Protocol Violation|3
5238107|NCT00837694|18075989|P6|Overall Study|Lost to Follow-up|1
5238108|NCT00837694|18075990|P5|Overall Study|Lost to Follow-up|1
5238109|NCT00837694|18075991|P4|Overall Study|Lost to Follow-up|1
5238110|NCT00837694|18075992|P3|Overall Study|Lost to Follow-up|2
5238111|NCT00837694|18075993|P2|Overall Study|Lost to Follow-up|0
5238112|NCT00837694|18075994|P1|Overall Study|Lost to Follow-up|2
5238113|NCT00837616|18076010|P2|Overall Study|Withdrawal by Subject|1
5238114|NCT00837616|18076011|P1|Overall Study|Withdrawal by Subject|0
5238115|NCT00837577|18076050|P2|Open-label Period|Other Reason|1
5238116|NCT00837577|18076051|P1|Open-label Period|Other Reason|1
5238117|NCT00837577|18076050|P2|Open-label Period|Withdrawal by Subject|2
5238118|NCT00837577|18076051|P1|Open-label Period|Withdrawal by Subject|1
5238119|NCT00837577|18076050|P2|Open-label Period|Lack of Efficacy|3
5238120|NCT00837577|18076051|P1|Open-label Period|Lack of Efficacy|4
5238121|NCT00837577|18076050|P2|Open-label Period|Laboratory Adverse Event|1
5238122|NCT00837577|18076051|P1|Open-label Period|Laboratory Adverse Event|0
5238123|NCT00837577|18076050|P2|Open-label Period|Clinical Adverse Event|2
5238124|NCT00837577|18076051|P1|Open-label Period|Clinical Adverse Event|2
5238125|NCT00837577|18076050|P2|Double-blind Period|Withdrawal by Subject|0
5238126|NCT00837577|18076051|P1|Double-blind Period|Withdrawal by Subject|1
5238127|NCT00837577|18076050|P2|Double-blind Period|Clinical Adverse Event|0
5238128|NCT00837577|18076051|P1|Double-blind Period|Clinical Adverse Event|1
5238129|NCT00837486|18076071|P2|Long-term Follow-up Phase - Open Label|Death|0
5238130|NCT00837486|18076072|P1|Long-term Follow-up Phase - Open Label|Death|1
5238131|NCT00837486|18076071|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
5238132|NCT00837486|18076072|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
5238133|NCT00837486|18076071|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
5238134|NCT00837486|18076072|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
5238135|NCT00837486|18076071|P2|Blinded-treatment Phase|Physician Decision|0
5238136|NCT00837486|18076072|P1|Blinded-treatment Phase|Physician Decision|1
5238137|NCT00837473|18076084|P1|Overall Study|Withdrawal by Subject|2
5238138|NCT00837473|18076084|P1|Overall Study|Lost to Follow-up|1
5238139|NCT00837434|18076104|P2|Overall Study|Unable to obtain study drug|0
5238140|NCT00837434|18076105|P1|Overall Study|Unable to obtain study drug|1
5238141|NCT00837434|18076104|P2|Overall Study|Baseline assessments not done in time|0
5238142|NCT00837434|18076105|P1|Overall Study|Baseline assessments not done in time|1
5238143|NCT00837434|18076104|P2|Overall Study|Noncompliant|0
5238144|NCT00837434|18076105|P1|Overall Study|Noncompliant|2
5238145|NCT00837434|18076104|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
5238146|NCT00837434|18076105|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
5238147|NCT00837434|18076104|P2|Overall Study|Lost to Follow-up|1
5238148|NCT00837434|18076105|P1|Overall Study|Lost to Follow-up|1
5238149|NCT00837434|18076104|P2|Overall Study|Physician Decision|0
5238150|NCT00837434|18076105|P1|Overall Study|Physician Decision|3
5238151|NCT00837330|18076125|P2|Overall Study|Lost to Follow-up|3
5238152|NCT00837330|18076126|P1|Overall Study|Lost to Follow-up|1
5238153|NCT00837213|18076149|P2|Overall Study|not stated|1
5238154|NCT00837213|18076150|P1|Overall Study|not stated|1
5238155|NCT00837213|18076149|P2|Overall Study|Withdrawal by Subject|2
5238156|NCT00837213|18076150|P1|Overall Study|Withdrawal by Subject|2
5238157|NCT00837213|18076149|P2|Overall Study|Lost to Follow-up|2
5238158|NCT00837213|18076150|P1|Overall Study|Lost to Follow-up|3
5238159|NCT00837161|18076176|P1|Overall Study|refused hysterectomy|2
5238160|NCT00837148|18076184|P1|Overall Study|Death|1
5238161|NCT00837148|18076184|P1|Overall Study|Adverse Event|1
5238162|NCT00837096|18076190|P2|Overall Study|Not reported|8
5238163|NCT00837096|18076191|P1|Overall Study|Not reported|9
5238164|NCT00837096|18076190|P2|Overall Study|Physician Decision|1
5238165|NCT00837096|18076191|P1|Overall Study|Physician Decision|1
5238166|NCT00836953|18076203|P1|Overall Study|Lost to Follow-up|1
5238167|NCT00836953|18076203|P1|Overall Study|Withdrawal by Subject|1
5238168|NCT00836927|18076214|P5|Overall Study|Withdrawal by Subject|0
5238169|NCT00836927|18076215|P4|Overall Study|Withdrawal by Subject|0
5238170|NCT00836927|18076216|P3|Overall Study|Withdrawal by Subject|0
5238171|NCT00836927|18076217|P2|Overall Study|Withdrawal by Subject|0
5238172|NCT00836927|18076218|P1|Overall Study|Withdrawal by Subject|1
5238173|NCT00836927|18076214|P5|Overall Study|Progressive disease|1
5238174|NCT00836927|18076215|P4|Overall Study|Progressive disease|1
5238175|NCT00836927|18076216|P3|Overall Study|Progressive disease|0
5238176|NCT00836927|18076217|P2|Overall Study|Progressive disease|0
5238177|NCT00836927|18076218|P1|Overall Study|Progressive disease|2
5238178|NCT00836901|18076254|P2|First Intervention|Withdrawal by Subject|0
5238179|NCT00836901|18076255|P1|First Intervention|Withdrawal by Subject|1
5238180|NCT00836875|18076304|P2|Overall Study|Withdrawal by Subject|1
5238181|NCT00836875|18076305|P1|Overall Study|Withdrawal by Subject|0
5238182|NCT00836875|18076304|P2|Overall Study|Death|2
5238183|NCT00836875|18076305|P1|Overall Study|Death|3
5238184|NCT00836810|18076321|P2|Overall Study|New diagnosis|0
5238185|NCT00836810|18076322|P1|Overall Study|New diagnosis|1
5238186|NCT00836745|18076344|P1|Overall Study|Other|2
5238187|NCT00836745|18076344|P1|Overall Study|Objective progression or relapse|4
5238188|NCT00836745|18076344|P1|Overall Study|Adverse Event|3
5238189|NCT00836745|18076344|P1|Overall Study|Lost to Follow-up|10
5238190|NCT00836745|18076344|P1|Overall Study|Death|2
5238191|NCT00836706|18076358|P2|Washout: 7 Days|Withdrawal by Subject|1
5238192|NCT00836706|18076359|P1|Washout: 7 Days|Withdrawal by Subject|0
5238193|NCT00836693|18076369|P2|Overall Study|Lost to Follow-up|0
5238194|NCT00836693|18076370|P1|Overall Study|Lost to Follow-up|1
5238195|NCT00836693|18076369|P2|Overall Study|Protocol Violation|0
5238196|NCT00836693|18076370|P1|Overall Study|Protocol Violation|1
5238197|NCT00836693|18076369|P2|Overall Study|Withdrawal by Subject|4
5238198|NCT00836693|18076370|P1|Overall Study|Withdrawal by Subject|9
5238199|NCT00836693|18076369|P2|Overall Study|Physician Decision|0
5238200|NCT00836693|18076370|P1|Overall Study|Physician Decision|2
5238201|NCT00836693|18076369|P2|Overall Study|Sponsor Decision|1
5238202|NCT00836693|18076370|P1|Overall Study|Sponsor Decision|0
5238203|NCT00836693|18076369|P2|Overall Study|Adverse Event|1
5238204|NCT00836693|18076370|P1|Overall Study|Adverse Event|4
5238205|NCT00836589|18076420|P1|Overall Study|Withdrawal by Subject or Physician|591
5238206|NCT00836589|18076420|P1|Overall Study|Death|429
5238207|NCT00836589|18076420|P1|Overall Study|Lost to Follow-up|246
5238208|NCT00836498|18076453|P2|Overall Study|Withdrawal by Subject|1
5238209|NCT00836498|18076454|P1|Overall Study|Withdrawal by Subject|2
5238210|NCT00836498|18076453|P2|Overall Study|Lost to Follow-up|0
5238211|NCT00836498|18076454|P1|Overall Study|Lost to Follow-up|1
5238212|NCT00836498|18076453|P2|Overall Study|Adverse Event|0
5238213|NCT00836498|18076454|P1|Overall Study|Adverse Event|1
5238214|NCT00836472|18076486|P2|Washout|Withdrawal by Subject|1
5238215|NCT00836472|18076487|P1|Washout|Withdrawal by Subject|1
5238216|NCT00836472|18076486|P2|Washout|Adverse Event|2
5238217|NCT00836472|18076487|P1|Washout|Adverse Event|1
5238218|NCT00836277|18076564|P1|Overall Study|Not evaluable for response|6
5238219|NCT00836186|18076572|P1|Overall Study|Blood could not be drawn|1
5238220|NCT00836095|18076580|P2|Overall Study|Physician Decision|3
5238221|NCT00836095|18076581|P1|Overall Study|Physician Decision|0
5238222|NCT00836056|18076591|P2|First Intervention|Adverse Event|0
5238223|NCT00836056|18076592|P1|First Intervention|Adverse Event|1
5238224|NCT00835991|18076621|P2|Washout|Withdrawal by Subject|1
5238225|NCT00835991|18076622|P1|Washout|Withdrawal by Subject|3
5238226|NCT00835991|18076621|P2|Washout|Protocol Violation|2
5238227|NCT00835991|18076622|P1|Washout|Protocol Violation|0
5238228|NCT00835991|18076621|P2|First Intervention|Adverse Event|1
5238229|NCT00835991|18076622|P1|First Intervention|Adverse Event|0
5238230|NCT00835978|18076640|P4|Overall Study|Study terminated by sponsor|0
5238231|NCT00835978|18076641|P3|Overall Study|Study terminated by sponsor|30
5238232|NCT00835978|18076642|P2|Overall Study|Study terminated by sponsor|8
5238233|NCT00835978|18076643|P1|Overall Study|Study terminated by sponsor|12
5238234|NCT00835978|18076640|P4|Overall Study|Withdrawal by Subject|5
5238235|NCT00835978|18076641|P3|Overall Study|Withdrawal by Subject|0
5238236|NCT00835978|18076642|P2|Overall Study|Withdrawal by Subject|3
5238237|NCT00835978|18076643|P1|Overall Study|Withdrawal by Subject|0
5238238|NCT00835978|18076640|P4|Overall Study|Adverse Event|0
5238239|NCT00835978|18076641|P3|Overall Study|Adverse Event|1
5238240|NCT00835978|18076642|P2|Overall Study|Adverse Event|0
5238241|NCT00835978|18076643|P1|Overall Study|Adverse Event|1
5238242|NCT00835978|18076640|P4|Overall Study|Objective progression or relapse|0
5238243|NCT00835978|18076641|P3|Overall Study|Objective progression or relapse|1
5238244|NCT00835978|18076642|P2|Overall Study|Objective progression or relapse|0
5238245|NCT00835978|18076643|P1|Overall Study|Objective progression or relapse|2
5238246|NCT00835978|18076640|P4|Overall Study|Other|0
5238247|NCT00835978|18076641|P3|Overall Study|Other|8
5238248|NCT00835978|18076642|P2|Overall Study|Other|1
5238249|NCT00835978|18076643|P1|Overall Study|Other|5
5238250|NCT00835978|18076640|P4|Overall Study|Lost to Follow-up|1
5238251|NCT00835978|18076641|P3|Overall Study|Lost to Follow-up|2
5238252|NCT00835978|18076642|P2|Overall Study|Lost to Follow-up|4
5238253|NCT00835978|18076643|P1|Overall Study|Lost to Follow-up|3
5238254|NCT00835978|18076640|P4|Overall Study|Death|4
5238255|NCT00835978|18076641|P3|Overall Study|Death|49
5238256|NCT00835978|18076642|P2|Overall Study|Death|40
5238257|NCT00835978|18076643|P1|Overall Study|Death|33
5238258|NCT00835796|18076754|P2|First Intervention|Withdrawal by Subject|1
5238259|NCT00835796|18076755|P1|First Intervention|Withdrawal by Subject|0
5238260|NCT00835731|18076765|P2|Overall Study|Physician Decision|1
5238261|NCT00835731|18076766|P1|Overall Study|Physician Decision|1
5238262|NCT00835731|18076765|P2|Overall Study|Withdrawal by Subject|0
5238263|NCT00835731|18076766|P1|Overall Study|Withdrawal by Subject|1
5238264|NCT00835705|18076786|P2|Second Intervention|Difficulty with vein|0
5238265|NCT00835705|18076787|P1|Second Intervention|Difficulty with vein|1
5238266|NCT00835705|18076786|P2|First Intervention|Difficulty with vein|0
5238267|NCT00835705|18076787|P1|First Intervention|Difficulty with vein|1
5238268|NCT00835692|18076803|P2|First Intervention|Withdrawal by Subject|0
5238269|NCT00835692|18076804|P1|First Intervention|Withdrawal by Subject|1
5238270|NCT00835679|18076816|P4|Overall Study|Withdrawal by Subject|0
5238271|NCT00835679|18076817|P3|Overall Study|Withdrawal by Subject|0
5238272|NCT00835679|18076818|P2|Overall Study|Withdrawal by Subject|0
5238273|NCT00835679|18076819|P1|Overall Study|Withdrawal by Subject|1
5238274|NCT00835666|18076843|P2|Washout|Withdrawal by Subject|0
5238275|NCT00835666|18076844|P1|Washout|Withdrawal by Subject|1
5238276|NCT00835666|18076843|P2|Washout|Protocol Violation|0
5238277|NCT00835666|18076844|P1|Washout|Protocol Violation|1
5238278|NCT00835640|18076854|P2|Second Intervention|Protocol Violation|0
5238279|NCT00835640|18076855|P1|Second Intervention|Protocol Violation|1
5238280|NCT00835575|18076887|P2|Washout of 14 Days|Withdrawal by Subject|0
5238281|NCT00835575|18076888|P1|Washout of 14 Days|Withdrawal by Subject|1
5238282|NCT00835549|18076898|P2|Washout of 7 Days|Withdrawal by Subject|0
5238283|NCT00835549|18076899|P1|Washout of 7 Days|Withdrawal by Subject|2
5238284|NCT00835536|18076909|P2|Washout of 5 Weeks|Withdrawal by Subject|0
5238285|NCT00835536|18076910|P1|Washout of 5 Weeks|Withdrawal by Subject|1
5238286|NCT00835406|18076971|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
5238287|NCT00835406|18076972|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
5238288|NCT00835406|18076971|P2|Period: First Intervention|Withdrawal by Subject|0
5238289|NCT00835406|18076972|P1|Period: First Intervention|Withdrawal by Subject|2
5238290|NCT00835406|18076971|P2|Period: First Intervention|Adverse Event|1
5238291|NCT00835406|18076972|P1|Period: First Intervention|Adverse Event|0
5238292|NCT00835380|18076978|P1|Overall Study|Withdrawal by Subject|2
5238293|NCT00835367|18076985|P2|Second Intervention|Adverse Event|1
5238294|NCT00835367|18076986|P1|Second Intervention|Adverse Event|1
5238295|NCT00835367|18076985|P2|Washout|Withdrawal by Subject|0
5238296|NCT00835367|18076986|P1|Washout|Withdrawal by Subject|1
5238297|NCT00835367|18076985|P2|Washout|Adverse Event|0
5238298|NCT00835367|18076986|P1|Washout|Adverse Event|2
5238299|NCT00835354|18077008|P2|First Intervention|Adverse Event|1
5238300|NCT00835354|18077009|P1|First Intervention|Adverse Event|0
5238301|NCT00835341|18077019|P2|Overall Study|Lost to Follow-up|12
5238302|NCT00835341|18077020|P1|Overall Study|Lost to Follow-up|3
5238303|NCT00835263|18077083|P2|Second Intervention|Adverse Event|0
5238304|NCT00835263|18077084|P1|Second Intervention|Adverse Event|1
5238305|NCT00835237|18077094|P2|Overall Study|Withdrawal by Subject|0
5238306|NCT00835237|18077095|P1|Overall Study|Withdrawal by Subject|2
5238307|NCT00835237|18077094|P2|Overall Study|Lost to Follow-up|0
5238308|NCT00835237|18077095|P1|Overall Study|Lost to Follow-up|4
5238309|NCT00835211|18077135|P2|Washout: 7 Days|Withdrawal by Subject|0
5238310|NCT00835211|18077136|P1|Washout: 7 Days|Withdrawal by Subject|1
5238311|NCT00835211|18077135|P2|Washout: 7 Days|Adverse Event|1
5238312|NCT00835211|18077136|P1|Washout: 7 Days|Adverse Event|2
5238313|NCT00835211|18077135|P2|First Intervention|Withdrawal by Subject|1
5238314|NCT00835211|18077136|P1|First Intervention|Withdrawal by Subject|0
5238315|NCT00835172|18077182|P2|Washout|Protocol Violation|1
5238316|NCT00835172|18077183|P1|Washout|Protocol Violation|0
5238317|NCT00835120|18077209|P1|Overall Study|Withdrawal by Subject|2
5238318|NCT00835120|18077209|P1|Overall Study|Adverse Event|2
5238319|NCT00835120|18077209|P1|Overall Study|Lost to Follow-up|3
5238320|NCT00835120|18077209|P1|Overall Study|Lack of Efficacy|1
5238321|NCT00835081|18077219|P2|Washout of 7 Days|Withdrawal by Subject|0
5238322|NCT00835081|18077220|P1|Washout of 7 Days|Withdrawal by Subject|1
5238323|NCT00835068|18077230|P2|Overall Study|Withdrawal by Subject|0
5238324|NCT00835068|18077231|P1|Overall Study|Withdrawal by Subject|1
5238325|NCT00835068|18077230|P2|Overall Study|Other|0
5238326|NCT00835068|18077231|P1|Overall Study|Other|8
5238327|NCT00835068|18077230|P2|Overall Study|Adverse Event|1
5238328|NCT00835068|18077231|P1|Overall Study|Adverse Event|0
5238329|NCT00835068|18077230|P2|Overall Study|Death|0
5238330|NCT00835068|18077231|P1|Overall Study|Death|1
5238331|NCT00835042|18077251|P2|Washout of 21 Days|Withdrawal by Subject|2
5238332|NCT00835042|18077252|P1|Washout of 21 Days|Withdrawal by Subject|0
5238333|NCT00835042|18077251|P2|First Intervention|Adverse Event|2
5238334|NCT00835042|18077252|P1|First Intervention|Adverse Event|1
5238335|NCT00835042|18077251|P2|First Intervention|Withdrawal by Subject|0
5238336|NCT00835042|18077252|P1|First Intervention|Withdrawal by Subject|3
5238337|NCT00834912|18077338|P6|Treatment Period 2|Withdrawal by Subject|0
5238338|NCT00834912|18077339|P5|Treatment Period 2|Withdrawal by Subject|1
5238339|NCT00834912|18077340|P4|Treatment Period 2|Withdrawal by Subject|0
5238340|NCT00834912|18077341|P3|Treatment Period 2|Withdrawal by Subject|1
5238341|NCT00834912|18077342|P2|Treatment Period 2|Withdrawal by Subject|0
5238342|NCT00834912|18077343|P1|Treatment Period 2|Withdrawal by Subject|0
5238343|NCT00834912|18077338|P6|Treatment Period 1|Adverse Event|0
5238344|NCT00834912|18077339|P5|Treatment Period 1|Adverse Event|0
5238345|NCT00834912|18077340|P4|Treatment Period 1|Adverse Event|1
5238346|NCT00834912|18077341|P3|Treatment Period 1|Adverse Event|0
5238347|NCT00834912|18077342|P2|Treatment Period 1|Adverse Event|1
5238348|NCT00834912|18077343|P1|Treatment Period 1|Adverse Event|0
5238349|NCT00834899|18077365|P2|Overall Study|Withdrawal by Subject|1
5238350|NCT00834899|18077366|P1|Overall Study|Withdrawal by Subject|1
5238351|NCT00834873|18077405|P2|First Intervention|Adverse Event|1
5238352|NCT00834873|18077406|P1|First Intervention|Adverse Event|0
5238353|NCT00834834|18077416|P2|Overall Study|Withdrawal by Subject|3
5238354|NCT00834834|18077417|P1|Overall Study|Withdrawal by Subject|4
5238355|NCT00834795|18077452|P2|Second Intervention|Adverse Event|0
5238356|NCT00834795|18077453|P1|Second Intervention|Adverse Event|1
5238357|NCT00834795|18077452|P2|Washout: 7 Days|Withdrawal by Subject|1
5238358|NCT00834795|18077453|P1|Washout: 7 Days|Withdrawal by Subject|0
5238359|NCT00834756|18077463|P2|Washout: 21 Days|Withdrawal by Subject|0
5238360|NCT00834756|18077464|P1|Washout: 21 Days|Withdrawal by Subject|1
5238361|NCT00834756|18077463|P2|First Intervention|Adverse Event|0
5238362|NCT00834756|18077464|P1|First Intervention|Adverse Event|1
5238363|NCT00834743|18077474|P2|Second Intervention|Withdrawal by Subject|0
5238364|NCT00834743|18077475|P1|Second Intervention|Withdrawal by Subject|1
5238365|NCT00834717|18077485|P2|First Intervention|Withdrawal by Subject|1
5238366|NCT00834717|18077486|P1|First Intervention|Withdrawal by Subject|0
5238367|NCT00834717|18077485|P2|First Intervention|Adverse Event|0
5238368|NCT00834717|18077486|P1|First Intervention|Adverse Event|1
5238369|NCT00834639|18077517|P2|Second Intervention|Physician Decision|2
5238370|NCT00834639|18077518|P1|Second Intervention|Physician Decision|0
5238371|NCT00834613|18077535|P2|First Intervention|Protocol Violation|0
5238372|NCT00834613|18077536|P1|First Intervention|Protocol Violation|1
5238373|NCT00834587|18077546|P2|Washout: 7 Days|Withdrawal by Subject|0
5238374|NCT00834587|18077547|P1|Washout: 7 Days|Withdrawal by Subject|1
5238375|NCT00834522|18077596|P2|Washout|Withdrawal by Subject|1
5238376|NCT00834522|18077597|P1|Washout|Withdrawal by Subject|2
5238377|NCT00834522|18077596|P2|Washout|Adverse Event|0
5238378|NCT00834522|18077597|P1|Washout|Adverse Event|1
5238379|NCT00834444|18077620|P2|Second Intervention|Adverse Event|0
5238380|NCT00834444|18077621|P1|Second Intervention|Adverse Event|1
5238381|NCT00834444|18077620|P2|Washout of 7 Days|Withdrawal by Subject|1
5238382|NCT00834444|18077621|P1|Washout of 7 Days|Withdrawal by Subject|0
5238383|NCT00834444|18077620|P2|First Intervention|Intolerance to Venopuncture|1
5238384|NCT00834444|18077621|P1|First Intervention|Intolerance to Venopuncture|0
5238385|NCT00834444|18077620|P2|First Intervention|Adverse Event|0
5238386|NCT00834444|18077621|P1|First Intervention|Adverse Event|1
5238387|NCT00834431|18077631|P2|Washout of 7 Days|Withdrawal by Subject|1
5238388|NCT00834431|18077632|P1|Washout of 7 Days|Withdrawal by Subject|0
5238389|NCT00834431|18077631|P2|First Intervention|Adverse Event|1
5238390|NCT00834431|18077632|P1|First Intervention|Adverse Event|0
5238391|NCT00834418|18077642|P2|Overall Study|Adverse Event|2
5238392|NCT00834418|18077643|P1|Overall Study|Adverse Event|0
5238393|NCT00834366|18077660|P2|Treatment Period 1|Adverse Event|1
5238394|NCT00834366|18077661|P1|Treatment Period 1|Adverse Event|1
5238395|NCT00834340|18077677|P2|Washout|Withdrawal by Subject|0
5238396|NCT00834340|18077678|P1|Washout|Withdrawal by Subject|1
5238397|NCT00834340|18077677|P2|Washout|Adverse Event|0
5238398|NCT00834340|18077678|P1|Washout|Adverse Event|1
5238399|NCT00834249|18077722|P2|Second Intervention|Adverse Event|0
5238400|NCT00834249|18077723|P1|Second Intervention|Adverse Event|1
5238401|NCT00834249|18077722|P2|Washout: 7 Days|Withdrawal by Subject|1
5238402|NCT00834249|18077723|P1|Washout: 7 Days|Withdrawal by Subject|1
5238403|NCT00834080|18077819|P1|Overall Study|Subject Relocated|1
5238404|NCT00834080|18077819|P1|Overall Study|Physician Decision|1
5238405|NCT00834080|18077819|P1|Overall Study|Other - False positive tests of the UDS|1
5238406|NCT00834080|18077819|P1|Overall Study|Other - Pregnancy|1
5238407|NCT00834080|18077819|P1|Overall Study|Withdrawal by Subject|5
5238408|NCT00834080|18077819|P1|Overall Study|Lost to Follow-up|7
5238409|NCT00834080|18077819|P1|Overall Study|Adverse Event|7
5238410|NCT00834067|18077825|P2|Washout of 21 Days|Protocol Violation|1
5238411|NCT00834067|18077826|P1|Washout of 21 Days|Protocol Violation|0
5238412|NCT00834041|18077848|P2|Overall Study|Lost to Follow-up|1
5238413|NCT00834041|18077849|P1|Overall Study|Lost to Follow-up|0
5238414|NCT00834041|18077848|P2|Overall Study|Withdrawal by Subject|0
5238415|NCT00834041|18077849|P1|Overall Study|Withdrawal by Subject|1
5238416|NCT00833989|18077867|P4|Overall Study|Withdrawal by Subject|1
5238417|NCT00833989|18077868|P3|Overall Study|Withdrawal by Subject|1
5238418|NCT00833989|18077869|P2|Overall Study|Withdrawal by Subject|0
5238419|NCT00833989|18077870|P1|Overall Study|Withdrawal by Subject|3
5238420|NCT00833989|18077867|P4|Overall Study|Physician Decision|1
5238421|NCT00833989|18077868|P3|Overall Study|Physician Decision|0
5238422|NCT00833989|18077869|P2|Overall Study|Physician Decision|0
5238423|NCT00833989|18077870|P1|Overall Study|Physician Decision|0
5238424|NCT00833976|18077974|P1|Overall Study|Physician Decision|1
5238425|NCT00833976|18077974|P1|Overall Study|Did not meet eligibility criteria|41
5238426|NCT00833976|18077974|P1|Overall Study|Lost to Follow-up|4
5238427|NCT00833976|18077974|P1|Overall Study|Withdrawal by Subject|5
5238428|NCT00833937|18077982|P2|Washout|Withdrawal by Subject|0
5238429|NCT00833937|18077983|P1|Washout|Withdrawal by Subject|1
5238430|NCT00833924|18077991|P1|Overall Study|In study follow-up|71
5238431|NCT00833924|18077991|P1|Overall Study|Withdrawal by Subject|13
5238432|NCT00833924|18077991|P1|Overall Study|Lost to Follow-up|2
5238433|NCT00833924|18077991|P1|Overall Study|Conversion|2
5238434|NCT00833924|18077991|P1|Overall Study|Death|21
5238435|NCT00833911|18077996|P1|Maintenance Phase II|Lack of Efficacy|1
5238436|NCT00833911|18077996|P1|Maintenance Phase II|Withdrawal by Subject|1
5238437|NCT00833911|18077996|P1|Maintenance Phase II|Physician Decision|2
5238438|NCT00833911|18077996|P1|Maintenance Phase II|Adverse Event|6
5238439|NCT00833911|18077996|P1|Maintenance Phase I|Lack of Efficacy|4
5238440|NCT00833911|18077996|P1|Maintenance Phase I|Physician Decision|10
5238441|NCT00833911|18077996|P1|Maintenance Phase I|Withdrawal by Subject|11
5238442|NCT00833911|18077996|P1|Maintenance Phase I|Adverse Event|73
5238443|NCT00833911|18077996|P1|Titration|Withdrawal by Subject|3
5238444|NCT00833911|18077996|P1|Titration|Adverse Event|18
5238445|NCT00833898|18078006|P2|Overall Study|Patient did not receive transplant|2
5238446|NCT00833898|18078007|P1|Overall Study|Patient did not receive transplant|0
5238447|NCT00833898|18078006|P2|Overall Study|Lost to Follow-up|7
5238448|NCT00833898|18078007|P1|Overall Study|Lost to Follow-up|7
5238449|NCT00833898|18078006|P2|Overall Study|Withdrawal by Subject|27
5238450|NCT00833898|18078007|P1|Overall Study|Withdrawal by Subject|33
5238451|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
5238452|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5238453|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5238454|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5238455|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5238456|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5238457|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Other|3
5238458|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Other|4
5238459|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Other|0
5238460|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Other|0
5238461|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Other|0
5238462|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Other|0
5238463|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
5238464|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
5238465|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5238466|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5238467|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5238468|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5238469|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
5238470|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
5238471|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238472|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238473|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238474|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238475|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Death|9
5238476|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Death|8
5238477|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Death|0
5238478|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Death|0
5238479|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Death|0
5238480|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Death|0
5238481|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
5238482|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
5238483|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
5238484|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
5238485|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
5238486|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
5238487|NCT00833833|18078066|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
5238488|NCT00833833|18078067|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
5238489|NCT00833833|18078068|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
5238490|NCT00833833|18078069|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
5238491|NCT00833833|18078070|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
5238492|NCT00833833|18078071|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
5238493|NCT00833833|18078066|P6|Phase 1 (as of 01 April 2011)|Other|0
5238494|NCT00833833|18078067|P5|Phase 1 (as of 01 April 2011)|Other|0
5238495|NCT00833833|18078068|P4|Phase 1 (as of 01 April 2011)|Other|1
5238496|NCT00833833|18078069|P3|Phase 1 (as of 01 April 2011)|Other|0
5238497|NCT00833833|18078070|P2|Phase 1 (as of 01 April 2011)|Other|3
5238498|NCT00833833|18078071|P1|Phase 1 (as of 01 April 2011)|Other|1
5238499|NCT00833833|18078066|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238500|NCT00833833|18078067|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238501|NCT00833833|18078068|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238502|NCT00833833|18078069|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
5238503|NCT00833833|18078070|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5238504|NCT00833833|18078071|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
5238505|NCT00833833|18078066|P6|Phase 1 (as of 01 April 2011)|Death|0
5238506|NCT00833833|18078067|P5|Phase 1 (as of 01 April 2011)|Death|0
5238507|NCT00833833|18078068|P4|Phase 1 (as of 01 April 2011)|Death|0
5238508|NCT00833833|18078069|P3|Phase 1 (as of 01 April 2011)|Death|2
5238509|NCT00833833|18078070|P2|Phase 1 (as of 01 April 2011)|Death|1
5238510|NCT00833833|18078071|P1|Phase 1 (as of 01 April 2011)|Death|0
5238511|NCT00833833|18078066|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
5238512|NCT00833833|18078067|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
5238513|NCT00833833|18078068|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
5238514|NCT00833833|18078069|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
5238515|NCT00833833|18078070|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
5238516|NCT00833833|18078071|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
5238517|NCT00833833|18078066|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
5238518|NCT00833833|18078067|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
5238519|NCT00833833|18078068|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
5238520|NCT00833833|18078069|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
5238521|NCT00833833|18078070|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
5238522|NCT00833833|18078071|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
5238523|NCT00833833|18078066|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
5238524|NCT00833833|18078067|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
5238525|NCT00833833|18078068|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
5238526|NCT00833833|18078069|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
5238527|NCT00833833|18078070|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
5238528|NCT00833833|18078071|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
5238529|NCT00833794|18078111|P2|Double-blind Phase|Administrative reason|3
5238530|NCT00833794|18078112|P1|Double-blind Phase|Administrative reason|1
5238531|NCT00833794|18078111|P2|Double-blind Phase|Physician Decision|7
5238532|NCT00833794|18078112|P1|Double-blind Phase|Physician Decision|4
5238533|NCT00833794|18078111|P2|Double-blind Phase|Withdrawal by Subject|6
5238534|NCT00833794|18078112|P1|Double-blind Phase|Withdrawal by Subject|23
5238535|NCT00833794|18078111|P2|Double-blind Phase|Lack of Efficacy|22
5238536|NCT00833794|18078112|P1|Double-blind Phase|Lack of Efficacy|34
5238537|NCT00833794|18078111|P2|Double-blind Phase|Adverse Event|11
5238538|NCT00833794|18078112|P1|Double-blind Phase|Adverse Event|44
5238539|NCT00833794|18078111|P2|Open-label Phase|enrolled in error (immediately D/C)|0
5238540|NCT00833794|18078112|P1|Open-label Phase|enrolled in error (immediately D/C)|1
5238541|NCT00833794|18078111|P2|Open-label Phase|Did not complete wash-out period|0
5238542|NCT00833794|18078112|P1|Open-label Phase|Did not complete wash-out period|12
5238543|NCT00833794|18078111|P2|Open-label Phase|Protocol Violation|0
5238544|NCT00833794|18078112|P1|Open-label Phase|Protocol Violation|47
5238545|NCT00833794|18078111|P2|Open-label Phase|Administrative reason|0
5238546|NCT00833794|18078112|P1|Open-label Phase|Administrative reason|1
5238547|NCT00833794|18078111|P2|Open-label Phase|Physician Decision|0
5238548|NCT00833794|18078112|P1|Open-label Phase|Physician Decision|20
5238549|NCT00833794|18078111|P2|Open-label Phase|Withdrawal by Subject|0
5238550|NCT00833794|18078112|P1|Open-label Phase|Withdrawal by Subject|48
5238551|NCT00833794|18078111|P2|Open-label Phase|Lack of Efficacy|0
5238552|NCT00833794|18078112|P1|Open-label Phase|Lack of Efficacy|28
5238553|NCT00833794|18078111|P2|Open-label Phase|Adverse Event|0
5238554|NCT00833794|18078112|P1|Open-label Phase|Adverse Event|225
5238555|NCT00833755|18078156|P4|Overall Study|Subject had scheduling issues|0
5238556|NCT00833755|18078157|P3|Overall Study|Subject had scheduling issues|0
5238557|NCT00833755|18078158|P2|Overall Study|Subject had scheduling issues|1
5238558|NCT00833755|18078159|P1|Overall Study|Subject had scheduling issues|0
5238559|NCT00833755|18078156|P4|Overall Study|Physician Decision|6
5238560|NCT00833755|18078157|P3|Overall Study|Physician Decision|2
5238561|NCT00833755|18078158|P2|Overall Study|Physician Decision|4
5238562|NCT00833755|18078159|P1|Overall Study|Physician Decision|4
5238563|NCT00833703|18078179|P2|Overall Study|Parent(s)/guardian(s)'s request|1
5238564|NCT00833703|18078180|P1|Overall Study|Parent(s)/guardian(s)'s request|0
5238565|NCT00833690|18078193|P3|Overall Study|Discontinued study drug|0
5238566|NCT00833690|18078194|P2|Overall Study|Discontinued study drug|2
5238567|NCT00833690|18078195|P1|Overall Study|Discontinued study drug|3
5238568|NCT00833690|18078193|P3|Overall Study|Withdrawal by Subject|0
5238569|NCT00833690|18078194|P2|Overall Study|Withdrawal by Subject|0
5238570|NCT00833690|18078195|P1|Overall Study|Withdrawal by Subject|1
5238571|NCT00833638|18078331|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
5238572|NCT00833638|18078332|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
5238573|NCT00833638|18078333|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
5238574|NCT00833638|18078331|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
5238575|NCT00833638|18078332|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
5238576|NCT00833638|18078333|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
5238577|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
5238578|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
5238579|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
5238580|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
5238581|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
5238582|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
5238583|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
5238584|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
5238585|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
5238586|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
5238587|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
5238588|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
5238589|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
5238590|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
5238591|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
5238592|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
5238593|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
5238594|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
5238595|NCT00833638|18078331|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
5238596|NCT00833638|18078332|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
5238597|NCT00833638|18078333|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
5238598|NCT00833560|18078384|P1|Overall Study|Other|5
5238599|NCT00833560|18078384|P1|Overall Study|Pregression of other disease|1
5238600|NCT00833560|18078384|P1|Overall Study|Death|2
5238601|NCT00833560|18078384|P1|Overall Study|Lack of Efficacy|4
5238602|NCT00833560|18078384|P1|Overall Study|Protocol Violation|6
5238603|NCT00833560|18078384|P1|Overall Study|Adverse Event|11
5238604|NCT00833560|18078384|P1|Overall Study|Toxicity|13
5238605|NCT00833547|18078393|P2|Overall Study|Withdrawal by Subject|2
5238606|NCT00833547|18078394|P1|Overall Study|Withdrawal by Subject|2
5238607|NCT00833482|18078415|P6|Days 21-30|Withdrawal by Subject|0
5238608|NCT00833482|18078416|P5|Days 21-30|Withdrawal by Subject|1
5238609|NCT00833482|18078417|P4|Days 21-30|Withdrawal by Subject|0
5238610|NCT00833482|18078418|P3|Days 21-30|Withdrawal by Subject|0
5238611|NCT00833482|18078419|P2|Days 21-30|Withdrawal by Subject|0
5238612|NCT00833482|18078420|P1|Days 21-30|Withdrawal by Subject|0
5238613|NCT00833482|18078415|P6|Days 21-30|Adverse Event|0
5238614|NCT00833482|18078416|P5|Days 21-30|Adverse Event|0
5238615|NCT00833482|18078417|P4|Days 21-30|Adverse Event|0
5238616|NCT00833482|18078418|P3|Days 21-30|Adverse Event|1
5238617|NCT00833482|18078419|P2|Days 21-30|Adverse Event|0
5238618|NCT00833482|18078420|P1|Days 21-30|Adverse Event|0
5238619|NCT00833482|18078415|P6|Days 11-20|Withdrawal by Subject|0
5238620|NCT00833482|18078416|P5|Days 11-20|Withdrawal by Subject|0
5238621|NCT00833482|18078417|P4|Days 11-20|Withdrawal by Subject|0
5238622|NCT00833482|18078418|P3|Days 11-20|Withdrawal by Subject|0
5238623|NCT00833482|18078419|P2|Days 11-20|Withdrawal by Subject|1
5238624|NCT00833482|18078420|P1|Days 11-20|Withdrawal by Subject|0
5238625|NCT00833482|18078415|P6|Days 11-20|Adverse Event|0
5238626|NCT00833482|18078416|P5|Days 11-20|Adverse Event|0
5238627|NCT00833482|18078417|P4|Days 11-20|Adverse Event|0
5238628|NCT00833482|18078418|P3|Days 11-20|Adverse Event|0
5238629|NCT00833482|18078419|P2|Days 11-20|Adverse Event|2
5238630|NCT00833482|18078420|P1|Days 11-20|Adverse Event|0
5238631|NCT00833469|18078476|P1|Overall Study|Lost to Follow-up|1
5238632|NCT00833469|18078476|P1|Overall Study|Withdrawal by Subject|1
5238633|NCT00833417|18078499|P2|Overall Study|Reason Not Specified|1
5238634|NCT00833417|18078500|P1|Overall Study|Reason Not Specified|0
5238635|NCT00833417|18078499|P2|Overall Study|Disease Progression|17
5238636|NCT00833417|18078500|P1|Overall Study|Disease Progression|18
5238637|NCT00833417|18078499|P2|Overall Study|Sponsor Decision to Terminate Study|2
5238638|NCT00833417|18078500|P1|Overall Study|Sponsor Decision to Terminate Study|1
5238639|NCT00833417|18078499|P2|Overall Study|Patient Decision to Withdraw|23
5238640|NCT00833417|18078500|P1|Overall Study|Patient Decision to Withdraw|4
5238641|NCT00833417|18078499|P2|Overall Study|Physician Decision to Withdraw Patient|7
5238642|NCT00833417|18078500|P1|Overall Study|Physician Decision to Withdraw Patient|3
5238643|NCT00833417|18078499|P2|Overall Study|Lost to Follow-up|2
5238644|NCT00833417|18078500|P1|Overall Study|Lost to Follow-up|1
5238645|NCT00833417|18078499|P2|Overall Study|Death|3
5238646|NCT00833417|18078500|P1|Overall Study|Death|1
5238647|NCT00833417|18078499|P2|Overall Study|Adverse Event|16
5238648|NCT00833417|18078500|P1|Overall Study|Adverse Event|5
5238649|NCT00833261|18078524|P1|Overall Study|Withdrawal by Subject|4
5238650|NCT00833248|18078531|P2|Overall Study|Withdrawal by Subject|1
5238651|NCT00833248|18078532|P1|Overall Study|Withdrawal by Subject|0
5238652|NCT00833248|18078531|P2|Overall Study|Protocol Violation|2
5238653|NCT00833248|18078532|P1|Overall Study|Protocol Violation|1
5238654|NCT00833248|18078531|P2|Overall Study|Adverse Event|0
5238655|NCT00833248|18078532|P1|Overall Study|Adverse Event|3
5238656|NCT00833105|18078554|P1|Overall Study|Adverse Event|2
5238657|NCT00833105|18078554|P1|Overall Study|Withdrawal by Subject|1
5238658|NCT00833092|18078572|P2|Overall Study|constipation|1
5238659|NCT00833092|18078573|P1|Overall Study|constipation|0
5238660|NCT00833092|18078572|P2|Overall Study|Diarrhea|2
5238661|NCT00833092|18078573|P1|Overall Study|Diarrhea|0
5238662|NCT00833092|18078572|P2|Overall Study|Protocol Violation|1
5238663|NCT00833092|18078573|P1|Overall Study|Protocol Violation|2
5238664|NCT00833092|18078572|P2|Overall Study|Withdrawal by Subject|3
5238665|NCT00833092|18078573|P1|Overall Study|Withdrawal by Subject|2
5238666|NCT00833053|18078581|P2|Overall Study|Protocol Violation|1
5238667|NCT00833053|18078582|P1|Overall Study|Protocol Violation|2
5238668|NCT00833053|18078581|P2|Overall Study|Withdrawal by Subject|1
5238669|NCT00833053|18078582|P1|Overall Study|Withdrawal by Subject|0
5238670|NCT00833053|18078581|P2|Overall Study|Treatment Failure|1
5238671|NCT00833053|18078582|P1|Overall Study|Treatment Failure|3
5238672|NCT00833053|18078581|P2|Overall Study|Adverse Event|0
5238673|NCT00833053|18078582|P1|Overall Study|Adverse Event|4
5238674|NCT00833040|18078600|P6|Overall Study|Adverse Event|1
5238675|NCT00833040|18078601|P5|Overall Study|Adverse Event|0
5238676|NCT00833040|18078602|P4|Overall Study|Adverse Event|0
5238677|NCT00833040|18078603|P3|Overall Study|Adverse Event|0
5238678|NCT00833040|18078604|P2|Overall Study|Adverse Event|0
5238679|NCT00833040|18078605|P1|Overall Study|Adverse Event|0
5238680|NCT00833027|18078610|P1|Overall Study|Missing|10
5238681|NCT00833027|18078610|P1|Overall Study|Withdrawal by Subject|16
5238682|NCT00833027|18078610|P1|Overall Study|Protocol Violation|115
5238683|NCT00833027|18078610|P1|Overall Study|Lost to Follow-up|24
5238684|NCT00833027|18078610|P1|Overall Study|Lack of Efficacy|12
5238685|NCT00833027|18078610|P1|Overall Study|Death|1
5238686|NCT00833027|18078610|P1|Overall Study|Adverse Event|33
5238687|NCT00832975|18078615|P1|Overall Study|Other reasons|14
5238688|NCT00832975|18078615|P1|Overall Study|Withdrawal by Subject|3
5238689|NCT00832975|18078615|P1|Overall Study|Physician Decision|4
5238690|NCT00832975|18078615|P1|Overall Study|Death|5
5238691|NCT00832975|18078615|P1|Overall Study|Protocol Violation|6
5238692|NCT00832975|18078615|P1|Overall Study|Lost to Follow-up|7
5238693|NCT00832819|18078629|P3|Overall Study|Protocol Violation|1
5238694|NCT00832819|18078630|P2|Overall Study|Protocol Violation|0
5238695|NCT00832819|18078631|P1|Overall Study|Protocol Violation|0
5238696|NCT00832819|18078629|P3|Overall Study|Adverse Event|0
5238697|NCT00832819|18078630|P2|Overall Study|Adverse Event|1
5238698|NCT00832819|18078631|P1|Overall Study|Adverse Event|0
5238699|NCT00832780|18078637|P1|Overall Study|Physician Decision|1
5238700|NCT00832780|18078637|P1|Overall Study|other complicating condition|2
5238701|NCT00832780|18078637|P1|Overall Study|no reason given|2
5238702|NCT00832780|18078637|P1|Overall Study|Lost to Follow-up|4
5238703|NCT00832780|18078637|P1|Overall Study|Death|16
5238704|NCT00832650|18078679|P3|Overall Study|Randomized but not treated|1
5238705|NCT00832650|18078680|P2|Overall Study|Randomized but not treated|0
5238706|NCT00832650|18078681|P1|Overall Study|Randomized but not treated|0
5238707|NCT00832624|18078721|P1|Overall Study|Study Terminated|10
5238708|NCT00832585|18078731|P1|Overall Study|Lost to Follow-up|1
5238709|NCT00832585|18078731|P1|Overall Study|Withdrawal by Subject|1
5238710|NCT00832455|18078756|P1|Overall Study|Patient moved|1
5238711|NCT00832455|18078756|P1|Overall Study|No improvement|3
5238712|NCT00832455|18078756|P1|Overall Study|Parent dissatisfied|1
5238713|NCT00832455|18078756|P1|Overall Study|Parent misunderstood study|1
5238714|NCT00832455|18078756|P1|Overall Study|Stopped Medication|4
5238715|NCT00832455|18078756|P1|Overall Study|Screening Failure|2
5238716|NCT00832455|18078756|P1|Overall Study|Withdrawal by Subject|17
5238717|NCT00832455|18078756|P1|Overall Study|Protocol Violation|4
5238718|NCT00832455|18078756|P1|Overall Study|Lost to Follow-up|26
5238719|NCT00832455|18078756|P1|Overall Study|Adverse Event|13
5238720|NCT00832416|18078780|P4|Overall Study|Death|0
5238721|NCT00832416|18078781|P3|Overall Study|Death|0
5238722|NCT00832416|18078782|P2|Overall Study|Death|0
5238723|NCT00832416|18078783|P1|Overall Study|Death|1
5238724|NCT00832416|18078780|P4|Overall Study|Adverse Event|10
5238725|NCT00832416|18078781|P3|Overall Study|Adverse Event|41
5238726|NCT00832416|18078782|P2|Overall Study|Adverse Event|19
5238727|NCT00832416|18078783|P1|Overall Study|Adverse Event|21
5238728|NCT00832416|18078780|P4|Overall Study|Administrative|1
5238729|NCT00832416|18078781|P3|Overall Study|Administrative|0
5238730|NCT00832416|18078782|P2|Overall Study|Administrative|0
5238731|NCT00832416|18078783|P1|Overall Study|Administrative|0
5238732|NCT00832416|18078780|P4|Overall Study|Physician Decision|10
5238733|NCT00832416|18078781|P3|Overall Study|Physician Decision|5
5238734|NCT00832416|18078782|P2|Overall Study|Physician Decision|12
5238735|NCT00832416|18078783|P1|Overall Study|Physician Decision|2
5238736|NCT00832416|18078780|P4|Overall Study|Withdrawal by Subject|10
5238737|NCT00832416|18078781|P3|Overall Study|Withdrawal by Subject|2
5238738|NCT00832416|18078782|P2|Overall Study|Withdrawal by Subject|7
5238739|NCT00832416|18078783|P1|Overall Study|Withdrawal by Subject|5
5238740|NCT00832416|18078780|P4|Overall Study|Lack of Efficacy|52
5238741|NCT00832416|18078781|P3|Overall Study|Lack of Efficacy|13
5238742|NCT00832416|18078782|P2|Overall Study|Lack of Efficacy|15
5238743|NCT00832416|18078783|P1|Overall Study|Lack of Efficacy|17
5238744|NCT00832377|18078834|P1|Overall Study|Protocol Violation|1
5238745|NCT00832117|18078880|P1|Overall Study|Disease Progression|11
5238746|NCT00832117|18078880|P1|Overall Study|Death|1
5238747|NCT00832091|18078899|P2|Overall Study|Prohibited Medication|0
5238748|NCT00832091|18078900|P1|Overall Study|Prohibited Medication|1
5238749|NCT00832091|18078899|P2|Overall Study|Withdrawal by Subject|1
5238750|NCT00832091|18078900|P1|Overall Study|Withdrawal by Subject|2
5238751|NCT00832091|18078899|P2|Overall Study|Protocol Violation|0
5238752|NCT00832091|18078900|P1|Overall Study|Protocol Violation|1
5238753|NCT00832091|18078899|P2|Overall Study|Adverse Event|1
5238754|NCT00832091|18078900|P1|Overall Study|Adverse Event|1
5238755|NCT00832078|18078908|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
5238756|NCT00832078|18078909|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
5238757|NCT00832078|18078908|P2|Test Day 1-2 Period|Lack of Efficacy|2
5238758|NCT00832078|18078909|P1|Test Day 1-2 Period|Lack of Efficacy|0
5238759|NCT00832000|18078915|P2|Overall Study|No calls to IVR in period 2|0
5238760|NCT00832000|18078916|P1|Overall Study|No calls to IVR in period 2|2
5238761|NCT00832000|18078915|P2|Overall Study|No calls to IVR in either period|1
5238762|NCT00832000|18078916|P1|Overall Study|No calls to IVR in either period|1
5238763|NCT00832000|18078915|P2|Overall Study|Withdrawal by Subject|0
5238764|NCT00832000|18078916|P1|Overall Study|Withdrawal by Subject|1
5238765|NCT00832000|18078915|P2|Overall Study|Adverse Event|0
5238766|NCT00832000|18078916|P1|Overall Study|Adverse Event|2
5238767|NCT00831844|18078977|P10|Overall Study|Ineligible|0
5238768|NCT00831844|18078978|P9|Overall Study|Ineligible|0
5238769|NCT00831844|18078979|P8|Overall Study|Ineligible|0
5238770|NCT00831844|18078980|P7|Overall Study|Ineligible|0
5238771|NCT00831844|18078981|P6|Overall Study|Ineligible|0
5238772|NCT00831844|18078982|P5|Overall Study|Ineligible|1
5238773|NCT00831844|18078983|P4|Overall Study|Ineligible|0
5238774|NCT00831844|18078984|P3|Overall Study|Ineligible|1
5238775|NCT00831844|18078985|P2|Overall Study|Ineligible|1
5238776|NCT00831844|18078986|P1|Overall Study|Ineligible|0
5238777|NCT00831844|18078977|P10|Overall Study|Withdrawal by Subject|0
5238778|NCT00831844|18078978|P9|Overall Study|Withdrawal by Subject|1
5238779|NCT00831844|18078979|P8|Overall Study|Withdrawal by Subject|1
5238780|NCT00831844|18078980|P7|Overall Study|Withdrawal by Subject|0
5238781|NCT00831844|18078981|P6|Overall Study|Withdrawal by Subject|0
5238782|NCT00831844|18078982|P5|Overall Study|Withdrawal by Subject|0
5238783|NCT00831844|18078983|P4|Overall Study|Withdrawal by Subject|0
5238784|NCT00831844|18078984|P3|Overall Study|Withdrawal by Subject|1
5238785|NCT00831844|18078985|P2|Overall Study|Withdrawal by Subject|0
5238786|NCT00831844|18078986|P1|Overall Study|Withdrawal by Subject|0
5238787|NCT00831844|18078977|P10|Overall Study|Physician Decision|0
5238788|NCT00831844|18078978|P9|Overall Study|Physician Decision|1
5238789|NCT00831844|18078979|P8|Overall Study|Physician Decision|0
5238790|NCT00831844|18078980|P7|Overall Study|Physician Decision|0
5238791|NCT00831844|18078981|P6|Overall Study|Physician Decision|1
5238792|NCT00831844|18078982|P5|Overall Study|Physician Decision|1
5238793|NCT00831844|18078983|P4|Overall Study|Physician Decision|1
5238794|NCT00831844|18078984|P3|Overall Study|Physician Decision|3
5238795|NCT00831844|18078985|P2|Overall Study|Physician Decision|1
5238796|NCT00831844|18078986|P1|Overall Study|Physician Decision|0
5238797|NCT00831844|18078977|P10|Overall Study|Lack of Efficacy|0
5238798|NCT00831844|18078978|P9|Overall Study|Lack of Efficacy|7
5238799|NCT00831844|18078979|P8|Overall Study|Lack of Efficacy|9
5238800|NCT00831844|18078980|P7|Overall Study|Lack of Efficacy|8
5238801|NCT00831844|18078981|P6|Overall Study|Lack of Efficacy|17
5238802|NCT00831844|18078982|P5|Overall Study|Lack of Efficacy|11
5238803|NCT00831844|18078983|P4|Overall Study|Lack of Efficacy|8
5238804|NCT00831844|18078984|P3|Overall Study|Lack of Efficacy|15
5238805|NCT00831844|18078985|P2|Overall Study|Lack of Efficacy|10
5238806|NCT00831844|18078986|P1|Overall Study|Lack of Efficacy|8
5238807|NCT00831844|18078977|P10|Overall Study|Death|0
5238808|NCT00831844|18078978|P9|Overall Study|Death|0
5238809|NCT00831844|18078979|P8|Overall Study|Death|0
5238810|NCT00831844|18078980|P7|Overall Study|Death|0
5238811|NCT00831844|18078981|P6|Overall Study|Death|0
5238812|NCT00831844|18078982|P5|Overall Study|Death|0
5238813|NCT00831844|18078983|P4|Overall Study|Death|1
5238814|NCT00831844|18078984|P3|Overall Study|Death|0
5238815|NCT00831844|18078985|P2|Overall Study|Death|0
5238816|NCT00831844|18078986|P1|Overall Study|Death|0
5238817|NCT00831844|18078977|P10|Overall Study|Adverse Event|0
5238818|NCT00831844|18078978|P9|Overall Study|Adverse Event|0
5238819|NCT00831844|18078979|P8|Overall Study|Adverse Event|0
5238820|NCT00831844|18078980|P7|Overall Study|Adverse Event|2
5238821|NCT00831844|18078981|P6|Overall Study|Adverse Event|1
5238822|NCT00831844|18078982|P5|Overall Study|Adverse Event|1
5238823|NCT00831844|18078983|P4|Overall Study|Adverse Event|0
5238824|NCT00831844|18078984|P3|Overall Study|Adverse Event|0
5238825|NCT00831844|18078985|P2|Overall Study|Adverse Event|0
5238826|NCT00831844|18078986|P1|Overall Study|Adverse Event|2
5238827|NCT00831792|18079008|P1|Overall Study|Lack of Efficacy|1
5238828|NCT00831792|18079008|P1|Overall Study|Death|1
5238829|NCT00831792|18079008|P1|Overall Study|Adverse Event|1
5238830|NCT00831792|18079008|P1|Overall Study|Not Eligible|3
5238831|NCT00831779|18079014|P2|Overall Study|No longer met criteria|1
5238832|NCT00831779|18079015|P1|Overall Study|No longer met criteria|0
5238833|NCT00831779|18079014|P2|Overall Study|Lost to Follow-up|0
5238834|NCT00831779|18079015|P1|Overall Study|Lost to Follow-up|1
5238835|NCT00831701|18079052|P2|Overall Study|Lost to Follow-up|3
5238836|NCT00831701|18079053|P1|Overall Study|Lost to Follow-up|1
5238837|NCT00831701|18079052|P2|Overall Study|Stone expulsion before first medication|2
5238838|NCT00831701|18079053|P1|Overall Study|Stone expulsion before first medication|2
5238839|NCT00831701|18079052|P2|Overall Study|Withdrawal by Subject|0
5238840|NCT00831701|18079053|P1|Overall Study|Withdrawal by Subject|2
5238841|NCT00831493|18079082|P1|Overall Study|Intractable nausea and vomiting|1
5238842|NCT00831441|18079092|P2|Follow Up (30 Days)|missing end of study status|1
5238843|NCT00831441|18079093|P1|Follow Up (30 Days)|missing end of study status|0
5238844|NCT00831441|18079092|P2|Follow Up (30 Days)|non-specified|26
5238845|NCT00831441|18079093|P1|Follow Up (30 Days)|non-specified|16
5238846|NCT00831441|18079092|P2|Follow Up (30 Days)|Death|86
5238847|NCT00831441|18079093|P1|Follow Up (30 Days)|Death|63
5238848|NCT00831441|18079092|P2|Follow Up (30 Days)|Lost to Follow-up|27
5238849|NCT00831441|18079093|P1|Follow Up (30 Days)|Lost to Follow-up|13
5238850|NCT00831441|18079092|P2|Follow Up (30 Days)|Withdrawal by Subject|34
5238851|NCT00831441|18079093|P1|Follow Up (30 Days)|Withdrawal by Subject|41
5238852|NCT00831441|18079092|P2|Randomized|non-specified|266
5238853|NCT00831441|18079093|P1|Randomized|non-specified|276
5238854|NCT00831441|18079092|P2|Randomized|poor/non-compliance|38
5238855|NCT00831441|18079093|P1|Randomized|poor/non-compliance|30
5238856|NCT00831441|18079092|P2|Randomized|Administrative reason by sponsor|2671
5238857|NCT00831441|18079093|P1|Randomized|Administrative reason by sponsor|2780
5238858|NCT00831441|18079092|P2|Randomized|Lost to Follow-up|35
5238859|NCT00831441|18079093|P1|Randomized|Lost to Follow-up|26
5238860|NCT00831441|18079092|P2|Randomized|Withdrawal by Subject|212
5238861|NCT00831441|18079093|P1|Randomized|Withdrawal by Subject|178
5238862|NCT00831441|18079092|P2|Randomized|No longer met criteria|19
5238863|NCT00831441|18079093|P1|Randomized|No longer met criteria|13
5238864|NCT00831441|18079092|P2|Randomized|Physician Decision|35
5238865|NCT00831441|18079093|P1|Randomized|Physician Decision|26
5238866|NCT00831441|18079092|P2|Randomized|Elective procedure|25
5238867|NCT00831441|18079093|P1|Randomized|Elective procedure|26
5238868|NCT00831441|18079092|P2|Randomized|Emergency procedure|2
5238869|NCT00831441|18079093|P1|Randomized|Emergency procedure|2
5238870|NCT00831441|18079092|P2|Randomized|Adverse Event|321
5238871|NCT00831441|18079093|P1|Randomized|Adverse Event|248
5238872|NCT00831441|18079092|P2|Randomized|Death|81
5238873|NCT00831441|18079093|P1|Randomized|Death|82
5238874|NCT00831415|18079125|P1|Overall Study|Death|1
5238875|NCT00831415|18079125|P1|Overall Study|Unsatisfactory response - Efficacy|4
5238876|NCT00831415|18079125|P1|Overall Study|Withdrawal by Subject|35
5238877|NCT00831415|18079125|P1|Overall Study|Protocol Violation|3
5238878|NCT00831415|18079125|P1|Overall Study|Lost to Follow-up|9
5238879|NCT00831415|18079125|P1|Overall Study|Physician Decision|6
5238880|NCT00831415|18079125|P1|Overall Study|Failed to return|3
5238881|NCT00831415|18079125|P1|Overall Study|Adverse Event|14
5238882|NCT00831389|18079134|P2|Overall Study|Withdrawal by Subject|1
5238883|NCT00831389|18079135|P1|Overall Study|Withdrawal by Subject|0
5238884|NCT00831311|18079161|P2|Overall Study|Withdrawal by Subject|4
5238885|NCT00831311|18079162|P1|Overall Study|Withdrawal by Subject|6
5238886|NCT00831311|18079161|P2|Overall Study|Physician Decision|1
5238887|NCT00831311|18079162|P1|Overall Study|Physician Decision|0
5238888|NCT00831311|18079161|P2|Overall Study|Lost to Follow-up|0
5238889|NCT00831311|18079162|P1|Overall Study|Lost to Follow-up|3
5238890|NCT00831311|18079161|P2|Overall Study|Definitive Contraindication|3
5238891|NCT00831311|18079162|P1|Overall Study|Definitive Contraindication|3
5238892|NCT00831233|18079199|P2|Overall Study|Selection Criteria Not Met|0
5238893|NCT00831233|18079200|P1|Overall Study|Selection Criteria Not Met|2
5238894|NCT00831233|18079199|P2|Overall Study|Protocol Violation|0
5238895|NCT00831233|18079200|P1|Overall Study|Protocol Violation|1
5238896|NCT00831233|18079199|P2|Overall Study|Adverse Event|1
5238897|NCT00831233|18079200|P1|Overall Study|Adverse Event|0
5238898|NCT00831181|18079224|P1|Overall Study|Adverse Event|12
5238899|NCT00831129|18079237|P2|Overall Study|9 lost to follow-up reasons uknown|9
5238900|NCT00831129|18079238|P1|Overall Study|9 lost to follow-up reasons uknown|0
5238901|NCT00831129|18079237|P2|Overall Study|Adverse Event|1
5238902|NCT00831129|18079238|P1|Overall Study|Adverse Event|0
5238903|NCT00830960|18079280|P6|Overall Study|No study drug received|7
5238904|NCT00830960|18079281|P5|Overall Study|No study drug received|5
5238905|NCT00830960|18079282|P4|Overall Study|No study drug received|3
5238906|NCT00830960|18079283|P3|Overall Study|No study drug received|4
5238907|NCT00830960|18079284|P2|Overall Study|No study drug received|2
5238908|NCT00830960|18079285|P1|Overall Study|No study drug received|7
5238909|NCT00830960|18079280|P6|Overall Study|Sponsor Decision|7
5238910|NCT00830960|18079281|P5|Overall Study|Sponsor Decision|5
5238911|NCT00830960|18079282|P4|Overall Study|Sponsor Decision|4
5238912|NCT00830960|18079283|P3|Overall Study|Sponsor Decision|3
5238913|NCT00830960|18079284|P2|Overall Study|Sponsor Decision|2
5238914|NCT00830960|18079285|P1|Overall Study|Sponsor Decision|1
5238915|NCT00830960|18079280|P6|Overall Study|Withdrawal by Subject|21
5238916|NCT00830960|18079281|P5|Overall Study|Withdrawal by Subject|16
5238917|NCT00830960|18079282|P4|Overall Study|Withdrawal by Subject|23
5238918|NCT00830960|18079283|P3|Overall Study|Withdrawal by Subject|18
5238919|NCT00830960|18079284|P2|Overall Study|Withdrawal by Subject|19
5238920|NCT00830960|18079285|P1|Overall Study|Withdrawal by Subject|19
5238921|NCT00830960|18079280|P6|Overall Study|Lost to Follow-up|1
5238922|NCT00830960|18079281|P5|Overall Study|Lost to Follow-up|0
5238923|NCT00830960|18079282|P4|Overall Study|Lost to Follow-up|0
5238924|NCT00830960|18079283|P3|Overall Study|Lost to Follow-up|1
5238925|NCT00830960|18079284|P2|Overall Study|Lost to Follow-up|1
5238926|NCT00830960|18079285|P1|Overall Study|Lost to Follow-up|1
5238927|NCT00830960|18079280|P6|Overall Study|Death|1
5238928|NCT00830960|18079281|P5|Overall Study|Death|6
5238929|NCT00830960|18079282|P4|Overall Study|Death|2
5238930|NCT00830960|18079283|P3|Overall Study|Death|3
5238931|NCT00830960|18079284|P2|Overall Study|Death|4
5238932|NCT00830960|18079285|P1|Overall Study|Death|5
5238933|NCT00830947|18079401|P2|Overall Study|Lost to Follow-up|4
5238934|NCT00830947|18079402|P1|Overall Study|Lost to Follow-up|4
5238935|NCT00830869|18079420|P12|Period 2: Part 2|Other|0
5238936|NCT00830869|18079421|P11|Period 2: Part 2|Other|0
5238937|NCT00830869|18079422|P10|Period 2: Part 2|Other|1
5238938|NCT00830869|18079423|P9|Period 2: Part 2|Other|0
5238939|NCT00830869|18079424|P8|Period 2: Part 2|Other|0
5238940|NCT00830869|18079425|P7|Period 2: Part 2|Other|0
5238941|NCT00830869|18079426|P6|Period 2: Part 2|Other|0
5238942|NCT00830869|18079427|P5|Period 2: Part 2|Other|0
5238943|NCT00830869|18079428|P4|Period 2: Part 2|Other|0
5238944|NCT00830869|18079429|P3|Period 2: Part 2|Other|0
5238945|NCT00830869|18079430|P2|Period 2: Part 2|Other|0
5238946|NCT00830869|18079431|P1|Period 2: Part 2|Other|0
5238947|NCT00830869|18079420|P12|Period 2: Part 2|Progressive disease|15
5238948|NCT00830869|18079421|P11|Period 2: Part 2|Progressive disease|8
5238949|NCT00830869|18079422|P10|Period 2: Part 2|Progressive disease|12
5238950|NCT00830869|18079423|P9|Period 2: Part 2|Progressive disease|11
5238951|NCT00830869|18079424|P8|Period 2: Part 2|Progressive disease|14
5238952|NCT00830869|18079425|P7|Period 2: Part 2|Progressive disease|0
5238953|NCT00830869|18079426|P6|Period 2: Part 2|Progressive disease|0
5238954|NCT00830869|18079427|P5|Period 2: Part 2|Progressive disease|0
5238955|NCT00830869|18079428|P4|Period 2: Part 2|Progressive disease|0
5238956|NCT00830869|18079429|P3|Period 2: Part 2|Progressive disease|0
5238957|NCT00830869|18079430|P2|Period 2: Part 2|Progressive disease|0
5238958|NCT00830869|18079431|P1|Period 2: Part 2|Progressive disease|0
5238959|NCT00830869|18079420|P12|Period 2: Part 2|Symptomatic Deterioration|4
5238960|NCT00830869|18079421|P11|Period 2: Part 2|Symptomatic Deterioration|1
5238961|NCT00830869|18079422|P10|Period 2: Part 2|Symptomatic Deterioration|3
5238962|NCT00830869|18079423|P9|Period 2: Part 2|Symptomatic Deterioration|6
5238963|NCT00830869|18079424|P8|Period 2: Part 2|Symptomatic Deterioration|0
5238964|NCT00830869|18079425|P7|Period 2: Part 2|Symptomatic Deterioration|0
5238965|NCT00830869|18079426|P6|Period 2: Part 2|Symptomatic Deterioration|0
5238966|NCT00830869|18079427|P5|Period 2: Part 2|Symptomatic Deterioration|0
5238967|NCT00830869|18079428|P4|Period 2: Part 2|Symptomatic Deterioration|0
5238968|NCT00830869|18079429|P3|Period 2: Part 2|Symptomatic Deterioration|0
5238969|NCT00830869|18079430|P2|Period 2: Part 2|Symptomatic Deterioration|0
5238970|NCT00830869|18079431|P1|Period 2: Part 2|Symptomatic Deterioration|0
5238971|NCT00830869|18079420|P12|Period 2: Part 2|Adverse Event|0
5238972|NCT00830869|18079421|P11|Period 2: Part 2|Adverse Event|2
5238973|NCT00830869|18079422|P10|Period 2: Part 2|Adverse Event|2
5238974|NCT00830869|18079423|P9|Period 2: Part 2|Adverse Event|3
5238975|NCT00830869|18079424|P8|Period 2: Part 2|Adverse Event|4
5238976|NCT00830869|18079425|P7|Period 2: Part 2|Adverse Event|0
5238977|NCT00830869|18079426|P6|Period 2: Part 2|Adverse Event|0
5238978|NCT00830869|18079427|P5|Period 2: Part 2|Adverse Event|0
5238979|NCT00830869|18079428|P4|Period 2: Part 2|Adverse Event|0
5238980|NCT00830869|18079429|P3|Period 2: Part 2|Adverse Event|0
5238981|NCT00830869|18079430|P2|Period 2: Part 2|Adverse Event|0
5238982|NCT00830869|18079431|P1|Period 2: Part 2|Adverse Event|0
5238983|NCT00830869|18079420|P12|Period 2: Part 2|Withdrawal by Subject|1
5238984|NCT00830869|18079421|P11|Period 2: Part 2|Withdrawal by Subject|0
5238985|NCT00830869|18079422|P10|Period 2: Part 2|Withdrawal by Subject|1
5238986|NCT00830869|18079423|P9|Period 2: Part 2|Withdrawal by Subject|2
5238987|NCT00830869|18079424|P8|Period 2: Part 2|Withdrawal by Subject|1
5238988|NCT00830869|18079425|P7|Period 2: Part 2|Withdrawal by Subject|0
5238989|NCT00830869|18079426|P6|Period 2: Part 2|Withdrawal by Subject|0
5238990|NCT00830869|18079427|P5|Period 2: Part 2|Withdrawal by Subject|0
5238991|NCT00830869|18079428|P4|Period 2: Part 2|Withdrawal by Subject|0
5238992|NCT00830869|18079429|P3|Period 2: Part 2|Withdrawal by Subject|0
5238993|NCT00830869|18079430|P2|Period 2: Part 2|Withdrawal by Subject|0
5238994|NCT00830869|18079431|P1|Period 2: Part 2|Withdrawal by Subject|0
5238995|NCT00830869|18079420|P12|Period 2: Part 2|Protocol Violation|0
5238996|NCT00830869|18079421|P11|Period 2: Part 2|Protocol Violation|0
5238997|NCT00830869|18079422|P10|Period 2: Part 2|Protocol Violation|1
5238998|NCT00830869|18079423|P9|Period 2: Part 2|Protocol Violation|0
5238999|NCT00830869|18079424|P8|Period 2: Part 2|Protocol Violation|1
5239000|NCT00830869|18079425|P7|Period 2: Part 2|Protocol Violation|0
5239001|NCT00830869|18079426|P6|Period 2: Part 2|Protocol Violation|0
5239002|NCT00830869|18079427|P5|Period 2: Part 2|Protocol Violation|0
5239003|NCT00830869|18079428|P4|Period 2: Part 2|Protocol Violation|0
5239004|NCT00830869|18079429|P3|Period 2: Part 2|Protocol Violation|0
5239005|NCT00830869|18079430|P2|Period 2: Part 2|Protocol Violation|0
5239006|NCT00830869|18079431|P1|Period 2: Part 2|Protocol Violation|0
5239007|NCT00830869|18079420|P12|Period 1: Part 1|Progressive disease|0
5239008|NCT00830869|18079421|P11|Period 1: Part 1|Progressive disease|0
5239009|NCT00830869|18079422|P10|Period 1: Part 1|Progressive disease|0
5239010|NCT00830869|18079423|P9|Period 1: Part 1|Progressive disease|0
5239011|NCT00830869|18079424|P8|Period 1: Part 1|Progressive disease|0
5239012|NCT00830869|18079425|P7|Period 1: Part 1|Progressive disease|1
5239013|NCT00830869|18079426|P6|Period 1: Part 1|Progressive disease|4
5239014|NCT00830869|18079427|P5|Period 1: Part 1|Progressive disease|4
5239015|NCT00830869|18079428|P4|Period 1: Part 1|Progressive disease|6
5239016|NCT00830869|18079429|P3|Period 1: Part 1|Progressive disease|1
5239017|NCT00830869|18079430|P2|Period 1: Part 1|Progressive disease|0
5239018|NCT00830869|18079431|P1|Period 1: Part 1|Progressive disease|1
5239019|NCT00830869|18079420|P12|Period 1: Part 1|Adverse Event|0
5239020|NCT00830869|18079421|P11|Period 1: Part 1|Adverse Event|0
5239021|NCT00830869|18079422|P10|Period 1: Part 1|Adverse Event|0
5239022|NCT00830869|18079423|P9|Period 1: Part 1|Adverse Event|0
5239023|NCT00830869|18079424|P8|Period 1: Part 1|Adverse Event|0
5239024|NCT00830869|18079425|P7|Period 1: Part 1|Adverse Event|1
5239025|NCT00830869|18079426|P6|Period 1: Part 1|Adverse Event|1
5239026|NCT00830869|18079427|P5|Period 1: Part 1|Adverse Event|0
5239027|NCT00830869|18079428|P4|Period 1: Part 1|Adverse Event|0
5239028|NCT00830869|18079429|P3|Period 1: Part 1|Adverse Event|0
5239029|NCT00830869|18079430|P2|Period 1: Part 1|Adverse Event|0
5239030|NCT00830869|18079431|P1|Period 1: Part 1|Adverse Event|0
5239031|NCT00830869|18079420|P12|Period 1: Part 1|Withdrawal by Subject|0
5239032|NCT00830869|18079421|P11|Period 1: Part 1|Withdrawal by Subject|0
5239033|NCT00830869|18079422|P10|Period 1: Part 1|Withdrawal by Subject|0
5239034|NCT00830869|18079423|P9|Period 1: Part 1|Withdrawal by Subject|0
5239035|NCT00830869|18079424|P8|Period 1: Part 1|Withdrawal by Subject|0
5239036|NCT00830869|18079425|P7|Period 1: Part 1|Withdrawal by Subject|0
5239037|NCT00830869|18079426|P6|Period 1: Part 1|Withdrawal by Subject|0
5239038|NCT00830869|18079427|P5|Period 1: Part 1|Withdrawal by Subject|0
5239039|NCT00830869|18079428|P4|Period 1: Part 1|Withdrawal by Subject|0
5239040|NCT00830869|18079429|P3|Period 1: Part 1|Withdrawal by Subject|0
5239041|NCT00830869|18079430|P2|Period 1: Part 1|Withdrawal by Subject|1
5239042|NCT00830869|18079431|P1|Period 1: Part 1|Withdrawal by Subject|0
5239043|NCT00830869|18079420|P12|Period 1: Part 1|Symptomatic deterioration|0
5239044|NCT00830869|18079421|P11|Period 1: Part 1|Symptomatic deterioration|0
5239045|NCT00830869|18079422|P10|Period 1: Part 1|Symptomatic deterioration|0
5239046|NCT00830869|18079423|P9|Period 1: Part 1|Symptomatic deterioration|0
5239047|NCT00830869|18079424|P8|Period 1: Part 1|Symptomatic deterioration|0
5239048|NCT00830869|18079425|P7|Period 1: Part 1|Symptomatic deterioration|1
5239049|NCT00830869|18079426|P6|Period 1: Part 1|Symptomatic deterioration|1
5239050|NCT00830869|18079427|P5|Period 1: Part 1|Symptomatic deterioration|0
5239051|NCT00830869|18079428|P4|Period 1: Part 1|Symptomatic deterioration|1
5239052|NCT00830869|18079429|P3|Period 1: Part 1|Symptomatic deterioration|0
5239053|NCT00830869|18079430|P2|Period 1: Part 1|Symptomatic deterioration|0
5239054|NCT00830869|18079431|P1|Period 1: Part 1|Symptomatic deterioration|0
5239055|NCT00830804|18079567|P1|Overall Study|Unwilling to adhere to study requirement|1
5239056|NCT00830804|18079567|P1|Overall Study|Consent withdrawn|2
5239057|NCT00830804|18079567|P1|Overall Study|Unable to get to clinic|7
5239058|NCT00830804|18079567|P1|Overall Study|Death|1
5239059|NCT00830804|18079567|P1|Overall Study|Lost to Follow-up|4
5239060|NCT00830765|18079647|P2|Overall Study|Protocol Violation|2
5239061|NCT00830765|18079648|P1|Overall Study|Protocol Violation|3
5239062|NCT00830518|18079681|P2|Overall Study|Reason not Specified|1
5239063|NCT00830518|18079682|P1|Overall Study|Reason not Specified|8
5239064|NCT00830518|18079681|P2|Overall Study|Withdrawal by Patient|0
5239065|NCT00830518|18079682|P1|Overall Study|Withdrawal by Patient|2
5239066|NCT00830518|18079681|P2|Overall Study|Adverse Event|1
5239067|NCT00830518|18079682|P1|Overall Study|Adverse Event|14
5239068|NCT00830518|18079681|P2|Overall Study|Symptomatic Deterioration|1
5239069|NCT00830518|18079682|P1|Overall Study|Symptomatic Deterioration|4
5239070|NCT00830518|18079681|P2|Overall Study|Progressive Disease|8
5239071|NCT00830518|18079682|P1|Overall Study|Progressive Disease|18
5239072|NCT00830440|18079701|P2|Overall Study|Adverse Event|0
5239073|NCT00830440|18079702|P1|Overall Study|Adverse Event|2
5239074|NCT00830440|18079701|P2|Overall Study|unsuccessful procedure|0
5239075|NCT00830440|18079702|P1|Overall Study|unsuccessful procedure|4
5239076|NCT00830440|18079701|P2|Overall Study|Withdrawal by Subject|0
5239077|NCT00830440|18079702|P1|Overall Study|Withdrawal by Subject|1
5239078|NCT00830440|18079701|P2|Overall Study|Protocol Violation|0
5239079|NCT00830440|18079702|P1|Overall Study|Protocol Violation|1
5239080|NCT00830375|18079717|P1|Overall Study|Lost to Follow-up|1
5239081|NCT00830336|18079732|P2|Washout: 21 Days|Withdrawal by Subject|0
5239082|NCT00830336|18079733|P1|Washout: 21 Days|Withdrawal by Subject|1
5239083|NCT00830258|18079760|P2|Washout: 7 Days|Protocol Violation|0
5239084|NCT00830258|18079761|P1|Washout: 7 Days|Protocol Violation|1
5239085|NCT00830258|18079760|P2|First Intervention|Adverse Event|0
5239086|NCT00830258|18079761|P1|First Intervention|Adverse Event|1
5239087|NCT00830219|18079780|P2|Washout of 7 Days|Withdrawal by Subject|1
5239088|NCT00830219|18079781|P1|Washout of 7 Days|Withdrawal by Subject|1
5239089|NCT00830206|18079791|P2|Washout: 21 Days|Withdrawal by Subject|1
5239090|NCT00830206|18079792|P1|Washout: 21 Days|Withdrawal by Subject|1
5239091|NCT00830167|18079802|P2|Overall Study|Other|2
5239092|NCT00830167|18079803|P1|Overall Study|Other|2
5239093|NCT00830167|18079802|P2|Overall Study|Protocol Violation|1
5239094|NCT00830167|18079803|P1|Overall Study|Protocol Violation|0
5239095|NCT00830167|18079802|P2|Overall Study|Lost to Follow-up|1
5239096|NCT00830167|18079803|P1|Overall Study|Lost to Follow-up|0
5239097|NCT00830167|18079802|P2|Overall Study|Withdrawal by Subject|0
5239098|NCT00830167|18079803|P1|Overall Study|Withdrawal by Subject|2
5239099|NCT00830167|18079802|P2|Overall Study|Not meeting entrance criteria|5
5239100|NCT00830167|18079803|P1|Overall Study|Not meeting entrance criteria|2
5239101|NCT00830167|18079802|P2|Overall Study|Adverse Event|24
5239102|NCT00830167|18079803|P1|Overall Study|Adverse Event|8
5239103|NCT00830167|18079802|P2|Overall Study|Lack of Efficacy|10
5239104|NCT00830167|18079803|P1|Overall Study|Lack of Efficacy|26
5239105|NCT00830128|18079873|P1|Overall Study|Operating a vehicle|1
5239106|NCT00830128|18079873|P1|Overall Study|Work obligation|1
5239107|NCT00830128|18079873|P1|Overall Study|Relocation|1
5239108|NCT00830128|18079873|P1|Overall Study|Family obligation|1
5239109|NCT00830128|18079873|P1|Overall Study|Withdrawal by Subject|2
5239110|NCT00830128|18079873|P1|Overall Study|Protocol Violation|1
5239111|NCT00830128|18079873|P1|Overall Study|Lack of Efficacy|7
5239112|NCT00830128|18079873|P1|Overall Study|Adverse Event|5
5239113|NCT00830115|18079888|P1|Overall Study|Improvement/recovery|1
5239114|NCT00830115|18079888|P1|Overall Study|Adverse Event|2
5239115|NCT00830037|18079915|P2|Overall Study|Active when terminated by DSMB|14
5239116|NCT00830037|18079916|P1|Overall Study|Active when terminated by DSMB|15
5239117|NCT00830037|18079915|P2|Overall Study|Lost to Follow-up|2
5239118|NCT00830037|18079916|P1|Overall Study|Lost to Follow-up|1
5239119|NCT00830037|18079915|P2|Overall Study|Withdrawal by Subject|3
5239120|NCT00830037|18079916|P1|Overall Study|Withdrawal by Subject|2
5239121|NCT00830024|18079926|P2|Washout: 7 Days|Withdrawal by Subject|0
5239122|NCT00830024|18079927|P1|Washout: 7 Days|Withdrawal by Subject|1
5239123|NCT00829998|18079937|P2|Washout|Adverse Event|1
5239124|NCT00829998|18079938|P1|Washout|Adverse Event|0
5239125|NCT00829933|18079967|P4|Overall Study|withdrew before treatment started|9
5239126|NCT00829933|18079968|P3|Overall Study|withdrew before treatment started|2
5239127|NCT00829933|18079969|P2|Overall Study|withdrew before treatment started|1
5239128|NCT00829933|18079970|P1|Overall Study|withdrew before treatment started|5
5239129|NCT00829933|18079967|P4|Overall Study|Protocol Violation|0
5239130|NCT00829933|18079968|P3|Overall Study|Protocol Violation|0
5239131|NCT00829933|18079969|P2|Overall Study|Protocol Violation|1
5239132|NCT00829933|18079970|P1|Overall Study|Protocol Violation|2
5239133|NCT00829933|18079967|P4|Overall Study|Pregnancy|2
5239134|NCT00829933|18079968|P3|Overall Study|Pregnancy|0
5239135|NCT00829933|18079969|P2|Overall Study|Pregnancy|0
5239136|NCT00829933|18079970|P1|Overall Study|Pregnancy|0
5239137|NCT00829933|18079967|P4|Overall Study|Physician Decision|1
5239138|NCT00829933|18079968|P3|Overall Study|Physician Decision|8
5239139|NCT00829933|18079969|P2|Overall Study|Physician Decision|7
5239140|NCT00829933|18079970|P1|Overall Study|Physician Decision|5
5239141|NCT00829933|18079967|P4|Overall Study|Lack of Efficacy|0
5239142|NCT00829933|18079968|P3|Overall Study|Lack of Efficacy|0
5239143|NCT00829933|18079969|P2|Overall Study|Lack of Efficacy|1
5239144|NCT00829933|18079970|P1|Overall Study|Lack of Efficacy|0
5239145|NCT00829933|18079967|P4|Overall Study|Death|1
5239146|NCT00829933|18079968|P3|Overall Study|Death|1
5239147|NCT00829933|18079969|P2|Overall Study|Death|0
5239148|NCT00829933|18079970|P1|Overall Study|Death|0
5239149|NCT00829933|18079967|P4|Overall Study|Adverse Event|1
5239150|NCT00829933|18079968|P3|Overall Study|Adverse Event|2
5239151|NCT00829933|18079969|P2|Overall Study|Adverse Event|3
5239152|NCT00829933|18079970|P1|Overall Study|Adverse Event|2
5239153|NCT00829868|18079982|P2|Washout|Physician Decision|0
5239154|NCT00829868|18079983|P1|Washout|Physician Decision|1
5239155|NCT00829829|18079994|P3|Overall Study|Other than specified above|1
5239156|NCT00829829|18079995|P2|Overall Study|Other than specified above|2
5239157|NCT00829829|18079996|P1|Overall Study|Other than specified above|2
5239158|NCT00829829|18079994|P3|Overall Study|Lost to Follow-up|3
5239159|NCT00829829|18079995|P2|Overall Study|Lost to Follow-up|3
5239160|NCT00829829|18079996|P1|Overall Study|Lost to Follow-up|7
5239161|NCT00829829|18079994|P3|Overall Study|Decision by the Sponsor|2
5239162|NCT00829829|18079995|P2|Overall Study|Decision by the Sponsor|0
5239163|NCT00829829|18079996|P1|Overall Study|Decision by the Sponsor|1
5239164|NCT00829829|18079994|P3|Overall Study|Withdrawal by Subject|2
5239165|NCT00829829|18079995|P2|Overall Study|Withdrawal by Subject|4
5239166|NCT00829829|18079996|P1|Overall Study|Withdrawal by Subject|8
5239167|NCT00829829|18079994|P3|Overall Study|Adverse Event|3
5239168|NCT00829829|18079995|P2|Overall Study|Adverse Event|4
5239169|NCT00829829|18079996|P1|Overall Study|Adverse Event|4
5239170|NCT00829829|18079994|P3|Overall Study|Protocol Violation|0
5239171|NCT00829829|18079995|P2|Overall Study|Protocol Violation|3
5239172|NCT00829829|18079996|P1|Overall Study|Protocol Violation|0
5239173|NCT00829790|18080021|P2|Washout of 14 Days|Withdrawal by Subject|1
5239174|NCT00829790|18080022|P1|Washout of 14 Days|Withdrawal by Subject|0
5239175|NCT00829764|18080032|P2|First Intervention|Withdrawal by Subject|1
5239176|NCT00829764|18080033|P1|First Intervention|Withdrawal by Subject|1
5239177|NCT00829764|18080032|P2|First Intervention|Adverse Event|0
5239178|NCT00829764|18080033|P1|First Intervention|Adverse Event|1
5239179|NCT00829712|18080059|P2|Washout of 7 Days|Withdrawal by Subject|1
5239180|NCT00829712|18080060|P1|Washout of 7 Days|Withdrawal by Subject|0
5239181|NCT00829673|18080079|P2|Washout of 7 Days|Withdrawal by Subject|0
5239182|NCT00829673|18080080|P1|Washout of 7 Days|Withdrawal by Subject|1
5239183|NCT00829621|18080090|P2|Overall Study|Lost to Follow-up|4
5239184|NCT00829621|18080091|P1|Overall Study|Lost to Follow-up|3
5239185|NCT00829621|18080090|P2|Overall Study|Death|0
5239186|NCT00829621|18080091|P1|Overall Study|Death|1
5239187|NCT00829530|18080099|P2|Second Intervention|Intolerance to Venopuncture|0
5239188|NCT00829530|18080100|P1|Second Intervention|Intolerance to Venopuncture|1
5239189|NCT00829530|18080099|P2|First Intervention|Intolerance to Venopuncture|1
5239190|NCT00829530|18080100|P1|First Intervention|Intolerance to Venopuncture|0
5239191|NCT00829530|18080099|P2|First Intervention|Adverse Event|1
5239192|NCT00829530|18080100|P1|First Intervention|Adverse Event|0
5239193|NCT00829504|18080114|P2|Second Intervention|Physician Decision|0
5239194|NCT00829504|18080115|P1|Second Intervention|Physician Decision|1
5239195|NCT00829504|18080114|P2|Washout of 7 Days|Withdrawal by Subject|0
5239196|NCT00829504|18080115|P1|Washout of 7 Days|Withdrawal by Subject|1
5239197|NCT00829504|18080114|P2|First Intervention|Adverse Event|0
5239198|NCT00829504|18080115|P1|First Intervention|Adverse Event|1
5239199|NCT00829452|18080125|P2|Second Intervention|Physician Decision|1
5239200|NCT00829452|18080126|P1|Second Intervention|Physician Decision|0
5239201|NCT00829452|18080125|P2|Washout of 42 Days|Withdrawal by Subject|1
5239202|NCT00829452|18080126|P1|Washout of 42 Days|Withdrawal by Subject|0
5239203|NCT00829452|18080125|P2|First Intervention|Withdrawal by Subject|1
5239204|NCT00829452|18080126|P1|First Intervention|Withdrawal by Subject|0
5239205|NCT00829439|18080138|P4|Overall Study|Adverse Event|0
5239206|NCT00829439|18080139|P3|Overall Study|Adverse Event|1
5239207|NCT00829439|18080140|P2|Overall Study|Adverse Event|0
5239208|NCT00829439|18080141|P1|Overall Study|Adverse Event|0
5239209|NCT00829426|18080147|P2|Washout: 7 Days|Withdrawal by Subject|0
5239210|NCT00829426|18080148|P1|Washout: 7 Days|Withdrawal by Subject|1
5239211|NCT00829413|18080156|P1|Overall Study|Indeterminate diagnosis from truth stand|3
5239212|NCT00829413|18080156|P1|Overall Study|Technically inadequate truth standard|2
5239213|NCT00829413|18080156|P1|Overall Study|No truth standard procedure available|9
5239214|NCT00829413|18080156|P1|Overall Study|Training Patients|67
5239215|NCT00829413|18080156|P1|Overall Study|No study drug admimnistered|13
5239216|NCT00829387|18080205|P2|Overall Study|Disqualified by PI|0
5239217|NCT00829387|18080206|P1|Overall Study|Disqualified by PI|1
5239218|NCT00829387|18080205|P2|Overall Study|Withdrawal by Subject|3
5239219|NCT00829387|18080206|P1|Overall Study|Withdrawal by Subject|2
5239220|NCT00829309|18080224|P2|Washout: 7 Days|Protocol Violation|0
5239221|NCT00829309|18080225|P1|Washout: 7 Days|Protocol Violation|1
5239222|NCT00829296|18080235|P2|Overall Study|Adverse Event|4
5239223|NCT00829296|18080236|P1|Overall Study|Adverse Event|5
5239224|NCT00829283|18080250|P2|Overall Study|Lost to Follow-up|25
5239225|NCT00829283|18080251|P1|Overall Study|Lost to Follow-up|7
5239226|NCT00829244|18080261|P2|Overall Study|No embryo cleavage|2
5239227|NCT00829244|18080262|P1|Overall Study|No embryo cleavage|0
5239228|NCT00829244|18080261|P2|Overall Study|All embryos discarded|3
5239229|NCT00829244|18080262|P1|Overall Study|All embryos discarded|0
5239230|NCT00829244|18080261|P2|Overall Study|No fertilization|2
5239231|NCT00829244|18080262|P1|Overall Study|No fertilization|2
5239232|NCT00829244|18080261|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
5239233|NCT00829244|18080262|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
5239234|NCT00829244|18080261|P2|Overall Study|Lack of ovarian response to stimulation|5
5239235|NCT00829244|18080262|P1|Overall Study|Lack of ovarian response to stimulation|9
5239236|NCT00829244|18080261|P2|Overall Study|Protocol Violation|0
5239237|NCT00829244|18080262|P1|Overall Study|Protocol Violation|1
5239238|NCT00829244|18080261|P2|Overall Study|Adverse Event|3
5239239|NCT00829244|18080262|P1|Overall Study|Adverse Event|1
5239240|NCT00829179|18080292|P1|Overall Study|Withdrawal by Subject|1
5239241|NCT00829166|18080298|P2|Overall Study|Reason Not Specified|3
5239242|NCT00829166|18080299|P1|Overall Study|Reason Not Specified|3
5239243|NCT00829166|18080298|P2|Overall Study|Sponsor's Decision|98
5239244|NCT00829166|18080299|P1|Overall Study|Sponsor's Decision|137
5239245|NCT00829166|18080298|P2|Overall Study|Subject's Decision|55
5239246|NCT00829166|18080299|P1|Overall Study|Subject's Decision|41
5239247|NCT00829166|18080298|P2|Overall Study|Physician's Decision|3
5239248|NCT00829166|18080299|P1|Overall Study|Physician's Decision|4
5239249|NCT00829166|18080298|P2|Overall Study|Lost to Follow-up|4
5239250|NCT00829166|18080299|P1|Overall Study|Lost to Follow-up|5
5239251|NCT00829166|18080298|P2|Overall Study|Death|333
5239252|NCT00829166|18080299|P1|Overall Study|Death|305
5239253|NCT00829010|18080362|P5|Overall Study|Migrated/Moved from study area|0
5239254|NCT00829010|18080363|P4|Overall Study|Migrated/Moved from study area|5
5239255|NCT00829010|18080364|P3|Overall Study|Migrated/Moved from study area|0
5239256|NCT00829010|18080365|P2|Overall Study|Migrated/Moved from study area|4
5239257|NCT00829010|18080366|P1|Overall Study|Migrated/Moved from study area|3
5239258|NCT00829010|18080362|P5|Overall Study|Fatality|0
5239259|NCT00829010|18080363|P4|Overall Study|Fatality|3
5239260|NCT00829010|18080364|P3|Overall Study|Fatality|0
5239261|NCT00829010|18080365|P2|Overall Study|Fatality|4
5239262|NCT00829010|18080366|P1|Overall Study|Fatality|5
5239263|NCT00829010|18080362|P5|Overall Study|Lost to Follow-up|0
5239264|NCT00829010|18080363|P4|Overall Study|Lost to Follow-up|0
5239265|NCT00829010|18080364|P3|Overall Study|Lost to Follow-up|2
5239266|NCT00829010|18080365|P2|Overall Study|Lost to Follow-up|0
5239267|NCT00829010|18080366|P1|Overall Study|Lost to Follow-up|1
5239268|NCT00829010|18080362|P5|Overall Study|Withdrawal by Subject|2
5239269|NCT00829010|18080363|P4|Overall Study|Withdrawal by Subject|0
5239270|NCT00829010|18080364|P3|Overall Study|Withdrawal by Subject|1
5239271|NCT00829010|18080365|P2|Overall Study|Withdrawal by Subject|1
5239272|NCT00829010|18080366|P1|Overall Study|Withdrawal by Subject|0
5239273|NCT00829010|18080362|P5|Overall Study|Adverse Event|0
5239274|NCT00829010|18080363|P4|Overall Study|Adverse Event|0
5239275|NCT00829010|18080364|P3|Overall Study|Adverse Event|0
5239276|NCT00829010|18080365|P2|Overall Study|Adverse Event|0
5239277|NCT00829010|18080366|P1|Overall Study|Adverse Event|1
5239278|NCT00828984|18080531|P3|Overall Study|ConMed|1
5239279|NCT00828984|18080532|P2|Overall Study|ConMed|1
5239280|NCT00828984|18080533|P1|Overall Study|ConMed|1
5239281|NCT00828984|18080531|P3|Overall Study|Noncompliant|3
5239282|NCT00828984|18080532|P2|Overall Study|Noncompliant|2
5239283|NCT00828984|18080533|P1|Overall Study|Noncompliant|1
5239284|NCT00828984|18080531|P3|Overall Study|Medical Contraindication|0
5239285|NCT00828984|18080532|P2|Overall Study|Medical Contraindication|1
5239286|NCT00828984|18080533|P1|Overall Study|Medical Contraindication|0
5239287|NCT00828984|18080531|P3|Overall Study|Ineligable|0
5239288|NCT00828984|18080532|P2|Overall Study|Ineligable|2
5239289|NCT00828984|18080533|P1|Overall Study|Ineligable|1
5239290|NCT00828984|18080531|P3|Overall Study|Withdrawal by Subject|4
5239291|NCT00828984|18080532|P2|Overall Study|Withdrawal by Subject|4
5239292|NCT00828984|18080533|P1|Overall Study|Withdrawal by Subject|4
5239293|NCT00828984|18080531|P3|Overall Study|Lost to Follow-up|1
5239294|NCT00828984|18080532|P2|Overall Study|Lost to Follow-up|3
5239295|NCT00828984|18080533|P1|Overall Study|Lost to Follow-up|5
5239296|NCT00828984|18080531|P3|Overall Study|Adverse Event|0
5239297|NCT00828984|18080532|P2|Overall Study|Adverse Event|3
5239298|NCT00828984|18080533|P1|Overall Study|Adverse Event|2
5239299|NCT00828945|18080556|P1|Overall Study|Other|36
5239300|NCT00828945|18080556|P1|Overall Study|Participant was missing|1
5239301|NCT00828945|18080556|P1|Overall Study|Death|4
5239302|NCT00828750|18080588|P1|Overall Study|Normal PC Remained While No Treatment|1
5239303|NCT00828750|18080588|P1|Overall Study|Lack of Efficacy|3
5239304|NCT00828711|18080602|P3|Overall Study|Lost to Follow-up|0
5239305|NCT00828711|18080603|P2|Overall Study|Lost to Follow-up|0
5239306|NCT00828711|18080604|P1|Overall Study|Lost to Follow-up|1
5239307|NCT00828672|18080635|P2|Post-surgery (<30 Days)|No central review materials|1
5239308|NCT00828672|18080636|P1|Post-surgery (<30 Days)|No central review materials|0
5239309|NCT00828672|18080635|P2|Study Treatment|Complete response, no surgery|1
5239310|NCT00828672|18080636|P1|Study Treatment|Complete response, no surgery|1
5239311|NCT00828672|18080635|P2|Study Treatment|Adverse Event|1
5239312|NCT00828672|18080636|P1|Study Treatment|Adverse Event|0
5239313|NCT00828672|18080635|P2|Study Treatment|Lost to Follow-up|0
5239314|NCT00828672|18080636|P1|Study Treatment|Lost to Follow-up|1
5239315|NCT00828568|18080657|P3|Treated - Received at Least One Dose|Protocol Violation|3
5239316|NCT00828568|18080658|P2|Treated - Received at Least One Dose|Protocol Violation|5
5239317|NCT00828568|18080659|P1|Treated - Received at Least One Dose|Protocol Violation|9
5239318|NCT00828568|18080657|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
5239319|NCT00828568|18080658|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
5239320|NCT00828568|18080659|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
5239321|NCT00828568|18080657|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
5239322|NCT00828568|18080658|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
5239323|NCT00828568|18080659|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
5239324|NCT00828568|18080657|P3|Treated - Received at Least One Dose|Adverse Event|1
5239325|NCT00828568|18080658|P2|Treated - Received at Least One Dose|Adverse Event|8
5239326|NCT00828568|18080659|P1|Treated - Received at Least One Dose|Adverse Event|11
5239327|NCT00828568|18080657|P3|Randomized|Withdrawal by Subject|2
5239328|NCT00828568|18080658|P2|Randomized|Withdrawal by Subject|0
5239329|NCT00828568|18080659|P1|Randomized|Withdrawal by Subject|1
5239330|NCT00828516|18080681|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
5239331|NCT00828464|18080686|P1|Overall Study|Withdrawal by Subject|1
5239332|NCT00828451|18080703|P1|Overall Study|Deterioration in clinical status|1
5239333|NCT00828451|18080703|P1|Overall Study|Withdrawal by Subject|1
5239334|NCT00828451|18080703|P1|Overall Study|Lack of intravenous line|7
5239335|NCT00828451|18080703|P1|Overall Study|Death|2
5239336|NCT00828321|18080729|P2|Second Intervention|Protocol Violation|1
5239337|NCT00828321|18080730|P1|Second Intervention|Protocol Violation|0
5239338|NCT00828321|18080729|P2|Washout of 42 Days|Withdrawal by Subject|0
5239339|NCT00828321|18080730|P1|Washout of 42 Days|Withdrawal by Subject|2
5239340|NCT00828204|18080759|P2|Extension Study|Physician Decision|2
5239341|NCT00828204|18080760|P1|Extension Study|Physician Decision|0
5239342|NCT00828204|18080759|P2|Extension Study|Lost to Follow-up|1
5239343|NCT00828204|18080760|P1|Extension Study|Lost to Follow-up|0
5239344|NCT00828204|18080759|P2|Main Study: After Study Restart|Noncompliance|1
5239345|NCT00828204|18080760|P1|Main Study: After Study Restart|Noncompliance|0
5239346|NCT00828204|18080759|P2|Main Study: After Study Restart|Adverse Event|2
5239347|NCT00828204|18080760|P1|Main Study: After Study Restart|Adverse Event|0
5239348|NCT00828204|18080759|P2|Main Study: Prior to Study Suspension|Study Suspension|0
5239349|NCT00828204|18080760|P1|Main Study: Prior to Study Suspension|Study Suspension|11
5239350|NCT00828204|18080759|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
5239351|NCT00828204|18080760|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
5239352|NCT00828204|18080759|P2|Main Study: Prior to Study Suspension|Adverse Event|0
5239353|NCT00828204|18080760|P1|Main Study: Prior to Study Suspension|Adverse Event|1
5239354|NCT00828139|18080807|P4|Overall Study|Other|2
5239355|NCT00828139|18080808|P3|Overall Study|Other|5
5239356|NCT00828139|18080809|P2|Overall Study|Other|2
5239357|NCT00828139|18080810|P1|Overall Study|Other|4
5239358|NCT00828139|18080807|P4|Overall Study|Disease Progression|39
5239359|NCT00828139|18080808|P3|Overall Study|Disease Progression|35
5239360|NCT00828139|18080809|P2|Overall Study|Disease Progression|33
5239361|NCT00828139|18080810|P1|Overall Study|Disease Progression|24
5239362|NCT00828139|18080807|P4|Overall Study|Refusal unrelated to toxicity|3
5239363|NCT00828139|18080808|P3|Overall Study|Refusal unrelated to toxicity|5
5239364|NCT00828139|18080809|P2|Overall Study|Refusal unrelated to toxicity|4
5239365|NCT00828139|18080810|P1|Overall Study|Refusal unrelated to toxicity|3
5239366|NCT00828139|18080807|P4|Overall Study|Death|2
5239367|NCT00828139|18080808|P3|Overall Study|Death|0
5239368|NCT00828139|18080809|P2|Overall Study|Death|1
5239369|NCT00828139|18080810|P1|Overall Study|Death|2
5239370|NCT00828139|18080807|P4|Overall Study|Adverse Event|5
5239371|NCT00828139|18080808|P3|Overall Study|Adverse Event|10
5239372|NCT00828139|18080809|P2|Overall Study|Adverse Event|1
5239373|NCT00828139|18080810|P1|Overall Study|Adverse Event|8
5239374|NCT00828113|18080830|P2|Overall Study|Lost to Follow-up|5
5239375|NCT00828113|18080831|P1|Overall Study|Lost to Follow-up|3
5239376|NCT00828113|18080830|P2|Overall Study|Withdrawal by Subject|26
5239377|NCT00828113|18080831|P1|Overall Study|Withdrawal by Subject|27
5239378|NCT00828009|18080869|P1|Step 2 - Maintenance Therapy|Other|1
5239379|NCT00828009|18080869|P1|Step 2 - Maintenance Therapy|Complicating disease|2
5239380|NCT00828009|18080869|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
5239381|NCT00828009|18080869|P1|Step 2 - Maintenance Therapy|Death|1
5239382|NCT00828009|18080869|P1|Step 2 - Maintenance Therapy|Adverse Event|13
5239383|NCT00828009|18080869|P1|Step 2 - Maintenance Therapy|Progressive disease|12
5239473|NCT00827242|18081135|P2|Overall Study|Physician Decision|0
5239384|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
5239385|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
5239386|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
5239387|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
5239388|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
5239389|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
5239390|NCT00828009|18080869|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
5239391|NCT00827931|18080912|P2|Overall Study|Other|0
5239392|NCT00827931|18080913|P1|Overall Study|Other|1
5239393|NCT00827931|18080912|P2|Overall Study|Withdrawal by Subject|1
5239394|NCT00827931|18080913|P1|Overall Study|Withdrawal by Subject|0
5239395|NCT00827931|18080912|P2|Overall Study|Lost to Follow-up|0
5239396|NCT00827931|18080913|P1|Overall Study|Lost to Follow-up|1
5239397|NCT00827931|18080912|P2|Overall Study|Adverse Event|0
5239398|NCT00827931|18080913|P1|Overall Study|Adverse Event|1
5239399|NCT00827931|18080912|P2|Overall Study|Death|5
5239400|NCT00827931|18080913|P1|Overall Study|Death|3
5239401|NCT00827918|18080934|P3|Overall Study|Withdrawal by Subject|6
5239402|NCT00827918|18080935|P2|Overall Study|Withdrawal by Subject|2
5239403|NCT00827918|18080936|P1|Overall Study|Withdrawal by Subject|6
5239404|NCT00827918|18080934|P3|Overall Study|Protocol Violation|0
5239405|NCT00827918|18080935|P2|Overall Study|Protocol Violation|1
5239406|NCT00827918|18080936|P1|Overall Study|Protocol Violation|0
5239407|NCT00827918|18080934|P3|Overall Study|Progressive Disease|0
5239408|NCT00827918|18080935|P2|Overall Study|Progressive Disease|1
5239409|NCT00827918|18080936|P1|Overall Study|Progressive Disease|1
5239410|NCT00827918|18080934|P3|Overall Study|Pregnancy|0
5239411|NCT00827918|18080935|P2|Overall Study|Pregnancy|1
5239412|NCT00827918|18080936|P1|Overall Study|Pregnancy|0
5239413|NCT00827918|18080934|P3|Overall Study|Physician Decision|0
5239414|NCT00827918|18080935|P2|Overall Study|Physician Decision|0
5239415|NCT00827918|18080936|P1|Overall Study|Physician Decision|1
5239416|NCT00827918|18080934|P3|Overall Study|Lack of Efficacy|15
5239417|NCT00827918|18080935|P2|Overall Study|Lack of Efficacy|4
5239418|NCT00827918|18080936|P1|Overall Study|Lack of Efficacy|16
5239419|NCT00827918|18080934|P3|Overall Study|Adverse Event|0
5239420|NCT00827918|18080935|P2|Overall Study|Adverse Event|0
5239421|NCT00827918|18080936|P1|Overall Study|Adverse Event|4
5239422|NCT00827827|18080964|P2|Overall Study|Burned with water at home|0
5239423|NCT00827827|18080965|P1|Overall Study|Burned with water at home|1
5239424|NCT00827827|18080964|P2|Overall Study|Transportation issues|0
5239425|NCT00827827|18080965|P1|Overall Study|Transportation issues|1
5239426|NCT00827827|18080964|P2|Overall Study|Gout|0
5239427|NCT00827827|18080965|P1|Overall Study|Gout|1
5239428|NCT00827827|18080964|P2|Overall Study|Another cerebrovascular accident (CVA)|0
5239429|NCT00827827|18080965|P1|Overall Study|Another cerebrovascular accident (CVA)|1
5239430|NCT00827827|18080964|P2|Overall Study|Fall at home- hospitalization|0
5239431|NCT00827827|18080965|P1|Overall Study|Fall at home- hospitalization|1
5239432|NCT00827827|18080964|P2|Overall Study|Lost to Follow-up|0
5239433|NCT00827827|18080965|P1|Overall Study|Lost to Follow-up|3
5239434|NCT00827775|18081009|P2|Overall Study|Withdrawal by Subject|5
5239435|NCT00827775|18081010|P1|Overall Study|Withdrawal by Subject|0
5239436|NCT00827632|18081020|P2|Overall Study|Early withdrawal|11
5239437|NCT00827632|18081021|P1|Overall Study|Early withdrawal|14
5239438|NCT00827632|18081020|P2|Overall Study|Lost to Follow-up|12
5239439|NCT00827632|18081021|P1|Overall Study|Lost to Follow-up|8
5239440|NCT00827606|18081033|P2|Overall Study|Adverse Event|2
5239441|NCT00827606|18081034|P1|Overall Study|Adverse Event|4
5239442|NCT00827606|18081033|P2|Overall Study|LDL below 2.59 mmol/L|12
5239443|NCT00827606|18081034|P1|Overall Study|LDL below 2.59 mmol/L|4
5239444|NCT00827606|18081033|P2|Overall Study|Other|13
5239445|NCT00827606|18081034|P1|Overall Study|Other|5
5239446|NCT00827606|18081033|P2|Overall Study|Pregnancy|1
5239447|NCT00827606|18081034|P1|Overall Study|Pregnancy|0
5239448|NCT00827606|18081033|P2|Overall Study|Withdrawal by Subject|6
5239449|NCT00827606|18081034|P1|Overall Study|Withdrawal by Subject|7
5239450|NCT00827606|18081033|P2|Overall Study|Lost to Follow-up|1
5239451|NCT00827606|18081034|P1|Overall Study|Lost to Follow-up|3
5239452|NCT00827606|18081033|P2|Overall Study|Protocol Violation|3
5239453|NCT00827606|18081034|P1|Overall Study|Protocol Violation|4
5239454|NCT00827567|18081095|P1|Overall Study|Progression of Disease/Screen Failure|4
5239455|NCT00827541|18081101|P2|Overall Study|Lack of effectiveness|0
5239456|NCT00827541|18081102|P1|Overall Study|Lack of effectiveness|1
5239457|NCT00827541|18081101|P2|Overall Study|Pathogen not susceptible|0
5239458|NCT00827541|18081102|P1|Overall Study|Pathogen not susceptible|1
5239459|NCT00827541|18081101|P2|Overall Study|Other|3
5239460|NCT00827541|18081102|P1|Overall Study|Other|1
5239461|NCT00827541|18081101|P2|Overall Study|Exitus|8
5239462|NCT00827541|18081102|P1|Overall Study|Exitus|1
5239463|NCT00827502|18081114|P1|Overall Study|Withdrawal by Subject|5
5239464|NCT00827502|18081114|P1|Overall Study|Lost to Follow-up|4
5239465|NCT00827502|18081114|P1|Overall Study|Adverse Event|1
5239466|NCT00827502|18081114|P1|Overall Study|randomized but not treated|11
5239467|NCT00827372|18081120|P1|Overall Study|Lack of Efficacy|3
5239468|NCT00827372|18081120|P1|Overall Study|Adverse Event|5
5239469|NCT00827242|18081135|P2|Overall Study|Lack of Efficacy|0
5239470|NCT00827242|18081136|P1|Overall Study|Lack of Efficacy|1
5239471|NCT00827242|18081135|P2|Overall Study|Death|0
5239472|NCT00827242|18081136|P1|Overall Study|Death|1
5239474|NCT00827242|18081136|P1|Overall Study|Physician Decision|2
5239475|NCT00827242|18081135|P2|Overall Study|Entry Criteria Not Met|1
5239476|NCT00827242|18081136|P1|Overall Study|Entry Criteria Not Met|4
5239477|NCT00827242|18081135|P2|Overall Study|Adverse Event Excluding Death|1
5239478|NCT00827242|18081136|P1|Overall Study|Adverse Event Excluding Death|2
5239479|NCT00827242|18081135|P2|Overall Study|Lost to Follow-up|3
5239480|NCT00827242|18081136|P1|Overall Study|Lost to Follow-up|0
5239481|NCT00827242|18081135|P2|Overall Study|Protocol Violation|3
5239482|NCT00827242|18081136|P1|Overall Study|Protocol Violation|1
5239483|NCT00827242|18081135|P2|Overall Study|Withdrawal by Subject|4
5239484|NCT00827242|18081136|P1|Overall Study|Withdrawal by Subject|2
5239485|NCT00827112|18081174|P2|Overall Study|Other|3
5239486|NCT00827112|18081175|P1|Overall Study|Other|1
5239487|NCT00827112|18081174|P2|Overall Study|Randomized but not treated|3
5239488|NCT00827112|18081175|P1|Overall Study|Randomized but not treated|5
5239489|NCT00827112|18081174|P2|Overall Study|Withdrawal by Subject|1
5239490|NCT00827112|18081175|P1|Overall Study|Withdrawal by Subject|2
5239491|NCT00827112|18081174|P2|Overall Study|Protocol Violation|2
5239492|NCT00827112|18081175|P1|Overall Study|Protocol Violation|0
5239493|NCT00827112|18081174|P2|Overall Study|Pregnancy|1
5239494|NCT00827112|18081175|P1|Overall Study|Pregnancy|0
5239495|NCT00827112|18081174|P2|Overall Study|Lost to Follow-up|2
5239496|NCT00827112|18081175|P1|Overall Study|Lost to Follow-up|3
5239497|NCT00827112|18081174|P2|Overall Study|Lack of Efficacy|0
5239498|NCT00827112|18081175|P1|Overall Study|Lack of Efficacy|2
5239499|NCT00827112|18081174|P2|Overall Study|Adverse Event|0
5239500|NCT00827112|18081175|P1|Overall Study|Adverse Event|2
5239501|NCT00826943|18081228|P6|Overall Study|Withdrawal by Subject|0
5239502|NCT00826943|18081229|P5|Overall Study|Withdrawal by Subject|1
5239503|NCT00826943|18081230|P4|Overall Study|Withdrawal by Subject|0
5239504|NCT00826943|18081231|P3|Overall Study|Withdrawal by Subject|0
5239505|NCT00826943|18081232|P2|Overall Study|Withdrawal by Subject|0
5239506|NCT00826943|18081233|P1|Overall Study|Withdrawal by Subject|0
5239507|NCT00826748|18081254|P3|Overall Study|Samples Did Not pass QC|1
5239508|NCT00826748|18081255|P2|Overall Study|Samples Did Not pass QC|0
5239509|NCT00826748|18081256|P1|Overall Study|Samples Did Not pass QC|0
5239510|NCT00826748|18081254|P3|Overall Study|Physician Decision|1
5239511|NCT00826748|18081255|P2|Overall Study|Physician Decision|0
5239512|NCT00826748|18081256|P1|Overall Study|Physician Decision|0
5239513|NCT00826748|18081254|P3|Overall Study|Withdrawal by Subject|2
5239514|NCT00826748|18081255|P2|Overall Study|Withdrawal by Subject|0
5239515|NCT00826748|18081256|P1|Overall Study|Withdrawal by Subject|0
5239516|NCT00826618|18081264|P1|Overall Study|Withdrawal by Subject|1
5239517|NCT00826540|18081268|P1|Overall Study|Withdrawal by Subject|1
5239518|NCT00826540|18081268|P1|Overall Study|ineligible|3
5239519|NCT00826449|18081274|P1|Overall Study|Withdrawal by Subject|1
5239520|NCT00826449|18081274|P1|Overall Study|Disease Progression|4
5239521|NCT00826280|18081283|P3|Overall Study|One or more non-interpretable scan|1
5239522|NCT00826280|18081284|P2|Overall Study|One or more non-interpretable scan|1
5239523|NCT00826280|18081285|P1|Overall Study|One or more non-interpretable scan|0
5239524|NCT00826280|18081283|P3|Overall Study|Machine Failure|0
5239525|NCT00826280|18081284|P2|Overall Study|Machine Failure|1
5239526|NCT00826280|18081285|P1|Overall Study|Machine Failure|1
5239527|NCT00826280|18081283|P3|Overall Study|Interpretation Failure|0
5239528|NCT00826280|18081284|P2|Overall Study|Interpretation Failure|0
5239529|NCT00826280|18081285|P1|Overall Study|Interpretation Failure|1
5239530|NCT00826280|18081283|P3|Overall Study|Reversible ischemic defect not present|44
5239531|NCT00826280|18081284|P2|Overall Study|Reversible ischemic defect not present|40
5239532|NCT00826280|18081285|P1|Overall Study|Reversible ischemic defect not present|43
5239533|NCT00826280|18081283|P3|Overall Study|Sponsor discontinued subject or study|0
5239534|NCT00826280|18081284|P2|Overall Study|Sponsor discontinued subject or study|0
5239535|NCT00826280|18081285|P1|Overall Study|Sponsor discontinued subject or study|1
5239536|NCT00826280|18081283|P3|Overall Study|Lost to Follow-up|0
5239537|NCT00826280|18081284|P2|Overall Study|Lost to Follow-up|1
5239538|NCT00826280|18081285|P1|Overall Study|Lost to Follow-up|0
5239539|NCT00826280|18081283|P3|Overall Study|Adverse Event|0
5239540|NCT00826280|18081284|P2|Overall Study|Adverse Event|3
5239541|NCT00826280|18081285|P1|Overall Study|Adverse Event|1
5239542|NCT00826280|18081283|P3|Overall Study|Randomized but drug not received|1
5239543|NCT00826280|18081284|P2|Overall Study|Randomized but drug not received|0
5239544|NCT00826280|18081285|P1|Overall Study|Randomized but drug not received|1
5239545|NCT00826267|18081314|P3|Overall Study|Other Adverse Event|0
5239546|NCT00826267|18081315|P2|Overall Study|Other Adverse Event|0
5239547|NCT00826267|18081316|P1|Overall Study|Other Adverse Event|1
5239548|NCT00826241|18081334|P1|Overall Study|Pt opt not to proceed w/trmt|1
5239549|NCT00826241|18081334|P1|Overall Study|Pt unable to proceed to registration|1
5239550|NCT00826241|18081334|P1|Overall Study|Screen failure|2
5239551|NCT00826241|18081334|P1|Overall Study|Could not obtain records|1
5239552|NCT00826241|18081334|P1|Overall Study|Lost to Follow-up|9
5239553|NCT00826241|18081334|P1|Overall Study|Patient refused follow-up|3
5239554|NCT00826241|18081334|P1|Overall Study|Progression of disease|1
5239555|NCT00826241|18081334|P1|Overall Study|Non-compliance|1
5239556|NCT00826241|18081334|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
5239557|NCT00826241|18081334|P1|Overall Study|Death|4
5239558|NCT00826241|18081334|P1|Overall Study|Withdrew consent|2
5239559|NCT00826241|18081334|P1|Overall Study|Withdrawal from Follow-up|1
5239560|NCT00826228|18081340|P1|Overall Study|Withdrawal by Subject|1
5239561|NCT00826176|18081362|P2|Overall Study|Administrative|0
5239562|NCT00826176|18081363|P1|Overall Study|Administrative|9
5239563|NCT00826176|18081362|P2|Overall Study|Subject Withdrew Consent|0
5239564|NCT00826176|18081363|P1|Overall Study|Subject Withdrew Consent|3
5239565|NCT00826176|18081362|P2|Overall Study|Lost to Follow-up|0
5239566|NCT00826176|18081363|P1|Overall Study|Lost to Follow-up|1
5239567|NCT00826111|18081412|P2|Overall Study|Physician Decision|1
5239568|NCT00826111|18081413|P1|Overall Study|Physician Decision|1
5239569|NCT00826111|18081412|P2|Overall Study|Withdrawal by Subject|0
5239570|NCT00826111|18081413|P1|Overall Study|Withdrawal by Subject|5
5239571|NCT00826111|18081412|P2|Overall Study|Protocol Violation|0
5239572|NCT00826111|18081413|P1|Overall Study|Protocol Violation|1
5239573|NCT00826111|18081412|P2|Overall Study|Lost to Follow-up|1
5239574|NCT00826111|18081413|P1|Overall Study|Lost to Follow-up|0
5239575|NCT00825994|18081448|P1|Overall Study|Placebo Responder at V2|1
5239576|NCT00825994|18081448|P1|Overall Study|Protocol Violation|1
5239577|NCT00825994|18081448|P1|Overall Study|Lost to Follow-up|1
5239578|NCT00825994|18081448|P1|Overall Study|Withdrawal by Subject|2
5239579|NCT00825916|18081456|P3|Overall Study|Lost to Follow-up|1
5239580|NCT00825916|18081457|P2|Overall Study|Lost to Follow-up|2
5239581|NCT00825916|18081458|P1|Overall Study|Lost to Follow-up|4
5239582|NCT00825825|18081499|P6|Third Medication Period (14 Days)|poor data quality|0
5239583|NCT00825825|18081500|P5|Third Medication Period (14 Days)|poor data quality|0
5239584|NCT00825825|18081501|P4|Third Medication Period (14 Days)|poor data quality|0
5239585|NCT00825825|18081502|P3|Third Medication Period (14 Days)|poor data quality|0
5239586|NCT00825825|18081503|P2|Third Medication Period (14 Days)|poor data quality|1
5239587|NCT00825825|18081504|P1|Third Medication Period (14 Days)|poor data quality|0
5239588|NCT00825825|18081499|P6|Third Medication Period (14 Days)|Protocol Violation|2
5239589|NCT00825825|18081500|P5|Third Medication Period (14 Days)|Protocol Violation|0
5239590|NCT00825825|18081501|P4|Third Medication Period (14 Days)|Protocol Violation|0
5239591|NCT00825825|18081502|P3|Third Medication Period (14 Days)|Protocol Violation|0
5239592|NCT00825825|18081503|P2|Third Medication Period (14 Days)|Protocol Violation|0
5239593|NCT00825825|18081504|P1|Third Medication Period (14 Days)|Protocol Violation|0
5239594|NCT00825825|18081499|P6|Third Medication Period (14 Days)|Adverse Event|0
5239595|NCT00825825|18081500|P5|Third Medication Period (14 Days)|Adverse Event|0
5239596|NCT00825825|18081501|P4|Third Medication Period (14 Days)|Adverse Event|0
5239597|NCT00825825|18081502|P3|Third Medication Period (14 Days)|Adverse Event|0
5239598|NCT00825825|18081503|P2|Third Medication Period (14 Days)|Adverse Event|1
5239599|NCT00825825|18081504|P1|Third Medication Period (14 Days)|Adverse Event|0
5239600|NCT00825825|18081499|P6|Second Medication Period (14 Days)|Protocol Violation|0
5239601|NCT00825825|18081500|P5|Second Medication Period (14 Days)|Protocol Violation|1
5239602|NCT00825825|18081501|P4|Second Medication Period (14 Days)|Protocol Violation|0
5239603|NCT00825825|18081502|P3|Second Medication Period (14 Days)|Protocol Violation|0
5239604|NCT00825825|18081503|P2|Second Medication Period (14 Days)|Protocol Violation|0
5239605|NCT00825825|18081504|P1|Second Medication Period (14 Days)|Protocol Violation|1
5239606|NCT00825825|18081499|P6|Second Medication Period (14 Days)|Physician Decision|0
5239607|NCT00825825|18081500|P5|Second Medication Period (14 Days)|Physician Decision|0
5239608|NCT00825825|18081501|P4|Second Medication Period (14 Days)|Physician Decision|2
5239609|NCT00825825|18081502|P3|Second Medication Period (14 Days)|Physician Decision|0
5239610|NCT00825825|18081503|P2|Second Medication Period (14 Days)|Physician Decision|0
5239611|NCT00825825|18081504|P1|Second Medication Period (14 Days)|Physician Decision|1
5239612|NCT00825825|18081499|P6|First Medication Period (14 Days)|Physician Decision|1
5239613|NCT00825825|18081500|P5|First Medication Period (14 Days)|Physician Decision|0
5239614|NCT00825825|18081501|P4|First Medication Period (14 Days)|Physician Decision|0
5239615|NCT00825825|18081502|P3|First Medication Period (14 Days)|Physician Decision|1
5239616|NCT00825825|18081503|P2|First Medication Period (14 Days)|Physician Decision|0
5239617|NCT00825825|18081504|P1|First Medication Period (14 Days)|Physician Decision|2
5239618|NCT00825825|18081499|P6|First Medication Period (14 Days)|Adverse Event|1
5239619|NCT00825825|18081500|P5|First Medication Period (14 Days)|Adverse Event|0
5239620|NCT00825825|18081501|P4|First Medication Period (14 Days)|Adverse Event|0
5239621|NCT00825825|18081502|P3|First Medication Period (14 Days)|Adverse Event|0
5239622|NCT00825825|18081503|P2|First Medication Period (14 Days)|Adverse Event|0
5239623|NCT00825825|18081504|P1|First Medication Period (14 Days)|Adverse Event|1
5239624|NCT00825812|18081520|P4|Overall Study|Administrative|5
5239625|NCT00825812|18081521|P3|Overall Study|Administrative|3
5239626|NCT00825812|18081522|P2|Overall Study|Administrative|1
5239627|NCT00825812|18081523|P1|Overall Study|Administrative|0
5239628|NCT00825812|18081520|P4|Overall Study|Non-compliance with protocol|1
5239629|NCT00825812|18081521|P3|Overall Study|Non-compliance with protocol|0
5239630|NCT00825812|18081522|P2|Overall Study|Non-compliance with protocol|0
5239631|NCT00825812|18081523|P1|Overall Study|Non-compliance with protocol|0
5239632|NCT00825812|18081520|P4|Overall Study|Subject withdrew consent|2
5239633|NCT00825812|18081521|P3|Overall Study|Subject withdrew consent|3
5239634|NCT00825812|18081522|P2|Overall Study|Subject withdrew consent|0
5239635|NCT00825812|18081523|P1|Overall Study|Subject withdrew consent|0
5239636|NCT00825812|18081520|P4|Overall Study|Adverse Event|1
5239637|NCT00825812|18081521|P3|Overall Study|Adverse Event|0
5239638|NCT00825812|18081522|P2|Overall Study|Adverse Event|0
5239639|NCT00825812|18081523|P1|Overall Study|Adverse Event|0
5239640|NCT00825812|18081520|P4|Overall Study|Never entered follow up|1
5239641|NCT00825812|18081521|P3|Overall Study|Never entered follow up|0
5239642|NCT00825812|18081522|P2|Overall Study|Never entered follow up|0
5239643|NCT00825812|18081523|P1|Overall Study|Never entered follow up|0
5239644|NCT00825682|18081570|P2|Overall Study|personal reasons/ inconvenience|5
5239645|NCT00825682|18081571|P1|Overall Study|personal reasons/ inconvenience|13
5239646|NCT00825305|18081662|P2|Overall Study|Can not be classified|1
5239647|NCT00825305|18081663|P1|Overall Study|Can not be classified|0
5239648|NCT00825305|18081662|P2|Overall Study|Protocol Violation|9
5239649|NCT00825305|18081663|P1|Overall Study|Protocol Violation|9
5239650|NCT00825305|18081662|P2|Overall Study|Inappropriate inclusion|0
5239651|NCT00825305|18081663|P1|Overall Study|Inappropriate inclusion|1
5239652|NCT00825305|18081662|P2|Overall Study|Withdrawal by Subject|12
5239653|NCT00825305|18081663|P1|Overall Study|Withdrawal by Subject|6
5239654|NCT00825305|18081662|P2|Overall Study|Adverse Event|1
5239655|NCT00825305|18081663|P1|Overall Study|Adverse Event|1
5239656|NCT00825175|18081703|P2|Overall Study|Withdrawal by Subject|5
5239657|NCT00825175|18081704|P1|Overall Study|Withdrawal by Subject|0
5239658|NCT00825162|18081713|P3|Overall Study|Unable to attend the study visit|0
5239659|NCT00825162|18081714|P2|Overall Study|Unable to attend the study visit|2
5239660|NCT00825162|18081715|P1|Overall Study|Unable to attend the study visit|5
5239661|NCT00825162|18081713|P3|Overall Study|Move away from the study area|0
5239662|NCT00825162|18081714|P2|Overall Study|Move away from the study area|0
5239663|NCT00825162|18081715|P1|Overall Study|Move away from the study area|1
5239664|NCT00825162|18081713|P3|Overall Study|Physician Decision|0
5239665|NCT00825162|18081714|P2|Overall Study|Physician Decision|0
5239666|NCT00825162|18081715|P1|Overall Study|Physician Decision|2
5239667|NCT00825162|18081713|P3|Overall Study|Lost to Follow-up|3
5239668|NCT00825162|18081714|P2|Overall Study|Lost to Follow-up|6
5239669|NCT00825162|18081715|P1|Overall Study|Lost to Follow-up|9
5239670|NCT00825162|18081713|P3|Overall Study|Withdrawal by Subject|3
5239671|NCT00825162|18081714|P2|Overall Study|Withdrawal by Subject|13
5239672|NCT00825162|18081715|P1|Overall Study|Withdrawal by Subject|11
5239673|NCT00824993|18081741|P2|Overall Study|Death|3
5239674|NCT00824993|18081742|P1|Overall Study|Death|0
5239675|NCT00824993|18081741|P2|Overall Study|Insurance Issue|1
5239676|NCT00824993|18081742|P1|Overall Study|Insurance Issue|2
5239677|NCT00824993|18081741|P2|Overall Study|Non-Compliant|1
5239678|NCT00824993|18081742|P1|Overall Study|Non-Compliant|2
5239679|NCT00824993|18081741|P2|Overall Study|Rapid Bone Loss|1
5239680|NCT00824993|18081742|P1|Overall Study|Rapid Bone Loss|0
5239681|NCT00824993|18081741|P2|Overall Study|Malignancy Relapse|10
5239682|NCT00824993|18081742|P1|Overall Study|Malignancy Relapse|9
5239683|NCT00824993|18081741|P2|Overall Study|Withdrawal by Subject|1
5239684|NCT00824993|18081742|P1|Overall Study|Withdrawal by Subject|1
5239685|NCT00824850|18081750|P2|Overall Study|Withdrawal by Subject|1
5239686|NCT00824850|18081751|P1|Overall Study|Withdrawal by Subject|0
5239687|NCT00824772|18081804|P1|Overall Study|Withdrawal by Subject|8
5239688|NCT00824720|18081824|P3|Overall Study|Protocol Violation|1
5239689|NCT00824720|18081825|P2|Overall Study|Protocol Violation|0
5239690|NCT00824720|18081826|P1|Overall Study|Protocol Violation|0
5239691|NCT00824720|18081824|P3|Overall Study|failed plug insertion|0
5239692|NCT00824720|18081825|P2|Overall Study|failed plug insertion|1
5239693|NCT00824720|18081826|P1|Overall Study|failed plug insertion|3
5239694|NCT00824655|18081842|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
5239695|NCT00824655|18081843|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
5239696|NCT00824655|18081842|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
5239697|NCT00824655|18081843|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
5239698|NCT00824616|18081863|P2|Overall Study|Withdrawal by Subject|1
5239699|NCT00824616|18081864|P1|Overall Study|Withdrawal by Subject|1
5239700|NCT00824616|18081863|P2|Overall Study|Lost to Follow-up|1
5239701|NCT00824616|18081864|P1|Overall Study|Lost to Follow-up|0
5239702|NCT00824616|18081863|P2|Overall Study|Lack of Efficacy|1
5239703|NCT00824616|18081864|P1|Overall Study|Lack of Efficacy|2
5239704|NCT00824616|18081863|P2|Overall Study|Hyperglycemia|1
5239705|NCT00824616|18081864|P1|Overall Study|Hyperglycemia|1
5239706|NCT00824616|18081863|P2|Overall Study|Creatinine/Creatinine Clearance|2
5239707|NCT00824616|18081864|P1|Overall Study|Creatinine/Creatinine Clearance|0
5239708|NCT00824616|18081863|P2|Overall Study|Adverse Event|1
5239709|NCT00824616|18081864|P1|Overall Study|Adverse Event|2
5239710|NCT00824564|18081874|P2|Overall Study|Randomized, but not treated|0
5239711|NCT00824564|18081875|P1|Overall Study|Randomized, but not treated|1
5239712|NCT00824564|18081874|P2|Overall Study|Other|2
5239713|NCT00824564|18081875|P1|Overall Study|Other|1
5239714|NCT00824564|18081874|P2|Overall Study|Withdrawal by Subject|1
5239715|NCT00824564|18081875|P1|Overall Study|Withdrawal by Subject|1
5239716|NCT00824564|18081874|P2|Overall Study|Lost to Follow-up|7
5239717|NCT00824564|18081875|P1|Overall Study|Lost to Follow-up|5
5239718|NCT00824473|18081954|P2|Overall Study|Other|1
5239719|NCT00824473|18081955|P1|Overall Study|Other|1
5239720|NCT00824473|18081954|P2|Overall Study|Withdrawal by Subject|3
5239721|NCT00824473|18081955|P1|Overall Study|Withdrawal by Subject|2
5239722|NCT00824473|18081954|P2|Overall Study|Non-Compliance|2
5239723|NCT00824473|18081955|P1|Overall Study|Non-Compliance|4
5239724|NCT00824473|18081954|P2|Overall Study|Protocol Violation|0
5239725|NCT00824473|18081955|P1|Overall Study|Protocol Violation|2
5239726|NCT00824473|18081954|P2|Overall Study|Lack of Efficacy|2
5239727|NCT00824473|18081955|P1|Overall Study|Lack of Efficacy|2
5239728|NCT00824473|18081954|P2|Overall Study|Adverse Event|5
5239729|NCT00824473|18081955|P1|Overall Study|Adverse Event|4
5239730|NCT00824421|18082036|P3|Overall Study|Other|0
5239731|NCT00824421|18082037|P2|Overall Study|Other|1
5239732|NCT00824421|18082038|P1|Overall Study|Other|0
5239733|NCT00824421|18082036|P3|Overall Study|Randomized but not Treated|0
5239734|NCT00824421|18082037|P2|Overall Study|Randomized but not Treated|1
5239735|NCT00824421|18082038|P1|Overall Study|Randomized but not Treated|1
5239736|NCT00824421|18082036|P3|Overall Study|Withdrawal by Subject|3
5239737|NCT00824421|18082037|P2|Overall Study|Withdrawal by Subject|3
5239738|NCT00824421|18082038|P1|Overall Study|Withdrawal by Subject|2
5239739|NCT00824421|18082036|P3|Overall Study|Pregnancy|1
5239740|NCT00824421|18082037|P2|Overall Study|Pregnancy|0
5239741|NCT00824421|18082038|P1|Overall Study|Pregnancy|1
5239742|NCT00824421|18082036|P3|Overall Study|Lost to Follow-up|0
5239743|NCT00824421|18082037|P2|Overall Study|Lost to Follow-up|3
5239744|NCT00824421|18082038|P1|Overall Study|Lost to Follow-up|2
5239745|NCT00824421|18082036|P3|Overall Study|Lack of Efficacy|4
5239746|NCT00824421|18082037|P2|Overall Study|Lack of Efficacy|7
5239747|NCT00824421|18082038|P1|Overall Study|Lack of Efficacy|5
5239748|NCT00824421|18082036|P3|Overall Study|Death|0
5239749|NCT00824421|18082037|P2|Overall Study|Death|1
5239750|NCT00824421|18082038|P1|Overall Study|Death|0
5239751|NCT00824421|18082036|P3|Overall Study|Adverse Event|6
5239752|NCT00824421|18082037|P2|Overall Study|Adverse Event|6
5239753|NCT00824421|18082038|P1|Overall Study|Adverse Event|6
5239754|NCT00824408|18082089|P5|Randomized Phase|Other reason not defined above|4
5239755|NCT00824408|18082090|P4|Randomized Phase|Other reason not defined above|2
5239756|NCT00824408|18082091|P3|Randomized Phase|Other reason not defined above|4
5239757|NCT00824408|18082092|P2|Randomized Phase|Other reason not defined above|0
5239758|NCT00824408|18082093|P1|Randomized Phase|Other reason not defined above|0
5239759|NCT00824408|18082089|P5|Randomized Phase|Refused to continue medication|2
5239760|NCT00824408|18082090|P4|Randomized Phase|Refused to continue medication|2
5239761|NCT00824408|18082091|P3|Randomized Phase|Refused to continue medication|2
5239762|NCT00824408|18082092|P2|Randomized Phase|Refused to continue medication|0
5239763|NCT00824408|18082093|P1|Randomized Phase|Refused to continue medication|0
5239764|NCT00824408|18082089|P5|Randomized Phase|Adverse Event|5
5239765|NCT00824408|18082090|P4|Randomized Phase|Adverse Event|5
5239766|NCT00824408|18082091|P3|Randomized Phase|Adverse Event|4
5239767|NCT00824408|18082092|P2|Randomized Phase|Adverse Event|0
5239768|NCT00824408|18082093|P1|Randomized Phase|Adverse Event|0
5239769|NCT00824408|18082089|P5|Randomized Phase|Progressive disease|34
5239770|NCT00824408|18082090|P4|Randomized Phase|Progressive disease|36
5239771|NCT00824408|18082091|P3|Randomized Phase|Progressive disease|25
5239772|NCT00824408|18082092|P2|Randomized Phase|Progressive disease|0
5239773|NCT00824408|18082093|P1|Randomized Phase|Progressive disease|0
5239774|NCT00824408|18082089|P5|Randomized Phase|Not treated|1
5239775|NCT00824408|18082090|P4|Randomized Phase|Not treated|1
5239776|NCT00824408|18082091|P3|Randomized Phase|Not treated|1
5239777|NCT00824408|18082092|P2|Randomized Phase|Not treated|0
5239778|NCT00824408|18082093|P1|Randomized Phase|Not treated|0
5239779|NCT00824408|18082089|P5|Run-in Phase|Other reason not defined above|0
5239780|NCT00824408|18082090|P4|Run-in Phase|Other reason not defined above|0
5239781|NCT00824408|18082091|P3|Run-in Phase|Other reason not defined above|0
5239782|NCT00824408|18082092|P2|Run-in Phase|Other reason not defined above|1
5239783|NCT00824408|18082093|P1|Run-in Phase|Other reason not defined above|0
5239784|NCT00824408|18082089|P5|Run-in Phase|Refused to continue medication|0
5239785|NCT00824408|18082090|P4|Run-in Phase|Refused to continue medication|0
5239786|NCT00824408|18082091|P3|Run-in Phase|Refused to continue medication|0
5239787|NCT00824408|18082092|P2|Run-in Phase|Refused to continue medication|0
5239788|NCT00824408|18082093|P1|Run-in Phase|Refused to continue medication|1
5239789|NCT00824408|18082089|P5|Run-in Phase|Adverse Event|0
5239790|NCT00824408|18082090|P4|Run-in Phase|Adverse Event|0
5239791|NCT00824408|18082091|P3|Run-in Phase|Adverse Event|0
5239792|NCT00824408|18082092|P2|Run-in Phase|Adverse Event|1
5239793|NCT00824408|18082093|P1|Run-in Phase|Adverse Event|1
5239794|NCT00824408|18082089|P5|Run-in Phase|Progressive disease|0
5239795|NCT00824408|18082090|P4|Run-in Phase|Progressive disease|0
5239796|NCT00824408|18082091|P3|Run-in Phase|Progressive disease|0
5239797|NCT00824408|18082092|P2|Run-in Phase|Progressive disease|4
5239798|NCT00824408|18082093|P1|Run-in Phase|Progressive disease|4
5239799|NCT00824382|18082145|P4|Overall Study|Investigator's decision|0
5239800|NCT00824382|18082146|P3|Overall Study|Investigator's decision|2
5239801|NCT00824382|18082147|P2|Overall Study|Investigator's decision|1
5239802|NCT00824382|18082148|P1|Overall Study|Investigator's decision|0
5239803|NCT00824382|18082145|P4|Overall Study|Protocol Violation|1
5239804|NCT00824382|18082146|P3|Overall Study|Protocol Violation|0
5239805|NCT00824382|18082147|P2|Overall Study|Protocol Violation|0
5239806|NCT00824382|18082148|P1|Overall Study|Protocol Violation|1
5239807|NCT00824382|18082145|P4|Overall Study|Adverse Event|4
5239808|NCT00824382|18082146|P3|Overall Study|Adverse Event|1
5239809|NCT00824382|18082147|P2|Overall Study|Adverse Event|1
5239810|NCT00824382|18082148|P1|Overall Study|Adverse Event|4
5239811|NCT00824369|18082224|P6|Overall Study|Lost to Follow-up|0
5239812|NCT00824369|18082225|P5|Overall Study|Lost to Follow-up|1
5239813|NCT00824369|18082226|P4|Overall Study|Lost to Follow-up|0
5239814|NCT00824369|18082227|P3|Overall Study|Lost to Follow-up|0
5239815|NCT00824369|18082228|P2|Overall Study|Lost to Follow-up|0
5239816|NCT00824369|18082229|P1|Overall Study|Lost to Follow-up|0
5239817|NCT00824369|18082224|P6|Overall Study|Nolonger willing to participate in study|1
5239818|NCT00824369|18082225|P5|Overall Study|Nolonger willing to participate in study|0
5239819|NCT00824369|18082226|P4|Overall Study|Nolonger willing to participate in study|2
5239820|NCT00824369|18082227|P3|Overall Study|Nolonger willing to participate in study|1
5239821|NCT00824369|18082228|P2|Overall Study|Nolonger willing to participate in study|0
5239822|NCT00824369|18082229|P1|Overall Study|Nolonger willing to participate in study|1
5239823|NCT00824291|18082269|P2|Overall Study|Participant on prohibited medication|0
5239824|NCT00824291|18082270|P1|Overall Study|Participant on prohibited medication|1
5239825|NCT00824291|18082269|P2|Overall Study|Lack of Efficacy|8
5239826|NCT00824291|18082270|P1|Overall Study|Lack of Efficacy|7
5239827|NCT00824291|18082269|P2|Overall Study|Withdrawal by Subject|8
5239828|NCT00824291|18082270|P1|Overall Study|Withdrawal by Subject|14
5239829|NCT00824291|18082269|P2|Overall Study|Protocol Violation|1
5239830|NCT00824291|18082270|P1|Overall Study|Protocol Violation|4
5239831|NCT00824291|18082269|P2|Overall Study|Non-compliance|1
5239832|NCT00824291|18082270|P1|Overall Study|Non-compliance|1
5239833|NCT00824291|18082269|P2|Overall Study|Lost to Follow-up|9
5239834|NCT00824291|18082270|P1|Overall Study|Lost to Follow-up|11
5239835|NCT00824291|18082269|P2|Overall Study|Discontinuation of Study by Sponsor|2
5239836|NCT00824291|18082270|P1|Overall Study|Discontinuation of Study by Sponsor|1
5239837|NCT00824291|18082269|P2|Overall Study|Adverse Event|6
5239838|NCT00824291|18082270|P1|Overall Study|Adverse Event|15
5239839|NCT00824265|18082292|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
5239840|NCT00824265|18082293|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
5239841|NCT00824265|18082292|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
5239842|NCT00824265|18082293|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
5239843|NCT00824265|18082292|P2|Treatment Phase|Withdrawal by Subject|15
5239844|NCT00824265|18082293|P1|Treatment Phase|Withdrawal by Subject|6
5239845|NCT00824265|18082292|P2|Treatment Phase|Physician Decision|12
5239846|NCT00824265|18082293|P1|Treatment Phase|Physician Decision|6
5239847|NCT00824265|18082292|P2|Treatment Phase|Lost to Follow-up|1
5239848|NCT00824265|18082293|P1|Treatment Phase|Lost to Follow-up|1
5239849|NCT00824265|18082292|P2|Treatment Phase|Protocol Violation|0
5239850|NCT00824265|18082293|P1|Treatment Phase|Protocol Violation|1
5239851|NCT00824265|18082292|P2|Treatment Phase|Adverse Event,non-fatal|52
5239852|NCT00824265|18082293|P1|Treatment Phase|Adverse Event,non-fatal|50
5239853|NCT00824161|18082354|P1|Overall Study|Screen Failure|1
5239854|NCT00824161|18082354|P1|Overall Study|Withdrawal by Subject|1
5239855|NCT00824005|18082420|P2|Overall Study|Lost to Follow-up|1
5239856|NCT00824005|18082421|P1|Overall Study|Lost to Follow-up|0
5239857|NCT00824005|18082420|P2|Overall Study|Death|1
5239858|NCT00824005|18082421|P1|Overall Study|Death|0
5239859|NCT00823979|18082456|P3|Overall Study|Study Terminated by Sponsor|7
5239860|NCT00823979|18082457|P2|Overall Study|Study Terminated by Sponsor|5
5239861|NCT00823979|18082458|P1|Overall Study|Study Terminated by Sponsor|5
5239862|NCT00823979|18082456|P3|Overall Study|Randomized but not Treated|1
5239863|NCT00823979|18082457|P2|Overall Study|Randomized but not Treated|3
5239864|NCT00823979|18082458|P1|Overall Study|Randomized but not Treated|4
5239865|NCT00823979|18082456|P3|Overall Study|Other|1
5239866|NCT00823979|18082457|P2|Overall Study|Other|0
5239867|NCT00823979|18082458|P1|Overall Study|Other|2
5239868|NCT00823979|18082456|P3|Overall Study|Adverse Event|4
5239869|NCT00823979|18082457|P2|Overall Study|Adverse Event|2
5239870|NCT00823979|18082458|P1|Overall Study|Adverse Event|0
5239871|NCT00823979|18082456|P3|Overall Study|Pregnancy|0
5239872|NCT00823979|18082457|P2|Overall Study|Pregnancy|1
5239873|NCT00823979|18082458|P1|Overall Study|Pregnancy|0
5239874|NCT00823979|18082456|P3|Overall Study|Protocol Violation|0
5239875|NCT00823979|18082457|P2|Overall Study|Protocol Violation|1
5239876|NCT00823979|18082458|P1|Overall Study|Protocol Violation|1
5239877|NCT00823979|18082456|P3|Overall Study|Withdrawal by Subject|2
5239878|NCT00823979|18082457|P2|Overall Study|Withdrawal by Subject|3
5239879|NCT00823979|18082458|P1|Overall Study|Withdrawal by Subject|2
5239880|NCT00823979|18082456|P3|Overall Study|Lost to Follow-up|0
5239881|NCT00823979|18082457|P2|Overall Study|Lost to Follow-up|1
5239882|NCT00823979|18082458|P1|Overall Study|Lost to Follow-up|2
5239883|NCT00823979|18082456|P3|Overall Study|Lack of Efficacy|9
5239884|NCT00823979|18082457|P2|Overall Study|Lack of Efficacy|16
5239885|NCT00823979|18082458|P1|Overall Study|Lack of Efficacy|13
5239886|NCT00823901|18082503|P2|Overall Study|Lost to Follow-up|1
5239887|NCT00823901|18082504|P1|Overall Study|Lost to Follow-up|2
5239888|NCT00823901|18082503|P2|Overall Study|Lack of Efficacy|0
5239889|NCT00823901|18082504|P1|Overall Study|Lack of Efficacy|1
5239890|NCT00823901|18082503|P2|Overall Study|Adverse Event|1
5239891|NCT00823901|18082504|P1|Overall Study|Adverse Event|1
5239892|NCT00823836|18082512|P2|Long-term Phase|Withdrawal by Subject|1
5239893|NCT00823836|18082513|P1|Long-term Phase|Withdrawal by Subject|1
5239894|NCT00823836|18082512|P2|Long-term Phase|Physician Decision|2
5239895|NCT00823836|18082513|P1|Long-term Phase|Physician Decision|1
5239896|NCT00823836|18082512|P2|Long-term Phase|Adverse Event|2
5239897|NCT00823836|18082513|P1|Long-term Phase|Adverse Event|3
5239898|NCT00823836|18082512|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
5239899|NCT00823836|18082513|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
5239989|NCT00822120|18083224|P1|PET-directed Therapy|Death|0
5239900|NCT00823836|18082512|P2|NV and PR/XR Switching Phases|Physician Decision|2
5239901|NCT00823836|18082513|P1|NV and PR/XR Switching Phases|Physician Decision|5
5239902|NCT00823836|18082512|P2|NV and PR/XR Switching Phases|Protocol Violation|1
5239903|NCT00823836|18082513|P1|NV and PR/XR Switching Phases|Protocol Violation|1
5239904|NCT00823836|18082512|P2|NV and PR/XR Switching Phases|Adverse Event|21
5239905|NCT00823836|18082513|P1|NV and PR/XR Switching Phases|Adverse Event|22
5239906|NCT00823823|18082619|P2|Overall Study|Protocol Violation|5
5239907|NCT00823823|18082620|P1|Overall Study|Protocol Violation|5
5239908|NCT00823823|18082619|P2|Overall Study|Lost to Follow-up|1
5239909|NCT00823823|18082620|P1|Overall Study|Lost to Follow-up|3
5239910|NCT00823719|18082644|P2|Overall Study|Disease Progression|4
5239911|NCT00823719|18082645|P1|Overall Study|Disease Progression|4
5239912|NCT00823719|18082644|P2|Overall Study|Withdrawal by Subject|1
5239913|NCT00823719|18082645|P1|Overall Study|Withdrawal by Subject|0
5239914|NCT00823719|18082644|P2|Overall Study|Physician Decision|4
5239915|NCT00823719|18082645|P1|Overall Study|Physician Decision|1
5239916|NCT00823719|18082644|P2|Overall Study|Adverse Event|2
5239917|NCT00823719|18082645|P1|Overall Study|Adverse Event|1
5239918|NCT00823615|18082698|P2|Period 2|Time/Job Conflict|2
5239919|NCT00823615|18082699|P1|Period 2|Time/Job Conflict|1
5239920|NCT00823615|18082698|P2|Period 2|Lost to Follow-up|0
5239921|NCT00823615|18082699|P1|Period 2|Lost to Follow-up|2
5239922|NCT00823472|18082709|P2|Overall Study|Physician Decision|28
5239923|NCT00823472|18082710|P1|Overall Study|Physician Decision|24
5239924|NCT00823264|18082737|P2|Overall Study|Protocol Violation|0
5239925|NCT00823264|18082738|P1|Overall Study|Protocol Violation|2
5239926|NCT00823212|18082746|P2|Overall Study|Missed 12-month visit|21
5239927|NCT00823212|18082747|P1|Overall Study|Missed 12-month visit|21
5239928|NCT00823212|18082746|P2|Overall Study|Incarcerated|1
5239929|NCT00823212|18082747|P1|Overall Study|Incarcerated|0
5239930|NCT00823212|18082746|P2|Overall Study|Withdrawal by Subject|1
5239931|NCT00823212|18082747|P1|Overall Study|Withdrawal by Subject|6
5239932|NCT00823212|18082746|P2|Overall Study|Death|10
5239933|NCT00823212|18082747|P1|Overall Study|Death|8
5239934|NCT00823199|18082829|P1|Overall Study|Withdrawal by Subject|2
5239935|NCT00823134|18082835|P1|Overall Study|Invalid measurement|1
5239936|NCT00822926|18082908|P2|Second Injection Visit|Withdrawal by Subject|1
5239937|NCT00822926|18082909|P1|Second Injection Visit|Withdrawal by Subject|0
5239938|NCT00822926|18082908|P2|Second Injection Visit|Lost to Follow-up|0
5239939|NCT00822926|18082909|P1|Second Injection Visit|Lost to Follow-up|1
5239940|NCT00822900|18082923|P2|Overall Study|Became a ward of the state|1
5239941|NCT00822900|18082924|P1|Overall Study|Became a ward of the state|2
5239942|NCT00822900|18082923|P2|Overall Study|Death|69
5239943|NCT00822900|18082924|P1|Overall Study|Death|83
5239944|NCT00822900|18082923|P2|Overall Study|Lost to Follow-up|9
5239945|NCT00822900|18082924|P1|Overall Study|Lost to Follow-up|9
5239946|NCT00822900|18082923|P2|Overall Study|Withdrawal by Subject|14
5239947|NCT00822900|18082924|P1|Overall Study|Withdrawal by Subject|14
5239948|NCT00822770|18082954|P2|Overall Study|Death|1
5239949|NCT00822770|18082955|P1|Overall Study|Death|1
5239950|NCT00822770|18082954|P2|Overall Study|Complication/Incomplete treatment|0
5239951|NCT00822770|18082955|P1|Overall Study|Complication/Incomplete treatment|1
5239952|NCT00822770|18082954|P2|Overall Study|Not treated|0
5239953|NCT00822770|18082955|P1|Overall Study|Not treated|1
5239954|NCT00822692|18082977|P2|Overall Study|Lost to Follow-up|25
5239955|NCT00822692|18082978|P1|Overall Study|Lost to Follow-up|17
5239956|NCT00822237|18083116|P2|Dose 2 Vaccination|Lost to Follow-up|9
5239957|NCT00822237|18083117|P1|Dose 2 Vaccination|Lost to Follow-up|2
5239958|NCT00822237|18083116|P2|Dose 2 Vaccination|Withdrawal by Subject|2
5239959|NCT00822237|18083117|P1|Dose 2 Vaccination|Withdrawal by Subject|2
5239960|NCT00822237|18083116|P2|Dose 1 Vaccination|Lost to Follow-up|12
5239961|NCT00822237|18083117|P1|Dose 1 Vaccination|Lost to Follow-up|9
5239962|NCT00822237|18083116|P2|Dose 1 Vaccination|Withdrawal by Subject|14
5239963|NCT00822237|18083117|P1|Dose 1 Vaccination|Withdrawal by Subject|13
5239964|NCT00822237|18083116|P2|Dose 1 Vaccination|Not vaccinated|0
5239965|NCT00822237|18083117|P1|Dose 1 Vaccination|Not vaccinated|3
5239966|NCT00822172|18083198|P2|Overall Study|Other|1
5239967|NCT00822172|18083199|P1|Overall Study|Other|0
5239968|NCT00822172|18083198|P2|Overall Study|site closed|1
5239969|NCT00822172|18083199|P1|Overall Study|site closed|0
5239970|NCT00822172|18083198|P2|Overall Study|Withdrawal by Subject|4
5239971|NCT00822172|18083199|P1|Overall Study|Withdrawal by Subject|1
5239972|NCT00822172|18083198|P2|Overall Study|Lost to Follow-up|1
5239973|NCT00822172|18083199|P1|Overall Study|Lost to Follow-up|3
5239974|NCT00822172|18083198|P2|Overall Study|Death|0
5239975|NCT00822172|18083199|P1|Overall Study|Death|1
5239976|NCT00822172|18083198|P2|Overall Study|Adverse Event|12
5239977|NCT00822172|18083199|P1|Overall Study|Adverse Event|10
5239978|NCT00822120|18083219|P6|PET-directed Therapy|Protocol Violation|0
5239979|NCT00822120|18083220|P5|PET-directed Therapy|Protocol Violation|0
5239980|NCT00822120|18083221|P4|PET-directed Therapy|Protocol Violation|6
5239981|NCT00822120|18083222|P3|PET-directed Therapy|Protocol Violation|0
5239982|NCT00822120|18083223|P2|PET-directed Therapy|Protocol Violation|0
5239983|NCT00822120|18083224|P1|PET-directed Therapy|Protocol Violation|0
5239984|NCT00822120|18083219|P6|PET-directed Therapy|Death|0
5239985|NCT00822120|18083220|P5|PET-directed Therapy|Death|0
5239986|NCT00822120|18083221|P4|PET-directed Therapy|Death|2
5239987|NCT00822120|18083222|P3|PET-directed Therapy|Death|0
5239988|NCT00822120|18083223|P2|PET-directed Therapy|Death|0
5239990|NCT00822120|18083219|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5239991|NCT00822120|18083220|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5239992|NCT00822120|18083221|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
5239993|NCT00822120|18083222|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5239994|NCT00822120|18083223|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5239995|NCT00822120|18083224|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5239996|NCT00822120|18083219|P6|PET-directed Therapy|Adverse Event|0
5239997|NCT00822120|18083220|P5|PET-directed Therapy|Adverse Event|0
5239998|NCT00822120|18083221|P4|PET-directed Therapy|Adverse Event|1
5239999|NCT00822120|18083222|P3|PET-directed Therapy|Adverse Event|0
5240000|NCT00822120|18083223|P2|PET-directed Therapy|Adverse Event|0
5240001|NCT00822120|18083224|P1|PET-directed Therapy|Adverse Event|0
5240002|NCT00822120|18083219|P6|Initial Registration|Ineligible|0
5240003|NCT00822120|18083220|P5|Initial Registration|Ineligible|0
5240004|NCT00822120|18083221|P4|Initial Registration|Ineligible|0
5240005|NCT00822120|18083222|P3|Initial Registration|Ineligible|0
5240006|NCT00822120|18083223|P2|Initial Registration|Ineligible|1
5240007|NCT00822120|18083224|P1|Initial Registration|Ineligible|22
5240008|NCT00822120|18083219|P6|Initial Registration|Reasons not Protocol Specified|0
5240009|NCT00822120|18083220|P5|Initial Registration|Reasons not Protocol Specified|0
5240010|NCT00822120|18083221|P4|Initial Registration|Reasons not Protocol Specified|0
5240011|NCT00822120|18083222|P3|Initial Registration|Reasons not Protocol Specified|0
5240012|NCT00822120|18083223|P2|Initial Registration|Reasons not Protocol Specified|0
5240013|NCT00822120|18083224|P1|Initial Registration|Reasons not Protocol Specified|2
5240014|NCT00822120|18083219|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
5240015|NCT00822120|18083220|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
5240016|NCT00822120|18083221|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
5240017|NCT00822120|18083222|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
5240018|NCT00822120|18083223|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
5240019|NCT00822120|18083224|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
5240020|NCT00822120|18083219|P6|Initial Registration|Adverse Event|0
5240021|NCT00822120|18083220|P5|Initial Registration|Adverse Event|0
5240022|NCT00822120|18083221|P4|Initial Registration|Adverse Event|0
5240023|NCT00822120|18083222|P3|Initial Registration|Adverse Event|0
5240024|NCT00822120|18083223|P2|Initial Registration|Adverse Event|0
5240025|NCT00822120|18083224|P1|Initial Registration|Adverse Event|1
5240026|NCT00821873|18083290|P1|Overall Study|Lost to Follow-up|4
5240027|NCT00821678|18083320|P2|Overall Study|Death|2
5240028|NCT00821678|18083321|P1|Overall Study|Death|0
5240029|NCT00821678|18083320|P2|Overall Study|Lost to Follow-up|12
5240030|NCT00821678|18083321|P1|Overall Study|Lost to Follow-up|13
5240031|NCT00821678|18083320|P2|Overall Study|Withdrawal by Subject|0
5240032|NCT00821678|18083321|P1|Overall Study|Withdrawal by Subject|8
5240033|NCT00821587|18083356|P2|Overall Study|Physician Decision|1
5240034|NCT00821587|18083357|P1|Overall Study|Physician Decision|0
5240035|NCT00821509|18083366|P3|Overall Study|Withdrawal by Subject|34
5240036|NCT00821509|18083367|P2|Overall Study|Withdrawal by Subject|11
5240037|NCT00821509|18083368|P1|Overall Study|Withdrawal by Subject|12
5240038|NCT00821431|18083381|P2|Overall Study|Physician Decision|1
5240039|NCT00821431|18083382|P1|Overall Study|Physician Decision|0
5240040|NCT00821431|18083381|P2|Overall Study|Protocol Violation|1
5240041|NCT00821431|18083382|P1|Overall Study|Protocol Violation|3
5240042|NCT00821431|18083381|P2|Overall Study|Lost to Follow-up|0
5240043|NCT00821431|18083382|P1|Overall Study|Lost to Follow-up|1
5240044|NCT00821431|18083381|P2|Overall Study|Withdrawal by Subject|0
5240045|NCT00821431|18083382|P1|Overall Study|Withdrawal by Subject|5
5240046|NCT00821431|18083381|P2|Overall Study|Adverse Event|3
5240047|NCT00821431|18083382|P1|Overall Study|Adverse Event|6
5240048|NCT00821327|18083390|P1|Overall Study|Other/Unknown|5
5240049|NCT00821327|18083390|P1|Overall Study|Disease Progression|13
5240050|NCT00821327|18083390|P1|Overall Study|Sponsor Request|1
5240051|NCT00821327|18083390|P1|Overall Study|Investigator Request|2
5240052|NCT00821327|18083390|P1|Overall Study|Patient Request|1
5240053|NCT00821327|18083390|P1|Overall Study|Adverse Event|13
5240054|NCT00821236|18083399|P1|Overall Study|Lost to Follow-up|3
5240055|NCT00821093|18083439|P2|Overall Study|Administrative problems|2
5240056|NCT00821093|18083440|P1|Overall Study|Administrative problems|1
5240057|NCT00821093|18083439|P2|Overall Study|Abnormal test procedure result(s)|1
5240058|NCT00821093|18083440|P1|Overall Study|Abnormal test procedure result(s)|1
5240059|NCT00821093|18083439|P2|Overall Study|Death|1
5240060|NCT00821093|18083440|P1|Overall Study|Death|2
5240061|NCT00821093|18083439|P2|Overall Study|Lack of Efficacy|2
5240062|NCT00821093|18083440|P1|Overall Study|Lack of Efficacy|2
5240063|NCT00821093|18083439|P2|Overall Study|Abnormal laboratory value(s)|0
5240064|NCT00821093|18083440|P1|Overall Study|Abnormal laboratory value(s)|2
5240065|NCT00821093|18083439|P2|Overall Study|Protocol deviation|6
5240066|NCT00821093|18083440|P1|Overall Study|Protocol deviation|3
5240067|NCT00821093|18083439|P2|Overall Study|Lost to Follow-up|3
5240068|NCT00821093|18083440|P1|Overall Study|Lost to Follow-up|9
5240069|NCT00821093|18083439|P2|Overall Study|Withdrawal by Subject|13
5240070|NCT00821093|18083440|P1|Overall Study|Withdrawal by Subject|9
5240071|NCT00821093|18083439|P2|Overall Study|Adverse Event|12
5240072|NCT00821093|18083440|P1|Overall Study|Adverse Event|20
5240073|NCT00821015|18083459|P1|Overall Study|Lost to Follow-up|12
5240074|NCT00820898|18083470|P1|Overall Study|Inelgible - wrong primary site|1
5240075|NCT00820755|18083484|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
5240076|NCT00820755|18083485|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
5240077|NCT00820755|18083486|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
5240078|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Other|0
5240079|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Other|0
5240080|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Other|11
5240081|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
5240082|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
5240083|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
5240084|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Progressive disease|0
5240085|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Progressive disease|0
5240086|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Progressive disease|114
5240087|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
5240088|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
5240089|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
5240090|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
5240091|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
5240092|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
5240093|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
5240094|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
5240095|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
5240096|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Death|0
5240097|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Death|0
5240098|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Death|28
5240099|NCT00820755|18083484|P3|Period 1: Combination Therapy Phase|Adverse Event|0
5240100|NCT00820755|18083485|P2|Period 1: Combination Therapy Phase|Adverse Event|0
5240101|NCT00820755|18083486|P1|Period 1: Combination Therapy Phase|Adverse Event|77
5240102|NCT00820599|18083529|P1|Overall Study|Withdrawal by Subject|2
5240103|NCT00820599|18083529|P1|Overall Study|Death|129
5240104|NCT00820248|18083584|P2|Overall Study|No treated|1
5240105|NCT00820248|18083585|P1|Overall Study|No treated|4
5240106|NCT00820222|18083617|P2|Overall Study|Unkown|7
5240107|NCT00820222|18083618|P1|Overall Study|Unkown|11
5240108|NCT00820222|18083617|P2|Overall Study|Sponsor Terminated Study|65
5240109|NCT00820222|18083618|P1|Overall Study|Sponsor Terminated Study|43
5240110|NCT00820222|18083617|P2|Overall Study|Physician Decision|88
5240111|NCT00820222|18083618|P1|Overall Study|Physician Decision|93
5240112|NCT00820222|18083617|P2|Overall Study|Withdrawal by Subject|21
5240113|NCT00820222|18083618|P1|Overall Study|Withdrawal by Subject|19
5240114|NCT00820222|18083617|P2|Overall Study|Lost to Follow-up|9
5240115|NCT00820222|18083618|P1|Overall Study|Lost to Follow-up|10
5240116|NCT00820170|18083649|P5|Overall Study|Progressive Disease|2
5240117|NCT00820170|18083650|P4|Overall Study|Progressive Disease|0
5240118|NCT00820170|18083651|P3|Overall Study|Progressive Disease|0
5240119|NCT00820170|18083652|P2|Overall Study|Progressive Disease|0
5240120|NCT00820170|18083653|P1|Overall Study|Progressive Disease|0
5240121|NCT00820170|18083649|P5|Overall Study|Adverse Event|2
5240122|NCT00820170|18083650|P4|Overall Study|Adverse Event|0
5240123|NCT00820170|18083651|P3|Overall Study|Adverse Event|0
5240124|NCT00820170|18083652|P2|Overall Study|Adverse Event|0
5240125|NCT00820170|18083653|P1|Overall Study|Adverse Event|0
5240126|NCT00820027|18083705|P4|Overall Study|Withdrawal by Subject|6
5240127|NCT00820027|18083706|P3|Overall Study|Withdrawal by Subject|4
5240128|NCT00820027|18083707|P2|Overall Study|Withdrawal by Subject|4
5240129|NCT00820027|18083708|P1|Overall Study|Withdrawal by Subject|6
5240130|NCT00820027|18083705|P4|Overall Study|Protocol Violation|0
5240131|NCT00820027|18083706|P3|Overall Study|Protocol Violation|4
5240132|NCT00820027|18083707|P2|Overall Study|Protocol Violation|0
5240133|NCT00820027|18083708|P1|Overall Study|Protocol Violation|3
5240134|NCT00820027|18083705|P4|Overall Study|Physician Decision|0
5240135|NCT00820027|18083706|P3|Overall Study|Physician Decision|1
5240136|NCT00820027|18083707|P2|Overall Study|Physician Decision|1
5240137|NCT00820027|18083708|P1|Overall Study|Physician Decision|0
5240138|NCT00820027|18083705|P4|Overall Study|Lack of Efficacy|2
5240139|NCT00820027|18083706|P3|Overall Study|Lack of Efficacy|2
5240140|NCT00820027|18083707|P2|Overall Study|Lack of Efficacy|1
5240141|NCT00820027|18083708|P1|Overall Study|Lack of Efficacy|2
5240142|NCT00820027|18083705|P4|Overall Study|Adverse Event|5
5240143|NCT00820027|18083706|P3|Overall Study|Adverse Event|10
5240144|NCT00820027|18083707|P2|Overall Study|Adverse Event|8
5240145|NCT00820027|18083708|P1|Overall Study|Adverse Event|15
5240146|NCT00819910|18083750|P4|Overall Study|Lost to Follow-up|0
5240147|NCT00819910|18083751|P3|Overall Study|Lost to Follow-up|0
5240148|NCT00819910|18083752|P2|Overall Study|Lost to Follow-up|0
5240149|NCT00819910|18083753|P1|Overall Study|Lost to Follow-up|1
5240150|NCT00819910|18083750|P4|Overall Study|Withdrawal by Subject|0
5240151|NCT00819910|18083751|P3|Overall Study|Withdrawal by Subject|1
5240152|NCT00819910|18083752|P2|Overall Study|Withdrawal by Subject|1
5240153|NCT00819910|18083753|P1|Overall Study|Withdrawal by Subject|1
5240154|NCT00819910|18083750|P4|Overall Study|Adverse Event|1
5240155|NCT00819910|18083751|P3|Overall Study|Adverse Event|2
5240156|NCT00819910|18083752|P2|Overall Study|Adverse Event|0
5240157|NCT00819910|18083753|P1|Overall Study|Adverse Event|0
5240158|NCT00819832|18083785|P6|Overall Study|Sponsor Termination of Study|0
5240159|NCT00819832|18083786|P5|Overall Study|Sponsor Termination of Study|0
5240160|NCT00819832|18083787|P4|Overall Study|Sponsor Termination of Study|0
5240161|NCT00819832|18083788|P3|Overall Study|Sponsor Termination of Study|0
5240162|NCT00819832|18083789|P2|Overall Study|Sponsor Termination of Study|0
5240163|NCT00819832|18083790|P1|Overall Study|Sponsor Termination of Study|3
5240164|NCT00819780|18083811|P2|Overall Study|Still in treatment|17
5240165|NCT00819780|18083812|P1|Overall Study|Still in treatment|25
5240166|NCT00819780|18083811|P2|Overall Study|Did not receive study drug|4
5240167|NCT00819780|18083812|P1|Overall Study|Did not receive study drug|3
5240168|NCT00819767|18083846|P2|Overall Study|Unsatisfactory therapeutic effect|2
5240169|NCT00819767|18083847|P1|Overall Study|Unsatisfactory therapeutic effect|1
5240170|NCT00819741|18083859|P2|Overall Study|Reasons unknown|3
5240171|NCT00819741|18083860|P1|Overall Study|Reasons unknown|3
5240172|NCT00819741|18083859|P2|Overall Study|Unclassified|0
5240173|NCT00819741|18083860|P1|Overall Study|Unclassified|6
5240174|NCT00819741|18083859|P2|Overall Study|Withdrawal by Subject|2
5240175|NCT00819741|18083860|P1|Overall Study|Withdrawal by Subject|2
5240176|NCT00819741|18083859|P2|Overall Study|Protocol Violation|4
5240177|NCT00819741|18083860|P1|Overall Study|Protocol Violation|3
5240178|NCT00819741|18083859|P2|Overall Study|Lost to Follow-up|1
5240179|NCT00819741|18083860|P1|Overall Study|Lost to Follow-up|3
5240180|NCT00819741|18083859|P2|Overall Study|Lack of Efficacy|2
5240181|NCT00819741|18083860|P1|Overall Study|Lack of Efficacy|0
5240182|NCT00819741|18083859|P2|Overall Study|Adverse Event|2
5240183|NCT00819741|18083860|P1|Overall Study|Adverse Event|5
5240184|NCT00819585|18083914|P11|Extension Study|Death|0
5240185|NCT00819585|18083915|P10|Extension Study|Death|0
5240186|NCT00819585|18083916|P9|Extension Study|Death|2
5240187|NCT00819585|18083917|P8|Extension Study|Death|0
5240188|NCT00819585|18083918|P7|Extension Study|Death|0
5240189|NCT00819585|18083919|P6|Extension Study|Death|0
5240190|NCT00819585|18083920|P5|Extension Study|Death|0
5240191|NCT00819585|18083921|P4|Extension Study|Death|0
5240192|NCT00819585|18083922|P3|Extension Study|Death|0
5240193|NCT00819585|18083923|P2|Extension Study|Death|0
5240194|NCT00819585|18083924|P1|Extension Study|Death|0
5240195|NCT00819585|18083914|P11|Extension Study|Lost to Follow-up|1
5240196|NCT00819585|18083915|P10|Extension Study|Lost to Follow-up|1
5240197|NCT00819585|18083916|P9|Extension Study|Lost to Follow-up|2
5240198|NCT00819585|18083917|P8|Extension Study|Lost to Follow-up|0
5240199|NCT00819585|18083918|P7|Extension Study|Lost to Follow-up|0
5240200|NCT00819585|18083919|P6|Extension Study|Lost to Follow-up|0
5240201|NCT00819585|18083920|P5|Extension Study|Lost to Follow-up|0
5240202|NCT00819585|18083921|P4|Extension Study|Lost to Follow-up|0
5240203|NCT00819585|18083922|P3|Extension Study|Lost to Follow-up|0
5240204|NCT00819585|18083923|P2|Extension Study|Lost to Follow-up|0
5240205|NCT00819585|18083924|P1|Extension Study|Lost to Follow-up|0
5240206|NCT00819585|18083914|P11|Extension Study|Subject Withdrew Consent|1
5240207|NCT00819585|18083915|P10|Extension Study|Subject Withdrew Consent|0
5240208|NCT00819585|18083916|P9|Extension Study|Subject Withdrew Consent|3
5240209|NCT00819585|18083917|P8|Extension Study|Subject Withdrew Consent|0
5240210|NCT00819585|18083918|P7|Extension Study|Subject Withdrew Consent|0
5240211|NCT00819585|18083919|P6|Extension Study|Subject Withdrew Consent|0
5240212|NCT00819585|18083920|P5|Extension Study|Subject Withdrew Consent|0
5240213|NCT00819585|18083921|P4|Extension Study|Subject Withdrew Consent|0
5240214|NCT00819585|18083922|P3|Extension Study|Subject Withdrew Consent|0
5240215|NCT00819585|18083923|P2|Extension Study|Subject Withdrew Consent|0
5240216|NCT00819585|18083924|P1|Extension Study|Subject Withdrew Consent|0
5240217|NCT00819585|18083914|P11|Extension Study|Abnormal Laboratory Value(s)|0
5240218|NCT00819585|18083915|P10|Extension Study|Abnormal Laboratory Value(s)|0
5240219|NCT00819585|18083916|P9|Extension Study|Abnormal Laboratory Value(s)|1
5240220|NCT00819585|18083917|P8|Extension Study|Abnormal Laboratory Value(s)|0
5240221|NCT00819585|18083918|P7|Extension Study|Abnormal Laboratory Value(s)|0
5240222|NCT00819585|18083919|P6|Extension Study|Abnormal Laboratory Value(s)|0
5240223|NCT00819585|18083920|P5|Extension Study|Abnormal Laboratory Value(s)|0
5240224|NCT00819585|18083921|P4|Extension Study|Abnormal Laboratory Value(s)|0
5240225|NCT00819585|18083922|P3|Extension Study|Abnormal Laboratory Value(s)|0
5240226|NCT00819585|18083923|P2|Extension Study|Abnormal Laboratory Value(s)|0
5240227|NCT00819585|18083924|P1|Extension Study|Abnormal Laboratory Value(s)|0
5240228|NCT00819585|18083914|P11|Core Study|Protocol Violation|0
5240229|NCT00819585|18083915|P10|Core Study|Protocol Violation|0
5240230|NCT00819585|18083916|P9|Core Study|Protocol Violation|0
5240231|NCT00819585|18083917|P8|Core Study|Protocol Violation|0
5240232|NCT00819585|18083918|P7|Core Study|Protocol Violation|3
5240233|NCT00819585|18083919|P6|Core Study|Protocol Violation|1
5240234|NCT00819585|18083920|P5|Core Study|Protocol Violation|0
5240235|NCT00819585|18083921|P4|Core Study|Protocol Violation|0
5240236|NCT00819585|18083922|P3|Core Study|Protocol Violation|1
5240237|NCT00819585|18083923|P2|Core Study|Protocol Violation|0
5240238|NCT00819585|18083924|P1|Core Study|Protocol Violation|0
5240239|NCT00819585|18083914|P11|Core Study|Death|0
5240240|NCT00819585|18083915|P10|Core Study|Death|0
5240241|NCT00819585|18083916|P9|Core Study|Death|0
5240242|NCT00819585|18083917|P8|Core Study|Death|0
5240243|NCT00819585|18083918|P7|Core Study|Death|1
5240244|NCT00819585|18083919|P6|Core Study|Death|0
5240245|NCT00819585|18083920|P5|Core Study|Death|0
5240246|NCT00819585|18083921|P4|Core Study|Death|0
5240247|NCT00819585|18083922|P3|Core Study|Death|0
5240248|NCT00819585|18083923|P2|Core Study|Death|0
5240249|NCT00819585|18083924|P1|Core Study|Death|0
5240250|NCT00819585|18083914|P11|Core Study|Administrative Problems|0
5240251|NCT00819585|18083915|P10|Core Study|Administrative Problems|0
5240252|NCT00819585|18083916|P9|Core Study|Administrative Problems|0
5240253|NCT00819585|18083917|P8|Core Study|Administrative Problems|0
5240254|NCT00819585|18083918|P7|Core Study|Administrative Problems|2
5240255|NCT00819585|18083919|P6|Core Study|Administrative Problems|0
5240256|NCT00819585|18083920|P5|Core Study|Administrative Problems|0
5240257|NCT00819585|18083921|P4|Core Study|Administrative Problems|0
5240258|NCT00819585|18083922|P3|Core Study|Administrative Problems|0
5240259|NCT00819585|18083923|P2|Core Study|Administrative Problems|0
5240260|NCT00819585|18083924|P1|Core Study|Administrative Problems|0
5240261|NCT00819585|18083914|P11|Core Study|Lost to Follow-up|0
5240262|NCT00819585|18083915|P10|Core Study|Lost to Follow-up|0
5240263|NCT00819585|18083916|P9|Core Study|Lost to Follow-up|0
5240264|NCT00819585|18083917|P8|Core Study|Lost to Follow-up|0
5240265|NCT00819585|18083918|P7|Core Study|Lost to Follow-up|1
5240266|NCT00819585|18083919|P6|Core Study|Lost to Follow-up|1
5240267|NCT00819585|18083920|P5|Core Study|Lost to Follow-up|1
5240268|NCT00819585|18083921|P4|Core Study|Lost to Follow-up|0
5240269|NCT00819585|18083922|P3|Core Study|Lost to Follow-up|2
5240270|NCT00819585|18083923|P2|Core Study|Lost to Follow-up|1
5240271|NCT00819585|18083924|P1|Core Study|Lost to Follow-up|2
5240272|NCT00819585|18083914|P11|Core Study|Subject Withdrew Consent|0
5240273|NCT00819585|18083915|P10|Core Study|Subject Withdrew Consent|0
5240274|NCT00819585|18083916|P9|Core Study|Subject Withdrew Consent|0
5240275|NCT00819585|18083917|P8|Core Study|Subject Withdrew Consent|0
5240276|NCT00819585|18083918|P7|Core Study|Subject Withdrew Consent|3
5240277|NCT00819585|18083919|P6|Core Study|Subject Withdrew Consent|0
5240278|NCT00819585|18083920|P5|Core Study|Subject Withdrew Consent|0
5240279|NCT00819585|18083921|P4|Core Study|Subject Withdrew Consent|1
5240280|NCT00819585|18083922|P3|Core Study|Subject Withdrew Consent|2
5240281|NCT00819585|18083923|P2|Core Study|Subject Withdrew Consent|3
5240282|NCT00819585|18083924|P1|Core Study|Subject Withdrew Consent|0
5240283|NCT00819585|18083914|P11|Core Study|Subject No Longer Requires Study Drug|0
5240284|NCT00819585|18083915|P10|Core Study|Subject No Longer Requires Study Drug|0
5240285|NCT00819585|18083916|P9|Core Study|Subject No Longer Requires Study Drug|0
5240286|NCT00819585|18083917|P8|Core Study|Subject No Longer Requires Study Drug|0
5240287|NCT00819585|18083918|P7|Core Study|Subject No Longer Requires Study Drug|0
5240288|NCT00819585|18083919|P6|Core Study|Subject No Longer Requires Study Drug|0
5240289|NCT00819585|18083920|P5|Core Study|Subject No Longer Requires Study Drug|1
5240290|NCT00819585|18083921|P4|Core Study|Subject No Longer Requires Study Drug|0
5240291|NCT00819585|18083922|P3|Core Study|Subject No Longer Requires Study Drug|0
5240292|NCT00819585|18083923|P2|Core Study|Subject No Longer Requires Study Drug|0
5240293|NCT00819585|18083924|P1|Core Study|Subject No Longer Requires Study Drug|0
5240294|NCT00819585|18083914|P11|Core Study|Unsatisfactory Therapeutic Effect|0
5240295|NCT00819585|18083915|P10|Core Study|Unsatisfactory Therapeutic Effect|0
5240296|NCT00819585|18083916|P9|Core Study|Unsatisfactory Therapeutic Effect|0
5240297|NCT00819585|18083917|P8|Core Study|Unsatisfactory Therapeutic Effect|0
5240298|NCT00819585|18083918|P7|Core Study|Unsatisfactory Therapeutic Effect|1
5240299|NCT00819585|18083919|P6|Core Study|Unsatisfactory Therapeutic Effect|0
5240300|NCT00819585|18083920|P5|Core Study|Unsatisfactory Therapeutic Effect|0
5240301|NCT00819585|18083921|P4|Core Study|Unsatisfactory Therapeutic Effect|0
5240302|NCT00819585|18083922|P3|Core Study|Unsatisfactory Therapeutic Effect|0
5240303|NCT00819585|18083923|P2|Core Study|Unsatisfactory Therapeutic Effect|1
5240304|NCT00819585|18083924|P1|Core Study|Unsatisfactory Therapeutic Effect|0
5240305|NCT00819585|18083914|P11|Core Study|Abnormal Laboratory Value(s)|0
5240306|NCT00819585|18083915|P10|Core Study|Abnormal Laboratory Value(s)|0
5240307|NCT00819585|18083916|P9|Core Study|Abnormal Laboratory Value(s)|0
5240308|NCT00819585|18083917|P8|Core Study|Abnormal Laboratory Value(s)|0
5240309|NCT00819585|18083918|P7|Core Study|Abnormal Laboratory Value(s)|0
5240310|NCT00819585|18083919|P6|Core Study|Abnormal Laboratory Value(s)|0
5240311|NCT00819585|18083920|P5|Core Study|Abnormal Laboratory Value(s)|0
5240312|NCT00819585|18083921|P4|Core Study|Abnormal Laboratory Value(s)|0
5240313|NCT00819585|18083922|P3|Core Study|Abnormal Laboratory Value(s)|0
5240314|NCT00819585|18083923|P2|Core Study|Abnormal Laboratory Value(s)|0
5240315|NCT00819585|18083924|P1|Core Study|Abnormal Laboratory Value(s)|2
5240316|NCT00819585|18083914|P11|Core Study|Adverse Event|0
5240317|NCT00819585|18083915|P10|Core Study|Adverse Event|0
5240318|NCT00819585|18083916|P9|Core Study|Adverse Event|0
5240319|NCT00819585|18083917|P8|Core Study|Adverse Event|0
5240320|NCT00819585|18083918|P7|Core Study|Adverse Event|2
5240321|NCT00819585|18083919|P6|Core Study|Adverse Event|0
5240322|NCT00819585|18083920|P5|Core Study|Adverse Event|1
5240323|NCT00819585|18083921|P4|Core Study|Adverse Event|4
5240324|NCT00819585|18083922|P3|Core Study|Adverse Event|1
5240325|NCT00819585|18083923|P2|Core Study|Adverse Event|1
5240326|NCT00819585|18083924|P1|Core Study|Adverse Event|2
5240327|NCT00819390|18084015|P4|Overall Study|Adverse Event|0
5240328|NCT00819390|18084016|P3|Overall Study|Adverse Event|1
5240329|NCT00819390|18084017|P2|Overall Study|Adverse Event|0
5240330|NCT00819390|18084018|P1|Overall Study|Adverse Event|0
5240331|NCT00819390|18084015|P4|Overall Study|Withdrawal by Subject|0
5240332|NCT00819390|18084016|P3|Overall Study|Withdrawal by Subject|0
5240333|NCT00819390|18084017|P2|Overall Study|Withdrawal by Subject|0
5240334|NCT00819390|18084018|P1|Overall Study|Withdrawal by Subject|2
5240335|NCT00819390|18084015|P4|Overall Study|Lost to Follow-up|0
5240336|NCT00819390|18084016|P3|Overall Study|Lost to Follow-up|0
5240337|NCT00819390|18084017|P2|Overall Study|Lost to Follow-up|1
5240338|NCT00819390|18084018|P1|Overall Study|Lost to Follow-up|1
5240339|NCT00819247|18084154|P3|Overall Study|Other|0
5240340|NCT00819247|18084155|P2|Overall Study|Other|0
5240341|NCT00819247|18084156|P1|Overall Study|Other|1
5240342|NCT00819247|18084154|P3|Overall Study|Bad prostate-specific antigen response|0
5240343|NCT00819247|18084155|P2|Overall Study|Bad prostate-specific antigen response|2
5240344|NCT00819247|18084156|P1|Overall Study|Bad prostate-specific antigen response|3
5240345|NCT00819247|18084154|P3|Overall Study|Mistakenly withdrawn|0
5240346|NCT00819247|18084155|P2|Overall Study|Mistakenly withdrawn|1
5240347|NCT00819247|18084156|P1|Overall Study|Mistakenly withdrawn|0
5240348|NCT00819247|18084154|P3|Overall Study|Protocol Violation|1
5240349|NCT00819247|18084155|P2|Overall Study|Protocol Violation|0
5240350|NCT00819247|18084156|P1|Overall Study|Protocol Violation|1
5240351|NCT00819247|18084154|P3|Overall Study|Withdrawal by Subject|0
5240352|NCT00819247|18084155|P2|Overall Study|Withdrawal by Subject|0
5240353|NCT00819247|18084156|P1|Overall Study|Withdrawal by Subject|1
5240354|NCT00819247|18084154|P3|Overall Study|Insufficient testosterone response|10
5240355|NCT00819247|18084155|P2|Overall Study|Insufficient testosterone response|8
5240356|NCT00819247|18084156|P1|Overall Study|Insufficient testosterone response|5
5240357|NCT00819247|18084154|P3|Overall Study|Adverse Event|3
5240358|NCT00819247|18084155|P2|Overall Study|Adverse Event|5
5240359|NCT00819247|18084156|P1|Overall Study|Adverse Event|0
5240360|NCT00819234|18084182|P10|Overall Study|Lost to Follow-up|2
5240361|NCT00819234|18084183|P9|Overall Study|Lost to Follow-up|1
5240362|NCT00819234|18084184|P8|Overall Study|Lost to Follow-up|1
5240363|NCT00819234|18084185|P7|Overall Study|Lost to Follow-up|1
5240364|NCT00819234|18084186|P6|Overall Study|Lost to Follow-up|1
5240365|NCT00819234|18084187|P5|Overall Study|Lost to Follow-up|1
5240366|NCT00819234|18084188|P4|Overall Study|Lost to Follow-up|2
5240367|NCT00819234|18084189|P3|Overall Study|Lost to Follow-up|0
5240368|NCT00819234|18084190|P2|Overall Study|Lost to Follow-up|2
5240369|NCT00819234|18084191|P1|Overall Study|Lost to Follow-up|2
5240370|NCT00819234|18084182|P10|Overall Study|Protocol Violation|0
5240371|NCT00819234|18084183|P9|Overall Study|Protocol Violation|0
5240372|NCT00819234|18084184|P8|Overall Study|Protocol Violation|0
5240373|NCT00819234|18084185|P7|Overall Study|Protocol Violation|0
5240374|NCT00819234|18084186|P6|Overall Study|Protocol Violation|0
5240375|NCT00819234|18084187|P5|Overall Study|Protocol Violation|0
5240376|NCT00819234|18084188|P4|Overall Study|Protocol Violation|0
5240377|NCT00819234|18084189|P3|Overall Study|Protocol Violation|1
5240378|NCT00819234|18084190|P2|Overall Study|Protocol Violation|0
5240379|NCT00819234|18084191|P1|Overall Study|Protocol Violation|0
5240380|NCT00819234|18084182|P10|Overall Study|Physician Decision|2
5240381|NCT00819234|18084183|P9|Overall Study|Physician Decision|0
5240382|NCT00819234|18084184|P8|Overall Study|Physician Decision|0
5240383|NCT00819234|18084185|P7|Overall Study|Physician Decision|0
5240384|NCT00819234|18084186|P6|Overall Study|Physician Decision|0
5240385|NCT00819234|18084187|P5|Overall Study|Physician Decision|0
5240386|NCT00819234|18084188|P4|Overall Study|Physician Decision|1
5240387|NCT00819234|18084189|P3|Overall Study|Physician Decision|0
5240388|NCT00819234|18084190|P2|Overall Study|Physician Decision|0
5240389|NCT00819234|18084191|P1|Overall Study|Physician Decision|0
5240390|NCT00819234|18084182|P10|Overall Study|Adverse Event|0
5240391|NCT00819234|18084183|P9|Overall Study|Adverse Event|0
5240392|NCT00819234|18084184|P8|Overall Study|Adverse Event|0
5240393|NCT00819234|18084185|P7|Overall Study|Adverse Event|0
5240394|NCT00819234|18084186|P6|Overall Study|Adverse Event|2
5240395|NCT00819234|18084187|P5|Overall Study|Adverse Event|0
5240396|NCT00819234|18084188|P4|Overall Study|Adverse Event|0
5240397|NCT00819234|18084189|P3|Overall Study|Adverse Event|1
5240398|NCT00819234|18084190|P2|Overall Study|Adverse Event|0
5240399|NCT00819234|18084191|P1|Overall Study|Adverse Event|0
5240400|NCT00819234|18084182|P10|Overall Study|Withdrawal by Subject|3
5240401|NCT00819234|18084183|P9|Overall Study|Withdrawal by Subject|5
5240402|NCT00819234|18084184|P8|Overall Study|Withdrawal by Subject|8
5240403|NCT00819234|18084185|P7|Overall Study|Withdrawal by Subject|4
5240404|NCT00819234|18084186|P6|Overall Study|Withdrawal by Subject|4
5240405|NCT00819234|18084187|P5|Overall Study|Withdrawal by Subject|0
5240406|NCT00819234|18084188|P4|Overall Study|Withdrawal by Subject|3
5240407|NCT00819234|18084189|P3|Overall Study|Withdrawal by Subject|6
5240408|NCT00819234|18084190|P2|Overall Study|Withdrawal by Subject|13
5240409|NCT00819234|18084191|P1|Overall Study|Withdrawal by Subject|8
5240410|NCT00819156|18084390|P6|Overall Study|Prostate-specific antigen progression|0
5240411|NCT00819156|18084391|P5|Overall Study|Prostate-specific antigen progression|1
5240412|NCT00819156|18084392|P4|Overall Study|Prostate-specific antigen progression|0
5240413|NCT00819156|18084393|P3|Overall Study|Prostate-specific antigen progression|0
5240414|NCT00819156|18084394|P2|Overall Study|Prostate-specific antigen progression|0
5240415|NCT00819156|18084395|P1|Overall Study|Prostate-specific antigen progression|0
5240416|NCT00819156|18084390|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5240417|NCT00819156|18084391|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
5240418|NCT00819156|18084392|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5240419|NCT00819156|18084393|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5240420|NCT00819156|18084394|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5240421|NCT00819156|18084395|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
5240422|NCT00819156|18084390|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
5240423|NCT00819156|18084391|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
5240424|NCT00819156|18084392|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
5240425|NCT00819156|18084393|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
5240426|NCT00819156|18084394|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
5240427|NCT00819156|18084395|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
5240428|NCT00819156|18084390|P6|Overall Study|Lost to Follow-up|2
5240429|NCT00819156|18084391|P5|Overall Study|Lost to Follow-up|0
5240430|NCT00819156|18084392|P4|Overall Study|Lost to Follow-up|0
5240431|NCT00819156|18084393|P3|Overall Study|Lost to Follow-up|0
5240432|NCT00819156|18084394|P2|Overall Study|Lost to Follow-up|1
5240433|NCT00819156|18084395|P1|Overall Study|Lost to Follow-up|0
5240434|NCT00819156|18084390|P6|Overall Study|Protocol Violation|1
5240435|NCT00819156|18084391|P5|Overall Study|Protocol Violation|0
5240436|NCT00819156|18084392|P4|Overall Study|Protocol Violation|0
5240437|NCT00819156|18084393|P3|Overall Study|Protocol Violation|1
5240438|NCT00819156|18084394|P2|Overall Study|Protocol Violation|0
5240439|NCT00819156|18084395|P1|Overall Study|Protocol Violation|1
5240440|NCT00819156|18084390|P6|Overall Study|Withdrawal by Subject|0
5240441|NCT00819156|18084391|P5|Overall Study|Withdrawal by Subject|1
5240442|NCT00819156|18084392|P4|Overall Study|Withdrawal by Subject|0
5240443|NCT00819156|18084393|P3|Overall Study|Withdrawal by Subject|2
5240444|NCT00819156|18084394|P2|Overall Study|Withdrawal by Subject|3
5240445|NCT00819156|18084395|P1|Overall Study|Withdrawal by Subject|0
5240446|NCT00819156|18084390|P6|Overall Study|Adverse Event|3
5240447|NCT00819156|18084391|P5|Overall Study|Adverse Event|2
5240448|NCT00819156|18084392|P4|Overall Study|Adverse Event|1
5240449|NCT00819156|18084393|P3|Overall Study|Adverse Event|2
5240450|NCT00819156|18084394|P2|Overall Study|Adverse Event|4
5240451|NCT00819156|18084395|P1|Overall Study|Adverse Event|1
5240452|NCT00819091|18084485|P2|Overall Study|Other|2
5240453|NCT00819091|18084486|P1|Overall Study|Other|1
5240454|NCT00819091|18084485|P2|Overall Study|Withdrawal by Subject|2
5240455|NCT00819091|18084486|P1|Overall Study|Withdrawal by Subject|1
5240456|NCT00819091|18084485|P2|Overall Study|Lost to Follow-up|0
5240457|NCT00819091|18084486|P1|Overall Study|Lost to Follow-up|2
5240458|NCT00819091|18084485|P2|Overall Study|Protocol Violation|1
5240459|NCT00819091|18084486|P1|Overall Study|Protocol Violation|0
5240460|NCT00819091|18084485|P2|Overall Study|Adverse Event|5
5240461|NCT00819091|18084486|P1|Overall Study|Adverse Event|3
5240462|NCT00819052|18084512|P2|Overall Study|Death or events leading to death|0
5240463|NCT00819052|18084513|P1|Overall Study|Death or events leading to death|1
5240464|NCT00819052|18084512|P2|Overall Study|Pregnancy|2
5240465|NCT00819052|18084513|P1|Overall Study|Pregnancy|1
5240466|NCT00819052|18084512|P2|Overall Study|Lack of Efficacy|1
5240467|NCT00819052|18084513|P1|Overall Study|Lack of Efficacy|1
5240468|NCT00819052|18084512|P2|Overall Study|Withdrawal by Subject|2
5240469|NCT00819052|18084513|P1|Overall Study|Withdrawal by Subject|1
5240470|NCT00819052|18084512|P2|Overall Study|Lost to Follow-up|2
5240471|NCT00819052|18084513|P1|Overall Study|Lost to Follow-up|1
5240472|NCT00819052|18084512|P2|Overall Study|Protocol Violation|2
5240473|NCT00819052|18084513|P1|Overall Study|Protocol Violation|1
5240474|NCT00819052|18084512|P2|Overall Study|Adverse Event|5
5240475|NCT00819052|18084513|P1|Overall Study|Adverse Event|0
5240476|NCT00819039|18084628|P3|Overall Study|Protocol Violation|0
5240477|NCT00819039|18084629|P2|Overall Study|Protocol Violation|0
5240478|NCT00819039|18084630|P1|Overall Study|Protocol Violation|1
5240479|NCT00819039|18084628|P3|Overall Study|Physician Decision|1
5240480|NCT00819039|18084629|P2|Overall Study|Physician Decision|0
5240481|NCT00819039|18084630|P1|Overall Study|Physician Decision|1
5240482|NCT00819013|18084660|P4|Overall Study|Death|1
5240483|NCT00819013|18084661|P3|Overall Study|Death|0
5240484|NCT00819013|18084662|P2|Overall Study|Death|0
5240485|NCT00819013|18084663|P1|Overall Study|Death|0
5240486|NCT00819013|18084660|P4|Overall Study|Lost to Follow-up|2
5240487|NCT00819013|18084661|P3|Overall Study|Lost to Follow-up|1
5240488|NCT00819013|18084662|P2|Overall Study|Lost to Follow-up|0
5240489|NCT00819013|18084663|P1|Overall Study|Lost to Follow-up|0
5240490|NCT00819013|18084660|P4|Overall Study|Withdrawal by Subject|0
5240491|NCT00819013|18084661|P3|Overall Study|Withdrawal by Subject|1
5240492|NCT00819013|18084662|P2|Overall Study|Withdrawal by Subject|0
5240493|NCT00819013|18084663|P1|Overall Study|Withdrawal by Subject|1
5240494|NCT00819013|18084660|P4|Overall Study|Adverse Event|0
5240495|NCT00819013|18084661|P3|Overall Study|Adverse Event|1
5240496|NCT00819013|18084662|P2|Overall Study|Adverse Event|0
5240497|NCT00819013|18084663|P1|Overall Study|Adverse Event|0
5240498|NCT00819013|18084660|P4|Overall Study|Not meeting continuing study eligibility|1
5240499|NCT00819013|18084661|P3|Overall Study|Not meeting continuing study eligibility|2
5240500|NCT00819013|18084662|P2|Overall Study|Not meeting continuing study eligibility|1
5240501|NCT00819013|18084663|P1|Overall Study|Not meeting continuing study eligibility|2
5240502|NCT00818883|18084729|P2|Overall Study|Other|7
5240503|NCT00818883|18084730|P1|Overall Study|Other|2
5240504|NCT00818883|18084729|P2|Overall Study|Lack of Efficacy|2
5240505|NCT00818883|18084730|P1|Overall Study|Lack of Efficacy|0
5240506|NCT00818883|18084729|P2|Overall Study|Withdrawal by Subject|14
5240507|NCT00818883|18084730|P1|Overall Study|Withdrawal by Subject|16
5240508|NCT00818883|18084729|P2|Overall Study|Lost to Follow-up|2
5240509|NCT00818883|18084730|P1|Overall Study|Lost to Follow-up|3
5240510|NCT00818883|18084729|P2|Overall Study|Protocol Violation|2
5240511|NCT00818883|18084730|P1|Overall Study|Protocol Violation|2
5240512|NCT00818883|18084729|P2|Overall Study|Adverse Event|19
5240513|NCT00818883|18084730|P1|Overall Study|Adverse Event|28
5240514|NCT00818779|18084777|P2|Overall Study|Adverse Event|1
5240515|NCT00818779|18084778|P1|Overall Study|Adverse Event|4
5240516|NCT00818779|18084777|P2|Overall Study|Lost to Follow-up|0
5240517|NCT00818779|18084778|P1|Overall Study|Lost to Follow-up|1
5240518|NCT00818779|18084777|P2|Overall Study|Protocol Violation|0
5240519|NCT00818779|18084778|P1|Overall Study|Protocol Violation|1
5240520|NCT00818766|18084794|P2|Overall Study|Did not Receive Allocated Intervention|0
5240521|NCT00818766|18084795|P1|Overall Study|Did not Receive Allocated Intervention|3
5240522|NCT00818766|18084794|P2|Overall Study|Death|0
5240523|NCT00818766|18084795|P1|Overall Study|Death|1
5240524|NCT00818766|18084794|P2|Overall Study|Could not be Contacted on Day 28|10
5240525|NCT00818766|18084795|P1|Overall Study|Could not be Contacted on Day 28|11
5240526|NCT00818753|18084824|P3|Overall Study|Randomised and not treated|0
5240527|NCT00818753|18084825|P2|Overall Study|Randomised and not treated|0
5240528|NCT00818753|18084826|P1|Overall Study|Randomised and not treated|2
5240529|NCT00818753|18084824|P3|Overall Study|Other reason (not specified)|1
5240530|NCT00818753|18084825|P2|Overall Study|Other reason (not specified)|0
5240531|NCT00818753|18084826|P1|Overall Study|Other reason (not specified)|0
5240532|NCT00818753|18084824|P3|Overall Study|Protocol Violation|0
5240533|NCT00818753|18084825|P2|Overall Study|Protocol Violation|0
5240534|NCT00818753|18084826|P1|Overall Study|Protocol Violation|1
5240535|NCT00818662|18084850|P4|Overall Study|Admitted to long term nursing care|0
5240536|NCT00818662|18084851|P3|Overall Study|Admitted to long term nursing care|0
5240537|NCT00818662|18084852|P2|Overall Study|Admitted to long term nursing care|1
5240538|NCT00818662|18084853|P1|Overall Study|Admitted to long term nursing care|0
5240539|NCT00818662|18084850|P4|Overall Study|Study partner decision|1
5240540|NCT00818662|18084851|P3|Overall Study|Study partner decision|0
5240541|NCT00818662|18084852|P2|Overall Study|Study partner decision|0
5240542|NCT00818662|18084853|P1|Overall Study|Study partner decision|0
5240543|NCT00818662|18084850|P4|Overall Study|Change in living situation|1
5240544|NCT00818662|18084851|P3|Overall Study|Change in living situation|0
5240545|NCT00818662|18084852|P2|Overall Study|Change in living situation|0
5240546|NCT00818662|18084853|P1|Overall Study|Change in living situation|0
5240547|NCT00818662|18084850|P4|Overall Study|Declined move to another study site|0
5240548|NCT00818662|18084851|P3|Overall Study|Declined move to another study site|0
5240549|NCT00818662|18084852|P2|Overall Study|Declined move to another study site|0
5240550|NCT00818662|18084853|P1|Overall Study|Declined move to another study site|1
5240551|NCT00818662|18084850|P4|Overall Study|Moving out of state|1
5240552|NCT00818662|18084851|P3|Overall Study|Moving out of state|0
5240553|NCT00818662|18084852|P2|Overall Study|Moving out of state|0
5240554|NCT00818662|18084853|P1|Overall Study|Moving out of state|0
5240555|NCT00818662|18084850|P4|Overall Study|Caregiver to pursue other treatment|0
5240556|NCT00818662|18084851|P3|Overall Study|Caregiver to pursue other treatment|0
5240557|NCT00818662|18084852|P2|Overall Study|Caregiver to pursue other treatment|1
5240558|NCT00818662|18084853|P1|Overall Study|Caregiver to pursue other treatment|0
5240559|NCT00818662|18084850|P4|Overall Study|Participant's health declined|1
5240560|NCT00818662|18084851|P3|Overall Study|Participant's health declined|0
5240561|NCT00818662|18084852|P2|Overall Study|Participant's health declined|0
5240562|NCT00818662|18084853|P1|Overall Study|Participant's health declined|0
5240563|NCT00818662|18084850|P4|Overall Study|Study Partner Unwilling or Unable|1
5240564|NCT00818662|18084851|P3|Overall Study|Study Partner Unwilling or Unable|1
5240565|NCT00818662|18084852|P2|Overall Study|Study Partner Unwilling or Unable|2
5240566|NCT00818662|18084853|P1|Overall Study|Study Partner Unwilling or Unable|3
5240567|NCT00818662|18084850|P4|Overall Study|Safety Risk|1
5240568|NCT00818662|18084851|P3|Overall Study|Safety Risk|0
5240569|NCT00818662|18084852|P2|Overall Study|Safety Risk|1
5240570|NCT00818662|18084853|P1|Overall Study|Safety Risk|1
5240571|NCT00818662|18084850|P4|Overall Study|Requires a Prohibited Medication|0
5240572|NCT00818662|18084851|P3|Overall Study|Requires a Prohibited Medication|0
5240573|NCT00818662|18084852|P2|Overall Study|Requires a Prohibited Medication|0
5240574|NCT00818662|18084853|P1|Overall Study|Requires a Prohibited Medication|1
5240575|NCT00818662|18084850|P4|Overall Study|Protocol Violation|0
5240576|NCT00818662|18084851|P3|Overall Study|Protocol Violation|0
5240577|NCT00818662|18084852|P2|Overall Study|Protocol Violation|1
5240578|NCT00818662|18084853|P1|Overall Study|Protocol Violation|1
5240579|NCT00818662|18084850|P4|Overall Study|Unwilling or Unable to Participate|4
5240580|NCT00818662|18084851|P3|Overall Study|Unwilling or Unable to Participate|2
5240581|NCT00818662|18084852|P2|Overall Study|Unwilling or Unable to Participate|6
5240582|NCT00818662|18084853|P1|Overall Study|Unwilling or Unable to Participate|4
5240583|NCT00818662|18084850|P4|Overall Study|Lost to Follow-up|1
5240584|NCT00818662|18084851|P3|Overall Study|Lost to Follow-up|0
5240585|NCT00818662|18084852|P2|Overall Study|Lost to Follow-up|0
5240586|NCT00818662|18084853|P1|Overall Study|Lost to Follow-up|0
5240587|NCT00818662|18084850|P4|Overall Study|Physician Decision|0
5240588|NCT00818662|18084851|P3|Overall Study|Physician Decision|0
5240589|NCT00818662|18084852|P2|Overall Study|Physician Decision|0
5240590|NCT00818662|18084853|P1|Overall Study|Physician Decision|1
5240591|NCT00818662|18084850|P4|Overall Study|Death|0
5240592|NCT00818662|18084851|P3|Overall Study|Death|0
5240593|NCT00818662|18084852|P2|Overall Study|Death|3
5240594|NCT00818662|18084853|P1|Overall Study|Death|1
5240595|NCT00818662|18084850|P4|Overall Study|Withdrawal by Subject|2
5240596|NCT00818662|18084851|P3|Overall Study|Withdrawal by Subject|2
5240597|NCT00818662|18084852|P2|Overall Study|Withdrawal by Subject|4
5240598|NCT00818662|18084853|P1|Overall Study|Withdrawal by Subject|5
5240599|NCT00818662|18084850|P4|Overall Study|Adverse Event|3
5240600|NCT00818662|18084851|P3|Overall Study|Adverse Event|4
5240601|NCT00818662|18084852|P2|Overall Study|Adverse Event|14
5240602|NCT00818662|18084853|P1|Overall Study|Adverse Event|5
5240603|NCT00818649|18084939|P1|Overall Study|Adverse Event|1
5240604|NCT00818649|18084939|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
5240605|NCT00818649|18084939|P1|Overall Study|Declining performance status|2
5240606|NCT00818623|18084953|P8|Overall Study|Disease progression|0
5240607|NCT00818623|18084954|P7|Overall Study|Disease progression|1
5240608|NCT00818623|18084955|P6|Overall Study|Disease progression|0
5240609|NCT00818623|18084956|P5|Overall Study|Disease progression|0
5240610|NCT00818623|18084957|P4|Overall Study|Disease progression|0
5240611|NCT00818623|18084958|P3|Overall Study|Disease progression|0
5240612|NCT00818623|18084959|P2|Overall Study|Disease progression|0
5240613|NCT00818623|18084960|P1|Overall Study|Disease progression|0
5240614|NCT00818623|18084953|P8|Overall Study|Lack of trial drug at site|0
5240615|NCT00818623|18084954|P7|Overall Study|Lack of trial drug at site|1
5240616|NCT00818623|18084955|P6|Overall Study|Lack of trial drug at site|0
5240617|NCT00818623|18084956|P5|Overall Study|Lack of trial drug at site|2
5240618|NCT00818623|18084957|P4|Overall Study|Lack of trial drug at site|0
5240619|NCT00818623|18084958|P3|Overall Study|Lack of trial drug at site|0
5240620|NCT00818623|18084959|P2|Overall Study|Lack of trial drug at site|0
5240621|NCT00818623|18084960|P1|Overall Study|Lack of trial drug at site|0
5240622|NCT00818623|18084953|P8|Overall Study|Need of additional treatment|0
5240623|NCT00818623|18084954|P7|Overall Study|Need of additional treatment|0
5240624|NCT00818623|18084955|P6|Overall Study|Need of additional treatment|0
5240625|NCT00818623|18084956|P5|Overall Study|Need of additional treatment|1
5240626|NCT00818623|18084957|P4|Overall Study|Need of additional treatment|0
5240627|NCT00818623|18084958|P3|Overall Study|Need of additional treatment|0
5240628|NCT00818623|18084959|P2|Overall Study|Need of additional treatment|0
5240629|NCT00818623|18084960|P1|Overall Study|Need of additional treatment|0
5240630|NCT00818623|18084953|P8|Overall Study|Protocol Violation|0
5240631|NCT00818623|18084954|P7|Overall Study|Protocol Violation|1
5240632|NCT00818623|18084955|P6|Overall Study|Protocol Violation|0
5240633|NCT00818623|18084956|P5|Overall Study|Protocol Violation|1
5240634|NCT00818623|18084957|P4|Overall Study|Protocol Violation|0
5240635|NCT00818623|18084958|P3|Overall Study|Protocol Violation|0
5240636|NCT00818623|18084959|P2|Overall Study|Protocol Violation|0
5240637|NCT00818623|18084960|P1|Overall Study|Protocol Violation|1
5240638|NCT00818623|18084953|P8|Overall Study|Withdrawal by Subject|1
5240639|NCT00818623|18084954|P7|Overall Study|Withdrawal by Subject|1
5240640|NCT00818623|18084955|P6|Overall Study|Withdrawal by Subject|1
5240641|NCT00818623|18084956|P5|Overall Study|Withdrawal by Subject|0
5240642|NCT00818623|18084957|P4|Overall Study|Withdrawal by Subject|0
5240643|NCT00818623|18084958|P3|Overall Study|Withdrawal by Subject|1
5240644|NCT00818623|18084959|P2|Overall Study|Withdrawal by Subject|1
5240645|NCT00818623|18084960|P1|Overall Study|Withdrawal by Subject|0
5240646|NCT00818623|18084953|P8|Overall Study|Bad prostate specific antigen response|0
5240647|NCT00818623|18084954|P7|Overall Study|Bad prostate specific antigen response|0
5240648|NCT00818623|18084955|P6|Overall Study|Bad prostate specific antigen response|1
5240649|NCT00818623|18084956|P5|Overall Study|Bad prostate specific antigen response|0
5240650|NCT00818623|18084957|P4|Overall Study|Bad prostate specific antigen response|5
5240651|NCT00818623|18084958|P3|Overall Study|Bad prostate specific antigen response|2
5240652|NCT00818623|18084959|P2|Overall Study|Bad prostate specific antigen response|3
5240653|NCT00818623|18084960|P1|Overall Study|Bad prostate specific antigen response|0
5240654|NCT00818623|18084953|P8|Overall Study|Adverse Event|0
5240655|NCT00818623|18084954|P7|Overall Study|Adverse Event|0
5240656|NCT00818623|18084955|P6|Overall Study|Adverse Event|1
5240657|NCT00818623|18084956|P5|Overall Study|Adverse Event|0
5240658|NCT00818623|18084957|P4|Overall Study|Adverse Event|0
5240659|NCT00818623|18084958|P3|Overall Study|Adverse Event|1
5240660|NCT00818623|18084959|P2|Overall Study|Adverse Event|0
5240661|NCT00818623|18084960|P1|Overall Study|Adverse Event|1
5240662|NCT00818519|18085036|P2|Overall Study|participant will leave for long tme|0
5240663|NCT00818519|18085037|P1|Overall Study|participant will leave for long tme|1
5240664|NCT00818519|18085036|P2|Overall Study|participant recovered completely|0
5240665|NCT00818519|18085037|P1|Overall Study|participant recovered completely|1
5240666|NCT00818519|18085036|P2|Overall Study|Withdrawal by Subject|9
5240667|NCT00818519|18085037|P1|Overall Study|Withdrawal by Subject|4
5240668|NCT00818519|18085036|P2|Overall Study|Pregnancy|1
5240669|NCT00818519|18085037|P1|Overall Study|Pregnancy|0
5240670|NCT00818519|18085036|P2|Overall Study|Protocol Violation|1
5240671|NCT00818519|18085037|P1|Overall Study|Protocol Violation|2
5240672|NCT00818519|18085036|P2|Overall Study|Lost to Follow-up|6
5240673|NCT00818519|18085037|P1|Overall Study|Lost to Follow-up|4
5240674|NCT00818519|18085036|P2|Overall Study|Adverse Event|2
5240675|NCT00818519|18085037|P1|Overall Study|Adverse Event|2
5240676|NCT00818454|18085067|P4|Treatment Period 3|Adverse Event|1
5240677|NCT00818454|18085068|P3|Treatment Period 3|Adverse Event|0
5240678|NCT00818454|18085069|P2|Treatment Period 3|Adverse Event|0
5240679|NCT00818454|18085070|P1|Treatment Period 3|Adverse Event|0
5240680|NCT00818454|18085067|P4|Treatment Period 2|Other|0
5240681|NCT00818454|18085068|P3|Treatment Period 2|Other|0
5240682|NCT00818454|18085069|P2|Treatment Period 2|Other|1
5240683|NCT00818454|18085070|P1|Treatment Period 2|Other|2
5240684|NCT00818454|18085067|P4|Washout Period of 1 Week|Other|0
5240685|NCT00818454|18085068|P3|Washout Period of 1 Week|Other|0
5240686|NCT00818454|18085069|P2|Washout Period of 1 Week|Other|2
5240687|NCT00818454|18085070|P1|Washout Period of 1 Week|Other|1
5240688|NCT00818454|18085067|P4|Washout Period of 1 Week|Protocol Violation|0
5240689|NCT00818454|18085068|P3|Washout Period of 1 Week|Protocol Violation|0
5240690|NCT00818454|18085069|P2|Washout Period of 1 Week|Protocol Violation|0
5240691|NCT00818454|18085070|P1|Washout Period of 1 Week|Protocol Violation|2
5240692|NCT00818454|18085067|P4|Washout Period of 1 Week|Adverse Event|0
5240693|NCT00818454|18085068|P3|Washout Period of 1 Week|Adverse Event|0
5240694|NCT00818454|18085069|P2|Washout Period of 1 Week|Adverse Event|1
5240695|NCT00818454|18085070|P1|Washout Period of 1 Week|Adverse Event|1
5240696|NCT00818454|18085067|P4|Treatment Period 1|Other|0
5240697|NCT00818454|18085068|P3|Treatment Period 1|Other|0
5240698|NCT00818454|18085069|P2|Treatment Period 1|Other|0
5240699|NCT00818454|18085070|P1|Treatment Period 1|Other|3
5240700|NCT00818454|18085067|P4|Treatment Period 1|Adverse Event|0
5240701|NCT00818454|18085068|P3|Treatment Period 1|Adverse Event|0
5240702|NCT00818454|18085069|P2|Treatment Period 1|Adverse Event|1
5240703|NCT00818454|18085070|P1|Treatment Period 1|Adverse Event|0
5240704|NCT00818441|18085098|P2|Overall Study|Study terminated by sponsor|2
5240705|NCT00818441|18085099|P1|Overall Study|Study terminated by sponsor|11
5240706|NCT00818441|18085098|P2|Overall Study|Adverse Event|1
5240707|NCT00818441|18085099|P1|Overall Study|Adverse Event|0
5240708|NCT00818441|18085098|P2|Overall Study|Withdrawal by Subject|0
5240709|NCT00818441|18085099|P1|Overall Study|Withdrawal by Subject|2
5240710|NCT00818441|18085098|P2|Overall Study|Lost to Follow-up|1
5240711|NCT00818441|18085099|P1|Overall Study|Lost to Follow-up|2
5240712|NCT00818441|18085098|P2|Overall Study|Other|0
5240713|NCT00818441|18085099|P1|Overall Study|Other|5
5240714|NCT00818441|18085098|P2|Overall Study|Death|26
5240715|NCT00818441|18085099|P1|Overall Study|Death|69
5240716|NCT00818389|18085121|P2|Overall Study|Adverse Event|1
5240717|NCT00818389|18085122|P1|Overall Study|Adverse Event|0
5240718|NCT00818389|18085121|P2|Overall Study|Withdrawal by Subject|2
5240719|NCT00818389|18085122|P1|Overall Study|Withdrawal by Subject|2
5240720|NCT00818389|18085121|P2|Overall Study|ALS Disease Progression|0
5240721|NCT00818389|18085122|P1|Overall Study|ALS Disease Progression|1
5240722|NCT00818389|18085121|P2|Overall Study|Death|3
5240723|NCT00818389|18085122|P1|Overall Study|Death|1
5240724|NCT00818259|18085157|P9|Part V|Adverse Event|0
5240725|NCT00818259|18085158|P8|Part V|Adverse Event|1
5240726|NCT00818259|18085159|P7|Part V|Adverse Event|0
5240727|NCT00818259|18085160|P6|Part V|Adverse Event|0
5240728|NCT00818259|18085161|P5|Part V|Adverse Event|0
5240729|NCT00818259|18085162|P4|Part V|Adverse Event|0
5240730|NCT00818259|18085163|P3|Part V|Adverse Event|0
5240731|NCT00818259|18085164|P2|Part V|Adverse Event|0
5240732|NCT00818259|18085165|P1|Part V|Adverse Event|0
5240733|NCT00818259|18085157|P9|Part IV|Physician Decision|0
5240734|NCT00818259|18085158|P8|Part IV|Physician Decision|0
5240735|NCT00818259|18085159|P7|Part IV|Physician Decision|0
5240736|NCT00818259|18085160|P6|Part IV|Physician Decision|1
5240737|NCT00818259|18085161|P5|Part IV|Physician Decision|0
5240738|NCT00818259|18085162|P4|Part IV|Physician Decision|0
5240739|NCT00818259|18085163|P3|Part IV|Physician Decision|0
5240740|NCT00818259|18085164|P2|Part IV|Physician Decision|0
5240741|NCT00818259|18085165|P1|Part IV|Physician Decision|0
5240742|NCT00818259|18085157|P9|Part II|Not Treated|0
5240743|NCT00818259|18085158|P8|Part II|Not Treated|0
5240744|NCT00818259|18085159|P7|Part II|Not Treated|0
5240745|NCT00818259|18085160|P6|Part II|Not Treated|0
5240746|NCT00818259|18085161|P5|Part II|Not Treated|0
5240747|NCT00818259|18085162|P4|Part II|Not Treated|1
5240748|NCT00818259|18085163|P3|Part II|Not Treated|0
5240749|NCT00818259|18085164|P2|Part II|Not Treated|0
5240750|NCT00818259|18085165|P1|Part II|Not Treated|0
5240751|NCT00818259|18085157|P9|Part II|Lack of Efficacy|0
5240752|NCT00818259|18085158|P8|Part II|Lack of Efficacy|0
5240753|NCT00818259|18085159|P7|Part II|Lack of Efficacy|0
5240754|NCT00818259|18085160|P6|Part II|Lack of Efficacy|0
5240755|NCT00818259|18085161|P5|Part II|Lack of Efficacy|0
5240756|NCT00818259|18085162|P4|Part II|Lack of Efficacy|1
5240757|NCT00818259|18085163|P3|Part II|Lack of Efficacy|0
5240758|NCT00818259|18085164|P2|Part II|Lack of Efficacy|0
5240759|NCT00818259|18085165|P1|Part II|Lack of Efficacy|0
5240760|NCT00818259|18085157|P9|Part II|Physician Decision|0
5240761|NCT00818259|18085158|P8|Part II|Physician Decision|0
5240762|NCT00818259|18085159|P7|Part II|Physician Decision|0
5240763|NCT00818259|18085160|P6|Part II|Physician Decision|0
5240764|NCT00818259|18085161|P5|Part II|Physician Decision|0
5240765|NCT00818259|18085162|P4|Part II|Physician Decision|0
5240766|NCT00818259|18085163|P3|Part II|Physician Decision|1
5240767|NCT00818259|18085164|P2|Part II|Physician Decision|0
5240768|NCT00818259|18085165|P1|Part II|Physician Decision|0
5240769|NCT00818259|18085157|P9|Part I|Withdrawal by Subject|0
5240770|NCT00818259|18085158|P8|Part I|Withdrawal by Subject|0
5240771|NCT00818259|18085159|P7|Part I|Withdrawal by Subject|0
5240772|NCT00818259|18085160|P6|Part I|Withdrawal by Subject|0
5240773|NCT00818259|18085161|P5|Part I|Withdrawal by Subject|0
5240774|NCT00818259|18085162|P4|Part I|Withdrawal by Subject|0
5240775|NCT00818259|18085163|P3|Part I|Withdrawal by Subject|0
5240776|NCT00818259|18085164|P2|Part I|Withdrawal by Subject|0
5240777|NCT00818259|18085165|P1|Part I|Withdrawal by Subject|1
5240778|NCT00818246|18085237|P1|Overall Study|Impossible to match pictures|5
5240779|NCT00818207|18085246|P2|Overall Study|Death|5
5240780|NCT00818207|18085247|P1|Overall Study|Death|3
5240781|NCT00818207|18085246|P2|Overall Study|Withdrawal by Subject|104
5240782|NCT00818207|18085247|P1|Overall Study|Withdrawal by Subject|42
5240783|NCT00818207|18085246|P2|Overall Study|Multiple reasons|12
5240784|NCT00818207|18085247|P1|Overall Study|Multiple reasons|11
5240785|NCT00818207|18085246|P2|Overall Study|Lost to Follow-up|146
5240786|NCT00818207|18085247|P1|Overall Study|Lost to Follow-up|160
5240787|NCT00818207|18085246|P2|Overall Study|Adverse Event|0
5240788|NCT00818207|18085247|P1|Overall Study|Adverse Event|6
5240789|NCT00818168|18085261|P1|Overall Study|Participant Moved|2
5240790|NCT00818168|18085261|P1|Overall Study|Reason for Non-completion Not reported|6
5240791|NCT00818168|18085261|P1|Overall Study|Adverse Event|19
5240792|NCT00818168|18085261|P1|Overall Study|Lost to Follow-up|7
5240793|NCT00818168|18085261|P1|Overall Study|Withdrawal by Subject|16
5240794|NCT00818168|18085261|P1|Overall Study|Pregnancy|2
5240795|NCT00818168|18085261|P1|Overall Study|Lack of Efficacy|18
5240796|NCT00817778|18085301|P2|Overall Study|Poor venous access|0
5240797|NCT00817778|18085302|P1|Overall Study|Poor venous access|1
5240798|NCT00817778|18085301|P2|Overall Study|Study-specific discontinuation criteria|1
5240799|NCT00817778|18085302|P1|Overall Study|Study-specific discontinuation criteria|0
5240800|NCT00817778|18085301|P2|Overall Study|Protocol Violation|1
5240801|NCT00817778|18085302|P1|Overall Study|Protocol Violation|0
5240802|NCT00817778|18085301|P2|Overall Study|Withdrawal by Subject|1
5240803|NCT00817778|18085302|P1|Overall Study|Withdrawal by Subject|1
5240804|NCT00817778|18085301|P2|Overall Study|Adverse Event|0
5240805|NCT00817778|18085302|P1|Overall Study|Adverse Event|1
5240806|NCT00817531|18085331|P1|Overall Study|Lack of Efficacy|1
5240807|NCT00817531|18085331|P1|Overall Study|Adverse Event|1
5240808|NCT00817479|18085337|P2|Overall Study|Physician Decision|1
5240809|NCT00817479|18085338|P1|Overall Study|Physician Decision|1
5240810|NCT00817336|18085348|P2|Overall Study|Withdrawal by Subject|1
5240811|NCT00817336|18085349|P1|Overall Study|Withdrawal by Subject|1
5240812|NCT00817206|18085375|P2|Overall Study|Physician Decision|0
5240813|NCT00817206|18085376|P1|Overall Study|Physician Decision|2
5240814|NCT00817206|18085375|P2|Overall Study|Withdrawal by Subject|3
5240815|NCT00817206|18085376|P1|Overall Study|Withdrawal by Subject|7
5240816|NCT00817206|18085375|P2|Overall Study|Death|0
5240817|NCT00817206|18085376|P1|Overall Study|Death|2
5240818|NCT00817206|18085375|P2|Overall Study|Lost to Follow-up|1
5240819|NCT00817206|18085376|P1|Overall Study|Lost to Follow-up|0
5240820|NCT00817206|18085375|P2|Overall Study|Protocol Violation|2
5240821|NCT00817206|18085376|P1|Overall Study|Protocol Violation|0
5240822|NCT00817206|18085375|P2|Overall Study|Adverse Event|3
5240823|NCT00817206|18085376|P1|Overall Study|Adverse Event|10
5240824|NCT00817089|18085386|P4|Second Alcohol Challenge|Lost to Follow-up|0
5240825|NCT00817089|18085387|P3|Second Alcohol Challenge|Lost to Follow-up|0
5240826|NCT00817089|18085388|P2|Second Alcohol Challenge|Lost to Follow-up|1
5240827|NCT00817089|18085389|P1|Second Alcohol Challenge|Lost to Follow-up|0
5240828|NCT00817089|18085386|P4|First Alcohol Challenge|Lost to Follow-up|1
5240829|NCT00817089|18085387|P3|First Alcohol Challenge|Lost to Follow-up|0
5240830|NCT00817089|18085388|P2|First Alcohol Challenge|Lost to Follow-up|0
5240831|NCT00817089|18085389|P1|First Alcohol Challenge|Lost to Follow-up|0
5240832|NCT00817063|18085405|P2|Overall Study|Abnormality of Laboratory Test|1
5240833|NCT00817063|18085406|P1|Overall Study|Abnormality of Laboratory Test|2
5240834|NCT00817063|18085405|P2|Overall Study|Administrative|4
5240835|NCT00817063|18085406|P1|Overall Study|Administrative|10
5240836|NCT00817063|18085405|P2|Overall Study|Early Improvement|4
5240837|NCT00817063|18085406|P1|Overall Study|Early Improvement|19
5240838|NCT00817063|18085405|P2|Overall Study|Withdrawal by Subject|37
5240839|NCT00817063|18085406|P1|Overall Study|Withdrawal by Subject|17
5240840|NCT00817063|18085405|P2|Overall Study|Protocol Violation|8
5240841|NCT00817063|18085406|P1|Overall Study|Protocol Violation|3
5240842|NCT00817063|18085405|P2|Overall Study|Violation of Selection at Entry|4
5240843|NCT00817063|18085406|P1|Overall Study|Violation of Selection at Entry|7
5240844|NCT00817063|18085405|P2|Overall Study|Failure to Return|12
5240845|NCT00817063|18085406|P1|Overall Study|Failure to Return|13
5240846|NCT00817063|18085405|P2|Overall Study|Lack of Efficacy|86
5240847|NCT00817063|18085406|P1|Overall Study|Lack of Efficacy|33
5240848|NCT00817063|18085405|P2|Overall Study|Death|1
5240849|NCT00817063|18085406|P1|Overall Study|Death|1
5240850|NCT00817063|18085405|P2|Overall Study|Adverse Event|13
5240851|NCT00817063|18085406|P1|Overall Study|Adverse Event|32
5240852|NCT00816595|18085534|P2|Overall Study|Withdrawal by Subject|0
5240853|NCT00816595|18085535|P1|Overall Study|Withdrawal by Subject|2
5240854|NCT00816556|18085548|P3|Overall Study|Lost to Follow-up|1
5240855|NCT00816556|18085549|P2|Overall Study|Lost to Follow-up|0
5240856|NCT00816556|18085550|P1|Overall Study|Lost to Follow-up|0
5240857|NCT00816556|18085548|P3|Overall Study|Withdrawal by Subject|1
5240858|NCT00816556|18085549|P2|Overall Study|Withdrawal by Subject|1
5240859|NCT00816556|18085550|P1|Overall Study|Withdrawal by Subject|1
5240860|NCT00816556|18085548|P3|Overall Study|Adverse Event|1
5240861|NCT00816556|18085549|P2|Overall Study|Adverse Event|1
5240862|NCT00816556|18085550|P1|Overall Study|Adverse Event|1
5240863|NCT00816400|18085573|P9|Overall Study|In hospice care at the end of the study|0
5240864|NCT00816400|18085574|P8|Overall Study|In hospice care at the end of the study|0
5240865|NCT00816400|18085575|P7|Overall Study|In hospice care at the end of the study|0
5240866|NCT00816400|18085576|P6|Overall Study|In hospice care at the end of the study|0
5240867|NCT00816400|18085577|P5|Overall Study|In hospice care at the end of the study|0
5240868|NCT00816400|18085578|P4|Overall Study|In hospice care at the end of the study|0
5240869|NCT00816400|18085579|P3|Overall Study|In hospice care at the end of the study|2
5240870|NCT00816400|18085580|P2|Overall Study|In hospice care at the end of the study|0
5240871|NCT00816400|18085581|P1|Overall Study|In hospice care at the end of the study|0
5240872|NCT00816400|18085573|P9|Overall Study|Death|6
5240873|NCT00816400|18085574|P8|Overall Study|Death|5
5240874|NCT00816400|18085575|P7|Overall Study|Death|2
5240875|NCT00816400|18085576|P6|Overall Study|Death|3
5240876|NCT00816400|18085577|P5|Overall Study|Death|2
5240877|NCT00816400|18085578|P4|Overall Study|Death|3
5240878|NCT00816400|18085579|P3|Overall Study|Death|3
5240879|NCT00816400|18085580|P2|Overall Study|Death|3
5240880|NCT00816400|18085581|P1|Overall Study|Death|2
5240881|NCT00816361|18085772|P9|Overall Study|Other|1
5240882|NCT00816361|18085773|P8|Overall Study|Other|0
5240883|NCT00816361|18085774|P7|Overall Study|Other|0
5240884|NCT00816361|18085775|P6|Overall Study|Other|0
5240885|NCT00816361|18085776|P5|Overall Study|Other|0
5240886|NCT00816361|18085777|P4|Overall Study|Other|0
5240887|NCT00816361|18085778|P3|Overall Study|Other|0
5240888|NCT00816361|18085779|P2|Overall Study|Other|0
5240889|NCT00816361|18085780|P1|Overall Study|Other|0
5240890|NCT00816361|18085772|P9|Overall Study|Death|8
5240891|NCT00816361|18085773|P8|Overall Study|Death|7
5240892|NCT00816361|18085774|P7|Overall Study|Death|3
5240893|NCT00816361|18085775|P6|Overall Study|Death|1
5240894|NCT00816361|18085776|P5|Overall Study|Death|1
5240895|NCT00816361|18085777|P4|Overall Study|Death|3
5240896|NCT00816361|18085778|P3|Overall Study|Death|3
5240897|NCT00816361|18085779|P2|Overall Study|Death|3
5240898|NCT00816361|18085780|P1|Overall Study|Death|4
5240899|NCT00816361|18085772|P9|Overall Study|Withdrawal by Subject|1
5240900|NCT00816361|18085773|P8|Overall Study|Withdrawal by Subject|2
5240901|NCT00816361|18085774|P7|Overall Study|Withdrawal by Subject|0
5240902|NCT00816361|18085775|P6|Overall Study|Withdrawal by Subject|2
5240903|NCT00816361|18085776|P5|Overall Study|Withdrawal by Subject|1
5240904|NCT00816361|18085777|P4|Overall Study|Withdrawal by Subject|0
5240905|NCT00816361|18085778|P3|Overall Study|Withdrawal by Subject|0
5240906|NCT00816361|18085779|P2|Overall Study|Withdrawal by Subject|0
5240907|NCT00816361|18085780|P1|Overall Study|Withdrawal by Subject|0
5240908|NCT00816166|18085939|P2|Overall Study|Death|2
5240909|NCT00816166|18085940|P1|Overall Study|Death|4
5240910|NCT00816166|18085939|P2|Overall Study|Lost to Follow-up|10
5240911|NCT00816166|18085940|P1|Overall Study|Lost to Follow-up|6
5240912|NCT00816036|18085972|P2|Overall Study|Withdrawal by Subject|23
5240913|NCT00816036|18085973|P1|Overall Study|Withdrawal by Subject|54
5240914|NCT00816036|18085972|P2|Overall Study|Lost to Follow-up|57
5240915|NCT00816036|18085973|P1|Overall Study|Lost to Follow-up|75
5240916|NCT00816036|18085972|P2|Overall Study|Death|28
5240917|NCT00816036|18085973|P1|Overall Study|Death|47
5240918|NCT00816023|18085987|P4|Overall Study|Randomized Not Treated|11
5240919|NCT00816023|18085988|P3|Overall Study|Randomized Not Treated|6
5240920|NCT00816023|18085989|P2|Overall Study|Randomized Not Treated|4
5240921|NCT00816023|18085990|P1|Overall Study|Randomized Not Treated|6
5240922|NCT00816023|18085987|P4|Overall Study|assessments complete prior to window|1
5240923|NCT00816023|18085988|P3|Overall Study|assessments complete prior to window|2
5240924|NCT00816023|18085989|P2|Overall Study|assessments complete prior to window|1
5240925|NCT00816023|18085990|P1|Overall Study|assessments complete prior to window|1
5240926|NCT00816023|18085987|P4|Overall Study|Physician Decision|0
5240927|NCT00816023|18085988|P3|Overall Study|Physician Decision|1
5240928|NCT00816023|18085989|P2|Overall Study|Physician Decision|0
5240929|NCT00816023|18085990|P1|Overall Study|Physician Decision|0
5240930|NCT00816023|18085987|P4|Overall Study|Withdrawal by Subject|0
5240931|NCT00816023|18085988|P3|Overall Study|Withdrawal by Subject|0
5240932|NCT00816023|18085989|P2|Overall Study|Withdrawal by Subject|0
5240933|NCT00816023|18085990|P1|Overall Study|Withdrawal by Subject|1
5240934|NCT00816023|18085987|P4|Overall Study|Lost to Follow-up|0
5240935|NCT00816023|18085988|P3|Overall Study|Lost to Follow-up|0
5240936|NCT00816023|18085989|P2|Overall Study|Lost to Follow-up|1
5240937|NCT00816023|18085990|P1|Overall Study|Lost to Follow-up|1
5240938|NCT00815919|18086027|P1|Overall Study|Lack of Efficacy|2
5240939|NCT00815919|18086027|P1|Overall Study|AML Relapse|1
5240940|NCT00815919|18086027|P1|Overall Study|Unrelated Fungal Infection|1
5240941|NCT00815659|18086070|P1|Overall Study|Protocol Violation|1
5240942|NCT00815659|18086070|P1|Overall Study|Lost to Follow-up|4
5240943|NCT00815659|18086070|P1|Overall Study|Withdrawal by Subject|9
5240944|NCT00815659|18086070|P1|Overall Study|Adverse Event|9
5240945|NCT00815633|18086113|P1|Overall Study|study terminated|1
5240946|NCT00815516|18086120|P2|Overall Study|Physician Decision|0
5240947|NCT00815516|18086121|P1|Overall Study|Physician Decision|1
5240948|NCT00815516|18086120|P2|Overall Study|Death|1
5240949|NCT00815516|18086121|P1|Overall Study|Death|3
5240950|NCT00815308|18086186|P1|Overall Study|Protocol Violation|6
5240951|NCT00815308|18086186|P1|Overall Study|Withdrawal by Subject|0
5240952|NCT00815308|18086186|P1|Overall Study|Adverse Event|4
5240953|NCT00815295|18086195|P3|Overall Study|Cetuximab hypersensitivity reaction|3
5240954|NCT00815295|18086196|P2|Overall Study|Cetuximab hypersensitivity reaction|1
5240955|NCT00815295|18086197|P1|Overall Study|Cetuximab hypersensitivity reaction|0
5240956|NCT00815191|18086209|P2|Overall Study|Protocol Violation|1
5240957|NCT00815191|18086210|P1|Overall Study|Protocol Violation|1
5240958|NCT00814983|18086247|P2|Overall Study|Graft failure|0
5240959|NCT00814983|18086248|P1|Overall Study|Graft failure|1
5240960|NCT00814983|18086247|P2|Overall Study|Withdrawal by Subject|0
5240961|NCT00814983|18086248|P1|Overall Study|Withdrawal by Subject|1
5240962|NCT00814983|18086247|P2|Overall Study|Screen failure|0
5240963|NCT00814983|18086248|P1|Overall Study|Screen failure|1
5240964|NCT00814892|18086279|P1|Overall Study|Study Termination|1
5240965|NCT00814892|18086279|P1|Overall Study|Disease Progression|1
5240966|NCT00814879|18086291|P2|By Week 48|Death|1
5240967|NCT00814879|18086292|P1|By Week 48|Death|0
5240968|NCT00814879|18086291|P2|By Week 48|Lost to Follow-up|2
5240969|NCT00814879|18086292|P1|By Week 48|Lost to Follow-up|2
5240970|NCT00814879|18086291|P2|By Week 24|Incarceration|1
5240971|NCT00814879|18086292|P1|By Week 24|Incarceration|0
5240972|NCT00814879|18086291|P2|By Week 24|Cancer Diagnosis|0
5240973|NCT00814879|18086292|P1|By Week 24|Cancer Diagnosis|1
5240974|NCT00814801|18086311|P3|Overall Study|Other|4
5240975|NCT00814801|18086312|P2|Overall Study|Other|6
5240976|NCT00814801|18086313|P1|Overall Study|Other|2
5240977|NCT00814801|18086311|P3|Overall Study|Non-compliance|1
5240978|NCT00814801|18086312|P2|Overall Study|Non-compliance|1
5240979|NCT00814801|18086313|P1|Overall Study|Non-compliance|0
5240980|NCT00814801|18086311|P3|Overall Study|Missing or change of caregiver|4
5240981|NCT00814801|18086312|P2|Overall Study|Missing or change of caregiver|2
5240982|NCT00814801|18086313|P1|Overall Study|Missing or change of caregiver|6
5240983|NCT00814801|18086311|P3|Overall Study|Change of patients for CIBIC plus-J|0
5240984|NCT00814801|18086312|P2|Overall Study|Change of patients for CIBIC plus-J|1
5240985|NCT00814801|18086313|P1|Overall Study|Change of patients for CIBIC plus-J|1
5240986|NCT00814801|18086311|P3|Overall Study|Inappropriate as a subject|1
5240987|NCT00814801|18086312|P2|Overall Study|Inappropriate as a subject|1
5240988|NCT00814801|18086313|P1|Overall Study|Inappropriate as a subject|1
5240989|NCT00814801|18086311|P3|Overall Study|Withdrawal by Subject|14
5240990|NCT00814801|18086312|P2|Overall Study|Withdrawal by Subject|11
5240991|NCT00814801|18086313|P1|Overall Study|Withdrawal by Subject|9
5240992|NCT00814801|18086311|P3|Overall Study|Adverse Event|19
5240993|NCT00814801|18086312|P2|Overall Study|Adverse Event|16
5240994|NCT00814801|18086313|P1|Overall Study|Adverse Event|15
5240995|NCT00814710|18086352|P2|Overall Study|Lost to Follow-up|3
5240996|NCT00814710|18086353|P1|Overall Study|Lost to Follow-up|7
5240997|NCT00814710|18086352|P2|Overall Study|Adverse Event|0
5240998|NCT00814710|18086353|P1|Overall Study|Adverse Event|1
5240999|NCT00814658|18086421|P2|Overall Study|Adverse Event|3
5241000|NCT00814658|18086422|P1|Overall Study|Adverse Event|3
5241001|NCT00814658|18086421|P2|Overall Study|Physician Decision|0
5241002|NCT00814658|18086422|P1|Overall Study|Physician Decision|1
5241003|NCT00814658|18086421|P2|Overall Study|Lost to Follow-up|1
5241004|NCT00814658|18086422|P1|Overall Study|Lost to Follow-up|0
5241005|NCT00814632|18086488|P1|Overall Study|Lack of Efficacy|2
5241006|NCT00814580|18086494|P2|Overall Study|Did Not Take Drug|2
5241007|NCT00814580|18086495|P1|Overall Study|Did Not Take Drug|2
5241008|NCT00814580|18086494|P2|Overall Study|Other|3
5241009|NCT00814580|18086495|P1|Overall Study|Other|1
5241010|NCT00814580|18086494|P2|Overall Study|Withdrawal by Subject|2
5241011|NCT00814580|18086495|P1|Overall Study|Withdrawal by Subject|2
5241012|NCT00814580|18086494|P2|Overall Study|Protocol Violation|0
5241013|NCT00814580|18086495|P1|Overall Study|Protocol Violation|2
5241014|NCT00814580|18086494|P2|Overall Study|Lack of Efficacy|25
5241015|NCT00814580|18086495|P1|Overall Study|Lack of Efficacy|18
5241016|NCT00814580|18086494|P2|Overall Study|Adverse Event|15
5241017|NCT00814580|18086495|P1|Overall Study|Adverse Event|6
5241018|NCT00814502|18086625|P2|Overall Study|Withdrawal by Subject|2
5241019|NCT00814502|18086626|P1|Overall Study|Withdrawal by Subject|0
5241020|NCT00814502|18086625|P2|Overall Study|Adverse Event|0
5241021|NCT00814502|18086626|P1|Overall Study|Adverse Event|1
5241022|NCT00814489|18086639|P3|Overall Study|Other|1
5241023|NCT00814489|18086640|P2|Overall Study|Other|0
5241024|NCT00814489|18086641|P1|Overall Study|Other|2
5241025|NCT00814463|18086673|P1|Overall Study|Lost to Follow-up|1
5241026|NCT00814346|18086686|P2|Open Phase (17 Months)|Not otherwise specified|0
5241027|NCT00814346|18086687|P1|Open Phase (17 Months)|Not otherwise specified|1
5241028|NCT00814346|18086686|P2|Open Phase (17 Months)|Lost to Follow-up|0
5241029|NCT00814346|18086687|P1|Open Phase (17 Months)|Lost to Follow-up|2
5241030|NCT00814346|18086686|P2|Open Phase (17 Months)|Consent|0
5241031|NCT00814346|18086687|P1|Open Phase (17 Months)|Consent|2
5241032|NCT00814346|18086686|P2|Open Phase (17 Months)|Adverse Event|0
5241033|NCT00814346|18086687|P1|Open Phase (17 Months)|Adverse Event|5
5241034|NCT00814346|18086686|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
5241035|NCT00814346|18086687|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
5241036|NCT00814346|18086686|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
5241037|NCT00814346|18086687|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
5241038|NCT00814333|18086753|P2|Enrollment|Lost to Follow-up|0
5241039|NCT00814333|18086754|P1|Enrollment|Lost to Follow-up|1
5241040|NCT00814320|18086762|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
5241041|NCT00814320|18086763|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
5241042|NCT00814320|18086762|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
5241043|NCT00814320|18086763|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
5241044|NCT00814320|18086762|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
5241045|NCT00814320|18086763|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
5241046|NCT00814320|18086762|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
5241047|NCT00814320|18086763|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
5241048|NCT00814320|18086762|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
5241049|NCT00814320|18086763|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
5241050|NCT00814320|18086762|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
5241051|NCT00814320|18086763|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
5241052|NCT00814320|18086762|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
5241053|NCT00814320|18086763|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
5241054|NCT00814320|18086762|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
5241055|NCT00814320|18086763|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
5241056|NCT00814320|18086762|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
5241057|NCT00814320|18086763|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
5241058|NCT00814320|18086762|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
5241059|NCT00814320|18086763|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
5241060|NCT00814307|18086895|P4|Overall Study|Death|0
5241061|NCT00814307|18086896|P3|Overall Study|Death|0
5241062|NCT00814307|18086897|P2|Overall Study|Death|1
5241063|NCT00814307|18086898|P1|Overall Study|Death|0
5241064|NCT00814307|18086895|P4|Overall Study|Withdrawal by Subject|2
5241065|NCT00814307|18086896|P3|Overall Study|Withdrawal by Subject|0
5241066|NCT00814307|18086897|P2|Overall Study|Withdrawal by Subject|6
5241067|NCT00814307|18086898|P1|Overall Study|Withdrawal by Subject|4
5241068|NCT00814307|18086895|P4|Overall Study|Protocol Violation|1
5241069|NCT00814307|18086896|P3|Overall Study|Protocol Violation|1
5241070|NCT00814307|18086897|P2|Overall Study|Protocol Violation|8
5241071|NCT00814307|18086898|P1|Overall Study|Protocol Violation|2
5241072|NCT00814307|18086895|P4|Overall Study|Other|1
5241073|NCT00814307|18086896|P3|Overall Study|Other|0
5241074|NCT00814307|18086897|P2|Overall Study|Other|2
5241075|NCT00814307|18086898|P1|Overall Study|Other|1
5241076|NCT00814307|18086895|P4|Overall Study|Lack of Efficacy|4
5241077|NCT00814307|18086896|P3|Overall Study|Lack of Efficacy|3
5241078|NCT00814307|18086897|P2|Overall Study|Lack of Efficacy|1
5241079|NCT00814307|18086898|P1|Overall Study|Lack of Efficacy|1
5241080|NCT00814307|18086895|P4|Overall Study|Adverse Event|2
5241081|NCT00814307|18086896|P3|Overall Study|Adverse Event|3
5241082|NCT00814307|18086897|P2|Overall Study|Adverse Event|9
5241083|NCT00814307|18086898|P1|Overall Study|Adverse Event|3
5241084|NCT00814307|18086895|P4|Overall Study|Randomized but not treated|0
5241085|NCT00814307|18086896|P3|Overall Study|Randomized but not treated|0
5241086|NCT00814307|18086897|P2|Overall Study|Randomized but not treated|0
5241087|NCT00814307|18086898|P1|Overall Study|Randomized but not treated|1
5241088|NCT00814164|18087094|P1|Overall Study|Death|5
5241089|NCT00814164|18087094|P1|Overall Study|not stated|7
5241090|NCT00814164|18087094|P1|Overall Study|Progression|7
5241091|NCT00813995|18087128|P2|Overall Study|Withdrawal by Subject|5
5241092|NCT00813995|18087129|P1|Overall Study|Withdrawal by Subject|0
5241093|NCT00813995|18087128|P2|Overall Study|Subject moved|0
5241094|NCT00813995|18087129|P1|Overall Study|Subject moved|4
5241095|NCT00813995|18087128|P2|Overall Study|Protocol Violation|2
5241096|NCT00813995|18087129|P1|Overall Study|Protocol Violation|3
5241097|NCT00813995|18087128|P2|Overall Study|Other reason|2
5241098|NCT00813995|18087129|P1|Overall Study|Other reason|2
5241099|NCT00813995|18087128|P2|Overall Study|Lost to Follow-up|2
5241100|NCT00813995|18087129|P1|Overall Study|Lost to Follow-up|4
5241101|NCT00813995|18087128|P2|Overall Study|Lack of Efficacy|0
5241102|NCT00813995|18087129|P1|Overall Study|Lack of Efficacy|1
5241103|NCT00813995|18087128|P2|Overall Study|Laboratory adverse event|2
5241104|NCT00813995|18087129|P1|Overall Study|Laboratory adverse event|0
5241105|NCT00813995|18087128|P2|Overall Study|Clinical adverse event|3
5241106|NCT00813995|18087129|P1|Overall Study|Clinical adverse event|9
5241107|NCT00813943|18087152|P3|Overall Study|Ongoing at cut-off date|3
5241108|NCT00813943|18087153|P2|Overall Study|Ongoing at cut-off date|5
5241109|NCT00813943|18087154|P1|Overall Study|Ongoing at cut-off date|5
5241110|NCT00813917|18087184|P2|Overall Study|Lost to Follow-up|1
5241111|NCT00813917|18087185|P1|Overall Study|Lost to Follow-up|3
5241112|NCT00813917|18087184|P2|Overall Study|Withdrawal by Subject|4
5241113|NCT00813917|18087185|P1|Overall Study|Withdrawal by Subject|3
5241114|NCT00813917|18087184|P2|Overall Study|Adverse Event|1
5241115|NCT00813917|18087185|P1|Overall Study|Adverse Event|0
5241116|NCT00813904|18087191|P1|Overall Study|Death|1
5241117|NCT00813865|18087197|P1|Overall Study|Withdrawal by Subject|1
5241118|NCT00813865|18087197|P1|Overall Study|Lost to Follow-up|3
5241119|NCT00813865|18087197|P1|Overall Study|Failure to Respond|3
5241120|NCT00813813|18087205|P2|Overall Study|Other|1
5241121|NCT00813813|18087206|P1|Overall Study|Other|0
5241122|NCT00813813|18087205|P2|Overall Study|Lost to Follow-up|7
5241123|NCT00813813|18087206|P1|Overall Study|Lost to Follow-up|2
5241124|NCT00813813|18087205|P2|Overall Study|Withdrawal by Subject|1
5241125|NCT00813813|18087206|P1|Overall Study|Withdrawal by Subject|1
5241126|NCT00813800|18087222|P1|Overall Study|Physician Decision|1
5241127|NCT00813800|18087222|P1|Overall Study|Worsening of depression|2
5241128|NCT00813800|18087222|P1|Overall Study|Adverse Event|1
5241129|NCT00813800|18087222|P1|Overall Study|Screen Failure after Consent|2
5241130|NCT00813761|18087230|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
5241131|NCT00813761|18087231|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
5241132|NCT00813761|18087232|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
5241133|NCT00813761|18087233|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
5241134|NCT00813761|18087230|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
5241135|NCT00813761|18087231|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
5241136|NCT00813761|18087232|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
5241137|NCT00813761|18087233|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
5241138|NCT00813761|18087230|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
5241139|NCT00813761|18087231|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
5241140|NCT00813761|18087232|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
5241141|NCT00813761|18087233|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
5241142|NCT00813761|18087230|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
5241143|NCT00813761|18087231|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
5241144|NCT00813761|18087232|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
5241145|NCT00813761|18087233|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
5241146|NCT00813761|18087230|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
5241147|NCT00813761|18087231|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
5241148|NCT00813761|18087232|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
5241149|NCT00813761|18087233|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
5241150|NCT00813761|18087230|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
5241151|NCT00813761|18087231|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
5241152|NCT00813761|18087232|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
5241153|NCT00813761|18087233|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
5241154|NCT00813761|18087230|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
5241155|NCT00813761|18087231|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
5241156|NCT00813761|18087232|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
5241157|NCT00813761|18087233|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
5241158|NCT00813761|18087230|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
5241159|NCT00813761|18087231|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
5241160|NCT00813761|18087232|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
5241161|NCT00813761|18087233|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
5241162|NCT00813761|18087230|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
5241163|NCT00813761|18087231|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
5241164|NCT00813761|18087232|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
5241165|NCT00813761|18087233|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
5241166|NCT00813761|18087230|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
5241167|NCT00813761|18087231|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
5241168|NCT00813761|18087232|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
5241169|NCT00813761|18087233|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
5241170|NCT00813761|18087230|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
5241171|NCT00813761|18087231|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
5241172|NCT00813761|18087232|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
5241173|NCT00813761|18087233|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
5241174|NCT00813761|18087230|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
5241175|NCT00813761|18087231|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
5241176|NCT00813761|18087232|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
5241177|NCT00813761|18087233|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
5241178|NCT00813748|18087283|P2|Skin Test Substudy|Physician Decision|1
5241179|NCT00813748|18087284|P1|Skin Test Substudy|Physician Decision|0
5241180|NCT00813709|18087313|P6|Open Label Period|Other|6
5241181|NCT00813709|18087314|P5|Open Label Period|Other|5
5241182|NCT00813709|18087315|P4|Open Label Period|Other|11
5241183|NCT00813709|18087316|P3|Open Label Period|Other|0
5241184|NCT00813709|18087317|P2|Open Label Period|Other|0
5241185|NCT00813709|18087318|P1|Open Label Period|Other|0
5241186|NCT00813709|18087313|P6|Open Label Period|Randomized but not treated|1
5241187|NCT00813709|18087314|P5|Open Label Period|Randomized but not treated|0
5241188|NCT00813709|18087315|P4|Open Label Period|Randomized but not treated|1
5241189|NCT00813709|18087316|P3|Open Label Period|Randomized but not treated|0
5241190|NCT00813709|18087317|P2|Open Label Period|Randomized but not treated|0
5241191|NCT00813709|18087318|P1|Open Label Period|Randomized but not treated|0
5241192|NCT00813709|18087313|P6|Open Label Period|Lack of Efficacy|1
5241193|NCT00813709|18087314|P5|Open Label Period|Lack of Efficacy|1
5241194|NCT00813709|18087315|P4|Open Label Period|Lack of Efficacy|3
5241195|NCT00813709|18087316|P3|Open Label Period|Lack of Efficacy|0
5241196|NCT00813709|18087317|P2|Open Label Period|Lack of Efficacy|0
5241197|NCT00813709|18087318|P1|Open Label Period|Lack of Efficacy|0
5241198|NCT00813709|18087313|P6|Open Label Period|Adverse Event|3
5241199|NCT00813709|18087314|P5|Open Label Period|Adverse Event|4
5241200|NCT00813709|18087315|P4|Open Label Period|Adverse Event|5
5241201|NCT00813709|18087316|P3|Open Label Period|Adverse Event|0
5241202|NCT00813709|18087317|P2|Open Label Period|Adverse Event|0
5241203|NCT00813709|18087318|P1|Open Label Period|Adverse Event|0
5241204|NCT00813709|18087313|P6|Double Blind Period|Other|0
5241205|NCT00813709|18087314|P5|Double Blind Period|Other|0
5241206|NCT00813709|18087315|P4|Double Blind Period|Other|0
5241207|NCT00813709|18087316|P3|Double Blind Period|Other|6
5241208|NCT00813709|18087317|P2|Double Blind Period|Other|9
5241209|NCT00813709|18087318|P1|Double Blind Period|Other|14
5241210|NCT00813709|18087313|P6|Double Blind Period|Randomized but not treated|0
5241211|NCT00813709|18087314|P5|Double Blind Period|Randomized but not treated|0
5241212|NCT00813709|18087315|P4|Double Blind Period|Randomized but not treated|0
5241213|NCT00813709|18087316|P3|Double Blind Period|Randomized but not treated|1
5241214|NCT00813709|18087317|P2|Double Blind Period|Randomized but not treated|3
5241215|NCT00813709|18087318|P1|Double Blind Period|Randomized but not treated|1
5241216|NCT00813709|18087313|P6|Double Blind Period|Switched to open label phase|0
5241217|NCT00813709|18087314|P5|Double Blind Period|Switched to open label phase|0
5241218|NCT00813709|18087315|P4|Double Blind Period|Switched to open label phase|0
5241219|NCT00813709|18087316|P3|Double Blind Period|Switched to open label phase|18
5241220|NCT00813709|18087317|P2|Double Blind Period|Switched to open label phase|26
5241221|NCT00813709|18087318|P1|Double Blind Period|Switched to open label phase|9
5241222|NCT00813709|18087313|P6|Double Blind Period|Lost to Follow-up|0
5241223|NCT00813709|18087314|P5|Double Blind Period|Lost to Follow-up|0
5241224|NCT00813709|18087315|P4|Double Blind Period|Lost to Follow-up|0
5241225|NCT00813709|18087316|P3|Double Blind Period|Lost to Follow-up|2
5241226|NCT00813709|18087317|P2|Double Blind Period|Lost to Follow-up|2
5241227|NCT00813709|18087318|P1|Double Blind Period|Lost to Follow-up|3
5241228|NCT00813709|18087313|P6|Double Blind Period|Adverse Event|0
5241229|NCT00813709|18087314|P5|Double Blind Period|Adverse Event|0
5241230|NCT00813709|18087315|P4|Double Blind Period|Adverse Event|0
5241231|NCT00813709|18087316|P3|Double Blind Period|Adverse Event|4
5241232|NCT00813709|18087317|P2|Double Blind Period|Adverse Event|1
5241233|NCT00813709|18087318|P1|Double Blind Period|Adverse Event|4
5241234|NCT00813592|18087398|P1|Overall Study|Disease assessment was not completed per|2
5241235|NCT00813488|18087407|P2|Open-label Extension|Other|0
5241236|NCT00813488|18087408|P1|Open-label Extension|Other|1
5241237|NCT00813488|18087407|P2|Open-label Extension|Non-compliance study procedures|1
5241238|NCT00813488|18087408|P1|Open-label Extension|Non-compliance study procedures|2
5241239|NCT00813488|18087407|P2|Open-label Extension|Non-compliance study medication|0
5241240|NCT00813488|18087408|P1|Open-label Extension|Non-compliance study medication|4
5241241|NCT00813488|18087407|P2|Open-label Extension|Protocol Violation|2
5241242|NCT00813488|18087408|P1|Open-label Extension|Protocol Violation|1
5241243|NCT00813488|18087407|P2|Open-label Extension|Withdrawal by Subject|2
5241244|NCT00813488|18087408|P1|Open-label Extension|Withdrawal by Subject|0
5241245|NCT00813488|18087407|P2|Open-label Extension|Lack of Efficacy|0
5241246|NCT00813488|18087408|P1|Open-label Extension|Lack of Efficacy|3
5241247|NCT00813488|18087407|P2|Open-label Extension|Adverse Event|2
5241248|NCT00813488|18087408|P1|Open-label Extension|Adverse Event|1
5241249|NCT00813488|18087407|P2|Double-blind Treatment Period 2|Other|0
5241250|NCT00813488|18087408|P1|Double-blind Treatment Period 2|Other|1
5241251|NCT00813488|18087407|P2|Double-blind Treatment Period 2|Protocol Violation|0
5241252|NCT00813488|18087408|P1|Double-blind Treatment Period 2|Protocol Violation|2
5241253|NCT00813488|18087407|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
5241254|NCT00813488|18087408|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
5241255|NCT00813488|18087407|P2|Double-blind Treatment Period 2|Adverse Event|0
5241256|NCT00813488|18087408|P1|Double-blind Treatment Period 2|Adverse Event|1
5241257|NCT00813488|18087407|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
5241258|NCT00813488|18087408|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
5241259|NCT00813488|18087407|P2|Double-blind Treatment Period 1|Protocol Violation|2
5241260|NCT00813488|18087408|P1|Double-blind Treatment Period 1|Protocol Violation|0
5241261|NCT00813488|18087407|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
5241262|NCT00813488|18087408|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
5241263|NCT00813488|18087407|P2|Double-blind Treatment Period 1|Adverse Event|1
5241264|NCT00813488|18087408|P1|Double-blind Treatment Period 1|Adverse Event|1
5241265|NCT00813488|18087407|P2|Titration Period 2|Non-compliance with study procedures|1
5241266|NCT00813488|18087408|P1|Titration Period 2|Non-compliance with study procedures|2
5241267|NCT00813488|18087407|P2|Titration Period 2|Lost to Follow-up|0
5241268|NCT00813488|18087408|P1|Titration Period 2|Lost to Follow-up|1
5241269|NCT00813488|18087407|P2|Titration Period 2|Protocol Violation|2
5241270|NCT00813488|18087408|P1|Titration Period 2|Protocol Violation|3
5241271|NCT00813488|18087407|P2|Titration Period 2|Lack of Efficacy|4
5241272|NCT00813488|18087408|P1|Titration Period 2|Lack of Efficacy|8
5241273|NCT00813488|18087407|P2|Titration Period 2|Adverse Event|3
5241274|NCT00813488|18087408|P1|Titration Period 2|Adverse Event|2
5241275|NCT00813488|18087407|P2|Titration Period 1|Technical Difficulties|1
5241276|NCT00813488|18087408|P1|Titration Period 1|Technical Difficulties|0
5241277|NCT00813488|18087407|P2|Titration Period 1|Non-compliance to study procedures|2
5241278|NCT00813488|18087408|P1|Titration Period 1|Non-compliance to study procedures|2
5241279|NCT00813488|18087407|P2|Titration Period 1|Non-compliance to study medication|1
5241280|NCT00813488|18087408|P1|Titration Period 1|Non-compliance to study medication|4
5241281|NCT00813488|18087407|P2|Titration Period 1|Protocol Violation|3
5241282|NCT00813488|18087408|P1|Titration Period 1|Protocol Violation|4
5241283|NCT00813488|18087407|P2|Titration Period 1|Withdrawal by Subject|2
5241284|NCT00813488|18087408|P1|Titration Period 1|Withdrawal by Subject|2
5241285|NCT00813488|18087407|P2|Titration Period 1|Lack of Efficacy|7
5241286|NCT00813488|18087408|P1|Titration Period 1|Lack of Efficacy|9
5241287|NCT00813488|18087407|P2|Titration Period 1|Adverse Event|1
5241288|NCT00813488|18087408|P1|Titration Period 1|Adverse Event|6
5241289|NCT00813293|18087519|P2|Overall Study|Adverse Event|1
5241290|NCT00813293|18087520|P1|Overall Study|Adverse Event|0
5241291|NCT00813293|18087519|P2|Overall Study|Intercurrent illness|0
5241292|NCT00813293|18087520|P1|Overall Study|Intercurrent illness|1
5241293|NCT00813150|18087559|P2|Long Term Follow-up|Progression/Relapse|24
5241294|NCT00813150|18087560|P1|Long Term Follow-up|Progression/Relapse|22
5241295|NCT00813150|18087559|P2|Long Term Follow-up|Lost to Follow-up|0
5241296|NCT00813150|18087560|P1|Long Term Follow-up|Lost to Follow-up|2
5241297|NCT00813150|18087559|P2|Long Term Follow-up|Other|3
5241298|NCT00813150|18087560|P1|Long Term Follow-up|Other|0
5241299|NCT00813150|18087559|P2|Long Term Follow-up|Death|4
5241300|NCT00813150|18087560|P1|Long Term Follow-up|Death|0
5241301|NCT00813150|18087559|P2|Treatment Period|Data not available|2
5241302|NCT00813150|18087560|P1|Treatment Period|Data not available|1
5241303|NCT00813150|18087559|P2|Treatment Period|Reason not specified|4
5241304|NCT00813150|18087560|P1|Treatment Period|Reason not specified|3
5241305|NCT00813150|18087559|P2|Treatment Period|Non compliance|1
5241306|NCT00813150|18087560|P1|Treatment Period|Non compliance|0
5241307|NCT00813150|18087559|P2|Treatment Period|Withdrawal by Subject|3
5241308|NCT00813150|18087560|P1|Treatment Period|Withdrawal by Subject|5
5241309|NCT00813150|18087559|P2|Treatment Period|Protocol Violation|4
5241310|NCT00813150|18087560|P1|Treatment Period|Protocol Violation|3
5241311|NCT00813150|18087559|P2|Treatment Period|Stable disease|2
5241312|NCT00813150|18087560|P1|Treatment Period|Stable disease|1
5241313|NCT00813150|18087559|P2|Treatment Period|Complete response|1
5241314|NCT00813150|18087560|P1|Treatment Period|Complete response|0
5241315|NCT00813150|18087559|P2|Treatment Period|Progressive disease|0
5241316|NCT00813150|18087560|P1|Treatment Period|Progressive disease|1
5241317|NCT00813150|18087559|P2|Treatment Period|Death|0
5241318|NCT00813150|18087560|P1|Treatment Period|Death|2
5241319|NCT00813150|18087559|P2|Treatment Period|Adverse Event|15
5241320|NCT00813150|18087560|P1|Treatment Period|Adverse Event|16
5241321|NCT00813098|18087584|P3|Overall Study|Withdrew Consent|0
5241322|NCT00813098|18087585|P2|Overall Study|Withdrew Consent|1
5241323|NCT00813098|18087586|P1|Overall Study|Withdrew Consent|0
5241324|NCT00813098|18087584|P3|Overall Study|Principal Investigator decision|0
5241325|NCT00813098|18087585|P2|Overall Study|Principal Investigator decision|1
5241326|NCT00813098|18087586|P1|Overall Study|Principal Investigator decision|0
5241327|NCT00813098|18087584|P3|Overall Study|Protocol Violation|1
5241328|NCT00813098|18087585|P2|Overall Study|Protocol Violation|0
5241329|NCT00813098|18087586|P1|Overall Study|Protocol Violation|0
5241330|NCT00813098|18087584|P3|Overall Study|Lost to Follow-up|0
5241331|NCT00813098|18087585|P2|Overall Study|Lost to Follow-up|1
5241332|NCT00813098|18087586|P1|Overall Study|Lost to Follow-up|0
5241333|NCT00813098|18087584|P3|Overall Study|Inability to complete study procedures|0
5241334|NCT00813098|18087585|P2|Overall Study|Inability to complete study procedures|0
5241335|NCT00813098|18087586|P1|Overall Study|Inability to complete study procedures|1
5241336|NCT00813098|18087584|P3|Overall Study|Withdrawal by Subject|0
5241337|NCT00813098|18087585|P2|Overall Study|Withdrawal by Subject|1
5241338|NCT00813098|18087586|P1|Overall Study|Withdrawal by Subject|0
5241339|NCT00813098|18087584|P3|Overall Study|Adverse Event|1
5241340|NCT00813098|18087585|P2|Overall Study|Adverse Event|4
5241341|NCT00813098|18087586|P1|Overall Study|Adverse Event|2
5241342|NCT00812981|18087611|P2|Overall Study|Other|1
5241343|NCT00812981|18087612|P1|Overall Study|Other|0
5241344|NCT00812968|18087650|P1|Overall Study|Study closed due to marketing approval|3
5241345|NCT00812968|18087650|P1|Overall Study|No further treatment required|1
5241346|NCT00812968|18087650|P1|Overall Study|Disease progression|1
5241347|NCT00812968|18087650|P1|Overall Study|Relapse after erythroid response|6
5241348|NCT00812955|18087685|P4|Overall Study|randomized in error|0
5241349|NCT00812955|18087686|P3|Overall Study|randomized in error|1
5241350|NCT00812955|18087687|P2|Overall Study|randomized in error|0
5241351|NCT00812955|18087688|P1|Overall Study|randomized in error|0
5241352|NCT00812955|18087685|P4|Overall Study|Withdrawal by Subject|2
5241353|NCT00812955|18087686|P3|Overall Study|Withdrawal by Subject|1
5241354|NCT00812955|18087687|P2|Overall Study|Withdrawal by Subject|0
5241355|NCT00812955|18087688|P1|Overall Study|Withdrawal by Subject|1
5241356|NCT00812955|18087685|P4|Overall Study|Lost to Follow-up|2
5241357|NCT00812955|18087686|P3|Overall Study|Lost to Follow-up|1
5241358|NCT00812955|18087687|P2|Overall Study|Lost to Follow-up|1
5241359|NCT00812955|18087688|P1|Overall Study|Lost to Follow-up|2
5241360|NCT00812955|18087685|P4|Overall Study|Adverse Event|4
5241361|NCT00812955|18087686|P3|Overall Study|Adverse Event|3
5241362|NCT00812955|18087687|P2|Overall Study|Adverse Event|6
5241363|NCT00812955|18087688|P1|Overall Study|Adverse Event|7
5241364|NCT00812929|18087708|P10|Washout Period 3 (7 Days)|Adverse Event|0
5241365|NCT00812929|18087709|P9|Washout Period 3 (7 Days)|Adverse Event|0
5241366|NCT00812929|18087710|P8|Washout Period 3 (7 Days)|Adverse Event|0
5241367|NCT00812929|18087711|P7|Washout Period 3 (7 Days)|Adverse Event|0
5241368|NCT00812929|18087712|P6|Washout Period 3 (7 Days)|Adverse Event|1
5241369|NCT00812929|18087713|P5|Washout Period 3 (7 Days)|Adverse Event|0
5241370|NCT00812929|18087714|P4|Washout Period 3 (7 Days)|Adverse Event|0
5241371|NCT00812929|18087715|P3|Washout Period 3 (7 Days)|Adverse Event|0
5241372|NCT00812929|18087716|P2|Washout Period 3 (7 Days)|Adverse Event|0
5241373|NCT00812929|18087717|P1|Washout Period 3 (7 Days)|Adverse Event|0
5241374|NCT00812929|18087708|P10|Washout Period 2 (7 Days)|Physician Decision|1
5241375|NCT00812929|18087709|P9|Washout Period 2 (7 Days)|Physician Decision|0
5241376|NCT00812929|18087710|P8|Washout Period 2 (7 Days)|Physician Decision|0
5241377|NCT00812929|18087711|P7|Washout Period 2 (7 Days)|Physician Decision|0
5241378|NCT00812929|18087712|P6|Washout Period 2 (7 Days)|Physician Decision|0
5241379|NCT00812929|18087713|P5|Washout Period 2 (7 Days)|Physician Decision|0
5241380|NCT00812929|18087714|P4|Washout Period 2 (7 Days)|Physician Decision|0
5241381|NCT00812929|18087715|P3|Washout Period 2 (7 Days)|Physician Decision|0
5241382|NCT00812929|18087716|P2|Washout Period 2 (7 Days)|Physician Decision|0
5241383|NCT00812929|18087717|P1|Washout Period 2 (7 Days)|Physician Decision|0
5241384|NCT00812929|18087708|P10|Washout Period 1 (7 Days)|Physician Decision|0
5241385|NCT00812929|18087709|P9|Washout Period 1 (7 Days)|Physician Decision|0
5241386|NCT00812929|18087710|P8|Washout Period 1 (7 Days)|Physician Decision|0
5241387|NCT00812929|18087711|P7|Washout Period 1 (7 Days)|Physician Decision|0
5241388|NCT00812929|18087712|P6|Washout Period 1 (7 Days)|Physician Decision|0
5241389|NCT00812929|18087713|P5|Washout Period 1 (7 Days)|Physician Decision|0
5241390|NCT00812929|18087714|P4|Washout Period 1 (7 Days)|Physician Decision|0
5241391|NCT00812929|18087715|P3|Washout Period 1 (7 Days)|Physician Decision|1
5241392|NCT00812929|18087716|P2|Washout Period 1 (7 Days)|Physician Decision|0
5241393|NCT00812929|18087717|P1|Washout Period 1 (7 Days)|Physician Decision|0
5241394|NCT00812812|18087872|P2|Overall Study|Withdrawal by Subject|2
5241395|NCT00812812|18087873|P1|Overall Study|Withdrawal by Subject|0
5241396|NCT00812812|18087872|P2|Overall Study|Lost to Follow-up|1
5241397|NCT00812812|18087873|P1|Overall Study|Lost to Follow-up|0
5241398|NCT00812812|18087872|P2|Overall Study|Lack of Efficacy|0
5241399|NCT00812812|18087873|P1|Overall Study|Lack of Efficacy|1
5241400|NCT00812812|18087872|P2|Overall Study|Adverse Event|1
5241401|NCT00812812|18087873|P1|Overall Study|Adverse Event|2
5241402|NCT00812708|18087886|P1|Overall Study|Signed consent but later withdrew|3
5241403|NCT00812708|18087886|P1|Overall Study|Surgery cancelled due to uveitis|1
5241404|NCT00812708|18087886|P1|Overall Study|Switched to another study|1
5241405|NCT00812708|18087886|P1|Overall Study|Lack of medical insurance|1
5241406|NCT00812708|18087886|P1|Overall Study|Device could not be implanted|2
5241407|NCT00812565|18087914|P8|Overall Study|Reason Not Specified|0
5241408|NCT00812565|18087915|P7|Overall Study|Reason Not Specified|0
5241409|NCT00812565|18087916|P6|Overall Study|Reason Not Specified|1
5241410|NCT00812565|18087917|P5|Overall Study|Reason Not Specified|0
5241411|NCT00812565|18087918|P4|Overall Study|Reason Not Specified|0
5241412|NCT00812565|18087919|P3|Overall Study|Reason Not Specified|0
5241413|NCT00812565|18087920|P2|Overall Study|Reason Not Specified|0
5241414|NCT00812565|18087921|P1|Overall Study|Reason Not Specified|0
5241415|NCT00812565|18087914|P8|Overall Study|Withdrawal of Consent|0
5241416|NCT00812565|18087915|P7|Overall Study|Withdrawal of Consent|0
5241417|NCT00812565|18087916|P6|Overall Study|Withdrawal of Consent|0
5241418|NCT00812565|18087917|P5|Overall Study|Withdrawal of Consent|1
5241419|NCT00812565|18087918|P4|Overall Study|Withdrawal of Consent|0
5241420|NCT00812565|18087919|P3|Overall Study|Withdrawal of Consent|0
5241421|NCT00812565|18087920|P2|Overall Study|Withdrawal of Consent|0
5241422|NCT00812565|18087921|P1|Overall Study|Withdrawal of Consent|1
5241423|NCT00812565|18087914|P8|Overall Study|Did Not Come to Study Visit|0
5241424|NCT00812565|18087915|P7|Overall Study|Did Not Come to Study Visit|0
5241425|NCT00812565|18087916|P6|Overall Study|Did Not Come to Study Visit|0
5241426|NCT00812565|18087917|P5|Overall Study|Did Not Come to Study Visit|0
5241427|NCT00812565|18087918|P4|Overall Study|Did Not Come to Study Visit|0
5241428|NCT00812565|18087919|P3|Overall Study|Did Not Come to Study Visit|0
5241429|NCT00812565|18087920|P2|Overall Study|Did Not Come to Study Visit|0
5241430|NCT00812565|18087921|P1|Overall Study|Did Not Come to Study Visit|1
5241431|NCT00812565|18087914|P8|Overall Study|Adverse Event|1
5241432|NCT00812565|18087915|P7|Overall Study|Adverse Event|0
5241433|NCT00812565|18087916|P6|Overall Study|Adverse Event|0
5241434|NCT00812565|18087917|P5|Overall Study|Adverse Event|0
5241435|NCT00812565|18087918|P4|Overall Study|Adverse Event|2
5241436|NCT00812565|18087919|P3|Overall Study|Adverse Event|0
5241437|NCT00812565|18087920|P2|Overall Study|Adverse Event|0
5241438|NCT00812565|18087921|P1|Overall Study|Adverse Event|0
5241439|NCT00812565|18087914|P8|Overall Study|Did Not Receive Study Medication|0
5241440|NCT00812565|18087915|P7|Overall Study|Did Not Receive Study Medication|0
5241441|NCT00812565|18087916|P6|Overall Study|Did Not Receive Study Medication|0
5241442|NCT00812565|18087917|P5|Overall Study|Did Not Receive Study Medication|0
5241443|NCT00812565|18087918|P4|Overall Study|Did Not Receive Study Medication|0
5241444|NCT00812565|18087919|P3|Overall Study|Did Not Receive Study Medication|0
5241445|NCT00812565|18087920|P2|Overall Study|Did Not Receive Study Medication|1
5241446|NCT00812565|18087921|P1|Overall Study|Did Not Receive Study Medication|1
5241447|NCT00812487|18088045|P2|Overall Study|Protocol Violation|1
5241448|NCT00812487|18088046|P1|Overall Study|Protocol Violation|0
5241449|NCT00812487|18088045|P2|Overall Study|Transfer to ICU prior to intervention|0
5241450|NCT00812487|18088046|P1|Overall Study|Transfer to ICU prior to intervention|1
5241451|NCT00812487|18088045|P2|Overall Study|Withdrawal by Subject|2
5241452|NCT00812487|18088046|P1|Overall Study|Withdrawal by Subject|3
5241453|NCT00812487|18088045|P2|Overall Study|Lost to Follow-up|0
5241454|NCT00812487|18088046|P1|Overall Study|Lost to Follow-up|2
5241455|NCT00812461|18088072|P2|All Treated Patients|Other Reason|21
5241456|NCT00812461|18088073|P1|All Treated Patients|Other Reason|13
5241457|NCT00812461|18088072|P2|All Treated Patients|Lost to Follow-up|14
5241458|NCT00812461|18088073|P1|All Treated Patients|Lost to Follow-up|11
5241459|NCT00812461|18088072|P2|All Treated Patients|Withdrawal by Subject|54
5241460|NCT00812461|18088073|P1|All Treated Patients|Withdrawal by Subject|45
5241461|NCT00812461|18088072|P2|All Treated Patients|Protocol Violation|27
5241462|NCT00812461|18088073|P1|All Treated Patients|Protocol Violation|36
5241463|NCT00812461|18088072|P2|All Treated Patients|Non-compliance|9
5241464|NCT00812461|18088073|P1|All Treated Patients|Non-compliance|6
5241465|NCT00812461|18088072|P2|All Treated Patients|Lack of Efficacy|7
5241466|NCT00812461|18088073|P1|All Treated Patients|Lack of Efficacy|13
5241467|NCT00812461|18088072|P2|All Treated Patients|Adverse Event|15
5241468|NCT00812461|18088073|P1|All Treated Patients|Adverse Event|8
5241469|NCT00812461|18088072|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
5241470|NCT00812461|18088073|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
5241471|NCT00812331|18088096|P5|Overall Study|Adverse Event|0
5241472|NCT00812331|18088097|P4|Overall Study|Adverse Event|0
5241473|NCT00812331|18088098|P3|Overall Study|Adverse Event|0
5241474|NCT00812331|18088099|P2|Overall Study|Adverse Event|0
5241475|NCT00812331|18088100|P1|Overall Study|Adverse Event|1
5241476|NCT00812253|18088175|P2|Overall Study|Lost to Follow-up|0
5241477|NCT00812253|18088176|P1|Overall Study|Lost to Follow-up|2
5241478|NCT00812253|18088175|P2|Overall Study|Protocol Violation|1
5241479|NCT00812253|18088176|P1|Overall Study|Protocol Violation|1
5241480|NCT00812253|18088175|P2|Overall Study|Withdrawal by Subject|2
5241481|NCT00812253|18088176|P1|Overall Study|Withdrawal by Subject|3
5241482|NCT00812097|18088201|P4|Overall Study|Unknown reasons and patient/doctor moves|5
5241483|NCT00812097|18088202|P3|Overall Study|Unknown reasons and patient/doctor moves|15
5241484|NCT00812097|18088203|P2|Overall Study|Unknown reasons and patient/doctor moves|24
5241485|NCT00812097|18088204|P1|Overall Study|Unknown reasons and patient/doctor moves|111
5241486|NCT00812097|18088201|P4|Overall Study|Explantation of study device(s)|20
5241487|NCT00812097|18088202|P3|Overall Study|Explantation of study device(s)|14
5241488|NCT00812097|18088203|P2|Overall Study|Explantation of study device(s)|29
5241489|NCT00812097|18088204|P1|Overall Study|Explantation of study device(s)|27
5241490|NCT00812097|18088201|P4|Overall Study|Lost to Follow-up|5
5241491|NCT00812097|18088202|P3|Overall Study|Lost to Follow-up|17
5241492|NCT00812097|18088203|P2|Overall Study|Lost to Follow-up|14
5241493|NCT00812097|18088204|P1|Overall Study|Lost to Follow-up|90
5241494|NCT00812097|18088201|P4|Overall Study|Withdrawal by Subject|2
5241495|NCT00812097|18088202|P3|Overall Study|Withdrawal by Subject|8
5241496|NCT00812097|18088203|P2|Overall Study|Withdrawal by Subject|12
5241497|NCT00812097|18088204|P1|Overall Study|Withdrawal by Subject|14
5241498|NCT00812097|18088201|P4|Overall Study|Death|3
5241499|NCT00812097|18088202|P3|Overall Study|Death|3
5241500|NCT00812097|18088203|P2|Overall Study|Death|10
5241501|NCT00812097|18088204|P1|Overall Study|Death|3
5241502|NCT00812006|18088233|P3|Overall Study|Lack of Qualifying Event|2
5241503|NCT00812006|18088234|P2|Overall Study|Lack of Qualifying Event|2
5241504|NCT00812006|18088235|P1|Overall Study|Lack of Qualifying Event|4
5241505|NCT00812006|18088233|P3|Overall Study|Withdrawal by Subject|1
5241506|NCT00812006|18088234|P2|Overall Study|Withdrawal by Subject|1
5241507|NCT00812006|18088235|P1|Overall Study|Withdrawal by Subject|2
5241508|NCT00812006|18088233|P3|Overall Study|Physician Decision|1
5241509|NCT00812006|18088234|P2|Overall Study|Physician Decision|0
5241510|NCT00812006|18088235|P1|Overall Study|Physician Decision|0
5241511|NCT00812006|18088233|P3|Overall Study|Lost to Follow-up|2
5241512|NCT00812006|18088234|P2|Overall Study|Lost to Follow-up|0
5241513|NCT00812006|18088235|P1|Overall Study|Lost to Follow-up|0
5241514|NCT00811954|18088252|P3|Overall Study|Complete Protocol: No follow-up|1
5241515|NCT00811954|18088253|P2|Overall Study|Complete Protocol: No follow-up|0
5241516|NCT00811954|18088254|P1|Overall Study|Complete Protocol: No follow-up|0
5241517|NCT00811954|18088252|P3|Overall Study|Severe Debilitation|1
5241518|NCT00811954|18088253|P2|Overall Study|Severe Debilitation|0
5241519|NCT00811954|18088254|P1|Overall Study|Severe Debilitation|2
5241520|NCT00811954|18088252|P3|Overall Study|Site Closure|1
5241521|NCT00811954|18088253|P2|Overall Study|Site Closure|0
5241522|NCT00811954|18088254|P1|Overall Study|Site Closure|4
5241523|NCT00811954|18088252|P3|Overall Study|Withdraw consent prior study completion|5
5241524|NCT00811954|18088253|P2|Overall Study|Withdraw consent prior study completion|6
5241525|NCT00811954|18088254|P1|Overall Study|Withdraw consent prior study completion|4
5241526|NCT00811954|18088252|P3|Overall Study|Not willing to adhere to requirements|16
5241527|NCT00811954|18088253|P2|Overall Study|Not willing to adhere to requirements|2
5241528|NCT00811954|18088254|P1|Overall Study|Not willing to adhere to requirements|12
5241529|NCT00811954|18088252|P3|Overall Study|Not able to get to clinic|30
5241530|NCT00811954|18088253|P2|Overall Study|Not able to get to clinic|35
5241531|NCT00811954|18088254|P1|Overall Study|Not able to get to clinic|28
5241532|NCT00811954|18088252|P3|Overall Study|Lost to Follow-up|34
5241533|NCT00811954|18088253|P2|Overall Study|Lost to Follow-up|23
5241534|NCT00811954|18088254|P1|Overall Study|Lost to Follow-up|29
5241535|NCT00811954|18088252|P3|Overall Study|Death|13
5241536|NCT00811954|18088253|P2|Overall Study|Death|6
5241537|NCT00811954|18088254|P1|Overall Study|Death|10
5241538|NCT00811941|18088318|P2|All Treated Patients|Other Reason|14
5241539|NCT00811941|18088319|P1|All Treated Patients|Other Reason|4
5241540|NCT00811941|18088318|P2|All Treated Patients|Lost to Follow-up|12
5241541|NCT00811941|18088319|P1|All Treated Patients|Lost to Follow-up|3
5241542|NCT00811941|18088318|P2|All Treated Patients|Withdrawal by Subject|94
5241543|NCT00811941|18088319|P1|All Treated Patients|Withdrawal by Subject|35
5241544|NCT00811941|18088318|P2|All Treated Patients|Protocol Violation|17
5241545|NCT00811941|18088319|P1|All Treated Patients|Protocol Violation|5
5241546|NCT00811941|18088318|P2|All Treated Patients|Non-compliance|8
5241547|NCT00811941|18088319|P1|All Treated Patients|Non-compliance|1
5241548|NCT00811941|18088318|P2|All Treated Patients|Lack of Efficacy|3
5241549|NCT00811941|18088319|P1|All Treated Patients|Lack of Efficacy|2
5241550|NCT00811941|18088318|P2|All Treated Patients|Adverse Event|43
5241551|NCT00811941|18088319|P1|All Treated Patients|Adverse Event|2
5241552|NCT00811941|18088318|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
5241553|NCT00811941|18088319|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
5241554|NCT00811928|18088357|P2|Overall Study|Poor Compliance|5
5241555|NCT00811928|18088358|P1|Overall Study|Poor Compliance|2
5241556|NCT00811928|18088357|P2|Overall Study|Investigator Decision|1
5241557|NCT00811928|18088358|P1|Overall Study|Investigator Decision|2
5241558|NCT00811928|18088357|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
5241559|NCT00811928|18088358|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
5241560|NCT00811928|18088357|P2|Overall Study|Did Not Take Study Drug|0
5241561|NCT00811928|18088358|P1|Overall Study|Did Not Take Study Drug|3
5241562|NCT00811928|18088357|P2|Overall Study|Withdrawal by Subject|12
5241563|NCT00811928|18088358|P1|Overall Study|Withdrawal by Subject|18
5241564|NCT00811928|18088357|P2|Overall Study|AEs and SAEs Including Death|11
5241565|NCT00811928|18088358|P1|Overall Study|AEs and SAEs Including Death|7
5241566|NCT00811733|18088402|P2|Overall Study|Withdrawal by Subject|2
5241567|NCT00811733|18088403|P1|Overall Study|Withdrawal by Subject|1
5241568|NCT00811733|18088402|P2|Overall Study|Investigator Discretion|8
5241569|NCT00811733|18088403|P1|Overall Study|Investigator Discretion|10
5241570|NCT00811720|18088451|P2|All Treated Patients|Other Reason|4
5241571|NCT00811720|18088452|P1|All Treated Patients|Other Reason|7
5241572|NCT00811720|18088451|P2|All Treated Patients|Lost to Follow-up|16
5241573|NCT00811720|18088452|P1|All Treated Patients|Lost to Follow-up|10
5241574|NCT00811720|18088451|P2|All Treated Patients|Withdrawal by Subject|34
5241575|NCT00811720|18088452|P1|All Treated Patients|Withdrawal by Subject|28
5241576|NCT00811720|18088451|P2|All Treated Patients|Protocol Violation|16
5241577|NCT00811720|18088452|P1|All Treated Patients|Protocol Violation|9
5241578|NCT00811720|18088451|P2|All Treated Patients|Non-compliance|14
5241579|NCT00811720|18088452|P1|All Treated Patients|Non-compliance|0
5241580|NCT00811720|18088451|P2|All Treated Patients|Lack of Efficacy|18
5241581|NCT00811720|18088452|P1|All Treated Patients|Lack of Efficacy|22
5241582|NCT00811720|18088451|P2|All Treated Patients|Adverse Event|62
5241583|NCT00811720|18088452|P1|All Treated Patients|Adverse Event|20
5241584|NCT00811720|18088451|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
5241585|NCT00811720|18088452|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
5241586|NCT00811655|18088470|P1|Overall Study|Physician Decision|1
5241587|NCT00811642|18088482|P1|Overall Study|Cumulative use of antifungal agent|2
5241588|NCT00811642|18088482|P1|Overall Study|Withdrawal by Subject|7
5241589|NCT00811642|18088482|P1|Overall Study|Death|2
5241590|NCT00811642|18088482|P1|Overall Study|Protocol Violation|1
5241591|NCT00811642|18088482|P1|Overall Study|Adverse Event|3
5241592|NCT00811577|18088498|P2|Overall Study|Withdrawal by Subject|0
5241593|NCT00811577|18088499|P1|Overall Study|Withdrawal by Subject|3
5241594|NCT00811577|18088498|P2|Overall Study|Lost to Follow-up|1
5241595|NCT00811577|18088499|P1|Overall Study|Lost to Follow-up|7
5241596|NCT00811473|18088559|P2|Overall Study|Safety Reasons|0
5241597|NCT00811473|18088560|P1|Overall Study|Safety Reasons|1
5241598|NCT00811473|18088559|P2|Overall Study|Incorrect Enrollment|0
5241599|NCT00811473|18088560|P1|Overall Study|Incorrect Enrollment|1
5241600|NCT00811473|18088559|P2|Overall Study|Other 2|1
5241601|NCT00811473|18088560|P1|Overall Study|Other 2|4
5241602|NCT00811473|18088559|P2|Overall Study|Condition under investigation worsened|3
5241603|NCT00811473|18088560|P1|Overall Study|Condition under investigation worsened|1
5241604|NCT00811473|18088559|P2|Overall Study|Lack of therapeutic response|1
5241605|NCT00811473|18088560|P1|Overall Study|Lack of therapeutic response|4
5241606|NCT00811473|18088559|P2|Overall Study|Severe non-compliance to protocol|4
5241607|NCT00811473|18088560|P1|Overall Study|Severe non-compliance to protocol|2
5241608|NCT00811473|18088559|P2|Overall Study|Withdrawal by Subject|4
5241609|NCT00811473|18088560|P1|Overall Study|Withdrawal by Subject|2
5241610|NCT00811473|18088559|P2|Overall Study|Lost to Follow-up|1
5241611|NCT00811473|18088560|P1|Overall Study|Lost to Follow-up|5
5241612|NCT00811473|18088559|P2|Overall Study|Adverse Event|12
5241613|NCT00811473|18088560|P1|Overall Study|Adverse Event|3
5241614|NCT00811395|18088591|P6|Extension Treatment|Other than above|0
5241615|NCT00811395|18088592|P5|Extension Treatment|Other than above|0
5241616|NCT00811395|18088593|P4|Extension Treatment|Other than above|0
5241617|NCT00811395|18088594|P3|Extension Treatment|Other than above|1
5241618|NCT00811395|18088595|P2|Extension Treatment|Other than above|0
5241619|NCT00811395|18088596|P1|Extension Treatment|Other than above|0
5241620|NCT00811395|18088591|P6|Extension Treatment|Participant did not wish to continue|1
5241621|NCT00811395|18088592|P5|Extension Treatment|Participant did not wish to continue|0
5241622|NCT00811395|18088593|P4|Extension Treatment|Participant did not wish to continue|1
5241623|NCT00811395|18088594|P3|Extension Treatment|Participant did not wish to continue|0
5241624|NCT00811395|18088595|P2|Extension Treatment|Participant did not wish to continue|3
5241625|NCT00811395|18088596|P1|Extension Treatment|Participant did not wish to continue|0
5241626|NCT00811395|18088591|P6|Extension Treatment|Progressive disease|0
5241627|NCT00811395|18088592|P5|Extension Treatment|Progressive disease|0
5241628|NCT00811395|18088593|P4|Extension Treatment|Progressive disease|0
5241629|NCT00811395|18088594|P3|Extension Treatment|Progressive disease|0
5241630|NCT00811395|18088595|P2|Extension Treatment|Progressive disease|1
5241631|NCT00811395|18088596|P1|Extension Treatment|Progressive disease|1
5241632|NCT00811395|18088591|P6|Extension Treatment|Adverse Event|1
5241633|NCT00811395|18088592|P5|Extension Treatment|Adverse Event|0
5241634|NCT00811395|18088593|P4|Extension Treatment|Adverse Event|2
5241635|NCT00811395|18088594|P3|Extension Treatment|Adverse Event|2
5241636|NCT00811395|18088595|P2|Extension Treatment|Adverse Event|2
5241637|NCT00811395|18088596|P1|Extension Treatment|Adverse Event|1
5241638|NCT00811252|18088702|P3|Overall Study|Administrative or Other Reasons|2
5241639|NCT00811252|18088703|P2|Overall Study|Administrative or Other Reasons|3
5241640|NCT00811252|18088704|P1|Overall Study|Administrative or Other Reasons|0
5241641|NCT00811252|18088702|P3|Overall Study|Lost to Follow-up|2
5241642|NCT00811252|18088703|P2|Overall Study|Lost to Follow-up|0
5241643|NCT00811252|18088704|P1|Overall Study|Lost to Follow-up|0
5241644|NCT00811252|18088702|P3|Overall Study|Withdrawal of Consent|2
5241645|NCT00811252|18088703|P2|Overall Study|Withdrawal of Consent|2
5241646|NCT00811252|18088704|P1|Overall Study|Withdrawal of Consent|1
5241647|NCT00811252|18088702|P3|Overall Study|Protocol Violation|2
5241648|NCT00811252|18088703|P2|Overall Study|Protocol Violation|3
5241649|NCT00811252|18088704|P1|Overall Study|Protocol Violation|3
5241650|NCT00811252|18088702|P3|Overall Study|Lack of Efficacy|0
5241651|NCT00811252|18088703|P2|Overall Study|Lack of Efficacy|2
5241652|NCT00811252|18088704|P1|Overall Study|Lack of Efficacy|7
5241653|NCT00811252|18088702|P3|Overall Study|Adverse Event|15
5241654|NCT00811252|18088703|P2|Overall Study|Adverse Event|10
5241655|NCT00811252|18088704|P1|Overall Study|Adverse Event|6
5241656|NCT00811187|18088750|P2|Overall Study|Unable to place device / procedure abort|3
5241657|NCT00811187|18088751|P1|Overall Study|Unable to place device / procedure abort|3
5241658|NCT00811174|18088757|P1|Overall Study|Sponsors Decision|1
5241659|NCT00811174|18088757|P1|Overall Study|Protocol Violation|2
5241660|NCT00811135|18088768|P1|Overall Study|Ongoing|59
5241661|NCT00811135|18088768|P1|Overall Study|Administrative/Other Unspecified|11
5241662|NCT00811135|18088768|P1|Overall Study|Withdrawal by Subject|3
5241663|NCT00811135|18088768|P1|Overall Study|Refused Treatment|1
5241664|NCT00811135|18088768|P1|Overall Study|Violation of Selection Criteria|1
5241665|NCT00811135|18088768|P1|Overall Study|Protocol Violation|2
5241666|NCT00811135|18088768|P1|Overall Study|Death|3
5241667|NCT00811135|18088768|P1|Overall Study|Adverse Event/Intercurrent Illness|8
5241668|NCT00811070|18088786|P6|Overall Study|Physician Decision|1
5241669|NCT00811070|18088787|P5|Overall Study|Physician Decision|0
5241670|NCT00811070|18088788|P4|Overall Study|Physician Decision|0
5241671|NCT00811070|18088789|P3|Overall Study|Physician Decision|0
5241672|NCT00811070|18088790|P2|Overall Study|Physician Decision|0
5241673|NCT00811070|18088791|P1|Overall Study|Physician Decision|0
5241674|NCT00811070|18088786|P6|Overall Study|Withdrawal by Subject|0
5241675|NCT00811070|18088787|P5|Overall Study|Withdrawal by Subject|0
5241676|NCT00811070|18088788|P4|Overall Study|Withdrawal by Subject|0
5241677|NCT00811070|18088789|P3|Overall Study|Withdrawal by Subject|0
5241678|NCT00811070|18088790|P2|Overall Study|Withdrawal by Subject|1
5241679|NCT00811070|18088791|P1|Overall Study|Withdrawal by Subject|0
5241680|NCT00811070|18088786|P6|Overall Study|Other|0
5241681|NCT00811070|18088787|P5|Overall Study|Other|0
5241682|NCT00811070|18088788|P4|Overall Study|Other|0
5241683|NCT00811070|18088789|P3|Overall Study|Other|0
5241684|NCT00811070|18088790|P2|Overall Study|Other|0
5241685|NCT00811070|18088791|P1|Overall Study|Other|1
5241686|NCT00811070|18088786|P6|Overall Study|Death|0
5241687|NCT00811070|18088787|P5|Overall Study|Death|5
5241688|NCT00811070|18088788|P4|Overall Study|Death|2
5241689|NCT00811070|18088789|P3|Overall Study|Death|0
5241690|NCT00811070|18088790|P2|Overall Study|Death|0
5241691|NCT00811070|18088791|P1|Overall Study|Death|0
5241692|NCT00811057|18088851|P3|Overall Study|Protocol Violation|10
5241693|NCT00811057|18088852|P2|Overall Study|Protocol Violation|10
5241694|NCT00811057|18088853|P1|Overall Study|Protocol Violation|5
5241695|NCT00811018|18088864|P1|Overall Study|Other|26
5241696|NCT00811018|18088864|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
5241697|NCT00811018|18088864|P1|Overall Study|Withdrawal by Subject|70
5241698|NCT00811018|18088864|P1|Overall Study|Sponsor Decision|450
5241699|NCT00811018|18088864|P1|Overall Study|Pregnancy|6
5241700|NCT00811018|18088864|P1|Overall Study|Lost to Follow-up|19
5241701|NCT00811018|18088864|P1|Overall Study|Investigator Decision|57
5241702|NCT00811018|18088864|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
5241703|NCT00811018|18088864|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
5241704|NCT00811018|18088864|P1|Overall Study|Death|147
5241705|NCT00811018|18088864|P1|Overall Study|Adverse Event|79
5241706|NCT00811018|18088864|P1|Overall Study|Additional Chronic Treatment|31
5241707|NCT00810901|18088882|P2|Overall Study|Lost to Follow-up|58
5241708|NCT00810901|18088883|P1|Overall Study|Lost to Follow-up|88
5241709|NCT00810810|18088929|P4|Overall Study|Physician Decision|5
5241710|NCT00810810|18088930|P3|Overall Study|Physician Decision|1
5241711|NCT00810810|18088931|P2|Overall Study|Physician Decision|3
5241712|NCT00810810|18088932|P1|Overall Study|Physician Decision|0
5241713|NCT00810810|18088929|P4|Overall Study|Withdrawal by Subject|8
5241714|NCT00810810|18088930|P3|Overall Study|Withdrawal by Subject|10
5241715|NCT00810810|18088931|P2|Overall Study|Withdrawal by Subject|8
5241716|NCT00810810|18088932|P1|Overall Study|Withdrawal by Subject|0
5241717|NCT00810693|18088985|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
5241718|NCT00810693|18088986|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
5241719|NCT00810693|18088987|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
5241720|NCT00810693|18088985|P3|Follow-up Period (FUP)|Protocol Violation|0
5241721|NCT00810693|18088986|P2|Follow-up Period (FUP)|Protocol Violation|1
5241722|NCT00810693|18088987|P1|Follow-up Period (FUP)|Protocol Violation|0
5241723|NCT00810693|18088985|P3|Follow-up Period (FUP)|Lost to Follow-up|2
5241724|NCT00810693|18088986|P2|Follow-up Period (FUP)|Lost to Follow-up|0
5241725|NCT00810693|18088987|P1|Follow-up Period (FUP)|Lost to Follow-up|1
5241726|NCT00810693|18088985|P3|Follow-up Period (FUP)|Death|1
5241727|NCT00810693|18088986|P2|Follow-up Period (FUP)|Death|0
5241728|NCT00810693|18088987|P1|Follow-up Period (FUP)|Death|2
5241729|NCT00810693|18088985|P3|Follow-up Period (FUP)|Adverse Event|1
5241730|NCT00810693|18088986|P2|Follow-up Period (FUP)|Adverse Event|1
5241731|NCT00810693|18088987|P1|Follow-up Period (FUP)|Adverse Event|3
5241732|NCT00810693|18088985|P3|Treatment Period|Not treated|1
5241733|NCT00810693|18088986|P2|Treatment Period|Not treated|1
5241734|NCT00810693|18088987|P1|Treatment Period|Not treated|0
5241735|NCT00810693|18088985|P3|Treatment Period|Withdrawal by Subject|3
5241736|NCT00810693|18088986|P2|Treatment Period|Withdrawal by Subject|2
5241737|NCT00810693|18088987|P1|Treatment Period|Withdrawal by Subject|6
5241738|NCT00810693|18088985|P3|Treatment Period|Protocol Violation|2
5241739|NCT00810693|18088986|P2|Treatment Period|Protocol Violation|2
5241740|NCT00810693|18088987|P1|Treatment Period|Protocol Violation|1
5241741|NCT00810693|18088985|P3|Treatment Period|Non-compliance|0
5241742|NCT00810693|18088986|P2|Treatment Period|Non-compliance|0
5241743|NCT00810693|18088987|P1|Treatment Period|Non-compliance|1
5241744|NCT00810693|18088985|P3|Treatment Period|Lost to Follow-up|0
5241745|NCT00810693|18088986|P2|Treatment Period|Lost to Follow-up|0
5241746|NCT00810693|18088987|P1|Treatment Period|Lost to Follow-up|1
5241747|NCT00810693|18088985|P3|Treatment Period|Lack of Efficacy|1
5241748|NCT00810693|18088986|P2|Treatment Period|Lack of Efficacy|0
5241749|NCT00810693|18088987|P1|Treatment Period|Lack of Efficacy|0
5241750|NCT00810693|18088985|P3|Treatment Period|Death|2
5241751|NCT00810693|18088986|P2|Treatment Period|Death|1
5241752|NCT00810693|18088987|P1|Treatment Period|Death|0
5241753|NCT00810693|18088985|P3|Treatment Period|Adverse Event|7
5241754|NCT00810693|18088986|P2|Treatment Period|Adverse Event|1
5241755|NCT00810693|18088987|P1|Treatment Period|Adverse Event|8
5241756|NCT00810641|18089019|P3|Overall Study|Withdrawal by Subject|2
5241757|NCT00810641|18089020|P2|Overall Study|Withdrawal by Subject|1
5241758|NCT00810641|18089021|P1|Overall Study|Withdrawal by Subject|0
5241759|NCT00810615|18089031|P2|Overall Study|Withdrawal by Subject|1
5241760|NCT00810615|18089032|P1|Overall Study|Withdrawal by Subject|1
5241761|NCT00810602|18089082|P2|Overall Study|Withdrawal by Subject|3
5241762|NCT00810602|18089083|P1|Overall Study|Withdrawal by Subject|8
5241763|NCT00810511|18089096|P2|Overall Study|deposits on contact lens|1
5241764|NCT00810511|18089097|P1|Overall Study|deposits on contact lens|0
5241765|NCT00810511|18089096|P2|Overall Study|Lost to Follow-up|0
5241766|NCT00810511|18089097|P1|Overall Study|Lost to Follow-up|1
5241767|NCT00810511|18089096|P2|Overall Study|death in the family|1
5241768|NCT00810511|18089097|P1|Overall Study|death in the family|0
5241769|NCT00810511|18089096|P2|Overall Study|Lack of Efficacy|1
5241770|NCT00810511|18089097|P1|Overall Study|Lack of Efficacy|9
5241771|NCT00810511|18089096|P2|Overall Study|Protocol Violation|1
5241772|NCT00810511|18089097|P1|Overall Study|Protocol Violation|0
5241773|NCT00810407|18089115|P1|Overall Study|No Visit After First Day of Treatment|3
5241774|NCT00810407|18089115|P1|Overall Study|Protocol Violation|3
5241775|NCT00810394|18089127|P1|Overall Study|Withdrawal by Subject|3
5241776|NCT00810368|18089135|P2|Overall Study|Lack of Efficacy|0
5241777|NCT00810368|18089136|P1|Overall Study|Lack of Efficacy|2
5241778|NCT00810368|18089135|P2|Overall Study|Lost to Follow-up|2
5241779|NCT00810368|18089136|P1|Overall Study|Lost to Follow-up|4
5241780|NCT00810355|18089157|P3|Overall Study|Withdrawal by Subject|0
5241781|NCT00810355|18089158|P2|Overall Study|Withdrawal by Subject|0
5241782|NCT00810355|18089159|P1|Overall Study|Withdrawal by Subject|1
5241783|NCT00810355|18089157|P3|Overall Study|Lost to Follow-up|11
5241784|NCT00810355|18089158|P2|Overall Study|Lost to Follow-up|17
5241785|NCT00810355|18089159|P1|Overall Study|Lost to Follow-up|13
5241786|NCT00810342|18089175|P2|12-month Followup|Lost to Follow-up|1
5241787|NCT00810342|18089176|P1|12-month Followup|Lost to Follow-up|3
5241788|NCT00810342|18089175|P2|12-month Followup|Pregnancy|10
5241789|NCT00810342|18089176|P1|12-month Followup|Pregnancy|9
5241790|NCT00810342|18089175|P2|6-month Follow-up|Pregnancy|2
5241791|NCT00810342|18089176|P1|6-month Follow-up|Pregnancy|6
5241792|NCT00810342|18089175|P2|6-month Follow-up|Lost to Follow-up|6
5241793|NCT00810342|18089176|P1|6-month Follow-up|Lost to Follow-up|18
5241794|NCT00810342|18089175|P2|Month 1 Follow-up|Pregnancy|0
5241795|NCT00810342|18089176|P1|Month 1 Follow-up|Pregnancy|1
5241796|NCT00810342|18089175|P2|Month 1 Follow-up|Lost to Follow-up|2
5241797|NCT00810342|18089176|P1|Month 1 Follow-up|Lost to Follow-up|4
5241798|NCT00810277|18089209|P1|Overall Study|Adverse Event|1
5241799|NCT00810264|18089222|P1|Overall Study|Death|641
5241800|NCT00810264|18089222|P1|Overall Study|Withdrawal by subject or physician|721
5241801|NCT00810264|18089222|P1|Overall Study|Lost to Follow-up|191
5241802|NCT00810199|18089249|P2|Overall Study|Did not receive study drug|1
5241803|NCT00810199|18089250|P1|Overall Study|Did not receive study drug|2
5241804|NCT00810199|18089249|P2|Overall Study|Failure to return|4
5241805|NCT00810199|18089250|P1|Overall Study|Failure to return|1
5241806|NCT00810199|18089249|P2|Overall Study|Protocol Violation|6
5241807|NCT00810199|18089250|P1|Overall Study|Protocol Violation|2
5241808|NCT00810199|18089249|P2|Overall Study|Administrative/Other|6
5241809|NCT00810199|18089250|P1|Overall Study|Administrative/Other|5
5241810|NCT00810199|18089249|P2|Overall Study|Refused treatment/Did not cooperate|7
5241811|NCT00810199|18089250|P1|Overall Study|Refused treatment/Did not cooperate|7
5241812|NCT00810199|18089249|P2|Overall Study|Insufficient therapeutic response|14
5241813|NCT00810199|18089250|P1|Overall Study|Insufficient therapeutic response|5
5241814|NCT00810199|18089249|P2|Overall Study|Withdrew consent|12
5241815|NCT00810199|18089250|P1|Overall Study|Withdrew consent|9
5241816|NCT00810199|18089249|P2|Overall Study|Death|6
5241817|NCT00810199|18089250|P1|Overall Study|Death|4
5241818|NCT00810199|18089249|P2|Overall Study|Adverse Event|26
5241819|NCT00810199|18089250|P1|Overall Study|Adverse Event|24
5241820|NCT00810108|18089328|P2|Overall Study|Withdrawal by Subject|0
5241821|NCT00810108|18089329|P1|Overall Study|Withdrawal by Subject|1
5241822|NCT00810082|18089343|P2|Overall Study|Lost to Follow-up|4
5241823|NCT00810082|18089344|P1|Overall Study|Lost to Follow-up|0
5241824|NCT00810069|18089352|P3|Double-Blind Period II|Protocol Violation|6
5241825|NCT00810069|18089353|P2|Double-Blind Period II|Protocol Violation|7
5241826|NCT00810069|18089354|P1|Double-Blind Period II|Protocol Violation|0
5241827|NCT00810069|18089352|P3|Double-Blind Period II|Clinical relapse|0
5241828|NCT00810069|18089353|P2|Double-Blind Period II|Clinical relapse|3
5241829|NCT00810069|18089354|P1|Double-Blind Period II|Clinical relapse|0
5241830|NCT00810069|18089352|P3|Double-Blind Period II|Protocol entry criterion not met|1
5241831|NCT00810069|18089353|P2|Double-Blind Period II|Protocol entry criterion not met|0
5241832|NCT00810069|18089354|P1|Double-Blind Period II|Protocol entry criterion not met|0
5241833|NCT00810069|18089352|P3|Double-Blind Period II|Withdrawal by Subject|35
5241834|NCT00810069|18089353|P2|Double-Blind Period II|Withdrawal by Subject|21
5241835|NCT00810069|18089354|P1|Double-Blind Period II|Withdrawal by Subject|0
5241836|NCT00810069|18089352|P3|Double-Blind Period II|Physician Decision|1
5241837|NCT00810069|18089353|P2|Double-Blind Period II|Physician Decision|0
5241838|NCT00810069|18089354|P1|Double-Blind Period II|Physician Decision|0
5241839|NCT00810069|18089352|P3|Double-Blind Period II|Lost to Follow-up|9
5241840|NCT00810069|18089353|P2|Double-Blind Period II|Lost to Follow-up|9
5241841|NCT00810069|18089354|P1|Double-Blind Period II|Lost to Follow-up|0
5241842|NCT00810069|18089352|P3|Double-Blind Period II|Lack of Efficacy|12
5241843|NCT00810069|18089353|P2|Double-Blind Period II|Lack of Efficacy|7
5241844|NCT00810069|18089354|P1|Double-Blind Period II|Lack of Efficacy|0
5241845|NCT00810069|18089352|P3|Double-Blind Period II|Adverse Event|8
5241846|NCT00810069|18089353|P2|Double-Blind Period II|Adverse Event|9
5241847|NCT00810069|18089354|P1|Double-Blind Period II|Adverse Event|0
5241848|NCT00810069|18089352|P3|Lead-in Period I|Randomization criteria not met|0
5241849|NCT00810069|18089353|P2|Lead-in Period I|Randomization criteria not met|0
5241850|NCT00810069|18089354|P1|Lead-in Period I|Randomization criteria not met|158
5241851|NCT00810069|18089352|P3|Lead-in Period I|Protocol entry criterion not met|0
5241852|NCT00810069|18089353|P2|Lead-in Period I|Protocol entry criterion not met|0
5241853|NCT00810069|18089354|P1|Lead-in Period I|Protocol entry criterion not met|5
5241854|NCT00810069|18089352|P3|Lead-in Period I|Withdrawal by Subject|0
5241855|NCT00810069|18089353|P2|Lead-in Period I|Withdrawal by Subject|0
5241856|NCT00810069|18089354|P1|Lead-in Period I|Withdrawal by Subject|46
5241857|NCT00810069|18089352|P3|Lead-in Period I|Protocol Violation|0
5241858|NCT00810069|18089353|P2|Lead-in Period I|Protocol Violation|0
5241859|NCT00810069|18089354|P1|Lead-in Period I|Protocol Violation|1
5241860|NCT00810069|18089352|P3|Lead-in Period I|Physician Decision|0
5241861|NCT00810069|18089353|P2|Lead-in Period I|Physician Decision|0
5241862|NCT00810069|18089354|P1|Lead-in Period I|Physician Decision|1
5241863|NCT00810069|18089352|P3|Lead-in Period I|Lost to Follow-up|0
5241864|NCT00810069|18089353|P2|Lead-in Period I|Lost to Follow-up|0
5241865|NCT00810069|18089354|P1|Lead-in Period I|Lost to Follow-up|19
5241866|NCT00810069|18089352|P3|Lead-in Period I|Lack of Efficacy|0
5241867|NCT00810069|18089353|P2|Lead-in Period I|Lack of Efficacy|0
5241868|NCT00810069|18089354|P1|Lead-in Period I|Lack of Efficacy|1
5241869|NCT00810069|18089352|P3|Lead-in Period I|Adverse Event|0
5241870|NCT00810069|18089353|P2|Lead-in Period I|Adverse Event|0
5241871|NCT00810069|18089354|P1|Lead-in Period I|Adverse Event|43
5241872|NCT00810043|18089399|P3|Overall Study|No longer met enrollment criteria|3
5241873|NCT00810043|18089400|P2|Overall Study|No longer met enrollment criteria|0
5241874|NCT00810043|18089401|P1|Overall Study|No longer met enrollment criteria|0
5241875|NCT00810043|18089399|P3|Overall Study|Non-medical problem|1
5241876|NCT00810043|18089400|P2|Overall Study|Non-medical problem|0
5241877|NCT00810043|18089401|P1|Overall Study|Non-medical problem|0
5241878|NCT00810043|18089399|P3|Overall Study|Unrelated medical problem|0
5241879|NCT00810043|18089400|P2|Overall Study|Unrelated medical problem|1
5241880|NCT00810043|18089401|P1|Overall Study|Unrelated medical problem|0
5241881|NCT00810043|18089399|P3|Overall Study|Death|0
5241882|NCT00810043|18089400|P2|Overall Study|Death|0
5241883|NCT00810043|18089401|P1|Overall Study|Death|2
5241884|NCT00810043|18089399|P3|Overall Study|Physician Decision|2
5241885|NCT00810043|18089400|P2|Overall Study|Physician Decision|0
5241886|NCT00810043|18089401|P1|Overall Study|Physician Decision|0
5241887|NCT00810043|18089399|P3|Overall Study|Lost to Follow-up|0
5241888|NCT00810043|18089400|P2|Overall Study|Lost to Follow-up|0
5241889|NCT00810043|18089401|P1|Overall Study|Lost to Follow-up|1
5241890|NCT00810043|18089399|P3|Overall Study|Withdrawal by Subject|2
5241891|NCT00810043|18089400|P2|Overall Study|Withdrawal by Subject|0
5241892|NCT00810043|18089401|P1|Overall Study|Withdrawal by Subject|1
5241893|NCT00809965|18089423|P3|Overall Study|Other Reason|189
5241894|NCT00809965|18089424|P2|Overall Study|Other Reason|170
5241895|NCT00809965|18089425|P1|Overall Study|Other Reason|167
5241896|NCT00809965|18089423|P3|Overall Study|Withdrawal by Subject|441
5241897|NCT00809965|18089424|P2|Overall Study|Withdrawal by Subject|448
5241898|NCT00809965|18089425|P1|Overall Study|Withdrawal by Subject|405
5241899|NCT00809965|18089423|P3|Overall Study|Lost to Follow-up|18
5241900|NCT00809965|18089424|P2|Overall Study|Lost to Follow-up|10
5241901|NCT00809965|18089425|P1|Overall Study|Lost to Follow-up|17
5241902|NCT00809965|18089423|P3|Overall Study|Death|196
5241903|NCT00809965|18089424|P2|Overall Study|Death|147
5241904|NCT00809965|18089425|P1|Overall Study|Death|194
5241905|NCT00809926|18089447|P2|Overall Study|Protocol deviation|2
5241906|NCT00809926|18089448|P1|Overall Study|Protocol deviation|0
5241907|NCT00809926|18089447|P2|Overall Study|Administrative Problems|1
5241908|NCT00809926|18089448|P1|Overall Study|Administrative Problems|0
5241909|NCT00809926|18089447|P2|Overall Study|Lost to Follow-up|1
5241910|NCT00809926|18089448|P1|Overall Study|Lost to Follow-up|2
5241911|NCT00809926|18089447|P2|Overall Study|Patient withdrew consent|6
5241912|NCT00809926|18089448|P1|Overall Study|Patient withdrew consent|8
5241913|NCT00809926|18089447|P2|Overall Study|Unsatisfactory therapeutic effect|3
5241914|NCT00809926|18089448|P1|Overall Study|Unsatisfactory therapeutic effect|3
5241915|NCT00809926|18089447|P2|Overall Study|Adverse Event|10
5241916|NCT00809926|18089448|P1|Overall Study|Adverse Event|18
5241917|NCT00809835|18089502|P4|Overall Study|Withdrawal by Subject|0
5241918|NCT00809835|18089503|P3|Overall Study|Withdrawal by Subject|1
5241919|NCT00809835|18089504|P2|Overall Study|Withdrawal by Subject|1
5241920|NCT00809835|18089505|P1|Overall Study|Withdrawal by Subject|1
5241921|NCT00809835|18089502|P4|Overall Study|Lost to Follow-up|2
5241922|NCT00809835|18089503|P3|Overall Study|Lost to Follow-up|10
5241923|NCT00809835|18089504|P2|Overall Study|Lost to Follow-up|6
5241924|NCT00809835|18089505|P1|Overall Study|Lost to Follow-up|7
5241925|NCT00809757|18089535|P3|Overall Study|Noncompliance with Medication|1
5241926|NCT00809757|18089536|P2|Overall Study|Noncompliance with Medication|0
5241927|NCT00809757|18089537|P1|Overall Study|Noncompliance with Medication|0
5241928|NCT00809757|18089535|P3|Overall Study|Subject Uncooperative|2
5241929|NCT00809757|18089536|P2|Overall Study|Subject Uncooperative|0
5241930|NCT00809757|18089537|P1|Overall Study|Subject Uncooperative|1
5241931|NCT00809757|18089535|P3|Overall Study|Withdrawal by Subject|3
5241932|NCT00809757|18089536|P2|Overall Study|Withdrawal by Subject|1
5241933|NCT00809757|18089537|P1|Overall Study|Withdrawal by Subject|2
5241934|NCT00809757|18089535|P3|Overall Study|Protocol Violation|1
5241935|NCT00809757|18089536|P2|Overall Study|Protocol Violation|1
5241936|NCT00809757|18089537|P1|Overall Study|Protocol Violation|1
5241937|NCT00809757|18089535|P3|Overall Study|Lost to Follow-up|1
5241938|NCT00809757|18089536|P2|Overall Study|Lost to Follow-up|0
5241939|NCT00809757|18089537|P1|Overall Study|Lost to Follow-up|0
5241940|NCT00809757|18089535|P3|Overall Study|Adverse Event|3
5241941|NCT00809757|18089536|P2|Overall Study|Adverse Event|3
5241942|NCT00809757|18089537|P1|Overall Study|Adverse Event|2
5241943|NCT00809614|18089622|P2|Overall Study|Withdrawal by Subject|1
5241944|NCT00809614|18089623|P1|Overall Study|Withdrawal by Subject|1
5241945|NCT00809614|18089622|P2|Overall Study|Lack of Efficacy|3
5241946|NCT00809614|18089623|P1|Overall Study|Lack of Efficacy|2
5241947|NCT00809471|18089667|P3|Overall Study|Requirement for restricted medication|0
5241948|NCT00809471|18089668|P2|Overall Study|Requirement for restricted medication|1
5241949|NCT00809471|18089669|P1|Overall Study|Requirement for restricted medication|1
5241950|NCT00809471|18089667|P3|Overall Study|Adverse Event|2
5241951|NCT00809471|18089668|P2|Overall Study|Adverse Event|2
5241952|NCT00809471|18089669|P1|Overall Study|Adverse Event|0
5241953|NCT00809471|18089667|P3|Overall Study|Lost to Follow-up|9
5241954|NCT00809471|18089668|P2|Overall Study|Lost to Follow-up|2
5241955|NCT00809471|18089669|P1|Overall Study|Lost to Follow-up|4
5241956|NCT00809471|18089667|P3|Overall Study|Protocol non-compliance|6
5241957|NCT00809471|18089668|P2|Overall Study|Protocol non-compliance|15
5241958|NCT00809471|18089669|P1|Overall Study|Protocol non-compliance|15
5241959|NCT00809445|18089699|P3|6 Month Follow-up|Withdrew consent|1
5241960|NCT00809445|18089700|P2|6 Month Follow-up|Withdrew consent|0
5241961|NCT00809445|18089701|P1|6 Month Follow-up|Withdrew consent|0
5241962|NCT00809445|18089699|P3|6 Month Follow-up|Incarcerated|8
5241963|NCT00809445|18089700|P2|6 Month Follow-up|Incarcerated|8
5241964|NCT00809445|18089701|P1|6 Month Follow-up|Incarcerated|6
5241965|NCT00809445|18089699|P3|6 Month Follow-up|Death|1
5241966|NCT00809445|18089700|P2|6 Month Follow-up|Death|1
5241967|NCT00809445|18089701|P1|6 Month Follow-up|Death|2
5241968|NCT00809445|18089699|P3|6 Month Follow-up|Lost contact|14
5241969|NCT00809445|18089700|P2|6 Month Follow-up|Lost contact|14
5241970|NCT00809445|18089701|P1|6 Month Follow-up|Lost contact|16
5241971|NCT00809445|18089699|P3|1 Month Follow-up|Incarcerated|1
5241972|NCT00809445|18089700|P2|1 Month Follow-up|Incarcerated|0
5241973|NCT00809445|18089701|P1|1 Month Follow-up|Incarcerated|0
5241974|NCT00809445|18089699|P3|1 Month Follow-up|Death|1
5241975|NCT00809445|18089700|P2|1 Month Follow-up|Death|1
5241976|NCT00809445|18089701|P1|1 Month Follow-up|Death|0
5241977|NCT00809445|18089699|P3|1 Month Follow-up|Withdrew consent|1
5241978|NCT00809445|18089700|P2|1 Month Follow-up|Withdrew consent|1
5241979|NCT00809445|18089701|P1|1 Month Follow-up|Withdrew consent|1
5241980|NCT00809445|18089699|P3|1 Month Follow-up|Lost contact|1
5241981|NCT00809445|18089700|P2|1 Month Follow-up|Lost contact|2
5241982|NCT00809445|18089701|P1|1 Month Follow-up|Lost contact|1
5241983|NCT00809341|18089720|P2|Overall Study|Physician Decision|1
5241984|NCT00809341|18089721|P1|Overall Study|Physician Decision|0
5241985|NCT00809328|18089729|P1|Overall Study|Withdrawal by Subject|2
5241986|NCT00809328|18089729|P1|Overall Study|Protocol Violation|3
5241987|NCT00809328|18089729|P1|Overall Study|Adverse Event|6
5241988|NCT00809328|18089729|P1|Overall Study|Lack of Efficacy|18
5241989|NCT00809159|18089751|P6|Part 1 and 2|Withdrawal by Subject|1
5241990|NCT00809159|18089752|P5|Part 1 and 2|Withdrawal by Subject|0
5241991|NCT00809159|18089753|P4|Part 1 and 2|Withdrawal by Subject|0
5241992|NCT00809159|18089754|P3|Part 1 and 2|Withdrawal by Subject|4
5241993|NCT00809159|18089755|P2|Part 1 and 2|Withdrawal by Subject|0
5241994|NCT00809159|18089756|P1|Part 1 and 2|Withdrawal by Subject|0
5241995|NCT00809159|18089751|P6|Part 1 and 2|Lost to Follow-up|0
5241996|NCT00809159|18089752|P5|Part 1 and 2|Lost to Follow-up|0
5241997|NCT00809159|18089753|P4|Part 1 and 2|Lost to Follow-up|1
5241998|NCT00809159|18089754|P3|Part 1 and 2|Lost to Follow-up|1
5241999|NCT00809159|18089755|P2|Part 1 and 2|Lost to Follow-up|0
5242000|NCT00809159|18089756|P1|Part 1 and 2|Lost to Follow-up|0
5242001|NCT00809159|18089751|P6|Part 1 and 2|Adverse Event|1
5242002|NCT00809159|18089752|P5|Part 1 and 2|Adverse Event|1
5242003|NCT00809159|18089753|P4|Part 1 and 2|Adverse Event|0
5242004|NCT00809159|18089754|P3|Part 1 and 2|Adverse Event|1
5242005|NCT00809159|18089755|P2|Part 1 and 2|Adverse Event|0
5242006|NCT00809159|18089756|P1|Part 1 and 2|Adverse Event|0
5242007|NCT00809159|18089751|P6|Part 1 and 2|Administrative problems|0
5242008|NCT00809159|18089752|P5|Part 1 and 2|Administrative problems|0
5242009|NCT00809159|18089753|P4|Part 1 and 2|Administrative problems|1
5242010|NCT00809159|18089754|P3|Part 1 and 2|Administrative problems|0
5242011|NCT00809159|18089755|P2|Part 1 and 2|Administrative problems|0
5242012|NCT00809159|18089756|P1|Part 1 and 2|Administrative problems|0
5242013|NCT00809159|18089751|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
5242014|NCT00809159|18089752|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
5242015|NCT00809159|18089753|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
5242016|NCT00809159|18089754|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
5242017|NCT00809159|18089755|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
5242018|NCT00809159|18089756|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
5242019|NCT00809159|18089751|P6|Part 1|Unsatisfactory therapeutic effect|0
5242020|NCT00809159|18089752|P5|Part 1|Unsatisfactory therapeutic effect|0
5242021|NCT00809159|18089753|P4|Part 1|Unsatisfactory therapeutic effect|0
5242022|NCT00809159|18089754|P3|Part 1|Unsatisfactory therapeutic effect|0
5242023|NCT00809159|18089755|P2|Part 1|Unsatisfactory therapeutic effect|1
5242024|NCT00809159|18089756|P1|Part 1|Unsatisfactory therapeutic effect|3
5242025|NCT00809159|18089751|P6|Part 1|Withdrawal by Subject|0
5242026|NCT00809159|18089752|P5|Part 1|Withdrawal by Subject|0
5242027|NCT00809159|18089753|P4|Part 1|Withdrawal by Subject|0
5242028|NCT00809159|18089754|P3|Part 1|Withdrawal by Subject|0
5242029|NCT00809159|18089755|P2|Part 1|Withdrawal by Subject|1
5242030|NCT00809159|18089756|P1|Part 1|Withdrawal by Subject|3
5242031|NCT00809159|18089751|P6|Part 1|Lost to Follow-up|0
5242032|NCT00809159|18089752|P5|Part 1|Lost to Follow-up|0
5242033|NCT00809159|18089753|P4|Part 1|Lost to Follow-up|0
5242034|NCT00809159|18089754|P3|Part 1|Lost to Follow-up|0
5242035|NCT00809159|18089755|P2|Part 1|Lost to Follow-up|0
5242036|NCT00809159|18089756|P1|Part 1|Lost to Follow-up|1
5242037|NCT00809159|18089751|P6|Part 1|Adverse Event|0
5242038|NCT00809159|18089752|P5|Part 1|Adverse Event|0
5242039|NCT00809159|18089753|P4|Part 1|Adverse Event|0
5242040|NCT00809159|18089754|P3|Part 1|Adverse Event|0
5242041|NCT00809159|18089755|P2|Part 1|Adverse Event|1
5242042|NCT00809159|18089756|P1|Part 1|Adverse Event|1
5242043|NCT00809133|18089861|P14|Overall Study|Other not mentioned above|0
5242044|NCT00809133|18089862|P13|Overall Study|Other not mentioned above|0
5242045|NCT00809133|18089863|P12|Overall Study|Other not mentioned above|0
5242046|NCT00809133|18089864|P11|Overall Study|Other not mentioned above|0
5242047|NCT00809133|18089865|P10|Overall Study|Other not mentioned above|0
5242048|NCT00809133|18089866|P9|Overall Study|Other not mentioned above|0
5242049|NCT00809133|18089867|P8|Overall Study|Other not mentioned above|0
5242050|NCT00809133|18089868|P7|Overall Study|Other not mentioned above|0
5242051|NCT00809133|18089869|P6|Overall Study|Other not mentioned above|1
5242052|NCT00809133|18089870|P5|Overall Study|Other not mentioned above|0
5242053|NCT00809133|18089871|P4|Overall Study|Other not mentioned above|0
5242054|NCT00809133|18089872|P3|Overall Study|Other not mentioned above|0
5242055|NCT00809133|18089873|P2|Overall Study|Other not mentioned above|1
5242056|NCT00809133|18089874|P1|Overall Study|Other not mentioned above|0
5242057|NCT00809133|18089861|P14|Overall Study|Consent withdrawn|0
5242058|NCT00809133|18089862|P13|Overall Study|Consent withdrawn|0
5242059|NCT00809133|18089863|P12|Overall Study|Consent withdrawn|0
5242060|NCT00809133|18089864|P11|Overall Study|Consent withdrawn|0
5242061|NCT00809133|18089865|P10|Overall Study|Consent withdrawn|0
5242062|NCT00809133|18089866|P9|Overall Study|Consent withdrawn|0
5242063|NCT00809133|18089867|P8|Overall Study|Consent withdrawn|0
5242064|NCT00809133|18089868|P7|Overall Study|Consent withdrawn|0
5242065|NCT00809133|18089869|P6|Overall Study|Consent withdrawn|0
5242066|NCT00809133|18089870|P5|Overall Study|Consent withdrawn|1
5242067|NCT00809133|18089871|P4|Overall Study|Consent withdrawn|0
5242068|NCT00809133|18089872|P3|Overall Study|Consent withdrawn|0
5242069|NCT00809133|18089873|P2|Overall Study|Consent withdrawn|0
5242070|NCT00809133|18089874|P1|Overall Study|Consent withdrawn|0
5242071|NCT00809133|18089861|P14|Overall Study|Lost to Follow-up|0
5242072|NCT00809133|18089862|P13|Overall Study|Lost to Follow-up|0
5242073|NCT00809133|18089863|P12|Overall Study|Lost to Follow-up|0
5242074|NCT00809133|18089864|P11|Overall Study|Lost to Follow-up|0
5242075|NCT00809133|18089865|P10|Overall Study|Lost to Follow-up|0
5242076|NCT00809133|18089866|P9|Overall Study|Lost to Follow-up|0
5242077|NCT00809133|18089867|P8|Overall Study|Lost to Follow-up|0
5242078|NCT00809133|18089868|P7|Overall Study|Lost to Follow-up|0
5242079|NCT00809133|18089869|P6|Overall Study|Lost to Follow-up|1
5242080|NCT00809133|18089870|P5|Overall Study|Lost to Follow-up|0
5242081|NCT00809133|18089871|P4|Overall Study|Lost to Follow-up|0
5242082|NCT00809133|18089872|P3|Overall Study|Lost to Follow-up|0
5242083|NCT00809133|18089873|P2|Overall Study|Lost to Follow-up|0
5242084|NCT00809133|18089874|P1|Overall Study|Lost to Follow-up|0
5242085|NCT00809133|18089861|P14|Overall Study|Other adverse event|1
5242086|NCT00809133|18089862|P13|Overall Study|Other adverse event|0
5242087|NCT00809133|18089863|P12|Overall Study|Other adverse event|1
5242088|NCT00809133|18089864|P11|Overall Study|Other adverse event|1
5242089|NCT00809133|18089865|P10|Overall Study|Other adverse event|0
5242090|NCT00809133|18089866|P9|Overall Study|Other adverse event|0
5242091|NCT00809133|18089867|P8|Overall Study|Other adverse event|4
5242092|NCT00809133|18089868|P7|Overall Study|Other adverse event|2
5242093|NCT00809133|18089869|P6|Overall Study|Other adverse event|3
5242094|NCT00809133|18089870|P5|Overall Study|Other adverse event|0
5242095|NCT00809133|18089871|P4|Overall Study|Other adverse event|0
5242096|NCT00809133|18089872|P3|Overall Study|Other adverse event|1
5242097|NCT00809133|18089873|P2|Overall Study|Other adverse event|1
5242098|NCT00809133|18089874|P1|Overall Study|Other adverse event|1
5242099|NCT00809133|18089861|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
5242100|NCT00809133|18089862|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
5242101|NCT00809133|18089863|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
5242102|NCT00809133|18089864|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
5242103|NCT00809133|18089865|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
5242104|NCT00809133|18089866|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
5242105|NCT00809133|18089867|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
5242106|NCT00809133|18089868|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
5242107|NCT00809133|18089869|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
5242108|NCT00809133|18089870|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
5242109|NCT00809133|18089871|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5242110|NCT00809133|18089872|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
5242111|NCT00809133|18089873|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5242112|NCT00809133|18089874|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
5242113|NCT00809133|18089861|P14|Overall Study|Progressive disease|4
5242114|NCT00809133|18089862|P13|Overall Study|Progressive disease|5
5242115|NCT00809133|18089863|P12|Overall Study|Progressive disease|7
5242116|NCT00809133|18089864|P11|Overall Study|Progressive disease|5
5242117|NCT00809133|18089865|P10|Overall Study|Progressive disease|9
5242118|NCT00809133|18089866|P9|Overall Study|Progressive disease|3
5242119|NCT00809133|18089867|P8|Overall Study|Progressive disease|3
5242120|NCT00809133|18089868|P7|Overall Study|Progressive disease|3
5242121|NCT00809133|18089869|P6|Overall Study|Progressive disease|1
5242122|NCT00809133|18089870|P5|Overall Study|Progressive disease|4
5242123|NCT00809133|18089871|P4|Overall Study|Progressive disease|3
5242124|NCT00809133|18089872|P3|Overall Study|Progressive disease|5
5242125|NCT00809133|18089873|P2|Overall Study|Progressive disease|5
5242126|NCT00809133|18089874|P1|Overall Study|Progressive disease|2
5242127|NCT00809094|18090028|P2|Overall Study|Lost to Follow-up|1
5242128|NCT00809094|18090029|P1|Overall Study|Lost to Follow-up|0
5242129|NCT00808899|18090074|P1|Overall Study|Physician Decision|3
5242130|NCT00808899|18090074|P1|Overall Study|Death|1
5242131|NCT00808808|18090088|P3|Overall Study|Employee was not vaccinated.|2255
5242132|NCT00808808|18090089|P2|Overall Study|Employee was not vaccinated.|2268
5242133|NCT00808808|18090090|P1|Overall Study|Employee was not vaccinated.|2686
5242134|NCT00808808|18090088|P3|Overall Study|Vaccinated; survey not completed|302
5242135|NCT00808808|18090089|P2|Overall Study|Vaccinated; survey not completed|169
5242136|NCT00808808|18090090|P1|Overall Study|Vaccinated; survey not completed|131
5242137|NCT00808665|18090125|P2|Overall Study|Medication stopped by resident|1
5242138|NCT00808665|18090126|P1|Overall Study|Medication stopped by resident|0
5242139|NCT00808665|18090125|P2|Overall Study|Physician Decision|1
5242140|NCT00808665|18090126|P1|Overall Study|Physician Decision|3
5242141|NCT00808665|18090125|P2|Overall Study|required an additional procedure|1
5242142|NCT00808665|18090126|P1|Overall Study|required an additional procedure|0
5242143|NCT00808665|18090125|P2|Overall Study|surgery cancelled|0
5242144|NCT00808665|18090126|P1|Overall Study|surgery cancelled|1
5242145|NCT00808665|18090125|P2|Overall Study|only required minimally invasive surgery|0
5242146|NCT00808665|18090126|P1|Overall Study|only required minimally invasive surgery|1
5242147|NCT00808665|18090125|P2|Overall Study|Withdrawal by Subject|0
5242148|NCT00808665|18090126|P1|Overall Study|Withdrawal by Subject|1
5242149|NCT00808639|18090132|P1|Overall Study|Disease progression before surgery.|1
5242150|NCT00808509|18090140|P2|Randomized Phase|Patient refused rescue therapy|3
5242151|NCT00808509|18090141|P1|Randomized Phase|Patient refused rescue therapy|0
5242152|NCT00808509|18090140|P2|Randomized Phase|Reduced methotrexate dose|2
5242153|NCT00808509|18090141|P1|Randomized Phase|Reduced methotrexate dose|1
5242154|NCT00808509|18090140|P2|Randomized Phase|Did not meet eligibility criteria|0
5242155|NCT00808509|18090141|P1|Randomized Phase|Did not meet eligibility criteria|1
5242156|NCT00808483|18090239|P2|From 5 Months to 12 Months|Lack of Efficacy|0
5242157|NCT00808483|18090240|P1|From 5 Months to 12 Months|Lack of Efficacy|1
5242158|NCT00808483|18090239|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
5242159|NCT00808483|18090240|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
5242160|NCT00808483|18090239|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
5242161|NCT00808483|18090240|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
5242162|NCT00808444|18090277|P2|Overall Study|Lost to Follow-up|1
5242163|NCT00808444|18090278|P1|Overall Study|Lost to Follow-up|0
5242164|NCT00808444|18090277|P2|Overall Study|Withdrawal by Subject|0
5242165|NCT00808444|18090278|P1|Overall Study|Withdrawal by Subject|1
5242166|NCT00808249|18090353|P4|Overall Study|All other reasons|1
5242167|NCT00808249|18090354|P3|Overall Study|All other reasons|3
5242168|NCT00808249|18090355|P2|Overall Study|All other reasons|1
5242169|NCT00808249|18090356|P1|Overall Study|All other reasons|2
5242170|NCT00808249|18090353|P4|Overall Study|study specific discontinuation criteria|0
5242171|NCT00808249|18090354|P3|Overall Study|study specific discontinuation criteria|1
5242172|NCT00808249|18090355|P2|Overall Study|study specific discontinuation criteria|0
5242173|NCT00808249|18090356|P1|Overall Study|study specific discontinuation criteria|1
5242174|NCT00808249|18090353|P4|Overall Study|Lack of Efficacy|0
5242175|NCT00808249|18090354|P3|Overall Study|Lack of Efficacy|0
5242176|NCT00808249|18090355|P2|Overall Study|Lack of Efficacy|1
5242177|NCT00808249|18090356|P1|Overall Study|Lack of Efficacy|1
5242178|NCT00808249|18090353|P4|Overall Study|Protocol Violation|0
5242179|NCT00808249|18090354|P3|Overall Study|Protocol Violation|3
5242180|NCT00808249|18090355|P2|Overall Study|Protocol Violation|3
5242181|NCT00808249|18090356|P1|Overall Study|Protocol Violation|3
5242182|NCT00808249|18090353|P4|Overall Study|Withdrawal by Subject|4
5242183|NCT00808249|18090354|P3|Overall Study|Withdrawal by Subject|2
5242184|NCT00808249|18090355|P2|Overall Study|Withdrawal by Subject|0
5242185|NCT00808249|18090356|P1|Overall Study|Withdrawal by Subject|4
5242186|NCT00808249|18090353|P4|Overall Study|Lost to Follow-up|5
5242187|NCT00808249|18090354|P3|Overall Study|Lost to Follow-up|3
5242188|NCT00808249|18090355|P2|Overall Study|Lost to Follow-up|3
5242189|NCT00808249|18090356|P1|Overall Study|Lost to Follow-up|2
5242190|NCT00808249|18090353|P4|Overall Study|Adverse Event|6
5242191|NCT00808249|18090354|P3|Overall Study|Adverse Event|10
5242192|NCT00808249|18090355|P2|Overall Study|Adverse Event|7
5242193|NCT00808249|18090356|P1|Overall Study|Adverse Event|4
5242194|NCT00808236|18090384|P2|Overall Study|Death|30
5242195|NCT00808236|18090385|P1|Overall Study|Death|18
5242196|NCT00808236|18090384|P2|Overall Study|Physician Decision|1
5242197|NCT00808236|18090385|P1|Overall Study|Physician Decision|0
5242198|NCT00808236|18090384|P2|Overall Study|Lost to Follow-up|1
5242199|NCT00808236|18090385|P1|Overall Study|Lost to Follow-up|1
5242200|NCT00808236|18090384|P2|Overall Study|Pre-defined exclusion|3
5242201|NCT00808236|18090385|P1|Overall Study|Pre-defined exclusion|13
5242202|NCT00808236|18090384|P2|Overall Study|Was not resuscitated|56
5242203|NCT00808236|18090385|P1|Overall Study|Was not resuscitated|50
5242204|NCT00808210|18090415|P2|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
5242205|NCT00808210|18090416|P1|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
5242206|NCT00808210|18090415|P2|Double-Blind TX Period|Other reasons outside Sponsor decision|1
5242207|NCT00808210|18090416|P1|Double-Blind TX Period|Other reasons outside Sponsor decision|1
5242208|NCT00808210|18090415|P2|Double-Blind TX Period|Sponsor decision to terminate study|1
5242209|NCT00808210|18090416|P1|Double-Blind TX Period|Sponsor decision to terminate study|1
5242210|NCT00808210|18090415|P2|Double-Blind TX Period|Adverse Event|1
5242211|NCT00808210|18090416|P1|Double-Blind TX Period|Adverse Event|0
5242212|NCT00808210|18090415|P2|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
5242213|NCT00808210|18090416|P1|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
5242214|NCT00808210|18090415|P2|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
5242215|NCT00808210|18090416|P1|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
5242216|NCT00808132|18090441|P5|Overall Study|Unsatisfactory response|12
5242217|NCT00808132|18090442|P4|Overall Study|Unsatisfactory response|4
5242218|NCT00808132|18090443|P3|Overall Study|Unsatisfactory response|6
5242219|NCT00808132|18090444|P2|Overall Study|Unsatisfactory response|6
5242220|NCT00808132|18090445|P1|Overall Study|Unsatisfactory response|5
5242221|NCT00808132|18090441|P5|Overall Study|Randomized, but not treated|9
5242222|NCT00808132|18090442|P4|Overall Study|Randomized, but not treated|8
5242223|NCT00808132|18090443|P3|Overall Study|Randomized, but not treated|9
5242224|NCT00808132|18090444|P2|Overall Study|Randomized, but not treated|7
5242225|NCT00808132|18090445|P1|Overall Study|Randomized, but not treated|10
5242226|NCT00808132|18090441|P5|Overall Study|Other|15
5242227|NCT00808132|18090442|P4|Overall Study|Other|2
5242228|NCT00808132|18090443|P3|Overall Study|Other|6
5242229|NCT00808132|18090444|P2|Overall Study|Other|4
5242230|NCT00808132|18090445|P1|Overall Study|Other|6
5242231|NCT00808132|18090441|P5|Overall Study|Withdrawal by Subject|16
5242232|NCT00808132|18090442|P4|Overall Study|Withdrawal by Subject|7
5242233|NCT00808132|18090443|P3|Overall Study|Withdrawal by Subject|2
5242234|NCT00808132|18090444|P2|Overall Study|Withdrawal by Subject|18
5242235|NCT00808132|18090445|P1|Overall Study|Withdrawal by Subject|27
5242236|NCT00808132|18090441|P5|Overall Study|Protocol Violation|5
5242237|NCT00808132|18090442|P4|Overall Study|Protocol Violation|9
5242238|NCT00808132|18090443|P3|Overall Study|Protocol Violation|4
5242239|NCT00808132|18090444|P2|Overall Study|Protocol Violation|9
5242240|NCT00808132|18090445|P1|Overall Study|Protocol Violation|8
5242241|NCT00808132|18090441|P5|Overall Study|Lost to Follow-up|9
5242242|NCT00808132|18090442|P4|Overall Study|Lost to Follow-up|8
5242243|NCT00808132|18090443|P3|Overall Study|Lost to Follow-up|11
5242244|NCT00808132|18090444|P2|Overall Study|Lost to Follow-up|10
5242245|NCT00808132|18090445|P1|Overall Study|Lost to Follow-up|8
5242246|NCT00808132|18090441|P5|Overall Study|Physician Decision|0
5242247|NCT00808132|18090442|P4|Overall Study|Physician Decision|0
5242248|NCT00808132|18090443|P3|Overall Study|Physician Decision|0
5242249|NCT00808132|18090444|P2|Overall Study|Physician Decision|1
5242250|NCT00808132|18090445|P1|Overall Study|Physician Decision|0
5242251|NCT00808132|18090441|P5|Overall Study|Death|1
5242252|NCT00808132|18090442|P4|Overall Study|Death|0
5242253|NCT00808132|18090443|P3|Overall Study|Death|0
5242254|NCT00808132|18090444|P2|Overall Study|Death|0
5242255|NCT00808132|18090445|P1|Overall Study|Death|0
5242256|NCT00808132|18090441|P5|Overall Study|Adverse Event|33
5242257|NCT00808132|18090442|P4|Overall Study|Adverse Event|31
5242258|NCT00808132|18090443|P3|Overall Study|Adverse Event|16
5242259|NCT00808132|18090444|P2|Overall Study|Adverse Event|33
5242260|NCT00808132|18090445|P1|Overall Study|Adverse Event|34
5242261|NCT00808080|18090517|P1|Overall Study|Patients Became Ineligible for infusion|6
5242262|NCT00808067|18090524|P2|Overall Study|Excluded from analysis|19
5242263|NCT00808067|18090525|P1|Overall Study|Excluded from analysis|13
5242264|NCT00808067|18090524|P2|Overall Study|Other reason not defined above|5
5242265|NCT00808067|18090525|P1|Overall Study|Other reason not defined above|5
5242266|NCT00808067|18090524|P2|Overall Study|Site closed for cause|19
5242267|NCT00808067|18090525|P1|Overall Study|Site closed for cause|19
5242268|NCT00808067|18090524|P2|Overall Study|Patient elected|9
5242269|NCT00808067|18090525|P1|Overall Study|Patient elected|7
5242270|NCT00808067|18090524|P2|Overall Study|Protocol Violation|11
5242271|NCT00808067|18090525|P1|Overall Study|Protocol Violation|3
5242272|NCT00808067|18090524|P2|Overall Study|Physician Decision|38
5242273|NCT00808067|18090525|P1|Overall Study|Physician Decision|47
5242274|NCT00808067|18090524|P2|Overall Study|Site closed|3
5242275|NCT00808067|18090525|P1|Overall Study|Site closed|4
5242276|NCT00808067|18090524|P2|Overall Study|Withdrawal by Subject|25
5242277|NCT00808067|18090525|P1|Overall Study|Withdrawal by Subject|21
5242278|NCT00808067|18090524|P2|Overall Study|Procedure|7
5242279|NCT00808067|18090525|P1|Overall Study|Procedure|6
5242280|NCT00808067|18090524|P2|Overall Study|Death|1
5242281|NCT00808067|18090525|P1|Overall Study|Death|1
5242282|NCT00808067|18090524|P2|Overall Study|Missing|0
5242283|NCT00808067|18090525|P1|Overall Study|Missing|1
5242284|NCT00808067|18090524|P2|Overall Study|Patient refused to take study medication|76
5242285|NCT00808067|18090525|P1|Overall Study|Patient refused to take study medication|65
5242286|NCT00808067|18090524|P2|Overall Study|Elevated LFT results|3
5242287|NCT00808067|18090525|P1|Overall Study|Elevated LFT results|7
5242288|NCT00808067|18090524|P2|Overall Study|Reduced creatinine clearance|55
5242289|NCT00808067|18090525|P1|Overall Study|Reduced creatinine clearance|53
5242290|NCT00808067|18090524|P2|Overall Study|Hospitalization due to surgery|40
5242291|NCT00808067|18090525|P1|Overall Study|Hospitalization due to surgery|37
5242292|NCT00808067|18090524|P2|Overall Study|Hospitalization (not including surgery)|17
5242293|NCT00808067|18090525|P1|Overall Study|Hospitalization (not including surgery)|18
5242294|NCT00808067|18090524|P2|Overall Study|Adverse Event|121
5242295|NCT00808067|18090525|P1|Overall Study|Adverse Event|111
5242296|NCT00808067|18090524|P2|Overall Study|Outcome event - other|25
5242297|NCT00808067|18090525|P1|Overall Study|Outcome event - other|33
5242298|NCT00808067|18090524|P2|Overall Study|Major/minor bleed|44
5242299|NCT00808067|18090525|P1|Overall Study|Major/minor bleed|30
5242300|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
5242301|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
5242302|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
5242303|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
5242304|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Death|0
5242305|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Death|1
5242306|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Death|0
5242307|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Death|0
5242308|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
5242309|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
5242310|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
5242311|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
5242312|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Other|1
5242313|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Other|1
5242314|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Other|0
5242315|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Other|0
5242316|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
5242317|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
5242318|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
5242319|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
5242320|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
5242321|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
5242322|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
5242323|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
5242324|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
5242325|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
5242326|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
5242327|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
5242328|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
5242329|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
5242330|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
5242331|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
5242332|NCT00808028|18090561|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
5242333|NCT00808028|18090562|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
5242334|NCT00808028|18090563|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
5242335|NCT00808028|18090564|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
5242336|NCT00808028|18090561|P4|Stage 1 (6 Months)|Protocol Violation|1
5242337|NCT00808028|18090562|P3|Stage 1 (6 Months)|Protocol Violation|0
5242338|NCT00808028|18090563|P2|Stage 1 (6 Months)|Protocol Violation|0
5242339|NCT00808028|18090564|P1|Stage 1 (6 Months)|Protocol Violation|0
5242340|NCT00808028|18090561|P4|Stage 1 (6 Months)|Lost to Follow-up|0
5242341|NCT00808028|18090562|P3|Stage 1 (6 Months)|Lost to Follow-up|1
5242342|NCT00808028|18090563|P2|Stage 1 (6 Months)|Lost to Follow-up|0
5242343|NCT00808028|18090564|P1|Stage 1 (6 Months)|Lost to Follow-up|1
5242344|NCT00808028|18090561|P4|Stage 1 (6 Months)|Adverse Event|2
5242345|NCT00808028|18090562|P3|Stage 1 (6 Months)|Adverse Event|1
5242346|NCT00808028|18090563|P2|Stage 1 (6 Months)|Adverse Event|0
5242347|NCT00808028|18090564|P1|Stage 1 (6 Months)|Adverse Event|0
5242348|NCT00808028|18090561|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
5242349|NCT00808028|18090562|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
5242350|NCT00808028|18090563|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
5242351|NCT00808028|18090564|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
5242352|NCT00808028|18090561|P4|Stage 1 (6 Months)|Other|4
5242353|NCT00808028|18090562|P3|Stage 1 (6 Months)|Other|2
5242354|NCT00808028|18090563|P2|Stage 1 (6 Months)|Other|0
5242355|NCT00808028|18090564|P1|Stage 1 (6 Months)|Other|1
5242356|NCT00808028|18090561|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
5242357|NCT00808028|18090562|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
5242358|NCT00808028|18090563|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
5242359|NCT00808028|18090564|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
5242360|NCT00808015|18090600|P1|Overall Study|Enrolled but not treated|4
5242361|NCT00808015|18090600|P1|Overall Study|Other|25
5242362|NCT00808015|18090600|P1|Overall Study|Adverse Event|22
5242363|NCT00808015|18090600|P1|Overall Study|Participants not willing to participate|158
5242364|NCT00808015|18090600|P1|Overall Study|Lost to Follow-up|76
5242365|NCT00808015|18090600|P1|Overall Study|Lack of Efficacy|58
5242366|NCT00808015|18090600|P1|Overall Study|Death|1
5242367|NCT00807937|18090629|P4|Overall Study|All other reasons (not provided)|1
5242368|NCT00807937|18090630|P3|Overall Study|All other reasons (not provided)|0
5242369|NCT00807937|18090631|P2|Overall Study|All other reasons (not provided)|4
5242370|NCT00807937|18090632|P1|Overall Study|All other reasons (not provided)|2
5242371|NCT00807937|18090629|P4|Overall Study|Intake of prohibited medicine|0
5242372|NCT00807937|18090630|P3|Overall Study|Intake of prohibited medicine|2
5242373|NCT00807937|18090631|P2|Overall Study|Intake of prohibited medicine|0
5242374|NCT00807937|18090632|P1|Overall Study|Intake of prohibited medicine|0
5242375|NCT00807937|18090629|P4|Overall Study|Lack of Efficacy|2
5242376|NCT00807937|18090630|P3|Overall Study|Lack of Efficacy|1
5242377|NCT00807937|18090631|P2|Overall Study|Lack of Efficacy|0
5242378|NCT00807937|18090632|P1|Overall Study|Lack of Efficacy|0
5242379|NCT00807937|18090629|P4|Overall Study|Lost to Follow-up|1
5242380|NCT00807937|18090630|P3|Overall Study|Lost to Follow-up|2
5242381|NCT00807937|18090631|P2|Overall Study|Lost to Follow-up|0
5242382|NCT00807937|18090632|P1|Overall Study|Lost to Follow-up|4
5242383|NCT00807937|18090629|P4|Overall Study|Withdrawal by Subject|4
5242384|NCT00807937|18090630|P3|Overall Study|Withdrawal by Subject|1
5242385|NCT00807937|18090631|P2|Overall Study|Withdrawal by Subject|4
5242386|NCT00807937|18090632|P1|Overall Study|Withdrawal by Subject|5
5242387|NCT00807937|18090629|P4|Overall Study|Protocol Violation|3
5242388|NCT00807937|18090630|P3|Overall Study|Protocol Violation|3
5242389|NCT00807937|18090631|P2|Overall Study|Protocol Violation|5
5242390|NCT00807937|18090632|P1|Overall Study|Protocol Violation|4
5242391|NCT00807937|18090629|P4|Overall Study|Adverse Event|4
5242392|NCT00807937|18090630|P3|Overall Study|Adverse Event|5
5242393|NCT00807937|18090631|P2|Overall Study|Adverse Event|12
5242394|NCT00807937|18090632|P1|Overall Study|Adverse Event|12
5242395|NCT00807885|18090667|P9|Overall Study|Lost to Follow-up|0
5242396|NCT00807885|18090668|P8|Overall Study|Lost to Follow-up|0
5242397|NCT00807885|18090669|P7|Overall Study|Lost to Follow-up|0
5242398|NCT00807885|18090670|P6|Overall Study|Lost to Follow-up|1
5242399|NCT00807885|18090671|P5|Overall Study|Lost to Follow-up|0
5242400|NCT00807885|18090672|P4|Overall Study|Lost to Follow-up|0
5242401|NCT00807885|18090673|P3|Overall Study|Lost to Follow-up|0
5242402|NCT00807885|18090674|P2|Overall Study|Lost to Follow-up|0
5242403|NCT00807885|18090675|P1|Overall Study|Lost to Follow-up|0
5242404|NCT00807846|18090724|P2|Overall Study|Other|2
5242405|NCT00807846|18090725|P1|Overall Study|Other|1
5242406|NCT00807846|18090724|P2|Overall Study|Withdrawal by Subject|1
5242407|NCT00807846|18090725|P1|Overall Study|Withdrawal by Subject|2
5242408|NCT00807846|18090724|P2|Overall Study|Protocol Violation|1
5242409|NCT00807846|18090725|P1|Overall Study|Protocol Violation|2
5242410|NCT00807846|18090724|P2|Overall Study|Lack of Efficacy|0
5242411|NCT00807846|18090725|P1|Overall Study|Lack of Efficacy|2
5242412|NCT00807846|18090724|P2|Overall Study|Adverse Event|0
5242413|NCT00807846|18090725|P1|Overall Study|Adverse Event|5
5242414|NCT00807742|18090778|P2|Overall Study|Lost to Follow-up|51
5242415|NCT00807742|18090779|P1|Overall Study|Lost to Follow-up|35
5242416|NCT00807742|18090778|P2|Overall Study|Withdrawal by Subject|1
5242417|NCT00807742|18090779|P1|Overall Study|Withdrawal by Subject|2
5242418|NCT00807742|18090778|P2|Overall Study|Death|2
5242419|NCT00807742|18090779|P1|Overall Study|Death|9
5242420|NCT00807599|18090838|P3|Overall Study|Withdrawal by Subject|1
5242421|NCT00807599|18090839|P2|Overall Study|Withdrawal by Subject|0
5242422|NCT00807599|18090840|P1|Overall Study|Withdrawal by Subject|0
5242423|NCT00807599|18090838|P3|Overall Study|Inadequate response to induction|9
5242424|NCT00807599|18090839|P2|Overall Study|Inadequate response to induction|0
5242425|NCT00807599|18090840|P1|Overall Study|Inadequate response to induction|0
5242426|NCT00807599|18090838|P3|Overall Study|Adverse Event|5
5242427|NCT00807599|18090839|P2|Overall Study|Adverse Event|0
5242428|NCT00807599|18090840|P1|Overall Study|Adverse Event|0
5242429|NCT00807599|18090838|P3|Overall Study|Not treated on protocol study|2
5242430|NCT00807599|18090839|P2|Overall Study|Not treated on protocol study|0
5242431|NCT00807599|18090840|P1|Overall Study|Not treated on protocol study|0
5242432|NCT00807573|18090867|P1|Overall Study|Adverse Event|1
5242433|NCT00807573|18090867|P1|Overall Study|Withdrawal by Subject|1
5242434|NCT00807495|18090913|P5|Overall Study|Reason Not Specified|3
5242435|NCT00807495|18090914|P4|Overall Study|Reason Not Specified|0
5242436|NCT00807495|18090915|P3|Overall Study|Reason Not Specified|2
5242437|NCT00807495|18090916|P2|Overall Study|Reason Not Specified|3
5242438|NCT00807495|18090917|P1|Overall Study|Reason Not Specified|0
5242439|NCT00807495|18090913|P5|Overall Study|Withdrawal by Patient|0
5242440|NCT00807495|18090914|P4|Overall Study|Withdrawal by Patient|0
5242441|NCT00807495|18090915|P3|Overall Study|Withdrawal by Patient|1
5242442|NCT00807495|18090916|P2|Overall Study|Withdrawal by Patient|0
5242443|NCT00807495|18090917|P1|Overall Study|Withdrawal by Patient|2
5242444|NCT00807495|18090913|P5|Overall Study|Adverse Event|2
5242445|NCT00807495|18090914|P4|Overall Study|Adverse Event|1
5242446|NCT00807495|18090915|P3|Overall Study|Adverse Event|1
5242447|NCT00807495|18090916|P2|Overall Study|Adverse Event|3
5242448|NCT00807495|18090917|P1|Overall Study|Adverse Event|6
5242449|NCT00807365|18090963|P1|Overall Study|Study Terminated|5
5242450|NCT00807248|18090971|P4|Overall Study|Other Reason|0
5242451|NCT00807248|18090972|P3|Overall Study|Other Reason|2
5242452|NCT00807248|18090973|P2|Overall Study|Other Reason|0
5242453|NCT00807248|18090974|P1|Overall Study|Other Reason|0
5242454|NCT00807248|18090971|P4|Overall Study|Lost to Follow-up|0
5242455|NCT00807248|18090972|P3|Overall Study|Lost to Follow-up|0
5242456|NCT00807248|18090973|P2|Overall Study|Lost to Follow-up|0
5242457|NCT00807248|18090974|P1|Overall Study|Lost to Follow-up|1
5242458|NCT00807248|18090971|P4|Overall Study|Withdrawal of Consent|5
5242459|NCT00807248|18090972|P3|Overall Study|Withdrawal of Consent|5
5242460|NCT00807248|18090973|P2|Overall Study|Withdrawal of Consent|5
5242461|NCT00807248|18090974|P1|Overall Study|Withdrawal of Consent|5
5242462|NCT00807248|18090971|P4|Overall Study|Protocol Violation|0
5242463|NCT00807248|18090972|P3|Overall Study|Protocol Violation|1
5242464|NCT00807248|18090973|P2|Overall Study|Protocol Violation|1
5242465|NCT00807248|18090974|P1|Overall Study|Protocol Violation|0
5242466|NCT00807248|18090971|P4|Overall Study|Lack of Efficacy|3
5242467|NCT00807248|18090972|P3|Overall Study|Lack of Efficacy|8
5242468|NCT00807248|18090973|P2|Overall Study|Lack of Efficacy|4
5242469|NCT00807248|18090974|P1|Overall Study|Lack of Efficacy|14
5242470|NCT00807248|18090971|P4|Overall Study|Adverse Event|6
5242471|NCT00807248|18090972|P3|Overall Study|Adverse Event|2
5242472|NCT00807248|18090973|P2|Overall Study|Adverse Event|2
5242473|NCT00807248|18090974|P1|Overall Study|Adverse Event|1
5242474|NCT00807235|18091018|P2|Overall Study|Adverse Event|0
5242475|NCT00807235|18091019|P1|Overall Study|Adverse Event|1
5242476|NCT00807092|18091064|P2|Overall Study|CGMS data collection failed|1
5242477|NCT00807092|18091065|P1|Overall Study|CGMS data collection failed|0
5242478|NCT00807092|18091064|P2|Overall Study|Withdrawal by Subject|0
5242479|NCT00807092|18091065|P1|Overall Study|Withdrawal by Subject|1
5242480|NCT00807092|18091064|P2|Overall Study|Protocol Violation|2
5242481|NCT00807092|18091065|P1|Overall Study|Protocol Violation|0
5242482|NCT00807092|18091064|P2|Overall Study|Adverse Event|1
5242483|NCT00807092|18091065|P1|Overall Study|Adverse Event|0
5242484|NCT00807040|18091095|P2|Overall Study|Lost to Follow-up|6
5242485|NCT00807040|18091096|P1|Overall Study|Lost to Follow-up|4
5242486|NCT00807040|18091095|P2|Overall Study|Withdrawal by Subject|6
5242487|NCT00807040|18091096|P1|Overall Study|Withdrawal by Subject|8
5242488|NCT00807040|18091095|P2|Overall Study|Death|29
5242489|NCT00807040|18091096|P1|Overall Study|Death|24
5242490|NCT00807014|18091106|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
5242491|NCT00807014|18091107|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
5242492|NCT00807014|18091106|P2|Overall Study|Recovery|0
5242493|NCT00807014|18091107|P1|Overall Study|Recovery|1
5242494|NCT00807014|18091106|P2|Overall Study|Lost to Follow-up|7
5242495|NCT00807014|18091107|P1|Overall Study|Lost to Follow-up|9
5242496|NCT00807014|18091106|P2|Overall Study|Adverse Event|2
5242497|NCT00807014|18091107|P1|Overall Study|Adverse Event|0
5242498|NCT00807014|18091106|P2|Overall Study|Protocol Violation|8
5242499|NCT00807014|18091107|P1|Overall Study|Protocol Violation|2
5242500|NCT00807014|18091106|P2|Overall Study|Participant Considered Disease Not Cured|7
5242501|NCT00807014|18091107|P1|Overall Study|Participant Considered Disease Not Cured|2
5242502|NCT00807014|18091106|P2|Overall Study|Participant Considered Disease Cured|2
5242503|NCT00807014|18091107|P1|Overall Study|Participant Considered Disease Cured|13
5242504|NCT00807001|18091138|P5|Overall Study|Non-compliance|0
5242505|NCT00807001|18091139|P4|Overall Study|Non-compliance|0
5242506|NCT00807001|18091140|P3|Overall Study|Non-compliance|0
5242507|NCT00807001|18091141|P2|Overall Study|Non-compliance|1
5242508|NCT00807001|18091142|P1|Overall Study|Non-compliance|0
5242509|NCT00806988|18091161|P2|Overall Study|Lost to Follow-up|19
5242510|NCT00806988|18091162|P1|Overall Study|Lost to Follow-up|4
5242511|NCT00806988|18091161|P2|Overall Study|Withdrawal by Subject|8
5242512|NCT00806988|18091162|P1|Overall Study|Withdrawal by Subject|8
5242513|NCT00806988|18091161|P2|Overall Study|Death|16
5242514|NCT00806988|18091162|P1|Overall Study|Death|15
5242515|NCT00806819|18091172|P2|Overall Study|Reasons other than stated above|41
5242516|NCT00806819|18091173|P1|Overall Study|Reasons other than stated above|25
5242517|NCT00806819|18091172|P2|Overall Study|Not treated|3
5242518|NCT00806819|18091173|P1|Overall Study|Not treated|6
5242519|NCT00806819|18091172|P2|Overall Study|Withdrawal by Subject|29
5242520|NCT00806819|18091173|P1|Overall Study|Withdrawal by Subject|32
5242521|NCT00806819|18091172|P2|Overall Study|Lost to Follow-up|0
5242522|NCT00806819|18091173|P1|Overall Study|Lost to Follow-up|1
5242523|NCT00806819|18091172|P2|Overall Study|Protocol Violation|4
5242524|NCT00806819|18091173|P1|Overall Study|Protocol Violation|9
5242525|NCT00806819|18091172|P2|Overall Study|Other AE|40
5242526|NCT00806819|18091173|P1|Overall Study|Other AE|38
5242527|NCT00806819|18091172|P2|Overall Study|Worsening or AE of underlying disease|25
5242528|NCT00806819|18091173|P1|Overall Study|Worsening or AE of underlying disease|18
5242529|NCT00806819|18091172|P2|Overall Study|progressive disease (modified RECIST )|216
5242530|NCT00806819|18091173|P1|Overall Study|progressive disease (modified RECIST )|217
5242531|NCT00806624|18091242|P3|Overall Study|discontinued before start of treatment|1
5242532|NCT00806624|18091243|P2|Overall Study|discontinued before start of treatment|0
5242533|NCT00806624|18091244|P1|Overall Study|discontinued before start of treatment|0
5242534|NCT00806624|18091242|P3|Overall Study|Withdrawal by Subject|3
5242535|NCT00806624|18091243|P2|Overall Study|Withdrawal by Subject|3
5242536|NCT00806624|18091244|P1|Overall Study|Withdrawal by Subject|6
5242537|NCT00806624|18091242|P3|Overall Study|Lost to Follow-up|1
5242538|NCT00806624|18091243|P2|Overall Study|Lost to Follow-up|0
5242539|NCT00806624|18091244|P1|Overall Study|Lost to Follow-up|1
5242540|NCT00806624|18091242|P3|Overall Study|Death|1
5242541|NCT00806624|18091243|P2|Overall Study|Death|1
5242542|NCT00806624|18091244|P1|Overall Study|Death|0
5242543|NCT00806624|18091242|P3|Overall Study|Adverse Event|0
5242544|NCT00806624|18091243|P2|Overall Study|Adverse Event|8
5242545|NCT00806624|18091244|P1|Overall Study|Adverse Event|2
5242546|NCT00806585|18091261|P5|Overall Study|Completion status unknown|12
5242547|NCT00806585|18091262|P4|Overall Study|Completion status unknown|4
5242548|NCT00806585|18091263|P3|Overall Study|Completion status unknown|12
5242549|NCT00806585|18091264|P2|Overall Study|Completion status unknown|14
5242550|NCT00806585|18091265|P1|Overall Study|Completion status unknown|15
5242551|NCT00806585|18091261|P5|Overall Study|Withdrawal by Subject|11
5242552|NCT00806585|18091262|P4|Overall Study|Withdrawal by Subject|3
5242553|NCT00806585|18091263|P3|Overall Study|Withdrawal by Subject|9
5242554|NCT00806585|18091264|P2|Overall Study|Withdrawal by Subject|8
5242555|NCT00806585|18091265|P1|Overall Study|Withdrawal by Subject|10
5242556|NCT00806585|18091261|P5|Overall Study|Adverse Event|2
5242557|NCT00806585|18091262|P4|Overall Study|Adverse Event|4
5242558|NCT00806585|18091263|P3|Overall Study|Adverse Event|3
5242559|NCT00806585|18091264|P2|Overall Study|Adverse Event|5
5242560|NCT00806585|18091265|P1|Overall Study|Adverse Event|1
5242561|NCT00806585|18091261|P5|Overall Study|Lack of Efficacy|0
5242562|NCT00806585|18091262|P4|Overall Study|Lack of Efficacy|0
5242563|NCT00806585|18091263|P3|Overall Study|Lack of Efficacy|0
5242564|NCT00806585|18091264|P2|Overall Study|Lack of Efficacy|0
5242565|NCT00806585|18091265|P1|Overall Study|Lack of Efficacy|1
5242566|NCT00806585|18091261|P5|Overall Study|Lost to Follow-up|5
5242567|NCT00806585|18091262|P4|Overall Study|Lost to Follow-up|2
5242568|NCT00806585|18091263|P3|Overall Study|Lost to Follow-up|2
5242569|NCT00806585|18091264|P2|Overall Study|Lost to Follow-up|1
5242570|NCT00806585|18091265|P1|Overall Study|Lost to Follow-up|2
5242571|NCT00806585|18091261|P5|Overall Study|Physician Decision|1
5242572|NCT00806585|18091262|P4|Overall Study|Physician Decision|0
5242573|NCT00806585|18091263|P3|Overall Study|Physician Decision|3
5242574|NCT00806585|18091264|P2|Overall Study|Physician Decision|2
5242575|NCT00806585|18091265|P1|Overall Study|Physician Decision|0
5242576|NCT00806585|18091261|P5|Overall Study|Protocol Violation|0
5242577|NCT00806585|18091262|P4|Overall Study|Protocol Violation|0
5242578|NCT00806585|18091263|P3|Overall Study|Protocol Violation|2
5242579|NCT00806585|18091264|P2|Overall Study|Protocol Violation|1
5242580|NCT00806585|18091265|P1|Overall Study|Protocol Violation|3
5242581|NCT00806585|18091261|P5|Overall Study|Study terminated by Sponsor|0
5242582|NCT00806585|18091262|P4|Overall Study|Study terminated by Sponsor|2
5242583|NCT00806585|18091263|P3|Overall Study|Study terminated by Sponsor|1
5242584|NCT00806585|18091264|P2|Overall Study|Study terminated by Sponsor|0
5242585|NCT00806585|18091265|P1|Overall Study|Study terminated by Sponsor|0
5242586|NCT00806546|18091297|P1|Overall Study|Various|42
5242587|NCT00806546|18091297|P1|Overall Study|Protocol Violation|49
5242588|NCT00806546|18091297|P1|Overall Study|Withdrawal by Subject|75
5242589|NCT00806546|18091297|P1|Overall Study|Adverse Event|74
5242590|NCT00806546|18091297|P1|Overall Study|Lost to Follow-up|32
5242591|NCT00806546|18091297|P1|Overall Study|Enrolled, not treated|35
5242592|NCT00806494|18091301|P1|Overall Study|Withdrawal by Subject|5
5242593|NCT00806494|18091301|P1|Overall Study|Other|30
5242594|NCT00806494|18091301|P1|Overall Study|Lost to Follow-up|10
5242595|NCT00806494|18091301|P1|Overall Study|Lack of Efficacy|6
5242596|NCT00806494|18091301|P1|Overall Study|Adverse Event|29
5242597|NCT00806442|18091325|P2|Overall Study|Withdrawal by Subject|5
5242598|NCT00806442|18091326|P1|Overall Study|Withdrawal by Subject|1
5242599|NCT00806442|18091325|P2|Overall Study|Lost to Follow-up|2
5242600|NCT00806442|18091326|P1|Overall Study|Lost to Follow-up|3
5242601|NCT00806416|18091348|P4|Period 1 - Part II|Withdrawal by Subject|2
5242602|NCT00806416|18091349|P3|Period 1 - Part II|Withdrawal by Subject|0
5242603|NCT00806416|18091350|P2|Period 1 - Part II|Withdrawal by Subject|0
5242604|NCT00806416|18091351|P1|Period 1 - Part II|Withdrawal by Subject|0
5242605|NCT00806416|18091348|P4|Period 1 - Part I|Withdrawal by Subject|0
5242606|NCT00806416|18091349|P3|Period 1 - Part I|Withdrawal by Subject|0
5242607|NCT00806416|18091350|P2|Period 1 - Part I|Withdrawal by Subject|1
5242608|NCT00806416|18091351|P1|Period 1 - Part I|Withdrawal by Subject|3
5242609|NCT00806416|18091348|P4|Period 1 - Part I|Lost to Follow-up|0
5242610|NCT00806416|18091349|P3|Period 1 - Part I|Lost to Follow-up|0
5242611|NCT00806416|18091350|P2|Period 1 - Part I|Lost to Follow-up|2
5242612|NCT00806416|18091351|P1|Period 1 - Part I|Lost to Follow-up|0
5242613|NCT00806416|18091348|P4|Period 1 - Part I|Adverse Event|0
5242614|NCT00806416|18091349|P3|Period 1 - Part I|Adverse Event|0
5242615|NCT00806416|18091350|P2|Period 1 - Part I|Adverse Event|1
5242616|NCT00806416|18091351|P1|Period 1 - Part I|Adverse Event|0
5242617|NCT00806403|18091364|P2|Overall Study|Death|3
5242618|NCT00806403|18091365|P1|Overall Study|Death|4
5242619|NCT00806351|18091388|P2|Overall Study|Death|4
5242620|NCT00806351|18091389|P1|Overall Study|Death|5
5242621|NCT00806286|18091423|P3|Overall Study|Due to a variety of reasons|1
5242622|NCT00806286|18091424|P2|Overall Study|Due to a variety of reasons|2
5242623|NCT00806286|18091425|P1|Overall Study|Due to a variety of reasons|7
5242624|NCT00806286|18091423|P3|Overall Study|Physician Decision|0
5242625|NCT00806286|18091424|P2|Overall Study|Physician Decision|2
5242626|NCT00806286|18091425|P1|Overall Study|Physician Decision|2
5242627|NCT00806286|18091423|P3|Overall Study|Withdrawal by Subject|1
5242628|NCT00806286|18091424|P2|Overall Study|Withdrawal by Subject|3
5242629|NCT00806286|18091425|P1|Overall Study|Withdrawal by Subject|8
5242630|NCT00806286|18091423|P3|Overall Study|Lost to Follow-up|0
5242631|NCT00806286|18091424|P2|Overall Study|Lost to Follow-up|1
5242632|NCT00806286|18091425|P1|Overall Study|Lost to Follow-up|0
5242633|NCT00806286|18091423|P3|Overall Study|Death|0
5242634|NCT00806286|18091424|P2|Overall Study|Death|6
5242635|NCT00806286|18091425|P1|Overall Study|Death|1
5242636|NCT00806286|18091423|P3|Overall Study|Disease progression|1
5242637|NCT00806286|18091424|P2|Overall Study|Disease progression|38
5242638|NCT00806286|18091425|P1|Overall Study|Disease progression|31
5242639|NCT00806286|18091423|P3|Overall Study|Adverse Event|0
5242640|NCT00806286|18091424|P2|Overall Study|Adverse Event|2
5242641|NCT00806286|18091425|P1|Overall Study|Adverse Event|5
5242642|NCT00806260|18091447|P6|Period 3|Pregnancy|0
5242643|NCT00806260|18091448|P5|Period 3|Pregnancy|0
5242644|NCT00806260|18091449|P4|Period 3|Pregnancy|0
5242645|NCT00806260|18091450|P3|Period 3|Pregnancy|0
5242646|NCT00806260|18091451|P2|Period 3|Pregnancy|0
5242647|NCT00806260|18091452|P1|Period 3|Pregnancy|1
5242648|NCT00806260|18091447|P6|Period 3|Protocol Violation|0
5242649|NCT00806260|18091448|P5|Period 3|Protocol Violation|0
5242650|NCT00806260|18091449|P4|Period 3|Protocol Violation|0
5242651|NCT00806260|18091450|P3|Period 3|Protocol Violation|1
5242652|NCT00806260|18091451|P2|Period 3|Protocol Violation|1
5242653|NCT00806260|18091452|P1|Period 3|Protocol Violation|0
5242654|NCT00806260|18091447|P6|Period 2|sponsor request|0
5242655|NCT00806260|18091448|P5|Period 2|sponsor request|0
5242656|NCT00806260|18091449|P4|Period 2|sponsor request|1
5242657|NCT00806260|18091450|P3|Period 2|sponsor request|1
5242658|NCT00806260|18091451|P2|Period 2|sponsor request|0
5242659|NCT00806260|18091452|P1|Period 2|sponsor request|0
5242660|NCT00806260|18091447|P6|Period 2|Need to take concomitant medication|0
5242661|NCT00806260|18091448|P5|Period 2|Need to take concomitant medication|0
5242662|NCT00806260|18091449|P4|Period 2|Need to take concomitant medication|0
5242663|NCT00806260|18091450|P3|Period 2|Need to take concomitant medication|0
5242664|NCT00806260|18091451|P2|Period 2|Need to take concomitant medication|0
5242665|NCT00806260|18091452|P1|Period 2|Need to take concomitant medication|1
5242666|NCT00806260|18091447|P6|Period 2|Protocol Violation|0
5242667|NCT00806260|18091448|P5|Period 2|Protocol Violation|0
5242668|NCT00806260|18091449|P4|Period 2|Protocol Violation|0
5242669|NCT00806260|18091450|P3|Period 2|Protocol Violation|1
5242670|NCT00806260|18091451|P2|Period 2|Protocol Violation|0
5242671|NCT00806260|18091452|P1|Period 2|Protocol Violation|1
5242672|NCT00806260|18091447|P6|Period 2|Adverse Event|0
5242673|NCT00806260|18091448|P5|Period 2|Adverse Event|0
5242674|NCT00806260|18091449|P4|Period 2|Adverse Event|1
5242675|NCT00806260|18091450|P3|Period 2|Adverse Event|0
5242676|NCT00806260|18091451|P2|Period 2|Adverse Event|0
5242677|NCT00806260|18091452|P1|Period 2|Adverse Event|0
5242678|NCT00806260|18091447|P6|Period 1 (1 Day)|Adverse Event|0
5242679|NCT00806260|18091448|P5|Period 1 (1 Day)|Adverse Event|3
5242680|NCT00806260|18091449|P4|Period 1 (1 Day)|Adverse Event|0
5242681|NCT00806260|18091450|P3|Period 1 (1 Day)|Adverse Event|0
5242682|NCT00806260|18091451|P2|Period 1 (1 Day)|Adverse Event|0
5242683|NCT00806260|18091452|P1|Period 1 (1 Day)|Adverse Event|0
5242684|NCT00806195|18091497|P4|Overall Study|Protocol Violation|9
5242685|NCT00806195|18091498|P3|Overall Study|Protocol Violation|26
5242686|NCT00806195|18091499|P2|Overall Study|Protocol Violation|24
5242687|NCT00806195|18091500|P1|Overall Study|Protocol Violation|34
5242688|NCT00806195|18091497|P4|Overall Study|Administrative Reason|26
5242689|NCT00806195|18091498|P3|Overall Study|Administrative Reason|66
5242690|NCT00806195|18091499|P2|Overall Study|Administrative Reason|35
5242691|NCT00806195|18091500|P1|Overall Study|Administrative Reason|113
5242692|NCT00806195|18091497|P4|Overall Study|Inappropriate Enrollment|0
5242693|NCT00806195|18091498|P3|Overall Study|Inappropriate Enrollment|0
5242694|NCT00806195|18091499|P2|Overall Study|Inappropriate Enrollment|1
5242695|NCT00806195|18091500|P1|Overall Study|Inappropriate Enrollment|0
5242696|NCT00806195|18091497|P4|Overall Study|Lost to Follow-up|34
5242697|NCT00806195|18091498|P3|Overall Study|Lost to Follow-up|90
5242698|NCT00806195|18091499|P2|Overall Study|Lost to Follow-up|66
5242699|NCT00806195|18091500|P1|Overall Study|Lost to Follow-up|217
5242700|NCT00806195|18091497|P4|Overall Study|Withdrawal by Subject|35
5242701|NCT00806195|18091498|P3|Overall Study|Withdrawal by Subject|76
5242702|NCT00806195|18091499|P2|Overall Study|Withdrawal by Subject|31
5242703|NCT00806195|18091500|P1|Overall Study|Withdrawal by Subject|119
5242704|NCT00806195|18091497|P4|Overall Study|Adverse Event|2
5242705|NCT00806195|18091498|P3|Overall Study|Adverse Event|11
5242706|NCT00806195|18091499|P2|Overall Study|Adverse Event|5
5242707|NCT00806195|18091500|P1|Overall Study|Adverse Event|25
5242708|NCT00806195|18091497|P4|Overall Study|Death|0
5242709|NCT00806195|18091498|P3|Overall Study|Death|1
5242710|NCT00806195|18091499|P2|Overall Study|Death|0
5242711|NCT00806195|18091500|P1|Overall Study|Death|6
5242712|NCT00806026|18091531|P6|Overall Study|Adverse Event|9
5242713|NCT00806026|18091532|P5|Overall Study|Adverse Event|9
5242714|NCT00806026|18091533|P4|Overall Study|Adverse Event|17
5242715|NCT00806026|18091534|P3|Overall Study|Adverse Event|44
5242716|NCT00806026|18091535|P2|Overall Study|Adverse Event|35
5242717|NCT00806026|18091536|P1|Overall Study|Adverse Event|52
5242718|NCT00806026|18091531|P6|Overall Study|Protocol Violation|3
5242719|NCT00806026|18091532|P5|Overall Study|Protocol Violation|2
5242720|NCT00806026|18091533|P4|Overall Study|Protocol Violation|0
5242721|NCT00806026|18091534|P3|Overall Study|Protocol Violation|9
5242722|NCT00806026|18091535|P2|Overall Study|Protocol Violation|9
5242723|NCT00806026|18091536|P1|Overall Study|Protocol Violation|6
5242724|NCT00806026|18091531|P6|Overall Study|Other|4
5242725|NCT00806026|18091532|P5|Overall Study|Other|0
5242726|NCT00806026|18091533|P4|Overall Study|Other|2
5242727|NCT00806026|18091534|P3|Overall Study|Other|8
5242728|NCT00806026|18091535|P2|Overall Study|Other|6
5242729|NCT00806026|18091536|P1|Overall Study|Other|3
5242730|NCT00806026|18091531|P6|Overall Study|Withdrawal by Subject|3
5242731|NCT00806026|18091532|P5|Overall Study|Withdrawal by Subject|5
5242732|NCT00806026|18091533|P4|Overall Study|Withdrawal by Subject|2
5242733|NCT00806026|18091534|P3|Overall Study|Withdrawal by Subject|9
5242734|NCT00806026|18091535|P2|Overall Study|Withdrawal by Subject|17
5242735|NCT00806026|18091536|P1|Overall Study|Withdrawal by Subject|14
5242736|NCT00806026|18091531|P6|Overall Study|Lost to Follow-up|6
5242737|NCT00806026|18091532|P5|Overall Study|Lost to Follow-up|6
5242738|NCT00806026|18091533|P4|Overall Study|Lost to Follow-up|2
5242739|NCT00806026|18091534|P3|Overall Study|Lost to Follow-up|8
5242740|NCT00806026|18091535|P2|Overall Study|Lost to Follow-up|15
5242741|NCT00806026|18091536|P1|Overall Study|Lost to Follow-up|8
5242742|NCT00806026|18091531|P6|Overall Study|Lack of Efficacy|7
5242743|NCT00806026|18091532|P5|Overall Study|Lack of Efficacy|8
5242744|NCT00806026|18091533|P4|Overall Study|Lack of Efficacy|4
5242745|NCT00806026|18091534|P3|Overall Study|Lack of Efficacy|13
5242746|NCT00806026|18091535|P2|Overall Study|Lack of Efficacy|18
5242747|NCT00806026|18091536|P1|Overall Study|Lack of Efficacy|5
5242748|NCT00806026|18091531|P6|Overall Study|Did not meet entrance criteria|0
5242749|NCT00806026|18091532|P5|Overall Study|Did not meet entrance criteria|0
5242750|NCT00806026|18091533|P4|Overall Study|Did not meet entrance criteria|1
5242751|NCT00806026|18091534|P3|Overall Study|Did not meet entrance criteria|2
5242752|NCT00806026|18091535|P2|Overall Study|Did not meet entrance criteria|1
5242753|NCT00806026|18091536|P1|Overall Study|Did not meet entrance criteria|4
5242754|NCT00806026|18091531|P6|Overall Study|Death|0
5242755|NCT00806026|18091532|P5|Overall Study|Death|0
5242756|NCT00806026|18091533|P4|Overall Study|Death|1
5242757|NCT00806026|18091534|P3|Overall Study|Death|0
5242758|NCT00806026|18091535|P2|Overall Study|Death|0
5242759|NCT00806026|18091536|P1|Overall Study|Death|0
5242760|NCT00805961|18091631|P1|Maintenance Treatment|Withdrawn Consent|1
5242761|NCT00805961|18091631|P1|Maintenance Treatment|Symptomatic Deterioration|2
5242762|NCT00805961|18091631|P1|Maintenance Treatment|Withdrawal by Subject|5
5242763|NCT00805961|18091631|P1|Maintenance Treatment|Adverse Event|6
5242764|NCT00805961|18091631|P1|Maintenance Treatment|Intercurrent Illness|7
5242765|NCT00805961|18091631|P1|Maintenance Treatment|Lack of Efficacy|13
5242766|NCT00805961|18091631|P1|Treatment-Free Interval|Lack of Efficacy|1
5242767|NCT00805961|18091631|P1|Treatment-Free Interval|Physician Decision|1
5242768|NCT00805961|18091631|P1|Treatment-Free Interval|Intercurrent Illness|2
5242769|NCT00805961|18091631|P1|Treatment-Free Interval|Adverse Event|3
5242770|NCT00805961|18091631|P1|Modality Therapy|Disease Progression|2
5242771|NCT00805961|18091631|P1|Modality Therapy|Adverse Event|1
5242772|NCT00805961|18091631|P1|Modality Therapy|Withdrawal by Subject|1
5242773|NCT00805935|18091655|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
5242774|NCT00805935|18091656|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
5242775|NCT00805935|18091657|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
5242776|NCT00805935|18091658|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
5242777|NCT00805935|18091655|P4|Overall Study|Ectopic pregnancy|0
5242778|NCT00805935|18091656|P3|Overall Study|Ectopic pregnancy|1
5242779|NCT00805935|18091657|P2|Overall Study|Ectopic pregnancy|0
5242780|NCT00805935|18091658|P1|Overall Study|Ectopic pregnancy|0
5242781|NCT00805935|18091655|P4|Overall Study|Chemical pregnancy|2
5242782|NCT00805935|18091656|P3|Overall Study|Chemical pregnancy|3
5242783|NCT00805935|18091657|P2|Overall Study|Chemical pregnancy|5
5242784|NCT00805935|18091658|P1|Overall Study|Chemical pregnancy|0
5242785|NCT00805935|18091655|P4|Overall Study|Biochemical pregnancy|0
5242786|NCT00805935|18091656|P3|Overall Study|Biochemical pregnancy|0
5242787|NCT00805935|18091657|P2|Overall Study|Biochemical pregnancy|1
5242788|NCT00805935|18091658|P1|Overall Study|Biochemical pregnancy|0
5242789|NCT00805935|18091655|P4|Overall Study|Pregnancy loss/miscarriage|0
5242790|NCT00805935|18091656|P3|Overall Study|Pregnancy loss/miscarriage|0
5242791|NCT00805935|18091657|P2|Overall Study|Pregnancy loss/miscarriage|0
5242792|NCT00805935|18091658|P1|Overall Study|Pregnancy loss/miscarriage|2
5242793|NCT00805935|18091655|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
5242794|NCT00805935|18091656|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
5242795|NCT00805935|18091657|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
5242796|NCT00805935|18091658|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
5242797|NCT00805935|18091655|P4|Overall Study|No positive serum pregnancy|5
5242798|NCT00805935|18091656|P3|Overall Study|No positive serum pregnancy|6
5242799|NCT00805935|18091657|P2|Overall Study|No positive serum pregnancy|7
5242800|NCT00805935|18091658|P1|Overall Study|No positive serum pregnancy|8
5242801|NCT00805935|18091655|P4|Overall Study|Lost to Follow-up|0
5242802|NCT00805935|18091656|P3|Overall Study|Lost to Follow-up|0
5242803|NCT00805935|18091657|P2|Overall Study|Lost to Follow-up|0
5242804|NCT00805935|18091658|P1|Overall Study|Lost to Follow-up|1
5242805|NCT00805935|18091655|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
5242806|NCT00805935|18091656|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
5242807|NCT00805935|18091657|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
5242808|NCT00805935|18091658|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
5242809|NCT00805935|18091655|P4|Overall Study|Cycle cancellation for risk of OHSS|0
5242810|NCT00805935|18091656|P3|Overall Study|Cycle cancellation for risk of OHSS|1
5242811|NCT00805935|18091657|P2|Overall Study|Cycle cancellation for risk of OHSS|0
5242812|NCT00805935|18091658|P1|Overall Study|Cycle cancellation for risk of OHSS|1
5242813|NCT00805935|18091655|P4|Overall Study|Cycle cancelled|0
5242814|NCT00805935|18091656|P3|Overall Study|Cycle cancelled|2
5242815|NCT00805935|18091657|P2|Overall Study|Cycle cancelled|0
5242816|NCT00805935|18091658|P1|Overall Study|Cycle cancelled|0
5242817|NCT00805935|18091655|P4|Overall Study|Stimulation Failure|2
5242818|NCT00805935|18091656|P3|Overall Study|Stimulation Failure|2
5242819|NCT00805935|18091657|P2|Overall Study|Stimulation Failure|5
5242820|NCT00805935|18091658|P1|Overall Study|Stimulation Failure|1
5242821|NCT00805792|18091725|P1|Overall Study|Lost to Follow-up|2
5242822|NCT00805792|18091725|P1|Overall Study|Death|3
5242823|NCT00805766|18091733|P1|Increased Dose Period|Withdrawal by Subject|1
5242824|NCT00805766|18091733|P1|Increased Dose Period|Pregnancy|1
5242825|NCT00805766|18091733|P1|Increased Dose Period|Lack of Efficacy|7
5242826|NCT00805766|18091733|P1|Increased Dose Period|Adverse Event|4
5242827|NCT00805766|18091733|P1|Screening Period|Responder|2
5242828|NCT00805766|18091733|P1|Screening Period|Pregnancy|1
5242829|NCT00805766|18091733|P1|Screening Period|Lack of Efficacy|2
5242830|NCT00805766|18091733|P1|Screening Period|Adverse Event|1
5242831|NCT00805740|18091747|P2|Overall Study|Randomized, but not treated|0
5242832|NCT00805740|18091748|P1|Overall Study|Randomized, but not treated|2
5242833|NCT00805740|18091747|P2|Overall Study|Lost to Follow-up|0
5242834|NCT00805740|18091748|P1|Overall Study|Lost to Follow-up|1
5242835|NCT00805740|18091747|P2|Overall Study|Withdrawal by Subject|0
5242836|NCT00805740|18091748|P1|Overall Study|Withdrawal by Subject|1
5242837|NCT00805740|18091747|P2|Overall Study|Death|4
5242838|NCT00805740|18091748|P1|Overall Study|Death|7
5242839|NCT00805675|18091773|P3|Overall Study|Adverse Event|1
5242840|NCT00805675|18091774|P2|Overall Study|Adverse Event|0
5242841|NCT00805675|18091775|P1|Overall Study|Adverse Event|0
5242842|NCT00805545|18091809|P2|Overall Study|Protocol Violation|1
5242843|NCT00805545|18091810|P1|Overall Study|Protocol Violation|3
5242844|NCT00805545|18091809|P2|Overall Study|Protocol Violation|2
5242845|NCT00805545|18091810|P1|Overall Study|Protocol Violation|3
5242846|NCT00805532|18091818|P2|Overall Study|invalid data|1
5242847|NCT00805532|18091819|P1|Overall Study|invalid data|0
5242848|NCT00805480|18091853|P4|Overall Study|Adverse Event|0
5242849|NCT00805480|18091854|P3|Overall Study|Adverse Event|1
5242850|NCT00805480|18091855|P2|Overall Study|Adverse Event|0
5242851|NCT00805480|18091856|P1|Overall Study|Adverse Event|0
5242852|NCT00805480|18091853|P4|Overall Study|Lost to Follow-up|0
5242853|NCT00805480|18091854|P3|Overall Study|Lost to Follow-up|0
5242854|NCT00805480|18091855|P2|Overall Study|Lost to Follow-up|2
5242855|NCT00805480|18091856|P1|Overall Study|Lost to Follow-up|1
5242856|NCT00805480|18091853|P4|Overall Study|Withdrawal by Subject|5
5242857|NCT00805480|18091854|P3|Overall Study|Withdrawal by Subject|11
5242858|NCT00805480|18091855|P2|Overall Study|Withdrawal by Subject|5
5242859|NCT00805480|18091856|P1|Overall Study|Withdrawal by Subject|13
5242860|NCT00805467|18091885|P4|Overall Study|Not reported|7
5242861|NCT00805467|18091886|P3|Overall Study|Not reported|3
5242862|NCT00805467|18091887|P2|Overall Study|Not reported|0
5242863|NCT00805467|18091888|P1|Overall Study|Not reported|0
5242864|NCT00805467|18091885|P4|Overall Study|Physician Decision|6
5242865|NCT00805467|18091886|P3|Overall Study|Physician Decision|2
5242866|NCT00805467|18091887|P2|Overall Study|Physician Decision|1
5242867|NCT00805467|18091888|P1|Overall Study|Physician Decision|0
5242868|NCT00805467|18091885|P4|Overall Study|Death|5
5242869|NCT00805467|18091886|P3|Overall Study|Death|7
5242870|NCT00805467|18091887|P2|Overall Study|Death|2
5242871|NCT00805467|18091888|P1|Overall Study|Death|0
5242872|NCT00805467|18091885|P4|Overall Study|Adverse Event|57
5242873|NCT00805467|18091886|P3|Overall Study|Adverse Event|26
5242874|NCT00805467|18091887|P2|Overall Study|Adverse Event|13
5242875|NCT00805467|18091888|P1|Overall Study|Adverse Event|0
5242876|NCT00805467|18091885|P4|Overall Study|Protocol Violation|5
5242877|NCT00805467|18091886|P3|Overall Study|Protocol Violation|0
5242878|NCT00805467|18091887|P2|Overall Study|Protocol Violation|3
5242879|NCT00805467|18091888|P1|Overall Study|Protocol Violation|0
5242880|NCT00805467|18091885|P4|Overall Study|Withdrawal by Subject|50
5242881|NCT00805467|18091886|P3|Overall Study|Withdrawal by Subject|45
5242882|NCT00805467|18091887|P2|Overall Study|Withdrawal by Subject|6
5242883|NCT00805467|18091888|P1|Overall Study|Withdrawal by Subject|0
5242884|NCT00805467|18091885|P4|Overall Study|Lost to Follow-up|21
5242885|NCT00805467|18091886|P3|Overall Study|Lost to Follow-up|7
5242886|NCT00805467|18091887|P2|Overall Study|Lost to Follow-up|1
5242887|NCT00805467|18091888|P1|Overall Study|Lost to Follow-up|0
5242888|NCT00805467|18091885|P4|Overall Study|Lack of Efficacy|86
5242889|NCT00805467|18091886|P3|Overall Study|Lack of Efficacy|13
5242890|NCT00805467|18091887|P2|Overall Study|Lack of Efficacy|8
5242891|NCT00805467|18091888|P1|Overall Study|Lack of Efficacy|0
5242892|NCT00805441|18091908|P2|Overall Study|Acute Alcohol Withdrawal|1
5242893|NCT00805441|18091909|P1|Overall Study|Acute Alcohol Withdrawal|0
5242894|NCT00805441|18091908|P2|Overall Study|Physician Decision|1
5242895|NCT00805441|18091909|P1|Overall Study|Physician Decision|0
5242896|NCT00805441|18091908|P2|Overall Study|Withdrawal by Subject|9
5242897|NCT00805441|18091909|P1|Overall Study|Withdrawal by Subject|15
5242898|NCT00805441|18091908|P2|Overall Study|Lost to Follow-up|13
5242899|NCT00805441|18091909|P1|Overall Study|Lost to Follow-up|10
5242900|NCT00805441|18091908|P2|Overall Study|Protocol Violation|8
5242901|NCT00805441|18091909|P1|Overall Study|Protocol Violation|4
5242902|NCT00805441|18091908|P2|Overall Study|Lack of Efficacy|2
5242903|NCT00805441|18091909|P1|Overall Study|Lack of Efficacy|0
5242904|NCT00805441|18091908|P2|Overall Study|Adverse Event|2
5242905|NCT00805441|18091909|P1|Overall Study|Adverse Event|5
5242906|NCT00805389|18091944|P5|Overall Study|Withdrawal by Subject|4
5242907|NCT00805389|18091945|P4|Overall Study|Withdrawal by Subject|5
5242908|NCT00805389|18091946|P3|Overall Study|Withdrawal by Subject|4
5242909|NCT00805389|18091947|P2|Overall Study|Withdrawal by Subject|2
5242910|NCT00805389|18091948|P1|Overall Study|Withdrawal by Subject|3
5242911|NCT00805389|18091944|P5|Overall Study|Protocol Violation|0
5242912|NCT00805389|18091945|P4|Overall Study|Protocol Violation|0
5242913|NCT00805389|18091946|P3|Overall Study|Protocol Violation|1
5242914|NCT00805389|18091947|P2|Overall Study|Protocol Violation|0
5242915|NCT00805389|18091948|P1|Overall Study|Protocol Violation|0
5242916|NCT00805389|18091944|P5|Overall Study|Lost to Follow-up|9
5242917|NCT00805389|18091945|P4|Overall Study|Lost to Follow-up|10
5242918|NCT00805389|18091946|P3|Overall Study|Lost to Follow-up|6
5242919|NCT00805389|18091947|P2|Overall Study|Lost to Follow-up|3
5242920|NCT00805389|18091948|P1|Overall Study|Lost to Follow-up|4
5242921|NCT00805389|18091944|P5|Overall Study|Adverse Event|0
5242922|NCT00805389|18091945|P4|Overall Study|Adverse Event|2
5242923|NCT00805389|18091946|P3|Overall Study|Adverse Event|1
5242924|NCT00805389|18091947|P2|Overall Study|Adverse Event|0
5242925|NCT00805389|18091948|P1|Overall Study|Adverse Event|0
5242926|NCT00805285|18092195|P1|Overall Study|Lack of Efficacy|1
5242927|NCT00805207|18092212|P9|Overall Study|Withdrawal by Subject|0
5242928|NCT00805207|18092213|P8|Overall Study|Withdrawal by Subject|0
5242929|NCT00805207|18092214|P7|Overall Study|Withdrawal by Subject|0
5242930|NCT00805207|18092215|P6|Overall Study|Withdrawal by Subject|2
5242931|NCT00805207|18092216|P5|Overall Study|Withdrawal by Subject|1
5242932|NCT00805207|18092217|P4|Overall Study|Withdrawal by Subject|0
5242933|NCT00805207|18092218|P3|Overall Study|Withdrawal by Subject|0
5242934|NCT00805207|18092219|P2|Overall Study|Withdrawal by Subject|1
5242935|NCT00805207|18092220|P1|Overall Study|Withdrawal by Subject|0
5242936|NCT00805207|18092212|P9|Overall Study|Physician Decision|0
5242937|NCT00805207|18092213|P8|Overall Study|Physician Decision|0
5242938|NCT00805207|18092214|P7|Overall Study|Physician Decision|0
5242939|NCT00805207|18092215|P6|Overall Study|Physician Decision|1
5242940|NCT00805207|18092216|P5|Overall Study|Physician Decision|0
5242941|NCT00805207|18092217|P4|Overall Study|Physician Decision|0
5242942|NCT00805207|18092218|P3|Overall Study|Physician Decision|0
5242943|NCT00805207|18092219|P2|Overall Study|Physician Decision|1
5242944|NCT00805207|18092220|P1|Overall Study|Physician Decision|0
5242945|NCT00805207|18092212|P9|Overall Study|Protocol Violation|0
5242946|NCT00805207|18092213|P8|Overall Study|Protocol Violation|0
5242947|NCT00805207|18092214|P7|Overall Study|Protocol Violation|0
5242948|NCT00805207|18092215|P6|Overall Study|Protocol Violation|0
5242949|NCT00805207|18092216|P5|Overall Study|Protocol Violation|0
5242950|NCT00805207|18092217|P4|Overall Study|Protocol Violation|0
5242951|NCT00805207|18092218|P3|Overall Study|Protocol Violation|1
5242952|NCT00805207|18092219|P2|Overall Study|Protocol Violation|0
5242953|NCT00805207|18092220|P1|Overall Study|Protocol Violation|0
5242954|NCT00805194|18092278|P2|Overall Study|Reasons other than stated above|16
5242955|NCT00805194|18092279|P1|Overall Study|Reasons other than stated above|20
5242956|NCT00805194|18092278|P2|Overall Study|Not treated|4
5242957|NCT00805194|18092279|P1|Overall Study|Not treated|3
5242958|NCT00805194|18092278|P2|Overall Study|Withdrawal by Subject|42
5242959|NCT00805194|18092279|P1|Overall Study|Withdrawal by Subject|60
5242960|NCT00805194|18092278|P2|Overall Study|Lost to Follow-up|5
5242961|NCT00805194|18092279|P1|Overall Study|Lost to Follow-up|5
5242962|NCT00805194|18092278|P2|Overall Study|Protocol Violation|9
5242963|NCT00805194|18092279|P1|Overall Study|Protocol Violation|9
5242964|NCT00805194|18092278|P2|Overall Study|Other AE|73
5242965|NCT00805194|18092279|P1|Overall Study|Other AE|84
5242966|NCT00805194|18092278|P2|Overall Study|Worsening or AE of underlying disease|70
5242967|NCT00805194|18092279|P1|Overall Study|Worsening or AE of underlying disease|64
5242968|NCT00805194|18092278|P2|Overall Study|Progressive disease (modified RECIST)|435
5242969|NCT00805194|18092279|P1|Overall Study|Progressive disease (modified RECIST)|404
5242970|NCT00805142|18092313|P2|Maintenance Period|Other|1
5242971|NCT00805142|18092314|P1|Maintenance Period|Other|0
5242972|NCT00805142|18092313|P2|Maintenance Period|Adverse Event|1
5242973|NCT00805142|18092314|P1|Maintenance Period|Adverse Event|0
5242974|NCT00805142|18092313|P2|Titration Period|Other|3
5242975|NCT00805142|18092314|P1|Titration Period|Other|0
5242976|NCT00805142|18092313|P2|Titration Period|Withdrawal of consent|1
5242977|NCT00805142|18092314|P1|Titration Period|Withdrawal of consent|0
5242978|NCT00805142|18092313|P2|Titration Period|Disease Progression|1
5242979|NCT00805142|18092314|P1|Titration Period|Disease Progression|2
5242980|NCT00805142|18092313|P2|Titration Period|Lost to Follow-up|1
5242981|NCT00805142|18092314|P1|Titration Period|Lost to Follow-up|0
5242982|NCT00805142|18092313|P2|Titration Period|Lack of Efficacy|1
5242983|NCT00805142|18092314|P1|Titration Period|Lack of Efficacy|1
5242984|NCT00805142|18092313|P2|Titration Period|Adverse Event|3
5242985|NCT00805142|18092314|P1|Titration Period|Adverse Event|3
5242986|NCT00805025|18092347|P1|Overall Study|Physician Decision|1
5242987|NCT00805025|18092347|P1|Overall Study|Withdrawal by Subject|2
5242988|NCT00805025|18092347|P1|Overall Study|Adverse Event|4
5242989|NCT00805025|18092347|P1|Overall Study|Screened but not enrolled/treated|42
5242990|NCT00804986|18092376|P6|Overall Study|Physician Decision|0
5242991|NCT00804986|18092377|P5|Overall Study|Physician Decision|0
5242992|NCT00804986|18092378|P4|Overall Study|Physician Decision|0
5242993|NCT00804986|18092379|P3|Overall Study|Physician Decision|0
5242994|NCT00804986|18092380|P2|Overall Study|Physician Decision|0
5242995|NCT00804986|18092381|P1|Overall Study|Physician Decision|1
5242996|NCT00804986|18092376|P6|Overall Study|Sponsor Decision|0
5242997|NCT00804986|18092377|P5|Overall Study|Sponsor Decision|0
5242998|NCT00804986|18092378|P4|Overall Study|Sponsor Decision|0
5242999|NCT00804986|18092379|P3|Overall Study|Sponsor Decision|0
5243000|NCT00804986|18092380|P2|Overall Study|Sponsor Decision|1
5243001|NCT00804986|18092381|P1|Overall Study|Sponsor Decision|0
5243002|NCT00804986|18092376|P6|Overall Study|Inclusion/Exclusion criteria not met|1
5243003|NCT00804986|18092377|P5|Overall Study|Inclusion/Exclusion criteria not met|0
5243004|NCT00804986|18092378|P4|Overall Study|Inclusion/Exclusion criteria not met|1
5243005|NCT00804986|18092379|P3|Overall Study|Inclusion/Exclusion criteria not met|0
5243006|NCT00804986|18092380|P2|Overall Study|Inclusion/Exclusion criteria not met|2
5243007|NCT00804986|18092381|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5243008|NCT00804986|18092376|P6|Overall Study|Withdrawal by Subject|3
5243009|NCT00804986|18092377|P5|Overall Study|Withdrawal by Subject|5
5243010|NCT00804986|18092378|P4|Overall Study|Withdrawal by Subject|3
5243011|NCT00804986|18092379|P3|Overall Study|Withdrawal by Subject|0
5243012|NCT00804986|18092380|P2|Overall Study|Withdrawal by Subject|3
5243013|NCT00804986|18092381|P1|Overall Study|Withdrawal by Subject|0
5243014|NCT00804986|18092376|P6|Overall Study|Protocol Violation|0
5243015|NCT00804986|18092377|P5|Overall Study|Protocol Violation|0
5243016|NCT00804986|18092378|P4|Overall Study|Protocol Violation|1
5243017|NCT00804986|18092379|P3|Overall Study|Protocol Violation|0
5243018|NCT00804986|18092380|P2|Overall Study|Protocol Violation|1
5243019|NCT00804986|18092381|P1|Overall Study|Protocol Violation|0
5243020|NCT00804986|18092376|P6|Overall Study|Lost to Follow-up|3
5243021|NCT00804986|18092377|P5|Overall Study|Lost to Follow-up|1
5243022|NCT00804986|18092378|P4|Overall Study|Lost to Follow-up|1
5243023|NCT00804986|18092379|P3|Overall Study|Lost to Follow-up|0
5243024|NCT00804986|18092380|P2|Overall Study|Lost to Follow-up|0
5243025|NCT00804986|18092381|P1|Overall Study|Lost to Follow-up|0
5243026|NCT00804986|18092376|P6|Overall Study|Lack of Efficacy|3
5243027|NCT00804986|18092377|P5|Overall Study|Lack of Efficacy|0
5243028|NCT00804986|18092378|P4|Overall Study|Lack of Efficacy|1
5243029|NCT00804986|18092379|P3|Overall Study|Lack of Efficacy|0
5243030|NCT00804986|18092380|P2|Overall Study|Lack of Efficacy|0
5243031|NCT00804986|18092381|P1|Overall Study|Lack of Efficacy|0
5243032|NCT00804986|18092376|P6|Overall Study|Adverse Event|0
5243033|NCT00804986|18092377|P5|Overall Study|Adverse Event|3
5243034|NCT00804986|18092378|P4|Overall Study|Adverse Event|1
5243035|NCT00804986|18092379|P3|Overall Study|Adverse Event|2
5243036|NCT00804986|18092380|P2|Overall Study|Adverse Event|1
5243037|NCT00804986|18092381|P1|Overall Study|Adverse Event|0
5243038|NCT00804908|18092516|P3|Overall Study|Other|114
5243039|NCT00804908|18092517|P2|Overall Study|Other|116
5243040|NCT00804908|18092518|P1|Overall Study|Other|115
5243041|NCT00804843|18092549|P2|Overall Study|Withdrawal by Subject|2
5243042|NCT00804843|18092550|P1|Overall Study|Withdrawal by Subject|1
5243043|NCT00804843|18092549|P2|Overall Study|Adverse Event|5
5243044|NCT00804843|18092550|P1|Overall Study|Adverse Event|8
5243045|NCT00804843|18092549|P2|Overall Study|Protocol Violation|0
5243046|NCT00804843|18092550|P1|Overall Study|Protocol Violation|1
5243047|NCT00804687|18092568|P6|Period 5: Treatment Period|Positive drug test|0
5243048|NCT00804687|18092569|P5|Period 5: Treatment Period|Positive drug test|0
5243049|NCT00804687|18092570|P4|Period 5: Treatment Period|Positive drug test|0
5243050|NCT00804687|18092571|P3|Period 5: Treatment Period|Positive drug test|0
5243051|NCT00804687|18092572|P2|Period 5: Treatment Period|Positive drug test|0
5243052|NCT00804687|18092573|P1|Period 5: Treatment Period|Positive drug test|1
5243053|NCT00804687|18092568|P6|Period 5: Treatment Period|Positive drugs of abuse|0
5243054|NCT00804687|18092569|P5|Period 5: Treatment Period|Positive drugs of abuse|0
5243055|NCT00804687|18092570|P4|Period 5: Treatment Period|Positive drugs of abuse|0
5243056|NCT00804687|18092571|P3|Period 5: Treatment Period|Positive drugs of abuse|1
5243057|NCT00804687|18092572|P2|Period 5: Treatment Period|Positive drugs of abuse|0
5243058|NCT00804687|18092573|P1|Period 5: Treatment Period|Positive drugs of abuse|0
5243059|NCT00804687|18092568|P6|Period 5: Treatment Period|Withdrawal by Subject|0
5243060|NCT00804687|18092569|P5|Period 5: Treatment Period|Withdrawal by Subject|1
5243061|NCT00804687|18092570|P4|Period 5: Treatment Period|Withdrawal by Subject|0
5243062|NCT00804687|18092571|P3|Period 5: Treatment Period|Withdrawal by Subject|0
5243063|NCT00804687|18092572|P2|Period 5: Treatment Period|Withdrawal by Subject|0
5243064|NCT00804687|18092573|P1|Period 5: Treatment Period|Withdrawal by Subject|0
5243065|NCT00804687|18092568|P6|Period 3: Treatment Period|Positive Drug screen|0
5243066|NCT00804687|18092569|P5|Period 3: Treatment Period|Positive Drug screen|0
5243067|NCT00804687|18092570|P4|Period 3: Treatment Period|Positive Drug screen|1
5243068|NCT00804687|18092571|P3|Period 3: Treatment Period|Positive Drug screen|0
5243069|NCT00804687|18092572|P2|Period 3: Treatment Period|Positive Drug screen|0
5243070|NCT00804687|18092573|P1|Period 3: Treatment Period|Positive Drug screen|0
5243071|NCT00804570|18092652|P2|Overall Study|Withdrawal by Subject|38
5243072|NCT00804570|18092653|P1|Overall Study|Withdrawal by Subject|21
5243073|NCT00804570|18092652|P2|Overall Study|Sponsor decision|4
5243074|NCT00804570|18092653|P1|Overall Study|Sponsor decision|1
5243075|NCT00804570|18092652|P2|Overall Study|Physician Decision|2
5243076|NCT00804570|18092653|P1|Overall Study|Physician Decision|1
5243077|NCT00804570|18092652|P2|Overall Study|Protocol Violation|16
5243078|NCT00804570|18092653|P1|Overall Study|Protocol Violation|12
5243079|NCT00804570|18092652|P2|Overall Study|Entry criteria not met|5
5243080|NCT00804570|18092653|P1|Overall Study|Entry criteria not met|5
5243081|NCT00804570|18092652|P2|Overall Study|Lost to Follow-up|21
5243082|NCT00804570|18092653|P1|Overall Study|Lost to Follow-up|18
5243083|NCT00804570|18092652|P2|Overall Study|Lack of Efficacy|1
5243084|NCT00804570|18092653|P1|Overall Study|Lack of Efficacy|0
5243085|NCT00804570|18092652|P2|Overall Study|Adverse Event|7
5243086|NCT00804570|18092653|P1|Overall Study|Adverse Event|14
5243087|NCT00804193|18092727|P3|Overall Study|Withdrawal by Subject|2
5243088|NCT00804193|18092728|P2|Overall Study|Withdrawal by Subject|1
5243089|NCT00804193|18092729|P1|Overall Study|Withdrawal by Subject|3
5243090|NCT00804193|18092727|P3|Overall Study|Lost to Follow-up|4
5243091|NCT00804193|18092728|P2|Overall Study|Lost to Follow-up|3
5243092|NCT00804193|18092729|P1|Overall Study|Lost to Follow-up|3
5243093|NCT00804193|18092727|P3|Overall Study|Protocol Violation|2
5243094|NCT00804193|18092728|P2|Overall Study|Protocol Violation|8
5243095|NCT00804193|18092729|P1|Overall Study|Protocol Violation|0
5243096|NCT00804193|18092727|P3|Overall Study|Lack of Efficacy|3
5243097|NCT00804193|18092728|P2|Overall Study|Lack of Efficacy|1
5243098|NCT00804193|18092729|P1|Overall Study|Lack of Efficacy|1
5243099|NCT00804193|18092727|P3|Overall Study|Adverse Event|2
5243100|NCT00804193|18092728|P2|Overall Study|Adverse Event|0
5243101|NCT00804193|18092729|P1|Overall Study|Adverse Event|0
5243102|NCT00804193|18092727|P3|Overall Study|Lack of baseline fungus|19
5243103|NCT00804193|18092728|P2|Overall Study|Lack of baseline fungus|31
5243104|NCT00804193|18092729|P1|Overall Study|Lack of baseline fungus|32
5243105|NCT00804141|18092743|P1|Overall Study|Enrolled but not treated|6
5243106|NCT00804141|18092743|P1|Overall Study|Other than specified|30
5243107|NCT00804141|18092743|P1|Overall Study|Lack of Efficacy|46
5243108|NCT00804141|18092743|P1|Overall Study|Withdrawal by Subject|131
5243109|NCT00804141|18092743|P1|Overall Study|Protocol Violation|85
5243110|NCT00804141|18092743|P1|Overall Study|Investigator request|8
5243111|NCT00804141|18092743|P1|Overall Study|Failed to return|96
5243112|NCT00804141|18092743|P1|Overall Study|Death|4
5243113|NCT00804141|18092743|P1|Overall Study|Adverse Event|157
5243114|NCT00803790|18092783|P4|Period 2|Positive Drug Screen or Personal Reasons|0
5243115|NCT00803790|18092784|P3|Period 2|Positive Drug Screen or Personal Reasons|0
5243116|NCT00803790|18092785|P2|Period 2|Positive Drug Screen or Personal Reasons|0
5243117|NCT00803790|18092786|P1|Period 2|Positive Drug Screen or Personal Reasons|1
5243118|NCT00803790|18092783|P4|Period 2|Withdrawal by Subject|0
5243119|NCT00803790|18092784|P3|Period 2|Withdrawal by Subject|0
5243120|NCT00803790|18092785|P2|Period 2|Withdrawal by Subject|0
5243121|NCT00803790|18092786|P1|Period 2|Withdrawal by Subject|1
5243122|NCT00803790|18092783|P4|Period 2|Adverse Event|1
5243123|NCT00803790|18092784|P3|Period 2|Adverse Event|1
5243124|NCT00803790|18092785|P2|Period 2|Adverse Event|0
5243125|NCT00803790|18092786|P1|Period 2|Adverse Event|0
5243126|NCT00803790|18092783|P4|Period 1|Protocol Violation|0
5243127|NCT00803790|18092784|P3|Period 1|Protocol Violation|1
5243128|NCT00803790|18092785|P2|Period 1|Protocol Violation|0
5243129|NCT00803790|18092786|P1|Period 1|Protocol Violation|0
5243130|NCT00803790|18092783|P4|Period 1|positive drug screen or personal reasons|4
5243131|NCT00803790|18092784|P3|Period 1|positive drug screen or personal reasons|0
5243132|NCT00803790|18092785|P2|Period 1|positive drug screen or personal reasons|3
5243133|NCT00803790|18092786|P1|Period 1|positive drug screen or personal reasons|0
5243134|NCT00803790|18092783|P4|Period 1|Withdrawal by Subject|0
5243135|NCT00803790|18092784|P3|Period 1|Withdrawal by Subject|0
5243136|NCT00803790|18092785|P2|Period 1|Withdrawal by Subject|6
5243137|NCT00803790|18092786|P1|Period 1|Withdrawal by Subject|8
5243138|NCT00803790|18092783|P4|Period 1|Lost to Follow-up|0
5243139|NCT00803790|18092784|P3|Period 1|Lost to Follow-up|0
5243140|NCT00803790|18092785|P2|Period 1|Lost to Follow-up|2
5243141|NCT00803790|18092786|P1|Period 1|Lost to Follow-up|1
5243142|NCT00803790|18092783|P4|Period 1|Adverse Event|0
5243143|NCT00803790|18092784|P3|Period 1|Adverse Event|0
5243144|NCT00803790|18092785|P2|Period 1|Adverse Event|1
5243145|NCT00803790|18092786|P1|Period 1|Adverse Event|0
5243146|NCT00803738|18092826|P2|Overall Study|Positive Results for STD or abnormal PAP|8
5243147|NCT00803738|18092827|P1|Overall Study|Positive Results for STD or abnormal PAP|2
5243148|NCT00803738|18092826|P2|Overall Study|Negative Baseline Culture of Candida|63
5243149|NCT00803738|18092827|P1|Overall Study|Negative Baseline Culture of Candida|56
5243150|NCT00803738|18092826|P2|Overall Study|Lack of Efficacy|16
5243151|NCT00803738|18092827|P1|Overall Study|Lack of Efficacy|10
5243152|NCT00803738|18092826|P2|Overall Study|Withdrawal by Subject|4
5243153|NCT00803738|18092827|P1|Overall Study|Withdrawal by Subject|1
5243154|NCT00803738|18092826|P2|Overall Study|Protocol Violation|10
5243155|NCT00803738|18092827|P1|Overall Study|Protocol Violation|18
5243156|NCT00803738|18092826|P2|Overall Study|Lost to Follow-up|4
5243157|NCT00803738|18092827|P1|Overall Study|Lost to Follow-up|4
5243158|NCT00803738|18092826|P2|Overall Study|Adverse Event|5
5243159|NCT00803738|18092827|P1|Overall Study|Adverse Event|3
5243160|NCT00803712|18092839|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
5243161|NCT00803712|18092840|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
5243162|NCT00803712|18092839|P2|Overall Study|Administrative decision|3
5243163|NCT00803712|18092840|P1|Overall Study|Administrative decision|2
5243164|NCT00803712|18092839|P2|Overall Study|Protocol criteria (renal transplant)|8
5243165|NCT00803712|18092840|P1|Overall Study|Protocol criteria (renal transplant)|12
5243166|NCT00803712|18092839|P2|Overall Study|Protocol criteria (other)|2
5243167|NCT00803712|18092840|P1|Overall Study|Protocol criteria (other)|0
5243168|NCT00803712|18092839|P2|Overall Study|"Other in electronic Case Report Form"|1
5243169|NCT00803712|18092840|P1|Overall Study|"Other in electronic Case Report Form"|0
5243170|NCT00803712|18092839|P2|Overall Study|Withdrawal by Subject|4
5243171|NCT00803712|18092840|P1|Overall Study|Withdrawal by Subject|2
5243172|NCT00803712|18092839|P2|Overall Study|Lost to Follow-up|1
5243173|NCT00803712|18092840|P1|Overall Study|Lost to Follow-up|3
5243174|NCT00803712|18092839|P2|Overall Study|Death|7
5243175|NCT00803712|18092840|P1|Overall Study|Death|8
5243176|NCT00803712|18092839|P2|Overall Study|Adverse Event|0
5243177|NCT00803712|18092840|P1|Overall Study|Adverse Event|5
5243178|NCT00803712|18092839|P2|Overall Study|Noncompliance|0
5243179|NCT00803712|18092840|P1|Overall Study|Noncompliance|3
5243180|NCT00803634|18092939|P2|Overall Study|Death|2
5243181|NCT00803634|18092940|P1|Overall Study|Death|3
5243182|NCT00803634|18092939|P2|Overall Study|Lost to Follow-up|3
5243183|NCT00803634|18092940|P1|Overall Study|Lost to Follow-up|2
5243184|NCT00803634|18092939|P2|Overall Study|Withdrew Consent|0
5243185|NCT00803634|18092940|P1|Overall Study|Withdrew Consent|1
5243186|NCT00803595|18092969|P3|Overall Study|Withdrawal by Subject|3
5243187|NCT00803595|18092970|P2|Overall Study|Withdrawal by Subject|2
5243188|NCT00803595|18092971|P1|Overall Study|Withdrawal by Subject|5
5243189|NCT00803595|18092969|P3|Overall Study|Protocol Violation|12
5243190|NCT00803595|18092970|P2|Overall Study|Protocol Violation|2
5243191|NCT00803595|18092971|P1|Overall Study|Protocol Violation|7
5243192|NCT00803595|18092969|P3|Overall Study|Adverse Event|1
5243193|NCT00803595|18092970|P2|Overall Study|Adverse Event|4
5243194|NCT00803595|18092971|P1|Overall Study|Adverse Event|3
5243195|NCT00803569|18092982|P1|Overall Study|Noncompliance|1
5243196|NCT00803569|18092982|P1|Overall Study|Progressive Disease|3
5243197|NCT00803452|18093016|P2|Overall Study|Lost to Follow-up|3
5243198|NCT00803452|18093017|P1|Overall Study|Lost to Follow-up|0
5243199|NCT00803452|18093016|P2|Overall Study|Adverse Event|2
5243200|NCT00803452|18093017|P1|Overall Study|Adverse Event|0
5243201|NCT00803361|18093055|P2|Overall Study|Withdrawal by Subject|6
5243202|NCT00803361|18093056|P1|Overall Study|Withdrawal by Subject|5
5243203|NCT00803361|18093055|P2|Overall Study|Protocol Violation|4
5243204|NCT00803361|18093056|P1|Overall Study|Protocol Violation|2
5243205|NCT00803361|18093055|P2|Overall Study|Physician Decision|0
5243206|NCT00803361|18093056|P1|Overall Study|Physician Decision|1
5243207|NCT00803361|18093055|P2|Overall Study|Lost to Follow-up|2
5243208|NCT00803361|18093056|P1|Overall Study|Lost to Follow-up|1
5243209|NCT00803361|18093055|P2|Overall Study|Lack of Efficacy|13
5243210|NCT00803361|18093056|P1|Overall Study|Lack of Efficacy|4
5243211|NCT00803361|18093055|P2|Overall Study|Adverse Event|3
5243212|NCT00803361|18093056|P1|Overall Study|Adverse Event|13
5243213|NCT00803270|18093103|P2|Overall Study|Lost to Follow-up|2
5243214|NCT00803270|18093104|P1|Overall Study|Lost to Follow-up|1
5243215|NCT00803244|18093114|P2|Overall Study|Any other reason not above-mentioned|10
5243216|NCT00803244|18093115|P1|Overall Study|Any other reason not above-mentioned|4
5243217|NCT00803244|18093114|P2|Overall Study|Withdrawal by Subject|3
5243218|NCT00803244|18093115|P1|Overall Study|Withdrawal by Subject|2
5243219|NCT00803244|18093114|P2|Overall Study|Adverse Event|2
5243220|NCT00803244|18093115|P1|Overall Study|Adverse Event|1
5243221|NCT00803205|18093125|P2|Overall Study|Sponsor Decision|1
5243222|NCT00803205|18093126|P1|Overall Study|Sponsor Decision|0
5243223|NCT00803205|18093125|P2|Overall Study|Acquired a Lung Infection|1
5243224|NCT00803205|18093126|P1|Overall Study|Acquired a Lung Infection|0
5243225|NCT00803205|18093125|P2|Overall Study|Medical Monitor Decision|0
5243226|NCT00803205|18093126|P1|Overall Study|Medical Monitor Decision|1
5243227|NCT00803205|18093125|P2|Overall Study|Protocol Violation|1
5243228|NCT00803205|18093126|P1|Overall Study|Protocol Violation|1
5243229|NCT00803205|18093125|P2|Overall Study|Physician Decision|0
5243230|NCT00803205|18093126|P1|Overall Study|Physician Decision|1
5243231|NCT00803205|18093125|P2|Overall Study|Withdrawal by Subject|9
5243232|NCT00803205|18093126|P1|Overall Study|Withdrawal by Subject|9
5243233|NCT00803205|18093125|P2|Overall Study|Lost to Follow-up|0
5243234|NCT00803205|18093126|P1|Overall Study|Lost to Follow-up|1
5243235|NCT00803205|18093125|P2|Overall Study|Adverse Event|2
5243236|NCT00803205|18093126|P1|Overall Study|Adverse Event|7
5243237|NCT00803179|18093169|P1|Overall Study|Lost to Follow-up|3
5243238|NCT00803101|18093188|P2|Overall Study|Patient did not have surgery|1
5243239|NCT00803101|18093189|P1|Overall Study|Patient did not have surgery|1
5243240|NCT00803101|18093188|P2|Overall Study|Patient did not attend scheduled visit|1
5243241|NCT00803101|18093189|P1|Overall Study|Patient did not attend scheduled visit|2
5243242|NCT00803101|18093188|P2|Overall Study|Patient died outside SAE report period|0
5243243|NCT00803101|18093189|P1|Overall Study|Patient died outside SAE report period|1
5243244|NCT00803101|18093188|P2|Overall Study|Surgery finished outside protocol window|1
5243245|NCT00803101|18093189|P1|Overall Study|Surgery finished outside protocol window|1
5243246|NCT00803101|18093188|P2|Overall Study|Protocol Violation|7
5243247|NCT00803101|18093189|P1|Overall Study|Protocol Violation|1
5243248|NCT00803101|18093188|P2|Overall Study|Lost to Follow-up|2
5243249|NCT00803101|18093189|P1|Overall Study|Lost to Follow-up|2
5243250|NCT00803101|18093188|P2|Overall Study|Withdrawal by Subject|4
5243251|NCT00803101|18093189|P1|Overall Study|Withdrawal by Subject|6
5243252|NCT00803101|18093188|P2|Overall Study|Death / Serious Adverse Event|6
5243253|NCT00803101|18093189|P1|Overall Study|Death / Serious Adverse Event|4
5243254|NCT00803049|18093240|P4|Overall Study|Other than Specified Above|5
5243255|NCT00803049|18093241|P3|Overall Study|Other than Specified Above|2
5243256|NCT00803049|18093242|P2|Overall Study|Other than Specified Above|9
5243257|NCT00803049|18093243|P1|Overall Study|Other than Specified Above|3
5243258|NCT00803049|18093240|P4|Overall Study|Randomized and Not Treated|2
5243259|NCT00803049|18093241|P3|Overall Study|Randomized and Not Treated|0
5243260|NCT00803049|18093242|P2|Overall Study|Randomized and Not Treated|0
5243261|NCT00803049|18093243|P1|Overall Study|Randomized and Not Treated|0
5243262|NCT00803049|18093240|P4|Overall Study|Protocol Violation|0
5243263|NCT00803049|18093241|P3|Overall Study|Protocol Violation|1
5243264|NCT00803049|18093242|P2|Overall Study|Protocol Violation|1
5243265|NCT00803049|18093243|P1|Overall Study|Protocol Violation|0
5243266|NCT00803049|18093240|P4|Overall Study|Withdrawal by Subject|44
5243267|NCT00803049|18093241|P3|Overall Study|Withdrawal by Subject|16
5243268|NCT00803049|18093242|P2|Overall Study|Withdrawal by Subject|43
5243269|NCT00803049|18093243|P1|Overall Study|Withdrawal by Subject|19
5243270|NCT00803049|18093240|P4|Overall Study|Progressive Disease|6
5243271|NCT00803049|18093241|P3|Overall Study|Progressive Disease|6
5243272|NCT00803049|18093242|P2|Overall Study|Progressive Disease|10
5243273|NCT00803049|18093243|P1|Overall Study|Progressive Disease|6
5243274|NCT00803049|18093240|P4|Overall Study|Death|2
5243275|NCT00803049|18093241|P3|Overall Study|Death|0
5243276|NCT00803049|18093242|P2|Overall Study|Death|1
5243277|NCT00803049|18093243|P1|Overall Study|Death|2
5243278|NCT00803049|18093240|P4|Overall Study|Lost to Follow-up|3
5243279|NCT00803049|18093241|P3|Overall Study|Lost to Follow-up|0
5243280|NCT00803049|18093242|P2|Overall Study|Lost to Follow-up|2
5243281|NCT00803049|18093243|P1|Overall Study|Lost to Follow-up|0
5243282|NCT00803049|18093240|P4|Overall Study|Lack of Efficacy|13
5243283|NCT00803049|18093241|P3|Overall Study|Lack of Efficacy|6
5243284|NCT00803049|18093242|P2|Overall Study|Lack of Efficacy|19
5243285|NCT00803049|18093243|P1|Overall Study|Lack of Efficacy|10
5243286|NCT00803049|18093240|P4|Overall Study|Adverse Event|27
5243287|NCT00803049|18093241|P3|Overall Study|Adverse Event|13
5243288|NCT00803049|18093242|P2|Overall Study|Adverse Event|33
5243289|NCT00803049|18093243|P1|Overall Study|Adverse Event|21
5243290|NCT00803023|18093277|P4|Overall Study|Lack of Efficacy|1
5243291|NCT00803023|18093278|P3|Overall Study|Lack of Efficacy|1
5243292|NCT00803023|18093279|P2|Overall Study|Lack of Efficacy|1
5243293|NCT00803023|18093280|P1|Overall Study|Lack of Efficacy|0
5243294|NCT00803023|18093277|P4|Overall Study|Lost to Follow-up|1
5243295|NCT00803023|18093278|P3|Overall Study|Lost to Follow-up|2
5243296|NCT00803023|18093279|P2|Overall Study|Lost to Follow-up|1
5243297|NCT00803023|18093280|P1|Overall Study|Lost to Follow-up|0
5243298|NCT00803023|18093277|P4|Overall Study|Withdrawal by Subject|0
5243299|NCT00803023|18093278|P3|Overall Study|Withdrawal by Subject|0
5243300|NCT00803023|18093279|P2|Overall Study|Withdrawal by Subject|2
5243301|NCT00803023|18093280|P1|Overall Study|Withdrawal by Subject|0
5243302|NCT00803023|18093277|P4|Overall Study|Adverse Event|6
5243303|NCT00803023|18093278|P3|Overall Study|Adverse Event|8
5243304|NCT00803023|18093279|P2|Overall Study|Adverse Event|4
5243305|NCT00803023|18093280|P1|Overall Study|Adverse Event|5
5243306|NCT00802945|18093318|P2|Overall Study|Terminated by sponsor|12
5243307|NCT00802945|18093319|P1|Overall Study|Terminated by sponsor|8
5243308|NCT00802945|18093318|P2|Overall Study|Death|23
5243309|NCT00802945|18093319|P1|Overall Study|Death|27
5243310|NCT00802893|18093350|P1|Overall Study|study terminated|3
5243311|NCT00802867|18093374|P1|Overall Study|Withdrawal by Subject|1
5243312|NCT00802867|18093374|P1|Overall Study|Protocol Violation|6
5243313|NCT00802867|18093374|P1|Overall Study|Lost to Follow-up|6
5243314|NCT00802841|18093397|P2|Overall Study|Treatment duration completed|76
5243315|NCT00802841|18093398|P1|Overall Study|Treatment duration completed|66
5243316|NCT00802841|18093397|P2|Overall Study|Protocol deviation|6
5243317|NCT00802841|18093398|P1|Overall Study|Protocol deviation|2
5243318|NCT00802841|18093397|P2|Overall Study|Withdrawal by Subject|5
5243319|NCT00802841|18093398|P1|Overall Study|Withdrawal by Subject|9
5243320|NCT00802841|18093397|P2|Overall Study|Disease progression|3
5243321|NCT00802841|18093398|P1|Overall Study|Disease progression|7
5243322|NCT00802841|18093397|P2|Overall Study|Adverse Event|2
5243323|NCT00802841|18093398|P1|Overall Study|Adverse Event|8
5243324|NCT00802841|18093397|P2|Overall Study|Death|2
5243325|NCT00802841|18093398|P1|Overall Study|Death|1
5243326|NCT00802841|18093397|P2|Overall Study|Lost to Follow-up|1
5243327|NCT00802841|18093398|P1|Overall Study|Lost to Follow-up|2
5243328|NCT00802841|18093397|P2|Overall Study|Administrative problems|0
5243329|NCT00802841|18093398|P1|Overall Study|Administrative problems|1
5243330|NCT00802737|18093423|P3|Overall Study|Participant too Unwell|0
5243331|NCT00802737|18093424|P2|Overall Study|Participant too Unwell|2
5243332|NCT00802737|18093425|P1|Overall Study|Participant too Unwell|0
5243333|NCT00802737|18093423|P3|Overall Study|Ongoing CLL-Treatment|0
5243334|NCT00802737|18093424|P2|Overall Study|Ongoing CLL-Treatment|1
5243335|NCT00802737|18093425|P1|Overall Study|Ongoing CLL-Treatment|0
5243336|NCT00802737|18093423|P3|Overall Study|Received Prohibited Therapy|0
5243337|NCT00802737|18093424|P2|Overall Study|Received Prohibited Therapy|0
5243338|NCT00802737|18093425|P1|Overall Study|Received Prohibited Therapy|1
5243339|NCT00802737|18093423|P3|Overall Study|Adverse Event|0
5243340|NCT00802737|18093424|P2|Overall Study|Adverse Event|0
5243341|NCT00802737|18093425|P1|Overall Study|Adverse Event|1
5243342|NCT00802737|18093423|P3|Overall Study|Death|1
5243343|NCT00802737|18093424|P2|Overall Study|Death|5
5243344|NCT00802737|18093425|P1|Overall Study|Death|6
5243345|NCT00802737|18093423|P3|Overall Study|Withdrawn due to Disease Progression|0
5243346|NCT00802737|18093424|P2|Overall Study|Withdrawn due to Disease Progression|3
5243347|NCT00802737|18093425|P1|Overall Study|Withdrawn due to Disease Progression|9
5243348|NCT00802672|18093485|P3|Overall Study|other|2
5243349|NCT00802672|18093486|P2|Overall Study|other|1
5243350|NCT00802672|18093487|P1|Overall Study|other|3
5243351|NCT00802672|18093485|P3|Overall Study|Withdrawal by Subject|2
5243352|NCT00802672|18093486|P2|Overall Study|Withdrawal by Subject|1
5243353|NCT00802672|18093487|P1|Overall Study|Withdrawal by Subject|1
5243354|NCT00802672|18093485|P3|Overall Study|Lost to Follow-up|3
5243355|NCT00802672|18093486|P2|Overall Study|Lost to Follow-up|5
5243356|NCT00802672|18093487|P1|Overall Study|Lost to Follow-up|5
5243357|NCT00802672|18093485|P3|Overall Study|Protocol Violation|1
5243358|NCT00802672|18093486|P2|Overall Study|Protocol Violation|1
5243359|NCT00802672|18093487|P1|Overall Study|Protocol Violation|2
5243360|NCT00802672|18093485|P3|Overall Study|Adverse Event|1
5243361|NCT00802672|18093486|P2|Overall Study|Adverse Event|1
5243362|NCT00802672|18093487|P1|Overall Study|Adverse Event|1
5243363|NCT00802672|18093485|P3|Overall Study|Lack of fungal pathogen at baseline|25
5243364|NCT00802672|18093486|P2|Overall Study|Lack of fungal pathogen at baseline|43
5243365|NCT00802672|18093487|P1|Overall Study|Lack of fungal pathogen at baseline|56
5243366|NCT00802659|18093505|P4|Overall Study|Physician Decision|0
5243367|NCT00802659|18093506|P3|Overall Study|Physician Decision|0
5243368|NCT00802659|18093507|P2|Overall Study|Physician Decision|1
5243369|NCT00802659|18093508|P1|Overall Study|Physician Decision|0
5243370|NCT00802529|18093547|P2|Overall Study|Lost to Follow-up|1
5243371|NCT00802529|18093548|P1|Overall Study|Lost to Follow-up|0
5243372|NCT00802464|18093587|P4|Month 8 - Month 14|Lost to Follow-up|0
5243373|NCT00802464|18093588|P3|Month 8 - Month 14|Lost to Follow-up|1
5243374|NCT00802464|18093589|P2|Month 8 - Month 14|Lost to Follow-up|0
5243375|NCT00802464|18093590|P1|Month 8 - Month 14|Lost to Follow-up|0
5243376|NCT00802464|18093587|P4|Month 8 - Month 14|Withdrawal by Subject|0
5243377|NCT00802464|18093588|P3|Month 8 - Month 14|Withdrawal by Subject|0
5243378|NCT00802464|18093589|P2|Month 8 - Month 14|Withdrawal by Subject|1
5243379|NCT00802464|18093590|P1|Month 8 - Month 14|Withdrawal by Subject|1
5243380|NCT00802464|18093587|P4|Month 8 - Month 14|Adverse Event|0
5243381|NCT00802464|18093588|P3|Month 8 - Month 14|Adverse Event|0
5243382|NCT00802464|18093589|P2|Month 8 - Month 14|Adverse Event|1
5243383|NCT00802464|18093590|P1|Month 8 - Month 14|Adverse Event|0
5243384|NCT00802464|18093587|P4|Month 0 - Month 8|Other|0
5243385|NCT00802464|18093588|P3|Month 0 - Month 8|Other|1
5243386|NCT00802464|18093589|P2|Month 0 - Month 8|Other|0
5243387|NCT00802464|18093590|P1|Month 0 - Month 8|Other|0
5243388|NCT00802464|18093587|P4|Month 0 - Month 8|Lost to Follow-up|2
5243389|NCT00802464|18093588|P3|Month 0 - Month 8|Lost to Follow-up|2
5243390|NCT00802464|18093589|P2|Month 0 - Month 8|Lost to Follow-up|1
5243391|NCT00802464|18093590|P1|Month 0 - Month 8|Lost to Follow-up|0
5243392|NCT00802464|18093587|P4|Month 0 - Month 8|Withdrawal by Subject|5
5243393|NCT00802464|18093588|P3|Month 0 - Month 8|Withdrawal by Subject|2
5243394|NCT00802464|18093589|P2|Month 0 - Month 8|Withdrawal by Subject|1
5243395|NCT00802464|18093590|P1|Month 0 - Month 8|Withdrawal by Subject|0
5243396|NCT00802464|18093587|P4|Month 0 - Month 8|Protocol Violation|0
5243397|NCT00802464|18093588|P3|Month 0 - Month 8|Protocol Violation|1
5243398|NCT00802464|18093589|P2|Month 0 - Month 8|Protocol Violation|0
5243399|NCT00802464|18093590|P1|Month 0 - Month 8|Protocol Violation|0
5243400|NCT00802464|18093587|P4|Month 0 - Month 8|Adverse Event|2
5243401|NCT00802464|18093588|P3|Month 0 - Month 8|Adverse Event|1
5243402|NCT00802464|18093589|P2|Month 0 - Month 8|Adverse Event|1
5243403|NCT00802464|18093590|P1|Month 0 - Month 8|Adverse Event|0
5243404|NCT00802438|18093676|P1|Overall Study|Physician Decision|1
5243405|NCT00802438|18093676|P1|Overall Study|Withdrawal by Subject|7
5243406|NCT00802438|18093676|P1|Overall Study|Screen Failure|20
5243407|NCT00802360|18093696|P4|Overall Study|Other|3
5243408|NCT00802360|18093697|P3|Overall Study|Other|6
5243409|NCT00802360|18093698|P2|Overall Study|Other|3
5243410|NCT00802360|18093699|P1|Overall Study|Other|2
5243411|NCT00802360|18093696|P4|Overall Study|Pregnancy loss/miscarriage|3
5243412|NCT00802360|18093697|P3|Overall Study|Pregnancy loss/miscarriage|0
5243413|NCT00802360|18093698|P2|Overall Study|Pregnancy loss/miscarriage|2
5243414|NCT00802360|18093699|P1|Overall Study|Pregnancy loss/miscarriage|0
5243415|NCT00802360|18093696|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
5243416|NCT00802360|18093697|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
5243417|NCT00802360|18093698|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
5243418|NCT00802360|18093699|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
5243419|NCT00802360|18093696|P4|Overall Study|No positive serum pregnancy|10
5243420|NCT00802360|18093697|P3|Overall Study|No positive serum pregnancy|14
5243421|NCT00802360|18093698|P2|Overall Study|No positive serum pregnancy|20
5243422|NCT00802360|18093699|P1|Overall Study|No positive serum pregnancy|17
5243423|NCT00802360|18093696|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
5243424|NCT00802360|18093697|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
5243425|NCT00802360|18093698|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
5243426|NCT00802360|18093699|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
5243427|NCT00802360|18093696|P4|Overall Study|Cycle cancelled|1
5243428|NCT00802360|18093697|P3|Overall Study|Cycle cancelled|1
5243429|NCT00802360|18093698|P2|Overall Study|Cycle cancelled|1
5243430|NCT00802360|18093699|P1|Overall Study|Cycle cancelled|0
5243431|NCT00802360|18093696|P4|Overall Study|Inadequate number of oocytes retrieved|1
5243432|NCT00802360|18093697|P3|Overall Study|Inadequate number of oocytes retrieved|0
5243433|NCT00802360|18093698|P2|Overall Study|Inadequate number of oocytes retrieved|0
5243434|NCT00802360|18093699|P1|Overall Study|Inadequate number of oocytes retrieved|0
5243435|NCT00802360|18093696|P4|Overall Study|Stimulation failure|3
5243436|NCT00802360|18093697|P3|Overall Study|Stimulation failure|3
5243437|NCT00802360|18093698|P2|Overall Study|Stimulation failure|0
5243438|NCT00802360|18093699|P1|Overall Study|Stimulation failure|4
5243439|NCT00802178|18093766|P1|Overall Study|Patients wish and other reason|1
5243440|NCT00802178|18093766|P1|Overall Study|IT and patient wish|8
5243441|NCT00802178|18093766|P1|Overall Study|Lack of efficacy and patient wish|1
5243442|NCT00802178|18093766|P1|Overall Study|Other|32
5243443|NCT00802178|18093766|P1|Overall Study|Withdrawal by Subject|18
5243444|NCT00802178|18093766|P1|Overall Study|Insufficient tolerability (IT)|17
5243445|NCT00802178|18093766|P1|Overall Study|Lack of Efficacy|36
5243446|NCT00802074|18093814|P6|Overall Study|Withdrawal by Subject|0
5243447|NCT00802074|18093815|P5|Overall Study|Withdrawal by Subject|0
5243448|NCT00802074|18093816|P4|Overall Study|Withdrawal by Subject|0
5243449|NCT00802074|18093817|P3|Overall Study|Withdrawal by Subject|0
5243450|NCT00802074|18093818|P2|Overall Study|Withdrawal by Subject|0
5243451|NCT00802074|18093819|P1|Overall Study|Withdrawal by Subject|1
5243452|NCT00802074|18093814|P6|Overall Study|Adverse Event|0
5243453|NCT00802074|18093815|P5|Overall Study|Adverse Event|0
5243454|NCT00802074|18093816|P4|Overall Study|Adverse Event|0
5243455|NCT00802074|18093817|P3|Overall Study|Adverse Event|1
5243456|NCT00802074|18093818|P2|Overall Study|Adverse Event|1
5243457|NCT00802074|18093819|P1|Overall Study|Adverse Event|1
5243458|NCT00801983|18093853|P2|Period 2|Withdrawal by Subject|1
5243459|NCT00801983|18093854|P1|Period 2|Withdrawal by Subject|2
5243460|NCT00801983|18093853|P2|Period 1|Withdrawal by Subject|8
5243461|NCT00801983|18093854|P1|Period 1|Withdrawal by Subject|2
5243462|NCT00801983|18093853|P2|Period 1|Lost to Follow-up|0
5243463|NCT00801983|18093854|P1|Period 1|Lost to Follow-up|2
5243464|NCT00801892|18093869|P2|Sham Crossover Period|Lost to Follow-up|2
5243465|NCT00801892|18093870|P1|Sham Crossover Period|Lost to Follow-up|0
5243466|NCT00801892|18093869|P2|Main Study Period|Withdrawal by Subject|1
5243467|NCT00801892|18093870|P1|Main Study Period|Withdrawal by Subject|0
5243468|NCT00801632|18093930|P1|Overall Study|Re-transplant|1
5243469|NCT00801242|18094008|P1|Overall Study|Miscellaneous reasons|20
5243470|NCT00801242|18094008|P1|Overall Study|Lost to Follow-up|1
5243471|NCT00801242|18094008|P1|Overall Study|Physician Decision|3
5243472|NCT00801242|18094008|P1|Overall Study|Protocol Violation|5
5243473|NCT00801242|18094008|P1|Overall Study|Withdrawal by Subject|13
5243474|NCT00801242|18094008|P1|Overall Study|Adverse Event|10
5243475|NCT00801229|18094021|P2|Received Study Drug/Placebo|Adverse Event|1
5243476|NCT00801229|18094022|P1|Received Study Drug/Placebo|Adverse Event|1
5243477|NCT00801229|18094021|P2|Received Study Drug/Placebo|Lost to Follow-up|1
5243478|NCT00801229|18094022|P1|Received Study Drug/Placebo|Lost to Follow-up|0
5243479|NCT00801229|18094021|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
5243480|NCT00801229|18094022|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
5243481|NCT00801229|18094021|P2|Received Study Drug/Placebo|Simulator sickness|1
5243482|NCT00801229|18094022|P1|Received Study Drug/Placebo|Simulator sickness|1
5243483|NCT00801229|18094021|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
5243484|NCT00801229|18094022|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
5243485|NCT00801229|18094021|P2|Received Study Drug/Placebo|Elevated SGOT level|0
5243486|NCT00801229|18094022|P1|Received Study Drug/Placebo|Elevated SGOT level|1
5243487|NCT00801229|18094021|P2|Signed Consent|Found Ineligible|1
5243488|NCT00801229|18094022|P1|Signed Consent|Found Ineligible|1
5243489|NCT00801229|18094021|P2|Signed Consent|Withdrawal by Subject|2
5243490|NCT00801229|18094022|P1|Signed Consent|Withdrawal by Subject|2
5243491|NCT00801099|18094057|P1|Overall Study|Lost to Follow-up|101
5243492|NCT00800982|18094063|P2|Overall Study|Patient moved out of state|0
5243493|NCT00800982|18094064|P1|Overall Study|Patient moved out of state|1
5243494|NCT00800982|18094063|P2|Overall Study|Withdrawal by Subject|1
5243495|NCT00800982|18094064|P1|Overall Study|Withdrawal by Subject|0
5243496|NCT00800982|18094063|P2|Overall Study|Lost to Follow-up|2
5243497|NCT00800982|18094064|P1|Overall Study|Lost to Follow-up|1
5243498|NCT00800735|18094090|P1|Overall Study|Withdrew Consent|3
5243499|NCT00800735|18094090|P1|Overall Study|Violation of Selection Criteria at Entry|7
5243500|NCT00800735|18094090|P1|Overall Study|Insufficient Therapeutic Response|2
5243501|NCT00800735|18094090|P1|Overall Study|Administrative/Other|2
5243502|NCT00800683|18094096|P2|Overall Study|Other|2
5243503|NCT00800683|18094097|P1|Overall Study|Other|1
5243504|NCT00800683|18094096|P2|Overall Study|Lack of Efficacy|1
5243505|NCT00800683|18094097|P1|Overall Study|Lack of Efficacy|1
5243506|NCT00800683|18094096|P2|Overall Study|Withdrawal by Subject|7
5243507|NCT00800683|18094097|P1|Overall Study|Withdrawal by Subject|1
5243508|NCT00800683|18094096|P2|Overall Study|Lost to Follow-up|1
5243509|NCT00800683|18094097|P1|Overall Study|Lost to Follow-up|3
5243510|NCT00800683|18094096|P2|Overall Study|Adverse Event|8
5243511|NCT00800683|18094097|P1|Overall Study|Adverse Event|11
5243512|NCT00800540|18094143|P2|Period 2: 6 Weeks|Adverse Event|1
5243513|NCT00800540|18094144|P1|Period 2: 6 Weeks|Adverse Event|0
5243514|NCT00800540|18094143|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
5243515|NCT00800540|18094144|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
5243516|NCT00800540|18094143|P2|Period One: 6 Weeks|Noncompliance|0
5243517|NCT00800540|18094144|P1|Period One: 6 Weeks|Noncompliance|1
5243518|NCT00800436|18094179|P7|Overall Study|Withdrawal by Subject|0
5243519|NCT00800436|18094180|P6|Overall Study|Withdrawal by Subject|0
5243520|NCT00800436|18094181|P5|Overall Study|Withdrawal by Subject|0
5243521|NCT00800436|18094182|P4|Overall Study|Withdrawal by Subject|1
5243522|NCT00800436|18094183|P3|Overall Study|Withdrawal by Subject|1
5243523|NCT00800436|18094184|P2|Overall Study|Withdrawal by Subject|0
5243524|NCT00800436|18094185|P1|Overall Study|Withdrawal by Subject|0
5243525|NCT00800384|18094231|P2|Overall Study|Lost to Follow-up|26
5243526|NCT00800384|18094232|P1|Overall Study|Lost to Follow-up|17
5243527|NCT00800384|18094231|P2|Overall Study|Withdrawal by Subject|17
5243528|NCT00800384|18094232|P1|Overall Study|Withdrawal by Subject|24
5243529|NCT00800202|18094270|P2|Overall Study|Disease Progression|18
5243530|NCT00800202|18094271|P1|Overall Study|Disease Progression|54
5243531|NCT00800202|18094270|P2|Overall Study|Other|0
5243532|NCT00800202|18094271|P1|Overall Study|Other|5
5243533|NCT00800202|18094270|P2|Overall Study|Death|0
5243534|NCT00800202|18094271|P1|Overall Study|Death|1
5243535|NCT00800202|18094270|P2|Overall Study|Adverse Event|6
5243536|NCT00800202|18094271|P1|Overall Study|Adverse Event|7
5243537|NCT00800176|18094295|P6|Overall Study|Other|0
5243538|NCT00800176|18094296|P5|Overall Study|Other|2
5243539|NCT00800176|18094297|P4|Overall Study|Other|0
5243540|NCT00800176|18094298|P3|Overall Study|Other|0
5243541|NCT00800176|18094299|P2|Overall Study|Other|0
5243542|NCT00800176|18094300|P1|Overall Study|Other|1
5243543|NCT00800176|18094295|P6|Overall Study|Failure to return|0
5243544|NCT00800176|18094296|P5|Overall Study|Failure to return|0
5243545|NCT00800176|18094297|P4|Overall Study|Failure to return|2
5243546|NCT00800176|18094298|P3|Overall Study|Failure to return|0
5243547|NCT00800176|18094299|P2|Overall Study|Failure to return|3
5243548|NCT00800176|18094300|P1|Overall Study|Failure to return|3
5243549|NCT00800176|18094295|P6|Overall Study|Refused treatment|4
5243550|NCT00800176|18094296|P5|Overall Study|Refused treatment|1
5243551|NCT00800176|18094297|P4|Overall Study|Refused treatment|0
5243552|NCT00800176|18094298|P3|Overall Study|Refused treatment|0
5243553|NCT00800176|18094299|P2|Overall Study|Refused treatment|2
5243554|NCT00800176|18094300|P1|Overall Study|Refused treatment|3
5243555|NCT00800176|18094295|P6|Overall Study|Adverse Event|1
5243556|NCT00800176|18094296|P5|Overall Study|Adverse Event|1
5243557|NCT00800176|18094297|P4|Overall Study|Adverse Event|2
5243558|NCT00800176|18094298|P3|Overall Study|Adverse Event|0
5243559|NCT00800176|18094299|P2|Overall Study|Adverse Event|1
5243560|NCT00800176|18094300|P1|Overall Study|Adverse Event|2
5243561|NCT00799903|18094376|P2|Overall Study|Lost to Follow-up|80
5243562|NCT00799903|18094377|P1|Overall Study|Lost to Follow-up|69
5243563|NCT00799903|18094376|P2|Overall Study|Withdrawal by Subject|175
5243564|NCT00799903|18094377|P1|Overall Study|Withdrawal by Subject|179
5243565|NCT00799903|18094376|P2|Overall Study|Investigator Site Closed|23
5243566|NCT00799903|18094377|P1|Overall Study|Investigator Site Closed|25
5243567|NCT00799825|18094397|P1|Overall Study|Pregnancy|3
5243568|NCT00799825|18094397|P1|Overall Study|Lost to Follow-up|38
5243569|NCT00799825|18094397|P1|Overall Study|Withdrawal by Subject|6
5243570|NCT00799825|18094397|P1|Overall Study|Adverse Event|1
5243571|NCT00799708|18094437|P3|Overall Study|non-compliance|0
5243572|NCT00799708|18094438|P2|Overall Study|non-compliance|0
5243573|NCT00799708|18094439|P1|Overall Study|non-compliance|1
5243574|NCT00799617|18094462|P2|Anemia Trial|Withdrawal by Subject|3
5243575|NCT00799617|18094463|P1|Anemia Trial|Withdrawal by Subject|3
5243576|NCT00799617|18094462|P2|Cognitive Function Trial|Lost to Follow-up|1
5243577|NCT00799617|18094463|P1|Cognitive Function Trial|Lost to Follow-up|0
5243578|NCT00799617|18094462|P2|Bone Trial|Month 12 scan not available|16
5243579|NCT00799617|18094463|P1|Bone Trial|Month 12 scan not available|6
5243580|NCT00799617|18094462|P2|Cardiovascular Trial|Baseline scan not analyzable|2
5243581|NCT00799617|18094463|P1|Cardiovascular Trial|Baseline scan not analyzable|0
5243582|NCT00799617|18094462|P2|Cardiovascular Trial|Month 12 scan not available|15
5243583|NCT00799617|18094463|P1|Cardiovascular Trial|Month 12 scan not available|15
5243584|NCT00799617|18094462|P2|Vitality Trial|Lost to Follow-up|22
5243585|NCT00799617|18094463|P1|Vitality Trial|Lost to Follow-up|7
5243586|NCT00799617|18094462|P2|Physical Function Trial|Lost to Follow-up|11
5243587|NCT00799617|18094463|P1|Physical Function Trial|Lost to Follow-up|6
5243588|NCT00799617|18094462|P2|Sexual Funtion Trial|No Baseline Data|7
5243589|NCT00799617|18094463|P1|Sexual Funtion Trial|No Baseline Data|4
5243590|NCT00799617|18094462|P2|Sexual Funtion Trial|Lost to Follow-up|14
5243591|NCT00799617|18094463|P1|Sexual Funtion Trial|Lost to Follow-up|12
5243592|NCT00799617|18094462|P2|Main Testosterone Trial|Lost to Follow-up|20
5243593|NCT00799617|18094463|P1|Main Testosterone Trial|Lost to Follow-up|18
5243594|NCT00799617|18094462|P2|Main Testosterone Trial|Randomized in error|1
5243595|NCT00799617|18094463|P1|Main Testosterone Trial|Randomized in error|1
5243596|NCT00799591|18094570|P1|Overall Study|Infectious origin not probable|1
5243597|NCT00799591|18094570|P1|Overall Study|Antibiotic changed, no apparent reason|1
5243598|NCT00799591|18094570|P1|Overall Study|Persistance of fever undetermined origin|1
5243599|NCT00799591|18094570|P1|Overall Study|Resistance germ and technical failure|2
5243600|NCT00799591|18094570|P1|Overall Study|New infection|4
5243601|NCT00799591|18094570|P1|Overall Study|Resistant germ|11
5243602|NCT00799591|18094570|P1|Overall Study|Technical failure|12
5243603|NCT00799591|18094570|P1|Overall Study|Death|14
5243604|NCT00799591|18094570|P1|Overall Study|De-escalation of doses|20
5243605|NCT00799487|18094588|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
5243606|NCT00799487|18094589|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
5243607|NCT00799487|18094590|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
5243608|NCT00799487|18094588|P3|Double-Blind Assessment Period|Subject was out of the state|1
5243609|NCT00799487|18094589|P2|Double-Blind Assessment Period|Subject was out of the state|0
5243610|NCT00799487|18094590|P1|Double-Blind Assessment Period|Subject was out of the state|0
5243611|NCT00799487|18094588|P3|Double-Blind Assessment Period|Lost to Follow-up|1
5243612|NCT00799487|18094589|P2|Double-Blind Assessment Period|Lost to Follow-up|0
5243613|NCT00799487|18094590|P1|Double-Blind Assessment Period|Lost to Follow-up|0
5243614|NCT00799487|18094588|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
5243615|NCT00799487|18094589|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
5243616|NCT00799487|18094590|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
5243617|NCT00799487|18094588|P3|Dose Adjustment Period|Missed laboratory day 1|0
5243618|NCT00799487|18094589|P2|Dose Adjustment Period|Missed laboratory day 1|0
5243619|NCT00799487|18094590|P1|Dose Adjustment Period|Missed laboratory day 1|1
5243620|NCT00799487|18094588|P3|Dose Adjustment Period|Child too young (exclusion)|0
5243621|NCT00799487|18094589|P2|Dose Adjustment Period|Child too young (exclusion)|0
5243622|NCT00799487|18094590|P1|Dose Adjustment Period|Child too young (exclusion)|1
5243623|NCT00799487|18094588|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
5243624|NCT00799487|18094589|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
5243625|NCT00799487|18094590|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
5243626|NCT00799487|18094588|P3|Dose Adjustment Period|Withdrawal by Subject|0
5243627|NCT00799487|18094589|P2|Dose Adjustment Period|Withdrawal by Subject|0
5243628|NCT00799487|18094590|P1|Dose Adjustment Period|Withdrawal by Subject|3
5243629|NCT00799487|18094588|P3|Dose Adjustment Period|Investigator Discretion|0
5243630|NCT00799487|18094589|P2|Dose Adjustment Period|Investigator Discretion|0
5243631|NCT00799487|18094590|P1|Dose Adjustment Period|Investigator Discretion|2
5243632|NCT00799487|18094588|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
5243633|NCT00799487|18094589|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
5243634|NCT00799487|18094590|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
5243635|NCT00799487|18094588|P3|Dose Adjustment Period|Adverse Event|0
5243636|NCT00799487|18094589|P2|Dose Adjustment Period|Adverse Event|0
5243637|NCT00799487|18094590|P1|Dose Adjustment Period|Adverse Event|2
5243638|NCT00799487|18094588|P3|Dose Adjustment Period|Lost to Follow-up|0
5243639|NCT00799487|18094589|P2|Dose Adjustment Period|Lost to Follow-up|0
5243640|NCT00799487|18094590|P1|Dose Adjustment Period|Lost to Follow-up|1
5243641|NCT00799422|18094687|P6|First Week of Wear|Adverse Event|0
5243642|NCT00799422|18094688|P5|First Week of Wear|Adverse Event|0
5243643|NCT00799422|18094689|P4|First Week of Wear|Adverse Event|1
5243644|NCT00799422|18094690|P3|First Week of Wear|Adverse Event|0
5243645|NCT00799422|18094691|P2|First Week of Wear|Adverse Event|0
5243646|NCT00799422|18094692|P1|First Week of Wear|Adverse Event|0
5243647|NCT00799422|18094687|P6|First Week of Wear|Lost to Follow-up|0
5243648|NCT00799422|18094688|P5|First Week of Wear|Lost to Follow-up|0
5243649|NCT00799422|18094689|P4|First Week of Wear|Lost to Follow-up|0
5243650|NCT00799422|18094690|P3|First Week of Wear|Lost to Follow-up|1
5243651|NCT00799422|18094691|P2|First Week of Wear|Lost to Follow-up|0
5243652|NCT00799422|18094692|P1|First Week of Wear|Lost to Follow-up|0
5243653|NCT00799409|18094709|P3|Overall Study|medication compliance|0
5243654|NCT00799409|18094710|P2|Overall Study|medication compliance|0
5243655|NCT00799409|18094711|P1|Overall Study|medication compliance|1
5243656|NCT00799409|18094709|P3|Overall Study|Did not attend lab school day 1|0
5243657|NCT00799409|18094710|P2|Overall Study|Did not attend lab school day 1|0
5243658|NCT00799409|18094711|P1|Overall Study|Did not attend lab school day 1|1
5243659|NCT00799409|18094709|P3|Overall Study|Failure to follow study protocol)|0
5243660|NCT00799409|18094710|P2|Overall Study|Failure to follow study protocol)|0
5243661|NCT00799409|18094711|P1|Overall Study|Failure to follow study protocol)|1
5243662|NCT00799409|18094709|P3|Overall Study|Optimal Dose Not Achieved|0
5243663|NCT00799409|18094710|P2|Overall Study|Optimal Dose Not Achieved|0
5243664|NCT00799409|18094711|P1|Overall Study|Optimal Dose Not Achieved|2
5243665|NCT00799409|18094709|P3|Overall Study|Lost to Follow-up|0
5243666|NCT00799409|18094710|P2|Overall Study|Lost to Follow-up|0
5243667|NCT00799409|18094711|P1|Overall Study|Lost to Follow-up|1
5243668|NCT00799409|18094709|P3|Overall Study|Withdrawal by Subject|0
5243669|NCT00799409|18094710|P2|Overall Study|Withdrawal by Subject|0
5243670|NCT00799409|18094711|P1|Overall Study|Withdrawal by Subject|1
5243671|NCT00799396|18094791|P1|Clopidogrel Plus Aspirin|Physician Decision|4
5243672|NCT00799396|18094791|P1|Clopidogrel Plus Aspirin|Adverse Event|2
5243673|NCT00799396|18094791|P1|Clopidogrel Treatment|Withdrawal by Subject|2
5243674|NCT00799396|18094791|P1|Clopidogrel Treatment|Physician Decision|5
5243675|NCT00799396|18094791|P1|Clopidogrel Treatment|Adverse Event|6
5243676|NCT00799383|18094798|P2|Overall Study|Withdrawal by Subject|1
5243677|NCT00799383|18094799|P1|Overall Study|Withdrawal by Subject|0
5243678|NCT00799383|18094798|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
5243679|NCT00799383|18094799|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
5243680|NCT00799383|18094798|P2|Overall Study|Lost to Follow-up|2
5243681|NCT00799383|18094799|P1|Overall Study|Lost to Follow-up|1
5243682|NCT00799383|18094798|P2|Overall Study|Adverse Event|1
5243683|NCT00799383|18094799|P1|Overall Study|Adverse Event|0
5243684|NCT00799383|18094798|P2|Overall Study|Protocol Violation|1
5243685|NCT00799383|18094799|P1|Overall Study|Protocol Violation|1
5243686|NCT00799266|18094828|P2|Overall Study|Subject withdrew consent|0
5243687|NCT00799266|18094829|P1|Overall Study|Subject withdrew consent|3
5243688|NCT00799266|18094828|P2|Overall Study|Adverse Event|1
5243689|NCT00799266|18094829|P1|Overall Study|Adverse Event|0
5243690|NCT00798967|18094869|P2|Overall Study|Randomized in error by site|0
5243691|NCT00798967|18094870|P1|Overall Study|Randomized in error by site|1
5243692|NCT00798967|18094869|P2|Overall Study|Physician Decision|0
5243693|NCT00798967|18094870|P1|Overall Study|Physician Decision|1
5243694|NCT00798967|18094869|P2|Overall Study|Withdrawal by Subject|1
5243695|NCT00798967|18094870|P1|Overall Study|Withdrawal by Subject|0
5243696|NCT00798967|18094869|P2|Overall Study|Adverse Event|3
5243697|NCT00798967|18094870|P1|Overall Study|Adverse Event|2
5243698|NCT00798889|18094878|P1|Overall Study|Enrolled, Not treated|3
5243699|NCT00798889|18094878|P1|Overall Study|Decision of Sponsor|11
5243700|NCT00798889|18094878|P1|Overall Study|Lack of Efficacy|213
5243701|NCT00798889|18094878|P1|Overall Study|Lost to Follow-up|1
5243702|NCT00798889|18094878|P1|Overall Study|Withdrawal by Subject|31
5243703|NCT00798889|18094878|P1|Overall Study|Protocol Violation|2
5243704|NCT00798889|18094878|P1|Overall Study|Adverse Event|53
5243705|NCT00798759|18094884|P2|Overall Study|Other|1
5243706|NCT00798759|18094885|P1|Overall Study|Other|0
5243707|NCT00798759|18094884|P2|Overall Study|Protocol Violation|8
5243708|NCT00798759|18094885|P1|Overall Study|Protocol Violation|4
5243709|NCT00798759|18094884|P2|Overall Study|Lost to Follow-up|1
5243710|NCT00798759|18094885|P1|Overall Study|Lost to Follow-up|1
5243711|NCT00798759|18094884|P2|Overall Study|Adverse Event|3
5243712|NCT00798759|18094885|P1|Overall Study|Adverse Event|3
5243713|NCT00798707|18094903|P3|Overall Study|Randomized not treated|1
5243714|NCT00798707|18094904|P2|Overall Study|Randomized not treated|5
5243715|NCT00798707|18094905|P1|Overall Study|Randomized not treated|4
5243716|NCT00798707|18094903|P3|Overall Study|Withdrawal by Subject|2
5243717|NCT00798707|18094904|P2|Overall Study|Withdrawal by Subject|8
5243718|NCT00798707|18094905|P1|Overall Study|Withdrawal by Subject|3
5243719|NCT00798707|18094903|P3|Overall Study|Protocol Violation|2
5243720|NCT00798707|18094904|P2|Overall Study|Protocol Violation|0
5243721|NCT00798707|18094905|P1|Overall Study|Protocol Violation|4
5243722|NCT00798707|18094903|P3|Overall Study|Other|0
5243723|NCT00798707|18094904|P2|Overall Study|Other|1
5243724|NCT00798707|18094905|P1|Overall Study|Other|0
5243725|NCT00798707|18094903|P3|Overall Study|Lost to Follow-up|6
5243726|NCT00798707|18094904|P2|Overall Study|Lost to Follow-up|6
5243727|NCT00798707|18094905|P1|Overall Study|Lost to Follow-up|5
5243728|NCT00798707|18094903|P3|Overall Study|Lack of Efficacy|1
5243729|NCT00798707|18094904|P2|Overall Study|Lack of Efficacy|2
5243730|NCT00798707|18094905|P1|Overall Study|Lack of Efficacy|2
5243731|NCT00798707|18094903|P3|Overall Study|Investigator|2
5243732|NCT00798707|18094904|P2|Overall Study|Investigator|1
5243733|NCT00798707|18094905|P1|Overall Study|Investigator|0
5243734|NCT00798707|18094903|P3|Overall Study|Failed to return|0
5243735|NCT00798707|18094904|P2|Overall Study|Failed to return|2
5243736|NCT00798707|18094905|P1|Overall Study|Failed to return|2
5243737|NCT00798707|18094903|P3|Overall Study|Adverse Event|8
5243738|NCT00798707|18094904|P2|Overall Study|Adverse Event|8
5243739|NCT00798707|18094905|P1|Overall Study|Adverse Event|6
5243740|NCT00798694|18094957|P2|Overall Study|Physician Decision|0
5243741|NCT00798694|18094958|P1|Overall Study|Physician Decision|1
5243742|NCT00798694|18094957|P2|Overall Study|Lost to Follow-up|1
5243743|NCT00798694|18094958|P1|Overall Study|Lost to Follow-up|1
5243744|NCT00798655|18094982|P1|Overall Study|Did not receive at least one dose of pan|2
5243745|NCT00798603|18094987|P1|Overall Study|Lack of insurance coverage|1
5243746|NCT00798603|18094987|P1|Overall Study|Physician Decision|1
5243747|NCT00798603|18094987|P1|Overall Study|Adverse Event|22
5243748|NCT00798603|18094987|P1|Overall Study|Withdrawal by Subject|10
5243749|NCT00798603|18094987|P1|Overall Study|Still on treatment as of 11/6/2012|1
5243750|NCT00798590|18095009|P2|Overall Study|P.I, Left institution. Study terminated|8
5243751|NCT00798590|18095010|P1|Overall Study|P.I, Left institution. Study terminated|11
5243752|NCT00798434|18095044|P2|Open-Label|Not Treated|1
5243753|NCT00798434|18095045|P1|Open-Label|Not Treated|0
5243754|NCT00798434|18095044|P2|Open-Label|Other|2
5243755|NCT00798434|18095045|P1|Open-Label|Other|1
5243756|NCT00798434|18095044|P2|Open-Label|Protocol Violation|0
5243757|NCT00798434|18095045|P1|Open-Label|Protocol Violation|1
5243758|NCT00798434|18095044|P2|Open-Label|Withdrawal by Subject|7
5243759|NCT00798434|18095045|P1|Open-Label|Withdrawal by Subject|2
5243760|NCT00798434|18095044|P2|Open-Label|Lack of Efficacy|11
5243761|NCT00798434|18095045|P1|Open-Label|Lack of Efficacy|5
5243762|NCT00798434|18095044|P2|Open-Label|Adverse Event|11
5243763|NCT00798434|18095045|P1|Open-Label|Adverse Event|33
5243764|NCT00798434|18095044|P2|Double-Blind|Not Treated|6
5243765|NCT00798434|18095045|P1|Double-Blind|Not Treated|3
5243766|NCT00798434|18095044|P2|Double-Blind|Other|0
5243767|NCT00798434|18095045|P1|Double-Blind|Other|1
5243768|NCT00798434|18095044|P2|Double-Blind|Did Not Meet Entrance Criteria|1
5243769|NCT00798434|18095045|P1|Double-Blind|Did Not Meet Entrance Criteria|2
5243770|NCT00798434|18095044|P2|Double-Blind|Protocol Violation|4
5243771|NCT00798434|18095045|P1|Double-Blind|Protocol Violation|1
5243772|NCT00798434|18095044|P2|Double-Blind|Withdrawal by Subject|14
5243773|NCT00798434|18095045|P1|Double-Blind|Withdrawal by Subject|17
5243774|NCT00798434|18095044|P2|Double-Blind|Lack of Efficacy|12
5243775|NCT00798434|18095045|P1|Double-Blind|Lack of Efficacy|8
5243776|NCT00798434|18095044|P2|Double-Blind|Lost to Follow-up|0
5243777|NCT00798434|18095045|P1|Double-Blind|Lost to Follow-up|1
5243778|NCT00798434|18095044|P2|Double-Blind|Death|1
5243779|NCT00798434|18095045|P1|Double-Blind|Death|0
5243780|NCT00798434|18095044|P2|Double-Blind|Adverse Event|46
5243781|NCT00798434|18095045|P1|Double-Blind|Adverse Event|22
5243782|NCT00798369|18095131|P6|Overall Study|Adminstrative problems|1
5243783|NCT00798369|18095132|P5|Overall Study|Adminstrative problems|0
5243784|NCT00798369|18095133|P4|Overall Study|Adminstrative problems|0
5243785|NCT00798369|18095134|P3|Overall Study|Adminstrative problems|0
5243786|NCT00798369|18095135|P2|Overall Study|Adminstrative problems|0
5243787|NCT00798369|18095136|P1|Overall Study|Adminstrative problems|0
5243788|NCT00798369|18095131|P6|Overall Study|Lost to Follow-up|0
5243789|NCT00798369|18095132|P5|Overall Study|Lost to Follow-up|1
5243790|NCT00798369|18095133|P4|Overall Study|Lost to Follow-up|0
5243791|NCT00798369|18095134|P3|Overall Study|Lost to Follow-up|1
5243792|NCT00798369|18095135|P2|Overall Study|Lost to Follow-up|1
5243793|NCT00798369|18095136|P1|Overall Study|Lost to Follow-up|1
5243794|NCT00798369|18095131|P6|Overall Study|Subject withdrew consent|2
5243795|NCT00798369|18095132|P5|Overall Study|Subject withdrew consent|0
5243796|NCT00798369|18095133|P4|Overall Study|Subject withdrew consent|1
5243797|NCT00798369|18095134|P3|Overall Study|Subject withdrew consent|1
5243798|NCT00798369|18095135|P2|Overall Study|Subject withdrew consent|0
5243799|NCT00798369|18095136|P1|Overall Study|Subject withdrew consent|0
5243800|NCT00798317|18095183|P2|Overall Study|Death|0
5243801|NCT00798317|18095184|P1|Overall Study|Death|1
5243802|NCT00798317|18095183|P2|Overall Study|Adverse Event|0
5243803|NCT00798317|18095184|P1|Overall Study|Adverse Event|2
5243804|NCT00798317|18095183|P2|Overall Study|Lost to Follow-up|2
5243805|NCT00798317|18095184|P1|Overall Study|Lost to Follow-up|2
5243806|NCT00798317|18095183|P2|Overall Study|Withdrawal by Subject|4
5243807|NCT00798317|18095184|P1|Overall Study|Withdrawal by Subject|5
5243808|NCT00798317|18095183|P2|Overall Study|Physician Decision|1
5243809|NCT00798317|18095184|P1|Overall Study|Physician Decision|0
5243810|NCT00798304|18095195|P3|Overall Study|Discontinuation by Sponsor|9
5243811|NCT00798304|18095196|P2|Overall Study|Discontinuation by Sponsor|21
5243812|NCT00798304|18095197|P1|Overall Study|Discontinuation by Sponsor|14
5243813|NCT00798304|18095195|P3|Overall Study|Adverse Event|1
5243814|NCT00798304|18095196|P2|Overall Study|Adverse Event|1
5243815|NCT00798304|18095197|P1|Overall Study|Adverse Event|0
5243816|NCT00798174|18095223|P2|Overall Study|Inability to sedate for DFT testing|0
5243817|NCT00798174|18095224|P1|Overall Study|Inability to sedate for DFT testing|1
5243818|NCT00798174|18095223|P2|Overall Study|inability to implant azygos coil|3
5243819|NCT00798174|18095224|P1|Overall Study|inability to implant azygos coil|3
5243820|NCT00798161|18095235|P7|Overall Study|Other reason (incl. lack of efficacy)|5
5243821|NCT00798161|18095236|P6|Overall Study|Other reason (incl. lack of efficacy)|4
5243822|NCT00798161|18095237|P5|Overall Study|Other reason (incl. lack of efficacy)|2
5243823|NCT00798161|18095238|P4|Overall Study|Other reason (incl. lack of efficacy)|5
5243824|NCT00798161|18095239|P3|Overall Study|Other reason (incl. lack of efficacy)|3
5243825|NCT00798161|18095240|P2|Overall Study|Other reason (incl. lack of efficacy)|5
5243826|NCT00798161|18095241|P1|Overall Study|Other reason (incl. lack of efficacy)|7
5243827|NCT00798161|18095235|P7|Overall Study|Withdrawal by Subject|1
5243828|NCT00798161|18095236|P6|Overall Study|Withdrawal by Subject|3
5243829|NCT00798161|18095237|P5|Overall Study|Withdrawal by Subject|2
5243830|NCT00798161|18095238|P4|Overall Study|Withdrawal by Subject|4
5243831|NCT00798161|18095239|P3|Overall Study|Withdrawal by Subject|5
5243832|NCT00798161|18095240|P2|Overall Study|Withdrawal by Subject|4
5243833|NCT00798161|18095241|P1|Overall Study|Withdrawal by Subject|5
5243834|NCT00798161|18095235|P7|Overall Study|Lost to Follow-up|0
5243835|NCT00798161|18095236|P6|Overall Study|Lost to Follow-up|0
5243836|NCT00798161|18095237|P5|Overall Study|Lost to Follow-up|4
5243837|NCT00798161|18095238|P4|Overall Study|Lost to Follow-up|3
5243838|NCT00798161|18095239|P3|Overall Study|Lost to Follow-up|4
5243839|NCT00798161|18095240|P2|Overall Study|Lost to Follow-up|3
5243840|NCT00798161|18095241|P1|Overall Study|Lost to Follow-up|1
5243841|NCT00798161|18095235|P7|Overall Study|Protocol Violation|0
5243842|NCT00798161|18095236|P6|Overall Study|Protocol Violation|2
5243843|NCT00798161|18095237|P5|Overall Study|Protocol Violation|3
5243844|NCT00798161|18095238|P4|Overall Study|Protocol Violation|3
5243845|NCT00798161|18095239|P3|Overall Study|Protocol Violation|3
5243846|NCT00798161|18095240|P2|Overall Study|Protocol Violation|1
5243847|NCT00798161|18095241|P1|Overall Study|Protocol Violation|2
5243848|NCT00798161|18095235|P7|Overall Study|Adverse Event|4
5243849|NCT00798161|18095236|P6|Overall Study|Adverse Event|2
5243850|NCT00798161|18095237|P5|Overall Study|Adverse Event|5
5243851|NCT00798161|18095238|P4|Overall Study|Adverse Event|6
5243852|NCT00798161|18095239|P3|Overall Study|Adverse Event|6
5243853|NCT00798161|18095240|P2|Overall Study|Adverse Event|4
5243854|NCT00798161|18095241|P1|Overall Study|Adverse Event|3
5243855|NCT00798135|18095348|P1|Overall Study|Physician Decision|1
5243856|NCT00798135|18095348|P1|Overall Study|Disease progression, refractory|1
5243857|NCT00798135|18095348|P1|Overall Study|Disease progression, relapse|11
5243858|NCT00798096|18095354|P1|Overall Study|Ongoing|2
5243859|NCT00797966|18095382|P6|Phase A+|Protocol deviation|4
5243860|NCT00797966|18095383|P5|Phase A+|Protocol deviation|0
5243861|NCT00797966|18095384|P4|Phase A+|Protocol deviation|0
5243862|NCT00797966|18095385|P3|Phase A+|Protocol deviation|0
5243863|NCT00797966|18095386|P2|Phase A+|Protocol deviation|0
5243864|NCT00797966|18095387|P1|Phase A+|Protocol deviation|0
5243865|NCT00797966|18095382|P6|Phase A+|Adverse Event|4
5243866|NCT00797966|18095383|P5|Phase A+|Adverse Event|0
5243867|NCT00797966|18095384|P4|Phase A+|Adverse Event|0
5243868|NCT00797966|18095385|P3|Phase A+|Adverse Event|0
5243869|NCT00797966|18095386|P2|Phase A+|Adverse Event|0
5243870|NCT00797966|18095387|P1|Phase A+|Adverse Event|0
5243871|NCT00797966|18095382|P6|Phase A+|Withdrawal by Subject|6
5243872|NCT00797966|18095383|P5|Phase A+|Withdrawal by Subject|0
5243873|NCT00797966|18095384|P4|Phase A+|Withdrawal by Subject|0
5243874|NCT00797966|18095385|P3|Phase A+|Withdrawal by Subject|0
5243875|NCT00797966|18095386|P2|Phase A+|Withdrawal by Subject|0
5243876|NCT00797966|18095387|P1|Phase A+|Withdrawal by Subject|0
5243877|NCT00797966|18095382|P6|Phase A+|Met withdrawal criteria|5
5243878|NCT00797966|18095383|P5|Phase A+|Met withdrawal criteria|0
5243879|NCT00797966|18095384|P4|Phase A+|Met withdrawal criteria|0
5243880|NCT00797966|18095385|P3|Phase A+|Met withdrawal criteria|0
5243881|NCT00797966|18095386|P2|Phase A+|Met withdrawal criteria|0
5243882|NCT00797966|18095387|P1|Phase A+|Met withdrawal criteria|0
5243883|NCT00797966|18095382|P6|Phase A+|Lost to Follow-up|9
5243884|NCT00797966|18095383|P5|Phase A+|Lost to Follow-up|0
5243885|NCT00797966|18095384|P4|Phase A+|Lost to Follow-up|0
5243886|NCT00797966|18095385|P3|Phase A+|Lost to Follow-up|0
5243887|NCT00797966|18095386|P2|Phase A+|Lost to Follow-up|0
5243888|NCT00797966|18095387|P1|Phase A+|Lost to Follow-up|0
5243889|NCT00797966|18095382|P6|Phase B|Lack of Efficacy|0
5243890|NCT00797966|18095383|P5|Phase B|Lack of Efficacy|0
5243891|NCT00797966|18095384|P4|Phase B|Lack of Efficacy|4
5243892|NCT00797966|18095385|P3|Phase B|Lack of Efficacy|1
5243893|NCT00797966|18095386|P2|Phase B|Lack of Efficacy|1
5243894|NCT00797966|18095387|P1|Phase B|Lack of Efficacy|0
5243895|NCT00797966|18095382|P6|Phase B|Protocol Deviation|0
5243896|NCT00797966|18095383|P5|Phase B|Protocol Deviation|0
5243897|NCT00797966|18095384|P4|Phase B|Protocol Deviation|6
5243898|NCT00797966|18095385|P3|Phase B|Protocol Deviation|2
5243899|NCT00797966|18095386|P2|Phase B|Protocol Deviation|8
5243900|NCT00797966|18095387|P1|Phase B|Protocol Deviation|4
5243901|NCT00797966|18095382|P6|Phase B|Withdrawal by Subject|0
5243902|NCT00797966|18095383|P5|Phase B|Withdrawal by Subject|0
5243903|NCT00797966|18095384|P4|Phase B|Withdrawal by Subject|3
5243904|NCT00797966|18095385|P3|Phase B|Withdrawal by Subject|3
5243905|NCT00797966|18095386|P2|Phase B|Withdrawal by Subject|4
5243906|NCT00797966|18095387|P1|Phase B|Withdrawal by Subject|1
5243907|NCT00797966|18095382|P6|Phase B|Physician Decision|0
5243908|NCT00797966|18095383|P5|Phase B|Physician Decision|0
5243909|NCT00797966|18095384|P4|Phase B|Physician Decision|1
5243910|NCT00797966|18095385|P3|Phase B|Physician Decision|3
5243911|NCT00797966|18095386|P2|Phase B|Physician Decision|0
5243912|NCT00797966|18095387|P1|Phase B|Physician Decision|1
5243913|NCT00797966|18095382|P6|Phase B|Met Withdrawal Criteria|0
5243914|NCT00797966|18095383|P5|Phase B|Met Withdrawal Criteria|0
5243915|NCT00797966|18095384|P4|Phase B|Met Withdrawal Criteria|1
5243916|NCT00797966|18095385|P3|Phase B|Met Withdrawal Criteria|6
5243917|NCT00797966|18095386|P2|Phase B|Met Withdrawal Criteria|3
5243918|NCT00797966|18095387|P1|Phase B|Met Withdrawal Criteria|3
5243919|NCT00797966|18095382|P6|Phase B|Adverse Event|0
5243920|NCT00797966|18095383|P5|Phase B|Adverse Event|0
5243921|NCT00797966|18095384|P4|Phase B|Adverse Event|1
5243922|NCT00797966|18095385|P3|Phase B|Adverse Event|3
5243923|NCT00797966|18095386|P2|Phase B|Adverse Event|1
5243924|NCT00797966|18095387|P1|Phase B|Adverse Event|2
5243925|NCT00797966|18095382|P6|Phase B|Lost to Follow-up|0
5243926|NCT00797966|18095383|P5|Phase B|Lost to Follow-up|0
5243927|NCT00797966|18095384|P4|Phase B|Lost to Follow-up|0
5243928|NCT00797966|18095385|P3|Phase B|Lost to Follow-up|3
5243929|NCT00797966|18095386|P2|Phase B|Lost to Follow-up|1
5243930|NCT00797966|18095387|P1|Phase B|Lost to Follow-up|0
5243931|NCT00797966|18095382|P6|Phase A|Protocol deviation|0
5243932|NCT00797966|18095383|P5|Phase A|Protocol deviation|56
5243933|NCT00797966|18095384|P4|Phase A|Protocol deviation|0
5243934|NCT00797966|18095385|P3|Phase A|Protocol deviation|0
5243935|NCT00797966|18095386|P2|Phase A|Protocol deviation|0
5243936|NCT00797966|18095387|P1|Phase A|Protocol deviation|0
5243937|NCT00797966|18095382|P6|Phase A|Withdrawal by Subject|0
5243938|NCT00797966|18095383|P5|Phase A|Withdrawal by Subject|33
5243939|NCT00797966|18095384|P4|Phase A|Withdrawal by Subject|0
5243940|NCT00797966|18095385|P3|Phase A|Withdrawal by Subject|0
5243941|NCT00797966|18095386|P2|Phase A|Withdrawal by Subject|0
5243942|NCT00797966|18095387|P1|Phase A|Withdrawal by Subject|0
5243943|NCT00797966|18095382|P6|Phase A|Physician Decision|0
5243944|NCT00797966|18095383|P5|Phase A|Physician Decision|13
5243945|NCT00797966|18095384|P4|Phase A|Physician Decision|0
5243946|NCT00797966|18095385|P3|Phase A|Physician Decision|0
5243947|NCT00797966|18095386|P2|Phase A|Physician Decision|0
5243948|NCT00797966|18095387|P1|Phase A|Physician Decision|0
5243949|NCT00797966|18095382|P6|Phase A|Met withdrawal criteria|0
5243950|NCT00797966|18095383|P5|Phase A|Met withdrawal criteria|4
5243951|NCT00797966|18095384|P4|Phase A|Met withdrawal criteria|0
5243952|NCT00797966|18095385|P3|Phase A|Met withdrawal criteria|0
5243953|NCT00797966|18095386|P2|Phase A|Met withdrawal criteria|0
5243954|NCT00797966|18095387|P1|Phase A|Met withdrawal criteria|0
5243955|NCT00797966|18095382|P6|Phase A|Adverse Event|0
5243956|NCT00797966|18095383|P5|Phase A|Adverse Event|46
5243957|NCT00797966|18095384|P4|Phase A|Adverse Event|0
5243958|NCT00797966|18095385|P3|Phase A|Adverse Event|0
5243959|NCT00797966|18095386|P2|Phase A|Adverse Event|0
5243960|NCT00797966|18095387|P1|Phase A|Adverse Event|0
5243961|NCT00797966|18095382|P6|Phase A|Lost to Follow-up|0
5243962|NCT00797966|18095383|P5|Phase A|Lost to Follow-up|33
5243963|NCT00797966|18095384|P4|Phase A|Lost to Follow-up|0
5243964|NCT00797966|18095385|P3|Phase A|Lost to Follow-up|0
5243965|NCT00797966|18095386|P2|Phase A|Lost to Follow-up|0
5243966|NCT00797966|18095387|P1|Phase A|Lost to Follow-up|0
5243967|NCT00797862|18095452|P3|Overall Study|Mis-randomized|1
5243968|NCT00797862|18095453|P2|Overall Study|Mis-randomized|3
5243969|NCT00797862|18095454|P1|Overall Study|Mis-randomized|3
5243970|NCT00797862|18095452|P3|Overall Study|Protocol Violation|8
5243971|NCT00797862|18095453|P2|Overall Study|Protocol Violation|6
5243972|NCT00797862|18095454|P1|Overall Study|Protocol Violation|4
5243973|NCT00797862|18095452|P3|Overall Study|Administrative Problem|0
5243974|NCT00797862|18095453|P2|Overall Study|Administrative Problem|0
5243975|NCT00797862|18095454|P1|Overall Study|Administrative Problem|4
5243976|NCT00797862|18095452|P3|Overall Study|Lost to Follow-up|5
5243977|NCT00797862|18095453|P2|Overall Study|Lost to Follow-up|0
5243978|NCT00797862|18095454|P1|Overall Study|Lost to Follow-up|11
5243979|NCT00797862|18095452|P3|Overall Study|Withdrawal by Subject|7
5243980|NCT00797862|18095453|P2|Overall Study|Withdrawal by Subject|7
5243981|NCT00797862|18095454|P1|Overall Study|Withdrawal by Subject|14
5243982|NCT00797862|18095452|P3|Overall Study|No longer required study medication|0
5243983|NCT00797862|18095453|P2|Overall Study|No longer required study medication|0
5243984|NCT00797862|18095454|P1|Overall Study|No longer required study medication|1
5243985|NCT00797862|18095452|P3|Overall Study|Lack of Efficacy|6
5243986|NCT00797862|18095453|P2|Overall Study|Lack of Efficacy|7
5243987|NCT00797862|18095454|P1|Overall Study|Lack of Efficacy|1
5243988|NCT00797862|18095452|P3|Overall Study|Abnormal Test Procedure Result|1
5243989|NCT00797862|18095453|P2|Overall Study|Abnormal Test Procedure Result|1
5243990|NCT00797862|18095454|P1|Overall Study|Abnormal Test Procedure Result|0
5243991|NCT00797862|18095452|P3|Overall Study|Adverse Event|58
5243992|NCT00797862|18095453|P2|Overall Study|Adverse Event|44
5243993|NCT00797862|18095454|P1|Overall Study|Adverse Event|86
5243994|NCT00797823|18095483|P3|First Period (Initial Randomization)|Physician Decision|0
5243995|NCT00797823|18095484|P2|First Period (Initial Randomization)|Physician Decision|0
5243996|NCT00797823|18095485|P1|First Period (Initial Randomization)|Physician Decision|1
5243997|NCT00797732|18095507|P3|Overall Study|Refused to Participate|123
5243998|NCT00797732|18095508|P2|Overall Study|Refused to Participate|0
5243999|NCT00797732|18095509|P1|Overall Study|Refused to Participate|0
5244000|NCT00797732|18095507|P3|Overall Study|Excluded due to time constraints|24
5244001|NCT00797732|18095508|P2|Overall Study|Excluded due to time constraints|0
5244002|NCT00797732|18095509|P1|Overall Study|Excluded due to time constraints|0
5244003|NCT00797732|18095507|P3|Overall Study|Not meet inclusion criteria|7
5244004|NCT00797732|18095508|P2|Overall Study|Not meet inclusion criteria|0
5244005|NCT00797732|18095509|P1|Overall Study|Not meet inclusion criteria|0
5244006|NCT00797732|18095507|P3|Overall Study|Death|0
5244007|NCT00797732|18095508|P2|Overall Study|Death|0
5244008|NCT00797732|18095509|P1|Overall Study|Death|1
5244009|NCT00797732|18095507|P3|Overall Study|Lost to Follow-up|0
5244010|NCT00797732|18095508|P2|Overall Study|Lost to Follow-up|0
5244011|NCT00797732|18095509|P1|Overall Study|Lost to Follow-up|1
5244012|NCT00797732|18095507|P3|Overall Study|Withdrawal by Subject|0
5244013|NCT00797732|18095508|P2|Overall Study|Withdrawal by Subject|3
5244014|NCT00797732|18095509|P1|Overall Study|Withdrawal by Subject|3
5244015|NCT00797667|18095524|P3|Overall Study|Adverse Event|8
5244016|NCT00797667|18095525|P2|Overall Study|Adverse Event|8
5244017|NCT00797667|18095526|P1|Overall Study|Adverse Event|19
5244018|NCT00797667|18095524|P3|Overall Study|Withdrawal by Subject|2
5244019|NCT00797667|18095525|P2|Overall Study|Withdrawal by Subject|14
5244020|NCT00797667|18095526|P1|Overall Study|Withdrawal by Subject|9
5244021|NCT00797667|18095524|P3|Overall Study|Study Terminated by Sponsor|115
5244022|NCT00797667|18095525|P2|Overall Study|Study Terminated by Sponsor|216
5244023|NCT00797667|18095526|P1|Overall Study|Study Terminated by Sponsor|217
5244024|NCT00797667|18095524|P3|Overall Study|Protocol Violation|0
5244025|NCT00797667|18095525|P2|Overall Study|Protocol Violation|7
5244026|NCT00797667|18095526|P1|Overall Study|Protocol Violation|2
5244027|NCT00797667|18095524|P3|Overall Study|Pregnancy|0
5244028|NCT00797667|18095525|P2|Overall Study|Pregnancy|0
5244029|NCT00797667|18095526|P1|Overall Study|Pregnancy|2
5244030|NCT00797667|18095524|P3|Overall Study|Physician Decision|0
5244031|NCT00797667|18095525|P2|Overall Study|Physician Decision|1
5244032|NCT00797667|18095526|P1|Overall Study|Physician Decision|3
5244033|NCT00797667|18095524|P3|Overall Study|Lost to Follow-up|2
5244034|NCT00797667|18095525|P2|Overall Study|Lost to Follow-up|12
5244035|NCT00797667|18095526|P1|Overall Study|Lost to Follow-up|8
5244036|NCT00797667|18095524|P3|Overall Study|Lack of Efficacy|0
5244037|NCT00797667|18095525|P2|Overall Study|Lack of Efficacy|1
5244038|NCT00797667|18095526|P1|Overall Study|Lack of Efficacy|0
5244039|NCT00797563|18095552|P1|Overall Study|Adverse Event|1
5244040|NCT00797511|18095558|P1|Overall Study|Withdrawal by Subject|1
5244041|NCT00797316|18095576|P2|Overall Study|Unsatisfactory therapeutic effect|13
5244042|NCT00797316|18095577|P1|Overall Study|Unsatisfactory therapeutic effect|0
5244043|NCT00797316|18095576|P2|Overall Study|Patient withdrew consent|6
5244044|NCT00797316|18095577|P1|Overall Study|Patient withdrew consent|12
5244045|NCT00797316|18095576|P2|Overall Study|Protocol Deviation|2
5244046|NCT00797316|18095577|P1|Overall Study|Protocol Deviation|1
5244047|NCT00797316|18095576|P2|Overall Study|Lost to Follow-up|8
5244048|NCT00797316|18095577|P1|Overall Study|Lost to Follow-up|4
5244049|NCT00797316|18095576|P2|Overall Study|Adverse Event|3
5244050|NCT00797316|18095577|P1|Overall Study|Adverse Event|5
5244051|NCT00797316|18095576|P2|Overall Study|Administrative problems|0
5244052|NCT00797316|18095577|P1|Overall Study|Administrative problems|1
5244053|NCT00797225|18095606|P8|Weeks 13 to 24|Sponsor Decision|0
5244054|NCT00797225|18095607|P7|Weeks 13 to 24|Sponsor Decision|1
5244055|NCT00797225|18095608|P6|Weeks 13 to 24|Sponsor Decision|0
5244056|NCT00797225|18095609|P5|Weeks 13 to 24|Sponsor Decision|0
5244057|NCT00797225|18095610|P4|Weeks 13 to 24|Sponsor Decision|0
5244058|NCT00797225|18095611|P3|Weeks 13 to 24|Sponsor Decision|0
5244059|NCT00797225|18095612|P2|Weeks 13 to 24|Sponsor Decision|0
5244060|NCT00797225|18095613|P1|Weeks 13 to 24|Sponsor Decision|0
5244061|NCT00797225|18095606|P8|Weeks 13 to 24|Adverse Event|0
5244062|NCT00797225|18095607|P7|Weeks 13 to 24|Adverse Event|1
5244063|NCT00797225|18095608|P6|Weeks 13 to 24|Adverse Event|0
5244064|NCT00797225|18095609|P5|Weeks 13 to 24|Adverse Event|0
5244065|NCT00797225|18095610|P4|Weeks 13 to 24|Adverse Event|0
5244066|NCT00797225|18095611|P3|Weeks 13 to 24|Adverse Event|0
5244067|NCT00797225|18095612|P2|Weeks 13 to 24|Adverse Event|1
5244068|NCT00797225|18095613|P1|Weeks 13 to 24|Adverse Event|0
5244069|NCT00797225|18095606|P8|Weeks 13 to 24|Lost to Follow-up|0
5244070|NCT00797225|18095607|P7|Weeks 13 to 24|Lost to Follow-up|0
5244071|NCT00797225|18095608|P6|Weeks 13 to 24|Lost to Follow-up|0
5244072|NCT00797225|18095609|P5|Weeks 13 to 24|Lost to Follow-up|1
5244073|NCT00797225|18095610|P4|Weeks 13 to 24|Lost to Follow-up|0
5244074|NCT00797225|18095611|P3|Weeks 13 to 24|Lost to Follow-up|1
5244075|NCT00797225|18095612|P2|Weeks 13 to 24|Lost to Follow-up|0
5244076|NCT00797225|18095613|P1|Weeks 13 to 24|Lost to Follow-up|0
5244077|NCT00797225|18095606|P8|Weeks 13 to 24|Withdrawal by Subject|0
5244078|NCT00797225|18095607|P7|Weeks 13 to 24|Withdrawal by Subject|0
5244079|NCT00797225|18095608|P6|Weeks 13 to 24|Withdrawal by Subject|0
5244080|NCT00797225|18095609|P5|Weeks 13 to 24|Withdrawal by Subject|0
5244081|NCT00797225|18095610|P4|Weeks 13 to 24|Withdrawal by Subject|0
5244082|NCT00797225|18095611|P3|Weeks 13 to 24|Withdrawal by Subject|1
5244083|NCT00797225|18095612|P2|Weeks 13 to 24|Withdrawal by Subject|1
5244084|NCT00797225|18095613|P1|Weeks 13 to 24|Withdrawal by Subject|0
5244085|NCT00797225|18095606|P8|Weeks 13 to 24|Non-compliance|0
5244086|NCT00797225|18095607|P7|Weeks 13 to 24|Non-compliance|0
5244087|NCT00797225|18095608|P6|Weeks 13 to 24|Non-compliance|0
5244088|NCT00797225|18095609|P5|Weeks 13 to 24|Non-compliance|0
5244089|NCT00797225|18095610|P4|Weeks 13 to 24|Non-compliance|0
5244090|NCT00797225|18095611|P3|Weeks 13 to 24|Non-compliance|0
5244091|NCT00797225|18095612|P2|Weeks 13 to 24|Non-compliance|2
5244092|NCT00797225|18095613|P1|Weeks 13 to 24|Non-compliance|0
5244093|NCT00797225|18095606|P8|Weeks 1 to 12|Sponsor Decision|0
5244094|NCT00797225|18095607|P7|Weeks 1 to 12|Sponsor Decision|0
5244095|NCT00797225|18095608|P6|Weeks 1 to 12|Sponsor Decision|0
5244096|NCT00797225|18095609|P5|Weeks 1 to 12|Sponsor Decision|0
5244097|NCT00797225|18095610|P4|Weeks 1 to 12|Sponsor Decision|0
5244098|NCT00797225|18095611|P3|Weeks 1 to 12|Sponsor Decision|0
5244099|NCT00797225|18095612|P2|Weeks 1 to 12|Sponsor Decision|0
5244100|NCT00797225|18095613|P1|Weeks 1 to 12|Sponsor Decision|1
5244101|NCT00797225|18095606|P8|Weeks 1 to 12|Lack of Efficacy|0
5244102|NCT00797225|18095607|P7|Weeks 1 to 12|Lack of Efficacy|0
5244103|NCT00797225|18095608|P6|Weeks 1 to 12|Lack of Efficacy|0
5244104|NCT00797225|18095609|P5|Weeks 1 to 12|Lack of Efficacy|0
5244105|NCT00797225|18095610|P4|Weeks 1 to 12|Lack of Efficacy|0
5244106|NCT00797225|18095611|P3|Weeks 1 to 12|Lack of Efficacy|0
5244107|NCT00797225|18095612|P2|Weeks 1 to 12|Lack of Efficacy|0
5244108|NCT00797225|18095613|P1|Weeks 1 to 12|Lack of Efficacy|1
5244109|NCT00797225|18095606|P8|Weeks 1 to 12|Non-compliance|0
5244110|NCT00797225|18095607|P7|Weeks 1 to 12|Non-compliance|0
5244111|NCT00797225|18095608|P6|Weeks 1 to 12|Non-compliance|0
5244112|NCT00797225|18095609|P5|Weeks 1 to 12|Non-compliance|0
5244113|NCT00797225|18095610|P4|Weeks 1 to 12|Non-compliance|0
5244114|NCT00797225|18095611|P3|Weeks 1 to 12|Non-compliance|0
5244115|NCT00797225|18095612|P2|Weeks 1 to 12|Non-compliance|1
5244116|NCT00797225|18095613|P1|Weeks 1 to 12|Non-compliance|0
5244117|NCT00797225|18095606|P8|Weeks 1 to 12|Adverse Event|0
5244118|NCT00797225|18095607|P7|Weeks 1 to 12|Adverse Event|0
5244119|NCT00797225|18095608|P6|Weeks 1 to 12|Adverse Event|0
5244120|NCT00797225|18095609|P5|Weeks 1 to 12|Adverse Event|0
5244121|NCT00797225|18095610|P4|Weeks 1 to 12|Adverse Event|0
5244122|NCT00797225|18095611|P3|Weeks 1 to 12|Adverse Event|1
5244123|NCT00797225|18095612|P2|Weeks 1 to 12|Adverse Event|0
5244124|NCT00797225|18095613|P1|Weeks 1 to 12|Adverse Event|0
5244125|NCT00797108|18095730|P3|Overall Study|Randomized but not Treated|0
5244126|NCT00797108|18095731|P2|Overall Study|Randomized but not Treated|0
5244127|NCT00797108|18095732|P1|Overall Study|Randomized but not Treated|2
5244128|NCT00797108|18095730|P3|Overall Study|Other|2
5244129|NCT00797108|18095731|P2|Overall Study|Other|0
5244130|NCT00797108|18095732|P1|Overall Study|Other|0
5244131|NCT00797108|18095730|P3|Overall Study|Lack of Efficacy|1
5244132|NCT00797108|18095731|P2|Overall Study|Lack of Efficacy|0
5244133|NCT00797108|18095732|P1|Overall Study|Lack of Efficacy|1
5244134|NCT00797108|18095730|P3|Overall Study|Global Deterioration of Health Status|0
5244135|NCT00797108|18095731|P2|Overall Study|Global Deterioration of Health Status|1
5244136|NCT00797108|18095732|P1|Overall Study|Global Deterioration of Health Status|0
5244137|NCT00797108|18095730|P3|Overall Study|Did Not Meet Entrance Criteria|0
5244138|NCT00797108|18095731|P2|Overall Study|Did Not Meet Entrance Criteria|1
5244139|NCT00797108|18095732|P1|Overall Study|Did Not Meet Entrance Criteria|0
5244140|NCT00797108|18095730|P3|Overall Study|Adverse Event|3
5244141|NCT00797108|18095731|P2|Overall Study|Adverse Event|0
5244142|NCT00797108|18095732|P1|Overall Study|Adverse Event|1
5244143|NCT00796991|18095767|P3|Overall Study|Withdrawal by Subject|1
5244144|NCT00796991|18095768|P2|Overall Study|Withdrawal by Subject|0
5244145|NCT00796991|18095769|P1|Overall Study|Withdrawal by Subject|0
5244146|NCT00796991|18095767|P3|Overall Study|Study Drug Toxicity|5
5244147|NCT00796991|18095768|P2|Overall Study|Study Drug Toxicity|3
5244148|NCT00796991|18095769|P1|Overall Study|Study Drug Toxicity|3
5244149|NCT00796991|18095767|P3|Overall Study|Disease Progression|7
5244150|NCT00796991|18095768|P2|Overall Study|Disease Progression|9
5244151|NCT00796991|18095769|P1|Overall Study|Disease Progression|10
5244152|NCT00796991|18095767|P3|Overall Study|Death|0
5244153|NCT00796991|18095768|P2|Overall Study|Death|0
5244154|NCT00796991|18095769|P1|Overall Study|Death|2
5244155|NCT00796991|18095767|P3|Overall Study|Adverse Event|1
5244156|NCT00796991|18095768|P2|Overall Study|Adverse Event|0
5244157|NCT00796991|18095769|P1|Overall Study|Adverse Event|0
5244158|NCT00796978|18095867|P1|Overall Study|Withdrawal by Subject|3
5244159|NCT00796978|18095867|P1|Overall Study|Adverse Event|4
5244160|NCT00796978|18095867|P1|Overall Study|Cardiac adverse event|5
5244161|NCT00796861|18095893|P1|Overall Study|Death|2
5244162|NCT00796861|18095893|P1|Overall Study|Withdrawal by Subject|2
5244163|NCT00796822|18095899|P2|Overall Study|Adverse Event|0
5244164|NCT00796822|18095900|P1|Overall Study|Adverse Event|1
5244165|NCT00796822|18095899|P2|Overall Study|Lost to Follow-up|0
5244166|NCT00796822|18095900|P1|Overall Study|Lost to Follow-up|2
5244167|NCT00796757|18095908|P1|Overall Study|Other|7
5244168|NCT00796757|18095908|P1|Overall Study|Investigator's decision|2
5244169|NCT00796757|18095908|P1|Overall Study|Participant noncompliance|1
5244170|NCT00796757|18095908|P1|Overall Study|Protocol Violation|1
5244171|NCT00796757|18095908|P1|Overall Study|Death|61
5244172|NCT00796757|18095908|P1|Overall Study|Withdrawal by Subject|14
5244173|NCT00796718|18095942|P1|Overall Study|Withdrawal by Informed Consent|1
5244174|NCT00796718|18095942|P1|Overall Study|Lost to Follow-up|5
5244175|NCT00796718|18095942|P1|Overall Study|Exclusion Criteria|1
5244176|NCT00796718|18095942|P1|Overall Study|Adverse Event|2
5244177|NCT00796666|18095994|P2|Overall Study|Randomized and not treated|0
5244178|NCT00796666|18095995|P1|Overall Study|Randomized and not treated|1
5244179|NCT00796666|18095994|P2|Overall Study|Terminated by sponsor|55
5244180|NCT00796666|18095995|P1|Overall Study|Terminated by sponsor|53
5244181|NCT00796666|18095994|P2|Overall Study|Other|0
5244182|NCT00796666|18095995|P1|Overall Study|Other|1
5244183|NCT00796666|18095994|P2|Overall Study|Protocol Violation|0
5244184|NCT00796666|18095995|P1|Overall Study|Protocol Violation|1
5244185|NCT00796666|18095994|P2|Overall Study|Adverse Event|5
5244186|NCT00796666|18095995|P1|Overall Study|Adverse Event|7
5244187|NCT00796666|18095994|P2|Overall Study|Withdrawal by Subject|0
5244188|NCT00796666|18095995|P1|Overall Study|Withdrawal by Subject|2
5244189|NCT00796666|18095994|P2|Overall Study|Death|4
5244190|NCT00796666|18095995|P1|Overall Study|Death|2
5244191|NCT00796653|18096029|P4|Overall Study|Other reason not described above|4
5244192|NCT00796653|18096030|P3|Overall Study|Other reason not described above|7
5244193|NCT00796653|18096031|P2|Overall Study|Other reason not described above|9
5244194|NCT00796653|18096032|P1|Overall Study|Other reason not described above|4
5244195|NCT00796653|18096029|P4|Overall Study|Non compliance with protocol|2
5244196|NCT00796653|18096030|P3|Overall Study|Non compliance with protocol|0
5244197|NCT00796653|18096031|P2|Overall Study|Non compliance with protocol|2
5244198|NCT00796653|18096032|P1|Overall Study|Non compliance with protocol|2
5244199|NCT00796653|18096029|P4|Overall Study|Lack of Efficacy|2
5244200|NCT00796653|18096030|P3|Overall Study|Lack of Efficacy|3
5244201|NCT00796653|18096031|P2|Overall Study|Lack of Efficacy|1
5244202|NCT00796653|18096032|P1|Overall Study|Lack of Efficacy|8
5244203|NCT00796653|18096029|P4|Overall Study|Withdrawal by Subject|13
5244204|NCT00796653|18096030|P3|Overall Study|Withdrawal by Subject|8
5244205|NCT00796653|18096031|P2|Overall Study|Withdrawal by Subject|8
5244206|NCT00796653|18096032|P1|Overall Study|Withdrawal by Subject|16
5244207|NCT00796653|18096029|P4|Overall Study|Lost to Follow-up|3
5244208|NCT00796653|18096030|P3|Overall Study|Lost to Follow-up|2
5244209|NCT00796653|18096031|P2|Overall Study|Lost to Follow-up|1
5244210|NCT00796653|18096032|P1|Overall Study|Lost to Follow-up|2
5244211|NCT00796653|18096029|P4|Overall Study|Adverse Event|16
5244212|NCT00796653|18096030|P3|Overall Study|Adverse Event|16
5244213|NCT00796653|18096031|P2|Overall Study|Adverse Event|16
5244214|NCT00796653|18096032|P1|Overall Study|Adverse Event|19
5244215|NCT00796614|18096317|P4|Overall Study|Other than stated|0
5244216|NCT00796614|18096318|P3|Overall Study|Other than stated|0
5244217|NCT00796614|18096319|P2|Overall Study|Other than stated|0
5244218|NCT00796614|18096320|P1|Overall Study|Other than stated|1
5244219|NCT00796614|18096317|P4|Overall Study|Withdrawal by Subject|1
5244220|NCT00796614|18096318|P3|Overall Study|Withdrawal by Subject|0
5244221|NCT00796614|18096319|P2|Overall Study|Withdrawal by Subject|0
5244222|NCT00796614|18096320|P1|Overall Study|Withdrawal by Subject|1
5244223|NCT00796614|18096317|P4|Overall Study|Lost to Follow-up|0
5244224|NCT00796614|18096318|P3|Overall Study|Lost to Follow-up|1
5244225|NCT00796614|18096319|P2|Overall Study|Lost to Follow-up|2
5244226|NCT00796614|18096320|P1|Overall Study|Lost to Follow-up|2
5244227|NCT00796614|18096317|P4|Overall Study|Protocol Violation|0
5244228|NCT00796614|18096318|P3|Overall Study|Protocol Violation|2
5244229|NCT00796614|18096319|P2|Overall Study|Protocol Violation|0
5244230|NCT00796614|18096320|P1|Overall Study|Protocol Violation|0
5244231|NCT00796614|18096317|P4|Overall Study|Adverse Event|0
5244232|NCT00796614|18096318|P3|Overall Study|Adverse Event|0
5244233|NCT00796614|18096319|P2|Overall Study|Adverse Event|2
5244234|NCT00796614|18096320|P1|Overall Study|Adverse Event|1
5244235|NCT00796562|18096362|P1|Overall Study|Death|49
5244236|NCT00796549|18096371|P1|Overall Study|Progressive disease|56
5244237|NCT00796549|18096371|P1|Overall Study|Other|2
5244238|NCT00796549|18096371|P1|Overall Study|not entered|149
5244239|NCT00796549|18096371|P1|Overall Study|Adverse Event|11
5244240|NCT00796523|18096388|P2|Overall Study|Lost to Follow-up|7
5244241|NCT00796523|18096389|P1|Overall Study|Lost to Follow-up|9
5244242|NCT00796510|18096399|P2|Overall Study|Study Terminated|0
5244243|NCT00796510|18096400|P1|Overall Study|Study Terminated|2
5244244|NCT00796510|18096399|P2|Overall Study|Death|0
5244245|NCT00796510|18096400|P1|Overall Study|Death|1
5244246|NCT00796445|18096412|P2|Overall Study|Withdrawal by Subject|9
5244247|NCT00796445|18096413|P1|Overall Study|Withdrawal by Subject|18
5244248|NCT00796445|18096412|P2|Overall Study|Other|7
5244249|NCT00796445|18096413|P1|Overall Study|Other|10
5244250|NCT00796445|18096412|P2|Overall Study|Disease progression/recurrence|268
5244251|NCT00796445|18096413|P1|Overall Study|Disease progression/recurrence|537
5244252|NCT00796445|18096412|P2|Overall Study|Adverse event, non-fatal|0
5244253|NCT00796445|18096413|P1|Overall Study|Adverse event, non-fatal|4
5244254|NCT00796445|18096412|P2|Overall Study|Adverse event, serious fatal|5
5244255|NCT00796445|18096413|P1|Overall Study|Adverse event, serious fatal|10
5244256|NCT00796445|18096412|P2|Overall Study|Protocol Violation|3
5244257|NCT00796445|18096413|P1|Overall Study|Protocol Violation|5
5244258|NCT00796419|18096465|P2|Overall Study|Death|1
5244259|NCT00796419|18096466|P1|Overall Study|Death|0
5244260|NCT00796367|18096479|P3|Overall Study|other|3
5244261|NCT00796367|18096480|P2|Overall Study|other|4
5244262|NCT00796367|18096481|P1|Overall Study|other|2
5244263|NCT00796367|18096479|P3|Overall Study|Requirement for restricted medication|2
5244264|NCT00796367|18096480|P2|Overall Study|Requirement for restricted medication|0
5244265|NCT00796367|18096481|P1|Overall Study|Requirement for restricted medication|2
5244266|NCT00796367|18096479|P3|Overall Study|Pregnancy|1
5244267|NCT00796367|18096480|P2|Overall Study|Pregnancy|0
5244268|NCT00796367|18096481|P1|Overall Study|Pregnancy|1
5244269|NCT00796367|18096479|P3|Overall Study|non compliance|1
5244270|NCT00796367|18096480|P2|Overall Study|non compliance|1
5244271|NCT00796367|18096481|P1|Overall Study|non compliance|3
5244272|NCT00796367|18096479|P3|Overall Study|Lack of Efficacy|0
5244273|NCT00796367|18096480|P2|Overall Study|Lack of Efficacy|1
5244274|NCT00796367|18096481|P1|Overall Study|Lack of Efficacy|2
5244275|NCT00796367|18096479|P3|Overall Study|Withdrawal by Subject|12
5244276|NCT00796367|18096480|P2|Overall Study|Withdrawal by Subject|11
5244277|NCT00796367|18096481|P1|Overall Study|Withdrawal by Subject|9
5244278|NCT00796367|18096479|P3|Overall Study|Lost to Follow-up|21
5244279|NCT00796367|18096480|P2|Overall Study|Lost to Follow-up|4
5244280|NCT00796367|18096481|P1|Overall Study|Lost to Follow-up|5
5244281|NCT00796367|18096479|P3|Overall Study|Adverse Event|7
5244282|NCT00796367|18096480|P2|Overall Study|Adverse Event|4
5244283|NCT00796367|18096481|P1|Overall Study|Adverse Event|6
5244284|NCT00796328|18096492|P1|Overall Study|experienced hypotension requiring tx|6
5244285|NCT00796315|18096496|P3|Overall Study|Protocol Violation|0
5244286|NCT00796315|18096497|P2|Overall Study|Protocol Violation|1
5244287|NCT00796315|18096498|P1|Overall Study|Protocol Violation|0
5244288|NCT00796224|18096526|P2|Overall Study|Protocol Violation|1
5244289|NCT00796224|18096527|P1|Overall Study|Protocol Violation|0
5244290|NCT00796224|18096526|P2|Overall Study|Adverse Event|0
5244291|NCT00796224|18096527|P1|Overall Study|Adverse Event|1
5244292|NCT00796120|18096547|P2|Overall Study|Randomized but not treated|3
5244293|NCT00796120|18096548|P1|Overall Study|Randomized but not treated|0
5244294|NCT00796120|18096547|P2|Overall Study|Physician Decision|17
5244295|NCT00796120|18096548|P1|Overall Study|Physician Decision|16
5244296|NCT00796120|18096547|P2|Overall Study|Other|17
5244297|NCT00796120|18096548|P1|Overall Study|Other|6
5244298|NCT00796120|18096547|P2|Overall Study|Participant refusal|4
5244299|NCT00796120|18096548|P1|Overall Study|Participant refusal|3
5244300|NCT00796120|18096547|P2|Overall Study|Progressive disease|13
5244301|NCT00796120|18096548|P1|Overall Study|Progressive disease|22
5244302|NCT00796120|18096547|P2|Overall Study|Adverse Event|6
5244303|NCT00796120|18096548|P1|Overall Study|Adverse Event|11
5244304|NCT00796120|18096547|P2|Overall Study|Death|0
5244305|NCT00796120|18096548|P1|Overall Study|Death|3
5244306|NCT00796107|18096562|P1|Overall Study|Progressive Disease|5
5244307|NCT00796107|18096562|P1|Overall Study|Lack of Efficacy|1
5244308|NCT00796003|18096571|P2|Overall Study|Participants Not treated|2
5244309|NCT00796003|18096572|P1|Overall Study|Participants Not treated|0
5244310|NCT00796003|18096571|P2|Overall Study|Other|1
5244311|NCT00796003|18096572|P1|Overall Study|Other|0
5244312|NCT00796003|18096571|P2|Overall Study|Withdrawal by Subject|1
5244313|NCT00796003|18096572|P1|Overall Study|Withdrawal by Subject|0
5244314|NCT00796003|18096571|P2|Overall Study|Physician Decision|4
5244315|NCT00796003|18096572|P1|Overall Study|Physician Decision|0
5244316|NCT00796003|18096571|P2|Overall Study|Specified organ function not met|1
5244317|NCT00796003|18096572|P1|Overall Study|Specified organ function not met|0
5244318|NCT00796003|18096571|P2|Overall Study|Adverse Event|7
5244319|NCT00796003|18096572|P1|Overall Study|Adverse Event|1
5244320|NCT00796003|18096571|P2|Overall Study|Disease Progression|13
5244321|NCT00796003|18096572|P1|Overall Study|Disease Progression|2
5244322|NCT00795951|18096593|P1|Overall Study|Withdrawal by Subject|1
5244323|NCT00795951|18096593|P1|Overall Study|Lost to Follow-up|1
5244324|NCT00795886|18096686|P1|Overall Study|Death|10
5244325|NCT00795821|18096694|P2|Taper Phase|Withdrawal by Subject|0
5244326|NCT00795821|18096695|P1|Taper Phase|Withdrawal by Subject|4
5244327|NCT00795821|18096694|P2|Taper Phase|Physician Decision|0
5244328|NCT00795821|18096695|P1|Taper Phase|Physician Decision|2
5244329|NCT00795821|18096694|P2|Taper Phase|Lost to Follow-up|0
5244330|NCT00795821|18096695|P1|Taper Phase|Lost to Follow-up|1
5244331|NCT00795821|18096694|P2|Taper Phase|Adverse Event|0
5244332|NCT00795821|18096695|P1|Taper Phase|Adverse Event|2
5244333|NCT00795821|18096694|P2|Long-term Extension Phase|Withdrawal by Subject|25
5244334|NCT00795821|18096695|P1|Long-term Extension Phase|Withdrawal by Subject|25
5244335|NCT00795821|18096694|P2|Long-term Extension Phase|Protocol Violation|5
5244336|NCT00795821|18096695|P1|Long-term Extension Phase|Protocol Violation|3
5244337|NCT00795821|18096694|P2|Long-term Extension Phase|Physician Decision|2
5244338|NCT00795821|18096695|P1|Long-term Extension Phase|Physician Decision|1
5244339|NCT00795821|18096694|P2|Long-term Extension Phase|Lost to Follow-up|16
5244340|NCT00795821|18096695|P1|Long-term Extension Phase|Lost to Follow-up|20
5244341|NCT00795821|18096694|P2|Long-term Extension Phase|Lack of Efficacy|12
5244342|NCT00795821|18096695|P1|Long-term Extension Phase|Lack of Efficacy|16
5244343|NCT00795821|18096694|P2|Long-term Extension Phase|Adverse Event|32
5244344|NCT00795821|18096695|P1|Long-term Extension Phase|Adverse Event|25
5244345|NCT00795821|18096694|P2|Acute Treatment Phase|Withdrawal by Subject|10
5244346|NCT00795821|18096695|P1|Acute Treatment Phase|Withdrawal by Subject|16
5244347|NCT00795821|18096694|P2|Acute Treatment Phase|Protocol Violation|2
5244348|NCT00795821|18096695|P1|Acute Treatment Phase|Protocol Violation|1
5244349|NCT00795821|18096694|P2|Acute Treatment Phase|Physician Decision|1
5244350|NCT00795821|18096695|P1|Acute Treatment Phase|Physician Decision|1
5244351|NCT00795821|18096694|P2|Acute Treatment Phase|Lost to Follow-up|12
5244352|NCT00795821|18096695|P1|Acute Treatment Phase|Lost to Follow-up|9
5244353|NCT00795821|18096694|P2|Acute Treatment Phase|Lack of Efficacy|2
5244354|NCT00795821|18096695|P1|Acute Treatment Phase|Lack of Efficacy|5
5244355|NCT00795821|18096694|P2|Acute Treatment Phase|Death|0
5244356|NCT00795821|18096695|P1|Acute Treatment Phase|Death|1
5244357|NCT00795821|18096694|P2|Acute Treatment Phase|Adverse Event|4
5244358|NCT00795821|18096695|P1|Acute Treatment Phase|Adverse Event|23
5244359|NCT00795717|18096770|P2|Phase II|too busy|1
5244360|NCT00795717|18096771|P1|Phase II|too busy|0
5244361|NCT00795717|18096770|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
5244362|NCT00795717|18096771|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
5244363|NCT00795717|18096770|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
5244364|NCT00795717|18096771|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
5244365|NCT00795717|18096770|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
5244366|NCT00795717|18096771|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
5244367|NCT00795704|18096783|P2|Overall Study|Adverse Event|1
5244368|NCT00795704|18096784|P1|Overall Study|Adverse Event|1
5244369|NCT00795704|18096783|P2|Overall Study|Withdrawal by Subject|2
5244370|NCT00795704|18096784|P1|Overall Study|Withdrawal by Subject|3
5244371|NCT00795639|18096804|P2|Overall Study|Randomized and not treated|1
5244372|NCT00795639|18096805|P1|Overall Study|Randomized and not treated|0
5244373|NCT00795639|18096804|P2|Overall Study|Terminated by sponsor|12
5244374|NCT00795639|18096805|P1|Overall Study|Terminated by sponsor|13
5244375|NCT00795639|18096804|P2|Overall Study|Other|2
5244376|NCT00795639|18096805|P1|Overall Study|Other|0
5244377|NCT00795639|18096804|P2|Overall Study|Adverse Event|2
5244378|NCT00795639|18096805|P1|Overall Study|Adverse Event|5
5244379|NCT00795639|18096804|P2|Overall Study|Pregnancy|0
5244380|NCT00795639|18096805|P1|Overall Study|Pregnancy|1
5244381|NCT00795639|18096804|P2|Overall Study|Withdrawal by Subject|3
5244382|NCT00795639|18096805|P1|Overall Study|Withdrawal by Subject|1
5244383|NCT00795639|18096804|P2|Overall Study|Death|6
5244384|NCT00795639|18096805|P1|Overall Study|Death|1
5244385|NCT00795600|18096817|P2|Overall Study|Unclassified|1
5244386|NCT00795600|18096818|P1|Overall Study|Unclassified|1
5244387|NCT00795600|18096817|P2|Overall Study|Withdrawal by Subject|0
5244388|NCT00795600|18096818|P1|Overall Study|Withdrawal by Subject|1
5244389|NCT00795600|18096817|P2|Overall Study|Protocol Violation|2
5244390|NCT00795600|18096818|P1|Overall Study|Protocol Violation|1
5244391|NCT00795600|18096817|P2|Overall Study|Adverse Event|1
5244392|NCT00795600|18096818|P1|Overall Study|Adverse Event|1
5244393|NCT00795535|18096938|P1|Overall Study|incomplete data and technical problems|20
5244394|NCT00795509|18096945|P1|Overall Study|Protocol Violation|31
5244395|NCT00795184|18097014|P2|Overall Study|Tissue sampling incomplete/conclusive|13
5244396|NCT00795184|18097015|P1|Overall Study|Tissue sampling incomplete/conclusive|8
5244397|NCT00795132|18097076|P1|Overall Study|Relapse|2
5244398|NCT00795132|18097076|P1|Overall Study|Death|1
5244399|NCT00794963|18097103|P2|Overall Study|Withdrawal by Subject|4
5244400|NCT00794963|18097104|P1|Overall Study|Withdrawal by Subject|1
5244401|NCT00794950|18097110|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
5244402|NCT00794950|18097110|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
5244403|NCT00794950|18097110|P1|Beginning Sunitinib Treatment|Physician Decision|5
5244404|NCT00794950|18097110|P1|Beginning Sunitinib Treatment|cystectomy|5
5244405|NCT00794950|18097110|P1|BCG Induction|Adverse Event|1
5244406|NCT00794950|18097110|P1|BCG Induction|noncompliant w. BCG|1
5244407|NCT00794950|18097110|P1|BCG Induction|ineligible|3
5244408|NCT00794950|18097110|P1|BCG Induction|Withdrawal by Subject|2
5244409|NCT00794924|18097119|P2|Overall Study|Adverse Event|2
5244410|NCT00794924|18097120|P1|Overall Study|Adverse Event|6
5244411|NCT00794924|18097119|P2|Overall Study|Withdrawal by Subject|60
5244412|NCT00794924|18097120|P1|Overall Study|Withdrawal by Subject|48
5244413|NCT00794924|18097119|P2|Overall Study|Lost to Follow-up|8
5244414|NCT00794924|18097120|P1|Overall Study|Lost to Follow-up|6
5244415|NCT00794820|18097124|P1|Overall Study|Ineligible/Screen Failure|1
5244416|NCT00794820|18097124|P1|Overall Study|Resistant Disease|2
5244417|NCT00794820|18097124|P1|Overall Study|Secondary Malignancies|2
5244418|NCT00794820|18097124|P1|Overall Study|Adverse Event|11
5244419|NCT00794677|18097132|P2|First Intervention|Withdrawal by Subject|0
5244420|NCT00794677|18097133|P1|First Intervention|Withdrawal by Subject|2
5244421|NCT00794664|18097155|P2|Follow-up Period|Protocol non-compliance|1
5244422|NCT00794664|18097156|P1|Follow-up Period|Protocol non-compliance|0
5244423|NCT00794664|18097155|P2|Follow-up Period|Withdrawal by Subject|2
5244424|NCT00794664|18097156|P1|Follow-up Period|Withdrawal by Subject|0
5244425|NCT00794664|18097155|P2|Follow-up Period|Other|2
5244426|NCT00794664|18097156|P1|Follow-up Period|Other|1
5244427|NCT00794664|18097155|P2|Treatment Period|Adverse Event|8
5244428|NCT00794664|18097156|P1|Treatment Period|Adverse Event|1
5244429|NCT00794664|18097155|P2|Treatment Period|Other|1
5244430|NCT00794664|18097156|P1|Treatment Period|Other|0
5244431|NCT00794664|18097155|P2|Treatment Period|Protocol non-compliance|1
5244432|NCT00794664|18097156|P1|Treatment Period|Protocol non-compliance|0
5244433|NCT00794664|18097155|P2|Treatment Period|Withdrawal by Subject|2
5244434|NCT00794664|18097156|P1|Treatment Period|Withdrawal by Subject|0
5244435|NCT00794573|18097202|P2|Overall Study|Lost to Follow-up|33
5244436|NCT00794573|18097203|P1|Overall Study|Lost to Follow-up|26
5244437|NCT00794573|18097202|P2|Overall Study|Withdrawal by Subject|12
5244438|NCT00794573|18097203|P1|Overall Study|Withdrawal by Subject|9
5244439|NCT00794573|18097202|P2|Overall Study|Death|0
5244440|NCT00794573|18097203|P1|Overall Study|Death|3
5244441|NCT00794365|18097272|P1|Overall Study|Lack of Efficacy|3
5244442|NCT00794365|18097272|P1|Overall Study|Adverse Event|10
5244443|NCT00794365|18097272|P1|Overall Study|Poor Compliance|11
5244444|NCT00794365|18097272|P1|Overall Study|Other|17
5244445|NCT00794365|18097272|P1|Overall Study|Lost to Follow-up|38
5244446|NCT00794196|18097293|P2|Overall Study|Lost to Follow-up|23
5244447|NCT00794196|18097294|P1|Overall Study|Lost to Follow-up|5
5244448|NCT00794157|18097314|P3|Overall Study|Protocol deviation|1
5244449|NCT00794157|18097315|P2|Overall Study|Protocol deviation|1
5244450|NCT00794157|18097316|P1|Overall Study|Protocol deviation|0
5244451|NCT00794157|18097314|P3|Overall Study|Abnormal test procedure result(s)|0
5244452|NCT00794157|18097315|P2|Overall Study|Abnormal test procedure result(s)|1
5244453|NCT00794157|18097316|P1|Overall Study|Abnormal test procedure result(s)|0
5244454|NCT00794157|18097314|P3|Overall Study|Administrative problems|4
5244455|NCT00794157|18097315|P2|Overall Study|Administrative problems|7
5244456|NCT00794157|18097316|P1|Overall Study|Administrative problems|1
5244457|NCT00794157|18097314|P3|Overall Study|Unsatisfactory therapeutic effect|2
5244458|NCT00794157|18097315|P2|Overall Study|Unsatisfactory therapeutic effect|0
5244459|NCT00794157|18097316|P1|Overall Study|Unsatisfactory therapeutic effect|1
5244460|NCT00794157|18097314|P3|Overall Study|Lost to Follow-up|1
5244461|NCT00794157|18097315|P2|Overall Study|Lost to Follow-up|0
5244462|NCT00794157|18097316|P1|Overall Study|Lost to Follow-up|2
5244463|NCT00794157|18097314|P3|Overall Study|Subject withdrew consent|3
5244464|NCT00794157|18097315|P2|Overall Study|Subject withdrew consent|0
5244465|NCT00794157|18097316|P1|Overall Study|Subject withdrew consent|2
5244466|NCT00794157|18097314|P3|Overall Study|Adverse Event|8
5244467|NCT00794157|18097315|P2|Overall Study|Adverse Event|1
5244468|NCT00794157|18097316|P1|Overall Study|Adverse Event|4
5244469|NCT00794118|18097345|P1|Overall Study|Changed hospital center|2
5244470|NCT00794118|18097345|P1|Overall Study|Withdrawal by Subject|9
5244471|NCT00794118|18097345|P1|Overall Study|Lost to Follow-up|16
5244472|NCT00794040|18097405|P2|Overall Study|Physician Decision|1
5244473|NCT00794040|18097406|P1|Overall Study|Physician Decision|0
5244474|NCT00794040|18097405|P2|Overall Study|Withdrawal by Subject|4
5244475|NCT00794040|18097406|P1|Overall Study|Withdrawal by Subject|3
5244476|NCT00793910|18097422|P2|Overall Study|Withdrawal by Subject|1
5244477|NCT00793910|18097423|P1|Overall Study|Withdrawal by Subject|0
5244478|NCT00793910|18097422|P2|Overall Study|decided to undergo LASIK instead of PRK|1
5244479|NCT00793910|18097423|P1|Overall Study|decided to undergo LASIK instead of PRK|2
5244480|NCT00793910|18097422|P2|Overall Study|ineligible based on entry criteria|3
5244481|NCT00793910|18097423|P1|Overall Study|ineligible based on entry criteria|2
5244482|NCT00793910|18097422|P2|Overall Study|did not pick up medications|1
5244483|NCT00793910|18097423|P1|Overall Study|did not pick up medications|1
5244484|NCT00793910|18097422|P2|Overall Study|discarded study pills|1
5244485|NCT00793910|18097423|P1|Overall Study|discarded study pills|0
5244486|NCT00793871|18097437|P1|Overall Study|Study terminated by the Sponsor|7
5244487|NCT00793871|18097437|P1|Overall Study|Lost to Follow-up|3
5244488|NCT00793871|18097437|P1|Overall Study|Death|50
5244489|NCT00793819|18097451|P2|Overall Study|Lost to Follow-up|1
5244490|NCT00793819|18097452|P1|Overall Study|Lost to Follow-up|1
5244491|NCT00793819|18097451|P2|Overall Study|Withdrawal by Subject|3
5244492|NCT00793819|18097452|P1|Overall Study|Withdrawal by Subject|4
5244493|NCT00793819|18097451|P2|Overall Study|Lack of Efficacy|1
5244494|NCT00793819|18097452|P1|Overall Study|Lack of Efficacy|1
5244495|NCT00793819|18097451|P2|Overall Study|Adverse Event|4
5244496|NCT00793819|18097452|P1|Overall Study|Adverse Event|8
5244497|NCT00793793|18097470|P12|Overall Study|reason not specified|4
5244498|NCT00793793|18097471|P11|Overall Study|reason not specified|2
5244499|NCT00793793|18097472|P10|Overall Study|reason not specified|6
5244500|NCT00793793|18097473|P9|Overall Study|reason not specified|7
5244501|NCT00793793|18097474|P8|Overall Study|reason not specified|0
5244502|NCT00793793|18097475|P7|Overall Study|reason not specified|2
5244503|NCT00793793|18097476|P6|Overall Study|reason not specified|1
5244504|NCT00793793|18097477|P5|Overall Study|reason not specified|1
5244505|NCT00793793|18097478|P4|Overall Study|reason not specified|1
5244506|NCT00793793|18097479|P3|Overall Study|reason not specified|0
5244507|NCT00793793|18097480|P2|Overall Study|reason not specified|1
5244508|NCT00793793|18097481|P1|Overall Study|reason not specified|0
5244509|NCT00793793|18097470|P12|Overall Study|Withdrawal by Subject|0
5244510|NCT00793793|18097471|P11|Overall Study|Withdrawal by Subject|0
5244511|NCT00793793|18097472|P10|Overall Study|Withdrawal by Subject|0
5244512|NCT00793793|18097473|P9|Overall Study|Withdrawal by Subject|1
5244513|NCT00793793|18097474|P8|Overall Study|Withdrawal by Subject|0
5244514|NCT00793793|18097475|P7|Overall Study|Withdrawal by Subject|0
5244515|NCT00793793|18097476|P6|Overall Study|Withdrawal by Subject|0
5244516|NCT00793793|18097477|P5|Overall Study|Withdrawal by Subject|1
5244517|NCT00793793|18097478|P4|Overall Study|Withdrawal by Subject|0
5244518|NCT00793793|18097479|P3|Overall Study|Withdrawal by Subject|0
5244519|NCT00793793|18097480|P2|Overall Study|Withdrawal by Subject|0
5244520|NCT00793793|18097481|P1|Overall Study|Withdrawal by Subject|0
5244521|NCT00793793|18097470|P12|Overall Study|Lost to Follow-up|0
5244522|NCT00793793|18097471|P11|Overall Study|Lost to Follow-up|1
5244523|NCT00793793|18097472|P10|Overall Study|Lost to Follow-up|3
5244524|NCT00793793|18097473|P9|Overall Study|Lost to Follow-up|1
5244525|NCT00793793|18097474|P8|Overall Study|Lost to Follow-up|0
5244526|NCT00793793|18097475|P7|Overall Study|Lost to Follow-up|0
5244527|NCT00793793|18097476|P6|Overall Study|Lost to Follow-up|0
5244528|NCT00793793|18097477|P5|Overall Study|Lost to Follow-up|0
5244529|NCT00793793|18097478|P4|Overall Study|Lost to Follow-up|0
5244530|NCT00793793|18097479|P3|Overall Study|Lost to Follow-up|1
5244531|NCT00793793|18097480|P2|Overall Study|Lost to Follow-up|0
5244532|NCT00793793|18097481|P1|Overall Study|Lost to Follow-up|0
5244533|NCT00793793|18097470|P12|Overall Study|Protocol Violation|0
5244534|NCT00793793|18097471|P11|Overall Study|Protocol Violation|0
5244535|NCT00793793|18097472|P10|Overall Study|Protocol Violation|0
5244536|NCT00793793|18097473|P9|Overall Study|Protocol Violation|0
5244537|NCT00793793|18097474|P8|Overall Study|Protocol Violation|0
5244538|NCT00793793|18097475|P7|Overall Study|Protocol Violation|0
5244539|NCT00793793|18097476|P6|Overall Study|Protocol Violation|0
5244540|NCT00793793|18097477|P5|Overall Study|Protocol Violation|0
5244541|NCT00793793|18097478|P4|Overall Study|Protocol Violation|1
5244542|NCT00793793|18097479|P3|Overall Study|Protocol Violation|0
5244543|NCT00793793|18097480|P2|Overall Study|Protocol Violation|0
5244544|NCT00793793|18097481|P1|Overall Study|Protocol Violation|0
5244545|NCT00793793|18097470|P12|Overall Study|Adverse Event|2
5244546|NCT00793793|18097471|P11|Overall Study|Adverse Event|0
5244547|NCT00793793|18097472|P10|Overall Study|Adverse Event|0
5244548|NCT00793793|18097473|P9|Overall Study|Adverse Event|0
5244549|NCT00793793|18097474|P8|Overall Study|Adverse Event|0
5244550|NCT00793793|18097475|P7|Overall Study|Adverse Event|2
5244551|NCT00793793|18097476|P6|Overall Study|Adverse Event|1
5244552|NCT00793793|18097477|P5|Overall Study|Adverse Event|0
5244553|NCT00793793|18097478|P4|Overall Study|Adverse Event|1
5244554|NCT00793793|18097479|P3|Overall Study|Adverse Event|1
5244555|NCT00793793|18097480|P2|Overall Study|Adverse Event|0
5244556|NCT00793793|18097481|P1|Overall Study|Adverse Event|0
5244557|NCT00793780|18097856|P2|Overall Study|Withdrawal by Subject|1
5244558|NCT00793780|18097857|P1|Overall Study|Withdrawal by Subject|2
5244559|NCT00793624|18097888|P4|Overall Study|Other reason not described above|3
5244560|NCT00793624|18097889|P3|Overall Study|Other reason not described above|6
5244561|NCT00793624|18097890|P2|Overall Study|Other reason not described above|4
5244562|NCT00793624|18097891|P1|Overall Study|Other reason not described above|6
5244563|NCT00793624|18097888|P4|Overall Study|Non compliance with protocol|3
5244564|NCT00793624|18097889|P3|Overall Study|Non compliance with protocol|2
5244565|NCT00793624|18097890|P2|Overall Study|Non compliance with protocol|3
5244566|NCT00793624|18097891|P1|Overall Study|Non compliance with protocol|2
5244567|NCT00793624|18097888|P4|Overall Study|Lack of Efficacy|3
5244568|NCT00793624|18097889|P3|Overall Study|Lack of Efficacy|1
5244569|NCT00793624|18097890|P2|Overall Study|Lack of Efficacy|2
5244570|NCT00793624|18097891|P1|Overall Study|Lack of Efficacy|9
5244571|NCT00793624|18097888|P4|Overall Study|Withdrawal by Subject|14
5244572|NCT00793624|18097889|P3|Overall Study|Withdrawal by Subject|11
5244573|NCT00793624|18097890|P2|Overall Study|Withdrawal by Subject|9
5244574|NCT00793624|18097891|P1|Overall Study|Withdrawal by Subject|20
5244575|NCT00793624|18097888|P4|Overall Study|Lost to Follow-up|0
5244576|NCT00793624|18097889|P3|Overall Study|Lost to Follow-up|4
5244577|NCT00793624|18097890|P2|Overall Study|Lost to Follow-up|2
5244578|NCT00793624|18097891|P1|Overall Study|Lost to Follow-up|2
5244579|NCT00793624|18097888|P4|Overall Study|Adverse Event|20
5244580|NCT00793624|18097889|P3|Overall Study|Adverse Event|15
5244581|NCT00793624|18097890|P2|Overall Study|Adverse Event|16
5244582|NCT00793624|18097891|P1|Overall Study|Adverse Event|18
5244583|NCT00793585|18098172|P2|Overall Study|Protocol Violation|2
5244584|NCT00793585|18098173|P1|Overall Study|Protocol Violation|1
5244585|NCT00793585|18098172|P2|Overall Study|Adverse Event|1
5244586|NCT00793585|18098173|P1|Overall Study|Adverse Event|1
5244587|NCT00793546|18098192|P2|Overall Study|Other|0
5244588|NCT00793546|18098193|P1|Overall Study|Other|1
5244589|NCT00793546|18098192|P2|Overall Study|Study Terminated by Sponsor|27
5244590|NCT00793546|18098193|P1|Overall Study|Study Terminated by Sponsor|8
5244591|NCT00793546|18098192|P2|Overall Study|Withdrawal by Subject|1
5244592|NCT00793546|18098193|P1|Overall Study|Withdrawal by Subject|1
5244593|NCT00793546|18098192|P2|Overall Study|Lost to Follow-up|0
5244594|NCT00793546|18098193|P1|Overall Study|Lost to Follow-up|1
5244595|NCT00793546|18098192|P2|Overall Study|Death|0
5244596|NCT00793546|18098193|P1|Overall Study|Death|3
5244597|NCT00793403|18098243|P1|Overall Study|Other|73
5244598|NCT00793325|18098290|P1|Overall Study|Lost to Follow-up|1
5244599|NCT00793325|18098290|P1|Overall Study|Protocol Violation|18
5244600|NCT00793182|18098316|P2|Overall Study|Adverse Event|1
5244601|NCT00793182|18098317|P1|Overall Study|Adverse Event|0
5244602|NCT00793104|18098327|P1|Overall Study|Lost to Follow-up|1
5244603|NCT00792948|18098335|P1|Overall Study|Protocol Violation|1
5244604|NCT00792948|18098335|P1|Overall Study|Physician Decision|11
5244605|NCT00792948|18098335|P1|Overall Study|Insurance denial - not treated|1
5244606|NCT00792948|18098335|P1|Overall Study|Ineligible|2
5244607|NCT00792948|18098335|P1|Overall Study|Withdrawal by Subject|3
5244608|NCT00792948|18098335|P1|Overall Study|Death|4
5244609|NCT00792948|18098335|P1|Overall Study|Adverse Event|6
5244610|NCT00792935|18098346|P2|Overall Study|Withdrawal by Subject|1
5244611|NCT00792935|18098347|P1|Overall Study|Withdrawal by Subject|0
5244612|NCT00792935|18098346|P2|Overall Study|Protocol Violation|0
5244613|NCT00792935|18098347|P1|Overall Study|Protocol Violation|2
5244614|NCT00792935|18098346|P2|Overall Study|Lost to Follow-up|1
5244615|NCT00792935|18098347|P1|Overall Study|Lost to Follow-up|0
5244616|NCT00792935|18098346|P2|Overall Study|Adverse Event|1
5244617|NCT00792935|18098347|P1|Overall Study|Adverse Event|2
5244618|NCT00792909|18098379|P3|Overall Study|Withdrawal by Subject|0
5244619|NCT00792909|18098380|P2|Overall Study|Withdrawal by Subject|1
5244620|NCT00792909|18098381|P1|Overall Study|Withdrawal by Subject|0
5244621|NCT00792805|18098437|P3|Overall Study|Protocol deviation|1
5244622|NCT00792805|18098438|P2|Overall Study|Protocol deviation|1
5244623|NCT00792805|18098439|P1|Overall Study|Protocol deviation|0
5244624|NCT00792805|18098437|P3|Overall Study|Abnormal laboratory value(s)|1
5244625|NCT00792805|18098438|P2|Overall Study|Abnormal laboratory value(s)|0
5244626|NCT00792805|18098439|P1|Overall Study|Abnormal laboratory value(s)|0
5244627|NCT00792805|18098437|P3|Overall Study|Lost to Follow-up|6
5244628|NCT00792805|18098438|P2|Overall Study|Lost to Follow-up|1
5244629|NCT00792805|18098439|P1|Overall Study|Lost to Follow-up|1
5244630|NCT00792805|18098437|P3|Overall Study|Unsatisfactory therapeutic effect|6
5244631|NCT00792805|18098438|P2|Overall Study|Unsatisfactory therapeutic effect|6
5244632|NCT00792805|18098439|P1|Overall Study|Unsatisfactory therapeutic effect|1
5244633|NCT00792805|18098437|P3|Overall Study|Abnormal test procedure result(s)|0
5244634|NCT00792805|18098438|P2|Overall Study|Abnormal test procedure result(s)|2
5244635|NCT00792805|18098439|P1|Overall Study|Abnormal test procedure result(s)|1
5244636|NCT00792805|18098437|P3|Overall Study|Administrative problems|4
5244637|NCT00792805|18098438|P2|Overall Study|Administrative problems|0
5244638|NCT00792805|18098439|P1|Overall Study|Administrative problems|2
5244639|NCT00792805|18098437|P3|Overall Study|Subject withdrew consent|5
5244640|NCT00792805|18098438|P2|Overall Study|Subject withdrew consent|6
5244641|NCT00792805|18098439|P1|Overall Study|Subject withdrew consent|5
5244642|NCT00792805|18098437|P3|Overall Study|Adverse Event|10
5244643|NCT00792805|18098438|P2|Overall Study|Adverse Event|10
5244644|NCT00792805|18098439|P1|Overall Study|Adverse Event|12
5244645|NCT00792701|18098449|P2|Overall Study|Not protocol specified|0
5244646|NCT00792701|18098450|P1|Overall Study|Not protocol specified|17
5244647|NCT00792701|18098449|P2|Overall Study|Withdrawal by Subject|19
5244648|NCT00792701|18098450|P1|Overall Study|Withdrawal by Subject|1
5244649|NCT00792701|18098449|P2|Overall Study|Ineligible|3
5244650|NCT00792701|18098450|P1|Overall Study|Ineligible|1
5244651|NCT00792701|18098449|P2|Overall Study|Adverse Event|22
5244652|NCT00792701|18098450|P1|Overall Study|Adverse Event|0
5244653|NCT00792636|18098480|P3|Overall Study|Investigator Discretion|2
5244654|NCT00792636|18098481|P2|Overall Study|Investigator Discretion|0
5244655|NCT00792636|18098482|P1|Overall Study|Investigator Discretion|2
5244656|NCT00792636|18098480|P3|Overall Study|Adverse Event|3
5244657|NCT00792636|18098481|P2|Overall Study|Adverse Event|2
5244658|NCT00792636|18098482|P1|Overall Study|Adverse Event|4
5244659|NCT00792636|18098480|P3|Overall Study|Lack of Efficacy|13
5244660|NCT00792636|18098481|P2|Overall Study|Lack of Efficacy|4
5244661|NCT00792636|18098482|P1|Overall Study|Lack of Efficacy|3
5244662|NCT00792636|18098480|P3|Overall Study|Withdrew Consent|9
5244663|NCT00792636|18098481|P2|Overall Study|Withdrew Consent|13
5244664|NCT00792636|18098482|P1|Overall Study|Withdrew Consent|10
5244665|NCT00792636|18098480|P3|Overall Study|Lost to Follow-up|14
5244666|NCT00792636|18098481|P2|Overall Study|Lost to Follow-up|19
5244667|NCT00792636|18098482|P1|Overall Study|Lost to Follow-up|13
5244668|NCT00792636|18098480|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
5244669|NCT00792636|18098481|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
5244670|NCT00792636|18098482|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
5244671|NCT00792636|18098480|P3|Overall Study|Protocol Violation|20
5244672|NCT00792636|18098481|P2|Overall Study|Protocol Violation|23
5244673|NCT00792636|18098482|P1|Overall Study|Protocol Violation|17
5244674|NCT00792623|18098519|P1|Overall Study|Withdrawal by Subject|5
5244675|NCT00792623|18098519|P1|Overall Study|Adverse Event|2
5244676|NCT00792571|18098536|P1|Overall Study|Other|4
5244677|NCT00792571|18098536|P1|Overall Study|Withdrawal by Subject|1
5244678|NCT00792571|18098536|P1|Overall Study|Adverse Event|4
5244679|NCT00792571|18098536|P1|Overall Study|Death|1
5244680|NCT00792298|18098556|P8|Treatment Period 2|Withdrawal by Subject|2
5244681|NCT00792298|18098557|P7|Treatment Period 2|Withdrawal by Subject|0
5244682|NCT00792298|18098558|P6|Treatment Period 2|Withdrawal by Subject|0
5244683|NCT00792298|18098559|P5|Treatment Period 2|Withdrawal by Subject|1
5244684|NCT00792298|18098560|P4|Treatment Period 2|Withdrawal by Subject|2
5244685|NCT00792298|18098561|P3|Treatment Period 2|Withdrawal by Subject|0
5244686|NCT00792298|18098562|P2|Treatment Period 2|Withdrawal by Subject|1
5244687|NCT00792298|18098563|P1|Treatment Period 2|Withdrawal by Subject|1
5244688|NCT00792298|18098556|P8|Treatment Period 2|Pregnancy|0
5244689|NCT00792298|18098557|P7|Treatment Period 2|Pregnancy|0
5244690|NCT00792298|18098558|P6|Treatment Period 2|Pregnancy|0
5244691|NCT00792298|18098559|P5|Treatment Period 2|Pregnancy|0
5244692|NCT00792298|18098560|P4|Treatment Period 2|Pregnancy|0
5244693|NCT00792298|18098561|P3|Treatment Period 2|Pregnancy|1
5244694|NCT00792298|18098562|P2|Treatment Period 2|Pregnancy|0
5244695|NCT00792298|18098563|P1|Treatment Period 2|Pregnancy|0
5244696|NCT00792298|18098556|P8|Treatment Period 2|Physician Decision|0
5244697|NCT00792298|18098557|P7|Treatment Period 2|Physician Decision|1
5244698|NCT00792298|18098558|P6|Treatment Period 2|Physician Decision|0
5244699|NCT00792298|18098559|P5|Treatment Period 2|Physician Decision|0
5244700|NCT00792298|18098560|P4|Treatment Period 2|Physician Decision|0
5244701|NCT00792298|18098561|P3|Treatment Period 2|Physician Decision|0
5244702|NCT00792298|18098562|P2|Treatment Period 2|Physician Decision|0
5244703|NCT00792298|18098563|P1|Treatment Period 2|Physician Decision|0
5244704|NCT00792298|18098556|P8|Treatment Period 2|Lack of Efficacy|0
5244705|NCT00792298|18098557|P7|Treatment Period 2|Lack of Efficacy|0
5244706|NCT00792298|18098558|P6|Treatment Period 2|Lack of Efficacy|0
5244707|NCT00792298|18098559|P5|Treatment Period 2|Lack of Efficacy|1
5244708|NCT00792298|18098560|P4|Treatment Period 2|Lack of Efficacy|0
5244709|NCT00792298|18098561|P3|Treatment Period 2|Lack of Efficacy|0
5244710|NCT00792298|18098562|P2|Treatment Period 2|Lack of Efficacy|0
5244711|NCT00792298|18098563|P1|Treatment Period 2|Lack of Efficacy|0
5244712|NCT00792298|18098556|P8|Washout|Withdrawal by Subject|0
5244713|NCT00792298|18098557|P7|Washout|Withdrawal by Subject|0
5244714|NCT00792298|18098558|P6|Washout|Withdrawal by Subject|1
5244715|NCT00792298|18098559|P5|Washout|Withdrawal by Subject|0
5244716|NCT00792298|18098560|P4|Washout|Withdrawal by Subject|0
5244717|NCT00792298|18098561|P3|Washout|Withdrawal by Subject|1
5244718|NCT00792298|18098562|P2|Washout|Withdrawal by Subject|0
5244719|NCT00792298|18098563|P1|Washout|Withdrawal by Subject|0
5244720|NCT00792298|18098556|P8|Washout|Adverse Event|0
5244721|NCT00792298|18098557|P7|Washout|Adverse Event|0
5244722|NCT00792298|18098558|P6|Washout|Adverse Event|1
5244723|NCT00792298|18098559|P5|Washout|Adverse Event|0
5244724|NCT00792298|18098560|P4|Washout|Adverse Event|0
5244725|NCT00792298|18098561|P3|Washout|Adverse Event|0
5244726|NCT00792298|18098562|P2|Washout|Adverse Event|0
5244727|NCT00792298|18098563|P1|Washout|Adverse Event|0
5244728|NCT00792298|18098556|P8|Treatment Period 1|Protocol Violation|1
5244729|NCT00792298|18098557|P7|Treatment Period 1|Protocol Violation|0
5244730|NCT00792298|18098558|P6|Treatment Period 1|Protocol Violation|0
5244731|NCT00792298|18098559|P5|Treatment Period 1|Protocol Violation|0
5244732|NCT00792298|18098560|P4|Treatment Period 1|Protocol Violation|0
5244733|NCT00792298|18098561|P3|Treatment Period 1|Protocol Violation|0
5244734|NCT00792298|18098562|P2|Treatment Period 1|Protocol Violation|0
5244735|NCT00792298|18098563|P1|Treatment Period 1|Protocol Violation|0
5244736|NCT00792298|18098556|P8|Treatment Period 1|Physician Decision|0
5244737|NCT00792298|18098557|P7|Treatment Period 1|Physician Decision|1
5244738|NCT00792298|18098558|P6|Treatment Period 1|Physician Decision|0
5244739|NCT00792298|18098559|P5|Treatment Period 1|Physician Decision|0
5244740|NCT00792298|18098560|P4|Treatment Period 1|Physician Decision|1
5244741|NCT00792298|18098561|P3|Treatment Period 1|Physician Decision|0
5244742|NCT00792298|18098562|P2|Treatment Period 1|Physician Decision|0
5244743|NCT00792298|18098563|P1|Treatment Period 1|Physician Decision|0
5244744|NCT00792298|18098556|P8|Treatment Period 1|Lost to Follow-up|0
5244745|NCT00792298|18098557|P7|Treatment Period 1|Lost to Follow-up|1
5244746|NCT00792298|18098558|P6|Treatment Period 1|Lost to Follow-up|0
5244747|NCT00792298|18098559|P5|Treatment Period 1|Lost to Follow-up|0
5244748|NCT00792298|18098560|P4|Treatment Period 1|Lost to Follow-up|0
5244749|NCT00792298|18098561|P3|Treatment Period 1|Lost to Follow-up|0
5244750|NCT00792298|18098562|P2|Treatment Period 1|Lost to Follow-up|0
5244751|NCT00792298|18098563|P1|Treatment Period 1|Lost to Follow-up|0
5244752|NCT00792298|18098556|P8|Treatment Period 1|Withdrawal by Subject|0
5244753|NCT00792298|18098557|P7|Treatment Period 1|Withdrawal by Subject|1
5244754|NCT00792298|18098558|P6|Treatment Period 1|Withdrawal by Subject|2
5244755|NCT00792298|18098559|P5|Treatment Period 1|Withdrawal by Subject|0
5244756|NCT00792298|18098560|P4|Treatment Period 1|Withdrawal by Subject|2
5244757|NCT00792298|18098561|P3|Treatment Period 1|Withdrawal by Subject|1
5244758|NCT00792298|18098562|P2|Treatment Period 1|Withdrawal by Subject|0
5244759|NCT00792298|18098563|P1|Treatment Period 1|Withdrawal by Subject|1
5244760|NCT00792298|18098556|P8|Treatment Period 1|Lack of Efficacy|0
5244761|NCT00792298|18098557|P7|Treatment Period 1|Lack of Efficacy|0
5244762|NCT00792298|18098558|P6|Treatment Period 1|Lack of Efficacy|0
5244763|NCT00792298|18098559|P5|Treatment Period 1|Lack of Efficacy|0
5244764|NCT00792298|18098560|P4|Treatment Period 1|Lack of Efficacy|0
5244765|NCT00792298|18098561|P3|Treatment Period 1|Lack of Efficacy|1
5244766|NCT00792298|18098562|P2|Treatment Period 1|Lack of Efficacy|0
5244767|NCT00792298|18098563|P1|Treatment Period 1|Lack of Efficacy|0
5244768|NCT00792298|18098556|P8|Treatment Period 1|Adverse Event|0
5244769|NCT00792298|18098557|P7|Treatment Period 1|Adverse Event|1
5244770|NCT00792298|18098558|P6|Treatment Period 1|Adverse Event|1
5244771|NCT00792298|18098559|P5|Treatment Period 1|Adverse Event|0
5244772|NCT00792298|18098560|P4|Treatment Period 1|Adverse Event|1
5244773|NCT00792298|18098561|P3|Treatment Period 1|Adverse Event|0
5244774|NCT00792298|18098562|P2|Treatment Period 1|Adverse Event|1
5244775|NCT00792298|18098563|P1|Treatment Period 1|Adverse Event|0
5244776|NCT00792259|18098593|P3|Overall Study|Poor Quality Scans|0
5244777|NCT00792259|18098594|P2|Overall Study|Poor Quality Scans|0
5244778|NCT00792259|18098595|P1|Overall Study|Poor Quality Scans|1
5244779|NCT00792116|18098612|P2|Overall Study|Discontnued intervention|0
5244780|NCT00792116|18098613|P1|Overall Study|Discontnued intervention|1
5244781|NCT00792116|18098612|P2|Overall Study|Lost to Follow-up|1
5244782|NCT00792116|18098613|P1|Overall Study|Lost to Follow-up|0
5244783|NCT00792103|18098623|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
5244784|NCT00792103|18098623|P1|Overall Study|Protocol Violation|10
5244785|NCT00792103|18098623|P1|Overall Study|Withdrawal by Subject|52
5244786|NCT00792103|18098623|P1|Overall Study|Adverse Event|25
5244787|NCT00792103|18098623|P1|Overall Study|Lost to Follow-up|17
5244788|NCT00792103|18098623|P1|Overall Study|Enrolled, not treated|15
5244789|NCT00791999|18098635|P4|Overall Study|Reason other than those above|0
5244790|NCT00791999|18098636|P3|Overall Study|Reason other than those above|1
5244791|NCT00791999|18098637|P2|Overall Study|Reason other than those above|0
5244792|NCT00791999|18098638|P1|Overall Study|Reason other than those above|1
5244793|NCT00791999|18098635|P4|Overall Study|Lack of Efficacy|2
5244794|NCT00791999|18098636|P3|Overall Study|Lack of Efficacy|0
5244795|NCT00791999|18098637|P2|Overall Study|Lack of Efficacy|1
5244796|NCT00791999|18098638|P1|Overall Study|Lack of Efficacy|0
5244797|NCT00791999|18098635|P4|Overall Study|Adverse Event|3
5244798|NCT00791999|18098636|P3|Overall Study|Adverse Event|7
5244799|NCT00791999|18098637|P2|Overall Study|Adverse Event|3
5244800|NCT00791999|18098638|P1|Overall Study|Adverse Event|3
5244801|NCT00791999|18098635|P4|Overall Study|Protocol Violation|0
5244802|NCT00791999|18098636|P3|Overall Study|Protocol Violation|1
5244803|NCT00791999|18098637|P2|Overall Study|Protocol Violation|0
5244804|NCT00791999|18098638|P1|Overall Study|Protocol Violation|3
5244805|NCT00791999|18098635|P4|Overall Study|Withdrawal by Subject|2
5244806|NCT00791999|18098636|P3|Overall Study|Withdrawal by Subject|0
5244807|NCT00791999|18098637|P2|Overall Study|Withdrawal by Subject|1
5244808|NCT00791999|18098638|P1|Overall Study|Withdrawal by Subject|0
5244809|NCT00791999|18098635|P4|Overall Study|Protocol planed withdrawal|45
5244810|NCT00791999|18098636|P3|Overall Study|Protocol planed withdrawal|11
5244811|NCT00791999|18098637|P2|Overall Study|Protocol planed withdrawal|11
5244812|NCT00791999|18098638|P1|Overall Study|Protocol planed withdrawal|14
5244813|NCT00791934|18098663|P1|Overall Study|Did not consent for extended follow-up|13
5244814|NCT00791934|18098663|P1|Overall Study|Withdrawal by Subject|2
5244815|NCT00791921|18098673|P2|Overall Study|Reason other than those above|1
5244816|NCT00791921|18098674|P1|Overall Study|Reason other than those above|0
5244817|NCT00791921|18098673|P2|Overall Study|Lack of study drug administration|1
5244818|NCT00791921|18098674|P1|Overall Study|Lack of study drug administration|1
5244819|NCT00791921|18098673|P2|Overall Study|Lack of Efficacy|2
5244820|NCT00791921|18098674|P1|Overall Study|Lack of Efficacy|0
5244821|NCT00791921|18098673|P2|Overall Study|Adverse Event|2
5244822|NCT00791921|18098674|P1|Overall Study|Adverse Event|8
5244823|NCT00791921|18098673|P2|Overall Study|Withdrawal by Subject|2
5244824|NCT00791921|18098674|P1|Overall Study|Withdrawal by Subject|1
5244825|NCT00791921|18098673|P2|Overall Study|Protocol planed|88
5244826|NCT00791921|18098674|P1|Overall Study|Protocol planed|24
5244827|NCT00791778|18098705|P2|Follow-up|Lost to Follow-up|1
5244828|NCT00791778|18098706|P1|Follow-up|Lost to Follow-up|2
5244829|NCT00791778|18098705|P2|Follow-up|Withdrawal by Subject|0
5244830|NCT00791778|18098706|P1|Follow-up|Withdrawal by Subject|3
5244831|NCT00791778|18098705|P2|Double-blind Treatment|Non-compliant with study medication|0
5244832|NCT00791778|18098706|P1|Double-blind Treatment|Non-compliant with study medication|2
5244833|NCT00791778|18098705|P2|Double-blind Treatment|Withdrawal by Subject|9
5244834|NCT00791778|18098706|P1|Double-blind Treatment|Withdrawal by Subject|20
5244835|NCT00791778|18098705|P2|Double-blind Treatment|Protocol Violation|4
5244836|NCT00791778|18098706|P1|Double-blind Treatment|Protocol Violation|0
5244837|NCT00791778|18098705|P2|Double-blind Treatment|Physician Decision|26
5244838|NCT00791778|18098706|P1|Double-blind Treatment|Physician Decision|6
5244839|NCT00791778|18098705|P2|Double-blind Treatment|Adverse Event|9
5244840|NCT00791778|18098706|P1|Double-blind Treatment|Adverse Event|49
5244841|NCT00791765|18098760|P2|Weeks 13 to 24|Other|1
5244842|NCT00791765|18098761|P1|Weeks 13 to 24|Other|0
5244843|NCT00791765|18098760|P2|Weeks 13 to 24|Lost to Follow-up|2
5244844|NCT00791765|18098761|P1|Weeks 13 to 24|Lost to Follow-up|1
5244845|NCT00791765|18098760|P2|Weeks 13 to 24|Disease progression|1
5244846|NCT00791765|18098761|P1|Weeks 13 to 24|Disease progression|0
5244847|NCT00791765|18098760|P2|Weeks 13 to 24|Withdrawal by Subject|1
5244848|NCT00791765|18098761|P1|Weeks 13 to 24|Withdrawal by Subject|2
5244849|NCT00791765|18098760|P2|Weeks 13 to 24|Adverse Event|3
5244850|NCT00791765|18098761|P1|Weeks 13 to 24|Adverse Event|0
5244851|NCT00791765|18098760|P2|Weeks 13 to 24|Protocol deviation|0
5244852|NCT00791765|18098761|P1|Weeks 13 to 24|Protocol deviation|2
5244853|NCT00791765|18098760|P2|Weeks 1 to 12|Ineligibility determined|3
5244854|NCT00791765|18098761|P1|Weeks 1 to 12|Ineligibility determined|0
5244855|NCT00791765|18098760|P2|Weeks 1 to 12|Disease progression|0
5244856|NCT00791765|18098761|P1|Weeks 1 to 12|Disease progression|3
5244857|NCT00791765|18098760|P2|Weeks 1 to 12|Physician Decision|0
5244858|NCT00791765|18098761|P1|Weeks 1 to 12|Physician Decision|1
5244859|NCT00791765|18098760|P2|Weeks 1 to 12|Withdrawal by Subject|0
5244860|NCT00791765|18098761|P1|Weeks 1 to 12|Withdrawal by Subject|3
5244861|NCT00791765|18098760|P2|Weeks 1 to 12|Lost to Follow-up|0
5244862|NCT00791765|18098761|P1|Weeks 1 to 12|Lost to Follow-up|1
5244863|NCT00791765|18098760|P2|Weeks 1 to 12|Adverse Event|1
5244864|NCT00791765|18098761|P1|Weeks 1 to 12|Adverse Event|0
5244865|NCT00791700|18098776|P4|Overall Study|Adverse Event|1
5244866|NCT00791700|18098777|P3|Overall Study|Adverse Event|1
5244867|NCT00791700|18098778|P2|Overall Study|Adverse Event|0
5244868|NCT00791700|18098779|P1|Overall Study|Adverse Event|0
5244869|NCT00791700|18098776|P4|Overall Study|Lost to Follow-up|6
5244870|NCT00791700|18098777|P3|Overall Study|Lost to Follow-up|4
5244871|NCT00791700|18098778|P2|Overall Study|Lost to Follow-up|3
5244872|NCT00791700|18098779|P1|Overall Study|Lost to Follow-up|4
5244873|NCT00791700|18098776|P4|Overall Study|Death|1
5244874|NCT00791700|18098777|P3|Overall Study|Death|0
5244875|NCT00791700|18098778|P2|Overall Study|Death|0
5244876|NCT00791700|18098779|P1|Overall Study|Death|0
5244877|NCT00791700|18098776|P4|Overall Study|Other|1
5244878|NCT00791700|18098777|P3|Overall Study|Other|0
5244879|NCT00791700|18098778|P2|Overall Study|Other|1
5244880|NCT00791700|18098779|P1|Overall Study|Other|0
5244881|NCT00791700|18098776|P4|Overall Study|Withdrawn due to pregnancy|1
5244882|NCT00791700|18098777|P3|Overall Study|Withdrawn due to pregnancy|0
5244883|NCT00791700|18098778|P2|Overall Study|Withdrawn due to pregnancy|0
5244884|NCT00791700|18098779|P1|Overall Study|Withdrawn due to pregnancy|0
5244885|NCT00791700|18098776|P4|Overall Study|Non-compliance with study treatment|4
5244886|NCT00791700|18098777|P3|Overall Study|Non-compliance with study treatment|0
5244887|NCT00791700|18098778|P2|Overall Study|Non-compliance with study treatment|2
5244888|NCT00791700|18098779|P1|Overall Study|Non-compliance with study treatment|0
5244889|NCT00791700|18098776|P4|Overall Study|No longer willing to participate|8
5244890|NCT00791700|18098777|P3|Overall Study|No longer willing to participate|0
5244891|NCT00791700|18098778|P2|Overall Study|No longer willing to participate|1
5244892|NCT00791700|18098779|P1|Overall Study|No longer willing to participate|1
5244893|NCT00791700|18098776|P4|Overall Study|Insufficient clinical response|8
5244894|NCT00791700|18098777|P3|Overall Study|Insufficient clinical response|1
5244895|NCT00791700|18098778|P2|Overall Study|Insufficient clinical response|4
5244896|NCT00791700|18098779|P1|Overall Study|Insufficient clinical response|1
5244897|NCT00791661|18098867|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
5244898|NCT00791661|18098868|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
5244899|NCT00791661|18098869|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
5244900|NCT00791661|18098867|P3|7 Day Wash-out|Adverse Event|1
5244901|NCT00791661|18098868|P2|7 Day Wash-out|Adverse Event|0
5244902|NCT00791661|18098869|P1|7 Day Wash-out|Adverse Event|0
5244903|NCT00791648|18098962|P2|Overall Study|Withdrawal by Subject|1
5244904|NCT00791648|18098963|P1|Overall Study|Withdrawal by Subject|0
5244905|NCT00791648|18098962|P2|Overall Study|Physician Decision|1
5244906|NCT00791648|18098963|P1|Overall Study|Physician Decision|0
5244907|NCT00791557|18098999|P1|Overall Study|Adverse Event|1
5244908|NCT00791518|18099003|P1|Overall Study|Protocol Violation|93
5244909|NCT00791492|18099031|P2|Overall Study|Liver transplantation|1
5244910|NCT00791492|18099032|P1|Overall Study|Liver transplantation|5
5244911|NCT00791492|18099031|P2|Overall Study|Withdrawal by Subject|2
5244912|NCT00791492|18099032|P1|Overall Study|Withdrawal by Subject|1
5244913|NCT00791479|18099080|P6|Overall Study|Withdrawal by Subject|1
5244914|NCT00791479|18099081|P5|Overall Study|Withdrawal by Subject|0
5244915|NCT00791479|18099082|P4|Overall Study|Withdrawal by Subject|1
5244916|NCT00791479|18099083|P3|Overall Study|Withdrawal by Subject|0
5244917|NCT00791479|18099084|P2|Overall Study|Withdrawal by Subject|0
5244918|NCT00791479|18099085|P1|Overall Study|Withdrawal by Subject|0
5244919|NCT00791479|18099080|P6|Overall Study|Protocol Violation|0
5244920|NCT00791479|18099081|P5|Overall Study|Protocol Violation|0
5244921|NCT00791479|18099082|P4|Overall Study|Protocol Violation|1
5244922|NCT00791479|18099083|P3|Overall Study|Protocol Violation|0
5244923|NCT00791479|18099084|P2|Overall Study|Protocol Violation|1
5244924|NCT00791479|18099085|P1|Overall Study|Protocol Violation|2
5244925|NCT00791479|18099080|P6|Overall Study|Lost to Follow-up|1
5244926|NCT00791479|18099081|P5|Overall Study|Lost to Follow-up|0
5244927|NCT00791479|18099082|P4|Overall Study|Lost to Follow-up|0
5244928|NCT00791479|18099083|P3|Overall Study|Lost to Follow-up|0
5244929|NCT00791479|18099084|P2|Overall Study|Lost to Follow-up|1
5244930|NCT00791479|18099085|P1|Overall Study|Lost to Follow-up|0
5244931|NCT00791479|18099080|P6|Overall Study|Adverse Event|1
5244932|NCT00791479|18099081|P5|Overall Study|Adverse Event|0
5244933|NCT00791479|18099082|P4|Overall Study|Adverse Event|2
5244934|NCT00791479|18099083|P3|Overall Study|Adverse Event|0
5244935|NCT00791479|18099084|P2|Overall Study|Adverse Event|1
5244936|NCT00791479|18099085|P1|Overall Study|Adverse Event|0
5244937|NCT00791479|18099080|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
5244938|NCT00791479|18099081|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
5244939|NCT00791479|18099082|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
5244940|NCT00791479|18099083|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
5244941|NCT00791479|18099084|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
5244942|NCT00791479|18099085|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
5244943|NCT00791388|18099184|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
5244944|NCT00791388|18099185|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
5244945|NCT00791388|18099186|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
5244946|NCT00791388|18099187|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
5244947|NCT00791388|18099188|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
5244948|NCT00791388|18099184|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5244949|NCT00791388|18099185|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5244950|NCT00791388|18099186|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5244951|NCT00791388|18099187|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5244952|NCT00791388|18099188|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
5244953|NCT00791388|18099184|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5244954|NCT00791388|18099185|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5244955|NCT00791388|18099186|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5244956|NCT00791388|18099187|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
5244957|NCT00791388|18099188|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5244958|NCT00791258|18099230|P1|Overall Study|Lack of Efficacy|1
5244959|NCT00791258|18099230|P1|Overall Study|Subject required restricted medication|1
5244960|NCT00791258|18099230|P1|Overall Study|Subject incarcerated|1
5244961|NCT00791258|18099230|P1|Overall Study|non-compliance|3
5244962|NCT00791258|18099230|P1|Overall Study|subject left area|2
5244963|NCT00791258|18099230|P1|Overall Study|Did not take medication for >3 days|1
5244964|NCT00791258|18099230|P1|Overall Study|Withdrawal by Subject|40
5244965|NCT00791258|18099230|P1|Overall Study|Protocol Violation|109
5244966|NCT00791258|18099230|P1|Overall Study|Lost to Follow-up|18
5244967|NCT00791258|18099230|P1|Overall Study|Adverse Event|87
5244968|NCT00791128|18099323|P1|Overall Study|abdominal tumor, unrelated to device|1
5244969|NCT00791128|18099323|P1|Overall Study|non-compliance by subject|2
5244970|NCT00791128|18099323|P1|Overall Study|Device migration|2
5244971|NCT00791128|18099323|P1|Overall Study|Adverse Event|4
5244972|NCT00791076|18099354|P1|Overall Study|Study was terminated,PI left institution|8
5244973|NCT00790933|18099374|P5|Overall Study|Reason Not Specified|9
5244974|NCT00790933|18099375|P4|Overall Study|Reason Not Specified|1
5244975|NCT00790933|18099376|P3|Overall Study|Reason Not Specified|4
5244976|NCT00790933|18099377|P2|Overall Study|Reason Not Specified|16
5244977|NCT00790933|18099378|P1|Overall Study|Reason Not Specified|8
5244978|NCT00790933|18099374|P5|Overall Study|Lost to Follow-up|15
5244979|NCT00790933|18099375|P4|Overall Study|Lost to Follow-up|1
5244980|NCT00790933|18099376|P3|Overall Study|Lost to Follow-up|10
5244981|NCT00790933|18099377|P2|Overall Study|Lost to Follow-up|31
5244982|NCT00790933|18099378|P1|Overall Study|Lost to Follow-up|13
5244983|NCT00790933|18099374|P5|Overall Study|Withdrawal by Subject|50
5244984|NCT00790933|18099375|P4|Overall Study|Withdrawal by Subject|6
5244985|NCT00790933|18099376|P3|Overall Study|Withdrawal by Subject|52
5244986|NCT00790933|18099377|P2|Overall Study|Withdrawal by Subject|120
5244987|NCT00790933|18099378|P1|Overall Study|Withdrawal by Subject|123
5244988|NCT00790933|18099374|P5|Overall Study|Study Terminated by Sponsor|0
5244989|NCT00790933|18099375|P4|Overall Study|Study Terminated by Sponsor|0
5244990|NCT00790933|18099376|P3|Overall Study|Study Terminated by Sponsor|1
5244991|NCT00790933|18099377|P2|Overall Study|Study Terminated by Sponsor|0
5244992|NCT00790933|18099378|P1|Overall Study|Study Terminated by Sponsor|0
5244993|NCT00790933|18099374|P5|Overall Study|Lack of Efficacy|121
5244994|NCT00790933|18099375|P4|Overall Study|Lack of Efficacy|1
5244995|NCT00790933|18099376|P3|Overall Study|Lack of Efficacy|130
5244996|NCT00790933|18099377|P2|Overall Study|Lack of Efficacy|176
5244997|NCT00790933|18099378|P1|Overall Study|Lack of Efficacy|192
5244998|NCT00790933|18099374|P5|Overall Study|Protocol Violation(s)|12
5244999|NCT00790933|18099375|P4|Overall Study|Protocol Violation(s)|0
5245000|NCT00790933|18099376|P3|Overall Study|Protocol Violation(s)|7
5245001|NCT00790933|18099377|P2|Overall Study|Protocol Violation(s)|18
5245002|NCT00790933|18099378|P1|Overall Study|Protocol Violation(s)|8
5245003|NCT00790933|18099374|P5|Overall Study|Adverse Event|69
5245004|NCT00790933|18099375|P4|Overall Study|Adverse Event|5
5245005|NCT00790933|18099376|P3|Overall Study|Adverse Event|65
5245006|NCT00790933|18099377|P2|Overall Study|Adverse Event|119
5245007|NCT00790933|18099378|P1|Overall Study|Adverse Event|94
5245008|NCT00790907|18099909|P3|Overall Study|Did Not Receive Study Drug|0
5245009|NCT00790907|18099910|P2|Overall Study|Did Not Receive Study Drug|0
5245010|NCT00790907|18099911|P1|Overall Study|Did Not Receive Study Drug|10
5245011|NCT00790907|18099909|P3|Overall Study|Verbatim Reason on the Case Report Form|29
5245012|NCT00790907|18099910|P2|Overall Study|Verbatim Reason on the Case Report Form|20
5245013|NCT00790907|18099911|P1|Overall Study|Verbatim Reason on the Case Report Form|74
5245014|NCT00790907|18099909|P3|Overall Study|Qualifying Condition Not Present|16
5245015|NCT00790907|18099910|P2|Overall Study|Qualifying Condition Not Present|14
5245016|NCT00790907|18099911|P1|Overall Study|Qualifying Condition Not Present|29
5245017|NCT00790907|18099909|P3|Overall Study|Required Protocol-prohibited Therapy|7
5245018|NCT00790907|18099910|P2|Overall Study|Required Protocol-prohibited Therapy|5
5245019|NCT00790907|18099911|P1|Overall Study|Required Protocol-prohibited Therapy|17
5245020|NCT00790907|18099909|P3|Overall Study|Bleeding Event|21
5245021|NCT00790907|18099910|P2|Overall Study|Bleeding Event|16
5245022|NCT00790907|18099911|P1|Overall Study|Bleeding Event|11
5245023|NCT00790907|18099909|P3|Overall Study|Withdrawal by Subject|5
5245024|NCT00790907|18099910|P2|Overall Study|Withdrawal by Subject|7
5245025|NCT00790907|18099911|P1|Overall Study|Withdrawal by Subject|1
5245026|NCT00790907|18099909|P3|Overall Study|Physician Decision|255
5245027|NCT00790907|18099910|P2|Overall Study|Physician Decision|271
5245028|NCT00790907|18099911|P1|Overall Study|Physician Decision|304
5245029|NCT00790907|18099909|P3|Overall Study|Adverse Event|6
5245030|NCT00790907|18099910|P2|Overall Study|Adverse Event|7
5245031|NCT00790907|18099911|P1|Overall Study|Adverse Event|9
5245032|NCT00790868|18099934|P2|Overall Study|Lost to Follow-up|12
5245033|NCT00790868|18099935|P1|Overall Study|Lost to Follow-up|2
5245034|NCT00790868|18099934|P2|Overall Study|Withdrawal by Subject|5
5245035|NCT00790868|18099935|P1|Overall Study|Withdrawal by Subject|4
5245036|NCT00790842|18099957|P11|Expansion Cohort|Study Closure|0
5245037|NCT00790842|18099958|P10|Expansion Cohort|Study Closure|0
5245038|NCT00790842|18099959|P9|Expansion Cohort|Study Closure|0
5245039|NCT00790842|18099960|P8|Expansion Cohort|Study Closure|0
5245040|NCT00790842|18099961|P7|Expansion Cohort|Study Closure|0
5245041|NCT00790842|18099962|P6|Expansion Cohort|Study Closure|0
5245042|NCT00790842|18099963|P5|Expansion Cohort|Study Closure|0
5245043|NCT00790842|18099964|P4|Expansion Cohort|Study Closure|0
5245044|NCT00790842|18099965|P3|Expansion Cohort|Study Closure|1
5245045|NCT00790842|18099966|P2|Expansion Cohort|Study Closure|0
5245046|NCT00790842|18099967|P1|Expansion Cohort|Study Closure|0
5245047|NCT00790842|18099957|P11|Expansion Cohort|Withdrawal by Subject|0
5245048|NCT00790842|18099958|P10|Expansion Cohort|Withdrawal by Subject|0
5245049|NCT00790842|18099959|P9|Expansion Cohort|Withdrawal by Subject|0
5245050|NCT00790842|18099960|P8|Expansion Cohort|Withdrawal by Subject|0
5245051|NCT00790842|18099961|P7|Expansion Cohort|Withdrawal by Subject|0
5245052|NCT00790842|18099962|P6|Expansion Cohort|Withdrawal by Subject|0
5245053|NCT00790842|18099963|P5|Expansion Cohort|Withdrawal by Subject|0
5245054|NCT00790842|18099964|P4|Expansion Cohort|Withdrawal by Subject|0
5245055|NCT00790842|18099965|P3|Expansion Cohort|Withdrawal by Subject|3
5245056|NCT00790842|18099966|P2|Expansion Cohort|Withdrawal by Subject|0
5245057|NCT00790842|18099967|P1|Expansion Cohort|Withdrawal by Subject|0
5245058|NCT00790842|18099957|P11|Expansion Cohort|Physician Decision|0
5245059|NCT00790842|18099958|P10|Expansion Cohort|Physician Decision|0
5245060|NCT00790842|18099959|P9|Expansion Cohort|Physician Decision|0
5245061|NCT00790842|18099960|P8|Expansion Cohort|Physician Decision|0
5245062|NCT00790842|18099961|P7|Expansion Cohort|Physician Decision|0
5245063|NCT00790842|18099962|P6|Expansion Cohort|Physician Decision|0
5245064|NCT00790842|18099963|P5|Expansion Cohort|Physician Decision|0
5245065|NCT00790842|18099964|P4|Expansion Cohort|Physician Decision|0
5245066|NCT00790842|18099965|P3|Expansion Cohort|Physician Decision|1
5245067|NCT00790842|18099966|P2|Expansion Cohort|Physician Decision|0
5245068|NCT00790842|18099967|P1|Expansion Cohort|Physician Decision|0
5245069|NCT00790842|18099957|P11|Expansion Cohort|Death|0
5245070|NCT00790842|18099958|P10|Expansion Cohort|Death|0
5245071|NCT00790842|18099959|P9|Expansion Cohort|Death|0
5245072|NCT00790842|18099960|P8|Expansion Cohort|Death|0
5245073|NCT00790842|18099961|P7|Expansion Cohort|Death|0
5245074|NCT00790842|18099962|P6|Expansion Cohort|Death|0
5245075|NCT00790842|18099963|P5|Expansion Cohort|Death|0
5245076|NCT00790842|18099964|P4|Expansion Cohort|Death|0
5245077|NCT00790842|18099965|P3|Expansion Cohort|Death|2
5245078|NCT00790842|18099966|P2|Expansion Cohort|Death|0
5245079|NCT00790842|18099967|P1|Expansion Cohort|Death|0
5245080|NCT00790842|18099957|P11|Expansion Cohort|Adverse Event|0
5245081|NCT00790842|18099958|P10|Expansion Cohort|Adverse Event|0
5245082|NCT00790842|18099959|P9|Expansion Cohort|Adverse Event|0
5245083|NCT00790842|18099960|P8|Expansion Cohort|Adverse Event|0
5245084|NCT00790842|18099961|P7|Expansion Cohort|Adverse Event|1
5245085|NCT00790842|18099962|P6|Expansion Cohort|Adverse Event|0
5245086|NCT00790842|18099963|P5|Expansion Cohort|Adverse Event|0
5245087|NCT00790842|18099964|P4|Expansion Cohort|Adverse Event|0
5245088|NCT00790842|18099965|P3|Expansion Cohort|Adverse Event|0
5245089|NCT00790842|18099966|P2|Expansion Cohort|Adverse Event|0
5245090|NCT00790842|18099967|P1|Expansion Cohort|Adverse Event|0
5245091|NCT00790842|18099957|P11|Dose Level 4|Withdrawal by Subject|1
5245092|NCT00790842|18099958|P10|Dose Level 4|Withdrawal by Subject|0
5245093|NCT00790842|18099959|P9|Dose Level 4|Withdrawal by Subject|0
5245094|NCT00790842|18099960|P8|Dose Level 4|Withdrawal by Subject|0
5245095|NCT00790842|18099961|P7|Dose Level 4|Withdrawal by Subject|0
5245096|NCT00790842|18099962|P6|Dose Level 4|Withdrawal by Subject|0
5245097|NCT00790842|18099963|P5|Dose Level 4|Withdrawal by Subject|0
5245098|NCT00790842|18099964|P4|Dose Level 4|Withdrawal by Subject|0
5245099|NCT00790842|18099965|P3|Dose Level 4|Withdrawal by Subject|0
5245100|NCT00790842|18099966|P2|Dose Level 4|Withdrawal by Subject|0
5245101|NCT00790842|18099967|P1|Dose Level 4|Withdrawal by Subject|0
5245102|NCT00790842|18099957|P11|Dose Level 4|Physician Decision|1
5245103|NCT00790842|18099958|P10|Dose Level 4|Physician Decision|0
5245104|NCT00790842|18099959|P9|Dose Level 4|Physician Decision|0
5245105|NCT00790842|18099960|P8|Dose Level 4|Physician Decision|0
5245106|NCT00790842|18099961|P7|Dose Level 4|Physician Decision|1
5245107|NCT00790842|18099962|P6|Dose Level 4|Physician Decision|0
5245108|NCT00790842|18099963|P5|Dose Level 4|Physician Decision|0
5245109|NCT00790842|18099964|P4|Dose Level 4|Physician Decision|0
5245110|NCT00790842|18099965|P3|Dose Level 4|Physician Decision|0
5245111|NCT00790842|18099966|P2|Dose Level 4|Physician Decision|0
5245112|NCT00790842|18099967|P1|Dose Level 4|Physician Decision|0
5245113|NCT00790842|18099957|P11|Dose Level 4|Adverse Event|0
5245114|NCT00790842|18099958|P10|Dose Level 4|Adverse Event|0
5245115|NCT00790842|18099959|P9|Dose Level 4|Adverse Event|0
5245116|NCT00790842|18099960|P8|Dose Level 4|Adverse Event|0
5245117|NCT00790842|18099961|P7|Dose Level 4|Adverse Event|1
5245118|NCT00790842|18099962|P6|Dose Level 4|Adverse Event|0
5245119|NCT00790842|18099963|P5|Dose Level 4|Adverse Event|0
5245120|NCT00790842|18099964|P4|Dose Level 4|Adverse Event|0
5245121|NCT00790842|18099965|P3|Dose Level 4|Adverse Event|0
5245122|NCT00790842|18099966|P2|Dose Level 4|Adverse Event|0
5245123|NCT00790842|18099967|P1|Dose Level 4|Adverse Event|0
5245124|NCT00790842|18099957|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245125|NCT00790842|18099958|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245126|NCT00790842|18099959|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245127|NCT00790842|18099960|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245128|NCT00790842|18099961|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245129|NCT00790842|18099962|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245130|NCT00790842|18099963|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245131|NCT00790842|18099964|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245132|NCT00790842|18099965|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
5245133|NCT00790842|18099966|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245134|NCT00790842|18099967|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
5245135|NCT00790842|18099957|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245136|NCT00790842|18099958|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245137|NCT00790842|18099959|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245138|NCT00790842|18099960|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245139|NCT00790842|18099961|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245140|NCT00790842|18099962|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
5245141|NCT00790842|18099963|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245142|NCT00790842|18099964|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245143|NCT00790842|18099965|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245144|NCT00790842|18099966|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245145|NCT00790842|18099967|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5245146|NCT00790842|18099957|P11|Dose Level 3|Withdrawal by Subject|0
5245147|NCT00790842|18099958|P10|Dose Level 3|Withdrawal by Subject|2
5245148|NCT00790842|18099959|P9|Dose Level 3|Withdrawal by Subject|0
5245149|NCT00790842|18099960|P8|Dose Level 3|Withdrawal by Subject|0
5245150|NCT00790842|18099961|P7|Dose Level 3|Withdrawal by Subject|0
5245151|NCT00790842|18099962|P6|Dose Level 3|Withdrawal by Subject|0
5245152|NCT00790842|18099963|P5|Dose Level 3|Withdrawal by Subject|0
5245153|NCT00790842|18099964|P4|Dose Level 3|Withdrawal by Subject|0
5245154|NCT00790842|18099965|P3|Dose Level 3|Withdrawal by Subject|3
5245155|NCT00790842|18099966|P2|Dose Level 3|Withdrawal by Subject|0
5245156|NCT00790842|18099967|P1|Dose Level 3|Withdrawal by Subject|0
5245157|NCT00790842|18099957|P11|Dose Level 3|Adverse Event|0
5245158|NCT00790842|18099958|P10|Dose Level 3|Adverse Event|0
5245159|NCT00790842|18099959|P9|Dose Level 3|Adverse Event|0
5245160|NCT00790842|18099960|P8|Dose Level 3|Adverse Event|0
5245161|NCT00790842|18099961|P7|Dose Level 3|Adverse Event|0
5245162|NCT00790842|18099962|P6|Dose Level 3|Adverse Event|0
5245163|NCT00790842|18099963|P5|Dose Level 3|Adverse Event|0
5245164|NCT00790842|18099964|P4|Dose Level 3|Adverse Event|0
5245165|NCT00790842|18099965|P3|Dose Level 3|Adverse Event|1
5245166|NCT00790842|18099966|P2|Dose Level 3|Adverse Event|0
5245167|NCT00790842|18099967|P1|Dose Level 3|Adverse Event|0
5245168|NCT00790842|18099957|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245169|NCT00790842|18099958|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245170|NCT00790842|18099959|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
5245171|NCT00790842|18099960|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245172|NCT00790842|18099961|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245173|NCT00790842|18099962|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245174|NCT00790842|18099963|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245175|NCT00790842|18099964|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245176|NCT00790842|18099965|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245177|NCT00790842|18099966|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245178|NCT00790842|18099967|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
5245179|NCT00790842|18099957|P11|Dose Level 2|Withdrawal by Subject|0
5245180|NCT00790842|18099958|P10|Dose Level 2|Withdrawal by Subject|0
5245181|NCT00790842|18099959|P9|Dose Level 2|Withdrawal by Subject|0
5245182|NCT00790842|18099960|P8|Dose Level 2|Withdrawal by Subject|0
5245183|NCT00790842|18099961|P7|Dose Level 2|Withdrawal by Subject|0
5245184|NCT00790842|18099962|P6|Dose Level 2|Withdrawal by Subject|0
5245185|NCT00790842|18099963|P5|Dose Level 2|Withdrawal by Subject|0
5245186|NCT00790842|18099964|P4|Dose Level 2|Withdrawal by Subject|0
5245187|NCT00790842|18099965|P3|Dose Level 2|Withdrawal by Subject|0
5245188|NCT00790842|18099966|P2|Dose Level 2|Withdrawal by Subject|1
5245189|NCT00790842|18099967|P1|Dose Level 2|Withdrawal by Subject|0
5245190|NCT00790842|18099957|P11|Dose Level 2|Physician Decision|0
5245191|NCT00790842|18099958|P10|Dose Level 2|Physician Decision|0
5245192|NCT00790842|18099959|P9|Dose Level 2|Physician Decision|0
5245193|NCT00790842|18099960|P8|Dose Level 2|Physician Decision|0
5245194|NCT00790842|18099961|P7|Dose Level 2|Physician Decision|0
5245195|NCT00790842|18099962|P6|Dose Level 2|Physician Decision|0
5245196|NCT00790842|18099963|P5|Dose Level 2|Physician Decision|0
5245197|NCT00790842|18099964|P4|Dose Level 2|Physician Decision|0
5245198|NCT00790842|18099965|P3|Dose Level 2|Physician Decision|0
5245199|NCT00790842|18099966|P2|Dose Level 2|Physician Decision|1
5245200|NCT00790842|18099967|P1|Dose Level 2|Physician Decision|0
5245201|NCT00790842|18099957|P11|Dose Level 2|Death|0
5245202|NCT00790842|18099958|P10|Dose Level 2|Death|0
5245203|NCT00790842|18099959|P9|Dose Level 2|Death|0
5245204|NCT00790842|18099960|P8|Dose Level 2|Death|0
5245205|NCT00790842|18099961|P7|Dose Level 2|Death|0
5245206|NCT00790842|18099962|P6|Dose Level 2|Death|0
5245207|NCT00790842|18099963|P5|Dose Level 2|Death|1
5245208|NCT00790842|18099964|P4|Dose Level 2|Death|0
5245209|NCT00790842|18099965|P3|Dose Level 2|Death|0
5245210|NCT00790842|18099966|P2|Dose Level 2|Death|1
5245211|NCT00790842|18099967|P1|Dose Level 2|Death|0
5245212|NCT00790842|18099957|P11|Dose Level 1|Withdrawal by Subject|0
5245213|NCT00790842|18099958|P10|Dose Level 1|Withdrawal by Subject|0
5245214|NCT00790842|18099959|P9|Dose Level 1|Withdrawal by Subject|0
5245215|NCT00790842|18099960|P8|Dose Level 1|Withdrawal by Subject|0
5245216|NCT00790842|18099961|P7|Dose Level 1|Withdrawal by Subject|0
5245217|NCT00790842|18099962|P6|Dose Level 1|Withdrawal by Subject|0
5245218|NCT00790842|18099963|P5|Dose Level 1|Withdrawal by Subject|0
5245219|NCT00790842|18099964|P4|Dose Level 1|Withdrawal by Subject|0
5245220|NCT00790842|18099965|P3|Dose Level 1|Withdrawal by Subject|0
5245221|NCT00790842|18099966|P2|Dose Level 1|Withdrawal by Subject|0
5245222|NCT00790842|18099967|P1|Dose Level 1|Withdrawal by Subject|1
5245223|NCT00790842|18099957|P11|Dose Level 1|Physician Decision|0
5245224|NCT00790842|18099958|P10|Dose Level 1|Physician Decision|0
5245225|NCT00790842|18099959|P9|Dose Level 1|Physician Decision|0
5245226|NCT00790842|18099960|P8|Dose Level 1|Physician Decision|1
5245227|NCT00790842|18099961|P7|Dose Level 1|Physician Decision|0
5245228|NCT00790842|18099962|P6|Dose Level 1|Physician Decision|0
5245229|NCT00790842|18099963|P5|Dose Level 1|Physician Decision|0
5245230|NCT00790842|18099964|P4|Dose Level 1|Physician Decision|0
5245231|NCT00790842|18099965|P3|Dose Level 1|Physician Decision|0
5245232|NCT00790842|18099966|P2|Dose Level 1|Physician Decision|0
5245233|NCT00790842|18099967|P1|Dose Level 1|Physician Decision|1
5245234|NCT00790842|18099957|P11|Dose Level 1|Adverse Event|0
5245235|NCT00790842|18099958|P10|Dose Level 1|Adverse Event|0
5245236|NCT00790842|18099959|P9|Dose Level 1|Adverse Event|0
5245237|NCT00790842|18099960|P8|Dose Level 1|Adverse Event|1
5245238|NCT00790842|18099961|P7|Dose Level 1|Adverse Event|0
5245239|NCT00790842|18099962|P6|Dose Level 1|Adverse Event|0
5245240|NCT00790842|18099963|P5|Dose Level 1|Adverse Event|0
5245241|NCT00790842|18099964|P4|Dose Level 1|Adverse Event|2
5245242|NCT00790842|18099965|P3|Dose Level 1|Adverse Event|0
5245243|NCT00790842|18099966|P2|Dose Level 1|Adverse Event|0
5245244|NCT00790842|18099967|P1|Dose Level 1|Adverse Event|1
5245245|NCT00790790|18100035|P3|Study Period 2: Therapy Phase|Physician Decision|0
5245246|NCT00790790|18100036|P2|Study Period 2: Therapy Phase|Physician Decision|1
5245247|NCT00790790|18100037|P1|Study Period 2: Therapy Phase|Physician Decision|0
5245248|NCT00790790|18100035|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
5245249|NCT00790790|18100036|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
5245250|NCT00790790|18100037|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
5245251|NCT00790790|18100035|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
5245252|NCT00790790|18100036|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
5245253|NCT00790790|18100037|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
5245254|NCT00790790|18100035|P3|Study Period 2: Therapy Phase|Protocol Violation|0
5245255|NCT00790790|18100036|P2|Study Period 2: Therapy Phase|Protocol Violation|1
5245256|NCT00790790|18100037|P1|Study Period 2: Therapy Phase|Protocol Violation|1
5245257|NCT00790790|18100035|P3|Study Period 2: Therapy Phase|Adverse Event|16
5245258|NCT00790790|18100036|P2|Study Period 2: Therapy Phase|Adverse Event|16
5245259|NCT00790790|18100037|P1|Study Period 2: Therapy Phase|Adverse Event|3
5245260|NCT00790751|18100114|P4|Overall Study|Physician Decision|1
5245261|NCT00790751|18100115|P3|Overall Study|Physician Decision|0
5245262|NCT00790751|18100116|P2|Overall Study|Physician Decision|0
5245263|NCT00790751|18100117|P1|Overall Study|Physician Decision|0
5245264|NCT00790751|18100114|P4|Overall Study|Death|0
5245265|NCT00790751|18100115|P3|Overall Study|Death|1
5245266|NCT00790751|18100116|P2|Overall Study|Death|0
5245267|NCT00790751|18100117|P1|Overall Study|Death|0
5245268|NCT00790751|18100114|P4|Overall Study|Requirement for restricted medication|0
5245269|NCT00790751|18100115|P3|Overall Study|Requirement for restricted medication|0
5245270|NCT00790751|18100116|P2|Overall Study|Requirement for restricted medication|2
5245271|NCT00790751|18100117|P1|Overall Study|Requirement for restricted medication|0
5245272|NCT00790751|18100114|P4|Overall Study|Adverse Event|4
5245273|NCT00790751|18100115|P3|Overall Study|Adverse Event|5
5245274|NCT00790751|18100116|P2|Overall Study|Adverse Event|3
5245275|NCT00790751|18100117|P1|Overall Study|Adverse Event|5
5245276|NCT00790751|18100114|P4|Overall Study|Lost to Follow-up|5
5245277|NCT00790751|18100115|P3|Overall Study|Lost to Follow-up|4
5245278|NCT00790751|18100116|P2|Overall Study|Lost to Follow-up|9
5245279|NCT00790751|18100117|P1|Overall Study|Lost to Follow-up|4
5245280|NCT00790751|18100114|P4|Overall Study|Protocol non-compliance|11
5245281|NCT00790751|18100115|P3|Overall Study|Protocol non-compliance|10
5245282|NCT00790751|18100116|P2|Overall Study|Protocol non-compliance|16
5245283|NCT00790751|18100117|P1|Overall Study|Protocol non-compliance|16
5245284|NCT00790647|18100176|P1|Overall Study|Adverse Event|1
5245285|NCT00790582|18100185|P2|Overall Study|Withdrawal by Subject|51
5245286|NCT00790582|18100186|P1|Overall Study|Withdrawal by Subject|7
5245287|NCT00790582|18100185|P2|Overall Study|Lost to Follow-up|3
5245288|NCT00790582|18100186|P1|Overall Study|Lost to Follow-up|3
5245289|NCT00790582|18100185|P2|Overall Study|Physician Decision|1
5245290|NCT00790582|18100186|P1|Overall Study|Physician Decision|7
5245291|NCT00790582|18100185|P2|Overall Study|Death|32
5245292|NCT00790582|18100186|P1|Overall Study|Death|14
5245293|NCT00790569|18100197|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
5245294|NCT00790569|18100198|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
5245295|NCT00790569|18100199|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
5245296|NCT00790569|18100197|P3|End of Treatment (6 Month Interview)|Incarcerated|3
5245297|NCT00790569|18100198|P2|End of Treatment (6 Month Interview)|Incarcerated|0
5245298|NCT00790569|18100199|P1|End of Treatment (6 Month Interview)|Incarcerated|0
5245299|NCT00790569|18100197|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
5245300|NCT00790569|18100198|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
5245301|NCT00790569|18100199|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
5245302|NCT00790569|18100197|P3|End of Treatment (6 Month Interview)|Hospitalized|0
5245303|NCT00790569|18100198|P2|End of Treatment (6 Month Interview)|Hospitalized|0
5245304|NCT00790569|18100199|P1|End of Treatment (6 Month Interview)|Hospitalized|2
5245305|NCT00790569|18100197|P3|End of Treatment (6 Month Interview)|Death|1
5245306|NCT00790569|18100198|P2|End of Treatment (6 Month Interview)|Death|2
5245307|NCT00790569|18100199|P1|End of Treatment (6 Month Interview)|Death|0
5245308|NCT00790569|18100197|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
5245309|NCT00790569|18100198|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
5245310|NCT00790569|18100199|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
5245311|NCT00790556|18100240|P2|Treatment Period 1|Withdrawal by Subject|0
5245312|NCT00790556|18100241|P1|Treatment Period 1|Withdrawal by Subject|1
5245313|NCT00790556|18100240|P2|Treatment Period 1|Physician Decision|0
5245314|NCT00790556|18100241|P1|Treatment Period 1|Physician Decision|1
5245315|NCT00790452|18100253|P2|Overall Study|Drug supply issue|0
5245316|NCT00790452|18100254|P1|Overall Study|Drug supply issue|1
5245317|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|New treatment|0
5245318|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|New treatment|2
5245319|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
5245320|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
5245321|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Disease progression|0
5245322|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Disease progression|5
5245323|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Death|0
5245324|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Death|1
5245325|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Administrative problems|0
5245326|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Administrative problems|2
5245327|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
5245328|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
5245329|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
5245330|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
5245331|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
5245332|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
5245333|NCT00790400|18100262|P2|Everolimus Period (Core or Extension)|Adverse Event|0
5245334|NCT00790400|18100263|P1|Everolimus Period (Core or Extension)|Adverse Event|9
5245335|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Death|0
5245336|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Death|1
5245337|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Administrative problems|0
5245338|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Administrative problems|1
5245339|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
5245340|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
5245341|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
5245342|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
5245343|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Adverse Event|4
5245344|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Adverse Event|2
5245345|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Progressive disease|9
5245346|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Progressive disease|0
5245347|NCT00790400|18100262|P2|Double-blind Period (Core Phase)|Protocol Violation|0
5245348|NCT00790400|18100263|P1|Double-blind Period (Core Phase)|Protocol Violation|1
5245349|NCT00790296|18100353|P2|Overall Study|Adverse Event|1
5245350|NCT00790296|18100354|P1|Overall Study|Adverse Event|0
5245351|NCT00790296|18100353|P2|Overall Study|Did not meet study eligibility criteria|1
5245352|NCT00790296|18100354|P1|Overall Study|Did not meet study eligibility criteria|1
5245353|NCT00790218|18100376|P3|Overall Study|Death|0
5245354|NCT00790218|18100377|P2|Overall Study|Death|0
5245355|NCT00790218|18100378|P1|Overall Study|Death|1
5245356|NCT00790205|18100388|P2|Overall Study|Withdrawal by Subject|363
5245357|NCT00790205|18100389|P1|Overall Study|Withdrawal by Subject|299
5245358|NCT00790205|18100388|P2|Overall Study|Lost to Follow-up|71
5245359|NCT00790205|18100389|P1|Overall Study|Lost to Follow-up|61
5245360|NCT00790088|18100450|P1|Overall Study|Physician Decision|4
5245361|NCT00790088|18100450|P1|Overall Study|Lost to Follow-up|7
5245362|NCT00790088|18100450|P1|Overall Study|Withdrawal by Subject|17
5245363|NCT00790088|18100450|P1|Overall Study|Protocol Violation|11
5245364|NCT00790036|18100496|P2|Overall Study|Subject/guardian decision|7
5245365|NCT00790036|18100497|P1|Overall Study|Subject/guardian decision|20
5245366|NCT00790036|18100496|P2|Overall Study|Withdrawal by Subject|7
5245367|NCT00790036|18100497|P1|Overall Study|Withdrawal by Subject|18
5245368|NCT00790036|18100496|P2|Overall Study|Protocol Violation|2
5245369|NCT00790036|18100497|P1|Overall Study|Protocol Violation|10
5245370|NCT00790036|18100496|P2|Overall Study|Lost to Follow-up|2
5245371|NCT00790036|18100497|P1|Overall Study|Lost to Follow-up|1
5245372|NCT00790036|18100496|P2|Overall Study|Disease progression|48
5245373|NCT00790036|18100497|P1|Overall Study|Disease progression|24
5245374|NCT00790036|18100496|P2|Overall Study|Death|0
5245375|NCT00790036|18100497|P1|Overall Study|Death|1
5245376|NCT00790036|18100496|P2|Overall Study|Adverse Event|44
5245377|NCT00790036|18100497|P1|Overall Study|Adverse Event|113
5245378|NCT00790036|18100496|P2|Overall Study|Administrative problems|9
5245379|NCT00790036|18100497|P1|Overall Study|Administrative problems|5
5245380|NCT00790036|18100496|P2|Overall Study|Abnormal lab values|2
5245381|NCT00790036|18100497|P1|Overall Study|Abnormal lab values|3
5245382|NCT00790023|18100511|P3|Overall Study|Other|8
5245383|NCT00790023|18100512|P2|Overall Study|Other|5
5245384|NCT00790023|18100513|P1|Overall Study|Other|5
5245385|NCT00790023|18100511|P3|Overall Study|Lost to Follow-up|1
5245386|NCT00790023|18100512|P2|Overall Study|Lost to Follow-up|0
5245387|NCT00790023|18100513|P1|Overall Study|Lost to Follow-up|0
5245388|NCT00790023|18100511|P3|Overall Study|Withdrawal by Subject|6
5245389|NCT00790023|18100512|P2|Overall Study|Withdrawal by Subject|0
5245390|NCT00790023|18100513|P1|Overall Study|Withdrawal by Subject|2
5245391|NCT00790023|18100511|P3|Overall Study|Protocol Violation|2
5245392|NCT00790023|18100512|P2|Overall Study|Protocol Violation|4
5245393|NCT00790023|18100513|P1|Overall Study|Protocol Violation|2
5245394|NCT00790023|18100511|P3|Overall Study|Adverse Event|4
5245395|NCT00790023|18100512|P2|Overall Study|Adverse Event|1
5245396|NCT00790023|18100513|P1|Overall Study|Adverse Event|2
5245397|NCT00789958|18100612|P1|Overall Study|Not eligible/not analyzable|26
5245398|NCT00789958|18100612|P1|Overall Study|not protocol specified|1
5245399|NCT00789958|18100612|P1|Overall Study|Progression|3
5245400|NCT00789958|18100612|P1|Overall Study|Withdrawal by Subject|4
5245401|NCT00789958|18100612|P1|Overall Study|Adverse Event|3
5245402|NCT00789880|18100631|P6|Overall Study|Withdrawal by Subject|0
5245403|NCT00789880|18100632|P5|Overall Study|Withdrawal by Subject|2
5245404|NCT00789880|18100633|P4|Overall Study|Withdrawal by Subject|0
5245405|NCT00789880|18100634|P3|Overall Study|Withdrawal by Subject|0
5245406|NCT00789880|18100635|P2|Overall Study|Withdrawal by Subject|0
5245407|NCT00789880|18100636|P1|Overall Study|Withdrawal by Subject|1
5245408|NCT00789880|18100631|P6|Overall Study|Protocol Violation|0
5245409|NCT00789880|18100632|P5|Overall Study|Protocol Violation|0
5245410|NCT00789880|18100633|P4|Overall Study|Protocol Violation|1
5245411|NCT00789880|18100634|P3|Overall Study|Protocol Violation|0
5245412|NCT00789880|18100635|P2|Overall Study|Protocol Violation|1
5245413|NCT00789880|18100636|P1|Overall Study|Protocol Violation|0
5245414|NCT00789880|18100631|P6|Overall Study|Adverse Event|0
5245415|NCT00789880|18100632|P5|Overall Study|Adverse Event|1
5245416|NCT00789880|18100633|P4|Overall Study|Adverse Event|0
5245417|NCT00789880|18100634|P3|Overall Study|Adverse Event|0
5245418|NCT00789880|18100635|P2|Overall Study|Adverse Event|0
5245419|NCT00789880|18100636|P1|Overall Study|Adverse Event|0
5245420|NCT00789854|18100693|P3|Overall Study|Other|5
5245421|NCT00789854|18100694|P2|Overall Study|Other|0
5245422|NCT00789854|18100695|P1|Overall Study|Other|6
5245423|NCT00789854|18100693|P3|Overall Study|Safety reasons|2
5245424|NCT00789854|18100694|P2|Overall Study|Safety reasons|0
5245425|NCT00789854|18100695|P1|Overall Study|Safety reasons|0
5245426|NCT00789854|18100693|P3|Overall Study|Severe non-compliance to the protocol|0
5245427|NCT00789854|18100694|P2|Overall Study|Severe non-compliance to the protocol|0
5245428|NCT00789854|18100695|P1|Overall Study|Severe non-compliance to the protocol|3
5245429|NCT00789854|18100693|P3|Overall Study|Eligibility criteria not fulfilled|1
5245430|NCT00789854|18100694|P2|Overall Study|Eligibility criteria not fulfilled|5
5245431|NCT00789854|18100695|P1|Overall Study|Eligibility criteria not fulfilled|2
5245432|NCT00789854|18100693|P3|Overall Study|Withdrawal by Subject|17
5245433|NCT00789854|18100694|P2|Overall Study|Withdrawal by Subject|6
5245434|NCT00789854|18100695|P1|Overall Study|Withdrawal by Subject|9
5245435|NCT00789854|18100693|P3|Overall Study|Lost to Follow-up|4
5245436|NCT00789854|18100694|P2|Overall Study|Lost to Follow-up|1
5245437|NCT00789854|18100695|P1|Overall Study|Lost to Follow-up|1
5245438|NCT00789854|18100693|P3|Overall Study|Adverse Event|18
5245439|NCT00789854|18100694|P2|Overall Study|Adverse Event|23
5245440|NCT00789854|18100695|P1|Overall Study|Adverse Event|28
5245441|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
5245442|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
5245443|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|Disease progression|0
5245444|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|Disease progression|1
5245445|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|Death|0
5245446|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|Death|1
5245447|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|Administrative problems|0
5245448|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|Administrative problems|7
5245449|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
5245450|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
5245451|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
5245452|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
5245453|NCT00789828|18100792|P2|Open-label Extension Period (4 Years)|Adverse Event|0
5245454|NCT00789828|18100793|P1|Open-label Extension Period (4 Years)|Adverse Event|10
5245455|NCT00789828|18100792|P2|Core Period (48 Weeks)|Lost to Follow-up|1
5245456|NCT00789828|18100793|P1|Core Period (48 Weeks)|Lost to Follow-up|0
5245457|NCT00789828|18100792|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
5245458|NCT00789828|18100793|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
5245459|NCT00789828|18100792|P2|Core Period (48 Weeks)|Administrative problems|1
5245460|NCT00789828|18100793|P1|Core Period (48 Weeks)|Administrative problems|0
5245461|NCT00789815|18100827|P2|Overall Study|Intubation due to massive bleeding|0
5245462|NCT00789815|18100828|P1|Overall Study|Intubation due to massive bleeding|1
5245463|NCT00789815|18100827|P2|Overall Study|Protocol Violation|1
5245464|NCT00789815|18100828|P1|Overall Study|Protocol Violation|6
5245465|NCT00789737|18100938|P2|Overall Study|Other|7
5245466|NCT00789737|18100939|P1|Overall Study|Other|11
5245467|NCT00789737|18100938|P2|Overall Study|hyperglycemia that met protocol-specifie|4
5245468|NCT00789737|18100939|P1|Overall Study|hyperglycemia that met protocol-specifie|0
5245469|NCT00789737|18100938|P2|Overall Study|Lack of Efficacy|0
5245470|NCT00789737|18100939|P1|Overall Study|Lack of Efficacy|3
5245471|NCT00789737|18100938|P2|Overall Study|Protocol Violation|0
5245472|NCT00789737|18100939|P1|Overall Study|Protocol Violation|3
5245473|NCT00789737|18100938|P2|Overall Study|Adverse Event|8
5245474|NCT00789737|18100939|P1|Overall Study|Adverse Event|8
5245475|NCT00789737|18100938|P2|Overall Study|Lost to Follow-up|14
5245476|NCT00789737|18100939|P1|Overall Study|Lost to Follow-up|10
5245477|NCT00789737|18100938|P2|Overall Study|Withdrawal by Subject|22
5245478|NCT00789737|18100939|P1|Overall Study|Withdrawal by Subject|13
5245479|NCT00789698|18100982|P4|Overall Study|Administrative|1
5245480|NCT00789698|18100983|P3|Overall Study|Administrative|3
5245481|NCT00789698|18100984|P2|Overall Study|Administrative|3
5245482|NCT00789698|18100985|P1|Overall Study|Administrative|0
5245483|NCT00789698|18100982|P4|Overall Study|Withdrawal by Subject|19
5245484|NCT00789698|18100983|P3|Overall Study|Withdrawal by Subject|12
5245485|NCT00789698|18100984|P2|Overall Study|Withdrawal by Subject|15
5245486|NCT00789698|18100985|P1|Overall Study|Withdrawal by Subject|14
5245487|NCT00789698|18100982|P4|Overall Study|Protocol Violation|1
5245488|NCT00789698|18100983|P3|Overall Study|Protocol Violation|2
5245489|NCT00789698|18100984|P2|Overall Study|Protocol Violation|1
5245490|NCT00789698|18100985|P1|Overall Study|Protocol Violation|6
5245491|NCT00789698|18100982|P4|Overall Study|Lost to Follow-up|9
5245492|NCT00789698|18100983|P3|Overall Study|Lost to Follow-up|2
5245493|NCT00789698|18100984|P2|Overall Study|Lost to Follow-up|5
5245494|NCT00789698|18100985|P1|Overall Study|Lost to Follow-up|5
5245495|NCT00789698|18100982|P4|Overall Study|Adverse Event|4
5245496|NCT00789698|18100983|P3|Overall Study|Adverse Event|3
5245497|NCT00789698|18100984|P2|Overall Study|Adverse Event|5
5245498|NCT00789698|18100985|P1|Overall Study|Adverse Event|5
5245499|NCT00789698|18100982|P4|Overall Study|Lack of Efficacy|18
5245500|NCT00789698|18100983|P3|Overall Study|Lack of Efficacy|5
5245501|NCT00789698|18100984|P2|Overall Study|Lack of Efficacy|4
5245502|NCT00789698|18100985|P1|Overall Study|Lack of Efficacy|10
5245503|NCT00789581|18101040|P2|Adjuvant Therapy|Other|1
5245504|NCT00789581|18101041|P1|Adjuvant Therapy|Other|0
5245505|NCT00789581|18101040|P2|Adjuvant Therapy|Protocol Violation|1
5245506|NCT00789581|18101041|P1|Adjuvant Therapy|Protocol Violation|1
5245507|NCT00789581|18101040|P2|Adjuvant Therapy|Intercurrent Illness|3
5245508|NCT00789581|18101041|P1|Adjuvant Therapy|Intercurrent Illness|1
5245509|NCT00789581|18101040|P2|Adjuvant Therapy|Disease recurrence|1
5245510|NCT00789581|18101041|P1|Adjuvant Therapy|Disease recurrence|2
5245511|NCT00789581|18101040|P2|Adjuvant Therapy|Withdrawal by Subject|5
5245512|NCT00789581|18101041|P1|Adjuvant Therapy|Withdrawal by Subject|14
5245513|NCT00789581|18101040|P2|Adjuvant Therapy|Adverse Event|44
5245514|NCT00789581|18101041|P1|Adjuvant Therapy|Adverse Event|20
5245515|NCT00789581|18101040|P2|Adjuvant Therapy|Never treated|2
5245516|NCT00789581|18101041|P1|Adjuvant Therapy|Never treated|2
5245517|NCT00789581|18101040|P2|AC Therapy|Other|2
5245518|NCT00789581|18101041|P1|AC Therapy|Other|0
5245519|NCT00789581|18101040|P2|AC Therapy|Never Treated|4
5245520|NCT00789581|18101041|P1|AC Therapy|Never Treated|1
5245521|NCT00789581|18101040|P2|AC Therapy|Intercurrent Illness|0
5245522|NCT00789581|18101041|P1|AC Therapy|Intercurrent Illness|1
5245523|NCT00789581|18101040|P2|AC Therapy|Disease recurrence|1
5245524|NCT00789581|18101041|P1|AC Therapy|Disease recurrence|3
5245525|NCT00789581|18101040|P2|AC Therapy|Withdrawal by Subject|7
5245526|NCT00789581|18101041|P1|AC Therapy|Withdrawal by Subject|4
5245527|NCT00789581|18101040|P2|AC Therapy|Adverse Event|3
5245528|NCT00789581|18101041|P1|AC Therapy|Adverse Event|2
5245529|NCT00789555|18101052|P3|Overall Study|Protocol Violation|13
5245530|NCT00789555|18101053|P2|Overall Study|Protocol Violation|9
5245531|NCT00789555|18101054|P1|Overall Study|Protocol Violation|6
5245532|NCT00789555|18101052|P3|Overall Study|Treatment failure|12
5245533|NCT00789555|18101053|P2|Overall Study|Treatment failure|8
5245534|NCT00789555|18101054|P1|Overall Study|Treatment failure|11
5245535|NCT00789555|18101052|P3|Overall Study|Patient decision unnrelated to adv event|26
5245536|NCT00789555|18101053|P2|Overall Study|Patient decision unnrelated to adv event|29
5245537|NCT00789555|18101054|P1|Overall Study|Patient decision unnrelated to adv event|38
5245538|NCT00789555|18101052|P3|Overall Study|Lost to Follow-up|18
5245539|NCT00789555|18101053|P2|Overall Study|Lost to Follow-up|10
5245540|NCT00789555|18101054|P1|Overall Study|Lost to Follow-up|9
5245541|NCT00789555|18101052|P3|Overall Study|Adverse Event|10
5245542|NCT00789555|18101053|P2|Overall Study|Adverse Event|7
5245543|NCT00789555|18101054|P1|Overall Study|Adverse Event|17
5245544|NCT00789555|18101052|P3|Overall Study|Protocol Amendment|80
5245545|NCT00789555|18101053|P2|Overall Study|Protocol Amendment|76
5245546|NCT00789555|18101054|P1|Overall Study|Protocol Amendment|78
5245547|NCT00789529|18101079|P2|Overall Study|Other Reason|0
5245548|NCT00789529|18101080|P1|Overall Study|Other Reason|1
5245549|NCT00789529|18101079|P2|Overall Study|Withdrawal by Subject|1
5245550|NCT00789529|18101080|P1|Overall Study|Withdrawal by Subject|0
5245551|NCT00789477|18101093|P5|Overall Study|Other|0
5245552|NCT00789477|18101094|P4|Overall Study|Other|3
5245553|NCT00789477|18101095|P3|Overall Study|Other|1
5245554|NCT00789477|18101096|P2|Overall Study|Other|0
5245555|NCT00789477|18101097|P1|Overall Study|Other|2
5245556|NCT00789477|18101093|P5|Overall Study|Lack of Efficacy|0
5245557|NCT00789477|18101094|P4|Overall Study|Lack of Efficacy|0
5245558|NCT00789477|18101095|P3|Overall Study|Lack of Efficacy|0
5245559|NCT00789477|18101096|P2|Overall Study|Lack of Efficacy|0
5245560|NCT00789477|18101097|P1|Overall Study|Lack of Efficacy|2
5245561|NCT00789477|18101093|P5|Overall Study|Lost to Follow-up|4
5245562|NCT00789477|18101094|P4|Overall Study|Lost to Follow-up|2
5245563|NCT00789477|18101095|P3|Overall Study|Lost to Follow-up|4
5245564|NCT00789477|18101096|P2|Overall Study|Lost to Follow-up|1
5245565|NCT00789477|18101097|P1|Overall Study|Lost to Follow-up|0
5245566|NCT00789477|18101093|P5|Overall Study|Death|0
5245567|NCT00789477|18101094|P4|Overall Study|Death|2
5245568|NCT00789477|18101095|P3|Overall Study|Death|2
5245569|NCT00789477|18101096|P2|Overall Study|Death|1
5245570|NCT00789477|18101097|P1|Overall Study|Death|1
5245571|NCT00789477|18101093|P5|Overall Study|Adverse Event|0
5245572|NCT00789477|18101094|P4|Overall Study|Adverse Event|0
5245573|NCT00789477|18101095|P3|Overall Study|Adverse Event|1
5245574|NCT00789477|18101096|P2|Overall Study|Adverse Event|3
5245575|NCT00789477|18101097|P1|Overall Study|Adverse Event|3
5245576|NCT00789477|18101093|P5|Overall Study|Protocol Violation|0
5245577|NCT00789477|18101094|P4|Overall Study|Protocol Violation|1
5245578|NCT00789477|18101095|P3|Overall Study|Protocol Violation|0
5245579|NCT00789477|18101096|P2|Overall Study|Protocol Violation|0
5245580|NCT00789477|18101097|P1|Overall Study|Protocol Violation|1
5245581|NCT00789477|18101093|P5|Overall Study|Withdrawal by Subject|3
5245582|NCT00789477|18101094|P4|Overall Study|Withdrawal by Subject|2
5245583|NCT00789477|18101095|P3|Overall Study|Withdrawal by Subject|3
5245584|NCT00789477|18101096|P2|Overall Study|Withdrawal by Subject|1
5245585|NCT00789477|18101097|P1|Overall Study|Withdrawal by Subject|2
5245586|NCT00789373|18101142|P3|Maintenance|Participants On-Going at Data Cut-Off|0
5245587|NCT00789373|18101143|P2|Maintenance|Participants On-Going at Data Cut-Off|4
5245588|NCT00789373|18101144|P1|Maintenance|Participants On-Going at Data Cut-Off|0
5245589|NCT00789373|18101142|P3|Maintenance|Sponsor Decision|2
5245590|NCT00789373|18101143|P2|Maintenance|Sponsor Decision|0
5245591|NCT00789373|18101144|P1|Maintenance|Sponsor Decision|0
5245592|NCT00789373|18101142|P3|Maintenance|Withdrawal by Subject|8
5245593|NCT00789373|18101143|P2|Maintenance|Withdrawal by Subject|21
5245594|NCT00789373|18101144|P1|Maintenance|Withdrawal by Subject|0
5245595|NCT00789373|18101142|P3|Maintenance|Progressive Disease|152
5245596|NCT00789373|18101143|P2|Maintenance|Progressive Disease|253
5245597|NCT00789373|18101144|P1|Maintenance|Progressive Disease|0
5245598|NCT00789373|18101142|P3|Maintenance|Lost to Follow-up|0
5245599|NCT00789373|18101143|P2|Maintenance|Lost to Follow-up|2
5245600|NCT00789373|18101144|P1|Maintenance|Lost to Follow-up|0
5245601|NCT00789373|18101142|P3|Maintenance|Protocol entry criteria not met|0
5245602|NCT00789373|18101143|P2|Maintenance|Protocol entry criteria not met|2
5245603|NCT00789373|18101144|P1|Maintenance|Protocol entry criteria not met|0
5245604|NCT00789373|18101142|P3|Maintenance|Investigator Decision|2
5245605|NCT00789373|18101143|P2|Maintenance|Investigator Decision|4
5245606|NCT00789373|18101144|P1|Maintenance|Investigator Decision|0
5245607|NCT00789373|18101142|P3|Maintenance|Death due to toxicity|2
5245608|NCT00789373|18101143|P2|Maintenance|Death due to toxicity|1
5245609|NCT00789373|18101144|P1|Maintenance|Death due to toxicity|0
5245610|NCT00789373|18101142|P3|Maintenance|Death due to adverse event|1
5245611|NCT00789373|18101143|P2|Maintenance|Death due to adverse event|4
5245612|NCT00789373|18101144|P1|Maintenance|Death due to adverse event|0
5245613|NCT00789373|18101142|P3|Maintenance|Death due to study disease|1
5245614|NCT00789373|18101143|P2|Maintenance|Death due to study disease|3
5245615|NCT00789373|18101144|P1|Maintenance|Death due to study disease|0
5245616|NCT00789373|18101142|P3|Maintenance|Adverse Event|12
5245617|NCT00789373|18101143|P2|Maintenance|Adverse Event|65
5245618|NCT00789373|18101144|P1|Maintenance|Adverse Event|0
5245619|NCT00789373|18101142|P3|Induction|Withdrawal by Subject|0
5245620|NCT00789373|18101143|P2|Induction|Withdrawal by Subject|0
5245621|NCT00789373|18101144|P1|Induction|Withdrawal by Subject|37
5245622|NCT00789373|18101142|P3|Induction|Progressive Disease|0
5245623|NCT00789373|18101143|P2|Induction|Progressive Disease|0
5245624|NCT00789373|18101144|P1|Induction|Progressive Disease|220
5245625|NCT00789373|18101142|P3|Induction|Protocol Violation|0
5245626|NCT00789373|18101143|P2|Induction|Protocol Violation|0
5245627|NCT00789373|18101144|P1|Induction|Protocol Violation|1
5245628|NCT00789373|18101142|P3|Induction|Lost to Follow-up|0
5245629|NCT00789373|18101143|P2|Induction|Lost to Follow-up|0
5245630|NCT00789373|18101144|P1|Induction|Lost to Follow-up|6
5245631|NCT00789373|18101142|P3|Induction|Protocol entry criteria not met|0
5245632|NCT00789373|18101143|P2|Induction|Protocol entry criteria not met|0
5245633|NCT00789373|18101144|P1|Induction|Protocol entry criteria not met|9
5245634|NCT00789373|18101142|P3|Induction|Investigator decision|0
5245635|NCT00789373|18101143|P2|Induction|Investigator decision|0
5245636|NCT00789373|18101144|P1|Induction|Investigator decision|7
5245637|NCT00789373|18101142|P3|Induction|Death due to procedure|0
5245638|NCT00789373|18101143|P2|Induction|Death due to procedure|0
5245639|NCT00789373|18101144|P1|Induction|Death due to procedure|1
5245640|NCT00789373|18101142|P3|Induction|Death due to toxicity|0
5245641|NCT00789373|18101143|P2|Induction|Death due to toxicity|0
5245642|NCT00789373|18101144|P1|Induction|Death due to toxicity|11
5245643|NCT00789373|18101142|P3|Induction|Death due to adverse event|0
5245644|NCT00789373|18101143|P2|Induction|Death due to adverse event|0
5245645|NCT00789373|18101144|P1|Induction|Death due to adverse event|19
5245646|NCT00789373|18101142|P3|Induction|Death Due to study disease|0
5245647|NCT00789373|18101143|P2|Induction|Death Due to study disease|0
5245648|NCT00789373|18101144|P1|Induction|Death Due to study disease|24
5245649|NCT00789373|18101142|P3|Induction|Adverse Event|0
5245650|NCT00789373|18101143|P2|Induction|Adverse Event|0
5245651|NCT00789373|18101144|P1|Induction|Adverse Event|64
5245652|NCT00789360|18101171|P2|Overall Study|Protocol Violation|1
5245653|NCT00789360|18101172|P1|Overall Study|Protocol Violation|3
5245654|NCT00789321|18101182|P2|Overall Study|Adverse Event|1
5245655|NCT00789321|18101183|P1|Overall Study|Adverse Event|0
5245656|NCT00789191|18101205|P2|Overall Study|Unclassified|3
5245657|NCT00789191|18101206|P1|Overall Study|Unclassified|5
5245658|NCT00789191|18101205|P2|Overall Study|Withdrawal Criteria|4
5245659|NCT00789191|18101206|P1|Overall Study|Withdrawal Criteria|2
5245660|NCT00789191|18101205|P2|Overall Study|Protocol Violation|3
5245661|NCT00789191|18101206|P1|Overall Study|Protocol Violation|5
5245662|NCT00789191|18101205|P2|Overall Study|Lack of Efficacy|5
5245663|NCT00789191|18101206|P1|Overall Study|Lack of Efficacy|0
5245664|NCT00789191|18101205|P2|Overall Study|Adverse Event|4
5245665|NCT00789191|18101206|P1|Overall Study|Adverse Event|2
5245666|NCT00789035|18101263|P5|Overall Study|Other reason not defined above|1
5245667|NCT00789035|18101264|P4|Overall Study|Other reason not defined above|0
5245668|NCT00789035|18101265|P3|Overall Study|Other reason not defined above|1
5245669|NCT00789035|18101266|P2|Overall Study|Other reason not defined above|3
5245670|NCT00789035|18101267|P1|Overall Study|Other reason not defined above|2
5245671|NCT00789035|18101263|P5|Overall Study|Withdrawal by Subject|0
5245672|NCT00789035|18101264|P4|Overall Study|Withdrawal by Subject|0
5245673|NCT00789035|18101265|P3|Overall Study|Withdrawal by Subject|0
5245674|NCT00789035|18101266|P2|Overall Study|Withdrawal by Subject|2
5245675|NCT00789035|18101267|P1|Overall Study|Withdrawal by Subject|0
5245676|NCT00789035|18101263|P5|Overall Study|Protocol Violation|0
5245677|NCT00789035|18101264|P4|Overall Study|Protocol Violation|0
5245678|NCT00789035|18101265|P3|Overall Study|Protocol Violation|0
5245679|NCT00789035|18101266|P2|Overall Study|Protocol Violation|0
5245680|NCT00789035|18101267|P1|Overall Study|Protocol Violation|1
5245681|NCT00789035|18101263|P5|Overall Study|Lack of Efficacy|2
5245682|NCT00789035|18101264|P4|Overall Study|Lack of Efficacy|0
5245683|NCT00789035|18101265|P3|Overall Study|Lack of Efficacy|0
5245684|NCT00789035|18101266|P2|Overall Study|Lack of Efficacy|0
5245685|NCT00789035|18101267|P1|Overall Study|Lack of Efficacy|3
5245686|NCT00789035|18101263|P5|Overall Study|Adverse Event|3
5245687|NCT00789035|18101264|P4|Overall Study|Adverse Event|1
5245688|NCT00789035|18101265|P3|Overall Study|Adverse Event|0
5245689|NCT00789035|18101266|P2|Overall Study|Adverse Event|2
5245690|NCT00789035|18101267|P1|Overall Study|Adverse Event|0
5245691|NCT00788957|18101326|P6|Part 3|On-study at time of data cut-off|0
5245692|NCT00788957|18101327|P5|Part 3|On-study at time of data cut-off|1
5245693|NCT00788957|18101328|P4|Part 3|On-study at time of data cut-off|0
5245694|NCT00788957|18101329|P3|Part 3|On-study at time of data cut-off|0
5245695|NCT00788957|18101330|P2|Part 3|On-study at time of data cut-off|0
5245696|NCT00788957|18101331|P1|Part 3|On-study at time of data cut-off|0
5245697|NCT00788957|18101326|P6|Part 3|Death|9
5245698|NCT00788957|18101327|P5|Part 3|Death|8
5245699|NCT00788957|18101328|P4|Part 3|Death|0
5245700|NCT00788957|18101329|P3|Part 3|Death|0
5245701|NCT00788957|18101330|P2|Part 3|Death|0
5245702|NCT00788957|18101331|P1|Part 3|Death|0
5245703|NCT00788957|18101326|P6|Part 3|Withdrawal by Subject|2
5245704|NCT00788957|18101327|P5|Part 3|Withdrawal by Subject|0
5245705|NCT00788957|18101328|P4|Part 3|Withdrawal by Subject|0
5245706|NCT00788957|18101329|P3|Part 3|Withdrawal by Subject|0
5245707|NCT00788957|18101330|P2|Part 3|Withdrawal by Subject|0
5245708|NCT00788957|18101331|P1|Part 3|Withdrawal by Subject|0
5245709|NCT00788957|18101326|P6|Part 2|On-study at time of data cut-off|0
5245710|NCT00788957|18101327|P5|Part 2|On-study at time of data cut-off|0
5245711|NCT00788957|18101328|P4|Part 2|On-study at time of data cut-off|1
5245712|NCT00788957|18101329|P3|Part 2|On-study at time of data cut-off|1
5245713|NCT00788957|18101330|P2|Part 2|On-study at time of data cut-off|1
5245714|NCT00788957|18101331|P1|Part 2|On-study at time of data cut-off|0
5245715|NCT00788957|18101326|P6|Part 2|Lost to Follow-up|0
5245716|NCT00788957|18101327|P5|Part 2|Lost to Follow-up|0
5245717|NCT00788957|18101328|P4|Part 2|Lost to Follow-up|0
5245718|NCT00788957|18101329|P3|Part 2|Lost to Follow-up|3
5245719|NCT00788957|18101330|P2|Part 2|Lost to Follow-up|0
5245720|NCT00788957|18101331|P1|Part 2|Lost to Follow-up|0
5245721|NCT00788957|18101326|P6|Part 2|Death|0
5245722|NCT00788957|18101327|P5|Part 2|Death|0
5245723|NCT00788957|18101328|P4|Part 2|Death|37
5245724|NCT00788957|18101329|P3|Part 2|Death|35
5245725|NCT00788957|18101330|P2|Part 2|Death|32
5245726|NCT00788957|18101331|P1|Part 2|Death|0
5245727|NCT00788957|18101326|P6|Part 2|Withdrawal by Subject|0
5245728|NCT00788957|18101327|P5|Part 2|Withdrawal by Subject|0
5245729|NCT00788957|18101328|P4|Part 2|Withdrawal by Subject|3
5245730|NCT00788957|18101329|P3|Part 2|Withdrawal by Subject|5
5245731|NCT00788957|18101330|P2|Part 2|Withdrawal by Subject|9
5245732|NCT00788957|18101331|P1|Part 2|Withdrawal by Subject|0
5245733|NCT00788957|18101326|P6|Part 1|Lost to Follow-up|0
5245734|NCT00788957|18101327|P5|Part 1|Lost to Follow-up|0
5245735|NCT00788957|18101328|P4|Part 1|Lost to Follow-up|0
5245736|NCT00788957|18101329|P3|Part 1|Lost to Follow-up|0
5245737|NCT00788957|18101330|P2|Part 1|Lost to Follow-up|0
5245738|NCT00788957|18101331|P1|Part 1|Lost to Follow-up|1
5245739|NCT00788957|18101326|P6|Part 1|Death|0
5245740|NCT00788957|18101327|P5|Part 1|Death|0
5245741|NCT00788957|18101328|P4|Part 1|Death|0
5245742|NCT00788957|18101329|P3|Part 1|Death|0
5245743|NCT00788957|18101330|P2|Part 1|Death|0
5245744|NCT00788957|18101331|P1|Part 1|Death|8
5245745|NCT00788827|18101404|P1|Overall Study|Lack of Efficacy|2
5245746|NCT00788775|18101418|P2|Overall Study|Patient's measurable disease resected.|0
5245747|NCT00788775|18101419|P1|Overall Study|Patient's measurable disease resected.|1
5245748|NCT00788775|18101418|P2|Overall Study|Patient Non-Compliance|0
5245749|NCT00788775|18101419|P1|Overall Study|Patient Non-Compliance|1
5245750|NCT00788775|18101418|P2|Overall Study|Withdrawal by Subject|2
5245751|NCT00788775|18101419|P1|Overall Study|Withdrawal by Subject|0
5245752|NCT00788775|18101418|P2|Overall Study|Progressive Disease|6
5245753|NCT00788775|18101419|P1|Overall Study|Progressive Disease|8
5245754|NCT00788710|18101434|P3|Overall Study|Withdrawal by Subject|0
5245755|NCT00788710|18101435|P2|Overall Study|Withdrawal by Subject|2
5245756|NCT00788710|18101436|P1|Overall Study|Withdrawal by Subject|2
5245757|NCT00788710|18101434|P3|Overall Study|Protocol Violation|1
5245758|NCT00788710|18101435|P2|Overall Study|Protocol Violation|1
5245759|NCT00788710|18101436|P1|Overall Study|Protocol Violation|0
5245760|NCT00788710|18101434|P3|Overall Study|Physician Decision|0
5245761|NCT00788710|18101435|P2|Overall Study|Physician Decision|1
5245762|NCT00788710|18101436|P1|Overall Study|Physician Decision|2
5245763|NCT00788710|18101434|P3|Overall Study|Lost to Follow-up|0
5245764|NCT00788710|18101435|P2|Overall Study|Lost to Follow-up|1
5245765|NCT00788710|18101436|P1|Overall Study|Lost to Follow-up|0
5245766|NCT00788710|18101434|P3|Overall Study|Lack of Efficacy|1
5245767|NCT00788710|18101435|P2|Overall Study|Lack of Efficacy|0
5245768|NCT00788710|18101436|P1|Overall Study|Lack of Efficacy|0
5245769|NCT00788710|18101434|P3|Overall Study|Adverse Event|4
5245770|NCT00788710|18101435|P2|Overall Study|Adverse Event|3
5245771|NCT00788710|18101436|P1|Overall Study|Adverse Event|1
5245772|NCT00788697|18101450|P1|Overall Study|Indeterminate diagnosis from truth stand|17
5245773|NCT00788697|18101450|P1|Overall Study|Technically inadequate truth standard|1
5245774|NCT00788697|18101450|P1|Overall Study|no truth standard procedure available|5
5245775|NCT00788697|18101450|P1|Overall Study|Training Patients|74
5245776|NCT00788697|18101450|P1|Overall Study|No study drug administered|12
5245777|NCT00788593|18101497|P3|Second Intervention Period|Other|1
5245778|NCT00788593|18101498|P2|Second Intervention Period|Other|0
5245779|NCT00788593|18101499|P1|Second Intervention Period|Other|0
5245780|NCT00788593|18101497|P3|Second Intervention Period|Lost to Follow-up|0
5245781|NCT00788593|18101498|P2|Second Intervention Period|Lost to Follow-up|1
5245782|NCT00788593|18101499|P1|Second Intervention Period|Lost to Follow-up|0
5245783|NCT00788593|18101497|P3|First Intervention Period|Adverse Event|0
5245784|NCT00788593|18101498|P2|First Intervention Period|Adverse Event|1
5245785|NCT00788593|18101499|P1|First Intervention Period|Adverse Event|0
5245786|NCT00788593|18101497|P3|Placebo Run-in Phase|Protocol Violation|0
5245787|NCT00788593|18101498|P2|Placebo Run-in Phase|Protocol Violation|0
5245788|NCT00788593|18101499|P1|Placebo Run-in Phase|Protocol Violation|2
5245789|NCT00788593|18101497|P3|Placebo Run-in Phase|Withdrawal by Subject|0
5245790|NCT00788593|18101498|P2|Placebo Run-in Phase|Withdrawal by Subject|0
5245791|NCT00788593|18101499|P1|Placebo Run-in Phase|Withdrawal by Subject|2
5245792|NCT00788593|18101497|P3|Placebo Run-in Phase|Adverse Event|0
5245793|NCT00788593|18101498|P2|Placebo Run-in Phase|Adverse Event|0
5245794|NCT00788593|18101499|P1|Placebo Run-in Phase|Adverse Event|2
5245795|NCT00788372|18101516|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
5245796|NCT00788372|18101516|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
5245797|NCT00788372|18101516|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
5245798|NCT00788372|18101516|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
5245799|NCT00788372|18101516|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
5245800|NCT00788372|18101516|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
5245801|NCT00788372|18101516|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
5245802|NCT00788151|18101545|P2|Overall Study|Enrolled but not treated|1
5245803|NCT00788151|18101546|P1|Overall Study|Enrolled but not treated|1
5245804|NCT00788151|18101545|P2|Overall Study|Withdrawal by Subject|6
5245805|NCT00788151|18101546|P1|Overall Study|Withdrawal by Subject|13
5245806|NCT00788151|18101545|P2|Overall Study|Protocol Violation|1
5245807|NCT00788151|18101546|P1|Overall Study|Protocol Violation|0
5245808|NCT00788151|18101545|P2|Overall Study|Other adverse event|2
5245809|NCT00788151|18101546|P1|Overall Study|Other adverse event|0
5245810|NCT00788073|18101590|P2|Placebo Then STX209|Protocol Violation|1
5245811|NCT00788073|18101591|P1|Placebo Then STX209|Protocol Violation|0
5245812|NCT00788073|18101590|P2|Placebo Then STX209|Adverse Event|0
5245813|NCT00788073|18101591|P1|Placebo Then STX209|Adverse Event|2
5245814|NCT00788073|18101590|P2|STX209 Then Placebo|unable to return due to travel|1
5245815|NCT00788073|18101591|P1|STX209 Then Placebo|unable to return due to travel|0
5245816|NCT00788073|18101590|P2|STX209 Then Placebo|Withdrawal by Subject|1
5245817|NCT00788073|18101591|P1|STX209 Then Placebo|Withdrawal by Subject|0
5245818|NCT00788073|18101590|P2|STX209 Then Placebo|Lost to Follow-up|1
5245819|NCT00788073|18101591|P1|STX209 Then Placebo|Lost to Follow-up|0
5245820|NCT00788073|18101590|P2|STX209 Then Placebo|Adverse Event|0
5245821|NCT00788073|18101591|P1|STX209 Then Placebo|Adverse Event|1
5245822|NCT00787930|18101616|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
5245823|NCT00787917|18101631|P2|Open Label|Administrative problems|0
5245824|NCT00787917|18101632|P1|Open Label|Administrative problems|3
5245825|NCT00787917|18101631|P2|Open Label|Unsatisfactory therapeutic effect|0
5245826|NCT00787917|18101632|P1|Open Label|Unsatisfactory therapeutic effect|1
5245827|NCT00787917|18101631|P2|Blinded Treatment|Administrative problems|2
5245828|NCT00787917|18101632|P1|Blinded Treatment|Administrative problems|3
5245829|NCT00787917|18101631|P2|Blinded Treatment|Lack of Efficacy|0
5245830|NCT00787917|18101632|P1|Blinded Treatment|Lack of Efficacy|1
5245831|NCT00787917|18101631|P2|Blinded Treatment|Adverse Event|0
5245832|NCT00787917|18101632|P1|Blinded Treatment|Adverse Event|1
5245833|NCT00787891|18101662|P2|Maintenance Double-blind Phase (Part 2)|Other|2
5245834|NCT00787891|18101663|P1|Maintenance Double-blind Phase (Part 2)|Other|5
5245835|NCT00787891|18101662|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
5245836|NCT00787891|18101663|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
5245837|NCT00787891|18101662|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
5245838|NCT00787891|18101663|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
5245839|NCT00787891|18101662|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
5245840|NCT00787891|18101663|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
5245841|NCT00787891|18101662|P2|Short-term Double-blind Phase (Part 1)|Other|2
5245842|NCT00787891|18101663|P1|Short-term Double-blind Phase (Part 1)|Other|0
5245843|NCT00787891|18101662|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
5245844|NCT00787891|18101663|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
5245845|NCT00787891|18101662|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
5245846|NCT00787891|18101663|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
5245847|NCT00787891|18101662|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
5245848|NCT00787891|18101663|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
5245849|NCT00787891|18101662|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
5245850|NCT00787891|18101663|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
5245851|NCT00787891|18101662|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
5245852|NCT00787891|18101663|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
5245853|NCT00787839|18101690|P1|Overall Study|Failure to have the OGTT was most common|404
5245854|NCT00787800|18101713|P2|Overall Study|Death|2
5245855|NCT00787800|18101714|P1|Overall Study|Death|0
5245856|NCT00787800|18101713|P2|Overall Study|Withdrawal by Subject|5
5245857|NCT00787800|18101714|P1|Overall Study|Withdrawal by Subject|3
5245858|NCT00787787|18101730|P1|Overall Study|Adverse Event|3
5245859|NCT00787787|18101730|P1|Overall Study|Lack of Efficacy|4
5245860|NCT00787644|18101758|P2|Overall Study|Withdrawal by Subject|1
5245861|NCT00787644|18101759|P1|Overall Study|Withdrawal by Subject|1
5245862|NCT00787644|18101758|P2|Overall Study|Lost to Follow-up|1
5245863|NCT00787644|18101759|P1|Overall Study|Lost to Follow-up|1
5245864|NCT00787605|18101780|P2|Overall Study|Lack of Efficacy|9
5245865|NCT00787605|18101781|P1|Overall Study|Lack of Efficacy|13
5245866|NCT00787605|18101780|P2|Overall Study|Withdrawal by Subject|13
5245867|NCT00787605|18101781|P1|Overall Study|Withdrawal by Subject|6
5245868|NCT00787605|18101780|P2|Overall Study|Protocol Violation|3
5245869|NCT00787605|18101781|P1|Overall Study|Protocol Violation|7
5245870|NCT00787605|18101780|P2|Overall Study|Lost to Follow-up|6
5245871|NCT00787605|18101781|P1|Overall Study|Lost to Follow-up|3
5245872|NCT00787605|18101780|P2|Overall Study|Adverse Event|25
5245873|NCT00787605|18101781|P1|Overall Study|Adverse Event|14
5245874|NCT00787605|18101780|P2|Overall Study|Administrative Problems|0
5245875|NCT00787605|18101781|P1|Overall Study|Administrative Problems|3
5245876|NCT00787566|18101800|P3|Overall Study|AE related to chemotherapy|0
5245877|NCT00787566|18101801|P2|Overall Study|AE related to chemotherapy|1
5245878|NCT00787566|18101802|P1|Overall Study|AE related to chemotherapy|0
5245879|NCT00787527|18101810|P1|Overall Study|Toxicity|3
5245880|NCT00787319|18101827|P1|Overall Study|Inactive disease|5
5245881|NCT00787319|18101827|P1|Overall Study|Stabilized disease findings|3
5245882|NCT00787319|18101827|P1|Overall Study|No health insurance reimbursement|2
5245883|NCT00787319|18101827|P1|Overall Study|Unresponsiveness to visit invitation|1
5245884|NCT00787319|18101827|P1|Overall Study|Budget exhausted/exceeded|1
5245885|NCT00787319|18101827|P1|Overall Study|Lack of Efficacy|1
5245886|NCT00787319|18101827|P1|Overall Study|Objective progression or relapse|30
5245887|NCT00787319|18101827|P1|Overall Study|Adverse Event|3
5245888|NCT00787319|18101827|P1|Overall Study|Withdrawal by Subject|15
5245889|NCT00787319|18101827|P1|Overall Study|Lost to Follow-up|2
5245890|NCT00787267|18101839|P1|Overall Study|Withdrawal by Subject|1
5245891|NCT00787267|18101839|P1|Overall Study|No Reason Provided|1
5245892|NCT00787267|18101839|P1|Overall Study|Screen failure/Ineligible|10
5245893|NCT00787254|18101849|P2|Overall Study|Physician Decision|8
5245894|NCT00787254|18101850|P1|Overall Study|Physician Decision|4
5245895|NCT00787254|18101849|P2|Overall Study|Institution closed|0
5245896|NCT00787254|18101850|P1|Overall Study|Institution closed|1
5245897|NCT00787254|18101849|P2|Overall Study|NSAIDs discontinuation|2
5245898|NCT00787254|18101850|P1|Overall Study|NSAIDs discontinuation|1
5245899|NCT00787254|18101849|P2|Overall Study|Lack of Efficacy|15
5245900|NCT00787254|18101850|P1|Overall Study|Lack of Efficacy|4
5245901|NCT00787254|18101849|P2|Overall Study|Withdrawal by Subject|11
5245902|NCT00787254|18101850|P1|Overall Study|Withdrawal by Subject|16
5245903|NCT00787254|18101849|P2|Overall Study|Protocol Violation|23
5245904|NCT00787254|18101850|P1|Overall Study|Protocol Violation|26
5245905|NCT00787254|18101849|P2|Overall Study|Adverse Event|23
5245906|NCT00787254|18101850|P1|Overall Study|Adverse Event|24
5245907|NCT00787202|18101974|P5|Overall Study|Randomized, not treated|0
5245908|NCT00787202|18101975|P4|Overall Study|Randomized, not treated|0
5245909|NCT00787202|18101976|P3|Overall Study|Randomized, not treated|0
5245910|NCT00787202|18101977|P2|Overall Study|Randomized, not treated|0
5245911|NCT00787202|18101978|P1|Overall Study|Randomized, not treated|1
5245912|NCT00787202|18101974|P5|Overall Study|Protocol Violation|1
5245913|NCT00787202|18101975|P4|Overall Study|Protocol Violation|0
5245914|NCT00787202|18101976|P3|Overall Study|Protocol Violation|0
5245915|NCT00787202|18101977|P2|Overall Study|Protocol Violation|1
5245916|NCT00787202|18101978|P1|Overall Study|Protocol Violation|2
5245917|NCT00787202|18101974|P5|Overall Study|Withdrawal by Subject|0
5245918|NCT00787202|18101975|P4|Overall Study|Withdrawal by Subject|0
5245919|NCT00787202|18101976|P3|Overall Study|Withdrawal by Subject|2
5245920|NCT00787202|18101977|P2|Overall Study|Withdrawal by Subject|2
5245921|NCT00787202|18101978|P1|Overall Study|Withdrawal by Subject|2
5245922|NCT00787202|18101974|P5|Overall Study|Lost to Follow-up|0
5245923|NCT00787202|18101975|P4|Overall Study|Lost to Follow-up|0
5245924|NCT00787202|18101976|P3|Overall Study|Lost to Follow-up|0
5245925|NCT00787202|18101977|P2|Overall Study|Lost to Follow-up|0
5245926|NCT00787202|18101978|P1|Overall Study|Lost to Follow-up|1
5245927|NCT00787202|18101974|P5|Overall Study|Lack of Efficacy|1
5245928|NCT00787202|18101975|P4|Overall Study|Lack of Efficacy|2
5245929|NCT00787202|18101976|P3|Overall Study|Lack of Efficacy|5
5245930|NCT00787202|18101977|P2|Overall Study|Lack of Efficacy|6
5245931|NCT00787202|18101978|P1|Overall Study|Lack of Efficacy|5
5245932|NCT00787202|18101974|P5|Overall Study|Adverse Event|2
5245933|NCT00787202|18101975|P4|Overall Study|Adverse Event|0
5245934|NCT00787202|18101976|P3|Overall Study|Adverse Event|0
5245935|NCT00787202|18101977|P2|Overall Study|Adverse Event|2
5245936|NCT00787202|18101978|P1|Overall Study|Adverse Event|3
5245937|NCT00787189|18102031|P2|Overall Study|Lost to Follow-up|2
5245938|NCT00787189|18102032|P1|Overall Study|Lost to Follow-up|2
5245939|NCT00787150|18102041|P3|Overall Study|Dosing incorrect study durg|0
5245940|NCT00787150|18102042|P2|Overall Study|Dosing incorrect study durg|0
5245941|NCT00787150|18102043|P1|Overall Study|Dosing incorrect study durg|2
5245942|NCT00787150|18102041|P3|Overall Study|Withdrawal by Subject|0
5245943|NCT00787150|18102042|P2|Overall Study|Withdrawal by Subject|1
5245944|NCT00787150|18102043|P1|Overall Study|Withdrawal by Subject|2
5245945|NCT00787150|18102041|P3|Overall Study|Physician Decision|1
5245946|NCT00787150|18102042|P2|Overall Study|Physician Decision|2
5245947|NCT00787150|18102043|P1|Overall Study|Physician Decision|1
5245948|NCT00787150|18102041|P3|Overall Study|Adverse Event|4
5245949|NCT00787150|18102042|P2|Overall Study|Adverse Event|4
5245950|NCT00787150|18102043|P1|Overall Study|Adverse Event|4
5245951|NCT00787137|18102088|P3|Overall Study|Study Termination|1
5245952|NCT00787137|18102089|P2|Overall Study|Study Termination|0
5245953|NCT00787137|18102090|P1|Overall Study|Study Termination|0
5245954|NCT00786864|18102165|P2|Overall Study|Sustained serious back injury|0
5245955|NCT00786864|18102166|P1|Overall Study|Sustained serious back injury|1
5245956|NCT00786864|18102165|P2|Overall Study|Lost to Follow-up|1
5245957|NCT00786864|18102166|P1|Overall Study|Lost to Follow-up|0
5245958|NCT00786838|18102178|P1|Overall Study|Withdrawal by Subject|4
5245959|NCT00786838|18102178|P1|Overall Study|Progressive disease|31
5245960|NCT00786838|18102178|P1|Overall Study|Adverse Event|6
5245961|NCT00786838|18102178|P1|Overall Study|Death|4
5245962|NCT00786838|18102178|P1|Overall Study|Physician Decision|4
5245963|NCT00786799|18102214|P2|Overall Study|Lost to Follow-up|1
5245964|NCT00786799|18102215|P1|Overall Study|Lost to Follow-up|1
5245965|NCT00786565|18102245|P1|Post Surgery|Adapt AO implanted posterior side up|1
5245966|NCT00786565|18102245|P1|Post Surgery|Abnormal macular pucker|1
5245967|NCT00786565|18102245|P1|Enrollment Prior to Surgery|Protocol Violation|3
5245968|NCT00786565|18102245|P1|Enrollment Prior to Surgery|Site Closed|3
5245969|NCT00786474|18102302|P2|Overall Study|Other|4
5245970|NCT00786474|18102303|P1|Overall Study|Other|4
5245971|NCT00786474|18102302|P2|Overall Study|Physician Decision|1
5245972|NCT00786474|18102303|P1|Overall Study|Physician Decision|2
5245973|NCT00786474|18102302|P2|Overall Study|Lost to Follow-up|3
5245974|NCT00786474|18102303|P1|Overall Study|Lost to Follow-up|3
5245975|NCT00786474|18102302|P2|Overall Study|Withdrawal by Subject|31
5245976|NCT00786474|18102303|P1|Overall Study|Withdrawal by Subject|23
5245977|NCT00786474|18102302|P2|Overall Study|Death|4
5245978|NCT00786474|18102303|P1|Overall Study|Death|5
5245979|NCT00786422|18102315|P1|Follow-up Period|End-of-study done up to 4 days early|2
5245980|NCT00786422|18102315|P1|Follow-up Period|Death|1
5245981|NCT00786422|18102315|P1|Rivaroxaban Treatment|Adverse Event|2
5245982|NCT00786422|18102315|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
5245983|NCT00786422|18102315|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
5245984|NCT00786422|18102315|P1|Rivaroxaban Treatment|Physician Decision|1
5245985|NCT00786422|18102315|P1|Rivaroxaban Treatment|Lack of Efficacy|1
5245986|NCT00786422|18102315|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
5245987|NCT00786422|18102315|P1|Rivaroxaban Treatment|Death|2
5245988|NCT00786409|18102331|P1|Overall Study|Lost to Follow-up|1
5245989|NCT00786409|18102331|P1|Overall Study|Pregnancy|2
5245990|NCT00786409|18102331|P1|Overall Study|Adverse Event|2
5245991|NCT00786409|18102331|P1|Overall Study|Withdrawal by Subject|2
5245992|NCT00786188|18102348|P2|Overall Study|Withdrawal by Subject|0
5245993|NCT00786188|18102349|P1|Overall Study|Withdrawal by Subject|2
5245994|NCT00786188|18102348|P2|Overall Study|Adverse Event|1
5245995|NCT00786188|18102349|P1|Overall Study|Adverse Event|3
5245996|NCT00786032|18102375|P1|Overall Study|Did not complete in the timeframe|6
5245997|NCT00786032|18102375|P1|Overall Study|Withdrawal by Subject|14
5245998|NCT00786032|18102375|P1|Overall Study|Death|4
5245999|NCT00785980|18102396|P1|7 Day Washout Period|Protocol Violation|3
5246000|NCT00785928|18102414|P7|Treatment Phase|Withdrawal by Subject|0
5246001|NCT00785928|18102415|P6|Treatment Phase|Withdrawal by Subject|0
5246002|NCT00785928|18102416|P5|Treatment Phase|Withdrawal by Subject|1
5246003|NCT00785928|18102417|P4|Treatment Phase|Withdrawal by Subject|0
5246004|NCT00785928|18102418|P3|Treatment Phase|Withdrawal by Subject|0
5246005|NCT00785928|18102419|P2|Treatment Phase|Withdrawal by Subject|2
5246006|NCT00785928|18102420|P1|Treatment Phase|Withdrawal by Subject|1
5246007|NCT00785928|18102414|P7|Treatment Phase|Sponsor Decision|1
5246008|NCT00785928|18102415|P6|Treatment Phase|Sponsor Decision|0
5246009|NCT00785928|18102416|P5|Treatment Phase|Sponsor Decision|0
5246010|NCT00785928|18102417|P4|Treatment Phase|Sponsor Decision|0
5246011|NCT00785928|18102418|P3|Treatment Phase|Sponsor Decision|0
5246012|NCT00785928|18102419|P2|Treatment Phase|Sponsor Decision|0
5246013|NCT00785928|18102420|P1|Treatment Phase|Sponsor Decision|1
5246014|NCT00785928|18102414|P7|Treatment Phase|Physician Decision|0
5246015|NCT00785928|18102415|P6|Treatment Phase|Physician Decision|0
5246016|NCT00785928|18102416|P5|Treatment Phase|Physician Decision|1
5246017|NCT00785928|18102417|P4|Treatment Phase|Physician Decision|0
5246018|NCT00785928|18102418|P3|Treatment Phase|Physician Decision|0
5246019|NCT00785928|18102419|P2|Treatment Phase|Physician Decision|0
5246020|NCT00785928|18102420|P1|Treatment Phase|Physician Decision|0
5246021|NCT00785928|18102414|P7|Treatment Phase|Lack of Efficacy|0
5246022|NCT00785928|18102415|P6|Treatment Phase|Lack of Efficacy|0
5246023|NCT00785928|18102416|P5|Treatment Phase|Lack of Efficacy|0
5246024|NCT00785928|18102417|P4|Treatment Phase|Lack of Efficacy|0
5246025|NCT00785928|18102418|P3|Treatment Phase|Lack of Efficacy|1
5246026|NCT00785928|18102419|P2|Treatment Phase|Lack of Efficacy|1
5246027|NCT00785928|18102420|P1|Treatment Phase|Lack of Efficacy|0
5246028|NCT00785928|18102414|P7|Treatment Phase|Inadequate Response|0
5246029|NCT00785928|18102415|P6|Treatment Phase|Inadequate Response|0
5246030|NCT00785928|18102416|P5|Treatment Phase|Inadequate Response|0
5246031|NCT00785928|18102417|P4|Treatment Phase|Inadequate Response|0
5246032|NCT00785928|18102418|P3|Treatment Phase|Inadequate Response|0
5246033|NCT00785928|18102419|P2|Treatment Phase|Inadequate Response|1
5246034|NCT00785928|18102420|P1|Treatment Phase|Inadequate Response|0
5246035|NCT00785928|18102414|P7|Treatment Phase|Adverse Event|2
5246036|NCT00785928|18102415|P6|Treatment Phase|Adverse Event|0
5246037|NCT00785928|18102416|P5|Treatment Phase|Adverse Event|0
5246038|NCT00785928|18102417|P4|Treatment Phase|Adverse Event|0
5246039|NCT00785928|18102418|P3|Treatment Phase|Adverse Event|2
5246040|NCT00785928|18102419|P2|Treatment Phase|Adverse Event|1
5246041|NCT00785928|18102420|P1|Treatment Phase|Adverse Event|1
5246042|NCT00785785|18102567|P2|Optional Extension Phase|Study terminated by sponsor|37
5246043|NCT00785785|18102568|P1|Optional Extension Phase|Study terminated by sponsor|3
5246044|NCT00785785|18102567|P2|Optional Extension Phase|Protocol deviation|2
5246045|NCT00785785|18102568|P1|Optional Extension Phase|Protocol deviation|0
5246046|NCT00785785|18102567|P2|Optional Extension Phase|Disease progression|70
5246047|NCT00785785|18102568|P1|Optional Extension Phase|Disease progression|22
5246048|NCT00785785|18102567|P2|Optional Extension Phase|Death|5
5246049|NCT00785785|18102568|P1|Optional Extension Phase|Death|1
5246050|NCT00785785|18102567|P2|Optional Extension Phase|Administrative problems|0
5246051|NCT00785785|18102568|P1|Optional Extension Phase|Administrative problems|2
5246052|NCT00785785|18102567|P2|Optional Extension Phase|Lost to Follow-up|0
5246053|NCT00785785|18102568|P1|Optional Extension Phase|Lost to Follow-up|1
5246054|NCT00785785|18102567|P2|Optional Extension Phase|Withdrawal by Subject|6
5246055|NCT00785785|18102568|P1|Optional Extension Phase|Withdrawal by Subject|6
5246056|NCT00785785|18102567|P2|Optional Extension Phase|Adverse Event|5
5246057|NCT00785785|18102568|P1|Optional Extension Phase|Adverse Event|4
5246058|NCT00785785|18102567|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
5246059|NCT00785785|18102568|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
5246060|NCT00785785|18102567|P2|Core Phase up to 36 Months|Protocol deviation|6
5246061|NCT00785785|18102568|P1|Core Phase up to 36 Months|Protocol deviation|5
5246062|NCT00785785|18102567|P2|Core Phase up to 36 Months|Disease progression|119
5246063|NCT00785785|18102568|P1|Core Phase up to 36 Months|Disease progression|139
5246064|NCT00785785|18102567|P2|Core Phase up to 36 Months|Death|8
5246065|NCT00785785|18102568|P1|Core Phase up to 36 Months|Death|5
5246066|NCT00785785|18102567|P2|Core Phase up to 36 Months|Administrative problems|3
5246067|NCT00785785|18102568|P1|Core Phase up to 36 Months|Administrative problems|3
5246068|NCT00785785|18102567|P2|Core Phase up to 36 Months|Lost to Follow-up|7
5246069|NCT00785785|18102568|P1|Core Phase up to 36 Months|Lost to Follow-up|3
5246070|NCT00785785|18102567|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
5246071|NCT00785785|18102568|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
5246072|NCT00785785|18102567|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
5246073|NCT00785785|18102568|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
5246074|NCT00785785|18102567|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
5246075|NCT00785785|18102568|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
5246076|NCT00785785|18102567|P2|Core Phase up to 36 Months|Adverse Event|21
5246077|NCT00785785|18102568|P1|Core Phase up to 36 Months|Adverse Event|31
5246078|NCT00785785|18102567|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
5246079|NCT00785785|18102568|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
5246080|NCT00785707|18102582|P1|Overall Study|Lost to Follow-up|7
5246081|NCT00785629|18102591|P4|Overall Study|Withdrawal by Subject|2
5246082|NCT00785629|18102592|P3|Overall Study|Withdrawal by Subject|2
5246083|NCT00785629|18102593|P2|Overall Study|Withdrawal by Subject|1
5246084|NCT00785629|18102594|P1|Overall Study|Withdrawal by Subject|0
5246085|NCT00785629|18102591|P4|Overall Study|administrative decision|4
5246086|NCT00785629|18102592|P3|Overall Study|administrative decision|3
5246087|NCT00785629|18102593|P2|Overall Study|administrative decision|1
5246088|NCT00785629|18102594|P1|Overall Study|administrative decision|5
5246089|NCT00785629|18102591|P4|Overall Study|Protocol Violation|5
5246090|NCT00785629|18102592|P3|Overall Study|Protocol Violation|4
5246091|NCT00785629|18102593|P2|Overall Study|Protocol Violation|2
5246092|NCT00785629|18102594|P1|Overall Study|Protocol Violation|1
5246093|NCT00785629|18102591|P4|Overall Study|Adverse Event|5
5246094|NCT00785629|18102592|P3|Overall Study|Adverse Event|1
5246095|NCT00785629|18102593|P2|Overall Study|Adverse Event|1
5246096|NCT00785629|18102594|P1|Overall Study|Adverse Event|2
5246097|NCT00785577|18102607|P5|Study Period 3: 1-Week Washout Phase|Death|1
5246098|NCT00785577|18102608|P4|Study Period 3: 1-Week Washout Phase|Death|0
5246099|NCT00785577|18102609|P3|Study Period 3: 1-Week Washout Phase|Death|0
5246100|NCT00785577|18102610|P2|Study Period 3: 1-Week Washout Phase|Death|0
5246101|NCT00785577|18102611|P1|Study Period 3: 1-Week Washout Phase|Death|0
5246102|NCT00785577|18102607|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5246103|NCT00785577|18102608|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
5246104|NCT00785577|18102609|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5246105|NCT00785577|18102610|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5246106|NCT00785577|18102611|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5246107|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
5246108|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
5246109|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
5246110|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
5246111|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
5246112|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
5246113|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
5246114|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
5246115|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
5246116|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
5246117|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
5246118|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
5246119|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
5246120|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
5246121|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
5246122|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Protocol Violation|1
5246123|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Protocol Violation|0
5246124|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Protocol Violation|1
5246125|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Protocol Violation|1
5246126|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Protocol Violation|1
5246127|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Physician Decision|0
5246128|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Physician Decision|0
5246129|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Physician Decision|0
5246130|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Physician Decision|0
5246131|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Physician Decision|1
5246132|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
5246133|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
5246134|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
5246135|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
5246136|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
5246137|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
5246138|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
5246139|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
5246140|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
5246141|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
5246142|NCT00785577|18102607|P5|Study Period 2: Therapy Phase|Adverse Event|17
5246143|NCT00785577|18102608|P4|Study Period 2: Therapy Phase|Adverse Event|10
5246144|NCT00785577|18102609|P3|Study Period 2: Therapy Phase|Adverse Event|14
5246145|NCT00785577|18102610|P2|Study Period 2: Therapy Phase|Adverse Event|7
5246146|NCT00785577|18102611|P1|Study Period 2: Therapy Phase|Adverse Event|5
5246147|NCT00785538|18102751|P4|Treatment Period|Withdrawal by Subject|1
5246148|NCT00785538|18102752|P3|Treatment Period|Withdrawal by Subject|0
5246149|NCT00785538|18102753|P2|Treatment Period|Withdrawal by Subject|0
5246150|NCT00785538|18102754|P1|Treatment Period|Withdrawal by Subject|0
5246151|NCT00785538|18102751|P4|Treatment Period|Adverse Event|0
5246152|NCT00785538|18102752|P3|Treatment Period|Adverse Event|2
5246153|NCT00785538|18102753|P2|Treatment Period|Adverse Event|2
5246154|NCT00785538|18102754|P1|Treatment Period|Adverse Event|1
5246155|NCT00785512|18102802|P2|Overall Study|Lack of compliance|1
5246156|NCT00785512|18102803|P1|Overall Study|Lack of compliance|0
5246157|NCT00785512|18102802|P2|Overall Study|Physician Decision|0
5246158|NCT00785512|18102803|P1|Overall Study|Physician Decision|0
5246159|NCT00785512|18102802|P2|Overall Study|IVRS Programing Error|0
5246160|NCT00785512|18102803|P1|Overall Study|IVRS Programing Error|0
5246161|NCT00785512|18102802|P2|Overall Study|Precedure Refused|0
5246162|NCT00785512|18102803|P1|Overall Study|Precedure Refused|0
5246163|NCT00785512|18102802|P2|Overall Study|Lost to Follow-up|0
5246164|NCT00785512|18102803|P1|Overall Study|Lost to Follow-up|3
5246165|NCT00785512|18102802|P2|Overall Study|Withdrawal by Subject|1
5246166|NCT00785512|18102803|P1|Overall Study|Withdrawal by Subject|0
5246167|NCT00785512|18102802|P2|Overall Study|Lack of Efficacy|2
5246168|NCT00785512|18102803|P1|Overall Study|Lack of Efficacy|0
5246169|NCT00785512|18102802|P2|Overall Study|Adverse Event|0
5246170|NCT00785512|18102803|P1|Overall Study|Adverse Event|0
5246171|NCT00785512|18102802|P2|Overall Study|Inclusion/Exclusion not meet|0
5246172|NCT00785512|18102803|P1|Overall Study|Inclusion/Exclusion not meet|0
5246173|NCT00785486|18102812|P1|Midazolam Alone|Withdrawal by Subject|1
5246174|NCT00785356|18102836|P1|Overall Study|Study prematurely terminated|8
5246175|NCT00785291|18102847|P3|Overall Study|Other Medical Reasons|15
5246176|NCT00785291|18102848|P2|Overall Study|Other Medical Reasons|25
5246177|NCT00785291|18102849|P1|Overall Study|Other Medical Reasons|29
5246178|NCT00785291|18102847|P3|Overall Study|Complicating illness|4
5246179|NCT00785291|18102848|P2|Overall Study|Complicating illness|4
5246180|NCT00785291|18102849|P1|Overall Study|Complicating illness|6
5246181|NCT00785291|18102847|P3|Overall Study|Alternative Therapy|7
5246182|NCT00785291|18102848|P2|Overall Study|Alternative Therapy|6
5246183|NCT00785291|18102849|P1|Overall Study|Alternative Therapy|12
5246184|NCT00785291|18102847|P3|Overall Study|Withdrawal by Subject|17
5246185|NCT00785291|18102848|P2|Overall Study|Withdrawal by Subject|36
5246186|NCT00785291|18102849|P1|Overall Study|Withdrawal by Subject|35
5246187|NCT00785291|18102847|P3|Overall Study|Death|3
5246188|NCT00785291|18102848|P2|Overall Study|Death|4
5246189|NCT00785291|18102849|P1|Overall Study|Death|7
5246190|NCT00785291|18102847|P3|Overall Study|Adverse Event|56
5246191|NCT00785291|18102848|P2|Overall Study|Adverse Event|70
5246192|NCT00785291|18102849|P1|Overall Study|Adverse Event|39
5246193|NCT00785291|18102847|P3|Overall Study|Never began treatment|4
5246194|NCT00785291|18102848|P2|Overall Study|Never began treatment|4
5246195|NCT00785291|18102849|P1|Overall Study|Never began treatment|8
5246196|NCT00785213|18102869|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
5246197|NCT00785213|18102869|P1|Quinine Sulfate Alone|Adverse Event|4
5246198|NCT00785044|18102880|P1|Overall Study|Withdrawal by Subject|1
5246199|NCT00785044|18102880|P1|Overall Study|Lost to Follow-up|266
5246200|NCT00785044|18102880|P1|Overall Study|Death|77
5246201|NCT00785044|18102880|P1|Overall Study|Dosed at non-participating sites|152
5246202|NCT00784979|18102885|P1|Overall Study|incomplete data|6
5246203|NCT00784927|18102889|P1|Overall Study|Ineligible|1
5246204|NCT00784927|18102889|P1|Overall Study|Protocol Violation|1
5246205|NCT00784927|18102889|P1|Overall Study|Cancel Prior to Initiating Treatment|1
5246206|NCT00784875|18102901|P4|Period D|Lost to Follow-up|1
5246207|NCT00784875|18102902|P3|Period D|Lost to Follow-up|1
5246208|NCT00784875|18102903|P2|Period D|Lost to Follow-up|0
5246209|NCT00784875|18102904|P1|Period D|Lost to Follow-up|1
5246210|NCT00784875|18102901|P4|Period D|Sponsor Decision|0
5246211|NCT00784875|18102902|P3|Period D|Sponsor Decision|1
5246212|NCT00784875|18102903|P2|Period D|Sponsor Decision|1
5246213|NCT00784875|18102904|P1|Period D|Sponsor Decision|1
5246214|NCT00784875|18102901|P4|Period D|Physician Decision|0
5246215|NCT00784875|18102902|P3|Period D|Physician Decision|0
5246216|NCT00784875|18102903|P2|Period D|Physician Decision|1
5246217|NCT00784875|18102904|P1|Period D|Physician Decision|0
5246218|NCT00784875|18102901|P4|Period D|Withdrawal by Subject|0
5246219|NCT00784875|18102902|P3|Period D|Withdrawal by Subject|2
5246220|NCT00784875|18102903|P2|Period D|Withdrawal by Subject|0
5246221|NCT00784875|18102904|P1|Period D|Withdrawal by Subject|2
5246222|NCT00784875|18102901|P4|Period D|Protocol Violation|0
5246223|NCT00784875|18102902|P3|Period D|Protocol Violation|0
5246224|NCT00784875|18102903|P2|Period D|Protocol Violation|0
5246225|NCT00784875|18102904|P1|Period D|Protocol Violation|1
5246226|NCT00784875|18102901|P4|Period D|Adverse Event|0
5246227|NCT00784875|18102902|P3|Period D|Adverse Event|2
5246228|NCT00784875|18102903|P2|Period D|Adverse Event|2
5246229|NCT00784875|18102904|P1|Period D|Adverse Event|0
5246230|NCT00784875|18102901|P4|Period C|Sponsor Decision|2
5246231|NCT00784875|18102902|P3|Period C|Sponsor Decision|4
5246232|NCT00784875|18102903|P2|Period C|Sponsor Decision|5
5246233|NCT00784875|18102904|P1|Period C|Sponsor Decision|5
5246234|NCT00784875|18102901|P4|Period C|Physician Decision|1
5246235|NCT00784875|18102902|P3|Period C|Physician Decision|1
5246236|NCT00784875|18102903|P2|Period C|Physician Decision|0
5246237|NCT00784875|18102904|P1|Period C|Physician Decision|0
5246238|NCT00784875|18102901|P4|Period C|Withdrawal by Subject|0
5246239|NCT00784875|18102902|P3|Period C|Withdrawal by Subject|2
5246240|NCT00784875|18102903|P2|Period C|Withdrawal by Subject|1
5246241|NCT00784875|18102904|P1|Period C|Withdrawal by Subject|1
5246242|NCT00784875|18102901|P4|Period C|Lack of Efficacy|0
5246243|NCT00784875|18102902|P3|Period C|Lack of Efficacy|1
5246244|NCT00784875|18102903|P2|Period C|Lack of Efficacy|0
5246245|NCT00784875|18102904|P1|Period C|Lack of Efficacy|0
5246246|NCT00784875|18102901|P4|Period C|Protocol Violation|2
5246247|NCT00784875|18102902|P3|Period C|Protocol Violation|1
5246248|NCT00784875|18102903|P2|Period C|Protocol Violation|0
5246249|NCT00784875|18102904|P1|Period C|Protocol Violation|0
5246250|NCT00784875|18102901|P4|Period C|Adverse Event|2
5246251|NCT00784875|18102902|P3|Period C|Adverse Event|4
5246252|NCT00784875|18102903|P2|Period C|Adverse Event|0
5246253|NCT00784875|18102904|P1|Period C|Adverse Event|1
5246254|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
5246255|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
5246256|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
5246257|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
5246258|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
5246259|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
5246260|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
5246261|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
5246262|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Physician Decision|0
5246263|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Physician Decision|1
5246264|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Physician Decision|0
5246265|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Physician Decision|0
5246266|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
5246267|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
5246268|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
5246269|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
5246270|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
5246271|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
5246272|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
5246273|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
5246274|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Protocol Violation|3
5246275|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Protocol Violation|2
5246276|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Protocol Violation|1
5246277|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Protocol Violation|1
5246278|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Adverse Event|1
5246279|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Adverse Event|2
5246280|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Adverse Event|3
5246281|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Adverse Event|0
5246282|NCT00784875|18102901|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
5246283|NCT00784875|18102902|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
5246284|NCT00784875|18102903|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
5246285|NCT00784875|18102904|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
5246286|NCT00784875|18102901|P4|Period A - Baseline|Lost to Follow-up|2
5246287|NCT00784875|18102902|P3|Period A - Baseline|Lost to Follow-up|0
5246288|NCT00784875|18102903|P2|Period A - Baseline|Lost to Follow-up|0
5246289|NCT00784875|18102904|P1|Period A - Baseline|Lost to Follow-up|0
5246290|NCT00784875|18102901|P4|Period A - Baseline|Sponsor Decision|113
5246291|NCT00784875|18102902|P3|Period A - Baseline|Sponsor Decision|0
5246292|NCT00784875|18102903|P2|Period A - Baseline|Sponsor Decision|0
5246293|NCT00784875|18102904|P1|Period A - Baseline|Sponsor Decision|0
5246294|NCT00784875|18102901|P4|Period A - Baseline|Physician Decision|2
5246295|NCT00784875|18102902|P3|Period A - Baseline|Physician Decision|0
5246296|NCT00784875|18102903|P2|Period A - Baseline|Physician Decision|0
5246297|NCT00784875|18102904|P1|Period A - Baseline|Physician Decision|0
5246298|NCT00784875|18102901|P4|Period A - Baseline|Withdrawal by Subject|27
5246299|NCT00784875|18102902|P3|Period A - Baseline|Withdrawal by Subject|0
5246300|NCT00784875|18102903|P2|Period A - Baseline|Withdrawal by Subject|0
5246301|NCT00784875|18102904|P1|Period A - Baseline|Withdrawal by Subject|0
5246302|NCT00784875|18102901|P4|Period A - Baseline|Protocol Violation|25
5246303|NCT00784875|18102902|P3|Period A - Baseline|Protocol Violation|0
5246304|NCT00784875|18102903|P2|Period A - Baseline|Protocol Violation|0
5246305|NCT00784875|18102904|P1|Period A - Baseline|Protocol Violation|0
5246306|NCT00784875|18102901|P4|Period A - Baseline|Adverse Event|8
5246307|NCT00784875|18102902|P3|Period A - Baseline|Adverse Event|0
5246308|NCT00784875|18102903|P2|Period A - Baseline|Adverse Event|0
5246309|NCT00784875|18102904|P1|Period A - Baseline|Adverse Event|0
5246310|NCT00784875|18102901|P4|Period A - Baseline|Entry Criteria Not Met|5
5246311|NCT00784875|18102902|P3|Period A - Baseline|Entry Criteria Not Met|0
5246312|NCT00784875|18102903|P2|Period A - Baseline|Entry Criteria Not Met|0
5246313|NCT00784875|18102904|P1|Period A - Baseline|Entry Criteria Not Met|0
5246314|NCT00784836|18103024|P1|Overall Study|Early Study Termination|3
5246315|NCT00784810|18103031|P2|Overall Study|Lost to Follow-up|1
5246316|NCT00784810|18103032|P1|Overall Study|Lost to Follow-up|1
5246317|NCT00784810|18103031|P2|Overall Study|Administrative|8
5246318|NCT00784810|18103032|P1|Overall Study|Administrative|5
5246319|NCT00784810|18103031|P2|Overall Study|Withdrawal by Subject|9
5246320|NCT00784810|18103032|P1|Overall Study|Withdrawal by Subject|11
5246321|NCT00784810|18103031|P2|Overall Study|Lack of Efficacy|11
5246322|NCT00784810|18103032|P1|Overall Study|Lack of Efficacy|14
5246323|NCT00784810|18103031|P2|Overall Study|Adverse Event|20
5246324|NCT00784810|18103032|P1|Overall Study|Adverse Event|32
5246325|NCT00784784|18103042|P2|Overall Study|Withdrawal by Subject|2
5246326|NCT00784784|18103043|P1|Overall Study|Withdrawal by Subject|2
5246327|NCT00784758|18103053|P2|Overall Study|Adverse Event|0
5246328|NCT00784758|18103054|P1|Overall Study|Adverse Event|1
5246329|NCT00784758|18103053|P2|Overall Study|Withdrawal by Subject|0
5246330|NCT00784758|18103054|P1|Overall Study|Withdrawal by Subject|3
5246331|NCT00784719|18103103|P7|Overall Study|Withdrawal by Subject|1
5246332|NCT00784719|18103104|P6|Overall Study|Withdrawal by Subject|0
5246333|NCT00784719|18103105|P5|Overall Study|Withdrawal by Subject|2
5246334|NCT00784719|18103106|P4|Overall Study|Withdrawal by Subject|0
5246335|NCT00784719|18103107|P3|Overall Study|Withdrawal by Subject|0
5246336|NCT00784719|18103108|P2|Overall Study|Withdrawal by Subject|0
5246337|NCT00784719|18103109|P1|Overall Study|Withdrawal by Subject|1
5246338|NCT00784719|18103103|P7|Overall Study|Other|3
5246339|NCT00784719|18103104|P6|Overall Study|Other|1
5246340|NCT00784719|18103105|P5|Overall Study|Other|2
5246341|NCT00784719|18103106|P4|Overall Study|Other|0
5246342|NCT00784719|18103107|P3|Overall Study|Other|1
5246343|NCT00784719|18103108|P2|Overall Study|Other|1
5246344|NCT00784719|18103109|P1|Overall Study|Other|2
5246345|NCT00784719|18103103|P7|Overall Study|Lost to Follow-up|0
5246346|NCT00784719|18103104|P6|Overall Study|Lost to Follow-up|1
5246347|NCT00784719|18103105|P5|Overall Study|Lost to Follow-up|1
5246348|NCT00784719|18103106|P4|Overall Study|Lost to Follow-up|0
5246349|NCT00784719|18103107|P3|Overall Study|Lost to Follow-up|0
5246350|NCT00784719|18103108|P2|Overall Study|Lost to Follow-up|0
5246351|NCT00784719|18103109|P1|Overall Study|Lost to Follow-up|0
5246352|NCT00784719|18103103|P7|Overall Study|Adverse Event|1
5246353|NCT00784719|18103104|P6|Overall Study|Adverse Event|1
5246354|NCT00784719|18103105|P5|Overall Study|Adverse Event|1
5246355|NCT00784719|18103106|P4|Overall Study|Adverse Event|0
5246356|NCT00784719|18103107|P3|Overall Study|Adverse Event|0
5246357|NCT00784719|18103108|P2|Overall Study|Adverse Event|2
5246358|NCT00784719|18103109|P1|Overall Study|Adverse Event|0
5246359|NCT00784654|18103279|P3|Randomized Withdrawal Period|Family reasons|1
5246360|NCT00784654|18103280|P2|Randomized Withdrawal Period|Family reasons|0
5246361|NCT00784654|18103281|P1|Randomized Withdrawal Period|Family reasons|0
5246362|NCT00784654|18103279|P3|Randomized Withdrawal Period|Did not complete a visit|0
5246363|NCT00784654|18103280|P2|Randomized Withdrawal Period|Did not complete a visit|1
5246364|NCT00784654|18103281|P1|Randomized Withdrawal Period|Did not complete a visit|0
5246365|NCT00784654|18103279|P3|Randomized Withdrawal Period|Adverse Event|1
5246366|NCT00784654|18103280|P2|Randomized Withdrawal Period|Adverse Event|1
5246367|NCT00784654|18103281|P1|Randomized Withdrawal Period|Adverse Event|0
5246368|NCT00784654|18103279|P3|Randomized Withdrawal Period|Protocol Violation|1
5246369|NCT00784654|18103280|P2|Randomized Withdrawal Period|Protocol Violation|2
5246370|NCT00784654|18103281|P1|Randomized Withdrawal Period|Protocol Violation|0
5246371|NCT00784654|18103279|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
5246372|NCT00784654|18103280|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
5246373|NCT00784654|18103281|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
5246374|NCT00784654|18103279|P3|Randomized Withdrawal Period|Lack of Efficacy|18
5246375|NCT00784654|18103280|P2|Randomized Withdrawal Period|Lack of Efficacy|5
5246376|NCT00784654|18103281|P1|Randomized Withdrawal Period|Lack of Efficacy|0
5246377|NCT00784654|18103279|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
5246378|NCT00784654|18103280|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
5246379|NCT00784654|18103281|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
5246380|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
5246381|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
5246382|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
5246383|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
5246384|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
5246385|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
5246386|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
5246387|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
5246388|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
5246389|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
5246390|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
5246391|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
5246392|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
5246393|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
5246394|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
5246395|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
5246396|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
5246397|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
5246398|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
5246399|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
5246400|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
5246401|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
5246402|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
5246403|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
5246404|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
5246405|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
5246406|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
5246407|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
5246408|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
5246409|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
5246410|NCT00784654|18103279|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
5246411|NCT00784654|18103280|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
5246412|NCT00784654|18103281|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
5246413|NCT00784563|18103329|P3|Year 3|Adverse Event|1
5246414|NCT00784563|18103330|P2|Year 3|Adverse Event|0
5246415|NCT00784563|18103331|P1|Year 3|Adverse Event|0
5246416|NCT00784563|18103329|P3|Year 3|Withdrawal by Subject|2
5246417|NCT00784563|18103330|P2|Year 3|Withdrawal by Subject|0
5246418|NCT00784563|18103331|P1|Year 3|Withdrawal by Subject|0
5246419|NCT00784563|18103329|P3|Years 1 & 2|Adverse Event|0
5246420|NCT00784563|18103330|P2|Years 1 & 2|Adverse Event|3
5246421|NCT00784563|18103331|P1|Years 1 & 2|Adverse Event|0
5246422|NCT00784563|18103329|P3|Years 1 & 2|Withdrawal by Subject|0
5246423|NCT00784563|18103330|P2|Years 1 & 2|Withdrawal by Subject|2
5246424|NCT00784563|18103331|P1|Years 1 & 2|Withdrawal by Subject|3
5246425|NCT00784550|18103349|P2|Overall Study|Withdrawal by Subject|13
5246426|NCT00784550|18103350|P1|Overall Study|Withdrawal by Subject|4
5246427|NCT00784550|18103349|P2|Overall Study|Physician Decision|3
5246428|NCT00784550|18103350|P1|Overall Study|Physician Decision|2
5246429|NCT00784550|18103349|P2|Overall Study|Lost to Follow-up|5
5246430|NCT00784550|18103350|P1|Overall Study|Lost to Follow-up|8
5246431|NCT00784550|18103349|P2|Overall Study|Protocol Violation|10
5246432|NCT00784550|18103350|P1|Overall Study|Protocol Violation|10
5246433|NCT00784550|18103349|P2|Overall Study|Lack of Efficacy|1
5246434|NCT00784550|18103350|P1|Overall Study|Lack of Efficacy|0
5246435|NCT00784550|18103349|P2|Overall Study|Adverse Event|10
5246436|NCT00784550|18103350|P1|Overall Study|Adverse Event|12
5246437|NCT00784459|18103376|P2|Overall Study|Adverse Event|2
5246438|NCT00784459|18103377|P1|Overall Study|Adverse Event|0
5246439|NCT00784368|18103388|P3|Overall Study|Withdrawal of informed consent|0
5246440|NCT00784368|18103389|P2|Overall Study|Withdrawal of informed consent|1
5246441|NCT00784368|18103390|P1|Overall Study|Withdrawal of informed consent|0
5246442|NCT00784368|18103388|P3|Overall Study|Worsening of symptoms|0
5246443|NCT00784368|18103389|P2|Overall Study|Worsening of symptoms|1
5246444|NCT00784368|18103390|P1|Overall Study|Worsening of symptoms|0
5246445|NCT00784368|18103388|P3|Overall Study|Worsening of complications|1
5246446|NCT00784368|18103389|P2|Overall Study|Worsening of complications|0
5246447|NCT00784368|18103390|P1|Overall Study|Worsening of complications|0
5246448|NCT00784368|18103388|P3|Overall Study|Diagnosis of fever|1
5246449|NCT00784368|18103389|P2|Overall Study|Diagnosis of fever|0
5246450|NCT00784368|18103390|P1|Overall Study|Diagnosis of fever|0
5246451|NCT00784368|18103388|P3|Overall Study|Adverse Event|2
5246452|NCT00784368|18103389|P2|Overall Study|Adverse Event|9
5246453|NCT00784368|18103390|P1|Overall Study|Adverse Event|6
5246454|NCT00784368|18103388|P3|Overall Study|Lack of Efficacy|1
5246455|NCT00784368|18103389|P2|Overall Study|Lack of Efficacy|0
5246456|NCT00784368|18103390|P1|Overall Study|Lack of Efficacy|2
5246457|NCT00784368|18103388|P3|Overall Study|Physician Decision|6
5246458|NCT00784368|18103389|P2|Overall Study|Physician Decision|0
5246459|NCT00784368|18103390|P1|Overall Study|Physician Decision|0
5246460|NCT00784277|18103466|P7|ER Treatment|Other|2
5246461|NCT00784277|18103467|P6|ER Treatment|Other|3
5246462|NCT00784277|18103468|P5|ER Treatment|Other|1
5246463|NCT00784277|18103469|P4|ER Treatment|Other|0
5246464|NCT00784277|18103470|P3|ER Treatment|Other|0
5246465|NCT00784277|18103471|P2|ER Treatment|Other|0
5246466|NCT00784277|18103472|P1|ER Treatment|Other|0
5246467|NCT00784277|18103466|P7|ER Treatment|Study Medication Non-Compliant|3
5246468|NCT00784277|18103467|P6|ER Treatment|Study Medication Non-Compliant|3
5246469|NCT00784277|18103468|P5|ER Treatment|Study Medication Non-Compliant|2
5246470|NCT00784277|18103469|P4|ER Treatment|Study Medication Non-Compliant|0
5246471|NCT00784277|18103470|P3|ER Treatment|Study Medication Non-Compliant|0
5246472|NCT00784277|18103471|P2|ER Treatment|Study Medication Non-Compliant|0
5246473|NCT00784277|18103472|P1|ER Treatment|Study Medication Non-Compliant|0
5246474|NCT00784277|18103466|P7|ER Treatment|Withdrawal by Subject|3
5246475|NCT00784277|18103467|P6|ER Treatment|Withdrawal by Subject|5
5246476|NCT00784277|18103468|P5|ER Treatment|Withdrawal by Subject|2
5246477|NCT00784277|18103469|P4|ER Treatment|Withdrawal by Subject|0
5246478|NCT00784277|18103470|P3|ER Treatment|Withdrawal by Subject|0
5246479|NCT00784277|18103471|P2|ER Treatment|Withdrawal by Subject|0
5246480|NCT00784277|18103472|P1|ER Treatment|Withdrawal by Subject|0
5246481|NCT00784277|18103466|P7|ER Treatment|Lost to Follow-up|0
5246482|NCT00784277|18103467|P6|ER Treatment|Lost to Follow-up|2
5246483|NCT00784277|18103468|P5|ER Treatment|Lost to Follow-up|0
5246484|NCT00784277|18103469|P4|ER Treatment|Lost to Follow-up|0
5246485|NCT00784277|18103470|P3|ER Treatment|Lost to Follow-up|0
5246486|NCT00784277|18103471|P2|ER Treatment|Lost to Follow-up|0
5246487|NCT00784277|18103472|P1|ER Treatment|Lost to Follow-up|0
5246488|NCT00784277|18103466|P7|ER Treatment|Lack of Efficacy|0
5246489|NCT00784277|18103467|P6|ER Treatment|Lack of Efficacy|4
5246490|NCT00784277|18103468|P5|ER Treatment|Lack of Efficacy|3
5246491|NCT00784277|18103469|P4|ER Treatment|Lack of Efficacy|0
5246492|NCT00784277|18103470|P3|ER Treatment|Lack of Efficacy|0
5246493|NCT00784277|18103471|P2|ER Treatment|Lack of Efficacy|0
5246494|NCT00784277|18103472|P1|ER Treatment|Lack of Efficacy|0
5246495|NCT00784277|18103466|P7|ER Treatment|Adverse Event|7
5246496|NCT00784277|18103467|P6|ER Treatment|Adverse Event|7
5246497|NCT00784277|18103468|P5|ER Treatment|Adverse Event|1
5246498|NCT00784277|18103469|P4|ER Treatment|Adverse Event|0
5246499|NCT00784277|18103470|P3|ER Treatment|Adverse Event|0
5246500|NCT00784277|18103471|P2|ER Treatment|Adverse Event|0
5246501|NCT00784277|18103472|P1|ER Treatment|Adverse Event|0
5246502|NCT00784277|18103466|P7|IR Treatment|Other|0
5246503|NCT00784277|18103467|P6|IR Treatment|Other|0
5246504|NCT00784277|18103468|P5|IR Treatment|Other|0
5246505|NCT00784277|18103469|P4|IR Treatment|Other|2
5246506|NCT00784277|18103470|P3|IR Treatment|Other|3
5246507|NCT00784277|18103471|P2|IR Treatment|Other|3
5246508|NCT00784277|18103472|P1|IR Treatment|Other|2
5246509|NCT00784277|18103466|P7|IR Treatment|Resolution Of Pain|0
5246510|NCT00784277|18103467|P6|IR Treatment|Resolution Of Pain|0
5246511|NCT00784277|18103468|P5|IR Treatment|Resolution Of Pain|0
5246512|NCT00784277|18103469|P4|IR Treatment|Resolution Of Pain|0
5246513|NCT00784277|18103470|P3|IR Treatment|Resolution Of Pain|0
5246514|NCT00784277|18103471|P2|IR Treatment|Resolution Of Pain|1
5246515|NCT00784277|18103472|P1|IR Treatment|Resolution Of Pain|0
5246516|NCT00784277|18103466|P7|IR Treatment|Withdrawal by Subject|0
5246517|NCT00784277|18103467|P6|IR Treatment|Withdrawal by Subject|0
5246518|NCT00784277|18103468|P5|IR Treatment|Withdrawal by Subject|0
5246519|NCT00784277|18103469|P4|IR Treatment|Withdrawal by Subject|6
5246520|NCT00784277|18103470|P3|IR Treatment|Withdrawal by Subject|4
5246521|NCT00784277|18103471|P2|IR Treatment|Withdrawal by Subject|1
5246522|NCT00784277|18103472|P1|IR Treatment|Withdrawal by Subject|5
5246523|NCT00784277|18103466|P7|IR Treatment|Lost to Follow-up|0
5246524|NCT00784277|18103467|P6|IR Treatment|Lost to Follow-up|0
5246525|NCT00784277|18103468|P5|IR Treatment|Lost to Follow-up|0
5246526|NCT00784277|18103469|P4|IR Treatment|Lost to Follow-up|0
5246527|NCT00784277|18103470|P3|IR Treatment|Lost to Follow-up|1
5246528|NCT00784277|18103471|P2|IR Treatment|Lost to Follow-up|0
5246529|NCT00784277|18103472|P1|IR Treatment|Lost to Follow-up|1
5246530|NCT00784277|18103466|P7|IR Treatment|Lack of Efficacy|0
5246531|NCT00784277|18103467|P6|IR Treatment|Lack of Efficacy|0
5246532|NCT00784277|18103468|P5|IR Treatment|Lack of Efficacy|0
5246533|NCT00784277|18103469|P4|IR Treatment|Lack of Efficacy|0
5246534|NCT00784277|18103470|P3|IR Treatment|Lack of Efficacy|1
5246535|NCT00784277|18103471|P2|IR Treatment|Lack of Efficacy|4
5246536|NCT00784277|18103472|P1|IR Treatment|Lack of Efficacy|4
5246537|NCT00784277|18103466|P7|IR Treatment|Adverse Event|0
5246538|NCT00784277|18103467|P6|IR Treatment|Adverse Event|0
5246539|NCT00784277|18103468|P5|IR Treatment|Adverse Event|0
5246540|NCT00784277|18103469|P4|IR Treatment|Adverse Event|35
5246541|NCT00784277|18103470|P3|IR Treatment|Adverse Event|19
5246542|NCT00784277|18103471|P2|IR Treatment|Adverse Event|8
5246543|NCT00784277|18103472|P1|IR Treatment|Adverse Event|4
5246544|NCT00784238|18103489|P1|Overall Study|Other|14
5246545|NCT00784238|18103489|P1|Overall Study|Withdrawal by Subject|26
5246546|NCT00784238|18103489|P1|Overall Study|Pregnancy|1
5246547|NCT00784238|18103489|P1|Overall Study|Lost to Follow-up|29
5246548|NCT00784238|18103489|P1|Overall Study|Lack of Efficacy|33
5246549|NCT00784238|18103489|P1|Overall Study|Death|2
5246550|NCT00784238|18103489|P1|Overall Study|Adverse Event|14
5246551|NCT00784147|18103561|P2|Overall Study|Death|0
5246552|NCT00784147|18103562|P1|Overall Study|Death|2
5246553|NCT00784147|18103561|P2|Overall Study|Protocol Violation|1
5246554|NCT00784147|18103562|P1|Overall Study|Protocol Violation|1
5246555|NCT00784147|18103561|P2|Overall Study|Physician Decision|1
5246556|NCT00784147|18103562|P1|Overall Study|Physician Decision|2
5246557|NCT00784147|18103561|P2|Overall Study|Withdrawal by Subject|3
5246558|NCT00784147|18103562|P1|Overall Study|Withdrawal by Subject|1
5246559|NCT00784147|18103561|P2|Overall Study|Lost to Follow-up|4
5246560|NCT00784147|18103562|P1|Overall Study|Lost to Follow-up|2
5246561|NCT00784134|18103582|P2|Overall Study|Lost to Follow-up|6
5246562|NCT00784134|18103583|P1|Overall Study|Lost to Follow-up|3
5246563|NCT00784043|18103706|P2|Overall Study|Protocol Terminated|1
5246564|NCT00784043|18103707|P1|Overall Study|Protocol Terminated|23
5246565|NCT00784043|18103706|P2|Overall Study|Withdrawal by Subject|5
5246566|NCT00784043|18103707|P1|Overall Study|Withdrawal by Subject|8
5246567|NCT00783835|18103742|P1|Overall Study|Participant not Adherent|3
5246568|NCT00783835|18103742|P1|Overall Study|Lost to Follow-up|1
5246569|NCT00783835|18103742|P1|Overall Study|Withdrawal by Subject|2
5246570|NCT00783835|18103742|P1|Overall Study|Medical Criteria|1
5246571|NCT00783835|18103742|P1|Overall Study|Adverse Event|3
5246572|NCT00783796|18103754|P1|Overall Study|Received commercial XIENCE V stent|1
5246573|NCT00783796|18103754|P1|Overall Study|Received non-XIENCE V stent|1
5246574|NCT00783796|18103754|P1|Overall Study|Did not receive any stent|4
5246575|NCT00783718|18103859|P7|Maintenance Phase|Lost to Follow-up|2
5246576|NCT00783718|18103860|P6|Maintenance Phase|Lost to Follow-up|0
5246577|NCT00783718|18103861|P5|Maintenance Phase|Lost to Follow-up|2
5246578|NCT00783718|18103862|P4|Maintenance Phase|Lost to Follow-up|0
5246579|NCT00783718|18103863|P3|Maintenance Phase|Lost to Follow-up|0
5246580|NCT00783718|18103864|P2|Maintenance Phase|Lost to Follow-up|0
5246581|NCT00783718|18103865|P1|Maintenance Phase|Lost to Follow-up|3
5246582|NCT00783718|18103859|P7|Maintenance Phase|Withdrawal by Subject|20
5246583|NCT00783718|18103860|P6|Maintenance Phase|Withdrawal by Subject|2
5246584|NCT00783718|18103861|P5|Maintenance Phase|Withdrawal by Subject|5
5246585|NCT00783718|18103862|P4|Maintenance Phase|Withdrawal by Subject|2
5246586|NCT00783718|18103863|P3|Maintenance Phase|Withdrawal by Subject|0
5246587|NCT00783718|18103864|P2|Maintenance Phase|Withdrawal by Subject|0
5246588|NCT00783718|18103865|P1|Maintenance Phase|Withdrawal by Subject|6
5246589|NCT00783718|18103859|P7|Maintenance Phase|Lack of Efficacy|155
5246590|NCT00783718|18103860|P6|Maintenance Phase|Lack of Efficacy|33
5246591|NCT00783718|18103861|P5|Maintenance Phase|Lack of Efficacy|31
5246592|NCT00783718|18103862|P4|Maintenance Phase|Lack of Efficacy|61
5246593|NCT00783718|18103863|P3|Maintenance Phase|Lack of Efficacy|0
5246594|NCT00783718|18103864|P2|Maintenance Phase|Lack of Efficacy|0
5246595|NCT00783718|18103865|P1|Maintenance Phase|Lack of Efficacy|83
5246596|NCT00783718|18103859|P7|Maintenance Phase|Protocol Violation|2
5246597|NCT00783718|18103860|P6|Maintenance Phase|Protocol Violation|0
5246598|NCT00783718|18103861|P5|Maintenance Phase|Protocol Violation|0
5246599|NCT00783718|18103862|P4|Maintenance Phase|Protocol Violation|0
5246600|NCT00783718|18103863|P3|Maintenance Phase|Protocol Violation|0
5246601|NCT00783718|18103864|P2|Maintenance Phase|Protocol Violation|0
5246602|NCT00783718|18103865|P1|Maintenance Phase|Protocol Violation|1
5246603|NCT00783718|18103859|P7|Maintenance Phase|Adverse Event|16
5246604|NCT00783718|18103860|P6|Maintenance Phase|Adverse Event|6
5246605|NCT00783718|18103861|P5|Maintenance Phase|Adverse Event|7
5246606|NCT00783718|18103862|P4|Maintenance Phase|Adverse Event|15
5246607|NCT00783718|18103863|P3|Maintenance Phase|Adverse Event|0
5246608|NCT00783718|18103864|P2|Maintenance Phase|Adverse Event|0
5246609|NCT00783718|18103865|P1|Maintenance Phase|Adverse Event|12
5246610|NCT00783718|18103859|P7|Induction Phase|Lost to Follow-up|0
5246611|NCT00783718|18103860|P6|Induction Phase|Lost to Follow-up|0
5246612|NCT00783718|18103861|P5|Induction Phase|Lost to Follow-up|0
5246613|NCT00783718|18103862|P4|Induction Phase|Lost to Follow-up|0
5246614|NCT00783718|18103863|P3|Induction Phase|Lost to Follow-up|1
5246615|NCT00783718|18103864|P2|Induction Phase|Lost to Follow-up|0
5246616|NCT00783718|18103865|P1|Induction Phase|Lost to Follow-up|1
5246617|NCT00783718|18103859|P7|Induction Phase|Withdrawal by Subject|0
5246618|NCT00783718|18103860|P6|Induction Phase|Withdrawal by Subject|0
5246619|NCT00783718|18103861|P5|Induction Phase|Withdrawal by Subject|0
5246620|NCT00783718|18103862|P4|Induction Phase|Withdrawal by Subject|0
5246621|NCT00783718|18103863|P3|Induction Phase|Withdrawal by Subject|8
5246622|NCT00783718|18103864|P2|Induction Phase|Withdrawal by Subject|4
5246623|NCT00783718|18103865|P1|Induction Phase|Withdrawal by Subject|3
5246624|NCT00783718|18103859|P7|Induction Phase|Lack of Efficacy|0
5246625|NCT00783718|18103860|P6|Induction Phase|Lack of Efficacy|0
5246626|NCT00783718|18103861|P5|Induction Phase|Lack of Efficacy|0
5246627|NCT00783718|18103862|P4|Induction Phase|Lack of Efficacy|0
5246628|NCT00783718|18103863|P3|Induction Phase|Lack of Efficacy|14
5246629|NCT00783718|18103864|P2|Induction Phase|Lack of Efficacy|2
5246630|NCT00783718|18103865|P1|Induction Phase|Lack of Efficacy|5
5246631|NCT00783718|18103859|P7|Induction Phase|Protocol Violation|0
5246632|NCT00783718|18103860|P6|Induction Phase|Protocol Violation|0
5246633|NCT00783718|18103861|P5|Induction Phase|Protocol Violation|0
5246634|NCT00783718|18103862|P4|Induction Phase|Protocol Violation|0
5246635|NCT00783718|18103863|P3|Induction Phase|Protocol Violation|6
5246636|NCT00783718|18103864|P2|Induction Phase|Protocol Violation|1
5246637|NCT00783718|18103865|P1|Induction Phase|Protocol Violation|1
5246638|NCT00783718|18103859|P7|Induction Phase|Adverse Event|0
5246639|NCT00783718|18103860|P6|Induction Phase|Adverse Event|0
5246640|NCT00783718|18103861|P5|Induction Phase|Adverse Event|0
5246641|NCT00783718|18103862|P4|Induction Phase|Adverse Event|0
5246642|NCT00783718|18103863|P3|Induction Phase|Adverse Event|7
5246643|NCT00783718|18103864|P2|Induction Phase|Adverse Event|0
5246644|NCT00783718|18103865|P1|Induction Phase|Adverse Event|4
5246645|NCT00783705|18103893|P2|Overall Study|Lost to Follow-up|3
5246646|NCT00783705|18103894|P1|Overall Study|Lost to Follow-up|1
5246647|NCT00783705|18103893|P2|Overall Study|Withdrawal by Subject|2
5246648|NCT00783705|18103894|P1|Overall Study|Withdrawal by Subject|3
5246649|NCT00783705|18103893|P2|Overall Study|Adverse Event|0
5246650|NCT00783705|18103894|P1|Overall Study|Adverse Event|2
5246651|NCT00783692|18103941|P7|Maintenance Phase|Other|1
5246652|NCT00783692|18103942|P6|Maintenance Phase|Other|1
5246653|NCT00783692|18103943|P5|Maintenance Phase|Other|0
5246654|NCT00783692|18103944|P4|Maintenance Phase|Other|1
5246655|NCT00783692|18103945|P3|Maintenance Phase|Other|0
5246656|NCT00783692|18103946|P2|Maintenance Phase|Other|0
5246657|NCT00783692|18103947|P1|Maintenance Phase|Other|0
5246658|NCT00783692|18103941|P7|Maintenance Phase|Lost to Follow-up|5
5246659|NCT00783692|18103942|P6|Maintenance Phase|Lost to Follow-up|2
5246660|NCT00783692|18103943|P5|Maintenance Phase|Lost to Follow-up|3
5246661|NCT00783692|18103944|P4|Maintenance Phase|Lost to Follow-up|1
5246662|NCT00783692|18103945|P3|Maintenance Phase|Lost to Follow-up|0
5246663|NCT00783692|18103946|P2|Maintenance Phase|Lost to Follow-up|0
5246664|NCT00783692|18103947|P1|Maintenance Phase|Lost to Follow-up|2
5246665|NCT00783692|18103941|P7|Maintenance Phase|Withdrawal by Subject|24
5246666|NCT00783692|18103942|P6|Maintenance Phase|Withdrawal by Subject|9
5246667|NCT00783692|18103943|P5|Maintenance Phase|Withdrawal by Subject|6
5246668|NCT00783692|18103944|P4|Maintenance Phase|Withdrawal by Subject|7
5246669|NCT00783692|18103945|P3|Maintenance Phase|Withdrawal by Subject|0
5246670|NCT00783692|18103946|P2|Maintenance Phase|Withdrawal by Subject|0
5246671|NCT00783692|18103947|P1|Maintenance Phase|Withdrawal by Subject|7
5246672|NCT00783692|18103941|P7|Maintenance Phase|Lack of Efficacy|177
5246673|NCT00783692|18103942|P6|Maintenance Phase|Lack of Efficacy|48
5246674|NCT00783692|18103943|P5|Maintenance Phase|Lack of Efficacy|58
5246675|NCT00783692|18103944|P4|Maintenance Phase|Lack of Efficacy|64
5246676|NCT00783692|18103945|P3|Maintenance Phase|Lack of Efficacy|0
5246677|NCT00783692|18103946|P2|Maintenance Phase|Lack of Efficacy|0
5246678|NCT00783692|18103947|P1|Maintenance Phase|Lack of Efficacy|79
5246679|NCT00783692|18103941|P7|Maintenance Phase|Protocol Violation|4
5246680|NCT00783692|18103942|P6|Maintenance Phase|Protocol Violation|3
5246681|NCT00783692|18103943|P5|Maintenance Phase|Protocol Violation|2
5246682|NCT00783692|18103944|P4|Maintenance Phase|Protocol Violation|1
5246683|NCT00783692|18103945|P3|Maintenance Phase|Protocol Violation|0
5246684|NCT00783692|18103946|P2|Maintenance Phase|Protocol Violation|0
5246685|NCT00783692|18103947|P1|Maintenance Phase|Protocol Violation|0
5246686|NCT00783692|18103941|P7|Maintenance Phase|Adverse Event|38
5246687|NCT00783692|18103942|P6|Maintenance Phase|Adverse Event|9
5246688|NCT00783692|18103943|P5|Maintenance Phase|Adverse Event|12
5246689|NCT00783692|18103944|P4|Maintenance Phase|Adverse Event|15
5246690|NCT00783692|18103945|P3|Maintenance Phase|Adverse Event|0
5246691|NCT00783692|18103946|P2|Maintenance Phase|Adverse Event|0
5246692|NCT00783692|18103947|P1|Maintenance Phase|Adverse Event|7
5246693|NCT00783692|18103941|P7|Induction Phase|Other|0
5246694|NCT00783692|18103942|P6|Induction Phase|Other|0
5246695|NCT00783692|18103943|P5|Induction Phase|Other|0
5246696|NCT00783692|18103944|P4|Induction Phase|Other|0
5246697|NCT00783692|18103945|P3|Induction Phase|Other|2
5246698|NCT00783692|18103946|P2|Induction Phase|Other|0
5246699|NCT00783692|18103947|P1|Induction Phase|Other|0
5246700|NCT00783692|18103941|P7|Induction Phase|Lost to Follow-up|0
5246701|NCT00783692|18103942|P6|Induction Phase|Lost to Follow-up|0
5246702|NCT00783692|18103943|P5|Induction Phase|Lost to Follow-up|0
5246703|NCT00783692|18103944|P4|Induction Phase|Lost to Follow-up|0
5246704|NCT00783692|18103945|P3|Induction Phase|Lost to Follow-up|3
5246705|NCT00783692|18103946|P2|Induction Phase|Lost to Follow-up|0
5246706|NCT00783692|18103947|P1|Induction Phase|Lost to Follow-up|0
5246707|NCT00783692|18103941|P7|Induction Phase|Withdrawal by Subject|0
5246708|NCT00783692|18103942|P6|Induction Phase|Withdrawal by Subject|0
5246709|NCT00783692|18103943|P5|Induction Phase|Withdrawal by Subject|0
5246710|NCT00783692|18103944|P4|Induction Phase|Withdrawal by Subject|0
5246711|NCT00783692|18103945|P3|Induction Phase|Withdrawal by Subject|16
5246712|NCT00783692|18103946|P2|Induction Phase|Withdrawal by Subject|9
5246713|NCT00783692|18103947|P1|Induction Phase|Withdrawal by Subject|3
5246714|NCT00783692|18103941|P7|Induction Phase|Lack of Efficacy|0
5246715|NCT00783692|18103942|P6|Induction Phase|Lack of Efficacy|0
5246716|NCT00783692|18103943|P5|Induction Phase|Lack of Efficacy|0
5246717|NCT00783692|18103944|P4|Induction Phase|Lack of Efficacy|0
5246718|NCT00783692|18103945|P3|Induction Phase|Lack of Efficacy|28
5246719|NCT00783692|18103946|P2|Induction Phase|Lack of Efficacy|3
5246720|NCT00783692|18103947|P1|Induction Phase|Lack of Efficacy|1
5246721|NCT00783692|18103941|P7|Induction Phase|Protocol Violation|0
5246722|NCT00783692|18103942|P6|Induction Phase|Protocol Violation|0
5246723|NCT00783692|18103943|P5|Induction Phase|Protocol Violation|0
5246724|NCT00783692|18103944|P4|Induction Phase|Protocol Violation|0
5246725|NCT00783692|18103945|P3|Induction Phase|Protocol Violation|1
5246726|NCT00783692|18103946|P2|Induction Phase|Protocol Violation|0
5246727|NCT00783692|18103947|P1|Induction Phase|Protocol Violation|0
5246728|NCT00783692|18103941|P7|Induction Phase|Adverse Event|0
5246729|NCT00783692|18103942|P6|Induction Phase|Adverse Event|0
5246730|NCT00783692|18103943|P5|Induction Phase|Adverse Event|0
5246731|NCT00783692|18103944|P4|Induction Phase|Adverse Event|0
5246732|NCT00783692|18103945|P3|Induction Phase|Adverse Event|24
5246733|NCT00783692|18103946|P2|Induction Phase|Adverse Event|9
5246734|NCT00783692|18103947|P1|Induction Phase|Adverse Event|7
5246735|NCT00783432|18103993|P2|Overall Study|Protocol Violation|9
5246736|NCT00783432|18103994|P1|Overall Study|Protocol Violation|6
5246737|NCT00783432|18103993|P2|Overall Study|subject moved|5
5246738|NCT00783432|18103994|P1|Overall Study|subject moved|3
5246739|NCT00783432|18103993|P2|Overall Study|Withdrawal by Subject|20
5246740|NCT00783432|18103994|P1|Overall Study|Withdrawal by Subject|23
5246741|NCT00783432|18103993|P2|Overall Study|Lost to Follow-up|6
5246742|NCT00783432|18103994|P1|Overall Study|Lost to Follow-up|11
5246743|NCT00783432|18103993|P2|Overall Study|Lack of Efficacy|21
5246744|NCT00783432|18103994|P1|Overall Study|Lack of Efficacy|20
5246745|NCT00783432|18103993|P2|Overall Study|Adverse Event|17
5246746|NCT00783432|18103994|P1|Overall Study|Adverse Event|22
5246747|NCT00783302|18104004|P1|Overall Study|Withdrawal by Subject|3
5246748|NCT00783302|18104004|P1|Overall Study|Physician Decision|1
5246749|NCT00783302|18104004|P1|Overall Study|Protocol Violation|3
5246750|NCT00783302|18104004|P1|Overall Study|Technical Problems|11
5246751|NCT00783302|18104004|P1|Overall Study|Lost to Follow-up|17
5246752|NCT00783289|18104026|P4|Overall Study|Protocol Violation|0
5246753|NCT00783289|18104027|P3|Overall Study|Protocol Violation|0
5246754|NCT00783289|18104028|P2|Overall Study|Protocol Violation|1
5246755|NCT00783289|18104029|P1|Overall Study|Protocol Violation|0
5246756|NCT00783263|18104059|P4|Overall Study|Withdrawal by Subject|2
5246757|NCT00783263|18104060|P3|Overall Study|Withdrawal by Subject|1
5246758|NCT00783263|18104061|P2|Overall Study|Withdrawal by Subject|1
5246759|NCT00783263|18104062|P1|Overall Study|Withdrawal by Subject|0
5246760|NCT00783263|18104059|P4|Overall Study|Lost to Follow-up|0
5246761|NCT00783263|18104060|P3|Overall Study|Lost to Follow-up|0
5246762|NCT00783263|18104061|P2|Overall Study|Lost to Follow-up|1
5246763|NCT00783263|18104062|P1|Overall Study|Lost to Follow-up|1
5246764|NCT00783263|18104059|P4|Overall Study|Adverse Event|1
5246765|NCT00783263|18104060|P3|Overall Study|Adverse Event|2
5246766|NCT00783263|18104061|P2|Overall Study|Adverse Event|0
5246767|NCT00783263|18104062|P1|Overall Study|Adverse Event|3
5246768|NCT00783224|18104092|P4|Overall Study|Inappropriate as a study subject|1
5246769|NCT00783224|18104093|P3|Overall Study|Inappropriate as a study subject|0
5246770|NCT00783224|18104094|P2|Overall Study|Inappropriate as a study subject|0
5246771|NCT00783224|18104095|P1|Overall Study|Inappropriate as a study subject|0
5246772|NCT00783224|18104092|P4|Overall Study|Discarded the Investigational Drug Used|1
5246773|NCT00783224|18104093|P3|Overall Study|Discarded the Investigational Drug Used|0
5246774|NCT00783224|18104094|P2|Overall Study|Discarded the Investigational Drug Used|0
5246775|NCT00783224|18104095|P1|Overall Study|Discarded the Investigational Drug Used|0
5246776|NCT00783224|18104092|P4|Overall Study|Adverse Event|0
5246777|NCT00783224|18104093|P3|Overall Study|Adverse Event|1
5246778|NCT00783224|18104094|P2|Overall Study|Adverse Event|0
5246779|NCT00783224|18104095|P1|Overall Study|Adverse Event|0
5246780|NCT00783198|18104107|P3|Overall Study|Administrative|2
5246781|NCT00783198|18104108|P2|Overall Study|Administrative|1
5246782|NCT00783198|18104109|P1|Overall Study|Administrative|2
5246783|NCT00783198|18104107|P3|Overall Study|Did not meet protocol eligibility|0
5246784|NCT00783198|18104108|P2|Overall Study|Did not meet protocol eligibility|1
5246785|NCT00783198|18104109|P1|Overall Study|Did not meet protocol eligibility|0
5246786|NCT00783198|18104107|P3|Overall Study|Noncompliance with protocol|10
5246787|NCT00783198|18104108|P2|Overall Study|Noncompliance with protocol|7
5246788|NCT00783198|18104109|P1|Overall Study|Noncompliance with protocol|7
5246789|NCT00783198|18104107|P3|Overall Study|Withdrawal by Subject|20
5246790|NCT00783198|18104108|P2|Overall Study|Withdrawal by Subject|14
5246791|NCT00783198|18104109|P1|Overall Study|Withdrawal by Subject|22
5246792|NCT00783198|18104107|P3|Overall Study|Lost to Follow-up|7
5246793|NCT00783198|18104108|P2|Overall Study|Lost to Follow-up|1
5246794|NCT00783198|18104109|P1|Overall Study|Lost to Follow-up|11
5246795|NCT00783198|18104107|P3|Overall Study|Adverse Event|3
5246796|NCT00783198|18104108|P2|Overall Study|Adverse Event|19
5246797|NCT00783198|18104109|P1|Overall Study|Adverse Event|15
5246798|NCT00783094|18104132|P3|Open-Label Extension Period|Lack of Efficacy|0
5246799|NCT00783094|18104133|P2|Open-Label Extension Period|Lack of Efficacy|4
5246800|NCT00783094|18104134|P1|Open-Label Extension Period|Lack of Efficacy|1
5246801|NCT00783094|18104132|P3|Open-Label Extension Period|Physician Decision|3
5246802|NCT00783094|18104133|P2|Open-Label Extension Period|Physician Decision|2
5246803|NCT00783094|18104134|P1|Open-Label Extension Period|Physician Decision|4
5246804|NCT00783094|18104132|P3|Open-Label Extension Period|Withdrawal by Subject|3
5246805|NCT00783094|18104133|P2|Open-Label Extension Period|Withdrawal by Subject|1
5246806|NCT00783094|18104134|P1|Open-Label Extension Period|Withdrawal by Subject|1
5246807|NCT00783094|18104132|P3|Open-Label Extension Period|Protocol Violation|7
5246808|NCT00783094|18104133|P2|Open-Label Extension Period|Protocol Violation|5
5246809|NCT00783094|18104134|P1|Open-Label Extension Period|Protocol Violation|4
5246810|NCT00783094|18104132|P3|Open-Label Extension Period|Death|1
5246811|NCT00783094|18104133|P2|Open-Label Extension Period|Death|0
5246812|NCT00783094|18104134|P1|Open-Label Extension Period|Death|0
5246813|NCT00783094|18104132|P3|Open-Label Extension Period|Adverse Event|16
5246814|NCT00783094|18104133|P2|Open-Label Extension Period|Adverse Event|7
5246815|NCT00783094|18104134|P1|Open-Label Extension Period|Adverse Event|12
5246816|NCT00783094|18104132|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
5246817|NCT00783094|18104133|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
5246818|NCT00783094|18104134|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
5246819|NCT00783094|18104132|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
5246820|NCT00783094|18104133|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
5246821|NCT00783094|18104134|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
5246822|NCT00783094|18104132|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
5246823|NCT00783094|18104133|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
5246824|NCT00783094|18104134|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
5246825|NCT00783094|18104132|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
5246826|NCT00783094|18104133|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
5246827|NCT00783094|18104134|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
5246828|NCT00783094|18104132|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
5246829|NCT00783094|18104133|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
5246830|NCT00783094|18104134|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
5246831|NCT00782834|18104210|P1|Treatment Phase|fibrous tumor not GIST|1
5246832|NCT00782795|18104250|P2|Overall Study|Withdrawal by Subject|2
5246833|NCT00782795|18104251|P1|Overall Study|Withdrawal by Subject|1
5246834|NCT00782717|18104291|P2|Overall Study|Exited in error|2
5246835|NCT00782717|18104292|P1|Overall Study|Exited in error|0
5246836|NCT00782717|18104291|P2|Overall Study|Did not meet entrance criteria|3
5246837|NCT00782717|18104292|P1|Overall Study|Did not meet entrance criteria|1
5246838|NCT00782717|18104291|P2|Overall Study|Enrollment close prior to surgery|0
5246839|NCT00782717|18104292|P1|Overall Study|Enrollment close prior to surgery|1
5246840|NCT00782717|18104291|P2|Overall Study|Treatment failure|14
5246841|NCT00782717|18104292|P1|Overall Study|Treatment failure|3
5246842|NCT00782717|18104291|P2|Overall Study|Noncompliance|1
5246843|NCT00782717|18104292|P1|Overall Study|Noncompliance|2
5246844|NCT00782717|18104291|P2|Overall Study|Patient decision unrelated to AE|3
5246845|NCT00782717|18104292|P1|Overall Study|Patient decision unrelated to AE|6
5246846|NCT00782717|18104291|P2|Overall Study|Adverse Event|5
5246847|NCT00782717|18104292|P1|Overall Study|Adverse Event|2
5246848|NCT00782626|18104319|P1|Overall Study|Other Complicating Disease|1
5246849|NCT00782626|18104319|P1|Overall Study|Progressive Disease|5
5246850|NCT00782626|18104319|P1|Overall Study|Adverse Event|1
5246851|NCT00782509|18104326|P3|Overall Study|Lack of Efficacy|2
5246852|NCT00782509|18104327|P2|Overall Study|Lack of Efficacy|5
5246853|NCT00782509|18104328|P1|Overall Study|Lack of Efficacy|10
5246854|NCT00782509|18104326|P3|Overall Study|Other reasons not stated above|3
5246855|NCT00782509|18104327|P2|Overall Study|Other reasons not stated above|2
5246856|NCT00782509|18104328|P1|Overall Study|Other reasons not stated above|5
5246857|NCT00782509|18104326|P3|Overall Study|Non compliance with protocol|0
5246858|NCT00782509|18104327|P2|Overall Study|Non compliance with protocol|0
5246859|NCT00782509|18104328|P1|Overall Study|Non compliance with protocol|2
5246860|NCT00782509|18104326|P3|Overall Study|Withdrawal by Subject|8
5246861|NCT00782509|18104327|P2|Overall Study|Withdrawal by Subject|5
5246862|NCT00782509|18104328|P1|Overall Study|Withdrawal by Subject|3
5246863|NCT00782509|18104326|P3|Overall Study|Lost to Follow-up|3
5246864|NCT00782509|18104327|P2|Overall Study|Lost to Follow-up|2
5246865|NCT00782509|18104328|P1|Overall Study|Lost to Follow-up|1
5246866|NCT00782509|18104326|P3|Overall Study|Adverse Event|20
5246867|NCT00782509|18104327|P2|Overall Study|Adverse Event|10
5246868|NCT00782509|18104328|P1|Overall Study|Adverse Event|20
5246869|NCT00782496|18104521|P2|Overall Study|Lost to Follow-up|15
5246870|NCT00782496|18104522|P1|Overall Study|Lost to Follow-up|14
5246871|NCT00782483|18104529|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
5246872|NCT00782418|18104533|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5246873|NCT00782418|18104534|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
5246874|NCT00782418|18104535|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
5246875|NCT00782418|18104536|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5246876|NCT00782418|18104537|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5246877|NCT00782418|18104538|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5246878|NCT00782418|18104539|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
5246879|NCT00782418|18104533|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
5246880|NCT00782418|18104534|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
5246881|NCT00782418|18104535|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
5246882|NCT00782418|18104536|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
5246883|NCT00782418|18104537|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
5246884|NCT00782418|18104538|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
5246885|NCT00782418|18104539|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
5246886|NCT00782340|18104576|P3|Open Label Titration|Randomized in error|0
5246887|NCT00782340|18104577|P2|Open Label Titration|Randomized in error|0
5246888|NCT00782340|18104578|P1|Open Label Titration|Randomized in error|6
5246889|NCT00782340|18104576|P3|Open Label Titration|Lost to Follow-up|0
5246890|NCT00782340|18104577|P2|Open Label Titration|Lost to Follow-up|0
5246891|NCT00782340|18104578|P1|Open Label Titration|Lost to Follow-up|5
5246892|NCT00782340|18104576|P3|Open Label Titration|Did not meet responder criteria|0
5246893|NCT00782340|18104577|P2|Open Label Titration|Did not meet responder criteria|0
5246894|NCT00782340|18104578|P1|Open Label Titration|Did not meet responder criteria|2
5246895|NCT00782340|18104576|P3|Open Label Titration|Enrollment capped|0
5246896|NCT00782340|18104577|P2|Open Label Titration|Enrollment capped|0
5246897|NCT00782340|18104578|P1|Open Label Titration|Enrollment capped|16
5246898|NCT00782340|18104576|P3|Open Label Titration|Withdrawal by Subject|0
5246899|NCT00782340|18104577|P2|Open Label Titration|Withdrawal by Subject|0
5246900|NCT00782340|18104578|P1|Open Label Titration|Withdrawal by Subject|5
5246901|NCT00782340|18104576|P3|Open Label Titration|Protocol Violation|0
5246902|NCT00782340|18104577|P2|Open Label Titration|Protocol Violation|0
5246903|NCT00782340|18104578|P1|Open Label Titration|Protocol Violation|5
5246904|NCT00782340|18104576|P3|Open Label Titration|Treatment failure|0
5246905|NCT00782340|18104577|P2|Open Label Titration|Treatment failure|0
5246906|NCT00782340|18104578|P1|Open Label Titration|Treatment failure|50
5246907|NCT00782340|18104576|P3|Open Label Titration|Adverse Event|0
5246908|NCT00782340|18104577|P2|Open Label Titration|Adverse Event|0
5246909|NCT00782340|18104578|P1|Open Label Titration|Adverse Event|12
5246910|NCT00782275|18104648|P1|Overall Study|Other|3
5246911|NCT00782275|18104648|P1|Overall Study|Not started treatment|1
5246912|NCT00782275|18104648|P1|Overall Study|Physician Decision|4
5246913|NCT00782275|18104648|P1|Overall Study|Progressive Disease|21
5246914|NCT00782275|18104648|P1|Overall Study|Withdrawal by Subject|1
5246915|NCT00782275|18104648|P1|Overall Study|Adverse Event|11
5246916|NCT00782210|18104657|P3|Overall Study|Other reason not described above|3
5246917|NCT00782210|18104658|P2|Overall Study|Other reason not described above|2
5246918|NCT00782210|18104659|P1|Overall Study|Other reason not described above|3
5246919|NCT00782210|18104657|P3|Overall Study|Lack of Efficacy|1
5246920|NCT00782210|18104658|P2|Overall Study|Lack of Efficacy|4
5246921|NCT00782210|18104659|P1|Overall Study|Lack of Efficacy|13
5246922|NCT00782210|18104657|P3|Overall Study|Non compliance with protocol|2
5246923|NCT00782210|18104658|P2|Overall Study|Non compliance with protocol|3
5246924|NCT00782210|18104659|P1|Overall Study|Non compliance with protocol|0
5246925|NCT00782210|18104657|P3|Overall Study|Withdrawal by Subject|11
5246926|NCT00782210|18104658|P2|Overall Study|Withdrawal by Subject|8
5246927|NCT00782210|18104659|P1|Overall Study|Withdrawal by Subject|11
5246928|NCT00782210|18104657|P3|Overall Study|Lost to Follow-up|2
5246929|NCT00782210|18104658|P2|Overall Study|Lost to Follow-up|1
5246930|NCT00782210|18104659|P1|Overall Study|Lost to Follow-up|2
5246931|NCT00782210|18104657|P3|Overall Study|Adverse Event|16
5246932|NCT00782210|18104658|P2|Overall Study|Adverse Event|17
5246933|NCT00782210|18104659|P1|Overall Study|Adverse Event|21
5246934|NCT00782184|18104852|P2|Overall Study|Withdrawal by Subject|2
5246935|NCT00782184|18104853|P1|Overall Study|Withdrawal by Subject|3
5246936|NCT00782184|18104852|P2|Overall Study|Protocol Violation|1
5246937|NCT00782184|18104853|P1|Overall Study|Protocol Violation|0
5246938|NCT00782184|18104852|P2|Overall Study|Adverse Event|2
5246939|NCT00782184|18104853|P1|Overall Study|Adverse Event|1
5246940|NCT00782171|18104890|P2|Overall Study|not eligible|6
5246941|NCT00782171|18104891|P1|Overall Study|not eligible|8
5246942|NCT00782171|18104890|P2|Overall Study|others|9
5246943|NCT00782171|18104891|P1|Overall Study|others|7
5246944|NCT00782171|18104890|P2|Overall Study|complications|1
5246945|NCT00782171|18104891|P1|Overall Study|complications|3
5246946|NCT00782171|18104890|P2|Overall Study|Withdrawal by Subject|1
5246947|NCT00782171|18104891|P1|Overall Study|Withdrawal by Subject|2
5246948|NCT00782171|18104890|P2|Overall Study|Lost to Follow-up|2
5246949|NCT00782171|18104891|P1|Overall Study|Lost to Follow-up|2
5246950|NCT00782067|18104923|P1|Overall Study|Protocol deviation|2
5246951|NCT00782067|18104923|P1|Overall Study|Disease progression|43
5246952|NCT00782067|18104923|P1|Overall Study|Death|9
5246953|NCT00782067|18104923|P1|Overall Study|Administrative problems|14
5246954|NCT00782067|18104923|P1|Overall Study|Lost to Follow-up|2
5246955|NCT00782067|18104923|P1|Overall Study|Subject withdrew consent|11
5246956|NCT00782067|18104923|P1|Overall Study|Adverse Event|35
5246957|NCT00781963|18104935|P2|Overall Study|Refused follow-up|0
5246958|NCT00781963|18104936|P1|Overall Study|Refused follow-up|9
5246959|NCT00781963|18104935|P2|Overall Study|Withdrawal by Subject|1
5246960|NCT00781963|18104936|P1|Overall Study|Withdrawal by Subject|3
5246961|NCT00781963|18104935|P2|Overall Study|Lost to Follow-up|1
5246962|NCT00781963|18104936|P1|Overall Study|Lost to Follow-up|2
5246963|NCT00781963|18104935|P2|Overall Study|Death|0
5246964|NCT00781963|18104936|P1|Overall Study|Death|3
5246965|NCT00781937|18104965|P2|Follow up Period (Week 56-68)|Unclassified|4
5246966|NCT00781937|18104966|P1|Follow up Period (Week 56-68)|Unclassified|5
5246967|NCT00781937|18104965|P2|Follow up Period (Week 56-68)|Protocol Violation|1
5246968|NCT00781937|18104966|P1|Follow up Period (Week 56-68)|Protocol Violation|1
5246969|NCT00781937|18104965|P2|Main Trial Period Through Week 56|Unclassified|15
5246970|NCT00781937|18104966|P1|Main Trial Period Through Week 56|Unclassified|10
5246971|NCT00781937|18104965|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
5246972|NCT00781937|18104966|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
5246973|NCT00781937|18104965|P2|Main Trial Period Through Week 56|Protocol Violation|5
5246974|NCT00781937|18104966|P1|Main Trial Period Through Week 56|Protocol Violation|8
5246975|NCT00781937|18104965|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
5246976|NCT00781937|18104966|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
5246977|NCT00781937|18104965|P2|Main Trial Period Through Week 56|Adverse Event|18
5246978|NCT00781937|18104966|P1|Main Trial Period Through Week 56|Adverse Event|18
5246979|NCT00781911|18105024|P2|Overall Study|Sponsor Decision|0
5246980|NCT00781911|18105025|P1|Overall Study|Sponsor Decision|1
5246981|NCT00781911|18105024|P2|Overall Study|Physician Decision|2
5246982|NCT00781911|18105025|P1|Overall Study|Physician Decision|0
5246983|NCT00781911|18105024|P2|Overall Study|Withdrawal by Subject|2
5246984|NCT00781911|18105025|P1|Overall Study|Withdrawal by Subject|1
5246985|NCT00781911|18105024|P2|Overall Study|Adverse Event|4
5246986|NCT00781911|18105025|P1|Overall Study|Adverse Event|4
5246987|NCT00781885|18105060|P1|Overall Study|Physician Decision|1
5246988|NCT00781859|18105077|P2|Overall Study|Death|0
5246989|NCT00781859|18105078|P1|Overall Study|Death|3
5246990|NCT00781859|18105077|P2|Overall Study|Lost to Follow-up|3
5246991|NCT00781859|18105078|P1|Overall Study|Lost to Follow-up|6
5246992|NCT00781859|18105077|P2|Overall Study|Withdrawal by Subject|4
5246993|NCT00781859|18105078|P1|Overall Study|Withdrawal by Subject|8
5246994|NCT00781859|18105077|P2|Overall Study|Adverse Event|2
5246995|NCT00781859|18105078|P1|Overall Study|Adverse Event|2
5246996|NCT00781768|18105088|P2|Overall Study|Not transplanted.|2
5246997|NCT00781768|18105089|P1|Overall Study|Not transplanted.|0
5246998|NCT00781599|18105097|P2|Overall Study|Lost to Follow-up|4
5246999|NCT00781599|18105098|P1|Overall Study|Lost to Follow-up|7
5247000|NCT00781456|18105123|P2|Overall Study|Other Reason, Unknown|1
5247001|NCT00781456|18105124|P1|Overall Study|Other Reason, Unknown|0
5247002|NCT00781456|18105123|P2|Overall Study|Lost to Follow-up|5
5247003|NCT00781456|18105124|P1|Overall Study|Lost to Follow-up|10
5247004|NCT00781456|18105123|P2|Overall Study|Noncompliance With Protocol|1
5247005|NCT00781456|18105124|P1|Overall Study|Noncompliance With Protocol|1
5247006|NCT00781456|18105123|P2|Overall Study|Protocol Violation|1
5247007|NCT00781456|18105124|P1|Overall Study|Protocol Violation|4
5247008|NCT00781456|18105123|P2|Overall Study|Withdrawal by Subject|5
5247009|NCT00781456|18105124|P1|Overall Study|Withdrawal by Subject|3
5247010|NCT00781456|18105123|P2|Overall Study|Adverse Event|3
5247011|NCT00781456|18105124|P1|Overall Study|Adverse Event|3
5247012|NCT00781391|18105147|P3|Overall Study|Lost to Follow-up|1
5247013|NCT00781391|18105148|P2|Overall Study|Lost to Follow-up|0
5247014|NCT00781391|18105149|P1|Overall Study|Lost to Follow-up|0
5247015|NCT00781391|18105147|P3|Overall Study|Withdrawal by Subject|25
5247016|NCT00781391|18105148|P2|Overall Study|Withdrawal by Subject|37
5247017|NCT00781391|18105149|P1|Overall Study|Withdrawal by Subject|47
5247018|NCT00781391|18105147|P3|Overall Study|Death|706
5247019|NCT00781391|18105148|P2|Overall Study|Death|730
5247020|NCT00781391|18105149|P1|Overall Study|Death|789
5247021|NCT00781391|18105147|P3|Overall Study|Protocol Violation|20
5247022|NCT00781391|18105148|P2|Overall Study|Protocol Violation|17
5247023|NCT00781391|18105149|P1|Overall Study|Protocol Violation|19
5247024|NCT00781391|18105147|P3|Overall Study|never received study drug|32
5247025|NCT00781391|18105148|P2|Overall Study|never received study drug|23
5247026|NCT00781391|18105149|P1|Overall Study|never received study drug|24
5247027|NCT00781365|18105183|P2|Overall Study|Language barrier|0
5247028|NCT00781365|18105184|P1|Overall Study|Language barrier|1
5247029|NCT00781365|18105183|P2|Overall Study|Did Not Attend Visit|28
5247030|NCT00781365|18105184|P1|Overall Study|Did Not Attend Visit|20
5247031|NCT00781365|18105183|P2|Overall Study|Withdrawal by Subject|8
5247032|NCT00781365|18105184|P1|Overall Study|Withdrawal by Subject|13
5247033|NCT00781326|18105194|P1|Phase I|Physician Decision|2
5247034|NCT00781326|18105194|P1|Phase I|Withdrawal by Subject|1
5247035|NCT00781326|18105194|P1|Phase I|Adverse Event|1
5247036|NCT00781274|18105198|P1|Overall Study|Withdrawal by Subject|2
5247037|NCT00780975|18105221|P1|Overall Study|Toxicity|5
5247038|NCT00780975|18105221|P1|Overall Study|Progressive disease|3
5247039|NCT00780910|18105239|P1|Overall Study|Adverse Event|2
5247040|NCT00780559|18105301|P2|Overall Study|Death|0
5247041|NCT00780559|18105302|P1|Overall Study|Death|1
5247042|NCT00780559|18105301|P2|Overall Study|Lost to Follow-up|7
5247043|NCT00780559|18105302|P1|Overall Study|Lost to Follow-up|2
5247044|NCT00780416|18105370|P2|Overall Study|Withdrawal by Subject|6
5247045|NCT00780416|18105371|P1|Overall Study|Withdrawal by Subject|8
5247046|NCT00780416|18105370|P2|Overall Study|Protocol Violation|0
5247047|NCT00780416|18105371|P1|Overall Study|Protocol Violation|1
5247048|NCT00780416|18105370|P2|Overall Study|Physician Decision|3
5247049|NCT00780416|18105371|P1|Overall Study|Physician Decision|3
5247050|NCT00780273|18105416|P1|Overall Study|Lost to Follow-up|1
5247051|NCT00780273|18105416|P1|Overall Study|Death|1
5247052|NCT00780143|18105439|P1|Overall Study|Adverse Event|1
5247053|NCT00780143|18105439|P1|Overall Study|Toxicity|1
5247054|NCT00780143|18105439|P1|Overall Study|Progressive disease|1
5247055|NCT00779909|18105470|P4|Overall Study|Withdrawal by Subject|0
5247056|NCT00779909|18105471|P3|Overall Study|Withdrawal by Subject|0
5247057|NCT00779909|18105472|P2|Overall Study|Withdrawal by Subject|1
5247058|NCT00779909|18105473|P1|Overall Study|Withdrawal by Subject|0
5247059|NCT00779909|18105470|P4|Overall Study|Lost to Follow-up|1
5247060|NCT00779909|18105471|P3|Overall Study|Lost to Follow-up|0
5247061|NCT00779909|18105472|P2|Overall Study|Lost to Follow-up|0
5247062|NCT00779909|18105473|P1|Overall Study|Lost to Follow-up|1
5247063|NCT00779857|18105537|P1|Overall Study|Missed Visit|2
5247064|NCT00779857|18105537|P1|Overall Study|Withdrawal by Subject|3
5247065|NCT00779857|18105537|P1|Overall Study|Death|1
5247066|NCT00779779|18105542|P1|Overall Study|Lost to Follow-up|5
5247067|NCT00779779|18105542|P1|Overall Study|Withdrawal by Subject|4
5247068|NCT00779779|18105542|P1|Overall Study|Protocol Violation|14
5247069|NCT00779779|18105542|P1|Overall Study|Adverse Event|1
5247070|NCT00779766|18105551|P2|Month 72|Other|1
5247071|NCT00779766|18105552|P1|Month 72|Other|0
5247072|NCT00779766|18105551|P2|Month 72|Lost to Follow-up|8
5247073|NCT00779766|18105552|P1|Month 72|Lost to Follow-up|6
5247074|NCT00779766|18105551|P2|Month 72|Migrated/moved from study area|109
5247075|NCT00779766|18105552|P1|Month 72|Migrated/moved from study area|124
5247076|NCT00779766|18105551|P2|Month 72|Withdrawal by Subject|71
5247077|NCT00779766|18105552|P1|Month 72|Withdrawal by Subject|55
5247078|NCT00779766|18105551|P2|Month 48|Other|0
5247079|NCT00779766|18105552|P1|Month 48|Other|1
5247080|NCT00779766|18105551|P2|Month 48|Lost to Follow-up|30
5247081|NCT00779766|18105552|P1|Month 48|Lost to Follow-up|29
5247082|NCT00779766|18105551|P2|Month 48|Migrated/moved from study area|75
5247083|NCT00779766|18105552|P1|Month 48|Migrated/moved from study area|76
5247084|NCT00779766|18105551|P2|Month 48|Withdrawal by Subject|63
5247085|NCT00779766|18105552|P1|Month 48|Withdrawal by Subject|68
5247086|NCT00779766|18105551|P2|Month 24|Other|27
5247087|NCT00779766|18105552|P1|Month 24|Other|18
5247088|NCT00779766|18105551|P2|Month 24|Lost to Follow-up|9
5247089|NCT00779766|18105552|P1|Month 24|Lost to Follow-up|9
5247090|NCT00779766|18105551|P2|Month 24|Migrated/moved from study area|162
5247091|NCT00779766|18105552|P1|Month 24|Migrated/moved from study area|138
5247092|NCT00779766|18105551|P2|Month 24|Withdrawal by Subject|127
5247093|NCT00779766|18105552|P1|Month 24|Withdrawal by Subject|159
5247094|NCT00779766|18105551|P2|Month 24|Protocol Violation|1
5247095|NCT00779766|18105552|P1|Month 24|Protocol Violation|3
5247096|NCT00779766|18105551|P2|Month 24|Adverse Event|3
5247097|NCT00779766|18105552|P1|Month 24|Adverse Event|3
5247098|NCT00779766|18105551|P2|Month 24|Serious Adverse Event|3
5247099|NCT00779766|18105552|P1|Month 24|Serious Adverse Event|2
5247100|NCT00779675|18105640|P1|Extended Treatment Period|Lost to Follow-up|6
5247101|NCT00779675|18105640|P1|Extended Treatment Period|Protocol defined clinical event|1
5247102|NCT00779675|18105640|P1|Extended Treatment Period|Treatment Failure|11
5247103|NCT00779675|18105640|P1|Extended Treatment Period|Adverse Event|6
5247104|NCT00779675|18105640|P1|Extended Treatment Period|Protocol Violation|13
5247105|NCT00779675|18105640|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
5247106|NCT00779675|18105640|P1|Treatment Period|Administrative|3
5247107|NCT00779675|18105640|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
5247108|NCT00779675|18105640|P1|Treatment Period|Protocol Violation|54
5247109|NCT00779675|18105640|P1|Treatment Period|Withdrawal by Subject|46
5247110|NCT00779675|18105640|P1|Treatment Period|Lost to Follow-up|23
5247111|NCT00779675|18105640|P1|Treatment Period|Transferred to Another Study|38
5247112|NCT00779675|18105640|P1|Treatment Period|Treatment Failure|80
5247113|NCT00779675|18105640|P1|Treatment Period|Adverse Event|87
5247114|NCT00779584|18105668|P9|Overall Study|Ongoing in Study|0
5247115|NCT00779584|18105669|P8|Overall Study|Ongoing in Study|0
5247116|NCT00779584|18105670|P7|Overall Study|Ongoing in Study|0
5247117|NCT00779584|18105671|P6|Overall Study|Ongoing in Study|1
5247118|NCT00779584|18105672|P5|Overall Study|Ongoing in Study|1
5247119|NCT00779584|18105673|P4|Overall Study|Ongoing in Study|0
5247120|NCT00779584|18105674|P3|Overall Study|Ongoing in Study|0
5247121|NCT00779584|18105675|P2|Overall Study|Ongoing in Study|0
5247122|NCT00779584|18105676|P1|Overall Study|Ongoing in Study|0
5247123|NCT00779584|18105668|P9|Overall Study|Symptomatic Deterioration|0
5247124|NCT00779584|18105669|P8|Overall Study|Symptomatic Deterioration|0
5247125|NCT00779584|18105670|P7|Overall Study|Symptomatic Deterioration|1
5247126|NCT00779584|18105671|P6|Overall Study|Symptomatic Deterioration|1
5247127|NCT00779584|18105672|P5|Overall Study|Symptomatic Deterioration|0
5247128|NCT00779584|18105673|P4|Overall Study|Symptomatic Deterioration|0
5247129|NCT00779584|18105674|P3|Overall Study|Symptomatic Deterioration|1
5247130|NCT00779584|18105675|P2|Overall Study|Symptomatic Deterioration|1
5247131|NCT00779584|18105676|P1|Overall Study|Symptomatic Deterioration|1
5247132|NCT00779584|18105668|P9|Overall Study|Adverse Event|1
5247133|NCT00779584|18105669|P8|Overall Study|Adverse Event|1
5247134|NCT00779584|18105670|P7|Overall Study|Adverse Event|2
5247135|NCT00779584|18105671|P6|Overall Study|Adverse Event|0
5247136|NCT00779584|18105672|P5|Overall Study|Adverse Event|0
5247137|NCT00779584|18105673|P4|Overall Study|Adverse Event|0
5247138|NCT00779584|18105674|P3|Overall Study|Adverse Event|2
5247139|NCT00779584|18105675|P2|Overall Study|Adverse Event|0
5247140|NCT00779584|18105676|P1|Overall Study|Adverse Event|1
5247141|NCT00779584|18105668|P9|Overall Study|Progression of Disease|1
5247142|NCT00779584|18105669|P8|Overall Study|Progression of Disease|2
5247143|NCT00779584|18105670|P7|Overall Study|Progression of Disease|4
5247144|NCT00779584|18105671|P6|Overall Study|Progression of Disease|1
5247145|NCT00779584|18105672|P5|Overall Study|Progression of Disease|5
5247146|NCT00779584|18105673|P4|Overall Study|Progression of Disease|6
5247147|NCT00779584|18105674|P3|Overall Study|Progression of Disease|2
5247148|NCT00779584|18105675|P2|Overall Study|Progression of Disease|1
5247149|NCT00779584|18105676|P1|Overall Study|Progression of Disease|0
5247150|NCT00779584|18105668|P9|Overall Study|Lost to Follow-up|0
5247151|NCT00779584|18105669|P8|Overall Study|Lost to Follow-up|0
5247152|NCT00779584|18105670|P7|Overall Study|Lost to Follow-up|0
5247153|NCT00779584|18105671|P6|Overall Study|Lost to Follow-up|0
5247154|NCT00779584|18105672|P5|Overall Study|Lost to Follow-up|1
5247155|NCT00779584|18105673|P4|Overall Study|Lost to Follow-up|0
5247156|NCT00779584|18105674|P3|Overall Study|Lost to Follow-up|0
5247157|NCT00779584|18105675|P2|Overall Study|Lost to Follow-up|0
5247158|NCT00779584|18105676|P1|Overall Study|Lost to Follow-up|0
5247159|NCT00779584|18105668|P9|Overall Study|Withdrawal by Subject|0
5247160|NCT00779584|18105669|P8|Overall Study|Withdrawal by Subject|0
5247161|NCT00779584|18105670|P7|Overall Study|Withdrawal by Subject|1
5247162|NCT00779584|18105671|P6|Overall Study|Withdrawal by Subject|2
5247163|NCT00779584|18105672|P5|Overall Study|Withdrawal by Subject|0
5247164|NCT00779584|18105673|P4|Overall Study|Withdrawal by Subject|0
5247165|NCT00779584|18105674|P3|Overall Study|Withdrawal by Subject|2
5247166|NCT00779584|18105675|P2|Overall Study|Withdrawal by Subject|1
5247167|NCT00779584|18105676|P1|Overall Study|Withdrawal by Subject|1
5247168|NCT00779584|18105668|P9|Overall Study|Protocol Violation|0
5247169|NCT00779584|18105669|P8|Overall Study|Protocol Violation|0
5247170|NCT00779584|18105670|P7|Overall Study|Protocol Violation|0
5247171|NCT00779584|18105671|P6|Overall Study|Protocol Violation|1
5247172|NCT00779584|18105672|P5|Overall Study|Protocol Violation|0
5247173|NCT00779584|18105673|P4|Overall Study|Protocol Violation|0
5247174|NCT00779584|18105674|P3|Overall Study|Protocol Violation|0
5247175|NCT00779584|18105675|P2|Overall Study|Protocol Violation|0
5247176|NCT00779584|18105676|P1|Overall Study|Protocol Violation|0
5247177|NCT00779506|18105767|P1|Overall Study|Lost to Follow-up|1
5247178|NCT00779506|18105767|P1|Overall Study|Withdrawal by Subject|6
5247179|NCT00779506|18105767|P1|Overall Study|Protocol Violation|5
5247180|NCT00779506|18105767|P1|Overall Study|Lack of Efficacy|11
5247181|NCT00779506|18105767|P1|Overall Study|Adverse Event|4
5247182|NCT00779506|18105767|P1|Overall Study|Screening Failed|2
5247183|NCT00779467|18105781|P4|Overall Study|unavailable research staff|1
5247184|NCT00779467|18105782|P3|Overall Study|unavailable research staff|0
5247185|NCT00779467|18105783|P2|Overall Study|unavailable research staff|0
5247186|NCT00779467|18105784|P1|Overall Study|unavailable research staff|0
5247187|NCT00779467|18105781|P4|Overall Study|technical issue|1
5247188|NCT00779467|18105782|P3|Overall Study|technical issue|2
5247189|NCT00779467|18105783|P2|Overall Study|technical issue|0
5247190|NCT00779467|18105784|P1|Overall Study|technical issue|0
5247191|NCT00779467|18105781|P4|Overall Study|missing data|4
5247192|NCT00779467|18105782|P3|Overall Study|missing data|1
5247193|NCT00779467|18105783|P2|Overall Study|missing data|0
5247194|NCT00779467|18105784|P1|Overall Study|missing data|1
5247195|NCT00779467|18105781|P4|Overall Study|failed inclusion criteria|2
5247196|NCT00779467|18105782|P3|Overall Study|failed inclusion criteria|1
5247197|NCT00779467|18105783|P2|Overall Study|failed inclusion criteria|3
5247198|NCT00779467|18105784|P1|Overall Study|failed inclusion criteria|3
5247199|NCT00779467|18105781|P4|Overall Study|Lack of Efficacy|11
5247200|NCT00779467|18105782|P3|Overall Study|Lack of Efficacy|6
5247201|NCT00779467|18105783|P2|Overall Study|Lack of Efficacy|2
5247202|NCT00779467|18105784|P1|Overall Study|Lack of Efficacy|11
5247203|NCT00779402|18105824|P2|Long-term Follow-up|Completed Protocol Visits|2
5247204|NCT00779402|18105825|P1|Long-term Follow-up|Completed Protocol Visits|6
5247205|NCT00779402|18105824|P2|Long-term Follow-up|Closure of Study|4
5247206|NCT00779402|18105825|P1|Long-term Follow-up|Closure of Study|8
5247207|NCT00779402|18105824|P2|Long-term Follow-up|Other|0
5247208|NCT00779402|18105825|P1|Long-term Follow-up|Other|5
5247209|NCT00779402|18105824|P2|Long-term Follow-up|Patient refused to continue|0
5247210|NCT00779402|18105825|P1|Long-term Follow-up|Patient refused to continue|2
5247211|NCT00779402|18105824|P2|Surveillance Phase|Completed Protocol Visits|2
5247212|NCT00779402|18105825|P1|Surveillance Phase|Completed Protocol Visits|3
5247213|NCT00779402|18105824|P2|Surveillance Phase|Closure of study|6
5247214|NCT00779402|18105825|P1|Surveillance Phase|Closure of study|5
5247215|NCT00779402|18105824|P2|Surveillance Phase|Withdrawal by Subject|1
5247216|NCT00779402|18105825|P1|Surveillance Phase|Withdrawal by Subject|4
5247217|NCT00779402|18105824|P2|Surveillance Phase|Other|5
5247218|NCT00779402|18105825|P1|Surveillance Phase|Other|5
5247219|NCT00779402|18105824|P2|Surveillance Phase|Intercurrent Illness|0
5247220|NCT00779402|18105825|P1|Surveillance Phase|Intercurrent Illness|2
5247221|NCT00779402|18105824|P2|Surveillance Phase|Death|1
5247222|NCT00779402|18105825|P1|Surveillance Phase|Death|0
5247223|NCT00779402|18105824|P2|Surveillance Phase|Lost to Follow-up|1
5247224|NCT00779402|18105825|P1|Surveillance Phase|Lost to Follow-up|2
5247225|NCT00779402|18105824|P2|Surveillance Phase|Patient refused to continue|14
5247226|NCT00779402|18105825|P1|Surveillance Phase|Patient refused to continue|22
5247227|NCT00779402|18105824|P2|Surveillance Phase|Protocol Violation|1
5247228|NCT00779402|18105825|P1|Surveillance Phase|Protocol Violation|0
5247229|NCT00779402|18105824|P2|Treatment Phase 1|Completed Protocol Visits|6
5247230|NCT00779402|18105825|P1|Treatment Phase 1|Completed Protocol Visits|3
5247231|NCT00779402|18105824|P2|Treatment Phase 1|Closure of Study|2
5247232|NCT00779402|18105825|P1|Treatment Phase 1|Closure of Study|3
5247233|NCT00779402|18105824|P2|Treatment Phase 1|Other|2
5247234|NCT00779402|18105825|P1|Treatment Phase 1|Other|4
5247235|NCT00779402|18105824|P2|Treatment Phase 1|Withdrawal by Subject|0
5247236|NCT00779402|18105825|P1|Treatment Phase 1|Withdrawal by Subject|1
5247237|NCT00779402|18105824|P2|Treatment Phase 1|Intercurrent Illness|1
5247238|NCT00779402|18105825|P1|Treatment Phase 1|Intercurrent Illness|1
5247239|NCT00779402|18105824|P2|Treatment Phase 1|Death|1
5247240|NCT00779402|18105825|P1|Treatment Phase 1|Death|0
5247241|NCT00779402|18105824|P2|Treatment Phase 1|Lost to Follow-up|1
5247242|NCT00779402|18105825|P1|Treatment Phase 1|Lost to Follow-up|0
5247243|NCT00779402|18105824|P2|Treatment Phase 1|Patient Refused to Continue|2
5247244|NCT00779402|18105825|P1|Treatment Phase 1|Patient Refused to Continue|17
5247245|NCT00779402|18105824|P2|Treatment Phase 1|Protocol Violation|0
5247246|NCT00779402|18105825|P1|Treatment Phase 1|Protocol Violation|1
5247247|NCT00779402|18105824|P2|Treatment Phase 1|Adverse Event|0
5247248|NCT00779402|18105825|P1|Treatment Phase 1|Adverse Event|2
5247249|NCT00779402|18105824|P2|Treatment Phase 1|Disease Progression|0
5247250|NCT00779402|18105825|P1|Treatment Phase 1|Disease Progression|1
5247251|NCT00779259|18105868|P1|Quinine Alone|Adverse Event|2
5247252|NCT00779246|18105889|P2|Overall Study|Missing sufficient data for analysis|53
5247253|NCT00779246|18105890|P1|Overall Study|Missing sufficient data for analysis|33
5247254|NCT00779142|18105909|P1|Overall Study|Screen Failures|3
5247255|NCT00779038|18105923|P1|Overall Study|Study Prematurely Terminated|13
5247256|NCT00779025|18105932|P1|Overall Study|Withdrawal by Subject|1
5247257|NCT00778999|18105943|P2|Overall Study|Did not receive recFSH|20
5247258|NCT00778999|18105944|P1|Overall Study|Did not receive recFSH|14
5247259|NCT00778999|18105943|P2|Overall Study|Discontinuation: no embryo transfer|14
5247260|NCT00778999|18105944|P1|Overall Study|Discontinuation: no embryo transfer|14
5247261|NCT00778921|18105953|P3|Overall Study|Not treated|2
5247262|NCT00778921|18105954|P2|Overall Study|Not treated|2
5247263|NCT00778921|18105955|P1|Overall Study|Not treated|0
5247264|NCT00778921|18105953|P3|Overall Study|Protocol Violation|2
5247265|NCT00778921|18105954|P2|Overall Study|Protocol Violation|0
5247266|NCT00778921|18105955|P1|Overall Study|Protocol Violation|3
5247267|NCT00778921|18105953|P3|Overall Study|Administrative Problems|0
5247268|NCT00778921|18105954|P2|Overall Study|Administrative Problems|2
5247269|NCT00778921|18105955|P1|Overall Study|Administrative Problems|1
5247270|NCT00778921|18105953|P3|Overall Study|Lost to Follow-up|1
5247271|NCT00778921|18105954|P2|Overall Study|Lost to Follow-up|2
5247272|NCT00778921|18105955|P1|Overall Study|Lost to Follow-up|0
5247273|NCT00778921|18105953|P3|Overall Study|Patient withdrew request|6
5247274|NCT00778921|18105954|P2|Overall Study|Patient withdrew request|1
5247275|NCT00778921|18105955|P1|Overall Study|Patient withdrew request|3
5247276|NCT00778921|18105953|P3|Overall Study|Patient No Longer Requires Study Drug|0
5247277|NCT00778921|18105954|P2|Overall Study|Patient No Longer Requires Study Drug|1
5247278|NCT00778921|18105955|P1|Overall Study|Patient No Longer Requires Study Drug|0
5247279|NCT00778921|18105953|P3|Overall Study|Unsatisfactory therapeutic response|1
5247280|NCT00778921|18105954|P2|Overall Study|Unsatisfactory therapeutic response|1
5247281|NCT00778921|18105955|P1|Overall Study|Unsatisfactory therapeutic response|1
5247282|NCT00778921|18105953|P3|Overall Study|Abnormal Test Procedure Result(s)|2
5247283|NCT00778921|18105954|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5247284|NCT00778921|18105955|P1|Overall Study|Abnormal Test Procedure Result(s)|0
5247285|NCT00778921|18105953|P3|Overall Study|Abnormal Laboratory Value(s)|0
5247286|NCT00778921|18105954|P2|Overall Study|Abnormal Laboratory Value(s)|0
5247287|NCT00778921|18105955|P1|Overall Study|Abnormal Laboratory Value(s)|1
5247288|NCT00778921|18105953|P3|Overall Study|Adverse Event|14
5247289|NCT00778921|18105954|P2|Overall Study|Adverse Event|10
5247290|NCT00778921|18105955|P1|Overall Study|Adverse Event|9
5247291|NCT00778895|18105972|P3|ESFU Phase|Other|0
5247292|NCT00778895|18105973|P2|ESFU Phase|Other|0
5247293|NCT00778895|18105974|P1|ESFU Phase|Other|2
5247294|NCT00778895|18105972|P3|ESFU Phase|Lost to Follow-up|2
5247295|NCT00778895|18105973|P2|ESFU Phase|Lost to Follow-up|7
5247296|NCT00778895|18105974|P1|ESFU Phase|Lost to Follow-up|6
5247297|NCT00778895|18105972|P3|ESFU Phase|Withdrawal by Subject|0
5247298|NCT00778895|18105973|P2|ESFU Phase|Withdrawal by Subject|4
5247299|NCT00778895|18105974|P1|ESFU Phase|Withdrawal by Subject|1
5247300|NCT00778895|18105972|P3|ESFU Phase|Adverse Event|0
5247301|NCT00778895|18105973|P2|ESFU Phase|Adverse Event|1
5247302|NCT00778895|18105974|P1|ESFU Phase|Adverse Event|2
5247303|NCT00778895|18105972|P3|Active Phase|Other|0
5247304|NCT00778895|18105973|P2|Active Phase|Other|0
5247305|NCT00778895|18105974|P1|Active Phase|Other|2
5247306|NCT00778895|18105972|P3|Active Phase|Lost to Follow-up|0
5247307|NCT00778895|18105973|P2|Active Phase|Lost to Follow-up|1
5247308|NCT00778895|18105974|P1|Active Phase|Lost to Follow-up|1
5247309|NCT00778895|18105972|P3|Active Phase|Withdrawal by Subject|0
5247310|NCT00778895|18105973|P2|Active Phase|Withdrawal by Subject|4
5247311|NCT00778895|18105974|P1|Active Phase|Withdrawal by Subject|1
5247312|NCT00778895|18105972|P3|Active Phase|Adverse Event|0
5247313|NCT00778895|18105973|P2|Active Phase|Adverse Event|1
5247314|NCT00778895|18105974|P1|Active Phase|Adverse Event|3
5247315|NCT00778830|18106018|P2|Overall Study|Ongoing at data cut-off|1
5247316|NCT00778830|18106019|P1|Overall Study|Ongoing at data cut-off|0
5247317|NCT00778817|18106031|P1|Overall Study|Withdrawal by Subject|2
5247318|NCT00778817|18106031|P1|Overall Study|Adverse Event|2
5247319|NCT00778622|18106058|P3|Overall Study|Other|1
5247320|NCT00778622|18106059|P2|Overall Study|Other|0
5247321|NCT00778622|18106060|P1|Overall Study|Other|1
5247322|NCT00778622|18106058|P3|Overall Study|immigration|0
5247323|NCT00778622|18106059|P2|Overall Study|immigration|0
5247324|NCT00778622|18106060|P1|Overall Study|immigration|1
5247325|NCT00778622|18106058|P3|Overall Study|Lack of Efficacy|0
5247326|NCT00778622|18106059|P2|Overall Study|Lack of Efficacy|0
5247327|NCT00778622|18106060|P1|Overall Study|Lack of Efficacy|2
5247328|NCT00778622|18106058|P3|Overall Study|Protocol Violation|0
5247329|NCT00778622|18106059|P2|Overall Study|Protocol Violation|3
5247330|NCT00778622|18106060|P1|Overall Study|Protocol Violation|0
5247331|NCT00778622|18106058|P3|Overall Study|Lost to Follow-up|2
5247332|NCT00778622|18106059|P2|Overall Study|Lost to Follow-up|3
5247333|NCT00778622|18106060|P1|Overall Study|Lost to Follow-up|3
5247334|NCT00778622|18106058|P3|Overall Study|Withdrawal by Subject|5
5247335|NCT00778622|18106059|P2|Overall Study|Withdrawal by Subject|5
5247336|NCT00778622|18106060|P1|Overall Study|Withdrawal by Subject|4
5247337|NCT00778622|18106058|P3|Overall Study|Adverse Event|7
5247338|NCT00778622|18106059|P2|Overall Study|Adverse Event|4
5247339|NCT00778622|18106060|P1|Overall Study|Adverse Event|5
5247340|NCT00778375|18106113|P1|Overall Study|Ineligible|3
5247341|NCT00778336|18106127|P4|3 Month Follow Up|Death|0
5247342|NCT00778336|18106128|P3|3 Month Follow Up|Death|2
5247343|NCT00778336|18106129|P2|3 Month Follow Up|Death|3
5247344|NCT00778336|18106130|P1|3 Month Follow Up|Death|8
5247345|NCT00778336|18106127|P4|3 Month Follow Up|Lost to Follow-up|0
5247346|NCT00778336|18106128|P3|3 Month Follow Up|Lost to Follow-up|3
5247347|NCT00778336|18106129|P2|3 Month Follow Up|Lost to Follow-up|20
5247348|NCT00778336|18106130|P1|3 Month Follow Up|Lost to Follow-up|15
5247349|NCT00778336|18106127|P4|Index Procedure-Discharge|Death|0
5247350|NCT00778336|18106128|P3|Index Procedure-Discharge|Death|2
5247351|NCT00778336|18106129|P2|Index Procedure-Discharge|Death|3
5247352|NCT00778336|18106130|P1|Index Procedure-Discharge|Death|6
5247353|NCT00778258|18106168|P9|Overall Study|Other|0
5247354|NCT00778258|18106169|P8|Overall Study|Other|0
5247355|NCT00778258|18106170|P7|Overall Study|Other|1
5247356|NCT00778258|18106171|P6|Overall Study|Other|0
5247357|NCT00778258|18106172|P5|Overall Study|Other|0
5247358|NCT00778258|18106173|P4|Overall Study|Other|0
5247359|NCT00778258|18106174|P3|Overall Study|Other|0
5247360|NCT00778258|18106175|P2|Overall Study|Other|0
5247361|NCT00778258|18106176|P1|Overall Study|Other|0
5247362|NCT00778258|18106168|P9|Overall Study|Non-compliance|0
5247363|NCT00778258|18106169|P8|Overall Study|Non-compliance|0
5247364|NCT00778258|18106170|P7|Overall Study|Non-compliance|0
5247365|NCT00778258|18106171|P6|Overall Study|Non-compliance|0
5247366|NCT00778258|18106172|P5|Overall Study|Non-compliance|0
5247367|NCT00778258|18106173|P4|Overall Study|Non-compliance|1
5247368|NCT00778258|18106174|P3|Overall Study|Non-compliance|0
5247369|NCT00778258|18106175|P2|Overall Study|Non-compliance|0
5247370|NCT00778258|18106176|P1|Overall Study|Non-compliance|0
5247371|NCT00778258|18106168|P9|Overall Study|New Contraindication|0
5247372|NCT00778258|18106169|P8|Overall Study|New Contraindication|1
5247373|NCT00778258|18106170|P7|Overall Study|New Contraindication|0
5247374|NCT00778258|18106171|P6|Overall Study|New Contraindication|0
5247375|NCT00778258|18106172|P5|Overall Study|New Contraindication|0
5247376|NCT00778258|18106173|P4|Overall Study|New Contraindication|0
5247377|NCT00778258|18106174|P3|Overall Study|New Contraindication|0
5247378|NCT00778258|18106175|P2|Overall Study|New Contraindication|0
5247379|NCT00778258|18106176|P1|Overall Study|New Contraindication|0
5247380|NCT00778258|18106168|P9|Overall Study|Withdrawal by Subject|4
5247381|NCT00778258|18106169|P8|Overall Study|Withdrawal by Subject|12
5247382|NCT00778258|18106170|P7|Overall Study|Withdrawal by Subject|12
5247383|NCT00778258|18106171|P6|Overall Study|Withdrawal by Subject|6
5247384|NCT00778258|18106172|P5|Overall Study|Withdrawal by Subject|0
5247385|NCT00778258|18106173|P4|Overall Study|Withdrawal by Subject|2
5247386|NCT00778258|18106174|P3|Overall Study|Withdrawal by Subject|8
5247387|NCT00778258|18106175|P2|Overall Study|Withdrawal by Subject|2
5247388|NCT00778258|18106176|P1|Overall Study|Withdrawal by Subject|6
5247389|NCT00778258|18106168|P9|Overall Study|Lost to Follow-up|0
5247390|NCT00778258|18106169|P8|Overall Study|Lost to Follow-up|2
5247391|NCT00778258|18106170|P7|Overall Study|Lost to Follow-up|2
5247392|NCT00778258|18106171|P6|Overall Study|Lost to Follow-up|3
5247393|NCT00778258|18106172|P5|Overall Study|Lost to Follow-up|0
5247394|NCT00778258|18106173|P4|Overall Study|Lost to Follow-up|0
5247395|NCT00778258|18106174|P3|Overall Study|Lost to Follow-up|2
5247396|NCT00778258|18106175|P2|Overall Study|Lost to Follow-up|0
5247397|NCT00778258|18106176|P1|Overall Study|Lost to Follow-up|0
5247398|NCT00778258|18106168|P9|Overall Study|Adverse Event|0
5247399|NCT00778258|18106169|P8|Overall Study|Adverse Event|0
5247400|NCT00778258|18106170|P7|Overall Study|Adverse Event|0
5247401|NCT00778258|18106171|P6|Overall Study|Adverse Event|1
5247402|NCT00778258|18106172|P5|Overall Study|Adverse Event|0
5247403|NCT00778258|18106173|P4|Overall Study|Adverse Event|0
5247404|NCT00778258|18106174|P3|Overall Study|Adverse Event|0
5247405|NCT00778258|18106175|P2|Overall Study|Adverse Event|0
5247406|NCT00778258|18106176|P1|Overall Study|Adverse Event|1
5247407|NCT00778102|18106243|P2|Overall Study|Administrative Reason|10
5247408|NCT00778102|18106244|P1|Overall Study|Administrative Reason|7
5247409|NCT00778102|18106243|P2|Overall Study|Withdrawal by Subject|1
5247410|NCT00778102|18106244|P1|Overall Study|Withdrawal by Subject|1
5247411|NCT00778102|18106243|P2|Overall Study|Refused Treatment|3
5247412|NCT00778102|18106244|P1|Overall Study|Refused Treatment|2
5247413|NCT00778102|18106243|P2|Overall Study|Protocol Violation|1
5247414|NCT00778102|18106244|P1|Overall Study|Protocol Violation|0
5247415|NCT00778102|18106243|P2|Overall Study|Violation of Selection Criteria|1
5247416|NCT00778102|18106244|P1|Overall Study|Violation of Selection Criteria|1
5247417|NCT00778102|18106243|P2|Overall Study|Lost to Follow-up|0
5247418|NCT00778102|18106244|P1|Overall Study|Lost to Follow-up|1
5247419|NCT00778102|18106243|P2|Overall Study|Death|1
5247420|NCT00778102|18106244|P1|Overall Study|Death|1
5247421|NCT00778102|18106243|P2|Overall Study|Adverse Event|5
5247422|NCT00778102|18106244|P1|Overall Study|Adverse Event|8
5247423|NCT00777946|18106279|P3|Overall Study|Randomized in error|0
5247424|NCT00777946|18106280|P2|Overall Study|Randomized in error|1
5247425|NCT00777946|18106281|P1|Overall Study|Randomized in error|1
5247426|NCT00777946|18106279|P3|Overall Study|Protocol deviation|1
5247427|NCT00777946|18106280|P2|Overall Study|Protocol deviation|1
5247428|NCT00777946|18106281|P1|Overall Study|Protocol deviation|2
5247429|NCT00777946|18106279|P3|Overall Study|Lost to Follow-up|0
5247430|NCT00777946|18106280|P2|Overall Study|Lost to Follow-up|1
5247431|NCT00777946|18106281|P1|Overall Study|Lost to Follow-up|3
5247432|NCT00777946|18106279|P3|Overall Study|Patient withdrew consent|3
5247433|NCT00777946|18106280|P2|Overall Study|Patient withdrew consent|2
5247434|NCT00777946|18106281|P1|Overall Study|Patient withdrew consent|3
5247435|NCT00777946|18106279|P3|Overall Study|Condition no longer required study drug|0
5247436|NCT00777946|18106280|P2|Overall Study|Condition no longer required study drug|0
5247437|NCT00777946|18106281|P1|Overall Study|Condition no longer required study drug|1
5247438|NCT00777946|18106279|P3|Overall Study|Lack of Efficacy|9
5247439|NCT00777946|18106280|P2|Overall Study|Lack of Efficacy|0
5247440|NCT00777946|18106281|P1|Overall Study|Lack of Efficacy|0
5247441|NCT00777946|18106279|P3|Overall Study|Adverse Event|3
5247442|NCT00777946|18106280|P2|Overall Study|Adverse Event|1
5247443|NCT00777946|18106281|P1|Overall Study|Adverse Event|11
5247444|NCT00777920|18106304|P1|Overall Study|Other, not specified|4
5247445|NCT00777920|18106304|P1|Overall Study|Clinical status did not improve|1
5247446|NCT00777920|18106304|P1|Overall Study|Investigator's discretion|1
5247447|NCT00777920|18106304|P1|Overall Study|Lost to Follow-up|1
5247448|NCT00777920|18106304|P1|Overall Study|Withdrawal of Consent|4
5247449|NCT00777920|18106304|P1|Overall Study|Adverse Event|39
5247450|NCT00777803|18106320|P2|Overall Study|Non-compliance|2
5247451|NCT00777803|18106321|P1|Overall Study|Non-compliance|2
5247452|NCT00777803|18106320|P2|Overall Study|Adverse Event|0
5247453|NCT00777803|18106321|P1|Overall Study|Adverse Event|1
5247454|NCT00777803|18106320|P2|Overall Study|Lost to Follow-up|5
5247455|NCT00777803|18106321|P1|Overall Study|Lost to Follow-up|12
5247456|NCT00777608|18106400|P2|Overall Study|Investigator Decision|2
5247457|NCT00777608|18106401|P1|Overall Study|Investigator Decision|1
5247458|NCT00777608|18106400|P2|Overall Study|Protocol Violation|0
5247459|NCT00777608|18106401|P1|Overall Study|Protocol Violation|1
5247460|NCT00777608|18106400|P2|Overall Study|Withdrawal by Subject|3
5247461|NCT00777608|18106401|P1|Overall Study|Withdrawal by Subject|1
5247462|NCT00777608|18106400|P2|Overall Study|Lost to Follow-up|1
5247463|NCT00777608|18106401|P1|Overall Study|Lost to Follow-up|1
5247464|NCT00777556|18106411|P1|Overall Study|Did not complete all 3 follow-up visits|20
5247465|NCT00777556|18106411|P1|Overall Study|Dispensed but did not use product|12
5247466|NCT00777556|18106411|P1|Overall Study|Inappropriate self-selection|34
5247467|NCT00777491|18106420|P2|Overall Study|Did not receive any protocol treatment|0
5247468|NCT00777491|18106421|P1|Overall Study|Did not receive any protocol treatment|2
5247469|NCT00777491|18106420|P2|Overall Study|Protocol Violation|2
5247470|NCT00777491|18106421|P1|Overall Study|Protocol Violation|0
5247471|NCT00777296|18106454|P4|Overall Study|CRF form not completed|0
5247472|NCT00777296|18106455|P3|Overall Study|CRF form not completed|2
5247473|NCT00777296|18106456|P2|Overall Study|CRF form not completed|0
5247474|NCT00777296|18106457|P1|Overall Study|CRF form not completed|0
5247475|NCT00777296|18106454|P4|Overall Study|Withdrawal by Subject|0
5247476|NCT00777296|18106455|P3|Overall Study|Withdrawal by Subject|0
5247477|NCT00777296|18106456|P2|Overall Study|Withdrawal by Subject|0
5247478|NCT00777296|18106457|P1|Overall Study|Withdrawal by Subject|1
5247479|NCT00777296|18106454|P4|Overall Study|Adverse Event|1
5247480|NCT00777296|18106455|P3|Overall Study|Adverse Event|0
5247481|NCT00777296|18106456|P2|Overall Study|Adverse Event|1
5247482|NCT00777296|18106457|P1|Overall Study|Adverse Event|0
5247483|NCT00777257|18106499|P3|Overall Study|Withdrawal by Subject|5
5247484|NCT00777257|18106500|P2|Overall Study|Withdrawal by Subject|6
5247485|NCT00777257|18106501|P1|Overall Study|Withdrawal by Subject|3
5247486|NCT00777257|18106499|P3|Overall Study|Protocol Violation|2
5247487|NCT00777257|18106500|P2|Overall Study|Protocol Violation|2
5247488|NCT00777257|18106501|P1|Overall Study|Protocol Violation|2
5247489|NCT00777257|18106499|P3|Overall Study|Lost to Follow-up|2
5247490|NCT00777257|18106500|P2|Overall Study|Lost to Follow-up|3
5247491|NCT00777257|18106501|P1|Overall Study|Lost to Follow-up|3
5247492|NCT00777257|18106499|P3|Overall Study|Adverse Event|0
5247493|NCT00777257|18106500|P2|Overall Study|Adverse Event|1
5247494|NCT00777257|18106501|P1|Overall Study|Adverse Event|3
5247495|NCT00777205|18106520|P2|Overall Study|Protocol Violation|56
5247496|NCT00777205|18106521|P1|Overall Study|Protocol Violation|0
5247497|NCT00777205|18106520|P2|Overall Study|Death|2
5247498|NCT00777205|18106521|P1|Overall Study|Death|0
5247499|NCT00777205|18106520|P2|Overall Study|Withdrawal by Subject|4
5247500|NCT00777205|18106521|P1|Overall Study|Withdrawal by Subject|6
5247501|NCT00777205|18106520|P2|Overall Study|Lost to Follow-up|9
5247502|NCT00777205|18106521|P1|Overall Study|Lost to Follow-up|25
5247503|NCT00777153|18106555|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
5247504|NCT00777153|18106556|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
5247505|NCT00777153|18106557|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
5247506|NCT00777153|18106555|P3|Overall Study|Withdrawal by Subject|3
5247507|NCT00777153|18106556|P2|Overall Study|Withdrawal by Subject|4
5247508|NCT00777153|18106557|P1|Overall Study|Withdrawal by Subject|3
5247509|NCT00777153|18106555|P3|Overall Study|Death|33
5247510|NCT00777153|18106556|P2|Overall Study|Death|73
5247511|NCT00777153|18106557|P1|Overall Study|Death|85
5247512|NCT00777153|18106555|P3|Overall Study|Lost to Follow-up|0
5247513|NCT00777153|18106556|P2|Overall Study|Lost to Follow-up|1
5247514|NCT00777153|18106557|P1|Overall Study|Lost to Follow-up|1
5247515|NCT00777101|18106582|P2|Overall Study|Failed to Return|1
5247516|NCT00777101|18106583|P1|Overall Study|Failed to Return|0
5247517|NCT00777101|18106582|P2|Overall Study|Discontinuation of Study by Sponsor|0
5247518|NCT00777101|18106583|P1|Overall Study|Discontinuation of Study by Sponsor|1
5247519|NCT00777101|18106582|P2|Overall Study|Lost to Follow-up|1
5247520|NCT00777101|18106583|P1|Overall Study|Lost to Follow-up|2
5247521|NCT00777101|18106582|P2|Overall Study|Withdrawal by Subject|6
5247522|NCT00777101|18106583|P1|Overall Study|Withdrawal by Subject|11
5247523|NCT00777101|18106582|P2|Overall Study|Death|43
5247524|NCT00777101|18106583|P1|Overall Study|Death|48
5247525|NCT00777088|18106601|P1|Overall Study|PED Treatment not attempted|1
5247526|NCT00777049|18106626|P2|Overall Study|No treatment (elevated liver enzymes)|1
5247527|NCT00777049|18106627|P1|Overall Study|No treatment (elevated liver enzymes)|0
5247528|NCT00777049|18106626|P2|Overall Study|Withdrawal by Subject|0
5247529|NCT00777049|18106627|P1|Overall Study|Withdrawal by Subject|1
5247530|NCT00777036|18106636|P3|Follow-Up|Death|0
5247531|NCT00777036|18106637|P2|Follow-Up|Death|8
5247532|NCT00777036|18106638|P1|Follow-Up|Death|1
5247533|NCT00777036|18106636|P3|Follow-Up|Withdrawal by Subject|4
5247534|NCT00777036|18106637|P2|Follow-Up|Withdrawal by Subject|0
5247535|NCT00777036|18106638|P1|Follow-Up|Withdrawal by Subject|1
5247536|NCT00777036|18106636|P3|Follow-Up|Reason Not Specified|0
5247537|NCT00777036|18106637|P2|Follow-Up|Reason Not Specified|0
5247538|NCT00777036|18106638|P1|Follow-Up|Reason Not Specified|2
5247539|NCT00777036|18106636|P3|Follow-Up|Lost to Follow-up|0
5247540|NCT00777036|18106637|P2|Follow-Up|Lost to Follow-up|0
5247541|NCT00777036|18106638|P1|Follow-Up|Lost to Follow-up|1
5247542|NCT00777036|18106636|P3|On Treatment|Progressive Disease|6
5247543|NCT00777036|18106637|P2|On Treatment|Progressive Disease|4
5247544|NCT00777036|18106638|P1|On Treatment|Progressive Disease|5
5247545|NCT00777036|18106636|P3|On Treatment|Study Drug Toxicity|1
5247546|NCT00777036|18106637|P2|On Treatment|Study Drug Toxicity|0
5247547|NCT00777036|18106638|P1|On Treatment|Study Drug Toxicity|0
5247548|NCT00777036|18106636|P3|On Treatment|Death|0
5247549|NCT00777036|18106637|P2|On Treatment|Death|2
5247550|NCT00777036|18106638|P1|On Treatment|Death|0
5247551|NCT00777036|18106636|P3|On Treatment|Withdrawal by Subject|3
5247552|NCT00777036|18106637|P2|On Treatment|Withdrawal by Subject|2
5247553|NCT00777036|18106638|P1|On Treatment|Withdrawal by Subject|3
5247554|NCT00777036|18106636|P3|On Treatment|Maximum Clinical Benefit|1
5247555|NCT00777036|18106637|P2|On Treatment|Maximum Clinical Benefit|0
5247556|NCT00777036|18106638|P1|On Treatment|Maximum Clinical Benefit|2
5247557|NCT00777036|18106636|P3|On Treatment|Non-compliance with Study Drug|0
5247558|NCT00777036|18106637|P2|On Treatment|Non-compliance with Study Drug|0
5247559|NCT00777036|18106638|P1|On Treatment|Non-compliance with Study Drug|1
5247560|NCT00777036|18106636|P3|On Treatment|Failure to Meet Study Criteria|0
5247561|NCT00777036|18106637|P2|On Treatment|Failure to Meet Study Criteria|1
5247562|NCT00777036|18106638|P1|On Treatment|Failure to Meet Study Criteria|0
5247563|NCT00777036|18106636|P3|On Treatment|Reason Not Specified|12
5247564|NCT00777036|18106637|P2|On Treatment|Reason Not Specified|7
5247565|NCT00777036|18106638|P1|On Treatment|Reason Not Specified|4
5247566|NCT00777023|18106734|P3|Overall Study|Last dose date unknown|1
5247567|NCT00777023|18106735|P2|Overall Study|Last dose date unknown|3
5247568|NCT00777023|18106736|P1|Overall Study|Last dose date unknown|3
5247569|NCT00777023|18106734|P3|Overall Study|Reasons not specified|2
5247570|NCT00777023|18106735|P2|Overall Study|Reasons not specified|4
5247571|NCT00777023|18106736|P1|Overall Study|Reasons not specified|4
5247572|NCT00777023|18106734|P3|Overall Study|Missing data|0
5247573|NCT00777023|18106735|P2|Overall Study|Missing data|1
5247574|NCT00777023|18106736|P1|Overall Study|Missing data|1
5247575|NCT00777023|18106734|P3|Overall Study|Withdrawal by Subject|8
5247576|NCT00777023|18106735|P2|Overall Study|Withdrawal by Subject|7
5247577|NCT00777023|18106736|P1|Overall Study|Withdrawal by Subject|7
5247578|NCT00777023|18106734|P3|Overall Study|Death|0
5247579|NCT00777023|18106735|P2|Overall Study|Death|1
5247580|NCT00777023|18106736|P1|Overall Study|Death|0
5247581|NCT00777023|18106734|P3|Overall Study|Lost to Follow-up|3
5247582|NCT00777023|18106735|P2|Overall Study|Lost to Follow-up|3
5247583|NCT00777023|18106736|P1|Overall Study|Lost to Follow-up|2
5247584|NCT00777023|18106734|P3|Overall Study|Protocol Violation|1
5247585|NCT00777023|18106735|P2|Overall Study|Protocol Violation|1
5247586|NCT00777023|18106736|P1|Overall Study|Protocol Violation|2
5247587|NCT00777023|18106734|P3|Overall Study|Lack of Efficacy|14
5247588|NCT00777023|18106735|P2|Overall Study|Lack of Efficacy|0
5247589|NCT00777023|18106736|P1|Overall Study|Lack of Efficacy|1
5247590|NCT00777023|18106734|P3|Overall Study|Adverse Event|8
5247591|NCT00777023|18106735|P2|Overall Study|Adverse Event|21
5247592|NCT00777023|18106736|P1|Overall Study|Adverse Event|15
5247593|NCT00776997|18106753|P1|Overall Study|Adverse Event|2
5247594|NCT00776984|18106762|P2|Overall Study|Other|9
5247595|NCT00776984|18106763|P1|Overall Study|Other|5
5247596|NCT00776984|18106762|P2|Overall Study|Lack of Efficacy|1
5247597|NCT00776984|18106763|P1|Overall Study|Lack of Efficacy|0
5247598|NCT00776984|18106762|P2|Overall Study|Withdrawal by Subject|7
5247599|NCT00776984|18106763|P1|Overall Study|Withdrawal by Subject|12
5247600|NCT00776984|18106762|P2|Overall Study|Lost to Follow-up|0
5247601|NCT00776984|18106763|P1|Overall Study|Lost to Follow-up|2
5247602|NCT00776984|18106762|P2|Overall Study|Protocol Violation|2
5247603|NCT00776984|18106763|P1|Overall Study|Protocol Violation|4
5247604|NCT00776984|18106762|P2|Overall Study|Adverse Event|2
5247605|NCT00776984|18106763|P1|Overall Study|Adverse Event|8
5247606|NCT00776919|18106837|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
5247607|NCT00776919|18106838|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
5247608|NCT00776919|18106839|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
5247609|NCT00776919|18106840|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
5247610|NCT00776919|18106837|P4|Overall Study|Protocol Violation|1
5247611|NCT00776919|18106838|P3|Overall Study|Protocol Violation|0
5247612|NCT00776919|18106839|P2|Overall Study|Protocol Violation|2
5247613|NCT00776919|18106840|P1|Overall Study|Protocol Violation|1
5247614|NCT00776919|18106837|P4|Overall Study|Adverse Event|2
5247615|NCT00776919|18106838|P3|Overall Study|Adverse Event|2
5247616|NCT00776919|18106839|P2|Overall Study|Adverse Event|0
5247617|NCT00776919|18106840|P1|Overall Study|Adverse Event|1
5247618|NCT00776919|18106837|P4|Overall Study|Lost to Follow-up|8
5247619|NCT00776919|18106838|P3|Overall Study|Lost to Follow-up|11
5247620|NCT00776919|18106839|P2|Overall Study|Lost to Follow-up|12
5247621|NCT00776919|18106840|P1|Overall Study|Lost to Follow-up|8
5247622|NCT00776919|18106837|P4|Overall Study|Withdrawal by Subject|26
5247623|NCT00776919|18106838|P3|Overall Study|Withdrawal by Subject|15
5247624|NCT00776919|18106839|P2|Overall Study|Withdrawal by Subject|14
5247625|NCT00776919|18106840|P1|Overall Study|Withdrawal by Subject|16
5247626|NCT00776789|18106904|P2|Overall Study|Poor quality video|1
5247627|NCT00776789|18106905|P1|Overall Study|Poor quality video|1
5247628|NCT00776789|18106904|P2|Overall Study|Consent refusal|2
5247629|NCT00776789|18106905|P1|Overall Study|Consent refusal|2
5247630|NCT00776659|18106917|P1|Overall Study|Study Terminated by Sponsor|1
5247631|NCT00776659|18106917|P1|Overall Study|Withdrawal by Subject|10
5247632|NCT00776659|18106917|P1|Overall Study|Lost to Follow-up|15
5247633|NCT00776555|18106944|P2|Overall Study|Study terminated|0
5247634|NCT00776555|18106945|P1|Overall Study|Study terminated|3
5247635|NCT00776230|18106963|P3|Overall Study|Subject missed Visit 4|0
5247636|NCT00776230|18106964|P2|Overall Study|Subject missed Visit 4|1
5247637|NCT00776230|18106965|P1|Overall Study|Subject missed Visit 4|0
5247638|NCT00776230|18106963|P3|Overall Study|Withdrawal by Subject|0
5247639|NCT00776230|18106964|P2|Overall Study|Withdrawal by Subject|1
5247640|NCT00776230|18106965|P1|Overall Study|Withdrawal by Subject|0
5247641|NCT00776230|18106963|P3|Overall Study|Not vaccinated at Day 0|0
5247642|NCT00776230|18106964|P2|Overall Study|Not vaccinated at Day 0|0
5247643|NCT00776230|18106965|P1|Overall Study|Not vaccinated at Day 0|1
5247644|NCT00776230|18106963|P3|Overall Study|Lost to Follow-up|5
5247645|NCT00776230|18106964|P2|Overall Study|Lost to Follow-up|1
5247646|NCT00776230|18106965|P1|Overall Study|Lost to Follow-up|2
5247647|NCT00776100|18106975|P2|Overall Study|Disease Progression|0
5247648|NCT00776100|18106976|P1|Overall Study|Disease Progression|1
5247649|NCT00776009|18106998|P6|Period 3: Third Intervention|Withdrawal by Subject|0
5247650|NCT00776009|18106999|P5|Period 3: Third Intervention|Withdrawal by Subject|0
5247651|NCT00776009|18107000|P4|Period 3: Third Intervention|Withdrawal by Subject|0
5247652|NCT00776009|18107001|P3|Period 3: Third Intervention|Withdrawal by Subject|0
5247653|NCT00776009|18107002|P2|Period 3: Third Intervention|Withdrawal by Subject|0
5247654|NCT00776009|18107003|P1|Period 3: Third Intervention|Withdrawal by Subject|1
5247655|NCT00776009|18106998|P6|Period 2: Second Intervention|Protocol Violation|0
5247656|NCT00776009|18106999|P5|Period 2: Second Intervention|Protocol Violation|0
5247657|NCT00776009|18107000|P4|Period 2: Second Intervention|Protocol Violation|0
5247658|NCT00776009|18107001|P3|Period 2: Second Intervention|Protocol Violation|1
5247659|NCT00776009|18107002|P2|Period 2: Second Intervention|Protocol Violation|0
5247660|NCT00776009|18107003|P1|Period 2: Second Intervention|Protocol Violation|1
5247661|NCT00776009|18106998|P6|Period 2: Second Intervention|Withdrawal by Subject|1
5247662|NCT00776009|18106999|P5|Period 2: Second Intervention|Withdrawal by Subject|0
5247663|NCT00776009|18107000|P4|Period 2: Second Intervention|Withdrawal by Subject|0
5247664|NCT00776009|18107001|P3|Period 2: Second Intervention|Withdrawal by Subject|0
5247665|NCT00776009|18107002|P2|Period 2: Second Intervention|Withdrawal by Subject|0
5247666|NCT00776009|18107003|P1|Period 2: Second Intervention|Withdrawal by Subject|0
5247667|NCT00776009|18106998|P6|Period 1: First Intervention|Protocol Violation|0
5247668|NCT00776009|18106999|P5|Period 1: First Intervention|Protocol Violation|1
5247669|NCT00776009|18107000|P4|Period 1: First Intervention|Protocol Violation|0
5247670|NCT00776009|18107001|P3|Period 1: First Intervention|Protocol Violation|0
5247671|NCT00776009|18107002|P2|Period 1: First Intervention|Protocol Violation|1
5247672|NCT00776009|18107003|P1|Period 1: First Intervention|Protocol Violation|0
5247673|NCT00776009|18106998|P6|Period 1: First Intervention|Withdrawal by Subject|0
5247674|NCT00776009|18106999|P5|Period 1: First Intervention|Withdrawal by Subject|1
5247675|NCT00776009|18107000|P4|Period 1: First Intervention|Withdrawal by Subject|0
5247676|NCT00776009|18107001|P3|Period 1: First Intervention|Withdrawal by Subject|1
5247677|NCT00776009|18107002|P2|Period 1: First Intervention|Withdrawal by Subject|0
5247678|NCT00776009|18107003|P1|Period 1: First Intervention|Withdrawal by Subject|0
5247679|NCT00775983|18107025|P2|Overall Study|Protocol Violation|2
5247680|NCT00775983|18107026|P1|Overall Study|Protocol Violation|1
5247681|NCT00775606|18107152|P2|Overall Study|Study sponsor terminated funding|0
5247682|NCT00775606|18107153|P1|Overall Study|Study sponsor terminated funding|3
5247683|NCT00775593|18107163|P1|Overall Study|Death|1
5247684|NCT00775593|18107163|P1|Overall Study|Unmet eligibility criteria|6
5247685|NCT00775528|18107170|P1|Overall Study|Protocol Violation|1
5247686|NCT00775463|18107179|P2|Overall Study|Lack of Efficacy|1
5247687|NCT00775463|18107180|P1|Overall Study|Lack of Efficacy|1
5247688|NCT00775463|18107179|P2|Overall Study|Lost to Follow-up|0
5247689|NCT00775463|18107180|P1|Overall Study|Lost to Follow-up|1
5247690|NCT00775463|18107179|P2|Overall Study|Protocol Violation|2
5247691|NCT00775463|18107180|P1|Overall Study|Protocol Violation|2
5247692|NCT00775463|18107179|P2|Overall Study|Adverse Event|9
5247693|NCT00775463|18107180|P1|Overall Study|Adverse Event|7
5247694|NCT00775463|18107179|P2|Overall Study|Withdrawal by Subject|1
5247695|NCT00775463|18107180|P1|Overall Study|Withdrawal by Subject|0
5247696|NCT00775450|18107217|P5|Overall Study|Withdrawal by Subject|1
5247697|NCT00775450|18107218|P4|Overall Study|Withdrawal by Subject|0
5247698|NCT00775450|18107219|P3|Overall Study|Withdrawal by Subject|0
5247699|NCT00775450|18107220|P2|Overall Study|Withdrawal by Subject|0
5247700|NCT00775450|18107221|P1|Overall Study|Withdrawal by Subject|1
5247701|NCT00775450|18107217|P5|Overall Study|Protocol Violation|1
5247702|NCT00775450|18107218|P4|Overall Study|Protocol Violation|0
5247703|NCT00775450|18107219|P3|Overall Study|Protocol Violation|0
5247704|NCT00775450|18107220|P2|Overall Study|Protocol Violation|0
5247705|NCT00775450|18107221|P1|Overall Study|Protocol Violation|0
5247706|NCT00775450|18107217|P5|Overall Study|Serious Adverse Event|0
5247707|NCT00775450|18107218|P4|Overall Study|Serious Adverse Event|0
5247708|NCT00775450|18107219|P3|Overall Study|Serious Adverse Event|0
5247709|NCT00775450|18107220|P2|Overall Study|Serious Adverse Event|0
5247710|NCT00775450|18107221|P1|Overall Study|Serious Adverse Event|2
5247711|NCT00775437|18107248|P1|Overall Study|Lost to Follow-up|1
5247712|NCT00775437|18107248|P1|Overall Study|Withdrawal by Subject|3
5247713|NCT00775437|18107248|P1|Overall Study|Loss of efficacy|2
5247714|NCT00775203|18107323|P2|Overall Study|Physician Decision|1
5247715|NCT00775203|18107324|P1|Overall Study|Physician Decision|0
5247716|NCT00775203|18107323|P2|Overall Study|Entered other study|0
5247717|NCT00775203|18107324|P1|Overall Study|Entered other study|1
5247718|NCT00775203|18107323|P2|Overall Study|Protocol Violation|1
5247719|NCT00775203|18107324|P1|Overall Study|Protocol Violation|0
5247720|NCT00775203|18107323|P2|Overall Study|Noncompliance|2
5247721|NCT00775203|18107324|P1|Overall Study|Noncompliance|4
5247722|NCT00775203|18107323|P2|Overall Study|Administrative reason|0
5247723|NCT00775203|18107324|P1|Overall Study|Administrative reason|2
5247724|NCT00775203|18107323|P2|Overall Study|Lost to Follow-up|15
5247725|NCT00775203|18107324|P1|Overall Study|Lost to Follow-up|11
5247726|NCT00775203|18107323|P2|Overall Study|Withdrawal by Subject|9
5247727|NCT00775203|18107324|P1|Overall Study|Withdrawal by Subject|11
5247728|NCT00775203|18107323|P2|Overall Study|Lack of Efficacy|9
5247729|NCT00775203|18107324|P1|Overall Study|Lack of Efficacy|8
5247730|NCT00775203|18107323|P2|Overall Study|Adverse Event|6
5247731|NCT00775203|18107324|P1|Overall Study|Adverse Event|25
5247732|NCT00775190|18107358|P2|Overall Study|Protocol Violation|0
5247733|NCT00775190|18107359|P1|Overall Study|Protocol Violation|1
5247734|NCT00775190|18107358|P2|Overall Study|Withdrawal by Subject|2
5247735|NCT00775190|18107359|P1|Overall Study|Withdrawal by Subject|1
5247736|NCT00775190|18107358|P2|Overall Study|Lost to Follow-up|3
5247737|NCT00775190|18107359|P1|Overall Study|Lost to Follow-up|2
5247738|NCT00775138|18107385|P4|Overall Study|Adverse Event|0
5247739|NCT00775138|18107386|P3|Overall Study|Adverse Event|1
5247740|NCT00775138|18107387|P2|Overall Study|Adverse Event|0
5247741|NCT00775138|18107388|P1|Overall Study|Adverse Event|0
5247742|NCT00775138|18107385|P4|Overall Study|Withdrawal by Subject|2
5247743|NCT00775138|18107386|P3|Overall Study|Withdrawal by Subject|2
5247744|NCT00775138|18107387|P2|Overall Study|Withdrawal by Subject|0
5247745|NCT00775138|18107388|P1|Overall Study|Withdrawal by Subject|0
5247746|NCT00775021|18107434|P2|Second Intervention|Adverse Event|1
5247747|NCT00775021|18107435|P1|Second Intervention|Adverse Event|0
5247748|NCT00775021|18107434|P2|First Intervention|Lost to Follow-up|0
5247749|NCT00775021|18107435|P1|First Intervention|Lost to Follow-up|1
5247750|NCT00774995|18107453|P4|Overall Study|Protocol Violation|0
5247751|NCT00774995|18107454|P3|Overall Study|Protocol Violation|1
5247752|NCT00774995|18107455|P2|Overall Study|Protocol Violation|0
5247753|NCT00774995|18107456|P1|Overall Study|Protocol Violation|0
5247754|NCT00774930|18107496|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
5247755|NCT00774930|18107497|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
5247756|NCT00774930|18107496|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
5247757|NCT00774930|18107497|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
5247758|NCT00774930|18107496|P2|LTOLE Phase|Disease Progression|5
5247759|NCT00774930|18107497|P1|LTOLE Phase|Disease Progression|2
5247760|NCT00774930|18107496|P2|LTOLE Phase|Sponsor decision|1
5247761|NCT00774930|18107497|P1|LTOLE Phase|Sponsor decision|2
5247762|NCT00774930|18107496|P2|LTOLE Phase|Physician Decision|1
5247763|NCT00774930|18107497|P1|LTOLE Phase|Physician Decision|4
5247764|NCT00774930|18107496|P2|LTOLE Phase|Subject decision|5
5247765|NCT00774930|18107497|P1|LTOLE Phase|Subject decision|0
5247766|NCT00774930|18107496|P2|LTOLE Phase|Adverse Event|3
5247767|NCT00774930|18107497|P1|LTOLE Phase|Adverse Event|7
5247768|NCT00774930|18107496|P2|IOL Phase|Brain radiation|1
5247769|NCT00774930|18107497|P1|IOL Phase|Brain radiation|0
5247770|NCT00774930|18107496|P2|IOL Phase|Other|0
5247771|NCT00774930|18107497|P1|IOL Phase|Other|1
5247772|NCT00774930|18107496|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
5247773|NCT00774930|18107497|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
5247774|NCT00774930|18107496|P2|IOL Phase|Subject Consumed Prohibited Medication|0
5247775|NCT00774930|18107497|P1|IOL Phase|Subject Consumed Prohibited Medication|1
5247776|NCT00774930|18107496|P2|IOL Phase|Disease Progression|1
5247777|NCT00774930|18107497|P1|IOL Phase|Disease Progression|2
5247778|NCT00774930|18107496|P2|IOL Phase|Sponsor Decision|0
5247779|NCT00774930|18107497|P1|IOL Phase|Sponsor Decision|1
5247780|NCT00774930|18107496|P2|IOL Phase|Physician Decision|2
5247781|NCT00774930|18107497|P1|IOL Phase|Physician Decision|3
5247782|NCT00774930|18107496|P2|IOL Phase|Subject Decision|3
5247783|NCT00774930|18107497|P1|IOL Phase|Subject Decision|4
5247784|NCT00774930|18107496|P2|IOL Phase|Adverse Event|1
5247785|NCT00774930|18107497|P1|IOL Phase|Adverse Event|1
5247786|NCT00774930|18107496|P2|DB Phase|Started Nonprotocol Radiation therapy|1
5247787|NCT00774930|18107497|P1|DB Phase|Started Nonprotocol Radiation therapy|0
5247788|NCT00774930|18107496|P2|DB Phase|Disease Progression|1
5247789|NCT00774930|18107497|P1|DB Phase|Disease Progression|1
5247790|NCT00774930|18107496|P2|DB Phase|Sponsor Decision|1
5247791|NCT00774930|18107497|P1|DB Phase|Sponsor Decision|0
5247792|NCT00774930|18107496|P2|DB Phase|Subject Decision|5
5247793|NCT00774930|18107497|P1|DB Phase|Subject Decision|1
5247794|NCT00774930|18107496|P2|DB Phase|Adverse Event|2
5247795|NCT00774930|18107497|P1|DB Phase|Adverse Event|1
5247796|NCT00774930|18107496|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
5247797|NCT00774930|18107497|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
5247798|NCT00774852|18107525|P2|Overall Study|Subject received prohibited medication|0
5247799|NCT00774852|18107526|P1|Overall Study|Subject received prohibited medication|1
5247800|NCT00774852|18107525|P2|Overall Study|Protocol Violation|0
5247801|NCT00774852|18107526|P1|Overall Study|Protocol Violation|1
5247802|NCT00774852|18107525|P2|Overall Study|Subject non-compliance|1
5247803|NCT00774852|18107526|P1|Overall Study|Subject non-compliance|0
5247804|NCT00774852|18107525|P2|Overall Study|Non-responder|11
5247805|NCT00774852|18107526|P1|Overall Study|Non-responder|15
5247806|NCT00774852|18107525|P2|Overall Study|Withdrawal by Subject|2
5247807|NCT00774852|18107526|P1|Overall Study|Withdrawal by Subject|2
5247808|NCT00774852|18107525|P2|Overall Study|Pregnancy|2
5247809|NCT00774852|18107526|P1|Overall Study|Pregnancy|1
5247810|NCT00774852|18107525|P2|Overall Study|Physician Decision|6
5247811|NCT00774852|18107526|P1|Overall Study|Physician Decision|2
5247812|NCT00774852|18107525|P2|Overall Study|Lost to Follow-up|5
5247813|NCT00774852|18107526|P1|Overall Study|Lost to Follow-up|9
5247814|NCT00774852|18107525|P2|Overall Study|Lack of Efficacy|7
5247815|NCT00774852|18107526|P1|Overall Study|Lack of Efficacy|3
5247816|NCT00774852|18107525|P2|Overall Study|Death|1
5247817|NCT00774852|18107526|P1|Overall Study|Death|2
5247818|NCT00774852|18107525|P2|Overall Study|Adverse Event|6
5247819|NCT00774852|18107526|P1|Overall Study|Adverse Event|9
5247820|NCT00774800|18107574|P1|Intervention 4|Withdrawal by Subject|1
5247821|NCT00774787|18107596|P1|Overall Study|Lost to Follow-up|1
5247822|NCT00774748|18107603|P1|Overall Study|Lost to Follow-up|3
5247823|NCT00774397|18107629|P7|Overall Study|Other than those stated above|1
5247824|NCT00774397|18107630|P6|Overall Study|Other than those stated above|0
5247825|NCT00774397|18107631|P5|Overall Study|Other than those stated above|2
5247826|NCT00774397|18107632|P4|Overall Study|Other than those stated above|2
5247827|NCT00774397|18107633|P3|Overall Study|Other than those stated above|3
5247828|NCT00774397|18107634|P2|Overall Study|Other than those stated above|1
5247829|NCT00774397|18107635|P1|Overall Study|Other than those stated above|1
5247830|NCT00774397|18107629|P7|Overall Study|Not treated|1
5247831|NCT00774397|18107630|P6|Overall Study|Not treated|0
5247832|NCT00774397|18107631|P5|Overall Study|Not treated|1
5247833|NCT00774397|18107632|P4|Overall Study|Not treated|0
5247834|NCT00774397|18107633|P3|Overall Study|Not treated|0
5247835|NCT00774397|18107634|P2|Overall Study|Not treated|0
5247836|NCT00774397|18107635|P1|Overall Study|Not treated|0
5247837|NCT00774397|18107629|P7|Overall Study|Refused to continue trial medication|3
5247838|NCT00774397|18107630|P6|Overall Study|Refused to continue trial medication|2
5247839|NCT00774397|18107631|P5|Overall Study|Refused to continue trial medication|6
5247840|NCT00774397|18107632|P4|Overall Study|Refused to continue trial medication|2
5247841|NCT00774397|18107633|P3|Overall Study|Refused to continue trial medication|2
5247842|NCT00774397|18107634|P2|Overall Study|Refused to continue trial medication|3
5247843|NCT00774397|18107635|P1|Overall Study|Refused to continue trial medication|1
5247844|NCT00774397|18107629|P7|Overall Study|Lost to Follow-up|0
5247845|NCT00774397|18107630|P6|Overall Study|Lost to Follow-up|1
5247846|NCT00774397|18107631|P5|Overall Study|Lost to Follow-up|0
5247847|NCT00774397|18107632|P4|Overall Study|Lost to Follow-up|1
5247848|NCT00774397|18107633|P3|Overall Study|Lost to Follow-up|1
5247849|NCT00774397|18107634|P2|Overall Study|Lost to Follow-up|1
5247850|NCT00774397|18107635|P1|Overall Study|Lost to Follow-up|0
5247851|NCT00774397|18107629|P7|Overall Study|Protocol Violation|0
5247852|NCT00774397|18107630|P6|Overall Study|Protocol Violation|1
5247853|NCT00774397|18107631|P5|Overall Study|Protocol Violation|2
5247854|NCT00774397|18107632|P4|Overall Study|Protocol Violation|1
5247855|NCT00774397|18107633|P3|Overall Study|Protocol Violation|3
5247856|NCT00774397|18107634|P2|Overall Study|Protocol Violation|1
5247857|NCT00774397|18107635|P1|Overall Study|Protocol Violation|0
5247858|NCT00774397|18107629|P7|Overall Study|Lack of Efficacy|9
5247859|NCT00774397|18107630|P6|Overall Study|Lack of Efficacy|15
5247860|NCT00774397|18107631|P5|Overall Study|Lack of Efficacy|27
5247861|NCT00774397|18107632|P4|Overall Study|Lack of Efficacy|3
5247862|NCT00774397|18107633|P3|Overall Study|Lack of Efficacy|5
5247863|NCT00774397|18107634|P2|Overall Study|Lack of Efficacy|4
5247864|NCT00774397|18107635|P1|Overall Study|Lack of Efficacy|11
5247865|NCT00774397|18107629|P7|Overall Study|Adverse Event|16
5247866|NCT00774397|18107630|P6|Overall Study|Adverse Event|3
5247867|NCT00774397|18107631|P5|Overall Study|Adverse Event|8
5247868|NCT00774397|18107632|P4|Overall Study|Adverse Event|8
5247869|NCT00774397|18107633|P3|Overall Study|Adverse Event|16
5247870|NCT00774397|18107634|P2|Overall Study|Adverse Event|3
5247871|NCT00774397|18107635|P1|Overall Study|Adverse Event|1
5247872|NCT00774306|18107871|P4|Overall Study|Death|0
5247873|NCT00774306|18107872|P3|Overall Study|Death|0
5247874|NCT00774306|18107873|P2|Overall Study|Death|1
5247875|NCT00774306|18107874|P1|Overall Study|Death|1
5247876|NCT00774306|18107871|P4|Overall Study|Lost to Follow-up|5
5247877|NCT00774306|18107872|P3|Overall Study|Lost to Follow-up|4
5247878|NCT00774306|18107873|P2|Overall Study|Lost to Follow-up|0
5247879|NCT00774306|18107874|P1|Overall Study|Lost to Follow-up|6
5247880|NCT00774306|18107871|P4|Overall Study|Withdrawal by Subject|0
5247881|NCT00774306|18107872|P3|Overall Study|Withdrawal by Subject|1
5247882|NCT00774306|18107873|P2|Overall Study|Withdrawal by Subject|1
5247883|NCT00774306|18107874|P1|Overall Study|Withdrawal by Subject|6
5247884|NCT00774306|18107871|P4|Overall Study|Protocol Violation|0
5247885|NCT00774306|18107872|P3|Overall Study|Protocol Violation|3
5247886|NCT00774306|18107873|P2|Overall Study|Protocol Violation|0
5247887|NCT00774306|18107874|P1|Overall Study|Protocol Violation|2
5247888|NCT00774306|18107871|P4|Overall Study|Adverse Event|0
5247889|NCT00774306|18107872|P3|Overall Study|Adverse Event|0
5247890|NCT00774306|18107873|P2|Overall Study|Adverse Event|0
5247891|NCT00774306|18107874|P1|Overall Study|Adverse Event|3
5247892|NCT00774046|18107955|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
5247893|NCT00774046|18107955|P1|Enrollment|Desired other therapy/refused|28
5247894|NCT00774046|18107955|P1|Screening|Not eligible|56
5247895|NCT00773968|18107965|P1|Overall Study|Other|8
5247896|NCT00773968|18107965|P1|Overall Study|Screen Failure|17
5247897|NCT00773968|18107965|P1|Overall Study|Withdrawal by Subject|11
5247898|NCT00773968|18107965|P1|Overall Study|Protocol Violation|1
5247899|NCT00773968|18107965|P1|Overall Study|Lack of Efficacy|3
5247900|NCT00773968|18107965|P1|Overall Study|Failure to Return|2
5247901|NCT00773968|18107965|P1|Overall Study|Death|1
5247902|NCT00773968|18107965|P1|Overall Study|Adverse Event|2
5247903|NCT00773734|18107996|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5247904|NCT00773734|18107997|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5247905|NCT00773734|18107998|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
5247906|NCT00773734|18107999|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
5247907|NCT00773734|18108000|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5247908|NCT00773734|18108001|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5247909|NCT00773734|18107996|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5247910|NCT00773734|18107997|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5247911|NCT00773734|18107998|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
5247912|NCT00773734|18107999|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
5247913|NCT00773734|18108000|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5247914|NCT00773734|18108001|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5247915|NCT00773734|18107996|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5247916|NCT00773734|18107997|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5247917|NCT00773734|18107998|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
5247918|NCT00773734|18107999|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
5247919|NCT00773734|18108000|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5247920|NCT00773734|18108001|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5247921|NCT00773734|18107996|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
5247922|NCT00773734|18107997|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
5247923|NCT00773734|18107998|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
5247924|NCT00773734|18107999|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
5247925|NCT00773734|18108000|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
5247926|NCT00773734|18108001|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
5247927|NCT00773734|18107996|P6|Extension: Active Treatment Week 24-52|Other|1
5247928|NCT00773734|18107997|P5|Extension: Active Treatment Week 24-52|Other|0
5247929|NCT00773734|18107998|P4|Extension: Active Treatment Week 24-52|Other|2
5247930|NCT00773734|18107999|P3|Extension: Active Treatment Week 24-52|Other|1
5247931|NCT00773734|18108000|P2|Extension: Active Treatment Week 24-52|Other|0
5247932|NCT00773734|18108001|P1|Extension: Active Treatment Week 24-52|Other|0
5247933|NCT00773734|18107996|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
5247934|NCT00773734|18107997|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
5247935|NCT00773734|18107998|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
5247936|NCT00773734|18107999|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
5247937|NCT00773734|18108000|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
5247938|NCT00773734|18108001|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
5247939|NCT00773734|18107996|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
5247940|NCT00773734|18107997|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
5247941|NCT00773734|18107998|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
5247942|NCT00773734|18107999|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
5247943|NCT00773734|18108000|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
5247944|NCT00773734|18108001|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
5247945|NCT00773734|18107996|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
5247946|NCT00773734|18107997|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
5247947|NCT00773734|18107998|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
5247948|NCT00773734|18107999|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
5247949|NCT00773734|18108000|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
5247950|NCT00773734|18108001|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
5247951|NCT00773734|18107996|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
5247952|NCT00773734|18107997|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
5247953|NCT00773734|18107998|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
5247954|NCT00773734|18107999|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
5247955|NCT00773734|18108000|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
5247956|NCT00773734|18108001|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
5247957|NCT00773734|18107996|P6|Core: Active Treatment Phase Week 16-24|Other|0
5247958|NCT00773734|18107997|P5|Core: Active Treatment Phase Week 16-24|Other|0
5247959|NCT00773734|18107998|P4|Core: Active Treatment Phase Week 16-24|Other|0
5247960|NCT00773734|18107999|P3|Core: Active Treatment Phase Week 16-24|Other|0
5247961|NCT00773734|18108000|P2|Core: Active Treatment Phase Week 16-24|Other|1
5247962|NCT00773734|18108001|P1|Core: Active Treatment Phase Week 16-24|Other|0
5247963|NCT00773734|18107996|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5247964|NCT00773734|18107997|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
5247965|NCT00773734|18107998|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5247966|NCT00773734|18107999|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5247967|NCT00773734|18108000|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5247968|NCT00773734|18108001|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
5247969|NCT00773734|18107996|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5247970|NCT00773734|18107997|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5247971|NCT00773734|18107998|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5247972|NCT00773734|18107999|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
5247973|NCT00773734|18108000|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
5247974|NCT00773734|18108001|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5247975|NCT00773734|18107996|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
5247976|NCT00773734|18107997|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
5247977|NCT00773734|18107998|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
5247978|NCT00773734|18107999|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
5247979|NCT00773734|18108000|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
5247980|NCT00773734|18108001|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
5247981|NCT00773734|18107996|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
5247982|NCT00773734|18107997|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
5247983|NCT00773734|18107998|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
5247984|NCT00773734|18107999|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
5247985|NCT00773734|18108000|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
5247986|NCT00773734|18108001|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
5247987|NCT00773734|18107996|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
5247988|NCT00773734|18107997|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
5247989|NCT00773734|18107998|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
5247990|NCT00773734|18107999|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
5247991|NCT00773734|18108000|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
5247992|NCT00773734|18108001|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
5247993|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
5247994|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
5247995|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
5247996|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
5247997|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
5247998|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
5247999|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
5248000|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
5248001|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
5248002|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
5248003|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
5248004|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
5248005|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5248006|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5248007|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
5248008|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5248009|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5248010|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
5248011|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
5248012|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
5248013|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
5248014|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
5248015|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
5248016|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
5248017|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
5248018|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
5248019|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
5248020|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
5248021|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
5248022|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
5248023|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
5248024|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
5248025|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
5248026|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
5248027|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
5248028|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
5248029|NCT00773734|18107996|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
5248030|NCT00773734|18107997|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
5248031|NCT00773734|18107998|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
5248032|NCT00773734|18107999|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
5248033|NCT00773734|18108000|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
5248034|NCT00773734|18108001|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
5248035|NCT00773513|18108569|P2|Overall Study|Death|545
5248036|NCT00773513|18108570|P1|Overall Study|Death|531
5248037|NCT00773513|18108569|P2|Overall Study|Reason Not Specified|126
5248038|NCT00773513|18108570|P1|Overall Study|Reason Not Specified|159
5248039|NCT00773513|18108569|P2|Overall Study|Insufficient Therapeutic Response|18
5248040|NCT00773513|18108570|P1|Overall Study|Insufficient Therapeutic Response|1
5248041|NCT00773513|18108569|P2|Overall Study|Failure to Return|8
5248042|NCT00773513|18108570|P1|Overall Study|Failure to Return|22
5248043|NCT00773513|18108569|P2|Overall Study|Refused Treatment / Did not Cooperate|32
5248044|NCT00773513|18108570|P1|Overall Study|Refused Treatment / Did not Cooperate|26
5248045|NCT00773513|18108569|P2|Overall Study|Withdrew Consent|69
5248046|NCT00773513|18108570|P1|Overall Study|Withdrew Consent|68
5248047|NCT00773513|18108569|P2|Overall Study|Adverse Event / Intercurrent Illness|48
5248048|NCT00773513|18108570|P1|Overall Study|Adverse Event / Intercurrent Illness|40
5248049|NCT00773513|18108569|P2|Overall Study|Renal Transplant|263
5248050|NCT00773513|18108570|P1|Overall Study|Renal Transplant|254
5248051|NCT00773461|18108599|P2|Overall Study|Withdrawal by Subject|1
5248052|NCT00773461|18108600|P1|Overall Study|Withdrawal by Subject|4
5248053|NCT00773461|18108599|P2|Overall Study|Adverse Event|3
5248054|NCT00773461|18108600|P1|Overall Study|Adverse Event|1
5248055|NCT00773383|18108654|P1|Overall Study|No study dose received|1
5248056|NCT00773383|18108654|P1|Overall Study|Other|2
5248057|NCT00773383|18108654|P1|Overall Study|Progression of Disease|23
5248058|NCT00773383|18108654|P1|Overall Study|Death|1
5248059|NCT00773383|18108654|P1|Overall Study|Adverse Event|4
5248060|NCT00773279|18108689|P2|Period 2|Unclassified|2
5248061|NCT00773279|18108690|P1|Period 2|Unclassified|2
5248062|NCT00773279|18108689|P2|Period 2|Protocol Violation|3
5248063|NCT00773279|18108690|P1|Period 2|Protocol Violation|0
5248064|NCT00773279|18108689|P2|Period 2|Lack of Efficacy|0
5248065|NCT00773279|18108690|P1|Period 2|Lack of Efficacy|1
5248066|NCT00773279|18108689|P2|Period 2|Adverse Event|1
5248067|NCT00773279|18108690|P1|Period 2|Adverse Event|0
5248068|NCT00773279|18108689|P2|Period 1|Unclassified|1
5248069|NCT00773279|18108690|P1|Period 1|Unclassified|5
5248070|NCT00773279|18108689|P2|Period 1|Lack of Efficacy|2
5248071|NCT00773279|18108690|P1|Period 1|Lack of Efficacy|0
5248072|NCT00773279|18108689|P2|Period 1|Adverse Event|1
5248073|NCT00773279|18108690|P1|Period 1|Adverse Event|2
5248074|NCT00773253|18108711|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
5248075|NCT00773253|18108712|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
5248076|NCT00773175|18108722|P2|Overall Study|Consent Withdrawn|2
5248077|NCT00773175|18108723|P1|Overall Study|Consent Withdrawn|0
5248078|NCT00773175|18108722|P2|Overall Study|Adverse Event|0
5248079|NCT00773175|18108723|P1|Overall Study|Adverse Event|2
5248080|NCT00773136|18108815|P1|Overall Study|Physician Decision|2
5248081|NCT00773097|18108820|P1|Overall Study|Physician Decision|6
5248082|NCT00773097|18108820|P1|Overall Study|Withdrawal by Subject|1
5248083|NCT00772967|18108826|P6|Crossover Treatment 3|Adverse Event|0
5248084|NCT00772967|18108827|P5|Crossover Treatment 3|Adverse Event|1
5248085|NCT00772967|18108828|P4|Crossover Treatment 3|Adverse Event|0
5248086|NCT00772967|18108829|P3|Crossover Treatment 3|Adverse Event|0
5248087|NCT00772967|18108830|P2|Crossover Treatment 3|Adverse Event|0
5248088|NCT00772967|18108831|P1|Crossover Treatment 3|Adverse Event|0
5248089|NCT00772967|18108826|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
5248090|NCT00772967|18108827|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
5248091|NCT00772967|18108828|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
5248092|NCT00772967|18108829|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
5248093|NCT00772967|18108830|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
5248094|NCT00772967|18108831|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
5248095|NCT00772967|18108826|P6|Crossover Treatment 1|Adverse Event (Pain)|0
5248096|NCT00772967|18108827|P5|Crossover Treatment 1|Adverse Event (Pain)|0
5248097|NCT00772967|18108828|P4|Crossover Treatment 1|Adverse Event (Pain)|1
5248098|NCT00772967|18108829|P3|Crossover Treatment 1|Adverse Event (Pain)|0
5248099|NCT00772967|18108830|P2|Crossover Treatment 1|Adverse Event (Pain)|0
5248100|NCT00772967|18108831|P1|Crossover Treatment 1|Adverse Event (Pain)|0
5248101|NCT00772954|18108851|P3|Overall Study|Adverse Event|1
5248102|NCT00772954|18108852|P2|Overall Study|Adverse Event|0
5248103|NCT00772954|18108853|P1|Overall Study|Adverse Event|0
5248104|NCT00772941|18108861|P1|Overall Study|GPSP Violation|90
5248105|NCT00772941|18108861|P1|Overall Study|Poor Compliance|7
5248106|NCT00772941|18108861|P1|Overall Study|Missed Visits|374
5248107|NCT00772941|18108861|P1|Overall Study|Study not completed|16
5248108|NCT00772941|18108861|P1|Overall Study|CRFs not available|195
5248109|NCT00772928|18108892|P2|Overall Study|Did not receive vaccine|1
5248110|NCT00772928|18108893|P1|Overall Study|Did not receive vaccine|0
5248111|NCT00772928|18108892|P2|Overall Study|Withdrawal by Subject|22
5248112|NCT00772928|18108893|P1|Overall Study|Withdrawal by Subject|25
5248113|NCT00772928|18108892|P2|Overall Study|Protocol Violation|12
5248114|NCT00772928|18108893|P1|Overall Study|Protocol Violation|10
5248115|NCT00772928|18108892|P2|Overall Study|Lost to Follow-up|6
5248116|NCT00772928|18108893|P1|Overall Study|Lost to Follow-up|9
5248117|NCT00772889|18108914|P3|Overall Study|Lost to Follow-up|7
5248118|NCT00772889|18108915|P2|Overall Study|Lost to Follow-up|6
5248119|NCT00772889|18108916|P1|Overall Study|Lost to Follow-up|6
5248120|NCT00772889|18108914|P3|Overall Study|Withdrawal by Subject|9
5248121|NCT00772889|18108915|P2|Overall Study|Withdrawal by Subject|8
5248122|NCT00772889|18108916|P1|Overall Study|Withdrawal by Subject|9
5248123|NCT00772889|18108914|P3|Overall Study|Adverse Event|0
5248124|NCT00772889|18108915|P2|Overall Study|Adverse Event|4
5248125|NCT00772889|18108916|P1|Overall Study|Adverse Event|7
5248126|NCT00772707|18108974|P1|Overall Study|Withdrawn|3
5248127|NCT00772668|18108979|P1|Overall Study|Physician Decision|3
5248128|NCT00772629|18108988|P2|Overall Study|Subject was not vaccinated|0
5248129|NCT00772629|18108989|P1|Overall Study|Subject was not vaccinated|1
5248130|NCT00772603|18108998|P3|Overall Study|Other|2
5248131|NCT00772603|18108999|P2|Overall Study|Other|0
5248132|NCT00772603|18109000|P1|Overall Study|Other|2
5248133|NCT00772603|18108998|P3|Overall Study|Physician Decision|1
5248134|NCT00772603|18108999|P2|Overall Study|Physician Decision|0
5248135|NCT00772603|18109000|P1|Overall Study|Physician Decision|0
5248136|NCT00772603|18108998|P3|Overall Study|Lost to Follow-up|2
5248137|NCT00772603|18108999|P2|Overall Study|Lost to Follow-up|5
5248138|NCT00772603|18109000|P1|Overall Study|Lost to Follow-up|1
5248139|NCT00772603|18108998|P3|Overall Study|Protocol Violation|1
5248140|NCT00772603|18108999|P2|Overall Study|Protocol Violation|1
5248141|NCT00772603|18109000|P1|Overall Study|Protocol Violation|0
5248142|NCT00772603|18108998|P3|Overall Study|Subject Non-compliance|4
5248143|NCT00772603|18108999|P2|Overall Study|Subject Non-compliance|6
5248144|NCT00772603|18109000|P1|Overall Study|Subject Non-compliance|1
5248145|NCT00772603|18108998|P3|Overall Study|Adverse Event|10
5248146|NCT00772603|18108999|P2|Overall Study|Adverse Event|18
5248147|NCT00772603|18109000|P1|Overall Study|Adverse Event|37
5248148|NCT00772603|18108998|P3|Overall Study|Withdrawal by Subject|6
5248149|NCT00772603|18108999|P2|Overall Study|Withdrawal by Subject|10
5248150|NCT00772603|18109000|P1|Overall Study|Withdrawal by Subject|11
5248151|NCT00772577|18109039|P2|Overall Study|Protocol Deviation|2
5248152|NCT00772577|18109040|P1|Overall Study|Protocol Deviation|3
5248153|NCT00772577|18109039|P2|Overall Study|Administrative problems|1
5248154|NCT00772577|18109040|P1|Overall Study|Administrative problems|2
5248155|NCT00772577|18109039|P2|Overall Study|Lost to Follow-up|3
5248156|NCT00772577|18109040|P1|Overall Study|Lost to Follow-up|4
5248157|NCT00772577|18109039|P2|Overall Study|Patient withdrew consent|5
5248158|NCT00772577|18109040|P1|Overall Study|Patient withdrew consent|8
5248159|NCT00772577|18109039|P2|Overall Study|Unsatisfactory therapeutic effect|8
5248160|NCT00772577|18109040|P1|Overall Study|Unsatisfactory therapeutic effect|0
5248161|NCT00772577|18109039|P2|Overall Study|Abnormal laboratory values|1
5248162|NCT00772577|18109040|P1|Overall Study|Abnormal laboratory values|0
5248163|NCT00772577|18109039|P2|Overall Study|Adverse Event|3
5248164|NCT00772577|18109040|P1|Overall Study|Adverse Event|6
5248165|NCT00772538|18109056|P2|Overall Study|Other|7
5248166|NCT00772538|18109057|P1|Overall Study|Other|7
5248167|NCT00772538|18109056|P2|Overall Study|Lack of Efficacy|1
5248168|NCT00772538|18109057|P1|Overall Study|Lack of Efficacy|0
5248169|NCT00772538|18109056|P2|Overall Study|Withdrawal by Subject|8
5248170|NCT00772538|18109057|P1|Overall Study|Withdrawal by Subject|3
5248171|NCT00772538|18109056|P2|Overall Study|Lost to Follow-up|1
5248172|NCT00772538|18109057|P1|Overall Study|Lost to Follow-up|1
5248173|NCT00772538|18109056|P2|Overall Study|Protocol Violation|3
5248174|NCT00772538|18109057|P1|Overall Study|Protocol Violation|3
5248175|NCT00772538|18109056|P2|Overall Study|Adverse Event|6
5248176|NCT00772538|18109057|P1|Overall Study|Adverse Event|6
5248177|NCT00772447|18109129|P2|Overall Study|all others|2
5248178|NCT00772447|18109130|P1|Overall Study|all others|2
5248179|NCT00772447|18109129|P2|Overall Study|Protocol Violation|1
5248180|NCT00772447|18109130|P1|Overall Study|Protocol Violation|0
5248181|NCT00772447|18109129|P2|Overall Study|incorrect enrolment|4
5248182|NCT00772447|18109130|P1|Overall Study|incorrect enrolment|3
5248183|NCT00772447|18109129|P2|Overall Study|Lost to Follow-up|4
5248184|NCT00772447|18109130|P1|Overall Study|Lost to Follow-up|2
5248185|NCT00772447|18109129|P2|Overall Study|Physician Decision|8
5248186|NCT00772447|18109130|P1|Overall Study|Physician Decision|4
5248187|NCT00772447|18109129|P2|Overall Study|Withdrawal by Subject|5
5248188|NCT00772447|18109130|P1|Overall Study|Withdrawal by Subject|9
5248189|NCT00772382|18109158|P1|Overall Study|Other Reasons|10
5248190|NCT00772382|18109158|P1|Overall Study|Withdrawal by Subject|10
5248191|NCT00772382|18109158|P1|Overall Study|Protocol Violation|1
5248192|NCT00772382|18109158|P1|Overall Study|Physician Decision|5
5248193|NCT00772382|18109158|P1|Overall Study|Lack of Efficacy|4
5248194|NCT00772382|18109158|P1|Overall Study|Death|6
5248195|NCT00772382|18109158|P1|Overall Study|Adverse Event|19
5248196|NCT00772369|18109163|P1|Overall Study|Did not return record release form|1
5248197|NCT00772148|18109174|P2|Maintenance Phase (Week 52)|Administrative/other|2
5248198|NCT00772148|18109175|P1|Maintenance Phase (Week 52)|Administrative/other|1
5248199|NCT00772148|18109174|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
5248200|NCT00772148|18109175|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
5248201|NCT00772148|18109174|P2|Maintenance Phase (Week 52)|Adverse Event|0
5248202|NCT00772148|18109175|P1|Maintenance Phase (Week 52)|Adverse Event|1
5248203|NCT00772148|18109174|P2|Maintenance Phase (Week 52)|Death|2
5248204|NCT00772148|18109175|P1|Maintenance Phase (Week 52)|Death|2
5248205|NCT00772148|18109174|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
5248206|NCT00772148|18109175|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
5248207|NCT00772148|18109174|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
5248208|NCT00772148|18109175|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
5248209|NCT00772148|18109174|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
5248210|NCT00772148|18109175|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
5248211|NCT00772109|18109195|P4|Overall Study|Withdrawal by Subject|16
5248212|NCT00772109|18109196|P3|Overall Study|Withdrawal by Subject|6
5248213|NCT00772109|18109197|P2|Overall Study|Withdrawal by Subject|8
5248214|NCT00772109|18109198|P1|Overall Study|Withdrawal by Subject|8
5248215|NCT00772109|18109195|P4|Overall Study|Lost to Follow-up|9
5248216|NCT00772109|18109196|P3|Overall Study|Lost to Follow-up|5
5248217|NCT00772109|18109197|P2|Overall Study|Lost to Follow-up|3
5248218|NCT00772109|18109198|P1|Overall Study|Lost to Follow-up|7
5248219|NCT00772109|18109195|P4|Overall Study|Protocol Violation|6
5248220|NCT00772109|18109196|P3|Overall Study|Protocol Violation|7
5248221|NCT00772109|18109197|P2|Overall Study|Protocol Violation|8
5248222|NCT00772109|18109198|P1|Overall Study|Protocol Violation|5
5248223|NCT00772109|18109195|P4|Overall Study|Serious adverse event|0
5248224|NCT00772109|18109196|P3|Overall Study|Serious adverse event|1
5248225|NCT00772109|18109197|P2|Overall Study|Serious adverse event|0
5248226|NCT00772109|18109198|P1|Overall Study|Serious adverse event|1
5248227|NCT00772070|18109222|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
5248228|NCT00772070|18109223|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
5248229|NCT00772070|18109222|P2|Overall Study|Withdrawal by Subject|2
5248230|NCT00772070|18109223|P1|Overall Study|Withdrawal by Subject|0
5248231|NCT00772070|18109222|P2|Overall Study|Lost to Follow-up|8
5248232|NCT00772070|18109223|P1|Overall Study|Lost to Follow-up|0
5248233|NCT00772031|18109235|P2|Overall Study|Lost to Follow-up|33
5248234|NCT00772031|18109236|P1|Overall Study|Lost to Follow-up|20
5248235|NCT00772031|18109235|P2|Overall Study|Early termination of trial|10
5248236|NCT00772031|18109236|P1|Overall Study|Early termination of trial|12
5248237|NCT00772005|18109262|P4|Overall Study|Non-compliance with drug administration|1
5248238|NCT00772005|18109263|P3|Overall Study|Non-compliance with drug administration|1
5248239|NCT00772005|18109264|P2|Overall Study|Non-compliance with drug administration|0
5248240|NCT00772005|18109265|P1|Overall Study|Non-compliance with drug administration|3
5248241|NCT00772005|18109262|P4|Overall Study|Non-compliance with study procedures|1
5248242|NCT00772005|18109263|P3|Overall Study|Non-compliance with study procedures|0
5248243|NCT00772005|18109264|P2|Overall Study|Non-compliance with study procedures|1
5248244|NCT00772005|18109265|P1|Overall Study|Non-compliance with study procedures|1
5248245|NCT00772005|18109262|P4|Overall Study|Lost to Follow-up|3
5248246|NCT00772005|18109263|P3|Overall Study|Lost to Follow-up|6
5248247|NCT00772005|18109264|P2|Overall Study|Lost to Follow-up|3
5248248|NCT00772005|18109265|P1|Overall Study|Lost to Follow-up|7
5248249|NCT00772005|18109262|P4|Overall Study|Protocol Violation|6
5248250|NCT00772005|18109263|P3|Overall Study|Protocol Violation|1
5248251|NCT00772005|18109264|P2|Overall Study|Protocol Violation|4
5248252|NCT00772005|18109265|P1|Overall Study|Protocol Violation|2
5248253|NCT00772005|18109262|P4|Overall Study|Withdrawal by Subject|2
5248254|NCT00772005|18109263|P3|Overall Study|Withdrawal by Subject|10
5248255|NCT00772005|18109264|P2|Overall Study|Withdrawal by Subject|7
5248256|NCT00772005|18109265|P1|Overall Study|Withdrawal by Subject|3
5248257|NCT00772005|18109262|P4|Overall Study|Lack of Efficacy|0
5248258|NCT00772005|18109263|P3|Overall Study|Lack of Efficacy|0
5248259|NCT00772005|18109264|P2|Overall Study|Lack of Efficacy|1
5248260|NCT00772005|18109265|P1|Overall Study|Lack of Efficacy|0
5248261|NCT00772005|18109262|P4|Overall Study|Adverse Event|13
5248262|NCT00772005|18109263|P3|Overall Study|Adverse Event|10
5248263|NCT00772005|18109264|P2|Overall Study|Adverse Event|14
5248264|NCT00772005|18109265|P1|Overall Study|Adverse Event|9
5248265|NCT00771953|18109953|P2|Overall Study|Withdrawal by Subject|3
5248266|NCT00771953|18109954|P1|Overall Study|Withdrawal by Subject|0
5248267|NCT00771953|18109953|P2|Overall Study|Other complicating disease|0
5248268|NCT00771953|18109954|P1|Overall Study|Other complicating disease|1
5248269|NCT00771953|18109953|P2|Overall Study|Sponsor decision|0
5248270|NCT00771953|18109954|P1|Overall Study|Sponsor decision|1
5248271|NCT00771953|18109953|P2|Overall Study|Progression before active Tx|2
5248272|NCT00771953|18109954|P1|Overall Study|Progression before active Tx|1
5248273|NCT00771953|18109953|P2|Overall Study|Death|2
5248274|NCT00771953|18109954|P1|Overall Study|Death|2
5248275|NCT00771953|18109953|P2|Overall Study|Adverse Event|3
5248276|NCT00771953|18109954|P1|Overall Study|Adverse Event|5
5248277|NCT00771927|18109964|P2|Overall Study|Other reason|27
5248278|NCT00771927|18109965|P1|Overall Study|Other reason|23
5248279|NCT00771927|18109964|P2|Overall Study|Withdrawal by Subject|17
5248280|NCT00771927|18109965|P1|Overall Study|Withdrawal by Subject|16
5248281|NCT00771927|18109964|P2|Overall Study|Lost to Follow-up|46
5248282|NCT00771927|18109965|P1|Overall Study|Lost to Follow-up|46
5248283|NCT00771927|18109964|P2|Overall Study|Lack of Efficacy|42
5248284|NCT00771927|18109965|P1|Overall Study|Lack of Efficacy|70
5248285|NCT00771927|18109964|P2|Overall Study|Adverse Event|105
5248286|NCT00771927|18109965|P1|Overall Study|Adverse Event|100
5248287|NCT00771914|18109977|P4|Overall Study|Lost to Follow-up|1
5248288|NCT00771914|18109978|P3|Overall Study|Lost to Follow-up|0
5248289|NCT00771914|18109979|P2|Overall Study|Lost to Follow-up|0
5248290|NCT00771914|18109980|P1|Overall Study|Lost to Follow-up|0
5248291|NCT00771914|18109977|P4|Overall Study|Physician Decision|1
5248292|NCT00771914|18109978|P3|Overall Study|Physician Decision|0
5248293|NCT00771914|18109979|P2|Overall Study|Physician Decision|0
5248294|NCT00771914|18109980|P1|Overall Study|Physician Decision|0
5248295|NCT00771901|18109993|P3|Overall Study|Dissat w/# of study medication (40/day)|4
5248296|NCT00771901|18109994|P2|Overall Study|Dissat w/# of study medication (40/day)|0
5248297|NCT00771901|18109995|P1|Overall Study|Dissat w/# of study medication (40/day)|0
5248298|NCT00771849|18110042|P2|Overall Study|Not vaccinated|1
5248299|NCT00771849|18110043|P1|Overall Study|Not vaccinated|0
5248300|NCT00771849|18110042|P2|Overall Study|Withdrawal by Subject|1
5248301|NCT00771849|18110043|P1|Overall Study|Withdrawal by Subject|1
5248302|NCT00771849|18110042|P2|Overall Study|Lost to Follow-up|2
5248303|NCT00771849|18110043|P1|Overall Study|Lost to Follow-up|1
5248304|NCT00771810|18110054|P3|Overall Study|Other|1
5248305|NCT00771810|18110055|P2|Overall Study|Other|0
5248306|NCT00771810|18110056|P1|Overall Study|Other|0
5248307|NCT00771810|18110054|P3|Overall Study|Withdrawal by Subject|0
5248308|NCT00771810|18110055|P2|Overall Study|Withdrawal by Subject|2
5248309|NCT00771810|18110056|P1|Overall Study|Withdrawal by Subject|1
5248310|NCT00771810|18110054|P3|Overall Study|Protocol Violation|1
5248311|NCT00771810|18110055|P2|Overall Study|Protocol Violation|1
5248312|NCT00771810|18110056|P1|Overall Study|Protocol Violation|0
5248313|NCT00771810|18110054|P3|Overall Study|Physician Decision|2
5248314|NCT00771810|18110055|P2|Overall Study|Physician Decision|2
5248315|NCT00771810|18110056|P1|Overall Study|Physician Decision|1
5248316|NCT00771810|18110054|P3|Overall Study|Lost to Follow-up|1
5248317|NCT00771810|18110055|P2|Overall Study|Lost to Follow-up|0
5248318|NCT00771810|18110056|P1|Overall Study|Lost to Follow-up|0
5248319|NCT00771810|18110054|P3|Overall Study|Adverse Event|2
5248320|NCT00771810|18110055|P2|Overall Study|Adverse Event|0
5248321|NCT00771810|18110056|P1|Overall Study|Adverse Event|3
5248322|NCT00771758|18110094|P3|Overall Study|Other|0
5248323|NCT00771758|18110095|P2|Overall Study|Other|2
5248324|NCT00771758|18110096|P1|Overall Study|Other|3
5248325|NCT00771758|18110094|P3|Overall Study|Withdrawal by Subject|0
5248326|NCT00771758|18110095|P2|Overall Study|Withdrawal by Subject|0
5248327|NCT00771758|18110096|P1|Overall Study|Withdrawal by Subject|1
5248328|NCT00771758|18110094|P3|Overall Study|Protocol Violation|0
5248329|NCT00771758|18110095|P2|Overall Study|Protocol Violation|0
5248330|NCT00771758|18110096|P1|Overall Study|Protocol Violation|1
5248331|NCT00771758|18110094|P3|Overall Study|Lost to Follow-up|0
5248332|NCT00771758|18110095|P2|Overall Study|Lost to Follow-up|0
5248333|NCT00771758|18110096|P1|Overall Study|Lost to Follow-up|1
5248334|NCT00771758|18110094|P3|Overall Study|Lack of Efficacy|1
5248335|NCT00771758|18110095|P2|Overall Study|Lack of Efficacy|2
5248336|NCT00771758|18110096|P1|Overall Study|Lack of Efficacy|0
5248337|NCT00771758|18110094|P3|Overall Study|Adverse Event|1
5248338|NCT00771758|18110095|P2|Overall Study|Adverse Event|8
5248339|NCT00771758|18110096|P1|Overall Study|Adverse Event|2
5248340|NCT00771667|18110257|P10|Maintenance Phase|Other|3
5248341|NCT00771667|18110258|P9|Maintenance Phase|Other|3
5248342|NCT00771667|18110259|P8|Maintenance Phase|Other|2
5248343|NCT00771667|18110260|P7|Maintenance Phase|Other|2
5248344|NCT00771667|18110261|P6|Maintenance Phase|Other|1
5248345|NCT00771667|18110262|P5|Maintenance Phase|Other|0
5248346|NCT00771667|18110263|P4|Maintenance Phase|Other|0
5248347|NCT00771667|18110264|P3|Maintenance Phase|Other|0
5248348|NCT00771667|18110265|P2|Maintenance Phase|Other|0
5248349|NCT00771667|18110266|P1|Maintenance Phase|Other|0
5248350|NCT00771667|18110257|P10|Maintenance Phase|Lack of Efficacy|7
5248351|NCT00771667|18110258|P9|Maintenance Phase|Lack of Efficacy|11
5248352|NCT00771667|18110259|P8|Maintenance Phase|Lack of Efficacy|2
5248353|NCT00771667|18110260|P7|Maintenance Phase|Lack of Efficacy|3
5248354|NCT00771667|18110261|P6|Maintenance Phase|Lack of Efficacy|3
5248355|NCT00771667|18110262|P5|Maintenance Phase|Lack of Efficacy|1
5248356|NCT00771667|18110263|P4|Maintenance Phase|Lack of Efficacy|0
5248357|NCT00771667|18110264|P3|Maintenance Phase|Lack of Efficacy|0
5248358|NCT00771667|18110265|P2|Maintenance Phase|Lack of Efficacy|0
5248359|NCT00771667|18110266|P1|Maintenance Phase|Lack of Efficacy|0
5248360|NCT00771667|18110257|P10|Maintenance Phase|Adverse Event|7
5248361|NCT00771667|18110258|P9|Maintenance Phase|Adverse Event|8
5248362|NCT00771667|18110259|P8|Maintenance Phase|Adverse Event|1
5248363|NCT00771667|18110260|P7|Maintenance Phase|Adverse Event|5
5248364|NCT00771667|18110261|P6|Maintenance Phase|Adverse Event|3
5248365|NCT00771667|18110262|P5|Maintenance Phase|Adverse Event|1
5248366|NCT00771667|18110263|P4|Maintenance Phase|Adverse Event|0
5248367|NCT00771667|18110264|P3|Maintenance Phase|Adverse Event|0
5248368|NCT00771667|18110265|P2|Maintenance Phase|Adverse Event|0
5248369|NCT00771667|18110266|P1|Maintenance Phase|Adverse Event|0
5248370|NCT00771667|18110257|P10|Induction Phase|Other|0
5248371|NCT00771667|18110258|P9|Induction Phase|Other|0
5248372|NCT00771667|18110259|P8|Induction Phase|Other|0
5248373|NCT00771667|18110260|P7|Induction Phase|Other|0
5248374|NCT00771667|18110261|P6|Induction Phase|Other|0
5248375|NCT00771667|18110262|P5|Induction Phase|Other|0
5248376|NCT00771667|18110263|P4|Induction Phase|Other|4
5248377|NCT00771667|18110264|P3|Induction Phase|Other|3
5248378|NCT00771667|18110265|P2|Induction Phase|Other|6
5248379|NCT00771667|18110266|P1|Induction Phase|Other|4
5248380|NCT00771667|18110257|P10|Induction Phase|Lost to Follow-up|0
5248381|NCT00771667|18110258|P9|Induction Phase|Lost to Follow-up|0
5248382|NCT00771667|18110259|P8|Induction Phase|Lost to Follow-up|0
5248383|NCT00771667|18110260|P7|Induction Phase|Lost to Follow-up|0
5248384|NCT00771667|18110261|P6|Induction Phase|Lost to Follow-up|0
5248385|NCT00771667|18110262|P5|Induction Phase|Lost to Follow-up|0
5248386|NCT00771667|18110263|P4|Induction Phase|Lost to Follow-up|0
5248387|NCT00771667|18110264|P3|Induction Phase|Lost to Follow-up|1
5248388|NCT00771667|18110265|P2|Induction Phase|Lost to Follow-up|0
5248389|NCT00771667|18110266|P1|Induction Phase|Lost to Follow-up|1
5248390|NCT00771667|18110257|P10|Induction Phase|Lack of Efficacy|0
5248391|NCT00771667|18110258|P9|Induction Phase|Lack of Efficacy|0
5248392|NCT00771667|18110259|P8|Induction Phase|Lack of Efficacy|0
5248393|NCT00771667|18110260|P7|Induction Phase|Lack of Efficacy|0
5248394|NCT00771667|18110261|P6|Induction Phase|Lack of Efficacy|0
5248395|NCT00771667|18110262|P5|Induction Phase|Lack of Efficacy|0
5248396|NCT00771667|18110263|P4|Induction Phase|Lack of Efficacy|3
5248397|NCT00771667|18110264|P3|Induction Phase|Lack of Efficacy|4
5248398|NCT00771667|18110265|P2|Induction Phase|Lack of Efficacy|2
5248399|NCT00771667|18110266|P1|Induction Phase|Lack of Efficacy|9
5248400|NCT00771667|18110257|P10|Induction Phase|Adverse Event|0
5248401|NCT00771667|18110258|P9|Induction Phase|Adverse Event|0
5248402|NCT00771667|18110259|P8|Induction Phase|Adverse Event|0
5248403|NCT00771667|18110260|P7|Induction Phase|Adverse Event|0
5248404|NCT00771667|18110261|P6|Induction Phase|Adverse Event|0
5248405|NCT00771667|18110262|P5|Induction Phase|Adverse Event|0
5248406|NCT00771667|18110263|P4|Induction Phase|Adverse Event|1
5248407|NCT00771667|18110264|P3|Induction Phase|Adverse Event|4
5248408|NCT00771667|18110265|P2|Induction Phase|Adverse Event|2
5248409|NCT00771667|18110266|P1|Induction Phase|Adverse Event|5
5248410|NCT00771615|18110311|P9|Overall Study|Lost to Follow-up|0
5248411|NCT00771615|18110312|P8|Overall Study|Lost to Follow-up|0
5248412|NCT00771615|18110313|P7|Overall Study|Lost to Follow-up|1
5248413|NCT00771615|18110314|P6|Overall Study|Lost to Follow-up|1
5248414|NCT00771615|18110315|P5|Overall Study|Lost to Follow-up|0
5248415|NCT00771615|18110316|P4|Overall Study|Lost to Follow-up|1
5248416|NCT00771615|18110317|P3|Overall Study|Lost to Follow-up|1
5248417|NCT00771615|18110318|P2|Overall Study|Lost to Follow-up|1
5248418|NCT00771615|18110319|P1|Overall Study|Lost to Follow-up|1
5248419|NCT00771615|18110311|P9|Overall Study|Withdrawal by Subject|0
5248420|NCT00771615|18110312|P8|Overall Study|Withdrawal by Subject|1
5248421|NCT00771615|18110313|P7|Overall Study|Withdrawal by Subject|0
5248422|NCT00771615|18110314|P6|Overall Study|Withdrawal by Subject|0
5248423|NCT00771615|18110315|P5|Overall Study|Withdrawal by Subject|0
5248424|NCT00771615|18110316|P4|Overall Study|Withdrawal by Subject|0
5248425|NCT00771615|18110317|P3|Overall Study|Withdrawal by Subject|0
5248426|NCT00771615|18110318|P2|Overall Study|Withdrawal by Subject|1
5248427|NCT00771615|18110319|P1|Overall Study|Withdrawal by Subject|0
5248428|NCT00771472|18110580|P2|Overall Study|Protocol Violation|0
5248429|NCT00771472|18110581|P1|Overall Study|Protocol Violation|1
5248430|NCT00771472|18110580|P2|Overall Study|Progressive Disease|1
5248431|NCT00771472|18110581|P1|Overall Study|Progressive Disease|3
5248432|NCT00771472|18110580|P2|Overall Study|Physician Decision|3
5248433|NCT00771472|18110581|P1|Overall Study|Physician Decision|2
5248434|NCT00771316|18110601|P2|Overall Study|Discontinued due to early termination|0
5248435|NCT00771316|18110602|P1|Overall Study|Discontinued due to early termination|1
5248436|NCT00771316|18110601|P2|Overall Study|Patient withdrew consent|0
5248437|NCT00771316|18110602|P1|Overall Study|Patient withdrew consent|1
5248438|NCT00771316|18110601|P2|Overall Study|Adverse Event|1
5248439|NCT00771316|18110602|P1|Overall Study|Adverse Event|0
5248440|NCT00770991|18110654|P2|Overall Study|Pregnancy|0
5248441|NCT00770991|18110655|P1|Overall Study|Pregnancy|1
5248442|NCT00770991|18110654|P2|Overall Study|Adverse Event|5
5248443|NCT00770991|18110655|P1|Overall Study|Adverse Event|1
5248444|NCT00770991|18110654|P2|Overall Study|Withdrawal by Subject|0
5248445|NCT00770991|18110655|P1|Overall Study|Withdrawal by Subject|1
5248446|NCT00770991|18110654|P2|Overall Study|Physician Decision|0
5248447|NCT00770991|18110655|P1|Overall Study|Physician Decision|2
5248448|NCT00770965|18110671|P4|Excluded Set|Withdrawal by Subject|3
5248449|NCT00770965|18110672|P3|Excluded Set|Withdrawal by Subject|2
5248450|NCT00770965|18110673|P2|Excluded Set|Withdrawal by Subject|1
5248451|NCT00770965|18110674|P1|Excluded Set|Withdrawal by Subject|1
5248452|NCT00770965|18110671|P4|Excluded Set|Administrative problems|10
5248453|NCT00770965|18110672|P3|Excluded Set|Administrative problems|12
5248454|NCT00770965|18110673|P2|Excluded Set|Administrative problems|12
5248455|NCT00770965|18110674|P1|Excluded Set|Administrative problems|14
5248456|NCT00770965|18110671|P4|Safety Set|Protocol deviation|0
5248457|NCT00770965|18110672|P3|Safety Set|Protocol deviation|1
5248458|NCT00770965|18110673|P2|Safety Set|Protocol deviation|0
5248459|NCT00770965|18110674|P1|Safety Set|Protocol deviation|0
5248460|NCT00770965|18110671|P4|Safety Set|Withdrawal by Subject|1
5248461|NCT00770965|18110672|P3|Safety Set|Withdrawal by Subject|0
5248462|NCT00770965|18110673|P2|Safety Set|Withdrawal by Subject|0
5248463|NCT00770965|18110674|P1|Safety Set|Withdrawal by Subject|0
5248464|NCT00770913|18110695|P3|Overall Study|Incorrect drug was allocated|0
5248465|NCT00770913|18110696|P2|Overall Study|Incorrect drug was allocated|0
5248466|NCT00770913|18110697|P1|Overall Study|Incorrect drug was allocated|1
5248467|NCT00770913|18110695|P3|Overall Study|Protocol Violation|1
5248468|NCT00770913|18110696|P2|Overall Study|Protocol Violation|0
5248469|NCT00770913|18110697|P1|Overall Study|Protocol Violation|3
5248470|NCT00770913|18110695|P3|Overall Study|Physician Decision|1
5248471|NCT00770913|18110696|P2|Overall Study|Physician Decision|1
5248472|NCT00770913|18110697|P1|Overall Study|Physician Decision|0
5248473|NCT00770913|18110695|P3|Overall Study|Refusal to continue participation|5
5248474|NCT00770913|18110696|P2|Overall Study|Refusal to continue participation|4
5248475|NCT00770913|18110697|P1|Overall Study|Refusal to continue participation|6
5248476|NCT00770913|18110695|P3|Overall Study|Adverse Event|6
5248477|NCT00770913|18110696|P2|Overall Study|Adverse Event|3
5248478|NCT00770913|18110697|P1|Overall Study|Adverse Event|1
5248479|NCT00770809|18110730|P3|Overall Study|Other Medical Reasons|3
5248480|NCT00770809|18110731|P2|Overall Study|Other Medical Reasons|4
5248481|NCT00770809|18110732|P1|Overall Study|Other Medical Reasons|2
5248482|NCT00770809|18110730|P3|Overall Study|Complicating illness|1
5248483|NCT00770809|18110731|P2|Overall Study|Complicating illness|0
5248484|NCT00770809|18110732|P1|Overall Study|Complicating illness|0
5248485|NCT00770809|18110730|P3|Overall Study|Progression|0
5248486|NCT00770809|18110731|P2|Overall Study|Progression|2
5248487|NCT00770809|18110732|P1|Overall Study|Progression|2
5248488|NCT00770809|18110730|P3|Overall Study|Withdrawal by Subject|7
5248489|NCT00770809|18110731|P2|Overall Study|Withdrawal by Subject|3
5248490|NCT00770809|18110732|P1|Overall Study|Withdrawal by Subject|3
5248491|NCT00770809|18110730|P3|Overall Study|Death|0
5248492|NCT00770809|18110731|P2|Overall Study|Death|0
5248493|NCT00770809|18110732|P1|Overall Study|Death|1
5248494|NCT00770809|18110730|P3|Overall Study|Adverse Event|12
5248495|NCT00770809|18110731|P2|Overall Study|Adverse Event|1
5248496|NCT00770809|18110732|P1|Overall Study|Adverse Event|9
5248497|NCT00770770|18110742|P2|Overall Study|Study Terminated|0
5248498|NCT00770770|18110743|P1|Overall Study|Study Terminated|8
5248499|NCT00770770|18110742|P2|Overall Study|Death|1
5248500|NCT00770770|18110743|P1|Overall Study|Death|0
5248501|NCT00770770|18110742|P2|Overall Study|Withdrawal by Subject|0
5248502|NCT00770770|18110743|P1|Overall Study|Withdrawal by Subject|1
5248503|NCT00770770|18110742|P2|Overall Study|Lost to Follow-up|0
5248504|NCT00770770|18110743|P1|Overall Study|Lost to Follow-up|1
5248505|NCT00770692|18110761|P4|Overall Study|Investigator judgment|1
5248506|NCT00770692|18110762|P3|Overall Study|Investigator judgment|1
5248507|NCT00770692|18110763|P2|Overall Study|Investigator judgment|0
5248508|NCT00770692|18110764|P1|Overall Study|Investigator judgment|2
5248509|NCT00770692|18110761|P4|Overall Study|Adverse Event|4
5248510|NCT00770692|18110762|P3|Overall Study|Adverse Event|4
5248511|NCT00770692|18110763|P2|Overall Study|Adverse Event|0
5248512|NCT00770692|18110764|P1|Overall Study|Adverse Event|3
5248513|NCT00770692|18110761|P4|Overall Study|Withdrawal by Subject|6
5248514|NCT00770692|18110762|P3|Overall Study|Withdrawal by Subject|9
5248515|NCT00770692|18110763|P2|Overall Study|Withdrawal by Subject|9
5248516|NCT00770692|18110764|P1|Overall Study|Withdrawal by Subject|7
5248517|NCT00770679|18110790|P1|Overall Study|Follow-up LDL measurement not collected|3
5248518|NCT00770679|18110790|P1|Overall Study|Lost to Follow-up|3
5248519|NCT00770653|18110798|P2|Overall Study|Physician Decision|0
5248520|NCT00770653|18110799|P1|Overall Study|Physician Decision|1
5248521|NCT00770653|18110798|P2|Overall Study|Lost to Follow-up|2
5248522|NCT00770653|18110799|P1|Overall Study|Lost to Follow-up|1
5248523|NCT00770653|18110798|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
5248524|NCT00770653|18110799|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
5248525|NCT00770653|18110798|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
5248526|NCT00770653|18110799|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
5248527|NCT00770653|18110798|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
5248528|NCT00770653|18110799|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
5248529|NCT00770653|18110798|P2|Overall Study|Lack of Compliance|4
5248530|NCT00770653|18110799|P1|Overall Study|Lack of Compliance|1
5248531|NCT00770653|18110798|P2|Overall Study|Withdrawal by Subject|7
5248532|NCT00770653|18110799|P1|Overall Study|Withdrawal by Subject|4
5248533|NCT00770653|18110798|P2|Overall Study|Protocol Violation|6
5248534|NCT00770653|18110799|P1|Overall Study|Protocol Violation|8
5248535|NCT00770653|18110798|P2|Overall Study|Adverse Event|5
5248536|NCT00770653|18110799|P1|Overall Study|Adverse Event|13
5248537|NCT00770588|18110869|P2|Overall Study|Withdrawal by Subject|1
5248538|NCT00770588|18110870|P1|Overall Study|Withdrawal by Subject|1
5248539|NCT00770588|18110869|P2|Overall Study|Lost to Follow-up|1
5248540|NCT00770588|18110870|P1|Overall Study|Lost to Follow-up|1
5248541|NCT00770588|18110869|P2|Overall Study|Death caused by progression of disease|91
5248542|NCT00770588|18110870|P1|Overall Study|Death caused by progression of disease|70
5248543|NCT00770588|18110869|P2|Overall Study|Adverse Event|2
5248544|NCT00770588|18110870|P1|Overall Study|Adverse Event|9
5248545|NCT00770562|18110886|P2|Overall Study|Did not take treatment|1
5248546|NCT00770562|18110887|P1|Overall Study|Did not take treatment|1
5248547|NCT00770510|18110898|P1|Overall Study|Withdrawal by Subject|2
5248548|NCT00770510|18110898|P1|Overall Study|Pregnancy|1
5248549|NCT00770510|18110898|P1|Overall Study|Lost to Follow-up|2
5248550|NCT00770484|18110937|P2|Overall Study|Withdrawal by Subject|0
5248551|NCT00770484|18110938|P1|Overall Study|Withdrawal by Subject|1
5248552|NCT00770432|18110946|P2|Overall Study|Non-compliance|1
5248553|NCT00770432|18110947|P1|Overall Study|Non-compliance|0
5248554|NCT00770432|18110946|P2|Overall Study|Other|6
5248555|NCT00770432|18110947|P1|Overall Study|Other|4
5248556|NCT00770367|18110955|P2|Second Intervention|Lost to Follow-up|0
5248557|NCT00770367|18110956|P1|Second Intervention|Lost to Follow-up|2
5248558|NCT00770367|18110955|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
5248559|NCT00770367|18110956|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
5248560|NCT00770367|18110955|P2|First Intervention|Withdrawal by Subject|2
5248561|NCT00770367|18110956|P1|First Intervention|Withdrawal by Subject|0
5248562|NCT00770341|18110967|P3|Overall Study|Not treated|0
5248563|NCT00770341|18110968|P2|Overall Study|Not treated|0
5248564|NCT00770341|18110969|P1|Overall Study|Not treated|1
5248565|NCT00770341|18110967|P3|Overall Study|Other|0
5248566|NCT00770341|18110968|P2|Overall Study|Other|0
5248567|NCT00770341|18110969|P1|Overall Study|Other|1
5248568|NCT00770341|18110967|P3|Overall Study|Lack of Efficacy|1
5248569|NCT00770341|18110968|P2|Overall Study|Lack of Efficacy|0
5248570|NCT00770341|18110969|P1|Overall Study|Lack of Efficacy|3
5248571|NCT00770341|18110967|P3|Overall Study|Laboratory adverse event|0
5248572|NCT00770341|18110968|P2|Overall Study|Laboratory adverse event|3
5248573|NCT00770341|18110969|P1|Overall Study|Laboratory adverse event|3
5248574|NCT00770341|18110967|P3|Overall Study|Clinical Adverse Event|2
5248575|NCT00770341|18110968|P2|Overall Study|Clinical Adverse Event|1
5248576|NCT00770341|18110969|P1|Overall Study|Clinical Adverse Event|3
5248577|NCT00770341|18110967|P3|Overall Study|Withdrawal by Subject|0
5248578|NCT00770341|18110968|P2|Overall Study|Withdrawal by Subject|1
5248579|NCT00770341|18110969|P1|Overall Study|Withdrawal by Subject|0
5248580|NCT00770341|18110967|P3|Overall Study|Did not meet eligibility criteria|0
5248581|NCT00770341|18110968|P2|Overall Study|Did not meet eligibility criteria|0
5248582|NCT00770341|18110969|P1|Overall Study|Did not meet eligibility criteria|1
5248583|NCT00770328|18110995|P2|Overall Study|Lost to Follow-up|2
5248584|NCT00770328|18110996|P1|Overall Study|Lost to Follow-up|2
5248585|NCT00770328|18110995|P2|Overall Study|Adverse Event|2
5248586|NCT00770328|18110996|P1|Overall Study|Adverse Event|11
5248587|NCT00770315|18111012|P4|Overall Study|Noncompliance with Protocol|9
5248588|NCT00770315|18111013|P3|Overall Study|Noncompliance with Protocol|7
5248589|NCT00770315|18111014|P2|Overall Study|Noncompliance with Protocol|4
5248590|NCT00770315|18111015|P1|Overall Study|Noncompliance with Protocol|7
5248591|NCT00770315|18111012|P4|Overall Study|Withdrawal by Subject|20
5248592|NCT00770315|18111013|P3|Overall Study|Withdrawal by Subject|24
5248593|NCT00770315|18111014|P2|Overall Study|Withdrawal by Subject|17
5248594|NCT00770315|18111015|P1|Overall Study|Withdrawal by Subject|13
5248595|NCT00770315|18111012|P4|Overall Study|Lost to Follow-up|3
5248596|NCT00770315|18111013|P3|Overall Study|Lost to Follow-up|10
5248597|NCT00770315|18111014|P2|Overall Study|Lost to Follow-up|5
5248598|NCT00770315|18111015|P1|Overall Study|Lost to Follow-up|9
5248599|NCT00770315|18111012|P4|Overall Study|Adverse Event|6
5248600|NCT00770315|18111013|P3|Overall Study|Adverse Event|16
5248601|NCT00770315|18111014|P2|Overall Study|Adverse Event|17
5248602|NCT00770315|18111015|P1|Overall Study|Adverse Event|11
5248603|NCT00770289|18111041|P1|Overall Study|Other|6
5248604|NCT00770224|18111050|P2|Step 2: Maintenance|Ineligible|2
5248605|NCT00770224|18111051|P1|Step 2: Maintenance|Ineligible|0
5248606|NCT00770224|18111050|P2|Step 2: Maintenance|Other reason not protocol specified|7
5248607|NCT00770224|18111051|P1|Step 2: Maintenance|Other reason not protocol specified|0
5248608|NCT00770224|18111050|P2|Step 2: Maintenance|Death|2
5248609|NCT00770224|18111051|P1|Step 2: Maintenance|Death|0
5248610|NCT00770224|18111050|P2|Step 2: Maintenance|Progression/relapse|1
5248611|NCT00770224|18111051|P1|Step 2: Maintenance|Progression/relapse|0
5248612|NCT00770224|18111050|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
5248613|NCT00770224|18111051|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
5248614|NCT00770224|18111050|P2|Step 2: Maintenance|Adverse Event|10
5248615|NCT00770224|18111051|P1|Step 2: Maintenance|Adverse Event|0
5248616|NCT00770224|18111050|P2|Step 1: Induction|No protocol treatment given|0
5248617|NCT00770224|18111051|P1|Step 1: Induction|No protocol treatment given|1
5248618|NCT00770224|18111050|P2|Step 1: Induction|Ineligible|0
5248619|NCT00770224|18111051|P1|Step 1: Induction|Ineligible|2
5248620|NCT00770224|18111050|P2|Step 1: Induction|Other reason not protocol specified|0
5248621|NCT00770224|18111051|P1|Step 1: Induction|Other reason not protocol specified|2
5248622|NCT00770224|18111050|P2|Step 1: Induction|Refusal unrelated to adverse event|0
5248623|NCT00770224|18111051|P1|Step 1: Induction|Refusal unrelated to adverse event|6
5248624|NCT00770224|18111050|P2|Step 1: Induction|Adverse Event|0
5248625|NCT00770224|18111051|P1|Step 1: Induction|Adverse Event|3
5248626|NCT00770211|18111063|P2|Overall Study|Withdrawal by Subject|2
5248627|NCT00770211|18111064|P1|Overall Study|Withdrawal by Subject|0
5248628|NCT00770211|18111063|P2|Overall Study|Lost to Follow-up|0
5248629|NCT00770211|18111064|P1|Overall Study|Lost to Follow-up|1
5248630|NCT00770146|18111080|P2|Follow-up Period|Other|5
5248631|NCT00770146|18111081|P1|Follow-up Period|Other|4
5248632|NCT00770146|18111080|P2|Follow-up Period|Adverse Event|2
5248633|NCT00770146|18111081|P1|Follow-up Period|Adverse Event|0
5248634|NCT00770146|18111080|P2|Follow-up Period|Withdrawal by Subject|13
5248635|NCT00770146|18111081|P1|Follow-up Period|Withdrawal by Subject|7
5248636|NCT00770146|18111080|P2|Treatment Period|Protocol non-compliance|1
5248637|NCT00770146|18111081|P1|Treatment Period|Protocol non-compliance|0
5248638|NCT00770146|18111080|P2|Treatment Period|Other|5
5248639|NCT00770146|18111081|P1|Treatment Period|Other|1
5248640|NCT00770146|18111080|P2|Treatment Period|Adverse Event|26
5248641|NCT00770146|18111081|P1|Treatment Period|Adverse Event|2
5248642|NCT00770146|18111080|P2|Treatment Period|Withdrawal by Subject|13
5248643|NCT00770146|18111081|P1|Treatment Period|Withdrawal by Subject|6
5248644|NCT00770120|18111170|P1|Overall Study|Reason under Review|1
5248645|NCT00770120|18111170|P1|Overall Study|Never Received Treatment/Not Analyzable|1
5248646|NCT00770120|18111170|P1|Overall Study|Ineligible|1
5248647|NCT00770120|18111170|P1|Overall Study|Withdrawal by Subject|2
5248648|NCT00770120|18111170|P1|Overall Study|Death|3
5248649|NCT00770120|18111170|P1|Overall Study|Not Protocol Specified|11
5248650|NCT00770120|18111170|P1|Overall Study|Adverse Event|11
5248651|NCT00770120|18111170|P1|Overall Study|Progression|31
5248652|NCT00770029|18111179|P2|Overall Study|Adverse Event|0
5248653|NCT00770029|18111180|P1|Overall Study|Adverse Event|1
5248654|NCT00770029|18111179|P2|Overall Study|Withdrawal by Subject|3
5248655|NCT00770029|18111180|P1|Overall Study|Withdrawal by Subject|3
5248656|NCT00770029|18111179|P2|Overall Study|Lost to Follow-up|0
5248657|NCT00770029|18111180|P1|Overall Study|Lost to Follow-up|2
5248658|NCT00769860|18111241|P2|Overall Study|Withdrawal by Subject|0
5248659|NCT00769860|18111242|P1|Overall Study|Withdrawal by Subject|2
5248660|NCT00769704|18111280|P2|Overall Study|Other|2
5248661|NCT00769704|18111281|P1|Overall Study|Other|1
5248662|NCT00769704|18111280|P2|Overall Study|Withdrawal by Subject|5
5248663|NCT00769704|18111281|P1|Overall Study|Withdrawal by Subject|12
5248664|NCT00769704|18111280|P2|Overall Study|Death|190
5248665|NCT00769704|18111281|P1|Overall Study|Death|95
5248666|NCT00769704|18111280|P2|Overall Study|Lost to Follow-up|2
5248667|NCT00769704|18111281|P1|Overall Study|Lost to Follow-up|3
5248668|NCT00769561|18111331|P2|Overall Study|Lost to Follow-up|3
5248669|NCT00769561|18111332|P1|Overall Study|Lost to Follow-up|1
5248670|NCT00769561|18111331|P2|Overall Study|Withdrawal by Subject|2
5248671|NCT00769561|18111332|P1|Overall Study|Withdrawal by Subject|2
5248672|NCT00769483|18111358|P6|Overall Study|Withdrawal by Subject|0
5248673|NCT00769483|18111359|P5|Overall Study|Withdrawal by Subject|1
5248674|NCT00769483|18111360|P4|Overall Study|Withdrawal by Subject|0
5248675|NCT00769483|18111361|P3|Overall Study|Withdrawal by Subject|0
5248676|NCT00769483|18111362|P2|Overall Study|Withdrawal by Subject|1
5248677|NCT00769483|18111363|P1|Overall Study|Withdrawal by Subject|0
5248678|NCT00769184|18111435|P2|No Treatment (6 Weeks)|Adverse Event|1
5248679|NCT00769184|18111436|P1|No Treatment (6 Weeks)|Adverse Event|1
5248680|NCT00769184|18111435|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
5248681|NCT00769184|18111436|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
5248682|NCT00769184|18111435|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
5248683|NCT00769184|18111436|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
5248684|NCT00769132|18111444|P4|Period 4|Withdrawal by Subject|0
5248685|NCT00769132|18111445|P3|Period 4|Withdrawal by Subject|0
5248686|NCT00769132|18111446|P2|Period 4|Withdrawal by Subject|1
5248687|NCT00769132|18111447|P1|Period 4|Withdrawal by Subject|0
5248688|NCT00769132|18111444|P4|Period 3|Withdrawal by Subject|0
5248689|NCT00769132|18111445|P3|Period 3|Withdrawal by Subject|0
5248690|NCT00769132|18111446|P2|Period 3|Withdrawal by Subject|0
5248691|NCT00769132|18111447|P1|Period 3|Withdrawal by Subject|1
5248692|NCT00769132|18111444|P4|Period 2|Withdrawal by Subject|1
5248693|NCT00769132|18111445|P3|Period 2|Withdrawal by Subject|0
5248694|NCT00769132|18111446|P2|Period 2|Withdrawal by Subject|0
5248695|NCT00769132|18111447|P1|Period 2|Withdrawal by Subject|0
5248696|NCT00769132|18111444|P4|Period 1|Adverse Event|1
5248697|NCT00769132|18111445|P3|Period 1|Adverse Event|0
5248698|NCT00769132|18111446|P2|Period 1|Adverse Event|0
5248699|NCT00769132|18111447|P1|Period 1|Adverse Event|1
5248700|NCT00769119|18111463|P2|Overall Study|Disallowed medication|0
5248701|NCT00769119|18111464|P1|Overall Study|Disallowed medication|1
5248702|NCT00769119|18111463|P2|Overall Study|Adverse Event|1
5248703|NCT00769119|18111464|P1|Overall Study|Adverse Event|1
5248704|NCT00769119|18111463|P2|Overall Study|Voluntary discontinuation|2
5248705|NCT00769119|18111464|P1|Overall Study|Voluntary discontinuation|0
5248706|NCT00769067|18111510|P2|Overall Study|Withdrawal by Subject|1
5248707|NCT00769067|18111511|P1|Overall Study|Withdrawal by Subject|0
5248708|NCT00769067|18111510|P2|Overall Study|Other|3
5248709|NCT00769067|18111511|P1|Overall Study|Other|1
5248710|NCT00769067|18111510|P2|Overall Study|Study terminated by sponsor|3
5248711|NCT00769067|18111511|P1|Overall Study|Study terminated by sponsor|1
5248712|NCT00769067|18111510|P2|Overall Study|Lost to Follow-up|1
5248713|NCT00769067|18111511|P1|Overall Study|Lost to Follow-up|3
5248714|NCT00769067|18111510|P2|Overall Study|Death|86
5248715|NCT00769067|18111511|P1|Overall Study|Death|89
5248716|NCT00769002|18111561|P2|Overall Study|Study was not completed, no data|9
5248717|NCT00769002|18111562|P1|Overall Study|Study was not completed, no data|9
5248718|NCT00768989|18111569|P2|On or After Week 36|Sponsor Termination|26
5248719|NCT00768989|18111570|P1|On or After Week 36|Sponsor Termination|45
5248720|NCT00768989|18111569|P2|On or After Week 36|Did not attend termination visit|0
5248721|NCT00768989|18111570|P1|On or After Week 36|Did not attend termination visit|2
5248722|NCT00768989|18111569|P2|On or After Week 36|Protocol Violation|0
5248723|NCT00768989|18111570|P1|On or After Week 36|Protocol Violation|1
5248724|NCT00768989|18111569|P2|On or After Week 36|Poor Compliance|0
5248725|NCT00768989|18111570|P1|On or After Week 36|Poor Compliance|1
5248726|NCT00768989|18111569|P2|On or After Week 36|Lost to Follow-up|0
5248727|NCT00768989|18111570|P1|On or After Week 36|Lost to Follow-up|1
5248728|NCT00768989|18111569|P2|On or After Week 36|Adverse Event|1
5248729|NCT00768989|18111570|P1|On or After Week 36|Adverse Event|0
5248730|NCT00768989|18111569|P2|On or After Week 36|Lack of Efficacy|0
5248731|NCT00768989|18111570|P1|On or After Week 36|Lack of Efficacy|1
5248732|NCT00768989|18111569|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
5248733|NCT00768989|18111570|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
5248734|NCT00768989|18111569|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
5248735|NCT00768989|18111570|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
5248736|NCT00768989|18111569|P2|Week 24 to Prior to Week 36|Adverse Event|0
5248737|NCT00768989|18111570|P1|Week 24 to Prior to Week 36|Adverse Event|1
5248738|NCT00768989|18111569|P2|Prior to Week 24|Protocol Violation|2
5248739|NCT00768989|18111570|P1|Prior to Week 24|Protocol Violation|0
5248740|NCT00768989|18111569|P2|Prior to Week 24|Lost to Follow-up|1
5248741|NCT00768989|18111570|P1|Prior to Week 24|Lost to Follow-up|0
5248742|NCT00768989|18111569|P2|Prior to Week 24|Adverse Event|0
5248743|NCT00768989|18111570|P1|Prior to Week 24|Adverse Event|3
5248744|NCT00768989|18111569|P2|Prior to Week 24|Withdrawal by Subject|0
5248745|NCT00768989|18111570|P1|Prior to Week 24|Withdrawal by Subject|1
5248746|NCT00768898|18111618|P1|Overall Study|Headache|1
5248747|NCT00768898|18111618|P1|Overall Study|Unrelated injury|1
5248748|NCT00768755|18111642|P4|Phase 2|Randomized but not treated|2
5248749|NCT00768755|18111643|P3|Phase 2|Randomized but not treated|0
5248750|NCT00768755|18111644|P2|Phase 2|Randomized but not treated|0
5248751|NCT00768755|18111645|P1|Phase 2|Randomized but not treated|0
5248752|NCT00768755|18111642|P4|Phase 2|Study Terminated by Sponsor|14
5248753|NCT00768755|18111643|P3|Phase 2|Study Terminated by Sponsor|7
5248754|NCT00768755|18111644|P2|Phase 2|Study Terminated by Sponsor|13
5248755|NCT00768755|18111645|P1|Phase 2|Study Terminated by Sponsor|0
5248756|NCT00768755|18111642|P4|Phase 2|Other|4
5248757|NCT00768755|18111643|P3|Phase 2|Other|2
5248758|NCT00768755|18111644|P2|Phase 2|Other|1
5248759|NCT00768755|18111645|P1|Phase 2|Other|0
5248760|NCT00768755|18111642|P4|Phase 2|Withdrawal by Subject|1
5248761|NCT00768755|18111643|P3|Phase 2|Withdrawal by Subject|0
5248762|NCT00768755|18111644|P2|Phase 2|Withdrawal by Subject|1
5248763|NCT00768755|18111645|P1|Phase 2|Withdrawal by Subject|0
5248764|NCT00768755|18111642|P4|Phase 2|Lost to Follow-up|4
5248765|NCT00768755|18111643|P3|Phase 2|Lost to Follow-up|1
5248766|NCT00768755|18111644|P2|Phase 2|Lost to Follow-up|1
5248767|NCT00768755|18111645|P1|Phase 2|Lost to Follow-up|0
5248768|NCT00768755|18111642|P4|Phase 2|Protocol Violation|1
5248769|NCT00768755|18111643|P3|Phase 2|Protocol Violation|0
5248770|NCT00768755|18111644|P2|Phase 2|Protocol Violation|2
5248771|NCT00768755|18111645|P1|Phase 2|Protocol Violation|0
5248772|NCT00768755|18111642|P4|Phase 2|Death|31
5248773|NCT00768755|18111643|P3|Phase 2|Death|48
5248774|NCT00768755|18111644|P2|Phase 2|Death|37
5248775|NCT00768755|18111645|P1|Phase 2|Death|0
5248776|NCT00768755|18111642|P4|Phase 1|Other|0
5248777|NCT00768755|18111643|P3|Phase 1|Other|0
5248778|NCT00768755|18111644|P2|Phase 1|Other|0
5248779|NCT00768755|18111645|P1|Phase 1|Other|4
5248780|NCT00768755|18111642|P4|Phase 1|Death|0
5248781|NCT00768755|18111643|P3|Phase 1|Death|0
5248782|NCT00768755|18111644|P2|Phase 1|Death|0
5248783|NCT00768755|18111645|P1|Phase 1|Death|6
5248784|NCT00768651|18111693|P1|Overall Study|Withdrawal by Subject|1
5248785|NCT00768560|18111732|P6|Intervention Set 1|Adverse Event|0
5248786|NCT00768560|18111733|P5|Intervention Set 1|Adverse Event|0
5248787|NCT00768560|18111734|P4|Intervention Set 1|Adverse Event|0
5248788|NCT00768560|18111735|P3|Intervention Set 1|Adverse Event|0
5248789|NCT00768560|18111736|P2|Intervention Set 1|Adverse Event|1
5248790|NCT00768560|18111737|P1|Intervention Set 1|Adverse Event|0
5248791|NCT00768469|18111774|P2|Overall Study|Withdrawal by Subject|1
5248792|NCT00768469|18111775|P1|Overall Study|Withdrawal by Subject|0
5248793|NCT00768469|18111774|P2|Overall Study|Disease Progression|4
5248794|NCT00768469|18111775|P1|Overall Study|Disease Progression|3
5248795|NCT00768469|18111774|P2|Overall Study|Adverse Event|2
5248796|NCT00768469|18111775|P1|Overall Study|Adverse Event|0
5248797|NCT00768430|18111790|P2|7 Day Endpoint|Withdrawal by Subject|3
5248798|NCT00768430|18111791|P1|7 Day Endpoint|Withdrawal by Subject|2
5248799|NCT00768300|18111799|P2|Overall Study|Missing data|0
5248800|NCT00768300|18111800|P1|Overall Study|Missing data|1
5248801|NCT00768300|18111799|P2|Overall Study|Treated but never dosed with Study drug|0
5248802|NCT00768300|18111800|P1|Overall Study|Treated but never dosed with Study drug|1
5248803|NCT00768300|18111799|P2|Overall Study|Began prohibited concomitant medication|1
5248804|NCT00768300|18111800|P1|Overall Study|Began prohibited concomitant medication|0
5248805|NCT00768300|18111799|P2|Overall Study|Lost to Follow-up|1
5248806|NCT00768300|18111800|P1|Overall Study|Lost to Follow-up|0
5248807|NCT00768300|18111799|P2|Overall Study|Received lung transplant|1
5248808|NCT00768300|18111800|P1|Overall Study|Received lung transplant|1
5248809|NCT00768300|18111799|P2|Overall Study|Screen failure following randomization|0
5248810|NCT00768300|18111800|P1|Overall Study|Screen failure following randomization|1
5248811|NCT00768300|18111799|P2|Overall Study|Subject moved to pursue lung transplant|1
5248812|NCT00768300|18111800|P1|Overall Study|Subject moved to pursue lung transplant|1
5248813|NCT00768300|18111799|P2|Overall Study|Death|5
5248814|NCT00768300|18111800|P1|Overall Study|Death|21
5248815|NCT00768300|18111799|P2|Overall Study|Study discontinued by Sponsor|140
5248816|NCT00768300|18111800|P1|Overall Study|Study discontinued by Sponsor|271
5248817|NCT00768300|18111799|P2|Overall Study|Physician Decision|3
5248818|NCT00768300|18111800|P1|Overall Study|Physician Decision|2
5248819|NCT00768300|18111799|P2|Overall Study|Withdrawal by Subject|7
5248820|NCT00768300|18111800|P1|Overall Study|Withdrawal by Subject|13
5248821|NCT00768300|18111799|P2|Overall Study|Protocol Violation|1
5248822|NCT00768300|18111800|P1|Overall Study|Protocol Violation|6
5248823|NCT00768300|18111799|P2|Overall Study|Adverse Event|2
5248824|NCT00768300|18111800|P1|Overall Study|Adverse Event|10
5248825|NCT00768300|18111799|P2|Overall Study|Randomized but not treated|1
5248826|NCT00768300|18111800|P1|Overall Study|Randomized but not treated|1
5248827|NCT00768248|18111884|P2|Overall Study|Research coordinator didn't collect data|1
5248828|NCT00768248|18111885|P1|Overall Study|Research coordinator didn't collect data|1
5248829|NCT00768222|18111901|P2|Overall Study|Protocol Violation|2
5248830|NCT00768222|18111902|P1|Overall Study|Protocol Violation|0
5248831|NCT00768222|18111901|P2|Overall Study|Withdrawal by Subject|1
5248832|NCT00768222|18111902|P1|Overall Study|Withdrawal by Subject|3
5248833|NCT00768222|18111901|P2|Overall Study|Lost to Follow-up|1
5248834|NCT00768222|18111902|P1|Overall Study|Lost to Follow-up|1
5248835|NCT00768144|18111924|P1|Overall Study|Pt Withdrew Consent|1
5248836|NCT00768144|18111924|P1|Overall Study|Patient or MD Decision to End Treatment|1
5248837|NCT00768144|18111924|P1|Overall Study|Progressive Disease|21
5248838|NCT00768144|18111924|P1|Overall Study|Adverse Event|13
5248839|NCT00768079|18111937|P3|Overall Study|Participant incarcerated|0
5248840|NCT00768079|18111938|P2|Overall Study|Participant incarcerated|1
5248841|NCT00768079|18111939|P1|Overall Study|Participant incarcerated|0
5248842|NCT00768079|18111937|P3|Overall Study|Lost to Follow-up|4
5248843|NCT00768079|18111938|P2|Overall Study|Lost to Follow-up|0
5248844|NCT00768079|18111939|P1|Overall Study|Lost to Follow-up|2
5248845|NCT00768066|18111996|P3|Overall Study|Did not receive study product injection.|0
5248846|NCT00768066|18111997|P2|Overall Study|Did not receive study product injection.|3
5248847|NCT00768066|18111998|P1|Overall Study|Did not receive study product injection.|3
5248848|NCT00768053|18112030|P1|Overall Study|Lost to Follow-up|1
5248849|NCT00768053|18112030|P1|Overall Study|Adverse Event|10
5248850|NCT00768040|18112061|P2|Overall Study|Abnormal laboratory value|1
5248851|NCT00768040|18112062|P1|Overall Study|Abnormal laboratory value|1
5248852|NCT00768040|18112061|P2|Overall Study|Adverse Event|2
5248853|NCT00768040|18112062|P1|Overall Study|Adverse Event|3
5248854|NCT00767819|18112071|P3|Overall Study|Lost to Follow-up|0
5248855|NCT00767819|18112072|P2|Overall Study|Lost to Follow-up|0
5248856|NCT00767819|18112073|P1|Overall Study|Lost to Follow-up|1
5248857|NCT00767819|18112071|P3|Overall Study|Abnormal lab values|0
5248858|NCT00767819|18112072|P2|Overall Study|Abnormal lab values|0
5248859|NCT00767819|18112073|P1|Overall Study|Abnormal lab values|1
5248860|NCT00767819|18112071|P3|Overall Study|Adverse Event|0
5248861|NCT00767819|18112072|P2|Overall Study|Adverse Event|0
5248862|NCT00767819|18112073|P1|Overall Study|Adverse Event|2
5248863|NCT00767819|18112071|P3|Overall Study|Death|0
5248864|NCT00767819|18112072|P2|Overall Study|Death|3
5248865|NCT00767819|18112073|P1|Overall Study|Death|2
5248866|NCT00767819|18112071|P3|Overall Study|Administrative problems|0
5248867|NCT00767819|18112072|P2|Overall Study|Administrative problems|1
5248868|NCT00767819|18112073|P1|Overall Study|Administrative problems|0
5248869|NCT00767819|18112071|P3|Overall Study|Withdrawal by Subject|0
5248870|NCT00767819|18112072|P2|Overall Study|Withdrawal by Subject|1
5248871|NCT00767819|18112073|P1|Overall Study|Withdrawal by Subject|1
5248872|NCT00767819|18112071|P3|Overall Study|Unsatisfactory therapeutic effect|0
5248873|NCT00767819|18112072|P2|Overall Study|Unsatisfactory therapeutic effect|14
5248874|NCT00767819|18112073|P1|Overall Study|Unsatisfactory therapeutic effect|18
5248875|NCT00767806|18112098|P2|Overall Study|Sponsor Decision|1
5248876|NCT00767806|18112099|P1|Overall Study|Sponsor Decision|0
5248877|NCT00767806|18112098|P2|Overall Study|Entry Criteria Not Met|1
5248878|NCT00767806|18112099|P1|Overall Study|Entry Criteria Not Met|1
5248879|NCT00767806|18112098|P2|Overall Study|Lost to Follow-up|4
5248880|NCT00767806|18112099|P1|Overall Study|Lost to Follow-up|1
5248881|NCT00767806|18112098|P2|Overall Study|Physician Decision|3
5248882|NCT00767806|18112099|P1|Overall Study|Physician Decision|4
5248883|NCT00767806|18112098|P2|Overall Study|Lack of Efficacy|9
5248884|NCT00767806|18112099|P1|Overall Study|Lack of Efficacy|1
5248885|NCT00767806|18112098|P2|Overall Study|Protocol Violation|5
5248886|NCT00767806|18112099|P1|Overall Study|Protocol Violation|6
5248887|NCT00767806|18112098|P2|Overall Study|Withdrawal by Subject|13
5248888|NCT00767806|18112099|P1|Overall Study|Withdrawal by Subject|8
5248889|NCT00767806|18112098|P2|Overall Study|Adverse Event|11
5248890|NCT00767806|18112099|P1|Overall Study|Adverse Event|30
5248891|NCT00767676|18112176|P1|Overall Study|Investigator error|54
5248892|NCT00767520|18112199|P2|Overall Study|Randomized in error and Never treated|2
5248893|NCT00767520|18112200|P1|Overall Study|Randomized in error and Never treated|0
5248894|NCT00767520|18112199|P2|Overall Study|Participants still on treatment|15
5248895|NCT00767520|18112200|P1|Overall Study|Participants still on treatment|11
5248896|NCT00767455|18112253|P1|Overall Study|Investigator error|19
5248897|NCT00767325|18112287|P1|Overall Study|Missed visit due to family reasons|1
5248898|NCT00767325|18112287|P1|Overall Study|No longer met study criteria|2
5248899|NCT00767325|18112287|P1|Overall Study|Lost to Follow-up|3
5248900|NCT00767325|18112287|P1|Overall Study|Adverse Event|7
5248901|NCT00767325|18112287|P1|Overall Study|Lack of Efficacy|2
5248902|NCT00767104|18112298|P2|Overall Study|Lost to Follow-up|2
5248903|NCT00767104|18112299|P1|Overall Study|Lost to Follow-up|1
5248904|NCT00767039|18112309|P2|Overall Study|Death|2
5248905|NCT00767039|18112310|P1|Overall Study|Death|5
5248906|NCT00767000|18112341|P5|Optional 104-week Extension|Study terminated by sponsor|4
5248907|NCT00767000|18112342|P4|Optional 104-week Extension|Study terminated by sponsor|2
5248908|NCT00767000|18112343|P3|Optional 104-week Extension|Study terminated by sponsor|7
5248909|NCT00767000|18112344|P2|Optional 104-week Extension|Study terminated by sponsor|3
5248910|NCT00767000|18112345|P1|Optional 104-week Extension|Study terminated by sponsor|7
5248911|NCT00767000|18112341|P5|54-week Study|Reason not reported|0
5248912|NCT00767000|18112342|P4|54-week Study|Reason not reported|1
5248913|NCT00767000|18112343|P3|54-week Study|Reason not reported|0
5248914|NCT00767000|18112344|P2|54-week Study|Reason not reported|0
5248915|NCT00767000|18112345|P1|54-week Study|Reason not reported|0
5248916|NCT00767000|18112341|P5|54-week Study|Study terminated by sponsor|194
5248917|NCT00767000|18112342|P4|54-week Study|Study terminated by sponsor|196
5248918|NCT00767000|18112343|P3|54-week Study|Study terminated by sponsor|89
5248919|NCT00767000|18112344|P2|54-week Study|Study terminated by sponsor|102
5248920|NCT00767000|18112345|P1|54-week Study|Study terminated by sponsor|90
5248921|NCT00767000|18112341|P5|54-week Study|Withdrawal by Subject|13
5248922|NCT00767000|18112342|P4|54-week Study|Withdrawal by Subject|11
5248923|NCT00767000|18112343|P3|54-week Study|Withdrawal by Subject|5
5248924|NCT00767000|18112344|P2|54-week Study|Withdrawal by Subject|3
5248925|NCT00767000|18112345|P1|54-week Study|Withdrawal by Subject|2
5248926|NCT00767000|18112341|P5|54-week Study|Protocol Violation|0
5248927|NCT00767000|18112342|P4|54-week Study|Protocol Violation|2
5248928|NCT00767000|18112343|P3|54-week Study|Protocol Violation|1
5248929|NCT00767000|18112344|P2|54-week Study|Protocol Violation|0
5248930|NCT00767000|18112345|P1|54-week Study|Protocol Violation|0
5248931|NCT00767000|18112341|P5|54-week Study|Progressive disease|0
5248932|NCT00767000|18112342|P4|54-week Study|Progressive disease|0
5248933|NCT00767000|18112343|P3|54-week Study|Progressive disease|1
5248934|NCT00767000|18112344|P2|54-week Study|Progressive disease|0
5248935|NCT00767000|18112345|P1|54-week Study|Progressive disease|0
5248936|NCT00767000|18112341|P5|54-week Study|Physician Decision|1
5248937|NCT00767000|18112342|P4|54-week Study|Physician Decision|1
5248938|NCT00767000|18112343|P3|54-week Study|Physician Decision|1
5248939|NCT00767000|18112344|P2|54-week Study|Physician Decision|0
5248940|NCT00767000|18112345|P1|54-week Study|Physician Decision|4
5248941|NCT00767000|18112341|P5|54-week Study|Lost to Follow-up|2
5248942|NCT00767000|18112342|P4|54-week Study|Lost to Follow-up|4
5248943|NCT00767000|18112343|P3|54-week Study|Lost to Follow-up|1
5248944|NCT00767000|18112344|P2|54-week Study|Lost to Follow-up|0
5248945|NCT00767000|18112345|P1|54-week Study|Lost to Follow-up|4
5248946|NCT00767000|18112341|P5|54-week Study|Lack of Efficacy|5
5248947|NCT00767000|18112342|P4|54-week Study|Lack of Efficacy|0
5248948|NCT00767000|18112343|P3|54-week Study|Lack of Efficacy|1
5248949|NCT00767000|18112344|P2|54-week Study|Lack of Efficacy|0
5248950|NCT00767000|18112345|P1|54-week Study|Lack of Efficacy|2
5248951|NCT00767000|18112341|P5|54-week Study|Interruption of study medication|0
5248952|NCT00767000|18112342|P4|54-week Study|Interruption of study medication|0
5248953|NCT00767000|18112343|P3|54-week Study|Interruption of study medication|1
5248954|NCT00767000|18112344|P2|54-week Study|Interruption of study medication|0
5248955|NCT00767000|18112345|P1|54-week Study|Interruption of study medication|0
5248956|NCT00767000|18112341|P5|54-week Study|Hypoglycemia|0
5248957|NCT00767000|18112342|P4|54-week Study|Hypoglycemia|0
5248958|NCT00767000|18112343|P3|54-week Study|Hypoglycemia|0
5248959|NCT00767000|18112344|P2|54-week Study|Hypoglycemia|1
5248960|NCT00767000|18112345|P1|54-week Study|Hypoglycemia|0
5248961|NCT00767000|18112341|P5|54-week Study|Hyperglycemia|1
5248962|NCT00767000|18112342|P4|54-week Study|Hyperglycemia|0
5248963|NCT00767000|18112343|P3|54-week Study|Hyperglycemia|1
5248964|NCT00767000|18112344|P2|54-week Study|Hyperglycemia|0
5248965|NCT00767000|18112345|P1|54-week Study|Hyperglycemia|0
5248966|NCT00767000|18112341|P5|54-week Study|Creaninine/creatinine clearance|4
5248967|NCT00767000|18112342|P4|54-week Study|Creaninine/creatinine clearance|2
5248968|NCT00767000|18112343|P3|54-week Study|Creaninine/creatinine clearance|2
5248969|NCT00767000|18112344|P2|54-week Study|Creaninine/creatinine clearance|1
5248970|NCT00767000|18112345|P1|54-week Study|Creaninine/creatinine clearance|2
5248971|NCT00767000|18112341|P5|54-week Study|Adverse Event|4
5248972|NCT00767000|18112342|P4|54-week Study|Adverse Event|8
5248973|NCT00767000|18112343|P3|54-week Study|Adverse Event|6
5248974|NCT00767000|18112344|P2|54-week Study|Adverse Event|6
5248975|NCT00767000|18112345|P1|54-week Study|Adverse Event|4
5248976|NCT00766831|18112387|P1|Overall Study|Other|28
5248977|NCT00766831|18112387|P1|Overall Study|Non cooperation by participants|14
5248978|NCT00766831|18112387|P1|Overall Study|Withdrawal of consent|26
5248979|NCT00766831|18112387|P1|Overall Study|Physician Decision|5
5248980|NCT00766831|18112387|P1|Overall Study|Protocol Violation|15
5248981|NCT00766831|18112387|P1|Overall Study|Adverse Event|20
5248982|NCT00766831|18112387|P1|Overall Study|Lost to Follow-up|3
5248983|NCT00766831|18112387|P1|Overall Study|Withdrawal by Subject|4
5248984|NCT00766675|18112417|P1|Overall Study|Insufficient therapy|1
5248985|NCT00766675|18112417|P1|Overall Study|Receive other anti-neoplastic treatment|1
5248986|NCT00766675|18112417|P1|Overall Study|Participant took prohibited medication|1
5248987|NCT00766675|18112417|P1|Overall Study|Protocol Violation|8
5248988|NCT00766675|18112417|P1|Overall Study|Withdrawal by Subject|11
5248989|NCT00766675|18112417|P1|Overall Study|Lost to Follow-up|2
5248990|NCT00766675|18112417|P1|Overall Study|Adverse Event|16
5248991|NCT00766636|18112446|P2|Overall Study|Disease Progression|0
5248992|NCT00766636|18112447|P1|Overall Study|Disease Progression|1
5248993|NCT00766636|18112446|P2|Overall Study|Adverse Event|0
5248994|NCT00766636|18112447|P1|Overall Study|Adverse Event|1
5248995|NCT00766636|18112446|P2|Overall Study|Incomplete Treatment|1
5248996|NCT00766636|18112447|P1|Overall Study|Incomplete Treatment|0
5248997|NCT00766636|18112446|P2|Overall Study|Withdrawal by Subject|1
5248998|NCT00766636|18112447|P1|Overall Study|Withdrawal by Subject|1
5248999|NCT00766597|18112453|P1|Overall Study|Without CCR5-tropic virus|5
5249000|NCT00766597|18112453|P1|Overall Study|Unexpected closure of study|4
5249001|NCT00766532|18112465|P1|Overall Study|Protocol Violation|2
5249002|NCT00766506|18112471|P2|Overall Study|Other|2
5249003|NCT00766506|18112472|P1|Overall Study|Other|2
5249004|NCT00766506|18112471|P2|Overall Study|Use rescue medication after 3 hours|0
5249005|NCT00766506|18112472|P1|Overall Study|Use rescue medication after 3 hours|3
5249006|NCT00766493|18112496|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
5249007|NCT00766493|18112496|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
5249008|NCT00766493|18112496|P1|30 Days Post-Procedure|Discontinued|7
5249009|NCT00766467|18112506|P2|Overall Study|Physician Decision|0
5249010|NCT00766467|18112507|P1|Overall Study|Physician Decision|1
5249011|NCT00766467|18112506|P2|Overall Study|Tumor Progression on Study|1
5249012|NCT00766467|18112507|P1|Overall Study|Tumor Progression on Study|0
5249013|NCT00766467|18112506|P2|Overall Study|Protocol Violation|4
5249014|NCT00766467|18112507|P1|Overall Study|Protocol Violation|2
5249015|NCT00766467|18112506|P2|Overall Study|Adverse Event|1
5249016|NCT00766467|18112507|P1|Overall Study|Adverse Event|1
5249017|NCT00766467|18112506|P2|Overall Study|Withdrawal by Subject|2
5249018|NCT00766467|18112507|P1|Overall Study|Withdrawal by Subject|7
5249019|NCT00766415|18112519|P2|Overall Study|Withdrawal by Subject|1
5249020|NCT00766415|18112520|P1|Overall Study|Withdrawal by Subject|0
5249021|NCT00766376|18112568|P1|Overall Study|Withdrawal by Subject|27
5249022|NCT00766363|18112577|P4|Overall Study|Adverse Event Prior to Randomization|0
5249023|NCT00766363|18112578|P3|Overall Study|Adverse Event Prior to Randomization|0
5249024|NCT00766363|18112579|P2|Overall Study|Adverse Event Prior to Randomization|1
5249025|NCT00766363|18112580|P1|Overall Study|Adverse Event Prior to Randomization|0
5249026|NCT00766363|18112577|P4|Overall Study|Withdrawal by Subject|0
5249027|NCT00766363|18112578|P3|Overall Study|Withdrawal by Subject|0
5249028|NCT00766363|18112579|P2|Overall Study|Withdrawal by Subject|0
5249029|NCT00766363|18112580|P1|Overall Study|Withdrawal by Subject|1
5249030|NCT00766090|18112626|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249031|NCT00766090|18112627|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249032|NCT00766090|18112628|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249033|NCT00766090|18112629|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249034|NCT00766090|18112630|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249035|NCT00766090|18112631|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249036|NCT00766090|18112632|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249037|NCT00766090|18112633|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
5249038|NCT00766090|18112634|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249039|NCT00766090|18112635|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249040|NCT00766090|18112636|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249041|NCT00766090|18112637|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5249042|NCT00766090|18112626|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
5249043|NCT00766090|18112627|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249044|NCT00766090|18112628|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249045|NCT00766090|18112629|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249046|NCT00766090|18112630|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249047|NCT00766090|18112631|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249048|NCT00766090|18112632|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249049|NCT00766090|18112633|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249050|NCT00766090|18112634|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
5249051|NCT00766090|18112635|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249052|NCT00766090|18112636|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
5249053|NCT00766090|18112637|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5249054|NCT00766090|18112626|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
5249055|NCT00766090|18112627|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
5249056|NCT00766090|18112628|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
5249057|NCT00766090|18112629|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
5249058|NCT00766090|18112630|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
5249059|NCT00766090|18112631|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
5249060|NCT00766090|18112632|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
5249061|NCT00766090|18112633|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
5249062|NCT00766090|18112634|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
5249063|NCT00766090|18112635|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
5249064|NCT00766090|18112636|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
5249065|NCT00766090|18112637|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
5249066|NCT00766090|18112626|P12|Washout Period 2 (14 Days)|Physician Decision|0
5249067|NCT00766090|18112627|P11|Washout Period 2 (14 Days)|Physician Decision|0
5249068|NCT00766090|18112628|P10|Washout Period 2 (14 Days)|Physician Decision|0
5249069|NCT00766090|18112629|P9|Washout Period 2 (14 Days)|Physician Decision|0
5249070|NCT00766090|18112630|P8|Washout Period 2 (14 Days)|Physician Decision|0
5249071|NCT00766090|18112631|P7|Washout Period 2 (14 Days)|Physician Decision|0
5249072|NCT00766090|18112632|P6|Washout Period 2 (14 Days)|Physician Decision|0
5249073|NCT00766090|18112633|P5|Washout Period 2 (14 Days)|Physician Decision|0
5249074|NCT00766090|18112634|P4|Washout Period 2 (14 Days)|Physician Decision|0
5249075|NCT00766090|18112635|P3|Washout Period 2 (14 Days)|Physician Decision|1
5249076|NCT00766090|18112636|P2|Washout Period 2 (14 Days)|Physician Decision|0
5249077|NCT00766090|18112637|P1|Washout Period 2 (14 Days)|Physician Decision|0
5249078|NCT00766090|18112626|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249079|NCT00766090|18112627|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249080|NCT00766090|18112628|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249081|NCT00766090|18112629|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249082|NCT00766090|18112630|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249083|NCT00766090|18112631|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249084|NCT00766090|18112632|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249085|NCT00766090|18112633|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249086|NCT00766090|18112634|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249087|NCT00766090|18112635|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
5249088|NCT00766090|18112636|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249089|NCT00766090|18112637|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5249090|NCT00766090|18112626|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249091|NCT00766090|18112627|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249092|NCT00766090|18112628|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249093|NCT00766090|18112629|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249094|NCT00766090|18112630|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249095|NCT00766090|18112631|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249096|NCT00766090|18112632|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249097|NCT00766090|18112633|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
5249098|NCT00766090|18112634|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249099|NCT00766090|18112635|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249100|NCT00766090|18112636|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249101|NCT00766090|18112637|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5249102|NCT00766090|18112626|P12|Washout Period 1 (14 Days)|Protocol Violation|0
5249103|NCT00766090|18112627|P11|Washout Period 1 (14 Days)|Protocol Violation|0
5249104|NCT00766090|18112628|P10|Washout Period 1 (14 Days)|Protocol Violation|0
5249105|NCT00766090|18112629|P9|Washout Period 1 (14 Days)|Protocol Violation|0
5249106|NCT00766090|18112630|P8|Washout Period 1 (14 Days)|Protocol Violation|0
5249107|NCT00766090|18112631|P7|Washout Period 1 (14 Days)|Protocol Violation|0
5249108|NCT00766090|18112632|P6|Washout Period 1 (14 Days)|Protocol Violation|0
5249109|NCT00766090|18112633|P5|Washout Period 1 (14 Days)|Protocol Violation|0
5249110|NCT00766090|18112634|P4|Washout Period 1 (14 Days)|Protocol Violation|0
5249111|NCT00766090|18112635|P3|Washout Period 1 (14 Days)|Protocol Violation|1
5249112|NCT00766090|18112636|P2|Washout Period 1 (14 Days)|Protocol Violation|0
5249113|NCT00766090|18112637|P1|Washout Period 1 (14 Days)|Protocol Violation|0
5249114|NCT00766090|18112626|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249115|NCT00766090|18112627|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249116|NCT00766090|18112628|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249117|NCT00766090|18112629|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249118|NCT00766090|18112630|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249119|NCT00766090|18112631|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249120|NCT00766090|18112632|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249121|NCT00766090|18112633|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249122|NCT00766090|18112634|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5249123|NCT00766090|18112635|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249124|NCT00766090|18112636|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5249125|NCT00766090|18112637|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5249126|NCT00766090|18112626|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249127|NCT00766090|18112627|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249128|NCT00766090|18112628|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249129|NCT00766090|18112629|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249130|NCT00766090|18112630|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249131|NCT00766090|18112631|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249132|NCT00766090|18112632|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249133|NCT00766090|18112633|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249134|NCT00766090|18112634|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249135|NCT00766090|18112635|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249136|NCT00766090|18112636|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5249137|NCT00766090|18112637|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
5249138|NCT00766090|18112626|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249139|NCT00766090|18112627|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249140|NCT00766090|18112628|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249141|NCT00766090|18112629|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
5249142|NCT00766090|18112630|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249143|NCT00766090|18112631|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249144|NCT00766090|18112632|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249145|NCT00766090|18112633|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249146|NCT00766090|18112634|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249147|NCT00766090|18112635|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249148|NCT00766090|18112636|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249149|NCT00766090|18112637|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5249150|NCT00766051|18112678|P2|Overall Study|Withdrawal by Subject|0
5249151|NCT00766051|18112679|P1|Overall Study|Withdrawal by Subject|2
5249152|NCT00766038|18112691|P2|Overall Study|Lost to Follow-up|14
5249153|NCT00766038|18112692|P1|Overall Study|Lost to Follow-up|15
5249154|NCT00765999|18112708|P1|Overall Study|Other Miscellaneous Reasons|51
5249155|NCT00765999|18112708|P1|Overall Study|Study Terminated by Sponsor|2
5249156|NCT00765999|18112708|P1|Overall Study|Lost to Follow-up|131
5249157|NCT00765999|18112708|P1|Overall Study|Consent Withdrawn|202
5249158|NCT00765999|18112708|P1|Overall Study|Protocol Violation|95
5249159|NCT00765999|18112708|P1|Overall Study|Insufficient Therapeutic Response|100
5249160|NCT00765999|18112708|P1|Overall Study|Adverse Event|203
5249161|NCT00765882|18112735|P3|Overall Study|Other Reason|2
5249162|NCT00765882|18112736|P2|Overall Study|Other Reason|1
5249163|NCT00765882|18112737|P1|Overall Study|Other Reason|3
5249164|NCT00765882|18112735|P3|Overall Study|Lost to Follow-up|6
5249165|NCT00765882|18112736|P2|Overall Study|Lost to Follow-up|9
5249166|NCT00765882|18112737|P1|Overall Study|Lost to Follow-up|1
5249167|NCT00765882|18112735|P3|Overall Study|Withdrawal by Subject|6
5249168|NCT00765882|18112736|P2|Overall Study|Withdrawal by Subject|6
5249169|NCT00765882|18112737|P1|Overall Study|Withdrawal by Subject|2
5249170|NCT00765882|18112735|P3|Overall Study|Protocol Violation|1
5249171|NCT00765882|18112736|P2|Overall Study|Protocol Violation|3
5249172|NCT00765882|18112737|P1|Overall Study|Protocol Violation|4
5249173|NCT00765882|18112735|P3|Overall Study|Lack of Efficacy|1
5249174|NCT00765882|18112736|P2|Overall Study|Lack of Efficacy|0
5249175|NCT00765882|18112737|P1|Overall Study|Lack of Efficacy|4
5249176|NCT00765882|18112735|P3|Overall Study|Adverse Event|20
5249177|NCT00765882|18112736|P2|Overall Study|Adverse Event|21
5249178|NCT00765882|18112737|P1|Overall Study|Adverse Event|10
5249179|NCT00765843|18112769|P3|Overall Study|Adverse Event|1
5249180|NCT00765843|18112770|P2|Overall Study|Adverse Event|0
5249181|NCT00765843|18112771|P1|Overall Study|Adverse Event|0
5249182|NCT00765843|18112769|P3|Overall Study|did not return to receive intervention|0
5249183|NCT00765843|18112770|P2|Overall Study|did not return to receive intervention|1
5249184|NCT00765843|18112771|P1|Overall Study|did not return to receive intervention|0
5249185|NCT00765843|18112769|P3|Overall Study|Lost to Follow-up|2
5249186|NCT00765843|18112770|P2|Overall Study|Lost to Follow-up|3
5249187|NCT00765843|18112771|P1|Overall Study|Lost to Follow-up|1
5249188|NCT00765817|18112781|P2|Overall Study|Subject decision|11
5249189|NCT00765817|18112782|P1|Overall Study|Subject decision|7
5249190|NCT00765817|18112781|P2|Overall Study|Protocol Violation|1
5249191|NCT00765817|18112782|P1|Overall Study|Protocol Violation|1
5249192|NCT00765817|18112781|P2|Overall Study|Physician Decision|1
5249193|NCT00765817|18112782|P1|Overall Study|Physician Decision|2
5249194|NCT00765817|18112781|P2|Overall Study|Lost to Follow-up|3
5249195|NCT00765817|18112782|P1|Overall Study|Lost to Follow-up|1
5249196|NCT00765817|18112781|P2|Overall Study|Loss of glucose control|2
5249197|NCT00765817|18112782|P1|Overall Study|Loss of glucose control|0
5249198|NCT00765817|18112781|P2|Overall Study|Entry criteria not met|2
5249199|NCT00765817|18112782|P1|Overall Study|Entry criteria not met|2
5249200|NCT00765817|18112781|P2|Overall Study|Death|1
5249201|NCT00765817|18112782|P1|Overall Study|Death|0
5249202|NCT00765817|18112781|P2|Overall Study|Adverse Event|1
5249203|NCT00765817|18112782|P1|Overall Study|Adverse Event|13
5249204|NCT00765726|18112830|P1|Overall Study|Discontinuation of study by sponsor|8
5249205|NCT00765726|18112830|P1|Overall Study|Withdrawal by Subject|1
5249206|NCT00765674|18112838|P4|Overall Study|Randomized in Error - No Study Drug|1
5249207|NCT00765674|18112839|P3|Overall Study|Randomized in Error - No Study Drug|0
5249208|NCT00765674|18112840|P2|Overall Study|Randomized in Error - No Study Drug|1
5249209|NCT00765674|18112841|P1|Overall Study|Randomized in Error - No Study Drug|0
5249210|NCT00765674|18112838|P4|Overall Study|Lost to Follow-up|1
5249211|NCT00765674|18112839|P3|Overall Study|Lost to Follow-up|2
5249212|NCT00765674|18112840|P2|Overall Study|Lost to Follow-up|6
5249213|NCT00765674|18112841|P1|Overall Study|Lost to Follow-up|4
5249214|NCT00765674|18112838|P4|Overall Study|Withdrawal by Subject|8
5249215|NCT00765674|18112839|P3|Overall Study|Withdrawal by Subject|3
5249216|NCT00765674|18112840|P2|Overall Study|Withdrawal by Subject|7
5249217|NCT00765674|18112841|P1|Overall Study|Withdrawal by Subject|5
5249218|NCT00765674|18112838|P4|Overall Study|Protocol Violation|0
5249219|NCT00765674|18112839|P3|Overall Study|Protocol Violation|1
5249220|NCT00765674|18112840|P2|Overall Study|Protocol Violation|0
5249221|NCT00765674|18112841|P1|Overall Study|Protocol Violation|2
5249222|NCT00765674|18112838|P4|Overall Study|Lack of Efficacy|2
5249223|NCT00765674|18112839|P3|Overall Study|Lack of Efficacy|1
5249224|NCT00765674|18112840|P2|Overall Study|Lack of Efficacy|3
5249225|NCT00765674|18112841|P1|Overall Study|Lack of Efficacy|2
5249226|NCT00765674|18112838|P4|Overall Study|Abnormal Test Procedure Result(s)|2
5249227|NCT00765674|18112839|P3|Overall Study|Abnormal Test Procedure Result(s)|1
5249228|NCT00765674|18112840|P2|Overall Study|Abnormal Test Procedure Result(s)|3
5249229|NCT00765674|18112841|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5249230|NCT00765674|18112838|P4|Overall Study|Abnormal Laboratory Value(s)|0
5249231|NCT00765674|18112839|P3|Overall Study|Abnormal Laboratory Value(s)|1
5249232|NCT00765674|18112840|P2|Overall Study|Abnormal Laboratory Value(s)|0
5249233|NCT00765674|18112841|P1|Overall Study|Abnormal Laboratory Value(s)|0
5249234|NCT00765674|18112838|P4|Overall Study|Adverse Event|11
5249235|NCT00765674|18112839|P3|Overall Study|Adverse Event|8
5249236|NCT00765674|18112840|P2|Overall Study|Adverse Event|2
5249237|NCT00765674|18112841|P1|Overall Study|Adverse Event|7
5249238|NCT00765388|18112908|P2|Period 1|Hip operation|1
5249239|NCT00765388|18112909|P1|Period 1|Hip operation|0
5249240|NCT00765388|18112908|P2|Period 1|Herpes Zoster|1
5249241|NCT00765388|18112909|P1|Period 1|Herpes Zoster|0
5249242|NCT00765388|18112908|P2|Period 1|Lost to Follow-up|1
5249243|NCT00765388|18112909|P1|Period 1|Lost to Follow-up|0
5249244|NCT00765388|18112908|P2|Period 1|Lack of Efficacy|2
5249245|NCT00765388|18112909|P1|Period 1|Lack of Efficacy|1
5249246|NCT00765362|18112943|P1|Overall Study|Lost to Follow-up|95
5249247|NCT00765362|18112943|P1|Overall Study|Withdrawal by Subject|13
5249248|NCT00765362|18112943|P1|Overall Study|Protocol Violation|18
5249249|NCT00765362|18112943|P1|Overall Study|Adverse Event|2
5249250|NCT00765362|18112943|P1|Overall Study|Death|9
5249251|NCT00765336|18112951|P2|Overall Study|Adverse Event|1
5249252|NCT00765336|18112952|P1|Overall Study|Adverse Event|2
5249253|NCT00765336|18112951|P2|Overall Study|Lost to Follow-up|9
5249254|NCT00765336|18112952|P1|Overall Study|Lost to Follow-up|7
5249255|NCT00765336|18112951|P2|Overall Study|Withdrawal by Subject|4
5249256|NCT00765336|18112952|P1|Overall Study|Withdrawal by Subject|6
5249257|NCT00765336|18112951|P2|Overall Study|Protocol Violation|2
5249258|NCT00765336|18112952|P1|Overall Study|Protocol Violation|4
5249259|NCT00765245|18112960|P2|Overall Study|Death|0
5249260|NCT00765245|18112961|P1|Overall Study|Death|1
5249261|NCT00765245|18112960|P2|Overall Study|Physician Decision|0
5249262|NCT00765245|18112961|P1|Overall Study|Physician Decision|1
5249263|NCT00765245|18112960|P2|Overall Study|Adverse Event|0
5249264|NCT00765245|18112961|P1|Overall Study|Adverse Event|5
5249265|NCT00765245|18112960|P2|Overall Study|Withdrawal by Subject|0
5249266|NCT00765245|18112961|P1|Overall Study|Withdrawal by Subject|3
5249267|NCT00765245|18112960|P2|Overall Study|disease progression|2
5249268|NCT00765245|18112961|P1|Overall Study|disease progression|3
5249269|NCT00765102|18113007|P1|Overall Study|Protocol Violation|1
5249270|NCT00765102|18113007|P1|Overall Study|Withdrawal by Subject|2
5249271|NCT00765102|18113007|P1|Overall Study|Physician Decision|4
5249272|NCT00765102|18113007|P1|Overall Study|Adverse Event|6
5249273|NCT00765102|18113007|P1|Overall Study|Progressive disease|18
5249274|NCT00765076|18113032|P3|Overall Study|Withdrawal by Subject|1
5249275|NCT00765076|18113033|P2|Overall Study|Withdrawal by Subject|0
5249276|NCT00765076|18113034|P1|Overall Study|Withdrawal by Subject|0
5249277|NCT00765076|18113032|P3|Overall Study|Adverse Event|0
5249278|NCT00765076|18113033|P2|Overall Study|Adverse Event|0
5249279|NCT00765076|18113034|P1|Overall Study|Adverse Event|1
5249280|NCT00765063|18113087|P1|Overall Study|Adverse Event|4
5249281|NCT00765063|18113087|P1|Overall Study|Protocol Violation|6
5249282|NCT00765063|18113087|P1|Overall Study|Other|16
5249283|NCT00765063|18113087|P1|Overall Study|Withdrawal by Subject|1
5249284|NCT00765063|18113087|P1|Overall Study|Lack of Efficacy|5
5249285|NCT00765037|18113103|P1|Overall Study|Adverse Event|1
5249286|NCT00765037|18113103|P1|Overall Study|Lost to Follow-up|5
5249287|NCT00764946|18113110|P3|Overall Study|Never Treated|1
5249288|NCT00764946|18113111|P2|Overall Study|Never Treated|1
5249289|NCT00764946|18113112|P1|Overall Study|Never Treated|1
5249290|NCT00764946|18113110|P3|Overall Study|Withdrawal by Subject|2
5249291|NCT00764946|18113111|P2|Overall Study|Withdrawal by Subject|6
5249292|NCT00764946|18113112|P1|Overall Study|Withdrawal by Subject|3
5249293|NCT00764946|18113110|P3|Overall Study|Adverse Event|1
5249294|NCT00764946|18113111|P2|Overall Study|Adverse Event|2
5249295|NCT00764946|18113112|P1|Overall Study|Adverse Event|3
5249296|NCT00764946|18113110|P3|Overall Study|Physician Decision|0
5249297|NCT00764946|18113111|P2|Overall Study|Physician Decision|4
5249298|NCT00764946|18113112|P1|Overall Study|Physician Decision|2
5249299|NCT00764946|18113110|P3|Overall Study|Lost to Follow-up|0
5249300|NCT00764946|18113111|P2|Overall Study|Lost to Follow-up|4
5249301|NCT00764946|18113112|P1|Overall Study|Lost to Follow-up|3
5249302|NCT00764946|18113110|P3|Overall Study|Lack of Efficacy|0
5249303|NCT00764946|18113111|P2|Overall Study|Lack of Efficacy|0
5249304|NCT00764946|18113112|P1|Overall Study|Lack of Efficacy|1
5249305|NCT00764881|18113140|P2|Overall Study|no treatment or no observation|2
5249306|NCT00764881|18113141|P1|Overall Study|no treatment or no observation|2
5249307|NCT00764881|18113140|P2|Overall Study|Possibly noncompliant (study drug)|2
5249308|NCT00764881|18113141|P1|Overall Study|Possibly noncompliant (study drug)|0
5249309|NCT00764881|18113140|P2|Overall Study|Carcinoma detected|0
5249310|NCT00764881|18113141|P1|Overall Study|Carcinoma detected|1
5249311|NCT00764881|18113140|P2|Overall Study|Wished to become pregnant|0
5249312|NCT00764881|18113141|P1|Overall Study|Wished to become pregnant|1
5249313|NCT00764881|18113140|P2|Overall Study|Accidentally discontinued study drug|0
5249314|NCT00764881|18113141|P1|Overall Study|Accidentally discontinued study drug|1
5249315|NCT00764881|18113140|P2|Overall Study|Noncompliant|0
5249316|NCT00764881|18113141|P1|Overall Study|Noncompliant|1
5249317|NCT00764881|18113140|P2|Overall Study|Lost to Follow-up|0
5249318|NCT00764881|18113141|P1|Overall Study|Lost to Follow-up|2
5249319|NCT00764881|18113140|P2|Overall Study|Protocol Violation|2
5249320|NCT00764881|18113141|P1|Overall Study|Protocol Violation|2
5249321|NCT00764881|18113140|P2|Overall Study|Withdrawal by Subject|3
5249322|NCT00764881|18113141|P1|Overall Study|Withdrawal by Subject|1
5249323|NCT00764881|18113140|P2|Overall Study|Adverse Event|1
5249324|NCT00764881|18113141|P1|Overall Study|Adverse Event|5
5249325|NCT00764868|18113365|P1|Overall Study|Sponsor requested withdrawal|1
5249326|NCT00764868|18113365|P1|Overall Study|Positive drug screen|2
5249327|NCT00764868|18113365|P1|Overall Study|Met an exclusion criteria|1
5249328|NCT00764868|18113365|P1|Overall Study|Subject sent to boarding school|1
5249329|NCT00764868|18113365|P1|Overall Study|Misuse and compliance of study drug|1
5249330|NCT00764868|18113365|P1|Overall Study|Out of town|1
5249331|NCT00764868|18113365|P1|Overall Study|Prohibited medication|1
5249332|NCT00764868|18113365|P1|Overall Study|Pregnancy|3
5249333|NCT00764868|18113365|P1|Overall Study|Subject moved|7
5249334|NCT00764868|18113365|P1|Overall Study|Lack of Efficacy|5
5249335|NCT00764868|18113365|P1|Overall Study|Lost to Follow-up|25
5249336|NCT00764868|18113365|P1|Overall Study|Non-compliance|16
5249337|NCT00764868|18113365|P1|Overall Study|Withdrawal by Subject|31
5249338|NCT00764868|18113365|P1|Overall Study|Adverse Event|18
5249339|NCT00764790|18113374|P3|Overall Study|Lost to Follow-up|23
5249340|NCT00764790|18113375|P2|Overall Study|Lost to Follow-up|29
5249341|NCT00764790|18113376|P1|Overall Study|Lost to Follow-up|28
5249342|NCT00764790|18113374|P3|Overall Study|Withdrawal by Subject|6
5249343|NCT00764790|18113375|P2|Overall Study|Withdrawal by Subject|12
5249344|NCT00764790|18113376|P1|Overall Study|Withdrawal by Subject|10
5249345|NCT00764790|18113374|P3|Overall Study|Protocol Violation|1
5249346|NCT00764790|18113375|P2|Overall Study|Protocol Violation|0
5249347|NCT00764790|18113376|P1|Overall Study|Protocol Violation|0
5249348|NCT00764751|18113410|P2|Overall Study|Psoriasis flare up on the scalp|0
5249349|NCT00764751|18113411|P1|Overall Study|Psoriasis flare up on the scalp|1
5249350|NCT00764751|18113410|P2|Overall Study|Adverse Event|1
5249351|NCT00764751|18113411|P1|Overall Study|Adverse Event|1
5249352|NCT00764699|18113474|P1|Overall Study|PI left and study terminated|3
5249353|NCT00764673|18113478|P1|Overall Study|Revision of Device|2
5249354|NCT00764673|18113478|P1|Overall Study|Withdrawal by Subject|6
5249355|NCT00764673|18113478|P1|Overall Study|Lost to Follow-up|3
5249356|NCT00764673|18113478|P1|Overall Study|Death|1
5249357|NCT00764660|18113488|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5249358|NCT00764660|18113489|P1|Overall Study|Did Not Meet Protocol Eligibility|1
5249359|NCT00764660|18113488|P2|Overall Study|Noncompliance With Protocol|1
5249360|NCT00764660|18113489|P1|Overall Study|Noncompliance With Protocol|5
5249361|NCT00764660|18113488|P2|Overall Study|Withdrawal by Subject|3
5249362|NCT00764660|18113489|P1|Overall Study|Withdrawal by Subject|7
5249363|NCT00764660|18113488|P2|Overall Study|Lost to Follow-up|4
5249364|NCT00764660|18113489|P1|Overall Study|Lost to Follow-up|3
5249365|NCT00764660|18113488|P2|Overall Study|Adverse Event|3
5249366|NCT00764660|18113489|P1|Overall Study|Adverse Event|6
5249367|NCT00764517|18113523|P2|Overall Study|Physician Decision|0
5249368|NCT00764517|18113524|P1|Overall Study|Physician Decision|3
5249369|NCT00764517|18113523|P2|Overall Study|Death|11
5249370|NCT00764517|18113524|P1|Overall Study|Death|3
5249371|NCT00764517|18113523|P2|Overall Study|Adverse Event|3
5249372|NCT00764517|18113524|P1|Overall Study|Adverse Event|9
5249373|NCT00764504|18113545|P3|Overall Study|Lost to Follow-up|72
5249374|NCT00764504|18113546|P2|Overall Study|Lost to Follow-up|34
5249375|NCT00764504|18113547|P1|Overall Study|Lost to Follow-up|40
5249376|NCT00764504|18113545|P3|Overall Study|Withdrawal by Subject|4
5249377|NCT00764504|18113546|P2|Overall Study|Withdrawal by Subject|7
5249378|NCT00764504|18113547|P1|Overall Study|Withdrawal by Subject|1
5249379|NCT00764504|18113545|P3|Overall Study|Physician Decision|0
5249380|NCT00764504|18113546|P2|Overall Study|Physician Decision|0
5249381|NCT00764504|18113547|P1|Overall Study|Physician Decision|1
5249382|NCT00764504|18113545|P3|Overall Study|Revision of Device|14
5249383|NCT00764504|18113546|P2|Overall Study|Revision of Device|23
5249384|NCT00764504|18113547|P1|Overall Study|Revision of Device|12
5249385|NCT00764504|18113545|P3|Overall Study|Death|13
5249386|NCT00764504|18113546|P2|Overall Study|Death|6
5249387|NCT00764504|18113547|P1|Overall Study|Death|12
5249388|NCT00764478|18113576|P3|Overall Study|Protocol Violation|1
5249389|NCT00764478|18113577|P2|Overall Study|Protocol Violation|1
5249390|NCT00764478|18113578|P1|Overall Study|Protocol Violation|0
5249391|NCT00764478|18113576|P3|Overall Study|Lost to Follow-up|5
5249392|NCT00764478|18113577|P2|Overall Study|Lost to Follow-up|8
5249393|NCT00764478|18113578|P1|Overall Study|Lost to Follow-up|7
5249394|NCT00764478|18113576|P3|Overall Study|Withdrawal by Subject|1
5249395|NCT00764478|18113577|P2|Overall Study|Withdrawal by Subject|12
5249396|NCT00764478|18113578|P1|Overall Study|Withdrawal by Subject|7
5249397|NCT00764478|18113576|P3|Overall Study|Adverse Event|1
5249398|NCT00764478|18113577|P2|Overall Study|Adverse Event|1
5249399|NCT00764478|18113578|P1|Overall Study|Adverse Event|1
5249400|NCT00764465|18113658|P6|Overall Study|Withdrawal by Subject|0
5249401|NCT00764465|18113659|P5|Overall Study|Withdrawal by Subject|0
5249402|NCT00764465|18113660|P4|Overall Study|Withdrawal by Subject|0
5249403|NCT00764465|18113661|P3|Overall Study|Withdrawal by Subject|1
5249404|NCT00764465|18113662|P2|Overall Study|Withdrawal by Subject|1
5249405|NCT00764465|18113663|P1|Overall Study|Withdrawal by Subject|0
5249406|NCT00764465|18113658|P6|Overall Study|Adverse Event|1
5249407|NCT00764465|18113659|P5|Overall Study|Adverse Event|1
5249408|NCT00764465|18113660|P4|Overall Study|Adverse Event|1
5249409|NCT00764465|18113661|P3|Overall Study|Adverse Event|0
5249410|NCT00764465|18113662|P2|Overall Study|Adverse Event|0
5249411|NCT00764465|18113663|P1|Overall Study|Adverse Event|2
5249412|NCT00764361|18113691|P2|Overall Study|Adverse Event|1
5249413|NCT00764361|18113692|P1|Overall Study|Adverse Event|0
5249414|NCT00764361|18113691|P2|Overall Study|Withdrawal by Subject|3
5249415|NCT00764361|18113692|P1|Overall Study|Withdrawal by Subject|2
5249416|NCT00764322|18113700|P1|Overall Study|No CYP2D6 genotyping|9
5249417|NCT00764322|18113700|P1|Overall Study|Withdrawal by Subject|11
5249418|NCT00763971|18113727|P3|Overall Study|Participation in 489-326 required|0
5249419|NCT00763971|18113728|P2|Overall Study|Participation in 489-326 required|0
5249420|NCT00763971|18113729|P1|Overall Study|Participation in 489-326 required|1
5249421|NCT00763971|18113727|P3|Overall Study|Performed final visit on phone|0
5249422|NCT00763971|18113728|P2|Overall Study|Performed final visit on phone|1
5249423|NCT00763971|18113729|P1|Overall Study|Performed final visit on phone|0
5249424|NCT00763971|18113727|P3|Overall Study|Lack of availability|0
5249425|NCT00763971|18113728|P2|Overall Study|Lack of availability|1
5249426|NCT00763971|18113729|P1|Overall Study|Lack of availability|0
5249427|NCT00763971|18113727|P3|Overall Study|Subject wanted dose reduction|0
5249428|NCT00763971|18113728|P2|Overall Study|Subject wanted dose reduction|1
5249429|NCT00763971|18113729|P1|Overall Study|Subject wanted dose reduction|0
5249430|NCT00763971|18113727|P3|Overall Study|Moved to another country|0
5249431|NCT00763971|18113728|P2|Overall Study|Moved to another country|1
5249432|NCT00763971|18113729|P1|Overall Study|Moved to another country|0
5249433|NCT00763971|18113727|P3|Overall Study|Medical monitor decision|1
5249434|NCT00763971|18113728|P2|Overall Study|Medical monitor decision|0
5249435|NCT00763971|18113729|P1|Overall Study|Medical monitor decision|0
5249436|NCT00763971|18113727|P3|Overall Study|Randomization error|1
5249437|NCT00763971|18113728|P2|Overall Study|Randomization error|0
5249438|NCT00763971|18113729|P1|Overall Study|Randomization error|0
5249439|NCT00763971|18113727|P3|Overall Study|Due to holiday season|1
5249440|NCT00763971|18113728|P2|Overall Study|Due to holiday season|0
5249441|NCT00763971|18113729|P1|Overall Study|Due to holiday season|2
5249442|NCT00763971|18113727|P3|Overall Study|Sponsor decision|0
5249443|NCT00763971|18113728|P2|Overall Study|Sponsor decision|0
5249444|NCT00763971|18113729|P1|Overall Study|Sponsor decision|1
5249445|NCT00763971|18113727|P3|Overall Study|Exclusion criteria met|0
5249446|NCT00763971|18113728|P2|Overall Study|Exclusion criteria met|0
5249447|NCT00763971|18113729|P1|Overall Study|Exclusion criteria met|1
5249448|NCT00763971|18113727|P3|Overall Study|Personal reason|0
5249449|NCT00763971|18113728|P2|Overall Study|Personal reason|0
5249450|NCT00763971|18113729|P1|Overall Study|Personal reason|3
5249451|NCT00763971|18113727|P3|Overall Study|Unable to swallow capsule|1
5249452|NCT00763971|18113728|P2|Overall Study|Unable to swallow capsule|1
5249453|NCT00763971|18113729|P1|Overall Study|Unable to swallow capsule|2
5249454|NCT00763971|18113727|P3|Overall Study|Lack of Efficacy|54
5249455|NCT00763971|18113728|P2|Overall Study|Lack of Efficacy|22
5249456|NCT00763971|18113729|P1|Overall Study|Lack of Efficacy|11
5249457|NCT00763971|18113727|P3|Overall Study|Lost to Follow-up|0
5249458|NCT00763971|18113728|P2|Overall Study|Lost to Follow-up|1
5249459|NCT00763971|18113729|P1|Overall Study|Lost to Follow-up|0
5249460|NCT00763971|18113727|P3|Overall Study|Withdrawal by Subject|5
5249461|NCT00763971|18113728|P2|Overall Study|Withdrawal by Subject|5
5249462|NCT00763971|18113729|P1|Overall Study|Withdrawal by Subject|4
5249463|NCT00763971|18113727|P3|Overall Study|Protocol Violation|2
5249464|NCT00763971|18113728|P2|Overall Study|Protocol Violation|3
5249465|NCT00763971|18113729|P1|Overall Study|Protocol Violation|3
5249466|NCT00763971|18113727|P3|Overall Study|Adverse Event|4
5249467|NCT00763971|18113728|P2|Overall Study|Adverse Event|2
5249468|NCT00763971|18113729|P1|Overall Study|Adverse Event|5
5249469|NCT00763958|18113760|P2|Overall Study|Believed they were receiving placebo|5
5249470|NCT00763958|18113761|P1|Overall Study|Believed they were receiving placebo|0
5249471|NCT00763958|18113760|P2|Overall Study|Lost to Follow-up|2
5249472|NCT00763958|18113761|P1|Overall Study|Lost to Follow-up|10
5249473|NCT00763958|18113760|P2|Overall Study|did not meet final criteria|4
5249474|NCT00763958|18113761|P1|Overall Study|did not meet final criteria|4
5249475|NCT00763815|18113896|P2|Overall Study|Sponsor's Decision|1
5249476|NCT00763815|18113897|P1|Overall Study|Sponsor's Decision|0
5249477|NCT00763815|18113896|P2|Overall Study|Protocol Violation|5
5249478|NCT00763815|18113897|P1|Overall Study|Protocol Violation|2
5249479|NCT00763815|18113896|P2|Overall Study|Withdrawal by Subject|12
5249480|NCT00763815|18113897|P1|Overall Study|Withdrawal by Subject|7
5249481|NCT00763815|18113896|P2|Overall Study|Physician Decision|0
5249482|NCT00763815|18113897|P1|Overall Study|Physician Decision|1
5249483|NCT00763815|18113896|P2|Overall Study|Familial and Personal Reasons|16
5249484|NCT00763815|18113897|P1|Overall Study|Familial and Personal Reasons|9
5249485|NCT00763815|18113896|P2|Overall Study|Early Termination|0
5249486|NCT00763815|18113897|P1|Overall Study|Early Termination|1
5249487|NCT00763815|18113896|P2|Overall Study|Lost to Follow-up|4
5249488|NCT00763815|18113897|P1|Overall Study|Lost to Follow-up|2
5249489|NCT00763815|18113896|P2|Overall Study|Poor Compliance to Protocol|6
5249490|NCT00763815|18113897|P1|Overall Study|Poor Compliance to Protocol|6
5249491|NCT00763815|18113896|P2|Overall Study|Lack of Efficacy|11
5249492|NCT00763815|18113897|P1|Overall Study|Lack of Efficacy|10
5249493|NCT00763815|18113896|P2|Overall Study|Adverse Event|29
5249494|NCT00763815|18113897|P1|Overall Study|Adverse Event|14
5249495|NCT00763698|18113925|P1|Overall Study|Withdrawal by Subject|1
5249496|NCT00763698|18113925|P1|Overall Study|Death|4
5249497|NCT00763698|18113925|P1|Overall Study|Unsuccessful Implant|5
5249498|NCT00763451|18113942|P4|Overall Study|Study Site Reason|1
5249499|NCT00763451|18113943|P3|Overall Study|Study Site Reason|1
5249500|NCT00763451|18113944|P2|Overall Study|Study Site Reason|1
5249501|NCT00763451|18113945|P1|Overall Study|Study Site Reason|0
5249502|NCT00763451|18113942|P4|Overall Study|Randomized but not Treated|0
5249503|NCT00763451|18113943|P3|Overall Study|Randomized but not Treated|0
5249504|NCT00763451|18113944|P2|Overall Study|Randomized but not Treated|1
5249505|NCT00763451|18113945|P1|Overall Study|Randomized but not Treated|1
5249506|NCT00763451|18113942|P4|Overall Study|Familial and Personal Reasons|4
5249507|NCT00763451|18113943|P3|Overall Study|Familial and Personal Reasons|5
5249508|NCT00763451|18113944|P2|Overall Study|Familial and Personal Reasons|3
5249509|NCT00763451|18113945|P1|Overall Study|Familial and Personal Reasons|5
5249510|NCT00763451|18113942|P4|Overall Study|Poor Compliance to Protocol|2
5249511|NCT00763451|18113943|P3|Overall Study|Poor Compliance to Protocol|2
5249512|NCT00763451|18113944|P2|Overall Study|Poor Compliance to Protocol|1
5249513|NCT00763451|18113945|P1|Overall Study|Poor Compliance to Protocol|1
5249514|NCT00763451|18113942|P4|Overall Study|Protocol Violation|0
5249515|NCT00763451|18113943|P3|Overall Study|Protocol Violation|1
5249516|NCT00763451|18113944|P2|Overall Study|Protocol Violation|0
5249517|NCT00763451|18113945|P1|Overall Study|Protocol Violation|0
5249518|NCT00763451|18113942|P4|Overall Study|Withdrawal by Subject|7
5249519|NCT00763451|18113943|P3|Overall Study|Withdrawal by Subject|9
5249520|NCT00763451|18113944|P2|Overall Study|Withdrawal by Subject|6
5249521|NCT00763451|18113945|P1|Overall Study|Withdrawal by Subject|1
5249522|NCT00763451|18113942|P4|Overall Study|Lack of Efficacy|2
5249523|NCT00763451|18113943|P3|Overall Study|Lack of Efficacy|3
5249524|NCT00763451|18113944|P2|Overall Study|Lack of Efficacy|4
5249525|NCT00763451|18113945|P1|Overall Study|Lack of Efficacy|1
5249526|NCT00763451|18113942|P4|Overall Study|Adverse Event|14
5249527|NCT00763451|18113943|P3|Overall Study|Adverse Event|19
5249528|NCT00763451|18113944|P2|Overall Study|Adverse Event|6
5249529|NCT00763451|18113945|P1|Overall Study|Adverse Event|4
5249530|NCT00763386|18114004|P2|Overall Study|Study Prosthesis Removed|0
5249531|NCT00763386|18114005|P1|Overall Study|Study Prosthesis Removed|1
5249532|NCT00763386|18114004|P2|Overall Study|CRF missing|1
5249533|NCT00763386|18114005|P1|Overall Study|CRF missing|0
5249534|NCT00763386|18114004|P2|Overall Study|Withdrawal by Subject|1
5249535|NCT00763386|18114005|P1|Overall Study|Withdrawal by Subject|0
5249536|NCT00763386|18114004|P2|Overall Study|Lost to Follow-up|3
5249537|NCT00763386|18114005|P1|Overall Study|Lost to Follow-up|3
5249538|NCT00763386|18114004|P2|Overall Study|Death|2
5249539|NCT00763386|18114005|P1|Overall Study|Death|1
5249540|NCT00763386|18114004|P2|Overall Study|Adverse Event|33
5249541|NCT00763386|18114005|P1|Overall Study|Adverse Event|43
5249542|NCT00763321|18114038|P3|Double-blind Period|Other|3
5249543|NCT00763321|18114039|P2|Double-blind Period|Other|2
5249544|NCT00763321|18114040|P1|Double-blind Period|Other|0
5249545|NCT00763321|18114038|P3|Double-blind Period|Withdrawal by Subject|3
5249546|NCT00763321|18114039|P2|Double-blind Period|Withdrawal by Subject|2
5249547|NCT00763321|18114040|P1|Double-blind Period|Withdrawal by Subject|0
5249548|NCT00763321|18114038|P3|Double-blind Period|Lost to Follow-up|2
5249549|NCT00763321|18114039|P2|Double-blind Period|Lost to Follow-up|4
5249550|NCT00763321|18114040|P1|Double-blind Period|Lost to Follow-up|0
5249551|NCT00763321|18114038|P3|Double-blind Period|Adverse Event|4
5249552|NCT00763321|18114039|P2|Double-blind Period|Adverse Event|4
5249553|NCT00763321|18114040|P1|Double-blind Period|Adverse Event|0
5249554|NCT00763321|18114038|P3|Double-blind Period|Lack of Efficacy|17
5249555|NCT00763321|18114039|P2|Double-blind Period|Lack of Efficacy|9
5249556|NCT00763321|18114040|P1|Double-blind Period|Lack of Efficacy|0
5249557|NCT00763321|18114038|P3|Open-label Period|Other|0
5249558|NCT00763321|18114039|P2|Open-label Period|Other|0
5249559|NCT00763321|18114040|P1|Open-label Period|Other|4
5249560|NCT00763321|18114038|P3|Open-label Period|Lack of Efficacy|0
5249561|NCT00763321|18114039|P2|Open-label Period|Lack of Efficacy|0
5249562|NCT00763321|18114040|P1|Open-label Period|Lack of Efficacy|2
5249563|NCT00763321|18114038|P3|Open-label Period|Did not meet DB randomization criteria|0
5249564|NCT00763321|18114039|P2|Open-label Period|Did not meet DB randomization criteria|0
5249565|NCT00763321|18114040|P1|Open-label Period|Did not meet DB randomization criteria|5
5249566|NCT00763321|18114038|P3|Open-label Period|Subject noncompliant|0
5249567|NCT00763321|18114039|P2|Open-label Period|Subject noncompliant|0
5249568|NCT00763321|18114040|P1|Open-label Period|Subject noncompliant|7
5249569|NCT00763321|18114038|P3|Open-label Period|Withdrawal by Subject|0
5249570|NCT00763321|18114039|P2|Open-label Period|Withdrawal by Subject|0
5249571|NCT00763321|18114040|P1|Open-label Period|Withdrawal by Subject|7
5249572|NCT00763321|18114038|P3|Open-label Period|Lost to Follow-up|0
5249573|NCT00763321|18114039|P2|Open-label Period|Lost to Follow-up|0
5249574|NCT00763321|18114040|P1|Open-label Period|Lost to Follow-up|14
5249575|NCT00763321|18114038|P3|Open-label Period|Adverse Event|0
5249576|NCT00763321|18114039|P2|Open-label Period|Adverse Event|0
5249577|NCT00763321|18114040|P1|Open-label Period|Adverse Event|24
5249578|NCT00763282|18114051|P2|Overall Study|Lost to Follow-up|26
5249579|NCT00763282|18114052|P1|Overall Study|Lost to Follow-up|22
5249580|NCT00763282|18114051|P2|Overall Study|Death|3
5249581|NCT00763282|18114052|P1|Overall Study|Death|4
5249582|NCT00763282|18114051|P2|Overall Study|Withdrawal by Subject|5
5249583|NCT00763282|18114052|P1|Overall Study|Withdrawal by Subject|6
5249584|NCT00763269|18114068|P2|Overall Study|Lost to Follow-up|13
5249585|NCT00763269|18114069|P1|Overall Study|Lost to Follow-up|12
5249586|NCT00763256|18114083|P2|Overall Study|Didn't return for appointments|10
5249587|NCT00763256|18114084|P1|Overall Study|Didn't return for appointments|7
5249588|NCT00763139|18114120|P2|Overall Study|med change not allowed by protocol|0
5249589|NCT00763139|18114121|P1|Overall Study|med change not allowed by protocol|1
5249590|NCT00763139|18114120|P2|Overall Study|Withdrawal by Subject|1
5249591|NCT00763139|18114121|P1|Overall Study|Withdrawal by Subject|0
5249592|NCT00763139|18114120|P2|Overall Study|Adverse Event|2
5249593|NCT00763139|18114121|P1|Overall Study|Adverse Event|4
5249594|NCT00763035|18114183|P2|Second Intervention|Physician Decision|0
5249595|NCT00763035|18114184|P1|Second Intervention|Physician Decision|2
5249596|NCT00763035|18114183|P2|Second Intervention|Adverse Event|0
5249597|NCT00763035|18114184|P1|Second Intervention|Adverse Event|1
5249598|NCT00763035|18114183|P2|First Intervention|Adverse Event|1
5249599|NCT00763035|18114184|P1|First Intervention|Adverse Event|0
5249600|NCT00763035|18114183|P2|First Intervention|Did not meeting inclusion/exclusion|0
5249601|NCT00763035|18114184|P1|First Intervention|Did not meeting inclusion/exclusion|1
5249602|NCT00763009|18114202|P1|Overall Study|Coronary Anatomy unsuitable|1
5249603|NCT00762996|18114207|P4|Period One|Withdrawal by Subject|0
5249604|NCT00762996|18114208|P3|Period One|Withdrawal by Subject|1
5249605|NCT00762996|18114209|P2|Period One|Withdrawal by Subject|0
5249606|NCT00762996|18114210|P1|Period One|Withdrawal by Subject|0
5249607|NCT00762996|18114207|P4|Period One|Adverse Event|0
5249608|NCT00762996|18114208|P3|Period One|Adverse Event|1
5249609|NCT00762996|18114209|P2|Period One|Adverse Event|0
5249610|NCT00762996|18114210|P1|Period One|Adverse Event|0
5249611|NCT00762996|18114207|P4|Period One|ineligible|1
5249612|NCT00762996|18114208|P3|Period One|ineligible|1
5249613|NCT00762996|18114209|P2|Period One|ineligible|0
5249614|NCT00762996|18114210|P1|Period One|ineligible|0
5249615|NCT00762996|18114207|P4|Period One|Protocol Violation|0
5249616|NCT00762996|18114208|P3|Period One|Protocol Violation|1
5249617|NCT00762996|18114209|P2|Period One|Protocol Violation|0
5249618|NCT00762996|18114210|P1|Period One|Protocol Violation|0
5249619|NCT00762970|18114223|P3|Overall Study|Difficulty of handling lens|0
5249620|NCT00762970|18114224|P2|Overall Study|Difficulty of handling lens|2
5249621|NCT00762970|18114225|P1|Overall Study|Difficulty of handling lens|1
5249622|NCT00762970|18114223|P3|Overall Study|Lost to Follow-up|0
5249623|NCT00762970|18114224|P2|Overall Study|Lost to Follow-up|2
5249624|NCT00762970|18114225|P1|Overall Study|Lost to Follow-up|1
5249625|NCT00762970|18114223|P3|Overall Study|Protocol Violation|1
5249626|NCT00762970|18114224|P2|Overall Study|Protocol Violation|1
5249627|NCT00762970|18114225|P1|Overall Study|Protocol Violation|3
5249628|NCT00762970|18114223|P3|Overall Study|Withdrawal by Subject|0
5249629|NCT00762970|18114224|P2|Overall Study|Withdrawal by Subject|4
5249630|NCT00762970|18114225|P1|Overall Study|Withdrawal by Subject|7
5249631|NCT00762892|18114243|P2|Overall Study|Incarceration|0
5249632|NCT00762892|18114244|P1|Overall Study|Incarceration|1
5249633|NCT00762892|18114243|P2|Overall Study|Pregnancy|0
5249634|NCT00762892|18114244|P1|Overall Study|Pregnancy|1
5249635|NCT00762892|18114243|P2|Overall Study|Death|0
5249636|NCT00762892|18114244|P1|Overall Study|Death|1
5249637|NCT00762892|18114243|P2|Overall Study|Withdrawal by Subject|1
5249638|NCT00762892|18114244|P1|Overall Study|Withdrawal by Subject|0
5249639|NCT00762892|18114243|P2|Overall Study|Lost to Follow-up|5
5249640|NCT00762892|18114244|P1|Overall Study|Lost to Follow-up|2
5249641|NCT00762788|18114273|P6|Overall Study|Lost to Follow-up|21
5249642|NCT00762788|18114274|P5|Overall Study|Lost to Follow-up|13
5249643|NCT00762788|18114275|P4|Overall Study|Lost to Follow-up|26
5249644|NCT00762788|18114276|P3|Overall Study|Lost to Follow-up|21
5249645|NCT00762788|18114277|P2|Overall Study|Lost to Follow-up|37
5249646|NCT00762788|18114278|P1|Overall Study|Lost to Follow-up|26
5249647|NCT00762762|18114300|P2|Overall Study|Did not report for appointments|10
5249648|NCT00762762|18114301|P1|Overall Study|Did not report for appointments|8
5249649|NCT00762723|18114318|P3|Overall Study|Study Terminated slow enrollement|3
5249650|NCT00762723|18114319|P2|Overall Study|Study Terminated slow enrollement|5
5249651|NCT00762723|18114320|P1|Overall Study|Study Terminated slow enrollement|5
5249652|NCT00762606|18114493|P2|Overall Study|Lost to Follow-up|13
5249653|NCT00762606|18114494|P1|Overall Study|Lost to Follow-up|18
5249654|NCT00762502|18114539|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
5249655|NCT00762502|18114540|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
5249656|NCT00762502|18114541|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
5249657|NCT00762502|18114539|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
5249658|NCT00762502|18114540|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
5249659|NCT00762502|18114541|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
5249660|NCT00762502|18114539|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
5249661|NCT00762502|18114540|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
5249662|NCT00762502|18114541|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
5249663|NCT00762476|18114555|P2|Overall Study|Seasonal allergies|0
5249664|NCT00762476|18114556|P1|Overall Study|Seasonal allergies|1
5249665|NCT00762476|18114555|P2|Overall Study|non-compliance with study visits|2
5249666|NCT00762476|18114556|P1|Overall Study|non-compliance with study visits|0
5249667|NCT00762476|18114555|P2|Overall Study|antibiotic use|1
5249668|NCT00762476|18114556|P1|Overall Study|antibiotic use|0
5249669|NCT00762476|18114555|P2|Overall Study|Withdrawal by Subject|12
5249670|NCT00762476|18114556|P1|Overall Study|Withdrawal by Subject|6
5249671|NCT00762476|18114555|P2|Overall Study|Physician Decision|14
5249672|NCT00762476|18114556|P1|Overall Study|Physician Decision|2
5249673|NCT00762476|18114555|P2|Overall Study|Protocol Violation|6
5249674|NCT00762476|18114556|P1|Overall Study|Protocol Violation|5
5249675|NCT00762476|18114555|P2|Overall Study|Lost to Follow-up|0
5249676|NCT00762476|18114556|P1|Overall Study|Lost to Follow-up|2
5249677|NCT00762476|18114555|P2|Overall Study|Adverse Event|1
5249678|NCT00762476|18114556|P1|Overall Study|Adverse Event|7
5249679|NCT00762463|18114568|P4|Extension Phase (Week 6 to Week 12)|Other|1
5249680|NCT00762463|18114569|P3|Extension Phase (Week 6 to Week 12)|Other|0
5249681|NCT00762463|18114570|P2|Extension Phase (Week 6 to Week 12)|Other|0
5249682|NCT00762463|18114571|P1|Extension Phase (Week 6 to Week 12)|Other|0
5249683|NCT00762463|18114568|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
5249684|NCT00762463|18114569|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
5249685|NCT00762463|18114570|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
5249686|NCT00762463|18114571|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
5249687|NCT00762463|18114568|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
5249688|NCT00762463|18114569|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
5249689|NCT00762463|18114570|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
5249690|NCT00762463|18114571|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
5249691|NCT00762463|18114568|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
5249692|NCT00762463|18114569|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
5249693|NCT00762463|18114570|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
5249694|NCT00762463|18114571|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
5249695|NCT00762463|18114568|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
5249696|NCT00762463|18114569|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
5249697|NCT00762463|18114570|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
5249698|NCT00762463|18114571|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
5249699|NCT00762463|18114568|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
5249700|NCT00762463|18114569|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
5249701|NCT00762463|18114570|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
5249702|NCT00762463|18114571|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
5249703|NCT00762463|18114568|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
5249704|NCT00762463|18114569|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
5249705|NCT00762463|18114570|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
5249706|NCT00762463|18114571|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
5249707|NCT00762463|18114568|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
5249708|NCT00762463|18114569|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
5249709|NCT00762463|18114570|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
5249710|NCT00762463|18114571|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
5249711|NCT00762411|18114677|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
5249712|NCT00762411|18114678|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
5249713|NCT00762411|18114677|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
5249714|NCT00762411|18114678|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
5249715|NCT00762411|18114677|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
5249716|NCT00762411|18114678|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
5249717|NCT00762411|18114677|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
5249718|NCT00762411|18114678|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
5249719|NCT00762411|18114677|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
5249720|NCT00762411|18114678|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
5249721|NCT00762411|18114677|P2|Safety Follow Up (SFU)-Optional|Death|8
5249722|NCT00762411|18114678|P1|Safety Follow Up (SFU)-Optional|Death|1
5249723|NCT00762411|18114677|P2|Delayed Start|Caregiver Decision|1
5249724|NCT00762411|18114678|P1|Delayed Start|Caregiver Decision|1
5249725|NCT00762411|18114677|P2|Delayed Start|Sponsor Decision|20
5249726|NCT00762411|18114678|P1|Delayed Start|Sponsor Decision|16
5249727|NCT00762411|18114677|P2|Delayed Start|Protocol Violation|1
5249728|NCT00762411|18114678|P1|Delayed Start|Protocol Violation|0
5249729|NCT00762411|18114677|P2|Delayed Start|Adverse Event|4
5249730|NCT00762411|18114678|P1|Delayed Start|Adverse Event|0
5249731|NCT00762411|18114677|P2|Initial Treatment|Entry Criteria Exclusion|1
5249732|NCT00762411|18114678|P1|Initial Treatment|Entry Criteria Exclusion|0
5249733|NCT00762411|18114677|P2|Initial Treatment|Abnormal Lab/ECG Result|4
5249734|NCT00762411|18114678|P1|Initial Treatment|Abnormal Lab/ECG Result|6
5249735|NCT00762411|18114677|P2|Initial Treatment|Caregiver Decision|16
5249736|NCT00762411|18114678|P1|Initial Treatment|Caregiver Decision|21
5249737|NCT00762411|18114677|P2|Initial Treatment|Lost to Follow-up|0
5249738|NCT00762411|18114678|P1|Initial Treatment|Lost to Follow-up|5
5249739|NCT00762411|18114677|P2|Initial Treatment|Sponsor Decision|401
5249740|NCT00762411|18114678|P1|Initial Treatment|Sponsor Decision|293
5249741|NCT00762411|18114677|P2|Initial Treatment|Physician Decision|0
5249742|NCT00762411|18114678|P1|Initial Treatment|Physician Decision|1
5249743|NCT00762411|18114677|P2|Initial Treatment|Withdrawal by Subject|52
5249744|NCT00762411|18114678|P1|Initial Treatment|Withdrawal by Subject|65
5249745|NCT00762411|18114677|P2|Initial Treatment|Protocol Violation|1
5249746|NCT00762411|18114678|P1|Initial Treatment|Protocol Violation|4
5249747|NCT00762411|18114677|P2|Initial Treatment|Adverse Event|40
5249748|NCT00762411|18114678|P1|Initial Treatment|Adverse Event|132
5249749|NCT00762411|18114677|P2|Initial Treatment|Death|6
5249750|NCT00762411|18114678|P1|Initial Treatment|Death|7
5249751|NCT00762385|18114742|P2|Second Intervention|Protocol Violation|3
5249752|NCT00762385|18114743|P1|Second Intervention|Protocol Violation|3
5249753|NCT00762385|18114742|P2|First Intervention|Protocol Violation|1
5249754|NCT00762385|18114743|P1|First Intervention|Protocol Violation|0
5249755|NCT00762385|18114742|P2|First Intervention|Ineligible|0
5249756|NCT00762385|18114743|P1|First Intervention|Ineligible|1
5249757|NCT00762385|18114742|P2|First Intervention|Lost to Follow-up|2
5249758|NCT00762385|18114743|P1|First Intervention|Lost to Follow-up|0
5249759|NCT00762385|18114742|P2|First Intervention|Lens Issue|1
5249760|NCT00762385|18114743|P1|First Intervention|Lens Issue|1
5249761|NCT00762372|18114756|P3|Overall Study|Adverse Event|0
5249762|NCT00762372|18114757|P2|Overall Study|Adverse Event|0
5249763|NCT00762372|18114758|P1|Overall Study|Adverse Event|1
5249764|NCT00762359|18114834|P2|Overall Study|Withdrew consent|0
5249765|NCT00762359|18114835|P1|Overall Study|Withdrew consent|1
5249766|NCT00762359|18114834|P2|Overall Study|Removal|1
5249767|NCT00762359|18114835|P1|Overall Study|Removal|0
5249768|NCT00762359|18114834|P2|Overall Study|Physician Decision|3
5249769|NCT00762359|18114835|P1|Overall Study|Physician Decision|2
5249770|NCT00762359|18114834|P2|Overall Study|Institution closed|3
5249771|NCT00762359|18114835|P1|Overall Study|Institution closed|2
5249772|NCT00762359|18114834|P2|Overall Study|Lack of Efficacy|4
5249773|NCT00762359|18114835|P1|Overall Study|Lack of Efficacy|0
5249774|NCT00762359|18114834|P2|Overall Study|Withdrawal by Subject|10
5249775|NCT00762359|18114835|P1|Overall Study|Withdrawal by Subject|13
5249776|NCT00762359|18114834|P2|Overall Study|Protocol Violation|13
5249777|NCT00762359|18114835|P1|Overall Study|Protocol Violation|21
5249778|NCT00762359|18114834|P2|Overall Study|Adverse Event|23
5249779|NCT00762359|18114835|P1|Overall Study|Adverse Event|20
5249780|NCT00762268|18114952|P2|Overall Study|Withdrawal by Subject|3
5249781|NCT00762268|18114953|P1|Overall Study|Withdrawal by Subject|3
5249782|NCT00762229|18114965|P2|Overall Study|did not recveive intervention|1
5249783|NCT00762229|18114966|P1|Overall Study|did not recveive intervention|0
5249784|NCT00762229|18114965|P2|Overall Study|Lost to Follow-up|1
5249785|NCT00762229|18114966|P1|Overall Study|Lost to Follow-up|1
5249786|NCT00762164|18115063|P2|Overall Study|Withdrawal by Subject|1
5249787|NCT00762164|18115064|P1|Overall Study|Withdrawal by Subject|0
5249788|NCT00762164|18115063|P2|Overall Study|Discontinued medication|0
5249789|NCT00762164|18115064|P1|Overall Study|Discontinued medication|2
5249790|NCT00762164|18115063|P2|Overall Study|Lost to Follow-up|1
5249791|NCT00762164|18115064|P1|Overall Study|Lost to Follow-up|1
5249792|NCT00762086|18115074|P2|Overall Study|Ineligible to participate in the study|0
5249793|NCT00762086|18115075|P1|Overall Study|Ineligible to participate in the study|1
5249794|NCT00762086|18115074|P2|Overall Study|Withdrawal by Subject|2
5249795|NCT00762086|18115075|P1|Overall Study|Withdrawal by Subject|2
5249796|NCT00762086|18115074|P2|Overall Study|Non compliance|0
5249797|NCT00762086|18115075|P1|Overall Study|Non compliance|1
5249798|NCT00762086|18115074|P2|Overall Study|Lost to Follow-up|2
5249799|NCT00762086|18115075|P1|Overall Study|Lost to Follow-up|0
5249800|NCT00762086|18115074|P2|Overall Study|Adverse Event|0
5249801|NCT00762086|18115075|P1|Overall Study|Adverse Event|2
5249802|NCT00762073|18115085|P4|Overall Study|Not on treatment for >/= 77 days|0
5249803|NCT00762073|18115086|P3|Overall Study|Not on treatment for >/= 77 days|0
5249804|NCT00762073|18115087|P2|Overall Study|Not on treatment for >/= 77 days|0
5249805|NCT00762073|18115088|P1|Overall Study|Not on treatment for >/= 77 days|1
5249806|NCT00762073|18115085|P4|Overall Study|Withdrawal by Subject|1
5249807|NCT00762073|18115086|P3|Overall Study|Withdrawal by Subject|1
5249808|NCT00762073|18115087|P2|Overall Study|Withdrawal by Subject|2
5249809|NCT00762073|18115088|P1|Overall Study|Withdrawal by Subject|1
5249810|NCT00762073|18115085|P4|Overall Study|Significant Subject Noncompliance|1
5249811|NCT00762073|18115086|P3|Overall Study|Significant Subject Noncompliance|0
5249812|NCT00762073|18115087|P2|Overall Study|Significant Subject Noncompliance|1
5249813|NCT00762073|18115088|P1|Overall Study|Significant Subject Noncompliance|0
5249814|NCT00762073|18115085|P4|Overall Study|Adverse Event|1
5249815|NCT00762073|18115086|P3|Overall Study|Adverse Event|1
5249816|NCT00762073|18115087|P2|Overall Study|Adverse Event|0
5249817|NCT00762073|18115088|P1|Overall Study|Adverse Event|1
5249818|NCT00762073|18115085|P4|Overall Study|Lack of Efficacy|0
5249819|NCT00762073|18115086|P3|Overall Study|Lack of Efficacy|0
5249820|NCT00762073|18115087|P2|Overall Study|Lack of Efficacy|1
5249821|NCT00762073|18115088|P1|Overall Study|Lack of Efficacy|1
5249822|NCT00762034|18115152|P2|Maintenance Period|Other|1
5249823|NCT00762034|18115153|P1|Maintenance Period|Other|1
5249824|NCT00762034|18115152|P2|Maintenance Period|Death due to study disease|3
5249825|NCT00762034|18115153|P1|Maintenance Period|Death due to study disease|3
5249826|NCT00762034|18115152|P2|Maintenance Period|Death not due to study disease|5
5249827|NCT00762034|18115153|P1|Maintenance Period|Death not due to study disease|2
5249828|NCT00762034|18115152|P2|Maintenance Period|Withdrawal by Subject|14
5249829|NCT00762034|18115153|P1|Maintenance Period|Withdrawal by Subject|34
5249830|NCT00762034|18115152|P2|Maintenance Period|Physician Decision|20
5249831|NCT00762034|18115153|P1|Maintenance Period|Physician Decision|25
5249832|NCT00762034|18115152|P2|Maintenance Period|Progressive Disease|224
5249833|NCT00762034|18115153|P1|Maintenance Period|Progressive Disease|186
5249834|NCT00762034|18115152|P2|Maintenance Period|Adverse Event|26
5249835|NCT00762034|18115153|P1|Maintenance Period|Adverse Event|42
5249836|NCT00762034|18115152|P2|Maintenance Period|Entry Criterion Not Met|2
5249837|NCT00762034|18115153|P1|Maintenance Period|Entry Criterion Not Met|0
5249838|NCT00762034|18115152|P2|Maintenance Period|Protocol Violation|3
5249839|NCT00762034|18115153|P1|Maintenance Period|Protocol Violation|1
5249840|NCT00762034|18115152|P2|Induction Period|Deaths Due to Study Disease|9
5249841|NCT00762034|18115153|P1|Induction Period|Deaths Due to Study Disease|9
5249842|NCT00762034|18115152|P2|Induction Period|Deaths Not Due to Study Disease|14
5249843|NCT00762034|18115153|P1|Induction Period|Deaths Not Due to Study Disease|19
5249844|NCT00762034|18115152|P2|Induction Period|Withdrawal by Subject|19
5249845|NCT00762034|18115153|P1|Induction Period|Withdrawal by Subject|15
5249846|NCT00762034|18115152|P2|Induction Period|Physician Decision|20
5249847|NCT00762034|18115153|P1|Induction Period|Physician Decision|21
5249848|NCT00762034|18115152|P2|Induction Period|Progressive Disease|55
5249849|NCT00762034|18115153|P1|Induction Period|Progressive Disease|73
5249850|NCT00762034|18115152|P2|Induction Period|Lost to Follow-up|1
5249851|NCT00762034|18115153|P1|Induction Period|Lost to Follow-up|1
5249852|NCT00762034|18115152|P2|Induction Period|Adverse Event|38
5249853|NCT00762034|18115153|P1|Induction Period|Adverse Event|27
5249854|NCT00762034|18115152|P2|Induction Period|Entry Criterion Not Met|11
5249855|NCT00762034|18115153|P1|Induction Period|Entry Criterion Not Met|12
5249856|NCT00762034|18115152|P2|Induction Period|Protocol Violation|2
5249857|NCT00762034|18115153|P1|Induction Period|Protocol Violation|1
5249858|NCT00761969|18115225|P2|Overall Study|Lost to Follow-up|93
5249859|NCT00761969|18115226|P1|Overall Study|Lost to Follow-up|88
5249860|NCT00761969|18115225|P2|Overall Study|Death|47
5249861|NCT00761969|18115226|P1|Overall Study|Death|112
5249862|NCT00761956|18115236|P2|Overall Study|Adverse Event|34
5249863|NCT00761956|18115237|P1|Overall Study|Adverse Event|26
5249864|NCT00761956|18115236|P2|Overall Study|Death|1
5249865|NCT00761956|18115237|P1|Overall Study|Death|0
5249866|NCT00761956|18115236|P2|Overall Study|Withdrawal by Subject|8
5249867|NCT00761956|18115237|P1|Overall Study|Withdrawal by Subject|3
5249868|NCT00761956|18115236|P2|Overall Study|Lost to Follow-up|11
5249869|NCT00761956|18115237|P1|Overall Study|Lost to Follow-up|6
5249870|NCT00761891|18115264|P1|Overall Study|Withdrawal by Subject|10
5249871|NCT00761865|18115271|P2|Overall Study|Lost to Follow-up|7
5249872|NCT00761865|18115272|P1|Overall Study|Lost to Follow-up|8
5249873|NCT00761774|18115293|P1|Overall Study|IP stopped by hospital physician|1
5249874|NCT00761774|18115293|P1|Overall Study|Subject IP non-compliance|1
5249875|NCT00761774|18115293|P1|Overall Study|Coordinator leaving site|1
5249876|NCT00761774|18115293|P1|Overall Study|Patient moved out of study area|1
5249877|NCT00761774|18115293|P1|Overall Study|Investigator clinical judgement|1
5249878|NCT00761774|18115293|P1|Overall Study|Sponsor decision|1
5249879|NCT00761774|18115293|P1|Overall Study|Medical decision to read SUSAR reports|1
5249880|NCT00761774|18115293|P1|Overall Study|Reclassification of seizures|1
5249881|NCT00761774|18115293|P1|Overall Study|End of study|2
5249882|NCT00761774|18115293|P1|Overall Study|Non-compliance|4
5249883|NCT00761774|18115293|P1|Overall Study|Withdrawal by Subject|9
5249884|NCT00761774|18115293|P1|Overall Study|Lost to Follow-up|2
5249885|NCT00761774|18115293|P1|Overall Study|Lack of Efficacy|37
5249886|NCT00761774|18115293|P1|Overall Study|Adverse Event|17
5249887|NCT00761761|18115304|P2|Overall Study|Withdrawal by Subject|0
5249888|NCT00761761|18115305|P1|Overall Study|Withdrawal by Subject|3
5249889|NCT00761761|18115304|P2|Overall Study|Lost to Follow-up|1
5249890|NCT00761761|18115305|P1|Overall Study|Lost to Follow-up|3
5249891|NCT00761748|18115317|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
5249892|NCT00761748|18115318|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
5249893|NCT00761748|18115317|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
5249894|NCT00761748|18115318|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
5249895|NCT00761735|18115324|P1|Overall Study|Administrative|1
5249896|NCT00761735|18115324|P1|Overall Study|Non-compliance with protocol|1
5249897|NCT00761735|18115324|P1|Overall Study|Withdrawal by Subject|6
5249898|NCT00761735|18115324|P1|Overall Study|Lost to Follow-up|6
5249899|NCT00761631|18115340|P6|Overall Study|Other|1
5249900|NCT00761631|18115341|P5|Overall Study|Other|1
5249901|NCT00761631|18115342|P4|Overall Study|Other|0
5249902|NCT00761631|18115343|P3|Overall Study|Other|0
5249903|NCT00761631|18115344|P2|Overall Study|Other|0
5249904|NCT00761631|18115345|P1|Overall Study|Other|0
5249905|NCT00761631|18115340|P6|Overall Study|Physician Decision|0
5249906|NCT00761631|18115341|P5|Overall Study|Physician Decision|0
5249907|NCT00761631|18115342|P4|Overall Study|Physician Decision|0
5249908|NCT00761631|18115343|P3|Overall Study|Physician Decision|0
5249909|NCT00761631|18115344|P2|Overall Study|Physician Decision|0
5249910|NCT00761631|18115345|P1|Overall Study|Physician Decision|1
5249911|NCT00761631|18115340|P6|Overall Study|Failed to return|2
5249912|NCT00761631|18115341|P5|Overall Study|Failed to return|5
5249913|NCT00761631|18115342|P4|Overall Study|Failed to return|1
5249914|NCT00761631|18115343|P3|Overall Study|Failed to return|1
5249915|NCT00761631|18115344|P2|Overall Study|Failed to return|0
5249916|NCT00761631|18115345|P1|Overall Study|Failed to return|1
5249917|NCT00761631|18115340|P6|Overall Study|Randomized, not treated|0
5249918|NCT00761631|18115341|P5|Overall Study|Randomized, not treated|0
5249919|NCT00761631|18115342|P4|Overall Study|Randomized, not treated|0
5249920|NCT00761631|18115343|P3|Overall Study|Randomized, not treated|0
5249921|NCT00761631|18115344|P2|Overall Study|Randomized, not treated|0
5249922|NCT00761631|18115345|P1|Overall Study|Randomized, not treated|1
5249923|NCT00761631|18115340|P6|Overall Study|Protocol Violation|1
5249924|NCT00761631|18115341|P5|Overall Study|Protocol Violation|5
5249925|NCT00761631|18115342|P4|Overall Study|Protocol Violation|1
5249926|NCT00761631|18115343|P3|Overall Study|Protocol Violation|0
5249927|NCT00761631|18115344|P2|Overall Study|Protocol Violation|0
5249928|NCT00761631|18115345|P1|Overall Study|Protocol Violation|2
5249929|NCT00761631|18115340|P6|Overall Study|Lost to Follow-up|1
5249930|NCT00761631|18115341|P5|Overall Study|Lost to Follow-up|6
5249931|NCT00761631|18115342|P4|Overall Study|Lost to Follow-up|1
5249932|NCT00761631|18115343|P3|Overall Study|Lost to Follow-up|7
5249933|NCT00761631|18115344|P2|Overall Study|Lost to Follow-up|4
5249934|NCT00761631|18115345|P1|Overall Study|Lost to Follow-up|2
5249935|NCT00761631|18115340|P6|Overall Study|Parent/legal guardian request|0
5249936|NCT00761631|18115341|P5|Overall Study|Parent/legal guardian request|5
5249937|NCT00761631|18115342|P4|Overall Study|Parent/legal guardian request|0
5249938|NCT00761631|18115343|P3|Overall Study|Parent/legal guardian request|8
5249939|NCT00761631|18115344|P2|Overall Study|Parent/legal guardian request|3
5249940|NCT00761631|18115345|P1|Overall Study|Parent/legal guardian request|8
5249941|NCT00761605|18115380|P1|Overall Study|Other|21
5249942|NCT00761605|18115380|P1|Overall Study|Withdrawal by Subject|37
5249943|NCT00761605|18115380|P1|Overall Study|Lost to Follow-up|29
5249944|NCT00761605|18115380|P1|Overall Study|Lack of Efficacy|26
5249945|NCT00761605|18115380|P1|Overall Study|Death|2
5249946|NCT00761605|18115380|P1|Overall Study|Adverse Event|26
5249947|NCT00761579|18115424|P1|Overall Study|Intake of prohibited concomitant drug|1
5249948|NCT00761579|18115424|P1|Overall Study|Lost survey form|1
5249949|NCT00761579|18115424|P1|Overall Study|Aggravation of symptoms by changing drug|1
5249950|NCT00761579|18115424|P1|Overall Study|Aggravation of depression|1
5249951|NCT00761579|18115424|P1|Overall Study|Drug overdose|1
5249952|NCT00761579|18115424|P1|Overall Study|Protocol deviation|1
5249953|NCT00761579|18115424|P1|Overall Study|Lack of compliance|2
5249954|NCT00761579|18115424|P1|Overall Study|Withdrawal by Subject|34
5249955|NCT00761579|18115424|P1|Overall Study|Pregnancy|1
5249956|NCT00761579|18115424|P1|Overall Study|Lost to Follow-up|16
5249957|NCT00761579|18115424|P1|Overall Study|Lack of Efficacy|21
5249958|NCT00761579|18115424|P1|Overall Study|Death|2
5249959|NCT00761579|18115424|P1|Overall Study|Adverse Event|10
5249960|NCT00761527|18115457|P1|Overall Study|Unknown reason|2
5249961|NCT00761527|18115457|P1|Overall Study|Lost to Follow-up|9
5249962|NCT00761527|18115457|P1|Overall Study|Poor Compliance|8
5249963|NCT00761527|18115457|P1|Overall Study|Adverse Event|3
5249964|NCT00761514|18115464|P1|Overall Study|Unable to pay for medications|1
5249965|NCT00761514|18115464|P1|Overall Study|Problem complying with study visit|1
5249966|NCT00761514|18115464|P1|Overall Study|Health insurance didn't cover study drug|1
5249967|NCT00761514|18115464|P1|Overall Study|Lost to Follow-up|1
5249968|NCT00761514|18115464|P1|Overall Study|Withdrawal by Subject|2
5249969|NCT00761514|18115464|P1|Overall Study|Adverse Event|1
5249970|NCT00761462|18115471|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
5249971|NCT00761462|18115472|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
5249972|NCT00761462|18115471|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
5249973|NCT00761462|18115472|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
5249974|NCT00761462|18115471|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
5249975|NCT00761462|18115472|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
5249976|NCT00761462|18115471|P2|Treatment|Subjects never received study medication|12
5249977|NCT00761462|18115472|P1|Treatment|Subjects never received study medication|23
5249978|NCT00761319|18115486|P2|Overall Study|Missing|0
5249979|NCT00761319|18115487|P1|Overall Study|Missing|1
5249980|NCT00761319|18115486|P2|Overall Study|Nonspecified|2
5249981|NCT00761319|18115487|P1|Overall Study|Nonspecified|2
5249982|NCT00761319|18115486|P2|Overall Study|Lost to Follow-up|1
5249983|NCT00761319|18115487|P1|Overall Study|Lost to Follow-up|1
5249984|NCT00761319|18115486|P2|Overall Study|Noncompliance|3
5249985|NCT00761319|18115487|P1|Overall Study|Noncompliance|4
5249986|NCT00761319|18115486|P2|Overall Study|Withdrawal by Subject|7
5249987|NCT00761319|18115487|P1|Overall Study|Withdrawal by Subject|8
5249988|NCT00761319|18115486|P2|Overall Study|Adverse Event|7
5249989|NCT00761319|18115487|P1|Overall Study|Adverse Event|11
5249990|NCT00761319|18115486|P2|Overall Study|Protocol Violation|14
5249991|NCT00761319|18115487|P1|Overall Study|Protocol Violation|21
5249992|NCT00761306|18115495|P1|Overall Study|Administrative or Other Reasons|5
5249993|NCT00761306|18115495|P1|Overall Study|Lost to Follow-up|1
5249994|NCT00761306|18115495|P1|Overall Study|Withdrawal of Consent|3
5249995|NCT00761306|18115495|P1|Overall Study|Protocol Violation|2
5249996|NCT00761306|18115495|P1|Overall Study|Lack of Efficacy|4
5249997|NCT00761306|18115495|P1|Overall Study|Adverse Event|5
5249998|NCT00761280|18115506|P2|First Dose to End of Study|Lost to Follow-up|1
5249999|NCT00761280|18115507|P1|First Dose to End of Study|Lost to Follow-up|0
5250000|NCT00761280|18115506|P2|First Dose to End of Study|Death|0
5250001|NCT00761280|18115507|P1|First Dose to End of Study|Death|1
5250002|NCT00761280|18115506|P2|First Dose to End of Study|Sponsor decision|2
5250003|NCT00761280|18115507|P1|First Dose to End of Study|Sponsor decision|1
5250004|NCT00761280|18115506|P2|First Dose to End of Study|Progressive disease|3
5250005|NCT00761280|18115507|P1|First Dose to End of Study|Progressive disease|5
5250006|NCT00761280|18115506|P2|First Dose to End of Study|End of trial|5
5250007|NCT00761280|18115507|P1|First Dose to End of Study|End of trial|5
5250008|NCT00761280|18115506|P2|Randomization to First Dose|Other|0
5250009|NCT00761280|18115507|P1|Randomization to First Dose|Other|1
5250010|NCT00761280|18115506|P2|Randomization to First Dose|Sponsor decision|0
5250011|NCT00761280|18115507|P1|Randomization to First Dose|Sponsor decision|1
5250012|NCT00761280|18115506|P2|Randomization to First Dose|Withdrawal by Subject|2
5250013|NCT00761280|18115507|P1|Randomization to First Dose|Withdrawal by Subject|0
5250014|NCT00761267|18115538|P3|Overall Study|Withdrawal by Subject|0
5250015|NCT00761267|18115539|P2|Overall Study|Withdrawal by Subject|1
5250016|NCT00761267|18115540|P1|Overall Study|Withdrawal by Subject|0
5250017|NCT00761267|18115538|P3|Overall Study|Randomized but not treated|0
5250018|NCT00761267|18115539|P2|Overall Study|Randomized but not treated|1
5250019|NCT00761267|18115540|P1|Overall Study|Randomized but not treated|1
5250020|NCT00761267|18115538|P3|Overall Study|Lost to Follow-up|1
5250021|NCT00761267|18115539|P2|Overall Study|Lost to Follow-up|0
5250022|NCT00761267|18115540|P1|Overall Study|Lost to Follow-up|0
5250023|NCT00761267|18115538|P3|Overall Study|Death|5
5250024|NCT00761267|18115539|P2|Overall Study|Death|2
5250025|NCT00761267|18115540|P1|Overall Study|Death|1
5250026|NCT00761215|18115591|P3|Overall Study|Bacteremia|0
5250027|NCT00761215|18115592|P2|Overall Study|Bacteremia|0
5250028|NCT00761215|18115593|P1|Overall Study|Bacteremia|1
5250029|NCT00761215|18115591|P3|Overall Study|Withdrawal by Subject|0
5250030|NCT00761215|18115592|P2|Overall Study|Withdrawal by Subject|0
5250031|NCT00761215|18115593|P1|Overall Study|Withdrawal by Subject|1
5250032|NCT00761215|18115591|P3|Overall Study|Lost to Follow-up|6
5250033|NCT00761215|18115592|P2|Overall Study|Lost to Follow-up|3
5250034|NCT00761215|18115593|P1|Overall Study|Lost to Follow-up|6
5250035|NCT00761215|18115591|P3|Overall Study|Randomized but didn't receive drug|2
5250036|NCT00761215|18115592|P2|Overall Study|Randomized but didn't receive drug|1
5250037|NCT00761215|18115593|P1|Overall Study|Randomized but didn't receive drug|1
5250038|NCT00761189|18115635|P1|Overall Study|Other|13
5250039|NCT00761189|18115635|P1|Overall Study|Withdrawal by Subject|49
5250040|NCT00761189|18115635|P1|Overall Study|Lost to Follow-up|36
5250041|NCT00761189|18115635|P1|Overall Study|Lack of Efficacy|45
5250042|NCT00761189|18115635|P1|Overall Study|Adverse Event|42
5250043|NCT00761176|18115652|P2|Overall Study|Withdrawal by Subject|1
5250044|NCT00761176|18115653|P1|Overall Study|Withdrawal by Subject|1
5250045|NCT00761176|18115652|P2|Overall Study|Death|0
5250046|NCT00761176|18115653|P1|Overall Study|Death|1
5250047|NCT00761150|18115662|P3|Double-blind Period|Other|3
5250048|NCT00761150|18115663|P2|Double-blind Period|Other|3
5250049|NCT00761150|18115664|P1|Double-blind Period|Other|0
5250050|NCT00761150|18115662|P3|Double-blind Period|Noncompliance|0
5250051|NCT00761150|18115663|P2|Double-blind Period|Noncompliance|1
5250052|NCT00761150|18115664|P1|Double-blind Period|Noncompliance|0
5250053|NCT00761150|18115662|P3|Double-blind Period|Did not meet DB randomization criteria|1
5250054|NCT00761150|18115663|P2|Double-blind Period|Did not meet DB randomization criteria|0
5250055|NCT00761150|18115664|P1|Double-blind Period|Did not meet DB randomization criteria|0
5250056|NCT00761150|18115662|P3|Double-blind Period|Lost to Follow-up|1
5250057|NCT00761150|18115663|P2|Double-blind Period|Lost to Follow-up|2
5250058|NCT00761150|18115664|P1|Double-blind Period|Lost to Follow-up|0
5250059|NCT00761150|18115662|P3|Double-blind Period|Withdrawal by Subject|2
5250060|NCT00761150|18115663|P2|Double-blind Period|Withdrawal by Subject|3
5250061|NCT00761150|18115664|P1|Double-blind Period|Withdrawal by Subject|0
5250062|NCT00761150|18115662|P3|Double-blind Period|Adverse Event|3
5250063|NCT00761150|18115663|P2|Double-blind Period|Adverse Event|3
5250064|NCT00761150|18115664|P1|Double-blind Period|Adverse Event|0
5250065|NCT00761150|18115662|P3|Double-blind Period|Lack of Efficacy|19
5250066|NCT00761150|18115663|P2|Double-blind Period|Lack of Efficacy|2
5250067|NCT00761150|18115664|P1|Double-blind Period|Lack of Efficacy|0
5250068|NCT00761150|18115662|P3|Open-label Period|Other|0
5250069|NCT00761150|18115663|P2|Open-label Period|Other|0
5250070|NCT00761150|18115664|P1|Open-label Period|Other|5
5250071|NCT00761150|18115662|P3|Open-label Period|Noncompliance|0
5250072|NCT00761150|18115663|P2|Open-label Period|Noncompliance|0
5250073|NCT00761150|18115664|P1|Open-label Period|Noncompliance|2
5250074|NCT00761150|18115662|P3|Open-label Period|Withdrawal by Subject|0
5250075|NCT00761150|18115663|P2|Open-label Period|Withdrawal by Subject|0
5250076|NCT00761150|18115664|P1|Open-label Period|Withdrawal by Subject|5
5250077|NCT00761150|18115662|P3|Open-label Period|Lack of Efficacy|0
5250078|NCT00761150|18115663|P2|Open-label Period|Lack of Efficacy|0
5250079|NCT00761150|18115664|P1|Open-label Period|Lack of Efficacy|4
5250080|NCT00761150|18115662|P3|Open-label Period|Lost to Follow-up|0
5250081|NCT00761150|18115663|P2|Open-label Period|Lost to Follow-up|0
5250082|NCT00761150|18115664|P1|Open-label Period|Lost to Follow-up|7
5250083|NCT00761150|18115662|P3|Open-label Period|Did not meet DB randomization criteria|0
5250084|NCT00761150|18115663|P2|Open-label Period|Did not meet DB randomization criteria|0
5250085|NCT00761150|18115664|P1|Open-label Period|Did not meet DB randomization criteria|11
5250086|NCT00761150|18115662|P3|Open-label Period|Adverse Event|0
5250087|NCT00761150|18115663|P2|Open-label Period|Adverse Event|0
5250088|NCT00761150|18115664|P1|Open-label Period|Adverse Event|36
5250089|NCT00760994|18115737|P3|Overall Study|Lost to Follow-up|3
5250090|NCT00760994|18115738|P2|Overall Study|Lost to Follow-up|4
5250091|NCT00760994|18115739|P1|Overall Study|Lost to Follow-up|4
5250092|NCT00760877|18115752|P2|Overall Study|Treatment failure|0
5250093|NCT00760877|18115753|P1|Overall Study|Treatment failure|1
5250094|NCT00760877|18115752|P2|Overall Study|Participants transferred to AMN107A2408|1
5250095|NCT00760877|18115753|P1|Overall Study|Participants transferred to AMN107A2408|11
5250096|NCT00760877|18115752|P2|Overall Study|Physician Decision|2
5250097|NCT00760877|18115753|P1|Overall Study|Physician Decision|1
5250098|NCT00760877|18115752|P2|Overall Study|Participant not eligible to cross-over|1
5250099|NCT00760877|18115753|P1|Overall Study|Participant not eligible to cross-over|0
5250100|NCT00760877|18115752|P2|Overall Study|Participant diagnosed with AML|1
5250101|NCT00760877|18115753|P1|Overall Study|Participant diagnosed with AML|0
5250102|NCT00760877|18115752|P2|Overall Study|Adverse Event|12
5250103|NCT00760877|18115753|P1|Overall Study|Adverse Event|19
5250104|NCT00760877|18115752|P2|Overall Study|Withdrawal by Subject|3
5250105|NCT00760877|18115753|P1|Overall Study|Withdrawal by Subject|7
5250106|NCT00760877|18115752|P2|Overall Study|Death|1
5250107|NCT00760877|18115753|P1|Overall Study|Death|2
5250108|NCT00760877|18115752|P2|Overall Study|Pregnancy|4
5250109|NCT00760877|18115753|P1|Overall Study|Pregnancy|1
5250110|NCT00760877|18115752|P2|Overall Study|Non-compliance with protocol treatment|1
5250111|NCT00760877|18115753|P1|Overall Study|Non-compliance with protocol treatment|2
5250112|NCT00760877|18115752|P2|Overall Study|Protocol Violation|0
5250113|NCT00760877|18115753|P1|Overall Study|Protocol Violation|1
5250114|NCT00760838|18115771|P2|Overall Study|Withdrawal by Subject|1
5250115|NCT00760838|18115772|P1|Overall Study|Withdrawal by Subject|1
5250116|NCT00760838|18115771|P2|Overall Study|Lost to Follow-up|0
5250117|NCT00760838|18115772|P1|Overall Study|Lost to Follow-up|2
5250118|NCT00760838|18115771|P2|Overall Study|Lack of Efficacy|0
5250119|NCT00760838|18115772|P1|Overall Study|Lack of Efficacy|1
5250120|NCT00760838|18115771|P2|Overall Study|Adverse Event|1
5250121|NCT00760838|18115772|P1|Overall Study|Adverse Event|1
5250122|NCT00760747|18115790|P2|Study Period III|Physician Decision|1
5250123|NCT00760747|18115791|P1|Study Period III|Physician Decision|0
5250124|NCT00760747|18115790|P2|Study Period III|Protocol Violation|1
5250125|NCT00760747|18115791|P1|Study Period III|Protocol Violation|1
5250126|NCT00760747|18115790|P2|Study Period III|Parent/Caregiver Decision|1
5250127|NCT00760747|18115791|P1|Study Period III|Parent/Caregiver Decision|0
5250128|NCT00760747|18115790|P2|Study Period III|Lack of Efficacy|0
5250129|NCT00760747|18115791|P1|Study Period III|Lack of Efficacy|1
5250130|NCT00760747|18115790|P2|Study Period III|Adverse Event|0
5250131|NCT00760747|18115791|P1|Study Period III|Adverse Event|1
5250132|NCT00760747|18115790|P2|Study Period II|No drug administered|1
5250133|NCT00760747|18115791|P1|Study Period II|No drug administered|0
5250134|NCT00760747|18115790|P2|Study Period II|Withdrawal by Subject|0
5250135|NCT00760747|18115791|P1|Study Period II|Withdrawal by Subject|1
5250136|NCT00760747|18115790|P2|Study Period II|Protocol Violation|3
5250137|NCT00760747|18115791|P1|Study Period II|Protocol Violation|6
5250138|NCT00760747|18115790|P2|Study Period II|Parent/Caregiver Decision|0
5250139|NCT00760747|18115791|P1|Study Period II|Parent/Caregiver Decision|3
5250140|NCT00760747|18115790|P2|Study Period II|Lack of Efficacy|6
5250141|NCT00760747|18115791|P1|Study Period II|Lack of Efficacy|0
5250142|NCT00760747|18115790|P2|Study Period II|Adverse Event|4
5250143|NCT00760747|18115791|P1|Study Period II|Adverse Event|3
5250144|NCT00760669|18115819|P1|Overall Study|Took drug before entering in contract|5
5250145|NCT00760669|18115819|P1|Overall Study|Participants with overlapping cases|1
5250146|NCT00760669|18115819|P1|Overall Study|Participants missing efficacy assessment|6
5250147|NCT00760669|18115819|P1|Overall Study|Not assessed for overall improvement|18
5250148|NCT00760617|18115836|P3|Overall Study|Lost to Follow-up|5
5250149|NCT00760617|18115837|P2|Overall Study|Lost to Follow-up|0
5250150|NCT00760617|18115838|P1|Overall Study|Lost to Follow-up|0
5250151|NCT00760617|18115836|P3|Overall Study|Adverse Event|0
5250152|NCT00760617|18115837|P2|Overall Study|Adverse Event|2
5250153|NCT00760617|18115838|P1|Overall Study|Adverse Event|5
5250154|NCT00760552|18115952|P2|Overall Study|Lost to Follow-up|10
5250155|NCT00760552|18115953|P1|Overall Study|Lost to Follow-up|11
5250156|NCT00760552|18115952|P2|Overall Study|Death|0
5250157|NCT00760552|18115953|P1|Overall Study|Death|2
5250158|NCT00760513|18115989|P2|Overall Study|Withdrawal by Subject|7
5250159|NCT00760513|18115990|P1|Overall Study|Withdrawal by Subject|5
5250160|NCT00760487|18116000|P1|Overall Study|Unilateral implantation|3
5250161|NCT00760474|18116006|P2|Period 2 (P2)|Adverse Event|1
5250162|NCT00760474|18116007|P1|Period 2 (P2)|Adverse Event|0
5250163|NCT00760474|18116006|P2|Period 2 (P2)|Lost to Follow-up|0
5250164|NCT00760474|18116007|P1|Period 2 (P2)|Lost to Follow-up|1
5250165|NCT00760474|18116006|P2|Placebo Washout Period|Other|1
5250166|NCT00760474|18116007|P1|Placebo Washout Period|Other|0
5250167|NCT00760474|18116006|P2|Period 1 (P1)|Discontinued then re-entered|1
5250168|NCT00760474|18116007|P1|Period 1 (P1)|Discontinued then re-entered|1
5250169|NCT00760383|18116064|P2|Overall Study|moved away; withdrew; medical reasons|7
5250170|NCT00760383|18116065|P1|Overall Study|moved away; withdrew; medical reasons|5
5250171|NCT00760266|18116077|P2|Overall Study|Administrative Problems|1
5250172|NCT00760266|18116078|P1|Overall Study|Administrative Problems|0
5250173|NCT00760266|18116077|P2|Overall Study|Lost to Follow-up|1
5250174|NCT00760266|18116078|P1|Overall Study|Lost to Follow-up|2
5250175|NCT00760266|18116077|P2|Overall Study|Patient withdrew consent|3
5250176|NCT00760266|18116078|P1|Overall Study|Patient withdrew consent|3
5250177|NCT00760266|18116077|P2|Overall Study|Protocol deviation|4
5250178|NCT00760266|18116078|P1|Overall Study|Protocol deviation|2
5250179|NCT00760266|18116077|P2|Overall Study|Lack of Efficacy|2
5250180|NCT00760266|18116078|P1|Overall Study|Lack of Efficacy|2
5250181|NCT00760266|18116077|P2|Overall Study|Abnormal test procedure result(s)|0
5250182|NCT00760266|18116078|P1|Overall Study|Abnormal test procedure result(s)|1
5250183|NCT00760266|18116077|P2|Overall Study|Abnormal laboratory value(s)|0
5250184|NCT00760266|18116078|P1|Overall Study|Abnormal laboratory value(s)|1
5250185|NCT00760266|18116077|P2|Overall Study|Adverse Event|7
5250186|NCT00760266|18116078|P1|Overall Study|Adverse Event|13
5250187|NCT00760214|18116095|P3|Overall Study|Other|6
5250188|NCT00760214|18116096|P2|Overall Study|Other|4
5250189|NCT00760214|18116097|P1|Overall Study|Other|3
5250190|NCT00760214|18116095|P3|Overall Study|Physician Decision|1
5250191|NCT00760214|18116096|P2|Overall Study|Physician Decision|1
5250192|NCT00760214|18116097|P1|Overall Study|Physician Decision|1
5250193|NCT00760214|18116095|P3|Overall Study|Pregnancy|1
5250194|NCT00760214|18116096|P2|Overall Study|Pregnancy|0
5250195|NCT00760214|18116097|P1|Overall Study|Pregnancy|0
5250196|NCT00760214|18116095|P3|Overall Study|Lack of Efficacy|4
5250197|NCT00760214|18116096|P2|Overall Study|Lack of Efficacy|2
5250198|NCT00760214|18116097|P1|Overall Study|Lack of Efficacy|3
5250199|NCT00760214|18116095|P3|Overall Study|Withdrawal by Subject|13
5250200|NCT00760214|18116096|P2|Overall Study|Withdrawal by Subject|14
5250201|NCT00760214|18116097|P1|Overall Study|Withdrawal by Subject|12
5250202|NCT00760214|18116095|P3|Overall Study|Lost to Follow-up|1
5250203|NCT00760214|18116096|P2|Overall Study|Lost to Follow-up|0
5250204|NCT00760214|18116097|P1|Overall Study|Lost to Follow-up|0
5250205|NCT00760214|18116095|P3|Overall Study|Protocol Violation|3
5250206|NCT00760214|18116096|P2|Overall Study|Protocol Violation|0
5250207|NCT00760214|18116097|P1|Overall Study|Protocol Violation|3
5250208|NCT00760214|18116095|P3|Overall Study|Adverse Event|12
5250209|NCT00760214|18116096|P2|Overall Study|Adverse Event|9
5250210|NCT00760214|18116097|P1|Overall Study|Adverse Event|8
5250211|NCT00760084|18116138|P1|Overall Study|Progressive Disease|3
5250212|NCT00760084|18116138|P1|Overall Study|Withdrawal by Subject|2
5250213|NCT00760084|18116138|P1|Overall Study|Physician Decision|5
5250214|NCT00759954|18116181|P2|Overall Study|Adverse Event|2
5250215|NCT00759954|18116182|P1|Overall Study|Adverse Event|1
5250216|NCT00759954|18116181|P2|Overall Study|Personal reason|0
5250217|NCT00759954|18116182|P1|Overall Study|Personal reason|1
5250218|NCT00759941|18116196|P2|Overall Study|Exited in error by site|1
5250219|NCT00759941|18116197|P1|Overall Study|Exited in error by site|1
5250220|NCT00759941|18116196|P2|Overall Study|Adverse Event|0
5250221|NCT00759941|18116197|P1|Overall Study|Adverse Event|1
5250222|NCT00759941|18116196|P2|Overall Study|Use of medication|0
5250223|NCT00759941|18116197|P1|Overall Study|Use of medication|1
5250224|NCT00759915|18116211|P2|Overall Study|Adverse Event|1
5250225|NCT00759915|18116212|P1|Overall Study|Adverse Event|0
5250226|NCT00759915|18116211|P2|Overall Study|Withdrawal by Subject|0
5250227|NCT00759915|18116212|P1|Overall Study|Withdrawal by Subject|1
5250228|NCT00759902|18116226|P2|Overall Study|Adverse Event|1
5250229|NCT00759902|18116227|P1|Overall Study|Adverse Event|0
5250230|NCT00759876|18116239|P1|Overall Study|Sponsor terminated study early|36
5250231|NCT00759863|18116263|P2|Overall Study|Death, moved, or lost contact|18
5250232|NCT00759863|18116264|P1|Overall Study|Death, moved, or lost contact|20
5250233|NCT00759785|18116285|P2|Overall Study|Withdrawal by Subject|1
5250234|NCT00759785|18116286|P1|Overall Study|Withdrawal by Subject|0
5250235|NCT00759785|18116285|P2|Overall Study|Physician Decision|1
5250236|NCT00759785|18116286|P1|Overall Study|Physician Decision|0
5250237|NCT00759785|18116285|P2|Overall Study|Protocol Violation|0
5250238|NCT00759785|18116286|P1|Overall Study|Protocol Violation|1
5250239|NCT00759785|18116285|P2|Overall Study|Participant sample lost|1
5250240|NCT00759785|18116286|P1|Overall Study|Participant sample lost|0
5250241|NCT00759785|18116285|P2|Overall Study|Participant sample not evaluable|2
5250242|NCT00759785|18116286|P1|Overall Study|Participant sample not evaluable|11
5250243|NCT00759759|18116309|P2|Overall Study|Withdrawal by Subject|1
5250244|NCT00759759|18116310|P1|Overall Study|Withdrawal by Subject|2
5250245|NCT00759759|18116309|P2|Overall Study|Didn't receive drug in period 2|0
5250246|NCT00759759|18116310|P1|Overall Study|Didn't receive drug in period 2|1
5250247|NCT00759759|18116309|P2|Overall Study|didn't return for period 2|0
5250248|NCT00759759|18116310|P1|Overall Study|didn't return for period 2|1
5250249|NCT00759681|18116328|P2|Overall Study|Lost to Follow-up|5
5250250|NCT00759681|18116329|P1|Overall Study|Lost to Follow-up|8
5250251|NCT00759681|18116328|P2|Overall Study|Death|5
5250252|NCT00759681|18116329|P1|Overall Study|Death|2
5250253|NCT00759655|18116356|P1|Overall Study|Termination of the study by sponsor|1
5250254|NCT00759564|18116384|P5|Washout Period (at Least 14 Days)|Adverse Event|1
5250255|NCT00759564|18116385|P4|Washout Period (at Least 14 Days)|Adverse Event|0
5250256|NCT00759564|18116386|P3|Washout Period (at Least 14 Days)|Adverse Event|0
5250257|NCT00759564|18116387|P2|Washout Period (at Least 14 Days)|Adverse Event|0
5250258|NCT00759564|18116388|P1|Washout Period (at Least 14 Days)|Adverse Event|0
5250259|NCT00759395|18116565|P2|Overall Study|Lack of Efficacy|2
5250260|NCT00759395|18116566|P1|Overall Study|Lack of Efficacy|0
5250261|NCT00759395|18116565|P2|Overall Study|Withdrawal by Subject|0
5250262|NCT00759395|18116566|P1|Overall Study|Withdrawal by Subject|1
5250263|NCT00759395|18116565|P2|Overall Study|Adverse Event|0
5250264|NCT00759395|18116566|P1|Overall Study|Adverse Event|1
5250265|NCT00759356|18116582|P2|Overall Study|Subject was unable to return|0
5250266|NCT00759356|18116583|P1|Overall Study|Subject was unable to return|1
5250267|NCT00759356|18116582|P2|Overall Study|Withdrawal by Subject|2
5250268|NCT00759356|18116583|P1|Overall Study|Withdrawal by Subject|0
5250269|NCT00759356|18116582|P2|Overall Study|Adverse Event|1
5250270|NCT00759356|18116583|P1|Overall Study|Adverse Event|0
5250271|NCT00759174|18116663|P2|Overall Study|Other|2
5250272|NCT00759174|18116664|P1|Overall Study|Other|0
5250273|NCT00759148|18116688|P2|Overall Study|Reason not given|0
5250274|NCT00759148|18116689|P1|Overall Study|Reason not given|1
5250275|NCT00759148|18116688|P2|Overall Study|Treatment Failure|10
5250276|NCT00759148|18116689|P1|Overall Study|Treatment Failure|6
5250277|NCT00759148|18116688|P2|Overall Study|Lost to Follow-up|9
5250278|NCT00759148|18116689|P1|Overall Study|Lost to Follow-up|3
5250279|NCT00759148|18116688|P2|Overall Study|Withdrawal by Subject|7
5250280|NCT00759148|18116689|P1|Overall Study|Withdrawal by Subject|3
5250281|NCT00759148|18116688|P2|Overall Study|Adverse Event|6
5250282|NCT00759148|18116689|P1|Overall Study|Adverse Event|1
5250283|NCT00759109|18116699|P2|Overall Study|Lost during study|0
5250284|NCT00759109|18116700|P1|Overall Study|Lost during study|1
5250285|NCT00759109|18116699|P2|Overall Study|Participant had a liver transplant|1
5250286|NCT00759109|18116700|P1|Overall Study|Participant had a liver transplant|0
5250287|NCT00759109|18116699|P2|Overall Study|Participant moved to a different city|1
5250288|NCT00759109|18116700|P1|Overall Study|Participant moved to a different city|0
5250289|NCT00759109|18116699|P2|Overall Study|HCV RNA negative|0
5250290|NCT00759109|18116700|P1|Overall Study|HCV RNA negative|1
5250291|NCT00759109|18116699|P2|Overall Study|Started new therapy|6
5250292|NCT00759109|18116700|P1|Overall Study|Started new therapy|2
5250293|NCT00759109|18116699|P2|Overall Study|Lost to Follow-up|6
5250294|NCT00759109|18116700|P1|Overall Study|Lost to Follow-up|4
5250295|NCT00759109|18116699|P2|Overall Study|Death|3
5250296|NCT00759109|18116700|P1|Overall Study|Death|4
5250297|NCT00759109|18116699|P2|Overall Study|Withdrawal by Subject|5
5250298|NCT00759109|18116700|P1|Overall Study|Withdrawal by Subject|9
5250299|NCT00759109|18116699|P2|Overall Study|Inability to comply|1
5250300|NCT00759109|18116700|P1|Overall Study|Inability to comply|1
5250301|NCT00759109|18116699|P2|Overall Study|Adverse Event|12
5250302|NCT00759109|18116700|P1|Overall Study|Adverse Event|17
5250303|NCT00759031|18116722|P2|First Intervention (1 Day)|Screening failure|0
5250304|NCT00759031|18116723|P1|First Intervention (1 Day)|Screening failure|1
5250305|NCT00759031|18116722|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5250306|NCT00759031|18116723|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5250307|NCT00759031|18116722|P2|First Intervention (1 Day)|Physician Decision|0
5250308|NCT00759031|18116723|P1|First Intervention (1 Day)|Physician Decision|1
5250309|NCT00758771|18116782|P2|Overall Study|Did not meet eligibility criteria|4
5250310|NCT00758771|18116783|P1|Overall Study|Did not meet eligibility criteria|2
5250311|NCT00758771|18116782|P2|Overall Study|Withdrawal by Subject|1
5250312|NCT00758771|18116783|P1|Overall Study|Withdrawal by Subject|1
5250313|NCT00758706|18116841|P2|Overall Study|Adverse Event|4
5250314|NCT00758706|18116842|P1|Overall Study|Adverse Event|4
5250315|NCT00758680|18116878|P10|Overall Study|Withdrawal by Subject|0
5250316|NCT00758680|18116879|P9|Overall Study|Withdrawal by Subject|1
5250317|NCT00758680|18116880|P8|Overall Study|Withdrawal by Subject|0
5250318|NCT00758680|18116881|P7|Overall Study|Withdrawal by Subject|1
5250319|NCT00758680|18116882|P6|Overall Study|Withdrawal by Subject|0
5250320|NCT00758680|18116883|P5|Overall Study|Withdrawal by Subject|0
5250321|NCT00758680|18116884|P4|Overall Study|Withdrawal by Subject|0
5250322|NCT00758680|18116885|P3|Overall Study|Withdrawal by Subject|0
5250323|NCT00758680|18116886|P2|Overall Study|Withdrawal by Subject|0
5250324|NCT00758680|18116887|P1|Overall Study|Withdrawal by Subject|0
5250325|NCT00758680|18116878|P10|Overall Study|Laboratory Adverse Event|0
5250326|NCT00758680|18116879|P9|Overall Study|Laboratory Adverse Event|1
5250327|NCT00758680|18116880|P8|Overall Study|Laboratory Adverse Event|0
5250328|NCT00758680|18116881|P7|Overall Study|Laboratory Adverse Event|0
5250329|NCT00758680|18116882|P6|Overall Study|Laboratory Adverse Event|0
5250330|NCT00758680|18116883|P5|Overall Study|Laboratory Adverse Event|0
5250331|NCT00758680|18116884|P4|Overall Study|Laboratory Adverse Event|0
5250332|NCT00758680|18116885|P3|Overall Study|Laboratory Adverse Event|0
5250333|NCT00758680|18116886|P2|Overall Study|Laboratory Adverse Event|0
5250334|NCT00758680|18116887|P1|Overall Study|Laboratory Adverse Event|0
5250335|NCT00758680|18116878|P10|Overall Study|Adverse Event|1
5250336|NCT00758680|18116879|P9|Overall Study|Adverse Event|0
5250337|NCT00758680|18116880|P8|Overall Study|Adverse Event|1
5250338|NCT00758680|18116881|P7|Overall Study|Adverse Event|0
5250339|NCT00758680|18116882|P6|Overall Study|Adverse Event|0
5250340|NCT00758680|18116883|P5|Overall Study|Adverse Event|0
5250341|NCT00758680|18116884|P4|Overall Study|Adverse Event|0
5250342|NCT00758680|18116885|P3|Overall Study|Adverse Event|0
5250343|NCT00758680|18116886|P2|Overall Study|Adverse Event|0
5250344|NCT00758680|18116887|P1|Overall Study|Adverse Event|0
5250345|NCT00758602|18116940|P2|Overall Study|Reason not specified|3
5250346|NCT00758602|18116941|P1|Overall Study|Reason not specified|3
5250347|NCT00758602|18116940|P2|Overall Study|Death|1
5250348|NCT00758602|18116941|P1|Overall Study|Death|0
5250349|NCT00758602|18116940|P2|Overall Study|Protocol Violation|2
5250350|NCT00758602|18116941|P1|Overall Study|Protocol Violation|0
5250351|NCT00758602|18116940|P2|Overall Study|Withdrawal by Subject|3
5250352|NCT00758602|18116941|P1|Overall Study|Withdrawal by Subject|1
5250353|NCT00758602|18116940|P2|Overall Study|Lost to Follow-up|3
5250354|NCT00758602|18116941|P1|Overall Study|Lost to Follow-up|4
5250355|NCT00758602|18116940|P2|Overall Study|Adverse Event|10
5250356|NCT00758602|18116941|P1|Overall Study|Adverse Event|11
5250357|NCT00758589|18116967|P4|Overall Study|Palm stopped to work|1
5250358|NCT00758589|18116968|P3|Overall Study|Palm stopped to work|0
5250359|NCT00758589|18116969|P2|Overall Study|Palm stopped to work|0
5250360|NCT00758589|18116970|P1|Overall Study|Palm stopped to work|0
5250361|NCT00758589|18116967|P4|Overall Study|Withdrawal by Subject|1
5250362|NCT00758589|18116968|P3|Overall Study|Withdrawal by Subject|1
5250363|NCT00758589|18116969|P2|Overall Study|Withdrawal by Subject|1
5250364|NCT00758589|18116970|P1|Overall Study|Withdrawal by Subject|0
5250365|NCT00758589|18116967|P4|Overall Study|Adverse Event|4
5250366|NCT00758589|18116968|P3|Overall Study|Adverse Event|5
5250367|NCT00758589|18116969|P2|Overall Study|Adverse Event|2
5250368|NCT00758589|18116970|P1|Overall Study|Adverse Event|3
5250369|NCT00758498|18117063|P3|Overall Study|Noncompliance to study procedures|1
5250370|NCT00758498|18117064|P2|Overall Study|Noncompliance to study procedures|0
5250371|NCT00758498|18117065|P1|Overall Study|Noncompliance to study procedures|0
5250372|NCT00758498|18117063|P3|Overall Study|Withdrawal by Subject|1
5250373|NCT00758498|18117064|P2|Overall Study|Withdrawal by Subject|0
5250374|NCT00758498|18117065|P1|Overall Study|Withdrawal by Subject|0
5250375|NCT00758498|18117063|P3|Overall Study|Subject legally detained out of state|0
5250376|NCT00758498|18117064|P2|Overall Study|Subject legally detained out of state|0
5250377|NCT00758498|18117065|P1|Overall Study|Subject legally detained out of state|1
5250378|NCT00758498|18117063|P3|Overall Study|Adverse Event|3
5250379|NCT00758498|18117064|P2|Overall Study|Adverse Event|2
5250380|NCT00758498|18117065|P1|Overall Study|Adverse Event|2
5250381|NCT00758485|18117150|P2|Overall Study|Not Treated|2
5250382|NCT00758485|18117151|P1|Overall Study|Not Treated|1
5250383|NCT00758485|18117150|P2|Overall Study|Lost to Follow-up|1
5250384|NCT00758485|18117151|P1|Overall Study|Lost to Follow-up|0
5250385|NCT00758459|18117163|P2|Overall Study|Withdrawal by Subject|1
5250386|NCT00758459|18117164|P1|Overall Study|Withdrawal by Subject|0
5250387|NCT00758459|18117163|P2|Overall Study|Protocol Violation|1
5250388|NCT00758459|18117164|P1|Overall Study|Protocol Violation|0
5250389|NCT00758459|18117163|P2|Overall Study|Adverse Event|2
5250390|NCT00758459|18117164|P1|Overall Study|Adverse Event|3
5250391|NCT00758394|18117209|P4|3rd Intervention|Lost to Follow-up|1
5250392|NCT00758394|18117210|P3|3rd Intervention|Lost to Follow-up|0
5250393|NCT00758394|18117211|P2|3rd Intervention|Lost to Follow-up|0
5250394|NCT00758394|18117212|P1|3rd Intervention|Lost to Follow-up|1
5250395|NCT00758394|18117209|P4|2nd Intervention Order|Lost to Follow-up|0
5250396|NCT00758394|18117210|P3|2nd Intervention Order|Lost to Follow-up|0
5250397|NCT00758394|18117211|P2|2nd Intervention Order|Lost to Follow-up|1
5250398|NCT00758394|18117212|P1|2nd Intervention Order|Lost to Follow-up|0
5250399|NCT00758264|18117241|P3|Active Phase|Other|4
5250400|NCT00758264|18117242|P2|Active Phase|Other|0
5250401|NCT00758264|18117243|P1|Active Phase|Other|0
5250402|NCT00758264|18117241|P3|Active Phase|Lost to Follow-up|0
5250403|NCT00758264|18117242|P2|Active Phase|Lost to Follow-up|0
5250404|NCT00758264|18117243|P1|Active Phase|Lost to Follow-up|1
5250405|NCT00758264|18117241|P3|Active Phase|Withdrawal by Subject|1
5250406|NCT00758264|18117242|P2|Active Phase|Withdrawal by Subject|0
5250407|NCT00758264|18117243|P1|Active Phase|Withdrawal by Subject|0
5250408|NCT00758160|18117302|P1|Overall Study|Withdrawal by Subject|8
5250409|NCT00758160|18117302|P1|Overall Study|Protocol Violation|12
5250410|NCT00758160|18117302|P1|Overall Study|Lost to Follow-up|14
5250411|NCT00758160|18117302|P1|Overall Study|Lack of Efficacy|10
5250412|NCT00758160|18117302|P1|Overall Study|Adverse Event|15
5250413|NCT00758160|18117302|P1|Overall Study|Administration Problems|3
5250414|NCT00758160|18117302|P1|Overall Study|No Longer Requires Study Medication|4
5250415|NCT00758069|18117323|P3|Overall Study|Incorrect Study Drug|0
5250416|NCT00758069|18117324|P2|Overall Study|Incorrect Study Drug|0
5250417|NCT00758069|18117325|P1|Overall Study|Incorrect Study Drug|1
5250418|NCT00758069|18117323|P3|Overall Study|Lack of Efficacy|1
5250419|NCT00758069|18117324|P2|Overall Study|Lack of Efficacy|0
5250420|NCT00758069|18117325|P1|Overall Study|Lack of Efficacy|0
5250421|NCT00758043|18117340|P4|Overall Study|Other Reasons|5
5250422|NCT00758043|18117341|P3|Overall Study|Other Reasons|0
5250423|NCT00758043|18117342|P2|Overall Study|Other Reasons|1
5250424|NCT00758043|18117343|P1|Overall Study|Other Reasons|0
5250425|NCT00758043|18117340|P4|Overall Study|Non-Compliant With study Drug|1
5250426|NCT00758043|18117341|P3|Overall Study|Non-Compliant With study Drug|0
5250427|NCT00758043|18117342|P2|Overall Study|Non-Compliant With study Drug|0
5250428|NCT00758043|18117343|P1|Overall Study|Non-Compliant With study Drug|0
5250429|NCT00758043|18117340|P4|Overall Study|Required Prohibited Medication|3
5250430|NCT00758043|18117341|P3|Overall Study|Required Prohibited Medication|1
5250431|NCT00758043|18117342|P2|Overall Study|Required Prohibited Medication|0
5250432|NCT00758043|18117343|P1|Overall Study|Required Prohibited Medication|0
5250433|NCT00758043|18117340|P4|Overall Study|Withdrawal by Subject|4
5250434|NCT00758043|18117341|P3|Overall Study|Withdrawal by Subject|1
5250435|NCT00758043|18117342|P2|Overall Study|Withdrawal by Subject|1
5250436|NCT00758043|18117343|P1|Overall Study|Withdrawal by Subject|0
5250437|NCT00758043|18117340|P4|Overall Study|Lost to Follow-up|5
5250438|NCT00758043|18117341|P3|Overall Study|Lost to Follow-up|2
5250439|NCT00758043|18117342|P2|Overall Study|Lost to Follow-up|2
5250440|NCT00758043|18117343|P1|Overall Study|Lost to Follow-up|0
5250441|NCT00758043|18117340|P4|Overall Study|Refused Further Treatment|8
5250442|NCT00758043|18117341|P3|Overall Study|Refused Further Treatment|5
5250443|NCT00758043|18117342|P2|Overall Study|Refused Further Treatment|11
5250444|NCT00758043|18117343|P1|Overall Study|Refused Further Treatment|0
5250445|NCT00758043|18117340|P4|Overall Study|Lack of Efficacy|12
5250446|NCT00758043|18117341|P3|Overall Study|Lack of Efficacy|18
5250447|NCT00758043|18117342|P2|Overall Study|Lack of Efficacy|6
5250448|NCT00758043|18117343|P1|Overall Study|Lack of Efficacy|0
5250449|NCT00758043|18117340|P4|Overall Study|Adverse Event|62
5250450|NCT00758043|18117341|P3|Overall Study|Adverse Event|12
5250451|NCT00758043|18117342|P2|Overall Study|Adverse Event|20
5250452|NCT00758043|18117343|P1|Overall Study|Adverse Event|1
5250453|NCT00757848|18117371|P2|Overall Study|Incorrect enrolment|0
5250454|NCT00757848|18117372|P1|Overall Study|Incorrect enrolment|1
5250455|NCT00757848|18117371|P2|Overall Study|Adverse Event|2
5250456|NCT00757848|18117372|P1|Overall Study|Adverse Event|1
5250457|NCT00757848|18117371|P2|Overall Study|Voluntary discontinuation|0
5250458|NCT00757848|18117372|P1|Overall Study|Voluntary discontinuation|1
5250459|NCT00757783|18117441|P2|Overall Study|Other|2
5250460|NCT00757783|18117442|P1|Overall Study|Other|1
5250461|NCT00757783|18117441|P2|Overall Study|Withdrawal by Subject|1
5250462|NCT00757783|18117442|P1|Overall Study|Withdrawal by Subject|2
5250463|NCT00757783|18117441|P2|Overall Study|Protocol Violation|0
5250464|NCT00757783|18117442|P1|Overall Study|Protocol Violation|1
5250465|NCT00757783|18117441|P2|Overall Study|Lost to Follow-up|1
5250466|NCT00757783|18117442|P1|Overall Study|Lost to Follow-up|1
5250467|NCT00757783|18117441|P2|Overall Study|Adverse Event|2
5250468|NCT00757783|18117442|P1|Overall Study|Adverse Event|0
5250469|NCT00757705|18117478|P1|Overall Study|Other|18
5250470|NCT00757705|18117478|P1|Overall Study|Non-compliant|9
5250471|NCT00757705|18117478|P1|Overall Study|Ineligible to continue|8
5250472|NCT00757705|18117478|P1|Overall Study|Insufficient Response|26
5250473|NCT00757705|18117478|P1|Overall Study|Withdrawal by Subject|25
5250474|NCT00757705|18117478|P1|Overall Study|Lost to Follow-up|16
5250475|NCT00757705|18117478|P1|Overall Study|Adverse Event|19
5250476|NCT00757627|18117507|P1|Overall Study|Other|1
5250477|NCT00757627|18117507|P1|Overall Study|Withdrawal by Subject|27
5250478|NCT00757627|18117507|P1|Overall Study|Lost to Follow-up|28
5250479|NCT00757627|18117507|P1|Overall Study|Lack of Efficacy|10
5250480|NCT00757627|18117507|P1|Overall Study|Adverse Event|15
5250481|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Other|0
5250482|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Other|1
5250483|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
5250484|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
5250485|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
5250486|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
5250487|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
5250488|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
5250489|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
5250490|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
5250491|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
5250492|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
5250493|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
5250494|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
5250495|NCT00757588|18117642|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
5250496|NCT00757588|18117643|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
5250497|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Other|1
5250498|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Other|0
5250499|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
5250500|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
5250501|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
5250502|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
5250503|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
5250504|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
5250505|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Death|0
5250506|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Death|1
5250507|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
5250508|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
5250509|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
5250510|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
5250511|NCT00757588|18117642|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
5250512|NCT00757588|18117643|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
5250513|NCT00757237|18117684|P2|Overall Study|Other|2
5250514|NCT00757237|18117685|P1|Overall Study|Other|0
5250515|NCT00757237|18117684|P2|Overall Study|Safety or Tolerability|5
5250516|NCT00757237|18117685|P1|Overall Study|Safety or Tolerability|3
5250517|NCT00757237|18117684|P2|Overall Study|Withdrawal by Subject|12
5250518|NCT00757237|18117685|P1|Overall Study|Withdrawal by Subject|8
5250519|NCT00757237|18117684|P2|Overall Study|Physician Decision|3
5250520|NCT00757237|18117685|P1|Overall Study|Physician Decision|2
5250521|NCT00757237|18117684|P2|Overall Study|Protocol Violation|2
5250522|NCT00757237|18117685|P1|Overall Study|Protocol Violation|0
5250523|NCT00757237|18117684|P2|Overall Study|Lost to Follow-up|1
5250524|NCT00757237|18117685|P1|Overall Study|Lost to Follow-up|0
5250525|NCT00757172|18117713|P1|Overall Study|Progression|4
5250526|NCT00757172|18117713|P1|Overall Study|Physician Decision|3
5250527|NCT00757172|18117713|P1|Overall Study|Withdrawal by Subject|4
5250528|NCT00757003|18117721|P1|Overall Study|Not implanted|1
5250529|NCT00757003|18117721|P1|Overall Study|Surgically explanted|2
5250530|NCT00757003|18117721|P1|Overall Study|Withdrawal by Subject|4
5250531|NCT00757003|18117721|P1|Overall Study|Lost to Follow-up|9
5250532|NCT00757003|18117721|P1|Overall Study|Death|33
5250533|NCT00756938|18117768|P4|Optional Extension|Adverse Event|1
5250534|NCT00756938|18117769|P3|Optional Extension|Adverse Event|0
5250535|NCT00756938|18117770|P2|Optional Extension|Adverse Event|0
5250536|NCT00756938|18117771|P1|Optional Extension|Adverse Event|0
5250537|NCT00756938|18117768|P4|Optional Extension|Withdrawal by Subject|10
5250538|NCT00756938|18117769|P3|Optional Extension|Withdrawal by Subject|0
5250539|NCT00756938|18117770|P2|Optional Extension|Withdrawal by Subject|0
5250540|NCT00756938|18117771|P1|Optional Extension|Withdrawal by Subject|0
5250541|NCT00756938|18117768|P4|Optional Extension|Protocol Violation|1
5250542|NCT00756938|18117769|P3|Optional Extension|Protocol Violation|0
5250543|NCT00756938|18117770|P2|Optional Extension|Protocol Violation|0
5250544|NCT00756938|18117771|P1|Optional Extension|Protocol Violation|0
5250545|NCT00756938|18117768|P4|Optional Extension|Lost to Follow-up|1
5250546|NCT00756938|18117769|P3|Optional Extension|Lost to Follow-up|0
5250547|NCT00756938|18117770|P2|Optional Extension|Lost to Follow-up|0
5250548|NCT00756938|18117771|P1|Optional Extension|Lost to Follow-up|0
5250549|NCT00756938|18117768|P4|Optional Extension|Physician Decision|3
5250550|NCT00756938|18117769|P3|Optional Extension|Physician Decision|0
5250551|NCT00756938|18117770|P2|Optional Extension|Physician Decision|0
5250552|NCT00756938|18117771|P1|Optional Extension|Physician Decision|0
5250553|NCT00756938|18117768|P4|Optional Extension|Protocol-specific criteria met|9
5250554|NCT00756938|18117769|P3|Optional Extension|Protocol-specific criteria met|0
5250555|NCT00756938|18117770|P2|Optional Extension|Protocol-specific criteria met|0
5250556|NCT00756938|18117771|P1|Optional Extension|Protocol-specific criteria met|0
5250557|NCT00756938|18117768|P4|Optional Extension|End of Study|11
5250558|NCT00756938|18117769|P3|Optional Extension|End of Study|0
5250559|NCT00756938|18117770|P2|Optional Extension|End of Study|0
5250560|NCT00756938|18117771|P1|Optional Extension|End of Study|0
5250561|NCT00756938|18117768|P4|Optional Extension|Lack of Efficacy|1
5250562|NCT00756938|18117769|P3|Optional Extension|Lack of Efficacy|0
5250563|NCT00756938|18117770|P2|Optional Extension|Lack of Efficacy|0
5250564|NCT00756938|18117771|P1|Optional Extension|Lack of Efficacy|0
5250565|NCT00756938|18117768|P4|12-week Base Study|Lost to Follow-up|0
5250566|NCT00756938|18117769|P3|12-week Base Study|Lost to Follow-up|0
5250567|NCT00756938|18117770|P2|12-week Base Study|Lost to Follow-up|0
5250568|NCT00756938|18117771|P1|12-week Base Study|Lost to Follow-up|1
5250569|NCT00756938|18117768|P4|12-week Base Study|Protocol Violation|0
5250570|NCT00756938|18117769|P3|12-week Base Study|Protocol Violation|1
5250571|NCT00756938|18117770|P2|12-week Base Study|Protocol Violation|0
5250572|NCT00756938|18117771|P1|12-week Base Study|Protocol Violation|0
5250573|NCT00756938|18117768|P4|12-week Base Study|Protocol-specific Criteria Met|0
5250574|NCT00756938|18117769|P3|12-week Base Study|Protocol-specific Criteria Met|1
5250575|NCT00756938|18117770|P2|12-week Base Study|Protocol-specific Criteria Met|0
5250576|NCT00756938|18117771|P1|12-week Base Study|Protocol-specific Criteria Met|1
5250577|NCT00756886|18117799|P2|Overall Study|Ineligible|4
5250578|NCT00756886|18117800|P1|Overall Study|Ineligible|9
5250579|NCT00756886|18117799|P2|Overall Study|Lack of Efficacy|0
5250580|NCT00756886|18117800|P1|Overall Study|Lack of Efficacy|1
5250581|NCT00756886|18117799|P2|Overall Study|Adverse Event|3
5250582|NCT00756886|18117800|P1|Overall Study|Adverse Event|0
5250583|NCT00756886|18117799|P2|Overall Study|Lost to Follow-up|0
5250584|NCT00756886|18117800|P1|Overall Study|Lost to Follow-up|1
5250585|NCT00756730|18117808|P2|Overall Study|persistent low-level viremmia|1
5250586|NCT00756730|18117809|P1|Overall Study|persistent low-level viremmia|0
5250587|NCT00756730|18117808|P2|Overall Study|discontinued due to rash prior to week 4|1
5250588|NCT00756730|18117809|P1|Overall Study|discontinued due to rash prior to week 4|0
5250589|NCT00756717|18117829|P1|Overall Study|Withdrawal by Subject|2
5250590|NCT00756652|18117846|P2|Re-Op Phase|Withdrawn after explant|0
5250591|NCT00756652|18117847|P1|Re-Op Phase|Withdrawn after explant|14
5250592|NCT00756652|18117846|P2|Re-Op Phase|Site Closed|0
5250593|NCT00756652|18117847|P1|Re-Op Phase|Site Closed|2454
5250594|NCT00756652|18117846|P2|Re-Op Phase|Lost to Follow-up|0
5250595|NCT00756652|18117847|P1|Re-Op Phase|Lost to Follow-up|340
5250596|NCT00756652|18117846|P2|Re-Op Phase|Death|0
5250597|NCT00756652|18117847|P1|Re-Op Phase|Death|6
5250598|NCT00756652|18117846|P2|Re-Op Phase|Withdrawal by Subject|0
5250599|NCT00756652|18117847|P1|Re-Op Phase|Withdrawal by Subject|62
5250600|NCT00756652|18117846|P2|Original Phase|Not due for F/U at Phase One closure|2
5250601|NCT00756652|18117847|P1|Original Phase|Not due for F/U at Phase One closure|11076
5250602|NCT00756652|18117846|P2|Original Phase|Death|1
5250603|NCT00756652|18117847|P1|Original Phase|Death|168
5250604|NCT00756652|18117846|P2|Original Phase|Participants without data|466
5250605|NCT00756652|18117847|P1|Original Phase|Participants without data|3259
5250606|NCT00756652|18117846|P2|Original Phase|Unknown Discontinuation Reason|0
5250607|NCT00756652|18117847|P1|Original Phase|Unknown Discontinuation Reason|2
5250608|NCT00756652|18117846|P2|Original Phase|Participant Noncompliance|424
5250609|NCT00756652|18117847|P1|Original Phase|Participant Noncompliance|18622
5250610|NCT00756652|18117846|P2|Original Phase|Other Discontinuation|5
5250611|NCT00756652|18117847|P1|Original Phase|Other Discontinuation|797
5250612|NCT00756652|18117846|P2|Original Phase|Lost to Follow-up|0
5250613|NCT00756652|18117847|P1|Original Phase|Lost to Follow-up|601
5250614|NCT00756652|18117846|P2|Original Phase|Withdrawal by Subject|23
5250615|NCT00756652|18117847|P1|Original Phase|Withdrawal by Subject|864
5250616|NCT00756574|18117958|P2|Overall Study|Lost to Follow-up|4
5250617|NCT00756574|18117959|P1|Overall Study|Lost to Follow-up|4
5250618|NCT00756574|18117958|P2|Overall Study|Withdrawal by Subject|7
5250619|NCT00756574|18117959|P1|Overall Study|Withdrawal by Subject|9
5250620|NCT00756470|18118003|P1|Overall Study|Adverse Event|4
5250621|NCT00756470|18118003|P1|Overall Study|Withdrawal by Subject|1
5250622|NCT00756457|18118010|P2|Overall Study|Lost to Follow-up|2
5250623|NCT00756457|18118011|P1|Overall Study|Lost to Follow-up|1
5250624|NCT00756444|18118041|P2|Overall Study|Ineligibility Determined|0
5250625|NCT00756444|18118042|P1|Overall Study|Ineligibility Determined|1
5250626|NCT00756444|18118041|P2|Overall Study|Disease Progression|7
5250627|NCT00756444|18118042|P1|Overall Study|Disease Progression|2
5250628|NCT00756444|18118041|P2|Overall Study|Death|4
5250629|NCT00756444|18118042|P1|Overall Study|Death|5
5250630|NCT00756444|18118041|P2|Overall Study|Lost to Follow-up|1
5250631|NCT00756444|18118042|P1|Overall Study|Lost to Follow-up|0
5250632|NCT00756444|18118041|P2|Overall Study|Withdrawal by Subject|8
5250633|NCT00756444|18118042|P1|Overall Study|Withdrawal by Subject|6
5250634|NCT00756444|18118041|P2|Overall Study|Adverse Event|1
5250635|NCT00756444|18118042|P1|Overall Study|Adverse Event|1
5250636|NCT00756314|18118053|P2|Overall Study|Lost to Follow-up|59
5250637|NCT00756314|18118054|P1|Overall Study|Lost to Follow-up|2
5250638|NCT00756275|18118070|P2|Overall Study|Withdrawal by Subject|7
5250639|NCT00756275|18118071|P1|Overall Study|Withdrawal by Subject|4
5250640|NCT00756275|18118070|P2|Overall Study|Lost to Follow-up|21
5250641|NCT00756275|18118071|P1|Overall Study|Lost to Follow-up|25
5250642|NCT00756002|18118135|P2|Double-Blind Treatment Period|Other|2
5250643|NCT00756002|18118136|P1|Double-Blind Treatment Period|Other|2
5250644|NCT00756002|18118135|P2|Double-Blind Treatment Period|Protocol Violation|5
5250645|NCT00756002|18118136|P1|Double-Blind Treatment Period|Protocol Violation|6
5250646|NCT00756002|18118135|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
5250647|NCT00756002|18118136|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
5250648|NCT00756002|18118135|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5250649|NCT00756002|18118136|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5250650|NCT00756002|18118135|P2|Double-Blind Treatment Period|Lack of Efficacy|1
5250651|NCT00756002|18118136|P1|Double-Blind Treatment Period|Lack of Efficacy|1
5250652|NCT00755937|18118230|P1|Observational Follow-up|Lost to Follow-up|148
5250653|NCT00755937|18118230|P1|Recruitment|Unknown if infliximab received|164
5250654|NCT00755846|18118257|P6|Overall Study|Participant Non-compliance|0
5250655|NCT00755846|18118258|P5|Overall Study|Participant Non-compliance|1
5250656|NCT00755846|18118259|P4|Overall Study|Participant Non-compliance|0
5250657|NCT00755846|18118260|P3|Overall Study|Participant Non-compliance|0
5250658|NCT00755846|18118261|P2|Overall Study|Participant Non-compliance|0
5250659|NCT00755846|18118262|P1|Overall Study|Participant Non-compliance|0
5250660|NCT00755846|18118257|P6|Overall Study|Administrative Error|0
5250661|NCT00755846|18118258|P5|Overall Study|Administrative Error|0
5250662|NCT00755846|18118259|P4|Overall Study|Administrative Error|0
5250663|NCT00755846|18118260|P3|Overall Study|Administrative Error|0
5250664|NCT00755846|18118261|P2|Overall Study|Administrative Error|1
5250665|NCT00755846|18118262|P1|Overall Study|Administrative Error|0
5250666|NCT00755846|18118257|P6|Overall Study|Physician Decision|1
5250667|NCT00755846|18118258|P5|Overall Study|Physician Decision|0
5250668|NCT00755846|18118259|P4|Overall Study|Physician Decision|1
5250669|NCT00755846|18118260|P3|Overall Study|Physician Decision|0
5250670|NCT00755846|18118261|P2|Overall Study|Physician Decision|3
5250671|NCT00755846|18118262|P1|Overall Study|Physician Decision|1
5250672|NCT00755846|18118257|P6|Overall Study|Hyperglycemic Rescue|7
5250673|NCT00755846|18118258|P5|Overall Study|Hyperglycemic Rescue|8
5250674|NCT00755846|18118259|P4|Overall Study|Hyperglycemic Rescue|8
5250675|NCT00755846|18118260|P3|Overall Study|Hyperglycemic Rescue|5
5250676|NCT00755846|18118261|P2|Overall Study|Hyperglycemic Rescue|7
5250677|NCT00755846|18118262|P1|Overall Study|Hyperglycemic Rescue|21
5250678|NCT00755846|18118257|P6|Overall Study|Withdrawal by Subject|1
5250679|NCT00755846|18118258|P5|Overall Study|Withdrawal by Subject|0
5250680|NCT00755846|18118259|P4|Overall Study|Withdrawal by Subject|2
5250681|NCT00755846|18118260|P3|Overall Study|Withdrawal by Subject|5
5250682|NCT00755846|18118261|P2|Overall Study|Withdrawal by Subject|3
5250683|NCT00755846|18118262|P1|Overall Study|Withdrawal by Subject|2
5250684|NCT00755846|18118257|P6|Overall Study|Lost to Follow-up|2
5250685|NCT00755846|18118258|P5|Overall Study|Lost to Follow-up|4
5250686|NCT00755846|18118259|P4|Overall Study|Lost to Follow-up|0
5250687|NCT00755846|18118260|P3|Overall Study|Lost to Follow-up|1
5250688|NCT00755846|18118261|P2|Overall Study|Lost to Follow-up|2
5250689|NCT00755846|18118262|P1|Overall Study|Lost to Follow-up|0
5250690|NCT00755846|18118257|P6|Overall Study|Protocol Violation|1
5250691|NCT00755846|18118258|P5|Overall Study|Protocol Violation|1
5250692|NCT00755846|18118259|P4|Overall Study|Protocol Violation|1
5250693|NCT00755846|18118260|P3|Overall Study|Protocol Violation|1
5250694|NCT00755846|18118261|P2|Overall Study|Protocol Violation|1
5250695|NCT00755846|18118262|P1|Overall Study|Protocol Violation|1
5250696|NCT00755846|18118257|P6|Overall Study|Adverse Event|2
5250697|NCT00755846|18118258|P5|Overall Study|Adverse Event|3
5250698|NCT00755846|18118259|P4|Overall Study|Adverse Event|1
5250699|NCT00755846|18118260|P3|Overall Study|Adverse Event|0
5250700|NCT00755846|18118261|P2|Overall Study|Adverse Event|0
5250701|NCT00755846|18118262|P1|Overall Study|Adverse Event|0
5250702|NCT00755807|18118362|P2|Open-label Extension Phase|Sponsor Decision|1
5250703|NCT00755807|18118363|P1|Open-label Extension Phase|Sponsor Decision|0
5250704|NCT00755807|18118362|P2|Open-label Extension Phase|Lost to Follow-up|0
5250705|NCT00755807|18118363|P1|Open-label Extension Phase|Lost to Follow-up|2
5250706|NCT00755807|18118362|P2|Open-label Extension Phase|Withdrawal by Subject|3
5250707|NCT00755807|18118363|P1|Open-label Extension Phase|Withdrawal by Subject|1
5250708|NCT00755807|18118362|P2|Open-label Extension Phase|Lack of Efficacy|3
5250709|NCT00755807|18118363|P1|Open-label Extension Phase|Lack of Efficacy|3
5250710|NCT00755807|18118362|P2|Open-label Extension Phase|Protocol Violation|2
5250711|NCT00755807|18118363|P1|Open-label Extension Phase|Protocol Violation|5
5250712|NCT00755807|18118362|P2|Open-label Extension Phase|Adverse Event|7
5250713|NCT00755807|18118363|P1|Open-label Extension Phase|Adverse Event|7
5250714|NCT00755807|18118362|P2|Acute Phase|Physician Decision|1
5250715|NCT00755807|18118363|P1|Acute Phase|Physician Decision|0
5250716|NCT00755807|18118362|P2|Acute Phase|Lack of Efficacy|1
5250717|NCT00755807|18118363|P1|Acute Phase|Lack of Efficacy|0
5250718|NCT00755807|18118362|P2|Acute Phase|Withdrawal by Subject|2
5250719|NCT00755807|18118363|P1|Acute Phase|Withdrawal by Subject|1
5250720|NCT00755807|18118362|P2|Acute Phase|Protocol Violation|3
5250721|NCT00755807|18118363|P1|Acute Phase|Protocol Violation|1
5250722|NCT00755807|18118362|P2|Acute Phase|Adverse Event|5
5250723|NCT00755807|18118363|P1|Acute Phase|Adverse Event|16
5250724|NCT00755716|18118443|P3|Overall Study|work schedule issues|1
5250725|NCT00755716|18118444|P2|Overall Study|work schedule issues|1
5250726|NCT00755716|18118445|P1|Overall Study|work schedule issues|0
5250727|NCT00755716|18118443|P3|Overall Study|Lost to Follow-up|1
5250728|NCT00755716|18118444|P2|Overall Study|Lost to Follow-up|3
5250729|NCT00755716|18118445|P1|Overall Study|Lost to Follow-up|5
5250730|NCT00755716|18118443|P3|Overall Study|Lack of Efficacy|0
5250731|NCT00755716|18118444|P2|Overall Study|Lack of Efficacy|0
5250732|NCT00755716|18118445|P1|Overall Study|Lack of Efficacy|2
5250733|NCT00755716|18118443|P3|Overall Study|Adverse Event|1
5250734|NCT00755716|18118444|P2|Overall Study|Adverse Event|4
5250735|NCT00755716|18118445|P1|Overall Study|Adverse Event|1
5250736|NCT00755417|18118459|P3|Overall Study|Not specified or missing data|12
5250737|NCT00755417|18118460|P2|Overall Study|Not specified or missing data|18
5250738|NCT00755417|18118461|P1|Overall Study|Not specified or missing data|9
5250739|NCT00755417|18118459|P3|Overall Study|Withdrawal by Subject|12
5250740|NCT00755417|18118460|P2|Overall Study|Withdrawal by Subject|12
5250741|NCT00755417|18118461|P1|Overall Study|Withdrawal by Subject|12
5250742|NCT00755417|18118459|P3|Overall Study|Lost to Follow-up|1
5250743|NCT00755417|18118460|P2|Overall Study|Lost to Follow-up|0
5250744|NCT00755417|18118461|P1|Overall Study|Lost to Follow-up|3
5250745|NCT00755417|18118459|P3|Overall Study|Protocol Violation|1
5250746|NCT00755417|18118460|P2|Overall Study|Protocol Violation|1
5250747|NCT00755417|18118461|P1|Overall Study|Protocol Violation|2
5250748|NCT00755417|18118459|P3|Overall Study|Lack of Efficacy|9
5250749|NCT00755417|18118460|P2|Overall Study|Lack of Efficacy|4
5250750|NCT00755417|18118461|P1|Overall Study|Lack of Efficacy|8
5250751|NCT00755417|18118459|P3|Overall Study|Adverse Event|7
5250752|NCT00755417|18118460|P2|Overall Study|Adverse Event|20
5250753|NCT00755417|18118461|P1|Overall Study|Adverse Event|28
5250754|NCT00755326|18118480|P2|Overall Study|Lost to Follow-up|3
5250755|NCT00755326|18118481|P1|Overall Study|Lost to Follow-up|2
5250756|NCT00755222|18118531|P2|Overall Study|Protocol Violation|0
5250757|NCT00755222|18118532|P1|Overall Study|Protocol Violation|2
5250758|NCT00755222|18118531|P2|Overall Study|Adverse Event|0
5250759|NCT00755222|18118532|P1|Overall Study|Adverse Event|2
5250760|NCT00755222|18118531|P2|Overall Study|Withdrawal by Subject|2
5250761|NCT00755222|18118532|P1|Overall Study|Withdrawal by Subject|4
5250762|NCT00755196|18118546|P1|Overall Study|Lack of Efficiency|1
5250763|NCT00755196|18118546|P1|Overall Study|Lost to Follow-up|1
5250764|NCT00755183|18118553|P2|Overall Study|Administrative|1
5250765|NCT00755183|18118554|P1|Overall Study|Administrative|2
5250766|NCT00755183|18118553|P2|Overall Study|Withdrawal by Subject|2
5250767|NCT00755183|18118554|P1|Overall Study|Withdrawal by Subject|0
5250768|NCT00755183|18118553|P2|Overall Study|Protocol Violation|1
5250769|NCT00755183|18118554|P1|Overall Study|Protocol Violation|0
5250770|NCT00755183|18118553|P2|Overall Study|Adverse Event|2
5250771|NCT00755183|18118554|P1|Overall Study|Adverse Event|5
5250772|NCT00755105|18118578|P3|Overall Study|Withdrawal by Subject|4
5250773|NCT00755105|18118579|P2|Overall Study|Withdrawal by Subject|11
5250774|NCT00755105|18118580|P1|Overall Study|Withdrawal by Subject|9
5250775|NCT00755079|18118590|P2|Overall Study|Withdrawal by Subject|2
5250776|NCT00755079|18118591|P1|Overall Study|Withdrawal by Subject|0
5250777|NCT00755079|18118590|P2|Overall Study|Adverse Event|1
5250778|NCT00755079|18118591|P1|Overall Study|Adverse Event|0
5250779|NCT00755079|18118590|P2|Overall Study|Lost to Follow-up|3
5250780|NCT00755079|18118591|P1|Overall Study|Lost to Follow-up|1
5250781|NCT00754936|18118610|P1|Overall Study|Inter-current medical events|3
5250782|NCT00754936|18118610|P1|Overall Study|Side Effects|3
5250783|NCT00754936|18118610|P1|Overall Study|Withdrawal by Subject|2
5250784|NCT00754936|18118610|P1|Overall Study|Physician Decision|1
5250785|NCT00754936|18118610|P1|Overall Study|Lost to Follow-up|3
5250786|NCT00754793|18118650|P2|Overall Study|voluntary withdrawn from study|1
5250787|NCT00754793|18118651|P1|Overall Study|voluntary withdrawn from study|0
5250788|NCT00754741|18118669|P3|Overall Study|Died or disenrolled|54
5250789|NCT00754741|18118670|P2|Overall Study|Died or disenrolled|69
5250790|NCT00754741|18118671|P1|Overall Study|Died or disenrolled|57
5250791|NCT00754650|18118718|P1|Overall Study|Disease Progression|2
5250792|NCT00754624|18118723|P1|Overall Study|Lost to Follow-up|3
5250793|NCT00754624|18118723|P1|Overall Study|Various|12
5250794|NCT00754624|18118723|P1|Overall Study|Withdrawal by Subject|28
5250795|NCT00754624|18118723|P1|Overall Study|Protocol Violation|1
5250796|NCT00754624|18118723|P1|Overall Study|Physician Decision|8
5250797|NCT00754624|18118723|P1|Overall Study|Death|1
5250798|NCT00754624|18118723|P1|Overall Study|Adverse Event|16
5250799|NCT00754572|18118733|P1|Overall Study|Lost to Follow-up|1
5250800|NCT00754572|18118733|P1|Overall Study|Administrative Reason|3
5250801|NCT00754572|18118733|P1|Overall Study|Death|1
5250802|NCT00754572|18118733|P1|Overall Study|Lack of Efficacy|2
5250803|NCT00754572|18118733|P1|Overall Study|Withdrawal by Subject|3
5250804|NCT00754572|18118733|P1|Overall Study|Protocol Violation|3
5250805|NCT00754572|18118733|P1|Overall Study|Other|39
5250806|NCT00754572|18118733|P1|Overall Study|Adverse Event|19
5250807|NCT00754559|18118760|P1|Overall Study|Withdrawal by Subject|3
5250808|NCT00754559|18118760|P1|Overall Study|Other|5
5250809|NCT00754559|18118760|P1|Overall Study|Administrative reason|1
5250810|NCT00754559|18118760|P1|Overall Study|Lost to Follow-up|2
5250811|NCT00754559|18118760|P1|Overall Study|Lack of Efficacy|10
5250812|NCT00754559|18118760|P1|Overall Study|Protocol Violation|11
5250813|NCT00754559|18118760|P1|Overall Study|Adverse Event|15
5250814|NCT00754442|18118860|P2|Overall Study|Withdrawal by Subject|3
5250815|NCT00754442|18118861|P1|Overall Study|Withdrawal by Subject|5
5250816|NCT00754390|18118868|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
5250817|NCT00754390|18118868|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
5250818|NCT00754390|18118868|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
5250819|NCT00754390|18118868|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
5250820|NCT00754338|18118890|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
5250821|NCT00754338|18118891|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
5250822|NCT00754338|18118892|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
5250823|NCT00754338|18118893|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
5250824|NCT00754338|18118890|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
5250825|NCT00754338|18118891|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
5250826|NCT00754338|18118892|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
5250827|NCT00754338|18118893|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
5250828|NCT00754325|18118925|P2|Initial Treatment|Disease Progression|35
5250829|NCT00754325|18118926|P1|Initial Treatment|Disease Progression|35
5250830|NCT00754325|18118925|P2|Initial Treatment|Sponsor Request|1
5250831|NCT00754325|18118926|P1|Initial Treatment|Sponsor Request|0
5250832|NCT00754325|18118925|P2|Initial Treatment|Physician Decision|0
5250833|NCT00754325|18118926|P1|Initial Treatment|Physician Decision|2
5250834|NCT00754325|18118925|P2|Initial Treatment|Withdrawal by Subject|2
5250835|NCT00754325|18118926|P1|Initial Treatment|Withdrawal by Subject|2
5250836|NCT00754325|18118925|P2|Initial Treatment|Adverse Event|6
5250837|NCT00754325|18118926|P1|Initial Treatment|Adverse Event|7
5250838|NCT00754325|18118925|P2|Initial Treatment|Continuing Active Treatment|5
5250839|NCT00754325|18118926|P1|Initial Treatment|Continuing Active Treatment|4
5250840|NCT00754234|18118979|P1|Overall Study|Withdrawal by Subject|3
5250841|NCT00754065|18119065|P2|Overall Study|Reason not specified or unknown, etc.|27
5250842|NCT00754065|18119066|P1|Overall Study|Reason not specified or unknown, etc.|21
5250843|NCT00754065|18119065|P2|Overall Study|Pregnancy|0
5250844|NCT00754065|18119066|P1|Overall Study|Pregnancy|6
5250845|NCT00754065|18119065|P2|Overall Study|Withdrawal by Subject|5
5250846|NCT00754065|18119066|P1|Overall Study|Withdrawal by Subject|4
5250847|NCT00754065|18119065|P2|Overall Study|Protocol Violation|10
5250848|NCT00754065|18119066|P1|Overall Study|Protocol Violation|12
5250849|NCT00754065|18119065|P2|Overall Study|Lost to Follow-up|11
5250850|NCT00754065|18119066|P1|Overall Study|Lost to Follow-up|7
5250851|NCT00754065|18119065|P2|Overall Study|Adverse Event|25
5250852|NCT00754065|18119066|P1|Overall Study|Adverse Event|19
5250853|NCT00754065|18119065|P2|Overall Study|Never received treatment|2
5250854|NCT00754065|18119066|P1|Overall Study|Never received treatment|12
5250855|NCT00754052|18119306|P2|Overall Study|Study terminated by Sponsor|3
5250856|NCT00754052|18119307|P1|Overall Study|Study terminated by Sponsor|5
5250857|NCT00754013|18119321|P2|Overall Study|didn't return after study termed|4
5250858|NCT00754013|18119322|P1|Overall Study|didn't return after study termed|3
5250859|NCT00754013|18119321|P2|Overall Study|Lost to Follow-up|1
5250860|NCT00754013|18119322|P1|Overall Study|Lost to Follow-up|1
5250861|NCT00753922|18119359|P4|Overall Study|Discontinuation Due to Explantation|4
5250862|NCT00753922|18119360|P3|Overall Study|Discontinuation Due to Explantation|14
5250863|NCT00753922|18119361|P2|Overall Study|Discontinuation Due to Explantation|14
5250864|NCT00753922|18119362|P1|Overall Study|Discontinuation Due to Explantation|14
5250865|NCT00753922|18119359|P4|Overall Study|Death|1
5250866|NCT00753922|18119360|P3|Overall Study|Death|2
5250867|NCT00753922|18119361|P2|Overall Study|Death|23
5250868|NCT00753922|18119362|P1|Overall Study|Death|2
5250869|NCT00753922|18119359|P4|Overall Study|Patients Not Completing Visit|0
5250870|NCT00753922|18119360|P3|Overall Study|Patients Not Completing Visit|1
5250871|NCT00753922|18119361|P2|Overall Study|Patients Not Completing Visit|0
5250872|NCT00753922|18119362|P1|Overall Study|Patients Not Completing Visit|11
5250873|NCT00753922|18119359|P4|Overall Study|Patient Non-compliance|11
5250874|NCT00753922|18119360|P3|Overall Study|Patient Non-compliance|14
5250875|NCT00753922|18119361|P2|Overall Study|Patient Non-compliance|22
5250876|NCT00753922|18119362|P1|Overall Study|Patient Non-compliance|55
5250877|NCT00753922|18119359|P4|Overall Study|Withdrawal by Subject|2
5250878|NCT00753922|18119360|P3|Overall Study|Withdrawal by Subject|4
5250879|NCT00753922|18119361|P2|Overall Study|Withdrawal by Subject|11
5250880|NCT00753922|18119362|P1|Overall Study|Withdrawal by Subject|9
5250881|NCT00753922|18119359|P4|Overall Study|Lost to Follow-up|5
5250882|NCT00753922|18119360|P3|Overall Study|Lost to Follow-up|28
5250883|NCT00753922|18119361|P2|Overall Study|Lost to Follow-up|24
5250884|NCT00753922|18119362|P1|Overall Study|Lost to Follow-up|155
5250885|NCT00753896|18119392|P1|Overall Study|Entry Criteria Not Met|4
5250886|NCT00753896|18119392|P1|Overall Study|Withdrawal by Subject|4
5250887|NCT00753896|18119392|P1|Overall Study|Protocol Violation|1
5250888|NCT00753896|18119392|P1|Overall Study|Lost to Follow-up|2
5250889|NCT00753896|18119392|P1|Overall Study|Death|1
5250890|NCT00753896|18119392|P1|Overall Study|Adverse Event|4
5250891|NCT00753766|18119408|P2|Overall Study|Physician Decision|0
5250892|NCT00753766|18119409|P1|Overall Study|Physician Decision|1
5250893|NCT00753714|18119431|P2|Overall Study|Other|5
5250894|NCT00753714|18119432|P1|Overall Study|Other|7
5250895|NCT00753714|18119431|P2|Overall Study|Death|3
5250896|NCT00753714|18119432|P1|Overall Study|Death|3
5250897|NCT00753714|18119431|P2|Overall Study|Withdrawal by Subject|1
5250898|NCT00753714|18119432|P1|Overall Study|Withdrawal by Subject|2
5250899|NCT00753714|18119431|P2|Overall Study|Lost to Follow-up|1
5250900|NCT00753714|18119432|P1|Overall Study|Lost to Follow-up|0
5250901|NCT00753714|18119431|P2|Overall Study|Protocol Violation|0
5250902|NCT00753714|18119432|P1|Overall Study|Protocol Violation|1
5250903|NCT00753714|18119431|P2|Overall Study|Adverse Event|18
5250904|NCT00753714|18119432|P1|Overall Study|Adverse Event|26
5250905|NCT00753714|18119431|P2|Overall Study|Lack of Efficacy|34
5250906|NCT00753714|18119432|P1|Overall Study|Lack of Efficacy|21
5250907|NCT00753688|18119448|P2|Overall Study|Adverse Event|1
5250908|NCT00753688|18119449|P1|Overall Study|Adverse Event|0
5250909|NCT00753688|18119448|P2|Overall Study|Ongoing - in Follow-up|31
5250910|NCT00753688|18119449|P1|Overall Study|Ongoing - in Follow-up|15
5250911|NCT00753688|18119448|P2|Overall Study|Participant Withdrew Consent|2
5250912|NCT00753688|18119449|P1|Overall Study|Participant Withdrew Consent|2
5250913|NCT00753688|18119448|P2|Overall Study|Missing|9
5250914|NCT00753688|18119449|P1|Overall Study|Missing|4
5250915|NCT00753688|18119448|P2|Overall Study|Death|203
5250916|NCT00753688|18119449|P1|Overall Study|Death|102
5250917|NCT00753675|18119478|P3|Overall Study|Lost to Follow-up|0
5250918|NCT00753675|18119479|P2|Overall Study|Lost to Follow-up|0
5250919|NCT00753675|18119480|P1|Overall Study|Lost to Follow-up|1
5250920|NCT00753675|18119478|P3|Overall Study|Withdrawal by Subject|0
5250921|NCT00753675|18119479|P2|Overall Study|Withdrawal by Subject|1
5250922|NCT00753675|18119480|P1|Overall Study|Withdrawal by Subject|0
5250923|NCT00753675|18119478|P3|Overall Study|Objective progression of disease|35
5250924|NCT00753675|18119479|P2|Overall Study|Objective progression of disease|35
5250925|NCT00753675|18119480|P1|Overall Study|Objective progression of disease|35
5250926|NCT00753675|18119478|P3|Overall Study|Adverse Event|4
5250927|NCT00753675|18119479|P2|Overall Study|Adverse Event|9
5250928|NCT00753675|18119480|P1|Overall Study|Adverse Event|11
5250929|NCT00753675|18119478|P3|Overall Study|Death|4
5250930|NCT00753675|18119479|P2|Overall Study|Death|2
5250931|NCT00753675|18119480|P1|Overall Study|Death|1
5250932|NCT00753675|18119478|P3|Overall Study|other reason|13
5250933|NCT00753675|18119479|P2|Overall Study|other reason|12
5250934|NCT00753675|18119480|P1|Overall Study|other reason|11
5250935|NCT00753649|18119502|P2|Overall Study|Protocol Violation|0
5250936|NCT00753649|18119503|P1|Overall Study|Protocol Violation|2
5250937|NCT00753649|18119502|P2|Overall Study|Lost to follow-up-complete vaccination|0
5250938|NCT00753649|18119503|P1|Overall Study|Lost to follow-up-complete vaccination|1
5250939|NCT00753649|18119502|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
5250940|NCT00753649|18119503|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
5250941|NCT00753649|18119502|P2|Overall Study|Migrated/moved from study area|0
5250942|NCT00753649|18119503|P1|Overall Study|Migrated/moved from study area|1
5250943|NCT00753623|18119535|P2|Phase II (14 Days)|Physician Decision|1
5250944|NCT00753623|18119536|P1|Phase II (14 Days)|Physician Decision|0
5250945|NCT00753623|18119535|P2|Washout (7 Days)|Physician Decision|0
5250946|NCT00753623|18119536|P1|Washout (7 Days)|Physician Decision|1
5250947|NCT00753623|18119535|P2|Phase I (14 Days)|Adverse Event|1
5250948|NCT00753623|18119536|P1|Phase I (14 Days)|Adverse Event|0
5250949|NCT00753623|18119535|P2|Phase I (14 Days)|Physician Decision|2
5250950|NCT00753623|18119536|P1|Phase I (14 Days)|Physician Decision|1
5250951|NCT00753623|18119535|P2|Phase I (14 Days)|Withdrawal by Subject|1
5250952|NCT00753623|18119536|P1|Phase I (14 Days)|Withdrawal by Subject|1
5250953|NCT00753545|18119544|P2|Overall Study|Voluntary Discontinuation of Patient|3
5250954|NCT00753545|18119545|P1|Overall Study|Voluntary Discontinuation of Patient|7
5250955|NCT00753545|18119544|P2|Overall Study|Protocol Violation|0
5250956|NCT00753545|18119545|P1|Overall Study|Protocol Violation|1
5250957|NCT00753545|18119544|P2|Overall Study|Lost to Follow-up|3
5250958|NCT00753545|18119545|P1|Overall Study|Lost to Follow-up|2
5250959|NCT00753545|18119544|P2|Overall Study|Death|112
5250960|NCT00753545|18119545|P1|Overall Study|Death|98
5250961|NCT00753519|18119583|P2|Overall Study|Withdrawal by Subject|2
5250962|NCT00753519|18119584|P1|Overall Study|Withdrawal by Subject|0
5250963|NCT00753506|18119606|P2|Overall Study|Other reason|1
5250964|NCT00753506|18119607|P1|Overall Study|Other reason|1
5250965|NCT00753506|18119606|P2|Overall Study|Lost to Follow-up|0
5250966|NCT00753506|18119607|P1|Overall Study|Lost to Follow-up|2
5250967|NCT00753506|18119606|P2|Overall Study|Withdrawal by Subject|1
5250968|NCT00753506|18119607|P1|Overall Study|Withdrawal by Subject|4
5250969|NCT00753454|18119613|P1|Overall Study|Investigator Decision|1
5250970|NCT00753454|18119613|P1|Overall Study|Withdrawal by Subject|5
5250971|NCT00753454|18119613|P1|Overall Study|Lost to Follow-up|3
5250972|NCT00753454|18119613|P1|Overall Study|Lack of Efficacy|1
5250973|NCT00753454|18119613|P1|Overall Study|Adverse Event|4
5250974|NCT00753415|18119647|P10|Part B|Disease progression|1
5250975|NCT00753415|18119648|P9|Part B|Disease progression|2
5250976|NCT00753415|18119649|P8|Part B|Disease progression|0
5250977|NCT00753415|18119650|P7|Part B|Disease progression|0
5250978|NCT00753415|18119651|P6|Part B|Disease progression|0
5250979|NCT00753415|18119652|P5|Part B|Disease progression|0
5250980|NCT00753415|18119653|P4|Part B|Disease progression|0
5250981|NCT00753415|18119654|P3|Part B|Disease progression|0
5250982|NCT00753415|18119655|P2|Part B|Disease progression|0
5250983|NCT00753415|18119656|P1|Part B|Disease progression|0
5250984|NCT00753415|18119647|P10|Part B|Lost to Follow-up|0
5250985|NCT00753415|18119648|P9|Part B|Lost to Follow-up|1
5250986|NCT00753415|18119649|P8|Part B|Lost to Follow-up|1
5250987|NCT00753415|18119650|P7|Part B|Lost to Follow-up|0
5250988|NCT00753415|18119651|P6|Part B|Lost to Follow-up|0
5250989|NCT00753415|18119652|P5|Part B|Lost to Follow-up|0
5250990|NCT00753415|18119653|P4|Part B|Lost to Follow-up|0
5250991|NCT00753415|18119654|P3|Part B|Lost to Follow-up|0
5250992|NCT00753415|18119655|P2|Part B|Lost to Follow-up|0
5250993|NCT00753415|18119656|P1|Part B|Lost to Follow-up|0
5250994|NCT00753415|18119647|P10|Part A|Withdrawal by Subject|0
5250995|NCT00753415|18119648|P9|Part A|Withdrawal by Subject|0
5250996|NCT00753415|18119649|P8|Part A|Withdrawal by Subject|0
5250997|NCT00753415|18119650|P7|Part A|Withdrawal by Subject|0
5250998|NCT00753415|18119651|P6|Part A|Withdrawal by Subject|0
5250999|NCT00753415|18119652|P5|Part A|Withdrawal by Subject|0
5251000|NCT00753415|18119653|P4|Part A|Withdrawal by Subject|0
5251001|NCT00753415|18119654|P3|Part A|Withdrawal by Subject|1
5251002|NCT00753415|18119655|P2|Part A|Withdrawal by Subject|0
5251003|NCT00753415|18119656|P1|Part A|Withdrawal by Subject|0
5251004|NCT00753415|18119647|P10|Part A|Disease progression|0
5251005|NCT00753415|18119648|P9|Part A|Disease progression|0
5251006|NCT00753415|18119649|P8|Part A|Disease progression|0
5251007|NCT00753415|18119650|P7|Part A|Disease progression|0
5251008|NCT00753415|18119651|P6|Part A|Disease progression|0
5251009|NCT00753415|18119652|P5|Part A|Disease progression|0
5251010|NCT00753415|18119653|P4|Part A|Disease progression|2
5251011|NCT00753415|18119654|P3|Part A|Disease progression|1
5251012|NCT00753415|18119655|P2|Part A|Disease progression|0
5251013|NCT00753415|18119656|P1|Part A|Disease progression|1
5251014|NCT00753272|18119746|P2|Overall Study|Other|1088
5251015|NCT00753272|18119747|P1|Overall Study|Other|1104
5251016|NCT00753272|18119746|P2|Overall Study|Lost to Follow-up|497
5251017|NCT00753272|18119747|P1|Overall Study|Lost to Follow-up|491
5251018|NCT00753272|18119746|P2|Overall Study|Withdrawal by Subject|2407
5251019|NCT00753272|18119747|P1|Overall Study|Withdrawal by Subject|2481
5251020|NCT00753272|18119746|P2|Overall Study|Protocol Violation|46
5251021|NCT00753272|18119747|P1|Overall Study|Protocol Violation|28
5251022|NCT00753272|18119746|P2|Overall Study|Adverse Event|869
5251023|NCT00753272|18119747|P1|Overall Study|Adverse Event|878
5251024|NCT00753012|18119831|P2|Overall Study|Confounded endpoint data|0
5251025|NCT00753012|18119832|P1|Overall Study|Confounded endpoint data|1
5251026|NCT00753012|18119831|P2|Overall Study|Lost to Follow-up|0
5251027|NCT00753012|18119832|P1|Overall Study|Lost to Follow-up|4
5251028|NCT00753012|18119831|P2|Overall Study|Withdrawal by Subject|1
5251029|NCT00753012|18119832|P1|Overall Study|Withdrawal by Subject|0
5251030|NCT00753012|18119831|P2|Overall Study|Adverse Event|0
5251031|NCT00753012|18119832|P1|Overall Study|Adverse Event|2
5251032|NCT00753012|18119831|P2|Overall Study|Ineligible, abnormal cardiac histo|0
5251033|NCT00753012|18119832|P1|Overall Study|Ineligible, abnormal cardiac histo|1
5251034|NCT00752986|18119845|P3|Overall Study|Protocol Violation|0
5251035|NCT00752986|18119846|P2|Overall Study|Protocol Violation|0
5251036|NCT00752986|18119847|P1|Overall Study|Protocol Violation|3
5251037|NCT00752986|18119845|P3|Overall Study|Withdrawal by Subject|2
5251038|NCT00752986|18119846|P2|Overall Study|Withdrawal by Subject|1
5251039|NCT00752986|18119847|P1|Overall Study|Withdrawal by Subject|2
5251040|NCT00752895|18119887|P2|Overall Study|Withdrawal by Subject|3
5251041|NCT00752895|18119888|P1|Overall Study|Withdrawal by Subject|8
5251042|NCT00752856|18119898|P2|Overall Study|randomized but did not do viral kinetics|1
5251043|NCT00752856|18119899|P1|Overall Study|randomized but did not do viral kinetics|0
5251044|NCT00752791|18119911|P1|Overall Study|Protocol deviation|1
5251045|NCT00752791|18119911|P1|Overall Study|Switched to hemodialysis|2
5251046|NCT00752791|18119911|P1|Overall Study|Renal transplant|3
5251047|NCT00752791|18119911|P1|Overall Study|Death|1
5251048|NCT00752791|18119911|P1|Overall Study|Physician Decision|1
5251049|NCT00752791|18119911|P1|Overall Study|Withdrawal by Subject|1
5251050|NCT00752791|18119911|P1|Overall Study|Adverse Event|7
5251051|NCT00752726|18119923|P2|Overall Study|Other Reason|2
5251052|NCT00752726|18119924|P1|Overall Study|Other Reason|1
5251053|NCT00752726|18119923|P2|Overall Study|Withdrawal by Subject|10
5251054|NCT00752726|18119924|P1|Overall Study|Withdrawal by Subject|5
5251055|NCT00752726|18119923|P2|Overall Study|Adverse Event|0
5251056|NCT00752726|18119924|P1|Overall Study|Adverse Event|3
5251057|NCT00752726|18119923|P2|Overall Study|Lost to Follow-up|1
5251058|NCT00752726|18119924|P1|Overall Study|Lost to Follow-up|2
5251059|NCT00752622|18119949|P1|Interventional Phase|Premature Study Termination|5
5251060|NCT00752622|18119949|P1|Interventional Phase|Physician Decision|1
5251061|NCT00752622|18119949|P1|Interventional Phase|Non-responder|2
5251062|NCT00752622|18119949|P1|Observational Phase|Other|2
5251063|NCT00752622|18119949|P1|Observational Phase|Adverse Event|1
5251064|NCT00752622|18119949|P1|Observational Phase|Withdrawal by Subject|2
5251065|NCT00752622|18119949|P1|Observational Phase|Non-responder|2
5251066|NCT00752622|18119949|P1|Observational Phase|Premature Study Termination|36
5251067|NCT00752622|18119949|P1|Induction Phase|Premature study termination|14
5251068|NCT00752622|18119949|P1|Induction Phase|Withdrawal by Subject|1
5251069|NCT00752622|18119949|P1|Induction Phase|Non-responder|14
5251070|NCT00752622|18119949|P1|Induction Phase|Other|3
5251071|NCT00752622|18119949|P1|Induction Phase|Adverse Event|3
5251072|NCT00752609|18119962|P2|Overall Study|Received Aranesp in error|0
5251073|NCT00752609|18119963|P1|Overall Study|Received Aranesp in error|1
5251074|NCT00752609|18119962|P2|Overall Study|Met exclusion criteria|0
5251075|NCT00752609|18119963|P1|Overall Study|Met exclusion criteria|1
5251076|NCT00752609|18119962|P2|Overall Study|Death|0
5251077|NCT00752609|18119963|P1|Overall Study|Death|1
5251078|NCT00752609|18119962|P2|Overall Study|Physician Decision|0
5251079|NCT00752609|18119963|P1|Overall Study|Physician Decision|1
5251080|NCT00752609|18119962|P2|Overall Study|Withdrawal by Subject|0
5251081|NCT00752609|18119963|P1|Overall Study|Withdrawal by Subject|3
5251082|NCT00752609|18119962|P2|Overall Study|Adverse Event|2
5251083|NCT00752609|18119963|P1|Overall Study|Adverse Event|2
5251084|NCT00752557|18119985|P3|Overall Study|Lost to Follow-up|1
5251085|NCT00752557|18119986|P2|Overall Study|Lost to Follow-up|0
5251086|NCT00752557|18119987|P1|Overall Study|Lost to Follow-up|1
5251087|NCT00752557|18119985|P3|Overall Study|Unspecified resaons|2
5251088|NCT00752557|18119986|P2|Overall Study|Unspecified resaons|2
5251089|NCT00752557|18119987|P1|Overall Study|Unspecified resaons|0
5251090|NCT00752557|18119985|P3|Overall Study|Withdrawal by Subject|3
5251091|NCT00752557|18119986|P2|Overall Study|Withdrawal by Subject|3
5251092|NCT00752557|18119987|P1|Overall Study|Withdrawal by Subject|4
5251093|NCT00752232|18120019|P7|Overall Study|Caregiver could not attend the subject|0
5251094|NCT00752232|18120020|P6|Overall Study|Caregiver could not attend the subject|0
5251095|NCT00752232|18120021|P5|Overall Study|Caregiver could not attend the subject|1
5251096|NCT00752232|18120022|P4|Overall Study|Caregiver could not attend the subject|0
5251097|NCT00752232|18120023|P3|Overall Study|Caregiver could not attend the subject|0
5251098|NCT00752232|18120024|P2|Overall Study|Caregiver could not attend the subject|0
5251099|NCT00752232|18120025|P1|Overall Study|Caregiver could not attend the subject|0
5251100|NCT00752232|18120019|P7|Overall Study|Group home admission|0
5251101|NCT00752232|18120020|P6|Overall Study|Group home admission|0
5251102|NCT00752232|18120021|P5|Overall Study|Group home admission|0
5251103|NCT00752232|18120022|P4|Overall Study|Group home admission|1
5251104|NCT00752232|18120023|P3|Overall Study|Group home admission|0
5251105|NCT00752232|18120024|P2|Overall Study|Group home admission|0
5251106|NCT00752232|18120025|P1|Overall Study|Group home admission|0
5251107|NCT00752232|18120019|P7|Overall Study|Subject request|0
5251108|NCT00752232|18120020|P6|Overall Study|Subject request|0
5251109|NCT00752232|18120021|P5|Overall Study|Subject request|0
5251110|NCT00752232|18120022|P4|Overall Study|Subject request|0
5251111|NCT00752232|18120023|P3|Overall Study|Subject request|1
5251112|NCT00752232|18120024|P2|Overall Study|Subject request|0
5251113|NCT00752232|18120025|P1|Overall Study|Subject request|0
5251114|NCT00752232|18120019|P7|Overall Study|Investigator request|0
5251115|NCT00752232|18120020|P6|Overall Study|Investigator request|0
5251116|NCT00752232|18120021|P5|Overall Study|Investigator request|1
5251117|NCT00752232|18120022|P4|Overall Study|Investigator request|0
5251118|NCT00752232|18120023|P3|Overall Study|Investigator request|0
5251119|NCT00752232|18120024|P2|Overall Study|Investigator request|0
5251120|NCT00752232|18120025|P1|Overall Study|Investigator request|0
5251121|NCT00752232|18120019|P7|Overall Study|Caregiver request|0
5251122|NCT00752232|18120020|P6|Overall Study|Caregiver request|0
5251123|NCT00752232|18120021|P5|Overall Study|Caregiver request|1
5251124|NCT00752232|18120022|P4|Overall Study|Caregiver request|0
5251125|NCT00752232|18120023|P3|Overall Study|Caregiver request|0
5251126|NCT00752232|18120024|P2|Overall Study|Caregiver request|0
5251127|NCT00752232|18120025|P1|Overall Study|Caregiver request|2
5251128|NCT00752232|18120019|P7|Overall Study|Protocol Violation|0
5251129|NCT00752232|18120020|P6|Overall Study|Protocol Violation|1
5251130|NCT00752232|18120021|P5|Overall Study|Protocol Violation|0
5251131|NCT00752232|18120022|P4|Overall Study|Protocol Violation|0
5251132|NCT00752232|18120023|P3|Overall Study|Protocol Violation|0
5251133|NCT00752232|18120024|P2|Overall Study|Protocol Violation|0
5251134|NCT00752232|18120025|P1|Overall Study|Protocol Violation|0
5251135|NCT00752219|18120099|P2|Overall Study|Other|0
5251136|NCT00752219|18120100|P1|Overall Study|Other|3
5251137|NCT00752219|18120099|P2|Overall Study|Randomized but not treated|0
5251138|NCT00752219|18120100|P1|Overall Study|Randomized but not treated|1
5251139|NCT00752219|18120099|P2|Overall Study|Lost to Follow-up|2
5251140|NCT00752219|18120100|P1|Overall Study|Lost to Follow-up|1
5251141|NCT00752219|18120099|P2|Overall Study|Protocol deviation|0
5251142|NCT00752219|18120100|P1|Overall Study|Protocol deviation|1
5251143|NCT00752219|18120099|P2|Overall Study|Adverse Event|3
5251144|NCT00752219|18120100|P1|Overall Study|Adverse Event|5
5251145|NCT00752219|18120099|P2|Overall Study|Clinical failure|1
5251146|NCT00752219|18120100|P1|Overall Study|Clinical failure|0
5251147|NCT00752206|18120126|P2|Overall Study|Pregnancy|0
5251148|NCT00752206|18120127|P1|Overall Study|Pregnancy|1
5251149|NCT00752206|18120126|P2|Overall Study|Disease progression|11
5251150|NCT00752206|18120127|P1|Overall Study|Disease progression|8
5251151|NCT00752128|18120145|P1|Overall Study|Withdrawal by Subject|4
5251152|NCT00752089|18120159|P1|Overall Study|Cannot continue the study|1
5251153|NCT00752089|18120159|P1|Overall Study|Not capable of wearing partial denture|1
5251154|NCT00752089|18120159|P1|Overall Study|Could not attend visit 9|1
5251155|NCT00752089|18120159|P1|Overall Study|Protocol Deviation|2
5251156|NCT00752089|18120159|P1|Overall Study|Adverse Event|1
5251157|NCT00751998|18120173|P1|Overall Study|Withdrawal by Subject|2
5251158|NCT00751998|18120173|P1|Overall Study|Death|11
5251159|NCT00751998|18120173|P1|Overall Study|Lost to Follow-up|7
5251160|NCT00751933|18120192|P4|Overall Study|Physician Decision|1
5251161|NCT00751933|18120193|P3|Overall Study|Physician Decision|1
5251162|NCT00751933|18120194|P2|Overall Study|Physician Decision|0
5251163|NCT00751933|18120195|P1|Overall Study|Physician Decision|0
5251164|NCT00751933|18120192|P4|Overall Study|Withdrawal by Subject|0
5251165|NCT00751933|18120193|P3|Overall Study|Withdrawal by Subject|0
5251166|NCT00751933|18120194|P2|Overall Study|Withdrawal by Subject|1
5251167|NCT00751933|18120195|P1|Overall Study|Withdrawal by Subject|0
5251168|NCT00751881|18120203|P3|Extension Study Period|Other than specified above|18
5251169|NCT00751881|18120204|P2|Extension Study Period|Other than specified above|30
5251170|NCT00751881|18120205|P1|Extension Study Period|Other than specified above|26
5251171|NCT00751881|18120203|P3|Extension Study Period|Poor Compliance to Protocol|1
5251172|NCT00751881|18120204|P2|Extension Study Period|Poor Compliance to Protocol|2
5251173|NCT00751881|18120205|P1|Extension Study Period|Poor Compliance to Protocol|3
5251174|NCT00751881|18120203|P3|Extension Study Period|Lost to Follow-up|6
5251175|NCT00751881|18120204|P2|Extension Study Period|Lost to Follow-up|9
5251176|NCT00751881|18120205|P1|Extension Study Period|Lost to Follow-up|4
5251177|NCT00751881|18120203|P3|Extension Study Period|Lack of Efficacy|20
5251178|NCT00751881|18120204|P2|Extension Study Period|Lack of Efficacy|10
5251179|NCT00751881|18120205|P1|Extension Study Period|Lack of Efficacy|14
5251180|NCT00751881|18120203|P3|Extension Study Period|Adverse Event|21
5251181|NCT00751881|18120204|P2|Extension Study Period|Adverse Event|20
5251182|NCT00751881|18120205|P1|Extension Study Period|Adverse Event|18
5251183|NCT00751881|18120203|P3|Core Treatment Period|Other:participant's decision/unspecified|16
5251184|NCT00751881|18120204|P2|Core Treatment Period|Other:participant's decision/unspecified|22
5251185|NCT00751881|18120205|P1|Core Treatment Period|Other:participant's decision/unspecified|19
5251186|NCT00751881|18120203|P3|Core Treatment Period|Other: tolerability complaints|0
5251187|NCT00751881|18120204|P2|Core Treatment Period|Other: tolerability complaints|0
5251188|NCT00751881|18120205|P1|Core Treatment Period|Other: tolerability complaints|2
5251189|NCT00751881|18120203|P3|Core Treatment Period|Other: MS treatment change|4
5251190|NCT00751881|18120204|P2|Core Treatment Period|Other: MS treatment change|4
5251191|NCT00751881|18120205|P1|Core Treatment Period|Other: MS treatment change|6
5251192|NCT00751881|18120203|P3|Core Treatment Period|Other: personal/family constraints|10
5251193|NCT00751881|18120204|P2|Core Treatment Period|Other: personal/family constraints|7
5251194|NCT00751881|18120205|P1|Core Treatment Period|Other: personal/family constraints|6
5251195|NCT00751881|18120203|P3|Core Treatment Period|Other: wish to parent|4
5251196|NCT00751881|18120204|P2|Core Treatment Period|Other: wish to parent|7
5251197|NCT00751881|18120205|P1|Core Treatment Period|Other: wish to parent|5
5251198|NCT00751881|18120203|P3|Core Treatment Period|Other: protocol deviation|7
5251199|NCT00751881|18120204|P2|Core Treatment Period|Other: protocol deviation|3
5251200|NCT00751881|18120205|P1|Core Treatment Period|Other: protocol deviation|3
5251201|NCT00751881|18120203|P3|Core Treatment Period|Lost to Follow-up|3
5251202|NCT00751881|18120204|P2|Core Treatment Period|Lost to Follow-up|4
5251203|NCT00751881|18120205|P1|Core Treatment Period|Lost to Follow-up|6
5251204|NCT00751881|18120203|P3|Core Treatment Period|Poor compliance to protocol|4
5251205|NCT00751881|18120204|P2|Core Treatment Period|Poor compliance to protocol|3
5251206|NCT00751881|18120205|P1|Core Treatment Period|Poor compliance to protocol|15
5251207|NCT00751881|18120203|P3|Core Treatment Period|Lack of Efficacy|20
5251208|NCT00751881|18120204|P2|Core Treatment Period|Lack of Efficacy|30
5251209|NCT00751881|18120205|P1|Core Treatment Period|Lack of Efficacy|37
5251210|NCT00751881|18120203|P3|Core Treatment Period|Adverse Event|58
5251211|NCT00751881|18120204|P2|Core Treatment Period|Adverse Event|54
5251212|NCT00751881|18120205|P1|Core Treatment Period|Adverse Event|26
5251213|NCT00751881|18120203|P3|Core Treatment Period|Not treated|2
5251214|NCT00751881|18120204|P2|Core Treatment Period|Not treated|1
5251215|NCT00751881|18120205|P1|Core Treatment Period|Not treated|1
5251216|NCT00751790|18120252|P1|Overall Study|Withdrawal by Subject|1
5251217|NCT00751790|18120252|P1|Overall Study|Death|3
5251218|NCT00751790|18120252|P1|Overall Study|Lost to Follow-up|1
5251219|NCT00751621|18120283|P1|Overall Study|Poor adherence to asthma treatment|1
5251220|NCT00751621|18120283|P1|Overall Study|Subject moved to another country|1
5251221|NCT00751621|18120283|P1|Overall Study|Withdrawal by Subject|1
5251222|NCT00751621|18120283|P1|Overall Study|Adverse Event|1
5251223|NCT00751400|18120317|P1|Overall Study|Lost to Follow-up|10
5251224|NCT00751348|18120332|P2|Overall Study|Migration from study area|0
5251225|NCT00751348|18120333|P1|Overall Study|Migration from study area|1
5251226|NCT00751348|18120332|P2|Overall Study|Withdrawal by Subject|2
5251227|NCT00751348|18120333|P1|Overall Study|Withdrawal by Subject|5
5251228|NCT00751296|18120366|P1|Overall Study|Adverse Event|2
5251229|NCT00751140|18120394|P1|Overall Study|benign angioma excluded from analysis|1
5251230|NCT00751114|18120404|P2|Overall Study|Move to another city|0
5251231|NCT00751114|18120405|P1|Overall Study|Move to another city|1
5251232|NCT00751114|18120404|P2|Overall Study|Out of country for 2 months|0
5251233|NCT00751114|18120405|P1|Overall Study|Out of country for 2 months|1
5251234|NCT00751114|18120404|P2|Overall Study|Not Treated|1
5251235|NCT00751114|18120405|P1|Overall Study|Not Treated|13
5251236|NCT00751114|18120404|P2|Overall Study|Lack of Efficacy|7
5251237|NCT00751114|18120405|P1|Overall Study|Lack of Efficacy|0
5251238|NCT00751114|18120404|P2|Overall Study|Lost to Follow-up|7
5251239|NCT00751114|18120405|P1|Overall Study|Lost to Follow-up|4
5251240|NCT00751114|18120404|P2|Overall Study|Withdrawal by Subject|4
5251241|NCT00751114|18120405|P1|Overall Study|Withdrawal by Subject|9
5251242|NCT00751114|18120404|P2|Overall Study|Protocol Violation|9
5251243|NCT00751114|18120405|P1|Overall Study|Protocol Violation|8
5251244|NCT00751114|18120404|P2|Overall Study|Adverse Event|4
5251245|NCT00751114|18120405|P1|Overall Study|Adverse Event|2
5251246|NCT00751101|18120430|P2|Overall Study|Physician Decision|1
5251247|NCT00751101|18120431|P1|Overall Study|Physician Decision|0
5251248|NCT00751101|18120430|P2|Overall Study|Never began capecitabine|0
5251249|NCT00751101|18120431|P1|Overall Study|Never began capecitabine|1
5251250|NCT00751101|18120430|P2|Overall Study|No HFS / Never Started Patch/|4
5251251|NCT00751101|18120431|P1|Overall Study|No HFS / Never Started Patch/|0
5251252|NCT00751101|18120430|P2|Overall Study|Withdrawal by Subject|0
5251253|NCT00751101|18120431|P1|Overall Study|Withdrawal by Subject|1
5251254|NCT00751036|18120451|P2|Overall Study|Missing end of Treatment Page|3
5251255|NCT00751036|18120452|P1|Overall Study|Missing end of Treatment Page|2
5251256|NCT00751036|18120451|P2|Overall Study|Protocol Violation|0
5251257|NCT00751036|18120452|P1|Overall Study|Protocol Violation|1
5251258|NCT00751036|18120451|P2|Overall Study|Lost to Follow-up|1
5251259|NCT00751036|18120452|P1|Overall Study|Lost to Follow-up|0
5251260|NCT00751036|18120451|P2|Overall Study|Death|3
5251261|NCT00751036|18120452|P1|Overall Study|Death|3
5251262|NCT00751036|18120451|P2|Overall Study|Withdrawal by Subject|2
5251263|NCT00751036|18120452|P1|Overall Study|Withdrawal by Subject|5
5251264|NCT00751036|18120451|P2|Overall Study|Administrative Problems|4
5251265|NCT00751036|18120452|P1|Overall Study|Administrative Problems|3
5251266|NCT00751036|18120451|P2|Overall Study|Adverse Event|4
5251267|NCT00751036|18120452|P1|Overall Study|Adverse Event|6
5251268|NCT00751036|18120451|P2|Overall Study|Disease Progression|29
5251269|NCT00751036|18120452|P1|Overall Study|Disease Progression|28
5251270|NCT00751023|18120466|P2|Overall Study|Lost to Follow-up|7
5251271|NCT00751023|18120467|P1|Overall Study|Lost to Follow-up|11
5251272|NCT00750919|18120487|P1|Overall Study|Other|36
5251273|NCT00750919|18120487|P1|Overall Study|Could not cooperate, unrelated to trial|4
5251274|NCT00750919|18120487|P1|Overall Study|Lack of Efficacy|8
5251275|NCT00750919|18120487|P1|Overall Study|Withdrawal by Subject|1
5251276|NCT00750919|18120487|P1|Overall Study|Adverse Event|9
5251277|NCT00750893|18120495|P1|Overall Study|Other|17
5251278|NCT00750893|18120495|P1|Overall Study|Lost to Follow-up|510
5251279|NCT00750893|18120495|P1|Overall Study|Withdrawal by Subject|10
5251280|NCT00750893|18120495|P1|Overall Study|Adverse Event|5
5251281|NCT00750880|18120507|P1|Overall Study|Administrative|11
5251282|NCT00750880|18120507|P1|Overall Study|Physician Decision|20
5251283|NCT00750880|18120507|P1|Overall Study|Withdrawal by Subject|33
5251284|NCT00750880|18120507|P1|Overall Study|Protocol Violation|15
5251285|NCT00750880|18120507|P1|Overall Study|Lost to Follow-up|10
5251286|NCT00750880|18120507|P1|Overall Study|Lack of Efficacy|46
5251287|NCT00750880|18120507|P1|Overall Study|Death|4
5251288|NCT00750880|18120507|P1|Overall Study|Adverse Event|76
5251289|NCT00750867|18120530|P1|Overall Study|Adverse Event|2
5251290|NCT00750737|18120551|P2|Overall Study|Withdrawal by Subject|3
5251291|NCT00750737|18120552|P1|Overall Study|Withdrawal by Subject|3
5251292|NCT00750438|18120567|P2|Overall Study|Withdrawal by Subject|1
5251293|NCT00750438|18120568|P1|Overall Study|Withdrawal by Subject|1
5251294|NCT00750438|18120567|P2|Overall Study|Physician Decision|2
5251295|NCT00750438|18120568|P1|Overall Study|Physician Decision|2
5251296|NCT00750438|18120567|P2|Overall Study|Protocol Violation|1
5251297|NCT00750438|18120568|P1|Overall Study|Protocol Violation|4
5251298|NCT00750308|18120634|P12|Third Treatment|Withdrawal by Subject|0
5251299|NCT00750308|18120635|P11|Third Treatment|Withdrawal by Subject|0
5251300|NCT00750308|18120636|P10|Third Treatment|Withdrawal by Subject|0
5251301|NCT00750308|18120637|P9|Third Treatment|Withdrawal by Subject|0
5251302|NCT00750308|18120638|P8|Third Treatment|Withdrawal by Subject|0
5251303|NCT00750308|18120639|P7|Third Treatment|Withdrawal by Subject|0
5251304|NCT00750308|18120640|P6|Third Treatment|Withdrawal by Subject|0
5251305|NCT00750308|18120641|P5|Third Treatment|Withdrawal by Subject|0
5251306|NCT00750308|18120642|P4|Third Treatment|Withdrawal by Subject|0
5251307|NCT00750308|18120643|P3|Third Treatment|Withdrawal by Subject|0
5251308|NCT00750308|18120644|P2|Third Treatment|Withdrawal by Subject|1
5251309|NCT00750308|18120645|P1|Third Treatment|Withdrawal by Subject|0
5251310|NCT00750308|18120634|P12|Second Treatment|Withdrawal by Subject|0
5251311|NCT00750308|18120635|P11|Second Treatment|Withdrawal by Subject|0
5251312|NCT00750308|18120636|P10|Second Treatment|Withdrawal by Subject|0
5251313|NCT00750308|18120637|P9|Second Treatment|Withdrawal by Subject|0
5251314|NCT00750308|18120638|P8|Second Treatment|Withdrawal by Subject|0
5251315|NCT00750308|18120639|P7|Second Treatment|Withdrawal by Subject|0
5251316|NCT00750308|18120640|P6|Second Treatment|Withdrawal by Subject|0
5251317|NCT00750308|18120641|P5|Second Treatment|Withdrawal by Subject|1
5251318|NCT00750308|18120642|P4|Second Treatment|Withdrawal by Subject|0
5251319|NCT00750308|18120643|P3|Second Treatment|Withdrawal by Subject|0
5251320|NCT00750308|18120644|P2|Second Treatment|Withdrawal by Subject|0
5251321|NCT00750308|18120645|P1|Second Treatment|Withdrawal by Subject|0
5251322|NCT00750308|18120634|P12|Second Treatment|Adverse Event|0
5251323|NCT00750308|18120635|P11|Second Treatment|Adverse Event|0
5251324|NCT00750308|18120636|P10|Second Treatment|Adverse Event|0
5251325|NCT00750308|18120637|P9|Second Treatment|Adverse Event|1
5251326|NCT00750308|18120638|P8|Second Treatment|Adverse Event|0
5251327|NCT00750308|18120639|P7|Second Treatment|Adverse Event|0
5251328|NCT00750308|18120640|P6|Second Treatment|Adverse Event|1
5251329|NCT00750308|18120641|P5|Second Treatment|Adverse Event|0
5251330|NCT00750308|18120642|P4|Second Treatment|Adverse Event|0
5251331|NCT00750308|18120643|P3|Second Treatment|Adverse Event|0
5251332|NCT00750308|18120644|P2|Second Treatment|Adverse Event|0
5251333|NCT00750308|18120645|P1|Second Treatment|Adverse Event|0
5251334|NCT00750308|18120634|P12|First Treatment|Withdrawal by Subject|0
5251335|NCT00750308|18120635|P11|First Treatment|Withdrawal by Subject|0
5251336|NCT00750308|18120636|P10|First Treatment|Withdrawal by Subject|0
5251337|NCT00750308|18120637|P9|First Treatment|Withdrawal by Subject|0
5251338|NCT00750308|18120638|P8|First Treatment|Withdrawal by Subject|1
5251339|NCT00750308|18120639|P7|First Treatment|Withdrawal by Subject|0
5251340|NCT00750308|18120640|P6|First Treatment|Withdrawal by Subject|0
5251341|NCT00750308|18120641|P5|First Treatment|Withdrawal by Subject|0
5251342|NCT00750308|18120642|P4|First Treatment|Withdrawal by Subject|1
5251343|NCT00750308|18120643|P3|First Treatment|Withdrawal by Subject|0
5251344|NCT00750308|18120644|P2|First Treatment|Withdrawal by Subject|0
5251345|NCT00750308|18120645|P1|First Treatment|Withdrawal by Subject|0
5251346|NCT00750308|18120634|P12|First Treatment|Adverse Event|1
5251347|NCT00750308|18120635|P11|First Treatment|Adverse Event|1
5251348|NCT00750308|18120636|P10|First Treatment|Adverse Event|0
5251349|NCT00750308|18120637|P9|First Treatment|Adverse Event|0
5251350|NCT00750308|18120638|P8|First Treatment|Adverse Event|0
5251351|NCT00750308|18120639|P7|First Treatment|Adverse Event|0
5251352|NCT00750308|18120640|P6|First Treatment|Adverse Event|0
5251353|NCT00750308|18120641|P5|First Treatment|Adverse Event|0
5251354|NCT00750308|18120642|P4|First Treatment|Adverse Event|0
5251355|NCT00750308|18120643|P3|First Treatment|Adverse Event|0
5251356|NCT00750308|18120644|P2|First Treatment|Adverse Event|1
5251357|NCT00750308|18120645|P1|First Treatment|Adverse Event|0
5251358|NCT00750269|18120695|P5|Overall Study|Fiducials could not be placed|1
5251359|NCT00750269|18120696|P4|Overall Study|Fiducials could not be placed|0
5251360|NCT00750269|18120697|P3|Overall Study|Fiducials could not be placed|0
5251361|NCT00750269|18120698|P2|Overall Study|Fiducials could not be placed|0
5251362|NCT00750269|18120699|P1|Overall Study|Fiducials could not be placed|0
5251363|NCT00750269|18120695|P5|Overall Study|SBRT plan could not be drawn|1
5251364|NCT00750269|18120696|P4|Overall Study|SBRT plan could not be drawn|0
5251365|NCT00750269|18120697|P3|Overall Study|SBRT plan could not be drawn|0
5251366|NCT00750269|18120698|P2|Overall Study|SBRT plan could not be drawn|0
5251367|NCT00750269|18120699|P1|Overall Study|SBRT plan could not be drawn|0
5251368|NCT00750269|18120695|P5|Overall Study|Site error|0
5251369|NCT00750269|18120696|P4|Overall Study|Site error|1
5251370|NCT00750269|18120697|P3|Overall Study|Site error|0
5251371|NCT00750269|18120698|P2|Overall Study|Site error|0
5251372|NCT00750269|18120699|P1|Overall Study|Site error|0
5251373|NCT00750269|18120695|P5|Overall Study|Patient too large for positioning|0
5251374|NCT00750269|18120696|P4|Overall Study|Patient too large for positioning|0
5251375|NCT00750269|18120697|P3|Overall Study|Patient too large for positioning|1
5251376|NCT00750269|18120698|P2|Overall Study|Patient too large for positioning|0
5251377|NCT00750269|18120699|P1|Overall Study|Patient too large for positioning|0
5251378|NCT00750269|18120695|P5|Overall Study|Physician Decision|2
5251379|NCT00750269|18120696|P4|Overall Study|Physician Decision|0
5251380|NCT00750269|18120697|P3|Overall Study|Physician Decision|0
5251381|NCT00750269|18120698|P2|Overall Study|Physician Decision|0
5251382|NCT00750269|18120699|P1|Overall Study|Physician Decision|0
5251383|NCT00750269|18120695|P5|Overall Study|Withdrawal by Subject|2
5251384|NCT00750269|18120696|P4|Overall Study|Withdrawal by Subject|2
5251385|NCT00750269|18120697|P3|Overall Study|Withdrawal by Subject|2
5251386|NCT00750269|18120698|P2|Overall Study|Withdrawal by Subject|0
5251387|NCT00750269|18120699|P1|Overall Study|Withdrawal by Subject|0
5251388|NCT00750269|18120695|P5|Overall Study|Protocol Violation|4
5251389|NCT00750269|18120696|P4|Overall Study|Protocol Violation|2
5251390|NCT00750269|18120697|P3|Overall Study|Protocol Violation|1
5251391|NCT00750269|18120698|P2|Overall Study|Protocol Violation|1
5251392|NCT00750269|18120699|P1|Overall Study|Protocol Violation|0
5251393|NCT00750204|18120746|P2|Overall Study|study halted prematurely|1
5251394|NCT00750204|18120747|P1|Overall Study|study halted prematurely|1
5251395|NCT00750152|18120777|P2|Overall Study|Other|8
5251396|NCT00750152|18120778|P1|Overall Study|Other|7
5251397|NCT00750152|18120777|P2|Overall Study|Termination by sponsor|0
5251398|NCT00750152|18120778|P1|Overall Study|Termination by sponsor|1
5251399|NCT00750152|18120777|P2|Overall Study|Non-compliance|1
5251400|NCT00750152|18120778|P1|Overall Study|Non-compliance|0
5251401|NCT00750152|18120777|P2|Overall Study|Physician Decision|1
5251402|NCT00750152|18120778|P1|Overall Study|Physician Decision|1
5251403|NCT00750152|18120777|P2|Overall Study|Withdrawal by Subject|3
5251404|NCT00750152|18120778|P1|Overall Study|Withdrawal by Subject|3
5251405|NCT00750152|18120777|P2|Overall Study|Lost to Follow-up|13
5251406|NCT00750152|18120778|P1|Overall Study|Lost to Follow-up|8
5251407|NCT00750152|18120777|P2|Overall Study|Adverse Event|1
5251408|NCT00750152|18120778|P1|Overall Study|Adverse Event|2
5251409|NCT00750139|18120790|P4|Overall Study|Non-specific|33
5251410|NCT00750139|18120791|P3|Overall Study|Non-specific|79
5251411|NCT00750139|18120792|P2|Overall Study|Non-specific|42
5251412|NCT00750139|18120793|P1|Overall Study|Non-specific|62
5251413|NCT00750139|18120790|P4|Overall Study|Termination by sponsor|1
5251414|NCT00750139|18120791|P3|Overall Study|Termination by sponsor|0
5251415|NCT00750139|18120792|P2|Overall Study|Termination by sponsor|0
5251416|NCT00750139|18120793|P1|Overall Study|Termination by sponsor|4
5251417|NCT00750139|18120790|P4|Overall Study|Non-compliance|3
5251418|NCT00750139|18120791|P3|Overall Study|Non-compliance|1
5251419|NCT00750139|18120792|P2|Overall Study|Non-compliance|0
5251420|NCT00750139|18120793|P1|Overall Study|Non-compliance|1
5251421|NCT00750139|18120790|P4|Overall Study|Physician Decision|0
5251422|NCT00750139|18120791|P3|Overall Study|Physician Decision|0
5251423|NCT00750139|18120792|P2|Overall Study|Physician Decision|1
5251424|NCT00750139|18120793|P1|Overall Study|Physician Decision|1
5251425|NCT00750139|18120790|P4|Overall Study|Withdrawal by Subject|2
5251426|NCT00750139|18120791|P3|Overall Study|Withdrawal by Subject|6
5251427|NCT00750139|18120792|P2|Overall Study|Withdrawal by Subject|2
5251428|NCT00750139|18120793|P1|Overall Study|Withdrawal by Subject|3
5251429|NCT00750139|18120790|P4|Overall Study|Lost to Follow-up|6
5251430|NCT00750139|18120791|P3|Overall Study|Lost to Follow-up|15
5251431|NCT00750139|18120792|P2|Overall Study|Lost to Follow-up|12
5251432|NCT00750139|18120793|P1|Overall Study|Lost to Follow-up|17
5251433|NCT00750139|18120790|P4|Overall Study|Adverse Event|1
5251434|NCT00750139|18120791|P3|Overall Study|Adverse Event|0
5251435|NCT00750139|18120792|P2|Overall Study|Adverse Event|2
5251436|NCT00750139|18120793|P1|Overall Study|Adverse Event|1
5251437|NCT00750061|18120809|P2|Overall Study|Physician Decision|1
5251438|NCT00750061|18120810|P1|Overall Study|Physician Decision|0
5251439|NCT00750061|18120809|P2|Overall Study|Withdrawal by Subject|1
5251440|NCT00750061|18120810|P1|Overall Study|Withdrawal by Subject|0
5251441|NCT00750061|18120809|P2|Overall Study|Adverse Event|0
5251442|NCT00750061|18120810|P1|Overall Study|Adverse Event|2
5251443|NCT00749996|18120820|P2|Overall Study|Death|0
5251444|NCT00749996|18120821|P1|Overall Study|Death|1
5251445|NCT00749996|18120820|P2|Overall Study|Adverse Event|0
5251446|NCT00749996|18120821|P1|Overall Study|Adverse Event|1
5251447|NCT00749996|18120820|P2|Overall Study|Pregnancy|2
5251448|NCT00749996|18120821|P1|Overall Study|Pregnancy|0
5251449|NCT00749996|18120820|P2|Overall Study|Physician Decision|0
5251450|NCT00749996|18120821|P1|Overall Study|Physician Decision|2
5251451|NCT00749996|18120820|P2|Overall Study|Protocol Violation|3
5251452|NCT00749996|18120821|P1|Overall Study|Protocol Violation|2
5251453|NCT00749996|18120820|P2|Overall Study|Withdrawal by Subject|4
5251454|NCT00749996|18120821|P1|Overall Study|Withdrawal by Subject|5
5251455|NCT00749996|18120820|P2|Overall Study|Lost to Follow-up|4
5251456|NCT00749996|18120821|P1|Overall Study|Lost to Follow-up|7
5251457|NCT00749944|18120844|P2|Overall Study|Withdrawal by Subject|0
5251458|NCT00749944|18120845|P1|Overall Study|Withdrawal by Subject|2
5251459|NCT00749944|18120844|P2|Overall Study|Other|0
5251460|NCT00749944|18120845|P1|Overall Study|Other|1
5251461|NCT00749944|18120844|P2|Overall Study|Lost to Follow-up|1
5251462|NCT00749944|18120845|P1|Overall Study|Lost to Follow-up|2
5251463|NCT00749892|18120924|P1|Overall Study|Withdrawal by Subject|3
5251464|NCT00749775|18120960|P1|Overall Study|No drug administration|3
5251465|NCT00749775|18120960|P1|Overall Study|No visit after first day of treatment|44
5251466|NCT00749775|18120960|P1|Overall Study|Lost to Follow-up|36
5251467|NCT00749775|18120960|P1|Overall Study|Protocol Violation|24
5251468|NCT00749684|18120997|P1|Overall Study|Missing|9
5251469|NCT00749684|18120997|P1|Overall Study|AE+discontinuation on participants wish|1
5251470|NCT00749684|18120997|P1|Overall Study|Therapy according to protocol + AE|2
5251471|NCT00749684|18120997|P1|Overall Study|Progressive Desease|31
5251472|NCT00749684|18120997|P1|Overall Study|Not Documented|1
5251473|NCT00749684|18120997|P1|Overall Study|Participant's Wish|10
5251474|NCT00749684|18120997|P1|Overall Study|Adverse Event|27
5251475|NCT00749684|18120997|P1|Overall Study|Death|1
5251476|NCT00749580|18121045|P2|Overall Study|Adverse Event|1
5251477|NCT00749580|18121046|P1|Overall Study|Adverse Event|0
5251478|NCT00749580|18121045|P2|Overall Study|Lost to Follow-up|8
5251479|NCT00749580|18121046|P1|Overall Study|Lost to Follow-up|4
5251480|NCT00749463|18121080|P3|Overall Study|Withdrawal by Subject|0
5251481|NCT00749463|18121081|P2|Overall Study|Withdrawal by Subject|0
5251482|NCT00749463|18121082|P1|Overall Study|Withdrawal by Subject|1
5251483|NCT00749463|18121080|P3|Overall Study|Adverse Event|1
5251484|NCT00749463|18121081|P2|Overall Study|Adverse Event|4
5251485|NCT00749463|18121082|P1|Overall Study|Adverse Event|0
5251486|NCT00749411|18121110|P2|Overall Study|Protocol-defined stopping criteria|1
5251487|NCT00749411|18121111|P1|Overall Study|Protocol-defined stopping criteria|0
5251488|NCT00749411|18121110|P2|Overall Study|Protocol Violation|1
5251489|NCT00749411|18121111|P1|Overall Study|Protocol Violation|1
5251490|NCT00749411|18121110|P2|Overall Study|Lack of Efficacy|1
5251491|NCT00749411|18121111|P1|Overall Study|Lack of Efficacy|0
5251492|NCT00749411|18121110|P2|Overall Study|Adverse Event|2
5251493|NCT00749411|18121111|P1|Overall Study|Adverse Event|0
5251494|NCT00749398|18121119|P1|Overall Study|Unknown reason|1
5251495|NCT00749398|18121119|P1|Overall Study|Reason not specified|2
5251496|NCT00749398|18121119|P1|Overall Study|Lost to Follow-up|11
5251497|NCT00749398|18121119|P1|Overall Study|Withdrawal by Subject|17
5251498|NCT00749398|18121119|P1|Overall Study|Serious adverse event|11
5251499|NCT00749398|18121119|P1|Overall Study|Adverse Event|4
5251500|NCT00749398|18121119|P1|Overall Study|Lack of Efficacy|7
5251669|NCT00747149|18121783|P2|Overall Study|Lost to Follow-up|10
5251501|NCT00749203|18121162|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
5251502|NCT00749203|18121163|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
5251503|NCT00749203|18121162|P2|Second Infusion at 2 Weeks|Protocol Violation|1
5251504|NCT00749203|18121163|P1|Second Infusion at 2 Weeks|Protocol Violation|0
5251505|NCT00749203|18121162|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
5251506|NCT00749203|18121163|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
5251507|NCT00749203|18121162|P2|no Infusion at Week 1|delayed-onset sedation|1
5251508|NCT00749203|18121163|P1|no Infusion at Week 1|delayed-onset sedation|0
5251509|NCT00749203|18121162|P2|no Infusion at Week 1|Withdrawal by Subject|1
5251510|NCT00749203|18121163|P1|no Infusion at Week 1|Withdrawal by Subject|0
5251511|NCT00749203|18121162|P2|no Infusion at Week 1|Lost to Follow-up|1
5251512|NCT00749203|18121163|P1|no Infusion at Week 1|Lost to Follow-up|0
5251513|NCT00749190|18121184|P7|Overall Study|Other reason not defined above|0
5251514|NCT00749190|18121185|P6|Overall Study|Other reason not defined above|0
5251515|NCT00749190|18121186|P5|Overall Study|Other reason not defined above|0
5251516|NCT00749190|18121187|P4|Overall Study|Other reason not defined above|1
5251517|NCT00749190|18121188|P3|Overall Study|Other reason not defined above|0
5251518|NCT00749190|18121189|P2|Overall Study|Other reason not defined above|0
5251519|NCT00749190|18121190|P1|Overall Study|Other reason not defined above|0
5251520|NCT00749190|18121184|P7|Overall Study|Protocol Violation|1
5251521|NCT00749190|18121185|P6|Overall Study|Protocol Violation|0
5251522|NCT00749190|18121186|P5|Overall Study|Protocol Violation|0
5251523|NCT00749190|18121187|P4|Overall Study|Protocol Violation|0
5251524|NCT00749190|18121188|P3|Overall Study|Protocol Violation|0
5251525|NCT00749190|18121189|P2|Overall Study|Protocol Violation|1
5251526|NCT00749190|18121190|P1|Overall Study|Protocol Violation|0
5251527|NCT00749190|18121184|P7|Overall Study|Withdrawal by Subject|0
5251528|NCT00749190|18121185|P6|Overall Study|Withdrawal by Subject|1
5251529|NCT00749190|18121186|P5|Overall Study|Withdrawal by Subject|0
5251530|NCT00749190|18121187|P4|Overall Study|Withdrawal by Subject|0
5251531|NCT00749190|18121188|P3|Overall Study|Withdrawal by Subject|0
5251532|NCT00749190|18121189|P2|Overall Study|Withdrawal by Subject|1
5251533|NCT00749190|18121190|P1|Overall Study|Withdrawal by Subject|2
5251534|NCT00749190|18121184|P7|Overall Study|Lack of Efficacy|0
5251535|NCT00749190|18121185|P6|Overall Study|Lack of Efficacy|1
5251536|NCT00749190|18121186|P5|Overall Study|Lack of Efficacy|0
5251537|NCT00749190|18121187|P4|Overall Study|Lack of Efficacy|0
5251538|NCT00749190|18121188|P3|Overall Study|Lack of Efficacy|1
5251539|NCT00749190|18121189|P2|Overall Study|Lack of Efficacy|1
5251540|NCT00749190|18121190|P1|Overall Study|Lack of Efficacy|3
5251541|NCT00749190|18121184|P7|Overall Study|Adverse Event|0
5251542|NCT00749190|18121185|P6|Overall Study|Adverse Event|3
5251543|NCT00749190|18121186|P5|Overall Study|Adverse Event|0
5251544|NCT00749190|18121187|P4|Overall Study|Adverse Event|4
5251545|NCT00749190|18121188|P3|Overall Study|Adverse Event|0
5251546|NCT00749190|18121189|P2|Overall Study|Adverse Event|2
5251547|NCT00749190|18121190|P1|Overall Study|Adverse Event|0
5251548|NCT00748969|18121299|P2|Overall Study|Withdrawal by Subject|1
5251549|NCT00748969|18121300|P1|Overall Study|Withdrawal by Subject|0
5251550|NCT00748969|18121299|P2|Overall Study|Withdrawal by Subject|0
5251551|NCT00748969|18121300|P1|Overall Study|Withdrawal by Subject|1
5251552|NCT00748709|18121350|P1|Overall Study|Other Reasons|1
5251553|NCT00748709|18121350|P1|Overall Study|Withdrawal by Subject|1
5251554|NCT00748709|18121350|P1|Overall Study|Other Adverse Event|1
5251555|NCT00748709|18121350|P1|Overall Study|Drug reducing Toxity|2
5251556|NCT00748709|18121350|P1|Overall Study|Progressive disease|15
5251557|NCT00748566|18121393|P1|Overall Study|Other|9
5251558|NCT00748566|18121393|P1|Overall Study|Study terminated by sponsor|5
5251559|NCT00748566|18121393|P1|Overall Study|Withdrawal by Subject|22
5251560|NCT00748566|18121393|P1|Overall Study|Protocol Violation|13
5251561|NCT00748566|18121393|P1|Overall Study|Lost to Follow-up|1
5251562|NCT00748566|18121393|P1|Overall Study|Lack of Efficacy|12
5251563|NCT00748566|18121393|P1|Overall Study|Death|1
5251564|NCT00748566|18121393|P1|Overall Study|Adverse Event|49
5251565|NCT00748553|18121423|P2|Overall Study|noncompliance|0
5251566|NCT00748553|18121424|P1|Overall Study|noncompliance|1
5251567|NCT00748553|18121423|P2|Overall Study|disease progression|0
5251568|NCT00748553|18121424|P1|Overall Study|disease progression|2
5251569|NCT00748553|18121423|P2|Overall Study|Adverse Event|1
5251570|NCT00748553|18121424|P1|Overall Study|Adverse Event|0
5251571|NCT00748540|18121431|P1|Overall Study|Physician Decision|1
5251572|NCT00748241|18121457|P1|Overall Study|Death|2
5251573|NCT00748241|18121457|P1|Overall Study|Lost to Follow-up|5
5251574|NCT00748241|18121457|P1|Overall Study|Implant failure|1
5251575|NCT00748189|18121467|P2|Overall Study|Study terminated by Sponsor|79
5251576|NCT00748189|18121468|P1|Overall Study|Study terminated by Sponsor|70
5251577|NCT00748189|18121467|P2|Overall Study|Lost to Follow-up|15
5251578|NCT00748189|18121468|P1|Overall Study|Lost to Follow-up|8
5251579|NCT00748189|18121467|P2|Overall Study|Physician Decision|5
5251580|NCT00748189|18121468|P1|Overall Study|Physician Decision|16
5251581|NCT00748189|18121467|P2|Overall Study|Withdrawal by Subject|29
5251582|NCT00748189|18121468|P1|Overall Study|Withdrawal by Subject|23
5251583|NCT00748189|18121467|P2|Overall Study|Death|84
5251584|NCT00748189|18121468|P1|Overall Study|Death|99
5251585|NCT00748098|18121523|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
5251586|NCT00748098|18121524|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
5251587|NCT00748098|18121523|P2|Second Treatment Intervention Period|Lost to Follow-up|1
5251588|NCT00748098|18121524|P1|Second Treatment Intervention Period|Lost to Follow-up|1
5251589|NCT00748098|18121523|P2|Second Treatment Intervention Period|Adverse Event|1
5251590|NCT00748098|18121524|P1|Second Treatment Intervention Period|Adverse Event|4
5251591|NCT00748098|18121523|P2|1-Week Washout Period|Withdrawal by Subject|0
5251592|NCT00748098|18121524|P1|1-Week Washout Period|Withdrawal by Subject|2
5251593|NCT00748098|18121523|P2|1-Week Washout Period|Adverse Event|1
5251594|NCT00748098|18121524|P1|1-Week Washout Period|Adverse Event|0
5251595|NCT00748098|18121523|P2|First Taper Period|Protocol Stopping Criteria Met|1
5251596|NCT00748098|18121524|P1|First Taper Period|Protocol Stopping Criteria Met|0
5251597|NCT00748098|18121523|P2|First Taper Period|Withdrawal by Subject|0
5251598|NCT00748098|18121524|P1|First Taper Period|Withdrawal by Subject|2
5251599|NCT00748098|18121523|P2|First Taper Period|Protocol Violation|0
5251600|NCT00748098|18121524|P1|First Taper Period|Protocol Violation|1
5251601|NCT00748098|18121523|P2|First Treatment Intervention Period|Withdrawal by Subject|0
5251602|NCT00748098|18121524|P1|First Treatment Intervention Period|Withdrawal by Subject|2
5251603|NCT00748098|18121523|P2|First Treatment Intervention Period|Lost to Follow-up|0
5251604|NCT00748098|18121524|P1|First Treatment Intervention Period|Lost to Follow-up|1
5251605|NCT00748098|18121523|P2|First Treatment Intervention Period|Protocol Violation|0
5251606|NCT00748098|18121524|P1|First Treatment Intervention Period|Protocol Violation|1
5251607|NCT00748098|18121523|P2|First Treatment Intervention Period|Adverse Event|1
5251608|NCT00748098|18121524|P1|First Treatment Intervention Period|Adverse Event|1
5251609|NCT00747812|18121605|P2|Overall Study|Research Site Staff Relocation|3
5251610|NCT00747812|18121606|P1|Overall Study|Research Site Staff Relocation|5
5251611|NCT00747643|18121644|P2|Overall Study|Withdrawal by Subject|27
5251612|NCT00747643|18121645|P1|Overall Study|Withdrawal by Subject|36
5251613|NCT00747617|18121659|P2|Overall Study|Lost to Follow-up|1
5251614|NCT00747617|18121660|P1|Overall Study|Lost to Follow-up|3
5251615|NCT00747565|18121670|P2|Overall Study|Lost to Follow-up|1
5251616|NCT00747565|18121671|P1|Overall Study|Lost to Follow-up|4
5251617|NCT00747565|18121670|P2|Overall Study|Withdrawal by Subject|6
5251618|NCT00747565|18121671|P1|Overall Study|Withdrawal by Subject|10
5251619|NCT00747474|18121684|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251620|NCT00747474|18121685|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251621|NCT00747474|18121686|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251622|NCT00747474|18121687|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251623|NCT00747474|18121688|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
5251624|NCT00747474|18121689|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251625|NCT00747474|18121690|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251626|NCT00747474|18121691|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251627|NCT00747474|18121692|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251628|NCT00747474|18121693|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251629|NCT00747474|18121694|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251630|NCT00747474|18121695|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5251631|NCT00747461|18121721|P1|Overall Study|study terminated by sponsor|5
5251632|NCT00747435|18121726|P1|Overall Study|Still undergoing follow up|1
5251633|NCT00747435|18121726|P1|Overall Study|Withdrawal by Subject|3
5251634|NCT00747435|18121726|P1|Overall Study|Lost to Follow-up|2
5251635|NCT00747344|18121736|P4|After Controlled Period|Adverse Event|1
5251636|NCT00747344|18121737|P3|After Controlled Period|Adverse Event|0
5251637|NCT00747344|18121738|P2|After Controlled Period|Adverse Event|0
5251638|NCT00747344|18121739|P1|After Controlled Period|Adverse Event|0
5251639|NCT00747344|18121736|P4|Controlled Period|Other|0
5251640|NCT00747344|18121737|P3|Controlled Period|Other|0
5251641|NCT00747344|18121738|P2|Controlled Period|Other|3
5251642|NCT00747344|18121739|P1|Controlled Period|Other|0
5251643|NCT00747344|18121736|P4|Controlled Period|Lack of Efficacy|0
5251644|NCT00747344|18121737|P3|Controlled Period|Lack of Efficacy|0
5251645|NCT00747344|18121738|P2|Controlled Period|Lack of Efficacy|1
5251646|NCT00747344|18121739|P1|Controlled Period|Lack of Efficacy|2
5251647|NCT00747344|18121736|P4|Controlled Period|Adverse Event|0
5251648|NCT00747344|18121737|P3|Controlled Period|Adverse Event|0
5251649|NCT00747344|18121738|P2|Controlled Period|Adverse Event|0
5251650|NCT00747344|18121739|P1|Controlled Period|Adverse Event|3
5251651|NCT00747227|18121753|P2|Overall Study|Illness|1
5251652|NCT00747227|18121754|P1|Overall Study|Illness|1
5251653|NCT00747227|18121753|P2|Overall Study|Lost to Follow-up|2
5251654|NCT00747227|18121754|P1|Overall Study|Lost to Follow-up|1
5251655|NCT00747227|18121753|P2|Overall Study|Withdrawal by Subject|0
5251656|NCT00747227|18121754|P1|Overall Study|Withdrawal by Subject|1
5251657|NCT00747227|18121753|P2|Overall Study|Death|1
5251658|NCT00747227|18121754|P1|Overall Study|Death|3
5251659|NCT00747149|18121783|P2|Overall Study|Not reported|4
5251660|NCT00747149|18121784|P1|Overall Study|Not reported|1
5251661|NCT00747149|18121783|P2|Overall Study|Severe non-compliance to protocol|1
5251662|NCT00747149|18121784|P1|Overall Study|Severe non-compliance to protocol|0
5251663|NCT00747149|18121783|P2|Overall Study|Incorrect enrollment|6
5251664|NCT00747149|18121784|P1|Overall Study|Incorrect enrollment|0
5251665|NCT00747149|18121783|P2|Overall Study|Did not receive treatment|1
5251666|NCT00747149|18121784|P1|Overall Study|Did not receive treatment|0
5251667|NCT00747149|18121783|P2|Overall Study|Withdrawal by Subject|6
5251668|NCT00747149|18121784|P1|Overall Study|Withdrawal by Subject|0
5251670|NCT00747149|18121784|P1|Overall Study|Lost to Follow-up|0
5251671|NCT00747149|18121783|P2|Overall Study|Adverse Event|15
5251672|NCT00747149|18121784|P1|Overall Study|Adverse Event|0
5251673|NCT00747006|18121799|P3|Overall Study|Physician Decision|1
5251674|NCT00747006|18121800|P2|Overall Study|Physician Decision|0
5251675|NCT00747006|18121801|P1|Overall Study|Physician Decision|2
5251676|NCT00747006|18121799|P3|Overall Study|Lost to Follow-up|0
5251677|NCT00747006|18121800|P2|Overall Study|Lost to Follow-up|1
5251678|NCT00747006|18121801|P1|Overall Study|Lost to Follow-up|0
5251679|NCT00747006|18121799|P3|Overall Study|Adverse Event|0
5251680|NCT00747006|18121800|P2|Overall Study|Adverse Event|0
5251681|NCT00747006|18121801|P1|Overall Study|Adverse Event|1
5251682|NCT00746941|18121879|P4|Overall Study|Adverse Event|1
5251683|NCT00746941|18121880|P3|Overall Study|Adverse Event|0
5251684|NCT00746941|18121881|P2|Overall Study|Adverse Event|0
5251685|NCT00746941|18121882|P1|Overall Study|Adverse Event|0
5251686|NCT00746941|18121879|P4|Overall Study|Other, reason not provided|4
5251687|NCT00746941|18121880|P3|Overall Study|Other, reason not provided|0
5251688|NCT00746941|18121881|P2|Overall Study|Other, reason not provided|4
5251689|NCT00746941|18121882|P1|Overall Study|Other, reason not provided|2
5251690|NCT00746941|18121879|P4|Overall Study|Withdrawal by Subject|2
5251691|NCT00746941|18121880|P3|Overall Study|Withdrawal by Subject|0
5251692|NCT00746941|18121881|P2|Overall Study|Withdrawal by Subject|0
5251693|NCT00746941|18121882|P1|Overall Study|Withdrawal by Subject|3
5251694|NCT00746941|18121879|P4|Overall Study|Physician Decision|0
5251695|NCT00746941|18121880|P3|Overall Study|Physician Decision|2
5251696|NCT00746941|18121881|P2|Overall Study|Physician Decision|0
5251697|NCT00746941|18121882|P1|Overall Study|Physician Decision|0
5251698|NCT00746941|18121879|P4|Overall Study|Death|6
5251699|NCT00746941|18121880|P3|Overall Study|Death|0
5251700|NCT00746941|18121881|P2|Overall Study|Death|0
5251701|NCT00746941|18121882|P1|Overall Study|Death|2
5251702|NCT00746798|18121940|P4|Overall Study|Participant unable to return for visit|0
5251703|NCT00746798|18121941|P3|Overall Study|Participant unable to return for visit|0
5251704|NCT00746798|18121942|P2|Overall Study|Participant unable to return for visit|0
5251705|NCT00746798|18121943|P1|Overall Study|Participant unable to return for visit|1
5251706|NCT00746798|18121940|P4|Overall Study|Death|0
5251707|NCT00746798|18121941|P3|Overall Study|Death|2
5251708|NCT00746798|18121942|P2|Overall Study|Death|0
5251709|NCT00746798|18121943|P1|Overall Study|Death|0
5251710|NCT00746798|18121940|P4|Overall Study|Withdrawal by Subject|0
5251711|NCT00746798|18121941|P3|Overall Study|Withdrawal by Subject|1
5251712|NCT00746798|18121942|P2|Overall Study|Withdrawal by Subject|1
5251713|NCT00746798|18121943|P1|Overall Study|Withdrawal by Subject|0
5251714|NCT00746798|18121940|P4|Overall Study|Protocol Violation|0
5251715|NCT00746798|18121941|P3|Overall Study|Protocol Violation|0
5251716|NCT00746798|18121942|P2|Overall Study|Protocol Violation|1
5251717|NCT00746798|18121943|P1|Overall Study|Protocol Violation|0
5251718|NCT00746785|18121968|P3|Overall Study|Lost to Follow-up|27
5251719|NCT00746785|18121969|P2|Overall Study|Lost to Follow-up|25
5251720|NCT00746785|18121970|P1|Overall Study|Lost to Follow-up|29
5251721|NCT00746733|18121978|P2|Third Intervention|Withdrawal by Subject|1
5251722|NCT00746733|18121979|P1|Third Intervention|Withdrawal by Subject|1
5251723|NCT00746733|18121978|P2|Second Intervention|Adverse Event|0
5251724|NCT00746733|18121979|P1|Second Intervention|Adverse Event|1
5251725|NCT00746590|18122063|P1|Overall Study|Death|1
5251726|NCT00746564|18122067|P1|Overall Study|Required Pacemaker/ICD Implant|2
5251727|NCT00746551|18122082|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
5251728|NCT00746551|18122083|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
5251729|NCT00746551|18122082|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
5251730|NCT00746551|18122083|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
5251731|NCT00746551|18122082|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
5251732|NCT00746551|18122083|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
5251733|NCT00746356|18122134|P2|Overall Study|Patient relocated|0
5251734|NCT00746356|18122135|P1|Overall Study|Patient relocated|1
5251735|NCT00746356|18122134|P2|Overall Study|Removal of Device|1
5251736|NCT00746356|18122135|P1|Overall Study|Removal of Device|0
5251737|NCT00746356|18122134|P2|Overall Study|Lost to Follow-up|0
5251738|NCT00746356|18122135|P1|Overall Study|Lost to Follow-up|1
5251739|NCT00746356|18122134|P2|Overall Study|Death|3
5251740|NCT00746356|18122135|P1|Overall Study|Death|7
5251741|NCT00746356|18122134|P2|Overall Study|Withdrawal by Subject|3
5251742|NCT00746356|18122135|P1|Overall Study|Withdrawal by Subject|2
5251743|NCT00746330|18122147|P4|Period 1|Abnormal test procedure result|0
5251744|NCT00746330|18122148|P3|Period 1|Abnormal test procedure result|1
5251745|NCT00746330|18122149|P2|Period 1|Abnormal test procedure result|0
5251746|NCT00746330|18122150|P1|Period 1|Abnormal test procedure result|0
5251747|NCT00746252|18122180|P2|Overall Study|weight gain >7.5 %|2
5251748|NCT00746252|18122181|P1|Overall Study|weight gain >7.5 %|1
5251749|NCT00746096|18122216|P2|Overall Study|No study drug treatment|1
5251750|NCT00746096|18122217|P1|Overall Study|No study drug treatment|1
5251751|NCT00746096|18122216|P2|Overall Study|Protocol Violation|0
5251752|NCT00746096|18122217|P1|Overall Study|Protocol Violation|1
5251753|NCT00746096|18122216|P2|Overall Study|Lost to Follow-up|1
5251754|NCT00746096|18122217|P1|Overall Study|Lost to Follow-up|2
5251755|NCT00746096|18122216|P2|Overall Study|Withdrawal by Subject|1
5251756|NCT00746096|18122217|P1|Overall Study|Withdrawal by Subject|5
5251757|NCT00746096|18122216|P2|Overall Study|Adverse Event|0
5251758|NCT00746096|18122217|P1|Overall Study|Adverse Event|1
5251759|NCT00745901|18122248|P2|Overall Study|Patient didn't take any study medication|3
5251760|NCT00745901|18122249|P1|Overall Study|Patient didn't take any study medication|7
5251761|NCT00745901|18122248|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
5251762|NCT00745901|18122249|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
5251763|NCT00745901|18122248|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
5251764|NCT00745901|18122249|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
5251765|NCT00745901|18122248|P2|Overall Study|Patient's next menses did not start with|0
5251766|NCT00745901|18122249|P1|Overall Study|Patient's next menses did not start with|1
5251767|NCT00745901|18122248|P2|Overall Study|Lack of compliance|2
5251768|NCT00745901|18122249|P1|Overall Study|Lack of compliance|2
5251769|NCT00745901|18122248|P2|Overall Study|Pregnancy|4
5251770|NCT00745901|18122249|P1|Overall Study|Pregnancy|2
5251771|NCT00745901|18122248|P2|Overall Study|Lost to Follow-up|4
5251772|NCT00745901|18122249|P1|Overall Study|Lost to Follow-up|7
5251773|NCT00745901|18122248|P2|Overall Study|Withdrawal by Subject|0
5251774|NCT00745901|18122249|P1|Overall Study|Withdrawal by Subject|1
5251775|NCT00745901|18122248|P2|Overall Study|Protocol Violation|1
5251776|NCT00745901|18122249|P1|Overall Study|Protocol Violation|0
5251777|NCT00745901|18122248|P2|Overall Study|Adverse Event|4
5251778|NCT00745901|18122249|P1|Overall Study|Adverse Event|3
5251779|NCT00745875|18122295|P2|Overall Study|Continuing study treatment|4
5251780|NCT00745875|18122296|P1|Overall Study|Continuing study treatment|4
5251781|NCT00745849|18122304|P2|Second Intervention|Lost to Follow-up|1
5251782|NCT00745849|18122305|P1|Second Intervention|Lost to Follow-up|2
5251783|NCT00745849|18122304|P2|First Intervention|Lost to Follow-up|1
5251784|NCT00745849|18122305|P1|First Intervention|Lost to Follow-up|1
5251785|NCT00745849|18122304|P2|First Intervention|Withdrawal by Subject|1
5251786|NCT00745849|18122305|P1|First Intervention|Withdrawal by Subject|0
5251787|NCT00745823|18122313|P2|Overall Study|Study Terminated by Sponsor|349
5251788|NCT00745823|18122314|P1|Overall Study|Study Terminated by Sponsor|326
5251789|NCT00745823|18122313|P2|Overall Study|Withdrawal by Subject|8
5251790|NCT00745823|18122314|P1|Overall Study|Withdrawal by Subject|14
5251791|NCT00745823|18122313|P2|Overall Study|Pregnancy|4
5251792|NCT00745823|18122314|P1|Overall Study|Pregnancy|0
5251793|NCT00745823|18122313|P2|Overall Study|Physician Decision|5
5251794|NCT00745823|18122314|P1|Overall Study|Physician Decision|10
5251795|NCT00745823|18122313|P2|Overall Study|Lost to Follow-up|11
5251796|NCT00745823|18122314|P1|Overall Study|Lost to Follow-up|10
5251797|NCT00745823|18122313|P2|Overall Study|Lack of Efficacy|6
5251798|NCT00745823|18122314|P1|Overall Study|Lack of Efficacy|20
5251799|NCT00745823|18122313|P2|Overall Study|Adverse Event|3
5251800|NCT00745823|18122314|P1|Overall Study|Adverse Event|5
5251801|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
5251802|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
5251803|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5251804|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5251805|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5251806|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5251807|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Death|1
5251808|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Death|0
5251809|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Death|0
5251810|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Death|0
5251811|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Death|0
5251812|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Death|0
5251813|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
5251814|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5251815|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5251816|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5251817|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5251818|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5251819|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
5251820|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
5251821|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5251822|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5251823|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5251824|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5251825|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
5251826|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
5251827|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5251828|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5251829|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5251830|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5251831|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
5251832|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
5251833|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5251834|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5251835|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5251836|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5251837|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
5251838|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
5251839|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5251840|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5251841|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5251842|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5251843|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
5251844|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
5251845|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5251846|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5251847|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5251848|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5251849|NCT00745615|18122342|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
5251850|NCT00745615|18122343|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
5251851|NCT00745615|18122344|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5251852|NCT00745615|18122345|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5251853|NCT00745615|18122346|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5251854|NCT00745615|18122347|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5251855|NCT00745615|18122342|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5251856|NCT00745615|18122343|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5251857|NCT00745615|18122344|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5251858|NCT00745615|18122345|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5251859|NCT00745615|18122346|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
5251860|NCT00745615|18122347|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5251861|NCT00745615|18122342|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
5251862|NCT00745615|18122343|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
5251863|NCT00745615|18122344|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
5251864|NCT00745615|18122345|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
5251865|NCT00745615|18122346|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
5251866|NCT00745615|18122347|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
5251867|NCT00745615|18122342|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
5251868|NCT00745615|18122343|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
5251869|NCT00745615|18122344|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
5251870|NCT00745615|18122345|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
5251871|NCT00745615|18122346|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
5251872|NCT00745615|18122347|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
5251873|NCT00745615|18122342|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
5251874|NCT00745615|18122343|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
5251875|NCT00745615|18122344|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
5251876|NCT00745615|18122345|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
5251877|NCT00745615|18122346|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
5251878|NCT00745615|18122347|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
5251879|NCT00745615|18122342|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
5251880|NCT00745615|18122343|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
5251881|NCT00745615|18122344|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
5251882|NCT00745615|18122345|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
5251883|NCT00745615|18122346|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
5251884|NCT00745615|18122347|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
5251885|NCT00745498|18122396|P3|Overall Study|Edophthalmitis after preoperative IVB|0
5251886|NCT00745498|18122397|P2|Overall Study|Edophthalmitis after preoperative IVB|0
5251887|NCT00745498|18122398|P1|Overall Study|Edophthalmitis after preoperative IVB|1
5251888|NCT00745498|18122396|P3|Overall Study|Non-PDR related VH|1
5251889|NCT00745498|18122397|P2|Overall Study|Non-PDR related VH|1
5251890|NCT00745498|18122398|P1|Overall Study|Non-PDR related VH|0
5251891|NCT00745498|18122396|P3|Overall Study|Injection of intravitreal silicone oil o|4
5251892|NCT00745498|18122397|P2|Overall Study|Injection of intravitreal silicone oil o|4
5251893|NCT00745498|18122398|P1|Overall Study|Injection of intravitreal silicone oil o|3
5251894|NCT00745498|18122396|P3|Overall Study|Lost to Follow-up|3
5251895|NCT00745498|18122397|P2|Overall Study|Lost to Follow-up|1
5251896|NCT00745498|18122398|P1|Overall Study|Lost to Follow-up|1
5251897|NCT00745420|18122412|P1|Overall Study|Ineligible|1
5251898|NCT00745368|18122429|P1|Overall Study|Unable to provide sample|3
5251899|NCT00745251|18122451|P2|Overall Study|Withdrawal by Subject|1
5251900|NCT00745251|18122452|P1|Overall Study|Withdrawal by Subject|1
5251901|NCT00745251|18122451|P2|Overall Study|Adverse Event|2
5251902|NCT00745251|18122452|P1|Overall Study|Adverse Event|1
5251903|NCT00745121|18122462|P2|Overall Study|Withdrawal by Subject|2
5251904|NCT00745121|18122463|P1|Overall Study|Withdrawal by Subject|4
5251905|NCT00745121|18122462|P2|Overall Study|Lost to Follow-up|0
5251906|NCT00745121|18122463|P1|Overall Study|Lost to Follow-up|1
5251907|NCT00745121|18122462|P2|Overall Study|Adverse Event|0
5251908|NCT00745121|18122463|P1|Overall Study|Adverse Event|1
5251909|NCT00745121|18122462|P2|Overall Study|Death|0
5251910|NCT00745121|18122463|P1|Overall Study|Death|3
5251911|NCT00745095|18122475|P6|Overall Study|Ineligible due to GFR criteria|28
5251912|NCT00745095|18122476|P5|Overall Study|Ineligible due to GFR criteria|30
5251913|NCT00745095|18122477|P4|Overall Study|Ineligible due to GFR criteria|3
5251914|NCT00745095|18122478|P3|Overall Study|Ineligible due to GFR criteria|3
5251915|NCT00745095|18122479|P2|Overall Study|Ineligible due to GFR criteria|2
5251916|NCT00745095|18122480|P1|Overall Study|Ineligible due to GFR criteria|0
5251917|NCT00745095|18122475|P6|Overall Study|Declined to participate|95
5251918|NCT00745095|18122476|P5|Overall Study|Declined to participate|92
5251919|NCT00745095|18122477|P4|Overall Study|Declined to participate|0
5251920|NCT00745095|18122478|P3|Overall Study|Declined to participate|0
5251921|NCT00745095|18122479|P2|Overall Study|Declined to participate|0
5251922|NCT00745095|18122480|P1|Overall Study|Declined to participate|1
5251923|NCT00744991|18122509|P1|Overall Study|Protocol Entry Criteria Unmet|1
5251924|NCT00744991|18122509|P1|Overall Study|Adverse Event|2
5251925|NCT00744991|18122509|P1|Overall Study|Physician Decision|3
5251926|NCT00744991|18122509|P1|Overall Study|Withdrawal by Subject|8
5251927|NCT00744991|18122509|P1|Overall Study|Progressive Disease|11
5251928|NCT00744978|18122526|P2|Period 2|Adverse Event|1
5251929|NCT00744978|18122527|P1|Period 2|Adverse Event|0
5251930|NCT00744978|18122526|P2|Period 1|Randomized but not Treated|1
5251931|NCT00744978|18122527|P1|Period 1|Randomized but not Treated|1
5251932|NCT00744978|18122526|P2|Period 1|Adverse Event|0
5251933|NCT00744978|18122527|P1|Period 1|Adverse Event|4
5251934|NCT00744978|18122526|P2|Period 1|Other|2
5251935|NCT00744978|18122527|P1|Period 1|Other|0
5251936|NCT00744978|18122526|P2|Period 1|Withdrawal by Subject|2
5251937|NCT00744978|18122527|P1|Period 1|Withdrawal by Subject|0
5251938|NCT00744978|18122526|P2|Period 1|Lost to Follow-up|0
5251939|NCT00744978|18122527|P1|Period 1|Lost to Follow-up|1
5251940|NCT00744939|18122608|P1|Overall Study|incorrect race|1
5251941|NCT00744939|18122608|P1|Overall Study|coma|1
5251942|NCT00744939|18122608|P1|Overall Study|Failed inclusion/exclusion criteria|19
5251943|NCT00744939|18122608|P1|Overall Study|Did not receive Magnevist|7
5251944|NCT00744939|18122608|P1|Overall Study|Medical history exclusionary|1
5251945|NCT00744939|18122608|P1|Overall Study|Lost to Follow-up|12
5251946|NCT00744939|18122608|P1|Overall Study|distance|4
5251947|NCT00744939|18122608|P1|Overall Study|Death|24
5251948|NCT00744939|18122608|P1|Overall Study|Protocol Violation|13
5251949|NCT00744939|18122608|P1|Overall Study|Withdrawal by Subject|9
5251950|NCT00744874|18122644|P1|Overall Study|Unable to accomodate schedule|1
5251951|NCT00744874|18122644|P1|Overall Study|Study Device not available at procedure|1
5251952|NCT00744874|18122644|P1|Overall Study|Withdrawal by Subject|1
5251953|NCT00744874|18122644|P1|Overall Study|Lost to Follow-up|1
5251954|NCT00744757|18122669|P1|Overall Study|Adverse Event|2
5251955|NCT00744757|18122669|P1|Overall Study|Death|6
5251956|NCT00744757|18122669|P1|Overall Study|Withdrawal by Subject|1
5251957|NCT00744757|18122669|P1|Overall Study|Physician Decision|5
5251958|NCT00744757|18122669|P1|Overall Study|Objective disease progression|7
5251959|NCT00744653|18122694|P1|Overall Study|Physician Decision|3
5251960|NCT00744653|18122694|P1|Overall Study|Lost to Follow-up|1
5251961|NCT00744653|18122694|P1|Overall Study|Death|1
5251962|NCT00744653|18122694|P1|Overall Study|antineoplastic treatment|11
5251963|NCT00744627|18122702|P2|Overall Study|Other|0
5251964|NCT00744627|18122703|P1|Overall Study|Other|1
5251965|NCT00744627|18122702|P2|Overall Study|Lost to Follow-up|1
5251966|NCT00744627|18122703|P1|Overall Study|Lost to Follow-up|2
5251967|NCT00744627|18122702|P2|Overall Study|Voluntary Withdrawal|6
5251968|NCT00744627|18122703|P1|Overall Study|Voluntary Withdrawal|9
5251969|NCT00744627|18122702|P2|Overall Study|Protocol Deviations|2
5251970|NCT00744627|18122703|P1|Overall Study|Protocol Deviations|0
5251971|NCT00744627|18122702|P2|Overall Study|Noncompliance|1
5251972|NCT00744627|18122703|P1|Overall Study|Noncompliance|0
5251973|NCT00744627|18122702|P2|Overall Study|Lack of Efficacy|3
5251974|NCT00744627|18122703|P1|Overall Study|Lack of Efficacy|7
5251975|NCT00744627|18122702|P2|Overall Study|Adverse Event|9
5251976|NCT00744627|18122703|P1|Overall Study|Adverse Event|6
5251977|NCT00744523|18122759|P2|30 Days After the Procedure|Insufficient follow-up|5
5251978|NCT00744523|18122760|P1|30 Days After the Procedure|Insufficient follow-up|0
5251979|NCT00744497|18122780|P2|Overall Study|Not defined|13
5251980|NCT00744497|18122781|P1|Overall Study|Not defined|19
5251981|NCT00744497|18122780|P2|Overall Study|Maximum clinical benefit|142
5251982|NCT00744497|18122781|P1|Overall Study|Maximum clinical benefit|141
5251983|NCT00744497|18122780|P2|Overall Study|Patient requested to stop study drug|80
5251984|NCT00744497|18122781|P1|Overall Study|Patient requested to stop study drug|65
5251985|NCT00744497|18122780|P2|Overall Study|Adverse event unrelated to study drug|122
5251986|NCT00744497|18122781|P1|Overall Study|Adverse event unrelated to study drug|78
5251987|NCT00744497|18122780|P2|Overall Study|Study drug toxicity|141
5251988|NCT00744497|18122781|P1|Overall Study|Study drug toxicity|68
5251989|NCT00744497|18122780|P2|Overall Study|Disease progression|219
5251990|NCT00744497|18122781|P1|Overall Study|Disease progression|312
5251991|NCT00744497|18122780|P2|Overall Study|Administrative Reason By Sponsor|8
5251992|NCT00744497|18122781|P1|Overall Study|Administrative Reason By Sponsor|25
5251993|NCT00744497|18122780|P2|Overall Study|No longer meets study criteria|3
5251994|NCT00744497|18122781|P1|Overall Study|No longer meets study criteria|7
5251995|NCT00744497|18122780|P2|Overall Study|Poor compliance/noncompliance|5
5251996|NCT00744497|18122781|P1|Overall Study|Poor compliance/noncompliance|9
5251997|NCT00744497|18122780|P2|Overall Study|Lost to Follow-up|2
5251998|NCT00744497|18122781|P1|Overall Study|Lost to Follow-up|4
5251999|NCT00744497|18122780|P2|Overall Study|Death|9
5252000|NCT00744497|18122781|P1|Overall Study|Death|11
5252001|NCT00744497|18122780|P2|Overall Study|Withdrawal by Subject|18
5252002|NCT00744497|18122781|P1|Overall Study|Withdrawal by Subject|21
5252003|NCT00744328|18122841|P3|Overall Study|Found ineligible after randomization|1
5252004|NCT00744328|18122842|P2|Overall Study|Found ineligible after randomization|0
5252005|NCT00744328|18122843|P1|Overall Study|Found ineligible after randomization|0
5252006|NCT00744328|18122841|P3|Overall Study|Withdrawal by Subject|4
5252007|NCT00744328|18122842|P2|Overall Study|Withdrawal by Subject|3
5252008|NCT00744328|18122843|P1|Overall Study|Withdrawal by Subject|5
5252009|NCT00744328|18122841|P3|Overall Study|Lost to Follow-up|3
5252010|NCT00744328|18122842|P2|Overall Study|Lost to Follow-up|5
5252011|NCT00744328|18122843|P1|Overall Study|Lost to Follow-up|2
5252012|NCT00744263|18122856|P2|Overall Study|Other|2
5252013|NCT00744263|18122857|P1|Overall Study|Other|2
5252014|NCT00744263|18122856|P2|Overall Study|Adverse Event|0
5252015|NCT00744263|18122857|P1|Overall Study|Adverse Event|1
5252016|NCT00744263|18122856|P2|Overall Study|Protocol Violation|5
5252017|NCT00744263|18122857|P1|Overall Study|Protocol Violation|3
5252018|NCT00744263|18122856|P2|Overall Study|Physician Decision|23
5252019|NCT00744263|18122857|P1|Overall Study|Physician Decision|20
5252020|NCT00744263|18122856|P2|Overall Study|Withdrawal by Subject|150
5252021|NCT00744263|18122857|P1|Overall Study|Withdrawal by Subject|166
5252022|NCT00744263|18122856|P2|Overall Study|Lost to Follow-up|2135
5252023|NCT00744263|18122857|P1|Overall Study|Lost to Follow-up|2038
5252024|NCT00744263|18122856|P2|Overall Study|Death|3005
5252025|NCT00744263|18122857|P1|Overall Study|Death|3006
5252026|NCT00744237|18122880|P3|Overall Study|Adverse Event|5
5252027|NCT00744237|18122881|P2|Overall Study|Adverse Event|13
5252028|NCT00744237|18122882|P1|Overall Study|Adverse Event|9
5252029|NCT00744237|18122880|P3|Overall Study|Administrative. Site Closed|1
5252030|NCT00744237|18122881|P2|Overall Study|Administrative. Site Closed|1
5252031|NCT00744237|18122882|P1|Overall Study|Administrative. Site Closed|1
5252032|NCT00744237|18122880|P3|Overall Study|Poor Compliance|0
5252033|NCT00744237|18122881|P2|Overall Study|Poor Compliance|2
5252034|NCT00744237|18122882|P1|Overall Study|Poor Compliance|0
5252035|NCT00744237|18122880|P3|Overall Study|Prohibited Concomitant Medication|1
5252036|NCT00744237|18122881|P2|Overall Study|Prohibited Concomitant Medication|0
5252037|NCT00744237|18122882|P1|Overall Study|Prohibited Concomitant Medication|0
5252038|NCT00744237|18122880|P3|Overall Study|Study Drug Error|0
5252039|NCT00744237|18122881|P2|Overall Study|Study Drug Error|0
5252040|NCT00744237|18122882|P1|Overall Study|Study Drug Error|1
5252041|NCT00744237|18122880|P3|Overall Study|Dosing Error|1
5252042|NCT00744237|18122881|P2|Overall Study|Dosing Error|0
5252043|NCT00744237|18122882|P1|Overall Study|Dosing Error|1
5252044|NCT00744237|18122880|P3|Overall Study|Inclusion/Exclusion criteria not met|0
5252045|NCT00744237|18122881|P2|Overall Study|Inclusion/Exclusion criteria not met|0
5252046|NCT00744237|18122882|P1|Overall Study|Inclusion/Exclusion criteria not met|1
5252047|NCT00744237|18122880|P3|Overall Study|Protocol Violation|3
5252048|NCT00744237|18122881|P2|Overall Study|Protocol Violation|4
5252049|NCT00744237|18122882|P1|Overall Study|Protocol Violation|3
5252050|NCT00744237|18122880|P3|Overall Study|Lost to Follow-up|1
5252051|NCT00744237|18122881|P2|Overall Study|Lost to Follow-up|1
5252052|NCT00744237|18122882|P1|Overall Study|Lost to Follow-up|1
5252053|NCT00744237|18122880|P3|Overall Study|Withdrawal by Subject|3
5252054|NCT00744237|18122881|P2|Overall Study|Withdrawal by Subject|5
5252055|NCT00744237|18122882|P1|Overall Study|Withdrawal by Subject|9
5252056|NCT00744237|18122880|P3|Overall Study|Lack of Efficacy|0
5252057|NCT00744237|18122881|P2|Overall Study|Lack of Efficacy|1
5252058|NCT00744237|18122882|P1|Overall Study|Lack of Efficacy|1
5252059|NCT00744055|18122916|P2|Overall Study|Lost to Follow-up|1
5252060|NCT00744055|18122917|P1|Overall Study|Lost to Follow-up|0
5252061|NCT00744055|18122916|P2|Overall Study|Protocol Violation|1
5252062|NCT00744055|18122917|P1|Overall Study|Protocol Violation|1
5252063|NCT00744055|18122916|P2|Overall Study|Physician Decision|2
5252064|NCT00744055|18122917|P1|Overall Study|Physician Decision|0
5252065|NCT00744055|18122916|P2|Overall Study|Lack of Efficacy|1
5252066|NCT00744055|18122917|P1|Overall Study|Lack of Efficacy|0
5252067|NCT00744055|18122916|P2|Overall Study|Withdrawal by Subject|9
5252068|NCT00744055|18122917|P1|Overall Study|Withdrawal by Subject|6
5252069|NCT00744042|18122925|P1|Overall Study|Withdrawal by Subject|1
5252070|NCT00743652|18122971|P5|Overall Study|Lost to Follow-up|0
5252071|NCT00743652|18122972|P4|Overall Study|Lost to Follow-up|0
5252072|NCT00743652|18122973|P3|Overall Study|Lost to Follow-up|0
5252073|NCT00743652|18122974|P2|Overall Study|Lost to Follow-up|0
5252074|NCT00743652|18122975|P1|Overall Study|Lost to Follow-up|1
5252075|NCT00743652|18122971|P5|Overall Study|Other|0
5252076|NCT00743652|18122972|P4|Overall Study|Other|0
5252077|NCT00743652|18122973|P3|Overall Study|Other|0
5252078|NCT00743652|18122974|P2|Overall Study|Other|1
5252079|NCT00743652|18122975|P1|Overall Study|Other|1
5252080|NCT00743652|18122971|P5|Overall Study|Investigator Request|0
5252081|NCT00743652|18122972|P4|Overall Study|Investigator Request|2
5252082|NCT00743652|18122973|P3|Overall Study|Investigator Request|0
5252083|NCT00743652|18122974|P2|Overall Study|Investigator Request|0
5252084|NCT00743652|18122975|P1|Overall Study|Investigator Request|0
5252085|NCT00743652|18122971|P5|Overall Study|Death|0
5252086|NCT00743652|18122972|P4|Overall Study|Death|0
5252087|NCT00743652|18122973|P3|Overall Study|Death|0
5252088|NCT00743652|18122974|P2|Overall Study|Death|0
5252089|NCT00743652|18122975|P1|Overall Study|Death|2
5252090|NCT00743652|18122971|P5|Overall Study|Adverse Event|0
5252091|NCT00743652|18122972|P4|Overall Study|Adverse Event|0
5252092|NCT00743652|18122973|P3|Overall Study|Adverse Event|0
5252093|NCT00743652|18122974|P2|Overall Study|Adverse Event|0
5252094|NCT00743652|18122975|P1|Overall Study|Adverse Event|3
5252095|NCT00743652|18122971|P5|Overall Study|Parent/Legal Guardian Request|0
5252096|NCT00743652|18122972|P4|Overall Study|Parent/Legal Guardian Request|2
5252097|NCT00743652|18122973|P3|Overall Study|Parent/Legal Guardian Request|2
5252098|NCT00743652|18122974|P2|Overall Study|Parent/Legal Guardian Request|2
5252099|NCT00743652|18122975|P1|Overall Study|Parent/Legal Guardian Request|3
5252100|NCT00743509|18123059|P1|Overall Study|Withdrawal by Subject|2
5252101|NCT00743483|18123064|P1|Treatment Period|Adverse Event|1
5252102|NCT00743483|18123064|P1|Baseline Period|Physician Decision|1
5252103|NCT00743444|18123068|P2|Washout Period|Adverse Event|1
5252104|NCT00743444|18123069|P1|Washout Period|Adverse Event|0
5252105|NCT00743444|18123068|P2|First Intervention|Catheter placement problems|1
5252106|NCT00743444|18123069|P1|First Intervention|Catheter placement problems|0
5252107|NCT00743431|18123078|P1|Overall Study|No documentation available|13
5252108|NCT00743431|18123078|P1|Overall Study|Reason for discontinuation not specified|29
5252109|NCT00743431|18123078|P1|Overall Study|Death|9
5252110|NCT00743431|18123078|P1|Overall Study|Withdrawal by Subject|13
5252111|NCT00743431|18123078|P1|Overall Study|Tumor progression|56
5252112|NCT00743431|18123078|P1|Overall Study|Toxicity|6
5252113|NCT00743366|18123082|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
5252114|NCT00743366|18123083|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
5252115|NCT00743340|18123089|P1|Overall Study|Participant Relocated|1
5252116|NCT00743340|18123089|P1|Overall Study|Rolled over to other Gilead Study|23
5252117|NCT00743340|18123089|P1|Overall Study|Pregnancy|1
5252118|NCT00743340|18123089|P1|Overall Study|Virologic failure|8
5252119|NCT00743340|18123089|P1|Overall Study|Protocol Violation|1
5252120|NCT00743340|18123089|P1|Overall Study|Withdrawal from the Study|5
5252121|NCT00743340|18123089|P1|Overall Study|Lost to Follow-up|1
5252122|NCT00743340|18123089|P1|Overall Study|Study medication non-compliance|1
5252123|NCT00743288|18123093|P7|Overall Study|Worsening of condition (Not PD)|0
5252124|NCT00743288|18123094|P6|Overall Study|Worsening of condition (Not PD)|0
5252125|NCT00743288|18123095|P5|Overall Study|Worsening of condition (Not PD)|0
5252126|NCT00743288|18123096|P4|Overall Study|Worsening of condition (Not PD)|1
5252127|NCT00743288|18123097|P3|Overall Study|Worsening of condition (Not PD)|1
5252128|NCT00743288|18123098|P2|Overall Study|Worsening of condition (Not PD)|2
5252129|NCT00743288|18123099|P1|Overall Study|Worsening of condition (Not PD)|0
5252130|NCT00743288|18123093|P7|Overall Study|Progressive disease (PD)|6
5252131|NCT00743288|18123094|P6|Overall Study|Progressive disease (PD)|3
5252132|NCT00743288|18123095|P5|Overall Study|Progressive disease (PD)|5
5252133|NCT00743288|18123096|P4|Overall Study|Progressive disease (PD)|4
5252134|NCT00743288|18123097|P3|Overall Study|Progressive disease (PD)|1
5252135|NCT00743288|18123098|P2|Overall Study|Progressive disease (PD)|0
5252136|NCT00743288|18123099|P1|Overall Study|Progressive disease (PD)|2
5252137|NCT00743288|18123093|P7|Overall Study|Withdrawal by Subject|1
5252138|NCT00743288|18123094|P6|Overall Study|Withdrawal by Subject|1
5252139|NCT00743288|18123095|P5|Overall Study|Withdrawal by Subject|0
5252140|NCT00743288|18123096|P4|Overall Study|Withdrawal by Subject|0
5252141|NCT00743288|18123097|P3|Overall Study|Withdrawal by Subject|1
5252142|NCT00743288|18123098|P2|Overall Study|Withdrawal by Subject|0
5252143|NCT00743288|18123099|P1|Overall Study|Withdrawal by Subject|0
5252144|NCT00743288|18123093|P7|Overall Study|Adverse Event|2
5252145|NCT00743288|18123094|P6|Overall Study|Adverse Event|1
5252146|NCT00743288|18123095|P5|Overall Study|Adverse Event|1
5252147|NCT00743288|18123096|P4|Overall Study|Adverse Event|2
5252148|NCT00743288|18123097|P3|Overall Study|Adverse Event|2
5252149|NCT00743288|18123098|P2|Overall Study|Adverse Event|1
5252150|NCT00743288|18123099|P1|Overall Study|Adverse Event|1
5252151|NCT00743275|18123113|P2|Overall Study|Protocol Violation|1
5252152|NCT00743275|18123114|P1|Overall Study|Protocol Violation|0
5252153|NCT00743249|18123134|P2|Overall Study|Unsuccessful insertion of stent|1
5252154|NCT00743249|18123135|P1|Overall Study|Unsuccessful insertion of stent|2
5252155|NCT00743249|18123134|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
5252156|NCT00743249|18123135|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
5252157|NCT00743249|18123134|P2|Overall Study|Adverse Event|4
5252158|NCT00743249|18123135|P1|Overall Study|Adverse Event|0
5252159|NCT00743197|18123145|P2|Overall Study|Study terminated due to departure of PI.|2
5252160|NCT00743197|18123146|P1|Overall Study|Study terminated due to departure of PI.|1
5252161|NCT00743145|18123152|P1|Overall Study|Pregnancy|1
5252162|NCT00743145|18123152|P1|Overall Study|Adverse Event|2
5252163|NCT00743145|18123152|P1|Overall Study|Withdrawal by Subject|1
5252164|NCT00743119|18123166|P1|Overall Study|Withdrawal by Subject|1
5252165|NCT00743119|18123166|P1|Overall Study|unreliable|3
5252166|NCT00743106|18123180|P2|Overall Study|Met intraoperative exclusion criterion|5
5252167|NCT00743106|18123181|P1|Overall Study|Met intraoperative exclusion criterion|8
5252168|NCT00742924|18123208|P4|Overall Study|Withdrawal by Subject|0
5252169|NCT00742924|18123209|P3|Overall Study|Withdrawal by Subject|1
5252170|NCT00742924|18123210|P2|Overall Study|Withdrawal by Subject|1
5252171|NCT00742924|18123211|P1|Overall Study|Withdrawal by Subject|0
5252172|NCT00742924|18123208|P4|Overall Study|Physician Decision|1
5252173|NCT00742924|18123209|P3|Overall Study|Physician Decision|0
5252174|NCT00742924|18123210|P2|Overall Study|Physician Decision|0
5252175|NCT00742924|18123211|P1|Overall Study|Physician Decision|0
5252176|NCT00742924|18123208|P4|Overall Study|Lack of Efficacy|4
5252177|NCT00742924|18123209|P3|Overall Study|Lack of Efficacy|2
5252178|NCT00742924|18123210|P2|Overall Study|Lack of Efficacy|1
5252179|NCT00742924|18123211|P1|Overall Study|Lack of Efficacy|5
5252180|NCT00742924|18123208|P4|Overall Study|Adverse Event|1
5252181|NCT00742924|18123209|P3|Overall Study|Adverse Event|1
5252182|NCT00742924|18123210|P2|Overall Study|Adverse Event|0
5252183|NCT00742924|18123211|P1|Overall Study|Adverse Event|0
5252184|NCT00742885|18123223|P2|Overall Study|Lost to Follow-up|0
5252185|NCT00742885|18123224|P1|Overall Study|Lost to Follow-up|1
5252186|NCT00742859|18123283|P4|Overall Study|Site error|1
5252187|NCT00742859|18123284|P3|Overall Study|Site error|1
5252188|NCT00742859|18123285|P2|Overall Study|Site error|0
5252189|NCT00742859|18123286|P1|Overall Study|Site error|0
5252190|NCT00742859|18123283|P4|Overall Study|Sponsor request patient out of town|1
5252191|NCT00742859|18123284|P3|Overall Study|Sponsor request patient out of town|1
5252192|NCT00742859|18123285|P2|Overall Study|Sponsor request patient out of town|0
5252193|NCT00742859|18123286|P1|Overall Study|Sponsor request patient out of town|0
5252194|NCT00742859|18123283|P4|Overall Study|Sponsor req visit schedule noncompliance|1
5252195|NCT00742859|18123284|P3|Overall Study|Sponsor req visit schedule noncompliance|0
5252196|NCT00742859|18123285|P2|Overall Study|Sponsor req visit schedule noncompliance|0
5252197|NCT00742859|18123286|P1|Overall Study|Sponsor req visit schedule noncompliance|0
5252198|NCT00742859|18123283|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
5252199|NCT00742859|18123284|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
5252200|NCT00742859|18123285|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
5252201|NCT00742859|18123286|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
5252202|NCT00742859|18123283|P4|Overall Study|Endpoint|2
5252203|NCT00742859|18123284|P3|Overall Study|Endpoint|1
5252204|NCT00742859|18123285|P2|Overall Study|Endpoint|1
5252205|NCT00742859|18123286|P1|Overall Study|Endpoint|0
5252206|NCT00742859|18123283|P4|Overall Study|Withdrawal by Subject|1
5252207|NCT00742859|18123284|P3|Overall Study|Withdrawal by Subject|4
5252208|NCT00742859|18123285|P2|Overall Study|Withdrawal by Subject|2
5252209|NCT00742859|18123286|P1|Overall Study|Withdrawal by Subject|4
5252210|NCT00742859|18123283|P4|Overall Study|Physician Decision|0
5252211|NCT00742859|18123284|P3|Overall Study|Physician Decision|0
5252212|NCT00742859|18123285|P2|Overall Study|Physician Decision|2
5252213|NCT00742859|18123286|P1|Overall Study|Physician Decision|1
5252214|NCT00742859|18123283|P4|Overall Study|Death|1
5252215|NCT00742859|18123284|P3|Overall Study|Death|0
5252216|NCT00742859|18123285|P2|Overall Study|Death|0
5252217|NCT00742859|18123286|P1|Overall Study|Death|1
5252218|NCT00742859|18123283|P4|Overall Study|Adverse Event|1
5252219|NCT00742859|18123284|P3|Overall Study|Adverse Event|3
5252220|NCT00742859|18123285|P2|Overall Study|Adverse Event|6
5252221|NCT00742859|18123286|P1|Overall Study|Adverse Event|5
5252222|NCT00742781|18123300|P1|Overall Study|Withdrawal by Subject|3
5252223|NCT00742625|18123309|P1|Consolidation|Non protocol therapy|13
5252224|NCT00742625|18123309|P1|Consolidation|Refused|1
5252225|NCT00742625|18123309|P1|Consolidation|Death|1
5252226|NCT00742625|18123309|P1|Consolidation|Adverse Event|1
5252227|NCT00742625|18123309|P1|Consolidation|Progression|5
5252228|NCT00742625|18123309|P1|Remission Induction|Other, not specified|5
5252229|NCT00742625|18123309|P1|Remission Induction|Non protocol treatment|17
5252230|NCT00742625|18123309|P1|Remission Induction|Refusal|5
5252231|NCT00742625|18123309|P1|Remission Induction|Death|10
5252232|NCT00742625|18123309|P1|Remission Induction|Adverse Event|3
5252233|NCT00742625|18123309|P1|Remission Induction|Failed induction|8
5252234|NCT00742625|18123309|P1|Remission Induction|Progression|6
5252235|NCT00742560|18123334|P5|Overall Study|MIssing|1
5252236|NCT00742560|18123335|P4|Overall Study|MIssing|0
5252237|NCT00742560|18123336|P3|Overall Study|MIssing|0
5252238|NCT00742560|18123337|P2|Overall Study|MIssing|0
5252239|NCT00742560|18123338|P1|Overall Study|MIssing|0
5252240|NCT00742560|18123334|P5|Overall Study|Other|9
5252241|NCT00742560|18123335|P4|Overall Study|Other|9
5252242|NCT00742560|18123336|P3|Overall Study|Other|8
5252243|NCT00742560|18123337|P2|Overall Study|Other|1
5252244|NCT00742560|18123338|P1|Overall Study|Other|0
5252245|NCT00742560|18123334|P5|Overall Study|New Multiple Myeloma Therapy|4
5252246|NCT00742560|18123335|P4|Overall Study|New Multiple Myeloma Therapy|3
5252247|NCT00742560|18123336|P3|Overall Study|New Multiple Myeloma Therapy|2
5252248|NCT00742560|18123337|P2|Overall Study|New Multiple Myeloma Therapy|0
5252249|NCT00742560|18123338|P1|Overall Study|New Multiple Myeloma Therapy|1
5252250|NCT00742560|18123334|P5|Overall Study|Disease Progression|16
5252251|NCT00742560|18123335|P4|Overall Study|Disease Progression|17
5252252|NCT00742560|18123336|P3|Overall Study|Disease Progression|5
5252253|NCT00742560|18123337|P2|Overall Study|Disease Progression|0
5252254|NCT00742560|18123338|P1|Overall Study|Disease Progression|1
5252255|NCT00742560|18123334|P5|Overall Study|Investigator's Decision|0
5252256|NCT00742560|18123335|P4|Overall Study|Investigator's Decision|1
5252257|NCT00742560|18123336|P3|Overall Study|Investigator's Decision|4
5252258|NCT00742560|18123337|P2|Overall Study|Investigator's Decision|0
5252259|NCT00742560|18123338|P1|Overall Study|Investigator's Decision|0
5252260|NCT00742560|18123334|P5|Overall Study|Subject's Decision|3
5252261|NCT00742560|18123335|P4|Overall Study|Subject's Decision|3
5252262|NCT00742560|18123336|P3|Overall Study|Subject's Decision|2
5252263|NCT00742560|18123337|P2|Overall Study|Subject's Decision|0
5252264|NCT00742560|18123338|P1|Overall Study|Subject's Decision|1
5252265|NCT00742560|18123334|P5|Overall Study|Death|3
5252266|NCT00742560|18123335|P4|Overall Study|Death|2
5252267|NCT00742560|18123336|P3|Overall Study|Death|0
5252268|NCT00742560|18123337|P2|Overall Study|Death|2
5252269|NCT00742560|18123338|P1|Overall Study|Death|0
5252270|NCT00742560|18123334|P5|Overall Study|Adverse Event|1
5252271|NCT00742560|18123335|P4|Overall Study|Adverse Event|1
5252272|NCT00742560|18123336|P3|Overall Study|Adverse Event|1
5252273|NCT00742560|18123337|P2|Overall Study|Adverse Event|0
5252274|NCT00742560|18123338|P1|Overall Study|Adverse Event|0
5252275|NCT00742508|18123412|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
5252276|NCT00742508|18123413|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
5252277|NCT00742508|18123412|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
5252278|NCT00742508|18123413|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
5252279|NCT00742508|18123412|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
5252280|NCT00742508|18123413|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
5252281|NCT00742508|18123412|P2|8-Week Primary Evaluation Period|Protocol Violation|0
5252282|NCT00742508|18123413|P1|8-Week Primary Evaluation Period|Protocol Violation|1
5252283|NCT00742508|18123412|P2|8-Week Primary Evaluation Period|Adverse Event|4
5252284|NCT00742508|18123413|P1|8-Week Primary Evaluation Period|Adverse Event|2
5252285|NCT00742417|18123486|P2|Intensive Period|Adverse Event|0
5252286|NCT00742417|18123487|P1|Intensive Period|Adverse Event|2
5252287|NCT00742417|18123486|P2|Intensive Period|Withdrawal by Subject|1
5252288|NCT00742417|18123487|P1|Intensive Period|Withdrawal by Subject|1
5252289|NCT00742417|18123486|P2|Randomized|Physician Decision|0
5252290|NCT00742417|18123487|P1|Randomized|Physician Decision|1
5252291|NCT00742417|18123486|P2|Randomized|Withdrawal by Subject|0
5252292|NCT00742417|18123487|P1|Randomized|Withdrawal by Subject|1
5252293|NCT00742417|18123486|P2|Randomized|Withdrawal by legal representative|1
5252294|NCT00742417|18123487|P1|Randomized|Withdrawal by legal representative|0
5252295|NCT00742391|18123511|P2|Overall Study|Protocol Violation|0
5252296|NCT00742391|18123512|P1|Overall Study|Protocol Violation|1
5252297|NCT00742391|18123511|P2|Overall Study|Lost to Follow-up|0
5252298|NCT00742391|18123512|P1|Overall Study|Lost to Follow-up|1
5252299|NCT00742391|18123511|P2|Overall Study|Adverse Event|1
5252300|NCT00742391|18123512|P1|Overall Study|Adverse Event|2
5252301|NCT00742326|18123522|P2|Overall Study|Physician Decision|1
5252302|NCT00742326|18123523|P1|Overall Study|Physician Decision|0
5252303|NCT00742274|18123542|P2|Overall Study|Removed for medical reasons|1
5252304|NCT00742274|18123543|P1|Overall Study|Removed for medical reasons|1
5252305|NCT00742274|18123542|P2|Overall Study|Withdrawal by Subject|2
5252306|NCT00742274|18123543|P1|Overall Study|Withdrawal by Subject|1
5252307|NCT00742274|18123542|P2|Overall Study|Death|0
5252308|NCT00742274|18123543|P1|Overall Study|Death|1
5252309|NCT00742235|18123551|P2|Overall Study|Lost to Follow-up|31
5252310|NCT00742235|18123552|P1|Overall Study|Lost to Follow-up|0
5252311|NCT00742209|18123565|P5|Overall Study|Investigator Discretion|1
5252312|NCT00742209|18123566|P4|Overall Study|Investigator Discretion|1
5252313|NCT00742209|18123567|P3|Overall Study|Investigator Discretion|5
5252314|NCT00742209|18123568|P2|Overall Study|Investigator Discretion|0
5252315|NCT00742209|18123569|P1|Overall Study|Investigator Discretion|0
5252316|NCT00742209|18123565|P5|Overall Study|Lack of Efficacy|1
5252317|NCT00742209|18123566|P4|Overall Study|Lack of Efficacy|3
5252318|NCT00742209|18123567|P3|Overall Study|Lack of Efficacy|1
5252319|NCT00742209|18123568|P2|Overall Study|Lack of Efficacy|1
5252320|NCT00742209|18123569|P1|Overall Study|Lack of Efficacy|6
5252321|NCT00742209|18123565|P5|Overall Study|Lost to Follow-up|3
5252322|NCT00742209|18123566|P4|Overall Study|Lost to Follow-up|5
5252323|NCT00742209|18123567|P3|Overall Study|Lost to Follow-up|5
5252324|NCT00742209|18123568|P2|Overall Study|Lost to Follow-up|4
5252325|NCT00742209|18123569|P1|Overall Study|Lost to Follow-up|3
5252326|NCT00742209|18123565|P5|Overall Study|Protocol Violation|3
5252327|NCT00742209|18123566|P4|Overall Study|Protocol Violation|5
5252328|NCT00742209|18123567|P3|Overall Study|Protocol Violation|4
5252329|NCT00742209|18123568|P2|Overall Study|Protocol Violation|5
5252330|NCT00742209|18123569|P1|Overall Study|Protocol Violation|6
5252331|NCT00742209|18123565|P5|Overall Study|Participant Withdrew Consent|4
5252332|NCT00742209|18123566|P4|Overall Study|Participant Withdrew Consent|7
5252333|NCT00742209|18123567|P3|Overall Study|Participant Withdrew Consent|14
5252334|NCT00742209|18123568|P2|Overall Study|Participant Withdrew Consent|4
5252335|NCT00742209|18123569|P1|Overall Study|Participant Withdrew Consent|8
5252336|NCT00742209|18123565|P5|Overall Study|Adverse Event|13
5252337|NCT00742209|18123566|P4|Overall Study|Adverse Event|16
5252338|NCT00742209|18123567|P3|Overall Study|Adverse Event|17
5252339|NCT00742209|18123568|P2|Overall Study|Adverse Event|4
5252340|NCT00742209|18123569|P1|Overall Study|Adverse Event|11
5252341|NCT00742183|18123672|P2|Overall Study|Lack of Efficacy|3
5252342|NCT00742183|18123673|P1|Overall Study|Lack of Efficacy|0
5252343|NCT00742183|18123672|P2|Overall Study|Withdrawal by Subject|0
5252344|NCT00742183|18123673|P1|Overall Study|Withdrawal by Subject|1
5252345|NCT00742183|18123672|P2|Overall Study|Required skin-graft|1
5252346|NCT00742183|18123673|P1|Overall Study|Required skin-graft|1
5252347|NCT00742183|18123672|P2|Overall Study|Lost to Follow-up|4
5252348|NCT00742183|18123673|P1|Overall Study|Lost to Follow-up|4
5252349|NCT00742183|18123672|P2|Overall Study|Physician Decision|2
5252350|NCT00742183|18123673|P1|Overall Study|Physician Decision|0
5252351|NCT00742183|18123672|P2|Overall Study|Death|0
5252352|NCT00742183|18123673|P1|Overall Study|Death|1
5252353|NCT00742183|18123672|P2|Overall Study|Adverse Event|2
5252354|NCT00742183|18123673|P1|Overall Study|Adverse Event|2
5252355|NCT00742079|18123692|P2|Overall Study|Lost to Follow-up|1
5252356|NCT00742079|18123693|P1|Overall Study|Lost to Follow-up|0
5252357|NCT00742001|18123714|P3|Overall Study|Withdrawn; health exclusion (flu)|1
5252358|NCT00742001|18123715|P2|Overall Study|Withdrawn; health exclusion (flu)|0
5252359|NCT00742001|18123716|P1|Overall Study|Withdrawn; health exclusion (flu)|0
5252360|NCT00741988|18123732|P2|Overall Study|Lack of Efficacy|0
5252361|NCT00741988|18123733|P1|Overall Study|Lack of Efficacy|2
5252362|NCT00741988|18123732|P2|Overall Study|Adverse Event|4
5252363|NCT00741988|18123733|P1|Overall Study|Adverse Event|2
5252364|NCT00741936|18123745|P2|Overall Study|Low compliance|0
5252365|NCT00741936|18123746|P1|Overall Study|Low compliance|3
5252366|NCT00741936|18123745|P2|Overall Study|Lack of Efficacy|2
5252367|NCT00741936|18123746|P1|Overall Study|Lack of Efficacy|0
5252368|NCT00741936|18123745|P2|Overall Study|Protocol Violation|0
5252369|NCT00741936|18123746|P1|Overall Study|Protocol Violation|2
5252370|NCT00741936|18123745|P2|Overall Study|Pregnancy|1
5252371|NCT00741936|18123746|P1|Overall Study|Pregnancy|0
5252372|NCT00741936|18123745|P2|Overall Study|Adverse Event|4
5252373|NCT00741936|18123746|P1|Overall Study|Adverse Event|3
5252374|NCT00741936|18123745|P2|Overall Study|Lost to Follow-up|1
5252375|NCT00741936|18123746|P1|Overall Study|Lost to Follow-up|1
5252376|NCT00741819|18123781|P1|Overall Study|Disease progression|1
5252377|NCT00741819|18123781|P1|Overall Study|Death|1
5252378|NCT00741819|18123781|P1|Overall Study|Withdrawal by Subject|3
5252379|NCT00741819|18123781|P1|Overall Study|Adverse Event|3
5252380|NCT00741611|18123795|P3|Overall Study|Withdrawal by Subject|2
5252381|NCT00741611|18123796|P2|Overall Study|Withdrawal by Subject|2
5252382|NCT00741611|18123797|P1|Overall Study|Withdrawal by Subject|0
5252383|NCT00741611|18123795|P3|Overall Study|Death|1
5252384|NCT00741611|18123796|P2|Overall Study|Death|0
5252385|NCT00741611|18123797|P1|Overall Study|Death|0
5252386|NCT00741598|18123816|P2|Overall Study|Withdrawal by Subject|2
5252387|NCT00741598|18123817|P1|Overall Study|Withdrawal by Subject|3
5252388|NCT00741598|18123816|P2|Overall Study|Pregnancy|0
5252389|NCT00741598|18123817|P1|Overall Study|Pregnancy|1
5252390|NCT00741598|18123816|P2|Overall Study|Physician Decision|1
5252391|NCT00741598|18123817|P1|Overall Study|Physician Decision|1
5252392|NCT00741598|18123816|P2|Overall Study|Lack of Efficacy|2
5252393|NCT00741598|18123817|P1|Overall Study|Lack of Efficacy|1
5252394|NCT00741598|18123816|P2|Overall Study|Lost to Follow-up|4
5252395|NCT00741598|18123817|P1|Overall Study|Lost to Follow-up|3
5252396|NCT00741338|18123872|P2|Overall Study|Adverse Event|1
5252397|NCT00741338|18123873|P1|Overall Study|Adverse Event|0
5252398|NCT00741286|18123883|P2|Overall Study|Primary Outcome|1
5252399|NCT00741286|18123884|P1|Overall Study|Primary Outcome|1
5252400|NCT00741286|18123883|P2|Overall Study|Protocol Violation|2
5252401|NCT00741286|18123884|P1|Overall Study|Protocol Violation|3
5252402|NCT00741286|18123883|P2|Overall Study|Adverse Event|6
5252403|NCT00741286|18123884|P1|Overall Study|Adverse Event|1
5252404|NCT00741286|18123883|P2|Overall Study|Lost to Follow-up|10
5252405|NCT00741286|18123884|P1|Overall Study|Lost to Follow-up|15
5252406|NCT00741260|18123918|P7|Overall Study|Other|1
5252407|NCT00741260|18123919|P6|Overall Study|Other|3
5252408|NCT00741260|18123920|P5|Overall Study|Other|1
5252409|NCT00741260|18123921|P4|Overall Study|Other|2
5252410|NCT00741260|18123922|P3|Overall Study|Other|1
5252411|NCT00741260|18123923|P2|Overall Study|Other|1
5252412|NCT00741260|18123924|P1|Overall Study|Other|2
5252413|NCT00741260|18123918|P7|Overall Study|Physician Decision|0
5252414|NCT00741260|18123919|P6|Overall Study|Physician Decision|0
5252415|NCT00741260|18123920|P5|Overall Study|Physician Decision|0
5252416|NCT00741260|18123921|P4|Overall Study|Physician Decision|0
5252417|NCT00741260|18123922|P3|Overall Study|Physician Decision|0
5252418|NCT00741260|18123923|P2|Overall Study|Physician Decision|1
5252419|NCT00741260|18123924|P1|Overall Study|Physician Decision|1
5252420|NCT00741260|18123918|P7|Overall Study|Withdrawal by Subject|1
5252421|NCT00741260|18123919|P6|Overall Study|Withdrawal by Subject|3
5252422|NCT00741260|18123920|P5|Overall Study|Withdrawal by Subject|1
5252423|NCT00741260|18123921|P4|Overall Study|Withdrawal by Subject|0
5252424|NCT00741260|18123922|P3|Overall Study|Withdrawal by Subject|0
5252425|NCT00741260|18123923|P2|Overall Study|Withdrawal by Subject|0
5252426|NCT00741260|18123924|P1|Overall Study|Withdrawal by Subject|0
5252427|NCT00741260|18123918|P7|Overall Study|Death|1
5252428|NCT00741260|18123919|P6|Overall Study|Death|2
5252429|NCT00741260|18123920|P5|Overall Study|Death|2
5252430|NCT00741260|18123921|P4|Overall Study|Death|1
5252431|NCT00741260|18123922|P3|Overall Study|Death|0
5252432|NCT00741260|18123923|P2|Overall Study|Death|1
5252433|NCT00741260|18123924|P1|Overall Study|Death|0
5252434|NCT00741260|18123918|P7|Overall Study|Disease Progression|4
5252435|NCT00741260|18123919|P6|Overall Study|Disease Progression|37
5252436|NCT00741260|18123920|P5|Overall Study|Disease Progression|5
5252437|NCT00741260|18123921|P4|Overall Study|Disease Progression|3
5252438|NCT00741260|18123922|P3|Overall Study|Disease Progression|3
5252439|NCT00741260|18123923|P2|Overall Study|Disease Progression|5
5252440|NCT00741260|18123924|P1|Overall Study|Disease Progression|3
5252441|NCT00741091|18123973|P1|Overall Study|Missed Visit|22
5252442|NCT00741091|18123973|P1|Overall Study|Withdrawal by Subject|6
5252443|NCT00741091|18123973|P1|Overall Study|Lost to Follow-up|16
5252444|NCT00741091|18123973|P1|Overall Study|Death|13
5252445|NCT00741039|18123983|P2|Overall Study|Patient non-compliance|0
5252446|NCT00741039|18123984|P1|Overall Study|Patient non-compliance|2
5252447|NCT00741013|18124021|P3|Overall Study|Discovered failed screen after enrolled|0
5252448|NCT00741013|18124022|P2|Overall Study|Discovered failed screen after enrolled|2
5252449|NCT00741013|18124023|P1|Overall Study|Discovered failed screen after enrolled|0
5252450|NCT00741013|18124021|P3|Overall Study|Withdrawal by Subject|1
5252451|NCT00741013|18124022|P2|Overall Study|Withdrawal by Subject|0
5252452|NCT00741013|18124023|P1|Overall Study|Withdrawal by Subject|0
5252453|NCT00741013|18124021|P3|Overall Study|Adverse Event|0
5252454|NCT00741013|18124022|P2|Overall Study|Adverse Event|0
5252455|NCT00741013|18124023|P1|Overall Study|Adverse Event|1
5252456|NCT00740870|18124034|P1|Overall Study|Further testing contraindicated implant|17
5252457|NCT00740870|18124034|P1|Overall Study|Not Catheterized|4
5252458|NCT00740857|18124049|P3|Overall Study|Withdrawal by Subject|0
5252459|NCT00740857|18124050|P2|Overall Study|Withdrawal by Subject|0
5252460|NCT00740857|18124051|P1|Overall Study|Withdrawal by Subject|1
5252461|NCT00740792|18124106|P4|Overall Study|administrative|2
5252462|NCT00740792|18124107|P3|Overall Study|administrative|8
5252463|NCT00740792|18124108|P2|Overall Study|administrative|3
5252464|NCT00740792|18124109|P1|Overall Study|administrative|3
5252465|NCT00740792|18124106|P4|Overall Study|Withdrawal by Subject|0
5252466|NCT00740792|18124107|P3|Overall Study|Withdrawal by Subject|0
5252467|NCT00740792|18124108|P2|Overall Study|Withdrawal by Subject|1
5252468|NCT00740792|18124109|P1|Overall Study|Withdrawal by Subject|1
5252469|NCT00740792|18124106|P4|Overall Study|Protocol Violation|2
5252470|NCT00740792|18124107|P3|Overall Study|Protocol Violation|0
5252471|NCT00740792|18124108|P2|Overall Study|Protocol Violation|1
5252472|NCT00740792|18124109|P1|Overall Study|Protocol Violation|0
5252473|NCT00740792|18124106|P4|Overall Study|Lost to Follow-up|0
5252474|NCT00740792|18124107|P3|Overall Study|Lost to Follow-up|0
5252475|NCT00740792|18124108|P2|Overall Study|Lost to Follow-up|1
5252476|NCT00740792|18124109|P1|Overall Study|Lost to Follow-up|2
5252477|NCT00740792|18124106|P4|Overall Study|Lack of Efficacy|3
5252478|NCT00740792|18124107|P3|Overall Study|Lack of Efficacy|0
5252479|NCT00740792|18124108|P2|Overall Study|Lack of Efficacy|1
5252480|NCT00740792|18124109|P1|Overall Study|Lack of Efficacy|1
5252481|NCT00740792|18124106|P4|Overall Study|Adverse Event|3
5252482|NCT00740792|18124107|P3|Overall Study|Adverse Event|1
5252483|NCT00740792|18124108|P2|Overall Study|Adverse Event|1
5252484|NCT00740792|18124109|P1|Overall Study|Adverse Event|3
5252485|NCT00740779|18124130|P3|Overall Study|Lost to Follow-up|5
5252486|NCT00740779|18124131|P2|Overall Study|Lost to Follow-up|3
5252487|NCT00740779|18124132|P1|Overall Study|Lost to Follow-up|2
5252488|NCT00740779|18124130|P3|Overall Study|Withdrawal by Subject|2
5252489|NCT00740779|18124131|P2|Overall Study|Withdrawal by Subject|4
5252490|NCT00740779|18124132|P1|Overall Study|Withdrawal by Subject|2
5252491|NCT00740779|18124130|P3|Overall Study|Lack of Efficacy|2
5252492|NCT00740779|18124131|P2|Overall Study|Lack of Efficacy|0
5252493|NCT00740779|18124132|P1|Overall Study|Lack of Efficacy|0
5252494|NCT00740779|18124130|P3|Overall Study|Protocol Violation|1
5252495|NCT00740779|18124131|P2|Overall Study|Protocol Violation|1
5252496|NCT00740779|18124132|P1|Overall Study|Protocol Violation|1
5252497|NCT00740779|18124130|P3|Overall Study|Adverse Event|3
5252498|NCT00740779|18124131|P2|Overall Study|Adverse Event|6
5252499|NCT00740779|18124132|P1|Overall Study|Adverse Event|4
5252500|NCT00740714|18124149|P3|Overall Study|Withdrawal by Subject|29
5252501|NCT00740714|18124150|P2|Overall Study|Withdrawal by Subject|19
5252502|NCT00740714|18124151|P1|Overall Study|Withdrawal by Subject|17
5252503|NCT00740636|18124227|P2|Overall Study|Death|0
5252504|NCT00740636|18124228|P1|Overall Study|Death|1
5252505|NCT00740636|18124227|P2|Overall Study|Progressive Disease|0
5252506|NCT00740636|18124228|P1|Overall Study|Progressive Disease|1
5252507|NCT00740636|18124227|P2|Overall Study|Patient Not Treated|1
5252508|NCT00740636|18124228|P1|Overall Study|Patient Not Treated|0
5252509|NCT00740636|18124227|P2|Overall Study|Patient Ineligible|1
5252510|NCT00740636|18124228|P1|Overall Study|Patient Ineligible|0
5252511|NCT00740636|18124227|P2|Overall Study|Adverse Event|2
5252512|NCT00740636|18124228|P1|Overall Study|Adverse Event|0
5252513|NCT00740597|18124234|P1|Overall Study|insurance would not cover treatment|1
5252514|NCT00740584|18124238|P1|Overall Study|Withdrawal by Subject|1
5252515|NCT00740480|18124243|P1|Overall Study|Physician Decision|1
5252516|NCT00740480|18124243|P1|Overall Study|Adverse Event|1
5252517|NCT00740220|18124268|P1|Overall Study|screen failures (non-COPD patients)|9
5252518|NCT00740051|18124293|P2|Overall Study|Other reason (not specified)|1
5252519|NCT00740051|18124294|P1|Overall Study|Other reason (not specified)|4
5252520|NCT00740051|18124293|P2|Overall Study|Withdrawal by Subject|8
5252521|NCT00740051|18124294|P1|Overall Study|Withdrawal by Subject|6
5252522|NCT00740051|18124293|P2|Overall Study|Lost to Follow-up|8
5252523|NCT00740051|18124294|P1|Overall Study|Lost to Follow-up|3
5252524|NCT00740051|18124293|P2|Overall Study|Protocol Violation|6
5252525|NCT00740051|18124294|P1|Overall Study|Protocol Violation|2
5252526|NCT00740051|18124293|P2|Overall Study|Adverse Event|4
5252527|NCT00740051|18124294|P1|Overall Study|Adverse Event|1
5252528|NCT00740051|18124293|P2|Overall Study|Lack of Efficacy|5
5252529|NCT00740051|18124294|P1|Overall Study|Lack of Efficacy|2
5252530|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252531|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252532|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
5252533|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252534|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252535|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252536|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252537|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
5252538|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5252539|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
5252540|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
5252541|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
5252542|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
5252543|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
5252544|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
5252545|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
5252546|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
5252547|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
5252548|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252549|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252550|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
5252551|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252552|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252553|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252554|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252555|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252556|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5252557|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
5252558|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
5252559|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
5252560|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
5252561|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
5252562|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
5252563|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
5252564|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
5252565|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
5252566|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5252567|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
5252568|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
5252569|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5252570|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5252571|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
5252572|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5252573|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
5252574|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5252575|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252576|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252577|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252578|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252579|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252580|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252581|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
5252582|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252583|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5252584|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
5252585|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
5252586|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
5252587|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
5252588|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
5252589|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
5252590|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
5252591|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
5252592|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
5252593|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252594|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252595|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252596|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252597|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252598|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252599|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5252600|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
5252601|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
5252602|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252603|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
5252604|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252605|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252606|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
5252607|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252608|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252609|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252610|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5252611|NCT00739973|18124397|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
5252612|NCT00739973|18124398|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
5252613|NCT00739973|18124399|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
5252614|NCT00739973|18124400|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
5252615|NCT00739973|18124401|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
5252616|NCT00739973|18124402|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
5252617|NCT00739973|18124403|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
5252618|NCT00739973|18124404|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
5252619|NCT00739973|18124405|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
5252620|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252621|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252622|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252623|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252624|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252625|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252626|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252627|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5252628|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
5252629|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252630|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252631|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252632|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252633|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252634|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252635|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252636|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5252637|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
5252638|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252639|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252640|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252641|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252642|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252643|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252644|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252645|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5252646|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
5252647|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252648|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252649|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252650|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252651|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252652|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252653|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252654|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5252655|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
5252656|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252657|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252658|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252659|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252660|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252661|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252662|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252908|NCT00738062|18125008|P1|Open-Label Extension|Adverse Event|5
5252663|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5252664|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
5252665|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252666|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252667|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252668|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252669|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252670|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252671|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252672|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5252673|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
5252674|NCT00739973|18124397|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252675|NCT00739973|18124398|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252676|NCT00739973|18124399|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252677|NCT00739973|18124400|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252678|NCT00739973|18124401|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252679|NCT00739973|18124402|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252680|NCT00739973|18124403|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252681|NCT00739973|18124404|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5252682|NCT00739973|18124405|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
5252683|NCT00739934|18124496|P1|Voriconazole Oral|Other|3
5252684|NCT00739934|18124496|P1|Voriconazole IV|Adverse Event|6
5252685|NCT00739908|18124518|P2|Overall Study|Relocation|1
5252686|NCT00739908|18124519|P1|Overall Study|Relocation|0
5252687|NCT00739908|18124518|P2|Overall Study|Lack of Efficacy|1
5252688|NCT00739908|18124519|P1|Overall Study|Lack of Efficacy|0
5252689|NCT00739908|18124518|P2|Overall Study|Non-Compliance With Study Medication|3
5252690|NCT00739908|18124519|P1|Overall Study|Non-Compliance With Study Medication|0
5252691|NCT00739908|18124518|P2|Overall Study|Non-Compliance With Study Procedures|3
5252692|NCT00739908|18124519|P1|Overall Study|Non-Compliance With Study Procedures|2
5252693|NCT00739908|18124518|P2|Overall Study|Lost to Follow-up|9
5252694|NCT00739908|18124519|P1|Overall Study|Lost to Follow-up|14
5252695|NCT00739908|18124518|P2|Overall Study|Withdrawal by Subject|2
5252696|NCT00739908|18124519|P1|Overall Study|Withdrawal by Subject|4
5252697|NCT00739908|18124518|P2|Overall Study|Adverse Event|6
5252698|NCT00739908|18124519|P1|Overall Study|Adverse Event|5
5252699|NCT00739882|18124539|P2|Open-label Period|Other|5
5252700|NCT00739882|18124540|P1|Open-label Period|Other|9
5252701|NCT00739882|18124539|P2|Open-label Period|Adverse Event|0
5252702|NCT00739882|18124540|P1|Open-label Period|Adverse Event|1
5252703|NCT00739882|18124539|P2|Double-blind Period|Other|8
5252704|NCT00739882|18124540|P1|Double-blind Period|Other|16
5252705|NCT00739882|18124539|P2|Double-blind Period|Lack of Efficacy|1
5252706|NCT00739882|18124540|P1|Double-blind Period|Lack of Efficacy|1
5252707|NCT00739882|18124539|P2|Double-blind Period|Protocol Violation|0
5252708|NCT00739882|18124540|P1|Double-blind Period|Protocol Violation|1
5252709|NCT00739882|18124539|P2|Double-blind Period|Adverse Event|2
5252710|NCT00739882|18124540|P1|Double-blind Period|Adverse Event|1
5252711|NCT00739674|18124601|P2|Overall Study|Erectile dysfunction|1
5252712|NCT00739674|18124602|P1|Overall Study|Erectile dysfunction|0
5252713|NCT00739674|18124601|P2|Overall Study|Home monitoring off meds|0
5252714|NCT00739674|18124602|P1|Overall Study|Home monitoring off meds|1
5252715|NCT00739674|18124601|P2|Overall Study|Unable to attend visit|1
5252716|NCT00739674|18124602|P1|Overall Study|Unable to attend visit|3
5252717|NCT00739674|18124601|P2|Overall Study|Non compliant|0
5252718|NCT00739674|18124602|P1|Overall Study|Non compliant|4
5252719|NCT00739674|18124601|P2|Overall Study|Patient moved|2
5252720|NCT00739674|18124602|P1|Overall Study|Patient moved|3
5252721|NCT00739674|18124601|P2|Overall Study|Clinic closed|4
5252722|NCT00739674|18124602|P1|Overall Study|Clinic closed|6
5252723|NCT00739674|18124601|P2|Overall Study|Reason missing|0
5252724|NCT00739674|18124602|P1|Overall Study|Reason missing|2
5252725|NCT00739674|18124601|P2|Overall Study|Withdrawal by Subject|9
5252726|NCT00739674|18124602|P1|Overall Study|Withdrawal by Subject|9
5252727|NCT00739674|18124601|P2|Overall Study|Protocol Violation|5
5252728|NCT00739674|18124602|P1|Overall Study|Protocol Violation|5
5252729|NCT00739674|18124601|P2|Overall Study|Lost to Follow-up|30
5252730|NCT00739674|18124602|P1|Overall Study|Lost to Follow-up|52
5252731|NCT00739674|18124601|P2|Overall Study|Lack of Efficacy|0
5252732|NCT00739674|18124602|P1|Overall Study|Lack of Efficacy|1
5252733|NCT00739674|18124601|P2|Overall Study|Death|0
5252734|NCT00739674|18124602|P1|Overall Study|Death|1
5252735|NCT00739674|18124601|P2|Overall Study|Adverse Event|13
5252736|NCT00739674|18124602|P1|Overall Study|Adverse Event|22
5252737|NCT00739674|18124601|P2|Overall Study|Dietician consultation >30 days|9
5252738|NCT00739674|18124602|P1|Overall Study|Dietician consultation >30 days|1
5252739|NCT00739674|18124601|P2|Overall Study|No follow-up data|18
5252740|NCT00739674|18124602|P1|Overall Study|No follow-up data|33
5252741|NCT00739674|18124601|P2|Overall Study|Site 212 removal|13
5252742|NCT00739674|18124602|P1|Overall Study|Site 212 removal|19
5252743|NCT00739674|18124601|P2|Overall Study|Screening failures|17
5252744|NCT00739674|18124602|P1|Overall Study|Screening failures|19
5252745|NCT00739661|18124630|P2|Overall Study|Reason for discontinuation not available|1
5252746|NCT00739661|18124631|P1|Overall Study|Reason for discontinuation not available|1
5252747|NCT00739661|18124630|P2|Overall Study|Disease progression, radiographic|37
5252748|NCT00739661|18124631|P1|Overall Study|Disease progression, radiographic|33
5252749|NCT00739661|18124630|P2|Overall Study|Patient decision to withdraw|4
5252750|NCT00739661|18124631|P1|Overall Study|Patient decision to withdraw|9
5252751|NCT00739661|18124630|P2|Overall Study|Physician decision to withdraw patient|0
5252752|NCT00739661|18124631|P1|Overall Study|Physician decision to withdraw patient|1
5252753|NCT00739661|18124630|P2|Overall Study|Adverse Event|0
5252754|NCT00739661|18124631|P1|Overall Study|Adverse Event|2
5252755|NCT00739648|18124643|P2|Overall Study|Do not know|6
5252756|NCT00739648|18124644|P1|Overall Study|Do not know|4
5252757|NCT00739648|18124643|P2|Overall Study|Death|0
5252758|NCT00739648|18124644|P1|Overall Study|Death|2
5252759|NCT00739648|18124643|P2|Overall Study|Lost to Follow-up|7
5252760|NCT00739648|18124644|P1|Overall Study|Lost to Follow-up|4
5252761|NCT00739648|18124643|P2|Overall Study|Withdrawal by Subject|25
5252762|NCT00739648|18124644|P1|Overall Study|Withdrawal by Subject|13
5252763|NCT00739648|18124643|P2|Overall Study|Adverse Event|15
5252764|NCT00739648|18124644|P1|Overall Study|Adverse Event|3
5252765|NCT00739596|18124658|P2|Overall Study|Protocol Deviation|1
5252766|NCT00739596|18124659|P1|Overall Study|Protocol Deviation|1
5252767|NCT00739596|18124658|P2|Overall Study|Lost to Follow-up|2
5252768|NCT00739596|18124659|P1|Overall Study|Lost to Follow-up|0
5252769|NCT00739596|18124658|P2|Overall Study|Patient Withdrew Consent|8
5252770|NCT00739596|18124659|P1|Overall Study|Patient Withdrew Consent|8
5252771|NCT00739596|18124658|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5252772|NCT00739596|18124659|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
5252773|NCT00739596|18124658|P2|Overall Study|Adverse Event|6
5252774|NCT00739596|18124659|P1|Overall Study|Adverse Event|12
5252775|NCT00739310|18124701|P1|Overall Study|Lost to Follow-up|2
5252776|NCT00739310|18124701|P1|Overall Study|Withdrawal by Subject|1
5252777|NCT00739310|18124701|P1|Overall Study|Poor adherance to prescribed therapy|4
5252778|NCT00739297|18124706|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
5252779|NCT00739297|18124707|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
5252780|NCT00739297|18124708|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5252781|NCT00739297|18124709|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5252782|NCT00739297|18124710|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5252783|NCT00739297|18124711|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5252784|NCT00739297|18124712|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5252785|NCT00739297|18124706|P7|First Washout Period of 4-7 Days|Adverse Event|2
5252786|NCT00739297|18124707|P6|First Washout Period of 4-7 Days|Adverse Event|0
5252787|NCT00739297|18124708|P5|First Washout Period of 4-7 Days|Adverse Event|0
5252788|NCT00739297|18124709|P4|First Washout Period of 4-7 Days|Adverse Event|2
5252789|NCT00739297|18124710|P3|First Washout Period of 4-7 Days|Adverse Event|0
5252790|NCT00739297|18124711|P2|First Washout Period of 4-7 Days|Adverse Event|0
5252791|NCT00739297|18124712|P1|First Washout Period of 4-7 Days|Adverse Event|0
5252792|NCT00739102|18124740|P1|Overall Study|Withdrawal by Subject|10
5252793|NCT00739102|18124740|P1|Overall Study|Death|5
5252794|NCT00739063|18124756|P1|Overall Study|Screen failures|8
5252795|NCT00738894|18124801|P2|Overall Study|Death|0
5252796|NCT00738894|18124802|P1|Overall Study|Death|2
5252797|NCT00738894|18124801|P2|Overall Study|Physician Decision|5
5252798|NCT00738894|18124802|P1|Overall Study|Physician Decision|4
5252799|NCT00738894|18124801|P2|Overall Study|Withdrawal by Subject|15
5252800|NCT00738894|18124802|P1|Overall Study|Withdrawal by Subject|10
5252801|NCT00738894|18124801|P2|Overall Study|Lost to Follow-up|13
5252802|NCT00738894|18124802|P1|Overall Study|Lost to Follow-up|23
5252803|NCT00738881|18124815|P2|Overall Study|Withdrawal by Subject|2
5252804|NCT00738881|18124816|P1|Overall Study|Withdrawal by Subject|0
5252805|NCT00738699|18124830|P2|Overall Study|Other|0
5252806|NCT00738699|18124831|P1|Overall Study|Other|2
5252807|NCT00738699|18124830|P2|Overall Study|Discontinuation of study by Sponsor|72
5252808|NCT00738699|18124831|P1|Overall Study|Discontinuation of study by Sponsor|123
5252809|NCT00738699|18124830|P2|Overall Study|Death|68
5252810|NCT00738699|18124831|P1|Overall Study|Death|144
5252811|NCT00738699|18124830|P2|Overall Study|Lost to Follow-up|0
5252812|NCT00738699|18124831|P1|Overall Study|Lost to Follow-up|1
5252813|NCT00738699|18124830|P2|Overall Study|Withdrawal by Subject|0
5252814|NCT00738699|18124831|P1|Overall Study|Withdrawal by Subject|5
5252815|NCT00738673|18124849|P2|Overall Study|Withdrawal by Subject|1
5252816|NCT00738673|18124850|P1|Overall Study|Withdrawal by Subject|3
5252817|NCT00738673|18124849|P2|Overall Study|Protocol Violation|2
5252818|NCT00738673|18124850|P1|Overall Study|Protocol Violation|1
5252819|NCT00738673|18124849|P2|Overall Study|Lack of Efficacy|8
5252820|NCT00738673|18124850|P1|Overall Study|Lack of Efficacy|19
5252821|NCT00738673|18124849|P2|Overall Study|Adverse Event|0
5252822|NCT00738673|18124850|P1|Overall Study|Adverse Event|1
5252823|NCT00738530|18124888|P2|Overall Study|Withdrawal by Subject|8
5252824|NCT00738530|18124889|P1|Overall Study|Withdrawal by Subject|6
5252825|NCT00738530|18124888|P2|Overall Study|Lost to Follow-up|6
5252826|NCT00738530|18124889|P1|Overall Study|Lost to Follow-up|8
5252827|NCT00738530|18124888|P2|Overall Study|Death|224
5252828|NCT00738530|18124889|P1|Overall Study|Death|220
5252829|NCT00738400|18124924|P2|Overall Study|Non-compliant with study medication|1
5252830|NCT00738400|18124925|P1|Overall Study|Non-compliant with study medication|0
5252831|NCT00738400|18124924|P2|Overall Study|Protocol Violation|0
5252832|NCT00738400|18124925|P1|Overall Study|Protocol Violation|1
5252833|NCT00738400|18124924|P2|Overall Study|Lost to Follow-up|3
5252834|NCT00738400|18124925|P1|Overall Study|Lost to Follow-up|0
5252835|NCT00738400|18124924|P2|Overall Study|Lack of Efficacy|1
5252836|NCT00738400|18124925|P1|Overall Study|Lack of Efficacy|0
5252837|NCT00738400|18124924|P2|Overall Study|Withdrawal by Subject|1
5252838|NCT00738400|18124925|P1|Overall Study|Withdrawal by Subject|0
5252839|NCT00738400|18124924|P2|Overall Study|Adverse Event|1
5252840|NCT00738400|18124925|P1|Overall Study|Adverse Event|3
5252841|NCT00738374|18124946|P4|Maintenance Treatment/Observation Phase|Other|0
5252842|NCT00738374|18124947|P3|Maintenance Treatment/Observation Phase|Other|0
5252843|NCT00738374|18124948|P2|Maintenance Treatment/Observation Phase|Other|1
5252844|NCT00738374|18124949|P1|Maintenance Treatment/Observation Phase|Other|0
5252845|NCT00738374|18124946|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
5252846|NCT00738374|18124947|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
5252847|NCT00738374|18124948|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
5252848|NCT00738374|18124949|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
5252849|NCT00738374|18124946|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
5252850|NCT00738374|18124947|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
5252851|NCT00738374|18124948|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
5252852|NCT00738374|18124949|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
5252853|NCT00738374|18124946|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
5252854|NCT00738374|18124947|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
5252855|NCT00738374|18124948|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
5252856|NCT00738374|18124949|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
5252857|NCT00738374|18124946|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
5252858|NCT00738374|18124947|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
5252859|NCT00738374|18124948|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
5252860|NCT00738374|18124949|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
5252861|NCT00738374|18124946|P4|Induction Treatment Phase|Withdrawal by Subject|0
5252862|NCT00738374|18124947|P3|Induction Treatment Phase|Withdrawal by Subject|0
5252863|NCT00738374|18124948|P2|Induction Treatment Phase|Withdrawal by Subject|0
5252864|NCT00738374|18124949|P1|Induction Treatment Phase|Withdrawal by Subject|1
5252865|NCT00738374|18124946|P4|Induction Treatment Phase|Non-compliance|0
5252866|NCT00738374|18124947|P3|Induction Treatment Phase|Non-compliance|0
5252867|NCT00738374|18124948|P2|Induction Treatment Phase|Non-compliance|0
5252868|NCT00738374|18124949|P1|Induction Treatment Phase|Non-compliance|1
5252869|NCT00738374|18124946|P4|Induction Treatment Phase|Protocol Violation|0
5252870|NCT00738374|18124947|P3|Induction Treatment Phase|Protocol Violation|0
5252871|NCT00738374|18124948|P2|Induction Treatment Phase|Protocol Violation|0
5252872|NCT00738374|18124949|P1|Induction Treatment Phase|Protocol Violation|2
5252873|NCT00738374|18124946|P4|Induction Treatment Phase|Physician Decision|0
5252874|NCT00738374|18124947|P3|Induction Treatment Phase|Physician Decision|0
5252875|NCT00738374|18124948|P2|Induction Treatment Phase|Physician Decision|0
5252876|NCT00738374|18124949|P1|Induction Treatment Phase|Physician Decision|2
5252877|NCT00738374|18124946|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
5252878|NCT00738374|18124947|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
5252879|NCT00738374|18124948|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
5252880|NCT00738374|18124949|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
5252881|NCT00738374|18124946|P4|Induction Treatment Phase|Adverse Event|0
5252882|NCT00738374|18124947|P3|Induction Treatment Phase|Adverse Event|0
5252883|NCT00738374|18124948|P2|Induction Treatment Phase|Adverse Event|0
5252884|NCT00738374|18124949|P1|Induction Treatment Phase|Adverse Event|14
5252885|NCT00738283|18124987|P1|Overall Study|Discharge home prior to end of study|1
5252886|NCT00738283|18124987|P1|Overall Study|Transfer to another facility|2
5252887|NCT00738283|18124987|P1|Overall Study|Death|1
5252888|NCT00738101|18124991|P1|Overall Study|Repeat enrollment|1
5252889|NCT00738101|18124991|P1|Overall Study|Death|1
5252890|NCT00738101|18124991|P1|Overall Study|Physician Decision|5
5252891|NCT00738062|18125006|P3|Open-Label Extension|Study Terminated|0
5252892|NCT00738062|18125007|P2|Open-Label Extension|Study Terminated|0
5252893|NCT00738062|18125008|P1|Open-Label Extension|Study Terminated|2
5252894|NCT00738062|18125006|P3|Open-Label Extension|Protocol Violation|0
5252895|NCT00738062|18125007|P2|Open-Label Extension|Protocol Violation|0
5252896|NCT00738062|18125008|P1|Open-Label Extension|Protocol Violation|1
5252897|NCT00738062|18125006|P3|Open-Label Extension|Withdrawal by Subject|0
5252898|NCT00738062|18125007|P2|Open-Label Extension|Withdrawal by Subject|0
5252899|NCT00738062|18125008|P1|Open-Label Extension|Withdrawal by Subject|6
5252900|NCT00738062|18125006|P3|Open-Label Extension|Lack of Efficacy|0
5252901|NCT00738062|18125007|P2|Open-Label Extension|Lack of Efficacy|0
5252902|NCT00738062|18125008|P1|Open-Label Extension|Lack of Efficacy|2
5252903|NCT00738062|18125006|P3|Open-Label Extension|Physician Decision|0
5252904|NCT00738062|18125007|P2|Open-Label Extension|Physician Decision|0
5252905|NCT00738062|18125008|P1|Open-Label Extension|Physician Decision|1
5252906|NCT00738062|18125006|P3|Open-Label Extension|Adverse Event|0
5252907|NCT00738062|18125007|P2|Open-Label Extension|Adverse Event|0
5252909|NCT00738062|18125006|P3|Open Label Treatment|Investigator Decision|0
5252910|NCT00738062|18125007|P2|Open Label Treatment|Investigator Decision|0
5252911|NCT00738062|18125008|P1|Open Label Treatment|Investigator Decision|1
5252912|NCT00738062|18125006|P3|Open Label Treatment|Withdrawal by Subject|0
5252913|NCT00738062|18125007|P2|Open Label Treatment|Withdrawal by Subject|0
5252914|NCT00738062|18125008|P1|Open Label Treatment|Withdrawal by Subject|9
5252915|NCT00738062|18125006|P3|Open Label Treatment|Protocol Violation|0
5252916|NCT00738062|18125007|P2|Open Label Treatment|Protocol Violation|0
5252917|NCT00738062|18125008|P1|Open Label Treatment|Protocol Violation|2
5252918|NCT00738062|18125006|P3|Open Label Treatment|Adverse Event|0
5252919|NCT00738062|18125007|P2|Open Label Treatment|Adverse Event|0
5252920|NCT00738062|18125008|P1|Open Label Treatment|Adverse Event|11
5252921|NCT00738062|18125006|P3|Open Label Treatment|Lack of Efficacy|0
5252922|NCT00738062|18125007|P2|Open Label Treatment|Lack of Efficacy|0
5252923|NCT00738062|18125008|P1|Open Label Treatment|Lack of Efficacy|5
5252924|NCT00737711|18125121|P1|Overall Study|Other|5
5252925|NCT00737711|18125121|P1|Overall Study|Blood transfusion|6
5252926|NCT00737711|18125121|P1|Overall Study|Withdrawal by Subject|5
5252927|NCT00737711|18125121|P1|Overall Study|Protocol Violation|1
5252928|NCT00737711|18125121|P1|Overall Study|Failure to return|4
5252929|NCT00737711|18125121|P1|Overall Study|Death|8
5252930|NCT00737711|18125121|P1|Overall Study|Adverse Event|2
5252931|NCT00737698|18125155|P3|Overall Study|Death|1
5252932|NCT00737698|18125156|P2|Overall Study|Death|0
5252933|NCT00737698|18125157|P1|Overall Study|Death|0
5252934|NCT00737698|18125155|P3|Overall Study|Withdrawal by Subject|3
5252935|NCT00737698|18125156|P2|Overall Study|Withdrawal by Subject|5
5252936|NCT00737698|18125157|P1|Overall Study|Withdrawal by Subject|6
5252937|NCT00737672|18125167|P2|Overall Study|Physician Decision|2
5252938|NCT00737672|18125168|P1|Overall Study|Physician Decision|0
5252939|NCT00737672|18125167|P2|Overall Study|Miscellaneous|1
5252940|NCT00737672|18125168|P1|Overall Study|Miscellaneous|7
5252941|NCT00737672|18125167|P2|Overall Study|Lost to Follow-up|0
5252942|NCT00737672|18125168|P1|Overall Study|Lost to Follow-up|1
5252943|NCT00737672|18125167|P2|Overall Study|Withdrawal by Subject|2
5252944|NCT00737672|18125168|P1|Overall Study|Withdrawal by Subject|1
5252945|NCT00737672|18125167|P2|Overall Study|Death|22
5252946|NCT00737672|18125168|P1|Overall Study|Death|23
5252947|NCT00737672|18125167|P2|Overall Study|Graft Abandonment|56
5252948|NCT00737672|18125168|P1|Overall Study|Graft Abandonment|48
5252949|NCT00737633|18125206|P2|Overall Study|protocol non-compliance|1
5252950|NCT00737633|18125207|P1|Overall Study|protocol non-compliance|0
5252951|NCT00737633|18125206|P2|Overall Study|Lost to Follow-up|1
5252952|NCT00737633|18125207|P1|Overall Study|Lost to Follow-up|0
5252953|NCT00737633|18125206|P2|Overall Study|Study terminated by sponsor|55
5252954|NCT00737633|18125207|P1|Overall Study|Study terminated by sponsor|44
5252955|NCT00737568|18125230|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
5252956|NCT00737568|18125231|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
5252957|NCT00737568|18125230|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
5252958|NCT00737568|18125231|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
5252959|NCT00737568|18125230|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
5252960|NCT00737568|18125231|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
5252961|NCT00737568|18125230|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
5252962|NCT00737568|18125231|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
5252963|NCT00737568|18125230|P2|Treatment Period Through Week 240|Protocol Violation|3
5252964|NCT00737568|18125231|P1|Treatment Period Through Week 240|Protocol Violation|2
5252965|NCT00737568|18125230|P2|Treatment Period Through Week 240|Lost to Follow-up|3
5252966|NCT00737568|18125231|P1|Treatment Period Through Week 240|Lost to Follow-up|3
5252967|NCT00737568|18125230|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
5252968|NCT00737568|18125231|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
5252969|NCT00737568|18125230|P2|Treatment Period Through Week 240|Withdrew Consent|6
5252970|NCT00737568|18125231|P1|Treatment Period Through Week 240|Withdrew Consent|5
5252971|NCT00737568|18125230|P2|Treatment Period Through Week 240|Investigator's Discretion|5
5252972|NCT00737568|18125231|P1|Treatment Period Through Week 240|Investigator's Discretion|6
5252973|NCT00737529|18125261|P1|Overall Study|Other|4
5252974|NCT00737529|18125261|P1|Overall Study|Protocol Violation|1
5252975|NCT00737529|18125261|P1|Overall Study|Death|4
5252976|NCT00737529|18125261|P1|Overall Study|Withdrawal by Subject|5
5252977|NCT00737529|18125261|P1|Overall Study|Adverse Event|24
5252978|NCT00737529|18125261|P1|Overall Study|Disease Progression|95
5252979|NCT00737477|18125275|P1|Overall Study|Other|4
5252980|NCT00737477|18125275|P1|Overall Study|Renal Transplantation|10
5252981|NCT00737477|18125275|P1|Overall Study|Withdrawal by Subject|1
5252982|NCT00737477|18125275|P1|Overall Study|Treatment Refusal|1
5252983|NCT00737477|18125275|P1|Overall Study|Death|9
5252984|NCT00737477|18125275|P1|Overall Study|Adverse Event|9
5252985|NCT00737464|18125291|P1|Overall Study|Other reasons|4
5252986|NCT00737464|18125291|P1|Overall Study|Refused Treatment / Withdrew Consent|6
5252987|NCT00737464|18125291|P1|Overall Study|Other - Failure to Return|1
5252988|NCT00737464|18125291|P1|Overall Study|Death|6
5252989|NCT00737464|18125291|P1|Overall Study|Adverse Event|1
5252990|NCT00737438|18125312|P1|Overall Study|Patient ineligible|1
5252991|NCT00737438|18125312|P1|Overall Study|Withdrawal by Subject|2
5252992|NCT00737282|18125325|P1|Overall Study|Study prematurely terminated|175
5253161|NCT00735943|18126121|P1|Overall Study|Adverse Event|1
5252993|NCT00737100|18125368|P3|Overall Study|Reason discontinued not explained above|1
5252994|NCT00737100|18125369|P2|Overall Study|Reason discontinued not explained above|1
5252995|NCT00737100|18125370|P1|Overall Study|Reason discontinued not explained above|1
5252996|NCT00737100|18125368|P3|Overall Study|Withdrawal by Subject|3
5252997|NCT00737100|18125369|P2|Overall Study|Withdrawal by Subject|0
5252998|NCT00737100|18125370|P1|Overall Study|Withdrawal by Subject|0
5252999|NCT00737100|18125368|P3|Overall Study|Lost to Follow-up|0
5253000|NCT00737100|18125369|P2|Overall Study|Lost to Follow-up|1
5253001|NCT00737100|18125370|P1|Overall Study|Lost to Follow-up|0
5253002|NCT00737100|18125368|P3|Overall Study|Adverse Event|3
5253003|NCT00737100|18125369|P2|Overall Study|Adverse Event|5
5253004|NCT00737100|18125370|P1|Overall Study|Adverse Event|6
5253005|NCT00737061|18125414|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
5253006|NCT00737061|18125414|P1|1 Year Wearing Period|Discontinued reilance|3
5253007|NCT00737061|18125414|P1|1 Year Wearing Period|Withdrawal by Subject|2
5253008|NCT00737061|18125414|P1|1 Year Wearing Period|Lost to Follow-up|11
5253009|NCT00737061|18125414|P1|Waiting Period|Elected surgical tubal ligation|5
5253010|NCT00737061|18125414|P1|Waiting Period|Alternative contraception failure|3
5253011|NCT00737061|18125414|P1|Waiting Period|Deemed patent following HSG|26
5253012|NCT00737061|18125414|P1|Waiting Period|Bilateral placement failure|34
5253013|NCT00737061|18125414|P1|Waiting Period|Withdrawal by Subject|1
5253014|NCT00737061|18125414|P1|Waiting Period|Lost to Follow-up|6
5253015|NCT00737048|18125431|P3|Overall Study|Worsening of the symptoms|3
5253016|NCT00737048|18125432|P2|Overall Study|Worsening of the symptoms|5
5253017|NCT00737048|18125433|P1|Overall Study|Worsening of the symptoms|3
5253018|NCT00737048|18125431|P3|Overall Study|Adverse Event|0
5253019|NCT00737048|18125432|P2|Overall Study|Adverse Event|1
5253020|NCT00737048|18125433|P1|Overall Study|Adverse Event|0
5253021|NCT00737048|18125431|P3|Overall Study|Physician Decision|1
5253022|NCT00737048|18125432|P2|Overall Study|Physician Decision|0
5253023|NCT00737048|18125433|P1|Overall Study|Physician Decision|0
5253024|NCT00736996|18125477|P3|Overall Study|Lost to Follow-up|2
5253025|NCT00736996|18125478|P2|Overall Study|Lost to Follow-up|9
5253026|NCT00736996|18125479|P1|Overall Study|Lost to Follow-up|1
5253027|NCT00736957|18125493|P1|Overall Study|Physician Decision|5
5253028|NCT00736957|18125493|P1|Overall Study|not eligible for Treatment Period I|22
5253029|NCT00736957|18125493|P1|Overall Study|did not attend hospital appointments|1
5253030|NCT00736957|18125493|P1|Overall Study|violation of eligibility criteria|2
5253031|NCT00736957|18125493|P1|Overall Study|Withdrawal by Subject|49
5253032|NCT00736957|18125493|P1|Overall Study|Adverse Event|43
5253033|NCT00736944|18125503|P1|Definitive Treatment|Physician Decision|1
5253034|NCT00736944|18125503|P1|Induction|Death|1
5253035|NCT00736879|18125537|P4|Follow up Period - No Drug Treatment|non-specified|0
5253036|NCT00736879|18125538|P3|Follow up Period - No Drug Treatment|non-specified|0
5253037|NCT00736879|18125539|P2|Follow up Period - No Drug Treatment|non-specified|2
5253038|NCT00736879|18125540|P1|Follow up Period - No Drug Treatment|non-specified|1
5253039|NCT00736879|18125537|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
5253040|NCT00736879|18125538|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
5253041|NCT00736879|18125539|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
5253042|NCT00736879|18125540|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
5253043|NCT00736879|18125537|P4|Double Blind Treatment Period|non-specified|0
5253044|NCT00736879|18125538|P3|Double Blind Treatment Period|non-specified|0
5253045|NCT00736879|18125539|P2|Double Blind Treatment Period|non-specified|1
5253046|NCT00736879|18125540|P1|Double Blind Treatment Period|non-specified|0
5253047|NCT00736879|18125537|P4|Double Blind Treatment Period|No longer met criteria|0
5253048|NCT00736879|18125538|P3|Double Blind Treatment Period|No longer met criteria|0
5253049|NCT00736879|18125539|P2|Double Blind Treatment Period|No longer met criteria|1
5253050|NCT00736879|18125540|P1|Double Blind Treatment Period|No longer met criteria|0
5253051|NCT00736879|18125537|P4|Double Blind Treatment Period|Poor non-compliance|1
5253052|NCT00736879|18125538|P3|Double Blind Treatment Period|Poor non-compliance|1
5253053|NCT00736879|18125539|P2|Double Blind Treatment Period|Poor non-compliance|0
5253054|NCT00736879|18125540|P1|Double Blind Treatment Period|Poor non-compliance|0
5253055|NCT00736879|18125537|P4|Double Blind Treatment Period|Lost to Follow-up|1
5253056|NCT00736879|18125538|P3|Double Blind Treatment Period|Lost to Follow-up|2
5253057|NCT00736879|18125539|P2|Double Blind Treatment Period|Lost to Follow-up|0
5253058|NCT00736879|18125540|P1|Double Blind Treatment Period|Lost to Follow-up|0
5253059|NCT00736879|18125537|P4|Double Blind Treatment Period|Withdrawal by Subject|3
5253060|NCT00736879|18125538|P3|Double Blind Treatment Period|Withdrawal by Subject|3
5253061|NCT00736879|18125539|P2|Double Blind Treatment Period|Withdrawal by Subject|1
5253062|NCT00736879|18125540|P1|Double Blind Treatment Period|Withdrawal by Subject|2
5253063|NCT00736879|18125537|P4|Double Blind Treatment Period|Adverse Event|0
5253064|NCT00736879|18125538|P3|Double Blind Treatment Period|Adverse Event|1
5253065|NCT00736879|18125539|P2|Double Blind Treatment Period|Adverse Event|1
5253066|NCT00736879|18125540|P1|Double Blind Treatment Period|Adverse Event|0
5253067|NCT00736879|18125537|P4|Double Blind Treatment Period|Lack of Efficacy|0
5253068|NCT00736879|18125538|P3|Double Blind Treatment Period|Lack of Efficacy|0
5253069|NCT00736879|18125539|P2|Double Blind Treatment Period|Lack of Efficacy|0
5253070|NCT00736879|18125540|P1|Double Blind Treatment Period|Lack of Efficacy|1
5253071|NCT00736853|18125594|P3|Double-Blind Period|Ineligible to participate the study|0
5253072|NCT00736853|18125595|P2|Double-Blind Period|Ineligible to participate the study|1
5253073|NCT00736853|18125596|P1|Double-Blind Period|Ineligible to participate the study|0
5253074|NCT00736853|18125594|P3|Double-Blind Period|Withdrawal by Subject|4
5253075|NCT00736853|18125595|P2|Double-Blind Period|Withdrawal by Subject|1
5253076|NCT00736853|18125596|P1|Double-Blind Period|Withdrawal by Subject|0
5253077|NCT00736853|18125594|P3|Double-Blind Period|Adverse Event|2
5253078|NCT00736853|18125595|P2|Double-Blind Period|Adverse Event|3
5253079|NCT00736853|18125596|P1|Double-Blind Period|Adverse Event|0
5253080|NCT00736853|18125594|P3|Double-Blind Period|Lack of Efficacy|42
5253081|NCT00736853|18125595|P2|Double-Blind Period|Lack of Efficacy|19
5253082|NCT00736853|18125596|P1|Double-Blind Period|Lack of Efficacy|0
5253083|NCT00736853|18125594|P3|Open-Label Period|Unable to attend hospital appointments|0
5253084|NCT00736853|18125595|P2|Open-Label Period|Unable to attend hospital appointments|0
5253085|NCT00736853|18125596|P1|Open-Label Period|Unable to attend hospital appointments|1
5253086|NCT00736853|18125594|P3|Open-Label Period|Failed to meet the transfer criteria|0
5253087|NCT00736853|18125595|P2|Open-Label Period|Failed to meet the transfer criteria|0
5253088|NCT00736853|18125596|P1|Open-Label Period|Failed to meet the transfer criteria|40
5253089|NCT00736853|18125594|P3|Open-Label Period|Started but not treated|0
5253090|NCT00736853|18125595|P2|Open-Label Period|Started but not treated|0
5253091|NCT00736853|18125596|P1|Open-Label Period|Started but not treated|42
5253092|NCT00736853|18125594|P3|Open-Label Period|Withdrawal by Subject|0
5253093|NCT00736853|18125595|P2|Open-Label Period|Withdrawal by Subject|0
5253094|NCT00736853|18125596|P1|Open-Label Period|Withdrawal by Subject|16
5253095|NCT00736853|18125594|P3|Open-Label Period|Adverse Event|0
5253096|NCT00736853|18125595|P2|Open-Label Period|Adverse Event|0
5253097|NCT00736853|18125596|P1|Open-Label Period|Adverse Event|31
5253098|NCT00736853|18125594|P3|Open-Label Period|Physician Decision|0
5253099|NCT00736853|18125595|P2|Open-Label Period|Physician Decision|0
5253100|NCT00736853|18125596|P1|Open-Label Period|Physician Decision|2
5253101|NCT00736840|18125636|P1|Overall Study|Lost to Follow-up|13
5253102|NCT00736723|18125643|P2|Overall Study|Withdrawal by Subject|3
5253103|NCT00736723|18125644|P1|Overall Study|Withdrawal by Subject|4
5253104|NCT00736645|18125654|P4|Overall Study|Adverse Event|0
5253105|NCT00736645|18125655|P3|Overall Study|Adverse Event|0
5253106|NCT00736645|18125656|P2|Overall Study|Adverse Event|2
5253107|NCT00736645|18125657|P1|Overall Study|Adverse Event|0
5253108|NCT00736502|18125707|P1|Overall Study|Lost to Follow-up|27
5253109|NCT00736502|18125707|P1|Overall Study|Lack of Efficacy|16
5253110|NCT00736502|18125707|P1|Overall Study|Adverse Event|22
5253111|NCT00736489|18125713|P6|Period 1|Withdrawal by Subject|1
5253112|NCT00736489|18125714|P5|Period 1|Withdrawal by Subject|0
5253113|NCT00736489|18125715|P4|Period 1|Withdrawal by Subject|0
5253114|NCT00736489|18125716|P3|Period 1|Withdrawal by Subject|0
5253115|NCT00736489|18125717|P2|Period 1|Withdrawal by Subject|0
5253116|NCT00736489|18125718|P1|Period 1|Withdrawal by Subject|0
5253117|NCT00736489|18125713|P6|Period 1|Lost to Follow-up|0
5253118|NCT00736489|18125714|P5|Period 1|Lost to Follow-up|0
5253119|NCT00736489|18125715|P4|Period 1|Lost to Follow-up|0
5253120|NCT00736489|18125716|P3|Period 1|Lost to Follow-up|0
5253121|NCT00736489|18125717|P2|Period 1|Lost to Follow-up|0
5253122|NCT00736489|18125718|P1|Period 1|Lost to Follow-up|1
5253123|NCT00736476|18125872|P2|Overall Study|Adverse Event|0
5253124|NCT00736476|18125873|P1|Overall Study|Adverse Event|1
5253125|NCT00736450|18125893|P1|Overall Study|Physician Decision|1
5253126|NCT00736450|18125893|P1|Overall Study|Withdrawal by Subject|5
5253127|NCT00736450|18125893|P1|Overall Study|Not ABC gene eligible|19
5253128|NCT00736385|18125901|P2|Overall Study|Adverse Event|1
5253129|NCT00736385|18125902|P1|Overall Study|Adverse Event|0
5253130|NCT00736385|18125901|P2|Overall Study|Withdrawal by Subject|2
5253131|NCT00736385|18125902|P1|Overall Study|Withdrawal by Subject|2
5253132|NCT00736333|18125914|P1|Overall Study|Other|4
5253133|NCT00736333|18125914|P1|Overall Study|Death|7
5253134|NCT00736333|18125914|P1|Overall Study|Withdrawal by Subject|10
5253135|NCT00736333|18125914|P1|Overall Study|Toxicity|6
5253136|NCT00736333|18125914|P1|Overall Study|Tumor Progression|75
5253137|NCT00736333|18125914|P1|Overall Study|Data Missing|2
5253138|NCT00736333|18125914|P1|Overall Study|Did Not Receive Drug or Not Documented|7
5253139|NCT00736255|18125925|P2|Overall Study|Non-compliance|1
5253140|NCT00736255|18125926|P1|Overall Study|Non-compliance|1
5253141|NCT00736255|18125925|P2|Overall Study|Physician Decision|0
5253142|NCT00736255|18125926|P1|Overall Study|Physician Decision|1
5253143|NCT00736255|18125925|P2|Overall Study|Adverse Event|0
5253144|NCT00736255|18125926|P1|Overall Study|Adverse Event|1
5253145|NCT00736190|18125973|P1|Overall Study|Adverse Event|1
5253146|NCT00736190|18125973|P1|Overall Study|Withdrawal by Subject|1
5253147|NCT00736190|18125973|P1|Overall Study|Pregnancy|1
5253148|NCT00736099|18126003|P2|Overall Study|Other reason|10
5253149|NCT00736099|18126004|P1|Overall Study|Other reason|43
5253150|NCT00736099|18126003|P2|Overall Study|Lack of Efficacy|8
5253151|NCT00736099|18126004|P1|Overall Study|Lack of Efficacy|15
5253152|NCT00736099|18126003|P2|Overall Study|Withdrawal by Subject|13
5253153|NCT00736099|18126004|P1|Overall Study|Withdrawal by Subject|42
5253154|NCT00736099|18126003|P2|Overall Study|Lost to Follow-up|5
5253155|NCT00736099|18126004|P1|Overall Study|Lost to Follow-up|12
5253156|NCT00736099|18126003|P2|Overall Study|Protocol Violation|4
5253157|NCT00736099|18126004|P1|Overall Study|Protocol Violation|10
5253158|NCT00736099|18126003|P2|Overall Study|Adverse Event|18
5253159|NCT00736099|18126004|P1|Overall Study|Adverse Event|61
5253160|NCT00736034|18126113|P1|Overall Study|Adverse Event|2
5253162|NCT00735943|18126121|P1|Overall Study|Lost to Follow-up|1
5253163|NCT00735904|18126146|P1|Overall Study|Other|8
5253164|NCT00735904|18126146|P1|Overall Study|Study Terminated by Sponsor|5
5253165|NCT00735904|18126146|P1|Overall Study|Withdrawal by Subject|1
5253166|NCT00735904|18126146|P1|Overall Study|Protocol Violation|1
5253167|NCT00735904|18126146|P1|Overall Study|Death|20
5253168|NCT00735904|18126146|P1|Overall Study|Adverse Event|3
5253169|NCT00735878|18126156|P3|Phase I- Dose Determination|Withdrawal by Subject|1
5253170|NCT00735878|18126157|P2|Phase I- Dose Determination|Withdrawal by Subject|0
5253171|NCT00735878|18126158|P1|Phase I- Dose Determination|Withdrawal by Subject|0
5253172|NCT00735709|18126237|P4|Overall Study|Excluded medication|1
5253173|NCT00735709|18126238|P3|Overall Study|Excluded medication|0
5253174|NCT00735709|18126239|P2|Overall Study|Excluded medication|0
5253175|NCT00735709|18126240|P1|Overall Study|Excluded medication|1
5253176|NCT00735709|18126237|P4|Overall Study|Lost to Follow-up|1
5253177|NCT00735709|18126238|P3|Overall Study|Lost to Follow-up|1
5253178|NCT00735709|18126239|P2|Overall Study|Lost to Follow-up|1
5253179|NCT00735709|18126240|P1|Overall Study|Lost to Follow-up|0
5253180|NCT00735709|18126237|P4|Overall Study|Voluntary Withdrawal|7
5253181|NCT00735709|18126238|P3|Overall Study|Voluntary Withdrawal|5
5253182|NCT00735709|18126239|P2|Overall Study|Voluntary Withdrawal|3
5253183|NCT00735709|18126240|P1|Overall Study|Voluntary Withdrawal|1
5253184|NCT00735709|18126237|P4|Overall Study|Protocol deviations|1
5253185|NCT00735709|18126238|P3|Overall Study|Protocol deviations|1
5253186|NCT00735709|18126239|P2|Overall Study|Protocol deviations|2
5253187|NCT00735709|18126240|P1|Overall Study|Protocol deviations|1
5253188|NCT00735709|18126237|P4|Overall Study|Noncompliance|0
5253189|NCT00735709|18126238|P3|Overall Study|Noncompliance|1
5253190|NCT00735709|18126239|P2|Overall Study|Noncompliance|0
5253191|NCT00735709|18126240|P1|Overall Study|Noncompliance|0
5253192|NCT00735709|18126237|P4|Overall Study|Lack of Efficacy|3
5253193|NCT00735709|18126238|P3|Overall Study|Lack of Efficacy|2
5253194|NCT00735709|18126239|P2|Overall Study|Lack of Efficacy|4
5253195|NCT00735709|18126240|P1|Overall Study|Lack of Efficacy|8
5253196|NCT00735709|18126237|P4|Overall Study|Adverse Event|5
5253197|NCT00735709|18126238|P3|Overall Study|Adverse Event|1
5253198|NCT00735709|18126239|P2|Overall Study|Adverse Event|3
5253199|NCT00735709|18126240|P1|Overall Study|Adverse Event|2
5253200|NCT00735696|18126350|P1|Overall Study|Enrolled but never Treated|1
5253201|NCT00735696|18126350|P1|Overall Study|Withdrawal by Subject|1
5253202|NCT00735644|18126378|P5|Overall Study|Withdrawal by Subject|0
5253203|NCT00735644|18126379|P4|Overall Study|Withdrawal by Subject|1
5253204|NCT00735644|18126380|P3|Overall Study|Withdrawal by Subject|1
5253205|NCT00735644|18126381|P2|Overall Study|Withdrawal by Subject|1
5253206|NCT00735644|18126382|P1|Overall Study|Withdrawal by Subject|0
5253207|NCT00735644|18126378|P5|Overall Study|Did not receive study vaccine|0
5253208|NCT00735644|18126379|P4|Overall Study|Did not receive study vaccine|0
5253209|NCT00735644|18126380|P3|Overall Study|Did not receive study vaccine|0
5253210|NCT00735644|18126381|P2|Overall Study|Did not receive study vaccine|1
5253211|NCT00735644|18126382|P1|Overall Study|Did not receive study vaccine|0
5253212|NCT00735553|18126426|P1|Overall Study|Study prematurely terminated|77
5253213|NCT00735475|18126436|P2|Overall Study|Withdrawal by Subject|5
5253214|NCT00735475|18126437|P1|Overall Study|Withdrawal by Subject|4
5253215|NCT00735475|18126436|P2|Overall Study|Physician Decision|1
5253216|NCT00735475|18126437|P1|Overall Study|Physician Decision|0
5253217|NCT00735475|18126436|P2|Overall Study|Lost to Follow-up|3
5253218|NCT00735475|18126437|P1|Overall Study|Lost to Follow-up|3
5253219|NCT00735475|18126436|P2|Overall Study|Death|1
5253220|NCT00735475|18126437|P1|Overall Study|Death|1
5253221|NCT00735475|18126436|P2|Overall Study|Adverse Event|1
5253222|NCT00735475|18126437|P1|Overall Study|Adverse Event|0
5253223|NCT00735397|18126497|P1|Overall Study|Administrative/Other|502
5253224|NCT00735397|18126497|P1|Overall Study|Inadequate therapeutic effect|202
5253225|NCT00735397|18126497|P1|Overall Study|Participant choice|252
5253226|NCT00735397|18126497|P1|Overall Study|Lost to Follow-up|33
5253227|NCT00735397|18126497|P1|Overall Study|Adverse Event|194
5253228|NCT00735371|18126511|P4|Overall Study|Exclusion criteria|0
5253229|NCT00735371|18126512|P3|Overall Study|Exclusion criteria|0
5253230|NCT00735371|18126513|P2|Overall Study|Exclusion criteria|0
5253231|NCT00735371|18126514|P1|Overall Study|Exclusion criteria|1
5253232|NCT00735371|18126511|P4|Overall Study|Prior Vyvanse Exposure|0
5253233|NCT00735371|18126512|P3|Overall Study|Prior Vyvanse Exposure|0
5253234|NCT00735371|18126513|P2|Overall Study|Prior Vyvanse Exposure|1
5253235|NCT00735371|18126514|P1|Overall Study|Prior Vyvanse Exposure|1
5253236|NCT00735371|18126511|P4|Overall Study|Protocol Violation|0
5253237|NCT00735371|18126512|P3|Overall Study|Protocol Violation|2
5253238|NCT00735371|18126513|P2|Overall Study|Protocol Violation|1
5253239|NCT00735371|18126514|P1|Overall Study|Protocol Violation|0
5253240|NCT00735371|18126511|P4|Overall Study|Sponsor Decision|1
5253241|NCT00735371|18126512|P3|Overall Study|Sponsor Decision|0
5253242|NCT00735371|18126513|P2|Overall Study|Sponsor Decision|1
5253243|NCT00735371|18126514|P1|Overall Study|Sponsor Decision|3
5253244|NCT00735371|18126511|P4|Overall Study|Lack of Efficacy|4
5253245|NCT00735371|18126512|P3|Overall Study|Lack of Efficacy|0
5253246|NCT00735371|18126513|P2|Overall Study|Lack of Efficacy|2
5253247|NCT00735371|18126514|P1|Overall Study|Lack of Efficacy|4
5253248|NCT00735371|18126511|P4|Overall Study|Lost to Follow-up|1
5253249|NCT00735371|18126512|P3|Overall Study|Lost to Follow-up|3
5253250|NCT00735371|18126513|P2|Overall Study|Lost to Follow-up|1
5253251|NCT00735371|18126514|P1|Overall Study|Lost to Follow-up|1
5253252|NCT00735371|18126511|P4|Overall Study|Withdrawal by Subject|0
5253253|NCT00735371|18126512|P3|Overall Study|Withdrawal by Subject|2
5253254|NCT00735371|18126513|P2|Overall Study|Withdrawal by Subject|2
5253255|NCT00735371|18126514|P1|Overall Study|Withdrawal by Subject|0
5253256|NCT00735371|18126511|P4|Overall Study|Protocol Violation|3
5253257|NCT00735371|18126512|P3|Overall Study|Protocol Violation|0
5253258|NCT00735371|18126513|P2|Overall Study|Protocol Violation|2
5253259|NCT00735371|18126514|P1|Overall Study|Protocol Violation|2
5253260|NCT00735371|18126511|P4|Overall Study|Adverse Event|1
5253261|NCT00735371|18126512|P3|Overall Study|Adverse Event|4
5253262|NCT00735371|18126513|P2|Overall Study|Adverse Event|3
5253263|NCT00735371|18126514|P1|Overall Study|Adverse Event|3
5253264|NCT00735254|18126542|P4|Overall Study|Protocol Violation|0
5253265|NCT00735254|18126543|P3|Overall Study|Protocol Violation|1
5253266|NCT00735254|18126544|P2|Overall Study|Protocol Violation|1
5253267|NCT00735254|18126545|P1|Overall Study|Protocol Violation|1
5253268|NCT00735072|18126557|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
5253269|NCT00735072|18126558|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
5253270|NCT00735072|18126557|P2|Overall Study|interrupted study med during ARV change|0
5253271|NCT00735072|18126558|P1|Overall Study|interrupted study med during ARV change|1
5253272|NCT00735007|18126572|P1|Overall Study|Protocol Violation|1
5253273|NCT00735007|18126572|P1|Overall Study|Adverse Event|4
5253274|NCT00734994|18126597|P1|Overall Study|Withdrawal by Subject|1
5253275|NCT00734929|18126617|P2|Overall Study|No intervention/ screen fail|3
5253276|NCT00734929|18126618|P1|Overall Study|No intervention/ screen fail|5
5253277|NCT00734929|18126617|P2|Overall Study|Lost to Follow-up|2
5253278|NCT00734929|18126618|P1|Overall Study|Lost to Follow-up|1
5253279|NCT00734851|18126675|P1|Overall Study|Physician Decision|18
5253280|NCT00734851|18126675|P1|Overall Study|Lost to Follow-up|1
5253281|NCT00734851|18126675|P1|Overall Study|Withdrawal by Subject|2
5253282|NCT00734747|18126696|P1|6 Month Follow-up|Did not meet inclusion criteria|3
5253283|NCT00734747|18126696|P1|SRS Procedure|No staples placed|3
5253284|NCT00734656|18126710|P4|Lab Session 4|Withdrawal by Subject|1
5253285|NCT00734656|18126711|P3|Lab Session 4|Withdrawal by Subject|0
5253286|NCT00734656|18126712|P2|Lab Session 4|Withdrawal by Subject|0
5253287|NCT00734656|18126713|P1|Lab Session 4|Withdrawal by Subject|0
5253288|NCT00734656|18126710|P4|Washout 3|Withdrawal by Subject|1
5253289|NCT00734656|18126711|P3|Washout 3|Withdrawal by Subject|0
5253290|NCT00734656|18126712|P2|Washout 3|Withdrawal by Subject|0
5253291|NCT00734656|18126713|P1|Washout 3|Withdrawal by Subject|1
5253292|NCT00734656|18126710|P4|Washout 2|Withdrawal by Subject|0
5253293|NCT00734656|18126711|P3|Washout 2|Withdrawal by Subject|1
5253294|NCT00734656|18126712|P2|Washout 2|Withdrawal by Subject|1
5253295|NCT00734656|18126713|P1|Washout 2|Withdrawal by Subject|1
5253296|NCT00734656|18126710|P4|Lab Session 2|Withdrawal by Subject|1
5253297|NCT00734656|18126711|P3|Lab Session 2|Withdrawal by Subject|0
5253298|NCT00734656|18126712|P2|Lab Session 2|Withdrawal by Subject|0
5253299|NCT00734656|18126713|P1|Lab Session 2|Withdrawal by Subject|1
5253300|NCT00734656|18126710|P4|Washout 1|Withdrawal by Subject|3
5253301|NCT00734656|18126711|P3|Washout 1|Withdrawal by Subject|2
5253302|NCT00734656|18126712|P2|Washout 1|Withdrawal by Subject|5
5253303|NCT00734656|18126713|P1|Washout 1|Withdrawal by Subject|1
5253304|NCT00734656|18126710|P4|Lab Session 1|Withdrawal by Subject|0
5253305|NCT00734656|18126711|P3|Lab Session 1|Withdrawal by Subject|0
5253306|NCT00734656|18126712|P2|Lab Session 1|Withdrawal by Subject|0
5253307|NCT00734656|18126713|P1|Lab Session 1|Withdrawal by Subject|2
5253308|NCT00734630|18126737|P2|Overall Study|Poor Compliance|1
5253309|NCT00734630|18126738|P1|Overall Study|Poor Compliance|1
5253310|NCT00734630|18126737|P2|Overall Study|Tested Positive for Illegal Drug Use|1
5253311|NCT00734630|18126738|P1|Overall Study|Tested Positive for Illegal Drug Use|1
5253312|NCT00734630|18126737|P2|Overall Study|Randomized in Error|1
5253313|NCT00734630|18126738|P1|Overall Study|Randomized in Error|0
5253314|NCT00734630|18126737|P2|Overall Study|Adverse Event|6
5253315|NCT00734630|18126738|P1|Overall Study|Adverse Event|3
5253316|NCT00734630|18126737|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5253317|NCT00734630|18126738|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5253318|NCT00734630|18126737|P2|Overall Study|Protocol Violation|3
5253319|NCT00734630|18126738|P1|Overall Study|Protocol Violation|0
5253320|NCT00734630|18126737|P2|Overall Study|Lost to Follow-up|7
5253321|NCT00734630|18126738|P1|Overall Study|Lost to Follow-up|13
5253322|NCT00734630|18126737|P2|Overall Study|Withdrawal by Subject|9
5253323|NCT00734630|18126738|P1|Overall Study|Withdrawal by Subject|7
5253324|NCT00734630|18126737|P2|Overall Study|Lack of Efficacy|4
5253325|NCT00734630|18126738|P1|Overall Study|Lack of Efficacy|4
5253326|NCT00734617|18126748|P2|Overall Study|Withdrawal by Subject|95
5253327|NCT00734617|18126749|P1|Overall Study|Withdrawal by Subject|103
5253328|NCT00734617|18126748|P2|Overall Study|Adverse Event|7
5253329|NCT00734617|18126749|P1|Overall Study|Adverse Event|4
5253330|NCT00734604|18126761|P6|Overall Study|Lack of Efficacy|0
5253331|NCT00734604|18126762|P5|Overall Study|Lack of Efficacy|0
5253332|NCT00734604|18126763|P4|Overall Study|Lack of Efficacy|0
5253333|NCT00734604|18126764|P3|Overall Study|Lack of Efficacy|1
5253334|NCT00734604|18126765|P2|Overall Study|Lack of Efficacy|1
5253335|NCT00734604|18126766|P1|Overall Study|Lack of Efficacy|0
5253336|NCT00734604|18126761|P6|Overall Study|Withdrawal by Subject|1
5253337|NCT00734604|18126762|P5|Overall Study|Withdrawal by Subject|2
5253338|NCT00734604|18126763|P4|Overall Study|Withdrawal by Subject|1
5253339|NCT00734604|18126764|P3|Overall Study|Withdrawal by Subject|0
5253340|NCT00734604|18126765|P2|Overall Study|Withdrawal by Subject|2
5253341|NCT00734604|18126766|P1|Overall Study|Withdrawal by Subject|0
5253342|NCT00734604|18126761|P6|Overall Study|Sponsor Decision|0
5253343|NCT00734604|18126762|P5|Overall Study|Sponsor Decision|2
5253344|NCT00734604|18126763|P4|Overall Study|Sponsor Decision|0
5253345|NCT00734604|18126764|P3|Overall Study|Sponsor Decision|1
5253346|NCT00734604|18126765|P2|Overall Study|Sponsor Decision|2
5253347|NCT00734604|18126766|P1|Overall Study|Sponsor Decision|1
5253348|NCT00734604|18126761|P6|Overall Study|Protocol Violation|0
5253349|NCT00734604|18126762|P5|Overall Study|Protocol Violation|1
5253350|NCT00734604|18126763|P4|Overall Study|Protocol Violation|0
5253351|NCT00734604|18126764|P3|Overall Study|Protocol Violation|0
5253352|NCT00734604|18126765|P2|Overall Study|Protocol Violation|2
5253353|NCT00734604|18126766|P1|Overall Study|Protocol Violation|0
5253354|NCT00734604|18126761|P6|Overall Study|Physician Decision|0
5253355|NCT00734604|18126762|P5|Overall Study|Physician Decision|0
5253356|NCT00734604|18126763|P4|Overall Study|Physician Decision|0
5253357|NCT00734604|18126764|P3|Overall Study|Physician Decision|1
5253358|NCT00734604|18126765|P2|Overall Study|Physician Decision|1
5253359|NCT00734604|18126766|P1|Overall Study|Physician Decision|0
5253360|NCT00734604|18126761|P6|Overall Study|Lost to Follow-up|3
5253361|NCT00734604|18126762|P5|Overall Study|Lost to Follow-up|2
5253362|NCT00734604|18126763|P4|Overall Study|Lost to Follow-up|4
5253363|NCT00734604|18126764|P3|Overall Study|Lost to Follow-up|2
5253364|NCT00734604|18126765|P2|Overall Study|Lost to Follow-up|2
5253365|NCT00734604|18126766|P1|Overall Study|Lost to Follow-up|1
5253366|NCT00734604|18126761|P6|Overall Study|Serious Adverse Event|1
5253367|NCT00734604|18126762|P5|Overall Study|Serious Adverse Event|0
5253368|NCT00734604|18126763|P4|Overall Study|Serious Adverse Event|2
5253369|NCT00734604|18126764|P3|Overall Study|Serious Adverse Event|1
5253370|NCT00734604|18126765|P2|Overall Study|Serious Adverse Event|0
5253371|NCT00734604|18126766|P1|Overall Study|Serious Adverse Event|1
5253372|NCT00734604|18126761|P6|Overall Study|Adverse Event|1
5253373|NCT00734604|18126762|P5|Overall Study|Adverse Event|1
5253374|NCT00734604|18126763|P4|Overall Study|Adverse Event|2
5253375|NCT00734604|18126764|P3|Overall Study|Adverse Event|0
5253376|NCT00734604|18126765|P2|Overall Study|Adverse Event|2
5253377|NCT00734604|18126766|P1|Overall Study|Adverse Event|0
5253378|NCT00734591|18126816|P2|Prospective Period|Other|2
5253379|NCT00734591|18126817|P1|Prospective Period|Other|2
5253380|NCT00734591|18126816|P2|Prospective Period|Study Terminated|0
5253381|NCT00734591|18126817|P1|Prospective Period|Study Terminated|1
5253382|NCT00734591|18126816|P2|Prospective Period|Lost to Follow-up|33
5253383|NCT00734591|18126817|P1|Prospective Period|Lost to Follow-up|37
5253384|NCT00734591|18126816|P2|Prospective Period|Withdrawal by Subject|9
5253385|NCT00734591|18126817|P1|Prospective Period|Withdrawal by Subject|11
5253386|NCT00734591|18126816|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
5253387|NCT00734591|18126817|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
5253388|NCT00734591|18126816|P2|Screening for Prospective Period|Site did not participate|1488
5253389|NCT00734591|18126817|P1|Screening for Prospective Period|Site did not participate|1604
5253390|NCT00734578|18126832|P3|Overall Study|Exclusion criteria|0
5253391|NCT00734578|18126833|P2|Overall Study|Exclusion criteria|0
5253392|NCT00734578|18126834|P1|Overall Study|Exclusion criteria|1
5253393|NCT00734578|18126832|P3|Overall Study|Randomized in error|0
5253394|NCT00734578|18126833|P2|Overall Study|Randomized in error|0
5253395|NCT00734578|18126834|P1|Overall Study|Randomized in error|1
5253396|NCT00734578|18126832|P3|Overall Study|Lack of Efficacy|5
5253397|NCT00734578|18126833|P2|Overall Study|Lack of Efficacy|2
5253398|NCT00734578|18126834|P1|Overall Study|Lack of Efficacy|3
5253399|NCT00734578|18126832|P3|Overall Study|Lost to Follow-up|5
5253400|NCT00734578|18126833|P2|Overall Study|Lost to Follow-up|3
5253401|NCT00734578|18126834|P1|Overall Study|Lost to Follow-up|9
5253402|NCT00734578|18126832|P3|Overall Study|Withdrawal by Subject|11
5253403|NCT00734578|18126833|P2|Overall Study|Withdrawal by Subject|8
5253404|NCT00734578|18126834|P1|Overall Study|Withdrawal by Subject|7
5253405|NCT00734578|18126832|P3|Overall Study|Protocol Violation|3
5253406|NCT00734578|18126833|P2|Overall Study|Protocol Violation|6
5253407|NCT00734578|18126834|P1|Overall Study|Protocol Violation|8
5253408|NCT00734578|18126832|P3|Overall Study|Adverse Event|1
5253409|NCT00734578|18126833|P2|Overall Study|Adverse Event|6
5253410|NCT00734578|18126834|P1|Overall Study|Adverse Event|4
5253411|NCT00734539|18126868|P2|Main Study|Enrolled in error; ineligible|0
5253412|NCT00734539|18126869|P1|Main Study|Enrolled in error; ineligible|1
5253413|NCT00734539|18126868|P2|Main Study|Withdrawal by Subject|3
5253414|NCT00734539|18126869|P1|Main Study|Withdrawal by Subject|1
5253415|NCT00734539|18126868|P2|Main Study|Physician Decision|0
5253416|NCT00734539|18126869|P1|Main Study|Physician Decision|2
5253417|NCT00734539|18126868|P2|Main Study|Death|32
5253418|NCT00734539|18126869|P1|Main Study|Death|33
5253419|NCT00734474|18126911|P9|Overall Study|Lack of Efficacy|6
5253420|NCT00734474|18126912|P8|Overall Study|Lack of Efficacy|4
5253421|NCT00734474|18126913|P7|Overall Study|Lack of Efficacy|0
5253422|NCT00734474|18126914|P6|Overall Study|Lack of Efficacy|0
5253423|NCT00734474|18126915|P5|Overall Study|Lack of Efficacy|0
5253424|NCT00734474|18126916|P4|Overall Study|Lack of Efficacy|0
5253425|NCT00734474|18126917|P3|Overall Study|Lack of Efficacy|4
5253426|NCT00734474|18126918|P2|Overall Study|Lack of Efficacy|0
5253427|NCT00734474|18126919|P1|Overall Study|Lack of Efficacy|0
5253428|NCT00734474|18126911|P9|Overall Study|Death|1
5253429|NCT00734474|18126912|P8|Overall Study|Death|2
5253430|NCT00734474|18126913|P7|Overall Study|Death|0
5253431|NCT00734474|18126914|P6|Overall Study|Death|0
5253432|NCT00734474|18126915|P5|Overall Study|Death|0
5253433|NCT00734474|18126916|P4|Overall Study|Death|0
5253434|NCT00734474|18126917|P3|Overall Study|Death|1
5253435|NCT00734474|18126918|P2|Overall Study|Death|0
5253436|NCT00734474|18126919|P1|Overall Study|Death|0
5253437|NCT00734474|18126911|P9|Overall Study|Sponsor Decision|0
5253438|NCT00734474|18126912|P8|Overall Study|Sponsor Decision|0
5253439|NCT00734474|18126913|P7|Overall Study|Sponsor Decision|0
5253440|NCT00734474|18126914|P6|Overall Study|Sponsor Decision|0
5253441|NCT00734474|18126915|P5|Overall Study|Sponsor Decision|2
5253442|NCT00734474|18126916|P4|Overall Study|Sponsor Decision|0
5253443|NCT00734474|18126917|P3|Overall Study|Sponsor Decision|0
5253444|NCT00734474|18126918|P2|Overall Study|Sponsor Decision|0
5253445|NCT00734474|18126919|P1|Overall Study|Sponsor Decision|0
5253446|NCT00734474|18126911|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
5253447|NCT00734474|18126912|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
5253448|NCT00734474|18126913|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
5253449|NCT00734474|18126914|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
5253450|NCT00734474|18126915|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
5253451|NCT00734474|18126916|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
5253452|NCT00734474|18126917|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
5253453|NCT00734474|18126918|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
5253454|NCT00734474|18126919|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
5253455|NCT00734474|18126911|P9|Overall Study|Protocol Violation|1
5253456|NCT00734474|18126912|P8|Overall Study|Protocol Violation|3
5253457|NCT00734474|18126913|P7|Overall Study|Protocol Violation|0
5253458|NCT00734474|18126914|P6|Overall Study|Protocol Violation|0
5253459|NCT00734474|18126915|P5|Overall Study|Protocol Violation|3
5253460|NCT00734474|18126916|P4|Overall Study|Protocol Violation|0
5253461|NCT00734474|18126917|P3|Overall Study|Protocol Violation|4
5253462|NCT00734474|18126918|P2|Overall Study|Protocol Violation|0
5253463|NCT00734474|18126919|P1|Overall Study|Protocol Violation|0
5253464|NCT00734474|18126911|P9|Overall Study|Adverse Event|39
5253465|NCT00734474|18126912|P8|Overall Study|Adverse Event|65
5253466|NCT00734474|18126913|P7|Overall Study|Adverse Event|1
5253467|NCT00734474|18126914|P6|Overall Study|Adverse Event|0
5253468|NCT00734474|18126915|P5|Overall Study|Adverse Event|64
5253469|NCT00734474|18126916|P4|Overall Study|Adverse Event|1
5253470|NCT00734474|18126917|P3|Overall Study|Adverse Event|63
5253471|NCT00734474|18126918|P2|Overall Study|Adverse Event|4
5253472|NCT00734474|18126919|P1|Overall Study|Adverse Event|4
5253473|NCT00734474|18126911|P9|Overall Study|Physician Decision|9
5253474|NCT00734474|18126912|P8|Overall Study|Physician Decision|9
5253475|NCT00734474|18126913|P7|Overall Study|Physician Decision|0
5253476|NCT00734474|18126914|P6|Overall Study|Physician Decision|0
5253477|NCT00734474|18126915|P5|Overall Study|Physician Decision|11
5253478|NCT00734474|18126916|P4|Overall Study|Physician Decision|1
5253479|NCT00734474|18126917|P3|Overall Study|Physician Decision|4
5253480|NCT00734474|18126918|P2|Overall Study|Physician Decision|0
5253481|NCT00734474|18126919|P1|Overall Study|Physician Decision|0
5253482|NCT00734474|18126911|P9|Overall Study|Withdrawal by Subject|21
5253483|NCT00734474|18126912|P8|Overall Study|Withdrawal by Subject|36
5253484|NCT00734474|18126913|P7|Overall Study|Withdrawal by Subject|0
5253485|NCT00734474|18126914|P6|Overall Study|Withdrawal by Subject|2
5253486|NCT00734474|18126915|P5|Overall Study|Withdrawal by Subject|24
5253487|NCT00734474|18126916|P4|Overall Study|Withdrawal by Subject|0
5253488|NCT00734474|18126917|P3|Overall Study|Withdrawal by Subject|18
5253489|NCT00734474|18126918|P2|Overall Study|Withdrawal by Subject|1
5253490|NCT00734474|18126919|P1|Overall Study|Withdrawal by Subject|2
5253491|NCT00734474|18126911|P9|Overall Study|Lost to Follow-up|4
5253492|NCT00734474|18126912|P8|Overall Study|Lost to Follow-up|9
5253493|NCT00734474|18126913|P7|Overall Study|Lost to Follow-up|0
5253494|NCT00734474|18126914|P6|Overall Study|Lost to Follow-up|1
5253495|NCT00734474|18126915|P5|Overall Study|Lost to Follow-up|11
5253496|NCT00734474|18126916|P4|Overall Study|Lost to Follow-up|0
5253497|NCT00734474|18126917|P3|Overall Study|Lost to Follow-up|13
5253498|NCT00734474|18126918|P2|Overall Study|Lost to Follow-up|0
5253499|NCT00734474|18126919|P1|Overall Study|Lost to Follow-up|1
5253500|NCT00734474|18126911|P9|Overall Study|Entry Criteria Not Met|1
5253501|NCT00734474|18126912|P8|Overall Study|Entry Criteria Not Met|1
5253502|NCT00734474|18126913|P7|Overall Study|Entry Criteria Not Met|0
5253503|NCT00734474|18126914|P6|Overall Study|Entry Criteria Not Met|1
5253504|NCT00734474|18126915|P5|Overall Study|Entry Criteria Not Met|3
5253505|NCT00734474|18126916|P4|Overall Study|Entry Criteria Not Met|0
5253506|NCT00734474|18126917|P3|Overall Study|Entry Criteria Not Met|5
5253507|NCT00734474|18126918|P2|Overall Study|Entry Criteria Not Met|0
5253508|NCT00734474|18126919|P1|Overall Study|Entry Criteria Not Met|0
5253509|NCT00734214|18127209|P2|Overall Study|MD withdrawal|0
5253510|NCT00734214|18127210|P1|Overall Study|MD withdrawal|1
5253511|NCT00734214|18127209|P2|Overall Study|Withdrawal by Subject|4
5253512|NCT00734214|18127210|P1|Overall Study|Withdrawal by Subject|3
5253513|NCT00734162|18127220|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
5253514|NCT00734162|18127221|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
5253515|NCT00734162|18127222|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
5253516|NCT00734162|18127223|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
5253517|NCT00734162|18127220|P4|Open-Label Phase|Lost to Follow-up|1
5253518|NCT00734162|18127221|P3|Open-Label Phase|Lost to Follow-up|0
5253519|NCT00734162|18127222|P2|Open-Label Phase|Lost to Follow-up|2
5253520|NCT00734162|18127223|P1|Open-Label Phase|Lost to Follow-up|1
5253521|NCT00734162|18127220|P4|Open-Label Phase|Withdrew Consent|1
5253522|NCT00734162|18127221|P3|Open-Label Phase|Withdrew Consent|1
5253523|NCT00734162|18127222|P2|Open-Label Phase|Withdrew Consent|0
5253524|NCT00734162|18127223|P1|Open-Label Phase|Withdrew Consent|1
5253525|NCT00734162|18127220|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
5253526|NCT00734162|18127221|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
5253527|NCT00734162|18127222|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
5253528|NCT00734162|18127223|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
5253529|NCT00734162|18127220|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
5253530|NCT00734162|18127221|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
5253531|NCT00734162|18127222|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
5253532|NCT00734162|18127223|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
5253533|NCT00734162|18127220|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
5253534|NCT00734162|18127221|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
5253535|NCT00734162|18127222|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
5253536|NCT00734162|18127223|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
5253537|NCT00734149|18127447|P1|Overall Study|Withdrawal by Subject|1
5253538|NCT00734097|18127454|P1|Open Label|Protocol Violation|4
5253539|NCT00734097|18127454|P1|Open Label|Withdrawal by Subject|5
5253540|NCT00734097|18127454|P1|Open Label|Lost to Follow-up|7
5253541|NCT00734097|18127454|P1|Screening|Unconfirmed pregnancy|1
5253542|NCT00734097|18127454|P1|Screening|Lost to Follow-up|2
5253543|NCT00734097|18127454|P1|Screening|Withdrawal by Subject|5
5253544|NCT00734097|18127454|P1|Screening|Protocol Violation|12
5253545|NCT00734071|18127471|P2|Overall Study|Other|2
5253546|NCT00734071|18127472|P1|Overall Study|Other|1
5253547|NCT00734071|18127471|P2|Overall Study|Lost to Follow-up|8
5253548|NCT00734071|18127472|P1|Overall Study|Lost to Follow-up|16
5253549|NCT00734071|18127471|P2|Overall Study|Voluntary Withdrawal|7
5253550|NCT00734071|18127472|P1|Overall Study|Voluntary Withdrawal|9
5253551|NCT00734071|18127471|P2|Overall Study|Protocol Deviations|4
5253552|NCT00734071|18127472|P1|Overall Study|Protocol Deviations|3
5253553|NCT00734071|18127471|P2|Overall Study|Noncompliance|2
5253554|NCT00734071|18127472|P1|Overall Study|Noncompliance|2
5253555|NCT00734071|18127471|P2|Overall Study|Lack of Efficacy|1
5253556|NCT00734071|18127472|P1|Overall Study|Lack of Efficacy|3
5253557|NCT00734071|18127471|P2|Overall Study|Adverse Event|3
5253558|NCT00734071|18127472|P1|Overall Study|Adverse Event|4
5253559|NCT00734032|18127530|P4|Overall Study|Adverse Event|0
5253560|NCT00734032|18127531|P3|Overall Study|Adverse Event|0
5253561|NCT00734032|18127532|P2|Overall Study|Adverse Event|1
5253562|NCT00734032|18127533|P1|Overall Study|Adverse Event|0
5253563|NCT00733980|18127589|P2|Overall Study|Withdrawal by Subject|2
5253564|NCT00733980|18127590|P1|Overall Study|Withdrawal by Subject|6
5253565|NCT00733980|18127589|P2|Overall Study|Physician Decision|3
5253566|NCT00733980|18127590|P1|Overall Study|Physician Decision|2
5253567|NCT00733980|18127589|P2|Overall Study|Lost to Follow-up|11
5253568|NCT00733980|18127590|P1|Overall Study|Lost to Follow-up|6
5253569|NCT00733980|18127589|P2|Overall Study|Protocol defined stopping criteria reach|1
5253570|NCT00733980|18127590|P1|Overall Study|Protocol defined stopping criteria reach|1
5253571|NCT00733980|18127589|P2|Overall Study|Protocol Violation|1
5253572|NCT00733980|18127590|P1|Overall Study|Protocol Violation|2
5253573|NCT00733980|18127589|P2|Overall Study|Lack of Efficacy|1
5253574|NCT00733980|18127590|P1|Overall Study|Lack of Efficacy|0
5253575|NCT00733980|18127589|P2|Overall Study|Adverse Event|2
5253576|NCT00733980|18127590|P1|Overall Study|Adverse Event|5
5253577|NCT00733954|18127634|P2|Overall Study|Withdrawal by Subject|0
5253578|NCT00733954|18127635|P1|Overall Study|Withdrawal by Subject|2
5253579|NCT00733954|18127634|P2|Overall Study|Protocol Violation|0
5253580|NCT00733954|18127635|P1|Overall Study|Protocol Violation|1
5253581|NCT00733954|18127634|P2|Overall Study|Lost to Follow-up|2
5253582|NCT00733954|18127635|P1|Overall Study|Lost to Follow-up|5
5253583|NCT00733824|18127682|P5|Phase I|Withdrawal by Subject|0
5253584|NCT00733824|18127683|P4|Phase I|Withdrawal by Subject|0
5253585|NCT00733824|18127684|P3|Phase I|Withdrawal by Subject|0
5253586|NCT00733824|18127685|P2|Phase I|Withdrawal by Subject|0
5253587|NCT00733824|18127686|P1|Phase I|Withdrawal by Subject|1
5253588|NCT00733746|18127705|P1|Overall Study|Ineligible|5
5253589|NCT00733499|18127720|P2|10 Year Followup|missing, unable to locate|2
5253590|NCT00733499|18127721|P1|10 Year Followup|missing, unable to locate|0
5253591|NCT00733499|18127720|P2|10 Year Followup|Withdrawal by Subject|5
5253592|NCT00733499|18127721|P1|10 Year Followup|Withdrawal by Subject|5
5253593|NCT00733499|18127720|P2|10 Year Followup|Lost to Follow-up|2
5253594|NCT00733499|18127721|P1|10 Year Followup|Lost to Follow-up|3
5253595|NCT00733499|18127720|P2|10 Year Followup|Adverse Event|3
5253596|NCT00733499|18127721|P1|10 Year Followup|Adverse Event|3
5253597|NCT00733499|18127720|P2|10 Year Followup|Death|7
5253598|NCT00733499|18127721|P1|10 Year Followup|Death|9
5253599|NCT00733499|18127720|P2|5 Year Followup|Withdrawal by Subject|1
5253600|NCT00733499|18127721|P1|5 Year Followup|Withdrawal by Subject|4
5253601|NCT00733499|18127720|P2|5 Year Followup|missing, unable to locate|1
5253602|NCT00733499|18127721|P1|5 Year Followup|missing, unable to locate|0
5253603|NCT00733499|18127720|P2|5 Year Followup|Death|19
5253604|NCT00733499|18127721|P1|5 Year Followup|Death|13
5253605|NCT00733499|18127720|P2|5 Year Followup|Lost to Follow-up|0
5253606|NCT00733499|18127721|P1|5 Year Followup|Lost to Follow-up|2
5253607|NCT00733499|18127720|P2|5 Year Followup|Revision of Study Implant|1
5253608|NCT00733499|18127721|P1|5 Year Followup|Revision of Study Implant|0
5253609|NCT00733499|18127720|P2|5 Year Followup|Non device related AE|1
5253610|NCT00733499|18127721|P1|5 Year Followup|Non device related AE|0
5253611|NCT00733499|18127720|P2|5 Year Followup|Adverse Event|2
5253612|NCT00733499|18127721|P1|5 Year Followup|Adverse Event|2
5253613|NCT00733499|18127720|P2|24 Months Follow-up|Death|1
5253614|NCT00733499|18127721|P1|24 Months Follow-up|Death|0
5253615|NCT00733499|18127720|P2|12 Months Follow-up|Death|1
5253616|NCT00733499|18127721|P1|12 Months Follow-up|Death|2
5253617|NCT00733499|18127720|P2|6 Months Follow-up|Adverse Event|1
5253618|NCT00733499|18127721|P1|6 Months Follow-up|Adverse Event|0
5253619|NCT00733499|18127720|P2|6 Months Follow-up|Death|2
5253620|NCT00733499|18127721|P1|6 Months Follow-up|Death|0
5253621|NCT00733499|18127720|P2|3 Months Follow-up|Death|2
5253622|NCT00733499|18127721|P1|3 Months Follow-up|Death|1
5253623|NCT00733499|18127720|P2|Pre-operative|Protocol Violation|1
5253624|NCT00733499|18127721|P1|Pre-operative|Protocol Violation|0
5253625|NCT00733421|18127781|P2|Overall Study|Withdrawal by Subject|1
5253626|NCT00733421|18127782|P1|Overall Study|Withdrawal by Subject|1
5253627|NCT00733408|18127804|P1|Overall Study|Adverse Event|4
5253628|NCT00733369|18127816|P2|Overall Study|Protocol Violation|4
5253629|NCT00733369|18127817|P1|Overall Study|Protocol Violation|4
5253630|NCT00733369|18127816|P2|Overall Study|Adverse Event|4
5253631|NCT00733369|18127817|P1|Overall Study|Adverse Event|4
5253632|NCT00733369|18127816|P2|Overall Study|Lost to Follow-up|1
5253633|NCT00733369|18127817|P1|Overall Study|Lost to Follow-up|2
5253634|NCT00733304|18128116|P3|Overall Study|Withdrawal by Subject|0
5253635|NCT00733304|18128117|P2|Overall Study|Withdrawal by Subject|1
5253636|NCT00733304|18128118|P1|Overall Study|Withdrawal by Subject|1
5253637|NCT00733304|18128116|P3|Overall Study|Physician Decision|3
5253638|NCT00733304|18128117|P2|Overall Study|Physician Decision|1
5253639|NCT00733304|18128118|P1|Overall Study|Physician Decision|3
5253640|NCT00733304|18128116|P3|Overall Study|Lost to Follow-up|0
5253641|NCT00733304|18128117|P2|Overall Study|Lost to Follow-up|1
5253642|NCT00733304|18128118|P1|Overall Study|Lost to Follow-up|0
5253643|NCT00733304|18128116|P3|Overall Study|Lack of Efficacy|2
5253644|NCT00733304|18128117|P2|Overall Study|Lack of Efficacy|0
5253645|NCT00733304|18128118|P1|Overall Study|Lack of Efficacy|0
5253646|NCT00733304|18128116|P3|Overall Study|Adverse Event|0
5253647|NCT00733304|18128117|P2|Overall Study|Adverse Event|0
5253648|NCT00733304|18128118|P1|Overall Study|Adverse Event|3
5253649|NCT00733291|18128200|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
5253650|NCT00733291|18128201|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
5253651|NCT00733291|18128202|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
5253652|NCT00733291|18128203|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
5253653|NCT00733226|18128232|P2|Overall Study|moved to another place|0
5253654|NCT00733226|18128233|P1|Overall Study|moved to another place|2
5253655|NCT00733226|18128232|P2|Overall Study|Lost to Follow-up|0
5253656|NCT00733226|18128233|P1|Overall Study|Lost to Follow-up|2
5253657|NCT00733226|18128232|P2|Overall Study|Withdrawal by Subject|0
5253658|NCT00733226|18128233|P1|Overall Study|Withdrawal by Subject|1
5253659|NCT00733005|18128282|P2|Overall Study|Protocol Violation|0
5253660|NCT00733005|18128283|P1|Overall Study|Protocol Violation|2
5253661|NCT00733005|18128282|P2|Overall Study|Withdrawal by Subject|1
5253662|NCT00733005|18128283|P1|Overall Study|Withdrawal by Subject|0
5253663|NCT00733005|18128282|P2|Overall Study|Treatment Failure|1
5253664|NCT00733005|18128283|P1|Overall Study|Treatment Failure|0
5253665|NCT00733005|18128282|P2|Overall Study|Adverse Event|1
5253666|NCT00733005|18128283|P1|Overall Study|Adverse Event|0
5253667|NCT00732992|18128293|P2|Overall Study|Withdrawal by Subject|0
5253668|NCT00732992|18128294|P1|Overall Study|Withdrawal by Subject|1
5253669|NCT00732992|18128293|P2|Overall Study|Global Deterioration of Health Status|0
5253670|NCT00732992|18128294|P1|Overall Study|Global Deterioration of Health Status|1
5253671|NCT00732992|18128293|P2|Overall Study|Objective Progression or Relapse|5
5253672|NCT00732992|18128294|P1|Overall Study|Objective Progression or Relapse|3
5253673|NCT00732992|18128293|P2|Overall Study|Adverse Event|1
5253674|NCT00732992|18128294|P1|Overall Study|Adverse Event|1
5253675|NCT00732940|18128313|P2|Overall Study|Lost to Follow-up|0
5253676|NCT00732940|18128314|P1|Overall Study|Lost to Follow-up|1
5253677|NCT00732940|18128313|P2|Overall Study|Adverse Event|1
5253678|NCT00732940|18128314|P1|Overall Study|Adverse Event|0
5253679|NCT00732940|18128313|P2|Overall Study|Withdrawal by Subject|2
5253680|NCT00732940|18128314|P1|Overall Study|Withdrawal by Subject|1
5253681|NCT00732875|18128395|P1|Overall Study|Lack of Efficacy|13
5253682|NCT00732875|18128395|P1|Overall Study|Withdrawal by Subject|6
5253683|NCT00732875|18128395|P1|Overall Study|Adverse Event|16
5253684|NCT00732758|18128403|P2|Overall Study|Lost to Follow-up|16
5253685|NCT00732758|18128404|P1|Overall Study|Lost to Follow-up|8
5253686|NCT00732641|18128444|P2|Overall Study|Other|5
5253687|NCT00732641|18128445|P1|Overall Study|Other|18
5253688|NCT00732641|18128444|P2|Overall Study|Unable to Complete|1
5253689|NCT00732641|18128445|P1|Overall Study|Unable to Complete|1
5253690|NCT00732641|18128444|P2|Overall Study|Withdrawal by Subject|2
5253691|NCT00732641|18128445|P1|Overall Study|Withdrawal by Subject|4
5253692|NCT00732641|18128444|P2|Overall Study|Physician Decision|0
5253693|NCT00732641|18128445|P1|Overall Study|Physician Decision|6
5253694|NCT00732641|18128444|P2|Overall Study|Serious Adverse Events|3
5253695|NCT00732641|18128445|P1|Overall Study|Serious Adverse Events|12
5253696|NCT00732641|18128444|P2|Overall Study|Relapse or Progressive Disease|101
5253697|NCT00732641|18128445|P1|Overall Study|Relapse or Progressive Disease|65
5253698|NCT00732615|18128465|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
5253699|NCT00732615|18128466|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
5253700|NCT00732615|18128465|P2|Overall Study|Physician Decision|0
5253701|NCT00732615|18128466|P1|Overall Study|Physician Decision|3
5253702|NCT00732615|18128465|P2|Overall Study|Adverse Event|2
5253703|NCT00732615|18128466|P1|Overall Study|Adverse Event|0
5253704|NCT00732615|18128465|P2|Overall Study|Lost to Follow-up|1
5253705|NCT00732615|18128466|P1|Overall Study|Lost to Follow-up|0
5253706|NCT00732615|18128465|P2|Overall Study|Withdrawal by Subject|1
5253707|NCT00732615|18128466|P1|Overall Study|Withdrawal by Subject|3
5253708|NCT00732498|18128478|P1|Overall Study|Physician Decision|3
5253709|NCT00732498|18128478|P1|Overall Study|Adverse Event|2
5253710|NCT00732498|18128478|P1|Overall Study|Ineligible|1
5253711|NCT00732472|18128489|P4|Overall Study|Withdrawal by Subject|1
5253712|NCT00732472|18128490|P3|Overall Study|Withdrawal by Subject|0
5253713|NCT00732472|18128491|P2|Overall Study|Withdrawal by Subject|2
5253714|NCT00732472|18128492|P1|Overall Study|Withdrawal by Subject|0
5253715|NCT00732472|18128489|P4|Overall Study|Protocol Violation|1
5253716|NCT00732472|18128490|P3|Overall Study|Protocol Violation|0
5253717|NCT00732472|18128491|P2|Overall Study|Protocol Violation|0
5253718|NCT00732472|18128492|P1|Overall Study|Protocol Violation|0
5253719|NCT00732472|18128489|P4|Overall Study|Adverse Event|1
5253720|NCT00732472|18128490|P3|Overall Study|Adverse Event|1
5253721|NCT00732472|18128491|P2|Overall Study|Adverse Event|1
5253722|NCT00732472|18128492|P1|Overall Study|Adverse Event|0
5253723|NCT00732381|18128592|P2|Overall Study|Treatment Failure|1
5253724|NCT00732381|18128593|P1|Overall Study|Treatment Failure|1
5253725|NCT00732381|18128592|P2|Overall Study|Adverse Event|0
5253726|NCT00732381|18128593|P1|Overall Study|Adverse Event|1
5253727|NCT00732303|18128601|P1|Overall Study|Study Terminated|2
5253728|NCT00732251|18128607|P1|Overall Study|Early Term due to Site Closure|1
5253729|NCT00732251|18128607|P1|Overall Study|Withdrawal by Subject|3
5253730|NCT00732251|18128607|P1|Overall Study|Lost to Follow-up|3
5253731|NCT00732238|18128615|P2|Overall Study|Asymptomatic bacteriuria|0
5253732|NCT00732238|18128616|P1|Overall Study|Asymptomatic bacteriuria|1
5253733|NCT00732238|18128615|P2|Overall Study|Bacteremia|1
5253734|NCT00732238|18128616|P1|Overall Study|Bacteremia|4
5253735|NCT00732199|18128717|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
5253736|NCT00732199|18128718|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
5253737|NCT00732199|18128717|P2|Overall Study|Withdrawal by Subject|18
5253738|NCT00732199|18128718|P1|Overall Study|Withdrawal by Subject|25
5253739|NCT00732160|18128733|P4|Overall Study|scheduling|1
5253740|NCT00732160|18128734|P3|Overall Study|scheduling|2
5253741|NCT00732160|18128735|P2|Overall Study|scheduling|4
5253742|NCT00732160|18128736|P1|Overall Study|scheduling|4
5253743|NCT00732160|18128733|P4|Overall Study|Adverse Event|1
5253744|NCT00732160|18128734|P3|Overall Study|Adverse Event|1
5253745|NCT00732160|18128735|P2|Overall Study|Adverse Event|0
5253746|NCT00732160|18128736|P1|Overall Study|Adverse Event|1
5253747|NCT00732069|18128750|P6|Washout After First Study Drug|Adverse Event|0
5253748|NCT00732069|18128751|P5|Washout After First Study Drug|Adverse Event|0
5253749|NCT00732069|18128752|P4|Washout After First Study Drug|Adverse Event|0
5253750|NCT00732069|18128753|P3|Washout After First Study Drug|Adverse Event|0
5253751|NCT00732069|18128754|P2|Washout After First Study Drug|Adverse Event|0
5253752|NCT00732069|18128755|P1|Washout After First Study Drug|Adverse Event|1
5253753|NCT00731939|18128773|P1|Overall Study|Did not meet enrollment criteria|2
5253754|NCT00731939|18128773|P1|Overall Study|Withdrawal by Subject|2
5253755|NCT00731939|18128773|P1|Overall Study|Not implanted with study device|9
5253756|NCT00731939|18128773|P1|Overall Study|Lost to Follow-up|15
5253757|NCT00731939|18128773|P1|Overall Study|Adverse Event|6
5253758|NCT00731822|18128850|P2|Overall Study|Lost to Follow-up|0
5253759|NCT00731822|18128851|P1|Overall Study|Lost to Follow-up|1
5253760|NCT00731822|18128850|P2|Overall Study|Protocol Violation|0
5253761|NCT00731822|18128851|P1|Overall Study|Protocol Violation|1
5253762|NCT00731822|18128850|P2|Overall Study|Adverse Event|1
5253763|NCT00731822|18128851|P1|Overall Study|Adverse Event|2
5253764|NCT00731783|18128865|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
5253765|NCT00731783|18128866|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
5253766|NCT00731783|18128865|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
5253767|NCT00731783|18128866|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
5253768|NCT00731783|18128865|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
5253769|NCT00731783|18128866|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
5253770|NCT00731783|18128865|P2|One Month Follow-Up Visit|Lost to Follow-up|22
5253771|NCT00731783|18128866|P1|One Month Follow-Up Visit|Lost to Follow-up|14
5253772|NCT00731731|18128900|P3|Overall Study|Cancel prior to treatment|2
5253773|NCT00731731|18128901|P2|Overall Study|Cancel prior to treatment|0
5253774|NCT00731731|18128902|P1|Overall Study|Cancel prior to treatment|0
5253775|NCT00731731|18128900|P3|Overall Study|Protocol Violation|1
5253776|NCT00731731|18128901|P2|Overall Study|Protocol Violation|0
5253777|NCT00731731|18128902|P1|Overall Study|Protocol Violation|0
5253778|NCT00731692|18128920|P3|Extension Phase|Adverse Event|15
5253779|NCT00731692|18128921|P2|Extension Phase|Adverse Event|1
5253780|NCT00731692|18128922|P1|Extension Phase|Adverse Event|1
5253781|NCT00731692|18128920|P3|Extension Phase|Withdrawal by Subject|3
5253782|NCT00731692|18128921|P2|Extension Phase|Withdrawal by Subject|5
5253783|NCT00731692|18128922|P1|Extension Phase|Withdrawal by Subject|4
5253784|NCT00731692|18128920|P3|Extension Phase|Lost to Follow-up|4
5253785|NCT00731692|18128921|P2|Extension Phase|Lost to Follow-up|1
5253786|NCT00731692|18128922|P1|Extension Phase|Lost to Follow-up|0
5253787|NCT00731692|18128920|P3|Extension Phase|Abnormal lab values|1
5253788|NCT00731692|18128921|P2|Extension Phase|Abnormal lab values|0
5253789|NCT00731692|18128922|P1|Extension Phase|Abnormal lab values|0
5253790|NCT00731692|18128920|P3|Extension Phase|Abnormal test procedure|1
5253791|NCT00731692|18128921|P2|Extension Phase|Abnormal test procedure|0
5253792|NCT00731692|18128922|P1|Extension Phase|Abnormal test procedure|0
5253793|NCT00731692|18128920|P3|Extension Phase|Admin Problems: Terminated # patients|277
5253794|NCT00731692|18128921|P2|Extension Phase|Admin Problems: Terminated # patients|189
5253795|NCT00731692|18128922|P1|Extension Phase|Admin Problems: Terminated # patients|69
5253796|NCT00731692|18128920|P3|Core Study (36 Months)|Withdrawal by Subject|46
5253797|NCT00731692|18128921|P2|Core Study (36 Months)|Withdrawal by Subject|32
5253798|NCT00731692|18128922|P1|Core Study (36 Months)|Withdrawal by Subject|12
5253799|NCT00731692|18128920|P3|Core Study (36 Months)|Adverse Event|29
5253800|NCT00731692|18128921|P2|Core Study (36 Months)|Adverse Event|28
5253801|NCT00731692|18128922|P1|Core Study (36 Months)|Adverse Event|25
5253802|NCT00731692|18128920|P3|Core Study (36 Months)|Abnormal Lab values|5
5253803|NCT00731692|18128921|P2|Core Study (36 Months)|Abnormal Lab values|19
5253804|NCT00731692|18128922|P1|Core Study (36 Months)|Abnormal Lab values|6
5253805|NCT00731692|18128920|P3|Core Study (36 Months)|Protocol Violation|8
5253806|NCT00731692|18128921|P2|Core Study (36 Months)|Protocol Violation|5
5253807|NCT00731692|18128922|P1|Core Study (36 Months)|Protocol Violation|4
5253808|NCT00731692|18128920|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
5253809|NCT00731692|18128921|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
5253810|NCT00731692|18128922|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
5253811|NCT00731692|18128920|P3|Core Study (36 Months)|Administrative|6
5253812|NCT00731692|18128921|P2|Core Study (36 Months)|Administrative|2
5253813|NCT00731692|18128922|P1|Core Study (36 Months)|Administrative|2
5253814|NCT00731692|18128920|P3|Core Study (36 Months)|Lost to Follow-up|3
5253815|NCT00731692|18128921|P2|Core Study (36 Months)|Lost to Follow-up|3
5253816|NCT00731692|18128922|P1|Core Study (36 Months)|Lost to Follow-up|1
5253817|NCT00731692|18128920|P3|Core Study (36 Months)|Death|2
5253818|NCT00731692|18128921|P2|Core Study (36 Months)|Death|1
5253819|NCT00731692|18128922|P1|Core Study (36 Months)|Death|2
5253820|NCT00731692|18128920|P3|Core Study (36 Months)|Physician Decision|2
5253821|NCT00731692|18128921|P2|Core Study (36 Months)|Physician Decision|0
5253822|NCT00731692|18128922|P1|Core Study (36 Months)|Physician Decision|1
5253823|NCT00731692|18128920|P3|Core Study (36 Months)|Lack of Efficacy|64
5253824|NCT00731692|18128921|P2|Core Study (36 Months)|Lack of Efficacy|23
5253825|NCT00731692|18128922|P1|Core Study (36 Months)|Lack of Efficacy|11
5253826|NCT00731679|18128968|P2|Overall Study|Pregnancy|1
5253827|NCT00731679|18128969|P1|Overall Study|Pregnancy|0
5253828|NCT00731679|18128968|P2|Overall Study|Noncompliance|1
5253829|NCT00731679|18128969|P1|Overall Study|Noncompliance|0
5253830|NCT00731679|18128968|P2|Overall Study|Lost to Follow-up|8
5253831|NCT00731679|18128969|P1|Overall Study|Lost to Follow-up|7
5253832|NCT00731679|18128968|P2|Overall Study|Withdrawal by Subject|8
5253833|NCT00731679|18128969|P1|Overall Study|Withdrawal by Subject|8
5253834|NCT00731679|18128968|P2|Overall Study|Adverse Event|8
5253835|NCT00731679|18128969|P1|Overall Study|Adverse Event|7
5253836|NCT00731666|18128977|P1|Overall Study|Withdrawal by Subject|2
5253837|NCT00731666|18128977|P1|Overall Study|Lost to Follow-up|8
5253838|NCT00731666|18128977|P1|Overall Study|Adverse Event|2
5253839|NCT00731549|18129013|P1|Overall Study|Lack of efficacy without AE|6
5253840|NCT00731549|18129013|P1|Overall Study|Lack of efficacy with AE|37
5253841|NCT00731549|18129013|P1|Overall Study|Adverse Event|31
5253842|NCT00731549|18129013|P1|Overall Study|Protocol deviation|1
5253843|NCT00731549|18129013|P1|Overall Study|Withdrawal by Subject|89
5253844|NCT00731549|18129013|P1|Overall Study|Physician Decision|16
5253845|NCT00731549|18129013|P1|Overall Study|Met withdrawal criteria|24
5253846|NCT00731549|18129013|P1|Overall Study|Lost to Follow-up|19
5253847|NCT00731133|18129053|P1|Overall Study|Withdrawal by Subject|10
5253848|NCT00731120|18129061|P3|Overall Study|Other|1
5253849|NCT00731120|18129062|P2|Overall Study|Other|0
5253850|NCT00731120|18129063|P1|Overall Study|Other|4
5253851|NCT00731120|18129061|P3|Overall Study|Lost to Follow-up|17
5253852|NCT00731120|18129062|P2|Overall Study|Lost to Follow-up|15
5253853|NCT00731120|18129063|P1|Overall Study|Lost to Follow-up|10
5253854|NCT00731120|18129061|P3|Overall Study|Withdrawal of Consent|4
5253855|NCT00731120|18129062|P2|Overall Study|Withdrawal of Consent|8
5253856|NCT00731120|18129063|P1|Overall Study|Withdrawal of Consent|13
5253857|NCT00731120|18129061|P3|Overall Study|Protocol Deviations|1
5253858|NCT00731120|18129062|P2|Overall Study|Protocol Deviations|6
5253859|NCT00731120|18129063|P1|Overall Study|Protocol Deviations|1
5253860|NCT00731120|18129061|P3|Overall Study|Noncompliance with Study Drug|1
5253861|NCT00731120|18129062|P2|Overall Study|Noncompliance with Study Drug|3
5253862|NCT00731120|18129063|P1|Overall Study|Noncompliance with Study Drug|3
5253863|NCT00731120|18129061|P3|Overall Study|Lack of Efficacy|4
5253864|NCT00731120|18129062|P2|Overall Study|Lack of Efficacy|5
5253865|NCT00731120|18129063|P1|Overall Study|Lack of Efficacy|4
5253866|NCT00731120|18129061|P3|Overall Study|Adverse Event|8
5253867|NCT00731120|18129062|P2|Overall Study|Adverse Event|6
5253868|NCT00731120|18129063|P1|Overall Study|Adverse Event|7
5253869|NCT00731042|18129180|P2|Second Intervention|Did not meet inclusion criteria|2
5253870|NCT00731042|18129181|P1|Second Intervention|Did not meet inclusion criteria|0
5253871|NCT00730925|18129192|P1|Overall Study|Other|1
5253872|NCT00730925|18129192|P1|Overall Study|Switch to combination therapy|8
5253873|NCT00730925|18129192|P1|Overall Study|Withdrawal by Subject|1
5253874|NCT00730925|18129192|P1|Overall Study|Protocol Violation|1
5253875|NCT00730925|18129192|P1|Overall Study|Other Averse Event|7
5253876|NCT00730925|18129192|P1|Overall Study|Dose reducing Event|2
5253877|NCT00730925|18129192|P1|Overall Study|Progressive Disease|21
5253878|NCT00730912|18129202|P3|Overall Study|Discontinued|1
5253879|NCT00730912|18129203|P2|Overall Study|Discontinued|0
5253880|NCT00730912|18129204|P1|Overall Study|Discontinued|0
5253881|NCT00730886|18129217|P2|Overall Study|Physician Decision|0
5253882|NCT00730886|18129218|P1|Overall Study|Physician Decision|1
5253883|NCT00730886|18129217|P2|Overall Study|Lost to Follow-up|0
5253884|NCT00730886|18129218|P1|Overall Study|Lost to Follow-up|1
5253885|NCT00730847|18129242|P1|Overall Study|Other|24
5253886|NCT00730847|18129242|P1|Overall Study|Unknown completion status|21
5253887|NCT00730847|18129242|P1|Overall Study|Lost to Follow-up|67
5253888|NCT00730847|18129242|P1|Overall Study|Withdrawal by Subject|16
5253889|NCT00730847|18129242|P1|Overall Study|Protocol Violation|2
5253890|NCT00730847|18129242|P1|Overall Study|Adverse Event|1
5253891|NCT00730756|18129251|P2|Overall Study|Withdrew Consent|1
5253892|NCT00730756|18129252|P1|Overall Study|Withdrew Consent|0
5253893|NCT00730756|18129251|P2|Overall Study|Lost to Follow-up|1
5253894|NCT00730756|18129252|P1|Overall Study|Lost to Follow-up|0
5253895|NCT00730756|18129251|P2|Overall Study|Protocol Deviation|2
5253896|NCT00730756|18129252|P1|Overall Study|Protocol Deviation|1
5253897|NCT00730756|18129251|P2|Overall Study|Lack of Efficacy|1
5253898|NCT00730756|18129252|P1|Overall Study|Lack of Efficacy|1
5253899|NCT00730756|18129251|P2|Overall Study|Adverse Event|0
5253900|NCT00730756|18129252|P1|Overall Study|Adverse Event|2
5253901|NCT00730691|18129286|P5|Overall Study|Other|2
5253902|NCT00730691|18129287|P4|Overall Study|Other|2
5253903|NCT00730691|18129288|P3|Overall Study|Other|1
5253904|NCT00730691|18129289|P2|Overall Study|Other|1
5253905|NCT00730691|18129290|P1|Overall Study|Other|1
5253906|NCT00730691|18129286|P5|Overall Study|Lost to Follow-up|13
5253907|NCT00730691|18129287|P4|Overall Study|Lost to Follow-up|15
5253908|NCT00730691|18129288|P3|Overall Study|Lost to Follow-up|13
5253909|NCT00730691|18129289|P2|Overall Study|Lost to Follow-up|8
5253910|NCT00730691|18129290|P1|Overall Study|Lost to Follow-up|11
5253911|NCT00730691|18129286|P5|Overall Study|Withdrawal of Consent|3
5253912|NCT00730691|18129287|P4|Overall Study|Withdrawal of Consent|6
5253913|NCT00730691|18129288|P3|Overall Study|Withdrawal of Consent|3
5253914|NCT00730691|18129289|P2|Overall Study|Withdrawal of Consent|9
5253915|NCT00730691|18129290|P1|Overall Study|Withdrawal of Consent|7
5253916|NCT00730691|18129286|P5|Overall Study|Protocol Deviations|5
5253917|NCT00730691|18129287|P4|Overall Study|Protocol Deviations|7
5253918|NCT00730691|18129288|P3|Overall Study|Protocol Deviations|3
5253919|NCT00730691|18129289|P2|Overall Study|Protocol Deviations|5
5253920|NCT00730691|18129290|P1|Overall Study|Protocol Deviations|3
5253921|NCT00730691|18129286|P5|Overall Study|Non-compliance with Study Drug|3
5253922|NCT00730691|18129287|P4|Overall Study|Non-compliance with Study Drug|3
5253923|NCT00730691|18129288|P3|Overall Study|Non-compliance with Study Drug|6
5253924|NCT00730691|18129289|P2|Overall Study|Non-compliance with Study Drug|1
5253925|NCT00730691|18129290|P1|Overall Study|Non-compliance with Study Drug|6
5253926|NCT00730691|18129286|P5|Overall Study|Lack of Efficacy|1
5253927|NCT00730691|18129287|P4|Overall Study|Lack of Efficacy|1
5253928|NCT00730691|18129288|P3|Overall Study|Lack of Efficacy|2
5253929|NCT00730691|18129289|P2|Overall Study|Lack of Efficacy|4
5253930|NCT00730691|18129290|P1|Overall Study|Lack of Efficacy|4
5253931|NCT00730691|18129286|P5|Overall Study|Adverse Event|23
5253932|NCT00730691|18129287|P4|Overall Study|Adverse Event|11
5253933|NCT00730691|18129288|P3|Overall Study|Adverse Event|11
5253934|NCT00730691|18129289|P2|Overall Study|Adverse Event|8
5253935|NCT00730691|18129290|P1|Overall Study|Adverse Event|4
5253936|NCT00730639|18129382|P5|Overall Study|Treatment on-going|4
5253937|NCT00730639|18129383|P4|Overall Study|Treatment on-going|4
5253938|NCT00730639|18129384|P3|Overall Study|Treatment on-going|5
5253939|NCT00730639|18129385|P2|Overall Study|Treatment on-going|5
5253940|NCT00730639|18129386|P1|Overall Study|Treatment on-going|2
5253941|NCT00730639|18129382|P5|Overall Study|Withdrawal by Subject|4
5253942|NCT00730639|18129383|P4|Overall Study|Withdrawal by Subject|3
5253943|NCT00730639|18129384|P3|Overall Study|Withdrawal by Subject|6
5253944|NCT00730639|18129385|P2|Overall Study|Withdrawal by Subject|0
5253945|NCT00730639|18129386|P1|Overall Study|Withdrawal by Subject|0
5253946|NCT00730639|18129382|P5|Overall Study|Protocol Violation|0
5253947|NCT00730639|18129383|P4|Overall Study|Protocol Violation|0
5253948|NCT00730639|18129384|P3|Overall Study|Protocol Violation|1
5253949|NCT00730639|18129385|P2|Overall Study|Protocol Violation|0
5253950|NCT00730639|18129386|P1|Overall Study|Protocol Violation|0
5253951|NCT00730639|18129382|P5|Overall Study|non-specified|3
5253952|NCT00730639|18129383|P4|Overall Study|non-specified|2
5253953|NCT00730639|18129384|P3|Overall Study|non-specified|4
5253954|NCT00730639|18129385|P2|Overall Study|non-specified|0
5253955|NCT00730639|18129386|P1|Overall Study|non-specified|0
5253956|NCT00730639|18129382|P5|Overall Study|Disease Progression|88
5253957|NCT00730639|18129383|P4|Overall Study|Disease Progression|32
5253958|NCT00730639|18129384|P3|Overall Study|Disease Progression|48
5253959|NCT00730639|18129385|P2|Overall Study|Disease Progression|13
5253960|NCT00730639|18129386|P1|Overall Study|Disease Progression|12
5253961|NCT00730639|18129382|P5|Overall Study|Death|2
5253962|NCT00730639|18129383|P4|Overall Study|Death|0
5253963|NCT00730639|18129384|P3|Overall Study|Death|0
5253964|NCT00730639|18129385|P2|Overall Study|Death|0
5253965|NCT00730639|18129386|P1|Overall Study|Death|0
5253966|NCT00730639|18129382|P5|Overall Study|Completed Maximum Cycles|6
5253967|NCT00730639|18129383|P4|Overall Study|Completed Maximum Cycles|3
5253968|NCT00730639|18129384|P3|Overall Study|Completed Maximum Cycles|11
5253969|NCT00730639|18129385|P2|Overall Study|Completed Maximum Cycles|0
5253970|NCT00730639|18129386|P1|Overall Study|Completed Maximum Cycles|0
5253971|NCT00730639|18129382|P5|Overall Study|Complete Response|1
5253972|NCT00730639|18129383|P4|Overall Study|Complete Response|2
5253973|NCT00730639|18129384|P3|Overall Study|Complete Response|2
5253974|NCT00730639|18129385|P2|Overall Study|Complete Response|0
5253975|NCT00730639|18129386|P1|Overall Study|Complete Response|0
5253976|NCT00730639|18129382|P5|Overall Study|Adverse Event|23
5253977|NCT00730639|18129383|P4|Overall Study|Adverse Event|8
5253978|NCT00730639|18129384|P3|Overall Study|Adverse Event|9
5253979|NCT00730639|18129385|P2|Overall Study|Adverse Event|0
5253980|NCT00730639|18129386|P1|Overall Study|Adverse Event|3
5253981|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
5253982|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
5253983|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
5253984|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
5253985|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
5253986|NCT00730405|18129463|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5253987|NCT00730405|18129464|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
5253988|NCT00730405|18129465|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5253989|NCT00730405|18129466|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5253990|NCT00730405|18129467|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5253991|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Other Protocol violation|0
5253992|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Other Protocol violation|0
5253993|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Other Protocol violation|1
5253994|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Other Protocol violation|0
5253995|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Other Protocol violation|0
5253996|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Mis-randomized|0
5253997|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Mis-randomized|0
5253998|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Mis-randomized|0
5253999|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Mis-randomized|1
5254000|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Mis-randomized|0
5254001|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5254002|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5254003|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
5254004|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5254005|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5254006|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
5254007|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
5254008|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
5254009|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
5254010|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
5254011|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Missing|0
5254012|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Missing|0
5254013|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Missing|2
5254014|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Missing|0
5254015|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Missing|0
5254016|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Non-compliance|0
5254017|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Non-compliance|0
5254018|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Non-compliance|2
5254019|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Non-compliance|0
5254020|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Non-compliance|1
5254021|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Use of restricted medication|0
5254022|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Use of restricted medication|0
5254023|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Use of restricted medication|0
5254024|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Use of restricted medication|1
5254025|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Use of restricted medication|0
5254026|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
5254027|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
5254028|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
5254029|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
5254030|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
5254031|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
5254032|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
5254033|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
5254034|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
5254035|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
5254036|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5254037|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
5254038|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5254039|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5254040|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5254041|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5254042|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5254043|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5254044|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5254045|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
5254046|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
5254047|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5254048|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5254049|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5254050|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5254051|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5254052|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5254053|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
5254054|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5254055|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5254056|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5254057|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5254058|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
5254059|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5254060|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5254061|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Did not met eligibility|0
5254062|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Did not met eligibility|0
5254063|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Did not met eligibility|1
5254064|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Did not met eligibility|0
5254065|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Did not met eligibility|0
5254066|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Change of location|0
5254067|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Change of location|1
5254068|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Change of location|0
5254069|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Change of location|1
5254070|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Change of location|1
5254071|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Death|0
5254072|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Death|1
5254073|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Death|0
5254074|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Death|1
5254075|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Death|0
5254076|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
5254077|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
5254078|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
5254079|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
5254080|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
5254081|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
5254082|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
5254083|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
5254084|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
5254085|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
5254086|NCT00730405|18129463|P5|Overall Study-follow-up Phase|Adverse Event|4
5254087|NCT00730405|18129464|P4|Overall Study-follow-up Phase|Adverse Event|3
5254088|NCT00730405|18129465|P3|Overall Study-follow-up Phase|Adverse Event|2
5254089|NCT00730405|18129466|P2|Overall Study-follow-up Phase|Adverse Event|6
5254090|NCT00730405|18129467|P1|Overall Study-follow-up Phase|Adverse Event|2
5254091|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
5254092|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
5254093|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
5254094|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
5254095|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
5254096|NCT00730405|18129463|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
5254097|NCT00730405|18129464|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5254098|NCT00730405|18129465|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5254257|NCT00730015|18129730|P2|Overall Study|Protocol Violation|6
5254099|NCT00730405|18129466|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5254100|NCT00730405|18129467|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5254101|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Pregnancy|0
5254102|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Pregnancy|0
5254103|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Pregnancy|0
5254104|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Pregnancy|1
5254105|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Pregnancy|0
5254106|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Change of location|0
5254107|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Change of location|1
5254108|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Change of location|0
5254109|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Change of location|0
5254110|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Change of location|0
5254111|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5254112|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5254113|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
5254114|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5254115|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5254116|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5254117|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
5254118|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5254119|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5254120|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5254121|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Study drug interrupted|0
5254122|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Study drug interrupted|0
5254123|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Study drug interrupted|0
5254124|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Study drug interrupted|1
5254125|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Study drug interrupted|0
5254126|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Misrandomized|0
5254127|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Misrandomized|0
5254128|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Misrandomized|0
5254129|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Misrandomized|1
5254130|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Misrandomized|0
5254131|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5254132|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5254133|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
5254134|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5254135|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5254136|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
5254137|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
5254138|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
5254139|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
5254140|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
5254141|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
5254142|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
5254143|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
5254144|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
5254145|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
5254146|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5254147|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5254148|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5254149|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5254150|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
5254151|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
5254152|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
5254153|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
5254154|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
5254155|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
5254156|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Did not met eligibility|0
5254157|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Did not met eligibility|0
5254158|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Did not met eligibility|1
5254159|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Did not met eligibility|0
5254160|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Did not met eligibility|0
5254161|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
5254162|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
5254163|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
5254164|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
5254165|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
5254166|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
5254167|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
5254168|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
5254169|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
5254170|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
5254171|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
5254172|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
5254173|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
5254174|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
5254175|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
5254176|NCT00730405|18129463|P5|Overall Study-Treatment Phase|Adverse Event|4
5254177|NCT00730405|18129464|P4|Overall Study-Treatment Phase|Adverse Event|8
5254178|NCT00730405|18129465|P3|Overall Study-Treatment Phase|Adverse Event|4
5254179|NCT00730405|18129466|P2|Overall Study-Treatment Phase|Adverse Event|10
5254180|NCT00730405|18129467|P1|Overall Study-Treatment Phase|Adverse Event|5
5254181|NCT00730327|18129514|P2|Overall Study|Subject withdrew (reason not specified)|7
5254182|NCT00730327|18129515|P1|Overall Study|Subject withdrew (reason not specified)|2
5254183|NCT00730327|18129514|P2|Overall Study|Withdrawal by Subject|13
5254184|NCT00730327|18129515|P1|Overall Study|Withdrawal by Subject|3
5254185|NCT00730327|18129514|P2|Overall Study|Adverse Event|1
5254186|NCT00730327|18129515|P1|Overall Study|Adverse Event|8
5254187|NCT00730327|18129514|P2|Overall Study|Lost to Follow-up|16
5254188|NCT00730327|18129515|P1|Overall Study|Lost to Follow-up|14
5254189|NCT00730275|18129540|P4|Overall Study|Withdrawal by Subject|1
5254190|NCT00730275|18129541|P3|Overall Study|Withdrawal by Subject|0
5254191|NCT00730275|18129542|P2|Overall Study|Withdrawal by Subject|0
5254192|NCT00730275|18129543|P1|Overall Study|Withdrawal by Subject|0
5254193|NCT00730236|18129569|P1|Overall Study|Non-compliance|1
5254194|NCT00730236|18129569|P1|Overall Study|Withdrawal by Subject|1
5254195|NCT00730236|18129569|P1|Overall Study|Adverse Event|4
5254196|NCT00730171|18129584|P1|Overall Study|Other|61
5254197|NCT00730171|18129584|P1|Overall Study|Insufficient Therapeutic Response|141
5254198|NCT00730171|18129584|P1|Overall Study|Lost to Follow-up|121
5254199|NCT00730171|18129584|P1|Overall Study|Withdrawal by Subject|202
5254200|NCT00730171|18129584|P1|Overall Study|Protocol Violation|48
5254201|NCT00730171|18129584|P1|Overall Study|Adverse Event|193
5254202|NCT00730171|18129584|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
5254203|NCT00730158|18129594|P2|Overall Study|Withdrawal by Subject|1
5254204|NCT00730158|18129595|P1|Overall Study|Withdrawal by Subject|1
5254205|NCT00730132|18129633|P1|Overall Study|Death|1
5254206|NCT00730132|18129633|P1|Overall Study|Protocol Violation|154
5254207|NCT00730041|18129651|P2|Overall Study|Lost to Follow-up|2
5254208|NCT00730041|18129652|P1|Overall Study|Lost to Follow-up|0
5254209|NCT00730028|18129675|P5|Overall Study|Randomization Error|2
5254210|NCT00730028|18129676|P4|Overall Study|Randomization Error|0
5254211|NCT00730028|18129677|P3|Overall Study|Randomization Error|0
5254212|NCT00730028|18129678|P2|Overall Study|Randomization Error|0
5254213|NCT00730028|18129679|P1|Overall Study|Randomization Error|1
5254214|NCT00730028|18129675|P5|Overall Study|Treatment Failure|1
5254215|NCT00730028|18129676|P4|Overall Study|Treatment Failure|0
5254216|NCT00730028|18129677|P3|Overall Study|Treatment Failure|0
5254217|NCT00730028|18129678|P2|Overall Study|Treatment Failure|5
5254218|NCT00730028|18129679|P1|Overall Study|Treatment Failure|5
5254219|NCT00730028|18129675|P5|Overall Study|Physician Decision|2
5254220|NCT00730028|18129676|P4|Overall Study|Physician Decision|3
5254221|NCT00730028|18129677|P3|Overall Study|Physician Decision|2
5254222|NCT00730028|18129678|P2|Overall Study|Physician Decision|3
5254223|NCT00730028|18129679|P1|Overall Study|Physician Decision|3
5254224|NCT00730028|18129675|P5|Overall Study|Withdrawal by Subject|9
5254225|NCT00730028|18129676|P4|Overall Study|Withdrawal by Subject|5
5254226|NCT00730028|18129677|P3|Overall Study|Withdrawal by Subject|4
5254227|NCT00730028|18129678|P2|Overall Study|Withdrawal by Subject|5
5254228|NCT00730028|18129679|P1|Overall Study|Withdrawal by Subject|9
5254229|NCT00730028|18129675|P5|Overall Study|Protocol Violation|0
5254230|NCT00730028|18129676|P4|Overall Study|Protocol Violation|2
5254231|NCT00730028|18129677|P3|Overall Study|Protocol Violation|1
5254232|NCT00730028|18129678|P2|Overall Study|Protocol Violation|1
5254233|NCT00730028|18129679|P1|Overall Study|Protocol Violation|6
5254234|NCT00730028|18129675|P5|Overall Study|Lost to Follow-up|25
5254235|NCT00730028|18129676|P4|Overall Study|Lost to Follow-up|26
5254236|NCT00730028|18129677|P3|Overall Study|Lost to Follow-up|22
5254237|NCT00730028|18129678|P2|Overall Study|Lost to Follow-up|26
5254238|NCT00730028|18129679|P1|Overall Study|Lost to Follow-up|13
5254239|NCT00730028|18129675|P5|Overall Study|Adverse Event|43
5254240|NCT00730028|18129676|P4|Overall Study|Adverse Event|20
5254241|NCT00730028|18129677|P3|Overall Study|Adverse Event|16
5254242|NCT00730028|18129678|P2|Overall Study|Adverse Event|26
5254243|NCT00730028|18129679|P1|Overall Study|Adverse Event|23
5254244|NCT00730015|18129729|P3|Overall Study|Other Reason|1
5254245|NCT00730015|18129730|P2|Overall Study|Other Reason|0
5254246|NCT00730015|18129731|P1|Overall Study|Other Reason|1
5254247|NCT00730015|18129729|P3|Overall Study|Lack of Efficacy|8
5254248|NCT00730015|18129730|P2|Overall Study|Lack of Efficacy|2
5254249|NCT00730015|18129731|P1|Overall Study|Lack of Efficacy|1
5254250|NCT00730015|18129729|P3|Overall Study|Lost to Follow-up|3
5254251|NCT00730015|18129730|P2|Overall Study|Lost to Follow-up|10
5254252|NCT00730015|18129731|P1|Overall Study|Lost to Follow-up|4
5254253|NCT00730015|18129729|P3|Overall Study|Withdrawal by Subject|8
5254254|NCT00730015|18129730|P2|Overall Study|Withdrawal by Subject|12
5254255|NCT00730015|18129731|P1|Overall Study|Withdrawal by Subject|12
5254256|NCT00730015|18129729|P3|Overall Study|Protocol Violation|4
5254258|NCT00730015|18129731|P1|Overall Study|Protocol Violation|2
5254259|NCT00730015|18129729|P3|Overall Study|Adverse Event|8
5254260|NCT00730015|18129730|P2|Overall Study|Adverse Event|10
5254261|NCT00730015|18129731|P1|Overall Study|Adverse Event|11
5254262|NCT00729937|18129771|P6|Overall Study|Incarcerated|0
5254263|NCT00729937|18129772|P5|Overall Study|Incarcerated|0
5254264|NCT00729937|18129773|P4|Overall Study|Incarcerated|1
5254265|NCT00729937|18129774|P3|Overall Study|Incarcerated|1
5254266|NCT00729937|18129775|P2|Overall Study|Incarcerated|2
5254267|NCT00729937|18129776|P1|Overall Study|Incarcerated|0
5254268|NCT00729937|18129771|P6|Overall Study|Did not meet eligibility criteria|0
5254269|NCT00729937|18129772|P5|Overall Study|Did not meet eligibility criteria|0
5254270|NCT00729937|18129773|P4|Overall Study|Did not meet eligibility criteria|0
5254271|NCT00729937|18129774|P3|Overall Study|Did not meet eligibility criteria|0
5254272|NCT00729937|18129775|P2|Overall Study|Did not meet eligibility criteria|1
5254273|NCT00729937|18129776|P1|Overall Study|Did not meet eligibility criteria|2
5254274|NCT00729937|18129771|P6|Overall Study|Randomized but not treated|3
5254275|NCT00729937|18129772|P5|Overall Study|Randomized but not treated|1
5254276|NCT00729937|18129773|P4|Overall Study|Randomized but not treated|0
5254277|NCT00729937|18129774|P3|Overall Study|Randomized but not treated|1
5254278|NCT00729937|18129775|P2|Overall Study|Randomized but not treated|6
5254279|NCT00729937|18129776|P1|Overall Study|Randomized but not treated|12
5254280|NCT00729937|18129771|P6|Overall Study|Withdrawal by Subject|2
5254281|NCT00729937|18129772|P5|Overall Study|Withdrawal by Subject|4
5254282|NCT00729937|18129773|P4|Overall Study|Withdrawal by Subject|0
5254283|NCT00729937|18129774|P3|Overall Study|Withdrawal by Subject|6
5254284|NCT00729937|18129775|P2|Overall Study|Withdrawal by Subject|5
5254285|NCT00729937|18129776|P1|Overall Study|Withdrawal by Subject|3
5254286|NCT00729937|18129771|P6|Overall Study|Death|1
5254287|NCT00729937|18129772|P5|Overall Study|Death|0
5254288|NCT00729937|18129773|P4|Overall Study|Death|0
5254289|NCT00729937|18129774|P3|Overall Study|Death|1
5254290|NCT00729937|18129775|P2|Overall Study|Death|0
5254291|NCT00729937|18129776|P1|Overall Study|Death|1
5254292|NCT00729937|18129771|P6|Overall Study|Physician Decision|8
5254293|NCT00729937|18129772|P5|Overall Study|Physician Decision|5
5254294|NCT00729937|18129773|P4|Overall Study|Physician Decision|0
5254295|NCT00729937|18129774|P3|Overall Study|Physician Decision|2
5254296|NCT00729937|18129775|P2|Overall Study|Physician Decision|16
5254297|NCT00729937|18129776|P1|Overall Study|Physician Decision|7
5254298|NCT00729937|18129771|P6|Overall Study|Lost to Follow-up|23
5254299|NCT00729937|18129772|P5|Overall Study|Lost to Follow-up|18
5254300|NCT00729937|18129773|P4|Overall Study|Lost to Follow-up|33
5254301|NCT00729937|18129774|P3|Overall Study|Lost to Follow-up|18
5254302|NCT00729937|18129775|P2|Overall Study|Lost to Follow-up|58
5254303|NCT00729937|18129776|P1|Overall Study|Lost to Follow-up|49
5254304|NCT00729859|18129980|P3|Overall Study|Withdrawal by Subject|0
5254305|NCT00729859|18129981|P2|Overall Study|Withdrawal by Subject|1
5254306|NCT00729859|18129982|P1|Overall Study|Withdrawal by Subject|0
5254307|NCT00729859|18129980|P3|Overall Study|Adverse Event|0
5254308|NCT00729859|18129981|P2|Overall Study|Adverse Event|1
5254309|NCT00729859|18129982|P1|Overall Study|Adverse Event|0
5254310|NCT00729833|18130026|P4|Overall Study|Unspecified Reasons|1
5254311|NCT00729833|18130027|P3|Overall Study|Unspecified Reasons|5
5254312|NCT00729833|18130028|P2|Overall Study|Unspecified Reasons|5
5254313|NCT00729833|18130029|P1|Overall Study|Unspecified Reasons|11
5254314|NCT00729833|18130026|P4|Overall Study|Withdrawal by Subject|0
5254315|NCT00729833|18130027|P3|Overall Study|Withdrawal by Subject|3
5254316|NCT00729833|18130028|P2|Overall Study|Withdrawal by Subject|1
5254317|NCT00729833|18130029|P1|Overall Study|Withdrawal by Subject|3
5254318|NCT00729833|18130026|P4|Overall Study|Lost to Follow-up|0
5254319|NCT00729833|18130027|P3|Overall Study|Lost to Follow-up|0
5254320|NCT00729833|18130028|P2|Overall Study|Lost to Follow-up|0
5254321|NCT00729833|18130029|P1|Overall Study|Lost to Follow-up|1
5254322|NCT00729833|18130026|P4|Overall Study|Study Terminated by Sponsor|0
5254323|NCT00729833|18130027|P3|Overall Study|Study Terminated by Sponsor|1
5254324|NCT00729833|18130028|P2|Overall Study|Study Terminated by Sponsor|0
5254325|NCT00729833|18130029|P1|Overall Study|Study Terminated by Sponsor|0
5254326|NCT00729833|18130026|P4|Overall Study|Death|5
5254327|NCT00729833|18130027|P3|Overall Study|Death|3
5254328|NCT00729833|18130028|P2|Overall Study|Death|1
5254329|NCT00729833|18130029|P1|Overall Study|Death|5
5254330|NCT00729690|18130087|P3|Overall Study|IT Catheter Malfunction|2
5254331|NCT00729690|18130088|P2|Overall Study|IT Catheter Malfunction|2
5254332|NCT00729690|18130089|P1|Overall Study|IT Catheter Malfunction|0
5254333|NCT00729651|18130119|P2|Overall Study|Subject's private reason|0
5254334|NCT00729651|18130120|P1|Overall Study|Subject's private reason|2
5254335|NCT00729651|18130119|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
5254336|NCT00729651|18130120|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
5254337|NCT00729651|18130119|P2|Overall Study|Adverse Event|3
5254338|NCT00729651|18130120|P1|Overall Study|Adverse Event|7
5254339|NCT00729651|18130119|P2|Overall Study|Protocol Violation|1
5254340|NCT00729651|18130120|P1|Overall Study|Protocol Violation|0
5254341|NCT00729651|18130119|P2|Overall Study|Lost to Follow-up|4
5254342|NCT00729651|18130120|P1|Overall Study|Lost to Follow-up|5
5254343|NCT00729651|18130119|P2|Overall Study|Withdrawal by Subject|6
5254344|NCT00729651|18130120|P1|Overall Study|Withdrawal by Subject|5
5254345|NCT00729612|18130132|P1|Overall Study|Non evaluable for response|10
5254346|NCT00729586|18130141|P2|Overall Study|never treated|0
5254347|NCT00729586|18130142|P1|Overall Study|never treated|1
5254348|NCT00729586|18130141|P2|Overall Study|Ineligible|1
5254349|NCT00729586|18130142|P1|Overall Study|Ineligible|0
5254350|NCT00729560|18130155|P1|Overall Study|Withdrawal by Subject|3
5254351|NCT00729469|18130181|P2|Overall Study|Other-Not mentioned|4
5254352|NCT00729469|18130182|P1|Overall Study|Other-Not mentioned|9
5254353|NCT00729469|18130181|P2|Overall Study|Withdrawal by Subject|8
5254354|NCT00729469|18130182|P1|Overall Study|Withdrawal by Subject|19
5254355|NCT00729469|18130181|P2|Overall Study|Protocol Violation|1
5254356|NCT00729469|18130182|P1|Overall Study|Protocol Violation|2
5254357|NCT00729469|18130181|P2|Overall Study|Lost to Follow-up|9
5254358|NCT00729469|18130182|P1|Overall Study|Lost to Follow-up|9
5254359|NCT00729469|18130181|P2|Overall Study|Adverse Event|25
5254360|NCT00729469|18130182|P1|Overall Study|Adverse Event|14
5254361|NCT00729378|18130235|P2|36-months|Lost to Follow-up|6
5254362|NCT00729378|18130236|P1|36-months|Lost to Follow-up|15
5254363|NCT00729378|18130235|P2|24-months|Lost to Follow-up|51
5254364|NCT00729378|18130236|P1|24-months|Lost to Follow-up|72
5254365|NCT00729378|18130235|P2|12-months|Lost to Follow-up|65
5254366|NCT00729378|18130236|P1|12-months|Lost to Follow-up|100
5254367|NCT00729378|18130235|P2|Baseline|Withdrawal by Subject|59
5254368|NCT00729378|18130236|P1|Baseline|Withdrawal by Subject|66
5254369|NCT00729378|18130235|P2|Baseline|Did not complete study measurements|33
5254370|NCT00729378|18130236|P1|Baseline|Did not complete study measurements|72
5254371|NCT00729365|18130435|P3|Overall Study|Physician Decision|7
5254372|NCT00729365|18130436|P2|Overall Study|Physician Decision|6
5254373|NCT00729365|18130437|P1|Overall Study|Physician Decision|33
5254374|NCT00729326|18130450|P2|Overall Study|Sponsor Decision|2
5254375|NCT00729326|18130451|P1|Overall Study|Sponsor Decision|1
5254376|NCT00729326|18130450|P2|Overall Study|Subject Decision|4
5254377|NCT00729326|18130451|P1|Overall Study|Subject Decision|4
5254378|NCT00729326|18130450|P2|Overall Study|Protocol Violation|2
5254379|NCT00729326|18130451|P1|Overall Study|Protocol Violation|3
5254380|NCT00729326|18130450|P2|Overall Study|Physician Decision|1
5254381|NCT00729326|18130451|P1|Overall Study|Physician Decision|0
5254382|NCT00729326|18130450|P2|Overall Study|Lost to Follow-up|0
5254383|NCT00729326|18130451|P1|Overall Study|Lost to Follow-up|2
5254384|NCT00729248|18130493|P1|Overall Study|Physician Decision|2
5254385|NCT00729183|18130500|P2|Overall Study|Withdrawal by Subject|7
5254386|NCT00729183|18130501|P1|Overall Study|Withdrawal by Subject|9
5254387|NCT00729183|18130500|P2|Overall Study|Protocol Violation|0
5254388|NCT00729183|18130501|P1|Overall Study|Protocol Violation|1
5254389|NCT00729183|18130500|P2|Overall Study|Physician Decision|1
5254390|NCT00729183|18130501|P1|Overall Study|Physician Decision|1
5254391|NCT00729183|18130500|P2|Overall Study|Lost to Follow-up|1
5254392|NCT00729183|18130501|P1|Overall Study|Lost to Follow-up|3
5254393|NCT00729183|18130500|P2|Overall Study|Lack of Efficacy|1
5254394|NCT00729183|18130501|P1|Overall Study|Lack of Efficacy|0
5254395|NCT00729183|18130500|P2|Overall Study|Adverse Event|5
5254396|NCT00729183|18130501|P1|Overall Study|Adverse Event|11
5254397|NCT00729157|18130533|P1|Overall Study|Withdrawal by Subject|1
5254398|NCT00728988|18130576|P2|Overall Study|Withdrawal by Subject|6
5254399|NCT00728988|18130577|P1|Overall Study|Withdrawal by Subject|2
5254400|NCT00728988|18130576|P2|Overall Study|Other|77
5254401|NCT00728988|18130577|P1|Overall Study|Other|85
5254402|NCT00728988|18130576|P2|Overall Study|Adverse Event|2
5254403|NCT00728988|18130577|P1|Overall Study|Adverse Event|3
5254404|NCT00728988|18130576|P2|Overall Study|Death|1
5254405|NCT00728988|18130577|P1|Overall Study|Death|1
5254406|NCT00728988|18130576|P2|Overall Study|Not Treated|2
5254407|NCT00728988|18130577|P1|Overall Study|Not Treated|2
5254408|NCT00728962|18130595|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
5254409|NCT00728962|18130595|P1|Permanent Prosthesis Placement|Adverse Event|3
5254410|NCT00728962|18130595|P1|Implant Placement Surgery|Protocol Violation|1
5254411|NCT00728962|18130595|P1|Implant Placement Surgery|Lost to Follow-up|1
5254412|NCT00728962|18130595|P1|Implant Placement Surgery|Adverse Event|8
5254413|NCT00728949|18130601|P2|Overall Study|On treatment at cutoff date|0
5254414|NCT00728949|18130602|P1|Overall Study|On treatment at cutoff date|1
5254415|NCT00728949|18130601|P2|Overall Study|Abnormal Lab Results|2
5254416|NCT00728949|18130602|P1|Overall Study|Abnormal Lab Results|0
5254417|NCT00728949|18130601|P2|Overall Study|Withdrawal by Subject|2
5254418|NCT00728949|18130602|P1|Overall Study|Withdrawal by Subject|2
5254419|NCT00728949|18130601|P2|Overall Study|Adverse Event|0
5254420|NCT00728949|18130602|P1|Overall Study|Adverse Event|8
5254421|NCT00728936|18130627|P7|Overall Study|Withdrawal by Subject|0
5254422|NCT00728936|18130628|P6|Overall Study|Withdrawal by Subject|1
5254423|NCT00728936|18130629|P5|Overall Study|Withdrawal by Subject|0
5254424|NCT00728936|18130630|P4|Overall Study|Withdrawal by Subject|0
5254425|NCT00728936|18130631|P3|Overall Study|Withdrawal by Subject|0
5254426|NCT00728936|18130632|P2|Overall Study|Withdrawal by Subject|0
5254427|NCT00728936|18130633|P1|Overall Study|Withdrawal by Subject|0
5254428|NCT00728884|18130666|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
5254429|NCT00728884|18130666|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
5254430|NCT00728754|18130702|P2|One Year Post Placement Follow-up|Adverse Event|0
5254431|NCT00728754|18130703|P1|One Year Post Placement Follow-up|Adverse Event|1
5254432|NCT00728754|18130702|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
5254433|NCT00728754|18130703|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
5254434|NCT00728754|18130702|P2|Permanent Prosthesis Placement|Adverse Event|1
5254435|NCT00728754|18130703|P1|Permanent Prosthesis Placement|Adverse Event|1
5254436|NCT00728689|18130732|P2|Washout Period (Days 4 - 10)|Death in family|0
5254437|NCT00728689|18130733|P1|Washout Period (Days 4 - 10)|Death in family|1
5254438|NCT00728494|18130762|P2|Overall Study|No data available|1
5254439|NCT00728494|18130763|P1|Overall Study|No data available|0
5254440|NCT00728494|18130762|P2|Overall Study|Lack of Efficacy|4
5254441|NCT00728494|18130763|P1|Overall Study|Lack of Efficacy|2
5254442|NCT00728494|18130762|P2|Overall Study|Withdrawal by Subject|2
5254443|NCT00728494|18130763|P1|Overall Study|Withdrawal by Subject|0
5254444|NCT00728494|18130762|P2|Overall Study|Adverse Event|0
5254445|NCT00728494|18130763|P1|Overall Study|Adverse Event|7
5254446|NCT00728481|18130781|P2|Overall Study|Incorrectly assigned to opposite arm|0
5254447|NCT00728481|18130782|P1|Overall Study|Incorrectly assigned to opposite arm|1
5254448|NCT00728481|18130781|P2|Overall Study|Study medication non-compliance|2
5254449|NCT00728481|18130782|P1|Overall Study|Study medication non-compliance|0
5254450|NCT00728481|18130781|P2|Overall Study|Adverse Event|1
5254451|NCT00728481|18130782|P1|Overall Study|Adverse Event|0
5254452|NCT00728481|18130781|P2|Overall Study|Withdrawal by Subject|1
5254453|NCT00728481|18130782|P1|Overall Study|Withdrawal by Subject|0
5254454|NCT00728468|18130798|P1|Overall Study|Study terminated by sponsor|1
5254455|NCT00728468|18130798|P1|Overall Study|Objective progression or relapse|9
5254456|NCT00728468|18130798|P1|Overall Study|Protocol Violation|4
5254457|NCT00728468|18130798|P1|Overall Study|Death|1
5254458|NCT00728468|18130798|P1|Overall Study|Enrolled but not treated|1
5254459|NCT00728416|18130822|P2|Overall Study|Withdrawal by Subject|0
5254460|NCT00728416|18130823|P1|Overall Study|Withdrawal by Subject|1
5254461|NCT00728416|18130822|P2|Overall Study|Treatment Failure|1
5254462|NCT00728416|18130823|P1|Overall Study|Treatment Failure|0
5254463|NCT00728416|18130822|P2|Overall Study|Adverse Event|1
5254464|NCT00728416|18130823|P1|Overall Study|Adverse Event|1
5254465|NCT00728182|18130839|P2|Overall Study|Protocol Noncompliance|1
5254466|NCT00728182|18130840|P1|Overall Study|Protocol Noncompliance|0
5254467|NCT00728182|18130839|P2|Overall Study|Death|2
5254468|NCT00728182|18130840|P1|Overall Study|Death|0
5254469|NCT00728182|18130839|P2|Overall Study|Lost to Follow-up|0
5254470|NCT00728182|18130840|P1|Overall Study|Lost to Follow-up|2
5254471|NCT00728182|18130839|P2|Overall Study|Adverse Event|0
5254472|NCT00728182|18130840|P1|Overall Study|Adverse Event|1
5254473|NCT00728130|18130868|P1|Overall Study|Physician Decision|1
5254474|NCT00728130|18130868|P1|Overall Study|Paperwork not completed in time|1
5254475|NCT00728130|18130868|P1|Overall Study|Withdrawal by Subject|1
5254476|NCT00727961|18130873|P1|Overall Study|Progression|30
5254477|NCT00727961|18130873|P1|Overall Study|Patient's refusal|2
5254478|NCT00727961|18130873|P1|Overall Study|Adverse Event|4
5254479|NCT00727961|18130873|P1|Overall Study|Lost to Follow-up|1
5254480|NCT00727909|18130883|P4|Overall Study|Death|0
5254481|NCT00727909|18130884|P3|Overall Study|Death|1
5254482|NCT00727909|18130885|P2|Overall Study|Death|0
5254483|NCT00727909|18130886|P1|Overall Study|Death|0
5254484|NCT00727909|18130883|P4|Overall Study|Withdrawal by Subject|5
5254485|NCT00727909|18130884|P3|Overall Study|Withdrawal by Subject|8
5254486|NCT00727909|18130885|P2|Overall Study|Withdrawal by Subject|11
5254487|NCT00727909|18130886|P1|Overall Study|Withdrawal by Subject|5
5254488|NCT00727844|18130983|P4|Initial Randomization|Physician Decision|0
5254489|NCT00727844|18130984|P3|Initial Randomization|Physician Decision|0
5254490|NCT00727844|18130985|P2|Initial Randomization|Physician Decision|0
5254491|NCT00727844|18130986|P1|Initial Randomization|Physician Decision|2
5254492|NCT00727714|18131000|P1|Overall Study|Lost to Follow-up|2
5254493|NCT00727649|18131010|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
5254494|NCT00727649|18131011|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
5254495|NCT00727649|18131010|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
5254496|NCT00727649|18131011|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
5254497|NCT00727649|18131010|P2|Second Intervention (4-weeks)|Death|0
5254498|NCT00727649|18131011|P1|Second Intervention (4-weeks)|Death|1
5254499|NCT00727649|18131010|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
5254500|NCT00727649|18131011|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
5254501|NCT00727649|18131010|P2|Wash-out (2-weeks)|Lost to Follow-up|1
5254502|NCT00727649|18131011|P1|Wash-out (2-weeks)|Lost to Follow-up|3
5254503|NCT00727649|18131010|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
5254504|NCT00727649|18131011|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
5254505|NCT00727649|18131010|P2|First Intervention (4-weeks)|Lost to Follow-up|2
5254506|NCT00727649|18131011|P1|First Intervention (4-weeks)|Lost to Follow-up|1
5254507|NCT00727571|18131053|P4|Overall Study|Other|0
5254508|NCT00727571|18131054|P3|Overall Study|Other|6
5254509|NCT00727571|18131055|P2|Overall Study|Other|4
5254510|NCT00727571|18131056|P1|Overall Study|Other|0
5254511|NCT00727571|18131053|P4|Overall Study|AE not leading to hospitalization|0
5254512|NCT00727571|18131054|P3|Overall Study|AE not leading to hospitalization|2
5254513|NCT00727571|18131055|P2|Overall Study|AE not leading to hospitalization|0
5254514|NCT00727571|18131056|P1|Overall Study|AE not leading to hospitalization|0
5254515|NCT00727571|18131053|P4|Overall Study|Hospitalization|1
5254516|NCT00727571|18131054|P3|Overall Study|Hospitalization|0
5254517|NCT00727571|18131055|P2|Overall Study|Hospitalization|1
5254518|NCT00727571|18131056|P1|Overall Study|Hospitalization|0
5254519|NCT00727571|18131053|P4|Overall Study|Dismissed from nursing home|0
5254520|NCT00727571|18131054|P3|Overall Study|Dismissed from nursing home|5
5254521|NCT00727571|18131055|P2|Overall Study|Dismissed from nursing home|9
5254522|NCT00727571|18131056|P1|Overall Study|Dismissed from nursing home|0
5254523|NCT00727571|18131053|P4|Overall Study|Subject Non Compliance|4
5254524|NCT00727571|18131054|P3|Overall Study|Subject Non Compliance|0
5254525|NCT00727571|18131055|P2|Overall Study|Subject Non Compliance|6
5254526|NCT00727571|18131056|P1|Overall Study|Subject Non Compliance|0
5254527|NCT00727571|18131053|P4|Overall Study|Withdrawal by Subject|0
5254528|NCT00727571|18131054|P3|Overall Study|Withdrawal by Subject|11
5254529|NCT00727571|18131055|P2|Overall Study|Withdrawal by Subject|10
5254530|NCT00727571|18131056|P1|Overall Study|Withdrawal by Subject|0
5254531|NCT00727571|18131053|P4|Overall Study|Physician Decision|0
5254532|NCT00727571|18131054|P3|Overall Study|Physician Decision|0
5254533|NCT00727571|18131055|P2|Overall Study|Physician Decision|5
5254534|NCT00727571|18131056|P1|Overall Study|Physician Decision|0
5254535|NCT00727571|18131053|P4|Overall Study|Death|1
5254536|NCT00727571|18131054|P3|Overall Study|Death|5
5254537|NCT00727571|18131055|P2|Overall Study|Death|19
5254538|NCT00727571|18131056|P1|Overall Study|Death|0
5254539|NCT00727571|18131053|P4|Overall Study|Ineligibility determined|0
5254540|NCT00727571|18131054|P3|Overall Study|Ineligibility determined|1
5254541|NCT00727571|18131055|P2|Overall Study|Ineligibility determined|1
5254542|NCT00727571|18131056|P1|Overall Study|Ineligibility determined|1
5254543|NCT00727558|18131083|P2|Overall Study|Lost to Follow-up|0
5254544|NCT00727558|18131084|P1|Overall Study|Lost to Follow-up|1
5254545|NCT00727558|18131083|P2|Overall Study|Subject unable to return for follow-up|1
5254546|NCT00727558|18131084|P1|Overall Study|Subject unable to return for follow-up|1
5254547|NCT00727558|18131083|P2|Overall Study|Adverse Event|1
5254548|NCT00727558|18131084|P1|Overall Study|Adverse Event|0
5254549|NCT00727558|18131083|P2|Overall Study|Lens issue|1
5254550|NCT00727558|18131084|P1|Overall Study|Lens issue|0
5254551|NCT00727532|18131102|P1|Overall Study|Withdrawal by Subject|1
5254552|NCT00727532|18131102|P1|Overall Study|Adverse Event|1
5254553|NCT00727506|18131114|P6|Overall Study|Other reason not described above|1
5254554|NCT00727506|18131115|P5|Overall Study|Other reason not described above|1
5254555|NCT00727506|18131116|P4|Overall Study|Other reason not described above|4
5254556|NCT00727506|18131117|P3|Overall Study|Other reason not described above|1
5254557|NCT00727506|18131118|P2|Overall Study|Other reason not described above|0
5254558|NCT00727506|18131119|P1|Overall Study|Other reason not described above|0
5254559|NCT00727506|18131114|P6|Overall Study|Refused to continue medication|2
5254560|NCT00727506|18131115|P5|Overall Study|Refused to continue medication|1
5254561|NCT00727506|18131116|P4|Overall Study|Refused to continue medication|3
5254562|NCT00727506|18131117|P3|Overall Study|Refused to continue medication|2
5254563|NCT00727506|18131118|P2|Overall Study|Refused to continue medication|1
5254564|NCT00727506|18131119|P1|Overall Study|Refused to continue medication|0
5254565|NCT00727506|18131114|P6|Overall Study|Progressive disease|28
5254566|NCT00727506|18131115|P5|Overall Study|Progressive disease|38
5254567|NCT00727506|18131116|P4|Overall Study|Progressive disease|28
5254568|NCT00727506|18131117|P3|Overall Study|Progressive disease|9
5254569|NCT00727506|18131118|P2|Overall Study|Progressive disease|7
5254570|NCT00727506|18131119|P1|Overall Study|Progressive disease|4
5254571|NCT00727506|18131114|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
5254572|NCT00727506|18131115|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
5254573|NCT00727506|18131116|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5254574|NCT00727506|18131117|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
5254575|NCT00727506|18131118|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5254576|NCT00727506|18131119|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
5254577|NCT00727506|18131114|P6|Overall Study|Adverse Event|8
5254578|NCT00727506|18131115|P5|Overall Study|Adverse Event|1
5254579|NCT00727506|18131116|P4|Overall Study|Adverse Event|4
5254580|NCT00727506|18131117|P3|Overall Study|Adverse Event|4
5254581|NCT00727506|18131118|P2|Overall Study|Adverse Event|0
5254582|NCT00727506|18131119|P1|Overall Study|Adverse Event|0
5254583|NCT00727441|18131215|P3|Overall Study|Withdrawal by Subject|0
5254584|NCT00727441|18131216|P2|Overall Study|Withdrawal by Subject|1
5254585|NCT00727441|18131217|P1|Overall Study|Withdrawal by Subject|0
5254586|NCT00727441|18131215|P3|Overall Study|Physician Decision|0
5254587|NCT00727441|18131216|P2|Overall Study|Physician Decision|1
5254588|NCT00727441|18131217|P1|Overall Study|Physician Decision|0
5254589|NCT00727441|18131215|P3|Overall Study|Death|1
5254590|NCT00727441|18131216|P2|Overall Study|Death|1
5254591|NCT00727441|18131217|P1|Overall Study|Death|0
5254592|NCT00727441|18131215|P3|Overall Study|Eligibility|7
5254593|NCT00727441|18131216|P2|Overall Study|Eligibility|5
5254594|NCT00727441|18131217|P1|Overall Study|Eligibility|7
5254595|NCT00727441|18131215|P3|Overall Study|Disease Progression|17
5254596|NCT00727441|18131216|P2|Overall Study|Disease Progression|14
5254597|NCT00727441|18131217|P1|Overall Study|Disease Progression|11
5254598|NCT00727415|18131237|P1|Phase I|Dose Limiting Toxicity|2
5254599|NCT00727402|18131246|P1|Overall Study|Physician Decision|116
5254600|NCT00727311|18131275|P1|Overall Study|Multiple reasons|39
5254601|NCT00727311|18131275|P1|Overall Study|Other|97
5254602|NCT00727311|18131275|P1|Overall Study|Withdrawal by Subject|77
5254603|NCT00727311|18131275|P1|Overall Study|Lost to Follow-up|73
5254604|NCT00727311|18131275|P1|Overall Study|Lack of Efficacy|242
5254605|NCT00727311|18131275|P1|Overall Study|Adverse Event|58
5254606|NCT00727311|18131275|P1|Overall Study|Missing end of therapy data|205
5254607|NCT00727311|18131275|P1|Overall Study|Did not receive drug|316
5254608|NCT00727272|18131288|P3|Washout Period B|Withdrawal by Subject|1
5254609|NCT00727272|18131289|P2|Washout Period B|Withdrawal by Subject|0
5254610|NCT00727272|18131290|P1|Washout Period B|Withdrawal by Subject|0
5254611|NCT00727272|18131288|P3|Washout Period A|Adverse Event|1
5254612|NCT00727272|18131289|P2|Washout Period A|Adverse Event|0
5254613|NCT00727272|18131290|P1|Washout Period A|Adverse Event|0
5254614|NCT00727259|18131307|P1|Overall Study|Not all questionnaires completed|1055
5254615|NCT00727246|18131316|P4|Overall Study|withdrawn|0
5254616|NCT00727246|18131317|P3|Overall Study|withdrawn|1
5254617|NCT00727246|18131318|P2|Overall Study|withdrawn|0
5254618|NCT00727246|18131319|P1|Overall Study|withdrawn|0
5254619|NCT00727246|18131316|P4|Overall Study|incidental finding|1
5254620|NCT00727246|18131317|P3|Overall Study|incidental finding|0
5254621|NCT00727246|18131318|P2|Overall Study|incidental finding|0
5254622|NCT00727246|18131319|P1|Overall Study|incidental finding|0
5254623|NCT00727246|18131316|P4|Overall Study|could not complete MRI|1
5254624|NCT00727246|18131317|P3|Overall Study|could not complete MRI|0
5254625|NCT00727246|18131318|P2|Overall Study|could not complete MRI|1
5254626|NCT00727246|18131319|P1|Overall Study|could not complete MRI|0
5254627|NCT00727194|18131342|P3|Treatment Period 2|Lack of Efficacy|0
5254628|NCT00727194|18131343|P2|Treatment Period 2|Lack of Efficacy|1
5254629|NCT00727194|18131344|P1|Treatment Period 2|Lack of Efficacy|0
5254630|NCT00727194|18131342|P3|Screening Period|History of thymoma|1
5254631|NCT00727194|18131343|P2|Screening Period|History of thymoma|0
5254632|NCT00727194|18131344|P1|Screening Period|History of thymoma|0
5254633|NCT00727194|18131342|P3|Screening Period|Severe infections|2
5254634|NCT00727194|18131343|P2|Screening Period|Severe infections|0
5254635|NCT00727194|18131344|P1|Screening Period|Severe infections|0
5254636|NCT00727194|18131342|P3|Screening Period|Not stable on concomitant MG therapy|2
5254637|NCT00727194|18131343|P2|Screening Period|Not stable on concomitant MG therapy|0
5254638|NCT00727194|18131344|P1|Screening Period|Not stable on concomitant MG therapy|0
5254639|NCT00727194|18131342|P3|Screening Period|Lacked AChR antibodies|5
5254640|NCT00727194|18131343|P2|Screening Period|Lacked AChR antibodies|0
5254641|NCT00727194|18131344|P1|Screening Period|Lacked AChR antibodies|0
5254642|NCT00727194|18131342|P3|Screening Period|Low QMG scores|6
5254643|NCT00727194|18131343|P2|Screening Period|Low QMG scores|0
5254644|NCT00727194|18131344|P1|Screening Period|Low QMG scores|0
5254645|NCT00727025|18131416|P1|Overall Study|Physician Decision|23
5254646|NCT00726999|18131428|P2|Overall Study|Protocol Violation|0
5254647|NCT00726999|18131429|P1|Overall Study|Protocol Violation|1
5254648|NCT00726999|18131428|P2|Overall Study|Withdrawal by Subject|0
5254649|NCT00726999|18131429|P1|Overall Study|Withdrawal by Subject|2
5254650|NCT00726999|18131428|P2|Overall Study|Physician Decision|1
5254651|NCT00726999|18131429|P1|Overall Study|Physician Decision|0
5254652|NCT00726986|18131441|P1|Maintenance Phase|Lack of Efficacy|2
5254653|NCT00726986|18131441|P1|Maintenance Phase|Adverse Event|1
5254654|NCT00726986|18131441|P1|Induction Phase|Secondary Disease|2
5254655|NCT00726986|18131441|P1|Induction Phase|Lack of Efficacy|5
5254656|NCT00726986|18131441|P1|Induction Phase|Death|2
5254657|NCT00726986|18131441|P1|Induction Phase|Withdrawal by Subject|2
5254658|NCT00726986|18131441|P1|Induction Phase|Adverse Event|4
5254659|NCT00726895|18131448|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5254660|NCT00726895|18131449|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5254661|NCT00726882|18131462|P1|Overall Study|Other|10
5254662|NCT00726882|18131462|P1|Overall Study|Lost to Follow-up|7
5254663|NCT00726882|18131462|P1|Overall Study|Withdrawal by Subject|5
5254664|NCT00726752|18131477|P1|Overall Study|Lack of Efficacy|6
5254665|NCT00726661|18131539|P2|Overall Study|Other|35
5254666|NCT00726661|18131540|P1|Overall Study|Other|47
5254667|NCT00726661|18131539|P2|Overall Study|Physician Decision|13
5254668|NCT00726661|18131540|P1|Overall Study|Physician Decision|25
5254669|NCT00726661|18131539|P2|Overall Study|Death|159
5254670|NCT00726661|18131540|P1|Overall Study|Death|475
5254671|NCT00726661|18131539|P2|Overall Study|Trial terminated by sponsor|187
5254672|NCT00726661|18131540|P1|Overall Study|Trial terminated by sponsor|214
5254673|NCT00726661|18131539|P2|Overall Study|Withdrawal by Subject|13
5254674|NCT00726661|18131540|P1|Overall Study|Withdrawal by Subject|17
5254675|NCT00726661|18131539|P2|Overall Study|Lost to Follow-up|11
5254676|NCT00726661|18131540|P1|Overall Study|Lost to Follow-up|36
5254677|NCT00726622|18131557|P2|Overall Study|Metastasis|0
5254678|NCT00726622|18131558|P1|Overall Study|Metastasis|2
5254679|NCT00726622|18131557|P2|Overall Study|Physician Decision|1
5254680|NCT00726622|18131558|P1|Overall Study|Physician Decision|0
5254681|NCT00726622|18131557|P2|Overall Study|Withdrawal by Subject|2
5254682|NCT00726622|18131558|P1|Overall Study|Withdrawal by Subject|16
5254683|NCT00726609|18131576|P1|Overall Study|Other|3
5254684|NCT00726609|18131576|P1|Overall Study|Missing|42
5254685|NCT00726609|18131576|P1|Overall Study|Other|16
5254686|NCT00726609|18131576|P1|Overall Study|Lack of Efficacy|25
5254687|NCT00726609|18131576|P1|Overall Study|Withdrawal by Subject|2
5254688|NCT00726609|18131576|P1|Overall Study|Adverse Event|10
5254689|NCT00726557|18131580|P1|Overall Study|Inclusion criteria not met|15
5254690|NCT00726557|18131580|P1|Overall Study|Treatment less than 3 months|17
5254691|NCT00726557|18131580|P1|Overall Study|No follow-up documentation available|55
5254692|NCT00726557|18131580|P1|Overall Study|No end of treatment documentation|37
5254693|NCT00726557|18131580|P1|Overall Study|Screening failure|4
5254694|NCT00726453|18131587|P2|38 mm Length Group|Death|3
5254695|NCT00726453|18131588|P1|38 mm Length Group|Death|0
5254696|NCT00726453|18131587|P2|Primary Enrollment Group|Withdrawal by Subject|0
5254697|NCT00726453|18131588|P1|Primary Enrollment Group|Withdrawal by Subject|13
5254698|NCT00726453|18131587|P2|Primary Enrollment Group|Death|0
5254699|NCT00726453|18131588|P1|Primary Enrollment Group|Death|18
5254700|NCT00726323|18131616|P2|Overall Study|Metastatic lesions inferred cyst|1
5254701|NCT00726323|18131617|P1|Overall Study|Metastatic lesions inferred cyst|0
5254702|NCT00726323|18131616|P2|Overall Study|Participant wished to discontinue|1
5254703|NCT00726323|18131617|P1|Overall Study|Participant wished to discontinue|0
5254704|NCT00726323|18131616|P2|Overall Study|Death|0
5254705|NCT00726323|18131617|P1|Overall Study|Death|1
5254706|NCT00726323|18131616|P2|Overall Study|Adverse Event|9
5254707|NCT00726323|18131617|P1|Overall Study|Adverse Event|9
5254708|NCT00726323|18131616|P2|Overall Study|Clinical progression|3
5254709|NCT00726323|18131617|P1|Overall Study|Clinical progression|0
5254710|NCT00726323|18131616|P2|Overall Study|Progressive disease|16
5254711|NCT00726323|18131617|P1|Overall Study|Progressive disease|23
5254712|NCT00726323|18131616|P2|Overall Study|Physician Decision|0
5254713|NCT00726323|18131617|P1|Overall Study|Physician Decision|1
5254714|NCT00726323|18131616|P2|Overall Study|Withdrawal by Subject|1
5254715|NCT00726323|18131617|P1|Overall Study|Withdrawal by Subject|3
5254716|NCT00726232|18131647|P8|Expansion Phase|Unspecified reason|0
5254717|NCT00726232|18131648|P7|Expansion Phase|Unspecified reason|1
5254718|NCT00726232|18131649|P6|Expansion Phase|Unspecified reason|0
5254719|NCT00726232|18131650|P5|Expansion Phase|Unspecified reason|0
5254720|NCT00726232|18131651|P4|Expansion Phase|Unspecified reason|0
5254721|NCT00726232|18131652|P3|Expansion Phase|Unspecified reason|0
5254722|NCT00726232|18131653|P2|Expansion Phase|Unspecified reason|0
5254723|NCT00726232|18131654|P1|Expansion Phase|Unspecified reason|0
5254724|NCT00726232|18131647|P8|Expansion Phase|Per Investigator: lack of response|7
5254725|NCT00726232|18131648|P7|Expansion Phase|Per Investigator: lack of response|1
5254726|NCT00726232|18131649|P6|Expansion Phase|Per Investigator: lack of response|0
5254727|NCT00726232|18131650|P5|Expansion Phase|Per Investigator: lack of response|0
5254728|NCT00726232|18131651|P4|Expansion Phase|Per Investigator: lack of response|0
5254729|NCT00726232|18131652|P3|Expansion Phase|Per Investigator: lack of response|0
5254730|NCT00726232|18131653|P2|Expansion Phase|Per Investigator: lack of response|0
5254731|NCT00726232|18131654|P1|Expansion Phase|Per Investigator: lack of response|0
5254732|NCT00726232|18131647|P8|Expansion Phase|Termination of the trial by sponsor|16
5254733|NCT00726232|18131648|P7|Expansion Phase|Termination of the trial by sponsor|10
5254734|NCT00726232|18131649|P6|Expansion Phase|Termination of the trial by sponsor|0
5254735|NCT00726232|18131650|P5|Expansion Phase|Termination of the trial by sponsor|0
5254736|NCT00726232|18131651|P4|Expansion Phase|Termination of the trial by sponsor|0
5254737|NCT00726232|18131652|P3|Expansion Phase|Termination of the trial by sponsor|0
5254738|NCT00726232|18131653|P2|Expansion Phase|Termination of the trial by sponsor|0
5254739|NCT00726232|18131654|P1|Expansion Phase|Termination of the trial by sponsor|0
5254740|NCT00726232|18131647|P8|Expansion Phase|Disease progression|0
5254741|NCT00726232|18131648|P7|Expansion Phase|Disease progression|4
5254742|NCT00726232|18131649|P6|Expansion Phase|Disease progression|0
5254743|NCT00726232|18131650|P5|Expansion Phase|Disease progression|0
5254744|NCT00726232|18131651|P4|Expansion Phase|Disease progression|0
5254745|NCT00726232|18131652|P3|Expansion Phase|Disease progression|0
5254746|NCT00726232|18131653|P2|Expansion Phase|Disease progression|0
5254747|NCT00726232|18131654|P1|Expansion Phase|Disease progression|0
5254748|NCT00726232|18131647|P8|Expansion Phase|Withdrawal by Subject|3
5254749|NCT00726232|18131648|P7|Expansion Phase|Withdrawal by Subject|2
5254750|NCT00726232|18131649|P6|Expansion Phase|Withdrawal by Subject|0
5254751|NCT00726232|18131650|P5|Expansion Phase|Withdrawal by Subject|0
5254752|NCT00726232|18131651|P4|Expansion Phase|Withdrawal by Subject|0
5254753|NCT00726232|18131652|P3|Expansion Phase|Withdrawal by Subject|0
5254754|NCT00726232|18131653|P2|Expansion Phase|Withdrawal by Subject|0
5254755|NCT00726232|18131654|P1|Expansion Phase|Withdrawal by Subject|0
5254756|NCT00726232|18131647|P8|Expansion Phase|Adverse Event|11
5254757|NCT00726232|18131648|P7|Expansion Phase|Adverse Event|6
5254758|NCT00726232|18131649|P6|Expansion Phase|Adverse Event|0
5254759|NCT00726232|18131650|P5|Expansion Phase|Adverse Event|0
5254760|NCT00726232|18131651|P4|Expansion Phase|Adverse Event|0
5254761|NCT00726232|18131652|P3|Expansion Phase|Adverse Event|0
5254762|NCT00726232|18131653|P2|Expansion Phase|Adverse Event|0
5254763|NCT00726232|18131654|P1|Expansion Phase|Adverse Event|0
5254764|NCT00726232|18131647|P8|Expansion Phase|Death|1
5254765|NCT00726232|18131648|P7|Expansion Phase|Death|0
5254766|NCT00726232|18131649|P6|Expansion Phase|Death|0
5254767|NCT00726232|18131650|P5|Expansion Phase|Death|0
5254768|NCT00726232|18131651|P4|Expansion Phase|Death|0
5254769|NCT00726232|18131652|P3|Expansion Phase|Death|0
5254770|NCT00726232|18131653|P2|Expansion Phase|Death|0
5254771|NCT00726232|18131654|P1|Expansion Phase|Death|0
5254772|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Unspecified reason|0
5254773|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Unspecified reason|0
5254774|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Unspecified reason|0
5254775|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Unspecified reason|0
5254776|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Unspecified reason|0
5254777|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Unspecified reason|0
5254778|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Unspecified reason|0
5254779|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Unspecified reason|1
5254780|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5254781|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5254782|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
5254783|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
5254784|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
5254785|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5254786|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5254787|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
5254788|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
5254789|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
5254790|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
5254791|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
5254792|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
5254793|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
5254794|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
5254795|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
5254796|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Disease progression|0
5254797|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Disease progression|0
5254798|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Disease progression|0
5254799|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Disease progression|0
5254800|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Disease progression|0
5254801|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Disease progression|0
5254802|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Disease progression|1
5254803|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Disease progression|3
5254804|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5254805|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5254806|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
5254807|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5254808|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
5254809|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5254810|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5254811|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
5254812|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Adverse Event|0
5254813|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Adverse Event|0
5254814|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Adverse Event|3
5254815|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Adverse Event|7
5254816|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Adverse Event|1
5254817|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Adverse Event|2
5254818|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Adverse Event|2
5254819|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Adverse Event|2
5254820|NCT00726232|18131647|P8|Initial Phase (Dose-finding)|Death|0
5254821|NCT00726232|18131648|P7|Initial Phase (Dose-finding)|Death|0
5254822|NCT00726232|18131649|P6|Initial Phase (Dose-finding)|Death|0
5254823|NCT00726232|18131650|P5|Initial Phase (Dose-finding)|Death|1
5254824|NCT00726232|18131651|P4|Initial Phase (Dose-finding)|Death|0
5254825|NCT00726232|18131652|P3|Initial Phase (Dose-finding)|Death|0
5254826|NCT00726232|18131653|P2|Initial Phase (Dose-finding)|Death|0
5254827|NCT00726232|18131654|P1|Initial Phase (Dose-finding)|Death|0
5254828|NCT00726063|18131706|P2|Overall Study|Adverse Event|7
5254829|NCT00726063|18131707|P1|Overall Study|Adverse Event|9
5254830|NCT00725985|18131721|P12|LTFU (No Cladribine Treatment)|Other|14
5254831|NCT00725985|18131722|P11|LTFU (No Cladribine Treatment)|Other|36
5254832|NCT00725985|18131723|P10|LTFU (No Cladribine Treatment)|Other|34
5254833|NCT00725985|18131724|P9|LTFU (No Cladribine Treatment)|Other|0
5254834|NCT00725985|18131725|P8|LTFU (No Cladribine Treatment)|Other|0
5254835|NCT00725985|18131726|P7|LTFU (No Cladribine Treatment)|Other|0
5254836|NCT00725985|18131727|P6|LTFU (No Cladribine Treatment)|Other|0
5254837|NCT00725985|18131728|P5|LTFU (No Cladribine Treatment)|Other|0
5254838|NCT00725985|18131729|P4|LTFU (No Cladribine Treatment)|Other|0
5254839|NCT00725985|18131730|P3|LTFU (No Cladribine Treatment)|Other|0
5254840|NCT00725985|18131731|P2|LTFU (No Cladribine Treatment)|Other|0
5254841|NCT00725985|18131732|P1|LTFU (No Cladribine Treatment)|Other|0
5254842|NCT00725985|18131721|P12|LTFU (With Cladribine Treatment)|Other|0
5254843|NCT00725985|18131722|P11|LTFU (With Cladribine Treatment)|Other|0
5254844|NCT00725985|18131723|P10|LTFU (With Cladribine Treatment)|Other|0
5254845|NCT00725985|18131724|P9|LTFU (With Cladribine Treatment)|Other|16
5254846|NCT00725985|18131725|P8|LTFU (With Cladribine Treatment)|Other|8
5254847|NCT00725985|18131726|P7|LTFU (With Cladribine Treatment)|Other|9
5254848|NCT00725985|18131727|P6|LTFU (With Cladribine Treatment)|Other|0
5254849|NCT00725985|18131728|P5|LTFU (With Cladribine Treatment)|Other|0
5254850|NCT00725985|18131729|P4|LTFU (With Cladribine Treatment)|Other|0
5254851|NCT00725985|18131730|P3|LTFU (With Cladribine Treatment)|Other|0
5254852|NCT00725985|18131731|P2|LTFU (With Cladribine Treatment)|Other|0
5254853|NCT00725985|18131732|P1|LTFU (With Cladribine Treatment)|Other|0
5254854|NCT00725985|18131721|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254855|NCT00725985|18131722|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254856|NCT00725985|18131723|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254857|NCT00725985|18131724|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
5254858|NCT00725985|18131725|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254859|NCT00725985|18131726|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254860|NCT00725985|18131727|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254861|NCT00725985|18131728|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254862|NCT00725985|18131729|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254863|NCT00725985|18131730|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254864|NCT00725985|18131731|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254865|NCT00725985|18131732|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5254866|NCT00725985|18131721|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
5254867|NCT00725985|18131722|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
5254868|NCT00725985|18131723|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
5254869|NCT00725985|18131724|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
5254870|NCT00725985|18131725|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
5254871|NCT00725985|18131726|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
5254872|NCT00725985|18131727|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
5254873|NCT00725985|18131728|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
5254874|NCT00725985|18131729|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
5254875|NCT00725985|18131730|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
5254876|NCT00725985|18131731|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
5254877|NCT00725985|18131732|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
5254878|NCT00725985|18131721|P12|OLMP|Other|0
5254879|NCT00725985|18131722|P11|OLMP|Other|0
5254880|NCT00725985|18131723|P10|OLMP|Other|0
5254881|NCT00725985|18131724|P9|OLMP|Other|0
5254882|NCT00725985|18131725|P8|OLMP|Other|0
5254883|NCT00725985|18131726|P7|OLMP|Other|0
5254884|NCT00725985|18131727|P6|OLMP|Other|44
5254885|NCT00725985|18131728|P5|OLMP|Other|20
5254886|NCT00725985|18131729|P4|OLMP|Other|15
5254887|NCT00725985|18131730|P3|OLMP|Other|0
5254888|NCT00725985|18131731|P2|OLMP|Other|0
5254889|NCT00725985|18131732|P1|OLMP|Other|0
5254890|NCT00725985|18131721|P12|OLMP|Disease progression|0
5254891|NCT00725985|18131722|P11|OLMP|Disease progression|0
5254892|NCT00725985|18131723|P10|OLMP|Disease progression|0
5254893|NCT00725985|18131724|P9|OLMP|Disease progression|0
5254894|NCT00725985|18131725|P8|OLMP|Disease progression|0
5254895|NCT00725985|18131726|P7|OLMP|Disease progression|0
5254896|NCT00725985|18131727|P6|OLMP|Disease progression|4
5254897|NCT00725985|18131728|P5|OLMP|Disease progression|0
5254898|NCT00725985|18131729|P4|OLMP|Disease progression|0
5254899|NCT00725985|18131730|P3|OLMP|Disease progression|0
5254900|NCT00725985|18131731|P2|OLMP|Disease progression|0
5254901|NCT00725985|18131732|P1|OLMP|Disease progression|0
5254902|NCT00725985|18131721|P12|OLMP|Lost to Follow-up|0
5254903|NCT00725985|18131722|P11|OLMP|Lost to Follow-up|0
5254904|NCT00725985|18131723|P10|OLMP|Lost to Follow-up|0
5254905|NCT00725985|18131724|P9|OLMP|Lost to Follow-up|0
5254906|NCT00725985|18131725|P8|OLMP|Lost to Follow-up|0
5254907|NCT00725985|18131726|P7|OLMP|Lost to Follow-up|0
5254908|NCT00725985|18131727|P6|OLMP|Lost to Follow-up|0
5254909|NCT00725985|18131728|P5|OLMP|Lost to Follow-up|0
5254910|NCT00725985|18131729|P4|OLMP|Lost to Follow-up|1
5254911|NCT00725985|18131730|P3|OLMP|Lost to Follow-up|0
5254912|NCT00725985|18131731|P2|OLMP|Lost to Follow-up|0
5254913|NCT00725985|18131732|P1|OLMP|Lost to Follow-up|0
5254914|NCT00725985|18131721|P12|OLMP|Death|0
5254915|NCT00725985|18131722|P11|OLMP|Death|0
5254916|NCT00725985|18131723|P10|OLMP|Death|0
5254917|NCT00725985|18131724|P9|OLMP|Death|0
5254918|NCT00725985|18131725|P8|OLMP|Death|0
5254919|NCT00725985|18131726|P7|OLMP|Death|0
5254920|NCT00725985|18131727|P6|OLMP|Death|0
5254921|NCT00725985|18131728|P5|OLMP|Death|1
5254922|NCT00725985|18131729|P4|OLMP|Death|0
5254923|NCT00725985|18131730|P3|OLMP|Death|0
5254924|NCT00725985|18131731|P2|OLMP|Death|0
5254925|NCT00725985|18131732|P1|OLMP|Death|0
5254926|NCT00725985|18131721|P12|OLMP|Adverse Event|0
5254927|NCT00725985|18131722|P11|OLMP|Adverse Event|0
5254928|NCT00725985|18131723|P10|OLMP|Adverse Event|0
5254929|NCT00725985|18131724|P9|OLMP|Adverse Event|0
5254930|NCT00725985|18131725|P8|OLMP|Adverse Event|0
5254931|NCT00725985|18131726|P7|OLMP|Adverse Event|0
5254932|NCT00725985|18131727|P6|OLMP|Adverse Event|5
5254933|NCT00725985|18131728|P5|OLMP|Adverse Event|2
5254934|NCT00725985|18131729|P4|OLMP|Adverse Event|2
5254935|NCT00725985|18131730|P3|OLMP|Adverse Event|0
5254936|NCT00725985|18131731|P2|OLMP|Adverse Event|0
5254937|NCT00725985|18131732|P1|OLMP|Adverse Event|0
5254938|NCT00725985|18131721|P12|ITP (Up to 96 Weeks)|Other|0
5254939|NCT00725985|18131722|P11|ITP (Up to 96 Weeks)|Other|0
5254940|NCT00725985|18131723|P10|ITP (Up to 96 Weeks)|Other|0
5254941|NCT00725985|18131724|P9|ITP (Up to 96 Weeks)|Other|0
5254942|NCT00725985|18131725|P8|ITP (Up to 96 Weeks)|Other|0
5254943|NCT00725985|18131726|P7|ITP (Up to 96 Weeks)|Other|0
5254944|NCT00725985|18131727|P6|ITP (Up to 96 Weeks)|Other|0
5254945|NCT00725985|18131728|P5|ITP (Up to 96 Weeks)|Other|0
5254946|NCT00725985|18131729|P4|ITP (Up to 96 Weeks)|Other|0
5254947|NCT00725985|18131730|P3|ITP (Up to 96 Weeks)|Other|24
5254948|NCT00725985|18131731|P2|ITP (Up to 96 Weeks)|Other|38
5254949|NCT00725985|18131732|P1|ITP (Up to 96 Weeks)|Other|50
5254950|NCT00725985|18131721|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254951|NCT00725985|18131722|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254952|NCT00725985|18131723|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254953|NCT00725985|18131724|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254954|NCT00725985|18131725|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254955|NCT00725985|18131726|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254956|NCT00725985|18131727|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254957|NCT00725985|18131728|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254958|NCT00725985|18131729|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
5254959|NCT00725985|18131730|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
5254960|NCT00725985|18131731|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
5254961|NCT00725985|18131732|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
5254962|NCT00725985|18131721|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254963|NCT00725985|18131722|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254964|NCT00725985|18131723|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254965|NCT00725985|18131724|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254966|NCT00725985|18131725|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254967|NCT00725985|18131726|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254968|NCT00725985|18131727|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254969|NCT00725985|18131728|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254970|NCT00725985|18131729|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254971|NCT00725985|18131730|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254972|NCT00725985|18131731|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
5254973|NCT00725985|18131732|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
5254974|NCT00725985|18131721|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254975|NCT00725985|18131722|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254976|NCT00725985|18131723|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254977|NCT00725985|18131724|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254978|NCT00725985|18131725|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254979|NCT00725985|18131726|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254980|NCT00725985|18131727|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254981|NCT00725985|18131728|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254982|NCT00725985|18131729|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254983|NCT00725985|18131730|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
5254984|NCT00725985|18131731|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254985|NCT00725985|18131732|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5254986|NCT00725985|18131721|P12|ITP (Up to 96 Weeks)|Adverse Event|0
5254987|NCT00725985|18131722|P11|ITP (Up to 96 Weeks)|Adverse Event|0
5254988|NCT00725985|18131723|P10|ITP (Up to 96 Weeks)|Adverse Event|0
5254989|NCT00725985|18131724|P9|ITP (Up to 96 Weeks)|Adverse Event|0
5254990|NCT00725985|18131725|P8|ITP (Up to 96 Weeks)|Adverse Event|0
5254991|NCT00725985|18131726|P7|ITP (Up to 96 Weeks)|Adverse Event|0
5254992|NCT00725985|18131727|P6|ITP (Up to 96 Weeks)|Adverse Event|0
5254993|NCT00725985|18131728|P5|ITP (Up to 96 Weeks)|Adverse Event|0
5254994|NCT00725985|18131729|P4|ITP (Up to 96 Weeks)|Adverse Event|0
5254995|NCT00725985|18131730|P3|ITP (Up to 96 Weeks)|Adverse Event|5
5254996|NCT00725985|18131731|P2|ITP (Up to 96 Weeks)|Adverse Event|10
5254997|NCT00725985|18131732|P1|ITP (Up to 96 Weeks)|Adverse Event|20
5254998|NCT00725920|18131769|P2|Overall Study|Lack of Efficacy|6
5254999|NCT00725920|18131770|P1|Overall Study|Lack of Efficacy|3
5255000|NCT00725842|18131776|P1|Overall Study|No Visit 1 data|1
5255001|NCT00725842|18131776|P1|Overall Study|Inclusion criterion not met|1
5255002|NCT00725842|18131776|P1|Overall Study|Consent date prior to study start date|5
5255003|NCT00725842|18131776|P1|Overall Study|Positive HCV-RNA at Visit 2|13
5255004|NCT00725842|18131776|P1|Overall Study|Death|1
5255005|NCT00725842|18131776|P1|Overall Study|Lost to Follow-up|19
5255006|NCT00725764|18131783|P1|Overall Study|Decline in performance status|1
5255007|NCT00725764|18131783|P1|Overall Study|Participant non compliant with protocol|1
5255008|NCT00725764|18131783|P1|Overall Study|Death|1
5255009|NCT00725764|18131783|P1|Overall Study|Lost to Follow-up|1
5255010|NCT00725764|18131783|P1|Overall Study|Progressive Disease|7
5255011|NCT00725764|18131783|P1|Overall Study|Physician Decision|1
5255012|NCT00725764|18131783|P1|Overall Study|Withdrawal by Subject|2
5255013|NCT00725725|18131816|P3|Overall Study|Protocol Violation|0
5255014|NCT00725725|18131817|P2|Overall Study|Protocol Violation|1
5255015|NCT00725725|18131818|P1|Overall Study|Protocol Violation|0
5255016|NCT00725725|18131816|P3|Overall Study|Withdrawal by Subject|1
5255017|NCT00725725|18131817|P2|Overall Study|Withdrawal by Subject|0
5255018|NCT00725725|18131818|P1|Overall Study|Withdrawal by Subject|1
5255019|NCT00725725|18131816|P3|Overall Study|Lost to Follow-up|2
5255020|NCT00725725|18131817|P2|Overall Study|Lost to Follow-up|0
5255021|NCT00725725|18131818|P1|Overall Study|Lost to Follow-up|2
5255022|NCT00725725|18131816|P3|Overall Study|Adverse Event|2
5255023|NCT00725725|18131817|P2|Overall Study|Adverse Event|3
5255024|NCT00725725|18131818|P1|Overall Study|Adverse Event|1
5255025|NCT00725712|18131861|P2|Overall Study|Hospitalized, unable to continue|1
5255026|NCT00725712|18131862|P1|Overall Study|Hospitalized, unable to continue|0
5255027|NCT00725712|18131861|P2|Overall Study|Other: Death|0
5255028|NCT00725712|18131862|P1|Overall Study|Other: Death|1
5255029|NCT00725712|18131861|P2|Overall Study|Death|0
5255030|NCT00725712|18131862|P1|Overall Study|Death|2
5255031|NCT00725712|18131861|P2|Overall Study|Adverse Event|5
5255032|NCT00725712|18131862|P1|Overall Study|Adverse Event|5
5255033|NCT00725712|18131861|P2|Overall Study|Clinical progression not based on RECIST|3
5255034|NCT00725712|18131862|P1|Overall Study|Clinical progression not based on RECIST|0
5255035|NCT00725712|18131861|P2|Overall Study|Progressive disease|16
5255036|NCT00725712|18131862|P1|Overall Study|Progressive disease|37
5255037|NCT00725712|18131861|P2|Overall Study|Protocol Violation|0
5255038|NCT00725712|18131862|P1|Overall Study|Protocol Violation|1
5255039|NCT00725712|18131861|P2|Overall Study|Withdrawal by Subject|1
5255040|NCT00725712|18131862|P1|Overall Study|Withdrawal by Subject|2
5255041|NCT00725621|18131898|P1|Overall Study|Reason not specified|55
5255042|NCT00725621|18131898|P1|Overall Study|Prepared for elective surgery|1
5255043|NCT00725621|18131898|P1|Overall Study|Switched to other drug|1
5255044|NCT00725621|18131898|P1|Overall Study|Switched to other study|1
5255045|NCT00725621|18131898|P1|Overall Study|Continued treatment by other physician|6
5255046|NCT00725621|18131898|P1|Overall Study|Non-compliance|8
5255047|NCT00725621|18131898|P1|Overall Study|Lost to Follow-up|52
5255048|NCT00725621|18131898|P1|Overall Study|Physician Decision|19
5255049|NCT00725621|18131898|P1|Overall Study|Withdrawal by Subject|57
5255050|NCT00725621|18131898|P1|Overall Study|Lack of Efficacy|46
5255051|NCT00725621|18131898|P1|Overall Study|Adverse Event|25
5255052|NCT00725608|18131921|P1|Overall Study|Other|7
5255053|NCT00725608|18131921|P1|Overall Study|Individual reasons|86
5255054|NCT00725608|18131921|P1|Overall Study|Adverse Event|14
5255055|NCT00725608|18131921|P1|Overall Study|Lost to Follow-up|60
5255056|NCT00725543|18131927|P1|Overall Study|Other|119
5255057|NCT00725543|18131927|P1|Overall Study|Non-compliance|2
5255058|NCT00725543|18131927|P1|Overall Study|Lost to Follow-up|4
5255059|NCT00725543|18131927|P1|Overall Study|Physician Decision|5
5255060|NCT00725543|18131927|P1|Overall Study|Withdrawal by Subject|10
5255061|NCT00725543|18131927|P1|Overall Study|Lack of Efficacy|3
5255062|NCT00725543|18131927|P1|Overall Study|Adverse Event|10
5255063|NCT00725491|18131952|P2|Overall Study|No/too few embryos/ bad quality embryos|2
5255064|NCT00725491|18131953|P1|Overall Study|No/too few embryos/ bad quality embryos|3
5255065|NCT00725491|18131952|P2|Overall Study|Fertilization failure|1
5255066|NCT00725491|18131953|P1|Overall Study|Fertilization failure|0
5255067|NCT00725491|18131952|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
5255068|NCT00725491|18131953|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
5255069|NCT00725491|18131952|P2|Overall Study|Risk for hyperstimulation|9
5255070|NCT00725491|18131953|P1|Overall Study|Risk for hyperstimulation|2
5255071|NCT00725491|18131952|P2|Overall Study|Pregnancy|3
5255072|NCT00725491|18131953|P1|Overall Study|Pregnancy|0
5255073|NCT00725491|18131952|P2|Overall Study|Adverse Event|2
5255074|NCT00725491|18131953|P1|Overall Study|Adverse Event|3
5255075|NCT00725452|18131959|P1|Overall Study|Lost to Follow-up|1
5255076|NCT00725452|18131959|P1|Overall Study|Withdrawal by Subject|3
5255077|NCT00725452|18131959|P1|Overall Study|Physician Decision|1
5255078|NCT00725452|18131959|P1|Overall Study|Reason not specified|1
5255079|NCT00725452|18131959|P1|Overall Study|Lack of Efficacy|2
5255080|NCT00725452|18131959|P1|Overall Study|Adverse Event|3
5255081|NCT00725322|18131978|P2|Washout (28 Days)|Protocol Violation|1
5255082|NCT00725322|18131979|P1|Washout (28 Days)|Protocol Violation|0
5255083|NCT00725322|18131978|P2|Washout (28 Days)|Withdrawal by Subject|0
5255084|NCT00725322|18131979|P1|Washout (28 Days)|Withdrawal by Subject|2
5255085|NCT00725296|18131987|P1|Overall Study|Other|38
5255086|NCT00725296|18131987|P1|Overall Study|Lost to Follow-up|1
5255087|NCT00725296|18131987|P1|Overall Study|Non-Compliance|2
5255088|NCT00725296|18131987|P1|Overall Study|Withdrawal by Subject|3
5255089|NCT00725296|18131987|P1|Overall Study|Lack of Efficacy|7
5255090|NCT00725296|18131987|P1|Overall Study|Adverse Event|11
5255091|NCT00725283|18131996|P1|Overall Study|Withdrawal by Subject|10
5255092|NCT00725283|18131996|P1|Overall Study|Other|6
5255093|NCT00725283|18131996|P1|Overall Study|Death|5
5255094|NCT00725283|18131996|P1|Overall Study|Missing Code|3
5255095|NCT00725205|18132017|P1|Overall Study|Treatment Failure|41
5255096|NCT00725205|18132017|P1|Overall Study|Protocol Defined Clinical Event|1
5255097|NCT00725205|18132017|P1|Overall Study|Other|8
5255098|NCT00725205|18132017|P1|Overall Study|Non-compliance With Protocol|14
5255099|NCT00725205|18132017|P1|Overall Study|Investigator Discontinued|1
5255100|NCT00725205|18132017|P1|Overall Study|Adverse Event|22
5255101|NCT00725101|18132030|P1|Overall Study|not specified/no reason given|11
5255102|NCT00725101|18132030|P1|Overall Study|Withdrawal by Subject|127
5255103|NCT00725101|18132030|P1|Overall Study|Protocol Violation|1
5255104|NCT00725101|18132030|P1|Overall Study|Lost to Follow-up|353
5255105|NCT00725101|18132030|P1|Overall Study|Death|3
5255106|NCT00725075|18132053|P3|Overall Study|Other|0
5255107|NCT00725075|18132054|P2|Overall Study|Other|0
5255108|NCT00725075|18132055|P1|Overall Study|Other|1
5255109|NCT00725075|18132053|P3|Overall Study|Inclusion/Exclusion Criteria|1
5255110|NCT00725075|18132054|P2|Overall Study|Inclusion/Exclusion Criteria|0
5255111|NCT00725075|18132055|P1|Overall Study|Inclusion/Exclusion Criteria|1
5255112|NCT00725075|18132053|P3|Overall Study|Worsening of Disease|2
5255113|NCT00725075|18132054|P2|Overall Study|Worsening of Disease|1
5255114|NCT00725075|18132055|P1|Overall Study|Worsening of Disease|2
5255115|NCT00725075|18132053|P3|Overall Study|Adverse Event|1
5255116|NCT00725075|18132054|P2|Overall Study|Adverse Event|1
5255117|NCT00725075|18132055|P1|Overall Study|Adverse Event|2
5255118|NCT00725075|18132053|P3|Overall Study|Withdrawal by Subject|4
5255119|NCT00725075|18132054|P2|Overall Study|Withdrawal by Subject|5
5255120|NCT00725075|18132055|P1|Overall Study|Withdrawal by Subject|4
5255121|NCT00725075|18132053|P3|Overall Study|Lost to Follow-up|0
5255122|NCT00725075|18132054|P2|Overall Study|Lost to Follow-up|0
5255123|NCT00725075|18132055|P1|Overall Study|Lost to Follow-up|1
5255124|NCT00725075|18132053|P3|Overall Study|Protocol Violation|1
5255125|NCT00725075|18132054|P2|Overall Study|Protocol Violation|0
5255126|NCT00725075|18132055|P1|Overall Study|Protocol Violation|0
5255127|NCT00725075|18132053|P3|Overall Study|Use of Excluded Medication|0
5255128|NCT00725075|18132054|P2|Overall Study|Use of Excluded Medication|1
5255129|NCT00725075|18132055|P1|Overall Study|Use of Excluded Medication|0
5255130|NCT00725010|18132108|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
5255131|NCT00725010|18132108|P1|Overall Study|No further documentation|1
5255132|NCT00725010|18132108|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
5255133|NCT00725010|18132108|P1|Overall Study|Hepatopathy probably not Temodal-related|1
5255134|NCT00725010|18132108|P1|Overall Study|Lost to Follow-up|1
5255135|NCT00725010|18132108|P1|Overall Study|Death|1
5255136|NCT00725010|18132108|P1|Overall Study|Withdrawal by Subject|2
5255137|NCT00725010|18132108|P1|Overall Study|Tumor Progression|7
5255138|NCT00725010|18132108|P1|Overall Study|Toxicity|9
5255139|NCT00724971|18132141|P1|Overall Study|Withdrawal by Subject|1
5255140|NCT00724971|18132141|P1|Overall Study|Adverse Event|5
5255141|NCT00724958|18132156|P1|Overall Study|No documentation for end of therapy|13
5255142|NCT00724958|18132156|P1|Overall Study|Other Reason|76
5255143|NCT00724958|18132156|P1|Overall Study|Remission|7
5255144|NCT00724958|18132156|P1|Overall Study|No Response|18
5255145|NCT00724958|18132156|P1|Overall Study|Loss of Response|40
5255146|NCT00724958|18132156|P1|Overall Study|Adverse Event|28
5255147|NCT00724945|18132165|P2|Period 2|lens physiology issue|0
5255148|NCT00724945|18132166|P1|Period 2|lens physiology issue|1
5255149|NCT00724945|18132165|P2|Period 2|lens comfort issue|0
5255150|NCT00724945|18132166|P1|Period 2|lens comfort issue|3
5255151|NCT00724945|18132165|P2|Period 1|Lost to Follow-up|0
5255152|NCT00724945|18132166|P1|Period 1|Lost to Follow-up|1
5255153|NCT00724945|18132165|P2|Period 1|Adverse Event|1
5255154|NCT00724945|18132166|P1|Period 1|Adverse Event|1
5255155|NCT00724945|18132165|P2|Period 1|non-compliance|0
5255156|NCT00724945|18132166|P1|Period 1|non-compliance|1
5255157|NCT00724932|18132178|P2|Overall Study|Not treated|3
5255158|NCT00724932|18132179|P1|Overall Study|Not treated|4
5255159|NCT00724932|18132178|P2|Overall Study|Lost to Follow-up|0
5255160|NCT00724932|18132179|P1|Overall Study|Lost to Follow-up|1
5255161|NCT00724893|18132250|P2|Overall Study|Unknown, missing data|1
5255162|NCT00724893|18132251|P1|Overall Study|Unknown, missing data|1
5255163|NCT00724893|18132250|P2|Overall Study|Lost to Follow-up|52
5255164|NCT00724893|18132251|P1|Overall Study|Lost to Follow-up|0
5255165|NCT00724893|18132250|P2|Overall Study|Assigned shorter treatment|2
5255166|NCT00724893|18132251|P1|Overall Study|Assigned shorter treatment|0
5255167|NCT00724893|18132250|P2|Overall Study|Financial reasons|2
5255168|NCT00724893|18132251|P1|Overall Study|Financial reasons|0
5255169|NCT00724893|18132250|P2|Overall Study|Substance abuse|3
5255170|NCT00724893|18132251|P1|Overall Study|Substance abuse|0
5255171|NCT00724893|18132250|P2|Overall Study|Incarceration|9
5255172|NCT00724893|18132251|P1|Overall Study|Incarceration|0
5255173|NCT00724893|18132250|P2|Overall Study|Geographic reasons|11
5255174|NCT00724893|18132251|P1|Overall Study|Geographic reasons|0
5255175|NCT00724893|18132250|P2|Overall Study|Patient choice|26
5255176|NCT00724893|18132251|P1|Overall Study|Patient choice|0
5255177|NCT00724893|18132250|P2|Overall Study|Reason not specified|7
5255178|NCT00724893|18132251|P1|Overall Study|Reason not specified|193
5255179|NCT00724893|18132250|P2|Overall Study|Lack of virologic response|202
5255180|NCT00724893|18132251|P1|Overall Study|Lack of virologic response|94
5255181|NCT00724893|18132250|P2|Overall Study|Withdrawal by Subject|1
5255182|NCT00724893|18132251|P1|Overall Study|Withdrawal by Subject|0
5255183|NCT00724893|18132250|P2|Overall Study|Adverse Event|142
5255184|NCT00724893|18132251|P1|Overall Study|Adverse Event|76
5255185|NCT00724867|18132319|P1|Overall Study|Elected to exit due to site closure|2
5255186|NCT00724867|18132319|P1|Overall Study|Subject moved out of state|1
5255187|NCT00724867|18132319|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
5255188|NCT00724867|18132319|P1|Overall Study|Subject incarcerated|1
5255189|NCT00724867|18132319|P1|Overall Study|Sponsor decision to end study|14
5255190|NCT00724867|18132319|P1|Overall Study|Withdrawal by Subject|31
5255191|NCT00724867|18132319|P1|Overall Study|Protocol Violation|1
5255192|NCT00724867|18132319|P1|Overall Study|Physician Decision|17
5255193|NCT00724867|18132319|P1|Overall Study|Non-compliance with study drug|6
5255194|NCT00724867|18132319|P1|Overall Study|Lost to Follow-up|12
5255195|NCT00724867|18132319|P1|Overall Study|Lack of Efficacy|14
5255196|NCT00724867|18132319|P1|Overall Study|Adverse Event|25
5255197|NCT00724854|18132359|P2|Overall Study|Adverse event + lack of efficacy|1
5255198|NCT00724854|18132360|P1|Overall Study|Adverse event + lack of efficacy|2
5255199|NCT00724854|18132359|P2|Overall Study|Withdrawal by Subject|0
5255200|NCT00724854|18132360|P1|Overall Study|Withdrawal by Subject|5
5255201|NCT00724854|18132359|P2|Overall Study|Change of treatment|0
5255202|NCT00724854|18132360|P1|Overall Study|Change of treatment|7
5255203|NCT00724854|18132359|P2|Overall Study|Death|0
5255204|NCT00724854|18132360|P1|Overall Study|Death|11
5255205|NCT00724854|18132359|P2|Overall Study|Other|3
5255206|NCT00724854|18132360|P1|Overall Study|Other|42
5255207|NCT00724854|18132359|P2|Overall Study|Adverse Event|4
5255208|NCT00724854|18132360|P1|Overall Study|Adverse Event|62
5255209|NCT00724854|18132359|P2|Overall Study|Lost to Follow-up|10
5255210|NCT00724854|18132360|P1|Overall Study|Lost to Follow-up|87
5255211|NCT00724854|18132359|P2|Overall Study|Lack of Efficacy|13
5255212|NCT00724854|18132360|P1|Overall Study|Lack of Efficacy|187
5255213|NCT00724815|18132377|P2|Overall Study|Other Various|5
5255214|NCT00724815|18132378|P1|Overall Study|Other Various|3
5255215|NCT00724815|18132377|P2|Overall Study|Lost to Follow-up|1
5255216|NCT00724815|18132378|P1|Overall Study|Lost to Follow-up|4
5255217|NCT00724815|18132377|P2|Overall Study|Adverse Event|3
5255218|NCT00724815|18132378|P1|Overall Study|Adverse Event|5
5255219|NCT00724815|18132377|P2|Overall Study|Randomized, not treated|30
5255220|NCT00724815|18132378|P1|Overall Study|Randomized, not treated|31
5255221|NCT00724711|18132411|P2|Overall Study|Protocol Violation|0
5255222|NCT00724711|18132412|P1|Overall Study|Protocol Violation|1
5255223|NCT00724711|18132411|P2|Overall Study|Lost to Follow-up|5
5255224|NCT00724711|18132412|P1|Overall Study|Lost to Follow-up|4
5255225|NCT00724711|18132411|P2|Overall Study|Withdrawal by Subject|4
5255226|NCT00724711|18132412|P1|Overall Study|Withdrawal by Subject|5
5255227|NCT00724711|18132411|P2|Overall Study|Physician Decision|3
5255228|NCT00724711|18132412|P1|Overall Study|Physician Decision|0
5255229|NCT00724711|18132411|P2|Overall Study|Lack of Efficacy|1
5255230|NCT00724711|18132412|P1|Overall Study|Lack of Efficacy|0
5255231|NCT00724711|18132411|P2|Overall Study|Pregnancy|1
5255232|NCT00724711|18132412|P1|Overall Study|Pregnancy|0
5255233|NCT00724711|18132411|P2|Overall Study|Adverse Event|3
5255234|NCT00724711|18132412|P1|Overall Study|Adverse Event|7
5255235|NCT00724698|18132444|P1|Overall Study|No Info|25
5255236|NCT00724698|18132444|P1|Overall Study|Lost to Follow-up|36
5255237|NCT00724698|18132444|P1|Overall Study|Poor Compliance|16
5255238|NCT00724698|18132444|P1|Overall Study|Failure of Therapy|4
5255239|NCT00724698|18132444|P1|Overall Study|Adverse Event|9
5255240|NCT00724503|18132497|P2|Overall Study|Not otherwise specified|7
5255241|NCT00724503|18132498|P1|Overall Study|Not otherwise specified|4
5255242|NCT00724503|18132497|P2|Overall Study|Adverse Event|0
5255243|NCT00724503|18132498|P1|Overall Study|Adverse Event|1
5255244|NCT00724503|18132497|P2|Overall Study|Death|182
5255245|NCT00724503|18132498|P1|Overall Study|Death|190
5255246|NCT00724503|18132497|P2|Overall Study|Withdrawal by Subject|23
5255247|NCT00724503|18132498|P1|Overall Study|Withdrawal by Subject|11
5255248|NCT00724503|18132497|P2|Overall Study|Lost to Follow-up|8
5255249|NCT00724503|18132498|P1|Overall Study|Lost to Follow-up|4
5255250|NCT00724451|18132522|P1|Overall Study|Investigator + Participant Decision|13
5255251|NCT00724451|18132522|P1|Overall Study|Withdrawal by Subject|45
5255252|NCT00724451|18132522|P1|Overall Study|Physician Decision|116
5255253|NCT00724451|18132522|P1|Overall Study|Unknown; No Data Sources Available|9
5255254|NCT00724451|18132522|P1|Overall Study|Never Started Treatment|89
5255255|NCT00724451|18132522|P1|Overall Study|Participant Refused Treatment|89
5255256|NCT00724451|18132522|P1|Overall Study|Not Eligible for Treatment|431
5255257|NCT00724451|18132522|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
5255258|NCT00724451|18132522|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
5255259|NCT00724373|18132528|P1|Overall Study|Tolerability|23
5255260|NCT00724373|18132528|P1|Overall Study|Drug Relapse|1
5255261|NCT00724373|18132528|P1|Overall Study|Acute HCV infection|1
5255262|NCT00724373|18132528|P1|Overall Study|Viral Relapse|1
5255263|NCT00724373|18132528|P1|Overall Study|Only to have 24 week regimen|1
5255264|NCT00724373|18132528|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
5255265|NCT00724373|18132528|P1|Overall Study|Participant moved away|1
5255266|NCT00724373|18132528|P1|Overall Study|HCV RNA negative after 4 weeks|9
5255267|NCT00724373|18132528|P1|Overall Study|Non-compliance|2
5255268|NCT00724373|18132528|P1|Overall Study|Lost to Follow-up|7
5255269|NCT00724373|18132528|P1|Overall Study|Lack of Efficacy|82
5255270|NCT00724373|18132528|P1|Overall Study|Adverse Event|41
5255271|NCT00724282|18132553|P1|Overall Study|Physician Decision|1
5255272|NCT00724282|18132553|P1|Overall Study|Withdrawal by Subject|3
5255273|NCT00724243|18132557|P1|Overall Study|Adverse Event|5
5255274|NCT00724243|18132557|P1|Overall Study|Lack of Efficacy|10
5255275|NCT00724152|18132567|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
5255276|NCT00724152|18132568|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
5255277|NCT00724152|18132569|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
5255278|NCT00724152|18132567|P3|Two-arm Study Period|Withdrawal by Subject|0
5255279|NCT00724152|18132568|P2|Two-arm Study Period|Withdrawal by Subject|2
5255280|NCT00724152|18132569|P1|Two-arm Study Period|Withdrawal by Subject|3
5255281|NCT00724126|18132586|P2|Overall Study|Subject had to leave vicinity of site|1
5255282|NCT00724126|18132587|P1|Overall Study|Subject had to leave vicinity of site|0
5255283|NCT00724126|18132586|P2|Overall Study|Subject randomized although ineligible|1
5255284|NCT00724126|18132587|P1|Overall Study|Subject randomized although ineligible|1
5255285|NCT00724126|18132586|P2|Overall Study|Noncompliance|1
5255286|NCT00724126|18132587|P1|Overall Study|Noncompliance|2
5255287|NCT00724126|18132586|P2|Overall Study|Lost to Follow-up|6
5255288|NCT00724126|18132587|P1|Overall Study|Lost to Follow-up|6
5255289|NCT00724126|18132586|P2|Overall Study|Withdrawal by Subject|6
5255290|NCT00724126|18132587|P1|Overall Study|Withdrawal by Subject|8
5255291|NCT00724126|18132586|P2|Overall Study|Adverse Event|0
5255292|NCT00724126|18132587|P1|Overall Study|Adverse Event|2
5255293|NCT00724061|18132595|P1|Dose Escalation Phase|Disease Progression|3
5255294|NCT00724061|18132595|P1|Dose Escalation Phase|Adverse Event|2
5255295|NCT00723957|18132615|P2|Overall Study|Never received treatment|3
5255296|NCT00723957|18132616|P1|Overall Study|Never received treatment|3
5255297|NCT00723957|18132615|P2|Overall Study|Reason not analyzed|0
5255298|NCT00723957|18132616|P1|Overall Study|Reason not analyzed|1
5255299|NCT00723957|18132615|P2|Overall Study|Withdrawal by Subject|5
5255300|NCT00723957|18132616|P1|Overall Study|Withdrawal by Subject|7
5255301|NCT00723957|18132615|P2|Overall Study|Study drug toxicity|6
5255302|NCT00723957|18132616|P1|Overall Study|Study drug toxicity|4
5255303|NCT00723957|18132615|P2|Overall Study|Investigator decision|1
5255304|NCT00723957|18132616|P1|Overall Study|Investigator decision|1
5255305|NCT00723957|18132615|P2|Overall Study|Maximum clinical benefit|5
5255306|NCT00723957|18132616|P1|Overall Study|Maximum clinical benefit|4
5255307|NCT00723957|18132615|P2|Overall Study|Disease progression|25
5255308|NCT00723957|18132616|P1|Overall Study|Disease progression|27
5255309|NCT00723957|18132615|P2|Overall Study|Death|4
5255310|NCT00723957|18132616|P1|Overall Study|Death|3
5255311|NCT00723957|18132615|P2|Overall Study|Adverse event unrelated to study drug|4
5255312|NCT00723957|18132616|P1|Overall Study|Adverse event unrelated to study drug|1
5255313|NCT00723944|18132640|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
5255314|NCT00723944|18132641|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
5255315|NCT00723944|18132640|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
5255316|NCT00723944|18132641|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
5255317|NCT00723944|18132640|P2|Permanent Prosthesis Placement|Adverse Event|7
5255318|NCT00723944|18132641|P1|Permanent Prosthesis Placement|Adverse Event|1
5255319|NCT00723892|18132654|P2|Overall Study|Drug addiction|0
5255320|NCT00723892|18132655|P1|Overall Study|Drug addiction|1
5255321|NCT00723892|18132654|P2|Overall Study|Intercurrent infection|0
5255322|NCT00723892|18132655|P1|Overall Study|Intercurrent infection|2
5255323|NCT00723892|18132654|P2|Overall Study|Alcohol abuse|1
5255324|NCT00723892|18132655|P1|Overall Study|Alcohol abuse|0
5255325|NCT00723892|18132654|P2|Overall Study|Weight loss|3
5255326|NCT00723892|18132655|P1|Overall Study|Weight loss|1
5255327|NCT00723892|18132654|P2|Overall Study|Study end|3
5255328|NCT00723892|18132655|P1|Overall Study|Study end|1
5255329|NCT00723892|18132654|P2|Overall Study|Other|3
5255330|NCT00723892|18132655|P1|Overall Study|Other|6
5255331|NCT00723892|18132654|P2|Overall Study|Multiple reasons|12
5255332|NCT00723892|18132655|P1|Overall Study|Multiple reasons|17
5255333|NCT00723892|18132654|P2|Overall Study|Bad tolerance|5
5255334|NCT00723892|18132655|P1|Overall Study|Bad tolerance|5
5255335|NCT00723892|18132654|P2|Overall Study|End planned|7
5255336|NCT00723892|18132655|P1|Overall Study|End planned|11
5255337|NCT00723892|18132654|P2|Overall Study|Withdrawal by Subject|9
5255338|NCT00723892|18132655|P1|Overall Study|Withdrawal by Subject|6
5255339|NCT00723892|18132654|P2|Overall Study|Virological criterion|9
5255340|NCT00723892|18132655|P1|Overall Study|Virological criterion|24
5255341|NCT00723892|18132654|P2|Overall Study|Participant not tracked|35
5255342|NCT00723892|18132655|P1|Overall Study|Participant not tracked|33
5255343|NCT00723840|18132662|P1|Overall Study|Unspecified reason|2
5255344|NCT00723840|18132662|P1|Overall Study|Other Medical Event|2
5255345|NCT00723840|18132662|P1|Overall Study|Serious Adverse Events|3
5255346|NCT00723840|18132662|P1|Overall Study|Withdrawal by Subject|55
5255347|NCT00723840|18132662|P1|Overall Study|Failure to return|18
5255348|NCT00723840|18132662|P1|Overall Study|Lost to Follow-up|2
5255349|NCT00723801|18132683|P2|Overall Study|Protocol Violation|1
5255350|NCT00723801|18132684|P1|Overall Study|Protocol Violation|2
5255351|NCT00723801|18132683|P2|Overall Study|Lost to Follow-up|2
5255352|NCT00723801|18132684|P1|Overall Study|Lost to Follow-up|1
5255353|NCT00723710|18132709|P1|Overall Study|Physician Decision|2
5255354|NCT00723710|18132709|P1|Overall Study|Withdrawal by Subject|36
5255355|NCT00723710|18132709|P1|Overall Study|Adverse Event|88
5255356|NCT00723710|18132709|P1|Overall Study|Disease progression|48
5255357|NCT00723697|18132713|P1|Overall Study|Other exclusion criteria applied|6
5255358|NCT00723697|18132713|P1|Overall Study|Missing Informed Consent Form|10
5255359|NCT00723697|18132713|P1|Overall Study|Physician questionnaires not received|2
5255360|NCT00723606|18132734|P2|Overall Study|Withdrawal by Subject|2
5255361|NCT00723606|18132735|P1|Overall Study|Withdrawal by Subject|0
5255362|NCT00723606|18132734|P2|Overall Study|Other|0
5255363|NCT00723606|18132735|P1|Overall Study|Other|2
5255364|NCT00723606|18132734|P2|Overall Study|Adverse Event|5
5255365|NCT00723606|18132735|P1|Overall Study|Adverse Event|2
5255366|NCT00723554|18132755|P1|Overall Study|Non-compliance|1
5255367|NCT00723554|18132755|P1|Overall Study|Lost to Follow-up|1
5255368|NCT00723554|18132755|P1|Overall Study|Other|3
5255369|NCT00723554|18132755|P1|Overall Study|Withdrawal of consent|3
5255370|NCT00723554|18132755|P1|Overall Study|Inhaled medication other than iloprost|4
5255371|NCT00723554|18132755|P1|Overall Study|Investigator's judgement|5
5255372|NCT00723554|18132755|P1|Overall Study|Adverse Event|12
5255373|NCT00723528|18132805|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
5255374|NCT00723528|18132806|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5255375|NCT00723528|18132807|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5255376|NCT00723528|18132808|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5255377|NCT00723528|18132809|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5255378|NCT00723528|18132810|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5255379|NCT00723528|18132811|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5255380|NCT00723528|18132805|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
5255381|NCT00723528|18132806|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5255382|NCT00723528|18132807|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5255383|NCT00723528|18132808|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5255384|NCT00723528|18132809|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5255385|NCT00723528|18132810|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5255386|NCT00723528|18132811|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5255387|NCT00723528|18132805|P7|Period 2: After Controlled Period|Adverse Event|1
5255388|NCT00723528|18132806|P6|Period 2: After Controlled Period|Adverse Event|0
5255389|NCT00723528|18132807|P5|Period 2: After Controlled Period|Adverse Event|1
5255390|NCT00723528|18132808|P4|Period 2: After Controlled Period|Adverse Event|0
5255391|NCT00723528|18132809|P3|Period 2: After Controlled Period|Adverse Event|0
5255392|NCT00723528|18132810|P2|Period 2: After Controlled Period|Adverse Event|0
5255393|NCT00723528|18132811|P1|Period 2: After Controlled Period|Adverse Event|0
5255394|NCT00723528|18132805|P7|Period 2: After Controlled Period|Other|0
5255395|NCT00723528|18132806|P6|Period 2: After Controlled Period|Other|4
5255396|NCT00723528|18132807|P5|Period 2: After Controlled Period|Other|1
5255397|NCT00723528|18132808|P4|Period 2: After Controlled Period|Other|0
5255398|NCT00723528|18132809|P3|Period 2: After Controlled Period|Other|0
5255399|NCT00723528|18132810|P2|Period 2: After Controlled Period|Other|0
5255400|NCT00723528|18132811|P1|Period 2: After Controlled Period|Other|0
5255401|NCT00723528|18132805|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5255402|NCT00723528|18132806|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
5255403|NCT00723528|18132807|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5255404|NCT00723528|18132808|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5255405|NCT00723528|18132809|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5255406|NCT00723528|18132810|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5255407|NCT00723528|18132811|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5255408|NCT00723528|18132805|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
5255409|NCT00723528|18132806|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
5255410|NCT00723528|18132807|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
5255411|NCT00723528|18132808|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
5255412|NCT00723528|18132809|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
5255413|NCT00723528|18132810|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
5255414|NCT00723528|18132811|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
5255415|NCT00723528|18132805|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5255416|NCT00723528|18132806|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5255417|NCT00723528|18132807|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5255418|NCT00723528|18132808|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5255419|NCT00723528|18132809|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
5255420|NCT00723528|18132810|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5255421|NCT00723528|18132811|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
5255422|NCT00723528|18132805|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5255423|NCT00723528|18132806|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5255424|NCT00723528|18132807|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5255425|NCT00723528|18132808|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5255426|NCT00723528|18132809|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
5255427|NCT00723528|18132810|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5255428|NCT00723528|18132811|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5255429|NCT00723528|18132805|P7|Period 1: Controlled Period (CP)|Physician Decision|0
5255430|NCT00723528|18132806|P6|Period 1: Controlled Period (CP)|Physician Decision|0
5255431|NCT00723528|18132807|P5|Period 1: Controlled Period (CP)|Physician Decision|0
5255432|NCT00723528|18132808|P4|Period 1: Controlled Period (CP)|Physician Decision|0
5255433|NCT00723528|18132809|P3|Period 1: Controlled Period (CP)|Physician Decision|1
5255434|NCT00723528|18132810|P2|Period 1: Controlled Period (CP)|Physician Decision|0
5255435|NCT00723528|18132811|P1|Period 1: Controlled Period (CP)|Physician Decision|0
5255436|NCT00723528|18132805|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5255437|NCT00723528|18132806|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5255438|NCT00723528|18132807|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5255439|NCT00723528|18132808|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5255440|NCT00723528|18132809|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5255441|NCT00723528|18132810|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5255442|NCT00723528|18132811|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
5255443|NCT00723528|18132805|P7|Period 1: Controlled Period (CP)|Adverse Event|0
5255444|NCT00723528|18132806|P6|Period 1: Controlled Period (CP)|Adverse Event|0
5255445|NCT00723528|18132807|P5|Period 1: Controlled Period (CP)|Adverse Event|0
5255446|NCT00723528|18132808|P4|Period 1: Controlled Period (CP)|Adverse Event|0
5255447|NCT00723528|18132809|P3|Period 1: Controlled Period (CP)|Adverse Event|1
5255448|NCT00723528|18132810|P2|Period 1: Controlled Period (CP)|Adverse Event|0
5255449|NCT00723528|18132811|P1|Period 1: Controlled Period (CP)|Adverse Event|0
5255450|NCT00723489|18132873|P4|Overall Study|Samples Collected Out of Window|0
5255451|NCT00723489|18132874|P3|Overall Study|Samples Collected Out of Window|0
5255452|NCT00723489|18132875|P2|Overall Study|Samples Collected Out of Window|3
5255453|NCT00723489|18132876|P1|Overall Study|Samples Collected Out of Window|0
5255454|NCT00723489|18132873|P4|Overall Study|Prohibited Medication|1
5255455|NCT00723489|18132874|P3|Overall Study|Prohibited Medication|0
5255456|NCT00723489|18132875|P2|Overall Study|Prohibited Medication|0
5255457|NCT00723489|18132876|P1|Overall Study|Prohibited Medication|0
5255458|NCT00723489|18132873|P4|Overall Study|Seropositive at baseline|0
5255459|NCT00723489|18132874|P3|Overall Study|Seropositive at baseline|0
5255460|NCT00723489|18132875|P2|Overall Study|Seropositive at baseline|0
5255461|NCT00723489|18132876|P1|Overall Study|Seropositive at baseline|1
5255462|NCT00723489|18132873|P4|Overall Study|Withdrawal by Subject|1
5255463|NCT00723489|18132874|P3|Overall Study|Withdrawal by Subject|0
5255464|NCT00723489|18132875|P2|Overall Study|Withdrawal by Subject|0
5255465|NCT00723489|18132876|P1|Overall Study|Withdrawal by Subject|0
5255466|NCT00723489|18132873|P4|Overall Study|Pregnancy|1
5255467|NCT00723489|18132874|P3|Overall Study|Pregnancy|0
5255468|NCT00723489|18132875|P2|Overall Study|Pregnancy|0
5255469|NCT00723489|18132876|P1|Overall Study|Pregnancy|0
5255470|NCT00723489|18132873|P4|Overall Study|Physician Decision|0
5255471|NCT00723489|18132874|P3|Overall Study|Physician Decision|0
5255472|NCT00723489|18132875|P2|Overall Study|Physician Decision|1
5255473|NCT00723489|18132876|P1|Overall Study|Physician Decision|0
5255474|NCT00723450|18132904|P3|Randomized Phase|Withdrawal by Subject|22
5255475|NCT00723450|18132905|P2|Randomized Phase|Withdrawal by Subject|14
5255476|NCT00723450|18132906|P1|Randomized Phase|Withdrawal by Subject|0
5255477|NCT00723450|18132904|P3|Randomized Phase|Physician Decision|1
5255478|NCT00723450|18132905|P2|Randomized Phase|Physician Decision|3
5255479|NCT00723450|18132906|P1|Randomized Phase|Physician Decision|0
5255480|NCT00723450|18132904|P3|Randomized Phase|Lost to Follow-up|3
5255481|NCT00723450|18132905|P2|Randomized Phase|Lost to Follow-up|2
5255482|NCT00723450|18132906|P1|Randomized Phase|Lost to Follow-up|0
5255483|NCT00723450|18132904|P3|Randomized Phase|Protocol Violation|13
5255484|NCT00723450|18132905|P2|Randomized Phase|Protocol Violation|9
5255485|NCT00723450|18132906|P1|Randomized Phase|Protocol Violation|0
5255486|NCT00723450|18132904|P3|Randomized Phase|Lack of Efficacy|11
5255487|NCT00723450|18132905|P2|Randomized Phase|Lack of Efficacy|11
5255488|NCT00723450|18132906|P1|Randomized Phase|Lack of Efficacy|0
5255489|NCT00723450|18132904|P3|Randomized Phase|Adverse Event|17
5255490|NCT00723450|18132905|P2|Randomized Phase|Adverse Event|26
5255491|NCT00723450|18132906|P1|Randomized Phase|Adverse Event|0
5255492|NCT00723450|18132904|P3|Open-Label Phase|Withdrawal by Subject|0
5255493|NCT00723450|18132905|P2|Open-Label Phase|Withdrawal by Subject|0
5255494|NCT00723450|18132906|P1|Open-Label Phase|Withdrawal by Subject|37
5255495|NCT00723450|18132904|P3|Open-Label Phase|Physician Decision|0
5255496|NCT00723450|18132905|P2|Open-Label Phase|Physician Decision|0
5255497|NCT00723450|18132906|P1|Open-Label Phase|Physician Decision|2
5255498|NCT00723450|18132904|P3|Open-Label Phase|Lost to Follow-up|0
5255499|NCT00723450|18132905|P2|Open-Label Phase|Lost to Follow-up|0
5255500|NCT00723450|18132906|P1|Open-Label Phase|Lost to Follow-up|7
5255501|NCT00723450|18132904|P3|Open-Label Phase|Protocol Violation|0
5255502|NCT00723450|18132905|P2|Open-Label Phase|Protocol Violation|0
5255503|NCT00723450|18132906|P1|Open-Label Phase|Protocol Violation|35
5255504|NCT00723450|18132904|P3|Open-Label Phase|Lack of Efficacy|0
5255505|NCT00723450|18132905|P2|Open-Label Phase|Lack of Efficacy|0
5255506|NCT00723450|18132906|P1|Open-Label Phase|Lack of Efficacy|18
5255507|NCT00723450|18132904|P3|Open-Label Phase|Adverse Event|0
5255508|NCT00723450|18132905|P2|Open-Label Phase|Adverse Event|0
5255509|NCT00723450|18132906|P1|Open-Label Phase|Adverse Event|26
5255510|NCT00723398|18132952|P5|Overall Study|Lost to Follow-up|0
5255511|NCT00723398|18132953|P4|Overall Study|Lost to Follow-up|0
5255512|NCT00723398|18132954|P3|Overall Study|Lost to Follow-up|0
5255513|NCT00723398|18132955|P2|Overall Study|Lost to Follow-up|1
5255514|NCT00723398|18132956|P1|Overall Study|Lost to Follow-up|0
5255515|NCT00723398|18132952|P5|Overall Study|Adverse Event|4
5255516|NCT00723398|18132953|P4|Overall Study|Adverse Event|1
5255517|NCT00723398|18132954|P3|Overall Study|Adverse Event|3
5255518|NCT00723398|18132955|P2|Overall Study|Adverse Event|5
5255519|NCT00723398|18132956|P1|Overall Study|Adverse Event|0
5255520|NCT00723398|18132952|P5|Overall Study|Physician Decision|1
5255521|NCT00723398|18132953|P4|Overall Study|Physician Decision|0
5255522|NCT00723398|18132954|P3|Overall Study|Physician Decision|5
5255523|NCT00723398|18132955|P2|Overall Study|Physician Decision|2
5255524|NCT00723398|18132956|P1|Overall Study|Physician Decision|2
5255525|NCT00723398|18132952|P5|Overall Study|Protocol Violation|0
5255526|NCT00723398|18132953|P4|Overall Study|Protocol Violation|0
5255527|NCT00723398|18132954|P3|Overall Study|Protocol Violation|5
5255528|NCT00723398|18132955|P2|Overall Study|Protocol Violation|1
5255529|NCT00723398|18132956|P1|Overall Study|Protocol Violation|2
5255530|NCT00723398|18132952|P5|Overall Study|Withdrawal by Subject|4
5255531|NCT00723398|18132953|P4|Overall Study|Withdrawal by Subject|4
5255532|NCT00723398|18132954|P3|Overall Study|Withdrawal by Subject|4
5255533|NCT00723398|18132955|P2|Overall Study|Withdrawal by Subject|6
5255534|NCT00723398|18132956|P1|Overall Study|Withdrawal by Subject|2
5255535|NCT00723294|18133018|P1|Overall Study|No treatment due to probe failure|1
5255536|NCT00723294|18133018|P1|Overall Study|Withdrawal by Subject|1
5255537|NCT00723294|18133018|P1|Overall Study|Benign lesion|1
5255538|NCT00723294|18133018|P1|Overall Study|Treated by non-credentialed surgeon|1
5255539|NCT00723294|18133018|P1|Overall Study|Treated prior to registration|1
5255540|NCT00723294|18133018|P1|Overall Study|Did not undergo surgery|1
5255541|NCT00723294|18133018|P1|Overall Study|No cryoabalation|2
5255542|NCT00723294|18133018|P1|Overall Study|1.0-Tesla MRI|1
5255543|NCT00723294|18133018|P1|Overall Study|No MRI tumor enhancement|1
5255544|NCT00723294|18133018|P1|Overall Study|>25% intraductal component|1
5255545|NCT00723294|18133018|P1|Overall Study|Lobular histology|2
5255546|NCT00723255|18133023|P1|Overall Study|Ineligible: Wrong Primary|2
5255547|NCT00723255|18133023|P1|Overall Study|Ineligible: Second primary|1
5255548|NCT00723255|18133023|P1|Overall Study|Ineligible: Inadequate pathology|1
5255549|NCT00723229|18133050|P2|First Intervention|Lost to Follow-up|3
5255550|NCT00723229|18133051|P1|First Intervention|Lost to Follow-up|7
5255551|NCT00723203|18133063|P1|Overall Study|Withdrawal by Subject|3
5255552|NCT00723190|18133067|P1|Overall Study|Other-Not included in safety population|2
5255553|NCT00723190|18133067|P1|Overall Study|Other-Premature Discontinuation|9
5255554|NCT00723190|18133067|P1|Overall Study|Protocol Violation|15
5255555|NCT00723190|18133067|P1|Overall Study|Lack of Efficacy|16
5255556|NCT00723190|18133067|P1|Overall Study|Adverse Event|18
5255557|NCT00723190|18133067|P1|Overall Study|Lost to Follow-up|37
5255558|NCT00723190|18133067|P1|Overall Study|Withdrawal by Subject|45
5255559|NCT00723125|18133100|P2|Overall Study|Adverse Event|0
5255560|NCT00723125|18133101|P1|Overall Study|Adverse Event|2
5255561|NCT00723125|18133100|P2|Overall Study|Withdrawal by Subject|6
5255562|NCT00723125|18133101|P1|Overall Study|Withdrawal by Subject|15
5255563|NCT00723125|18133100|P2|Overall Study|Met Dx|0
5255564|NCT00723125|18133101|P1|Overall Study|Met Dx|1
5255565|NCT00723021|18133150|P5|Intervention Period 4|Adverse Event|1
5255566|NCT00723021|18133151|P4|Intervention Period 4|Adverse Event|0
5255567|NCT00723021|18133152|P3|Intervention Period 4|Adverse Event|0
5255568|NCT00723021|18133153|P2|Intervention Period 4|Adverse Event|0
5255569|NCT00723021|18133154|P1|Intervention Period 4|Adverse Event|0
5255570|NCT00723008|18133208|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
5255571|NCT00723008|18133209|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
5255572|NCT00723008|18133208|P2|4-Week Unblinded Treatment|Adverse Event|0
5255573|NCT00723008|18133209|P1|4-Week Unblinded Treatment|Adverse Event|1
5255574|NCT00723008|18133208|P2|4-Week Double Blinded|Lost to Follow-up|3
5255575|NCT00723008|18133209|P1|4-Week Double Blinded|Lost to Follow-up|4
5255576|NCT00723008|18133208|P2|4-Week Double Blinded|Withdrawal by Subject|1
5255577|NCT00723008|18133209|P1|4-Week Double Blinded|Withdrawal by Subject|1
5255578|NCT00723008|18133208|P2|4-Week Double Blinded|Lack of Efficacy|1
5255579|NCT00723008|18133209|P1|4-Week Double Blinded|Lack of Efficacy|0
5255580|NCT00723008|18133208|P2|Enrollment|Lost to Follow-up|0
5255581|NCT00723008|18133209|P1|Enrollment|Lost to Follow-up|1
5255582|NCT00722800|18133241|P2|Overall Study|Physician Decision|0
5255583|NCT00722800|18133242|P1|Overall Study|Physician Decision|1
5255584|NCT00722800|18133241|P2|Overall Study|Withdrawal by Subject|0
5255585|NCT00722800|18133242|P1|Overall Study|Withdrawal by Subject|1
5255586|NCT00722761|18133254|P2|Overall Study|Withdrawal by Subject|2
5255587|NCT00722761|18133255|P1|Overall Study|Withdrawal by Subject|5
5255588|NCT00722761|18133254|P2|Overall Study|Lost to Follow-up|4
5255589|NCT00722761|18133255|P1|Overall Study|Lost to Follow-up|1
5255590|NCT00722423|18133312|P2|Overall Study|Protocol Violation|1
5255591|NCT00722423|18133313|P1|Overall Study|Protocol Violation|0
5255592|NCT00722371|18133328|P7|Overall Study|Withdrawal by Subject|26
5255593|NCT00722371|18133329|P6|Overall Study|Withdrawal by Subject|18
5255594|NCT00722371|18133330|P5|Overall Study|Withdrawal by Subject|19
5255595|NCT00722371|18133331|P4|Overall Study|Withdrawal by Subject|23
5255596|NCT00722371|18133332|P3|Overall Study|Withdrawal by Subject|19
5255597|NCT00722371|18133333|P2|Overall Study|Withdrawal by Subject|27
5255598|NCT00722371|18133334|P1|Overall Study|Withdrawal by Subject|18
5255599|NCT00722371|18133328|P7|Overall Study|Protocol Violation|1
5255600|NCT00722371|18133329|P6|Overall Study|Protocol Violation|2
5255601|NCT00722371|18133330|P5|Overall Study|Protocol Violation|4
5255602|NCT00722371|18133331|P4|Overall Study|Protocol Violation|1
5255603|NCT00722371|18133332|P3|Overall Study|Protocol Violation|0
5255604|NCT00722371|18133333|P2|Overall Study|Protocol Violation|1
5255605|NCT00722371|18133334|P1|Overall Study|Protocol Violation|6
5255606|NCT00722371|18133328|P7|Overall Study|Pregnancy|0
5255607|NCT00722371|18133329|P6|Overall Study|Pregnancy|1
5255608|NCT00722371|18133330|P5|Overall Study|Pregnancy|0
5255609|NCT00722371|18133331|P4|Overall Study|Pregnancy|0
5255610|NCT00722371|18133332|P3|Overall Study|Pregnancy|0
5255611|NCT00722371|18133333|P2|Overall Study|Pregnancy|1
5255612|NCT00722371|18133334|P1|Overall Study|Pregnancy|1
5255613|NCT00722371|18133328|P7|Overall Study|Physician Decision|4
5255614|NCT00722371|18133329|P6|Overall Study|Physician Decision|3
5255615|NCT00722371|18133330|P5|Overall Study|Physician Decision|2
5255616|NCT00722371|18133331|P4|Overall Study|Physician Decision|5
5255617|NCT00722371|18133332|P3|Overall Study|Physician Decision|2
5255618|NCT00722371|18133333|P2|Overall Study|Physician Decision|2
5255619|NCT00722371|18133334|P1|Overall Study|Physician Decision|5
5255620|NCT00722371|18133328|P7|Overall Study|Lost to Follow-up|13
5255621|NCT00722371|18133329|P6|Overall Study|Lost to Follow-up|16
5255622|NCT00722371|18133330|P5|Overall Study|Lost to Follow-up|8
5255623|NCT00722371|18133331|P4|Overall Study|Lost to Follow-up|13
5255624|NCT00722371|18133332|P3|Overall Study|Lost to Follow-up|21
5255625|NCT00722371|18133333|P2|Overall Study|Lost to Follow-up|14
5255626|NCT00722371|18133334|P1|Overall Study|Lost to Follow-up|11
5255627|NCT00722371|18133328|P7|Overall Study|Lack of Efficacy|0
5255628|NCT00722371|18133329|P6|Overall Study|Lack of Efficacy|3
5255629|NCT00722371|18133330|P5|Overall Study|Lack of Efficacy|2
5255630|NCT00722371|18133331|P4|Overall Study|Lack of Efficacy|6
5255631|NCT00722371|18133332|P3|Overall Study|Lack of Efficacy|6
5255632|NCT00722371|18133333|P2|Overall Study|Lack of Efficacy|6
5255633|NCT00722371|18133334|P1|Overall Study|Lack of Efficacy|4
5255634|NCT00722371|18133328|P7|Overall Study|Hypoglycemia|0
5255635|NCT00722371|18133329|P6|Overall Study|Hypoglycemia|0
5255636|NCT00722371|18133330|P5|Overall Study|Hypoglycemia|0
5255637|NCT00722371|18133331|P4|Overall Study|Hypoglycemia|0
5255638|NCT00722371|18133332|P3|Overall Study|Hypoglycemia|0
5255639|NCT00722371|18133333|P2|Overall Study|Hypoglycemia|0
5255640|NCT00722371|18133334|P1|Overall Study|Hypoglycemia|1
5255641|NCT00722371|18133328|P7|Overall Study|Hyperglycemia|1
5255642|NCT00722371|18133329|P6|Overall Study|Hyperglycemia|1
5255643|NCT00722371|18133330|P5|Overall Study|Hyperglycemia|5
5255644|NCT00722371|18133331|P4|Overall Study|Hyperglycemia|2
5255645|NCT00722371|18133332|P3|Overall Study|Hyperglycemia|4
5255646|NCT00722371|18133333|P2|Overall Study|Hyperglycemia|6
5255647|NCT00722371|18133334|P1|Overall Study|Hyperglycemia|2
5255648|NCT00722371|18133328|P7|Overall Study|Excluded medication|1
5255649|NCT00722371|18133329|P6|Overall Study|Excluded medication|0
5255650|NCT00722371|18133330|P5|Overall Study|Excluded medication|0
5255651|NCT00722371|18133331|P4|Overall Study|Excluded medication|0
5255652|NCT00722371|18133332|P3|Overall Study|Excluded medication|1
5255653|NCT00722371|18133333|P2|Overall Study|Excluded medication|1
5255654|NCT00722371|18133334|P1|Overall Study|Excluded medication|0
5255655|NCT00722371|18133328|P7|Overall Study|Creatinine / Creatinine clearance|1
5255656|NCT00722371|18133329|P6|Overall Study|Creatinine / Creatinine clearance|1
5255657|NCT00722371|18133330|P5|Overall Study|Creatinine / Creatinine clearance|2
5255658|NCT00722371|18133331|P4|Overall Study|Creatinine / Creatinine clearance|3
5255659|NCT00722371|18133332|P3|Overall Study|Creatinine / Creatinine clearance|2
5255660|NCT00722371|18133333|P2|Overall Study|Creatinine / Creatinine clearance|1
5255661|NCT00722371|18133334|P1|Overall Study|Creatinine / Creatinine clearance|2
5255662|NCT00722371|18133328|P7|Overall Study|Contraindication|0
5255663|NCT00722371|18133329|P6|Overall Study|Contraindication|0
5255664|NCT00722371|18133330|P5|Overall Study|Contraindication|0
5255665|NCT00722371|18133331|P4|Overall Study|Contraindication|0
5255666|NCT00722371|18133332|P3|Overall Study|Contraindication|1
5255667|NCT00722371|18133333|P2|Overall Study|Contraindication|0
5255668|NCT00722371|18133334|P1|Overall Study|Contraindication|0
5255669|NCT00722371|18133328|P7|Overall Study|Adverse Event|4
5255670|NCT00722371|18133329|P6|Overall Study|Adverse Event|8
5255671|NCT00722371|18133330|P5|Overall Study|Adverse Event|6
5255672|NCT00722371|18133331|P4|Overall Study|Adverse Event|10
5255673|NCT00722371|18133332|P3|Overall Study|Adverse Event|9
5255674|NCT00722371|18133333|P2|Overall Study|Adverse Event|13
5255675|NCT00722371|18133334|P1|Overall Study|Adverse Event|6
5255676|NCT00722137|18133387|P2|Overall Study|Randomized But Not Treated|3
5255677|NCT00722137|18133388|P1|Overall Study|Randomized But Not Treated|2
5255678|NCT00722137|18133387|P2|Overall Study|Other Reason Unknown|4
5255679|NCT00722137|18133388|P1|Overall Study|Other Reason Unknown|3
5255680|NCT00722137|18133387|P2|Overall Study|Withdrawal by Subject|9
5255681|NCT00722137|18133388|P1|Overall Study|Withdrawal by Subject|6
5255682|NCT00722137|18133387|P2|Overall Study|Death|7
5255683|NCT00722137|18133388|P1|Overall Study|Death|12
5255684|NCT00722137|18133387|P2|Overall Study|Adverse Event|21
5255685|NCT00722137|18133388|P1|Overall Study|Adverse Event|17
5255686|NCT00722137|18133387|P2|Overall Study|Overt Disease Progression|4
5255687|NCT00722137|18133388|P1|Overall Study|Overt Disease Progression|5
5255688|NCT00721968|18133466|P2|Overall Study|Lost to Follow-up|0
5255689|NCT00721968|18133467|P1|Overall Study|Lost to Follow-up|2
5255690|NCT00721955|18133478|P3|Overall Study|Adverse Event|2
5255691|NCT00721955|18133479|P2|Overall Study|Adverse Event|0
5255692|NCT00721955|18133480|P1|Overall Study|Adverse Event|0
5255693|NCT00721799|18133494|P1|Overall Study|withdraw by subject after scan 1|1
5255694|NCT00721799|18133494|P1|Overall Study|Withdrawal by Subject|7
5255695|NCT00721734|18133534|P5|Overall Study|Other|0
5255696|NCT00721734|18133535|P4|Overall Study|Other|1
5255697|NCT00721734|18133536|P3|Overall Study|Other|0
5255698|NCT00721734|18133537|P2|Overall Study|Other|0
5255699|NCT00721734|18133538|P1|Overall Study|Other|0
5255700|NCT00721734|18133534|P5|Overall Study|Withdrawal by Subject|1
5255701|NCT00721734|18133535|P4|Overall Study|Withdrawal by Subject|0
5255702|NCT00721734|18133536|P3|Overall Study|Withdrawal by Subject|0
5255703|NCT00721734|18133537|P2|Overall Study|Withdrawal by Subject|1
5255704|NCT00721734|18133538|P1|Overall Study|Withdrawal by Subject|2
5255705|NCT00721734|18133534|P5|Overall Study|Adverse Event|3
5255706|NCT00721734|18133535|P4|Overall Study|Adverse Event|0
5255707|NCT00721734|18133536|P3|Overall Study|Adverse Event|4
5255708|NCT00721734|18133537|P2|Overall Study|Adverse Event|1
5255709|NCT00721734|18133538|P1|Overall Study|Adverse Event|3
5255710|NCT00721734|18133534|P5|Overall Study|Progressive Disease|2
5255711|NCT00721734|18133535|P4|Overall Study|Progressive Disease|5
5255712|NCT00721734|18133536|P3|Overall Study|Progressive Disease|4
5255713|NCT00721734|18133537|P2|Overall Study|Progressive Disease|10
5255714|NCT00721734|18133538|P1|Overall Study|Progressive Disease|3
5255715|NCT00721630|18133650|P1|Overall Study|Participant found to be ineligible|1
5255716|NCT00721578|18133679|P2|Overall Study|Withdrawal by Subject|1
5255717|NCT00721578|18133680|P1|Overall Study|Withdrawal by Subject|1
5255718|NCT00721578|18133679|P2|Overall Study|Death|1
5255719|NCT00721578|18133680|P1|Overall Study|Death|1
5255720|NCT00721409|18133735|P3|Overall Study|Objective progression or relapse|62
5255721|NCT00721409|18133736|P2|Overall Study|Objective progression or relapse|55
5255722|NCT00721409|18133737|P1|Overall Study|Objective progression or relapse|8
5255723|NCT00721409|18133735|P3|Overall Study|Withdrawal by Subject|5
5255724|NCT00721409|18133736|P2|Overall Study|Withdrawal by Subject|6
5255725|NCT00721409|18133737|P1|Overall Study|Withdrawal by Subject|1
5255726|NCT00721409|18133735|P3|Overall Study|Lost to Follow-up|1
5255727|NCT00721409|18133736|P2|Overall Study|Lost to Follow-up|0
5255728|NCT00721409|18133737|P1|Overall Study|Lost to Follow-up|0
5255729|NCT00721409|18133735|P3|Overall Study|Adverse Event|2
5255730|NCT00721409|18133736|P2|Overall Study|Adverse Event|13
5255731|NCT00721409|18133737|P1|Overall Study|Adverse Event|0
5255732|NCT00721409|18133735|P3|Overall Study|Reason not specified|2
5255733|NCT00721409|18133736|P2|Overall Study|Reason not specified|0
5255734|NCT00721409|18133737|P1|Overall Study|Reason not specified|1
5255735|NCT00721409|18133735|P3|Overall Study|Randomized not Treated|4
5255736|NCT00721409|18133736|P2|Overall Study|Randomized not Treated|1
5255737|NCT00721409|18133737|P1|Overall Study|Randomized not Treated|0
5255738|NCT00721409|18133735|P3|Overall Study|Death|0
5255739|NCT00721409|18133736|P2|Overall Study|Death|1
5255740|NCT00721409|18133737|P1|Overall Study|Death|0
5255741|NCT00721409|18133735|P3|Overall Study|Global deterioration of health status|3
5255742|NCT00721409|18133736|P2|Overall Study|Global deterioration of health status|6
5255743|NCT00721409|18133737|P1|Overall Study|Global deterioration of health status|2
5255744|NCT00721396|18133864|P4|Overall Study|Administrative reason|0
5255745|NCT00721396|18133865|P3|Overall Study|Administrative reason|1
5255746|NCT00721396|18133866|P2|Overall Study|Administrative reason|0
5255747|NCT00721396|18133867|P1|Overall Study|Administrative reason|3
5255748|NCT00721396|18133864|P4|Overall Study|Inappropriate enrollment|0
5255749|NCT00721396|18133865|P3|Overall Study|Inappropriate enrollment|0
5255750|NCT00721396|18133866|P2|Overall Study|Inappropriate enrollment|2
5255751|NCT00721396|18133867|P1|Overall Study|Inappropriate enrollment|0
5255752|NCT00721396|18133864|P4|Overall Study|Protocol Violation|0
5255753|NCT00721396|18133865|P3|Overall Study|Protocol Violation|1
5255754|NCT00721396|18133866|P2|Overall Study|Protocol Violation|3
5255755|NCT00721396|18133867|P1|Overall Study|Protocol Violation|4
5255756|NCT00721396|18133864|P4|Overall Study|Lost to Follow-up|3
5255757|NCT00721396|18133865|P3|Overall Study|Lost to Follow-up|3
5255758|NCT00721396|18133866|P2|Overall Study|Lost to Follow-up|9
5255759|NCT00721396|18133867|P1|Overall Study|Lost to Follow-up|7
5255760|NCT00721396|18133864|P4|Overall Study|Withdrawal by Subject|7
5255761|NCT00721396|18133865|P3|Overall Study|Withdrawal by Subject|3
5255762|NCT00721396|18133866|P2|Overall Study|Withdrawal by Subject|15
5255763|NCT00721396|18133867|P1|Overall Study|Withdrawal by Subject|12
5255764|NCT00721396|18133864|P4|Overall Study|Adverse Event|0
5255765|NCT00721396|18133865|P3|Overall Study|Adverse Event|2
5255766|NCT00721396|18133866|P2|Overall Study|Adverse Event|7
5255767|NCT00721396|18133867|P1|Overall Study|Adverse Event|4
5255768|NCT00721279|18133918|P2|Overall Study|Other|16
5255769|NCT00721279|18133919|P1|Overall Study|Other|12
5255770|NCT00721279|18133918|P2|Overall Study|Withdrawal by Subject|3
5255771|NCT00721279|18133919|P1|Overall Study|Withdrawal by Subject|13
5255772|NCT00721279|18133918|P2|Overall Study|Tolerability insufficient|2
5255773|NCT00721279|18133919|P1|Overall Study|Tolerability insufficient|5
5255774|NCT00721279|18133918|P2|Overall Study|Lack of Efficacy|3
5255775|NCT00721279|18133919|P1|Overall Study|Lack of Efficacy|6
5255776|NCT00721227|18133947|P2|Overall Study|Noncompliance with scheduled visits.|0
5255777|NCT00721227|18133948|P1|Overall Study|Noncompliance with scheduled visits.|1
5255778|NCT00721227|18133947|P2|Overall Study|Lost to Follow-up|0
5255779|NCT00721227|18133948|P1|Overall Study|Lost to Follow-up|3
5255780|NCT00721214|18133958|P1|Overall Study|Death|3
5255781|NCT00721214|18133958|P1|Overall Study|Chose another center for transplant|1
5255782|NCT00721149|18134008|P1|Overall Study|Physician Decision|1
5255783|NCT00721123|18134042|P1|Overall Study|Withdrawal by Subject|5
5255784|NCT00721123|18134042|P1|Overall Study|Failure to Return|9
5255785|NCT00721123|18134042|P1|Overall Study|Refused Treatment|41
5255786|NCT00721123|18134042|P1|Overall Study|Protocol Violation|1
5255787|NCT00721123|18134042|P1|Overall Study|Insufficient Therapeutic Response|21
5255788|NCT00721123|18134042|P1|Overall Study|Death|10
5255789|NCT00721123|18134042|P1|Overall Study|Adverse Event|96
5255790|NCT00721110|18134120|P4|Overall Study|vertical incision|0
5255791|NCT00721110|18134121|P3|Overall Study|vertical incision|1
5255792|NCT00721110|18134122|P2|Overall Study|vertical incision|0
5255793|NCT00721110|18134123|P1|Overall Study|vertical incision|0
5255794|NCT00721110|18134120|P4|Overall Study|Ultram use|0
5255795|NCT00721110|18134121|P3|Overall Study|Ultram use|0
5255796|NCT00721110|18134122|P2|Overall Study|Ultram use|0
5255797|NCT00721110|18134123|P1|Overall Study|Ultram use|1
5255798|NCT00720941|18134151|P2|Overall Study|Ongoing|23
5255799|NCT00720941|18134152|P1|Overall Study|Ongoing|34
5255800|NCT00720941|18134151|P2|Overall Study|Withdrawal by Subject|35
5255801|NCT00720941|18134152|P1|Overall Study|Withdrawal by Subject|27
5255802|NCT00720941|18134151|P2|Overall Study|Physician Decision|5
5255803|NCT00720941|18134152|P1|Overall Study|Physician Decision|1
5255804|NCT00720941|18134151|P2|Overall Study|Lost to Follow-up|15
5255805|NCT00720941|18134152|P1|Overall Study|Lost to Follow-up|17
5255806|NCT00720941|18134151|P2|Overall Study|Protocol Violation|2
5255807|NCT00720941|18134152|P1|Overall Study|Protocol Violation|0
5255808|NCT00720941|18134151|P2|Overall Study|Death|335
5255809|NCT00720941|18134152|P1|Overall Study|Death|334
5255810|NCT00720876|18134192|P1|Overall Study|found to be ineligible after starting tx|2
5255811|NCT00720798|18134198|P1|Overall Study|Reason not Specified|83
5255812|NCT00720798|18134198|P1|Overall Study|Failure to Return|46
5255813|NCT00720798|18134198|P1|Overall Study|Refused Treatment|151
5255814|NCT00720798|18134198|P1|Overall Study|Protocol Violation|4
5255815|NCT00720798|18134198|P1|Overall Study|Insufficient Therapeutic Response|129
5255816|NCT00720798|18134198|P1|Overall Study|Death|39
5255817|NCT00720798|18134198|P1|Overall Study|Adverse Event|304
5255818|NCT00720759|18134221|P4|Overall Study|Lost to Follow-up|0
5255819|NCT00720759|18134222|P3|Overall Study|Lost to Follow-up|1
5255820|NCT00720759|18134223|P2|Overall Study|Lost to Follow-up|1
5255821|NCT00720759|18134224|P1|Overall Study|Lost to Follow-up|0
5255822|NCT00720499|18134244|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
5255823|NCT00720499|18134245|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
5255824|NCT00720499|18134244|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
5255825|NCT00720499|18134245|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
5255826|NCT00720499|18134244|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
5255827|NCT00720499|18134245|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
5255828|NCT00720434|18134338|P4|Open-Label Period (Week 5-72)|Other|2
5255829|NCT00720434|18134339|P3|Open-Label Period (Week 5-72)|Other|3
5255830|NCT00720434|18134340|P2|Open-Label Period (Week 5-72)|Other|3
5255831|NCT00720434|18134341|P1|Open-Label Period (Week 5-72)|Other|4
5255832|NCT00720434|18134338|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
5255833|NCT00720434|18134339|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
5255834|NCT00720434|18134340|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
5255835|NCT00720434|18134341|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
5255836|NCT00720434|18134338|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
5255837|NCT00720434|18134339|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
5255838|NCT00720434|18134340|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
5255839|NCT00720434|18134341|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
5255840|NCT00720434|18134338|P4|Open-Label Period (Week 5-72)|Adverse Event|2
5255841|NCT00720434|18134339|P3|Open-Label Period (Week 5-72)|Adverse Event|0
5255842|NCT00720434|18134340|P2|Open-Label Period (Week 5-72)|Adverse Event|0
5255843|NCT00720434|18134341|P1|Open-Label Period (Week 5-72)|Adverse Event|0
5255844|NCT00720434|18134338|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
5255845|NCT00720434|18134339|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
5255846|NCT00720434|18134340|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
5255847|NCT00720434|18134341|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
5255848|NCT00720382|18134365|P2|Overall Study|administrative|5
5255849|NCT00720382|18134366|P1|Overall Study|administrative|14
5255850|NCT00720382|18134365|P2|Overall Study|Lost to Follow-up|14
5255851|NCT00720382|18134366|P1|Overall Study|Lost to Follow-up|28
5255852|NCT00720382|18134365|P2|Overall Study|Withdrawal by Subject|11
5255853|NCT00720382|18134366|P1|Overall Study|Withdrawal by Subject|47
5255854|NCT00720382|18134365|P2|Overall Study|Non-Compliance|5
5255855|NCT00720382|18134366|P1|Overall Study|Non-Compliance|15
5255856|NCT00720382|18134365|P2|Overall Study|Lack of Efficacy|7
5255857|NCT00720382|18134366|P1|Overall Study|Lack of Efficacy|18
5255858|NCT00720382|18134365|P2|Overall Study|Adverse Event|17
5255859|NCT00720382|18134366|P1|Overall Study|Adverse Event|54
5255860|NCT00720356|18134385|P1|Follow up Until Death|Alive at last data collection|4
5255861|NCT00720356|18134385|P1|Follow up Until Death|Withdrawal by Subject|1
5255862|NCT00720356|18134385|P1|Went on to be Treated Cycle 3|Physician Decision|1
5255863|NCT00720356|18134385|P1|Went on to be Treated Cycle 3|Adverse Event|1
5255864|NCT00720356|18134385|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
5255865|NCT00720356|18134385|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
5255866|NCT00720356|18134385|P1|Registration to Study|Determined to have methylated MGMT|67
5255867|NCT00720343|18134399|P1|Overall Study|No data|3
5255868|NCT00720343|18134399|P1|Overall Study|Physician Decision|3
5255869|NCT00720278|18134433|P3|Overall Study|eligibility criteria violation|1
5255870|NCT00720278|18134434|P2|Overall Study|eligibility criteria violation|0
5255871|NCT00720278|18134435|P1|Overall Study|eligibility criteria violation|1
5255872|NCT00720278|18134433|P3|Overall Study|Non-compliance|0
5255873|NCT00720278|18134434|P2|Overall Study|Non-compliance|0
5255874|NCT00720278|18134435|P1|Overall Study|Non-compliance|1
5255875|NCT00720278|18134433|P3|Overall Study|Lost to Follow-up|1
5255876|NCT00720278|18134434|P2|Overall Study|Lost to Follow-up|0
5255877|NCT00720278|18134435|P1|Overall Study|Lost to Follow-up|0
5255878|NCT00720278|18134433|P3|Overall Study|Withdrawal by Subject|0
5255879|NCT00720278|18134434|P2|Overall Study|Withdrawal by Subject|1
5255880|NCT00720278|18134435|P1|Overall Study|Withdrawal by Subject|0
5255881|NCT00720278|18134433|P3|Overall Study|Adverse Event|4
5255882|NCT00720278|18134434|P2|Overall Study|Adverse Event|3
5255883|NCT00720278|18134435|P1|Overall Study|Adverse Event|5
5255884|NCT00720226|18134457|P2|Overall Study|Withdrawal by Subject|4
5255885|NCT00720226|18134458|P1|Overall Study|Withdrawal by Subject|7
5255886|NCT00720213|18134466|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
5255887|NCT00720213|18134467|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
5255888|NCT00720213|18134468|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
5255889|NCT00720122|18134506|P1|Overall Study|Withdrawal by Subject|7
5255890|NCT00720122|18134506|P1|Overall Study|Physician Decision|1
5255891|NCT00720122|18134506|P1|Overall Study|Lost to Follow-up|1
5255892|NCT00720109|18134510|P3|Risk Stratification Period|Development of second malignant neoplasm|0
5255893|NCT00720109|18134511|P2|Risk Stratification Period|Development of second malignant neoplasm|1
5255894|NCT00720109|18134512|P1|Risk Stratification Period|Development of second malignant neoplasm|0
5255895|NCT00720109|18134510|P3|Risk Stratification Period|Disease progression or relapse|0
5255896|NCT00720109|18134511|P2|Risk Stratification Period|Disease progression or relapse|2
5255897|NCT00720109|18134512|P1|Risk Stratification Period|Disease progression or relapse|0
5255898|NCT00720109|18134510|P3|Risk Stratification Period|Bone marrow transplant|7
5255899|NCT00720109|18134511|P2|Risk Stratification Period|Bone marrow transplant|9
5255900|NCT00720109|18134512|P1|Risk Stratification Period|Bone marrow transplant|0
5255901|NCT00720109|18134510|P3|Risk Stratification Period|Physician Decision|1
5255902|NCT00720109|18134511|P2|Risk Stratification Period|Physician Decision|2
5255903|NCT00720109|18134512|P1|Risk Stratification Period|Physician Decision|0
5255904|NCT00720109|18134510|P3|Risk Stratification Period|Adverse Event|0
5255905|NCT00720109|18134511|P2|Risk Stratification Period|Adverse Event|1
5255906|NCT00720109|18134512|P1|Risk Stratification Period|Adverse Event|0
5255907|NCT00720109|18134510|P3|Induction Period|Physician Decision|0
5255908|NCT00720109|18134511|P2|Induction Period|Physician Decision|0
5255909|NCT00720109|18134512|P1|Induction Period|Physician Decision|1
5255910|NCT00720109|18134510|P3|Induction Period|Bone Marrow Transplant|0
5255911|NCT00720109|18134511|P2|Induction Period|Bone Marrow Transplant|0
5255912|NCT00720109|18134512|P1|Induction Period|Bone Marrow Transplant|2
5255913|NCT00720109|18134510|P3|Induction Period|Did not meet eligibility criteria|0
5255914|NCT00720109|18134511|P2|Induction Period|Did not meet eligibility criteria|0
5255915|NCT00720109|18134512|P1|Induction Period|Did not meet eligibility criteria|3
5255916|NCT00720096|18134532|P2|Overall Study|Withdrawal by Subject|2
5255917|NCT00720096|18134533|P1|Overall Study|Withdrawal by Subject|0
5255918|NCT00720083|18134545|P2|Overall Study|Ineligible|2
5255919|NCT00720083|18134546|P1|Overall Study|Ineligible|1
5255920|NCT00720057|18134554|P2|Overall Study|Withdrawal by Subject|1
5255921|NCT00720057|18134555|P1|Overall Study|Withdrawal by Subject|0
5255922|NCT00720057|18134554|P2|Overall Study|Protocol Violation|0
5255923|NCT00720057|18134555|P1|Overall Study|Protocol Violation|1
5255924|NCT00720057|18134554|P2|Overall Study|Lost to Follow-up|2
5255925|NCT00720057|18134555|P1|Overall Study|Lost to Follow-up|0
5255926|NCT00719953|18134571|P1|Overall Study|Adverse Event|4
5255927|NCT00719901|18134584|P1|Overall Study|Availability of Study Drug|1
5255928|NCT00719901|18134584|P1|Overall Study|Disease Progression|3
5255929|NCT00719901|18134584|P1|Overall Study|Alternate Treatment|1
5255930|NCT00719901|18134584|P1|Overall Study|Withdrawal by Subject|1
5255931|NCT00719901|18134584|P1|Overall Study|Adverse Event|5
5255932|NCT00719862|18134596|P2|Overall Study|Other|3
5255933|NCT00719862|18134597|P1|Overall Study|Other|2
5255934|NCT00719862|18134596|P2|Overall Study|Lost to Follow-up|1
5255935|NCT00719862|18134597|P1|Overall Study|Lost to Follow-up|0
5255936|NCT00719862|18134596|P2|Overall Study|Withdrawal by Subject|0
5255937|NCT00719862|18134597|P1|Overall Study|Withdrawal by Subject|1
5255938|NCT00719862|18134596|P2|Overall Study|Non-Compliance|0
5255939|NCT00719862|18134597|P1|Overall Study|Non-Compliance|1
5255940|NCT00719862|18134596|P2|Overall Study|Lack of Efficacy|0
5255941|NCT00719862|18134597|P1|Overall Study|Lack of Efficacy|3
5255942|NCT00719862|18134596|P2|Overall Study|Adverse Event|2
5255943|NCT00719862|18134597|P1|Overall Study|Adverse Event|1
5255944|NCT00719849|18134615|P2|Overall Study|Death|1
5255945|NCT00719849|18134616|P1|Overall Study|Death|0
5255946|NCT00719810|18134655|P3|Overall Study|Withdrawal by Subject|2
5255947|NCT00719810|18134656|P2|Overall Study|Withdrawal by Subject|1
5255948|NCT00719810|18134657|P1|Overall Study|Withdrawal by Subject|1
5255949|NCT00719810|18134655|P3|Overall Study|Physician Decision|0
5255950|NCT00719810|18134656|P2|Overall Study|Physician Decision|1
5255951|NCT00719810|18134657|P1|Overall Study|Physician Decision|0
5255952|NCT00719810|18134655|P3|Overall Study|Lost to Follow-up|3
5255953|NCT00719810|18134656|P2|Overall Study|Lost to Follow-up|0
5255954|NCT00719810|18134657|P1|Overall Study|Lost to Follow-up|2
5255955|NCT00719810|18134655|P3|Overall Study|Adverse Event|3
5255956|NCT00719810|18134656|P2|Overall Study|Adverse Event|2
5255957|NCT00719810|18134657|P1|Overall Study|Adverse Event|0
5255958|NCT00719732|18134668|P1|Overall Study|Illness not associated with device|1
5255959|NCT00719732|18134668|P1|Overall Study|Unilateral (not bilateral) implantation|1
5255960|NCT00719732|18134668|P1|Overall Study|Lost to Follow-up|20
5255961|NCT00719706|18134674|P2|Overall Study|Protocol Violation|0
5255962|NCT00719706|18134675|P1|Overall Study|Protocol Violation|3
5255963|NCT00719706|18134674|P2|Overall Study|Withdrawal by Subject|2
5255964|NCT00719706|18134675|P1|Overall Study|Withdrawal by Subject|1
5255965|NCT00719706|18134674|P2|Overall Study|Adverse Event|4
5255966|NCT00719706|18134675|P1|Overall Study|Adverse Event|5
5255967|NCT00719680|18134689|P1|Overall Study|Withdrawal by Subject|3
5255968|NCT00719680|18134689|P1|Overall Study|Lost to Follow-up|1
5255969|NCT00719680|18134689|P1|Overall Study|Adverse Event|1
5255970|NCT00719563|18134745|P2|Overall Study|Lost to Follow-up|3
5255971|NCT00719563|18134746|P1|Overall Study|Lost to Follow-up|5
5255972|NCT00719563|18134745|P2|Overall Study|Noncompliant|1
5255973|NCT00719563|18134746|P1|Overall Study|Noncompliant|1
5255974|NCT00719563|18134745|P2|Overall Study|Unknown reasons|6
5255975|NCT00719563|18134746|P1|Overall Study|Unknown reasons|4
5255976|NCT00719563|18134745|P2|Overall Study|Personal reasons|7
5255977|NCT00719563|18134746|P1|Overall Study|Personal reasons|6
5255978|NCT00719563|18134745|P2|Overall Study|Lack of Efficacy|7
5255979|NCT00719563|18134746|P1|Overall Study|Lack of Efficacy|3
5255980|NCT00719563|18134745|P2|Overall Study|Medical condition changed|5
5255981|NCT00719563|18134746|P1|Overall Study|Medical condition changed|3
5255982|NCT00719563|18134745|P2|Overall Study|Adverse Event|13
5255983|NCT00719563|18134746|P1|Overall Study|Adverse Event|16
5255984|NCT00719537|18134778|P2|Overall Study|Lost to Follow-up|1
5255985|NCT00719537|18134779|P1|Overall Study|Lost to Follow-up|0
5255986|NCT00719537|18134778|P2|Overall Study|Withdrawal by Subject|0
5255987|NCT00719537|18134779|P1|Overall Study|Withdrawal by Subject|1
5255988|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Various Reasons|25
5255989|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
5255990|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
5255991|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
5255992|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Disease progression|3
5255993|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Death|6
5255994|NCT00719472|18134785|P1|Received Cycle 2 Treatment|Adverse Event|12
5255995|NCT00719472|18134785|P1|Received Cycle 1 Treatment|Various Reasons|13
5255996|NCT00719472|18134785|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
5255997|NCT00719472|18134785|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
5255998|NCT00719472|18134785|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
5255999|NCT00719472|18134785|P1|Received Cycle 1 Treatment|Death|5
5256000|NCT00719472|18134785|P1|Received Cycle 1 Treatment|Adverse Event|8
5256001|NCT00719472|18134785|P1|Enrolled in Study|Various Reasons|17
5256002|NCT00719472|18134785|P1|Enrolled in Study|Subject decision to withdraw|8
5256003|NCT00719472|18134785|P1|Enrolled in Study|Physician decision to withdraw patient|1
5256004|NCT00719355|18134796|P2|Overall Study|Moved|1
5256005|NCT00719355|18134797|P1|Overall Study|Moved|0
5256006|NCT00719355|18134796|P2|Overall Study|Compliance|6
5256007|NCT00719355|18134797|P1|Overall Study|Compliance|4
5256008|NCT00719355|18134796|P2|Overall Study|Medical|5
5256009|NCT00719355|18134797|P1|Overall Study|Medical|14
5256010|NCT00719355|18134796|P2|Overall Study|Death|1
5256011|NCT00719355|18134797|P1|Overall Study|Death|0
5256012|NCT00719264|18134826|P2|Overall Study|Disease Progression|107
5256013|NCT00719264|18134827|P1|Overall Study|Disease Progression|104
5256014|NCT00719264|18134826|P2|Overall Study|New Cancer Therapy|2
5256015|NCT00719264|18134827|P1|Overall Study|New Cancer Therapy|4
5256016|NCT00719264|18134826|P2|Overall Study|Protocol Deviation|3
5256017|NCT00719264|18134827|P1|Overall Study|Protocol Deviation|1
5256018|NCT00719264|18134826|P2|Overall Study|Withdrawal by Subject|7
5256019|NCT00719264|18134827|P1|Overall Study|Withdrawal by Subject|12
5256020|NCT00719264|18134826|P2|Overall Study|Lost to Follow-up|1
5256021|NCT00719264|18134827|P1|Overall Study|Lost to Follow-up|1
5256022|NCT00719264|18134826|P2|Overall Study|Administrative Problems|4
5256023|NCT00719264|18134827|P1|Overall Study|Administrative Problems|6
5256024|NCT00719264|18134826|P2|Overall Study|Death|10
5256025|NCT00719264|18134827|P1|Overall Study|Death|13
5256026|NCT00719264|18134826|P2|Overall Study|Adverse Event|49
5256027|NCT00719264|18134827|P1|Overall Study|Adverse Event|41
5256028|NCT00719212|18134846|P1|Overall Study|Withdrawal by Subject|1
5256029|NCT00719212|18134846|P1|Overall Study|Lost to Follow-up|2
5256030|NCT00719212|18134846|P1|Overall Study|Death|41
5256031|NCT00719043|18134894|P7|Overall Study|Withdrawal by Subject|14
5256032|NCT00719043|18134895|P6|Overall Study|Withdrawal by Subject|18
5256033|NCT00719043|18134896|P5|Overall Study|Withdrawal by Subject|16
5256034|NCT00719043|18134897|P4|Overall Study|Withdrawal by Subject|10
5256035|NCT00719043|18134898|P3|Overall Study|Withdrawal by Subject|9
5256036|NCT00719043|18134899|P2|Overall Study|Withdrawal by Subject|14
5256037|NCT00719043|18134900|P1|Overall Study|Withdrawal by Subject|12
5256038|NCT00719043|18134894|P7|Overall Study|Other|1
5256039|NCT00719043|18134895|P6|Overall Study|Other|2
5256040|NCT00719043|18134896|P5|Overall Study|Other|0
5256041|NCT00719043|18134897|P4|Overall Study|Other|2
5256042|NCT00719043|18134898|P3|Overall Study|Other|1
5256043|NCT00719043|18134899|P2|Overall Study|Other|0
5256044|NCT00719043|18134900|P1|Overall Study|Other|1
5256045|NCT00719043|18134894|P7|Overall Study|Protocol Violation|0
5256046|NCT00719043|18134895|P6|Overall Study|Protocol Violation|1
5256047|NCT00719043|18134896|P5|Overall Study|Protocol Violation|0
5256048|NCT00719043|18134897|P4|Overall Study|Protocol Violation|0
5256049|NCT00719043|18134898|P3|Overall Study|Protocol Violation|0
5256050|NCT00719043|18134899|P2|Overall Study|Protocol Violation|0
5256051|NCT00719043|18134900|P1|Overall Study|Protocol Violation|0
5256052|NCT00719043|18134894|P7|Overall Study|Lost to Follow-up|9
5256053|NCT00719043|18134895|P6|Overall Study|Lost to Follow-up|9
5256054|NCT00719043|18134896|P5|Overall Study|Lost to Follow-up|10
5256055|NCT00719043|18134897|P4|Overall Study|Lost to Follow-up|9
5256056|NCT00719043|18134898|P3|Overall Study|Lost to Follow-up|8
5256057|NCT00719043|18134899|P2|Overall Study|Lost to Follow-up|10
5256058|NCT00719043|18134900|P1|Overall Study|Lost to Follow-up|14
5256059|NCT00719043|18134894|P7|Overall Study|Adverse Event|4
5256060|NCT00719043|18134895|P6|Overall Study|Adverse Event|4
5256061|NCT00719043|18134896|P5|Overall Study|Adverse Event|1
5256062|NCT00719043|18134897|P4|Overall Study|Adverse Event|2
5256063|NCT00719043|18134898|P3|Overall Study|Adverse Event|2
5256064|NCT00719043|18134899|P2|Overall Study|Adverse Event|1
5256065|NCT00719043|18134900|P1|Overall Study|Adverse Event|5
5256066|NCT00718887|18135024|P2|Overall Study|Not identified|7
5256067|NCT00718887|18135025|P1|Overall Study|Not identified|2
5256068|NCT00718887|18135024|P2|Overall Study|Withdrawal by Subject|2
5256069|NCT00718887|18135025|P1|Overall Study|Withdrawal by Subject|3
5256070|NCT00718861|18135049|P2|Overall Study|Death|5
5256071|NCT00718861|18135050|P1|Overall Study|Death|1
5256072|NCT00718861|18135049|P2|Overall Study|Administrative Problems|1
5256073|NCT00718861|18135050|P1|Overall Study|Administrative Problems|1
5256074|NCT00718861|18135049|P2|Overall Study|Lost to Follow-up|1
5256075|NCT00718861|18135050|P1|Overall Study|Lost to Follow-up|2
5256076|NCT00718861|18135049|P2|Overall Study|Adverse Event|1
5256077|NCT00718861|18135050|P1|Overall Study|Adverse Event|2
5256078|NCT00718861|18135049|P2|Overall Study|Withdrawal by Subject|10
5256079|NCT00718861|18135050|P1|Overall Study|Withdrawal by Subject|15
5256080|NCT00718809|18135078|P2|Overall Study|Noncompliance|0
5256081|NCT00718809|18135079|P1|Overall Study|Noncompliance|1
5256082|NCT00718809|18135078|P2|Overall Study|Lost to Follow-up|0
5256083|NCT00718809|18135079|P1|Overall Study|Lost to Follow-up|1
5256084|NCT00718809|18135078|P2|Overall Study|Withdrawal by Subject|1
5256085|NCT00718809|18135079|P1|Overall Study|Withdrawal by Subject|0
5256086|NCT00718809|18135078|P2|Overall Study|Adverse Event|1
5256087|NCT00718809|18135079|P1|Overall Study|Adverse Event|1
5256088|NCT00718809|18135078|P2|Overall Study|Disease progression|7
5256089|NCT00718809|18135079|P1|Overall Study|Disease progression|9
5256090|NCT00718770|18135093|P1|Overall Study|Adverse Event|1
5256091|NCT00718770|18135093|P1|Overall Study|Lack of Efficacy|1
5256092|NCT00718770|18135093|P1|Overall Study|Adverse Event|1
5256093|NCT00718770|18135093|P1|Overall Study|Lack of Efficacy|1
5256094|NCT00718770|18135093|P1|Overall Study|Adverse Event|1
5256095|NCT00718770|18135093|P1|Overall Study|Lack of Efficacy|1
5256096|NCT00718770|18135093|P1|Overall Study|Lack of Efficacy|1
5256097|NCT00718770|18135093|P1|Overall Study|Adverse Event|1
5256098|NCT00718718|18135104|P10|Week 12 to End of Study|Other|0
5256099|NCT00718718|18135105|P9|Week 12 to End of Study|Other|0
5256100|NCT00718718|18135106|P8|Week 12 to End of Study|Other|0
5256101|NCT00718718|18135107|P7|Week 12 to End of Study|Other|1
5256102|NCT00718718|18135108|P6|Week 12 to End of Study|Other|0
5256103|NCT00718718|18135109|P5|Week 12 to End of Study|Other|0
5256104|NCT00718718|18135110|P4|Week 12 to End of Study|Other|1
5256105|NCT00718718|18135111|P3|Week 12 to End of Study|Other|0
5256106|NCT00718718|18135112|P2|Week 12 to End of Study|Other|1
5256107|NCT00718718|18135113|P1|Week 12 to End of Study|Other|0
5256108|NCT00718718|18135104|P10|Week 12 to End of Study|Lost to Follow-up|0
5256109|NCT00718718|18135105|P9|Week 12 to End of Study|Lost to Follow-up|1
5256110|NCT00718718|18135106|P8|Week 12 to End of Study|Lost to Follow-up|0
5256111|NCT00718718|18135107|P7|Week 12 to End of Study|Lost to Follow-up|0
5256112|NCT00718718|18135108|P6|Week 12 to End of Study|Lost to Follow-up|0
5256113|NCT00718718|18135109|P5|Week 12 to End of Study|Lost to Follow-up|0
5256114|NCT00718718|18135110|P4|Week 12 to End of Study|Lost to Follow-up|0
5256115|NCT00718718|18135111|P3|Week 12 to End of Study|Lost to Follow-up|0
5256116|NCT00718718|18135112|P2|Week 12 to End of Study|Lost to Follow-up|0
5256117|NCT00718718|18135113|P1|Week 12 to End of Study|Lost to Follow-up|0
5256118|NCT00718718|18135104|P10|Week 12 to End of Study|Withdrawal by Subject|0
5256119|NCT00718718|18135105|P9|Week 12 to End of Study|Withdrawal by Subject|0
5256120|NCT00718718|18135106|P8|Week 12 to End of Study|Withdrawal by Subject|0
5256121|NCT00718718|18135107|P7|Week 12 to End of Study|Withdrawal by Subject|1
5256122|NCT00718718|18135108|P6|Week 12 to End of Study|Withdrawal by Subject|2
5256123|NCT00718718|18135109|P5|Week 12 to End of Study|Withdrawal by Subject|0
5256124|NCT00718718|18135110|P4|Week 12 to End of Study|Withdrawal by Subject|0
5256125|NCT00718718|18135111|P3|Week 12 to End of Study|Withdrawal by Subject|0
5256126|NCT00718718|18135112|P2|Week 12 to End of Study|Withdrawal by Subject|0
5256127|NCT00718718|18135113|P1|Week 12 to End of Study|Withdrawal by Subject|0
5256128|NCT00718718|18135104|P10|Week 12 to End of Study|Death|0
5256129|NCT00718718|18135105|P9|Week 12 to End of Study|Death|0
5256130|NCT00718718|18135106|P8|Week 12 to End of Study|Death|0
5256131|NCT00718718|18135107|P7|Week 12 to End of Study|Death|0
5256132|NCT00718718|18135108|P6|Week 12 to End of Study|Death|1
5256133|NCT00718718|18135109|P5|Week 12 to End of Study|Death|0
5256134|NCT00718718|18135110|P4|Week 12 to End of Study|Death|0
5256135|NCT00718718|18135111|P3|Week 12 to End of Study|Death|0
5256136|NCT00718718|18135112|P2|Week 12 to End of Study|Death|0
5256137|NCT00718718|18135113|P1|Week 12 to End of Study|Death|0
5256138|NCT00718718|18135104|P10|Week 12 to End of Study|Adverse Event|0
5256139|NCT00718718|18135105|P9|Week 12 to End of Study|Adverse Event|0
5256140|NCT00718718|18135106|P8|Week 12 to End of Study|Adverse Event|1
5256141|NCT00718718|18135107|P7|Week 12 to End of Study|Adverse Event|0
5256142|NCT00718718|18135108|P6|Week 12 to End of Study|Adverse Event|0
5256143|NCT00718718|18135109|P5|Week 12 to End of Study|Adverse Event|0
5256144|NCT00718718|18135110|P4|Week 12 to End of Study|Adverse Event|0
5256145|NCT00718718|18135111|P3|Week 12 to End of Study|Adverse Event|0
5256146|NCT00718718|18135112|P2|Week 12 to End of Study|Adverse Event|0
5256147|NCT00718718|18135113|P1|Week 12 to End of Study|Adverse Event|0
5256148|NCT00718718|18135104|P10|Prior to Week 12|Other|0
5256149|NCT00718718|18135105|P9|Prior to Week 12|Other|0
5256150|NCT00718718|18135106|P8|Prior to Week 12|Other|0
5256151|NCT00718718|18135107|P7|Prior to Week 12|Other|0
5256152|NCT00718718|18135108|P6|Prior to Week 12|Other|0
5256153|NCT00718718|18135109|P5|Prior to Week 12|Other|0
5256154|NCT00718718|18135110|P4|Prior to Week 12|Other|0
5256155|NCT00718718|18135111|P3|Prior to Week 12|Other|1
5256156|NCT00718718|18135112|P2|Prior to Week 12|Other|0
5256157|NCT00718718|18135113|P1|Prior to Week 12|Other|1
5256158|NCT00718718|18135104|P10|Prior to Week 12|Withdrawal by Subject|0
5256159|NCT00718718|18135105|P9|Prior to Week 12|Withdrawal by Subject|1
5256160|NCT00718718|18135106|P8|Prior to Week 12|Withdrawal by Subject|1
5256161|NCT00718718|18135107|P7|Prior to Week 12|Withdrawal by Subject|1
5256162|NCT00718718|18135108|P6|Prior to Week 12|Withdrawal by Subject|0
5256163|NCT00718718|18135109|P5|Prior to Week 12|Withdrawal by Subject|3
5256164|NCT00718718|18135110|P4|Prior to Week 12|Withdrawal by Subject|0
5256165|NCT00718718|18135111|P3|Prior to Week 12|Withdrawal by Subject|0
5256166|NCT00718718|18135112|P2|Prior to Week 12|Withdrawal by Subject|0
5256167|NCT00718718|18135113|P1|Prior to Week 12|Withdrawal by Subject|0
5256168|NCT00718718|18135104|P10|Prior to Week 12|Adverse Event|0
5256169|NCT00718718|18135105|P9|Prior to Week 12|Adverse Event|1
5256170|NCT00718718|18135106|P8|Prior to Week 12|Adverse Event|1
5256171|NCT00718718|18135107|P7|Prior to Week 12|Adverse Event|0
5256172|NCT00718718|18135108|P6|Prior to Week 12|Adverse Event|0
5256173|NCT00718718|18135109|P5|Prior to Week 12|Adverse Event|0
5256174|NCT00718718|18135110|P4|Prior to Week 12|Adverse Event|0
5256175|NCT00718718|18135111|P3|Prior to Week 12|Adverse Event|0
5256176|NCT00718718|18135112|P2|Prior to Week 12|Adverse Event|0
5256177|NCT00718718|18135113|P1|Prior to Week 12|Adverse Event|0
5256178|NCT00718666|18135156|P3|Booster Phase Year 5|Lost to Follow-up|4
5256179|NCT00718666|18135157|P2|Booster Phase Year 5|Lost to Follow-up|0
5256180|NCT00718666|18135158|P1|Booster Phase Year 5|Lost to Follow-up|1
5256181|NCT00718666|18135156|P3|Booster Phase Year 5|Withdrawal by Subject|1
5256182|NCT00718666|18135157|P2|Booster Phase Year 5|Withdrawal by Subject|0
5256183|NCT00718666|18135158|P1|Booster Phase Year 5|Withdrawal by Subject|0
5256184|NCT00718666|18135156|P3|Booster Phase Year 5|Declined v-4 serology|0
5256185|NCT00718666|18135157|P2|Booster Phase Year 5|Declined v-4 serology|0
5256186|NCT00718666|18135158|P1|Booster Phase Year 5|Declined v-4 serology|1
5256187|NCT00718666|18135156|P3|Booster Phase Year 5|No active participation request|1
5256188|NCT00718666|18135157|P2|Booster Phase Year 5|No active participation request|0
5256189|NCT00718666|18135158|P1|Booster Phase Year 5|No active participation request|0
5256190|NCT00718640|18135242|P1|Overall Study|Unresolved toxicity after 2 weeks|2
5256191|NCT00718640|18135242|P1|Overall Study|Death|1
5256192|NCT00718640|18135242|P1|Overall Study|Adverse Event|4
5256193|NCT00718549|18135254|P3|Maintenance/ Observation Phase|Relapse|2
5256194|NCT00718549|18135255|P2|Maintenance/ Observation Phase|Relapse|3
5256195|NCT00718549|18135256|P1|Maintenance/ Observation Phase|Relapse|0
5256196|NCT00718549|18135254|P3|Maintenance/ Observation Phase|Progression|14
5256197|NCT00718549|18135255|P2|Maintenance/ Observation Phase|Progression|5
5256198|NCT00718549|18135256|P1|Maintenance/ Observation Phase|Progression|0
5256199|NCT00718549|18135254|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
5256200|NCT00718549|18135255|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
5256201|NCT00718549|18135256|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
5256202|NCT00718549|18135254|P3|Maintenance/ Observation Phase|Death|2
5256203|NCT00718549|18135255|P2|Maintenance/ Observation Phase|Death|1
5256204|NCT00718549|18135256|P1|Maintenance/ Observation Phase|Death|0
5256205|NCT00718549|18135254|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
5256206|NCT00718549|18135255|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
5256207|NCT00718549|18135256|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
5256208|NCT00718549|18135254|P3|Induction Phase|Early Termination - No Additional Info|0
5256209|NCT00718549|18135255|P2|Induction Phase|Early Termination - No Additional Info|0
5256210|NCT00718549|18135256|P1|Induction Phase|Early Termination - No Additional Info|59
5256211|NCT00718549|18135254|P3|Induction Phase|Eligibility Criteria Violation|0
5256212|NCT00718549|18135255|P2|Induction Phase|Eligibility Criteria Violation|0
5256213|NCT00718549|18135256|P1|Induction Phase|Eligibility Criteria Violation|2
5256214|NCT00718549|18135254|P3|Induction Phase|Disease Progression|0
5256215|NCT00718549|18135255|P2|Induction Phase|Disease Progression|0
5256216|NCT00718549|18135256|P1|Induction Phase|Disease Progression|1
5256217|NCT00718523|18135281|P2|Overall Study|Death|17
5256218|NCT00718523|18135282|P1|Overall Study|Death|13
5256219|NCT00718523|18135281|P2|Overall Study|Withdrawal by Subject|7
5256220|NCT00718523|18135282|P1|Overall Study|Withdrawal by Subject|5
5256221|NCT00718510|18135294|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5256222|NCT00718510|18135295|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
5256223|NCT00718510|18135294|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5256224|NCT00718510|18135295|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
5256225|NCT00718419|18135307|P2|Overall Study|Death Due to Adverse Events|0
5256226|NCT00718419|18135308|P1|Overall Study|Death Due to Adverse Events|1
5256227|NCT00718419|18135307|P2|Overall Study|Death Due to Study Drug Related|1
5256228|NCT00718419|18135308|P1|Overall Study|Death Due to Study Drug Related|0
5256229|NCT00718419|18135307|P2|Overall Study|Death Due to Progressive Disease|0
5256230|NCT00718419|18135308|P1|Overall Study|Death Due to Progressive Disease|2
5256231|NCT00718419|18135307|P2|Overall Study|Progressive Disease|25
5256232|NCT00718419|18135308|P1|Overall Study|Progressive Disease|7
5256233|NCT00718419|18135307|P2|Overall Study|Withdrawal by Subject|5
5256234|NCT00718419|18135308|P1|Overall Study|Withdrawal by Subject|0
5256235|NCT00718419|18135307|P2|Overall Study|Sponsor decision|1
5256236|NCT00718419|18135308|P1|Overall Study|Sponsor decision|0
5256237|NCT00718419|18135307|P2|Overall Study|Physician Decision|6
5256238|NCT00718419|18135308|P1|Overall Study|Physician Decision|1
5256239|NCT00718419|18135307|P2|Overall Study|Adverse Event|1
5256240|NCT00718419|18135308|P1|Overall Study|Adverse Event|2
5256241|NCT00718328|18135324|P2|Overall Study|Lost to Follow-up|0
5256242|NCT00718328|18135325|P1|Overall Study|Lost to Follow-up|1
5256243|NCT00718315|18135334|P3|Overall Study|Use of ATB and Corticoids|2
5256244|NCT00718315|18135335|P2|Overall Study|Use of ATB and Corticoids|1
5256245|NCT00718315|18135336|P1|Overall Study|Use of ATB and Corticoids|0
5256246|NCT00718315|18135334|P3|Overall Study|Other|1
5256247|NCT00718315|18135335|P2|Overall Study|Other|0
5256248|NCT00718315|18135336|P1|Overall Study|Other|0
5256249|NCT00718315|18135334|P3|Overall Study|Disease progression|1
5256250|NCT00718315|18135335|P2|Overall Study|Disease progression|1
5256251|NCT00718315|18135336|P1|Overall Study|Disease progression|0
5256252|NCT00718315|18135334|P3|Overall Study|Use of Minocyclin|1
5256253|NCT00718315|18135335|P2|Overall Study|Use of Minocyclin|1
5256254|NCT00718315|18135336|P1|Overall Study|Use of Minocyclin|1
5256255|NCT00718315|18135334|P3|Overall Study|Erlotinib dose decreased|1
5256256|NCT00718315|18135335|P2|Overall Study|Erlotinib dose decreased|3
5256257|NCT00718315|18135336|P1|Overall Study|Erlotinib dose decreased|4
5256258|NCT00718315|18135334|P3|Overall Study|Protocol Violation|3
5256259|NCT00718315|18135335|P2|Overall Study|Protocol Violation|5
5256260|NCT00718315|18135336|P1|Overall Study|Protocol Violation|5
5256261|NCT00718315|18135334|P3|Overall Study|Lost to Follow-up|4
5256262|NCT00718315|18135335|P2|Overall Study|Lost to Follow-up|3
5256263|NCT00718315|18135336|P1|Overall Study|Lost to Follow-up|2
5256264|NCT00718315|18135334|P3|Overall Study|Death|5
5256265|NCT00718315|18135335|P2|Overall Study|Death|6
5256266|NCT00718315|18135336|P1|Overall Study|Death|6
5256267|NCT00718315|18135334|P3|Overall Study|Adverse Event|3
5256268|NCT00718315|18135335|P2|Overall Study|Adverse Event|2
5256269|NCT00718315|18135336|P1|Overall Study|Adverse Event|1
5256270|NCT00718237|18135387|P2|Overall Study|Withdrawal by Subject|10
5256271|NCT00718237|18135388|P1|Overall Study|Withdrawal by Subject|9
5256272|NCT00718237|18135387|P2|Overall Study|Physician Decision|0
5256273|NCT00718237|18135388|P1|Overall Study|Physician Decision|1
5256274|NCT00718237|18135387|P2|Overall Study|Lost to Follow-up|2
5256275|NCT00718237|18135388|P1|Overall Study|Lost to Follow-up|2
5256276|NCT00718237|18135387|P2|Overall Study|Adverse Event|3
5256277|NCT00718237|18135388|P1|Overall Study|Adverse Event|1
5256278|NCT00718159|18135405|P7|Overall Study|Investigator Decision|1
5256279|NCT00718159|18135406|P6|Overall Study|Investigator Decision|1
5256280|NCT00718159|18135407|P5|Overall Study|Investigator Decision|0
5256281|NCT00718159|18135408|P4|Overall Study|Investigator Decision|0
5256282|NCT00718159|18135409|P3|Overall Study|Investigator Decision|0
5256283|NCT00718159|18135410|P2|Overall Study|Investigator Decision|0
5256284|NCT00718159|18135411|P1|Overall Study|Investigator Decision|0
5256285|NCT00718159|18135405|P7|Overall Study|Death due to Study Drug Toxicity|0
5256286|NCT00718159|18135406|P6|Overall Study|Death due to Study Drug Toxicity|0
5256287|NCT00718159|18135407|P5|Overall Study|Death due to Study Drug Toxicity|0
5256288|NCT00718159|18135408|P4|Overall Study|Death due to Study Drug Toxicity|2
5256289|NCT00718159|18135409|P3|Overall Study|Death due to Study Drug Toxicity|1
5256290|NCT00718159|18135410|P2|Overall Study|Death due to Study Drug Toxicity|0
5256291|NCT00718159|18135411|P1|Overall Study|Death due to Study Drug Toxicity|0
5256292|NCT00718159|18135405|P7|Overall Study|Death due to Adverse Event|0
5256293|NCT00718159|18135406|P6|Overall Study|Death due to Adverse Event|0
5256294|NCT00718159|18135407|P5|Overall Study|Death due to Adverse Event|2
5256295|NCT00718159|18135408|P4|Overall Study|Death due to Adverse Event|2
5256296|NCT00718159|18135409|P3|Overall Study|Death due to Adverse Event|0
5256297|NCT00718159|18135410|P2|Overall Study|Death due to Adverse Event|0
5256298|NCT00718159|18135411|P1|Overall Study|Death due to Adverse Event|0
5256299|NCT00718159|18135405|P7|Overall Study|Progressive Disease|0
5256300|NCT00718159|18135406|P6|Overall Study|Progressive Disease|0
5256301|NCT00718159|18135407|P5|Overall Study|Progressive Disease|6
5256302|NCT00718159|18135408|P4|Overall Study|Progressive Disease|0
5256303|NCT00718159|18135409|P3|Overall Study|Progressive Disease|2
5256304|NCT00718159|18135410|P2|Overall Study|Progressive Disease|3
5256305|NCT00718159|18135411|P1|Overall Study|Progressive Disease|3
5256306|NCT00718081|18135468|P3|Overall Study|Lack of Efficacy|21
5256307|NCT00718081|18135469|P2|Overall Study|Lack of Efficacy|3
5256308|NCT00718081|18135470|P1|Overall Study|Lack of Efficacy|7
5256309|NCT00718081|18135468|P3|Overall Study|Adverse Event|0
5256310|NCT00718081|18135469|P2|Overall Study|Adverse Event|1
5256311|NCT00718081|18135470|P1|Overall Study|Adverse Event|0
5256312|NCT00718042|18135487|P6|Donor Follow-up|Lost to Follow-up|0
5256313|NCT00718042|18135488|P5|Donor Follow-up|Lost to Follow-up|19
5256314|NCT00718042|18135489|P4|Donor Follow-up|Lost to Follow-up|0
5256315|NCT00718042|18135490|P3|Donor Follow-up|Lost to Follow-up|0
5256316|NCT00718042|18135491|P2|Donor Follow-up|Lost to Follow-up|0
5256317|NCT00718042|18135492|P1|Donor Follow-up|Lost to Follow-up|13
5256318|NCT00718042|18135487|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5256319|NCT00718042|18135488|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5256320|NCT00718042|18135489|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5256321|NCT00718042|18135490|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5256322|NCT00718042|18135491|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
5256323|NCT00718042|18135492|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5256324|NCT00718042|18135487|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5256325|NCT00718042|18135488|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5256326|NCT00718042|18135489|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5256488|NCT00717197|18135787|P1|Overall Study|Tumor Progression|1
5256327|NCT00718042|18135490|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
5256328|NCT00718042|18135491|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
5256329|NCT00718042|18135492|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5256330|NCT00718042|18135487|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5256331|NCT00718042|18135488|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
5256332|NCT00718042|18135489|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5256333|NCT00718042|18135490|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5256334|NCT00718042|18135491|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5256335|NCT00718042|18135492|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
5256336|NCT00718042|18135487|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5256337|NCT00718042|18135488|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
5256338|NCT00718042|18135489|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5256339|NCT00718042|18135490|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5256340|NCT00718042|18135491|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5256341|NCT00718042|18135492|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5256342|NCT00717886|18135548|P1|Overall Study|Treatment Failure|1
5256343|NCT00717886|18135548|P1|Overall Study|Withdrawal by Subject|3
5256344|NCT00717860|18135563|P2|Overall Study|Withdrew consent|3
5256345|NCT00717860|18135564|P1|Overall Study|Withdrew consent|7
5256346|NCT00717860|18135563|P2|Overall Study|Discontinued for other reason|1
5256347|NCT00717860|18135564|P1|Overall Study|Discontinued for other reason|6
5256348|NCT00717860|18135563|P2|Overall Study|Lack of Efficacy|13
5256349|NCT00717860|18135564|P1|Overall Study|Lack of Efficacy|7
5256350|NCT00717860|18135563|P2|Overall Study|Laboratory adverse experience|2
5256351|NCT00717860|18135564|P1|Overall Study|Laboratory adverse experience|2
5256352|NCT00717860|18135563|P2|Overall Study|Clinical adverse experience|9
5256353|NCT00717860|18135564|P1|Overall Study|Clinical adverse experience|5
5256354|NCT00717756|18135574|P1|Overall Study|Withdrawal by Subject|1
5256355|NCT00717522|18135597|P1|Overall Study|Death|1
5256356|NCT00717522|18135597|P1|Overall Study|Adverse Event|1
5256357|NCT00717522|18135597|P1|Overall Study|Disease Progression|5
5256358|NCT00717366|18135633|P2|Extension Period (52 Weeks)|Withdrew consent|1
5256359|NCT00717366|18135634|P1|Extension Period (52 Weeks)|Withdrew consent|1
5256360|NCT00717366|18135633|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
5256361|NCT00717366|18135634|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
5256362|NCT00717366|18135633|P2|Extension Period (52 Weeks)|Renal transplant|13
5256363|NCT00717366|18135634|P1|Extension Period (52 Weeks)|Renal transplant|3
5256364|NCT00717366|18135633|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
5256365|NCT00717366|18135634|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
5256366|NCT00717366|18135633|P2|Core Study Period (20 Weeks)|Death|1
5256367|NCT00717366|18135634|P1|Core Study Period (20 Weeks)|Death|0
5256368|NCT00717366|18135633|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
5256369|NCT00717366|18135634|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
5256370|NCT00717366|18135633|P2|Core Study Period (20 Weeks)|Renal transplant|9
5256371|NCT00717366|18135634|P1|Core Study Period (20 Weeks)|Renal transplant|4
5256372|NCT00717314|18135658|P2|Overall Study|Withdrawal by Subject|3
5256373|NCT00717314|18135659|P1|Overall Study|Withdrawal by Subject|1
5256374|NCT00717314|18135658|P2|Overall Study|Lost to Follow-up|5
5256375|NCT00717314|18135659|P1|Overall Study|Lost to Follow-up|1
5256376|NCT00717314|18135658|P2|Overall Study|Protocol Violation|0
5256377|NCT00717314|18135659|P1|Overall Study|Protocol Violation|1
5256378|NCT00717314|18135658|P2|Overall Study|Adverse Event|2
5256379|NCT00717314|18135659|P1|Overall Study|Adverse Event|3
5256380|NCT00717275|18135696|P1|Overall Study|Premature study termination.|3
5256381|NCT00717249|18135702|P2|Overall Study|Headaches|0
5256382|NCT00717249|18135703|P1|Overall Study|Headaches|1
5256383|NCT00717249|18135702|P2|Overall Study|Subject relocated|0
5256384|NCT00717249|18135703|P1|Overall Study|Subject relocated|1
5256385|NCT00717249|18135702|P2|Overall Study|Diagnosed with Multiple Scletosis|0
5256386|NCT00717249|18135703|P1|Overall Study|Diagnosed with Multiple Scletosis|1
5256387|NCT00717249|18135702|P2|Overall Study|Diagnosed with Diabetes|0
5256388|NCT00717249|18135703|P1|Overall Study|Diagnosed with Diabetes|1
5256389|NCT00717249|18135702|P2|Overall Study|Gastric Surgery|1
5256390|NCT00717249|18135703|P1|Overall Study|Gastric Surgery|0
5256391|NCT00717249|18135702|P2|Overall Study|Unsatisfactory Physiological Response|1
5256392|NCT00717249|18135703|P1|Overall Study|Unsatisfactory Physiological Response|0
5256393|NCT00717249|18135702|P2|Overall Study|Subject became Ineligible|1
5256394|NCT00717249|18135703|P1|Overall Study|Subject became Ineligible|1
5256395|NCT00717249|18135702|P2|Overall Study|Protocol Violation|2
5256396|NCT00717249|18135703|P1|Overall Study|Protocol Violation|0
5256397|NCT00717249|18135702|P2|Overall Study|Pregnancy|3
5256398|NCT00717249|18135703|P1|Overall Study|Pregnancy|6
5256399|NCT00717249|18135702|P2|Overall Study|Withdrawal by Subject|2
5256400|NCT00717249|18135703|P1|Overall Study|Withdrawal by Subject|1
5256401|NCT00717249|18135702|P2|Overall Study|Lost to Follow-up|0
5256402|NCT00717249|18135703|P1|Overall Study|Lost to Follow-up|2
5256403|NCT00717249|18135702|P2|Overall Study|Adverse Event|2
5256404|NCT00717249|18135703|P1|Overall Study|Adverse Event|4
5256405|NCT00717249|18135702|P2|Overall Study|Unsatisfactory visual Response|2
5256406|NCT00717249|18135703|P1|Overall Study|Unsatisfactory visual Response|0
5256407|NCT00717249|18135702|P2|Overall Study|Lens Discomfort|1
5256408|NCT00717249|18135703|P1|Overall Study|Lens Discomfort|4
5256409|NCT00717236|18135717|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
5256410|NCT00717236|18135718|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
5256411|NCT00717236|18135717|P2|Open-Label Period|Other: Completion Accidently Performed|0
5256412|NCT00717236|18135718|P1|Open-Label Period|Other: Completion Accidently Performed|1
5256413|NCT00717236|18135717|P2|Open-Label Period|Other: Administration of Golimumab|0
5256414|NCT00717236|18135718|P1|Open-Label Period|Other: Administration of Golimumab|1
5256415|NCT00717236|18135717|P2|Open-Label Period|Other: Cataract Surgery|0
5256416|NCT00717236|18135718|P1|Open-Label Period|Other: Cataract Surgery|1
5256417|NCT00717236|18135717|P2|Open-Label Period|Other: Sponsor Request|0
5256418|NCT00717236|18135718|P1|Open-Label Period|Other: Sponsor Request|3
5256419|NCT00717236|18135717|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
5256420|NCT00717236|18135718|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
5256421|NCT00717236|18135717|P2|Open-Label Period|Other: Investigator Decision|0
5256422|NCT00717236|18135718|P1|Open-Label Period|Other: Investigator Decision|1
5256423|NCT00717236|18135717|P2|Open-Label Period|Other: Moved|0
5256424|NCT00717236|18135718|P1|Open-Label Period|Other: Moved|1
5256425|NCT00717236|18135717|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
5256426|NCT00717236|18135718|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
5256427|NCT00717236|18135717|P2|Open-Label Period|Other: Lack of Compliance|1
5256428|NCT00717236|18135718|P1|Open-Label Period|Other: Lack of Compliance|1
5256429|NCT00717236|18135717|P2|Open-Label Period|Other: Peripheral Neuropathy|1
5256430|NCT00717236|18135718|P1|Open-Label Period|Other: Peripheral Neuropathy|0
5256431|NCT00717236|18135717|P2|Open-Label Period|Loss of Efficacy|1
5256432|NCT00717236|18135718|P1|Open-Label Period|Loss of Efficacy|6
5256433|NCT00717236|18135717|P2|Open-Label Period|Withdrawal by Subject|2
5256434|NCT00717236|18135718|P1|Open-Label Period|Withdrawal by Subject|20
5256435|NCT00717236|18135717|P2|Open-Label Period|Lost to Follow-up|4
5256436|NCT00717236|18135718|P1|Open-Label Period|Lost to Follow-up|28
5256437|NCT00717236|18135717|P2|Open-Label Period|Lack of Efficacy|8
5256438|NCT00717236|18135718|P1|Open-Label Period|Lack of Efficacy|30
5256439|NCT00717236|18135717|P2|Open-Label Period|Adverse Event|4
5256440|NCT00717236|18135718|P1|Open-Label Period|Adverse Event|29
5256441|NCT00717236|18135717|P2|Double-Blind Period|Other: Investigator Decision|1
5256442|NCT00717236|18135718|P1|Double-Blind Period|Other: Investigator Decision|0
5256443|NCT00717236|18135717|P2|Double-Blind Period|Other: Transportation problems|1
5256444|NCT00717236|18135718|P1|Double-Blind Period|Other: Transportation problems|0
5256445|NCT00717236|18135717|P2|Double-Blind Period|Other: Prohibited medication taken|2
5256446|NCT00717236|18135718|P1|Double-Blind Period|Other: Prohibited medication taken|2
5256447|NCT00717236|18135717|P2|Double-Blind Period|Other: Stopped taking DMARD|0
5256448|NCT00717236|18135718|P1|Double-Blind Period|Other: Stopped taking DMARD|1
5256449|NCT00717236|18135717|P2|Double-Blind Period|Other: Subject moved|1
5256450|NCT00717236|18135718|P1|Double-Blind Period|Other: Subject moved|1
5256451|NCT00717236|18135717|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
5256452|NCT00717236|18135718|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
5256453|NCT00717236|18135717|P2|Double-Blind Period|Other: Inappropriate randomization|0
5256454|NCT00717236|18135718|P1|Double-Blind Period|Other: Inappropriate randomization|1
5256455|NCT00717236|18135717|P2|Double-Blind Period|Other: Sponsor request|0
5256456|NCT00717236|18135718|P1|Double-Blind Period|Other: Sponsor request|1
5256457|NCT00717236|18135717|P2|Double-Blind Period|Other: History of cancer|0
5256458|NCT00717236|18135718|P1|Double-Blind Period|Other: History of cancer|1
5256459|NCT00717236|18135717|P2|Double-Blind Period|Other: History of adenoid grown|0
5256460|NCT00717236|18135718|P1|Double-Blind Period|Other: History of adenoid grown|1
5256461|NCT00717236|18135717|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
5256462|NCT00717236|18135718|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
5256463|NCT00717236|18135717|P2|Double-Blind Period|Other: subject withdrew consent|1
5256464|NCT00717236|18135718|P1|Double-Blind Period|Other: subject withdrew consent|1
5256465|NCT00717236|18135717|P2|Double-Blind Period|Other: Screening failure|0
5256466|NCT00717236|18135718|P1|Double-Blind Period|Other: Screening failure|1
5256467|NCT00717236|18135717|P2|Double-Blind Period|Other: Site withdrew|0
5256468|NCT00717236|18135718|P1|Double-Blind Period|Other: Site withdrew|2
5256469|NCT00717236|18135717|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
5256470|NCT00717236|18135718|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
5256471|NCT00717236|18135717|P2|Double-Blind Period|Other: Protocol Violation|0
5256472|NCT00717236|18135718|P1|Double-Blind Period|Other: Protocol Violation|2
5256473|NCT00717236|18135717|P2|Double-Blind Period|Other: Pregnancy|0
5256474|NCT00717236|18135718|P1|Double-Blind Period|Other: Pregnancy|1
5256475|NCT00717236|18135717|P2|Double-Blind Period|Other: Death|0
5256476|NCT00717236|18135718|P1|Double-Blind Period|Other: Death|1
5256477|NCT00717236|18135717|P2|Double-Blind Period|Loss of efficacy|0
5256478|NCT00717236|18135718|P1|Double-Blind Period|Loss of efficacy|3
5256479|NCT00717236|18135717|P2|Double-Blind Period|Withdrawal by Subject|2
5256480|NCT00717236|18135718|P1|Double-Blind Period|Withdrawal by Subject|10
5256481|NCT00717236|18135717|P2|Double-Blind Period|Lost to Follow-up|5
5256482|NCT00717236|18135718|P1|Double-Blind Period|Lost to Follow-up|3
5256483|NCT00717236|18135717|P2|Double-Blind Period|Lack of Efficacy|6
5256484|NCT00717236|18135718|P1|Double-Blind Period|Lack of Efficacy|6
5256485|NCT00717236|18135717|P2|Double-Blind Period|Adverse Event|6
5256486|NCT00717236|18135718|P1|Double-Blind Period|Adverse Event|33
5256487|NCT00717197|18135787|P1|Overall Study|Physician Decision|1
5256489|NCT00717197|18135787|P1|Overall Study|Unable to purchase study drug|5
5256490|NCT00717093|18135793|P2|Overall Study|Randomized but not treated|0
5256491|NCT00717093|18135794|P1|Overall Study|Randomized but not treated|1
5256492|NCT00717093|18135793|P2|Overall Study|Other|1
5256493|NCT00717093|18135794|P1|Overall Study|Other|0
5256494|NCT00717093|18135793|P2|Overall Study|Withdrawal by Subject|19
5256495|NCT00717093|18135794|P1|Overall Study|Withdrawal by Subject|12
5256496|NCT00717093|18135793|P2|Overall Study|Lost to Follow-up|6
5256497|NCT00717093|18135794|P1|Overall Study|Lost to Follow-up|9
5256498|NCT00717093|18135793|P2|Overall Study|Lack of Efficacy|13
5256499|NCT00717093|18135794|P1|Overall Study|Lack of Efficacy|3
5256500|NCT00717093|18135793|P2|Overall Study|Adverse Event|9
5256501|NCT00717093|18135794|P1|Overall Study|Adverse Event|19
5256502|NCT00717067|18135811|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5256503|NCT00717067|18135812|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5256504|NCT00717067|18135813|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
5256505|NCT00717067|18135814|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5256506|NCT00717067|18135815|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5256507|NCT00716976|18135922|P2|Overall Study|Ineligibles|2
5256508|NCT00716976|18135923|P1|Overall Study|Ineligibles|4
5256509|NCT00716976|18135922|P2|Overall Study|Radiation during protocol|0
5256510|NCT00716976|18135923|P1|Overall Study|Radiation during protocol|1
5256511|NCT00716976|18135922|P2|Overall Study|Premature discontinuation cisplatin|4
5256512|NCT00716976|18135923|P1|Overall Study|Premature discontinuation cisplatin|5
5256513|NCT00716976|18135922|P2|Overall Study|Withdrawal by Subject|1
5256514|NCT00716976|18135923|P1|Overall Study|Withdrawal by Subject|5
5256515|NCT00716976|18135922|P2|Overall Study|Physician Decision|2
5256516|NCT00716976|18135923|P1|Overall Study|Physician Decision|2
5256517|NCT00716976|18135922|P2|Overall Study|Death|0
5256518|NCT00716976|18135923|P1|Overall Study|Death|1
5256519|NCT00716976|18135922|P2|Overall Study|Adverse Event|0
5256520|NCT00716976|18135923|P1|Overall Study|Adverse Event|2
5256521|NCT00716859|18135963|P2|Overall Study|Not treated|1
5256522|NCT00716859|18135964|P1|Overall Study|Not treated|1
5256523|NCT00716859|18135963|P2|Overall Study|Withdrawal by Subject|3
5256524|NCT00716859|18135964|P1|Overall Study|Withdrawal by Subject|1
5256525|NCT00716859|18135963|P2|Overall Study|Lack of Efficacy|0
5256526|NCT00716859|18135964|P1|Overall Study|Lack of Efficacy|3
5256527|NCT00716859|18135963|P2|Overall Study|Adverse Event|1
5256528|NCT00716859|18135964|P1|Overall Study|Adverse Event|4
5256529|NCT00716625|18136049|P1|Overall Study|Safety was not Assessable|1
5256530|NCT00716482|18136074|P1|Overall Study|inclusion/exclusion criteria not met|25
5256531|NCT00716482|18136074|P1|Overall Study|technical/machine error|28
5256532|NCT00716482|18136074|P1|Overall Study|no pathology obtained|10
5256533|NCT00716482|18136074|P1|Overall Study|Inadequate acquisition or analysis|50
5256534|NCT00716482|18136074|P1|Overall Study|Lost to Follow-up|6
5256535|NCT00716456|18136087|P3|Overall Study|Adverse Event|0
5256536|NCT00716456|18136088|P2|Overall Study|Adverse Event|2
5256537|NCT00716456|18136089|P1|Overall Study|Adverse Event|0
5256538|NCT00716417|18136140|P10|Overall Study|On patient request due to toxicities|0
5256539|NCT00716417|18136141|P9|Overall Study|On patient request due to toxicities|0
5256540|NCT00716417|18136142|P8|Overall Study|On patient request due to toxicities|1
5256541|NCT00716417|18136143|P7|Overall Study|On patient request due to toxicities|0
5256542|NCT00716417|18136144|P6|Overall Study|On patient request due to toxicities|0
5256543|NCT00716417|18136145|P5|Overall Study|On patient request due to toxicities|0
5256544|NCT00716417|18136146|P4|Overall Study|On patient request due to toxicities|0
5256545|NCT00716417|18136147|P3|Overall Study|On patient request due to toxicities|0
5256546|NCT00716417|18136148|P2|Overall Study|On patient request due to toxicities|0
5256547|NCT00716417|18136149|P1|Overall Study|On patient request due to toxicities|0
5256548|NCT00716417|18136140|P10|Overall Study|Dose limiting toxicity (DLT)|0
5256549|NCT00716417|18136141|P9|Overall Study|Dose limiting toxicity (DLT)|0
5256550|NCT00716417|18136142|P8|Overall Study|Dose limiting toxicity (DLT)|0
5256551|NCT00716417|18136143|P7|Overall Study|Dose limiting toxicity (DLT)|0
5256552|NCT00716417|18136144|P6|Overall Study|Dose limiting toxicity (DLT)|0
5256553|NCT00716417|18136145|P5|Overall Study|Dose limiting toxicity (DLT)|1
5256554|NCT00716417|18136146|P4|Overall Study|Dose limiting toxicity (DLT)|0
5256555|NCT00716417|18136147|P3|Overall Study|Dose limiting toxicity (DLT)|0
5256556|NCT00716417|18136148|P2|Overall Study|Dose limiting toxicity (DLT)|0
5256557|NCT00716417|18136149|P1|Overall Study|Dose limiting toxicity (DLT)|0
5256558|NCT00716417|18136140|P10|Overall Study|Progressive disease|0
5256559|NCT00716417|18136141|P9|Overall Study|Progressive disease|5
5256560|NCT00716417|18136142|P8|Overall Study|Progressive disease|1
5256561|NCT00716417|18136143|P7|Overall Study|Progressive disease|3
5256562|NCT00716417|18136144|P6|Overall Study|Progressive disease|3
5256563|NCT00716417|18136145|P5|Overall Study|Progressive disease|0
5256564|NCT00716417|18136146|P4|Overall Study|Progressive disease|8
5256565|NCT00716417|18136147|P3|Overall Study|Progressive disease|3
5256566|NCT00716417|18136148|P2|Overall Study|Progressive disease|5
5256567|NCT00716417|18136149|P1|Overall Study|Progressive disease|3
5256568|NCT00716417|18136140|P10|Overall Study|Withdrawal by Subject|0
5256569|NCT00716417|18136141|P9|Overall Study|Withdrawal by Subject|0
5256570|NCT00716417|18136142|P8|Overall Study|Withdrawal by Subject|0
5256571|NCT00716417|18136143|P7|Overall Study|Withdrawal by Subject|1
5256572|NCT00716417|18136144|P6|Overall Study|Withdrawal by Subject|0
5256573|NCT00716417|18136145|P5|Overall Study|Withdrawal by Subject|0
5256574|NCT00716417|18136146|P4|Overall Study|Withdrawal by Subject|2
5256575|NCT00716417|18136147|P3|Overall Study|Withdrawal by Subject|0
5256576|NCT00716417|18136148|P2|Overall Study|Withdrawal by Subject|1
5256577|NCT00716417|18136149|P1|Overall Study|Withdrawal by Subject|0
5256578|NCT00716417|18136140|P10|Overall Study|Adverse Event|3
5256579|NCT00716417|18136141|P9|Overall Study|Adverse Event|0
5256580|NCT00716417|18136142|P8|Overall Study|Adverse Event|1
5256581|NCT00716417|18136143|P7|Overall Study|Adverse Event|3
5256582|NCT00716417|18136144|P6|Overall Study|Adverse Event|0
5256583|NCT00716417|18136145|P5|Overall Study|Adverse Event|0
5256584|NCT00716417|18136146|P4|Overall Study|Adverse Event|1
5256585|NCT00716417|18136147|P3|Overall Study|Adverse Event|2
5256586|NCT00716417|18136148|P2|Overall Study|Adverse Event|0
5256587|NCT00716417|18136149|P1|Overall Study|Adverse Event|0
5256588|NCT00716274|18136196|P6|Study Period III (16-Weeks)|Adverse Event|0
5256589|NCT00716274|18136197|P5|Study Period III (16-Weeks)|Adverse Event|1
5256590|NCT00716274|18136198|P4|Study Period III (16-Weeks)|Adverse Event|0
5256591|NCT00716274|18136199|P3|Study Period III (16-Weeks)|Adverse Event|0
5256592|NCT00716274|18136200|P2|Study Period III (16-Weeks)|Adverse Event|0
5256593|NCT00716274|18136201|P1|Study Period III (16-Weeks)|Adverse Event|0
5256594|NCT00716274|18136196|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5256595|NCT00716274|18136197|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
5256596|NCT00716274|18136198|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
5256597|NCT00716274|18136199|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5256598|NCT00716274|18136200|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5256599|NCT00716274|18136201|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5256600|NCT00716274|18136196|P6|Study Period III (16-Weeks)|Physician Decision|0
5256601|NCT00716274|18136197|P5|Study Period III (16-Weeks)|Physician Decision|1
5256602|NCT00716274|18136198|P4|Study Period III (16-Weeks)|Physician Decision|0
5256603|NCT00716274|18136199|P3|Study Period III (16-Weeks)|Physician Decision|0
5256604|NCT00716274|18136200|P2|Study Period III (16-Weeks)|Physician Decision|0
5256605|NCT00716274|18136201|P1|Study Period III (16-Weeks)|Physician Decision|0
5256606|NCT00716274|18136196|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
5256607|NCT00716274|18136197|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
5256608|NCT00716274|18136198|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
5256609|NCT00716274|18136199|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
5256610|NCT00716274|18136200|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
5256611|NCT00716274|18136201|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
5256612|NCT00716274|18136196|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
5256613|NCT00716274|18136197|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
5256614|NCT00716274|18136198|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
5256615|NCT00716274|18136199|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
5256616|NCT00716274|18136200|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
5256617|NCT00716274|18136201|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
5256618|NCT00716274|18136196|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5256619|NCT00716274|18136197|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5256620|NCT00716274|18136198|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5256621|NCT00716274|18136199|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5256622|NCT00716274|18136200|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
5256623|NCT00716274|18136201|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
5256624|NCT00716274|18136196|P6|Study Period II (16-Weeks)|Physician Decision|1
5256625|NCT00716274|18136197|P5|Study Period II (16-Weeks)|Physician Decision|0
5256626|NCT00716274|18136198|P4|Study Period II (16-Weeks)|Physician Decision|0
5256627|NCT00716274|18136199|P3|Study Period II (16-Weeks)|Physician Decision|0
5256628|NCT00716274|18136200|P2|Study Period II (16-Weeks)|Physician Decision|1
5256629|NCT00716274|18136201|P1|Study Period II (16-Weeks)|Physician Decision|3
5256630|NCT00716274|18136196|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
5256631|NCT00716274|18136197|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
5256632|NCT00716274|18136198|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
5256633|NCT00716274|18136199|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
5256634|NCT00716274|18136200|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
5256635|NCT00716274|18136201|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
5256636|NCT00716274|18136196|P6|Study Period II (16-Weeks)|Protocol Violation|1
5256637|NCT00716274|18136197|P5|Study Period II (16-Weeks)|Protocol Violation|0
5256638|NCT00716274|18136198|P4|Study Period II (16-Weeks)|Protocol Violation|0
5256639|NCT00716274|18136199|P3|Study Period II (16-Weeks)|Protocol Violation|0
5256640|NCT00716274|18136200|P2|Study Period II (16-Weeks)|Protocol Violation|3
5256641|NCT00716274|18136201|P1|Study Period II (16-Weeks)|Protocol Violation|0
5256642|NCT00716274|18136196|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5256643|NCT00716274|18136197|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5256644|NCT00716274|18136198|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5256645|NCT00716274|18136199|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5256646|NCT00716274|18136200|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5256647|NCT00716274|18136201|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
5256648|NCT00716144|18136335|P4|Overall Study|Clinical Depression|0
5256649|NCT00716144|18136336|P3|Overall Study|Clinical Depression|0
5256650|NCT00716144|18136337|P2|Overall Study|Clinical Depression|1
5256651|NCT00716144|18136338|P1|Overall Study|Clinical Depression|0
5256652|NCT00716144|18136335|P4|Overall Study|Adverse event: left foot pain|0
5256653|NCT00716144|18136336|P3|Overall Study|Adverse event: left foot pain|0
5256654|NCT00716144|18136337|P2|Overall Study|Adverse event: left foot pain|1
5256655|NCT00716144|18136338|P1|Overall Study|Adverse event: left foot pain|0
5256656|NCT00716144|18136335|P4|Overall Study|Withdrew consent, allowed use of data|0
5256657|NCT00716144|18136336|P3|Overall Study|Withdrew consent, allowed use of data|1
5256658|NCT00716144|18136337|P2|Overall Study|Withdrew consent, allowed use of data|0
5256659|NCT00716144|18136338|P1|Overall Study|Withdrew consent, allowed use of data|0
5256660|NCT00716144|18136335|P4|Overall Study|Intercurrent illness|0
5256661|NCT00716144|18136336|P3|Overall Study|Intercurrent illness|1
5256662|NCT00716144|18136337|P2|Overall Study|Intercurrent illness|0
5256663|NCT00716144|18136338|P1|Overall Study|Intercurrent illness|0
5256664|NCT00716144|18136335|P4|Overall Study|Physician Decision|2
5256665|NCT00716144|18136336|P3|Overall Study|Physician Decision|2
5256666|NCT00716144|18136337|P2|Overall Study|Physician Decision|1
5256667|NCT00716144|18136338|P1|Overall Study|Physician Decision|0
5256668|NCT00716144|18136335|P4|Overall Study|Protocol Violation|0
5256669|NCT00716144|18136336|P3|Overall Study|Protocol Violation|1
5256670|NCT00716144|18136337|P2|Overall Study|Protocol Violation|0
5256671|NCT00716144|18136338|P1|Overall Study|Protocol Violation|2
5256672|NCT00716144|18136335|P4|Overall Study|Non-compliance|0
5256673|NCT00716144|18136336|P3|Overall Study|Non-compliance|0
5256674|NCT00716144|18136337|P2|Overall Study|Non-compliance|0
5256675|NCT00716144|18136338|P1|Overall Study|Non-compliance|1
5256676|NCT00716144|18136335|P4|Overall Study|Adverse Event|2
5256677|NCT00716144|18136336|P3|Overall Study|Adverse Event|0
5256678|NCT00716144|18136337|P2|Overall Study|Adverse Event|0
5256679|NCT00716144|18136338|P1|Overall Study|Adverse Event|0
5256680|NCT00716144|18136335|P4|Overall Study|Lost to Follow-up|2
5256681|NCT00716144|18136336|P3|Overall Study|Lost to Follow-up|1
5256682|NCT00716144|18136337|P2|Overall Study|Lost to Follow-up|2
5256683|NCT00716144|18136338|P1|Overall Study|Lost to Follow-up|2
5256684|NCT00716144|18136335|P4|Overall Study|Withdrawal by Subject|6
5256685|NCT00716144|18136336|P3|Overall Study|Withdrawal by Subject|6
5256686|NCT00716144|18136337|P2|Overall Study|Withdrawal by Subject|2
5256687|NCT00716144|18136338|P1|Overall Study|Withdrawal by Subject|4
5256688|NCT00716092|18136363|P3|Overall Study|Other incl. Lack of Efficacy|0
5256689|NCT00716092|18136364|P2|Overall Study|Other incl. Lack of Efficacy|1
5256690|NCT00716092|18136365|P1|Overall Study|Other incl. Lack of Efficacy|2
5256691|NCT00715949|18136418|P1|Overall Study|could not finish first test|4
5256692|NCT00715910|18136426|P6|Booster and ESFU Phase|Other|0
5256693|NCT00715910|18136427|P5|Booster and ESFU Phase|Other|1
5256694|NCT00715910|18136428|P4|Booster and ESFU Phase|Other|5
5256695|NCT00715910|18136429|P3|Booster and ESFU Phase|Other|0
5256696|NCT00715910|18136430|P2|Booster and ESFU Phase|Other|0
5256697|NCT00715910|18136431|P1|Booster and ESFU Phase|Other|0
5256698|NCT00715910|18136426|P6|Booster and ESFU Phase|Lost to Follow-up|13
5256699|NCT00715910|18136427|P5|Booster and ESFU Phase|Lost to Follow-up|1
5256700|NCT00715910|18136428|P4|Booster and ESFU Phase|Lost to Follow-up|6
5256701|NCT00715910|18136429|P3|Booster and ESFU Phase|Lost to Follow-up|0
5256702|NCT00715910|18136430|P2|Booster and ESFU Phase|Lost to Follow-up|0
5256703|NCT00715910|18136431|P1|Booster and ESFU Phase|Lost to Follow-up|0
5256704|NCT00715793|18136550|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
5256705|NCT00715793|18136551|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
5256706|NCT00715793|18136550|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
5256707|NCT00715793|18136551|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
5256708|NCT00715676|18136612|P3|Overall Study|Elevated Blood Glucose|0
5256709|NCT00715676|18136613|P2|Overall Study|Elevated Blood Glucose|1
5256710|NCT00715676|18136614|P1|Overall Study|Elevated Blood Glucose|0
5256711|NCT00715676|18136612|P3|Overall Study|Use of Exclusionary Medication|1
5256712|NCT00715676|18136613|P2|Overall Study|Use of Exclusionary Medication|0
5256713|NCT00715676|18136614|P1|Overall Study|Use of Exclusionary Medication|0
5256714|NCT00715676|18136612|P3|Overall Study|Did Not Meet Entry Criteria|1
5256715|NCT00715676|18136613|P2|Overall Study|Did Not Meet Entry Criteria|0
5256716|NCT00715676|18136614|P1|Overall Study|Did Not Meet Entry Criteria|0
5256717|NCT00715676|18136612|P3|Overall Study|Terminated by Sponsor|0
5256718|NCT00715676|18136613|P2|Overall Study|Terminated by Sponsor|0
5256719|NCT00715676|18136614|P1|Overall Study|Terminated by Sponsor|1
5256720|NCT00715676|18136612|P3|Overall Study|Lost to Follow-up|1
5256721|NCT00715676|18136613|P2|Overall Study|Lost to Follow-up|2
5256722|NCT00715676|18136614|P1|Overall Study|Lost to Follow-up|1
5256723|NCT00715676|18136612|P3|Overall Study|Withdrawal by Subject|8
5256724|NCT00715676|18136613|P2|Overall Study|Withdrawal by Subject|3
5256725|NCT00715676|18136614|P1|Overall Study|Withdrawal by Subject|1
5256726|NCT00715676|18136612|P3|Overall Study|Adverse Event|21
5256727|NCT00715676|18136613|P2|Overall Study|Adverse Event|5
5256728|NCT00715676|18136614|P1|Overall Study|Adverse Event|3
5256729|NCT00715624|18136657|P2|Overall Study|Other|1
5256730|NCT00715624|18136658|P1|Overall Study|Other|0
5256731|NCT00715624|18136657|P2|Overall Study|Incorrect randomization (not treated)|1
5256732|NCT00715624|18136658|P1|Overall Study|Incorrect randomization (not treated)|0
5256733|NCT00715624|18136657|P2|Overall Study|Sponsor decision|4
5256734|NCT00715624|18136658|P1|Overall Study|Sponsor decision|0
5256735|NCT00715624|18136657|P2|Overall Study|Poor compliance|13
5256736|NCT00715624|18136658|P1|Overall Study|Poor compliance|6
5256737|NCT00715624|18136657|P2|Overall Study|Familial and personal reasons|22
5256738|NCT00715624|18136658|P1|Overall Study|Familial and personal reasons|10
5256739|NCT00715624|18136657|P2|Overall Study|Withdrawal by Subject|25
5256740|NCT00715624|18136658|P1|Overall Study|Withdrawal by Subject|11
5256741|NCT00715624|18136657|P2|Overall Study|Protocol Violation|0
5256742|NCT00715624|18136658|P1|Overall Study|Protocol Violation|1
5256743|NCT00715624|18136657|P2|Overall Study|Lost to Follow-up|2
5256744|NCT00715624|18136658|P1|Overall Study|Lost to Follow-up|1
5256745|NCT00715624|18136657|P2|Overall Study|Lack of Efficacy|11
5256746|NCT00715624|18136658|P1|Overall Study|Lack of Efficacy|11
5256747|NCT00715624|18136657|P2|Overall Study|Adverse Event|37
5256748|NCT00715624|18136658|P1|Overall Study|Adverse Event|12
5256749|NCT00715559|18136686|P1|Overall Study|medication not tolerated - nausea|1
5256750|NCT00715520|18136696|P3|Overall Study|Withdrawal by Subject|1
5256751|NCT00715520|18136697|P2|Overall Study|Withdrawal by Subject|0
5256752|NCT00715520|18136698|P1|Overall Study|Withdrawal by Subject|2
5256753|NCT00715520|18136696|P3|Overall Study|Screen failure|1
5256754|NCT00715520|18136697|P2|Overall Study|Screen failure|1
5256755|NCT00715520|18136698|P1|Overall Study|Screen failure|8
5256756|NCT00715429|18136713|P2|Overall Study|Did not complete the study diary|1
5256757|NCT00715429|18136714|P1|Overall Study|Did not complete the study diary|0
5256758|NCT00715403|18136729|P7|Overall Study|Other reason not defined above|0
5256759|NCT00715403|18136730|P6|Overall Study|Other reason not defined above|1
5256760|NCT00715403|18136731|P5|Overall Study|Other reason not defined above|1
5256761|NCT00715403|18136732|P4|Overall Study|Other reason not defined above|0
5256762|NCT00715403|18136733|P3|Overall Study|Other reason not defined above|1
5256763|NCT00715403|18136734|P2|Overall Study|Other reason not defined above|0
5256764|NCT00715403|18136735|P1|Overall Study|Other reason not defined above|0
5256765|NCT00715403|18136729|P7|Overall Study|Protocol Violation|0
5256766|NCT00715403|18136730|P6|Overall Study|Protocol Violation|1
5256767|NCT00715403|18136731|P5|Overall Study|Protocol Violation|0
5256768|NCT00715403|18136732|P4|Overall Study|Protocol Violation|0
5256769|NCT00715403|18136733|P3|Overall Study|Protocol Violation|0
5256770|NCT00715403|18136734|P2|Overall Study|Protocol Violation|0
5256771|NCT00715403|18136735|P1|Overall Study|Protocol Violation|0
5256772|NCT00715403|18136729|P7|Overall Study|Other Adverse Event than DLT|0
5256773|NCT00715403|18136730|P6|Overall Study|Other Adverse Event than DLT|2
5256774|NCT00715403|18136731|P5|Overall Study|Other Adverse Event than DLT|0
5256775|NCT00715403|18136732|P4|Overall Study|Other Adverse Event than DLT|0
5256776|NCT00715403|18136733|P3|Overall Study|Other Adverse Event than DLT|0
5256777|NCT00715403|18136734|P2|Overall Study|Other Adverse Event than DLT|0
5256778|NCT00715403|18136735|P1|Overall Study|Other Adverse Event than DLT|1
5256779|NCT00715403|18136729|P7|Overall Study|Dose limiting Toxicity (DLT)|0
5256780|NCT00715403|18136730|P6|Overall Study|Dose limiting Toxicity (DLT)|1
5256781|NCT00715403|18136731|P5|Overall Study|Dose limiting Toxicity (DLT)|0
5256782|NCT00715403|18136732|P4|Overall Study|Dose limiting Toxicity (DLT)|0
5256783|NCT00715403|18136733|P3|Overall Study|Dose limiting Toxicity (DLT)|0
5256784|NCT00715403|18136734|P2|Overall Study|Dose limiting Toxicity (DLT)|0
5256785|NCT00715403|18136735|P1|Overall Study|Dose limiting Toxicity (DLT)|0
5256786|NCT00715403|18136729|P7|Overall Study|Progressive disease|1
5256787|NCT00715403|18136730|P6|Overall Study|Progressive disease|14
5256788|NCT00715403|18136731|P5|Overall Study|Progressive disease|5
5256789|NCT00715403|18136732|P4|Overall Study|Progressive disease|9
5256790|NCT00715403|18136733|P3|Overall Study|Progressive disease|3
5256791|NCT00715403|18136734|P2|Overall Study|Progressive disease|1
5256792|NCT00715403|18136735|P1|Overall Study|Progressive disease|0
5256793|NCT00715299|18136874|P1|Overall Study|failed the pre-screen exercise test|2
5256794|NCT00715299|18136874|P1|Overall Study|Adverse Event|3
5256795|NCT00715299|18136874|P1|Overall Study|Withdrawal by Subject|1
5256796|NCT00715208|18136880|P2|Overall Study|Lack of Efficacy|2
5256797|NCT00715208|18136881|P1|Overall Study|Lack of Efficacy|0
5256798|NCT00715208|18136880|P2|Overall Study|Adverse Event|6
5256799|NCT00715208|18136881|P1|Overall Study|Adverse Event|0
5256800|NCT00715208|18136880|P2|Overall Study|Withdrawal by Subject|1
5256801|NCT00715208|18136881|P1|Overall Study|Withdrawal by Subject|1
5256802|NCT00715117|18136897|P2|Overall Study|Crohn's flare and rescue with steroids|1
5256803|NCT00715117|18136898|P1|Overall Study|Crohn's flare and rescue with steroids|0
5256804|NCT00715078|18136966|P3|Overall Study|Unable to start due to disease prog.|1
5256805|NCT00715078|18136967|P2|Overall Study|Unable to start due to disease prog.|0
5256806|NCT00715078|18136968|P1|Overall Study|Unable to start due to disease prog.|0
5256807|NCT00715078|18136966|P3|Overall Study|Withdrawal by Subject|1
5256808|NCT00715078|18136967|P2|Overall Study|Withdrawal by Subject|0
5256809|NCT00715078|18136968|P1|Overall Study|Withdrawal by Subject|1
5256810|NCT00715078|18136966|P3|Overall Study|Death|36
5256811|NCT00715078|18136967|P2|Overall Study|Death|36
5256812|NCT00715078|18136968|P1|Overall Study|Death|29
5256813|NCT00715026|18136976|P1|Overall Study|Surgery done on non-study consented hip|1
5256814|NCT00715026|18136976|P1|Overall Study|Protocol Violation|1
5256815|NCT00715026|18136976|P1|Overall Study|Lost to Follow-up|3
5256816|NCT00715026|18136976|P1|Overall Study|Withdrawal by Subject|5
5256817|NCT00714948|18136981|P1|Overall Study|Adverse Event|2
5256818|NCT00714870|18136987|P2|Overall Study|did not attend minimum of 4 sessions|0
5256819|NCT00714870|18136988|P1|Overall Study|did not attend minimum of 4 sessions|4
5256820|NCT00714870|18136987|P2|Overall Study|patient unable to come b/c back pain|0
5256821|NCT00714870|18136988|P1|Overall Study|patient unable to come b/c back pain|1
5256822|NCT00714870|18136987|P2|Overall Study|Lost to Follow-up|5
5256823|NCT00714870|18136988|P1|Overall Study|Lost to Follow-up|22
5256824|NCT00714714|18137012|P1|Overall Study|Adverse Event|1
5256825|NCT00714688|18137021|P3|Overall Study|Other|5
5256826|NCT00714688|18137022|P2|Overall Study|Other|6
5256827|NCT00714688|18137023|P1|Overall Study|Other|1
5256828|NCT00714688|18137021|P3|Overall Study|Sponsor's Decision|0
5256829|NCT00714688|18137022|P2|Overall Study|Sponsor's Decision|2
5256830|NCT00714688|18137023|P1|Overall Study|Sponsor's Decision|0
5256831|NCT00714688|18137021|P3|Overall Study|Ineligible to Continue the Study|1
5256832|NCT00714688|18137022|P2|Overall Study|Ineligible to Continue the Study|1
5256833|NCT00714688|18137023|P1|Overall Study|Ineligible to Continue the Study|0
5256834|NCT00714688|18137021|P3|Overall Study|Subject Non-compliant|5
5256835|NCT00714688|18137022|P2|Overall Study|Subject Non-compliant|5
5256836|NCT00714688|18137023|P1|Overall Study|Subject Non-compliant|3
5256837|NCT00714688|18137021|P3|Overall Study|Adverse Event|19
5256838|NCT00714688|18137022|P2|Overall Study|Adverse Event|15
5256839|NCT00714688|18137023|P1|Overall Study|Adverse Event|2
5256840|NCT00714688|18137021|P3|Overall Study|Lost to Follow-up|0
5256841|NCT00714688|18137022|P2|Overall Study|Lost to Follow-up|2
5256842|NCT00714688|18137023|P1|Overall Study|Lost to Follow-up|5
5256843|NCT00714688|18137021|P3|Overall Study|Withdrawal by Subject|3
5256844|NCT00714688|18137022|P2|Overall Study|Withdrawal by Subject|3
5256845|NCT00714688|18137023|P1|Overall Study|Withdrawal by Subject|4
5256846|NCT00714688|18137021|P3|Overall Study|Lack of Efficacy|4
5256847|NCT00714688|18137022|P2|Overall Study|Lack of Efficacy|1
5256848|NCT00714688|18137023|P1|Overall Study|Lack of Efficacy|14
5256849|NCT00714493|18137065|P1|Overall Study|OTHER|2
5256850|NCT00714493|18137065|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
5256851|NCT00714493|18137065|P1|Overall Study|Protocol Violation|12
5256852|NCT00714493|18137065|P1|Overall Study|Lost to Follow-up|3
5256853|NCT00714493|18137065|P1|Overall Study|Lack of Efficacy|10
5256854|NCT00714493|18137065|P1|Overall Study|Death|3
5256855|NCT00714493|18137065|P1|Overall Study|Adverse Event|11
5256856|NCT00714415|18137077|P2|Overall Study|Death|0
5256857|NCT00714415|18137078|P1|Overall Study|Death|1
5256858|NCT00714415|18137077|P2|Overall Study|Lack of Efficacy|0
5256859|NCT00714415|18137078|P1|Overall Study|Lack of Efficacy|1
5256860|NCT00714285|18137128|P4|Overall Study|Migrated/moved from study area|0
5256861|NCT00714285|18137129|P3|Overall Study|Migrated/moved from study area|0
5256862|NCT00714285|18137130|P2|Overall Study|Migrated/moved from study area|1
5256863|NCT00714285|18137131|P1|Overall Study|Migrated/moved from study area|0
5256864|NCT00714285|18137128|P4|Overall Study|Lost to Follow-up|1
5256865|NCT00714285|18137129|P3|Overall Study|Lost to Follow-up|0
5256866|NCT00714285|18137130|P2|Overall Study|Lost to Follow-up|2
5256867|NCT00714285|18137131|P1|Overall Study|Lost to Follow-up|0
5256868|NCT00714259|18137192|P1|Overall Study|Death|2
5256869|NCT00714168|18137238|P2|Overall Study|Non-study medical condition|2
5256870|NCT00714168|18137239|P1|Overall Study|Non-study medical condition|3
5256871|NCT00714168|18137238|P2|Overall Study|Relocation|3
5256872|NCT00714168|18137239|P1|Overall Study|Relocation|4
5256873|NCT00714168|18137238|P2|Overall Study|Lost to Follow-up|50
5256874|NCT00714168|18137239|P1|Overall Study|Lost to Follow-up|32
5256875|NCT00714168|18137238|P2|Overall Study|Pregnancy|4
5256876|NCT00714168|18137239|P1|Overall Study|Pregnancy|5
5256877|NCT00714051|18137255|P2|Overall Study|Death|1
5256878|NCT00714051|18137256|P1|Overall Study|Death|0
5256879|NCT00714051|18137255|P2|Overall Study|Withdrawal by Subject|0
5256880|NCT00714051|18137256|P1|Overall Study|Withdrawal by Subject|1
5256881|NCT00713830|18137264|P2|Overall Study|Sponsor Decision|10
5256882|NCT00713830|18137265|P1|Overall Study|Sponsor Decision|4
5256883|NCT00713830|18137264|P2|Overall Study|Familial and Personal Reasons|34
5256884|NCT00713830|18137265|P1|Overall Study|Familial and Personal Reasons|9
5256885|NCT00713830|18137264|P2|Overall Study|Poor Compliance to Protocol|14
5256886|NCT00713830|18137265|P1|Overall Study|Poor Compliance to Protocol|7
5256887|NCT00713830|18137264|P2|Overall Study|Withdrawal by Subject|23
5256888|NCT00713830|18137265|P1|Overall Study|Withdrawal by Subject|13
5256889|NCT00713830|18137264|P2|Overall Study|Lost to Follow-up|9
5256890|NCT00713830|18137265|P1|Overall Study|Lost to Follow-up|2
5256891|NCT00713830|18137264|P2|Overall Study|Lack of Efficacy|16
5256892|NCT00713830|18137265|P1|Overall Study|Lack of Efficacy|24
5256893|NCT00713830|18137264|P2|Overall Study|Adverse Event|71
5256894|NCT00713830|18137265|P1|Overall Study|Adverse Event|23
5256895|NCT00713700|18137322|P1|Overall Study|Withdrawal by Subject|1
5256896|NCT00713700|18137322|P1|Overall Study|Lost to Follow-up|3
5256897|NCT00713648|18137348|P1|Overall Study|Development of antibodies|3
5256898|NCT00713648|18137348|P1|Overall Study|According to Protocol|2
5256899|NCT00713648|18137348|P1|Overall Study|Unclassified|2
5256900|NCT00713648|18137348|P1|Overall Study|Adverse Event|1
5256901|NCT00713609|18137361|P6|Overall Study|Protocol Violation|0
5256902|NCT00713609|18137362|P5|Overall Study|Protocol Violation|2
5256903|NCT00713609|18137363|P4|Overall Study|Protocol Violation|1
5256904|NCT00713609|18137364|P3|Overall Study|Protocol Violation|1
5256905|NCT00713609|18137365|P2|Overall Study|Protocol Violation|3
5256906|NCT00713609|18137366|P1|Overall Study|Protocol Violation|6
5256907|NCT00713609|18137361|P6|Overall Study|Withdrawal by Subject|7
5256908|NCT00713609|18137362|P5|Overall Study|Withdrawal by Subject|5
5256909|NCT00713609|18137363|P4|Overall Study|Withdrawal by Subject|1
5256910|NCT00713609|18137364|P3|Overall Study|Withdrawal by Subject|5
5256911|NCT00713609|18137365|P2|Overall Study|Withdrawal by Subject|1
5256912|NCT00713609|18137366|P1|Overall Study|Withdrawal by Subject|6
5256913|NCT00713609|18137361|P6|Overall Study|Non-Compliance with Study Treatment|0
5256914|NCT00713609|18137362|P5|Overall Study|Non-Compliance with Study Treatment|1
5256915|NCT00713609|18137363|P4|Overall Study|Non-Compliance with Study Treatment|0
5256916|NCT00713609|18137364|P3|Overall Study|Non-Compliance with Study Treatment|2
5256917|NCT00713609|18137365|P2|Overall Study|Non-Compliance with Study Treatment|1
5256918|NCT00713609|18137366|P1|Overall Study|Non-Compliance with Study Treatment|1
5256919|NCT00713609|18137361|P6|Overall Study|Lack of Efficacy|0
5256920|NCT00713609|18137362|P5|Overall Study|Lack of Efficacy|1
5256921|NCT00713609|18137363|P4|Overall Study|Lack of Efficacy|0
5256922|NCT00713609|18137364|P3|Overall Study|Lack of Efficacy|0
5256923|NCT00713609|18137365|P2|Overall Study|Lack of Efficacy|3
5256924|NCT00713609|18137366|P1|Overall Study|Lack of Efficacy|1
5256925|NCT00713609|18137361|P6|Overall Study|Lost to Follow-up|0
5256926|NCT00713609|18137362|P5|Overall Study|Lost to Follow-up|7
5256927|NCT00713609|18137363|P4|Overall Study|Lost to Follow-up|5
5256928|NCT00713609|18137364|P3|Overall Study|Lost to Follow-up|5
5256929|NCT00713609|18137365|P2|Overall Study|Lost to Follow-up|7
5256930|NCT00713609|18137366|P1|Overall Study|Lost to Follow-up|5
5256931|NCT00713609|18137361|P6|Overall Study|Adverse Event|1
5256932|NCT00713609|18137362|P5|Overall Study|Adverse Event|3
5256933|NCT00713609|18137363|P4|Overall Study|Adverse Event|2
5256934|NCT00713609|18137364|P3|Overall Study|Adverse Event|2
5256935|NCT00713609|18137365|P2|Overall Study|Adverse Event|0
5256936|NCT00713609|18137366|P1|Overall Study|Adverse Event|2
5256937|NCT00713596|18137401|P3|Overall Study|Study was terminated|2
5256938|NCT00713596|18137402|P2|Overall Study|Study was terminated|3
5256939|NCT00713596|18137403|P1|Overall Study|Study was terminated|2
5256940|NCT00713544|18137429|P6|Overall Study|Hepatotoxicity - not an AE|0
5256941|NCT00713544|18137430|P5|Overall Study|Hepatotoxicity - not an AE|1
5256942|NCT00713544|18137431|P4|Overall Study|Hepatotoxicity - not an AE|0
5256943|NCT00713544|18137432|P3|Overall Study|Hepatotoxicity - not an AE|0
5256944|NCT00713544|18137433|P2|Overall Study|Hepatotoxicity - not an AE|0
5256945|NCT00713544|18137434|P1|Overall Study|Hepatotoxicity - not an AE|0
5256946|NCT00713544|18137429|P6|Overall Study|Incorrect enrollment|0
5256947|NCT00713544|18137430|P5|Overall Study|Incorrect enrollment|0
5256948|NCT00713544|18137431|P4|Overall Study|Incorrect enrollment|0
5256949|NCT00713544|18137432|P3|Overall Study|Incorrect enrollment|0
5256950|NCT00713544|18137433|P2|Overall Study|Incorrect enrollment|1
5256951|NCT00713544|18137434|P1|Overall Study|Incorrect enrollment|0
5256952|NCT00713544|18137429|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
5256953|NCT00713544|18137430|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
5256954|NCT00713544|18137431|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
5256955|NCT00713544|18137432|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
5256956|NCT00713544|18137433|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
5256957|NCT00713544|18137434|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
5256958|NCT00713544|18137429|P6|Overall Study|Lost to Follow-up|0
5256959|NCT00713544|18137430|P5|Overall Study|Lost to Follow-up|0
5256960|NCT00713544|18137431|P4|Overall Study|Lost to Follow-up|0
5256961|NCT00713544|18137432|P3|Overall Study|Lost to Follow-up|1
5256962|NCT00713544|18137433|P2|Overall Study|Lost to Follow-up|0
5256963|NCT00713544|18137434|P1|Overall Study|Lost to Follow-up|0
5256964|NCT00713544|18137429|P6|Overall Study|Lack of Efficacy|0
5256965|NCT00713544|18137430|P5|Overall Study|Lack of Efficacy|1
5256966|NCT00713544|18137431|P4|Overall Study|Lack of Efficacy|1
5256967|NCT00713544|18137432|P3|Overall Study|Lack of Efficacy|0
5256968|NCT00713544|18137433|P2|Overall Study|Lack of Efficacy|1
5256969|NCT00713544|18137434|P1|Overall Study|Lack of Efficacy|0
5256970|NCT00713544|18137429|P6|Overall Study|Physician Decision|2
5256971|NCT00713544|18137430|P5|Overall Study|Physician Decision|0
5256972|NCT00713544|18137431|P4|Overall Study|Physician Decision|0
5256973|NCT00713544|18137432|P3|Overall Study|Physician Decision|0
5256974|NCT00713544|18137433|P2|Overall Study|Physician Decision|0
5256975|NCT00713544|18137434|P1|Overall Study|Physician Decision|0
5256976|NCT00713544|18137429|P6|Overall Study|Protocol Violation|1
5256977|NCT00713544|18137430|P5|Overall Study|Protocol Violation|0
5256978|NCT00713544|18137431|P4|Overall Study|Protocol Violation|0
5256979|NCT00713544|18137432|P3|Overall Study|Protocol Violation|0
5256980|NCT00713544|18137433|P2|Overall Study|Protocol Violation|0
5256981|NCT00713544|18137434|P1|Overall Study|Protocol Violation|0
5256982|NCT00713544|18137429|P6|Overall Study|Withdrawal by Subject|1
5256983|NCT00713544|18137430|P5|Overall Study|Withdrawal by Subject|3
5256984|NCT00713544|18137431|P4|Overall Study|Withdrawal by Subject|2
5256985|NCT00713544|18137432|P3|Overall Study|Withdrawal by Subject|3
5256986|NCT00713544|18137433|P2|Overall Study|Withdrawal by Subject|0
5256987|NCT00713544|18137434|P1|Overall Study|Withdrawal by Subject|2
5256988|NCT00713544|18137429|P6|Overall Study|Adverse Event|5
5256989|NCT00713544|18137430|P5|Overall Study|Adverse Event|3
5256990|NCT00713544|18137431|P4|Overall Study|Adverse Event|7
5256991|NCT00713544|18137432|P3|Overall Study|Adverse Event|7
5256992|NCT00713544|18137433|P2|Overall Study|Adverse Event|3
5256993|NCT00713544|18137434|P1|Overall Study|Adverse Event|5
5256994|NCT00713349|18137485|P1|Overall Study|Protocol Violation|1
5256995|NCT00713323|18137491|P1|Overall Study|Treatment that may interact with Sativex|1
5256996|NCT00713323|18137491|P1|Overall Study|Subject travelling to Dominica Republic|1
5256997|NCT00713323|18137491|P1|Overall Study|Subject travelling to USA|1
5256998|NCT00713323|18137491|P1|Overall Study|Pain resolved|1
5256999|NCT00713323|18137491|P1|Overall Study|Non-compliance|1
5257000|NCT00713323|18137491|P1|Overall Study|Pain free|1
5257001|NCT00713323|18137491|P1|Overall Study|Surgery cured allodynic pain|1
5257002|NCT00713323|18137491|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
5257003|NCT00713323|18137491|P1|Overall Study|Low creatine clearance at screening|1
5257004|NCT00713323|18137491|P1|Overall Study|Lack of Efficacy|36
5257005|NCT00713323|18137491|P1|Overall Study|Lost to Follow-up|11
5257006|NCT00713323|18137491|P1|Overall Study|Withdrawal by Subject|15
5257007|NCT00713323|18137491|P1|Overall Study|Adverse Event|75
5257008|NCT00713310|18137504|P2|Overall Study|Withdrawal by Subject|2
5257009|NCT00713310|18137505|P1|Overall Study|Withdrawal by Subject|0
5257010|NCT00713310|18137504|P2|Overall Study|Lack of Efficacy|2
5257011|NCT00713310|18137505|P1|Overall Study|Lack of Efficacy|0
5257012|NCT00713310|18137504|P2|Overall Study|Adverse Event|2
5257013|NCT00713310|18137505|P1|Overall Study|Adverse Event|5
5257014|NCT00713258|18137519|P2|Overall Study|Other|1
5257015|NCT00713258|18137520|P1|Overall Study|Other|1
5257016|NCT00713258|18137519|P2|Overall Study|Non-Compliance|1
5257017|NCT00713258|18137520|P1|Overall Study|Non-Compliance|2
5257018|NCT00713258|18137519|P2|Overall Study|Adverse Event|4
5257019|NCT00713258|18137520|P1|Overall Study|Adverse Event|2
5257020|NCT00713219|18137528|P1|Overall Study|Protocol Violation|1
5257021|NCT00713219|18137528|P1|Overall Study|Death|1
5257022|NCT00713206|18137534|P2|Overall Study|Adverse Event|1
5257023|NCT00713206|18137535|P1|Overall Study|Adverse Event|2
5257024|NCT00713206|18137534|P2|Overall Study|Lost to Follow-up|2
5257025|NCT00713206|18137535|P1|Overall Study|Lost to Follow-up|5
5257026|NCT00712985|18137541|P1|Overall Study|Lack of Efficacy|3
5257027|NCT00712985|18137541|P1|Overall Study|1 patient moved out of state|1
5257028|NCT00712985|18137541|P1|Overall Study|1 withdrew prior to start of drug|1
5257029|NCT00712959|18137547|P2|Overall Study|Withdrawal by Subject|0
5257030|NCT00712959|18137548|P1|Overall Study|Withdrawal by Subject|3
5257031|NCT00712959|18137547|P2|Overall Study|Lost to Follow-up|2
5257032|NCT00712959|18137548|P1|Overall Study|Lost to Follow-up|13
5257033|NCT00712959|18137547|P2|Overall Study|Protocol Violation|1
5257034|NCT00712959|18137548|P1|Overall Study|Protocol Violation|3
5257035|NCT00712933|18137566|P1|Overall Study|Withdrawal by Subject|151
5257036|NCT00712933|18137566|P1|Overall Study|Protocol Violation|4
5257037|NCT00712933|18137566|P1|Overall Study|Physician Decision|36
5257038|NCT00712933|18137566|P1|Overall Study|Participant received medication|1
5257039|NCT00712933|18137566|P1|Overall Study|Not committed to contraception|1
5257040|NCT00712933|18137566|P1|Overall Study|Other Physician decision|1
5257041|NCT00712933|18137566|P1|Overall Study|Death of patient|1
5257042|NCT00712933|18137566|P1|Overall Study|Participant travelled overseas|2
5257043|NCT00712933|18137566|P1|Overall Study|Participant hospitalized|1
5257044|NCT00712933|18137566|P1|Overall Study|Involved in Clinical research|3
5257045|NCT00712933|18137566|P1|Overall Study|Hip replacement surgery|1
5257046|NCT00712933|18137566|P1|Overall Study|Withdrew consent|4
5257047|NCT00712933|18137566|P1|Overall Study|Sponsor decision|14
5257048|NCT00712933|18137566|P1|Overall Study|Other Pregnancy|37
5257049|NCT00712933|18137566|P1|Overall Study|Non-compliance with study drug|13
5257050|NCT00712933|18137566|P1|Overall Study|Lost to Follow-up|22
5257051|NCT00712933|18137566|P1|Overall Study|Lack of Efficacy|6
5257052|NCT00712933|18137566|P1|Overall Study|Adverse Event|69
5257053|NCT00712920|18137596|P3|Overall Study|Non-compliance|0
5257054|NCT00712920|18137597|P2|Overall Study|Non-compliance|0
5257055|NCT00712920|18137598|P1|Overall Study|Non-compliance|3
5257056|NCT00712920|18137596|P3|Overall Study|Other|3
5257057|NCT00712920|18137597|P2|Overall Study|Other|7
5257058|NCT00712920|18137598|P1|Overall Study|Other|5
5257059|NCT00712920|18137596|P3|Overall Study|Lack of Efficacy|1
5257060|NCT00712920|18137597|P2|Overall Study|Lack of Efficacy|0
5257061|NCT00712920|18137598|P1|Overall Study|Lack of Efficacy|1
5257062|NCT00712920|18137596|P3|Overall Study|Lost to Follow-up|0
5257063|NCT00712920|18137597|P2|Overall Study|Lost to Follow-up|4
5257064|NCT00712920|18137598|P1|Overall Study|Lost to Follow-up|1
5257065|NCT00712920|18137596|P3|Overall Study|Withdrawal by Subject|1
5257066|NCT00712920|18137597|P2|Overall Study|Withdrawal by Subject|2
5257067|NCT00712920|18137598|P1|Overall Study|Withdrawal by Subject|4
5257068|NCT00712920|18137596|P3|Overall Study|Adverse Event|7
5257069|NCT00712920|18137597|P2|Overall Study|Adverse Event|4
5257070|NCT00712920|18137598|P1|Overall Study|Adverse Event|3
5257071|NCT00712725|18137626|P8|Overall Study|Protocol Specified Criteria|1
5257072|NCT00712725|18137627|P7|Overall Study|Protocol Specified Criteria|2
5257073|NCT00712725|18137628|P6|Overall Study|Protocol Specified Criteria|0
5257074|NCT00712725|18137629|P5|Overall Study|Protocol Specified Criteria|1
5257075|NCT00712725|18137630|P4|Overall Study|Protocol Specified Criteria|2
5257076|NCT00712725|18137631|P3|Overall Study|Protocol Specified Criteria|1
5257077|NCT00712725|18137632|P2|Overall Study|Protocol Specified Criteria|0
5257078|NCT00712725|18137633|P1|Overall Study|Protocol Specified Criteria|3
5257079|NCT00712725|18137626|P8|Overall Study|Lack of Qualifying Event|6
5257080|NCT00712725|18137627|P7|Overall Study|Lack of Qualifying Event|11
5257081|NCT00712725|18137628|P6|Overall Study|Lack of Qualifying Event|13
5257082|NCT00712725|18137629|P5|Overall Study|Lack of Qualifying Event|11
5257083|NCT00712725|18137630|P4|Overall Study|Lack of Qualifying Event|8
5257084|NCT00712725|18137631|P3|Overall Study|Lack of Qualifying Event|6
5257085|NCT00712725|18137632|P2|Overall Study|Lack of Qualifying Event|2
5257086|NCT00712725|18137633|P1|Overall Study|Lack of Qualifying Event|16
5257087|NCT00712725|18137626|P8|Overall Study|Withdrawal by Subject|2
5257088|NCT00712725|18137627|P7|Overall Study|Withdrawal by Subject|1
5257089|NCT00712725|18137628|P6|Overall Study|Withdrawal by Subject|1
5257090|NCT00712725|18137629|P5|Overall Study|Withdrawal by Subject|1
5257091|NCT00712725|18137630|P4|Overall Study|Withdrawal by Subject|2
5257092|NCT00712725|18137631|P3|Overall Study|Withdrawal by Subject|1
5257093|NCT00712725|18137632|P2|Overall Study|Withdrawal by Subject|1
5257094|NCT00712725|18137633|P1|Overall Study|Withdrawal by Subject|2
5257095|NCT00712725|18137626|P8|Overall Study|Protocol Violation|1
5257096|NCT00712725|18137627|P7|Overall Study|Protocol Violation|1
5257097|NCT00712725|18137628|P6|Overall Study|Protocol Violation|0
5257098|NCT00712725|18137629|P5|Overall Study|Protocol Violation|2
5257099|NCT00712725|18137630|P4|Overall Study|Protocol Violation|3
5257100|NCT00712725|18137631|P3|Overall Study|Protocol Violation|1
5257101|NCT00712725|18137632|P2|Overall Study|Protocol Violation|0
5257102|NCT00712725|18137633|P1|Overall Study|Protocol Violation|2
5257103|NCT00712725|18137626|P8|Overall Study|Pregnancy|0
5257104|NCT00712725|18137627|P7|Overall Study|Pregnancy|2
5257105|NCT00712725|18137628|P6|Overall Study|Pregnancy|0
5257106|NCT00712725|18137629|P5|Overall Study|Pregnancy|1
5257107|NCT00712725|18137630|P4|Overall Study|Pregnancy|0
5257108|NCT00712725|18137631|P3|Overall Study|Pregnancy|0
5257109|NCT00712725|18137632|P2|Overall Study|Pregnancy|1
5257110|NCT00712725|18137633|P1|Overall Study|Pregnancy|0
5257111|NCT00712725|18137626|P8|Overall Study|Physician Decision|0
5257112|NCT00712725|18137627|P7|Overall Study|Physician Decision|2
5257113|NCT00712725|18137628|P6|Overall Study|Physician Decision|0
5257114|NCT00712725|18137629|P5|Overall Study|Physician Decision|1
5257115|NCT00712725|18137630|P4|Overall Study|Physician Decision|0
5257116|NCT00712725|18137631|P3|Overall Study|Physician Decision|0
5257117|NCT00712725|18137632|P2|Overall Study|Physician Decision|0
5257118|NCT00712725|18137633|P1|Overall Study|Physician Decision|2
5257119|NCT00712725|18137626|P8|Overall Study|Lost to Follow-up|1
5257120|NCT00712725|18137627|P7|Overall Study|Lost to Follow-up|3
5257121|NCT00712725|18137628|P6|Overall Study|Lost to Follow-up|2
5257122|NCT00712725|18137629|P5|Overall Study|Lost to Follow-up|2
5257123|NCT00712725|18137630|P4|Overall Study|Lost to Follow-up|1
5257124|NCT00712725|18137631|P3|Overall Study|Lost to Follow-up|1
5257125|NCT00712725|18137632|P2|Overall Study|Lost to Follow-up|2
5257126|NCT00712725|18137633|P1|Overall Study|Lost to Follow-up|3
5257127|NCT00712725|18137626|P8|Overall Study|Adverse Event|0
5257128|NCT00712725|18137627|P7|Overall Study|Adverse Event|0
5257129|NCT00712725|18137628|P6|Overall Study|Adverse Event|0
5257130|NCT00712725|18137629|P5|Overall Study|Adverse Event|0
5257131|NCT00712725|18137630|P4|Overall Study|Adverse Event|1
5257132|NCT00712725|18137631|P3|Overall Study|Adverse Event|0
5257133|NCT00712725|18137632|P2|Overall Study|Adverse Event|0
5257134|NCT00712725|18137633|P1|Overall Study|Adverse Event|1
5257135|NCT00712673|18137694|P4|Overall Study|Protocol Violation|0
5257136|NCT00712673|18137695|P3|Overall Study|Protocol Violation|2
5257137|NCT00712673|18137696|P2|Overall Study|Protocol Violation|0
5257138|NCT00712673|18137697|P1|Overall Study|Protocol Violation|0
5257139|NCT00712673|18137694|P4|Overall Study|Investigator's Decision|0
5257140|NCT00712673|18137695|P3|Overall Study|Investigator's Decision|0
5257141|NCT00712673|18137696|P2|Overall Study|Investigator's Decision|0
5257142|NCT00712673|18137697|P1|Overall Study|Investigator's Decision|1
5257143|NCT00712673|18137694|P4|Overall Study|Familial and Personal Reasons|2
5257144|NCT00712673|18137695|P3|Overall Study|Familial and Personal Reasons|5
5257145|NCT00712673|18137696|P2|Overall Study|Familial and Personal Reasons|0
5257146|NCT00712673|18137697|P1|Overall Study|Familial and Personal Reasons|5
5257147|NCT00712673|18137694|P4|Overall Study|Withdrawal by Subject|20
5257148|NCT00712673|18137695|P3|Overall Study|Withdrawal by Subject|15
5257149|NCT00712673|18137696|P2|Overall Study|Withdrawal by Subject|7
5257150|NCT00712673|18137697|P1|Overall Study|Withdrawal by Subject|6
5257151|NCT00712673|18137694|P4|Overall Study|Lost to Follow-up|0
5257152|NCT00712673|18137695|P3|Overall Study|Lost to Follow-up|2
5257153|NCT00712673|18137696|P2|Overall Study|Lost to Follow-up|0
5257154|NCT00712673|18137697|P1|Overall Study|Lost to Follow-up|1
5257155|NCT00712673|18137694|P4|Overall Study|Poor Compliance to Protocol|16
5257156|NCT00712673|18137695|P3|Overall Study|Poor Compliance to Protocol|4
5257157|NCT00712673|18137696|P2|Overall Study|Poor Compliance to Protocol|3
5257158|NCT00712673|18137697|P1|Overall Study|Poor Compliance to Protocol|3
5257159|NCT00712673|18137694|P4|Overall Study|Lack of Efficacy|6
5257160|NCT00712673|18137695|P3|Overall Study|Lack of Efficacy|8
5257161|NCT00712673|18137696|P2|Overall Study|Lack of Efficacy|8
5257162|NCT00712673|18137697|P1|Overall Study|Lack of Efficacy|2
5257163|NCT00712673|18137694|P4|Overall Study|Adverse Event|26
5257164|NCT00712673|18137695|P3|Overall Study|Adverse Event|21
5257165|NCT00712673|18137696|P2|Overall Study|Adverse Event|3
5257166|NCT00712673|18137697|P1|Overall Study|Adverse Event|3
5257167|NCT00712543|18137761|P2|Day 8-14|Lost to Follow-up|2
5257168|NCT00712543|18137762|P1|Day 8-14|Lost to Follow-up|0
5257169|NCT00712348|18137796|P1|Overall Study|Withdrawal by Subject|1
5257170|NCT00712335|18137808|P5|Overall Study|Other Reason|0
5257171|NCT00712335|18137809|P4|Overall Study|Other Reason|0
5257172|NCT00712335|18137810|P3|Overall Study|Other Reason|1
5257173|NCT00712335|18137811|P2|Overall Study|Other Reason|3
5257174|NCT00712335|18137812|P1|Overall Study|Other Reason|0
5257175|NCT00712335|18137808|P5|Overall Study|Lack of Efficacy|0
5257176|NCT00712335|18137809|P4|Overall Study|Lack of Efficacy|1
5257177|NCT00712335|18137810|P3|Overall Study|Lack of Efficacy|1
5257178|NCT00712335|18137811|P2|Overall Study|Lack of Efficacy|0
5257179|NCT00712335|18137812|P1|Overall Study|Lack of Efficacy|0
5257180|NCT00712335|18137808|P5|Overall Study|Protocol Violation|0
5257181|NCT00712335|18137809|P4|Overall Study|Protocol Violation|0
5257182|NCT00712335|18137810|P3|Overall Study|Protocol Violation|1
5257183|NCT00712335|18137811|P2|Overall Study|Protocol Violation|2
5257184|NCT00712335|18137812|P1|Overall Study|Protocol Violation|1
5257185|NCT00712335|18137808|P5|Overall Study|Lost to Follow-up|0
5257186|NCT00712335|18137809|P4|Overall Study|Lost to Follow-up|1
5257187|NCT00712335|18137810|P3|Overall Study|Lost to Follow-up|0
5257188|NCT00712335|18137811|P2|Overall Study|Lost to Follow-up|5
5257189|NCT00712335|18137812|P1|Overall Study|Lost to Follow-up|2
5257190|NCT00712335|18137808|P5|Overall Study|Withdrawal by Subject|0
5257191|NCT00712335|18137809|P4|Overall Study|Withdrawal by Subject|3
5257192|NCT00712335|18137810|P3|Overall Study|Withdrawal by Subject|2
5257193|NCT00712335|18137811|P2|Overall Study|Withdrawal by Subject|7
5257194|NCT00712335|18137812|P1|Overall Study|Withdrawal by Subject|0
5257195|NCT00712270|18137942|P1|Overall Study|Screen Failure|3
5257196|NCT00712270|18137942|P1|Overall Study|Withdrawal by Subject|11
5257197|NCT00712166|18138006|P2|Overall Study|Noncompliance|1
5257198|NCT00712166|18138007|P1|Overall Study|Noncompliance|0
5257199|NCT00712010|18138050|P1|Washout (7 Days)|Withdrawal by Subject|1
5257200|NCT00711971|18138089|P3|Overall Study|Lost to Follow-up|1
5257201|NCT00711971|18138090|P2|Overall Study|Lost to Follow-up|4
5257202|NCT00711971|18138091|P1|Overall Study|Lost to Follow-up|3
5257203|NCT00711958|18138125|P2|Overall Study|Progression of disease|0
5257204|NCT00711958|18138126|P1|Overall Study|Progression of disease|1
5257205|NCT00711958|18138125|P2|Overall Study|Death|5
5257206|NCT00711958|18138126|P1|Overall Study|Death|10
5257207|NCT00711958|18138125|P2|Overall Study|Lost to Follow-up|2
5257208|NCT00711958|18138126|P1|Overall Study|Lost to Follow-up|2
5257209|NCT00711958|18138125|P2|Overall Study|Protocol Violation|0
5257210|NCT00711958|18138126|P1|Overall Study|Protocol Violation|1
5257211|NCT00711958|18138125|P2|Overall Study|Adverse Event|7
5257212|NCT00711958|18138126|P1|Overall Study|Adverse Event|9
5257213|NCT00711958|18138125|P2|Overall Study|Clinical deterioration|0
5257214|NCT00711958|18138126|P1|Overall Study|Clinical deterioration|1
5257215|NCT00711958|18138125|P2|Overall Study|Lack of Efficacy|1
5257216|NCT00711958|18138126|P1|Overall Study|Lack of Efficacy|3
5257217|NCT00711958|18138125|P2|Overall Study|Withdrawal by Subject|8
5257218|NCT00711958|18138126|P1|Overall Study|Withdrawal by Subject|6
5257219|NCT00711880|18138134|P2|Overall Study|Lack of Efficacy|5
5257220|NCT00711880|18138135|P1|Overall Study|Lack of Efficacy|1
5257221|NCT00711880|18138134|P2|Overall Study|Patient non-compliance|0
5257222|NCT00711880|18138135|P1|Overall Study|Patient non-compliance|1
5257223|NCT00711880|18138134|P2|Overall Study|Adverse Event|2
5257224|NCT00711880|18138135|P1|Overall Study|Adverse Event|11
5257225|NCT00711802|18138197|P8|Overall Study|Reason not reported|0
5257226|NCT00711802|18138198|P7|Overall Study|Reason not reported|1
5257227|NCT00711802|18138199|P6|Overall Study|Reason not reported|0
5257228|NCT00711802|18138200|P5|Overall Study|Reason not reported|1
5257229|NCT00711802|18138201|P4|Overall Study|Reason not reported|0
5257230|NCT00711802|18138202|P3|Overall Study|Reason not reported|1
5257231|NCT00711802|18138203|P2|Overall Study|Reason not reported|1
5257232|NCT00711802|18138204|P1|Overall Study|Reason not reported|0
5257233|NCT00711802|18138197|P8|Overall Study|Lost to Follow-up|2
5257234|NCT00711802|18138198|P7|Overall Study|Lost to Follow-up|4
5257235|NCT00711802|18138199|P6|Overall Study|Lost to Follow-up|6
5257236|NCT00711802|18138200|P5|Overall Study|Lost to Follow-up|10
5257237|NCT00711802|18138201|P4|Overall Study|Lost to Follow-up|1
5257238|NCT00711802|18138202|P3|Overall Study|Lost to Follow-up|3
5257239|NCT00711802|18138203|P2|Overall Study|Lost to Follow-up|0
5257240|NCT00711802|18138204|P1|Overall Study|Lost to Follow-up|0
5257241|NCT00711802|18138197|P8|Overall Study|Withdrawal by Subject|0
5257242|NCT00711802|18138198|P7|Overall Study|Withdrawal by Subject|0
5257243|NCT00711802|18138199|P6|Overall Study|Withdrawal by Subject|0
5257244|NCT00711802|18138200|P5|Overall Study|Withdrawal by Subject|0
5257245|NCT00711802|18138201|P4|Overall Study|Withdrawal by Subject|1
5257246|NCT00711802|18138202|P3|Overall Study|Withdrawal by Subject|0
5257247|NCT00711802|18138203|P2|Overall Study|Withdrawal by Subject|1
5257248|NCT00711802|18138204|P1|Overall Study|Withdrawal by Subject|0
5257249|NCT00711802|18138197|P8|Overall Study|Physician Decision|0
5257250|NCT00711802|18138198|P7|Overall Study|Physician Decision|0
5257251|NCT00711802|18138199|P6|Overall Study|Physician Decision|0
5257252|NCT00711802|18138200|P5|Overall Study|Physician Decision|0
5257253|NCT00711802|18138201|P4|Overall Study|Physician Decision|0
5257254|NCT00711802|18138202|P3|Overall Study|Physician Decision|0
5257255|NCT00711802|18138203|P2|Overall Study|Physician Decision|2
5257256|NCT00711802|18138204|P1|Overall Study|Physician Decision|0
5257257|NCT00711802|18138197|P8|Overall Study|Protocol Violation|0
5257258|NCT00711802|18138198|P7|Overall Study|Protocol Violation|0
5257259|NCT00711802|18138199|P6|Overall Study|Protocol Violation|0
5257260|NCT00711802|18138200|P5|Overall Study|Protocol Violation|0
5257261|NCT00711802|18138201|P4|Overall Study|Protocol Violation|1
5257262|NCT00711802|18138202|P3|Overall Study|Protocol Violation|0
5257263|NCT00711802|18138203|P2|Overall Study|Protocol Violation|0
5257264|NCT00711802|18138204|P1|Overall Study|Protocol Violation|0
5257265|NCT00711802|18138197|P8|Overall Study|Microbiological failure|0
5257266|NCT00711802|18138198|P7|Overall Study|Microbiological failure|0
5257267|NCT00711802|18138199|P6|Overall Study|Microbiological failure|1
5257268|NCT00711802|18138200|P5|Overall Study|Microbiological failure|0
5257269|NCT00711802|18138201|P4|Overall Study|Microbiological failure|0
5257270|NCT00711802|18138202|P3|Overall Study|Microbiological failure|0
5257271|NCT00711802|18138203|P2|Overall Study|Microbiological failure|1
5257272|NCT00711802|18138204|P1|Overall Study|Microbiological failure|0
5257273|NCT00711802|18138197|P8|Overall Study|Adverse Event|0
5257274|NCT00711802|18138198|P7|Overall Study|Adverse Event|0
5257275|NCT00711802|18138199|P6|Overall Study|Adverse Event|1
5257276|NCT00711802|18138200|P5|Overall Study|Adverse Event|1
5257277|NCT00711802|18138201|P4|Overall Study|Adverse Event|0
5257278|NCT00711802|18138202|P3|Overall Study|Adverse Event|0
5257279|NCT00711802|18138203|P2|Overall Study|Adverse Event|0
5257280|NCT00711802|18138204|P1|Overall Study|Adverse Event|0
5257281|NCT00711802|18138197|P8|Overall Study|Not treated (no further detail)|0
5257282|NCT00711802|18138198|P7|Overall Study|Not treated (no further detail)|0
5257283|NCT00711802|18138199|P6|Overall Study|Not treated (no further detail)|0
5257284|NCT00711802|18138200|P5|Overall Study|Not treated (no further detail)|2
5257285|NCT00711802|18138201|P4|Overall Study|Not treated (no further detail)|0
5257286|NCT00711802|18138202|P3|Overall Study|Not treated (no further detail)|2
5257287|NCT00711802|18138203|P2|Overall Study|Not treated (no further detail)|1
5257288|NCT00711802|18138204|P1|Overall Study|Not treated (no further detail)|2
5257289|NCT00711646|18138247|P2|Overall Study|patient non-compliance|0
5257290|NCT00711646|18138248|P1|Overall Study|patient non-compliance|1
5257291|NCT00711646|18138247|P2|Overall Study|administrative decision|1
5257292|NCT00711646|18138248|P1|Overall Study|administrative decision|0
5257293|NCT00711646|18138247|P2|Overall Study|Lost to Follow-up|0
5257294|NCT00711646|18138248|P1|Overall Study|Lost to Follow-up|1
5257295|NCT00711646|18138247|P2|Overall Study|Protocol Violation|1
5257296|NCT00711646|18138248|P1|Overall Study|Protocol Violation|0
5257297|NCT00711646|18138247|P2|Overall Study|Withdrawal by Subject|0
5257298|NCT00711646|18138248|P1|Overall Study|Withdrawal by Subject|4
5257299|NCT00711646|18138247|P2|Overall Study|Adverse Event|1
5257300|NCT00711646|18138248|P1|Overall Study|Adverse Event|6
5257301|NCT00711594|18138270|P4|Overall Study|Withdrawal by Subject|2
5257302|NCT00711594|18138271|P3|Overall Study|Withdrawal by Subject|0
5257303|NCT00711594|18138272|P2|Overall Study|Withdrawal by Subject|1
5257304|NCT00711594|18138273|P1|Overall Study|Withdrawal by Subject|0
5257305|NCT00711594|18138270|P4|Overall Study|Other Adverse Event|16
5257306|NCT00711594|18138271|P3|Overall Study|Other Adverse Event|0
5257307|NCT00711594|18138272|P2|Overall Study|Other Adverse Event|0
5257308|NCT00711594|18138273|P1|Overall Study|Other Adverse Event|1
5257309|NCT00711594|18138270|P4|Overall Study|Progressive disease|44
5257310|NCT00711594|18138271|P3|Overall Study|Progressive disease|6
5257311|NCT00711594|18138272|P2|Overall Study|Progressive disease|2
5257312|NCT00711594|18138273|P1|Overall Study|Progressive disease|2
5257313|NCT00711555|18138310|P1|Overall Study|Adverse Event|3
5257314|NCT00711529|18138319|P2|Overall Study|Withdrawal by Subject|6
5257315|NCT00711529|18138320|P1|Overall Study|Withdrawal by Subject|2
5257316|NCT00711529|18138319|P2|Overall Study|Protocol Violation|0
5257317|NCT00711529|18138320|P1|Overall Study|Protocol Violation|2
5257318|NCT00711516|18138344|P2|Overall Study|Protocol Violation|1
5257319|NCT00711516|18138345|P1|Overall Study|Protocol Violation|0
5257320|NCT00711516|18138344|P2|Overall Study|Withdrawal by Subject|1
5257321|NCT00711516|18138345|P1|Overall Study|Withdrawal by Subject|0
5257322|NCT00711516|18138344|P2|Overall Study|Adverse Event|1
5257323|NCT00711516|18138345|P1|Overall Study|Adverse Event|1
5257324|NCT00711477|18138452|P2|Overall Study|Noncompliance|1
5257325|NCT00711477|18138453|P1|Overall Study|Noncompliance|0
5257326|NCT00711477|18138452|P2|Overall Study|Lost to Follow-up|1
5257327|NCT00711477|18138453|P1|Overall Study|Lost to Follow-up|0
5257328|NCT00711477|18138452|P2|Overall Study|Adverse Event|1
5257329|NCT00711477|18138453|P1|Overall Study|Adverse Event|3
5257330|NCT00711425|18138499|P1|Overall Study|Lost to Follow-up|1
5257331|NCT00711425|18138499|P1|Overall Study|Death|2
5257332|NCT00711425|18138499|P1|Overall Study|Protocol Violation|1
5257333|NCT00711412|18138505|P1|Survival Follow up Until Death|Other|12
5257334|NCT00711412|18138505|P1|Evaluation for Response and Surgery|Death|1
5257335|NCT00711412|18138505|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
5257336|NCT00711412|18138505|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
5257337|NCT00711412|18138505|P1|Evaluation for Response and Surgery|Progressive Disease|2
5257338|NCT00711412|18138505|P1|Combination Treatment|Progressive Disease|1
5257339|NCT00711412|18138505|P1|Evaluated for Combination Treatment|Progressive disease|2
5257340|NCT00711412|18138505|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
5257341|NCT00711412|18138505|P1|Evaluated for Combination Treatment|Death|1
5257342|NCT00711412|18138505|P1|Evaluated for Combination Treatment|Adverse Event|2
5257343|NCT00711412|18138505|P1|Induction Treatment|Other|1
5257344|NCT00711412|18138505|P1|Induction Treatment|Adverse Event|1
5257345|NCT00711412|18138505|P1|Induction Treatment|Death|2
5257346|NCT00711243|18138583|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
5257347|NCT00711243|18138584|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5257348|NCT00711243|18138585|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5257349|NCT00711243|18138586|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5257350|NCT00711243|18138587|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5257351|NCT00711243|18138588|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5257352|NCT00711243|18138583|P6|Treated Cycle 5 After First Response|Decline in performance status|1
5257353|NCT00711243|18138584|P5|Treated Cycle 5 After First Response|Decline in performance status|0
5257354|NCT00711243|18138585|P4|Treated Cycle 5 After First Response|Decline in performance status|0
5257355|NCT00711243|18138586|P3|Treated Cycle 5 After First Response|Decline in performance status|0
5257356|NCT00711243|18138587|P2|Treated Cycle 5 After First Response|Decline in performance status|0
5257357|NCT00711243|18138588|P1|Treated Cycle 5 After First Response|Decline in performance status|0
5257358|NCT00711243|18138583|P6|Treated Cycle 5 After First Response|Death|2
5257359|NCT00711243|18138584|P5|Treated Cycle 5 After First Response|Death|0
5257360|NCT00711243|18138585|P4|Treated Cycle 5 After First Response|Death|0
5257361|NCT00711243|18138586|P3|Treated Cycle 5 After First Response|Death|0
5257362|NCT00711243|18138587|P2|Treated Cycle 5 After First Response|Death|0
5257363|NCT00711243|18138588|P1|Treated Cycle 5 After First Response|Death|0
5257364|NCT00711243|18138583|P6|Treated Cycle 5 After First Response|Progressive disease|1
5257365|NCT00711243|18138584|P5|Treated Cycle 5 After First Response|Progressive disease|1
5257366|NCT00711243|18138585|P4|Treated Cycle 5 After First Response|Progressive disease|0
5257367|NCT00711243|18138586|P3|Treated Cycle 5 After First Response|Progressive disease|0
5257368|NCT00711243|18138587|P2|Treated Cycle 5 After First Response|Progressive disease|2
5257369|NCT00711243|18138588|P1|Treated Cycle 5 After First Response|Progressive disease|1
5257370|NCT00711243|18138583|P6|Reached First Response/4 Cycles|Progressive disease|0
5257371|NCT00711243|18138584|P5|Reached First Response/4 Cycles|Progressive disease|0
5257372|NCT00711243|18138585|P4|Reached First Response/4 Cycles|Progressive disease|1
5257373|NCT00711243|18138586|P3|Reached First Response/4 Cycles|Progressive disease|0
5257374|NCT00711243|18138587|P2|Reached First Response/4 Cycles|Progressive disease|0
5257375|NCT00711243|18138588|P1|Reached First Response/4 Cycles|Progressive disease|0
5257376|NCT00711243|18138583|P6|Reached First Response/4 Cycles|Death|2
5257377|NCT00711243|18138584|P5|Reached First Response/4 Cycles|Death|0
5257378|NCT00711243|18138585|P4|Reached First Response/4 Cycles|Death|0
5257379|NCT00711243|18138586|P3|Reached First Response/4 Cycles|Death|0
5257380|NCT00711243|18138587|P2|Reached First Response/4 Cycles|Death|0
5257381|NCT00711243|18138588|P1|Reached First Response/4 Cycles|Death|0
5257382|NCT00711243|18138583|P6|Registed and Started Treatment|Withdrawal by Subject|1
5257383|NCT00711243|18138584|P5|Registed and Started Treatment|Withdrawal by Subject|0
5257384|NCT00711243|18138585|P4|Registed and Started Treatment|Withdrawal by Subject|0
5257385|NCT00711243|18138586|P3|Registed and Started Treatment|Withdrawal by Subject|0
5257386|NCT00711243|18138587|P2|Registed and Started Treatment|Withdrawal by Subject|0
5257387|NCT00711243|18138588|P1|Registed and Started Treatment|Withdrawal by Subject|0
5257388|NCT00711191|18138611|P3|Overall Study|Withdrawal by Subject|3
5257389|NCT00711191|18138612|P2|Overall Study|Withdrawal by Subject|1
5257390|NCT00711191|18138613|P1|Overall Study|Withdrawal by Subject|0
5257391|NCT00711191|18138611|P3|Overall Study|Objective progression or relapse|7
5257392|NCT00711191|18138612|P2|Overall Study|Objective progression or relapse|3
5257393|NCT00711191|18138613|P1|Overall Study|Objective progression or relapse|2
5257394|NCT00711191|18138611|P3|Overall Study|Adverse Event|2
5257395|NCT00711191|18138612|P2|Overall Study|Adverse Event|1
5257396|NCT00711191|18138613|P1|Overall Study|Adverse Event|1
5257397|NCT00711113|18138650|P1|Overall Study|Implant lost|2
5257398|NCT00711113|18138650|P1|Overall Study|Lost to Follow-up|9
5257399|NCT00711100|18138656|P1|Overall Study|Withdrawal by Subject|8
5257400|NCT00711100|18138656|P1|Overall Study|Lack of Efficacy|5
5257401|NCT00711087|18138674|P2|Overall Study|Lost to Follow-up|0
5257402|NCT00711087|18138675|P1|Overall Study|Lost to Follow-up|1
5257403|NCT00711009|18138687|P2|Overall Study|Dose adjustment|0
5257404|NCT00711009|18138688|P1|Overall Study|Dose adjustment|1
5257405|NCT00711009|18138687|P2|Overall Study|Site closing|1
5257406|NCT00711009|18138688|P1|Overall Study|Site closing|0
5257407|NCT00711009|18138687|P2|Overall Study|Pregnancy|0
5257408|NCT00711009|18138688|P1|Overall Study|Pregnancy|1
5257409|NCT00711009|18138687|P2|Overall Study|Virologic Failure|1
5257410|NCT00711009|18138688|P1|Overall Study|Virologic Failure|2
5257411|NCT00711009|18138687|P2|Overall Study|Participant Noncompliant|1
5257412|NCT00711009|18138688|P1|Overall Study|Participant Noncompliant|0
5257413|NCT00711009|18138687|P2|Overall Study|Lost to Follow-up|9
5257414|NCT00711009|18138688|P1|Overall Study|Lost to Follow-up|3
5257415|NCT00711009|18138687|P2|Overall Study|Withdrawal by Subject|2
5257416|NCT00711009|18138688|P1|Overall Study|Withdrawal by Subject|4
5257417|NCT00711009|18138687|P2|Overall Study|Adverse Event/HIV-Related Event|5
5257418|NCT00711009|18138688|P1|Overall Study|Adverse Event/HIV-Related Event|4
5257419|NCT00710970|18138869|P1|Overall Study|Never took drug|2
5257420|NCT00710970|18138869|P1|Overall Study|Lost to Follow-up|8
5257421|NCT00710879|18138896|P2|Overall Study|Protocol Violation|3
5257422|NCT00710879|18138897|P1|Overall Study|Protocol Violation|0
5257423|NCT00710879|18138896|P2|Overall Study|Lost to Follow-up|1
5257424|NCT00710879|18138897|P1|Overall Study|Lost to Follow-up|2
5257425|NCT00710866|18138909|P2|Overall Study|Failed to meet eligibility|1
5257426|NCT00710866|18138910|P1|Overall Study|Failed to meet eligibility|1
5257427|NCT00710866|18138909|P2|Overall Study|Lost to Follow-up|0
5257428|NCT00710866|18138910|P1|Overall Study|Lost to Follow-up|1
5257429|NCT00710866|18138909|P2|Overall Study|Withdrawal by Subject|1
5257430|NCT00710866|18138910|P1|Overall Study|Withdrawal by Subject|2
5257431|NCT00710866|18138909|P2|Overall Study|Protocol Violation|4
5257432|NCT00710866|18138910|P1|Overall Study|Protocol Violation|5
5257433|NCT00710762|18138956|P2|Overall Study|Reason other than listed above|2
5257434|NCT00710762|18138957|P1|Overall Study|Reason other than listed above|2
5257435|NCT00710762|18138956|P2|Overall Study|Lost to Follow-up|0
5257436|NCT00710762|18138957|P1|Overall Study|Lost to Follow-up|1
5257437|NCT00710762|18138956|P2|Overall Study|Other Adverse Event|7
5257438|NCT00710762|18138957|P1|Overall Study|Other Adverse Event|7
5257439|NCT00710762|18138956|P2|Overall Study|Adverse Event other disease worsening|1
5257440|NCT00710762|18138957|P1|Overall Study|Adverse Event other disease worsening|2
5257441|NCT00710762|18138956|P2|Overall Study|Progressive disease|30
5257442|NCT00710762|18138957|P1|Overall Study|Progressive disease|27
5257443|NCT00710749|18138973|P2|First Intervention|Withdrawal by Subject|0
5257444|NCT00710749|18138974|P1|First Intervention|Withdrawal by Subject|1
5257445|NCT00710684|18138985|P3|Overall Study|Did not continue after week 24|16
5257446|NCT00710684|18138986|P2|Overall Study|Did not continue after week 24|21
5257447|NCT00710684|18138987|P1|Overall Study|Did not continue after week 24|25
5257448|NCT00710684|18138985|P3|Overall Study|Missing|0
5257449|NCT00710684|18138986|P2|Overall Study|Missing|0
5257450|NCT00710684|18138987|P1|Overall Study|Missing|1
5257451|NCT00710684|18138985|P3|Overall Study|Withdrawal by Subject|11
5257452|NCT00710684|18138986|P2|Overall Study|Withdrawal by Subject|18
5257453|NCT00710684|18138987|P1|Overall Study|Withdrawal by Subject|24
5257454|NCT00710684|18138985|P3|Overall Study|Physician Decision|4
5257455|NCT00710684|18138986|P2|Overall Study|Physician Decision|2
5257456|NCT00710684|18138987|P1|Overall Study|Physician Decision|0
5257457|NCT00710684|18138985|P3|Overall Study|Lost to Follow-up|7
5257458|NCT00710684|18138986|P2|Overall Study|Lost to Follow-up|6
5257459|NCT00710684|18138987|P1|Overall Study|Lost to Follow-up|4
5257460|NCT00710684|18138985|P3|Overall Study|Protocol Violation|5
5257461|NCT00710684|18138986|P2|Overall Study|Protocol Violation|5
5257462|NCT00710684|18138987|P1|Overall Study|Protocol Violation|5
5257463|NCT00710684|18138985|P3|Overall Study|Lack of Efficacy|5
5257464|NCT00710684|18138986|P2|Overall Study|Lack of Efficacy|3
5257465|NCT00710684|18138987|P1|Overall Study|Lack of Efficacy|4
5257466|NCT00710684|18138985|P3|Overall Study|Adverse Event|16
5257467|NCT00710684|18138986|P2|Overall Study|Adverse Event|19
5257468|NCT00710684|18138987|P1|Overall Study|Adverse Event|11
5257469|NCT00710606|18139044|P2|Overall Study|Adverse Event|2
5257470|NCT00710606|18139045|P1|Overall Study|Adverse Event|0
5257471|NCT00710593|18139057|P2|Overall Study|Prem disc vaccine, completed all visits|2
5257472|NCT00710593|18139058|P1|Overall Study|Prem disc vaccine, completed all visits|6
5257473|NCT00710593|18139057|P2|Overall Study|Protocol Violation|1
5257474|NCT00710593|18139058|P1|Overall Study|Protocol Violation|1
5257475|NCT00710593|18139057|P2|Overall Study|Failure to adhere or complete study eval|1
5257476|NCT00710593|18139058|P1|Overall Study|Failure to adhere or complete study eval|1
5257477|NCT00710593|18139057|P2|Overall Study|Moved out of area|0
5257478|NCT00710593|18139058|P1|Overall Study|Moved out of area|1
5257479|NCT00710593|18139057|P2|Overall Study|Lost to Follow-up|1
5257480|NCT00710593|18139058|P1|Overall Study|Lost to Follow-up|3
5257481|NCT00710593|18139057|P2|Overall Study|Unable to complete Wk 48 within window|0
5257482|NCT00710593|18139058|P1|Overall Study|Unable to complete Wk 48 within window|2
5257483|NCT00710593|18139057|P2|Overall Study|Incarceration|0
5257484|NCT00710593|18139058|P1|Overall Study|Incarceration|1
5257485|NCT00710554|18139101|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
5257486|NCT00710554|18139102|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
5257487|NCT00710554|18139101|P2|Overall Study|Lack of Efficacy|12
5257488|NCT00710554|18139102|P1|Overall Study|Lack of Efficacy|11
5257489|NCT00710554|18139101|P2|Overall Study|Lost to Follow-up|1
5257490|NCT00710554|18139102|P1|Overall Study|Lost to Follow-up|7
5257491|NCT00710554|18139101|P2|Overall Study|Withdrawal by Subject|3
5257492|NCT00710554|18139102|P1|Overall Study|Withdrawal by Subject|7
5257493|NCT00710554|18139101|P2|Overall Study|Adverse Event|7
5257494|NCT00710554|18139102|P1|Overall Study|Adverse Event|24
5257495|NCT00710424|18139130|P2|Overall Study|Felt good so stopped treatment|1
5257496|NCT00710424|18139131|P1|Overall Study|Felt good so stopped treatment|0
5257497|NCT00710424|18139130|P2|Overall Study|Subject preferred paracetamol|1
5257498|NCT00710424|18139131|P1|Overall Study|Subject preferred paracetamol|0
5257499|NCT00710424|18139130|P2|Overall Study|Ceased treatment due to travel|0
5257500|NCT00710424|18139131|P1|Overall Study|Ceased treatment due to travel|1
5257501|NCT00710424|18139130|P2|Overall Study|Subject thought medication changed|0
5257502|NCT00710424|18139131|P1|Overall Study|Subject thought medication changed|1
5257503|NCT00710424|18139130|P2|Overall Study|Did not meet entry criteria at visit 1|0
5257504|NCT00710424|18139131|P1|Overall Study|Did not meet entry criteria at visit 1|1
5257505|NCT00710424|18139130|P2|Overall Study|Non-compliance with stable analgesia|0
5257506|NCT00710424|18139131|P1|Overall Study|Non-compliance with stable analgesia|1
5257507|NCT00710424|18139130|P2|Overall Study|Refused medication, no side effects|0
5257508|NCT00710424|18139131|P1|Overall Study|Refused medication, no side effects|1
5257509|NCT00710424|18139130|P2|Overall Study|Lost to Follow-up|1
5257510|NCT00710424|18139131|P1|Overall Study|Lost to Follow-up|0
5257511|NCT00710424|18139130|P2|Overall Study|Withdrawal by Subject|3
5257512|NCT00710424|18139131|P1|Overall Study|Withdrawal by Subject|5
5257513|NCT00710424|18139130|P2|Overall Study|Lack of Efficacy|5
5257514|NCT00710424|18139131|P1|Overall Study|Lack of Efficacy|4
5257515|NCT00710424|18139130|P2|Overall Study|Adverse Event|12
5257516|NCT00710424|18139131|P1|Overall Study|Adverse Event|30
5257517|NCT00710385|18139155|P1|Overall Study|Undisclosed excessive methadone use|1
5257518|NCT00710385|18139155|P1|Overall Study|Physician Decision|1
5257519|NCT00710385|18139155|P1|Overall Study|Undisclosed back pain|1
5257520|NCT00710385|18139155|P1|Overall Study|Withdrawal by Subject|1
5257521|NCT00710385|18139155|P1|Overall Study|Did not qualify|1
5257522|NCT00710034|18139200|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
5257523|NCT00710034|18139201|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
5257524|NCT00710034|18139200|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
5257525|NCT00710034|18139201|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
5257526|NCT00710034|18139200|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
5257527|NCT00710034|18139201|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
5257528|NCT00710034|18139200|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
5257529|NCT00710034|18139201|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
5257530|NCT00710034|18139200|P2|Completed 12 Weeks of Treatment|Adverse Event|1
5257531|NCT00710034|18139201|P1|Completed 12 Weeks of Treatment|Adverse Event|0
5257532|NCT00710034|18139200|P2|Completed 6 Weeks of Treatment|Physician Decision|0
5257533|NCT00710034|18139201|P1|Completed 6 Weeks of Treatment|Physician Decision|1
5257534|NCT00710034|18139200|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
5257535|NCT00710034|18139201|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
5257536|NCT00710034|18139200|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
5257537|NCT00710034|18139201|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
5257538|NCT00710034|18139200|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
5257539|NCT00710034|18139201|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
5257540|NCT00710034|18139200|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
5257541|NCT00710034|18139201|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
5257542|NCT00710034|18139200|P2|Completed 6 Weeks of Treatment|Adverse Event|12
5257543|NCT00710034|18139201|P1|Completed 6 Weeks of Treatment|Adverse Event|5
5257544|NCT00710021|18139218|P3|Overall Study|Physician Decision|0
5257545|NCT00710021|18139219|P2|Overall Study|Physician Decision|1
5257546|NCT00710021|18139220|P1|Overall Study|Physician Decision|0
5257547|NCT00710021|18139218|P3|Overall Study|Subject misrandomized|1
5257548|NCT00710021|18139219|P2|Overall Study|Subject misrandomized|1
5257549|NCT00710021|18139220|P1|Overall Study|Subject misrandomized|0
5257550|NCT00710021|18139218|P3|Overall Study|Subject's Decision|0
5257551|NCT00710021|18139219|P2|Overall Study|Subject's Decision|1
5257552|NCT00710021|18139220|P1|Overall Study|Subject's Decision|0
5257553|NCT00710021|18139218|P3|Overall Study|Lost to Follow-up|0
5257554|NCT00710021|18139219|P2|Overall Study|Lost to Follow-up|0
5257555|NCT00710021|18139220|P1|Overall Study|Lost to Follow-up|1
5257556|NCT00709995|18139335|P2|Overall Study|Withdrawal by Subject|3
5257557|NCT00709995|18139336|P1|Overall Study|Withdrawal by Subject|1
5257558|NCT00709995|18139335|P2|Overall Study|Adverse Event|2
5257559|NCT00709995|18139336|P1|Overall Study|Adverse Event|4
5257560|NCT00709956|18139354|P2|Overall Study|Inclusion/exclusion criteria violation|3
5257561|NCT00709956|18139355|P1|Overall Study|Inclusion/exclusion criteria violation|2
5257562|NCT00709956|18139354|P2|Overall Study|Withdrawal by Subject|1
5257563|NCT00709956|18139355|P1|Overall Study|Withdrawal by Subject|1
5257564|NCT00709852|18139385|P2|Period 2|No 72-hour follow-up|0
5257565|NCT00709852|18139386|P1|Period 2|No 72-hour follow-up|3
5257566|NCT00709852|18139385|P2|Period 2|Lost to Follow-up|0
5257567|NCT00709852|18139386|P1|Period 2|Lost to Follow-up|1
5257568|NCT00709852|18139385|P2|Period 2|Adverse Event|1
5257569|NCT00709852|18139386|P1|Period 2|Adverse Event|1
5257570|NCT00709852|18139385|P2|Period 2|Protocol Violation|1
5257571|NCT00709852|18139386|P1|Period 2|Protocol Violation|4
5257572|NCT00709852|18139385|P2|Period 1|Lost to Follow-up|0
5257573|NCT00709852|18139386|P1|Period 1|Lost to Follow-up|1
5257574|NCT00709852|18139385|P2|Period 1|Defective scanner|1
5257575|NCT00709852|18139386|P1|Period 1|Defective scanner|0
5257576|NCT00709852|18139385|P2|Period 1|Protocol Violation|0
5257577|NCT00709852|18139386|P1|Period 1|Protocol Violation|1
5257578|NCT00709852|18139385|P2|Period 1|Withdrawal by Subject|2
5257579|NCT00709852|18139386|P1|Period 1|Withdrawal by Subject|4
5257580|NCT00709852|18139385|P2|Period 1|Adverse Event|0
5257581|NCT00709852|18139386|P1|Period 1|Adverse Event|2
5257582|NCT00709761|18139550|P1|Overall Study|Lost to Follow-up|2
5257583|NCT00709761|18139550|P1|Overall Study|study closed/terminated|17
5257584|NCT00709761|18139550|P1|Overall Study|Withdrawal by Subject|8
5257585|NCT00709735|18139561|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
5257586|NCT00709735|18139562|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
5257587|NCT00709735|18139561|P2|Overall Study|Relapse into Opioid Abuse|1
5257588|NCT00709735|18139562|P1|Overall Study|Relapse into Opioid Abuse|0
5257589|NCT00709735|18139561|P2|Overall Study|Lost to Follow-up|1
5257590|NCT00709735|18139562|P1|Overall Study|Lost to Follow-up|1
5257591|NCT00709722|18139570|P1|Overall Study|Adverse Event|1
5257592|NCT00709618|18139585|P1|Overall Study|Study Closed/Terminated|25
5257593|NCT00709618|18139585|P1|Overall Study|Lost to Follow-up|1
5257594|NCT00709618|18139585|P1|Overall Study|Withdrawal by Subject|4
5257595|NCT00709592|18139597|P2|Overall Study|Unable to proceed to transplant|1
5257596|NCT00709592|18139598|P1|Overall Study|Unable to proceed to transplant|0
5257597|NCT00709319|18139620|P1|Overall Study|Withdrawal by Subject|2
5257598|NCT00709319|18139620|P1|Overall Study|Death|4
5257599|NCT00709228|18139649|P1|Overall Study|Non-compliance|5
5257600|NCT00709228|18139649|P1|Overall Study|Lost to Follow-up|6
5257601|NCT00709228|18139649|P1|Overall Study|Disease progression|1
5257602|NCT00709228|18139649|P1|Overall Study|Discontinued follow-up|5
5257603|NCT00709228|18139649|P1|Overall Study|Did not enter follow-up|4
5257604|NCT00709228|18139649|P1|Overall Study|Discontinued treatment|14
5257605|NCT00709228|18139649|P1|Overall Study|Adverse events|2
5257606|NCT00709228|18139649|P1|Overall Study|Eligibility criteria not met|281
5257607|NCT00709228|18139649|P1|Overall Study|Not treated|14
5257608|NCT00709202|18139655|P2|Overall Study|Withdrawal by Subject|6
5257609|NCT00709202|18139656|P1|Overall Study|Withdrawal by Subject|6
5257610|NCT00709124|18139684|P2|Overall Study|encephalopathy; can't do assessment|0
5257611|NCT00709124|18139685|P1|Overall Study|encephalopathy; can't do assessment|1
5257612|NCT00709124|18139684|P2|Overall Study|Death|1
5257613|NCT00709124|18139685|P1|Overall Study|Death|3
5257614|NCT00709111|18139719|P1|Overall Study|Unable to attend clinic visits|1
5257615|NCT00709111|18139719|P1|Overall Study|Withdrawal by Subject|1
5257616|NCT00709098|18139760|P3|Open-label Period|Lost to Follow-up|1
5257617|NCT00709098|18139761|P2|Open-label Period|Lost to Follow-up|0
5257618|NCT00709098|18139762|P1|Open-label Period|Lost to Follow-up|0
5257619|NCT00709098|18139760|P3|Open-label Period|Death|1
5257620|NCT00709098|18139761|P2|Open-label Period|Death|0
5257621|NCT00709098|18139762|P1|Open-label Period|Death|0
5257622|NCT00709098|18139760|P3|Open-label Period|Administrative reason|5
5257623|NCT00709098|18139761|P2|Open-label Period|Administrative reason|0
5257624|NCT00709098|18139762|P1|Open-label Period|Administrative reason|0
5257625|NCT00709098|18139760|P3|Open-label Period|Withdrawal of consent|7
5257626|NCT00709098|18139761|P2|Open-label Period|Withdrawal of consent|0
5257627|NCT00709098|18139762|P1|Open-label Period|Withdrawal of consent|0
5257628|NCT00709098|18139760|P3|Double-blind Period|Lost to Follow-up|0
5257629|NCT00709098|18139761|P2|Double-blind Period|Lost to Follow-up|1
5257630|NCT00709098|18139762|P1|Double-blind Period|Lost to Follow-up|1
5257631|NCT00709098|18139760|P3|Double-blind Period|Death|0
5257632|NCT00709098|18139761|P2|Double-blind Period|Death|1
5257633|NCT00709098|18139762|P1|Double-blind Period|Death|1
5257634|NCT00709098|18139760|P3|Double-blind Period|Administrative reason|0
5257635|NCT00709098|18139761|P2|Double-blind Period|Administrative reason|3
5257636|NCT00709098|18139762|P1|Double-blind Period|Administrative reason|1
5257637|NCT00709098|18139760|P3|Double-blind Period|Withdrawal of consent|0
5257638|NCT00709098|18139761|P2|Double-blind Period|Withdrawal of consent|3
5257639|NCT00709098|18139762|P1|Double-blind Period|Withdrawal of consent|3
5257640|NCT00709059|18139781|P1|Overall Study|Serious side effects|11
5257641|NCT00709059|18139781|P1|Overall Study|Side effects|20
5257642|NCT00709059|18139781|P1|Overall Study|Disease complication|3
5257643|NCT00709059|18139781|P1|Overall Study|Physician Decision|7
5257644|NCT00709059|18139781|P1|Overall Study|Withdrawal by Subject|19
5257645|NCT00709059|18139781|P1|Overall Study|Lost to Follow-up|34
5257646|NCT00708734|18139828|P1|Overall Study|leg fracture|1
5257647|NCT00708734|18139828|P1|Overall Study|vertigo|1
5257648|NCT00708734|18139828|P1|Overall Study|knee replacement|1
5257649|NCT00708734|18139828|P1|Overall Study|leg injury|1
5257650|NCT00708734|18139828|P1|Overall Study|moved|1
5257651|NCT00708734|18139828|P1|Overall Study|scheduling conflict|2
5257652|NCT00708708|18139848|P1|Overall Study|Missing values|392
5257653|NCT00708708|18139848|P1|Overall Study|Adverse Event|3
5257654|NCT00708708|18139848|P1|Overall Study|Pregnancy|3
5257655|NCT00708708|18139848|P1|Overall Study|Lack of compliance|3
5257656|NCT00708708|18139848|P1|Overall Study|Lack of effectiveness|4
5257657|NCT00708708|18139848|P1|Overall Study|Administrative reasons|7
5257658|NCT00708708|18139848|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
5257659|NCT00708708|18139848|P1|Overall Study|Good effectiveness|9
5257660|NCT00708708|18139848|P1|Overall Study|Other unspecified|11
5257661|NCT00708708|18139848|P1|Overall Study|Another therapy along with Enbrel|15
5257662|NCT00708708|18139848|P1|Overall Study|Intolerance|42
5257663|NCT00708708|18139848|P1|Overall Study|Withdrawal by Subject|51
5257664|NCT00708708|18139848|P1|Overall Study|Lost to Follow-up|52
5257665|NCT00708708|18139848|P1|Overall Study|Another therapy instead of Enbrel|141
5257666|NCT00708682|18139896|P1|Toddler Dose|Failed to Return|4
5257667|NCT00708682|18139896|P1|Toddler Dose|Lost to Follow-up|3
5257668|NCT00708682|18139896|P1|Toddler Dose|Parent/Legal Guardian Request|1
5257669|NCT00708682|18139896|P1|After Infant Series|Parent/Legal Guardian Request|1
5257670|NCT00708682|18139896|P1|Infant Series|Other|19
5257671|NCT00708682|18139896|P1|Infant Series|Failed to return|2
5257672|NCT00708682|18139896|P1|Infant Series|Parent/legal guardian request|6
5257673|NCT00708682|18139896|P1|Infant Series|Protocol Violation|1
5257674|NCT00708682|18139896|P1|Infant Series|Lost to Follow-up|4
5257675|NCT00708682|18139896|P1|Infant Series|Adverse Event|1
5257676|NCT00708643|18139917|P2|Overall Study|Adverse Event|1
5257677|NCT00708643|18139918|P1|Overall Study|Adverse Event|0
5257678|NCT00708552|18139938|P4|Overall Study|Withdrawal by Subject|10
5257679|NCT00708552|18139939|P3|Overall Study|Withdrawal by Subject|8
5257680|NCT00708552|18139940|P2|Overall Study|Withdrawal by Subject|7
5257681|NCT00708552|18139941|P1|Overall Study|Withdrawal by Subject|12
5257682|NCT00708552|18139938|P4|Overall Study|Physician Decision|0
5257683|NCT00708552|18139939|P3|Overall Study|Physician Decision|0
5257684|NCT00708552|18139940|P2|Overall Study|Physician Decision|2
5257685|NCT00708552|18139941|P1|Overall Study|Physician Decision|1
5257686|NCT00708552|18139938|P4|Overall Study|Lost to Follow-up|1
5257687|NCT00708552|18139939|P3|Overall Study|Lost to Follow-up|0
5257688|NCT00708552|18139940|P2|Overall Study|Lost to Follow-up|2
5257689|NCT00708552|18139941|P1|Overall Study|Lost to Follow-up|4
5257690|NCT00708552|18139938|P4|Overall Study|Protocol Violation|4
5257691|NCT00708552|18139939|P3|Overall Study|Protocol Violation|2
5257692|NCT00708552|18139940|P2|Overall Study|Protocol Violation|0
5257693|NCT00708552|18139941|P1|Overall Study|Protocol Violation|0
5257694|NCT00708552|18139938|P4|Overall Study|Lack of Efficacy|0
5257695|NCT00708552|18139939|P3|Overall Study|Lack of Efficacy|1
5257696|NCT00708552|18139940|P2|Overall Study|Lack of Efficacy|4
5257697|NCT00708552|18139941|P1|Overall Study|Lack of Efficacy|0
5257698|NCT00708552|18139938|P4|Overall Study|Adverse Event|6
5257699|NCT00708552|18139939|P3|Overall Study|Adverse Event|4
5257700|NCT00708552|18139940|P2|Overall Study|Adverse Event|3
5257701|NCT00708552|18139941|P1|Overall Study|Adverse Event|10
5257702|NCT00708500|18140103|P3|FOLLOWUP|Non-compliance with protocol|1
5257703|NCT00708500|18140104|P2|FOLLOWUP|Non-compliance with protocol|0
5257704|NCT00708500|18140105|P1|FOLLOWUP|Non-compliance with protocol|5
5257705|NCT00708500|18140103|P3|FOLLOWUP|Subject withdrew consent|5
5257706|NCT00708500|18140104|P2|FOLLOWUP|Subject withdrew consent|4
5257707|NCT00708500|18140105|P1|FOLLOWUP|Subject withdrew consent|31
5257708|NCT00708500|18140103|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
5257709|NCT00708500|18140104|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
5257710|NCT00708500|18140105|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
5257711|NCT00708500|18140103|P3|FOLLOWUP|Lost to Follow-up|4
5257712|NCT00708500|18140104|P2|FOLLOWUP|Lost to Follow-up|6
5257713|NCT00708500|18140105|P1|FOLLOWUP|Lost to Follow-up|1
5257714|NCT00708500|18140103|P3|FOLLOWUP|Adverse Event|0
5257715|NCT00708500|18140104|P2|FOLLOWUP|Adverse Event|1
5257716|NCT00708500|18140105|P1|FOLLOWUP|Adverse Event|0
5257717|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
5257718|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
5257719|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
5257720|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
5257721|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
5257722|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
5257723|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
5257724|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
5257725|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
5257726|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
5257727|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
5257728|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
5257729|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
5257730|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
5257731|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
5257732|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
5257733|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
5257734|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
5257735|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
5257736|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
5257737|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
5257738|NCT00708500|18140103|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
5257739|NCT00708500|18140104|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
5257740|NCT00708500|18140105|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
5257741|NCT00708500|18140103|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
5257742|NCT00708500|18140104|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
5257743|NCT00708500|18140105|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
5257744|NCT00708500|18140103|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
5257745|NCT00708500|18140104|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
5257746|NCT00708500|18140105|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
5257747|NCT00708500|18140103|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
5257748|NCT00708500|18140104|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
5257749|NCT00708500|18140105|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
5257750|NCT00708500|18140103|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
5257751|NCT00708500|18140104|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
5257752|NCT00708500|18140105|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
5257753|NCT00708500|18140103|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
5257754|NCT00708500|18140104|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
5257755|NCT00708500|18140105|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
5257756|NCT00708461|18140124|P2|Overall Study|left workforce|180
5257757|NCT00708461|18140125|P1|Overall Study|left workforce|115
5257758|NCT00708461|18140124|P2|Overall Study|Withdrawal by Subject|9
5257759|NCT00708461|18140125|P1|Overall Study|Withdrawal by Subject|8
5257760|NCT00708461|18140124|P2|Overall Study|Lost to Follow-up|11
5257761|NCT00708461|18140125|P1|Overall Study|Lost to Follow-up|18
5257762|NCT00708435|18140133|P2|Overall Study|Refused hospitalization|0
5257763|NCT00708435|18140134|P1|Overall Study|Refused hospitalization|1
5257764|NCT00708435|18140133|P2|Overall Study|Intervention by primary care physician|0
5257765|NCT00708435|18140134|P1|Overall Study|Intervention by primary care physician|1
5257766|NCT00708435|18140133|P2|Overall Study|Protocol Violation|1
5257767|NCT00708435|18140134|P1|Overall Study|Protocol Violation|0
5257768|NCT00708435|18140133|P2|Overall Study|Adverse Event|0
5257769|NCT00708435|18140134|P1|Overall Study|Adverse Event|1
5257770|NCT00708435|18140133|P2|Overall Study|Withdrawal by Subject|7
5257771|NCT00708435|18140134|P1|Overall Study|Withdrawal by Subject|3
5257772|NCT00708435|18140133|P2|Overall Study|Lost to Follow-up|4
5257773|NCT00708435|18140134|P1|Overall Study|Lost to Follow-up|9
5257774|NCT00708435|18140133|P2|Overall Study|Death / Serious Adverse Event|5
5257775|NCT00708435|18140134|P1|Overall Study|Death / Serious Adverse Event|10
5257776|NCT00708422|18140161|P2|Overall Study|Withdrawal by Subject|0
5257777|NCT00708422|18140162|P1|Overall Study|Withdrawal by Subject|1
5257778|NCT00708422|18140161|P2|Overall Study|Adverse Event|1
5257779|NCT00708422|18140162|P1|Overall Study|Adverse Event|3
5257780|NCT00708305|18140170|P4|Period 3|Other Reason|0
5257781|NCT00708305|18140171|P3|Period 3|Other Reason|0
5257782|NCT00708305|18140172|P2|Period 3|Other Reason|0
5257783|NCT00708305|18140173|P1|Period 3|Other Reason|1
5257784|NCT00708305|18140170|P4|Period 3|Protocol Violation|0
5257785|NCT00708305|18140171|P3|Period 3|Protocol Violation|0
5257786|NCT00708305|18140172|P2|Period 3|Protocol Violation|2
5257787|NCT00708305|18140173|P1|Period 3|Protocol Violation|0
5257788|NCT00708305|18140170|P4|Period 2|Other Reason|1
5257789|NCT00708305|18140171|P3|Period 2|Other Reason|0
5257790|NCT00708305|18140172|P2|Period 2|Other Reason|0
5257791|NCT00708305|18140173|P1|Period 2|Other Reason|1
5257792|NCT00708305|18140170|P4|Period 2|Protocol Violation|0
5257793|NCT00708305|18140171|P3|Period 2|Protocol Violation|0
5257794|NCT00708305|18140172|P2|Period 2|Protocol Violation|1
5257795|NCT00708305|18140173|P1|Period 2|Protocol Violation|0
5257796|NCT00708305|18140170|P4|Period 2|Lost to Follow-up|0
5257797|NCT00708305|18140171|P3|Period 2|Lost to Follow-up|0
5257798|NCT00708305|18140172|P2|Period 2|Lost to Follow-up|1
5257799|NCT00708305|18140173|P1|Period 2|Lost to Follow-up|0
5257800|NCT00708305|18140170|P4|Period 1|Other Reason|2
5257801|NCT00708305|18140171|P3|Period 1|Other Reason|0
5257802|NCT00708305|18140172|P2|Period 1|Other Reason|0
5257803|NCT00708305|18140173|P1|Period 1|Other Reason|0
5257804|NCT00708305|18140170|P4|Period 1|Protocol Violation|0
5257805|NCT00708305|18140171|P3|Period 1|Protocol Violation|1
5257806|NCT00708305|18140172|P2|Period 1|Protocol Violation|0
5257807|NCT00708305|18140173|P1|Period 1|Protocol Violation|1
5257808|NCT00708227|18140209|P4|Overall Study|Withdrawal by Subject|1
5257809|NCT00708227|18140210|P3|Overall Study|Withdrawal by Subject|0
5257810|NCT00708227|18140211|P2|Overall Study|Withdrawal by Subject|2
5257811|NCT00708227|18140212|P1|Overall Study|Withdrawal by Subject|1
5257812|NCT00708227|18140209|P4|Overall Study|Physician Decision|2
5257813|NCT00708227|18140210|P3|Overall Study|Physician Decision|1
5257814|NCT00708227|18140211|P2|Overall Study|Physician Decision|3
5257815|NCT00708227|18140212|P1|Overall Study|Physician Decision|0
5257816|NCT00708214|18140245|P3|Overall Study|Progressive Disease|5
5257817|NCT00708214|18140246|P2|Overall Study|Progressive Disease|6
5257818|NCT00708214|18140247|P1|Overall Study|Progressive Disease|4
5257819|NCT00708214|18140245|P3|Overall Study|Other|1
5257820|NCT00708214|18140246|P2|Overall Study|Other|1
5257821|NCT00708214|18140247|P1|Overall Study|Other|0
5257822|NCT00708214|18140245|P3|Overall Study|Other Adverse Event|2
5257823|NCT00708214|18140246|P2|Overall Study|Other Adverse Event|6
5257824|NCT00708214|18140247|P1|Overall Study|Other Adverse Event|3
5257825|NCT00708201|18140290|P2|Overall Study|Protocol Violation|1
5257826|NCT00708201|18140291|P1|Overall Study|Protocol Violation|0
5257827|NCT00708201|18140290|P2|Overall Study|Lost to Follow-up|0
5257828|NCT00708201|18140291|P1|Overall Study|Lost to Follow-up|2
5257829|NCT00708201|18140290|P2|Overall Study|Withdrawal by Subject|1
5257830|NCT00708201|18140291|P1|Overall Study|Withdrawal by Subject|1
5257831|NCT00708201|18140290|P2|Overall Study|Adverse Event|4
5257832|NCT00708201|18140291|P1|Overall Study|Adverse Event|4
5257833|NCT00708175|18140315|P2|Overall Study|BMD loss >7%|3
5257834|NCT00708175|18140316|P1|Overall Study|BMD loss >7%|2
5257835|NCT00708175|18140315|P2|Overall Study|Withdrawal by Subject|7
5257836|NCT00708175|18140316|P1|Overall Study|Withdrawal by Subject|5
5257837|NCT00708175|18140315|P2|Overall Study|Lost to Follow-up|3
5257838|NCT00708175|18140316|P1|Overall Study|Lost to Follow-up|5
5257839|NCT00708175|18140315|P2|Overall Study|Protocol Violation|3
5257840|NCT00708175|18140316|P1|Overall Study|Protocol Violation|2
5257841|NCT00708175|18140315|P2|Overall Study|Adverse Event|5
5257842|NCT00708175|18140316|P1|Overall Study|Adverse Event|4
5257843|NCT00708162|18140332|P2|Open-Label Phase|Other|0
5257844|NCT00708162|18140333|P1|Open-Label Phase|Other|1
5257845|NCT00708162|18140332|P2|Open-Label Phase|Adverse Event|2
5257846|NCT00708162|18140333|P1|Open-Label Phase|Adverse Event|1
5257847|NCT00708162|18140332|P2|Open-Label Phase|Death|1
5257848|NCT00708162|18140333|P1|Open-Label Phase|Death|3
5257849|NCT00708162|18140332|P2|Open-Label Phase|Investigator's Discretion|2
5257850|NCT00708162|18140333|P1|Open-Label Phase|Investigator's Discretion|3
5257851|NCT00708162|18140332|P2|Open-Label Phase|Lack of Efficacy|4
5257852|NCT00708162|18140333|P1|Open-Label Phase|Lack of Efficacy|7
5257853|NCT00708162|18140332|P2|Open-Label Phase|Participant Noncompliance|7
5257854|NCT00708162|18140333|P1|Open-Label Phase|Participant Noncompliance|7
5257855|NCT00708162|18140332|P2|Open-Label Phase|Withdrew Consent|6
5257856|NCT00708162|18140333|P1|Open-Label Phase|Withdrew Consent|12
5257857|NCT00708162|18140332|P2|Open-Label Phase|Lost to Follow-up|8
5257858|NCT00708162|18140333|P1|Open-Label Phase|Lost to Follow-up|10
5257859|NCT00708162|18140332|P2|Randomized Phase|Pregnancy|0
5257860|NCT00708162|18140333|P1|Randomized Phase|Pregnancy|3
5257861|NCT00708162|18140332|P2|Randomized Phase|Death|9
5257862|NCT00708162|18140333|P1|Randomized Phase|Death|2
5257863|NCT00708162|18140332|P2|Randomized Phase|Investigator's Discretion|10
5257864|NCT00708162|18140333|P1|Randomized Phase|Investigator's Discretion|7
5257865|NCT00708162|18140332|P2|Randomized Phase|Adverse Event|12
5257866|NCT00708162|18140333|P1|Randomized Phase|Adverse Event|8
5257867|NCT00708162|18140332|P2|Randomized Phase|Protocol Violation|11
5257868|NCT00708162|18140333|P1|Randomized Phase|Protocol Violation|10
5257869|NCT00708162|18140332|P2|Randomized Phase|Lack of Efficacy|19
5257870|NCT00708162|18140333|P1|Randomized Phase|Lack of Efficacy|14
5257871|NCT00708162|18140332|P2|Randomized Phase|Withdrew Consent|22
5257872|NCT00708162|18140333|P1|Randomized Phase|Withdrew Consent|31
5257873|NCT00708162|18140332|P2|Randomized Phase|Lost to Follow-up|34
5257874|NCT00708162|18140333|P1|Randomized Phase|Lost to Follow-up|34
5257875|NCT00708162|18140332|P2|Randomized Phase|Participant Noncompliance|32
5257876|NCT00708162|18140333|P1|Randomized Phase|Participant Noncompliance|40
5257877|NCT00708162|18140332|P2|Randomized Phase|Randomized but Not Treated|5
5257878|NCT00708162|18140333|P1|Randomized Phase|Randomized but Not Treated|7
5257879|NCT00708123|18140374|P5|Period 4|Protocol Violation|0
5257880|NCT00708123|18140375|P4|Period 4|Protocol Violation|0
5257881|NCT00708123|18140376|P3|Period 4|Protocol Violation|0
5257882|NCT00708123|18140377|P2|Period 4|Protocol Violation|1
5257883|NCT00708123|18140378|P1|Period 4|Protocol Violation|0
5257884|NCT00708123|18140374|P5|Period 3|Lost to Follow-up|0
5257885|NCT00708123|18140375|P4|Period 3|Lost to Follow-up|1
5257886|NCT00708123|18140376|P3|Period 3|Lost to Follow-up|1
5257887|NCT00708123|18140377|P2|Period 3|Lost to Follow-up|0
5257888|NCT00708123|18140378|P1|Period 3|Lost to Follow-up|0
5257889|NCT00708123|18140374|P5|Period 2|Other Reason|0
5257890|NCT00708123|18140375|P4|Period 2|Other Reason|0
5257891|NCT00708123|18140376|P3|Period 2|Other Reason|0
5257892|NCT00708123|18140377|P2|Period 2|Other Reason|0
5257893|NCT00708123|18140378|P1|Period 2|Other Reason|1
5257894|NCT00708123|18140374|P5|Period 2|Protocol Violation|0
5257895|NCT00708123|18140375|P4|Period 2|Protocol Violation|1
5257896|NCT00708123|18140376|P3|Period 2|Protocol Violation|0
5257897|NCT00708123|18140377|P2|Period 2|Protocol Violation|0
5257898|NCT00708123|18140378|P1|Period 2|Protocol Violation|0
5257899|NCT00708123|18140374|P5|Period 1|Adverse Event|0
5257900|NCT00708123|18140375|P4|Period 1|Adverse Event|0
5257901|NCT00708123|18140376|P3|Period 1|Adverse Event|1
5257902|NCT00708123|18140377|P2|Period 1|Adverse Event|0
5257903|NCT00708123|18140378|P1|Period 1|Adverse Event|0
5257904|NCT00708123|18140374|P5|Period 1|Protocol Violation|0
5257905|NCT00708123|18140375|P4|Period 1|Protocol Violation|1
5257906|NCT00708123|18140376|P3|Period 1|Protocol Violation|0
5257907|NCT00708123|18140377|P2|Period 1|Protocol Violation|1
5257908|NCT00708123|18140378|P1|Period 1|Protocol Violation|0
5257909|NCT00708097|18140511|P5|Period 2|Protocol Violation|0
5257910|NCT00708097|18140512|P4|Period 2|Protocol Violation|1
5257911|NCT00708097|18140513|P3|Period 2|Protocol Violation|1
5257912|NCT00708097|18140514|P2|Period 2|Protocol Violation|1
5257913|NCT00708097|18140515|P1|Period 2|Protocol Violation|0
5257914|NCT00708097|18140511|P5|Period 1|Other Reason|1
5257915|NCT00708097|18140512|P4|Period 1|Other Reason|0
5257916|NCT00708097|18140513|P3|Period 1|Other Reason|0
5257917|NCT00708097|18140514|P2|Period 1|Other Reason|0
5257918|NCT00708097|18140515|P1|Period 1|Other Reason|0
5257919|NCT00708097|18140511|P5|Period 1|Protocol Violation|0
5257920|NCT00708097|18140512|P4|Period 1|Protocol Violation|2
5257921|NCT00708097|18140513|P3|Period 1|Protocol Violation|0
5257922|NCT00708097|18140514|P2|Period 1|Protocol Violation|1
5257923|NCT00708097|18140515|P1|Period 1|Protocol Violation|0
5257924|NCT00708032|18140625|P2|Overall Study|Withdrawal by Subject|1
5257925|NCT00708032|18140626|P1|Overall Study|Withdrawal by Subject|0
5257926|NCT00708032|18140625|P2|Overall Study|Protocol Violation|1
5257927|NCT00708032|18140626|P1|Overall Study|Protocol Violation|4
5257928|NCT00708032|18140625|P2|Overall Study|Did not meet protocol criteria|2
5257929|NCT00708032|18140626|P1|Overall Study|Did not meet protocol criteria|1
5257930|NCT00708032|18140625|P2|Overall Study|Visit out of range at month 12|1
5257931|NCT00708032|18140626|P1|Overall Study|Visit out of range at month 12|4
5257932|NCT00708032|18140625|P2|Overall Study|Poor vision|6
5257933|NCT00708032|18140626|P1|Overall Study|Poor vision|0
5257934|NCT00708032|18140625|P2|Overall Study|Pregnancy|1
5257935|NCT00708032|18140626|P1|Overall Study|Pregnancy|0
5257936|NCT00708032|18140625|P2|Overall Study|Lost to Follow-up|2
5257937|NCT00708032|18140626|P1|Overall Study|Lost to Follow-up|1
5257938|NCT00708032|18140625|P2|Overall Study|Adverse Event|2
5257939|NCT00708032|18140626|P1|Overall Study|Adverse Event|0
5257940|NCT00707993|18140653|P2|Overall Study|Other|0
5257941|NCT00707993|18140654|P1|Overall Study|Other|2
5257942|NCT00707993|18140653|P2|Overall Study|Hyperglycemic Rescue|47
5257943|NCT00707993|18140654|P1|Overall Study|Hyperglycemic Rescue|55
5257944|NCT00707993|18140653|P2|Overall Study|Withdrawal by Subject|16
5257945|NCT00707993|18140654|P1|Overall Study|Withdrawal by Subject|12
5257946|NCT00707993|18140653|P2|Overall Study|Lost to Follow-up|4
5257947|NCT00707993|18140654|P1|Overall Study|Lost to Follow-up|0
5257948|NCT00707993|18140653|P2|Overall Study|Protocol Violation|7
5257949|NCT00707993|18140654|P1|Overall Study|Protocol Violation|4
5257950|NCT00707993|18140653|P2|Overall Study|Adverse Event|20
5257951|NCT00707993|18140654|P1|Overall Study|Adverse Event|16
5257952|NCT00707980|18140696|P1|Overall Study|Other|39
5257953|NCT00707980|18140696|P1|Overall Study|Lost to Follow-up|59
5257954|NCT00707980|18140696|P1|Overall Study|Withdrawal of Consent|81
5257955|NCT00707980|18140696|P1|Overall Study|Protocol Deviations|19
5257956|NCT00707980|18140696|P1|Overall Study|Non-Compliance with Study Drug|28
5257957|NCT00707980|18140696|P1|Overall Study|Lack of Efficacy|35
5257958|NCT00707980|18140696|P1|Overall Study|Adverse Event|49
5257959|NCT00707954|18140780|P5|Overall Study|Physician Decision|1
5257960|NCT00707954|18140781|P4|Overall Study|Physician Decision|0
5257961|NCT00707954|18140782|P3|Overall Study|Physician Decision|0
5257962|NCT00707954|18140783|P2|Overall Study|Physician Decision|0
5257963|NCT00707954|18140784|P1|Overall Study|Physician Decision|0
5257964|NCT00707746|18140825|P2|Treatment Period|Ineligibility|1
5257965|NCT00707746|18140826|P1|Treatment Period|Ineligibility|0
5257966|NCT00707746|18140825|P2|Treatment Period|Adverse Event|4
5257967|NCT00707746|18140826|P1|Treatment Period|Adverse Event|2
5257968|NCT00707577|18140887|P2|Overall Study|Pregnancy|1
5257969|NCT00707577|18140888|P1|Overall Study|Pregnancy|4
5257970|NCT00707577|18140887|P2|Overall Study|Left employment|10
5257971|NCT00707577|18140888|P1|Overall Study|Left employment|13
5257972|NCT00707577|18140887|P2|Overall Study|Lost to Follow-up|25
5257973|NCT00707577|18140888|P1|Overall Study|Lost to Follow-up|34
5257974|NCT00707577|18140887|P2|Overall Study|Withdrawal by Subject|2
5257975|NCT00707577|18140888|P1|Overall Study|Withdrawal by Subject|3
5257976|NCT00707486|18140894|P1|Overall Study|Withdrawal by Subject|1
5257977|NCT00707434|18140930|P1|Overall Study|Adverse Event|1
5257978|NCT00707239|18140941|P3|Overall Study|Other|5
5257979|NCT00707239|18140942|P2|Overall Study|Other|3
5257980|NCT00707239|18140943|P1|Overall Study|Other|8
5257981|NCT00707239|18140941|P3|Overall Study|Randomized, but not treated|1
5257982|NCT00707239|18140942|P2|Overall Study|Randomized, but not treated|1
5257983|NCT00707239|18140943|P1|Overall Study|Randomized, but not treated|1
5257984|NCT00707239|18140941|P3|Overall Study|Lack of Efficacy|0
5257985|NCT00707239|18140942|P2|Overall Study|Lack of Efficacy|2
5257986|NCT00707239|18140943|P1|Overall Study|Lack of Efficacy|1
5257987|NCT00707239|18140941|P3|Overall Study|Protocol Violation|1
5257988|NCT00707239|18140942|P2|Overall Study|Protocol Violation|0
5257989|NCT00707239|18140943|P1|Overall Study|Protocol Violation|0
5257990|NCT00707239|18140941|P3|Overall Study|Physician Decision|2
5257991|NCT00707239|18140942|P2|Overall Study|Physician Decision|1
5257992|NCT00707239|18140943|P1|Overall Study|Physician Decision|1
5257993|NCT00707239|18140941|P3|Overall Study|Death|3
5257994|NCT00707239|18140942|P2|Overall Study|Death|1
5257995|NCT00707239|18140943|P1|Overall Study|Death|3
5257996|NCT00707239|18140941|P3|Overall Study|Adverse Event|2
5257997|NCT00707239|18140942|P2|Overall Study|Adverse Event|3
5257998|NCT00707239|18140943|P1|Overall Study|Adverse Event|5
5257999|NCT00707174|18140991|P2|Overall Study|Withdrawal by Subject|1
5258000|NCT00707174|18140992|P1|Overall Study|Withdrawal by Subject|4
5258001|NCT00707174|18140991|P2|Overall Study|Adverse Event|6
5258002|NCT00707174|18140992|P1|Overall Study|Adverse Event|1
5258003|NCT00707161|18140998|P1|Overall Study|Physician Decision|6
5258004|NCT00707057|18141004|P2|Overall Study|Dosed incorrectly|1
5258005|NCT00707057|18141005|P1|Overall Study|Dosed incorrectly|0
5258006|NCT00707057|18141004|P2|Overall Study|Withdrawal by Subject|3
5258007|NCT00707057|18141005|P1|Overall Study|Withdrawal by Subject|8
5258008|NCT00707031|18141039|P2|Overall Study|Sponsor Decision|8
5258009|NCT00707031|18141040|P1|Overall Study|Sponsor Decision|9
5258010|NCT00707031|18141039|P2|Overall Study|Serious Noncompliance|3
5258011|NCT00707031|18141040|P1|Overall Study|Serious Noncompliance|2
5258012|NCT00707031|18141039|P2|Overall Study|Familial or Personal Reasons|15
5258013|NCT00707031|18141040|P1|Overall Study|Familial or Personal Reasons|12
5258014|NCT00707031|18141039|P2|Overall Study|Poor Compliance to Protocol|13
5258015|NCT00707031|18141040|P1|Overall Study|Poor Compliance to Protocol|7
5258016|NCT00707031|18141039|P2|Overall Study|Withdrawal by Subject|8
5258017|NCT00707031|18141040|P1|Overall Study|Withdrawal by Subject|7
5258018|NCT00707031|18141039|P2|Overall Study|Protocol Violation|0
5258019|NCT00707031|18141040|P1|Overall Study|Protocol Violation|1
5258020|NCT00707031|18141039|P2|Overall Study|Lost to Follow-up|1
5258021|NCT00707031|18141040|P1|Overall Study|Lost to Follow-up|2
5258022|NCT00707031|18141039|P2|Overall Study|Lack of Efficacy|6
5258023|NCT00707031|18141040|P1|Overall Study|Lack of Efficacy|19
5258024|NCT00707031|18141039|P2|Overall Study|Adverse Event|45
5258025|NCT00707031|18141040|P1|Overall Study|Adverse Event|45
5258026|NCT00706992|18141069|P7|Overall Study|Disease progression before treatment|0
5258027|NCT00706992|18141070|P6|Overall Study|Disease progression before treatment|0
5258028|NCT00706992|18141071|P5|Overall Study|Disease progression before treatment|1
5258029|NCT00706992|18141072|P4|Overall Study|Disease progression before treatment|0
5258030|NCT00706992|18141073|P3|Overall Study|Disease progression before treatment|0
5258031|NCT00706992|18141074|P2|Overall Study|Disease progression before treatment|0
5258032|NCT00706992|18141075|P1|Overall Study|Disease progression before treatment|0
5258033|NCT00706992|18141069|P7|Overall Study|Study termination|3
5258034|NCT00706992|18141070|P6|Overall Study|Study termination|2
5258035|NCT00706992|18141071|P5|Overall Study|Study termination|3
5258036|NCT00706992|18141072|P4|Overall Study|Study termination|2
5258037|NCT00706992|18141073|P3|Overall Study|Study termination|6
5258038|NCT00706992|18141074|P2|Overall Study|Study termination|5
5258039|NCT00706992|18141075|P1|Overall Study|Study termination|5
5258040|NCT00706966|18141107|P1|Overall Study|Adverse Event|1
5258041|NCT00706914|18141143|P3|Overall Study|Protocol Violation|1
5258042|NCT00706914|18141144|P2|Overall Study|Protocol Violation|1
5258043|NCT00706914|18141145|P1|Overall Study|Protocol Violation|3
5258044|NCT00706914|18141143|P3|Overall Study|Adverse Event|0
5258045|NCT00706914|18141144|P2|Overall Study|Adverse Event|2
5258046|NCT00706914|18141145|P1|Overall Study|Adverse Event|2
5258047|NCT00706914|18141143|P3|Overall Study|Lost to Follow-up|0
5258048|NCT00706914|18141144|P2|Overall Study|Lost to Follow-up|0
5258049|NCT00706914|18141145|P1|Overall Study|Lost to Follow-up|1
5258050|NCT00706914|18141143|P3|Overall Study|Lack of Efficacy|0
5258051|NCT00706914|18141144|P2|Overall Study|Lack of Efficacy|1
5258052|NCT00706914|18141145|P1|Overall Study|Lack of Efficacy|0
5258053|NCT00706901|18141168|P3|Overall Study|Death|0
5258054|NCT00706901|18141169|P2|Overall Study|Death|0
5258055|NCT00706901|18141170|P1|Overall Study|Death|1
5258056|NCT00706901|18141168|P3|Overall Study|In Jail|1
5258057|NCT00706901|18141169|P2|Overall Study|In Jail|0
5258058|NCT00706901|18141170|P1|Overall Study|In Jail|1
5258059|NCT00706901|18141168|P3|Overall Study|Withdrawal by Subject|5
5258060|NCT00706901|18141169|P2|Overall Study|Withdrawal by Subject|2
5258061|NCT00706901|18141170|P1|Overall Study|Withdrawal by Subject|4
5258062|NCT00706901|18141168|P3|Overall Study|Lost to Follow-up|2
5258063|NCT00706901|18141169|P2|Overall Study|Lost to Follow-up|3
5258064|NCT00706901|18141170|P1|Overall Study|Lost to Follow-up|2
5258065|NCT00706849|18141195|P2|Follow-up Period|Protocol non-compliance|1
5258066|NCT00706849|18141196|P1|Follow-up Period|Protocol non-compliance|0
5258067|NCT00706849|18141195|P2|Follow-up Period|Withdrawal by Subject|2
5258068|NCT00706849|18141196|P1|Follow-up Period|Withdrawal by Subject|0
5258069|NCT00706849|18141195|P2|Treatment Period|Other|1
5258070|NCT00706849|18141196|P1|Treatment Period|Other|0
5258071|NCT00706849|18141195|P2|Treatment Period|Adverse Event|9
5258072|NCT00706849|18141196|P1|Treatment Period|Adverse Event|0
5258073|NCT00706797|18141274|P2|Overall Study|Other|0
5258074|NCT00706797|18141275|P1|Overall Study|Other|1
5258075|NCT00706797|18141274|P2|Overall Study|Lost to Follow-up|2
5258076|NCT00706797|18141275|P1|Overall Study|Lost to Follow-up|1
5258077|NCT00706797|18141274|P2|Overall Study|Protocol Violation|2
5258078|NCT00706797|18141275|P1|Overall Study|Protocol Violation|3
5258079|NCT00706797|18141274|P2|Overall Study|Discontinuation of study by sponsor|63
5258080|NCT00706797|18141275|P1|Overall Study|Discontinuation of study by sponsor|52
5258081|NCT00706797|18141274|P2|Overall Study|Death|0
5258082|NCT00706797|18141275|P1|Overall Study|Death|1
5258083|NCT00706797|18141274|P2|Overall Study|Withdrawal by Subject|1
5258084|NCT00706797|18141275|P1|Overall Study|Withdrawal by Subject|8
5258085|NCT00706797|18141274|P2|Overall Study|Adverse Event|3
5258086|NCT00706797|18141275|P1|Overall Study|Adverse Event|0
5258087|NCT00706797|18141274|P2|Overall Study|Lack of Efficacy|0
5258088|NCT00706797|18141275|P1|Overall Study|Lack of Efficacy|3
5258089|NCT00706706|18141344|P1|Overall Study|Study endpoint had reached|45
5258090|NCT00706706|18141344|P1|Overall Study|Lost to Follow-up|7
5258091|NCT00706706|18141344|P1|Overall Study|Death|53
5258092|NCT00706654|18141354|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
5258093|NCT00706654|18141355|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
5258094|NCT00706654|18141356|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
5258095|NCT00706654|18141357|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
5258096|NCT00706654|18141354|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
5258097|NCT00706654|18141355|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
5258098|NCT00706654|18141356|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
5258099|NCT00706654|18141357|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
5258100|NCT00706654|18141354|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
5258101|NCT00706654|18141355|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
5258102|NCT00706654|18141356|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
5258103|NCT00706654|18141357|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
5258104|NCT00706654|18141354|P4|Depot Maintenance Phase|Protocol Deviation|1
5258105|NCT00706654|18141355|P3|Depot Maintenance Phase|Protocol Deviation|3
5258106|NCT00706654|18141356|P2|Depot Maintenance Phase|Protocol Deviation|2
5258107|NCT00706654|18141357|P1|Depot Maintenance Phase|Protocol Deviation|0
5258108|NCT00706654|18141354|P4|Depot Maintenance Phase|Withdrew Consent|14
5258109|NCT00706654|18141355|P3|Depot Maintenance Phase|Withdrew Consent|29
5258110|NCT00706654|18141356|P2|Depot Maintenance Phase|Withdrew Consent|21
5258111|NCT00706654|18141357|P1|Depot Maintenance Phase|Withdrew Consent|0
5258112|NCT00706654|18141354|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
5258113|NCT00706654|18141355|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
5258114|NCT00706654|18141356|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
5258115|NCT00706654|18141357|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
5258116|NCT00706654|18141354|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
5258117|NCT00706654|18141355|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
5258118|NCT00706654|18141356|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
5258119|NCT00706654|18141357|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
5258120|NCT00706654|18141354|P4|Depot Maintenance Phase|Lost to Follow-up|6
5258121|NCT00706654|18141355|P3|Depot Maintenance Phase|Lost to Follow-up|10
5258122|NCT00706654|18141356|P2|Depot Maintenance Phase|Lost to Follow-up|4
5258123|NCT00706654|18141357|P1|Depot Maintenance Phase|Lost to Follow-up|0
5258124|NCT00706654|18141354|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258125|NCT00706654|18141355|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258126|NCT00706654|18141356|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258127|NCT00706654|18141357|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
5258128|NCT00706654|18141354|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258129|NCT00706654|18141355|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258130|NCT00706654|18141356|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258131|NCT00706654|18141357|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
5258132|NCT00706654|18141354|P4|Oral Stabilization Phase|Adverse Event|0
5258133|NCT00706654|18141355|P3|Oral Stabilization Phase|Adverse Event|0
5258134|NCT00706654|18141356|P2|Oral Stabilization Phase|Adverse Event|0
5258135|NCT00706654|18141357|P1|Oral Stabilization Phase|Adverse Event|21
5258136|NCT00706654|18141354|P4|Oral Stabilization Phase|Protocol Deviation|0
5258137|NCT00706654|18141355|P3|Oral Stabilization Phase|Protocol Deviation|0
5258138|NCT00706654|18141356|P2|Oral Stabilization Phase|Protocol Deviation|0
5258139|NCT00706654|18141357|P1|Oral Stabilization Phase|Protocol Deviation|2
5258140|NCT00706654|18141354|P4|Oral Stabilization Phase|Withdrew consent|0
5258141|NCT00706654|18141355|P3|Oral Stabilization Phase|Withdrew consent|0
5258142|NCT00706654|18141356|P2|Oral Stabilization Phase|Withdrew consent|0
5258143|NCT00706654|18141357|P1|Oral Stabilization Phase|Withdrew consent|55
5258144|NCT00706654|18141354|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
5258145|NCT00706654|18141355|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
5258146|NCT00706654|18141356|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
5258147|NCT00706654|18141357|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
5258148|NCT00706654|18141354|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
5258149|NCT00706654|18141355|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
5258150|NCT00706654|18141356|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
5258151|NCT00706654|18141357|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
5258152|NCT00706654|18141354|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
5258153|NCT00706654|18141355|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
5258154|NCT00706654|18141356|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
5258155|NCT00706654|18141357|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
5258156|NCT00706654|18141354|P4|Oral Stabilization Phase|Lost to Follow-up|0
5258157|NCT00706654|18141355|P3|Oral Stabilization Phase|Lost to Follow-up|0
5258158|NCT00706654|18141356|P2|Oral Stabilization Phase|Lost to Follow-up|0
5258159|NCT00706654|18141357|P1|Oral Stabilization Phase|Lost to Follow-up|17
5258160|NCT00706654|18141354|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
5258161|NCT00706654|18141355|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
5258162|NCT00706654|18141356|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
5258163|NCT00706654|18141357|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
5258164|NCT00706654|18141354|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
5258165|NCT00706654|18141355|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
5258166|NCT00706654|18141356|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
5258167|NCT00706654|18141357|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
5258168|NCT00706654|18141354|P4|Conversion Phase|Adverse Event|0
5258169|NCT00706654|18141355|P3|Conversion Phase|Adverse Event|0
5258170|NCT00706654|18141356|P2|Conversion Phase|Adverse Event|0
5258171|NCT00706654|18141357|P1|Conversion Phase|Adverse Event|18
5258172|NCT00706654|18141354|P4|Conversion Phase|Withdrew Consent|0
5258173|NCT00706654|18141355|P3|Conversion Phase|Withdrew Consent|0
5258174|NCT00706654|18141356|P2|Conversion Phase|Withdrew Consent|0
5258175|NCT00706654|18141357|P1|Conversion Phase|Withdrew Consent|38
5258176|NCT00706654|18141354|P4|Conversion Phase|Withdrawn by Investigator|0
5258177|NCT00706654|18141355|P3|Conversion Phase|Withdrawn by Investigator|0
5258178|NCT00706654|18141356|P2|Conversion Phase|Withdrawn by Investigator|0
5258179|NCT00706654|18141357|P1|Conversion Phase|Withdrawn by Investigator|14
5258180|NCT00706654|18141354|P4|Conversion Phase|Met Withdrawal Criteria|0
5258181|NCT00706654|18141355|P3|Conversion Phase|Met Withdrawal Criteria|0
5258182|NCT00706654|18141356|P2|Conversion Phase|Met Withdrawal Criteria|0
5258183|NCT00706654|18141357|P1|Conversion Phase|Met Withdrawal Criteria|2
5258184|NCT00706654|18141354|P4|Conversion Phase|Sponsor Discontinued Trial|0
5258185|NCT00706654|18141355|P3|Conversion Phase|Sponsor Discontinued Trial|0
5258186|NCT00706654|18141356|P2|Conversion Phase|Sponsor Discontinued Trial|0
5258187|NCT00706654|18141357|P1|Conversion Phase|Sponsor Discontinued Trial|8
5258188|NCT00706654|18141354|P4|Conversion Phase|Lost to Follow-up|0
5258189|NCT00706654|18141355|P3|Conversion Phase|Lost to Follow-up|0
5258190|NCT00706654|18141356|P2|Conversion Phase|Lost to Follow-up|0
5258191|NCT00706654|18141357|P1|Conversion Phase|Lost to Follow-up|4
5258192|NCT00706641|18141376|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
5258193|NCT00706641|18141376|P1|Dasatinib Administration|Ineligible after start of therapy|1
5258194|NCT00706641|18141376|P1|Dasatinib Administration|Withdrawal by Subject|1
5258195|NCT00706628|18141390|P4|Overall Study|Not treated|0
5258196|NCT00706628|18141391|P3|Overall Study|Not treated|0
5258197|NCT00706628|18141392|P2|Overall Study|Not treated|1
5258198|NCT00706628|18141393|P1|Overall Study|Not treated|1
5258199|NCT00706628|18141390|P4|Overall Study|Other than those stated above|0
5258200|NCT00706628|18141391|P3|Overall Study|Other than those stated above|0
5258201|NCT00706628|18141392|P2|Overall Study|Other than those stated above|0
5258202|NCT00706628|18141393|P1|Overall Study|Other than those stated above|4
5258203|NCT00706628|18141390|P4|Overall Study|Progressive disease|1
5258204|NCT00706628|18141391|P3|Overall Study|Progressive disease|8
5258205|NCT00706628|18141392|P2|Overall Study|Progressive disease|13
5258206|NCT00706628|18141393|P1|Overall Study|Progressive disease|20
5258207|NCT00706628|18141390|P4|Overall Study|Consent withdrawn|0
5258208|NCT00706628|18141391|P3|Overall Study|Consent withdrawn|3
5258209|NCT00706628|18141392|P2|Overall Study|Consent withdrawn|1
5258210|NCT00706628|18141393|P1|Overall Study|Consent withdrawn|6
5258211|NCT00706628|18141390|P4|Overall Study|Non compliant with protocol|0
5258212|NCT00706628|18141391|P3|Overall Study|Non compliant with protocol|0
5258213|NCT00706628|18141392|P2|Overall Study|Non compliant with protocol|1
5258214|NCT00706628|18141393|P1|Overall Study|Non compliant with protocol|0
5258215|NCT00706628|18141390|P4|Overall Study|Other Adverse Event|2
5258216|NCT00706628|18141391|P3|Overall Study|Other Adverse Event|5
5258217|NCT00706628|18141392|P2|Overall Study|Other Adverse Event|5
5258218|NCT00706628|18141393|P1|Overall Study|Other Adverse Event|16
5258219|NCT00706511|18141498|P4|Overall Study|Withdrawal by Subject|0
5258220|NCT00706511|18141499|P3|Overall Study|Withdrawal by Subject|0
5258221|NCT00706511|18141500|P2|Overall Study|Withdrawal by Subject|0
5258222|NCT00706511|18141501|P1|Overall Study|Withdrawal by Subject|1
5258223|NCT00706433|18141592|P4|Overall Study|new job|1
5258224|NCT00706433|18141593|P3|Overall Study|new job|0
5258225|NCT00706433|18141594|P2|Overall Study|new job|0
5258226|NCT00706433|18141595|P1|Overall Study|new job|0
5258227|NCT00706433|18141592|P4|Overall Study|Protocol Violation|0
5258228|NCT00706433|18141593|P3|Overall Study|Protocol Violation|0
5258229|NCT00706433|18141594|P2|Overall Study|Protocol Violation|0
5258230|NCT00706433|18141595|P1|Overall Study|Protocol Violation|1
5258231|NCT00706433|18141592|P4|Overall Study|Adverse Event|0
5258232|NCT00706433|18141593|P3|Overall Study|Adverse Event|1
5258233|NCT00706433|18141594|P2|Overall Study|Adverse Event|0
5258234|NCT00706433|18141595|P1|Overall Study|Adverse Event|0
5258235|NCT00706433|18141592|P4|Overall Study|Withdrawal by Subject|1
5258236|NCT00706433|18141593|P3|Overall Study|Withdrawal by Subject|3
5258237|NCT00706433|18141594|P2|Overall Study|Withdrawal by Subject|2
5258238|NCT00706433|18141595|P1|Overall Study|Withdrawal by Subject|1
5258239|NCT00706433|18141592|P4|Overall Study|Lost to Follow-up|0
5258240|NCT00706433|18141593|P3|Overall Study|Lost to Follow-up|6
5258241|NCT00706433|18141594|P2|Overall Study|Lost to Follow-up|1
5258242|NCT00706433|18141595|P1|Overall Study|Lost to Follow-up|3
5258243|NCT00706381|18141922|P4|Overall Study|Lost to Follow-up|0
5258244|NCT00706381|18141923|P3|Overall Study|Lost to Follow-up|1
5258245|NCT00706381|18141924|P2|Overall Study|Lost to Follow-up|1
5258246|NCT00706381|18141925|P1|Overall Study|Lost to Follow-up|0
5258247|NCT00706355|18141946|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
5258248|NCT00706355|18141947|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
5258249|NCT00706355|18141948|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
5258250|NCT00706355|18141949|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
5258251|NCT00706355|18141946|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
5258252|NCT00706355|18141947|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
5258253|NCT00706355|18141948|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
5258254|NCT00706355|18141949|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
5258255|NCT00706355|18141946|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
5258256|NCT00706355|18141947|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
5258257|NCT00706355|18141948|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
5258258|NCT00706355|18141949|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
5258259|NCT00706355|18141946|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
5258260|NCT00706355|18141947|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
5258261|NCT00706355|18141948|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
5258262|NCT00706355|18141949|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
5258263|NCT00706355|18141946|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
5258264|NCT00706355|18141947|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
5258265|NCT00706355|18141948|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
5258266|NCT00706355|18141949|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
5258267|NCT00706355|18141946|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
5258268|NCT00706355|18141947|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
5258269|NCT00706355|18141948|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
5258270|NCT00706355|18141949|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
5258271|NCT00706355|18141946|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
5258272|NCT00706355|18141947|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
5258273|NCT00706355|18141948|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
5258274|NCT00706355|18141949|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
5258275|NCT00706355|18141946|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
5258276|NCT00706355|18141947|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
5258277|NCT00706355|18141948|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
5258278|NCT00706355|18141949|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
5258279|NCT00706355|18141946|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
5258280|NCT00706355|18141947|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
5258281|NCT00706355|18141948|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
5258282|NCT00706355|18141949|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
5258283|NCT00706342|18142001|P1|Overall Study|WIthdrawal of consent|1
5258284|NCT00706342|18142001|P1|Overall Study|Ongoing|6
5258285|NCT00706342|18142001|P1|Overall Study|Non-responder Week 12|1
5258286|NCT00706342|18142001|P1|Overall Study|Investigator discretion|2
5258287|NCT00706342|18142001|P1|Overall Study|Withdrew from the study on his own.|1
5258288|NCT00706342|18142001|P1|Overall Study|Death|1
5258289|NCT00706342|18142001|P1|Overall Study|Withdrawn due to failure to respond|1
5258290|NCT00706342|18142001|P1|Overall Study|Not responding to treatment|2
5258291|NCT00706342|18142001|P1|Overall Study|Adverse Event|3
5258292|NCT00706238|18142014|P1|Overall Study|Other|1
5258293|NCT00706238|18142014|P1|Overall Study|Disease progression|4
5258294|NCT00706134|18142031|P4|Overall Study|Did not meet study criteria|0
5258295|NCT00706134|18142032|P3|Overall Study|Did not meet study criteria|0
5258296|NCT00706134|18142033|P2|Overall Study|Did not meet study criteria|0
5258297|NCT00706134|18142034|P1|Overall Study|Did not meet study criteria|2
5258298|NCT00706134|18142031|P4|Overall Study|Unsatisfactory therapeutic effect|5
5258299|NCT00706134|18142032|P3|Overall Study|Unsatisfactory therapeutic effect|3
5258300|NCT00706134|18142033|P2|Overall Study|Unsatisfactory therapeutic effect|3
5258301|NCT00706134|18142034|P1|Overall Study|Unsatisfactory therapeutic effect|9
5258302|NCT00706134|18142031|P4|Overall Study|Withdrawal by Subject|0
5258303|NCT00706134|18142032|P3|Overall Study|Withdrawal by Subject|1
5258304|NCT00706134|18142033|P2|Overall Study|Withdrawal by Subject|2
5258305|NCT00706134|18142034|P1|Overall Study|Withdrawal by Subject|1
5258306|NCT00706134|18142031|P4|Overall Study|Protocol Violation|3
5258307|NCT00706134|18142032|P3|Overall Study|Protocol Violation|0
5258308|NCT00706134|18142033|P2|Overall Study|Protocol Violation|6
5258309|NCT00706134|18142034|P1|Overall Study|Protocol Violation|0
5258310|NCT00706134|18142031|P4|Overall Study|Lost to Follow-up|0
5258311|NCT00706134|18142032|P3|Overall Study|Lost to Follow-up|0
5258312|NCT00706134|18142033|P2|Overall Study|Lost to Follow-up|1
5258313|NCT00706134|18142034|P1|Overall Study|Lost to Follow-up|0
5258314|NCT00706134|18142031|P4|Overall Study|Adverse Event|3
5258315|NCT00706134|18142032|P3|Overall Study|Adverse Event|2
5258316|NCT00706134|18142033|P2|Overall Study|Adverse Event|7
5258317|NCT00706134|18142034|P1|Overall Study|Adverse Event|8
5258318|NCT00706095|18142100|P3|Overall Study|Withdrawal by Subject|0
5258319|NCT00706095|18142101|P2|Overall Study|Withdrawal by Subject|0
5258320|NCT00706095|18142102|P1|Overall Study|Withdrawal by Subject|1
5258321|NCT00706095|18142100|P3|Overall Study|Clinical Progression|2
5258322|NCT00706095|18142101|P2|Overall Study|Clinical Progression|2
5258323|NCT00706095|18142102|P1|Overall Study|Clinical Progression|1
5258324|NCT00706095|18142100|P3|Overall Study|Progressive Disease|3
5258325|NCT00706095|18142101|P2|Overall Study|Progressive Disease|5
5258326|NCT00706095|18142102|P1|Overall Study|Progressive Disease|4
5258327|NCT00706030|18142120|P4|Overall Study|Death|0
5258328|NCT00706030|18142121|P3|Overall Study|Death|1
5258329|NCT00706030|18142122|P2|Overall Study|Death|0
5258330|NCT00706030|18142123|P1|Overall Study|Death|0
5258331|NCT00706030|18142120|P4|Overall Study|No treatment received|1
5258332|NCT00706030|18142121|P3|Overall Study|No treatment received|0
5258333|NCT00706030|18142122|P2|Overall Study|No treatment received|0
5258334|NCT00706030|18142123|P1|Overall Study|No treatment received|0
5258335|NCT00706030|18142120|P4|Overall Study|Symptomatic Deterioration|0
5258336|NCT00706030|18142121|P3|Overall Study|Symptomatic Deterioration|1
5258337|NCT00706030|18142122|P2|Overall Study|Symptomatic Deterioration|0
5258338|NCT00706030|18142123|P1|Overall Study|Symptomatic Deterioration|0
5258339|NCT00706030|18142120|P4|Overall Study|Failed to return|0
5258340|NCT00706030|18142121|P3|Overall Study|Failed to return|1
5258341|NCT00706030|18142122|P2|Overall Study|Failed to return|0
5258342|NCT00706030|18142123|P1|Overall Study|Failed to return|0
5258343|NCT00706030|18142120|P4|Overall Study|Protocol Violation|1
5258344|NCT00706030|18142121|P3|Overall Study|Protocol Violation|1
5258345|NCT00706030|18142122|P2|Overall Study|Protocol Violation|0
5258346|NCT00706030|18142123|P1|Overall Study|Protocol Violation|0
5258347|NCT00706030|18142120|P4|Overall Study|Not recorded|0
5258348|NCT00706030|18142121|P3|Overall Study|Not recorded|2
5258349|NCT00706030|18142122|P2|Overall Study|Not recorded|0
5258350|NCT00706030|18142123|P1|Overall Study|Not recorded|0
5258351|NCT00706030|18142120|P4|Overall Study|Physician Decision|0
5258352|NCT00706030|18142121|P3|Overall Study|Physician Decision|2
5258353|NCT00706030|18142122|P2|Overall Study|Physician Decision|0
5258354|NCT00706030|18142123|P1|Overall Study|Physician Decision|0
5258355|NCT00706030|18142120|P4|Overall Study|Withdrawal by Subject|0
5258356|NCT00706030|18142121|P3|Overall Study|Withdrawal by Subject|2
5258357|NCT00706030|18142122|P2|Overall Study|Withdrawal by Subject|0
5258358|NCT00706030|18142123|P1|Overall Study|Withdrawal by Subject|1
5258359|NCT00706030|18142120|P4|Overall Study|Adverse Event|2
5258360|NCT00706030|18142121|P3|Overall Study|Adverse Event|4
5258361|NCT00706030|18142122|P2|Overall Study|Adverse Event|0
5258362|NCT00706030|18142123|P1|Overall Study|Adverse Event|1
5258363|NCT00706030|18142120|P4|Overall Study|Disease Progression|12
5258364|NCT00706030|18142121|P3|Overall Study|Disease Progression|46
5258365|NCT00706030|18142122|P2|Overall Study|Disease Progression|6
5258366|NCT00706030|18142123|P1|Overall Study|Disease Progression|4
5258367|NCT00706004|18142138|P1|Overall Study|Did not meet eligibility criteria|2
5258368|NCT00705939|18142166|P3|Overall Study|Physician Decision|0
5258369|NCT00705939|18142167|P2|Overall Study|Physician Decision|1
5258370|NCT00705939|18142168|P1|Overall Study|Physician Decision|0
5258371|NCT00705939|18142166|P3|Overall Study|Withdrawal by Subject|3
5258372|NCT00705939|18142167|P2|Overall Study|Withdrawal by Subject|1
5258373|NCT00705939|18142168|P1|Overall Study|Withdrawal by Subject|0
5258374|NCT00705939|18142166|P3|Overall Study|Protocol Violation|1
5258375|NCT00705939|18142167|P2|Overall Study|Protocol Violation|0
5258376|NCT00705939|18142168|P1|Overall Study|Protocol Violation|0
5258377|NCT00705783|18142222|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
5258378|NCT00705783|18142223|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
5258379|NCT00705783|18142224|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
5258380|NCT00705783|18142222|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
5258381|NCT00705783|18142223|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
5258382|NCT00705783|18142224|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
5258383|NCT00705783|18142222|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
5258384|NCT00705783|18142223|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
5258385|NCT00705783|18142224|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
5258386|NCT00705783|18142222|P3|Depot Maintenance Phase|Protocol Deviation|0
5258387|NCT00705783|18142223|P2|Depot Maintenance Phase|Protocol Deviation|2
5258388|NCT00705783|18142224|P1|Depot Maintenance Phase|Protocol Deviation|0
5258389|NCT00705783|18142222|P3|Depot Maintenance Phase|Withdrew Consent|4
5258390|NCT00705783|18142223|P2|Depot Maintenance Phase|Withdrew Consent|14
5258391|NCT00705783|18142224|P1|Depot Maintenance Phase|Withdrew Consent|0
5258392|NCT00705783|18142222|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
5258393|NCT00705783|18142223|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
5258394|NCT00705783|18142224|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
5258395|NCT00705783|18142222|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
5258396|NCT00705783|18142223|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
5258397|NCT00705783|18142224|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
5258398|NCT00705783|18142222|P3|Depot Maintenance Phase|Lost to Follow-up|3
5258399|NCT00705783|18142223|P2|Depot Maintenance Phase|Lost to Follow-up|5
5258400|NCT00705783|18142224|P1|Depot Maintenance Phase|Lost to Follow-up|0
5258401|NCT00705783|18142222|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
5258402|NCT00705783|18142223|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
5258403|NCT00705783|18142224|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
5258404|NCT00705783|18142222|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258405|NCT00705783|18142223|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258406|NCT00705783|18142224|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
5258407|NCT00705783|18142222|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258408|NCT00705783|18142223|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258409|NCT00705783|18142224|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
5258410|NCT00705783|18142222|P3|Depot Stabilization Phase|Adverse Event|0
5258411|NCT00705783|18142223|P2|Depot Stabilization Phase|Adverse Event|0
5258412|NCT00705783|18142224|P1|Depot Stabilization Phase|Adverse Event|17
5258413|NCT00705783|18142222|P3|Depot Stabilization Phase|Withdrew Consent|0
5258414|NCT00705783|18142223|P2|Depot Stabilization Phase|Withdrew Consent|0
5258415|NCT00705783|18142224|P1|Depot Stabilization Phase|Withdrew Consent|29
5258416|NCT00705783|18142222|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
5258417|NCT00705783|18142223|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
5258418|NCT00705783|18142224|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
5258419|NCT00705783|18142222|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
5258420|NCT00705783|18142223|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
5258421|NCT00705783|18142224|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
5258422|NCT00705783|18142222|P3|Depot Stabilization Phase|Lost to Follow-up|0
5258423|NCT00705783|18142223|P2|Depot Stabilization Phase|Lost to Follow-up|0
5258424|NCT00705783|18142224|P1|Depot Stabilization Phase|Lost to Follow-up|11
5258425|NCT00705783|18142222|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
5258426|NCT00705783|18142223|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
5258427|NCT00705783|18142224|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
5258428|NCT00705783|18142222|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258429|NCT00705783|18142223|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5258430|NCT00705783|18142224|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
5258431|NCT00705783|18142222|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258432|NCT00705783|18142223|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5258433|NCT00705783|18142224|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
5258434|NCT00705783|18142222|P3|Oral Stabilization Phase|Adverse Event|0
5258435|NCT00705783|18142223|P2|Oral Stabilization Phase|Adverse Event|0
5258436|NCT00705783|18142224|P1|Oral Stabilization Phase|Adverse Event|14
5258437|NCT00705783|18142222|P3|Oral Stabilization Phase|Withdrew Consent|0
5258438|NCT00705783|18142223|P2|Oral Stabilization Phase|Withdrew Consent|0
5258439|NCT00705783|18142224|P1|Oral Stabilization Phase|Withdrew Consent|29
5258440|NCT00705783|18142222|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
5258441|NCT00705783|18142223|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
5258442|NCT00705783|18142224|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
5258443|NCT00705783|18142222|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
5258444|NCT00705783|18142223|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
5258445|NCT00705783|18142224|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
5258446|NCT00705783|18142222|P3|Oral Stabilization Phase|Lost to Follow-up|0
5258447|NCT00705783|18142223|P2|Oral Stabilization Phase|Lost to Follow-up|0
5258448|NCT00705783|18142224|P1|Oral Stabilization Phase|Lost to Follow-up|7
5258449|NCT00705783|18142222|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
5258450|NCT00705783|18142223|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
5258451|NCT00705783|18142224|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
5258452|NCT00705783|18142222|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
5258453|NCT00705783|18142223|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
5258454|NCT00705783|18142224|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
5258455|NCT00705783|18142222|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
5258456|NCT00705783|18142223|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
5258457|NCT00705783|18142224|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
5258458|NCT00705783|18142222|P3|Conversion Phase|Adverse Event|0
5258459|NCT00705783|18142223|P2|Conversion Phase|Adverse Event|0
5258460|NCT00705783|18142224|P1|Conversion Phase|Adverse Event|11
5258461|NCT00705783|18142222|P3|Conversion Phase|Protocol Deviation|0
5258462|NCT00705783|18142223|P2|Conversion Phase|Protocol Deviation|0
5258463|NCT00705783|18142224|P1|Conversion Phase|Protocol Deviation|2
5258464|NCT00705783|18142222|P3|Conversion Phase|Withdrew Consent|0
5258465|NCT00705783|18142223|P2|Conversion Phase|Withdrew Consent|0
5258466|NCT00705783|18142224|P1|Conversion Phase|Withdrew Consent|24
5258467|NCT00705783|18142222|P3|Conversion Phase|Withdrawn by Investigator|0
5258468|NCT00705783|18142223|P2|Conversion Phase|Withdrawn by Investigator|0
5258469|NCT00705783|18142224|P1|Conversion Phase|Withdrawn by Investigator|4
5258470|NCT00705783|18142222|P3|Conversion Phase|Met Withdrawal Criteria|0
5258471|NCT00705783|18142223|P2|Conversion Phase|Met Withdrawal Criteria|0
5258472|NCT00705783|18142224|P1|Conversion Phase|Met Withdrawal Criteria|4
5258473|NCT00705783|18142222|P3|Conversion Phase|Lost to Follow-up|0
5258474|NCT00705783|18142223|P2|Conversion Phase|Lost to Follow-up|0
5258475|NCT00705783|18142224|P1|Conversion Phase|Lost to Follow-up|13
5258476|NCT00705783|18142222|P3|Conversion Phase|Sponsor Discontinued Study|0
5258477|NCT00705783|18142223|P2|Conversion Phase|Sponsor Discontinued Study|0
5258478|NCT00705783|18142224|P1|Conversion Phase|Sponsor Discontinued Study|54
5258479|NCT00705757|18142254|P3|Overall Study|Withdrawal by Subject|2
5258480|NCT00705757|18142255|P2|Overall Study|Withdrawal by Subject|1
5258481|NCT00705757|18142256|P1|Overall Study|Withdrawal by Subject|1
5258482|NCT00705757|18142254|P3|Overall Study|Lost to Follow-up|6
5258483|NCT00705757|18142255|P2|Overall Study|Lost to Follow-up|6
5258484|NCT00705757|18142256|P1|Overall Study|Lost to Follow-up|7
5258485|NCT00705757|18142254|P3|Overall Study|Lack of Efficacy|3
5258486|NCT00705757|18142255|P2|Overall Study|Lack of Efficacy|1
5258487|NCT00705757|18142256|P1|Overall Study|Lack of Efficacy|5
5258488|NCT00705718|18142266|P2|Overall Study|Follow up not done|4
5258489|NCT00705718|18142267|P1|Overall Study|Follow up not done|1
5258490|NCT00705718|18142266|P2|Overall Study|Not due for Visit|12
5258491|NCT00705718|18142267|P1|Overall Study|Not due for Visit|0
5258492|NCT00705718|18142266|P2|Overall Study|Death|6
5258493|NCT00705718|18142267|P1|Overall Study|Death|6
5258494|NCT00705679|18142288|P5|Overall Study|Withdrawal by Subject|33
5258495|NCT00705679|18142289|P4|Overall Study|Withdrawal by Subject|47
5258496|NCT00705679|18142290|P3|Overall Study|Withdrawal by Subject|68
5258497|NCT00705679|18142291|P2|Overall Study|Withdrawal by Subject|77
5258498|NCT00705679|18142292|P1|Overall Study|Withdrawal by Subject|32
5258499|NCT00705679|18142288|P5|Overall Study|Physician Decision|0
5258500|NCT00705679|18142289|P4|Overall Study|Physician Decision|1
5258501|NCT00705679|18142290|P3|Overall Study|Physician Decision|0
5258502|NCT00705679|18142291|P2|Overall Study|Physician Decision|1
5258503|NCT00705679|18142292|P1|Overall Study|Physician Decision|0
5258504|NCT00705679|18142288|P5|Overall Study|Lost to Follow-up|35
5258505|NCT00705679|18142289|P4|Overall Study|Lost to Follow-up|30
5258506|NCT00705679|18142290|P3|Overall Study|Lost to Follow-up|44
5258507|NCT00705679|18142291|P2|Overall Study|Lost to Follow-up|60
5258508|NCT00705679|18142292|P1|Overall Study|Lost to Follow-up|32
5258509|NCT00705679|18142288|P5|Overall Study|Death|1
5258510|NCT00705679|18142289|P4|Overall Study|Death|2
5258511|NCT00705679|18142290|P3|Overall Study|Death|3
5258512|NCT00705679|18142291|P2|Overall Study|Death|0
5258513|NCT00705679|18142292|P1|Overall Study|Death|0
5258514|NCT00705679|18142288|P5|Overall Study|Adverse Event|0
5258515|NCT00705679|18142289|P4|Overall Study|Adverse Event|0
5258516|NCT00705679|18142290|P3|Overall Study|Adverse Event|0
5258517|NCT00705679|18142291|P2|Overall Study|Adverse Event|1
5258518|NCT00705679|18142292|P1|Overall Study|Adverse Event|1
5258519|NCT00705666|18142327|P1|Overall Study|Untreated|5
5258520|NCT00705666|18142327|P1|Overall Study|Lack of data|3
5258521|NCT00705666|18142327|P1|Overall Study|Other|2
5258522|NCT00705666|18142327|P1|Overall Study|Other|12
5258523|NCT00705666|18142327|P1|Overall Study|Adverse Event|4
5258524|NCT00705666|18142327|P1|Overall Study|Death|1
5258525|NCT00705666|18142327|P1|Overall Study|Lost to Follow-up|5
5258526|NCT00705666|18142327|P1|Overall Study|Physician Decision|7
5258527|NCT00705666|18142327|P1|Overall Study|Withdrawal by Subject|21
5258528|NCT00705666|18142327|P1|Overall Study|No post-treatment questionnaire|279
5258529|NCT00705614|18142338|P2|Switch to Remicade|Administrative Reason|9
5258530|NCT00705614|18142339|P1|Switch to Remicade|Administrative Reason|0
5258531|NCT00705614|18142338|P2|Switch to Remicade|Withdrawal by Subject|12
5258532|NCT00705614|18142339|P1|Switch to Remicade|Withdrawal by Subject|0
5258533|NCT00705614|18142338|P2|Switch to Remicade|Lost to Follow-up|23
5258534|NCT00705614|18142339|P1|Switch to Remicade|Lost to Follow-up|0
5258535|NCT00705614|18142338|P2|Switch to Remicade|Adverse Event|5
5258536|NCT00705614|18142339|P1|Switch to Remicade|Adverse Event|0
5258537|NCT00705614|18142338|P2|Initial Intervention|Status completion unknown|0
5258538|NCT00705614|18142339|P1|Initial Intervention|Status completion unknown|3
5258539|NCT00705614|18142338|P2|Initial Intervention|Administrative Reason|38
5258540|NCT00705614|18142339|P1|Initial Intervention|Administrative Reason|51
5258541|NCT00705614|18142338|P2|Initial Intervention|Withdrawal by Subject|71
5258542|NCT00705614|18142339|P1|Initial Intervention|Withdrawal by Subject|114
5258543|NCT00705614|18142338|P2|Initial Intervention|Lost to Follow-up|191
5258544|NCT00705614|18142339|P1|Initial Intervention|Lost to Follow-up|310
5258545|NCT00705614|18142338|P2|Initial Intervention|Adverse Event|21
5258546|NCT00705614|18142339|P1|Initial Intervention|Adverse Event|40
5258547|NCT00705575|18142388|P2|Overall Study|Withdrawal by Subject|10
5258548|NCT00705575|18142389|P1|Overall Study|Withdrawal by Subject|5
5258549|NCT00705575|18142388|P2|Overall Study|Protocol Violation|2
5258550|NCT00705575|18142389|P1|Overall Study|Protocol Violation|2
5258551|NCT00705575|18142388|P2|Overall Study|Lost to Follow-up|4
5258552|NCT00705575|18142389|P1|Overall Study|Lost to Follow-up|3
5258553|NCT00705575|18142388|P2|Overall Study|Adverse Event|15
5258554|NCT00705575|18142389|P1|Overall Study|Adverse Event|11
5258555|NCT00705575|18142388|P2|Overall Study|Abnormal test procedure result(s)|12
5258556|NCT00705575|18142389|P1|Overall Study|Abnormal test procedure result(s)|2
5258557|NCT00705575|18142388|P2|Overall Study|Abnormal laboratory value(s)|3
5258558|NCT00705575|18142389|P1|Overall Study|Abnormal laboratory value(s)|0
5258559|NCT00705536|18142403|P4|Start Period 1|Withdrawal by Subject|1
5258560|NCT00705536|18142404|P3|Start Period 1|Withdrawal by Subject|0
5258561|NCT00705536|18142405|P2|Start Period 1|Withdrawal by Subject|0
5258562|NCT00705536|18142406|P1|Start Period 1|Withdrawal by Subject|0
5258563|NCT00705523|18142467|P2|Overall Study|Lost to Follow-up|3
5258564|NCT00705523|18142468|P1|Overall Study|Lost to Follow-up|2
5258565|NCT00705484|18142478|P2|Overall Study|Administrative|59
5258566|NCT00705484|18142479|P1|Overall Study|Administrative|89
5258567|NCT00705484|18142478|P2|Overall Study|Withdrawal by Subject|72
5258568|NCT00705484|18142479|P1|Overall Study|Withdrawal by Subject|96
5258569|NCT00705484|18142478|P2|Overall Study|Lost to Follow-up|250
5258570|NCT00705484|18142479|P1|Overall Study|Lost to Follow-up|169
5258571|NCT00705484|18142478|P2|Overall Study|Adverse Event|27
5258572|NCT00705484|18142479|P1|Overall Study|Adverse Event|28
5258573|NCT00705432|18142493|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
5258574|NCT00705432|18142494|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
5258575|NCT00705432|18142495|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
5258576|NCT00705432|18142496|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
5258577|NCT00705432|18142497|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
5258578|NCT00705432|18142498|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
5258579|NCT00705432|18142493|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
5258580|NCT00705432|18142494|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
5258581|NCT00705432|18142495|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
5258582|NCT00705432|18142496|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
5258583|NCT00705432|18142497|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
5258584|NCT00705432|18142498|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
5258585|NCT00705432|18142493|P6|Treatment Period|Non medical reason|7
5258586|NCT00705432|18142494|P5|Treatment Period|Non medical reason|7
5258587|NCT00705432|18142495|P4|Treatment Period|Non medical reason|4
5258588|NCT00705432|18142496|P3|Treatment Period|Non medical reason|37
5258589|NCT00705432|18142497|P2|Treatment Period|Non medical reason|32
5258590|NCT00705432|18142498|P1|Treatment Period|Non medical reason|26
5258591|NCT00705432|18142493|P6|Treatment Period|Treatment failure|14
5258592|NCT00705432|18142494|P5|Treatment Period|Treatment failure|13
5258593|NCT00705432|18142495|P4|Treatment Period|Treatment failure|25
5258594|NCT00705432|18142496|P3|Treatment Period|Treatment failure|33
5258595|NCT00705432|18142497|P2|Treatment Period|Treatment failure|42
5258596|NCT00705432|18142498|P1|Treatment Period|Treatment failure|92
5258597|NCT00705432|18142493|P6|Treatment Period|Adverse Event|9
5258598|NCT00705432|18142494|P5|Treatment Period|Adverse Event|8
5258599|NCT00705432|18142495|P4|Treatment Period|Adverse Event|12
5258600|NCT00705432|18142496|P3|Treatment Period|Adverse Event|51
5258601|NCT00705432|18142497|P2|Treatment Period|Adverse Event|37
5258602|NCT00705432|18142498|P1|Treatment Period|Adverse Event|45
5258603|NCT00705406|18142535|P2|Overall Study|Did not receive study drug|2
5258604|NCT00705406|18142536|P1|Overall Study|Did not receive study drug|1
5258605|NCT00705406|18142535|P2|Overall Study|Lost to Follow-up|3
5258606|NCT00705406|18142536|P1|Overall Study|Lost to Follow-up|3
5258607|NCT00705367|18142560|P2|Long-term Extension Period|Administrative reason by sponsor|0
5258608|NCT00705367|18142561|P1|Long-term Extension Period|Administrative reason by sponsor|3
5258609|NCT00705367|18142560|P2|Long-term Extension Period|No longer met study criteria|0
5258610|NCT00705367|18142561|P1|Long-term Extension Period|No longer met study criteria|1
5258611|NCT00705367|18142560|P2|Long-term Extension Period|Lack of Efficacy|0
5258612|NCT00705367|18142561|P1|Long-term Extension Period|Lack of Efficacy|1
5258613|NCT00705367|18142560|P2|Long-term Extension Period|Withdrawal by Subject|0
5258614|NCT00705367|18142561|P1|Long-term Extension Period|Withdrawal by Subject|2
5258615|NCT00705367|18142560|P2|Long-term Extension Period|Adverse Event|0
5258616|NCT00705367|18142561|P1|Long-term Extension Period|Adverse Event|2
5258617|NCT00705341|18142588|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
5258618|NCT00705341|18142589|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
5258619|NCT00705341|18142590|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
5258620|NCT00705341|18142591|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
5258621|NCT00705341|18142588|P4|Phase 2: Trial|Withdrawal by Subject|4
5258622|NCT00705341|18142589|P3|Phase 2: Trial|Withdrawal by Subject|6
5258623|NCT00705341|18142590|P2|Phase 2: Trial|Withdrawal by Subject|0
5258624|NCT00705341|18142591|P1|Phase 2: Trial|Withdrawal by Subject|0
5258625|NCT00705289|18142599|P1|Overall Study|Subject or treating physician's choice|131
5258626|NCT00705263|18142623|P1|Overall Study|Withdrawal by Subject|2
5258627|NCT00705250|18142627|P1|Overall Study|Patient died in car accident|1
5258628|NCT00705250|18142627|P1|Overall Study|Withdrawal by Subject|1
5258629|NCT00705224|18142631|P1|Overall Study|Lost to Follow-up|5
5258630|NCT00705224|18142631|P1|Overall Study|Withdrawal by Subject|3
5258631|NCT00705224|18142631|P1|Overall Study|Lack of Efficacy|2
5258632|NCT00705224|18142631|P1|Overall Study|Adverse Event|1
5258633|NCT00705159|18142647|P4|Overall Study|Screen Failure|1
5258634|NCT00705159|18142648|P3|Overall Study|Screen Failure|0
5258635|NCT00705159|18142649|P2|Overall Study|Screen Failure|0
5258636|NCT00705159|18142650|P1|Overall Study|Screen Failure|0
5258637|NCT00705159|18142647|P4|Overall Study|Lost to Follow-up|2
5258638|NCT00705159|18142648|P3|Overall Study|Lost to Follow-up|3
5258639|NCT00705159|18142649|P2|Overall Study|Lost to Follow-up|0
5258640|NCT00705159|18142650|P1|Overall Study|Lost to Follow-up|0
5258641|NCT00705159|18142647|P4|Overall Study|Adverse Event|0
5258642|NCT00705159|18142648|P3|Overall Study|Adverse Event|1
5258643|NCT00705159|18142649|P2|Overall Study|Adverse Event|0
5258644|NCT00705159|18142650|P1|Overall Study|Adverse Event|0
5258645|NCT00705159|18142647|P4|Overall Study|Protocol Violation|0
5258646|NCT00705159|18142648|P3|Overall Study|Protocol Violation|0
5258647|NCT00705159|18142649|P2|Overall Study|Protocol Violation|1
5258648|NCT00705159|18142650|P1|Overall Study|Protocol Violation|0
5258649|NCT00705159|18142647|P4|Overall Study|Withdrawal by Subject|1
5258650|NCT00705159|18142648|P3|Overall Study|Withdrawal by Subject|1
5258651|NCT00705159|18142649|P2|Overall Study|Withdrawal by Subject|1
5258652|NCT00705159|18142650|P1|Overall Study|Withdrawal by Subject|0
5258653|NCT00705146|18142670|P2|Overall Study|Lost to Follow-up|1
5258654|NCT00705146|18142671|P1|Overall Study|Lost to Follow-up|1
5258655|NCT00705016|18142707|P3|Overall Study|Other|6
5258656|NCT00705016|18142708|P2|Overall Study|Other|6
5258657|NCT00705016|18142709|P1|Overall Study|Other|9
5258658|NCT00705016|18142707|P3|Overall Study|Symptomatic Deterioration|1
5258659|NCT00705016|18142708|P2|Overall Study|Symptomatic Deterioration|1
5258660|NCT00705016|18142709|P1|Overall Study|Symptomatic Deterioration|3
5258661|NCT00705016|18142707|P3|Overall Study|Progressive Disease|33
5258662|NCT00705016|18142708|P2|Overall Study|Progressive Disease|29
5258663|NCT00705016|18142709|P1|Overall Study|Progressive Disease|33
5258664|NCT00705016|18142707|P3|Overall Study|Withdrawal by Subject|2
5258665|NCT00705016|18142708|P2|Overall Study|Withdrawal by Subject|3
5258666|NCT00705016|18142709|P1|Overall Study|Withdrawal by Subject|4
5258667|NCT00705016|18142707|P3|Overall Study|Protocol Violation|1
5258668|NCT00705016|18142708|P2|Overall Study|Protocol Violation|1
5258669|NCT00705016|18142709|P1|Overall Study|Protocol Violation|0
5258670|NCT00705016|18142707|P3|Overall Study|Death|5
5258671|NCT00705016|18142708|P2|Overall Study|Death|7
5258672|NCT00705016|18142709|P1|Overall Study|Death|5
5258673|NCT00705016|18142707|P3|Overall Study|Adverse Event|10
5258674|NCT00705016|18142708|P2|Overall Study|Adverse Event|11
5258675|NCT00705016|18142709|P1|Overall Study|Adverse Event|6
5258676|NCT00704964|18142760|P1|Overall Study|Not completed on time|328
5258677|NCT00704808|18142821|P1|Overall Study|Treatment change|1
5258678|NCT00704808|18142821|P1|Overall Study|Lost to Follow-up|1
5258679|NCT00704808|18142821|P1|Overall Study|Adverse Event|1
5258680|NCT00704808|18142821|P1|Overall Study|Early therapy discontinuation|16
5258681|NCT00704808|18142821|P1|Overall Study|Patient's decision|11
5258682|NCT00704808|18142821|P1|Overall Study|Tumor progression|80
5258683|NCT00704808|18142821|P1|Overall Study|Death|7
5258684|NCT00704808|18142821|P1|Overall Study|Discontinued prior to starting treatment|14
5258685|NCT00704730|18142832|P2|Overall Study|Withdrawal by Subject|13
5258686|NCT00704730|18142833|P1|Overall Study|Withdrawal by Subject|9
5258687|NCT00704730|18142832|P2|Overall Study|data unavailable|0
5258688|NCT00704730|18142833|P1|Overall Study|data unavailable|1
5258689|NCT00704730|18142832|P2|Overall Study|Disease progression per PI|67
5258690|NCT00704730|18142833|P1|Overall Study|Disease progression per PI|58
5258691|NCT00704730|18142832|P2|Overall Study|Did not receive drug|2
5258692|NCT00704730|18142833|P1|Overall Study|Did not receive drug|5
5258693|NCT00704730|18142832|P2|Overall Study|Physician Decision|0
5258694|NCT00704730|18142833|P1|Overall Study|Physician Decision|2
5258695|NCT00704730|18142832|P2|Overall Study|Death|5
5258696|NCT00704730|18142833|P1|Overall Study|Death|11
5258697|NCT00704730|18142832|P2|Overall Study|Adverse Event|9
5258698|NCT00704730|18142833|P1|Overall Study|Adverse Event|35
5258699|NCT00704535|18142853|P1|Overall Study|Completed status not on Case Report Form|124
5258700|NCT00704535|18142853|P1|Overall Study|Protocol Violation|10
5258701|NCT00704535|18142853|P1|Overall Study|Lost to Follow-up|8
5258702|NCT00704535|18142853|P1|Overall Study|Death|2
5258703|NCT00704535|18142853|P1|Overall Study|Adverse Event|2
5258704|NCT00704522|18142866|P2|Overall Study|No information on therapy end|2
5258705|NCT00704522|18142867|P1|Overall Study|No information on therapy end|27
5258706|NCT00704522|18142866|P2|Overall Study|Undefined causes|7
5258707|NCT00704522|18142867|P1|Overall Study|Undefined causes|9
5258708|NCT00704522|18142866|P2|Overall Study|Adverse Event|1
5258709|NCT00704522|18142867|P1|Overall Study|Adverse Event|9
5258710|NCT00704522|18142866|P2|Overall Study|Withdrawal by Subject|8
5258711|NCT00704522|18142867|P1|Overall Study|Withdrawal by Subject|17
5258712|NCT00704522|18142866|P2|Overall Study|Failure to appear again at hospital|10
5258713|NCT00704522|18142867|P1|Overall Study|Failure to appear again at hospital|56
5258714|NCT00704522|18142866|P2|Overall Study|Lack of Efficacy|17
5258715|NCT00704522|18142867|P1|Overall Study|Lack of Efficacy|65
5258716|NCT00704418|18142887|P2|Overall Study|Over-enrolled/surgery postponed|6
5258717|NCT00704418|18142888|P1|Overall Study|Over-enrolled/surgery postponed|3
5258718|NCT00704418|18142887|P2|Overall Study|Withdrawal by Subject|0
5258719|NCT00704418|18142888|P1|Overall Study|Withdrawal by Subject|2
5258720|NCT00704405|18142901|P5|Overall Study (C Population)|Lost to Follow-up|0
5258721|NCT00704405|18142902|P4|Overall Study (C Population)|Lost to Follow-up|0
5258722|NCT00704405|18142903|P3|Overall Study (C Population)|Lost to Follow-up|0
5258723|NCT00704405|18142904|P2|Overall Study (C Population)|Lost to Follow-up|2
5258724|NCT00704405|18142905|P1|Overall Study (C Population)|Lost to Follow-up|0
5258725|NCT00704405|18142901|P5|Overall Study (C Population)|Withdrawal by Subject|0
5258726|NCT00704405|18142902|P4|Overall Study (C Population)|Withdrawal by Subject|1
5258727|NCT00704405|18142903|P3|Overall Study (C Population)|Withdrawal by Subject|1
5258728|NCT00704405|18142904|P2|Overall Study (C Population)|Withdrawal by Subject|1
5258729|NCT00704405|18142905|P1|Overall Study (C Population)|Withdrawal by Subject|1
5258730|NCT00704405|18142901|P5|Overall Study (NC Population)|Other|1
5258731|NCT00704405|18142902|P4|Overall Study (NC Population)|Other|0
5258732|NCT00704405|18142903|P3|Overall Study (NC Population)|Other|0
5258733|NCT00704405|18142904|P2|Overall Study (NC Population)|Other|0
5258734|NCT00704405|18142905|P1|Overall Study (NC Population)|Other|0
5258735|NCT00704405|18142901|P5|Overall Study (NC Population)|Withdrawal by Subject|2
5258736|NCT00704405|18142902|P4|Overall Study (NC Population)|Withdrawal by Subject|2
5258737|NCT00704405|18142903|P3|Overall Study (NC Population)|Withdrawal by Subject|2
5258738|NCT00704405|18142904|P2|Overall Study (NC Population)|Withdrawal by Subject|3
5258739|NCT00704405|18142905|P1|Overall Study (NC Population)|Withdrawal by Subject|2
5258740|NCT00704405|18142901|P5|Overall Study (NC Population)|Lost to Follow-up|2
5258741|NCT00704405|18142902|P4|Overall Study (NC Population)|Lost to Follow-up|2
5258742|NCT00704405|18142903|P3|Overall Study (NC Population)|Lost to Follow-up|1
5258743|NCT00704405|18142904|P2|Overall Study (NC Population)|Lost to Follow-up|1
5258744|NCT00704405|18142905|P1|Overall Study (NC Population)|Lost to Follow-up|2
5258745|NCT00704405|18142901|P5|Overall Study (NC Population)|Adverse Event|0
5258746|NCT00704405|18142902|P4|Overall Study (NC Population)|Adverse Event|0
5258747|NCT00704405|18142903|P3|Overall Study (NC Population)|Adverse Event|0
5258748|NCT00704405|18142904|P2|Overall Study (NC Population)|Adverse Event|0
5258749|NCT00704405|18142905|P1|Overall Study (NC Population)|Adverse Event|1
5258750|NCT00704340|18142963|P2|Overall Study|Death|1
5258751|NCT00704340|18142964|P1|Overall Study|Death|0
5258752|NCT00704340|18142963|P2|Overall Study|Lost to Follow-up|1
5258753|NCT00704340|18142964|P1|Overall Study|Lost to Follow-up|2
5258754|NCT00704184|18142995|P5|Open-Label Treatment|Withdrawal by Subject|0
5258755|NCT00704184|18142996|P4|Open-Label Treatment|Withdrawal by Subject|3
5258756|NCT00704184|18142997|P3|Open-Label Treatment|Withdrawal by Subject|0
5258757|NCT00704184|18142998|P2|Open-Label Treatment|Withdrawal by Subject|0
5258758|NCT00704184|18142999|P1|Open-Label Treatment|Withdrawal by Subject|1
5258759|NCT00704184|18142995|P5|Open-Label Treatment|Physician Decision|1
5258760|NCT00704184|18142996|P4|Open-Label Treatment|Physician Decision|0
5258761|NCT00704184|18142997|P3|Open-Label Treatment|Physician Decision|0
5258762|NCT00704184|18142998|P2|Open-Label Treatment|Physician Decision|0
5258763|NCT00704184|18142999|P1|Open-Label Treatment|Physician Decision|0
5258764|NCT00704184|18142995|P5|Open-Label Treatment|Lack of Efficacy|1
5258765|NCT00704184|18142996|P4|Open-Label Treatment|Lack of Efficacy|2
5258766|NCT00704184|18142997|P3|Open-Label Treatment|Lack of Efficacy|2
5258767|NCT00704184|18142998|P2|Open-Label Treatment|Lack of Efficacy|2
5258768|NCT00704184|18142999|P1|Open-Label Treatment|Lack of Efficacy|0
5258769|NCT00704184|18142995|P5|Open-Label Treatment|Adverse Event|1
5258770|NCT00704184|18142996|P4|Open-Label Treatment|Adverse Event|0
5258771|NCT00704184|18142997|P3|Open-Label Treatment|Adverse Event|2
5258772|NCT00704184|18142998|P2|Open-Label Treatment|Adverse Event|0
5258773|NCT00704184|18142999|P1|Open-Label Treatment|Adverse Event|0
5258774|NCT00704184|18142995|P5|Double-Blind Treatment|Withdrawal by Subject|0
5258775|NCT00704184|18142996|P4|Double-Blind Treatment|Withdrawal by Subject|0
5258776|NCT00704184|18142997|P3|Double-Blind Treatment|Withdrawal by Subject|0
5258777|NCT00704184|18142998|P2|Double-Blind Treatment|Withdrawal by Subject|0
5258778|NCT00704184|18142999|P1|Double-Blind Treatment|Withdrawal by Subject|1
5258779|NCT00704171|18143038|P2|Overall Study|Withdrawal by Subject|0
5258780|NCT00704171|18143039|P1|Overall Study|Withdrawal by Subject|1
5258781|NCT00704132|18143057|P2|Overall Study|Withdrawal by Subject|1
5258782|NCT00704132|18143058|P1|Overall Study|Withdrawal by Subject|0
5258783|NCT00704132|18143057|P2|Overall Study|Lack of Efficacy|1
5258784|NCT00704132|18143058|P1|Overall Study|Lack of Efficacy|0
5258785|NCT00704132|18143057|P2|Overall Study|Clinical Adverse Experience|0
5258786|NCT00704132|18143058|P1|Overall Study|Clinical Adverse Experience|1
5258787|NCT00703963|18143086|P2|Overall Study|Physician Decision|1
5258788|NCT00703963|18143087|P1|Overall Study|Physician Decision|0
5258789|NCT00703963|18143086|P2|Overall Study|Withdrawal by Subject|13
5258790|NCT00703963|18143087|P1|Overall Study|Withdrawal by Subject|7
5258791|NCT00703924|18143108|P2|Overall Study|Withdrawal by Subject|1
5258792|NCT00703924|18143109|P1|Overall Study|Withdrawal by Subject|1
5258793|NCT00703911|18143125|P1|Overall Study|Withdrawal by Subject|2
5258794|NCT00703911|18143125|P1|Overall Study|Lost to Follow-up|1
5258795|NCT00703911|18143125|P1|Overall Study|Physician Decision|6
5258796|NCT00703911|18143125|P1|Overall Study|Death|1
5258797|NCT00703846|18143158|P1|Overall Study|Did Not Receive Study Drug|2
5258798|NCT00703846|18143158|P1|Overall Study|Other|14
5258799|NCT00703846|18143158|P1|Overall Study|Death|1
5258800|NCT00703846|18143158|P1|Overall Study|Withdrawal by Subject|40
5258801|NCT00703846|18143158|P1|Overall Study|Noncompliance with Study Treatment|2
5258802|NCT00703846|18143158|P1|Overall Study|Lack of Efficacy|15
5258803|NCT00703846|18143158|P1|Overall Study|Lost to Follow-up|55
5258804|NCT00703846|18143158|P1|Overall Study|Adverse Event|8
5258805|NCT00703820|18143174|P2|Overall Study|Withdrawal by Subject|1
5258806|NCT00703820|18143175|P1|Overall Study|Withdrawal by Subject|2
5258807|NCT00703820|18143174|P2|Overall Study|Physician Decision|5
5258808|NCT00703820|18143175|P1|Overall Study|Physician Decision|4
5258809|NCT00703820|18143174|P2|Overall Study|Received non-protocol therapy|0
5258810|NCT00703820|18143175|P1|Overall Study|Received non-protocol therapy|1
5258811|NCT00703820|18143174|P2|Overall Study|Lack of Efficacy|11
5258812|NCT00703820|18143175|P1|Overall Study|Lack of Efficacy|11
5258813|NCT00703820|18143174|P2|Overall Study|Death|0
5258814|NCT00703820|18143175|P1|Overall Study|Death|5
5258815|NCT00703820|18143174|P2|Overall Study|Adverse Event|17
5258816|NCT00703820|18143175|P1|Overall Study|Adverse Event|12
5258817|NCT00703781|18143184|P2|Overall Study|Cancelled surgery|0
5258818|NCT00703781|18143185|P1|Overall Study|Cancelled surgery|1
5258819|NCT00703781|18143184|P2|Overall Study|Withdrawal by Subject|2
5258820|NCT00703781|18143185|P1|Overall Study|Withdrawal by Subject|1
5258821|NCT00703677|18143230|P1|Overall Study|Dropout-withdrawal not related to drug|3
5258822|NCT00703534|18143270|P2|Overall Study|Severe Non Compliance|5
5258823|NCT00703534|18143271|P1|Overall Study|Severe Non Compliance|1
5258824|NCT00703534|18143270|P2|Overall Study|Lost to Follow-up|4
5258825|NCT00703534|18143271|P1|Overall Study|Lost to Follow-up|1
5258826|NCT00703534|18143270|P2|Overall Study|Incorrect Enrollment|6
5258827|NCT00703534|18143271|P1|Overall Study|Incorrect Enrollment|6
5258828|NCT00703534|18143270|P2|Overall Study|Withdrawal by Subject|7
5258829|NCT00703534|18143271|P1|Overall Study|Withdrawal by Subject|8
5258830|NCT00703534|18143270|P2|Overall Study|Adverse Event|3
5258831|NCT00703534|18143271|P1|Overall Study|Adverse Event|14
5258832|NCT00703326|18143343|P2|Overall Study|Withdrawal by Subject|20
5258833|NCT00703326|18143344|P1|Overall Study|Withdrawal by Subject|42
5258834|NCT00703326|18143343|P2|Overall Study|Lost to Follow-up|8
5258835|NCT00703326|18143344|P1|Overall Study|Lost to Follow-up|25
5258836|NCT00703326|18143343|P2|Overall Study|Still on study|197
5258837|NCT00703326|18143344|P1|Overall Study|Still on study|380
5258838|NCT00703157|18143376|P2|Overall Study|source data permanently lost/ other|1
5258839|NCT00703157|18143377|P1|Overall Study|source data permanently lost/ other|4
5258840|NCT00703157|18143376|P2|Overall Study|Lost to Follow-up|1
5258841|NCT00703157|18143377|P1|Overall Study|Lost to Follow-up|0
5258842|NCT00703118|18143411|P3|Overall Study|Other|1
5258843|NCT00703118|18143412|P2|Overall Study|Other|0
5258844|NCT00703118|18143413|P1|Overall Study|Other|0
5258845|NCT00703118|18143411|P3|Overall Study|Withdrawal by Subject|13
5258846|NCT00703118|18143412|P2|Overall Study|Withdrawal by Subject|7
5258847|NCT00703118|18143413|P1|Overall Study|Withdrawal by Subject|8
5258848|NCT00703118|18143411|P3|Overall Study|Lost to Follow-up|4
5258849|NCT00703118|18143412|P2|Overall Study|Lost to Follow-up|4
5258850|NCT00703118|18143413|P1|Overall Study|Lost to Follow-up|6
5258851|NCT00703118|18143411|P3|Overall Study|Subject Ineligible To Continue The Trial|2
5258852|NCT00703118|18143412|P2|Overall Study|Subject Ineligible To Continue The Trial|3
5258853|NCT00703118|18143413|P1|Overall Study|Subject Ineligible To Continue The Trial|6
5258854|NCT00703118|18143411|P3|Overall Study|Adverse Event|2
5258855|NCT00703118|18143412|P2|Overall Study|Adverse Event|2
5258856|NCT00703118|18143413|P1|Overall Study|Adverse Event|1
5258857|NCT00703092|18143444|P1|Overall Study|Withdrawal by Subject|2
5258858|NCT00703014|18143652|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
5258859|NCT00703014|18143653|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
5258860|NCT00703014|18143654|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
5258861|NCT00703014|18143655|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
5258862|NCT00703014|18143652|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
5258863|NCT00703014|18143653|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
5258864|NCT00703014|18143654|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
5258865|NCT00703014|18143655|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
5258866|NCT00702962|18143675|P2|Overall Study|Hospitalized for other health disorder|0
5258867|NCT00702962|18143676|P1|Overall Study|Hospitalized for other health disorder|1
5258868|NCT00702962|18143675|P2|Overall Study|Progressive disease|1
5258869|NCT00702962|18143676|P1|Overall Study|Progressive disease|0
5258870|NCT00702949|18143687|P3|Overall Study|Other Medical Reason/unknown|3
5258871|NCT00702949|18143688|P2|Overall Study|Other Medical Reason/unknown|1
5258872|NCT00702949|18143689|P1|Overall Study|Other Medical Reason/unknown|1
5258873|NCT00702949|18143687|P3|Overall Study|Adverse Event|3
5258874|NCT00702949|18143688|P2|Overall Study|Adverse Event|6
5258875|NCT00702949|18143689|P1|Overall Study|Adverse Event|1
5258876|NCT00702949|18143687|P3|Overall Study|Refusal|2
5258877|NCT00702949|18143688|P2|Overall Study|Refusal|2
5258878|NCT00702949|18143689|P1|Overall Study|Refusal|3
5258879|NCT00702923|18143714|P1|Overall Study|Adverse Event|1
5258880|NCT00702845|18143737|P2|Overall Study|Not randomized|1
5258881|NCT00702845|18143738|P1|Overall Study|Not randomized|0
5258882|NCT00702845|18143737|P2|Overall Study|Patient's decision|1
5258883|NCT00702845|18143738|P1|Overall Study|Patient's decision|2
5258884|NCT00702845|18143737|P2|Overall Study|No or abnormal fertilization|2
5258885|NCT00702845|18143738|P1|Overall Study|No or abnormal fertilization|4
5258886|NCT00702845|18143737|P2|Overall Study|No/too few/bad quality embryos retrieved|1
5258887|NCT00702845|18143738|P1|Overall Study|No/too few/bad quality embryos retrieved|7
5258888|NCT00702845|18143737|P2|Overall Study|Insufficient ovarian response|0
5258889|NCT00702845|18143738|P1|Overall Study|Insufficient ovarian response|1
5258890|NCT00702845|18143737|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
5258891|NCT00702845|18143738|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
5258892|NCT00702845|18143737|P2|Overall Study|Too high ovarian response|1
5258893|NCT00702845|18143738|P1|Overall Study|Too high ovarian response|5
5258894|NCT00702845|18143737|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
5258895|NCT00702845|18143738|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
5258896|NCT00702715|18143800|P2|Overall Study|Lost to Follow-up|0
5258897|NCT00702715|18143801|P1|Overall Study|Lost to Follow-up|1
5258898|NCT00702702|18143814|P1|Overall Study|Study prematurely terminated|56
5258899|NCT00702689|18143822|P1|Overall Study|Adverse Event|1
5258900|NCT00702689|18143822|P1|Overall Study|Recurrent malignancy|1
5258901|NCT00702689|18143822|P1|Overall Study|Withdrawal by Subject|4
5258902|NCT00702650|18143833|P1|Overall Study|Adverse Event|3
5258903|NCT00702650|18143833|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
5258904|NCT00702650|18143833|P1|Overall Study|Sponsor Request|1
5258905|NCT00702650|18143833|P1|Overall Study|Non-Compliance with Site Directives|1
5258906|NCT00702650|18143833|P1|Overall Study|Lost to Follow-up|2
5258907|NCT00702650|18143833|P1|Overall Study|Non-Compliance of Study Drug|3
5258908|NCT00702650|18143833|P1|Overall Study|Withdrawal by Subject|9
5258909|NCT00702520|18143895|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
5258910|NCT00702520|18143896|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
5258911|NCT00702520|18143897|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
5258912|NCT00702520|18143898|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
5258913|NCT00702520|18143895|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
5258914|NCT00702520|18143896|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
5258915|NCT00702520|18143897|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
5258916|NCT00702520|18143898|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
5258917|NCT00702520|18143895|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
5258918|NCT00702520|18143896|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
5258919|NCT00702520|18143897|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
5258920|NCT00702520|18143898|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
5258921|NCT00702507|18143914|P1|Follow-up Phase|Late Enrollment|1
5258922|NCT00702507|18143914|P1|Follow-up Phase|Lost to Follow-up|23
5258923|NCT00702507|18143914|P1|Follow-up Phase|Protocol Violation|2
5258924|NCT00702507|18143914|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
5258925|NCT00702507|18143914|P1|Initial Treatment Phase|Negative Candida Culture|34
5258926|NCT00702507|18143914|P1|Initial Treatment Phase|Lost to Follow-up|2
5258927|NCT00702507|18143914|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
5258928|NCT00702507|18143914|P1|Initial Treatment Phase|Adverse Event|2
5258929|NCT00702403|18143951|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
5258930|NCT00702403|18143951|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
5258931|NCT00702403|18143951|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
5258932|NCT00702403|18143951|P1|From Engraftment to Study Completion|Suicide|1
5258933|NCT00702403|18143951|P1|From Engraftment to Study Completion|Liver GVHD|1
5258934|NCT00702403|18143951|P1|From Engraftment to Study Completion|Adenocarcinoma|1
5258935|NCT00702403|18143951|P1|From Engraftment to Study Completion|Non-compliance|2
5258936|NCT00702403|18143951|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
5258937|NCT00702403|18143951|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
5258938|NCT00702403|18143951|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
5258939|NCT00702403|18143951|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
5258940|NCT00702403|18143951|P1|From Consent to Engraftment|Myocardial infarction|1
5258941|NCT00702403|18143951|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
5258942|NCT00702403|18143951|P1|From Consent to Engraftment|Critically ill|2
5258943|NCT00702403|18143951|P1|From Consent to Engraftment|Progressive leukemia|6
5258944|NCT00702325|18144005|P2|Overall Study|Incorrectly Discontinued|1
5258945|NCT00702325|18144006|P1|Overall Study|Incorrectly Discontinued|0
5258946|NCT00702325|18144005|P2|Overall Study|Withdrew consent|1
5258947|NCT00702325|18144006|P1|Overall Study|Withdrew consent|0
5258948|NCT00702325|18144005|P2|Overall Study|Didn't follow study medication dosage|2
5258949|NCT00702325|18144006|P1|Overall Study|Didn't follow study medication dosage|0
5258950|NCT00702325|18144005|P2|Overall Study|Termination due to lab results|0
5258951|NCT00702325|18144006|P1|Overall Study|Termination due to lab results|1
5258952|NCT00702325|18144005|P2|Overall Study|Severe noncompliance to protocol|3
5258953|NCT00702325|18144006|P1|Overall Study|Severe noncompliance to protocol|3
5258954|NCT00702325|18144005|P2|Overall Study|Developed study discontinuation criteria|28
5258955|NCT00702325|18144006|P1|Overall Study|Developed study discontinuation criteria|18
5258956|NCT00702325|18144005|P2|Overall Study|Incorrect enrollment|7
5258957|NCT00702325|18144006|P1|Overall Study|Incorrect enrollment|5
5258958|NCT00702325|18144005|P2|Overall Study|Lost to Follow-up|4
5258959|NCT00702325|18144006|P1|Overall Study|Lost to Follow-up|3
5258960|NCT00702325|18144005|P2|Overall Study|Withdrawal by Subject|7
5258961|NCT00702325|18144006|P1|Overall Study|Withdrawal by Subject|7
5258962|NCT00702325|18144005|P2|Overall Study|Adverse Event|0
5258963|NCT00702325|18144006|P1|Overall Study|Adverse Event|1
5258964|NCT00702221|18144102|P2|Overall Study|Adverse Event|3
5258965|NCT00702221|18144103|P1|Overall Study|Adverse Event|4
5258966|NCT00702208|18144109|P1|Overall Study|Unsatisfactory colposcopy|2
5258967|NCT00702208|18144109|P1|Overall Study|Did not self-lavage|1
5258968|NCT00702208|18144109|P1|Overall Study|Lost to Follow-up|28
5258969|NCT00702143|18144118|P3|Overall Study|Lost to Follow-up|1
5258970|NCT00702143|18144119|P2|Overall Study|Lost to Follow-up|0
5258971|NCT00702143|18144120|P1|Overall Study|Lost to Follow-up|0
5258972|NCT00701805|18144169|P4|Overall Study|Resumption criteria were not met|0
5258973|NCT00701805|18144170|P3|Overall Study|Resumption criteria were not met|0
5258974|NCT00701805|18144171|P2|Overall Study|Resumption criteria were not met|1
5258975|NCT00701805|18144172|P1|Overall Study|Resumption criteria were not met|0
5258976|NCT00701805|18144169|P4|Overall Study|Difficult to travel to dialysis site|0
5258977|NCT00701805|18144170|P3|Overall Study|Difficult to travel to dialysis site|1
5258978|NCT00701805|18144171|P2|Overall Study|Difficult to travel to dialysis site|0
5258979|NCT00701805|18144172|P1|Overall Study|Difficult to travel to dialysis site|0
5258980|NCT00701805|18144169|P4|Overall Study|Physician decision, change of therapy|1
5258981|NCT00701805|18144170|P3|Overall Study|Physician decision, change of therapy|0
5258982|NCT00701805|18144171|P2|Overall Study|Physician decision, change of therapy|0
5258983|NCT00701805|18144172|P1|Overall Study|Physician decision, change of therapy|0
5258984|NCT00701805|18144169|P4|Overall Study|Admitted to hospital for 2 weeks|0
5258985|NCT00701805|18144170|P3|Overall Study|Admitted to hospital for 2 weeks|1
5258986|NCT00701805|18144171|P2|Overall Study|Admitted to hospital for 2 weeks|0
5258987|NCT00701805|18144172|P1|Overall Study|Admitted to hospital for 2 weeks|0
5258988|NCT00701805|18144169|P4|Overall Study|Missed 7 consecutive doses|0
5258989|NCT00701805|18144170|P3|Overall Study|Missed 7 consecutive doses|0
5258990|NCT00701805|18144171|P2|Overall Study|Missed 7 consecutive doses|1
5258991|NCT00701805|18144172|P1|Overall Study|Missed 7 consecutive doses|0
5258992|NCT00701805|18144169|P4|Overall Study|Adverse Event|0
5258993|NCT00701805|18144170|P3|Overall Study|Adverse Event|1
5258994|NCT00701805|18144171|P2|Overall Study|Adverse Event|1
5258995|NCT00701805|18144172|P1|Overall Study|Adverse Event|0
5258996|NCT00701805|18144169|P4|Overall Study|Withdrawal by Subject|3
5258997|NCT00701805|18144170|P3|Overall Study|Withdrawal by Subject|4
5258998|NCT00701805|18144171|P2|Overall Study|Withdrawal by Subject|1
5258999|NCT00701805|18144172|P1|Overall Study|Withdrawal by Subject|3
5259000|NCT00701779|18144222|P1|Overall Study|Withdrawal by Subject|2
5259001|NCT00701779|18144222|P1|Overall Study|Lost to Follow-up|1
5259002|NCT00701779|18144222|P1|Overall Study|Adverse Event|6
5259003|NCT00701727|18144234|P2|Second Treatment Period|Withdrawal by Subject|0
5259004|NCT00701727|18144235|P1|Second Treatment Period|Withdrawal by Subject|2
5259005|NCT00701727|18144234|P2|First Treatment Period|Lost to Follow-up|1
5259006|NCT00701727|18144235|P1|First Treatment Period|Lost to Follow-up|0
5259007|NCT00701727|18144234|P2|First Treatment Period|sponsor decision|1
5259008|NCT00701727|18144235|P1|First Treatment Period|sponsor decision|0
5259009|NCT00701727|18144234|P2|First Treatment Period|Withdrawal by Subject|0
5259010|NCT00701727|18144235|P1|First Treatment Period|Withdrawal by Subject|1
5259011|NCT00701727|18144234|P2|First Treatment Period|Adverse Event|0
5259012|NCT00701727|18144235|P1|First Treatment Period|Adverse Event|0
5259013|NCT00701701|18144270|P2|Overall Study|Adverse Event|1
5259014|NCT00701701|18144271|P1|Overall Study|Adverse Event|0
5259015|NCT00701701|18144270|P2|Overall Study|Withdrawal by Subject|1
5259016|NCT00701701|18144271|P1|Overall Study|Withdrawal by Subject|0
5259017|NCT00701662|18144306|P1|Overall Study|Lack of Efficacy|1
5259018|NCT00701558|18144331|P1|Overall Study|Lost to Follow-up|8
5259019|NCT00701558|18144331|P1|Overall Study|Death|7
5259020|NCT00701441|18144339|P2|Overall Study|failure in cpap compliance|4
5259021|NCT00701441|18144340|P1|Overall Study|failure in cpap compliance|0
5259022|NCT00701415|18144352|P2|Overall Study|Social/family issues and needle phobia|0
5259023|NCT00701415|18144353|P1|Overall Study|Social/family issues and needle phobia|1
5259024|NCT00701415|18144352|P2|Overall Study|Adverse Event|1
5259025|NCT00701415|18144353|P1|Overall Study|Adverse Event|0
5259026|NCT00701363|18144412|P4|Treatment Phase 2|Withdrawal by Subject|0
5259027|NCT00701363|18144413|P3|Treatment Phase 2|Withdrawal by Subject|1
5259028|NCT00701363|18144414|P2|Treatment Phase 2|Withdrawal by Subject|0
5259029|NCT00701363|18144415|P1|Treatment Phase 2|Withdrawal by Subject|0
5259030|NCT00701363|18144412|P4|Treatment Phase 2|Adverse Event|0
5259031|NCT00701363|18144413|P3|Treatment Phase 2|Adverse Event|1
5259032|NCT00701363|18144414|P2|Treatment Phase 2|Adverse Event|0
5259033|NCT00701363|18144415|P1|Treatment Phase 2|Adverse Event|0
5259034|NCT00701363|18144412|P4|Treatment Phase 1|Lack of Efficacy|0
5259035|NCT00701363|18144413|P3|Treatment Phase 1|Lack of Efficacy|0
5259036|NCT00701363|18144414|P2|Treatment Phase 1|Lack of Efficacy|0
5259037|NCT00701363|18144415|P1|Treatment Phase 1|Lack of Efficacy|1
5259038|NCT00701363|18144412|P4|Treatment Phase 1|Withdrawal by Subject|0
5259039|NCT00701363|18144413|P3|Treatment Phase 1|Withdrawal by Subject|0
5259040|NCT00701363|18144414|P2|Treatment Phase 1|Withdrawal by Subject|0
5259041|NCT00701363|18144415|P1|Treatment Phase 1|Withdrawal by Subject|5
5259042|NCT00701363|18144412|P4|Treatment Phase 1|Protocol Violation|0
5259043|NCT00701363|18144413|P3|Treatment Phase 1|Protocol Violation|0
5259044|NCT00701363|18144414|P2|Treatment Phase 1|Protocol Violation|0
5259045|NCT00701363|18144415|P1|Treatment Phase 1|Protocol Violation|1
5259046|NCT00701363|18144412|P4|Treatment Phase 1|Adverse Event|0
5259047|NCT00701363|18144413|P3|Treatment Phase 1|Adverse Event|0
5259048|NCT00701363|18144414|P2|Treatment Phase 1|Adverse Event|0
5259049|NCT00701363|18144415|P1|Treatment Phase 1|Adverse Event|7
5259050|NCT00701363|18144412|P4|Treatment Phase 1|Does not meet entry Criteria|0
5259051|NCT00701363|18144413|P3|Treatment Phase 1|Does not meet entry Criteria|0
5259052|NCT00701363|18144414|P2|Treatment Phase 1|Does not meet entry Criteria|0
5259053|NCT00701363|18144415|P1|Treatment Phase 1|Does not meet entry Criteria|1
5259054|NCT00701363|18144412|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
5259055|NCT00701363|18144413|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
5259056|NCT00701363|18144414|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
5259057|NCT00701363|18144415|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
5259058|NCT00701311|18144455|P1|Overall Study|Withdrawal by Subject|2
5259059|NCT00701311|18144455|P1|Overall Study|Adverse Event|3
5259060|NCT00701311|18144455|P1|Overall Study|Lack of Efficacy|3
5259061|NCT00701129|18144459|P1|Overall Study|Death|2
5259062|NCT00701103|18144481|P11|Overall Study|Other|0
5259063|NCT00701103|18144482|P10|Overall Study|Other|1
5259064|NCT00701103|18144483|P9|Overall Study|Other|1
5259065|NCT00701103|18144484|P8|Overall Study|Other|0
5259066|NCT00701103|18144485|P7|Overall Study|Other|0
5259067|NCT00701103|18144486|P6|Overall Study|Other|0
5259068|NCT00701103|18144487|P5|Overall Study|Other|0
5259069|NCT00701103|18144488|P4|Overall Study|Other|0
5259070|NCT00701103|18144489|P3|Overall Study|Other|0
5259071|NCT00701103|18144490|P2|Overall Study|Other|0
5259072|NCT00701103|18144491|P1|Overall Study|Other|0
5259073|NCT00701103|18144481|P11|Overall Study|Withdrawal by Subject|0
5259074|NCT00701103|18144482|P10|Overall Study|Withdrawal by Subject|0
5259075|NCT00701103|18144483|P9|Overall Study|Withdrawal by Subject|0
5259076|NCT00701103|18144484|P8|Overall Study|Withdrawal by Subject|0
5259077|NCT00701103|18144485|P7|Overall Study|Withdrawal by Subject|0
5259078|NCT00701103|18144486|P6|Overall Study|Withdrawal by Subject|0
5259079|NCT00701103|18144487|P5|Overall Study|Withdrawal by Subject|0
5259080|NCT00701103|18144488|P4|Overall Study|Withdrawal by Subject|0
5259081|NCT00701103|18144489|P3|Overall Study|Withdrawal by Subject|1
5259082|NCT00701103|18144490|P2|Overall Study|Withdrawal by Subject|1
5259083|NCT00701103|18144491|P1|Overall Study|Withdrawal by Subject|0
5259084|NCT00701103|18144481|P11|Overall Study|Progressive Disease|11
5259085|NCT00701103|18144482|P10|Overall Study|Progressive Disease|8
5259086|NCT00701103|18144483|P9|Overall Study|Progressive Disease|8
5259087|NCT00701103|18144484|P8|Overall Study|Progressive Disease|7
5259088|NCT00701103|18144485|P7|Overall Study|Progressive Disease|7
5259089|NCT00701103|18144486|P6|Overall Study|Progressive Disease|5
5259090|NCT00701103|18144487|P5|Overall Study|Progressive Disease|6
5259091|NCT00701103|18144488|P4|Overall Study|Progressive Disease|5
5259092|NCT00701103|18144489|P3|Overall Study|Progressive Disease|6
5259093|NCT00701103|18144490|P2|Overall Study|Progressive Disease|2
5259094|NCT00701103|18144491|P1|Overall Study|Progressive Disease|5
5259095|NCT00701103|18144481|P11|Overall Study|Adverse Event|0
5259096|NCT00701103|18144482|P10|Overall Study|Adverse Event|2
5259097|NCT00701103|18144483|P9|Overall Study|Adverse Event|0
5259098|NCT00701103|18144484|P8|Overall Study|Adverse Event|0
5259099|NCT00701103|18144485|P7|Overall Study|Adverse Event|1
5259100|NCT00701103|18144486|P6|Overall Study|Adverse Event|1
5259101|NCT00701103|18144487|P5|Overall Study|Adverse Event|0
5259102|NCT00701103|18144488|P4|Overall Study|Adverse Event|1
5259103|NCT00701103|18144489|P3|Overall Study|Adverse Event|1
5259104|NCT00701103|18144490|P2|Overall Study|Adverse Event|0
5259105|NCT00701103|18144491|P1|Overall Study|Adverse Event|0
5259106|NCT00701090|18144597|P2|Overall Study|Other|12
5259107|NCT00701090|18144598|P1|Overall Study|Other|7
5259108|NCT00701090|18144597|P2|Overall Study|Withdrawal by Subject|16
5259109|NCT00701090|18144598|P1|Overall Study|Withdrawal by Subject|11
5259110|NCT00701090|18144597|P2|Overall Study|Protocol Violation|3
5259111|NCT00701090|18144598|P1|Overall Study|Protocol Violation|2
5259112|NCT00701090|18144597|P2|Overall Study|Physician Decision|4
5259113|NCT00701090|18144598|P1|Overall Study|Physician Decision|3
5259114|NCT00701090|18144597|P2|Overall Study|Lost to Follow-up|9
5259115|NCT00701090|18144598|P1|Overall Study|Lost to Follow-up|9
5259116|NCT00701090|18144597|P2|Overall Study|Lack of Efficacy|4
5259117|NCT00701090|18144598|P1|Overall Study|Lack of Efficacy|5
5259118|NCT00701090|18144597|P2|Overall Study|Death|1
5259119|NCT00701090|18144598|P1|Overall Study|Death|0
5259120|NCT00701090|18144597|P2|Overall Study|Adverse Event|2
5259121|NCT00701090|18144598|P1|Overall Study|Adverse Event|11
5259122|NCT00701064|18144616|P2|Overall Study|initiated other PTSD treatment|2
5259123|NCT00701064|18144617|P1|Overall Study|initiated other PTSD treatment|2
5259124|NCT00701064|18144616|P2|Overall Study|Withdrawal by Subject|1
5259125|NCT00701064|18144617|P1|Overall Study|Withdrawal by Subject|1
5259126|NCT00701064|18144616|P2|Overall Study|Protocol Violation|1
5259127|NCT00701064|18144617|P1|Overall Study|Protocol Violation|1
5259128|NCT00701051|18144629|P3|Exercise Intervention|time conflict; non-study related illness|3
5259129|NCT00701051|18144630|P2|Exercise Intervention|time conflict; non-study related illness|5
5259130|NCT00701051|18144631|P1|Exercise Intervention|time conflict; non-study related illness|0
5259131|NCT00701051|18144629|P3|Screening|Time conflicts|0
5259132|NCT00701051|18144630|P2|Screening|Time conflicts|0
5259133|NCT00701051|18144631|P1|Screening|Time conflicts|19
5259134|NCT00701051|18144629|P3|Screening|Failed Screening|0
5259135|NCT00701051|18144630|P2|Screening|Failed Screening|0
5259136|NCT00701051|18144631|P1|Screening|Failed Screening|40
5259137|NCT00701038|18144649|P2|Overall Study|study amended pilot group of patients|4
5259138|NCT00701038|18144650|P1|Overall Study|study amended pilot group of patients|4
5259139|NCT00700999|18144658|P2|Overall Study|Withdrawal by Subject|1
5259140|NCT00700999|18144659|P1|Overall Study|Withdrawal by Subject|8
5259141|NCT00700999|18144658|P2|Overall Study|Excluded - did not meet study criteria|1
5259142|NCT00700999|18144659|P1|Overall Study|Excluded - did not meet study criteria|0
5259143|NCT00700999|18144658|P2|Overall Study|Lost to Follow-up|7
5259144|NCT00700999|18144659|P1|Overall Study|Lost to Follow-up|7
5259145|NCT00700882|18144674|P1|Overall Study|No KIT mutation|51
5259146|NCT00700882|18144674|P1|Overall Study|Ineligible|2
5259147|NCT00700882|18144674|P1|Overall Study|Never received treatment|6
5259148|NCT00700817|18144683|P5|Week 52-78 (Extension Period 2)|Unclassified|1
5259149|NCT00700817|18144684|P4|Week 52-78 (Extension Period 2)|Unclassified|0
5259150|NCT00700817|18144685|P3|Week 52-78 (Extension Period 2)|Unclassified|0
5259151|NCT00700817|18144686|P2|Week 52-78 (Extension Period 2)|Unclassified|4
5259152|NCT00700817|18144687|P1|Week 52-78 (Extension Period 2)|Unclassified|2
5259153|NCT00700817|18144683|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
5259154|NCT00700817|18144684|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
5259155|NCT00700817|18144685|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
5259156|NCT00700817|18144686|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
5259157|NCT00700817|18144687|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
5259158|NCT00700817|18144683|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
5259159|NCT00700817|18144684|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
5259160|NCT00700817|18144685|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
5259161|NCT00700817|18144686|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
5259162|NCT00700817|18144687|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
5259163|NCT00700817|18144683|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
5259164|NCT00700817|18144684|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
5259165|NCT00700817|18144685|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
5259166|NCT00700817|18144686|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
5259167|NCT00700817|18144687|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
5259168|NCT00700817|18144683|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
5259169|NCT00700817|18144684|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
5259170|NCT00700817|18144685|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
5259171|NCT00700817|18144686|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
5259172|NCT00700817|18144687|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
5259173|NCT00700817|18144683|P5|Week 26-52 (Extension Period 1)|Unclassified|0
5259174|NCT00700817|18144684|P4|Week 26-52 (Extension Period 1)|Unclassified|0
5259175|NCT00700817|18144685|P3|Week 26-52 (Extension Period 1)|Unclassified|1
5259176|NCT00700817|18144686|P2|Week 26-52 (Extension Period 1)|Unclassified|3
5259177|NCT00700817|18144687|P1|Week 26-52 (Extension Period 1)|Unclassified|4
5259178|NCT00700817|18144683|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
5259179|NCT00700817|18144684|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
5259180|NCT00700817|18144685|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
5259181|NCT00700817|18144686|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
5259182|NCT00700817|18144687|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
5259183|NCT00700817|18144683|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
5259184|NCT00700817|18144684|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
5259185|NCT00700817|18144685|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
5259186|NCT00700817|18144686|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
5259187|NCT00700817|18144687|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
5259188|NCT00700817|18144683|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
5259189|NCT00700817|18144684|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
5259190|NCT00700817|18144685|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
5259191|NCT00700817|18144686|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
5259192|NCT00700817|18144687|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
5259193|NCT00700817|18144683|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
5259194|NCT00700817|18144684|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
5259195|NCT00700817|18144685|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
5259196|NCT00700817|18144686|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
5259197|NCT00700817|18144687|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
5259198|NCT00700817|18144683|P5|Week 0-26 (Main Period)|Unclassified|0
5259199|NCT00700817|18144684|P4|Week 0-26 (Main Period)|Unclassified|0
5259200|NCT00700817|18144685|P3|Week 0-26 (Main Period)|Unclassified|8
5259201|NCT00700817|18144686|P2|Week 0-26 (Main Period)|Unclassified|4
5259202|NCT00700817|18144687|P1|Week 0-26 (Main Period)|Unclassified|14
5259203|NCT00700817|18144683|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
5259204|NCT00700817|18144684|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
5259205|NCT00700817|18144685|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
5259206|NCT00700817|18144686|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
5259207|NCT00700817|18144687|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
5259208|NCT00700817|18144683|P5|Week 0-26 (Main Period)|Protocol Violation|0
5259209|NCT00700817|18144684|P4|Week 0-26 (Main Period)|Protocol Violation|0
5259210|NCT00700817|18144685|P3|Week 0-26 (Main Period)|Protocol Violation|4
5259211|NCT00700817|18144686|P2|Week 0-26 (Main Period)|Protocol Violation|4
5259212|NCT00700817|18144687|P1|Week 0-26 (Main Period)|Protocol Violation|14
5259213|NCT00700817|18144683|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
5259214|NCT00700817|18144684|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
5259215|NCT00700817|18144685|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
5259216|NCT00700817|18144686|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
5259217|NCT00700817|18144687|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
5259218|NCT00700817|18144683|P5|Week 0-26 (Main Period)|Adverse Event|0
5259219|NCT00700817|18144684|P4|Week 0-26 (Main Period)|Adverse Event|0
5259220|NCT00700817|18144685|P3|Week 0-26 (Main Period)|Adverse Event|4
5259221|NCT00700817|18144686|P2|Week 0-26 (Main Period)|Adverse Event|15
5259222|NCT00700817|18144687|P1|Week 0-26 (Main Period)|Adverse Event|14
5259223|NCT00700804|18145069|P2|Overall Study|Loose Stools|1
5259224|NCT00700804|18145070|P1|Overall Study|Loose Stools|1
5259225|NCT00700804|18145069|P2|Overall Study|Protocol Violation|1
5259226|NCT00700804|18145070|P1|Overall Study|Protocol Violation|1
5259227|NCT00700804|18145069|P2|Overall Study|Withdrawal by Subject|2
5259228|NCT00700804|18145070|P1|Overall Study|Withdrawal by Subject|1
5259229|NCT00700752|18145078|P2|First Intervention|Withdrawal by Subject|2
5259230|NCT00700752|18145079|P1|First Intervention|Withdrawal by Subject|0
5259231|NCT00700739|18145087|P2|Overall Study|Lost to Follow-up|4
5259232|NCT00700739|18145088|P1|Overall Study|Lost to Follow-up|4
5259233|NCT00700713|18145127|P3|Overall Study|Withdrawal by Subject|1
5259234|NCT00700713|18145128|P2|Overall Study|Withdrawal by Subject|0
5259235|NCT00700713|18145129|P1|Overall Study|Withdrawal by Subject|0
5259236|NCT00700713|18145127|P3|Overall Study|Protocol Violation|1
5259237|NCT00700713|18145128|P2|Overall Study|Protocol Violation|0
5259238|NCT00700713|18145129|P1|Overall Study|Protocol Violation|1
5259239|NCT00700635|18145146|P3|Overall Study|Withdrawal by Subject|1
5259240|NCT00700635|18145147|P2|Overall Study|Withdrawal by Subject|3
5259241|NCT00700635|18145148|P1|Overall Study|Withdrawal by Subject|7
5259242|NCT00700635|18145146|P3|Overall Study|Protocol Violation|0
5259243|NCT00700635|18145147|P2|Overall Study|Protocol Violation|2
5259244|NCT00700635|18145148|P1|Overall Study|Protocol Violation|2
5259245|NCT00700635|18145146|P3|Overall Study|Lost to Follow-up|0
5259246|NCT00700635|18145147|P2|Overall Study|Lost to Follow-up|3
5259247|NCT00700635|18145148|P1|Overall Study|Lost to Follow-up|1
5259248|NCT00700635|18145146|P3|Overall Study|Adverse Event|0
5259249|NCT00700635|18145147|P2|Overall Study|Adverse Event|0
5259250|NCT00700635|18145148|P1|Overall Study|Adverse Event|1
5259251|NCT00700622|18145170|P2|Overall Study|Other|1
5259252|NCT00700622|18145171|P1|Overall Study|Other|3
5259253|NCT00700622|18145170|P2|Overall Study|Withdrawal by Subject|1
5259254|NCT00700622|18145171|P1|Overall Study|Withdrawal by Subject|4
5259255|NCT00700622|18145170|P2|Overall Study|Protocol Violation|1
5259256|NCT00700622|18145171|P1|Overall Study|Protocol Violation|0
5259257|NCT00700622|18145170|P2|Overall Study|Physician Decision|1
5259258|NCT00700622|18145171|P1|Overall Study|Physician Decision|2
5259259|NCT00700622|18145170|P2|Overall Study|Lost to Follow-up|1
5259260|NCT00700622|18145171|P1|Overall Study|Lost to Follow-up|0
5259261|NCT00700622|18145170|P2|Overall Study|Adverse Event|0
5259262|NCT00700622|18145171|P1|Overall Study|Adverse Event|4
5259263|NCT00700570|18145179|P2|Overall Study|Withdrawal by Subject|6
5259264|NCT00700570|18145180|P1|Overall Study|Withdrawal by Subject|1
5259265|NCT00700570|18145179|P2|Overall Study|Disease Progression|11
5259266|NCT00700570|18145180|P1|Overall Study|Disease Progression|8
5259267|NCT00700570|18145179|P2|Overall Study|Discretion of Investigator or Sponsor|3
5259268|NCT00700570|18145180|P1|Overall Study|Discretion of Investigator or Sponsor|0
5259269|NCT00700570|18145179|P2|Overall Study|Adverse Event|6
5259270|NCT00700570|18145180|P1|Overall Study|Adverse Event|2
5259271|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
5259272|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5259273|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5259274|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5259275|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5259276|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
5259277|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5259278|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5259279|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5259280|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5259281|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
5259282|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5259283|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5259284|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5259285|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5259286|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
5259287|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5259288|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5259289|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5259290|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5259291|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
5259292|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
5259293|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
5259294|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
5259295|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
5259296|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
5259297|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5259298|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5259299|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5259300|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5259301|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
5259302|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5259303|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5259304|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5259305|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5259306|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Death|1
5259307|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Death|0
5259308|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Death|0
5259309|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Death|0
5259310|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Death|0
5259311|NCT00700427|18145196|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
5259312|NCT00700427|18145197|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
5259313|NCT00700427|18145198|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
5259314|NCT00700427|18145199|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
5259315|NCT00700427|18145200|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
5259316|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Death|0
5259317|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Death|0
5259318|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Death|1
5259319|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Death|0
5259320|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Death|0
5259321|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5259322|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5259323|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
5259324|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5259325|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5259326|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
5259327|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
5259328|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
5259329|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
5259330|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
5259331|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5259332|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
5259333|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5259334|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5259335|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5259336|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5259337|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
5259338|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5259339|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5259340|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5259341|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
5259342|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
5259343|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
5259344|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
5259345|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
5259346|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
5259347|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
5259348|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
5259349|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
5259350|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
5259351|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
5259352|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
5259353|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
5259354|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
5259355|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
5259356|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
5259357|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
5259358|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
5259359|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
5259360|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
5259361|NCT00700427|18145196|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
5259362|NCT00700427|18145197|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
5259363|NCT00700427|18145198|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
5259364|NCT00700427|18145199|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
5259365|NCT00700427|18145200|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
5259366|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5259367|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5259368|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5259369|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
5259370|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5259371|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5259372|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5259373|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5259374|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
5259375|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5259376|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5259377|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5259378|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5259379|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
5259380|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5259381|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5259382|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5259383|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5259384|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
5259385|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5259386|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5259387|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5259388|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5259389|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
5259390|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5259391|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5259392|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5259393|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5259394|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
5259395|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5259396|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5259397|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5259398|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5259399|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
5259400|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5259401|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5259402|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5259403|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5259404|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
5259405|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5259406|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5259407|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5259408|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5259409|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
5259410|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5259411|NCT00700427|18145196|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5259412|NCT00700427|18145197|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5259413|NCT00700427|18145198|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5259414|NCT00700427|18145199|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
5259415|NCT00700427|18145200|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5259416|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5259417|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5259418|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5259419|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5259420|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
5259421|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5259422|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5259423|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5259424|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5259425|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
5259426|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5259427|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5259428|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5259429|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5259430|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
5259431|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5259432|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5259433|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5259434|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5259435|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
5259436|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5259437|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5259438|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5259439|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5259440|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
5259441|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5259442|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5259443|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5259444|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5259445|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
5259446|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5259447|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5259448|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5259449|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5259450|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
5259451|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5259452|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5259453|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5259454|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5259455|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
5259456|NCT00700427|18145196|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5259457|NCT00700427|18145197|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5259458|NCT00700427|18145198|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5259459|NCT00700427|18145199|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5259460|NCT00700427|18145200|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
5259461|NCT00700401|18145222|P1|Overall Study|Withdrawal by Subject|2
5259462|NCT00700401|18145222|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
5259463|NCT00700401|18145222|P1|Overall Study|Treatment never started|1
5259464|NCT00700401|18145222|P1|Overall Study|Lost to Follow-up|1
5259465|NCT00700401|18145222|P1|Overall Study|Refused Treatment|2
5259466|NCT00700401|18145222|P1|Overall Study|Adverse Event|5
5259467|NCT00700401|18145222|P1|Overall Study|Detectable HCV RNA after Week 4|82
5259468|NCT00700310|18145246|P4|Overall Study|Randomized, Not Treated|2
5259469|NCT00700310|18145247|P3|Overall Study|Randomized, Not Treated|2
5259470|NCT00700310|18145248|P2|Overall Study|Randomized, Not Treated|0
5259471|NCT00700310|18145249|P1|Overall Study|Randomized, Not Treated|2
5259472|NCT00700310|18145246|P4|Overall Study|Administrative/Other|3
5259473|NCT00700310|18145247|P3|Overall Study|Administrative/Other|1
5259474|NCT00700310|18145248|P2|Overall Study|Administrative/Other|3
5259475|NCT00700310|18145249|P1|Overall Study|Administrative/Other|1
5259476|NCT00700310|18145246|P4|Overall Study|Lack of Efficacy|1
5259477|NCT00700310|18145247|P3|Overall Study|Lack of Efficacy|0
5259478|NCT00700310|18145248|P2|Overall Study|Lack of Efficacy|3
5259479|NCT00700310|18145249|P1|Overall Study|Lack of Efficacy|0
5259480|NCT00700310|18145246|P4|Overall Study|Withdrawal by Subject|8
5259481|NCT00700310|18145247|P3|Overall Study|Withdrawal by Subject|8
5259482|NCT00700310|18145248|P2|Overall Study|Withdrawal by Subject|9
5259483|NCT00700310|18145249|P1|Overall Study|Withdrawal by Subject|8
5259484|NCT00700310|18145246|P4|Overall Study|Lost to Follow-up|1
5259485|NCT00700310|18145247|P3|Overall Study|Lost to Follow-up|0
5259486|NCT00700310|18145248|P2|Overall Study|Lost to Follow-up|1
5259487|NCT00700310|18145249|P1|Overall Study|Lost to Follow-up|4
5259488|NCT00700310|18145246|P4|Overall Study|Adverse Event|11
5259489|NCT00700310|18145247|P3|Overall Study|Adverse Event|5
5259490|NCT00700310|18145248|P2|Overall Study|Adverse Event|10
5259491|NCT00700310|18145249|P1|Overall Study|Adverse Event|6
5259492|NCT00700271|18145269|P2|Overall Study|Lost to Follow-up|2
5259493|NCT00700271|18145270|P1|Overall Study|Lost to Follow-up|2
5259494|NCT00700271|18145269|P2|Overall Study|Withdrawal by Subject|4
5259495|NCT00700271|18145270|P1|Overall Study|Withdrawal by Subject|6
5259496|NCT00700271|18145269|P2|Overall Study|Administrative Reasons|0
5259497|NCT00700271|18145270|P1|Overall Study|Administrative Reasons|1
5259498|NCT00700271|18145269|P2|Overall Study|Protocol Violation|0
5259499|NCT00700271|18145270|P1|Overall Study|Protocol Violation|1
5259500|NCT00700271|18145269|P2|Overall Study|Adverse Event|6
5259501|NCT00700271|18145270|P1|Overall Study|Adverse Event|4
5259502|NCT00700180|18145298|P2|Overall Study|Lost to Follow-up|5
5259503|NCT00700180|18145299|P1|Overall Study|Lost to Follow-up|4
5259504|NCT00700180|18145298|P2|Overall Study|Alive in follow-up|27
5259505|NCT00700180|18145299|P1|Overall Study|Alive in follow-up|46
5259506|NCT00700180|18145298|P2|Overall Study|Alive on treatment|3
5259507|NCT00700180|18145299|P1|Overall Study|Alive on treatment|5
5259508|NCT00700180|18145298|P2|Overall Study|Death|114
5259509|NCT00700180|18145299|P1|Overall Study|Death|99
5259510|NCT00700115|18145328|P2|Overall Study|Lost to Follow-up|1
5259511|NCT00700115|18145329|P1|Overall Study|Lost to Follow-up|0
5259512|NCT00700115|18145328|P2|Overall Study|Withdrawal by Subject|0
5259513|NCT00700115|18145329|P1|Overall Study|Withdrawal by Subject|1
5259514|NCT00700102|18145339|P2|Overall Study|Lost to Follow-up|10
5259515|NCT00700102|18145340|P1|Overall Study|Lost to Follow-up|8
5259516|NCT00700102|18145339|P2|Overall Study|Died|385
5259517|NCT00700102|18145340|P1|Overall Study|Died|394
5259518|NCT00700011|18145479|P2|Overall Study|Death|1
5259519|NCT00700011|18145480|P1|Overall Study|Death|0
5259520|NCT00699998|18145496|P4|Overall Study|Lost to Follow-up|1
5259521|NCT00699998|18145497|P3|Overall Study|Lost to Follow-up|3
5259522|NCT00699998|18145498|P2|Overall Study|Lost to Follow-up|1
5259523|NCT00699998|18145499|P1|Overall Study|Lost to Follow-up|2
5259524|NCT00699998|18145496|P4|Overall Study|Physician Decision|1
5259525|NCT00699998|18145497|P3|Overall Study|Physician Decision|1
5259526|NCT00699998|18145498|P2|Overall Study|Physician Decision|2
5259527|NCT00699998|18145499|P1|Overall Study|Physician Decision|3
5259528|NCT00699998|18145496|P4|Overall Study|Withdrawal by Subject|80
5259529|NCT00699998|18145497|P3|Overall Study|Withdrawal by Subject|202
5259530|NCT00699998|18145498|P2|Overall Study|Withdrawal by Subject|83
5259531|NCT00699998|18145499|P1|Overall Study|Withdrawal by Subject|194
5259532|NCT00699972|18145544|P3|Overall Study|Randomized, Not Treated|1
5259533|NCT00699972|18145545|P2|Overall Study|Randomized, Not Treated|0
5259534|NCT00699972|18145546|P1|Overall Study|Randomized, Not Treated|1
5259535|NCT00699972|18145544|P3|Overall Study|Administrative/Other|4
5259536|NCT00699972|18145545|P2|Overall Study|Administrative/Other|1
5259537|NCT00699972|18145546|P1|Overall Study|Administrative/Other|3
5259538|NCT00699972|18145544|P3|Overall Study|Lack of Efficacy|2
5259539|NCT00699972|18145545|P2|Overall Study|Lack of Efficacy|0
5259540|NCT00699972|18145546|P1|Overall Study|Lack of Efficacy|2
5259541|NCT00699972|18145544|P3|Overall Study|Withdrawal by Subject|4
5259542|NCT00699972|18145545|P2|Overall Study|Withdrawal by Subject|7
5259543|NCT00699972|18145546|P1|Overall Study|Withdrawal by Subject|3
5259544|NCT00699972|18145544|P3|Overall Study|Lost to Follow-up|0
5259545|NCT00699972|18145545|P2|Overall Study|Lost to Follow-up|2
5259546|NCT00699972|18145546|P1|Overall Study|Lost to Follow-up|0
5259547|NCT00699972|18145544|P3|Overall Study|Adverse Event|24
5259548|NCT00699972|18145545|P2|Overall Study|Adverse Event|9
5259549|NCT00699972|18145546|P1|Overall Study|Adverse Event|7
5259550|NCT00699907|18145563|P3|Overall Study|No usable sample|8
5259551|NCT00699907|18145564|P2|Overall Study|No usable sample|9
5259552|NCT00699907|18145565|P1|Overall Study|No usable sample|0
5259553|NCT00699907|18145563|P3|Overall Study|Withdrawal by Subject|0
5259554|NCT00699907|18145564|P2|Overall Study|Withdrawal by Subject|1
5259555|NCT00699907|18145565|P1|Overall Study|Withdrawal by Subject|2
5259556|NCT00699842|18145600|P3|Overall Study|Death|0
5259557|NCT00699842|18145601|P2|Overall Study|Death|1
5259558|NCT00699842|18145602|P1|Overall Study|Death|0
5259559|NCT00699816|18145615|P2|Overall Study|Protocol Violation|3
5259560|NCT00699816|18145616|P1|Overall Study|Protocol Violation|1
5259561|NCT00699751|18145643|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
5259562|NCT00699751|18145644|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
5259563|NCT00699751|18145643|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
5259564|NCT00699751|18145644|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
5259565|NCT00699751|18145643|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
5259566|NCT00699751|18145644|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
5259567|NCT00699751|18145643|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
5259568|NCT00699751|18145644|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
5259569|NCT00699751|18145643|P2|Period 1: Without/Before Drug Switch|Other|20
5259570|NCT00699751|18145644|P1|Period 1: Without/Before Drug Switch|Other|30
5259571|NCT00699751|18145643|P2|Period 1: Without/Before Drug Switch|Subject Request|23
5259572|NCT00699751|18145644|P1|Period 1: Without/Before Drug Switch|Subject Request|43
5259573|NCT00699751|18145643|P2|Period 1: Without/Before Drug Switch|Death|29
5259574|NCT00699751|18145644|P1|Period 1: Without/Before Drug Switch|Death|28
5259575|NCT00699751|18145643|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
5259576|NCT00699751|18145644|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
5259577|NCT00699699|18145729|P1|Overall Study|Individual different reasons|21
5259578|NCT00699699|18145729|P1|Overall Study|Adverse Event|36
5259579|NCT00699660|18145738|P2|Overall Study|missing reports and recording failures|6
5259580|NCT00699660|18145739|P1|Overall Study|missing reports and recording failures|10
5259581|NCT00699660|18145738|P2|Overall Study|Lost to Follow-up|2
5259582|NCT00699660|18145739|P1|Overall Study|Lost to Follow-up|4
5259583|NCT00699608|18145751|P6|Second Intervention|Withdrawal by Subject|0
5259584|NCT00699608|18145752|P5|Second Intervention|Withdrawal by Subject|0
5259585|NCT00699608|18145753|P4|Second Intervention|Withdrawal by Subject|1
5259586|NCT00699608|18145754|P3|Second Intervention|Withdrawal by Subject|0
5259587|NCT00699608|18145755|P2|Second Intervention|Withdrawal by Subject|0
5259588|NCT00699608|18145756|P1|Second Intervention|Withdrawal by Subject|0
5259589|NCT00699608|18145751|P6|Second Intervention|Adverse Event|0
5259590|NCT00699608|18145752|P5|Second Intervention|Adverse Event|0
5259591|NCT00699608|18145753|P4|Second Intervention|Adverse Event|0
5259592|NCT00699608|18145754|P3|Second Intervention|Adverse Event|1
5259593|NCT00699608|18145755|P2|Second Intervention|Adverse Event|0
5259594|NCT00699608|18145756|P1|Second Intervention|Adverse Event|0
5259595|NCT00699608|18145751|P6|First Intervention|Protocol Violation|0
5259596|NCT00699608|18145752|P5|First Intervention|Protocol Violation|1
5259597|NCT00699608|18145753|P4|First Intervention|Protocol Violation|0
5259598|NCT00699608|18145754|P3|First Intervention|Protocol Violation|0
5259599|NCT00699608|18145755|P2|First Intervention|Protocol Violation|0
5259600|NCT00699608|18145756|P1|First Intervention|Protocol Violation|0
5259601|NCT00699608|18145751|P6|First Intervention|Withdrawal by Subject|0
5259602|NCT00699608|18145752|P5|First Intervention|Withdrawal by Subject|0
5259603|NCT00699608|18145753|P4|First Intervention|Withdrawal by Subject|0
5259604|NCT00699608|18145754|P3|First Intervention|Withdrawal by Subject|1
5259605|NCT00699608|18145755|P2|First Intervention|Withdrawal by Subject|0
5259606|NCT00699608|18145756|P1|First Intervention|Withdrawal by Subject|0
5259607|NCT00699582|18145809|P3|Overall Study|Randomized, Not Treated|0
5259608|NCT00699582|18145810|P2|Overall Study|Randomized, Not Treated|1
5259609|NCT00699582|18145811|P1|Overall Study|Randomized, Not Treated|2
5259610|NCT00699582|18145809|P3|Overall Study|Administrative/Other|0
5259611|NCT00699582|18145810|P2|Overall Study|Administrative/Other|3
5259612|NCT00699582|18145811|P1|Overall Study|Administrative/Other|4
5259613|NCT00699582|18145809|P3|Overall Study|Progressive Disease|0
5259614|NCT00699582|18145810|P2|Overall Study|Progressive Disease|0
5259615|NCT00699582|18145811|P1|Overall Study|Progressive Disease|1
5259616|NCT00699582|18145809|P3|Overall Study|Lack of Efficacy|1
5259617|NCT00699582|18145810|P2|Overall Study|Lack of Efficacy|0
5259618|NCT00699582|18145811|P1|Overall Study|Lack of Efficacy|1
5259619|NCT00699582|18145809|P3|Overall Study|Withdrawal by Subject|4
5259620|NCT00699582|18145810|P2|Overall Study|Withdrawal by Subject|7
5259621|NCT00699582|18145811|P1|Overall Study|Withdrawal by Subject|6
5259622|NCT00699582|18145809|P3|Overall Study|Adverse Event|23
5259623|NCT00699582|18145810|P2|Overall Study|Adverse Event|11
5259624|NCT00699582|18145811|P1|Overall Study|Adverse Event|4
5259625|NCT00699413|18145866|P2|Overall Study|Study terminated by sponsor|2
5259626|NCT00699413|18145867|P1|Overall Study|Study terminated by sponsor|4
5259627|NCT00699413|18145866|P2|Overall Study|Withdrawal by Subject|2
5259628|NCT00699413|18145867|P1|Overall Study|Withdrawal by Subject|0
5259629|NCT00699374|18145921|P2|Overall Study|Died 28 days after last dose|9
5259630|NCT00699374|18145922|P1|Overall Study|Died 28 days after last dose|5
5259631|NCT00699374|18145921|P2|Overall Study|Randomized but not treated|2
5259632|NCT00699374|18145922|P1|Overall Study|Randomized but not treated|4
5259633|NCT00699374|18145921|P2|Overall Study|Study terminated by sponsor|28
5259634|NCT00699374|18145922|P1|Overall Study|Study terminated by sponsor|13
5259635|NCT00699374|18145921|P2|Overall Study|Protocol Violation|6
5259636|NCT00699374|18145922|P1|Overall Study|Protocol Violation|2
5259637|NCT00699374|18145921|P2|Overall Study|Other|15
5259638|NCT00699374|18145922|P1|Overall Study|Other|18
5259639|NCT00699374|18145921|P2|Overall Study|Objective progression or relapse|277
5259640|NCT00699374|18145922|P1|Overall Study|Objective progression or relapse|281
5259641|NCT00699374|18145921|P2|Overall Study|Withdrawal by Subject|44
5259642|NCT00699374|18145922|P1|Overall Study|Withdrawal by Subject|34
5259643|NCT00699374|18145921|P2|Overall Study|Lost to Follow-up|5
5259644|NCT00699374|18145922|P1|Overall Study|Lost to Follow-up|3
5259645|NCT00699374|18145921|P2|Overall Study|Global deterioration of health status|8
5259646|NCT00699374|18145922|P1|Overall Study|Global deterioration of health status|7
5259647|NCT00699374|18145921|P2|Overall Study|Adverse Event|67
5259648|NCT00699374|18145922|P1|Overall Study|Adverse Event|70
5259649|NCT00699374|18145921|P2|Overall Study|Death|83
5259650|NCT00699374|18145922|P1|Overall Study|Death|93
5259651|NCT00699348|18145934|P1|Overall Study|Other|5
5259652|NCT00699348|18145934|P1|Overall Study|Renal transplantation|10
5259653|NCT00699348|18145934|P1|Overall Study|Blood transfusion|24
5259654|NCT00699348|18145934|P1|Overall Study|Failure to return|1
5259655|NCT00699348|18145934|P1|Overall Study|Lack of Efficacy|8
5259656|NCT00699348|18145934|P1|Overall Study|Protocol Violation|10
5259657|NCT00699348|18145934|P1|Overall Study|Withdrawal by Subject|11
5259658|NCT00699348|18145934|P1|Overall Study|Adverse Event|15
5259659|NCT00699348|18145934|P1|Overall Study|Death|6
5259660|NCT00699335|18145943|P1|Overall Study|Missing data|52
5259661|NCT00699335|18145943|P1|Overall Study|Combination of multiple reasons|176
5259662|NCT00699283|18145976|P2|Overall Study|AE of unknown type|0
5259663|NCT00699283|18145977|P1|Overall Study|AE of unknown type|1
5259664|NCT00699283|18145976|P2|Overall Study|AE, non-serious non-fatal|1
5259665|NCT00699283|18145977|P1|Overall Study|AE, non-serious non-fatal|8
5259666|NCT00699283|18145976|P2|Overall Study|SAE, non-fatal|1
5259667|NCT00699283|18145977|P1|Overall Study|SAE, non-fatal|1
5259668|NCT00699283|18145976|P2|Overall Study|Other Reason|1
5259669|NCT00699283|18145977|P1|Overall Study|Other Reason|5
5259670|NCT00699283|18145976|P2|Overall Study|Withdrawal by Subject|0
5259671|NCT00699283|18145977|P1|Overall Study|Withdrawal by Subject|1
5259672|NCT00699283|18145976|P2|Overall Study|Lost to Follow-up|0
5259673|NCT00699283|18145977|P1|Overall Study|Lost to Follow-up|2
5259674|NCT00699283|18145976|P2|Overall Study|Lack of Efficacy|5
5259675|NCT00699283|18145977|P1|Overall Study|Lack of Efficacy|15
5259676|NCT00699192|18145990|P3|Overall Study|Protocol Violation|0
5259677|NCT00699192|18145991|P2|Overall Study|Protocol Violation|2
5259678|NCT00699192|18145992|P1|Overall Study|Protocol Violation|2
5259679|NCT00699192|18145990|P3|Overall Study|Administrative problems|1
5259680|NCT00699192|18145991|P2|Overall Study|Administrative problems|3
5259681|NCT00699192|18145992|P1|Overall Study|Administrative problems|1
5259682|NCT00699192|18145990|P3|Overall Study|Withdrawal by Subject|4
5259683|NCT00699192|18145991|P2|Overall Study|Withdrawal by Subject|2
5259684|NCT00699192|18145992|P1|Overall Study|Withdrawal by Subject|3
5259685|NCT00699192|18145990|P3|Overall Study|Lack of Efficacy|1
5259686|NCT00699192|18145991|P2|Overall Study|Lack of Efficacy|0
5259687|NCT00699192|18145992|P1|Overall Study|Lack of Efficacy|0
5259688|NCT00699192|18145990|P3|Overall Study|Abnormal test procedure result(s)|1
5259689|NCT00699192|18145991|P2|Overall Study|Abnormal test procedure result(s)|0
5259690|NCT00699192|18145992|P1|Overall Study|Abnormal test procedure result(s)|0
5259691|NCT00699192|18145990|P3|Overall Study|Adverse Event|3
5259692|NCT00699192|18145991|P2|Overall Study|Adverse Event|4
5259693|NCT00699192|18145992|P1|Overall Study|Adverse Event|9
5259694|NCT00699192|18145990|P3|Overall Study|Missing|1
5259695|NCT00699192|18145991|P2|Overall Study|Missing|1
5259696|NCT00699192|18145992|P1|Overall Study|Missing|1
5259697|NCT00699153|18146014|P2|Overall Study|Travel Problem|0
5259698|NCT00699153|18146015|P1|Overall Study|Travel Problem|1
5259699|NCT00699153|18146014|P2|Overall Study|Protocol Violation|0
5259700|NCT00699153|18146015|P1|Overall Study|Protocol Violation|1
5259701|NCT00699153|18146014|P2|Overall Study|Adverse Event|2
5259702|NCT00699153|18146015|P1|Overall Study|Adverse Event|0
5259703|NCT00699153|18146014|P2|Overall Study|Lost to Follow-up|0
5259704|NCT00699153|18146015|P1|Overall Study|Lost to Follow-up|1
5259705|NCT00698997|18146050|P2|Overall Study|Withdrawal by Subject|27
5259706|NCT00698997|18146051|P1|Overall Study|Withdrawal by Subject|7
5259707|NCT00698997|18146050|P2|Overall Study|Lost to Follow-up|0
5259708|NCT00698997|18146051|P1|Overall Study|Lost to Follow-up|3
5259709|NCT00698932|18146065|P2|Overall Study|Death|0
5259710|NCT00698932|18146066|P1|Overall Study|Death|1
5259711|NCT00698932|18146065|P2|Overall Study|Safety reasons|2
5259712|NCT00698932|18146066|P1|Overall Study|Safety reasons|0
5259713|NCT00698932|18146065|P2|Overall Study|Severe non-compliance to protocol|2
5259714|NCT00698932|18146066|P1|Overall Study|Severe non-compliance to protocol|1
5259715|NCT00698932|18146065|P2|Overall Study|Lost to Follow-up|1
5259716|NCT00698932|18146066|P1|Overall Study|Lost to Follow-up|6
5259717|NCT00698932|18146065|P2|Overall Study|Withdrawal by Subject|23
5259718|NCT00698932|18146066|P1|Overall Study|Withdrawal by Subject|11
5259719|NCT00698932|18146065|P2|Overall Study|Study specific discontinuation criteria|4
5259720|NCT00698932|18146066|P1|Overall Study|Study specific discontinuation criteria|3
5259721|NCT00698932|18146065|P2|Overall Study|Incorrect enrollment|2
5259722|NCT00698932|18146066|P1|Overall Study|Incorrect enrollment|0
5259723|NCT00698932|18146065|P2|Overall Study|Adverse Event|2
5259724|NCT00698932|18146066|P1|Overall Study|Adverse Event|0
5259725|NCT00698841|18146092|P1|Overall Study|Other|2
5259726|NCT00698841|18146092|P1|Overall Study|Study drug toxicity|2
5259727|NCT00698841|18146092|P1|Overall Study|Failure to meet eligibility criteria|2
5259728|NCT00698841|18146092|P1|Overall Study|Disease progression|7
5259729|NCT00698841|18146092|P1|Overall Study|Adverse Event|3
5259730|NCT00698841|18146092|P1|Overall Study|Withdrawal by Subject|2
5259731|NCT00698815|18146106|P3|Overall Study|Did not receive protocol treatment|2
5259732|NCT00698815|18146107|P2|Overall Study|Did not receive protocol treatment|2
5259733|NCT00698815|18146108|P1|Overall Study|Did not receive protocol treatment|1
5259734|NCT00698815|18146106|P3|Overall Study|MD discretion|2
5259735|NCT00698815|18146107|P2|Overall Study|MD discretion|7
5259736|NCT00698815|18146108|P1|Overall Study|MD discretion|2
5259737|NCT00698815|18146106|P3|Overall Study|Withdrawal by Subject|2
5259738|NCT00698815|18146107|P2|Overall Study|Withdrawal by Subject|3
5259739|NCT00698815|18146108|P1|Overall Study|Withdrawal by Subject|6
5259740|NCT00698815|18146106|P3|Overall Study|Death|4
5259741|NCT00698815|18146107|P2|Overall Study|Death|2
5259742|NCT00698815|18146108|P1|Overall Study|Death|1
5259743|NCT00698685|18146125|P1|Overall Study|Off study pre transplant by clinic MD|1
5259744|NCT00698685|18146125|P1|Overall Study|Sister withdrew as donor|1
5259745|NCT00698646|18146133|P3|Overall Study|Administrative problems|1
5259746|NCT00698646|18146134|P2|Overall Study|Administrative problems|0
5259747|NCT00698646|18146135|P1|Overall Study|Administrative problems|1
5259748|NCT00698646|18146133|P3|Overall Study|Lost to Follow-up|2
5259749|NCT00698646|18146134|P2|Overall Study|Lost to Follow-up|0
5259750|NCT00698646|18146135|P1|Overall Study|Lost to Follow-up|0
5259751|NCT00698646|18146133|P3|Overall Study|Withdrawal by Subject|8
5259752|NCT00698646|18146134|P2|Overall Study|Withdrawal by Subject|11
5259753|NCT00698646|18146135|P1|Overall Study|Withdrawal by Subject|10
5259754|NCT00698646|18146133|P3|Overall Study|Protocol Deviation|3
5259755|NCT00698646|18146134|P2|Overall Study|Protocol Deviation|2
5259756|NCT00698646|18146135|P1|Overall Study|Protocol Deviation|6
5259757|NCT00698646|18146133|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
5259758|NCT00698646|18146134|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
5259759|NCT00698646|18146135|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
5259760|NCT00698646|18146133|P3|Overall Study|Adverse Event|8
5259761|NCT00698646|18146134|P2|Overall Study|Adverse Event|7
5259762|NCT00698646|18146135|P1|Overall Study|Adverse Event|8
5259763|NCT00698581|18146160|P2|Overall Study|AE of unknown type|0
5259764|NCT00698581|18146161|P1|Overall Study|AE of unknown type|1
5259765|NCT00698581|18146160|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5259766|NCT00698581|18146161|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5259767|NCT00698581|18146160|P2|Overall Study|AE, non-serious non-fatal|0
5259768|NCT00698581|18146161|P1|Overall Study|AE, non-serious non-fatal|4
5259769|NCT00698581|18146160|P2|Overall Study|SAE, non-fatal|0
5259770|NCT00698581|18146161|P1|Overall Study|SAE, non-fatal|1
5259771|NCT00698581|18146160|P2|Overall Study|Other reason|1
5259772|NCT00698581|18146161|P1|Overall Study|Other reason|9
5259773|NCT00698581|18146160|P2|Overall Study|Withdrawal by Subject|0
5259774|NCT00698581|18146161|P1|Overall Study|Withdrawal by Subject|6
5259775|NCT00698581|18146160|P2|Overall Study|Lack of Efficacy|11
5259776|NCT00698581|18146161|P1|Overall Study|Lack of Efficacy|23
5259777|NCT00698516|18146172|P1|Overall Study|Withdrawal by Subject|3
5259778|NCT00698516|18146172|P1|Overall Study|Study Termination|2
5259779|NCT00698451|18146190|P1|Overall Study|Disease progression|3
5259780|NCT00698451|18146190|P1|Overall Study|Withdrawal by Subject|6
5259781|NCT00698451|18146190|P1|Overall Study|Protocol Violation|6
5259782|NCT00698451|18146190|P1|Overall Study|Physician Decision|2
5259783|NCT00698451|18146190|P1|Overall Study|Adverse Event|22
5259784|NCT00698204|18146197|P2|Overall Study|Withdrawal by Subject|0
5259785|NCT00698204|18146198|P1|Overall Study|Withdrawal by Subject|1
5259786|NCT00698009|18146258|P1|Overall Study|Withdrawal by Subject|1
5259787|NCT00697827|18146264|P2|Overall Study|enrolled but not treated|1
5259788|NCT00697827|18146265|P1|Overall Study|enrolled but not treated|2
5259789|NCT00697788|18146292|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259790|NCT00697788|18146293|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259791|NCT00697788|18146294|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259792|NCT00697788|18146295|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
5259793|NCT00697788|18146296|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259794|NCT00697788|18146297|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259795|NCT00697788|18146298|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259796|NCT00697788|18146299|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5259797|NCT00697788|18146292|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259798|NCT00697788|18146293|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259799|NCT00697788|18146294|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259800|NCT00697788|18146295|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259801|NCT00697788|18146296|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259802|NCT00697788|18146297|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259803|NCT00697788|18146298|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
5259804|NCT00697788|18146299|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5259805|NCT00697619|18146354|P2|Overall Study|Adverse Event|6
5259806|NCT00697619|18146355|P1|Overall Study|Adverse Event|4
5259807|NCT00697619|18146354|P2|Overall Study|Lack of Efficacy|2
5259808|NCT00697619|18146355|P1|Overall Study|Lack of Efficacy|2
5259809|NCT00697593|18146361|P1|Overall Study|Suspension of the study by sponsor|12
5259810|NCT00697593|18146361|P1|Overall Study|Lack of Efficacy|3
5259811|NCT00697593|18146361|P1|Overall Study|Protocol Violation|1
5259812|NCT00697593|18146361|P1|Overall Study|Adverse Event|3
5259813|NCT00697515|18146405|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
5259814|NCT00697515|18146406|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
5259815|NCT00697515|18146405|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
5259816|NCT00697515|18146406|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
5259817|NCT00697515|18146405|P2|First Intervention (Crossover Period)|Adverse Event|2
5259818|NCT00697515|18146406|P1|First Intervention (Crossover Period)|Adverse Event|0
5259819|NCT00697515|18146405|P2|First Intervention (Crossover Period)|Natural disaster|9
5259820|NCT00697515|18146406|P1|First Intervention (Crossover Period)|Natural disaster|8
5259821|NCT00697515|18146405|P2|Dose Optimization Period|elevated QTc|0
5259822|NCT00697515|18146406|P1|Dose Optimization Period|elevated QTc|1
5259823|NCT00697515|18146405|P2|Dose Optimization Period|called to active duty|0
5259824|NCT00697515|18146406|P1|Dose Optimization Period|called to active duty|1
5259825|NCT00697515|18146405|P2|Dose Optimization Period|sponsor request|0
5259826|NCT00697515|18146406|P1|Dose Optimization Period|sponsor request|2
5259827|NCT00697515|18146405|P2|Dose Optimization Period|Lost to Follow-up|0
5259828|NCT00697515|18146406|P1|Dose Optimization Period|Lost to Follow-up|2
5259829|NCT00697515|18146405|P2|Dose Optimization Period|Withdrawal by Subject|0
5259830|NCT00697515|18146406|P1|Dose Optimization Period|Withdrawal by Subject|5
5259831|NCT00697515|18146405|P2|Dose Optimization Period|Adverse Event|0
5259832|NCT00697515|18146406|P1|Dose Optimization Period|Adverse Event|4
5259833|NCT00697463|18146434|P1|Overall Study|Withdrawal by Subject|1
5259834|NCT00697346|18146441|P3|Overall Study|Reason not Specified|1
5259835|NCT00697346|18146442|P2|Overall Study|Reason not Specified|0
5259836|NCT00697346|18146443|P1|Overall Study|Reason not Specified|3
5259837|NCT00697346|18146441|P3|Overall Study|Withdrawal by Subject|0
5259838|NCT00697346|18146442|P2|Overall Study|Withdrawal by Subject|2
5259839|NCT00697346|18146443|P1|Overall Study|Withdrawal by Subject|2
5259840|NCT00697346|18146441|P3|Overall Study|Symptomatic Deterioration|0
5259841|NCT00697346|18146442|P2|Overall Study|Symptomatic Deterioration|1
5259842|NCT00697346|18146443|P1|Overall Study|Symptomatic Deterioration|0
5259843|NCT00697346|18146441|P3|Overall Study|Progressive Disease|0
5259844|NCT00697346|18146442|P2|Overall Study|Progressive Disease|18
5259845|NCT00697346|18146443|P1|Overall Study|Progressive Disease|19
5259846|NCT00697346|18146441|P3|Overall Study|Adverse Event|0
5259847|NCT00697346|18146442|P2|Overall Study|Adverse Event|5
5259848|NCT00697346|18146443|P1|Overall Study|Adverse Event|4
5259849|NCT00697255|18146551|P2|Stage 1b|Insufficient ovarian response|1
5259850|NCT00697255|18146552|P1|Stage 1b|Insufficient ovarian response|0
5259851|NCT00697255|18146551|P2|Stage 1b|Not growing of dominant follicle|1
5259852|NCT00697255|18146552|P1|Stage 1b|Not growing of dominant follicle|0
5259853|NCT00697255|18146551|P2|Stage 1a|Not growing of dominant follicle|0
5259854|NCT00697255|18146552|P1|Stage 1a|Not growing of dominant follicle|1
5259855|NCT00697255|18146551|P2|Stage 1a|Multifollicular growth|0
5259856|NCT00697255|18146552|P1|Stage 1a|Multifollicular growth|1
5259857|NCT00697255|18146551|P2|Stage 1a|Insufficient ovarian response|0
5259858|NCT00697255|18146552|P1|Stage 1a|Insufficient ovarian response|1
5259859|NCT00697112|18146640|P1|Overall Study|Did not meet inclusion criteria|1
5259860|NCT00697112|18146640|P1|Overall Study|Lost to Follow-up|1
5259861|NCT00697112|18146640|P1|Overall Study|Adverse Event|8
5259862|NCT00697073|18146664|P1|Overall Study|non compliance and other|6
5259863|NCT00697073|18146664|P1|Overall Study|Pregnancy|1
5259864|NCT00697073|18146664|P1|Overall Study|Withdrawal by Subject|2
5259865|NCT00696878|18146668|P1|Overall Study|Other reason (not specified)|55
5259866|NCT00696878|18146668|P1|Overall Study|Trial stopped|32
5259867|NCT00696878|18146668|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
5259868|NCT00696878|18146668|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
5259869|NCT00696878|18146668|P1|Overall Study|Withdrawal by Subject|87
5259870|NCT00696878|18146668|P1|Overall Study|Adverse Event|8
5259871|NCT00696800|18146742|P2|Overall Study|Not treated|2
5259872|NCT00696800|18146743|P1|Overall Study|Not treated|1
5259873|NCT00696800|18146742|P2|Overall Study|Other Reasons|3
5259874|NCT00696800|18146743|P1|Overall Study|Other Reasons|5
5259875|NCT00696800|18146742|P2|Overall Study|No/too few/bad quality embryos|18
5259876|NCT00696800|18146743|P1|Overall Study|No/too few/bad quality embryos|24
5259877|NCT00696800|18146742|P2|Overall Study|No/abnormal fertilization|13
5259878|NCT00696800|18146743|P1|Overall Study|No/abnormal fertilization|11
5259879|NCT00696800|18146742|P2|Overall Study|No/too few/bad quality oocytes|3
5259880|NCT00696800|18146743|P1|Overall Study|No/too few/bad quality oocytes|4
5259881|NCT00696800|18146742|P2|Overall Study|Too high ovarian response|1
5259882|NCT00696800|18146743|P1|Overall Study|Too high ovarian response|6
5259883|NCT00696800|18146742|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
5259884|NCT00696800|18146743|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
5259885|NCT00696800|18146742|P2|Overall Study|Insufficient ovarian response|1
5259886|NCT00696800|18146743|P1|Overall Study|Insufficient ovarian response|4
5259887|NCT00696800|18146742|P2|Overall Study|Insufficient ovarian response on Day 8|1
5259888|NCT00696800|18146743|P1|Overall Study|Insufficient ovarian response on Day 8|4
5259889|NCT00696800|18146742|P2|Overall Study|Insufficient compliance with medication|1
5259890|NCT00696800|18146743|P1|Overall Study|Insufficient compliance with medication|2
5259891|NCT00696800|18146742|P2|Overall Study|Adverse Event|3
5259892|NCT00696800|18146743|P1|Overall Study|Adverse Event|16
5259893|NCT00696787|18146796|P3|Overall Study|Failed to return|1
5259894|NCT00696787|18146797|P2|Overall Study|Failed to return|3
5259895|NCT00696787|18146798|P1|Overall Study|Failed to return|1
5259896|NCT00696787|18146796|P3|Overall Study|Withdrawal by Subject|2
5259897|NCT00696787|18146797|P2|Overall Study|Withdrawal by Subject|3
5259898|NCT00696787|18146798|P1|Overall Study|Withdrawal by Subject|0
5259899|NCT00696787|18146796|P3|Overall Study|Lost to Follow-up|3
5259900|NCT00696787|18146797|P2|Overall Study|Lost to Follow-up|0
5259901|NCT00696787|18146798|P1|Overall Study|Lost to Follow-up|4
5259902|NCT00696787|18146796|P3|Overall Study|Lack of Efficacy|0
5259903|NCT00696787|18146797|P2|Overall Study|Lack of Efficacy|1
5259904|NCT00696787|18146798|P1|Overall Study|Lack of Efficacy|0
5259905|NCT00696787|18146796|P3|Overall Study|Discontinuation by Sponsor|14
5259906|NCT00696787|18146797|P2|Overall Study|Discontinuation by Sponsor|13
5259907|NCT00696787|18146798|P1|Overall Study|Discontinuation by Sponsor|9
5259908|NCT00696787|18146796|P3|Overall Study|Adverse Event|6
5259909|NCT00696787|18146797|P2|Overall Study|Adverse Event|0
5259910|NCT00696787|18146798|P1|Overall Study|Adverse Event|1
5259911|NCT00696774|18146812|P3|Period III|Lack of Efficacy|0
5259912|NCT00696774|18146813|P2|Period III|Lack of Efficacy|2
5259913|NCT00696774|18146814|P1|Period III|Lack of Efficacy|0
5259914|NCT00696774|18146812|P3|Period III|Sponsor Decision|0
5259915|NCT00696774|18146813|P2|Period III|Sponsor Decision|0
5259916|NCT00696774|18146814|P1|Period III|Sponsor Decision|2
5259917|NCT00696774|18146812|P3|Period III|Withdrawal by Subject|0
5259918|NCT00696774|18146813|P2|Period III|Withdrawal by Subject|2
5259919|NCT00696774|18146814|P1|Period III|Withdrawal by Subject|1
5259920|NCT00696774|18146812|P3|Period III|Protocol Violation|0
5259921|NCT00696774|18146813|P2|Period III|Protocol Violation|1
5259922|NCT00696774|18146814|P1|Period III|Protocol Violation|1
5259923|NCT00696774|18146812|P3|Period III|Lost to Follow-up|0
5259924|NCT00696774|18146813|P2|Period III|Lost to Follow-up|1
5259925|NCT00696774|18146814|P1|Period III|Lost to Follow-up|2
5259926|NCT00696774|18146812|P3|Period III|Adverse Event|0
5259927|NCT00696774|18146813|P2|Period III|Adverse Event|1
5259928|NCT00696774|18146814|P1|Period III|Adverse Event|1
5259929|NCT00696774|18146812|P3|Period II|Lack of Efficacy|2
5259930|NCT00696774|18146813|P2|Period II|Lack of Efficacy|0
5259931|NCT00696774|18146814|P1|Period II|Lack of Efficacy|0
5259932|NCT00696774|18146812|P3|Period II|Sponsor Decision|0
5259933|NCT00696774|18146813|P2|Period II|Sponsor Decision|0
5259934|NCT00696774|18146814|P1|Period II|Sponsor Decision|0
5259935|NCT00696774|18146812|P3|Period II|Withdrawal by Subject|4
5259936|NCT00696774|18146813|P2|Period II|Withdrawal by Subject|0
5259937|NCT00696774|18146814|P1|Period II|Withdrawal by Subject|0
5259938|NCT00696774|18146812|P3|Period II|Protocol Violation|11
5259939|NCT00696774|18146813|P2|Period II|Protocol Violation|0
5259940|NCT00696774|18146814|P1|Period II|Protocol Violation|0
5259941|NCT00696774|18146812|P3|Period II|Lost to Follow-up|4
5259942|NCT00696774|18146813|P2|Period II|Lost to Follow-up|0
5259943|NCT00696774|18146814|P1|Period II|Lost to Follow-up|0
5259944|NCT00696774|18146812|P3|Period II|Adverse Event|15
5259945|NCT00696774|18146813|P2|Period II|Adverse Event|0
5259946|NCT00696774|18146814|P1|Period II|Adverse Event|0
5259947|NCT00696709|18146874|P5|Overall Study|Adverse Event|0
5259948|NCT00696709|18146875|P4|Overall Study|Adverse Event|1
5259949|NCT00696709|18146876|P3|Overall Study|Adverse Event|0
5259950|NCT00696709|18146877|P2|Overall Study|Adverse Event|0
5259951|NCT00696709|18146878|P1|Overall Study|Adverse Event|0
5259952|NCT00696709|18146874|P5|Overall Study|Lost to Follow-up|0
5259953|NCT00696709|18146875|P4|Overall Study|Lost to Follow-up|0
5259954|NCT00696709|18146876|P3|Overall Study|Lost to Follow-up|0
5259955|NCT00696709|18146877|P2|Overall Study|Lost to Follow-up|1
5259956|NCT00696709|18146878|P1|Overall Study|Lost to Follow-up|1
5259957|NCT00696709|18146874|P5|Overall Study|Protocol Violation|0
5259958|NCT00696709|18146875|P4|Overall Study|Protocol Violation|0
5259959|NCT00696709|18146876|P3|Overall Study|Protocol Violation|0
5259960|NCT00696709|18146877|P2|Overall Study|Protocol Violation|0
5259961|NCT00696709|18146878|P1|Overall Study|Protocol Violation|1
5259962|NCT00696709|18146874|P5|Overall Study|Withdrawal by Subject|3
5259963|NCT00696709|18146875|P4|Overall Study|Withdrawal by Subject|4
5259964|NCT00696709|18146876|P3|Overall Study|Withdrawal by Subject|1
5259965|NCT00696709|18146877|P2|Overall Study|Withdrawal by Subject|2
5259966|NCT00696709|18146878|P1|Overall Study|Withdrawal by Subject|1
5259967|NCT00696696|18146914|P1|Overall Study|Death|3
5259968|NCT00696696|18146914|P1|Overall Study|Physician Decision|2
5259969|NCT00696696|18146914|P1|Overall Study|Withdrawal by Subject|8
5259970|NCT00696696|18146914|P1|Overall Study|Adverse Event|5
5259971|NCT00696657|18146929|P9|Overall Study|Adverse Event|5
5259972|NCT00696657|18146930|P8|Overall Study|Adverse Event|2
5259973|NCT00696657|18146931|P7|Overall Study|Adverse Event|14
5259974|NCT00696657|18146932|P6|Overall Study|Adverse Event|9
5259975|NCT00696657|18146933|P5|Overall Study|Adverse Event|6
5259976|NCT00696657|18146934|P4|Overall Study|Adverse Event|7
5259977|NCT00696657|18146935|P3|Overall Study|Adverse Event|3
5259978|NCT00696657|18146936|P2|Overall Study|Adverse Event|0
5259979|NCT00696657|18146937|P1|Overall Study|Adverse Event|0
5259980|NCT00696657|18146929|P9|Overall Study|Unclassified|1
5259981|NCT00696657|18146930|P8|Overall Study|Unclassified|0
5259982|NCT00696657|18146931|P7|Overall Study|Unclassified|0
5259983|NCT00696657|18146932|P6|Overall Study|Unclassified|2
5259984|NCT00696657|18146933|P5|Overall Study|Unclassified|4
5259985|NCT00696657|18146934|P4|Overall Study|Unclassified|2
5259986|NCT00696657|18146935|P3|Overall Study|Unclassified|3
5259987|NCT00696657|18146936|P2|Overall Study|Unclassified|1
5259988|NCT00696657|18146937|P1|Overall Study|Unclassified|0
5259989|NCT00696657|18146929|P9|Overall Study|Withdrawal criteria|2
5259990|NCT00696657|18146930|P8|Overall Study|Withdrawal criteria|1
5259991|NCT00696657|18146931|P7|Overall Study|Withdrawal criteria|1
5259992|NCT00696657|18146932|P6|Overall Study|Withdrawal criteria|0
5259993|NCT00696657|18146933|P5|Overall Study|Withdrawal criteria|0
5259994|NCT00696657|18146934|P4|Overall Study|Withdrawal criteria|2
5259995|NCT00696657|18146935|P3|Overall Study|Withdrawal criteria|2
5259996|NCT00696657|18146936|P2|Overall Study|Withdrawal criteria|3
5259997|NCT00696657|18146937|P1|Overall Study|Withdrawal criteria|1
5259998|NCT00696657|18146929|P9|Overall Study|Lack of Efficacy|0
5259999|NCT00696657|18146930|P8|Overall Study|Lack of Efficacy|0
5260000|NCT00696657|18146931|P7|Overall Study|Lack of Efficacy|0
5260001|NCT00696657|18146932|P6|Overall Study|Lack of Efficacy|0
5260002|NCT00696657|18146933|P5|Overall Study|Lack of Efficacy|0
5260003|NCT00696657|18146934|P4|Overall Study|Lack of Efficacy|0
5260004|NCT00696657|18146935|P3|Overall Study|Lack of Efficacy|0
5260005|NCT00696657|18146936|P2|Overall Study|Lack of Efficacy|1
5260006|NCT00696657|18146937|P1|Overall Study|Lack of Efficacy|0
5260007|NCT00696657|18146929|P9|Overall Study|Protocol Violation|1
5260008|NCT00696657|18146930|P8|Overall Study|Protocol Violation|0
5260009|NCT00696657|18146931|P7|Overall Study|Protocol Violation|0
5260010|NCT00696657|18146932|P6|Overall Study|Protocol Violation|1
5260011|NCT00696657|18146933|P5|Overall Study|Protocol Violation|0
5260012|NCT00696657|18146934|P4|Overall Study|Protocol Violation|0
5260013|NCT00696657|18146935|P3|Overall Study|Protocol Violation|0
5260014|NCT00696657|18146936|P2|Overall Study|Protocol Violation|0
5260015|NCT00696657|18146937|P1|Overall Study|Protocol Violation|0
5260016|NCT00696436|18147306|P5|Overall Study|Missing|0
5260017|NCT00696436|18147307|P4|Overall Study|Missing|0
5260018|NCT00696436|18147308|P3|Overall Study|Missing|1
5260019|NCT00696436|18147309|P2|Overall Study|Missing|1
5260020|NCT00696436|18147310|P1|Overall Study|Missing|0
5260021|NCT00696436|18147306|P5|Overall Study|Administrative Decision|0
5260022|NCT00696436|18147307|P4|Overall Study|Administrative Decision|0
5260023|NCT00696436|18147308|P3|Overall Study|Administrative Decision|0
5260024|NCT00696436|18147309|P2|Overall Study|Administrative Decision|0
5260025|NCT00696436|18147310|P1|Overall Study|Administrative Decision|1
5260026|NCT00696436|18147306|P5|Overall Study|Participant Non-compliance|0
5260027|NCT00696436|18147307|P4|Overall Study|Participant Non-compliance|2
5260028|NCT00696436|18147308|P3|Overall Study|Participant Non-compliance|1
5260029|NCT00696436|18147309|P2|Overall Study|Participant Non-compliance|0
5260030|NCT00696436|18147310|P1|Overall Study|Participant Non-compliance|0
5260031|NCT00696436|18147306|P5|Overall Study|Administrative Error|0
5260032|NCT00696436|18147307|P4|Overall Study|Administrative Error|0
5260033|NCT00696436|18147308|P3|Overall Study|Administrative Error|2
5260034|NCT00696436|18147309|P2|Overall Study|Administrative Error|0
5260035|NCT00696436|18147310|P1|Overall Study|Administrative Error|2
5260036|NCT00696436|18147306|P5|Overall Study|Participant Unavailability|0
5260037|NCT00696436|18147307|P4|Overall Study|Participant Unavailability|1
5260038|NCT00696436|18147308|P3|Overall Study|Participant Unavailability|2
5260039|NCT00696436|18147309|P2|Overall Study|Participant Unavailability|0
5260040|NCT00696436|18147310|P1|Overall Study|Participant Unavailability|2
5260041|NCT00696436|18147306|P5|Overall Study|Lack of Efficacy|4
5260042|NCT00696436|18147307|P4|Overall Study|Lack of Efficacy|2
5260043|NCT00696436|18147308|P3|Overall Study|Lack of Efficacy|5
5260044|NCT00696436|18147309|P2|Overall Study|Lack of Efficacy|1
5260045|NCT00696436|18147310|P1|Overall Study|Lack of Efficacy|3
5260046|NCT00696436|18147306|P5|Overall Study|Withdrawal by Subject|1
5260047|NCT00696436|18147307|P4|Overall Study|Withdrawal by Subject|7
5260048|NCT00696436|18147308|P3|Overall Study|Withdrawal by Subject|5
5260049|NCT00696436|18147309|P2|Overall Study|Withdrawal by Subject|11
5260050|NCT00696436|18147310|P1|Overall Study|Withdrawal by Subject|4
5260051|NCT00696436|18147306|P5|Overall Study|Lost to Follow-up|3
5260052|NCT00696436|18147307|P4|Overall Study|Lost to Follow-up|4
5260053|NCT00696436|18147308|P3|Overall Study|Lost to Follow-up|2
5260054|NCT00696436|18147309|P2|Overall Study|Lost to Follow-up|6
5260055|NCT00696436|18147310|P1|Overall Study|Lost to Follow-up|1
5260056|NCT00696436|18147306|P5|Overall Study|Protocol Violation|1
5260057|NCT00696436|18147307|P4|Overall Study|Protocol Violation|0
5260058|NCT00696436|18147308|P3|Overall Study|Protocol Violation|2
5260059|NCT00696436|18147309|P2|Overall Study|Protocol Violation|2
5260060|NCT00696436|18147310|P1|Overall Study|Protocol Violation|3
5260061|NCT00696436|18147306|P5|Overall Study|Adverse Event|4
5260062|NCT00696436|18147307|P4|Overall Study|Adverse Event|6
5260063|NCT00696436|18147308|P3|Overall Study|Adverse Event|8
5260064|NCT00696436|18147309|P2|Overall Study|Adverse Event|9
5260065|NCT00696436|18147310|P1|Overall Study|Adverse Event|7
5260066|NCT00696423|18147394|P2|Overall Study|Lost to Follow-up|5
5260067|NCT00696423|18147395|P1|Overall Study|Lost to Follow-up|0
5260068|NCT00696410|18147427|P2|Overall Study|Physician Decision|0
5260069|NCT00696410|18147428|P1|Overall Study|Physician Decision|3
5260070|NCT00696410|18147427|P2|Overall Study|Withdrawal by Subject|0
5260071|NCT00696410|18147428|P1|Overall Study|Withdrawal by Subject|8
5260072|NCT00696410|18147427|P2|Overall Study|Lost to Follow-up|0
5260073|NCT00696410|18147428|P1|Overall Study|Lost to Follow-up|2
5260074|NCT00696384|18147442|P3|Double Blind Phase|Physician Decision|0
5260075|NCT00696384|18147443|P2|Double Blind Phase|Physician Decision|2
5260076|NCT00696384|18147444|P1|Double Blind Phase|Physician Decision|0
5260077|NCT00696384|18147442|P3|Double Blind Phase|Lack of Efficacy|0
5260078|NCT00696384|18147443|P2|Double Blind Phase|Lack of Efficacy|1
5260079|NCT00696384|18147444|P1|Double Blind Phase|Lack of Efficacy|0
5260080|NCT00696384|18147442|P3|Double Blind Phase|Withdrawal by Subject|3
5260081|NCT00696384|18147443|P2|Double Blind Phase|Withdrawal by Subject|4
5260082|NCT00696384|18147444|P1|Double Blind Phase|Withdrawal by Subject|0
5260083|NCT00696384|18147442|P3|Double Blind Phase|Lost to Follow-up|1
5260084|NCT00696384|18147443|P2|Double Blind Phase|Lost to Follow-up|2
5260085|NCT00696384|18147444|P1|Double Blind Phase|Lost to Follow-up|0
5260086|NCT00696384|18147442|P3|Double Blind Phase|Adverse Event|2
5260087|NCT00696384|18147443|P2|Double Blind Phase|Adverse Event|2
5260088|NCT00696384|18147444|P1|Double Blind Phase|Adverse Event|0
5260089|NCT00696384|18147442|P3|Open Label Phase|Physician Decision|0
5260090|NCT00696384|18147443|P2|Open Label Phase|Physician Decision|0
5260091|NCT00696384|18147444|P1|Open Label Phase|Physician Decision|4
5260092|NCT00696384|18147442|P3|Open Label Phase|Lack of Efficacy|0
5260093|NCT00696384|18147443|P2|Open Label Phase|Lack of Efficacy|0
5260094|NCT00696384|18147444|P1|Open Label Phase|Lack of Efficacy|3
5260095|NCT00696384|18147442|P3|Open Label Phase|Other|0
5260096|NCT00696384|18147443|P2|Open Label Phase|Other|0
5260097|NCT00696384|18147444|P1|Open Label Phase|Other|6
5260098|NCT00696384|18147442|P3|Open Label Phase|Withdrawal by Subject|0
5260099|NCT00696384|18147443|P2|Open Label Phase|Withdrawal by Subject|0
5260100|NCT00696384|18147444|P1|Open Label Phase|Withdrawal by Subject|37
5260101|NCT00696384|18147442|P3|Open Label Phase|Lost to Follow-up|0
5260102|NCT00696384|18147443|P2|Open Label Phase|Lost to Follow-up|0
5260103|NCT00696384|18147444|P1|Open Label Phase|Lost to Follow-up|24
5260104|NCT00696384|18147442|P3|Open Label Phase|Protocol Violation|0
5260105|NCT00696384|18147443|P2|Open Label Phase|Protocol Violation|0
5260106|NCT00696384|18147444|P1|Open Label Phase|Protocol Violation|18
5260107|NCT00696384|18147442|P3|Open Label Phase|Adverse Event|0
5260108|NCT00696384|18147443|P2|Open Label Phase|Adverse Event|0
5260109|NCT00696384|18147444|P1|Open Label Phase|Adverse Event|27
5260110|NCT00696241|18147468|P5|Overall Study|Other|1
5260111|NCT00696241|18147469|P4|Overall Study|Other|2
5260112|NCT00696241|18147470|P3|Overall Study|Other|5
5260113|NCT00696241|18147471|P2|Overall Study|Other|1
5260114|NCT00696241|18147472|P1|Overall Study|Other|6
5260115|NCT00696241|18147468|P5|Overall Study|Lack of Efficacy|3
5260116|NCT00696241|18147469|P4|Overall Study|Lack of Efficacy|5
5260117|NCT00696241|18147470|P3|Overall Study|Lack of Efficacy|4
5260118|NCT00696241|18147471|P2|Overall Study|Lack of Efficacy|5
5260119|NCT00696241|18147472|P1|Overall Study|Lack of Efficacy|1
5260120|NCT00696241|18147468|P5|Overall Study|Withdrawal by Subject|0
5260121|NCT00696241|18147469|P4|Overall Study|Withdrawal by Subject|1
5260122|NCT00696241|18147470|P3|Overall Study|Withdrawal by Subject|6
5260123|NCT00696241|18147471|P2|Overall Study|Withdrawal by Subject|8
5260124|NCT00696241|18147472|P1|Overall Study|Withdrawal by Subject|4
5260125|NCT00696241|18147468|P5|Overall Study|Lost to Follow-up|0
5260126|NCT00696241|18147469|P4|Overall Study|Lost to Follow-up|2
5260127|NCT00696241|18147470|P3|Overall Study|Lost to Follow-up|1
5260128|NCT00696241|18147471|P2|Overall Study|Lost to Follow-up|4
5260129|NCT00696241|18147472|P1|Overall Study|Lost to Follow-up|1
5260130|NCT00696241|18147468|P5|Overall Study|Protocol Violation|3
5260131|NCT00696241|18147469|P4|Overall Study|Protocol Violation|0
5260132|NCT00696241|18147470|P3|Overall Study|Protocol Violation|2
5260133|NCT00696241|18147471|P2|Overall Study|Protocol Violation|1
5260134|NCT00696241|18147472|P1|Overall Study|Protocol Violation|1
5260135|NCT00696241|18147468|P5|Overall Study|Adverse Event|5
5260136|NCT00696241|18147469|P4|Overall Study|Adverse Event|4
5260137|NCT00696241|18147470|P3|Overall Study|Adverse Event|6
5260138|NCT00696241|18147471|P2|Overall Study|Adverse Event|3
5260139|NCT00696241|18147472|P1|Overall Study|Adverse Event|11
5260140|NCT00696137|18147554|P1|Overall Study|Withdrawal by Subject|2
5260141|NCT00696072|18147560|P2|Overall Study|Non-specified|2
5260142|NCT00696072|18147561|P1|Overall Study|Non-specified|1
5260143|NCT00696072|18147560|P2|Overall Study|Disease Progression|30
5260144|NCT00696072|18147561|P1|Overall Study|Disease Progression|32
5260145|NCT00696072|18147560|P2|Overall Study|Sponsor Request|1
5260146|NCT00696072|18147561|P1|Overall Study|Sponsor Request|0
5260147|NCT00696072|18147560|P2|Overall Study|Investigator Request|4
5260148|NCT00696072|18147561|P1|Overall Study|Investigator Request|1
5260149|NCT00696072|18147560|P2|Overall Study|Patient Request|7
5260150|NCT00696072|18147561|P1|Overall Study|Patient Request|3
5260151|NCT00696072|18147560|P2|Overall Study|Adverse Event|6
5260152|NCT00696072|18147561|P1|Overall Study|Adverse Event|10
5260153|NCT00696072|18147560|P2|Overall Study|continuing active treatment|13
5260154|NCT00696072|18147561|P1|Overall Study|continuing active treatment|10
5260155|NCT00696020|18147582|P4|Overall Study|Other not stated above|1
5260156|NCT00696020|18147583|P3|Overall Study|Other not stated above|1
5260157|NCT00696020|18147584|P2|Overall Study|Other not stated above|0
5260158|NCT00696020|18147585|P1|Overall Study|Other not stated above|0
5260159|NCT00696020|18147582|P4|Overall Study|Withdrawal by Subject|1
5260160|NCT00696020|18147583|P3|Overall Study|Withdrawal by Subject|0
5260161|NCT00696020|18147584|P2|Overall Study|Withdrawal by Subject|1
5260162|NCT00696020|18147585|P1|Overall Study|Withdrawal by Subject|0
5260163|NCT00696020|18147582|P4|Overall Study|Protocol Violation|1
5260164|NCT00696020|18147583|P3|Overall Study|Protocol Violation|0
5260165|NCT00696020|18147584|P2|Overall Study|Protocol Violation|0
5260166|NCT00696020|18147585|P1|Overall Study|Protocol Violation|0
5260167|NCT00696020|18147582|P4|Overall Study|Lack of Efficacy|0
5260168|NCT00696020|18147583|P3|Overall Study|Lack of Efficacy|0
5260169|NCT00696020|18147584|P2|Overall Study|Lack of Efficacy|0
5260170|NCT00696020|18147585|P1|Overall Study|Lack of Efficacy|1
5260171|NCT00696020|18147582|P4|Overall Study|Adverse Event|1
5260172|NCT00696020|18147583|P3|Overall Study|Adverse Event|2
5260173|NCT00696020|18147584|P2|Overall Study|Adverse Event|1
5260174|NCT00696020|18147585|P1|Overall Study|Adverse Event|3
5260175|NCT00695955|18147693|P1|Cohort 2|Other|5
5260176|NCT00695955|18147693|P1|Cohort 2|Lack of Efficacy|4
5260177|NCT00695955|18147693|P1|Cohort 2|Withdrawal by Subject|28
5260178|NCT00695955|18147693|P1|Cohort 2|Lost to Follow-up|38
5260179|NCT00695955|18147693|P1|Cohort 2|Protocol Violation|5
5260180|NCT00695955|18147693|P1|Cohort 2|Adverse Event|24
5260181|NCT00695955|18147693|P1|Cohort 1|Other|16
5260182|NCT00695955|18147693|P1|Cohort 1|Lack of Efficacy|3
5260183|NCT00695955|18147693|P1|Cohort 1|Withdrawal by Subject|25
5260184|NCT00695955|18147693|P1|Cohort 1|Lost to Follow-up|30
5260185|NCT00695955|18147693|P1|Cohort 1|Protocol Violation|2
5260186|NCT00695955|18147693|P1|Cohort 1|Adverse Event|26
5260187|NCT00695903|18147705|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
5260188|NCT00695903|18147706|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
5260189|NCT00695903|18147705|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
5260190|NCT00695903|18147706|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
5260191|NCT00695903|18147705|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
5260192|NCT00695903|18147706|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
5260193|NCT00695903|18147705|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
5260194|NCT00695903|18147706|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
5260195|NCT00695903|18147705|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
5260196|NCT00695903|18147706|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
5260197|NCT00695903|18147705|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
5260198|NCT00695903|18147706|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
5260199|NCT00695903|18147705|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
5260200|NCT00695903|18147706|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
5260201|NCT00695903|18147705|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
5260202|NCT00695903|18147706|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
5260203|NCT00695903|18147705|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
5260204|NCT00695903|18147706|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
5260205|NCT00695864|18147718|P1|Placebo|Physician Decision|4
5260206|NCT00695864|18147718|P1|Placebo|Withdrawal by Subject|1
5260207|NCT00695669|18147728|P4|Overall Study|Lost to Follow-up|4
5260208|NCT00695669|18147729|P3|Overall Study|Lost to Follow-up|1
5260209|NCT00695669|18147730|P2|Overall Study|Lost to Follow-up|4
5260210|NCT00695669|18147731|P1|Overall Study|Lost to Follow-up|4
5260211|NCT00695669|18147728|P4|Overall Study|Adverse Event|0
5260212|NCT00695669|18147729|P3|Overall Study|Adverse Event|2
5260213|NCT00695669|18147730|P2|Overall Study|Adverse Event|0
5260214|NCT00695669|18147731|P1|Overall Study|Adverse Event|0
5260215|NCT00695565|18147816|P2|Overall Study|Subject did not follow instructions|1
5260216|NCT00695565|18147817|P1|Overall Study|Subject did not follow instructions|1
5260217|NCT00695565|18147816|P2|Overall Study|Lack of Efficacy|1
5260218|NCT00695565|18147817|P1|Overall Study|Lack of Efficacy|1
5260219|NCT00695565|18147816|P2|Overall Study|Withdrawal by Subject|1
5260220|NCT00695565|18147817|P1|Overall Study|Withdrawal by Subject|1
5260221|NCT00695565|18147816|P2|Overall Study|Protocol Violation|1
5260222|NCT00695565|18147817|P1|Overall Study|Protocol Violation|3
5260223|NCT00695565|18147816|P2|Overall Study|Adverse Event|1
5260224|NCT00695565|18147817|P1|Overall Study|Adverse Event|3
5260225|NCT00695565|18147816|P2|Overall Study|Lost to Follow-up|4
5260226|NCT00695565|18147817|P1|Overall Study|Lost to Follow-up|4
5260227|NCT00695396|18147890|P3|Overall Study|Withdrawal by Subject|0
5260228|NCT00695396|18147891|P2|Overall Study|Withdrawal by Subject|2
5260229|NCT00695396|18147892|P1|Overall Study|Withdrawal by Subject|2
5260230|NCT00695396|18147890|P3|Overall Study|Study Closed Prematurely|8
5260231|NCT00695396|18147891|P2|Overall Study|Study Closed Prematurely|6
5260232|NCT00695396|18147892|P1|Overall Study|Study Closed Prematurely|5
5260233|NCT00695318|18147908|P2|Overall Study|Study Terminated|0
5260234|NCT00695318|18147909|P1|Overall Study|Study Terminated|1
5260235|NCT00695318|18147908|P2|Overall Study|Death|1
5260236|NCT00695318|18147909|P1|Overall Study|Death|1
5260237|NCT00695318|18147908|P2|Overall Study|Withdrawal by Subject|0
5260238|NCT00695318|18147909|P1|Overall Study|Withdrawal by Subject|2
5260239|NCT00695318|18147908|P2|Overall Study|Lost to Follow-up|0
5260240|NCT00695318|18147909|P1|Overall Study|Lost to Follow-up|1
5260241|NCT00695136|18147934|P1|Overall Study|unrelated adverse event|1
5260242|NCT00695136|18147934|P1|Overall Study|Withdrawal by Subject|1
5260243|NCT00695019|18147950|P3|Overall Study|Various|4
5260244|NCT00695019|18147951|P2|Overall Study|Various|5
5260245|NCT00695019|18147952|P1|Overall Study|Various|4
5260246|NCT00695019|18147950|P3|Overall Study|Lack of Efficacy|1
5260247|NCT00695019|18147951|P2|Overall Study|Lack of Efficacy|0
5260248|NCT00695019|18147952|P1|Overall Study|Lack of Efficacy|0
5260249|NCT00695019|18147950|P3|Overall Study|Protocol Violation|1
5260250|NCT00695019|18147951|P2|Overall Study|Protocol Violation|3
5260251|NCT00695019|18147952|P1|Overall Study|Protocol Violation|1
5260252|NCT00695019|18147950|P3|Overall Study|Withdrawal by Subject|4
5260253|NCT00695019|18147951|P2|Overall Study|Withdrawal by Subject|6
5260254|NCT00695019|18147952|P1|Overall Study|Withdrawal by Subject|8
5260255|NCT00694707|18147986|P5|Overall Study|Notification of Past Head Injury|0
5260256|NCT00694707|18147987|P4|Overall Study|Notification of Past Head Injury|1
5260257|NCT00694707|18147988|P3|Overall Study|Notification of Past Head Injury|0
5260258|NCT00694707|18147989|P2|Overall Study|Notification of Past Head Injury|0
5260259|NCT00694707|18147990|P1|Overall Study|Notification of Past Head Injury|0
5260260|NCT00694707|18147986|P5|Overall Study|Administrative Reasons|0
5260261|NCT00694707|18147987|P4|Overall Study|Administrative Reasons|2
5260262|NCT00694707|18147988|P3|Overall Study|Administrative Reasons|0
5260263|NCT00694707|18147989|P2|Overall Study|Administrative Reasons|1
5260264|NCT00694707|18147990|P1|Overall Study|Administrative Reasons|0
5260265|NCT00694707|18147986|P5|Overall Study|Arrest by Police|0
5260266|NCT00694707|18147987|P4|Overall Study|Arrest by Police|0
5260267|NCT00694707|18147988|P3|Overall Study|Arrest by Police|0
5260268|NCT00694707|18147989|P2|Overall Study|Arrest by Police|1
5260269|NCT00694707|18147990|P1|Overall Study|Arrest by Police|0
5260270|NCT00694707|18147986|P5|Overall Study|Death in the Family|0
5260271|NCT00694707|18147987|P4|Overall Study|Death in the Family|0
5260272|NCT00694707|18147988|P3|Overall Study|Death in the Family|0
5260273|NCT00694707|18147989|P2|Overall Study|Death in the Family|0
5260274|NCT00694707|18147990|P1|Overall Study|Death in the Family|1
5260275|NCT00694707|18147986|P5|Overall Study|Jeopardizing Parole Status|0
5260276|NCT00694707|18147987|P4|Overall Study|Jeopardizing Parole Status|0
5260277|NCT00694707|18147988|P3|Overall Study|Jeopardizing Parole Status|0
5260278|NCT00694707|18147989|P2|Overall Study|Jeopardizing Parole Status|0
5260279|NCT00694707|18147990|P1|Overall Study|Jeopardizing Parole Status|1
5260280|NCT00694707|18147986|P5|Overall Study|Lost to Follow-up|0
5260281|NCT00694707|18147987|P4|Overall Study|Lost to Follow-up|0
5260282|NCT00694707|18147988|P3|Overall Study|Lost to Follow-up|2
5260283|NCT00694707|18147989|P2|Overall Study|Lost to Follow-up|1
5260284|NCT00694707|18147990|P1|Overall Study|Lost to Follow-up|0
5260285|NCT00694707|18147986|P5|Overall Study|Withdrawal of Consent|15
5260286|NCT00694707|18147987|P4|Overall Study|Withdrawal of Consent|16
5260287|NCT00694707|18147988|P3|Overall Study|Withdrawal of Consent|22
5260288|NCT00694707|18147989|P2|Overall Study|Withdrawal of Consent|18
5260289|NCT00694707|18147990|P1|Overall Study|Withdrawal of Consent|14
5260290|NCT00694707|18147986|P5|Overall Study|Protocol Violation|1
5260291|NCT00694707|18147987|P4|Overall Study|Protocol Violation|3
5260292|NCT00694707|18147988|P3|Overall Study|Protocol Violation|1
5260293|NCT00694707|18147989|P2|Overall Study|Protocol Violation|2
5260294|NCT00694707|18147990|P1|Overall Study|Protocol Violation|1
5260295|NCT00694707|18147986|P5|Overall Study|Insufficient Therapeutic Response|10
5260296|NCT00694707|18147987|P4|Overall Study|Insufficient Therapeutic Response|15
5260297|NCT00694707|18147988|P3|Overall Study|Insufficient Therapeutic Response|17
5260298|NCT00694707|18147989|P2|Overall Study|Insufficient Therapeutic Response|18
5260299|NCT00694707|18147990|P1|Overall Study|Insufficient Therapeutic Response|33
5260300|NCT00694707|18147986|P5|Overall Study|Adverse Event|13
5260301|NCT00694707|18147987|P4|Overall Study|Adverse Event|12
5260302|NCT00694707|18147988|P3|Overall Study|Adverse Event|8
5260303|NCT00694707|18147989|P2|Overall Study|Adverse Event|14
5260304|NCT00694707|18147990|P1|Overall Study|Adverse Event|22
5260305|NCT00694707|18147986|P5|Overall Study|Did Not Receive Treatment|1
5260306|NCT00694707|18147987|P4|Overall Study|Did Not Receive Treatment|1
5260307|NCT00694707|18147988|P3|Overall Study|Did Not Receive Treatment|1
5260308|NCT00694707|18147989|P2|Overall Study|Did Not Receive Treatment|0
5260309|NCT00694707|18147990|P1|Overall Study|Did Not Receive Treatment|0
5260310|NCT00694551|18148019|P3|Overall Study|Disease Progression|1
5260311|NCT00694551|18148020|P2|Overall Study|Disease Progression|0
5260312|NCT00694551|18148021|P1|Overall Study|Disease Progression|1
5260313|NCT00694369|18148050|P5|Overall Study|Withdrawal by Subject|2
5260314|NCT00694369|18148051|P4|Overall Study|Withdrawal by Subject|1
5260315|NCT00694369|18148052|P3|Overall Study|Withdrawal by Subject|1
5260316|NCT00694369|18148053|P2|Overall Study|Withdrawal by Subject|1
5260317|NCT00694369|18148054|P1|Overall Study|Withdrawal by Subject|1
5260318|NCT00694369|18148050|P5|Overall Study|Protocol Violation|0
5260319|NCT00694369|18148051|P4|Overall Study|Protocol Violation|0
5260320|NCT00694369|18148052|P3|Overall Study|Protocol Violation|0
5260321|NCT00694369|18148053|P2|Overall Study|Protocol Violation|1
5260322|NCT00694369|18148054|P1|Overall Study|Protocol Violation|0
5260323|NCT00694369|18148050|P5|Overall Study|Physician Decision|1
5260324|NCT00694369|18148051|P4|Overall Study|Physician Decision|0
5260325|NCT00694369|18148052|P3|Overall Study|Physician Decision|0
5260326|NCT00694369|18148053|P2|Overall Study|Physician Decision|0
5260327|NCT00694369|18148054|P1|Overall Study|Physician Decision|0
5260328|NCT00694369|18148050|P5|Overall Study|Lost to Follow-up|0
5260329|NCT00694369|18148051|P4|Overall Study|Lost to Follow-up|1
5260330|NCT00694369|18148052|P3|Overall Study|Lost to Follow-up|1
5260331|NCT00694369|18148053|P2|Overall Study|Lost to Follow-up|0
5260332|NCT00694369|18148054|P1|Overall Study|Lost to Follow-up|0
5260333|NCT00694369|18148050|P5|Overall Study|Adverse Event|3
5260334|NCT00694369|18148051|P4|Overall Study|Adverse Event|1
5260335|NCT00694369|18148052|P3|Overall Study|Adverse Event|0
5260336|NCT00694369|18148053|P2|Overall Study|Adverse Event|1
5260337|NCT00694369|18148054|P1|Overall Study|Adverse Event|0
5260338|NCT00694356|18148074|P3|Overall Study|Progressive Disease|6
5260339|NCT00694356|18148075|P2|Overall Study|Progressive Disease|6
5260340|NCT00694356|18148076|P1|Overall Study|Progressive Disease|2
5260341|NCT00694356|18148074|P3|Overall Study|Adverse Event|0
5260342|NCT00694356|18148075|P2|Overall Study|Adverse Event|0
5260343|NCT00694356|18148076|P1|Overall Study|Adverse Event|1
5260344|NCT00694304|18148111|P1|Overall Study|Administrative or Other Reasons|32
5260345|NCT00694304|18148111|P1|Overall Study|Lost to Follow-up|15
5260346|NCT00694304|18148111|P1|Overall Study|Withdrawal of Consent|61
5260347|NCT00694304|18148111|P1|Overall Study|Protocol Violation|6
5260348|NCT00694304|18148111|P1|Overall Study|Non-compliance With Study Product|16
5260349|NCT00694304|18148111|P1|Overall Study|Lack of Efficacy|35
5260350|NCT00694304|18148111|P1|Overall Study|Adverse Event|42
5260351|NCT00694161|18148124|P1|Part 2 (After Week 6 up to Month 12)|Death|1
5260352|NCT00694161|18148124|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
5260353|NCT00694161|18148124|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
5260354|NCT00694122|18148163|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
5260355|NCT00694122|18148164|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
5260356|NCT00694122|18148163|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
5260357|NCT00694122|18148164|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
5260358|NCT00694122|18148163|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
5260359|NCT00694122|18148164|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
5260360|NCT00694109|18148180|P1|Overall Study|Consented but no additional treatment|3
5260361|NCT00694109|18148180|P1|Overall Study|Other|2
5260362|NCT00694109|18148180|P1|Overall Study|Enrolled but not treated|1
5260363|NCT00694109|18148180|P1|Overall Study|Pregnancy|1
5260364|NCT00694109|18148180|P1|Overall Study|Withdrawal by Subject|13
5260365|NCT00694109|18148180|P1|Overall Study|Lack of Efficacy|2
5260366|NCT00694109|18148180|P1|Overall Study|Not consent of more 2 years of treatment|18
5260367|NCT00694109|18148180|P1|Overall Study|Adverse Event|74
5260368|NCT00694109|18148180|P1|Overall Study|Physician Decision|3
5260369|NCT00694096|18148204|P1|Overall Study|Withdrawal by Subject|5
5260370|NCT00693784|18148244|P1|Overall Study|Withdrawal by Subject|2
5260371|NCT00693784|18148244|P1|Overall Study|Lost to Follow-up|2
5260372|NCT00693706|18148257|P2|Overall Study|Protocol Violation|1
5260373|NCT00693706|18148258|P1|Overall Study|Protocol Violation|0
5260374|NCT00693693|18148285|P3|Overall Study|Lost to Follow-up|2
5260375|NCT00693693|18148286|P2|Overall Study|Lost to Follow-up|1
5260376|NCT00693693|18148287|P1|Overall Study|Lost to Follow-up|1
5260377|NCT00693472|18148346|P4|Part 2|Withdrew - reason unrelated to treatment|2
5260378|NCT00693472|18148347|P3|Part 2|Withdrew - reason unrelated to treatment|1
5260379|NCT00693472|18148348|P2|Part 2|Withdrew - reason unrelated to treatment|0
5260380|NCT00693472|18148349|P1|Part 2|Withdrew - reason unrelated to treatment|0
5260381|NCT00693472|18148346|P4|Part 2|Adverse Event|0
5260382|NCT00693472|18148347|P3|Part 2|Adverse Event|1
5260383|NCT00693472|18148348|P2|Part 2|Adverse Event|0
5260384|NCT00693472|18148349|P1|Part 2|Adverse Event|0
5260385|NCT00693472|18148346|P4|Part 1|Withdrew - reason unrelated to treatment|0
5260386|NCT00693472|18148347|P3|Part 1|Withdrew - reason unrelated to treatment|0
5260387|NCT00693472|18148348|P2|Part 1|Withdrew - reason unrelated to treatment|2
5260388|NCT00693472|18148349|P1|Part 1|Withdrew - reason unrelated to treatment|5
5260389|NCT00693472|18148346|P4|Part 1|Lost to Follow-up|0
5260390|NCT00693472|18148347|P3|Part 1|Lost to Follow-up|0
5260391|NCT00693472|18148348|P2|Part 1|Lost to Follow-up|1
5260392|NCT00693472|18148349|P1|Part 1|Lost to Follow-up|0
5260393|NCT00693472|18148346|P4|Part 1|Adverse Event|0
5260394|NCT00693472|18148347|P3|Part 1|Adverse Event|0
5260395|NCT00693472|18148348|P2|Part 1|Adverse Event|1
5260396|NCT00693472|18148349|P1|Part 1|Adverse Event|1
5260397|NCT00693420|18148369|P2|Overall Study|Personal Reasons|4
5260398|NCT00693420|18148370|P1|Overall Study|Personal Reasons|1
5260399|NCT00693420|18148369|P2|Overall Study|Sponsor Request - Conflict of Interest|2
5260400|NCT00693420|18148370|P1|Overall Study|Sponsor Request - Conflict of Interest|0
5260401|NCT00693420|18148369|P2|Overall Study|Protocol Violation|2
5260402|NCT00693420|18148370|P1|Overall Study|Protocol Violation|0
5260403|NCT00693420|18148369|P2|Overall Study|Withdrawal by Subject|0
5260404|NCT00693420|18148370|P1|Overall Study|Withdrawal by Subject|1
5260405|NCT00693420|18148369|P2|Overall Study|Lost to Follow-up|3
5260406|NCT00693420|18148370|P1|Overall Study|Lost to Follow-up|0
5260407|NCT00693420|18148369|P2|Overall Study|Adverse Event|4
5260408|NCT00693420|18148370|P1|Overall Study|Adverse Event|4
5260409|NCT00693225|18148409|P2|Overall Study|Adverse Event|3
5260410|NCT00693225|18148410|P1|Overall Study|Adverse Event|1
5260411|NCT00693225|18148409|P2|Overall Study|Lost to Follow-up|2
5260412|NCT00693225|18148410|P1|Overall Study|Lost to Follow-up|1
5260413|NCT00693017|18148433|P2|Overall Study|Death|1
5260414|NCT00693017|18148434|P1|Overall Study|Death|0
5260415|NCT00693017|18148433|P2|Overall Study|Sponsor Decision|1
5260416|NCT00693017|18148434|P1|Overall Study|Sponsor Decision|2
5260417|NCT00692913|18148465|P2|Overall Study|Withdrawal by Subject|20
5260418|NCT00692913|18148466|P1|Overall Study|Withdrawal by Subject|15
5260419|NCT00692913|18148465|P2|Overall Study|Protocol Violation|1
5260420|NCT00692913|18148466|P1|Overall Study|Protocol Violation|1
5260421|NCT00692913|18148465|P2|Overall Study|Physician Decision|0
5260422|NCT00692913|18148466|P1|Overall Study|Physician Decision|2
5260423|NCT00692913|18148465|P2|Overall Study|Lost to Follow-up|5
5260424|NCT00692913|18148466|P1|Overall Study|Lost to Follow-up|3
5260425|NCT00692913|18148465|P2|Overall Study|Adverse Event|4
5260426|NCT00692913|18148466|P1|Overall Study|Adverse Event|8
5260427|NCT00692770|18148488|P2|Overall Study|Randomized but not treated|4
5260428|NCT00692770|18148489|P1|Overall Study|Randomized but not treated|3
5260429|NCT00692770|18148488|P2|Overall Study|Study terminated by sponsor|2
5260430|NCT00692770|18148489|P1|Overall Study|Study terminated by sponsor|2
5260431|NCT00692770|18148488|P2|Overall Study|Clinical endpoint reached|43
5260432|NCT00692770|18148489|P1|Overall Study|Clinical endpoint reached|16
5260433|NCT00692770|18148488|P2|Overall Study|Radiological and clinical progression|8
5260434|NCT00692770|18148489|P1|Overall Study|Radiological and clinical progression|8
5260435|NCT00692770|18148488|P2|Overall Study|Completed all planned assessments|101
5260436|NCT00692770|18148489|P1|Overall Study|Completed all planned assessments|79
5260437|NCT00692770|18148488|P2|Overall Study|Protocol driven decision point|7
5260438|NCT00692770|18148489|P1|Overall Study|Protocol driven decision point|3
5260439|NCT00692770|18148488|P2|Overall Study|Disease progression, recurrence/relapse|279
5260440|NCT00692770|18148489|P1|Overall Study|Disease progression, recurrence/relapse|170
5260441|NCT00692770|18148488|P2|Overall Study|Physician decision not protocol driven|14
5260442|NCT00692770|18148489|P1|Overall Study|Physician decision not protocol driven|10
5260443|NCT00692770|18148488|P2|Overall Study|Progression by clinical judgment|3
5260444|NCT00692770|18148489|P1|Overall Study|Progression by clinical judgment|2
5260445|NCT00692770|18148488|P2|Overall Study|Non-compliant with study medication|5
5260446|NCT00692770|18148489|P1|Overall Study|Non-compliant with study medication|11
5260447|NCT00692770|18148488|P2|Overall Study|Lost to Follow-up|3
5260448|NCT00692770|18148489|P1|Overall Study|Lost to Follow-up|7
5260449|NCT00692770|18148488|P2|Overall Study|Death|5
5260450|NCT00692770|18148489|P1|Overall Study|Death|10
5260451|NCT00692770|18148488|P2|Overall Study|Adverse Event|41
5260452|NCT00692770|18148489|P1|Overall Study|Adverse Event|136
5260453|NCT00692770|18148488|P2|Overall Study|Withdrawal by Subject|36
5260454|NCT00692770|18148489|P1|Overall Study|Withdrawal by Subject|97
5260455|NCT00692770|18148488|P2|Overall Study|Protocol Violation|7
5260456|NCT00692770|18148489|P1|Overall Study|Protocol Violation|2
5260457|NCT00692406|18148535|P1|Overall Study|PI dropped, bad data|57
5260458|NCT00692237|18148606|P2|Overall Study|Adverse Event|1
5260459|NCT00692237|18148607|P1|Overall Study|Adverse Event|0
5260460|NCT00692237|18148606|P2|Overall Study|Withdrawal by Subject|3
5260461|NCT00692237|18148607|P1|Overall Study|Withdrawal by Subject|1
5260462|NCT00692003|18148694|P2|Overall Study|Sponsor Decision|1
5260463|NCT00692003|18148695|P1|Overall Study|Sponsor Decision|5
5260464|NCT00691938|18148710|P7|Overall Study|QTc prolongation|0
5260465|NCT00691938|18148711|P6|Overall Study|QTc prolongation|0
5260466|NCT00691938|18148712|P5|Overall Study|QTc prolongation|0
5260467|NCT00691938|18148713|P4|Overall Study|QTc prolongation|0
5260468|NCT00691938|18148714|P3|Overall Study|QTc prolongation|0
5260469|NCT00691938|18148715|P2|Overall Study|QTc prolongation|0
5260470|NCT00691938|18148716|P1|Overall Study|QTc prolongation|1
5260471|NCT00691704|18148783|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
5260472|NCT00691704|18148783|P1|Two Years of Maintenance Therapy|Physician Decision|4
5260473|NCT00691704|18148783|P1|Two Years of Maintenance Therapy|Disease Progression|8
5260474|NCT00691704|18148783|P1|Induction Therapy|Active Hepatitis|1
5260475|NCT00691704|18148783|P1|Induction Therapy|Disease Progression|1
5260476|NCT00691483|18148844|P2|Overall Study|Randomized by not treated|1
5260477|NCT00691483|18148845|P1|Overall Study|Randomized by not treated|7
5260478|NCT00691483|18148844|P2|Overall Study|Other known cause|1
5260479|NCT00691483|18148845|P1|Overall Study|Other known cause|6
5260480|NCT00691483|18148844|P2|Overall Study|Withdrawal by Subject|7
5260481|NCT00691483|18148845|P1|Overall Study|Withdrawal by Subject|24
5260482|NCT00691483|18148844|P2|Overall Study|Lost to Follow-up|10
5260483|NCT00691483|18148845|P1|Overall Study|Lost to Follow-up|17
5260484|NCT00691483|18148844|P2|Overall Study|Adverse Event|6
5260485|NCT00691483|18148845|P1|Overall Study|Adverse Event|14
5260486|NCT00691301|18148888|P1|Overall Study|Did not initiate study treatment|1
5260487|NCT00691301|18148888|P1|Overall Study|other reason|3
5260488|NCT00691301|18148888|P1|Overall Study|Concurrent illness|2
5260489|NCT00691301|18148888|P1|Overall Study|Withdrawal by Subject|4
5260490|NCT00691301|18148888|P1|Overall Study|Lack of Efficacy|32
5260491|NCT00691301|18148888|P1|Overall Study|Death|2
5260492|NCT00691301|18148888|P1|Overall Study|Adverse Event|10
5260493|NCT00691210|18148908|P8|Overall Study|Lack of Efficacy|0
5260494|NCT00691210|18148909|P7|Overall Study|Lack of Efficacy|0
5260495|NCT00691210|18148910|P6|Overall Study|Lack of Efficacy|1
5260496|NCT00691210|18148911|P5|Overall Study|Lack of Efficacy|0
5260497|NCT00691210|18148912|P4|Overall Study|Lack of Efficacy|1
5260498|NCT00691210|18148913|P3|Overall Study|Lack of Efficacy|0
5260499|NCT00691210|18148914|P2|Overall Study|Lack of Efficacy|0
5260500|NCT00691210|18148915|P1|Overall Study|Lack of Efficacy|0
5260501|NCT00691210|18148908|P8|Overall Study|Progression of Disease|0
5260502|NCT00691210|18148909|P7|Overall Study|Progression of Disease|0
5260503|NCT00691210|18148910|P6|Overall Study|Progression of Disease|0
5260504|NCT00691210|18148911|P5|Overall Study|Progression of Disease|0
5260505|NCT00691210|18148912|P4|Overall Study|Progression of Disease|2
5260506|NCT00691210|18148913|P3|Overall Study|Progression of Disease|0
5260507|NCT00691210|18148914|P2|Overall Study|Progression of Disease|0
5260508|NCT00691210|18148915|P1|Overall Study|Progression of Disease|0
5260509|NCT00691132|18148950|P2|Overall Study|Withdrawal by Subject|10
5260510|NCT00691132|18148951|P1|Overall Study|Withdrawal by Subject|10
5260511|NCT00691132|18148950|P2|Overall Study|Adverse Event|3
5260512|NCT00691132|18148951|P1|Overall Study|Adverse Event|2
5260513|NCT00691093|18148970|P1|Overall Study|Ongoing at Date of Cut-Off|4
5260514|NCT00691093|18148970|P1|Overall Study|Lack of Efficacy|1
5260515|NCT00691093|18148970|P1|Overall Study|Lost to Follow-up|1
5260516|NCT00691093|18148970|P1|Overall Study|Adverse Event|1
5260517|NCT00691054|18149004|P1|Overall Study|Withdrawal by Subject|1
5260518|NCT00691028|18149016|P4|Double-blind Period|not come to a hospital.|0
5260519|NCT00691028|18149017|P3|Double-blind Period|not come to a hospital.|0
5260520|NCT00691028|18149018|P2|Double-blind Period|not come to a hospital.|1
5260521|NCT00691028|18149019|P1|Double-blind Period|not come to a hospital.|0
5260522|NCT00691028|18149016|P4|Double-blind Period|Withdrawal by Subject|0
5260523|NCT00691028|18149017|P3|Double-blind Period|Withdrawal by Subject|1
5260524|NCT00691028|18149018|P2|Double-blind Period|Withdrawal by Subject|0
5260525|NCT00691028|18149019|P1|Double-blind Period|Withdrawal by Subject|1
5260526|NCT00691028|18149016|P4|Double-blind Period|Lack of Efficacy|0
5260527|NCT00691028|18149017|P3|Double-blind Period|Lack of Efficacy|2
5260528|NCT00691028|18149018|P2|Double-blind Period|Lack of Efficacy|3
5260529|NCT00691028|18149019|P1|Double-blind Period|Lack of Efficacy|4
5260530|NCT00691028|18149016|P4|Double-blind Period|Adverse Event|0
5260531|NCT00691028|18149017|P3|Double-blind Period|Adverse Event|6
5260532|NCT00691028|18149018|P2|Double-blind Period|Adverse Event|9
5260533|NCT00691028|18149019|P1|Double-blind Period|Adverse Event|8
5260534|NCT00691028|18149016|P4|Open-label Period|not come to a hospital|1
5260535|NCT00691028|18149017|P3|Open-label Period|not come to a hospital|0
5260536|NCT00691028|18149018|P2|Open-label Period|not come to a hospital|0
5260537|NCT00691028|18149019|P1|Open-label Period|not come to a hospital|0
5260538|NCT00691028|18149016|P4|Open-label Period|Withdrawal by Subject|3
5260539|NCT00691028|18149017|P3|Open-label Period|Withdrawal by Subject|0
5260540|NCT00691028|18149018|P2|Open-label Period|Withdrawal by Subject|0
5260541|NCT00691028|18149019|P1|Open-label Period|Withdrawal by Subject|0
5260542|NCT00691028|18149016|P4|Open-label Period|Adverse Event|16
5260543|NCT00691028|18149017|P3|Open-label Period|Adverse Event|0
5260544|NCT00691028|18149018|P2|Open-label Period|Adverse Event|0
5260545|NCT00691028|18149019|P1|Open-label Period|Adverse Event|0
5260546|NCT00691015|18149052|P1|Overall Study|Refused further treatment|1
5260547|NCT00690898|18149067|P1|TREATMENT|Other (not otherwise specified)|1
5260548|NCT00690898|18149067|P1|TREATMENT|Withdrawal by Subject|4
5260549|NCT00690898|18149067|P1|TREATMENT|Lack of Efficacy|18
5260550|NCT00690898|18149067|P1|TREATMENT|Adverse Event|3
5260551|NCT00690898|18149067|P1|SCREENING|Screen failure|18
5260552|NCT00690820|18149087|P2|Period 1|Withdrawal by Subject|1
5260553|NCT00690820|18149088|P1|Period 1|Withdrawal by Subject|0
5260554|NCT00690794|18149110|P2|Overall Study|Other not specified|3
5260555|NCT00690794|18149111|P1|Overall Study|Other not specified|1
5260556|NCT00690794|18149110|P2|Overall Study|Noncompliance|2
5260557|NCT00690794|18149111|P1|Overall Study|Noncompliance|1
5260558|NCT00690794|18149110|P2|Overall Study|Protocol Violation|7
5260559|NCT00690794|18149111|P1|Overall Study|Protocol Violation|6
5260560|NCT00690794|18149110|P2|Overall Study|Withdrawal by Subject|9
5260561|NCT00690794|18149111|P1|Overall Study|Withdrawal by Subject|0
5260562|NCT00690794|18149110|P2|Overall Study|Lost to Follow-up|4
5260563|NCT00690794|18149111|P1|Overall Study|Lost to Follow-up|1
5260564|NCT00690794|18149110|P2|Overall Study|Adverse Event|10
5260565|NCT00690794|18149111|P1|Overall Study|Adverse Event|12
5260566|NCT00690755|18149126|P7|Overall Study|Physician Decision|0
5260567|NCT00690755|18149127|P6|Overall Study|Physician Decision|4
5260568|NCT00690755|18149128|P5|Overall Study|Physician Decision|0
5260569|NCT00690755|18149129|P4|Overall Study|Physician Decision|5
5260570|NCT00690755|18149130|P3|Overall Study|Physician Decision|46
5260571|NCT00690755|18149131|P2|Overall Study|Physician Decision|0
5260572|NCT00690755|18149132|P1|Overall Study|Physician Decision|2
5260573|NCT00690612|18149148|P1|Overall Study|Withdrawal by Subject|2
5260574|NCT00690612|18149148|P1|Overall Study|Adverse Event|1
5260575|NCT00690573|18149153|P1|Overall Study|Withdrawal by Subject|1
5260576|NCT00690573|18149153|P1|Overall Study|Lack of Efficacy|8
5260577|NCT00690482|18149172|P2|Overall Study|withdrew consent at rand.day|1
5260578|NCT00690482|18149173|P1|Overall Study|withdrew consent at rand.day|0
5260579|NCT00690482|18149172|P2|Overall Study|Intake of prohibited medicine|0
5260580|NCT00690482|18149173|P1|Overall Study|Intake of prohibited medicine|1
5260581|NCT00690482|18149172|P2|Overall Study|Study-specific discontinuation criteria|0
5260582|NCT00690482|18149173|P1|Overall Study|Study-specific discontinuation criteria|1
5260583|NCT00690482|18149172|P2|Overall Study|Incorrect enrolment|1
5260584|NCT00690482|18149173|P1|Overall Study|Incorrect enrolment|0
5260585|NCT00690482|18149172|P2|Overall Study|Adverse Event|1
5260586|NCT00690482|18149173|P1|Overall Study|Adverse Event|2
5260587|NCT00690443|18149207|P2|Overall Study|Adverse Event|2
5260588|NCT00690443|18149208|P1|Overall Study|Adverse Event|1
5260589|NCT00690430|18149218|P3|Extension Phase|Early Termination|3
5260590|NCT00690430|18149219|P2|Extension Phase|Early Termination|1
5260591|NCT00690430|18149220|P1|Extension Phase|Early Termination|10
5260592|NCT00690430|18149218|P3|Extension Phase|Withdrawal by Subject|2
5260593|NCT00690430|18149219|P2|Extension Phase|Withdrawal by Subject|0
5260594|NCT00690430|18149220|P1|Extension Phase|Withdrawal by Subject|0
5260595|NCT00690430|18149218|P3|Extension Phase|Death|1
5260596|NCT00690430|18149219|P2|Extension Phase|Death|1
5260597|NCT00690430|18149220|P1|Extension Phase|Death|1
5260598|NCT00690430|18149218|P3|Extension Phase|Adverse Event|2
5260599|NCT00690430|18149219|P2|Extension Phase|Adverse Event|1
5260600|NCT00690430|18149220|P1|Extension Phase|Adverse Event|2
5260601|NCT00690430|18149218|P3|Extension Phase|Administrative Problems|1
5260602|NCT00690430|18149219|P2|Extension Phase|Administrative Problems|1
5260603|NCT00690430|18149220|P1|Extension Phase|Administrative Problems|0
5260604|NCT00690430|18149218|P3|Extension Phase|Abnormal test procedure results|0
5260605|NCT00690430|18149219|P2|Extension Phase|Abnormal test procedure results|0
5260606|NCT00690430|18149220|P1|Extension Phase|Abnormal test procedure results|1
5260607|NCT00690430|18149218|P3|Extension Phase|Abnormal Lab Values|0
5260608|NCT00690430|18149219|P2|Extension Phase|Abnormal Lab Values|0
5260609|NCT00690430|18149220|P1|Extension Phase|Abnormal Lab Values|1
5260610|NCT00690430|18149218|P3|Extension Phase|Lack of Efficacy|4
5260611|NCT00690430|18149219|P2|Extension Phase|Lack of Efficacy|1
5260612|NCT00690430|18149220|P1|Extension Phase|Lack of Efficacy|3
5260613|NCT00690430|18149218|P3|Core Phase|Early Termination|0
5260614|NCT00690430|18149219|P2|Core Phase|Early Termination|5
5260615|NCT00690430|18149220|P1|Core Phase|Early Termination|0
5260616|NCT00690430|18149218|P3|Core Phase|Administrative Problems|0
5260617|NCT00690430|18149219|P2|Core Phase|Administrative Problems|1
5260618|NCT00690430|18149220|P1|Core Phase|Administrative Problems|0
5260619|NCT00690430|18149218|P3|Core Phase|Lack of Efficacy|0
5260620|NCT00690430|18149219|P2|Core Phase|Lack of Efficacy|10
5260621|NCT00690430|18149220|P1|Core Phase|Lack of Efficacy|8
5260622|NCT00690430|18149218|P3|Core Phase|Subject no longer requires study drug|0
5260623|NCT00690430|18149219|P2|Core Phase|Subject no longer requires study drug|0
5260624|NCT00690430|18149220|P1|Core Phase|Subject no longer requires study drug|1
5260625|NCT00690430|18149218|P3|Core Phase|Withdrawal by Subject|0
5260626|NCT00690430|18149219|P2|Core Phase|Withdrawal by Subject|3
5260627|NCT00690430|18149220|P1|Core Phase|Withdrawal by Subject|3
5260628|NCT00690430|18149218|P3|Core Phase|Protocol Violation|0
5260629|NCT00690430|18149219|P2|Core Phase|Protocol Violation|0
5260630|NCT00690430|18149220|P1|Core Phase|Protocol Violation|1
5260631|NCT00690430|18149218|P3|Core Phase|Death|0
5260632|NCT00690430|18149219|P2|Core Phase|Death|2
5260633|NCT00690430|18149220|P1|Core Phase|Death|0
5260634|NCT00690430|18149218|P3|Core Phase|Adverse Event|0
5260635|NCT00690430|18149219|P2|Core Phase|Adverse Event|1
5260636|NCT00690430|18149220|P1|Core Phase|Adverse Event|5
5260637|NCT00690430|18149218|P3|Core Phase|Abnormal Laboratory value|0
5260638|NCT00690430|18149219|P2|Core Phase|Abnormal Laboratory value|1
5260639|NCT00690430|18149220|P1|Core Phase|Abnormal Laboratory value|0
5260640|NCT00690378|18149249|P2|Overall Study|Social problem|0
5260641|NCT00690378|18149250|P1|Overall Study|Social problem|1
5260642|NCT00690378|18149249|P2|Overall Study|Did not meet inc/exc criteria|11
5260643|NCT00690378|18149250|P1|Overall Study|Did not meet inc/exc criteria|13
5260644|NCT00690378|18149249|P2|Overall Study|Lost to Follow-up|3
5260645|NCT00690378|18149250|P1|Overall Study|Lost to Follow-up|2
5260646|NCT00690378|18149249|P2|Overall Study|Protocol Violation|0
5260647|NCT00690378|18149250|P1|Overall Study|Protocol Violation|1
5260648|NCT00690378|18149249|P2|Overall Study|Withdrawal by Subject|0
5260649|NCT00690378|18149250|P1|Overall Study|Withdrawal by Subject|2
5260650|NCT00690378|18149249|P2|Overall Study|Adverse Event|0
5260651|NCT00690378|18149250|P1|Overall Study|Adverse Event|1
5260652|NCT00689936|18149347|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
5260653|NCT00689936|18149348|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
5260654|NCT00689936|18149349|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
5260655|NCT00689936|18149347|P3|Active Treatment Phase|Miscellaneous|47
5260656|NCT00689936|18149348|P2|Active Treatment Phase|Miscellaneous|34
5260657|NCT00689936|18149349|P1|Active Treatment Phase|Miscellaneous|52
5260658|NCT00689936|18149347|P3|Active Treatment Phase|Study Close Out|21
5260659|NCT00689936|18149348|P2|Active Treatment Phase|Study Close Out|26
5260660|NCT00689936|18149349|P1|Active Treatment Phase|Study Close Out|64
5260661|NCT00689936|18149347|P3|Active Treatment Phase|Protocol Violation|4
5260662|NCT00689936|18149348|P2|Active Treatment Phase|Protocol Violation|2
5260663|NCT00689936|18149349|P1|Active Treatment Phase|Protocol Violation|2
5260664|NCT00689936|18149347|P3|Active Treatment Phase|Lost to Follow-up|2
5260665|NCT00689936|18149348|P2|Active Treatment Phase|Lost to Follow-up|2
5260666|NCT00689936|18149349|P1|Active Treatment Phase|Lost to Follow-up|0
5260667|NCT00689936|18149347|P3|Active Treatment Phase|Death|37
5260668|NCT00689936|18149348|P2|Active Treatment Phase|Death|28
5260669|NCT00689936|18149349|P1|Active Treatment Phase|Death|60
5260670|NCT00689936|18149347|P3|Active Treatment Phase|Withdrawal by Subject|21
5260671|NCT00689936|18149348|P2|Active Treatment Phase|Withdrawal by Subject|16
5260672|NCT00689936|18149349|P1|Active Treatment Phase|Withdrawal by Subject|16
5260673|NCT00689936|18149347|P3|Active Treatment Phase|Disease Progression|339
5260674|NCT00689936|18149348|P2|Active Treatment Phase|Disease Progression|362
5260675|NCT00689936|18149349|P1|Active Treatment Phase|Disease Progression|273
5260676|NCT00689936|18149347|P3|Active Treatment Phase|Adverse Event|76
5260677|NCT00689936|18149348|P2|Active Treatment Phase|Adverse Event|71
5260678|NCT00689936|18149349|P1|Active Treatment Phase|Adverse Event|68
5260679|NCT00689871|18149498|P4|Overall Study|Physician Decision|0
5260680|NCT00689871|18149499|P3|Overall Study|Physician Decision|1
5260681|NCT00689871|18149500|P2|Overall Study|Physician Decision|1
5260682|NCT00689871|18149501|P1|Overall Study|Physician Decision|2
5260683|NCT00689871|18149498|P4|Overall Study|Death|2
5260684|NCT00689871|18149499|P3|Overall Study|Death|2
5260685|NCT00689871|18149500|P2|Overall Study|Death|10
5260686|NCT00689871|18149501|P1|Overall Study|Death|1
5260687|NCT00689871|18149498|P4|Overall Study|Withdrawal by Subject|1
5260688|NCT00689871|18149499|P3|Overall Study|Withdrawal by Subject|4
5260689|NCT00689871|18149500|P2|Overall Study|Withdrawal by Subject|3
5260690|NCT00689871|18149501|P1|Overall Study|Withdrawal by Subject|13
5260691|NCT00689871|18149498|P4|Overall Study|Explanted of All Study Devices|3
5260692|NCT00689871|18149499|P3|Overall Study|Explanted of All Study Devices|29
5260693|NCT00689871|18149500|P2|Overall Study|Explanted of All Study Devices|25
5260694|NCT00689871|18149501|P1|Overall Study|Explanted of All Study Devices|36
5260695|NCT00689871|18149498|P4|Overall Study|Lost to Follow-up|1
5260696|NCT00689871|18149499|P3|Overall Study|Lost to Follow-up|37
5260697|NCT00689871|18149500|P2|Overall Study|Lost to Follow-up|13
5260698|NCT00689871|18149501|P1|Overall Study|Lost to Follow-up|123
5260699|NCT00689793|18149528|P2|Overall Study|Lost to Follow-up|5
5260700|NCT00689793|18149529|P1|Overall Study|Lost to Follow-up|4
5260701|NCT00689728|18149548|P3|Optional Follow-Up|Withdrawal by Subject|3
5260702|NCT00689728|18149549|P2|Optional Follow-Up|Withdrawal by Subject|4
5260703|NCT00689728|18149550|P1|Optional Follow-Up|Withdrawal by Subject|2
5260704|NCT00689728|18149548|P3|Optional Follow-Up|Protocol Violation|1
5260705|NCT00689728|18149549|P2|Optional Follow-Up|Protocol Violation|0
5260706|NCT00689728|18149550|P1|Optional Follow-Up|Protocol Violation|0
5260707|NCT00689728|18149548|P3|Optional Follow-Up|Lost to Follow-up|1
5260708|NCT00689728|18149549|P2|Optional Follow-Up|Lost to Follow-up|1
5260709|NCT00689728|18149550|P1|Optional Follow-Up|Lost to Follow-up|0
5260710|NCT00689728|18149548|P3|Optional Follow-Up|Lack of Efficacy|1
5260711|NCT00689728|18149549|P2|Optional Follow-Up|Lack of Efficacy|1
5260712|NCT00689728|18149550|P1|Optional Follow-Up|Lack of Efficacy|0
5260713|NCT00689728|18149548|P3|Optional Follow-Up|Adverse Event|0
5260714|NCT00689728|18149549|P2|Optional Follow-Up|Adverse Event|0
5260715|NCT00689728|18149550|P1|Optional Follow-Up|Adverse Event|1
5260716|NCT00689728|18149548|P3|Rescue|Withdrawal by Subject|1
5260717|NCT00689728|18149549|P2|Rescue|Withdrawal by Subject|1
5260718|NCT00689728|18149550|P1|Rescue|Withdrawal by Subject|1
5260719|NCT00689728|18149548|P3|Rescue|Adverse Event|0
5260720|NCT00689728|18149549|P2|Rescue|Adverse Event|1
5260721|NCT00689728|18149550|P1|Rescue|Adverse Event|0
5260722|NCT00689728|18149548|P3|Double-Blind Treatment|Lack of Efficacy|2
5260723|NCT00689728|18149549|P2|Double-Blind Treatment|Lack of Efficacy|1
5260724|NCT00689728|18149550|P1|Double-Blind Treatment|Lack of Efficacy|0
5260725|NCT00689728|18149548|P3|Double-Blind Treatment|Withdrawal by Subject|2
5260726|NCT00689728|18149549|P2|Double-Blind Treatment|Withdrawal by Subject|3
5260727|NCT00689728|18149550|P1|Double-Blind Treatment|Withdrawal by Subject|3
5260728|NCT00689728|18149548|P3|Double-Blind Treatment|Protocol Violation|1
5260729|NCT00689728|18149549|P2|Double-Blind Treatment|Protocol Violation|0
5260730|NCT00689728|18149550|P1|Double-Blind Treatment|Protocol Violation|0
5260731|NCT00689728|18149548|P3|Double-Blind Treatment|Adverse Event|0
5260732|NCT00689728|18149549|P2|Double-Blind Treatment|Adverse Event|0
5260733|NCT00689728|18149550|P1|Double-Blind Treatment|Adverse Event|1
5260734|NCT00689611|18149633|P2|Overall Study|Lost to Follow-up|28
5260735|NCT00689611|18149634|P1|Overall Study|Lost to Follow-up|27
5260736|NCT00689611|18149633|P2|Overall Study|Withdrawal by Subject|9
5260737|NCT00689611|18149634|P1|Overall Study|Withdrawal by Subject|8
5260738|NCT00689611|18149633|P2|Overall Study|Death|9
5260739|NCT00689611|18149634|P1|Overall Study|Death|6
5260740|NCT00689481|18149644|P2|Overall Study|Subject early term, left on vacation|1
5260741|NCT00689481|18149645|P1|Overall Study|Subject early term, left on vacation|0
5260742|NCT00689481|18149644|P2|Overall Study|Excluded medication started during study|1
5260743|NCT00689481|18149645|P1|Overall Study|Excluded medication started during study|0
5260744|NCT00689481|18149644|P2|Overall Study|Withdrawal by Subject|4
5260745|NCT00689481|18149645|P1|Overall Study|Withdrawal by Subject|8
5260746|NCT00689481|18149644|P2|Overall Study|Non-compliance with study treatment|1
5260747|NCT00689481|18149645|P1|Overall Study|Non-compliance with study treatment|1
5260748|NCT00689481|18149644|P2|Overall Study|Lack of Efficacy|3
5260749|NCT00689481|18149645|P1|Overall Study|Lack of Efficacy|4
5260750|NCT00689481|18149644|P2|Overall Study|Lost to Follow-up|3
5260751|NCT00689481|18149645|P1|Overall Study|Lost to Follow-up|4
5260752|NCT00689481|18149644|P2|Overall Study|Adverse Event|1
5260753|NCT00689481|18149645|P1|Overall Study|Adverse Event|7
5260754|NCT00689390|18149663|P2|Overall Study|Administrative|0
5260755|NCT00689390|18149664|P1|Overall Study|Administrative|37
5260756|NCT00689390|18149663|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5260757|NCT00689390|18149664|P1|Overall Study|Did Not Meet Protocol Eligibility|1
5260758|NCT00689390|18149663|P2|Overall Study|Non-Compliance With Protocol|0
5260759|NCT00689390|18149664|P1|Overall Study|Non-Compliance With Protocol|21
5260760|NCT00689390|18149663|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
5260761|NCT00689390|18149664|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
5260762|NCT00689390|18149663|P2|Overall Study|Withdrawal by Subject|3
5260763|NCT00689390|18149664|P1|Overall Study|Withdrawal by Subject|117
5260764|NCT00689390|18149663|P2|Overall Study|Lost to Follow-up|7
5260765|NCT00689390|18149664|P1|Overall Study|Lost to Follow-up|179
5260766|NCT00689390|18149663|P2|Overall Study|Adverse Event|0
5260767|NCT00689390|18149664|P1|Overall Study|Adverse Event|19
5260768|NCT00689351|18149682|P2|After Infant Series|Parent/legal guardian request|0
5260769|NCT00689351|18149683|P1|After Infant Series|Parent/legal guardian request|1
5260770|NCT00689351|18149682|P2|Infant Series of Dosing|Lost to Follow-up|1
5260771|NCT00689351|18149683|P1|Infant Series of Dosing|Lost to Follow-up|0
5260772|NCT00689351|18149682|P2|Infant Series of Dosing|Adverse Event|0
5260773|NCT00689351|18149683|P1|Infant Series of Dosing|Adverse Event|1
5260774|NCT00689351|18149682|P2|Infant Series of Dosing|Parent/legal guardian request|0
5260775|NCT00689351|18149683|P1|Infant Series of Dosing|Parent/legal guardian request|5
5260776|NCT00689338|18149715|P1|Overall Study|Protocol Violation|15
5260777|NCT00689338|18149715|P1|Overall Study|Withdrawal by Subject|3
5260778|NCT00689338|18149715|P1|Overall Study|Lost to Follow-up|5
5260779|NCT00689338|18149715|P1|Overall Study|Did not Meet Entrance Criteria|27
5260780|NCT00689338|18149715|P1|Overall Study|Other|8
5260781|NCT00689338|18149715|P1|Overall Study|Lack of Efficacy|6
5260782|NCT00689338|18149715|P1|Overall Study|Insufficient Clinical Response|1
5260783|NCT00689338|18149715|P1|Overall Study|Adverse Event|13
5260784|NCT00689338|18149715|P1|Overall Study|Death|65
5260785|NCT00689299|18149728|P3|Overall Study|Protocol Violation|0
5260786|NCT00689299|18149729|P2|Overall Study|Protocol Violation|0
5260787|NCT00689299|18149730|P1|Overall Study|Protocol Violation|1
5260788|NCT00689299|18149728|P3|Overall Study|Withdrawal by Subject|3
5260789|NCT00689299|18149729|P2|Overall Study|Withdrawal by Subject|1
5260790|NCT00689299|18149730|P1|Overall Study|Withdrawal by Subject|4
5260791|NCT00689299|18149728|P3|Overall Study|Lost to Follow-up|1
5260792|NCT00689299|18149729|P2|Overall Study|Lost to Follow-up|1
5260793|NCT00689299|18149730|P1|Overall Study|Lost to Follow-up|0
5260794|NCT00689299|18149728|P3|Overall Study|Adverse Event|1
5260795|NCT00689299|18149729|P2|Overall Study|Adverse Event|1
5260796|NCT00689299|18149730|P1|Overall Study|Adverse Event|2
5260797|NCT00689221|18149759|P2|Overall Study|Ongoing at cut-off date|36
5260798|NCT00689221|18149760|P1|Overall Study|Ongoing at cut-off date|39
5260799|NCT00689117|18149789|P4|Overall Study|Dispensing Error|0
5260800|NCT00689117|18149790|P3|Overall Study|Dispensing Error|0
5260801|NCT00689117|18149791|P2|Overall Study|Dispensing Error|1
5260802|NCT00689117|18149792|P1|Overall Study|Dispensing Error|0
5260803|NCT00689117|18149789|P4|Overall Study|Personal Reason|0
5260804|NCT00689117|18149790|P3|Overall Study|Personal Reason|0
5260805|NCT00689117|18149791|P2|Overall Study|Personal Reason|1
5260806|NCT00689117|18149792|P1|Overall Study|Personal Reason|0
5260807|NCT00689117|18149789|P4|Overall Study|Patient Withdrew from Study|1
5260808|NCT00689117|18149790|P3|Overall Study|Patient Withdrew from Study|0
5260809|NCT00689117|18149791|P2|Overall Study|Patient Withdrew from Study|0
5260810|NCT00689117|18149792|P1|Overall Study|Patient Withdrew from Study|0
5260811|NCT00689117|18149789|P4|Overall Study|Transportation|0
5260812|NCT00689117|18149790|P3|Overall Study|Transportation|0
5260813|NCT00689117|18149791|P2|Overall Study|Transportation|0
5260814|NCT00689117|18149792|P1|Overall Study|Transportation|1
5260815|NCT00689117|18149789|P4|Overall Study|Fear of Birth Defects|0
5260816|NCT00689117|18149790|P3|Overall Study|Fear of Birth Defects|1
5260817|NCT00689117|18149791|P2|Overall Study|Fear of Birth Defects|0
5260818|NCT00689117|18149792|P1|Overall Study|Fear of Birth Defects|0
5260819|NCT00689117|18149789|P4|Overall Study|Incarceration|0
5260820|NCT00689117|18149790|P3|Overall Study|Incarceration|0
5260821|NCT00689117|18149791|P2|Overall Study|Incarceration|0
5260822|NCT00689117|18149792|P1|Overall Study|Incarceration|2
5260823|NCT00689117|18149789|P4|Overall Study|Pregnancy|2
5260824|NCT00689117|18149790|P3|Overall Study|Pregnancy|0
5260825|NCT00689117|18149791|P2|Overall Study|Pregnancy|2
5260826|NCT00689117|18149792|P1|Overall Study|Pregnancy|0
5260827|NCT00689117|18149789|P4|Overall Study|Use of Prohibitive Medication|0
5260828|NCT00689117|18149790|P3|Overall Study|Use of Prohibitive Medication|3
5260829|NCT00689117|18149791|P2|Overall Study|Use of Prohibitive Medication|1
5260830|NCT00689117|18149792|P1|Overall Study|Use of Prohibitive Medication|2
5260831|NCT00689117|18149789|P4|Overall Study|Change/Discontinuation of Birth Control|0
5260832|NCT00689117|18149790|P3|Overall Study|Change/Discontinuation of Birth Control|1
5260833|NCT00689117|18149791|P2|Overall Study|Change/Discontinuation of Birth Control|1
5260834|NCT00689117|18149792|P1|Overall Study|Change/Discontinuation of Birth Control|1
5260835|NCT00689117|18149789|P4|Overall Study|Non-compliance with Treatment Regimen|0
5260836|NCT00689117|18149790|P3|Overall Study|Non-compliance with Treatment Regimen|0
5260837|NCT00689117|18149791|P2|Overall Study|Non-compliance with Treatment Regimen|1
5260838|NCT00689117|18149792|P1|Overall Study|Non-compliance with Treatment Regimen|0
5260839|NCT00689117|18149789|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5260840|NCT00689117|18149790|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5260841|NCT00689117|18149791|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
5260842|NCT00689117|18149792|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
5260843|NCT00689117|18149789|P4|Overall Study|Unable to Comply with Visit Schedule|1
5260844|NCT00689117|18149790|P3|Overall Study|Unable to Comply with Visit Schedule|1
5260845|NCT00689117|18149791|P2|Overall Study|Unable to Comply with Visit Schedule|0
5260846|NCT00689117|18149792|P1|Overall Study|Unable to Comply with Visit Schedule|0
5260847|NCT00689117|18149789|P4|Overall Study|Withdrawal by Subject|13
5260848|NCT00689117|18149790|P3|Overall Study|Withdrawal by Subject|26
5260849|NCT00689117|18149791|P2|Overall Study|Withdrawal by Subject|18
5260850|NCT00689117|18149792|P1|Overall Study|Withdrawal by Subject|19
5260851|NCT00689117|18149789|P4|Overall Study|Non-Compliance with Study Treatment|1
5260852|NCT00689117|18149790|P3|Overall Study|Non-Compliance with Study Treatment|3
5260853|NCT00689117|18149791|P2|Overall Study|Non-Compliance with Study Treatment|3
5260854|NCT00689117|18149792|P1|Overall Study|Non-Compliance with Study Treatment|3
5260855|NCT00689117|18149789|P4|Overall Study|Lack of Efficacy|2
5260856|NCT00689117|18149790|P3|Overall Study|Lack of Efficacy|2
5260857|NCT00689117|18149791|P2|Overall Study|Lack of Efficacy|2
5260858|NCT00689117|18149792|P1|Overall Study|Lack of Efficacy|1
5260859|NCT00689117|18149789|P4|Overall Study|Lost to Follow-up|11
5260860|NCT00689117|18149790|P3|Overall Study|Lost to Follow-up|17
5260861|NCT00689117|18149791|P2|Overall Study|Lost to Follow-up|19
5260862|NCT00689117|18149792|P1|Overall Study|Lost to Follow-up|26
5260863|NCT00689117|18149789|P4|Overall Study|Adverse Event|0
5260864|NCT00689117|18149790|P3|Overall Study|Adverse Event|5
5260865|NCT00689117|18149791|P2|Overall Study|Adverse Event|0
5260866|NCT00689117|18149792|P1|Overall Study|Adverse Event|6
5260867|NCT00689104|18149822|P4|Overall Study|Non-compliance with study procedures|0
5260868|NCT00689104|18149823|P3|Overall Study|Non-compliance with study procedures|1
5260869|NCT00689104|18149824|P2|Overall Study|Non-compliance with study procedures|0
5260870|NCT00689104|18149825|P1|Overall Study|Non-compliance with study procedures|0
5260871|NCT00689104|18149822|P4|Overall Study|Physician Decision|0
5260872|NCT00689104|18149823|P3|Overall Study|Physician Decision|0
5260873|NCT00689104|18149824|P2|Overall Study|Physician Decision|0
5260874|NCT00689104|18149825|P1|Overall Study|Physician Decision|1
5260875|NCT00689104|18149822|P4|Overall Study|Randomized but never received study drug|0
5260876|NCT00689104|18149823|P3|Overall Study|Randomized but never received study drug|1
5260877|NCT00689104|18149824|P2|Overall Study|Randomized but never received study drug|1
5260878|NCT00689104|18149825|P1|Overall Study|Randomized but never received study drug|2
5260879|NCT00689104|18149822|P4|Overall Study|Protocol Violation|3
5260880|NCT00689104|18149823|P3|Overall Study|Protocol Violation|5
5260881|NCT00689104|18149824|P2|Overall Study|Protocol Violation|3
5260882|NCT00689104|18149825|P1|Overall Study|Protocol Violation|2
5260883|NCT00689104|18149822|P4|Overall Study|Lost to Follow-up|5
5260884|NCT00689104|18149823|P3|Overall Study|Lost to Follow-up|2
5260885|NCT00689104|18149824|P2|Overall Study|Lost to Follow-up|3
5260886|NCT00689104|18149825|P1|Overall Study|Lost to Follow-up|4
5260887|NCT00689104|18149822|P4|Overall Study|Withdrawal by Subject|11
5260888|NCT00689104|18149823|P3|Overall Study|Withdrawal by Subject|18
5260889|NCT00689104|18149824|P2|Overall Study|Withdrawal by Subject|11
5260890|NCT00689104|18149825|P1|Overall Study|Withdrawal by Subject|12
5260891|NCT00689104|18149822|P4|Overall Study|Lack of Efficacy|3
5260892|NCT00689104|18149823|P3|Overall Study|Lack of Efficacy|2
5260893|NCT00689104|18149824|P2|Overall Study|Lack of Efficacy|6
5260894|NCT00689104|18149825|P1|Overall Study|Lack of Efficacy|5
5260895|NCT00689104|18149822|P4|Overall Study|Adverse Event|24
5260896|NCT00689104|18149823|P3|Overall Study|Adverse Event|16
5260897|NCT00689104|18149824|P2|Overall Study|Adverse Event|25
5260898|NCT00689104|18149825|P1|Overall Study|Adverse Event|13
5260899|NCT00689104|18149822|P4|Overall Study|Eligibility criterion not met|4
5260900|NCT00689104|18149823|P3|Overall Study|Eligibility criterion not met|0
5260901|NCT00689104|18149824|P2|Overall Study|Eligibility criterion not met|8
5260902|NCT00689104|18149825|P1|Overall Study|Eligibility criterion not met|5
5260903|NCT00689052|18150031|P2|Overall Study|Early termination of the trial|24
5260904|NCT00689052|18150032|P1|Overall Study|Early termination of the trial|22
5260905|NCT00689052|18150031|P2|Overall Study|Withdrawal by Subject|0
5260906|NCT00689052|18150032|P1|Overall Study|Withdrawal by Subject|2
5260907|NCT00689052|18150031|P2|Overall Study|Lost to Follow-up|0
5260908|NCT00689052|18150032|P1|Overall Study|Lost to Follow-up|2
5260909|NCT00689052|18150031|P2|Overall Study|Protocol Violation|0
5260910|NCT00689052|18150032|P1|Overall Study|Protocol Violation|1
5260911|NCT00689052|18150031|P2|Overall Study|Adverse Event|6
5260912|NCT00689052|18150032|P1|Overall Study|Adverse Event|4
5260913|NCT00689026|18150064|P2|Overall Study|Withdrawal by Subject|6
5260914|NCT00689026|18150065|P1|Overall Study|Withdrawal by Subject|13
5260915|NCT00688870|18150078|P2|Infant Series|Parent or legal guardian request|0
5260916|NCT00688870|18150079|P1|Infant Series|Parent or legal guardian request|4
5260917|NCT00688844|18150111|P1|Overall Study|Lost to Follow-up|10
5260918|NCT00688753|18150121|P1|Overall Study|Lost to Follow-up|3
5260919|NCT00688753|18150121|P1|Overall Study|Protocol Violation|1
5260920|NCT00688753|18150121|P1|Overall Study|Adverse Event|20
5260921|NCT00688753|18150121|P1|Overall Study|Withdrawal by Subject|3
5260922|NCT00688753|18150121|P1|Overall Study|Death|9
5260923|NCT00688753|18150121|P1|Overall Study|Missing|1
5260924|NCT00688753|18150121|P1|Overall Study|Disease progression|55
5260925|NCT00688740|18150132|P2|Overall Study|Violation of Inclusion Criteria|3
5260926|NCT00688740|18150133|P1|Overall Study|Violation of Inclusion Criteria|1
5260927|NCT00688740|18150132|P2|Overall Study|Breast Cancer Relapse|4
5260928|NCT00688740|18150133|P1|Overall Study|Breast Cancer Relapse|1
5260929|NCT00688740|18150132|P2|Overall Study|Consent Withdrawn|17
5260930|NCT00688740|18150133|P1|Overall Study|Consent Withdrawn|17
5260931|NCT00688740|18150132|P2|Overall Study|Lost to Follow-up|1
5260932|NCT00688740|18150133|P1|Overall Study|Lost to Follow-up|0
5260933|NCT00688740|18150132|P2|Overall Study|Death|2
5260934|NCT00688740|18150133|P1|Overall Study|Death|2
5260935|NCT00688740|18150132|P2|Overall Study|Adverse Event|8
5260936|NCT00688740|18150133|P1|Overall Study|Adverse Event|45
5260937|NCT00688701|18150146|P4|Overall Study|Poor compliance to protocol|0
5260938|NCT00688701|18150147|P3|Overall Study|Poor compliance to protocol|1
5260939|NCT00688701|18150148|P2|Overall Study|Poor compliance to protocol|1
5260940|NCT00688701|18150149|P1|Overall Study|Poor compliance to protocol|0
5260941|NCT00688701|18150146|P4|Overall Study|Withdrawal by Subject|8
5260942|NCT00688701|18150147|P3|Overall Study|Withdrawal by Subject|4
5260943|NCT00688701|18150148|P2|Overall Study|Withdrawal by Subject|3
5260944|NCT00688701|18150149|P1|Overall Study|Withdrawal by Subject|3
5260945|NCT00688701|18150146|P4|Overall Study|Lack of Efficacy|0
5260946|NCT00688701|18150147|P3|Overall Study|Lack of Efficacy|0
5260947|NCT00688701|18150148|P2|Overall Study|Lack of Efficacy|1
5260948|NCT00688701|18150149|P1|Overall Study|Lack of Efficacy|0
5260949|NCT00688701|18150146|P4|Overall Study|Adverse Event|3
5260950|NCT00688701|18150147|P3|Overall Study|Adverse Event|5
5260951|NCT00688701|18150148|P2|Overall Study|Adverse Event|0
5260952|NCT00688701|18150149|P1|Overall Study|Adverse Event|1
5260953|NCT00688688|18150190|P3|Overall Study|Violation of exclusion criterion|0
5260954|NCT00688688|18150191|P2|Overall Study|Violation of exclusion criterion|1
5260955|NCT00688688|18150192|P1|Overall Study|Violation of exclusion criterion|0
5260956|NCT00688688|18150190|P3|Overall Study|Site closure|0
5260957|NCT00688688|18150191|P2|Overall Study|Site closure|1
5260958|NCT00688688|18150192|P1|Overall Study|Site closure|0
5260959|NCT00688688|18150190|P3|Overall Study|Taking exclusionary medications|0
5260960|NCT00688688|18150191|P2|Overall Study|Taking exclusionary medications|0
5260961|NCT00688688|18150192|P1|Overall Study|Taking exclusionary medications|1
5260962|NCT00688688|18150190|P3|Overall Study|Non-compliance with study procedures|4
5260963|NCT00688688|18150191|P2|Overall Study|Non-compliance with study procedures|3
5260964|NCT00688688|18150192|P1|Overall Study|Non-compliance with study procedures|5
5260965|NCT00688688|18150190|P3|Overall Study|Randomized but never received study drug|0
5260966|NCT00688688|18150191|P2|Overall Study|Randomized but never received study drug|0
5260967|NCT00688688|18150192|P1|Overall Study|Randomized but never received study drug|1
5260968|NCT00688688|18150190|P3|Overall Study|Protocol Violation|11
5260969|NCT00688688|18150191|P2|Overall Study|Protocol Violation|9
5260970|NCT00688688|18150192|P1|Overall Study|Protocol Violation|6
5260971|NCT00688688|18150190|P3|Overall Study|Lost to Follow-up|7
5260972|NCT00688688|18150191|P2|Overall Study|Lost to Follow-up|7
5260973|NCT00688688|18150192|P1|Overall Study|Lost to Follow-up|14
5260974|NCT00688688|18150190|P3|Overall Study|Withdrawal by Subject|65
5260975|NCT00688688|18150191|P2|Overall Study|Withdrawal by Subject|75
5260976|NCT00688688|18150192|P1|Overall Study|Withdrawal by Subject|66
5260977|NCT00688688|18150190|P3|Overall Study|Lack of Efficacy|45
5260978|NCT00688688|18150191|P2|Overall Study|Lack of Efficacy|25
5260979|NCT00688688|18150192|P1|Overall Study|Lack of Efficacy|34
5260980|NCT00688688|18150190|P3|Overall Study|Adverse Event|50
5260981|NCT00688688|18150191|P2|Overall Study|Adverse Event|51
5260982|NCT00688688|18150192|P1|Overall Study|Adverse Event|52
5260983|NCT00688688|18150190|P3|Overall Study|Eligibility criterion not met|10
5260984|NCT00688688|18150191|P2|Overall Study|Eligibility criterion not met|7
5260985|NCT00688688|18150192|P1|Overall Study|Eligibility criterion not met|7
5260986|NCT00688636|18150294|P2|Overall Study|Adverse Event|1
5260987|NCT00688636|18150295|P1|Overall Study|Adverse Event|2
5260988|NCT00688623|18150309|P1|Overall Study|Protocol Violation|2
5260989|NCT00688623|18150309|P1|Overall Study|disease progression|23
5260990|NCT00688623|18150309|P1|Overall Study|Death|3
5260991|NCT00688623|18150309|P1|Overall Study|Withdrawal by Subject|4
5260992|NCT00688623|18150309|P1|Overall Study|abnormal lab value|1
5260993|NCT00688623|18150309|P1|Overall Study|Adverse Event|22
5260994|NCT00688597|18150323|P3|Overall Study|Physician Decision|0
5260995|NCT00688597|18150324|P2|Overall Study|Physician Decision|0
5260996|NCT00688597|18150325|P1|Overall Study|Physician Decision|1
5260997|NCT00688597|18150323|P3|Overall Study|Adverse Event|0
5260998|NCT00688597|18150324|P2|Overall Study|Adverse Event|0
5260999|NCT00688597|18150325|P1|Overall Study|Adverse Event|2
5261000|NCT00688545|18150338|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
5261001|NCT00688545|18150339|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
5261002|NCT00688545|18150338|P2|Overall Study|Withdrawal by Subject|3
5261003|NCT00688545|18150339|P1|Overall Study|Withdrawal by Subject|2
5261004|NCT00688545|18150338|P2|Overall Study|Insurance/cost of drug|1
5261005|NCT00688545|18150339|P1|Overall Study|Insurance/cost of drug|0
5261006|NCT00688545|18150338|P2|Overall Study|Lost to Follow-up|4
5261007|NCT00688545|18150339|P1|Overall Study|Lost to Follow-up|1
5261008|NCT00688519|18150349|P2|Overall Study|Pregnancy|1
5261009|NCT00688519|18150350|P1|Overall Study|Pregnancy|0
5261010|NCT00688519|18150349|P2|Overall Study|Subject moved out of area|0
5261011|NCT00688519|18150350|P1|Overall Study|Subject moved out of area|1
5261012|NCT00688519|18150349|P2|Overall Study|Investigator decision|0
5261013|NCT00688519|18150350|P1|Overall Study|Investigator decision|1
5261014|NCT00688519|18150349|P2|Overall Study|Subject moved out of state|0
5261015|NCT00688519|18150350|P1|Overall Study|Subject moved out of state|1
5261016|NCT00688519|18150349|P2|Overall Study|Non-compliance|1
5261017|NCT00688519|18150350|P1|Overall Study|Non-compliance|0
5261018|NCT00688519|18150349|P2|Overall Study|Prohibited medication|0
5261019|NCT00688519|18150350|P1|Overall Study|Prohibited medication|1
5261020|NCT00688519|18150349|P2|Overall Study|Withdrawal by Subject|6
5261021|NCT00688519|18150350|P1|Overall Study|Withdrawal by Subject|7
5261022|NCT00688519|18150349|P2|Overall Study|Lack of Efficacy|1
5261023|NCT00688519|18150350|P1|Overall Study|Lack of Efficacy|3
5261024|NCT00688519|18150349|P2|Overall Study|Lost to Follow-up|3
5261025|NCT00688519|18150350|P1|Overall Study|Lost to Follow-up|3
5261026|NCT00688519|18150349|P2|Overall Study|Adverse Event|3
5261027|NCT00688519|18150350|P1|Overall Study|Adverse Event|2
5261028|NCT00688467|18150368|P2|Treatment Period 2|Adverse Event|1
5261029|NCT00688467|18150369|P1|Treatment Period 2|Adverse Event|0
5261030|NCT00688467|18150368|P2|Treatment Period 2|Protocol Violation|1
5261031|NCT00688467|18150369|P1|Treatment Period 2|Protocol Violation|0
5261032|NCT00688467|18150368|P2|Treatment Period 1|Did not meet protocol eligibility|1
5261033|NCT00688467|18150369|P1|Treatment Period 1|Did not meet protocol eligibility|0
5261034|NCT00688467|18150368|P2|Treatment Period 1|Adverse Event|1
5261035|NCT00688467|18150369|P1|Treatment Period 1|Adverse Event|2
5261036|NCT00688376|18150401|P2|Blinded Extension Phase|Other|0
5261037|NCT00688376|18150402|P1|Blinded Extension Phase|Other|1
5261038|NCT00688376|18150401|P2|Blinded Extension Phase|Physician Decision|0
5261039|NCT00688376|18150402|P1|Blinded Extension Phase|Physician Decision|1
5261040|NCT00688376|18150401|P2|Blinded Extension Phase|Withdrawal by Subject|1
5261041|NCT00688376|18150402|P1|Blinded Extension Phase|Withdrawal by Subject|0
5261042|NCT00688376|18150401|P2|Blinded Extension Phase|Adverse Event|4
5261043|NCT00688376|18150402|P1|Blinded Extension Phase|Adverse Event|3
5261044|NCT00688376|18150401|P2|Double-Blind Phase|Not treated|1
5261045|NCT00688376|18150402|P1|Double-Blind Phase|Not treated|0
5261046|NCT00688376|18150401|P2|Double-Blind Phase|Withdrawal by Subject|0
5261047|NCT00688376|18150402|P1|Double-Blind Phase|Withdrawal by Subject|1
5261048|NCT00688376|18150401|P2|Double-Blind Phase|Protocol Violation|2
5261049|NCT00688376|18150402|P1|Double-Blind Phase|Protocol Violation|1
5261050|NCT00688376|18150401|P2|Double-Blind Phase|Adverse Event|4
5261051|NCT00688376|18150402|P1|Double-Blind Phase|Adverse Event|4
5261052|NCT00688324|18150416|P1|Overall Study|Lost to Follow-up|1
5261053|NCT00688324|18150416|P1|Overall Study|Physician Decision|5
5261054|NCT00688324|18150416|P1|Overall Study|Withdrawal by Subject|2
5261055|NCT00688259|18150461|P2|Overall Study|Hospitalized at Follow-up|1
5261056|NCT00688259|18150462|P1|Overall Study|Hospitalized at Follow-up|0
5261057|NCT00688259|18150461|P2|Overall Study|Declined Interview|3
5261058|NCT00688259|18150462|P1|Overall Study|Declined Interview|2
5261059|NCT00688259|18150461|P2|Overall Study|Withdrawal by Subject|0
5261060|NCT00688259|18150462|P1|Overall Study|Withdrawal by Subject|2
5261061|NCT00688259|18150461|P2|Overall Study|Physician Decision|0
5261062|NCT00688259|18150462|P1|Overall Study|Physician Decision|1
5261063|NCT00688259|18150461|P2|Overall Study|Lost to Follow-up|4
5261064|NCT00688259|18150462|P1|Overall Study|Lost to Follow-up|2
5261065|NCT00688155|18150482|P4|Overall Study|Withdrawal by Subject|1
5261066|NCT00688155|18150483|P3|Overall Study|Withdrawal by Subject|1
5261067|NCT00688155|18150484|P2|Overall Study|Withdrawal by Subject|2
5261068|NCT00688155|18150485|P1|Overall Study|Withdrawal by Subject|2
5261069|NCT00688103|18150505|P2|Overall Study|complex reasons|9
5261070|NCT00688103|18150506|P1|Overall Study|complex reasons|11
5261071|NCT00688103|18150505|P2|Overall Study|Withdrawal by Subject|2
5261072|NCT00688103|18150506|P1|Overall Study|Withdrawal by Subject|4
5261073|NCT00688103|18150505|P2|Overall Study|Lack of Efficacy|1
5261074|NCT00688103|18150506|P1|Overall Study|Lack of Efficacy|11
5261075|NCT00688103|18150505|P2|Overall Study|Adverse Event|1
5261076|NCT00688103|18150506|P1|Overall Study|Adverse Event|4
5261077|NCT00688064|18150518|P2|Overall Study|Any other reasons|3
5261078|NCT00688064|18150519|P1|Overall Study|Any other reasons|1
5261079|NCT00688064|18150518|P2|Overall Study|Pregnancy|0
5261080|NCT00688064|18150519|P1|Overall Study|Pregnancy|1
5261081|NCT00688064|18150518|P2|Overall Study|Lack of Efficacy|1
5261082|NCT00688064|18150519|P1|Overall Study|Lack of Efficacy|0
5261083|NCT00688064|18150518|P2|Overall Study|Lost to Follow-up|10
5261084|NCT00688064|18150519|P1|Overall Study|Lost to Follow-up|10
5261085|NCT00688064|18150518|P2|Overall Study|Withdrawal by Subject|7
5261086|NCT00688064|18150519|P1|Overall Study|Withdrawal by Subject|7
5261087|NCT00688064|18150518|P2|Overall Study|Adverse Event|4
5261088|NCT00688064|18150519|P1|Overall Study|Adverse Event|2
5261089|NCT00688064|18150518|P2|Overall Study|Protocol Violation|1
5261090|NCT00688064|18150519|P1|Overall Study|Protocol Violation|0
5261091|NCT00687973|18150535|P2|Overall Study|Withdrawal by Subject|3
5261092|NCT00687973|18150536|P1|Overall Study|Withdrawal by Subject|3
5261093|NCT00687973|18150535|P2|Overall Study|Administrative Reasons|2
5261094|NCT00687973|18150536|P1|Overall Study|Administrative Reasons|0
5261095|NCT00687973|18150535|P2|Overall Study|Protocol Violation|2
5261096|NCT00687973|18150536|P1|Overall Study|Protocol Violation|1
5261097|NCT00687973|18150535|P2|Overall Study|Lack of Efficacy|3
5261098|NCT00687973|18150536|P1|Overall Study|Lack of Efficacy|2
5261099|NCT00687973|18150535|P2|Overall Study|Adverse Event|28
5261100|NCT00687973|18150536|P1|Overall Study|Adverse Event|18
5261101|NCT00687804|18150598|P3|Open-Label Extension Study|Death|3
5261102|NCT00687804|18150599|P2|Open-Label Extension Study|Death|3
5261103|NCT00687804|18150600|P1|Open-Label Extension Study|Death|2
5261104|NCT00687804|18150598|P3|Open-Label Extension Study|Administrative problems|0
5261105|NCT00687804|18150599|P2|Open-Label Extension Study|Administrative problems|1
5261106|NCT00687804|18150600|P1|Open-Label Extension Study|Administrative problems|1
5261107|NCT00687804|18150598|P3|Open-Label Extension Study|Lost to Follow-up|2
5261108|NCT00687804|18150599|P2|Open-Label Extension Study|Lost to Follow-up|1
5261109|NCT00687804|18150600|P1|Open-Label Extension Study|Lost to Follow-up|2
5261110|NCT00687804|18150598|P3|Open-Label Extension Study|Subject withdrew consent|4
5261111|NCT00687804|18150599|P2|Open-Label Extension Study|Subject withdrew consent|4
5261112|NCT00687804|18150600|P1|Open-Label Extension Study|Subject withdrew consent|3
5261113|NCT00687804|18150598|P3|Open-Label Extension Study|Adverse Event|2
5261114|NCT00687804|18150599|P2|Open-Label Extension Study|Adverse Event|2
5261115|NCT00687804|18150600|P1|Open-Label Extension Study|Adverse Event|2
5261116|NCT00687804|18150598|P3|Core Study|Protocol Violation|0
5261117|NCT00687804|18150599|P2|Core Study|Protocol Violation|1
5261118|NCT00687804|18150600|P1|Core Study|Protocol Violation|1
5261119|NCT00687804|18150598|P3|Core Study|Death|2
5261120|NCT00687804|18150599|P2|Core Study|Death|2
5261121|NCT00687804|18150600|P1|Core Study|Death|2
5261122|NCT00687804|18150598|P3|Core Study|Lost to Follow-up|0
5261123|NCT00687804|18150599|P2|Core Study|Lost to Follow-up|1
5261124|NCT00687804|18150600|P1|Core Study|Lost to Follow-up|0
5261125|NCT00687804|18150598|P3|Core Study|Withdrawal by Subject|7
5261126|NCT00687804|18150599|P2|Core Study|Withdrawal by Subject|7
5261127|NCT00687804|18150600|P1|Core Study|Withdrawal by Subject|4
5261128|NCT00687804|18150598|P3|Core Study|Lack of Efficacy|1
5261129|NCT00687804|18150599|P2|Core Study|Lack of Efficacy|1
5261130|NCT00687804|18150600|P1|Core Study|Lack of Efficacy|1
5261131|NCT00687804|18150598|P3|Core Study|Abnormal laboratory value(s)|0
5261132|NCT00687804|18150599|P2|Core Study|Abnormal laboratory value(s)|0
5261133|NCT00687804|18150600|P1|Core Study|Abnormal laboratory value(s)|1
5261134|NCT00687804|18150598|P3|Core Study|Adverse Event|3
5261135|NCT00687804|18150599|P2|Core Study|Adverse Event|3
5261136|NCT00687804|18150600|P1|Core Study|Adverse Event|5
5261137|NCT00687739|18150647|P4|Overall Study|Adverse Event|0
5261138|NCT00687739|18150648|P3|Overall Study|Adverse Event|1
5261139|NCT00687739|18150649|P2|Overall Study|Adverse Event|1
5261140|NCT00687739|18150650|P1|Overall Study|Adverse Event|0
5261141|NCT00687739|18150647|P4|Overall Study|Lost to Follow-up|2
5261142|NCT00687739|18150648|P3|Overall Study|Lost to Follow-up|1
5261143|NCT00687739|18150649|P2|Overall Study|Lost to Follow-up|2
5261144|NCT00687739|18150650|P1|Overall Study|Lost to Follow-up|2
5261145|NCT00687609|18150692|P1|Overall Study|Withdrawal by Subject|2
5261146|NCT00687609|18150692|P1|Overall Study|Physician Decision|1
5261147|NCT00687531|18150715|P1|Overall Study|Lost to Follow-up|26
5261148|NCT00687531|18150715|P1|Overall Study|Adverse Event|5
5261149|NCT00687531|18150715|P1|Overall Study|Did not meet protocol eligibility|104
5261150|NCT00687440|18150738|P1|Overall Study|Missing|1
5261151|NCT00687440|18150738|P1|Overall Study|Other|1
5261152|NCT00687440|18150738|P1|Overall Study|Death|2
5261153|NCT00687440|18150738|P1|Overall Study|Lack of Efficacy|2
5261154|NCT00687440|18150738|P1|Overall Study|Lost to Follow-up|3
5261155|NCT00687440|18150738|P1|Overall Study|Adverse Event|3
5261156|NCT00687401|18150742|P1|Overall Study|For reasons different from those above|4
5261157|NCT00687401|18150742|P1|Overall Study|Did not return for visit|3
5261158|NCT00687401|18150742|P1|Overall Study|Withdrawal by Subject|4
5261159|NCT00687401|18150742|P1|Overall Study|Lack of Efficacy|6
5261160|NCT00687401|18150742|P1|Overall Study|Adverse Event|6
5261161|NCT00687401|18150742|P1|Overall Study|Protocol Violation|7
5261162|NCT00687362|18150747|P1|Overall Study|Withdrawal by Subject|1
5261163|NCT00687362|18150747|P1|Overall Study|Protocol Violation|2
5261164|NCT00687323|18150751|P1|Overall Study|Screen failure|148
5261165|NCT00687323|18150751|P1|Overall Study|Excluded from efficacy evaluations|6
5261166|NCT00687323|18150751|P1|Overall Study|Withdrawal by Subject|1
5261167|NCT00687323|18150751|P1|Overall Study|Death|25
5261168|NCT00687297|18150767|P2|Induction|Other|1
5261169|NCT00687297|18150768|P1|Induction|Other|0
5261170|NCT00687297|18150767|P2|Induction|Physician Decision|2
5261171|NCT00687297|18150768|P1|Induction|Physician Decision|0
5261172|NCT00687297|18150767|P2|Induction|Patient Noncompliance|0
5261173|NCT00687297|18150768|P1|Induction|Patient Noncompliance|1
5261174|NCT00687297|18150767|P2|Induction|Ineligible|1
5261175|NCT00687297|18150768|P1|Induction|Ineligible|0
5261176|NCT00687297|18150767|P2|Induction|Lack of Efficacy|21
5261177|NCT00687297|18150768|P1|Induction|Lack of Efficacy|17
5261178|NCT00687297|18150767|P2|Induction|Death|11
5261179|NCT00687297|18150768|P1|Induction|Death|7
5261180|NCT00687297|18150767|P2|Induction|Adverse Event|15
5261181|NCT00687297|18150768|P1|Induction|Adverse Event|16
5261182|NCT00687297|18150767|P2|Induction|Withdrawal by Subject|4
5261183|NCT00687297|18150768|P1|Induction|Withdrawal by Subject|4
5261184|NCT00687297|18150767|P2|Randomization|Withdrew before treatment, ineligible|1
5261185|NCT00687297|18150768|P1|Randomization|Withdrew before treatment, ineligible|1
5261186|NCT00687297|18150767|P2|Randomization|Withdrawal by Subject|0
5261187|NCT00687297|18150768|P1|Randomization|Withdrawal by Subject|2
5261188|NCT00687271|18150782|P4|Overall Study|Withdrawal by Subject|0
5261189|NCT00687271|18150783|P3|Overall Study|Withdrawal by Subject|3
5261190|NCT00687271|18150784|P2|Overall Study|Withdrawal by Subject|1
5261191|NCT00687271|18150785|P1|Overall Study|Withdrawal by Subject|0
5261192|NCT00687271|18150782|P4|Overall Study|Protocol Violation|0
5261193|NCT00687271|18150783|P3|Overall Study|Protocol Violation|1
5261194|NCT00687271|18150784|P2|Overall Study|Protocol Violation|1
5261195|NCT00687271|18150785|P1|Overall Study|Protocol Violation|2
5261196|NCT00687271|18150782|P4|Overall Study|Lost to Follow-up|0
5261197|NCT00687271|18150783|P3|Overall Study|Lost to Follow-up|0
5261198|NCT00687271|18150784|P2|Overall Study|Lost to Follow-up|1
5261199|NCT00687271|18150785|P1|Overall Study|Lost to Follow-up|0
5261200|NCT00687271|18150782|P4|Overall Study|Adverse Event|0
5261201|NCT00687271|18150783|P3|Overall Study|Adverse Event|1
5261202|NCT00687271|18150784|P2|Overall Study|Adverse Event|3
5261203|NCT00687271|18150785|P1|Overall Study|Adverse Event|1
5261204|NCT00687219|18150823|P1|Overall Study|Lack of Efficacy|1
5261205|NCT00687219|18150823|P1|Overall Study|Withdrawal by Subject|1
5261206|NCT00687219|18150823|P1|Overall Study|HCV-RNA positive conversion|34
5261207|NCT00687219|18150823|P1|Overall Study|Discontinuance criteria met|7
5261208|NCT00687219|18150823|P1|Overall Study|Adverse Event|8
5261209|NCT00687193|18150835|P6|Overall Study|Protocol Violation|0
5261210|NCT00687193|18150836|P5|Overall Study|Protocol Violation|2
5261211|NCT00687193|18150837|P4|Overall Study|Protocol Violation|1
5261212|NCT00687193|18150838|P3|Overall Study|Protocol Violation|0
5261213|NCT00687193|18150839|P2|Overall Study|Protocol Violation|2
5261214|NCT00687193|18150840|P1|Overall Study|Protocol Violation|1
5261215|NCT00687193|18150835|P6|Overall Study|Lack of Efficacy|2
5261216|NCT00687193|18150836|P5|Overall Study|Lack of Efficacy|0
5261217|NCT00687193|18150837|P4|Overall Study|Lack of Efficacy|0
5261218|NCT00687193|18150838|P3|Overall Study|Lack of Efficacy|0
5261219|NCT00687193|18150839|P2|Overall Study|Lack of Efficacy|1
5261220|NCT00687193|18150840|P1|Overall Study|Lack of Efficacy|1
5261221|NCT00687193|18150835|P6|Overall Study|Adverse Event|2
5261222|NCT00687193|18150836|P5|Overall Study|Adverse Event|0
5261223|NCT00687193|18150837|P4|Overall Study|Adverse Event|3
5261224|NCT00687193|18150838|P3|Overall Study|Adverse Event|2
5261225|NCT00687193|18150839|P2|Overall Study|Adverse Event|1
5261226|NCT00687193|18150840|P1|Overall Study|Adverse Event|0
5261227|NCT00686998|18151050|P3|Overall Study|Safety Reasons|0
5261228|NCT00686998|18151051|P2|Overall Study|Safety Reasons|0
5261229|NCT00686998|18151052|P1|Overall Study|Safety Reasons|1
5261230|NCT00686998|18151050|P3|Overall Study|Other|1
5261231|NCT00686998|18151051|P2|Overall Study|Other|0
5261232|NCT00686998|18151052|P1|Overall Study|Other|0
5261233|NCT00686998|18151050|P3|Overall Study|Lack of Efficacy|0
5261234|NCT00686998|18151051|P2|Overall Study|Lack of Efficacy|5
5261235|NCT00686998|18151052|P1|Overall Study|Lack of Efficacy|7
5261236|NCT00686998|18151050|P3|Overall Study|Withdrawal by Subject|2
5261237|NCT00686998|18151051|P2|Overall Study|Withdrawal by Subject|1
5261238|NCT00686998|18151052|P1|Overall Study|Withdrawal by Subject|2
5261239|NCT00686998|18151050|P3|Overall Study|Adverse Event|1
5261240|NCT00686998|18151051|P2|Overall Study|Adverse Event|2
5261241|NCT00686998|18151052|P1|Overall Study|Adverse Event|3
5261329|NCT00686712|18151189|P2|Overall Study|Protocol Violation|8
5261242|NCT00686972|18151060|P1|Overall Study|P.I, Left institution. Study terminated|51
5261243|NCT00686959|18151066|P2|Overall Study|Participants censored (no death events)|117
5261244|NCT00686959|18151067|P1|Overall Study|Participants censored (no death events)|124
5261245|NCT00686920|18151087|P2|Overall Study|Principal Investigator Decision|0
5261246|NCT00686920|18151088|P1|Overall Study|Principal Investigator Decision|2
5261247|NCT00686920|18151087|P2|Overall Study|Noncompliance|0
5261248|NCT00686920|18151088|P1|Overall Study|Noncompliance|9
5261249|NCT00686920|18151087|P2|Overall Study|Transferred to Nursing Home|0
5261250|NCT00686920|18151088|P1|Overall Study|Transferred to Nursing Home|1
5261251|NCT00686920|18151087|P2|Overall Study|Moved to Another State|0
5261252|NCT00686920|18151088|P1|Overall Study|Moved to Another State|1
5261253|NCT00686920|18151087|P2|Overall Study|Lost to Follow-up|3
5261254|NCT00686920|18151088|P1|Overall Study|Lost to Follow-up|15
5261255|NCT00686920|18151087|P2|Overall Study|Personal Reason|1
5261256|NCT00686920|18151088|P1|Overall Study|Personal Reason|0
5261257|NCT00686920|18151087|P2|Overall Study|Adverse Event|2
5261258|NCT00686920|18151088|P1|Overall Study|Adverse Event|10
5261259|NCT00686920|18151087|P2|Overall Study|Protocol Violation|1
5261260|NCT00686920|18151088|P1|Overall Study|Protocol Violation|2
5261261|NCT00686920|18151087|P2|Overall Study|Withdrawal by Subject|5
5261262|NCT00686920|18151088|P1|Overall Study|Withdrawal by Subject|23
5261263|NCT00686920|18151087|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
5261264|NCT00686920|18151088|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
5261265|NCT00686920|18151087|P2|Overall Study|Liver Transplant|8
5261266|NCT00686920|18151088|P1|Overall Study|Liver Transplant|23
5261267|NCT00686920|18151087|P2|Overall Study|Death|14
5261268|NCT00686920|18151088|P1|Overall Study|Death|45
5261269|NCT00686894|18151100|P1|Overall Study|Protocol Violation|4
5261270|NCT00686894|18151100|P1|Overall Study|Relapse|2
5261271|NCT00686881|18151106|P2|Overall Study|Never received study drug|6
5261272|NCT00686881|18151107|P1|Overall Study|Never received study drug|2
5261273|NCT00686881|18151106|P2|Overall Study|Study discontinuation|32
5261274|NCT00686881|18151107|P1|Overall Study|Study discontinuation|35
5261275|NCT00686881|18151106|P2|Overall Study|Irregular visits|0
5261276|NCT00686881|18151107|P1|Overall Study|Irregular visits|1
5261277|NCT00686881|18151106|P2|Overall Study|Did not meet protocol eligibility|0
5261278|NCT00686881|18151107|P1|Overall Study|Did not meet protocol eligibility|1
5261279|NCT00686881|18151106|P2|Overall Study|Circumstances of site|1
5261280|NCT00686881|18151107|P1|Overall Study|Circumstances of site|1
5261281|NCT00686881|18151106|P2|Overall Study|Physician Decision|0
5261282|NCT00686881|18151107|P1|Overall Study|Physician Decision|1
5261283|NCT00686881|18151106|P2|Overall Study|Lack of Efficacy|3
5261284|NCT00686881|18151107|P1|Overall Study|Lack of Efficacy|4
5261285|NCT00686881|18151106|P2|Overall Study|Onset of malignant tumor|11
5261286|NCT00686881|18151107|P1|Overall Study|Onset of malignant tumor|11
5261287|NCT00686881|18151106|P2|Overall Study|Met discontinuation criteria|0
5261288|NCT00686881|18151107|P1|Overall Study|Met discontinuation criteria|5
5261289|NCT00686881|18151106|P2|Overall Study|Treatment-related adverse event|9
5261290|NCT00686881|18151107|P1|Overall Study|Treatment-related adverse event|10
5261291|NCT00686881|18151106|P2|Overall Study|Lost to Follow-up|1
5261292|NCT00686881|18151107|P1|Overall Study|Lost to Follow-up|0
5261293|NCT00686881|18151106|P2|Overall Study|Withdrawal by Subject|18
5261294|NCT00686881|18151107|P1|Overall Study|Withdrawal by Subject|11
5261295|NCT00686855|18151119|P2|Overall Study|Progressive GVHD|1
5261296|NCT00686855|18151120|P1|Overall Study|Progressive GVHD|0
5261297|NCT00686855|18151119|P2|Overall Study|Lost to Follow-up|0
5261298|NCT00686855|18151120|P1|Overall Study|Lost to Follow-up|1
5261299|NCT00686790|18151146|P1|Overall Study|Lost to Follow-up|12
5261300|NCT00686790|18151146|P1|Overall Study|Death|1
5261301|NCT00686790|18151146|P1|Overall Study|Withdrawal by Subject|1
5261302|NCT00686790|18151146|P1|Overall Study|Adverse Event|2
5261303|NCT00686777|18151154|P1|Overall Study|No Visit|1
5261304|NCT00686777|18151154|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
5261305|NCT00686777|18151154|P1|Overall Study|Withdrawal by Subject|2
5261306|NCT00686777|18151154|P1|Overall Study|Pregnancy|1
5261307|NCT00686777|18151154|P1|Overall Study|Adverse Event|2
5261308|NCT00686725|18151162|P2|Overall Study|Other|3
5261309|NCT00686725|18151163|P1|Overall Study|Other|1
5261310|NCT00686725|18151162|P2|Overall Study|Protocol Violation|3
5261311|NCT00686725|18151163|P1|Overall Study|Protocol Violation|1
5261312|NCT00686725|18151162|P2|Overall Study|Withdrawal by Subject|4
5261313|NCT00686725|18151163|P1|Overall Study|Withdrawal by Subject|13
5261314|NCT00686725|18151162|P2|Overall Study|Death|3
5261315|NCT00686725|18151163|P1|Overall Study|Death|6
5261316|NCT00686725|18151162|P2|Overall Study|Lost to Follow-up|5
5261317|NCT00686725|18151163|P1|Overall Study|Lost to Follow-up|7
5261318|NCT00686725|18151162|P2|Overall Study|Progressive Disease|23
5261319|NCT00686725|18151163|P1|Overall Study|Progressive Disease|17
5261320|NCT00686725|18151162|P2|Overall Study|Adverse Event|1
5261321|NCT00686725|18151163|P1|Overall Study|Adverse Event|1
5261322|NCT00686712|18151188|P3|Overall Study|Adverse Event|0
5261323|NCT00686712|18151189|P2|Overall Study|Adverse Event|1
5261324|NCT00686712|18151190|P1|Overall Study|Adverse Event|1
5261325|NCT00686712|18151188|P3|Overall Study|Lost to Follow-up|3
5261326|NCT00686712|18151189|P2|Overall Study|Lost to Follow-up|2
5261327|NCT00686712|18151190|P1|Overall Study|Lost to Follow-up|1
5261328|NCT00686712|18151188|P3|Overall Study|Protocol Violation|10
5261330|NCT00686712|18151190|P1|Overall Study|Protocol Violation|8
5261331|NCT00686699|18151218|P2|Treatment Period 1|Adverse Event|2
5261332|NCT00686699|18151219|P1|Treatment Period 1|Adverse Event|0
5261333|NCT00686686|18151243|P1|Overall Study|Lost to Follow-up|3
5261334|NCT00686686|18151243|P1|Overall Study|Adverse Event|2
5261335|NCT00686686|18151243|P1|Overall Study|Non-compliance|1
5261336|NCT00686647|18151251|P1|Overall Study|Death|1
5261337|NCT00686647|18151251|P1|Overall Study|Lost to Follow-up|1
5261338|NCT00686634|18151257|P1|Overall Study|Protocol Violation|6
5261339|NCT00686595|18151264|P1|Overall Study|Poor Compliance|1
5261340|NCT00686595|18151264|P1|Overall Study|Lack of Efficacy|1
5261341|NCT00686595|18151264|P1|Overall Study|Lost to Follow-up|1
5261342|NCT00686595|18151264|P1|Overall Study|Protocol Violation|1
5261343|NCT00686595|18151264|P1|Overall Study|Adverse Event|3
5261344|NCT00686543|18151324|P4|Overall Study|Protocol Violation|1
5261345|NCT00686543|18151325|P3|Overall Study|Protocol Violation|2
5261346|NCT00686543|18151326|P2|Overall Study|Protocol Violation|0
5261347|NCT00686543|18151327|P1|Overall Study|Protocol Violation|3
5261348|NCT00686543|18151324|P4|Overall Study|Withdrawal by Subject|0
5261349|NCT00686543|18151325|P3|Overall Study|Withdrawal by Subject|0
5261350|NCT00686543|18151326|P2|Overall Study|Withdrawal by Subject|0
5261351|NCT00686543|18151327|P1|Overall Study|Withdrawal by Subject|2
5261352|NCT00686543|18151324|P4|Overall Study|Adverse Event|2
5261353|NCT00686543|18151325|P3|Overall Study|Adverse Event|3
5261354|NCT00686543|18151326|P2|Overall Study|Adverse Event|1
5261355|NCT00686543|18151327|P1|Overall Study|Adverse Event|9
5261356|NCT00686517|18151348|P3|Treatment|Protocol Violation|0
5261357|NCT00686517|18151349|P2|Treatment|Protocol Violation|1
5261358|NCT00686517|18151350|P1|Treatment|Protocol Violation|2
5261359|NCT00686517|18151348|P3|Treatment|Poor Protocol Compliance|0
5261360|NCT00686517|18151349|P2|Treatment|Poor Protocol Compliance|0
5261361|NCT00686517|18151350|P1|Treatment|Poor Protocol Compliance|1
5261362|NCT00686517|18151348|P3|Treatment|Adverse Event|0
5261363|NCT00686517|18151349|P2|Treatment|Adverse Event|0
5261364|NCT00686517|18151350|P1|Treatment|Adverse Event|2
5261365|NCT00686517|18151348|P3|Treatment|Serious Adverse Event|1
5261366|NCT00686517|18151349|P2|Treatment|Serious Adverse Event|2
5261367|NCT00686517|18151350|P1|Treatment|Serious Adverse Event|1
5261368|NCT00686374|18151373|P1|Overall Study|Other, not specified|4
5261369|NCT00686374|18151373|P1|Overall Study|Missing reason|33
5261370|NCT00686374|18151373|P1|Overall Study|Lost to Follow-up|1
5261371|NCT00686374|18151373|P1|Overall Study|Withdrew consent|5
5261372|NCT00686374|18151373|P1|Overall Study|Adverse Event|8
5261373|NCT00686374|18151373|P1|Overall Study|Lack of Efficacy|10
5261374|NCT00686335|18151384|P1|Run-in Period|violation of inclusion/exclusion criteri|3
5261375|NCT00686335|18151384|P1|Run-in Period|asthma exacerbation|1
5261376|NCT00686335|18151384|P1|Run-in Period|Adverse Event|1
5261377|NCT00686205|18151428|P2|Overall Study|Specimens not confirmed HIV positive|981
5261378|NCT00686205|18151429|P1|Overall Study|Specimens not confirmed HIV positive|0
5261379|NCT00686205|18151428|P2|Overall Study|Specimen handling procedure altered|0
5261380|NCT00686205|18151429|P1|Overall Study|Specimen handling procedure altered|5878
5261381|NCT00686205|18151428|P2|Overall Study|Withdrawal by Subject|0
5261382|NCT00686205|18151429|P1|Overall Study|Withdrawal by Subject|2
5261383|NCT00686205|18151428|P2|Overall Study|Protocol Violation|0
5261384|NCT00686205|18151429|P1|Overall Study|Protocol Violation|127
5261385|NCT00686166|18151435|P1|Overall Study|Did not begin protocol therapy|4
5261386|NCT00686166|18151435|P1|Overall Study|Ineligible|5
5261387|NCT00686166|18151435|P1|Overall Study|Not Protocol Specified|1
5261388|NCT00686166|18151435|P1|Overall Study|Death|1
5261389|NCT00686166|18151435|P1|Overall Study|Progression/Relapse|1
5261390|NCT00686166|18151435|P1|Overall Study|Withdrawal by Subject|1
5261391|NCT00686166|18151435|P1|Overall Study|Adverse Event|7
5261392|NCT00686127|18151447|P2|Overall Study|Withdrawal by Subject|6
5261393|NCT00686127|18151448|P1|Overall Study|Withdrawal by Subject|14
5261394|NCT00686075|18151464|P10|Overall Study|Other|1
5261395|NCT00686075|18151465|P9|Overall Study|Other|0
5261396|NCT00686075|18151466|P8|Overall Study|Other|0
5261397|NCT00686075|18151467|P7|Overall Study|Other|0
5261398|NCT00686075|18151468|P6|Overall Study|Other|0
5261399|NCT00686075|18151469|P5|Overall Study|Other|0
5261400|NCT00686075|18151470|P4|Overall Study|Other|0
5261401|NCT00686075|18151471|P3|Overall Study|Other|0
5261402|NCT00686075|18151472|P2|Overall Study|Other|1
5261403|NCT00686075|18151473|P1|Overall Study|Other|1
5261404|NCT00686075|18151464|P10|Overall Study|Lost to Follow-up|3
5261405|NCT00686075|18151465|P9|Overall Study|Lost to Follow-up|2
5261406|NCT00686075|18151466|P8|Overall Study|Lost to Follow-up|0
5261407|NCT00686075|18151467|P7|Overall Study|Lost to Follow-up|0
5261408|NCT00686075|18151468|P6|Overall Study|Lost to Follow-up|3
5261409|NCT00686075|18151469|P5|Overall Study|Lost to Follow-up|3
5261410|NCT00686075|18151470|P4|Overall Study|Lost to Follow-up|2
5261411|NCT00686075|18151471|P3|Overall Study|Lost to Follow-up|3
5261412|NCT00686075|18151472|P2|Overall Study|Lost to Follow-up|6
5261413|NCT00686075|18151473|P1|Overall Study|Lost to Follow-up|3
5261414|NCT00686075|18151464|P10|Overall Study|Withdrawal by Subject|6
5261415|NCT00686075|18151465|P9|Overall Study|Withdrawal by Subject|4
5261416|NCT00686075|18151466|P8|Overall Study|Withdrawal by Subject|2
5261417|NCT00686075|18151467|P7|Overall Study|Withdrawal by Subject|0
5261418|NCT00686075|18151468|P6|Overall Study|Withdrawal by Subject|0
5261419|NCT00686075|18151469|P5|Overall Study|Withdrawal by Subject|1
5261420|NCT00686075|18151470|P4|Overall Study|Withdrawal by Subject|7
5261421|NCT00686075|18151471|P3|Overall Study|Withdrawal by Subject|3
5261422|NCT00686075|18151472|P2|Overall Study|Withdrawal by Subject|3
5261423|NCT00686075|18151473|P1|Overall Study|Withdrawal by Subject|4
5261424|NCT00686036|18151667|P2|Overall Study|Other reasons not identified|4
5261425|NCT00686036|18151668|P1|Overall Study|Other reasons not identified|0
5261426|NCT00686036|18151667|P2|Overall Study|PSA ≥ 10ng/mL|0
5261427|NCT00686036|18151668|P1|Overall Study|PSA ≥ 10ng/mL|1
5261428|NCT00686036|18151667|P2|Overall Study|Study terminated by AstraZeneca|1
5261429|NCT00686036|18151668|P1|Overall Study|Study terminated by AstraZeneca|2
5261430|NCT00686036|18151667|P2|Overall Study|Withdrawal by Subject|1
5261431|NCT00686036|18151668|P1|Overall Study|Withdrawal by Subject|3
5261432|NCT00686036|18151667|P2|Overall Study|Adverse Event|0
5261433|NCT00686036|18151668|P1|Overall Study|Adverse Event|3
5261434|NCT00685945|18151680|P1|L-NMMA + Bradykinin|Physician Decision|1
5261435|NCT00685802|18151715|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5261436|NCT00685802|18151716|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5261437|NCT00685802|18151715|P2|Washout Period of 7 Days|Protocol Violation|0
5261438|NCT00685802|18151716|P1|Washout Period of 7 Days|Protocol Violation|2
5261439|NCT00685763|18151726|P1|Overall Study|Protocol Violation|1
5261440|NCT00685763|18151726|P1|Overall Study|Intercurrent death-incomplete treatment|1
5261441|NCT00685750|18151737|P7|Overall Study|Eligibility criteria not fulfilled|0
5261442|NCT00685750|18151738|P6|Overall Study|Eligibility criteria not fulfilled|0
5261443|NCT00685750|18151739|P5|Overall Study|Eligibility criteria not fulfilled|0
5261444|NCT00685750|18151740|P4|Overall Study|Eligibility criteria not fulfilled|0
5261445|NCT00685750|18151741|P3|Overall Study|Eligibility criteria not fulfilled|1
5261446|NCT00685750|18151742|P2|Overall Study|Eligibility criteria not fulfilled|0
5261447|NCT00685750|18151743|P1|Overall Study|Eligibility criteria not fulfilled|0
5261448|NCT00685750|18151737|P7|Overall Study|Patient didn't receive the treatment|1
5261449|NCT00685750|18151738|P6|Overall Study|Patient didn't receive the treatment|0
5261450|NCT00685750|18151739|P5|Overall Study|Patient didn't receive the treatment|0
5261451|NCT00685750|18151740|P4|Overall Study|Patient didn't receive the treatment|0
5261452|NCT00685750|18151741|P3|Overall Study|Patient didn't receive the treatment|0
5261453|NCT00685750|18151742|P2|Overall Study|Patient didn't receive the treatment|0
5261454|NCT00685750|18151743|P1|Overall Study|Patient didn't receive the treatment|0
5261455|NCT00685750|18151737|P7|Overall Study|Tumor sampling failure|0
5261456|NCT00685750|18151738|P6|Overall Study|Tumor sampling failure|0
5261457|NCT00685750|18151739|P5|Overall Study|Tumor sampling failure|0
5261458|NCT00685750|18151740|P4|Overall Study|Tumor sampling failure|0
5261459|NCT00685750|18151741|P3|Overall Study|Tumor sampling failure|1
5261460|NCT00685750|18151742|P2|Overall Study|Tumor sampling failure|0
5261461|NCT00685750|18151743|P1|Overall Study|Tumor sampling failure|0
5261462|NCT00685698|18151771|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
5261463|NCT00685698|18151771|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
5261464|NCT00685698|18151771|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
5261465|NCT00685698|18151771|P1|Overall Study|Adverse Event|3
5261466|NCT00685698|18151771|P1|Overall Study|Protocol Violation|6
5261467|NCT00685698|18151771|P1|Overall Study|Withdrawal by Subject|1
5261468|NCT00685685|18151806|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5261469|NCT00685685|18151807|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5261470|NCT00685685|18151806|P2|Washout Period of 7 Days|Adverse Event|0
5261471|NCT00685685|18151807|P1|Washout Period of 7 Days|Adverse Event|2
5261472|NCT00685399|18151960|P8|Extension|Adverse Event|0
5261473|NCT00685399|18151961|P7|Extension|Adverse Event|0
5261474|NCT00685399|18151962|P6|Extension|Adverse Event|0
5261475|NCT00685399|18151963|P5|Extension|Adverse Event|0
5261476|NCT00685399|18151964|P4|Extension|Adverse Event|2
5261477|NCT00685399|18151965|P3|Extension|Adverse Event|0
5261478|NCT00685399|18151966|P2|Extension|Adverse Event|0
5261479|NCT00685399|18151967|P1|Extension|Adverse Event|0
5261480|NCT00685399|18151960|P8|Extension|Lack of Efficacy|0
5261481|NCT00685399|18151961|P7|Extension|Lack of Efficacy|0
5261482|NCT00685399|18151962|P6|Extension|Lack of Efficacy|0
5261483|NCT00685399|18151963|P5|Extension|Lack of Efficacy|0
5261484|NCT00685399|18151964|P4|Extension|Lack of Efficacy|2
5261485|NCT00685399|18151965|P3|Extension|Lack of Efficacy|0
5261486|NCT00685399|18151966|P2|Extension|Lack of Efficacy|0
5261487|NCT00685399|18151967|P1|Extension|Lack of Efficacy|0
5261488|NCT00685399|18151960|P8|Extension|Protocol Violation|0
5261489|NCT00685399|18151961|P7|Extension|Protocol Violation|0
5261490|NCT00685399|18151962|P6|Extension|Protocol Violation|0
5261491|NCT00685399|18151963|P5|Extension|Protocol Violation|0
5261492|NCT00685399|18151964|P4|Extension|Protocol Violation|1
5261493|NCT00685399|18151965|P3|Extension|Protocol Violation|0
5261494|NCT00685399|18151966|P2|Extension|Protocol Violation|0
5261495|NCT00685399|18151967|P1|Extension|Protocol Violation|0
5261496|NCT00685399|18151960|P8|Extension|Withdrawal by Subject|0
5261497|NCT00685399|18151961|P7|Extension|Withdrawal by Subject|0
5261498|NCT00685399|18151962|P6|Extension|Withdrawal by Subject|0
5261499|NCT00685399|18151963|P5|Extension|Withdrawal by Subject|0
5261500|NCT00685399|18151964|P4|Extension|Withdrawal by Subject|1
5261501|NCT00685399|18151965|P3|Extension|Withdrawal by Subject|0
5261502|NCT00685399|18151966|P2|Extension|Withdrawal by Subject|0
5261503|NCT00685399|18151967|P1|Extension|Withdrawal by Subject|0
5261504|NCT00685399|18151960|P8|Extension|Administrative Issues|0
5261505|NCT00685399|18151961|P7|Extension|Administrative Issues|0
5261506|NCT00685399|18151962|P6|Extension|Administrative Issues|0
5261507|NCT00685399|18151963|P5|Extension|Administrative Issues|0
5261508|NCT00685399|18151964|P4|Extension|Administrative Issues|1
5261509|NCT00685399|18151965|P3|Extension|Administrative Issues|0
5261510|NCT00685399|18151966|P2|Extension|Administrative Issues|0
5261511|NCT00685399|18151967|P1|Extension|Administrative Issues|0
5261512|NCT00685399|18151960|P8|Treatment Period 2|Lack of Efficacy|0
5261513|NCT00685399|18151961|P7|Treatment Period 2|Lack of Efficacy|0
5261514|NCT00685399|18151962|P6|Treatment Period 2|Lack of Efficacy|1
5261515|NCT00685399|18151963|P5|Treatment Period 2|Lack of Efficacy|0
5261516|NCT00685399|18151964|P4|Treatment Period 2|Lack of Efficacy|0
5261517|NCT00685399|18151965|P3|Treatment Period 2|Lack of Efficacy|2
5261518|NCT00685399|18151966|P2|Treatment Period 2|Lack of Efficacy|10
5261519|NCT00685399|18151967|P1|Treatment Period 2|Lack of Efficacy|0
5261520|NCT00685399|18151960|P8|Treatment Period 2|Adverse Event|0
5261521|NCT00685399|18151961|P7|Treatment Period 2|Adverse Event|0
5261522|NCT00685399|18151962|P6|Treatment Period 2|Adverse Event|1
5261523|NCT00685399|18151963|P5|Treatment Period 2|Adverse Event|0
5261524|NCT00685399|18151964|P4|Treatment Period 2|Adverse Event|0
5261525|NCT00685399|18151965|P3|Treatment Period 2|Adverse Event|0
5261526|NCT00685399|18151966|P2|Treatment Period 2|Adverse Event|0
5261527|NCT00685399|18151967|P1|Treatment Period 2|Adverse Event|0
5261528|NCT00685399|18151960|P8|Treatment Period 2|Withdrawal by Subject|2
5261529|NCT00685399|18151961|P7|Treatment Period 2|Withdrawal by Subject|0
5261530|NCT00685399|18151962|P6|Treatment Period 2|Withdrawal by Subject|0
5261531|NCT00685399|18151963|P5|Treatment Period 2|Withdrawal by Subject|0
5261532|NCT00685399|18151964|P4|Treatment Period 2|Withdrawal by Subject|0
5261533|NCT00685399|18151965|P3|Treatment Period 2|Withdrawal by Subject|0
5261534|NCT00685399|18151966|P2|Treatment Period 2|Withdrawal by Subject|0
5261535|NCT00685399|18151967|P1|Treatment Period 2|Withdrawal by Subject|0
5261536|NCT00685399|18151960|P8|Treatment Period 2|Administrative Problems|0
5261537|NCT00685399|18151961|P7|Treatment Period 2|Administrative Problems|0
5261538|NCT00685399|18151962|P6|Treatment Period 2|Administrative Problems|0
5261539|NCT00685399|18151963|P5|Treatment Period 2|Administrative Problems|0
5261540|NCT00685399|18151964|P4|Treatment Period 2|Administrative Problems|0
5261541|NCT00685399|18151965|P3|Treatment Period 2|Administrative Problems|1
5261542|NCT00685399|18151966|P2|Treatment Period 2|Administrative Problems|2
5261543|NCT00685399|18151967|P1|Treatment Period 2|Administrative Problems|0
5261544|NCT00685399|18151960|P8|Treatment Period 1|Lack of Efficacy|0
5261545|NCT00685399|18151961|P7|Treatment Period 1|Lack of Efficacy|0
5261546|NCT00685399|18151962|P6|Treatment Period 1|Lack of Efficacy|0
5261547|NCT00685399|18151963|P5|Treatment Period 1|Lack of Efficacy|0
5261548|NCT00685399|18151964|P4|Treatment Period 1|Lack of Efficacy|0
5261549|NCT00685399|18151965|P3|Treatment Period 1|Lack of Efficacy|0
5261550|NCT00685399|18151966|P2|Treatment Period 1|Lack of Efficacy|0
5261551|NCT00685399|18151967|P1|Treatment Period 1|Lack of Efficacy|1
5261552|NCT00685399|18151960|P8|Treatment Period 1|Administrative|0
5261553|NCT00685399|18151961|P7|Treatment Period 1|Administrative|0
5261554|NCT00685399|18151962|P6|Treatment Period 1|Administrative|0
5261555|NCT00685399|18151963|P5|Treatment Period 1|Administrative|0
5261556|NCT00685399|18151964|P4|Treatment Period 1|Administrative|0
5261557|NCT00685399|18151965|P3|Treatment Period 1|Administrative|0
5261558|NCT00685399|18151966|P2|Treatment Period 1|Administrative|0
5261559|NCT00685399|18151967|P1|Treatment Period 1|Administrative|2
5261560|NCT00685399|18151960|P8|Treatment Period 1|Protocol Violation|0
5261561|NCT00685399|18151961|P7|Treatment Period 1|Protocol Violation|0
5261562|NCT00685399|18151962|P6|Treatment Period 1|Protocol Violation|0
5261563|NCT00685399|18151963|P5|Treatment Period 1|Protocol Violation|0
5261564|NCT00685399|18151964|P4|Treatment Period 1|Protocol Violation|0
5261565|NCT00685399|18151965|P3|Treatment Period 1|Protocol Violation|0
5261566|NCT00685399|18151966|P2|Treatment Period 1|Protocol Violation|0
5261567|NCT00685399|18151967|P1|Treatment Period 1|Protocol Violation|1
5261568|NCT00685399|18151960|P8|Treatment Period 1|Withdrawal by Subject|0
5261569|NCT00685399|18151961|P7|Treatment Period 1|Withdrawal by Subject|0
5261570|NCT00685399|18151962|P6|Treatment Period 1|Withdrawal by Subject|0
5261571|NCT00685399|18151963|P5|Treatment Period 1|Withdrawal by Subject|0
5261572|NCT00685399|18151964|P4|Treatment Period 1|Withdrawal by Subject|0
5261573|NCT00685399|18151965|P3|Treatment Period 1|Withdrawal by Subject|0
5261574|NCT00685399|18151966|P2|Treatment Period 1|Withdrawal by Subject|0
5261575|NCT00685399|18151967|P1|Treatment Period 1|Withdrawal by Subject|2
5261576|NCT00685373|18152000|P1|Overall Study|Protocol Violation|1
5261577|NCT00685373|18152000|P1|Overall Study|Lost to Follow-up|2
5261578|NCT00685373|18152000|P1|Overall Study|Condition no longer requires study drug|1
5261579|NCT00685373|18152000|P1|Overall Study|Lack of Efficacy|3
5261580|NCT00685373|18152000|P1|Overall Study|Withdrawal by Subject|5
5261581|NCT00685373|18152000|P1|Overall Study|Adverse Event|3
5261582|NCT00685334|18152009|P2|Overall Study|Chose to enter hospital|1
5261583|NCT00685334|18152010|P1|Overall Study|Chose to enter hospital|1
5261584|NCT00685334|18152009|P2|Overall Study|Lost to Follow-up|0
5261585|NCT00685334|18152010|P1|Overall Study|Lost to Follow-up|4
5261586|NCT00685334|18152009|P2|Overall Study|Withdrawal by Subject|6
5261587|NCT00685334|18152010|P1|Overall Study|Withdrawal by Subject|5
5261588|NCT00685178|18152035|P4|Overall Study|Pregnancy|1
5261589|NCT00685178|18152036|P3|Overall Study|Pregnancy|0
5261590|NCT00685178|18152037|P2|Overall Study|Pregnancy|0
5261591|NCT00685178|18152038|P1|Overall Study|Pregnancy|0
5261592|NCT00685178|18152035|P4|Overall Study|administrative (disciplinary) discharge|2
5261593|NCT00685178|18152036|P3|Overall Study|administrative (disciplinary) discharge|0
5261594|NCT00685178|18152037|P2|Overall Study|administrative (disciplinary) discharge|1
5261595|NCT00685178|18152038|P1|Overall Study|administrative (disciplinary) discharge|0
5261596|NCT00685178|18152035|P4|Overall Study|incarcerated|0
5261597|NCT00685178|18152036|P3|Overall Study|incarcerated|7
5261598|NCT00685178|18152037|P2|Overall Study|incarcerated|3
5261599|NCT00685178|18152038|P1|Overall Study|incarcerated|1
5261600|NCT00685178|18152035|P4|Overall Study|voluntary study discharge|1
5261601|NCT00685178|18152036|P3|Overall Study|voluntary study discharge|1
5261602|NCT00685178|18152037|P2|Overall Study|voluntary study discharge|5
5261603|NCT00685178|18152038|P1|Overall Study|voluntary study discharge|4
5261604|NCT00685178|18152035|P4|Overall Study|missed 3 consecutive methadone clin days|6
5261605|NCT00685178|18152036|P3|Overall Study|missed 3 consecutive methadone clin days|2
5261606|NCT00685178|18152037|P2|Overall Study|missed 3 consecutive methadone clin days|5
5261607|NCT00685178|18152038|P1|Overall Study|missed 3 consecutive methadone clin days|7
5261608|NCT00685178|18152035|P4|Overall Study|Adverse Event|4
5261609|NCT00685178|18152036|P3|Overall Study|Adverse Event|2
5261610|NCT00685178|18152037|P2|Overall Study|Adverse Event|5
5261611|NCT00685178|18152038|P1|Overall Study|Adverse Event|1
5261612|NCT00685165|18152052|P2|Washout Period of 14 Days|Adverse Event|0
5261613|NCT00685165|18152053|P1|Washout Period of 14 Days|Adverse Event|1
5261614|NCT00685035|18152072|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
5261615|NCT00685035|18152073|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
5261616|NCT00684996|18152097|P1|Overall Study|Other reasons not protocol specified|1
5261617|NCT00684996|18152097|P1|Overall Study|Progression/relapse|2
5261618|NCT00684996|18152097|P1|Overall Study|Refusal unrelated to adverse event|1
5261619|NCT00684996|18152097|P1|Overall Study|Adverse Event|1
5261620|NCT00684814|18152129|P2|Second Intervention|Adverse Event|0
5261621|NCT00684814|18152130|P1|Second Intervention|Adverse Event|1
5261622|NCT00684814|18152129|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5261623|NCT00684814|18152130|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5261624|NCT00684814|18152129|P2|Washout Period of 7 Days|Adverse Event|2
5261625|NCT00684814|18152130|P1|Washout Period of 7 Days|Adverse Event|1
5261626|NCT00684762|18152182|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5261627|NCT00684762|18152183|P1|Washout Period of 7 Days|Withdrawal by Subject|2
5261628|NCT00684671|18152211|P3|Overall Study|Alcoholic dependance|0
5261629|NCT00684671|18152212|P2|Overall Study|Alcoholic dependance|0
5261630|NCT00684671|18152213|P1|Overall Study|Alcoholic dependance|1
5261631|NCT00684671|18152211|P3|Overall Study|Lost to Follow-up|0
5261632|NCT00684671|18152212|P2|Overall Study|Lost to Follow-up|0
5261633|NCT00684671|18152213|P1|Overall Study|Lost to Follow-up|1
5261634|NCT00684671|18152211|P3|Overall Study|Adverse Event|0
5261635|NCT00684671|18152212|P2|Overall Study|Adverse Event|0
5261636|NCT00684671|18152213|P1|Overall Study|Adverse Event|1
5261637|NCT00684645|18152242|P1|Overall Study|Other|15
5261638|NCT00684645|18152242|P1|Overall Study|Lost to Follow-up|3
5261639|NCT00684645|18152242|P1|Overall Study|Adverse Event|27
5261640|NCT00684645|18152242|P1|Overall Study|Progressive disease|67
5261641|NCT00684645|18152242|P1|Overall Study|Death|2
5261642|NCT00684593|18152262|P2|Overall Study|Adverse Event|2
5261643|NCT00684593|18152263|P1|Overall Study|Adverse Event|0
5261644|NCT00684567|18152275|P1|Monotherapy Period|Progression of primary disease|11
5261645|NCT00684567|18152275|P1|Monotherapy Period|Death|1
5261646|NCT00684567|18152275|P1|Monotherapy Period|Adverse Event|2
5261647|NCT00684567|18152275|P1|Concomitant Radiotherapy Period|Adverse Event|2
5261648|NCT00684515|18152308|P3|Overall Study|Protocol-Defined Clinical Event|0
5261649|NCT00684515|18152309|P2|Overall Study|Protocol-Defined Clinical Event|0
5261650|NCT00684515|18152310|P1|Overall Study|Protocol-Defined Clinical Event|1
5261651|NCT00684515|18152308|P3|Overall Study|Adverse Event|1
5261652|NCT00684515|18152309|P2|Overall Study|Adverse Event|3
5261653|NCT00684515|18152310|P1|Overall Study|Adverse Event|3
5261654|NCT00684424|18152333|P1|Overall Study|Other|2
5261655|NCT00684424|18152333|P1|Overall Study|Lost to Follow-up|2
5261656|NCT00684424|18152333|P1|Overall Study|Adverse Event|1
5261657|NCT00684411|18152348|P1|Overall Study|Adverse Event|1
5261658|NCT00684411|18152348|P1|Overall Study|Disease Progression|10
5261659|NCT00684411|18152348|P1|Overall Study|New Primary Cancer|1
5261660|NCT00684307|18152370|P5|Overall Study|Criteria from the CSR|3
5261661|NCT00684307|18152371|P4|Overall Study|Criteria from the CSR|3
5261662|NCT00684307|18152372|P3|Overall Study|Criteria from the CSR|1
5261663|NCT00684307|18152373|P2|Overall Study|Criteria from the CSR|0
5261664|NCT00684307|18152374|P1|Overall Study|Criteria from the CSR|0
5261665|NCT00684307|18152370|P5|Overall Study|Participant not willing to continue|8
5261666|NCT00684307|18152371|P4|Overall Study|Participant not willing to continue|5
5261667|NCT00684307|18152372|P3|Overall Study|Participant not willing to continue|11
5261668|NCT00684307|18152373|P2|Overall Study|Participant not willing to continue|10
5261669|NCT00684307|18152374|P1|Overall Study|Participant not willing to continue|7
5261670|NCT00684307|18152370|P5|Overall Study|Severe non compliance to protocol|2
5261671|NCT00684307|18152371|P4|Overall Study|Severe non compliance to protocol|1
5261672|NCT00684307|18152372|P3|Overall Study|Severe non compliance to protocol|0
5261673|NCT00684307|18152373|P2|Overall Study|Severe non compliance to protocol|0
5261674|NCT00684307|18152374|P1|Overall Study|Severe non compliance to protocol|1
5261675|NCT00684307|18152370|P5|Overall Study|Interupted IP for more than 7 days|3
5261676|NCT00684307|18152371|P4|Overall Study|Interupted IP for more than 7 days|3
5261677|NCT00684307|18152372|P3|Overall Study|Interupted IP for more than 7 days|1
5261678|NCT00684307|18152373|P2|Overall Study|Interupted IP for more than 7 days|4
5261679|NCT00684307|18152374|P1|Overall Study|Interupted IP for more than 7 days|0
5261680|NCT00684307|18152370|P5|Overall Study|Incorrect enrolment or randomization|0
5261681|NCT00684307|18152371|P4|Overall Study|Incorrect enrolment or randomization|0
5261682|NCT00684307|18152372|P3|Overall Study|Incorrect enrolment or randomization|0
5261683|NCT00684307|18152373|P2|Overall Study|Incorrect enrolment or randomization|0
5261684|NCT00684307|18152374|P1|Overall Study|Incorrect enrolment or randomization|4
5261685|NCT00684307|18152370|P5|Overall Study|Fullfillment of exclusion criteria|1
5261686|NCT00684307|18152371|P4|Overall Study|Fullfillment of exclusion criteria|3
5261687|NCT00684307|18152372|P3|Overall Study|Fullfillment of exclusion criteria|0
5261688|NCT00684307|18152373|P2|Overall Study|Fullfillment of exclusion criteria|0
5261689|NCT00684307|18152374|P1|Overall Study|Fullfillment of exclusion criteria|1
5261690|NCT00684307|18152370|P5|Overall Study|Development of increasing Liver Function|0
5261691|NCT00684307|18152371|P4|Overall Study|Development of increasing Liver Function|1
5261692|NCT00684307|18152372|P3|Overall Study|Development of increasing Liver Function|0
5261693|NCT00684307|18152373|P2|Overall Study|Development of increasing Liver Function|2
5261694|NCT00684307|18152374|P1|Overall Study|Development of increasing Liver Function|0
5261695|NCT00684307|18152370|P5|Overall Study|Adverse Event|8
5261696|NCT00684307|18152371|P4|Overall Study|Adverse Event|16
5261697|NCT00684307|18152372|P3|Overall Study|Adverse Event|15
5261698|NCT00684307|18152373|P2|Overall Study|Adverse Event|6
5261699|NCT00684307|18152374|P1|Overall Study|Adverse Event|11
5261700|NCT00684203|18152456|P6|Overall Study|Did not meet protocol eligibility|0
5261701|NCT00684203|18152457|P5|Overall Study|Did not meet protocol eligibility|0
5261702|NCT00684203|18152458|P4|Overall Study|Did not meet protocol eligibility|0
5261703|NCT00684203|18152459|P3|Overall Study|Did not meet protocol eligibility|0
5261704|NCT00684203|18152460|P2|Overall Study|Did not meet protocol eligibility|1
5261705|NCT00684203|18152461|P1|Overall Study|Did not meet protocol eligibility|0
5261706|NCT00684203|18152456|P6|Overall Study|Withdrawal by Subject|0
5261707|NCT00684203|18152457|P5|Overall Study|Withdrawal by Subject|0
5261708|NCT00684203|18152458|P4|Overall Study|Withdrawal by Subject|0
5261709|NCT00684203|18152459|P3|Overall Study|Withdrawal by Subject|1
5261710|NCT00684203|18152460|P2|Overall Study|Withdrawal by Subject|2
5261711|NCT00684203|18152461|P1|Overall Study|Withdrawal by Subject|0
5261712|NCT00684203|18152456|P6|Overall Study|Protocol-defined clinical event|0
5261713|NCT00684203|18152457|P5|Overall Study|Protocol-defined clinical event|0
5261714|NCT00684203|18152458|P4|Overall Study|Protocol-defined clinical event|0
5261715|NCT00684203|18152459|P3|Overall Study|Protocol-defined clinical event|0
5261716|NCT00684203|18152460|P2|Overall Study|Protocol-defined clinical event|1
5261717|NCT00684203|18152461|P1|Overall Study|Protocol-defined clinical event|3
5261718|NCT00684203|18152456|P6|Overall Study|Adverse Event|0
5261719|NCT00684203|18152457|P5|Overall Study|Adverse Event|0
5261720|NCT00684203|18152458|P4|Overall Study|Adverse Event|0
5261721|NCT00684203|18152459|P3|Overall Study|Adverse Event|8
5261722|NCT00684203|18152460|P2|Overall Study|Adverse Event|4
5261723|NCT00684203|18152461|P1|Overall Study|Adverse Event|6
5261724|NCT00684177|18152522|P2|Overall Study|Other|2
5261725|NCT00684177|18152523|P1|Overall Study|Other|1
5261726|NCT00684177|18152522|P2|Overall Study|Withdrawal by Subject|2
5261727|NCT00684177|18152523|P1|Overall Study|Withdrawal by Subject|1
5261728|NCT00684177|18152522|P2|Overall Study|Physician Decision|0
5261729|NCT00684177|18152523|P1|Overall Study|Physician Decision|2
5261730|NCT00684177|18152522|P2|Overall Study|Lost to Follow-up|1
5261731|NCT00684177|18152523|P1|Overall Study|Lost to Follow-up|2
5261732|NCT00684177|18152522|P2|Overall Study|Protocol Violation|0
5261733|NCT00684177|18152523|P1|Overall Study|Protocol Violation|1
5261734|NCT00684177|18152522|P2|Overall Study|Lack of Efficacy|15
5261735|NCT00684177|18152523|P1|Overall Study|Lack of Efficacy|10
5261736|NCT00684177|18152522|P2|Overall Study|Adverse Event|3
5261737|NCT00684177|18152523|P1|Overall Study|Adverse Event|4
5261738|NCT00684073|18152558|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
5261739|NCT00684073|18152558|P1|Selection|request of the sponsor|1
5261740|NCT00684073|18152558|P1|Selection|Lost to Follow-up|1
5261741|NCT00684073|18152558|P1|Selection|noncompliance|1
5261742|NCT00684073|18152558|P1|Selection|Death|1
5261743|NCT00684073|18152558|P1|Selection|Selection/non-selection criteria|3
5261744|NCT00684060|18152568|P2|Overall Study|Death|1
5261745|NCT00684060|18152569|P1|Overall Study|Death|0
5261746|NCT00684060|18152568|P2|Overall Study|Unable to collect MRI|2
5261747|NCT00684060|18152569|P1|Overall Study|Unable to collect MRI|1
5261748|NCT00684060|18152568|P2|Overall Study|New stenosis identified|0
5261749|NCT00684060|18152569|P1|Overall Study|New stenosis identified|1
5261750|NCT00684060|18152568|P2|Overall Study|Lost to Follow-up|0
5261751|NCT00684060|18152569|P1|Overall Study|Lost to Follow-up|1
5261752|NCT00684021|18152608|P4|Overall Study|Death|0
5261753|NCT00684021|18152609|P3|Overall Study|Death|0
5261754|NCT00684021|18152610|P2|Overall Study|Death|0
5261755|NCT00684021|18152611|P1|Overall Study|Death|1
5261756|NCT00684021|18152608|P4|Overall Study|MRI not performed|2
5261757|NCT00684021|18152609|P3|Overall Study|MRI not performed|1
5261758|NCT00684021|18152610|P2|Overall Study|MRI not performed|1
5261759|NCT00684021|18152611|P1|Overall Study|MRI not performed|0
5261760|NCT00684021|18152608|P4|Overall Study|MRI Contraindicated|0
5261761|NCT00684021|18152609|P3|Overall Study|MRI Contraindicated|1
5261762|NCT00684021|18152610|P2|Overall Study|MRI Contraindicated|1
5261763|NCT00684021|18152611|P1|Overall Study|MRI Contraindicated|1
5261764|NCT00683917|18152672|P1|Overall Study|Study prematurely terminated|10
5261765|NCT00683904|18152682|P2|Dose Level 2|Adverse Event|2
5261766|NCT00683904|18152683|P1|Dose Level 2|Adverse Event|0
5261767|NCT00683904|18152682|P2|Dose Level 1|Adverse Event|0
5261768|NCT00683904|18152683|P1|Dose Level 1|Adverse Event|1
5261769|NCT00683904|18152682|P2|Dose Level 1|Disease progression|0
5261770|NCT00683904|18152683|P1|Dose Level 1|Disease progression|2
5261771|NCT00683878|18152719|P3|Overall Study|Non-compliance, not met criteria etc.|0
5261772|NCT00683878|18152720|P2|Overall Study|Non-compliance, not met criteria etc.|2
5261773|NCT00683878|18152721|P1|Overall Study|Non-compliance, not met criteria etc.|3
5261774|NCT00683878|18152719|P3|Overall Study|Lost to Follow-up|4
5261775|NCT00683878|18152720|P2|Overall Study|Lost to Follow-up|2
5261776|NCT00683878|18152721|P1|Overall Study|Lost to Follow-up|4
5261777|NCT00683878|18152719|P3|Overall Study|Death|0
5261778|NCT00683878|18152720|P2|Overall Study|Death|1
5261779|NCT00683878|18152721|P1|Overall Study|Death|0
5261780|NCT00683878|18152719|P3|Overall Study|Withdrawal by Subject|6
5261781|NCT00683878|18152720|P2|Overall Study|Withdrawal by Subject|8
5261782|NCT00683878|18152721|P1|Overall Study|Withdrawal by Subject|9
5261783|NCT00683878|18152719|P3|Overall Study|Adverse Event|3
5261784|NCT00683878|18152720|P2|Overall Study|Adverse Event|3
5261785|NCT00683878|18152721|P1|Overall Study|Adverse Event|4
5261786|NCT00683878|18152719|P3|Overall Study|Lack of Efficacy|1
5261787|NCT00683878|18152720|P2|Overall Study|Lack of Efficacy|0
5261788|NCT00683878|18152721|P1|Overall Study|Lack of Efficacy|3
5261789|NCT00683800|18152795|P2|Overall Study|Randomized, not treated|33
5261790|NCT00683800|18152796|P1|Overall Study|Randomized, not treated|35
5261791|NCT00683800|18152795|P2|Overall Study|Lack of Efficacy|104
5261792|NCT00683800|18152796|P1|Overall Study|Lack of Efficacy|61
5261793|NCT00683800|18152795|P2|Overall Study|Withdrawal by Subject|64
5261794|NCT00683800|18152796|P1|Overall Study|Withdrawal by Subject|66
5261795|NCT00683800|18152795|P2|Overall Study|Protocol Violation|16
5261796|NCT00683800|18152796|P1|Overall Study|Protocol Violation|13
5261797|NCT00683800|18152795|P2|Overall Study|Other|2
5261798|NCT00683800|18152796|P1|Overall Study|Other|5
5261799|NCT00683800|18152795|P2|Overall Study|Lost to Follow-up|44
5261800|NCT00683800|18152796|P1|Overall Study|Lost to Follow-up|57
5261801|NCT00683800|18152795|P2|Overall Study|Death|1
5261802|NCT00683800|18152796|P1|Overall Study|Death|0
5261803|NCT00683800|18152795|P2|Overall Study|Adverse Event|102
5261804|NCT00683800|18152796|P1|Overall Study|Adverse Event|195
5261805|NCT00683787|18152863|P3|Overall Study|Adverse Event|2
5261806|NCT00683787|18152864|P2|Overall Study|Adverse Event|0
5261807|NCT00683787|18152865|P1|Overall Study|Adverse Event|0
5261808|NCT00683787|18152863|P3|Overall Study|Progression|0
5261809|NCT00683787|18152864|P2|Overall Study|Progression|3
5261810|NCT00683787|18152865|P1|Overall Study|Progression|3
5261811|NCT00683774|18152884|P2|Overall Study|Physician Decision|0
5261812|NCT00683774|18152885|P1|Overall Study|Physician Decision|3
5261813|NCT00683774|18152884|P2|Overall Study|Withdrawal by Subject|1
5261814|NCT00683774|18152885|P1|Overall Study|Withdrawal by Subject|0
5261815|NCT00683696|18152895|P2|Overall Study|Death|30
5261816|NCT00683696|18152896|P1|Overall Study|Death|46
5261817|NCT00683696|18152895|P2|Overall Study|Vital status follow-up only|3
5261818|NCT00683696|18152896|P1|Overall Study|Vital status follow-up only|3
5261819|NCT00683696|18152895|P2|Overall Study|Lost to Follow-up|6
5261820|NCT00683696|18152896|P1|Overall Study|Lost to Follow-up|5
5261821|NCT00683696|18152895|P2|Overall Study|Withdrawn prior to study closure|28
5261822|NCT00683696|18152896|P1|Overall Study|Withdrawn prior to study closure|13
5261823|NCT00683696|18152895|P2|Overall Study|Withdrawn due to study closure|338
5261824|NCT00683696|18152896|P1|Overall Study|Withdrawn due to study closure|337
5261825|NCT00683657|18152915|P2|Overall Study|Subject Withdrew Consent|0
5261826|NCT00683657|18152916|P1|Overall Study|Subject Withdrew Consent|1
5261827|NCT00683657|18152915|P2|Overall Study|Adverse Event|1
5261828|NCT00683657|18152916|P1|Overall Study|Adverse Event|0
5261829|NCT00683644|18152932|P2|Overall Study|Low copper, other health problems,|6
5261830|NCT00683644|18152933|P1|Overall Study|Low copper, other health problems,|7
5261831|NCT00683644|18152932|P2|Overall Study|Adverse Event|2
5261832|NCT00683644|18152933|P1|Overall Study|Adverse Event|1
5261833|NCT00683644|18152932|P2|Overall Study|Lost to Follow-up|4
5261834|NCT00683644|18152933|P1|Overall Study|Lost to Follow-up|1
5261835|NCT00683644|18152932|P2|Overall Study|Withdrawal by Subject|2
5261836|NCT00683644|18152933|P1|Overall Study|Withdrawal by Subject|4
5261837|NCT00683618|18152946|P3|Extension Treatment Period|Protocol Violation|0
5261838|NCT00683618|18152947|P2|Extension Treatment Period|Protocol Violation|0
5261839|NCT00683618|18152948|P1|Extension Treatment Period|Protocol Violation|1
5261840|NCT00683618|18152946|P3|Extension Treatment Period|Adverse Event|0
5261841|NCT00683618|18152947|P2|Extension Treatment Period|Adverse Event|0
5261842|NCT00683618|18152948|P1|Extension Treatment Period|Adverse Event|1
5261843|NCT00683618|18152946|P3|Extension Treatment Period|Withdrawal by Subject|0
5261844|NCT00683618|18152947|P2|Extension Treatment Period|Withdrawal by Subject|0
5261845|NCT00683618|18152948|P1|Extension Treatment Period|Withdrawal by Subject|1
5261846|NCT00683618|18152946|P3|Randomised Treatment Period|Reason not provided|2
5261847|NCT00683618|18152947|P2|Randomised Treatment Period|Reason not provided|0
5261848|NCT00683618|18152948|P1|Randomised Treatment Period|Reason not provided|0
5261849|NCT00683618|18152946|P3|Randomised Treatment Period|Adverse Event|2
5261850|NCT00683618|18152947|P2|Randomised Treatment Period|Adverse Event|0
5261851|NCT00683618|18152948|P1|Randomised Treatment Period|Adverse Event|2
5261852|NCT00683618|18152946|P3|Randomised Treatment Period|Protocol Violation|0
5261853|NCT00683618|18152947|P2|Randomised Treatment Period|Protocol Violation|1
5261854|NCT00683618|18152948|P1|Randomised Treatment Period|Protocol Violation|0
5261855|NCT00683618|18152946|P3|Randomised Treatment Period|Withdrawal by Subject|2
5261856|NCT00683618|18152947|P2|Randomised Treatment Period|Withdrawal by Subject|1
5261857|NCT00683618|18152948|P1|Randomised Treatment Period|Withdrawal by Subject|4
5261858|NCT00683592|18152998|P2|Overall Study|Other|1
5261859|NCT00683592|18152999|P1|Overall Study|Other|1
5261860|NCT00683592|18152998|P2|Overall Study|Non-compliance|5
5261861|NCT00683592|18152999|P1|Overall Study|Non-compliance|3
5261862|NCT00683592|18152998|P2|Overall Study|Physician Decision|1
5261863|NCT00683592|18152999|P1|Overall Study|Physician Decision|0
5261864|NCT00683592|18152998|P2|Overall Study|Lack of Efficacy|7
5261865|NCT00683592|18152999|P1|Overall Study|Lack of Efficacy|3
5261866|NCT00683592|18152998|P2|Overall Study|Lost to Follow-up|17
5261867|NCT00683592|18152999|P1|Overall Study|Lost to Follow-up|17
5261868|NCT00683592|18152998|P2|Overall Study|Withdrawal by Subject|11
5261869|NCT00683592|18152999|P1|Overall Study|Withdrawal by Subject|11
5261870|NCT00683592|18152998|P2|Overall Study|Adverse Event|4
5261871|NCT00683592|18152999|P1|Overall Study|Adverse Event|12
5261872|NCT00683475|18153017|P2|Overall Study|Never Treated: Progressive Disease|0
5261873|NCT00683475|18153018|P1|Overall Study|Never Treated: Progressive Disease|1
5261874|NCT00683475|18153017|P2|Overall Study|Never Treated: Adverse Event|3
5261875|NCT00683475|18153018|P1|Overall Study|Never Treated: Adverse Event|2
5261876|NCT00683475|18153017|P2|Overall Study|Withdrawal by Subject|0
5261877|NCT00683475|18153018|P1|Overall Study|Withdrawal by Subject|1
5261878|NCT00683449|18153053|P5|Overall Study|Lost to Follow-up|0
5261879|NCT00683449|18153054|P4|Overall Study|Lost to Follow-up|0
5261880|NCT00683449|18153055|P3|Overall Study|Lost to Follow-up|0
5261881|NCT00683449|18153056|P2|Overall Study|Lost to Follow-up|1
5261882|NCT00683449|18153057|P1|Overall Study|Lost to Follow-up|0
5261883|NCT00683384|18153083|P1|Overall Study|Adverse Event|1
5261884|NCT00683384|18153083|P1|Overall Study|Death|1
5261885|NCT00683293|18153093|P2|Overall Study|Withdrawal by Subject|3
5261886|NCT00683293|18153094|P1|Overall Study|Withdrawal by Subject|2
5261887|NCT00682929|18153157|P3|Overall Study|lag in DEA renewal|0
5261888|NCT00682929|18153158|P2|Overall Study|lag in DEA renewal|0
5261889|NCT00682929|18153159|P1|Overall Study|lag in DEA renewal|1
5261890|NCT00682929|18153157|P3|Overall Study|dosing compliance < 80%|0
5261891|NCT00682929|18153158|P2|Overall Study|dosing compliance < 80%|2
5261892|NCT00682929|18153159|P1|Overall Study|dosing compliance < 80%|0
5261893|NCT00682929|18153157|P3|Overall Study|Withdrawal by Subject|1
5261894|NCT00682929|18153158|P2|Overall Study|Withdrawal by Subject|2
5261895|NCT00682929|18153159|P1|Overall Study|Withdrawal by Subject|1
5261896|NCT00682929|18153157|P3|Overall Study|Adverse Event|1
5261897|NCT00682929|18153158|P2|Overall Study|Adverse Event|1
5261898|NCT00682929|18153159|P1|Overall Study|Adverse Event|4
5261899|NCT00682890|18153328|P2|Overall Study|heavy menstrual bleeding|0
5261900|NCT00682890|18153329|P1|Overall Study|heavy menstrual bleeding|1
5261901|NCT00682890|18153328|P2|Overall Study|subject moved away|1
5261902|NCT00682890|18153329|P1|Overall Study|subject moved away|0
5261903|NCT00682890|18153328|P2|Overall Study|Lost to Follow-up|1
5261904|NCT00682890|18153329|P1|Overall Study|Lost to Follow-up|1
5261905|NCT00682786|18153371|P2|Overall Study|Did not receive irinotecan|1
5261906|NCT00682786|18153372|P1|Overall Study|Did not receive irinotecan|0
5261907|NCT00682786|18153371|P2|Overall Study|Withdrawal by Subject|2
5261908|NCT00682786|18153372|P1|Overall Study|Withdrawal by Subject|2
5261909|NCT00682643|18153421|P2|Overall Study|Did Not Receive Study Drug|1
5261910|NCT00682643|18153422|P1|Overall Study|Did Not Receive Study Drug|1
5261911|NCT00682643|18153421|P2|Overall Study|Withdrawal by Subject|53
5261912|NCT00682643|18153422|P1|Overall Study|Withdrawal by Subject|19
5261913|NCT00682643|18153421|P2|Overall Study|Physician Decision|6
5261914|NCT00682643|18153422|P1|Overall Study|Physician Decision|2
5261915|NCT00682643|18153421|P2|Overall Study|Lost to Follow-up|6
5261916|NCT00682643|18153422|P1|Overall Study|Lost to Follow-up|1
5261917|NCT00682643|18153421|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
5261918|NCT00682643|18153422|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
5261919|NCT00682643|18153421|P2|Overall Study|Protocol Violation|76
5261920|NCT00682643|18153422|P1|Overall Study|Protocol Violation|38
5261921|NCT00682643|18153421|P2|Overall Study|Lack of Efficacy|0
5261922|NCT00682643|18153422|P1|Overall Study|Lack of Efficacy|2
5261923|NCT00682643|18153421|P2|Overall Study|Adverse Event|23
5261924|NCT00682643|18153422|P1|Overall Study|Adverse Event|12
5261925|NCT00682539|18153496|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
5261926|NCT00682539|18153497|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
5261927|NCT00682539|18153498|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
5261928|NCT00682539|18153496|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
5261929|NCT00682539|18153497|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
5261930|NCT00682539|18153498|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
5261931|NCT00682461|18153511|P2|Overall Study|Withdrawal by Subject|19
5261932|NCT00682461|18153512|P1|Overall Study|Withdrawal by Subject|12
5261933|NCT00682461|18153511|P2|Overall Study|Lost to Follow-up|5
5261934|NCT00682461|18153512|P1|Overall Study|Lost to Follow-up|8
5261935|NCT00682461|18153511|P2|Overall Study|Adverse Event|7
5261936|NCT00682461|18153512|P1|Overall Study|Adverse Event|5
5261937|NCT00682435|18153526|P1|Overall Study|Erroneously enrolled twice|2
5261938|NCT00682435|18153526|P1|Overall Study|Insufficient data|5
5261939|NCT00681863|18153559|P1|Overall Study|Other|18
5261940|NCT00681863|18153559|P1|Overall Study|Lack of Efficacy|2
5261941|NCT00681863|18153559|P1|Overall Study|Lost to Follow-up|2
5261942|NCT00681863|18153559|P1|Overall Study|Adverse Event|1
5261943|NCT00681824|18153607|P3|Overall Study|Death|0
5261944|NCT00681824|18153608|P2|Overall Study|Death|1
5261945|NCT00681824|18153609|P1|Overall Study|Death|0
5261946|NCT00681824|18153607|P3|Overall Study|scheduling conflict|0
5261947|NCT00681824|18153608|P2|Overall Study|scheduling conflict|0
5261948|NCT00681824|18153609|P1|Overall Study|scheduling conflict|1
5261949|NCT00681824|18153607|P3|Overall Study|withdrawn by investigator|1
5261950|NCT00681824|18153608|P2|Overall Study|withdrawn by investigator|0
5261951|NCT00681824|18153609|P1|Overall Study|withdrawn by investigator|0
5261952|NCT00681811|18153627|P2|Overall Study|Non-compliance|1
5261953|NCT00681811|18153628|P1|Overall Study|Non-compliance|0
5261954|NCT00681811|18153627|P2|Overall Study|Withdrawal by Subject|2
5261955|NCT00681811|18153628|P1|Overall Study|Withdrawal by Subject|2
5261956|NCT00681811|18153627|P2|Overall Study|Adverse Event|1
5261957|NCT00681811|18153628|P1|Overall Study|Adverse Event|1
5261958|NCT00681668|18153656|P1|Overall Study|Withdrawal by Subject|1
5261959|NCT00681668|18153656|P1|Overall Study|Protocol Violation|1
5261960|NCT00681629|18153665|P2|Overall Study|Adverse Event|0
5261961|NCT00681629|18153666|P1|Overall Study|Adverse Event|1
5261962|NCT00681629|18153665|P2|Overall Study|Study termination|2
5261963|NCT00681629|18153666|P1|Overall Study|Study termination|4
5261964|NCT00681590|18153712|P2|Overall Study|Withdrawal by Subject|12
5261965|NCT00681590|18153713|P1|Overall Study|Withdrawal by Subject|2
5261966|NCT00681564|18153723|P2|Overall Study|Death|1
5261967|NCT00681564|18153724|P1|Overall Study|Death|0
5261968|NCT00681564|18153723|P2|Overall Study|Withdrawal by Subject|1
5261969|NCT00681564|18153724|P1|Overall Study|Withdrawal by Subject|0
5261970|NCT00681564|18153723|P2|Overall Study|Lost to Follow-up|6
5261971|NCT00681564|18153724|P1|Overall Study|Lost to Follow-up|6
5261972|NCT00681187|18153816|P2|Overall Study|Adverse Event|1
5261973|NCT00681187|18153817|P1|Overall Study|Adverse Event|0
5261974|NCT00681187|18153816|P2|Overall Study|Death|1
5261975|NCT00681187|18153817|P1|Overall Study|Death|0
5261976|NCT00681187|18153816|P2|Overall Study|Withdrawal by Subject|0
5261977|NCT00681187|18153817|P1|Overall Study|Withdrawal by Subject|1
5261978|NCT00681109|18153852|P3|Overall Study|Lost to Follow-up|0
5261979|NCT00681109|18153853|P2|Overall Study|Lost to Follow-up|6
5261980|NCT00681109|18153854|P1|Overall Study|Lost to Follow-up|2
5261981|NCT00680992|18153895|P3|Overall Study|Ineligibility Determined|0
5261982|NCT00680992|18153896|P2|Overall Study|Ineligibility Determined|1
5261983|NCT00680992|18153897|P1|Overall Study|Ineligibility Determined|0
5261984|NCT00680992|18153895|P3|Overall Study|Death|0
5261985|NCT00680992|18153896|P2|Overall Study|Death|1
5261986|NCT00680992|18153897|P1|Overall Study|Death|5
5261987|NCT00680992|18153895|P3|Overall Study|Pregnancy|1
5261988|NCT00680992|18153896|P2|Overall Study|Pregnancy|0
5261989|NCT00680992|18153897|P1|Overall Study|Pregnancy|5
5261990|NCT00680992|18153895|P3|Overall Study|Requirement for Alternative Therapy|0
5261991|NCT00680992|18153896|P2|Overall Study|Requirement for Alternative Therapy|2
5261992|NCT00680992|18153897|P1|Overall Study|Requirement for Alternative Therapy|8
5261993|NCT00680992|18153895|P3|Overall Study|Noncompliance|0
5261994|NCT00680992|18153896|P2|Overall Study|Noncompliance|6
5261995|NCT00680992|18153897|P1|Overall Study|Noncompliance|4
5261996|NCT00680992|18153895|P3|Overall Study|Lost to Follow-up|0
5261997|NCT00680992|18153896|P2|Overall Study|Lost to Follow-up|14
5261998|NCT00680992|18153897|P1|Overall Study|Lost to Follow-up|12
5261999|NCT00680992|18153895|P3|Overall Study|Disease Progression|0
5262000|NCT00680992|18153896|P2|Overall Study|Disease Progression|9
5262001|NCT00680992|18153897|P1|Overall Study|Disease Progression|21
5262002|NCT00680992|18153895|P3|Overall Study|Other|1
5262003|NCT00680992|18153896|P2|Overall Study|Other|14
5262004|NCT00680992|18153897|P1|Overall Study|Other|19
5262005|NCT00680992|18153895|P3|Overall Study|Adverse Event|1
5262006|NCT00680992|18153896|P2|Overall Study|Adverse Event|19
5262007|NCT00680992|18153897|P1|Overall Study|Adverse Event|21
5262008|NCT00680992|18153895|P3|Overall Study|Withdrawal by Subject|1
5262009|NCT00680992|18153896|P2|Overall Study|Withdrawal by Subject|11
5262010|NCT00680992|18153897|P1|Overall Study|Withdrawal by Subject|33
5262011|NCT00680992|18153895|P3|Overall Study|End of Trial|3
5262012|NCT00680992|18153896|P2|Overall Study|End of Trial|12
5262013|NCT00680992|18153897|P1|Overall Study|End of Trial|32
5262014|NCT00680992|18153895|P3|Overall Study|Administrative Decision|5
5262015|NCT00680992|18153896|P2|Overall Study|Administrative Decision|42
5262016|NCT00680992|18153897|P1|Overall Study|Administrative Decision|83
5262017|NCT00680992|18153895|P3|Overall Study|Complete Resection (as per protocol)|0
5262018|NCT00680992|18153896|P2|Overall Study|Complete Resection (as per protocol)|121
5262019|NCT00680992|18153897|P1|Overall Study|Complete Resection (as per protocol)|25
5262020|NCT00680914|18153931|P2|Overall Study|serious adverse event (SAE)|1
5262021|NCT00680914|18153932|P1|Overall Study|serious adverse event (SAE)|0
5262022|NCT00680914|18153931|P2|Overall Study|Lost to Follow-up|0
5262023|NCT00680914|18153932|P1|Overall Study|Lost to Follow-up|4
5262024|NCT00680914|18153931|P2|Overall Study|Consent withdrawal|3
5262025|NCT00680914|18153932|P1|Overall Study|Consent withdrawal|6
5262026|NCT00680901|18153966|P2|Overall Study|Ongoing: In Follow Up|41
5262027|NCT00680901|18153967|P1|Overall Study|Ongoing: In Follow Up|45
5262028|NCT00680901|18153966|P2|Overall Study|Ongoing: On Study Treatment|13
5262029|NCT00680901|18153967|P1|Overall Study|Ongoing: On Study Treatment|16
5262030|NCT00680901|18153966|P2|Overall Study|Physician Decision|1
5262031|NCT00680901|18153967|P1|Overall Study|Physician Decision|0
5262032|NCT00680901|18153966|P2|Overall Study|Withdrawal by Subject|13
5262033|NCT00680901|18153967|P1|Overall Study|Withdrawal by Subject|4
5262034|NCT00680901|18153966|P2|Overall Study|Lost to Follow-up|8
5262035|NCT00680901|18153967|P1|Overall Study|Lost to Follow-up|8
5262036|NCT00680836|18154005|P2|Overall Study|Physician Decision|1
5262037|NCT00680836|18154006|P1|Overall Study|Physician Decision|2
5262038|NCT00680836|18154005|P2|Overall Study|Lost to Follow-up|1
5262039|NCT00680836|18154006|P1|Overall Study|Lost to Follow-up|3
5262040|NCT00680836|18154005|P2|Overall Study|Withdrawal by Subject|0
5262041|NCT00680836|18154006|P1|Overall Study|Withdrawal by Subject|3
5262042|NCT00680771|18154060|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
5262043|NCT00680771|18154061|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
5262044|NCT00680771|18154060|P2|Overall Study|Sleep Apnea suspected after PSG|0
5262045|NCT00680771|18154061|P1|Overall Study|Sleep Apnea suspected after PSG|1
5262046|NCT00680771|18154060|P2|Overall Study|Withdrawal by Subject|0
5262047|NCT00680771|18154061|P1|Overall Study|Withdrawal by Subject|1
5262048|NCT00680745|18154071|P4|Overall Study|False Treatment|0
5262049|NCT00680745|18154072|P3|Overall Study|False Treatment|3
5262050|NCT00680745|18154073|P2|Overall Study|False Treatment|1
5262051|NCT00680745|18154074|P1|Overall Study|False Treatment|0
5262052|NCT00680745|18154071|P4|Overall Study|Subject No Longer Meets Study Criteria|2
5262053|NCT00680745|18154072|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5262054|NCT00680745|18154073|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5262055|NCT00680745|18154074|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5262056|NCT00680745|18154071|P4|Overall Study|Poor/Non-compliance|0
5262057|NCT00680745|18154072|P3|Overall Study|Poor/Non-compliance|0
5262058|NCT00680745|18154073|P2|Overall Study|Poor/Non-compliance|3
5262059|NCT00680745|18154074|P1|Overall Study|Poor/Non-compliance|0
5262060|NCT00680745|18154071|P4|Overall Study|Adverse Event|3
5262061|NCT00680745|18154072|P3|Overall Study|Adverse Event|3
5262062|NCT00680745|18154073|P2|Overall Study|Adverse Event|3
5262063|NCT00680745|18154074|P1|Overall Study|Adverse Event|5
5262064|NCT00680745|18154071|P4|Overall Study|Death|0
5262065|NCT00680745|18154072|P3|Overall Study|Death|1
5262066|NCT00680745|18154073|P2|Overall Study|Death|0
5262067|NCT00680745|18154074|P1|Overall Study|Death|1
5262068|NCT00680745|18154071|P4|Overall Study|Lost to Follow-up|0
5262069|NCT00680745|18154072|P3|Overall Study|Lost to Follow-up|1
5262070|NCT00680745|18154073|P2|Overall Study|Lost to Follow-up|1
5262071|NCT00680745|18154074|P1|Overall Study|Lost to Follow-up|0
5262072|NCT00680745|18154071|P4|Overall Study|Withdrawal by Subject|8
5262073|NCT00680745|18154072|P3|Overall Study|Withdrawal by Subject|2
5262074|NCT00680745|18154073|P2|Overall Study|Withdrawal by Subject|3
5262075|NCT00680745|18154074|P1|Overall Study|Withdrawal by Subject|8
5262076|NCT00680407|18154148|P3|Overall Study|Withdrawal by Subject|2
5262077|NCT00680407|18154149|P2|Overall Study|Withdrawal by Subject|2
5262078|NCT00680407|18154150|P1|Overall Study|Withdrawal by Subject|5
5262079|NCT00680407|18154148|P3|Overall Study|Lost to Follow-up|1
5262080|NCT00680407|18154149|P2|Overall Study|Lost to Follow-up|3
5262081|NCT00680407|18154150|P1|Overall Study|Lost to Follow-up|3
5262082|NCT00680368|18154164|P1|Overall Study|not supervised, not eligible|15
5262083|NCT00680186|18154192|P2|Overall Study|Other|1
5262084|NCT00680186|18154193|P1|Overall Study|Other|4
5262085|NCT00680186|18154192|P2|Overall Study|Withdrawal by Subject|39
5262086|NCT00680186|18154193|P1|Overall Study|Withdrawal by Subject|32
5262087|NCT00680186|18154192|P2|Overall Study|Lost to Follow-up|6
5262088|NCT00680186|18154193|P1|Overall Study|Lost to Follow-up|11
5262089|NCT00680186|18154192|P2|Overall Study|Protocol Violation|26
5262090|NCT00680186|18154193|P1|Overall Study|Protocol Violation|31
5262091|NCT00680186|18154192|P2|Overall Study|Adverse Event|44
5262092|NCT00680186|18154193|P1|Overall Study|Adverse Event|47
5262093|NCT00680121|18154219|P2|Overall Study|Lost to Follow-up|23
5262094|NCT00680121|18154220|P1|Overall Study|Lost to Follow-up|27
5262095|NCT00680056|18154234|P2|Second Intervention|Protocol Violation|1
5262096|NCT00680056|18154235|P1|Second Intervention|Protocol Violation|3
5262097|NCT00680056|18154234|P2|First Intervention|Mainly Exacerbation of COPD|2
5262098|NCT00680056|18154235|P1|First Intervention|Mainly Exacerbation of COPD|1
5262099|NCT00680043|18154246|P3|Overall Study|Renal Transplant|4
5262100|NCT00680043|18154247|P2|Overall Study|Renal Transplant|0
5262101|NCT00680043|18154248|P1|Overall Study|Renal Transplant|1
5262102|NCT00680043|18154246|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
5262103|NCT00680043|18154247|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
5262104|NCT00680043|18154248|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
5262105|NCT00680043|18154246|P3|Overall Study|Withdrawal by Subject|0
5262106|NCT00680043|18154247|P2|Overall Study|Withdrawal by Subject|0
5262107|NCT00680043|18154248|P1|Overall Study|Withdrawal by Subject|1
5262108|NCT00680017|18154264|P2|Overall Study|Lost to Follow-up|0
5262109|NCT00680017|18154265|P1|Overall Study|Lost to Follow-up|2
5262110|NCT00680017|18154264|P2|Overall Study|Withdrawal by Subject|5
5262111|NCT00680017|18154265|P1|Overall Study|Withdrawal by Subject|2
5262112|NCT00680017|18154264|P2|Overall Study|Adverse Event|7
5262113|NCT00680017|18154265|P1|Overall Study|Adverse Event|13
5262114|NCT00679939|18154284|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
5262115|NCT00679939|18154285|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
5262116|NCT00679939|18154284|P2|24-Week Open-Label (OL) Period|Physician Decision|0
5262117|NCT00679939|18154285|P1|24-Week Open-Label (OL) Period|Physician Decision|1
5262118|NCT00679939|18154284|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
5262119|NCT00679939|18154285|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
5262120|NCT00679939|18154284|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
5262121|NCT00679939|18154285|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
5262122|NCT00679939|18154284|P2|24-Week Open-Label (OL) Period|Adverse Event|1
5262123|NCT00679939|18154285|P1|24-Week Open-Label (OL) Period|Adverse Event|0
5262124|NCT00679939|18154284|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
5262125|NCT00679939|18154285|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
5262126|NCT00679939|18154284|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
5262127|NCT00679939|18154285|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
5262128|NCT00679939|18154284|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
5262129|NCT00679939|18154285|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
5262130|NCT00679939|18154284|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
5262131|NCT00679939|18154285|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
5262132|NCT00679939|18154284|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
5262133|NCT00679939|18154285|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
5262134|NCT00679913|18154436|P2|Overall Study|Protocol Violation|13
5262135|NCT00679913|18154437|P1|Overall Study|Protocol Violation|18
5262136|NCT00679783|18154452|P7|Overall Study|Ongoing at data cut-off|0
5262137|NCT00679783|18154453|P6|Overall Study|Ongoing at data cut-off|0
5262138|NCT00679783|18154454|P5|Overall Study|Ongoing at data cut-off|1
5262139|NCT00679783|18154455|P4|Overall Study|Ongoing at data cut-off|9
5262140|NCT00679783|18154456|P3|Overall Study|Ongoing at data cut-off|0
5262141|NCT00679783|18154457|P2|Overall Study|Ongoing at data cut-off|2
5262142|NCT00679783|18154458|P1|Overall Study|Ongoing at data cut-off|2
5262143|NCT00679783|18154452|P7|Overall Study|Not Captured|0
5262144|NCT00679783|18154453|P6|Overall Study|Not Captured|0
5262145|NCT00679783|18154454|P5|Overall Study|Not Captured|0
5262146|NCT00679783|18154455|P4|Overall Study|Not Captured|5
5262147|NCT00679783|18154456|P3|Overall Study|Not Captured|0
5262148|NCT00679783|18154457|P2|Overall Study|Not Captured|0
5262149|NCT00679783|18154458|P1|Overall Study|Not Captured|0
5262150|NCT00679783|18154452|P7|Overall Study|Withdrawal by Subject|0
5262151|NCT00679783|18154453|P6|Overall Study|Withdrawal by Subject|0
5262152|NCT00679783|18154454|P5|Overall Study|Withdrawal by Subject|0
5262153|NCT00679783|18154455|P4|Overall Study|Withdrawal by Subject|1
5262154|NCT00679783|18154456|P3|Overall Study|Withdrawal by Subject|1
5262155|NCT00679783|18154457|P2|Overall Study|Withdrawal by Subject|0
5262156|NCT00679783|18154458|P1|Overall Study|Withdrawal by Subject|0
5262157|NCT00679783|18154452|P7|Overall Study|Lack of Efficacy|0
5262158|NCT00679783|18154453|P6|Overall Study|Lack of Efficacy|0
5262159|NCT00679783|18154454|P5|Overall Study|Lack of Efficacy|0
5262160|NCT00679783|18154455|P4|Overall Study|Lack of Efficacy|2
5262161|NCT00679783|18154456|P3|Overall Study|Lack of Efficacy|0
5262162|NCT00679783|18154457|P2|Overall Study|Lack of Efficacy|1
5262163|NCT00679783|18154458|P1|Overall Study|Lack of Efficacy|0
5262164|NCT00679783|18154452|P7|Overall Study|Adverse Event|1
5262165|NCT00679783|18154453|P6|Overall Study|Adverse Event|0
5262166|NCT00679783|18154454|P5|Overall Study|Adverse Event|0
5262167|NCT00679783|18154455|P4|Overall Study|Adverse Event|3
5262168|NCT00679783|18154456|P3|Overall Study|Adverse Event|0
5262169|NCT00679783|18154457|P2|Overall Study|Adverse Event|0
5262170|NCT00679783|18154458|P1|Overall Study|Adverse Event|0
5262171|NCT00679627|18154511|P2|Overall Study|Early Study Closure|405
5262172|NCT00679627|18154512|P1|Overall Study|Early Study Closure|425
5262173|NCT00679627|18154511|P2|Overall Study|Lost to Follow-up|26
5262174|NCT00679627|18154512|P1|Overall Study|Lost to Follow-up|22
5262175|NCT00679627|18154511|P2|Overall Study|Withdrawal by Subject|172
5262176|NCT00679627|18154512|P1|Overall Study|Withdrawal by Subject|168
5262177|NCT00679627|18154511|P2|Overall Study|Adverse Event|53
5262178|NCT00679627|18154512|P1|Overall Study|Adverse Event|43
5262179|NCT00679627|18154511|P2|Overall Study|Death|29
5262180|NCT00679627|18154512|P1|Overall Study|Death|41
5262181|NCT00679549|18154536|P2|Overall Study|missing outcome echocardiograms|5
5262182|NCT00679549|18154537|P1|Overall Study|missing outcome echocardiograms|4
5262183|NCT00679549|18154536|P2|Overall Study|dropout|4
5262184|NCT00679549|18154537|P1|Overall Study|dropout|2
5262185|NCT00679432|18154547|P4|Overall Study|Randomization error, return to prior Rx|0
5262186|NCT00679432|18154548|P3|Overall Study|Randomization error, return to prior Rx|3
5262187|NCT00679432|18154549|P2|Overall Study|Randomization error, return to prior Rx|0
5262188|NCT00679432|18154550|P1|Overall Study|Randomization error, return to prior Rx|0
5262189|NCT00679432|18154547|P4|Overall Study|Infectious colitis, normal histology|3
5262190|NCT00679432|18154548|P3|Overall Study|Infectious colitis, normal histology|8
5262191|NCT00679432|18154549|P2|Overall Study|Infectious colitis, normal histology|4
5262192|NCT00679432|18154550|P1|Overall Study|Infectious colitis, normal histology|5
5262193|NCT00679432|18154547|P4|Overall Study|Lack of Efficacy|8
5262194|NCT00679432|18154548|P3|Overall Study|Lack of Efficacy|14
5262195|NCT00679432|18154549|P2|Overall Study|Lack of Efficacy|9
5262196|NCT00679432|18154550|P1|Overall Study|Lack of Efficacy|13
5262197|NCT00679432|18154547|P4|Overall Study|Sponsor decision|0
5262198|NCT00679432|18154548|P3|Overall Study|Sponsor decision|0
5262199|NCT00679432|18154549|P2|Overall Study|Sponsor decision|0
5262200|NCT00679432|18154550|P1|Overall Study|Sponsor decision|1
5262201|NCT00679432|18154547|P4|Overall Study|Physician Decision|2
5262202|NCT00679432|18154548|P3|Overall Study|Physician Decision|2
5262203|NCT00679432|18154549|P2|Overall Study|Physician Decision|2
5262204|NCT00679432|18154550|P1|Overall Study|Physician Decision|3
5262205|NCT00679432|18154547|P4|Overall Study|Lost to Follow-up|2
5262206|NCT00679432|18154548|P3|Overall Study|Lost to Follow-up|4
5262207|NCT00679432|18154549|P2|Overall Study|Lost to Follow-up|5
5262208|NCT00679432|18154550|P1|Overall Study|Lost to Follow-up|1
5262209|NCT00679432|18154547|P4|Overall Study|Withdrawal by Subject|9
5262210|NCT00679432|18154548|P3|Overall Study|Withdrawal by Subject|10
5262211|NCT00679432|18154549|P2|Overall Study|Withdrawal by Subject|11
5262212|NCT00679432|18154550|P1|Overall Study|Withdrawal by Subject|8
5262213|NCT00679432|18154547|P4|Overall Study|Protocol Violation|1
5262214|NCT00679432|18154548|P3|Overall Study|Protocol Violation|2
5262215|NCT00679432|18154549|P2|Overall Study|Protocol Violation|1
5262216|NCT00679432|18154550|P1|Overall Study|Protocol Violation|1
5262217|NCT00679432|18154547|P4|Overall Study|Adverse Event|7
5262218|NCT00679432|18154548|P3|Overall Study|Adverse Event|10
5262219|NCT00679432|18154549|P2|Overall Study|Adverse Event|6
5262220|NCT00679432|18154550|P1|Overall Study|Adverse Event|5
5262221|NCT00679367|18154593|P1|Overall Study|Withdrawal by Subject|1
5262222|NCT00679367|18154593|P1|Overall Study|Lack of Efficacy|3
5262223|NCT00679367|18154593|P1|Overall Study|inability to swallow oral drugs|1
5262224|NCT00679367|18154593|P1|Overall Study|Adverse Event|7
5262225|NCT00679354|18154599|P1|Overall Study|Ineligible|1
5262226|NCT00679354|18154599|P1|Overall Study|Physician Decision|4
5262227|NCT00679354|18154599|P1|Overall Study|Lack of Efficacy|22
5262228|NCT00679354|18154599|P1|Overall Study|Death|3
5262229|NCT00679341|18154617|P2|Overall Study|Physician/patient decision to withdraw|6
5262230|NCT00679341|18154618|P1|Overall Study|Physician/patient decision to withdraw|0
5262231|NCT00679341|18154617|P2|Overall Study|Not treated|2
5262232|NCT00679341|18154618|P1|Overall Study|Not treated|0
5262233|NCT00679341|18154617|P2|Overall Study|Physician Decision|0
5262234|NCT00679341|18154618|P1|Overall Study|Physician Decision|1
5262235|NCT00679341|18154617|P2|Overall Study|Other|0
5262236|NCT00679341|18154618|P1|Overall Study|Other|1
5262237|NCT00679341|18154617|P2|Overall Study|Death|1
5262238|NCT00679341|18154618|P1|Overall Study|Death|1
5262239|NCT00679341|18154617|P2|Overall Study|Subject/guardian decision to discontinue|0
5262240|NCT00679341|18154618|P1|Overall Study|Subject/guardian decision to discontinue|3
5262241|NCT00679341|18154617|P2|Overall Study|Adverse Event|6
5262242|NCT00679341|18154618|P1|Overall Study|Adverse Event|5
5262243|NCT00679341|18154617|P2|Overall Study|Disease progression|36
5262244|NCT00679341|18154618|P1|Overall Study|Disease progression|42
5262245|NCT00679302|18154638|P2|Overall Study|Lost to Follow-up|4
5262246|NCT00679302|18154639|P1|Overall Study|Lost to Follow-up|8
5262247|NCT00679289|18154650|P3|Overall Study|Physician Decision|1
5262248|NCT00679289|18154651|P2|Overall Study|Physician Decision|0
5262249|NCT00679289|18154652|P1|Overall Study|Physician Decision|1
5262250|NCT00679289|18154650|P3|Overall Study|Adverse Event|3
5262251|NCT00679289|18154651|P2|Overall Study|Adverse Event|0
5262252|NCT00679289|18154652|P1|Overall Study|Adverse Event|0
5262253|NCT00679289|18154650|P3|Overall Study|Withdrawal by Subject|1
5262254|NCT00679289|18154651|P2|Overall Study|Withdrawal by Subject|1
5262255|NCT00679289|18154652|P1|Overall Study|Withdrawal by Subject|0
5262256|NCT00679289|18154650|P3|Overall Study|Progressive disease|18
5262257|NCT00679289|18154651|P2|Overall Study|Progressive disease|5
5262258|NCT00679289|18154652|P1|Overall Study|Progressive disease|4
5262259|NCT00679263|18154674|P3|Visit 2/Dose 1|subject not compliance|0
5262260|NCT00679263|18154675|P2|Visit 2/Dose 1|subject not compliance|1
5262261|NCT00679263|18154676|P1|Visit 2/Dose 1|subject not compliance|1
5262262|NCT00679263|18154674|P3|Visit 2/Dose 1|Adverse Event|0
5262263|NCT00679263|18154675|P2|Visit 2/Dose 1|Adverse Event|0
5262264|NCT00679263|18154676|P1|Visit 2/Dose 1|Adverse Event|1
5262265|NCT00679211|18154687|P1|Overall Study|Other|1
5262266|NCT00679211|18154687|P1|Overall Study|Transferred to extension study TDM4529g|12
5262267|NCT00679211|18154687|P1|Overall Study|Refused to undergo protocol procedures|1
5262268|NCT00679211|18154687|P1|Overall Study|Physician Decision|5
5262269|NCT00679211|18154687|P1|Overall Study|Withdrawal by Subject|2
5262270|NCT00679211|18154687|P1|Overall Study|Adverse Event|7
5262271|NCT00679211|18154687|P1|Overall Study|Progressive disease|82
5262272|NCT00679172|18154704|P5|Overall Study|Other not specified|0
5262273|NCT00679172|18154705|P4|Overall Study|Other not specified|0
5262274|NCT00679172|18154706|P3|Overall Study|Other not specified|1
5262275|NCT00679172|18154707|P2|Overall Study|Other not specified|0
5262276|NCT00679172|18154708|P1|Overall Study|Other not specified|0
5262277|NCT00679172|18154704|P5|Overall Study|Non-compliance|0
5262278|NCT00679172|18154705|P4|Overall Study|Non-compliance|1
5262279|NCT00679172|18154706|P3|Overall Study|Non-compliance|0
5262280|NCT00679172|18154707|P2|Overall Study|Non-compliance|1
5262281|NCT00679172|18154708|P1|Overall Study|Non-compliance|1
5262282|NCT00679081|18154771|P1|Overall Study|Lost to Follow-up|1
5262283|NCT00679055|18154781|P2|Overall Study|Study Terminated|1
5262284|NCT00679055|18154782|P1|Overall Study|Study Terminated|2
5262285|NCT00679055|18154781|P2|Overall Study|Other|3
5262286|NCT00679055|18154782|P1|Overall Study|Other|0
5262287|NCT00679055|18154781|P2|Overall Study|Adverse Event|1
5262288|NCT00679055|18154782|P1|Overall Study|Adverse Event|0
5262289|NCT00679029|18154792|P1|Overall Study|Lost to Follow-up|1
5262290|NCT00679029|18154792|P1|Overall Study|Withdrawal by Subject|1
5262291|NCT00679029|18154792|P1|Overall Study|Adverse Event|3
5262292|NCT00678899|18154799|P1|Overall Study|Adverse Event|1
5262293|NCT00678886|18154808|P4|Overall Study|Other|0
5262294|NCT00678886|18154809|P3|Overall Study|Other|1
5262295|NCT00678886|18154810|P2|Overall Study|Other|0
5262296|NCT00678886|18154811|P1|Overall Study|Other|0
5262297|NCT00678886|18154808|P4|Overall Study|Lost to Follow-up|2
5262298|NCT00678886|18154809|P3|Overall Study|Lost to Follow-up|3
5262299|NCT00678886|18154810|P2|Overall Study|Lost to Follow-up|0
5262300|NCT00678886|18154811|P1|Overall Study|Lost to Follow-up|0
5262301|NCT00678886|18154808|P4|Overall Study|Physician Decision|1
5262302|NCT00678886|18154809|P3|Overall Study|Physician Decision|1
5262303|NCT00678886|18154810|P2|Overall Study|Physician Decision|0
5262304|NCT00678886|18154811|P1|Overall Study|Physician Decision|0
5262305|NCT00678886|18154808|P4|Overall Study|Withdrawal by Subject|6
5262306|NCT00678886|18154809|P3|Overall Study|Withdrawal by Subject|4
5262307|NCT00678886|18154810|P2|Overall Study|Withdrawal by Subject|0
5262308|NCT00678886|18154811|P1|Overall Study|Withdrawal by Subject|0
5262309|NCT00678795|18154880|P2|Overall Study|Lack of Efficacy|1
5262310|NCT00678795|18154881|P1|Overall Study|Lack of Efficacy|1
5262311|NCT00678795|18154880|P2|Overall Study|Lost to Follow-up|1
5262312|NCT00678795|18154881|P1|Overall Study|Lost to Follow-up|0
5262313|NCT00678795|18154880|P2|Overall Study|Protocol Violation|1
5262314|NCT00678795|18154881|P1|Overall Study|Protocol Violation|0
5262315|NCT00678795|18154880|P2|Overall Study|Withdrawal by Subject|0
5262316|NCT00678795|18154881|P1|Overall Study|Withdrawal by Subject|3
5262317|NCT00678795|18154880|P2|Overall Study|Adverse Event|3
5262318|NCT00678795|18154881|P1|Overall Study|Adverse Event|7
5262319|NCT00678691|18154903|P2|Overall Study|Adverse Event|4
5262320|NCT00678691|18154904|P1|Overall Study|Adverse Event|6
5262321|NCT00678652|18154914|P4|Overall Study|Relocation|0
5262322|NCT00678652|18154915|P3|Overall Study|Relocation|0
5262323|NCT00678652|18154916|P2|Overall Study|Relocation|0
5262324|NCT00678652|18154917|P1|Overall Study|Relocation|1
5262325|NCT00678652|18154914|P4|Overall Study|Pregnancy|0
5262326|NCT00678652|18154915|P3|Overall Study|Pregnancy|1
5262327|NCT00678652|18154916|P2|Overall Study|Pregnancy|0
5262328|NCT00678652|18154917|P1|Overall Study|Pregnancy|0
5262329|NCT00678652|18154914|P4|Overall Study|Protocol Violation|0
5262330|NCT00678652|18154915|P3|Overall Study|Protocol Violation|0
5262331|NCT00678652|18154916|P2|Overall Study|Protocol Violation|0
5262332|NCT00678652|18154917|P1|Overall Study|Protocol Violation|2
5262333|NCT00678639|18154941|P2|Overall Study|Lost to Follow-up at 30 days|0
5262334|NCT00678639|18154942|P1|Overall Study|Lost to Follow-up at 30 days|2
5262335|NCT00678587|18154957|P2|Overall Study|Withdrew Consent|3
5262336|NCT00678587|18154958|P1|Overall Study|Withdrew Consent|8
5262337|NCT00678587|18154957|P2|Overall Study|Investigator Discretion|6
5262338|NCT00678587|18154958|P1|Overall Study|Investigator Discretion|2
5262339|NCT00678587|18154957|P2|Overall Study|Lost to Follow-up|5
5262340|NCT00678587|18154958|P1|Overall Study|Lost to Follow-up|3
5262341|NCT00678587|18154957|P2|Overall Study|Study Closed/Terminated|0
5262342|NCT00678587|18154958|P1|Overall Study|Study Closed/Terminated|1
5262343|NCT00678587|18154957|P2|Overall Study|Protocol Violation|1
5262344|NCT00678587|18154958|P1|Overall Study|Protocol Violation|2
5262345|NCT00678587|18154957|P2|Overall Study|Lack of Efficacy|0
5262346|NCT00678587|18154958|P1|Overall Study|Lack of Efficacy|1
5262347|NCT00678587|18154957|P2|Overall Study|Adverse Event|3
5262348|NCT00678587|18154958|P1|Overall Study|Adverse Event|3
5262349|NCT00678392|18155052|P2|Overall Study|Other|53
5262350|NCT00678392|18155053|P1|Overall Study|Other|56
5262351|NCT00678392|18155052|P2|Overall Study|Randomized But Not Treated|7
5262352|NCT00678392|18155053|P1|Overall Study|Randomized But Not Treated|2
5262353|NCT00678392|18155052|P2|Overall Study|Withdrawal by Subject|4
5262354|NCT00678392|18155053|P1|Overall Study|Withdrawal by Subject|4
5262355|NCT00678392|18155052|P2|Overall Study|Sponsor's Decision|2
5262356|NCT00678392|18155053|P1|Overall Study|Sponsor's Decision|1
5262357|NCT00678392|18155052|P2|Overall Study|Objective Progression or Relapse|8
5262358|NCT00678392|18155053|P1|Overall Study|Objective Progression or Relapse|3
5262359|NCT00678392|18155052|P2|Overall Study|Lost to Follow-up|13
5262360|NCT00678392|18155053|P1|Overall Study|Lost to Follow-up|15
5262361|NCT00678392|18155052|P2|Overall Study|Death|269
5262362|NCT00678392|18155053|P1|Overall Study|Death|280
5262363|NCT00678392|18155052|P2|Overall Study|Adverse Event|6
5262364|NCT00678392|18155053|P1|Overall Study|Adverse Event|0
5262365|NCT00678379|18155088|P3|Overall Study|Incomplete Data|3
5262366|NCT00678379|18155089|P2|Overall Study|Incomplete Data|3
5262367|NCT00678379|18155090|P1|Overall Study|Incomplete Data|4
5262368|NCT00678379|18155088|P3|Overall Study|Injection performed after tonsillectomy|1
5262369|NCT00678379|18155089|P2|Overall Study|Injection performed after tonsillectomy|0
5262370|NCT00678379|18155090|P1|Overall Study|Injection performed after tonsillectomy|2
5262371|NCT00678301|18155118|P2|Overall Study|Lost to Follow-up|1
5262372|NCT00678301|18155119|P1|Overall Study|Lost to Follow-up|3
5262373|NCT00678301|18155118|P2|Overall Study|Withdrawal by Subject|0
5262374|NCT00678301|18155119|P1|Overall Study|Withdrawal by Subject|4
5262375|NCT00678301|18155118|P2|Overall Study|Adverse Event|0
5262376|NCT00678301|18155119|P1|Overall Study|Adverse Event|1
5262377|NCT00678301|18155118|P2|Overall Study|Non-compliance with study procedures|1
5262378|NCT00678301|18155119|P1|Overall Study|Non-compliance with study procedures|0
5262379|NCT00678288|18155177|P2|Overall Study|Disease progression/recurrence/relapse|1
5262380|NCT00678288|18155178|P1|Overall Study|Disease progression/recurrence/relapse|6
5262381|NCT00678288|18155177|P2|Overall Study|Reason not reported|0
5262382|NCT00678288|18155178|P1|Overall Study|Reason not reported|1
5262383|NCT00678288|18155177|P2|Overall Study|Switch to commercial drug|1
5262384|NCT00678288|18155178|P1|Overall Study|Switch to commercial drug|0
5262385|NCT00678288|18155177|P2|Overall Study|Not compliant with study medication|1
5262386|NCT00678288|18155178|P1|Overall Study|Not compliant with study medication|0
5262387|NCT00678288|18155177|P2|Overall Study|Study terminated by the sponsor|0
5262388|NCT00678288|18155178|P1|Overall Study|Study terminated by the sponsor|2
5262389|NCT00678288|18155177|P2|Overall Study|Withdrawal by Subject|1
5262390|NCT00678288|18155178|P1|Overall Study|Withdrawal by Subject|1
5262391|NCT00678288|18155177|P2|Overall Study|Adverse Event|2
5262392|NCT00678288|18155178|P1|Overall Study|Adverse Event|0
5262393|NCT00678210|18155233|P4|Overall Study|Other|0
5262394|NCT00678210|18155234|P3|Overall Study|Other|1
5262395|NCT00678210|18155235|P2|Overall Study|Other|0
5262396|NCT00678210|18155236|P1|Overall Study|Other|1
5262397|NCT00678210|18155233|P4|Overall Study|Withdrawal by Subject|7
5262398|NCT00678210|18155234|P3|Overall Study|Withdrawal by Subject|1
5262399|NCT00678210|18155235|P2|Overall Study|Withdrawal by Subject|4
5262400|NCT00678210|18155236|P1|Overall Study|Withdrawal by Subject|3
5262401|NCT00678210|18155233|P4|Overall Study|Lost to Follow-up|1
5262402|NCT00678210|18155234|P3|Overall Study|Lost to Follow-up|0
5262403|NCT00678210|18155235|P2|Overall Study|Lost to Follow-up|2
5262404|NCT00678210|18155236|P1|Overall Study|Lost to Follow-up|4
5262405|NCT00678210|18155233|P4|Overall Study|Lack of Efficacy|9
5262406|NCT00678210|18155234|P3|Overall Study|Lack of Efficacy|1
5262407|NCT00678210|18155235|P2|Overall Study|Lack of Efficacy|3
5262408|NCT00678210|18155236|P1|Overall Study|Lack of Efficacy|2
5262409|NCT00678210|18155233|P4|Overall Study|Adverse Event|3
5262410|NCT00678210|18155234|P3|Overall Study|Adverse Event|3
5262411|NCT00678210|18155235|P2|Overall Study|Adverse Event|2
5262412|NCT00678210|18155236|P1|Overall Study|Adverse Event|1
5262413|NCT00678080|18155272|P2|Overall Study|Withdrawal by Subject|1
5262414|NCT00678080|18155273|P1|Overall Study|Withdrawal by Subject|0
5262415|NCT00678080|18155272|P2|Overall Study|Lost to Follow-up|0
5262416|NCT00678080|18155273|P1|Overall Study|Lost to Follow-up|1
5262417|NCT00678080|18155272|P2|Overall Study|Physician Decision|0
5262418|NCT00678080|18155273|P1|Overall Study|Physician Decision|2
5262419|NCT00678041|18155299|P2|Overall Study|Physician Decision|5
5262420|NCT00678041|18155300|P1|Overall Study|Physician Decision|5
5262421|NCT00677833|18155353|P4|Overall Study|Lost to Follow-up|0
5262422|NCT00677833|18155354|P3|Overall Study|Lost to Follow-up|1
5262423|NCT00677833|18155355|P2|Overall Study|Lost to Follow-up|0
5262424|NCT00677833|18155356|P1|Overall Study|Lost to Follow-up|0
5262425|NCT00677833|18155353|P4|Overall Study|Withdrawal by Subject|3
5262426|NCT00677833|18155354|P3|Overall Study|Withdrawal by Subject|1
5262427|NCT00677833|18155355|P2|Overall Study|Withdrawal by Subject|0
5262428|NCT00677833|18155356|P1|Overall Study|Withdrawal by Subject|4
5262429|NCT00677820|18155406|P2|Overall Study|Lost to Follow-up|0
5262430|NCT00677820|18155407|P1|Overall Study|Lost to Follow-up|1
5262431|NCT00677807|18155428|P3|Overall Study|Protocol Deviation|0
5262432|NCT00677807|18155429|P2|Overall Study|Protocol Deviation|3
5262433|NCT00677807|18155430|P1|Overall Study|Protocol Deviation|1
5262434|NCT00677807|18155428|P3|Overall Study|Death|1
5262435|NCT00677807|18155429|P2|Overall Study|Death|1
5262436|NCT00677807|18155430|P1|Overall Study|Death|0
5262437|NCT00677807|18155428|P3|Overall Study|Administrative problems|2
5262438|NCT00677807|18155429|P2|Overall Study|Administrative problems|1
5262439|NCT00677807|18155430|P1|Overall Study|Administrative problems|1
5262440|NCT00677807|18155428|P3|Overall Study|Lost to Follow-up|2
5262441|NCT00677807|18155429|P2|Overall Study|Lost to Follow-up|2
5262442|NCT00677807|18155430|P1|Overall Study|Lost to Follow-up|2
5262443|NCT00677807|18155428|P3|Overall Study|Withdrawal by Subject|6
5262444|NCT00677807|18155429|P2|Overall Study|Withdrawal by Subject|3
5262445|NCT00677807|18155430|P1|Overall Study|Withdrawal by Subject|10
5262446|NCT00677807|18155428|P3|Overall Study|Participant no longer needs study drug|1
5262447|NCT00677807|18155429|P2|Overall Study|Participant no longer needs study drug|0
5262448|NCT00677807|18155430|P1|Overall Study|Participant no longer needs study drug|0
5262449|NCT00677807|18155428|P3|Overall Study|Lack of Efficacy|2
5262450|NCT00677807|18155429|P2|Overall Study|Lack of Efficacy|0
5262451|NCT00677807|18155430|P1|Overall Study|Lack of Efficacy|0
5262452|NCT00677807|18155428|P3|Overall Study|Adverse Event|6
5262453|NCT00677807|18155429|P2|Overall Study|Adverse Event|1
5262454|NCT00677807|18155430|P1|Overall Study|Adverse Event|4
5262455|NCT00677534|18155476|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
5262456|NCT00677534|18155476|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
5262457|NCT00677534|18155476|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
5262458|NCT00677365|18155484|P4|Overall Study|Other reason|1
5262459|NCT00677365|18155485|P3|Overall Study|Other reason|0
5262460|NCT00677365|18155486|P2|Overall Study|Other reason|0
5262461|NCT00677365|18155487|P1|Overall Study|Other reason|0
5262462|NCT00677365|18155484|P4|Overall Study|Withdrawal by Subject|0
5262463|NCT00677365|18155485|P3|Overall Study|Withdrawal by Subject|1
5262464|NCT00677365|18155486|P2|Overall Study|Withdrawal by Subject|0
5262465|NCT00677365|18155487|P1|Overall Study|Withdrawal by Subject|0
5262466|NCT00677365|18155484|P4|Overall Study|Adverse Event|2
5262467|NCT00677365|18155485|P3|Overall Study|Adverse Event|1
5262468|NCT00677365|18155486|P2|Overall Study|Adverse Event|1
5262469|NCT00677365|18155487|P1|Overall Study|Adverse Event|2
5262470|NCT00677352|18155519|P2|Tapering Phase|Job transfer|1
5262471|NCT00677352|18155520|P1|Tapering Phase|Job transfer|0
5262472|NCT00677352|18155519|P2|Tapering Phase|Pregnancy|1
5262473|NCT00677352|18155520|P1|Tapering Phase|Pregnancy|0
5262474|NCT00677352|18155519|P2|Tapering Phase|Withdrawal by Subject|3
5262475|NCT00677352|18155520|P1|Tapering Phase|Withdrawal by Subject|5
5262476|NCT00677352|18155519|P2|Tapering Phase|Adverse Event|5
5262477|NCT00677352|18155520|P1|Tapering Phase|Adverse Event|1
5262478|NCT00677352|18155519|P2|Treatment Phase|Not treated|2
5262479|NCT00677352|18155520|P1|Treatment Phase|Not treated|0
5262480|NCT00677352|18155519|P2|Treatment Phase|Transference or work related matter|5
5262481|NCT00677352|18155520|P1|Treatment Phase|Transference or work related matter|0
5262482|NCT00677352|18155519|P2|Treatment Phase|Protocol Violation|1
5262483|NCT00677352|18155520|P1|Treatment Phase|Protocol Violation|1
5262484|NCT00677352|18155519|P2|Treatment Phase|Pregnancy|1
5262485|NCT00677352|18155520|P1|Treatment Phase|Pregnancy|0
5262486|NCT00677352|18155519|P2|Treatment Phase|Physician Decision|0
5262487|NCT00677352|18155520|P1|Treatment Phase|Physician Decision|1
5262488|NCT00677352|18155519|P2|Treatment Phase|Withdrawal by Subject|7
5262489|NCT00677352|18155520|P1|Treatment Phase|Withdrawal by Subject|7
5262490|NCT00677352|18155519|P2|Treatment Phase|Lost to Follow-up|1
5262491|NCT00677352|18155520|P1|Treatment Phase|Lost to Follow-up|0
5262492|NCT00677352|18155519|P2|Treatment Phase|Lack of Efficacy|3
5262493|NCT00677352|18155520|P1|Treatment Phase|Lack of Efficacy|2
5262494|NCT00677352|18155519|P2|Treatment Phase|Adverse Event|22
5262495|NCT00677352|18155520|P1|Treatment Phase|Adverse Event|14
5262496|NCT00677235|18155540|P2|Overall Study|Adverse Experience|0
5262497|NCT00677235|18155541|P1|Overall Study|Adverse Experience|1
5262498|NCT00677235|18155540|P2|Overall Study|Death|36
5262499|NCT00677235|18155541|P1|Overall Study|Death|37
5262500|NCT00677235|18155540|P2|Overall Study|Lost to Follow-up|1
5262501|NCT00677235|18155541|P1|Overall Study|Lost to Follow-up|2
5262502|NCT00677235|18155540|P2|Overall Study|Withdrawal by Subject|1
5262503|NCT00677235|18155541|P1|Overall Study|Withdrawal by Subject|1
5262504|NCT00677092|18155581|P1|Overall Study|Death Prior to Receiving Treatment|1
5262505|NCT00677092|18155581|P1|Overall Study|Withdrawal by Subject|3
5262506|NCT00677092|18155581|P1|Overall Study|Lost to Follow-up|1
5262507|NCT00677092|18155581|P1|Overall Study|Adverse Event|1
5262508|NCT00677014|18155598|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
5262509|NCT00677014|18155599|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
5262510|NCT00677014|18155600|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
5262511|NCT00677014|18155598|P3|Overall Study|Death|7
5262512|NCT00677014|18155599|P2|Overall Study|Death|15
5262513|NCT00677014|18155600|P1|Overall Study|Death|6
5262514|NCT00677014|18155598|P3|Overall Study|Lost to Follow-up|24
5262515|NCT00677014|18155599|P2|Overall Study|Lost to Follow-up|12
5262516|NCT00677014|18155600|P1|Overall Study|Lost to Follow-up|20
5262517|NCT00676715|18155653|P4|Overall Study|Participants Ongoing|24
5262518|NCT00676715|18155654|P3|Overall Study|Participants Ongoing|17
5262519|NCT00676715|18155655|P2|Overall Study|Participants Ongoing|29
5262520|NCT00676715|18155656|P1|Overall Study|Participants Ongoing|29
5262521|NCT00676715|18155653|P4|Overall Study|Adverse Event|0
5262522|NCT00676715|18155654|P3|Overall Study|Adverse Event|2
5262523|NCT00676715|18155655|P2|Overall Study|Adverse Event|1
5262524|NCT00676715|18155656|P1|Overall Study|Adverse Event|0
5262525|NCT00676715|18155653|P4|Overall Study|Death|0
5262526|NCT00676715|18155654|P3|Overall Study|Death|1
5262527|NCT00676715|18155655|P2|Overall Study|Death|1
5262528|NCT00676715|18155656|P1|Overall Study|Death|1
5262529|NCT00676715|18155653|P4|Overall Study|Lost to Follow-up|3
5262530|NCT00676715|18155654|P3|Overall Study|Lost to Follow-up|7
5262531|NCT00676715|18155655|P2|Overall Study|Lost to Follow-up|1
5262532|NCT00676715|18155656|P1|Overall Study|Lost to Follow-up|1
5262533|NCT00676715|18155653|P4|Overall Study|Other|3
5262534|NCT00676715|18155654|P3|Overall Study|Other|4
5262535|NCT00676715|18155655|P2|Overall Study|Other|6
5262536|NCT00676715|18155656|P1|Overall Study|Other|2
5262537|NCT00676715|18155653|P4|Overall Study|Withdrawal by Subject|10
5262538|NCT00676715|18155654|P3|Overall Study|Withdrawal by Subject|10
5262539|NCT00676715|18155655|P2|Overall Study|Withdrawal by Subject|9
5262540|NCT00676715|18155656|P1|Overall Study|Withdrawal by Subject|7
5262541|NCT00676689|18155686|P1|Overall Study|Continuing FU|49
5262542|NCT00676689|18155686|P1|Overall Study|Withdrawal by Subject|3
5262543|NCT00676689|18155686|P1|Overall Study|Physician Decision|1
5262544|NCT00676689|18155686|P1|Overall Study|Lost to Follow-up|4
5262545|NCT00676689|18155686|P1|Overall Study|Death|2
5262546|NCT00676689|18155686|P1|Overall Study|Screen Failure|2
5262547|NCT00676663|18155698|P2|Overall Study|Lost to Follow-up|3
5262548|NCT00676663|18155699|P1|Overall Study|Lost to Follow-up|1
5262549|NCT00676663|18155698|P2|Overall Study|Withdrew Consent|8
5262550|NCT00676663|18155699|P1|Overall Study|Withdrew Consent|1
5262551|NCT00676663|18155698|P2|Overall Study|Death|27
5262552|NCT00676663|18155699|P1|Overall Study|Death|43
5262553|NCT00676650|18155715|P2|Overall Study|Randomized but not treated|4
5262554|NCT00676650|18155716|P1|Overall Study|Randomized but not treated|3
5262555|NCT00676650|18155715|P2|Overall Study|Withdrawal by Subject|24
5262556|NCT00676650|18155716|P1|Overall Study|Withdrawal by Subject|48
5262557|NCT00676650|18155715|P2|Overall Study|Study terminated by sponsor|43
5262558|NCT00676650|18155716|P1|Overall Study|Study terminated by sponsor|57
5262559|NCT00676650|18155715|P2|Overall Study|Protocol Violation|1
5262560|NCT00676650|18155716|P1|Overall Study|Protocol Violation|3
5262561|NCT00676650|18155715|P2|Overall Study|Other|10
5262562|NCT00676650|18155716|P1|Overall Study|Other|14
5262563|NCT00676650|18155715|P2|Overall Study|Objective progression or relapse|140
5262564|NCT00676650|18155716|P1|Overall Study|Objective progression or relapse|189
5262565|NCT00676650|18155715|P2|Overall Study|Lost to Follow-up|1
5262566|NCT00676650|18155716|P1|Overall Study|Lost to Follow-up|0
5262567|NCT00676650|18155715|P2|Overall Study|Global deterioration of health status|31
5262568|NCT00676650|18155716|P1|Overall Study|Global deterioration of health status|66
5262569|NCT00676650|18155715|P2|Overall Study|Adverse Event|21
5262570|NCT00676650|18155716|P1|Overall Study|Adverse Event|159
5262571|NCT00676650|18155715|P2|Overall Study|Death|14
5262572|NCT00676650|18155716|P1|Overall Study|Death|45
5262573|NCT00676520|18155758|P1|Overall Study|Other Reason|18
5262574|NCT00676520|18155758|P1|Overall Study|Ineligible for Randomization to DAPT|209
5262575|NCT00676520|18155758|P1|Overall Study|Physician Decision|20
5262576|NCT00676520|18155758|P1|Overall Study|Death|159
5262577|NCT00676520|18155758|P1|Overall Study|Lost to Follow-up|162
5262578|NCT00676520|18155758|P1|Overall Study|Withdrawal by Subject|163
5262579|NCT00676494|18155815|P1|Overall Study|Withdrawal by Subject|6
5262580|NCT00676494|18155815|P1|Overall Study|Missed Visit|8
5262581|NCT00676403|18155832|P6|Overall Study|Withdrawal by Subject|1
5262582|NCT00676403|18155833|P5|Overall Study|Withdrawal by Subject|0
5262583|NCT00676403|18155834|P4|Overall Study|Withdrawal by Subject|0
5262584|NCT00676403|18155835|P3|Overall Study|Withdrawal by Subject|0
5262585|NCT00676403|18155836|P2|Overall Study|Withdrawal by Subject|0
5262586|NCT00676403|18155837|P1|Overall Study|Withdrawal by Subject|0
5262587|NCT00676403|18155832|P6|Overall Study|Reason Unspecified|1
5262588|NCT00676403|18155833|P5|Overall Study|Reason Unspecified|0
5262589|NCT00676403|18155834|P4|Overall Study|Reason Unspecified|0
5262590|NCT00676403|18155835|P3|Overall Study|Reason Unspecified|1
5262591|NCT00676403|18155836|P2|Overall Study|Reason Unspecified|0
5262592|NCT00676403|18155837|P1|Overall Study|Reason Unspecified|1
5262593|NCT00676403|18155832|P6|Overall Study|Lost to Follow-up|1
5262594|NCT00676403|18155833|P5|Overall Study|Lost to Follow-up|0
5262595|NCT00676403|18155834|P4|Overall Study|Lost to Follow-up|0
5262596|NCT00676403|18155835|P3|Overall Study|Lost to Follow-up|0
5262597|NCT00676403|18155836|P2|Overall Study|Lost to Follow-up|0
5262598|NCT00676403|18155837|P1|Overall Study|Lost to Follow-up|0
5262599|NCT00676403|18155832|P6|Overall Study|Adverse Event|2
5262600|NCT00676403|18155833|P5|Overall Study|Adverse Event|1
5262601|NCT00676403|18155834|P4|Overall Study|Adverse Event|5
5262602|NCT00676403|18155835|P3|Overall Study|Adverse Event|0
5262603|NCT00676403|18155836|P2|Overall Study|Adverse Event|2
5262604|NCT00676403|18155837|P1|Overall Study|Adverse Event|1
5262605|NCT00676338|18155980|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
5262606|NCT00676338|18155981|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
5262607|NCT00676338|18155982|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
5262608|NCT00676338|18155983|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
5262609|NCT00676338|18155980|P4|Overall Study|Entry Criteria Not Met|1
5262610|NCT00676338|18155981|P3|Overall Study|Entry Criteria Not Met|1
5262611|NCT00676338|18155982|P2|Overall Study|Entry Criteria Not Met|2
5262612|NCT00676338|18155983|P1|Overall Study|Entry Criteria Not Met|0
5262613|NCT00676338|18155980|P4|Overall Study|Withdrawal by Subject|6
5262614|NCT00676338|18155981|P3|Overall Study|Withdrawal by Subject|12
5262615|NCT00676338|18155982|P2|Overall Study|Withdrawal by Subject|9
5262616|NCT00676338|18155983|P1|Overall Study|Withdrawal by Subject|17
5262617|NCT00676338|18155980|P4|Overall Study|Protocol Violation|5
5262618|NCT00676338|18155981|P3|Overall Study|Protocol Violation|2
5262619|NCT00676338|18155982|P2|Overall Study|Protocol Violation|9
5262620|NCT00676338|18155983|P1|Overall Study|Protocol Violation|5
5262621|NCT00676338|18155980|P4|Overall Study|Physician Decision|3
5262622|NCT00676338|18155981|P3|Overall Study|Physician Decision|2
5262623|NCT00676338|18155982|P2|Overall Study|Physician Decision|3
5262624|NCT00676338|18155983|P1|Overall Study|Physician Decision|3
5262625|NCT00676338|18155980|P4|Overall Study|Lost to Follow-up|4
5262626|NCT00676338|18155981|P3|Overall Study|Lost to Follow-up|3
5262627|NCT00676338|18155982|P2|Overall Study|Lost to Follow-up|1
5262628|NCT00676338|18155983|P1|Overall Study|Lost to Follow-up|4
5262629|NCT00676338|18155980|P4|Overall Study|Adverse Event|1
5262630|NCT00676338|18155981|P3|Overall Study|Adverse Event|5
5262631|NCT00676338|18155982|P2|Overall Study|Adverse Event|6
5262632|NCT00676338|18155983|P1|Overall Study|Adverse Event|6
5262633|NCT00676208|18156035|P2|Overall Study|Incomplete data|4
5262634|NCT00676208|18156036|P1|Overall Study|Incomplete data|2
5262635|NCT00676208|18156035|P2|Overall Study|Lost to Follow-up|2
5262636|NCT00676208|18156036|P1|Overall Study|Lost to Follow-up|0
5262637|NCT00676195|18156044|P1|Overall Study|Physician Decision|1
5262638|NCT00676195|18156044|P1|Overall Study|Adverse Event|1
5262639|NCT00676195|18156044|P1|Overall Study|Lost to Follow-up|1
5262640|NCT00676143|18156069|P2|Overall Study|Vasogenic edema recurrence|3
5262641|NCT00676143|18156070|P1|Overall Study|Vasogenic edema recurrence|1
5262642|NCT00676143|18156069|P2|Overall Study|Participant participation unknown|4
5262643|NCT00676143|18156070|P1|Overall Study|Participant participation unknown|1
5262644|NCT00676143|18156069|P2|Overall Study|Other|20
5262645|NCT00676143|18156070|P1|Overall Study|Other|11
5262646|NCT00676143|18156069|P2|Overall Study|Loss of caregiver|3
5262647|NCT00676143|18156070|P1|Overall Study|Loss of caregiver|5
5262648|NCT00676143|18156069|P2|Overall Study|Failed to return|1
5262649|NCT00676143|18156070|P1|Overall Study|Failed to return|2
5262650|NCT00676143|18156069|P2|Overall Study|Discontinuation of study by sponsor|88
5262651|NCT00676143|18156070|P1|Overall Study|Discontinuation of study by sponsor|65
5262652|NCT00676143|18156069|P2|Overall Study|Withdrawal by Subject|42
5262653|NCT00676143|18156070|P1|Overall Study|Withdrawal by Subject|24
5262654|NCT00676143|18156069|P2|Overall Study|Protocol Violation|8
5262655|NCT00676143|18156070|P1|Overall Study|Protocol Violation|4
5262656|NCT00676143|18156069|P2|Overall Study|Physician Decision|8
5262657|NCT00676143|18156070|P1|Overall Study|Physician Decision|5
5262658|NCT00676143|18156069|P2|Overall Study|Lost to Follow-up|13
5262659|NCT00676143|18156070|P1|Overall Study|Lost to Follow-up|0
5262660|NCT00676143|18156069|P2|Overall Study|Lack of Efficacy|6
5262661|NCT00676143|18156070|P1|Overall Study|Lack of Efficacy|0
5262662|NCT00676143|18156069|P2|Overall Study|Death|4
5262663|NCT00676143|18156070|P1|Overall Study|Death|4
5262664|NCT00676143|18156069|P2|Overall Study|Adverse Event|60
5262665|NCT00676143|18156070|P1|Overall Study|Adverse Event|34
5262666|NCT00676130|18156110|P2|Overall Study|Withdrawal by Subject|1
5262667|NCT00676130|18156111|P1|Overall Study|Withdrawal by Subject|0
5262668|NCT00676130|18156110|P2|Overall Study|Found ineligible|2
5262669|NCT00676130|18156111|P1|Overall Study|Found ineligible|3
5262670|NCT00676130|18156110|P2|Overall Study|Lost to Follow-up|1
5262671|NCT00676130|18156111|P1|Overall Study|Lost to Follow-up|0
5262672|NCT00676091|18156121|P2|Toddler Dose|Parent or legal guardian request|0
5262673|NCT00676091|18156122|P1|Toddler Dose|Parent or legal guardian request|1
5262674|NCT00676091|18156121|P2|Toddler Dose|Failed to return|0
5262675|NCT00676091|18156122|P1|Toddler Dose|Failed to return|2
5262676|NCT00676091|18156121|P2|After Infant Series|Failed to return|1
5262677|NCT00676091|18156122|P1|After Infant Series|Failed to return|1
5262678|NCT00676091|18156121|P2|After Infant Series|Protocol Violation|1
5262679|NCT00676091|18156122|P1|After Infant Series|Protocol Violation|0
5262680|NCT00676091|18156121|P2|After Infant Series|Adverse Event|1
5262681|NCT00676091|18156122|P1|After Infant Series|Adverse Event|0
5262682|NCT00676091|18156121|P2|Infant Series|Died prior to receiving 7vPnC|1
5262683|NCT00676091|18156122|P1|Infant Series|Died prior to receiving 7vPnC|0
5262684|NCT00676091|18156121|P2|Infant Series|Lost to Follow-up|0
5262685|NCT00676091|18156122|P1|Infant Series|Lost to Follow-up|1
5262686|NCT00676091|18156121|P2|Infant Series|Failed to return|3
5262687|NCT00676091|18156122|P1|Infant Series|Failed to return|1
5262688|NCT00676091|18156121|P2|Infant Series|Adverse Event|3
5262689|NCT00676091|18156122|P1|Infant Series|Adverse Event|2
5262690|NCT00676091|18156121|P2|Infant Series|Protocol Violation|3
5262691|NCT00676091|18156122|P1|Infant Series|Protocol Violation|6
5262692|NCT00676091|18156121|P2|Infant Series|Parent or legal guardian request|8
5262693|NCT00676091|18156122|P1|Infant Series|Parent or legal guardian request|10
5262694|NCT00676052|18156179|P6|Overall Study|Withdrawal by Subject|0
5262695|NCT00676052|18156180|P5|Overall Study|Withdrawal by Subject|0
5262696|NCT00676052|18156181|P4|Overall Study|Withdrawal by Subject|0
5262697|NCT00676052|18156182|P3|Overall Study|Withdrawal by Subject|1
5262698|NCT00676052|18156183|P2|Overall Study|Withdrawal by Subject|0
5262699|NCT00676052|18156184|P1|Overall Study|Withdrawal by Subject|1
5262700|NCT00676052|18156179|P6|Overall Study|Physician Decision|1
5262701|NCT00676052|18156180|P5|Overall Study|Physician Decision|0
5262702|NCT00676052|18156181|P4|Overall Study|Physician Decision|0
5262703|NCT00676052|18156182|P3|Overall Study|Physician Decision|1
5262704|NCT00676052|18156183|P2|Overall Study|Physician Decision|1
5262705|NCT00676052|18156184|P1|Overall Study|Physician Decision|1
5262706|NCT00676052|18156179|P6|Overall Study|Lost to Follow-up|0
5262707|NCT00676052|18156180|P5|Overall Study|Lost to Follow-up|1
5262708|NCT00676052|18156181|P4|Overall Study|Lost to Follow-up|0
5262709|NCT00676052|18156182|P3|Overall Study|Lost to Follow-up|0
5262710|NCT00676052|18156183|P2|Overall Study|Lost to Follow-up|0
5262711|NCT00676052|18156184|P1|Overall Study|Lost to Follow-up|0
5262712|NCT00676052|18156179|P6|Overall Study|Protocol Violation|2
5262713|NCT00676052|18156180|P5|Overall Study|Protocol Violation|1
5262714|NCT00676052|18156181|P4|Overall Study|Protocol Violation|2
5262715|NCT00676052|18156182|P3|Overall Study|Protocol Violation|2
5262716|NCT00676052|18156183|P2|Overall Study|Protocol Violation|3
5262717|NCT00676052|18156184|P1|Overall Study|Protocol Violation|5
5262718|NCT00676052|18156179|P6|Overall Study|Lack of Efficacy|1
5262719|NCT00676052|18156180|P5|Overall Study|Lack of Efficacy|2
5262720|NCT00676052|18156181|P4|Overall Study|Lack of Efficacy|1
5262721|NCT00676052|18156182|P3|Overall Study|Lack of Efficacy|1
5262722|NCT00676052|18156183|P2|Overall Study|Lack of Efficacy|2
5262723|NCT00676052|18156184|P1|Overall Study|Lack of Efficacy|2
5262724|NCT00676052|18156179|P6|Overall Study|Adverse Event|2
5262725|NCT00676052|18156180|P5|Overall Study|Adverse Event|2
5262726|NCT00676052|18156181|P4|Overall Study|Adverse Event|2
5262727|NCT00676052|18156182|P3|Overall Study|Adverse Event|1
5262728|NCT00676052|18156183|P2|Overall Study|Adverse Event|1
5262729|NCT00676052|18156184|P1|Overall Study|Adverse Event|0
5262730|NCT00675948|18156254|P2|Overall Study|Patient feels unable to take medication|1
5262731|NCT00675948|18156255|P1|Overall Study|Patient feels unable to take medication|0
5262732|NCT00675948|18156254|P2|Overall Study|Patient unable to comply with diaries|0
5262733|NCT00675948|18156255|P1|Overall Study|Patient unable to comply with diaries|1
5262734|NCT00675948|18156254|P2|Overall Study|Patient died|0
5262735|NCT00675948|18156255|P1|Overall Study|Patient died|1
5262736|NCT00675948|18156254|P2|Overall Study|Sponsor decision|1
5262737|NCT00675948|18156255|P1|Overall Study|Sponsor decision|0
5262738|NCT00675948|18156254|P2|Overall Study|Pain under control|0
5262739|NCT00675948|18156255|P1|Overall Study|Pain under control|1
5262740|NCT00675948|18156254|P2|Overall Study|Protocol Violation|0
5262741|NCT00675948|18156255|P1|Overall Study|Protocol Violation|1
5262742|NCT00675948|18156254|P2|Overall Study|Lost to Follow-up|0
5262743|NCT00675948|18156255|P1|Overall Study|Lost to Follow-up|2
5262744|NCT00675948|18156254|P2|Overall Study|Withdrawal by Subject|0
5262745|NCT00675948|18156255|P1|Overall Study|Withdrawal by Subject|7
5262746|NCT00675948|18156254|P2|Overall Study|Lack of Efficacy|0
5262747|NCT00675948|18156255|P1|Overall Study|Lack of Efficacy|3
5262748|NCT00675948|18156254|P2|Overall Study|Adverse Event|1
5262749|NCT00675948|18156255|P1|Overall Study|Adverse Event|23
5262750|NCT00675766|18156318|P4|Overall Study|Lost to Follow-up|26
5262751|NCT00675766|18156319|P3|Overall Study|Lost to Follow-up|21
5262752|NCT00675766|18156320|P2|Overall Study|Lost to Follow-up|5
5262753|NCT00675766|18156321|P1|Overall Study|Lost to Follow-up|6
5262754|NCT00675597|18156331|P1|Overall Study|Withdrawal by Subject|3
5262755|NCT00675506|18156385|P2|Overall Study|Schedule conflict|1
5262756|NCT00675506|18156386|P1|Overall Study|Schedule conflict|0
5262757|NCT00675506|18156385|P2|Overall Study|Declined participation|0
5262758|NCT00675506|18156386|P1|Overall Study|Declined participation|1
5262759|NCT00675506|18156385|P2|Overall Study|Disclosed history of cancer|0
5262760|NCT00675506|18156386|P1|Overall Study|Disclosed history of cancer|1
5262761|NCT00675506|18156385|P2|Overall Study|Hypersensitivity Reaction|0
5262762|NCT00675506|18156386|P1|Overall Study|Hypersensitivity Reaction|1
5262763|NCT00675506|18156385|P2|Overall Study|Elevated IGF-1|0
5262764|NCT00675506|18156386|P1|Overall Study|Elevated IGF-1|2
5262765|NCT00675506|18156385|P2|Overall Study|Elevated IGF-1 prior to treatment|0
5262766|NCT00675506|18156386|P1|Overall Study|Elevated IGF-1 prior to treatment|1
5262767|NCT00675506|18156385|P2|Overall Study|Elevated fasting glucose|1
5262768|NCT00675506|18156386|P1|Overall Study|Elevated fasting glucose|2
5262769|NCT00675506|18156385|P2|Overall Study|Lost interest|5
5262770|NCT00675506|18156386|P1|Overall Study|Lost interest|3
5262771|NCT00675506|18156385|P2|Overall Study|Lost to Follow-up|5
5262772|NCT00675506|18156386|P1|Overall Study|Lost to Follow-up|1
5262773|NCT00675441|18156402|P1|Overall Study|Death|1
5262774|NCT00675441|18156402|P1|Overall Study|Withdrawal by Subject|2
5262775|NCT00675428|18156408|P2|Overall Study|Physician Decision|0
5262776|NCT00675428|18156409|P1|Overall Study|Physician Decision|1
5262777|NCT00675428|18156408|P2|Overall Study|No Disease Response After Cycle 6|1
5262778|NCT00675428|18156409|P1|Overall Study|No Disease Response After Cycle 6|0
5262779|NCT00675428|18156408|P2|Overall Study|Disease Progression|2
5262780|NCT00675428|18156409|P1|Overall Study|Disease Progression|2
5262781|NCT00675103|18156451|P1|Overall Study|Adverse Event|1
5262782|NCT00675103|18156451|P1|Overall Study|Lack of Efficacy|2
5262783|NCT00674986|18156458|P2|Overall Study|Other reasons|8
5262784|NCT00674986|18156459|P1|Overall Study|Other reasons|4
5262785|NCT00674986|18156458|P2|Overall Study|Lost to Follow-up|53
5262786|NCT00674986|18156459|P1|Overall Study|Lost to Follow-up|25
5262787|NCT00674986|18156458|P2|Overall Study|Subject withdrew consent|19
5262788|NCT00674986|18156459|P1|Overall Study|Subject withdrew consent|12
5262789|NCT00674986|18156458|P2|Overall Study|Adverse Event|1
5262790|NCT00674986|18156459|P1|Overall Study|Adverse Event|2
5262791|NCT00674973|18156480|P2|Overall Study|Protocol Violation|1
5262792|NCT00674973|18156481|P1|Overall Study|Protocol Violation|0
5262793|NCT00674973|18156480|P2|Overall Study|Death|15
5262794|NCT00674973|18156481|P1|Overall Study|Death|19
5262795|NCT00674973|18156480|P2|Overall Study|Adverse Event|9
5262796|NCT00674973|18156481|P1|Overall Study|Adverse Event|2
5262797|NCT00674973|18156480|P2|Overall Study|Failure to Return|0
5262798|NCT00674973|18156481|P1|Overall Study|Failure to Return|1
5262799|NCT00674973|18156480|P2|Overall Study|Refused Treatment|5
5262800|NCT00674973|18156481|P1|Overall Study|Refused Treatment|1
5262801|NCT00674973|18156480|P2|Overall Study|Insufficient Therapeutic Response|72
5262802|NCT00674973|18156481|P1|Overall Study|Insufficient Therapeutic Response|77
5262803|NCT00674817|18156495|P1|Period 4|Adverse Event|1
5262804|NCT00674817|18156495|P1|Period 3|Protocol Violation|1
5262805|NCT00674817|18156495|P1|Period 3|Adverse Event|1
5262806|NCT00674817|18156495|P1|Period 1|Protocol Violation|1
5262807|NCT00674817|18156495|P1|Period 1|Withdrawal by Subject|2
5262808|NCT00674700|18156672|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
5262809|NCT00674700|18156673|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
5262810|NCT00674700|18156674|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
5262811|NCT00674700|18156672|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
5262812|NCT00674700|18156673|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
5262813|NCT00674700|18156674|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
5262814|NCT00674700|18156672|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
5262815|NCT00674700|18156673|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
5262816|NCT00674700|18156674|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
5262817|NCT00674700|18156672|P3|Year 1|Any other reason not above-mentioned|6
5262818|NCT00674700|18156673|P2|Year 1|Any other reason not above-mentioned|7
5262819|NCT00674700|18156674|P1|Year 1|Any other reason not above-mentioned|7
5262820|NCT00674700|18156672|P3|Year 1|Withdrawal by Subject|6
5262821|NCT00674700|18156673|P2|Year 1|Withdrawal by Subject|7
5262822|NCT00674700|18156674|P1|Year 1|Withdrawal by Subject|7
5262823|NCT00674700|18156672|P3|Year 1|Adverse Event|5
5262824|NCT00674700|18156673|P2|Year 1|Adverse Event|20
5262825|NCT00674700|18156674|P1|Year 1|Adverse Event|17
5262826|NCT00674661|18156687|P2|Overall Study|Withdrawal by Subject|5
5262827|NCT00674661|18156688|P1|Overall Study|Withdrawal by Subject|0
5262828|NCT00674661|18156687|P2|Overall Study|Lost to Follow-up|3
5262829|NCT00674661|18156688|P1|Overall Study|Lost to Follow-up|6
5262830|NCT00674661|18156687|P2|Overall Study|Other|7
5262831|NCT00674661|18156688|P1|Overall Study|Other|5
5262832|NCT00674570|18156786|P3|Overall Study|Withdrawal by Subject|0
5262833|NCT00674570|18156787|P2|Overall Study|Withdrawal by Subject|2
5262834|NCT00674570|18156788|P1|Overall Study|Withdrawal by Subject|0
5262835|NCT00674362|18156827|P2|Open Label|Other: Subject moved to extension study|0
5262836|NCT00674362|18156828|P1|Open Label|Other: Subject moved to extension study|1
5262837|NCT00674362|18156827|P2|Open Label|Adverse Event|0
5262838|NCT00674362|18156828|P1|Open Label|Adverse Event|1
5262839|NCT00674362|18156827|P2|Double Blind|Other: Surgery|1
5262840|NCT00674362|18156828|P1|Double Blind|Other: Surgery|0
5262841|NCT00674362|18156827|P2|Double Blind|Other: Loss of Patient Compliance|1
5262842|NCT00674362|18156828|P1|Double Blind|Other: Loss of Patient Compliance|0
5262843|NCT00674362|18156827|P2|Double Blind|Withdrawal by Subject|3
5262844|NCT00674362|18156828|P1|Double Blind|Withdrawal by Subject|4
5262845|NCT00674362|18156827|P2|Double Blind|Loss of efficacy|1
5262846|NCT00674362|18156828|P1|Double Blind|Loss of efficacy|0
5262847|NCT00674362|18156827|P2|Double Blind|Lack of Efficacy|6
5262848|NCT00674362|18156828|P1|Double Blind|Lack of Efficacy|2
5262849|NCT00674362|18156827|P2|Double Blind|Adverse Event|6
5262850|NCT00674362|18156828|P1|Double Blind|Adverse Event|6
5262851|NCT00674323|18156896|P3|Overall Study|Protocol Violation|0
5262852|NCT00674323|18156897|P2|Overall Study|Protocol Violation|0
5262853|NCT00674323|18156898|P1|Overall Study|Protocol Violation|1
5262854|NCT00674323|18156896|P3|Overall Study|Adverse Event|0
5262855|NCT00674323|18156897|P2|Overall Study|Adverse Event|1
5262856|NCT00674323|18156898|P1|Overall Study|Adverse Event|0
5262857|NCT00674154|18156949|P2|Overall Study|Did not want parathyroidectomy|2
5262858|NCT00674154|18156950|P1|Overall Study|Did not want parathyroidectomy|0
5262859|NCT00674154|18156949|P2|Overall Study|Withdrawal by Subject|1
5262860|NCT00674154|18156950|P1|Overall Study|Withdrawal by Subject|3
5262861|NCT00674128|18156958|P2|Overall Study|Withdrawal by Subject|23
5262862|NCT00674128|18156959|P1|Overall Study|Withdrawal by Subject|25
5262863|NCT00673933|18156984|P1|Overall Study|Lost to Follow-up|1
5262864|NCT00673933|18156984|P1|Overall Study|Withdrawal by Subject|2
5262865|NCT00673894|18157002|P2|First Intervention 4 Weeks|Adverse Event|0
5262866|NCT00673894|18157003|P1|First Intervention 4 Weeks|Adverse Event|1
5262867|NCT00673894|18157002|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
5262868|NCT00673894|18157003|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
5262869|NCT00673881|18157011|P1|Overall Study|Withdrawal by Subject|1
5262870|NCT00673816|18157025|P1|Overall Study|Withdrawal by Subject|1
5262871|NCT00673816|18157025|P1|Overall Study|Adverse Event|1
5262872|NCT00673790|18157035|P3|Overall Study|Randomization criteria not met|0
5262873|NCT00673790|18157036|P2|Overall Study|Randomization criteria not met|1
5262874|NCT00673790|18157037|P1|Overall Study|Randomization criteria not met|0
5262875|NCT00673790|18157035|P3|Overall Study|Unconfirmed pregnancy|0
5262876|NCT00673790|18157036|P2|Overall Study|Unconfirmed pregnancy|1
5262877|NCT00673790|18157037|P1|Overall Study|Unconfirmed pregnancy|0
5262878|NCT00673790|18157035|P3|Overall Study|Participated in two Nebivolol studies|1
5262879|NCT00673790|18157036|P2|Overall Study|Participated in two Nebivolol studies|0
5262880|NCT00673790|18157037|P1|Overall Study|Participated in two Nebivolol studies|0
5262881|NCT00673790|18157035|P3|Overall Study|Poor compliance|0
5262882|NCT00673790|18157036|P2|Overall Study|Poor compliance|0
5262883|NCT00673790|18157037|P1|Overall Study|Poor compliance|1
5262884|NCT00673790|18157035|P3|Overall Study|Sponsor Terminated due to PI oversight|0
5262885|NCT00673790|18157036|P2|Overall Study|Sponsor Terminated due to PI oversight|1
5262886|NCT00673790|18157037|P1|Overall Study|Sponsor Terminated due to PI oversight|0
5262887|NCT00673790|18157035|P3|Overall Study|Lost to Follow-up|5
5262888|NCT00673790|18157036|P2|Overall Study|Lost to Follow-up|6
5262889|NCT00673790|18157037|P1|Overall Study|Lost to Follow-up|6
5262890|NCT00673790|18157035|P3|Overall Study|Withdrawal by Subject|1
5262891|NCT00673790|18157036|P2|Overall Study|Withdrawal by Subject|4
5262892|NCT00673790|18157037|P1|Overall Study|Withdrawal by Subject|7
5262893|NCT00673790|18157035|P3|Overall Study|Protocol Violation|1
5262894|NCT00673790|18157036|P2|Overall Study|Protocol Violation|9
5262895|NCT00673790|18157037|P1|Overall Study|Protocol Violation|6
5262896|NCT00673790|18157035|P3|Overall Study|Lack of Efficacy|2
5262897|NCT00673790|18157036|P2|Overall Study|Lack of Efficacy|2
5262898|NCT00673790|18157037|P1|Overall Study|Lack of Efficacy|2
5262899|NCT00673790|18157035|P3|Overall Study|Adverse Event|2
5262900|NCT00673790|18157036|P2|Overall Study|Adverse Event|14
5262901|NCT00673790|18157037|P1|Overall Study|Adverse Event|23
5262902|NCT00673673|18157075|P1|Overall Study|Investigators' discretion|2
5262903|NCT00673673|18157075|P1|Overall Study|Withdrawal by Subject|3
5262904|NCT00673673|18157075|P1|Overall Study|Adverse Event|4
5262905|NCT00673673|18157075|P1|Overall Study|Progressive disease|27
5262906|NCT00673660|18157081|P1|Overall Study|Lost to Follow-up|107
5262907|NCT00673465|18157103|P12|Part 1/Period 2 (United States)|Protocol Violation|0
5262908|NCT00673465|18157104|P11|Part 1/Period 2 (United States)|Protocol Violation|0
5262909|NCT00673465|18157105|P10|Part 1/Period 2 (United States)|Protocol Violation|0
5262910|NCT00673465|18157106|P9|Part 1/Period 2 (United States)|Protocol Violation|0
5262911|NCT00673465|18157107|P8|Part 1/Period 2 (United States)|Protocol Violation|0
5262912|NCT00673465|18157108|P7|Part 1/Period 2 (United States)|Protocol Violation|0
5262913|NCT00673465|18157109|P6|Part 1/Period 2 (United States)|Protocol Violation|0
5262914|NCT00673465|18157110|P5|Part 1/Period 2 (United States)|Protocol Violation|1
5262915|NCT00673465|18157111|P4|Part 1/Period 2 (United States)|Protocol Violation|0
5262916|NCT00673465|18157112|P3|Part 1/Period 2 (United States)|Protocol Violation|0
5262917|NCT00673465|18157113|P2|Part 1/Period 2 (United States)|Protocol Violation|0
5262918|NCT00673465|18157114|P1|Part 1/Period 2 (United States)|Protocol Violation|0
5262919|NCT00673465|18157103|P12|Part 1/Period 1 (United States)|Protocol Violation|0
5262920|NCT00673465|18157104|P11|Part 1/Period 1 (United States)|Protocol Violation|0
5262921|NCT00673465|18157105|P10|Part 1/Period 1 (United States)|Protocol Violation|0
5262922|NCT00673465|18157106|P9|Part 1/Period 1 (United States)|Protocol Violation|0
5262923|NCT00673465|18157107|P8|Part 1/Period 1 (United States)|Protocol Violation|0
5262924|NCT00673465|18157108|P7|Part 1/Period 1 (United States)|Protocol Violation|0
5262925|NCT00673465|18157109|P6|Part 1/Period 1 (United States)|Protocol Violation|1
5262926|NCT00673465|18157110|P5|Part 1/Period 1 (United States)|Protocol Violation|1
5262927|NCT00673465|18157111|P4|Part 1/Period 1 (United States)|Protocol Violation|0
5262928|NCT00673465|18157112|P3|Part 1/Period 1 (United States)|Protocol Violation|0
5262929|NCT00673465|18157113|P2|Part 1/Period 1 (United States)|Protocol Violation|0
5262930|NCT00673465|18157114|P1|Part 1/Period 1 (United States)|Protocol Violation|0
5262931|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
5262932|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
5262933|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Physician Decision|0
5262934|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Physician Decision|2
5262935|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Sponsor Decision|3
5262936|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Sponsor Decision|0
5262937|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Protocol Violation|3
5262938|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Protocol Violation|2
5262939|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
5262940|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
5262941|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
5262942|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
5262943|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
5262944|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
5262945|NCT00673452|18157163|P2|Continuation Double-Blind Phase|Adverse Event|13
5262946|NCT00673452|18157164|P1|Continuation Double-Blind Phase|Adverse Event|5
5262947|NCT00673452|18157163|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
5262948|NCT00673452|18157164|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
5262949|NCT00673452|18157163|P2|Acute Double-Blind Phase|Sponsor Decision|1
5262950|NCT00673452|18157164|P1|Acute Double-Blind Phase|Sponsor Decision|0
5262951|NCT00673452|18157163|P2|Acute Double-Blind Phase|Protocol Violation|3
5262952|NCT00673452|18157164|P1|Acute Double-Blind Phase|Protocol Violation|5
5262953|NCT00673452|18157163|P2|Acute Double-Blind Phase|Physician Decision|6
5262954|NCT00673452|18157164|P1|Acute Double-Blind Phase|Physician Decision|0
5262955|NCT00673452|18157163|P2|Acute Double-Blind Phase|Lost to Follow-up|19
5262956|NCT00673452|18157164|P1|Acute Double-Blind Phase|Lost to Follow-up|16
5262957|NCT00673452|18157163|P2|Acute Double-Blind Phase|Lack of Efficacy|14
5262958|NCT00673452|18157164|P1|Acute Double-Blind Phase|Lack of Efficacy|9
5262959|NCT00673452|18157163|P2|Acute Double-Blind Phase|Adverse Event|24
5262960|NCT00673452|18157164|P1|Acute Double-Blind Phase|Adverse Event|41
5262961|NCT00673387|18157228|P8|Overall Study|Lost to Follow-up|5
5262962|NCT00673387|18157229|P7|Overall Study|Lost to Follow-up|8
5262963|NCT00673387|18157230|P6|Overall Study|Lost to Follow-up|5
5262964|NCT00673387|18157231|P5|Overall Study|Lost to Follow-up|6
5262965|NCT00673387|18157232|P4|Overall Study|Lost to Follow-up|6
5262966|NCT00673387|18157233|P3|Overall Study|Lost to Follow-up|5
5262967|NCT00673387|18157234|P2|Overall Study|Lost to Follow-up|6
5262968|NCT00673387|18157235|P1|Overall Study|Lost to Follow-up|8
5262969|NCT00673387|18157228|P8|Overall Study|Protocol Violation|3
5262970|NCT00673387|18157229|P7|Overall Study|Protocol Violation|1
5262971|NCT00673387|18157230|P6|Overall Study|Protocol Violation|1
5262972|NCT00673387|18157231|P5|Overall Study|Protocol Violation|0
5262973|NCT00673387|18157232|P4|Overall Study|Protocol Violation|2
5262974|NCT00673387|18157233|P3|Overall Study|Protocol Violation|1
5262975|NCT00673387|18157234|P2|Overall Study|Protocol Violation|0
5262976|NCT00673387|18157235|P1|Overall Study|Protocol Violation|3
5262977|NCT00673387|18157228|P8|Overall Study|Physician Decision|1
5262978|NCT00673387|18157229|P7|Overall Study|Physician Decision|1
5262979|NCT00673387|18157230|P6|Overall Study|Physician Decision|5
5262980|NCT00673387|18157231|P5|Overall Study|Physician Decision|0
5262981|NCT00673387|18157232|P4|Overall Study|Physician Decision|0
5262982|NCT00673387|18157233|P3|Overall Study|Physician Decision|0
5262983|NCT00673387|18157234|P2|Overall Study|Physician Decision|0
5262984|NCT00673387|18157235|P1|Overall Study|Physician Decision|0
5262985|NCT00673387|18157228|P8|Overall Study|Adverse Event|5
5262986|NCT00673387|18157229|P7|Overall Study|Adverse Event|5
5262987|NCT00673387|18157230|P6|Overall Study|Adverse Event|2
5262988|NCT00673387|18157231|P5|Overall Study|Adverse Event|6
5262989|NCT00673387|18157232|P4|Overall Study|Adverse Event|2
5262990|NCT00673387|18157233|P3|Overall Study|Adverse Event|5
5262991|NCT00673387|18157234|P2|Overall Study|Adverse Event|1
5262992|NCT00673387|18157235|P1|Overall Study|Adverse Event|3
5262993|NCT00673387|18157228|P8|Overall Study|Withdrawal by Subject|21
5262994|NCT00673387|18157229|P7|Overall Study|Withdrawal by Subject|15
5262995|NCT00673387|18157230|P6|Overall Study|Withdrawal by Subject|21
5262996|NCT00673387|18157231|P5|Overall Study|Withdrawal by Subject|18
5262997|NCT00673387|18157232|P4|Overall Study|Withdrawal by Subject|16
5262998|NCT00673387|18157233|P3|Overall Study|Withdrawal by Subject|20
5262999|NCT00673387|18157234|P2|Overall Study|Withdrawal by Subject|16
5263000|NCT00673387|18157235|P1|Overall Study|Withdrawal by Subject|15
5263001|NCT00673361|18157451|P1|Overall Study|Screen Failure|2
5263002|NCT00673257|18157487|P1|Overall Study|Unable to obtain specimen|1
5263003|NCT00673257|18157487|P1|Overall Study|Withdrawal by Subject|4
5263004|NCT00673231|18157496|P4|Overall Study|Study criteria,compliance,safety, other|4
5263005|NCT00673231|18157497|P3|Overall Study|Study criteria,compliance,safety, other|7
5263006|NCT00673231|18157498|P2|Overall Study|Study criteria,compliance,safety, other|5
5263007|NCT00673231|18157499|P1|Overall Study|Study criteria,compliance,safety, other|8
5263008|NCT00673231|18157496|P4|Overall Study|Death|0
5263009|NCT00673231|18157497|P3|Overall Study|Death|1
5263010|NCT00673231|18157498|P2|Overall Study|Death|0
5263011|NCT00673231|18157499|P1|Overall Study|Death|0
5263012|NCT00673231|18157496|P4|Overall Study|Lost to Follow-up|2
5263013|NCT00673231|18157497|P3|Overall Study|Lost to Follow-up|1
5263014|NCT00673231|18157498|P2|Overall Study|Lost to Follow-up|2
5263015|NCT00673231|18157499|P1|Overall Study|Lost to Follow-up|1
5263016|NCT00673231|18157496|P4|Overall Study|Adverse Event|6
5263017|NCT00673231|18157497|P3|Overall Study|Adverse Event|9
5263018|NCT00673231|18157498|P2|Overall Study|Adverse Event|5
5263019|NCT00673231|18157499|P1|Overall Study|Adverse Event|6
5263020|NCT00673231|18157496|P4|Overall Study|Withdrawal by Subject|6
5263021|NCT00673231|18157497|P3|Overall Study|Withdrawal by Subject|8
5263022|NCT00673231|18157498|P2|Overall Study|Withdrawal by Subject|10
5263023|NCT00673231|18157499|P1|Overall Study|Withdrawal by Subject|14
5263024|NCT00673179|18157531|P2|Overall Study|Toxicity/Complications|0
5263025|NCT00673179|18157532|P1|Overall Study|Toxicity/Complications|3
5263026|NCT00673049|18157581|P4|After Progression on Erlotinib|study terminated by sponsor|4
5263027|NCT00673049|18157582|P3|After Progression on Erlotinib|study terminated by sponsor|0
5263028|NCT00673049|18157583|P2|After Progression on Erlotinib|study terminated by sponsor|0
5263029|NCT00673049|18157584|P1|After Progression on Erlotinib|study terminated by sponsor|0
5263030|NCT00673049|18157581|P4|After Progression on Erlotinib|Withdrawal by Subject|5
5263031|NCT00673049|18157582|P3|After Progression on Erlotinib|Withdrawal by Subject|0
5263032|NCT00673049|18157583|P2|After Progression on Erlotinib|Withdrawal by Subject|0
5263033|NCT00673049|18157584|P1|After Progression on Erlotinib|Withdrawal by Subject|0
5263034|NCT00673049|18157581|P4|After Progression on Erlotinib|Lost to Follow-up|3
5263035|NCT00673049|18157582|P3|After Progression on Erlotinib|Lost to Follow-up|0
5263036|NCT00673049|18157583|P2|After Progression on Erlotinib|Lost to Follow-up|0
5263037|NCT00673049|18157584|P1|After Progression on Erlotinib|Lost to Follow-up|0
5263038|NCT00673049|18157581|P4|After Progression on Erlotinib|Death|71
5263039|NCT00673049|18157582|P3|After Progression on Erlotinib|Death|0
5263040|NCT00673049|18157583|P2|After Progression on Erlotinib|Death|0
5263041|NCT00673049|18157584|P1|After Progression on Erlotinib|Death|0
5263042|NCT00673049|18157581|P4|Before Progression on Erlotinib|Switched to figitumumab|0
5263043|NCT00673049|18157582|P3|Before Progression on Erlotinib|Switched to figitumumab|0
5263044|NCT00673049|18157583|P2|Before Progression on Erlotinib|Switched to figitumumab|83
5263045|NCT00673049|18157584|P1|Before Progression on Erlotinib|Switched to figitumumab|0
5263046|NCT00673049|18157581|P4|Before Progression on Erlotinib|study terminated by sponsor|0
5263047|NCT00673049|18157582|P3|Before Progression on Erlotinib|study terminated by sponsor|0
5263048|NCT00673049|18157583|P2|Before Progression on Erlotinib|study terminated by sponsor|14
5263049|NCT00673049|18157584|P1|Before Progression on Erlotinib|study terminated by sponsor|18
5263050|NCT00673049|18157581|P4|Before Progression on Erlotinib|Other|0
5263051|NCT00673049|18157582|P3|Before Progression on Erlotinib|Other|0
5263052|NCT00673049|18157583|P2|Before Progression on Erlotinib|Other|2
5263053|NCT00673049|18157584|P1|Before Progression on Erlotinib|Other|1
5263054|NCT00673049|18157581|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
5263055|NCT00673049|18157582|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
5263056|NCT00673049|18157583|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
5263057|NCT00673049|18157584|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
5263058|NCT00673049|18157581|P4|Before Progression on Erlotinib|Lost to Follow-up|0
5263059|NCT00673049|18157582|P3|Before Progression on Erlotinib|Lost to Follow-up|0
5263060|NCT00673049|18157583|P2|Before Progression on Erlotinib|Lost to Follow-up|5
5263061|NCT00673049|18157584|P1|Before Progression on Erlotinib|Lost to Follow-up|9
5263062|NCT00673049|18157581|P4|Before Progression on Erlotinib|Death|0
5263063|NCT00673049|18157582|P3|Before Progression on Erlotinib|Death|1
5263064|NCT00673049|18157583|P2|Before Progression on Erlotinib|Death|167
5263065|NCT00673049|18157584|P1|Before Progression on Erlotinib|Death|235
5263066|NCT00673049|18157581|P4|Before Progression on Erlotinib|Randomized but not treated|0
5263067|NCT00673049|18157582|P3|Before Progression on Erlotinib|Randomized but not treated|0
5263068|NCT00673049|18157583|P2|Before Progression on Erlotinib|Randomized but not treated|1
5263069|NCT00673049|18157584|P1|Before Progression on Erlotinib|Randomized but not treated|3
5263070|NCT00672984|18157608|P3|Third Intervention|Adverse Event|1
5263071|NCT00672984|18157609|P2|Third Intervention|Adverse Event|0
5263072|NCT00672984|18157610|P1|Third Intervention|Adverse Event|1
5263073|NCT00672984|18157608|P3|Second Intervention|Protocol Violation|1
5263074|NCT00672984|18157609|P2|Second Intervention|Protocol Violation|1
5263075|NCT00672984|18157610|P1|Second Intervention|Protocol Violation|0
5263076|NCT00672984|18157608|P3|Second Intervention|Withdrawal by Subject|0
5263077|NCT00672984|18157609|P2|Second Intervention|Withdrawal by Subject|3
5263078|NCT00672984|18157610|P1|Second Intervention|Withdrawal by Subject|0
5263079|NCT00672984|18157608|P3|Second Intervention|Non-compliance with facility policies|0
5263080|NCT00672984|18157609|P2|Second Intervention|Non-compliance with facility policies|2
5263081|NCT00672984|18157610|P1|Second Intervention|Non-compliance with facility policies|0
5263082|NCT00672984|18157608|P3|First Intervention|Sponsor decision|0
5263083|NCT00672984|18157609|P2|First Intervention|Sponsor decision|0
5263084|NCT00672984|18157610|P1|First Intervention|Sponsor decision|3
5263085|NCT00672984|18157608|P3|First Intervention|Withdrawal by Subject|2
5263086|NCT00672984|18157609|P2|First Intervention|Withdrawal by Subject|2
5263087|NCT00672984|18157610|P1|First Intervention|Withdrawal by Subject|1
5263088|NCT00672984|18157608|P3|First Intervention|Adverse Event|0
5263089|NCT00672984|18157609|P2|First Intervention|Adverse Event|0
5263090|NCT00672984|18157610|P1|First Intervention|Adverse Event|5
5263091|NCT00672958|18157661|P2|Overall Study|Reason not specified|3
5263092|NCT00672958|18157662|P1|Overall Study|Reason not specified|0
5263093|NCT00672958|18157661|P2|Overall Study|Lost to Follow-up|17
5263094|NCT00672958|18157662|P1|Overall Study|Lost to Follow-up|22
5263095|NCT00672958|18157661|P2|Overall Study|Voluntary withdrawal|8
5263096|NCT00672958|18157662|P1|Overall Study|Voluntary withdrawal|12
5263097|NCT00672958|18157661|P2|Overall Study|Protocol deviations|5
5263098|NCT00672958|18157662|P1|Overall Study|Protocol deviations|11
5263099|NCT00672958|18157661|P2|Overall Study|Non-compliance with study drug|3
5263100|NCT00672958|18157662|P1|Overall Study|Non-compliance with study drug|2
5263101|NCT00672958|18157661|P2|Overall Study|Lack of Efficacy|11
5263102|NCT00672958|18157662|P1|Overall Study|Lack of Efficacy|6
5263103|NCT00672958|18157661|P2|Overall Study|Adverse Event|9
5263104|NCT00672958|18157662|P1|Overall Study|Adverse Event|11
5263105|NCT00672841|18157728|P2|Overall Study|Pregnancy|1
5263106|NCT00672841|18157729|P1|Overall Study|Pregnancy|0
5263107|NCT00672841|18157728|P2|Overall Study|Adverse Event|3
5263108|NCT00672841|18157729|P1|Overall Study|Adverse Event|0
5263109|NCT00672841|18157728|P2|Overall Study|Antifungal therapy, negative glucan|4
5263110|NCT00672841|18157729|P1|Overall Study|Antifungal therapy, negative glucan|0
5263111|NCT00672841|18157728|P2|Overall Study|icteric specimens|3
5263112|NCT00672841|18157729|P1|Overall Study|icteric specimens|0
5263113|NCT00672841|18157728|P2|Overall Study|Comfort care|4
5263114|NCT00672841|18157729|P1|Overall Study|Comfort care|1
5263115|NCT00672646|18157751|P3|Overall Study|Withdrawal by Subject|1
5263116|NCT00672646|18157752|P2|Overall Study|Withdrawal by Subject|0
5263117|NCT00672646|18157753|P1|Overall Study|Withdrawal by Subject|0
5263118|NCT00672646|18157751|P3|Overall Study|Lost to Follow-up|2
5263119|NCT00672646|18157752|P2|Overall Study|Lost to Follow-up|1
5263120|NCT00672646|18157753|P1|Overall Study|Lost to Follow-up|0
5263121|NCT00672633|18157778|P2|Overall Study|Withdrawal by Subject|1
5263122|NCT00672633|18157779|P1|Overall Study|Withdrawal by Subject|0
5263123|NCT00672620|18157793|P4|Overall Study|Reason not Specified|1
5263124|NCT00672620|18157794|P3|Overall Study|Reason not Specified|2
5263125|NCT00672620|18157795|P2|Overall Study|Reason not Specified|3
5263126|NCT00672620|18157796|P1|Overall Study|Reason not Specified|3
5263127|NCT00672620|18157793|P4|Overall Study|Lost to Follow-up|11
5263128|NCT00672620|18157794|P3|Overall Study|Lost to Follow-up|8
5263129|NCT00672620|18157795|P2|Overall Study|Lost to Follow-up|19
5263130|NCT00672620|18157796|P1|Overall Study|Lost to Follow-up|8
5263131|NCT00672620|18157793|P4|Overall Study|Withdrawal of Consent|6
5263132|NCT00672620|18157794|P3|Overall Study|Withdrawal of Consent|5
5263133|NCT00672620|18157795|P2|Overall Study|Withdrawal of Consent|12
5263134|NCT00672620|18157796|P1|Overall Study|Withdrawal of Consent|6
5263135|NCT00672620|18157793|P4|Overall Study|Protocol Deviations|5
5263136|NCT00672620|18157794|P3|Overall Study|Protocol Deviations|2
5263137|NCT00672620|18157795|P2|Overall Study|Protocol Deviations|7
5263138|NCT00672620|18157796|P1|Overall Study|Protocol Deviations|5
5263139|NCT00672620|18157793|P4|Overall Study|Noncompliance with Study Drug|2
5263140|NCT00672620|18157794|P3|Overall Study|Noncompliance with Study Drug|0
5263141|NCT00672620|18157795|P2|Overall Study|Noncompliance with Study Drug|4
5263142|NCT00672620|18157796|P1|Overall Study|Noncompliance with Study Drug|3
5263143|NCT00672620|18157793|P4|Overall Study|Lack of Efficacy|0
5263144|NCT00672620|18157794|P3|Overall Study|Lack of Efficacy|2
5263145|NCT00672620|18157795|P2|Overall Study|Lack of Efficacy|2
5263146|NCT00672620|18157796|P1|Overall Study|Lack of Efficacy|1
5263147|NCT00672620|18157793|P4|Overall Study|Adverse Event|17
5263148|NCT00672620|18157794|P3|Overall Study|Adverse Event|12
5263149|NCT00672620|18157795|P2|Overall Study|Adverse Event|7
5263150|NCT00672620|18157796|P1|Overall Study|Adverse Event|7
5263151|NCT00672555|18157861|P1|Overall Study|Did not want to answer questionnaire|2
5263152|NCT00672555|18157861|P1|Overall Study|Lost to Follow-up|4
5263153|NCT00672490|18157872|P2|Overall Study|No reason was provided|2
5263154|NCT00672490|18157873|P1|Overall Study|No reason was provided|6
5263155|NCT00672490|18157872|P2|Overall Study|Lost to Follow-up|5
5263156|NCT00672490|18157873|P1|Overall Study|Lost to Follow-up|1
5263157|NCT00672490|18157872|P2|Overall Study|Intolerance|2
5263158|NCT00672490|18157873|P1|Overall Study|Intolerance|0
5263159|NCT00672490|18157872|P2|Overall Study|Violation of Concomitant Medicine|0
5263160|NCT00672490|18157873|P1|Overall Study|Violation of Concomitant Medicine|1
5263161|NCT00672490|18157872|P2|Overall Study|Adverse Event|8
5263162|NCT00672490|18157873|P1|Overall Study|Adverse Event|5
5263163|NCT00672490|18157872|P2|Overall Study|Mismatch Include/Exclude Criteria|0
5263164|NCT00672490|18157873|P1|Overall Study|Mismatch Include/Exclude Criteria|1
5263165|NCT00672490|18157872|P2|Overall Study|Lack of Compliance|7
5263166|NCT00672490|18157873|P1|Overall Study|Lack of Compliance|2
5263167|NCT00672490|18157872|P2|Overall Study|Withdrawal by Subject|8
5263168|NCT00672490|18157873|P1|Overall Study|Withdrawal by Subject|8
5263169|NCT00672477|18157897|P2|Overall Study|no study drug for low GFR, health cond.|3
5263170|NCT00672477|18157898|P1|Overall Study|no study drug for low GFR, health cond.|1
5263171|NCT00672477|18157897|P2|Overall Study|Lack of Efficacy|1
5263172|NCT00672477|18157898|P1|Overall Study|Lack of Efficacy|1
5263173|NCT00672477|18157897|P2|Overall Study|Withdrawal by Subject|3
5263174|NCT00672477|18157898|P1|Overall Study|Withdrawal by Subject|5
5263175|NCT00672477|18157897|P2|Overall Study|Protocol Violation|1
5263176|NCT00672477|18157898|P1|Overall Study|Protocol Violation|1
5263177|NCT00672477|18157897|P2|Overall Study|Physician Decision|0
5263178|NCT00672477|18157898|P1|Overall Study|Physician Decision|2
5263179|NCT00672477|18157897|P2|Overall Study|Death|11
5263180|NCT00672477|18157898|P1|Overall Study|Death|7
5263181|NCT00672477|18157897|P2|Overall Study|Adverse Event|7
5263182|NCT00672477|18157898|P1|Overall Study|Adverse Event|10
5263183|NCT00672256|18157951|P1|Overall Study|PI dropped, bad data|44
5263184|NCT00672139|18157976|P2|Overall Study|hospice discharge, caregiver requests|2
5263185|NCT00672139|18157977|P1|Overall Study|hospice discharge, caregiver requests|3
5263186|NCT00672139|18157976|P2|Overall Study|Protocol Violation|1
5263187|NCT00672139|18157977|P1|Overall Study|Protocol Violation|1
5263188|NCT00672139|18157976|P2|Overall Study|Lack of Efficacy|1
5263189|NCT00672139|18157977|P1|Overall Study|Lack of Efficacy|4
5263190|NCT00672139|18157976|P2|Overall Study|Physician Decision|0
5263191|NCT00672139|18157977|P1|Overall Study|Physician Decision|2
5263192|NCT00672139|18157976|P2|Overall Study|Adverse Event|7
5263193|NCT00672139|18157977|P1|Overall Study|Adverse Event|4
5263194|NCT00672139|18157976|P2|Overall Study|Withdrawal by Subject|11
5263195|NCT00672139|18157977|P1|Overall Study|Withdrawal by Subject|2
5263196|NCT00672139|18157976|P2|Overall Study|Death|23
5263197|NCT00672139|18157977|P1|Overall Study|Death|14
5263198|NCT00671931|18158034|P5|Overall Study|Physician Decision|1
5263199|NCT00671931|18158035|P4|Overall Study|Physician Decision|2
5263200|NCT00671931|18158036|P3|Overall Study|Physician Decision|0
5263201|NCT00671931|18158037|P2|Overall Study|Physician Decision|0
5263202|NCT00671931|18158038|P1|Overall Study|Physician Decision|1
5263203|NCT00671879|18158058|P3|Overall Study|Withdrawal by Subject|6
5263204|NCT00671879|18158059|P2|Overall Study|Withdrawal by Subject|4
5263205|NCT00671879|18158060|P1|Overall Study|Withdrawal by Subject|0
5263206|NCT00671853|18158073|P2|Overall Study|Non-adherence with study procedures|4
5263207|NCT00671853|18158074|P1|Overall Study|Non-adherence with study procedures|1
5263208|NCT00671853|18158073|P2|Overall Study|Physician Decision|2
5263209|NCT00671853|18158074|P1|Overall Study|Physician Decision|0
5263210|NCT00671853|18158073|P2|Overall Study|Lost to Follow-up|8
5263211|NCT00671853|18158074|P1|Overall Study|Lost to Follow-up|8
5263212|NCT00671853|18158073|P2|Overall Study|Withdrawal by Subject|5
5263213|NCT00671853|18158074|P1|Overall Study|Withdrawal by Subject|1
5263214|NCT00671853|18158073|P2|Overall Study|Adverse Event|1
5263215|NCT00671853|18158074|P1|Overall Study|Adverse Event|7
5263216|NCT00671853|18158073|P2|Overall Study|Lack of Efficacy|7
5263217|NCT00671853|18158074|P1|Overall Study|Lack of Efficacy|3
5263218|NCT00671788|18158090|P1|Overall Study|Other|1
5263219|NCT00671788|18158090|P1|Overall Study|MD Decision|1
5263220|NCT00671788|18158090|P1|Overall Study|Ineligible|1
5263221|NCT00671788|18158090|P1|Overall Study|Refused further treatment|3
5263222|NCT00671788|18158090|P1|Overall Study|Adverse Event|8
5263223|NCT00671749|18158097|P1|Overall Study|Lost to Follow-up|1
5263224|NCT00671749|18158097|P1|Overall Study|Protocol Violation|1
5263225|NCT00671749|18158097|P1|Overall Study|Withdrawal by Subject|4
5263226|NCT00671749|18158097|P1|Overall Study|Adverse Event|2
5263227|NCT00671554|18158156|P1|Overall Study|Disease progression|3
5263228|NCT00671437|18158195|P1|Overall Study|Ineligible post-hoc|1
5263229|NCT00671437|18158195|P1|Overall Study|Adverse Event|3
5263230|NCT00671437|18158195|P1|Overall Study|Cutaneous SCC of head and neck|3
5263231|NCT00671437|18158195|P1|Overall Study|Progressive disease before C1 week 8|8
5263232|NCT00671060|18158229|P2|Overall Study|Physician Decision|1
5263233|NCT00671060|18158230|P1|Overall Study|Physician Decision|0
5263234|NCT00671060|18158229|P2|Overall Study|Protocol Violation|0
5263235|NCT00671060|18158230|P1|Overall Study|Protocol Violation|1
5263236|NCT00671034|18158239|P3|Overall Study|includes Alternative therapy, etc.|7
5263237|NCT00671034|18158240|P2|Overall Study|includes Alternative therapy, etc.|1
5263238|NCT00671034|18158241|P1|Overall Study|includes Alternative therapy, etc.|6
5263239|NCT00671034|18158239|P3|Overall Study|Refusal|5
5263240|NCT00671034|18158240|P2|Overall Study|Refusal|3
5263241|NCT00671034|18158241|P1|Overall Study|Refusal|5
5263242|NCT00671034|18158239|P3|Overall Study|VHR ALL feature|5
5263243|NCT00671034|18158240|P2|Overall Study|VHR ALL feature|3
5263244|NCT00671034|18158241|P1|Overall Study|VHR ALL feature|8
5263245|NCT00671034|18158239|P3|Overall Study|Physician Decision|5
5263246|NCT00671034|18158240|P2|Overall Study|Physician Decision|4
5263247|NCT00671034|18158241|P1|Overall Study|Physician Decision|12
5263248|NCT00671034|18158239|P3|Overall Study|Death|1
5263249|NCT00671034|18158240|P2|Overall Study|Death|2
5263250|NCT00671034|18158241|P1|Overall Study|Death|3
5263251|NCT00671034|18158239|P3|Overall Study|Adverse Event|1
5263252|NCT00671034|18158240|P2|Overall Study|Adverse Event|7
5263253|NCT00671034|18158241|P1|Overall Study|Adverse Event|5
5263254|NCT00670930|18158296|P2|Overall Study|Lost to Follow-up|0
5263255|NCT00670930|18158297|P1|Overall Study|Lost to Follow-up|1
5263256|NCT00670930|18158296|P2|Overall Study|Adminstrative Problem|1
5263257|NCT00670930|18158297|P1|Overall Study|Adminstrative Problem|0
5263258|NCT00670800|18158313|P2|Overall Study|2 controls were insulin resistant|2
5263259|NCT00670800|18158314|P1|Overall Study|2 controls were insulin resistant|0
5263260|NCT00670748|18158345|P4|Overall Study|Not off study|1
5263261|NCT00670748|18158346|P3|Overall Study|Not off study|1
5263262|NCT00670748|18158347|P2|Overall Study|Not off study|1
5263263|NCT00670748|18158348|P1|Overall Study|Not off study|2
5263264|NCT00670748|18158345|P4|Overall Study|Death during treatment|0
5263265|NCT00670748|18158346|P3|Overall Study|Death during treatment|1
5263266|NCT00670748|18158347|P2|Overall Study|Death during treatment|1
5263267|NCT00670748|18158348|P1|Overall Study|Death during treatment|1
5263268|NCT00670540|18158383|P1|Overall Study|missing information inclusion criteria|1
5263269|NCT00670540|18158383|P1|Overall Study|controls randomised for no follow up|2770
5263270|NCT00670540|18158383|P1|Overall Study|refused to participate|189
5263271|NCT00670540|18158383|P1|Overall Study|not living in France|348
5263272|NCT00670540|18158383|P1|Overall Study|ineligible|17
5263273|NCT00670488|18158403|P10|Overall Study|Withdrawal by Subject|0
5263274|NCT00670488|18158404|P9|Overall Study|Withdrawal by Subject|1
5263275|NCT00670488|18158405|P8|Overall Study|Withdrawal by Subject|0
5263276|NCT00670488|18158406|P7|Overall Study|Withdrawal by Subject|1
5263277|NCT00670488|18158407|P6|Overall Study|Withdrawal by Subject|0
5263278|NCT00670488|18158408|P5|Overall Study|Withdrawal by Subject|0
5263279|NCT00670488|18158409|P4|Overall Study|Withdrawal by Subject|1
5263280|NCT00670488|18158410|P3|Overall Study|Withdrawal by Subject|0
5263281|NCT00670488|18158411|P2|Overall Study|Withdrawal by Subject|1
5263282|NCT00670488|18158412|P1|Overall Study|Withdrawal by Subject|0
5263283|NCT00670488|18158403|P10|Overall Study|Progressive Disease|1
5263284|NCT00670488|18158404|P9|Overall Study|Progressive Disease|2
5263285|NCT00670488|18158405|P8|Overall Study|Progressive Disease|2
5263286|NCT00670488|18158406|P7|Overall Study|Progressive Disease|11
5263287|NCT00670488|18158407|P6|Overall Study|Progressive Disease|4
5263288|NCT00670488|18158408|P5|Overall Study|Progressive Disease|2
5263289|NCT00670488|18158409|P4|Overall Study|Progressive Disease|2
5263290|NCT00670488|18158410|P3|Overall Study|Progressive Disease|3
5263291|NCT00670488|18158411|P2|Overall Study|Progressive Disease|41
5263292|NCT00670488|18158412|P1|Overall Study|Progressive Disease|2
5263293|NCT00670488|18158403|P10|Overall Study|Physician Decision|0
5263294|NCT00670488|18158404|P9|Overall Study|Physician Decision|0
5263295|NCT00670488|18158405|P8|Overall Study|Physician Decision|0
5263296|NCT00670488|18158406|P7|Overall Study|Physician Decision|0
5263297|NCT00670488|18158407|P6|Overall Study|Physician Decision|0
5263298|NCT00670488|18158408|P5|Overall Study|Physician Decision|0
5263299|NCT00670488|18158409|P4|Overall Study|Physician Decision|1
5263300|NCT00670488|18158410|P3|Overall Study|Physician Decision|0
5263301|NCT00670488|18158411|P2|Overall Study|Physician Decision|9
5263302|NCT00670488|18158412|P1|Overall Study|Physician Decision|1
5263303|NCT00670488|18158403|P10|Overall Study|Adverse Event|1
5263304|NCT00670488|18158404|P9|Overall Study|Adverse Event|0
5263305|NCT00670488|18158405|P8|Overall Study|Adverse Event|1
5263306|NCT00670488|18158406|P7|Overall Study|Adverse Event|5
5263307|NCT00670488|18158407|P6|Overall Study|Adverse Event|1
5263308|NCT00670488|18158408|P5|Overall Study|Adverse Event|1
5263309|NCT00670488|18158409|P4|Overall Study|Adverse Event|3
5263310|NCT00670488|18158410|P3|Overall Study|Adverse Event|0
5263311|NCT00670488|18158411|P2|Overall Study|Adverse Event|7
5263312|NCT00670488|18158412|P1|Overall Study|Adverse Event|0
5263313|NCT00670449|18158599|P4|Overall Study|Abnormal Laboratory Value(s)|0
5263314|NCT00670449|18158600|P3|Overall Study|Abnormal Laboratory Value(s)|0
5263315|NCT00670449|18158601|P2|Overall Study|Abnormal Laboratory Value(s)|2
5263316|NCT00670449|18158602|P1|Overall Study|Abnormal Laboratory Value(s)|0
5263317|NCT00670449|18158599|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
5263318|NCT00670449|18158600|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
5263319|NCT00670449|18158601|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5263320|NCT00670449|18158602|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
5263321|NCT00670449|18158599|P4|Overall Study|Subject Withdrew Consent|1
5263322|NCT00670449|18158600|P3|Overall Study|Subject Withdrew Consent|0
5263323|NCT00670449|18158601|P2|Overall Study|Subject Withdrew Consent|2
5263324|NCT00670449|18158602|P1|Overall Study|Subject Withdrew Consent|0
5263325|NCT00670449|18158599|P4|Overall Study|Administrative Problems|1
5263326|NCT00670449|18158600|P3|Overall Study|Administrative Problems|0
5263327|NCT00670449|18158601|P2|Overall Study|Administrative Problems|2
5263328|NCT00670449|18158602|P1|Overall Study|Administrative Problems|0
5263329|NCT00670449|18158599|P4|Overall Study|Protocol Deviation|1
5263330|NCT00670449|18158600|P3|Overall Study|Protocol Deviation|0
5263331|NCT00670449|18158601|P2|Overall Study|Protocol Deviation|2
5263332|NCT00670449|18158602|P1|Overall Study|Protocol Deviation|1
5263333|NCT00670449|18158599|P4|Overall Study|Adverse Event|5
5263334|NCT00670449|18158600|P3|Overall Study|Adverse Event|8
5263335|NCT00670449|18158601|P2|Overall Study|Adverse Event|2
5263336|NCT00670449|18158602|P1|Overall Study|Adverse Event|6
5263337|NCT00670306|18158626|P1|Overall Study|incl/excl criterias did not meet|19
5263338|NCT00670306|18158626|P1|Overall Study|Lost to Follow-up|8
5263339|NCT00670306|18158626|P1|Overall Study|Physician Decision|1
5263340|NCT00670306|18158626|P1|Overall Study|Withdrawal by Subject|9
5263341|NCT00670306|18158626|P1|Overall Study|Lack of Efficacy|10
5263342|NCT00670306|18158626|P1|Overall Study|Adverse Event|8
5263343|NCT00670228|18158665|P2|Overall Study|Not meeting the selection criteria|0
5263344|NCT00670228|18158666|P1|Overall Study|Not meeting the selection criteria|2
5263345|NCT00670228|18158665|P2|Overall Study|Not treated|2
5263346|NCT00670228|18158666|P1|Overall Study|Not treated|2
5263347|NCT00670228|18158665|P2|Overall Study|Death or MACE|1
5263348|NCT00670228|18158666|P1|Overall Study|Death or MACE|0
5263349|NCT00670228|18158665|P2|Overall Study|Adverse Event|0
5263350|NCT00670228|18158666|P1|Overall Study|Adverse Event|1
5263351|NCT00670111|18158690|P3|Enrollment to One Month|Physician Decision|0
5263352|NCT00670111|18158691|P2|Enrollment to One Month|Physician Decision|0
5263353|NCT00670111|18158692|P1|Enrollment to One Month|Physician Decision|1
5263354|NCT00670111|18158690|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
5263355|NCT00670111|18158691|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
5263356|NCT00670111|18158692|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
5263357|NCT00670111|18158690|P3|Enrollment to One Month|Testing Failure|13
5263358|NCT00670111|18158691|P2|Enrollment to One Month|Testing Failure|0
5263359|NCT00670111|18158692|P1|Enrollment to One Month|Testing Failure|0
5263360|NCT00670046|18158702|P2|Overall Study|Withdrawal by Subject|1
5263361|NCT00670046|18158703|P1|Overall Study|Withdrawal by Subject|0
5263362|NCT00670046|18158702|P2|Overall Study|Lost to Follow-up|1
5263363|NCT00670046|18158703|P1|Overall Study|Lost to Follow-up|1
5263364|NCT00670007|18158717|P1|Overall Study|Withdrawal by Subject|4
5263365|NCT00670007|18158717|P1|Overall Study|Adverse Event|1
5263366|NCT00670007|18158717|P1|Overall Study|Adverse event, serious fatal|1
5263367|NCT00670007|18158717|P1|Overall Study|Travel/Vacation|1
5263368|NCT00670007|18158717|P1|Overall Study|Lung transplant|1
5263369|NCT00670007|18158717|P1|Overall Study|Drug abuse|1
5263370|NCT00669955|18158744|P2|Overall Study|not compliant with study drug/visit|3
5263371|NCT00669955|18158745|P1|Overall Study|not compliant with study drug/visit|2
5263372|NCT00669955|18158744|P2|Overall Study|Investigator Sponsor Judgement|1
5263373|NCT00669955|18158745|P1|Overall Study|Investigator Sponsor Judgement|0
5263374|NCT00669955|18158744|P2|Overall Study|Protocol Violation|7
5263375|NCT00669955|18158745|P1|Overall Study|Protocol Violation|2
5263376|NCT00669955|18158744|P2|Overall Study|Lost to Follow-up|7
5263377|NCT00669955|18158745|P1|Overall Study|Lost to Follow-up|5
5263378|NCT00669955|18158744|P2|Overall Study|Withdrawal by Subject|3
5263379|NCT00669955|18158745|P1|Overall Study|Withdrawal by Subject|2
5263380|NCT00669955|18158744|P2|Overall Study|Death|1
5263381|NCT00669955|18158745|P1|Overall Study|Death|0
5263382|NCT00669955|18158744|P2|Overall Study|Adverse Event|5
5263383|NCT00669955|18158745|P1|Overall Study|Adverse Event|3
5263384|NCT00669942|18158775|P12|Parts 2 and 3|Protocol Violation|0
5263385|NCT00669942|18158776|P11|Parts 2 and 3|Protocol Violation|0
5263386|NCT00669942|18158777|P10|Parts 2 and 3|Protocol Violation|0
5263387|NCT00669942|18158778|P9|Parts 2 and 3|Protocol Violation|0
5263388|NCT00669942|18158779|P8|Parts 2 and 3|Protocol Violation|0
5263389|NCT00669942|18158780|P7|Parts 2 and 3|Protocol Violation|0
5263390|NCT00669942|18158781|P6|Parts 2 and 3|Protocol Violation|1
5263391|NCT00669942|18158782|P5|Parts 2 and 3|Protocol Violation|0
5263392|NCT00669942|18158783|P4|Parts 2 and 3|Protocol Violation|0
5263393|NCT00669942|18158784|P3|Parts 2 and 3|Protocol Violation|0
5263394|NCT00669942|18158785|P2|Parts 2 and 3|Protocol Violation|0
5263395|NCT00669942|18158786|P1|Parts 2 and 3|Protocol Violation|0
5263396|NCT00669942|18158775|P12|Parts 2 and 3|Withdrawal by Subject|0
5263397|NCT00669942|18158776|P11|Parts 2 and 3|Withdrawal by Subject|0
5263398|NCT00669942|18158777|P10|Parts 2 and 3|Withdrawal by Subject|0
5263399|NCT00669942|18158778|P9|Parts 2 and 3|Withdrawal by Subject|2
5263400|NCT00669942|18158779|P8|Parts 2 and 3|Withdrawal by Subject|0
5263401|NCT00669942|18158780|P7|Parts 2 and 3|Withdrawal by Subject|0
5263402|NCT00669942|18158781|P6|Parts 2 and 3|Withdrawal by Subject|1
5263403|NCT00669942|18158782|P5|Parts 2 and 3|Withdrawal by Subject|0
5263404|NCT00669942|18158783|P4|Parts 2 and 3|Withdrawal by Subject|0
5263405|NCT00669942|18158784|P3|Parts 2 and 3|Withdrawal by Subject|0
5263406|NCT00669942|18158785|P2|Parts 2 and 3|Withdrawal by Subject|0
5263407|NCT00669942|18158786|P1|Parts 2 and 3|Withdrawal by Subject|0
5263408|NCT00669942|18158775|P12|Parts 2 and 3|Adverse Event|0
5263409|NCT00669942|18158776|P11|Parts 2 and 3|Adverse Event|0
5263410|NCT00669942|18158777|P10|Parts 2 and 3|Adverse Event|0
5263411|NCT00669942|18158778|P9|Parts 2 and 3|Adverse Event|1
5263412|NCT00669942|18158779|P8|Parts 2 and 3|Adverse Event|2
5263413|NCT00669942|18158780|P7|Parts 2 and 3|Adverse Event|0
5263414|NCT00669942|18158781|P6|Parts 2 and 3|Adverse Event|0
5263415|NCT00669942|18158782|P5|Parts 2 and 3|Adverse Event|0
5263416|NCT00669942|18158783|P4|Parts 2 and 3|Adverse Event|0
5263417|NCT00669942|18158784|P3|Parts 2 and 3|Adverse Event|0
5263418|NCT00669942|18158785|P2|Parts 2 and 3|Adverse Event|0
5263419|NCT00669942|18158786|P1|Parts 2 and 3|Adverse Event|0
5263420|NCT00669903|18158869|P4|Overall Study|Protocol Violation|0
5263421|NCT00669903|18158870|P3|Overall Study|Protocol Violation|0
5263422|NCT00669903|18158871|P2|Overall Study|Protocol Violation|1
5263423|NCT00669903|18158872|P1|Overall Study|Protocol Violation|0
5263424|NCT00669903|18158869|P4|Overall Study|Lost to Follow-up|1
5263425|NCT00669903|18158870|P3|Overall Study|Lost to Follow-up|0
5263426|NCT00669903|18158871|P2|Overall Study|Lost to Follow-up|1
5263427|NCT00669903|18158872|P1|Overall Study|Lost to Follow-up|1
5263428|NCT00669903|18158869|P4|Overall Study|Withdrawal by Subject|2
5263429|NCT00669903|18158870|P3|Overall Study|Withdrawal by Subject|2
5263430|NCT00669903|18158871|P2|Overall Study|Withdrawal by Subject|2
5263431|NCT00669903|18158872|P1|Overall Study|Withdrawal by Subject|0
5263432|NCT00669903|18158869|P4|Overall Study|Adverse Event|1
5263433|NCT00669903|18158870|P3|Overall Study|Adverse Event|3
5263434|NCT00669903|18158871|P2|Overall Study|Adverse Event|1
5263435|NCT00669903|18158872|P1|Overall Study|Adverse Event|0
5263436|NCT00669877|18158902|P1|Overall Study|Disease Progression/Death|4
5263437|NCT00669864|18158907|P1|Overall Study|Other|2
5263438|NCT00669864|18158907|P1|Overall Study|Withdrawal by Subject|3
5263439|NCT00669864|18158907|P1|Overall Study|Protocol Violation|2
5263440|NCT00669864|18158907|P1|Overall Study|Lost to Follow-up|2
5263441|NCT00669669|18158921|P1|Overall Study|To late to start treatment|1
5263442|NCT00669617|18158926|P5|Period 3|Lost to Follow-up|0
5263443|NCT00669617|18158927|P4|Period 3|Lost to Follow-up|0
5263444|NCT00669617|18158928|P3|Period 3|Lost to Follow-up|0
5263445|NCT00669617|18158929|P2|Period 3|Lost to Follow-up|0
5263446|NCT00669617|18158930|P1|Period 3|Lost to Follow-up|1
5263447|NCT00669617|18158926|P5|Period 1|Protocol Deviation|1
5263448|NCT00669617|18158927|P4|Period 1|Protocol Deviation|0
5263449|NCT00669617|18158928|P3|Period 1|Protocol Deviation|0
5263450|NCT00669617|18158929|P2|Period 1|Protocol Deviation|0
5263451|NCT00669617|18158930|P1|Period 1|Protocol Deviation|0
5263452|NCT00669617|18158926|P5|Period 1|Withdrawal by Subject|0
5263453|NCT00669617|18158927|P4|Period 1|Withdrawal by Subject|0
5263454|NCT00669617|18158928|P3|Period 1|Withdrawal by Subject|1
5263455|NCT00669617|18158929|P2|Period 1|Withdrawal by Subject|0
5263456|NCT00669617|18158930|P1|Period 1|Withdrawal by Subject|0
5263457|NCT00669396|18158978|P2|Overall Study|Lost to Follow-up|12
5263458|NCT00669396|18158979|P1|Overall Study|Lost to Follow-up|10
5263459|NCT00669331|18159006|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
5263460|NCT00669331|18159007|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
5263461|NCT00669331|18159006|P2|Blinded Treatment Period|Physician Decision|3
5263462|NCT00669331|18159007|P1|Blinded Treatment Period|Physician Decision|3
5263463|NCT00669331|18159006|P2|Blinded Treatment Period|Death|2
5263464|NCT00669331|18159007|P1|Blinded Treatment Period|Death|0
5263465|NCT00669331|18159006|P2|Blinded Treatment Period|Lost to Follow-up|2
5263466|NCT00669331|18159007|P1|Blinded Treatment Period|Lost to Follow-up|3
5263467|NCT00669331|18159006|P2|Blinded Treatment Period|Withdrawal by Subject|19
5263468|NCT00669331|18159007|P1|Blinded Treatment Period|Withdrawal by Subject|17
5263469|NCT00669331|18159006|P2|Blinded Treatment Period|Protocol Violation|1
5263470|NCT00669331|18159007|P1|Blinded Treatment Period|Protocol Violation|1
5263471|NCT00669331|18159006|P2|Blinded Treatment Period|Adverse Event|10
5263472|NCT00669331|18159007|P1|Blinded Treatment Period|Adverse Event|16
5263473|NCT00669331|18159006|P2|Randomisation to First Dose|Randomised in error|10
5263474|NCT00669331|18159007|P1|Randomisation to First Dose|Randomised in error|3
5263475|NCT00669331|18159006|P2|Randomisation to First Dose|Sponsor decision|1
5263476|NCT00669331|18159007|P1|Randomisation to First Dose|Sponsor decision|0
5263477|NCT00669331|18159006|P2|Randomisation to First Dose|Death|0
5263478|NCT00669331|18159007|P1|Randomisation to First Dose|Death|1
5263479|NCT00669331|18159006|P2|Randomisation to First Dose|Lost to Follow-up|0
5263480|NCT00669331|18159007|P1|Randomisation to First Dose|Lost to Follow-up|2
5263481|NCT00669331|18159006|P2|Randomisation to First Dose|Withdrawal by Subject|2
5263482|NCT00669331|18159007|P1|Randomisation to First Dose|Withdrawal by Subject|3
5263483|NCT00669331|18159006|P2|Randomisation to First Dose|Protocol Violation|0
5263484|NCT00669331|18159007|P1|Randomisation to First Dose|Protocol Violation|1
5263485|NCT00669331|18159006|P2|Randomisation to First Dose|Adverse Event|0
5263486|NCT00669331|18159007|P1|Randomisation to First Dose|Adverse Event|1
5263487|NCT00669318|18159049|P1|Overall Study|Withdrawal by Subject|2
5263488|NCT00669240|18159066|P1|Overall Study|Enrolled but no dosing record|1
5263489|NCT00669240|18159066|P1|Overall Study|Enrolled but not treated|15
5263490|NCT00669240|18159066|P1|Overall Study|Other|19
5263491|NCT00669240|18159066|P1|Overall Study|Adverse Event|21
5263492|NCT00669240|18159066|P1|Overall Study|Lost to Follow-up|34
5263493|NCT00669240|18159066|P1|Overall Study|Withdrawal by Subject|42
5263494|NCT00669240|18159066|P1|Overall Study|Lack of Efficacy|33
5263495|NCT00669162|18159115|P1|Overall Study|Withdrawal by Subject|1
5263496|NCT00669110|18159121|P2|Overall Study|Withdrawal by Subject|2
5263497|NCT00669110|18159122|P1|Overall Study|Withdrawal by Subject|0
5263498|NCT00669110|18159121|P2|Overall Study|Protocol Violation|5
5263499|NCT00669110|18159122|P1|Overall Study|Protocol Violation|0
5263500|NCT00669110|18159121|P2|Overall Study|Lost to Follow-up|0
5263501|NCT00669110|18159122|P1|Overall Study|Lost to Follow-up|1
5263502|NCT00669110|18159121|P2|Overall Study|Physician Decision|1
5263503|NCT00669110|18159122|P1|Overall Study|Physician Decision|0
5263504|NCT00669110|18159121|P2|Overall Study|Caregiver request|2
5263505|NCT00669110|18159122|P1|Overall Study|Caregiver request|3
5263506|NCT00669110|18159121|P2|Overall Study|Adverse Event|3
5263507|NCT00669110|18159122|P1|Overall Study|Adverse Event|4
5263508|NCT00669071|18159158|P1|Overall Study|Final visit 40 days out of window|1
5263509|NCT00669071|18159158|P1|Overall Study|Lost to Follow-up|3
5263510|NCT00669032|18159179|P2|Overall Study|No fulfilment of the selection criteria|5
5263511|NCT00669032|18159180|P1|Overall Study|No fulfilment of the selection criteria|5
5263512|NCT00669032|18159179|P2|Overall Study|Physician Decision|1
5263513|NCT00669032|18159180|P1|Overall Study|Physician Decision|1
5263514|NCT00669032|18159179|P2|Overall Study|Adverse Event|16
5263515|NCT00669032|18159180|P1|Overall Study|Adverse Event|12
5263516|NCT00669032|18159179|P2|Overall Study|Withdrawal by Subject|13
5263517|NCT00669032|18159180|P1|Overall Study|Withdrawal by Subject|12
5263518|NCT00669032|18159179|P2|Overall Study|Lack of Efficacy|19
5263519|NCT00669032|18159180|P1|Overall Study|Lack of Efficacy|8
5263520|NCT00669032|18159179|P2|Overall Study|Lost to Follow-up|5
5263521|NCT00669032|18159180|P1|Overall Study|Lost to Follow-up|6
5263522|NCT00668863|18159226|P1|Overall Study|Physician Decision|1
5263523|NCT00668863|18159226|P1|Overall Study|Subject's work scheduling problem|1
5263524|NCT00668863|18159226|P1|Overall Study|Surgery|1
5263525|NCT00668863|18159226|P1|Overall Study|Withdrawal by Subject|1
5263526|NCT00668863|18159226|P1|Overall Study|Global Deterioration of Health Status|4
5263527|NCT00668863|18159226|P1|Overall Study|Study Terminated by Sponsor|8
5263528|NCT00668863|18159226|P1|Overall Study|Adverse Event|13
5263529|NCT00668863|18159226|P1|Overall Study|Objective Progression or Relapse|42
5263530|NCT00668746|18159258|P2|Overall Study|Lost to Follow-up|1
5263531|NCT00668746|18159259|P1|Overall Study|Lost to Follow-up|2
5263532|NCT00668733|18159279|P2|Overall Study|Withdrawal by Subject|4
5263533|NCT00668733|18159280|P1|Overall Study|Withdrawal by Subject|0
5263534|NCT00668733|18159279|P2|Overall Study|Lost to Follow-up|3
5263535|NCT00668733|18159280|P1|Overall Study|Lost to Follow-up|2
5263536|NCT00668395|18159325|P3|Overall Study|Physician Decision|0
5263537|NCT00668395|18159326|P2|Overall Study|Physician Decision|1
5263538|NCT00668395|18159327|P1|Overall Study|Physician Decision|1
5263539|NCT00668395|18159325|P3|Overall Study|Adverse Event|0
5263540|NCT00668395|18159326|P2|Overall Study|Adverse Event|1
5263541|NCT00668395|18159327|P1|Overall Study|Adverse Event|1
5263542|NCT00668395|18159325|P3|Overall Study|Withdrawal by Subject|1
5263543|NCT00668395|18159326|P2|Overall Study|Withdrawal by Subject|4
5263544|NCT00668395|18159327|P1|Overall Study|Withdrawal by Subject|4
5263545|NCT00668317|18159339|P1|Overall Study|Adverse Event|2
5263546|NCT00668200|18159354|P1|Overall Study|Lost to Follow-up|1
5263547|NCT00668200|18159354|P1|Overall Study|Withdrawal by Subject|2
5263548|NCT00668148|18159360|P1|Overall Study|Withdrawal of Consent|2
5263549|NCT00668148|18159360|P1|Overall Study|Progressive Disease Before Treatment|2
5263550|NCT00668148|18159360|P1|Overall Study|Subject Non-compliance|1
5263551|NCT00668148|18159360|P1|Overall Study|Adverse Event|5
5263552|NCT00667992|18159399|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
5263553|NCT00667992|18159400|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
5263554|NCT00667992|18159399|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
5263555|NCT00667992|18159400|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
5263556|NCT00667992|18159399|P2|Wash-out|Withdrawal by Subject|0
5263557|NCT00667992|18159400|P1|Wash-out|Withdrawal by Subject|1
5263558|NCT00667992|18159399|P2|Wash-out|Failure to wash-out|2
5263559|NCT00667992|18159400|P1|Wash-out|Failure to wash-out|2
5263560|NCT00667992|18159399|P2|Wash-out|Not within one doubling dilution|3
5263561|NCT00667992|18159400|P1|Wash-out|Not within one doubling dilution|4
5263562|NCT00667992|18159399|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
5263563|NCT00667992|18159400|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
5263564|NCT00667992|18159399|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
5263565|NCT00667992|18159400|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
5263566|NCT00667992|18159399|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
5263567|NCT00667992|18159400|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
5263568|NCT00667992|18159399|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
5263569|NCT00667992|18159400|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
5263570|NCT00667992|18159399|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
5263571|NCT00667992|18159400|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
5263572|NCT00667992|18159399|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
5263573|NCT00667992|18159400|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
5263574|NCT00667992|18159399|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
5263575|NCT00667992|18159400|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
5263576|NCT00667992|18159399|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
5263577|NCT00667992|18159400|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
5263578|NCT00667875|18159457|P3|Overall Study|Withdrawal by Subject|7
5263579|NCT00667875|18159458|P2|Overall Study|Withdrawal by Subject|9
5263580|NCT00667875|18159459|P1|Overall Study|Withdrawal by Subject|10
5263581|NCT00667875|18159457|P3|Overall Study|Adverse Event|6
5263582|NCT00667875|18159458|P2|Overall Study|Adverse Event|2
5263583|NCT00667875|18159459|P1|Overall Study|Adverse Event|0
5263584|NCT00667810|18159493|P4|Overall Study|Other|0
5263585|NCT00667810|18159494|P3|Overall Study|Other|5
5263586|NCT00667810|18159495|P2|Overall Study|Other|6
5263587|NCT00667810|18159496|P1|Overall Study|Other|6
5263588|NCT00667810|18159493|P4|Overall Study|Vasogenic Edema Recurrence|0
5263589|NCT00667810|18159494|P3|Overall Study|Vasogenic Edema Recurrence|0
5263590|NCT00667810|18159495|P2|Overall Study|Vasogenic Edema Recurrence|3
5263591|NCT00667810|18159496|P1|Overall Study|Vasogenic Edema Recurrence|0
5263592|NCT00667810|18159493|P4|Overall Study|Loss of Caregiver|0
5263593|NCT00667810|18159494|P3|Overall Study|Loss of Caregiver|3
5263594|NCT00667810|18159495|P2|Overall Study|Loss of Caregiver|1
5263595|NCT00667810|18159496|P1|Overall Study|Loss of Caregiver|0
5263596|NCT00667810|18159493|P4|Overall Study|Failed to Return|0
5263597|NCT00667810|18159494|P3|Overall Study|Failed to Return|2
5263598|NCT00667810|18159495|P2|Overall Study|Failed to Return|0
5263599|NCT00667810|18159496|P1|Overall Study|Failed to Return|0
5263600|NCT00667810|18159493|P4|Overall Study|Discontinuation of Study by Sponsor|0
5263601|NCT00667810|18159494|P3|Overall Study|Discontinuation of Study by Sponsor|155
5263602|NCT00667810|18159495|P2|Overall Study|Discontinuation of Study by Sponsor|118
5263603|NCT00667810|18159496|P1|Overall Study|Discontinuation of Study by Sponsor|130
5263604|NCT00667810|18159493|P4|Overall Study|Withdrawal by Subject|1
5263605|NCT00667810|18159494|P3|Overall Study|Withdrawal by Subject|29
5263606|NCT00667810|18159495|P2|Overall Study|Withdrawal by Subject|20
5263607|NCT00667810|18159496|P1|Overall Study|Withdrawal by Subject|14
5263608|NCT00667810|18159493|P4|Overall Study|Protocol Violation|0
5263609|NCT00667810|18159494|P3|Overall Study|Protocol Violation|0
5263610|NCT00667810|18159495|P2|Overall Study|Protocol Violation|2
5263611|NCT00667810|18159496|P1|Overall Study|Protocol Violation|0
5263612|NCT00667810|18159493|P4|Overall Study|Physician Decision|0
5263613|NCT00667810|18159494|P3|Overall Study|Physician Decision|2
5263614|NCT00667810|18159495|P2|Overall Study|Physician Decision|1
5263615|NCT00667810|18159496|P1|Overall Study|Physician Decision|1
5263616|NCT00667810|18159493|P4|Overall Study|Lost to Follow-up|0
5263617|NCT00667810|18159494|P3|Overall Study|Lost to Follow-up|2
5263618|NCT00667810|18159495|P2|Overall Study|Lost to Follow-up|4
5263619|NCT00667810|18159496|P1|Overall Study|Lost to Follow-up|1
5263620|NCT00667810|18159493|P4|Overall Study|Lack of Efficacy|0
5263621|NCT00667810|18159494|P3|Overall Study|Lack of Efficacy|2
5263622|NCT00667810|18159495|P2|Overall Study|Lack of Efficacy|0
5263623|NCT00667810|18159496|P1|Overall Study|Lack of Efficacy|1
5263624|NCT00667810|18159493|P4|Overall Study|Death|0
5263625|NCT00667810|18159494|P3|Overall Study|Death|3
5263626|NCT00667810|18159495|P2|Overall Study|Death|1
5263627|NCT00667810|18159496|P1|Overall Study|Death|1
5263628|NCT00667810|18159493|P4|Overall Study|Adverse Event|1
5263629|NCT00667810|18159494|P3|Overall Study|Adverse Event|19
5263630|NCT00667810|18159495|P2|Overall Study|Adverse Event|14
5263631|NCT00667810|18159496|P1|Overall Study|Adverse Event|13
5263632|NCT00667732|18159572|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
5263633|NCT00667732|18159573|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
5263634|NCT00667732|18159574|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
5263635|NCT00667732|18159572|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
5263636|NCT00667732|18159573|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
5263637|NCT00667732|18159574|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
5263638|NCT00667732|18159572|P3|Run -In (8 Weeks)|Adverse Event|0
5263639|NCT00667732|18159573|P2|Run -In (8 Weeks)|Adverse Event|0
5263640|NCT00667732|18159574|P1|Run -In (8 Weeks)|Adverse Event|4
5263641|NCT00667602|18159610|P3|Overall Study|Protocol Violation|0
5263642|NCT00667602|18159611|P2|Overall Study|Protocol Violation|1
5263643|NCT00667602|18159612|P1|Overall Study|Protocol Violation|0
5263644|NCT00667602|18159610|P3|Overall Study|Administrative reason|2
5263645|NCT00667602|18159611|P2|Overall Study|Administrative reason|0
5263646|NCT00667602|18159612|P1|Overall Study|Administrative reason|0
5263647|NCT00667602|18159610|P3|Overall Study|Lost to Follow-up|6
5263648|NCT00667602|18159611|P2|Overall Study|Lost to Follow-up|5
5263649|NCT00667602|18159612|P1|Overall Study|Lost to Follow-up|4
5263650|NCT00667602|18159610|P3|Overall Study|Withdrawal by Subject|10
5263651|NCT00667602|18159611|P2|Overall Study|Withdrawal by Subject|9
5263652|NCT00667602|18159612|P1|Overall Study|Withdrawal by Subject|4
5263653|NCT00667576|18159680|P5|Overall Study|Missed Visit|0
5263654|NCT00667576|18159681|P4|Overall Study|Missed Visit|1
5263655|NCT00667576|18159682|P3|Overall Study|Missed Visit|0
5263656|NCT00667576|18159683|P2|Overall Study|Missed Visit|0
5263657|NCT00667576|18159684|P1|Overall Study|Missed Visit|0
5263658|NCT00667576|18159680|P5|Overall Study|Physician Decision|0
5263659|NCT00667576|18159681|P4|Overall Study|Physician Decision|1
5263660|NCT00667576|18159682|P3|Overall Study|Physician Decision|0
5263661|NCT00667576|18159683|P2|Overall Study|Physician Decision|0
5263662|NCT00667576|18159684|P1|Overall Study|Physician Decision|0
5263663|NCT00667576|18159680|P5|Overall Study|Protocol Violation|0
5263664|NCT00667576|18159681|P4|Overall Study|Protocol Violation|1
5263665|NCT00667576|18159682|P3|Overall Study|Protocol Violation|0
5263666|NCT00667576|18159683|P2|Overall Study|Protocol Violation|0
5263667|NCT00667576|18159684|P1|Overall Study|Protocol Violation|0
5263668|NCT00667576|18159680|P5|Overall Study|Lost to Follow-up|0
5263669|NCT00667576|18159681|P4|Overall Study|Lost to Follow-up|0
5263670|NCT00667576|18159682|P3|Overall Study|Lost to Follow-up|1
5263671|NCT00667576|18159683|P2|Overall Study|Lost to Follow-up|0
5263672|NCT00667576|18159684|P1|Overall Study|Lost to Follow-up|0
5263673|NCT00667576|18159680|P5|Overall Study|Adverse Event|0
5263674|NCT00667576|18159681|P4|Overall Study|Adverse Event|0
5263675|NCT00667576|18159682|P3|Overall Study|Adverse Event|0
5263676|NCT00667576|18159683|P2|Overall Study|Adverse Event|1
5263677|NCT00667576|18159684|P1|Overall Study|Adverse Event|1
5263678|NCT00667576|18159680|P5|Overall Study|Withdrawal by Subject|1
5263679|NCT00667576|18159681|P4|Overall Study|Withdrawal by Subject|1
5263680|NCT00667576|18159682|P3|Overall Study|Withdrawal by Subject|1
5263681|NCT00667576|18159683|P2|Overall Study|Withdrawal by Subject|0
5263682|NCT00667576|18159684|P1|Overall Study|Withdrawal by Subject|1
5263683|NCT00667563|18159731|P1|Overall Study|Protocol Violation|24
5263684|NCT00667459|18159751|P2|Overall Study|Lost to Follow-up|43
5263685|NCT00667459|18159752|P1|Overall Study|Lost to Follow-up|8
5263686|NCT00667459|18159751|P2|Overall Study|Death|2
5263687|NCT00667459|18159752|P1|Overall Study|Death|0
5263688|NCT00667446|18159794|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
5263689|NCT00667446|18159795|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
5263690|NCT00667446|18159794|P2|Treatment Period (36 Months)|Therapeutic Failure|1
5263691|NCT00667446|18159795|P1|Treatment Period (36 Months)|Therapeutic Failure|1
5263692|NCT00667446|18159794|P2|Treatment Period (36 Months)|Protocol Violation|1
5263693|NCT00667446|18159795|P1|Treatment Period (36 Months)|Protocol Violation|1
5263694|NCT00667446|18159794|P2|Treatment Period (36 Months)|Lost to Follow-up|0
5263695|NCT00667446|18159795|P1|Treatment Period (36 Months)|Lost to Follow-up|1
5263696|NCT00667446|18159794|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
5263697|NCT00667446|18159795|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
5263698|NCT00667446|18159794|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
5263699|NCT00667446|18159795|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
5263700|NCT00667446|18159794|P2|Treatment Period (36 Months)|Personal reasons|2
5263701|NCT00667446|18159795|P1|Treatment Period (36 Months)|Personal reasons|2
5263702|NCT00667446|18159794|P2|Treatment Period (36 Months)|Other|2
5263703|NCT00667446|18159795|P1|Treatment Period (36 Months)|Other|2
5263704|NCT00667446|18159794|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
5263705|NCT00667446|18159795|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
5263706|NCT00667420|18159817|P1|Overall Study|Withdrawal by Subject|2
5263707|NCT00667420|18159817|P1|Overall Study|Physician Decision|1
5263708|NCT00667420|18159817|P1|Overall Study|Lack of Efficacy|5
5263709|NCT00667420|18159817|P1|Overall Study|Adverse Event|2
5263710|NCT00667394|18159827|P2|Overall Study|Progressive disease|0
5263711|NCT00667394|18159828|P1|Overall Study|Progressive disease|1
5263712|NCT00667394|18159827|P2|Overall Study|Adverse Event|0
5263713|NCT00667394|18159828|P1|Overall Study|Adverse Event|3
5263714|NCT00667368|18159855|P2|Overall Study|Discontinued early|17
5263715|NCT00667368|18159856|P1|Overall Study|Discontinued early|24
5263716|NCT00667368|18159855|P2|Overall Study|Lost to Follow-up|155
5263717|NCT00667368|18159856|P1|Overall Study|Lost to Follow-up|176
5263718|NCT00667355|18159864|P1|Overall Study|Other reason was not specified|5
5263719|NCT00667355|18159864|P1|Overall Study|Lost to Follow-up|1
5263720|NCT00667355|18159864|P1|Overall Study|Adverse Event|5
5263721|NCT00667342|18159889|P3|Overall Study|Ineligible|1
5263722|NCT00667342|18159890|P2|Overall Study|Ineligible|0
5263723|NCT00667342|18159891|P1|Overall Study|Ineligible|0
5263724|NCT00667342|18159889|P3|Overall Study|Adverse Event|1
5263725|NCT00667342|18159890|P2|Overall Study|Adverse Event|0
5263726|NCT00667342|18159891|P1|Overall Study|Adverse Event|0
5263727|NCT00667342|18159889|P3|Overall Study|Relapse or tumor progression|7
5263728|NCT00667342|18159890|P2|Overall Study|Relapse or tumor progression|0
5263729|NCT00667342|18159891|P1|Overall Study|Relapse or tumor progression|9
5263730|NCT00667342|18159889|P3|Overall Study|Physician Decision|0
5263731|NCT00667342|18159890|P2|Overall Study|Physician Decision|0
5263732|NCT00667342|18159891|P1|Overall Study|Physician Decision|3
5263733|NCT00667342|18159889|P3|Overall Study|Withdrawal by Subject|0
5263734|NCT00667342|18159890|P2|Overall Study|Withdrawal by Subject|0
5263735|NCT00667342|18159891|P1|Overall Study|Withdrawal by Subject|1
5263736|NCT00667342|18159889|P3|Overall Study|Protocol Violation|0
5263737|NCT00667342|18159890|P2|Overall Study|Protocol Violation|0
5263738|NCT00667342|18159891|P1|Overall Study|Protocol Violation|1
5263739|NCT00667277|18159929|P1|Overall Study|Withdrawal by Subject|2
5263740|NCT00667251|18159936|P2|Overall Study|Symptomatic progression|2
5263741|NCT00667251|18159937|P1|Overall Study|Symptomatic progression|1
5263742|NCT00667251|18159936|P2|Overall Study|Intercurrent Illness|3
5263743|NCT00667251|18159937|P1|Overall Study|Intercurrent Illness|4
5263744|NCT00667251|18159936|P2|Overall Study|Other/missing|84
5263745|NCT00667251|18159937|P1|Overall Study|Other/missing|46
5263746|NCT00667251|18159936|P2|Overall Study|Withdrawal by Subject|2
5263747|NCT00667251|18159937|P1|Overall Study|Withdrawal by Subject|6
5263748|NCT00667251|18159936|P2|Overall Study|Adverse Event|4
5263749|NCT00667251|18159937|P1|Overall Study|Adverse Event|13
5263750|NCT00667225|18159963|P2|Overall Study|Lost to Follow-up|1
5263751|NCT00667225|18159964|P1|Overall Study|Lost to Follow-up|0
5263752|NCT00667225|18159963|P2|Overall Study|Subject had no more lesions to treat.|0
5263753|NCT00667225|18159964|P1|Overall Study|Subject had no more lesions to treat.|1
5263754|NCT00667095|18159985|P2|Overall Study|Withdrawal by Subject|1
5263755|NCT00667095|18159986|P1|Overall Study|Withdrawal by Subject|0
5263756|NCT00667017|18160002|P1|Overall Study|Withdrawal by Subject|1
5263757|NCT00666965|18160031|P4|Overall Study|Withdrawal by Subject|2
5263758|NCT00666965|18160032|P3|Overall Study|Withdrawal by Subject|0
5263759|NCT00666965|18160033|P2|Overall Study|Withdrawal by Subject|0
5263760|NCT00666965|18160034|P1|Overall Study|Withdrawal by Subject|0
5263761|NCT00666965|18160031|P4|Overall Study|Discontinuation criteria|2
5263762|NCT00666965|18160032|P3|Overall Study|Discontinuation criteria|1
5263763|NCT00666965|18160033|P2|Overall Study|Discontinuation criteria|1
5263764|NCT00666965|18160034|P1|Overall Study|Discontinuation criteria|2
5263765|NCT00666965|18160031|P4|Overall Study|Protocol Violation|2
5263766|NCT00666965|18160032|P3|Overall Study|Protocol Violation|0
5263767|NCT00666965|18160033|P2|Overall Study|Protocol Violation|0
5263768|NCT00666965|18160034|P1|Overall Study|Protocol Violation|0
5263769|NCT00666965|18160031|P4|Overall Study|Lack of Efficacy|0
5263770|NCT00666965|18160032|P3|Overall Study|Lack of Efficacy|0
5263771|NCT00666965|18160033|P2|Overall Study|Lack of Efficacy|1
5263772|NCT00666965|18160034|P1|Overall Study|Lack of Efficacy|1
5263773|NCT00666965|18160031|P4|Overall Study|Adverse Event|9
5263774|NCT00666965|18160032|P3|Overall Study|Adverse Event|1
5263775|NCT00666965|18160033|P2|Overall Study|Adverse Event|2
5263776|NCT00666965|18160034|P1|Overall Study|Adverse Event|0
5263777|NCT00666926|18160064|P16|Overall Study|Death|0
5263778|NCT00666926|18160065|P15|Overall Study|Death|0
5263779|NCT00666926|18160066|P14|Overall Study|Death|0
5263780|NCT00666926|18160067|P13|Overall Study|Death|0
5263781|NCT00666926|18160068|P12|Overall Study|Death|1
5263782|NCT00666926|18160069|P11|Overall Study|Death|0
5263783|NCT00666926|18160070|P10|Overall Study|Death|0
5263784|NCT00666926|18160071|P9|Overall Study|Death|0
5263785|NCT00666926|18160072|P8|Overall Study|Death|0
5263786|NCT00666926|18160073|P7|Overall Study|Death|0
5263787|NCT00666926|18160074|P6|Overall Study|Death|0
5263788|NCT00666926|18160075|P5|Overall Study|Death|0
5263789|NCT00666926|18160076|P4|Overall Study|Death|0
5263790|NCT00666926|18160077|P3|Overall Study|Death|0
5263791|NCT00666926|18160078|P2|Overall Study|Death|0
5263792|NCT00666926|18160079|P1|Overall Study|Death|0
5263793|NCT00666926|18160064|P16|Overall Study|Withdrawal by Subject|3
5263794|NCT00666926|18160065|P15|Overall Study|Withdrawal by Subject|3
5263795|NCT00666926|18160066|P14|Overall Study|Withdrawal by Subject|1
5263796|NCT00666926|18160067|P13|Overall Study|Withdrawal by Subject|0
5263797|NCT00666926|18160068|P12|Overall Study|Withdrawal by Subject|3
5263798|NCT00666926|18160069|P11|Overall Study|Withdrawal by Subject|0
5263799|NCT00666926|18160070|P10|Overall Study|Withdrawal by Subject|3
5263800|NCT00666926|18160071|P9|Overall Study|Withdrawal by Subject|0
5263801|NCT00666926|18160072|P8|Overall Study|Withdrawal by Subject|1
5263802|NCT00666926|18160073|P7|Overall Study|Withdrawal by Subject|0
5263803|NCT00666926|18160074|P6|Overall Study|Withdrawal by Subject|0
5263804|NCT00666926|18160075|P5|Overall Study|Withdrawal by Subject|0
5263805|NCT00666926|18160076|P4|Overall Study|Withdrawal by Subject|0
5263806|NCT00666926|18160077|P3|Overall Study|Withdrawal by Subject|0
5263807|NCT00666926|18160078|P2|Overall Study|Withdrawal by Subject|0
5263808|NCT00666926|18160079|P1|Overall Study|Withdrawal by Subject|0
5263809|NCT00666926|18160064|P16|Overall Study|Other|4
5263810|NCT00666926|18160065|P15|Overall Study|Other|4
5263811|NCT00666926|18160066|P14|Overall Study|Other|2
5263812|NCT00666926|18160067|P13|Overall Study|Other|3
5263813|NCT00666926|18160068|P12|Overall Study|Other|26
5263814|NCT00666926|18160069|P11|Overall Study|Other|3
5263815|NCT00666926|18160070|P10|Overall Study|Other|5
5263816|NCT00666926|18160071|P9|Overall Study|Other|3
5263817|NCT00666926|18160072|P8|Overall Study|Other|0
5263818|NCT00666926|18160073|P7|Overall Study|Other|4
5263819|NCT00666926|18160074|P6|Overall Study|Other|3
5263820|NCT00666926|18160075|P5|Overall Study|Other|3
5263821|NCT00666926|18160076|P4|Overall Study|Other|3
5263822|NCT00666926|18160077|P3|Overall Study|Other|3
5263823|NCT00666926|18160078|P2|Overall Study|Other|4
5263824|NCT00666926|18160079|P1|Overall Study|Other|2
5263825|NCT00666926|18160064|P16|Overall Study|Lost to Follow-up|0
5263826|NCT00666926|18160065|P15|Overall Study|Lost to Follow-up|0
5263827|NCT00666926|18160066|P14|Overall Study|Lost to Follow-up|0
5263828|NCT00666926|18160067|P13|Overall Study|Lost to Follow-up|0
5263829|NCT00666926|18160068|P12|Overall Study|Lost to Follow-up|0
5263830|NCT00666926|18160069|P11|Overall Study|Lost to Follow-up|0
5263831|NCT00666926|18160070|P10|Overall Study|Lost to Follow-up|0
5263832|NCT00666926|18160071|P9|Overall Study|Lost to Follow-up|0
5263833|NCT00666926|18160072|P8|Overall Study|Lost to Follow-up|0
5263834|NCT00666926|18160073|P7|Overall Study|Lost to Follow-up|0
5263835|NCT00666926|18160074|P6|Overall Study|Lost to Follow-up|0
5263836|NCT00666926|18160075|P5|Overall Study|Lost to Follow-up|0
5263837|NCT00666926|18160076|P4|Overall Study|Lost to Follow-up|1
5263838|NCT00666926|18160077|P3|Overall Study|Lost to Follow-up|0
5263839|NCT00666926|18160078|P2|Overall Study|Lost to Follow-up|0
5263840|NCT00666926|18160079|P1|Overall Study|Lost to Follow-up|0
5263841|NCT00666926|18160064|P16|Overall Study|Lack of Efficacy|0
5263842|NCT00666926|18160065|P15|Overall Study|Lack of Efficacy|0
5263843|NCT00666926|18160066|P14|Overall Study|Lack of Efficacy|0
5263844|NCT00666926|18160067|P13|Overall Study|Lack of Efficacy|0
5263845|NCT00666926|18160068|P12|Overall Study|Lack of Efficacy|1
5263846|NCT00666926|18160069|P11|Overall Study|Lack of Efficacy|0
5263847|NCT00666926|18160070|P10|Overall Study|Lack of Efficacy|0
5263848|NCT00666926|18160071|P9|Overall Study|Lack of Efficacy|0
5263849|NCT00666926|18160072|P8|Overall Study|Lack of Efficacy|0
5263850|NCT00666926|18160073|P7|Overall Study|Lack of Efficacy|0
5263851|NCT00666926|18160074|P6|Overall Study|Lack of Efficacy|1
5263852|NCT00666926|18160075|P5|Overall Study|Lack of Efficacy|0
5263853|NCT00666926|18160076|P4|Overall Study|Lack of Efficacy|0
5263854|NCT00666926|18160077|P3|Overall Study|Lack of Efficacy|0
5263855|NCT00666926|18160078|P2|Overall Study|Lack of Efficacy|0
5263856|NCT00666926|18160079|P1|Overall Study|Lack of Efficacy|0
5263857|NCT00666926|18160064|P16|Overall Study|Laboratory abnormality|1
5263858|NCT00666926|18160065|P15|Overall Study|Laboratory abnormality|0
5263859|NCT00666926|18160066|P14|Overall Study|Laboratory abnormality|0
5263860|NCT00666926|18160067|P13|Overall Study|Laboratory abnormality|0
5263861|NCT00666926|18160068|P12|Overall Study|Laboratory abnormality|0
5263862|NCT00666926|18160069|P11|Overall Study|Laboratory abnormality|1
5263863|NCT00666926|18160070|P10|Overall Study|Laboratory abnormality|0
5263864|NCT00666926|18160071|P9|Overall Study|Laboratory abnormality|0
5263865|NCT00666926|18160072|P8|Overall Study|Laboratory abnormality|0
5263866|NCT00666926|18160073|P7|Overall Study|Laboratory abnormality|0
5263867|NCT00666926|18160074|P6|Overall Study|Laboratory abnormality|0
5263868|NCT00666926|18160075|P5|Overall Study|Laboratory abnormality|0
5263869|NCT00666926|18160076|P4|Overall Study|Laboratory abnormality|0
5263870|NCT00666926|18160077|P3|Overall Study|Laboratory abnormality|0
5263871|NCT00666926|18160078|P2|Overall Study|Laboratory abnormality|0
5263872|NCT00666926|18160079|P1|Overall Study|Laboratory abnormality|0
5263873|NCT00666926|18160064|P16|Overall Study|Adverse Event|0
5263874|NCT00666926|18160065|P15|Overall Study|Adverse Event|0
5263875|NCT00666926|18160066|P14|Overall Study|Adverse Event|1
5263876|NCT00666926|18160067|P13|Overall Study|Adverse Event|0
5263877|NCT00666926|18160068|P12|Overall Study|Adverse Event|2
5263878|NCT00666926|18160069|P11|Overall Study|Adverse Event|2
5263879|NCT00666926|18160070|P10|Overall Study|Adverse Event|2
5263880|NCT00666926|18160071|P9|Overall Study|Adverse Event|0
5263881|NCT00666926|18160072|P8|Overall Study|Adverse Event|0
5263882|NCT00666926|18160073|P7|Overall Study|Adverse Event|0
5263883|NCT00666926|18160074|P6|Overall Study|Adverse Event|0
5263884|NCT00666926|18160075|P5|Overall Study|Adverse Event|0
5263885|NCT00666926|18160076|P4|Overall Study|Adverse Event|0
5263886|NCT00666926|18160077|P3|Overall Study|Adverse Event|0
5263887|NCT00666926|18160078|P2|Overall Study|Adverse Event|0
5263888|NCT00666926|18160079|P1|Overall Study|Adverse Event|0
5263889|NCT00666835|18160388|P2|Overall Study|Physician Decision|2
5263890|NCT00666835|18160389|P1|Overall Study|Physician Decision|1
5263891|NCT00666835|18160388|P2|Overall Study|Planned operation|0
5263892|NCT00666835|18160389|P1|Overall Study|Planned operation|2
5263893|NCT00666835|18160388|P2|Overall Study|Hemoglobulin concentration|3
5263894|NCT00666835|18160389|P1|Overall Study|Hemoglobulin concentration|4
5263895|NCT00666835|18160388|P2|Overall Study|Kidney Transplantation (NTX)|2
5263896|NCT00666835|18160389|P1|Overall Study|Kidney Transplantation (NTX)|10
5263897|NCT00666835|18160388|P2|Overall Study|Death|4
5263898|NCT00666835|18160389|P1|Overall Study|Death|15
5263899|NCT00666835|18160388|P2|Overall Study|Protocol Violation|0
5263900|NCT00666835|18160389|P1|Overall Study|Protocol Violation|2
5263901|NCT00666835|18160388|P2|Overall Study|Adverse Event|6
5263902|NCT00666835|18160389|P1|Overall Study|Adverse Event|7
5263903|NCT00666835|18160388|P2|Overall Study|Incl./excl. not fulfilled|2
5263904|NCT00666835|18160389|P1|Overall Study|Incl./excl. not fulfilled|7
5263905|NCT00666835|18160388|P2|Overall Study|Lack of Efficacy|1
5263906|NCT00666835|18160389|P1|Overall Study|Lack of Efficacy|0
5263907|NCT00666835|18160388|P2|Overall Study|Withdrawal by Subject|2
5263908|NCT00666835|18160389|P1|Overall Study|Withdrawal by Subject|5
5263909|NCT00666757|18160399|P2|Overall Study|Sponsor decision|1
5263910|NCT00666757|18160400|P1|Overall Study|Sponsor decision|0
5263911|NCT00666757|18160399|P2|Overall Study|Physician Decision|2
5263912|NCT00666757|18160400|P1|Overall Study|Physician Decision|0
5263913|NCT00666757|18160399|P2|Overall Study|Lack of Efficacy|6
5263914|NCT00666757|18160400|P1|Overall Study|Lack of Efficacy|3
5263915|NCT00666757|18160399|P2|Overall Study|Withdrawal by Subject|17
5263916|NCT00666757|18160400|P1|Overall Study|Withdrawal by Subject|13
5263917|NCT00666757|18160399|P2|Overall Study|Adverse Event|12
5263918|NCT00666757|18160400|P1|Overall Study|Adverse Event|22
5263919|NCT00666757|18160399|P2|Overall Study|Protocol Violation|24
5263920|NCT00666757|18160400|P1|Overall Study|Protocol Violation|23
5263921|NCT00666757|18160399|P2|Overall Study|Lost to Follow-up|35
5263922|NCT00666757|18160400|P1|Overall Study|Lost to Follow-up|39
5263923|NCT00666718|18160459|P2|Overall Study|Physician Decision|2
5263924|NCT00666718|18160460|P1|Overall Study|Physician Decision|0
5263925|NCT00666718|18160459|P2|Overall Study|Withdrawal by Subject|12
5263926|NCT00666718|18160460|P1|Overall Study|Withdrawal by Subject|7
5263927|NCT00666718|18160459|P2|Overall Study|Protocol Violation|3
5263928|NCT00666718|18160460|P1|Overall Study|Protocol Violation|1
5263929|NCT00666718|18160459|P2|Overall Study|Entry Criteria Not Met|0
5263930|NCT00666718|18160460|P1|Overall Study|Entry Criteria Not Met|2
5263931|NCT00666718|18160459|P2|Overall Study|Lost to Follow-up|0
5263932|NCT00666718|18160460|P1|Overall Study|Lost to Follow-up|1
5263933|NCT00666718|18160459|P2|Overall Study|Death|0
5263934|NCT00666718|18160460|P1|Overall Study|Death|1
5263935|NCT00666718|18160459|P2|Overall Study|Adverse Event|1
5263936|NCT00666718|18160460|P1|Overall Study|Adverse Event|0
5263937|NCT00666705|18160486|P1|Overall Study|Withdrawal by Subject|1
5263938|NCT00666679|18160505|P2|Second Intervention|Death|1
5263939|NCT00666679|18160506|P1|Second Intervention|Death|0
5263940|NCT00666679|18160505|P2|Second Intervention|Adverse Event|0
5263941|NCT00666679|18160506|P1|Second Intervention|Adverse Event|1
5263942|NCT00666679|18160505|P2|Washout Period of 1 Week|Protocol Violation|1
5263943|NCT00666679|18160506|P1|Washout Period of 1 Week|Protocol Violation|0
5263944|NCT00666679|18160505|P2|Washout Period of 1 Week|Lost to Follow-up|1
5263945|NCT00666679|18160506|P1|Washout Period of 1 Week|Lost to Follow-up|0
5263946|NCT00666679|18160505|P2|First Intervention|Randomized did not start treatment|1
5263947|NCT00666679|18160506|P1|First Intervention|Randomized did not start treatment|1
5263948|NCT00666679|18160505|P2|First Intervention|Withdrawal by Subject|0
5263949|NCT00666679|18160506|P1|First Intervention|Withdrawal by Subject|1
5263950|NCT00666679|18160505|P2|First Intervention|Protocol Violation|0
5263951|NCT00666679|18160506|P1|First Intervention|Protocol Violation|1
5263952|NCT00666679|18160505|P2|First Intervention|Lost to Follow-up|0
5263953|NCT00666679|18160506|P1|First Intervention|Lost to Follow-up|1
5263954|NCT00666588|18160536|P4|Overall Study|inevaluable|0
5263955|NCT00666588|18160537|P3|Overall Study|inevaluable|0
5263956|NCT00666588|18160538|P2|Overall Study|inevaluable|0
5263957|NCT00666588|18160539|P1|Overall Study|inevaluable|2
5263958|NCT00666588|18160536|P4|Overall Study|ineligible|2
5263959|NCT00666588|18160537|P3|Overall Study|ineligible|0
5263960|NCT00666588|18160538|P2|Overall Study|ineligible|0
5263961|NCT00666588|18160539|P1|Overall Study|ineligible|2
5263962|NCT00666562|18160572|P3|Overall Study|Concomitant Medication|0
5263963|NCT00666562|18160573|P2|Overall Study|Concomitant Medication|1
5263964|NCT00666562|18160574|P1|Overall Study|Concomitant Medication|0
5263965|NCT00666562|18160572|P3|Overall Study|Withdrawal by Subject|0
5263966|NCT00666562|18160573|P2|Overall Study|Withdrawal by Subject|1
5263967|NCT00666562|18160574|P1|Overall Study|Withdrawal by Subject|0
5263968|NCT00666536|18160621|P2|Overall Study|Lost to Follow-up|3
5263969|NCT00666536|18160622|P1|Overall Study|Lost to Follow-up|4
5263970|NCT00666536|18160621|P2|Overall Study|Withdrawal by Subject|9
5263971|NCT00666536|18160622|P1|Overall Study|Withdrawal by Subject|10
5263972|NCT00666536|18160621|P2|Overall Study|Protocol deviation(s)|6
5263973|NCT00666536|18160622|P1|Overall Study|Protocol deviation(s)|8
5263974|NCT00666536|18160621|P2|Overall Study|Unsatisfactory therapeutic effect|0
5263975|NCT00666536|18160622|P1|Overall Study|Unsatisfactory therapeutic effect|2
5263976|NCT00666536|18160621|P2|Overall Study|Adverse Event|19
5263977|NCT00666536|18160622|P1|Overall Study|Adverse Event|9
5263978|NCT00666458|18160640|P2|Overall Study|Medical history of anemia|0
5263979|NCT00666458|18160641|P1|Overall Study|Medical history of anemia|1
5263980|NCT00666458|18160640|P2|Overall Study|Safety reasons|0
5263981|NCT00666458|18160641|P1|Overall Study|Safety reasons|1
5263982|NCT00666458|18160640|P2|Overall Study|Severe non-compliance to the protocol|1
5263983|NCT00666458|18160641|P1|Overall Study|Severe non-compliance to the protocol|1
5263984|NCT00666458|18160640|P2|Overall Study|Study specific discontinuation criteria|7
5263985|NCT00666458|18160641|P1|Overall Study|Study specific discontinuation criteria|14
5263986|NCT00666458|18160640|P2|Overall Study|Incorrect enrollment|1
5263987|NCT00666458|18160641|P1|Overall Study|Incorrect enrollment|7
5263988|NCT00666458|18160640|P2|Overall Study|Administrative reason by sponsor|1
5263989|NCT00666458|18160641|P1|Overall Study|Administrative reason by sponsor|1
5263990|NCT00666458|18160640|P2|Overall Study|Lost to Follow-up|3
5263991|NCT00666458|18160641|P1|Overall Study|Lost to Follow-up|0
5263992|NCT00666458|18160640|P2|Overall Study|Withdrawal by Subject|4
5263993|NCT00666458|18160641|P1|Overall Study|Withdrawal by Subject|5
5263994|NCT00666458|18160640|P2|Overall Study|Adverse Event|7
5263995|NCT00666458|18160641|P1|Overall Study|Adverse Event|8
5263996|NCT00666328|18160729|P1|Overall Study|No longer met eligibility criteria|1
5263997|NCT00666328|18160729|P1|Overall Study|Lost to Follow-up|2
5263998|NCT00666328|18160729|P1|Overall Study|Death|2
5263999|NCT00666276|18160742|P1|Overall Study|Protocol Violation|34
5264000|NCT00666263|18160766|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
5264001|NCT00666263|18160767|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
5264002|NCT00666263|18160766|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
5264003|NCT00666263|18160767|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
5264004|NCT00666263|18160766|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
5264005|NCT00666263|18160767|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
5264006|NCT00666224|18160911|P2|Open-Label|Undefined/Unknown|1
5264007|NCT00666224|18160912|P1|Open-Label|Undefined/Unknown|1
5264008|NCT00666224|18160911|P2|Open-Label|Noncompliance|1
5264009|NCT00666224|18160912|P1|Open-Label|Noncompliance|2
5264010|NCT00666224|18160911|P2|Open-Label|Pregnancy|5
5264011|NCT00666224|18160912|P1|Open-Label|Pregnancy|1
5264012|NCT00666224|18160911|P2|Open-Label|Physician Decision|5
5264013|NCT00666224|18160912|P1|Open-Label|Physician Decision|7
5264014|NCT00666224|18160911|P2|Open-Label|Withdrawal by Subject|25
5264015|NCT00666224|18160912|P1|Open-Label|Withdrawal by Subject|12
5264016|NCT00666224|18160911|P2|Open-Label|Lost to Follow-up|5
5264017|NCT00666224|18160912|P1|Open-Label|Lost to Follow-up|4
5264018|NCT00666224|18160911|P2|Open-Label|Adverse Event|43
5264019|NCT00666224|18160912|P1|Open-Label|Adverse Event|8
5264020|NCT00666224|18160911|P2|Double-Blind|Undefined/Unknown|1
5264021|NCT00666224|18160912|P1|Double-Blind|Undefined/Unknown|4
5264022|NCT00666224|18160911|P2|Double-Blind|Death|0
5264023|NCT00666224|18160912|P1|Double-Blind|Death|1
5264024|NCT00666224|18160911|P2|Double-Blind|Noncompliance|0
5264025|NCT00666224|18160912|P1|Double-Blind|Noncompliance|1
5264026|NCT00666224|18160911|P2|Double-Blind|Pregnancy|2
5264027|NCT00666224|18160912|P1|Double-Blind|Pregnancy|3
5264028|NCT00666224|18160911|P2|Double-Blind|Sponsor decision|0
5264029|NCT00666224|18160912|P1|Double-Blind|Sponsor decision|1
5264030|NCT00666224|18160911|P2|Double-Blind|Physician Decision|3
5264031|NCT00666224|18160912|P1|Double-Blind|Physician Decision|0
5264032|NCT00666224|18160911|P2|Double-Blind|Withdrawal by Subject|14
5264033|NCT00666224|18160912|P1|Double-Blind|Withdrawal by Subject|18
5264034|NCT00666224|18160911|P2|Double-Blind|Lost to Follow-up|2
5264035|NCT00666224|18160912|P1|Double-Blind|Lost to Follow-up|2
5264036|NCT00666224|18160911|P2|Double-Blind|Adverse Event|5
5264037|NCT00666224|18160912|P1|Double-Blind|Adverse Event|15
5264038|NCT00666211|18160931|P2|Overall Study|Physician Decision|1
5264039|NCT00666211|18160932|P1|Overall Study|Physician Decision|0
5264040|NCT00666211|18160931|P2|Overall Study|off tx for other complicating disease|1
5264041|NCT00666211|18160932|P1|Overall Study|off tx for other complicating disease|0
5264042|NCT00666211|18160931|P2|Overall Study|Death|2
5264043|NCT00666211|18160932|P1|Overall Study|Death|0
5264044|NCT00666211|18160931|P2|Overall Study|hospital admission|5
5264045|NCT00666211|18160932|P1|Overall Study|hospital admission|0
5264046|NCT00666211|18160931|P2|Overall Study|toxicity|2
5264047|NCT00666211|18160932|P1|Overall Study|toxicity|0
5264048|NCT00666211|18160931|P2|Overall Study|Lost to Follow-up|0
5264049|NCT00666211|18160932|P1|Overall Study|Lost to Follow-up|2
5264050|NCT00666211|18160931|P2|Overall Study|disease progression|8
5264051|NCT00666211|18160932|P1|Overall Study|disease progression|1
5264052|NCT00666211|18160931|P2|Overall Study|patient non-compliant|6
5264053|NCT00666211|18160932|P1|Overall Study|patient non-compliant|6
5264054|NCT00666211|18160931|P2|Overall Study|went off medication, no more pain|0
5264055|NCT00666211|18160932|P1|Overall Study|went off medication, no more pain|1
5264056|NCT00666211|18160931|P2|Overall Study|Withdrawal by Subject|13
5264057|NCT00666211|18160932|P1|Overall Study|Withdrawal by Subject|10
5264058|NCT00666198|18160950|P1|Overall Study|No Drug Administration|4
5264059|NCT00666198|18160950|P1|Overall Study|Safety Not Assessable|6
5264060|NCT00666198|18160950|P1|Overall Study|No Visit After First Day of Treatment|13
5264061|NCT00666198|18160950|P1|Overall Study|Protocol Violation|10
5264062|NCT00665925|18160978|P4|Overall Study|Due to exclusion criteria|0
5264063|NCT00665925|18160979|P3|Overall Study|Due to exclusion criteria|0
5264064|NCT00665925|18160980|P2|Overall Study|Due to exclusion criteria|0
5264065|NCT00665925|18160981|P1|Overall Study|Due to exclusion criteria|1
5264066|NCT00665925|18160978|P4|Overall Study|Enrolled by mistake|1
5264067|NCT00665925|18160979|P3|Overall Study|Enrolled by mistake|0
5264068|NCT00665925|18160980|P2|Overall Study|Enrolled by mistake|0
5264069|NCT00665925|18160981|P1|Overall Study|Enrolled by mistake|0
5264070|NCT00665925|18160978|P4|Overall Study|Adverse Event|5
5264071|NCT00665925|18160979|P3|Overall Study|Adverse Event|10
5264072|NCT00665925|18160980|P2|Overall Study|Adverse Event|5
5264073|NCT00665925|18160981|P1|Overall Study|Adverse Event|1
5264074|NCT00665925|18160978|P4|Overall Study|Severe Non-Compliance to Protocol|1
5264075|NCT00665925|18160979|P3|Overall Study|Severe Non-Compliance to Protocol|1
5264076|NCT00665925|18160980|P2|Overall Study|Severe Non-Compliance to Protocol|0
5264077|NCT00665925|18160981|P1|Overall Study|Severe Non-Compliance to Protocol|0
5264078|NCT00665925|18160978|P4|Overall Study|Physician Decision|2
5264079|NCT00665925|18160979|P3|Overall Study|Physician Decision|1
5264080|NCT00665925|18160980|P2|Overall Study|Physician Decision|0
5264081|NCT00665925|18160981|P1|Overall Study|Physician Decision|0
5264082|NCT00665925|18160978|P4|Overall Study|Withdrawal by Subject|2
5264083|NCT00665925|18160979|P3|Overall Study|Withdrawal by Subject|3
5264084|NCT00665925|18160980|P2|Overall Study|Withdrawal by Subject|2
5264085|NCT00665925|18160981|P1|Overall Study|Withdrawal by Subject|2
5264086|NCT00665925|18160978|P4|Overall Study|Lost to Follow-up|2
5264087|NCT00665925|18160979|P3|Overall Study|Lost to Follow-up|2
5264088|NCT00665925|18160980|P2|Overall Study|Lost to Follow-up|2
5264089|NCT00665925|18160981|P1|Overall Study|Lost to Follow-up|1
5264090|NCT00665925|18160978|P4|Overall Study|Lack of Efficacy|8
5264091|NCT00665925|18160979|P3|Overall Study|Lack of Efficacy|9
5264092|NCT00665925|18160980|P2|Overall Study|Lack of Efficacy|8
5264093|NCT00665925|18160981|P1|Overall Study|Lack of Efficacy|10
5264094|NCT00665847|18161392|P1|Overall Study|Switch to Commercial Medication|1
5264095|NCT00665847|18161392|P1|Overall Study|Subject ineligible to continue the trial|1
5264096|NCT00665847|18161392|P1|Overall Study|Resistance to TMC125|1
5264097|NCT00665847|18161392|P1|Overall Study|Subject reached a virologic endpoint|4
5264098|NCT00665847|18161392|P1|Overall Study|Subject non-compliant|8
5264099|NCT00665847|18161392|P1|Overall Study|Withdrawal by Subject|2
5264100|NCT00665847|18161392|P1|Overall Study|Adverse Event|8
5264101|NCT00665652|18161409|P1|Overall Study|No longer met inclusion criteria.|1
5264102|NCT00665652|18161409|P1|Overall Study|Death|1
5264103|NCT00665652|18161409|P1|Overall Study|Adverse Event|4
5264104|NCT00665626|18161415|P2|Overall Study|Death|0
5264105|NCT00665626|18161416|P1|Overall Study|Death|1
5264106|NCT00665626|18161415|P2|Overall Study|Unably to comply with dosing regimen|1
5264107|NCT00665626|18161416|P1|Overall Study|Unably to comply with dosing regimen|0
5264108|NCT00665626|18161415|P2|Overall Study|Did not fulfil inclusion criteria|1
5264109|NCT00665626|18161416|P1|Overall Study|Did not fulfil inclusion criteria|0
5264110|NCT00665626|18161415|P2|Overall Study|Due to exclusion criteria|1
5264111|NCT00665626|18161416|P1|Overall Study|Due to exclusion criteria|0
5264112|NCT00665626|18161415|P2|Overall Study|Adverse Event|9
5264113|NCT00665626|18161416|P1|Overall Study|Adverse Event|1
5264114|NCT00665626|18161415|P2|Overall Study|Protocol Violation|2
5264115|NCT00665626|18161416|P1|Overall Study|Protocol Violation|0
5264116|NCT00665626|18161415|P2|Overall Study|Withdrawal by Subject|1
5264117|NCT00665626|18161416|P1|Overall Study|Withdrawal by Subject|0
5264118|NCT00665626|18161415|P2|Overall Study|Lost to Follow-up|2
5264119|NCT00665626|18161416|P1|Overall Study|Lost to Follow-up|0
5264120|NCT00665626|18161415|P2|Overall Study|Lack of Efficacy|5
5264121|NCT00665626|18161416|P1|Overall Study|Lack of Efficacy|8
5264122|NCT00665561|18161484|P2|Overall Study|Withdrawn due to pregnancy|1
5264123|NCT00665561|18161485|P1|Overall Study|Withdrawn due to pregnancy|0
5264124|NCT00665561|18161484|P2|Overall Study|Site closed|0
5264125|NCT00665561|18161485|P1|Overall Study|Site closed|8
5264126|NCT00665561|18161484|P2|Overall Study|Other|108
5264127|NCT00665561|18161485|P1|Overall Study|Other|123
5264128|NCT00665561|18161484|P2|Overall Study|Withdrawal by Subject|65
5264129|NCT00665561|18161485|P1|Overall Study|Withdrawal by Subject|74
5264130|NCT00665561|18161484|P2|Overall Study|Lost to Follow-up|264
5264131|NCT00665561|18161485|P1|Overall Study|Lost to Follow-up|203
5264132|NCT00665561|18161484|P2|Overall Study|Does not meet entrance criteria|21
5264133|NCT00665561|18161485|P1|Overall Study|Does not meet entrance criteria|19
5264134|NCT00665561|18161484|P2|Overall Study|Death recorded on subject summary pages|75
5264135|NCT00665561|18161485|P1|Overall Study|Death recorded on subject summary pages|75
5264136|NCT00665444|18161535|P1|Overall Study|Study Terminated by Study Sponsor|1
5264137|NCT00665444|18161535|P1|Overall Study|Physician Decision|1
5264138|NCT00665431|18161547|P3|Overall Study|Other|2
5264139|NCT00665431|18161548|P2|Overall Study|Other|7
5264140|NCT00665431|18161549|P1|Overall Study|Other|4
5264141|NCT00665431|18161547|P3|Overall Study|Lost to Follow-up|1
5264142|NCT00665431|18161548|P2|Overall Study|Lost to Follow-up|3
5264143|NCT00665431|18161549|P1|Overall Study|Lost to Follow-up|3
5264144|NCT00665431|18161547|P3|Overall Study|Withdrawal by Subject|15
5264145|NCT00665431|18161548|P2|Overall Study|Withdrawal by Subject|25
5264146|NCT00665431|18161549|P1|Overall Study|Withdrawal by Subject|17
5264147|NCT00665431|18161547|P3|Overall Study|Adverse Event|6
5264148|NCT00665431|18161548|P2|Overall Study|Adverse Event|22
5264149|NCT00665431|18161549|P1|Overall Study|Adverse Event|16
5264150|NCT00665366|18161592|P2|Overall Study|Other reasons|1
5264151|NCT00665366|18161593|P1|Overall Study|Other reasons|4
5264152|NCT00665366|18161592|P2|Overall Study|No longer meets study criteria|1
5264153|NCT00665366|18161593|P1|Overall Study|No longer meets study criteria|0
5264154|NCT00665366|18161592|P2|Overall Study|Pregnancy|0
5264155|NCT00665366|18161593|P1|Overall Study|Pregnancy|1
5264156|NCT00665366|18161592|P2|Overall Study|Poor compliance/noncompliance|5
5264157|NCT00665366|18161593|P1|Overall Study|Poor compliance/noncompliance|3
5264158|NCT00665366|18161592|P2|Overall Study|Lost to Follow-up|5
5264159|NCT00665366|18161593|P1|Overall Study|Lost to Follow-up|3
5264160|NCT00665366|18161592|P2|Overall Study|Withdrawal by Subject|14
5264161|NCT00665366|18161593|P1|Overall Study|Withdrawal by Subject|11
5264162|NCT00665366|18161592|P2|Overall Study|Adverse Event|23
5264163|NCT00665366|18161593|P1|Overall Study|Adverse Event|25
5264164|NCT00665366|18161592|P2|Overall Study|Lack of Efficacy|10
5264165|NCT00665366|18161593|P1|Overall Study|Lack of Efficacy|11
5264166|NCT00665353|18161621|P1|Study Step 2|Lack of Efficacy|12
5264167|NCT00665353|18161621|P1|Study Step 2|Lost to Follow-up|2
5264168|NCT00665353|18161621|P1|Study Step 1|Withdrawal by Subject|2
5264169|NCT00665353|18161621|P1|Study Step 1|Adverse Event|1
5264170|NCT00665002|18161638|P1|Overall Study|Cytogenetic resistance|1
5264171|NCT00665002|18161638|P1|Overall Study|Progression/relapse during treatment|11
5264172|NCT00664859|18161646|P3|Overall Study|Other|2
5264173|NCT00664859|18161647|P2|Overall Study|Other|1
5264174|NCT00664859|18161648|P1|Overall Study|Other|0
5264175|NCT00664859|18161646|P3|Overall Study|Lost to Follow-up|1
5264176|NCT00664859|18161647|P2|Overall Study|Lost to Follow-up|2
5264177|NCT00664859|18161648|P1|Overall Study|Lost to Follow-up|2
5264178|NCT00664859|18161646|P3|Overall Study|Withdrawal by Subject|3
5264179|NCT00664859|18161647|P2|Overall Study|Withdrawal by Subject|1
5264180|NCT00664859|18161648|P1|Overall Study|Withdrawal by Subject|4
5264181|NCT00664859|18161646|P3|Overall Study|Laboratory abnormality|4
5264182|NCT00664859|18161647|P2|Overall Study|Laboratory abnormality|1
5264183|NCT00664859|18161648|P1|Overall Study|Laboratory abnormality|2
5264184|NCT00664859|18161646|P3|Overall Study|Noncompliance with protocol|4
5264185|NCT00664859|18161647|P2|Overall Study|Noncompliance with protocol|0
5264186|NCT00664859|18161648|P1|Overall Study|Noncompliance with protocol|1
5264187|NCT00664859|18161646|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
5264188|NCT00664859|18161647|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
5264189|NCT00664859|18161648|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
5264190|NCT00664859|18161646|P3|Overall Study|Adverse Event|3
5264191|NCT00664859|18161647|P2|Overall Study|Adverse Event|1
5264192|NCT00664859|18161648|P1|Overall Study|Adverse Event|2
5264193|NCT00664742|18161668|P1|Overall Study|Lost to Follow-up|92
5264194|NCT00664742|18161668|P1|Overall Study|Withdrawal by Subject|31
5264195|NCT00664742|18161668|P1|Overall Study|Withdrawn due to adverse events|3
5264196|NCT00664560|18161676|P3|Overall Study|Other|5
5264197|NCT00664560|18161677|P2|Overall Study|Other|4
5264198|NCT00664560|18161678|P1|Overall Study|Other|11
5264199|NCT00664560|18161676|P3|Overall Study|Lost to Follow-up|0
5264200|NCT00664560|18161677|P2|Overall Study|Lost to Follow-up|2
5264201|NCT00664560|18161678|P1|Overall Study|Lost to Follow-up|0
5264202|NCT00664560|18161676|P3|Overall Study|Withdrawal by Subject|7
5264203|NCT00664560|18161677|P2|Overall Study|Withdrawal by Subject|13
5264204|NCT00664560|18161678|P1|Overall Study|Withdrawal by Subject|9
5264205|NCT00664560|18161676|P3|Overall Study|Adverse Event|7
5264206|NCT00664560|18161677|P2|Overall Study|Adverse Event|16
5264207|NCT00664560|18161678|P1|Overall Study|Adverse Event|19
5264208|NCT00664534|18161721|P2|Overall Study|Sponsor decision|6
5264209|NCT00664534|18161722|P1|Overall Study|Sponsor decision|8
5264210|NCT00664534|18161721|P2|Overall Study|Physician Decision|0
5264211|NCT00664534|18161722|P1|Overall Study|Physician Decision|8
5264212|NCT00664534|18161721|P2|Overall Study|Withdrawal by Subject|6
5264213|NCT00664534|18161722|P1|Overall Study|Withdrawal by Subject|7
5264214|NCT00664534|18161721|P2|Overall Study|Protocol Violation|8
5264215|NCT00664534|18161722|P1|Overall Study|Protocol Violation|10
5264216|NCT00664534|18161721|P2|Overall Study|Lost to Follow-up|10
5264217|NCT00664534|18161722|P1|Overall Study|Lost to Follow-up|6
5264218|NCT00664534|18161721|P2|Overall Study|Adverse Event|3
5264219|NCT00664534|18161722|P1|Overall Study|Adverse Event|2
5264220|NCT00664521|18161750|P2|Overall Study|Other|0
5264221|NCT00664521|18161751|P1|Overall Study|Other|1
5264222|NCT00664521|18161750|P2|Overall Study|Lost to Follow-up|0
5264223|NCT00664521|18161751|P1|Overall Study|Lost to Follow-up|1
5264224|NCT00664521|18161750|P2|Overall Study|Adverse Event|1
5264225|NCT00664521|18161751|P1|Overall Study|Adverse Event|4
5264226|NCT00664326|18161777|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
5264227|NCT00664326|18161777|P1|Overall Study|Death|2
5264228|NCT00664326|18161777|P1|Overall Study|Other Reasons|3
5264229|NCT00664326|18161777|P1|Overall Study|Physician Decision|1
5264230|NCT00664326|18161777|P1|Overall Study|Withdrawal by Subject|1
5264231|NCT00664326|18161777|P1|Overall Study|Noncompliance with study medication|3
5264232|NCT00664326|18161777|P1|Overall Study|Adverse Event|14
5264233|NCT00664209|18161796|P1|Study Treatment Period|Withdrawal by Subject|2
5264234|NCT00664209|18161796|P1|Study Treatment Period|Physician Decision|4
5264235|NCT00664209|18161796|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
5264236|NCT00664105|18161804|P1|Overall Study|Disease progression|7
5264237|NCT00664105|18161804|P1|Overall Study|Adverse Event|9
5264238|NCT00664105|18161804|P1|Overall Study|Withdrawal by Subject|5
5264239|NCT00664105|18161804|P1|Overall Study|Death|3
5264240|NCT00664066|18161811|P1|Overall Study|Study terminated|3
5264241|NCT00663962|18161817|P2|Overall Study|somnolence|0
5264242|NCT00663962|18161818|P1|Overall Study|somnolence|1
5264243|NCT00663923|18161824|P1|Overall Study|Lost to Follow-up|2
5264244|NCT00663858|18161841|P3|Overall Study|Other|4
5264245|NCT00663858|18161842|P2|Overall Study|Other|2
5264246|NCT00663858|18161843|P1|Overall Study|Other|8
5264247|NCT00663858|18161841|P3|Overall Study|Protocol Violation|4
5264248|NCT00663858|18161842|P2|Overall Study|Protocol Violation|3
5264249|NCT00663858|18161843|P1|Overall Study|Protocol Violation|5
5264250|NCT00663858|18161841|P3|Overall Study|Withdrawal by Subject|3
5264251|NCT00663858|18161842|P2|Overall Study|Withdrawal by Subject|3
5264252|NCT00663858|18161843|P1|Overall Study|Withdrawal by Subject|7
5264253|NCT00663858|18161841|P3|Overall Study|Lack of Efficacy|3
5264254|NCT00663858|18161842|P2|Overall Study|Lack of Efficacy|1
5264255|NCT00663858|18161843|P1|Overall Study|Lack of Efficacy|5
5264256|NCT00663858|18161841|P3|Overall Study|Adverse Event|6
5264257|NCT00663858|18161842|P2|Overall Study|Adverse Event|1
5264258|NCT00663858|18161843|P1|Overall Study|Adverse Event|9
5264259|NCT00663702|18161881|P2|Overall Study|Lack of Efficacy|3
5264260|NCT00663702|18161882|P1|Overall Study|Lack of Efficacy|3
5264261|NCT00663702|18161881|P2|Overall Study|Death|1
5264262|NCT00663702|18161882|P1|Overall Study|Death|1
5264263|NCT00663702|18161881|P2|Overall Study|Lost to Follow-up|0
5264264|NCT00663702|18161882|P1|Overall Study|Lost to Follow-up|3
5264265|NCT00663702|18161881|P2|Overall Study|Pregnancy|1
5264266|NCT00663702|18161882|P1|Overall Study|Pregnancy|0
5264267|NCT00663702|18161881|P2|Overall Study|Withdrawal by Subject|1
5264268|NCT00663702|18161882|P1|Overall Study|Withdrawal by Subject|3
5264269|NCT00663702|18161881|P2|Overall Study|Adverse Event|4
5264270|NCT00663702|18161882|P1|Overall Study|Adverse Event|8
5264271|NCT00663260|18161918|P3|Overall Study|non-compliance, not met criteria, etc.|3
5264272|NCT00663260|18161919|P2|Overall Study|non-compliance, not met criteria, etc.|2
5264273|NCT00663260|18161920|P1|Overall Study|non-compliance, not met criteria, etc.|3
5264274|NCT00663260|18161918|P3|Overall Study|Lost to Follow-up|0
5264275|NCT00663260|18161919|P2|Overall Study|Lost to Follow-up|1
5264276|NCT00663260|18161920|P1|Overall Study|Lost to Follow-up|0
5264277|NCT00663260|18161918|P3|Overall Study|Death|1
5264278|NCT00663260|18161919|P2|Overall Study|Death|0
5264279|NCT00663260|18161920|P1|Overall Study|Death|1
5264280|NCT00663260|18161918|P3|Overall Study|Withdrawal by Subject|6
5264281|NCT00663260|18161919|P2|Overall Study|Withdrawal by Subject|1
5264282|NCT00663260|18161920|P1|Overall Study|Withdrawal by Subject|3
5264283|NCT00663260|18161918|P3|Overall Study|Adverse Event|6
5264284|NCT00663260|18161919|P2|Overall Study|Adverse Event|7
5264285|NCT00663260|18161920|P1|Overall Study|Adverse Event|12
5264286|NCT00663260|18161918|P3|Overall Study|Lack of Efficacy|0
5264287|NCT00663260|18161919|P2|Overall Study|Lack of Efficacy|0
5264288|NCT00663260|18161920|P1|Overall Study|Lack of Efficacy|2
5264289|NCT00663234|18161934|P1|Overall Study|Not willing to adhere to requirements|1
5264290|NCT00663208|18161967|P7|Follow-up Period|Other reason|1
5264291|NCT00663208|18161968|P6|Follow-up Period|Other reason|0
5264292|NCT00663208|18161969|P5|Follow-up Period|Other reason|0
5264293|NCT00663208|18161970|P4|Follow-up Period|Other reason|0
5264294|NCT00663208|18161971|P3|Follow-up Period|Other reason|0
5264295|NCT00663208|18161972|P2|Follow-up Period|Other reason|0
5264296|NCT00663208|18161973|P1|Follow-up Period|Other reason|1
5264297|NCT00663208|18161967|P7|Follow-up Period|Lost to Follow-up|0
5264298|NCT00663208|18161968|P6|Follow-up Period|Lost to Follow-up|0
5264299|NCT00663208|18161969|P5|Follow-up Period|Lost to Follow-up|0
5264300|NCT00663208|18161970|P4|Follow-up Period|Lost to Follow-up|2
5264301|NCT00663208|18161971|P3|Follow-up Period|Lost to Follow-up|3
5264302|NCT00663208|18161972|P2|Follow-up Period|Lost to Follow-up|0
5264303|NCT00663208|18161973|P1|Follow-up Period|Lost to Follow-up|2
5264304|NCT00663208|18161967|P7|Treatment Period|Lost to Follow-up|0
5264305|NCT00663208|18161968|P6|Treatment Period|Lost to Follow-up|0
5264306|NCT00663208|18161969|P5|Treatment Period|Lost to Follow-up|0
5264307|NCT00663208|18161970|P4|Treatment Period|Lost to Follow-up|0
5264308|NCT00663208|18161971|P3|Treatment Period|Lost to Follow-up|0
5264309|NCT00663208|18161972|P2|Treatment Period|Lost to Follow-up|1
5264310|NCT00663208|18161973|P1|Treatment Period|Lost to Follow-up|0
5264311|NCT00663117|18162151|P2|Overall Study|Lack of Efficacy|0
5264312|NCT00663117|18162152|P1|Overall Study|Lack of Efficacy|1
5264313|NCT00663052|18162166|P2|Overall Study|Other|1
5264314|NCT00663052|18162167|P1|Overall Study|Other|0
5264315|NCT00663052|18162166|P2|Overall Study|Unsatisfactory Response - Efficacy|1
5264316|NCT00663052|18162167|P1|Overall Study|Unsatisfactory Response - Efficacy|1
5264317|NCT00663052|18162166|P2|Overall Study|Withdrawal by Subject|5
5264318|NCT00663052|18162167|P1|Overall Study|Withdrawal by Subject|2
5264319|NCT00663052|18162166|P2|Overall Study|Protocol Violation|0
5264320|NCT00663052|18162167|P1|Overall Study|Protocol Violation|1
5264321|NCT00663052|18162166|P2|Overall Study|Discontinuation of Study by Sponsor|0
5264322|NCT00663052|18162167|P1|Overall Study|Discontinuation of Study by Sponsor|2
5264323|NCT00663052|18162166|P2|Overall Study|Adverse Event|3
5264324|NCT00663052|18162167|P1|Overall Study|Adverse Event|6
5264325|NCT00663026|18162273|P3|Overall Study|Withdrawal by Subject|1
5264326|NCT00663026|18162274|P2|Overall Study|Withdrawal by Subject|0
5264327|NCT00663026|18162275|P1|Overall Study|Withdrawal by Subject|0
5264328|NCT00663026|18162273|P3|Overall Study|Caregiver Request|0
5264329|NCT00663026|18162274|P2|Overall Study|Caregiver Request|2
5264330|NCT00663026|18162275|P1|Overall Study|Caregiver Request|0
5264331|NCT00663026|18162273|P3|Overall Study|Adverse Event|3
5264332|NCT00663026|18162274|P2|Overall Study|Adverse Event|2
5264333|NCT00663026|18162275|P1|Overall Study|Adverse Event|0
5264334|NCT00663026|18162273|P3|Overall Study|Other|0
5264335|NCT00663026|18162274|P2|Overall Study|Other|2
5264336|NCT00663026|18162275|P1|Overall Study|Other|1
5264337|NCT00663026|18162273|P3|Overall Study|Lost to Follow-up|0
5264338|NCT00663026|18162274|P2|Overall Study|Lost to Follow-up|0
5264339|NCT00663026|18162275|P1|Overall Study|Lost to Follow-up|1
5264340|NCT00662909|18162298|P3|Overall Study|Eligibility criterion not met|1
5264341|NCT00662909|18162299|P2|Overall Study|Eligibility criterion not met|1
5264342|NCT00662909|18162300|P1|Overall Study|Eligibility criterion not met|0
5264343|NCT00662909|18162298|P3|Overall Study|Physician Decision|2
5264344|NCT00662909|18162299|P2|Overall Study|Physician Decision|1
5264345|NCT00662909|18162300|P1|Overall Study|Physician Decision|1
5264346|NCT00662909|18162298|P3|Overall Study|Non-compliance with study procedures|2
5264347|NCT00662909|18162299|P2|Overall Study|Non-compliance with study procedures|3
5264348|NCT00662909|18162300|P1|Overall Study|Non-compliance with study procedures|3
5264349|NCT00662909|18162298|P3|Overall Study|Randomized- never received study drug|0
5264350|NCT00662909|18162299|P2|Overall Study|Randomized- never received study drug|0
5264351|NCT00662909|18162300|P1|Overall Study|Randomized- never received study drug|1
5264352|NCT00662909|18162298|P3|Overall Study|Protocol Violation|5
5264353|NCT00662909|18162299|P2|Overall Study|Protocol Violation|4
5264354|NCT00662909|18162300|P1|Overall Study|Protocol Violation|7
5264355|NCT00662909|18162298|P3|Overall Study|Lost to Follow-up|3
5264356|NCT00662909|18162299|P2|Overall Study|Lost to Follow-up|9
5264357|NCT00662909|18162300|P1|Overall Study|Lost to Follow-up|2
5264358|NCT00662909|18162298|P3|Overall Study|Withdrawal by Subject|16
5264359|NCT00662909|18162299|P2|Overall Study|Withdrawal by Subject|22
5264360|NCT00662909|18162300|P1|Overall Study|Withdrawal by Subject|29
5264361|NCT00662909|18162298|P3|Overall Study|Lack of Efficacy|5
5264362|NCT00662909|18162299|P2|Overall Study|Lack of Efficacy|1
5264363|NCT00662909|18162300|P1|Overall Study|Lack of Efficacy|9
5264364|NCT00662909|18162298|P3|Overall Study|Adverse Event|19
5264365|NCT00662909|18162299|P2|Overall Study|Adverse Event|18
5264366|NCT00662909|18162300|P1|Overall Study|Adverse Event|17
5264367|NCT00662857|18162398|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
5264368|NCT00662857|18162399|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
5264369|NCT00662857|18162398|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
5264370|NCT00662857|18162399|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
5264371|NCT00662857|18162398|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
5264372|NCT00662857|18162399|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
5264373|NCT00662831|18162414|P2|Overall Study|Adverse Event|16
5264374|NCT00662831|18162415|P1|Overall Study|Adverse Event|23
5264375|NCT00662831|18162414|P2|Overall Study|Protocol Violation|4
5264376|NCT00662831|18162415|P1|Overall Study|Protocol Violation|8
5264377|NCT00662831|18162414|P2|Overall Study|Other|31
5264378|NCT00662831|18162415|P1|Overall Study|Other|62
5264379|NCT00662831|18162414|P2|Overall Study|Withdrawal by Subject|1
5264380|NCT00662831|18162415|P1|Overall Study|Withdrawal by Subject|2
5264381|NCT00662831|18162414|P2|Overall Study|Lost to Follow-up|0
5264382|NCT00662831|18162415|P1|Overall Study|Lost to Follow-up|1
5264383|NCT00662831|18162414|P2|Overall Study|Lack of Efficacy|6
5264384|NCT00662831|18162415|P1|Overall Study|Lack of Efficacy|6
5264385|NCT00662831|18162414|P2|Overall Study|Death|1
5264386|NCT00662831|18162415|P1|Overall Study|Death|4
5264387|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
5264388|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
5264389|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
5264390|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
5264391|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
5264392|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5264393|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5264394|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5264395|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
5264396|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5264397|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
5264398|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
5264399|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
5264400|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
5264401|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
5264402|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
5264403|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
5264404|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
5264405|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
5264406|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
5264407|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
5264408|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
5264409|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
5264410|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
5264411|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
5264412|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Adverse Event|10
5264413|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Adverse Event|6
5264414|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Adverse Event|0
5264415|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Adverse Event|9
5264416|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Adverse Event|6
5264417|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Administrative problems|0
5264418|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Administrative problems|1
5264419|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Administrative problems|0
5264420|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Administrative problems|0
5264421|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Administrative problems|0
5264422|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
5264423|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
5264424|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
5264425|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
5264426|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
5264427|NCT00662649|18162495|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
5264428|NCT00662649|18162496|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
5264429|NCT00662649|18162497|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
5264430|NCT00662649|18162498|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
5264431|NCT00662649|18162499|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
5264432|NCT00662649|18162495|P5|Core Study (24 Months)|Death|0
5264433|NCT00662649|18162496|P4|Core Study (24 Months)|Death|0
5264434|NCT00662649|18162497|P3|Core Study (24 Months)|Death|2
5264435|NCT00662649|18162498|P2|Core Study (24 Months)|Death|0
5264436|NCT00662649|18162499|P1|Core Study (24 Months)|Death|1
5264437|NCT00662649|18162495|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
5264438|NCT00662649|18162496|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
5264439|NCT00662649|18162497|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
5264440|NCT00662649|18162498|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
5264441|NCT00662649|18162499|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
5264442|NCT00662649|18162495|P5|Core Study (24 Months)|Protocol Violation|0
5264443|NCT00662649|18162496|P4|Core Study (24 Months)|Protocol Violation|0
5264444|NCT00662649|18162497|P3|Core Study (24 Months)|Protocol Violation|4
5264445|NCT00662649|18162498|P2|Core Study (24 Months)|Protocol Violation|5
5264446|NCT00662649|18162499|P1|Core Study (24 Months)|Protocol Violation|5
5264447|NCT00662649|18162495|P5|Core Study (24 Months)|Lost to Follow-up|0
5264448|NCT00662649|18162496|P4|Core Study (24 Months)|Lost to Follow-up|0
5264449|NCT00662649|18162497|P3|Core Study (24 Months)|Lost to Follow-up|7
5264450|NCT00662649|18162498|P2|Core Study (24 Months)|Lost to Follow-up|5
5264451|NCT00662649|18162499|P1|Core Study (24 Months)|Lost to Follow-up|3
5264452|NCT00662649|18162495|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
5264453|NCT00662649|18162496|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
5264454|NCT00662649|18162497|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
5264455|NCT00662649|18162498|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
5264456|NCT00662649|18162499|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
5264457|NCT00662649|18162495|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
5264458|NCT00662649|18162496|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
5264459|NCT00662649|18162497|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
5264460|NCT00662649|18162498|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
5264461|NCT00662649|18162499|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
5264462|NCT00662649|18162495|P5|Core Study (24 Months)|Adverse Event|0
5264463|NCT00662649|18162496|P4|Core Study (24 Months)|Adverse Event|0
5264464|NCT00662649|18162497|P3|Core Study (24 Months)|Adverse Event|18
5264465|NCT00662649|18162498|P2|Core Study (24 Months)|Adverse Event|13
5264466|NCT00662649|18162499|P1|Core Study (24 Months)|Adverse Event|22
5264467|NCT00662649|18162495|P5|Core Study (24 Months)|Withdrawal by Subject|0
5264468|NCT00662649|18162496|P4|Core Study (24 Months)|Withdrawal by Subject|0
5264469|NCT00662649|18162497|P3|Core Study (24 Months)|Withdrawal by Subject|28
5264470|NCT00662649|18162498|P2|Core Study (24 Months)|Withdrawal by Subject|17
5264471|NCT00662649|18162499|P1|Core Study (24 Months)|Withdrawal by Subject|31
5264472|NCT00662558|18162539|P2|Overall Study|Randomized But Did Not Receive Treatment|8
5264473|NCT00662558|18162540|P1|Overall Study|Randomized But Did Not Receive Treatment|2
5264474|NCT00662558|18162539|P2|Overall Study|Withdrawal by Subject|12
5264475|NCT00662558|18162540|P1|Overall Study|Withdrawal by Subject|7
5264476|NCT00662558|18162539|P2|Overall Study|Other|14
5264477|NCT00662558|18162540|P1|Overall Study|Other|9
5264478|NCT00662558|18162539|P2|Overall Study|Lost to Follow-up|10
5264479|NCT00662558|18162540|P1|Overall Study|Lost to Follow-up|13
5264480|NCT00662558|18162539|P2|Overall Study|Lack of Efficacy|7
5264481|NCT00662558|18162540|P1|Overall Study|Lack of Efficacy|4
5264482|NCT00662558|18162539|P2|Overall Study|Adverse Event|59
5264483|NCT00662558|18162540|P1|Overall Study|Adverse Event|21
5264484|NCT00662532|18162591|P2|Overall Study|Lost to Follow-up|1
5264485|NCT00662532|18162592|P1|Overall Study|Lost to Follow-up|0
5264486|NCT00662532|18162591|P2|Overall Study|Adverse Event|1
5264487|NCT00662532|18162592|P1|Overall Study|Adverse Event|0
5264488|NCT00662363|18162607|P2|Overall Study|Protocol Violation|1
5264489|NCT00662363|18162608|P1|Overall Study|Protocol Violation|1
5264490|NCT00662363|18162607|P2|Overall Study|Discharged early from rehab|1
5264491|NCT00662363|18162608|P1|Overall Study|Discharged early from rehab|4
5264492|NCT00662363|18162607|P2|Overall Study|Adverse Event|3
5264493|NCT00662363|18162608|P1|Overall Study|Adverse Event|0
5264494|NCT00662363|18162607|P2|Overall Study|Withdrawal by Subject|5
5264495|NCT00662363|18162608|P1|Overall Study|Withdrawal by Subject|6
5264496|NCT00662311|18162619|P3|Overall Study|Respiratory Infection|0
5264497|NCT00662311|18162620|P2|Overall Study|Respiratory Infection|0
5264498|NCT00662311|18162621|P1|Overall Study|Respiratory Infection|1
5264499|NCT00662259|18162656|P2|Overall Study|Adverse Event|0
5264500|NCT00662259|18162657|P1|Overall Study|Adverse Event|2
5264501|NCT00662129|18162699|P1|Overall Study|Ineligible|1
5264502|NCT00662129|18162699|P1|Overall Study|Cancel prior to beginning treatment|1
5264503|NCT00662129|18162699|P1|Overall Study|Protocol Violation|1
5264504|NCT00662038|18162709|P1|Overall Study|Continued treatment|5
5264505|NCT00662038|18162709|P1|Overall Study|Adverse Event|358
5264506|NCT00662038|18162709|P1|Overall Study|Death|95
5264507|NCT00662038|18162709|P1|Overall Study|Lost to Follow-up|1
5264508|NCT00662038|18162709|P1|Overall Study|Lung transplantation|44
5264509|NCT00662038|18162709|P1|Overall Study|Physician Decision|19
5264510|NCT00662038|18162709|P1|Overall Study|Sponsor decision|1
5264511|NCT00662038|18162709|P1|Overall Study|Withdrawal by Subject|83
5264512|NCT00662038|18162709|P1|Overall Study|Withdrawn consent|22
5264513|NCT00662038|18162709|P1|Overall Study|Reason not specified|3
5264514|NCT00662025|18162713|P1|Overall Study|Domestic circumstances|1
5264515|NCT00662025|18162713|P1|Overall Study|Target lesion cannot be evaluated|1
5264516|NCT00662025|18162713|P1|Overall Study|Results of other clinical study|2
5264517|NCT00662025|18162713|P1|Overall Study|Withdrawal by Subject|1
5264518|NCT00662025|18162713|P1|Overall Study|Adverse Event|7
5264519|NCT00662025|18162713|P1|Overall Study|Objective progression or relapse|51
5264520|NCT00662012|18162733|P1|Overall Study|Withdrawal by Subject|1
5264521|NCT00662012|18162733|P1|Overall Study|Death|1
5264522|NCT00662012|18162733|P1|Overall Study|Lost to Follow-up|85
5264523|NCT00661999|18162741|P3|Overall Study|Other Medical Problems|9
5264524|NCT00661999|18162742|P2|Overall Study|Other Medical Problems|4
5264525|NCT00661999|18162743|P1|Overall Study|Other Medical Problems|4
5264526|NCT00661999|18162741|P3|Overall Study|Alternative Treatment|0
5264527|NCT00661999|18162742|P2|Overall Study|Alternative Treatment|0
5264528|NCT00661999|18162743|P1|Overall Study|Alternative Treatment|1
5264529|NCT00661999|18162741|P3|Overall Study|Withdrawal by Subject|14
5264530|NCT00661999|18162742|P2|Overall Study|Withdrawal by Subject|23
5264531|NCT00661999|18162743|P1|Overall Study|Withdrawal by Subject|30
5264532|NCT00661999|18162741|P3|Overall Study|Other Reasons|23
5264533|NCT00661999|18162742|P2|Overall Study|Other Reasons|12
5264534|NCT00661999|18162743|P1|Overall Study|Other Reasons|5
5264535|NCT00661999|18162741|P3|Overall Study|Death|3
5264536|NCT00661999|18162742|P2|Overall Study|Death|6
5264537|NCT00661999|18162743|P1|Overall Study|Death|8
5264538|NCT00661999|18162741|P3|Overall Study|Adverse Event|8
5264539|NCT00661999|18162742|P2|Overall Study|Adverse Event|5
5264540|NCT00661999|18162743|P1|Overall Study|Adverse Event|11
5264541|NCT00661830|18162820|P2|Overall Study|Other reason|5
5264542|NCT00661830|18162821|P1|Overall Study|Other reason|1
5264543|NCT00661830|18162820|P2|Overall Study|Withdrawal by Subject|1
5264544|NCT00661830|18162821|P1|Overall Study|Withdrawal by Subject|1
5264545|NCT00661830|18162820|P2|Overall Study|Lost to Follow-up|3
5264546|NCT00661830|18162821|P1|Overall Study|Lost to Follow-up|1
5264547|NCT00661830|18162820|P2|Overall Study|Death|33
5264548|NCT00661830|18162821|P1|Overall Study|Death|37
5264549|NCT00661778|18162833|P1|Overall Study|Withdrawal of Consent|1
5264550|NCT00661778|18162833|P1|Overall Study|Protocol Violation|2
5264551|NCT00661778|18162833|P1|Overall Study|Reason not Specified|6
5264552|NCT00661778|18162833|P1|Overall Study|Adverse Event|18
5264553|NCT00661778|18162833|P1|Overall Study|Disease Progression|23
5264554|NCT00661726|18162840|P1|Overall Study|Adverse Event|1
5264555|NCT00661713|18162863|P8|Overall Study|Inappropriate Enrollment|0
5264556|NCT00661713|18162864|P7|Overall Study|Inappropriate Enrollment|1
5264557|NCT00661713|18162865|P6|Overall Study|Inappropriate Enrollment|0
5264558|NCT00661713|18162866|P5|Overall Study|Inappropriate Enrollment|0
5264559|NCT00661713|18162867|P4|Overall Study|Inappropriate Enrollment|0
5264560|NCT00661713|18162868|P3|Overall Study|Inappropriate Enrollment|0
5264561|NCT00661713|18162869|P2|Overall Study|Inappropriate Enrollment|0
5264562|NCT00661713|18162870|P1|Overall Study|Inappropriate Enrollment|0
5264563|NCT00661713|18162863|P8|Overall Study|Adverse Event|0
5264564|NCT00661713|18162864|P7|Overall Study|Adverse Event|1
5264565|NCT00661713|18162865|P6|Overall Study|Adverse Event|0
5264566|NCT00661713|18162866|P5|Overall Study|Adverse Event|0
5264567|NCT00661713|18162867|P4|Overall Study|Adverse Event|0
5264568|NCT00661713|18162868|P3|Overall Study|Adverse Event|0
5264569|NCT00661713|18162869|P2|Overall Study|Adverse Event|0
5264570|NCT00661713|18162870|P1|Overall Study|Adverse Event|0
5264571|NCT00661713|18162863|P8|Overall Study|Administrative Reason|0
5264572|NCT00661713|18162864|P7|Overall Study|Administrative Reason|1
5264573|NCT00661713|18162865|P6|Overall Study|Administrative Reason|2
5264574|NCT00661713|18162866|P5|Overall Study|Administrative Reason|2
5264575|NCT00661713|18162867|P4|Overall Study|Administrative Reason|2
5264576|NCT00661713|18162868|P3|Overall Study|Administrative Reason|0
5264577|NCT00661713|18162869|P2|Overall Study|Administrative Reason|1
5264578|NCT00661713|18162870|P1|Overall Study|Administrative Reason|0
5264579|NCT00661713|18162863|P8|Overall Study|Lost to Follow-up|1
5264580|NCT00661713|18162864|P7|Overall Study|Lost to Follow-up|14
5264581|NCT00661713|18162865|P6|Overall Study|Lost to Follow-up|7
5264582|NCT00661713|18162866|P5|Overall Study|Lost to Follow-up|5
5264583|NCT00661713|18162867|P4|Overall Study|Lost to Follow-up|2
5264584|NCT00661713|18162868|P3|Overall Study|Lost to Follow-up|2
5264585|NCT00661713|18162869|P2|Overall Study|Lost to Follow-up|7
5264586|NCT00661713|18162870|P1|Overall Study|Lost to Follow-up|2
5264587|NCT00661713|18162863|P8|Overall Study|Withdrawal by Subject|9
5264588|NCT00661713|18162864|P7|Overall Study|Withdrawal by Subject|45
5264589|NCT00661713|18162865|P6|Overall Study|Withdrawal by Subject|26
5264590|NCT00661713|18162866|P5|Overall Study|Withdrawal by Subject|12
5264591|NCT00661713|18162867|P4|Overall Study|Withdrawal by Subject|21
5264592|NCT00661713|18162868|P3|Overall Study|Withdrawal by Subject|12
5264593|NCT00661713|18162869|P2|Overall Study|Withdrawal by Subject|25
5264594|NCT00661713|18162870|P1|Overall Study|Withdrawal by Subject|11
5264595|NCT00661713|18162863|P8|Overall Study|Protocol Violation|1
5264596|NCT00661713|18162864|P7|Overall Study|Protocol Violation|2
5264597|NCT00661713|18162865|P6|Overall Study|Protocol Violation|2
5264598|NCT00661713|18162866|P5|Overall Study|Protocol Violation|0
5264599|NCT00661713|18162867|P4|Overall Study|Protocol Violation|3
5264600|NCT00661713|18162868|P3|Overall Study|Protocol Violation|3
5264601|NCT00661713|18162869|P2|Overall Study|Protocol Violation|6
5264602|NCT00661713|18162870|P1|Overall Study|Protocol Violation|1
5264603|NCT00661713|18162863|P8|Overall Study|Unable to Classify|0
5264604|NCT00661713|18162864|P7|Overall Study|Unable to Classify|0
5264605|NCT00661713|18162865|P6|Overall Study|Unable to Classify|0
5264606|NCT00661713|18162866|P5|Overall Study|Unable to Classify|0
5264607|NCT00661713|18162867|P4|Overall Study|Unable to Classify|0
5264608|NCT00661713|18162868|P3|Overall Study|Unable to Classify|0
5264609|NCT00661713|18162869|P2|Overall Study|Unable to Classify|0
5264610|NCT00661713|18162870|P1|Overall Study|Unable to Classify|1
5264611|NCT00661713|18162863|P8|Overall Study|Death|0
5264612|NCT00661713|18162864|P7|Overall Study|Death|0
5264613|NCT00661713|18162865|P6|Overall Study|Death|0
5264614|NCT00661713|18162866|P5|Overall Study|Death|1
5264615|NCT00661713|18162867|P4|Overall Study|Death|0
5264616|NCT00661713|18162868|P3|Overall Study|Death|0
5264617|NCT00661713|18162869|P2|Overall Study|Death|0
5264618|NCT00661713|18162870|P1|Overall Study|Death|1
5264619|NCT00661687|18162962|P1|Overall Study|Adverse Event|2
5264620|NCT00661687|18162962|P1|Overall Study|Physician Decision|1
5264621|NCT00661687|18162962|P1|Overall Study|Inability to maintain wearing schedule|3
5264622|NCT00661687|18162962|P1|Overall Study|Positive slit lamp findings|4
5264623|NCT00661687|18162962|P1|Overall Study|Study related symptoms and complaints|5
5264624|NCT00661661|18162990|P2|Overall Study|Not assigned treatment|0
5264625|NCT00661661|18162991|P1|Overall Study|Not assigned treatment|1
5264626|NCT00661661|18162990|P2|Overall Study|Other|7
5264627|NCT00661661|18162991|P1|Overall Study|Other|22
5264628|NCT00661661|18162990|P2|Overall Study|Withdrawal by Subject|5
5264629|NCT00661661|18162991|P1|Overall Study|Withdrawal by Subject|15
5264630|NCT00661661|18162990|P2|Overall Study|Lost to Follow-up|1
5264631|NCT00661661|18162991|P1|Overall Study|Lost to Follow-up|0
5264632|NCT00661661|18162990|P2|Overall Study|Lack of Efficacy|2
5264633|NCT00661661|18162991|P1|Overall Study|Lack of Efficacy|3
5264634|NCT00661661|18162990|P2|Overall Study|Adverse Event|24
5264635|NCT00661661|18162991|P1|Overall Study|Adverse Event|99
5264636|NCT00661622|18163067|P2|Overall Study|Protocol Violation|0
5264637|NCT00661622|18163068|P1|Overall Study|Protocol Violation|1
5264638|NCT00661609|18163082|P1|Overall Study|Disease progression|3
5264639|NCT00661609|18163082|P1|Overall Study|Survival follow up stage discontinued|11
5264640|NCT00661609|18163082|P1|Overall Study|PI Decision|1
5264641|NCT00661609|18163082|P1|Overall Study|Withdrawal by Subject|2
5264642|NCT00661609|18163082|P1|Overall Study|Death|20
5264643|NCT00661609|18163082|P1|Overall Study|Adverse Event|4
5264644|NCT00661531|18163149|P1|Overall Study|Withdrawal by Subject|3
5264645|NCT00661505|18163154|P1|Overall Study|Other|2
5264646|NCT00661505|18163154|P1|Overall Study|Lost to Follow-up|3
5264647|NCT00661505|18163154|P1|Overall Study|Withdrawal by Subject|8
5264648|NCT00661505|18163154|P1|Overall Study|Protocol Violation|14
5264649|NCT00661505|18163154|P1|Overall Study|Adverse Event|3
5264650|NCT00661492|18163182|P2|Overall Study|Other|0
5264651|NCT00661492|18163183|P1|Overall Study|Other|1
5264652|NCT00661492|18163182|P2|Overall Study|Lost to Follow-up|1
5264653|NCT00661492|18163183|P1|Overall Study|Lost to Follow-up|0
5264654|NCT00661492|18163182|P2|Overall Study|Investigator Request|0
5264655|NCT00661492|18163183|P1|Overall Study|Investigator Request|1
5264656|NCT00661492|18163182|P2|Overall Study|Patient Request|1
5264657|NCT00661492|18163183|P1|Overall Study|Patient Request|6
5264658|NCT00661492|18163182|P2|Overall Study|Disease Progression|14
5264659|NCT00661492|18163183|P1|Overall Study|Disease Progression|44
5264660|NCT00661492|18163182|P2|Overall Study|Adverse Event|13
5264661|NCT00661492|18163183|P1|Overall Study|Adverse Event|16
5264662|NCT00661427|18163258|P2|Overall Study|Patient not treated|2
5264663|NCT00661427|18163259|P1|Overall Study|Patient not treated|0
5264664|NCT00661427|18163258|P2|Overall Study|Adverse Event|5
5264665|NCT00661427|18163259|P1|Overall Study|Adverse Event|5
5264666|NCT00661388|18163267|P1|Overall Study|Administrative reasons|1
5264667|NCT00661388|18163267|P1|Overall Study|Dialysis initiation|1
5264668|NCT00661388|18163267|P1|Overall Study|Renal transplantation|1
5264669|NCT00661388|18163267|P1|Overall Study|Protocol Violation|7
5264670|NCT00661388|18163267|P1|Overall Study|Adverse Event|14
5264671|NCT00661362|18163290|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
5264672|NCT00661362|18163291|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
5264673|NCT00661362|18163290|P2|Overall Study|Safety reasons|0
5264674|NCT00661362|18163291|P1|Overall Study|Safety reasons|1
5264675|NCT00661362|18163290|P2|Overall Study|Severe non-compliance to protocol|1
5264676|NCT00661362|18163291|P1|Overall Study|Severe non-compliance to protocol|0
5264677|NCT00661362|18163290|P2|Overall Study|Lost to Follow-up|1
5264678|NCT00661362|18163291|P1|Overall Study|Lost to Follow-up|3
5264679|NCT00661362|18163290|P2|Overall Study|Withdrawal by Subject|23
5264680|NCT00661362|18163291|P1|Overall Study|Withdrawal by Subject|13
5264681|NCT00661362|18163290|P2|Overall Study|Study specific discontinuation criteria|11
5264682|NCT00661362|18163291|P1|Overall Study|Study specific discontinuation criteria|4
5264683|NCT00661362|18163290|P2|Overall Study|Incorrect enrollment|0
5264684|NCT00661362|18163291|P1|Overall Study|Incorrect enrollment|2
5264685|NCT00661362|18163290|P2|Overall Study|Adverse Event|4
5264686|NCT00661362|18163291|P1|Overall Study|Adverse Event|5
5264687|NCT00661271|18163309|P2|Overall Study|Lost to Follow-up|25
5264688|NCT00661271|18163310|P1|Overall Study|Lost to Follow-up|28
5264689|NCT00661258|18163320|P2|Overall Study|caught by police and in detox center|1
5264690|NCT00661258|18163321|P1|Overall Study|caught by police and in detox center|2
5264691|NCT00661258|18163320|P2|Overall Study|Death|0
5264692|NCT00661258|18163321|P1|Overall Study|Death|1
5264693|NCT00661193|18163331|P2|Overall Study|Not protocol specified|0
5264694|NCT00661193|18163332|P1|Overall Study|Not protocol specified|1
5264695|NCT00661193|18163331|P2|Overall Study|Progression|24
5264696|NCT00661193|18163332|P1|Overall Study|Progression|27
5264697|NCT00661193|18163331|P2|Overall Study|Withdrawal by Subject|1
5264698|NCT00661193|18163332|P1|Overall Study|Withdrawal by Subject|3
5264699|NCT00661193|18163331|P2|Overall Study|Adverse Event|1
5264700|NCT00661193|18163332|P1|Overall Study|Adverse Event|2
5264701|NCT00661089|18163557|P2|Overall Study|death at 8 weeks due to new stroke|1
5264702|NCT00661089|18163558|P1|Overall Study|death at 8 weeks due to new stroke|0
5264703|NCT00661089|18163557|P2|Overall Study|1 subject withdrawal|1
5264704|NCT00661089|18163558|P1|Overall Study|1 subject withdrawal|0
5264705|NCT00660907|18163606|P2|Overall Study|Various|8
5264706|NCT00660907|18163607|P1|Overall Study|Various|11
5264707|NCT00660907|18163606|P2|Overall Study|Death|3
5264708|NCT00660907|18163607|P1|Overall Study|Death|1
5264709|NCT00660907|18163606|P2|Overall Study|Safety|0
5264710|NCT00660907|18163607|P1|Overall Study|Safety|1
5264711|NCT00660907|18163606|P2|Overall Study|Poor/Non-Compliance|1
5264712|NCT00660907|18163607|P1|Overall Study|Poor/Non-Compliance|5
5264713|NCT00660907|18163606|P2|Overall Study|Lost to Follow-up|3
5264714|NCT00660907|18163607|P1|Overall Study|Lost to Follow-up|3
5264715|NCT00660907|18163606|P2|Overall Study|Withdrawal by Subject|32
5264716|NCT00660907|18163607|P1|Overall Study|Withdrawal by Subject|23
5264717|NCT00660907|18163606|P2|Overall Study|Subject No Longer Meets Study Criteria|27
5264718|NCT00660907|18163607|P1|Overall Study|Subject No Longer Meets Study Criteria|6
5264719|NCT00660907|18163606|P2|Overall Study|Adverse Event|19
5264720|NCT00660907|18163607|P1|Overall Study|Adverse Event|33
5264721|NCT00660907|18163606|P2|Overall Study|Incorrect Enrollment|1
5264722|NCT00660907|18163607|P1|Overall Study|Incorrect Enrollment|1
5264723|NCT00660829|18163621|P2|Overall Study|Other|4
5264724|NCT00660829|18163622|P1|Overall Study|Other|9
5264725|NCT00660829|18163621|P2|Overall Study|Lost to Follow-up|2
5264726|NCT00660829|18163622|P1|Overall Study|Lost to Follow-up|3
5264727|NCT00660829|18163621|P2|Overall Study|Withdrawal by Subject|2
5264728|NCT00660829|18163622|P1|Overall Study|Withdrawal by Subject|1
5264729|NCT00660829|18163621|P2|Overall Study|Non-Compliance|4
5264730|NCT00660829|18163622|P1|Overall Study|Non-Compliance|0
5264731|NCT00660829|18163621|P2|Overall Study|Lack of Efficacy|3
5264732|NCT00660829|18163622|P1|Overall Study|Lack of Efficacy|2
5264733|NCT00660829|18163621|P2|Overall Study|Adverse Event|4
5264734|NCT00660829|18163622|P1|Overall Study|Adverse Event|3
5264735|NCT00660816|18163640|P2|Overall Study|Complicating Disease|1
5264736|NCT00660816|18163641|P1|Overall Study|Complicating Disease|0
5264737|NCT00660816|18163640|P2|Overall Study|Disease Progression|12
5264738|NCT00660816|18163641|P1|Overall Study|Disease Progression|16
5264739|NCT00660816|18163640|P2|Overall Study|Protocol Violation|0
5264740|NCT00660816|18163641|P1|Overall Study|Protocol Violation|1
5264741|NCT00660816|18163640|P2|Overall Study|Physician Decision|2
5264742|NCT00660816|18163641|P1|Overall Study|Physician Decision|0
5264743|NCT00660816|18163640|P2|Overall Study|Lack of Efficacy|0
5264744|NCT00660816|18163641|P1|Overall Study|Lack of Efficacy|1
5264745|NCT00660816|18163640|P2|Overall Study|Death|2
5264746|NCT00660816|18163641|P1|Overall Study|Death|0
5264747|NCT00660816|18163640|P2|Overall Study|Withdrawal by Subject|0
5264748|NCT00660816|18163641|P1|Overall Study|Withdrawal by Subject|1
5264749|NCT00660816|18163640|P2|Overall Study|Adverse Event|2
5264750|NCT00660816|18163641|P1|Overall Study|Adverse Event|1
5264751|NCT00660790|18163653|P1|3 Months to 2 Years|Withdrawal by Subject|17
5264752|NCT00660790|18163653|P1|Baseline to 3 Months|Withdrawal by Subject|2
5264753|NCT00660790|18163653|P1|Baseline to 3 Months|Death|1
5264754|NCT00660699|18163657|P1|Overall Study|Withdrawal by Subject|2
5264755|NCT00660660|18163673|P2|Overall Study|New medication after randomization|0
5264756|NCT00660660|18163674|P1|Overall Study|New medication after randomization|1
5264757|NCT00660660|18163673|P2|Overall Study|Incorrect enrollment and other|1
5264758|NCT00660660|18163674|P1|Overall Study|Incorrect enrollment and other|0
5264759|NCT00660660|18163673|P2|Overall Study|Withdrawal by Subject|0
5264760|NCT00660660|18163674|P1|Overall Study|Withdrawal by Subject|3
5264761|NCT00660660|18163673|P2|Overall Study|Lack of Efficacy|2
5264762|NCT00660660|18163674|P1|Overall Study|Lack of Efficacy|0
5264763|NCT00660660|18163673|P2|Overall Study|Lost to Follow-up|6
5264764|NCT00660660|18163674|P1|Overall Study|Lost to Follow-up|0
5264765|NCT00660660|18163673|P2|Overall Study|Adverse Event|0
5264766|NCT00660660|18163674|P1|Overall Study|Adverse Event|1
5264767|NCT00660595|18163774|P2|Overall Study|Non Specified reasons|0
5264768|NCT00660595|18163775|P1|Overall Study|Non Specified reasons|5
5264769|NCT00660595|18163774|P2|Overall Study|Participant left hospital|0
5264770|NCT00660595|18163775|P1|Overall Study|Participant left hospital|1
5264771|NCT00660595|18163774|P2|Overall Study|Did not consent to participate in study|8
5264772|NCT00660595|18163775|P1|Overall Study|Did not consent to participate in study|12
5264773|NCT00660595|18163774|P2|Overall Study|Lost to Follow-up|1
5264774|NCT00660595|18163775|P1|Overall Study|Lost to Follow-up|0
5264775|NCT00660400|18163842|P1|Overall Study|Withdrawal by Subject|1
5264776|NCT00660400|18163842|P1|Overall Study|Intracranial hemorrhage|1
5264777|NCT00660400|18163842|P1|Overall Study|Suboptimal organ function|1
5264778|NCT00660400|18163842|P1|Overall Study|Lack of insurance approval|1
5264779|NCT00660387|18163851|P2|Overall Study|Protocol Violation|0
5264780|NCT00660387|18163852|P1|Overall Study|Protocol Violation|1
5264781|NCT00660387|18163851|P2|Overall Study|Lack of Efficacy|1
5264782|NCT00660387|18163852|P1|Overall Study|Lack of Efficacy|0
5264783|NCT00660387|18163851|P2|Overall Study|Adverse Event|2
5264784|NCT00660387|18163852|P1|Overall Study|Adverse Event|1
5264785|NCT00660348|18163906|P2|Overall Study|Withdrawal by Subject|0
5264786|NCT00660348|18163907|P1|Overall Study|Withdrawal by Subject|1
5264787|NCT00660309|18163915|P2|Overall Study|Withdrawal by Subject|3
5264788|NCT00660309|18163916|P1|Overall Study|Withdrawal by Subject|0
5264789|NCT00660309|18163915|P2|Overall Study|Adverse Event|0
5264790|NCT00660309|18163916|P1|Overall Study|Adverse Event|2
5264791|NCT00660192|18163957|P2|Overall Study|Lost to Follow-up|3
5264792|NCT00660192|18163958|P1|Overall Study|Lost to Follow-up|2
5264793|NCT00660179|18163969|P3|Overall Study|Incorrect randomization|0
5264794|NCT00660179|18163970|P2|Overall Study|Incorrect randomization|0
5264795|NCT00660179|18163971|P1|Overall Study|Incorrect randomization|1
5264796|NCT00660179|18163969|P3|Overall Study|Administrative reason|1
5264797|NCT00660179|18163970|P2|Overall Study|Administrative reason|0
5264798|NCT00660179|18163971|P1|Overall Study|Administrative reason|0
5264799|NCT00660179|18163969|P3|Overall Study|Lost to Follow-up|2
5264800|NCT00660179|18163970|P2|Overall Study|Lost to Follow-up|5
5264801|NCT00660179|18163971|P1|Overall Study|Lost to Follow-up|7
5264802|NCT00660179|18163969|P3|Overall Study|Withdrawal of consent|4
5264803|NCT00660179|18163970|P2|Overall Study|Withdrawal of consent|6
5264804|NCT00660179|18163971|P1|Overall Study|Withdrawal of consent|4
5264805|NCT00660179|18163969|P3|Overall Study|Death|34
5264806|NCT00660179|18163970|P2|Overall Study|Death|47
5264807|NCT00660179|18163971|P1|Overall Study|Death|44
5264808|NCT00660023|18164016|P1|Overall Study|Other Screening Failure|9
5264809|NCT00660023|18164016|P1|Overall Study|Missed Pregnancy Test|1
5264810|NCT00660023|18164016|P1|Overall Study|Withdrawal by Subject|1
5264811|NCT00660023|18164016|P1|Overall Study|Renal Transplantation|3
5264812|NCT00660023|18164016|P1|Overall Study|Blood Transfusion|5
5264813|NCT00660023|18164016|P1|Overall Study|Death|8
5264814|NCT00660023|18164016|P1|Overall Study|Adverse Event|2
5264815|NCT00660010|18164027|P1|Overall Study|Noncompliance with visit schedule|3
5264816|NCT00660010|18164027|P1|Overall Study|Adverse Event|1
5264817|NCT00660010|18164027|P1|Overall Study|Lost to Follow-up|3
5264818|NCT00660010|18164027|P1|Overall Study|Withdrawal by Subject|2
5264819|NCT00659984|18164041|P1|Overall Study|Adverse Event|1
5264820|NCT00659880|18164061|P1|Overall Study|Lost to Follow-up|5
5264821|NCT00659815|18164074|P2|Overall Study|Withdrawal by Subject|1
5264822|NCT00659815|18164075|P1|Overall Study|Withdrawal by Subject|1
5264823|NCT00659815|18164074|P2|Overall Study|Inability to maintain wearing schedule|2
5264824|NCT00659815|18164075|P1|Overall Study|Inability to maintain wearing schedule|1
5264825|NCT00659815|18164074|P2|Overall Study|Study related symptoms and complaints|1
5264826|NCT00659815|18164075|P1|Overall Study|Study related symptoms and complaints|2
5264827|NCT00659607|18164154|P1|Overall Study|Inconsistent BP measuring date|2
5264828|NCT00659607|18164154|P1|Overall Study|No recorded efficacy data|15
5264829|NCT00659607|18164154|P1|Overall Study|'Unable to evaluate' for the final asses|67
5264830|NCT00659607|18164154|P1|Overall Study|Unknown measuring date of blood pressure|85
5264831|NCT00659607|18164154|P1|Overall Study|No blood pressure recorded|147
5264832|NCT00659581|18164172|P1|Overall Study|Other|6393
5264833|NCT00659581|18164172|P1|Overall Study|Lack of Efficacy|1183
5264834|NCT00659581|18164172|P1|Overall Study|Adverse Event|1006
5264835|NCT00659529|18164184|P1|Overall Study|Screen failure|9
5264836|NCT00659529|18164184|P1|Overall Study|Protocol Violation|3
5264837|NCT00659529|18164184|P1|Overall Study|Withdrawal by Subject|4
5264838|NCT00659490|18164191|P3|Overall Study|Lost to Follow-up|1
5264839|NCT00659490|18164192|P2|Overall Study|Lost to Follow-up|0
5264840|NCT00659490|18164193|P1|Overall Study|Lost to Follow-up|2
5264841|NCT00659438|18164266|P2|Overall Study|Lost to Follow-up|0
5264842|NCT00659438|18164267|P1|Overall Study|Lost to Follow-up|1
5264843|NCT00659438|18164266|P2|Overall Study|Death|6
5264844|NCT00659438|18164267|P1|Overall Study|Death|11
5264845|NCT00659438|18164266|P2|Overall Study|Withdrawal by Subject|2
5264846|NCT00659438|18164267|P1|Overall Study|Withdrawal by Subject|2
5264847|NCT00659425|18164299|P10|Overall Study|Other|6
5264848|NCT00659425|18164300|P9|Overall Study|Other|0
5264849|NCT00659425|18164301|P8|Overall Study|Other|2
5264850|NCT00659425|18164302|P7|Overall Study|Other|3
5264851|NCT00659425|18164303|P6|Overall Study|Other|0
5264852|NCT00659425|18164304|P5|Overall Study|Other|4
5264853|NCT00659425|18164305|P4|Overall Study|Other|2
5264854|NCT00659425|18164306|P3|Overall Study|Other|1
5264855|NCT00659425|18164307|P2|Overall Study|Other|1
5264856|NCT00659425|18164308|P1|Overall Study|Other|0
5264857|NCT00659425|18164299|P10|Overall Study|Investigator Discretion|0
5264858|NCT00659425|18164300|P9|Overall Study|Investigator Discretion|0
5264859|NCT00659425|18164301|P8|Overall Study|Investigator Discretion|3
5264860|NCT00659425|18164302|P7|Overall Study|Investigator Discretion|0
5264861|NCT00659425|18164303|P6|Overall Study|Investigator Discretion|1
5264862|NCT00659425|18164304|P5|Overall Study|Investigator Discretion|0
5264863|NCT00659425|18164305|P4|Overall Study|Investigator Discretion|0
5264864|NCT00659425|18164306|P3|Overall Study|Investigator Discretion|0
5264865|NCT00659425|18164307|P2|Overall Study|Investigator Discretion|0
5264866|NCT00659425|18164308|P1|Overall Study|Investigator Discretion|0
5264867|NCT00659425|18164299|P10|Overall Study|Adverse Event|4
5264868|NCT00659425|18164300|P9|Overall Study|Adverse Event|1
5264869|NCT00659425|18164301|P8|Overall Study|Adverse Event|3
5264870|NCT00659425|18164302|P7|Overall Study|Adverse Event|0
5264871|NCT00659425|18164303|P6|Overall Study|Adverse Event|1
5264872|NCT00659425|18164304|P5|Overall Study|Adverse Event|0
5264873|NCT00659425|18164305|P4|Overall Study|Adverse Event|0
5264874|NCT00659425|18164306|P3|Overall Study|Adverse Event|0
5264875|NCT00659425|18164307|P2|Overall Study|Adverse Event|0
5264876|NCT00659425|18164308|P1|Overall Study|Adverse Event|0
5264877|NCT00659425|18164299|P10|Overall Study|Death|0
5264878|NCT00659425|18164300|P9|Overall Study|Death|0
5264879|NCT00659425|18164301|P8|Overall Study|Death|0
5264880|NCT00659425|18164302|P7|Overall Study|Death|1
5264881|NCT00659425|18164303|P6|Overall Study|Death|0
5264882|NCT00659425|18164304|P5|Overall Study|Death|0
5264883|NCT00659425|18164305|P4|Overall Study|Death|1
5264884|NCT00659425|18164306|P3|Overall Study|Death|0
5264885|NCT00659425|18164307|P2|Overall Study|Death|0
5264886|NCT00659425|18164308|P1|Overall Study|Death|0
5264887|NCT00659425|18164299|P10|Overall Study|Disease progression|3
5264888|NCT00659425|18164300|P9|Overall Study|Disease progression|5
5264889|NCT00659425|18164301|P8|Overall Study|Disease progression|3
5264890|NCT00659425|18164302|P7|Overall Study|Disease progression|4
5264891|NCT00659425|18164303|P6|Overall Study|Disease progression|2
5264892|NCT00659425|18164304|P5|Overall Study|Disease progression|0
5264893|NCT00659425|18164305|P4|Overall Study|Disease progression|1
5264894|NCT00659425|18164306|P3|Overall Study|Disease progression|0
5264895|NCT00659425|18164307|P2|Overall Study|Disease progression|0
5264896|NCT00659425|18164308|P1|Overall Study|Disease progression|1
5264897|NCT00659373|18164539|P2|Overall Study|Assessment Missed|2
5264898|NCT00659373|18164540|P1|Overall Study|Assessment Missed|2
5264899|NCT00659373|18164539|P2|Overall Study|Withdrawal by Subject|5
5264900|NCT00659373|18164540|P1|Overall Study|Withdrawal by Subject|3
5264901|NCT00659334|18164562|P7|Overall Study|Screen Failure|1
5264902|NCT00659334|18164563|P6|Overall Study|Screen Failure|0
5264903|NCT00659334|18164564|P5|Overall Study|Screen Failure|0
5264904|NCT00659334|18164565|P4|Overall Study|Screen Failure|0
5264905|NCT00659334|18164566|P3|Overall Study|Screen Failure|0
5264906|NCT00659334|18164567|P2|Overall Study|Screen Failure|5
5264907|NCT00659334|18164568|P1|Overall Study|Screen Failure|8
5264908|NCT00659269|18164595|P2|Overall Study|Physician Decision|1
5264909|NCT00659269|18164596|P1|Overall Study|Physician Decision|1
5264910|NCT00659230|18164626|P2|Overall Study|Did not return post-randomization|3
5264911|NCT00659230|18164627|P1|Overall Study|Did not return post-randomization|2
5264912|NCT00659230|18164626|P2|Overall Study|Lost source documentation|4
5264913|NCT00659230|18164627|P1|Overall Study|Lost source documentation|5
5264914|NCT00659230|18164626|P2|Overall Study|Lost to Follow-up|5
5264915|NCT00659230|18164627|P1|Overall Study|Lost to Follow-up|2
5264916|NCT00659061|18164650|P2|Overall Study|Migration due to political unrest|15
5264917|NCT00659061|18164651|P1|Overall Study|Migration due to political unrest|21
5264918|NCT00658996|18164669|P2|Second Intervention|Positive slit lamp finding|1
5264919|NCT00658996|18164670|P1|Second Intervention|Positive slit lamp finding|0
5264920|NCT00658996|18164669|P2|Second Intervention|Developed a stye on upper lid|0
5264921|NCT00658996|18164670|P1|Second Intervention|Developed a stye on upper lid|1
5264922|NCT00658996|18164669|P2|Crossover Period|Ineligible|1
5264923|NCT00658996|18164670|P1|Crossover Period|Ineligible|1
5264924|NCT00658996|18164669|P2|Crossover Period|Physician Decision|0
5264925|NCT00658996|18164670|P1|Crossover Period|Physician Decision|1
5264926|NCT00658996|18164669|P2|First Intervention|Lack of lenses|1
5264927|NCT00658996|18164670|P1|First Intervention|Lack of lenses|0
5264928|NCT00658996|18164669|P2|First Intervention|Positive slit lamp finding|0
5264929|NCT00658996|18164670|P1|First Intervention|Positive slit lamp finding|1
5264930|NCT00658879|18164680|P1|Overall Study|Protocol Violation|1
5264931|NCT00658814|18164697|P2|Maintenance Therapy|Not eligible|0
5264932|NCT00658814|18164698|P1|Maintenance Therapy|Not eligible|1
5264933|NCT00658814|18164697|P2|Maintenance Therapy|Not protocol specified|0
5264934|NCT00658814|18164698|P1|Maintenance Therapy|Not protocol specified|1
5264935|NCT00658814|18164697|P2|Maintenance Therapy|Adverse Event|1
5264936|NCT00658814|18164698|P1|Maintenance Therapy|Adverse Event|1
5264937|NCT00658814|18164697|P2|Consolidation Therapy|Not eligible|2
5264938|NCT00658814|18164698|P1|Consolidation Therapy|Not eligible|2
5264939|NCT00658814|18164697|P2|Consolidation Therapy|Not protocol specified|1
5264940|NCT00658814|18164698|P1|Consolidation Therapy|Not protocol specified|0
5264941|NCT00658814|18164697|P2|Remission Induction Chemotherapy|Not eligible|2
5264942|NCT00658814|18164698|P1|Remission Induction Chemotherapy|Not eligible|1
5264943|NCT00658814|18164697|P2|Remission Induction Chemotherapy|Not protocol specified|4
5264944|NCT00658814|18164698|P1|Remission Induction Chemotherapy|Not protocol specified|2
5264945|NCT00658814|18164697|P2|Remission Induction Chemotherapy|Death|4
5264946|NCT00658814|18164698|P1|Remission Induction Chemotherapy|Death|1
5264947|NCT00658814|18164697|P2|Remission Induction Chemotherapy|Progression/Relapse|1
5264948|NCT00658814|18164698|P1|Remission Induction Chemotherapy|Progression/Relapse|0
5264949|NCT00658814|18164697|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
5264950|NCT00658814|18164698|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
5264951|NCT00658814|18164697|P2|Remission Induction Chemotherapy|Adverse Event|3
5264952|NCT00658814|18164698|P1|Remission Induction Chemotherapy|Adverse Event|1
5264953|NCT00658788|18164712|P1|Overall Study|Treatment Discontinuation|32
5264954|NCT00658788|18164712|P1|Overall Study|Lost to Follow-up|18
5264955|NCT00658788|18164712|P1|Overall Study|Withdrawal by Subject|13
5264956|NCT00658788|18164712|P1|Overall Study|Adverse Event|11
5264957|NCT00658775|18164767|P2|Overall Study|Other|8
5264958|NCT00658775|18164768|P1|Overall Study|Other|7
5264959|NCT00658775|18164767|P2|Overall Study|Withdrawal of consent|7
5264960|NCT00658775|18164768|P1|Overall Study|Withdrawal of consent|8
5264961|NCT00658775|18164767|P2|Overall Study|Withdrawal by Subject|4
5264962|NCT00658775|18164768|P1|Overall Study|Withdrawal by Subject|6
5264963|NCT00658775|18164767|P2|Overall Study|Lost to Follow-up|18
5264964|NCT00658775|18164768|P1|Overall Study|Lost to Follow-up|17
5264965|NCT00658775|18164767|P2|Overall Study|Adverse Event|6
5264966|NCT00658775|18164768|P1|Overall Study|Adverse Event|4
5264967|NCT00658723|18164791|P3|Overall Study|Withdrawal by Subject|1
5264968|NCT00658723|18164792|P2|Overall Study|Withdrawal by Subject|0
5264969|NCT00658723|18164793|P1|Overall Study|Withdrawal by Subject|1
5264970|NCT00658723|18164791|P3|Overall Study|Scheduling Issue|0
5264971|NCT00658723|18164792|P2|Overall Study|Scheduling Issue|1
5264972|NCT00658723|18164793|P1|Overall Study|Scheduling Issue|1
5264973|NCT00658723|18164791|P3|Overall Study|Death|4
5264974|NCT00658723|18164792|P2|Overall Study|Death|1
5264975|NCT00658723|18164793|P1|Overall Study|Death|2
5264976|NCT00658723|18164791|P3|Overall Study|Lost to Follow-up|2
5264977|NCT00658723|18164792|P2|Overall Study|Lost to Follow-up|2
5264978|NCT00658723|18164793|P1|Overall Study|Lost to Follow-up|0
5264979|NCT00658684|18164831|P4|Overall Study|Pregnancy|0
5264980|NCT00658684|18164832|P3|Overall Study|Pregnancy|0
5264981|NCT00658684|18164833|P2|Overall Study|Pregnancy|1
5264982|NCT00658684|18164834|P1|Overall Study|Pregnancy|1
5264983|NCT00658684|18164831|P4|Overall Study|Protocol Violation|0
5264984|NCT00658684|18164832|P3|Overall Study|Protocol Violation|0
5264985|NCT00658684|18164833|P2|Overall Study|Protocol Violation|1
5264986|NCT00658684|18164834|P1|Overall Study|Protocol Violation|1
5264987|NCT00658684|18164831|P4|Overall Study|Lack of Efficacy|0
5264988|NCT00658684|18164832|P3|Overall Study|Lack of Efficacy|0
5264989|NCT00658684|18164833|P2|Overall Study|Lack of Efficacy|1
5264990|NCT00658684|18164834|P1|Overall Study|Lack of Efficacy|1
5264991|NCT00658684|18164831|P4|Overall Study|Withdrawal by Subject|1
5264992|NCT00658684|18164832|P3|Overall Study|Withdrawal by Subject|1
5264993|NCT00658684|18164833|P2|Overall Study|Withdrawal by Subject|4
5264994|NCT00658684|18164834|P1|Overall Study|Withdrawal by Subject|6
5264995|NCT00658684|18164831|P4|Overall Study|Adverse Event|0
5264996|NCT00658684|18164832|P3|Overall Study|Adverse Event|2
5264997|NCT00658684|18164833|P2|Overall Study|Adverse Event|8
5264998|NCT00658684|18164834|P1|Overall Study|Adverse Event|10
5264999|NCT00658658|18164889|P5|Overall Study|Other|1
5265000|NCT00658658|18164890|P4|Overall Study|Other|0
5265001|NCT00658658|18164891|P3|Overall Study|Other|0
5265002|NCT00658658|18164892|P2|Overall Study|Other|0
5265003|NCT00658658|18164893|P1|Overall Study|Other|0
5265004|NCT00658658|18164889|P5|Overall Study|Protocol-specified Criteria|0
5265005|NCT00658658|18164890|P4|Overall Study|Protocol-specified Criteria|0
5265006|NCT00658658|18164891|P3|Overall Study|Protocol-specified Criteria|0
5265007|NCT00658658|18164892|P2|Overall Study|Protocol-specified Criteria|0
5265008|NCT00658658|18164893|P1|Overall Study|Protocol-specified Criteria|1
5265009|NCT00658658|18164889|P5|Overall Study|Disease Progression|3
5265010|NCT00658658|18164890|P4|Overall Study|Disease Progression|1
5265011|NCT00658658|18164891|P3|Overall Study|Disease Progression|0
5265012|NCT00658658|18164892|P2|Overall Study|Disease Progression|1
5265013|NCT00658658|18164893|P1|Overall Study|Disease Progression|0
5265014|NCT00658658|18164889|P5|Overall Study|Death|1
5265015|NCT00658658|18164890|P4|Overall Study|Death|1
5265016|NCT00658658|18164891|P3|Overall Study|Death|0
5265017|NCT00658658|18164892|P2|Overall Study|Death|0
5265018|NCT00658658|18164893|P1|Overall Study|Death|4
5265019|NCT00658658|18164889|P5|Overall Study|Withdrawal by Subject|0
5265020|NCT00658658|18164890|P4|Overall Study|Withdrawal by Subject|0
5265021|NCT00658658|18164891|P3|Overall Study|Withdrawal by Subject|0
5265022|NCT00658658|18164892|P2|Overall Study|Withdrawal by Subject|1
5265023|NCT00658658|18164893|P1|Overall Study|Withdrawal by Subject|0
5265024|NCT00658632|18164952|P2|Overall Study|Other|8
5265025|NCT00658632|18164953|P1|Overall Study|Other|7
5265026|NCT00658632|18164952|P2|Overall Study|Pregnancy|1
5265027|NCT00658632|18164953|P1|Overall Study|Pregnancy|1
5265028|NCT00658632|18164952|P2|Overall Study|Withdrawal of consent|14
5265029|NCT00658632|18164953|P1|Overall Study|Withdrawal of consent|8
5265030|NCT00658632|18164952|P2|Overall Study|Lack of Efficacy|1
5265031|NCT00658632|18164953|P1|Overall Study|Lack of Efficacy|0
5265032|NCT00658632|18164952|P2|Overall Study|Withdrawal by Subject|7
5265033|NCT00658632|18164953|P1|Overall Study|Withdrawal by Subject|10
5265034|NCT00658632|18164952|P2|Overall Study|Lost to Follow-up|23
5265035|NCT00658632|18164953|P1|Overall Study|Lost to Follow-up|25
5265036|NCT00658632|18164952|P2|Overall Study|Adverse Event|11
5265037|NCT00658632|18164953|P1|Overall Study|Adverse Event|13
5265038|NCT00658606|18164994|P2|Overall Study|Lack of Compliance|3
5265039|NCT00658606|18164995|P1|Overall Study|Lack of Compliance|0
5265040|NCT00658606|18164994|P2|Overall Study|Withdrawal by Subject|16
5265041|NCT00658606|18164995|P1|Overall Study|Withdrawal by Subject|7
5265042|NCT00658606|18164994|P2|Overall Study|Lost to Follow-up|0
5265043|NCT00658606|18164995|P1|Overall Study|Lost to Follow-up|1
5265044|NCT00658606|18164994|P2|Overall Study|Lack of Efficacy|3
5265045|NCT00658606|18164995|P1|Overall Study|Lack of Efficacy|6
5265046|NCT00658606|18164994|P2|Overall Study|Adverse Event|1
5265047|NCT00658606|18164995|P1|Overall Study|Adverse Event|2
5265048|NCT00658567|18165024|P3|Overall Study|At Discretion of Sponsor|1
5265049|NCT00658567|18165025|P2|Overall Study|At Discretion of Sponsor|1
5265050|NCT00658567|18165026|P1|Overall Study|At Discretion of Sponsor|1
5265051|NCT00658567|18165024|P3|Overall Study|Physician Decision|0
5265052|NCT00658567|18165025|P2|Overall Study|Physician Decision|1
5265053|NCT00658567|18165026|P1|Overall Study|Physician Decision|0
5265054|NCT00658567|18165024|P3|Overall Study|Voluntary Withdrawal of Consent|2
5265055|NCT00658567|18165025|P2|Overall Study|Voluntary Withdrawal of Consent|0
5265056|NCT00658567|18165026|P1|Overall Study|Voluntary Withdrawal of Consent|2
5265057|NCT00658567|18165024|P3|Overall Study|Adverse Event|3
5265058|NCT00658567|18165025|P2|Overall Study|Adverse Event|2
5265059|NCT00658567|18165026|P1|Overall Study|Adverse Event|5
5265060|NCT00658541|18165037|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5265061|NCT00658541|18165038|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5265062|NCT00658541|18165037|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5265063|NCT00658541|18165038|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5265064|NCT00658528|18165050|P2|Overall Study|Other|4
5265065|NCT00658528|18165051|P1|Overall Study|Other|8
5265066|NCT00658528|18165050|P2|Overall Study|Withdrawal of consent|6
5265067|NCT00658528|18165051|P1|Overall Study|Withdrawal of consent|5
5265068|NCT00658528|18165050|P2|Overall Study|Withdrawal by Subject|6
5265069|NCT00658528|18165051|P1|Overall Study|Withdrawal by Subject|8
5265070|NCT00658528|18165050|P2|Overall Study|Lost to Follow-up|22
5265071|NCT00658528|18165051|P1|Overall Study|Lost to Follow-up|14
5265072|NCT00658528|18165050|P2|Overall Study|Adverse Event|7
5265073|NCT00658528|18165051|P1|Overall Study|Adverse Event|5
5265074|NCT00658359|18165091|P3|Overall Study|Lack of Efficacy|0
5265075|NCT00658359|18165092|P2|Overall Study|Lack of Efficacy|1
5265076|NCT00658359|18165093|P1|Overall Study|Lack of Efficacy|0
5265077|NCT00658359|18165091|P3|Overall Study|Lost to Follow-up|4
5265078|NCT00658359|18165092|P2|Overall Study|Lost to Follow-up|2
5265079|NCT00658359|18165093|P1|Overall Study|Lost to Follow-up|2
5265080|NCT00658359|18165091|P3|Overall Study|Withdrawal by Subject|2
5265081|NCT00658359|18165092|P2|Overall Study|Withdrawal by Subject|4
5265082|NCT00658359|18165093|P1|Overall Study|Withdrawal by Subject|7
5265083|NCT00658359|18165091|P3|Overall Study|Includes protocol Amendments 3 and 4|29
5265084|NCT00658359|18165092|P2|Overall Study|Includes protocol Amendments 3 and 4|31
5265085|NCT00658359|18165093|P1|Overall Study|Includes protocol Amendments 3 and 4|2
5265086|NCT00658359|18165091|P3|Overall Study|Protocol Violation|0
5265087|NCT00658359|18165092|P2|Overall Study|Protocol Violation|0
5265088|NCT00658359|18165093|P1|Overall Study|Protocol Violation|1
5265089|NCT00658359|18165091|P3|Overall Study|Adverse Event|9
5265090|NCT00658359|18165092|P2|Overall Study|Adverse Event|6
5265091|NCT00658359|18165093|P1|Overall Study|Adverse Event|13
5265092|NCT00658359|18165091|P3|Overall Study|Death|2
5265093|NCT00658359|18165092|P2|Overall Study|Death|1
5265094|NCT00658359|18165093|P1|Overall Study|Death|3
5265095|NCT00658333|18165181|P2|Overall Study|Adverse Event|1
5265096|NCT00658333|18165182|P1|Overall Study|Adverse Event|2
5265097|NCT00658320|18165192|P2|Extension Study: After Month 24|Subject withdrew consent|0
5265098|NCT00658320|18165193|P1|Extension Study: After Month 24|Subject withdrew consent|2
5265099|NCT00658320|18165192|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
5265100|NCT00658320|18165193|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
5265101|NCT00658320|18165192|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
5265102|NCT00658320|18165193|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
5265103|NCT00658320|18165192|P2|Core Study: 12 Months|Subject withdrew consent|3
5265104|NCT00658320|18165193|P1|Core Study: 12 Months|Subject withdrew consent|5
5265105|NCT00657709|18165236|P5|Overall Study|Protocol Violation|2
5265106|NCT00657709|18165237|P4|Overall Study|Protocol Violation|1
5265107|NCT00657709|18165238|P3|Overall Study|Protocol Violation|0
5265108|NCT00657709|18165239|P2|Overall Study|Protocol Violation|2
5265109|NCT00657709|18165240|P1|Overall Study|Protocol Violation|0
5265110|NCT00657709|18165236|P5|Overall Study|Lost to Follow-up|21
5265111|NCT00657709|18165237|P4|Overall Study|Lost to Follow-up|1
5265112|NCT00657709|18165238|P3|Overall Study|Lost to Follow-up|7
5265113|NCT00657709|18165239|P2|Overall Study|Lost to Follow-up|9
5265114|NCT00657709|18165240|P1|Overall Study|Lost to Follow-up|9
5265115|NCT00657709|18165236|P5|Overall Study|Withdrawal by Subject|9
5265116|NCT00657709|18165237|P4|Overall Study|Withdrawal by Subject|5
5265117|NCT00657709|18165238|P3|Overall Study|Withdrawal by Subject|15
5265118|NCT00657709|18165239|P2|Overall Study|Withdrawal by Subject|15
5265119|NCT00657709|18165240|P1|Overall Study|Withdrawal by Subject|7
5265120|NCT00657709|18165236|P5|Overall Study|AE or Death|1
5265121|NCT00657709|18165237|P4|Overall Study|AE or Death|7
5265122|NCT00657709|18165238|P3|Overall Study|AE or Death|6
5265123|NCT00657709|18165239|P2|Overall Study|AE or Death|7
5265124|NCT00657709|18165240|P1|Overall Study|AE or Death|7
5265125|NCT00657618|18165289|P1|Overall Study|didn't start due to schedule conflicts|1
5265126|NCT00657618|18165289|P1|Overall Study|negative for leishmaniasis|2
5265127|NCT00657618|18165289|P1|Overall Study|Withdrawal by Subject|8
5265128|NCT00657618|18165289|P1|Overall Study|Adverse Event|32
5265129|NCT00657553|18165301|P2|Overall Study|low accrual, no analysis run|5
5265130|NCT00657553|18165302|P1|Overall Study|low accrual, no analysis run|5
5265131|NCT00657540|18165310|P2|Overall Study|Lost to Follow-up|4
5265132|NCT00657540|18165311|P1|Overall Study|Lost to Follow-up|1
5265133|NCT00657371|18165325|P1|Overall Study|Pre-existing medical condition|4
5265134|NCT00657371|18165325|P1|Overall Study|Device- related reasons|13
5265135|NCT00657371|18165325|P1|Overall Study|Protocol Violation|2
5265136|NCT00657371|18165325|P1|Overall Study|Unable to intubate the cecum|5
5265137|NCT00657371|18165325|P1|Overall Study|Poor bowel preparation|15
5265138|NCT00657358|18165330|P1|Overall Study|Lack of Efficacy|6
5265139|NCT00657267|18165342|P1|Overall Study|Adverse Event|9
5265140|NCT00657267|18165342|P1|Overall Study|Progressive disease|45
5265141|NCT00657150|18165352|P2|Treatment|Other|15
5265142|NCT00657150|18165353|P1|Treatment|Other|13
5265143|NCT00657150|18165352|P2|Treatment|Withdrawal by Subject|20
5265144|NCT00657150|18165353|P1|Treatment|Withdrawal by Subject|23
5265145|NCT00657150|18165352|P2|Treatment|Lost to Follow-up|0
5265146|NCT00657150|18165353|P1|Treatment|Lost to Follow-up|1
5265147|NCT00657150|18165352|P2|Treatment|Non-compliant with protocol|9
5265148|NCT00657150|18165353|P1|Treatment|Non-compliant with protocol|10
5265149|NCT00657150|18165352|P2|Treatment|Adverse Event|53
5265150|NCT00657150|18165353|P1|Treatment|Adverse Event|60
5265151|NCT00657150|18165352|P2|Overall Study|Other|38
5265152|NCT00657150|18165353|P1|Overall Study|Other|38
5265153|NCT00657150|18165352|P2|Overall Study|Withdrawal by Subject|36
5265154|NCT00657150|18165353|P1|Overall Study|Withdrawal by Subject|51
5265155|NCT00657150|18165352|P2|Overall Study|Lost to Follow-up|0
5265156|NCT00657150|18165353|P1|Overall Study|Lost to Follow-up|2
5265157|NCT00657150|18165352|P2|Overall Study|Non-compliant with protocol|9
5265158|NCT00657150|18165353|P1|Overall Study|Non-compliant with protocol|5
5265159|NCT00657150|18165352|P2|Overall Study|Adverse Event|10
5265160|NCT00657150|18165353|P1|Overall Study|Adverse Event|19
5265161|NCT00657046|18165384|P3|Overall Study|Surgery|1
5265162|NCT00657046|18165385|P2|Overall Study|Surgery|0
5265163|NCT00657046|18165386|P1|Overall Study|Surgery|0
5265164|NCT00657046|18165384|P3|Overall Study|Death|1
5265165|NCT00657046|18165385|P2|Overall Study|Death|0
5265166|NCT00657046|18165386|P1|Overall Study|Death|0
5265167|NCT00657046|18165384|P3|Overall Study|Withdrawal by Subject|0
5265168|NCT00657046|18165385|P2|Overall Study|Withdrawal by Subject|0
5265169|NCT00657046|18165386|P1|Overall Study|Withdrawal by Subject|1
5265170|NCT00657046|18165384|P3|Overall Study|Protocol Violation|0
5265171|NCT00657046|18165385|P2|Overall Study|Protocol Violation|2
5265172|NCT00657046|18165386|P1|Overall Study|Protocol Violation|2
5265173|NCT00657046|18165384|P3|Overall Study|Adverse Event|0
5265174|NCT00657046|18165385|P2|Overall Study|Adverse Event|1
5265175|NCT00657046|18165386|P1|Overall Study|Adverse Event|1
5265176|NCT00657020|18165418|P2|PERIOD 1|Adverse Event|1
5265177|NCT00657020|18165419|P1|PERIOD 1|Adverse Event|0
5265178|NCT00656851|18165469|P2|Overall Study|Withdrawal by Subject|4
5265179|NCT00656851|18165470|P1|Overall Study|Withdrawal by Subject|0
5265180|NCT00656799|18165492|P1|Overall Study|Death|2
5265181|NCT00656669|18165514|P1|AC (Cycles 6-9)|Did not start segment 3|1
5265182|NCT00656669|18165514|P1|AC (Cycles 6-9)|Adverse Event|1
5265183|NCT00656669|18165514|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
5265184|NCT00656669|18165514|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
5265185|NCT00656617|18165553|P1|Overall Study|Move to different clinical trial|2
5265186|NCT00656617|18165553|P1|Overall Study|Insurance Issues|2
5265187|NCT00656617|18165553|P1|Overall Study|Death|2
5265188|NCT00656617|18165553|P1|Overall Study|Adverse Event|1
5265189|NCT00656513|18165562|P3|Overall Study|Missing baseline form|5
5265190|NCT00656513|18165563|P2|Overall Study|Missing baseline form|5
5265191|NCT00656513|18165564|P1|Overall Study|Missing baseline form|0
5265192|NCT00656513|18165562|P3|Overall Study|Treatment completed outside of timeframe|1
5265193|NCT00656513|18165563|P2|Overall Study|Treatment completed outside of timeframe|3
5265194|NCT00656513|18165564|P1|Overall Study|Treatment completed outside of timeframe|0
5265195|NCT00656513|18165562|P3|Overall Study|Incomplete treatment|0
5265196|NCT00656513|18165563|P2|Overall Study|Incomplete treatment|0
5265197|NCT00656513|18165564|P1|Overall Study|Incomplete treatment|3
5265198|NCT00656513|18165562|P3|Overall Study|Missing data|9
5265199|NCT00656513|18165563|P2|Overall Study|Missing data|11
5265200|NCT00656513|18165564|P1|Overall Study|Missing data|0
5265201|NCT00656513|18165562|P3|Overall Study|Death|1
5265202|NCT00656513|18165563|P2|Overall Study|Death|0
5265203|NCT00656513|18165564|P1|Overall Study|Death|0
5265204|NCT00656513|18165562|P3|Overall Study|Withdrawal by Subject|4
5265205|NCT00656513|18165563|P2|Overall Study|Withdrawal by Subject|11
5265206|NCT00656513|18165564|P1|Overall Study|Withdrawal by Subject|0
5265207|NCT00656513|18165562|P3|Overall Study|Protocol Violation|2
5265208|NCT00656513|18165563|P2|Overall Study|Protocol Violation|0
5265209|NCT00656513|18165564|P1|Overall Study|Protocol Violation|1
5265210|NCT00656474|18165611|P1|Overall Study|Other Reason|1
5265211|NCT00656370|18165629|P1|Overall Study|Alternates|3
5265212|NCT00656370|18165629|P1|Overall Study|Screen Failures|7
5265213|NCT00656292|18165658|P2|Overall Study|Screen failure|2
5265214|NCT00656292|18165659|P1|Overall Study|Screen failure|1
5265215|NCT00656292|18165658|P2|Overall Study|Withdrawal by Subject|3
5265216|NCT00656292|18165659|P1|Overall Study|Withdrawal by Subject|2
5265217|NCT00656175|18165686|P2|Overall Study|Transportation issues|1
5265218|NCT00656175|18165687|P1|Overall Study|Transportation issues|0
5265219|NCT00656175|18165686|P2|Overall Study|Adverse Event|0
5265220|NCT00656175|18165687|P1|Overall Study|Adverse Event|1
5265221|NCT00656136|18165695|P2|Overall Study|Unknown and others|4
5265222|NCT00656136|18165696|P1|Overall Study|Unknown and others|4
5265223|NCT00656136|18165695|P2|Overall Study|Patient refused to take study medication|10
5265224|NCT00656136|18165696|P1|Overall Study|Patient refused to take study medication|7
5265225|NCT00656136|18165695|P2|Overall Study|Protocol Violation|3
5265226|NCT00656136|18165696|P1|Overall Study|Protocol Violation|2
5265227|NCT00656136|18165695|P2|Overall Study|Other Adverse Event|51
5265228|NCT00656136|18165696|P1|Overall Study|Other Adverse Event|5
5265229|NCT00656136|18165695|P2|Overall Study|Progressive disease|322
5265230|NCT00656136|18165696|P1|Overall Study|Progressive disease|177
5265231|NCT00656084|18165706|P1|Overall Study|Investigator Request|1
5265232|NCT00656084|18165706|P1|Overall Study|Patient Request|1
5265233|NCT00656084|18165706|P1|Overall Study|Withdrawal by Subject|1
5265234|NCT00656084|18165706|P1|Overall Study|Adverse Event|4
5265235|NCT00656058|18165713|P1|Overall Study|Withdrawal by Subject|4
5265236|NCT00656058|18165713|P1|Overall Study|Withdrawal by Subject|2
5265237|NCT00656019|18165726|P4|Overall Study|Lost to Follow-up|0
5265238|NCT00656019|18165727|P3|Overall Study|Lost to Follow-up|0
5265239|NCT00656019|18165728|P2|Overall Study|Lost to Follow-up|1
5265240|NCT00656019|18165729|P1|Overall Study|Lost to Follow-up|2
5265241|NCT00656019|18165726|P4|Overall Study|Withdrawal by Subject|0
5265242|NCT00656019|18165727|P3|Overall Study|Withdrawal by Subject|0
5265243|NCT00656019|18165728|P2|Overall Study|Withdrawal by Subject|0
5265244|NCT00656019|18165729|P1|Overall Study|Withdrawal by Subject|2
5265245|NCT00656019|18165726|P4|Overall Study|Not Eligible|0
5265246|NCT00656019|18165727|P3|Overall Study|Not Eligible|0
5265247|NCT00656019|18165728|P2|Overall Study|Not Eligible|0
5265248|NCT00656019|18165729|P1|Overall Study|Not Eligible|10
5265249|NCT00655980|18165742|P3|Overall Study|surgery canceled; or subject or anesthes|5
5265250|NCT00655980|18165743|P2|Overall Study|surgery canceled; or subject or anesthes|31
5265251|NCT00655980|18165744|P1|Overall Study|surgery canceled; or subject or anesthes|26
5265252|NCT00655928|18165757|P2|Overall Study|Physician Decision|1
5265253|NCT00655928|18165758|P1|Overall Study|Physician Decision|1
5265254|NCT00655928|18165757|P2|Overall Study|Withdrawal by Subject|1
5265255|NCT00655928|18165758|P1|Overall Study|Withdrawal by Subject|2
5265256|NCT00655889|18165764|P1|Overall Study|Protocol Violation|1
5265257|NCT00655889|18165764|P1|Overall Study|Inadequate cell growth|1
5265258|NCT00655876|18165771|P2|Overall Study|Protocol Violation|7
5265259|NCT00655876|18165772|P1|Overall Study|Protocol Violation|9
5265260|NCT00655863|18165791|P3|Overall Study|Lost to Follow-up|1
5265261|NCT00655863|18165792|P2|Overall Study|Lost to Follow-up|0
5265262|NCT00655863|18165793|P1|Overall Study|Lost to Follow-up|0
5265263|NCT00655850|18165852|P1|Overall Study|Withdrawal by Subject|1
5265264|NCT00655850|18165852|P1|Overall Study|Death|2
5265265|NCT00655824|18165859|P1|Overall Study|Deterioration of Trial Disease|2
5265266|NCT00655824|18165859|P1|Overall Study|Withdrawal by Subject|4
5265267|NCT00655824|18165859|P1|Overall Study|Protocol Violation|1
5265268|NCT00655824|18165859|P1|Overall Study|Early Termination of Study by Sponsor|74
5265269|NCT00655824|18165859|P1|Overall Study|Adverse Event|3
5265270|NCT00655746|18165907|P1|Overall Study|Withdrawal by Subject|1
5265271|NCT00655733|18165926|P2|Overall Study|Physician Decision|1
5265272|NCT00655733|18165927|P1|Overall Study|Physician Decision|0
5265273|NCT00655733|18165926|P2|Overall Study|Withdrawal by Subject|3
5265274|NCT00655733|18165927|P1|Overall Study|Withdrawal by Subject|3
5265275|NCT00655733|18165926|P2|Overall Study|Adverse Event|2
5265276|NCT00655733|18165927|P1|Overall Study|Adverse Event|2
5265277|NCT00655733|18165926|P2|Overall Study|Lost to Follow-up|2
5265278|NCT00655733|18165927|P1|Overall Study|Lost to Follow-up|2
5265279|NCT00655668|18165960|P1|Overall Study|Withdrawal by Subject|2
5265280|NCT00655668|18165960|P1|Overall Study|New Lymphoma Treatment Started|4
5265281|NCT00655668|18165960|P1|Overall Study|Other|1
5265282|NCT00655668|18165960|P1|Overall Study|Study Terminated|9
5265283|NCT00655668|18165960|P1|Overall Study|Disease Progression|27
5265284|NCT00655668|18165960|P1|Overall Study|Death|5
5265285|NCT00655668|18165960|P1|Overall Study|Adverse Event|6
5265286|NCT00655629|18165987|P2|Overall Study|consent withdrawn|4
5265287|NCT00655629|18165988|P1|Overall Study|consent withdrawn|6
5265288|NCT00655629|18165987|P2|Overall Study|Protocol Violation|3
5265289|NCT00655629|18165988|P1|Overall Study|Protocol Violation|5
5265290|NCT00655629|18165987|P2|Overall Study|Lost to Follow-up|3
5265291|NCT00655629|18165988|P1|Overall Study|Lost to Follow-up|4
5265292|NCT00655629|18165987|P2|Overall Study|Lack of Efficacy|12
5265293|NCT00655629|18165988|P1|Overall Study|Lack of Efficacy|2
5265294|NCT00655629|18165987|P2|Overall Study|Adverse Event|1
5265295|NCT00655629|18165988|P1|Overall Study|Adverse Event|4
5265296|NCT00655564|18166024|P1|Overall Study|Desired Alternate Therapy|1
5265297|NCT00655564|18166024|P1|Overall Study|Lost to Follow-up|1
5265298|NCT00655564|18166024|P1|Overall Study|Adverse Event|1
5265299|NCT00655551|18166032|P3|Period 4 (up to 7 Days)|Adverse Event|0
5265300|NCT00655551|18166033|P2|Period 4 (up to 7 Days)|Adverse Event|2
5265301|NCT00655551|18166034|P1|Period 4 (up to 7 Days)|Adverse Event|0
5265302|NCT00655551|18166032|P3|Period 3 (up to 7 Days)|Adverse Event|4
5265303|NCT00655551|18166033|P2|Period 3 (up to 7 Days)|Adverse Event|0
5265304|NCT00655551|18166034|P1|Period 3 (up to 7 Days)|Adverse Event|0
5265305|NCT00655551|18166032|P3|Period 2 (up to 7 Days)|Adverse Event|0
5265306|NCT00655551|18166033|P2|Period 2 (up to 7 Days)|Adverse Event|1
5265307|NCT00655551|18166034|P1|Period 2 (up to 7 Days)|Adverse Event|0
5265308|NCT00655551|18166032|P3|All Periods Combined|Adverse Event|4
5265309|NCT00655551|18166033|P2|All Periods Combined|Adverse Event|3
5265310|NCT00655551|18166034|P1|All Periods Combined|Adverse Event|0
5265311|NCT00655486|18166071|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
5265312|NCT00655486|18166071|P1|Overall Study|Other: Could not tolerate BID dosing|1
5265313|NCT00655486|18166071|P1|Overall Study|Other: Pregnancy|1
5265314|NCT00655486|18166071|P1|Overall Study|Unsatisfactory compliance|2
5265315|NCT00655486|18166071|P1|Overall Study|Protocol Violation|1
5265316|NCT00655486|18166071|P1|Overall Study|Withdrawal by Subject|4
5265317|NCT00655486|18166071|P1|Overall Study|Lack of Efficacy|8
5265318|NCT00655486|18166071|P1|Overall Study|Adverse Event|10
5265319|NCT00655356|18166099|P2|Overall Study|Other Reason|0
5265320|NCT00655356|18166100|P1|Overall Study|Other Reason|1
5265321|NCT00655356|18166099|P2|Overall Study|Protocol Violation|1
5265322|NCT00655356|18166100|P1|Overall Study|Protocol Violation|2
5265323|NCT00655356|18166099|P2|Overall Study|Adverse Event|1
5265324|NCT00655356|18166100|P1|Overall Study|Adverse Event|1
5265325|NCT00655356|18166099|P2|Overall Study|Sponsor Request|4
5265326|NCT00655356|18166100|P1|Overall Study|Sponsor Request|10
5265327|NCT00655356|18166099|P2|Overall Study|Withdrawal by Subject|4
5265328|NCT00655356|18166100|P1|Overall Study|Withdrawal by Subject|3
5265329|NCT00654940|18166164|P2|Period 1|Intolerable Pain Level|0
5265330|NCT00654940|18166165|P1|Period 1|Intolerable Pain Level|1
5265331|NCT00654940|18166164|P2|Period 1|Adverse Event|1
5265332|NCT00654940|18166165|P1|Period 1|Adverse Event|0
5265333|NCT00654901|18166189|P4|Overall Study|Withdrawal by Subject|0
5265334|NCT00654901|18166190|P3|Overall Study|Withdrawal by Subject|1
5265335|NCT00654901|18166191|P2|Overall Study|Withdrawal by Subject|0
5265336|NCT00654901|18166192|P1|Overall Study|Withdrawal by Subject|3
5265337|NCT00654901|18166189|P4|Overall Study|Lost to Follow-up|0
5265338|NCT00654901|18166190|P3|Overall Study|Lost to Follow-up|1
5265339|NCT00654901|18166191|P2|Overall Study|Lost to Follow-up|0
5265340|NCT00654901|18166192|P1|Overall Study|Lost to Follow-up|1
5265341|NCT00654875|18166212|P2|Overall Study|Administrative Problems|0
5265342|NCT00654875|18166213|P1|Overall Study|Administrative Problems|1
5265343|NCT00654875|18166212|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5265344|NCT00654875|18166213|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5265345|NCT00654875|18166212|P2|Overall Study|Lost to Follow-up|3
5265346|NCT00654875|18166213|P1|Overall Study|Lost to Follow-up|1
5265347|NCT00654875|18166212|P2|Overall Study|Lack of Efficacy|2
5265348|NCT00654875|18166213|P1|Overall Study|Lack of Efficacy|2
5265349|NCT00654875|18166212|P2|Overall Study|Protocol Violation|3
5265350|NCT00654875|18166213|P1|Overall Study|Protocol Violation|3
5265351|NCT00654875|18166212|P2|Overall Study|Withdrawal by Subject|4
5265352|NCT00654875|18166213|P1|Overall Study|Withdrawal by Subject|4
5265353|NCT00654875|18166212|P2|Overall Study|Adverse Event|5
5265354|NCT00654875|18166213|P1|Overall Study|Adverse Event|5
5265355|NCT00654745|18166246|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
5265356|NCT00654745|18166246|P1|Overall Study|Withdrawal by Subject|10
5265357|NCT00654745|18166246|P1|Overall Study|Protocol Violation|11
5265358|NCT00654745|18166246|P1|Overall Study|Lost to Follow-up|7
5265359|NCT00654745|18166246|P1|Overall Study|Adverse Event|12
5265360|NCT00654732|18166286|P2|Overall Study|Adverse Event|6
5265361|NCT00654732|18166287|P1|Overall Study|Adverse Event|4
5265362|NCT00654641|18166300|P2|Overall Study|Lost to Follow-up|3
5265363|NCT00654641|18166301|P1|Overall Study|Lost to Follow-up|2
5265364|NCT00654628|18166307|P1|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
5265365|NCT00654628|18166307|P1|6 -Week Extension Period (Single Site)|Adverse Event|4
5265366|NCT00654628|18166307|P1|6-week Active Treatment Period|Out of window period|1
5265367|NCT00654628|18166307|P1|6-week Active Treatment Period|Transferred to branch hospital|1
5265368|NCT00654628|18166307|P1|6-week Active Treatment Period|Lost to Follow-up|10
5265369|NCT00654628|18166307|P1|6-week Active Treatment Period|Adverse Event|9
5265370|NCT00654498|18166356|P2|Overall Study|Other reason not defined above|5
5265371|NCT00654498|18166357|P1|Overall Study|Other reason not defined above|4
5265372|NCT00654498|18166356|P2|Overall Study|Withdrawal by Subject|0
5265373|NCT00654498|18166357|P1|Overall Study|Withdrawal by Subject|1
5265374|NCT00654498|18166356|P2|Overall Study|Lost to Follow-up|5
5265375|NCT00654498|18166357|P1|Overall Study|Lost to Follow-up|1
5265376|NCT00654498|18166356|P2|Overall Study|Protocol Violation|1
5265377|NCT00654498|18166357|P1|Overall Study|Protocol Violation|1
5265378|NCT00654498|18166356|P2|Overall Study|Adverse Event|1
5265379|NCT00654498|18166357|P1|Overall Study|Adverse Event|6
5265380|NCT00654498|18166356|P2|Overall Study|Not Treated|0
5265381|NCT00654498|18166357|P1|Overall Study|Not Treated|1
5265382|NCT00654420|18166389|P4|Phase II|Missing Disposition Record|0
5265383|NCT00654420|18166390|P3|Phase II|Missing Disposition Record|1
5265384|NCT00654420|18166391|P2|Phase II|Missing Disposition Record|0
5265385|NCT00654420|18166392|P1|Phase II|Missing Disposition Record|0
5265386|NCT00654420|18166389|P4|Phase II|Withdrawal by Subject|1
5265387|NCT00654420|18166390|P3|Phase II|Withdrawal by Subject|4
5265388|NCT00654420|18166391|P2|Phase II|Withdrawal by Subject|0
5265389|NCT00654420|18166392|P1|Phase II|Withdrawal by Subject|0
5265390|NCT00654420|18166389|P4|Phase II|Progressive Disease|29
5265391|NCT00654420|18166390|P3|Phase II|Progressive Disease|29
5265392|NCT00654420|18166391|P2|Phase II|Progressive Disease|0
5265393|NCT00654420|18166392|P1|Phase II|Progressive Disease|0
5265394|NCT00654420|18166389|P4|Phase II|Physician Decision|4
5265395|NCT00654420|18166390|P3|Phase II|Physician Decision|0
5265396|NCT00654420|18166391|P2|Phase II|Physician Decision|0
5265397|NCT00654420|18166392|P1|Phase II|Physician Decision|0
5265398|NCT00654420|18166389|P4|Phase II|Lost to Follow-up|1
5265399|NCT00654420|18166390|P3|Phase II|Lost to Follow-up|0
5265400|NCT00654420|18166391|P2|Phase II|Lost to Follow-up|0
5265401|NCT00654420|18166392|P1|Phase II|Lost to Follow-up|0
5265402|NCT00654420|18166389|P4|Phase II|Adverse Event|3
5265403|NCT00654420|18166390|P3|Phase II|Adverse Event|3
5265404|NCT00654420|18166391|P2|Phase II|Adverse Event|0
5265405|NCT00654420|18166392|P1|Phase II|Adverse Event|0
5265406|NCT00654420|18166389|P4|Phase I (Dose Escalation)|Progressive Disease|0
5265407|NCT00654420|18166390|P3|Phase I (Dose Escalation)|Progressive Disease|0
5265408|NCT00654420|18166391|P2|Phase I (Dose Escalation)|Progressive Disease|15
5265409|NCT00654420|18166392|P1|Phase I (Dose Escalation)|Progressive Disease|4
5265410|NCT00654420|18166389|P4|Phase I (Dose Escalation)|Adverse Event|0
5265411|NCT00654420|18166390|P3|Phase I (Dose Escalation)|Adverse Event|0
5265412|NCT00654420|18166391|P2|Phase I (Dose Escalation)|Adverse Event|1
5265413|NCT00654420|18166392|P1|Phase I (Dose Escalation)|Adverse Event|0
5265414|NCT00654381|18166418|P6|Extension Stage|Closure of the trial site|1
5265415|NCT00654381|18166419|P5|Extension Stage|Closure of the trial site|1
5265416|NCT00654381|18166420|P4|Extension Stage|Closure of the trial site|0
5265417|NCT00654381|18166421|P3|Extension Stage|Closure of the trial site|0
5265418|NCT00654381|18166422|P2|Extension Stage|Closure of the trial site|0
5265419|NCT00654381|18166423|P1|Extension Stage|Closure of the trial site|0
5265420|NCT00654381|18166418|P6|Extension Stage|Withdrawal by Subject|1
5265421|NCT00654381|18166419|P5|Extension Stage|Withdrawal by Subject|1
5265422|NCT00654381|18166420|P4|Extension Stage|Withdrawal by Subject|1
5265423|NCT00654381|18166421|P3|Extension Stage|Withdrawal by Subject|1
5265424|NCT00654381|18166422|P2|Extension Stage|Withdrawal by Subject|0
5265425|NCT00654381|18166423|P1|Extension Stage|Withdrawal by Subject|0
5265426|NCT00654381|18166418|P6|Extension Stage|Lack of Efficacy|0
5265427|NCT00654381|18166419|P5|Extension Stage|Lack of Efficacy|0
5265428|NCT00654381|18166420|P4|Extension Stage|Lack of Efficacy|0
5265429|NCT00654381|18166421|P3|Extension Stage|Lack of Efficacy|1
5265430|NCT00654381|18166422|P2|Extension Stage|Lack of Efficacy|0
5265431|NCT00654381|18166423|P1|Extension Stage|Lack of Efficacy|0
5265432|NCT00654381|18166418|P6|Extension Stage|Protocol Violation|0
5265433|NCT00654381|18166419|P5|Extension Stage|Protocol Violation|0
5265434|NCT00654381|18166420|P4|Extension Stage|Protocol Violation|1
5265435|NCT00654381|18166421|P3|Extension Stage|Protocol Violation|0
5265436|NCT00654381|18166422|P2|Extension Stage|Protocol Violation|0
5265437|NCT00654381|18166423|P1|Extension Stage|Protocol Violation|0
5265438|NCT00654381|18166418|P6|Extension Stage|Adverse Event|1
5265439|NCT00654381|18166419|P5|Extension Stage|Adverse Event|1
5265440|NCT00654381|18166420|P4|Extension Stage|Adverse Event|7
5265441|NCT00654381|18166421|P3|Extension Stage|Adverse Event|9
5265442|NCT00654381|18166422|P2|Extension Stage|Adverse Event|2
5265443|NCT00654381|18166423|P1|Extension Stage|Adverse Event|1
5265444|NCT00654381|18166418|P6|2nd Stage|Investigator's decision|0
5265445|NCT00654381|18166419|P5|2nd Stage|Investigator's decision|0
5265446|NCT00654381|18166420|P4|2nd Stage|Investigator's decision|1
5265447|NCT00654381|18166421|P3|2nd Stage|Investigator's decision|1
5265448|NCT00654381|18166422|P2|2nd Stage|Investigator's decision|0
5265449|NCT00654381|18166423|P1|2nd Stage|Investigator's decision|0
5265450|NCT00654381|18166418|P6|2nd Stage|Withdrawal by Subject|1
5265451|NCT00654381|18166419|P5|2nd Stage|Withdrawal by Subject|1
5265452|NCT00654381|18166420|P4|2nd Stage|Withdrawal by Subject|0
5265453|NCT00654381|18166421|P3|2nd Stage|Withdrawal by Subject|0
5265454|NCT00654381|18166422|P2|2nd Stage|Withdrawal by Subject|0
5265455|NCT00654381|18166423|P1|2nd Stage|Withdrawal by Subject|0
5265456|NCT00654381|18166418|P6|2nd Stage|Adverse Event|2
5265457|NCT00654381|18166419|P5|2nd Stage|Adverse Event|7
5265458|NCT00654381|18166420|P4|2nd Stage|Adverse Event|3
5265459|NCT00654381|18166421|P3|2nd Stage|Adverse Event|2
5265460|NCT00654381|18166422|P2|2nd Stage|Adverse Event|0
5265461|NCT00654381|18166423|P1|2nd Stage|Adverse Event|2
5265462|NCT00654381|18166418|P6|1st Stage|Investigator's decision|0
5265463|NCT00654381|18166419|P5|1st Stage|Investigator's decision|0
5265464|NCT00654381|18166420|P4|1st Stage|Investigator's decision|1
5265465|NCT00654381|18166421|P3|1st Stage|Investigator's decision|0
5265466|NCT00654381|18166422|P2|1st Stage|Investigator's decision|0
5265467|NCT00654381|18166423|P1|1st Stage|Investigator's decision|0
5265468|NCT00654381|18166418|P6|1st Stage|Withdrawal by Subject|1
5265469|NCT00654381|18166419|P5|1st Stage|Withdrawal by Subject|0
5265470|NCT00654381|18166420|P4|1st Stage|Withdrawal by Subject|1
5265471|NCT00654381|18166421|P3|1st Stage|Withdrawal by Subject|0
5265472|NCT00654381|18166422|P2|1st Stage|Withdrawal by Subject|0
5265473|NCT00654381|18166423|P1|1st Stage|Withdrawal by Subject|0
5265474|NCT00654381|18166418|P6|1st Stage|Adverse Event|1
5265475|NCT00654381|18166419|P5|1st Stage|Adverse Event|2
5265476|NCT00654381|18166420|P4|1st Stage|Adverse Event|3
5265477|NCT00654381|18166421|P3|1st Stage|Adverse Event|3
5265478|NCT00654381|18166422|P2|1st Stage|Adverse Event|3
5265479|NCT00654381|18166423|P1|1st Stage|Adverse Event|3
5265480|NCT00654368|18166460|P3|Overall Study|Adverse Event|6
5265481|NCT00654368|18166461|P2|Overall Study|Adverse Event|9
5265482|NCT00654368|18166462|P1|Overall Study|Adverse Event|14
5265483|NCT00654368|18166460|P3|Overall Study|Other|3
5265484|NCT00654368|18166461|P2|Overall Study|Other|2
5265485|NCT00654368|18166462|P1|Overall Study|Other|0
5265486|NCT00654368|18166460|P3|Overall Study|Pregnancy|2
5265487|NCT00654368|18166461|P2|Overall Study|Pregnancy|0
5265488|NCT00654368|18166462|P1|Overall Study|Pregnancy|0
5265489|NCT00654368|18166460|P3|Overall Study|Death|0
5265490|NCT00654368|18166461|P2|Overall Study|Death|0
5265491|NCT00654368|18166462|P1|Overall Study|Death|1
5265492|NCT00654368|18166460|P3|Overall Study|Physician Decision|2
5265493|NCT00654368|18166461|P2|Overall Study|Physician Decision|0
5265494|NCT00654368|18166462|P1|Overall Study|Physician Decision|0
5265495|NCT00654368|18166460|P3|Overall Study|Requirement for alternative therapy|1
5265496|NCT00654368|18166461|P2|Overall Study|Requirement for alternative therapy|1
5265497|NCT00654368|18166462|P1|Overall Study|Requirement for alternative therapy|1
5265498|NCT00654368|18166460|P3|Overall Study|Disease progression|13
5265499|NCT00654368|18166461|P2|Overall Study|Disease progression|31
5265500|NCT00654368|18166462|P1|Overall Study|Disease progression|21
5265501|NCT00654368|18166460|P3|Overall Study|Withdrawal by Subject|2
5265502|NCT00654368|18166461|P2|Overall Study|Withdrawal by Subject|2
5265503|NCT00654368|18166462|P1|Overall Study|Withdrawal by Subject|5
5265504|NCT00654368|18166460|P3|Overall Study|Non-compliance|2
5265505|NCT00654368|18166461|P2|Overall Study|Non-compliance|1
5265506|NCT00654368|18166462|P1|Overall Study|Non-compliance|2
5265507|NCT00654368|18166460|P3|Overall Study|Protocol deviation|1
5265508|NCT00654368|18166461|P2|Overall Study|Protocol deviation|2
5265509|NCT00654368|18166462|P1|Overall Study|Protocol deviation|3
5265510|NCT00654368|18166460|P3|Overall Study|Ineligibility determined|0
5265511|NCT00654368|18166461|P2|Overall Study|Ineligibility determined|0
5265512|NCT00654368|18166462|P1|Overall Study|Ineligibility determined|6
5265513|NCT00654355|18166495|P2|Overall Study|Lost to Follow-up|2
5265514|NCT00654355|18166496|P1|Overall Study|Lost to Follow-up|2
5265515|NCT00654238|18166527|P1|Overall Study|Screen Failures|4
5265516|NCT00654186|18166532|P1|Overall Study|Withdrawal by Subject|5
5265517|NCT00654095|18166557|P1|Overall Study|Did not meet inclusion criteria|1
5265518|NCT00654095|18166557|P1|Overall Study|Adverse reaction did not improve (5)|4
5265519|NCT00654095|18166557|P1|Overall Study|Elevated alanine aminotransferase (4)|7
5265520|NCT00654095|18166557|P1|Overall Study|Withdrawal by Subject|5
5265521|NCT00654095|18166557|P1|Overall Study|Adverse Event|11
5265522|NCT00654095|18166557|P1|Overall Study|Elevated alanine aminotransferase (3)|1
5265523|NCT00654095|18166557|P1|Overall Study|Elevated triglyceride level (2)|1
5265524|NCT00654095|18166557|P1|Overall Study|Drop in low density lipoprotein (1)|2
5265525|NCT00654004|18166580|P2|Overall Study|Lost to Follow-up|0
5265526|NCT00654004|18166581|P1|Overall Study|Lost to Follow-up|1
5265527|NCT00653991|18166597|P2|6 Month Follow-up|Participant would not respond|141
5265528|NCT00653991|18166598|P1|6 Month Follow-up|Participant would not respond|133
5265529|NCT00653991|18166597|P2|3 Month Follow-up|Participant would not respond|157
5265530|NCT00653991|18166598|P1|3 Month Follow-up|Participant would not respond|150
5265531|NCT00653939|18166610|P2|Overall Study|Other|6
5265532|NCT00653939|18166611|P1|Overall Study|Other|2
5265533|NCT00653939|18166610|P2|Overall Study|Disease Progression|3
5265534|NCT00653939|18166611|P1|Overall Study|Disease Progression|2
5265535|NCT00653939|18166610|P2|Overall Study|Physician Decision|0
5265536|NCT00653939|18166611|P1|Overall Study|Physician Decision|4
5265537|NCT00653939|18166610|P2|Overall Study|Withdrawal by Subject|3
5265538|NCT00653939|18166611|P1|Overall Study|Withdrawal by Subject|3
5265539|NCT00653939|18166610|P2|Overall Study|Adverse Event|3
5265540|NCT00653939|18166611|P1|Overall Study|Adverse Event|1
5265541|NCT00653523|18166636|P1|Overall Study|Adverse reaction did not improve (4)|1
5265542|NCT00653523|18166636|P1|Overall Study|Elevated alanine aminotransferase (3)|2
5265543|NCT00653523|18166636|P1|Overall Study|Withdrawal by Subject|6
5265544|NCT00653523|18166636|P1|Overall Study|Adverse Event|7
5265545|NCT00653523|18166636|P1|Overall Study|Elevated creatine phosphokinase (2)|1
5265546|NCT00653523|18166636|P1|Overall Study|Drop in low density lipoprotein (1)|2
5265547|NCT00653432|18166642|P2|Overall Study|Other - Reason Not Provided|3
5265548|NCT00653432|18166643|P1|Overall Study|Other - Reason Not Provided|5
5265549|NCT00653432|18166642|P2|Overall Study|Use/Need of Con Therapy|1
5265550|NCT00653432|18166643|P1|Overall Study|Use/Need of Con Therapy|2
5265551|NCT00653432|18166642|P2|Overall Study|Lost to Follow-up|6
5265552|NCT00653432|18166643|P1|Overall Study|Lost to Follow-up|7
5265553|NCT00653432|18166642|P2|Overall Study|Withdrawal by Subject|5
5265554|NCT00653432|18166643|P1|Overall Study|Withdrawal by Subject|4
5265555|NCT00653432|18166642|P2|Overall Study|Adverse Event|1
5265556|NCT00653432|18166643|P1|Overall Study|Adverse Event|4
5265557|NCT00653328|18166667|P1|Overall Study|Drug manufacturer no longing making drug|2
5265558|NCT00653328|18166667|P1|Overall Study|Disease progression|10
5265559|NCT00653328|18166667|P1|Overall Study|Adverse Event|2
5265560|NCT00653328|18166667|P1|Overall Study|Withdrawal by Subject|1
5265561|NCT00653263|18166674|P1|Overall Study|Physician Decision|1
5265562|NCT00653263|18166674|P1|Overall Study|Withdrawal by Subject|1
5265563|NCT00653224|18166682|P2|Overall Study|Other|4
5265564|NCT00653224|18166683|P1|Overall Study|Other|2
5265565|NCT00653224|18166682|P2|Overall Study|Lost to Follow-up|0
5265566|NCT00653224|18166683|P1|Overall Study|Lost to Follow-up|1
5265567|NCT00653224|18166682|P2|Overall Study|Loss of efficacy|0
5265568|NCT00653224|18166683|P1|Overall Study|Loss of efficacy|1
5265569|NCT00653224|18166682|P2|Overall Study|Lack of Efficacy|2
5265570|NCT00653224|18166683|P1|Overall Study|Lack of Efficacy|1
5265571|NCT00653224|18166682|P2|Overall Study|Adverse Event|1
5265572|NCT00653224|18166683|P1|Overall Study|Adverse Event|2
5265573|NCT00653159|18166869|P2|Overall Study|Lost to Follow-up|2
5265574|NCT00653159|18166870|P1|Overall Study|Lost to Follow-up|1
5265575|NCT00653159|18166869|P2|Overall Study|Adverse Event|1
5265576|NCT00653159|18166870|P1|Overall Study|Adverse Event|4
5265577|NCT00653068|18166897|P1|Overall Study|Ineligible|2
5265578|NCT00653068|18166897|P1|Overall Study|Withdrawal by Subject|1
5265579|NCT00653068|18166897|P1|Overall Study|Physician Decision|4
5265580|NCT00653068|18166897|P1|Overall Study|Lack of Efficacy|34
5265581|NCT00653068|18166897|P1|Overall Study|Death|9
5265582|NCT00652951|18166911|P3|Booster Phase|Other|0
5265583|NCT00652951|18166912|P2|Booster Phase|Other|0
5265584|NCT00652951|18166913|P1|Booster Phase|Other|1
5265585|NCT00652951|18166911|P3|Booster Phase|Adverse event, non-fatal|0
5265586|NCT00652951|18166912|P2|Booster Phase|Adverse event, non-fatal|1
5265587|NCT00652951|18166913|P1|Booster Phase|Adverse event, non-fatal|0
5265588|NCT00652938|18167050|P3|Overall Study|fear of blood sampling|0
5265589|NCT00652938|18167051|P2|Overall Study|fear of blood sampling|1
5265590|NCT00652938|18167052|P1|Overall Study|fear of blood sampling|0
5265591|NCT00652938|18167050|P3|Overall Study|Lost to Follow-up|2
5265592|NCT00652938|18167051|P2|Overall Study|Lost to Follow-up|0
5265593|NCT00652938|18167052|P1|Overall Study|Lost to Follow-up|0
5265594|NCT00652938|18167050|P3|Overall Study|Withdrawal by Subject|1
5265595|NCT00652938|18167051|P2|Overall Study|Withdrawal by Subject|6
5265596|NCT00652938|18167052|P1|Overall Study|Withdrawal by Subject|0
5265597|NCT00652938|18167050|P3|Overall Study|Adverse Event|2
5265598|NCT00652938|18167051|P2|Overall Study|Adverse Event|0
5265599|NCT00652938|18167052|P1|Overall Study|Adverse Event|1
5265600|NCT00652899|18167117|P1|Overall Study|Treating physician decision|1
5265601|NCT00652899|18167117|P1|Overall Study|Death|1
5265602|NCT00652834|18167127|P1|Overall Study|Lost to Follow-up|2
5265603|NCT00652834|18167127|P1|Overall Study|Withdrawal by Subject|3
5265604|NCT00652743|18167134|P3|Months 36-42|Other|8
5265605|NCT00652743|18167135|P2|Months 36-42|Other|2
5265606|NCT00652743|18167136|P1|Months 36-42|Other|4
5265607|NCT00652743|18167134|P3|Months 36-42|Migrated/moved from study area|0
5265608|NCT00652743|18167135|P2|Months 36-42|Migrated/moved from study area|0
5265609|NCT00652743|18167136|P1|Months 36-42|Migrated/moved from study area|1
5265610|NCT00652743|18167134|P3|Months 36-42|Lost to Follow-up|0
5265611|NCT00652743|18167135|P2|Months 36-42|Lost to Follow-up|1
5265612|NCT00652743|18167136|P1|Months 36-42|Lost to Follow-up|0
5265613|NCT00652743|18167134|P3|Months 36-42|Withdrawal by Subject|0
5265614|NCT00652743|18167135|P2|Months 36-42|Withdrawal by Subject|1
5265615|NCT00652743|18167136|P1|Months 36-42|Withdrawal by Subject|1
5265616|NCT00652743|18167134|P3|Months 36-42|Serious Adverse Events|1
5265617|NCT00652743|18167135|P2|Months 36-42|Serious Adverse Events|1
5265618|NCT00652743|18167136|P1|Months 36-42|Serious Adverse Events|0
5265619|NCT00652743|18167134|P3|Months 24-30|Other|11
5265620|NCT00652743|18167135|P2|Months 24-30|Other|1
5265621|NCT00652743|18167136|P1|Months 24-30|Other|5
5265622|NCT00652743|18167134|P3|Months 12-18|Lost to Follow-up|7
5265623|NCT00652743|18167135|P2|Months 12-18|Lost to Follow-up|2
5265624|NCT00652743|18167136|P1|Months 12-18|Lost to Follow-up|1
5265625|NCT00652626|18167218|P7|Extension Phase|Death|1
5265626|NCT00652626|18167219|P6|Extension Phase|Death|1
5265627|NCT00652626|18167220|P5|Extension Phase|Death|0
5265628|NCT00652626|18167221|P4|Extension Phase|Death|0
5265629|NCT00652626|18167222|P3|Extension Phase|Death|0
5265630|NCT00652626|18167223|P2|Extension Phase|Death|0
5265631|NCT00652626|18167224|P1|Extension Phase|Death|0
5265632|NCT00652626|18167218|P7|Extension Phase|Physician Decision|1
5265633|NCT00652626|18167219|P6|Extension Phase|Physician Decision|1
5265634|NCT00652626|18167220|P5|Extension Phase|Physician Decision|0
5265635|NCT00652626|18167221|P4|Extension Phase|Physician Decision|0
5265636|NCT00652626|18167222|P3|Extension Phase|Physician Decision|0
5265637|NCT00652626|18167223|P2|Extension Phase|Physician Decision|0
5265638|NCT00652626|18167224|P1|Extension Phase|Physician Decision|0
5265639|NCT00652626|18167218|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
5265640|NCT00652626|18167219|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
5265641|NCT00652626|18167220|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
5265642|NCT00652626|18167221|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
5265643|NCT00652626|18167222|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
5265644|NCT00652626|18167223|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
5265645|NCT00652626|18167224|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
5265646|NCT00652626|18167218|P7|Extension Phase|Adverse Event|1
5265647|NCT00652626|18167219|P6|Extension Phase|Adverse Event|2
5265648|NCT00652626|18167220|P5|Extension Phase|Adverse Event|0
5265649|NCT00652626|18167221|P4|Extension Phase|Adverse Event|0
5265650|NCT00652626|18167222|P3|Extension Phase|Adverse Event|0
5265651|NCT00652626|18167223|P2|Extension Phase|Adverse Event|0
5265652|NCT00652626|18167224|P1|Extension Phase|Adverse Event|0
5265653|NCT00652626|18167218|P7|Extension Phase|Withdrawal by Subject|0
5265654|NCT00652626|18167219|P6|Extension Phase|Withdrawal by Subject|2
5265655|NCT00652626|18167220|P5|Extension Phase|Withdrawal by Subject|0
5265656|NCT00652626|18167221|P4|Extension Phase|Withdrawal by Subject|0
5265657|NCT00652626|18167222|P3|Extension Phase|Withdrawal by Subject|0
5265658|NCT00652626|18167223|P2|Extension Phase|Withdrawal by Subject|0
5265659|NCT00652626|18167224|P1|Extension Phase|Withdrawal by Subject|0
5265660|NCT00652626|18167218|P7|Initial Treatment Phase|Lost to Follow-up|0
5265661|NCT00652626|18167219|P6|Initial Treatment Phase|Lost to Follow-up|0
5265662|NCT00652626|18167220|P5|Initial Treatment Phase|Lost to Follow-up|1
5265663|NCT00652626|18167221|P4|Initial Treatment Phase|Lost to Follow-up|0
5265664|NCT00652626|18167222|P3|Initial Treatment Phase|Lost to Follow-up|0
5265665|NCT00652626|18167223|P2|Initial Treatment Phase|Lost to Follow-up|0
5265666|NCT00652626|18167224|P1|Initial Treatment Phase|Lost to Follow-up|0
5265667|NCT00652626|18167218|P7|Initial Treatment Phase|Sponsor Request|0
5265668|NCT00652626|18167219|P6|Initial Treatment Phase|Sponsor Request|0
5265669|NCT00652626|18167220|P5|Initial Treatment Phase|Sponsor Request|0
5265670|NCT00652626|18167221|P4|Initial Treatment Phase|Sponsor Request|0
5265671|NCT00652626|18167222|P3|Initial Treatment Phase|Sponsor Request|1
5265672|NCT00652626|18167223|P2|Initial Treatment Phase|Sponsor Request|0
5265673|NCT00652626|18167224|P1|Initial Treatment Phase|Sponsor Request|0
5265674|NCT00652626|18167218|P7|Initial Treatment Phase|Physician Decision|0
5265675|NCT00652626|18167219|P6|Initial Treatment Phase|Physician Decision|0
5265676|NCT00652626|18167220|P5|Initial Treatment Phase|Physician Decision|1
5265677|NCT00652626|18167221|P4|Initial Treatment Phase|Physician Decision|0
5265678|NCT00652626|18167222|P3|Initial Treatment Phase|Physician Decision|0
5265679|NCT00652626|18167223|P2|Initial Treatment Phase|Physician Decision|0
5265680|NCT00652626|18167224|P1|Initial Treatment Phase|Physician Decision|0
5265681|NCT00652626|18167218|P7|Initial Treatment Phase|Protocol Violation|0
5265682|NCT00652626|18167219|P6|Initial Treatment Phase|Protocol Violation|0
5265683|NCT00652626|18167220|P5|Initial Treatment Phase|Protocol Violation|0
5265684|NCT00652626|18167221|P4|Initial Treatment Phase|Protocol Violation|1
5265685|NCT00652626|18167222|P3|Initial Treatment Phase|Protocol Violation|0
5265686|NCT00652626|18167223|P2|Initial Treatment Phase|Protocol Violation|0
5265687|NCT00652626|18167224|P1|Initial Treatment Phase|Protocol Violation|0
5265688|NCT00652626|18167218|P7|Initial Treatment Phase|Adverse Event|0
5265689|NCT00652626|18167219|P6|Initial Treatment Phase|Adverse Event|0
5265690|NCT00652626|18167220|P5|Initial Treatment Phase|Adverse Event|1
5265691|NCT00652626|18167221|P4|Initial Treatment Phase|Adverse Event|0
5265692|NCT00652626|18167222|P3|Initial Treatment Phase|Adverse Event|0
5265693|NCT00652626|18167223|P2|Initial Treatment Phase|Adverse Event|0
5265694|NCT00652626|18167224|P1|Initial Treatment Phase|Adverse Event|0
5265695|NCT00652366|18167293|P5|Overall Study|Other|0
5265696|NCT00652366|18167294|P4|Overall Study|Other|4
5265697|NCT00652366|18167295|P3|Overall Study|Other|3
5265698|NCT00652366|18167296|P2|Overall Study|Other|2
5265699|NCT00652366|18167297|P1|Overall Study|Other|5
5265700|NCT00652366|18167293|P5|Overall Study|Refused treatment|5
5265701|NCT00652366|18167294|P4|Overall Study|Refused treatment|17
5265702|NCT00652366|18167295|P3|Overall Study|Refused treatment|6
5265703|NCT00652366|18167296|P2|Overall Study|Refused treatment|7
5265704|NCT00652366|18167297|P1|Overall Study|Refused treatment|3
5265705|NCT00652366|18167293|P5|Overall Study|Protocol Violation|0
5265706|NCT00652366|18167294|P4|Overall Study|Protocol Violation|0
5265707|NCT00652366|18167295|P3|Overall Study|Protocol Violation|0
5265708|NCT00652366|18167296|P2|Overall Study|Protocol Violation|0
5265709|NCT00652366|18167297|P1|Overall Study|Protocol Violation|1
5265710|NCT00652366|18167293|P5|Overall Study|Violation of Selection Criteria|0
5265711|NCT00652366|18167294|P4|Overall Study|Violation of Selection Criteria|0
5265712|NCT00652366|18167295|P3|Overall Study|Violation of Selection Criteria|1
5265713|NCT00652366|18167296|P2|Overall Study|Violation of Selection Criteria|0
5265714|NCT00652366|18167297|P1|Overall Study|Violation of Selection Criteria|0
5265715|NCT00652366|18167293|P5|Overall Study|Lack of Efficacy|13
5265716|NCT00652366|18167294|P4|Overall Study|Lack of Efficacy|133
5265717|NCT00652366|18167295|P3|Overall Study|Lack of Efficacy|53
5265718|NCT00652366|18167296|P2|Overall Study|Lack of Efficacy|58
5265719|NCT00652366|18167297|P1|Overall Study|Lack of Efficacy|84
5265720|NCT00652366|18167293|P5|Overall Study|Death|5
5265721|NCT00652366|18167294|P4|Overall Study|Death|8
5265722|NCT00652366|18167295|P3|Overall Study|Death|1
5265723|NCT00652366|18167296|P2|Overall Study|Death|4
5265724|NCT00652366|18167297|P1|Overall Study|Death|5
5265725|NCT00652366|18167293|P5|Overall Study|Adverse Event|13
5265726|NCT00652366|18167294|P4|Overall Study|Adverse Event|17
5265727|NCT00652366|18167295|P3|Overall Study|Adverse Event|7
5265728|NCT00652366|18167296|P2|Overall Study|Adverse Event|4
5265729|NCT00652366|18167297|P1|Overall Study|Adverse Event|8
5265730|NCT00652340|18167332|P2|Overall Study|Had not progressed.|3
5265731|NCT00652340|18167333|P1|Overall Study|Had not progressed.|4
5265732|NCT00652327|18167343|P2|Overall Study|Lost to Follow-up|3
5265733|NCT00652327|18167344|P1|Overall Study|Lost to Follow-up|0
5265734|NCT00652327|18167343|P2|Overall Study|Adverse Event|2
5265735|NCT00652327|18167344|P1|Overall Study|Adverse Event|0
5265736|NCT00652093|18167386|P6|Overall Study|Physician Decision|0
5265737|NCT00652093|18167387|P5|Overall Study|Physician Decision|1
5265738|NCT00652093|18167388|P4|Overall Study|Physician Decision|0
5265739|NCT00652093|18167389|P3|Overall Study|Physician Decision|0
5265740|NCT00652093|18167390|P2|Overall Study|Physician Decision|0
5265741|NCT00652093|18167391|P1|Overall Study|Physician Decision|0
5265742|NCT00652093|18167386|P6|Overall Study|Withdrawal by Subject|0
5265743|NCT00652093|18167387|P5|Overall Study|Withdrawal by Subject|1
5265744|NCT00652093|18167388|P4|Overall Study|Withdrawal by Subject|0
5265745|NCT00652093|18167389|P3|Overall Study|Withdrawal by Subject|1
5265746|NCT00652093|18167390|P2|Overall Study|Withdrawal by Subject|0
5265747|NCT00652093|18167391|P1|Overall Study|Withdrawal by Subject|0
5265748|NCT00652028|18167481|P4|Overall Study|Physician Decision|0
5265749|NCT00652028|18167482|P3|Overall Study|Physician Decision|1
5265750|NCT00652028|18167483|P2|Overall Study|Physician Decision|0
5265751|NCT00652028|18167484|P1|Overall Study|Physician Decision|0
5265752|NCT00652028|18167481|P4|Overall Study|No Longer Meets Entry Criteria|0
5265753|NCT00652028|18167482|P3|Overall Study|No Longer Meets Entry Criteria|0
5265754|NCT00652028|18167483|P2|Overall Study|No Longer Meets Entry Criteria|1
5265755|NCT00652028|18167484|P1|Overall Study|No Longer Meets Entry Criteria|0
5265756|NCT00652028|18167481|P4|Overall Study|Adverse Event|0
5265757|NCT00652028|18167482|P3|Overall Study|Adverse Event|0
5265758|NCT00652028|18167483|P2|Overall Study|Adverse Event|0
5265759|NCT00652028|18167484|P1|Overall Study|Adverse Event|1
5265760|NCT00651937|18167528|P2|Overall Study|Withdrawal by Subject|1
5265761|NCT00651937|18167529|P1|Overall Study|Withdrawal by Subject|4
5265762|NCT00651924|18167539|P2|Overall Study|Withdrawal by Subject|5
5265763|NCT00651924|18167540|P1|Overall Study|Withdrawal by Subject|0
5265764|NCT00651924|18167539|P2|Overall Study|Withdrawal by PI|2
5265765|NCT00651924|18167540|P1|Overall Study|Withdrawal by PI|0
5265766|NCT00651820|18167546|P1|Overall Study|Lost to Follow-up|2
5265767|NCT00651755|18167578|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
5265768|NCT00651755|18167579|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
5265769|NCT00651755|18167578|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
5265770|NCT00651755|18167579|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
5265771|NCT00651664|18167605|P10|Overall Study|Reason not Specified|0
5265772|NCT00651664|18167606|P9|Overall Study|Reason not Specified|0
5265773|NCT00651664|18167607|P8|Overall Study|Reason not Specified|0
5265774|NCT00651664|18167608|P7|Overall Study|Reason not Specified|1
5265775|NCT00651664|18167609|P6|Overall Study|Reason not Specified|0
5265776|NCT00651664|18167610|P5|Overall Study|Reason not Specified|0
5265777|NCT00651664|18167611|P4|Overall Study|Reason not Specified|0
5265778|NCT00651664|18167612|P3|Overall Study|Reason not Specified|0
5265779|NCT00651664|18167613|P2|Overall Study|Reason not Specified|0
5265780|NCT00651664|18167614|P1|Overall Study|Reason not Specified|0
5265781|NCT00651664|18167605|P10|Overall Study|Symptomatic Deterioration|0
5265782|NCT00651664|18167606|P9|Overall Study|Symptomatic Deterioration|1
5265783|NCT00651664|18167607|P8|Overall Study|Symptomatic Deterioration|0
5265784|NCT00651664|18167608|P7|Overall Study|Symptomatic Deterioration|1
5265785|NCT00651664|18167609|P6|Overall Study|Symptomatic Deterioration|0
5265786|NCT00651664|18167610|P5|Overall Study|Symptomatic Deterioration|0
5265787|NCT00651664|18167611|P4|Overall Study|Symptomatic Deterioration|1
5265788|NCT00651664|18167612|P3|Overall Study|Symptomatic Deterioration|0
5265789|NCT00651664|18167613|P2|Overall Study|Symptomatic Deterioration|0
5265790|NCT00651664|18167614|P1|Overall Study|Symptomatic Deterioration|0
5265791|NCT00651664|18167605|P10|Overall Study|Patient Declined Further Treatment|1
5265792|NCT00651664|18167606|P9|Overall Study|Patient Declined Further Treatment|0
5265793|NCT00651664|18167607|P8|Overall Study|Patient Declined Further Treatment|0
5265794|NCT00651664|18167608|P7|Overall Study|Patient Declined Further Treatment|0
5265795|NCT00651664|18167609|P6|Overall Study|Patient Declined Further Treatment|1
5265796|NCT00651664|18167610|P5|Overall Study|Patient Declined Further Treatment|1
5265797|NCT00651664|18167611|P4|Overall Study|Patient Declined Further Treatment|1
5265798|NCT00651664|18167612|P3|Overall Study|Patient Declined Further Treatment|0
5265799|NCT00651664|18167613|P2|Overall Study|Patient Declined Further Treatment|0
5265800|NCT00651664|18167614|P1|Overall Study|Patient Declined Further Treatment|0
5265801|NCT00651664|18167605|P10|Overall Study|Progressive Disease|5
5265802|NCT00651664|18167606|P9|Overall Study|Progressive Disease|5
5265803|NCT00651664|18167607|P8|Overall Study|Progressive Disease|6
5265804|NCT00651664|18167608|P7|Overall Study|Progressive Disease|3
5265805|NCT00651664|18167609|P6|Overall Study|Progressive Disease|1
5265806|NCT00651664|18167610|P5|Overall Study|Progressive Disease|4
5265807|NCT00651664|18167611|P4|Overall Study|Progressive Disease|12
5265808|NCT00651664|18167612|P3|Overall Study|Progressive Disease|3
5265809|NCT00651664|18167613|P2|Overall Study|Progressive Disease|3
5265810|NCT00651664|18167614|P1|Overall Study|Progressive Disease|3
5265811|NCT00651664|18167605|P10|Overall Study|Unsatisfactory Therapeutic Response|1
5265812|NCT00651664|18167606|P9|Overall Study|Unsatisfactory Therapeutic Response|0
5265813|NCT00651664|18167607|P8|Overall Study|Unsatisfactory Therapeutic Response|1
5265814|NCT00651664|18167608|P7|Overall Study|Unsatisfactory Therapeutic Response|0
5265815|NCT00651664|18167609|P6|Overall Study|Unsatisfactory Therapeutic Response|1
5265816|NCT00651664|18167610|P5|Overall Study|Unsatisfactory Therapeutic Response|1
5265817|NCT00651664|18167611|P4|Overall Study|Unsatisfactory Therapeutic Response|0
5265818|NCT00651664|18167612|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5265819|NCT00651664|18167613|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5265820|NCT00651664|18167614|P1|Overall Study|Unsatisfactory Therapeutic Response|0
5265821|NCT00651664|18167605|P10|Overall Study|Occurrence of Adverse Event(s)|0
5265822|NCT00651664|18167606|P9|Overall Study|Occurrence of Adverse Event(s)|1
5265823|NCT00651664|18167607|P8|Overall Study|Occurrence of Adverse Event(s)|0
5265824|NCT00651664|18167608|P7|Overall Study|Occurrence of Adverse Event(s)|1
5265825|NCT00651664|18167609|P6|Overall Study|Occurrence of Adverse Event(s)|0
5265826|NCT00651664|18167610|P5|Overall Study|Occurrence of Adverse Event(s)|0
5265827|NCT00651664|18167611|P4|Overall Study|Occurrence of Adverse Event(s)|0
5265828|NCT00651664|18167612|P3|Overall Study|Occurrence of Adverse Event(s)|0
5265829|NCT00651664|18167613|P2|Overall Study|Occurrence of Adverse Event(s)|0
5265830|NCT00651664|18167614|P1|Overall Study|Occurrence of Adverse Event(s)|0
5265831|NCT00651313|18167786|P2|Overall Study|Adminstrative Discontinuation|3
5265832|NCT00651313|18167787|P1|Overall Study|Adminstrative Discontinuation|2
5265833|NCT00651313|18167786|P2|Overall Study|Lost to Follow-up|1
5265834|NCT00651313|18167787|P1|Overall Study|Lost to Follow-up|1
5265835|NCT00651313|18167786|P2|Overall Study|Withdrawal by Subject|1
5265836|NCT00651313|18167787|P1|Overall Study|Withdrawal by Subject|3
5265837|NCT00651313|18167786|P2|Overall Study|Adverse Event|1
5265838|NCT00651313|18167787|P1|Overall Study|Adverse Event|0
5265839|NCT00651261|18167795|P2|Overall Study|Never treated|3
5265840|NCT00651261|18167796|P1|Overall Study|Never treated|5
5265841|NCT00651261|18167795|P2|Overall Study|Other disease or participant decisions|23
5265842|NCT00651261|18167796|P1|Overall Study|Other disease or participant decisions|23
5265843|NCT00651261|18167795|P2|Overall Study|Alternative therapy|107
5265844|NCT00651261|18167796|P1|Overall Study|Alternative therapy|109
5265845|NCT00651261|18167795|P2|Overall Study|Disease progression|58
5265846|NCT00651261|18167796|P1|Overall Study|Disease progression|58
5265847|NCT00651261|18167795|P2|Overall Study|Induction failure|35
5265848|NCT00651261|18167796|P1|Overall Study|Induction failure|24
5265849|NCT00651261|18167795|P2|Overall Study|Withdrawal by Subject|40
5265850|NCT00651261|18167796|P1|Overall Study|Withdrawal by Subject|22
5265851|NCT00651261|18167795|P2|Overall Study|Death|18
5265852|NCT00651261|18167796|P1|Overall Study|Death|18
5265853|NCT00651261|18167795|P2|Overall Study|Adverse Event|22
5265854|NCT00651261|18167796|P1|Overall Study|Adverse Event|32
5265855|NCT00651183|18167812|P2|Overall Study|missing|0
5265856|NCT00651183|18167813|P1|Overall Study|missing|1
5265857|NCT00651183|18167812|P2|Overall Study|Other reasons|2
5265858|NCT00651183|18167813|P1|Overall Study|Other reasons|4
5265859|NCT00651183|18167812|P2|Overall Study|Lost to Follow-up|1
5265860|NCT00651183|18167813|P1|Overall Study|Lost to Follow-up|3
5265861|NCT00651183|18167812|P2|Overall Study|Withdrawal by Subject|3
5265862|NCT00651183|18167813|P1|Overall Study|Withdrawal by Subject|6
5265863|NCT00651183|18167812|P2|Overall Study|Tolerability insufficient +Patients wish|1
5265864|NCT00651183|18167813|P1|Overall Study|Tolerability insufficient +Patients wish|0
5265865|NCT00651183|18167812|P2|Overall Study|Tolerability insufficient|2
5265866|NCT00651183|18167813|P1|Overall Study|Tolerability insufficient|5
5265867|NCT00651183|18167812|P2|Overall Study|Efficacy insufficient + patients wish|1
5265868|NCT00651183|18167813|P1|Overall Study|Efficacy insufficient + patients wish|0
5265869|NCT00651183|18167812|P2|Overall Study|Lack of Efficacy|0
5265870|NCT00651183|18167813|P1|Overall Study|Lack of Efficacy|1
5265871|NCT00651157|18167825|P1|Overall Study|Protocol Violation|1
5265872|NCT00651157|18167825|P1|Overall Study|Death|1
5265873|NCT00651118|18167835|P4|Overall Study|Withdrawal by Subject|1
5265874|NCT00651118|18167836|P3|Overall Study|Withdrawal by Subject|1
5265875|NCT00651118|18167837|P2|Overall Study|Withdrawal by Subject|1
5265876|NCT00651118|18167838|P1|Overall Study|Withdrawal by Subject|0
5265877|NCT00651118|18167835|P4|Overall Study|administrative|1
5265878|NCT00651118|18167836|P3|Overall Study|administrative|2
5265879|NCT00651118|18167837|P2|Overall Study|administrative|4
5265880|NCT00651118|18167838|P1|Overall Study|administrative|1
5265881|NCT00651118|18167835|P4|Overall Study|Lost to Follow-up|2
5265882|NCT00651118|18167836|P3|Overall Study|Lost to Follow-up|1
5265883|NCT00651118|18167837|P2|Overall Study|Lost to Follow-up|0
5265884|NCT00651118|18167838|P1|Overall Study|Lost to Follow-up|2
5265885|NCT00651118|18167835|P4|Overall Study|Protocol Violation|2
5265886|NCT00651118|18167836|P3|Overall Study|Protocol Violation|6
5265887|NCT00651118|18167837|P2|Overall Study|Protocol Violation|2
5265888|NCT00651118|18167838|P1|Overall Study|Protocol Violation|2
5265889|NCT00651118|18167835|P4|Overall Study|Adverse Event|1
5265890|NCT00651118|18167836|P3|Overall Study|Adverse Event|1
5265891|NCT00651118|18167837|P2|Overall Study|Adverse Event|0
5265892|NCT00651118|18167838|P1|Overall Study|Adverse Event|4
5265893|NCT00650845|18167907|P2|Overall Study|Protocol Violation|13
5265894|NCT00650845|18167908|P1|Overall Study|Protocol Violation|0
5265895|NCT00650845|18167907|P2|Overall Study|Withdrawal by Subject|0
5265896|NCT00650845|18167908|P1|Overall Study|Withdrawal by Subject|5
5265897|NCT00650806|18167928|P4|Overall Study|Other|0
5265898|NCT00650806|18167929|P3|Overall Study|Other|2
5265899|NCT00650806|18167930|P2|Overall Study|Other|1
5265900|NCT00650806|18167931|P1|Overall Study|Other|1
5265901|NCT00650806|18167928|P4|Overall Study|Study terminated by sponsor|4
5265902|NCT00650806|18167929|P3|Overall Study|Study terminated by sponsor|5
5265903|NCT00650806|18167930|P2|Overall Study|Study terminated by sponsor|3
5265904|NCT00650806|18167931|P1|Overall Study|Study terminated by sponsor|2
5265905|NCT00650806|18167928|P4|Overall Study|Noncompliance with study drug regimen|0
5265906|NCT00650806|18167929|P3|Overall Study|Noncompliance with study drug regimen|0
5265907|NCT00650806|18167930|P2|Overall Study|Noncompliance with study drug regimen|1
5265908|NCT00650806|18167931|P1|Overall Study|Noncompliance with study drug regimen|1
5265909|NCT00650806|18167928|P4|Overall Study|Withdrawal by Subject|6
5265910|NCT00650806|18167929|P3|Overall Study|Withdrawal by Subject|8
5265911|NCT00650806|18167930|P2|Overall Study|Withdrawal by Subject|5
5265912|NCT00650806|18167931|P1|Overall Study|Withdrawal by Subject|7
5265913|NCT00650806|18167928|P4|Overall Study|Pregnancy|1
5265914|NCT00650806|18167929|P3|Overall Study|Pregnancy|0
5265915|NCT00650806|18167930|P2|Overall Study|Pregnancy|0
5265916|NCT00650806|18167931|P1|Overall Study|Pregnancy|0
5265917|NCT00650806|18167928|P4|Overall Study|Protocol Violation|1
5265918|NCT00650806|18167929|P3|Overall Study|Protocol Violation|0
5265919|NCT00650806|18167930|P2|Overall Study|Protocol Violation|0
5265920|NCT00650806|18167931|P1|Overall Study|Protocol Violation|0
5265921|NCT00650806|18167928|P4|Overall Study|Lost to Follow-up|10
5265922|NCT00650806|18167929|P3|Overall Study|Lost to Follow-up|11
5265923|NCT00650806|18167930|P2|Overall Study|Lost to Follow-up|6
5265924|NCT00650806|18167931|P1|Overall Study|Lost to Follow-up|7
5265925|NCT00650806|18167928|P4|Overall Study|Adverse Event|4
5265926|NCT00650806|18167929|P3|Overall Study|Adverse Event|3
5265927|NCT00650806|18167930|P2|Overall Study|Adverse Event|5
5265928|NCT00650806|18167931|P1|Overall Study|Adverse Event|0
5265929|NCT00650767|18167973|P4|Overall Study|Other|0
5265930|NCT00650767|18167974|P3|Overall Study|Other|0
5265931|NCT00650767|18167975|P2|Overall Study|Other|1
5265932|NCT00650767|18167976|P1|Overall Study|Other|1
5265933|NCT00650767|18167973|P4|Overall Study|Lost to Follow-up|0
5265934|NCT00650767|18167974|P3|Overall Study|Lost to Follow-up|1
5265935|NCT00650767|18167975|P2|Overall Study|Lost to Follow-up|1
5265936|NCT00650767|18167976|P1|Overall Study|Lost to Follow-up|1
5265937|NCT00650767|18167973|P4|Overall Study|Withdrawal by Subject|3
5265938|NCT00650767|18167974|P3|Overall Study|Withdrawal by Subject|3
5265939|NCT00650767|18167975|P2|Overall Study|Withdrawal by Subject|4
5265940|NCT00650767|18167976|P1|Overall Study|Withdrawal by Subject|2
5265941|NCT00650767|18167973|P4|Overall Study|Death|0
5265942|NCT00650767|18167974|P3|Overall Study|Death|0
5265943|NCT00650767|18167975|P2|Overall Study|Death|0
5265944|NCT00650767|18167976|P1|Overall Study|Death|1
5265945|NCT00650767|18167973|P4|Overall Study|Adverse Event|8
5265946|NCT00650767|18167974|P3|Overall Study|Adverse Event|10
5265947|NCT00650767|18167975|P2|Overall Study|Adverse Event|3
5265948|NCT00650767|18167976|P1|Overall Study|Adverse Event|0
5265949|NCT00650585|18168480|P2|Overall Study|Excluded/ruled ineligible|129
5265950|NCT00650585|18168481|P1|Overall Study|Excluded/ruled ineligible|357
5265951|NCT00650585|18168480|P2|Overall Study|No parental consent|866
5265952|NCT00650585|18168481|P1|Overall Study|No parental consent|935
5265953|NCT00650585|18168480|P2|Overall Study|Lost to Follow-up|482
5265954|NCT00650585|18168481|P1|Overall Study|Lost to Follow-up|505
5265955|NCT00650104|18168525|P1|Overall Study|Sponsor Terminated Dosing|1
5265956|NCT00650104|18168525|P1|Overall Study|Non-compliance|2
5265957|NCT00650104|18168525|P1|Overall Study|Lost to Follow-up|1
5265958|NCT00650104|18168525|P1|Overall Study|Physician Decision|7
5265959|NCT00650104|18168525|P1|Overall Study|Withdrawal by Subject|11
5265960|NCT00650104|18168525|P1|Overall Study|Death|2
5265961|NCT00650104|18168525|P1|Overall Study|Adverse Event|17
5265962|NCT00650091|18168540|P3|Amended Study Design|Other|0
5265963|NCT00650091|18168541|P2|Amended Study Design|Other|3
5265964|NCT00650091|18168542|P1|Amended Study Design|Other|1
5265965|NCT00650091|18168540|P3|Amended Study Design|Lung transplantation|0
5265966|NCT00650091|18168541|P2|Amended Study Design|Lung transplantation|2
5265967|NCT00650091|18168542|P1|Amended Study Design|Lung transplantation|4
5265968|NCT00650091|18168540|P3|Amended Study Design|Adverse Event|0
5265969|NCT00650091|18168541|P2|Amended Study Design|Adverse Event|4
5265970|NCT00650091|18168542|P1|Amended Study Design|Adverse Event|1
5265971|NCT00650091|18168540|P3|Amended Study Design|Physician Decision|0
5265972|NCT00650091|18168541|P2|Amended Study Design|Physician Decision|0
5265973|NCT00650091|18168542|P1|Amended Study Design|Physician Decision|5
5265974|NCT00650091|18168540|P3|Amended Study Design|Withdrawal by Subject|0
5265975|NCT00650091|18168541|P2|Amended Study Design|Withdrawal by Subject|11
5265976|NCT00650091|18168542|P1|Amended Study Design|Withdrawal by Subject|12
5265977|NCT00649428|18168585|P2|Overall Study|Physician Decision|1
5265978|NCT00649428|18168586|P1|Overall Study|Physician Decision|0
5265979|NCT00649428|18168585|P2|Overall Study|Protocol Violation|2
5265980|NCT00649428|18168586|P1|Overall Study|Protocol Violation|6
5265981|NCT00649428|18168585|P2|Overall Study|Insufficient manufacturing yield|1
5265982|NCT00649428|18168586|P1|Overall Study|Insufficient manufacturing yield|5
5265983|NCT00649428|18168585|P2|Overall Study|Lost to Follow-up|3
5265984|NCT00649428|18168586|P1|Overall Study|Lost to Follow-up|1
5265985|NCT00649428|18168585|P2|Overall Study|Withdrawal by Subject|6
5265986|NCT00649428|18168586|P1|Overall Study|Withdrawal by Subject|6
5265987|NCT00649428|18168585|P2|Overall Study|Adverse Event|2
5265988|NCT00649428|18168586|P1|Overall Study|Adverse Event|2
5265989|NCT00649389|18168602|P4|Overall Study|Other|6
5265990|NCT00649389|18168603|P3|Overall Study|Other|1
5265991|NCT00649389|18168604|P2|Overall Study|Other|9
5265992|NCT00649389|18168605|P1|Overall Study|Other|3
5265993|NCT00649389|18168602|P4|Overall Study|Withdrawal by Subject|23
5265994|NCT00649389|18168603|P3|Overall Study|Withdrawal by Subject|19
5265995|NCT00649389|18168604|P2|Overall Study|Withdrawal by Subject|21
5265996|NCT00649389|18168605|P1|Overall Study|Withdrawal by Subject|20
5265997|NCT00649389|18168602|P4|Overall Study|Protocol Violation|8
5265998|NCT00649389|18168603|P3|Overall Study|Protocol Violation|9
5265999|NCT00649389|18168604|P2|Overall Study|Protocol Violation|13
5266000|NCT00649389|18168605|P1|Overall Study|Protocol Violation|11
5266001|NCT00649389|18168602|P4|Overall Study|Lost to Follow-up|26
5266002|NCT00649389|18168603|P3|Overall Study|Lost to Follow-up|21
5266003|NCT00649389|18168604|P2|Overall Study|Lost to Follow-up|17
5266004|NCT00649389|18168605|P1|Overall Study|Lost to Follow-up|15
5266005|NCT00649389|18168602|P4|Overall Study|Adverse Event|48
5266006|NCT00649389|18168603|P3|Overall Study|Adverse Event|38
5266007|NCT00649389|18168604|P2|Overall Study|Adverse Event|46
5266008|NCT00649389|18168605|P1|Overall Study|Adverse Event|22
5266009|NCT00649220|18168627|P1|Overall Study|Withdrawal by Subject|1
5266010|NCT00649220|18168627|P1|Overall Study|Adverse Event|2
5266011|NCT00648895|18168648|P2|Overall Study|Lack of Efficacy|1
5266012|NCT00648895|18168649|P1|Overall Study|Lack of Efficacy|0
5266013|NCT00648739|18168655|P7|Overall Study|Follow-up Visits Not Completed|0
5266014|NCT00648739|18168656|P6|Overall Study|Follow-up Visits Not Completed|0
5266015|NCT00648739|18168657|P5|Overall Study|Follow-up Visits Not Completed|0
5266016|NCT00648739|18168658|P4|Overall Study|Follow-up Visits Not Completed|0
5266017|NCT00648739|18168659|P3|Overall Study|Follow-up Visits Not Completed|0
5266018|NCT00648739|18168660|P2|Overall Study|Follow-up Visits Not Completed|1
5266019|NCT00648739|18168661|P1|Overall Study|Follow-up Visits Not Completed|0
5266020|NCT00648739|18168655|P7|Overall Study|Positive Human Anti-human Antibody|0
5266021|NCT00648739|18168656|P6|Overall Study|Positive Human Anti-human Antibody|0
5266022|NCT00648739|18168657|P5|Overall Study|Positive Human Anti-human Antibody|0
5266023|NCT00648739|18168658|P4|Overall Study|Positive Human Anti-human Antibody|0
5266024|NCT00648739|18168659|P3|Overall Study|Positive Human Anti-human Antibody|1
5266025|NCT00648739|18168660|P2|Overall Study|Positive Human Anti-human Antibody|0
5266026|NCT00648739|18168661|P1|Overall Study|Positive Human Anti-human Antibody|0
5266027|NCT00648739|18168655|P7|Overall Study|Death|0
5266028|NCT00648739|18168656|P6|Overall Study|Death|0
5266029|NCT00648739|18168657|P5|Overall Study|Death|0
5266030|NCT00648739|18168658|P4|Overall Study|Death|0
5266031|NCT00648739|18168659|P3|Overall Study|Death|0
5266032|NCT00648739|18168660|P2|Overall Study|Death|1
5266033|NCT00648739|18168661|P1|Overall Study|Death|0
5266034|NCT00648739|18168655|P7|Overall Study|Investigator Considered it Advisable|1
5266035|NCT00648739|18168656|P6|Overall Study|Investigator Considered it Advisable|1
5266036|NCT00648739|18168657|P5|Overall Study|Investigator Considered it Advisable|0
5266037|NCT00648739|18168658|P4|Overall Study|Investigator Considered it Advisable|0
5266038|NCT00648739|18168659|P3|Overall Study|Investigator Considered it Advisable|0
5266039|NCT00648739|18168660|P2|Overall Study|Investigator Considered it Advisable|0
5266040|NCT00648739|18168661|P1|Overall Study|Investigator Considered it Advisable|0
5266041|NCT00648739|18168655|P7|Overall Study|Lack of Efficacy|0
5266042|NCT00648739|18168656|P6|Overall Study|Lack of Efficacy|2
5266043|NCT00648739|18168657|P5|Overall Study|Lack of Efficacy|1
5266044|NCT00648739|18168658|P4|Overall Study|Lack of Efficacy|0
5266045|NCT00648739|18168659|P3|Overall Study|Lack of Efficacy|0
5266046|NCT00648739|18168660|P2|Overall Study|Lack of Efficacy|0
5266047|NCT00648739|18168661|P1|Overall Study|Lack of Efficacy|0
5266048|NCT00648739|18168655|P7|Overall Study|Withdrawal by Subject|0
5266049|NCT00648739|18168656|P6|Overall Study|Withdrawal by Subject|2
5266050|NCT00648739|18168657|P5|Overall Study|Withdrawal by Subject|0
5266051|NCT00648739|18168658|P4|Overall Study|Withdrawal by Subject|0
5266052|NCT00648739|18168659|P3|Overall Study|Withdrawal by Subject|1
5266053|NCT00648739|18168660|P2|Overall Study|Withdrawal by Subject|0
5266054|NCT00648739|18168661|P1|Overall Study|Withdrawal by Subject|1
5266055|NCT00648739|18168655|P7|Overall Study|Adverse Event|0
5266056|NCT00648739|18168656|P6|Overall Study|Adverse Event|0
5266057|NCT00648739|18168657|P5|Overall Study|Adverse Event|1
5266058|NCT00648739|18168658|P4|Overall Study|Adverse Event|2
5266059|NCT00648739|18168659|P3|Overall Study|Adverse Event|1
5266060|NCT00648739|18168660|P2|Overall Study|Adverse Event|0
5266061|NCT00648739|18168661|P1|Overall Study|Adverse Event|1
5266062|NCT00648167|18168995|P1|Overall Study|unable to swallow tablets|1
5266063|NCT00648167|18168995|P1|Overall Study|Adverse Event|6
5266064|NCT00648037|18169015|P1|Overall Study|Other|1
5266065|NCT00648037|18169015|P1|Overall Study|Relapse|2
5266066|NCT00648037|18169015|P1|Overall Study|Adverse Event|11
5266067|NCT00648037|18169015|P1|Overall Study|Withdrawal by Subject|1
5266068|NCT00648037|18169015|P1|Overall Study|Not Treated|1
5266069|NCT00647699|18169034|P2|Overall Study|Withdrawal by Subject|8
5266070|NCT00647699|18169035|P1|Overall Study|Withdrawal by Subject|3
5266071|NCT00647699|18169034|P2|Overall Study|Lost to Follow-up|4
5266072|NCT00647699|18169035|P1|Overall Study|Lost to Follow-up|5
5266073|NCT00647556|18169043|P2|Overall Study|Surgery for pre-existing neck pain|0
5266074|NCT00647556|18169044|P1|Overall Study|Surgery for pre-existing neck pain|1
5266075|NCT00647556|18169043|P2|Overall Study|Withdrawal by Subject|0
5266076|NCT00647556|18169044|P1|Overall Study|Withdrawal by Subject|1
5266077|NCT00647556|18169043|P2|Overall Study|Protocol Violation|1
5266078|NCT00647556|18169044|P1|Overall Study|Protocol Violation|0
5266079|NCT00647556|18169043|P2|Overall Study|Lost to Follow-up|0
5266080|NCT00647556|18169044|P1|Overall Study|Lost to Follow-up|1
5266081|NCT00647556|18169043|P2|Overall Study|Adverse Event|1
5266082|NCT00647556|18169044|P1|Overall Study|Adverse Event|0
5266083|NCT00647426|18169058|P1|Overall Study|Withdrawal by Subject|2
5266084|NCT00647348|18169080|P2|Overall Study|Lost to Follow-up|6
5266085|NCT00647348|18169081|P1|Overall Study|Lost to Follow-up|3
5266086|NCT00647270|18169106|P3|Period 2, Placebo Switched to Adalimumab|Other|0
5266087|NCT00647270|18169107|P2|Period 2, Placebo Switched to Adalimumab|Other|6
5266088|NCT00647270|18169108|P1|Period 2, Placebo Switched to Adalimumab|Other|2
5266089|NCT00647270|18169106|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
5266090|NCT00647270|18169107|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
5266091|NCT00647270|18169108|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
5266092|NCT00647270|18169106|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
5266093|NCT00647270|18169107|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
5266094|NCT00647270|18169108|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
5266095|NCT00647270|18169106|P3|Period 1, Placebo-control (12 Weeks)|Other|8
5266096|NCT00647270|18169107|P2|Period 1, Placebo-control (12 Weeks)|Other|4
5266097|NCT00647270|18169108|P1|Period 1, Placebo-control (12 Weeks)|Other|4
5266098|NCT00647270|18169106|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
5266099|NCT00647270|18169107|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
5266100|NCT00647270|18169108|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
5266101|NCT00647270|18169106|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
5266102|NCT00647270|18169107|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
5266103|NCT00647270|18169108|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
5266104|NCT00647270|18169106|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
5266105|NCT00647270|18169107|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
5266106|NCT00647270|18169108|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
5266107|NCT00646958|18169134|P3|Overall Study|Did not receive study drug|2
5266108|NCT00646958|18169135|P2|Overall Study|Did not receive study drug|0
5266109|NCT00646958|18169136|P1|Overall Study|Did not receive study drug|2
5266110|NCT00646958|18169134|P3|Overall Study|Withdrawal by Subject|0
5266111|NCT00646958|18169135|P2|Overall Study|Withdrawal by Subject|2
5266112|NCT00646958|18169136|P1|Overall Study|Withdrawal by Subject|1
5266113|NCT00646958|18169134|P3|Overall Study|Abnormal screening lab tests|0
5266114|NCT00646958|18169135|P2|Overall Study|Abnormal screening lab tests|1
5266115|NCT00646958|18169136|P1|Overall Study|Abnormal screening lab tests|1
5266116|NCT00646958|18169134|P3|Overall Study|Protocol Violation|0
5266117|NCT00646958|18169135|P2|Overall Study|Protocol Violation|1
5266118|NCT00646958|18169136|P1|Overall Study|Protocol Violation|1
5266119|NCT00646958|18169134|P3|Overall Study|Lost to Follow-up|7
5266120|NCT00646958|18169135|P2|Overall Study|Lost to Follow-up|5
5266121|NCT00646958|18169136|P1|Overall Study|Lost to Follow-up|1
5266122|NCT00646958|18169134|P3|Overall Study|Adverse Event|0
5266123|NCT00646958|18169135|P2|Overall Study|Adverse Event|0
5266124|NCT00646958|18169136|P1|Overall Study|Adverse Event|4
5266125|NCT00646958|18169134|P3|Overall Study|Lack of Efficacy|0
5266126|NCT00646958|18169135|P2|Overall Study|Lack of Efficacy|0
5266127|NCT00646958|18169136|P1|Overall Study|Lack of Efficacy|1
5266128|NCT00646906|18169151|P7|Crossover Period 2|Physician Decision|1
5266129|NCT00646906|18169152|P6|Crossover Period 2|Physician Decision|0
5266130|NCT00646906|18169153|P5|Crossover Period 2|Physician Decision|0
5266131|NCT00646906|18169154|P4|Crossover Period 2|Physician Decision|0
5266132|NCT00646906|18169155|P3|Crossover Period 2|Physician Decision|0
5266133|NCT00646906|18169156|P2|Crossover Period 2|Physician Decision|0
5266134|NCT00646906|18169157|P1|Crossover Period 2|Physician Decision|0
5266135|NCT00646906|18169151|P7|Crossover Period 2|Withdrawal by Subject|0
5266136|NCT00646906|18169152|P6|Crossover Period 2|Withdrawal by Subject|0
5266137|NCT00646906|18169153|P5|Crossover Period 2|Withdrawal by Subject|0
5266138|NCT00646906|18169154|P4|Crossover Period 2|Withdrawal by Subject|1
5266139|NCT00646906|18169155|P3|Crossover Period 2|Withdrawal by Subject|2
5266140|NCT00646906|18169156|P2|Crossover Period 2|Withdrawal by Subject|1
5266141|NCT00646906|18169157|P1|Crossover Period 2|Withdrawal by Subject|0
5266142|NCT00646906|18169151|P7|Crossover Period 1|Withdrawal by Subject|0
5266143|NCT00646906|18169152|P6|Crossover Period 1|Withdrawal by Subject|1
5266144|NCT00646906|18169153|P5|Crossover Period 1|Withdrawal by Subject|0
5266145|NCT00646906|18169154|P4|Crossover Period 1|Withdrawal by Subject|0
5266146|NCT00646906|18169155|P3|Crossover Period 1|Withdrawal by Subject|0
5266147|NCT00646906|18169156|P2|Crossover Period 1|Withdrawal by Subject|0
5266148|NCT00646906|18169157|P1|Crossover Period 1|Withdrawal by Subject|1
5266149|NCT00646776|18169176|P2|Overall Study|Investigator discretion|4
5266150|NCT00646776|18169177|P1|Overall Study|Investigator discretion|0
5266151|NCT00646776|18169176|P2|Overall Study|Adverse Event|9
5266152|NCT00646776|18169177|P1|Overall Study|Adverse Event|1
5266153|NCT00646399|18169275|P2|Overall Study|Other Reason|11
5266154|NCT00646399|18169276|P1|Overall Study|Other Reason|11
5266155|NCT00646399|18169275|P2|Overall Study|Withdrawal by Subject|10
5266156|NCT00646399|18169276|P1|Overall Study|Withdrawal by Subject|9
5266157|NCT00646399|18169275|P2|Overall Study|Death|53
5266158|NCT00646399|18169276|P1|Overall Study|Death|63
5266159|NCT00646282|18169284|P2|Overall Study|Protocol terminated|4
5266160|NCT00646282|18169285|P1|Overall Study|Protocol terminated|4
5266161|NCT00646113|18169291|P1|Overall Study|Adverse Event|3
5266162|NCT00646113|18169291|P1|Overall Study|Lost to Follow-up|5
5266163|NCT00645944|18169312|P2|Received Medication|Protocol Violation|1
5266164|NCT00645944|18169313|P1|Received Medication|Protocol Violation|2
5266165|NCT00645944|18169312|P2|Received Medication|Lost to Follow-up|0
5266166|NCT00645944|18169313|P1|Received Medication|Lost to Follow-up|1
5266167|NCT00645944|18169312|P2|Received Medication|Withdrawal by Subject|1
5266168|NCT00645944|18169313|P1|Received Medication|Withdrawal by Subject|1
5266169|NCT00645944|18169312|P2|Received Medication|Adverse Event|1
5266170|NCT00645944|18169313|P1|Received Medication|Adverse Event|2
5266171|NCT00645944|18169312|P2|Randomized|Withdrawal by Subject|2
5266172|NCT00645944|18169313|P1|Randomized|Withdrawal by Subject|1
5266173|NCT00645853|18169321|P2|Overall Study|recall of ICF, planned operation, death|4
5266174|NCT00645853|18169322|P1|Overall Study|recall of ICF, planned operation, death|7
5266175|NCT00645853|18169321|P2|Overall Study|Discontinuation criteria|2
5266176|NCT00645853|18169322|P1|Overall Study|Discontinuation criteria|2
5266177|NCT00645853|18169321|P2|Overall Study|Protocol Violation|2
5266178|NCT00645853|18169322|P1|Overall Study|Protocol Violation|0
5266179|NCT00645853|18169321|P2|Overall Study|Withdrawal by Subject|2
5266180|NCT00645853|18169322|P1|Overall Study|Withdrawal by Subject|5
5266181|NCT00645853|18169321|P2|Overall Study|AZ study closure in Hungary|40
5266182|NCT00645853|18169322|P1|Overall Study|AZ study closure in Hungary|60
5266183|NCT00645853|18169321|P2|Overall Study|Adverse Event|7
5266184|NCT00645853|18169322|P1|Overall Study|Adverse Event|18
5266185|NCT00645840|18169340|P1|Overall Study|Protocol Violation|3
5266186|NCT00645788|18169358|P4|Overall Study|Pulmonary exacerbation|9
5266187|NCT00645788|18169359|P3|Overall Study|Pulmonary exacerbation|11
5266188|NCT00645788|18169360|P2|Overall Study|Pulmonary exacerbation|16
5266189|NCT00645788|18169361|P1|Overall Study|Pulmonary exacerbation|13
5266190|NCT00645788|18169358|P4|Overall Study|Withdrawal by Subject|2
5266191|NCT00645788|18169359|P3|Overall Study|Withdrawal by Subject|0
5266192|NCT00645788|18169360|P2|Overall Study|Withdrawal by Subject|1
5266193|NCT00645788|18169361|P1|Overall Study|Withdrawal by Subject|0
5266194|NCT00645788|18169358|P4|Overall Study|Protocol Violation|0
5266195|NCT00645788|18169359|P3|Overall Study|Protocol Violation|2
5266196|NCT00645788|18169360|P2|Overall Study|Protocol Violation|0
5266197|NCT00645788|18169361|P1|Overall Study|Protocol Violation|1
5266198|NCT00645788|18169358|P4|Overall Study|Lost to Follow-up|0
5266199|NCT00645788|18169359|P3|Overall Study|Lost to Follow-up|0
5266200|NCT00645788|18169360|P2|Overall Study|Lost to Follow-up|0
5266201|NCT00645788|18169361|P1|Overall Study|Lost to Follow-up|1
5266202|NCT00645788|18169358|P4|Overall Study|Adverse Event|3
5266203|NCT00645788|18169359|P3|Overall Study|Adverse Event|5
5266204|NCT00645788|18169360|P2|Overall Study|Adverse Event|9
5266205|NCT00645788|18169361|P1|Overall Study|Adverse Event|4
5266206|NCT00645788|18169358|P4|Overall Study|Did not receive study drug|0
5266207|NCT00645788|18169359|P3|Overall Study|Did not receive study drug|0
5266208|NCT00645788|18169360|P2|Overall Study|Did not receive study drug|1
5266209|NCT00645788|18169361|P1|Overall Study|Did not receive study drug|1
5266210|NCT00645671|18169439|P2|Overall Study|Physician Decision|1
5266211|NCT00645671|18169440|P1|Overall Study|Physician Decision|0
5266212|NCT00645671|18169439|P2|Overall Study|Adverse Event|1
5266213|NCT00645671|18169440|P1|Overall Study|Adverse Event|0
5266214|NCT00645671|18169439|P2|Overall Study|Withdrawal by Subject|4
5266215|NCT00645671|18169440|P1|Overall Study|Withdrawal by Subject|0
5266216|NCT00645671|18169439|P2|Overall Study|Protocol Violation|0
5266217|NCT00645671|18169440|P1|Overall Study|Protocol Violation|1
5266218|NCT00645593|18169454|P2|Overall Study|Later found to be ineligible|0
5266219|NCT00645593|18169455|P1|Overall Study|Later found to be ineligible|1
5266220|NCT00645567|18169467|P1|Overall Study|Adverse Event|1
5266221|NCT00645528|18169475|P1|Overall Study|Did not show up for Visit 2|7
5266222|NCT00645411|18169497|P4|Overall Study|Unable to classify|4
5266223|NCT00645411|18169498|P3|Overall Study|Unable to classify|3
5266224|NCT00645411|18169499|P2|Overall Study|Unable to classify|0
5266225|NCT00645411|18169500|P1|Overall Study|Unable to classify|0
5266226|NCT00645411|18169497|P4|Overall Study|Inappropriate enrollment|1
5266227|NCT00645411|18169498|P3|Overall Study|Inappropriate enrollment|4
5266228|NCT00645411|18169499|P2|Overall Study|Inappropriate enrollment|0
5266229|NCT00645411|18169500|P1|Overall Study|Inappropriate enrollment|0
5266230|NCT00645411|18169497|P4|Overall Study|Protocol Violation|0
5266231|NCT00645411|18169498|P3|Overall Study|Protocol Violation|1
5266232|NCT00645411|18169499|P2|Overall Study|Protocol Violation|0
5266233|NCT00645411|18169500|P1|Overall Study|Protocol Violation|1
5266234|NCT00645411|18169497|P4|Overall Study|Lost to Follow-up|75
5266235|NCT00645411|18169498|P3|Overall Study|Lost to Follow-up|124
5266236|NCT00645411|18169499|P2|Overall Study|Lost to Follow-up|5
5266237|NCT00645411|18169500|P1|Overall Study|Lost to Follow-up|10
5266238|NCT00645411|18169497|P4|Overall Study|Withdrawal by Subject|21
5266239|NCT00645411|18169498|P3|Overall Study|Withdrawal by Subject|19
5266240|NCT00645411|18169499|P2|Overall Study|Withdrawal by Subject|1
5266241|NCT00645411|18169500|P1|Overall Study|Withdrawal by Subject|2
5266242|NCT00645411|18169497|P4|Overall Study|Adverse Event|2
5266243|NCT00645411|18169498|P3|Overall Study|Adverse Event|0
5266244|NCT00645411|18169499|P2|Overall Study|Adverse Event|0
5266245|NCT00645411|18169500|P1|Overall Study|Adverse Event|0
5266246|NCT00645164|18169542|P1|Overall Study|Protocol Violation|1
5266247|NCT00645164|18169542|P1|Overall Study|Withdrawal by Subject|4
5266248|NCT00645164|18169542|P1|Overall Study|Lost to Follow-up|2
5266249|NCT00645099|18169548|P2|Overall Study|Other|5
5266250|NCT00645099|18169549|P1|Overall Study|Other|9
5266251|NCT00645099|18169548|P2|Overall Study|Adverse Event|5
5266252|NCT00645099|18169549|P1|Overall Study|Adverse Event|11
5266253|NCT00645099|18169548|P2|Overall Study|Lost to Follow-up|4
5266254|NCT00645099|18169549|P1|Overall Study|Lost to Follow-up|6
5266255|NCT00645099|18169548|P2|Overall Study|Withdrawal by Subject|22
5266256|NCT00645099|18169549|P1|Overall Study|Withdrawal by Subject|30
5266257|NCT00645099|18169548|P2|Overall Study|Lack of Efficacy|6
5266258|NCT00645099|18169549|P1|Overall Study|Lack of Efficacy|15
5266259|NCT00644995|18169618|P2|Overall Study|Refused|0
5266260|NCT00644995|18169619|P1|Overall Study|Refused|1
5266261|NCT00644995|18169618|P2|Overall Study|Lost to Follow-up|4
5266262|NCT00644995|18169619|P1|Overall Study|Lost to Follow-up|1
5266263|NCT00644969|18169639|P2|Post Treatment Phase|Other|0
5266264|NCT00644969|18169640|P1|Post Treatment Phase|Other|1
5266265|NCT00644969|18169639|P2|Post Treatment Phase|Lost to Follow-up|1
5266266|NCT00644969|18169640|P1|Post Treatment Phase|Lost to Follow-up|4
5266267|NCT00644969|18169639|P2|Post Treatment Phase|Withdrawal by Subject|2
5266268|NCT00644969|18169640|P1|Post Treatment Phase|Withdrawal by Subject|4
5266269|NCT00644969|18169639|P2|Post Treatment Phase|Death|0
5266270|NCT00644969|18169640|P1|Post Treatment Phase|Death|1
5266271|NCT00644969|18169639|P2|Treatment Phase|Other|1
5266272|NCT00644969|18169640|P1|Treatment Phase|Other|4
5266273|NCT00644969|18169639|P2|Treatment Phase|Lost to Follow-up|2
5266274|NCT00644969|18169640|P1|Treatment Phase|Lost to Follow-up|2
5266275|NCT00644969|18169639|P2|Treatment Phase|Withdrawal by Subject|0
5266276|NCT00644969|18169640|P1|Treatment Phase|Withdrawal by Subject|4
5266277|NCT00644969|18169639|P2|Treatment Phase|Adverse Event|0
5266278|NCT00644969|18169640|P1|Treatment Phase|Adverse Event|3
5266279|NCT00644969|18169639|P2|Treatment Phase|Randomized, not treated|0
5266280|NCT00644969|18169640|P1|Treatment Phase|Randomized, not treated|1
5266281|NCT00644917|18169686|P1|Overall Study|Withdrawal by Subject|2
5266282|NCT00644787|18169694|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
5266283|NCT00644787|18169695|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
5266284|NCT00644787|18169696|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
5266285|NCT00644787|18169694|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
5266286|NCT00644787|18169695|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
5266287|NCT00644787|18169696|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
5266288|NCT00644787|18169694|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
5266289|NCT00644787|18169695|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
5266290|NCT00644787|18169696|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
5266291|NCT00644787|18169694|P3|Period 2: Double Blind Phase|Adverse Event|4
5266292|NCT00644787|18169695|P2|Period 2: Double Blind Phase|Adverse Event|2
5266293|NCT00644787|18169696|P1|Period 2: Double Blind Phase|Adverse Event|0
5266294|NCT00644787|18169694|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
5266295|NCT00644787|18169695|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
5266296|NCT00644787|18169696|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
5266297|NCT00644787|18169694|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
5266298|NCT00644787|18169695|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
5266299|NCT00644787|18169696|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
5266300|NCT00644787|18169694|P3|Period 1: Titration Phase|Worsening of symptoms|0
5266301|NCT00644787|18169695|P2|Period 1: Titration Phase|Worsening of symptoms|0
5266302|NCT00644787|18169696|P1|Period 1: Titration Phase|Worsening of symptoms|1
5266303|NCT00644787|18169694|P3|Period 1: Titration Phase|Worsening of complications|0
5266304|NCT00644787|18169695|P2|Period 1: Titration Phase|Worsening of complications|0
5266305|NCT00644787|18169696|P1|Period 1: Titration Phase|Worsening of complications|1
5266306|NCT00644787|18169694|P3|Period 1: Titration Phase|Worsening of underlying disease|0
5266307|NCT00644787|18169695|P2|Period 1: Titration Phase|Worsening of underlying disease|0
5266308|NCT00644787|18169696|P1|Period 1: Titration Phase|Worsening of underlying disease|5
5266309|NCT00644787|18169694|P3|Period 1: Titration Phase|Physician Decision|0
5266310|NCT00644787|18169695|P2|Period 1: Titration Phase|Physician Decision|0
5266311|NCT00644787|18169696|P1|Period 1: Titration Phase|Physician Decision|1
5266312|NCT00644787|18169694|P3|Period 1: Titration Phase|Withdrawal by Subject|0
5266313|NCT00644787|18169695|P2|Period 1: Titration Phase|Withdrawal by Subject|0
5266314|NCT00644787|18169696|P1|Period 1: Titration Phase|Withdrawal by Subject|2
5266315|NCT00644787|18169694|P3|Period 1: Titration Phase|Adverse Event|0
5266316|NCT00644787|18169695|P2|Period 1: Titration Phase|Adverse Event|0
5266317|NCT00644787|18169696|P1|Period 1: Titration Phase|Adverse Event|11
5266318|NCT00644423|18169740|P2|Overall Study|Lost to Follow-up|1
5266319|NCT00644423|18169741|P1|Overall Study|Lost to Follow-up|1
5266320|NCT00644358|18169759|P1|Overall Study|Other Unspecified|11
5266321|NCT00644358|18169759|P1|Overall Study|Noncompliance|14
5266322|NCT00644358|18169759|P1|Overall Study|Protocol Violation|5
5266323|NCT00644358|18169759|P1|Overall Study|Lack of Effectiveness|39
5266324|NCT00644358|18169759|P1|Overall Study|Consent Withdrawal|64
5266325|NCT00644358|18169759|P1|Overall Study|Lost to Follow-up|105
5266326|NCT00644358|18169759|P1|Overall Study|Adverse Event|124
5266327|NCT00644332|18169766|P1|Overall Study|Could Not Attend Scheduled Visits|1
5266328|NCT00644332|18169766|P1|Overall Study|Did Not Meet Eligibility Requirements|1
5266329|NCT00644332|18169766|P1|Overall Study|Completion Status Unknown|2
5266330|NCT00644332|18169766|P1|Overall Study|Withdrawal by Subject|6
5266331|NCT00644332|18169766|P1|Overall Study|Adverse Event|11
5266332|NCT00644228|18169792|P2|Maintenance|On Treatment|40
5266333|NCT00644228|18169793|P1|Maintenance|On Treatment|26
5266334|NCT00644228|18169792|P2|Maintenance|Not Protocol-Specified|15
5266335|NCT00644228|18169793|P1|Maintenance|Not Protocol-Specified|14
5266336|NCT00644228|18169792|P2|Maintenance|Death|3
5266337|NCT00644228|18169793|P1|Maintenance|Death|3
5266338|NCT00644228|18169792|P2|Maintenance|Progression/Relapse|42
5266339|NCT00644228|18169793|P1|Maintenance|Progression/Relapse|67
5266340|NCT00644228|18169792|P2|Maintenance|Withdrawal by Subject|4
5266341|NCT00644228|18169793|P1|Maintenance|Withdrawal by Subject|6
5266342|NCT00644228|18169792|P2|Maintenance|Adverse Event|31
5266343|NCT00644228|18169793|P1|Maintenance|Adverse Event|27
5266344|NCT00644228|18169792|P2|Induction Therapy|Not Protocol-Specified|28
5266345|NCT00644228|18169793|P1|Induction Therapy|Not Protocol-Specified|24
5266346|NCT00644228|18169792|P2|Induction Therapy|Death|7
5266347|NCT00644228|18169793|P1|Induction Therapy|Death|3
5266348|NCT00644228|18169792|P2|Induction Therapy|Progression/Relapse|12
5266349|NCT00644228|18169793|P1|Induction Therapy|Progression/Relapse|24
5266350|NCT00644228|18169792|P2|Induction Therapy|Withdrawal by Subject|3
5266351|NCT00644228|18169793|P1|Induction Therapy|Withdrawal by Subject|10
5266352|NCT00644228|18169792|P2|Induction Therapy|Adverse Event|55
5266353|NCT00644228|18169793|P1|Induction Therapy|Adverse Event|22
5266354|NCT00644228|18169792|P2|Randomization & Eligibility|Invalid Consent|1
5266355|NCT00644228|18169793|P1|Randomization & Eligibility|Invalid Consent|0
5266356|NCT00644228|18169792|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
5266357|NCT00644228|18169793|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
5266358|NCT00644228|18169792|P2|Randomization & Eligibility|Ineligible|21
5266359|NCT00644228|18169793|P1|Randomization & Eligibility|Ineligible|31
5266360|NCT00644059|18169822|P3|Overall Study|Unable to classify|3
5266361|NCT00644059|18169823|P2|Overall Study|Unable to classify|2
5266362|NCT00644059|18169824|P1|Overall Study|Unable to classify|6
5266363|NCT00644059|18169822|P3|Overall Study|Protocol Deviation/violation|15
5266364|NCT00644059|18169823|P2|Overall Study|Protocol Deviation/violation|19
5266365|NCT00644059|18169824|P1|Overall Study|Protocol Deviation/violation|20
5266366|NCT00644059|18169822|P3|Overall Study|Inappropriate Enrollment|0
5266367|NCT00644059|18169823|P2|Overall Study|Inappropriate Enrollment|3
5266368|NCT00644059|18169824|P1|Overall Study|Inappropriate Enrollment|1
5266369|NCT00644059|18169822|P3|Overall Study|Adverse Event|1
5266370|NCT00644059|18169823|P2|Overall Study|Adverse Event|5
5266371|NCT00644059|18169824|P1|Overall Study|Adverse Event|8
5266372|NCT00644059|18169822|P3|Overall Study|Withdrawal by Subject|30
5266373|NCT00644059|18169823|P2|Overall Study|Withdrawal by Subject|60
5266374|NCT00644059|18169824|P1|Overall Study|Withdrawal by Subject|52
5266375|NCT00644059|18169822|P3|Overall Study|Lost to Follow-up|16
5266376|NCT00644059|18169823|P2|Overall Study|Lost to Follow-up|34
5266377|NCT00644059|18169824|P1|Overall Study|Lost to Follow-up|37
5266378|NCT00643916|18169914|P6|Overall Study|Not Vaccinated|0
5266379|NCT00643916|18169915|P5|Overall Study|Not Vaccinated|2
5266380|NCT00643916|18169916|P4|Overall Study|Not Vaccinated|0
5266381|NCT00643916|18169917|P3|Overall Study|Not Vaccinated|3
5266382|NCT00643916|18169918|P2|Overall Study|Not Vaccinated|2
5266383|NCT00643916|18169919|P1|Overall Study|Not Vaccinated|2
5266384|NCT00643916|18169914|P6|Overall Study|Withdrawal by Subject|1
5266385|NCT00643916|18169915|P5|Overall Study|Withdrawal by Subject|0
5266386|NCT00643916|18169916|P4|Overall Study|Withdrawal by Subject|1
5266387|NCT00643916|18169917|P3|Overall Study|Withdrawal by Subject|2
5266388|NCT00643916|18169918|P2|Overall Study|Withdrawal by Subject|2
5266389|NCT00643916|18169919|P1|Overall Study|Withdrawal by Subject|2
5266390|NCT00643916|18169914|P6|Overall Study|Lost to Follow-up|0
5266391|NCT00643916|18169915|P5|Overall Study|Lost to Follow-up|0
5266392|NCT00643916|18169916|P4|Overall Study|Lost to Follow-up|0
5266393|NCT00643916|18169917|P3|Overall Study|Lost to Follow-up|0
5266394|NCT00643916|18169918|P2|Overall Study|Lost to Follow-up|1
5266395|NCT00643916|18169919|P1|Overall Study|Lost to Follow-up|0
5266396|NCT00643916|18169914|P6|Overall Study|Protocol Violation|0
5266397|NCT00643916|18169915|P5|Overall Study|Protocol Violation|0
5266398|NCT00643916|18169916|P4|Overall Study|Protocol Violation|1
5266399|NCT00643916|18169917|P3|Overall Study|Protocol Violation|1
5266400|NCT00643916|18169918|P2|Overall Study|Protocol Violation|1
5266401|NCT00643916|18169919|P1|Overall Study|Protocol Violation|0
5266402|NCT00643851|18169948|P3|Overall Study|Non-compl., not met criteria, etc.|6
5266403|NCT00643851|18169949|P2|Overall Study|Non-compl., not met criteria, etc.|4
5266404|NCT00643851|18169950|P1|Overall Study|Non-compl., not met criteria, etc.|3
5266405|NCT00643851|18169948|P3|Overall Study|Withdrawal by Subject|9
5266406|NCT00643851|18169949|P2|Overall Study|Withdrawal by Subject|15
5266407|NCT00643851|18169950|P1|Overall Study|Withdrawal by Subject|8
5266408|NCT00643851|18169948|P3|Overall Study|Lost to Follow-up|9
5266409|NCT00643851|18169949|P2|Overall Study|Lost to Follow-up|6
5266410|NCT00643851|18169950|P1|Overall Study|Lost to Follow-up|4
5266411|NCT00643851|18169948|P3|Overall Study|Adverse Event|6
5266412|NCT00643851|18169949|P2|Overall Study|Adverse Event|6
5266413|NCT00643851|18169950|P1|Overall Study|Adverse Event|2
5266414|NCT00643851|18169948|P3|Overall Study|Lack of Efficacy|0
5266415|NCT00643851|18169949|P2|Overall Study|Lack of Efficacy|1
5266416|NCT00643851|18169950|P1|Overall Study|Lack of Efficacy|0
5266417|NCT00643851|18169948|P3|Overall Study|Death|0
5266418|NCT00643851|18169949|P2|Overall Study|Death|1
5266419|NCT00643851|18169950|P1|Overall Study|Death|0
5266420|NCT00643760|18169978|P5|Overall Study|Withdrawal by Subject|1
5266421|NCT00643760|18169979|P4|Overall Study|Withdrawal by Subject|4
5266422|NCT00643760|18169980|P3|Overall Study|Withdrawal by Subject|2
5266423|NCT00643760|18169981|P2|Overall Study|Withdrawal by Subject|1
5266424|NCT00643760|18169982|P1|Overall Study|Withdrawal by Subject|3
5266425|NCT00643760|18169978|P5|Overall Study|Investigator Discretion|0
5266426|NCT00643760|18169979|P4|Overall Study|Investigator Discretion|2
5266427|NCT00643760|18169980|P3|Overall Study|Investigator Discretion|0
5266428|NCT00643760|18169981|P2|Overall Study|Investigator Discretion|0
5266429|NCT00643760|18169982|P1|Overall Study|Investigator Discretion|0
5266430|NCT00643760|18169978|P5|Overall Study|Lost to Follow-up|3
5266431|NCT00643760|18169979|P4|Overall Study|Lost to Follow-up|3
5266432|NCT00643760|18169980|P3|Overall Study|Lost to Follow-up|1
5266433|NCT00643760|18169981|P2|Overall Study|Lost to Follow-up|2
5266434|NCT00643760|18169982|P1|Overall Study|Lost to Follow-up|6
5266435|NCT00643760|18169978|P5|Overall Study|Protocol Violation|6
5266436|NCT00643760|18169979|P4|Overall Study|Protocol Violation|4
5266437|NCT00643760|18169980|P3|Overall Study|Protocol Violation|4
5266438|NCT00643760|18169981|P2|Overall Study|Protocol Violation|6
5266439|NCT00643760|18169982|P1|Overall Study|Protocol Violation|7
5266440|NCT00643760|18169978|P5|Overall Study|Lack of Efficacy|3
5266441|NCT00643760|18169979|P4|Overall Study|Lack of Efficacy|4
5266442|NCT00643760|18169980|P3|Overall Study|Lack of Efficacy|0
5266443|NCT00643760|18169981|P2|Overall Study|Lack of Efficacy|1
5266444|NCT00643760|18169982|P1|Overall Study|Lack of Efficacy|3
5266445|NCT00643760|18169978|P5|Overall Study|Adverse Event|6
5266446|NCT00643760|18169979|P4|Overall Study|Adverse Event|21
5266447|NCT00643760|18169980|P3|Overall Study|Adverse Event|12
5266448|NCT00643760|18169981|P2|Overall Study|Adverse Event|5
5266449|NCT00643760|18169982|P1|Overall Study|Adverse Event|11
5266450|NCT00643682|18170086|P2|Overall Study|did not keep appointment|509
5266451|NCT00643682|18170087|P1|Overall Study|did not keep appointment|522
5266452|NCT00643604|18170099|P1|Overall Study|Death|1
5266453|NCT00643565|18170127|P2|Overall Study|Adverse Event|8
5266454|NCT00643565|18170128|P1|Overall Study|Adverse Event|5
5266455|NCT00643565|18170127|P2|Overall Study|Administrative|16
5266456|NCT00643565|18170128|P1|Overall Study|Administrative|22
5266457|NCT00643565|18170127|P2|Overall Study|Did Not Cooperate|1
5266458|NCT00643565|18170128|P1|Overall Study|Did Not Cooperate|0
5266459|NCT00643565|18170127|P2|Overall Study|Protocol Violation|0
5266460|NCT00643565|18170128|P1|Overall Study|Protocol Violation|3
5266461|NCT00643565|18170127|P2|Overall Study|Progression of Disease|14
5266462|NCT00643565|18170128|P1|Overall Study|Progression of Disease|18
5266463|NCT00643565|18170127|P2|Overall Study|Recurrence of Disease|1
5266464|NCT00643565|18170128|P1|Overall Study|Recurrence of Disease|2
5266465|NCT00643565|18170127|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
5266466|NCT00643565|18170128|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
5266467|NCT00643565|18170127|P2|Overall Study|Other|8
5266468|NCT00643565|18170128|P1|Overall Study|Other|7
5266469|NCT00643565|18170127|P2|Overall Study|Lost to Follow-up|6
5266470|NCT00643565|18170128|P1|Overall Study|Lost to Follow-up|0
5266471|NCT00643565|18170127|P2|Overall Study|Withdrawal by Subject|1
5266472|NCT00643565|18170128|P1|Overall Study|Withdrawal by Subject|4
5266473|NCT00643565|18170127|P2|Overall Study|Death|11
5266474|NCT00643565|18170128|P1|Overall Study|Death|12
5266475|NCT00643487|18170150|P1|Overall Study|Technical difficulty|3
5266476|NCT00643448|18170157|P3|Overall Study|QTcF>550 ms|0
5266477|NCT00643448|18170158|P2|Overall Study|QTcF>550 ms|3
5266478|NCT00643448|18170159|P1|Overall Study|QTcF>550 ms|0
5266479|NCT00643448|18170157|P3|Overall Study|Adverse Event|2
5266480|NCT00643448|18170158|P2|Overall Study|Adverse Event|2
5266481|NCT00643448|18170159|P1|Overall Study|Adverse Event|2
5266482|NCT00643448|18170157|P3|Overall Study|Lack of Efficacy|4
5266483|NCT00643448|18170158|P2|Overall Study|Lack of Efficacy|0
5266484|NCT00643448|18170159|P1|Overall Study|Lack of Efficacy|2
5266485|NCT00643279|18170176|P2|Overall Study|Physician Decision|1
5266486|NCT00643279|18170177|P1|Overall Study|Physician Decision|0
5266487|NCT00643279|18170176|P2|Overall Study|Lost to Follow-up|1
5266488|NCT00643279|18170177|P1|Overall Study|Lost to Follow-up|0
5266489|NCT00643279|18170176|P2|Overall Study|Withdrawal by Subject|0
5266490|NCT00643279|18170177|P1|Overall Study|Withdrawal by Subject|3
5266491|NCT00643279|18170176|P2|Overall Study|Death|11
5266492|NCT00643279|18170177|P1|Overall Study|Death|13
5266493|NCT00643201|18170199|P2|Completed Study Follow Up|non-specified|0
5266494|NCT00643201|18170200|P1|Completed Study Follow Up|non-specified|1
5266495|NCT00643201|18170199|P2|Completed Study Follow Up|Lost to Follow-up|16
5266496|NCT00643201|18170200|P1|Completed Study Follow Up|Lost to Follow-up|18
5266497|NCT00643201|18170199|P2|Completed Study Follow Up|Withdrawal by Subject|29
5266498|NCT00643201|18170200|P1|Completed Study Follow Up|Withdrawal by Subject|23
5266499|NCT00643201|18170199|P2|Completed Study Follow Up|Death|34
5266500|NCT00643201|18170200|P1|Completed Study Follow Up|Death|28
5266501|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Other|107
5266502|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Other|107
5266503|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
5266504|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
5266505|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
5266506|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
5266507|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
5266508|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
5266509|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
5266510|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
5266511|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
5266512|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
5266513|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
5266514|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
5266515|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
5266516|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
5266517|NCT00643201|18170199|P2|Randomized, Completed 6 Months of Study|Death|26
5266518|NCT00643201|18170200|P1|Randomized, Completed 6 Months of Study|Death|20
5266519|NCT00643162|18170248|P2|Overall Study|Withdrawal by Subject|1
5266520|NCT00643162|18170249|P1|Overall Study|Withdrawal by Subject|1
5266521|NCT00643123|18170261|P2|Overall Study|Withdrawal by Subject|1
5266522|NCT00643123|18170262|P1|Overall Study|Withdrawal by Subject|1
5266523|NCT00643123|18170261|P2|Overall Study|Lost to Follow-up|0
5266524|NCT00643123|18170262|P1|Overall Study|Lost to Follow-up|4
5266525|NCT00643006|18170294|P2|Overall Study|Lost to Follow-up|4
5266526|NCT00643006|18170295|P1|Overall Study|Lost to Follow-up|5
5266527|NCT00642993|18170305|P2|Overall Study|Administrative|0
5266528|NCT00642993|18170306|P1|Overall Study|Administrative|1
5266529|NCT00642993|18170305|P2|Overall Study|Did not meet protocol eligibility|1
5266530|NCT00642993|18170306|P1|Overall Study|Did not meet protocol eligibility|0
5266531|NCT00642993|18170305|P2|Overall Study|Protocol Violation|4
5266532|NCT00642993|18170306|P1|Overall Study|Protocol Violation|1
5266533|NCT00642993|18170305|P2|Overall Study|Withdrew - reason unrelated to treatment|3
5266534|NCT00642993|18170306|P1|Overall Study|Withdrew - reason unrelated to treatment|11
5266535|NCT00642993|18170305|P2|Overall Study|Lost to Follow-up|4
5266536|NCT00642993|18170306|P1|Overall Study|Lost to Follow-up|8
5266537|NCT00642993|18170305|P2|Overall Study|Adverse Event|4
5266538|NCT00642993|18170306|P1|Overall Study|Adverse Event|85
5266539|NCT00642954|18170325|P5|Overall Study|Adverse Event|6
5266540|NCT00642954|18170326|P4|Overall Study|Adverse Event|0
5266541|NCT00642954|18170327|P3|Overall Study|Adverse Event|0
5266542|NCT00642954|18170328|P2|Overall Study|Adverse Event|1
5266543|NCT00642954|18170329|P1|Overall Study|Adverse Event|1
5266544|NCT00642954|18170325|P5|Overall Study|Withdrawal by Subject|1
5266545|NCT00642954|18170326|P4|Overall Study|Withdrawal by Subject|0
5266546|NCT00642954|18170327|P3|Overall Study|Withdrawal by Subject|0
5266547|NCT00642954|18170328|P2|Overall Study|Withdrawal by Subject|0
5266548|NCT00642954|18170329|P1|Overall Study|Withdrawal by Subject|0
5266549|NCT00642954|18170325|P5|Overall Study|Progressive Disease|9
5266550|NCT00642954|18170326|P4|Overall Study|Progressive Disease|3
5266551|NCT00642954|18170327|P3|Overall Study|Progressive Disease|3
5266552|NCT00642954|18170328|P2|Overall Study|Progressive Disease|3
5266553|NCT00642954|18170329|P1|Overall Study|Progressive Disease|3
5266554|NCT00642902|18170355|P4|Overall Study|Other|4
5266555|NCT00642902|18170356|P3|Overall Study|Other|1
5266556|NCT00642902|18170357|P2|Overall Study|Other|5
5266557|NCT00642902|18170358|P1|Overall Study|Other|1
5266558|NCT00642902|18170355|P4|Overall Study|Randomized, but not treated|0
5266559|NCT00642902|18170356|P3|Overall Study|Randomized, but not treated|1
5266560|NCT00642902|18170357|P2|Overall Study|Randomized, but not treated|0
5266561|NCT00642902|18170358|P1|Overall Study|Randomized, but not treated|0
5266562|NCT00642902|18170355|P4|Overall Study|Premature termination of clinical trial|35
5266563|NCT00642902|18170356|P3|Overall Study|Premature termination of clinical trial|35
5266564|NCT00642902|18170357|P2|Overall Study|Premature termination of clinical trial|32
5266565|NCT00642902|18170358|P1|Overall Study|Premature termination of clinical trial|37
5266566|NCT00642902|18170355|P4|Overall Study|Death|0
5266567|NCT00642902|18170356|P3|Overall Study|Death|0
5266568|NCT00642902|18170357|P2|Overall Study|Death|0
5266569|NCT00642902|18170358|P1|Overall Study|Death|1
5266570|NCT00642902|18170355|P4|Overall Study|Lack of Efficacy|0
5266571|NCT00642902|18170356|P3|Overall Study|Lack of Efficacy|3
5266572|NCT00642902|18170357|P2|Overall Study|Lack of Efficacy|3
5266573|NCT00642902|18170358|P1|Overall Study|Lack of Efficacy|0
5266574|NCT00642902|18170355|P4|Overall Study|Lost to Follow-up|0
5266575|NCT00642902|18170356|P3|Overall Study|Lost to Follow-up|0
5266576|NCT00642902|18170357|P2|Overall Study|Lost to Follow-up|1
5266577|NCT00642902|18170358|P1|Overall Study|Lost to Follow-up|1
5266578|NCT00642902|18170355|P4|Overall Study|Adverse Event|1
5266579|NCT00642902|18170356|P3|Overall Study|Adverse Event|3
5266580|NCT00642902|18170357|P2|Overall Study|Adverse Event|1
5266581|NCT00642902|18170358|P1|Overall Study|Adverse Event|0
5266582|NCT00642850|18170380|P1|Overall Study|Other reasons|7
5266583|NCT00642850|18170380|P1|Overall Study|Blood transfusion|6
5266584|NCT00642850|18170380|P1|Overall Study|Kidney transplantation|8
5266585|NCT00642850|18170380|P1|Overall Study|Protocol Violation|2
5266586|NCT00642850|18170380|P1|Overall Study|Lack of Efficacy|1
5266587|NCT00642850|18170380|P1|Overall Study|Adverse Event|2
5266588|NCT00642850|18170380|P1|Overall Study|Death|7
5266589|NCT00642811|18170396|P6|Overall Study|Other|0
5266590|NCT00642811|18170397|P5|Overall Study|Other|0
5266591|NCT00642811|18170398|P4|Overall Study|Other|1
5266592|NCT00642811|18170399|P3|Overall Study|Other|0
5266593|NCT00642811|18170400|P2|Overall Study|Other|1
5266594|NCT00642811|18170401|P1|Overall Study|Other|0
5266595|NCT00642811|18170396|P6|Overall Study|Severe Non-compliance to protocol|0
5266596|NCT00642811|18170397|P5|Overall Study|Severe Non-compliance to protocol|0
5266597|NCT00642811|18170398|P4|Overall Study|Severe Non-compliance to protocol|0
5266598|NCT00642811|18170399|P3|Overall Study|Severe Non-compliance to protocol|0
5266599|NCT00642811|18170400|P2|Overall Study|Severe Non-compliance to protocol|0
5266600|NCT00642811|18170401|P1|Overall Study|Severe Non-compliance to protocol|1
5266601|NCT00642811|18170396|P6|Overall Study|Developement of discontinuation criteria|0
5266602|NCT00642811|18170397|P5|Overall Study|Developement of discontinuation criteria|1
5266603|NCT00642811|18170398|P4|Overall Study|Developement of discontinuation criteria|0
5266604|NCT00642811|18170399|P3|Overall Study|Developement of discontinuation criteria|0
5266605|NCT00642811|18170400|P2|Overall Study|Developement of discontinuation criteria|0
5266606|NCT00642811|18170401|P1|Overall Study|Developement of discontinuation criteria|0
5266607|NCT00642811|18170396|P6|Overall Study|Adverse Event|1
5266608|NCT00642811|18170397|P5|Overall Study|Adverse Event|0
5266609|NCT00642811|18170398|P4|Overall Study|Adverse Event|0
5266610|NCT00642811|18170399|P3|Overall Study|Adverse Event|0
5266611|NCT00642811|18170400|P2|Overall Study|Adverse Event|3
5266612|NCT00642811|18170401|P1|Overall Study|Adverse Event|2
5266613|NCT00642772|18170423|P1|Overall Study|Withdrawal by Subject|7
5266614|NCT00642772|18170423|P1|Overall Study|Lost to Follow-up|3
5266615|NCT00642759|18170427|P1|Overall Study|Protocol Violation|1
5266616|NCT00642746|18170436|P2|Overall Study|Patient unevaluable|0
5266617|NCT00642746|18170437|P1|Overall Study|Patient unevaluable|1
5266618|NCT00642707|18170451|P4|Overall Study|Withdrawal by Subject|0
5266619|NCT00642707|18170452|P3|Overall Study|Withdrawal by Subject|0
5266620|NCT00642707|18170453|P2|Overall Study|Withdrawal by Subject|0
5266621|NCT00642707|18170454|P1|Overall Study|Withdrawal by Subject|1
5266622|NCT00642707|18170451|P4|Overall Study|Adverse Event|2
5266623|NCT00642707|18170452|P3|Overall Study|Adverse Event|0
5266624|NCT00642707|18170453|P2|Overall Study|Adverse Event|0
5266625|NCT00642707|18170454|P1|Overall Study|Adverse Event|0
5266626|NCT00642668|18170489|P1|Overall Study|Blood Transfusion|2
5266627|NCT00642668|18170489|P1|Overall Study|Dialysis Initiation|5
5266628|NCT00642668|18170489|P1|Overall Study|Failure to Return|1
5266629|NCT00642668|18170489|P1|Overall Study|Insufficient Therapeutic Response|1
5266630|NCT00642668|18170489|P1|Overall Study|Death|2
5266631|NCT00642668|18170489|P1|Overall Study|Adverse Event|2
5266632|NCT00642668|18170489|P1|Overall Study|Lost to Follow-up|1
5266633|NCT00642642|18170497|P1|Treatment & Follow Up|Lost to Follow-up|10
5266634|NCT00642642|18170497|P1|Treatment & Follow Up|Withdrawal by Subject|5
5266635|NCT00642642|18170497|P1|Treatment & Follow Up|Adverse Event|2
5266636|NCT00642616|18170514|P4|Overall Study|Physician Decision|1
5266637|NCT00642616|18170515|P3|Overall Study|Physician Decision|1
5266638|NCT00642616|18170516|P2|Overall Study|Physician Decision|0
5266639|NCT00642616|18170517|P1|Overall Study|Physician Decision|0
5266640|NCT00642616|18170514|P4|Overall Study|Protocol Violation|0
5266641|NCT00642616|18170515|P3|Overall Study|Protocol Violation|2
5266642|NCT00642616|18170516|P2|Overall Study|Protocol Violation|0
5266643|NCT00642616|18170517|P1|Overall Study|Protocol Violation|0
5266644|NCT00642616|18170514|P4|Overall Study|Withdrawal by Subject|1
5266645|NCT00642616|18170515|P3|Overall Study|Withdrawal by Subject|1
5266646|NCT00642616|18170516|P2|Overall Study|Withdrawal by Subject|1
5266647|NCT00642616|18170517|P1|Overall Study|Withdrawal by Subject|0
5266648|NCT00642616|18170514|P4|Overall Study|Study Terminated by Sponsor|5
5266649|NCT00642616|18170515|P3|Overall Study|Study Terminated by Sponsor|4
5266650|NCT00642616|18170516|P2|Overall Study|Study Terminated by Sponsor|6
5266651|NCT00642616|18170517|P1|Overall Study|Study Terminated by Sponsor|7
5266652|NCT00642616|18170514|P4|Overall Study|Adverse Event|0
5266653|NCT00642616|18170515|P3|Overall Study|Adverse Event|1
5266654|NCT00642616|18170516|P2|Overall Study|Adverse Event|0
5266655|NCT00642616|18170517|P1|Overall Study|Adverse Event|2
5266656|NCT00642473|18170550|P2|Overall Study|Other|2
5266657|NCT00642473|18170551|P1|Overall Study|Other|2
5266658|NCT00642473|18170550|P2|Overall Study|Progression or death|4
5266659|NCT00642473|18170551|P1|Overall Study|Progression or death|2
5266660|NCT00642473|18170550|P2|Overall Study|Withdrawal by Subject|5
5266661|NCT00642473|18170551|P1|Overall Study|Withdrawal by Subject|0
5266662|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
5266663|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
5266664|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
5266665|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
5266666|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
5266667|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
5266668|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
5266669|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
5266670|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
5266671|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
5266672|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
5266673|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
5266674|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Death|3
5266675|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Death|0
5266676|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Death|0
5266677|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Death|0
5266678|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Death|0
5266679|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Death|0
5266680|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Other|2
5266681|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Other|2
5266682|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Other|0
5266683|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Other|0
5266684|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Other|0
5266685|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Other|0
5266686|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
5266687|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
5266688|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5266689|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5266690|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5266691|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5266692|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
5266693|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
5266694|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5266695|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5266696|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5266697|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5266698|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
5266699|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
5266700|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5266701|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5266702|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5266703|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5266704|NCT00642460|18170565|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
5266705|NCT00642460|18170566|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
5266706|NCT00642460|18170567|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
5266707|NCT00642460|18170568|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
5266708|NCT00642460|18170569|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
5266709|NCT00642460|18170570|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
5266710|NCT00642460|18170565|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
5266711|NCT00642460|18170566|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
5266712|NCT00642460|18170567|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
5266713|NCT00642460|18170568|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
5266714|NCT00642460|18170569|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
5266715|NCT00642460|18170570|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
5266716|NCT00642460|18170565|P6|Part II: Open-Label Up to Week 92|Failure to return|0
5266717|NCT00642460|18170566|P5|Part II: Open-Label Up to Week 92|Failure to return|0
5266718|NCT00642460|18170567|P4|Part II: Open-Label Up to Week 92|Failure to return|0
5266719|NCT00642460|18170568|P3|Part II: Open-Label Up to Week 92|Failure to return|0
5266720|NCT00642460|18170569|P2|Part II: Open-Label Up to Week 92|Failure to return|1
5266721|NCT00642460|18170570|P1|Part II: Open-Label Up to Week 92|Failure to return|0
5266722|NCT00642460|18170565|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
5266723|NCT00642460|18170566|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
5266724|NCT00642460|18170567|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
5266725|NCT00642460|18170568|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
5266726|NCT00642460|18170569|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
5266727|NCT00642460|18170570|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
5266728|NCT00642460|18170565|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5266729|NCT00642460|18170566|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5266730|NCT00642460|18170567|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5266731|NCT00642460|18170568|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5266732|NCT00642460|18170569|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
5266733|NCT00642460|18170570|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
5266734|NCT00642460|18170565|P6|Part II: Open-Label Up to Week 92|Death|0
5266735|NCT00642460|18170566|P5|Part II: Open-Label Up to Week 92|Death|0
5266736|NCT00642460|18170567|P4|Part II: Open-Label Up to Week 92|Death|2
5266737|NCT00642460|18170568|P3|Part II: Open-Label Up to Week 92|Death|0
5266738|NCT00642460|18170569|P2|Part II: Open-Label Up to Week 92|Death|1
5266739|NCT00642460|18170570|P1|Part II: Open-Label Up to Week 92|Death|0
5266740|NCT00642460|18170565|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
5266741|NCT00642460|18170566|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
5266742|NCT00642460|18170567|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
5266743|NCT00642460|18170568|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
5266744|NCT00642460|18170569|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
5266745|NCT00642460|18170570|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
5266746|NCT00642460|18170565|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
5266747|NCT00642460|18170566|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
5266748|NCT00642460|18170567|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
5266749|NCT00642460|18170568|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
5266750|NCT00642460|18170569|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
5266751|NCT00642460|18170570|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
5266752|NCT00642460|18170565|P6|Part I: 12 Week Double-Blind|Adverse Event|0
5266753|NCT00642460|18170566|P5|Part I: 12 Week Double-Blind|Adverse Event|0
5266754|NCT00642460|18170567|P4|Part I: 12 Week Double-Blind|Adverse Event|0
5266755|NCT00642460|18170568|P3|Part I: 12 Week Double-Blind|Adverse Event|1
5266756|NCT00642460|18170569|P2|Part I: 12 Week Double-Blind|Adverse Event|1
5266757|NCT00642460|18170570|P1|Part I: 12 Week Double-Blind|Adverse Event|0
5266758|NCT00642369|18170645|P2|Overall Study|Lack of Efficacy|2
5266759|NCT00642369|18170646|P1|Overall Study|Lack of Efficacy|2
5266760|NCT00642369|18170645|P2|Overall Study|misdiagnosis|1
5266761|NCT00642369|18170646|P1|Overall Study|misdiagnosis|0
5266762|NCT00642369|18170645|P2|Overall Study|Withdrawal by Subject|0
5266763|NCT00642369|18170646|P1|Overall Study|Withdrawal by Subject|1
5266764|NCT00642369|18170645|P2|Overall Study|Adverse Event|3
5266765|NCT00642369|18170646|P1|Overall Study|Adverse Event|2
5266766|NCT00642356|18170656|P2|Overall Study|Lack of Efficacy|0
5266767|NCT00642356|18170657|P1|Overall Study|Lack of Efficacy|1
5266768|NCT00642356|18170656|P2|Overall Study|Protocol Violation|3
5266769|NCT00642356|18170657|P1|Overall Study|Protocol Violation|0
5266770|NCT00642356|18170656|P2|Overall Study|Adverse Event|0
5266771|NCT00642356|18170657|P1|Overall Study|Adverse Event|1
5266772|NCT00642304|18170665|P1|Overall Study|Transplantation|1
5266773|NCT00642304|18170665|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
5266774|NCT00642304|18170665|P1|Overall Study|Blood transfusion|2
5266775|NCT00642304|18170665|P1|Overall Study|Death|1
5266776|NCT00642304|18170665|P1|Overall Study|Adverse Event|1
5266777|NCT00642278|18170681|P7|Overall Study|Other|0
5266778|NCT00642278|18170682|P6|Overall Study|Other|1
5266779|NCT00642278|18170683|P5|Overall Study|Other|0
5266780|NCT00642278|18170684|P4|Overall Study|Other|1
5266781|NCT00642278|18170685|P3|Overall Study|Other|0
5266782|NCT00642278|18170686|P2|Overall Study|Other|1
5266783|NCT00642278|18170687|P1|Overall Study|Other|2
5266784|NCT00642278|18170681|P7|Overall Study|Noncompliance with study drug regimen|0
5266785|NCT00642278|18170682|P6|Overall Study|Noncompliance with study drug regimen|0
5266786|NCT00642278|18170683|P5|Overall Study|Noncompliance with study drug regimen|0
5266787|NCT00642278|18170684|P4|Overall Study|Noncompliance with study drug regimen|1
5266788|NCT00642278|18170685|P3|Overall Study|Noncompliance with study drug regimen|0
5266789|NCT00642278|18170686|P2|Overall Study|Noncompliance with study drug regimen|0
5266790|NCT00642278|18170687|P1|Overall Study|Noncompliance with study drug regimen|0
5266791|NCT00642278|18170681|P7|Overall Study|Withdrawal by Subject|2
5266792|NCT00642278|18170682|P6|Overall Study|Withdrawal by Subject|2
5266793|NCT00642278|18170683|P5|Overall Study|Withdrawal by Subject|6
5266794|NCT00642278|18170684|P4|Overall Study|Withdrawal by Subject|3
5266795|NCT00642278|18170685|P3|Overall Study|Withdrawal by Subject|1
5266796|NCT00642278|18170686|P2|Overall Study|Withdrawal by Subject|1
5266797|NCT00642278|18170687|P1|Overall Study|Withdrawal by Subject|1
5266798|NCT00642278|18170681|P7|Overall Study|Protocol Violation|2
5266799|NCT00642278|18170682|P6|Overall Study|Protocol Violation|1
5266800|NCT00642278|18170683|P5|Overall Study|Protocol Violation|0
5266801|NCT00642278|18170684|P4|Overall Study|Protocol Violation|1
5266802|NCT00642278|18170685|P3|Overall Study|Protocol Violation|1
5266803|NCT00642278|18170686|P2|Overall Study|Protocol Violation|0
5266804|NCT00642278|18170687|P1|Overall Study|Protocol Violation|0
5266805|NCT00642278|18170681|P7|Overall Study|Physician Decision|0
5266806|NCT00642278|18170682|P6|Overall Study|Physician Decision|0
5266807|NCT00642278|18170683|P5|Overall Study|Physician Decision|0
5266808|NCT00642278|18170684|P4|Overall Study|Physician Decision|1
5266809|NCT00642278|18170685|P3|Overall Study|Physician Decision|0
5266810|NCT00642278|18170686|P2|Overall Study|Physician Decision|0
5266811|NCT00642278|18170687|P1|Overall Study|Physician Decision|0
5266812|NCT00642278|18170681|P7|Overall Study|Lost to Follow-up|1
5266813|NCT00642278|18170682|P6|Overall Study|Lost to Follow-up|1
5266814|NCT00642278|18170683|P5|Overall Study|Lost to Follow-up|0
5266815|NCT00642278|18170684|P4|Overall Study|Lost to Follow-up|1
5266816|NCT00642278|18170685|P3|Overall Study|Lost to Follow-up|0
5266817|NCT00642278|18170686|P2|Overall Study|Lost to Follow-up|1
5266818|NCT00642278|18170687|P1|Overall Study|Lost to Follow-up|5
5266819|NCT00642278|18170681|P7|Overall Study|Lack of Efficacy|0
5266820|NCT00642278|18170682|P6|Overall Study|Lack of Efficacy|0
5266821|NCT00642278|18170683|P5|Overall Study|Lack of Efficacy|0
5266822|NCT00642278|18170684|P4|Overall Study|Lack of Efficacy|0
5266823|NCT00642278|18170685|P3|Overall Study|Lack of Efficacy|0
5266824|NCT00642278|18170686|P2|Overall Study|Lack of Efficacy|1
5266825|NCT00642278|18170687|P1|Overall Study|Lack of Efficacy|0
5266826|NCT00642278|18170681|P7|Overall Study|Adverse Event|0
5266827|NCT00642278|18170682|P6|Overall Study|Adverse Event|2
5266828|NCT00642278|18170683|P5|Overall Study|Adverse Event|2
5266829|NCT00642278|18170684|P4|Overall Study|Adverse Event|1
5266830|NCT00642278|18170685|P3|Overall Study|Adverse Event|3
5266831|NCT00642278|18170686|P2|Overall Study|Adverse Event|1
5266832|NCT00642278|18170687|P1|Overall Study|Adverse Event|2
5266833|NCT00642174|18170740|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
5266834|NCT00642174|18170741|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
5266835|NCT00642018|18170757|P2|Overall Study|Entry Criteria Not Met|1
5266836|NCT00642018|18170758|P1|Overall Study|Entry Criteria Not Met|0
5266837|NCT00642018|18170757|P2|Overall Study|Death|3
5266838|NCT00642018|18170758|P1|Overall Study|Death|0
5266839|NCT00642018|18170757|P2|Overall Study|Protocol Violation|1
5266840|NCT00642018|18170758|P1|Overall Study|Protocol Violation|0
5266841|NCT00642018|18170757|P2|Overall Study|Physician Decision|10
5266842|NCT00642018|18170758|P1|Overall Study|Physician Decision|0
5266843|NCT00642018|18170757|P2|Overall Study|Progressive Disease|18
5266844|NCT00642018|18170758|P1|Overall Study|Progressive Disease|13
5266845|NCT00642018|18170757|P2|Overall Study|Withdrawal by Subject|10
5266846|NCT00642018|18170758|P1|Overall Study|Withdrawal by Subject|4
5266847|NCT00642018|18170757|P2|Overall Study|Adverse Event|36
5266848|NCT00642018|18170758|P1|Overall Study|Adverse Event|11
5266849|NCT00641719|18170825|P2|Overall Study|Reason Not Specified|2
5266850|NCT00641719|18170826|P1|Overall Study|Reason Not Specified|1
5266851|NCT00641719|18170825|P2|Overall Study|Withdrawal by Subject|4
5266852|NCT00641719|18170826|P1|Overall Study|Withdrawal by Subject|4
5266853|NCT00641719|18170825|P2|Overall Study|Adverse Event|29
5266854|NCT00641719|18170826|P1|Overall Study|Adverse Event|24
5266855|NCT00641719|18170825|P2|Overall Study|Lack of Efficacy|2
5266856|NCT00641719|18170826|P1|Overall Study|Lack of Efficacy|1
5266857|NCT00641706|18170850|P2|Overall Study|Lead Investigator Decision|1
5266858|NCT00641706|18170851|P1|Overall Study|Lead Investigator Decision|0
5266859|NCT00641706|18170850|P2|Overall Study|Clinical Decline|0
5266860|NCT00641706|18170851|P1|Overall Study|Clinical Decline|1
5266861|NCT00641706|18170850|P2|Overall Study|Withdrawal by Subject|1
5266862|NCT00641706|18170851|P1|Overall Study|Withdrawal by Subject|6
5266863|NCT00641706|18170850|P2|Overall Study|Adverse Event|1
5266864|NCT00641706|18170851|P1|Overall Study|Adverse Event|2
5266865|NCT00641667|18170863|P1|Overall Study|Worsening of underlying disease|3
5266866|NCT00641667|18170863|P1|Overall Study|Physician Decision|1
5266867|NCT00641667|18170863|P1|Overall Study|Adverse Event|1
5266868|NCT00641667|18170863|P1|Overall Study|Withdrawal by Subject|1
5266869|NCT00641537|18170891|P8|24-Week Supplemental Follow-up Period|Other|1
5266870|NCT00641537|18170892|P7|24-Week Supplemental Follow-up Period|Other|1
5266871|NCT00641537|18170893|P6|24-Week Supplemental Follow-up Period|Other|0
5266872|NCT00641537|18170894|P5|24-Week Supplemental Follow-up Period|Other|3
5266873|NCT00641537|18170895|P4|24-Week Supplemental Follow-up Period|Other|1
5266874|NCT00641537|18170896|P3|24-Week Supplemental Follow-up Period|Other|2
5266875|NCT00641537|18170897|P2|24-Week Supplemental Follow-up Period|Other|2
5266876|NCT00641537|18170898|P1|24-Week Supplemental Follow-up Period|Other|0
5266877|NCT00641537|18170891|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
5266878|NCT00641537|18170892|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
5266879|NCT00641537|18170893|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
5266880|NCT00641537|18170894|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
5266881|NCT00641537|18170895|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
5266882|NCT00641537|18170896|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
5266883|NCT00641537|18170897|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
5266884|NCT00641537|18170898|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
5266885|NCT00641537|18170891|P8|96-week Period|Other|6
5266886|NCT00641537|18170892|P7|96-week Period|Other|4
5266887|NCT00641537|18170893|P6|96-week Period|Other|6
5266888|NCT00641537|18170894|P5|96-week Period|Other|12
5266889|NCT00641537|18170895|P4|96-week Period|Other|9
5266890|NCT00641537|18170896|P3|96-week Period|Other|14
5266891|NCT00641537|18170897|P2|96-week Period|Other|7
5266892|NCT00641537|18170898|P1|96-week Period|Other|4
5266893|NCT00641537|18170891|P8|96-week Period|Death|0
5266894|NCT00641537|18170892|P7|96-week Period|Death|0
5266895|NCT00641537|18170893|P6|96-week Period|Death|0
5266896|NCT00641537|18170894|P5|96-week Period|Death|0
5266897|NCT00641537|18170895|P4|96-week Period|Death|0
5266898|NCT00641537|18170896|P3|96-week Period|Death|1
5266899|NCT00641537|18170897|P2|96-week Period|Death|0
5266900|NCT00641537|18170898|P1|96-week Period|Death|2
5266901|NCT00641537|18170891|P8|96-week Period|Protocol Violation|0
5266902|NCT00641537|18170892|P7|96-week Period|Protocol Violation|0
5266903|NCT00641537|18170893|P6|96-week Period|Protocol Violation|1
5266904|NCT00641537|18170894|P5|96-week Period|Protocol Violation|0
5266905|NCT00641537|18170895|P4|96-week Period|Protocol Violation|1
5266906|NCT00641537|18170896|P3|96-week Period|Protocol Violation|0
5266907|NCT00641537|18170897|P2|96-week Period|Protocol Violation|1
5266908|NCT00641537|18170898|P1|96-week Period|Protocol Violation|0
5266909|NCT00641537|18170891|P8|96-week Period|Lost to Follow-up|0
5266910|NCT00641537|18170892|P7|96-week Period|Lost to Follow-up|1
5266911|NCT00641537|18170893|P6|96-week Period|Lost to Follow-up|0
5266912|NCT00641537|18170894|P5|96-week Period|Lost to Follow-up|4
5266913|NCT00641537|18170895|P4|96-week Period|Lost to Follow-up|2
5266914|NCT00641537|18170896|P3|96-week Period|Lost to Follow-up|2
5266915|NCT00641537|18170897|P2|96-week Period|Lost to Follow-up|1
5266916|NCT00641537|18170898|P1|96-week Period|Lost to Follow-up|3
5266917|NCT00641537|18170891|P8|96-week Period|Adverse Event|0
5266918|NCT00641537|18170892|P7|96-week Period|Adverse Event|0
5266919|NCT00641537|18170893|P6|96-week Period|Adverse Event|0
5266920|NCT00641537|18170894|P5|96-week Period|Adverse Event|2
5266921|NCT00641537|18170895|P4|96-week Period|Adverse Event|0
5266922|NCT00641537|18170896|P3|96-week Period|Adverse Event|3
5266923|NCT00641537|18170897|P2|96-week Period|Adverse Event|1
5266924|NCT00641537|18170898|P1|96-week Period|Adverse Event|0
5266925|NCT00641147|18170953|P2|Completed 16 Months.|Lost to Follow-up|0
5266926|NCT00641147|18170954|P1|Completed 16 Months.|Lost to Follow-up|1
5266927|NCT00641147|18170953|P2|Completed 16 Months.|Physician Decision|0
5266928|NCT00641147|18170954|P1|Completed 16 Months.|Physician Decision|1
5266929|NCT00641147|18170953|P2|Completed 12 Months.|Withdrawal by Subject|1
5266930|NCT00641147|18170954|P1|Completed 12 Months.|Withdrawal by Subject|0
5266931|NCT00641147|18170953|P2|Completed 12 Months.|Physician Decision|1
5266932|NCT00641147|18170954|P1|Completed 12 Months.|Physician Decision|1
5266933|NCT00641147|18170953|P2|Completed 8 Months.|Withdrawal by Subject|1
5266934|NCT00641147|18170954|P1|Completed 8 Months.|Withdrawal by Subject|0
5266935|NCT00641147|18170953|P2|Completed 8 Months.|non compliance|0
5266936|NCT00641147|18170954|P1|Completed 8 Months.|non compliance|1
5266937|NCT00641147|18170953|P2|Completed 8 Months.|Physician Decision|1
5266938|NCT00641147|18170954|P1|Completed 8 Months.|Physician Decision|2
5266939|NCT00641147|18170953|P2|Completed 4 Months.|Adverse Event|0
5266940|NCT00641147|18170954|P1|Completed 4 Months.|Adverse Event|1
5266941|NCT00641147|18170953|P2|Completed 4 Months.|Physician Decision|0
5266942|NCT00641147|18170954|P1|Completed 4 Months.|Physician Decision|1
5266943|NCT00641056|18171007|P2|Overall Study|Sponsor Decision|2
5266944|NCT00641056|18171008|P1|Overall Study|Sponsor Decision|1
5266945|NCT00641056|18171007|P2|Overall Study|Subject Decision|19
5266946|NCT00641056|18171008|P1|Overall Study|Subject Decision|6
5266947|NCT00641056|18171007|P2|Overall Study|Entry Criteria Not Met|0
5266948|NCT00641056|18171008|P1|Overall Study|Entry Criteria Not Met|3
5266949|NCT00641056|18171007|P2|Overall Study|Protocol Violation|0
5266950|NCT00641056|18171008|P1|Overall Study|Protocol Violation|2
5266951|NCT00641056|18171007|P2|Overall Study|Physician Decision|1
5266952|NCT00641056|18171008|P1|Overall Study|Physician Decision|3
5266953|NCT00641056|18171007|P2|Overall Study|Lost to Follow-up|1
5266954|NCT00641056|18171008|P1|Overall Study|Lost to Follow-up|2
5266955|NCT00641056|18171007|P2|Overall Study|Adverse Event|2
5266956|NCT00641056|18171008|P1|Overall Study|Adverse Event|12
5266957|NCT00641043|18171036|P2|Overall Study|Other incl. lack of efficacy|2
5266958|NCT00641043|18171037|P1|Overall Study|Other incl. lack of efficacy|4
5266959|NCT00641043|18171036|P2|Overall Study|Withdrawal by Subject|4
5266960|NCT00641043|18171037|P1|Overall Study|Withdrawal by Subject|4
5266961|NCT00641043|18171036|P2|Overall Study|Lost to Follow-up|2
5266962|NCT00641043|18171037|P1|Overall Study|Lost to Follow-up|3
5266963|NCT00641043|18171036|P2|Overall Study|Protocol Violation|3
5266964|NCT00641043|18171037|P1|Overall Study|Protocol Violation|2
5266965|NCT00641043|18171036|P2|Overall Study|Adverse Event|4
5266966|NCT00641043|18171037|P1|Overall Study|Adverse Event|6
5266967|NCT00640926|18171074|P3|Overall Study|Withdrawal by Subject|1
5266968|NCT00640926|18171075|P2|Overall Study|Withdrawal by Subject|0
5266969|NCT00640926|18171076|P1|Overall Study|Withdrawal by Subject|1
5266970|NCT00640926|18171074|P3|Overall Study|Lost to Follow-up|2
5266971|NCT00640926|18171075|P2|Overall Study|Lost to Follow-up|1
5266972|NCT00640926|18171076|P1|Overall Study|Lost to Follow-up|3
5266973|NCT00640926|18171074|P3|Overall Study|Protocol Violation|2
5266974|NCT00640926|18171075|P2|Overall Study|Protocol Violation|0
5266975|NCT00640926|18171076|P1|Overall Study|Protocol Violation|2
5266976|NCT00640926|18171074|P3|Overall Study|Lack of Efficacy|1
5266977|NCT00640926|18171075|P2|Overall Study|Lack of Efficacy|2
5266978|NCT00640926|18171076|P1|Overall Study|Lack of Efficacy|0
5266979|NCT00640926|18171074|P3|Overall Study|Adverse Event|2
5266980|NCT00640926|18171075|P2|Overall Study|Adverse Event|3
5266981|NCT00640926|18171076|P1|Overall Study|Adverse Event|2
5266982|NCT00640835|18171089|P2|Overall Study|Other Reason|4
5266983|NCT00640835|18171090|P1|Overall Study|Other Reason|19
5266984|NCT00640835|18171089|P2|Overall Study|Lost to Follow-up|13
5266985|NCT00640835|18171090|P1|Overall Study|Lost to Follow-up|17
5266986|NCT00640835|18171089|P2|Overall Study|Protocol Violation|2
5266987|NCT00640835|18171090|P1|Overall Study|Protocol Violation|2
5266988|NCT00640835|18171089|P2|Overall Study|Sponsor's Decision|7
5266989|NCT00640835|18171090|P1|Overall Study|Sponsor's Decision|11
5266990|NCT00640835|18171089|P2|Overall Study|Physician Decision|14
5266991|NCT00640835|18171090|P1|Overall Study|Physician Decision|10
5266992|NCT00640835|18171089|P2|Overall Study|Withdrawal by Subject|14
5266993|NCT00640835|18171090|P1|Overall Study|Withdrawal by Subject|12
5266994|NCT00640835|18171089|P2|Overall Study|Adverse Event|3
5266995|NCT00640835|18171090|P1|Overall Study|Adverse Event|5
5266996|NCT00640614|18171154|P2|Overall Study|Lost to Follow-up|0
5266997|NCT00640614|18171155|P1|Overall Study|Lost to Follow-up|1
5266998|NCT00640601|18171197|P1|Overall Study|treatment naive, combination therapy|10
5266999|NCT00640601|18171197|P1|Overall Study|Physician Decision|8
5267000|NCT00640601|18171197|P1|Overall Study|Lost to Follow-up|9
5267001|NCT00640601|18171197|P1|Overall Study|Lack of Efficacy|16
5267002|NCT00640601|18171197|P1|Overall Study|Protocol Violation|6
5267003|NCT00640601|18171197|P1|Overall Study|Withdrawal by Subject|20
5267004|NCT00640601|18171197|P1|Overall Study|Adverse Event|43
5267005|NCT00640562|18171213|P2|Overall Study|Glycosylated Hemoglobin >8|0
5267006|NCT00640562|18171214|P1|Overall Study|Glycosylated Hemoglobin >8|1
5267007|NCT00640562|18171213|P2|Overall Study|Low study drug dose|1
5267008|NCT00640562|18171214|P1|Overall Study|Low study drug dose|0
5267009|NCT00640562|18171213|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
5267010|NCT00640562|18171214|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
5267011|NCT00640562|18171213|P2|Overall Study|Known risperidone intolerance|1
5267012|NCT00640562|18171214|P1|Overall Study|Known risperidone intolerance|0
5267013|NCT00640562|18171213|P2|Overall Study|Withdrawal by Subject|10
5267014|NCT00640562|18171214|P1|Overall Study|Withdrawal by Subject|6
5267015|NCT00640562|18171213|P2|Overall Study|Protocol Violation|4
5267016|NCT00640562|18171214|P1|Overall Study|Protocol Violation|2
5267017|NCT00640562|18171213|P2|Overall Study|Lack of Efficacy|4
5267018|NCT00640562|18171214|P1|Overall Study|Lack of Efficacy|1
5267019|NCT00640562|18171213|P2|Overall Study|Adverse Event|5
5267020|NCT00640562|18171214|P1|Overall Study|Adverse Event|8
5267021|NCT00640510|18171242|P2|Overall Study|Physician Decision|1
5267022|NCT00640510|18171243|P1|Overall Study|Physician Decision|0
5267023|NCT00640510|18171242|P2|Overall Study|Protocol Violation|0
5267024|NCT00640510|18171243|P1|Overall Study|Protocol Violation|1
5267025|NCT00640510|18171242|P2|Overall Study|Lack of Efficacy|1
5267026|NCT00640510|18171243|P1|Overall Study|Lack of Efficacy|0
5267027|NCT00640393|18171255|P3|Part 2|Adverse Event|0
5267028|NCT00640393|18171256|P2|Part 2|Adverse Event|1
5267029|NCT00640393|18171257|P1|Part 2|Adverse Event|0
5267030|NCT00640393|18171255|P3|Part 2|Non-adherence|0
5267031|NCT00640393|18171256|P2|Part 2|Non-adherence|1
5267032|NCT00640393|18171257|P1|Part 2|Non-adherence|0
5267033|NCT00640393|18171255|P3|Part 2|Withdrawal by Subject|1
5267034|NCT00640393|18171256|P2|Part 2|Withdrawal by Subject|6
5267035|NCT00640393|18171257|P1|Part 2|Withdrawal by Subject|0
5267036|NCT00640393|18171255|P3|Part 2|Lost to Follow-up|2
5267037|NCT00640393|18171256|P2|Part 2|Lost to Follow-up|2
5267038|NCT00640393|18171257|P1|Part 2|Lost to Follow-up|0
5267039|NCT00640393|18171255|P3|Randomization|Never randomized by site|0
5267040|NCT00640393|18171256|P2|Randomization|Never randomized by site|0
5267041|NCT00640393|18171257|P1|Randomization|Never randomized by site|2
5267042|NCT00640393|18171255|P3|Randomization|Withdrawn per protocol|0
5267043|NCT00640393|18171256|P2|Randomization|Withdrawn per protocol|0
5267044|NCT00640393|18171257|P1|Randomization|Withdrawn per protocol|17
5267045|NCT00640393|18171255|P3|Part 1|Withdrawal by Subject|0
5267046|NCT00640393|18171256|P2|Part 1|Withdrawal by Subject|0
5267047|NCT00640393|18171257|P1|Part 1|Withdrawal by Subject|3
5267048|NCT00640393|18171255|P3|Part 1|Lost to Follow-up|0
5267049|NCT00640393|18171256|P2|Part 1|Lost to Follow-up|0
5267050|NCT00640393|18171257|P1|Part 1|Lost to Follow-up|2
5267051|NCT00640341|18171322|P3|Overall Study|Adverse event and positive slit lamp|0
5267052|NCT00640341|18171323|P2|Overall Study|Adverse event and positive slit lamp|0
5267053|NCT00640341|18171324|P1|Overall Study|Adverse event and positive slit lamp|1
5267054|NCT00640341|18171322|P3|Overall Study|Ineligable at Baseline|2
5267055|NCT00640341|18171323|P2|Overall Study|Ineligable at Baseline|3
5267056|NCT00640341|18171324|P1|Overall Study|Ineligable at Baseline|5
5267057|NCT00640341|18171322|P3|Overall Study|Poor fit/Uncomfortable|0
5267058|NCT00640341|18171323|P2|Overall Study|Poor fit/Uncomfortable|0
5267059|NCT00640341|18171324|P1|Overall Study|Poor fit/Uncomfortable|4
5267060|NCT00640341|18171322|P3|Overall Study|Unacceptable Lens Movement|0
5267061|NCT00640341|18171323|P2|Overall Study|Unacceptable Lens Movement|0
5267062|NCT00640341|18171324|P1|Overall Study|Unacceptable Lens Movement|1
5267063|NCT00640341|18171322|P3|Overall Study|Withdrawal by Subject|1
5267064|NCT00640341|18171323|P2|Overall Study|Withdrawal by Subject|0
5267065|NCT00640341|18171324|P1|Overall Study|Withdrawal by Subject|4
5267066|NCT00640341|18171322|P3|Overall Study|Lost to Follow-up|0
5267067|NCT00640341|18171323|P2|Overall Study|Lost to Follow-up|0
5267068|NCT00640341|18171324|P1|Overall Study|Lost to Follow-up|2
5267069|NCT00640341|18171322|P3|Overall Study|Failure to Follow Subject Instructions|0
5267070|NCT00640341|18171323|P2|Overall Study|Failure to Follow Subject Instructions|0
5267071|NCT00640341|18171324|P1|Overall Study|Failure to Follow Subject Instructions|1
5267072|NCT00640341|18171322|P3|Overall Study|Inability to Maintain Wearing Schedule|0
5267073|NCT00640341|18171323|P2|Overall Study|Inability to Maintain Wearing Schedule|1
5267074|NCT00640341|18171324|P1|Overall Study|Inability to Maintain Wearing Schedule|1
5267075|NCT00640341|18171322|P3|Overall Study|Study Related Symptoms/Complaints|2
5267076|NCT00640341|18171323|P2|Overall Study|Study Related Symptoms/Complaints|1
5267077|NCT00640341|18171324|P1|Overall Study|Study Related Symptoms/Complaints|2
5267078|NCT00640341|18171322|P3|Overall Study|Positive Slit Lamp Findings|1
5267079|NCT00640341|18171323|P2|Overall Study|Positive Slit Lamp Findings|0
5267080|NCT00640341|18171324|P1|Overall Study|Positive Slit Lamp Findings|0
5267081|NCT00640341|18171322|P3|Overall Study|Adverse Event|1
5267082|NCT00640341|18171323|P2|Overall Study|Adverse Event|0
5267083|NCT00640341|18171324|P1|Overall Study|Adverse Event|0
5267084|NCT00640328|18171344|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5267085|NCT00640328|18171345|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5267086|NCT00640328|18171346|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
5267087|NCT00640328|18171347|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5267088|NCT00640328|18171348|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
5267089|NCT00640328|18171349|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5267090|NCT00640328|18171344|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5267091|NCT00640328|18171345|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5267092|NCT00640328|18171346|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5267093|NCT00640328|18171347|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
5267094|NCT00640328|18171348|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5267095|NCT00640328|18171349|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5267096|NCT00640328|18171344|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5267097|NCT00640328|18171345|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
5267098|NCT00640328|18171346|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5267099|NCT00640328|18171347|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5267100|NCT00640328|18171348|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5267101|NCT00640328|18171349|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5267102|NCT00640328|18171344|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
5267103|NCT00640328|18171345|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
5267104|NCT00640328|18171346|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
5267105|NCT00640328|18171347|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
5267106|NCT00640328|18171348|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
5267107|NCT00640328|18171349|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
5267108|NCT00640315|18171515|P2|Overall Study|Withdrawal by Subject|1
5267109|NCT00640315|18171516|P1|Overall Study|Withdrawal by Subject|0
5267110|NCT00640289|18171642|P1|Overall Study|Missing status|5
5267111|NCT00640289|18171642|P1|Overall Study|Transferred to another center|1
5267112|NCT00640289|18171642|P1|Overall Study|Data collected under different amendment|2
5267113|NCT00640289|18171642|P1|Overall Study|Lost to Follow-up|1
5267114|NCT00640289|18171642|P1|Overall Study|Withdrawal by Subject|1
5267115|NCT00640289|18171642|P1|Overall Study|Death|3
5267116|NCT00640224|18171754|P4|Overall Study|Headaches|0
5267117|NCT00640224|18171755|P3|Overall Study|Headaches|0
5267118|NCT00640224|18171756|P2|Overall Study|Headaches|1
5267119|NCT00640224|18171757|P1|Overall Study|Headaches|0
5267120|NCT00640224|18171754|P4|Overall Study|Withdrawal by Subject|0
5267121|NCT00640224|18171755|P3|Overall Study|Withdrawal by Subject|0
5267122|NCT00640224|18171756|P2|Overall Study|Withdrawal by Subject|0
5267123|NCT00640224|18171757|P1|Overall Study|Withdrawal by Subject|1
5267124|NCT00640224|18171754|P4|Overall Study|Lost to Follow-up|0
5267125|NCT00640224|18171755|P3|Overall Study|Lost to Follow-up|0
5267126|NCT00640224|18171756|P2|Overall Study|Lost to Follow-up|2
5267127|NCT00640224|18171757|P1|Overall Study|Lost to Follow-up|5
5267128|NCT00640146|18171857|P2|Overall Study|Randomized but not treated|3
5267129|NCT00640146|18171858|P1|Overall Study|Randomized but not treated|1
5267130|NCT00640146|18171857|P2|Overall Study|Withdrawal by Subject|1
5267131|NCT00640146|18171858|P1|Overall Study|Withdrawal by Subject|1
5267132|NCT00640146|18171857|P2|Overall Study|Lack of Efficacy|1
5267133|NCT00640146|18171858|P1|Overall Study|Lack of Efficacy|0
5267134|NCT00640146|18171857|P2|Overall Study|Lost to Follow-up|1
5267135|NCT00640146|18171858|P1|Overall Study|Lost to Follow-up|0
5267136|NCT00640146|18171857|P2|Overall Study|Adverse Event|0
5267137|NCT00640146|18171858|P1|Overall Study|Adverse Event|2
5267138|NCT00640133|18171870|P2|Open Label Phase (Month 4-12)|Adverse Event|0
5267139|NCT00640133|18171871|P1|Open Label Phase (Month 4-12)|Adverse Event|1
5267140|NCT00640133|18171870|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
5267141|NCT00640133|18171871|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
5267142|NCT00640133|18171870|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
5267143|NCT00640133|18171871|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
5267144|NCT00640042|18171891|P1|Enrollment|Did not receive study drug|83
5267145|NCT00640016|18171907|P4|Overall Study|Adverse Event|1
5267146|NCT00640016|18171908|P3|Overall Study|Adverse Event|0
5267147|NCT00640016|18171909|P2|Overall Study|Adverse Event|0
5267148|NCT00640016|18171910|P1|Overall Study|Adverse Event|0
5267149|NCT00640016|18171907|P4|Overall Study|Study termination|2
5267150|NCT00640016|18171908|P3|Overall Study|Study termination|3
5267151|NCT00640016|18171909|P2|Overall Study|Study termination|1
5267152|NCT00640016|18171910|P1|Overall Study|Study termination|2
5267153|NCT00640016|18171907|P4|Overall Study|Withdrawal by Subject|0
5267154|NCT00640016|18171908|P3|Overall Study|Withdrawal by Subject|0
5267155|NCT00640016|18171909|P2|Overall Study|Withdrawal by Subject|1
5267156|NCT00640016|18171910|P1|Overall Study|Withdrawal by Subject|0
5267157|NCT00639769|18171962|P1|Overall Study|Withdrawal by Subject|4
5267158|NCT00639769|18171962|P1|Overall Study|Disease progression|26
5267159|NCT00639769|18171962|P1|Overall Study|Lack of Efficacy|1
5267160|NCT00639769|18171962|P1|Overall Study|Adverse Event|7
5267161|NCT00639769|18171962|P1|Overall Study|Death|2
5267162|NCT00639678|18171979|P4|Overall Study|Lack of Compliance|0
5267163|NCT00639678|18171980|P3|Overall Study|Lack of Compliance|1
5267164|NCT00639678|18171981|P2|Overall Study|Lack of Compliance|0
5267165|NCT00639678|18171982|P1|Overall Study|Lack of Compliance|0
5267166|NCT00639678|18171979|P4|Overall Study|Adverse Event|0
5267167|NCT00639678|18171980|P3|Overall Study|Adverse Event|0
5267168|NCT00639678|18171981|P2|Overall Study|Adverse Event|1
5267169|NCT00639678|18171982|P1|Overall Study|Adverse Event|0
5267170|NCT00639678|18171979|P4|Overall Study|Lost to Follow-up|0
5267171|NCT00639678|18171980|P3|Overall Study|Lost to Follow-up|6
5267172|NCT00639678|18171981|P2|Overall Study|Lost to Follow-up|0
5267173|NCT00639678|18171982|P1|Overall Study|Lost to Follow-up|1
5267174|NCT00639678|18171979|P4|Overall Study|Withdrawal by Subject|0
5267175|NCT00639678|18171980|P3|Overall Study|Withdrawal by Subject|4
5267176|NCT00639678|18171981|P2|Overall Study|Withdrawal by Subject|0
5267177|NCT00639678|18171982|P1|Overall Study|Withdrawal by Subject|3
5267178|NCT00639509|18172047|P1|Overall Study|Death|1
5267179|NCT00639457|18172055|P2|Overall Study|Withdrawal by Subject|3
5267180|NCT00639457|18172056|P1|Overall Study|Withdrawal by Subject|2
5267181|NCT00639379|18172115|P2|Period 1 - 2 Weeks|lens issue|0
5267182|NCT00639379|18172116|P1|Period 1 - 2 Weeks|lens issue|3
5267183|NCT00639379|18172115|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
5267184|NCT00639379|18172116|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
5267185|NCT00639223|18172132|P2|Overall Study|Lost to Follow-up|2
5267186|NCT00639223|18172133|P1|Overall Study|Lost to Follow-up|0
5267187|NCT00639002|18172173|P1|Overall Study|Lack of Efficacy|1
5267188|NCT00639002|18172173|P1|Overall Study|Physician Decision|6
5267189|NCT00639002|18172173|P1|Overall Study|Disease progression|3
5267190|NCT00639002|18172173|P1|Overall Study|Protocol Violation|1
5267191|NCT00639002|18172173|P1|Overall Study|Adverse Event|1
5267192|NCT00639002|18172173|P1|Overall Study|Death|1
5267193|NCT00638989|18172182|P3|Overall Study|Lost to Follow-up|1
5267194|NCT00638989|18172183|P2|Overall Study|Lost to Follow-up|0
5267195|NCT00638989|18172184|P1|Overall Study|Lost to Follow-up|0
5267196|NCT00638963|18172224|P2|Overall Study|Withdrawal by Subject|0
5267197|NCT00638963|18172225|P1|Overall Study|Withdrawal by Subject|1
5267198|NCT00638846|18172266|P2|Overall Study|lens issue|3
5267199|NCT00638846|18172267|P1|Overall Study|lens issue|1
5267200|NCT00638846|18172266|P2|Overall Study|Lost to Follow-up|2
5267201|NCT00638846|18172267|P1|Overall Study|Lost to Follow-up|3
5267202|NCT00638846|18172266|P2|Overall Study|Adverse Event|1
5267203|NCT00638846|18172267|P1|Overall Study|Adverse Event|0
5267204|NCT00638690|18172311|P2|Overall Study|Lost to Follow-up|2
5267205|NCT00638690|18172312|P1|Overall Study|Lost to Follow-up|4
5267206|NCT00638690|18172311|P2|Overall Study|Withdrawal by Subject|5
5267207|NCT00638690|18172312|P1|Overall Study|Withdrawal by Subject|22
5267208|NCT00638690|18172311|P2|Overall Study|Death|335
5267209|NCT00638690|18172312|P1|Overall Study|Death|655
5267210|NCT00638508|18172332|P2|Overall Study|Physician Decision|2
5267211|NCT00638508|18172333|P1|Overall Study|Physician Decision|5
5267212|NCT00638456|18172379|P2|Overall Study|Withdrawal by Subject|2
5267213|NCT00638456|18172380|P1|Overall Study|Withdrawal by Subject|6
5267214|NCT00638443|18172390|P2|First Intervention|Adverse Event|1
5267215|NCT00638443|18172391|P1|First Intervention|Adverse Event|2
5267216|NCT00638404|18172421|P2|Overall Study|Physician Decision|0
5267217|NCT00638404|18172422|P1|Overall Study|Physician Decision|8
5267218|NCT00638378|18172434|P1|Overall Study|Physician Decision|4
5267219|NCT00638378|18172434|P1|Overall Study|Disease progression|15
5267220|NCT00638378|18172434|P1|Overall Study|Adverse Event|1
5267221|NCT00638378|18172434|P1|Overall Study|Death|2
5267222|NCT00638235|18172474|P9|Overall Study|Lost to Follow-up|18
5267223|NCT00638235|18172475|P8|Overall Study|Lost to Follow-up|1
5267224|NCT00638235|18172476|P7|Overall Study|Lost to Follow-up|0
5267225|NCT00638235|18172477|P6|Overall Study|Lost to Follow-up|26
5267226|NCT00638235|18172478|P5|Overall Study|Lost to Follow-up|13
5267227|NCT00638235|18172479|P4|Overall Study|Lost to Follow-up|10
5267228|NCT00638235|18172480|P3|Overall Study|Lost to Follow-up|18
5267229|NCT00638235|18172481|P2|Overall Study|Lost to Follow-up|3
5267230|NCT00638235|18172482|P1|Overall Study|Lost to Follow-up|31
5267231|NCT00638183|18172892|P1|Overall Study|Other reason not defined above|27
5267232|NCT00638183|18172892|P1|Overall Study|Lost to Follow-up|46
5267233|NCT00638183|18172892|P1|Overall Study|Physician Decision|9
5267234|NCT00638183|18172892|P1|Overall Study|Lack of Efficacy|14
5267235|NCT00638183|18172892|P1|Overall Study|Adverse Event|23
5267236|NCT00638157|18172901|P2|Overall Study|Randomized, not treated|0
5267237|NCT00638157|18172902|P1|Overall Study|Randomized, not treated|2
5267238|NCT00638157|18172901|P2|Overall Study|Other|2
5267239|NCT00638157|18172902|P1|Overall Study|Other|1
5267240|NCT00638157|18172901|P2|Overall Study|Physician Decision|0
5267241|NCT00638157|18172902|P1|Overall Study|Physician Decision|1
5267242|NCT00638157|18172901|P2|Overall Study|Lost to Follow-up|0
5267243|NCT00638157|18172902|P1|Overall Study|Lost to Follow-up|1
5267244|NCT00638157|18172901|P2|Overall Study|Microbiological failure|0
5267245|NCT00638157|18172902|P1|Overall Study|Microbiological failure|1
5267246|NCT00638157|18172901|P2|Overall Study|Clinical (symptomatic) failure|1
5267247|NCT00638157|18172902|P1|Overall Study|Clinical (symptomatic) failure|1
5267248|NCT00638157|18172901|P2|Overall Study|Adverse Event|1
5267249|NCT00638157|18172902|P1|Overall Study|Adverse Event|0
5267250|NCT00638027|18172912|P2|Overall Study|Adverse Event|2
5267251|NCT00638027|18172913|P1|Overall Study|Adverse Event|0
5267252|NCT00637806|18172960|P4|Extension Phase|Study Discontinued|1
5267253|NCT00637806|18172961|P3|Extension Phase|Study Discontinued|0
5267254|NCT00637806|18172962|P2|Extension Phase|Study Discontinued|0
5267255|NCT00637806|18172963|P1|Extension Phase|Study Discontinued|0
5267256|NCT00637806|18172960|P4|Double-blind Phase|Study Discontinued|0
5267257|NCT00637806|18172961|P3|Double-blind Phase|Study Discontinued|1
5267258|NCT00637806|18172962|P2|Double-blind Phase|Study Discontinued|0
5267259|NCT00637806|18172963|P1|Double-blind Phase|Study Discontinued|2
5267260|NCT00637728|18172998|P3|Double-blind Phase|Study Discontinued|0
5267261|NCT00637728|18172999|P2|Double-blind Phase|Study Discontinued|1
5267262|NCT00637728|18173000|P1|Double-blind Phase|Study Discontinued|1
5267263|NCT00637728|18172998|P3|Double-blind Phase|Non-compliance|0
5267264|NCT00637728|18172999|P2|Double-blind Phase|Non-compliance|0
5267265|NCT00637728|18173000|P1|Double-blind Phase|Non-compliance|2
5267266|NCT00637728|18172998|P3|Double-blind Phase|Adverse Event|0
5267267|NCT00637728|18172999|P2|Double-blind Phase|Adverse Event|0
5267268|NCT00637728|18173000|P1|Double-blind Phase|Adverse Event|1
5267269|NCT00637572|18173015|P2|Overall Study|Illicit Drug Use|0
5267270|NCT00637572|18173016|P1|Overall Study|Illicit Drug Use|1
5267271|NCT00637572|18173015|P2|Overall Study|Withdrawal by Subject|2
5267272|NCT00637572|18173016|P1|Overall Study|Withdrawal by Subject|0
5267273|NCT00637572|18173015|P2|Overall Study|Physician Decision|1
5267274|NCT00637572|18173016|P1|Overall Study|Physician Decision|1
5267275|NCT00637572|18173015|P2|Overall Study|Lost to Follow-up|1
5267276|NCT00637572|18173016|P1|Overall Study|Lost to Follow-up|0
5267277|NCT00637572|18173015|P2|Overall Study|Death|1
5267278|NCT00637572|18173016|P1|Overall Study|Death|0
5267279|NCT00637572|18173015|P2|Overall Study|Adverse Event|2
5267280|NCT00637572|18173016|P1|Overall Study|Adverse Event|1
5267281|NCT00637416|18173055|P2|Overall Study|Unable to take study drug|1
5267282|NCT00637416|18173056|P1|Overall Study|Unable to take study drug|0
5267283|NCT00637416|18173055|P2|Overall Study|Lost to Follow-up|1
5267284|NCT00637416|18173056|P1|Overall Study|Lost to Follow-up|1
5267285|NCT00637377|18173066|P4|Overall Study|Other (no further information available)|5
5267286|NCT00637377|18173067|P3|Overall Study|Other (no further information available)|10
5267287|NCT00637377|18173068|P2|Overall Study|Other (no further information available)|6
5267288|NCT00637377|18173069|P1|Overall Study|Other (no further information available)|7
5267289|NCT00637377|18173066|P4|Overall Study|Withdrawal by Subject|11
5267290|NCT00637377|18173067|P3|Overall Study|Withdrawal by Subject|13
5267291|NCT00637377|18173068|P2|Overall Study|Withdrawal by Subject|15
5267292|NCT00637377|18173069|P1|Overall Study|Withdrawal by Subject|11
5267293|NCT00637377|18173066|P4|Overall Study|Protocol Violation|0
5267294|NCT00637377|18173067|P3|Overall Study|Protocol Violation|1
5267295|NCT00637377|18173068|P2|Overall Study|Protocol Violation|1
5267296|NCT00637377|18173069|P1|Overall Study|Protocol Violation|2
5267297|NCT00637377|18173066|P4|Overall Study|Lost to Follow-up|2
5267298|NCT00637377|18173067|P3|Overall Study|Lost to Follow-up|2
5267299|NCT00637377|18173068|P2|Overall Study|Lost to Follow-up|1
5267300|NCT00637377|18173069|P1|Overall Study|Lost to Follow-up|4
5267301|NCT00637377|18173066|P4|Overall Study|Lack of Efficacy|1
5267302|NCT00637377|18173067|P3|Overall Study|Lack of Efficacy|1
5267303|NCT00637377|18173068|P2|Overall Study|Lack of Efficacy|0
5267304|NCT00637377|18173069|P1|Overall Study|Lack of Efficacy|0
5267305|NCT00637377|18173066|P4|Overall Study|Death|1
5267306|NCT00637377|18173067|P3|Overall Study|Death|2
5267307|NCT00637377|18173068|P2|Overall Study|Death|3
5267308|NCT00637377|18173069|P1|Overall Study|Death|1
5267309|NCT00637377|18173066|P4|Overall Study|Adverse Event|9
5267310|NCT00637377|18173067|P3|Overall Study|Adverse Event|8
5267311|NCT00637377|18173068|P2|Overall Study|Adverse Event|6
5267312|NCT00637377|18173069|P1|Overall Study|Adverse Event|2
5267313|NCT00637273|18173118|P3|Overall Study|Loss of Glucose Control|1
5267314|NCT00637273|18173119|P2|Overall Study|Loss of Glucose Control|1
5267315|NCT00637273|18173120|P1|Overall Study|Loss of Glucose Control|1
5267316|NCT00637273|18173118|P3|Overall Study|Administrative|0
5267317|NCT00637273|18173119|P2|Overall Study|Administrative|0
5267318|NCT00637273|18173120|P1|Overall Study|Administrative|2
5267319|NCT00637273|18173118|P3|Overall Study|Investigator Decision|1
5267320|NCT00637273|18173119|P2|Overall Study|Investigator Decision|3
5267321|NCT00637273|18173120|P1|Overall Study|Investigator Decision|1
5267322|NCT00637273|18173118|P3|Overall Study|Withdrawal of Consent|18
5267323|NCT00637273|18173119|P2|Overall Study|Withdrawal of Consent|6
5267324|NCT00637273|18173120|P1|Overall Study|Withdrawal of Consent|18
5267325|NCT00637273|18173118|P3|Overall Study|Protocol Violation|1
5267326|NCT00637273|18173119|P2|Overall Study|Protocol Violation|4
5267327|NCT00637273|18173120|P1|Overall Study|Protocol Violation|2
5267328|NCT00637273|18173118|P3|Overall Study|Lost to Follow-up|13
5267329|NCT00637273|18173119|P2|Overall Study|Lost to Follow-up|9
5267330|NCT00637273|18173120|P1|Overall Study|Lost to Follow-up|8
5267331|NCT00637273|18173118|P3|Overall Study|Adverse Event|7
5267332|NCT00637273|18173119|P2|Overall Study|Adverse Event|5
5267333|NCT00637273|18173120|P1|Overall Study|Adverse Event|11
5267334|NCT00637195|18173178|P2|Overall Study|Withdrawal by Subject|1
5267335|NCT00637195|18173179|P1|Overall Study|Withdrawal by Subject|0
5267336|NCT00637195|18173178|P2|Overall Study|Other|0
5267337|NCT00637195|18173179|P1|Overall Study|Other|2
5267338|NCT00637195|18173178|P2|Overall Study|Lost to Follow-up|0
5267339|NCT00637195|18173179|P1|Overall Study|Lost to Follow-up|1
5267340|NCT00637156|18173215|P2|Overall Study|Lost to Follow-up|16
5267341|NCT00637156|18173216|P1|Overall Study|Lost to Follow-up|10
5267342|NCT00637156|18173215|P2|Overall Study|Death|1
5267343|NCT00637156|18173216|P1|Overall Study|Death|0
5267344|NCT00637156|18173215|P2|Overall Study|Withdrawal by Subject|7
5267345|NCT00637156|18173216|P1|Overall Study|Withdrawal by Subject|0
5267346|NCT00637000|18173258|P2|Overall Study|Withdrawal by Subject|3
5267347|NCT00637000|18173259|P1|Overall Study|Withdrawal by Subject|4
5267348|NCT00636987|18173299|P1|Overall Study|5 year visit window not complete|69
5267349|NCT00636987|18173299|P1|Overall Study|Lost to Follow-up|63
5267350|NCT00636987|18173299|P1|Overall Study|Explanted|13
5267351|NCT00636987|18173299|P1|Overall Study|Death|44
5267352|NCT00636961|18173309|P2|Period 2|Adverse Event|0
5267353|NCT00636961|18173310|P1|Period 2|Adverse Event|1
5267354|NCT00636961|18173309|P2|Period 1|Administrative problems|1
5267355|NCT00636961|18173310|P1|Period 1|Administrative problems|1
5267356|NCT00636818|18173324|P1|Overall Study|Withdrawal by Subject|4
5267357|NCT00636818|18173324|P1|Overall Study|Protocol Violation|1
5267358|NCT00636818|18173324|P1|Overall Study|Entry Criteria Exclusion|3
5267359|NCT00636818|18173324|P1|Overall Study|Lost to Follow-up|2
5267360|NCT00636818|18173324|P1|Overall Study|Adverse Event|1
5267361|NCT00636792|18173349|P1|Overall Study|Other|3
5267362|NCT00636792|18173349|P1|Overall Study|Withdrawal by Subject|3
5267363|NCT00636792|18173349|P1|Overall Study|Progressive Disease|4
5267364|NCT00636792|18173349|P1|Overall Study|Physician Decision|7
5267365|NCT00636792|18173349|P1|Overall Study|Adverse Event|16
5267366|NCT00636675|18173365|P2|Overall Study|Withdrawal by Subject|10
5267367|NCT00636675|18173366|P1|Overall Study|Withdrawal by Subject|19
5267368|NCT00636675|18173365|P2|Overall Study|Lost to Follow-up|31
5267369|NCT00636675|18173366|P1|Overall Study|Lost to Follow-up|121
5267370|NCT00636636|18173409|P2|Overall Study|Withdrawal by Subject|9
5267371|NCT00636636|18173410|P1|Overall Study|Withdrawal by Subject|4
5267372|NCT00636636|18173409|P2|Overall Study|Death|1
5267373|NCT00636636|18173410|P1|Overall Study|Death|0
5267374|NCT00636636|18173409|P2|Overall Study|Lost to Follow-up|1
5267375|NCT00636636|18173410|P1|Overall Study|Lost to Follow-up|0
5267376|NCT00636636|18173409|P2|Overall Study|Protocol Violation|2
5267377|NCT00636636|18173410|P1|Overall Study|Protocol Violation|2
5267378|NCT00636636|18173409|P2|Overall Study|Lack of Efficacy|12
5267379|NCT00636636|18173410|P1|Overall Study|Lack of Efficacy|7
5267380|NCT00636636|18173409|P2|Overall Study|Adverse Event|8
5267381|NCT00636636|18173410|P1|Overall Study|Adverse Event|19
5267382|NCT00636636|18173409|P2|Overall Study|Other reason|6
5267383|NCT00636636|18173410|P1|Overall Study|Other reason|4
5267384|NCT00636610|18173426|P2|Overall Study|Reason for discontinuation not available|2
5267385|NCT00636610|18173427|P1|Overall Study|Reason for discontinuation not available|3
5267386|NCT00636610|18173426|P2|Overall Study|Disease progression - clinical|3
5267387|NCT00636610|18173427|P1|Overall Study|Disease progression - clinical|8
5267388|NCT00636610|18173426|P2|Overall Study|Disease progression - radiographic|51
5267389|NCT00636610|18173427|P1|Overall Study|Disease progression - radiographic|41
5267390|NCT00636610|18173426|P2|Overall Study|Subject decision to withdraw|11
5267391|NCT00636610|18173427|P1|Overall Study|Subject decision to withdraw|15
5267392|NCT00636610|18173426|P2|Overall Study|Physician decision to withdraw patient|9
5267393|NCT00636610|18173427|P1|Overall Study|Physician decision to withdraw patient|15
5267394|NCT00636610|18173426|P2|Overall Study|Death|3
5267395|NCT00636610|18173427|P1|Overall Study|Death|6
5267396|NCT00636610|18173426|P2|Overall Study|Adverse Event|4
5267397|NCT00636610|18173427|P1|Overall Study|Adverse Event|4
5267398|NCT00636506|18173437|P1|Overall Study|Procedure aborted|1
5267399|NCT00636506|18173437|P1|Overall Study|Withdrawal by Subject|6
5267400|NCT00636506|18173437|P1|Overall Study|Explanted|1
5267401|NCT00636506|18173437|P1|Overall Study|Lost to Follow-up|8
5267402|NCT00636441|18173484|P7|Overall Study|Screen Failure|17
5267403|NCT00636441|18173485|P6|Overall Study|Screen Failure|0
5267404|NCT00636441|18173486|P5|Overall Study|Screen Failure|0
5267405|NCT00636441|18173487|P4|Overall Study|Screen Failure|0
5267406|NCT00636441|18173488|P3|Overall Study|Screen Failure|0
5267407|NCT00636441|18173489|P2|Overall Study|Screen Failure|0
5267408|NCT00636441|18173490|P1|Overall Study|Screen Failure|0
5267409|NCT00636441|18173484|P7|Overall Study|Late, ineligible|1
5267410|NCT00636441|18173485|P6|Overall Study|Late, ineligible|0
5267411|NCT00636441|18173486|P5|Overall Study|Late, ineligible|0
5267412|NCT00636441|18173487|P4|Overall Study|Late, ineligible|0
5267413|NCT00636441|18173488|P3|Overall Study|Late, ineligible|0
5267414|NCT00636441|18173489|P2|Overall Study|Late, ineligible|0
5267415|NCT00636441|18173490|P1|Overall Study|Late, ineligible|0
5267416|NCT00636441|18173484|P7|Overall Study|Adverse Event|0
5267417|NCT00636441|18173485|P6|Overall Study|Adverse Event|1
5267418|NCT00636441|18173486|P5|Overall Study|Adverse Event|0
5267419|NCT00636441|18173487|P4|Overall Study|Adverse Event|0
5267420|NCT00636441|18173488|P3|Overall Study|Adverse Event|1
5267421|NCT00636441|18173489|P2|Overall Study|Adverse Event|1
5267422|NCT00636441|18173490|P1|Overall Study|Adverse Event|0
5267423|NCT00636363|18173533|P3|Overall Study|Withdrawal by Subject|2
5267424|NCT00636363|18173534|P2|Overall Study|Withdrawal by Subject|3
5267425|NCT00636363|18173535|P1|Overall Study|Withdrawal by Subject|1
5267426|NCT00636363|18173533|P3|Overall Study|Lost to Follow-up|2
5267427|NCT00636363|18173534|P2|Overall Study|Lost to Follow-up|4
5267428|NCT00636363|18173535|P1|Overall Study|Lost to Follow-up|3
5267429|NCT00636363|18173533|P3|Overall Study|Protocol Violation|0
5267430|NCT00636363|18173534|P2|Overall Study|Protocol Violation|3
5267431|NCT00636363|18173535|P1|Overall Study|Protocol Violation|0
5267432|NCT00636363|18173533|P3|Overall Study|Lack of motivation|1
5267433|NCT00636363|18173534|P2|Overall Study|Lack of motivation|0
5267434|NCT00636363|18173535|P1|Overall Study|Lack of motivation|1
5267435|NCT00636363|18173533|P3|Overall Study|Missed > 1 visit|3
5267436|NCT00636363|18173534|P2|Overall Study|Missed > 1 visit|1
5267437|NCT00636363|18173535|P1|Overall Study|Missed > 1 visit|0
5267438|NCT00636363|18173533|P3|Overall Study|Met ineligibility criteria|3
5267439|NCT00636363|18173534|P2|Overall Study|Met ineligibility criteria|0
5267440|NCT00636363|18173535|P1|Overall Study|Met ineligibility criteria|0
5267441|NCT00636363|18173533|P3|Overall Study|Study related symptoms/complaints|4
5267442|NCT00636363|18173534|P2|Overall Study|Study related symptoms/complaints|7
5267443|NCT00636363|18173535|P1|Overall Study|Study related symptoms/complaints|8
5267444|NCT00636363|18173533|P3|Overall Study|Positive slit lamp finding|1
5267445|NCT00636363|18173534|P2|Overall Study|Positive slit lamp finding|2
5267446|NCT00636363|18173535|P1|Overall Study|Positive slit lamp finding|0
5267447|NCT00636363|18173533|P3|Overall Study|Adverse Event|1
5267448|NCT00636363|18173534|P2|Overall Study|Adverse Event|0
5267449|NCT00636363|18173535|P1|Overall Study|Adverse Event|0
5267450|NCT00636363|18173533|P3|Overall Study|Conjunctivitis|1
5267451|NCT00636363|18173534|P2|Overall Study|Conjunctivitis|0
5267452|NCT00636363|18173535|P1|Overall Study|Conjunctivitis|0
5267453|NCT00636207|18173556|P7|Overall Study|Withdrawal by Subject|0
5267454|NCT00636207|18173557|P6|Overall Study|Withdrawal by Subject|0
5267455|NCT00636207|18173558|P5|Overall Study|Withdrawal by Subject|1
5267456|NCT00636207|18173559|P4|Overall Study|Withdrawal by Subject|0
5267457|NCT00636207|18173560|P3|Overall Study|Withdrawal by Subject|0
5267458|NCT00636207|18173561|P2|Overall Study|Withdrawal by Subject|1
5267459|NCT00636207|18173562|P1|Overall Study|Withdrawal by Subject|0
5267460|NCT00636207|18173556|P7|Overall Study|Adverse Event|0
5267461|NCT00636207|18173557|P6|Overall Study|Adverse Event|0
5267462|NCT00636207|18173558|P5|Overall Study|Adverse Event|0
5267463|NCT00636207|18173559|P4|Overall Study|Adverse Event|0
5267464|NCT00636207|18173560|P3|Overall Study|Adverse Event|0
5267465|NCT00636207|18173561|P2|Overall Study|Adverse Event|0
5267466|NCT00636207|18173562|P1|Overall Study|Adverse Event|1
5267467|NCT00636194|18173626|P2|Overall Study|Protocol Violation|0
5267468|NCT00636194|18173627|P1|Overall Study|Protocol Violation|2
5267469|NCT00636194|18173626|P2|Overall Study|Study related symptoms and complaints|0
5267470|NCT00636194|18173627|P1|Overall Study|Study related symptoms and complaints|1
5267471|NCT00636181|18173640|P3|Overall Study|Withdrawal by Subject|10
5267472|NCT00636181|18173641|P2|Overall Study|Withdrawal by Subject|6
5267473|NCT00636181|18173642|P1|Overall Study|Withdrawal by Subject|8
5267474|NCT00636168|18173670|P2|Long Term Follow-Up|Death|9
5267475|NCT00636168|18173671|P1|Long Term Follow-Up|Death|8
5267476|NCT00636168|18173670|P2|Long Term Follow-Up|Participant withdrew consent|2
5267477|NCT00636168|18173671|P1|Long Term Follow-Up|Participant withdrew consent|0
5267478|NCT00636168|18173670|P2|Long Term Follow-Up|Lost to Follow-up|3
5267479|NCT00636168|18173671|P1|Long Term Follow-Up|Lost to Follow-up|3
5267480|NCT00636168|18173670|P2|Treated With Study Drug|Other reason|3
5267481|NCT00636168|18173671|P1|Treated With Study Drug|Other reason|1
5267482|NCT00636168|18173670|P2|Treated With Study Drug|No longer meets study criteria|0
5267483|NCT00636168|18173671|P1|Treated With Study Drug|No longer meets study criteria|1
5267484|NCT00636168|18173670|P2|Treated With Study Drug|Pregnancy|0
5267485|NCT00636168|18173671|P1|Treated With Study Drug|Pregnancy|1
5267486|NCT00636168|18173670|P2|Treated With Study Drug|Death|0
5267487|NCT00636168|18173671|P1|Treated With Study Drug|Death|3
5267488|NCT00636168|18173670|P2|Treated With Study Drug|Poor/non-compliance|3
5267489|NCT00636168|18173671|P1|Treated With Study Drug|Poor/non-compliance|1
5267490|NCT00636168|18173670|P2|Treated With Study Drug|Participant withdrew consent|21
5267491|NCT00636168|18173671|P1|Treated With Study Drug|Participant withdrew consent|16
5267492|NCT00636168|18173670|P2|Treated With Study Drug|Adverse Event|22
5267493|NCT00636168|18173671|P1|Treated With Study Drug|Adverse Event|250
5267494|NCT00636168|18173670|P2|Treated With Study Drug|Recurrence of disease|282
5267495|NCT00636168|18173671|P1|Treated With Study Drug|Recurrence of disease|135
5267496|NCT00636168|18173670|P2|Randomized to Study Drug|No longer meets study criteria|0
5267497|NCT00636168|18173671|P1|Randomized to Study Drug|No longer meets study criteria|1
5267498|NCT00636168|18173670|P2|Randomized to Study Drug|Adverse Event|0
5267499|NCT00636168|18173671|P1|Randomized to Study Drug|Adverse Event|1
5267500|NCT00636168|18173670|P2|Randomized to Study Drug|Withdrawal by Subject|2
5267501|NCT00636168|18173671|P1|Randomized to Study Drug|Withdrawal by Subject|2
5267502|NCT00636155|18173699|P1|Overall Study|Physician Decision|5
5267503|NCT00636155|18173699|P1|Overall Study|Stem cell transplant|1
5267504|NCT00636155|18173699|P1|Overall Study|Withdrawal by Subject|3
5267505|NCT00636155|18173699|P1|Overall Study|Lack of Efficacy|1
5267506|NCT00636155|18173699|P1|Overall Study|Adverse Event|8
5267507|NCT00635999|18173741|P3|Overall Study|Withdrawal by Subject|1
5267508|NCT00635999|18173742|P2|Overall Study|Withdrawal by Subject|2
5267509|NCT00635999|18173743|P1|Overall Study|Withdrawal by Subject|4
5267510|NCT00635882|18173760|P6|Overall Study|Protocol Violation|0
5267511|NCT00635882|18173761|P5|Overall Study|Protocol Violation|0
5267512|NCT00635882|18173762|P4|Overall Study|Protocol Violation|0
5267513|NCT00635882|18173763|P3|Overall Study|Protocol Violation|0
5267514|NCT00635882|18173764|P2|Overall Study|Protocol Violation|0
5267515|NCT00635882|18173765|P1|Overall Study|Protocol Violation|1
5267516|NCT00635804|18173895|P8|Overall Study|Withdrawal by Subject|0
5267517|NCT00635804|18173896|P7|Overall Study|Withdrawal by Subject|0
5267518|NCT00635804|18173897|P6|Overall Study|Withdrawal by Subject|0
5267519|NCT00635804|18173898|P5|Overall Study|Withdrawal by Subject|0
5267520|NCT00635804|18173899|P4|Overall Study|Withdrawal by Subject|0
5267521|NCT00635804|18173900|P3|Overall Study|Withdrawal by Subject|0
5267522|NCT00635804|18173901|P2|Overall Study|Withdrawal by Subject|0
5267523|NCT00635804|18173902|P1|Overall Study|Withdrawal by Subject|1
5267524|NCT00635804|18173895|P8|Overall Study|Adverse Event|0
5267525|NCT00635804|18173896|P7|Overall Study|Adverse Event|0
5267526|NCT00635804|18173897|P6|Overall Study|Adverse Event|1
5267527|NCT00635804|18173898|P5|Overall Study|Adverse Event|0
5267528|NCT00635804|18173899|P4|Overall Study|Adverse Event|0
5267529|NCT00635804|18173900|P3|Overall Study|Adverse Event|0
5267530|NCT00635804|18173901|P2|Overall Study|Adverse Event|0
5267531|NCT00635804|18173902|P1|Overall Study|Adverse Event|0
5267532|NCT00635778|18174006|P7|Overall Study|Progressive disease|4
5267533|NCT00635778|18174007|P6|Overall Study|Progressive disease|14
5267534|NCT00635778|18174008|P5|Overall Study|Progressive disease|5
5267535|NCT00635778|18174009|P4|Overall Study|Progressive disease|4
5267536|NCT00635778|18174010|P3|Overall Study|Progressive disease|3
5267537|NCT00635778|18174011|P2|Overall Study|Progressive disease|3
5267538|NCT00635778|18174012|P1|Overall Study|Progressive disease|0
5267539|NCT00635778|18174006|P7|Overall Study|Withdrawal by Subject|1
5267540|NCT00635778|18174007|P6|Overall Study|Withdrawal by Subject|1
5267541|NCT00635778|18174008|P5|Overall Study|Withdrawal by Subject|0
5267542|NCT00635778|18174009|P4|Overall Study|Withdrawal by Subject|1
5267543|NCT00635778|18174010|P3|Overall Study|Withdrawal by Subject|0
5267544|NCT00635778|18174011|P2|Overall Study|Withdrawal by Subject|0
5267545|NCT00635778|18174012|P1|Overall Study|Withdrawal by Subject|0
5267546|NCT00635778|18174006|P7|Overall Study|Adverse Event|1
5267547|NCT00635778|18174007|P6|Overall Study|Adverse Event|6
5267548|NCT00635778|18174008|P5|Overall Study|Adverse Event|3
5267549|NCT00635778|18174009|P4|Overall Study|Adverse Event|3
5267550|NCT00635778|18174010|P3|Overall Study|Adverse Event|0
5267551|NCT00635778|18174011|P2|Overall Study|Adverse Event|0
5267552|NCT00635778|18174012|P1|Overall Study|Adverse Event|1
5267553|NCT00635661|18174083|P1|Overall Study|Withdrawal by Subject|4
5267554|NCT00635648|18174087|P1|Overall Study|Other reason|2
5267555|NCT00635648|18174087|P1|Overall Study|Noncompliance with protocol|1
5267556|NCT00635648|18174087|P1|Overall Study|No improvement after 7-10 days treatment|4
5267557|NCT00635648|18174087|P1|Overall Study|Use of other antifungal agent needed|1
5267558|NCT00635648|18174087|P1|Overall Study|Rapid progression of baseline disease|4
5267559|NCT00635648|18174087|P1|Overall Study|Physician Decision|4
5267560|NCT00635648|18174087|P1|Overall Study|Withdrawal by Subject|9
5267561|NCT00635648|18174087|P1|Overall Study|Adverse Event|12
5267562|NCT00635570|18174109|P2|Overall Study|Early termination(No sexual activity)|1
5267563|NCT00635570|18174110|P1|Overall Study|Early termination(No sexual activity)|1
5267564|NCT00635570|18174109|P2|Overall Study|Did not complete survey|1
5267565|NCT00635570|18174110|P1|Overall Study|Did not complete survey|2
5267566|NCT00635570|18174109|P2|Overall Study|Physician Decision|0
5267567|NCT00635570|18174110|P1|Overall Study|Physician Decision|1
5267568|NCT00635570|18174109|P2|Overall Study|Adverse Event|0
5267569|NCT00635570|18174110|P1|Overall Study|Adverse Event|2
5267570|NCT00635570|18174109|P2|Overall Study|Withdrawal by Subject|1
5267571|NCT00635570|18174110|P1|Overall Study|Withdrawal by Subject|1
5267572|NCT00635570|18174109|P2|Overall Study|Lost to Follow-up|8
5267573|NCT00635570|18174110|P1|Overall Study|Lost to Follow-up|8
5267574|NCT00635492|18174124|P2|Overall Study|Withdrawal by Subject|45
5267575|NCT00635492|18174125|P1|Overall Study|Withdrawal by Subject|82
5267576|NCT00635492|18174124|P2|Overall Study|Sponsor decision|3
5267577|NCT00635492|18174125|P1|Overall Study|Sponsor decision|2
5267578|NCT00635492|18174124|P2|Overall Study|Physician Decision|22
5267579|NCT00635492|18174125|P1|Overall Study|Physician Decision|32
5267580|NCT00635492|18174124|P2|Overall Study|Lost to Follow-up|172
5267581|NCT00635492|18174125|P1|Overall Study|Lost to Follow-up|151
5267582|NCT00635492|18174124|P2|Overall Study|Death|40
5267583|NCT00635492|18174125|P1|Overall Study|Death|12
5267584|NCT00635427|18174198|P5|Overall Study|Withdrawal Of Consent|2
5267585|NCT00635427|18174199|P4|Overall Study|Withdrawal Of Consent|2
5267586|NCT00635427|18174200|P3|Overall Study|Withdrawal Of Consent|0
5267587|NCT00635427|18174201|P2|Overall Study|Withdrawal Of Consent|0
5267588|NCT00635427|18174202|P1|Overall Study|Withdrawal Of Consent|0
5267589|NCT00635427|18174198|P5|Overall Study|Termination Of Study By Sponsor|6
5267590|NCT00635427|18174199|P4|Overall Study|Termination Of Study By Sponsor|6
5267591|NCT00635427|18174200|P3|Overall Study|Termination Of Study By Sponsor|10
5267592|NCT00635427|18174201|P2|Overall Study|Termination Of Study By Sponsor|6
5267593|NCT00635427|18174202|P1|Overall Study|Termination Of Study By Sponsor|12
5267594|NCT00635427|18174198|P5|Overall Study|Death|0
5267595|NCT00635427|18174199|P4|Overall Study|Death|1
5267596|NCT00635427|18174200|P3|Overall Study|Death|0
5267597|NCT00635427|18174201|P2|Overall Study|Death|0
5267598|NCT00635427|18174202|P1|Overall Study|Death|0
5267599|NCT00635427|18174198|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5267600|NCT00635427|18174199|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5267601|NCT00635427|18174200|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
5267602|NCT00635427|18174201|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5267603|NCT00635427|18174202|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5267604|NCT00635349|18174241|P2|Overall Study|Adverse Event|9
5267605|NCT00635349|18174242|P1|Overall Study|Adverse Event|11
5267606|NCT00635349|18174241|P2|Overall Study|Lost to Follow-up|3
5267607|NCT00635349|18174242|P1|Overall Study|Lost to Follow-up|4
5267608|NCT00635349|18174241|P2|Overall Study|Withdrawal by Subject|8
5267609|NCT00635349|18174242|P1|Overall Study|Withdrawal by Subject|3
5267610|NCT00635349|18174241|P2|Overall Study|Protocol Violation|22
5267611|NCT00635349|18174242|P1|Overall Study|Protocol Violation|18
5267612|NCT00635349|18174241|P2|Overall Study|Other|6
5267613|NCT00635349|18174242|P1|Overall Study|Other|8
5267614|NCT00635219|18174296|P5|Overall Study|Administrative or Other Reasons|1
5267615|NCT00635219|18174297|P4|Overall Study|Administrative or Other Reasons|0
5267616|NCT00635219|18174298|P3|Overall Study|Administrative or Other Reasons|1
5267617|NCT00635219|18174299|P2|Overall Study|Administrative or Other Reasons|1
5267618|NCT00635219|18174300|P1|Overall Study|Administrative or Other Reasons|0
5267619|NCT00635219|18174296|P5|Overall Study|Lost to Follow-up|3
5267620|NCT00635219|18174297|P4|Overall Study|Lost to Follow-up|0
5267621|NCT00635219|18174298|P3|Overall Study|Lost to Follow-up|2
5267622|NCT00635219|18174299|P2|Overall Study|Lost to Follow-up|0
5267623|NCT00635219|18174300|P1|Overall Study|Lost to Follow-up|0
5267624|NCT00635219|18174296|P5|Overall Study|Withdrawal of Consent|8
5267625|NCT00635219|18174297|P4|Overall Study|Withdrawal of Consent|11
5267626|NCT00635219|18174298|P3|Overall Study|Withdrawal of Consent|8
5267627|NCT00635219|18174299|P2|Overall Study|Withdrawal of Consent|6
5267628|NCT00635219|18174300|P1|Overall Study|Withdrawal of Consent|8
5267629|NCT00635219|18174296|P5|Overall Study|Protocol Violation|4
5267630|NCT00635219|18174297|P4|Overall Study|Protocol Violation|2
5267631|NCT00635219|18174298|P3|Overall Study|Protocol Violation|3
5267632|NCT00635219|18174299|P2|Overall Study|Protocol Violation|2
5267633|NCT00635219|18174300|P1|Overall Study|Protocol Violation|0
5267634|NCT00635219|18174296|P5|Overall Study|Non-compliance With Study Product|1
5267635|NCT00635219|18174297|P4|Overall Study|Non-compliance With Study Product|2
5267636|NCT00635219|18174298|P3|Overall Study|Non-compliance With Study Product|0
5267637|NCT00635219|18174299|P2|Overall Study|Non-compliance With Study Product|0
5267638|NCT00635219|18174300|P1|Overall Study|Non-compliance With Study Product|0
5267639|NCT00635219|18174296|P5|Overall Study|Lack of Efficacy|6
5267640|NCT00635219|18174297|P4|Overall Study|Lack of Efficacy|4
5267641|NCT00635219|18174298|P3|Overall Study|Lack of Efficacy|3
5267642|NCT00635219|18174299|P2|Overall Study|Lack of Efficacy|6
5267643|NCT00635219|18174300|P1|Overall Study|Lack of Efficacy|5
5267644|NCT00635219|18174296|P5|Overall Study|Adverse Event|19
5267645|NCT00635219|18174297|P4|Overall Study|Adverse Event|15
5267646|NCT00635219|18174298|P3|Overall Study|Adverse Event|18
5267647|NCT00635219|18174299|P2|Overall Study|Adverse Event|10
5267648|NCT00635219|18174300|P1|Overall Study|Adverse Event|12
5267649|NCT00635154|18174363|P1|Overall Study|Still on treatment|21
5267650|NCT00635154|18174363|P1|Overall Study|Other|4
5267651|NCT00635154|18174363|P1|Overall Study|Alternative Treatment|8
5267652|NCT00635102|18174406|P2|Overall Study|Withdrawal by Subject|8
5267653|NCT00635102|18174407|P1|Overall Study|Withdrawal by Subject|7
5267654|NCT00635089|18174501|P1|Overall Study|Other|31
5267655|NCT00635089|18174501|P1|Overall Study|Lost to Follow-up|8
5267656|NCT00635089|18174501|P1|Overall Study|Protocol Deviation|4
5267657|NCT00635089|18174501|P1|Overall Study|Lack of Efficacy|28
5267658|NCT00635089|18174501|P1|Overall Study|Adverse Event|7
5267659|NCT00635050|18174528|P1|Overall Study|Withdrawal by Subject|1
5267660|NCT00635024|18174535|P1|Overall Study|Adverse Event|1
5267661|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Other|1
5267662|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Other|0
5267663|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Other|5
5267664|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Other|0
5267665|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Other|0
5267666|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
5267667|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
5267668|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
5267669|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
5267670|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
5267671|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
5267672|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
5267673|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
5267674|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
5267675|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
5267676|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Protocol Violation|1
5267677|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Protocol Violation|0
5267678|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Protocol Violation|0
5267679|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Protocol Violation|0
5267680|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Protocol Violation|0
5267681|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Physician Decision|0
5267682|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Physician Decision|0
5267683|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Physician Decision|1
5267684|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Physician Decision|1
5267685|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Physician Decision|0
5267686|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
5267687|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
5267688|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
5267689|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
5267690|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
5267691|NCT00634933|18174546|P5|Part B: Week 24 to Week 52|Adverse Event|0
5267692|NCT00634933|18174547|P4|Part B: Week 24 to Week 52|Adverse Event|1
5267693|NCT00634933|18174548|P3|Part B: Week 24 to Week 52|Adverse Event|1
5267694|NCT00634933|18174549|P2|Part B: Week 24 to Week 52|Adverse Event|1
5267695|NCT00634933|18174550|P1|Part B: Week 24 to Week 52|Adverse Event|0
5267696|NCT00634933|18174546|P5|Between Part A and Part B|Physician Decision|0
5267697|NCT00634933|18174547|P4|Between Part A and Part B|Physician Decision|0
5267698|NCT00634933|18174548|P3|Between Part A and Part B|Physician Decision|0
5267699|NCT00634933|18174549|P2|Between Part A and Part B|Physician Decision|1
5267700|NCT00634933|18174550|P1|Between Part A and Part B|Physician Decision|0
5267701|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Other|0
5267702|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Other|0
5267703|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Other|5
5267704|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Other|8
5267705|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Other|1
5267706|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
5267707|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
5267708|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
5267709|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
5267710|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
5267711|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
5267712|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
5267713|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
5267714|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
5267715|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
5267716|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
5267717|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
5267718|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
5267719|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
5267720|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
5267721|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Investigator Request|0
5267722|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Investigator Request|0
5267723|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Investigator Request|1
5267724|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Investigator Request|1
5267725|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Investigator Request|1
5267726|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Failed to Return|0
5267727|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Failed to Return|0
5267728|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Failed to Return|0
5267729|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Failed to Return|0
5267730|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Failed to Return|1
5267731|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Death|0
5267732|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Death|0
5267733|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Death|0
5267734|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Death|0
5267735|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Death|1
5267736|NCT00634933|18174546|P5|Part A: Baseline to Week 24|Adverse Event|0
5267737|NCT00634933|18174547|P4|Part A: Baseline to Week 24|Adverse Event|0
5267738|NCT00634933|18174548|P3|Part A: Baseline to Week 24|Adverse Event|8
5267739|NCT00634933|18174549|P2|Part A: Baseline to Week 24|Adverse Event|4
5267740|NCT00634933|18174550|P1|Part A: Baseline to Week 24|Adverse Event|4
5267741|NCT00634920|18174619|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
5267742|NCT00634920|18174620|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
5267743|NCT00634920|18174621|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
5267744|NCT00634920|18174619|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
5267745|NCT00634920|18174620|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
5267746|NCT00634920|18174621|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
5267747|NCT00634920|18174619|P3|Period 2 - Post-Randomization|Death|0
5267748|NCT00634920|18174620|P2|Period 2 - Post-Randomization|Death|5
5267749|NCT00634920|18174621|P1|Period 2 - Post-Randomization|Death|2
5267750|NCT00634920|18174619|P3|Period 2 - Post-Randomization|Rejection|0
5267751|NCT00634920|18174620|P2|Period 2 - Post-Randomization|Rejection|5
5267752|NCT00634920|18174621|P1|Period 2 - Post-Randomization|Rejection|11
5267753|NCT00634920|18174619|P3|Period 2 - Post-Randomization|Adverse Event|0
5267754|NCT00634920|18174620|P2|Period 2 - Post-Randomization|Adverse Event|9
5267755|NCT00634920|18174621|P1|Period 2 - Post-Randomization|Adverse Event|37
5267756|NCT00634920|18174619|P3|Period 1 - Pre-Randomization|Other issues|6
5267757|NCT00634920|18174620|P2|Period 1 - Pre-Randomization|Other issues|0
5267758|NCT00634920|18174621|P1|Period 1 - Pre-Randomization|Other issues|0
5267759|NCT00634920|18174619|P3|Period 1 - Pre-Randomization|Non-Compliance|3
5267760|NCT00634920|18174620|P2|Period 1 - Pre-Randomization|Non-Compliance|0
5267761|NCT00634920|18174621|P1|Period 1 - Pre-Randomization|Non-Compliance|0
5267762|NCT00634920|18174619|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
5267763|NCT00634920|18174620|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
5267764|NCT00634920|18174621|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
5267765|NCT00634920|18174619|P3|Period 1 - Pre-Randomization|Rejections|55
5267766|NCT00634920|18174620|P2|Period 1 - Pre-Randomization|Rejections|0
5267767|NCT00634920|18174621|P1|Period 1 - Pre-Randomization|Rejections|0
5267768|NCT00634920|18174619|P3|Period 1 - Pre-Randomization|Wound healing problems|16
5267769|NCT00634920|18174620|P2|Period 1 - Pre-Randomization|Wound healing problems|0
5267770|NCT00634920|18174621|P1|Period 1 - Pre-Randomization|Wound healing problems|0
5267771|NCT00634920|18174619|P3|Period 1 - Pre-Randomization|Adverse Event|36
5267772|NCT00634920|18174620|P2|Period 1 - Pre-Randomization|Adverse Event|0
5267773|NCT00634920|18174621|P1|Period 1 - Pre-Randomization|Adverse Event|0
5267774|NCT00634907|18174665|P2|Overall Study|Withdrawal by Subject|8
5267775|NCT00634907|18174666|P1|Overall Study|Withdrawal by Subject|11
5267776|NCT00634907|18174665|P2|Overall Study|Physician Decision|9
5267777|NCT00634907|18174666|P1|Overall Study|Physician Decision|3
5267778|NCT00634907|18174665|P2|Overall Study|Withdrawal by Subject|0
5267779|NCT00634907|18174666|P1|Overall Study|Withdrawal by Subject|3
5267780|NCT00634842|18174690|P2|Overall Study|Subject off study drug for too long|1
5267781|NCT00634842|18174691|P1|Overall Study|Subject off study drug for too long|0
5267782|NCT00634842|18174690|P2|Overall Study|No wish to keep taking Avandia|1
5267783|NCT00634842|18174691|P1|Overall Study|No wish to keep taking Avandia|0
5267784|NCT00634842|18174690|P2|Overall Study|No need of study drug to treat diabetes|1
5267785|NCT00634842|18174691|P1|Overall Study|No need of study drug to treat diabetes|0
5267786|NCT00634842|18174690|P2|Overall Study|Discontinued due to injection|2
5267787|NCT00634842|18174691|P1|Overall Study|Discontinued due to injection|0
5267788|NCT00634842|18174690|P2|Overall Study|Lack of time and intolerance to drug|1
5267789|NCT00634842|18174691|P1|Overall Study|Lack of time and intolerance to drug|0
5267790|NCT00634842|18174690|P2|Overall Study|Withdrawal by Subject|3
5267791|NCT00634842|18174691|P1|Overall Study|Withdrawal by Subject|1
5267792|NCT00634842|18174690|P2|Overall Study|Physician Decision|0
5267793|NCT00634842|18174691|P1|Overall Study|Physician Decision|1
5267794|NCT00634842|18174690|P2|Overall Study|Lost to Follow-up|2
5267795|NCT00634842|18174691|P1|Overall Study|Lost to Follow-up|1
5267796|NCT00634842|18174690|P2|Overall Study|Inclusion criteria were not met|0
5267797|NCT00634842|18174691|P1|Overall Study|Inclusion criteria were not met|1
5267798|NCT00634842|18174690|P2|Overall Study|Move to another state|0
5267799|NCT00634842|18174691|P1|Overall Study|Move to another state|1
5267800|NCT00634842|18174690|P2|Overall Study|Protocol Violation|4
5267801|NCT00634842|18174691|P1|Overall Study|Protocol Violation|8
5267802|NCT00634842|18174690|P2|Overall Study|Adverse Event|3
5267803|NCT00634842|18174691|P1|Overall Study|Adverse Event|2
5267804|NCT00634803|18174706|P3|Overall Study|Lost to Follow-up|7
5267805|NCT00634803|18174707|P2|Overall Study|Lost to Follow-up|7
5267806|NCT00634803|18174708|P1|Overall Study|Lost to Follow-up|6
5267807|NCT00634751|18174726|P4|Pancreatic and Bilial Tract Cancer|Death|1
5267808|NCT00634751|18174727|P3|Pancreatic and Bilial Tract Cancer|Death|1
5267809|NCT00634751|18174728|P2|Pancreatic and Bilial Tract Cancer|Death|0
5267810|NCT00634751|18174729|P1|Pancreatic and Bilial Tract Cancer|Death|0
5267811|NCT00634751|18174726|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
5267812|NCT00634751|18174727|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
5267813|NCT00634751|18174728|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
5267814|NCT00634751|18174729|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
5267815|NCT00634751|18174726|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
5267816|NCT00634751|18174727|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
5267817|NCT00634751|18174728|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
5267818|NCT00634751|18174729|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
5267819|NCT00634647|18174747|P1|Overall Study|declined to participate before treatment|1
5267820|NCT00634647|18174747|P1|Overall Study|refused further treatment|3
5267821|NCT00634647|18174747|P1|Overall Study|death on study|3
5267822|NCT00634569|18174767|P2|Overall Study|Physician Decision|1
5267823|NCT00634569|18174768|P1|Overall Study|Physician Decision|0
5267824|NCT00634569|18174767|P2|Overall Study|Withdrawal by Subject|4
5267825|NCT00634569|18174768|P1|Overall Study|Withdrawal by Subject|0
5267826|NCT00634543|18174782|P2|Overall Study|Lost to Follow-up|1
5267827|NCT00634543|18174783|P1|Overall Study|Lost to Follow-up|0
5267828|NCT00634543|18174782|P2|Overall Study|Withdrawal by Subject|4
5267829|NCT00634543|18174783|P1|Overall Study|Withdrawal by Subject|4
5267830|NCT00634543|18174782|P2|Overall Study|Adverse Event|11
5267831|NCT00634543|18174783|P1|Overall Study|Adverse Event|11
5267832|NCT00634543|18174782|P2|Overall Study|Protocol Violation|3
5267833|NCT00634543|18174783|P1|Overall Study|Protocol Violation|3
5267834|NCT00634543|18174782|P2|Overall Study|Other|2
5267835|NCT00634543|18174783|P1|Overall Study|Other|1
5267836|NCT00634504|18174801|P2|Overall Study|Protocol Violation|0
5267837|NCT00634504|18174802|P1|Overall Study|Protocol Violation|1
5267838|NCT00634244|18174861|P3|Overall Study|Other complicating disease|0
5267839|NCT00634244|18174862|P2|Overall Study|Other complicating disease|1
5267840|NCT00634244|18174863|P1|Overall Study|Other complicating disease|0
5267841|NCT00634244|18174861|P3|Overall Study|Disease progression/relapse|0
5267842|NCT00634244|18174862|P2|Overall Study|Disease progression/relapse|1
5267843|NCT00634244|18174863|P1|Overall Study|Disease progression/relapse|0
5267844|NCT00634244|18174861|P3|Overall Study|Physician Decision|0
5267845|NCT00634244|18174862|P2|Overall Study|Physician Decision|1
5267846|NCT00634244|18174863|P1|Overall Study|Physician Decision|0
5267847|NCT00634244|18174861|P3|Overall Study|Withdrawal by Subject|0
5267848|NCT00634244|18174862|P2|Overall Study|Withdrawal by Subject|1
5267849|NCT00634244|18174863|P1|Overall Study|Withdrawal by Subject|0
5267850|NCT00634244|18174861|P3|Overall Study|Adverse Event|0
5267851|NCT00634244|18174862|P2|Overall Study|Adverse Event|2
5267852|NCT00634244|18174863|P1|Overall Study|Adverse Event|0
5267853|NCT00634244|18174861|P3|Overall Study|Death|0
5267854|NCT00634244|18174862|P2|Overall Study|Death|6
5267855|NCT00634244|18174863|P1|Overall Study|Death|1
5267856|NCT00634244|18174861|P3|Overall Study|Never started treatment|0
5267857|NCT00634244|18174862|P2|Overall Study|Never started treatment|1
5267858|NCT00634244|18174863|P1|Overall Study|Never started treatment|0
5267859|NCT00634179|18174874|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
5267860|NCT00634114|18174893|P3|Overall Study|Other reason|1
5267861|NCT00634114|18174894|P2|Overall Study|Other reason|1
5267862|NCT00634114|18174895|P1|Overall Study|Other reason|1
5267863|NCT00634114|18174893|P3|Overall Study|Difficult to continue|1
5267864|NCT00634114|18174894|P2|Overall Study|Difficult to continue|1
5267865|NCT00634114|18174895|P1|Overall Study|Difficult to continue|3
5267866|NCT00634114|18174893|P3|Overall Study|Recurrence of reflux esophagitis|21
5267867|NCT00634114|18174894|P2|Overall Study|Recurrence of reflux esophagitis|15
5267868|NCT00634114|18174895|P1|Overall Study|Recurrence of reflux esophagitis|5
5267869|NCT00634114|18174893|P3|Overall Study|Incorrect enrolment|0
5267870|NCT00634114|18174894|P2|Overall Study|Incorrect enrolment|1
5267871|NCT00634114|18174895|P1|Overall Study|Incorrect enrolment|0
5267872|NCT00634114|18174893|P3|Overall Study|Pregnancy|0
5267873|NCT00634114|18174894|P2|Overall Study|Pregnancy|0
5267874|NCT00634114|18174895|P1|Overall Study|Pregnancy|1
5267875|NCT00634114|18174893|P3|Overall Study|Protocol Violation|1
5267876|NCT00634114|18174894|P2|Overall Study|Protocol Violation|3
5267877|NCT00634114|18174895|P1|Overall Study|Protocol Violation|3
5267878|NCT00634114|18174893|P3|Overall Study|Lost to Follow-up|1
5267879|NCT00634114|18174894|P2|Overall Study|Lost to Follow-up|0
5267880|NCT00634114|18174895|P1|Overall Study|Lost to Follow-up|0
5267881|NCT00634114|18174893|P3|Overall Study|Withdrawal by Subject|11
5267882|NCT00634114|18174894|P2|Overall Study|Withdrawal by Subject|6
5267883|NCT00634114|18174895|P1|Overall Study|Withdrawal by Subject|9
5267884|NCT00634114|18174893|P3|Overall Study|Adverse Event|3
5267885|NCT00634114|18174894|P2|Overall Study|Adverse Event|8
5267886|NCT00634114|18174895|P1|Overall Study|Adverse Event|6
5267887|NCT00634101|18174911|P2|Overall Study|Lost to Follow-up|0
5267888|NCT00634101|18174912|P1|Overall Study|Lost to Follow-up|2
5267889|NCT00634101|18174911|P2|Overall Study|Study Terminated|3
5267890|NCT00634101|18174912|P1|Overall Study|Study Terminated|3
5267891|NCT00634088|18174946|P4|Time Period 3: Dose Level 3|Progressive disease|0
5267892|NCT00634088|18174947|P3|Time Period 3: Dose Level 3|Progressive disease|1
5267893|NCT00634088|18174948|P2|Time Period 3: Dose Level 3|Progressive disease|0
5267894|NCT00634088|18174949|P1|Time Period 3: Dose Level 3|Progressive disease|0
5267895|NCT00634088|18174946|P4|Time Period 2: Dose Level 2|Progressive disease|0
5267896|NCT00634088|18174947|P3|Time Period 2: Dose Level 2|Progressive disease|0
5267897|NCT00634088|18174948|P2|Time Period 2: Dose Level 2|Progressive disease|1
5267898|NCT00634088|18174949|P1|Time Period 2: Dose Level 2|Progressive disease|0
5267899|NCT00634088|18174946|P4|Time Period 2: Dose Level 2|Adverse Event|0
5267900|NCT00634088|18174947|P3|Time Period 2: Dose Level 2|Adverse Event|0
5267901|NCT00634088|18174948|P2|Time Period 2: Dose Level 2|Adverse Event|2
5267902|NCT00634088|18174949|P1|Time Period 2: Dose Level 2|Adverse Event|0
5267903|NCT00634088|18174946|P4|Time Period 1: Dose Level 1|Adverse Event|0
5267904|NCT00634088|18174947|P3|Time Period 1: Dose Level 1|Adverse Event|0
5267905|NCT00634088|18174948|P2|Time Period 1: Dose Level 1|Adverse Event|0
5267906|NCT00634088|18174949|P1|Time Period 1: Dose Level 1|Adverse Event|3
5267907|NCT00634088|18174946|P4|Time Period 1: Dose Level 1|Physician Decision|0
5267908|NCT00634088|18174947|P3|Time Period 1: Dose Level 1|Physician Decision|0
5267909|NCT00634088|18174948|P2|Time Period 1: Dose Level 1|Physician Decision|0
5267910|NCT00634088|18174949|P1|Time Period 1: Dose Level 1|Physician Decision|1
5267911|NCT00634088|18174946|P4|Time Period 1: Dose Level 1|Disease progression|0
5267912|NCT00634088|18174947|P3|Time Period 1: Dose Level 1|Disease progression|0
5267913|NCT00634088|18174948|P2|Time Period 1: Dose Level 1|Disease progression|0
5267914|NCT00634088|18174949|P1|Time Period 1: Dose Level 1|Disease progression|2
5267915|NCT00634049|18175000|P1|Overall Study|Screening failure|1
5267916|NCT00634049|18175000|P1|Overall Study|Died prior to receiving study drug|1
5267917|NCT00634049|18175000|P1|Overall Study|Never received study drug|1
5267918|NCT00634036|18175079|P2|Overall Study|Withdrawal by Subject|1
5267919|NCT00634036|18175080|P1|Overall Study|Withdrawal by Subject|1
5267920|NCT00634036|18175079|P2|Overall Study|Lost to Follow-up|1
5267921|NCT00634036|18175080|P1|Overall Study|Lost to Follow-up|1
5267922|NCT00634010|18175094|P2|Overall Study|Non-Compliant|1
5267923|NCT00634010|18175095|P1|Overall Study|Non-Compliant|1
5267924|NCT00634010|18175094|P2|Overall Study|Disease Progression|1
5267925|NCT00634010|18175095|P1|Overall Study|Disease Progression|1
5267926|NCT00634010|18175094|P2|Overall Study|Physician Decision|1
5267927|NCT00634010|18175095|P1|Overall Study|Physician Decision|1
5267928|NCT00634010|18175094|P2|Overall Study|Withdrawal by Subject|6
5267929|NCT00634010|18175095|P1|Overall Study|Withdrawal by Subject|5
5267930|NCT00634010|18175094|P2|Overall Study|Adverse Event|5
5267931|NCT00634010|18175095|P1|Overall Study|Adverse Event|2
5267932|NCT00633984|18175103|P2|Overall Study|Hospitalized|0
5267933|NCT00633984|18175104|P1|Overall Study|Hospitalized|1
5267934|NCT00633984|18175103|P2|Overall Study|Withdrawal by Subject|7
5267935|NCT00633984|18175104|P1|Overall Study|Withdrawal by Subject|8
5267936|NCT00633984|18175103|P2|Overall Study|Lost to Follow-up|6
5267937|NCT00633984|18175104|P1|Overall Study|Lost to Follow-up|0
5267938|NCT00633945|18175112|P1|Overall Study|Physician Decision|2
5267939|NCT00633932|18175128|P3|Overall Study|Moved Away|0
5267940|NCT00633932|18175129|P2|Overall Study|Moved Away|0
5267941|NCT00633932|18175130|P1|Overall Study|Moved Away|1
5267942|NCT00633932|18175128|P3|Overall Study|Doctor's judgement|0
5267943|NCT00633932|18175129|P2|Overall Study|Doctor's judgement|0
5267944|NCT00633932|18175130|P1|Overall Study|Doctor's judgement|1
5267945|NCT00633932|18175128|P3|Overall Study|Physician Decision|1
5267946|NCT00633932|18175129|P2|Overall Study|Physician Decision|0
5267947|NCT00633932|18175130|P1|Overall Study|Physician Decision|0
5267948|NCT00633932|18175128|P3|Overall Study|Protocol Violation|3
5267949|NCT00633932|18175129|P2|Overall Study|Protocol Violation|2
5267950|NCT00633932|18175130|P1|Overall Study|Protocol Violation|5
5267951|NCT00633932|18175128|P3|Overall Study|Lost to Follow-up|2
5267952|NCT00633932|18175129|P2|Overall Study|Lost to Follow-up|0
5267953|NCT00633932|18175130|P1|Overall Study|Lost to Follow-up|1
5267954|NCT00633932|18175128|P3|Overall Study|Withdrawal by Subject|1
5267955|NCT00633932|18175129|P2|Overall Study|Withdrawal by Subject|9
5267956|NCT00633932|18175130|P1|Overall Study|Withdrawal by Subject|3
5267957|NCT00633932|18175128|P3|Overall Study|Adverse Event|4
5267958|NCT00633932|18175129|P2|Overall Study|Adverse Event|3
5267959|NCT00633932|18175130|P1|Overall Study|Adverse Event|1
5267960|NCT00633893|18175161|P3|Overall Study|Other|31
5267961|NCT00633893|18175162|P2|Overall Study|Other|33
5267962|NCT00633893|18175163|P1|Overall Study|Other|28
5267963|NCT00633893|18175161|P3|Overall Study|Not meet/no longer meets criteria|4
5267964|NCT00633893|18175162|P2|Overall Study|Not meet/no longer meets criteria|6
5267965|NCT00633893|18175163|P1|Overall Study|Not meet/no longer meets criteria|4
5267966|NCT00633893|18175161|P3|Overall Study|Pregnancy|1
5267967|NCT00633893|18175162|P2|Overall Study|Pregnancy|1
5267968|NCT00633893|18175163|P1|Overall Study|Pregnancy|2
5267969|NCT00633893|18175161|P3|Overall Study|Poor/non-compliance|3
5267970|NCT00633893|18175162|P2|Overall Study|Poor/non-compliance|12
5267971|NCT00633893|18175163|P1|Overall Study|Poor/non-compliance|5
5267972|NCT00633893|18175161|P3|Overall Study|Lost to Follow-up|8
5267973|NCT00633893|18175162|P2|Overall Study|Lost to Follow-up|4
5267974|NCT00633893|18175163|P1|Overall Study|Lost to Follow-up|2
5267975|NCT00633893|18175161|P3|Overall Study|Withdrawal by Subject|6
5267976|NCT00633893|18175162|P2|Overall Study|Withdrawal by Subject|12
5267977|NCT00633893|18175163|P1|Overall Study|Withdrawal by Subject|7
5267978|NCT00633893|18175161|P3|Overall Study|Adverse Event|126
5267979|NCT00633893|18175162|P2|Overall Study|Adverse Event|58
5267980|NCT00633893|18175163|P1|Overall Study|Adverse Event|65
5267981|NCT00633893|18175161|P3|Overall Study|Death|9
5267982|NCT00633893|18175162|P2|Overall Study|Death|3
5267983|NCT00633893|18175163|P1|Overall Study|Death|1
5267984|NCT00633880|18175237|P3|Open Label Titration|Withdrawal by Subject|0
5267985|NCT00633880|18175238|P2|Open Label Titration|Withdrawal by Subject|0
5267986|NCT00633880|18175239|P1|Open Label Titration|Withdrawal by Subject|4
5267987|NCT00633880|18175237|P3|Open Label Titration|Physician Decision|0
5267988|NCT00633880|18175238|P2|Open Label Titration|Physician Decision|0
5267989|NCT00633880|18175239|P1|Open Label Titration|Physician Decision|1
5267990|NCT00633880|18175237|P3|Open Label Titration|Protocol Violation|0
5267991|NCT00633880|18175238|P2|Open Label Titration|Protocol Violation|0
5267992|NCT00633880|18175239|P1|Open Label Titration|Protocol Violation|6
5267993|NCT00633880|18175237|P3|Open Label Titration|Treatment Failure|0
5267994|NCT00633880|18175238|P2|Open Label Titration|Treatment Failure|0
5267995|NCT00633880|18175239|P1|Open Label Titration|Treatment Failure|55
5267996|NCT00633880|18175237|P3|Open Label Titration|Adverse Event|0
5267997|NCT00633880|18175238|P2|Open Label Titration|Adverse Event|0
5267998|NCT00633880|18175239|P1|Open Label Titration|Adverse Event|13
5267999|NCT00633880|18175237|P3|Open Label Titration|Lack of Efficacy|0
5268000|NCT00633880|18175238|P2|Open Label Titration|Lack of Efficacy|0
5268001|NCT00633880|18175239|P1|Open Label Titration|Lack of Efficacy|1
5268002|NCT00633750|18175275|P1|Overall Study|Withdrawal by Subject|3
5268003|NCT00633750|18175275|P1|Overall Study|Adverse Event|2
5268004|NCT00633594|18175284|P3|Overall Study|Disease Progression|1
5268005|NCT00633594|18175285|P2|Overall Study|Disease Progression|0
5268006|NCT00633594|18175286|P1|Overall Study|Disease Progression|0
5268007|NCT00633594|18175284|P3|Overall Study|Death|2
5268008|NCT00633594|18175285|P2|Overall Study|Death|1
5268009|NCT00633594|18175286|P1|Overall Study|Death|0
5268010|NCT00633594|18175284|P3|Overall Study|Adverse Event|7
5268011|NCT00633594|18175285|P2|Overall Study|Adverse Event|4
5268012|NCT00633594|18175286|P1|Overall Study|Adverse Event|0
5268013|NCT00633477|18175315|P2|Overall Study|Randomized but not treated|0
5268014|NCT00633477|18175316|P1|Overall Study|Randomized but not treated|1
5268015|NCT00633477|18175315|P2|Overall Study|Death|0
5268016|NCT00633477|18175316|P1|Overall Study|Death|1
5268017|NCT00633464|18175332|P2|Overall Study|Never Treated (Randomized in error)|1
5268018|NCT00633464|18175333|P1|Overall Study|Never Treated (Randomized in error)|0
5268019|NCT00633464|18175332|P2|Overall Study|Never Treated (Not met study criteria)|1
5268020|NCT00633464|18175333|P1|Overall Study|Never Treated (Not met study criteria)|0
5268021|NCT00633360|18175368|P2|Overall Study|Protocol Violation|1
5268022|NCT00633360|18175369|P1|Overall Study|Protocol Violation|0
5268023|NCT00633360|18175368|P2|Overall Study|Adverse Event|1
5268024|NCT00633360|18175369|P1|Overall Study|Adverse Event|3
5268025|NCT00633360|18175368|P2|Overall Study|Lost to Follow-up|1
5268026|NCT00633360|18175369|P1|Overall Study|Lost to Follow-up|1
5268027|NCT00633243|18175392|P2|Overall Study|Couldn't tolerate side-effects|1
5268028|NCT00633243|18175393|P1|Overall Study|Couldn't tolerate side-effects|1
5268029|NCT00633243|18175392|P2|Overall Study|Mental Health--Depression|1
5268030|NCT00633243|18175393|P1|Overall Study|Mental Health--Depression|0
5268031|NCT00633243|18175392|P2|Overall Study|Not comfortable with self-injecting|1
5268032|NCT00633243|18175393|P1|Overall Study|Not comfortable with self-injecting|0
5268033|NCT00633243|18175392|P2|Overall Study|Homeless--no refrigeration for meds|1
5268034|NCT00633243|18175393|P1|Overall Study|Homeless--no refrigeration for meds|0
5268035|NCT00633243|18175392|P2|Overall Study|incarceration|2
5268036|NCT00633243|18175393|P1|Overall Study|incarceration|0
5268037|NCT00633243|18175392|P2|Overall Study|Withdrawal by Subject|1
5268038|NCT00633243|18175393|P1|Overall Study|Withdrawal by Subject|0
5268039|NCT00633217|18175401|P2|Overall Study|Withdrew Consent|3
5268040|NCT00633217|18175402|P1|Overall Study|Withdrew Consent|3
5268041|NCT00633217|18175401|P2|Overall Study|Investigator Discretion|0
5268042|NCT00633217|18175402|P1|Overall Study|Investigator Discretion|2
5268043|NCT00633217|18175401|P2|Overall Study|Lost to Follow-up|2
5268044|NCT00633217|18175402|P1|Overall Study|Lost to Follow-up|2
5268045|NCT00633217|18175401|P2|Overall Study|Protocol Violation|7
5268046|NCT00633217|18175402|P1|Overall Study|Protocol Violation|3
5268047|NCT00633217|18175401|P2|Overall Study|Lack of Efficacy|2
5268048|NCT00633217|18175402|P1|Overall Study|Lack of Efficacy|0
5268049|NCT00633217|18175401|P2|Overall Study|Adverse Event|9
5268050|NCT00633217|18175402|P1|Overall Study|Adverse Event|5
5268051|NCT00633152|18175414|P2|Overall Study|Miscellaneous Other|2
5268052|NCT00633152|18175415|P1|Overall Study|Miscellaneous Other|3
5268053|NCT00633152|18175414|P2|Overall Study|Lost to Follow-up|1
5268054|NCT00633152|18175415|P1|Overall Study|Lost to Follow-up|4
5268055|NCT00633152|18175414|P2|Overall Study|Withdrawal by Subject|1
5268056|NCT00633152|18175415|P1|Overall Study|Withdrawal by Subject|1
5268057|NCT00633152|18175414|P2|Overall Study|Randomized, did not receive study drug|2
5268058|NCT00633152|18175415|P1|Overall Study|Randomized, did not receive study drug|5
5268059|NCT00633152|18175414|P2|Overall Study|Adverse Event|0
5268060|NCT00633152|18175415|P1|Overall Study|Adverse Event|1
5268061|NCT00633139|18175426|P3|Overall Study|Withdrawal by Subject|0
5268062|NCT00633139|18175427|P2|Overall Study|Withdrawal by Subject|1
5268063|NCT00633139|18175428|P1|Overall Study|Withdrawal by Subject|0
5268064|NCT00633139|18175426|P3|Overall Study|Non compliance|1
5268065|NCT00633139|18175427|P2|Overall Study|Non compliance|0
5268066|NCT00633139|18175428|P1|Overall Study|Non compliance|0
5268067|NCT00633126|18175442|P1|Overall Study|Did not receive full dose|1
5268068|NCT00633074|18175456|P2|Overall Study|Adverse Event|0
5268069|NCT00633074|18175457|P1|Overall Study|Adverse Event|1
5268070|NCT00633061|18175487|P2|Overall Study|Study closed|0
5268071|NCT00633061|18175488|P1|Overall Study|Study closed|86
5268072|NCT00633022|18175499|P3|Overall Study|Physician Decision|0
5268073|NCT00633022|18175500|P2|Overall Study|Physician Decision|1
5268074|NCT00633022|18175501|P1|Overall Study|Physician Decision|0
5268075|NCT00633022|18175499|P3|Overall Study|Adverse Event|5
5268076|NCT00633022|18175500|P2|Overall Study|Adverse Event|0
5268077|NCT00633022|18175501|P1|Overall Study|Adverse Event|1
5268078|NCT00632931|18175563|P3|Part 2|Withdrawal by Subject|3
5268079|NCT00632931|18175564|P2|Part 2|Withdrawal by Subject|0
5268080|NCT00632931|18175565|P1|Part 2|Withdrawal by Subject|0
5268081|NCT00632931|18175563|P3|Part 2|Lack of Efficacy|17
5268082|NCT00632931|18175564|P2|Part 2|Lack of Efficacy|0
5268083|NCT00632931|18175565|P1|Part 2|Lack of Efficacy|0
5268084|NCT00632931|18175563|P3|Part 2|Death|1
5268085|NCT00632931|18175564|P2|Part 2|Death|0
5268086|NCT00632931|18175565|P1|Part 2|Death|0
5268087|NCT00632931|18175563|P3|Part 2|Adverse Event|3
5268088|NCT00632931|18175564|P2|Part 2|Adverse Event|0
5268089|NCT00632931|18175565|P1|Part 2|Adverse Event|0
5268090|NCT00632931|18175563|P3|Part 1, Period 1|Withdrawal by Subject|0
5268091|NCT00632931|18175564|P2|Part 1, Period 1|Withdrawal by Subject|0
5268092|NCT00632931|18175565|P1|Part 1, Period 1|Withdrawal by Subject|1
5268093|NCT00632931|18175563|P3|Part 1, Period 1|Protocol Violation|0
5268094|NCT00632931|18175564|P2|Part 1, Period 1|Protocol Violation|0
5268095|NCT00632931|18175565|P1|Part 1, Period 1|Protocol Violation|1
5268096|NCT00632827|18175584|P1|Overall Study|Lost to Follow-up|1
5268097|NCT00632827|18175584|P1|Overall Study|Adverse Event|5
5268098|NCT00632827|18175584|P1|Overall Study|Death|2
5268099|NCT00632827|18175584|P1|Overall Study|Excluded after GVD (Not evaluable)|2
5268100|NCT00632749|18175642|P14|Overall Study|Reason other than those specified above|2
5268101|NCT00632749|18175643|P13|Overall Study|Reason other than those specified above|0
5268102|NCT00632749|18175644|P12|Overall Study|Reason other than those specified above|1
5268103|NCT00632749|18175645|P11|Overall Study|Reason other than those specified above|2
5268104|NCT00632749|18175646|P10|Overall Study|Reason other than those specified above|0
5268105|NCT00632749|18175647|P9|Overall Study|Reason other than those specified above|0
5268106|NCT00632749|18175648|P8|Overall Study|Reason other than those specified above|0
5268107|NCT00632749|18175649|P7|Overall Study|Reason other than those specified above|1
5268108|NCT00632749|18175650|P6|Overall Study|Reason other than those specified above|0
5268109|NCT00632749|18175651|P5|Overall Study|Reason other than those specified above|1
5268110|NCT00632749|18175652|P4|Overall Study|Reason other than those specified above|0
5268111|NCT00632749|18175653|P3|Overall Study|Reason other than those specified above|0
5268112|NCT00632749|18175654|P2|Overall Study|Reason other than those specified above|2
5268113|NCT00632749|18175655|P1|Overall Study|Reason other than those specified above|0
5268114|NCT00632749|18175642|P14|Overall Study|Refuse to continue medication|0
5268115|NCT00632749|18175643|P13|Overall Study|Refuse to continue medication|0
5268116|NCT00632749|18175644|P12|Overall Study|Refuse to continue medication|0
5268117|NCT00632749|18175645|P11|Overall Study|Refuse to continue medication|0
5268118|NCT00632749|18175646|P10|Overall Study|Refuse to continue medication|1
5268119|NCT00632749|18175647|P9|Overall Study|Refuse to continue medication|0
5268120|NCT00632749|18175648|P8|Overall Study|Refuse to continue medication|0
5268121|NCT00632749|18175649|P7|Overall Study|Refuse to continue medication|0
5268122|NCT00632749|18175650|P6|Overall Study|Refuse to continue medication|0
5268123|NCT00632749|18175651|P5|Overall Study|Refuse to continue medication|0
5268124|NCT00632749|18175652|P4|Overall Study|Refuse to continue medication|1
5268125|NCT00632749|18175653|P3|Overall Study|Refuse to continue medication|0
5268126|NCT00632749|18175654|P2|Overall Study|Refuse to continue medication|0
5268127|NCT00632749|18175655|P1|Overall Study|Refuse to continue medication|0
5268128|NCT00632749|18175642|P14|Overall Study|Other Adverse event|0
5268129|NCT00632749|18175643|P13|Overall Study|Other Adverse event|1
5268130|NCT00632749|18175644|P12|Overall Study|Other Adverse event|0
5268131|NCT00632749|18175645|P11|Overall Study|Other Adverse event|1
5268132|NCT00632749|18175646|P10|Overall Study|Other Adverse event|0
5268133|NCT00632749|18175647|P9|Overall Study|Other Adverse event|2
5268134|NCT00632749|18175648|P8|Overall Study|Other Adverse event|2
5268135|NCT00632749|18175649|P7|Overall Study|Other Adverse event|1
5268136|NCT00632749|18175650|P6|Overall Study|Other Adverse event|4
5268137|NCT00632749|18175651|P5|Overall Study|Other Adverse event|2
5268138|NCT00632749|18175652|P4|Overall Study|Other Adverse event|1
5268139|NCT00632749|18175653|P3|Overall Study|Other Adverse event|1
5268140|NCT00632749|18175654|P2|Overall Study|Other Adverse event|1
5268141|NCT00632749|18175655|P1|Overall Study|Other Adverse event|1
5268142|NCT00632749|18175642|P14|Overall Study|Progressive disease|4
5268143|NCT00632749|18175643|P13|Overall Study|Progressive disease|2
5268144|NCT00632749|18175644|P12|Overall Study|Progressive disease|3
5268145|NCT00632749|18175645|P11|Overall Study|Progressive disease|4
5268146|NCT00632749|18175646|P10|Overall Study|Progressive disease|2
5268147|NCT00632749|18175647|P9|Overall Study|Progressive disease|3
5268148|NCT00632749|18175648|P8|Overall Study|Progressive disease|2
5268149|NCT00632749|18175649|P7|Overall Study|Progressive disease|3
5268150|NCT00632749|18175650|P6|Overall Study|Progressive disease|4
5268151|NCT00632749|18175651|P5|Overall Study|Progressive disease|4
5268152|NCT00632749|18175652|P4|Overall Study|Progressive disease|2
5268153|NCT00632749|18175653|P3|Overall Study|Progressive disease|2
5268154|NCT00632749|18175654|P2|Overall Study|Progressive disease|2
5268155|NCT00632749|18175655|P1|Overall Study|Progressive disease|3
5268156|NCT00632736|18175949|P1|Overall Study|Other|16
5268157|NCT00632736|18175949|P1|Overall Study|Non-compliance|10
5268158|NCT00632736|18175949|P1|Overall Study|Sponsor terminated study|5
5268159|NCT00632736|18175949|P1|Overall Study|Lack of Efficacy|5
5268160|NCT00632736|18175949|P1|Overall Study|Withdrawal by Subject|99
5268161|NCT00632736|18175949|P1|Overall Study|Protocol Violation|14
5268162|NCT00632736|18175949|P1|Overall Study|Lost to Follow-up|15
5268163|NCT00632736|18175949|P1|Overall Study|Adverse Event|104
5268164|NCT00632541|18175984|P1|Overall Study|Adverse Event|7
5268165|NCT00632502|18175993|P2|Overall Study|Randomized not treated|0
5268166|NCT00632502|18175994|P1|Overall Study|Randomized not treated|3
5268167|NCT00632502|18175993|P2|Overall Study|Adverse Event|1
5268168|NCT00632502|18175994|P1|Overall Study|Adverse Event|0
5268169|NCT00632463|18176038|P3|Overall Study|Adverse Event|0
5268170|NCT00632463|18176039|P2|Overall Study|Adverse Event|1
5268171|NCT00632463|18176040|P1|Overall Study|Adverse Event|0
5268172|NCT00632424|18176057|P1|Overall Study|Study Drug Toxicity|1
5268173|NCT00632424|18176057|P1|Overall Study|Disease Progression|17
5268174|NCT00632359|18176088|P1|Overall Study|Withdrawal by Subject|2
5268175|NCT00632229|18176101|P2|Overall Study|Undisclosed reasons within the first wee|1
5268176|NCT00632229|18176102|P1|Overall Study|Undisclosed reasons within the first wee|0
5268177|NCT00632229|18176101|P2|Overall Study|Lack of Efficacy|2
5268178|NCT00632229|18176102|P1|Overall Study|Lack of Efficacy|0
5268179|NCT00632229|18176101|P2|Overall Study|Lost to Follow-up|3
5268180|NCT00632229|18176102|P1|Overall Study|Lost to Follow-up|0
5268181|NCT00632229|18176101|P2|Overall Study|Adverse Event|0
5268182|NCT00632229|18176102|P1|Overall Study|Adverse Event|6
5268183|NCT00632203|18176112|P2|Overall Study|Did not start study treatment|0
5268184|NCT00632203|18176113|P1|Overall Study|Did not start study treatment|1
5268185|NCT00632125|18176131|P1|Overall Study|Moved to other dialysis unit, etc.|102
5268186|NCT00632125|18176131|P1|Overall Study|Development of uncontrolled hypertension|5
5268187|NCT00632125|18176131|P1|Overall Study|Non-compliance|8
5268188|NCT00632125|18176131|P1|Overall Study|Need for systemic immunosuppressive medi|8
5268189|NCT00632125|18176131|P1|Overall Study|Renal transplantation|17
5268190|NCT00632125|18176131|P1|Overall Study|Adverse Event|36
5268191|NCT00632125|18176131|P1|Overall Study|Withdrawal by Subject|44
5268192|NCT00632125|18176131|P1|Overall Study|Death|82
5268193|NCT00632099|18176137|P2|Overall Study|Lost to Follow-up|3
5268194|NCT00632099|18176138|P1|Overall Study|Lost to Follow-up|3
5268195|NCT00632021|18176146|P2|Overall Study|Withdrawal/death|7
5268196|NCT00632021|18176147|P1|Overall Study|Withdrawal/death|4
5268197|NCT00631969|18176157|P2|Overall Study|No Drug Exposure|2
5268198|NCT00631969|18176158|P1|Overall Study|No Drug Exposure|2
5268199|NCT00631969|18176157|P2|Overall Study|Noncompliant With Study Medication|1
5268200|NCT00631969|18176158|P1|Overall Study|Noncompliant With Study Medication|0
5268201|NCT00631969|18176157|P2|Overall Study|Consent Withdrawn|7
5268202|NCT00631969|18176158|P1|Overall Study|Consent Withdrawn|5
5268203|NCT00631969|18176157|P2|Overall Study|Protocol Violation|1
5268204|NCT00631969|18176158|P1|Overall Study|Protocol Violation|1
5268205|NCT00631969|18176157|P2|Overall Study|Lost to Follow-up|1
5268206|NCT00631969|18176158|P1|Overall Study|Lost to Follow-up|2
5268207|NCT00631969|18176157|P2|Overall Study|Lack of Efficacy|8
5268208|NCT00631969|18176158|P1|Overall Study|Lack of Efficacy|2
5268209|NCT00631969|18176157|P2|Overall Study|Adverse Event|1
5268210|NCT00631969|18176158|P1|Overall Study|Adverse Event|3
5268211|NCT00631917|18176204|P2|Overall Study|Death|0
5268212|NCT00631917|18176205|P1|Overall Study|Death|1
5268213|NCT00631917|18176204|P2|Overall Study|Administrative problems|0
5268214|NCT00631917|18176205|P1|Overall Study|Administrative problems|2
5268215|NCT00631917|18176204|P2|Overall Study|Lost to Follow-up|7
5268216|NCT00631917|18176205|P1|Overall Study|Lost to Follow-up|7
5268217|NCT00631917|18176204|P2|Overall Study|Subject withdrew consent|33
5268218|NCT00631917|18176205|P1|Overall Study|Subject withdrew consent|25
5268219|NCT00631917|18176204|P2|Overall Study|Protocol deviation|5
5268220|NCT00631917|18176205|P1|Overall Study|Protocol deviation|6
5268221|NCT00631917|18176204|P2|Overall Study|No longer required study drug|1
5268222|NCT00631917|18176205|P1|Overall Study|No longer required study drug|0
5268223|NCT00631917|18176204|P2|Overall Study|Unsatisfactory therapeutic effect|14
5268224|NCT00631917|18176205|P1|Overall Study|Unsatisfactory therapeutic effect|8
5268225|NCT00631917|18176204|P2|Overall Study|Abnormal test procedure result(s)|2
5268226|NCT00631917|18176205|P1|Overall Study|Abnormal test procedure result(s)|3
5268227|NCT00631917|18176204|P2|Overall Study|Abnormal laboratory value(s)|1
5268228|NCT00631917|18176205|P1|Overall Study|Abnormal laboratory value(s)|2
5268229|NCT00631917|18176204|P2|Overall Study|Adverse Event|45
5268230|NCT00631917|18176205|P1|Overall Study|Adverse Event|34
5268231|NCT00631696|18176232|P2|Overall Study|Adverse Event|0
5268232|NCT00631696|18176233|P1|Overall Study|Adverse Event|5
5268233|NCT00631696|18176232|P2|Overall Study|Study terminated by sponsor|3
5268234|NCT00631696|18176233|P1|Overall Study|Study terminated by sponsor|3
5268235|NCT00631696|18176232|P2|Overall Study|Protocol Violation|9
5268236|NCT00631696|18176233|P1|Overall Study|Protocol Violation|9
5268237|NCT00631696|18176232|P2|Overall Study|Other|8
5268238|NCT00631696|18176233|P1|Overall Study|Other|8
5268239|NCT00631696|18176232|P2|Overall Study|Withdrawal by Subject|9
5268240|NCT00631696|18176233|P1|Overall Study|Withdrawal by Subject|2
5268241|NCT00631696|18176232|P2|Overall Study|Lost to Follow-up|10
5268242|NCT00631696|18176233|P1|Overall Study|Lost to Follow-up|7
5268243|NCT00631696|18176232|P2|Overall Study|Follow up after database release date|0
5268244|NCT00631696|18176233|P1|Overall Study|Follow up after database release date|1
5268245|NCT00631696|18176232|P2|Overall Study|Discontinued after database release date|0
5268246|NCT00631696|18176233|P1|Overall Study|Discontinued after database release date|1
5268247|NCT00631696|18176232|P2|Overall Study|Entered, not randomized to treatment|1
5268248|NCT00631696|18176233|P1|Overall Study|Entered, not randomized to treatment|1
5268249|NCT00631657|18176276|P3|7-Day Discontinuation Period|Other|0
5268250|NCT00631657|18176277|P2|7-Day Discontinuation Period|Other|0
5268251|NCT00631657|18176278|P1|7-Day Discontinuation Period|Other|1
5268252|NCT00631657|18176276|P3|7-Day Discontinuation Period|Not Treated|1
5268253|NCT00631657|18176277|P2|7-Day Discontinuation Period|Not Treated|1
5268254|NCT00631657|18176278|P1|7-Day Discontinuation Period|Not Treated|1
5268255|NCT00631657|18176276|P3|6-Month Treatment Period|Not Treated|1
5268256|NCT00631657|18176277|P2|6-Month Treatment Period|Not Treated|0
5268257|NCT00631657|18176278|P1|6-Month Treatment Period|Not Treated|2
5268258|NCT00631657|18176276|P3|6-Month Treatment Period|Other|4
5268259|NCT00631657|18176277|P2|6-Month Treatment Period|Other|0
5268260|NCT00631657|18176278|P1|6-Month Treatment Period|Other|16
5268261|NCT00631657|18176276|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
5268262|NCT00631657|18176277|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
5268263|NCT00631657|18176278|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
5268264|NCT00631657|18176276|P3|6-Month Treatment Period|Lost to Follow-up|2
5268265|NCT00631657|18176277|P2|6-Month Treatment Period|Lost to Follow-up|0
5268266|NCT00631657|18176278|P1|6-Month Treatment Period|Lost to Follow-up|7
5268267|NCT00631657|18176276|P3|6-Month Treatment Period|Lack of Efficacy|25
5268268|NCT00631657|18176277|P2|6-Month Treatment Period|Lack of Efficacy|0
5268269|NCT00631657|18176278|P1|6-Month Treatment Period|Lack of Efficacy|34
5268270|NCT00631657|18176276|P3|6-Month Treatment Period|Withdrawal by Subject|5
5268271|NCT00631657|18176277|P2|6-Month Treatment Period|Withdrawal by Subject|0
5268272|NCT00631657|18176278|P1|6-Month Treatment Period|Withdrawal by Subject|14
5268273|NCT00631657|18176276|P3|6-Month Treatment Period|Adverse Event|7
5268274|NCT00631657|18176277|P2|6-Month Treatment Period|Adverse Event|0
5268275|NCT00631657|18176278|P1|6-Month Treatment Period|Adverse Event|47
5268276|NCT00631540|18176327|P1|Overall Study|Core Lab Data Unavailable|3
5268277|NCT00631540|18176327|P1|Overall Study|Lost to Follow-up|2
5268278|NCT00631540|18176327|P1|Overall Study|Death|4
5268279|NCT00631540|18176327|P1|Overall Study|Withdrawal by Subject|5
5268280|NCT00631488|18176339|P3|Overall Study|Protocol Violation|1
5268281|NCT00631488|18176340|P2|Overall Study|Protocol Violation|0
5268282|NCT00631488|18176341|P1|Overall Study|Protocol Violation|0
5268283|NCT00631488|18176339|P3|Overall Study|Physician Decision|1
5268284|NCT00631488|18176340|P2|Overall Study|Physician Decision|0
5268285|NCT00631488|18176341|P1|Overall Study|Physician Decision|1
5268286|NCT00631488|18176339|P3|Overall Study|Lost to Follow-up|0
5268287|NCT00631488|18176340|P2|Overall Study|Lost to Follow-up|2
5268288|NCT00631488|18176341|P1|Overall Study|Lost to Follow-up|2
5268289|NCT00631488|18176339|P3|Overall Study|Adverse Event|0
5268290|NCT00631488|18176340|P2|Overall Study|Adverse Event|0
5268291|NCT00631488|18176341|P1|Overall Study|Adverse Event|1
5268292|NCT00631475|18176361|P1|Overall Study|Preparation for lung transplant|8
5268293|NCT00631475|18176361|P1|Overall Study|Withdrew consent|5
5268294|NCT00631475|18176361|P1|Overall Study|Adverse Event|14
5268295|NCT00631475|18176361|P1|Overall Study|Death|18
5268296|NCT00631410|18176382|P2|Overall Study|Surgery|0
5268297|NCT00631410|18176383|P1|Overall Study|Surgery|1
5268298|NCT00631410|18176382|P2|Overall Study|Objective Progression or Relapse|3
5268299|NCT00631410|18176383|P1|Overall Study|Objective Progression or Relapse|4
5268300|NCT00631410|18176382|P2|Overall Study|Adverse Event|3
5268301|NCT00631410|18176383|P1|Overall Study|Adverse Event|1
5268302|NCT00631371|18176402|P2|Overall Study|Death|239
5268303|NCT00631371|18176403|P1|Overall Study|Death|263
5268304|NCT00631371|18176402|P2|Overall Study|Discontinuation of study by Sponsor|76
5268305|NCT00631371|18176403|P1|Overall Study|Discontinuation of study by Sponsor|70
5268306|NCT00631371|18176402|P2|Overall Study|subject request|45
5268307|NCT00631371|18176403|P1|Overall Study|subject request|38
5268308|NCT00631371|18176402|P2|Overall Study|Other reason|12
5268309|NCT00631371|18176403|P1|Overall Study|Other reason|5
5268310|NCT00631371|18176402|P2|Overall Study|Lost to Follow-up|19
5268311|NCT00631371|18176403|P1|Overall Study|Lost to Follow-up|24
5268312|NCT00631189|18176446|P4|Treatment Phase|patient did not take pravastatin|0
5268313|NCT00631189|18176447|P3|Treatment Phase|patient did not take pravastatin|1
5268314|NCT00631189|18176448|P2|Treatment Phase|patient did not take pravastatin|0
5268315|NCT00631189|18176449|P1|Treatment Phase|patient did not take pravastatin|0
5268316|NCT00631189|18176446|P4|Treatment Phase|Pregnancy|0
5268317|NCT00631189|18176447|P3|Treatment Phase|Pregnancy|1
5268318|NCT00631189|18176448|P2|Treatment Phase|Pregnancy|0
5268319|NCT00631189|18176449|P1|Treatment Phase|Pregnancy|0
5268320|NCT00631189|18176446|P4|Treatment Phase|Lost to Follow-up|0
5268321|NCT00631189|18176447|P3|Treatment Phase|Lost to Follow-up|0
5268322|NCT00631189|18176448|P2|Treatment Phase|Lost to Follow-up|1
5268323|NCT00631189|18176449|P1|Treatment Phase|Lost to Follow-up|0
5268324|NCT00631189|18176446|P4|Treatment Phase|Adverse Event|4
5268325|NCT00631189|18176447|P3|Treatment Phase|Adverse Event|2
5268326|NCT00631189|18176448|P2|Treatment Phase|Adverse Event|3
5268327|NCT00631189|18176449|P1|Treatment Phase|Adverse Event|0
5268328|NCT00631189|18176446|P4|Treatment Phase|Protocol Violation|2
5268329|NCT00631189|18176447|P3|Treatment Phase|Protocol Violation|6
5268330|NCT00631189|18176448|P2|Treatment Phase|Protocol Violation|1
5268331|NCT00631189|18176449|P1|Treatment Phase|Protocol Violation|0
5268332|NCT00631189|18176446|P4|Treatment Phase|Withdrawal by Subject|1
5268333|NCT00631189|18176447|P3|Treatment Phase|Withdrawal by Subject|1
5268334|NCT00631189|18176448|P2|Treatment Phase|Withdrawal by Subject|2
5268335|NCT00631189|18176449|P1|Treatment Phase|Withdrawal by Subject|0
5268336|NCT00631189|18176446|P4|Initial Phase|Withdrawal by Subject|0
5268337|NCT00631189|18176447|P3|Initial Phase|Withdrawal by Subject|0
5268338|NCT00631189|18176448|P2|Initial Phase|Withdrawal by Subject|0
5268339|NCT00631189|18176449|P1|Initial Phase|Withdrawal by Subject|4
5268340|NCT00631189|18176446|P4|Initial Phase|Protocol Violation|0
5268341|NCT00631189|18176447|P3|Initial Phase|Protocol Violation|0
5268342|NCT00631189|18176448|P2|Initial Phase|Protocol Violation|0
5268343|NCT00631189|18176449|P1|Initial Phase|Protocol Violation|347
5268344|NCT00631137|18176493|P2|Overall Study|Withdrawal by Subject|0
5268345|NCT00631137|18176494|P1|Overall Study|Withdrawal by Subject|1
5268346|NCT00631020|18176512|P1|Overall Study|Incarcerated|1
5268347|NCT00631020|18176512|P1|Overall Study|Lost to Follow-up|7
5268348|NCT00631007|18176527|P6|Overall Study|Other|0
5268349|NCT00631007|18176528|P5|Overall Study|Other|1
5268350|NCT00631007|18176529|P4|Overall Study|Other|0
5268351|NCT00631007|18176530|P3|Overall Study|Other|0
5268352|NCT00631007|18176531|P2|Overall Study|Other|1
5268353|NCT00631007|18176532|P1|Overall Study|Other|2
5268354|NCT00631007|18176527|P6|Overall Study|Withdrawal by Subject|3
5268355|NCT00631007|18176528|P5|Overall Study|Withdrawal by Subject|1
5268356|NCT00631007|18176529|P4|Overall Study|Withdrawal by Subject|2
5268357|NCT00631007|18176530|P3|Overall Study|Withdrawal by Subject|2
5268358|NCT00631007|18176531|P2|Overall Study|Withdrawal by Subject|5
5268359|NCT00631007|18176532|P1|Overall Study|Withdrawal by Subject|4
5268360|NCT00631007|18176527|P6|Overall Study|Persistent Hyperglycemia|5
5268361|NCT00631007|18176528|P5|Overall Study|Persistent Hyperglycemia|2
5268362|NCT00631007|18176529|P4|Overall Study|Persistent Hyperglycemia|1
5268363|NCT00631007|18176530|P3|Overall Study|Persistent Hyperglycemia|5
5268364|NCT00631007|18176531|P2|Overall Study|Persistent Hyperglycemia|2
5268365|NCT00631007|18176532|P1|Overall Study|Persistent Hyperglycemia|2
5268366|NCT00631007|18176527|P6|Overall Study|Physician Decision|2
5268367|NCT00631007|18176528|P5|Overall Study|Physician Decision|0
5268368|NCT00631007|18176529|P4|Overall Study|Physician Decision|0
5268369|NCT00631007|18176530|P3|Overall Study|Physician Decision|1
5268370|NCT00631007|18176531|P2|Overall Study|Physician Decision|0
5268371|NCT00631007|18176532|P1|Overall Study|Physician Decision|1
5268372|NCT00631007|18176527|P6|Overall Study|Lost to Follow-up|3
5268373|NCT00631007|18176528|P5|Overall Study|Lost to Follow-up|5
5268374|NCT00631007|18176529|P4|Overall Study|Lost to Follow-up|4
5268375|NCT00631007|18176530|P3|Overall Study|Lost to Follow-up|2
5268376|NCT00631007|18176531|P2|Overall Study|Lost to Follow-up|1
5268377|NCT00631007|18176532|P1|Overall Study|Lost to Follow-up|2
5268378|NCT00631007|18176527|P6|Overall Study|Adverse Event|2
5268379|NCT00631007|18176528|P5|Overall Study|Adverse Event|3
5268380|NCT00631007|18176529|P4|Overall Study|Adverse Event|2
5268381|NCT00631007|18176530|P3|Overall Study|Adverse Event|0
5268382|NCT00631007|18176531|P2|Overall Study|Adverse Event|2
5268383|NCT00631007|18176532|P1|Overall Study|Adverse Event|0
5268384|NCT00630994|18176552|P1|Overall Study|Other|1
5268385|NCT00630994|18176552|P1|Overall Study|Lack of Efficacy|1
5268386|NCT00630994|18176552|P1|Overall Study|Disease Progression|1
5268387|NCT00630994|18176552|P1|Overall Study|Adverse Event|1
5268388|NCT00630916|18176582|P1|Overall Study|Lack of Efficacy|3
5268389|NCT00630916|18176582|P1|Overall Study|Physician Decision|47
5268390|NCT00630916|18176582|P1|Overall Study|Protocol Violation|7
5268391|NCT00630916|18176582|P1|Overall Study|Withdrawal by Subject|30
5268392|NCT00630916|18176582|P1|Overall Study|Lost to Follow-up|5
5268393|NCT00630916|18176582|P1|Overall Study|Explant|8
5268394|NCT00630916|18176582|P1|Overall Study|Death|110
5268395|NCT00630877|18176592|P3|Overall Study|Personal reasons|1
5268396|NCT00630877|18176593|P2|Overall Study|Personal reasons|0
5268397|NCT00630877|18176594|P1|Overall Study|Personal reasons|0
5268398|NCT00630877|18176592|P3|Overall Study|Protocol violation|1
5268399|NCT00630877|18176593|P2|Overall Study|Protocol violation|0
5268400|NCT00630877|18176594|P1|Overall Study|Protocol violation|1
5268401|NCT00630877|18176592|P3|Overall Study|Noncompliance|1
5268402|NCT00630877|18176593|P2|Overall Study|Noncompliance|3
5268403|NCT00630877|18176594|P1|Overall Study|Noncompliance|2
5268404|NCT00630877|18176592|P3|Overall Study|Lost to Follow-up|0
5268405|NCT00630877|18176593|P2|Overall Study|Lost to Follow-up|0
5268406|NCT00630877|18176594|P1|Overall Study|Lost to Follow-up|2
5268407|NCT00630877|18176592|P3|Overall Study|Withdrawal by Subject|0
5268408|NCT00630877|18176593|P2|Overall Study|Withdrawal by Subject|4
5268409|NCT00630877|18176594|P1|Overall Study|Withdrawal by Subject|3
5268410|NCT00630877|18176592|P3|Overall Study|Adverse Event|7
5268411|NCT00630877|18176593|P2|Overall Study|Adverse Event|8
5268412|NCT00630877|18176594|P1|Overall Study|Adverse Event|11
5268413|NCT00630864|18176612|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
5268414|NCT00630864|18176612|P1|Part 1 (up to Week 6)|Adverse Event|1
5268415|NCT00630838|18176651|P2|Overall Study|Lost to Follow-up|1
5268416|NCT00630838|18176652|P1|Overall Study|Lost to Follow-up|0
5268417|NCT00630838|18176651|P2|Overall Study|Death|1
5268418|NCT00630838|18176652|P1|Overall Study|Death|0
5268419|NCT00630825|18176664|P4|Overall Study|Withdrawal by Subject|3
5268420|NCT00630825|18176665|P3|Overall Study|Withdrawal by Subject|2
5268421|NCT00630825|18176666|P2|Overall Study|Withdrawal by Subject|2
5268422|NCT00630825|18176667|P1|Overall Study|Withdrawal by Subject|2
5268423|NCT00630825|18176664|P4|Overall Study|Physician Decision|0
5268424|NCT00630825|18176665|P3|Overall Study|Physician Decision|0
5268425|NCT00630825|18176666|P2|Overall Study|Physician Decision|0
5268426|NCT00630825|18176667|P1|Overall Study|Physician Decision|1
5268427|NCT00630825|18176664|P4|Overall Study|Lost to Follow-up|1
5268428|NCT00630825|18176665|P3|Overall Study|Lost to Follow-up|1
5268429|NCT00630825|18176666|P2|Overall Study|Lost to Follow-up|1
5268430|NCT00630825|18176667|P1|Overall Study|Lost to Follow-up|1
5268431|NCT00630825|18176664|P4|Overall Study|Entry Criteria Not Met|1
5268432|NCT00630825|18176665|P3|Overall Study|Entry Criteria Not Met|2
5268433|NCT00630825|18176666|P2|Overall Study|Entry Criteria Not Met|0
5268434|NCT00630825|18176667|P1|Overall Study|Entry Criteria Not Met|1
5268435|NCT00630825|18176664|P4|Overall Study|Adverse Event|1
5268436|NCT00630825|18176665|P3|Overall Study|Adverse Event|3
5268437|NCT00630825|18176666|P2|Overall Study|Adverse Event|4
5268438|NCT00630825|18176667|P1|Overall Study|Adverse Event|4
5268439|NCT00630812|18176738|P2|Double Blind Treatment Period|Non-compliance|1
5268440|NCT00630812|18176739|P1|Double Blind Treatment Period|Non-compliance|0
5268441|NCT00630812|18176738|P2|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
5268442|NCT00630812|18176739|P1|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
5268443|NCT00630812|18176738|P2|Double Blind Treatment Period|Withdrawal by Subject|7
5268444|NCT00630812|18176739|P1|Double Blind Treatment Period|Withdrawal by Subject|13
5268445|NCT00630812|18176738|P2|Double Blind Treatment Period|Protocol Violation|0
5268446|NCT00630812|18176739|P1|Double Blind Treatment Period|Protocol Violation|1
5268447|NCT00630812|18176738|P2|Double Blind Treatment Period|Physician Decision|1
5268448|NCT00630812|18176739|P1|Double Blind Treatment Period|Physician Decision|2
5268449|NCT00630812|18176738|P2|Double Blind Treatment Period|Lost to Follow-up|0
5268450|NCT00630812|18176739|P1|Double Blind Treatment Period|Lost to Follow-up|1
5268451|NCT00630812|18176738|P2|Double Blind Treatment Period|Adverse Event|5
5268452|NCT00630812|18176739|P1|Double Blind Treatment Period|Adverse Event|13
5268453|NCT00630812|18176738|P2|Randomisation to First Dose|Protocol Violation|1
5268454|NCT00630812|18176739|P1|Randomisation to First Dose|Protocol Violation|4
5268455|NCT00630812|18176738|P2|Randomisation to First Dose|Lost to Follow-up|0
5268456|NCT00630812|18176739|P1|Randomisation to First Dose|Lost to Follow-up|1
5268457|NCT00630812|18176738|P2|Randomisation to First Dose|Withdrawal by Subject|3
5268458|NCT00630812|18176739|P1|Randomisation to First Dose|Withdrawal by Subject|2
5268459|NCT00630812|18176738|P2|Randomisation to First Dose|Adverse Event|1
5268460|NCT00630812|18176739|P1|Randomisation to First Dose|Adverse Event|1
5268461|NCT00630786|18176764|P3|Overall Study|Other|0
5268462|NCT00630786|18176765|P2|Overall Study|Other|0
5268463|NCT00630786|18176766|P1|Overall Study|Other|1
5268464|NCT00630786|18176764|P3|Overall Study|Lost to Follow-up|0
5268465|NCT00630786|18176765|P2|Overall Study|Lost to Follow-up|1
5268466|NCT00630786|18176766|P1|Overall Study|Lost to Follow-up|0
5268467|NCT00630786|18176764|P3|Overall Study|Withdrawal by Subject|1
5268468|NCT00630786|18176765|P2|Overall Study|Withdrawal by Subject|1
5268469|NCT00630786|18176766|P1|Overall Study|Withdrawal by Subject|0
5268470|NCT00630786|18176764|P3|Overall Study|Physician Decision|1
5268471|NCT00630786|18176765|P2|Overall Study|Physician Decision|0
5268472|NCT00630786|18176766|P1|Overall Study|Physician Decision|0
5268473|NCT00630747|18176785|P1|Overall Study|Returned to country of origin|1
5268474|NCT00630747|18176785|P1|Overall Study|Transferred to Study TKT031NPU|7
5268475|NCT00630747|18176785|P1|Overall Study|Death|1
5268476|NCT00630539|18176838|P4|Overall Study|Withdrawal by Subject|1
5268477|NCT00630539|18176839|P3|Overall Study|Withdrawal by Subject|0
5268478|NCT00630539|18176840|P2|Overall Study|Withdrawal by Subject|1
5268479|NCT00630539|18176841|P1|Overall Study|Withdrawal by Subject|0
5268480|NCT00630539|18176838|P4|Overall Study|Adverse Event|2
5268481|NCT00630539|18176839|P3|Overall Study|Adverse Event|1
5268482|NCT00630539|18176840|P2|Overall Study|Adverse Event|3
5268483|NCT00630539|18176841|P1|Overall Study|Adverse Event|1
5268484|NCT00630396|18176937|P1|Overall Study|Lost to Follow-up|3
5268485|NCT00630396|18176937|P1|Overall Study|Death|4
5268486|NCT00630344|18176943|P1|Overall Study|Other|1
5268487|NCT00630344|18176943|P1|Overall Study|Intercurrent Illness|1
5268488|NCT00630344|18176943|P1|Overall Study|Withdrawal by Subject|1
5268489|NCT00630344|18176943|P1|Overall Study|Physician Decision|9
5268490|NCT00630344|18176943|P1|Overall Study|Progressive Disease|19
5268491|NCT00630344|18176943|P1|Overall Study|Adverse Event|5
5268492|NCT00630331|18176955|P3|Overall Study|Protocol Violation|6
5268493|NCT00630331|18176956|P2|Overall Study|Protocol Violation|5
5268494|NCT00630331|18176957|P1|Overall Study|Protocol Violation|4
5268495|NCT00630331|18176955|P3|Overall Study|Unable to classify|3
5268496|NCT00630331|18176956|P2|Overall Study|Unable to classify|4
5268497|NCT00630331|18176957|P1|Overall Study|Unable to classify|9
5268498|NCT00630331|18176955|P3|Overall Study|Inappropriate enrollment|3
5268499|NCT00630331|18176956|P2|Overall Study|Inappropriate enrollment|6
5268500|NCT00630331|18176957|P1|Overall Study|Inappropriate enrollment|3
5268501|NCT00630331|18176955|P3|Overall Study|Lost to Follow-up|170
5268502|NCT00630331|18176956|P2|Overall Study|Lost to Follow-up|143
5268503|NCT00630331|18176957|P1|Overall Study|Lost to Follow-up|175
5268504|NCT00630331|18176955|P3|Overall Study|Withdrawal by Subject|5
5268505|NCT00630331|18176956|P2|Overall Study|Withdrawal by Subject|7
5268506|NCT00630331|18176957|P1|Overall Study|Withdrawal by Subject|12
5268507|NCT00630331|18176955|P3|Overall Study|Adverse Event|0
5268508|NCT00630331|18176956|P2|Overall Study|Adverse Event|0
5268509|NCT00630331|18176957|P1|Overall Study|Adverse Event|1
5268510|NCT00630331|18176955|P3|Overall Study|Death|1
5268511|NCT00630331|18176956|P2|Overall Study|Death|1
5268512|NCT00630331|18176957|P1|Overall Study|Death|2
5268513|NCT00630305|18176998|P1|Overall Study|Inability to insert contact lens|1
5268514|NCT00630305|18176998|P1|Overall Study|Withdrawal by Subject|1
5268515|NCT00630292|18177020|P1|Overall Study|Withdrawal by Subject|1
5268516|NCT00630058|18177026|P2|Overall Study|stopping criteria|2
5268517|NCT00630058|18177027|P1|Overall Study|stopping criteria|3
5268518|NCT00630058|18177026|P2|Overall Study|Withdrawal by Subject|1
5268519|NCT00630058|18177027|P1|Overall Study|Withdrawal by Subject|0
5268520|NCT00630058|18177026|P2|Overall Study|Adverse Event|1
5268521|NCT00630058|18177027|P1|Overall Study|Adverse Event|1
5268522|NCT00629772|18177058|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
5268523|NCT00629772|18177059|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
5268524|NCT00629772|18177058|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
5268525|NCT00629772|18177059|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
5268526|NCT00629707|18177079|P2|Overall Study|Physician Decision|1
5268527|NCT00629707|18177080|P1|Overall Study|Physician Decision|0
5268528|NCT00629707|18177079|P2|Overall Study|Withdrawal by Subject|1
5268529|NCT00629707|18177080|P1|Overall Study|Withdrawal by Subject|0
5268530|NCT00629265|18177100|P2|Overall Study|Unknown Reason|2
5268531|NCT00629265|18177101|P1|Overall Study|Unknown Reason|2
5268532|NCT00629265|18177100|P2|Overall Study|Unrelated Medical Complications|1
5268533|NCT00629265|18177101|P1|Overall Study|Unrelated Medical Complications|3
5268534|NCT00629265|18177100|P2|Overall Study|Needed Esophageal Dilation|1
5268535|NCT00629265|18177101|P1|Overall Study|Needed Esophageal Dilation|4
5268536|NCT00629265|18177100|P2|Overall Study|Other CA Requiring Treatment|3
5268537|NCT00629265|18177101|P1|Overall Study|Other CA Requiring Treatment|1
5268538|NCT00629265|18177100|P2|Overall Study|HNC Recurrence|0
5268539|NCT00629265|18177101|P1|Overall Study|HNC Recurrence|4
5268540|NCT00629265|18177100|P2|Overall Study|Adverse Event|0
5268541|NCT00629265|18177101|P1|Overall Study|Adverse Event|2
5268542|NCT00629265|18177100|P2|Overall Study|Death|0
5268543|NCT00629265|18177101|P1|Overall Study|Death|1
5268544|NCT00629265|18177100|P2|Overall Study|Withdrawal by Subject|8
5268545|NCT00629265|18177101|P1|Overall Study|Withdrawal by Subject|11
5268546|NCT00629265|18177100|P2|Overall Study|Lost to Follow-up|5
5268547|NCT00629265|18177101|P1|Overall Study|Lost to Follow-up|4
5268548|NCT00629239|18177111|P2|Overall Study|Physician Decision|0
5268549|NCT00629239|18177112|P1|Overall Study|Physician Decision|1
5268550|NCT00629239|18177111|P2|Overall Study|Adverse Event|4
5268551|NCT00629239|18177112|P1|Overall Study|Adverse Event|7
5268552|NCT00629083|18177165|P2|Overall Study|Refused to return for 12 month visit|0
5268553|NCT00629083|18177166|P1|Overall Study|Refused to return for 12 month visit|1
5268554|NCT00629083|18177165|P2|Overall Study|Moved out of country/state|1
5268555|NCT00629083|18177166|P1|Overall Study|Moved out of country/state|2
5268556|NCT00629083|18177165|P2|Overall Study|Lost to Follow-up|8
5268557|NCT00629083|18177166|P1|Overall Study|Lost to Follow-up|12
5268558|NCT00629083|18177165|P2|Overall Study|Withdrawal by Subject|2
5268559|NCT00629083|18177166|P1|Overall Study|Withdrawal by Subject|10
5268560|NCT00629083|18177165|P2|Overall Study|Lack of Efficacy|1
5268561|NCT00629083|18177166|P1|Overall Study|Lack of Efficacy|3
5268562|NCT00629083|18177165|P2|Overall Study|Adverse Event|2
5268563|NCT00629083|18177166|P1|Overall Study|Adverse Event|0
5268564|NCT00628927|18177197|P2|Overall Study|Equipment failure|0
5268565|NCT00628927|18177198|P1|Overall Study|Equipment failure|1
5268566|NCT00628927|18177197|P2|Overall Study|Lost to Follow-up|0
5268567|NCT00628927|18177198|P1|Overall Study|Lost to Follow-up|1
5268568|NCT00628927|18177197|P2|Overall Study|Problems performing blood draw|0
5268569|NCT00628927|18177198|P1|Overall Study|Problems performing blood draw|6
5268570|NCT00628862|18177243|P3|Overall Study|COPD Exacerbation|0
5268571|NCT00628862|18177244|P2|Overall Study|COPD Exacerbation|1
5268572|NCT00628862|18177245|P1|Overall Study|COPD Exacerbation|0
5268573|NCT00628862|18177243|P3|Overall Study|Protocol Violation|0
5268574|NCT00628862|18177244|P2|Overall Study|Protocol Violation|0
5268575|NCT00628862|18177245|P1|Overall Study|Protocol Violation|1
5268576|NCT00628862|18177243|P3|Overall Study|Lost to Follow-up|1
5268577|NCT00628862|18177244|P2|Overall Study|Lost to Follow-up|2
5268578|NCT00628862|18177245|P1|Overall Study|Lost to Follow-up|0
5268579|NCT00628862|18177243|P3|Overall Study|Withdrawal by Subject|11
5268580|NCT00628862|18177244|P2|Overall Study|Withdrawal by Subject|6
5268581|NCT00628862|18177245|P1|Overall Study|Withdrawal by Subject|4
5268582|NCT00628862|18177243|P3|Overall Study|Adverse Event|10
5268583|NCT00628862|18177244|P2|Overall Study|Adverse Event|8
5268584|NCT00628862|18177245|P1|Overall Study|Adverse Event|6
5268585|NCT00628758|18177291|P2|Overall Study|Treatment Failure|2
5268586|NCT00628758|18177292|P1|Overall Study|Treatment Failure|0
5268587|NCT00628758|18177291|P2|Overall Study|Investigator Moved|0
5268588|NCT00628758|18177292|P1|Overall Study|Investigator Moved|3
5268589|NCT00628758|18177291|P2|Overall Study|Pregnancy|2
5268590|NCT00628758|18177292|P1|Overall Study|Pregnancy|2
5268591|NCT00628758|18177291|P2|Overall Study|Lost to Follow-up|31
5268592|NCT00628758|18177292|P1|Overall Study|Lost to Follow-up|25
5268593|NCT00628758|18177291|P2|Overall Study|Protocol Violation|1
5268594|NCT00628758|18177292|P1|Overall Study|Protocol Violation|5
5268595|NCT00628758|18177291|P2|Overall Study|Death|0
5268596|NCT00628758|18177292|P1|Overall Study|Death|1
5268597|NCT00628758|18177291|P2|Overall Study|Withdrawal by Subject|3
5268598|NCT00628758|18177292|P1|Overall Study|Withdrawal by Subject|6
5268599|NCT00628758|18177291|P2|Overall Study|Adverse Event|3
5268600|NCT00628758|18177292|P1|Overall Study|Adverse Event|2
5268601|NCT00628446|18177336|P1|Overall Study|Protocol Violation|3
5268602|NCT00628446|18177336|P1|Overall Study|Withdrawal by Subject|1
5268603|NCT00628446|18177336|P1|Overall Study|Lost to Follow-up|3
5268604|NCT00628355|18177368|P2|Overall Study|Withdrawal by Subject|1
5268605|NCT00628355|18177369|P1|Overall Study|Withdrawal by Subject|1
5268606|NCT00628251|18177380|P3|Ongoing Initial Study Treatment at DCO|Other|2
5268607|NCT00628251|18177381|P2|Ongoing Initial Study Treatment at DCO|Other|0
5268608|NCT00628251|18177382|P1|Ongoing Initial Study Treatment at DCO|Other|1
5268609|NCT00628251|18177380|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
5268610|NCT00628251|18177381|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
5268611|NCT00628251|18177382|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
5268612|NCT00628251|18177380|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
5268613|NCT00628251|18177381|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
5268614|NCT00628251|18177382|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
5268615|NCT00628251|18177380|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
5268616|NCT00628251|18177381|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
5268617|NCT00628251|18177382|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
5268618|NCT00628251|18177380|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
5268619|NCT00628251|18177381|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
5268620|NCT00628251|18177382|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
5268621|NCT00628251|18177380|P3|Randomised Part|Withdrawal by Subject|1
5268622|NCT00628251|18177381|P2|Randomised Part|Withdrawal by Subject|0
5268623|NCT00628251|18177382|P1|Randomised Part|Withdrawal by Subject|0
5268624|NCT00628212|18177428|P4|Overall Study|Physician Decision|3
5268625|NCT00628212|18177429|P3|Overall Study|Physician Decision|2
5268626|NCT00628212|18177430|P2|Overall Study|Physician Decision|1
5268627|NCT00628212|18177431|P1|Overall Study|Physician Decision|1
5268628|NCT00628212|18177428|P4|Overall Study|Adverse Event|2
5268629|NCT00628212|18177429|P3|Overall Study|Adverse Event|1
5268630|NCT00628212|18177430|P2|Overall Study|Adverse Event|0
5268631|NCT00628212|18177431|P1|Overall Study|Adverse Event|2
5268632|NCT00628108|18177479|P2|Overall Study|Withdrawal by Subject|0
5268633|NCT00628108|18177480|P1|Overall Study|Withdrawal by Subject|1
5268634|NCT00628108|18177479|P2|Overall Study|Adverse Event|3
5268635|NCT00628108|18177480|P1|Overall Study|Adverse Event|0
5268636|NCT00628030|18177512|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
5268637|NCT00628030|18177513|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
5268638|NCT00628030|18177512|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
5268639|NCT00628030|18177513|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
5268640|NCT00628030|18177512|P2|Baseline to Post-Assessment|Lost to Follow-up|29
5268641|NCT00628030|18177513|P1|Baseline to Post-Assessment|Lost to Follow-up|28
5268642|NCT00627926|18177539|P3|Overall Study|Noncompliance/unspecified|17
5268643|NCT00627926|18177540|P2|Overall Study|Noncompliance/unspecified|23
5268644|NCT00627926|18177541|P1|Overall Study|Noncompliance/unspecified|8
5268645|NCT00627926|18177539|P3|Overall Study|Lack of Efficacy|38
5268646|NCT00627926|18177540|P2|Overall Study|Lack of Efficacy|40
5268647|NCT00627926|18177541|P1|Overall Study|Lack of Efficacy|118
5268648|NCT00627926|18177539|P3|Overall Study|Withdrawal by Subject|0
5268649|NCT00627926|18177540|P2|Overall Study|Withdrawal by Subject|1
5268650|NCT00627926|18177541|P1|Overall Study|Withdrawal by Subject|2
5268651|NCT00627926|18177539|P3|Overall Study|Lost to Follow-up|4
5268652|NCT00627926|18177540|P2|Overall Study|Lost to Follow-up|3
5268653|NCT00627926|18177541|P1|Overall Study|Lost to Follow-up|4
5268654|NCT00627926|18177539|P3|Overall Study|Death|0
5268655|NCT00627926|18177540|P2|Overall Study|Death|0
5268656|NCT00627926|18177541|P1|Overall Study|Death|1
5268657|NCT00627926|18177539|P3|Overall Study|Adverse Event|36
5268658|NCT00627926|18177540|P2|Overall Study|Adverse Event|37
5268659|NCT00627926|18177541|P1|Overall Study|Adverse Event|26
5268660|NCT00627705|18177593|P2|Overall Study|Lost to Follow-up|1
5268661|NCT00627705|18177594|P1|Overall Study|Lost to Follow-up|0
5268662|NCT00627705|18177593|P2|Overall Study|Withdrawal by Subject|2
5268663|NCT00627705|18177594|P1|Overall Study|Withdrawal by Subject|0
5268664|NCT00627705|18177593|P2|Overall Study|Adverse Event|0
5268665|NCT00627705|18177594|P1|Overall Study|Adverse Event|1
5268666|NCT00627705|18177593|P2|Overall Study|Unwilling to take the compound (taste)|3
5268667|NCT00627705|18177594|P1|Overall Study|Unwilling to take the compound (taste)|1
5268668|NCT00627523|18177645|P2|Overall Study|Other|0
5268669|NCT00627523|18177646|P1|Overall Study|Other|1
5268670|NCT00627523|18177645|P2|Overall Study|Withdrawal by Subject|2
5268671|NCT00627523|18177646|P1|Overall Study|Withdrawal by Subject|0
5268672|NCT00627523|18177645|P2|Overall Study|Lack of Efficacy|0
5268673|NCT00627523|18177646|P1|Overall Study|Lack of Efficacy|1
5268674|NCT00627497|18177674|P4|Overall Study|Lost to Follow-up|0
5268675|NCT00627497|18177675|P3|Overall Study|Lost to Follow-up|0
5268676|NCT00627497|18177676|P2|Overall Study|Lost to Follow-up|1
5268677|NCT00627497|18177677|P1|Overall Study|Lost to Follow-up|1
5268678|NCT00627458|18177738|P3|Overall Study|Lost to Follow-up|0
5268679|NCT00627458|18177739|P2|Overall Study|Lost to Follow-up|1
5268680|NCT00627458|18177740|P1|Overall Study|Lost to Follow-up|1
5268681|NCT00627458|18177738|P3|Overall Study|Withdrawal by Subject|5
5268682|NCT00627458|18177739|P2|Overall Study|Withdrawal by Subject|6
5268683|NCT00627458|18177740|P1|Overall Study|Withdrawal by Subject|2
5268684|NCT00627458|18177738|P3|Overall Study|Migrated from study area|1
5268685|NCT00627458|18177739|P2|Overall Study|Migrated from study area|0
5268686|NCT00627458|18177740|P1|Overall Study|Migrated from study area|1
5268687|NCT00627445|18177815|P2|Overall Study|Other|8
5268688|NCT00627445|18177816|P1|Overall Study|Other|6
5268689|NCT00627445|18177815|P2|Overall Study|Lack of Efficacy|1
5268690|NCT00627445|18177816|P1|Overall Study|Lack of Efficacy|0
5268691|NCT00627445|18177815|P2|Overall Study|Adverse Event|3
5268692|NCT00627445|18177816|P1|Overall Study|Adverse Event|3
5268693|NCT00627393|18177859|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
5268694|NCT00627393|18177860|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
5268695|NCT00627393|18177859|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
5268696|NCT00627393|18177860|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
5268697|NCT00627393|18177859|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
5268698|NCT00627393|18177860|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
5268699|NCT00627393|18177859|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
5268700|NCT00627393|18177860|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
5268701|NCT00627094|18177896|P2|Overall Study|Other reason|0
5268702|NCT00627094|18177897|P1|Overall Study|Other reason|1
5268703|NCT00627094|18177896|P2|Overall Study|ulcer healed|7
5268704|NCT00627094|18177897|P1|Overall Study|ulcer healed|1
5268705|NCT00627094|18177896|P2|Overall Study|Withdrawal by Subject|1
5268706|NCT00627094|18177897|P1|Overall Study|Withdrawal by Subject|1
5268707|NCT00627094|18177896|P2|Overall Study|Lost to Follow-up|0
5268708|NCT00627094|18177897|P1|Overall Study|Lost to Follow-up|1
5268709|NCT00627094|18177896|P2|Overall Study|Adverse Event|7
5268710|NCT00627094|18177897|P1|Overall Study|Adverse Event|8
5268711|NCT00627042|18177909|P1|Overall Study|Withdrawal by Subject|2
5268712|NCT00627016|18177921|P2|Overall Study|Pregnancy|0
5268713|NCT00627016|18177922|P1|Overall Study|Pregnancy|1
5268714|NCT00627016|18177921|P2|Overall Study|Placed on Excluded Drugs|0
5268715|NCT00627016|18177922|P1|Overall Study|Placed on Excluded Drugs|1
5268716|NCT00627016|18177921|P2|Overall Study|Lack of Efficacy|0
5268717|NCT00627016|18177922|P1|Overall Study|Lack of Efficacy|1
5268718|NCT00627016|18177921|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
5268719|NCT00627016|18177922|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5268720|NCT00627016|18177921|P2|Overall Study|Withdrawal by Subject|1
5268721|NCT00627016|18177922|P1|Overall Study|Withdrawal by Subject|2
5268722|NCT00627016|18177921|P2|Overall Study|Lost to Follow-up|1
5268723|NCT00627016|18177922|P1|Overall Study|Lost to Follow-up|0
5268724|NCT00627016|18177921|P2|Overall Study|Protocol Violation|2
5268725|NCT00627016|18177922|P1|Overall Study|Protocol Violation|0
5268726|NCT00627016|18177921|P2|Overall Study|Adverse Event|1
5268727|NCT00627016|18177922|P1|Overall Study|Adverse Event|1
5268728|NCT00626925|18177934|P2|Overall Study|Time constraints|1
5268729|NCT00626925|18177935|P1|Overall Study|Time constraints|3
5268730|NCT00626925|18177934|P2|Overall Study|Lack of Efficacy|4
5268731|NCT00626925|18177935|P1|Overall Study|Lack of Efficacy|1
5268732|NCT00626925|18177934|P2|Overall Study|Adverse effect|2
5268733|NCT00626925|18177935|P1|Overall Study|Adverse effect|6
5268734|NCT00626925|18177934|P2|Overall Study|relapse|0
5268735|NCT00626925|18177935|P1|Overall Study|relapse|1
5268736|NCT00626925|18177934|P2|Overall Study|Lost to Follow-up|2
5268737|NCT00626925|18177935|P1|Overall Study|Lost to Follow-up|1
5268738|NCT00626821|18177982|P1|Overall Study|other/unknown reason|104
5268739|NCT00626821|18177982|P1|Overall Study|Product dysfunction|21
5268740|NCT00626821|18177982|P1|Overall Study|Physician Decision|9
5268741|NCT00626821|18177982|P1|Overall Study|Withdrawal by Subject|10
5268742|NCT00626821|18177982|P1|Overall Study|Protocol Violation|33
5268743|NCT00626821|18177982|P1|Overall Study|Adverse Event|44
5268744|NCT00626795|18178062|P3|Blinded Treatment|Missing reason for withdrawal|5
5268745|NCT00626795|18178063|P2|Blinded Treatment|Missing reason for withdrawal|3
5268746|NCT00626795|18178064|P1|Blinded Treatment|Missing reason for withdrawal|5
5268747|NCT00626795|18178062|P3|Blinded Treatment|Other reasons|2
5268748|NCT00626795|18178063|P2|Blinded Treatment|Other reasons|0
5268749|NCT00626795|18178064|P1|Blinded Treatment|Other reasons|2
5268750|NCT00626795|18178062|P3|Blinded Treatment|Withdrawal by Subject|0
5268751|NCT00626795|18178063|P2|Blinded Treatment|Withdrawal by Subject|1
5268752|NCT00626795|18178064|P1|Blinded Treatment|Withdrawal by Subject|1
5268753|NCT00626795|18178062|P3|Blinded Treatment|Protocol Violation|1
5268754|NCT00626795|18178063|P2|Blinded Treatment|Protocol Violation|1
5268755|NCT00626795|18178064|P1|Blinded Treatment|Protocol Violation|0
5268756|NCT00626795|18178062|P3|Blinded Treatment|Unacceptable adverse event|1
5268757|NCT00626795|18178063|P2|Blinded Treatment|Unacceptable adverse event|0
5268758|NCT00626795|18178064|P1|Blinded Treatment|Unacceptable adverse event|0
5268759|NCT00626795|18178062|P3|Blinded Treatment|Lack of Efficacy|0
5268760|NCT00626795|18178063|P2|Blinded Treatment|Lack of Efficacy|0
5268761|NCT00626795|18178064|P1|Blinded Treatment|Lack of Efficacy|2
5268762|NCT00626795|18178062|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
5268763|NCT00626795|18178063|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
5268764|NCT00626795|18178064|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
5268765|NCT00626639|18178115|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
5268766|NCT00626639|18178116|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
5268767|NCT00626561|18178162|P1|Overall Study|Disease Progression|2
5268768|NCT00626561|18178162|P1|Overall Study|Withdrawal by Subject|2
5268769|NCT00626548|18178168|P2|Overall Study|Other termination reason|613
5268770|NCT00626548|18178169|P1|Overall Study|Other termination reason|493
5268771|NCT00626548|18178168|P2|Overall Study|Lost to Follow-up|2
5268772|NCT00626548|18178169|P1|Overall Study|Lost to Follow-up|2
5268773|NCT00626548|18178168|P2|Overall Study|Protocol Violation|11
5268774|NCT00626548|18178169|P1|Overall Study|Protocol Violation|4
5268775|NCT00626548|18178168|P2|Overall Study|Withdrawal by Subject|46
5268776|NCT00626548|18178169|P1|Overall Study|Withdrawal by Subject|42
5268777|NCT00626548|18178168|P2|Overall Study|Adverse Event|44
5268778|NCT00626548|18178169|P1|Overall Study|Adverse Event|164
5268779|NCT00626522|18178183|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
5268780|NCT00626522|18178184|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
5268781|NCT00626522|18178185|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
5268782|NCT00626522|18178186|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
5268783|NCT00626522|18178187|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
5268784|NCT00626522|18178188|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
5268785|NCT00626522|18178183|P6|Overall Study|Inconsistent reason reported|0
5268786|NCT00626522|18178184|P5|Overall Study|Inconsistent reason reported|0
5268787|NCT00626522|18178185|P4|Overall Study|Inconsistent reason reported|0
5268788|NCT00626522|18178186|P3|Overall Study|Inconsistent reason reported|0
5268789|NCT00626522|18178187|P2|Overall Study|Inconsistent reason reported|0
5268790|NCT00626522|18178188|P1|Overall Study|Inconsistent reason reported|1
5268791|NCT00626522|18178183|P6|Overall Study|Lost to Follow-up|0
5268792|NCT00626522|18178184|P5|Overall Study|Lost to Follow-up|0
5268793|NCT00626522|18178185|P4|Overall Study|Lost to Follow-up|0
5268794|NCT00626522|18178186|P3|Overall Study|Lost to Follow-up|0
5268795|NCT00626522|18178187|P2|Overall Study|Lost to Follow-up|1
5268796|NCT00626522|18178188|P1|Overall Study|Lost to Follow-up|0
5268797|NCT00626522|18178183|P6|Overall Study|COPD exacerbation|0
5268798|NCT00626522|18178184|P5|Overall Study|COPD exacerbation|1
5268799|NCT00626522|18178185|P4|Overall Study|COPD exacerbation|1
5268800|NCT00626522|18178186|P3|Overall Study|COPD exacerbation|0
5268801|NCT00626522|18178187|P2|Overall Study|COPD exacerbation|0
5268802|NCT00626522|18178188|P1|Overall Study|COPD exacerbation|0
5268803|NCT00626522|18178183|P6|Overall Study|Withdrawal by Subject|1
5268804|NCT00626522|18178184|P5|Overall Study|Withdrawal by Subject|4
5268805|NCT00626522|18178185|P4|Overall Study|Withdrawal by Subject|0
5268806|NCT00626522|18178186|P3|Overall Study|Withdrawal by Subject|5
5268807|NCT00626522|18178187|P2|Overall Study|Withdrawal by Subject|5
5268808|NCT00626522|18178188|P1|Overall Study|Withdrawal by Subject|2
5268809|NCT00626522|18178183|P6|Overall Study|Adverse Event|1
5268810|NCT00626522|18178184|P5|Overall Study|Adverse Event|1
5268811|NCT00626522|18178185|P4|Overall Study|Adverse Event|0
5268812|NCT00626522|18178186|P3|Overall Study|Adverse Event|2
5268813|NCT00626522|18178187|P2|Overall Study|Adverse Event|1
5268814|NCT00626522|18178188|P1|Overall Study|Adverse Event|2
5268815|NCT00626522|18178183|P6|Overall Study|Protocol Violation|0
5268816|NCT00626522|18178184|P5|Overall Study|Protocol Violation|1
5268817|NCT00626522|18178185|P4|Overall Study|Protocol Violation|0
5268818|NCT00626522|18178186|P3|Overall Study|Protocol Violation|0
5268819|NCT00626522|18178187|P2|Overall Study|Protocol Violation|0
5268820|NCT00626522|18178188|P1|Overall Study|Protocol Violation|0
5268821|NCT00626405|18178251|P2|Overall Study|Withdrawal by Subject|1
5268822|NCT00626405|18178252|P1|Overall Study|Withdrawal by Subject|0
5268823|NCT00626405|18178251|P2|Overall Study|Deemed Ineligible|0
5268824|NCT00626405|18178252|P1|Overall Study|Deemed Ineligible|1
5268825|NCT00626392|18178268|P6|Coadministration Period|Other|1
5268826|NCT00626392|18178269|P5|Coadministration Period|Other|1
5268827|NCT00626392|18178270|P4|Coadministration Period|Other|1
5268828|NCT00626392|18178271|P3|Coadministration Period|Other|3
5268829|NCT00626392|18178272|P2|Coadministration Period|Other|2
5268830|NCT00626392|18178273|P1|Coadministration Period|Other|0
5268831|NCT00626392|18178268|P6|Coadministration Period|Protocol Violation|0
5268832|NCT00626392|18178269|P5|Coadministration Period|Protocol Violation|1
5268833|NCT00626392|18178270|P4|Coadministration Period|Protocol Violation|1
5268834|NCT00626392|18178271|P3|Coadministration Period|Protocol Violation|0
5268835|NCT00626392|18178272|P2|Coadministration Period|Protocol Violation|1
5268836|NCT00626392|18178273|P1|Coadministration Period|Protocol Violation|0
5268837|NCT00626392|18178268|P6|Coadministration Period|Withdrawal by Subject|1
5268838|NCT00626392|18178269|P5|Coadministration Period|Withdrawal by Subject|0
5268839|NCT00626392|18178270|P4|Coadministration Period|Withdrawal by Subject|1
5268840|NCT00626392|18178271|P3|Coadministration Period|Withdrawal by Subject|0
5268841|NCT00626392|18178272|P2|Coadministration Period|Withdrawal by Subject|1
5268842|NCT00626392|18178273|P1|Coadministration Period|Withdrawal by Subject|1
5268843|NCT00626392|18178268|P6|Coadministration Period|Adverse Event|4
5268844|NCT00626392|18178269|P5|Coadministration Period|Adverse Event|3
5268845|NCT00626392|18178270|P4|Coadministration Period|Adverse Event|4
5268846|NCT00626392|18178271|P3|Coadministration Period|Adverse Event|7
5268847|NCT00626392|18178272|P2|Coadministration Period|Adverse Event|1
5268848|NCT00626392|18178273|P1|Coadministration Period|Adverse Event|3
5268849|NCT00626392|18178268|P6|Run-in Period|Noncompliance|0
5268850|NCT00626392|18178269|P5|Run-in Period|Noncompliance|0
5268851|NCT00626392|18178270|P4|Run-in Period|Noncompliance|0
5268852|NCT00626392|18178271|P3|Run-in Period|Noncompliance|1
5268853|NCT00626392|18178272|P2|Run-in Period|Noncompliance|0
5268854|NCT00626392|18178273|P1|Run-in Period|Noncompliance|1
5268855|NCT00626392|18178268|P6|Run-in Period|Withdrawal by Subject|1
5268856|NCT00626392|18178269|P5|Run-in Period|Withdrawal by Subject|3
5268857|NCT00626392|18178270|P4|Run-in Period|Withdrawal by Subject|1
5268858|NCT00626392|18178271|P3|Run-in Period|Withdrawal by Subject|1
5268859|NCT00626392|18178272|P2|Run-in Period|Withdrawal by Subject|1
5268860|NCT00626392|18178273|P1|Run-in Period|Withdrawal by Subject|0
5268861|NCT00626392|18178268|P6|Run-in Period|Adverse Event|0
5268862|NCT00626392|18178269|P5|Run-in Period|Adverse Event|1
5268863|NCT00626392|18178270|P4|Run-in Period|Adverse Event|0
5268864|NCT00626392|18178271|P3|Run-in Period|Adverse Event|1
5268865|NCT00626392|18178272|P2|Run-in Period|Adverse Event|0
5268866|NCT00626392|18178273|P1|Run-in Period|Adverse Event|0
5268867|NCT00626327|18178301|P3|Overall Study|Protocol Violation|26
5268868|NCT00626327|18178302|P2|Overall Study|Protocol Violation|4
5268869|NCT00626327|18178303|P1|Overall Study|Protocol Violation|26
5268870|NCT00626327|18178301|P3|Overall Study|Administrative Reason|6
5268871|NCT00626327|18178302|P2|Overall Study|Administrative Reason|0
5268872|NCT00626327|18178303|P1|Overall Study|Administrative Reason|2
5268873|NCT00626327|18178301|P3|Overall Study|Inappropriate enrollment|3
5268874|NCT00626327|18178302|P2|Overall Study|Inappropriate enrollment|5
5268875|NCT00626327|18178303|P1|Overall Study|Inappropriate enrollment|4
5268876|NCT00626327|18178301|P3|Overall Study|Lost to Follow-up|23
5268877|NCT00626327|18178302|P2|Overall Study|Lost to Follow-up|21
5268878|NCT00626327|18178303|P1|Overall Study|Lost to Follow-up|24
5268879|NCT00626327|18178301|P3|Overall Study|Adverse Event|0
5268880|NCT00626327|18178302|P2|Overall Study|Adverse Event|0
5268881|NCT00626327|18178303|P1|Overall Study|Adverse Event|1
5268882|NCT00626327|18178301|P3|Overall Study|Withdrawal by Subject|30
5268883|NCT00626327|18178302|P2|Overall Study|Withdrawal by Subject|29
5268884|NCT00626327|18178303|P1|Overall Study|Withdrawal by Subject|21
5268885|NCT00626275|18178329|P8|Part B|Withdrawal by Subject|1
5268886|NCT00626275|18178330|P7|Part B|Withdrawal by Subject|0
5268887|NCT00626275|18178331|P6|Part B|Withdrawal by Subject|0
5268888|NCT00626275|18178332|P5|Part B|Withdrawal by Subject|0
5268889|NCT00626275|18178333|P4|Part B|Withdrawal by Subject|0
5268890|NCT00626275|18178334|P3|Part B|Withdrawal by Subject|0
5268891|NCT00626275|18178335|P2|Part B|Withdrawal by Subject|0
5268892|NCT00626275|18178336|P1|Part B|Withdrawal by Subject|0
5268893|NCT00626275|18178329|P8|Part B|Lost to Follow-up|0
5268894|NCT00626275|18178330|P7|Part B|Lost to Follow-up|1
5268895|NCT00626275|18178331|P6|Part B|Lost to Follow-up|0
5268896|NCT00626275|18178332|P5|Part B|Lost to Follow-up|0
5268897|NCT00626275|18178333|P4|Part B|Lost to Follow-up|0
5268898|NCT00626275|18178334|P3|Part B|Lost to Follow-up|0
5268899|NCT00626275|18178335|P2|Part B|Lost to Follow-up|0
5268900|NCT00626275|18178336|P1|Part B|Lost to Follow-up|0
5268901|NCT00626275|18178329|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
5268902|NCT00626275|18178330|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
5268903|NCT00626275|18178331|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
5268904|NCT00626275|18178332|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
5268905|NCT00626275|18178333|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
5268906|NCT00626275|18178334|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
5268907|NCT00626275|18178335|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
5268908|NCT00626275|18178336|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
5268909|NCT00626275|18178329|P8|Part A - Treatment Period 1|Adverse Event|0
5268910|NCT00626275|18178330|P7|Part A - Treatment Period 1|Adverse Event|0
5268911|NCT00626275|18178331|P6|Part A - Treatment Period 1|Adverse Event|0
5268912|NCT00626275|18178332|P5|Part A - Treatment Period 1|Adverse Event|0
5268913|NCT00626275|18178333|P4|Part A - Treatment Period 1|Adverse Event|0
5268914|NCT00626275|18178334|P3|Part A - Treatment Period 1|Adverse Event|0
5268915|NCT00626275|18178335|P2|Part A - Treatment Period 1|Adverse Event|0
5268916|NCT00626275|18178336|P1|Part A - Treatment Period 1|Adverse Event|1
5268917|NCT00626093|18178380|P1|Overall Study|One of the required devices not implante|6
5268918|NCT00626093|18178380|P1|Overall Study|Protocol Violation|1
5268919|NCT00626093|18178380|P1|Overall Study|Withdrawal by Subject|6
5268920|NCT00626093|18178380|P1|Overall Study|Physician Decision|4
5268921|NCT00626093|18178380|P1|Overall Study|Death|1
5268922|NCT00626093|18178380|P1|Overall Study|Lost to Follow-up|5
5268923|NCT00626028|18178387|P2|Overall Study|Inclusion/Exclusion Criteria|6
5268924|NCT00626028|18178388|P1|Overall Study|Inclusion/Exclusion Criteria|3
5268925|NCT00626028|18178387|P2|Overall Study|Physician Decision|1
5268926|NCT00626028|18178388|P1|Overall Study|Physician Decision|2
5268927|NCT00626028|18178387|P2|Overall Study|Device Failure|1
5268928|NCT00626028|18178388|P1|Overall Study|Device Failure|0
5268929|NCT00626028|18178387|P2|Overall Study|Adverse Event|1
5268930|NCT00626028|18178388|P1|Overall Study|Adverse Event|1
5268931|NCT00625872|18178412|P2|Overall Study|Randomized but not treated|1
5268932|NCT00625872|18178413|P1|Overall Study|Randomized but not treated|0
5268933|NCT00625872|18178412|P2|Overall Study|Terminated by sponsor|5
5268934|NCT00625872|18178413|P1|Overall Study|Terminated by sponsor|2
5268935|NCT00625872|18178412|P2|Overall Study|Does not meet inclusion criteria|0
5268936|NCT00625872|18178413|P1|Overall Study|Does not meet inclusion criteria|1
5268937|NCT00625872|18178412|P2|Overall Study|Withdrawal by Subject|0
5268938|NCT00625872|18178413|P1|Overall Study|Withdrawal by Subject|1
5268939|NCT00625846|18178527|P4|Overall Study|Withdrawal by Subject|2
5268940|NCT00625846|18178528|P3|Overall Study|Withdrawal by Subject|1
5268941|NCT00625846|18178529|P2|Overall Study|Withdrawal by Subject|0
5268942|NCT00625846|18178530|P1|Overall Study|Withdrawal by Subject|2
5268943|NCT00625820|18178556|P1|Overall Study|Withdrawal by Subject|1
5268944|NCT00625807|18178564|P2|Overall Study|schedule conflict|8
5268945|NCT00625807|18178565|P1|Overall Study|schedule conflict|2
5268946|NCT00625742|18178581|P1|Overall Study|Ineligible|1
5268947|NCT00625742|18178581|P1|Overall Study|Lost to Follow-up|4
5268948|NCT00625742|18178581|P1|Overall Study|Adverse Event|4
5268949|NCT00625742|18178581|P1|Overall Study|Withdrawal by Subject|1
5268950|NCT00625742|18178581|P1|Overall Study|Disease Progression|2
5268951|NCT00625586|18178600|P1|Overall Study|Adverse Event|1
5268952|NCT00625443|18178613|P3|Overall Study|Other|1
5268953|NCT00625443|18178614|P2|Overall Study|Other|1
5268954|NCT00625443|18178615|P1|Overall Study|Other|0
5268955|NCT00625443|18178613|P3|Overall Study|Physician Decision|2
5268956|NCT00625443|18178614|P2|Overall Study|Physician Decision|4
5268957|NCT00625443|18178615|P1|Overall Study|Physician Decision|0
5268958|NCT00625443|18178613|P3|Overall Study|Withdrawal by Subject|2
5268959|NCT00625443|18178614|P2|Overall Study|Withdrawal by Subject|1
5268960|NCT00625443|18178615|P1|Overall Study|Withdrawal by Subject|0
5268961|NCT00625443|18178613|P3|Overall Study|Platelet count increase >=500,000/mm3|0
5268962|NCT00625443|18178614|P2|Overall Study|Platelet count increase >=500,000/mm3|0
5268963|NCT00625443|18178615|P1|Overall Study|Platelet count increase >=500,000/mm3|1
5268964|NCT00625443|18178613|P3|Overall Study|Non-compliance with protocol|0
5268965|NCT00625443|18178614|P2|Overall Study|Non-compliance with protocol|1
5268966|NCT00625443|18178615|P1|Overall Study|Non-compliance with protocol|0
5268967|NCT00625443|18178613|P3|Overall Study|Adverse Event|0
5268968|NCT00625443|18178614|P2|Overall Study|Adverse Event|4
5268969|NCT00625443|18178615|P1|Overall Study|Adverse Event|1
5268970|NCT00625365|18178695|P1|Overall Study|VSD|1
5268971|NCT00625365|18178695|P1|Overall Study|No IV access|5
5268972|NCT00625365|18178695|P1|Overall Study|Withdrawal by Subject|1
5268973|NCT00625183|18178701|P1|Overall Study|Disease Progression|1
5268974|NCT00625131|18178712|P3|Overall Study|Withdrawal by Subject|5
5268975|NCT00625131|18178713|P2|Overall Study|Withdrawal by Subject|0
5268976|NCT00625131|18178714|P1|Overall Study|Withdrawal by Subject|1
5268977|NCT00625131|18178712|P3|Overall Study|Lost to Follow-up|0
5268978|NCT00625131|18178713|P2|Overall Study|Lost to Follow-up|2
5268979|NCT00625131|18178714|P1|Overall Study|Lost to Follow-up|3
5268980|NCT00624832|18178743|P4|Overall Study|Abnormal Laboratory Value|0
5268981|NCT00624832|18178744|P3|Overall Study|Abnormal Laboratory Value|0
5268982|NCT00624832|18178745|P2|Overall Study|Abnormal Laboratory Value|0
5268983|NCT00624832|18178746|P1|Overall Study|Abnormal Laboratory Value|2
5268984|NCT00624832|18178743|P4|Overall Study|Adverse Event|1
5268985|NCT00624832|18178744|P3|Overall Study|Adverse Event|0
5268986|NCT00624832|18178745|P2|Overall Study|Adverse Event|1
5268987|NCT00624832|18178746|P1|Overall Study|Adverse Event|0
5268988|NCT00624819|18178762|P4|Follow-up Period: Year 4|Lost to Follow-up|0
5268989|NCT00624819|18178763|P3|Follow-up Period: Year 4|Lost to Follow-up|0
5268990|NCT00624819|18178764|P2|Follow-up Period: Year 4|Lost to Follow-up|1
5268991|NCT00624819|18178765|P1|Follow-up Period: Year 4|Lost to Follow-up|1
5268992|NCT00624819|18178762|P4|Follow-up Period: Year 4|Parents decision|0
5268993|NCT00624819|18178763|P3|Follow-up Period: Year 4|Parents decision|1
5268994|NCT00624819|18178764|P2|Follow-up Period: Year 4|Parents decision|0
5268995|NCT00624819|18178765|P1|Follow-up Period: Year 4|Parents decision|0
5268996|NCT00624780|18178942|P6|Follow-up (Week 26)|Other|0
5268997|NCT00624780|18178943|P5|Follow-up (Week 26)|Other|0
5268998|NCT00624780|18178944|P4|Follow-up (Week 26)|Other|0
5268999|NCT00624780|18178945|P3|Follow-up (Week 26)|Other|0
5269000|NCT00624780|18178946|P2|Follow-up (Week 26)|Other|1
5269001|NCT00624780|18178947|P1|Follow-up (Week 26)|Other|1
5269002|NCT00624780|18178942|P6|Follow-up (Week 26)|Withdrawal by Subject|0
5269003|NCT00624780|18178943|P5|Follow-up (Week 26)|Withdrawal by Subject|0
5269004|NCT00624780|18178944|P4|Follow-up (Week 26)|Withdrawal by Subject|0
5269005|NCT00624780|18178945|P3|Follow-up (Week 26)|Withdrawal by Subject|0
5269006|NCT00624780|18178946|P2|Follow-up (Week 26)|Withdrawal by Subject|0
5269007|NCT00624780|18178947|P1|Follow-up (Week 26)|Withdrawal by Subject|1
5269008|NCT00624780|18178942|P6|Follow-up (Week 26)|Lost to Follow-up|0
5269009|NCT00624780|18178943|P5|Follow-up (Week 26)|Lost to Follow-up|1
5269010|NCT00624780|18178944|P4|Follow-up (Week 26)|Lost to Follow-up|0
5269011|NCT00624780|18178945|P3|Follow-up (Week 26)|Lost to Follow-up|1
5269012|NCT00624780|18178946|P2|Follow-up (Week 26)|Lost to Follow-up|0
5269013|NCT00624780|18178947|P1|Follow-up (Week 26)|Lost to Follow-up|0
5269014|NCT00624780|18178942|P6|Follow-up (Week 26)|Adverse Event|0
5269015|NCT00624780|18178943|P5|Follow-up (Week 26)|Adverse Event|1
5269016|NCT00624780|18178944|P4|Follow-up (Week 26)|Adverse Event|0
5269017|NCT00624780|18178945|P3|Follow-up (Week 26)|Adverse Event|0
5269018|NCT00624780|18178946|P2|Follow-up (Week 26)|Adverse Event|0
5269019|NCT00624780|18178947|P1|Follow-up (Week 26)|Adverse Event|0
5269020|NCT00624780|18178942|P6|Follow-up (Week 26)|Death|0
5269021|NCT00624780|18178943|P5|Follow-up (Week 26)|Death|0
5269022|NCT00624780|18178944|P4|Follow-up (Week 26)|Death|0
5269023|NCT00624780|18178945|P3|Follow-up (Week 26)|Death|1
5269024|NCT00624780|18178946|P2|Follow-up (Week 26)|Death|0
5269025|NCT00624780|18178947|P1|Follow-up (Week 26)|Death|0
5269026|NCT00624780|18178942|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5269027|NCT00624780|18178943|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5269028|NCT00624780|18178944|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5269029|NCT00624780|18178945|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
5269030|NCT00624780|18178946|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5269031|NCT00624780|18178947|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5269032|NCT00624780|18178942|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5269033|NCT00624780|18178943|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5269034|NCT00624780|18178944|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5269035|NCT00624780|18178945|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5269036|NCT00624780|18178946|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5269037|NCT00624780|18178947|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
5269038|NCT00624780|18178942|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
5269039|NCT00624780|18178943|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
5269040|NCT00624780|18178944|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
5269041|NCT00624780|18178945|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
5269042|NCT00624780|18178946|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
5269043|NCT00624780|18178947|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
5269044|NCT00624780|18178942|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
5269045|NCT00624780|18178943|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
5269046|NCT00624780|18178944|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
5269047|NCT00624780|18178945|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
5269048|NCT00624780|18178946|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
5269049|NCT00624780|18178947|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
5269050|NCT00624780|18178942|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
5269127|NCT00624377|18179266|P1|Overall Study|Non-evaluable population|84
5269051|NCT00624780|18178943|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
5269052|NCT00624780|18178944|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
5269053|NCT00624780|18178945|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
5269054|NCT00624780|18178946|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
5269055|NCT00624780|18178947|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
5269056|NCT00624780|18178942|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5269057|NCT00624780|18178943|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5269058|NCT00624780|18178944|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
5269059|NCT00624780|18178945|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5269060|NCT00624780|18178946|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
5269061|NCT00624780|18178947|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5269062|NCT00624780|18178942|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5269063|NCT00624780|18178943|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
5269064|NCT00624780|18178944|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
5269065|NCT00624780|18178945|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5269066|NCT00624780|18178946|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
5269067|NCT00624780|18178947|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5269068|NCT00624780|18178942|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
5269069|NCT00624780|18178943|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
5269070|NCT00624780|18178944|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
5269071|NCT00624780|18178945|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
5269072|NCT00624780|18178946|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
5269073|NCT00624780|18178947|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
5269074|NCT00624780|18178942|P6|Treatment Optimization (Up to Week 12)|Other|0
5269075|NCT00624780|18178943|P5|Treatment Optimization (Up to Week 12)|Other|9
5269076|NCT00624780|18178944|P4|Treatment Optimization (Up to Week 12)|Other|2
5269077|NCT00624780|18178945|P3|Treatment Optimization (Up to Week 12)|Other|8
5269078|NCT00624780|18178946|P2|Treatment Optimization (Up to Week 12)|Other|4
5269079|NCT00624780|18178947|P1|Treatment Optimization (Up to Week 12)|Other|10
5269080|NCT00624780|18178942|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
5269081|NCT00624780|18178943|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
5269082|NCT00624780|18178944|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
5269083|NCT00624780|18178945|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
5269084|NCT00624780|18178946|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
5269085|NCT00624780|18178947|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
5269086|NCT00624780|18178942|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
5269087|NCT00624780|18178943|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
5269088|NCT00624780|18178944|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
5269089|NCT00624780|18178945|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
5269090|NCT00624780|18178946|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
5269091|NCT00624780|18178947|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
5269092|NCT00624780|18178942|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
5269093|NCT00624780|18178943|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
5269094|NCT00624780|18178944|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
5269095|NCT00624780|18178945|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
5269096|NCT00624780|18178946|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
5269097|NCT00624780|18178947|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
5269098|NCT00624780|18178942|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
5269099|NCT00624780|18178943|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
5269100|NCT00624780|18178944|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
5269101|NCT00624780|18178945|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
5269102|NCT00624780|18178946|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
5269103|NCT00624780|18178947|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
5269104|NCT00624585|18179138|P1|Overall Study|Adverse Event|3
5269105|NCT00624585|18179138|P1|Overall Study|Disease Progression|6
5269106|NCT00624585|18179138|P1|Overall Study|Death|3
5269107|NCT00624520|18179168|P2|Overall Study|Death|1
5269108|NCT00624520|18179169|P1|Overall Study|Death|0
5269109|NCT00624520|18179168|P2|Overall Study|Withdrawal by Subject|7
5269110|NCT00624520|18179169|P1|Overall Study|Withdrawal by Subject|12
5269111|NCT00624468|18179196|P4|Safety Follow-up (SFU) Period|Other|1
5269112|NCT00624468|18179197|P3|Safety Follow-up (SFU) Period|Other|1
5269113|NCT00624468|18179198|P2|Safety Follow-up (SFU) Period|Other|0
5269114|NCT00624468|18179199|P1|Safety Follow-up (SFU) Period|Other|0
5269115|NCT00624468|18179196|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
5269116|NCT00624468|18179197|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
5269117|NCT00624468|18179198|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
5269118|NCT00624468|18179199|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
5269119|NCT00624468|18179196|P4|Double-blind Period|Withdrew Prematurely|0
5269120|NCT00624468|18179197|P3|Double-blind Period|Withdrew Prematurely|0
5269121|NCT00624468|18179198|P2|Double-blind Period|Withdrew Prematurely|1
5269122|NCT00624468|18179199|P1|Double-blind Period|Withdrew Prematurely|1
5269123|NCT00624468|18179196|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
5269124|NCT00624468|18179197|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
5269125|NCT00624468|18179198|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
5269126|NCT00624468|18179199|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
5269128|NCT00624377|18179266|P1|Overall Study|Other|91
5269129|NCT00624377|18179266|P1|Overall Study|Adverse Event|14
5269130|NCT00624377|18179266|P1|Overall Study|Withdrawal by Subject|100
5269131|NCT00624377|18179266|P1|Overall Study|Lost to Follow-up|355
5269132|NCT00624338|18179280|P3|Overall Study|Randomized but not treated|3
5269133|NCT00624338|18179281|P2|Overall Study|Randomized but not treated|1
5269134|NCT00624338|18179282|P1|Overall Study|Randomized but not treated|2
5269135|NCT00624338|18179280|P3|Overall Study|Other|9
5269136|NCT00624338|18179281|P2|Overall Study|Other|5
5269137|NCT00624338|18179282|P1|Overall Study|Other|15
5269138|NCT00624338|18179280|P3|Overall Study|Termination of 150 mg group by Sponsor|0
5269139|NCT00624338|18179281|P2|Overall Study|Termination of 150 mg group by Sponsor|55
5269140|NCT00624338|18179282|P1|Overall Study|Termination of 150 mg group by Sponsor|0
5269141|NCT00624338|18179280|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
5269142|NCT00624338|18179281|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
5269143|NCT00624338|18179282|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
5269144|NCT00624338|18179280|P3|Overall Study|Death|0
5269145|NCT00624338|18179281|P2|Overall Study|Death|2
5269146|NCT00624338|18179282|P1|Overall Study|Death|0
5269147|NCT00624338|18179280|P3|Overall Study|Protocol Violation|2
5269148|NCT00624338|18179281|P2|Overall Study|Protocol Violation|3
5269149|NCT00624338|18179282|P1|Overall Study|Protocol Violation|3
5269150|NCT00624338|18179280|P3|Overall Study|Lack of Efficacy|14
5269151|NCT00624338|18179281|P2|Overall Study|Lack of Efficacy|3
5269152|NCT00624338|18179282|P1|Overall Study|Lack of Efficacy|11
5269153|NCT00624338|18179280|P3|Overall Study|Lost to Follow-up|0
5269154|NCT00624338|18179281|P2|Overall Study|Lost to Follow-up|0
5269155|NCT00624338|18179282|P1|Overall Study|Lost to Follow-up|1
5269156|NCT00624338|18179280|P3|Overall Study|Adverse Event|18
5269157|NCT00624338|18179281|P2|Overall Study|Adverse Event|14
5269158|NCT00624338|18179282|P1|Overall Study|Adverse Event|14
5269159|NCT00624286|18179304|P2|Overall Study|Death|1
5269160|NCT00624286|18179305|P1|Overall Study|Death|0
5269161|NCT00624286|18179304|P2|Overall Study|Abnormal test procedure result(s)|1
5269162|NCT00624286|18179305|P1|Overall Study|Abnormal test procedure result(s)|0
5269163|NCT00624286|18179304|P2|Overall Study|Not stated|1
5269164|NCT00624286|18179305|P1|Overall Study|Not stated|0
5269165|NCT00624286|18179304|P2|Overall Study|Lack of Efficacy|6
5269166|NCT00624286|18179305|P1|Overall Study|Lack of Efficacy|1
5269167|NCT00624286|18179304|P2|Overall Study|Administrative problems|0
5269168|NCT00624286|18179305|P1|Overall Study|Administrative problems|3
5269169|NCT00624286|18179304|P2|Overall Study|Lost to Follow-up|2
5269170|NCT00624286|18179305|P1|Overall Study|Lost to Follow-up|3
5269171|NCT00624286|18179304|P2|Overall Study|Withdrawal by Subject|4
5269172|NCT00624286|18179305|P1|Overall Study|Withdrawal by Subject|5
5269173|NCT00624286|18179304|P2|Overall Study|Adverse Event|3
5269174|NCT00624286|18179305|P1|Overall Study|Adverse Event|6
5269175|NCT00624286|18179304|P2|Overall Study|Protocol Deviation|9
5269176|NCT00624286|18179305|P1|Overall Study|Protocol Deviation|7
5269177|NCT00624065|18179358|P2|Overall Study|Met protocol-defined stopping criteria|9
5269178|NCT00624065|18179359|P1|Overall Study|Met protocol-defined stopping criteria|4
5269179|NCT00624065|18179358|P2|Overall Study|Lack of Efficacy|3
5269180|NCT00624065|18179359|P1|Overall Study|Lack of Efficacy|0
5269181|NCT00624065|18179358|P2|Overall Study|Consent withdrawn|5
5269182|NCT00624065|18179359|P1|Overall Study|Consent withdrawn|6
5269183|NCT00624065|18179358|P2|Overall Study|Lost to Follow-up|1
5269184|NCT00624065|18179359|P1|Overall Study|Lost to Follow-up|4
5269185|NCT00624065|18179358|P2|Overall Study|Adverse Event|6
5269186|NCT00624065|18179359|P1|Overall Study|Adverse Event|5
5269187|NCT00624052|18179371|P4|Overall Study|Changed job/ran out if meds|0
5269188|NCT00624052|18179372|P3|Overall Study|Changed job/ran out if meds|0
5269189|NCT00624052|18179373|P2|Overall Study|Changed job/ran out if meds|2
5269190|NCT00624052|18179374|P1|Overall Study|Changed job/ran out if meds|0
5269191|NCT00624052|18179371|P4|Overall Study|Consent withdrawn|0
5269192|NCT00624052|18179372|P3|Overall Study|Consent withdrawn|1
5269193|NCT00624052|18179373|P2|Overall Study|Consent withdrawn|1
5269194|NCT00624052|18179374|P1|Overall Study|Consent withdrawn|3
5269195|NCT00624052|18179371|P4|Overall Study|Non compliant with the protocol|1
5269196|NCT00624052|18179372|P3|Overall Study|Non compliant with the protocol|1
5269197|NCT00624052|18179373|P2|Overall Study|Non compliant with the protocol|1
5269198|NCT00624052|18179374|P1|Overall Study|Non compliant with the protocol|2
5269199|NCT00624052|18179371|P4|Overall Study|Lost to Follow-up|0
5269200|NCT00624052|18179372|P3|Overall Study|Lost to Follow-up|1
5269201|NCT00624052|18179373|P2|Overall Study|Lost to Follow-up|3
5269202|NCT00624052|18179374|P1|Overall Study|Lost to Follow-up|2
5269203|NCT00624052|18179371|P4|Overall Study|Lack of Efficacy|0
5269204|NCT00624052|18179372|P3|Overall Study|Lack of Efficacy|0
5269205|NCT00624052|18179373|P2|Overall Study|Lack of Efficacy|1
5269206|NCT00624052|18179374|P1|Overall Study|Lack of Efficacy|1
5269207|NCT00624052|18179371|P4|Overall Study|Adverse Event|3
5269208|NCT00624052|18179372|P3|Overall Study|Adverse Event|0
5269209|NCT00624052|18179373|P2|Overall Study|Adverse Event|6
5269210|NCT00624052|18179374|P1|Overall Study|Adverse Event|7
5269211|NCT00623935|18179451|P1|Overall Study|Patient Declined Transplant|1
5269212|NCT00623935|18179451|P1|Overall Study|Death|1
5269213|NCT00623831|18179458|P2|Overall Study|Progressive Disease|1
5269214|NCT00623831|18179459|P1|Overall Study|Progressive Disease|0
5269215|NCT00623831|18179458|P2|Overall Study|Withdrawal by Subject|0
5269216|NCT00623831|18179459|P1|Overall Study|Withdrawal by Subject|1
5269217|NCT00623805|18179471|P2|Overall Study|Reason not Specified|6
5269218|NCT00623805|18179472|P1|Overall Study|Reason not Specified|3
5269219|NCT00623805|18179471|P2|Overall Study|Protocol Violation|1
5269220|NCT00623805|18179472|P1|Overall Study|Protocol Violation|1
5269221|NCT00623805|18179471|P2|Overall Study|Lost to Follow-up|2
5269222|NCT00623805|18179472|P1|Overall Study|Lost to Follow-up|2
5269223|NCT00623805|18179471|P2|Overall Study|Lack of Efficacy|7
5269224|NCT00623805|18179472|P1|Overall Study|Lack of Efficacy|3
5269225|NCT00623805|18179471|P2|Overall Study|Death|0
5269226|NCT00623805|18179472|P1|Overall Study|Death|2
5269227|NCT00623805|18179471|P2|Overall Study|Adverse Event|6
5269228|NCT00623805|18179472|P1|Overall Study|Adverse Event|9
5269229|NCT00623779|18179489|P3|Overall Study|Criteria from CSR|1
5269230|NCT00623779|18179490|P2|Overall Study|Criteria from CSR|0
5269231|NCT00623779|18179491|P1|Overall Study|Criteria from CSR|2
5269232|NCT00623779|18179489|P3|Overall Study|Adverse Event|0
5269233|NCT00623779|18179490|P2|Overall Study|Adverse Event|3
5269234|NCT00623779|18179491|P1|Overall Study|Adverse Event|1
5269235|NCT00623766|18179540|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
5269236|NCT00623766|18179541|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
5269237|NCT00623766|18179540|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
5269238|NCT00623766|18179541|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
5269239|NCT00623766|18179540|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
5269240|NCT00623766|18179541|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
5269241|NCT00623766|18179540|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
5269242|NCT00623766|18179541|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
5269243|NCT00623766|18179540|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
5269244|NCT00623766|18179541|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
5269245|NCT00623727|18179565|P2|Open Label Follow-up|Participant convenience|1
5269246|NCT00623727|18179566|P1|Open Label Follow-up|Participant convenience|0
5269247|NCT00623727|18179565|P2|Open Label Follow-up|Study termination|6
5269248|NCT00623727|18179566|P1|Open Label Follow-up|Study termination|0
5269249|NCT00623727|18179565|P2|Open Label Follow-up|Withdrawal by Subject|1
5269250|NCT00623727|18179566|P1|Open Label Follow-up|Withdrawal by Subject|0
5269251|NCT00623727|18179565|P2|Double Blind (DB)|Protocol Violation|2
5269252|NCT00623727|18179566|P1|Double Blind (DB)|Protocol Violation|2
5269253|NCT00623727|18179565|P2|Double Blind (DB)|Lost to Follow-up|1
5269254|NCT00623727|18179566|P1|Double Blind (DB)|Lost to Follow-up|1
5269255|NCT00623727|18179565|P2|Double Blind (DB)|Termination of the double-blind period|21
5269256|NCT00623727|18179566|P1|Double Blind (DB)|Termination of the double-blind period|22
5269257|NCT00623727|18179565|P2|Double Blind (DB)|Lack of Efficacy|2
5269258|NCT00623727|18179566|P1|Double Blind (DB)|Lack of Efficacy|2
5269259|NCT00623727|18179565|P2|Double Blind (DB)|Withdrawal by Subject|2
5269260|NCT00623727|18179566|P1|Double Blind (DB)|Withdrawal by Subject|8
5269261|NCT00623727|18179565|P2|Double Blind (DB)|Physician Decision|1
5269262|NCT00623727|18179566|P1|Double Blind (DB)|Physician Decision|0
5269263|NCT00623727|18179565|P2|Double Blind (DB)|Adverse Event|3
5269264|NCT00623727|18179566|P1|Double Blind (DB)|Adverse Event|1
5269265|NCT00623623|18179621|P2|Overall Study|Previous enrolment into this study|1
5269266|NCT00623623|18179622|P1|Overall Study|Previous enrolment into this study|1
5269267|NCT00623597|18179678|P2|Overall Study|Failed to return|0
5269268|NCT00623597|18179679|P1|Overall Study|Failed to return|1
5269269|NCT00623545|18179742|P1|Overall Study|Withdrawal by Subject|4
5269270|NCT00623545|18179742|P1|Overall Study|Adverse Event|6
5269271|NCT00623480|18179762|P2|Overall Study|Site closed by sponsor|1
5269272|NCT00623480|18179763|P1|Overall Study|Site closed by sponsor|0
5269273|NCT00623480|18179762|P2|Overall Study|Protocol Violation|1
5269274|NCT00623480|18179763|P1|Overall Study|Protocol Violation|0
5269275|NCT00623480|18179762|P2|Overall Study|Non-compliant with study medication|0
5269276|NCT00623480|18179763|P1|Overall Study|Non-compliant with study medication|4
5269277|NCT00623480|18179762|P2|Overall Study|Lack of Efficacy|0
5269278|NCT00623480|18179763|P1|Overall Study|Lack of Efficacy|1
5269279|NCT00623480|18179762|P2|Overall Study|Withdrawal by Subject|4
5269280|NCT00623480|18179763|P1|Overall Study|Withdrawal by Subject|2
5269281|NCT00623480|18179762|P2|Overall Study|Lost to Follow-up|1
5269282|NCT00623480|18179763|P1|Overall Study|Lost to Follow-up|0
5269283|NCT00623467|18179775|P1|Overall Study|Withdrawal by Subject|2
5269284|NCT00623467|18179775|P1|Overall Study|Protocol Violation|4
5269285|NCT00623467|18179775|P1|Overall Study|Lost to Follow-up|1
5269286|NCT00623428|18179845|P2|Follow-up Period|Death|1
5269287|NCT00623428|18179846|P1|Follow-up Period|Death|0
5269288|NCT00623428|18179845|P2|Follow-up Period|Reason not specified|1
5269289|NCT00623428|18179846|P1|Follow-up Period|Reason not specified|1
5269290|NCT00623428|18179845|P2|Follow-up Period|Did not cooperate|3
5269291|NCT00623428|18179846|P1|Follow-up Period|Did not cooperate|0
5269292|NCT00623428|18179845|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
5269293|NCT00623428|18179846|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
5269294|NCT00623428|18179845|P2|Follow-up Period|Patient withdrew consent|4
5269295|NCT00623428|18179846|P1|Follow-up Period|Patient withdrew consent|5
5269296|NCT00623428|18179845|P2|Follow-up Period|Failure to return|2
5269297|NCT00623428|18179846|P1|Follow-up Period|Failure to return|10
5269298|NCT00623428|18179845|P2|Follow-up Period|Relapse post-treatment|3
5269299|NCT00623428|18179846|P1|Follow-up Period|Relapse post-treatment|11
5269300|NCT00623428|18179845|P2|Treatment Period|Withdrawal by Subject|1
5269301|NCT00623428|18179846|P1|Treatment Period|Withdrawal by Subject|0
5269302|NCT00623428|18179845|P2|Treatment Period|Other|1
5269303|NCT00623428|18179846|P1|Treatment Period|Other|0
5269304|NCT00623428|18179845|P2|Treatment Period|Insufficient therapeutic response|2
5269305|NCT00623428|18179846|P1|Treatment Period|Insufficient therapeutic response|0
5269306|NCT00623428|18179845|P2|Treatment Period|Did not cooperate / refused treatment|13
5269307|NCT00623428|18179846|P1|Treatment Period|Did not cooperate / refused treatment|0
5269308|NCT00623428|18179845|P2|Treatment Period|Death|1
5269309|NCT00623428|18179846|P1|Treatment Period|Death|0
5269310|NCT00623428|18179845|P2|Treatment Period|Adverse event/intercurrent illness|9
5269311|NCT00623428|18179846|P1|Treatment Period|Adverse event/intercurrent illness|0
5269312|NCT00623233|18179864|P1|Overall Study|Withdrawal by Subject|3
5269313|NCT00623233|18179864|P1|Overall Study|Lost to Follow-up|1
5269314|NCT00623233|18179864|P1|Overall Study|Physician Decision|10
5269315|NCT00623233|18179864|P1|Overall Study|Adverse Event|10
5269316|NCT00623194|18179871|P1|Overall Study|Unclassified|1
5269317|NCT00623194|18179871|P1|Overall Study|Protocol Violation|3
5269318|NCT00623194|18179871|P1|Overall Study|Lack of Efficacy|1
5269319|NCT00623103|18179908|P2|Overall Study|Protocol deviation|1
5269320|NCT00623103|18179909|P1|Overall Study|Protocol deviation|2
5269321|NCT00623103|18179908|P2|Overall Study|Death|11
5269322|NCT00623103|18179909|P1|Overall Study|Death|11
5269323|NCT00623103|18179908|P2|Overall Study|Administrative problems|4
5269324|NCT00623103|18179909|P1|Overall Study|Administrative problems|2
5269325|NCT00623103|18179908|P2|Overall Study|Lost to Follow-up|1
5269326|NCT00623103|18179909|P1|Overall Study|Lost to Follow-up|4
5269327|NCT00623103|18179908|P2|Overall Study|Withdrawal by Subject|24
5269328|NCT00623103|18179909|P1|Overall Study|Withdrawal by Subject|18
5269329|NCT00623103|18179908|P2|Overall Study|Unsatisfactory therapeutic effect|12
5269330|NCT00623103|18179909|P1|Overall Study|Unsatisfactory therapeutic effect|4
5269331|NCT00623103|18179908|P2|Overall Study|Adverse Event|60
5269332|NCT00623103|18179909|P1|Overall Study|Adverse Event|70
5269333|NCT00622908|18179937|P2|Overall Study|Termination by study sponser|1
5269334|NCT00622908|18179938|P1|Overall Study|Termination by study sponser|0
5269335|NCT00622908|18179937|P2|Overall Study|Refusal|1
5269336|NCT00622908|18179938|P1|Overall Study|Refusal|0
5269337|NCT00622908|18179937|P2|Overall Study|Lost to Follow-up|0
5269338|NCT00622908|18179938|P1|Overall Study|Lost to Follow-up|1
5269339|NCT00622908|18179937|P2|Overall Study|Lack of Efficacy|7
5269340|NCT00622908|18179938|P1|Overall Study|Lack of Efficacy|1
5269341|NCT00622908|18179937|P2|Overall Study|Adverse Event|1
5269342|NCT00622908|18179938|P1|Overall Study|Adverse Event|0
5269343|NCT00622908|18179937|P2|Overall Study|Protocol Violation|0
5269344|NCT00622908|18179938|P1|Overall Study|Protocol Violation|1
5269345|NCT00622869|18179968|P3|Overall Study|Missing|1
5269346|NCT00622869|18179969|P2|Overall Study|Missing|1
5269347|NCT00622869|18179970|P1|Overall Study|Missing|0
5269348|NCT00622869|18179968|P3|Overall Study|Graft Loss|2
5269349|NCT00622869|18179969|P2|Overall Study|Graft Loss|3
5269350|NCT00622869|18179970|P1|Overall Study|Graft Loss|5
5269351|NCT00622869|18179968|P3|Overall Study|Lost to Follow-up|2
5269352|NCT00622869|18179969|P2|Overall Study|Lost to Follow-up|4
5269353|NCT00622869|18179970|P1|Overall Study|Lost to Follow-up|2
5269354|NCT00622869|18179968|P3|Overall Study|Death|10
5269355|NCT00622869|18179969|P2|Overall Study|Death|15
5269356|NCT00622869|18179970|P1|Overall Study|Death|12
5269357|NCT00622869|18179968|P3|Overall Study|Administrative Problems|13
5269358|NCT00622869|18179969|P2|Overall Study|Administrative Problems|17
5269359|NCT00622869|18179970|P1|Overall Study|Administrative Problems|11
5269360|NCT00622869|18179968|P3|Overall Study|Subject Withdrew Consent|11
5269361|NCT00622869|18179969|P2|Overall Study|Subject Withdrew Consent|17
5269362|NCT00622869|18179970|P1|Overall Study|Subject Withdrew Consent|13
5269363|NCT00622739|18179989|P2|Overall Study|Lost to Follow-up|1
5269364|NCT00622739|18179990|P1|Overall Study|Lost to Follow-up|0
5269365|NCT00622739|18179989|P2|Overall Study|Withdrawal by Subject|1
5269366|NCT00622739|18179990|P1|Overall Study|Withdrawal by Subject|0
5269367|NCT00622739|18179989|P2|Overall Study|Lack of Efficacy|2
5269368|NCT00622739|18179990|P1|Overall Study|Lack of Efficacy|0
5269369|NCT00622739|18179989|P2|Overall Study|Adverse Event|2
5269370|NCT00622739|18179990|P1|Overall Study|Adverse Event|1
5269371|NCT00622739|18179989|P2|Overall Study|Physician Decision|0
5269372|NCT00622739|18179990|P1|Overall Study|Physician Decision|1
5269373|NCT00622726|18180008|P2|August, 2010 to April, 2013|Death|5
5269374|NCT00622726|18180009|P1|August, 2010 to April, 2013|Death|1
5269375|NCT00622726|18180008|P2|March, 2008 to August, 2010|Death|2
5269376|NCT00622726|18180009|P1|March, 2008 to August, 2010|Death|5
5269377|NCT00622713|18180019|P1|Overall Study|Did not meet eligibility criteria|1
5269378|NCT00622713|18180019|P1|Overall Study|Subject no longer required study drug|1
5269379|NCT00622713|18180019|P1|Overall Study|Death|2
5269380|NCT00622713|18180019|P1|Overall Study|Lost to Follow-up|5
5269381|NCT00622713|18180019|P1|Overall Study|Withdrawal by Subject|11
5269382|NCT00622713|18180019|P1|Overall Study|Administrative problems|4
5269383|NCT00622713|18180019|P1|Overall Study|Adverse Event|35
5269384|NCT00622700|18180030|P7|Extension Treatment Period|Other than specified above|1
5269385|NCT00622700|18180031|P6|Extension Treatment Period|Other than specified above|1
5269386|NCT00622700|18180032|P5|Extension Treatment Period|Other than specified above|0
5269387|NCT00622700|18180033|P4|Extension Treatment Period|Other than specified above|0
5269388|NCT00622700|18180034|P3|Extension Treatment Period|Other than specified above|0
5269389|NCT00622700|18180035|P2|Extension Treatment Period|Other than specified above|0
5269390|NCT00622700|18180036|P1|Extension Treatment Period|Other than specified above|0
5269391|NCT00622700|18180030|P7|Extension Treatment Period|Missing|0
5269392|NCT00622700|18180031|P6|Extension Treatment Period|Missing|1
5269393|NCT00622700|18180032|P5|Extension Treatment Period|Missing|3
5269394|NCT00622700|18180033|P4|Extension Treatment Period|Missing|2
5269395|NCT00622700|18180034|P3|Extension Treatment Period|Missing|0
5269396|NCT00622700|18180035|P2|Extension Treatment Period|Missing|0
5269397|NCT00622700|18180036|P1|Extension Treatment Period|Missing|0
5269398|NCT00622700|18180030|P7|Extension Treatment Period|Withdrawal by Subject|10
5269399|NCT00622700|18180031|P6|Extension Treatment Period|Withdrawal by Subject|6
5269400|NCT00622700|18180032|P5|Extension Treatment Period|Withdrawal by Subject|16
5269401|NCT00622700|18180033|P4|Extension Treatment Period|Withdrawal by Subject|11
5269402|NCT00622700|18180034|P3|Extension Treatment Period|Withdrawal by Subject|0
5269403|NCT00622700|18180035|P2|Extension Treatment Period|Withdrawal by Subject|0
5269404|NCT00622700|18180036|P1|Extension Treatment Period|Withdrawal by Subject|0
5269405|NCT00622700|18180030|P7|Extension Treatment Period|Progressive Disease|2
5269406|NCT00622700|18180031|P6|Extension Treatment Period|Progressive Disease|0
5269407|NCT00622700|18180032|P5|Extension Treatment Period|Progressive Disease|2
5269408|NCT00622700|18180033|P4|Extension Treatment Period|Progressive Disease|1
5269409|NCT00622700|18180034|P3|Extension Treatment Period|Progressive Disease|0
5269410|NCT00622700|18180035|P2|Extension Treatment Period|Progressive Disease|0
5269411|NCT00622700|18180036|P1|Extension Treatment Period|Progressive Disease|0
5269412|NCT00622700|18180030|P7|Extension Treatment Period|Lost to Follow-up|0
5269413|NCT00622700|18180031|P6|Extension Treatment Period|Lost to Follow-up|0
5269414|NCT00622700|18180032|P5|Extension Treatment Period|Lost to Follow-up|1
5269415|NCT00622700|18180033|P4|Extension Treatment Period|Lost to Follow-up|0
5269416|NCT00622700|18180034|P3|Extension Treatment Period|Lost to Follow-up|0
5269417|NCT00622700|18180035|P2|Extension Treatment Period|Lost to Follow-up|0
5269418|NCT00622700|18180036|P1|Extension Treatment Period|Lost to Follow-up|0
5269419|NCT00622700|18180030|P7|Extension Treatment Period|Protocol Violation|0
5269420|NCT00622700|18180031|P6|Extension Treatment Period|Protocol Violation|2
5269421|NCT00622700|18180032|P5|Extension Treatment Period|Protocol Violation|0
5269422|NCT00622700|18180033|P4|Extension Treatment Period|Protocol Violation|0
5269423|NCT00622700|18180034|P3|Extension Treatment Period|Protocol Violation|0
5269424|NCT00622700|18180035|P2|Extension Treatment Period|Protocol Violation|0
5269425|NCT00622700|18180036|P1|Extension Treatment Period|Protocol Violation|0
5269426|NCT00622700|18180030|P7|Extension Treatment Period|Lack of Efficacy|9
5269427|NCT00622700|18180031|P6|Extension Treatment Period|Lack of Efficacy|1
5269428|NCT00622700|18180032|P5|Extension Treatment Period|Lack of Efficacy|8
5269429|NCT00622700|18180033|P4|Extension Treatment Period|Lack of Efficacy|2
5269430|NCT00622700|18180034|P3|Extension Treatment Period|Lack of Efficacy|0
5269431|NCT00622700|18180035|P2|Extension Treatment Period|Lack of Efficacy|0
5269432|NCT00622700|18180036|P1|Extension Treatment Period|Lack of Efficacy|0
5269433|NCT00622700|18180030|P7|Extension Treatment Period|Adverse Event|8
5269434|NCT00622700|18180031|P6|Extension Treatment Period|Adverse Event|6
5269435|NCT00622700|18180032|P5|Extension Treatment Period|Adverse Event|9
5269436|NCT00622700|18180033|P4|Extension Treatment Period|Adverse Event|5
5269437|NCT00622700|18180034|P3|Extension Treatment Period|Adverse Event|0
5269438|NCT00622700|18180035|P2|Extension Treatment Period|Adverse Event|0
5269439|NCT00622700|18180036|P1|Extension Treatment Period|Adverse Event|0
5269440|NCT00622700|18180030|P7|Core Treatment Period|Other than specified above|0
5269441|NCT00622700|18180031|P6|Core Treatment Period|Other than specified above|0
5269442|NCT00622700|18180032|P5|Core Treatment Period|Other than specified above|0
5269443|NCT00622700|18180033|P4|Core Treatment Period|Other than specified above|0
5269444|NCT00622700|18180034|P3|Core Treatment Period|Other than specified above|5
5269445|NCT00622700|18180035|P2|Core Treatment Period|Other than specified above|2
5269446|NCT00622700|18180036|P1|Core Treatment Period|Other than specified above|2
5269447|NCT00622700|18180030|P7|Core Treatment Period|Withdrawal by Subject|0
5269448|NCT00622700|18180031|P6|Core Treatment Period|Withdrawal by Subject|0
5269449|NCT00622700|18180032|P5|Core Treatment Period|Withdrawal by Subject|0
5269450|NCT00622700|18180033|P4|Core Treatment Period|Withdrawal by Subject|0
5269451|NCT00622700|18180034|P3|Core Treatment Period|Withdrawal by Subject|15
5269452|NCT00622700|18180035|P2|Core Treatment Period|Withdrawal by Subject|18
5269453|NCT00622700|18180036|P1|Core Treatment Period|Withdrawal by Subject|12
5269454|NCT00622700|18180030|P7|Core Treatment Period|Progressive Disease|0
5269455|NCT00622700|18180031|P6|Core Treatment Period|Progressive Disease|0
5269456|NCT00622700|18180032|P5|Core Treatment Period|Progressive Disease|0
5269457|NCT00622700|18180033|P4|Core Treatment Period|Progressive Disease|0
5269458|NCT00622700|18180034|P3|Core Treatment Period|Progressive Disease|0
5269459|NCT00622700|18180035|P2|Core Treatment Period|Progressive Disease|1
5269460|NCT00622700|18180036|P1|Core Treatment Period|Progressive Disease|3
5269461|NCT00622700|18180030|P7|Core Treatment Period|Death|0
5269462|NCT00622700|18180031|P6|Core Treatment Period|Death|0
5269463|NCT00622700|18180032|P5|Core Treatment Period|Death|0
5269464|NCT00622700|18180033|P4|Core Treatment Period|Death|0
5269465|NCT00622700|18180034|P3|Core Treatment Period|Death|0
5269466|NCT00622700|18180035|P2|Core Treatment Period|Death|0
5269467|NCT00622700|18180036|P1|Core Treatment Period|Death|1
5269468|NCT00622700|18180030|P7|Core Treatment Period|Lost to Follow-up|0
5269469|NCT00622700|18180031|P6|Core Treatment Period|Lost to Follow-up|0
5269470|NCT00622700|18180032|P5|Core Treatment Period|Lost to Follow-up|0
5269471|NCT00622700|18180033|P4|Core Treatment Period|Lost to Follow-up|0
5269472|NCT00622700|18180034|P3|Core Treatment Period|Lost to Follow-up|1
5269473|NCT00622700|18180035|P2|Core Treatment Period|Lost to Follow-up|1
5269474|NCT00622700|18180036|P1|Core Treatment Period|Lost to Follow-up|1
5269475|NCT00622700|18180030|P7|Core Treatment Period|Lack of Efficacy|0
5269476|NCT00622700|18180031|P6|Core Treatment Period|Lack of Efficacy|0
5269477|NCT00622700|18180032|P5|Core Treatment Period|Lack of Efficacy|0
5269478|NCT00622700|18180033|P4|Core Treatment Period|Lack of Efficacy|0
5269479|NCT00622700|18180034|P3|Core Treatment Period|Lack of Efficacy|12
5269480|NCT00622700|18180035|P2|Core Treatment Period|Lack of Efficacy|6
5269481|NCT00622700|18180036|P1|Core Treatment Period|Lack of Efficacy|19
5269482|NCT00622700|18180030|P7|Core Treatment Period|Adverse Event|0
5269483|NCT00622700|18180031|P6|Core Treatment Period|Adverse Event|0
5269484|NCT00622700|18180032|P5|Core Treatment Period|Adverse Event|0
5269485|NCT00622700|18180033|P4|Core Treatment Period|Adverse Event|0
5269486|NCT00622700|18180034|P3|Core Treatment Period|Adverse Event|18
5269487|NCT00622700|18180035|P2|Core Treatment Period|Adverse Event|25
5269488|NCT00622700|18180036|P1|Core Treatment Period|Adverse Event|18
5269489|NCT00622700|18180030|P7|Core Treatment Period|Randomized but Not Treated|0
5269490|NCT00622700|18180031|P6|Core Treatment Period|Randomized but Not Treated|0
5269491|NCT00622700|18180032|P5|Core Treatment Period|Randomized but Not Treated|0
5269492|NCT00622700|18180033|P4|Core Treatment Period|Randomized but Not Treated|0
5269493|NCT00622700|18180034|P3|Core Treatment Period|Randomized but Not Treated|2
5269494|NCT00622700|18180035|P2|Core Treatment Period|Randomized but Not Treated|2
5269495|NCT00622700|18180036|P1|Core Treatment Period|Randomized but Not Treated|0
5269496|NCT00622635|18180095|P6|Treatment Period 3|Withdrawal by Subject|0
5269497|NCT00622635|18180096|P5|Treatment Period 3|Withdrawal by Subject|0
5269498|NCT00622635|18180097|P4|Treatment Period 3|Withdrawal by Subject|1
5269499|NCT00622635|18180098|P3|Treatment Period 3|Withdrawal by Subject|0
5269500|NCT00622635|18180099|P2|Treatment Period 3|Withdrawal by Subject|0
5269501|NCT00622635|18180100|P1|Treatment Period 3|Withdrawal by Subject|0
5269502|NCT00622635|18180095|P6|Treatment Period 3|Adverse Event|0
5269503|NCT00622635|18180096|P5|Treatment Period 3|Adverse Event|0
5269504|NCT00622635|18180097|P4|Treatment Period 3|Adverse Event|2
5269505|NCT00622635|18180098|P3|Treatment Period 3|Adverse Event|0
5269506|NCT00622635|18180099|P2|Treatment Period 3|Adverse Event|0
5269507|NCT00622635|18180100|P1|Treatment Period 3|Adverse Event|0
5269508|NCT00622635|18180095|P6|Treatment Period 2|Adverse Event|0
5269509|NCT00622635|18180096|P5|Treatment Period 2|Adverse Event|0
5269510|NCT00622635|18180097|P4|Treatment Period 2|Adverse Event|0
5269511|NCT00622635|18180098|P3|Treatment Period 2|Adverse Event|0
5269512|NCT00622635|18180099|P2|Treatment Period 2|Adverse Event|0
5269513|NCT00622635|18180100|P1|Treatment Period 2|Adverse Event|1
5269514|NCT00622635|18180095|P6|Treatment Period 1|Abnormal test procedure result(s)|0
5269515|NCT00622635|18180096|P5|Treatment Period 1|Abnormal test procedure result(s)|1
5269516|NCT00622635|18180097|P4|Treatment Period 1|Abnormal test procedure result(s)|0
5269517|NCT00622635|18180098|P3|Treatment Period 1|Abnormal test procedure result(s)|0
5269518|NCT00622635|18180099|P2|Treatment Period 1|Abnormal test procedure result(s)|0
5269519|NCT00622635|18180100|P1|Treatment Period 1|Abnormal test procedure result(s)|0
5269520|NCT00622635|18180095|P6|Treatment Period 1|Withdrawal by Subject|0
5269521|NCT00622635|18180096|P5|Treatment Period 1|Withdrawal by Subject|0
5269522|NCT00622635|18180097|P4|Treatment Period 1|Withdrawal by Subject|0
5269523|NCT00622635|18180098|P3|Treatment Period 1|Withdrawal by Subject|0
5269524|NCT00622635|18180099|P2|Treatment Period 1|Withdrawal by Subject|1
5269525|NCT00622635|18180100|P1|Treatment Period 1|Withdrawal by Subject|0
5269526|NCT00622635|18180095|P6|Treatment Period 1|Adverse Event|0
5269527|NCT00622635|18180096|P5|Treatment Period 1|Adverse Event|0
5269528|NCT00622635|18180097|P4|Treatment Period 1|Adverse Event|0
5269529|NCT00622635|18180098|P3|Treatment Period 1|Adverse Event|1
5269530|NCT00622635|18180099|P2|Treatment Period 1|Adverse Event|0
5269531|NCT00622635|18180100|P1|Treatment Period 1|Adverse Event|0
5269532|NCT00622466|18180181|P1|Overall Study|Withdrawal by Subject|2
5269533|NCT00622466|18180181|P1|Overall Study|Adverse Event|1
5269534|NCT00622466|18180181|P1|Overall Study|Death|1
5269535|NCT00622440|18180194|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
5269536|NCT00622440|18180195|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
5269537|NCT00622440|18180194|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
5269538|NCT00622440|18180195|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
5269539|NCT00622440|18180194|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
5269540|NCT00622440|18180195|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
5269541|NCT00622440|18180194|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
5269542|NCT00622440|18180195|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
5269543|NCT00622401|18180221|P3|Overall Study|Disease progression prior to treatment|0
5269544|NCT00622401|18180222|P2|Overall Study|Disease progression prior to treatment|2
5269545|NCT00622401|18180223|P1|Overall Study|Disease progression prior to treatment|3
5269546|NCT00622388|18180230|P1|Overall Study|Insurance Expired|1
5269547|NCT00622388|18180230|P1|Overall Study|Withdrew Consent|1
5269548|NCT00622388|18180230|P1|Overall Study|Took Prohibited Medication|2
5269549|NCT00622388|18180230|P1|Overall Study|Received Alternate Anticancer Therapy|8
5269550|NCT00622388|18180230|P1|Overall Study|Death|3
5269551|NCT00622388|18180230|P1|Overall Study|Participant Refusal|1
5269552|NCT00622388|18180230|P1|Overall Study|Protocol Violation|3
5269553|NCT00622388|18180230|P1|Overall Study|Adverse Event|6
5269554|NCT00622388|18180230|P1|Overall Study|Disease Progression|47
5269555|NCT00622336|18180248|P1|Extension Phase|Other|9
5269556|NCT00622336|18180248|P1|Extension Phase|Lost to Follow-up|1
5269557|NCT00622336|18180248|P1|Extension Phase|Withdrawal by Subject|1
5269558|NCT00622336|18180248|P1|Extension Phase|Lack of therapeutic effect|2
5269559|NCT00622336|18180248|P1|Extension Phase|Progressive Disease|6
5269560|NCT00622336|18180248|P1|Extension Phase|Adverse Event|2
5269561|NCT00622336|18180248|P1|Treatment Phase|Lost to Follow-up|2
5269562|NCT00622336|18180248|P1|Treatment Phase|Withdrawal by Subject|13
5269563|NCT00622336|18180248|P1|Treatment Phase|Lack of therapeutic effect|13
5269564|NCT00622336|18180248|P1|Treatment Phase|Death|14
5269565|NCT00622336|18180248|P1|Treatment Phase|Other|40
5269566|NCT00622336|18180248|P1|Treatment Phase|Adverse Event|46
5269567|NCT00622336|18180248|P1|Treatment Phase|Progression of Disease|181
5269568|NCT00622284|18180259|P2|Overall Study|Other reason (not specified)|24
5269569|NCT00622284|18180260|P1|Overall Study|Other reason (not specified)|33
5269570|NCT00622284|18180259|P2|Overall Study|Withdrawal by Subject|24
5269571|NCT00622284|18180260|P1|Overall Study|Withdrawal by Subject|27
5269572|NCT00622284|18180259|P2|Overall Study|Lost to Follow-up|13
5269573|NCT00622284|18180260|P1|Overall Study|Lost to Follow-up|11
5269574|NCT00622284|18180259|P2|Overall Study|Protocol Violation|5
5269575|NCT00622284|18180260|P1|Overall Study|Protocol Violation|12
5269576|NCT00622284|18180259|P2|Overall Study|Adverse Event|90
5269577|NCT00622284|18180260|P1|Overall Study|Adverse Event|61
5269578|NCT00622284|18180259|P2|Overall Study|Lack of Efficacy|15
5269579|NCT00622284|18180260|P1|Overall Study|Lack of Efficacy|45
5269580|NCT00622180|18180322|P2|Overall Study|Lost to Follow-up|2
5269581|NCT00622180|18180323|P1|Overall Study|Lost to Follow-up|1
5269582|NCT00622167|18180329|P1|Overall Study|Did not meet angiographic criteria|20
5269583|NCT00621985|18180333|P1|Dexamethasone Admission|Adverse Event|1
5269584|NCT00621959|18180341|P2|Overall Study|Other|3
5269585|NCT00621959|18180342|P1|Overall Study|Other|1
5269586|NCT00621959|18180341|P2|Overall Study|Withdrawal by Subject|1
5269587|NCT00621959|18180342|P1|Overall Study|Withdrawal by Subject|1
5269588|NCT00621959|18180341|P2|Overall Study|Lost to Follow-up|2
5269589|NCT00621959|18180342|P1|Overall Study|Lost to Follow-up|0
5269590|NCT00621959|18180341|P2|Overall Study|Lack of Efficacy|1
5269591|NCT00621959|18180342|P1|Overall Study|Lack of Efficacy|1
5269592|NCT00621959|18180341|P2|Overall Study|Adverse Event|2
5269593|NCT00621959|18180342|P1|Overall Study|Adverse Event|4
5269594|NCT00621855|18180381|P5|Overall Study|Patients did not receive study drug|2
5269595|NCT00621855|18180382|P4|Overall Study|Patients did not receive study drug|4
5269596|NCT00621855|18180383|P3|Overall Study|Patients did not receive study drug|5
5269597|NCT00621855|18180384|P2|Overall Study|Patients did not receive study drug|3
5269598|NCT00621855|18180385|P1|Overall Study|Patients did not receive study drug|3
5269599|NCT00621855|18180381|P5|Overall Study|Other|4
5269600|NCT00621855|18180382|P4|Overall Study|Other|5
5269601|NCT00621855|18180383|P3|Overall Study|Other|6
5269602|NCT00621855|18180384|P2|Overall Study|Other|7
5269603|NCT00621855|18180385|P1|Overall Study|Other|9
5269604|NCT00621855|18180381|P5|Overall Study|Withdrawal by Subject|9
5269605|NCT00621855|18180382|P4|Overall Study|Withdrawal by Subject|13
5269606|NCT00621855|18180383|P3|Overall Study|Withdrawal by Subject|13
5269607|NCT00621855|18180384|P2|Overall Study|Withdrawal by Subject|11
5269608|NCT00621855|18180385|P1|Overall Study|Withdrawal by Subject|16
5269609|NCT00621855|18180381|P5|Overall Study|Protocol Violation|8
5269610|NCT00621855|18180382|P4|Overall Study|Protocol Violation|7
5269611|NCT00621855|18180383|P3|Overall Study|Protocol Violation|6
5269612|NCT00621855|18180384|P2|Overall Study|Protocol Violation|8
5269613|NCT00621855|18180385|P1|Overall Study|Protocol Violation|16
5269614|NCT00621855|18180381|P5|Overall Study|Lost to Follow-up|1
5269615|NCT00621855|18180382|P4|Overall Study|Lost to Follow-up|4
5269616|NCT00621855|18180383|P3|Overall Study|Lost to Follow-up|3
5269617|NCT00621855|18180384|P2|Overall Study|Lost to Follow-up|1
5269618|NCT00621855|18180385|P1|Overall Study|Lost to Follow-up|0
5269619|NCT00621855|18180381|P5|Overall Study|Adverse Event|31
5269620|NCT00621855|18180382|P4|Overall Study|Adverse Event|34
5269621|NCT00621855|18180383|P3|Overall Study|Adverse Event|48
5269622|NCT00621855|18180384|P2|Overall Study|Adverse Event|31
5269623|NCT00621855|18180385|P1|Overall Study|Adverse Event|32
5269624|NCT00621842|18180427|P1|Overall Study|Lack of Efficacy|2
5269625|NCT00621842|18180427|P1|Overall Study|Protocol Violation|4
5269626|NCT00621842|18180427|P1|Overall Study|Withdrawal by Subject|7
5269627|NCT00621842|18180427|P1|Overall Study|Adverse Event|6
5269628|NCT00621777|18180444|P2|Randomized Phase|Death|1
5269629|NCT00621777|18180445|P1|Randomized Phase|Death|0
5269630|NCT00621777|18180444|P2|Randomized Phase|administrative|3
5269631|NCT00621777|18180445|P1|Randomized Phase|administrative|0
5269632|NCT00621777|18180444|P2|Randomized Phase|Withdrawal by Subject|9
5269633|NCT00621777|18180445|P1|Randomized Phase|Withdrawal by Subject|1
5269634|NCT00621777|18180444|P2|Randomized Phase|Lost to Follow-up|3
5269635|NCT00621777|18180445|P1|Randomized Phase|Lost to Follow-up|3
5269636|NCT00621777|18180444|P2|Randomized Phase|Adverse Event|3
5269637|NCT00621777|18180445|P1|Randomized Phase|Adverse Event|3
5269638|NCT00621777|18180444|P2|Open Phase|Lost to Follow-up|0
5269639|NCT00621777|18180445|P1|Open Phase|Lost to Follow-up|10
5269640|NCT00621777|18180444|P2|Open Phase|administrative|0
5269641|NCT00621777|18180445|P1|Open Phase|administrative|13
5269642|NCT00621777|18180444|P2|Open Phase|Withdrawal by Subject|0
5269643|NCT00621777|18180445|P1|Open Phase|Withdrawal by Subject|17
5269644|NCT00621777|18180444|P2|Open Phase|Did not abstain during open phase|0
5269645|NCT00621777|18180445|P1|Open Phase|Did not abstain during open phase|56
5269646|NCT00621777|18180444|P2|Open Phase|Adverse Event|0
5269647|NCT00621777|18180445|P1|Open Phase|Adverse Event|20
5269648|NCT00621764|18180460|P4|Overall Study|Protocol Violation|1
5269649|NCT00621764|18180461|P3|Overall Study|Protocol Violation|0
5269650|NCT00621764|18180462|P2|Overall Study|Protocol Violation|0
5269651|NCT00621764|18180463|P1|Overall Study|Protocol Violation|0
5269652|NCT00621621|18180509|P2|Overall Study|Subjects were exited at EP study|0
5269653|NCT00621621|18180510|P1|Overall Study|Subjects were exited at EP study|30
5269654|NCT00621582|18180518|P1|Overall Study|issues not identified by investigators|18
5269655|NCT00621582|18180518|P1|Overall Study|Lost to Follow-up|24
5269656|NCT00621582|18180518|P1|Overall Study|Protocol Violation|57
5269657|NCT00621582|18180518|P1|Overall Study|Adverse Event|7
5269658|NCT00621543|18180525|P1|Overall Study|Lost to Follow-up|23
5269659|NCT00621517|18180549|P2|Overall Study|Adverse Event|0
5269660|NCT00621517|18180550|P1|Overall Study|Adverse Event|1
5269661|NCT00621517|18180549|P2|Overall Study|Withdrawal by Subject|4
5269662|NCT00621517|18180550|P1|Overall Study|Withdrawal by Subject|3
5269663|NCT00621517|18180549|P2|Overall Study|Lost to Follow-up|3
5269664|NCT00621517|18180550|P1|Overall Study|Lost to Follow-up|3
5269665|NCT00621504|18180562|P2|Overall Study|Death|6
5269666|NCT00621504|18180563|P1|Overall Study|Death|6
5269667|NCT00621504|18180562|P2|Overall Study|Other|0
5269668|NCT00621504|18180563|P1|Overall Study|Other|1
5269669|NCT00621504|18180562|P2|Overall Study|Lost to Follow-up|10
5269670|NCT00621504|18180563|P1|Overall Study|Lost to Follow-up|8
5269671|NCT00621504|18180562|P2|Overall Study|Withdrew consent|6
5269672|NCT00621504|18180563|P1|Overall Study|Withdrew consent|9
5269673|NCT00621504|18180562|P2|Overall Study|At the request of sponsor/investigator|0
5269674|NCT00621504|18180563|P1|Overall Study|At the request of sponsor/investigator|1
5269675|NCT00621504|18180562|P2|Overall Study|Adverse Event|3
5269676|NCT00621504|18180563|P1|Overall Study|Adverse Event|1
5269677|NCT00621322|18180597|P6|Overall Study|Migrated/moved from study area|2
5269678|NCT00621322|18180598|P5|Overall Study|Migrated/moved from study area|0
5269679|NCT00621322|18180599|P4|Overall Study|Migrated/moved from study area|1
5269680|NCT00621322|18180600|P3|Overall Study|Migrated/moved from study area|1
5269681|NCT00621322|18180601|P2|Overall Study|Migrated/moved from study area|0
5269682|NCT00621322|18180602|P1|Overall Study|Migrated/moved from study area|1
5269683|NCT00621322|18180597|P6|Overall Study|Withdrawal by Subject|2
5269684|NCT00621322|18180598|P5|Overall Study|Withdrawal by Subject|0
5269685|NCT00621322|18180599|P4|Overall Study|Withdrawal by Subject|1
5269686|NCT00621322|18180600|P3|Overall Study|Withdrawal by Subject|0
5269687|NCT00621322|18180601|P2|Overall Study|Withdrawal by Subject|0
5269688|NCT00621322|18180602|P1|Overall Study|Withdrawal by Subject|0
5269689|NCT00621322|18180597|P6|Overall Study|Physician Decision|0
5269690|NCT00621322|18180598|P5|Overall Study|Physician Decision|0
5269691|NCT00621322|18180599|P4|Overall Study|Physician Decision|1
5269692|NCT00621322|18180600|P3|Overall Study|Physician Decision|1
5269693|NCT00621322|18180601|P2|Overall Study|Physician Decision|0
5269694|NCT00621322|18180602|P1|Overall Study|Physician Decision|0
5269695|NCT00621322|18180597|P6|Overall Study|Lost to Follow-up|0
5269696|NCT00621322|18180598|P5|Overall Study|Lost to Follow-up|1
5269697|NCT00621322|18180599|P4|Overall Study|Lost to Follow-up|0
5269698|NCT00621322|18180600|P3|Overall Study|Lost to Follow-up|0
5269699|NCT00621322|18180601|P2|Overall Study|Lost to Follow-up|0
5269700|NCT00621322|18180602|P1|Overall Study|Lost to Follow-up|0
5269701|NCT00621309|18180682|P6|Overall Study|Withdrawal by Subject|1
5269702|NCT00621309|18180683|P5|Overall Study|Withdrawal by Subject|1
5269703|NCT00621309|18180684|P4|Overall Study|Withdrawal by Subject|1
5269704|NCT00621309|18180685|P3|Overall Study|Withdrawal by Subject|1
5269705|NCT00621309|18180686|P2|Overall Study|Withdrawal by Subject|0
5269706|NCT00621309|18180687|P1|Overall Study|Withdrawal by Subject|2
5269707|NCT00621296|18180693|P1|Overall Study|Stopping Criteria|3
5269708|NCT00621296|18180693|P1|Overall Study|Unmatch Criteria|1
5269709|NCT00621296|18180693|P1|Overall Study|Physician Decision|7
5269710|NCT00621296|18180693|P1|Overall Study|Lack of Efficacy|1
5269711|NCT00621296|18180693|P1|Overall Study|Adverse Event|2
5269712|NCT00621257|18180702|P5|Overall Study|Withdrawal by Subject|1
5269713|NCT00621257|18180703|P4|Overall Study|Withdrawal by Subject|1
5269714|NCT00621257|18180704|P3|Overall Study|Withdrawal by Subject|0
5269715|NCT00621257|18180705|P2|Overall Study|Withdrawal by Subject|0
5269716|NCT00621257|18180706|P1|Overall Study|Withdrawal by Subject|0
5269717|NCT00621257|18180702|P5|Overall Study|Physician Decision|1
5269718|NCT00621257|18180703|P4|Overall Study|Physician Decision|1
5269719|NCT00621257|18180704|P3|Overall Study|Physician Decision|0
5269720|NCT00621257|18180705|P2|Overall Study|Physician Decision|2
5269721|NCT00621257|18180706|P1|Overall Study|Physician Decision|0
5269722|NCT00621257|18180702|P5|Overall Study|Adverse Event|0
5269723|NCT00621257|18180703|P4|Overall Study|Adverse Event|0
5269724|NCT00621257|18180704|P3|Overall Study|Adverse Event|1
5269725|NCT00621257|18180705|P2|Overall Study|Adverse Event|1
5269726|NCT00621257|18180706|P1|Overall Study|Adverse Event|0
5269727|NCT00621257|18180702|P5|Overall Study|Lost to Follow-up|7
5269728|NCT00621257|18180703|P4|Overall Study|Lost to Follow-up|4
5269729|NCT00621257|18180704|P3|Overall Study|Lost to Follow-up|2
5269730|NCT00621257|18180705|P2|Overall Study|Lost to Follow-up|0
5269731|NCT00621257|18180706|P1|Overall Study|Lost to Follow-up|4
5269732|NCT00621244|18180722|P4|Overall Study|Administrative problems|2
5269733|NCT00621244|18180723|P3|Overall Study|Administrative problems|0
5269734|NCT00621244|18180724|P2|Overall Study|Administrative problems|1
5269735|NCT00621244|18180725|P1|Overall Study|Administrative problems|5
5269736|NCT00621244|18180722|P4|Overall Study|Adverse Event|2
5269737|NCT00621244|18180723|P3|Overall Study|Adverse Event|9
5269738|NCT00621244|18180724|P2|Overall Study|Adverse Event|7
5269739|NCT00621244|18180725|P1|Overall Study|Adverse Event|27
5269740|NCT00621244|18180722|P4|Overall Study|Death|1
5269741|NCT00621244|18180723|P3|Overall Study|Death|1
5269742|NCT00621244|18180724|P2|Overall Study|Death|3
5269743|NCT00621244|18180725|P1|Overall Study|Death|3
5269744|NCT00621244|18180722|P4|Overall Study|Disease progression|15
5269745|NCT00621244|18180723|P3|Overall Study|Disease progression|20
5269746|NCT00621244|18180724|P2|Overall Study|Disease progression|20
5269747|NCT00621244|18180725|P1|Overall Study|Disease progression|44
5269748|NCT00621244|18180722|P4|Overall Study|Withdrawal by Subject|3
5269749|NCT00621244|18180723|P3|Overall Study|Withdrawal by Subject|3
5269750|NCT00621244|18180724|P2|Overall Study|Withdrawal by Subject|3
5269751|NCT00621244|18180725|P1|Overall Study|Withdrawal by Subject|7
5269752|NCT00621192|18180829|P4|Overall Study|Final Assessments not Completed|1
5269753|NCT00621192|18180830|P3|Overall Study|Final Assessments not Completed|3
5269754|NCT00621192|18180831|P2|Overall Study|Final Assessments not Completed|0
5269755|NCT00621192|18180832|P1|Overall Study|Final Assessments not Completed|0
5269756|NCT00621192|18180829|P4|Overall Study|Death|0
5269757|NCT00621192|18180830|P3|Overall Study|Death|0
5269758|NCT00621192|18180831|P2|Overall Study|Death|5
5269759|NCT00621192|18180832|P1|Overall Study|Death|2
5269760|NCT00621192|18180829|P4|Overall Study|Adverse Event|1
5269761|NCT00621192|18180830|P3|Overall Study|Adverse Event|0
5269762|NCT00621192|18180831|P2|Overall Study|Adverse Event|1
5269763|NCT00621192|18180832|P1|Overall Study|Adverse Event|0
5269764|NCT00621192|18180829|P4|Overall Study|Protocol Violation|1
5269765|NCT00621192|18180830|P3|Overall Study|Protocol Violation|0
5269766|NCT00621192|18180831|P2|Overall Study|Protocol Violation|0
5269767|NCT00621192|18180832|P1|Overall Study|Protocol Violation|1
5269768|NCT00621192|18180829|P4|Overall Study|Physician Decision|0
5269769|NCT00621192|18180830|P3|Overall Study|Physician Decision|0
5269770|NCT00621192|18180831|P2|Overall Study|Physician Decision|3
5269771|NCT00621192|18180832|P1|Overall Study|Physician Decision|1
5269772|NCT00621192|18180829|P4|Overall Study|Withdrawal by Subject|0
5269773|NCT00621192|18180830|P3|Overall Study|Withdrawal by Subject|2
5269774|NCT00621192|18180831|P2|Overall Study|Withdrawal by Subject|0
5269775|NCT00621192|18180832|P1|Overall Study|Withdrawal by Subject|0
5269776|NCT00621153|18180873|P2|Overall Study|Withdrawal by Subject|5
5269777|NCT00621153|18180874|P1|Overall Study|Withdrawal by Subject|4
5269778|NCT00621153|18180873|P2|Overall Study|Lost to Follow-up|1
5269779|NCT00621153|18180874|P1|Overall Study|Lost to Follow-up|5
5269780|NCT00621153|18180873|P2|Overall Study|Adverse Event|2
5269781|NCT00621153|18180874|P1|Overall Study|Adverse Event|3
5269782|NCT00621153|18180873|P2|Overall Study|Safety Reason|7
5269783|NCT00621153|18180874|P1|Overall Study|Safety Reason|8
5269784|NCT00621140|18180882|P2|Overall Study|Other incl. lack of efficacy|5
5269785|NCT00621140|18180883|P1|Overall Study|Other incl. lack of efficacy|6
5269786|NCT00621140|18180882|P2|Overall Study|Withdrawal by Subject|6
5269787|NCT00621140|18180883|P1|Overall Study|Withdrawal by Subject|4
5269788|NCT00621140|18180882|P2|Overall Study|Lost to Follow-up|2
5269789|NCT00621140|18180883|P1|Overall Study|Lost to Follow-up|1
5269790|NCT00621140|18180882|P2|Overall Study|Adverse Event|5
5269791|NCT00621140|18180883|P1|Overall Study|Adverse Event|4
5269792|NCT00621023|18180930|P1|Overall Study|Follow up discontinued|1
5269793|NCT00621023|18180930|P1|Overall Study|Death|5
5269794|NCT00620854|18180947|P6|Washout 1|Withdrawal by Subject|0
5269795|NCT00620854|18180948|P5|Washout 1|Withdrawal by Subject|0
5269796|NCT00620854|18180949|P4|Washout 1|Withdrawal by Subject|1
5269797|NCT00620854|18180950|P3|Washout 1|Withdrawal by Subject|1
5269798|NCT00620854|18180951|P2|Washout 1|Withdrawal by Subject|0
5269799|NCT00620854|18180952|P1|Washout 1|Withdrawal by Subject|0
5269800|NCT00620815|18180983|P3|Overall Study|Protocol Violation|1
5269801|NCT00620815|18180984|P2|Overall Study|Protocol Violation|2
5269802|NCT00620815|18180985|P1|Overall Study|Protocol Violation|1
5269803|NCT00620815|18180983|P3|Overall Study|Inappropriate enrolment|1
5269804|NCT00620815|18180984|P2|Overall Study|Inappropriate enrolment|0
5269805|NCT00620815|18180985|P1|Overall Study|Inappropriate enrolment|0
5269806|NCT00620815|18180983|P3|Overall Study|Lost to Follow-up|3
5269807|NCT00620815|18180984|P2|Overall Study|Lost to Follow-up|6
5269808|NCT00620815|18180985|P1|Overall Study|Lost to Follow-up|1
5269809|NCT00620815|18180983|P3|Overall Study|Withdrawal by Subject|0
5269810|NCT00620815|18180984|P2|Overall Study|Withdrawal by Subject|2
5269811|NCT00620815|18180985|P1|Overall Study|Withdrawal by Subject|1
5269812|NCT00620815|18180983|P3|Overall Study|Adverse Event|2
5269813|NCT00620815|18180984|P2|Overall Study|Adverse Event|1
5269814|NCT00620815|18180985|P1|Overall Study|Adverse Event|1
5269815|NCT00620776|18181025|P2|Overall Study|Withdrawal by Subject|2
5269816|NCT00620776|18181026|P1|Overall Study|Withdrawal by Subject|3
5269817|NCT00620776|18181025|P2|Overall Study|Lost to Follow-up|5
5269818|NCT00620776|18181026|P1|Overall Study|Lost to Follow-up|2
5269819|NCT00620776|18181025|P2|Overall Study|Lack of Efficacy|1
5269820|NCT00620776|18181026|P1|Overall Study|Lack of Efficacy|2
5269821|NCT00620776|18181025|P2|Overall Study|Adverse Event|3
5269822|NCT00620776|18181026|P1|Overall Study|Adverse Event|2
5269823|NCT00620776|18181025|P2|Overall Study|Did not receive treatment|5
5269824|NCT00620776|18181026|P1|Overall Study|Did not receive treatment|3
5269825|NCT00620763|18181054|P2|Period: Second Intervention|Withdrawal by Subject|0
5269826|NCT00620763|18181055|P1|Period: Second Intervention|Withdrawal by Subject|1
5269827|NCT00620763|18181054|P2|Period: First Intervention|Protocol Violation|3
5269828|NCT00620763|18181055|P1|Period: First Intervention|Protocol Violation|0
5269829|NCT00620763|18181054|P2|Period: First Intervention|Withdrawal by Subject|2
5269830|NCT00620763|18181055|P1|Period: First Intervention|Withdrawal by Subject|0
5269831|NCT00620750|18181061|P1|Overall Study|Lost to Follow-up|25
5269832|NCT00620659|18181076|P6|Treatment Period 3|Withdrawal by Subject|0
5269833|NCT00620659|18181077|P5|Treatment Period 3|Withdrawal by Subject|0
5269834|NCT00620659|18181078|P4|Treatment Period 3|Withdrawal by Subject|1
5269835|NCT00620659|18181079|P3|Treatment Period 3|Withdrawal by Subject|0
5269836|NCT00620659|18181080|P2|Treatment Period 3|Withdrawal by Subject|0
5269837|NCT00620659|18181081|P1|Treatment Period 3|Withdrawal by Subject|0
5269838|NCT00620659|18181076|P6|Treatment Period 3|Adverse Event|0
5269839|NCT00620659|18181077|P5|Treatment Period 3|Adverse Event|0
5269840|NCT00620659|18181078|P4|Treatment Period 3|Adverse Event|0
5269841|NCT00620659|18181079|P3|Treatment Period 3|Adverse Event|0
5269842|NCT00620659|18181080|P2|Treatment Period 3|Adverse Event|2
5269843|NCT00620659|18181081|P1|Treatment Period 3|Adverse Event|0
5269844|NCT00620659|18181076|P6|Placebo Washout Period 2|Adverse Event|0
5269845|NCT00620659|18181077|P5|Placebo Washout Period 2|Adverse Event|0
5269846|NCT00620659|18181078|P4|Placebo Washout Period 2|Adverse Event|0
5269847|NCT00620659|18181079|P3|Placebo Washout Period 2|Adverse Event|0
5269848|NCT00620659|18181080|P2|Placebo Washout Period 2|Adverse Event|0
5269849|NCT00620659|18181081|P1|Placebo Washout Period 2|Adverse Event|2
5269850|NCT00620659|18181076|P6|Treatment Period 2|Withdrawal by Subject|0
5269851|NCT00620659|18181077|P5|Treatment Period 2|Withdrawal by Subject|3
5269852|NCT00620659|18181078|P4|Treatment Period 2|Withdrawal by Subject|0
5269853|NCT00620659|18181079|P3|Treatment Period 2|Withdrawal by Subject|1
5269854|NCT00620659|18181080|P2|Treatment Period 2|Withdrawal by Subject|0
5269855|NCT00620659|18181081|P1|Treatment Period 2|Withdrawal by Subject|0
5269856|NCT00620659|18181076|P6|Treatment Period 2|Adverse Event|0
5269857|NCT00620659|18181077|P5|Treatment Period 2|Adverse Event|2
5269858|NCT00620659|18181078|P4|Treatment Period 2|Adverse Event|0
5269859|NCT00620659|18181079|P3|Treatment Period 2|Adverse Event|0
5269860|NCT00620659|18181080|P2|Treatment Period 2|Adverse Event|3
5269861|NCT00620659|18181081|P1|Treatment Period 2|Adverse Event|0
5269862|NCT00620659|18181076|P6|Placebo Washout Period 1|Withdrawal by Subject|0
5269863|NCT00620659|18181077|P5|Placebo Washout Period 1|Withdrawal by Subject|0
5269864|NCT00620659|18181078|P4|Placebo Washout Period 1|Withdrawal by Subject|1
5269865|NCT00620659|18181079|P3|Placebo Washout Period 1|Withdrawal by Subject|0
5269866|NCT00620659|18181080|P2|Placebo Washout Period 1|Withdrawal by Subject|0
5269867|NCT00620659|18181081|P1|Placebo Washout Period 1|Withdrawal by Subject|0
5269868|NCT00620659|18181076|P6|Treatment Period 1|Withdrawal by Subject|0
5269869|NCT00620659|18181077|P5|Treatment Period 1|Withdrawal by Subject|1
5269870|NCT00620659|18181078|P4|Treatment Period 1|Withdrawal by Subject|0
5269871|NCT00620659|18181079|P3|Treatment Period 1|Withdrawal by Subject|1
5269872|NCT00620659|18181080|P2|Treatment Period 1|Withdrawal by Subject|0
5269873|NCT00620659|18181081|P1|Treatment Period 1|Withdrawal by Subject|1
5269874|NCT00620659|18181076|P6|Treatment Period 1|Protocol Violation|0
5269875|NCT00620659|18181077|P5|Treatment Period 1|Protocol Violation|0
5269876|NCT00620659|18181078|P4|Treatment Period 1|Protocol Violation|0
5269877|NCT00620659|18181079|P3|Treatment Period 1|Protocol Violation|0
5269878|NCT00620659|18181080|P2|Treatment Period 1|Protocol Violation|0
5269879|NCT00620659|18181081|P1|Treatment Period 1|Protocol Violation|1
5269880|NCT00620659|18181076|P6|Treatment Period 1|Adverse Event|0
5269881|NCT00620659|18181077|P5|Treatment Period 1|Adverse Event|0
5269882|NCT00620659|18181078|P4|Treatment Period 1|Adverse Event|3
5269883|NCT00620659|18181079|P3|Treatment Period 1|Adverse Event|0
5269884|NCT00620659|18181080|P2|Treatment Period 1|Adverse Event|0
5269885|NCT00620659|18181081|P1|Treatment Period 1|Adverse Event|1
5269886|NCT00620555|18181099|P1|Overall Study|Visit failure against planned|1
5269887|NCT00620555|18181099|P1|Overall Study|Choice of other treatment|1
5269888|NCT00620555|18181099|P1|Overall Study|Withdrawal by Subject|1
5269889|NCT00620555|18181099|P1|Overall Study|Lack of Efficacy|12
5269890|NCT00620555|18181099|P1|Overall Study|Protocol Violation|2
5269891|NCT00620555|18181099|P1|Overall Study|Adverse Event|4
5269892|NCT00620542|18181108|P4|Part B (2 Year Core Study)|IVUS not available|2
5269893|NCT00620542|18181109|P3|Part B (2 Year Core Study)|IVUS not available|3
5269894|NCT00620542|18181110|P2|Part B (2 Year Core Study)|IVUS not available|0
5269895|NCT00620542|18181111|P1|Part B (2 Year Core Study)|IVUS not available|0
5269896|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
5269897|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
5269898|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
5269899|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
5269900|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Safety reasons|3
5269901|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Safety reasons|2
5269902|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Safety reasons|0
5269903|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Safety reasons|0
5269904|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Protocol Violation|16
5269905|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Protocol Violation|13
5269906|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Protocol Violation|0
5269907|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Protocol Violation|0
5269908|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
5269909|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
5269910|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
5269911|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
5269912|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
5269913|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
5269914|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
5269915|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
5269916|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Protocol Violation|5
5269917|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Protocol Violation|3
5269918|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Protocol Violation|0
5269919|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Protocol Violation|0
5269920|NCT00620542|18181108|P4|Part B (2 Year Core Study)|Adverse Event|49
5269921|NCT00620542|18181109|P3|Part B (2 Year Core Study)|Adverse Event|46
5269922|NCT00620542|18181110|P2|Part B (2 Year Core Study)|Adverse Event|0
5269923|NCT00620542|18181111|P1|Part B (2 Year Core Study)|Adverse Event|0
5269924|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
5269925|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
5269926|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
5269927|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
5269928|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
5269929|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
5269930|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
5269931|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
5269932|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5269933|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5269934|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
5269935|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5269936|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
5269937|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
5269938|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
5269939|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
5269940|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
5269941|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
5269942|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
5269943|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
5269944|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5269945|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5269946|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
5269947|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
5269948|NCT00620542|18181108|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
5269949|NCT00620542|18181109|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
5269950|NCT00620542|18181110|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
5269951|NCT00620542|18181111|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
5269952|NCT00620464|18181176|P2|Overall Study|Used prohibited medication|0
5269953|NCT00620464|18181177|P1|Overall Study|Used prohibited medication|1
5269954|NCT00620464|18181176|P2|Overall Study|Personal|2
5269955|NCT00620464|18181177|P1|Overall Study|Personal|2
5269956|NCT00620464|18181176|P2|Overall Study|Planning Pregnancy|4
5269957|NCT00620464|18181177|P1|Overall Study|Planning Pregnancy|1
5269958|NCT00620464|18181176|P2|Overall Study|Lost to Follow-up|1
5269959|NCT00620464|18181177|P1|Overall Study|Lost to Follow-up|1
5269960|NCT00620464|18181176|P2|Overall Study|Adverse Event|17
5269961|NCT00620464|18181177|P1|Overall Study|Adverse Event|15
5269962|NCT00620373|18181196|P1|Overall Study|Unverified cancer status|33
5269963|NCT00620321|18181214|P2|Overall Study|Withdrawal by Subject|1
5269964|NCT00620321|18181215|P1|Overall Study|Withdrawal by Subject|1
5269965|NCT00620321|18181214|P2|Overall Study|Sponsor Decision|1
5269966|NCT00620321|18181215|P1|Overall Study|Sponsor Decision|0
5269967|NCT00620321|18181214|P2|Overall Study|Progressive Disease|5
5269968|NCT00620321|18181215|P1|Overall Study|Progressive Disease|5
5269969|NCT00620321|18181214|P2|Overall Study|Physician Decision|7
5269970|NCT00620321|18181215|P1|Overall Study|Physician Decision|0
5269971|NCT00620321|18181214|P2|Overall Study|Death|1
5269972|NCT00620321|18181215|P1|Overall Study|Death|1
5269973|NCT00620321|18181214|P2|Overall Study|Adverse Event|1
5269974|NCT00620321|18181215|P1|Overall Study|Adverse Event|1
5269975|NCT00620282|18181234|P3|Overall Study|Withdrawal by Subject|0
5269976|NCT00620282|18181235|P2|Overall Study|Withdrawal by Subject|1
5269977|NCT00620282|18181236|P1|Overall Study|Withdrawal by Subject|0
5269978|NCT00620282|18181234|P3|Overall Study|Arterial line unable to be placed|1
5269979|NCT00620282|18181235|P2|Overall Study|Arterial line unable to be placed|0
5269980|NCT00620282|18181236|P1|Overall Study|Arterial line unable to be placed|0
5269981|NCT00620282|18181234|P3|Overall Study|Adverse Event|0
5269982|NCT00620282|18181235|P2|Overall Study|Adverse Event|1
5269983|NCT00620282|18181236|P1|Overall Study|Adverse Event|0
5269984|NCT00620113|18181315|P4|Overall Study|Withdrawal by Subject|5
5269985|NCT00620113|18181316|P3|Overall Study|Withdrawal by Subject|3
5269986|NCT00620113|18181317|P2|Overall Study|Withdrawal by Subject|1
5269987|NCT00620113|18181318|P1|Overall Study|Withdrawal by Subject|5
5269988|NCT00620113|18181315|P4|Overall Study|Protocol Violation|0
5269989|NCT00620113|18181316|P3|Overall Study|Protocol Violation|0
5269990|NCT00620113|18181317|P2|Overall Study|Protocol Violation|1
5269991|NCT00620113|18181318|P1|Overall Study|Protocol Violation|2
5269992|NCT00620113|18181315|P4|Overall Study|Physician Decision|2
5269993|NCT00620113|18181316|P3|Overall Study|Physician Decision|0
5269994|NCT00620113|18181317|P2|Overall Study|Physician Decision|0
5269995|NCT00620113|18181318|P1|Overall Study|Physician Decision|1
5269996|NCT00620113|18181315|P4|Overall Study|Lack of Efficacy|2
5269997|NCT00620113|18181316|P3|Overall Study|Lack of Efficacy|0
5269998|NCT00620113|18181317|P2|Overall Study|Lack of Efficacy|3
5269999|NCT00620113|18181318|P1|Overall Study|Lack of Efficacy|2
5270000|NCT00620113|18181315|P4|Overall Study|Adverse Event|1
5270001|NCT00620113|18181316|P3|Overall Study|Adverse Event|2
5270002|NCT00620113|18181317|P2|Overall Study|Adverse Event|2
5270003|NCT00620113|18181318|P1|Overall Study|Adverse Event|3
5270004|NCT00620074|18181368|P1|Overall Study|Adverse Event|1
5270005|NCT00620035|18181391|P1|Overall Study|Other Reason|38
5270006|NCT00620035|18181391|P1|Overall Study|Withdrawal of Informed Consent|1
5270007|NCT00620035|18181391|P1|Overall Study|Adverse Event|106
5270008|NCT00620022|18181401|P2|Treatment Period 2|Adverse Event|2
5270009|NCT00620022|18181402|P1|Treatment Period 2|Adverse Event|2
5270010|NCT00620022|18181401|P2|Treatment Period 1|Subject withdrew consent|0
5270011|NCT00620022|18181402|P1|Treatment Period 1|Subject withdrew consent|1
5270012|NCT00620022|18181401|P2|Treatment Period 1|Adverse Event|6
5270013|NCT00620022|18181402|P1|Treatment Period 1|Adverse Event|4
5270014|NCT00619983|18181414|P4|Test Drug Alone|Failure of daily diary device|2
5270015|NCT00619983|18181415|P3|Test Drug Alone|Failure of daily diary device|2
5270016|NCT00619983|18181416|P2|Test Drug Alone|Failure of daily diary device|1
5270017|NCT00619983|18181417|P1|Test Drug Alone|Failure of daily diary device|1
5270018|NCT00619983|18181414|P4|Test Drug Alone|Withdrawal by Subject|1
5270019|NCT00619983|18181415|P3|Test Drug Alone|Withdrawal by Subject|0
5270020|NCT00619983|18181416|P2|Test Drug Alone|Withdrawal by Subject|0
5270021|NCT00619983|18181417|P1|Test Drug Alone|Withdrawal by Subject|1
5270022|NCT00619957|18181444|P2|Month 48 Open-Label|Withdrawal by Subject|9
5270023|NCT00619957|18181445|P1|Month 48 Open-Label|Withdrawal by Subject|6
5270024|NCT00619957|18181444|P2|Month 48 Open-Label|Lost to Follow-up|4
5270025|NCT00619957|18181445|P1|Month 48 Open-Label|Lost to Follow-up|2
5270026|NCT00619957|18181444|P2|Month 48 Open-Label|Adverse Event|4
5270027|NCT00619957|18181445|P1|Month 48 Open-Label|Adverse Event|4
5270028|NCT00619957|18181444|P2|Month 24 Double-Blind|Did not take any study medication|1
5270029|NCT00619957|18181445|P1|Month 24 Double-Blind|Did not take any study medication|0
5270030|NCT00619957|18181444|P2|Month 24 Double-Blind|Lost to Follow-up|0
5270031|NCT00619957|18181445|P1|Month 24 Double-Blind|Lost to Follow-up|1
5270032|NCT00619957|18181444|P2|Month 24 Double-Blind|Withdrawal by Subject|9
5270033|NCT00619957|18181445|P1|Month 24 Double-Blind|Withdrawal by Subject|7
5270034|NCT00619957|18181444|P2|Month 24 Double-Blind|Protocol Violation|0
5270035|NCT00619957|18181445|P1|Month 24 Double-Blind|Protocol Violation|1
5270036|NCT00619957|18181444|P2|Month 24 Double-Blind|Adverse Event|7
5270037|NCT00619957|18181445|P1|Month 24 Double-Blind|Adverse Event|9
5270038|NCT00619918|18181527|P2|Overall Study|Left before receiving first dose|8
5270039|NCT00619918|18181528|P1|Overall Study|Left before receiving first dose|5
5270040|NCT00619918|18181527|P2|Overall Study|Transfer to outside facility|3
5270041|NCT00619918|18181528|P1|Overall Study|Transfer to outside facility|3
5270042|NCT00619918|18181527|P2|Overall Study|Physician Decision|8
5270043|NCT00619918|18181528|P1|Overall Study|Physician Decision|8
5270044|NCT00619918|18181527|P2|Overall Study|Withdrawal by Subject|3
5270045|NCT00619918|18181528|P1|Overall Study|Withdrawal by Subject|4
5270046|NCT00619892|18181538|P2|Overall Study|Intercurrent illness|1
5270047|NCT00619892|18181539|P1|Overall Study|Intercurrent illness|0
5270048|NCT00619892|18181538|P2|Overall Study|Lost to Follow-up|1
5270049|NCT00619892|18181539|P1|Overall Study|Lost to Follow-up|0
5270050|NCT00619892|18181538|P2|Overall Study|Adverse Event|0
5270051|NCT00619892|18181539|P1|Overall Study|Adverse Event|3
5270052|NCT00619866|18181550|P5|Weeks 13 - 24|Lost to Follow-up|0
5270053|NCT00619866|18181551|P4|Weeks 13 - 24|Lost to Follow-up|0
5270054|NCT00619866|18181552|P3|Weeks 13 - 24|Lost to Follow-up|0
5270055|NCT00619866|18181553|P2|Weeks 13 - 24|Lost to Follow-up|3
5270056|NCT00619866|18181554|P1|Weeks 13 - 24|Lost to Follow-up|0
5270057|NCT00619866|18181550|P5|Weeks 13 - 24|Non-compliance|0
5270058|NCT00619866|18181551|P4|Weeks 13 - 24|Non-compliance|0
5270059|NCT00619866|18181552|P3|Weeks 13 - 24|Non-compliance|1
5270060|NCT00619866|18181553|P2|Weeks 13 - 24|Non-compliance|1
5270061|NCT00619866|18181554|P1|Weeks 13 - 24|Non-compliance|0
5270062|NCT00619866|18181550|P5|Weeks 13 - 24|Withdrawal by Subject|2
5270063|NCT00619866|18181551|P4|Weeks 13 - 24|Withdrawal by Subject|2
5270064|NCT00619866|18181552|P3|Weeks 13 - 24|Withdrawal by Subject|2
5270065|NCT00619866|18181553|P2|Weeks 13 - 24|Withdrawal by Subject|3
5270066|NCT00619866|18181554|P1|Weeks 13 - 24|Withdrawal by Subject|0
5270067|NCT00619866|18181550|P5|Weeks 13 - 24|Protocol Deviation|0
5270068|NCT00619866|18181551|P4|Weeks 13 - 24|Protocol Deviation|1
5270069|NCT00619866|18181552|P3|Weeks 13 - 24|Protocol Deviation|0
5270070|NCT00619866|18181553|P2|Weeks 13 - 24|Protocol Deviation|0
5270071|NCT00619866|18181554|P1|Weeks 13 - 24|Protocol Deviation|0
5270072|NCT00619866|18181550|P5|Weeks 13 - 24|Adverse Event|0
5270073|NCT00619866|18181551|P4|Weeks 13 - 24|Adverse Event|1
5270074|NCT00619866|18181552|P3|Weeks 13 - 24|Adverse Event|2
5270075|NCT00619866|18181553|P2|Weeks 13 - 24|Adverse Event|0
5270076|NCT00619866|18181554|P1|Weeks 13 - 24|Adverse Event|0
5270077|NCT00619866|18181550|P5|Weeks 1 - 12|Sponsor Decision|0
5270078|NCT00619866|18181551|P4|Weeks 1 - 12|Sponsor Decision|0
5270079|NCT00619866|18181552|P3|Weeks 1 - 12|Sponsor Decision|0
5270080|NCT00619866|18181553|P2|Weeks 1 - 12|Sponsor Decision|1
5270081|NCT00619866|18181554|P1|Weeks 1 - 12|Sponsor Decision|0
5270082|NCT00619866|18181550|P5|Weeks 1 - 12|Lost to Follow-up|0
5270083|NCT00619866|18181551|P4|Weeks 1 - 12|Lost to Follow-up|0
5270084|NCT00619866|18181552|P3|Weeks 1 - 12|Lost to Follow-up|2
5270085|NCT00619866|18181553|P2|Weeks 1 - 12|Lost to Follow-up|0
5270086|NCT00619866|18181554|P1|Weeks 1 - 12|Lost to Follow-up|4
5270087|NCT00619866|18181550|P5|Weeks 1 - 12|Lack of Efficacy|0
5270088|NCT00619866|18181551|P4|Weeks 1 - 12|Lack of Efficacy|0
5270089|NCT00619866|18181552|P3|Weeks 1 - 12|Lack of Efficacy|1
5270090|NCT00619866|18181553|P2|Weeks 1 - 12|Lack of Efficacy|2
5270091|NCT00619866|18181554|P1|Weeks 1 - 12|Lack of Efficacy|3
5270092|NCT00619866|18181550|P5|Weeks 1 - 12|Withdrawal by Subject|0
5270093|NCT00619866|18181551|P4|Weeks 1 - 12|Withdrawal by Subject|0
5270094|NCT00619866|18181552|P3|Weeks 1 - 12|Withdrawal by Subject|4
5270095|NCT00619866|18181553|P2|Weeks 1 - 12|Withdrawal by Subject|2
5270096|NCT00619866|18181554|P1|Weeks 1 - 12|Withdrawal by Subject|7
5270097|NCT00619866|18181550|P5|Weeks 1 - 12|Non-compliance|0
5270098|NCT00619866|18181551|P4|Weeks 1 - 12|Non-compliance|0
5270099|NCT00619866|18181552|P3|Weeks 1 - 12|Non-compliance|1
5270100|NCT00619866|18181553|P2|Weeks 1 - 12|Non-compliance|0
5270101|NCT00619866|18181554|P1|Weeks 1 - 12|Non-compliance|0
5270102|NCT00619866|18181550|P5|Weeks 1 - 12|Adverse Event|0
5270103|NCT00619866|18181551|P4|Weeks 1 - 12|Adverse Event|0
5270104|NCT00619866|18181552|P3|Weeks 1 - 12|Adverse Event|2
5270105|NCT00619866|18181553|P2|Weeks 1 - 12|Adverse Event|1
5270106|NCT00619866|18181554|P1|Weeks 1 - 12|Adverse Event|0
5270107|NCT00619827|18181641|P2|Overall Study|Withdrawal by Subject|2
5270108|NCT00619827|18181642|P1|Overall Study|Withdrawal by Subject|2
5270109|NCT00619827|18181641|P2|Overall Study|Adverse Event|2
5270110|NCT00619827|18181642|P1|Overall Study|Adverse Event|1
5270111|NCT00619801|18181650|P2|Overall Study|Loss of efficacy|1
5270112|NCT00619801|18181651|P1|Overall Study|Loss of efficacy|0
5270113|NCT00619801|18181650|P2|Overall Study|Withdrawal by Subject|1
5270114|NCT00619801|18181651|P1|Overall Study|Withdrawal by Subject|1
5270115|NCT00619801|18181650|P2|Overall Study|Lack of Efficacy|1
5270116|NCT00619801|18181651|P1|Overall Study|Lack of Efficacy|0
5270117|NCT00619645|18181708|P1|Overall Study|Adverse Event|1
5270118|NCT00619619|18181722|P8|Overall Study|Adverse Event|2
5270119|NCT00619619|18181723|P7|Overall Study|Adverse Event|0
5270120|NCT00619619|18181724|P6|Overall Study|Adverse Event|0
5270121|NCT00619619|18181725|P5|Overall Study|Adverse Event|2
5270122|NCT00619619|18181726|P4|Overall Study|Adverse Event|0
5270123|NCT00619619|18181727|P3|Overall Study|Adverse Event|0
5270124|NCT00619619|18181728|P2|Overall Study|Adverse Event|0
5270125|NCT00619619|18181729|P1|Overall Study|Adverse Event|0
5270126|NCT00619619|18181722|P8|Overall Study|Protocol Violation|1
5270127|NCT00619619|18181723|P7|Overall Study|Protocol Violation|1
5270128|NCT00619619|18181724|P6|Overall Study|Protocol Violation|0
5270129|NCT00619619|18181725|P5|Overall Study|Protocol Violation|0
5270130|NCT00619619|18181726|P4|Overall Study|Protocol Violation|1
5270131|NCT00619619|18181727|P3|Overall Study|Protocol Violation|0
5270132|NCT00619619|18181728|P2|Overall Study|Protocol Violation|0
5270133|NCT00619619|18181729|P1|Overall Study|Protocol Violation|0
5270134|NCT00619619|18181722|P8|Overall Study|Physician Decision|0
5270135|NCT00619619|18181723|P7|Overall Study|Physician Decision|0
5270136|NCT00619619|18181724|P6|Overall Study|Physician Decision|0
5270137|NCT00619619|18181725|P5|Overall Study|Physician Decision|0
5270138|NCT00619619|18181726|P4|Overall Study|Physician Decision|0
5270139|NCT00619619|18181727|P3|Overall Study|Physician Decision|1
5270140|NCT00619619|18181728|P2|Overall Study|Physician Decision|0
5270141|NCT00619619|18181729|P1|Overall Study|Physician Decision|0
5270142|NCT00619515|18181814|P1|Overall Study|Study Termination by IRB|73
5270143|NCT00619502|18181828|P2|Overall Study|Lost to Follow-up|10
5270144|NCT00619502|18181829|P1|Overall Study|Lost to Follow-up|8
5270145|NCT00619489|18181841|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
5270146|NCT00619489|18181842|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
5270147|NCT00619489|18181841|P2|Overall Study|Lack of Efficacy|11
5270148|NCT00619489|18181842|P1|Overall Study|Lack of Efficacy|0
5270149|NCT00619489|18181841|P2|Overall Study|Withdrawal by Subject|1
5270150|NCT00619489|18181842|P1|Overall Study|Withdrawal by Subject|1
5270151|NCT00619489|18181841|P2|Overall Study|Adverse Event|7
5270152|NCT00619489|18181842|P1|Overall Study|Adverse Event|0
5270153|NCT00619476|18181864|P4|Overall Study|Withdrawal by Subject|4
5270154|NCT00619476|18181865|P3|Overall Study|Withdrawal by Subject|5
5270155|NCT00619476|18181866|P2|Overall Study|Withdrawal by Subject|7
5270156|NCT00619476|18181867|P1|Overall Study|Withdrawal by Subject|5
5270157|NCT00619476|18181864|P4|Overall Study|Investigator Discretion|0
5270158|NCT00619476|18181865|P3|Overall Study|Investigator Discretion|2
5270159|NCT00619476|18181866|P2|Overall Study|Investigator Discretion|2
5270160|NCT00619476|18181867|P1|Overall Study|Investigator Discretion|2
5270161|NCT00619476|18181864|P4|Overall Study|Lost to Follow-up|1
5270162|NCT00619476|18181865|P3|Overall Study|Lost to Follow-up|0
5270163|NCT00619476|18181866|P2|Overall Study|Lost to Follow-up|2
5270164|NCT00619476|18181867|P1|Overall Study|Lost to Follow-up|1
5270165|NCT00619476|18181864|P4|Overall Study|Protocol Violation|9
5270166|NCT00619476|18181865|P3|Overall Study|Protocol Violation|4
5270167|NCT00619476|18181866|P2|Overall Study|Protocol Violation|4
5270168|NCT00619476|18181867|P1|Overall Study|Protocol Violation|5
5270169|NCT00619476|18181864|P4|Overall Study|Lack of Efficacy|4
5270170|NCT00619476|18181865|P3|Overall Study|Lack of Efficacy|1
5270171|NCT00619476|18181866|P2|Overall Study|Lack of Efficacy|1
5270172|NCT00619476|18181867|P1|Overall Study|Lack of Efficacy|6
5270173|NCT00619476|18181864|P4|Overall Study|Adverse Event|16
5270174|NCT00619476|18181865|P3|Overall Study|Adverse Event|12
5270175|NCT00619476|18181866|P2|Overall Study|Adverse Event|6
5270176|NCT00619476|18181867|P1|Overall Study|Adverse Event|12
5270177|NCT00619385|18181952|P3|Overall Study|Other|1
5270178|NCT00619385|18181953|P2|Overall Study|Other|2
5270179|NCT00619385|18181954|P1|Overall Study|Other|1
5270180|NCT00619385|18181952|P3|Overall Study|Adverse Event|3
5270181|NCT00619385|18181953|P2|Overall Study|Adverse Event|0
5270182|NCT00619385|18181954|P1|Overall Study|Adverse Event|0
5270183|NCT00619359|18181969|P2|Overall Study|Progressive Disease|1
5270184|NCT00619359|18181970|P1|Overall Study|Progressive Disease|3
5270185|NCT00619359|18181969|P2|Overall Study|Withdrawal by Subject|20
5270186|NCT00619359|18181970|P1|Overall Study|Withdrawal by Subject|19
5270187|NCT00619359|18181969|P2|Overall Study|Protocol Violation|1
5270188|NCT00619359|18181970|P1|Overall Study|Protocol Violation|1
5270189|NCT00619359|18181969|P2|Overall Study|Physician Decision|7
5270190|NCT00619359|18181970|P1|Overall Study|Physician Decision|0
5270191|NCT00619359|18181969|P2|Overall Study|Lost to Follow-up|16
5270192|NCT00619359|18181970|P1|Overall Study|Lost to Follow-up|12
5270193|NCT00619359|18181969|P2|Overall Study|Adverse Event|36
5270194|NCT00619359|18181970|P1|Overall Study|Adverse Event|32
5270195|NCT00619307|18181982|P2|Overall Study|MS attack plus steroids|1
5270196|NCT00619307|18181983|P1|Overall Study|MS attack plus steroids|0
5270197|NCT00619307|18181982|P2|Overall Study|Severe migraine|1
5270198|NCT00619307|18181983|P1|Overall Study|Severe migraine|0
5270199|NCT00619307|18181982|P2|Overall Study|Withdrew consent|0
5270200|NCT00619307|18181983|P1|Overall Study|Withdrew consent|1
5270201|NCT00619307|18181982|P2|Overall Study|Protocol Violation|0
5270202|NCT00619307|18181983|P1|Overall Study|Protocol Violation|3
5270203|NCT00619307|18181982|P2|Overall Study|Lost to Follow-up|1
5270204|NCT00619307|18181983|P1|Overall Study|Lost to Follow-up|0
5270205|NCT00619307|18181982|P2|Overall Study|Adverse Event|1
5270206|NCT00619307|18181983|P1|Overall Study|Adverse Event|0
5270207|NCT00619229|18182020|P2|Overall Study|Investigator planned Cataract Operation|0
5270208|NCT00619229|18182021|P1|Overall Study|Investigator planned Cataract Operation|1
5270209|NCT00619229|18182020|P2|Overall Study|Termination of the Study by the Sponsor|1
5270210|NCT00619229|18182021|P1|Overall Study|Termination of the Study by the Sponsor|1
5270211|NCT00619229|18182020|P2|Overall Study|Lost to Follow-up|0
5270212|NCT00619229|18182021|P1|Overall Study|Lost to Follow-up|1
5270213|NCT00619229|18182020|P2|Overall Study|Withdrawal by Subject|1
5270214|NCT00619229|18182021|P1|Overall Study|Withdrawal by Subject|1
5270215|NCT00619177|18182060|P1|Overall Study|Not specified reasons|6
5270216|NCT00619177|18182060|P1|Overall Study|Missing termination information|481
5270217|NCT00619177|18182060|P1|Overall Study|Lack of Efficacy|1
5270218|NCT00619177|18182060|P1|Overall Study|Lost to Follow-up|2
5270219|NCT00619177|18182060|P1|Overall Study|Adverse Event|18
5270220|NCT00619151|18182070|P2|Overall Study|Study terminated prior to followup|0
5270221|NCT00619151|18182071|P1|Overall Study|Study terminated prior to followup|1
5270222|NCT00619112|18182081|P2|Overall Study|Adverse Event|2
5270223|NCT00619112|18182082|P1|Overall Study|Adverse Event|1
5270224|NCT00619099|18182103|P2|Overall Study|Physician Decision|6
5270225|NCT00619099|18182104|P1|Overall Study|Physician Decision|9
5270226|NCT00619099|18182103|P2|Overall Study|Withdrawal by Subject|2
5270227|NCT00619099|18182104|P1|Overall Study|Withdrawal by Subject|10
5270228|NCT00619099|18182103|P2|Overall Study|Emergence of Clinically Significant Lab|2
5270229|NCT00619099|18182104|P1|Overall Study|Emergence of Clinically Significant Lab|1
5270230|NCT00619099|18182103|P2|Overall Study|Adverse Event|3
5270231|NCT00619099|18182104|P1|Overall Study|Adverse Event|4
5270232|NCT00619099|18182103|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
5270233|NCT00619099|18182104|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
5270234|NCT00619099|18182103|P2|Overall Study|Progressive Disease|5
5270235|NCT00619099|18182104|P1|Overall Study|Progressive Disease|7
5270236|NCT00618995|18182126|P4|Period 4|Adverse Event|0
5270237|NCT00618995|18182127|P3|Period 4|Adverse Event|0
5270238|NCT00618995|18182128|P2|Period 4|Adverse Event|0
5270239|NCT00618995|18182129|P1|Period 4|Adverse Event|1
5270240|NCT00618995|18182126|P4|Period 2|Protocol Violation|0
5270241|NCT00618995|18182127|P3|Period 2|Protocol Violation|1
5270242|NCT00618995|18182128|P2|Period 2|Protocol Violation|0
5270243|NCT00618995|18182129|P1|Period 2|Protocol Violation|0
5270244|NCT00618995|18182126|P4|Period 1|Protocol Violation|0
5270245|NCT00618995|18182127|P3|Period 1|Protocol Violation|1
5270246|NCT00618995|18182128|P2|Period 1|Protocol Violation|1
5270247|NCT00618995|18182129|P1|Period 1|Protocol Violation|0
5270248|NCT00618995|18182126|P4|Period 1|Adverse Event|0
5270249|NCT00618995|18182127|P3|Period 1|Adverse Event|1
5270250|NCT00618995|18182128|P2|Period 1|Adverse Event|0
5270251|NCT00618995|18182129|P1|Period 1|Adverse Event|0
5270252|NCT00618982|18182143|P1|Overall Study|ongoing, still treated with study med.|25
5270253|NCT00618982|18182143|P1|Overall Study|Protocol Violation|1
5270254|NCT00618982|18182143|P1|Overall Study|Withdrawal by Subject|1
5270255|NCT00618982|18182143|P1|Overall Study|Adverse Event|23
5270256|NCT00618956|18182166|P2|Overall Study|did not meet criteria, non-compliance|1
5270257|NCT00618956|18182167|P1|Overall Study|did not meet criteria, non-compliance|2
5270258|NCT00618956|18182166|P2|Overall Study|Protocol Violation|2
5270259|NCT00618956|18182167|P1|Overall Study|Protocol Violation|2
5270260|NCT00618956|18182166|P2|Overall Study|Lost to Follow-up|5
5270261|NCT00618956|18182167|P1|Overall Study|Lost to Follow-up|4
5270262|NCT00618956|18182166|P2|Overall Study|Withdrawal by Subject|7
5270263|NCT00618956|18182167|P1|Overall Study|Withdrawal by Subject|5
5270264|NCT00618956|18182166|P2|Overall Study|Lack of Efficacy|1
5270265|NCT00618956|18182167|P1|Overall Study|Lack of Efficacy|2
5270266|NCT00618956|18182166|P2|Overall Study|Adverse Event|34
5270267|NCT00618956|18182167|P1|Overall Study|Adverse Event|10
5270268|NCT00618826|18182192|P1|Overall Study|Adverse Event|1
5270269|NCT00618813|18182197|P1|Overall Study|Withdrawal by Subject|1
5270270|NCT00618813|18182197|P1|Overall Study|Physician Decision|2
5270271|NCT00618813|18182197|P1|Overall Study|Lack of Efficacy|1
5270272|NCT00618787|18182207|P2|Overall Study|Lost to Follow-up|0
5270273|NCT00618787|18182208|P1|Overall Study|Lost to Follow-up|1
5270274|NCT00618787|18182207|P2|Overall Study|Withdrawal by Subject|1
5270275|NCT00618787|18182208|P1|Overall Study|Withdrawal by Subject|2
5270276|NCT00618787|18182207|P2|Overall Study|Adverse Event|1
5270277|NCT00618787|18182208|P1|Overall Study|Adverse Event|0
5270278|NCT00618774|18182216|P2|Overall Study|Withdrawal by Subject|0
5270279|NCT00618774|18182217|P1|Overall Study|Withdrawal by Subject|1
5270280|NCT00618774|18182216|P2|Overall Study|Adverse Event|3
5270281|NCT00618774|18182217|P1|Overall Study|Adverse Event|5
5270282|NCT00618748|18182250|P3|Overall Study|Withdrawal by Subject|5
5270283|NCT00618748|18182251|P2|Overall Study|Withdrawal by Subject|1
5270284|NCT00618748|18182252|P1|Overall Study|Withdrawal by Subject|4
5270285|NCT00618748|18182250|P3|Overall Study|Physician Decision|1
5270286|NCT00618748|18182251|P2|Overall Study|Physician Decision|1
5270287|NCT00618748|18182252|P1|Overall Study|Physician Decision|3
5270288|NCT00618748|18182250|P3|Overall Study|Adverse Event|8
5270289|NCT00618748|18182251|P2|Overall Study|Adverse Event|3
5270290|NCT00618748|18182252|P1|Overall Study|Adverse Event|4
5270291|NCT00618722|18182297|P4|Overall Study|Miscellaneous Reasons|1
5270292|NCT00618722|18182298|P3|Overall Study|Miscellaneous Reasons|1
5270293|NCT00618722|18182299|P2|Overall Study|Miscellaneous Reasons|0
5270294|NCT00618722|18182300|P1|Overall Study|Miscellaneous Reasons|0
5270295|NCT00618722|18182297|P4|Overall Study|Lost to Follow-up|2
5270296|NCT00618722|18182298|P3|Overall Study|Lost to Follow-up|0
5270297|NCT00618722|18182299|P2|Overall Study|Lost to Follow-up|0
5270298|NCT00618722|18182300|P1|Overall Study|Lost to Follow-up|2
5270299|NCT00618722|18182297|P4|Overall Study|Inability to Complete Study Procedure|0
5270300|NCT00618722|18182298|P3|Overall Study|Inability to Complete Study Procedure|0
5270301|NCT00618722|18182299|P2|Overall Study|Inability to Complete Study Procedure|1
5270302|NCT00618722|18182300|P1|Overall Study|Inability to Complete Study Procedure|0
5270303|NCT00618722|18182297|P4|Overall Study|Patient Request|1
5270304|NCT00618722|18182298|P3|Overall Study|Patient Request|1
5270305|NCT00618722|18182299|P2|Overall Study|Patient Request|1
5270306|NCT00618722|18182300|P1|Overall Study|Patient Request|1
5270307|NCT00618722|18182297|P4|Overall Study|Refusal of Treatment|0
5270308|NCT00618722|18182298|P3|Overall Study|Refusal of Treatment|1
5270309|NCT00618722|18182299|P2|Overall Study|Refusal of Treatment|0
5270310|NCT00618722|18182300|P1|Overall Study|Refusal of Treatment|0
5270311|NCT00618618|18182338|P4|Overall Study|Death|0
5270312|NCT00618618|18182339|P3|Overall Study|Death|0
5270313|NCT00618618|18182340|P2|Overall Study|Death|1
5270314|NCT00618618|18182341|P1|Overall Study|Death|0
5270315|NCT00618618|18182338|P4|Overall Study|Did Not Meet Entry Criteria|0
5270316|NCT00618618|18182339|P3|Overall Study|Did Not Meet Entry Criteria|1
5270317|NCT00618618|18182340|P2|Overall Study|Did Not Meet Entry Criteria|0
5270318|NCT00618618|18182341|P1|Overall Study|Did Not Meet Entry Criteria|0
5270319|NCT00618618|18182338|P4|Overall Study|Non-compliance|0
5270320|NCT00618618|18182339|P3|Overall Study|Non-compliance|0
5270321|NCT00618618|18182340|P2|Overall Study|Non-compliance|1
5270322|NCT00618618|18182341|P1|Overall Study|Non-compliance|1
5270323|NCT00618618|18182338|P4|Overall Study|Lost to Follow-up|1
5270324|NCT00618618|18182339|P3|Overall Study|Lost to Follow-up|0
5270325|NCT00618618|18182340|P2|Overall Study|Lost to Follow-up|0
5270326|NCT00618618|18182341|P1|Overall Study|Lost to Follow-up|3
5270327|NCT00618618|18182338|P4|Overall Study|Inability to Complete Study Procedures|0
5270328|NCT00618618|18182339|P3|Overall Study|Inability to Complete Study Procedures|0
5270329|NCT00618618|18182340|P2|Overall Study|Inability to Complete Study Procedures|1
5270330|NCT00618618|18182341|P1|Overall Study|Inability to Complete Study Procedures|0
5270331|NCT00618618|18182338|P4|Overall Study|Patient Request|0
5270332|NCT00618618|18182339|P3|Overall Study|Patient Request|2
5270333|NCT00618618|18182340|P2|Overall Study|Patient Request|0
5270334|NCT00618618|18182341|P1|Overall Study|Patient Request|0
5270335|NCT00618514|18182400|P3|Overall Study|Lost to Follow-up|4
5270336|NCT00618514|18182401|P2|Overall Study|Lost to Follow-up|12
5270337|NCT00618514|18182402|P1|Overall Study|Lost to Follow-up|11
5270338|NCT00618449|18182422|P2|Overall Study|Lost to Follow-up|110
5270339|NCT00618449|18182423|P1|Overall Study|Lost to Follow-up|98
5270340|NCT00618410|18182442|P2|Washout Period (2 Weeks)|Physician Decision|1
5270341|NCT00618410|18182443|P1|Washout Period (2 Weeks)|Physician Decision|0
5270342|NCT00618371|18182459|P1|Overall Study|Withdrawal by Subject|2
5270343|NCT00618072|18182492|P3|Overall Study|Physician Decision|1
5270344|NCT00618072|18182493|P2|Overall Study|Physician Decision|1
5270345|NCT00618072|18182494|P1|Overall Study|Physician Decision|0
5270346|NCT00618072|18182492|P3|Overall Study|Lost to Follow-up|3
5270347|NCT00618072|18182493|P2|Overall Study|Lost to Follow-up|0
5270348|NCT00618072|18182494|P1|Overall Study|Lost to Follow-up|2
5270349|NCT00617929|18182550|P1|Overall Study|Physician Decision|1
5270350|NCT00617903|18182562|P2|Overall Study|noncompliance|1
5270351|NCT00617903|18182563|P1|Overall Study|noncompliance|0
5270352|NCT00617903|18182562|P2|Overall Study|Adverse Event|1
5270353|NCT00617903|18182563|P1|Overall Study|Adverse Event|0
5270354|NCT00617903|18182562|P2|Overall Study|Lack of Efficacy|1
5270355|NCT00617903|18182563|P1|Overall Study|Lack of Efficacy|0
5270356|NCT00617903|18182562|P2|Overall Study|Lost to Follow-up|1
5270357|NCT00617903|18182563|P1|Overall Study|Lost to Follow-up|1
5270358|NCT00617903|18182562|P2|Overall Study|Withdrawal by Subject|3
5270359|NCT00617903|18182563|P1|Overall Study|Withdrawal by Subject|2
5270360|NCT00617890|18182609|P4|Overall Study|Not treated|1
5270361|NCT00617890|18182610|P3|Overall Study|Not treated|1
5270362|NCT00617890|18182611|P2|Overall Study|Not treated|0
5270363|NCT00617890|18182612|P1|Overall Study|Not treated|1
5270364|NCT00617890|18182609|P4|Overall Study|Adverse Event|8
5270365|NCT00617890|18182610|P3|Overall Study|Adverse Event|3
5270366|NCT00617890|18182611|P2|Overall Study|Adverse Event|0
5270367|NCT00617890|18182612|P1|Overall Study|Adverse Event|1
5270368|NCT00617890|18182609|P4|Overall Study|Protocol Violation|0
5270369|NCT00617890|18182610|P3|Overall Study|Protocol Violation|0
5270370|NCT00617890|18182611|P2|Overall Study|Protocol Violation|1
5270371|NCT00617890|18182612|P1|Overall Study|Protocol Violation|2
5270372|NCT00617890|18182609|P4|Overall Study|Withdrawal by Subject|2
5270373|NCT00617890|18182610|P3|Overall Study|Withdrawal by Subject|0
5270374|NCT00617890|18182611|P2|Overall Study|Withdrawal by Subject|1
5270375|NCT00617890|18182612|P1|Overall Study|Withdrawal by Subject|4
5270376|NCT00617890|18182609|P4|Overall Study|Lost to Follow-up|2
5270377|NCT00617890|18182610|P3|Overall Study|Lost to Follow-up|1
5270378|NCT00617890|18182611|P2|Overall Study|Lost to Follow-up|0
5270379|NCT00617890|18182612|P1|Overall Study|Lost to Follow-up|0
5270380|NCT00617890|18182609|P4|Overall Study|Lack of Efficacy|97
5270381|NCT00617890|18182610|P3|Overall Study|Lack of Efficacy|30
5270382|NCT00617890|18182611|P2|Overall Study|Lack of Efficacy|26
5270383|NCT00617890|18182612|P1|Overall Study|Lack of Efficacy|23
5270384|NCT00617890|18182609|P4|Overall Study|Treatment ongoing at data cut-off|5
5270385|NCT00617890|18182610|P3|Overall Study|Treatment ongoing at data cut-off|0
5270386|NCT00617890|18182611|P2|Overall Study|Treatment ongoing at data cut-off|0
5270387|NCT00617890|18182612|P1|Overall Study|Treatment ongoing at data cut-off|0
5270388|NCT00617851|18182648|P4|Overall Study|Unable to classify|0
5270389|NCT00617851|18182649|P3|Overall Study|Unable to classify|1
5270390|NCT00617851|18182650|P2|Overall Study|Unable to classify|0
5270391|NCT00617851|18182651|P1|Overall Study|Unable to classify|1
5270392|NCT00617851|18182648|P4|Overall Study|Inappropriate Enrollment|1
5270393|NCT00617851|18182649|P3|Overall Study|Inappropriate Enrollment|1
5270394|NCT00617851|18182650|P2|Overall Study|Inappropriate Enrollment|4
5270395|NCT00617851|18182651|P1|Overall Study|Inappropriate Enrollment|5
5270396|NCT00617851|18182648|P4|Overall Study|Lost to Follow-up|19
5270397|NCT00617851|18182649|P3|Overall Study|Lost to Follow-up|31
5270398|NCT00617851|18182650|P2|Overall Study|Lost to Follow-up|29
5270399|NCT00617851|18182651|P1|Overall Study|Lost to Follow-up|27
5270400|NCT00617851|18182648|P4|Overall Study|Withdrawal by Subject|4
5270401|NCT00617851|18182649|P3|Overall Study|Withdrawal by Subject|12
5270402|NCT00617851|18182650|P2|Overall Study|Withdrawal by Subject|7
5270403|NCT00617851|18182651|P1|Overall Study|Withdrawal by Subject|14
5270404|NCT00617851|18182648|P4|Overall Study|Death|1
5270405|NCT00617851|18182649|P3|Overall Study|Death|0
5270406|NCT00617851|18182650|P2|Overall Study|Death|0
5270407|NCT00617851|18182651|P1|Overall Study|Death|0
5270408|NCT00617773|18182689|P1|Overall Study|Protocol Violation|1
5270409|NCT00617773|18182689|P1|Overall Study|Progressive disease|19
5270410|NCT00617773|18182689|P1|Overall Study|Death|1
5270411|NCT00617773|18182689|P1|Overall Study|Withdrawal by Subject|1
5270412|NCT00617773|18182689|P1|Overall Study|Lack of compliance with the protocol|1
5270413|NCT00617773|18182689|P1|Overall Study|Physician Decision|1
5270414|NCT00617734|18182706|P2|Overall Study|Lost to Follow-up|1
5270415|NCT00617734|18182707|P1|Overall Study|Lost to Follow-up|0
5270416|NCT00617734|18182706|P2|Overall Study|Found Ineligible After Randomization|4
5270417|NCT00617734|18182707|P1|Overall Study|Found Ineligible After Randomization|1
5270418|NCT00617734|18182706|P2|Overall Study|Protocol Violation|0
5270419|NCT00617734|18182707|P1|Overall Study|Protocol Violation|1
5270420|NCT00617734|18182706|P2|Overall Study|Adverse Event|1
5270421|NCT00617734|18182707|P1|Overall Study|Adverse Event|4
5270422|NCT00617734|18182706|P2|Overall Study|Withdrew Consent|0
5270423|NCT00617734|18182707|P1|Overall Study|Withdrew Consent|2
5270424|NCT00617708|18182728|P3|Overall Study|Not eligible|5
5270425|NCT00617708|18182729|P2|Overall Study|Not eligible|3
5270426|NCT00617708|18182730|P1|Overall Study|Not eligible|1
5270427|NCT00617708|18182728|P3|Overall Study|Not protocol specified|2
5270428|NCT00617708|18182729|P2|Overall Study|Not protocol specified|4
5270429|NCT00617708|18182730|P1|Overall Study|Not protocol specified|1
5270430|NCT00617708|18182728|P3|Overall Study|Progression/Relapse|36
5270431|NCT00617708|18182729|P2|Overall Study|Progression/Relapse|40
5270432|NCT00617708|18182730|P1|Overall Study|Progression/Relapse|7
5270433|NCT00617708|18182728|P3|Overall Study|Death|5
5270434|NCT00617708|18182729|P2|Overall Study|Death|6
5270435|NCT00617708|18182730|P1|Overall Study|Death|0
5270436|NCT00617708|18182728|P3|Overall Study|Withdrawal by Subject|7
5270437|NCT00617708|18182729|P2|Overall Study|Withdrawal by Subject|1
5270438|NCT00617708|18182730|P1|Overall Study|Withdrawal by Subject|1
5270439|NCT00617708|18182728|P3|Overall Study|Adverse Event|9
5270440|NCT00617708|18182729|P2|Overall Study|Adverse Event|6
5270441|NCT00617708|18182730|P1|Overall Study|Adverse Event|0
5270442|NCT00617669|18182747|P2|Overall Study|Patients randomized but not treated|3
5270443|NCT00617669|18182748|P1|Overall Study|Patients randomized but not treated|2
5270444|NCT00617669|18182747|P2|Overall Study|Reason not otherwise captured, eg; death|290
5270445|NCT00617669|18182748|P1|Overall Study|Reason not otherwise captured, eg; death|265
5270446|NCT00617669|18182747|P2|Overall Study|Protocol Violation|3
5270447|NCT00617669|18182748|P1|Overall Study|Protocol Violation|2
5270448|NCT00617669|18182747|P2|Overall Study|Adverse Event|76
5270449|NCT00617669|18182748|P1|Overall Study|Adverse Event|87
5270450|NCT00617669|18182747|P2|Overall Study|Lost to Follow-up|2
5270451|NCT00617669|18182748|P1|Overall Study|Lost to Follow-up|3
5270452|NCT00617669|18182747|P2|Overall Study|Withdrawal by Subject|77
5270453|NCT00617669|18182748|P1|Overall Study|Withdrawal by Subject|71
5270454|NCT00617604|18182770|P2|Overall Study|Randomized but Never Received Study Drug|3
5270455|NCT00617604|18182771|P1|Overall Study|Randomized but Never Received Study Drug|3
5270456|NCT00617604|18182770|P2|Overall Study|Withdrawal by Subject|6
5270457|NCT00617604|18182771|P1|Overall Study|Withdrawal by Subject|4
5270458|NCT00617604|18182770|P2|Overall Study|Miscellaneous Reasons|10
5270459|NCT00617604|18182771|P1|Overall Study|Miscellaneous Reasons|8
5270460|NCT00617604|18182770|P2|Overall Study|Lost to Follow-up|0
5270461|NCT00617604|18182771|P1|Overall Study|Lost to Follow-up|1
5270462|NCT00617604|18182770|P2|Overall Study|Death|1
5270463|NCT00617604|18182771|P1|Overall Study|Death|2
5270464|NCT00617591|18182815|P1|Overall Study|Withdrew consent during Maintenance|6
5270465|NCT00617591|18182815|P1|Overall Study|Withdrew consent during Induction|4
5270466|NCT00617461|18182831|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
5270467|NCT00617461|18182832|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
5270468|NCT00617461|18182831|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
5270469|NCT00617461|18182832|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
5270470|NCT00617461|18182831|P2|Second Treatment Intervention Period|Lack of Efficacy|3
5270471|NCT00617461|18182832|P1|Second Treatment Intervention Period|Lack of Efficacy|0
5270472|NCT00617461|18182831|P2|Second Treatment Intervention Period|Adverse Event|1
5270473|NCT00617461|18182832|P1|Second Treatment Intervention Period|Adverse Event|0
5270474|NCT00617461|18182831|P2|4-Day Crossover Period|Withdrawal by Subject|0
5270475|NCT00617461|18182832|P1|4-Day Crossover Period|Withdrawal by Subject|1
5270476|NCT00617461|18182831|P2|First Treatment Intervention Period|Withdrawal by Subject|0
5270477|NCT00617461|18182832|P1|First Treatment Intervention Period|Withdrawal by Subject|4
5270478|NCT00617461|18182831|P2|First Treatment Intervention Period|Investigator Discretion|1
5270479|NCT00617461|18182832|P1|First Treatment Intervention Period|Investigator Discretion|1
5270480|NCT00617461|18182831|P2|First Treatment Intervention Period|Lost to Follow-up|1
5270481|NCT00617461|18182832|P1|First Treatment Intervention Period|Lost to Follow-up|0
5270482|NCT00617461|18182831|P2|First Treatment Intervention Period|Protocol Violation|1
5270483|NCT00617461|18182832|P1|First Treatment Intervention Period|Protocol Violation|2
5270484|NCT00617461|18182831|P2|First Treatment Intervention Period|Lack of Efficacy|0
5270485|NCT00617461|18182832|P1|First Treatment Intervention Period|Lack of Efficacy|1
5270486|NCT00617461|18182831|P2|First Treatment Intervention Period|Adverse Event|0
5270487|NCT00617461|18182832|P1|First Treatment Intervention Period|Adverse Event|2
5270488|NCT00617409|18182888|P3|Overall Study|Alternative Therapy|0
5270489|NCT00617409|18182889|P2|Overall Study|Alternative Therapy|2
5270490|NCT00617409|18182890|P1|Overall Study|Alternative Therapy|1
5270491|NCT00617409|18182888|P3|Overall Study|Death|4
5270492|NCT00617409|18182889|P2|Overall Study|Death|5
5270493|NCT00617409|18182890|P1|Overall Study|Death|3
5270494|NCT00617409|18182888|P3|Overall Study|Disease Progression|18
5270495|NCT00617409|18182889|P2|Overall Study|Disease Progression|8
5270496|NCT00617409|18182890|P1|Overall Study|Disease Progression|8
5270497|NCT00617409|18182888|P3|Overall Study|Adverse Event|3
5270498|NCT00617409|18182889|P2|Overall Study|Adverse Event|2
5270499|NCT00617409|18182890|P1|Overall Study|Adverse Event|0
5270500|NCT00617409|18182888|P3|Overall Study|Withdrawal by Subject|2
5270501|NCT00617409|18182889|P2|Overall Study|Withdrawal by Subject|1
5270502|NCT00617409|18182890|P1|Overall Study|Withdrawal by Subject|4
5270503|NCT00617357|18182905|P1|Overall Study|Physician Decision|1
5270504|NCT00617357|18182905|P1|Overall Study|Withdrawal by Subject|1
5270505|NCT00617357|18182905|P1|Overall Study|insurance concerns|2
5270506|NCT00617357|18182905|P1|Overall Study|Death|5
5270507|NCT00617357|18182905|P1|Overall Study|Lost to Follow-up|7
5270508|NCT00617344|18182918|P3|Overall Study|Withdrawal by Subject|2
5270509|NCT00617344|18182919|P2|Overall Study|Withdrawal by Subject|9
5270510|NCT00617344|18182920|P1|Overall Study|Withdrawal by Subject|8
5270511|NCT00617344|18182918|P3|Overall Study|Lost to Follow-up|1
5270512|NCT00617344|18182919|P2|Overall Study|Lost to Follow-up|4
5270513|NCT00617344|18182920|P1|Overall Study|Lost to Follow-up|5
5270514|NCT00617344|18182918|P3|Overall Study|Protocol Violation|5
5270515|NCT00617344|18182919|P2|Overall Study|Protocol Violation|8
5270516|NCT00617344|18182920|P1|Overall Study|Protocol Violation|10
5270517|NCT00617344|18182918|P3|Overall Study|Other Adverse Event|0
5270518|NCT00617344|18182919|P2|Overall Study|Other Adverse Event|1
5270519|NCT00617344|18182920|P1|Overall Study|Other Adverse Event|1
5270520|NCT00617344|18182918|P3|Overall Study|Serious adverse event|0
5270521|NCT00617344|18182919|P2|Overall Study|Serious adverse event|0
5270522|NCT00617344|18182920|P1|Overall Study|Serious adverse event|1
5270523|NCT00617305|18182948|P3|Overall Study|Withdrawal by Subject|0
5270524|NCT00617305|18182949|P2|Overall Study|Withdrawal by Subject|0
5270525|NCT00617305|18182950|P1|Overall Study|Withdrawal by Subject|1
5270526|NCT00617305|18182948|P3|Overall Study|Protocol Violation|1
5270527|NCT00617305|18182949|P2|Overall Study|Protocol Violation|0
5270528|NCT00617305|18182950|P1|Overall Study|Protocol Violation|1
5270529|NCT00617305|18182948|P3|Overall Study|Physician Decision|0
5270530|NCT00617305|18182949|P2|Overall Study|Physician Decision|0
5270531|NCT00617305|18182950|P1|Overall Study|Physician Decision|1
5270532|NCT00617305|18182948|P3|Overall Study|Death|0
5270533|NCT00617305|18182949|P2|Overall Study|Death|0
5270534|NCT00617305|18182950|P1|Overall Study|Death|1
5270535|NCT00617305|18182948|P3|Overall Study|Adverse Event|0
5270536|NCT00617305|18182949|P2|Overall Study|Adverse Event|0
5270537|NCT00617305|18182950|P1|Overall Study|Adverse Event|4
5270538|NCT00617279|18183006|P2|Overall Study|Death|2
5270539|NCT00617279|18183007|P1|Overall Study|Death|1
5270540|NCT00617279|18183006|P2|Overall Study|Lost to Follow-up|0
5270541|NCT00617279|18183007|P1|Overall Study|Lost to Follow-up|1
5270542|NCT00617279|18183006|P2|Overall Study|Graft abandonment|0
5270543|NCT00617279|18183007|P1|Overall Study|Graft abandonment|2
5270544|NCT00617279|18183006|P2|Overall Study|Study terminated by Sponsor|15
5270545|NCT00617279|18183007|P1|Overall Study|Study terminated by Sponsor|10
5270546|NCT00617240|18183063|P2|Overall Study|Lack of Efficacy|0
5270547|NCT00617240|18183064|P1|Overall Study|Lack of Efficacy|1
5270548|NCT00617201|18183084|P2|Overall Study|Lost to Follow-up|13
5270549|NCT00617201|18183085|P1|Overall Study|Lost to Follow-up|9
5270550|NCT00617123|18183113|P2|Study Treatment Period|Noncompliance with Protocol|1
5270551|NCT00617123|18183114|P1|Study Treatment Period|Noncompliance with Protocol|0
5270552|NCT00617123|18183113|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
5270553|NCT00617123|18183114|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
5270554|NCT00617123|18183113|P2|Study Treatment Period|Adverse Event|3
5270555|NCT00617123|18183114|P1|Study Treatment Period|Adverse Event|7
5270556|NCT00617123|18183113|P2|Study Treatment Period|Withdrawal by Subject|12
5270557|NCT00617123|18183114|P1|Study Treatment Period|Withdrawal by Subject|8
5270558|NCT00617123|18183113|P2|Referral Screening Period|Adverse Event|1
5270559|NCT00617123|18183114|P1|Referral Screening Period|Adverse Event|0
5270560|NCT00617123|18183113|P2|Referral Screening Period|Did Not Wish To Continue|1
5270561|NCT00617123|18183114|P1|Referral Screening Period|Did Not Wish To Continue|3
5270562|NCT00617123|18183113|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
5270563|NCT00617123|18183114|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
5270564|NCT00617084|18183145|P2|Overall Study|Missed 12 Months visit|19
5270565|NCT00617084|18183146|P1|Overall Study|Missed 12 Months visit|16
5270566|NCT00617084|18183145|P2|Overall Study|Withdrawal by Subject|7
5270567|NCT00617084|18183146|P1|Overall Study|Withdrawal by Subject|5
5270568|NCT00616967|18183199|P3|Overall Study|Withdrawal by Subject|1
5270569|NCT00616967|18183200|P2|Overall Study|Withdrawal by Subject|0
5270570|NCT00616967|18183201|P1|Overall Study|Withdrawal by Subject|0
5270571|NCT00616941|18183226|P3|Overall Study|Vaccination Suspended|3
5270572|NCT00616941|18183227|P2|Overall Study|Vaccination Suspended|0
5270573|NCT00616941|18183228|P1|Overall Study|Vaccination Suspended|0
5270574|NCT00616941|18183226|P3|Overall Study|Unrelated Medical Illness/Complication|0
5270575|NCT00616941|18183227|P2|Overall Study|Unrelated Medical Illness/Complication|2
5270576|NCT00616941|18183228|P1|Overall Study|Unrelated Medical Illness/Complication|0
5270577|NCT00616941|18183226|P3|Overall Study|Subject Non-compliance|1
5270578|NCT00616941|18183227|P2|Overall Study|Subject Non-compliance|0
5270579|NCT00616941|18183228|P1|Overall Study|Subject Non-compliance|0
5270580|NCT00616941|18183226|P3|Overall Study|Adverse Event|1
5270581|NCT00616941|18183227|P2|Overall Study|Adverse Event|1
5270582|NCT00616941|18183228|P1|Overall Study|Adverse Event|0
5270583|NCT00616941|18183226|P3|Overall Study|Progressive Disease|1
5270584|NCT00616941|18183227|P2|Overall Study|Progressive Disease|2
5270585|NCT00616941|18183228|P1|Overall Study|Progressive Disease|1
5270586|NCT00616928|18183255|P4|Overall Study|Lost to Follow-up|0
5270587|NCT00616928|18183256|P3|Overall Study|Lost to Follow-up|0
5270588|NCT00616928|18183257|P2|Overall Study|Lost to Follow-up|7
5270589|NCT00616928|18183258|P1|Overall Study|Lost to Follow-up|5
5270590|NCT00616928|18183255|P4|Overall Study|Other|5
5270591|NCT00616928|18183256|P3|Overall Study|Other|15
5270592|NCT00616928|18183257|P2|Overall Study|Other|8
5270593|NCT00616928|18183258|P1|Overall Study|Other|51
5270594|NCT00616928|18183255|P4|Overall Study|Adverse Event|2
5270595|NCT00616928|18183256|P3|Overall Study|Adverse Event|2
5270596|NCT00616928|18183257|P2|Overall Study|Adverse Event|3
5270597|NCT00616928|18183258|P1|Overall Study|Adverse Event|6
5270598|NCT00616902|18183322|P2|Overall Study|Termination of study|6
5270599|NCT00616902|18183323|P1|Overall Study|Termination of study|6
5270600|NCT00616759|18183366|P2|Overall Study|Withdrawal by Subject|2
5270601|NCT00616759|18183367|P1|Overall Study|Withdrawal by Subject|1
5270602|NCT00616759|18183366|P2|Overall Study|Physician Decision|0
5270603|NCT00616759|18183367|P1|Overall Study|Physician Decision|2
5270604|NCT00616655|18183376|P3|Overall Study|Other|5
5270605|NCT00616655|18183377|P2|Overall Study|Other|6
5270606|NCT00616655|18183378|P1|Overall Study|Other|6
5270607|NCT00616655|18183376|P3|Overall Study|Does not meet in/ex criteria|2
5270608|NCT00616655|18183377|P2|Overall Study|Does not meet in/ex criteria|0
5270609|NCT00616655|18183378|P1|Overall Study|Does not meet in/ex criteria|0
5270610|NCT00616655|18183376|P3|Overall Study|Withdrawal by Subject|11
5270611|NCT00616655|18183377|P2|Overall Study|Withdrawal by Subject|7
5270612|NCT00616655|18183378|P1|Overall Study|Withdrawal by Subject|9
5270613|NCT00616655|18183376|P3|Overall Study|Protocol Violation|3
5270614|NCT00616655|18183377|P2|Overall Study|Protocol Violation|4
5270615|NCT00616655|18183378|P1|Overall Study|Protocol Violation|2
5270616|NCT00616655|18183376|P3|Overall Study|Lost to Follow-up|10
5270617|NCT00616655|18183377|P2|Overall Study|Lost to Follow-up|12
5270618|NCT00616655|18183378|P1|Overall Study|Lost to Follow-up|3
5270619|NCT00616655|18183376|P3|Overall Study|Lack of Efficacy|5
5270620|NCT00616655|18183377|P2|Overall Study|Lack of Efficacy|5
5270621|NCT00616655|18183378|P1|Overall Study|Lack of Efficacy|5
5270622|NCT00616655|18183376|P3|Overall Study|Adverse Event|12
5270623|NCT00616655|18183377|P2|Overall Study|Adverse Event|7
5270624|NCT00616655|18183378|P1|Overall Study|Adverse Event|10
5270625|NCT00616642|18183418|P2|Overall Study|Withdrawal by Subject|1
5270626|NCT00616642|18183419|P1|Overall Study|Withdrawal by Subject|0
5270627|NCT00616629|18183430|P5|Overall Study|AV-block|0
5270628|NCT00616629|18183431|P4|Overall Study|AV-block|0
5270629|NCT00616629|18183432|P3|Overall Study|AV-block|0
5270630|NCT00616629|18183433|P2|Overall Study|AV-block|0
5270631|NCT00616629|18183434|P1|Overall Study|AV-block|1
5270632|NCT00616629|18183430|P5|Overall Study|Protocol Violation|0
5270633|NCT00616629|18183431|P4|Overall Study|Protocol Violation|0
5270634|NCT00616629|18183432|P3|Overall Study|Protocol Violation|1
5270635|NCT00616629|18183433|P2|Overall Study|Protocol Violation|2
5270636|NCT00616629|18183434|P1|Overall Study|Protocol Violation|1
5270637|NCT00616603|18183479|P3|Overall Study|Physician Decision|2
5270638|NCT00616603|18183480|P2|Overall Study|Physician Decision|0
5270639|NCT00616603|18183481|P1|Overall Study|Physician Decision|2
5270640|NCT00616434|18183504|P2|Overall Study|Protocol deviation|1
5270641|NCT00616434|18183505|P1|Overall Study|Protocol deviation|0
5270642|NCT00616434|18183504|P2|Overall Study|Withdrawal by Subject|1
5270643|NCT00616434|18183505|P1|Overall Study|Withdrawal by Subject|1
5270644|NCT00616434|18183504|P2|Overall Study|Physician Decision|4
5270645|NCT00616434|18183505|P1|Overall Study|Physician Decision|0
5270646|NCT00616434|18183504|P2|Overall Study|Adverse Event|2
5270647|NCT00616434|18183505|P1|Overall Study|Adverse Event|5
5270648|NCT00616421|18183518|P3|Overall Study|Unable to classify|0
5270649|NCT00616421|18183519|P2|Overall Study|Unable to classify|0
5270650|NCT00616421|18183520|P1|Overall Study|Unable to classify|1
5270651|NCT00616421|18183518|P3|Overall Study|Protocol Violation|2
5270652|NCT00616421|18183519|P2|Overall Study|Protocol Violation|1
5270653|NCT00616421|18183520|P1|Overall Study|Protocol Violation|0
5270654|NCT00616421|18183518|P3|Overall Study|Administrative reason|0
5270655|NCT00616421|18183519|P2|Overall Study|Administrative reason|0
5270656|NCT00616421|18183520|P1|Overall Study|Administrative reason|1
5270657|NCT00616421|18183518|P3|Overall Study|Inappropriate enrollment|1
5270658|NCT00616421|18183519|P2|Overall Study|Inappropriate enrollment|0
5270659|NCT00616421|18183520|P1|Overall Study|Inappropriate enrollment|3
5270660|NCT00616421|18183518|P3|Overall Study|Lost to Follow-up|30
5270661|NCT00616421|18183519|P2|Overall Study|Lost to Follow-up|26
5270662|NCT00616421|18183520|P1|Overall Study|Lost to Follow-up|12
5270663|NCT00616421|18183518|P3|Overall Study|Withdrawal by Subject|8
5270664|NCT00616421|18183519|P2|Overall Study|Withdrawal by Subject|11
5270665|NCT00616421|18183520|P1|Overall Study|Withdrawal by Subject|9
5270666|NCT00616239|18183561|P1|Overall Study|Withdrawal by Subject|2
5270667|NCT00616018|18183591|P1|Overall Study|Protocol Violation|3
5270668|NCT00615992|18183596|P1|Overall Study|Protocol Violation|67
5270669|NCT00615914|18183622|P1|Overall Study|Irregularly enrolled patients|10
5270670|NCT00615914|18183622|P1|Overall Study|No treatment|2
5270671|NCT00615914|18183622|P1|Overall Study|No data was collected.|65
5270672|NCT00615914|18183622|P1|Overall Study|Physician Decision|4
5270673|NCT00615914|18183622|P1|Overall Study|Withdrawal by Subject|16
5270674|NCT00615914|18183622|P1|Overall Study|Lost to Follow-up|187
5270675|NCT00615914|18183622|P1|Overall Study|Lack of Efficacy|59
5270676|NCT00615914|18183622|P1|Overall Study|Death|20
5270677|NCT00615914|18183622|P1|Overall Study|Adverse Event|274
5270678|NCT00615901|18183629|P1|Overall Study|Adverse Event|7
5270679|NCT00615901|18183629|P1|Overall Study|Withdrawal by Subject|2
5270680|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5270681|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5270682|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5270683|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5270684|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
5270685|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Not reported|0
5270686|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Not reported|4
5270687|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Not reported|1
5270688|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Not reported|4
5270689|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Not reported|6
5270690|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Other|0
5270691|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Other|8
5270692|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Other|8
5270693|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Other|7
5270694|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Other|10
5270695|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
5270696|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
5270697|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
5270698|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
5270699|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
5270700|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
5270701|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
5270702|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
5270703|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
5270704|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
5270705|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
5270706|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
5270707|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
5270708|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
5270709|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
5270710|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
5270711|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
5270712|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
5270713|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
5270714|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
5270715|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
5270716|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
5270717|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
5270718|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
5270719|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
5270720|NCT00615836|18183637|P5|Extension Study (FE992026 CS31)|Adverse Event|0
5270721|NCT00615836|18183638|P4|Extension Study (FE992026 CS31)|Adverse Event|13
5270722|NCT00615836|18183639|P3|Extension Study (FE992026 CS31)|Adverse Event|15
5270723|NCT00615836|18183640|P2|Extension Study (FE992026 CS31)|Adverse Event|12
5270724|NCT00615836|18183641|P1|Extension Study (FE992026 CS31)|Adverse Event|7
5270725|NCT00615719|18183706|P1|Overall Study|Physician Decision|5
5270726|NCT00615550|18183720|P2|Overall Study|Lost to Follow-up|1
5270727|NCT00615550|18183721|P1|Overall Study|Lost to Follow-up|6
5270728|NCT00615459|18183744|P4|Period III|Unsatisfactory therapeutic effect|0
5270729|NCT00615459|18183745|P3|Period III|Unsatisfactory therapeutic effect|0
5270730|NCT00615459|18183746|P2|Period III|Unsatisfactory therapeutic effect|1
5270731|NCT00615459|18183747|P1|Period III|Unsatisfactory therapeutic effect|0
5270732|NCT00615459|18183744|P4|Period III|Administrative problems|0
5270733|NCT00615459|18183745|P3|Period III|Administrative problems|1
5270734|NCT00615459|18183746|P2|Period III|Administrative problems|1
5270735|NCT00615459|18183747|P1|Period III|Administrative problems|0
5270736|NCT00615459|18183744|P4|Period III|Adverse Event|0
5270737|NCT00615459|18183745|P3|Period III|Adverse Event|0
5270738|NCT00615459|18183746|P2|Period III|Adverse Event|1
5270739|NCT00615459|18183747|P1|Period III|Adverse Event|0
5270740|NCT00615459|18183744|P4|Period II|Lost to Follow-up|1
5270741|NCT00615459|18183745|P3|Period II|Lost to Follow-up|0
5270742|NCT00615459|18183746|P2|Period II|Lost to Follow-up|0
5270743|NCT00615459|18183747|P1|Period II|Lost to Follow-up|0
5270744|NCT00615459|18183744|P4|Period II|Adverse Event|0
5270745|NCT00615459|18183745|P3|Period II|Adverse Event|0
5270746|NCT00615459|18183746|P2|Period II|Adverse Event|0
5270747|NCT00615459|18183747|P1|Period II|Adverse Event|1
5270748|NCT00615459|18183744|P4|Period I|Abnormal test procedure results|0
5270749|NCT00615459|18183745|P3|Period I|Abnormal test procedure results|1
5270750|NCT00615459|18183746|P2|Period I|Abnormal test procedure results|1
5270751|NCT00615459|18183747|P1|Period I|Abnormal test procedure results|1
5270752|NCT00615459|18183744|P4|Period I|Subject withdrew consent|1
5270753|NCT00615459|18183745|P3|Period I|Subject withdrew consent|0
5270754|NCT00615459|18183746|P2|Period I|Subject withdrew consent|0
5270755|NCT00615459|18183747|P1|Period I|Subject withdrew consent|1
5270756|NCT00615459|18183744|P4|Period I|Adverse Event|0
5270757|NCT00615459|18183745|P3|Period I|Adverse Event|1
5270758|NCT00615459|18183746|P2|Period I|Adverse Event|0
5270759|NCT00615459|18183747|P1|Period I|Adverse Event|2
5270760|NCT00615290|18183793|P1|Overall Study|Other|2
5270761|NCT00615290|18183793|P1|Overall Study|Withdrawal by Subject|1
5270762|NCT00615290|18183793|P1|Overall Study|Lost to Follow-up|3
5270763|NCT00615290|18183793|P1|Overall Study|Adverse Event|2
5270764|NCT00615264|18183807|P2|Overall Study|Dermal Hypersensitivity|3
5270765|NCT00615264|18183808|P1|Overall Study|Dermal Hypersensitivity|0
5270766|NCT00615264|18183807|P2|Overall Study|Not defined|4
5270767|NCT00615264|18183808|P1|Overall Study|Not defined|7
5270768|NCT00615264|18183807|P2|Overall Study|Protocol Violation|7
5270769|NCT00615264|18183808|P1|Overall Study|Protocol Violation|11
5270770|NCT00615264|18183807|P2|Overall Study|Death|1
5270771|NCT00615264|18183808|P1|Overall Study|Death|1
5270772|NCT00615264|18183807|P2|Overall Study|Adverse Event|5
5270773|NCT00615264|18183808|P1|Overall Study|Adverse Event|8
5270774|NCT00615264|18183807|P2|Overall Study|Lost to Follow-up|13
5270775|NCT00615264|18183808|P1|Overall Study|Lost to Follow-up|6
5270776|NCT00615264|18183807|P2|Overall Study|Withdrawal by Subject|19
5270777|NCT00615264|18183808|P1|Overall Study|Withdrawal by Subject|17
5270778|NCT00615199|18183820|P4|Overall Study|Withdrawal by Subject|0
5270779|NCT00615199|18183821|P3|Overall Study|Withdrawal by Subject|0
5270780|NCT00615199|18183822|P2|Overall Study|Withdrawal by Subject|1
5270781|NCT00615199|18183823|P1|Overall Study|Withdrawal by Subject|2
5270782|NCT00615199|18183820|P4|Overall Study|Other|1
5270783|NCT00615199|18183821|P3|Overall Study|Other|0
5270784|NCT00615199|18183822|P2|Overall Study|Other|0
5270785|NCT00615199|18183823|P1|Overall Study|Other|0
5270786|NCT00615199|18183820|P4|Overall Study|Lost to Follow-up|0
5270787|NCT00615199|18183821|P3|Overall Study|Lost to Follow-up|0
5270788|NCT00615199|18183822|P2|Overall Study|Lost to Follow-up|0
5270789|NCT00615199|18183823|P1|Overall Study|Lost to Follow-up|1
5270790|NCT00615199|18183820|P4|Overall Study|Lack of Efficacy|1
5270791|NCT00615199|18183821|P3|Overall Study|Lack of Efficacy|0
5270792|NCT00615199|18183822|P2|Overall Study|Lack of Efficacy|0
5270793|NCT00615199|18183823|P1|Overall Study|Lack of Efficacy|2
5270794|NCT00615199|18183820|P4|Overall Study|Adverse Event|0
5270795|NCT00615199|18183821|P3|Overall Study|Adverse Event|1
5270796|NCT00615199|18183822|P2|Overall Study|Adverse Event|1
5270797|NCT00615199|18183823|P1|Overall Study|Adverse Event|3
5270798|NCT00615108|18183857|P1|Overall Study|Lost to Follow-up|15
5270799|NCT00615108|18183857|P1|Overall Study|Other|370
5270800|NCT00615108|18183857|P1|Overall Study|Adverse Event|122
5270801|NCT00615069|18183872|P1|Overall Study|Withdrawal by Subject|4
5270802|NCT00615069|18183872|P1|Overall Study|Physician Decision|2
5270803|NCT00615069|18183872|P1|Overall Study|Death|10
5270804|NCT00615056|18183881|P4|Overall Study|Randomized but not treated|0
5270805|NCT00615056|18183882|P3|Overall Study|Randomized but not treated|0
5270806|NCT00615056|18183883|P2|Overall Study|Randomized but not treated|0
5270807|NCT00615056|18183884|P1|Overall Study|Randomized but not treated|3
5270808|NCT00615056|18183881|P4|Overall Study|Discontinued by Sponsor|0
5270809|NCT00615056|18183882|P3|Overall Study|Discontinued by Sponsor|0
5270810|NCT00615056|18183883|P2|Overall Study|Discontinued by Sponsor|0
5270811|NCT00615056|18183884|P1|Overall Study|Discontinued by Sponsor|1
5270812|NCT00615056|18183881|P4|Overall Study|Withdrawal by Subject|0
5270813|NCT00615056|18183882|P3|Overall Study|Withdrawal by Subject|1
5270814|NCT00615056|18183883|P2|Overall Study|Withdrawal by Subject|1
5270815|NCT00615056|18183884|P1|Overall Study|Withdrawal by Subject|0
5270816|NCT00615056|18183881|P4|Overall Study|Objective progression or relapse|0
5270817|NCT00615056|18183882|P3|Overall Study|Objective progression or relapse|0
5270818|NCT00615056|18183883|P2|Overall Study|Objective progression or relapse|2
5270819|NCT00615056|18183884|P1|Overall Study|Objective progression or relapse|0
5270820|NCT00615056|18183881|P4|Overall Study|Other|7
5270821|NCT00615056|18183882|P3|Overall Study|Other|10
5270822|NCT00615056|18183883|P2|Overall Study|Other|15
5270823|NCT00615056|18183884|P1|Overall Study|Other|13
5270824|NCT00615056|18183881|P4|Overall Study|Lost to Follow-up|5
5270825|NCT00615056|18183882|P3|Overall Study|Lost to Follow-up|4
5270826|NCT00615056|18183883|P2|Overall Study|Lost to Follow-up|2
5270827|NCT00615056|18183884|P1|Overall Study|Lost to Follow-up|1
5270828|NCT00615056|18183881|P4|Overall Study|Death|23
5270829|NCT00615056|18183882|P3|Overall Study|Death|21
5270830|NCT00615056|18183883|P2|Overall Study|Death|31
5270831|NCT00615056|18183884|P1|Overall Study|Death|31
5270832|NCT00615030|18183914|P12|Period III|Administrative problems|0
5270833|NCT00615030|18183915|P11|Period III|Administrative problems|0
5270834|NCT00615030|18183916|P10|Period III|Administrative problems|0
5270835|NCT00615030|18183917|P9|Period III|Administrative problems|0
5270836|NCT00615030|18183918|P8|Period III|Administrative problems|0
5270837|NCT00615030|18183919|P7|Period III|Administrative problems|0
5270838|NCT00615030|18183920|P6|Period III|Administrative problems|0
5270839|NCT00615030|18183921|P5|Period III|Administrative problems|0
5270840|NCT00615030|18183922|P4|Period III|Administrative problems|1
5270841|NCT00615030|18183923|P3|Period III|Administrative problems|0
5270842|NCT00615030|18183924|P2|Period III|Administrative problems|0
5270843|NCT00615030|18183925|P1|Period III|Administrative problems|1
5270844|NCT00615030|18183914|P12|Period II|Subject withdrew consent|0
5270845|NCT00615030|18183915|P11|Period II|Subject withdrew consent|0
5270846|NCT00615030|18183916|P10|Period II|Subject withdrew consent|0
5270847|NCT00615030|18183917|P9|Period II|Subject withdrew consent|0
5270848|NCT00615030|18183918|P8|Period II|Subject withdrew consent|0
5270849|NCT00615030|18183919|P7|Period II|Subject withdrew consent|1
5270850|NCT00615030|18183920|P6|Period II|Subject withdrew consent|0
5270851|NCT00615030|18183921|P5|Period II|Subject withdrew consent|0
5270852|NCT00615030|18183922|P4|Period II|Subject withdrew consent|1
5270853|NCT00615030|18183923|P3|Period II|Subject withdrew consent|0
5270854|NCT00615030|18183924|P2|Period II|Subject withdrew consent|0
5270855|NCT00615030|18183925|P1|Period II|Subject withdrew consent|0
5270856|NCT00615030|18183914|P12|Period II|Adverse Event|0
5270857|NCT00615030|18183915|P11|Period II|Adverse Event|0
5270858|NCT00615030|18183916|P10|Period II|Adverse Event|0
5270859|NCT00615030|18183917|P9|Period II|Adverse Event|1
5270860|NCT00615030|18183918|P8|Period II|Adverse Event|0
5270861|NCT00615030|18183919|P7|Period II|Adverse Event|0
5270862|NCT00615030|18183920|P6|Period II|Adverse Event|0
5270863|NCT00615030|18183921|P5|Period II|Adverse Event|0
5270864|NCT00615030|18183922|P4|Period II|Adverse Event|0
5270865|NCT00615030|18183923|P3|Period II|Adverse Event|1
5270866|NCT00615030|18183924|P2|Period II|Adverse Event|0
5270867|NCT00615030|18183925|P1|Period II|Adverse Event|0
5270868|NCT00615030|18183914|P12|Period I|Abnormal laboratory value(s)|0
5270869|NCT00615030|18183915|P11|Period I|Abnormal laboratory value(s)|0
5270870|NCT00615030|18183916|P10|Period I|Abnormal laboratory value(s)|0
5270871|NCT00615030|18183917|P9|Period I|Abnormal laboratory value(s)|0
5270872|NCT00615030|18183918|P8|Period I|Abnormal laboratory value(s)|0
5270873|NCT00615030|18183919|P7|Period I|Abnormal laboratory value(s)|0
5270874|NCT00615030|18183920|P6|Period I|Abnormal laboratory value(s)|1
5270875|NCT00615030|18183921|P5|Period I|Abnormal laboratory value(s)|0
5270876|NCT00615030|18183922|P4|Period I|Abnormal laboratory value(s)|0
5270877|NCT00615030|18183923|P3|Period I|Abnormal laboratory value(s)|0
5270878|NCT00615030|18183924|P2|Period I|Abnormal laboratory value(s)|0
5270879|NCT00615030|18183925|P1|Period I|Abnormal laboratory value(s)|0
5270880|NCT00615030|18183914|P12|Period I|Subject withdrew consent|1
5270881|NCT00615030|18183915|P11|Period I|Subject withdrew consent|1
5270882|NCT00615030|18183916|P10|Period I|Subject withdrew consent|0
5270883|NCT00615030|18183917|P9|Period I|Subject withdrew consent|1
5270884|NCT00615030|18183918|P8|Period I|Subject withdrew consent|0
5270885|NCT00615030|18183919|P7|Period I|Subject withdrew consent|0
5270886|NCT00615030|18183920|P6|Period I|Subject withdrew consent|0
5270887|NCT00615030|18183921|P5|Period I|Subject withdrew consent|0
5270888|NCT00615030|18183922|P4|Period I|Subject withdrew consent|0
5270889|NCT00615030|18183923|P3|Period I|Subject withdrew consent|0
5270890|NCT00615030|18183924|P2|Period I|Subject withdrew consent|0
5270891|NCT00615030|18183925|P1|Period I|Subject withdrew consent|0
5270892|NCT00615030|18183914|P12|Period I|Protocol deviation|0
5270893|NCT00615030|18183915|P11|Period I|Protocol deviation|0
5270894|NCT00615030|18183916|P10|Period I|Protocol deviation|0
5270895|NCT00615030|18183917|P9|Period I|Protocol deviation|0
5270896|NCT00615030|18183918|P8|Period I|Protocol deviation|0
5270897|NCT00615030|18183919|P7|Period I|Protocol deviation|0
5270898|NCT00615030|18183920|P6|Period I|Protocol deviation|0
5270899|NCT00615030|18183921|P5|Period I|Protocol deviation|0
5270900|NCT00615030|18183922|P4|Period I|Protocol deviation|0
5270901|NCT00615030|18183923|P3|Period I|Protocol deviation|0
5270902|NCT00615030|18183924|P2|Period I|Protocol deviation|0
5270903|NCT00615030|18183925|P1|Period I|Protocol deviation|1
5270904|NCT00615030|18183914|P12|Period I|Administrative problem|0
5270905|NCT00615030|18183915|P11|Period I|Administrative problem|0
5270906|NCT00615030|18183916|P10|Period I|Administrative problem|0
5270907|NCT00615030|18183917|P9|Period I|Administrative problem|0
5270908|NCT00615030|18183918|P8|Period I|Administrative problem|0
5270909|NCT00615030|18183919|P7|Period I|Administrative problem|0
5270910|NCT00615030|18183920|P6|Period I|Administrative problem|0
5270911|NCT00615030|18183921|P5|Period I|Administrative problem|1
5270912|NCT00615030|18183922|P4|Period I|Administrative problem|0
5270913|NCT00615030|18183923|P3|Period I|Administrative problem|0
5270914|NCT00615030|18183924|P2|Period I|Administrative problem|0
5270915|NCT00615030|18183925|P1|Period I|Administrative problem|0
5270916|NCT00615017|18183945|P6|Overall Study|Physician discontinued drug|1
5270917|NCT00615017|18183946|P5|Overall Study|Physician discontinued drug|0
5270918|NCT00615017|18183947|P4|Overall Study|Physician discontinued drug|0
5270919|NCT00615017|18183948|P3|Overall Study|Physician discontinued drug|0
5270920|NCT00615017|18183949|P2|Overall Study|Physician discontinued drug|0
5270921|NCT00615017|18183950|P1|Overall Study|Physician discontinued drug|0
5270922|NCT00615017|18183945|P6|Overall Study|Transferred out of Intensive Care Unit|0
5270923|NCT00615017|18183946|P5|Overall Study|Transferred out of Intensive Care Unit|0
5270924|NCT00615017|18183947|P4|Overall Study|Transferred out of Intensive Care Unit|1
5270925|NCT00615017|18183948|P3|Overall Study|Transferred out of Intensive Care Unit|0
5270926|NCT00615017|18183949|P2|Overall Study|Transferred out of Intensive Care Unit|0
5270927|NCT00615017|18183950|P1|Overall Study|Transferred out of Intensive Care Unit|0
5270928|NCT00615017|18183945|P6|Overall Study|Sepsis resolved|0
5270929|NCT00615017|18183946|P5|Overall Study|Sepsis resolved|0
5270930|NCT00615017|18183947|P4|Overall Study|Sepsis resolved|0
5270931|NCT00615017|18183948|P3|Overall Study|Sepsis resolved|1
5270932|NCT00615017|18183949|P2|Overall Study|Sepsis resolved|0
5270933|NCT00615017|18183950|P1|Overall Study|Sepsis resolved|0
5270934|NCT00615017|18183945|P6|Overall Study|Death|1
5270935|NCT00615017|18183946|P5|Overall Study|Death|1
5270936|NCT00615017|18183947|P4|Overall Study|Death|0
5270937|NCT00615017|18183948|P3|Overall Study|Death|2
5270938|NCT00615017|18183949|P2|Overall Study|Death|0
5270939|NCT00615017|18183950|P1|Overall Study|Death|0
5270940|NCT00615017|18183945|P6|Overall Study|Adverse Event|1
5270941|NCT00615017|18183946|P5|Overall Study|Adverse Event|0
5270942|NCT00615017|18183947|P4|Overall Study|Adverse Event|0
5270943|NCT00615017|18183948|P3|Overall Study|Adverse Event|2
5270944|NCT00615017|18183949|P2|Overall Study|Adverse Event|1
5270945|NCT00615017|18183950|P1|Overall Study|Adverse Event|0
5270946|NCT00614991|18184108|P6|Overall Study|Adverse Event|0
5270947|NCT00614991|18184109|P5|Overall Study|Adverse Event|1
5270948|NCT00614991|18184110|P4|Overall Study|Adverse Event|0
5270949|NCT00614991|18184111|P3|Overall Study|Adverse Event|0
5270950|NCT00614991|18184112|P2|Overall Study|Adverse Event|3
5270951|NCT00614991|18184113|P1|Overall Study|Adverse Event|3
5270952|NCT00614939|18184147|P2|Overall Study|Hospitalized due to kidney transplant|0
5270953|NCT00614939|18184148|P1|Overall Study|Hospitalized due to kidney transplant|1
5270954|NCT00614939|18184147|P2|Overall Study|Poor/non-compliance|0
5270955|NCT00614939|18184148|P1|Overall Study|Poor/non-compliance|4
5270956|NCT00614939|18184147|P2|Overall Study|Death|3
5270957|NCT00614939|18184148|P1|Overall Study|Death|4
5270958|NCT00614939|18184147|P2|Overall Study|Incorrect enrollment|2
5270959|NCT00614939|18184148|P1|Overall Study|Incorrect enrollment|1
5270960|NCT00614939|18184147|P2|Overall Study|Adverse Event|5
5270961|NCT00614939|18184148|P1|Overall Study|Adverse Event|2
5270962|NCT00614939|18184147|P2|Overall Study|Study specific discontinuation criteris|16
5270963|NCT00614939|18184148|P1|Overall Study|Study specific discontinuation criteris|13
5270964|NCT00614939|18184147|P2|Overall Study|Withdrawal by Subject|17
5270965|NCT00614939|18184148|P1|Overall Study|Withdrawal by Subject|10
5270966|NCT00614926|18184182|P2|Overall Study|Adverse Event|0
5270967|NCT00614926|18184183|P1|Overall Study|Adverse Event|3
5270968|NCT00614926|18184182|P2|Overall Study|Burden of travel|0
5270969|NCT00614926|18184183|P1|Overall Study|Burden of travel|1
5270970|NCT00614874|18184196|P1|Overall Study|Withdrawal by Subject|1
5270971|NCT00614874|18184196|P1|Overall Study|Protocol Violation|1
5270972|NCT00614822|18184203|P1|Overall Study|Adverse Event|3
5270973|NCT00614744|18184212|P2|Overall Study|Incomplete for Behavior Issues|2
5270974|NCT00614744|18184213|P1|Overall Study|Incomplete for Behavior Issues|0
5270975|NCT00614744|18184212|P2|Overall Study|Lost to Follow-up|4
5270976|NCT00614744|18184213|P1|Overall Study|Lost to Follow-up|5
5270977|NCT00614614|18184239|P5|Booster Vaccination Phase|Other|1
5270978|NCT00614614|18184240|P4|Booster Vaccination Phase|Other|2
5270979|NCT00614614|18184241|P3|Booster Vaccination Phase|Other|3
5270980|NCT00614614|18184242|P2|Booster Vaccination Phase|Other|1
5270981|NCT00614614|18184243|P1|Booster Vaccination Phase|Other|0
5270982|NCT00614614|18184239|P5|Booster Vaccination Phase|Protocol Violation|0
5270983|NCT00614614|18184240|P4|Booster Vaccination Phase|Protocol Violation|3
5270984|NCT00614614|18184241|P3|Booster Vaccination Phase|Protocol Violation|2
5270985|NCT00614614|18184242|P2|Booster Vaccination Phase|Protocol Violation|0
5270986|NCT00614614|18184243|P1|Booster Vaccination Phase|Protocol Violation|0
5270987|NCT00614614|18184239|P5|Booster Vaccination Phase|Lost to Follow-up|8
5270988|NCT00614614|18184240|P4|Booster Vaccination Phase|Lost to Follow-up|10
5270989|NCT00614614|18184241|P3|Booster Vaccination Phase|Lost to Follow-up|17
5270990|NCT00614614|18184242|P2|Booster Vaccination Phase|Lost to Follow-up|5
5270991|NCT00614614|18184243|P1|Booster Vaccination Phase|Lost to Follow-up|0
5270992|NCT00614614|18184239|P5|Booster Vaccination Phase|Withdrawal by Subject|4
5270993|NCT00614614|18184240|P4|Booster Vaccination Phase|Withdrawal by Subject|3
5270994|NCT00614614|18184241|P3|Booster Vaccination Phase|Withdrawal by Subject|4
5270995|NCT00614614|18184242|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5270996|NCT00614614|18184243|P1|Booster Vaccination Phase|Withdrawal by Subject|0
5270997|NCT00614614|18184239|P5|Booster Vaccination Phase|Adverse Event|0
5270998|NCT00614614|18184240|P4|Booster Vaccination Phase|Adverse Event|1
5270999|NCT00614614|18184241|P3|Booster Vaccination Phase|Adverse Event|1
5271000|NCT00614614|18184242|P2|Booster Vaccination Phase|Adverse Event|0
5271001|NCT00614614|18184243|P1|Booster Vaccination Phase|Adverse Event|0
5271002|NCT00614614|18184239|P5|Primary Vaccination Phase|Other|0
5271003|NCT00614614|18184240|P4|Primary Vaccination Phase|Other|0
5271004|NCT00614614|18184241|P3|Primary Vaccination Phase|Other|0
5271005|NCT00614614|18184242|P2|Primary Vaccination Phase|Other|0
5271006|NCT00614614|18184243|P1|Primary Vaccination Phase|Other|4
5271007|NCT00614614|18184239|P5|Primary Vaccination Phase|Protocol Violation|0
5271008|NCT00614614|18184240|P4|Primary Vaccination Phase|Protocol Violation|0
5271009|NCT00614614|18184241|P3|Primary Vaccination Phase|Protocol Violation|0
5271010|NCT00614614|18184242|P2|Primary Vaccination Phase|Protocol Violation|3
5271011|NCT00614614|18184243|P1|Primary Vaccination Phase|Protocol Violation|9
5271012|NCT00614614|18184239|P5|Primary Vaccination Phase|Lost to Follow-up|0
5271013|NCT00614614|18184240|P4|Primary Vaccination Phase|Lost to Follow-up|0
5271014|NCT00614614|18184241|P3|Primary Vaccination Phase|Lost to Follow-up|0
5271015|NCT00614614|18184242|P2|Primary Vaccination Phase|Lost to Follow-up|8
5271016|NCT00614614|18184243|P1|Primary Vaccination Phase|Lost to Follow-up|26
5271017|NCT00614614|18184239|P5|Primary Vaccination Phase|Withdrawal by Subject|0
5271018|NCT00614614|18184240|P4|Primary Vaccination Phase|Withdrawal by Subject|0
5271019|NCT00614614|18184241|P3|Primary Vaccination Phase|Withdrawal by Subject|0
5271020|NCT00614614|18184242|P2|Primary Vaccination Phase|Withdrawal by Subject|6
5271021|NCT00614614|18184243|P1|Primary Vaccination Phase|Withdrawal by Subject|45
5271022|NCT00614614|18184239|P5|Primary Vaccination Phase|Adverse Event|0
5271023|NCT00614614|18184240|P4|Primary Vaccination Phase|Adverse Event|0
5271024|NCT00614614|18184241|P3|Primary Vaccination Phase|Adverse Event|0
5271025|NCT00614614|18184242|P2|Primary Vaccination Phase|Adverse Event|0
5271026|NCT00614614|18184243|P1|Primary Vaccination Phase|Adverse Event|6
5271027|NCT00614575|18184366|P1|Overall Study|No treatment|1
5271028|NCT00614575|18184366|P1|Overall Study|Irregularly enrolled patients|23
5271029|NCT00614575|18184366|P1|Overall Study|No data were collected.|18
5271030|NCT00614575|18184366|P1|Overall Study|Physician Decision|2
5271031|NCT00614575|18184366|P1|Overall Study|Death|3
5271032|NCT00614575|18184366|P1|Overall Study|Withdrawal by Subject|6
5271033|NCT00614575|18184366|P1|Overall Study|Lack of Efficacy|14
5271034|NCT00614575|18184366|P1|Overall Study|Lost to Follow-up|55
5271035|NCT00614575|18184366|P1|Overall Study|Adverse Event|106
5271036|NCT00614523|18184377|P2|Overall Study|Administrative Decision|46
5271037|NCT00614523|18184378|P1|Overall Study|Administrative Decision|23
5271038|NCT00614523|18184377|P2|Overall Study|Disease Progression|8
5271039|NCT00614523|18184378|P1|Overall Study|Disease Progression|0
5271040|NCT00614523|18184377|P2|Overall Study|Ineligibility Determined|2
5271041|NCT00614523|18184378|P1|Overall Study|Ineligibility Determined|1
5271042|NCT00614523|18184377|P2|Overall Study|Other|11
5271043|NCT00614523|18184378|P1|Overall Study|Other|6
5271044|NCT00614523|18184377|P2|Overall Study|Withdrawal by Subject|22
5271045|NCT00614523|18184378|P1|Overall Study|Withdrawal by Subject|12
5271046|NCT00614523|18184377|P2|Overall Study|Protocol Violation|2
5271047|NCT00614523|18184378|P1|Overall Study|Protocol Violation|3
5271048|NCT00614523|18184377|P2|Overall Study|Lost to Follow-up|1
5271049|NCT00614523|18184378|P1|Overall Study|Lost to Follow-up|0
5271050|NCT00614523|18184377|P2|Overall Study|Lack of Efficacy|11
5271051|NCT00614523|18184378|P1|Overall Study|Lack of Efficacy|9
5271052|NCT00614523|18184377|P2|Overall Study|Death|8
5271053|NCT00614523|18184378|P1|Overall Study|Death|5
5271054|NCT00614523|18184377|P2|Overall Study|Adverse Event|20
5271055|NCT00614523|18184378|P1|Overall Study|Adverse Event|4
5271056|NCT00614393|18184443|P5|Overall Study|Not Treated|2
5271057|NCT00614393|18184444|P4|Overall Study|Not Treated|0
5271058|NCT00614393|18184445|P3|Overall Study|Not Treated|0
5271059|NCT00614393|18184446|P2|Overall Study|Not Treated|0
5271060|NCT00614393|18184447|P1|Overall Study|Not Treated|0
5271061|NCT00614393|18184443|P5|Overall Study|Other|2
5271062|NCT00614393|18184444|P4|Overall Study|Other|4
5271063|NCT00614393|18184445|P3|Overall Study|Other|0
5271064|NCT00614393|18184446|P2|Overall Study|Other|0
5271065|NCT00614393|18184447|P1|Overall Study|Other|4
5271066|NCT00614393|18184443|P5|Overall Study|Withdrawal by Subject|13
5271067|NCT00614393|18184444|P4|Overall Study|Withdrawal by Subject|16
5271068|NCT00614393|18184445|P3|Overall Study|Withdrawal by Subject|1
5271069|NCT00614393|18184446|P2|Overall Study|Withdrawal by Subject|1
5271070|NCT00614393|18184447|P1|Overall Study|Withdrawal by Subject|20
5271071|NCT00614393|18184443|P5|Overall Study|Terminated by Sponsor|1
5271072|NCT00614393|18184444|P4|Overall Study|Terminated by Sponsor|0
5271073|NCT00614393|18184445|P3|Overall Study|Terminated by Sponsor|0
5271074|NCT00614393|18184446|P2|Overall Study|Terminated by Sponsor|0
5271075|NCT00614393|18184447|P1|Overall Study|Terminated by Sponsor|0
5271076|NCT00614393|18184443|P5|Overall Study|Protocol Violation|0
5271077|NCT00614393|18184444|P4|Overall Study|Protocol Violation|0
5271078|NCT00614393|18184445|P3|Overall Study|Protocol Violation|0
5271079|NCT00614393|18184446|P2|Overall Study|Protocol Violation|0
5271080|NCT00614393|18184447|P1|Overall Study|Protocol Violation|1
5271081|NCT00614393|18184443|P5|Overall Study|Progressive Disease|130
5271082|NCT00614393|18184444|P4|Overall Study|Progressive Disease|138
5271083|NCT00614393|18184445|P3|Overall Study|Progressive Disease|5
5271084|NCT00614393|18184446|P2|Overall Study|Progressive Disease|5
5271085|NCT00614393|18184447|P1|Overall Study|Progressive Disease|118
5271086|NCT00614393|18184443|P5|Overall Study|Physician Decision|9
5271087|NCT00614393|18184444|P4|Overall Study|Physician Decision|8
5271088|NCT00614393|18184445|P3|Overall Study|Physician Decision|1
5271089|NCT00614393|18184446|P2|Overall Study|Physician Decision|0
5271090|NCT00614393|18184447|P1|Overall Study|Physician Decision|17
5271091|NCT00614393|18184443|P5|Overall Study|Lost to Follow-up|2
5271092|NCT00614393|18184444|P4|Overall Study|Lost to Follow-up|1
5271093|NCT00614393|18184445|P3|Overall Study|Lost to Follow-up|0
5271094|NCT00614393|18184446|P2|Overall Study|Lost to Follow-up|0
5271095|NCT00614393|18184447|P1|Overall Study|Lost to Follow-up|0
5271096|NCT00614393|18184443|P5|Overall Study|Adverse Event|21
5271097|NCT00614393|18184444|P4|Overall Study|Adverse Event|13
5271098|NCT00614393|18184445|P3|Overall Study|Adverse Event|3
5271099|NCT00614393|18184446|P2|Overall Study|Adverse Event|2
5271100|NCT00614393|18184447|P1|Overall Study|Adverse Event|20
5271101|NCT00614380|18184493|P4|Overall Study|Consent withdrawn|0
5271102|NCT00614380|18184494|P3|Overall Study|Consent withdrawn|0
5271103|NCT00614380|18184495|P2|Overall Study|Consent withdrawn|1
5271104|NCT00614380|18184496|P1|Overall Study|Consent withdrawn|3
5271105|NCT00614380|18184493|P4|Overall Study|Non compliant with the protocol|2
5271106|NCT00614380|18184494|P3|Overall Study|Non compliant with the protocol|1
5271107|NCT00614380|18184495|P2|Overall Study|Non compliant with the protocol|2
5271108|NCT00614380|18184496|P1|Overall Study|Non compliant with the protocol|12
5271109|NCT00614380|18184493|P4|Overall Study|Lost to Follow-up|0
5271110|NCT00614380|18184494|P3|Overall Study|Lost to Follow-up|0
5271111|NCT00614380|18184495|P2|Overall Study|Lost to Follow-up|1
5271112|NCT00614380|18184496|P1|Overall Study|Lost to Follow-up|6
5271113|NCT00614380|18184493|P4|Overall Study|Adverse Event|0
5271114|NCT00614380|18184494|P3|Overall Study|Adverse Event|0
5271115|NCT00614380|18184495|P2|Overall Study|Adverse Event|4
5271116|NCT00614380|18184496|P1|Overall Study|Adverse Event|14
5271117|NCT00614120|18184563|P4|Overall Study|Lost to Follow-up|4
5271118|NCT00614120|18184564|P3|Overall Study|Lost to Follow-up|3
5271119|NCT00614120|18184565|P2|Overall Study|Lost to Follow-up|2
5271120|NCT00614120|18184566|P1|Overall Study|Lost to Follow-up|1
5271121|NCT00614120|18184563|P4|Overall Study|Taken inhibition medication eg Prandin|1
5271122|NCT00614120|18184564|P3|Overall Study|Taken inhibition medication eg Prandin|1
5271123|NCT00614120|18184565|P2|Overall Study|Taken inhibition medication eg Prandin|0
5271124|NCT00614120|18184566|P1|Overall Study|Taken inhibition medication eg Prandin|0
5271125|NCT00614120|18184563|P4|Overall Study|Late syphilis, latent|0
5271126|NCT00614120|18184564|P3|Overall Study|Late syphilis, latent|0
5271127|NCT00614120|18184565|P2|Overall Study|Late syphilis, latent|0
5271128|NCT00614120|18184566|P1|Overall Study|Late syphilis, latent|1
5271129|NCT00614120|18184563|P4|Overall Study|Lack of trial product|0
5271130|NCT00614120|18184564|P3|Overall Study|Lack of trial product|2
5271131|NCT00614120|18184565|P2|Overall Study|Lack of trial product|3
5271132|NCT00614120|18184566|P1|Overall Study|Lack of trial product|3
5271133|NCT00614120|18184563|P4|Overall Study|Hypoglycaemia|1
5271134|NCT00614120|18184564|P3|Overall Study|Hypoglycaemia|0
5271135|NCT00614120|18184565|P2|Overall Study|Hypoglycaemia|0
5271136|NCT00614120|18184566|P1|Overall Study|Hypoglycaemia|0
5271137|NCT00614120|18184563|P4|Overall Study|hCG positive (not pregnant)|0
5271138|NCT00614120|18184564|P3|Overall Study|hCG positive (not pregnant)|1
5271139|NCT00614120|18184565|P2|Overall Study|hCG positive (not pregnant)|0
5271140|NCT00614120|18184566|P1|Overall Study|hCG positive (not pregnant)|0
5271141|NCT00614120|18184563|P4|Overall Study|Did not meet trial criteria|1
5271142|NCT00614120|18184564|P3|Overall Study|Did not meet trial criteria|1
5271143|NCT00614120|18184565|P2|Overall Study|Did not meet trial criteria|1
5271144|NCT00614120|18184566|P1|Overall Study|Did not meet trial criteria|0
5271145|NCT00614120|18184563|P4|Overall Study|Withdrawal by Subject|3
5271146|NCT00614120|18184564|P3|Overall Study|Withdrawal by Subject|16
5271147|NCT00614120|18184565|P2|Overall Study|Withdrawal by Subject|10
5271148|NCT00614120|18184566|P1|Overall Study|Withdrawal by Subject|9
5271149|NCT00614120|18184563|P4|Overall Study|Withdrawal criteria|0
5271150|NCT00614120|18184564|P3|Overall Study|Withdrawal criteria|0
5271151|NCT00614120|18184565|P2|Overall Study|Withdrawal criteria|0
5271152|NCT00614120|18184566|P1|Overall Study|Withdrawal criteria|1
5271153|NCT00614120|18184563|P4|Overall Study|Protocol Violation|1
5271154|NCT00614120|18184564|P3|Overall Study|Protocol Violation|3
5271155|NCT00614120|18184565|P2|Overall Study|Protocol Violation|5
5271156|NCT00614120|18184566|P1|Overall Study|Protocol Violation|2
5271157|NCT00614120|18184563|P4|Overall Study|Lack of Efficacy|2
5271158|NCT00614120|18184564|P3|Overall Study|Lack of Efficacy|2
5271159|NCT00614120|18184565|P2|Overall Study|Lack of Efficacy|3
5271160|NCT00614120|18184566|P1|Overall Study|Lack of Efficacy|3
5271161|NCT00614120|18184563|P4|Overall Study|Adverse Event|3
5271162|NCT00614120|18184564|P3|Overall Study|Adverse Event|30
5271163|NCT00614120|18184565|P2|Overall Study|Adverse Event|22
5271164|NCT00614120|18184566|P1|Overall Study|Adverse Event|9
5271165|NCT00614055|18184607|P3|Overall Study|Unclassified|2
5271166|NCT00614055|18184608|P2|Overall Study|Unclassified|4
5271167|NCT00614055|18184609|P1|Overall Study|Unclassified|1
5271168|NCT00614055|18184607|P3|Overall Study|Lack of Efficacy|2
5271169|NCT00614055|18184608|P2|Overall Study|Lack of Efficacy|0
5271170|NCT00614055|18184609|P1|Overall Study|Lack of Efficacy|0
5271171|NCT00614055|18184607|P3|Overall Study|Protocol Violation|1
5271172|NCT00614055|18184608|P2|Overall Study|Protocol Violation|2
5271173|NCT00614055|18184609|P1|Overall Study|Protocol Violation|2
5271174|NCT00614055|18184607|P3|Overall Study|Adverse Event|0
5271175|NCT00614055|18184608|P2|Overall Study|Adverse Event|0
5271176|NCT00614055|18184609|P1|Overall Study|Adverse Event|1
5271177|NCT00613951|18184656|P3|Overall Study|Unclassified|2
5271178|NCT00613951|18184657|P2|Overall Study|Unclassified|3
5271179|NCT00613951|18184658|P1|Overall Study|Unclassified|5
5271180|NCT00613951|18184656|P3|Overall Study|Protocol Violation|1
5271181|NCT00613951|18184657|P2|Overall Study|Protocol Violation|1
5271182|NCT00613951|18184658|P1|Overall Study|Protocol Violation|1
5271183|NCT00613951|18184656|P3|Overall Study|Lack of Efficacy|1
5271184|NCT00613951|18184657|P2|Overall Study|Lack of Efficacy|1
5271185|NCT00613951|18184658|P1|Overall Study|Lack of Efficacy|0
5271186|NCT00613951|18184656|P3|Overall Study|Adverse Event|1
5271187|NCT00613951|18184657|P2|Overall Study|Adverse Event|0
5271188|NCT00613951|18184658|P1|Overall Study|Adverse Event|1
5271189|NCT00613938|18184703|P4|Overall Study|Other|3
5271190|NCT00613938|18184704|P3|Overall Study|Other|1
5271191|NCT00613938|18184705|P2|Overall Study|Other|2
5271192|NCT00613938|18184706|P1|Overall Study|Other|1
5271193|NCT00613938|18184703|P4|Overall Study|Lack of Efficacy|9
5271194|NCT00613938|18184704|P3|Overall Study|Lack of Efficacy|5
5271195|NCT00613938|18184705|P2|Overall Study|Lack of Efficacy|18
5271196|NCT00613938|18184706|P1|Overall Study|Lack of Efficacy|16
5271197|NCT00613938|18184703|P4|Overall Study|Adverse Event|5
5271198|NCT00613938|18184704|P3|Overall Study|Adverse Event|8
5271199|NCT00613938|18184705|P2|Overall Study|Adverse Event|4
5271200|NCT00613938|18184706|P1|Overall Study|Adverse Event|1
5271201|NCT00613938|18184703|P4|Overall Study|Withdrawal by Subject|9
5271202|NCT00613938|18184704|P3|Overall Study|Withdrawal by Subject|9
5271203|NCT00613938|18184705|P2|Overall Study|Withdrawal by Subject|4
5271204|NCT00613938|18184706|P1|Overall Study|Withdrawal by Subject|2
5271205|NCT00613925|18184738|P2|Overall Study|1 did not tolerate outpatient biopsy|1
5271206|NCT00613925|18184739|P1|Overall Study|1 did not tolerate outpatient biopsy|0
5271207|NCT00613834|18184749|P2|Overall Study|Withdrawal by Subject|3
5271208|NCT00613834|18184750|P1|Overall Study|Withdrawal by Subject|0
5271209|NCT00613821|18184762|P2|Overall Study|Physician Decision|1
5271210|NCT00613821|18184763|P1|Overall Study|Physician Decision|1
5271211|NCT00613821|18184762|P2|Overall Study|Withdrawal by Subject|0
5271212|NCT00613821|18184763|P1|Overall Study|Withdrawal by Subject|1
5271213|NCT00613730|18184769|P1|Overall Study|Administrative decision|1
5271214|NCT00613730|18184769|P1|Overall Study|Disease progression|2
5271215|NCT00613626|18184778|P3|Overall Study|Ineligible|0
5271216|NCT00613626|18184779|P2|Overall Study|Ineligible|1
5271217|NCT00613626|18184780|P1|Overall Study|Ineligible|0
5271218|NCT00613574|18184796|P1|Overall Study|Other|1
5271219|NCT00613574|18184796|P1|Overall Study|Lost to Follow-up|2
5271220|NCT00613574|18184796|P1|Overall Study|Adverse Event|3
5271221|NCT00613509|18184808|P2|Cycle 1|Other administrative reason|1
5271222|NCT00613509|18184809|P1|Cycle 1|Other administrative reason|0
5271223|NCT00613509|18184808|P2|Cycle 1|Unacceptable Toxicity|0
5271224|NCT00613509|18184809|P1|Cycle 1|Unacceptable Toxicity|1
5271225|NCT00613509|18184808|P2|Cycle 1|Disease Progression|6
5271226|NCT00613509|18184809|P1|Cycle 1|Disease Progression|2
5271227|NCT00613509|18184808|P2|Cycle 1|Adverse Event|1
5271228|NCT00613509|18184809|P1|Cycle 1|Adverse Event|2
5271229|NCT00613366|18184855|P2|Overall Study|Withdrawal by Subject|2
5271230|NCT00613366|18184856|P1|Overall Study|Withdrawal by Subject|3
5271231|NCT00613327|18184864|P1|Overall Study|Other|47
5271232|NCT00613327|18184864|P1|Overall Study|Protocol Violation|2
5271233|NCT00613327|18184864|P1|Overall Study|Withdrawal by Subject|6
5271234|NCT00613327|18184864|P1|Overall Study|Lost to Follow-up|8
5271235|NCT00613327|18184864|P1|Overall Study|Adverse Event|38
5271236|NCT00613314|18184883|P1|Overall Study|Other reason not defined above|90
5271237|NCT00613314|18184883|P1|Overall Study|Lost to Follow-up|46
5271238|NCT00613314|18184883|P1|Overall Study|Protocol Violation|14
5271239|NCT00613314|18184883|P1|Overall Study|Adverse Event|5
5271240|NCT00613301|18184891|P1|Overall Study|Irregularly enrolled patients|12
5271241|NCT00613301|18184891|P1|Overall Study|No data was collected|53
5271242|NCT00613301|18184891|P1|Overall Study|Physician Decision|2
5271243|NCT00613301|18184891|P1|Overall Study|Lack of Efficacy|13
5271244|NCT00613301|18184891|P1|Overall Study|Death|6
5271245|NCT00613301|18184891|P1|Overall Study|Withdrawal by Subject|5
5271246|NCT00613301|18184891|P1|Overall Study|Lost to Follow-up|88
5271247|NCT00613301|18184891|P1|Overall Study|Adverse Event|49
5271248|NCT00613106|18184900|P2|Overall Study|misc|3
5271249|NCT00613106|18184901|P1|Overall Study|misc|4
5271250|NCT00613106|18184900|P2|Overall Study|Lost to Follow-up|2
5271251|NCT00613106|18184901|P1|Overall Study|Lost to Follow-up|7
5271252|NCT00613106|18184900|P2|Overall Study|Withdrawal by Subject|3
5271253|NCT00613106|18184901|P1|Overall Study|Withdrawal by Subject|6
5271254|NCT00613106|18184900|P2|Overall Study|Adverse Event|1
5271255|NCT00613106|18184901|P1|Overall Study|Adverse Event|3
5271256|NCT00613080|18184907|P1|Overall Study|Ineligible / no protocol treatment|11
5271257|NCT00613015|18184942|P6|Overall Study|Lost to Follow-up|3
5271258|NCT00613015|18184943|P5|Overall Study|Lost to Follow-up|2
5271259|NCT00613015|18184944|P4|Overall Study|Lost to Follow-up|3
5271260|NCT00613015|18184945|P3|Overall Study|Lost to Follow-up|3
5271261|NCT00613015|18184946|P2|Overall Study|Lost to Follow-up|1
5271262|NCT00613015|18184947|P1|Overall Study|Lost to Follow-up|0
5271263|NCT00612807|18184983|P2|Overall Study|Withdrawal by Subject|0
5271264|NCT00612807|18184984|P1|Overall Study|Withdrawal by Subject|2
5271265|NCT00612690|18185019|P2|Overall Study|Withdrawal by Site|0
5271266|NCT00612690|18185020|P1|Overall Study|Withdrawal by Site|11
5271267|NCT00612690|18185019|P2|Overall Study|Withdrawal by Subject|20
5271268|NCT00612690|18185020|P1|Overall Study|Withdrawal by Subject|32
5271269|NCT00612690|18185019|P2|Overall Study|Lost to Follow-up|98
5271270|NCT00612690|18185020|P1|Overall Study|Lost to Follow-up|72
5271271|NCT00612677|18185028|P1|Overall Study|study closed before treatment started|1
5271272|NCT00612586|18185036|P2|Overall Study|Randomized and Not Treated|1
5271273|NCT00612586|18185037|P1|Overall Study|Randomized and Not Treated|1
5271274|NCT00612586|18185036|P2|Overall Study|Progressive Disease|24
5271275|NCT00612586|18185037|P1|Overall Study|Progressive Disease|26
5271276|NCT00612586|18185036|P2|Overall Study|Sponsor Decision|1
5271277|NCT00612586|18185037|P1|Overall Study|Sponsor Decision|1
5271278|NCT00612586|18185036|P2|Overall Study|Physician Decision|2
5271279|NCT00612586|18185037|P1|Overall Study|Physician Decision|1
5271280|NCT00612586|18185036|P2|Overall Study|Withdrawal by Subject|9
5271281|NCT00612586|18185037|P1|Overall Study|Withdrawal by Subject|7
5271282|NCT00612586|18185036|P2|Overall Study|Entry Criteria Not Met|2
5271283|NCT00612586|18185037|P1|Overall Study|Entry Criteria Not Met|0
5271284|NCT00612586|18185036|P2|Overall Study|Death|0
5271285|NCT00612586|18185037|P1|Overall Study|Death|1
5271286|NCT00612586|18185036|P2|Overall Study|Adverse Event|2
5271287|NCT00612586|18185037|P1|Overall Study|Adverse Event|6
5271288|NCT00612534|18185113|P4|Overall Study|Other Reason|0
5271289|NCT00612534|18185114|P3|Overall Study|Other Reason|0
5271290|NCT00612534|18185115|P2|Overall Study|Other Reason|1
5271291|NCT00612534|18185116|P1|Overall Study|Other Reason|0
5271292|NCT00612534|18185113|P4|Overall Study|Lack of Efficacy|16
5271293|NCT00612534|18185114|P3|Overall Study|Lack of Efficacy|5
5271294|NCT00612534|18185115|P2|Overall Study|Lack of Efficacy|12
5271295|NCT00612534|18185116|P1|Overall Study|Lack of Efficacy|13
5271296|NCT00612534|18185113|P4|Overall Study|Adverse Event|1
5271297|NCT00612534|18185114|P3|Overall Study|Adverse Event|2
5271298|NCT00612534|18185115|P2|Overall Study|Adverse Event|4
5271299|NCT00612534|18185116|P1|Overall Study|Adverse Event|0
5271300|NCT00612508|18185128|P2|Overall Study|Withdrawal by Subject|4
5271301|NCT00612508|18185129|P1|Overall Study|Withdrawal by Subject|3
5271302|NCT00612456|18185140|P3|Overall Study|Withdrawal by Subject|0
5271303|NCT00612456|18185141|P2|Overall Study|Withdrawal by Subject|1
5271304|NCT00612456|18185142|P1|Overall Study|Withdrawal by Subject|0
5271305|NCT00612456|18185140|P3|Overall Study|Lack of Efficacy|0
5271306|NCT00612456|18185141|P2|Overall Study|Lack of Efficacy|1
5271307|NCT00612456|18185142|P1|Overall Study|Lack of Efficacy|1
5271308|NCT00612456|18185140|P3|Overall Study|Adverse Event|0
5271309|NCT00612456|18185141|P2|Overall Study|Adverse Event|0
5271310|NCT00612456|18185142|P1|Overall Study|Adverse Event|1
5271311|NCT00612352|18185205|P2|Overall Study|didn't return calls/show up on test date|1
5271312|NCT00612352|18185206|P1|Overall Study|didn't return calls/show up on test date|4
5271313|NCT00612352|18185205|P2|Overall Study|moved out of state|0
5271314|NCT00612352|18185206|P1|Overall Study|moved out of state|1
5271315|NCT00612352|18185205|P2|Overall Study|Withdrawal by Subject|5
5271316|NCT00612352|18185206|P1|Overall Study|Withdrawal by Subject|3
5271317|NCT00612352|18185205|P2|Overall Study|Adverse Event|0
5271318|NCT00612352|18185206|P1|Overall Study|Adverse Event|1
5271319|NCT00612313|18185326|P2|Overall Study|Lost to Follow-up|4
5271320|NCT00612313|18185327|P1|Overall Study|Lost to Follow-up|11
5271321|NCT00612313|18185326|P2|Overall Study|Withdrawal by Subject|9
5271322|NCT00612313|18185327|P1|Overall Study|Withdrawal by Subject|6
5271323|NCT00612105|18185369|P2|Period Title 3: 3-Week Taper Phase|Other|0
5271324|NCT00612105|18185370|P1|Period Title 3: 3-Week Taper Phase|Other|1
5271325|NCT00612105|18185369|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
5271326|NCT00612105|18185370|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
5271327|NCT00612105|18185369|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
5271328|NCT00612105|18185370|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
5271329|NCT00612105|18185369|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
5271330|NCT00612105|18185370|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
5271331|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Other|1
5271332|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Other|0
5271333|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
5271334|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
5271335|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
5271336|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
5271337|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
5271338|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
5271339|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
5271340|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
5271341|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
5271342|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
5271343|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
5271344|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
5271345|NCT00612105|18185369|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
5271346|NCT00612105|18185370|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
5271347|NCT00612066|18185420|P1|Overall Study|Adverse Event|1
5271348|NCT00612040|18185427|P3|Overall Study|Unclassified|5
5271349|NCT00612040|18185428|P2|Overall Study|Unclassified|2
5271350|NCT00612040|18185429|P1|Overall Study|Unclassified|2
5271351|NCT00612040|18185427|P3|Overall Study|Lack of Efficacy|0
5271352|NCT00612040|18185428|P2|Overall Study|Lack of Efficacy|1
5271353|NCT00612040|18185429|P1|Overall Study|Lack of Efficacy|2
5271354|NCT00612040|18185427|P3|Overall Study|Protocol Violation|1
5271355|NCT00612040|18185428|P2|Overall Study|Protocol Violation|2
5271356|NCT00612040|18185429|P1|Overall Study|Protocol Violation|1
5271357|NCT00612040|18185427|P3|Overall Study|Adverse Event|1
5271358|NCT00612040|18185428|P2|Overall Study|Adverse Event|2
5271359|NCT00612040|18185429|P1|Overall Study|Adverse Event|0
5271360|NCT00611923|18185475|P2|Overall Study|Withdrawal by Subject|2
5271361|NCT00611923|18185476|P1|Overall Study|Withdrawal by Subject|2
5271362|NCT00611884|18185521|P4|Overall Study|Unclassified|3
5271363|NCT00611884|18185522|P3|Overall Study|Unclassified|2
5271364|NCT00611884|18185523|P2|Overall Study|Unclassified|4
5271365|NCT00611884|18185524|P1|Overall Study|Unclassified|7
5271366|NCT00611884|18185521|P4|Overall Study|Lack of Efficacy|0
5271367|NCT00611884|18185522|P3|Overall Study|Lack of Efficacy|0
5271368|NCT00611884|18185523|P2|Overall Study|Lack of Efficacy|1
5271369|NCT00611884|18185524|P1|Overall Study|Lack of Efficacy|0
5271370|NCT00611884|18185521|P4|Overall Study|Non-Compliance|2
5271371|NCT00611884|18185522|P3|Overall Study|Non-Compliance|2
5271372|NCT00611884|18185523|P2|Overall Study|Non-Compliance|4
5271373|NCT00611884|18185524|P1|Overall Study|Non-Compliance|1
5271374|NCT00611884|18185521|P4|Overall Study|Adverse Event|1
5271375|NCT00611884|18185522|P3|Overall Study|Adverse Event|0
5271376|NCT00611884|18185523|P2|Overall Study|Adverse Event|0
5271377|NCT00611884|18185524|P1|Overall Study|Adverse Event|1
5271378|NCT00611858|18185578|P1|Overall Study|Withdrawal by Subject|2
5271379|NCT00611858|18185578|P1|Overall Study|Adverse Event|2
5271380|NCT00611806|18185590|P2|Overall Study|Lost to Follow-up|0
5271381|NCT00611806|18185591|P1|Overall Study|Lost to Follow-up|6
5271382|NCT00611806|18185590|P2|Overall Study|Adverse Event|1
5271383|NCT00611806|18185591|P1|Overall Study|Adverse Event|2
5271384|NCT00611806|18185590|P2|Overall Study|Withdrawal by Subject|2
5271385|NCT00611806|18185591|P1|Overall Study|Withdrawal by Subject|8
5271386|NCT00611767|18185605|P2|Overall Study|Physician Decision|0
5271387|NCT00611767|18185606|P1|Overall Study|Physician Decision|1
5271388|NCT00611767|18185605|P2|Overall Study|didn't like the medication|1
5271389|NCT00611767|18185606|P1|Overall Study|didn't like the medication|1
5271390|NCT00611767|18185605|P2|Overall Study|Thiopental not available|0
5271391|NCT00611767|18185606|P1|Overall Study|Thiopental not available|3
5271392|NCT00611767|18185605|P2|Overall Study|Withdrawal by Subject|1
5271393|NCT00611767|18185606|P1|Overall Study|Withdrawal by Subject|4
5271394|NCT00611715|18185768|P2|Overall Study|two patients are still on treatment|0
5271395|NCT00611715|18185769|P1|Overall Study|two patients are still on treatment|2
5271396|NCT00611715|18185768|P2|Overall Study|Death|0
5271397|NCT00611715|18185769|P1|Overall Study|Death|1
5271398|NCT00611715|18185768|P2|Overall Study|Adverse Event|1
5271399|NCT00611715|18185769|P1|Overall Study|Adverse Event|9
5271400|NCT00611715|18185768|P2|Overall Study|Withdrawal by Subject|1
5271401|NCT00611715|18185769|P1|Overall Study|Withdrawal by Subject|5
5271402|NCT00611715|18185768|P2|Overall Study|Disease Progression|4
5271403|NCT00611715|18185769|P1|Overall Study|Disease Progression|24
5271404|NCT00611559|18185789|P3|Overall Study|Protocol Violation|1
5271405|NCT00611559|18185790|P2|Overall Study|Protocol Violation|0
5271406|NCT00611559|18185791|P1|Overall Study|Protocol Violation|1
5271407|NCT00611559|18185789|P3|Overall Study|Lost to Follow-up|0
5271408|NCT00611559|18185790|P2|Overall Study|Lost to Follow-up|1
5271409|NCT00611559|18185791|P1|Overall Study|Lost to Follow-up|0
5271410|NCT00611533|18185850|P2|Second Intervention (6 Weeks)|Adverse Event|2
5271411|NCT00611533|18185851|P1|Second Intervention (6 Weeks)|Adverse Event|0
5271412|NCT00611533|18185850|P2|First Intervention (6 Weeks)|Adverse Event|1
5271413|NCT00611533|18185851|P1|First Intervention (6 Weeks)|Adverse Event|0
5271414|NCT00611533|18185850|P2|First Intervention (6 Weeks)|Never started study|1
5271415|NCT00611533|18185851|P1|First Intervention (6 Weeks)|Never started study|0
5271416|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
5271417|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
5271418|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
5271419|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
5271420|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
5271421|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
5271422|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
5271423|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
5271424|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
5271425|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
5271426|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
5271427|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
5271428|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
5271429|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
5271430|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
5271431|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
5271432|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
5271433|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
5271434|NCT00611455|18185885|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
5271435|NCT00611455|18185886|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
5271436|NCT00611455|18185887|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
5271437|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5271438|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
5271439|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5271440|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
5271441|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
5271442|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
5271443|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
5271444|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
5271445|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
5271446|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5271447|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
5271448|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5271449|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5271450|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
5271451|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5271452|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
5271453|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
5271454|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
5271455|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5271456|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
5271457|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5271458|NCT00611455|18185885|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
5271459|NCT00611455|18185886|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
5271460|NCT00611455|18185887|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
5271461|NCT00611455|18185885|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
5271462|NCT00611455|18185886|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
5271463|NCT00611455|18185887|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
5271464|NCT00611455|18185885|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
5271465|NCT00611455|18185886|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
5271466|NCT00611455|18185887|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
5271467|NCT00611455|18185885|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
5271468|NCT00611455|18185886|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
5271469|NCT00611455|18185887|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
5271470|NCT00611455|18185885|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
5271471|NCT00611455|18185886|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
5271472|NCT00611455|18185887|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
5271473|NCT00611455|18185885|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5271474|NCT00611455|18185886|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5271475|NCT00611455|18185887|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
5271476|NCT00611455|18185885|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
5271477|NCT00611455|18185886|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
5271478|NCT00611455|18185887|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
5271479|NCT00611247|18186067|P2|Overall Study|Lack of Efficacy|16
5271480|NCT00611247|18186068|P1|Overall Study|Lack of Efficacy|1
5271481|NCT00611247|18186067|P2|Overall Study|Death|5
5271482|NCT00611247|18186068|P1|Overall Study|Death|1
5271483|NCT00611130|18186080|P2|Overall Study|Death|0
5271484|NCT00611130|18186081|P1|Overall Study|Death|1
5271485|NCT00611130|18186080|P2|Overall Study|Adverse Event|0
5271486|NCT00611130|18186081|P1|Overall Study|Adverse Event|1
5271487|NCT00611130|18186080|P2|Overall Study|Administrative|1
5271488|NCT00611130|18186081|P1|Overall Study|Administrative|1
5271489|NCT00611130|18186080|P2|Overall Study|Incarceration|2
5271490|NCT00611130|18186081|P1|Overall Study|Incarceration|3
5271491|NCT00611130|18186080|P2|Overall Study|Other|4
5271492|NCT00611130|18186081|P1|Overall Study|Other|5
5271493|NCT00611130|18186080|P2|Overall Study|Withdrawal by Subject|5
5271494|NCT00611130|18186081|P1|Overall Study|Withdrawal by Subject|6
5271495|NCT00611130|18186080|P2|Overall Study|Protocol noncompliance|6
5271496|NCT00611130|18186081|P1|Overall Study|Protocol noncompliance|7
5271497|NCT00611130|18186080|P2|Overall Study|Lost to Follow-up|29
5271498|NCT00611130|18186081|P1|Overall Study|Lost to Follow-up|25
5271499|NCT00611026|18186091|P3|Double-blind Treatment Period|Other|18
5271500|NCT00611026|18186092|P2|Double-blind Treatment Period|Other|20
5271501|NCT00611026|18186093|P1|Double-blind Treatment Period|Other|13
5271502|NCT00611026|18186091|P3|Double-blind Treatment Period|Withdrawal by Subject|16
5271503|NCT00611026|18186092|P2|Double-blind Treatment Period|Withdrawal by Subject|19
5271504|NCT00611026|18186093|P1|Double-blind Treatment Period|Withdrawal by Subject|7
5271505|NCT00611026|18186091|P3|Double-blind Treatment Period|Lost to Follow-up|14
5271506|NCT00611026|18186092|P2|Double-blind Treatment Period|Lost to Follow-up|11
5271507|NCT00611026|18186093|P1|Double-blind Treatment Period|Lost to Follow-up|6
5271508|NCT00611026|18186091|P3|Double-blind Treatment Period|Lack of Efficacy|4
5271509|NCT00611026|18186092|P2|Double-blind Treatment Period|Lack of Efficacy|10
5271510|NCT00611026|18186093|P1|Double-blind Treatment Period|Lack of Efficacy|11
5271511|NCT00611026|18186091|P3|Double-blind Treatment Period|Adverse Event|46
5271512|NCT00611026|18186092|P2|Double-blind Treatment Period|Adverse Event|28
5271513|NCT00611026|18186093|P1|Double-blind Treatment Period|Adverse Event|9
5271514|NCT00611026|18186091|P3|Double-blind Treatment Period|Death|0
5271515|NCT00611026|18186092|P2|Double-blind Treatment Period|Death|0
5271516|NCT00611026|18186093|P1|Double-blind Treatment Period|Death|1
5271517|NCT00611026|18186091|P3|Randomized to Double-blind Treatment|Not treated|3
5271518|NCT00611026|18186092|P2|Randomized to Double-blind Treatment|Not treated|1
5271519|NCT00611026|18186093|P1|Randomized to Double-blind Treatment|Not treated|2
5271520|NCT00610857|18186170|P1|Overall Study|Not evaluable for response|2
5271521|NCT00610714|18186214|P2|Overall Study|Study completion at 120 PFS events|2
5271522|NCT00610714|18186215|P1|Overall Study|Study completion at 120 PFS events|2
5271523|NCT00610714|18186214|P2|Overall Study|Withdrawal by Subject|3
5271524|NCT00610714|18186215|P1|Overall Study|Withdrawal by Subject|9
5271525|NCT00610714|18186214|P2|Overall Study|Death|18
5271526|NCT00610714|18186215|P1|Overall Study|Death|12
5271527|NCT00610714|18186214|P2|Overall Study|Adverse Event|1
5271528|NCT00610714|18186215|P1|Overall Study|Adverse Event|3
5271529|NCT00610675|18186253|P1|Overall Study|Other reason (not specified)|25
5271530|NCT00610675|18186253|P1|Overall Study|Lost to Follow-up|31
5271531|NCT00610675|18186253|P1|Overall Study|Lack of Compliance|7
5271532|NCT00610675|18186253|P1|Overall Study|Reasons unrelated to trial|27
5271533|NCT00610675|18186253|P1|Overall Study|Withdrawal by Subject|28
5271534|NCT00610675|18186253|P1|Overall Study|Insufficient Effect|31
5271535|NCT00610675|18186253|P1|Overall Study|Adverse Event|67
5271536|NCT00610675|18186253|P1|Overall Study|Untreated|4
5271537|NCT00610649|18186275|P11|Overall Study|Withdrawal by Subject|0
5271538|NCT00610649|18186276|P10|Overall Study|Withdrawal by Subject|1
5271539|NCT00610649|18186277|P9|Overall Study|Withdrawal by Subject|0
5271540|NCT00610649|18186278|P8|Overall Study|Withdrawal by Subject|0
5271541|NCT00610649|18186279|P7|Overall Study|Withdrawal by Subject|0
5271542|NCT00610649|18186280|P6|Overall Study|Withdrawal by Subject|0
5271543|NCT00610649|18186281|P5|Overall Study|Withdrawal by Subject|0
5271544|NCT00610649|18186282|P4|Overall Study|Withdrawal by Subject|0
5271545|NCT00610649|18186283|P3|Overall Study|Withdrawal by Subject|0
5271546|NCT00610649|18186284|P2|Overall Study|Withdrawal by Subject|0
5271547|NCT00610649|18186285|P1|Overall Study|Withdrawal by Subject|0
5271548|NCT00610649|18186275|P11|Overall Study|Family Emergency|0
5271549|NCT00610649|18186276|P10|Overall Study|Family Emergency|0
5271550|NCT00610649|18186277|P9|Overall Study|Family Emergency|0
5271551|NCT00610649|18186278|P8|Overall Study|Family Emergency|0
5271552|NCT00610649|18186279|P7|Overall Study|Family Emergency|0
5271553|NCT00610649|18186280|P6|Overall Study|Family Emergency|0
5271554|NCT00610649|18186281|P5|Overall Study|Family Emergency|0
5271555|NCT00610649|18186282|P4|Overall Study|Family Emergency|0
5271556|NCT00610649|18186283|P3|Overall Study|Family Emergency|0
5271557|NCT00610649|18186284|P2|Overall Study|Family Emergency|1
5271558|NCT00610649|18186285|P1|Overall Study|Family Emergency|0
5271559|NCT00610649|18186275|P11|Overall Study|Adverse Event|1
5271560|NCT00610649|18186276|P10|Overall Study|Adverse Event|0
5271561|NCT00610649|18186277|P9|Overall Study|Adverse Event|0
5271562|NCT00610649|18186278|P8|Overall Study|Adverse Event|0
5271563|NCT00610649|18186279|P7|Overall Study|Adverse Event|0
5271564|NCT00610649|18186280|P6|Overall Study|Adverse Event|0
5271565|NCT00610649|18186281|P5|Overall Study|Adverse Event|0
5271566|NCT00610649|18186282|P4|Overall Study|Adverse Event|0
5271567|NCT00610649|18186283|P3|Overall Study|Adverse Event|0
5271568|NCT00610649|18186284|P2|Overall Study|Adverse Event|0
5271569|NCT00610649|18186285|P1|Overall Study|Adverse Event|1
5271570|NCT00610441|18186380|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
5271571|NCT00610441|18186381|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
5271572|NCT00610441|18186382|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
5271573|NCT00610441|18186383|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
5271574|NCT00610441|18186380|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
5271575|NCT00610441|18186381|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
5271576|NCT00610441|18186382|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
5271577|NCT00610441|18186383|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
5271578|NCT00610441|18186380|P4|Treatment Period 2 - 3 Weeks|Other|1
5271579|NCT00610441|18186381|P3|Treatment Period 2 - 3 Weeks|Other|0
5271580|NCT00610441|18186382|P2|Treatment Period 2 - 3 Weeks|Other|1
5271581|NCT00610441|18186383|P1|Treatment Period 2 - 3 Weeks|Other|1
5271582|NCT00610441|18186380|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
5271583|NCT00610441|18186381|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
5271584|NCT00610441|18186382|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
5271585|NCT00610441|18186383|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
5271586|NCT00610441|18186380|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
5271587|NCT00610441|18186381|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
5271588|NCT00610441|18186382|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
5271589|NCT00610441|18186383|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
5271590|NCT00610441|18186380|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
5271591|NCT00610441|18186381|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
5271592|NCT00610441|18186382|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
5271593|NCT00610441|18186383|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
5271594|NCT00610441|18186380|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
5271595|NCT00610441|18186381|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
5271596|NCT00610441|18186382|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
5271597|NCT00610441|18186383|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
5271598|NCT00610441|18186380|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
5271599|NCT00610441|18186381|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
5271600|NCT00610441|18186382|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
5271601|NCT00610441|18186383|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
5271602|NCT00610441|18186380|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
5271603|NCT00610441|18186381|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
5271604|NCT00610441|18186382|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
5271605|NCT00610441|18186383|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
5271606|NCT00610363|18186492|P2|Overall Study|Other than specified above|1
5271607|NCT00610363|18186493|P1|Overall Study|Other than specified above|1
5271608|NCT00610363|18186492|P2|Overall Study|Withdrawal by Subject|0
5271609|NCT00610363|18186493|P1|Overall Study|Withdrawal by Subject|1
5271610|NCT00610363|18186492|P2|Overall Study|Lost to Follow-up|0
5271611|NCT00610363|18186493|P1|Overall Study|Lost to Follow-up|4
5271612|NCT00610363|18186492|P2|Overall Study|Lack of Efficacy|0
5271613|NCT00610363|18186493|P1|Overall Study|Lack of Efficacy|2
5271614|NCT00610363|18186492|P2|Overall Study|Adverse Event|1
5271615|NCT00610363|18186493|P1|Overall Study|Adverse Event|3
5271616|NCT00610363|18186492|P2|Overall Study|Non-compliance with protocol|1
5271617|NCT00610363|18186493|P1|Overall Study|Non-compliance with protocol|0
5271618|NCT00610207|18186518|P1|Overall Study|Lost to Follow-up|3
5271619|NCT00610168|18186525|P2|Overall Study|Withdrawal by Subject|0
5271620|NCT00610168|18186526|P1|Overall Study|Withdrawal by Subject|2
5271621|NCT00610155|18186545|P6|Period 3|Adverse Event|0
5271622|NCT00610155|18186546|P5|Period 3|Adverse Event|0
5271623|NCT00610155|18186547|P4|Period 3|Adverse Event|0
5271624|NCT00610155|18186548|P3|Period 3|Adverse Event|0
5271625|NCT00610155|18186549|P2|Period 3|Adverse Event|0
5271626|NCT00610155|18186550|P1|Period 3|Adverse Event|1
5271627|NCT00610155|18186545|P6|Period 1|Withdrawal by Subject|0
5271628|NCT00610155|18186546|P5|Period 1|Withdrawal by Subject|0
5271629|NCT00610155|18186547|P4|Period 1|Withdrawal by Subject|0
5271630|NCT00610155|18186548|P3|Period 1|Withdrawal by Subject|1
5271631|NCT00610155|18186549|P2|Period 1|Withdrawal by Subject|0
5271632|NCT00610155|18186550|P1|Period 1|Withdrawal by Subject|0
5271633|NCT00610129|18186597|P1|Overall Study|Not treated since patients ineligible|3
5271634|NCT00609986|18186603|P2|Overall Study|Did not receive transplant or treatment|3
5271635|NCT00609986|18186604|P1|Overall Study|Did not receive transplant or treatment|8
5271636|NCT00609973|18186618|P2|Overall Study|Withdrawal by Subject|1
5271637|NCT00609973|18186619|P1|Overall Study|Withdrawal by Subject|0
5271638|NCT00609973|18186618|P2|Overall Study|Lost to Follow-up|1
5271639|NCT00609973|18186619|P1|Overall Study|Lost to Follow-up|2
5271640|NCT00609973|18186618|P2|Overall Study|Protocol Violation|3
5271641|NCT00609973|18186619|P1|Overall Study|Protocol Violation|4
5271642|NCT00609973|18186618|P2|Overall Study|Adverse Event|1
5271643|NCT00609973|18186619|P1|Overall Study|Adverse Event|2
5271644|NCT00609947|18186627|P1|Overall Study|Death|1
5271645|NCT00609869|18186632|P1|Overall Study|Mantle cell: not evaluable|4
5271646|NCT00609869|18186632|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
5271647|NCT00609869|18186632|P1|Overall Study|Hepatitis B infection|1
5271648|NCT00609869|18186632|P1|Overall Study|Severe tumor flare reaction|1
5271649|NCT00609869|18186632|P1|Overall Study|Seizures|1
5271650|NCT00609869|18186632|P1|Overall Study|Withdrawal by Subject|1
5271651|NCT00609869|18186632|P1|Overall Study|Severe hematologic toxicity|1
5271652|NCT00609869|18186632|P1|Overall Study|Withdrawn, ischemic stroke|1
5271653|NCT00609765|18186651|P1|Overall Study|Study ended prior to 12 months|1
5271654|NCT00609674|18186665|P2|Overall Study|Withdrew consent|1
5271655|NCT00609674|18186666|P1|Overall Study|Withdrew consent|2
5271656|NCT00609674|18186665|P2|Overall Study|Lost to Follow-up|0
5271657|NCT00609674|18186666|P1|Overall Study|Lost to Follow-up|1
5271658|NCT00609674|18186665|P2|Overall Study|Protocol Violation|5
5271659|NCT00609674|18186666|P1|Overall Study|Protocol Violation|3
5271660|NCT00609674|18186665|P2|Overall Study|Adverse Event|1
5271661|NCT00609674|18186666|P1|Overall Study|Adverse Event|1
5271662|NCT00609622|18186702|P2|Overall Study|Global deterioration of health status|2
5271663|NCT00609622|18186703|P1|Overall Study|Global deterioration of health status|6
5271664|NCT00609622|18186702|P2|Overall Study|Other|14
5271665|NCT00609622|18186703|P1|Overall Study|Other|7
5271666|NCT00609622|18186702|P2|Overall Study|Study terminated by sponsor|3
5271667|NCT00609622|18186703|P1|Overall Study|Study terminated by sponsor|16
5271668|NCT00609622|18186702|P2|Overall Study|Objective progression or relapse|41
5271669|NCT00609622|18186703|P1|Overall Study|Objective progression or relapse|47
5271670|NCT00609622|18186702|P2|Overall Study|Protocol Violation|1
5271671|NCT00609622|18186703|P1|Overall Study|Protocol Violation|1
5271672|NCT00609622|18186702|P2|Overall Study|Death|4
5271673|NCT00609622|18186703|P1|Overall Study|Death|1
5271674|NCT00609622|18186702|P2|Overall Study|Withdrawal by Subject|20
5271675|NCT00609622|18186703|P1|Overall Study|Withdrawal by Subject|4
5271676|NCT00609622|18186702|P2|Overall Study|Adverse Event|10
5271677|NCT00609622|18186703|P1|Overall Study|Adverse Event|14
5271678|NCT00609609|18186725|P2|Overall Study|Progression|2
5271679|NCT00609609|18186726|P1|Overall Study|Progression|4
5271680|NCT00609609|18186725|P2|Overall Study|Withdrawal by Subject|0
5271681|NCT00609609|18186726|P1|Overall Study|Withdrawal by Subject|2
5271682|NCT00609518|18186738|P2|Overall Study|Death from Adverse Event|2
5271683|NCT00609518|18186739|P1|Overall Study|Death from Adverse Event|2
5271684|NCT00609518|18186738|P2|Overall Study|Physician Decision|3
5271685|NCT00609518|18186739|P1|Overall Study|Physician Decision|1
5271686|NCT00609518|18186738|P2|Overall Study|Lost to Follow-up|0
5271687|NCT00609518|18186739|P1|Overall Study|Lost to Follow-up|3
5271688|NCT00609518|18186738|P2|Overall Study|Withdrawal by Subject|3
5271689|NCT00609518|18186739|P1|Overall Study|Withdrawal by Subject|5
5271690|NCT00609518|18186738|P2|Overall Study|Death from Study Disease|32
5271691|NCT00609518|18186739|P1|Overall Study|Death from Study Disease|32
5271692|NCT00609492|18186754|P3|Overall Study|Lost to Follow-up|4
5271693|NCT00609492|18186755|P2|Overall Study|Lost to Follow-up|1
5271694|NCT00609492|18186756|P1|Overall Study|Lost to Follow-up|1
5271695|NCT00609492|18186754|P3|Overall Study|Withdrawal by Subject|3
5271696|NCT00609492|18186755|P2|Overall Study|Withdrawal by Subject|2
5271697|NCT00609492|18186756|P1|Overall Study|Withdrawal by Subject|0
5271698|NCT00609466|18186841|P3|Overall Study|Lack of Efficacy|2
5271699|NCT00609466|18186842|P2|Overall Study|Lack of Efficacy|2
5271700|NCT00609466|18186843|P1|Overall Study|Lack of Efficacy|0
5271701|NCT00609466|18186841|P3|Overall Study|Adverse Event|1
5271702|NCT00609466|18186842|P2|Overall Study|Adverse Event|3
5271703|NCT00609466|18186843|P1|Overall Study|Adverse Event|2
5271704|NCT00609466|18186841|P3|Overall Study|Withdrawal by Subject|1
5271705|NCT00609466|18186842|P2|Overall Study|Withdrawal by Subject|1
5271706|NCT00609466|18186843|P1|Overall Study|Withdrawal by Subject|0
5271707|NCT00609362|18186871|P2|Overall Study|Adverse Event|0
5271708|NCT00609362|18186872|P1|Overall Study|Adverse Event|1
5271709|NCT00609362|18186871|P2|Overall Study|Withdrawal by Subject|1
5271710|NCT00609362|18186872|P1|Overall Study|Withdrawal by Subject|2
5271711|NCT00609336|18186882|P1|Overall Study|LA or Met at Surgery|9
5271712|NCT00609336|18186882|P1|Overall Study|Death|1
5271713|NCT00609336|18186882|P1|Overall Study|Protocol Violation|3
5271714|NCT00609245|18186933|P1|Overall Study|Adverse Event|1
5271715|NCT00609167|18186941|P2|Overall Study|Stem Cell Transplant|6
5271716|NCT00609167|18186942|P1|Overall Study|Stem Cell Transplant|0
5271717|NCT00609167|18186941|P2|Overall Study|Disease Progression|0
5271718|NCT00609167|18186942|P1|Overall Study|Disease Progression|1
5271719|NCT00609167|18186941|P2|Overall Study|Adverse Event|1
5271720|NCT00609167|18186942|P1|Overall Study|Adverse Event|5
5271721|NCT00609167|18186941|P2|Overall Study|Lack of Efficacy|0
5271722|NCT00609167|18186942|P1|Overall Study|Lack of Efficacy|1
5271723|NCT00609167|18186941|P2|Overall Study|Withdrawal by Subject|0
5271724|NCT00609167|18186942|P1|Overall Study|Withdrawal by Subject|1
5271725|NCT00608985|18186973|P4|Overall Study|Lost to Follow-up|0
5271726|NCT00608985|18186974|P3|Overall Study|Lost to Follow-up|0
5271727|NCT00608985|18186975|P2|Overall Study|Lost to Follow-up|1
5271728|NCT00608985|18186976|P1|Overall Study|Lost to Follow-up|2
5271729|NCT00608985|18186973|P4|Overall Study|Withdrawal of Consent|1
5271730|NCT00608985|18186974|P3|Overall Study|Withdrawal of Consent|1
5271731|NCT00608985|18186975|P2|Overall Study|Withdrawal of Consent|1
5271732|NCT00608985|18186976|P1|Overall Study|Withdrawal of Consent|5
5271733|NCT00608985|18186973|P4|Overall Study|Administrative/Other|2
5271734|NCT00608985|18186974|P3|Overall Study|Administrative/Other|1
5271735|NCT00608985|18186975|P2|Overall Study|Administrative/Other|4
5271736|NCT00608985|18186976|P1|Overall Study|Administrative/Other|7
5271737|NCT00608985|18186973|P4|Overall Study|Adverse Event|6
5271738|NCT00608985|18186974|P3|Overall Study|Adverse Event|4
5271739|NCT00608985|18186975|P2|Overall Study|Adverse Event|7
5271740|NCT00608985|18186976|P1|Overall Study|Adverse Event|2
5271741|NCT00608959|18187008|P1|Part 1|Did not meet eligibility criteria|1
5271742|NCT00608907|18187021|P3|Overall Study|Progressive Disease|0
5271743|NCT00608907|18187022|P2|Overall Study|Progressive Disease|0
5271744|NCT00608907|18187023|P1|Overall Study|Progressive Disease|1
5271745|NCT00608907|18187021|P3|Overall Study|Withdrawal by Subject|0
5271746|NCT00608907|18187022|P2|Overall Study|Withdrawal by Subject|0
5271747|NCT00608907|18187023|P1|Overall Study|Withdrawal by Subject|4
5271748|NCT00608907|18187021|P3|Overall Study|Death|0
5271749|NCT00608907|18187022|P2|Overall Study|Death|0
5271750|NCT00608907|18187023|P1|Overall Study|Death|1
5271751|NCT00608907|18187021|P3|Overall Study|Adverse Event|1
5271752|NCT00608907|18187022|P2|Overall Study|Adverse Event|0
5271753|NCT00608907|18187023|P1|Overall Study|Adverse Event|6
5271754|NCT00608894|18187033|P2|Overall Study|Withdrawal by Subject|2
5271755|NCT00608894|18187034|P1|Overall Study|Withdrawal by Subject|0
5271756|NCT00608881|18187046|P2|Overall Study|Institutionalized|2
5271757|NCT00608881|18187047|P1|Overall Study|Institutionalized|1
5271758|NCT00608881|18187046|P2|Overall Study|Physician Decision|5
5271759|NCT00608881|18187047|P1|Overall Study|Physician Decision|5
5271760|NCT00608881|18187046|P2|Overall Study|Withdrawal by Subject|29
5271761|NCT00608881|18187047|P1|Overall Study|Withdrawal by Subject|18
5271762|NCT00608881|18187046|P2|Overall Study|Lost to Follow-up|14
5271763|NCT00608881|18187047|P1|Overall Study|Lost to Follow-up|28
5271764|NCT00608881|18187046|P2|Overall Study|Adverse Event|3
5271765|NCT00608881|18187047|P1|Overall Study|Adverse Event|5
5271766|NCT00608881|18187046|P2|Overall Study|Death|13
5271767|NCT00608881|18187047|P1|Overall Study|Death|22
5271768|NCT00608868|18187081|P1|Overall Study|Physician Decision|2
5271769|NCT00608868|18187081|P1|Overall Study|Adverse Event|1
5271770|NCT00608868|18187081|P1|Overall Study|Lost to Follow-up|2
5271771|NCT00608868|18187081|P1|Overall Study|Protocol Violation|3
5271772|NCT00608868|18187081|P1|Overall Study|Withdrawal by Subject|7
5271773|NCT00608842|18187092|P4|Overall Study|Lost to Follow-up|0
5271774|NCT00608842|18187093|P3|Overall Study|Lost to Follow-up|0
5271775|NCT00608842|18187094|P2|Overall Study|Lost to Follow-up|0
5271776|NCT00608842|18187095|P1|Overall Study|Lost to Follow-up|1
5271777|NCT00608842|18187092|P4|Overall Study|Participant's Request|1
5271778|NCT00608842|18187093|P3|Overall Study|Participant's Request|2
5271779|NCT00608842|18187094|P2|Overall Study|Participant's Request|1
5271780|NCT00608842|18187095|P1|Overall Study|Participant's Request|0
5271781|NCT00608829|18187129|P1|Overall Study|Subject refuses to follow up or return.|5
5271782|NCT00608829|18187129|P1|Overall Study|Withdrawal by Subject|4
5271783|NCT00608829|18187129|P1|Overall Study|Death|6
5271784|NCT00608582|18187155|P2|Overall Study|Early stage Design Change|3
5271785|NCT00608582|18187156|P1|Overall Study|Early stage Design Change|0
5271786|NCT00608582|18187155|P2|Overall Study|Illicit Drug Use|0
5271787|NCT00608582|18187156|P1|Overall Study|Illicit Drug Use|1
5271788|NCT00608582|18187155|P2|Overall Study|No Best Response in Phase 1 located|1
5271789|NCT00608582|18187156|P1|Overall Study|No Best Response in Phase 1 located|1
5271790|NCT00608582|18187155|P2|Overall Study|Lost to Follow-up|0
5271791|NCT00608582|18187156|P1|Overall Study|Lost to Follow-up|2
5271792|NCT00608569|18187166|P2|Overall Study|Unable to adhere with study requirements|1
5271793|NCT00608569|18187167|P1|Overall Study|Unable to adhere with study requirements|0
5271794|NCT00608569|18187166|P2|Overall Study|Adverse Event|0
5271795|NCT00608569|18187167|P1|Overall Study|Adverse Event|1
5271796|NCT00608569|18187166|P2|Overall Study|Withdrawal by Subject|0
5271797|NCT00608569|18187167|P1|Overall Study|Withdrawal by Subject|1
5271798|NCT00608569|18187166|P2|Overall Study|Lost to Follow-up|5
5271799|NCT00608569|18187167|P1|Overall Study|Lost to Follow-up|4
5271800|NCT00608569|18187166|P2|Overall Study|Death|3
5271801|NCT00608569|18187167|P1|Overall Study|Death|4
5271802|NCT00608543|18187187|P1|Overall Study|Adverse Event|4
5271803|NCT00608530|18187200|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
5271804|NCT00608530|18187201|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
5271805|NCT00608530|18187202|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
5271806|NCT00608530|18187203|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
5271807|NCT00608530|18187200|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
5271808|NCT00608530|18187201|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
5271809|NCT00608530|18187202|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
5271810|NCT00608530|18187203|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
5271811|NCT00608530|18187200|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
5271812|NCT00608530|18187201|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
5271813|NCT00608530|18187202|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
5271814|NCT00608530|18187203|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
5271815|NCT00608530|18187200|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
5271816|NCT00608530|18187201|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
5271817|NCT00608530|18187202|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
5271818|NCT00608530|18187203|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
5271819|NCT00608530|18187200|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
5271820|NCT00608530|18187201|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
5271821|NCT00608530|18187202|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
5271822|NCT00608530|18187203|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
5271823|NCT00608530|18187200|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
5271824|NCT00608530|18187201|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
5271825|NCT00608530|18187202|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
5271826|NCT00608530|18187203|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
5271827|NCT00608517|18187224|P3|Overall Study|Death|0
5271828|NCT00608517|18187225|P2|Overall Study|Death|0
5271829|NCT00608517|18187226|P1|Overall Study|Death|1
5271830|NCT00608426|18187406|P2|Overall Study|refused, health issues, wrong address|348
5271831|NCT00608426|18187407|P1|Overall Study|refused, health issues, wrong address|319
5271832|NCT00608426|18187406|P2|Overall Study|Lost to Follow-up|521
5271833|NCT00608426|18187407|P1|Overall Study|Lost to Follow-up|485
5271834|NCT00608426|18187406|P2|Overall Study|Death|36
5271835|NCT00608426|18187407|P1|Overall Study|Death|32
5271836|NCT00608322|18187419|P2|Overall Study|Death|1
5271837|NCT00608322|18187420|P1|Overall Study|Death|2
5271838|NCT00608244|18187426|P1|Overall Study|Low trough levels|1
5271839|NCT00608244|18187426|P1|Overall Study|Adverse Event|1
5271840|NCT00608205|18187437|P2|Overall Study|Patient non-compliant|1
5271841|NCT00608205|18187438|P1|Overall Study|Patient non-compliant|0
5271842|NCT00608205|18187437|P2|Overall Study|Adverse Event|2
5271843|NCT00608205|18187438|P1|Overall Study|Adverse Event|3
5271844|NCT00608023|18187555|P3|Overall Study|Unknown reason|0
5271845|NCT00608023|18187556|P2|Overall Study|Unknown reason|3
5271846|NCT00608023|18187557|P1|Overall Study|Unknown reason|0
5271847|NCT00608023|18187555|P3|Overall Study|Protocol Violation|1
5271848|NCT00608023|18187556|P2|Overall Study|Protocol Violation|3
5271849|NCT00608023|18187557|P1|Overall Study|Protocol Violation|1
5271850|NCT00608023|18187555|P3|Overall Study|Lost to Follow-up|1
5271851|NCT00608023|18187556|P2|Overall Study|Lost to Follow-up|2
5271852|NCT00608023|18187557|P1|Overall Study|Lost to Follow-up|2
5271853|NCT00608023|18187555|P3|Overall Study|Adverse Event|5
5271854|NCT00608023|18187556|P2|Overall Study|Adverse Event|4
5271855|NCT00608023|18187557|P1|Overall Study|Adverse Event|1
5271856|NCT00608023|18187555|P3|Overall Study|Withdrawal by Subject|7
5271857|NCT00608023|18187556|P2|Overall Study|Withdrawal by Subject|10
5271858|NCT00608023|18187557|P1|Overall Study|Withdrawal by Subject|8
5271859|NCT00607997|18187581|P4|Overall Study|Other without explanation|1
5271860|NCT00607997|18187582|P3|Overall Study|Other without explanation|4
5271861|NCT00607997|18187583|P2|Overall Study|Other without explanation|0
5271862|NCT00607997|18187584|P1|Overall Study|Other without explanation|2
5271863|NCT00607997|18187581|P4|Overall Study|Relapse, recurrent illness|0
5271864|NCT00607997|18187582|P3|Overall Study|Relapse, recurrent illness|2
5271865|NCT00607997|18187583|P2|Overall Study|Relapse, recurrent illness|0
5271866|NCT00607997|18187584|P1|Overall Study|Relapse, recurrent illness|4
5271867|NCT00607997|18187581|P4|Overall Study|Physician Decision|0
5271868|NCT00607997|18187582|P3|Overall Study|Physician Decision|0
5271869|NCT00607997|18187583|P2|Overall Study|Physician Decision|1
5271870|NCT00607997|18187584|P1|Overall Study|Physician Decision|4
5271871|NCT00607997|18187581|P4|Overall Study|Adverse Event|0
5271872|NCT00607997|18187582|P3|Overall Study|Adverse Event|2
5271873|NCT00607997|18187583|P2|Overall Study|Adverse Event|1
5271874|NCT00607997|18187584|P1|Overall Study|Adverse Event|3
5271875|NCT00607997|18187581|P4|Overall Study|Death|5
5271876|NCT00607997|18187582|P3|Overall Study|Death|2
5271877|NCT00607997|18187583|P2|Overall Study|Death|5
5271878|NCT00607997|18187584|P1|Overall Study|Death|8
5271879|NCT00607997|18187581|P4|Overall Study|Lack of Efficacy|10
5271880|NCT00607997|18187582|P3|Overall Study|Lack of Efficacy|14
5271881|NCT00607997|18187583|P2|Overall Study|Lack of Efficacy|20
5271882|NCT00607997|18187584|P1|Overall Study|Lack of Efficacy|6
5271883|NCT00607919|18187642|P2|Open-Label Phase|Parent/Caregiver Decision|2
5271884|NCT00607919|18187643|P1|Open-Label Phase|Parent/Caregiver Decision|1
5271885|NCT00607919|18187642|P2|Open-Label Phase|Withdrawal by Subject|2
5271886|NCT00607919|18187643|P1|Open-Label Phase|Withdrawal by Subject|2
5271887|NCT00607919|18187642|P2|Open-Label Phase|Protocol Violation|2
5271888|NCT00607919|18187643|P1|Open-Label Phase|Protocol Violation|2
5271889|NCT00607919|18187642|P2|Open-Label Phase|Lost to Follow-up|1
5271890|NCT00607919|18187643|P1|Open-Label Phase|Lost to Follow-up|4
5271891|NCT00607919|18187642|P2|Open-Label Phase|Adverse Event|5
5271892|NCT00607919|18187643|P1|Open-Label Phase|Adverse Event|1
5271893|NCT00607919|18187642|P2|Acute Phase|Withdrawal by Subject|3
5271894|NCT00607919|18187643|P1|Acute Phase|Withdrawal by Subject|3
5271895|NCT00607919|18187642|P2|Acute Phase|Protocol Violation|1
5271896|NCT00607919|18187643|P1|Acute Phase|Protocol Violation|5
5271897|NCT00607919|18187642|P2|Acute Phase|Parent/Caregiver Decision|4
5271898|NCT00607919|18187643|P1|Acute Phase|Parent/Caregiver Decision|6
5271899|NCT00607919|18187642|P2|Acute Phase|Lost to Follow-up|3
5271900|NCT00607919|18187643|P1|Acute Phase|Lost to Follow-up|9
5271901|NCT00607919|18187642|P2|Acute Phase|Lack of Efficacy|2
5271902|NCT00607919|18187643|P1|Acute Phase|Lack of Efficacy|1
5271903|NCT00607919|18187642|P2|Acute Phase|Entry Criteria Not Met|1
5271904|NCT00607919|18187643|P1|Acute Phase|Entry Criteria Not Met|1
5271905|NCT00607919|18187642|P2|Acute Phase|Adverse Event|2
5271906|NCT00607919|18187643|P1|Acute Phase|Adverse Event|9
5271907|NCT00607893|18187701|P2|Overall Study|Withdrew due to hypertensive urgency|1
5271908|NCT00607893|18187702|P1|Overall Study|Withdrew due to hypertensive urgency|1
5271909|NCT00607893|18187701|P2|Overall Study|Declined to be treated|0
5271910|NCT00607893|18187702|P1|Overall Study|Declined to be treated|1
5271911|NCT00607893|18187701|P2|Overall Study|withdrew could not tolerate CPAP|1
5271912|NCT00607893|18187702|P1|Overall Study|withdrew could not tolerate CPAP|0
5271913|NCT00607893|18187701|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
5271914|NCT00607893|18187702|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
5271915|NCT00607893|18187701|P2|Overall Study|withdrew due to loss of interest|1
5271916|NCT00607893|18187702|P1|Overall Study|withdrew due to loss of interest|0
5271917|NCT00607893|18187701|P2|Overall Study|Lost to Follow-up|0
5271918|NCT00607893|18187702|P1|Overall Study|Lost to Follow-up|4
5271919|NCT00607880|18187730|P2|Overall Study|Unable to place port due to occlusion|0
5271920|NCT00607880|18187731|P1|Overall Study|Unable to place port due to occlusion|1
5271921|NCT00607789|18187781|P2|Overall Study|Withdrawal by Subject|0
5271922|NCT00607789|18187782|P1|Overall Study|Withdrawal by Subject|1
5271923|NCT00607789|18187781|P2|Overall Study|Lost to Follow-up|5
5271924|NCT00607789|18187782|P1|Overall Study|Lost to Follow-up|0
5271925|NCT00607789|18187781|P2|Overall Study|Inadequate adherence|0
5271926|NCT00607789|18187782|P1|Overall Study|Inadequate adherence|3
5271927|NCT00607789|18187781|P2|Overall Study|Lack of Efficacy|1
5271928|NCT00607789|18187782|P1|Overall Study|Lack of Efficacy|0
5271929|NCT00607789|18187781|P2|Overall Study|Adverse Event|0
5271930|NCT00607789|18187782|P1|Overall Study|Adverse Event|3
5271931|NCT00607724|18187797|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5271932|NCT00607724|18187798|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5271933|NCT00607724|18187799|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5271934|NCT00607724|18187800|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
5271935|NCT00607724|18187801|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5271936|NCT00607724|18187802|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5271937|NCT00607724|18187803|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5271938|NCT00607724|18187797|P7|Stage 2: Expanded Cohort|Physician Decision|0
5271939|NCT00607724|18187798|P6|Stage 2: Expanded Cohort|Physician Decision|1
5271940|NCT00607724|18187799|P5|Stage 2: Expanded Cohort|Physician Decision|1
5271941|NCT00607724|18187800|P4|Stage 2: Expanded Cohort|Physician Decision|0
5271942|NCT00607724|18187801|P3|Stage 2: Expanded Cohort|Physician Decision|0
5271943|NCT00607724|18187802|P2|Stage 2: Expanded Cohort|Physician Decision|0
5271944|NCT00607724|18187803|P1|Stage 2: Expanded Cohort|Physician Decision|0
5271945|NCT00607724|18187797|P7|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
5271946|NCT00607724|18187798|P6|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
5271947|NCT00607724|18187799|P5|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
5271948|NCT00607724|18187800|P4|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
5271949|NCT00607724|18187801|P3|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
5271950|NCT00607724|18187802|P2|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
5271951|NCT00607724|18187803|P1|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
5271952|NCT00607724|18187797|P7|Stage 2: Expanded Cohort|Adverse Event|1
5271953|NCT00607724|18187798|P6|Stage 2: Expanded Cohort|Adverse Event|0
5271954|NCT00607724|18187799|P5|Stage 2: Expanded Cohort|Adverse Event|0
5271955|NCT00607724|18187800|P4|Stage 2: Expanded Cohort|Adverse Event|0
5271956|NCT00607724|18187801|P3|Stage 2: Expanded Cohort|Adverse Event|0
5271957|NCT00607724|18187802|P2|Stage 2: Expanded Cohort|Adverse Event|0
5271958|NCT00607724|18187803|P1|Stage 2: Expanded Cohort|Adverse Event|0
5271959|NCT00607724|18187797|P7|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5271960|NCT00607724|18187798|P6|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5271961|NCT00607724|18187799|P5|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5271962|NCT00607724|18187800|P4|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5271963|NCT00607724|18187801|P3|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
5271964|NCT00607724|18187802|P2|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
5271965|NCT00607724|18187803|P1|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
5271966|NCT00607386|18187966|P1|Overall Study|Physician Decision|1
5271967|NCT00607373|18187981|P2|Follow-up Period|Withdrawal by Subject|3
5271968|NCT00607373|18187982|P1|Follow-up Period|Withdrawal by Subject|1
5271969|NCT00607373|18187981|P2|Follow-up Period|Protocol Violation|1
5271970|NCT00607373|18187982|P1|Follow-up Period|Protocol Violation|0
5271971|NCT00607373|18187981|P2|Follow-up Period|Other|1
5271972|NCT00607373|18187982|P1|Follow-up Period|Other|0
5271973|NCT00607373|18187981|P2|Treatment Period|Withdrawal by Subject|1
5271974|NCT00607373|18187982|P1|Treatment Period|Withdrawal by Subject|0
5271975|NCT00607373|18187981|P2|Treatment Period|Physician Decision|1
5271976|NCT00607373|18187982|P1|Treatment Period|Physician Decision|0
5271977|NCT00607373|18187981|P2|Treatment Period|Adverse Event|4
5271978|NCT00607373|18187982|P1|Treatment Period|Adverse Event|0
5271979|NCT00607087|18188084|P3|Period 3|Adverse Event|0
5271980|NCT00607087|18188085|P2|Period 3|Adverse Event|1
5271981|NCT00607087|18188086|P1|Period 3|Adverse Event|0
5271982|NCT00607087|18188084|P3|Period 3|Withdrawal by Subject|0
5271983|NCT00607087|18188085|P2|Period 3|Withdrawal by Subject|1
5271984|NCT00607087|18188086|P1|Period 3|Withdrawal by Subject|2
5271985|NCT00607087|18188084|P3|Period 2|Poor compliance to protocol|1
5271986|NCT00607087|18188085|P2|Period 2|Poor compliance to protocol|0
5271987|NCT00607087|18188086|P1|Period 2|Poor compliance to protocol|0
5271988|NCT00607087|18188084|P3|Period 2|Adverse Event|3
5271989|NCT00607087|18188085|P2|Period 2|Adverse Event|1
5271990|NCT00607087|18188086|P1|Period 2|Adverse Event|0
5271991|NCT00607087|18188084|P3|Period 2|Other reason|0
5271992|NCT00607087|18188085|P2|Period 2|Other reason|1
5271993|NCT00607087|18188086|P1|Period 2|Other reason|1
5271994|NCT00607087|18188084|P3|Period 2|Withdrawal by Subject|1
5271995|NCT00607087|18188085|P2|Period 2|Withdrawal by Subject|1
5271996|NCT00607087|18188086|P1|Period 2|Withdrawal by Subject|0
5271997|NCT00607087|18188084|P3|Period 1|Other reason|2
5271998|NCT00607087|18188085|P2|Period 1|Other reason|4
5271999|NCT00607087|18188086|P1|Period 1|Other reason|0
5272000|NCT00607087|18188084|P3|Period 1|Lost to Follow-up|0
5272001|NCT00607087|18188085|P2|Period 1|Lost to Follow-up|0
5272002|NCT00607087|18188086|P1|Period 1|Lost to Follow-up|1
5272003|NCT00607087|18188084|P3|Period 1|Poor compliance to protocol|0
5272004|NCT00607087|18188085|P2|Period 1|Poor compliance to protocol|0
5272005|NCT00607087|18188086|P1|Period 1|Poor compliance to protocol|1
5272006|NCT00607087|18188084|P3|Period 1|Adverse Event|0
5272007|NCT00607087|18188085|P2|Period 1|Adverse Event|0
5272008|NCT00607087|18188086|P1|Period 1|Adverse Event|3
5272009|NCT00607087|18188084|P3|Period 1|Withdrawal by Subject|3
5272010|NCT00607087|18188085|P2|Period 1|Withdrawal by Subject|2
5272011|NCT00607087|18188086|P1|Period 1|Withdrawal by Subject|7
5272012|NCT00607087|18188084|P3|Overall Study|Lost to Follow-up|0
5272013|NCT00607087|18188085|P2|Overall Study|Lost to Follow-up|0
5272014|NCT00607087|18188086|P1|Overall Study|Lost to Follow-up|1
5272015|NCT00607087|18188084|P3|Overall Study|Poor compliance to protocol|1
5272016|NCT00607087|18188085|P2|Overall Study|Poor compliance to protocol|0
5272017|NCT00607087|18188086|P1|Overall Study|Poor compliance to protocol|1
5272018|NCT00607087|18188084|P3|Overall Study|Other reason|2
5272019|NCT00607087|18188085|P2|Overall Study|Other reason|5
5272020|NCT00607087|18188086|P1|Overall Study|Other reason|1
5272021|NCT00607087|18188084|P3|Overall Study|Adverse Event|3
5272022|NCT00607087|18188085|P2|Overall Study|Adverse Event|2
5272023|NCT00607087|18188086|P1|Overall Study|Adverse Event|3
5272024|NCT00607087|18188084|P3|Overall Study|Withdrawal by Subject|4
5272025|NCT00607087|18188085|P2|Overall Study|Withdrawal by Subject|4
5272026|NCT00607087|18188086|P1|Overall Study|Withdrawal by Subject|9
5272027|NCT00607048|18188144|P6|Overall Study|Other|1
5272028|NCT00607048|18188145|P5|Overall Study|Other|0
5272029|NCT00607048|18188146|P4|Overall Study|Other|0
5272030|NCT00607048|18188147|P3|Overall Study|Other|0
5272031|NCT00607048|18188148|P2|Overall Study|Other|1
5272032|NCT00607048|18188149|P1|Overall Study|Other|1
5272033|NCT00607048|18188144|P6|Overall Study|Withdrawal by Subject|2
5272034|NCT00607048|18188145|P5|Overall Study|Withdrawal by Subject|0
5272035|NCT00607048|18188146|P4|Overall Study|Withdrawal by Subject|1
5272036|NCT00607048|18188147|P3|Overall Study|Withdrawal by Subject|0
5272037|NCT00607048|18188148|P2|Overall Study|Withdrawal by Subject|0
5272038|NCT00607048|18188149|P1|Overall Study|Withdrawal by Subject|0
5272039|NCT00607048|18188144|P6|Overall Study|Objective disease progression - relapse|2
5272040|NCT00607048|18188145|P5|Overall Study|Objective disease progression - relapse|2
5272041|NCT00607048|18188146|P4|Overall Study|Objective disease progression - relapse|2
5272042|NCT00607048|18188147|P3|Overall Study|Objective disease progression - relapse|4
5272043|NCT00607048|18188148|P2|Overall Study|Objective disease progression - relapse|2
5272044|NCT00607048|18188149|P1|Overall Study|Objective disease progression - relapse|1
5272045|NCT00607048|18188144|P6|Overall Study|Global deterioration of health|0
5272046|NCT00607048|18188145|P5|Overall Study|Global deterioration of health|0
5272047|NCT00607048|18188146|P4|Overall Study|Global deterioration of health|0
5272048|NCT00607048|18188147|P3|Overall Study|Global deterioration of health|0
5272049|NCT00607048|18188148|P2|Overall Study|Global deterioration of health|0
5272050|NCT00607048|18188149|P1|Overall Study|Global deterioration of health|1
5272051|NCT00607048|18188144|P6|Overall Study|Adverse Event|0
5272052|NCT00607048|18188145|P5|Overall Study|Adverse Event|4
5272053|NCT00607048|18188146|P4|Overall Study|Adverse Event|0
5272054|NCT00607048|18188147|P3|Overall Study|Adverse Event|0
5272055|NCT00607048|18188148|P2|Overall Study|Adverse Event|1
5272056|NCT00607048|18188149|P1|Overall Study|Adverse Event|0
5272057|NCT00607022|18188234|P3|Overall Study|Withdrawal by Subject|0
5272058|NCT00607022|18188235|P2|Overall Study|Withdrawal by Subject|0
5272059|NCT00607022|18188236|P1|Overall Study|Withdrawal by Subject|1
5272060|NCT00606931|18188253|P1|Overall Study|Withdrawal by Subject|3
5272061|NCT00606905|18188261|P2|Overall Study|Withdrew|5
5272062|NCT00606905|18188262|P1|Overall Study|Withdrew|5
5272063|NCT00606905|18188261|P2|Overall Study|Non-Index Pregnancy|4
5272064|NCT00606905|18188262|P1|Overall Study|Non-Index Pregnancy|1
5272065|NCT00606905|18188261|P2|Overall Study|No Pregnancy|6
5272066|NCT00606905|18188262|P1|Overall Study|No Pregnancy|9
5272067|NCT00606892|18188268|P2|First Intervention|Protocol Violation|4
5272068|NCT00606892|18188269|P1|First Intervention|Protocol Violation|1
5272069|NCT00606801|18188303|P2|Intervention|Protocol Violation|3
5272070|NCT00606801|18188304|P1|Intervention|Protocol Violation|3
5272071|NCT00606684|18188332|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
5272072|NCT00606684|18188333|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
5272073|NCT00606684|18188334|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
5272074|NCT00606684|18188335|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
5272075|NCT00606684|18188336|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
5272076|NCT00606684|18188337|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5272077|NCT00606684|18188338|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5272078|NCT00606684|18188332|P7|Double-Blind Treatment Period|Physician Decision|2
5272079|NCT00606684|18188333|P6|Double-Blind Treatment Period|Physician Decision|1
5272080|NCT00606684|18188334|P5|Double-Blind Treatment Period|Physician Decision|3
5272081|NCT00606684|18188335|P4|Double-Blind Treatment Period|Physician Decision|0
5272082|NCT00606684|18188336|P3|Double-Blind Treatment Period|Physician Decision|1
5272083|NCT00606684|18188337|P2|Double-Blind Treatment Period|Physician Decision|5
5272084|NCT00606684|18188338|P1|Double-Blind Treatment Period|Physician Decision|0
5272085|NCT00606684|18188332|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
5272086|NCT00606684|18188333|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
5272087|NCT00606684|18188334|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
5272088|NCT00606684|18188335|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
5272089|NCT00606684|18188336|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
5272090|NCT00606684|18188337|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
5272091|NCT00606684|18188338|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
5272092|NCT00606684|18188332|P7|Double-Blind Treatment Period|Protocol Violation|4
5272093|NCT00606684|18188333|P6|Double-Blind Treatment Period|Protocol Violation|3
5272094|NCT00606684|18188334|P5|Double-Blind Treatment Period|Protocol Violation|0
5272095|NCT00606684|18188335|P4|Double-Blind Treatment Period|Protocol Violation|3
5272096|NCT00606684|18188336|P3|Double-Blind Treatment Period|Protocol Violation|5
5272097|NCT00606684|18188337|P2|Double-Blind Treatment Period|Protocol Violation|5
5272098|NCT00606684|18188338|P1|Double-Blind Treatment Period|Protocol Violation|0
5272099|NCT00606684|18188332|P7|Double-Blind Treatment Period|Lack of Efficacy|0
5272100|NCT00606684|18188333|P6|Double-Blind Treatment Period|Lack of Efficacy|0
5272101|NCT00606684|18188334|P5|Double-Blind Treatment Period|Lack of Efficacy|1
5272102|NCT00606684|18188335|P4|Double-Blind Treatment Period|Lack of Efficacy|0
5272103|NCT00606684|18188336|P3|Double-Blind Treatment Period|Lack of Efficacy|0
5272104|NCT00606684|18188337|P2|Double-Blind Treatment Period|Lack of Efficacy|1
5272105|NCT00606684|18188338|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5272106|NCT00606684|18188332|P7|Double-Blind Treatment Period|Adverse Event|1
5272107|NCT00606684|18188333|P6|Double-Blind Treatment Period|Adverse Event|0
5272108|NCT00606684|18188334|P5|Double-Blind Treatment Period|Adverse Event|2
5272109|NCT00606684|18188335|P4|Double-Blind Treatment Period|Adverse Event|4
5272110|NCT00606684|18188336|P3|Double-Blind Treatment Period|Adverse Event|2
5272111|NCT00606684|18188337|P2|Double-Blind Treatment Period|Adverse Event|3
5272112|NCT00606684|18188338|P1|Double-Blind Treatment Period|Adverse Event|0
5272113|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5272114|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5272115|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5272116|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5272117|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5272118|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5272119|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
5272120|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Adverse Event|0
5272121|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Adverse Event|0
5272122|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Adverse Event|0
5272123|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Adverse Event|0
5272124|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Adverse Event|0
5272125|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Adverse Event|0
5272126|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Adverse Event|2
5272127|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5272128|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5272129|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5272297|NCT00605839|18188722|P3|Overall Study|Protocol Violation|0
5272130|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5272131|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5272132|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5272133|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
5272134|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5272135|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5272136|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5272137|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5272138|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5272139|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5272140|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
5272141|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Physician Decision|0
5272142|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Physician Decision|0
5272143|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Physician Decision|0
5272144|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Physician Decision|0
5272145|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Physician Decision|0
5272146|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Physician Decision|0
5272147|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Physician Decision|18
5272148|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5272149|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5272150|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5272151|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5272152|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5272153|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5272154|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
5272155|NCT00606684|18188332|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5272156|NCT00606684|18188333|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5272157|NCT00606684|18188334|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5272158|NCT00606684|18188335|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5272159|NCT00606684|18188336|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5272160|NCT00606684|18188337|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5272161|NCT00606684|18188338|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
5272162|NCT00606632|18188370|P1|Overall Study|Miscellaneous reasons|9
5272163|NCT00606632|18188370|P1|Overall Study|Withdrawal by Subject|13
5272164|NCT00606593|18188383|P10|Overall Study|Administrative/Other|0
5272165|NCT00606593|18188384|P9|Overall Study|Administrative/Other|0
5272166|NCT00606593|18188385|P8|Overall Study|Administrative/Other|0
5272167|NCT00606593|18188386|P7|Overall Study|Administrative/Other|0
5272168|NCT00606593|18188387|P6|Overall Study|Administrative/Other|0
5272169|NCT00606593|18188388|P5|Overall Study|Administrative/Other|0
5272170|NCT00606593|18188389|P4|Overall Study|Administrative/Other|0
5272171|NCT00606593|18188390|P3|Overall Study|Administrative/Other|1
5272172|NCT00606593|18188391|P2|Overall Study|Administrative/Other|0
5272173|NCT00606593|18188392|P1|Overall Study|Administrative/Other|0
5272174|NCT00606593|18188383|P10|Overall Study|Withdrawal of consent|0
5272175|NCT00606593|18188384|P9|Overall Study|Withdrawal of consent|0
5272176|NCT00606593|18188385|P8|Overall Study|Withdrawal of consent|0
5272177|NCT00606593|18188386|P7|Overall Study|Withdrawal of consent|0
5272178|NCT00606593|18188387|P6|Overall Study|Withdrawal of consent|0
5272179|NCT00606593|18188388|P5|Overall Study|Withdrawal of consent|0
5272180|NCT00606593|18188389|P4|Overall Study|Withdrawal of consent|0
5272181|NCT00606593|18188390|P3|Overall Study|Withdrawal of consent|1
5272182|NCT00606593|18188391|P2|Overall Study|Withdrawal of consent|0
5272183|NCT00606593|18188392|P1|Overall Study|Withdrawal of consent|1
5272184|NCT00606593|18188383|P10|Overall Study|Adverse Event|0
5272185|NCT00606593|18188384|P9|Overall Study|Adverse Event|1
5272186|NCT00606593|18188385|P8|Overall Study|Adverse Event|2
5272187|NCT00606593|18188386|P7|Overall Study|Adverse Event|1
5272188|NCT00606593|18188387|P6|Overall Study|Adverse Event|0
5272189|NCT00606593|18188388|P5|Overall Study|Adverse Event|1
5272190|NCT00606593|18188389|P4|Overall Study|Adverse Event|1
5272191|NCT00606593|18188390|P3|Overall Study|Adverse Event|0
5272192|NCT00606593|18188391|P2|Overall Study|Adverse Event|0
5272193|NCT00606593|18188392|P1|Overall Study|Adverse Event|0
5272194|NCT00606580|18188413|P3|Overall Study|Withdrawal by Subject|0
5272195|NCT00606580|18188414|P2|Overall Study|Withdrawal by Subject|1
5272196|NCT00606580|18188415|P1|Overall Study|Withdrawal by Subject|0
5272197|NCT00606580|18188413|P3|Overall Study|Withdrawal by investigator|6
5272198|NCT00606580|18188414|P2|Overall Study|Withdrawal by investigator|1
5272199|NCT00606580|18188415|P1|Overall Study|Withdrawal by investigator|0
5272200|NCT00606580|18188413|P3|Overall Study|Clinical failures|12
5272201|NCT00606580|18188414|P2|Overall Study|Clinical failures|0
5272202|NCT00606580|18188415|P1|Overall Study|Clinical failures|1
5272203|NCT00606580|18188413|P3|Overall Study|Lost to Follow-up|4
5272204|NCT00606580|18188414|P2|Overall Study|Lost to Follow-up|1
5272205|NCT00606580|18188415|P1|Overall Study|Lost to Follow-up|1
5272206|NCT00606502|18188481|P2|Treatment|Treatment ongoing at time of data cutoff|3
5272207|NCT00606502|18188482|P1|Treatment|Treatment ongoing at time of data cutoff|0
5272208|NCT00606502|18188481|P2|Randomization|Randomized but not treated|0
5272209|NCT00606502|18188482|P1|Randomization|Randomized but not treated|3
5272210|NCT00606320|18188503|P1|Overall Study|Progression to depressive phase|4
5272211|NCT00606320|18188503|P1|Overall Study|Withdrawal by Subject|10
5272212|NCT00606320|18188503|P1|Overall Study|Protocol Violation|8
5272213|NCT00606320|18188503|P1|Overall Study|Physician Decision|7
5272214|NCT00606320|18188503|P1|Overall Study|Lack of Efficacy|5
5272215|NCT00606320|18188503|P1|Overall Study|Adverse Event|3
5272216|NCT00606307|18188508|P1|Overall Study|QTc prolongation|1
5272217|NCT00606307|18188508|P1|Overall Study|Disease progression|6
5272218|NCT00606307|18188508|P1|Overall Study|Withdrawal by Subject|2
5272219|NCT00606307|18188508|P1|Overall Study|Adverse Event|2
5272220|NCT00606294|18188516|P2|Overall Study|Withdrawal by Subject|0
5272221|NCT00606294|18188517|P1|Overall Study|Withdrawal by Subject|36
5272222|NCT00606281|18188531|P2|Overall Study|Change of residence or other commitments|1
5272223|NCT00606281|18188532|P1|Overall Study|Change of residence or other commitments|1
5272224|NCT00606281|18188531|P2|Overall Study|Progression to depressive phase|1
5272225|NCT00606281|18188532|P1|Overall Study|Progression to depressive phase|1
5272226|NCT00606281|18188531|P2|Overall Study|Withdrawal by Subject|13
5272227|NCT00606281|18188532|P1|Overall Study|Withdrawal by Subject|11
5272228|NCT00606281|18188531|P2|Overall Study|Protocol Violation|3
5272229|NCT00606281|18188532|P1|Overall Study|Protocol Violation|3
5272230|NCT00606281|18188531|P2|Overall Study|Physician Decision|1
5272231|NCT00606281|18188532|P1|Overall Study|Physician Decision|0
5272232|NCT00606281|18188531|P2|Overall Study|Lack of Efficacy|35
5272233|NCT00606281|18188532|P1|Overall Study|Lack of Efficacy|28
5272234|NCT00606281|18188531|P2|Overall Study|Death|0
5272235|NCT00606281|18188532|P1|Overall Study|Death|1
5272236|NCT00606281|18188531|P2|Overall Study|Adverse Event|12
5272237|NCT00606281|18188532|P1|Overall Study|Adverse Event|11
5272238|NCT00606229|18188540|P1|Overall Study|change of residence or other commitments|2
5272239|NCT00606229|18188540|P1|Overall Study|does not meet inclusion criterion 1-3|4
5272240|NCT00606229|18188540|P1|Overall Study|Withdrawal by Subject|4
5272241|NCT00606229|18188540|P1|Overall Study|Lack of Efficacy|1
5272242|NCT00606229|18188540|P1|Overall Study|Adverse Event|11
5272243|NCT00606177|18188547|P2|Overall Study|Change of residence or other commitments|1
5272244|NCT00606177|18188548|P1|Overall Study|Change of residence or other commitments|1
5272245|NCT00606177|18188547|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
5272246|NCT00606177|18188548|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
5272247|NCT00606177|18188547|P2|Overall Study|Progression to depressive phase|1
5272248|NCT00606177|18188548|P1|Overall Study|Progression to depressive phase|6
5272249|NCT00606177|18188547|P2|Overall Study|Withdrawal by Subject|6
5272250|NCT00606177|18188548|P1|Overall Study|Withdrawal by Subject|5
5272251|NCT00606177|18188547|P2|Overall Study|Protocol Violation|4
5272252|NCT00606177|18188548|P1|Overall Study|Protocol Violation|1
5272253|NCT00606177|18188547|P2|Overall Study|Physician Decision|0
5272254|NCT00606177|18188548|P1|Overall Study|Physician Decision|1
5272255|NCT00606177|18188547|P2|Overall Study|Lack of Efficacy|7
5272256|NCT00606177|18188548|P1|Overall Study|Lack of Efficacy|3
5272257|NCT00606177|18188547|P2|Overall Study|Adverse Event|5
5272258|NCT00606177|18188548|P1|Overall Study|Adverse Event|9
5272259|NCT00606086|18188575|P2|Overall Study|Randomized, not treated|2
5272260|NCT00606086|18188576|P1|Overall Study|Randomized, not treated|1
5272261|NCT00606086|18188575|P2|Overall Study|Non-compliance|1
5272262|NCT00606086|18188576|P1|Overall Study|Non-compliance|0
5272263|NCT00606086|18188575|P2|Overall Study|Withdrawal by Subject|3
5272264|NCT00606086|18188576|P1|Overall Study|Withdrawal by Subject|5
5272265|NCT00606086|18188575|P2|Overall Study|Protocol Violation|0
5272266|NCT00606086|18188576|P1|Overall Study|Protocol Violation|1
5272267|NCT00606086|18188575|P2|Overall Study|Lost to Follow-up|8
5272268|NCT00606086|18188576|P1|Overall Study|Lost to Follow-up|4
5272269|NCT00606086|18188575|P2|Overall Study|Adverse Event|1
5272270|NCT00606086|18188576|P1|Overall Study|Adverse Event|1
5272271|NCT00606034|18188586|P1|Overall Study|incarceration|1
5272272|NCT00606021|18188594|P3|Maintenance Phase|Lost to Follow-up|2
5272273|NCT00606021|18188595|P2|Maintenance Phase|Lost to Follow-up|5
5272274|NCT00606021|18188596|P1|Maintenance Phase|Lost to Follow-up|0
5272275|NCT00606021|18188594|P3|Maintenance Phase|Physician Decision|0
5272276|NCT00606021|18188595|P2|Maintenance Phase|Physician Decision|1
5272277|NCT00606021|18188596|P1|Maintenance Phase|Physician Decision|0
5272278|NCT00606021|18188594|P3|Maintenance Phase|Death|15
5272279|NCT00606021|18188595|P2|Maintenance Phase|Death|17
5272280|NCT00606021|18188596|P1|Maintenance Phase|Death|0
5272281|NCT00606021|18188594|P3|Induction Phase|Lost to Follow-up|0
5272282|NCT00606021|18188595|P2|Induction Phase|Lost to Follow-up|0
5272283|NCT00606021|18188596|P1|Induction Phase|Lost to Follow-up|10
5272284|NCT00606021|18188594|P3|Induction Phase|Withdrawal by Subject|0
5272285|NCT00606021|18188595|P2|Induction Phase|Withdrawal by Subject|0
5272286|NCT00606021|18188596|P1|Induction Phase|Withdrawal by Subject|2
5272287|NCT00606021|18188594|P3|Induction Phase|Physician Decision|0
5272288|NCT00606021|18188595|P2|Induction Phase|Physician Decision|0
5272289|NCT00606021|18188596|P1|Induction Phase|Physician Decision|2
5272290|NCT00606021|18188594|P3|Induction Phase|Death|0
5272291|NCT00606021|18188595|P2|Induction Phase|Death|0
5272292|NCT00606021|18188596|P1|Induction Phase|Death|73
5272293|NCT00606008|18188614|P1|Overall Study|Withdrawal by Subject|4
5272294|NCT00606008|18188614|P1|Overall Study|Adverse Event|1
5272295|NCT00605917|18188628|P1|Overall Study|Protocol Violation|79
5272296|NCT00605865|18188680|P1|Overall Study|Protocol Violation|115
5272298|NCT00605839|18188723|P2|Overall Study|Protocol Violation|0
5272299|NCT00605839|18188724|P1|Overall Study|Protocol Violation|1
5272300|NCT00605813|18188747|P1|Overall Study|Protocol Violation|25
5272301|NCT00605722|18188760|P1|Overall Study|Failure to return|1
5272302|NCT00605722|18188760|P1|Overall Study|Insufficient therapeutic response|44
5272303|NCT00605722|18188760|P1|Overall Study|Adverse Event|6
5272304|NCT00605657|18188781|P1|Overall Study|Protocol Violation|1
5272305|NCT00605657|18188781|P1|Overall Study|Adverse Event|1
5272306|NCT00605566|18188807|P1|Overall Study|Poor compliance in run-in period|1
5272307|NCT00605566|18188807|P1|Overall Study|Clinical deterioration|1
5272308|NCT00605566|18188807|P1|Overall Study|Adverse Event|1
5272309|NCT00605540|18188815|P1|Overall Study|Lost to Follow-up|23
5272310|NCT00605540|18188815|P1|Overall Study|Death|15
5272311|NCT00605475|18188833|P10|Overall Study|Withdrawal by Subject|1
5272312|NCT00605475|18188834|P9|Overall Study|Withdrawal by Subject|0
5272313|NCT00605475|18188835|P8|Overall Study|Withdrawal by Subject|0
5272314|NCT00605475|18188836|P7|Overall Study|Withdrawal by Subject|0
5272315|NCT00605475|18188837|P6|Overall Study|Withdrawal by Subject|2
5272316|NCT00605475|18188838|P5|Overall Study|Withdrawal by Subject|0
5272317|NCT00605475|18188839|P4|Overall Study|Withdrawal by Subject|0
5272318|NCT00605475|18188840|P3|Overall Study|Withdrawal by Subject|0
5272319|NCT00605475|18188841|P2|Overall Study|Withdrawal by Subject|0
5272320|NCT00605475|18188842|P1|Overall Study|Withdrawal by Subject|0
5272321|NCT00605475|18188833|P10|Overall Study|Protocol Violation|0
5272322|NCT00605475|18188834|P9|Overall Study|Protocol Violation|0
5272323|NCT00605475|18188835|P8|Overall Study|Protocol Violation|0
5272324|NCT00605475|18188836|P7|Overall Study|Protocol Violation|0
5272325|NCT00605475|18188837|P6|Overall Study|Protocol Violation|0
5272326|NCT00605475|18188838|P5|Overall Study|Protocol Violation|1
5272327|NCT00605475|18188839|P4|Overall Study|Protocol Violation|0
5272328|NCT00605475|18188840|P3|Overall Study|Protocol Violation|0
5272329|NCT00605475|18188841|P2|Overall Study|Protocol Violation|0
5272330|NCT00605475|18188842|P1|Overall Study|Protocol Violation|0
5272331|NCT00605475|18188833|P10|Overall Study|Lost to Follow-up|1
5272332|NCT00605475|18188834|P9|Overall Study|Lost to Follow-up|1
5272333|NCT00605475|18188835|P8|Overall Study|Lost to Follow-up|0
5272334|NCT00605475|18188836|P7|Overall Study|Lost to Follow-up|0
5272335|NCT00605475|18188837|P6|Overall Study|Lost to Follow-up|0
5272336|NCT00605475|18188838|P5|Overall Study|Lost to Follow-up|0
5272337|NCT00605475|18188839|P4|Overall Study|Lost to Follow-up|0
5272338|NCT00605475|18188840|P3|Overall Study|Lost to Follow-up|0
5272339|NCT00605475|18188841|P2|Overall Study|Lost to Follow-up|0
5272340|NCT00605475|18188842|P1|Overall Study|Lost to Follow-up|0
5272341|NCT00605475|18188833|P10|Overall Study|Administrative problems|0
5272342|NCT00605475|18188834|P9|Overall Study|Administrative problems|0
5272343|NCT00605475|18188835|P8|Overall Study|Administrative problems|0
5272344|NCT00605475|18188836|P7|Overall Study|Administrative problems|1
5272345|NCT00605475|18188837|P6|Overall Study|Administrative problems|0
5272346|NCT00605475|18188838|P5|Overall Study|Administrative problems|0
5272347|NCT00605475|18188839|P4|Overall Study|Administrative problems|0
5272348|NCT00605475|18188840|P3|Overall Study|Administrative problems|0
5272349|NCT00605475|18188841|P2|Overall Study|Administrative problems|0
5272350|NCT00605475|18188842|P1|Overall Study|Administrative problems|0
5272351|NCT00605475|18188833|P10|Overall Study|Abnormal Laboratory Values|0
5272352|NCT00605475|18188834|P9|Overall Study|Abnormal Laboratory Values|1
5272353|NCT00605475|18188835|P8|Overall Study|Abnormal Laboratory Values|0
5272354|NCT00605475|18188836|P7|Overall Study|Abnormal Laboratory Values|0
5272355|NCT00605475|18188837|P6|Overall Study|Abnormal Laboratory Values|0
5272356|NCT00605475|18188838|P5|Overall Study|Abnormal Laboratory Values|0
5272357|NCT00605475|18188839|P4|Overall Study|Abnormal Laboratory Values|0
5272358|NCT00605475|18188840|P3|Overall Study|Abnormal Laboratory Values|0
5272359|NCT00605475|18188841|P2|Overall Study|Abnormal Laboratory Values|0
5272360|NCT00605475|18188842|P1|Overall Study|Abnormal Laboratory Values|0
5272361|NCT00605345|18189019|P2|Overall Study|Protocol Violation|2
5272362|NCT00605345|18189020|P1|Overall Study|Protocol Violation|0
5272363|NCT00605345|18189019|P2|Overall Study|Adverse Event|1
5272364|NCT00605345|18189020|P1|Overall Study|Adverse Event|0
5272365|NCT00605345|18189019|P2|Overall Study|Withdrawal by Subject|0
5272366|NCT00605345|18189020|P1|Overall Study|Withdrawal by Subject|1
5272367|NCT00605319|18189036|P1|Overall Study|Adverse Event|6
5272368|NCT00605306|18189048|P2|Overall Study|Adverse Event|1
5272369|NCT00605306|18189049|P1|Overall Study|Adverse Event|0
5272370|NCT00605293|18189063|P2|Overall Study|Principal Investigator Decision|1
5272371|NCT00605293|18189064|P1|Overall Study|Principal Investigator Decision|0
5272372|NCT00605293|18189063|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
5272373|NCT00605293|18189064|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
5272374|NCT00605293|18189063|P2|Overall Study|Incorrect Epoetin Beta Administration|0
5272375|NCT00605293|18189064|P1|Overall Study|Incorrect Epoetin Beta Administration|1
5272376|NCT00605293|18189063|P2|Overall Study|Renal Transplantation|1
5272377|NCT00605293|18189064|P1|Overall Study|Renal Transplantation|3
5272378|NCT00605293|18189063|P2|Overall Study|Blood Transfusion|1
5272379|NCT00605293|18189064|P1|Overall Study|Blood Transfusion|7
5272380|NCT00605293|18189063|P2|Overall Study|Holidays Dialysis Out|0
5272381|NCT00605293|18189064|P1|Overall Study|Holidays Dialysis Out|1
5272382|NCT00605293|18189063|P2|Overall Study|Adverse Event|0
5272383|NCT00605293|18189064|P1|Overall Study|Adverse Event|1
5272384|NCT00605293|18189063|P2|Overall Study|Insufficient Therapeutic Response|0
5272385|NCT00605293|18189064|P1|Overall Study|Insufficient Therapeutic Response|2
5272386|NCT00605293|18189063|P2|Overall Study|Death|1
5272387|NCT00605293|18189064|P1|Overall Study|Death|2
5272388|NCT00605280|18189084|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
5272389|NCT00605280|18189085|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
5272390|NCT00605280|18189086|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
5272391|NCT00605280|18189087|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
5272392|NCT00605280|18189084|P4|Year 3 Extension|Other|0
5272393|NCT00605280|18189085|P3|Year 3 Extension|Other|0
5272394|NCT00605280|18189086|P2|Year 3 Extension|Other|0
5272395|NCT00605280|18189087|P1|Year 3 Extension|Other|2
5272396|NCT00605280|18189084|P4|Year 3 Extension|Withdrawal by Subject|5
5272397|NCT00605280|18189085|P3|Year 3 Extension|Withdrawal by Subject|0
5272398|NCT00605280|18189086|P2|Year 3 Extension|Withdrawal by Subject|0
5272399|NCT00605280|18189087|P1|Year 3 Extension|Withdrawal by Subject|2
5272400|NCT00605280|18189084|P4|Year 3 Extension|Physician Decision|2
5272401|NCT00605280|18189085|P3|Year 3 Extension|Physician Decision|0
5272402|NCT00605280|18189086|P2|Year 3 Extension|Physician Decision|0
5272403|NCT00605280|18189087|P1|Year 3 Extension|Physician Decision|0
5272404|NCT00605280|18189084|P4|Year 3 Extension|Adverse Event|2
5272405|NCT00605280|18189085|P3|Year 3 Extension|Adverse Event|0
5272406|NCT00605280|18189086|P2|Year 3 Extension|Adverse Event|0
5272407|NCT00605280|18189087|P1|Year 3 Extension|Adverse Event|2
5272408|NCT00605280|18189084|P4|Year 2|Lost to Follow-up or Patient non-comply|2
5272409|NCT00605280|18189085|P3|Year 2|Lost to Follow-up or Patient non-comply|0
5272410|NCT00605280|18189086|P2|Year 2|Lost to Follow-up or Patient non-comply|0
5272411|NCT00605280|18189087|P1|Year 2|Lost to Follow-up or Patient non-comply|4
5272412|NCT00605280|18189084|P4|Year 2|Other|1
5272413|NCT00605280|18189085|P3|Year 2|Other|0
5272414|NCT00605280|18189086|P2|Year 2|Other|0
5272415|NCT00605280|18189087|P1|Year 2|Other|1
5272416|NCT00605280|18189084|P4|Year 2|Withdrawal by Subject|4
5272417|NCT00605280|18189085|P3|Year 2|Withdrawal by Subject|0
5272418|NCT00605280|18189086|P2|Year 2|Withdrawal by Subject|0
5272419|NCT00605280|18189087|P1|Year 2|Withdrawal by Subject|4
5272420|NCT00605280|18189084|P4|Year 2|Physician Decision|11
5272421|NCT00605280|18189085|P3|Year 2|Physician Decision|4
5272422|NCT00605280|18189086|P2|Year 2|Physician Decision|6
5272423|NCT00605280|18189087|P1|Year 2|Physician Decision|11
5272424|NCT00605280|18189084|P4|Year 2|Adverse Event|4
5272425|NCT00605280|18189085|P3|Year 2|Adverse Event|2
5272426|NCT00605280|18189086|P2|Year 2|Adverse Event|0
5272427|NCT00605280|18189087|P1|Year 2|Adverse Event|4
5272428|NCT00605280|18189084|P4|Year 1|Lost to Follow-up or Patient non-comply|2
5272429|NCT00605280|18189085|P3|Year 1|Lost to Follow-up or Patient non-comply|0
5272430|NCT00605280|18189086|P2|Year 1|Lost to Follow-up or Patient non-comply|1
5272431|NCT00605280|18189087|P1|Year 1|Lost to Follow-up or Patient non-comply|5
5272432|NCT00605280|18189084|P4|Year 1|Other|1
5272433|NCT00605280|18189085|P3|Year 1|Other|0
5272434|NCT00605280|18189086|P2|Year 1|Other|1
5272435|NCT00605280|18189087|P1|Year 1|Other|2
5272436|NCT00605280|18189084|P4|Year 1|Withdrawal by Subject|4
5272437|NCT00605280|18189085|P3|Year 1|Withdrawal by Subject|0
5272438|NCT00605280|18189086|P2|Year 1|Withdrawal by Subject|4
5272439|NCT00605280|18189087|P1|Year 1|Withdrawal by Subject|2
5272440|NCT00605280|18189084|P4|Year 1|Physician Decision|6
5272441|NCT00605280|18189085|P3|Year 1|Physician Decision|0
5272442|NCT00605280|18189086|P2|Year 1|Physician Decision|4
5272443|NCT00605280|18189087|P1|Year 1|Physician Decision|7
5272444|NCT00605280|18189084|P4|Year 1|Adverse Event|5
5272445|NCT00605280|18189085|P3|Year 1|Adverse Event|1
5272446|NCT00605280|18189086|P2|Year 1|Adverse Event|1
5272447|NCT00605280|18189087|P1|Year 1|Adverse Event|3
5272448|NCT00605280|18189084|P4|Year 1|Protocol Violation|1
5272449|NCT00605280|18189085|P3|Year 1|Protocol Violation|0
5272450|NCT00605280|18189086|P2|Year 1|Protocol Violation|0
5272451|NCT00605280|18189087|P1|Year 1|Protocol Violation|0
5272452|NCT00605267|18189121|P2|Overall Study|Withdrawal by Subject|3
5272453|NCT00605267|18189122|P1|Overall Study|Withdrawal by Subject|2
5272454|NCT00605267|18189121|P2|Overall Study|Lack of Efficacy|5
5272455|NCT00605267|18189122|P1|Overall Study|Lack of Efficacy|1
5272456|NCT00605267|18189121|P2|Overall Study|Adverse Event|1
5272457|NCT00605267|18189122|P1|Overall Study|Adverse Event|0
5272458|NCT00605189|18189170|P3|Overall Study|Other|0
5272459|NCT00605189|18189171|P2|Overall Study|Other|2
5272460|NCT00605189|18189172|P1|Overall Study|Other|2
5272461|NCT00605189|18189170|P3|Overall Study|Adverse Event|0
5272462|NCT00605189|18189171|P2|Overall Study|Adverse Event|0
5272463|NCT00605189|18189172|P1|Overall Study|Adverse Event|1
5272464|NCT00605176|18189183|P3|Overall Study|Other (not due to AE)|0
5272465|NCT00605176|18189184|P2|Overall Study|Other (not due to AE)|1
5272466|NCT00605176|18189185|P1|Overall Study|Other (not due to AE)|1
5272467|NCT00605176|18189183|P3|Overall Study|Use of concomitant therapy|1
5272468|NCT00605176|18189184|P2|Overall Study|Use of concomitant therapy|0
5272469|NCT00605176|18189185|P1|Overall Study|Use of concomitant therapy|1
5272470|NCT00605176|18189183|P3|Overall Study|Non-complicance with study procedures|0
5272471|NCT00605176|18189184|P2|Overall Study|Non-complicance with study procedures|0
5272472|NCT00605176|18189185|P1|Overall Study|Non-complicance with study procedures|1
5272473|NCT00605176|18189183|P3|Overall Study|Lost to Follow-up|1
5272474|NCT00605176|18189184|P2|Overall Study|Lost to Follow-up|2
5272475|NCT00605176|18189185|P1|Overall Study|Lost to Follow-up|2
5272476|NCT00605176|18189183|P3|Overall Study|Withdrawal by Subject|4
5272477|NCT00605176|18189184|P2|Overall Study|Withdrawal by Subject|2
5272478|NCT00605176|18189185|P1|Overall Study|Withdrawal by Subject|4
5272479|NCT00605176|18189183|P3|Overall Study|Adverse Event|3
5272480|NCT00605176|18189184|P2|Overall Study|Adverse Event|1
5272481|NCT00605176|18189185|P1|Overall Study|Adverse Event|2
5272482|NCT00605085|18189209|P2|Overall Study|administrative reasons|8
5272483|NCT00605085|18189210|P1|Overall Study|administrative reasons|18
5272484|NCT00605085|18189209|P2|Overall Study|Lost to Follow-up|5
5272485|NCT00605085|18189210|P1|Overall Study|Lost to Follow-up|10
5272486|NCT00605085|18189209|P2|Overall Study|Protocol Violation|2
5272487|NCT00605085|18189210|P1|Overall Study|Protocol Violation|3
5272488|NCT00605085|18189209|P2|Overall Study|Pregnancy|0
5272489|NCT00605085|18189210|P1|Overall Study|Pregnancy|2
5272490|NCT00605085|18189209|P2|Overall Study|Adverse Event|5
5272491|NCT00605085|18189210|P1|Overall Study|Adverse Event|9
5272492|NCT00605085|18189209|P2|Overall Study|Withdrawal by Subject|5
5272493|NCT00605085|18189210|P1|Overall Study|Withdrawal by Subject|8
5272494|NCT00605033|18189243|P2|Overall Study|Protocol Violation|1
5272495|NCT00605033|18189244|P1|Overall Study|Protocol Violation|1
5272496|NCT00605033|18189243|P2|Overall Study|Withdrawal by Subject|4
5272497|NCT00605033|18189244|P1|Overall Study|Withdrawal by Subject|3
5272498|NCT00605033|18189243|P2|Overall Study|Lost to Follow-up|1
5272499|NCT00605033|18189244|P1|Overall Study|Lost to Follow-up|1
5272500|NCT00605033|18189243|P2|Overall Study|Adverse Event|2
5272501|NCT00605033|18189244|P1|Overall Study|Adverse Event|2
5272502|NCT00604825|18189288|P4|Overall Study|Exclusion criterion met|1
5272503|NCT00604825|18189289|P3|Overall Study|Exclusion criterion met|0
5272504|NCT00604825|18189290|P2|Overall Study|Exclusion criterion met|0
5272505|NCT00604825|18189291|P1|Overall Study|Exclusion criterion met|0
5272506|NCT00604825|18189288|P4|Overall Study|Physician Decision|1
5272507|NCT00604825|18189289|P3|Overall Study|Physician Decision|0
5272508|NCT00604825|18189290|P2|Overall Study|Physician Decision|0
5272509|NCT00604825|18189291|P1|Overall Study|Physician Decision|0
5272510|NCT00604825|18189288|P4|Overall Study|Did not meet eligibility criteria|0
5272511|NCT00604825|18189289|P3|Overall Study|Did not meet eligibility criteria|2
5272512|NCT00604825|18189290|P2|Overall Study|Did not meet eligibility criteria|0
5272513|NCT00604825|18189291|P1|Overall Study|Did not meet eligibility criteria|0
5272514|NCT00604825|18189288|P4|Overall Study|Lack of Efficacy|0
5272515|NCT00604825|18189289|P3|Overall Study|Lack of Efficacy|1
5272516|NCT00604825|18189290|P2|Overall Study|Lack of Efficacy|2
5272517|NCT00604825|18189291|P1|Overall Study|Lack of Efficacy|3
5272518|NCT00604825|18189288|P4|Overall Study|Withdrawal by Subject|5
5272519|NCT00604825|18189289|P3|Overall Study|Withdrawal by Subject|5
5272520|NCT00604825|18189290|P2|Overall Study|Withdrawal by Subject|3
5272521|NCT00604825|18189291|P1|Overall Study|Withdrawal by Subject|4
5272522|NCT00604825|18189288|P4|Overall Study|Protocol Violation|0
5272523|NCT00604825|18189289|P3|Overall Study|Protocol Violation|0
5272524|NCT00604825|18189290|P2|Overall Study|Protocol Violation|1
5272525|NCT00604825|18189291|P1|Overall Study|Protocol Violation|0
5272526|NCT00604825|18189288|P4|Overall Study|Lost to Follow-up|0
5272527|NCT00604825|18189289|P3|Overall Study|Lost to Follow-up|1
5272528|NCT00604825|18189290|P2|Overall Study|Lost to Follow-up|3
5272529|NCT00604825|18189291|P1|Overall Study|Lost to Follow-up|0
5272530|NCT00604825|18189288|P4|Overall Study|Adverse Event|4
5272531|NCT00604825|18189289|P3|Overall Study|Adverse Event|7
5272532|NCT00604825|18189290|P2|Overall Study|Adverse Event|6
5272533|NCT00604825|18189291|P1|Overall Study|Adverse Event|2
5272534|NCT00604786|18189519|P2|Overall Study|Lost to Follow-up|0
5272535|NCT00604786|18189520|P1|Overall Study|Lost to Follow-up|2
5272536|NCT00604721|18189526|P1|Overall Study|Withdrawal by Subject|1
5272537|NCT00604721|18189526|P1|Overall Study|Physician Decision|1
5272538|NCT00604708|18189534|P2|Overall Study|Adverse Event|6
5272539|NCT00604708|18189535|P1|Overall Study|Adverse Event|6
5272540|NCT00604708|18189534|P2|Overall Study|administrative reasons|11
5272541|NCT00604708|18189535|P1|Overall Study|administrative reasons|9
5272542|NCT00604708|18189534|P2|Overall Study|Lost to Follow-up|5
5272543|NCT00604708|18189535|P1|Overall Study|Lost to Follow-up|5
5272544|NCT00604708|18189534|P2|Overall Study|Protocol Violation|8
5272545|NCT00604708|18189535|P1|Overall Study|Protocol Violation|2
5272546|NCT00604708|18189534|P2|Overall Study|Withdrawal by Subject|10
5272547|NCT00604708|18189535|P1|Overall Study|Withdrawal by Subject|9
5272548|NCT00604695|18189545|P2|Overall Study|Did not receive first bolus.|4
5272549|NCT00604695|18189546|P1|Overall Study|Did not receive first bolus.|0
5272550|NCT00604669|18189568|P1|Overall Study|lack of information in chart|7
5272551|NCT00604565|18189574|P2|Overall Study|Study terminated|3
5272552|NCT00604565|18189575|P1|Overall Study|Study terminated|0
5272553|NCT00604500|18189594|P1|Overall Study|Did not meet protocol eligibility|1
5272554|NCT00604500|18189594|P1|Overall Study|Administrative|1
5272555|NCT00604500|18189594|P1|Overall Study|Withdrawal by Subject|4
5272556|NCT00604500|18189594|P1|Overall Study|Treatment Failure|1
5272557|NCT00604500|18189594|P1|Overall Study|Protocol Violation|2
5272558|NCT00604500|18189594|P1|Overall Study|Adverse Event|2
5272559|NCT00604383|18189608|P2|Overall Study|Physician Decision|3
5272560|NCT00604383|18189609|P1|Overall Study|Physician Decision|0
5272561|NCT00604383|18189608|P2|Overall Study|Adverse Event|9
5272562|NCT00604383|18189609|P1|Overall Study|Adverse Event|16
5272563|NCT00604383|18189608|P2|Overall Study|Death|22
5272564|NCT00604383|18189609|P1|Overall Study|Death|14
5272565|NCT00604383|18189608|P2|Overall Study|Lost to Follow-up|19
5272566|NCT00604383|18189609|P1|Overall Study|Lost to Follow-up|24
5272567|NCT00604383|18189608|P2|Overall Study|Withdrawal by Subject|31
5272568|NCT00604383|18189609|P1|Overall Study|Withdrawal by Subject|33
5272569|NCT00604279|18189625|P2|Overall Study|Other|4
5272570|NCT00604279|18189626|P1|Overall Study|Other|8
5272571|NCT00604279|18189625|P2|Overall Study|Adverse Event|5
5272572|NCT00604279|18189626|P1|Overall Study|Adverse Event|4
5272573|NCT00604279|18189625|P2|Overall Study|Withdrawal by Subject|5
5272574|NCT00604279|18189626|P1|Overall Study|Withdrawal by Subject|16
5272575|NCT00604279|18189625|P2|Overall Study|Protocol Violation|1
5272576|NCT00604279|18189626|P1|Overall Study|Protocol Violation|3
5272577|NCT00604279|18189625|P2|Overall Study|Pregnancy|0
5272578|NCT00604279|18189626|P1|Overall Study|Pregnancy|2
5272579|NCT00604279|18189625|P2|Overall Study|Lost to Follow-up|14
5272580|NCT00604279|18189626|P1|Overall Study|Lost to Follow-up|9
5272581|NCT00604279|18189625|P2|Overall Study|Lack of Efficacy|9
5272582|NCT00604279|18189626|P1|Overall Study|Lack of Efficacy|22
5272583|NCT00604214|18189642|P2|Day 91 to Day 180|Withdrawal by Subject|1
5272584|NCT00604214|18189643|P1|Day 91 to Day 180|Withdrawal by Subject|1
5272585|NCT00604214|18189642|P2|Day 91 to Day 180|Lost to Follow-up|8
5272586|NCT00604214|18189643|P1|Day 91 to Day 180|Lost to Follow-up|6
5272587|NCT00604214|18189642|P2|Day 91 to Day 180|Death|23
5272588|NCT00604214|18189643|P1|Day 91 to Day 180|Death|19
5272589|NCT00604214|18189642|P2|Day 29 to Day 90|Withdrawal by Subject|6
5272590|NCT00604214|18189643|P1|Day 29 to Day 90|Withdrawal by Subject|0
5272591|NCT00604214|18189642|P2|Day 29 to Day 90|Lost to Follow-up|6
5272592|NCT00604214|18189643|P1|Day 29 to Day 90|Lost to Follow-up|4
5272593|NCT00604214|18189642|P2|Day 29 to Day 90|Death|67
5272594|NCT00604214|18189643|P1|Day 29 to Day 90|Death|64
5272595|NCT00604214|18189642|P2|Baseline to Day 28|Withdrawal by Subject|7
5272596|NCT00604214|18189643|P1|Baseline to Day 28|Withdrawal by Subject|3
5272597|NCT00604214|18189642|P2|Baseline to Day 28|Lost to Follow-up|4
5272598|NCT00604214|18189643|P1|Baseline to Day 28|Lost to Follow-up|2
5272599|NCT00604214|18189642|P2|Baseline to Day 28|Death|202
5272600|NCT00604214|18189643|P1|Baseline to Day 28|Death|223
5272601|NCT00604188|18189691|P2|Overall Study|Did not receive study drug|1
5272602|NCT00604188|18189692|P1|Overall Study|Did not receive study drug|0
5272603|NCT00604188|18189691|P2|Overall Study|Non-compliance with protocol|4
5272604|NCT00604188|18189692|P1|Overall Study|Non-compliance with protocol|4
5272605|NCT00604188|18189691|P2|Overall Study|Withdrawal by Subject|1
5272606|NCT00604188|18189692|P1|Overall Study|Withdrawal by Subject|5
5272607|NCT00604188|18189691|P2|Overall Study|Lost to Follow-up|15
5272608|NCT00604188|18189692|P1|Overall Study|Lost to Follow-up|17
5272609|NCT00604188|18189691|P2|Overall Study|Adverse Event|4
5272610|NCT00604188|18189692|P1|Overall Study|Adverse Event|1
5272611|NCT00604175|18189715|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
5272612|NCT00604175|18189716|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
5272613|NCT00604175|18189717|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
5272614|NCT00604175|18189715|P3|Week 29 Through Week 72|Site closure|0
5272615|NCT00604175|18189716|P2|Week 29 Through Week 72|Site closure|1
5272616|NCT00604175|18189717|P1|Week 29 Through Week 72|Site closure|0
5272617|NCT00604175|18189715|P3|Week 29 Through Week 72|Lost to Follow-up|2
5272618|NCT00604175|18189716|P2|Week 29 Through Week 72|Lost to Follow-up|6
5272619|NCT00604175|18189717|P1|Week 29 Through Week 72|Lost to Follow-up|12
5272620|NCT00604175|18189715|P3|Week 29 Through Week 72|Death|1
5272621|NCT00604175|18189716|P2|Week 29 Through Week 72|Death|0
5272622|NCT00604175|18189717|P1|Week 29 Through Week 72|Death|0
5272623|NCT00604175|18189715|P3|Entry Through Week 28|Did not start intervention|1
5272624|NCT00604175|18189716|P2|Entry Through Week 28|Did not start intervention|0
5272625|NCT00604175|18189717|P1|Entry Through Week 28|Did not start intervention|2
5272626|NCT00604175|18189715|P3|Entry Through Week 28|Ineligible|0
5272627|NCT00604175|18189716|P2|Entry Through Week 28|Ineligible|0
5272628|NCT00604175|18189717|P1|Entry Through Week 28|Ineligible|1
5272629|NCT00604175|18189715|P3|Entry Through Week 28|Lost to Follow-up|0
5272630|NCT00604175|18189716|P2|Entry Through Week 28|Lost to Follow-up|3
5272631|NCT00604175|18189717|P1|Entry Through Week 28|Lost to Follow-up|4
5272632|NCT00604175|18189715|P3|Entry Through Week 28|Withdrawal by Subject|0
5272633|NCT00604175|18189716|P2|Entry Through Week 28|Withdrawal by Subject|0
5272634|NCT00604175|18189717|P1|Entry Through Week 28|Withdrawal by Subject|1
5272635|NCT00604175|18189715|P3|Entry Through Week 28|Death|0
5272636|NCT00604175|18189716|P2|Entry Through Week 28|Death|0
5272637|NCT00604175|18189717|P1|Entry Through Week 28|Death|2
5272638|NCT00604162|18189770|P1|Overall Study|Withdrawal by Subject|1
5272639|NCT00604162|18189770|P1|Overall Study|Physician Decision|3
5272640|NCT00603980|18189812|P1|Main Study|14th subject completed trial|1
5272641|NCT00603980|18189812|P1|Study Qualification|Inconsistent data reporting|13
5272642|NCT00603980|18189812|P1|Study Qualification|Protocol Violation|3
5272643|NCT00603941|18189931|P3|Overall Study|Withdrawal by Subject|0
5272644|NCT00603941|18189932|P2|Overall Study|Withdrawal by Subject|2
5272645|NCT00603941|18189933|P1|Overall Study|Withdrawal by Subject|0
5272646|NCT00603941|18189931|P3|Overall Study|Physician Decision|0
5272647|NCT00603941|18189932|P2|Overall Study|Physician Decision|1
5272648|NCT00603941|18189933|P1|Overall Study|Physician Decision|0
5272649|NCT00603941|18189931|P3|Overall Study|Adverse Event|1
5272650|NCT00603941|18189932|P2|Overall Study|Adverse Event|0
5272651|NCT00603941|18189933|P1|Overall Study|Adverse Event|1
5272652|NCT00603941|18189931|P3|Overall Study|Disease progression|1
5272653|NCT00603941|18189932|P2|Overall Study|Disease progression|7
5272654|NCT00603941|18189933|P1|Overall Study|Disease progression|6
5272655|NCT00603915|18189944|P1|Overall Study|Physician Decision|1
5272656|NCT00603837|18189974|P2|Overall Study|Physician Decision|0
5272657|NCT00603837|18189975|P1|Overall Study|Physician Decision|3
5272658|NCT00603798|18189984|P3|Overall Study|Not due to AE|4
5272659|NCT00603798|18189985|P2|Overall Study|Not due to AE|1
5272660|NCT00603798|18189986|P1|Overall Study|Not due to AE|1
5272661|NCT00603798|18189984|P3|Overall Study|Non-compliance with study procedures|0
5272662|NCT00603798|18189985|P2|Overall Study|Non-compliance with study procedures|1
5272663|NCT00603798|18189986|P1|Overall Study|Non-compliance with study procedures|0
5272664|NCT00603798|18189984|P3|Overall Study|Lost to Follow-up|1
5272665|NCT00603798|18189985|P2|Overall Study|Lost to Follow-up|0
5272666|NCT00603798|18189986|P1|Overall Study|Lost to Follow-up|1
5272667|NCT00603798|18189984|P3|Overall Study|Withdrawal by Subject|4
5272668|NCT00603798|18189985|P2|Overall Study|Withdrawal by Subject|3
5272669|NCT00603798|18189986|P1|Overall Study|Withdrawal by Subject|4
5272670|NCT00603798|18189984|P3|Overall Study|Adverse Event|1
5272671|NCT00603798|18189985|P2|Overall Study|Adverse Event|2
5272672|NCT00603798|18189986|P1|Overall Study|Adverse Event|4
5272673|NCT00603746|18190009|P6|Overall Study|Withdrawal by Subject|1
5272674|NCT00603746|18190010|P5|Overall Study|Withdrawal by Subject|3
5272675|NCT00603746|18190011|P4|Overall Study|Withdrawal by Subject|1
5272676|NCT00603746|18190012|P3|Overall Study|Withdrawal by Subject|0
5272677|NCT00603746|18190013|P2|Overall Study|Withdrawal by Subject|0
5272678|NCT00603746|18190014|P1|Overall Study|Withdrawal by Subject|1
5272679|NCT00603746|18190009|P6|Overall Study|Physician Decision|0
5272680|NCT00603746|18190010|P5|Overall Study|Physician Decision|1
5272681|NCT00603746|18190011|P4|Overall Study|Physician Decision|0
5272682|NCT00603746|18190012|P3|Overall Study|Physician Decision|0
5272683|NCT00603746|18190013|P2|Overall Study|Physician Decision|0
5272684|NCT00603746|18190014|P1|Overall Study|Physician Decision|1
5272685|NCT00603746|18190009|P6|Overall Study|Lost to Follow-up|0
5272686|NCT00603746|18190010|P5|Overall Study|Lost to Follow-up|0
5272687|NCT00603746|18190011|P4|Overall Study|Lost to Follow-up|0
5272688|NCT00603746|18190012|P3|Overall Study|Lost to Follow-up|1
5272689|NCT00603746|18190013|P2|Overall Study|Lost to Follow-up|1
5272690|NCT00603746|18190014|P1|Overall Study|Lost to Follow-up|0
5272691|NCT00603746|18190009|P6|Overall Study|Protocol Violation|0
5272692|NCT00603746|18190010|P5|Overall Study|Protocol Violation|1
5272693|NCT00603746|18190011|P4|Overall Study|Protocol Violation|0
5272694|NCT00603746|18190012|P3|Overall Study|Protocol Violation|1
5272695|NCT00603746|18190013|P2|Overall Study|Protocol Violation|3
5272696|NCT00603746|18190014|P1|Overall Study|Protocol Violation|0
5272697|NCT00603746|18190009|P6|Overall Study|Lack of Efficacy|8
5272698|NCT00603746|18190010|P5|Overall Study|Lack of Efficacy|12
5272699|NCT00603746|18190011|P4|Overall Study|Lack of Efficacy|11
5272700|NCT00603746|18190012|P3|Overall Study|Lack of Efficacy|6
5272701|NCT00603746|18190013|P2|Overall Study|Lack of Efficacy|11
5272702|NCT00603746|18190014|P1|Overall Study|Lack of Efficacy|34
5272703|NCT00603746|18190009|P6|Overall Study|Adverse Event|4
5272704|NCT00603746|18190010|P5|Overall Study|Adverse Event|0
5272705|NCT00603746|18190011|P4|Overall Study|Adverse Event|1
5272706|NCT00603746|18190012|P3|Overall Study|Adverse Event|0
5272707|NCT00603746|18190013|P2|Overall Study|Adverse Event|3
5272708|NCT00603746|18190014|P1|Overall Study|Adverse Event|2
5272709|NCT00603733|18190162|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
5272710|NCT00603733|18190163|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
5272711|NCT00603733|18190162|P2|Maintenance Phase ITT|Physician Decision|1
5272712|NCT00603733|18190163|P1|Maintenance Phase ITT|Physician Decision|0
5272713|NCT00603733|18190162|P2|Maintenance Phase ITT|Lack of Efficacy|2
5272714|NCT00603733|18190163|P1|Maintenance Phase ITT|Lack of Efficacy|2
5272715|NCT00603733|18190162|P2|Maintenance Phase ITT|Lost to Follow-up|1
5272716|NCT00603733|18190163|P1|Maintenance Phase ITT|Lost to Follow-up|0
5272717|NCT00603733|18190162|P2|Maintenance Phase ITT|Protocol Violation|1
5272718|NCT00603733|18190163|P1|Maintenance Phase ITT|Protocol Violation|1
5272719|NCT00603733|18190162|P2|Maintenance Phase ITT|Withdrawal by Subject|0
5272720|NCT00603733|18190163|P1|Maintenance Phase ITT|Withdrawal by Subject|1
5272721|NCT00603733|18190162|P2|Maintenance Phase ITT|Adverse Event|6
5272722|NCT00603733|18190163|P1|Maintenance Phase ITT|Adverse Event|3
5272723|NCT00603733|18190162|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
5272724|NCT00603733|18190163|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
5272725|NCT00603733|18190162|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
5272726|NCT00603733|18190163|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
5272727|NCT00603733|18190162|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
5272728|NCT00603733|18190163|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
5272729|NCT00603733|18190162|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
5272730|NCT00603733|18190163|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
5272731|NCT00603733|18190162|P2|Run-In Phase - 4 Weeks|Adverse Event|1
5272732|NCT00603733|18190163|P1|Run-In Phase - 4 Weeks|Adverse Event|2
5272733|NCT00603733|18190162|P2|Active Phase ITT|Subject moved, site closed|1
5272734|NCT00603733|18190163|P1|Active Phase ITT|Subject moved, site closed|1
5272735|NCT00603733|18190162|P2|Active Phase ITT|Lack of Efficacy|2
5272736|NCT00603733|18190163|P1|Active Phase ITT|Lack of Efficacy|1
5272737|NCT00603733|18190162|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
5272738|NCT00603733|18190163|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
5272739|NCT00603733|18190162|P2|Active Phase ITT|Lost to Follow-up|1
5272740|NCT00603733|18190163|P1|Active Phase ITT|Lost to Follow-up|0
5272741|NCT00603733|18190162|P2|Active Phase ITT|Withdrawal by Subject|3
5272742|NCT00603733|18190163|P1|Active Phase ITT|Withdrawal by Subject|0
5272743|NCT00603733|18190162|P2|Active Phase ITT|Adverse Event|7
5272744|NCT00603733|18190163|P1|Active Phase ITT|Adverse Event|8
5272745|NCT00603590|18190213|P2|Overall Study|Cardiovascular event|1
5272746|NCT00603590|18190214|P1|Overall Study|Cardiovascular event|0
5272747|NCT00603590|18190213|P2|Overall Study|Lost to Follow-up|4
5272748|NCT00603590|18190214|P1|Overall Study|Lost to Follow-up|8
5272749|NCT00603590|18190213|P2|Overall Study|Adverse Event|0
5272750|NCT00603590|18190214|P1|Overall Study|Adverse Event|2
5272751|NCT00603590|18190213|P2|Overall Study|Patient discontinued study drug|15
5272752|NCT00603590|18190214|P1|Overall Study|Patient discontinued study drug|22
5272753|NCT00603590|18190213|P2|Overall Study|Refused blood test|1
5272754|NCT00603590|18190214|P1|Overall Study|Refused blood test|5
5272755|NCT00603590|18190213|P2|Overall Study|Did not attend study clinic|30
5272756|NCT00603590|18190214|P1|Overall Study|Did not attend study clinic|39
5272757|NCT00603538|18190238|P3|Overall Study|Objective progression or relapse|0
5272758|NCT00603538|18190239|P2|Overall Study|Objective progression or relapse|0
5272759|NCT00603538|18190240|P1|Overall Study|Objective progression or relapse|3
5272760|NCT00603538|18190238|P3|Overall Study|Adverse Event|2
5272761|NCT00603538|18190239|P2|Overall Study|Adverse Event|4
5272762|NCT00603538|18190240|P1|Overall Study|Adverse Event|0
5272763|NCT00603525|18190280|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
5272764|NCT00603525|18190281|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
5272765|NCT00603525|18190282|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
5272766|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5272767|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
5272768|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5272769|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
5272770|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
5272771|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
5272772|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5272773|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
5272774|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5272775|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5272776|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
5272777|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5272778|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
5272779|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
5272780|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
5272781|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5272782|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
5272783|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5272784|NCT00603525|18190280|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
5272785|NCT00603525|18190281|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
5272786|NCT00603525|18190282|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
5272787|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
5272788|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
5272789|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
5272790|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
5272791|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
5272792|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
5272793|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
5272794|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
5272795|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
5272796|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
5272797|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
5272798|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
5272799|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
5272800|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
5272801|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
5272802|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5272803|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5272804|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
5272805|NCT00603525|18190280|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
5272806|NCT00603525|18190281|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
5272807|NCT00603525|18190282|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
5272808|NCT00603512|18190414|P5|Overall Study|Randomized but not treated|0
5272809|NCT00603512|18190415|P4|Overall Study|Randomized but not treated|2
5272810|NCT00603512|18190416|P3|Overall Study|Randomized but not treated|1
5272811|NCT00603512|18190417|P2|Overall Study|Randomized but not treated|1
5272812|NCT00603512|18190418|P1|Overall Study|Randomized but not treated|0
5272813|NCT00603512|18190414|P5|Overall Study|Withdrawal by Subject|1
5272814|NCT00603512|18190415|P4|Overall Study|Withdrawal by Subject|0
5272815|NCT00603512|18190416|P3|Overall Study|Withdrawal by Subject|0
5272816|NCT00603512|18190417|P2|Overall Study|Withdrawal by Subject|0
5272817|NCT00603512|18190418|P1|Overall Study|Withdrawal by Subject|0
5272818|NCT00603512|18190414|P5|Overall Study|Other|1
5272819|NCT00603512|18190415|P4|Overall Study|Other|1
5272820|NCT00603512|18190416|P3|Overall Study|Other|0
5272821|NCT00603512|18190417|P2|Overall Study|Other|1
5272822|NCT00603512|18190418|P1|Overall Study|Other|2
5272823|NCT00603512|18190414|P5|Overall Study|Lack of Efficacy|1
5272824|NCT00603512|18190415|P4|Overall Study|Lack of Efficacy|0
5272825|NCT00603512|18190416|P3|Overall Study|Lack of Efficacy|0
5272826|NCT00603512|18190417|P2|Overall Study|Lack of Efficacy|1
5272827|NCT00603512|18190418|P1|Overall Study|Lack of Efficacy|0
5272828|NCT00603512|18190414|P5|Overall Study|Adverse Event|2
5272829|NCT00603512|18190415|P4|Overall Study|Adverse Event|4
5272830|NCT00603512|18190416|P3|Overall Study|Adverse Event|4
5272831|NCT00603512|18190417|P2|Overall Study|Adverse Event|2
5272832|NCT00603512|18190418|P1|Overall Study|Adverse Event|0
5272833|NCT00603473|18190560|P1|Overall Study|Protocol Violation|1
5272834|NCT00603473|18190560|P1|Overall Study|Lack of Efficacy|4
5272835|NCT00603473|18190560|P1|Overall Study|Adverse Event|4
5272836|NCT00603447|18190573|P7|Overall Study|Withdrew Consent|1
5272837|NCT00603447|18190574|P6|Overall Study|Withdrew Consent|0
5272838|NCT00603447|18190575|P5|Overall Study|Withdrew Consent|1
5272839|NCT00603447|18190576|P4|Overall Study|Withdrew Consent|0
5272840|NCT00603447|18190577|P3|Overall Study|Withdrew Consent|0
5272841|NCT00603447|18190578|P2|Overall Study|Withdrew Consent|2
5272842|NCT00603447|18190579|P1|Overall Study|Withdrew Consent|0
5272843|NCT00603447|18190573|P7|Overall Study|Other|13
5272844|NCT00603447|18190574|P6|Overall Study|Other|0
5272845|NCT00603447|18190575|P5|Overall Study|Other|3
5272846|NCT00603447|18190576|P4|Overall Study|Other|0
5272847|NCT00603447|18190577|P3|Overall Study|Other|1
5272848|NCT00603447|18190578|P2|Overall Study|Other|0
5272849|NCT00603447|18190579|P1|Overall Study|Other|0
5272850|NCT00603447|18190573|P7|Overall Study|Adverse Event|10
5272851|NCT00603447|18190574|P6|Overall Study|Adverse Event|2
5272852|NCT00603447|18190575|P5|Overall Study|Adverse Event|1
5272853|NCT00603447|18190576|P4|Overall Study|Adverse Event|2
5272854|NCT00603447|18190577|P3|Overall Study|Adverse Event|1
5272855|NCT00603447|18190578|P2|Overall Study|Adverse Event|1
5272856|NCT00603447|18190579|P1|Overall Study|Adverse Event|0
5272857|NCT00603382|18190618|P6|Overall Study|Withdrawal by Subject|1
5272858|NCT00603382|18190619|P5|Overall Study|Withdrawal by Subject|0
5272859|NCT00603382|18190620|P4|Overall Study|Withdrawal by Subject|1
5272860|NCT00603382|18190621|P3|Overall Study|Withdrawal by Subject|1
5272861|NCT00603382|18190622|P2|Overall Study|Withdrawal by Subject|3
5272862|NCT00603382|18190623|P1|Overall Study|Withdrawal by Subject|3
5272863|NCT00603382|18190618|P6|Overall Study|Physician Decision|3
5272864|NCT00603382|18190619|P5|Overall Study|Physician Decision|1
5272865|NCT00603382|18190620|P4|Overall Study|Physician Decision|0
5272866|NCT00603382|18190621|P3|Overall Study|Physician Decision|2
5272867|NCT00603382|18190622|P2|Overall Study|Physician Decision|0
5272868|NCT00603382|18190623|P1|Overall Study|Physician Decision|0
5272869|NCT00603382|18190618|P6|Overall Study|Lost to Follow-up|1
5272870|NCT00603382|18190619|P5|Overall Study|Lost to Follow-up|0
5272871|NCT00603382|18190620|P4|Overall Study|Lost to Follow-up|1
5272872|NCT00603382|18190621|P3|Overall Study|Lost to Follow-up|1
5272873|NCT00603382|18190622|P2|Overall Study|Lost to Follow-up|1
5272874|NCT00603382|18190623|P1|Overall Study|Lost to Follow-up|0
5272875|NCT00603382|18190618|P6|Overall Study|Protocol Violation|0
5272876|NCT00603382|18190619|P5|Overall Study|Protocol Violation|1
5272877|NCT00603382|18190620|P4|Overall Study|Protocol Violation|2
5272878|NCT00603382|18190621|P3|Overall Study|Protocol Violation|1
5272879|NCT00603382|18190622|P2|Overall Study|Protocol Violation|0
5272880|NCT00603382|18190623|P1|Overall Study|Protocol Violation|1
5272881|NCT00603382|18190618|P6|Overall Study|Lack of Efficacy|11
5272882|NCT00603382|18190619|P5|Overall Study|Lack of Efficacy|6
5272883|NCT00603382|18190620|P4|Overall Study|Lack of Efficacy|6
5272884|NCT00603382|18190621|P3|Overall Study|Lack of Efficacy|3
5272885|NCT00603382|18190622|P2|Overall Study|Lack of Efficacy|9
5272886|NCT00603382|18190623|P1|Overall Study|Lack of Efficacy|14
5272887|NCT00603382|18190618|P6|Overall Study|Adverse Event|2
5272888|NCT00603382|18190619|P5|Overall Study|Adverse Event|1
5272889|NCT00603382|18190620|P4|Overall Study|Adverse Event|2
5272890|NCT00603382|18190621|P3|Overall Study|Adverse Event|1
5272891|NCT00603382|18190622|P2|Overall Study|Adverse Event|1
5272892|NCT00603382|18190623|P1|Overall Study|Adverse Event|0
5272893|NCT00603304|18190771|P2|Overall Study|Patient Decision|0
5272894|NCT00603304|18190772|P1|Overall Study|Patient Decision|2
5272895|NCT00603304|18190771|P2|Overall Study|Other|0
5272896|NCT00603304|18190772|P1|Overall Study|Other|2
5272897|NCT00603304|18190771|P2|Overall Study|Moved Away|2
5272898|NCT00603304|18190772|P1|Overall Study|Moved Away|0
5272899|NCT00603304|18190771|P2|Overall Study|Non-Compliant|1
5272900|NCT00603304|18190772|P1|Overall Study|Non-Compliant|0
5272901|NCT00603304|18190771|P2|Overall Study|Exclusionary Medication|3
5272902|NCT00603304|18190772|P1|Overall Study|Exclusionary Medication|2
5272903|NCT00603304|18190771|P2|Overall Study|Crossed Over to Open Label Therapy|3
5272904|NCT00603304|18190772|P1|Overall Study|Crossed Over to Open Label Therapy|3
5272905|NCT00603304|18190771|P2|Overall Study|Unacceptable Treatment Toxicity|8
5272906|NCT00603304|18190772|P1|Overall Study|Unacceptable Treatment Toxicity|5
5272907|NCT00603304|18190771|P2|Overall Study|Adverse Event|2
5272908|NCT00603304|18190772|P1|Overall Study|Adverse Event|4
5272909|NCT00603304|18190771|P2|Overall Study|Protocol Violation|0
5272910|NCT00603304|18190772|P1|Overall Study|Protocol Violation|1
5272911|NCT00603304|18190771|P2|Overall Study|Withdrawal by Subject|5
5272912|NCT00603304|18190772|P1|Overall Study|Withdrawal by Subject|8
5272913|NCT00603304|18190771|P2|Overall Study|Lost to Follow-up|7
5272914|NCT00603304|18190772|P1|Overall Study|Lost to Follow-up|5
5272915|NCT00603278|18190828|P6|Overall Study|Lost to Follow-up|0
5272916|NCT00603278|18190829|P5|Overall Study|Lost to Follow-up|1
5272917|NCT00603278|18190830|P4|Overall Study|Lost to Follow-up|0
5272918|NCT00603278|18190831|P3|Overall Study|Lost to Follow-up|0
5272919|NCT00603278|18190832|P2|Overall Study|Lost to Follow-up|0
5272920|NCT00603278|18190833|P1|Overall Study|Lost to Follow-up|1
5272921|NCT00603278|18190828|P6|Overall Study|Physician Decision|1
5272922|NCT00603278|18190829|P5|Overall Study|Physician Decision|2
5272923|NCT00603278|18190830|P4|Overall Study|Physician Decision|0
5272924|NCT00603278|18190831|P3|Overall Study|Physician Decision|0
5272925|NCT00603278|18190832|P2|Overall Study|Physician Decision|1
5272926|NCT00603278|18190833|P1|Overall Study|Physician Decision|0
5272927|NCT00603278|18190828|P6|Overall Study|Protocol Violation|1
5272928|NCT00603278|18190829|P5|Overall Study|Protocol Violation|0
5272929|NCT00603278|18190830|P4|Overall Study|Protocol Violation|1
5272930|NCT00603278|18190831|P3|Overall Study|Protocol Violation|1
5272931|NCT00603278|18190832|P2|Overall Study|Protocol Violation|0
5272932|NCT00603278|18190833|P1|Overall Study|Protocol Violation|3
5272933|NCT00603278|18190828|P6|Overall Study|Withdrawal by Subject|2
5272934|NCT00603278|18190829|P5|Overall Study|Withdrawal by Subject|1
5272935|NCT00603278|18190830|P4|Overall Study|Withdrawal by Subject|2
5272936|NCT00603278|18190831|P3|Overall Study|Withdrawal by Subject|1
5272937|NCT00603278|18190832|P2|Overall Study|Withdrawal by Subject|3
5272938|NCT00603278|18190833|P1|Overall Study|Withdrawal by Subject|2
5272939|NCT00603278|18190828|P6|Overall Study|Adverse Event|1
5272940|NCT00603278|18190829|P5|Overall Study|Adverse Event|2
5272941|NCT00603278|18190830|P4|Overall Study|Adverse Event|0
5272942|NCT00603278|18190831|P3|Overall Study|Adverse Event|1
5272943|NCT00603278|18190832|P2|Overall Study|Adverse Event|3
5272944|NCT00603278|18190833|P1|Overall Study|Adverse Event|0
5272945|NCT00603278|18190828|P6|Overall Study|Lack of Efficacy|14
5272946|NCT00603278|18190829|P5|Overall Study|Lack of Efficacy|7
5272947|NCT00603278|18190830|P4|Overall Study|Lack of Efficacy|8
5272948|NCT00603278|18190831|P3|Overall Study|Lack of Efficacy|11
5272949|NCT00603278|18190832|P2|Overall Study|Lack of Efficacy|10
5272950|NCT00603278|18190833|P1|Overall Study|Lack of Efficacy|35
5272951|NCT00603265|18190982|P3|Overall Study|Protocol Violation|0
5272952|NCT00603265|18190983|P2|Overall Study|Protocol Violation|0
5272953|NCT00603265|18190984|P1|Overall Study|Protocol Violation|1
5272954|NCT00603265|18190982|P3|Overall Study|Participant Left Country, No Responses|0
5272955|NCT00603265|18190983|P2|Overall Study|Participant Left Country, No Responses|1
5272956|NCT00603265|18190984|P1|Overall Study|Participant Left Country, No Responses|0
5272957|NCT00603265|18190982|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
5272958|NCT00603265|18190983|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
5272959|NCT00603265|18190984|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
5272960|NCT00603265|18190982|P3|Overall Study|Lost to Follow-up|0
5272961|NCT00603265|18190983|P2|Overall Study|Lost to Follow-up|1
5272962|NCT00603265|18190984|P1|Overall Study|Lost to Follow-up|0
5272963|NCT00603265|18190982|P3|Overall Study|Lack of Efficacy|3
5272964|NCT00603265|18190983|P2|Overall Study|Lack of Efficacy|0
5272965|NCT00603265|18190984|P1|Overall Study|Lack of Efficacy|3
5272966|NCT00603265|18190982|P3|Overall Study|Withdrawal by Subject|1
5272967|NCT00603265|18190983|P2|Overall Study|Withdrawal by Subject|2
5272968|NCT00603265|18190984|P1|Overall Study|Withdrawal by Subject|1
5272969|NCT00603265|18190982|P3|Overall Study|Adverse Event|1
5272970|NCT00603265|18190983|P2|Overall Study|Adverse Event|11
5272971|NCT00603265|18190984|P1|Overall Study|Adverse Event|2
5272972|NCT00603239|18191012|P2|Overall Study|Subject decision|1
5272973|NCT00603239|18191013|P1|Overall Study|Subject decision|2
5272974|NCT00603239|18191012|P2|Overall Study|Protocol Violation|0
5272975|NCT00603239|18191013|P1|Overall Study|Protocol Violation|2
5272976|NCT00603239|18191012|P2|Overall Study|Physician Decision|0
5272977|NCT00603239|18191013|P1|Overall Study|Physician Decision|2
5272978|NCT00603239|18191012|P2|Overall Study|Lost to Follow-up|1
5272979|NCT00603239|18191013|P1|Overall Study|Lost to Follow-up|2
5272980|NCT00603239|18191012|P2|Overall Study|Loss of glucose control|0
5272981|NCT00603239|18191013|P1|Overall Study|Loss of glucose control|3
5272982|NCT00603239|18191012|P2|Overall Study|Entry criteria not met|1
5272983|NCT00603239|18191013|P1|Overall Study|Entry criteria not met|0
5272984|NCT00603239|18191012|P2|Overall Study|Adverse Event|1
5272985|NCT00603239|18191013|P1|Overall Study|Adverse Event|4
5272986|NCT00602979|18191074|P5|Overall Study|Failed Intubation|0
5272987|NCT00602979|18191075|P4|Overall Study|Failed Intubation|1
5272988|NCT00602979|18191076|P3|Overall Study|Failed Intubation|0
5272989|NCT00602979|18191077|P2|Overall Study|Failed Intubation|1
5272990|NCT00602979|18191078|P1|Overall Study|Failed Intubation|0
5272991|NCT00602979|18191074|P5|Overall Study|Lost to Follow-up|3
5272992|NCT00602979|18191075|P4|Overall Study|Lost to Follow-up|2
5272993|NCT00602979|18191076|P3|Overall Study|Lost to Follow-up|3
5272994|NCT00602979|18191077|P2|Overall Study|Lost to Follow-up|2
5272995|NCT00602979|18191078|P1|Overall Study|Lost to Follow-up|3
5272996|NCT00602927|18191128|P2|Period 3: 13 Days|MRI data quality|2
5272997|NCT00602927|18191129|P1|Period 3: 13 Days|MRI data quality|2
5272998|NCT00602927|18191128|P2|Period 3: 13 Days|Protocol Violation|1
5272999|NCT00602927|18191129|P1|Period 3: 13 Days|Protocol Violation|0
5273000|NCT00602927|18191128|P2|Period 2: 14 Days|Protocol Violation|2
5273001|NCT00602927|18191129|P1|Period 2: 14 Days|Protocol Violation|0
5273002|NCT00602927|18191128|P2|Period 1: 13 Days|Claustrophobia|1
5273003|NCT00602927|18191129|P1|Period 1: 13 Days|Claustrophobia|0
5273004|NCT00602927|18191128|P2|Period 1: 13 Days|Time|0
5273005|NCT00602927|18191129|P1|Period 1: 13 Days|Time|1
5273006|NCT00602927|18191128|P2|Period 1: 13 Days|MRI scanner technical issue|0
5273007|NCT00602927|18191129|P1|Period 1: 13 Days|MRI scanner technical issue|1
5273008|NCT00602927|18191128|P2|Period 1: 13 Days|Protocol Violation|4
5273009|NCT00602927|18191129|P1|Period 1: 13 Days|Protocol Violation|2
5273010|NCT00602797|18191146|P1|Overall Study|Adverse Event|1
5273011|NCT00602667|18191164|P3|Overall Study|Progressive disease prior to therapy|1
5273012|NCT00602667|18191165|P2|Overall Study|Progressive disease prior to therapy|0
5273013|NCT00602667|18191166|P1|Overall Study|Progressive disease prior to therapy|0
5273014|NCT00602667|18191164|P3|Overall Study|Progressive disease|45
5273015|NCT00602667|18191165|P2|Overall Study|Progressive disease|48
5273016|NCT00602667|18191166|P1|Overall Study|Progressive disease|13
5273017|NCT00602667|18191164|P3|Overall Study|Physician Decision|8
5273018|NCT00602667|18191165|P2|Overall Study|Physician Decision|3
5273019|NCT00602667|18191166|P1|Overall Study|Physician Decision|2
5273020|NCT00602667|18191164|P3|Overall Study|Second malignancy|0
5273021|NCT00602667|18191165|P2|Overall Study|Second malignancy|1
5273022|NCT00602667|18191166|P1|Overall Study|Second malignancy|0
5273023|NCT00602667|18191164|P3|Overall Study|Excessive toxicity|0
5273024|NCT00602667|18191165|P2|Overall Study|Excessive toxicity|1
5273025|NCT00602667|18191166|P1|Overall Study|Excessive toxicity|1
5273026|NCT00602667|18191164|P3|Overall Study|Family request|6
5273027|NCT00602667|18191165|P2|Overall Study|Family request|25
5273028|NCT00602667|18191166|P1|Overall Study|Family request|3
5273029|NCT00602667|18191164|P3|Overall Study|Death|1
5273030|NCT00602667|18191165|P2|Overall Study|Death|1
5273031|NCT00602667|18191166|P1|Overall Study|Death|0
5273032|NCT00602667|18191164|P3|Overall Study|Still on Therapy|2
5273033|NCT00602667|18191165|P2|Overall Study|Still on Therapy|2
5273034|NCT00602667|18191166|P1|Overall Study|Still on Therapy|0
5273035|NCT00602641|18191345|P2|Overall Study|Other|1
5273036|NCT00602641|18191346|P1|Overall Study|Other|3
5273037|NCT00602641|18191345|P2|Overall Study|Administrative Closure|1
5273038|NCT00602641|18191346|P1|Overall Study|Administrative Closure|1
5273039|NCT00602641|18191345|P2|Overall Study|Physician Decision|4
5273040|NCT00602641|18191346|P1|Overall Study|Physician Decision|5
5273041|NCT00602641|18191345|P2|Overall Study|Other Complicating Disease|2
5273042|NCT00602641|18191346|P1|Overall Study|Other Complicating Disease|5
5273043|NCT00602641|18191345|P2|Overall Study|Alternative therapy|2
5273044|NCT00602641|18191346|P1|Overall Study|Alternative therapy|5
5273045|NCT00602641|18191345|P2|Overall Study|Withdrawal by Subject|12
5273046|NCT00602641|18191346|P1|Overall Study|Withdrawal by Subject|15
5273047|NCT00602641|18191345|P2|Overall Study|Death|5
5273048|NCT00602641|18191346|P1|Overall Study|Death|6
5273049|NCT00602641|18191345|P2|Overall Study|Disease progression|55
5273050|NCT00602641|18191346|P1|Overall Study|Disease progression|38
5273051|NCT00602641|18191345|P2|Overall Study|Adverse Event|53
5273052|NCT00602641|18191346|P1|Overall Study|Adverse Event|62
5273053|NCT00602641|18191345|P2|Overall Study|Still on treatment at time of analysis|15
5273054|NCT00602641|18191346|P1|Overall Study|Still on treatment at time of analysis|8
5273055|NCT00602641|18191345|P2|Overall Study|Never started protocol therapy|2
5273056|NCT00602641|18191346|P1|Overall Study|Never started protocol therapy|6
5273057|NCT00602537|18191360|P2|Follow Up Study Comparison|Withdrawal by Subject|2
5273058|NCT00602537|18191361|P1|Follow Up Study Comparison|Withdrawal by Subject|2
5273059|NCT00602537|18191360|P2|Follow Up Study Comparison|Lost to Follow-up|1
5273060|NCT00602537|18191361|P1|Follow Up Study Comparison|Lost to Follow-up|8
5273061|NCT00602537|18191360|P2|Follow Up Study Comparison|Adverse Event|0
5273062|NCT00602537|18191361|P1|Follow Up Study Comparison|Adverse Event|1
5273063|NCT00602537|18191360|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
5273064|NCT00602537|18191361|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
5273065|NCT00602537|18191360|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
5273066|NCT00602537|18191361|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
5273067|NCT00602537|18191360|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
5273068|NCT00602537|18191361|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
5273069|NCT00602537|18191360|P2|12 Week Double Blind Comparison|Adverse Event|5
5273070|NCT00602537|18191361|P1|12 Week Double Blind Comparison|Adverse Event|2
5273071|NCT00602472|18191371|P2|Overall Study|Other incl. lack of efficacy|2
5273072|NCT00602472|18191372|P1|Overall Study|Other incl. lack of efficacy|4
5273073|NCT00602472|18191371|P2|Overall Study|Withdrawal by Subject|14
5273074|NCT00602472|18191372|P1|Overall Study|Withdrawal by Subject|8
5273075|NCT00602472|18191371|P2|Overall Study|Protocol Violation|19
5273076|NCT00602472|18191372|P1|Overall Study|Protocol Violation|4
5273077|NCT00602472|18191371|P2|Overall Study|Adverse Event|23
5273078|NCT00602472|18191372|P1|Overall Study|Adverse Event|5
5273079|NCT00602420|18191437|P2|Overall Study|Adverse Event|0
5273080|NCT00602420|18191438|P1|Overall Study|Adverse Event|1
5273081|NCT00602420|18191437|P2|Overall Study|Withdrawal by Subject|17
5273082|NCT00602420|18191438|P1|Overall Study|Withdrawal by Subject|18
5273083|NCT00602420|18191437|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
5273084|NCT00602420|18191438|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
5273085|NCT00602420|18191437|P2|Overall Study|Death|4
5273086|NCT00602420|18191438|P1|Overall Study|Death|1
5273087|NCT00601900|18191546|P2|Overall Study|Withdrawal by Subject|3
5273088|NCT00601900|18191547|P1|Overall Study|Withdrawal by Subject|0
5273089|NCT00601835|18191571|P2|Overall Study|Relocate|2
5273090|NCT00601835|18191572|P1|Overall Study|Relocate|12
5273091|NCT00601835|18191571|P2|Overall Study|Adverse Event|1
5273092|NCT00601835|18191572|P1|Overall Study|Adverse Event|1
5273093|NCT00601835|18191571|P2|Overall Study|Lost to Follow-up|5
5273094|NCT00601835|18191572|P1|Overall Study|Lost to Follow-up|37
5273095|NCT00601835|18191571|P2|Overall Study|Physician Decision|0
5273096|NCT00601835|18191572|P1|Overall Study|Physician Decision|1
5273097|NCT00601835|18191571|P2|Overall Study|Withdrawal by Subject|6
5273098|NCT00601835|18191572|P1|Overall Study|Withdrawal by Subject|9
5273099|NCT00601705|18191661|P1|Overall Study|Withdrawal by Subject|1
5273100|NCT00601640|18191673|P3|Overall Study|change in eligibility status|1
5273101|NCT00601640|18191674|P2|Overall Study|change in eligibility status|1
5273102|NCT00601640|18191675|P1|Overall Study|change in eligibility status|0
5273103|NCT00601640|18191673|P3|Overall Study|intercurrent illness|0
5273104|NCT00601640|18191674|P2|Overall Study|intercurrent illness|0
5273105|NCT00601640|18191675|P1|Overall Study|intercurrent illness|1
5273106|NCT00601640|18191673|P3|Overall Study|Adverse Event|2
5273107|NCT00601640|18191674|P2|Overall Study|Adverse Event|4
5273108|NCT00601640|18191675|P1|Overall Study|Adverse Event|0
5273109|NCT00601640|18191673|P3|Overall Study|Death|0
5273110|NCT00601640|18191674|P2|Overall Study|Death|0
5273111|NCT00601640|18191675|P1|Overall Study|Death|1
5273112|NCT00601640|18191673|P3|Overall Study|Withdrawal by Subject|7
5273113|NCT00601640|18191674|P2|Overall Study|Withdrawal by Subject|0
5273114|NCT00601640|18191675|P1|Overall Study|Withdrawal by Subject|3
5273115|NCT00601523|18191700|P2|Overall Study|Other|1
5273116|NCT00601523|18191701|P1|Overall Study|Other|9
5273117|NCT00601523|18191700|P2|Overall Study|Withdrawal by Subject|9
5273118|NCT00601523|18191701|P1|Overall Study|Withdrawal by Subject|18
5273119|NCT00601523|18191700|P2|Overall Study|Lost to Follow-up|1
5273120|NCT00601523|18191701|P1|Overall Study|Lost to Follow-up|0
5273121|NCT00601523|18191700|P2|Overall Study|Protocol Violation|1
5273122|NCT00601523|18191701|P1|Overall Study|Protocol Violation|5
5273123|NCT00601523|18191700|P2|Overall Study|Lack of Efficacy|0
5273124|NCT00601523|18191701|P1|Overall Study|Lack of Efficacy|3
5273125|NCT00601523|18191700|P2|Overall Study|Adverse Event|14
5273126|NCT00601523|18191701|P1|Overall Study|Adverse Event|42
5273127|NCT00601458|18191736|P3|Overall Study|Early Termination|1
5273128|NCT00601458|18191737|P2|Overall Study|Early Termination|1
5273129|NCT00601458|18191738|P1|Overall Study|Early Termination|0
5273130|NCT00601458|18191736|P3|Overall Study|Protocol Violation|1
5273131|NCT00601458|18191737|P2|Overall Study|Protocol Violation|2
5273132|NCT00601458|18191738|P1|Overall Study|Protocol Violation|3
5273133|NCT00601458|18191736|P3|Overall Study|Incomplete Data|0
5273134|NCT00601458|18191737|P2|Overall Study|Incomplete Data|2
5273135|NCT00601458|18191738|P1|Overall Study|Incomplete Data|0
5273136|NCT00601458|18191736|P3|Overall Study|Dosing Error|0
5273137|NCT00601458|18191737|P2|Overall Study|Dosing Error|0
5273138|NCT00601458|18191738|P1|Overall Study|Dosing Error|1
5273139|NCT00601419|18191749|P1|Overall Study|Missed Visits|1
5273140|NCT00601419|18191749|P1|Overall Study|Lost to Follow-up|3
5273141|NCT00601354|18191779|P2|Overall Study|Lost to Follow-up|5
5273142|NCT00601354|18191780|P1|Overall Study|Lost to Follow-up|4
5273143|NCT00601250|18191792|P2|Overall Study|Other incl. lack of efficacy|9
5273144|NCT00601250|18191793|P1|Overall Study|Other incl. lack of efficacy|2
5273145|NCT00601250|18191792|P2|Overall Study|Withdrawal by Subject|13
5273146|NCT00601250|18191793|P1|Overall Study|Withdrawal by Subject|4
5273147|NCT00601250|18191792|P2|Overall Study|Lost to Follow-up|6
5273148|NCT00601250|18191793|P1|Overall Study|Lost to Follow-up|2
5273149|NCT00601250|18191792|P2|Overall Study|Protocol Violation|2
5273150|NCT00601250|18191793|P1|Overall Study|Protocol Violation|3
5273151|NCT00601250|18191792|P2|Overall Study|Adverse Event|9
5273152|NCT00601250|18191793|P1|Overall Study|Adverse Event|3
5273153|NCT00601172|18191829|P2|Overall Study|Did not meet continuation criteria|20
5273154|NCT00601172|18191830|P1|Overall Study|Did not meet continuation criteria|19
5273155|NCT00601172|18191829|P2|Overall Study|Withdrawal by Subject|27
5273156|NCT00601172|18191830|P1|Overall Study|Withdrawal by Subject|35
5273157|NCT00601172|18191829|P2|Overall Study|Physician Decision|28
5273158|NCT00601172|18191830|P1|Overall Study|Physician Decision|27
5273159|NCT00601172|18191829|P2|Overall Study|Lost to Follow-up|3
5273160|NCT00601172|18191830|P1|Overall Study|Lost to Follow-up|4
5273161|NCT00601172|18191829|P2|Overall Study|Protocol Violation|5
5273162|NCT00601172|18191830|P1|Overall Study|Protocol Violation|2
5273163|NCT00601172|18191829|P2|Overall Study|Lack of Efficacy|12
5273164|NCT00601172|18191830|P1|Overall Study|Lack of Efficacy|11
5273165|NCT00601172|18191829|P2|Overall Study|Adverse Event|32
5273166|NCT00601172|18191830|P1|Overall Study|Adverse Event|43
5273167|NCT00601107|18191887|P4|Overall Study|Undefined|0
5273168|NCT00601107|18191888|P3|Overall Study|Undefined|1
5273169|NCT00601107|18191889|P2|Overall Study|Undefined|0
5273170|NCT00601107|18191890|P1|Overall Study|Undefined|1
5273171|NCT00601107|18191887|P4|Overall Study|Worsening of Psoriasis|4
5273172|NCT00601107|18191888|P3|Overall Study|Worsening of Psoriasis|1
5273173|NCT00601107|18191889|P2|Overall Study|Worsening of Psoriasis|1
5273174|NCT00601107|18191890|P1|Overall Study|Worsening of Psoriasis|4
5273175|NCT00601107|18191887|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
5273176|NCT00601107|18191888|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
5273177|NCT00601107|18191889|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
5273178|NCT00601107|18191890|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
5273179|NCT00601107|18191887|P4|Overall Study|Lost to Follow-up|3
5273180|NCT00601107|18191888|P3|Overall Study|Lost to Follow-up|0
5273181|NCT00601107|18191889|P2|Overall Study|Lost to Follow-up|3
5273182|NCT00601107|18191890|P1|Overall Study|Lost to Follow-up|3
5273183|NCT00601107|18191887|P4|Overall Study|Withdrawal by Subject|4
5273184|NCT00601107|18191888|P3|Overall Study|Withdrawal by Subject|7
5273185|NCT00601107|18191889|P2|Overall Study|Withdrawal by Subject|4
5273186|NCT00601107|18191890|P1|Overall Study|Withdrawal by Subject|5
5273187|NCT00601107|18191887|P4|Overall Study|Adverse Event|0
5273188|NCT00601107|18191888|P3|Overall Study|Adverse Event|3
5273189|NCT00601107|18191889|P2|Overall Study|Adverse Event|1
5273190|NCT00601107|18191890|P1|Overall Study|Adverse Event|0
5273191|NCT00600938|18191910|P4|Extension Study|Death|0
5273192|NCT00600938|18191911|P3|Extension Study|Death|0
5273193|NCT00600938|18191912|P2|Extension Study|Death|0
5273194|NCT00600938|18191913|P1|Extension Study|Death|1
5273195|NCT00600938|18191910|P4|Extension Study|Lost to Follow-up|0
5273196|NCT00600938|18191911|P3|Extension Study|Lost to Follow-up|2
5273197|NCT00600938|18191912|P2|Extension Study|Lost to Follow-up|1
5273198|NCT00600938|18191913|P1|Extension Study|Lost to Follow-up|1
5273199|NCT00600938|18191910|P4|Extension Study|Withdrawal by Subject|0
5273200|NCT00600938|18191911|P3|Extension Study|Withdrawal by Subject|3
5273201|NCT00600938|18191912|P2|Extension Study|Withdrawal by Subject|2
5273202|NCT00600938|18191913|P1|Extension Study|Withdrawal by Subject|2
5273203|NCT00600938|18191910|P4|Extension Study|Unsatisfactory therapeutic effect|0
5273204|NCT00600938|18191911|P3|Extension Study|Unsatisfactory therapeutic effect|1
5273205|NCT00600938|18191912|P2|Extension Study|Unsatisfactory therapeutic effect|1
5273206|NCT00600938|18191913|P1|Extension Study|Unsatisfactory therapeutic effect|4
5273207|NCT00600938|18191910|P4|Extension Study|Abnormal test procedure results|1
5273208|NCT00600938|18191911|P3|Extension Study|Abnormal test procedure results|1
5273209|NCT00600938|18191912|P2|Extension Study|Abnormal test procedure results|1
5273210|NCT00600938|18191913|P1|Extension Study|Abnormal test procedure results|0
5273211|NCT00600938|18191910|P4|Extension Study|Adverse Event|0
5273212|NCT00600938|18191911|P3|Extension Study|Adverse Event|2
5273213|NCT00600938|18191912|P2|Extension Study|Adverse Event|0
5273214|NCT00600938|18191913|P1|Extension Study|Adverse Event|1
5273215|NCT00600938|18191910|P4|Core Study|Protocol Violation|0
5273216|NCT00600938|18191911|P3|Core Study|Protocol Violation|0
5273217|NCT00600938|18191912|P2|Core Study|Protocol Violation|2
5273218|NCT00600938|18191913|P1|Core Study|Protocol Violation|1
5273219|NCT00600938|18191910|P4|Core Study|Death|0
5273220|NCT00600938|18191911|P3|Core Study|Death|0
5273221|NCT00600938|18191912|P2|Core Study|Death|1
5273222|NCT00600938|18191913|P1|Core Study|Death|1
5273223|NCT00600938|18191910|P4|Core Study|Lost to Follow-up|0
5273224|NCT00600938|18191911|P3|Core Study|Lost to Follow-up|0
5273225|NCT00600938|18191912|P2|Core Study|Lost to Follow-up|2
5273226|NCT00600938|18191913|P1|Core Study|Lost to Follow-up|3
5273227|NCT00600938|18191910|P4|Core Study|Patient withdrew consent|0
5273228|NCT00600938|18191911|P3|Core Study|Patient withdrew consent|0
5273229|NCT00600938|18191912|P2|Core Study|Patient withdrew consent|12
5273230|NCT00600938|18191913|P1|Core Study|Patient withdrew consent|7
5273231|NCT00600938|18191910|P4|Core Study|Unsatisfactory therapeutic effect|0
5273232|NCT00600938|18191911|P3|Core Study|Unsatisfactory therapeutic effect|0
5273233|NCT00600938|18191912|P2|Core Study|Unsatisfactory therapeutic effect|2
5273234|NCT00600938|18191913|P1|Core Study|Unsatisfactory therapeutic effect|1
5273235|NCT00600938|18191910|P4|Core Study|Abnormal test procedure result(s)|0
5273236|NCT00600938|18191911|P3|Core Study|Abnormal test procedure result(s)|0
5273237|NCT00600938|18191912|P2|Core Study|Abnormal test procedure result(s)|2
5273238|NCT00600938|18191913|P1|Core Study|Abnormal test procedure result(s)|3
5273239|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Death|0
5273240|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Death|1
5273241|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
5273242|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
5273243|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
5273244|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
5273245|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Administrative Problems|4
5273246|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Administrative Problems|4
5273247|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
5273248|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
5273249|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
5273250|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
5273251|NCT00600886|18191977|P2|Extension - After Crossover (CAS)|Adverse Event|1
5273252|NCT00600886|18191978|P1|Extension - After Crossover (CAS)|Adverse Event|19
5273253|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
5273254|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
5273255|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Death|1
5273256|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Death|1
5273257|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
5273258|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
5273259|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Adverse Event|1
5273260|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Adverse Event|4
5273261|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
5273262|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
5273263|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
5273264|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
5273265|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
5273266|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
5273267|NCT00600886|18191977|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
5273268|NCT00600886|18191978|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
5273269|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Death|1
5273270|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Death|0
5273271|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
5273272|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
5273273|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
5273274|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
5273275|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
5273276|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
5273277|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
5273278|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
5273279|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
5273280|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
5273281|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
5273282|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
5273283|NCT00600886|18191977|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
5273284|NCT00600886|18191978|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
5273285|NCT00600821|18192042|P2|Overall Study|Other|3
5273286|NCT00600821|18192043|P1|Overall Study|Other|2
5273287|NCT00600821|18192042|P2|Overall Study|Randomized but not treated|1
5273288|NCT00600821|18192043|P1|Overall Study|Randomized but not treated|0
5273289|NCT00600821|18192042|P2|Overall Study|Objective progression or relapse|1
5273290|NCT00600821|18192043|P1|Overall Study|Objective progression or relapse|0
5273291|NCT00600821|18192042|P2|Overall Study|Terminated by sponsor|6
5273292|NCT00600821|18192043|P1|Overall Study|Terminated by sponsor|8
5273293|NCT00600821|18192042|P2|Overall Study|Withdrawal by Subject|1
5273294|NCT00600821|18192043|P1|Overall Study|Withdrawal by Subject|1
5273295|NCT00600821|18192042|P2|Overall Study|Lost to Follow-up|2
5273296|NCT00600821|18192043|P1|Overall Study|Lost to Follow-up|2
5273297|NCT00600821|18192042|P2|Overall Study|Death|46
5273298|NCT00600821|18192043|P1|Overall Study|Death|45
5273299|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
5273300|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
5273301|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
5273302|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
5273303|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
5273304|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
5273305|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
5273306|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
5273307|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
5273308|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
5273309|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
5273310|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
5273311|NCT00600756|18192071|P2|Overall Study Analysis After 12 Months|Adverse Event|44
5273312|NCT00600756|18192072|P1|Overall Study Analysis After 12 Months|Adverse Event|53
5273313|NCT00600756|18192071|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
5273314|NCT00600756|18192072|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
5273315|NCT00600756|18192071|P2|Analysis After 6 Months|Lost to Follow-up|8
5273316|NCT00600756|18192072|P1|Analysis After 6 Months|Lost to Follow-up|10
5273317|NCT00600756|18192071|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
5273318|NCT00600756|18192072|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
5273319|NCT00600756|18192071|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
5273320|NCT00600756|18192072|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
5273321|NCT00600756|18192071|P2|Analysis After 6 Months|Incorrect Enrollment|21
5273322|NCT00600756|18192072|P1|Analysis After 6 Months|Incorrect Enrollment|12
5273323|NCT00600756|18192071|P2|Analysis After 6 Months|Withdrawal by Subject|30
5273324|NCT00600756|18192072|P1|Analysis After 6 Months|Withdrawal by Subject|38
5273325|NCT00600756|18192071|P2|Analysis After 6 Months|Adverse Event|33
5273326|NCT00600756|18192072|P1|Analysis After 6 Months|Adverse Event|43
5273327|NCT00600613|18192181|P1|Overall Study|Protocol Deviation|1
5273328|NCT00600353|18192187|P2|Overall Study|History of prepartive regimen|1
5273329|NCT00600353|18192188|P1|Overall Study|History of prepartive regimen|0
5273330|NCT00600353|18192187|P2|Overall Study|history of malignancy within 5 years|0
5273331|NCT00600353|18192188|P1|Overall Study|history of malignancy within 5 years|1
5273332|NCT00600171|18192251|P6|Overall Study|Lost to Follow-up|0
5273333|NCT00600171|18192252|P5|Overall Study|Lost to Follow-up|0
5273334|NCT00600171|18192253|P4|Overall Study|Lost to Follow-up|1
5273335|NCT00600171|18192254|P3|Overall Study|Lost to Follow-up|0
5273336|NCT00600171|18192255|P2|Overall Study|Lost to Follow-up|0
5273337|NCT00600171|18192256|P1|Overall Study|Lost to Follow-up|0
5273338|NCT00600171|18192251|P6|Overall Study|Physician Decision|2
5273339|NCT00600171|18192252|P5|Overall Study|Physician Decision|0
5273340|NCT00600171|18192253|P4|Overall Study|Physician Decision|1
5273341|NCT00600171|18192254|P3|Overall Study|Physician Decision|0
5273342|NCT00600171|18192255|P2|Overall Study|Physician Decision|1
5273343|NCT00600171|18192256|P1|Overall Study|Physician Decision|0
5273344|NCT00600171|18192251|P6|Overall Study|Withdrawal by Subject|1
5273345|NCT00600171|18192252|P5|Overall Study|Withdrawal by Subject|1
5273346|NCT00600171|18192253|P4|Overall Study|Withdrawal by Subject|1
5273347|NCT00600171|18192254|P3|Overall Study|Withdrawal by Subject|0
5273348|NCT00600171|18192255|P2|Overall Study|Withdrawal by Subject|0
5273349|NCT00600171|18192256|P1|Overall Study|Withdrawal by Subject|3
5273350|NCT00600171|18192251|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
5273351|NCT00600171|18192252|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
5273352|NCT00600171|18192253|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
5273353|NCT00600171|18192254|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
5273354|NCT00600171|18192255|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5273355|NCT00600171|18192256|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
5273356|NCT00600171|18192251|P6|Overall Study|Protocol Violation|0
5273357|NCT00600171|18192252|P5|Overall Study|Protocol Violation|0
5273358|NCT00600171|18192253|P4|Overall Study|Protocol Violation|1
5273359|NCT00600171|18192254|P3|Overall Study|Protocol Violation|0
5273360|NCT00600171|18192255|P2|Overall Study|Protocol Violation|2
5273361|NCT00600171|18192256|P1|Overall Study|Protocol Violation|1
5273362|NCT00600171|18192251|P6|Overall Study|Lack of Efficacy|0
5273363|NCT00600171|18192252|P5|Overall Study|Lack of Efficacy|4
5273364|NCT00600171|18192253|P4|Overall Study|Lack of Efficacy|5
5273365|NCT00600171|18192254|P3|Overall Study|Lack of Efficacy|3
5273366|NCT00600171|18192255|P2|Overall Study|Lack of Efficacy|12
5273367|NCT00600171|18192256|P1|Overall Study|Lack of Efficacy|9
5273368|NCT00600171|18192251|P6|Overall Study|Adverse Event|0
5273369|NCT00600171|18192252|P5|Overall Study|Adverse Event|1
5273370|NCT00600171|18192253|P4|Overall Study|Adverse Event|0
5273371|NCT00600171|18192254|P3|Overall Study|Adverse Event|0
5273372|NCT00600171|18192255|P2|Overall Study|Adverse Event|1
5273373|NCT00600171|18192256|P1|Overall Study|Adverse Event|0
5273374|NCT00600119|18192330|P6|Follow-up Period|Other|0
5273375|NCT00600119|18192331|P5|Follow-up Period|Other|0
5273376|NCT00600119|18192332|P4|Follow-up Period|Other|0
5273377|NCT00600119|18192333|P3|Follow-up Period|Other|0
5273378|NCT00600119|18192334|P2|Follow-up Period|Other|0
5273379|NCT00600119|18192335|P1|Follow-up Period|Other|1
5273380|NCT00600119|18192330|P6|Follow-up Period|Adverse Event|1
5273381|NCT00600119|18192331|P5|Follow-up Period|Adverse Event|0
5273382|NCT00600119|18192332|P4|Follow-up Period|Adverse Event|0
5273383|NCT00600119|18192333|P3|Follow-up Period|Adverse Event|0
5273384|NCT00600119|18192334|P2|Follow-up Period|Adverse Event|0
5273385|NCT00600119|18192335|P1|Follow-up Period|Adverse Event|0
5273386|NCT00600119|18192330|P6|Double-blind Treatment Period|Adverse Event|10
5273387|NCT00600119|18192331|P5|Double-blind Treatment Period|Adverse Event|2
5273388|NCT00600119|18192332|P4|Double-blind Treatment Period|Adverse Event|1
5273389|NCT00600119|18192333|P3|Double-blind Treatment Period|Adverse Event|0
5273390|NCT00600119|18192334|P2|Double-blind Treatment Period|Adverse Event|1
5273391|NCT00600119|18192335|P1|Double-blind Treatment Period|Adverse Event|1
5273392|NCT00600119|18192330|P6|Double-blind Treatment Period|Lost to Follow-up|0
5273393|NCT00600119|18192331|P5|Double-blind Treatment Period|Lost to Follow-up|0
5273394|NCT00600119|18192332|P4|Double-blind Treatment Period|Lost to Follow-up|0
5273395|NCT00600119|18192333|P3|Double-blind Treatment Period|Lost to Follow-up|0
5273396|NCT00600119|18192334|P2|Double-blind Treatment Period|Lost to Follow-up|1
5273397|NCT00600119|18192335|P1|Double-blind Treatment Period|Lost to Follow-up|0
5273398|NCT00600119|18192330|P6|Double-blind Treatment Period|Physician Decision|0
5273399|NCT00600119|18192331|P5|Double-blind Treatment Period|Physician Decision|0
5273400|NCT00600119|18192332|P4|Double-blind Treatment Period|Physician Decision|0
5273401|NCT00600119|18192333|P3|Double-blind Treatment Period|Physician Decision|0
5273402|NCT00600119|18192334|P2|Double-blind Treatment Period|Physician Decision|0
5273403|NCT00600119|18192335|P1|Double-blind Treatment Period|Physician Decision|2
5273404|NCT00600119|18192330|P6|Double-blind Treatment Period|Sponsor Decision|0
5273405|NCT00600119|18192331|P5|Double-blind Treatment Period|Sponsor Decision|1
5273406|NCT00600119|18192332|P4|Double-blind Treatment Period|Sponsor Decision|0
5273407|NCT00600119|18192333|P3|Double-blind Treatment Period|Sponsor Decision|0
5273408|NCT00600119|18192334|P2|Double-blind Treatment Period|Sponsor Decision|1
5273409|NCT00600119|18192335|P1|Double-blind Treatment Period|Sponsor Decision|0
5273410|NCT00600119|18192330|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5273576|NCT00598871|18192790|P1|Overall Study|Adverse Event|0
5273411|NCT00600119|18192331|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5273412|NCT00600119|18192332|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5273413|NCT00600119|18192333|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5273414|NCT00600119|18192334|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
5273415|NCT00600119|18192335|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5273416|NCT00600119|18192330|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5273417|NCT00600119|18192331|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
5273418|NCT00600119|18192332|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5273419|NCT00600119|18192333|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5273420|NCT00600119|18192334|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
5273421|NCT00600119|18192335|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5273422|NCT00600119|18192330|P6|Double-blind Treatment Period|Other|1
5273423|NCT00600119|18192331|P5|Double-blind Treatment Period|Other|2
5273424|NCT00600119|18192332|P4|Double-blind Treatment Period|Other|0
5273425|NCT00600119|18192333|P3|Double-blind Treatment Period|Other|0
5273426|NCT00600119|18192334|P2|Double-blind Treatment Period|Other|0
5273427|NCT00600119|18192335|P1|Double-blind Treatment Period|Other|0
5273428|NCT00600119|18192330|P6|Double-blind Treatment Period|Withdrawal by Subject|3
5273429|NCT00600119|18192331|P5|Double-blind Treatment Period|Withdrawal by Subject|0
5273430|NCT00600119|18192332|P4|Double-blind Treatment Period|Withdrawal by Subject|1
5273431|NCT00600119|18192333|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5273432|NCT00600119|18192334|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5273433|NCT00600119|18192335|P1|Double-blind Treatment Period|Withdrawal by Subject|2
5273434|NCT00600119|18192330|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5273435|NCT00600119|18192331|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5273436|NCT00600119|18192332|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5273437|NCT00600119|18192333|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5273438|NCT00600119|18192334|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
5273439|NCT00600119|18192335|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
5273440|NCT00600119|18192330|P6|Single-blind Placebo run-in Period|Adverse Event|1
5273441|NCT00600119|18192331|P5|Single-blind Placebo run-in Period|Adverse Event|0
5273442|NCT00600119|18192332|P4|Single-blind Placebo run-in Period|Adverse Event|1
5273443|NCT00600119|18192333|P3|Single-blind Placebo run-in Period|Adverse Event|0
5273444|NCT00600119|18192334|P2|Single-blind Placebo run-in Period|Adverse Event|0
5273445|NCT00600119|18192335|P1|Single-blind Placebo run-in Period|Adverse Event|0
5273446|NCT00600119|18192330|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
5273447|NCT00600119|18192331|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
5273448|NCT00600119|18192332|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
5273449|NCT00600119|18192333|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
5273450|NCT00600119|18192334|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
5273451|NCT00600119|18192335|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
5273452|NCT00600119|18192330|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
5273453|NCT00600119|18192331|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
5273454|NCT00600119|18192332|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
5273455|NCT00600119|18192333|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
5273456|NCT00600119|18192334|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
5273457|NCT00600119|18192335|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
5273458|NCT00600119|18192330|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5273459|NCT00600119|18192331|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5273460|NCT00600119|18192332|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5273461|NCT00600119|18192333|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
5273462|NCT00600119|18192334|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
5273463|NCT00600119|18192335|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5273464|NCT00600119|18192330|P6|Single-blind Placebo run-in Period|Other - Not specified|1
5273465|NCT00600119|18192331|P5|Single-blind Placebo run-in Period|Other - Not specified|1
5273466|NCT00600119|18192332|P4|Single-blind Placebo run-in Period|Other - Not specified|0
5273467|NCT00600119|18192333|P3|Single-blind Placebo run-in Period|Other - Not specified|0
5273468|NCT00600119|18192334|P2|Single-blind Placebo run-in Period|Other - Not specified|0
5273469|NCT00600119|18192335|P1|Single-blind Placebo run-in Period|Other - Not specified|1
5273470|NCT00600106|18192369|P2|Overall Study|Withdrawal by Subject|1
5273471|NCT00600106|18192370|P1|Overall Study|Withdrawal by Subject|1
5273472|NCT00600067|18192417|P2|Overall Study|Lack of Efficacy|0
5273473|NCT00600067|18192418|P1|Overall Study|Lack of Efficacy|1
5273474|NCT00600067|18192417|P2|Overall Study|protocol non-compliance|3
5273475|NCT00600067|18192418|P1|Overall Study|protocol non-compliance|0
5273476|NCT00600067|18192417|P2|Overall Study|Lost to Follow-up|3
5273477|NCT00600067|18192418|P1|Overall Study|Lost to Follow-up|2
5273478|NCT00600067|18192417|P2|Overall Study|Adverse Event|1
5273479|NCT00600067|18192418|P1|Overall Study|Adverse Event|0
5273480|NCT00600028|18192428|P2|Second Intervention (12 Weeks)|Adverse Event|2
5273481|NCT00600028|18192429|P1|Second Intervention (12 Weeks)|Adverse Event|0
5273482|NCT00600028|18192428|P2|First Intervention (12 Weeks)|Adverse Event|1
5273483|NCT00600028|18192429|P1|First Intervention (12 Weeks)|Adverse Event|0
5273484|NCT00600028|18192428|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
5273485|NCT00600028|18192429|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5273486|NCT00599924|18192459|P7|Overall Study|Other|2
5273487|NCT00599924|18192460|P6|Overall Study|Other|0
5273488|NCT00599924|18192461|P5|Overall Study|Other|2
5273489|NCT00599924|18192462|P4|Overall Study|Other|1
5273490|NCT00599924|18192463|P3|Overall Study|Other|0
5273491|NCT00599924|18192464|P2|Overall Study|Other|0
5273492|NCT00599924|18192465|P1|Overall Study|Other|0
5273493|NCT00599924|18192459|P7|Overall Study|Withdrawal by Subject|0
5273494|NCT00599924|18192460|P6|Overall Study|Withdrawal by Subject|0
5273495|NCT00599924|18192461|P5|Overall Study|Withdrawal by Subject|1
5273496|NCT00599924|18192462|P4|Overall Study|Withdrawal by Subject|0
5273497|NCT00599924|18192463|P3|Overall Study|Withdrawal by Subject|1
5273498|NCT00599924|18192464|P2|Overall Study|Withdrawal by Subject|0
5273499|NCT00599924|18192465|P1|Overall Study|Withdrawal by Subject|0
5273500|NCT00599924|18192459|P7|Overall Study|Protocol Violation|0
5273501|NCT00599924|18192460|P6|Overall Study|Protocol Violation|0
5273502|NCT00599924|18192461|P5|Overall Study|Protocol Violation|0
5273503|NCT00599924|18192462|P4|Overall Study|Protocol Violation|1
5273504|NCT00599924|18192463|P3|Overall Study|Protocol Violation|0
5273505|NCT00599924|18192464|P2|Overall Study|Protocol Violation|0
5273506|NCT00599924|18192465|P1|Overall Study|Protocol Violation|0
5273507|NCT00599924|18192459|P7|Overall Study|Death|1
5273508|NCT00599924|18192460|P6|Overall Study|Death|2
5273509|NCT00599924|18192461|P5|Overall Study|Death|0
5273510|NCT00599924|18192462|P4|Overall Study|Death|2
5273511|NCT00599924|18192463|P3|Overall Study|Death|0
5273512|NCT00599924|18192464|P2|Overall Study|Death|0
5273513|NCT00599924|18192465|P1|Overall Study|Death|0
5273514|NCT00599924|18192459|P7|Overall Study|Adverse Event|2
5273515|NCT00599924|18192460|P6|Overall Study|Adverse Event|0
5273516|NCT00599924|18192461|P5|Overall Study|Adverse Event|0
5273517|NCT00599924|18192462|P4|Overall Study|Adverse Event|2
5273518|NCT00599924|18192463|P3|Overall Study|Adverse Event|0
5273519|NCT00599924|18192464|P2|Overall Study|Adverse Event|0
5273520|NCT00599924|18192465|P1|Overall Study|Adverse Event|0
5273521|NCT00599924|18192459|P7|Overall Study|Lack of Efficacy|0
5273522|NCT00599924|18192460|P6|Overall Study|Lack of Efficacy|2
5273523|NCT00599924|18192461|P5|Overall Study|Lack of Efficacy|3
5273524|NCT00599924|18192462|P4|Overall Study|Lack of Efficacy|2
5273525|NCT00599924|18192463|P3|Overall Study|Lack of Efficacy|1
5273526|NCT00599924|18192464|P2|Overall Study|Lack of Efficacy|5
5273527|NCT00599924|18192465|P1|Overall Study|Lack of Efficacy|3
5273528|NCT00599755|18192569|P1|Overall Study|No data available|1
5273529|NCT00599755|18192569|P1|Overall Study|Other Reason|2
5273530|NCT00599755|18192569|P1|Overall Study|Progression of Disease|3
5273531|NCT00599755|18192569|P1|Overall Study|Withdrawal by Subject|2
5273532|NCT00599755|18192569|P1|Overall Study|Adverse Event|11
5273533|NCT00599521|18192580|P2|Overall Study|Pregnancy|2
5273534|NCT00599521|18192581|P1|Overall Study|Pregnancy|0
5273535|NCT00599521|18192580|P2|Overall Study|Lost to Follow-up|23
5273536|NCT00599521|18192581|P1|Overall Study|Lost to Follow-up|23
5273537|NCT00599521|18192580|P2|Overall Study|Protocol Violation|1
5273538|NCT00599521|18192581|P1|Overall Study|Protocol Violation|1
5273539|NCT00599521|18192580|P2|Overall Study|Withdrawal by Subject|34
5273540|NCT00599521|18192581|P1|Overall Study|Withdrawal by Subject|28
5273541|NCT00599521|18192580|P2|Overall Study|Adverse Event|1
5273542|NCT00599521|18192581|P1|Overall Study|Adverse Event|4
5273543|NCT00599521|18192580|P2|Overall Study|Lack of Efficacy|8
5273544|NCT00599521|18192581|P1|Overall Study|Lack of Efficacy|4
5273545|NCT00599339|18192595|P1|Overall Study|Study Termination Status Unknown|12
5273546|NCT00599339|18192595|P1|Overall Study|No valid data consent|36
5273547|NCT00599339|18192595|P1|Overall Study|Lost to Follow-up|221
5273548|NCT00599339|18192595|P1|Overall Study|Other Reason|179
5273549|NCT00599339|18192595|P1|Overall Study|Withdrawal by Subject|137
5273550|NCT00599339|18192595|P1|Overall Study|Adverse Event|79
5273551|NCT00599326|18192697|P1|Overall Study|Noncompliant|1
5273552|NCT00599326|18192697|P1|Overall Study|Lost to Follow-up|1
5273553|NCT00599313|18192702|P1|Overall Study|Ineligible|1
5273554|NCT00599313|18192702|P1|Overall Study|Patient Request|4
5273555|NCT00599313|18192702|P1|Overall Study|Disease Progression|12
5273556|NCT00599313|18192702|P1|Overall Study|Adverse Event|19
5273557|NCT00599196|18192744|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
5273558|NCT00599196|18192744|P1|Overall Study|Other: Patient Stopped Due To Moving|1
5273559|NCT00599196|18192744|P1|Overall Study|Other: Pt Moved To Australia|1
5273560|NCT00599196|18192744|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
5273561|NCT00599196|18192744|P1|Overall Study|Other: Spouse Withdrew Consent|1
5273562|NCT00599196|18192744|P1|Overall Study|Other: Patient Leaving For Israel|1
5273563|NCT00599196|18192744|P1|Overall Study|Lost to Follow-up|17
5273564|NCT00599196|18192744|P1|Overall Study|Study ended per sponsor|197
5273565|NCT00599196|18192744|P1|Overall Study|Subject withdrew consent|43
5273566|NCT00599196|18192744|P1|Overall Study|Unsatisfactory compliance of subject|3
5273567|NCT00599196|18192744|P1|Overall Study|Adverse Event|93
5273568|NCT00599196|18192744|P1|Overall Study|Lack of Efficacy|22
5273569|NCT00599027|18192775|P2|Overall Study|Treatment Failure|1
5273570|NCT00599027|18192776|P1|Overall Study|Treatment Failure|0
5273571|NCT00599027|18192775|P2|Overall Study|Adverse Event|1
5273572|NCT00599027|18192776|P1|Overall Study|Adverse Event|0
5273573|NCT00599027|18192775|P2|Overall Study|Withdrawal by Subject|1
5273574|NCT00599027|18192776|P1|Overall Study|Withdrawal by Subject|1
5273575|NCT00598871|18192789|P2|Overall Study|Adverse Event|1
5273577|NCT00598832|18192800|P2|Overall Study|Non compliance|0
5273578|NCT00598832|18192801|P1|Overall Study|Non compliance|1
5273579|NCT00598832|18192800|P2|Overall Study|Physician Decision|4
5273580|NCT00598832|18192801|P1|Overall Study|Physician Decision|1
5273581|NCT00598832|18192800|P2|Overall Study|Pregnancy|2
5273582|NCT00598832|18192801|P1|Overall Study|Pregnancy|2
5273583|NCT00598832|18192800|P2|Overall Study|Lost to Follow-up|29
5273584|NCT00598832|18192801|P1|Overall Study|Lost to Follow-up|24
5273585|NCT00598832|18192800|P2|Overall Study|Protocol Violation|2
5273586|NCT00598832|18192801|P1|Overall Study|Protocol Violation|0
5273587|NCT00598832|18192800|P2|Overall Study|Withdrawal by Subject|36
5273588|NCT00598832|18192801|P1|Overall Study|Withdrawal by Subject|25
5273589|NCT00598832|18192800|P2|Overall Study|Adverse Event|2
5273590|NCT00598832|18192801|P1|Overall Study|Adverse Event|6
5273591|NCT00598832|18192800|P2|Overall Study|Lack of Efficacy|7
5273592|NCT00598832|18192801|P1|Overall Study|Lack of Efficacy|3
5273593|NCT00598702|18192854|P8|Overall Study|Dose limiting toxicity|0
5273594|NCT00598702|18192855|P7|Overall Study|Dose limiting toxicity|0
5273595|NCT00598702|18192856|P6|Overall Study|Dose limiting toxicity|1
5273596|NCT00598702|18192857|P5|Overall Study|Dose limiting toxicity|1
5273597|NCT00598702|18192858|P4|Overall Study|Dose limiting toxicity|1
5273598|NCT00598702|18192859|P3|Overall Study|Dose limiting toxicity|0
5273599|NCT00598702|18192860|P2|Overall Study|Dose limiting toxicity|0
5273600|NCT00598702|18192861|P1|Overall Study|Dose limiting toxicity|0
5273601|NCT00598702|18192854|P8|Overall Study|Physician Decision|0
5273602|NCT00598702|18192855|P7|Overall Study|Physician Decision|0
5273603|NCT00598702|18192856|P6|Overall Study|Physician Decision|0
5273604|NCT00598702|18192857|P5|Overall Study|Physician Decision|1
5273605|NCT00598702|18192858|P4|Overall Study|Physician Decision|0
5273606|NCT00598702|18192859|P3|Overall Study|Physician Decision|0
5273607|NCT00598702|18192860|P2|Overall Study|Physician Decision|0
5273608|NCT00598702|18192861|P1|Overall Study|Physician Decision|0
5273609|NCT00598702|18192854|P8|Overall Study|Withdrawal by Subject|0
5273610|NCT00598702|18192855|P7|Overall Study|Withdrawal by Subject|0
5273611|NCT00598702|18192856|P6|Overall Study|Withdrawal by Subject|0
5273612|NCT00598702|18192857|P5|Overall Study|Withdrawal by Subject|1
5273613|NCT00598702|18192858|P4|Overall Study|Withdrawal by Subject|1
5273614|NCT00598702|18192859|P3|Overall Study|Withdrawal by Subject|0
5273615|NCT00598702|18192860|P2|Overall Study|Withdrawal by Subject|0
5273616|NCT00598702|18192861|P1|Overall Study|Withdrawal by Subject|0
5273617|NCT00598702|18192854|P8|Overall Study|Adverse Event|0
5273618|NCT00598702|18192855|P7|Overall Study|Adverse Event|0
5273619|NCT00598702|18192856|P6|Overall Study|Adverse Event|0
5273620|NCT00598702|18192857|P5|Overall Study|Adverse Event|0
5273621|NCT00598702|18192858|P4|Overall Study|Adverse Event|1
5273622|NCT00598702|18192859|P3|Overall Study|Adverse Event|0
5273623|NCT00598702|18192860|P2|Overall Study|Adverse Event|0
5273624|NCT00598702|18192861|P1|Overall Study|Adverse Event|0
5273625|NCT00598702|18192854|P8|Overall Study|Early discharge from hospital|0
5273626|NCT00598702|18192855|P7|Overall Study|Early discharge from hospital|1
5273627|NCT00598702|18192856|P6|Overall Study|Early discharge from hospital|10
5273628|NCT00598702|18192857|P5|Overall Study|Early discharge from hospital|0
5273629|NCT00598702|18192858|P4|Overall Study|Early discharge from hospital|5
5273630|NCT00598702|18192859|P3|Overall Study|Early discharge from hospital|2
5273631|NCT00598702|18192860|P2|Overall Study|Early discharge from hospital|0
5273632|NCT00598702|18192861|P1|Overall Study|Early discharge from hospital|0
5273633|NCT00598702|18192854|P8|Overall Study|Other|0
5273634|NCT00598702|18192855|P7|Overall Study|Other|0
5273635|NCT00598702|18192856|P6|Overall Study|Other|1
5273636|NCT00598702|18192857|P5|Overall Study|Other|0
5273637|NCT00598702|18192858|P4|Overall Study|Other|0
5273638|NCT00598702|18192859|P3|Overall Study|Other|0
5273639|NCT00598702|18192860|P2|Overall Study|Other|2
5273640|NCT00598702|18192861|P1|Overall Study|Other|0
5273641|NCT00598650|18192937|P1|Overall Study|Physician Decision|2
5273642|NCT00598650|18192937|P1|Overall Study|Prohibited Concomitant Medication|2
5273643|NCT00598650|18192937|P1|Overall Study|Not eligible|1
5273644|NCT00598650|18192937|P1|Overall Study|No treatment for 3 weeks|1
5273645|NCT00598650|18192937|P1|Overall Study|Adverse Event|18
5273646|NCT00598650|18192937|P1|Overall Study|Withdrawal by Subject|3
5273647|NCT00598585|18192946|P2|Overall Study|Lost to Follow-up|0
5273648|NCT00598585|18192947|P1|Overall Study|Lost to Follow-up|1
5273649|NCT00598559|18192956|P3|Overall Study|Subject unable/unwilling to attend visit|0
5273650|NCT00598559|18192957|P2|Overall Study|Subject unable/unwilling to attend visit|7
5273651|NCT00598559|18192958|P1|Overall Study|Subject unable/unwilling to attend visit|4
5273652|NCT00598559|18192956|P3|Overall Study|Early discharge from hospital|3
5273653|NCT00598559|18192957|P2|Overall Study|Early discharge from hospital|12
5273654|NCT00598559|18192958|P1|Overall Study|Early discharge from hospital|9
5273655|NCT00598559|18192956|P3|Overall Study|Protocol Non-compliance|0
5273656|NCT00598559|18192957|P2|Overall Study|Protocol Non-compliance|0
5273657|NCT00598559|18192958|P1|Overall Study|Protocol Non-compliance|1
5273658|NCT00598559|18192956|P3|Overall Study|Withdrawal by Subject|0
5273659|NCT00598559|18192957|P2|Overall Study|Withdrawal by Subject|2
5273660|NCT00598559|18192958|P1|Overall Study|Withdrawal by Subject|2
5273661|NCT00598559|18192956|P3|Overall Study|Adverse Event|0
5273662|NCT00598559|18192957|P2|Overall Study|Adverse Event|7
5273663|NCT00598559|18192958|P1|Overall Study|Adverse Event|11
5273664|NCT00598481|18192982|P1|Treatment|Physician Decision|1
5273665|NCT00598442|18192992|P3|Overall Study|Started dialysis|0
5273666|NCT00598442|18192993|P2|Overall Study|Started dialysis|0
5273667|NCT00598442|18192994|P1|Overall Study|Started dialysis|1
5273668|NCT00598442|18192992|P3|Overall Study|Site closed by sponsor|1
5273669|NCT00598442|18192993|P2|Overall Study|Site closed by sponsor|2
5273670|NCT00598442|18192994|P1|Overall Study|Site closed by sponsor|5
5273671|NCT00598442|18192992|P3|Overall Study|Renal transplant|1
5273672|NCT00598442|18192993|P2|Overall Study|Renal transplant|0
5273673|NCT00598442|18192994|P1|Overall Study|Renal transplant|0
5273674|NCT00598442|18192992|P3|Overall Study|Relocation|0
5273675|NCT00598442|18192993|P2|Overall Study|Relocation|4
5273676|NCT00598442|18192994|P1|Overall Study|Relocation|1
5273677|NCT00598442|18192992|P3|Overall Study|Noncompliance|1
5273678|NCT00598442|18192993|P2|Overall Study|Noncompliance|2
5273679|NCT00598442|18192994|P1|Overall Study|Noncompliance|0
5273680|NCT00598442|18192992|P3|Overall Study|Withdrawal by Subject|6
5273681|NCT00598442|18192993|P2|Overall Study|Withdrawal by Subject|16
5273682|NCT00598442|18192994|P1|Overall Study|Withdrawal by Subject|8
5273683|NCT00598442|18192992|P3|Overall Study|Physician Decision|1
5273684|NCT00598442|18192993|P2|Overall Study|Physician Decision|1
5273685|NCT00598442|18192994|P1|Overall Study|Physician Decision|2
5273686|NCT00598442|18192992|P3|Overall Study|Lost to Follow-up|3
5273687|NCT00598442|18192993|P2|Overall Study|Lost to Follow-up|3
5273688|NCT00598442|18192994|P1|Overall Study|Lost to Follow-up|4
5273689|NCT00598442|18192992|P3|Overall Study|Death|11
5273690|NCT00598442|18192993|P2|Overall Study|Death|11
5273691|NCT00598442|18192994|P1|Overall Study|Death|19
5273692|NCT00598442|18192992|P3|Overall Study|Adverse Event|0
5273693|NCT00598442|18192993|P2|Overall Study|Adverse Event|0
5273694|NCT00598442|18192994|P1|Overall Study|Adverse Event|3
5273695|NCT00598273|18193011|P3|Overall Study|Started dialysis|5
5273696|NCT00598273|18193012|P2|Overall Study|Started dialysis|4
5273697|NCT00598273|18193013|P1|Overall Study|Started dialysis|6
5273698|NCT00598273|18193011|P3|Overall Study|Site elected to close|0
5273699|NCT00598273|18193012|P2|Overall Study|Site elected to close|0
5273700|NCT00598273|18193013|P1|Overall Study|Site elected to close|1
5273701|NCT00598273|18193011|P3|Overall Study|Renal transplant|1
5273702|NCT00598273|18193012|P2|Overall Study|Renal transplant|0
5273703|NCT00598273|18193013|P1|Overall Study|Renal transplant|1
5273704|NCT00598273|18193011|P3|Overall Study|Relocation|4
5273705|NCT00598273|18193012|P2|Overall Study|Relocation|2
5273706|NCT00598273|18193013|P1|Overall Study|Relocation|0
5273707|NCT00598273|18193011|P3|Overall Study|Noncompliance|3
5273708|NCT00598273|18193012|P2|Overall Study|Noncompliance|2
5273709|NCT00598273|18193013|P1|Overall Study|Noncompliance|3
5273710|NCT00598273|18193011|P3|Overall Study|Withdrawal by Subject|10
5273711|NCT00598273|18193012|P2|Overall Study|Withdrawal by Subject|10
5273712|NCT00598273|18193013|P1|Overall Study|Withdrawal by Subject|12
5273713|NCT00598273|18193011|P3|Overall Study|Physician Decision|1
5273714|NCT00598273|18193012|P2|Overall Study|Physician Decision|0
5273715|NCT00598273|18193013|P1|Overall Study|Physician Decision|0
5273716|NCT00598273|18193011|P3|Overall Study|Lost to Follow-up|5
5273717|NCT00598273|18193012|P2|Overall Study|Lost to Follow-up|3
5273718|NCT00598273|18193013|P1|Overall Study|Lost to Follow-up|8
5273719|NCT00598273|18193011|P3|Overall Study|Death|8
5273720|NCT00598273|18193012|P2|Overall Study|Death|12
5273721|NCT00598273|18193013|P1|Overall Study|Death|6
5273722|NCT00598273|18193011|P3|Overall Study|Adverse Event|2
5273723|NCT00598273|18193012|P2|Overall Study|Adverse Event|5
5273724|NCT00598273|18193013|P1|Overall Study|Adverse Event|4
5273725|NCT00598078|18193027|P2|Period 2 (Day 2)|Adverse Event|0
5273726|NCT00598078|18193028|P1|Period 2 (Day 2)|Adverse Event|1
5273727|NCT00597766|18193171|P3|Follow-up 2, Week 8|Lost to Follow-up|1
5273728|NCT00597766|18193172|P2|Follow-up 2, Week 8|Lost to Follow-up|0
5273729|NCT00597766|18193173|P1|Follow-up 2, Week 8|Lost to Follow-up|0
5273730|NCT00597766|18193171|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
5273731|NCT00597766|18193172|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
5273732|NCT00597766|18193173|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
5273733|NCT00597753|18193192|P2|Overall Study|Site elected to close|4
5273734|NCT00597753|18193193|P1|Overall Study|Site elected to close|2
5273735|NCT00597753|18193192|P2|Overall Study|Site closed by sponsor|7
5273736|NCT00597753|18193193|P1|Overall Study|Site closed by sponsor|19
5273737|NCT00597753|18193192|P2|Overall Study|Renal transplant|3
5273738|NCT00597753|18193193|P1|Overall Study|Renal transplant|10
5273739|NCT00597753|18193192|P2|Overall Study|Relocation|6
5273740|NCT00597753|18193193|P1|Overall Study|Relocation|17
5273741|NCT00597753|18193192|P2|Overall Study|Noncompliance|1
5273742|NCT00597753|18193193|P1|Overall Study|Noncompliance|2
5273743|NCT00597753|18193192|P2|Overall Study|Never dosed|0
5273744|NCT00597753|18193193|P1|Overall Study|Never dosed|2
5273745|NCT00597753|18193192|P2|Overall Study|Discontinued Dialysis|1
5273746|NCT00597753|18193193|P1|Overall Study|Discontinued Dialysis|0
5273747|NCT00597753|18193192|P2|Overall Study|Withdrawal by Subject|12
5273748|NCT00597753|18193193|P1|Overall Study|Withdrawal by Subject|35
5273749|NCT00597753|18193192|P2|Overall Study|Pregnancy|0
5273750|NCT00597753|18193193|P1|Overall Study|Pregnancy|1
5273751|NCT00597753|18193192|P2|Overall Study|Physician Decision|1
5273752|NCT00597753|18193193|P1|Overall Study|Physician Decision|5
5273753|NCT00597753|18193192|P2|Overall Study|Lost to Follow-up|3
5273754|NCT00597753|18193193|P1|Overall Study|Lost to Follow-up|10
5273755|NCT00597753|18193192|P2|Overall Study|Lack of Efficacy|0
5273756|NCT00597753|18193193|P1|Overall Study|Lack of Efficacy|2
5273757|NCT00597753|18193192|P2|Overall Study|Death|29
5273758|NCT00597753|18193193|P1|Overall Study|Death|55
5273759|NCT00597753|18193192|P2|Overall Study|Adverse Event|2
5273760|NCT00597753|18193193|P1|Overall Study|Adverse Event|6
5273761|NCT00597714|18193227|P3|Overall Study|Recipient death|10
5273762|NCT00597714|18193228|P2|Overall Study|Recipient death|0
5273763|NCT00597714|18193229|P1|Overall Study|Recipient death|0
5273764|NCT00597714|18193227|P3|Overall Study|Death|0
5273765|NCT00597714|18193228|P2|Overall Study|Death|46
5273766|NCT00597714|18193229|P1|Overall Study|Death|56
5273767|NCT00597701|18193241|P2|Overall Study|Did not start intervention (pharmacy er)|2
5273768|NCT00597701|18193242|P1|Overall Study|Did not start intervention (pharmacy er)|0
5273769|NCT00597701|18193241|P2|Overall Study|Physician Decision|0
5273770|NCT00597701|18193242|P1|Overall Study|Physician Decision|2
5273771|NCT00597701|18193241|P2|Overall Study|Death|1
5273772|NCT00597701|18193242|P1|Overall Study|Death|0
5273773|NCT00597701|18193241|P2|Overall Study|Withdrawal by Subject|5
5273774|NCT00597701|18193242|P1|Overall Study|Withdrawal by Subject|5
5273775|NCT00597584|18193264|P2|Overall Study|Renal transplant|7
5273776|NCT00597584|18193265|P1|Overall Study|Renal transplant|9
5273777|NCT00597584|18193264|P2|Overall Study|Relocation|6
5273778|NCT00597584|18193265|P1|Overall Study|Relocation|8
5273779|NCT00597584|18193264|P2|Overall Study|Never dosed|0
5273780|NCT00597584|18193265|P1|Overall Study|Never dosed|1
5273781|NCT00597584|18193264|P2|Overall Study|Lost ability to consent|1
5273782|NCT00597584|18193265|P1|Overall Study|Lost ability to consent|1
5273783|NCT00597584|18193264|P2|Overall Study|Discontinued Dialysis|1
5273784|NCT00597584|18193265|P1|Overall Study|Discontinued Dialysis|0
5273785|NCT00597584|18193264|P2|Overall Study|Withdrawal by Subject|12
5273786|NCT00597584|18193265|P1|Overall Study|Withdrawal by Subject|44
5273787|NCT00597584|18193264|P2|Overall Study|Pregnancy|0
5273788|NCT00597584|18193265|P1|Overall Study|Pregnancy|2
5273789|NCT00597584|18193264|P2|Overall Study|Physician Decision|0
5273790|NCT00597584|18193265|P1|Overall Study|Physician Decision|3
5273791|NCT00597584|18193264|P2|Overall Study|Lost to Follow-up|4
5273792|NCT00597584|18193265|P1|Overall Study|Lost to Follow-up|2
5273793|NCT00597584|18193264|P2|Overall Study|Lack of Efficacy|0
5273794|NCT00597584|18193265|P1|Overall Study|Lack of Efficacy|1
5273795|NCT00597584|18193264|P2|Overall Study|Death|30
5273796|NCT00597584|18193265|P1|Overall Study|Death|53
5273797|NCT00597584|18193264|P2|Overall Study|Adverse Event|2
5273798|NCT00597584|18193265|P1|Overall Study|Adverse Event|4
5273799|NCT00597519|18193290|P1|Overall Study|Death|1
5273800|NCT00597506|18193294|P1|Overall Study|Subject is being followed for survival|1
5273801|NCT00597376|18193344|P2|Overall Study|Adverse Event|1
5273802|NCT00597376|18193345|P1|Overall Study|Adverse Event|4
5273803|NCT00597376|18193344|P2|Overall Study|Withdrawal by Subject|3
5273804|NCT00597376|18193345|P1|Overall Study|Withdrawal by Subject|4
5273805|NCT00597207|18193386|P2|Overall Study|Lost to Follow-up|7
5273806|NCT00597207|18193387|P1|Overall Study|Lost to Follow-up|5
5273807|NCT00597116|18193395|P2|Overall Study|Progressive disease|6
5273808|NCT00597116|18193396|P1|Overall Study|Progressive disease|11
5273809|NCT00597116|18193395|P2|Overall Study|Lost to Follow-up|0
5273810|NCT00597116|18193396|P1|Overall Study|Lost to Follow-up|1
5273811|NCT00597116|18193395|P2|Overall Study|Death|1
5273812|NCT00597116|18193396|P1|Overall Study|Death|0
5273813|NCT00597116|18193395|P2|Overall Study|Physician Decision|1
5273814|NCT00597116|18193396|P1|Overall Study|Physician Decision|0
5273815|NCT00597116|18193395|P2|Overall Study|Withdrawal by Subject|2
5273816|NCT00597116|18193396|P1|Overall Study|Withdrawal by Subject|0
5273817|NCT00597116|18193395|P2|Overall Study|Adverse Event|1
5273818|NCT00597116|18193396|P1|Overall Study|Adverse Event|2
5273819|NCT00597012|18193422|P2|Overall Study|Lost to Follow-up|2
5273820|NCT00597012|18193423|P1|Overall Study|Lost to Follow-up|0
5273821|NCT00597012|18193422|P2|Overall Study|Ineligible|0
5273822|NCT00597012|18193423|P1|Overall Study|Ineligible|2
5273823|NCT00597012|18193422|P2|Overall Study|Withdrawal by Subject|4
5273824|NCT00597012|18193423|P1|Overall Study|Withdrawal by Subject|7
5273825|NCT00597012|18193422|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
5273826|NCT00597012|18193423|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
5273827|NCT00597012|18193422|P2|Overall Study|Death|1
5273828|NCT00597012|18193423|P1|Overall Study|Death|1
5273829|NCT00596960|18193439|P2|Overall Study|No alcohol use data|1
5273830|NCT00596960|18193440|P1|Overall Study|No alcohol use data|0
5273831|NCT00596960|18193439|P2|Overall Study|Protocol Violation|1
5273832|NCT00596960|18193440|P1|Overall Study|Protocol Violation|0
5273833|NCT00596960|18193439|P2|Overall Study|Physician Decision|0
5273834|NCT00596960|18193440|P1|Overall Study|Physician Decision|1
5273835|NCT00596960|18193439|P2|Overall Study|Incarcerated|0
5273836|NCT00596960|18193440|P1|Overall Study|Incarcerated|2
5273837|NCT00596960|18193439|P2|Overall Study|Withdrawal by Subject|0
5273838|NCT00596960|18193440|P1|Overall Study|Withdrawal by Subject|1
5273839|NCT00596960|18193439|P2|Overall Study|Lost to Follow-up|5
5273840|NCT00596960|18193440|P1|Overall Study|Lost to Follow-up|6
5273841|NCT00596960|18193439|P2|Overall Study|Death|2
5273842|NCT00596960|18193440|P1|Overall Study|Death|1
5273843|NCT00596947|18193452|P2|Overall Study|Lost to Follow-up|0
5273844|NCT00596947|18193453|P1|Overall Study|Lost to Follow-up|1
5273845|NCT00596947|18193452|P2|Overall Study|study halted due to low enrollment|3
5273846|NCT00596947|18193453|P1|Overall Study|study halted due to low enrollment|5
5273847|NCT00596934|18193493|P1|Overall Study|Withdrawal by Subject|1
5273848|NCT00596934|18193493|P1|Overall Study|Protocol Violation|1
5273849|NCT00596830|18193506|P2|Overall Study|Randomized but not treated|7
5273850|NCT00596830|18193507|P1|Overall Study|Randomized but not treated|3
5273851|NCT00596830|18193506|P2|Overall Study|Follow-up was discontinued|0
5273852|NCT00596830|18193507|P1|Overall Study|Follow-up was discontinued|1
5273853|NCT00596830|18193506|P2|Overall Study|Study terminated by sponsor|62
5273854|NCT00596830|18193507|P1|Overall Study|Study terminated by sponsor|51
5273855|NCT00596830|18193506|P2|Overall Study|Withdrawal by Subject|12
5273856|NCT00596830|18193507|P1|Overall Study|Withdrawal by Subject|22
5273857|NCT00596830|18193506|P2|Overall Study|Lost to Follow-up|11
5273858|NCT00596830|18193507|P1|Overall Study|Lost to Follow-up|7
5273859|NCT00596830|18193506|P2|Overall Study|Death|247
5273860|NCT00596830|18193507|P1|Overall Study|Death|258
5273861|NCT00596817|18193533|P2|Double-blind Period|Other Reasons|18
5273862|NCT00596817|18193534|P1|Double-blind Period|Other Reasons|10
5273863|NCT00596817|18193533|P2|Double-blind Period|Lost to Follow-up|2
5273864|NCT00596817|18193534|P1|Double-blind Period|Lost to Follow-up|0
5273865|NCT00596817|18193533|P2|Double-blind Period|Withdrawal of Consent|3
5273866|NCT00596817|18193534|P1|Double-blind Period|Withdrawal of Consent|7
5273867|NCT00596817|18193533|P2|Double-blind Period|Protocol Violation|8
5273868|NCT00596817|18193534|P1|Double-blind Period|Protocol Violation|11
5273869|NCT00596817|18193533|P2|Double-blind Period|Non-compliance With Study Product|4
5273870|NCT00596817|18193534|P1|Double-blind Period|Non-compliance With Study Product|3
5273871|NCT00596817|18193533|P2|Double-blind Period|Lack of Efficacy|28
5273872|NCT00596817|18193534|P1|Double-blind Period|Lack of Efficacy|52
5273873|NCT00596817|18193533|P2|Double-blind Period|Adverse Event|16
5273874|NCT00596817|18193534|P1|Double-blind Period|Adverse Event|5
5273875|NCT00596817|18193533|P2|Open-label Period to Double-blind Period|Other Reasons|14
5273876|NCT00596817|18193534|P1|Open-label Period to Double-blind Period|Other Reasons|0
5273877|NCT00596817|18193533|P2|Open-label Period to Double-blind Period|Not Eligible|49
5273878|NCT00596817|18193534|P1|Open-label Period to Double-blind Period|Not Eligible|0
5273879|NCT00596817|18193533|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
5273880|NCT00596817|18193534|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
5273881|NCT00596817|18193533|P2|Open-label Period to Double-blind Period|Adverse Event|5
5273882|NCT00596817|18193534|P1|Open-label Period to Double-blind Period|Adverse Event|0
5273883|NCT00596817|18193533|P2|Open-label Period|Other Reasons|65
5273884|NCT00596817|18193534|P1|Open-label Period|Other Reasons|0
5273885|NCT00596817|18193533|P2|Open-label Period|Lack of Efficacy|33
5273886|NCT00596817|18193534|P1|Open-label Period|Lack of Efficacy|0
5273887|NCT00596817|18193533|P2|Open-label Period|Adverse Event|49
5273888|NCT00596817|18193534|P1|Open-label Period|Adverse Event|0
5273889|NCT00596752|18193559|P2|Overall Study|Protocol Violation|0
5273890|NCT00596752|18193560|P1|Overall Study|Protocol Violation|1
5273891|NCT00596752|18193559|P2|Overall Study|Lack of Efficacy|7
5273892|NCT00596752|18193560|P1|Overall Study|Lack of Efficacy|4
5273893|NCT00596752|18193559|P2|Overall Study|Unsatisfactory Compliance|6
5273894|NCT00596752|18193560|P1|Overall Study|Unsatisfactory Compliance|9
5273895|NCT00596752|18193559|P2|Overall Study|Withdrawal by Subject|9
5273896|NCT00596752|18193560|P1|Overall Study|Withdrawal by Subject|12
5273897|NCT00596752|18193559|P2|Overall Study|Lost to Follow-up|38
5273898|NCT00596752|18193560|P1|Overall Study|Lost to Follow-up|22
5273899|NCT00596752|18193559|P2|Overall Study|Adverse Event|34
5273900|NCT00596752|18193560|P1|Overall Study|Adverse Event|34
5273901|NCT00596752|18193559|P2|Overall Study|Other Reason|49
5273902|NCT00596752|18193560|P1|Overall Study|Other Reason|44
5273903|NCT00596687|18193590|P2|Overall Study|cancelled surgery|1
5273904|NCT00596687|18193591|P1|Overall Study|cancelled surgery|1
5273905|NCT00596687|18193590|P2|Overall Study|Withdrawal by Subject|1
5273906|NCT00596687|18193591|P1|Overall Study|Withdrawal by Subject|3
5273907|NCT00596687|18193590|P2|Overall Study|continuous insulin infusion during TPN|1
5273908|NCT00596687|18193591|P1|Overall Study|continuous insulin infusion during TPN|2
5273909|NCT00596687|18193590|P2|Overall Study|< 24 hours of insulin treatment|6
5273910|NCT00596687|18193591|P1|Overall Study|< 24 hours of insulin treatment|8
5273911|NCT00596635|18193602|P3|Overall Study|Could not provide urine specimen|2
5273912|NCT00596635|18193603|P2|Overall Study|Could not provide urine specimen|2
5273913|NCT00596635|18193604|P1|Overall Study|Could not provide urine specimen|1
5273914|NCT00596635|18193602|P3|Overall Study|Hip fracture|3
5273915|NCT00596635|18193603|P2|Overall Study|Hip fracture|3
5273916|NCT00596635|18193604|P1|Overall Study|Hip fracture|2
5273917|NCT00596635|18193602|P3|Overall Study|Treatment for symptomatic UTI|3
5273918|NCT00596635|18193603|P2|Overall Study|Treatment for symptomatic UTI|6
5273919|NCT00596635|18193604|P1|Overall Study|Treatment for symptomatic UTI|4
5273920|NCT00596635|18193602|P3|Overall Study|Lost to Follow-up|0
5273921|NCT00596635|18193603|P2|Overall Study|Lost to Follow-up|2
5273922|NCT00596635|18193604|P1|Overall Study|Lost to Follow-up|0
5273923|NCT00596466|18193630|P1|Overall Study|Enrolled, not treated|2
5273924|NCT00596466|18193630|P1|Overall Study|Unpecified|2
5273925|NCT00596466|18193630|P1|Overall Study|Protocol Violation|2
5273926|NCT00596466|18193630|P1|Overall Study|Withdrawal by Subject|2
5273927|NCT00596466|18193630|P1|Overall Study|Adverse Event|4
5273928|NCT00596466|18193630|P1|Overall Study|Lack of Efficacy|5
5273929|NCT00596427|18193660|P2|Overall Study|Protocol Violation|0
5273930|NCT00596427|18193661|P1|Overall Study|Protocol Violation|1
5273931|NCT00596427|18193660|P2|Overall Study|Increased Fasting Triacylglycerol level|0
5273932|NCT00596427|18193661|P1|Overall Study|Increased Fasting Triacylglycerol level|1
5273933|NCT00596427|18193660|P2|Overall Study|Withdrawal by Subject|2
5273934|NCT00596427|18193661|P1|Overall Study|Withdrawal by Subject|2
5273935|NCT00596362|18193689|P1|Overall Study|Progressive Disease|1
5273936|NCT00596011|18193725|P2|Overall Study|Adverse Event|7
5273937|NCT00596011|18193726|P1|Overall Study|Adverse Event|11
5273938|NCT00596011|18193725|P2|Overall Study|Withdrawal by Subject|3
5273939|NCT00596011|18193726|P1|Overall Study|Withdrawal by Subject|2
5273940|NCT00595959|18193742|P1|Overall Study|Lost to Follow-up|1
5273941|NCT00595959|18193742|P1|Overall Study|Withdrawal by Subject|1
5273942|NCT00595920|18193776|P1|Overall Study|The OLTERMS study was discontinued by th|116
5273943|NCT00595868|18193787|P2|Overall Study|Lost to Follow-up|50
5273944|NCT00595868|18193788|P1|Overall Study|Lost to Follow-up|45
5273945|NCT00595764|18193811|P2|Overall Study|Withdrawal by Subject|0
5273946|NCT00595764|18193812|P1|Overall Study|Withdrawal by Subject|4
5273947|NCT00595764|18193811|P2|Overall Study|Missed 3 PM visits|7
5273948|NCT00595764|18193812|P1|Overall Study|Missed 3 PM visits|1
5273949|NCT00595764|18193811|P2|Overall Study|Missed Medication >1 week|17
5273950|NCT00595764|18193812|P1|Overall Study|Missed Medication >1 week|10
5273951|NCT00595764|18193811|P2|Overall Study|Protocol Violation|19
5273952|NCT00595764|18193812|P1|Overall Study|Protocol Violation|24
5273953|NCT00595621|18193828|P2|Randomization and Study|Withdrawal by Subject|1
5273954|NCT00595621|18193829|P1|Randomization and Study|Withdrawal by Subject|0
5273955|NCT00595621|18193828|P2|Randomization and Study|Adverse Event|0
5273956|NCT00595621|18193829|P1|Randomization and Study|Adverse Event|2
5273957|NCT00595621|18193828|P2|Open Label Run in|Withdrawal by Subject|0
5273958|NCT00595621|18193829|P1|Open Label Run in|Withdrawal by Subject|1
5273959|NCT00595621|18193828|P2|Open Label Run in|Physician Decision|0
5273960|NCT00595621|18193829|P1|Open Label Run in|Physician Decision|1
5273961|NCT00595621|18193828|P2|Open Label Run in|Adverse Event|0
5273962|NCT00595621|18193829|P1|Open Label Run in|Adverse Event|1
5273963|NCT00595582|18193846|P1|Overall Study|Physician Decision|5
5273964|NCT00595582|18193846|P1|Overall Study|Adverse Event|2
5273965|NCT00595582|18193846|P1|Overall Study|Lost to Follow-up|1
5273966|NCT00595582|18193846|P1|Overall Study|Pilot study that PI terminated|2
5273967|NCT00595517|18193872|P1|Overall Study|No intention to attend regularly|1
5273968|NCT00595517|18193872|P1|Overall Study|usage of prohibited treatment|1
5273969|NCT00595517|18193872|P1|Overall Study|Recurrence of ulcer|5
5273970|NCT00595517|18193872|P1|Overall Study|Protocol Violation|2
5273971|NCT00595517|18193872|P1|Overall Study|Withdrawal by Subject|4
5273972|NCT00595517|18193872|P1|Overall Study|Adverse Event|6
5273973|NCT00595504|18193881|P2|Overall Study|Physician Decision|0
5273974|NCT00595504|18193882|P1|Overall Study|Physician Decision|1
5273975|NCT00595504|18193881|P2|Overall Study|Withdrawal by Subject|3
5273976|NCT00595504|18193882|P1|Overall Study|Withdrawal by Subject|1
5273977|NCT00595478|18193894|P2|36-week Follow-up Period|Withdrawal by Subject|4
5273978|NCT00595478|18193895|P1|36-week Follow-up Period|Withdrawal by Subject|4
5273979|NCT00595478|18193894|P2|36-week Follow-up Period|Lost to Follow-up|4
5273980|NCT00595478|18193895|P1|36-week Follow-up Period|Lost to Follow-up|5
5273981|NCT00595465|18193906|P3|Overall Study|administrative reason|1
5273982|NCT00595465|18193907|P2|Overall Study|administrative reason|0
5273983|NCT00595465|18193908|P1|Overall Study|administrative reason|0
5273984|NCT00595465|18193906|P3|Overall Study|Lost to Follow-up|2
5273985|NCT00595465|18193907|P2|Overall Study|Lost to Follow-up|0
5273986|NCT00595465|18193908|P1|Overall Study|Lost to Follow-up|0
5273987|NCT00595465|18193906|P3|Overall Study|Protocol Violation|0
5273988|NCT00595465|18193907|P2|Overall Study|Protocol Violation|1
5273989|NCT00595465|18193908|P1|Overall Study|Protocol Violation|2
5273990|NCT00595465|18193906|P3|Overall Study|Pregnancy|1
5273991|NCT00595465|18193907|P2|Overall Study|Pregnancy|0
5273992|NCT00595465|18193908|P1|Overall Study|Pregnancy|0
5273993|NCT00595465|18193906|P3|Overall Study|Adverse Event|3
5273994|NCT00595465|18193907|P2|Overall Study|Adverse Event|3
5273995|NCT00595465|18193908|P1|Overall Study|Adverse Event|4
5273996|NCT00595413|18193920|P4|Overall Study|Other|0
5273997|NCT00595413|18193921|P3|Overall Study|Other|5
5273998|NCT00595413|18193922|P2|Overall Study|Other|1
5273999|NCT00595413|18193923|P1|Overall Study|Other|5
5274000|NCT00595413|18193920|P4|Overall Study|Death|0
5274001|NCT00595413|18193921|P3|Overall Study|Death|1
5274002|NCT00595413|18193922|P2|Overall Study|Death|0
5274003|NCT00595413|18193923|P1|Overall Study|Death|0
5274004|NCT00595413|18193920|P4|Overall Study|Lost to Follow-up|3
5274005|NCT00595413|18193921|P3|Overall Study|Lost to Follow-up|1
5274006|NCT00595413|18193922|P2|Overall Study|Lost to Follow-up|2
5274007|NCT00595413|18193923|P1|Overall Study|Lost to Follow-up|2
5274008|NCT00595413|18193920|P4|Overall Study|Adverse Event|1
5274009|NCT00595413|18193921|P3|Overall Study|Adverse Event|1
5274010|NCT00595413|18193922|P2|Overall Study|Adverse Event|2
5274011|NCT00595413|18193923|P1|Overall Study|Adverse Event|0
5274012|NCT00595335|18193964|P2|Six Months to Twelve Months|Disease Progression|0
5274013|NCT00595335|18193965|P1|Six Months to Twelve Months|Disease Progression|1
5274014|NCT00595335|18193964|P2|Six Months to Twelve Months|Withdrawal by Subject|1
5274015|NCT00595335|18193965|P1|Six Months to Twelve Months|Withdrawal by Subject|0
5274016|NCT00595335|18193964|P2|Baseline to Six Months|Adverse Event|0
5274017|NCT00595335|18193965|P1|Baseline to Six Months|Adverse Event|1
5274018|NCT00595335|18193964|P2|Baseline to Six Months|Disease Progression|1
5274019|NCT00595335|18193965|P1|Baseline to Six Months|Disease Progression|1
5274020|NCT00595335|18193964|P2|Baseline to Six Months|Withdrawal by Subject|1
5274021|NCT00595335|18193965|P1|Baseline to Six Months|Withdrawal by Subject|0
5274022|NCT00595309|18193985|P1|Overall Study|personal reason|1
5274023|NCT00595309|18193985|P1|Overall Study|acute infection after V0|1
5274024|NCT00595309|18193985|P1|Overall Study|planned vaccination against yellow fever|1
5274025|NCT00595309|18193985|P1|Overall Study|Lost to Follow-up|1
5274026|NCT00595127|18194034|P1|Overall Study|joined another trial|1
5274027|NCT00595127|18194034|P1|Overall Study|Relapsed|3
5274028|NCT00595127|18194034|P1|Overall Study|Death|6
5274029|NCT00595075|18194080|P2|Overall Study|Withdrawal by Subject|0
5274030|NCT00595075|18194081|P1|Overall Study|Withdrawal by Subject|1
5274031|NCT00594958|18194102|P3|Overall Study|administrative|2
5274032|NCT00594958|18194103|P2|Overall Study|administrative|0
5274033|NCT00594958|18194104|P1|Overall Study|administrative|3
5274034|NCT00594958|18194102|P3|Overall Study|Lost to Follow-up|3
5274035|NCT00594958|18194103|P2|Overall Study|Lost to Follow-up|0
5274036|NCT00594958|18194104|P1|Overall Study|Lost to Follow-up|5
5274037|NCT00594958|18194102|P3|Overall Study|Protocol Violation|2
5274038|NCT00594958|18194103|P2|Overall Study|Protocol Violation|0
5274039|NCT00594958|18194104|P1|Overall Study|Protocol Violation|1
5274040|NCT00594958|18194102|P3|Overall Study|Pregnancy|0
5274041|NCT00594958|18194103|P2|Overall Study|Pregnancy|2
5274042|NCT00594958|18194104|P1|Overall Study|Pregnancy|0
5274043|NCT00594958|18194102|P3|Overall Study|Adverse Event|2
5274044|NCT00594958|18194103|P2|Overall Study|Adverse Event|1
5274045|NCT00594958|18194104|P1|Overall Study|Adverse Event|4
5274046|NCT00594958|18194102|P3|Overall Study|Withdrawal by Subject|1
5274047|NCT00594958|18194103|P2|Overall Study|Withdrawal by Subject|0
5274048|NCT00594958|18194104|P1|Overall Study|Withdrawal by Subject|1
5274049|NCT00594932|18194125|P2|Final 3 Months|Withdrawal by Subject|3
5274050|NCT00594932|18194126|P1|Final 3 Months|Withdrawal by Subject|4
5274051|NCT00594932|18194125|P2|First 3 Months|Withdrawal by Subject|3
5274052|NCT00594932|18194126|P1|First 3 Months|Withdrawal by Subject|1
5274053|NCT00594906|18194138|P2|Overall Study|Death|1
5274054|NCT00594906|18194139|P1|Overall Study|Death|0
5274055|NCT00594906|18194138|P2|Overall Study|Physician Decision|1
5274056|NCT00594906|18194139|P1|Overall Study|Physician Decision|0
5274057|NCT00594906|18194138|P2|Overall Study|Physician Decision|0
5274058|NCT00594906|18194139|P1|Overall Study|Physician Decision|1
5274059|NCT00594880|18194147|P2|Overall Study|Lost to Follow-up|0
5274060|NCT00594880|18194148|P1|Overall Study|Lost to Follow-up|1
5274061|NCT00594880|18194147|P2|Overall Study|Withdrawal by Subject|1
5274062|NCT00594880|18194148|P1|Overall Study|Withdrawal by Subject|1
5274063|NCT00594854|18194160|P2|Overall Study|Study terminated|10
5274064|NCT00594854|18194161|P1|Overall Study|Study terminated|7
5274065|NCT00594815|18194171|P1|Overall Study|Toxicity|4
5274066|NCT00594815|18194171|P1|Overall Study|Withdrawal by Subject|2
5274067|NCT00594815|18194171|P1|Overall Study|Never Treated|3
5274068|NCT00594659|18194196|P3|Overall Study|Lost to Follow-up|7
5274069|NCT00594659|18194197|P2|Overall Study|Lost to Follow-up|9
5274070|NCT00594659|18194198|P1|Overall Study|Lost to Follow-up|13
5274071|NCT00594646|18194209|P1|Overall Study|Lost to Follow-up|15
5274072|NCT00594646|18194209|P1|Overall Study|Withdrawal by Subject|1
5274073|NCT00594568|18194217|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
5274074|NCT00594568|18194218|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
5274075|NCT00594568|18194219|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
5274076|NCT00594568|18194217|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
5274077|NCT00594568|18194218|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
5274078|NCT00594568|18194219|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
5274079|NCT00594568|18194217|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
5274080|NCT00594568|18194218|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
5274081|NCT00594568|18194219|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
5274082|NCT00594568|18194217|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
5274083|NCT00594568|18194218|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
5274084|NCT00594568|18194219|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
5274085|NCT00594568|18194217|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
5274086|NCT00594568|18194218|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
5274087|NCT00594568|18194219|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
5274088|NCT00594568|18194217|P3|Safety Follow Up (SFU)-Optional|Death|0
5274089|NCT00594568|18194218|P2|Safety Follow Up (SFU)-Optional|Death|1
5274090|NCT00594568|18194219|P1|Safety Follow Up (SFU)-Optional|Death|0
5274091|NCT00594568|18194217|P3|Delayed Start|Sponsor Decision|59
5274092|NCT00594568|18194218|P2|Delayed Start|Sponsor Decision|66
5274093|NCT00594568|18194219|P1|Delayed Start|Sponsor Decision|77
5274094|NCT00594568|18194217|P3|Delayed Start|Caregiver Decision|2
5274095|NCT00594568|18194218|P2|Delayed Start|Caregiver Decision|6
5274096|NCT00594568|18194219|P1|Delayed Start|Caregiver Decision|5
5274097|NCT00594568|18194217|P3|Delayed Start|Lost to Follow-up|1
5274098|NCT00594568|18194218|P2|Delayed Start|Lost to Follow-up|0
5274099|NCT00594568|18194219|P1|Delayed Start|Lost to Follow-up|0
5274100|NCT00594568|18194217|P3|Delayed Start|Physician Decision|1
5274101|NCT00594568|18194218|P2|Delayed Start|Physician Decision|0
5274102|NCT00594568|18194219|P1|Delayed Start|Physician Decision|0
5274103|NCT00594568|18194217|P3|Delayed Start|Withdrawal by Subject|0
5274104|NCT00594568|18194218|P2|Delayed Start|Withdrawal by Subject|3
5274105|NCT00594568|18194219|P1|Delayed Start|Withdrawal by Subject|4
5274106|NCT00594568|18194217|P3|Delayed Start|Adverse Event|2
5274107|NCT00594568|18194218|P2|Delayed Start|Adverse Event|2
5274108|NCT00594568|18194219|P1|Delayed Start|Adverse Event|12
5274109|NCT00594568|18194217|P3|Delayed Start|Death|1
5274110|NCT00594568|18194218|P2|Delayed Start|Death|0
5274111|NCT00594568|18194219|P1|Delayed Start|Death|0
5274112|NCT00594568|18194217|P3|Initial Treatment|Entry criteria exclusion|1
5274113|NCT00594568|18194218|P2|Initial Treatment|Entry criteria exclusion|1
5274114|NCT00594568|18194219|P1|Initial Treatment|Entry criteria exclusion|0
5274115|NCT00594568|18194217|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
5274116|NCT00594568|18194218|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
5274117|NCT00594568|18194219|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
5274118|NCT00594568|18194217|P3|Initial Treatment|Caregiver decision|36
5274119|NCT00594568|18194218|P2|Initial Treatment|Caregiver decision|36
5274120|NCT00594568|18194219|P1|Initial Treatment|Caregiver decision|21
5274121|NCT00594568|18194217|P3|Initial Treatment|Sponsor decision|147
5274122|NCT00594568|18194218|P2|Initial Treatment|Sponsor decision|142
5274123|NCT00594568|18194219|P1|Initial Treatment|Sponsor decision|193
5274124|NCT00594568|18194217|P3|Initial Treatment|Withdrawal by Subject|46
5274125|NCT00594568|18194218|P2|Initial Treatment|Withdrawal by Subject|31
5274126|NCT00594568|18194219|P1|Initial Treatment|Withdrawal by Subject|25
5274127|NCT00594568|18194217|P3|Initial Treatment|Protocol Violation|5
5274128|NCT00594568|18194218|P2|Initial Treatment|Protocol Violation|2
5274129|NCT00594568|18194219|P1|Initial Treatment|Protocol Violation|2
5274130|NCT00594568|18194217|P3|Initial Treatment|Physician Decision|4
5274131|NCT00594568|18194218|P2|Initial Treatment|Physician Decision|2
5274132|NCT00594568|18194219|P1|Initial Treatment|Physician Decision|3
5274133|NCT00594568|18194217|P3|Initial Treatment|Lost to Follow-up|4
5274134|NCT00594568|18194218|P2|Initial Treatment|Lost to Follow-up|1
5274135|NCT00594568|18194219|P1|Initial Treatment|Lost to Follow-up|4
5274136|NCT00594568|18194217|P3|Initial Treatment|Death|15
5274137|NCT00594568|18194218|P2|Initial Treatment|Death|11
5274138|NCT00594568|18194219|P1|Initial Treatment|Death|6
5274139|NCT00594568|18194217|P3|Initial Treatment|Adverse Event|144
5274140|NCT00594568|18194218|P2|Initial Treatment|Adverse Event|121
5274141|NCT00594568|18194219|P1|Initial Treatment|Adverse Event|51
5274142|NCT00594516|18194307|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
5274143|NCT00594516|18194308|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
5274144|NCT00594516|18194309|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
5274145|NCT00594516|18194307|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
5274146|NCT00594516|18194308|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
5274147|NCT00594516|18194309|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
5274148|NCT00594516|18194307|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
5274149|NCT00594516|18194308|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
5274150|NCT00594516|18194309|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
5274151|NCT00594516|18194307|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
5274152|NCT00594516|18194308|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
5274153|NCT00594516|18194309|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
5274154|NCT00594516|18194307|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
5274155|NCT00594516|18194308|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
5274156|NCT00594516|18194309|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
5274157|NCT00594516|18194307|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
5274158|NCT00594516|18194308|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
5274159|NCT00594516|18194309|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
5274160|NCT00594516|18194307|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
5274161|NCT00594516|18194308|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
5274162|NCT00594516|18194309|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
5274163|NCT00594516|18194307|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
5274164|NCT00594516|18194308|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
5274165|NCT00594516|18194309|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
5274166|NCT00594516|18194307|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
5274167|NCT00594516|18194308|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
5274168|NCT00594516|18194309|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
5274169|NCT00594464|18194317|P1|Overall Study|Delay in operation|2
5274170|NCT00594464|18194317|P1|Overall Study|Withdrawal by Subject|1
5274171|NCT00594399|18194446|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
5274172|NCT00594399|18194447|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
5274173|NCT00594399|18194448|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
5274174|NCT00594399|18194446|P3|Rerandomization Arm 1 Only|Death|0
5274175|NCT00594399|18194447|P2|Rerandomization Arm 1 Only|Death|1
5274176|NCT00594399|18194448|P1|Rerandomization Arm 1 Only|Death|2
5274177|NCT00594399|18194446|P3|Initial 3 Month Counseling|Family illness|0
5274178|NCT00594399|18194447|P2|Initial 3 Month Counseling|Family illness|0
5274179|NCT00594399|18194448|P1|Initial 3 Month Counseling|Family illness|1
5274180|NCT00594399|18194446|P3|Initial 3 Month Counseling|Moved|0
5274181|NCT00594399|18194447|P2|Initial 3 Month Counseling|Moved|0
5274182|NCT00594399|18194448|P1|Initial 3 Month Counseling|Moved|1
5274183|NCT00594399|18194446|P3|Initial 3 Month Counseling|Pain|0
5274184|NCT00594399|18194447|P2|Initial 3 Month Counseling|Pain|0
5274185|NCT00594399|18194448|P1|Initial 3 Month Counseling|Pain|2
5274186|NCT00594399|18194446|P3|Initial 3 Month Counseling|Too busy|0
5274187|NCT00594399|18194447|P2|Initial 3 Month Counseling|Too busy|1
5274188|NCT00594399|18194448|P1|Initial 3 Month Counseling|Too busy|7
5274189|NCT00594399|18194446|P3|Initial 3 Month Counseling|Personal issues|0
5274190|NCT00594399|18194447|P2|Initial 3 Month Counseling|Personal issues|0
5274191|NCT00594399|18194448|P1|Initial 3 Month Counseling|Personal issues|2
5274192|NCT00594399|18194446|P3|Initial 3 Month Counseling|Lack of Interest|0
5274193|NCT00594399|18194447|P2|Initial 3 Month Counseling|Lack of Interest|3
5274194|NCT00594399|18194448|P1|Initial 3 Month Counseling|Lack of Interest|3
5274195|NCT00594399|18194446|P3|Initial 3 Month Counseling|Not ready to exercise|0
5274196|NCT00594399|18194447|P2|Initial 3 Month Counseling|Not ready to exercise|0
5274197|NCT00594399|18194448|P1|Initial 3 Month Counseling|Not ready to exercise|1
5274198|NCT00594386|18194470|P1|Overall Study|Other: Loss of drivers license|1
5274199|NCT00594386|18194470|P1|Overall Study|Other: Patient wants prescription Neupro|1
5274200|NCT00594386|18194470|P1|Overall Study|Other: Site terminated participation|1
5274201|NCT00594386|18194470|P1|Overall Study|Other: Sponsor closure of study|1
5274202|NCT00594386|18194470|P1|Overall Study|Other: Study terminated per investigator|2
5274203|NCT00594386|18194470|P1|Overall Study|Other: Subject admitted to nursing home|1
5274204|NCT00594386|18194470|P1|Overall Study|Other: Subject moved to Seattle|1
5274205|NCT00594386|18194470|P1|Overall Study|Other: Patient went off patch (hospital)|1
5274206|NCT00594386|18194470|P1|Overall Study|Lost to Follow-up|6
5274207|NCT00594386|18194470|P1|Overall Study|Study ended per sponsor|115
5274208|NCT00594386|18194470|P1|Overall Study|Subject withdrew consent|35
5274209|NCT00594386|18194470|P1|Overall Study|Unsatisfactory compliance of subject|11
5274210|NCT00594386|18194470|P1|Overall Study|Adverse Event|68
5274211|NCT00594386|18194470|P1|Overall Study|Lack of Efficacy|12
5274212|NCT00594386|18194470|P1|Overall Study|Major protocol violation|2
5274213|NCT00594204|18194503|P2|Overall Study|Randomized but not treated|1
5274214|NCT00594204|18194504|P1|Overall Study|Randomized but not treated|4
5274215|NCT00594204|18194503|P2|Overall Study|Lack of Efficacy|4
5274216|NCT00594204|18194504|P1|Overall Study|Lack of Efficacy|3
5274217|NCT00594204|18194503|P2|Overall Study|Other|3
5274218|NCT00594204|18194504|P1|Overall Study|Other|4
5274219|NCT00594204|18194503|P2|Overall Study|Withdrawal by Subject|29
5274220|NCT00594204|18194504|P1|Overall Study|Withdrawal by Subject|23
5274221|NCT00594204|18194503|P2|Overall Study|Lost to Follow-up|5
5274222|NCT00594204|18194504|P1|Overall Study|Lost to Follow-up|9
5274223|NCT00594204|18194503|P2|Overall Study|Adverse Event|3
5274224|NCT00594204|18194504|P1|Overall Study|Adverse Event|15
5274225|NCT00594178|18194514|P1|Overall Study|Physician Decision|5
5274226|NCT00594165|18194519|P1|Overall Study|Other: Site terminated participation|2
5274227|NCT00594165|18194519|P1|Overall Study|Other: Subject enrolled in other trial|1
5274228|NCT00594165|18194519|P1|Overall Study|Other: House bound; can't get to clinic|1
5274229|NCT00594165|18194519|P1|Overall Study|Other: Brain surgery controlled symptoms|1
5274230|NCT00594165|18194519|P1|Overall Study|Other: Subject moving|3
5274231|NCT00594165|18194519|P1|Overall Study|Other: PI discretion|5
5274232|NCT00594165|18194519|P1|Overall Study|Lost to Follow-up|4
5274233|NCT00594165|18194519|P1|Overall Study|Study ended per sponsor|102
5274234|NCT00594165|18194519|P1|Overall Study|Subject withdrew consent|27
5274235|NCT00594165|18194519|P1|Overall Study|Unsatisfactory compliance of subject|6
5274236|NCT00594165|18194519|P1|Overall Study|Adverse Event|52
5274237|NCT00594165|18194519|P1|Overall Study|Lack of Efficacy|12
5274238|NCT00594165|18194519|P1|Overall Study|Major protocol violation|1
5274239|NCT00594100|18194525|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
5274240|NCT00594100|18194525|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
5274241|NCT00594100|18194525|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
5274242|NCT00594100|18194525|P1|Procedure|Technical Failure|9
5274243|NCT00594035|18194541|P2|Overall Study|Subject couldn't return due to job|1
5274244|NCT00594035|18194542|P1|Overall Study|Subject couldn't return due to job|0
5274245|NCT00594035|18194541|P2|Overall Study|Subject transferred to nursing home|1
5274246|NCT00594035|18194542|P1|Overall Study|Subject transferred to nursing home|0
5274247|NCT00594035|18194541|P2|Overall Study|Withdrawal by Subject|0
5274248|NCT00594035|18194542|P1|Overall Study|Withdrawal by Subject|1
5274249|NCT00594035|18194541|P2|Overall Study|Lost to Follow-up|1
5274250|NCT00594035|18194542|P1|Overall Study|Lost to Follow-up|1
5274251|NCT00593957|18194572|P3|Overall Study|Physician Decision|2
5274252|NCT00593957|18194573|P2|Overall Study|Physician Decision|1
5274253|NCT00593957|18194574|P1|Overall Study|Physician Decision|0
5274254|NCT00593918|18194598|P2|Overall Study|Withdrawal by Subject|24
5274255|NCT00593918|18194599|P1|Overall Study|Withdrawal by Subject|5
5274256|NCT00593840|18194612|P1|Overall Study|Withdrawal by Subject|1
5274257|NCT00593827|18194624|P2|Overall Study|On Active Treatment/Pending|2
5274258|NCT00593827|18194625|P1|Overall Study|On Active Treatment/Pending|0
5274259|NCT00593814|18194649|P2|Overall Study|Physician Decision|0
5274260|NCT00593814|18194650|P1|Overall Study|Physician Decision|3
5274261|NCT00593814|18194649|P2|Overall Study|Lost to Follow-up|0
5274262|NCT00593814|18194650|P1|Overall Study|Lost to Follow-up|7
5274263|NCT00593814|18194649|P2|Overall Study|Withdrawal by Subject|0
5274264|NCT00593814|18194650|P1|Overall Study|Withdrawal by Subject|7
5274265|NCT00593814|18194649|P2|Overall Study|Death|0
5274266|NCT00593814|18194650|P1|Overall Study|Death|7
5274267|NCT00593736|18194662|P4|Treatment Period and Placebo Run-out|Various|0
5274268|NCT00593736|18194663|P3|Treatment Period and Placebo Run-out|Various|1
5274269|NCT00593736|18194664|P2|Treatment Period and Placebo Run-out|Various|1
5274270|NCT00593736|18194665|P1|Treatment Period and Placebo Run-out|Various|1
5274271|NCT00593736|18194662|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
5274272|NCT00593736|18194663|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
5274273|NCT00593736|18194664|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
5274274|NCT00593736|18194665|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
5274275|NCT00593736|18194662|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
5274276|NCT00593736|18194663|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
5274277|NCT00593736|18194664|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
5274278|NCT00593736|18194665|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
5274279|NCT00593736|18194662|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
5274280|NCT00593736|18194663|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
5274281|NCT00593736|18194664|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
5274282|NCT00593736|18194665|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
5274283|NCT00593736|18194662|P4|Screening Period and Placebo Run-in|Various|25
5274284|NCT00593736|18194663|P3|Screening Period and Placebo Run-in|Various|0
5274285|NCT00593736|18194664|P2|Screening Period and Placebo Run-in|Various|0
5274286|NCT00593736|18194665|P1|Screening Period and Placebo Run-in|Various|0
5274287|NCT00593736|18194662|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
5274288|NCT00593736|18194663|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
5274289|NCT00593736|18194664|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
5274290|NCT00593736|18194665|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
5274291|NCT00593736|18194662|P4|Screening Period and Placebo Run-in|Study Termination|15
5274292|NCT00593736|18194663|P3|Screening Period and Placebo Run-in|Study Termination|0
5274293|NCT00593736|18194664|P2|Screening Period and Placebo Run-in|Study Termination|0
5274294|NCT00593736|18194665|P1|Screening Period and Placebo Run-in|Study Termination|0
5274295|NCT00593736|18194662|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
5274296|NCT00593736|18194663|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
5274297|NCT00593736|18194664|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
5274298|NCT00593736|18194665|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
5274299|NCT00593736|18194662|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
5274300|NCT00593736|18194663|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
5274301|NCT00593736|18194664|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
5274302|NCT00593736|18194665|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
5274303|NCT00593736|18194662|P4|Screening Period and Placebo Run-in|Adverse Event|3
5274304|NCT00593736|18194663|P3|Screening Period and Placebo Run-in|Adverse Event|0
5274305|NCT00593736|18194664|P2|Screening Period and Placebo Run-in|Adverse Event|0
5274306|NCT00593736|18194665|P1|Screening Period and Placebo Run-in|Adverse Event|0
5274307|NCT00593684|18194913|P2|Overall Study|Death|1
5274308|NCT00593684|18194914|P1|Overall Study|Death|2
5274309|NCT00593606|18194940|P1|Overall Study|Screen Failure|3
5274310|NCT00593606|18194940|P1|Overall Study|Run-In Failure|5
5274311|NCT00593606|18194940|P1|Overall Study|Lost to Follow-up|2
5274312|NCT00593606|18194940|P1|Overall Study|Protocol Violation|3
5274313|NCT00593606|18194940|P1|Overall Study|Withdrawal by Subject|1
5274314|NCT00593606|18194940|P1|Overall Study|Adverse Event|13
5274315|NCT00593554|18195038|P2|Overall Study|Disease Progression|2
5274316|NCT00593554|18195039|P1|Overall Study|Disease Progression|1
5274317|NCT00593554|18195038|P2|Overall Study|Withdrawal by Subject|0
5274318|NCT00593554|18195039|P1|Overall Study|Withdrawal by Subject|1
5274319|NCT00593554|18195038|P2|Overall Study|Physician Decision|1
5274320|NCT00593554|18195039|P1|Overall Study|Physician Decision|0
5274321|NCT00593554|18195038|P2|Overall Study|Death|2
5274322|NCT00593554|18195039|P1|Overall Study|Death|1
5274323|NCT00593385|18195134|P1|Overall Study|Withdrawal by Subject|9
5274324|NCT00593385|18195134|P1|Overall Study|Lost to Follow-up|17
5274325|NCT00593385|18195134|P1|Overall Study|Death|14
5274326|NCT00593333|18195195|P2|Overall Study|Lost to Follow-up|11
5274327|NCT00593333|18195196|P1|Overall Study|Lost to Follow-up|10
5274328|NCT00593112|18195219|P2|Overall Study|Withdrawal by Subject|0
5274329|NCT00593112|18195220|P1|Overall Study|Withdrawal by Subject|5
5274330|NCT00593112|18195219|P2|Overall Study|Unreadable Scan|0
5274331|NCT00593112|18195220|P1|Overall Study|Unreadable Scan|1
5274332|NCT00593112|18195219|P2|Overall Study|Abnormal Scan|0
5274333|NCT00593112|18195220|P1|Overall Study|Abnormal Scan|1
5274334|NCT00593112|18195219|P2|Overall Study|Scan Anxiety|0
5274335|NCT00593112|18195220|P1|Overall Study|Scan Anxiety|3
5274336|NCT00592904|18195247|P4|Overall Study|Other|0
5274337|NCT00592904|18195248|P3|Overall Study|Other|0
5274338|NCT00592904|18195249|P2|Overall Study|Other|3
5274339|NCT00592904|18195250|P1|Overall Study|Other|3
5274340|NCT00592904|18195247|P4|Overall Study|Physician Decision|0
5274341|NCT00592904|18195248|P3|Overall Study|Physician Decision|1
5274342|NCT00592904|18195249|P2|Overall Study|Physician Decision|3
5274343|NCT00592904|18195250|P1|Overall Study|Physician Decision|0
5274344|NCT00592904|18195247|P4|Overall Study|Lack of Efficacy|3
5274345|NCT00592904|18195248|P3|Overall Study|Lack of Efficacy|2
5274346|NCT00592904|18195249|P2|Overall Study|Lack of Efficacy|7
5274347|NCT00592904|18195250|P1|Overall Study|Lack of Efficacy|2
5274348|NCT00592904|18195247|P4|Overall Study|Withdrawal by Subject|2
5274349|NCT00592904|18195248|P3|Overall Study|Withdrawal by Subject|1
5274350|NCT00592904|18195249|P2|Overall Study|Withdrawal by Subject|16
5274351|NCT00592904|18195250|P1|Overall Study|Withdrawal by Subject|4
5274352|NCT00592904|18195247|P4|Overall Study|Protocol Violation|1
5274353|NCT00592904|18195248|P3|Overall Study|Protocol Violation|0
5274354|NCT00592904|18195249|P2|Overall Study|Protocol Violation|1
5274355|NCT00592904|18195250|P1|Overall Study|Protocol Violation|1
5274356|NCT00592904|18195247|P4|Overall Study|Adverse Event|5
5274357|NCT00592904|18195248|P3|Overall Study|Adverse Event|13
5274358|NCT00592904|18195249|P2|Overall Study|Adverse Event|25
5274359|NCT00592904|18195250|P1|Overall Study|Adverse Event|15
5274360|NCT00592852|18195276|P1|Overall Study|Withdrawal by Subject|1
5274361|NCT00592852|18195276|P1|Overall Study|Found ineligible|1
5274362|NCT00592852|18195276|P1|Overall Study|Adverse Event|3
5274363|NCT00592852|18195276|P1|Overall Study|Non-compliance|1
5274364|NCT00592839|18195284|P3|Overall Study|Lost to Follow-up|1
5274365|NCT00592839|18195285|P2|Overall Study|Lost to Follow-up|1
5274366|NCT00592839|18195286|P1|Overall Study|Lost to Follow-up|0
5274367|NCT00592839|18195284|P3|Overall Study|Adverse Event|0
5274368|NCT00592839|18195285|P2|Overall Study|Adverse Event|1
5274369|NCT00592839|18195286|P1|Overall Study|Adverse Event|0
5274370|NCT00592839|18195284|P3|Overall Study|Protocol Violation|2
5274371|NCT00592839|18195285|P2|Overall Study|Protocol Violation|1
5274372|NCT00592839|18195286|P1|Overall Study|Protocol Violation|1
5274373|NCT00592839|18195284|P3|Overall Study|Withdrawal by Subject|3
5274374|NCT00592839|18195285|P2|Overall Study|Withdrawal by Subject|1
5274375|NCT00592839|18195286|P1|Overall Study|Withdrawal by Subject|1
5274376|NCT00592774|18195314|P5|Overall Study|Other|2
5274377|NCT00592774|18195315|P4|Overall Study|Other|0
5274378|NCT00592774|18195316|P3|Overall Study|Other|1
5274379|NCT00592774|18195317|P2|Overall Study|Other|1
5274380|NCT00592774|18195318|P1|Overall Study|Other|0
5274381|NCT00592774|18195314|P5|Overall Study|Physician Decision|1
5274382|NCT00592774|18195315|P4|Overall Study|Physician Decision|0
5274383|NCT00592774|18195316|P3|Overall Study|Physician Decision|1
5274384|NCT00592774|18195317|P2|Overall Study|Physician Decision|1
5274385|NCT00592774|18195318|P1|Overall Study|Physician Decision|0
5274386|NCT00592774|18195314|P5|Overall Study|Lack of Efficacy|2
5274387|NCT00592774|18195315|P4|Overall Study|Lack of Efficacy|0
5274388|NCT00592774|18195316|P3|Overall Study|Lack of Efficacy|0
5274389|NCT00592774|18195317|P2|Overall Study|Lack of Efficacy|3
5274390|NCT00592774|18195318|P1|Overall Study|Lack of Efficacy|3
5274391|NCT00592774|18195314|P5|Overall Study|Withdrawal by Subject|0
5274392|NCT00592774|18195315|P4|Overall Study|Withdrawal by Subject|0
5274393|NCT00592774|18195316|P3|Overall Study|Withdrawal by Subject|0
5274394|NCT00592774|18195317|P2|Overall Study|Withdrawal by Subject|7
5274395|NCT00592774|18195318|P1|Overall Study|Withdrawal by Subject|3
5274396|NCT00592774|18195314|P5|Overall Study|Protocol Violation|1
5274397|NCT00592774|18195315|P4|Overall Study|Protocol Violation|0
5274398|NCT00592774|18195316|P3|Overall Study|Protocol Violation|0
5274399|NCT00592774|18195317|P2|Overall Study|Protocol Violation|1
5274400|NCT00592774|18195318|P1|Overall Study|Protocol Violation|0
5274401|NCT00592774|18195314|P5|Overall Study|Adverse Event|8
5274402|NCT00592774|18195315|P4|Overall Study|Adverse Event|14
5274403|NCT00592774|18195316|P3|Overall Study|Adverse Event|2
5274404|NCT00592774|18195317|P2|Overall Study|Adverse Event|19
5274405|NCT00592774|18195318|P1|Overall Study|Adverse Event|5
5274406|NCT00592683|18195390|P2|Overall Study|Lost to Follow-up|1
5274407|NCT00592683|18195391|P1|Overall Study|Lost to Follow-up|0
5274408|NCT00592683|18195390|P2|Overall Study|Other|0
5274409|NCT00592683|18195391|P1|Overall Study|Other|1
5274410|NCT00592683|18195390|P2|Overall Study|Study drug expired|0
5274411|NCT00592683|18195391|P1|Overall Study|Study drug expired|1
5274412|NCT00592683|18195390|P2|Overall Study|Protocol Violation|0
5274413|NCT00592683|18195391|P1|Overall Study|Protocol Violation|1
5274414|NCT00592683|18195390|P2|Overall Study|Adverse Event|2
5274415|NCT00592683|18195391|P1|Overall Study|Adverse Event|0
5274416|NCT00592683|18195390|P2|Overall Study|Withdrawal by Subject|0
5274417|NCT00592683|18195391|P1|Overall Study|Withdrawal by Subject|1
5274418|NCT00592683|18195390|P2|Overall Study|Found ineligible|1
5274419|NCT00592683|18195391|P1|Overall Study|Found ineligible|0
5274420|NCT00592631|18195401|P2|Overall Study|Lost to Follow-up|2
5274421|NCT00592631|18195402|P1|Overall Study|Lost to Follow-up|0
5274422|NCT00592553|18195411|P3|Overall Study|Protocol Noncompliance|0
5274423|NCT00592553|18195412|P2|Overall Study|Protocol Noncompliance|0
5274424|NCT00592553|18195413|P1|Overall Study|Protocol Noncompliance|1
5274425|NCT00592384|18195530|P2|Overall Study|Withdrawal by Subject|6
5274426|NCT00592384|18195531|P1|Overall Study|Withdrawal by Subject|5
5274427|NCT00592358|18195539|P1|Overall Study|Inability to swallow pills|1
5274428|NCT00592358|18195539|P1|Overall Study|Lack of Efficacy|2
5274429|NCT00592358|18195539|P1|Overall Study|Adverse Event|1
5274430|NCT00592358|18195539|P1|Overall Study|Withdrawal by Subject|2
5274431|NCT00592319|18195546|P2|Overall Study|Lost to Follow-up|3
5274432|NCT00592319|18195547|P1|Overall Study|Lost to Follow-up|0
5274433|NCT00592072|18195622|P2|Wash Out Period|Lost to Follow-up|1
5274434|NCT00592072|18195623|P1|Wash Out Period|Lost to Follow-up|1
5274435|NCT00592007|18195645|P1|Overall Study|patient ineligible (out of lab range)|1
5274436|NCT00592007|18195645|P1|Overall Study|Withdrawal by Subject|1
5274437|NCT00591864|18195657|P1|Overall Study|Incomplete Imaging|5
5274438|NCT00591851|18195663|P1|Overall Study|Progressive Disease|1
5274439|NCT00591851|18195663|P1|Overall Study|Adverse Event|2
5274440|NCT00591851|18195663|P1|Overall Study|Withdrawal by Subject|3
5274441|NCT00591838|18195672|P5|Overall Study|Withdrawal by Subject|0
5274442|NCT00591838|18195673|P4|Overall Study|Withdrawal by Subject|1
5274443|NCT00591838|18195674|P3|Overall Study|Withdrawal by Subject|0
5274444|NCT00591838|18195675|P2|Overall Study|Withdrawal by Subject|0
5274445|NCT00591838|18195676|P1|Overall Study|Withdrawal by Subject|0
5274446|NCT00591786|18195740|P10|Overall Study|Withdrawal of Informed Consent|0
5274447|NCT00591786|18195741|P9|Overall Study|Withdrawal of Informed Consent|0
5274448|NCT00591786|18195742|P8|Overall Study|Withdrawal of Informed Consent|0
5274449|NCT00591786|18195743|P7|Overall Study|Withdrawal of Informed Consent|0
5274450|NCT00591786|18195744|P6|Overall Study|Withdrawal of Informed Consent|0
5274451|NCT00591786|18195745|P5|Overall Study|Withdrawal of Informed Consent|0
5274452|NCT00591786|18195746|P4|Overall Study|Withdrawal of Informed Consent|0
5274453|NCT00591786|18195747|P3|Overall Study|Withdrawal of Informed Consent|1
5274454|NCT00591786|18195748|P2|Overall Study|Withdrawal of Informed Consent|0
5274455|NCT00591786|18195749|P1|Overall Study|Withdrawal of Informed Consent|0
5274456|NCT00591773|18195794|P3|Overall Study|Other|4
5274457|NCT00591773|18195795|P2|Overall Study|Other|1
5274458|NCT00591773|18195796|P1|Overall Study|Other|1
5274459|NCT00591773|18195794|P3|Overall Study|Lack of Efficacy|2
5274460|NCT00591773|18195795|P2|Overall Study|Lack of Efficacy|2
5274461|NCT00591773|18195796|P1|Overall Study|Lack of Efficacy|1
5274462|NCT00591773|18195794|P3|Overall Study|Withdrawal by Subject|3
5274463|NCT00591773|18195795|P2|Overall Study|Withdrawal by Subject|5
5274464|NCT00591773|18195796|P1|Overall Study|Withdrawal by Subject|2
5274465|NCT00591773|18195794|P3|Overall Study|Lost to Follow-up|1
5274466|NCT00591773|18195795|P2|Overall Study|Lost to Follow-up|4
5274467|NCT00591773|18195796|P1|Overall Study|Lost to Follow-up|1
5274468|NCT00591773|18195794|P3|Overall Study|Protocol Violation|0
5274469|NCT00591773|18195795|P2|Overall Study|Protocol Violation|3
5274470|NCT00591773|18195796|P1|Overall Study|Protocol Violation|2
5274471|NCT00591773|18195794|P3|Overall Study|Adverse Event|6
5274472|NCT00591773|18195795|P2|Overall Study|Adverse Event|9
5274473|NCT00591773|18195796|P1|Overall Study|Adverse Event|9
5274474|NCT00591734|18195855|P1|Overall Study|Intercurrent Illness|8
5274475|NCT00591734|18195855|P1|Overall Study|Physician Decision|5
5274476|NCT00591734|18195855|P1|Overall Study|Adverse Event|5
5274477|NCT00591734|18195855|P1|Overall Study|Lack of Efficacy|35
5274478|NCT00591721|18195861|P2|Overall Study|Intervention not received|8
5274479|NCT00591721|18195862|P1|Overall Study|Intervention not received|10
5274480|NCT00591721|18195861|P2|Overall Study|Lost to Follow-up|4
5274481|NCT00591721|18195862|P1|Overall Study|Lost to Follow-up|1
5274482|NCT00591721|18195861|P2|Overall Study|Withdrawal by Subject|10
5274483|NCT00591721|18195862|P1|Overall Study|Withdrawal by Subject|10
5274484|NCT00591591|18195870|P2|Overall Study|Lack of Efficacy|2
5274485|NCT00591591|18195871|P1|Overall Study|Lack of Efficacy|10
5274486|NCT00591591|18195870|P2|Overall Study|Withdrawal by Subject|37
5274487|NCT00591591|18195871|P1|Overall Study|Withdrawal by Subject|1
5274488|NCT00591578|18195888|P3|Open-Label Extension Phase|Other|0
5274489|NCT00591578|18195889|P2|Open-Label Extension Phase|Other|0
5274490|NCT00591578|18195890|P1|Open-Label Extension Phase|Other|1
5274491|NCT00591578|18195888|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5274492|NCT00591578|18195889|P2|Open-Label Extension Phase|Withdrawal by Subject|1
5274493|NCT00591578|18195890|P1|Open-Label Extension Phase|Withdrawal by Subject|1
5274494|NCT00591578|18195888|P3|Open-Label Extension Phase|Lost to Follow-up|0
5274495|NCT00591578|18195889|P2|Open-Label Extension Phase|Lost to Follow-up|4
5274496|NCT00591578|18195890|P1|Open-Label Extension Phase|Lost to Follow-up|1
5274497|NCT00591578|18195888|P3|Open-Label Extension Phase|Adverse Event|0
5274498|NCT00591578|18195889|P2|Open-Label Extension Phase|Adverse Event|5
5274499|NCT00591578|18195890|P1|Open-Label Extension Phase|Adverse Event|3
5274500|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Other|4
5274501|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Other|9
5274502|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Other|4
5274503|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
5274504|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
5274505|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
5274506|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Pregnancy|0
5274507|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Pregnancy|0
5274508|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Pregnancy|1
5274509|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
5274510|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
5274511|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
5274512|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
5274513|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
5274514|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
5274515|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Protocol Violation|3
5274516|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Protocol Violation|2
5274517|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Protocol Violation|3
5274518|NCT00591578|18195888|P3|Double-Blind Treatment Phase|Adverse Event|19
5274519|NCT00591578|18195889|P2|Double-Blind Treatment Phase|Adverse Event|26
5274520|NCT00591578|18195890|P1|Double-Blind Treatment Phase|Adverse Event|20
5274521|NCT00591565|18195941|P1|Overall Study|lost follow up, withdrawn|5
5274522|NCT00591409|18195955|P10|Overall Study|Not Treated|1
5274523|NCT00591409|18195956|P9|Overall Study|Not Treated|0
5274524|NCT00591409|18195957|P8|Overall Study|Not Treated|0
5274525|NCT00591409|18195958|P7|Overall Study|Not Treated|0
5274526|NCT00591409|18195959|P6|Overall Study|Not Treated|0
5274527|NCT00591409|18195960|P5|Overall Study|Not Treated|1
5274528|NCT00591409|18195961|P4|Overall Study|Not Treated|0
5274529|NCT00591409|18195962|P3|Overall Study|Not Treated|0
5274530|NCT00591409|18195963|P2|Overall Study|Not Treated|0
5274531|NCT00591409|18195964|P1|Overall Study|Not Treated|0
5274532|NCT00591370|18196006|P1|Overall Study|Not Treated|2
5274533|NCT00591344|18196014|P2|Overall Study|Did not want to come off medication|1
5274534|NCT00591344|18196015|P1|Overall Study|Did not want to come off medication|0
5274535|NCT00591344|18196014|P2|Overall Study|Lost to Follow-up|1
5274536|NCT00591344|18196015|P1|Overall Study|Lost to Follow-up|0
5274537|NCT00591344|18196014|P2|Overall Study|Death|1
5274538|NCT00591344|18196015|P1|Overall Study|Death|0
5274539|NCT00591344|18196014|P2|Overall Study|Underwent DBS|2
5274540|NCT00591344|18196015|P1|Overall Study|Underwent DBS|2
5274541|NCT00591344|18196014|P2|Overall Study|Medical complications|3
5274542|NCT00591344|18196015|P1|Overall Study|Medical complications|1
5274543|NCT00591344|18196014|P2|Overall Study|Moved out of state|0
5274544|NCT00591344|18196015|P1|Overall Study|Moved out of state|1
5274545|NCT00591344|18196014|P2|Overall Study|Transportation issues|0
5274546|NCT00591344|18196015|P1|Overall Study|Transportation issues|1
5274547|NCT00591266|18196041|P3|Overall Study|Other|5
5274548|NCT00591266|18196042|P2|Overall Study|Other|4
5274549|NCT00591266|18196043|P1|Overall Study|Other|1
5274550|NCT00591266|18196041|P3|Overall Study|Lack of Efficacy|0
5274551|NCT00591266|18196042|P2|Overall Study|Lack of Efficacy|2
5274552|NCT00591266|18196043|P1|Overall Study|Lack of Efficacy|0
5274553|NCT00591266|18196041|P3|Overall Study|Withdrawal by Subject|5
5274554|NCT00591266|18196042|P2|Overall Study|Withdrawal by Subject|2
5274555|NCT00591266|18196043|P1|Overall Study|Withdrawal by Subject|6
5274556|NCT00591266|18196041|P3|Overall Study|Protocol Violation|1
5274557|NCT00591266|18196042|P2|Overall Study|Protocol Violation|0
5274558|NCT00591266|18196043|P1|Overall Study|Protocol Violation|0
5274559|NCT00591266|18196041|P3|Overall Study|Lost to Follow-up|0
5274560|NCT00591266|18196042|P2|Overall Study|Lost to Follow-up|1
5274561|NCT00591266|18196043|P1|Overall Study|Lost to Follow-up|0
5274562|NCT00591266|18196041|P3|Overall Study|Adverse Event|3
5274563|NCT00591266|18196042|P2|Overall Study|Adverse Event|2
5274564|NCT00591266|18196043|P1|Overall Study|Adverse Event|2
5274565|NCT00591253|18196096|P3|Overall Study|Other|3
5274566|NCT00591253|18196097|P2|Overall Study|Other|5
5274567|NCT00591253|18196098|P1|Overall Study|Other|5
5274568|NCT00591253|18196096|P3|Overall Study|Lack of Efficacy|3
5274569|NCT00591253|18196097|P2|Overall Study|Lack of Efficacy|0
5274570|NCT00591253|18196098|P1|Overall Study|Lack of Efficacy|1
5274571|NCT00591253|18196096|P3|Overall Study|Withdrawal by Subject|6
5274572|NCT00591253|18196097|P2|Overall Study|Withdrawal by Subject|7
5274573|NCT00591253|18196098|P1|Overall Study|Withdrawal by Subject|1
5274574|NCT00591253|18196096|P3|Overall Study|Lost to Follow-up|0
5274575|NCT00591253|18196097|P2|Overall Study|Lost to Follow-up|4
5274576|NCT00591253|18196098|P1|Overall Study|Lost to Follow-up|2
5274577|NCT00591253|18196096|P3|Overall Study|Protocol Violation|2
5274578|NCT00591253|18196097|P2|Overall Study|Protocol Violation|2
5274579|NCT00591253|18196098|P1|Overall Study|Protocol Violation|2
5274580|NCT00591253|18196096|P3|Overall Study|Adverse Event|1
5274581|NCT00591253|18196097|P2|Overall Study|Adverse Event|3
5274582|NCT00591253|18196098|P1|Overall Study|Adverse Event|3
5274583|NCT00591214|18196166|P1|Overall Study|Withdrawal by Subject|1
5274584|NCT00591214|18196166|P1|Overall Study|Physician Decision|7
5274585|NCT00591149|18196175|P1|Overall Study|Withdrawal by Subject|1
5274586|NCT00591149|18196175|P1|Overall Study|Adverse Event|4
5274587|NCT00591006|18196191|P24|Overall Study|Adverse Event|0
5274588|NCT00591006|18196192|P23|Overall Study|Adverse Event|1
5274589|NCT00591006|18196193|P22|Overall Study|Adverse Event|0
5274590|NCT00591006|18196194|P21|Overall Study|Adverse Event|0
5274591|NCT00591006|18196195|P20|Overall Study|Adverse Event|0
5274592|NCT00591006|18196196|P19|Overall Study|Adverse Event|0
5274593|NCT00591006|18196197|P18|Overall Study|Adverse Event|0
5274594|NCT00591006|18196198|P17|Overall Study|Adverse Event|0
5274595|NCT00591006|18196199|P16|Overall Study|Adverse Event|0
5274596|NCT00591006|18196200|P15|Overall Study|Adverse Event|0
5274597|NCT00591006|18196201|P14|Overall Study|Adverse Event|0
5274598|NCT00591006|18196202|P13|Overall Study|Adverse Event|0
5274599|NCT00591006|18196203|P12|Overall Study|Adverse Event|0
5274600|NCT00591006|18196204|P11|Overall Study|Adverse Event|0
5274601|NCT00591006|18196205|P10|Overall Study|Adverse Event|0
5274602|NCT00591006|18196206|P9|Overall Study|Adverse Event|0
5274603|NCT00591006|18196207|P8|Overall Study|Adverse Event|0
5274604|NCT00591006|18196208|P7|Overall Study|Adverse Event|0
5274605|NCT00591006|18196209|P6|Overall Study|Adverse Event|0
5274606|NCT00591006|18196210|P5|Overall Study|Adverse Event|0
5274607|NCT00591006|18196211|P4|Overall Study|Adverse Event|0
5274608|NCT00591006|18196212|P3|Overall Study|Adverse Event|0
5274609|NCT00591006|18196213|P2|Overall Study|Adverse Event|0
5274610|NCT00591006|18196214|P1|Overall Study|Adverse Event|0
5274611|NCT00591006|18196191|P24|Overall Study|Withdrawal by Subject|1
5274612|NCT00591006|18196192|P23|Overall Study|Withdrawal by Subject|0
5274613|NCT00591006|18196193|P22|Overall Study|Withdrawal by Subject|0
5274614|NCT00591006|18196194|P21|Overall Study|Withdrawal by Subject|0
5274615|NCT00591006|18196195|P20|Overall Study|Withdrawal by Subject|0
5274616|NCT00591006|18196196|P19|Overall Study|Withdrawal by Subject|0
5274617|NCT00591006|18196197|P18|Overall Study|Withdrawal by Subject|0
5274618|NCT00591006|18196198|P17|Overall Study|Withdrawal by Subject|0
5274619|NCT00591006|18196199|P16|Overall Study|Withdrawal by Subject|1
5274620|NCT00591006|18196200|P15|Overall Study|Withdrawal by Subject|0
5274621|NCT00591006|18196201|P14|Overall Study|Withdrawal by Subject|0
5274622|NCT00591006|18196202|P13|Overall Study|Withdrawal by Subject|0
5274623|NCT00591006|18196203|P12|Overall Study|Withdrawal by Subject|0
5274624|NCT00591006|18196204|P11|Overall Study|Withdrawal by Subject|0
5274625|NCT00591006|18196205|P10|Overall Study|Withdrawal by Subject|0
5274626|NCT00591006|18196206|P9|Overall Study|Withdrawal by Subject|0
5274627|NCT00591006|18196207|P8|Overall Study|Withdrawal by Subject|0
5274628|NCT00591006|18196208|P7|Overall Study|Withdrawal by Subject|0
5274629|NCT00591006|18196209|P6|Overall Study|Withdrawal by Subject|0
5274630|NCT00591006|18196210|P5|Overall Study|Withdrawal by Subject|0
5274631|NCT00591006|18196211|P4|Overall Study|Withdrawal by Subject|0
5274632|NCT00591006|18196212|P3|Overall Study|Withdrawal by Subject|0
5274633|NCT00591006|18196213|P2|Overall Study|Withdrawal by Subject|0
5274634|NCT00591006|18196214|P1|Overall Study|Withdrawal by Subject|0
5274635|NCT00590980|18196232|P1|Overall Study|Did not meet all inclusion criteria|10
5274636|NCT00590967|18196238|P2|Overall Study|Did not receive chemo per protocol|0
5274637|NCT00590967|18196239|P1|Overall Study|Did not receive chemo per protocol|1
5274638|NCT00590967|18196238|P2|Overall Study|Did not sign consent form|1
5274639|NCT00590967|18196239|P1|Overall Study|Did not sign consent form|0
5274640|NCT00590967|18196238|P2|Overall Study|Non-compliant|2
5274641|NCT00590967|18196239|P1|Overall Study|Non-compliant|0
5274642|NCT00590967|18196238|P2|Overall Study|Poor performance status|1
5274643|NCT00590967|18196239|P1|Overall Study|Poor performance status|0
5274644|NCT00590967|18196238|P2|Overall Study|Ineligible|0
5274645|NCT00590967|18196239|P1|Overall Study|Ineligible|1
5274646|NCT00590967|18196238|P2|Overall Study|Withdrawal by Subject|1
5274647|NCT00590967|18196239|P1|Overall Study|Withdrawal by Subject|1
5274648|NCT00590954|18196251|P1|Overall Study|Inevaluable|2
5274649|NCT00590902|18196257|P1|Overall Study|Death|1
5274650|NCT00590824|18196290|P4|Overall Study|Adverse Event|1
5274651|NCT00590824|18196291|P3|Overall Study|Adverse Event|0
5274652|NCT00590824|18196292|P2|Overall Study|Adverse Event|0
5274653|NCT00590824|18196293|P1|Overall Study|Adverse Event|0
5274654|NCT00590824|18196290|P4|Overall Study|Disease could not be resected|0
5274655|NCT00590824|18196291|P3|Overall Study|Disease could not be resected|1
5274656|NCT00590824|18196292|P2|Overall Study|Disease could not be resected|2
5274657|NCT00590824|18196293|P1|Overall Study|Disease could not be resected|0
5274658|NCT00590759|18196319|P1|Overall Study|Lost to Follow-up|28
5274659|NCT00590759|18196319|P1|Overall Study|Death|52
5274660|NCT00590720|18196326|P2|Overall Study|Withdrawal by Subject|1
5274661|NCT00590720|18196327|P1|Overall Study|Withdrawal by Subject|0
5274662|NCT00590720|18196326|P2|Overall Study|Lost to Follow-up|0
5274663|NCT00590720|18196327|P1|Overall Study|Lost to Follow-up|1
5274664|NCT00590590|18196389|P3|Overall Study|Did not complete study|0
5274665|NCT00590590|18196390|P2|Overall Study|Did not complete study|1
5274666|NCT00590590|18196391|P1|Overall Study|Did not complete study|0
5274667|NCT00590590|18196389|P3|Overall Study|Did not complete due to study closure|1
5274668|NCT00590590|18196390|P2|Overall Study|Did not complete due to study closure|1
5274669|NCT00590590|18196391|P1|Overall Study|Did not complete due to study closure|1
5274670|NCT00590590|18196389|P3|Overall Study|Withdrawal by Subject|1
5274671|NCT00590590|18196390|P2|Overall Study|Withdrawal by Subject|1
5274672|NCT00590590|18196391|P1|Overall Study|Withdrawal by Subject|0
5274673|NCT00590590|18196389|P3|Overall Study|Lost to Follow-up|2
5274674|NCT00590590|18196390|P2|Overall Study|Lost to Follow-up|1
5274675|NCT00590590|18196391|P1|Overall Study|Lost to Follow-up|4
5274676|NCT00590590|18196389|P3|Overall Study|Protocol Violation|2
5274677|NCT00590590|18196390|P2|Overall Study|Protocol Violation|0
5274678|NCT00590590|18196391|P1|Overall Study|Protocol Violation|0
5274679|NCT00590590|18196389|P3|Overall Study|Adverse Event|0
5274680|NCT00590590|18196390|P2|Overall Study|Adverse Event|0
5274681|NCT00590590|18196391|P1|Overall Study|Adverse Event|1
5274682|NCT00590590|18196389|P3|Overall Study|Lack of Efficacy|0
5274683|NCT00590590|18196390|P2|Overall Study|Lack of Efficacy|2
5274684|NCT00590590|18196391|P1|Overall Study|Lack of Efficacy|1
5274685|NCT00590577|18196418|P4|Overall Study|Various reasons|2
5274686|NCT00590577|18196419|P3|Overall Study|Various reasons|1
5274687|NCT00590577|18196420|P2|Overall Study|Various reasons|3
5274688|NCT00590577|18196421|P1|Overall Study|Various reasons|1
5274689|NCT00590577|18196418|P4|Overall Study|Pregnancy|0
5274690|NCT00590577|18196419|P3|Overall Study|Pregnancy|0
5274691|NCT00590577|18196420|P2|Overall Study|Pregnancy|1
5274692|NCT00590577|18196421|P1|Overall Study|Pregnancy|0
5274693|NCT00590577|18196418|P4|Overall Study|Lost to Follow-up|9
5274694|NCT00590577|18196419|P3|Overall Study|Lost to Follow-up|6
5274695|NCT00590577|18196420|P2|Overall Study|Lost to Follow-up|6
5274696|NCT00590577|18196421|P1|Overall Study|Lost to Follow-up|12
5274697|NCT00590577|18196418|P4|Overall Study|Adverse Event|11
5274698|NCT00590577|18196419|P3|Overall Study|Adverse Event|13
5274699|NCT00590577|18196420|P2|Overall Study|Adverse Event|10
5274700|NCT00590577|18196421|P1|Overall Study|Adverse Event|10
5274701|NCT00590577|18196418|P4|Overall Study|Withdrawal by Subject|26
5274702|NCT00590577|18196419|P3|Overall Study|Withdrawal by Subject|30
5274703|NCT00590577|18196420|P2|Overall Study|Withdrawal by Subject|28
5274704|NCT00590577|18196421|P1|Overall Study|Withdrawal by Subject|23
5274705|NCT00590577|18196418|P4|Overall Study|Lack of Efficacy|45
5274706|NCT00590577|18196419|P3|Overall Study|Lack of Efficacy|23
5274707|NCT00590577|18196420|P2|Overall Study|Lack of Efficacy|28
5274708|NCT00590577|18196421|P1|Overall Study|Lack of Efficacy|31
5274709|NCT00590564|18196439|P1|Overall Study|Patient Non-compliance|6
5274710|NCT00590564|18196439|P1|Overall Study|Patient Found to be Ineligible|1
5274711|NCT00590564|18196439|P1|Overall Study|Protocol Violation|1
5274712|NCT00590564|18196439|P1|Overall Study|Lost to Follow-up|6
5274713|NCT00590564|18196439|P1|Overall Study|Withdrawal by Subject|4
5274714|NCT00590538|18196443|P1|Overall Study|Study terminated before completed|2
5274715|NCT00590317|18196489|P2|Overall Study|Lack of Efficacy|5
5274716|NCT00590317|18196490|P1|Overall Study|Lack of Efficacy|1
5274717|NCT00590135|18196520|P1|Overall Study|Primary endpoint measure not obtainable|59
5274718|NCT00590044|18196530|P2|Overall Study|Protocol Violation|0
5274719|NCT00590044|18196531|P1|Overall Study|Protocol Violation|1
5274720|NCT00590044|18196530|P2|Overall Study|wrong insulin arm assigned|0
5274721|NCT00590044|18196531|P1|Overall Study|wrong insulin arm assigned|1
5274722|NCT00590044|18196530|P2|Overall Study|Withdrawal by Subject|2
5274723|NCT00590044|18196531|P1|Overall Study|Withdrawal by Subject|2
5274724|NCT00590031|18196543|P1|Overall Study|Admin Hold|1
5274725|NCT00590031|18196543|P1|Overall Study|Metastatic Disease|1
5274726|NCT00590031|18196543|P1|Overall Study|Withdrawal by Subject|1
5274727|NCT00590031|18196543|P1|Overall Study|Adverse Event|3
5274728|NCT00589979|18196570|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
5274729|NCT00589979|18196571|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
5274730|NCT00589979|18196572|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
5274731|NCT00589979|18196570|P3|Double-Blind Treatment Period 3|Protocol Violation|0
5274732|NCT00589979|18196571|P2|Double-Blind Treatment Period 3|Protocol Violation|1
5274733|NCT00589979|18196572|P1|Double-Blind Treatment Period 3|Protocol Violation|0
5274734|NCT00589979|18196570|P3|Double-Blind Treatment Period 2|Other|1
5274735|NCT00589979|18196571|P2|Double-Blind Treatment Period 2|Other|0
5274736|NCT00589979|18196572|P1|Double-Blind Treatment Period 2|Other|0
5274737|NCT00589979|18196570|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
5274738|NCT00589979|18196571|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
5274739|NCT00589979|18196572|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
5274740|NCT00589979|18196570|P3|Double-Blind Treatment Period 2|Adverse Event|0
5274741|NCT00589979|18196571|P2|Double-Blind Treatment Period 2|Adverse Event|1
5274742|NCT00589979|18196572|P1|Double-Blind Treatment Period 2|Adverse Event|0
5274743|NCT00589979|18196570|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
5274744|NCT00589979|18196571|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
5274745|NCT00589979|18196572|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
5274746|NCT00589979|18196570|P3|Double-Blind Treatment Period 1|Protocol Violation|1
5274747|NCT00589979|18196571|P2|Double-Blind Treatment Period 1|Protocol Violation|1
5274748|NCT00589979|18196572|P1|Double-Blind Treatment Period 1|Protocol Violation|0
5274749|NCT00589979|18196570|P3|Double-Blind Treatment Period 1|Adverse Event|0
5274750|NCT00589979|18196571|P2|Double-Blind Treatment Period 1|Adverse Event|1
5274751|NCT00589979|18196572|P1|Double-Blind Treatment Period 1|Adverse Event|0
5274752|NCT00589979|18196570|P3|Run-In Period|Informed Consent Withdrawn|0
5274753|NCT00589979|18196571|P2|Run-In Period|Informed Consent Withdrawn|0
5274754|NCT00589979|18196572|P1|Run-In Period|Informed Consent Withdrawn|4
5274755|NCT00589979|18196570|P3|Run-In Period|Withdrawal by Subject|0
5274756|NCT00589979|18196571|P2|Run-In Period|Withdrawal by Subject|0
5274757|NCT00589979|18196572|P1|Run-In Period|Withdrawal by Subject|10
5274758|NCT00589979|18196570|P3|Run-In Period|Did not qualify for randomization|0
5274759|NCT00589979|18196571|P2|Run-In Period|Did not qualify for randomization|0
5274760|NCT00589979|18196572|P1|Run-In Period|Did not qualify for randomization|54
5274761|NCT00589979|18196570|P3|Run-In Period|Protocol Violation|0
5274762|NCT00589979|18196571|P2|Run-In Period|Protocol Violation|0
5274763|NCT00589979|18196572|P1|Run-In Period|Protocol Violation|3
5274764|NCT00589979|18196570|P3|Run-In Period|Adverse Event|0
5274765|NCT00589979|18196571|P2|Run-In Period|Adverse Event|0
5274766|NCT00589979|18196572|P1|Run-In Period|Adverse Event|5
5274767|NCT00589914|18196611|P2|Overall Study|Other|17
5274768|NCT00589914|18196612|P1|Overall Study|Other|22
5274769|NCT00589914|18196611|P2|Overall Study|Withdrawal by Subject|49
5274770|NCT00589914|18196612|P1|Overall Study|Withdrawal by Subject|55
5274771|NCT00589914|18196611|P2|Overall Study|Pregnancy|0
5274772|NCT00589914|18196612|P1|Overall Study|Pregnancy|1
5274773|NCT00589914|18196611|P2|Overall Study|Lost to Follow-up|18
5274774|NCT00589914|18196612|P1|Overall Study|Lost to Follow-up|11
5274775|NCT00589914|18196611|P2|Overall Study|Lack of Efficacy|43
5274776|NCT00589914|18196612|P1|Overall Study|Lack of Efficacy|40
5274777|NCT00589914|18196611|P2|Overall Study|Death|0
5274778|NCT00589914|18196612|P1|Overall Study|Death|2
5274779|NCT00589914|18196611|P2|Overall Study|Adverse Event|10
5274780|NCT00589914|18196612|P1|Overall Study|Adverse Event|19
5274781|NCT00589797|18196668|P2|Overall Study|Non-Randomized Training Subjects|6
5274782|NCT00589797|18196669|P1|Overall Study|Non-Randomized Training Subjects|46
5274783|NCT00589797|18196668|P2|Overall Study|Withdrawal by Subject|5
5274784|NCT00589797|18196669|P1|Overall Study|Withdrawal by Subject|6
5274785|NCT00589797|18196668|P2|Overall Study|Physician Decision|3
5274786|NCT00589797|18196669|P1|Overall Study|Physician Decision|8
5274787|NCT00589797|18196668|P2|Overall Study|Lost to Follow-up|9
5274788|NCT00589797|18196669|P1|Overall Study|Lost to Follow-up|12
5274789|NCT00589797|18196668|P2|Overall Study|Death|0
5274790|NCT00589797|18196669|P1|Overall Study|Death|1
5274791|NCT00589784|18196693|P2|Overall Study|Adverse Event|4
5274792|NCT00589784|18196694|P1|Overall Study|Adverse Event|0
5274793|NCT00589784|18196693|P2|Overall Study|Patient inevaluable|0
5274794|NCT00589784|18196694|P1|Overall Study|Patient inevaluable|1
5274795|NCT00589784|18196693|P2|Overall Study|Withdrawal by Subject|6
5274796|NCT00589784|18196694|P1|Overall Study|Withdrawal by Subject|0
5274797|NCT00589693|18196701|P2|Overall Study|Protocol Violation|1
5274798|NCT00589693|18196702|P1|Overall Study|Protocol Violation|1
5274799|NCT00589693|18196701|P2|Overall Study|Physician Decision|1
5274800|NCT00589693|18196702|P1|Overall Study|Physician Decision|0
5274801|NCT00589693|18196701|P2|Overall Study|Lost to Follow-up|0
5274802|NCT00589693|18196702|P1|Overall Study|Lost to Follow-up|1
5274803|NCT00589693|18196701|P2|Overall Study|Lack of Efficacy|1
5274804|NCT00589693|18196702|P1|Overall Study|Lack of Efficacy|0
5274805|NCT00589693|18196701|P2|Overall Study|Death|16
5274806|NCT00589693|18196702|P1|Overall Study|Death|26
5274807|NCT00589693|18196701|P2|Overall Study|Adverse Event|4
5274808|NCT00589693|18196702|P1|Overall Study|Adverse Event|4
5274809|NCT00589693|18196701|P2|Overall Study|randomized in error|6
5274810|NCT00589693|18196702|P1|Overall Study|randomized in error|12
5274811|NCT00589667|18196716|P1|Overall Study|Withdrawal by Subject|1
5274812|NCT00589667|18196716|P1|Overall Study|Adverse Event|2
5274813|NCT00589628|18196723|P2|Overall Study|Lost to Follow-up|1
5274814|NCT00589628|18196724|P1|Overall Study|Lost to Follow-up|0
5274815|NCT00589602|18196730|P1|Overall Study|Did not collect enough CD34+ cells|1
5274816|NCT00589472|18196765|P1|Overall Study|Adverse Event|1
5274817|NCT00589303|18196788|P2|Overall Study|Withdrawal by Subject|1
5274818|NCT00589303|18196789|P1|Overall Study|Withdrawal by Subject|2
5274819|NCT00589290|18196795|P1|Overall Study|Withdrawal by Subject|1
5274820|NCT00589121|18196818|P2|Overall Study|No protocol treatment received|1
5274821|NCT00589121|18196819|P1|Overall Study|No protocol treatment received|0
5274822|NCT00589121|18196818|P2|Overall Study|Protocol Violation|6
5274823|NCT00589121|18196819|P1|Overall Study|Protocol Violation|2
5274824|NCT00589108|18196841|P3|Overall Study|Death|4
5274825|NCT00589108|18196842|P2|Overall Study|Death|3
5274826|NCT00589108|18196843|P1|Overall Study|Death|3
5274827|NCT00589108|18196841|P3|Overall Study|Lost to Follow-up|1
5274828|NCT00589108|18196842|P2|Overall Study|Lost to Follow-up|1
5274829|NCT00589108|18196843|P1|Overall Study|Lost to Follow-up|1
5274830|NCT00588952|18196879|P2|Overall Study|Withdrawal by Subject|5
5274831|NCT00588952|18196880|P1|Overall Study|Withdrawal by Subject|3
5274832|NCT00588952|18196879|P2|Overall Study|Adverse Event|2
5274833|NCT00588952|18196880|P1|Overall Study|Adverse Event|0
5274834|NCT00588861|18196908|P2|10 Years|Incomplete due to study termination|114
5274835|NCT00588861|18196909|P1|10 Years|Incomplete due to study termination|107
5274836|NCT00588861|18196908|P2|8 Years|Patients did not return for follow-up|114
5274837|NCT00588861|18196909|P1|8 Years|Patients did not return for follow-up|105
5274838|NCT00588861|18196908|P2|6 Years|Patients did not return for follow-up|109
5274839|NCT00588861|18196909|P1|6 Years|Patients did not return for follow-up|104
5274840|NCT00588861|18196908|P2|4 Years|Patients did not return for follow-up|103
5274841|NCT00588861|18196909|P1|4 Years|Patients did not return for follow-up|91
5274842|NCT00588861|18196908|P2|2 Years|Patients did not return for follow-up|87
5274843|NCT00588861|18196909|P1|2 Years|Patients did not return for follow-up|92
5274844|NCT00588861|18196908|P2|1 Year|Patients did not return for follow-up|82
5274845|NCT00588861|18196909|P1|1 Year|Patients did not return for follow-up|89
5274846|NCT00588861|18196908|P2|6 Months|Patients did not return for follow-up|73
5274847|NCT00588861|18196909|P1|6 Months|Patients did not return for follow-up|98
5274848|NCT00588861|18196908|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
5274849|NCT00588861|18196909|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
5274850|NCT00588848|18196919|P2|Overall Study|Physician Decision|3
5274851|NCT00588848|18196920|P1|Overall Study|Physician Decision|0
5274852|NCT00588822|18196930|P1|Overall Study|progression of disease|8
5274853|NCT00588770|18196950|P2|Overall Study|Patient non-compliance|2
5274854|NCT00588770|18196951|P1|Overall Study|Patient non-compliance|2
5274855|NCT00588770|18196950|P2|Overall Study|Physician discretion|0
5274856|NCT00588770|18196951|P1|Overall Study|Physician discretion|2
5274857|NCT00588770|18196950|P2|Overall Study|Lack of Efficacy|10
5274858|NCT00588770|18196951|P1|Overall Study|Lack of Efficacy|8
5274859|NCT00588770|18196950|P2|Overall Study|Not start protocol therapy|9
5274860|NCT00588770|18196951|P1|Overall Study|Not start protocol therapy|0
5274861|NCT00588770|18196950|P2|Overall Study|Other complicating disease|2
5274862|NCT00588770|18196951|P1|Overall Study|Other complicating disease|3
5274863|NCT00588770|18196950|P2|Overall Study|Alternative therapy|4
5274864|NCT00588770|18196951|P1|Overall Study|Alternative therapy|2
5274865|NCT00588770|18196950|P2|Overall Study|Withdrawal by Subject|25
5274866|NCT00588770|18196951|P1|Overall Study|Withdrawal by Subject|15
5274867|NCT00588770|18196950|P2|Overall Study|Death|22
5274868|NCT00588770|18196951|P1|Overall Study|Death|13
5274869|NCT00588770|18196950|P2|Overall Study|Adverse Event|58
5274870|NCT00588770|18196951|P1|Overall Study|Adverse Event|29
5274871|NCT00588770|18196950|P2|Overall Study|Disease progression|68
5274872|NCT00588770|18196951|P1|Overall Study|Disease progression|85
5274873|NCT00588731|18196963|P2|Overall Study|Withdrawal by Subject|2
5274874|NCT00588731|18196964|P1|Overall Study|Withdrawal by Subject|3
5274875|NCT00588692|18196974|P2|Overall Study|Death|0
5274876|NCT00588692|18196975|P1|Overall Study|Death|1
5274877|NCT00588692|18196974|P2|Overall Study|Cancer|0
5274878|NCT00588692|18196975|P1|Overall Study|Cancer|1
5274879|NCT00588692|18196974|P2|Overall Study|Severe Peptic Ulcer Disease|0
5274880|NCT00588692|18196975|P1|Overall Study|Severe Peptic Ulcer Disease|1
5274881|NCT00588692|18196974|P2|Overall Study|Hip Surgery|1
5274882|NCT00588692|18196975|P1|Overall Study|Hip Surgery|0
5274883|NCT00588692|18196974|P2|Overall Study|Withdrawal by Subject|2
5274884|NCT00588692|18196975|P1|Overall Study|Withdrawal by Subject|4
5274885|NCT00588666|18197011|P1|Overall Study|Adverse Event|4
5274886|NCT00588640|18197016|P1|Overall Study|Ineligible Patient|1
5274887|NCT00588640|18197016|P1|Overall Study|Physician Decision|1
5274888|NCT00588445|18197035|P1|Overall Study|Not Treated|10
5274889|NCT00588445|18197035|P1|Overall Study|Disease Progression|1
5274890|NCT00588445|18197035|P1|Overall Study|Withdrawal by Subject|3
5274891|NCT00588445|18197035|P1|Overall Study|Protocol Violation|1
5274892|NCT00588354|18197059|P2|Baseline to 4 Weeks|Lost to Follow-up|1
5274893|NCT00588354|18197060|P1|Baseline to 4 Weeks|Lost to Follow-up|0
5274894|NCT00588354|18197059|P2|Baseline to 2 Weeks|Lack of Efficacy|0
5274895|NCT00588354|18197060|P1|Baseline to 2 Weeks|Lack of Efficacy|1
5274896|NCT00588354|18197059|P2|Baseline to 2 Weeks|Adverse Event|0
5274897|NCT00588354|18197060|P1|Baseline to 2 Weeks|Adverse Event|1
5274898|NCT00588341|18197080|P1|Overall Study|Patient ineligible|1
5274899|NCT00588341|18197080|P1|Overall Study|Not treated due to metastatic disease|1
5274900|NCT00588341|18197080|P1|Overall Study|Withdrawal by Subject|3
5274901|NCT00588237|18197084|P1|Overall Study|Patien not treated|1
5274902|NCT00588237|18197084|P1|Overall Study|Evaluable for toxicity only|3
5274903|NCT00588146|18197107|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
5274904|NCT00588146|18197108|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
5274905|NCT00588094|18197114|P1|Overall Study|Progression of Disease|2
5274906|NCT00588094|18197114|P1|Overall Study|Adverse Event|3
5274907|NCT00587990|18197121|P3|Overall Study|Death|1
5274908|NCT00587990|18197122|P2|Overall Study|Death|0
5274909|NCT00587990|18197123|P1|Overall Study|Death|0
5274910|NCT00587964|18197166|P1|Overall Study|Progression of Disease|4
5274911|NCT00587964|18197166|P1|Overall Study|Patient did not receive intervention|5
5274912|NCT00587964|18197166|P1|Overall Study|Patient found to be ineligible|1
5274913|NCT00587964|18197166|P1|Overall Study|Lost to Follow-up|1
5274914|NCT00587964|18197166|P1|Overall Study|Withdrawal by Subject|1
5274915|NCT00587860|18197172|P2|Overall Study|Withdrawal by Subject|3
5274916|NCT00587860|18197173|P1|Overall Study|Withdrawal by Subject|3
5274917|NCT00587860|18197172|P2|Overall Study|Lost to Follow-up|2
5274918|NCT00587860|18197173|P1|Overall Study|Lost to Follow-up|2
5274919|NCT00587847|18197193|P1|Overall Study|Adverse Event|2
5274920|NCT00587847|18197193|P1|Overall Study|Lack of Efficacy|5
5274921|NCT00587795|18197216|P2|Overall Study|Withdrawal by Subject|0
5274922|NCT00587795|18197217|P1|Overall Study|Withdrawal by Subject|1
5274923|NCT00587639|18197271|P1|Overall Study|Withdrawal by Subject|1
5274924|NCT00587587|18197278|P2|Overall Study|Lost to Follow-up|1
5274925|NCT00587587|18197279|P1|Overall Study|Lost to Follow-up|6
5274926|NCT00587457|18197333|P3|Overall Study|Development of neutralizing Abs|1
5274927|NCT00587457|18197334|P2|Overall Study|Development of neutralizing Abs|0
5274928|NCT00587457|18197335|P1|Overall Study|Development of neutralizing Abs|0
5274929|NCT00587457|18197333|P3|Overall Study|Undefined|1
5274930|NCT00587457|18197334|P2|Overall Study|Undefined|0
5274931|NCT00587457|18197335|P1|Overall Study|Undefined|0
5274932|NCT00587457|18197333|P3|Overall Study|Initiation of alternative therapy|0
5274933|NCT00587457|18197334|P2|Overall Study|Initiation of alternative therapy|1
5274934|NCT00587457|18197335|P1|Overall Study|Initiation of alternative therapy|0
5274935|NCT00587457|18197333|P3|Overall Study|Disease progression|2
5274936|NCT00587457|18197334|P2|Overall Study|Disease progression|0
5274937|NCT00587457|18197335|P1|Overall Study|Disease progression|2
5274938|NCT00587457|18197333|P3|Overall Study|Adverse Event|1
5274939|NCT00587457|18197334|P2|Overall Study|Adverse Event|2
5274940|NCT00587457|18197335|P1|Overall Study|Adverse Event|1
5274941|NCT00587431|18197372|P2|Overall Study|Withdrawal by Subject|1
5274942|NCT00587431|18197373|P1|Overall Study|Withdrawal by Subject|0
5274943|NCT00587431|18197372|P2|Overall Study|Adverse Event|0
5274944|NCT00587431|18197373|P1|Overall Study|Adverse Event|1
5274945|NCT00587288|18197384|P2|Overall Study|Protocol Violation|0
5274946|NCT00587288|18197385|P1|Overall Study|Protocol Violation|1
5274947|NCT00587288|18197384|P2|Overall Study|Lack of Efficacy|8
5274948|NCT00587288|18197385|P1|Overall Study|Lack of Efficacy|2
5274949|NCT00587288|18197384|P2|Overall Study|Adverse Event|1
5274950|NCT00587288|18197385|P1|Overall Study|Adverse Event|0
5274951|NCT00587223|18197403|P1|Overall Study|Adverse Event|1
5274952|NCT00587171|18197420|P2|Overall Study|Lost to Follow-up|1
5274953|NCT00587171|18197421|P1|Overall Study|Lost to Follow-up|1
5274954|NCT00587158|18197451|P2|Overall Study|Subject did not want to take study med|1
5274955|NCT00587158|18197452|P1|Overall Study|Subject did not want to take study med|0
5274956|NCT00587158|18197451|P2|Overall Study|Death|1
5274957|NCT00587158|18197452|P1|Overall Study|Death|0
5274958|NCT00587158|18197451|P2|Overall Study|Lost to Follow-up|2
5274959|NCT00587158|18197452|P1|Overall Study|Lost to Follow-up|1
5274960|NCT00587158|18197451|P2|Overall Study|Physician Decision|1
5274961|NCT00587158|18197452|P1|Overall Study|Physician Decision|0
5274962|NCT00587158|18197451|P2|Overall Study|Did not want to do 24 hr urine collect.|3
5274963|NCT00587158|18197452|P1|Overall Study|Did not want to do 24 hr urine collect.|4
5274964|NCT00587054|18197505|P1|Overall Study|Patient not treated|9
5274965|NCT00586924|18197531|P6|Overall Study|Other|6
5274966|NCT00586924|18197532|P5|Overall Study|Other|1
5274967|NCT00586924|18197533|P4|Overall Study|Other|1
5274968|NCT00586924|18197534|P3|Overall Study|Other|1
5274969|NCT00586924|18197535|P2|Overall Study|Other|0
5274970|NCT00586924|18197536|P1|Overall Study|Other|1
5274971|NCT00586924|18197531|P6|Overall Study|Complete response|2
5274972|NCT00586924|18197532|P5|Overall Study|Complete response|2
5274973|NCT00586924|18197533|P4|Overall Study|Complete response|0
5274974|NCT00586924|18197534|P3|Overall Study|Complete response|0
5274975|NCT00586924|18197535|P2|Overall Study|Complete response|1
5274976|NCT00586924|18197536|P1|Overall Study|Complete response|0
5274977|NCT00586924|18197531|P6|Overall Study|Development of neutralizing antibodies|22
5274978|NCT00586924|18197532|P5|Overall Study|Development of neutralizing antibodies|0
5274979|NCT00586924|18197533|P4|Overall Study|Development of neutralizing antibodies|0
5274980|NCT00586924|18197534|P3|Overall Study|Development of neutralizing antibodies|2
5274981|NCT00586924|18197535|P2|Overall Study|Development of neutralizing antibodies|2
5274982|NCT00586924|18197536|P1|Overall Study|Development of neutralizing antibodies|2
5274983|NCT00586924|18197531|P6|Overall Study|Disease progression|0
5274984|NCT00586924|18197532|P5|Overall Study|Disease progression|1
5274985|NCT00586924|18197533|P4|Overall Study|Disease progression|1
5274986|NCT00586924|18197534|P3|Overall Study|Disease progression|0
5274987|NCT00586924|18197535|P2|Overall Study|Disease progression|0
5274988|NCT00586924|18197536|P1|Overall Study|Disease progression|0
5274989|NCT00586924|18197531|P6|Overall Study|Initiation of alternative cancer therapy|1
5274990|NCT00586924|18197532|P5|Overall Study|Initiation of alternative cancer therapy|0
5274991|NCT00586924|18197533|P4|Overall Study|Initiation of alternative cancer therapy|0
5274992|NCT00586924|18197534|P3|Overall Study|Initiation of alternative cancer therapy|0
5274993|NCT00586924|18197535|P2|Overall Study|Initiation of alternative cancer therapy|0
5274994|NCT00586924|18197536|P1|Overall Study|Initiation of alternative cancer therapy|0
5274995|NCT00586924|18197531|P6|Overall Study|Adverse event/serious adverse event|2
5274996|NCT00586924|18197532|P5|Overall Study|Adverse event/serious adverse event|0
5274997|NCT00586924|18197533|P4|Overall Study|Adverse event/serious adverse event|1
5274998|NCT00586924|18197534|P3|Overall Study|Adverse event/serious adverse event|0
5274999|NCT00586924|18197535|P2|Overall Study|Adverse event/serious adverse event|0
5275000|NCT00586924|18197536|P1|Overall Study|Adverse event/serious adverse event|0
5275001|NCT00586898|18197736|P1|Overall Study|Evaluable for Toxicity Only|5
5275002|NCT00586898|18197736|P1|Overall Study|Patiemt Non-compliance|1
5275003|NCT00586898|18197736|P1|Overall Study|Adverse Event|1
5275004|NCT00586846|18197740|P1|Overall Study|Evaluable for Toxicity Only|4
5275005|NCT00586846|18197740|P1|Overall Study|Death|1
5275006|NCT00586846|18197740|P1|Overall Study|Physician Decision|1
5275007|NCT00586820|18197746|P2|Overall Study|Unsuccessful PCI|0
5275008|NCT00586820|18197747|P1|Overall Study|Unsuccessful PCI|1
5275009|NCT00586703|18197778|P1|Overall Study|Death|12
5275010|NCT00586690|18197785|P2|Overall Study|Lab can't accommodate|0
5275011|NCT00586690|18197786|P1|Overall Study|Lab can't accommodate|1
5275012|NCT00586690|18197785|P2|Overall Study|Lack of Efficacy|0
5275013|NCT00586690|18197786|P1|Overall Study|Lack of Efficacy|2
5275014|NCT00586690|18197785|P2|Overall Study|Adverse Event|0
5275015|NCT00586690|18197786|P1|Overall Study|Adverse Event|1
5275016|NCT00586690|18197785|P2|Overall Study|Disease Progression|0
5275017|NCT00586690|18197786|P1|Overall Study|Disease Progression|10
5275018|NCT00586690|18197785|P2|Overall Study|Death|0
5275019|NCT00586690|18197786|P1|Overall Study|Death|2
5275020|NCT00586664|18197796|P3|Overall Study|Exclusion criteria met|0
5275021|NCT00586664|18197797|P2|Overall Study|Exclusion criteria met|0
5275022|NCT00586664|18197798|P1|Overall Study|Exclusion criteria met|2
5275023|NCT00586664|18197796|P3|Overall Study|Withdrawal by Subject|1
5275024|NCT00586664|18197797|P2|Overall Study|Withdrawal by Subject|7
5275025|NCT00586664|18197798|P1|Overall Study|Withdrawal by Subject|3
5275026|NCT00586625|18197844|P2|Overall Study|Subject unable to return for visit|0
5275027|NCT00586625|18197845|P1|Overall Study|Subject unable to return for visit|2
5275028|NCT00586625|18197844|P2|Overall Study|Subject non-compliance|1
5275029|NCT00586625|18197845|P1|Overall Study|Subject non-compliance|0
5275030|NCT00586625|18197844|P2|Overall Study|Withdrawal by Subject|10
5275031|NCT00586625|18197845|P1|Overall Study|Withdrawal by Subject|32
5275032|NCT00586625|18197844|P2|Overall Study|Protocol Violation|0
5275033|NCT00586625|18197845|P1|Overall Study|Protocol Violation|3
5275034|NCT00586625|18197844|P2|Overall Study|Adverse Event|6
5275035|NCT00586625|18197845|P1|Overall Study|Adverse Event|6
5275036|NCT00586612|18197853|P2|Booster Phase|Lost to Follow-up|1
5275037|NCT00586612|18197854|P1|Booster Phase|Lost to Follow-up|3
5275038|NCT00586612|18197853|P2|Primary Phase|Withdrawal by Subject|2
5275039|NCT00586612|18197854|P1|Primary Phase|Withdrawal by Subject|0
5275040|NCT00586612|18197853|P2|Primary Phase|Lost to Follow-up|1
5275041|NCT00586612|18197854|P1|Primary Phase|Lost to Follow-up|0
5275042|NCT00586612|18197853|P2|Primary Phase|Protocol Violation|0
5275043|NCT00586612|18197854|P1|Primary Phase|Protocol Violation|1
5275044|NCT00586521|18197924|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
5275045|NCT00586508|18197933|P2|Overall Study|Withdrawal by Subject|0
5275046|NCT00586508|18197934|P1|Overall Study|Withdrawal by Subject|4
5275047|NCT00586508|18197933|P2|Overall Study|Adverse Event|4
5275048|NCT00586508|18197934|P1|Overall Study|Adverse Event|12
5275049|NCT00586508|18197933|P2|Overall Study|Death|1
5275050|NCT00586508|18197934|P1|Overall Study|Death|0
5275051|NCT00586508|18197933|P2|Overall Study|Progressive disease|8
5275052|NCT00586508|18197934|P1|Overall Study|Progressive disease|52
5275053|NCT00586495|18197950|P1|Follow-up|Switch to commercial drug|10
5275054|NCT00586495|18197950|P1|Follow-up|Protocol driven decision point|37
5275055|NCT00586495|18197950|P1|Follow-up|Withdrawal by Subject|4
5275056|NCT00586495|18197950|P1|Follow-up|Lost to Follow-up|1
5275057|NCT00586495|18197950|P1|Follow-up|Death|40
5275058|NCT00586495|18197950|P1|Treatment Period|Switch to commercial drug|10
5275059|NCT00586495|18197950|P1|Treatment Period|Disease progression, recurrence/relapse|71
5275060|NCT00586495|18197950|P1|Treatment Period|Withdrawal by Subject|1
5275061|NCT00586495|18197950|P1|Treatment Period|Protocol Violation|1
5275062|NCT00586495|18197950|P1|Treatment Period|Death|1
5275063|NCT00586495|18197950|P1|Treatment Period|Adverse Event|11
5275064|NCT00586469|18197979|P2|Overall Study|Adverse Event|1
5275065|NCT00586469|18197980|P1|Overall Study|Adverse Event|0
5275066|NCT00586339|18198007|P3|Overall Study|Lost to Follow-up|1
5275067|NCT00586339|18198008|P2|Overall Study|Lost to Follow-up|2
5275068|NCT00586339|18198009|P1|Overall Study|Lost to Follow-up|3
5275069|NCT00586339|18198007|P3|Overall Study|Migrated/moved from study area|4
5275070|NCT00586339|18198008|P2|Overall Study|Migrated/moved from study area|2
5275071|NCT00586339|18198009|P1|Overall Study|Migrated/moved from study area|3
5275072|NCT00586339|18198007|P3|Overall Study|Withdrawal by Subject|1
5275073|NCT00586339|18198008|P2|Overall Study|Withdrawal by Subject|3
5275074|NCT00586339|18198009|P1|Overall Study|Withdrawal by Subject|1
5275075|NCT00586326|18198110|P1|Treated Through 5-yr Follow Up-Treated|Other|2
5275076|NCT00586326|18198110|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
5275077|NCT00586326|18198110|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
5275078|NCT00586326|18198110|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
5275079|NCT00586326|18198110|P1|Treated Through 5-yr Follow Up-Treated|Death|2
5275080|NCT00586326|18198110|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
5275081|NCT00586326|18198110|P1|Device Placed toTreatment-ITT|Physician Decision|1
5275082|NCT00586326|18198110|P1|Device Placed toTreatment-ITT|Positive Margins|3
5275083|NCT00586326|18198110|P1|Device Placed toTreatment-ITT|Microinvasion|1
5275084|NCT00586326|18198110|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
5275085|NCT00586326|18198110|P1|Device Placed toTreatment-ITT|Skin Distance|7
5275086|NCT00586326|18198110|P1|Enrollment to Device Placement-Enrolled|Other|1
5275087|NCT00586326|18198110|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
5275088|NCT00586326|18198110|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
5275089|NCT00586326|18198110|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
5275090|NCT00586326|18198110|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
5275091|NCT00586326|18198110|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
5275092|NCT00586313|18198121|P1|Overall Study|Lack of Efficacy|2
5275093|NCT00586157|18198157|P2|Second Intervention|Adverse Event|1
5275094|NCT00586157|18198158|P1|Second Intervention|Adverse Event|0
5275095|NCT00586157|18198157|P2|Second Intervention|Worsening behavior|0
5275096|NCT00586157|18198158|P1|Second Intervention|Worsening behavior|1
5275097|NCT00586157|18198157|P2|Second Intervention|Withdrawal by Subject|0
5275098|NCT00586157|18198158|P1|Second Intervention|Withdrawal by Subject|1
5275099|NCT00586157|18198157|P2|First Intervention|Worsening behavior|0
5275100|NCT00586157|18198158|P1|First Intervention|Worsening behavior|1
5275101|NCT00586105|18198168|P1|Overall Study|Reason not reported|1
5275102|NCT00586105|18198168|P1|Overall Study|Switched to commercial drug|9
5275103|NCT00586105|18198168|P1|Overall Study|Disease progression|19
5275104|NCT00586105|18198168|P1|Overall Study|Withdrawal by Subject|3
5275105|NCT00586105|18198168|P1|Overall Study|Protocol Violation|1
5275106|NCT00586105|18198168|P1|Overall Study|Death|2
5275107|NCT00586105|18198168|P1|Overall Study|Adverse Event|4
5275108|NCT00586066|18198183|P2|Overall Study|Withdrawal of consent|2
5275109|NCT00586066|18198184|P1|Overall Study|Withdrawal of consent|4
5275110|NCT00586066|18198183|P2|Overall Study|Physician Decision|0
5275111|NCT00586066|18198184|P1|Overall Study|Physician Decision|1
5275112|NCT00586066|18198183|P2|Overall Study|Adverse Event|2
5275113|NCT00586066|18198184|P1|Overall Study|Adverse Event|2
5275114|NCT00586066|18198183|P2|Overall Study|Lack of Efficacy|3
5275115|NCT00586066|18198184|P1|Overall Study|Lack of Efficacy|5
5275116|NCT00586066|18198183|P2|Overall Study|Lost to Follow-up|3
5275117|NCT00586066|18198184|P1|Overall Study|Lost to Follow-up|6
5275118|NCT00585975|18198241|P2|Overall Study|Enrollment met/over-enrolled|9
5275119|NCT00585975|18198242|P1|Overall Study|Enrollment met/over-enrolled|10
5275120|NCT00585975|18198241|P2|Overall Study|Lost to Follow-up|1
5275121|NCT00585975|18198242|P1|Overall Study|Lost to Follow-up|2
5275122|NCT00585975|18198241|P2|Overall Study|Withdrawal by Subject|3
5275123|NCT00585975|18198242|P1|Overall Study|Withdrawal by Subject|3
5275124|NCT00585923|18198252|P2|Overall Study|Physician decided not to continue|33
5275125|NCT00585923|18198253|P1|Overall Study|Physician decided not to continue|31
5275126|NCT00585689|18198305|P1|Overall Study|Death|1
5275127|NCT00585689|18198305|P1|Overall Study|Patient had unresectable disease|1
5275128|NCT00585689|18198305|P1|Overall Study|Patient Declined Surgery|1
5275129|NCT00585689|18198305|P1|Overall Study|Adverse Event|1
5275130|NCT00585689|18198305|P1|Overall Study|Received different ABI-007 schedule|3
5275131|NCT00585585|18198364|P1|Overall Study|Adverse Event|1
5275132|NCT00585546|18198368|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
5275133|NCT00585546|18198368|P1|Clenbuterol Treatment - up to 12 Months|Death|1
5275134|NCT00585533|18198382|P1|Overall Study|objective or symptomatic progression|9
5275135|NCT00585468|18198391|P2|First Intervention|Withdrawal by Subject|1
5275136|NCT00585468|18198392|P1|First Intervention|Withdrawal by Subject|1
5275137|NCT00585351|18198424|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5275138|NCT00585351|18198425|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5275139|NCT00585351|18198426|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
5275140|NCT00585351|18198427|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
5275141|NCT00585351|18198428|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5275142|NCT00585351|18198429|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5275143|NCT00585351|18198430|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5275144|NCT00585351|18198431|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5275145|NCT00585351|18198424|P8|Enrollment Period (Intervention)|Death|0
5275146|NCT00585351|18198425|P7|Enrollment Period (Intervention)|Death|1
5275147|NCT00585351|18198426|P6|Enrollment Period (Intervention)|Death|0
5275148|NCT00585351|18198427|P5|Enrollment Period (Intervention)|Death|1
5275149|NCT00585351|18198428|P4|Enrollment Period (Intervention)|Death|0
5275150|NCT00585351|18198429|P3|Enrollment Period (Intervention)|Death|0
5275151|NCT00585351|18198430|P2|Enrollment Period (Intervention)|Death|0
5275152|NCT00585351|18198431|P1|Enrollment Period (Intervention)|Death|0
5275153|NCT00585351|18198424|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
5275154|NCT00585351|18198425|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
5275155|NCT00585351|18198426|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
5275156|NCT00585351|18198427|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
5275157|NCT00585351|18198428|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
5275158|NCT00585351|18198429|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
5275159|NCT00585351|18198430|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
5275160|NCT00585351|18198431|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
5275161|NCT00585351|18198424|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5275162|NCT00585351|18198425|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5275163|NCT00585351|18198426|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5275164|NCT00585351|18198427|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5275165|NCT00585351|18198428|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5275166|NCT00585351|18198429|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5275167|NCT00585351|18198430|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
5275168|NCT00585351|18198431|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
5275169|NCT00585351|18198424|P8|Notification Period (Informed Consent)|No study medication on flight|0
5275170|NCT00585351|18198425|P7|Notification Period (Informed Consent)|No study medication on flight|0
5275171|NCT00585351|18198426|P6|Notification Period (Informed Consent)|No study medication on flight|0
5275172|NCT00585351|18198427|P5|Notification Period (Informed Consent)|No study medication on flight|0
5275173|NCT00585351|18198428|P4|Notification Period (Informed Consent)|No study medication on flight|0
5275174|NCT00585351|18198429|P3|Notification Period (Informed Consent)|No study medication on flight|0
5275175|NCT00585351|18198430|P2|Notification Period (Informed Consent)|No study medication on flight|1
5275176|NCT00585351|18198431|P1|Notification Period (Informed Consent)|No study medication on flight|0
5275177|NCT00585351|18198424|P8|Notification Period (Informed Consent)|Flight aborted|0
5275178|NCT00585351|18198425|P7|Notification Period (Informed Consent)|Flight aborted|0
5275179|NCT00585351|18198426|P6|Notification Period (Informed Consent)|Flight aborted|0
5275180|NCT00585351|18198427|P5|Notification Period (Informed Consent)|Flight aborted|0
5275181|NCT00585351|18198428|P4|Notification Period (Informed Consent)|Flight aborted|0
5275182|NCT00585351|18198429|P3|Notification Period (Informed Consent)|Flight aborted|0
5275183|NCT00585351|18198430|P2|Notification Period (Informed Consent)|Flight aborted|1
5275184|NCT00585351|18198431|P1|Notification Period (Informed Consent)|Flight aborted|2
5275185|NCT00585351|18198424|P8|Notification Period (Informed Consent)|Physician Decision|0
5275186|NCT00585351|18198425|P7|Notification Period (Informed Consent)|Physician Decision|0
5275187|NCT00585351|18198426|P6|Notification Period (Informed Consent)|Physician Decision|0
5275188|NCT00585351|18198427|P5|Notification Period (Informed Consent)|Physician Decision|0
5275189|NCT00585351|18198428|P4|Notification Period (Informed Consent)|Physician Decision|0
5275190|NCT00585351|18198429|P3|Notification Period (Informed Consent)|Physician Decision|0
5275191|NCT00585351|18198430|P2|Notification Period (Informed Consent)|Physician Decision|2
5275192|NCT00585351|18198431|P1|Notification Period (Informed Consent)|Physician Decision|0
5275193|NCT00585325|18198447|P2|Overall Study|Withdrawal by Subject|1
5275194|NCT00585325|18198448|P1|Overall Study|Withdrawal by Subject|1
5275195|NCT00585312|18198456|P2|Overall Study|Study terminated by the sponsor|31
5275196|NCT00585312|18198457|P1|Overall Study|Study terminated by the sponsor|34
5275197|NCT00585312|18198456|P2|Overall Study|Withdrawal by Subject|1
5275198|NCT00585312|18198457|P1|Overall Study|Withdrawal by Subject|5
5275199|NCT00585312|18198456|P2|Overall Study|Reason not specified|0
5275200|NCT00585312|18198457|P1|Overall Study|Reason not specified|2
5275201|NCT00585312|18198456|P2|Overall Study|Lost to Follow-up|1
5275202|NCT00585312|18198457|P1|Overall Study|Lost to Follow-up|1
5275203|NCT00585312|18198456|P2|Overall Study|Lack of Efficacy|11
5275204|NCT00585312|18198457|P1|Overall Study|Lack of Efficacy|6
5275205|NCT00585312|18198456|P2|Overall Study|Adverse Event|0
5275206|NCT00585312|18198457|P1|Overall Study|Adverse Event|3
5275207|NCT00585286|18198469|P1|Overall Study|Lost to Follow-up|1
5275208|NCT00585221|18198485|P1|Overall Study|Protocol Violation|8
5275209|NCT00585169|18198495|P1|Overall Study|Withdrawal by Subject|1
5275210|NCT00585078|18198505|P1|Overall Study|Death|1
5275211|NCT00585078|18198505|P1|Overall Study|Adverse Event|10
5275212|NCT00585078|18198505|P1|Overall Study|Disease Progression|24
5275213|NCT00585078|18198505|P1|Overall Study|Poor performance status|1
5275214|NCT00585078|18198505|P1|Overall Study|Withdrawal by Subject|4
5275215|NCT00585052|18198512|P1|Overall Study|Withdrawal by Subject|1
5275216|NCT00585039|18198519|P2|Overall Study|medication spilled|0
5275217|NCT00585039|18198520|P1|Overall Study|medication spilled|2
5275218|NCT00584987|18198549|P4|Overall Study|Adverse Event|1
5275219|NCT00584987|18198550|P3|Overall Study|Adverse Event|0
5275220|NCT00584987|18198551|P2|Overall Study|Adverse Event|0
5275221|NCT00584987|18198552|P1|Overall Study|Adverse Event|0
5275222|NCT00584987|18198549|P4|Overall Study|Protocol Violation|0
5275223|NCT00584987|18198550|P3|Overall Study|Protocol Violation|1
5275224|NCT00584987|18198551|P2|Overall Study|Protocol Violation|1
5275225|NCT00584987|18198552|P1|Overall Study|Protocol Violation|1
5275226|NCT00584909|18198604|P1|Overall Study|Adverse Event|4
5275227|NCT00584844|18198614|P1|Overall Study|Screen Failure|20
5275228|NCT00584844|18198614|P1|Overall Study|Withdrawal by Subject|59
5275229|NCT00584805|18198664|P1|Overall Study|Screen failures|2
5275230|NCT00584805|18198664|P1|Overall Study|Lost to follow up|3
5275231|NCT00584805|18198664|P1|Overall Study|Non-compliance|1
5275232|NCT00584805|18198664|P1|Overall Study|Withdrawal by Subject|18
5275233|NCT00584805|18198664|P1|Overall Study|Relocation|36
5275234|NCT00584805|18198664|P1|Overall Study|No longer at risk of exposure|39
5275235|NCT00584740|18198677|P2|Overall Study|Lost to Follow-up|1
5275236|NCT00584740|18198678|P1|Overall Study|Lost to Follow-up|0
5275237|NCT00584740|18198677|P2|Overall Study|Withdrawal by Subject|2
5275238|NCT00584740|18198678|P1|Overall Study|Withdrawal by Subject|3
5275239|NCT00584740|18198677|P2|Overall Study|Lack of Efficacy|2
5275240|NCT00584740|18198678|P1|Overall Study|Lack of Efficacy|8
5275241|NCT00584740|18198677|P2|Overall Study|Adverse Event|1
5275242|NCT00584740|18198678|P1|Overall Study|Adverse Event|1
5275243|NCT00584727|18198696|P6|Third Intervention|Protocol Violation|2
5275244|NCT00584727|18198697|P5|Third Intervention|Protocol Violation|4
5275245|NCT00584727|18198698|P4|Third Intervention|Protocol Violation|0
5275246|NCT00584727|18198699|P3|Third Intervention|Protocol Violation|1
5275247|NCT00584727|18198700|P2|Third Intervention|Protocol Violation|0
5275248|NCT00584727|18198701|P1|Third Intervention|Protocol Violation|0
5275249|NCT00584727|18198696|P6|First Intervention|Discontinuation|0
5275250|NCT00584727|18198697|P5|First Intervention|Discontinuation|0
5275251|NCT00584727|18198698|P4|First Intervention|Discontinuation|0
5275252|NCT00584727|18198699|P3|First Intervention|Discontinuation|1
5275253|NCT00584727|18198700|P2|First Intervention|Discontinuation|0
5275254|NCT00584727|18198701|P1|First Intervention|Discontinuation|0
5275255|NCT00584454|18198739|P1|Overall Study|Clinical Hold|2
5275256|NCT00584454|18198739|P1|Overall Study|Relocation|1
5275257|NCT00584454|18198739|P1|Overall Study|Adverse Event|1
5275258|NCT00584415|18198743|P1|Overall Study|Adverse Event|7
5275259|NCT00584194|18198766|P1|Overall Study|Other|135
5275260|NCT00584012|18198779|P1|Overall Study|Withdrawal by Subject|1
5275261|NCT00583947|18198785|P2|Cross-over Period|Other|1
5275262|NCT00583947|18198786|P1|Cross-over Period|Other|1
5275263|NCT00583947|18198785|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
5275264|NCT00583947|18198786|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
5275265|NCT00583947|18198785|P2|Cross-over Period|Withdrawal by Subject|0
5275266|NCT00583947|18198786|P1|Cross-over Period|Withdrawal by Subject|2
5275267|NCT00583947|18198785|P2|Cross-over Period|Adverse Event|0
5275268|NCT00583947|18198786|P1|Cross-over Period|Adverse Event|2
5275269|NCT00583791|18198907|P1|Overall Study|Death|6
5275270|NCT00583791|18198907|P1|Overall Study|Other|67
5275271|NCT00583596|18198962|P1|Overall Study|Outside f-up window|26
5275272|NCT00583596|18198962|P1|Overall Study|Not consented|15
5275273|NCT00583596|18198962|P1|Overall Study|Data not complete|1
5275274|NCT00583596|18198962|P1|Overall Study|Lost to Follow-up|94
5275275|NCT00583596|18198962|P1|Overall Study|Withdrawal by Subject|6
5275276|NCT00583596|18198962|P1|Overall Study|Death|2
5275277|NCT00583596|18198962|P1|Overall Study|Excluded due to Hurricane Katrina|30
5275278|NCT00583596|18198962|P1|Overall Study|Lost to Follow-up|110
5275279|NCT00583557|18198967|P1|Overall Study|Did not receive belimumab in LBRA99|2
5275280|NCT00583557|18198967|P1|Overall Study|Other|5
5275281|NCT00583557|18198967|P1|Overall Study|Lack of Compliance|5
5275282|NCT00583557|18198967|P1|Overall Study|Lack of Efficacy|31
5275283|NCT00583557|18198967|P1|Overall Study|Adverse Event|9
5275284|NCT00583557|18198967|P1|Overall Study|Withdrawal by Subject|18
5275285|NCT00583453|18198998|P2|Overall Study|discontinued intervention|2
5275286|NCT00583453|18198999|P1|Overall Study|discontinued intervention|0
5275287|NCT00583362|18199036|P1|Overall Study|Withdrawal by Subject|57
5275288|NCT00583362|18199036|P1|Overall Study|Protocol Violation|2
5275289|NCT00583362|18199036|P1|Overall Study|Physician Decision|19
5275290|NCT00583362|18199036|P1|Overall Study|Sponsor request due to missed doses|1
5275291|NCT00583362|18199036|P1|Overall Study|Behavioral problems and non-compliance|1
5275292|NCT00583362|18199036|P1|Overall Study|Misunderstanding of protocol|1
5275293|NCT00583362|18199036|P1|Overall Study|Missed visits due to staff changes|1
5275294|NCT00583362|18199036|P1|Overall Study|Subject moved out of the country/state|2
5275295|NCT00583362|18199036|P1|Overall Study|Subject not dosed in LBSL99|1
5275296|NCT00583362|18199036|P1|Overall Study|Current site closed|7
5275297|NCT00583362|18199036|P1|Overall Study|Miscommunication of visit window|5
5275298|NCT00583362|18199036|P1|Overall Study|Pregnancy|7
5275299|NCT00583362|18199036|P1|Overall Study|Non-compliance with study drug|28
5275300|NCT00583362|18199036|P1|Overall Study|Lost to Follow-up|4
5275301|NCT00583362|18199036|P1|Overall Study|Lack of Efficacy|22
5275302|NCT00583362|18199036|P1|Overall Study|Adverse Event|44
5275303|NCT00583219|18199060|P1|Phase 2|Withdrawal by Subject|1
5275304|NCT00583115|18199077|P1|Overall Study|Death|1
5275305|NCT00583102|18199082|P1|Overall Study|Adverse Event|3
5275306|NCT00582972|18199099|P1|Overall Study|Protocol Violation|2
5275307|NCT00582933|18199108|P1|Overall Study|Physician Decision|3
5275308|NCT00582907|18199112|P4|2nd Course|Lack of Efficacy|0
5275309|NCT00582907|18199113|P3|2nd Course|Lack of Efficacy|0
5275310|NCT00582907|18199114|P2|2nd Course|Lack of Efficacy|0
5275311|NCT00582907|18199115|P1|2nd Course|Lack of Efficacy|1
5275312|NCT00582907|18199112|P4|1st Course|Lost to Follow-up|1
5275313|NCT00582907|18199113|P3|1st Course|Lost to Follow-up|0
5275314|NCT00582907|18199114|P2|1st Course|Lost to Follow-up|0
5275315|NCT00582907|18199115|P1|1st Course|Lost to Follow-up|0
5275316|NCT00582907|18199112|P4|1st Course|Withdrawal by Subject|0
5275317|NCT00582907|18199113|P3|1st Course|Withdrawal by Subject|0
5275318|NCT00582907|18199114|P2|1st Course|Withdrawal by Subject|0
5275319|NCT00582907|18199115|P1|1st Course|Withdrawal by Subject|1
5275320|NCT00582816|18199154|P1|Overall Study|Engraftment Failure|3
5275321|NCT00582790|18199164|P1|Overall Study|Rapid progression of disease|1
5275322|NCT00582738|18199173|P2|Overall Study|Withdrawal by Subject|3
5275323|NCT00582738|18199174|P1|Overall Study|Withdrawal by Subject|0
5275324|NCT00582738|18199173|P2|Overall Study|Protocol Violation|1
5275325|NCT00582738|18199174|P1|Overall Study|Protocol Violation|1
5275326|NCT00582738|18199173|P2|Overall Study|Other|0
5275327|NCT00582738|18199174|P1|Overall Study|Other|1
5275328|NCT00582738|18199173|P2|Overall Study|Graft Lost|1
5275329|NCT00582738|18199174|P1|Overall Study|Graft Lost|0
5275330|NCT00582738|18199173|P2|Overall Study|Adverse Event|5
5275331|NCT00582738|18199174|P1|Overall Study|Adverse Event|0
5275332|NCT00582738|18199173|P2|Overall Study|Administrative Problems|8
5275333|NCT00582738|18199174|P1|Overall Study|Administrative Problems|7
5275334|NCT00582712|18199198|P1|Overall Study|Complicating disease requiring treatment|1
5275335|NCT00582712|18199198|P1|Overall Study|Withdrawal by Subject|1
5275336|NCT00582712|18199198|P1|Overall Study|Lack of Efficacy|1
5275337|NCT00582712|18199198|P1|Overall Study|Adverse Event|1
5275338|NCT00582608|18199213|P1|Overall Study|Lack of accrual|4
5275339|NCT00582608|18199213|P1|Overall Study|Patient Ineligible|1
5275340|NCT00582608|18199213|P1|Overall Study|Not Treated|7
5275341|NCT00582556|18199220|P3|Overall Study|Physician Decision|1
5275342|NCT00582556|18199221|P2|Overall Study|Physician Decision|0
5275343|NCT00582556|18199222|P1|Overall Study|Physician Decision|0
5275344|NCT00582556|18199220|P3|Overall Study|Withdrawal by Subject|1
5275345|NCT00582556|18199221|P2|Overall Study|Withdrawal by Subject|1
5275346|NCT00582556|18199222|P1|Overall Study|Withdrawal by Subject|0
5275347|NCT00582491|18199250|P2|Overall Study|Withdrawal by Subject|0
5275348|NCT00582491|18199251|P1|Overall Study|Withdrawal by Subject|1
5275349|NCT00582426|18199275|P2|Overall Study|Use of illicit drugs|0
5275350|NCT00582426|18199276|P1|Overall Study|Use of illicit drugs|1
5275351|NCT00582426|18199275|P2|Overall Study|Disease Progression|2
5275352|NCT00582426|18199276|P1|Overall Study|Disease Progression|2
5275353|NCT00582426|18199275|P2|Overall Study|Withdrawal by Subject|2
5275354|NCT00582426|18199276|P1|Overall Study|Withdrawal by Subject|3
5275355|NCT00582426|18199275|P2|Overall Study|Death|3
5275356|NCT00582426|18199276|P1|Overall Study|Death|4
5275357|NCT00582426|18199275|P2|Overall Study|Protocol Violation|2
5275358|NCT00582426|18199276|P1|Overall Study|Protocol Violation|6
5275359|NCT00582426|18199275|P2|Overall Study|Adverse Event|2
5275360|NCT00582426|18199276|P1|Overall Study|Adverse Event|4
5275361|NCT00582426|18199275|P2|Overall Study|Lost to Follow-up|2
5275362|NCT00582426|18199276|P1|Overall Study|Lost to Follow-up|0
5275363|NCT00582309|18199323|P3|Overall Study|Protocol Violation|2
5275364|NCT00582309|18199324|P2|Overall Study|Protocol Violation|0
5275365|NCT00582309|18199325|P1|Overall Study|Protocol Violation|0
5275366|NCT00582166|18199338|P1|Overall Study|Ineligible pathology|1
5275367|NCT00582166|18199338|P1|Overall Study|Death|1
5275368|NCT00582114|18199348|P2|Overall Study|Stopped by data safety monitoring board|20
5275369|NCT00582114|18199349|P1|Overall Study|Stopped by data safety monitoring board|19
5275370|NCT00582114|18199348|P2|Overall Study|Physician Decision|6
5275371|NCT00582114|18199349|P1|Overall Study|Physician Decision|0
5275372|NCT00582114|18199348|P2|Overall Study|Adverse Event|1
5275373|NCT00582114|18199349|P1|Overall Study|Adverse Event|1
5275374|NCT00582114|18199348|P2|Overall Study|Withdrawal by Subject|16
5275375|NCT00582114|18199349|P1|Overall Study|Withdrawal by Subject|8
5275376|NCT00582114|18199348|P2|Overall Study|Lost to Follow-up|6
5275377|NCT00582114|18199349|P1|Overall Study|Lost to Follow-up|7
5275378|NCT00582114|18199348|P2|Overall Study|Kidney Transplant|1
5275379|NCT00582114|18199349|P1|Overall Study|Kidney Transplant|3
5275380|NCT00582114|18199348|P2|Overall Study|Death|4
5275381|NCT00582114|18199349|P1|Overall Study|Death|4
5275382|NCT00582036|18199364|P2|Overall Study|Withdrawal by Subject|1
5275383|NCT00582036|18199365|P1|Overall Study|Withdrawal by Subject|0
5275384|NCT00582010|18199373|P2|Overall Study|Death|1
5275385|NCT00582010|18199374|P1|Overall Study|Death|0
5275386|NCT00581945|18199403|P2|Overall Study|Death|0
5275387|NCT00581945|18199404|P1|Overall Study|Death|1
5275388|NCT00581945|18199403|P2|Overall Study|Withdrawal by Subject|6
5275389|NCT00581945|18199404|P1|Overall Study|Withdrawal by Subject|2
5275390|NCT00581945|18199403|P2|Overall Study|Unsatisfactory therapeutic effect|0
5275391|NCT00581945|18199404|P1|Overall Study|Unsatisfactory therapeutic effect|2
5275392|NCT00581945|18199403|P2|Overall Study|Adverse Event|4
5275393|NCT00581945|18199404|P1|Overall Study|Adverse Event|4
5275394|NCT00581919|18199420|P1|Overall Study|Withdrawal by Subject|1
5275395|NCT00581919|18199420|P1|Overall Study|Started Non-Protocol Therapy|2
5275396|NCT00581919|18199420|P1|Overall Study|Other Complicating Disease|1
5275397|NCT00581919|18199420|P1|Overall Study|Physician Decision|1
5275398|NCT00581919|18199420|P1|Overall Study|Disease Progression|10
5275399|NCT00581919|18199420|P1|Overall Study|Death|1
5275400|NCT00581919|18199420|P1|Overall Study|Adverse Event|8
5275401|NCT00581828|18199439|P1|Overall Study|Protocol Violation|1
5275402|NCT00581776|18199443|P1|Overall Study|Disease progression or no response|3
5275403|NCT00581555|18199461|P2|Overall Study|Other reasons|4
5275404|NCT00581555|18199462|P1|Overall Study|Other reasons|16
5275405|NCT00581555|18199461|P2|Overall Study|Lost to Follow-up|2
5275406|NCT00581555|18199462|P1|Overall Study|Lost to Follow-up|2
5275407|NCT00581555|18199461|P2|Overall Study|Withdrawal by Subject|9
5275408|NCT00581555|18199462|P1|Overall Study|Withdrawal by Subject|18
5275409|NCT00581555|18199461|P2|Overall Study|Physician Decision|2
5275410|NCT00581555|18199462|P1|Overall Study|Physician Decision|3
5275411|NCT00581555|18199461|P2|Overall Study|Adverse Event|3
5275412|NCT00581555|18199462|P1|Overall Study|Adverse Event|4
5275413|NCT00581542|18199486|P2|Overall Study|Lost to Follow-up|21
5275414|NCT00581542|18199487|P1|Overall Study|Lost to Follow-up|9
5275415|NCT00581542|18199486|P2|Overall Study|they met an exclusion criteria|2
5275416|NCT00581542|18199487|P1|Overall Study|they met an exclusion criteria|2
5275417|NCT00581360|18199541|P1|Overall Study|Withdrawal by Subject|1
5275418|NCT00581308|18199560|P1|Month 12|Other|1
5275419|NCT00581308|18199560|P1|Month 12|Device Removed|1
5275420|NCT00581308|18199560|P1|Month 12|Withdrawal by Subject|3
5275421|NCT00581308|18199560|P1|Month 12|Lost to Follow-up|14
5275422|NCT00581308|18199560|P1|Month 12|Death|1
5275423|NCT00581308|18199560|P1|Month 6|Withdrawal by Subject|2
5275424|NCT00581308|18199560|P1|Month 6|Lost to Follow-up|1
5275425|NCT00581308|18199560|P1|Month 1|Uknown|1
5275426|NCT00581308|18199560|P1|Month 1|Device Removed|2
5275427|NCT00581308|18199560|P1|Month 1|Withdrawal by Subject|2
5275428|NCT00581308|18199560|P1|Month 1|Lost to Follow-up|3
5275429|NCT00581308|18199560|P1|Pre Discharge|Device Removed|1
5275430|NCT00581308|18199560|P1|Pre Discharge|Lost to Follow-up|1
5275431|NCT00581113|18199591|P2|Overall Study|Withdrawal by Subject|1
5275432|NCT00581113|18199592|P1|Overall Study|Withdrawal by Subject|0
5275433|NCT00581100|18199602|P2|Overall Study|Other|0
5275434|NCT00581100|18199603|P1|Overall Study|Other|3
5275435|NCT00581100|18199602|P2|Overall Study|Withdrawal by Subject|4
5275436|NCT00581100|18199603|P1|Overall Study|Withdrawal by Subject|1
5275437|NCT00581100|18199602|P2|Overall Study|Adverse Event|1
5275438|NCT00581100|18199603|P1|Overall Study|Adverse Event|2
5275439|NCT00581100|18199602|P2|Overall Study|Death|0
5275440|NCT00581100|18199603|P1|Overall Study|Death|1
5275441|NCT00580983|18199656|P1|Overall Study|Did not complete 12 mon post RT studies|7
5275442|NCT00580970|18199663|P1|Treatment (Lovastatin)|Death|1
5275443|NCT00580970|18199663|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
5275444|NCT00580970|18199663|P1|Treatment (Lovastatin)|Physician Decision|4
5275445|NCT00580970|18199663|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
5275446|NCT00580970|18199663|P1|Treatment (Lovastatin)|Non-compliance|6
5275447|NCT00580970|18199663|P1|Pre-treatment|Non-compliance|1
5275448|NCT00580866|18199678|P2|Overall Study|Lost to Follow-up|2
5275449|NCT00580866|18199679|P1|Overall Study|Lost to Follow-up|2
5275450|NCT00580840|18199703|P4|Double-Blind|Other: Forbidden Medication|0
5275451|NCT00580840|18199704|P3|Double-Blind|Other: Forbidden Medication|1
5275452|NCT00580840|18199705|P2|Double-Blind|Other: Forbidden Medication|0
5275453|NCT00580840|18199706|P1|Double-Blind|Other: Forbidden Medication|0
5275454|NCT00580840|18199703|P4|Double-Blind|Other: Discontinued Methotrexate|0
5275455|NCT00580840|18199704|P3|Double-Blind|Other: Discontinued Methotrexate|0
5275456|NCT00580840|18199705|P2|Double-Blind|Other: Discontinued Methotrexate|1
5275457|NCT00580840|18199706|P1|Double-Blind|Other: Discontinued Methotrexate|0
5275458|NCT00580840|18199703|P4|Double-Blind|Withdrawal by Subject|2
5275459|NCT00580840|18199704|P3|Double-Blind|Withdrawal by Subject|2
5275460|NCT00580840|18199705|P2|Double-Blind|Withdrawal by Subject|1
5275461|NCT00580840|18199706|P1|Double-Blind|Withdrawal by Subject|0
5275462|NCT00580840|18199703|P4|Double-Blind|Lost to Follow-up|2
5275463|NCT00580840|18199704|P3|Double-Blind|Lost to Follow-up|0
5275464|NCT00580840|18199705|P2|Double-Blind|Lost to Follow-up|1
5275465|NCT00580840|18199706|P1|Double-Blind|Lost to Follow-up|0
5275466|NCT00580840|18199703|P4|Double-Blind|Loss of Efficacy|10
5275467|NCT00580840|18199704|P3|Double-Blind|Loss of Efficacy|2
5275468|NCT00580840|18199705|P2|Double-Blind|Loss of Efficacy|1
5275469|NCT00580840|18199706|P1|Double-Blind|Loss of Efficacy|0
5275470|NCT00580840|18199703|P4|Double-Blind|Adverse Event|1
5275471|NCT00580840|18199704|P3|Double-Blind|Adverse Event|4
5275472|NCT00580840|18199705|P2|Double-Blind|Adverse Event|3
5275473|NCT00580840|18199706|P1|Double-Blind|Adverse Event|0
5275474|NCT00580840|18199703|P4|Run-in|Other: Exclusionary Lab Value|0
5275475|NCT00580840|18199704|P3|Run-in|Other: Exclusionary Lab Value|0
5275476|NCT00580840|18199705|P2|Run-in|Other: Exclusionary Lab Value|0
5275477|NCT00580840|18199706|P1|Run-in|Other: Exclusionary Lab Value|1
5275478|NCT00580840|18199703|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
5275479|NCT00580840|18199704|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
5275571|NCT00579670|18200130|P5|Overall Study|Lost to Follow-up|0
5275480|NCT00580840|18199705|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
5275481|NCT00580840|18199706|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
5275482|NCT00580840|18199703|P4|Run-in|Other: Per Sponsor Request|0
5275483|NCT00580840|18199704|P3|Run-in|Other: Per Sponsor Request|0
5275484|NCT00580840|18199705|P2|Run-in|Other: Per Sponsor Request|0
5275485|NCT00580840|18199706|P1|Run-in|Other: Per Sponsor Request|2
5275486|NCT00580840|18199703|P4|Run-in|Withdrawal by Subject|0
5275487|NCT00580840|18199704|P3|Run-in|Withdrawal by Subject|0
5275488|NCT00580840|18199705|P2|Run-in|Withdrawal by Subject|0
5275489|NCT00580840|18199706|P1|Run-in|Withdrawal by Subject|5
5275490|NCT00580840|18199703|P4|Run-in|Lost to Follow-up|0
5275491|NCT00580840|18199704|P3|Run-in|Lost to Follow-up|0
5275492|NCT00580840|18199705|P2|Run-in|Lost to Follow-up|0
5275493|NCT00580840|18199706|P1|Run-in|Lost to Follow-up|4
5275494|NCT00580840|18199703|P4|Run-in|Loss of Efficacy|0
5275495|NCT00580840|18199704|P3|Run-in|Loss of Efficacy|0
5275496|NCT00580840|18199705|P2|Run-in|Loss of Efficacy|0
5275497|NCT00580840|18199706|P1|Run-in|Loss of Efficacy|1
5275498|NCT00580840|18199703|P4|Run-in|Lack of Efficacy|0
5275499|NCT00580840|18199704|P3|Run-in|Lack of Efficacy|0
5275500|NCT00580840|18199705|P2|Run-in|Lack of Efficacy|0
5275501|NCT00580840|18199706|P1|Run-in|Lack of Efficacy|93
5275502|NCT00580840|18199703|P4|Run-in|Adverse Event|0
5275503|NCT00580840|18199704|P3|Run-in|Adverse Event|0
5275504|NCT00580840|18199705|P2|Run-in|Adverse Event|0
5275505|NCT00580840|18199706|P1|Run-in|Adverse Event|17
5275506|NCT00580801|18199814|P3|Overall Study|Travel|0
5275507|NCT00580801|18199815|P2|Overall Study|Travel|0
5275508|NCT00580801|18199816|P1|Overall Study|Travel|1
5275509|NCT00580801|18199814|P3|Overall Study|Participant non-compliant|1
5275510|NCT00580801|18199815|P2|Overall Study|Participant non-compliant|0
5275511|NCT00580801|18199816|P1|Overall Study|Participant non-compliant|0
5275512|NCT00580801|18199814|P3|Overall Study|Reached a virologic endpoint|2
5275513|NCT00580801|18199815|P2|Overall Study|Reached a virologic endpoint|1
5275514|NCT00580801|18199816|P1|Overall Study|Reached a virologic endpoint|0
5275515|NCT00580801|18199814|P3|Overall Study|Lost to Follow-up|0
5275516|NCT00580801|18199815|P2|Overall Study|Lost to Follow-up|0
5275517|NCT00580801|18199816|P1|Overall Study|Lost to Follow-up|2
5275518|NCT00580801|18199814|P3|Overall Study|Adverse Event|0
5275519|NCT00580801|18199815|P2|Overall Study|Adverse Event|0
5275520|NCT00580801|18199816|P1|Overall Study|Adverse Event|2
5275521|NCT00580801|18199814|P3|Overall Study|Physician Decision|0
5275522|NCT00580801|18199815|P2|Overall Study|Physician Decision|0
5275523|NCT00580801|18199816|P1|Overall Study|Physician Decision|1
5275524|NCT00580788|18199855|P4|Overall Study|Adverse Event|1
5275525|NCT00580788|18199856|P3|Overall Study|Adverse Event|0
5275526|NCT00580788|18199857|P2|Overall Study|Adverse Event|0
5275527|NCT00580788|18199858|P1|Overall Study|Adverse Event|0
5275528|NCT00580723|18199916|P1|Overall Study|Lost to Follow-up|5
5275529|NCT00580723|18199916|P1|Overall Study|Did not want to participate in extension|3
5275530|NCT00580606|18199959|P2|Open Label (OL)|Needed Prohibited Medication|1
5275531|NCT00580606|18199960|P1|Open Label (OL)|Needed Prohibited Medication|0
5275532|NCT00580606|18199959|P2|Open Label (OL)|Physician Decision|1
5275533|NCT00580606|18199960|P1|Open Label (OL)|Physician Decision|1
5275534|NCT00580606|18199959|P2|Open Label (OL)|Non-compliance|0
5275535|NCT00580606|18199960|P1|Open Label (OL)|Non-compliance|2
5275536|NCT00580606|18199959|P2|Open Label (OL)|Pregnancy|1
5275537|NCT00580606|18199960|P1|Open Label (OL)|Pregnancy|0
5275538|NCT00580606|18199959|P2|Open Label (OL)|Lost to Follow-up|1
5275539|NCT00580606|18199960|P1|Open Label (OL)|Lost to Follow-up|0
5275540|NCT00580606|18199959|P2|Open Label (OL)|Dosing Symptoms|1
5275541|NCT00580606|18199960|P1|Open Label (OL)|Dosing Symptoms|0
5275542|NCT00580606|18199959|P2|Open Label (OL)|Withdrawal by Subject|6
5275543|NCT00580606|18199960|P1|Open Label (OL)|Withdrawal by Subject|4
5275544|NCT00580606|18199959|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
5275545|NCT00580606|18199960|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
5275546|NCT00580047|18200041|P3|Overall Study|Withdrawal by Subject|0
5275547|NCT00580047|18200042|P2|Overall Study|Withdrawal by Subject|0
5275548|NCT00580047|18200043|P1|Overall Study|Withdrawal by Subject|1
5275549|NCT00580047|18200041|P3|Overall Study|Withdrawal by Subject|2
5275550|NCT00580047|18200042|P2|Overall Study|Withdrawal by Subject|1
5275551|NCT00580047|18200043|P1|Overall Study|Withdrawal by Subject|1
5275552|NCT00580047|18200041|P3|Overall Study|Lost to Follow-up|0
5275553|NCT00580047|18200042|P2|Overall Study|Lost to Follow-up|1
5275554|NCT00580047|18200043|P1|Overall Study|Lost to Follow-up|1
5275555|NCT00580034|18200054|P2|Overall Study|Toxicity|0
5275556|NCT00580034|18200055|P1|Overall Study|Toxicity|10
5275557|NCT00579982|18200061|P1|Overall Study|Protocol Violation|4
5275558|NCT00579982|18200061|P1|Overall Study|Adverse Event|4
5275559|NCT00579826|18200095|P2|Overall Study|Withdrawal by Subject|3
5275560|NCT00579826|18200096|P1|Overall Study|Withdrawal by Subject|5
5275561|NCT00579670|18200130|P5|Overall Study|Withdrawal by Subject|0
5275562|NCT00579670|18200131|P4|Overall Study|Withdrawal by Subject|0
5275563|NCT00579670|18200132|P3|Overall Study|Withdrawal by Subject|1
5275564|NCT00579670|18200133|P2|Overall Study|Withdrawal by Subject|0
5275565|NCT00579670|18200134|P1|Overall Study|Withdrawal by Subject|0
5275566|NCT00579670|18200130|P5|Overall Study|Other|0
5275567|NCT00579670|18200131|P4|Overall Study|Other|2
5275568|NCT00579670|18200132|P3|Overall Study|Other|1
5275569|NCT00579670|18200133|P2|Overall Study|Other|0
5275570|NCT00579670|18200134|P1|Overall Study|Other|0
5275572|NCT00579670|18200131|P4|Overall Study|Lost to Follow-up|4
5275573|NCT00579670|18200132|P3|Overall Study|Lost to Follow-up|0
5275574|NCT00579670|18200133|P2|Overall Study|Lost to Follow-up|1
5275575|NCT00579670|18200134|P1|Overall Study|Lost to Follow-up|0
5275576|NCT00579670|18200130|P5|Overall Study|Lack of Efficacy|0
5275577|NCT00579670|18200131|P4|Overall Study|Lack of Efficacy|14
5275578|NCT00579670|18200132|P3|Overall Study|Lack of Efficacy|1
5275579|NCT00579670|18200133|P2|Overall Study|Lack of Efficacy|0
5275580|NCT00579670|18200134|P1|Overall Study|Lack of Efficacy|0
5275581|NCT00579670|18200130|P5|Overall Study|Adverse Event|0
5275582|NCT00579670|18200131|P4|Overall Study|Adverse Event|2
5275583|NCT00579670|18200132|P3|Overall Study|Adverse Event|1
5275584|NCT00579670|18200133|P2|Overall Study|Adverse Event|0
5275585|NCT00579670|18200134|P1|Overall Study|Adverse Event|1
5275586|NCT00579670|18200130|P5|Overall Study|Death|0
5275587|NCT00579670|18200131|P4|Overall Study|Death|0
5275588|NCT00579670|18200132|P3|Overall Study|Death|0
5275589|NCT00579670|18200133|P2|Overall Study|Death|0
5275590|NCT00579670|18200134|P1|Overall Study|Death|1
5275591|NCT00579527|18200346|P1|Overall Study|Death|4
5275592|NCT00579501|18200358|P1|Overall Study|Radiation therapy before surgery|1
5275593|NCT00579501|18200358|P1|Overall Study|Secondary lesion|1
5275594|NCT00579501|18200358|P1|Overall Study|toxicity|1
5275595|NCT00579501|18200358|P1|Overall Study|End of neoadjuvant therapy|25
5275596|NCT00579501|18200358|P1|Overall Study|Death|1
5275597|NCT00579345|18200386|P8|Overall Study|Death|0
5275598|NCT00579345|18200387|P7|Overall Study|Death|0
5275599|NCT00579345|18200388|P6|Overall Study|Death|0
5275600|NCT00579345|18200389|P5|Overall Study|Death|0
5275601|NCT00579345|18200390|P4|Overall Study|Death|1
5275602|NCT00579345|18200391|P3|Overall Study|Death|1
5275603|NCT00579345|18200392|P2|Overall Study|Death|1
5275604|NCT00579345|18200393|P1|Overall Study|Death|1
5275605|NCT00579345|18200386|P8|Overall Study|Protocol Violation|1
5275606|NCT00579345|18200387|P7|Overall Study|Protocol Violation|0
5275607|NCT00579345|18200388|P6|Overall Study|Protocol Violation|0
5275608|NCT00579345|18200389|P5|Overall Study|Protocol Violation|0
5275609|NCT00579345|18200390|P4|Overall Study|Protocol Violation|0
5275610|NCT00579345|18200391|P3|Overall Study|Protocol Violation|0
5275611|NCT00579345|18200392|P2|Overall Study|Protocol Violation|0
5275612|NCT00579345|18200393|P1|Overall Study|Protocol Violation|1
5275613|NCT00579345|18200386|P8|Overall Study|Adverse Event|0
5275614|NCT00579345|18200387|P7|Overall Study|Adverse Event|0
5275615|NCT00579345|18200388|P6|Overall Study|Adverse Event|0
5275616|NCT00579345|18200389|P5|Overall Study|Adverse Event|0
5275617|NCT00579345|18200390|P4|Overall Study|Adverse Event|0
5275618|NCT00579345|18200391|P3|Overall Study|Adverse Event|1
5275619|NCT00579345|18200392|P2|Overall Study|Adverse Event|0
5275620|NCT00579345|18200393|P1|Overall Study|Adverse Event|0
5275621|NCT00579345|18200386|P8|Overall Study|Lost to Follow-up|0
5275622|NCT00579345|18200387|P7|Overall Study|Lost to Follow-up|0
5275623|NCT00579345|18200388|P6|Overall Study|Lost to Follow-up|0
5275624|NCT00579345|18200389|P5|Overall Study|Lost to Follow-up|0
5275625|NCT00579345|18200390|P4|Overall Study|Lost to Follow-up|0
5275626|NCT00579345|18200391|P3|Overall Study|Lost to Follow-up|0
5275627|NCT00579345|18200392|P2|Overall Study|Lost to Follow-up|0
5275628|NCT00579345|18200393|P1|Overall Study|Lost to Follow-up|1
5275629|NCT00579345|18200386|P8|Overall Study|Withdrawal by Subject|1
5275630|NCT00579345|18200387|P7|Overall Study|Withdrawal by Subject|0
5275631|NCT00579345|18200388|P6|Overall Study|Withdrawal by Subject|0
5275632|NCT00579345|18200389|P5|Overall Study|Withdrawal by Subject|0
5275633|NCT00579345|18200390|P4|Overall Study|Withdrawal by Subject|0
5275634|NCT00579345|18200391|P3|Overall Study|Withdrawal by Subject|0
5275635|NCT00579345|18200392|P2|Overall Study|Withdrawal by Subject|0
5275636|NCT00579345|18200393|P1|Overall Study|Withdrawal by Subject|2
5275637|NCT00579254|18200468|P1|Overall Study|Discontinued when study terminated|73
5275638|NCT00579254|18200468|P1|Overall Study|Lost to Follow-up|39
5275639|NCT00579098|18200492|P2|Overall Study|AF returned after ablation|2
5275640|NCT00579098|18200493|P1|Overall Study|AF returned after ablation|3
5275641|NCT00579098|18200492|P2|Overall Study|Withdrawal by Subject|3
5275642|NCT00579098|18200493|P1|Overall Study|Withdrawal by Subject|2
5275643|NCT00579098|18200492|P2|Overall Study|Adverse Event|3
5275644|NCT00579098|18200493|P1|Overall Study|Adverse Event|2
5275645|NCT00579098|18200492|P2|Overall Study|Lost to Follow-up|0
5275646|NCT00579098|18200493|P1|Overall Study|Lost to Follow-up|2
5275647|NCT00579059|18200509|P2|Overall Study|Study Canceled at 1 Year|10
5275648|NCT00579059|18200510|P1|Overall Study|Study Canceled at 1 Year|21
5275649|NCT00578942|18200584|P1|Overall Study|Lost to Follow-up|1
5275650|NCT00578877|18200623|P2|Overall Study|did not provide follow-up data|17
5275651|NCT00578877|18200624|P1|Overall Study|did not provide follow-up data|12
5275652|NCT00578877|18200623|P2|Overall Study|early discontinue|101
5275653|NCT00578877|18200624|P1|Overall Study|early discontinue|61
5275654|NCT00578877|18200623|P2|Overall Study|Lost to Follow-up|10
5275655|NCT00578877|18200624|P1|Overall Study|Lost to Follow-up|8
5275656|NCT00578864|18200632|P2|Overall Study|Death|0
5275657|NCT00578864|18200633|P1|Overall Study|Death|1
5275658|NCT00578812|18200649|P2|Overall Study|Not treated|7
5275659|NCT00578812|18200650|P1|Overall Study|Not treated|6
5275660|NCT00578786|18200689|P3|Overall Study|Qualified but Not Enrolled in Extension|0
5275661|NCT00578786|18200690|P2|Overall Study|Qualified but Not Enrolled in Extension|3
5275662|NCT00578786|18200691|P1|Overall Study|Qualified but Not Enrolled in Extension|0
5275663|NCT00578786|18200689|P3|Overall Study|Not Otherwise Specified|1
5275664|NCT00578786|18200690|P2|Overall Study|Not Otherwise Specified|4
5275665|NCT00578786|18200691|P1|Overall Study|Not Otherwise Specified|0
5275666|NCT00578786|18200689|P3|Overall Study|Pregnancy|0
5275667|NCT00578786|18200690|P2|Overall Study|Pregnancy|1
5275668|NCT00578786|18200691|P1|Overall Study|Pregnancy|0
5275669|NCT00578786|18200689|P3|Overall Study|Lost to Follow-up|0
5275670|NCT00578786|18200690|P2|Overall Study|Lost to Follow-up|4
5275671|NCT00578786|18200691|P1|Overall Study|Lost to Follow-up|0
5275672|NCT00578786|18200689|P3|Overall Study|Sponsor Decision|1
5275673|NCT00578786|18200690|P2|Overall Study|Sponsor Decision|0
5275674|NCT00578786|18200691|P1|Overall Study|Sponsor Decision|0
5275675|NCT00578786|18200689|P3|Overall Study|Physician Decision|1
5275676|NCT00578786|18200690|P2|Overall Study|Physician Decision|0
5275677|NCT00578786|18200691|P1|Overall Study|Physician Decision|1
5275678|NCT00578786|18200689|P3|Overall Study|Protocol Violation|1
5275679|NCT00578786|18200690|P2|Overall Study|Protocol Violation|3
5275680|NCT00578786|18200691|P1|Overall Study|Protocol Violation|0
5275681|NCT00578786|18200689|P3|Overall Study|Withdrawal by Subject|5
5275682|NCT00578786|18200690|P2|Overall Study|Withdrawal by Subject|8
5275683|NCT00578786|18200691|P1|Overall Study|Withdrawal by Subject|7
5275684|NCT00578786|18200689|P3|Overall Study|Early Escape from Prior Study|2
5275685|NCT00578786|18200690|P2|Overall Study|Early Escape from Prior Study|1
5275686|NCT00578786|18200691|P1|Overall Study|Early Escape from Prior Study|2
5275687|NCT00578786|18200689|P3|Overall Study|Lack of Efficacy|2
5275688|NCT00578786|18200690|P2|Overall Study|Lack of Efficacy|5
5275689|NCT00578786|18200691|P1|Overall Study|Lack of Efficacy|2
5275690|NCT00578786|18200689|P3|Overall Study|Adverse Event|17
5275691|NCT00578786|18200690|P2|Overall Study|Adverse Event|37
5275692|NCT00578786|18200691|P1|Overall Study|Adverse Event|27
5275693|NCT00578643|18200792|P1|Overall Study|Lost to Follow-up|1
5275694|NCT00578643|18200792|P1|Overall Study|Death|1
5275695|NCT00578565|18200808|P1|Overall Study|Adverse Event|3
5275696|NCT00578448|18200838|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
5275697|NCT00578448|18200838|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
5275698|NCT00578448|18200838|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
5275699|NCT00578448|18200838|P1|Day 1 up to 3 Years of Planned Study|Death|1
5275700|NCT00578344|18200889|P1|Overall Study|Graft failure|1
5275701|NCT00578344|18200889|P1|Overall Study|Insurance problems|1
5275702|NCT00578318|18200908|P2|Overall Study|Physician Decision|0
5275703|NCT00578318|18200909|P1|Overall Study|Physician Decision|1
5275704|NCT00578318|18200908|P2|Overall Study|Lost to Follow-up|0
5275705|NCT00578318|18200909|P1|Overall Study|Lost to Follow-up|2
5275706|NCT00578292|18200979|P1|Overall Study|Graft failure|2
5275707|NCT00578292|18200979|P1|Overall Study|Death|1
5275708|NCT00578227|18201003|P3|Overall Study|Withdrawal by Subject|3
5275709|NCT00578227|18201004|P2|Overall Study|Withdrawal by Subject|1
5275710|NCT00578227|18201005|P1|Overall Study|Withdrawal by Subject|5
5275711|NCT00578227|18201003|P3|Overall Study|Lost to Follow-up|1
5275712|NCT00578227|18201004|P2|Overall Study|Lost to Follow-up|1
5275713|NCT00578227|18201005|P1|Overall Study|Lost to Follow-up|0
5275714|NCT00578175|18201130|P3|Overall Study|Other reasons|23
5275715|NCT00578175|18201131|P2|Overall Study|Other reasons|42
5275716|NCT00578175|18201132|P1|Overall Study|Other reasons|70
5275717|NCT00578175|18201130|P3|Overall Study|Adverse Event|1
5275718|NCT00578175|18201131|P2|Overall Study|Adverse Event|1
5275719|NCT00578175|18201132|P1|Overall Study|Adverse Event|0
5275720|NCT00578136|18201211|P2|Overall Study|Not given intervention|1
5275721|NCT00578136|18201212|P1|Overall Study|Not given intervention|1
5275722|NCT00577993|18201230|P3|Overall Study|Uninsured|0
5275723|NCT00577993|18201231|P2|Overall Study|Uninsured|0
5275724|NCT00577993|18201232|P1|Overall Study|Uninsured|1
5275725|NCT00577993|18201230|P3|Overall Study|Conversion|0
5275726|NCT00577993|18201231|P2|Overall Study|Conversion|5
5275727|NCT00577993|18201232|P1|Overall Study|Conversion|2
5275728|NCT00577993|18201230|P3|Overall Study|Withdrawal by Subject|2
5275729|NCT00577993|18201231|P2|Overall Study|Withdrawal by Subject|0
5275730|NCT00577993|18201232|P1|Overall Study|Withdrawal by Subject|1
5275731|NCT00577993|18201230|P3|Overall Study|Protocol Violation|0
5275732|NCT00577993|18201231|P2|Overall Study|Protocol Violation|3
5275733|NCT00577993|18201232|P1|Overall Study|Protocol Violation|2
5275734|NCT00577993|18201230|P3|Overall Study|Lack of Efficacy|0
5275735|NCT00577993|18201231|P2|Overall Study|Lack of Efficacy|1
5275736|NCT00577993|18201232|P1|Overall Study|Lack of Efficacy|0
5275737|NCT00577993|18201230|P3|Overall Study|Death|1
5275738|NCT00577993|18201231|P2|Overall Study|Death|1
5275739|NCT00577993|18201232|P1|Overall Study|Death|0
5275740|NCT00577993|18201230|P3|Overall Study|Adverse Event|0
5275741|NCT00577993|18201231|P2|Overall Study|Adverse Event|0
5275742|NCT00577993|18201232|P1|Overall Study|Adverse Event|1
5275743|NCT00577889|18201243|P3|Overall Study|Withdrawal by Subject|0
5275744|NCT00577889|18201244|P2|Overall Study|Withdrawal by Subject|0
5275745|NCT00577889|18201245|P1|Overall Study|Withdrawal by Subject|1
5275746|NCT00577863|18201264|P2|Overall Study|Did Not Receive at Least One Injection|1
5275747|NCT00577863|18201265|P1|Overall Study|Did Not Receive at Least One Injection|0
5275748|NCT00577863|18201264|P2|Overall Study|Sponsor Decision|7
5275749|NCT00577863|18201265|P1|Overall Study|Sponsor Decision|2
5275750|NCT00577863|18201264|P2|Overall Study|Withdrawal by Subject|2
5275751|NCT00577863|18201265|P1|Overall Study|Withdrawal by Subject|0
5275752|NCT00577863|18201264|P2|Overall Study|Entry Criteria Exclusion|0
5275753|NCT00577863|18201265|P1|Overall Study|Entry Criteria Exclusion|1
5275754|NCT00577863|18201264|P2|Overall Study|Lost to Follow-up|2
5275755|NCT00577863|18201265|P1|Overall Study|Lost to Follow-up|2
5275756|NCT00577863|18201264|P2|Overall Study|Death|0
5275757|NCT00577863|18201265|P1|Overall Study|Death|1
5275758|NCT00577863|18201264|P2|Overall Study|Adverse Event|2
5275759|NCT00577863|18201265|P1|Overall Study|Adverse Event|4
5275760|NCT00577824|18201307|P3|Overall Study|Protocol Violation|0
5275761|NCT00577824|18201308|P2|Overall Study|Protocol Violation|1
5275762|NCT00577824|18201309|P1|Overall Study|Protocol Violation|1
5275763|NCT00577824|18201307|P3|Overall Study|Patient decision|1
5275764|NCT00577824|18201308|P2|Overall Study|Patient decision|1
5275765|NCT00577824|18201309|P1|Overall Study|Patient decision|0
5275766|NCT00577824|18201307|P3|Overall Study|Adverse Event|1
5275767|NCT00577824|18201308|P2|Overall Study|Adverse Event|18
5275768|NCT00577824|18201309|P1|Overall Study|Adverse Event|6
5275769|NCT00577772|18201367|P2|Overall Study|Lost to Follow-up|1
5275770|NCT00577772|18201368|P1|Overall Study|Lost to Follow-up|0
5275771|NCT00577720|18201378|P4|Overall Study|Withdrawal by Subject|2
5275772|NCT00577720|18201379|P3|Overall Study|Withdrawal by Subject|0
5275773|NCT00577720|18201380|P2|Overall Study|Withdrawal by Subject|0
5275774|NCT00577720|18201381|P1|Overall Study|Withdrawal by Subject|2
5275775|NCT00577720|18201378|P4|Overall Study|Protocol Violation|1
5275776|NCT00577720|18201379|P3|Overall Study|Protocol Violation|0
5275777|NCT00577720|18201380|P2|Overall Study|Protocol Violation|0
5275778|NCT00577720|18201381|P1|Overall Study|Protocol Violation|0
5275779|NCT00577720|18201378|P4|Overall Study|Lost to Follow-up|0
5275780|NCT00577720|18201379|P3|Overall Study|Lost to Follow-up|1
5275781|NCT00577720|18201380|P2|Overall Study|Lost to Follow-up|0
5275782|NCT00577720|18201381|P1|Overall Study|Lost to Follow-up|0
5275783|NCT00577720|18201378|P4|Overall Study|Adverse Event|4
5275784|NCT00577720|18201379|P3|Overall Study|Adverse Event|0
5275785|NCT00577720|18201380|P2|Overall Study|Adverse Event|1
5275786|NCT00577720|18201381|P1|Overall Study|Adverse Event|2
5275787|NCT00577707|18201399|P1|Overall Study|Withdrawal by Subject|3
5275788|NCT00577655|18201407|P2|Overall Study|Lost to Follow-up|1
5275789|NCT00577655|18201408|P1|Overall Study|Lost to Follow-up|1
5275790|NCT00577655|18201407|P2|Overall Study|Protocol Violation|1
5275791|NCT00577655|18201408|P1|Overall Study|Protocol Violation|0
5275792|NCT00577655|18201407|P2|Overall Study|Patient Request|2
5275793|NCT00577655|18201408|P1|Overall Study|Patient Request|0
5275794|NCT00577642|18201446|P1|Overall Study|Clinical Disease Progression|1
5275795|NCT00577629|18201450|P1|Long Term Follow-Up|Physician Decision|1
5275796|NCT00577629|18201450|P1|Long Term Follow-Up|Withdrawal by Subject|4
5275797|NCT00577629|18201450|P1|Long Term Follow-Up|Lost to Follow-up|5
5275798|NCT00577629|18201450|P1|Long Term Follow-Up|Death|15
5275799|NCT00577629|18201450|P1|Treatment Period|Death|1
5275800|NCT00577473|18201477|P2|Overall Study|Lack of Efficacy|7
5275801|NCT00577473|18201478|P1|Overall Study|Lack of Efficacy|8
5275802|NCT00577473|18201477|P2|Overall Study|Physician Decision|2
5275803|NCT00577473|18201478|P1|Overall Study|Physician Decision|2
5275804|NCT00577473|18201477|P2|Overall Study|Withdrawal by Subject|6
5275805|NCT00577473|18201478|P1|Overall Study|Withdrawal by Subject|2
5275806|NCT00577473|18201477|P2|Overall Study|Adverse Event|5
5275807|NCT00577473|18201478|P1|Overall Study|Adverse Event|8
5275808|NCT00577473|18201477|P2|Overall Study|Protocol Violation|4
5275809|NCT00577473|18201478|P1|Overall Study|Protocol Violation|1
5275810|NCT00577460|18201509|P3|Overall Study|Other|2
5275811|NCT00577460|18201510|P2|Overall Study|Other|3
5275812|NCT00577460|18201511|P1|Overall Study|Other|0
5275813|NCT00577460|18201509|P3|Overall Study|Withdrawal by Subject|6
5275814|NCT00577460|18201510|P2|Overall Study|Withdrawal by Subject|5
5275815|NCT00577460|18201511|P1|Overall Study|Withdrawal by Subject|5
5275816|NCT00577460|18201509|P3|Overall Study|Lost to Follow-up|4
5275817|NCT00577460|18201510|P2|Overall Study|Lost to Follow-up|3
5275818|NCT00577460|18201511|P1|Overall Study|Lost to Follow-up|0
5275819|NCT00577460|18201509|P3|Overall Study|Protocol Violation|1
5275820|NCT00577460|18201510|P2|Overall Study|Protocol Violation|1
5275821|NCT00577460|18201511|P1|Overall Study|Protocol Violation|0
5275822|NCT00577460|18201509|P3|Overall Study|Adverse Event|14
5275823|NCT00577460|18201510|P2|Overall Study|Adverse Event|7
5275824|NCT00577460|18201511|P1|Overall Study|Adverse Event|11
5275825|NCT00577408|18201620|P2|Overall Study|Psychiatric hospitalization|1
5275826|NCT00577408|18201621|P1|Overall Study|Psychiatric hospitalization|0
5275827|NCT00577408|18201620|P2|Overall Study|Death|1
5275828|NCT00577408|18201621|P1|Overall Study|Death|0
5275829|NCT00577408|18201620|P2|Overall Study|Scheduling Issues|3
5275830|NCT00577408|18201621|P1|Overall Study|Scheduling Issues|0
5275831|NCT00577408|18201620|P2|Overall Study|Moved out of state|1
5275832|NCT00577408|18201621|P1|Overall Study|Moved out of state|0
5275833|NCT00577408|18201620|P2|Overall Study|Refused Oral Naltrexone|1
5275834|NCT00577408|18201621|P1|Overall Study|Refused Oral Naltrexone|0
5275835|NCT00577408|18201620|P2|Overall Study|Non-compliance with study meds|3
5275836|NCT00577408|18201621|P1|Overall Study|Non-compliance with study meds|0
5275837|NCT00577408|18201620|P2|Overall Study|Continued opioid use|2
5275838|NCT00577408|18201621|P1|Overall Study|Continued opioid use|3
5275839|NCT00577408|18201620|P2|Overall Study|Stopped attending study visits|11
5275840|NCT00577408|18201621|P1|Overall Study|Stopped attending study visits|9
5275841|NCT00577395|18201629|P2|Overall Study|Study was terminated early by Sponsor|6
5275842|NCT00577395|18201630|P1|Overall Study|Study was terminated early by Sponsor|7
5275843|NCT00577382|18201640|P2|Overall Study|Lost to Follow-up|2
5275844|NCT00577382|18201641|P1|Overall Study|Lost to Follow-up|2
5275845|NCT00577382|18201640|P2|Overall Study|Death|1
5275846|NCT00577382|18201641|P1|Overall Study|Death|1
5275847|NCT00577382|18201640|P2|Overall Study|Intercurrent Illness|2
5275848|NCT00577382|18201641|P1|Overall Study|Intercurrent Illness|1
5275849|NCT00577382|18201640|P2|Overall Study|Progressive Disease|19
5275850|NCT00577382|18201641|P1|Overall Study|Progressive Disease|17
5275851|NCT00577382|18201640|P2|Overall Study|Withdrawal by Subject|1
5275852|NCT00577382|18201641|P1|Overall Study|Withdrawal by Subject|0
5275853|NCT00577382|18201640|P2|Overall Study|Adverse Event|6
5275854|NCT00577382|18201641|P1|Overall Study|Adverse Event|0
5275855|NCT00577122|18201784|P2|Overall Study|Alternative Therapy|1
5275856|NCT00577122|18201785|P1|Overall Study|Alternative Therapy|0
5275857|NCT00577122|18201784|P2|Overall Study|Prog, refract disease during active trt|5
5275858|NCT00577122|18201785|P1|Overall Study|Prog, refract disease during active trt|8
5275859|NCT00577122|18201784|P2|Overall Study|Progression, relapse during active trt|8
5275860|NCT00577122|18201785|P1|Overall Study|Progression, relapse during active trt|6
5275861|NCT00577122|18201784|P2|Overall Study|Adverse Event|2
5275862|NCT00577122|18201785|P1|Overall Study|Adverse Event|0
5275863|NCT00577096|18201799|P2|Short Term Participation|Death|1
5275864|NCT00577096|18201800|P1|Short Term Participation|Death|1
5275865|NCT00577096|18201799|P2|Short Term Participation|Withdrawal by Subject|5
5275866|NCT00577096|18201800|P1|Short Term Participation|Withdrawal by Subject|3
5275867|NCT00577096|18201799|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
5275868|NCT00577096|18201800|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
5275869|NCT00577031|18201839|P1|Overall Study|Death|6
5275870|NCT00577031|18201839|P1|Overall Study|Medical decision|14
5275871|NCT00577031|18201839|P1|Overall Study|Need for surgery|17
5275872|NCT00577031|18201839|P1|Overall Study|Participant non-compliance|5
5275873|NCT00577031|18201839|P1|Overall Study|Participant withdrew consent|13
5275874|NCT00577031|18201839|P1|Overall Study|Protocol Violation|5
5275875|NCT00577031|18201839|P1|Overall Study|Progression of disease|93
5275876|NCT00577031|18201839|P1|Overall Study|Adverse Event|52
5275877|NCT00577005|18201860|P2|Overall Study|Withdrawal by Subject|1
5275878|NCT00577005|18201861|P1|Overall Study|Withdrawal by Subject|2
5275879|NCT00577005|18201860|P2|Overall Study|Lost to Follow-up|2
5275880|NCT00577005|18201861|P1|Overall Study|Lost to Follow-up|3
5275881|NCT00576927|18201875|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
5275882|NCT00576927|18201875|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
5275883|NCT00576927|18201875|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
5275884|NCT00576927|18201875|P1|Sleep Hygiene Behavioral Intervention|Death|1
5275885|NCT00576927|18201875|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
5275886|NCT00576927|18201875|P1|Baseline|Withdrawal by Subject|3
5275887|NCT00576927|18201875|P1|Baseline|Medication Change by PCP of subject|1
5275888|NCT00576927|18201875|P1|Baseline|Physician Decision|9
5275889|NCT00576927|18201875|P1|Clinical Assessment|Physician Decision|1
5275890|NCT00576927|18201875|P1|Clinical Assessment|Withdrawal by Subject|10
5275891|NCT00576927|18201875|P1|Clinical Assessment|Death|1
5275892|NCT00576927|18201875|P1|Clinical Assessment|Lack of Efficacy|24
5275893|NCT00576901|18201887|P1|Overall Study|Protocol Violation|1
5275894|NCT00576901|18201887|P1|Overall Study|Disease course|1
5275895|NCT00576901|18201887|P1|Overall Study|Withdrawal by Subject|1
5275896|NCT00576836|18201895|P2|Overall Study|Physician Decision|1
5275897|NCT00576836|18201896|P1|Overall Study|Physician Decision|0
5275898|NCT00576836|18201895|P2|Overall Study|Death|1
5275899|NCT00576836|18201896|P1|Overall Study|Death|0
5275900|NCT00576823|18201911|P3|40-week Safety Extension Phase|Lack of Efficacy|0
5275901|NCT00576823|18201912|P2|40-week Safety Extension Phase|Lack of Efficacy|0
5275902|NCT00576823|18201913|P1|40-week Safety Extension Phase|Lack of Efficacy|1
5275903|NCT00576823|18201911|P3|12-week Efficacy Phase|Parent's schedule issue|0
5275904|NCT00576823|18201912|P2|12-week Efficacy Phase|Parent's schedule issue|0
5275905|NCT00576823|18201913|P1|12-week Efficacy Phase|Parent's schedule issue|1
5275906|NCT00576758|18201929|P2|Follow-up Period|Withdrew consent|1
5275907|NCT00576758|18201930|P1|Follow-up Period|Withdrew consent|2
5275908|NCT00576758|18201929|P2|Follow-up Period|Insufficient therapeutic response|5
5275909|NCT00576758|18201930|P1|Follow-up Period|Insufficient therapeutic response|16
5275910|NCT00576758|18201929|P2|Follow-up Period|Death|3
5275911|NCT00576758|18201930|P1|Follow-up Period|Death|3
5275912|NCT00576758|18201929|P2|Follow-up Period|Administrative/Other|8
5275913|NCT00576758|18201930|P1|Follow-up Period|Administrative/Other|6
5275914|NCT00576758|18201929|P2|Extension Treatment Period|Administrative/Other|1
5275915|NCT00576758|18201930|P1|Extension Treatment Period|Administrative/Other|3
5275916|NCT00576758|18201929|P2|Extension Treatment Period|Insufficient therapeutic response|33
5275917|NCT00576758|18201930|P1|Extension Treatment Period|Insufficient therapeutic response|30
5275918|NCT00576758|18201929|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
5275919|NCT00576758|18201930|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
5275920|NCT00576758|18201929|P2|Extension Treatment Period|Death|1
5275921|NCT00576758|18201930|P1|Extension Treatment Period|Death|1
5275922|NCT00576758|18201929|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
5275923|NCT00576758|18201930|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
5275924|NCT00576758|18201929|P2|Induction Treatment Period|Withdrew consent|0
5275925|NCT00576758|18201930|P1|Induction Treatment Period|Withdrew consent|1
5275926|NCT00576758|18201929|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
5275927|NCT00576758|18201930|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
5275928|NCT00576758|18201929|P2|Induction Treatment Period|Death|0
5275929|NCT00576758|18201930|P1|Induction Treatment Period|Death|1
5275930|NCT00576758|18201929|P2|Induction Treatment Period|Violation of selection criteria at entry|1
5275931|NCT00576758|18201930|P1|Induction Treatment Period|Violation of selection criteria at entry|1
5275932|NCT00576758|18201929|P2|Induction Treatment Period|Insufficient therapeutic response|0
5275933|NCT00576758|18201930|P1|Induction Treatment Period|Insufficient therapeutic response|2
5275934|NCT00576758|18201929|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
5275935|NCT00576758|18201930|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
5275936|NCT00576732|18201976|P6|OPEN LABEL|Protocol Violation|0
5275937|NCT00576732|18201977|P5|OPEN LABEL|Protocol Violation|1
5275938|NCT00576732|18201978|P4|OPEN LABEL|Protocol Violation|2
5275939|NCT00576732|18201979|P3|OPEN LABEL|Protocol Violation|0
5275940|NCT00576732|18201980|P2|OPEN LABEL|Protocol Violation|0
5275941|NCT00576732|18201981|P1|OPEN LABEL|Protocol Violation|0
5275942|NCT00576732|18201976|P6|OPEN LABEL|Lack of Efficacy|3
5275943|NCT00576732|18201977|P5|OPEN LABEL|Lack of Efficacy|2
5275944|NCT00576732|18201978|P4|OPEN LABEL|Lack of Efficacy|2
5275945|NCT00576732|18201979|P3|OPEN LABEL|Lack of Efficacy|0
5275946|NCT00576732|18201980|P2|OPEN LABEL|Lack of Efficacy|0
5275947|NCT00576732|18201981|P1|OPEN LABEL|Lack of Efficacy|0
5275948|NCT00576732|18201976|P6|OPEN LABEL|OTHER|2
5275949|NCT00576732|18201977|P5|OPEN LABEL|OTHER|0
5275950|NCT00576732|18201978|P4|OPEN LABEL|OTHER|0
5275951|NCT00576732|18201979|P3|OPEN LABEL|OTHER|0
5275952|NCT00576732|18201980|P2|OPEN LABEL|OTHER|0
5275953|NCT00576732|18201981|P1|OPEN LABEL|OTHER|0
5275954|NCT00576732|18201976|P6|OPEN LABEL|Withdrawal by Subject|1
5275955|NCT00576732|18201977|P5|OPEN LABEL|Withdrawal by Subject|0
5275956|NCT00576732|18201978|P4|OPEN LABEL|Withdrawal by Subject|1
5275957|NCT00576732|18201979|P3|OPEN LABEL|Withdrawal by Subject|0
5275958|NCT00576732|18201980|P2|OPEN LABEL|Withdrawal by Subject|0
5275959|NCT00576732|18201981|P1|OPEN LABEL|Withdrawal by Subject|0
5275960|NCT00576732|18201976|P6|OPEN LABEL|Lost to Follow-up|1
5275961|NCT00576732|18201977|P5|OPEN LABEL|Lost to Follow-up|1
5275962|NCT00576732|18201978|P4|OPEN LABEL|Lost to Follow-up|2
5275963|NCT00576732|18201979|P3|OPEN LABEL|Lost to Follow-up|0
5275964|NCT00576732|18201980|P2|OPEN LABEL|Lost to Follow-up|0
5275965|NCT00576732|18201981|P1|OPEN LABEL|Lost to Follow-up|0
5275966|NCT00576732|18201976|P6|OPEN LABEL|Adverse Event|1
5275967|NCT00576732|18201977|P5|OPEN LABEL|Adverse Event|0
5275968|NCT00576732|18201978|P4|OPEN LABEL|Adverse Event|4
5275969|NCT00576732|18201979|P3|OPEN LABEL|Adverse Event|0
5275970|NCT00576732|18201980|P2|OPEN LABEL|Adverse Event|0
5275971|NCT00576732|18201981|P1|OPEN LABEL|Adverse Event|0
5275972|NCT00576732|18201976|P6|DOUBLE BLIND|Protocol Violation|0
5275973|NCT00576732|18201977|P5|DOUBLE BLIND|Protocol Violation|0
5275974|NCT00576732|18201978|P4|DOUBLE BLIND|Protocol Violation|0
5275975|NCT00576732|18201979|P3|DOUBLE BLIND|Protocol Violation|0
5275976|NCT00576732|18201980|P2|DOUBLE BLIND|Protocol Violation|0
5275977|NCT00576732|18201981|P1|DOUBLE BLIND|Protocol Violation|1
5275978|NCT00576732|18201976|P6|DOUBLE BLIND|Lack of Efficacy|0
5275979|NCT00576732|18201977|P5|DOUBLE BLIND|Lack of Efficacy|0
5275980|NCT00576732|18201978|P4|DOUBLE BLIND|Lack of Efficacy|0
5275981|NCT00576732|18201979|P3|DOUBLE BLIND|Lack of Efficacy|0
5275982|NCT00576732|18201980|P2|DOUBLE BLIND|Lack of Efficacy|1
5275983|NCT00576732|18201981|P1|DOUBLE BLIND|Lack of Efficacy|6
5275984|NCT00576732|18201976|P6|DOUBLE BLIND|OTHER|0
5275985|NCT00576732|18201977|P5|DOUBLE BLIND|OTHER|0
5275986|NCT00576732|18201978|P4|DOUBLE BLIND|OTHER|0
5275987|NCT00576732|18201979|P3|DOUBLE BLIND|OTHER|1
5275988|NCT00576732|18201980|P2|DOUBLE BLIND|OTHER|2
5275989|NCT00576732|18201981|P1|DOUBLE BLIND|OTHER|0
5275990|NCT00576732|18201976|P6|DOUBLE BLIND|Withdrawal by Subject|0
5275991|NCT00576732|18201977|P5|DOUBLE BLIND|Withdrawal by Subject|0
5275992|NCT00576732|18201978|P4|DOUBLE BLIND|Withdrawal by Subject|0
5275993|NCT00576732|18201979|P3|DOUBLE BLIND|Withdrawal by Subject|3
5275994|NCT00576732|18201980|P2|DOUBLE BLIND|Withdrawal by Subject|1
5275995|NCT00576732|18201981|P1|DOUBLE BLIND|Withdrawal by Subject|1
5275996|NCT00576732|18201976|P6|DOUBLE BLIND|Lost to Follow-up|0
5275997|NCT00576732|18201977|P5|DOUBLE BLIND|Lost to Follow-up|0
5275998|NCT00576732|18201978|P4|DOUBLE BLIND|Lost to Follow-up|0
5275999|NCT00576732|18201979|P3|DOUBLE BLIND|Lost to Follow-up|1
5276000|NCT00576732|18201980|P2|DOUBLE BLIND|Lost to Follow-up|1
5276001|NCT00576732|18201981|P1|DOUBLE BLIND|Lost to Follow-up|0
5276002|NCT00576732|18201976|P6|DOUBLE BLIND|Adverse Event|0
5276003|NCT00576732|18201977|P5|DOUBLE BLIND|Adverse Event|0
5276004|NCT00576732|18201978|P4|DOUBLE BLIND|Adverse Event|0
5276005|NCT00576732|18201979|P3|DOUBLE BLIND|Adverse Event|1
5276006|NCT00576732|18201980|P2|DOUBLE BLIND|Adverse Event|0
5276007|NCT00576732|18201981|P1|DOUBLE BLIND|Adverse Event|0
5276008|NCT00576693|18202013|P2|Overall Study|Withdrawal by Subject|13
5276009|NCT00576693|18202014|P1|Overall Study|Withdrawal by Subject|3
5276010|NCT00576693|18202013|P2|Overall Study|Lost to Follow-up|11
5276011|NCT00576693|18202014|P1|Overall Study|Lost to Follow-up|7
5276012|NCT00576628|18202026|P1|Overall Study|Dialysis|15
5276013|NCT00576628|18202026|P1|Overall Study|Transplantation|1
5276014|NCT00576628|18202026|P1|Overall Study|The patient move into other town|1
5276015|NCT00576628|18202026|P1|Overall Study|Progression of Renal Failure|1
5276016|NCT00576628|18202026|P1|Overall Study|Progression of Kidney Disease|1
5276017|NCT00576628|18202026|P1|Overall Study|RBC transfusion|1
5276018|NCT00576628|18202026|P1|Overall Study|Pregnancy|1
5276019|NCT00576628|18202026|P1|Overall Study|Refused Treatment|8
5276020|NCT00576628|18202026|P1|Overall Study|Failure to return|1
5276021|NCT00576628|18202026|P1|Overall Study|Death|2
5276022|NCT00576628|18202026|P1|Overall Study|Adverse Event|11
5276023|NCT00576576|18202046|P1|Overall Study|Protocol Violation|1
5276024|NCT00576576|18202046|P1|Overall Study|Lost to Follow-up|6
5276025|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
5276026|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
5276027|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
5276028|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
5276029|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
5276030|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
5276031|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
5276032|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
5276033|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
5276034|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
5276035|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
5276036|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
5276037|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
5276038|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
5276039|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
5276040|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Medical reasons|6
5276041|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Medical reasons|0
5276042|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Medical reasons|0
5276043|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Medical reasons|0
5276044|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Medical reasons|0
5276045|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Medical reasons|0
5276046|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Medical reasons|0
5276047|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Medical reasons|0
5276048|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Medical reasons|0
5276049|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Medical reasons|0
5276050|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Medical reasons|0
5276051|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Medical reasons|0
5276052|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Medical reasons|0
5276053|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Medical reasons|0
5276054|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Medical reasons|0
5276055|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
5276056|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276057|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276058|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276059|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276060|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276061|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276062|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276063|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276064|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276065|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276066|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276067|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276068|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276069|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
5276070|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Side effects|8
5276071|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Side effects|0
5276072|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Side effects|0
5276073|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Side effects|0
5276074|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Side effects|0
5276075|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Side effects|0
5276076|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Side effects|0
5276077|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Side effects|0
5276078|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Side effects|0
5276079|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Side effects|0
5276080|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Side effects|0
5276081|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Side effects|0
5276082|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Side effects|0
5276083|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Side effects|0
5276084|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Side effects|0
5276085|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Insufficient data|0
5276086|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Insufficient data|4
5276087|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Insufficient data|0
5276088|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Insufficient data|0
5276089|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Insufficient data|0
5276090|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Insufficient data|0
5276091|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Insufficient data|0
5276092|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Insufficient data|0
5276093|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Insufficient data|0
5276094|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Insufficient data|0
5276095|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Insufficient data|0
5276096|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Insufficient data|0
5276097|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Insufficient data|0
5276098|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Insufficient data|0
5276099|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Insufficient data|0
5276100|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Declined to participate|0
5276101|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Declined to participate|7
5276102|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Declined to participate|0
5276103|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Declined to participate|0
5276104|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Declined to participate|0
5276105|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Declined to participate|0
5276106|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Declined to participate|0
5276107|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Declined to participate|0
5276108|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Declined to participate|0
5276109|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Declined to participate|0
5276110|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Declined to participate|0
5276111|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Declined to participate|0
5276112|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Declined to participate|0
5276113|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Declined to participate|0
5276114|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Declined to participate|0
5276115|NCT00576472|18202080|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
5276116|NCT00576472|18202081|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
5276117|NCT00576472|18202082|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
5276118|NCT00576472|18202083|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
5276119|NCT00576472|18202084|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
5276120|NCT00576472|18202085|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
5276121|NCT00576472|18202086|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
5276122|NCT00576472|18202087|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
5276123|NCT00576472|18202088|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
5276124|NCT00576472|18202089|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
5276125|NCT00576472|18202090|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
5276126|NCT00576472|18202091|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
5276127|NCT00576472|18202092|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
5276128|NCT00576472|18202093|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
5276129|NCT00576472|18202094|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
5276130|NCT00576472|18202080|P15|MPH Cross Over Phase|Did not complete cross over phase|0
5276131|NCT00576472|18202081|P14|MPH Cross Over Phase|Did not complete cross over phase|0
5276132|NCT00576472|18202082|P13|MPH Cross Over Phase|Did not complete cross over phase|0
5276133|NCT00576472|18202083|P12|MPH Cross Over Phase|Did not complete cross over phase|1
5276134|NCT00576472|18202084|P11|MPH Cross Over Phase|Did not complete cross over phase|1
5276135|NCT00576472|18202085|P10|MPH Cross Over Phase|Did not complete cross over phase|0
5276136|NCT00576472|18202086|P9|MPH Cross Over Phase|Did not complete cross over phase|2
5276137|NCT00576472|18202087|P8|MPH Cross Over Phase|Did not complete cross over phase|0
5276138|NCT00576472|18202088|P7|MPH Cross Over Phase|Did not complete cross over phase|0
5276139|NCT00576472|18202089|P6|MPH Cross Over Phase|Did not complete cross over phase|0
5276140|NCT00576472|18202090|P5|MPH Cross Over Phase|Did not complete cross over phase|0
5276141|NCT00576472|18202091|P4|MPH Cross Over Phase|Did not complete cross over phase|0
5276142|NCT00576472|18202092|P3|MPH Cross Over Phase|Did not complete cross over phase|0
5276143|NCT00576472|18202093|P2|MPH Cross Over Phase|Did not complete cross over phase|0
5276144|NCT00576472|18202094|P1|MPH Cross Over Phase|Did not complete cross over phase|0
5276145|NCT00576472|18202080|P15|MPH Cross Over Phase|Physician Decision|0
5276146|NCT00576472|18202081|P14|MPH Cross Over Phase|Physician Decision|0
5276147|NCT00576472|18202082|P13|MPH Cross Over Phase|Physician Decision|0
5276148|NCT00576472|18202083|P12|MPH Cross Over Phase|Physician Decision|0
5276149|NCT00576472|18202084|P11|MPH Cross Over Phase|Physician Decision|0
5276150|NCT00576472|18202085|P10|MPH Cross Over Phase|Physician Decision|0
5276151|NCT00576472|18202086|P9|MPH Cross Over Phase|Physician Decision|0
5276152|NCT00576472|18202087|P8|MPH Cross Over Phase|Physician Decision|0
5276153|NCT00576472|18202088|P7|MPH Cross Over Phase|Physician Decision|4
5276154|NCT00576472|18202089|P6|MPH Cross Over Phase|Physician Decision|0
5276155|NCT00576472|18202090|P5|MPH Cross Over Phase|Physician Decision|0
5276156|NCT00576472|18202091|P4|MPH Cross Over Phase|Physician Decision|0
5276157|NCT00576472|18202092|P3|MPH Cross Over Phase|Physician Decision|0
5276158|NCT00576472|18202093|P2|MPH Cross Over Phase|Physician Decision|0
5276159|NCT00576472|18202094|P1|MPH Cross Over Phase|Physician Decision|0
5276160|NCT00576472|18202080|P15|MPH Cross Over Phase|Ineligible due to disease|0
5276161|NCT00576472|18202081|P14|MPH Cross Over Phase|Ineligible due to disease|0
5276162|NCT00576472|18202082|P13|MPH Cross Over Phase|Ineligible due to disease|0
5276163|NCT00576472|18202083|P12|MPH Cross Over Phase|Ineligible due to disease|0
5276164|NCT00576472|18202084|P11|MPH Cross Over Phase|Ineligible due to disease|0
5276165|NCT00576472|18202085|P10|MPH Cross Over Phase|Ineligible due to disease|0
5276166|NCT00576472|18202086|P9|MPH Cross Over Phase|Ineligible due to disease|0
5276167|NCT00576472|18202087|P8|MPH Cross Over Phase|Ineligible due to disease|0
5276247|NCT00576472|18202092|P3|MPH In-Lab Phase|Lost to Follow-up|0
5276168|NCT00576472|18202088|P7|MPH Cross Over Phase|Ineligible due to disease|2
5276169|NCT00576472|18202089|P6|MPH Cross Over Phase|Ineligible due to disease|0
5276170|NCT00576472|18202090|P5|MPH Cross Over Phase|Ineligible due to disease|0
5276171|NCT00576472|18202091|P4|MPH Cross Over Phase|Ineligible due to disease|0
5276172|NCT00576472|18202092|P3|MPH Cross Over Phase|Ineligible due to disease|0
5276173|NCT00576472|18202093|P2|MPH Cross Over Phase|Ineligible due to disease|0
5276174|NCT00576472|18202094|P1|MPH Cross Over Phase|Ineligible due to disease|0
5276175|NCT00576472|18202080|P15|MPH Cross Over Phase|Withdrawal by Subject|0
5276176|NCT00576472|18202081|P14|MPH Cross Over Phase|Withdrawal by Subject|0
5276177|NCT00576472|18202082|P13|MPH Cross Over Phase|Withdrawal by Subject|0
5276178|NCT00576472|18202083|P12|MPH Cross Over Phase|Withdrawal by Subject|0
5276179|NCT00576472|18202084|P11|MPH Cross Over Phase|Withdrawal by Subject|0
5276180|NCT00576472|18202085|P10|MPH Cross Over Phase|Withdrawal by Subject|0
5276181|NCT00576472|18202086|P9|MPH Cross Over Phase|Withdrawal by Subject|0
5276182|NCT00576472|18202087|P8|MPH Cross Over Phase|Withdrawal by Subject|0
5276183|NCT00576472|18202088|P7|MPH Cross Over Phase|Withdrawal by Subject|6
5276184|NCT00576472|18202089|P6|MPH Cross Over Phase|Withdrawal by Subject|0
5276185|NCT00576472|18202090|P5|MPH Cross Over Phase|Withdrawal by Subject|0
5276186|NCT00576472|18202091|P4|MPH Cross Over Phase|Withdrawal by Subject|0
5276187|NCT00576472|18202092|P3|MPH Cross Over Phase|Withdrawal by Subject|0
5276188|NCT00576472|18202093|P2|MPH Cross Over Phase|Withdrawal by Subject|0
5276189|NCT00576472|18202094|P1|MPH Cross Over Phase|Withdrawal by Subject|0
5276190|NCT00576472|18202080|P15|MPH In-Lab Phase|Psychiatric exclusion|0
5276191|NCT00576472|18202081|P14|MPH In-Lab Phase|Psychiatric exclusion|0
5276192|NCT00576472|18202082|P13|MPH In-Lab Phase|Psychiatric exclusion|0
5276193|NCT00576472|18202083|P12|MPH In-Lab Phase|Psychiatric exclusion|0
5276194|NCT00576472|18202084|P11|MPH In-Lab Phase|Psychiatric exclusion|0
5276195|NCT00576472|18202085|P10|MPH In-Lab Phase|Psychiatric exclusion|0
5276196|NCT00576472|18202086|P9|MPH In-Lab Phase|Psychiatric exclusion|0
5276197|NCT00576472|18202087|P8|MPH In-Lab Phase|Psychiatric exclusion|0
5276198|NCT00576472|18202088|P7|MPH In-Lab Phase|Psychiatric exclusion|0
5276199|NCT00576472|18202089|P6|MPH In-Lab Phase|Psychiatric exclusion|0
5276200|NCT00576472|18202090|P5|MPH In-Lab Phase|Psychiatric exclusion|0
5276201|NCT00576472|18202091|P4|MPH In-Lab Phase|Psychiatric exclusion|10
5276202|NCT00576472|18202092|P3|MPH In-Lab Phase|Psychiatric exclusion|0
5276203|NCT00576472|18202093|P2|MPH In-Lab Phase|Psychiatric exclusion|0
5276204|NCT00576472|18202094|P1|MPH In-Lab Phase|Psychiatric exclusion|0
5276205|NCT00576472|18202080|P15|MPH In-Lab Phase|No attention/academic problems|0
5276206|NCT00576472|18202081|P14|MPH In-Lab Phase|No attention/academic problems|0
5276207|NCT00576472|18202082|P13|MPH In-Lab Phase|No attention/academic problems|0
5276208|NCT00576472|18202083|P12|MPH In-Lab Phase|No attention/academic problems|0
5276209|NCT00576472|18202084|P11|MPH In-Lab Phase|No attention/academic problems|0
5276210|NCT00576472|18202085|P10|MPH In-Lab Phase|No attention/academic problems|0
5276211|NCT00576472|18202086|P9|MPH In-Lab Phase|No attention/academic problems|0
5276212|NCT00576472|18202087|P8|MPH In-Lab Phase|No attention/academic problems|0
5276213|NCT00576472|18202088|P7|MPH In-Lab Phase|No attention/academic problems|0
5276214|NCT00576472|18202089|P6|MPH In-Lab Phase|No attention/academic problems|0
5276215|NCT00576472|18202090|P5|MPH In-Lab Phase|No attention/academic problems|0
5276216|NCT00576472|18202091|P4|MPH In-Lab Phase|No attention/academic problems|245
5276217|NCT00576472|18202092|P3|MPH In-Lab Phase|No attention/academic problems|0
5276218|NCT00576472|18202093|P2|MPH In-Lab Phase|No attention/academic problems|0
5276219|NCT00576472|18202094|P1|MPH In-Lab Phase|No attention/academic problems|0
5276220|NCT00576472|18202080|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276221|NCT00576472|18202081|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276222|NCT00576472|18202082|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276223|NCT00576472|18202083|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276224|NCT00576472|18202084|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276225|NCT00576472|18202085|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276226|NCT00576472|18202086|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276227|NCT00576472|18202087|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276228|NCT00576472|18202088|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276229|NCT00576472|18202089|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276230|NCT00576472|18202090|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276231|NCT00576472|18202091|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
5276232|NCT00576472|18202092|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276233|NCT00576472|18202093|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276234|NCT00576472|18202094|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5276235|NCT00576472|18202080|P15|MPH In-Lab Phase|Lost to Follow-up|0
5276236|NCT00576472|18202081|P14|MPH In-Lab Phase|Lost to Follow-up|0
5276237|NCT00576472|18202082|P13|MPH In-Lab Phase|Lost to Follow-up|0
5276238|NCT00576472|18202083|P12|MPH In-Lab Phase|Lost to Follow-up|0
5276239|NCT00576472|18202084|P11|MPH In-Lab Phase|Lost to Follow-up|0
5276240|NCT00576472|18202085|P10|MPH In-Lab Phase|Lost to Follow-up|0
5276241|NCT00576472|18202086|P9|MPH In-Lab Phase|Lost to Follow-up|0
5276242|NCT00576472|18202087|P8|MPH In-Lab Phase|Lost to Follow-up|0
5276243|NCT00576472|18202088|P7|MPH In-Lab Phase|Lost to Follow-up|0
5276244|NCT00576472|18202089|P6|MPH In-Lab Phase|Lost to Follow-up|0
5276245|NCT00576472|18202090|P5|MPH In-Lab Phase|Lost to Follow-up|0
5276246|NCT00576472|18202091|P4|MPH In-Lab Phase|Lost to Follow-up|1
5276248|NCT00576472|18202093|P2|MPH In-Lab Phase|Lost to Follow-up|0
5276249|NCT00576472|18202094|P1|MPH In-Lab Phase|Lost to Follow-up|0
5276250|NCT00576472|18202080|P15|MPH In-Lab Phase|Declined participation in medication pha|0
5276251|NCT00576472|18202081|P14|MPH In-Lab Phase|Declined participation in medication pha|0
5276252|NCT00576472|18202082|P13|MPH In-Lab Phase|Declined participation in medication pha|0
5276253|NCT00576472|18202083|P12|MPH In-Lab Phase|Declined participation in medication pha|0
5276254|NCT00576472|18202084|P11|MPH In-Lab Phase|Declined participation in medication pha|0
5276255|NCT00576472|18202085|P10|MPH In-Lab Phase|Declined participation in medication pha|0
5276256|NCT00576472|18202086|P9|MPH In-Lab Phase|Declined participation in medication pha|0
5276257|NCT00576472|18202087|P8|MPH In-Lab Phase|Declined participation in medication pha|0
5276258|NCT00576472|18202088|P7|MPH In-Lab Phase|Declined participation in medication pha|0
5276259|NCT00576472|18202089|P6|MPH In-Lab Phase|Declined participation in medication pha|0
5276260|NCT00576472|18202090|P5|MPH In-Lab Phase|Declined participation in medication pha|0
5276261|NCT00576472|18202091|P4|MPH In-Lab Phase|Declined participation in medication pha|75
5276262|NCT00576472|18202092|P3|MPH In-Lab Phase|Declined participation in medication pha|0
5276263|NCT00576472|18202093|P2|MPH In-Lab Phase|Declined participation in medication pha|0
5276264|NCT00576472|18202094|P1|MPH In-Lab Phase|Declined participation in medication pha|0
5276265|NCT00576420|18202187|P3|Overall Study|Death|1
5276266|NCT00576420|18202188|P2|Overall Study|Death|0
5276267|NCT00576420|18202189|P1|Overall Study|Death|0
5276268|NCT00576407|18202354|P1|Overall Study|Physician Decision|1
5276269|NCT00576407|18202354|P1|Overall Study|Death|7
5276270|NCT00576381|18202366|P1|Overall Study|Adverse Event|4
5276271|NCT00576381|18202366|P1|Overall Study|Reoperation|3
5276272|NCT00576316|18202370|P1|Overall Study|Protocol Violation|9
5276273|NCT00576316|18202370|P1|Overall Study|Withdrawal by Subject|2
5276274|NCT00576316|18202370|P1|Overall Study|Adverse Event|9
5276275|NCT00576303|18202375|P1|Long Term Safety Period|Early withdrawal|16
5276276|NCT00576303|18202375|P1|Efficacy Evaluation Period|Early withdrawal|5
5276277|NCT00576303|18202375|P1|Dose Titration Period|Early withdrawal|17
5276278|NCT00576199|18202393|P1|Overall Study|Reason Unspecified|2
5276279|NCT00576199|18202393|P1|Overall Study|Refused Treatment|2
5276280|NCT00576199|18202393|P1|Overall Study|Insufficient Therapeutic Response|14
5276281|NCT00576199|18202393|P1|Overall Study|Adverse Event|12
5276282|NCT00576056|18202406|P1|Overall Study|Physician Decision|1
5276283|NCT00576056|18202406|P1|Overall Study|did not meet eligibility criteria|8
5276284|NCT00576056|18202406|P1|Overall Study|Withdrawal by Subject|2
5276285|NCT00576056|18202406|P1|Overall Study|Lack of Efficacy|1
5276286|NCT00576056|18202406|P1|Overall Study|Death|1
5276287|NCT00576056|18202406|P1|Overall Study|Adverse Event|1
5276288|NCT00575666|18202422|P2|Overall Study|Physician Decision|1
5276289|NCT00575666|18202423|P1|Overall Study|Physician Decision|1
5276290|NCT00575666|18202422|P2|Overall Study|Withdrawal by Subject|2
5276291|NCT00575666|18202423|P1|Overall Study|Withdrawal by Subject|3
5276292|NCT00575588|18202463|P2|Overall Study|Impossible to determine HbA1c|1
5276293|NCT00575588|18202464|P1|Overall Study|Impossible to determine HbA1c|0
5276294|NCT00575588|18202463|P2|Overall Study|Patient moved|3
5276295|NCT00575588|18202464|P1|Overall Study|Patient moved|1
5276296|NCT00575588|18202463|P2|Overall Study|Elevated triglyceride|0
5276297|NCT00575588|18202464|P1|Overall Study|Elevated triglyceride|1
5276298|NCT00575588|18202463|P2|Overall Study|Safety reasons|1
5276299|NCT00575588|18202464|P1|Overall Study|Safety reasons|2
5276300|NCT00575588|18202463|P2|Overall Study|Severe non-compliance to protocol|7
5276301|NCT00575588|18202464|P1|Overall Study|Severe non-compliance to protocol|5
5276302|NCT00575588|18202463|P2|Overall Study|Study specific discontinuation criteria|218
5276303|NCT00575588|18202464|P1|Overall Study|Study specific discontinuation criteria|203
5276304|NCT00575588|18202463|P2|Overall Study|Incorrect enrollment|4
5276305|NCT00575588|18202464|P1|Overall Study|Incorrect enrollment|8
5276306|NCT00575588|18202463|P2|Overall Study|Death|2
5276307|NCT00575588|18202464|P1|Overall Study|Death|4
5276308|NCT00575588|18202463|P2|Overall Study|Lost to Follow-up|3
5276309|NCT00575588|18202464|P1|Overall Study|Lost to Follow-up|1
5276310|NCT00575588|18202463|P2|Overall Study|Withdrawal by Subject|31
5276311|NCT00575588|18202464|P1|Overall Study|Withdrawal by Subject|27
5276312|NCT00575588|18202463|P2|Overall Study|Adverse Event|13
5276313|NCT00575588|18202464|P1|Overall Study|Adverse Event|11
5276314|NCT00575510|18202487|P3|Overall Study|Pregnancy|1
5276315|NCT00575510|18202488|P2|Overall Study|Pregnancy|0
5276316|NCT00575510|18202489|P1|Overall Study|Pregnancy|0
5276317|NCT00575510|18202487|P3|Overall Study|Clinic Called Patient|7
5276318|NCT00575510|18202488|P2|Overall Study|Clinic Called Patient|7
5276319|NCT00575510|18202489|P1|Overall Study|Clinic Called Patient|7
5276320|NCT00575510|18202487|P3|Overall Study|Withdrawal by Subject|0
5276321|NCT00575510|18202488|P2|Overall Study|Withdrawal by Subject|0
5276322|NCT00575510|18202489|P1|Overall Study|Withdrawal by Subject|1
5276323|NCT00575510|18202487|P3|Overall Study|Lost to Follow-up|9
5276324|NCT00575510|18202488|P2|Overall Study|Lost to Follow-up|6
5276325|NCT00575510|18202489|P1|Overall Study|Lost to Follow-up|4
5276326|NCT00575380|18202502|P2|Overall Study|Various|2
5276327|NCT00575380|18202503|P1|Overall Study|Various|0
5276328|NCT00575380|18202502|P2|Overall Study|Adverse Event|1
5276329|NCT00575380|18202503|P1|Overall Study|Adverse Event|0
5276330|NCT00575380|18202502|P2|Overall Study|Withdrawal by Subject|0
5276331|NCT00575380|18202503|P1|Overall Study|Withdrawal by Subject|1
5276332|NCT00575328|18202522|P2|Overall Study|Lost to Follow-up|1
5276333|NCT00575328|18202523|P1|Overall Study|Lost to Follow-up|2
5276334|NCT00575328|18202522|P2|Overall Study|Adverse Event|1
5276335|NCT00575328|18202523|P1|Overall Study|Adverse Event|1
5276336|NCT00575094|18202656|P1|Overall Study|Withdrawal by Subject|1
5276337|NCT00575094|18202656|P1|Overall Study|Adverse Event|2
5276338|NCT00575042|18202660|P1|Overall Study|Lost to Follow-up|1
5276339|NCT00575042|18202660|P1|Overall Study|Adverse Event|2
5276340|NCT00574951|18202711|P1|Overall Study|Ineligible - improper prior treatment|1
5276341|NCT00574912|18202719|P1|Overall Study|Physician Decision|2
5276342|NCT00574912|18202719|P1|Overall Study|scheduling conflicts|3
5276343|NCT00574912|18202719|P1|Overall Study|Could not place IV lines.|3
5276344|NCT00574873|18202733|P2|Overall Study|Extension Study|0
5276345|NCT00574873|18202734|P1|Overall Study|Extension Study|126
5276346|NCT00574873|18202733|P2|Overall Study|Blank, site closed per local regulations|2
5276347|NCT00574873|18202734|P1|Overall Study|Blank, site closed per local regulations|2
5276348|NCT00574873|18202733|P2|Overall Study|Discontinuation of study by sponsor|199
5276349|NCT00574873|18202734|P1|Overall Study|Discontinuation of study by sponsor|5
5276350|NCT00574873|18202733|P2|Overall Study|Other|4
5276351|NCT00574873|18202734|P1|Overall Study|Other|40
5276352|NCT00574873|18202733|P2|Overall Study|Lost to Follow-up|5
5276353|NCT00574873|18202734|P1|Overall Study|Lost to Follow-up|14
5276354|NCT00574873|18202733|P2|Overall Study|Death|14
5276355|NCT00574873|18202734|P1|Overall Study|Death|15
5276356|NCT00574873|18202733|P2|Overall Study|Investigator request|8
5276357|NCT00574873|18202734|P1|Overall Study|Investigator request|18
5276358|NCT00574873|18202733|P2|Overall Study|Withdrawal by Subject|19
5276359|NCT00574873|18202734|P1|Overall Study|Withdrawal by Subject|18
5276360|NCT00574847|18202752|P2|Overall Study|Did not receive medication (declined)|5
5276361|NCT00574847|18202753|P1|Overall Study|Did not receive medication (declined)|2
5276362|NCT00574847|18202752|P2|Overall Study|Physician Decision|0
5276363|NCT00574847|18202753|P1|Overall Study|Physician Decision|1
5276364|NCT00574847|18202752|P2|Overall Study|Withdrawal by Subject|2
5276365|NCT00574847|18202753|P1|Overall Study|Withdrawal by Subject|2
5276366|NCT00574847|18202752|P2|Overall Study|Death|0
5276367|NCT00574847|18202753|P1|Overall Study|Death|1
5276368|NCT00574847|18202752|P2|Overall Study|Adverse Event|0
5276369|NCT00574847|18202753|P1|Overall Study|Adverse Event|2
5276370|NCT00574795|18202798|P1|Toddler Dose|Withdrawal by Subject|1
5276371|NCT00574795|18202798|P1|After Infant Series|Adverse Event|2
5276372|NCT00574795|18202798|P1|After Infant Series|Withdrawal by Subject|1
5276373|NCT00574795|18202798|P1|Infant Series|Adverse Event|1
5276374|NCT00574795|18202798|P1|Infant Series|Protocol Violation|2
5276375|NCT00574795|18202798|P1|Infant Series|Withdrawal by Subject|2
5276376|NCT00574405|18202899|P2|Overall Study|Withdrawal by Subject|2
5276377|NCT00574405|18202900|P1|Overall Study|Withdrawal by Subject|3
5276378|NCT00574288|18202920|P7|Overall Study|Other|0
5276379|NCT00574288|18202921|P6|Overall Study|Other|0
5276380|NCT00574288|18202922|P5|Overall Study|Other|0
5276381|NCT00574288|18202923|P4|Overall Study|Other|0
5276382|NCT00574288|18202924|P3|Overall Study|Other|0
5276383|NCT00574288|18202925|P2|Overall Study|Other|1
5276384|NCT00574288|18202926|P1|Overall Study|Other|1
5276385|NCT00574288|18202920|P7|Overall Study|Progressive Disease|0
5276386|NCT00574288|18202921|P6|Overall Study|Progressive Disease|0
5276387|NCT00574288|18202922|P5|Overall Study|Progressive Disease|1
5276388|NCT00574288|18202923|P4|Overall Study|Progressive Disease|2
5276389|NCT00574288|18202924|P3|Overall Study|Progressive Disease|3
5276390|NCT00574288|18202925|P2|Overall Study|Progressive Disease|2
5276391|NCT00574288|18202926|P1|Overall Study|Progressive Disease|17
5276392|NCT00574288|18202920|P7|Overall Study|Study Terminated By Sponsor|5
5276393|NCT00574288|18202921|P6|Overall Study|Study Terminated By Sponsor|0
5276394|NCT00574288|18202922|P5|Overall Study|Study Terminated By Sponsor|0
5276395|NCT00574288|18202923|P4|Overall Study|Study Terminated By Sponsor|0
5276396|NCT00574288|18202924|P3|Overall Study|Study Terminated By Sponsor|0
5276397|NCT00574288|18202925|P2|Overall Study|Study Terminated By Sponsor|0
5276398|NCT00574288|18202926|P1|Overall Study|Study Terminated By Sponsor|0
5276399|NCT00574288|18202920|P7|Overall Study|Lost to Follow-up|2
5276400|NCT00574288|18202921|P6|Overall Study|Lost to Follow-up|1
5276401|NCT00574288|18202922|P5|Overall Study|Lost to Follow-up|0
5276402|NCT00574288|18202923|P4|Overall Study|Lost to Follow-up|0
5276403|NCT00574288|18202924|P3|Overall Study|Lost to Follow-up|0
5276404|NCT00574288|18202925|P2|Overall Study|Lost to Follow-up|0
5276405|NCT00574288|18202926|P1|Overall Study|Lost to Follow-up|0
5276406|NCT00574288|18202920|P7|Overall Study|Death|21
5276407|NCT00574288|18202921|P6|Overall Study|Death|25
5276408|NCT00574288|18202922|P5|Overall Study|Death|0
5276409|NCT00574288|18202923|P4|Overall Study|Death|0
5276410|NCT00574288|18202924|P3|Overall Study|Death|0
5276411|NCT00574288|18202925|P2|Overall Study|Death|0
5276412|NCT00574288|18202926|P1|Overall Study|Death|0
5276413|NCT00574288|18202920|P7|Overall Study|Adverse Event|0
5276414|NCT00574288|18202921|P6|Overall Study|Adverse Event|0
5276415|NCT00574288|18202922|P5|Overall Study|Adverse Event|1
5276416|NCT00574288|18202923|P4|Overall Study|Adverse Event|0
5276417|NCT00574288|18202924|P3|Overall Study|Adverse Event|0
5276418|NCT00574288|18202925|P2|Overall Study|Adverse Event|0
5276419|NCT00574288|18202926|P1|Overall Study|Adverse Event|2
5276420|NCT00574275|18202964|P2|Overall Study|Operation for curative intent|1
5276421|NCT00574275|18202965|P1|Overall Study|Operation for curative intent|0
5276422|NCT00574275|18202964|P2|Overall Study|Insurance change|1
5276423|NCT00574275|18202965|P1|Overall Study|Insurance change|0
5276596|NCT00573170|18203434|P5|Third Treatment Period|Withdrawal by Subject|0
5276424|NCT00574275|18202964|P2|Overall Study|Patient and Investigator decision|1
5276425|NCT00574275|18202965|P1|Overall Study|Patient and Investigator decision|0
5276426|NCT00574275|18202964|P2|Overall Study|Protocol Violation|1
5276427|NCT00574275|18202965|P1|Overall Study|Protocol Violation|0
5276428|NCT00574275|18202964|P2|Overall Study|Physician Decision|1
5276429|NCT00574275|18202965|P1|Overall Study|Physician Decision|1
5276430|NCT00574275|18202964|P2|Overall Study|Error calculating tumor measurement|0
5276431|NCT00574275|18202965|P1|Overall Study|Error calculating tumor measurement|1
5276432|NCT00574275|18202964|P2|Overall Study|Withdrawal by Subject|17
5276433|NCT00574275|18202965|P1|Overall Study|Withdrawal by Subject|15
5276434|NCT00574275|18202964|P2|Overall Study|Study stopped based on DMC decision|23
5276435|NCT00574275|18202965|P1|Overall Study|Study stopped based on DMC decision|62
5276436|NCT00574275|18202964|P2|Overall Study|Lost to Follow-up|1
5276437|NCT00574275|18202965|P1|Overall Study|Lost to Follow-up|2
5276438|NCT00574275|18202964|P2|Overall Study|Disease progression|146
5276439|NCT00574275|18202965|P1|Overall Study|Disease progression|160
5276440|NCT00574275|18202964|P2|Overall Study|Adverse Event|76
5276441|NCT00574275|18202965|P1|Overall Study|Adverse Event|32
5276442|NCT00574275|18202964|P2|Overall Study|Randomized but not treated|3
5276443|NCT00574275|18202965|P1|Overall Study|Randomized but not treated|2
5276444|NCT00574249|18202983|P2|Overall Study|PPD test taken twice|1
5276445|NCT00574249|18202984|P1|Overall Study|PPD test taken twice|0
5276446|NCT00574249|18202983|P2|Overall Study|Excluded by company|1
5276447|NCT00574249|18202984|P1|Overall Study|Excluded by company|0
5276448|NCT00574249|18202983|P2|Overall Study|Pregnancy|0
5276449|NCT00574249|18202984|P1|Overall Study|Pregnancy|1
5276450|NCT00574249|18202983|P2|Overall Study|Physician Decision|0
5276451|NCT00574249|18202984|P1|Overall Study|Physician Decision|1
5276452|NCT00574249|18202983|P2|Overall Study|Withdrawal by Subject|0
5276453|NCT00574249|18202984|P1|Overall Study|Withdrawal by Subject|3
5276454|NCT00574249|18202983|P2|Overall Study|History of carcinoma|0
5276455|NCT00574249|18202984|P1|Overall Study|History of carcinoma|1
5276456|NCT00574249|18202983|P2|Overall Study|Protocol Violation|2
5276457|NCT00574249|18202984|P1|Overall Study|Protocol Violation|5
5276458|NCT00574249|18202983|P2|Overall Study|Lost to Follow-up|3
5276459|NCT00574249|18202984|P1|Overall Study|Lost to Follow-up|4
5276460|NCT00574249|18202983|P2|Overall Study|Lack of Efficacy|3
5276461|NCT00574249|18202984|P1|Overall Study|Lack of Efficacy|5
5276462|NCT00574249|18202983|P2|Overall Study|Adverse Event|18
5276463|NCT00574249|18202984|P1|Overall Study|Adverse Event|6
5276464|NCT00574145|18203040|P2|Overall Study|Withdrawal by Subject|1
5276465|NCT00574145|18203041|P1|Overall Study|Withdrawal by Subject|2
5276466|NCT00574119|18203051|P1|Overall Study|Physician Decision|1
5276467|NCT00574119|18203051|P1|Overall Study|Withdrawal by Subject|1
5276468|NCT00574119|18203051|P1|Overall Study|Protocol Violation|1
5276469|NCT00574119|18203051|P1|Overall Study|Adverse Event|1
5276470|NCT00574080|18203065|P2|Overall Study|Death|10
5276471|NCT00574080|18203066|P1|Overall Study|Death|10
5276472|NCT00573937|18203135|P2|Overall Study|Study Terminated|1
5276473|NCT00573937|18203136|P1|Overall Study|Study Terminated|0
5276474|NCT00573859|18203150|P1|Smoking Versus Abstinence|Scheduling conflicts|12
5276475|NCT00573859|18203150|P1|Medication Versus Placebo|Scheduling conflicts|12
5276476|NCT00573833|18203156|P1|Overall Study|Not Treated|2
5276477|NCT00573794|18203163|P1|Overall Study|Other|46
5276478|NCT00573794|18203163|P1|Overall Study|Lack of Efficacy|94
5276479|NCT00573794|18203163|P1|Overall Study|Protocol Violation|6
5276480|NCT00573794|18203163|P1|Overall Study|Lost to Follow-up|13
5276481|NCT00573794|18203163|P1|Overall Study|Withdrew Consent|90
5276482|NCT00573794|18203163|P1|Overall Study|Adverse Event|81
5276483|NCT00573768|18203194|P3|Overall Study|Lost to Follow-up|1
5276484|NCT00573768|18203195|P2|Overall Study|Lost to Follow-up|0
5276485|NCT00573768|18203196|P1|Overall Study|Lost to Follow-up|0
5276486|NCT00573768|18203194|P3|Overall Study|Withdrawal by Subject|0
5276487|NCT00573768|18203195|P2|Overall Study|Withdrawal by Subject|1
5276488|NCT00573768|18203196|P1|Overall Study|Withdrawal by Subject|0
5276489|NCT00573768|18203194|P3|Overall Study|Protocol Violation|1
5276490|NCT00573768|18203195|P2|Overall Study|Protocol Violation|0
5276491|NCT00573768|18203196|P1|Overall Study|Protocol Violation|1
5276492|NCT00573768|18203194|P3|Overall Study|Adverse Event|2
5276493|NCT00573768|18203195|P2|Overall Study|Adverse Event|1
5276494|NCT00573768|18203196|P1|Overall Study|Adverse Event|1
5276495|NCT00573755|18203206|P2|Overall Study|Still receiving treatment|0
5276496|NCT00573755|18203207|P1|Overall Study|Still receiving treatment|1
5276497|NCT00573534|18203223|P1|Overall Study|oppositional behavior|3
5276498|NCT00573469|18203264|P3|Overall Study|Other|3
5276499|NCT00573469|18203265|P2|Overall Study|Other|1
5276500|NCT00573469|18203266|P1|Overall Study|Other|5
5276501|NCT00573469|18203264|P3|Overall Study|Withdrawal by Subject|0
5276502|NCT00573469|18203265|P2|Overall Study|Withdrawal by Subject|2
5276503|NCT00573469|18203266|P1|Overall Study|Withdrawal by Subject|0
5276504|NCT00573469|18203264|P3|Overall Study|Adverse Event|1
5276505|NCT00573469|18203265|P2|Overall Study|Adverse Event|1
5276506|NCT00573469|18203266|P1|Overall Study|Adverse Event|1
5276507|NCT00573443|18203289|P3|Open-Label Extension Phase|Other|0
5276508|NCT00573443|18203290|P2|Open-Label Extension Phase|Other|0
5276509|NCT00573443|18203291|P1|Open-Label Extension Phase|Other|2
5276510|NCT00573443|18203289|P3|Open-Label Extension Phase|Protocol Violation|0
5276511|NCT00573443|18203290|P2|Open-Label Extension Phase|Protocol Violation|0
5276512|NCT00573443|18203291|P1|Open-Label Extension Phase|Protocol Violation|2
5276513|NCT00573443|18203289|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5276514|NCT00573443|18203290|P2|Open-Label Extension Phase|Withdrawal by Subject|0
5276515|NCT00573443|18203291|P1|Open-Label Extension Phase|Withdrawal by Subject|3
5276516|NCT00573443|18203289|P3|Open-Label Extension Phase|Serious Adverse Event|0
5276517|NCT00573443|18203290|P2|Open-Label Extension Phase|Serious Adverse Event|0
5276518|NCT00573443|18203291|P1|Open-Label Extension Phase|Serious Adverse Event|5
5276519|NCT00573443|18203289|P3|Open-Label Extension Phase|Adverse Event|0
5276520|NCT00573443|18203290|P2|Open-Label Extension Phase|Adverse Event|0
5276521|NCT00573443|18203291|P1|Open-Label Extension Phase|Adverse Event|3
5276522|NCT00573443|18203289|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
5276523|NCT00573443|18203290|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
5276524|NCT00573443|18203291|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
5276525|NCT00573443|18203289|P3|Open-Label Extension Phase|Lost to Follow-up|0
5276526|NCT00573443|18203290|P2|Open-Label Extension Phase|Lost to Follow-up|0
5276527|NCT00573443|18203291|P1|Open-Label Extension Phase|Lost to Follow-up|1
5276528|NCT00573443|18203289|P3|Double-Blind Phase|Other|3
5276529|NCT00573443|18203290|P2|Double-Blind Phase|Other|2
5276530|NCT00573443|18203291|P1|Double-Blind Phase|Other|0
5276531|NCT00573443|18203289|P3|Double-Blind Phase|Protocol Violation|1
5276532|NCT00573443|18203290|P2|Double-Blind Phase|Protocol Violation|2
5276533|NCT00573443|18203291|P1|Double-Blind Phase|Protocol Violation|0
5276534|NCT00573443|18203289|P3|Double-Blind Phase|Withdrawal by Subject|7
5276535|NCT00573443|18203290|P2|Double-Blind Phase|Withdrawal by Subject|2
5276536|NCT00573443|18203291|P1|Double-Blind Phase|Withdrawal by Subject|2
5276537|NCT00573443|18203289|P3|Double-Blind Phase|Medication refusal due to AE|0
5276538|NCT00573443|18203290|P2|Double-Blind Phase|Medication refusal due to AE|2
5276539|NCT00573443|18203291|P1|Double-Blind Phase|Medication refusal due to AE|2
5276540|NCT00573443|18203289|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
5276541|NCT00573443|18203290|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
5276542|NCT00573443|18203291|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
5276543|NCT00573443|18203289|P3|Double-Blind Phase|Adverse Event|0
5276544|NCT00573443|18203290|P2|Double-Blind Phase|Adverse Event|5
5276545|NCT00573443|18203291|P1|Double-Blind Phase|Adverse Event|1
5276546|NCT00573443|18203289|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
5276547|NCT00573443|18203290|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
5276548|NCT00573443|18203291|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
5276549|NCT00573443|18203289|P3|Double-Blind Phase|Lost to Follow-up|2
5276550|NCT00573443|18203290|P2|Double-Blind Phase|Lost to Follow-up|3
5276551|NCT00573443|18203291|P1|Double-Blind Phase|Lost to Follow-up|1
5276552|NCT00573430|18203321|P3|Overall Study|Eligibility criteria not fulfilled|3
5276553|NCT00573430|18203322|P2|Overall Study|Eligibility criteria not fulfilled|0
5276554|NCT00573430|18203323|P1|Overall Study|Eligibility criteria not fulfilled|0
5276555|NCT00573430|18203321|P3|Overall Study|Protocol Violation|1
5276556|NCT00573430|18203322|P2|Overall Study|Protocol Violation|1
5276557|NCT00573430|18203323|P1|Overall Study|Protocol Violation|0
5276558|NCT00573430|18203321|P3|Overall Study|Withdrawal by Subject|1
5276559|NCT00573430|18203322|P2|Overall Study|Withdrawal by Subject|0
5276560|NCT00573430|18203323|P1|Overall Study|Withdrawal by Subject|1
5276561|NCT00573430|18203321|P3|Overall Study|Adverse Event|2
5276562|NCT00573430|18203322|P2|Overall Study|Adverse Event|0
5276563|NCT00573430|18203323|P1|Overall Study|Adverse Event|0
5276564|NCT00573430|18203321|P3|Overall Study|Incorrect enrollment of randomization|3
5276565|NCT00573430|18203322|P2|Overall Study|Incorrect enrollment of randomization|4
5276566|NCT00573430|18203323|P1|Overall Study|Incorrect enrollment of randomization|0
5276567|NCT00573391|18203345|P2|Overall Study|Death|0
5276568|NCT00573391|18203346|P1|Overall Study|Death|1
5276569|NCT00573391|18203345|P2|Overall Study|study stopped|2
5276570|NCT00573391|18203346|P1|Overall Study|study stopped|2
5276571|NCT00573313|18203356|P4|Overall Study|Protocol Violation|0
5276572|NCT00573313|18203357|P3|Overall Study|Protocol Violation|6
5276573|NCT00573313|18203358|P2|Overall Study|Protocol Violation|0
5276574|NCT00573313|18203359|P1|Overall Study|Protocol Violation|5
5276575|NCT00573248|18203409|P2|Overall Study|scheduling conflicts|11
5276576|NCT00573248|18203410|P1|Overall Study|scheduling conflicts|15
5276577|NCT00573183|18203424|P2|Overall Study|Other|2
5276578|NCT00573183|18203425|P1|Overall Study|Other|5
5276579|NCT00573183|18203424|P2|Overall Study|Incarceration|8
5276580|NCT00573183|18203425|P1|Overall Study|Incarceration|5
5276581|NCT00573183|18203424|P2|Overall Study|Adverse Event|0
5276582|NCT00573183|18203425|P1|Overall Study|Adverse Event|2
5276583|NCT00573183|18203424|P2|Overall Study|Death|1
5276584|NCT00573183|18203425|P1|Overall Study|Death|0
5276585|NCT00573183|18203424|P2|Overall Study|Withdrawal by Subject|2
5276586|NCT00573183|18203425|P1|Overall Study|Withdrawal by Subject|8
5276587|NCT00573183|18203424|P2|Overall Study|Lost to Follow-up|50
5276588|NCT00573183|18203425|P1|Overall Study|Lost to Follow-up|52
5276589|NCT00573170|18203433|P6|Third Treatment Period|Lost to Follow-up|2
5276590|NCT00573170|18203434|P5|Third Treatment Period|Lost to Follow-up|0
5276591|NCT00573170|18203435|P4|Third Treatment Period|Lost to Follow-up|0
5276592|NCT00573170|18203436|P3|Third Treatment Period|Lost to Follow-up|0
5276593|NCT00573170|18203437|P2|Third Treatment Period|Lost to Follow-up|0
5276594|NCT00573170|18203438|P1|Third Treatment Period|Lost to Follow-up|0
5276595|NCT00573170|18203433|P6|Third Treatment Period|Withdrawal by Subject|0
5276597|NCT00573170|18203435|P4|Third Treatment Period|Withdrawal by Subject|0
5276598|NCT00573170|18203436|P3|Third Treatment Period|Withdrawal by Subject|0
5276599|NCT00573170|18203437|P2|Third Treatment Period|Withdrawal by Subject|0
5276600|NCT00573170|18203438|P1|Third Treatment Period|Withdrawal by Subject|1
5276601|NCT00573170|18203433|P6|Second Washout Period|Other|2
5276602|NCT00573170|18203434|P5|Second Washout Period|Other|6
5276603|NCT00573170|18203435|P4|Second Washout Period|Other|4
5276604|NCT00573170|18203436|P3|Second Washout Period|Other|1
5276605|NCT00573170|18203437|P2|Second Washout Period|Other|2
5276606|NCT00573170|18203438|P1|Second Washout Period|Other|1
5276607|NCT00573170|18203433|P6|Second Washout Period|Lost to Follow-up|0
5276608|NCT00573170|18203434|P5|Second Washout Period|Lost to Follow-up|0
5276609|NCT00573170|18203435|P4|Second Washout Period|Lost to Follow-up|1
5276610|NCT00573170|18203436|P3|Second Washout Period|Lost to Follow-up|0
5276611|NCT00573170|18203437|P2|Second Washout Period|Lost to Follow-up|0
5276612|NCT00573170|18203438|P1|Second Washout Period|Lost to Follow-up|0
5276613|NCT00573170|18203433|P6|Second Washout Period|Withdrawal by Subject|0
5276614|NCT00573170|18203434|P5|Second Washout Period|Withdrawal by Subject|1
5276615|NCT00573170|18203435|P4|Second Washout Period|Withdrawal by Subject|0
5276616|NCT00573170|18203436|P3|Second Washout Period|Withdrawal by Subject|2
5276617|NCT00573170|18203437|P2|Second Washout Period|Withdrawal by Subject|1
5276618|NCT00573170|18203438|P1|Second Washout Period|Withdrawal by Subject|1
5276619|NCT00573170|18203433|P6|Second Washout Period|Protocol Violation|0
5276620|NCT00573170|18203434|P5|Second Washout Period|Protocol Violation|0
5276621|NCT00573170|18203435|P4|Second Washout Period|Protocol Violation|0
5276622|NCT00573170|18203436|P3|Second Washout Period|Protocol Violation|1
5276623|NCT00573170|18203437|P2|Second Washout Period|Protocol Violation|1
5276624|NCT00573170|18203438|P1|Second Washout Period|Protocol Violation|2
5276625|NCT00573170|18203433|P6|Second Washout Period|Adverse Event|0
5276626|NCT00573170|18203434|P5|Second Washout Period|Adverse Event|1
5276627|NCT00573170|18203435|P4|Second Washout Period|Adverse Event|0
5276628|NCT00573170|18203436|P3|Second Washout Period|Adverse Event|0
5276629|NCT00573170|18203437|P2|Second Washout Period|Adverse Event|0
5276630|NCT00573170|18203438|P1|Second Washout Period|Adverse Event|1
5276631|NCT00573170|18203433|P6|First Washout Period|Other|0
5276632|NCT00573170|18203434|P5|First Washout Period|Other|0
5276633|NCT00573170|18203435|P4|First Washout Period|Other|1
5276634|NCT00573170|18203436|P3|First Washout Period|Other|1
5276635|NCT00573170|18203437|P2|First Washout Period|Other|0
5276636|NCT00573170|18203438|P1|First Washout Period|Other|4
5276637|NCT00573170|18203433|P6|First Washout Period|Withdrawal by Subject|3
5276638|NCT00573170|18203434|P5|First Washout Period|Withdrawal by Subject|3
5276639|NCT00573170|18203435|P4|First Washout Period|Withdrawal by Subject|2
5276640|NCT00573170|18203436|P3|First Washout Period|Withdrawal by Subject|0
5276641|NCT00573170|18203437|P2|First Washout Period|Withdrawal by Subject|0
5276642|NCT00573170|18203438|P1|First Washout Period|Withdrawal by Subject|2
5276643|NCT00573170|18203433|P6|First Washout Period|Lost to Follow-up|2
5276644|NCT00573170|18203434|P5|First Washout Period|Lost to Follow-up|0
5276645|NCT00573170|18203435|P4|First Washout Period|Lost to Follow-up|2
5276646|NCT00573170|18203436|P3|First Washout Period|Lost to Follow-up|0
5276647|NCT00573170|18203437|P2|First Washout Period|Lost to Follow-up|1
5276648|NCT00573170|18203438|P1|First Washout Period|Lost to Follow-up|1
5276649|NCT00573170|18203433|P6|First Washout Period|Lack of Efficacy|1
5276650|NCT00573170|18203434|P5|First Washout Period|Lack of Efficacy|0
5276651|NCT00573170|18203435|P4|First Washout Period|Lack of Efficacy|0
5276652|NCT00573170|18203436|P3|First Washout Period|Lack of Efficacy|0
5276653|NCT00573170|18203437|P2|First Washout Period|Lack of Efficacy|0
5276654|NCT00573170|18203438|P1|First Washout Period|Lack of Efficacy|0
5276655|NCT00573170|18203433|P6|First Washout Period|Adverse Event|1
5276656|NCT00573170|18203434|P5|First Washout Period|Adverse Event|0
5276657|NCT00573170|18203435|P4|First Washout Period|Adverse Event|0
5276658|NCT00573170|18203436|P3|First Washout Period|Adverse Event|0
5276659|NCT00573170|18203437|P2|First Washout Period|Adverse Event|1
5276660|NCT00573170|18203438|P1|First Washout Period|Adverse Event|1
5276661|NCT00573170|18203433|P6|First Treatment Period|Did Not Treat Attack 1|0
5276662|NCT00573170|18203434|P5|First Treatment Period|Did Not Treat Attack 1|1
5276663|NCT00573170|18203435|P4|First Treatment Period|Did Not Treat Attack 1|0
5276664|NCT00573170|18203436|P3|First Treatment Period|Did Not Treat Attack 1|0
5276665|NCT00573170|18203437|P2|First Treatment Period|Did Not Treat Attack 1|0
5276666|NCT00573170|18203438|P1|First Treatment Period|Did Not Treat Attack 1|0
5276667|NCT00573157|18203514|P2|Overall Study|Other|1
5276668|NCT00573157|18203515|P1|Overall Study|Other|1
5276669|NCT00573157|18203514|P2|Overall Study|Adverse Event|1
5276670|NCT00573157|18203515|P1|Overall Study|Adverse Event|3
5276671|NCT00573144|18203527|P2|Overall Study|Withdrawal by Subject|3
5276672|NCT00573144|18203528|P1|Overall Study|Withdrawal by Subject|2
5276673|NCT00573131|18203540|P2|Overall Study|Withdrawal by Subject|8
5276674|NCT00573131|18203541|P1|Overall Study|Withdrawal by Subject|10
5276675|NCT00573066|18203547|P1|Overall Study|Postoperative bleeding|1
5276676|NCT00573066|18203547|P1|Overall Study|IV malfunction|1
5276677|NCT00573066|18203547|P1|Overall Study|Exclusion criteria|18
5276678|NCT00572910|18203591|P11|Overall Study|Withdrawal by Subject|1
5276679|NCT00572910|18203592|P10|Overall Study|Withdrawal by Subject|2
5276680|NCT00572910|18203593|P9|Overall Study|Withdrawal by Subject|2
5276681|NCT00572910|18203594|P8|Overall Study|Withdrawal by Subject|2
5276682|NCT00572910|18203595|P7|Overall Study|Withdrawal by Subject|0
5276683|NCT00572910|18203596|P6|Overall Study|Withdrawal by Subject|3
5276684|NCT00572910|18203597|P5|Overall Study|Withdrawal by Subject|1
5276685|NCT00572910|18203598|P4|Overall Study|Withdrawal by Subject|0
5276686|NCT00572910|18203599|P3|Overall Study|Withdrawal by Subject|1
5276687|NCT00572910|18203600|P2|Overall Study|Withdrawal by Subject|0
5276688|NCT00572910|18203601|P1|Overall Study|Withdrawal by Subject|3
5276689|NCT00572910|18203591|P11|Overall Study|Lost to Follow-up|0
5276690|NCT00572910|18203592|P10|Overall Study|Lost to Follow-up|1
5276691|NCT00572910|18203593|P9|Overall Study|Lost to Follow-up|0
5276692|NCT00572910|18203594|P8|Overall Study|Lost to Follow-up|0
5276693|NCT00572910|18203595|P7|Overall Study|Lost to Follow-up|0
5276694|NCT00572910|18203596|P6|Overall Study|Lost to Follow-up|0
5276695|NCT00572910|18203597|P5|Overall Study|Lost to Follow-up|1
5276696|NCT00572910|18203598|P4|Overall Study|Lost to Follow-up|2
5276697|NCT00572910|18203599|P3|Overall Study|Lost to Follow-up|1
5276698|NCT00572910|18203600|P2|Overall Study|Lost to Follow-up|1
5276699|NCT00572910|18203601|P1|Overall Study|Lost to Follow-up|0
5276700|NCT00572910|18203591|P11|Overall Study|Adverse Event|2
5276701|NCT00572910|18203592|P10|Overall Study|Adverse Event|3
5276702|NCT00572910|18203593|P9|Overall Study|Adverse Event|1
5276703|NCT00572910|18203594|P8|Overall Study|Adverse Event|2
5276704|NCT00572910|18203595|P7|Overall Study|Adverse Event|4
5276705|NCT00572910|18203596|P6|Overall Study|Adverse Event|0
5276706|NCT00572910|18203597|P5|Overall Study|Adverse Event|0
5276707|NCT00572910|18203598|P4|Overall Study|Adverse Event|2
5276708|NCT00572910|18203599|P3|Overall Study|Adverse Event|0
5276709|NCT00572910|18203600|P2|Overall Study|Adverse Event|2
5276710|NCT00572910|18203601|P1|Overall Study|Adverse Event|1
5276711|NCT00572832|18203668|P2|Overall Study|Pregnancy|1
5276712|NCT00572832|18203669|P1|Overall Study|Pregnancy|0
5276713|NCT00572832|18203668|P2|Overall Study|Lost to Follow-up|11
5276714|NCT00572832|18203669|P1|Overall Study|Lost to Follow-up|0
5276715|NCT00572728|18203675|P1|Overall Study|Pathology missing|1
5276716|NCT00572728|18203675|P1|Overall Study|FLT2 after second chemotherapy initiated|7
5276717|NCT00572728|18203675|P1|Overall Study|Second chemotherapy not initiated|1
5276718|NCT00572728|18203675|P1|Overall Study|FLT2 not completed|5
5276719|NCT00572728|18203675|P1|Overall Study|First Chemotherapy not initiated|2
5276720|NCT00572728|18203675|P1|Overall Study|FLT1 not completed|4
5276721|NCT00572728|18203675|P1|Overall Study|Offstudy due to complicating disease|1
5276722|NCT00572728|18203675|P1|Overall Study|Enrolled under Amendment 4|5
5276723|NCT00572728|18203675|P1|Overall Study|Ineligible|3
5276724|NCT00572728|18203675|P1|Overall Study|Withdrawal by Subject|10
5276725|NCT00572624|18203689|P2|Overall Study|Health issues unrelated to the study|0
5276726|NCT00572624|18203690|P1|Overall Study|Health issues unrelated to the study|1
5276727|NCT00572624|18203689|P2|Overall Study|Problem with vascular access|0
5276728|NCT00572624|18203690|P1|Overall Study|Problem with vascular access|1
5276729|NCT00572624|18203689|P2|Overall Study|Refused to do the stress test|0
5276730|NCT00572624|18203690|P1|Overall Study|Refused to do the stress test|1
5276731|NCT00572624|18203689|P2|Overall Study|Admitted to being a smoker|0
5276732|NCT00572624|18203690|P1|Overall Study|Admitted to being a smoker|1
5276733|NCT00572624|18203689|P2|Overall Study|Started a new job-- no time for study|0
5276734|NCT00572624|18203690|P1|Overall Study|Started a new job-- no time for study|1
5276735|NCT00572624|18203689|P2|Overall Study|Medication change|0
5276736|NCT00572624|18203690|P1|Overall Study|Medication change|1
5276737|NCT00572624|18203689|P2|Overall Study|Wanted to do a different diet program|0
5276738|NCT00572624|18203690|P1|Overall Study|Wanted to do a different diet program|1
5276739|NCT00572624|18203689|P2|Overall Study|Lost to Follow-up|4
5276740|NCT00572624|18203690|P1|Overall Study|Lost to Follow-up|10
5276741|NCT00572572|18203718|P2|Overall Study|Withdrawal by Subject|6
5276742|NCT00572572|18203719|P1|Overall Study|Withdrawal by Subject|3
5276743|NCT00572533|18203737|P2|Overall Study|Transfer out of Facility|1
5276744|NCT00572533|18203738|P1|Overall Study|Transfer out of Facility|0
5276745|NCT00572533|18203737|P2|Overall Study|Social Issues|0
5276746|NCT00572533|18203738|P1|Overall Study|Social Issues|1
5276747|NCT00572533|18203737|P2|Overall Study|Received Kidney Transplant|1
5276748|NCT00572533|18203738|P1|Overall Study|Received Kidney Transplant|2
5276749|NCT00572533|18203737|P2|Overall Study|Death|1
5276750|NCT00572533|18203738|P1|Overall Study|Death|4
5276751|NCT00572195|18203782|P1|Overall Study|Lost to Follow-up|5
5276752|NCT00572195|18203782|P1|Overall Study|Adverse Event|4
5276753|NCT00572195|18203782|P1|Overall Study|Death|9
5276754|NCT00572195|18203782|P1|Overall Study|Withdrawal by Subject|50
5276755|NCT00572156|18203794|P4|Overall Study|Sponsor Decision|19
5276756|NCT00572156|18203795|P3|Overall Study|Sponsor Decision|17
5276757|NCT00572156|18203796|P2|Overall Study|Sponsor Decision|16
5276758|NCT00572156|18203797|P1|Overall Study|Sponsor Decision|20
5276759|NCT00572156|18203794|P4|Overall Study|Patient/Parent Decision|3
5276760|NCT00572156|18203795|P3|Overall Study|Patient/Parent Decision|4
5276761|NCT00572156|18203796|P2|Overall Study|Patient/Parent Decision|6
5276762|NCT00572156|18203797|P1|Overall Study|Patient/Parent Decision|1
5276763|NCT00572156|18203794|P4|Overall Study|Protocol Violation|2
5276764|NCT00572156|18203795|P3|Overall Study|Protocol Violation|0
5276765|NCT00572156|18203796|P2|Overall Study|Protocol Violation|2
5276766|NCT00572156|18203797|P1|Overall Study|Protocol Violation|1
5276767|NCT00572156|18203794|P4|Overall Study|Lost to Follow-up|0
5276768|NCT00572156|18203795|P3|Overall Study|Lost to Follow-up|1
5276769|NCT00572156|18203796|P2|Overall Study|Lost to Follow-up|1
5276770|NCT00572156|18203797|P1|Overall Study|Lost to Follow-up|1
5276771|NCT00572156|18203794|P4|Overall Study|Adverse Event|1
5276772|NCT00572156|18203795|P3|Overall Study|Adverse Event|5
5276773|NCT00572156|18203796|P2|Overall Study|Adverse Event|1
5276774|NCT00572156|18203797|P1|Overall Study|Adverse Event|3
5276775|NCT00572039|18203868|P2|Overall Study|Ill|1
5276776|NCT00572039|18203869|P1|Overall Study|Ill|5
5276777|NCT00572039|18203868|P2|Overall Study|Death|3
5276778|NCT00572039|18203869|P1|Overall Study|Death|2
5276779|NCT00572039|18203868|P2|Overall Study|Withdrawal by Subject|6
5276780|NCT00572039|18203869|P1|Overall Study|Withdrawal by Subject|9
5276781|NCT00571948|18203901|P2|Overall Study|Parent were afraid of blood colection|5
5276782|NCT00571948|18203902|P1|Overall Study|Parent were afraid of blood colection|2
5276783|NCT00571948|18203901|P2|Overall Study|infant refused study meal|4
5276784|NCT00571948|18203902|P1|Overall Study|infant refused study meal|3
5276785|NCT00571948|18203901|P2|Overall Study|Protocol Violation|3
5276786|NCT00571948|18203902|P1|Overall Study|Protocol Violation|3
5276787|NCT00571948|18203901|P2|Overall Study|Withdrawal by Subject|2
5276788|NCT00571948|18203902|P1|Overall Study|Withdrawal by Subject|1
5276789|NCT00571948|18203901|P2|Overall Study|Lost to Follow-up|0
5276790|NCT00571948|18203902|P1|Overall Study|Lost to Follow-up|2
5276791|NCT00571922|18203910|P2|Overall Study|Completion unknown|36
5276792|NCT00571922|18203911|P1|Overall Study|Completion unknown|36
5276793|NCT00571701|18203921|P2|Second Intervention 12 Months|Withdrawal by Subject|0
5276794|NCT00571701|18203922|P1|Second Intervention 12 Months|Withdrawal by Subject|3
5276795|NCT00571701|18203921|P2|Second Intervention 12 Months|Adverse Event|1
5276796|NCT00571701|18203922|P1|Second Intervention 12 Months|Adverse Event|0
5276797|NCT00571701|18203921|P2|First Intervention 12 Months|Death|0
5276798|NCT00571701|18203922|P1|First Intervention 12 Months|Death|1
5276799|NCT00571701|18203921|P2|First Intervention 12 Months|Withdrawal by Subject|1
5276800|NCT00571701|18203922|P1|First Intervention 12 Months|Withdrawal by Subject|2
5276801|NCT00571688|18203948|P2|Overall Study|subject moved out of the area|0
5276802|NCT00571688|18203949|P1|Overall Study|subject moved out of the area|1
5276803|NCT00571688|18203948|P2|Overall Study|subject did not tolerate Consta|0
5276804|NCT00571688|18203949|P1|Overall Study|subject did not tolerate Consta|1
5276805|NCT00571688|18203948|P2|Overall Study|Lost to Follow-up|6
5276806|NCT00571688|18203949|P1|Overall Study|Lost to Follow-up|3
5276807|NCT00571662|18203955|P1|Overall Study|Adverse Event|5
5276808|NCT00571662|18203955|P1|Overall Study|psychiatric instability|1
5276809|NCT00571662|18203955|P1|Overall Study|Withdrawal by Subject|2
5276810|NCT00571649|18203966|P2|Follow-up Period|Protocol Violation|12
5276811|NCT00571649|18203967|P1|Follow-up Period|Protocol Violation|5
5276812|NCT00571649|18203966|P2|Follow-up Period|Patient convenience|121
5276813|NCT00571649|18203967|P1|Follow-up Period|Patient convenience|136
5276814|NCT00571649|18203966|P2|Follow-up Period|Lost to Follow-up|92
5276815|NCT00571649|18203967|P1|Follow-up Period|Lost to Follow-up|95
5276816|NCT00571649|18203966|P2|Follow-up Period|Physician Decision|13
5276817|NCT00571649|18203967|P1|Follow-up Period|Physician Decision|7
5276818|NCT00571649|18203966|P2|Follow-up Period|Death|133
5276819|NCT00571649|18203967|P1|Follow-up Period|Death|132
5276820|NCT00571649|18203966|P2|Follow-up Period|Withdrawal by Subject|115
5276821|NCT00571649|18203967|P1|Follow-up Period|Withdrawal by Subject|119
5276822|NCT00571649|18203966|P2|Follow-up Period|Clinical endpoint reached|2
5276823|NCT00571649|18203967|P1|Follow-up Period|Clinical endpoint reached|5
5276824|NCT00571649|18203966|P2|Follow-up Period|Adverse Event|40
5276825|NCT00571649|18203967|P1|Follow-up Period|Adverse Event|46
5276826|NCT00571649|18203966|P2|Treatment Period|Technical problems|5
5276827|NCT00571649|18203967|P1|Treatment Period|Technical problems|3
5276828|NCT00571649|18203966|P2|Treatment Period|Protocol Violation|92
5276829|NCT00571649|18203967|P1|Treatment Period|Protocol Violation|90
5276830|NCT00571649|18203966|P2|Treatment Period|Patient convenience|13
5276831|NCT00571649|18203967|P1|Treatment Period|Patient convenience|11
5276832|NCT00571649|18203966|P2|Treatment Period|Non-compliant with study medication|89
5276833|NCT00571649|18203967|P1|Treatment Period|Non-compliant with study medication|88
5276834|NCT00571649|18203966|P2|Treatment Period|Lost to Follow-up|41
5276835|NCT00571649|18203967|P1|Treatment Period|Lost to Follow-up|43
5276836|NCT00571649|18203966|P2|Treatment Period|Physician Decision|9
5276837|NCT00571649|18203967|P1|Treatment Period|Physician Decision|8
5276838|NCT00571649|18203966|P2|Treatment Period|Death|59
5276839|NCT00571649|18203967|P1|Treatment Period|Death|76
5276840|NCT00571649|18203966|P2|Treatment Period|Withdrawal by Subject|255
5276841|NCT00571649|18203967|P1|Treatment Period|Withdrawal by Subject|285
5276842|NCT00571649|18203966|P2|Treatment Period|Clinical endpoint reached|56
5276843|NCT00571649|18203967|P1|Treatment Period|Clinical endpoint reached|50
5276844|NCT00571649|18203966|P2|Treatment Period|Adverse Event|385
5276845|NCT00571649|18203967|P1|Treatment Period|Adverse Event|438
5276846|NCT00571103|18204065|P1|Overall Study|Lost to Follow-up|1
5276847|NCT00571103|18204065|P1|Overall Study|Withdrawal by Subject|1
5276848|NCT00571064|18204070|P1|Overall Study|Other|2
5276849|NCT00571064|18204070|P1|Overall Study|Withdrawal by Subject|2
5276850|NCT00571064|18204070|P1|Overall Study|Protocol Violation|4
5276851|NCT00571064|18204070|P1|Overall Study|Adverse Event|13
5276852|NCT00571038|18204085|P2|Overall Study|Moved out of state|2
5276853|NCT00571038|18204086|P1|Overall Study|Moved out of state|2
5276854|NCT00571038|18204085|P2|Overall Study|Withdrawal by Subject|3
5276855|NCT00571038|18204086|P1|Overall Study|Withdrawal by Subject|1
5276856|NCT00571038|18204085|P2|Overall Study|Death|5
5276857|NCT00571038|18204086|P1|Overall Study|Death|7
5276858|NCT00571038|18204085|P2|Overall Study|Lost to Follow-up|4
5276859|NCT00571038|18204086|P1|Overall Study|Lost to Follow-up|1
5276860|NCT00570921|18204141|P1|Overall Study|Physician Decision|1
5276861|NCT00570921|18204141|P1|Overall Study|Protocol Violation|1
5276862|NCT00570908|18204147|P1|Overall Study|Withdrawal by Subject|2
5276863|NCT00570908|18204147|P1|Overall Study|Adverse Event|5
5276864|NCT00570778|18204151|P4|Overall Study|Subject no longer requires study drug|0
5276865|NCT00570778|18204152|P3|Overall Study|Subject no longer requires study drug|0
5276866|NCT00570778|18204153|P2|Overall Study|Subject no longer requires study drug|1
5276867|NCT00570778|18204154|P1|Overall Study|Subject no longer requires study drug|0
5276868|NCT00570778|18204151|P4|Overall Study|Lost to Follow-up|0
5276869|NCT00570778|18204152|P3|Overall Study|Lost to Follow-up|1
5276870|NCT00570778|18204153|P2|Overall Study|Lost to Follow-up|0
5276871|NCT00570778|18204154|P1|Overall Study|Lost to Follow-up|0
5276872|NCT00570778|18204151|P4|Overall Study|Unsatisfactory therapeutic effect|0
5276873|NCT00570778|18204152|P3|Overall Study|Unsatisfactory therapeutic effect|0
5276874|NCT00570778|18204153|P2|Overall Study|Unsatisfactory therapeutic effect|0
5276875|NCT00570778|18204154|P1|Overall Study|Unsatisfactory therapeutic effect|1
5276876|NCT00570778|18204151|P4|Overall Study|Abnormal test procedure|0
5276877|NCT00570778|18204152|P3|Overall Study|Abnormal test procedure|0
5276878|NCT00570778|18204153|P2|Overall Study|Abnormal test procedure|0
5276879|NCT00570778|18204154|P1|Overall Study|Abnormal test procedure|1
5276880|NCT00570778|18204151|P4|Overall Study|Subject withdrew consent|1
5276881|NCT00570778|18204152|P3|Overall Study|Subject withdrew consent|0
5276882|NCT00570778|18204153|P2|Overall Study|Subject withdrew consent|1
5276883|NCT00570778|18204154|P1|Overall Study|Subject withdrew consent|0
5276884|NCT00570778|18204151|P4|Overall Study|Adverse Event|1
5276885|NCT00570778|18204152|P3|Overall Study|Adverse Event|4
5276886|NCT00570778|18204153|P2|Overall Study|Adverse Event|1
5276887|NCT00570778|18204154|P1|Overall Study|Adverse Event|0
5276888|NCT00570778|18204151|P4|Overall Study|Protocol deviation|2
5276889|NCT00570778|18204152|P3|Overall Study|Protocol deviation|2
5276890|NCT00570778|18204153|P2|Overall Study|Protocol deviation|1
5276891|NCT00570778|18204154|P1|Overall Study|Protocol deviation|2
5276892|NCT00570739|18204195|P4|Overall Study|Other|3
5276893|NCT00570739|18204196|P3|Overall Study|Other|5
5276894|NCT00570739|18204197|P2|Overall Study|Other|2
5276895|NCT00570739|18204198|P1|Overall Study|Other|0
5276896|NCT00570739|18204195|P4|Overall Study|Met discontinuation criteria|1
5276897|NCT00570739|18204196|P3|Overall Study|Met discontinuation criteria|1
5276898|NCT00570739|18204197|P2|Overall Study|Met discontinuation criteria|0
5276899|NCT00570739|18204198|P1|Overall Study|Met discontinuation criteria|1
5276900|NCT00570739|18204195|P4|Overall Study|Required restricted medication|0
5276901|NCT00570739|18204196|P3|Overall Study|Required restricted medication|1
5276902|NCT00570739|18204197|P2|Overall Study|Required restricted medication|0
5276903|NCT00570739|18204198|P1|Overall Study|Required restricted medication|0
5276904|NCT00570739|18204195|P4|Overall Study|Withdrawal by Subject|5
5276905|NCT00570739|18204196|P3|Overall Study|Withdrawal by Subject|3
5276906|NCT00570739|18204197|P2|Overall Study|Withdrawal by Subject|7
5276907|NCT00570739|18204198|P1|Overall Study|Withdrawal by Subject|7
5276908|NCT00570739|18204195|P4|Overall Study|Physician Decision|0
5276909|NCT00570739|18204196|P3|Overall Study|Physician Decision|0
5276910|NCT00570739|18204197|P2|Overall Study|Physician Decision|1
5276911|NCT00570739|18204198|P1|Overall Study|Physician Decision|1
5276912|NCT00570739|18204195|P4|Overall Study|Lost to Follow-up|1
5276913|NCT00570739|18204196|P3|Overall Study|Lost to Follow-up|4
5276914|NCT00570739|18204197|P2|Overall Study|Lost to Follow-up|5
5276915|NCT00570739|18204198|P1|Overall Study|Lost to Follow-up|4
5276916|NCT00570739|18204195|P4|Overall Study|Adverse Event|2
5276917|NCT00570739|18204196|P3|Overall Study|Adverse Event|2
5276918|NCT00570739|18204197|P2|Overall Study|Adverse Event|6
5276919|NCT00570739|18204198|P1|Overall Study|Adverse Event|8
5276920|NCT00570713|18204350|P2|Overall Study|Discontinuation of Study by the Sponsor|7
5276921|NCT00570713|18204351|P1|Overall Study|Discontinuation of Study by the Sponsor|10
5276922|NCT00570713|18204350|P2|Overall Study|Withdrawal by Subject|3
5276923|NCT00570713|18204351|P1|Overall Study|Withdrawal by Subject|3
5276924|NCT00570713|18204350|P2|Overall Study|Physician Decision|2
5276925|NCT00570713|18204351|P1|Overall Study|Physician Decision|2
5276926|NCT00570713|18204350|P2|Overall Study|Lack of Efficacy|49
5276927|NCT00570713|18204351|P1|Overall Study|Lack of Efficacy|40
5276928|NCT00570713|18204350|P2|Overall Study|Death|7
5276929|NCT00570713|18204351|P1|Overall Study|Death|7
5276930|NCT00570713|18204350|P2|Overall Study|Adverse Event|9
5276931|NCT00570713|18204351|P1|Overall Study|Adverse Event|16
5276932|NCT00570687|18204369|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276933|NCT00570687|18204370|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276934|NCT00570687|18204371|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276935|NCT00570687|18204372|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
5276936|NCT00570687|18204373|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276937|NCT00570687|18204374|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276938|NCT00570687|18204375|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276939|NCT00570687|18204376|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276940|NCT00570687|18204377|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276941|NCT00570687|18204378|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276942|NCT00570687|18204369|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276943|NCT00570687|18204370|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
5276944|NCT00570687|18204371|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276945|NCT00570687|18204372|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276946|NCT00570687|18204373|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276947|NCT00570687|18204374|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276948|NCT00570687|18204375|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276949|NCT00570687|18204376|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276950|NCT00570687|18204377|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276951|NCT00570687|18204378|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276952|NCT00570687|18204369|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5276953|NCT00570687|18204370|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
5276954|NCT00570687|18204371|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5276955|NCT00570687|18204372|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
5276956|NCT00570687|18204373|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5276957|NCT00570687|18204374|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5276958|NCT00570687|18204375|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276959|NCT00570687|18204376|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276960|NCT00570687|18204377|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276961|NCT00570687|18204378|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5276962|NCT00570674|18204404|P7|Overall Study|Withdrawal by Subject|0
5276963|NCT00570674|18204405|P6|Overall Study|Withdrawal by Subject|0
5276964|NCT00570674|18204406|P5|Overall Study|Withdrawal by Subject|0
5276965|NCT00570674|18204407|P4|Overall Study|Withdrawal by Subject|0
5276966|NCT00570674|18204408|P3|Overall Study|Withdrawal by Subject|1
5276967|NCT00570674|18204409|P2|Overall Study|Withdrawal by Subject|0
5276968|NCT00570674|18204410|P1|Overall Study|Withdrawal by Subject|0
5276969|NCT00570505|18204433|P1|Overall Study|Other loss to follow-up|4
5276970|NCT00570505|18204433|P1|Overall Study|Lost to Follow-up|23
5276971|NCT00570505|18204433|P1|Overall Study|Withdrawal by Subject|7
5276972|NCT00570505|18204433|P1|Overall Study|Adverse Event|7
5276973|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
5276974|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
5276975|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
5276976|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
5276977|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
5276978|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
5276979|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Physician Decision|4
5276980|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Physician Decision|2
5276981|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Physician Decision|0
5276982|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Adverse Event|5
5276983|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Adverse Event|5
5276984|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Adverse Event|0
5276985|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
5276986|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
5276987|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
5276988|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Protocol Violation|15
5276989|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Protocol Violation|12
5276990|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Protocol Violation|0
5276991|NCT00570492|18204446|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
5276992|NCT00570492|18204447|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
5276993|NCT00570492|18204448|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
5276994|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
5276995|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
5276996|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
5276997|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Adverse Event|0
5276998|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Adverse Event|0
5276999|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Adverse Event|1
5277000|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
5277001|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
5277002|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
5277003|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Protocol Violation|0
5277004|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Protocol Violation|0
5277005|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Protocol Violation|15
5277006|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
5277007|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
5277008|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
5277009|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
5277010|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
5277011|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
5277185|NCT00568555|18205212|P1|Overall Study|Withdrawal by Subject|1
5277012|NCT00570492|18204446|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
5277013|NCT00570492|18204447|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
5277014|NCT00570492|18204448|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
5277015|NCT00570401|18204486|P1|Overall Study|Adverse Event|2
5277016|NCT00570323|18204520|P2|Complete Study After Start|Physician Decision|0
5277017|NCT00570323|18204521|P1|Complete Study After Start|Physician Decision|1
5277018|NCT00570323|18204520|P2|Complete Study After Start|Withdrawal by Subject|0
5277019|NCT00570323|18204521|P1|Complete Study After Start|Withdrawal by Subject|2
5277020|NCT00570323|18204520|P2|Complete Study After Start|Lost to Follow-up|1
5277021|NCT00570323|18204521|P1|Complete Study After Start|Lost to Follow-up|0
5277022|NCT00570323|18204520|P2|Started Treatment After Randomization|Physician Decision|0
5277023|NCT00570323|18204521|P1|Started Treatment After Randomization|Physician Decision|1
5277024|NCT00570323|18204520|P2|Started Treatment After Randomization|Protocol Violation|0
5277025|NCT00570323|18204521|P1|Started Treatment After Randomization|Protocol Violation|1
5277026|NCT00570323|18204520|P2|Started Treatment After Randomization|Withdrawal by Subject|1
5277027|NCT00570323|18204521|P1|Started Treatment After Randomization|Withdrawal by Subject|0
5277028|NCT00570310|18204533|P2|Overall Study|Lack of Efficacy|4
5277029|NCT00570310|18204534|P1|Overall Study|Lack of Efficacy|1
5277030|NCT00570310|18204533|P2|Overall Study|Adverse Event|2
5277031|NCT00570310|18204534|P1|Overall Study|Adverse Event|1
5277032|NCT00570232|18204553|P1|Overall Study|discontinued due to noncompliance|2
5277033|NCT00570232|18204553|P1|Overall Study|discontinued due to recurrence|8
5277034|NCT00570232|18204553|P1|Overall Study|discontinued due to medical condition|3
5277035|NCT00570232|18204553|P1|Overall Study|Adverse Event|10
5277036|NCT00570141|18204559|P1|Overall Study|Lost to Follow-up|1
5277037|NCT00570141|18204559|P1|Overall Study|Missed visits|1
5277038|NCT00570141|18204559|P1|Overall Study|Adverse Event|1
5277039|NCT00570063|18204575|P2|Overall Study|Sponsor's Decision|3
5277040|NCT00570063|18204576|P1|Overall Study|Sponsor's Decision|7
5277041|NCT00570063|18204575|P2|Overall Study|Withdrawal by Subject|3
5277042|NCT00570063|18204576|P1|Overall Study|Withdrawal by Subject|4
5277043|NCT00570063|18204575|P2|Overall Study|Lack of Efficacy|1
5277044|NCT00570063|18204576|P1|Overall Study|Lack of Efficacy|0
5277045|NCT00570063|18204575|P2|Overall Study|Adverse Event|1
5277046|NCT00570063|18204576|P1|Overall Study|Adverse Event|4
5277047|NCT00570037|18204642|P2|Overall Study|Could not reach for 6-8 week contact|69
5277048|NCT00570037|18204643|P1|Overall Study|Could not reach for 6-8 week contact|44
5277049|NCT00569946|18204653|P1|Overall Study|Global Deterioration of Health Status|1
5277050|NCT00569946|18204653|P1|Overall Study|Objective Progression or Relapse|42
5277051|NCT00569946|18204653|P1|Overall Study|Adverse Event|16
5277052|NCT00569803|18204685|P8|Overall Study|Withdrawal by Subject|1
5277053|NCT00569803|18204686|P7|Overall Study|Withdrawal by Subject|0
5277054|NCT00569803|18204687|P6|Overall Study|Withdrawal by Subject|0
5277055|NCT00569803|18204688|P5|Overall Study|Withdrawal by Subject|0
5277056|NCT00569803|18204689|P4|Overall Study|Withdrawal by Subject|0
5277057|NCT00569803|18204690|P3|Overall Study|Withdrawal by Subject|0
5277058|NCT00569803|18204691|P2|Overall Study|Withdrawal by Subject|0
5277059|NCT00569803|18204692|P1|Overall Study|Withdrawal by Subject|0
5277060|NCT00569803|18204685|P8|Overall Study|injection syringe leaked during dosing|0
5277061|NCT00569803|18204686|P7|Overall Study|injection syringe leaked during dosing|0
5277062|NCT00569803|18204687|P6|Overall Study|injection syringe leaked during dosing|0
5277063|NCT00569803|18204688|P5|Overall Study|injection syringe leaked during dosing|0
5277064|NCT00569803|18204689|P4|Overall Study|injection syringe leaked during dosing|1
5277065|NCT00569803|18204690|P3|Overall Study|injection syringe leaked during dosing|0
5277066|NCT00569803|18204691|P2|Overall Study|injection syringe leaked during dosing|0
5277067|NCT00569803|18204692|P1|Overall Study|injection syringe leaked during dosing|0
5277068|NCT00569803|18204685|P8|Overall Study|Lost to Follow-up|0
5277069|NCT00569803|18204686|P7|Overall Study|Lost to Follow-up|0
5277070|NCT00569803|18204687|P6|Overall Study|Lost to Follow-up|0
5277071|NCT00569803|18204688|P5|Overall Study|Lost to Follow-up|0
5277072|NCT00569803|18204689|P4|Overall Study|Lost to Follow-up|0
5277073|NCT00569803|18204690|P3|Overall Study|Lost to Follow-up|0
5277074|NCT00569803|18204691|P2|Overall Study|Lost to Follow-up|0
5277075|NCT00569803|18204692|P1|Overall Study|Lost to Follow-up|1
5277076|NCT00569777|18204819|P2|Overall Study|pregnant|0
5277077|NCT00569777|18204820|P1|Overall Study|pregnant|1
5277078|NCT00569777|18204819|P2|Overall Study|did not meet exclusion criteria|2
5277079|NCT00569777|18204820|P1|Overall Study|did not meet exclusion criteria|1
5277080|NCT00569777|18204819|P2|Overall Study|scheduled eye surgery|1
5277081|NCT00569777|18204820|P1|Overall Study|scheduled eye surgery|0
5277082|NCT00569777|18204819|P2|Overall Study|Lost to Follow-up|0
5277083|NCT00569777|18204820|P1|Overall Study|Lost to Follow-up|1
5277084|NCT00569777|18204819|P2|Overall Study|Adverse Event|0
5277085|NCT00569777|18204820|P1|Overall Study|Adverse Event|3
5277086|NCT00569777|18204819|P2|Overall Study|Withdrawal by Subject|0
5277087|NCT00569777|18204820|P1|Overall Study|Withdrawal by Subject|4
5277088|NCT00569582|18204871|P1|Overall Study|Subject was non-compliant.|1
5277089|NCT00569582|18204871|P1|Overall Study|Subject was too ill to travel.|1
5277090|NCT00569582|18204871|P1|Overall Study|Adverse Event|7
5277091|NCT00569582|18204871|P1|Overall Study|Death|2
5277092|NCT00569582|18204871|P1|Overall Study|Withdrawal by Subject|5
5277093|NCT00569374|18204887|P1|Overall Study|Withdrawal by Subject|4
5277186|NCT00568451|18205230|P4|Overall Study|Disease Progression|7
5277094|NCT00569270|18204906|P2|Period: First Intervention|Protocol Violation|1
5277095|NCT00569270|18204907|P1|Period: First Intervention|Protocol Violation|0
5277096|NCT00569231|18204942|P1|Overall Study|Non-compliance|2
5277097|NCT00569231|18204942|P1|Overall Study|Car accident injury|1
5277098|NCT00569231|18204942|P1|Overall Study|Withdrawal by Subject|1
5277099|NCT00569231|18204942|P1|Overall Study|Airfare expense|2
5277100|NCT00569231|18204942|P1|Overall Study|Study unrelated surgery|1
5277101|NCT00569166|18204980|P3|Overall Study|Lost to Follow-up|1
5277102|NCT00569166|18204981|P2|Overall Study|Lost to Follow-up|1
5277103|NCT00569166|18204982|P1|Overall Study|Lost to Follow-up|2
5277104|NCT00569166|18204980|P3|Overall Study|Withdrawal by Subject|3
5277105|NCT00569166|18204981|P2|Overall Study|Withdrawal by Subject|5
5277106|NCT00569166|18204982|P1|Overall Study|Withdrawal by Subject|7
5277107|NCT00569127|18205016|P2|Overall Study|Still on Treatment|3
5277108|NCT00569127|18205017|P1|Overall Study|Still on Treatment|7
5277109|NCT00569127|18205016|P2|Overall Study|Not Eligible|11
5277110|NCT00569127|18205017|P1|Overall Study|Not Eligible|14
5277111|NCT00569127|18205016|P2|Overall Study|Lost to Follow-up|3
5277112|NCT00569127|18205017|P1|Overall Study|Lost to Follow-up|0
5277113|NCT00569127|18205016|P2|Overall Study|Other|19
5277114|NCT00569127|18205017|P1|Overall Study|Other|20
5277115|NCT00569127|18205016|P2|Overall Study|Death|3
5277116|NCT00569127|18205017|P1|Overall Study|Death|4
5277117|NCT00569127|18205016|P2|Overall Study|Progression|100
5277118|NCT00569127|18205017|P1|Overall Study|Progression|99
5277119|NCT00569127|18205016|P2|Overall Study|Withdrawal by Subject|27
5277120|NCT00569127|18205017|P1|Overall Study|Withdrawal by Subject|13
5277121|NCT00569127|18205016|P2|Overall Study|Adverse Event|47
5277122|NCT00569127|18205017|P1|Overall Study|Adverse Event|57
5277123|NCT00568958|18205052|P2|Follow-Up|Adverse Event|0
5277124|NCT00568958|18205053|P1|Follow-Up|Adverse Event|1
5277125|NCT00568958|18205052|P2|Follow-Up|Family Emergency|0
5277126|NCT00568958|18205053|P1|Follow-Up|Family Emergency|1
5277127|NCT00568958|18205052|P2|Follow-Up|Physician Decision|1
5277128|NCT00568958|18205053|P1|Follow-Up|Physician Decision|1
5277129|NCT00568958|18205052|P2|Follow-Up|Withdrawal by Subject|6
5277130|NCT00568958|18205053|P1|Follow-Up|Withdrawal by Subject|6
5277131|NCT00568958|18205052|P2|Allocation|Physician Decision|0
5277132|NCT00568958|18205053|P1|Allocation|Physician Decision|2
5277133|NCT00568958|18205052|P2|Allocation|Withdrawal by Subject|3
5277134|NCT00568958|18205053|P1|Allocation|Withdrawal by Subject|7
5277135|NCT00568776|18205100|P4|Overall Study|Miscellaeneous|4
5277136|NCT00568776|18205101|P3|Overall Study|Miscellaeneous|1
5277137|NCT00568776|18205102|P2|Overall Study|Miscellaeneous|3
5277138|NCT00568776|18205103|P1|Overall Study|Miscellaeneous|3
5277139|NCT00568776|18205100|P4|Overall Study|Sponsor Decision|42
5277140|NCT00568776|18205101|P3|Overall Study|Sponsor Decision|41
5277141|NCT00568776|18205102|P2|Overall Study|Sponsor Decision|2
5277142|NCT00568776|18205103|P1|Overall Study|Sponsor Decision|2
5277143|NCT00568776|18205100|P4|Overall Study|Loss of Caregiver|2
5277144|NCT00568776|18205101|P3|Overall Study|Loss of Caregiver|1
5277145|NCT00568776|18205102|P2|Overall Study|Loss of Caregiver|2
5277146|NCT00568776|18205103|P1|Overall Study|Loss of Caregiver|0
5277147|NCT00568776|18205100|P4|Overall Study|Withdrawal by Subject|7
5277148|NCT00568776|18205101|P3|Overall Study|Withdrawal by Subject|13
5277149|NCT00568776|18205102|P2|Overall Study|Withdrawal by Subject|15
5277150|NCT00568776|18205103|P1|Overall Study|Withdrawal by Subject|13
5277151|NCT00568776|18205100|P4|Overall Study|Protocol Violation|1
5277152|NCT00568776|18205101|P3|Overall Study|Protocol Violation|1
5277153|NCT00568776|18205102|P2|Overall Study|Protocol Violation|0
5277154|NCT00568776|18205103|P1|Overall Study|Protocol Violation|1
5277155|NCT00568776|18205100|P4|Overall Study|Lost to Follow-up|1
5277156|NCT00568776|18205101|P3|Overall Study|Lost to Follow-up|1
5277157|NCT00568776|18205102|P2|Overall Study|Lost to Follow-up|1
5277158|NCT00568776|18205103|P1|Overall Study|Lost to Follow-up|1
5277159|NCT00568776|18205100|P4|Overall Study|Lack of Efficacy|4
5277160|NCT00568776|18205101|P3|Overall Study|Lack of Efficacy|2
5277161|NCT00568776|18205102|P2|Overall Study|Lack of Efficacy|2
5277162|NCT00568776|18205103|P1|Overall Study|Lack of Efficacy|2
5277163|NCT00568776|18205100|P4|Overall Study|Physician Decision|0
5277164|NCT00568776|18205101|P3|Overall Study|Physician Decision|0
5277165|NCT00568776|18205102|P2|Overall Study|Physician Decision|2
5277166|NCT00568776|18205103|P1|Overall Study|Physician Decision|0
5277167|NCT00568776|18205100|P4|Overall Study|Death|3
5277168|NCT00568776|18205101|P3|Overall Study|Death|4
5277169|NCT00568776|18205102|P2|Overall Study|Death|1
5277170|NCT00568776|18205103|P1|Overall Study|Death|0
5277171|NCT00568776|18205100|P4|Overall Study|Adverse Event|8
5277172|NCT00568776|18205101|P3|Overall Study|Adverse Event|10
5277173|NCT00568776|18205102|P2|Overall Study|Adverse Event|8
5277174|NCT00568776|18205103|P1|Overall Study|Adverse Event|8
5277175|NCT00568685|18205152|P3|Overall Study|Protocol Violation|0
5277176|NCT00568685|18205153|P2|Overall Study|Protocol Violation|0
5277177|NCT00568685|18205154|P1|Overall Study|Protocol Violation|1
5277178|NCT00568685|18205152|P3|Overall Study|Withdrawal by Subject|2
5277179|NCT00568685|18205153|P2|Overall Study|Withdrawal by Subject|2
5277180|NCT00568685|18205154|P1|Overall Study|Withdrawal by Subject|7
5277181|NCT00568685|18205152|P3|Overall Study|Adverse Event|3
5277182|NCT00568685|18205153|P2|Overall Study|Adverse Event|3
5277183|NCT00568685|18205154|P1|Overall Study|Adverse Event|2
5277184|NCT00568555|18205211|P2|Overall Study|Withdrawal by Subject|1
5277187|NCT00568451|18205231|P3|Overall Study|Disease Progression|2
5277188|NCT00568451|18205232|P2|Overall Study|Disease Progression|0
5277189|NCT00568451|18205233|P1|Overall Study|Disease Progression|0
5277190|NCT00568399|18205249|P1|Overall Study|Withdrawal by Subject|8
5277191|NCT00568399|18205249|P1|Overall Study|Adverse Event|5
5277192|NCT00568399|18205249|P1|Overall Study|Death|2
5277193|NCT00568334|18205264|P2|Overall Study|Lost to Follow-up|0
5277194|NCT00568334|18205265|P1|Overall Study|Lost to Follow-up|1
5277195|NCT00568334|18205264|P2|Overall Study|Withdrawal by Subject|1
5277196|NCT00568334|18205265|P1|Overall Study|Withdrawal by Subject|0
5277197|NCT00568178|18205291|P6|Open Label Extension|Withdrawal by Subject|4
5277198|NCT00568178|18205292|P5|Open Label Extension|Withdrawal by Subject|4
5277199|NCT00568178|18205293|P4|Open Label Extension|Withdrawal by Subject|0
5277200|NCT00568178|18205294|P3|Open Label Extension|Withdrawal by Subject|0
5277201|NCT00568178|18205295|P2|Open Label Extension|Withdrawal by Subject|0
5277202|NCT00568178|18205296|P1|Open Label Extension|Withdrawal by Subject|0
5277203|NCT00568178|18205291|P6|Open Label Extension|Termination of Trial|47
5277204|NCT00568178|18205292|P5|Open Label Extension|Termination of Trial|45
5277205|NCT00568178|18205293|P4|Open Label Extension|Termination of Trial|0
5277206|NCT00568178|18205294|P3|Open Label Extension|Termination of Trial|0
5277207|NCT00568178|18205295|P2|Open Label Extension|Termination of Trial|0
5277208|NCT00568178|18205296|P1|Open Label Extension|Termination of Trial|0
5277209|NCT00568178|18205291|P6|Open Label Extension|Progressive Disease|1
5277210|NCT00568178|18205292|P5|Open Label Extension|Progressive Disease|3
5277211|NCT00568178|18205293|P4|Open Label Extension|Progressive Disease|0
5277212|NCT00568178|18205294|P3|Open Label Extension|Progressive Disease|0
5277213|NCT00568178|18205295|P2|Open Label Extension|Progressive Disease|0
5277214|NCT00568178|18205296|P1|Open Label Extension|Progressive Disease|0
5277215|NCT00568178|18205291|P6|Open Label Extension|Pregnancy|1
5277216|NCT00568178|18205292|P5|Open Label Extension|Pregnancy|0
5277217|NCT00568178|18205293|P4|Open Label Extension|Pregnancy|0
5277218|NCT00568178|18205294|P3|Open Label Extension|Pregnancy|0
5277219|NCT00568178|18205295|P2|Open Label Extension|Pregnancy|0
5277220|NCT00568178|18205296|P1|Open Label Extension|Pregnancy|0
5277221|NCT00568178|18205291|P6|Open Label Extension|Physician Decision|8
5277222|NCT00568178|18205292|P5|Open Label Extension|Physician Decision|9
5277223|NCT00568178|18205293|P4|Open Label Extension|Physician Decision|0
5277224|NCT00568178|18205294|P3|Open Label Extension|Physician Decision|0
5277225|NCT00568178|18205295|P2|Open Label Extension|Physician Decision|0
5277226|NCT00568178|18205296|P1|Open Label Extension|Physician Decision|0
5277227|NCT00568178|18205291|P6|Open Label Extension|Lost to Follow-up|11
5277228|NCT00568178|18205292|P5|Open Label Extension|Lost to Follow-up|6
5277229|NCT00568178|18205293|P4|Open Label Extension|Lost to Follow-up|0
5277230|NCT00568178|18205294|P3|Open Label Extension|Lost to Follow-up|0
5277231|NCT00568178|18205295|P2|Open Label Extension|Lost to Follow-up|0
5277232|NCT00568178|18205296|P1|Open Label Extension|Lost to Follow-up|0
5277233|NCT00568178|18205291|P6|Open Label Extension|Protocol Violation|0
5277234|NCT00568178|18205292|P5|Open Label Extension|Protocol Violation|1
5277235|NCT00568178|18205293|P4|Open Label Extension|Protocol Violation|0
5277236|NCT00568178|18205294|P3|Open Label Extension|Protocol Violation|0
5277237|NCT00568178|18205295|P2|Open Label Extension|Protocol Violation|0
5277238|NCT00568178|18205296|P1|Open Label Extension|Protocol Violation|0
5277239|NCT00568178|18205291|P6|Open Label Extension|Adverse Event|8
5277240|NCT00568178|18205292|P5|Open Label Extension|Adverse Event|11
5277241|NCT00568178|18205293|P4|Open Label Extension|Adverse Event|0
5277242|NCT00568178|18205294|P3|Open Label Extension|Adverse Event|0
5277243|NCT00568178|18205295|P2|Open Label Extension|Adverse Event|0
5277244|NCT00568178|18205296|P1|Open Label Extension|Adverse Event|0
5277245|NCT00568178|18205291|P6|Double Blind Base Study|Progressive Disease|0
5277246|NCT00568178|18205292|P5|Double Blind Base Study|Progressive Disease|0
5277247|NCT00568178|18205293|P4|Double Blind Base Study|Progressive Disease|1
5277248|NCT00568178|18205294|P3|Double Blind Base Study|Progressive Disease|0
5277249|NCT00568178|18205295|P2|Double Blind Base Study|Progressive Disease|0
5277250|NCT00568178|18205296|P1|Double Blind Base Study|Progressive Disease|0
5277251|NCT00568178|18205291|P6|Double Blind Base Study|Withdrawal by Subject|0
5277252|NCT00568178|18205292|P5|Double Blind Base Study|Withdrawal by Subject|0
5277253|NCT00568178|18205293|P4|Double Blind Base Study|Withdrawal by Subject|0
5277254|NCT00568178|18205294|P3|Double Blind Base Study|Withdrawal by Subject|0
5277255|NCT00568178|18205295|P2|Double Blind Base Study|Withdrawal by Subject|1
5277256|NCT00568178|18205296|P1|Double Blind Base Study|Withdrawal by Subject|1
5277257|NCT00568178|18205291|P6|Double Blind Base Study|Protocol Violation|0
5277258|NCT00568178|18205292|P5|Double Blind Base Study|Protocol Violation|0
5277259|NCT00568178|18205293|P4|Double Blind Base Study|Protocol Violation|0
5277260|NCT00568178|18205294|P3|Double Blind Base Study|Protocol Violation|0
5277261|NCT00568178|18205295|P2|Double Blind Base Study|Protocol Violation|2
5277262|NCT00568178|18205296|P1|Double Blind Base Study|Protocol Violation|3
5277263|NCT00568178|18205291|P6|Double Blind Base Study|Physician Decision|0
5277264|NCT00568178|18205292|P5|Double Blind Base Study|Physician Decision|0
5277265|NCT00568178|18205293|P4|Double Blind Base Study|Physician Decision|1
5277266|NCT00568178|18205294|P3|Double Blind Base Study|Physician Decision|0
5277267|NCT00568178|18205295|P2|Double Blind Base Study|Physician Decision|1
5277268|NCT00568178|18205296|P1|Double Blind Base Study|Physician Decision|1
5277269|NCT00568178|18205291|P6|Double Blind Base Study|Lost to Follow-up|0
5277270|NCT00568178|18205292|P5|Double Blind Base Study|Lost to Follow-up|0
5277271|NCT00568178|18205293|P4|Double Blind Base Study|Lost to Follow-up|1
5277272|NCT00568178|18205294|P3|Double Blind Base Study|Lost to Follow-up|0
5277273|NCT00568178|18205295|P2|Double Blind Base Study|Lost to Follow-up|0
5277274|NCT00568178|18205296|P1|Double Blind Base Study|Lost to Follow-up|1
5277275|NCT00568178|18205291|P6|Double Blind Base Study|Adverse Event|0
5277276|NCT00568178|18205292|P5|Double Blind Base Study|Adverse Event|0
5277277|NCT00568178|18205293|P4|Double Blind Base Study|Adverse Event|2
5277278|NCT00568178|18205294|P3|Double Blind Base Study|Adverse Event|1
5277279|NCT00568178|18205295|P2|Double Blind Base Study|Adverse Event|2
5277280|NCT00568178|18205296|P1|Double Blind Base Study|Adverse Event|0
5277281|NCT00568126|18205314|P2|Overall Study|Physician Decision|2
5277282|NCT00568126|18205315|P1|Overall Study|Physician Decision|2
5277283|NCT00568126|18205314|P2|Overall Study|Lack of Efficacy|1
5277284|NCT00568126|18205315|P1|Overall Study|Lack of Efficacy|0
5277285|NCT00568126|18205314|P2|Overall Study|Lost to Follow-up|3
5277286|NCT00568126|18205315|P1|Overall Study|Lost to Follow-up|4
5277287|NCT00568126|18205314|P2|Overall Study|Withdrawal by Subject|3
5277288|NCT00568126|18205315|P1|Overall Study|Withdrawal by Subject|2
5277289|NCT00568126|18205314|P2|Overall Study|Adverse Event|0
5277290|NCT00568126|18205315|P1|Overall Study|Adverse Event|3
5277291|NCT00568061|18205340|P2|Overall Study|Adverse Event|1
5277292|NCT00568061|18205341|P1|Overall Study|Adverse Event|0
5277293|NCT00568061|18205340|P2|Overall Study|Inclusion / exclusion criteria|1
5277294|NCT00568061|18205341|P1|Overall Study|Inclusion / exclusion criteria|5
5277295|NCT00567996|18205404|P3|Overall Study|Patient's inability to use the device|0
5277296|NCT00567996|18205405|P2|Overall Study|Patient's inability to use the device|1
5277297|NCT00567996|18205406|P1|Overall Study|Patient's inability to use the device|0
5277298|NCT00567996|18205404|P3|Overall Study|Death|2
5277299|NCT00567996|18205405|P2|Overall Study|Death|0
5277300|NCT00567996|18205406|P1|Overall Study|Death|1
5277301|NCT00567996|18205404|P3|Overall Study|Administrative problems|0
5277302|NCT00567996|18205405|P2|Overall Study|Administrative problems|1
5277303|NCT00567996|18205406|P1|Overall Study|Administrative problems|1
5277304|NCT00567996|18205404|P3|Overall Study|Unsatisfactory therapeutic effect|15
5277305|NCT00567996|18205405|P2|Overall Study|Unsatisfactory therapeutic effect|2
5277306|NCT00567996|18205406|P1|Overall Study|Unsatisfactory therapeutic effect|1
5277307|NCT00567996|18205404|P3|Overall Study|Lost to Follow-up|2
5277308|NCT00567996|18205405|P2|Overall Study|Lost to Follow-up|5
5277309|NCT00567996|18205406|P1|Overall Study|Lost to Follow-up|2
5277310|NCT00567996|18205404|P3|Overall Study|Abnormal test procedure result(s)|1
5277311|NCT00567996|18205405|P2|Overall Study|Abnormal test procedure result(s)|1
5277312|NCT00567996|18205406|P1|Overall Study|Abnormal test procedure result(s)|2
5277313|NCT00567996|18205404|P3|Overall Study|Abnormal Lab value(s)|2
5277314|NCT00567996|18205405|P2|Overall Study|Abnormal Lab value(s)|1
5277315|NCT00567996|18205406|P1|Overall Study|Abnormal Lab value(s)|2
5277316|NCT00567996|18205404|P3|Overall Study|Withdrawal by Subject|22
5277317|NCT00567996|18205405|P2|Overall Study|Withdrawal by Subject|12
5277318|NCT00567996|18205406|P1|Overall Study|Withdrawal by Subject|8
5277319|NCT00567996|18205404|P3|Overall Study|Protocol Deviation|13
5277320|NCT00567996|18205405|P2|Overall Study|Protocol Deviation|11
5277321|NCT00567996|18205406|P1|Overall Study|Protocol Deviation|9
5277322|NCT00567996|18205404|P3|Overall Study|Adverse Event|13
5277323|NCT00567996|18205405|P2|Overall Study|Adverse Event|16
5277324|NCT00567996|18205406|P1|Overall Study|Adverse Event|18
5277325|NCT00567892|18205422|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
5277326|NCT00567892|18205423|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5277327|NCT00567892|18205424|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5277328|NCT00567892|18205425|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5277329|NCT00567892|18205422|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
5277330|NCT00567892|18205423|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
5277331|NCT00567892|18205424|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5277332|NCT00567892|18205425|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5277333|NCT00567879|18205443|P6|Overall Study|Disease progression|3
5277334|NCT00567879|18205444|P5|Overall Study|Disease progression|11
5277335|NCT00567879|18205445|P4|Overall Study|Disease progression|5
5277336|NCT00567879|18205446|P3|Overall Study|Disease progression|15
5277337|NCT00567879|18205447|P2|Overall Study|Disease progression|7
5277338|NCT00567879|18205448|P1|Overall Study|Disease progression|5
5277339|NCT00567879|18205443|P6|Overall Study|New cancer therapy|0
5277340|NCT00567879|18205444|P5|Overall Study|New cancer therapy|0
5277341|NCT00567879|18205445|P4|Overall Study|New cancer therapy|0
5277342|NCT00567879|18205446|P3|Overall Study|New cancer therapy|1
5277343|NCT00567879|18205447|P2|Overall Study|New cancer therapy|0
5277344|NCT00567879|18205448|P1|Overall Study|New cancer therapy|0
5277345|NCT00567879|18205443|P6|Overall Study|Withdrawal by Subject|0
5277346|NCT00567879|18205444|P5|Overall Study|Withdrawal by Subject|0
5277347|NCT00567879|18205445|P4|Overall Study|Withdrawal by Subject|1
5277348|NCT00567879|18205446|P3|Overall Study|Withdrawal by Subject|3
5277349|NCT00567879|18205447|P2|Overall Study|Withdrawal by Subject|0
5277350|NCT00567879|18205448|P1|Overall Study|Withdrawal by Subject|0
5277351|NCT00567879|18205443|P6|Overall Study|Abnormal test procedure(s)|0
5277352|NCT00567879|18205444|P5|Overall Study|Abnormal test procedure(s)|0
5277353|NCT00567879|18205445|P4|Overall Study|Abnormal test procedure(s)|0
5277354|NCT00567879|18205446|P3|Overall Study|Abnormal test procedure(s)|1
5277355|NCT00567879|18205447|P2|Overall Study|Abnormal test procedure(s)|0
5277356|NCT00567879|18205448|P1|Overall Study|Abnormal test procedure(s)|0
5277357|NCT00567879|18205443|P6|Overall Study|Adverse Event|0
5277358|NCT00567879|18205444|P5|Overall Study|Adverse Event|1
5277359|NCT00567879|18205445|P4|Overall Study|Adverse Event|0
5277360|NCT00567879|18205446|P3|Overall Study|Adverse Event|1
5277361|NCT00567879|18205447|P2|Overall Study|Adverse Event|0
5277362|NCT00567879|18205448|P1|Overall Study|Adverse Event|2
5277363|NCT00567593|18205515|P1|Overall Study|Physician Decision|1
5277364|NCT00567593|18205515|P1|Overall Study|Adverse Event|1
5277365|NCT00567567|18205522|P3|Overall Study|Unable adequate stem cell for transplant|2
5277366|NCT00567567|18205523|P2|Overall Study|Unable adequate stem cell for transplant|0
5277367|NCT00567567|18205524|P1|Overall Study|Unable adequate stem cell for transplant|0
5277368|NCT00567567|18205522|P3|Overall Study|Enrolled another COG therapeutic study|0
5277369|NCT00567567|18205523|P2|Overall Study|Enrolled another COG therapeutic study|80
5277370|NCT00567567|18205524|P1|Overall Study|Enrolled another COG therapeutic study|99
5277371|NCT00567567|18205522|P3|Overall Study|Refusal by patient/parent/guardian|122
5277372|NCT00567567|18205523|P2|Overall Study|Refusal by patient/parent/guardian|16
5277373|NCT00567567|18205524|P1|Overall Study|Refusal by patient/parent/guardian|9
5277374|NCT00567567|18205522|P3|Overall Study|Ineligible|9
5277375|NCT00567567|18205523|P2|Overall Study|Ineligible|0
5277376|NCT00567567|18205524|P1|Overall Study|Ineligible|4
5277377|NCT00567567|18205522|P3|Overall Study|Withdrawal by Subject|2
5277378|NCT00567567|18205523|P2|Overall Study|Withdrawal by Subject|0
5277379|NCT00567567|18205524|P1|Overall Study|Withdrawal by Subject|0
5277380|NCT00567567|18205522|P3|Overall Study|Physician Decision|84
5277381|NCT00567567|18205523|P2|Overall Study|Physician Decision|18
5277382|NCT00567567|18205524|P1|Overall Study|Physician Decision|16
5277383|NCT00567567|18205522|P3|Overall Study|Lost to Follow-up|1
5277384|NCT00567567|18205523|P2|Overall Study|Lost to Follow-up|0
5277385|NCT00567567|18205524|P1|Overall Study|Lost to Follow-up|0
5277386|NCT00567567|18205522|P3|Overall Study|Lack of Efficacy|48
5277387|NCT00567567|18205523|P2|Overall Study|Lack of Efficacy|17
5277388|NCT00567567|18205524|P1|Overall Study|Lack of Efficacy|16
5277389|NCT00567567|18205522|P3|Overall Study|Death|5
5277390|NCT00567567|18205523|P2|Overall Study|Death|1
5277391|NCT00567567|18205524|P1|Overall Study|Death|8
5277392|NCT00567567|18205522|P3|Overall Study|Adverse Event|5
5277393|NCT00567567|18205523|P2|Overall Study|Adverse Event|2
5277394|NCT00567567|18205524|P1|Overall Study|Adverse Event|0
5277395|NCT00567541|18205572|P2|Overall Study|Adverse Event|1
5277396|NCT00567541|18205573|P1|Overall Study|Adverse Event|0
5277397|NCT00567502|18205583|P4|Overall Study|Never Initiated Treatment|72
5277398|NCT00567502|18205584|P3|Overall Study|Never Initiated Treatment|0
5277399|NCT00567502|18205585|P2|Overall Study|Never Initiated Treatment|0
5277400|NCT00567502|18205586|P1|Overall Study|Never Initiated Treatment|0
5277401|NCT00567502|18205583|P4|Overall Study|Sponsor request|1
5277402|NCT00567502|18205584|P3|Overall Study|Sponsor request|30
5277403|NCT00567502|18205585|P2|Overall Study|Sponsor request|0
5277404|NCT00567502|18205586|P1|Overall Study|Sponsor request|9
5277405|NCT00567502|18205583|P4|Overall Study|Participant request|1
5277406|NCT00567502|18205584|P3|Overall Study|Participant request|33
5277407|NCT00567502|18205585|P2|Overall Study|Participant request|1
5277408|NCT00567502|18205586|P1|Overall Study|Participant request|12
5277409|NCT00567502|18205583|P4|Overall Study|Other|6
5277410|NCT00567502|18205584|P3|Overall Study|Other|134
5277411|NCT00567502|18205585|P2|Overall Study|Other|2
5277412|NCT00567502|18205586|P1|Overall Study|Other|64
5277413|NCT00567502|18205583|P4|Overall Study|Death|5
5277414|NCT00567502|18205584|P3|Overall Study|Death|360
5277415|NCT00567502|18205585|P2|Overall Study|Death|16
5277416|NCT00567502|18205586|P1|Overall Study|Death|65
5277417|NCT00567502|18205583|P4|Overall Study|Lost to Follow-up|2
5277418|NCT00567502|18205584|P3|Overall Study|Lost to Follow-up|351
5277419|NCT00567502|18205585|P2|Overall Study|Lost to Follow-up|14
5277420|NCT00567502|18205586|P1|Overall Study|Lost to Follow-up|91
5277421|NCT00567489|18205623|P2|Overall Study|Other|0
5277422|NCT00567489|18205624|P1|Overall Study|Other|1
5277423|NCT00567489|18205623|P2|Overall Study|Renal Transplantation|3
5277424|NCT00567489|18205624|P1|Overall Study|Renal Transplantation|0
5277425|NCT00567489|18205623|P2|Overall Study|Withdrawal by Subject|2
5277426|NCT00567489|18205624|P1|Overall Study|Withdrawal by Subject|0
5277427|NCT00567489|18205623|P2|Overall Study|Physician Decision|4
5277428|NCT00567489|18205624|P1|Overall Study|Physician Decision|0
5277429|NCT00567489|18205623|P2|Overall Study|Adverse Event|14
5277430|NCT00567489|18205624|P1|Overall Study|Adverse Event|6
5277431|NCT00567476|18205674|P2|Overall Study|Non-adherence to protocol|1
5277432|NCT00567476|18205675|P1|Overall Study|Non-adherence to protocol|0
5277433|NCT00567476|18205674|P2|Overall Study|Medical Decision|1
5277434|NCT00567476|18205675|P1|Overall Study|Medical Decision|0
5277435|NCT00567476|18205674|P2|Overall Study|Administrative issues|0
5277436|NCT00567476|18205675|P1|Overall Study|Administrative issues|1
5277437|NCT00567476|18205674|P2|Overall Study|Lost to Follow-up|1
5277438|NCT00567476|18205675|P1|Overall Study|Lost to Follow-up|0
5277439|NCT00567476|18205674|P2|Overall Study|Protocol Violation|1
5277440|NCT00567476|18205675|P1|Overall Study|Protocol Violation|4
5277441|NCT00567476|18205674|P2|Overall Study|Pregnancy|0
5277442|NCT00567476|18205675|P1|Overall Study|Pregnancy|1
5277443|NCT00567476|18205674|P2|Overall Study|Adverse Event|0
5277444|NCT00567476|18205675|P1|Overall Study|Adverse Event|2
5277445|NCT00567398|18205701|P2|Overall Study|Other|0
5277446|NCT00567398|18205702|P1|Overall Study|Other|1
5277447|NCT00567398|18205701|P2|Overall Study|Renal Transplantation|3
5277448|NCT00567398|18205702|P1|Overall Study|Renal Transplantation|0
5277449|NCT00567398|18205701|P2|Overall Study|Withdrawal by Subject|2
5277450|NCT00567398|18205702|P1|Overall Study|Withdrawal by Subject|0
5277451|NCT00567398|18205701|P2|Overall Study|Physician Decision|4
5277452|NCT00567398|18205702|P1|Overall Study|Physician Decision|0
5277453|NCT00567398|18205701|P2|Overall Study|Adverse Event|14
5277454|NCT00567398|18205702|P1|Overall Study|Adverse Event|6
5277455|NCT00567359|18205750|P1|Overall Study|Withdrawal by Subject|1
5277456|NCT00567268|18205775|P1|Overall Study|"Safety Evaluation Not Assessable"|1
5277457|NCT00567268|18205775|P1|Overall Study|No Drug Administration|4
5277458|NCT00567268|18205775|P1|Overall Study|No Visit After First Day of Treatment|2
5277459|NCT00567268|18205775|P1|Overall Study|Lost to Follow-up|36
5277460|NCT00567268|18205775|P1|Overall Study|Protocol Violation|7
5277461|NCT00567255|18205826|P2|Overall Study|Drug noncompliance,moved,other|15
5277462|NCT00567255|18205827|P1|Overall Study|Drug noncompliance,moved,other|25
5277463|NCT00567255|18205826|P2|Overall Study|Pregnancy|0
5277464|NCT00567255|18205827|P1|Overall Study|Pregnancy|6
5277465|NCT00567255|18205826|P2|Overall Study|Protocol Violation|8
5277466|NCT00567255|18205827|P1|Overall Study|Protocol Violation|20
5277467|NCT00567255|18205826|P2|Overall Study|Lack of Efficacy|33
5277468|NCT00567255|18205827|P1|Overall Study|Lack of Efficacy|19
5277469|NCT00567255|18205826|P2|Overall Study|Withdrawal by Subject|56
5277470|NCT00567255|18205827|P1|Overall Study|Withdrawal by Subject|75
5277471|NCT00567255|18205826|P2|Overall Study|Lost to Follow-up|48
5277472|NCT00567255|18205827|P1|Overall Study|Lost to Follow-up|77
5277473|NCT00567255|18205826|P2|Overall Study|Adverse Event|68
5277474|NCT00567255|18205827|P1|Overall Study|Adverse Event|241
5277475|NCT00567190|18205890|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
5277476|NCT00567190|18205891|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
5277477|NCT00567190|18205890|P2|Overall Study|Death|280
5277478|NCT00567190|18205891|P1|Overall Study|Death|235
5277479|NCT00567164|18205942|P3|Overall Study|Missing|0
5277480|NCT00567164|18205943|P2|Overall Study|Missing|0
5277481|NCT00567164|18205944|P1|Overall Study|Missing|1
5277482|NCT00567164|18205942|P3|Overall Study|Primary Reason coded as 'Other'|16
5277483|NCT00567164|18205943|P2|Overall Study|Primary Reason coded as 'Other'|8
5277484|NCT00567164|18205944|P1|Overall Study|Primary Reason coded as 'Other'|37
5277485|NCT00567164|18205942|P3|Overall Study|Pregnancy|6
5277486|NCT00567164|18205943|P2|Overall Study|Pregnancy|4
5277487|NCT00567164|18205944|P1|Overall Study|Pregnancy|20
5277488|NCT00567164|18205942|P3|Overall Study|Lost to Follow-up|21
5277489|NCT00567164|18205943|P2|Overall Study|Lost to Follow-up|23
5277490|NCT00567164|18205944|P1|Overall Study|Lost to Follow-up|202
5277491|NCT00567164|18205942|P3|Overall Study|Death|1
5277492|NCT00567164|18205943|P2|Overall Study|Death|0
5277493|NCT00567164|18205944|P1|Overall Study|Death|0
5277494|NCT00567164|18205942|P3|Overall Study|Adverse Event|9
5277495|NCT00567164|18205943|P2|Overall Study|Adverse Event|13
5277496|NCT00567164|18205944|P1|Overall Study|Adverse Event|92
5277497|NCT00567164|18205942|P3|Overall Study|Protocol Violation|2
5277498|NCT00567164|18205943|P2|Overall Study|Protocol Violation|4
5277499|NCT00567164|18205944|P1|Overall Study|Protocol Violation|23
5277500|NCT00567164|18205942|P3|Overall Study|Withdrawal by Subject|17
5277501|NCT00567164|18205943|P2|Overall Study|Withdrawal by Subject|21
5277502|NCT00567164|18205944|P1|Overall Study|Withdrawal by Subject|171
5277503|NCT00567112|18206016|P3|Washout Period 3 (3 Days)|Protocol Violation|0
5277504|NCT00567112|18206017|P2|Washout Period 3 (3 Days)|Protocol Violation|0
5277505|NCT00567112|18206018|P1|Washout Period 3 (3 Days)|Protocol Violation|1
5277506|NCT00567112|18206016|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
5277507|NCT00567112|18206017|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
5277508|NCT00567112|18206018|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
5277509|NCT00567112|18206016|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
5277510|NCT00567112|18206017|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
5277511|NCT00567112|18206018|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
5277512|NCT00566995|18206049|P1|Overall Study|Withdrew consent|3
5277513|NCT00566995|18206049|P1|Overall Study|Toxicity|4
5277514|NCT00566982|18206064|P2|Overall Study|Other-family problems & doctor's request|2
5277515|NCT00566982|18206065|P1|Overall Study|Other-family problems & doctor's request|0
5277516|NCT00566982|18206064|P2|Overall Study|Lost to Follow-up|1
5277517|NCT00566982|18206065|P1|Overall Study|Lost to Follow-up|0
5277518|NCT00566982|18206064|P2|Overall Study|Protocol Violation|4
5277519|NCT00566982|18206065|P1|Overall Study|Protocol Violation|1
5277520|NCT00566982|18206064|P2|Overall Study|Withdrawal by Subject|14
5277521|NCT00566982|18206065|P1|Overall Study|Withdrawal by Subject|1
5277522|NCT00566982|18206064|P2|Overall Study|Adverse Event|48
5277523|NCT00566982|18206065|P1|Overall Study|Adverse Event|6
5277524|NCT00566852|18206130|P2|Overall Study|Missing reason not reported|20
5277525|NCT00566852|18206131|P1|Overall Study|Missing reason not reported|16
5277526|NCT00566852|18206130|P2|Overall Study|Missing reason not specified|2
5277527|NCT00566852|18206131|P1|Overall Study|Missing reason not specified|1
5277528|NCT00566852|18206130|P2|Overall Study|Not tested due to disability|12
5277529|NCT00566852|18206131|P1|Overall Study|Not tested due to disability|6
5277530|NCT00566852|18206130|P2|Overall Study|Patient refusal|37
5277531|NCT00566852|18206131|P1|Overall Study|Patient refusal|37
5277532|NCT00566852|18206130|P2|Overall Study|Withdrawal by Subject|25
5277533|NCT00566852|18206131|P1|Overall Study|Withdrawal by Subject|30
5277534|NCT00566852|18206130|P2|Overall Study|Death|78
5277535|NCT00566852|18206131|P1|Overall Study|Death|95
5277536|NCT00566852|18206130|P2|Overall Study|Protocol Violation|24
5277537|NCT00566852|18206131|P1|Overall Study|Protocol Violation|22
5277538|NCT00566735|18206162|P2|Overall Study|Switched into a manic episode|1
5277539|NCT00566735|18206163|P1|Overall Study|Switched into a manic episode|0
5277540|NCT00566735|18206162|P2|Overall Study|Refused neuropsychological testing|5
5277541|NCT00566735|18206163|P1|Overall Study|Refused neuropsychological testing|2
5277542|NCT00566735|18206162|P2|Overall Study|Withdrawal by Subject|1
5277543|NCT00566735|18206163|P1|Overall Study|Withdrawal by Subject|0
5277544|NCT00566722|18206176|P3|Overall Study|Noncompliant with drug administration|1
5277545|NCT00566722|18206177|P2|Overall Study|Noncompliant with drug administration|0
5277546|NCT00566722|18206178|P1|Overall Study|Noncompliant with drug administration|0
5277547|NCT00566722|18206176|P3|Overall Study|Serious adverse event|0
5277548|NCT00566722|18206177|P2|Overall Study|Serious adverse event|1
5277549|NCT00566722|18206178|P1|Overall Study|Serious adverse event|0
5277550|NCT00566722|18206176|P3|Overall Study|Did not meet exclusion criteria|2
5277551|NCT00566722|18206177|P2|Overall Study|Did not meet exclusion criteria|0
5277552|NCT00566722|18206178|P1|Overall Study|Did not meet exclusion criteria|0
5277553|NCT00566722|18206176|P3|Overall Study|Lack of Efficacy|4
5277554|NCT00566722|18206177|P2|Overall Study|Lack of Efficacy|2
5277555|NCT00566722|18206178|P1|Overall Study|Lack of Efficacy|1
5277556|NCT00566722|18206176|P3|Overall Study|Lost to Follow-up|1
5277557|NCT00566722|18206177|P2|Overall Study|Lost to Follow-up|1
5277558|NCT00566722|18206178|P1|Overall Study|Lost to Follow-up|1
5277559|NCT00566722|18206176|P3|Overall Study|Withdrawal by Subject|1
5277560|NCT00566722|18206177|P2|Overall Study|Withdrawal by Subject|0
5277561|NCT00566722|18206178|P1|Overall Study|Withdrawal by Subject|0
5277562|NCT00566722|18206176|P3|Overall Study|Adverse Event|0
5277563|NCT00566722|18206177|P2|Overall Study|Adverse Event|1
5277564|NCT00566722|18206178|P1|Overall Study|Adverse Event|0
5277565|NCT00566709|18206224|P2|Overall Study|Protocol Violation|0
5277566|NCT00566709|18206225|P1|Overall Study|Protocol Violation|5
5277567|NCT00566696|18206241|P1|Overall Study|Non-Patient Donors|37
5277568|NCT00566696|18206241|P1|Overall Study|Physician Decision|1
5277569|NCT00566696|18206241|P1|Overall Study|Health Status Change|1
5277570|NCT00566696|18206241|P1|Overall Study|Muromonab not available|1
5277571|NCT00566696|18206241|P1|Overall Study|Met Exclusion Criteria|2
5277572|NCT00566631|18206251|P1|Part 2: Extension Phase|Other|5
5277573|NCT00566631|18206251|P1|Part 2: Extension Phase|Death|1
5277574|NCT00566631|18206251|P1|Part 2: Extension Phase|Lost to Follow-up|6
5277575|NCT00566631|18206251|P1|Part 2: Extension Phase|Adverse Event|11
5277576|NCT00566631|18206251|P1|Part 2: Extension Phase|Withdrawal by Subject|34
5277577|NCT00566631|18206251|P1|Part 2: Extension Phase|Lack of Efficacy|25
5277578|NCT00566631|18206251|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
5277579|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
5277580|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
5277581|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
5277582|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
5277583|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Adverse Event|9
5277584|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Physician Decision|1
5277585|NCT00566631|18206251|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
5277586|NCT00566527|18206278|P3|Overall Study|Withdrawal by Subject|43
5277587|NCT00566527|18206279|P2|Overall Study|Withdrawal by Subject|43
5277588|NCT00566527|18206280|P1|Overall Study|Withdrawal by Subject|6
5277589|NCT00566527|18206278|P3|Overall Study|Lost to Follow-up|4
5277590|NCT00566527|18206279|P2|Overall Study|Lost to Follow-up|4
5277591|NCT00566527|18206280|P1|Overall Study|Lost to Follow-up|3
5277592|NCT00566527|18206278|P3|Overall Study|Physician Decision|20
5277593|NCT00566527|18206279|P2|Overall Study|Physician Decision|8
5277594|NCT00566527|18206280|P1|Overall Study|Physician Decision|3
5277595|NCT00566527|18206278|P3|Overall Study|Adverse Event|1
5277596|NCT00566527|18206279|P2|Overall Study|Adverse Event|0
5277597|NCT00566527|18206280|P1|Overall Study|Adverse Event|2
5277598|NCT00566527|18206278|P3|Overall Study|Reason not provided|10
5277599|NCT00566527|18206279|P2|Overall Study|Reason not provided|11
5277600|NCT00566527|18206280|P1|Overall Study|Reason not provided|3
5277601|NCT00566254|18206341|P2|Overall Study|Other|2
5277602|NCT00566254|18206342|P1|Overall Study|Other|0
5277603|NCT00566254|18206341|P2|Overall Study|Lack of Efficacy|6
5277604|NCT00566254|18206342|P1|Overall Study|Lack of Efficacy|5
5277605|NCT00566254|18206341|P2|Overall Study|Withdrawal by Subject|2
5277606|NCT00566254|18206342|P1|Overall Study|Withdrawal by Subject|1
5277607|NCT00566254|18206341|P2|Overall Study|Protocol Violation|3
5277608|NCT00566254|18206342|P1|Overall Study|Protocol Violation|1
5277609|NCT00566254|18206341|P2|Overall Study|Adverse Event|1
5277610|NCT00566254|18206342|P1|Overall Study|Adverse Event|3
5277611|NCT00566228|18206356|P2|Overall Study|progressed before infusion could occur|1
5277612|NCT00566228|18206357|P1|Overall Study|progressed before infusion could occur|0
5277613|NCT00566228|18206356|P2|Overall Study|Unable to collect sufficient CD34 cells|2
5277614|NCT00566228|18206357|P1|Overall Study|Unable to collect sufficient CD34 cells|3
5277615|NCT00566228|18206356|P2|Overall Study|Attempt to mobilize stem cells failed|2
5277616|NCT00566228|18206357|P1|Overall Study|Attempt to mobilize stem cells failed|2
5277617|NCT00566228|18206356|P2|Overall Study|Withdrawal by Subject|0
5277618|NCT00566228|18206357|P1|Overall Study|Withdrawal by Subject|1
5277619|NCT00566111|18206390|P2|Overall Study|Adverse Event|2
5277620|NCT00566111|18206391|P1|Overall Study|Adverse Event|0
5277621|NCT00566098|18206405|P1|Administration of ASCT+MILs|Lack of Efficacy|8
5277622|NCT00566098|18206405|P1|Administration of ASCT+MILs|Death|10
5277623|NCT00566098|18206405|P1|Generation of MILs Product|Relapsed|1
5277624|NCT00566098|18206405|P1|Collection of MILs|Relapsed|1
5277625|NCT00566098|18206405|P1|Collection of MILs|Withdrawal by Subject|1
5277626|NCT00566020|18206415|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
5277627|NCT00566020|18206416|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
5277628|NCT00566020|18206415|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
5277629|NCT00566020|18206416|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
5277630|NCT00566020|18206415|P2|46-week Long-term Administration Phase|Physician Decision|7
5277631|NCT00566020|18206416|P1|46-week Long-term Administration Phase|Physician Decision|0
5277632|NCT00566020|18206415|P2|46-week Long-term Administration Phase|Adverse Event|7
5277633|NCT00566020|18206416|P1|46-week Long-term Administration Phase|Adverse Event|0
5277634|NCT00566020|18206415|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
5277635|NCT00566020|18206416|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
5277636|NCT00566020|18206415|P2|6-week Dosage Adjustment Phase|Adverse Event|0
5277637|NCT00566020|18206416|P1|6-week Dosage Adjustment Phase|Adverse Event|5
5277638|NCT00565812|18206505|P3|Overall Study|Physician Decision|0
5277639|NCT00565812|18206506|P2|Overall Study|Physician Decision|0
5277640|NCT00565812|18206507|P1|Overall Study|Physician Decision|2
5277641|NCT00565812|18206505|P3|Overall Study|Follow-up Visit Not Completed|1
5277642|NCT00565812|18206506|P2|Overall Study|Follow-up Visit Not Completed|0
5277643|NCT00565812|18206507|P1|Overall Study|Follow-up Visit Not Completed|2
5277644|NCT00565812|18206505|P3|Overall Study|Low Compliance|1
5277645|NCT00565812|18206506|P2|Overall Study|Low Compliance|0
5277646|NCT00565812|18206507|P1|Overall Study|Low Compliance|1
5277647|NCT00565812|18206505|P3|Overall Study|Surgical Intervention|2
5277648|NCT00565812|18206506|P2|Overall Study|Surgical Intervention|1
5277649|NCT00565812|18206507|P1|Overall Study|Surgical Intervention|0
5277650|NCT00565812|18206505|P3|Overall Study|Research Site Closure|8
5277651|NCT00565812|18206506|P2|Overall Study|Research Site Closure|1
5277652|NCT00565812|18206507|P1|Overall Study|Research Site Closure|6
5277653|NCT00565812|18206505|P3|Overall Study|Domestic Reasons|3
5277654|NCT00565812|18206506|P2|Overall Study|Domestic Reasons|1
5277655|NCT00565812|18206507|P1|Overall Study|Domestic Reasons|7
5277656|NCT00565812|18206505|P3|Overall Study|Sponsor Decision|1
5277657|NCT00565812|18206506|P2|Overall Study|Sponsor Decision|5
5277658|NCT00565812|18206507|P1|Overall Study|Sponsor Decision|1
5277659|NCT00565812|18206505|P3|Overall Study|Relocated Out of Area|9
5277660|NCT00565812|18206506|P2|Overall Study|Relocated Out of Area|8
5277661|NCT00565812|18206507|P1|Overall Study|Relocated Out of Area|5
5277662|NCT00565812|18206505|P3|Overall Study|Jury Duty|0
5277663|NCT00565812|18206506|P2|Overall Study|Jury Duty|0
5277664|NCT00565812|18206507|P1|Overall Study|Jury Duty|1
5277665|NCT00565812|18206505|P3|Overall Study|Adverse Event|40
5277666|NCT00565812|18206506|P2|Overall Study|Adverse Event|54
5277667|NCT00565812|18206507|P1|Overall Study|Adverse Event|41
5277668|NCT00565812|18206505|P3|Overall Study|Protocol Violation|4
5277669|NCT00565812|18206506|P2|Overall Study|Protocol Violation|6
5277670|NCT00565812|18206507|P1|Overall Study|Protocol Violation|2
5277671|NCT00565812|18206505|P3|Overall Study|Work Schedule|1
5277672|NCT00565812|18206506|P2|Overall Study|Work Schedule|3
5277673|NCT00565812|18206507|P1|Overall Study|Work Schedule|5
5277674|NCT00565812|18206505|P3|Overall Study|Withdrawal by Subject|48
5277675|NCT00565812|18206506|P2|Overall Study|Withdrawal by Subject|47
5277676|NCT00565812|18206507|P1|Overall Study|Withdrawal by Subject|58
5277677|NCT00565812|18206505|P3|Overall Study|Lost to Follow-up|8
5277678|NCT00565812|18206506|P2|Overall Study|Lost to Follow-up|8
5277679|NCT00565812|18206507|P1|Overall Study|Lost to Follow-up|10
5277680|NCT00565812|18206505|P3|Overall Study|Did not Meet Entrance Criteria|1
5277681|NCT00565812|18206506|P2|Overall Study|Did not Meet Entrance Criteria|0
5277682|NCT00565812|18206507|P1|Overall Study|Did not Meet Entrance Criteria|1
5277683|NCT00565812|18206505|P3|Overall Study|Death|3
5277684|NCT00565812|18206506|P2|Overall Study|Death|1
5277685|NCT00565812|18206507|P1|Overall Study|Death|2
5277686|NCT00565773|18206644|P1|Overall Study|Physician Decision|1
5277687|NCT00565773|18206644|P1|Overall Study|Withdrawal by Subject|1
5277688|NCT00565747|18206656|P2|Overall Study|No embryo transfer|73
5277689|NCT00565747|18206657|P1|Overall Study|No embryo transfer|67
5277690|NCT00565721|18206667|P1|Overall Study|Other reasons|6
5277691|NCT00565721|18206667|P1|Overall Study|Physician Decision|2
5277692|NCT00565721|18206667|P1|Overall Study|Technical Problems|1
5277693|NCT00565721|18206667|P1|Overall Study|Lost to Follow-up|6
5277694|NCT00565721|18206667|P1|Overall Study|Screen Failure|2
5277695|NCT00565617|18206716|P1|Overall Study|Withdrawal by Subject|1
5277696|NCT00565604|18206720|P1|Overall Study|Lost to Follow-up|2
5277697|NCT00565604|18206720|P1|Overall Study|Failure to treat|2
5277698|NCT00565448|18206766|P2|Overall Study|Withdrawal by Subject|0
5277699|NCT00565448|18206767|P1|Overall Study|Withdrawal by Subject|1
5277700|NCT00565448|18206766|P2|Overall Study|Disease progression|0
5277701|NCT00565448|18206767|P1|Overall Study|Disease progression|1
5277702|NCT00565448|18206766|P2|Overall Study|Adverse Event|2
5277703|NCT00565448|18206767|P1|Overall Study|Adverse Event|1
5277704|NCT00565409|18206778|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
5277705|NCT00565409|18206779|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
5277706|NCT00565409|18206780|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
5277707|NCT00565409|18206781|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
5277708|NCT00565409|18206778|P4|Period 2 Double-Blind|Other|9
5277709|NCT00565409|18206779|P3|Period 2 Double-Blind|Other|5
5277710|NCT00565409|18206780|P2|Period 2 Double-Blind|Other|4
5277711|NCT00565409|18206781|P1|Period 2 Double-Blind|Other|0
5277712|NCT00565409|18206778|P4|Period 2 Double-Blind|Lost to Follow-up|0
5277713|NCT00565409|18206779|P3|Period 2 Double-Blind|Lost to Follow-up|1
5277714|NCT00565409|18206780|P2|Period 2 Double-Blind|Lost to Follow-up|0
5277715|NCT00565409|18206781|P1|Period 2 Double-Blind|Lost to Follow-up|0
5277716|NCT00565409|18206778|P4|Period 2 Double-Blind|Protocol Violation|2
5277717|NCT00565409|18206779|P3|Period 2 Double-Blind|Protocol Violation|6
5277718|NCT00565409|18206780|P2|Period 2 Double-Blind|Protocol Violation|4
5277719|NCT00565409|18206781|P1|Period 2 Double-Blind|Protocol Violation|0
5277720|NCT00565409|18206778|P4|Period 2 Double-Blind|Death|0
5277721|NCT00565409|18206779|P3|Period 2 Double-Blind|Death|0
5277722|NCT00565409|18206780|P2|Period 2 Double-Blind|Death|2
5277723|NCT00565409|18206781|P1|Period 2 Double-Blind|Death|0
5277724|NCT00565409|18206778|P4|Period 2 Double-Blind|Adverse Event|5
5277725|NCT00565409|18206779|P3|Period 2 Double-Blind|Adverse Event|4
5277726|NCT00565409|18206780|P2|Period 2 Double-Blind|Adverse Event|7
5277727|NCT00565409|18206781|P1|Period 2 Double-Blind|Adverse Event|0
5277728|NCT00565409|18206778|P4|After Period 1, Prior to Period 2|did not meet criteria|0
5277729|NCT00565409|18206779|P3|After Period 1, Prior to Period 2|did not meet criteria|0
5277730|NCT00565409|18206780|P2|After Period 1, Prior to Period 2|did not meet criteria|0
5277731|NCT00565409|18206781|P1|After Period 1, Prior to Period 2|did not meet criteria|152
5277732|NCT00565409|18206778|P4|Period 1 Open Label|no conclusion of participation record|0
5277733|NCT00565409|18206779|P3|Period 1 Open Label|no conclusion of participation record|0
5277734|NCT00565409|18206780|P2|Period 1 Open Label|no conclusion of participation record|0
5277735|NCT00565409|18206781|P1|Period 1 Open Label|no conclusion of participation record|1
5277736|NCT00565409|18206778|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
5277737|NCT00565409|18206779|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
5277738|NCT00565409|18206780|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
5277739|NCT00565409|18206781|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
5277740|NCT00565409|18206778|P4|Period 1 Open Label|Protocol Violation|0
5277741|NCT00565409|18206779|P3|Period 1 Open Label|Protocol Violation|0
5277742|NCT00565409|18206780|P2|Period 1 Open Label|Protocol Violation|0
5277743|NCT00565409|18206781|P1|Period 1 Open Label|Protocol Violation|14
5277744|NCT00565409|18206778|P4|Period 1 Open Label|Other|0
5277745|NCT00565409|18206779|P3|Period 1 Open Label|Other|0
5277746|NCT00565409|18206780|P2|Period 1 Open Label|Other|0
5277747|NCT00565409|18206781|P1|Period 1 Open Label|Other|21
5277748|NCT00565409|18206778|P4|Period 1 Open Label|Lost to Follow-up|0
5277749|NCT00565409|18206779|P3|Period 1 Open Label|Lost to Follow-up|0
5277750|NCT00565409|18206780|P2|Period 1 Open Label|Lost to Follow-up|0
5277751|NCT00565409|18206781|P1|Period 1 Open Label|Lost to Follow-up|1
5277752|NCT00565409|18206778|P4|Period 1 Open Label|Death|0
5277753|NCT00565409|18206779|P3|Period 1 Open Label|Death|0
5277754|NCT00565409|18206780|P2|Period 1 Open Label|Death|0
5277755|NCT00565409|18206781|P1|Period 1 Open Label|Death|2
5277756|NCT00565409|18206778|P4|Period 1 Open Label|Adverse Event|0
5277757|NCT00565409|18206779|P3|Period 1 Open Label|Adverse Event|0
5277758|NCT00565409|18206780|P2|Period 1 Open Label|Adverse Event|0
5277759|NCT00565409|18206781|P1|Period 1 Open Label|Adverse Event|17
5277760|NCT00565136|18206917|P1|Overall Study|Protocol Violation|1
5277761|NCT00565136|18206917|P1|Overall Study|Withdrawal by Subject|1
5277762|NCT00565136|18206917|P1|Overall Study|Lost to Follow-up|1
5277763|NCT00565058|18206958|P2|Overall Study|Adverse Event|0
5277764|NCT00565058|18206959|P1|Overall Study|Adverse Event|1
5277765|NCT00564902|18207006|P3|Overall Study|Death|0
5277766|NCT00564902|18207007|P2|Overall Study|Death|1
5277767|NCT00564902|18207008|P1|Overall Study|Death|1
5277768|NCT00564902|18207006|P3|Overall Study|Withdrawal by Subject|4
5277769|NCT00564902|18207007|P2|Overall Study|Withdrawal by Subject|3
5277770|NCT00564902|18207008|P1|Overall Study|Withdrawal by Subject|0
5277771|NCT00564889|18207040|P1|Overall Study|Other, not specified|4
5277772|NCT00564889|18207040|P1|Overall Study|Disease progression|3
5277773|NCT00564889|18207040|P1|Overall Study|Alternative treatment|3
5277774|NCT00564889|18207040|P1|Overall Study|Adverse Event|12
5277775|NCT00564889|18207040|P1|Overall Study|Death|7
5277776|NCT00564850|18207055|P1|Overall Study|Protocol Violation|2
5277777|NCT00564733|18207073|P1|Overall Study|Ineligible|5
5277778|NCT00564733|18207073|P1|Overall Study|Withdrawal by Subject|4
5277779|NCT00564629|18207107|P2|Overall Study|Vomited within 2 hours of receiving drug|9
5277780|NCT00564629|18207108|P1|Overall Study|Vomited within 2 hours of receiving drug|15
5277781|NCT00564486|18207133|P4|Overall Study|Lost to Follow-up|2
5277782|NCT00564486|18207134|P3|Overall Study|Lost to Follow-up|2
5277783|NCT00564486|18207135|P2|Overall Study|Lost to Follow-up|0
5277784|NCT00564486|18207136|P1|Overall Study|Lost to Follow-up|3
5277785|NCT00564486|18207133|P4|Overall Study|Subject refused to have blood drawn|0
5277786|NCT00564486|18207134|P3|Overall Study|Subject refused to have blood drawn|1
5277787|NCT00564486|18207135|P2|Overall Study|Subject refused to have blood drawn|0
5277788|NCT00564486|18207136|P1|Overall Study|Subject refused to have blood drawn|0
5277789|NCT00564486|18207133|P4|Overall Study|Withdrawal by Subject|5
5277790|NCT00564486|18207134|P3|Overall Study|Withdrawal by Subject|0
5277791|NCT00564486|18207135|P2|Overall Study|Withdrawal by Subject|0
5277792|NCT00564486|18207136|P1|Overall Study|Withdrawal by Subject|4
5277793|NCT00564486|18207133|P4|Overall Study|Adverse Event|0
5277794|NCT00564486|18207134|P3|Overall Study|Adverse Event|0
5277795|NCT00564486|18207135|P2|Overall Study|Adverse Event|1
5277796|NCT00564486|18207136|P1|Overall Study|Adverse Event|0
5277797|NCT00564395|18207185|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
5277798|NCT00564395|18207186|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
5277799|NCT00564395|18207185|P2|First Intervention (10 Days)|Withdrawal by Subject|0
5277800|NCT00564395|18207186|P1|First Intervention (10 Days)|Withdrawal by Subject|1
5277801|NCT00564278|18207194|P2|Overall Study|Withdrawal by Subject|7
5277802|NCT00564278|18207195|P1|Overall Study|Withdrawal by Subject|11
5277803|NCT00564278|18207194|P2|Overall Study|Physician Decision|2
5277804|NCT00564278|18207195|P1|Overall Study|Physician Decision|1
5277805|NCT00564278|18207194|P2|Overall Study|Lost to Follow-up|33
5277806|NCT00564278|18207195|P1|Overall Study|Lost to Follow-up|35
5277807|NCT00564070|18207217|P2|Overall Study|Worsening depression, referred to care|0
5277808|NCT00564070|18207218|P1|Overall Study|Worsening depression, referred to care|3
5277809|NCT00564070|18207217|P2|Overall Study|Lost to Follow-up|7
5277810|NCT00564070|18207218|P1|Overall Study|Lost to Follow-up|9
5277811|NCT00564018|18207245|P3|Overall Study|Withdrawal by Subject|1
5277812|NCT00564018|18207246|P2|Overall Study|Withdrawal by Subject|3
5277813|NCT00564018|18207247|P1|Overall Study|Withdrawal by Subject|2
5277814|NCT00563797|18207260|P2|Overall Study|Lost to Follow-up|2
5277815|NCT00563797|18207261|P1|Overall Study|Lost to Follow-up|7
5277816|NCT00563784|18207273|P1|Overall Study|Screen Failures|20
5277817|NCT00563784|18207273|P1|Overall Study|Withdrawal by Subject|2
5277818|NCT00563706|18207287|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
5277819|NCT00563706|18207288|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
5277820|NCT00563706|18207289|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277821|NCT00563706|18207290|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277822|NCT00563706|18207291|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277823|NCT00563706|18207292|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277824|NCT00563706|18207293|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277825|NCT00563706|18207294|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277826|NCT00563706|18207295|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
5277827|NCT00563706|18207287|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277828|NCT00563706|18207288|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
5277829|NCT00563706|18207289|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277830|NCT00563706|18207290|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277831|NCT00563706|18207291|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277832|NCT00563706|18207292|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277833|NCT00563706|18207293|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277834|NCT00563706|18207294|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5277835|NCT00563706|18207295|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
5277836|NCT00563706|18207287|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
5277837|NCT00563706|18207288|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
5277838|NCT00563706|18207289|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
5277839|NCT00563706|18207290|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
5277840|NCT00563706|18207291|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
5277841|NCT00563706|18207292|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
5277842|NCT00563706|18207293|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
5277843|NCT00563706|18207294|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
5277844|NCT00563706|18207295|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
5277845|NCT00563706|18207287|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
5277846|NCT00563706|18207288|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
5277847|NCT00563706|18207289|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5277848|NCT00563706|18207290|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5277849|NCT00563706|18207291|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
5277850|NCT00563706|18207292|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
5277851|NCT00563706|18207293|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5277852|NCT00563706|18207294|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
5277853|NCT00563706|18207295|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5277854|NCT00563706|18207287|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
5277855|NCT00563706|18207288|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5277856|NCT00563706|18207289|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
5277857|NCT00563706|18207290|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
5277858|NCT00563706|18207291|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
5277859|NCT00563706|18207292|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5277860|NCT00563706|18207293|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5277861|NCT00563706|18207294|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5277862|NCT00563706|18207295|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
5277863|NCT00563381|18207413|P2|Overall Study|Individual different reasons|34
5277864|NCT00563381|18207414|P1|Overall Study|Individual different reasons|24
5277865|NCT00563381|18207413|P2|Overall Study|Lack of Efficacy|24
5277866|NCT00563381|18207414|P1|Overall Study|Lack of Efficacy|32
5277867|NCT00563381|18207413|P2|Overall Study|Withdrawal by Subject|209
5277868|NCT00563381|18207414|P1|Overall Study|Withdrawal by Subject|192
5277869|NCT00563381|18207413|P2|Overall Study|Lost to Follow-up|15
5277870|NCT00563381|18207414|P1|Overall Study|Lost to Follow-up|7
5277871|NCT00563381|18207413|P2|Overall Study|Protocol Violation|74
5277872|NCT00563381|18207414|P1|Overall Study|Protocol Violation|66
5277873|NCT00563381|18207413|P2|Overall Study|Adverse Event|292
5277874|NCT00563381|18207414|P1|Overall Study|Adverse Event|264
5277875|NCT00563368|18207487|P7|Overall Study|Other|0
5277876|NCT00563368|18207488|P6|Overall Study|Other|4
5277877|NCT00563368|18207489|P5|Overall Study|Other|4
5277878|NCT00563368|18207490|P4|Overall Study|Other|4
5277879|NCT00563368|18207491|P3|Overall Study|Other|3
5277880|NCT00563368|18207492|P2|Overall Study|Other|5
5277881|NCT00563368|18207493|P1|Overall Study|Other|5
5277882|NCT00563368|18207487|P7|Overall Study|requirement for restricted medication|0
5277883|NCT00563368|18207488|P6|Overall Study|requirement for restricted medication|0
5277884|NCT00563368|18207489|P5|Overall Study|requirement for restricted medication|0
5277885|NCT00563368|18207490|P4|Overall Study|requirement for restricted medication|0
5277886|NCT00563368|18207491|P3|Overall Study|requirement for restricted medication|2
5277887|NCT00563368|18207492|P2|Overall Study|requirement for restricted medication|0
5277888|NCT00563368|18207493|P1|Overall Study|requirement for restricted medication|0
5277889|NCT00563368|18207487|P7|Overall Study|Pregnancy|0
5277890|NCT00563368|18207488|P6|Overall Study|Pregnancy|2
5277891|NCT00563368|18207489|P5|Overall Study|Pregnancy|1
5277892|NCT00563368|18207490|P4|Overall Study|Pregnancy|2
5277893|NCT00563368|18207491|P3|Overall Study|Pregnancy|1
5277894|NCT00563368|18207492|P2|Overall Study|Pregnancy|0
5277895|NCT00563368|18207493|P1|Overall Study|Pregnancy|1
5277896|NCT00563368|18207487|P7|Overall Study|protocol non-compliance|3
5277897|NCT00563368|18207488|P6|Overall Study|protocol non-compliance|1
5277898|NCT00563368|18207489|P5|Overall Study|protocol non-compliance|0
5277899|NCT00563368|18207490|P4|Overall Study|protocol non-compliance|1
5277900|NCT00563368|18207491|P3|Overall Study|protocol non-compliance|2
5277901|NCT00563368|18207492|P2|Overall Study|protocol non-compliance|1
5277902|NCT00563368|18207493|P1|Overall Study|protocol non-compliance|1
5277903|NCT00563368|18207487|P7|Overall Study|Withdrawal by Subject|4
5277904|NCT00563368|18207488|P6|Overall Study|Withdrawal by Subject|5
5277905|NCT00563368|18207489|P5|Overall Study|Withdrawal by Subject|8
5277906|NCT00563368|18207490|P4|Overall Study|Withdrawal by Subject|7
5277907|NCT00563368|18207491|P3|Overall Study|Withdrawal by Subject|5
5277908|NCT00563368|18207492|P2|Overall Study|Withdrawal by Subject|6
5277909|NCT00563368|18207493|P1|Overall Study|Withdrawal by Subject|11
5277910|NCT00563368|18207487|P7|Overall Study|Adverse Event|17
5277911|NCT00563368|18207488|P6|Overall Study|Adverse Event|10
5277912|NCT00563368|18207489|P5|Overall Study|Adverse Event|6
5277913|NCT00563368|18207490|P4|Overall Study|Adverse Event|9
5277914|NCT00563368|18207491|P3|Overall Study|Adverse Event|5
5277915|NCT00563368|18207492|P2|Overall Study|Adverse Event|4
5277916|NCT00563368|18207493|P1|Overall Study|Adverse Event|3
5277917|NCT00563368|18207487|P7|Overall Study|Lost to Follow-up|9
5277918|NCT00563368|18207488|P6|Overall Study|Lost to Follow-up|8
5277919|NCT00563368|18207489|P5|Overall Study|Lost to Follow-up|9
5277920|NCT00563368|18207490|P4|Overall Study|Lost to Follow-up|6
5277921|NCT00563368|18207491|P3|Overall Study|Lost to Follow-up|12
5277922|NCT00563368|18207492|P2|Overall Study|Lost to Follow-up|14
5277923|NCT00563368|18207493|P1|Overall Study|Lost to Follow-up|14
5277924|NCT00563316|18207516|P1|Overall Study|Other|1
5277925|NCT00563316|18207516|P1|Overall Study|On-going in study as of 16 July 2009.|5
5277926|NCT00563316|18207516|P1|Overall Study|Death|1
5277927|NCT00563316|18207516|P1|Overall Study|Lost to Follow-up|2
5277928|NCT00563316|18207516|P1|Overall Study|Physician Decision|1
5277929|NCT00563316|18207516|P1|Overall Study|Adverse Event|2
5277930|NCT00563186|18207541|P2|Overall Study|Incomplete data|1
5277931|NCT00563186|18207542|P1|Overall Study|Incomplete data|1
5277932|NCT00563186|18207541|P2|Overall Study|LOS<48 hours|74
5277933|NCT00563186|18207542|P1|Overall Study|LOS<48 hours|97
5277934|NCT00562965|18207553|P2|Overall Study|Other|1
5277935|NCT00562965|18207554|P1|Overall Study|Other|0
5277936|NCT00562965|18207553|P2|Overall Study|Lost to Follow-up|0
5277937|NCT00562965|18207554|P1|Overall Study|Lost to Follow-up|1
5277938|NCT00562965|18207553|P2|Overall Study|Death|4
5277939|NCT00562965|18207554|P1|Overall Study|Death|2
5277940|NCT00562965|18207553|P2|Overall Study|Withdrawal by Subject|1
5277941|NCT00562965|18207554|P1|Overall Study|Withdrawal by Subject|0
5277942|NCT00562861|18207575|P2|Overall Study|Lost to Follow-up|3
5277943|NCT00562861|18207576|P1|Overall Study|Lost to Follow-up|7
5277944|NCT00562861|18207575|P2|Overall Study|noncompliance, moved|2
5277945|NCT00562861|18207576|P1|Overall Study|noncompliance, moved|7
5277946|NCT00562861|18207575|P2|Overall Study|Lack of Efficacy|5
5277947|NCT00562861|18207576|P1|Overall Study|Lack of Efficacy|5
5277948|NCT00562861|18207575|P2|Overall Study|Adverse Event|1
5277949|NCT00562861|18207576|P1|Overall Study|Adverse Event|1
5277950|NCT00562718|18207582|P1|Overall Study|not stated|1
5277951|NCT00562718|18207582|P1|Overall Study|Lack of Efficacy|2
5277952|NCT00562718|18207582|P1|Overall Study|Adverse Event|4
5277953|NCT00562718|18207582|P1|Overall Study|Withdrawal by Subject|3
5277954|NCT00562718|18207582|P1|Overall Study|Death|1
5277955|NCT00562627|18207591|P3|Overall Study|Protocol Violation|1
5277956|NCT00562627|18207592|P2|Overall Study|Protocol Violation|1
5277957|NCT00562627|18207593|P1|Overall Study|Protocol Violation|1
5277958|NCT00562588|18207609|P2|Overall Study|Other|2
5277959|NCT00562588|18207610|P1|Overall Study|Other|0
5277960|NCT00562588|18207609|P2|Overall Study|Withdrawal by Subject|9
5277961|NCT00562588|18207610|P1|Overall Study|Withdrawal by Subject|10
5277962|NCT00562588|18207609|P2|Overall Study|Lost to Follow-up|4
5277963|NCT00562588|18207610|P1|Overall Study|Lost to Follow-up|12
5277964|NCT00562588|18207609|P2|Overall Study|Protocol Violation|26
5277965|NCT00562588|18207610|P1|Overall Study|Protocol Violation|30
5277966|NCT00562588|18207609|P2|Overall Study|Adverse Event|58
5277967|NCT00562588|18207610|P1|Overall Study|Adverse Event|40
5277968|NCT00562484|18207640|P2|Overall Study|Reason not provided or not specified|12
5277969|NCT00562484|18207641|P1|Overall Study|Reason not provided or not specified|25
5277970|NCT00562484|18207640|P2|Overall Study|Lost to Follow-up|71
5277971|NCT00562484|18207641|P1|Overall Study|Lost to Follow-up|132
5277972|NCT00562484|18207640|P2|Overall Study|Moved away from the study area|9
5277973|NCT00562484|18207641|P1|Overall Study|Moved away from the study area|20
5277974|NCT00562484|18207640|P2|Overall Study|Withdrawal by Subject|9
5277975|NCT00562484|18207641|P1|Overall Study|Withdrawal by Subject|12
5277976|NCT00562484|18207640|P2|Overall Study|Protocol Violation|2
5277977|NCT00562484|18207641|P1|Overall Study|Protocol Violation|11
5277978|NCT00562484|18207640|P2|Overall Study|Adverse Event|1
5277979|NCT00562484|18207641|P1|Overall Study|Adverse Event|6
5277980|NCT00562354|18207673|P2|Overall Study|Lost to Follow-up|1
5277981|NCT00562354|18207674|P1|Overall Study|Lost to Follow-up|0
5277982|NCT00562354|18207673|P2|Overall Study|Physician Decision|1
5277983|NCT00562354|18207674|P1|Overall Study|Physician Decision|0
5277984|NCT00562302|18207740|P2|Overall Study|Not stated|4
5277985|NCT00562302|18207741|P1|Overall Study|Not stated|1
5277986|NCT00562302|18207740|P2|Overall Study|Lung resection prior to study completion|7
5277987|NCT00562302|18207741|P1|Overall Study|Lung resection prior to study completion|7
5277988|NCT00562302|18207740|P2|Overall Study|Death|2
5277989|NCT00562302|18207741|P1|Overall Study|Death|1
5277990|NCT00562302|18207740|P2|Overall Study|Withdrawal by Subject|8
5277991|NCT00562302|18207741|P1|Overall Study|Withdrawal by Subject|7
5277992|NCT00562302|18207740|P2|Overall Study|Non-compliance|2
5277993|NCT00562302|18207741|P1|Overall Study|Non-compliance|1
5277994|NCT00562302|18207740|P2|Overall Study|Adverse Event|6
5277995|NCT00562302|18207741|P1|Overall Study|Adverse Event|0
5277996|NCT00562302|18207740|P2|Overall Study|Lost to Follow-up|3
5277997|NCT00562302|18207741|P1|Overall Study|Lost to Follow-up|3
5277998|NCT00562159|18207763|P2|Overall Study|Did not meet protocol eligibility|1
5277999|NCT00562159|18207764|P1|Overall Study|Did not meet protocol eligibility|1
5278000|NCT00562159|18207763|P2|Overall Study|Protocol Violation|12
5278001|NCT00562159|18207764|P1|Overall Study|Protocol Violation|12
5278002|NCT00562159|18207763|P2|Overall Study|Withdrawal by Subject|8
5278003|NCT00562159|18207764|P1|Overall Study|Withdrawal by Subject|9
5278004|NCT00562159|18207763|P2|Overall Study|Lost to Follow-up|4
5278005|NCT00562159|18207764|P1|Overall Study|Lost to Follow-up|5
5278006|NCT00562159|18207763|P2|Overall Study|Adverse Event|8
5278007|NCT00562159|18207764|P1|Overall Study|Adverse Event|11
5278008|NCT00562120|18207776|P4|First Intervention Period|Randomized but not Treated|0
5278009|NCT00562120|18207777|P3|First Intervention Period|Randomized but not Treated|0
5278010|NCT00562120|18207778|P2|First Intervention Period|Randomized but not Treated|0
5278011|NCT00562120|18207779|P1|First Intervention Period|Randomized but not Treated|1
5278012|NCT00562120|18207776|P4|First Intervention Period|Adverse Event|0
5278013|NCT00562120|18207777|P3|First Intervention Period|Adverse Event|0
5278014|NCT00562120|18207778|P2|First Intervention Period|Adverse Event|0
5278015|NCT00562120|18207779|P1|First Intervention Period|Adverse Event|1
5278016|NCT00562094|18207811|P1|Overall Study|Lost to Follow-up|62
5278017|NCT00561977|18207826|P3|Overall Study|Pregnancy|1
5278018|NCT00561977|18207827|P2|Overall Study|Pregnancy|1
5278019|NCT00561977|18207828|P1|Overall Study|Pregnancy|0
5278020|NCT00561977|18207826|P3|Overall Study|Withdrawal by Subject|1
5278021|NCT00561977|18207827|P2|Overall Study|Withdrawal by Subject|2
5278022|NCT00561977|18207828|P1|Overall Study|Withdrawal by Subject|0
5278023|NCT00561951|18207854|P3|Overall Study|Adverse Event Occured Before Treatment|1
5278024|NCT00561951|18207855|P2|Overall Study|Adverse Event Occured Before Treatment|2
5278025|NCT00561951|18207856|P1|Overall Study|Adverse Event Occured Before Treatment|1
5278026|NCT00561951|18207854|P3|Overall Study|Meet Withdrawal Criterion|1
5278027|NCT00561951|18207855|P2|Overall Study|Meet Withdrawal Criterion|1
5278028|NCT00561951|18207856|P1|Overall Study|Meet Withdrawal Criterion|0
5278029|NCT00561951|18207854|P3|Overall Study|Pregnancy|0
5278030|NCT00561951|18207855|P2|Overall Study|Pregnancy|1
5278031|NCT00561951|18207856|P1|Overall Study|Pregnancy|0
5278032|NCT00561951|18207854|P3|Overall Study|Physician Decision|0
5278033|NCT00561951|18207855|P2|Overall Study|Physician Decision|0
5278034|NCT00561951|18207856|P1|Overall Study|Physician Decision|1
5278035|NCT00561951|18207854|P3|Overall Study|Protocol Violation|4
5278036|NCT00561951|18207855|P2|Overall Study|Protocol Violation|3
5278037|NCT00561951|18207856|P1|Overall Study|Protocol Violation|4
5278038|NCT00561951|18207854|P3|Overall Study|Withdrawal by Subject|10
5278039|NCT00561951|18207855|P2|Overall Study|Withdrawal by Subject|9
5278040|NCT00561951|18207856|P1|Overall Study|Withdrawal by Subject|10
5278041|NCT00561951|18207854|P3|Overall Study|Lost to Follow-up|0
5278042|NCT00561951|18207855|P2|Overall Study|Lost to Follow-up|1
5278043|NCT00561951|18207856|P1|Overall Study|Lost to Follow-up|1
5278044|NCT00561951|18207854|P3|Overall Study|Lack of Efficacy|2
5278045|NCT00561951|18207855|P2|Overall Study|Lack of Efficacy|3
5278046|NCT00561951|18207856|P1|Overall Study|Lack of Efficacy|5
5278047|NCT00561951|18207854|P3|Overall Study|Adverse Event|14
5278048|NCT00561951|18207855|P2|Overall Study|Adverse Event|14
5278049|NCT00561951|18207856|P1|Overall Study|Adverse Event|11
5278050|NCT00561925|18207912|P5|Open-Label Extension Period|Declined entry into extension period|50
5278051|NCT00561925|18207913|P4|Open-Label Extension Period|Declined entry into extension period|43
5278052|NCT00561925|18207914|P3|Open-Label Extension Period|Declined entry into extension period|0
5278053|NCT00561925|18207915|P2|Open-Label Extension Period|Declined entry into extension period|0
5278054|NCT00561925|18207916|P1|Open-Label Extension Period|Declined entry into extension period|0
5278055|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Other|0
5278056|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Other|0
5278057|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Other|11
5278058|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Other|8
5278059|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Other|0
5278060|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
5278061|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
5278062|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
5278063|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
5278064|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
5278065|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Death|0
5278066|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Death|0
5278067|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Death|3
5278068|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Death|6
5278069|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Death|0
5278070|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Pregnancy|0
5278071|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Pregnancy|0
5278072|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Pregnancy|9
5278073|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Pregnancy|1
5278074|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Pregnancy|0
5278075|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
5278076|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
5278077|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
5278078|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
5278079|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
5278080|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
5278081|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
5278082|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
5278083|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
5278084|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
5278085|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
5278086|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
5278087|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
5278088|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
5278089|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
5278090|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
5278091|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
5278092|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
5278093|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
5278094|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
5278095|NCT00561925|18207912|P5|144-week Double-blind, Double-dummy|Adverse Event|0
5278096|NCT00561925|18207913|P4|144-week Double-blind, Double-dummy|Adverse Event|0
5278097|NCT00561925|18207914|P3|144-week Double-blind, Double-dummy|Adverse Event|43
5278098|NCT00561925|18207915|P2|144-week Double-blind, Double-dummy|Adverse Event|48
5278099|NCT00561925|18207916|P1|144-week Double-blind, Double-dummy|Adverse Event|0
5278100|NCT00561925|18207912|P5|14 Day Lead-In Period|Other|0
5278101|NCT00561925|18207913|P4|14 Day Lead-In Period|Other|0
5278102|NCT00561925|18207914|P3|14 Day Lead-In Period|Other|0
5278103|NCT00561925|18207915|P2|14 Day Lead-In Period|Other|0
5278104|NCT00561925|18207916|P1|14 Day Lead-In Period|Other|5
5278105|NCT00561925|18207912|P5|14 Day Lead-In Period|Withdrawal by Subject|0
5278106|NCT00561925|18207913|P4|14 Day Lead-In Period|Withdrawal by Subject|0
5278107|NCT00561925|18207914|P3|14 Day Lead-In Period|Withdrawal by Subject|0
5278108|NCT00561925|18207915|P2|14 Day Lead-In Period|Withdrawal by Subject|0
5278109|NCT00561925|18207916|P1|14 Day Lead-In Period|Withdrawal by Subject|4
5278110|NCT00561925|18207912|P5|14 Day Lead-In Period|Lost to Follow-up|0
5278111|NCT00561925|18207913|P4|14 Day Lead-In Period|Lost to Follow-up|0
5278112|NCT00561925|18207914|P3|14 Day Lead-In Period|Lost to Follow-up|0
5278113|NCT00561925|18207915|P2|14 Day Lead-In Period|Lost to Follow-up|0
5278114|NCT00561925|18207916|P1|14 Day Lead-In Period|Lost to Follow-up|4
5278115|NCT00561925|18207912|P5|14 Day Lead-In Period|In/Exclusion criteria|0
5278116|NCT00561925|18207913|P4|14 Day Lead-In Period|In/Exclusion criteria|0
5278117|NCT00561925|18207914|P3|14 Day Lead-In Period|In/Exclusion criteria|0
5278118|NCT00561925|18207915|P2|14 Day Lead-In Period|In/Exclusion criteria|0
5278119|NCT00561925|18207916|P1|14 Day Lead-In Period|In/Exclusion criteria|4
5278120|NCT00561925|18207912|P5|14 Day Lead-In Period|Adverse Event|0
5278121|NCT00561925|18207913|P4|14 Day Lead-In Period|Adverse Event|0
5278122|NCT00561925|18207914|P3|14 Day Lead-In Period|Adverse Event|0
5278123|NCT00561925|18207915|P2|14 Day Lead-In Period|Adverse Event|0
5278124|NCT00561925|18207916|P1|14 Day Lead-In Period|Adverse Event|38
5278125|NCT00561912|18207965|P1|Overall Study|ineligible|1
5278126|NCT00561821|18207977|P4|Overall Study|Adverse Event|1
5278127|NCT00561821|18207978|P3|Overall Study|Adverse Event|1
5278128|NCT00561821|18207979|P2|Overall Study|Adverse Event|3
5278129|NCT00561821|18207980|P1|Overall Study|Adverse Event|2
5278130|NCT00561821|18207977|P4|Overall Study|Other (reason not specified)|0
5278131|NCT00561821|18207978|P3|Overall Study|Other (reason not specified)|0
5278132|NCT00561821|18207979|P2|Overall Study|Other (reason not specified)|1
5278133|NCT00561821|18207980|P1|Overall Study|Other (reason not specified)|1
5278134|NCT00561821|18207977|P4|Overall Study|Reasons not related to trial|0
5278135|NCT00561821|18207978|P3|Overall Study|Reasons not related to trial|0
5278136|NCT00561821|18207979|P2|Overall Study|Reasons not related to trial|1
5278137|NCT00561821|18207980|P1|Overall Study|Reasons not related to trial|2
5278138|NCT00561821|18207977|P4|Overall Study|Withdrawal by Subject|2
5278139|NCT00561821|18207978|P3|Overall Study|Withdrawal by Subject|0
5278140|NCT00561821|18207979|P2|Overall Study|Withdrawal by Subject|1
5278141|NCT00561821|18207980|P1|Overall Study|Withdrawal by Subject|0
5278142|NCT00561821|18207977|P4|Overall Study|Not treated|0
5278143|NCT00561821|18207978|P3|Overall Study|Not treated|1
5278144|NCT00561821|18207979|P2|Overall Study|Not treated|0
5278145|NCT00561821|18207980|P1|Overall Study|Not treated|0
5278146|NCT00561795|18208056|P4|Overall Study|Physician Decision|0
5278147|NCT00561795|18208057|P3|Overall Study|Physician Decision|0
5278148|NCT00561795|18208058|P2|Overall Study|Physician Decision|0
5278149|NCT00561795|18208059|P1|Overall Study|Physician Decision|1
5278150|NCT00561795|18208056|P4|Overall Study|Study Closed/Terminated|0
5278151|NCT00561795|18208057|P3|Overall Study|Study Closed/Terminated|0
5278152|NCT00561795|18208058|P2|Overall Study|Study Closed/Terminated|3
5278153|NCT00561795|18208059|P1|Overall Study|Study Closed/Terminated|0
5278154|NCT00561795|18208056|P4|Overall Study|Adverse Event|0
5278155|NCT00561795|18208057|P3|Overall Study|Adverse Event|0
5278156|NCT00561795|18208058|P2|Overall Study|Adverse Event|3
5278157|NCT00561795|18208059|P1|Overall Study|Adverse Event|3
5278158|NCT00561730|18208079|P1|Overall Study|Not specified reasons|1
5278159|NCT00561730|18208079|P1|Overall Study|Lost to Follow-up|5
5278160|NCT00561730|18208079|P1|Overall Study|Handling of the drug|1
5278161|NCT00561730|18208079|P1|Overall Study|Adverse Event|2
5278162|NCT00561678|18208095|P2|Overall Study|anesthesia provider refusal|0
5278163|NCT00561678|18208096|P1|Overall Study|anesthesia provider refusal|1
5278164|NCT00561678|18208095|P2|Overall Study|surgery rescheduled to different site|2
5278165|NCT00561678|18208096|P1|Overall Study|surgery rescheduled to different site|2
5278166|NCT00561678|18208095|P2|Overall Study|surgery cancelled|1
5278167|NCT00561678|18208096|P1|Overall Study|surgery cancelled|1
5278168|NCT00561678|18208095|P2|Overall Study|Withdrawal by Subject|3
5278169|NCT00561678|18208096|P1|Overall Study|Withdrawal by Subject|4
5278170|NCT00561652|18208114|P2|Overall Study|Withdrawal by Subject|1
5278171|NCT00561652|18208115|P1|Overall Study|Withdrawal by Subject|0
5278172|NCT00561574|18208198|P2|Overall Study|Other|7
5278173|NCT00561574|18208199|P1|Overall Study|Other|5
5278174|NCT00561574|18208198|P2|Overall Study|Lost to Follow-up|0
5278175|NCT00561574|18208199|P1|Overall Study|Lost to Follow-up|1
5278176|NCT00561574|18208198|P2|Overall Study|Reason Unrelated to Trial|2
5278177|NCT00561574|18208199|P1|Overall Study|Reason Unrelated to Trial|6
5278178|NCT00561574|18208198|P2|Overall Study|Withdrawal by Subject|4
5278179|NCT00561574|18208199|P1|Overall Study|Withdrawal by Subject|4
5278180|NCT00561574|18208198|P2|Overall Study|Lack of Efficacy|21
5278181|NCT00561574|18208199|P1|Overall Study|Lack of Efficacy|11
5278182|NCT00561574|18208198|P2|Overall Study|Adverse Event|24
5278183|NCT00561574|18208199|P1|Overall Study|Adverse Event|21
5278184|NCT00561470|18208225|P2|Overall Study|Ongoing Treatment|14
5278185|NCT00561470|18208226|P1|Overall Study|Ongoing Treatment|11
5278186|NCT00561470|18208225|P2|Overall Study|Planning surgery|1
5278187|NCT00561470|18208226|P1|Overall Study|Planning surgery|1
5278188|NCT00561470|18208225|P2|Overall Study|Missed visit window|4
5278189|NCT00561470|18208226|P1|Overall Study|Missed visit window|1
5278190|NCT00561470|18208225|P2|Overall Study|Randomized but not treated|5
5278191|NCT00561470|18208226|P1|Overall Study|Randomized but not treated|5
5278192|NCT00561470|18208225|P2|Overall Study|Unauthorized procedure|1
5278193|NCT00561470|18208226|P1|Overall Study|Unauthorized procedure|3
5278194|NCT00561470|18208225|P2|Overall Study|Metastatic surgery|12
5278195|NCT00561470|18208226|P1|Overall Study|Metastatic surgery|10
5278196|NCT00561470|18208225|P2|Overall Study|Subject request|77
5278197|NCT00561470|18208226|P1|Overall Study|Subject request|43
5278198|NCT00561470|18208225|P2|Overall Study|Consent Withdrawn|6
5278199|NCT00561470|18208226|P1|Overall Study|Consent Withdrawn|2
5278200|NCT00561470|18208225|P2|Overall Study|Physician Decision|20
5278201|NCT00561470|18208226|P1|Overall Study|Physician Decision|21
5278202|NCT00561470|18208225|P2|Overall Study|Lost to Follow-up|0
5278203|NCT00561470|18208226|P1|Overall Study|Lost to Follow-up|2
5278204|NCT00561470|18208225|P2|Overall Study|poor compliance to protocol|4
5278205|NCT00561470|18208226|P1|Overall Study|poor compliance to protocol|4
5278206|NCT00561470|18208225|P2|Overall Study|Disease progression|305
5278207|NCT00561470|18208226|P1|Overall Study|Disease progression|437
5278208|NCT00561470|18208225|P2|Overall Study|Adverse Event|163
5278209|NCT00561470|18208226|P1|Overall Study|Adverse Event|74
5278210|NCT00561392|18208262|P1|Overall Study|Administrative problems|4
5278211|NCT00561392|18208262|P1|Overall Study|Withdrawal by Subject|8
5278212|NCT00561392|18208262|P1|Overall Study|Protocol Violation|1
5278213|NCT00561392|18208262|P1|Overall Study|Lack of Efficacy|2
5278214|NCT00561392|18208262|P1|Overall Study|Adverse Event|38
5278215|NCT00561353|18208284|P10|Overall Study|Withdrawal by Subject|0
5278216|NCT00561353|18208285|P9|Overall Study|Withdrawal by Subject|0
5278217|NCT00561353|18208286|P8|Overall Study|Withdrawal by Subject|0
5278218|NCT00561353|18208287|P7|Overall Study|Withdrawal by Subject|0
5278219|NCT00561353|18208288|P6|Overall Study|Withdrawal by Subject|0
5278220|NCT00561353|18208289|P5|Overall Study|Withdrawal by Subject|0
5278221|NCT00561353|18208290|P4|Overall Study|Withdrawal by Subject|0
5278222|NCT00561353|18208291|P3|Overall Study|Withdrawal by Subject|0
5278223|NCT00561353|18208292|P2|Overall Study|Withdrawal by Subject|2
5278224|NCT00561353|18208293|P1|Overall Study|Withdrawal by Subject|0
5278225|NCT00561353|18208284|P10|Overall Study|Lost to Follow-up|0
5278226|NCT00561353|18208285|P9|Overall Study|Lost to Follow-up|0
5278227|NCT00561353|18208286|P8|Overall Study|Lost to Follow-up|0
5278228|NCT00561353|18208287|P7|Overall Study|Lost to Follow-up|0
5278229|NCT00561353|18208288|P6|Overall Study|Lost to Follow-up|0
5278230|NCT00561353|18208289|P5|Overall Study|Lost to Follow-up|0
5278231|NCT00561353|18208290|P4|Overall Study|Lost to Follow-up|0
5278232|NCT00561353|18208291|P3|Overall Study|Lost to Follow-up|1
5278233|NCT00561353|18208292|P2|Overall Study|Lost to Follow-up|0
5278234|NCT00561353|18208293|P1|Overall Study|Lost to Follow-up|2
5278235|NCT00561353|18208284|P10|Overall Study|Adverse Event|1
5278236|NCT00561353|18208285|P9|Overall Study|Adverse Event|0
5278237|NCT00561353|18208286|P8|Overall Study|Adverse Event|0
5278238|NCT00561353|18208287|P7|Overall Study|Adverse Event|1
5278239|NCT00561353|18208288|P6|Overall Study|Adverse Event|0
5278240|NCT00561353|18208289|P5|Overall Study|Adverse Event|0
5278241|NCT00561353|18208290|P4|Overall Study|Adverse Event|2
5278242|NCT00561353|18208291|P3|Overall Study|Adverse Event|0
5278243|NCT00561353|18208292|P2|Overall Study|Adverse Event|0
5278244|NCT00561353|18208293|P1|Overall Study|Adverse Event|0
5278245|NCT00561353|18208284|P10|Overall Study|Other|0
5278246|NCT00561353|18208285|P9|Overall Study|Other|0
5278247|NCT00561353|18208286|P8|Overall Study|Other|0
5278248|NCT00561353|18208287|P7|Overall Study|Other|0
5278249|NCT00561353|18208288|P6|Overall Study|Other|2
5278250|NCT00561353|18208289|P5|Overall Study|Other|0
5278251|NCT00561353|18208290|P4|Overall Study|Other|0
5278252|NCT00561353|18208291|P3|Overall Study|Other|1
5278253|NCT00561353|18208292|P2|Overall Study|Other|0
5278254|NCT00561353|18208293|P1|Overall Study|Other|1
5278255|NCT00561353|18208284|P10|Overall Study|Subject ineligible to continue the trial|1
5278256|NCT00561353|18208285|P9|Overall Study|Subject ineligible to continue the trial|2
5278257|NCT00561353|18208286|P8|Overall Study|Subject ineligible to continue the trial|0
5278258|NCT00561353|18208287|P7|Overall Study|Subject ineligible to continue the trial|1
5278259|NCT00561353|18208288|P6|Overall Study|Subject ineligible to continue the trial|1
5278260|NCT00561353|18208289|P5|Overall Study|Subject ineligible to continue the trial|0
5278261|NCT00561353|18208290|P4|Overall Study|Subject ineligible to continue the trial|0
5278262|NCT00561353|18208291|P3|Overall Study|Subject ineligible to continue the trial|0
5278263|NCT00561353|18208292|P2|Overall Study|Subject ineligible to continue the trial|0
5278264|NCT00561353|18208293|P1|Overall Study|Subject ineligible to continue the trial|0
5278265|NCT00561353|18208284|P10|Overall Study|Subject reached a virologic endpoint|0
5278266|NCT00561353|18208285|P9|Overall Study|Subject reached a virologic endpoint|5
5278267|NCT00561353|18208286|P8|Overall Study|Subject reached a virologic endpoint|4
5278268|NCT00561353|18208287|P7|Overall Study|Subject reached a virologic endpoint|4
5278269|NCT00561353|18208288|P6|Overall Study|Subject reached a virologic endpoint|3
5278270|NCT00561353|18208289|P5|Overall Study|Subject reached a virologic endpoint|1
5278271|NCT00561353|18208290|P4|Overall Study|Subject reached a virologic endpoint|4
5278272|NCT00561353|18208291|P3|Overall Study|Subject reached a virologic endpoint|1
5278273|NCT00561353|18208292|P2|Overall Study|Subject reached a virologic endpoint|1
5278274|NCT00561353|18208293|P1|Overall Study|Subject reached a virologic endpoint|2
5278275|NCT00561340|18208448|P2|Overall Study|refused to drink pediasure|0
5278276|NCT00561340|18208449|P1|Overall Study|refused to drink pediasure|6
5278277|NCT00561080|18208469|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
5278278|NCT00561080|18208470|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
5278279|NCT00561080|18208471|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
5278280|NCT00561080|18208469|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
5278281|NCT00561080|18208470|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
5278282|NCT00561080|18208471|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
5278283|NCT00561080|18208469|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
5278284|NCT00561080|18208470|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
5278285|NCT00561080|18208471|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
5278286|NCT00561080|18208469|P3|12-month Post Last Dose Follow-up|Adverse Event|1
5278287|NCT00561080|18208470|P2|12-month Post Last Dose Follow-up|Adverse Event|3
5278288|NCT00561080|18208471|P1|12-month Post Last Dose Follow-up|Adverse Event|3
5278289|NCT00561080|18208469|P3|Vaccination Period (up to Month 4)|Other|1
5278290|NCT00561080|18208470|P2|Vaccination Period (up to Month 4)|Other|2
5278291|NCT00561080|18208471|P1|Vaccination Period (up to Month 4)|Other|0
5278292|NCT00561080|18208469|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
5278293|NCT00561080|18208470|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
5278294|NCT00561080|18208471|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
5278295|NCT00561080|18208469|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
5278296|NCT00561080|18208470|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
5278297|NCT00561080|18208471|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
5278298|NCT00561080|18208469|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
5278299|NCT00561080|18208470|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
5278300|NCT00561080|18208471|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
5278301|NCT00561080|18208469|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
5278302|NCT00561080|18208470|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
5278303|NCT00561080|18208471|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
5278304|NCT00561080|18208469|P3|Vaccination Period (up to Month 4)|Adverse Event|6
5278305|NCT00561080|18208470|P2|Vaccination Period (up to Month 4)|Adverse Event|4
5278306|NCT00561080|18208471|P1|Vaccination Period (up to Month 4)|Adverse Event|0
5278307|NCT00561015|18208548|P6|Overall Study|Participant non-compliance|0
5278308|NCT00561015|18208549|P5|Overall Study|Participant non-compliance|0
5278309|NCT00561015|18208550|P4|Overall Study|Participant non-compliance|0
5278310|NCT00561015|18208551|P3|Overall Study|Participant non-compliance|0
5278311|NCT00561015|18208552|P2|Overall Study|Participant non-compliance|0
5278312|NCT00561015|18208553|P1|Overall Study|Participant non-compliance|2
5278313|NCT00561015|18208548|P6|Overall Study|Lost to Follow-up|3
5278314|NCT00561015|18208549|P5|Overall Study|Lost to Follow-up|0
5278315|NCT00561015|18208550|P4|Overall Study|Lost to Follow-up|1
5278316|NCT00561015|18208551|P3|Overall Study|Lost to Follow-up|0
5278317|NCT00561015|18208552|P2|Overall Study|Lost to Follow-up|0
5278318|NCT00561015|18208553|P1|Overall Study|Lost to Follow-up|2
5278319|NCT00561015|18208548|P6|Overall Study|Adverse Event|0
5278320|NCT00561015|18208549|P5|Overall Study|Adverse Event|1
5278321|NCT00561015|18208550|P4|Overall Study|Adverse Event|0
5278322|NCT00561015|18208551|P3|Overall Study|Adverse Event|0
5278323|NCT00561015|18208552|P2|Overall Study|Adverse Event|0
5278324|NCT00561015|18208553|P1|Overall Study|Adverse Event|0
5278325|NCT00560950|18208644|P2|Overall Study|Lost to Follow-up|0
5278326|NCT00560950|18208645|P1|Overall Study|Lost to Follow-up|1
5278327|NCT00560937|18208683|P2|Overall Study|Physician Decision|1
5278328|NCT00560937|18208684|P1|Overall Study|Physician Decision|1
5278329|NCT00560937|18208683|P2|Overall Study|Withdrawal by Subject|1
5278330|NCT00560937|18208684|P1|Overall Study|Withdrawal by Subject|0
5278331|NCT00560885|18208700|P1|Overall Study|Withdrawal by Subject|1
5278332|NCT00560885|18208700|P1|Overall Study|Death|7
5278333|NCT00560833|18208725|P5|Overall Study|Never received drug|1
5278334|NCT00560833|18208726|P4|Overall Study|Never received drug|0
5278335|NCT00560833|18208727|P3|Overall Study|Never received drug|0
5278336|NCT00560833|18208728|P2|Overall Study|Never received drug|1
5278337|NCT00560833|18208729|P1|Overall Study|Never received drug|0
5278338|NCT00560833|18208725|P5|Overall Study|Other|0
5278339|NCT00560833|18208726|P4|Overall Study|Other|0
5278340|NCT00560833|18208727|P3|Overall Study|Other|3
5278341|NCT00560833|18208728|P2|Overall Study|Other|1
5278342|NCT00560833|18208729|P1|Overall Study|Other|1
5278343|NCT00560833|18208725|P5|Overall Study|Participant uncooperative|2
5278344|NCT00560833|18208726|P4|Overall Study|Participant uncooperative|4
5278345|NCT00560833|18208727|P3|Overall Study|Participant uncooperative|4
5278346|NCT00560833|18208728|P2|Overall Study|Participant uncooperative|5
5278347|NCT00560833|18208729|P1|Overall Study|Participant uncooperative|5
5278348|NCT00560833|18208725|P5|Overall Study|Lack of Efficacy|4
5278349|NCT00560833|18208726|P4|Overall Study|Lack of Efficacy|4
5278350|NCT00560833|18208727|P3|Overall Study|Lack of Efficacy|6
5278351|NCT00560833|18208728|P2|Overall Study|Lack of Efficacy|9
5278352|NCT00560833|18208729|P1|Overall Study|Lack of Efficacy|22
5278353|NCT00560833|18208725|P5|Overall Study|Lost to Follow-up|0
5278354|NCT00560833|18208726|P4|Overall Study|Lost to Follow-up|0
5278355|NCT00560833|18208727|P3|Overall Study|Lost to Follow-up|1
5278356|NCT00560833|18208728|P2|Overall Study|Lost to Follow-up|0
5278357|NCT00560833|18208729|P1|Overall Study|Lost to Follow-up|0
5278358|NCT00560833|18208725|P5|Overall Study|Adverse Event|35
5278359|NCT00560833|18208726|P4|Overall Study|Adverse Event|23
5278360|NCT00560833|18208727|P3|Overall Study|Adverse Event|25
5278361|NCT00560833|18208728|P2|Overall Study|Adverse Event|10
5278362|NCT00560833|18208729|P1|Overall Study|Adverse Event|16
5278363|NCT00560794|18208761|P1|Overall Study|Received Bone Marrow Transplant|6
5278364|NCT00560794|18208761|P1|Overall Study|Hematological Relapse|1
5278365|NCT00560794|18208761|P1|Overall Study|Minimal Residual Disease Relapse|1
5278366|NCT00560794|18208761|P1|Overall Study|Patient was not Compliant|1
5278367|NCT00560794|18208761|P1|Overall Study|Adverse Event|2
5278368|NCT00560755|18208778|P1|Overall Study|Physician Decision|2
5278369|NCT00560755|18208778|P1|Overall Study|Adverse Event|8
5278370|NCT00560755|18208778|P1|Overall Study|Lost to Follow-up|9
5278371|NCT00560755|18208778|P1|Overall Study|Withdrawal by Subject|26
5278372|NCT00560755|18208778|P1|Overall Study|Protocol Violation|15
5278373|NCT00560703|18208799|P2|Overall Study|non-compliance|1
5278374|NCT00560703|18208800|P1|Overall Study|non-compliance|0
5278375|NCT00560703|18208799|P2|Overall Study|Withdrawal by Subject|1
5278376|NCT00560703|18208800|P1|Overall Study|Withdrawal by Subject|0
5278377|NCT00560703|18208799|P2|Overall Study|Protocol Violation|2
5278378|NCT00560703|18208800|P1|Overall Study|Protocol Violation|0
5278379|NCT00560703|18208799|P2|Overall Study|Adverse Event|2
5278380|NCT00560703|18208800|P1|Overall Study|Adverse Event|0
5278381|NCT00560573|18208823|P6|Overall Study|Enrolled, not treated|0
5278382|NCT00560573|18208824|P5|Overall Study|Enrolled, not treated|1
5278383|NCT00560573|18208825|P4|Overall Study|Enrolled, not treated|0
5278384|NCT00560573|18208826|P3|Overall Study|Enrolled, not treated|0
5278385|NCT00560573|18208827|P2|Overall Study|Enrolled, not treated|0
5278386|NCT00560573|18208828|P1|Overall Study|Enrolled, not treated|0
5278387|NCT00560573|18208823|P6|Overall Study|Other|3
5278388|NCT00560573|18208824|P5|Overall Study|Other|3
5278389|NCT00560573|18208825|P4|Overall Study|Other|3
5278390|NCT00560573|18208826|P3|Overall Study|Other|2
5278391|NCT00560573|18208827|P2|Overall Study|Other|2
5278392|NCT00560573|18208828|P1|Overall Study|Other|2
5278393|NCT00560573|18208823|P6|Overall Study|Withdrawal by Subject|0
5278394|NCT00560573|18208824|P5|Overall Study|Withdrawal by Subject|1
5278395|NCT00560573|18208825|P4|Overall Study|Withdrawal by Subject|1
5278396|NCT00560573|18208826|P3|Overall Study|Withdrawal by Subject|0
5278397|NCT00560573|18208827|P2|Overall Study|Withdrawal by Subject|0
5278398|NCT00560573|18208828|P1|Overall Study|Withdrawal by Subject|0
5278399|NCT00560573|18208823|P6|Overall Study|Lost to Follow-up|0
5278400|NCT00560573|18208824|P5|Overall Study|Lost to Follow-up|1
5278401|NCT00560573|18208825|P4|Overall Study|Lost to Follow-up|1
5278402|NCT00560573|18208826|P3|Overall Study|Lost to Follow-up|0
5278403|NCT00560573|18208827|P2|Overall Study|Lost to Follow-up|0
5278404|NCT00560573|18208828|P1|Overall Study|Lost to Follow-up|0
5278405|NCT00560573|18208823|P6|Overall Study|Death|10
5278406|NCT00560573|18208824|P5|Overall Study|Death|1
5278407|NCT00560573|18208825|P4|Overall Study|Death|5
5278408|NCT00560573|18208826|P3|Overall Study|Death|4
5278409|NCT00560573|18208827|P2|Overall Study|Death|1
5278410|NCT00560573|18208828|P1|Overall Study|Death|4
5278411|NCT00560508|18208905|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
5278412|NCT00560508|18208906|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
5278413|NCT00560508|18208905|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
5278414|NCT00560508|18208906|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
5278415|NCT00560508|18208905|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
5278416|NCT00560508|18208906|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
5278417|NCT00560508|18208905|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
5278418|NCT00560508|18208906|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
5278419|NCT00560508|18208905|P2|12 Week Double-blind Period|Withdrawal by Subject|1
5278420|NCT00560508|18208906|P1|12 Week Double-blind Period|Withdrawal by Subject|1
5278421|NCT00560508|18208905|P2|12 Week Double-blind Period|Protocol Violation|0
5278422|NCT00560508|18208906|P1|12 Week Double-blind Period|Protocol Violation|1
5278423|NCT00560508|18208905|P2|12 Week Double-blind Period|Adverse Event|2
5278424|NCT00560508|18208906|P1|12 Week Double-blind Period|Adverse Event|3
5278425|NCT00560417|18208965|P2|Overall Study|Withdrawal by Subject|3
5278426|NCT00560417|18208966|P1|Overall Study|Withdrawal by Subject|3
5278427|NCT00560417|18208965|P2|Overall Study|Sponsor Decision|0
5278428|NCT00560417|18208966|P1|Overall Study|Sponsor Decision|2
5278429|NCT00560417|18208965|P2|Overall Study|Protocol Violation|5
5278430|NCT00560417|18208966|P1|Overall Study|Protocol Violation|6
5278431|NCT00560417|18208965|P2|Overall Study|Physician Decision|6
5278432|NCT00560417|18208966|P1|Overall Study|Physician Decision|2
5278433|NCT00560417|18208965|P2|Overall Study|Lost to Follow-up|1
5278434|NCT00560417|18208966|P1|Overall Study|Lost to Follow-up|0
5278435|NCT00560417|18208965|P2|Overall Study|Entry Criteria Not Met|0
5278436|NCT00560417|18208966|P1|Overall Study|Entry Criteria Not Met|1
5278437|NCT00560417|18208965|P2|Overall Study|Adverse Event|2
5278438|NCT00560417|18208966|P1|Overall Study|Adverse Event|3
5278439|NCT00560404|18208994|P2|Overall Study|Other withdrawal reason|5
5278440|NCT00560404|18208995|P1|Overall Study|Other withdrawal reason|13
5278441|NCT00560404|18208994|P2|Overall Study|Failure to return|2
5278442|NCT00560404|18208995|P1|Overall Study|Failure to return|1
5278443|NCT00560404|18208994|P2|Overall Study|Withdrew Consent|0
5278444|NCT00560404|18208995|P1|Overall Study|Withdrew Consent|4
5278445|NCT00560404|18208994|P2|Overall Study|Administrative Reasons|1
5278446|NCT00560404|18208995|P1|Overall Study|Administrative Reasons|1
5278447|NCT00560404|18208994|P2|Overall Study|Protocol Violation|7
5278448|NCT00560404|18208995|P1|Overall Study|Protocol Violation|12
5278449|NCT00560404|18208994|P2|Overall Study|Death|3
5278450|NCT00560404|18208995|P1|Overall Study|Death|3
5278451|NCT00560404|18208994|P2|Overall Study|Adverse Event|3
5278452|NCT00560404|18208995|P1|Overall Study|Adverse Event|2
5278453|NCT00560391|18209042|P5|Overall Study|Still on treatment|2
5278454|NCT00560391|18209043|P4|Overall Study|Still on treatment|1
5278455|NCT00560391|18209044|P3|Overall Study|Still on treatment|0
5278456|NCT00560391|18209045|P2|Overall Study|Still on treatment|0
5278457|NCT00560391|18209046|P1|Overall Study|Still on treatment|0
5278458|NCT00560352|18209102|P3|Overall Study|Maximum clinical benefit|0
5278459|NCT00560352|18209103|P2|Overall Study|Maximum clinical benefit|0
5278460|NCT00560352|18209104|P1|Overall Study|Maximum clinical benefit|1
5278461|NCT00560352|18209102|P3|Overall Study|Withdrawal by Subject|1
5278462|NCT00560352|18209103|P2|Overall Study|Withdrawal by Subject|1
5278463|NCT00560352|18209104|P1|Overall Study|Withdrawal by Subject|1
5278464|NCT00560352|18209102|P3|Overall Study|Disease progression|1
5278465|NCT00560352|18209103|P2|Overall Study|Disease progression|1
5278466|NCT00560352|18209104|P1|Overall Study|Disease progression|0
5278467|NCT00560352|18209102|P3|Overall Study|Study drug toxicity|1
5278468|NCT00560352|18209103|P2|Overall Study|Study drug toxicity|0
5278469|NCT00560352|18209104|P1|Overall Study|Study drug toxicity|3
5278470|NCT00560352|18209102|P3|Overall Study|Adverse event unrelated to study drug|1
5278471|NCT00560352|18209103|P2|Overall Study|Adverse event unrelated to study drug|1
5278472|NCT00560352|18209104|P1|Overall Study|Adverse event unrelated to study drug|2
5278473|NCT00560313|18209121|P1|Overall Study|Protocol Violation|1
5278474|NCT00560313|18209121|P1|Overall Study|Lost to Follow-up|1
5278475|NCT00560313|18209121|P1|Overall Study|Withdrawal by Subject|2
5278476|NCT00560313|18209121|P1|Overall Study|Adverse Events or Death|2
5278477|NCT00560235|18209148|P3|Phase 2|Ongoing at Date of Cut-Off|1
5278478|NCT00560235|18209149|P2|Phase 2|Ongoing at Date of Cut-Off|0
5278479|NCT00560235|18209150|P1|Phase 2|Ongoing at Date of Cut-Off|0
5278480|NCT00560235|18209148|P3|Phase 2|Discontinued|96
5278481|NCT00560235|18209149|P2|Phase 2|Discontinued|0
5278482|NCT00560235|18209150|P1|Phase 2|Discontinued|0
5278483|NCT00560235|18209148|P3|Phase 1B|Discontinued|0
5278484|NCT00560235|18209149|P2|Phase 1B|Discontinued|19
5278485|NCT00560235|18209150|P1|Phase 1B|Discontinued|0
5278486|NCT00560235|18209148|P3|Phase 1|Discontinued|0
5278487|NCT00560235|18209149|P2|Phase 1|Discontinued|0
5278488|NCT00560235|18209150|P1|Phase 1|Discontinued|8
5278489|NCT00560105|18209181|P2|Overall Study|musculoskeletal chest discomfort with us|2
5278490|NCT00560105|18209182|P1|Overall Study|musculoskeletal chest discomfort with us|1
5278491|NCT00560066|18209196|P2|Overall Study|Missing primary reason|2
5278492|NCT00560066|18209197|P1|Overall Study|Missing primary reason|0
5278493|NCT00560066|18209196|P2|Overall Study|Administrative reason|5
5278494|NCT00560066|18209197|P1|Overall Study|Administrative reason|0
5278495|NCT00560066|18209196|P2|Overall Study|Protocol Violation|1
5278496|NCT00560066|18209197|P1|Overall Study|Protocol Violation|0
5278497|NCT00560066|18209196|P2|Overall Study|Lost to Follow-up|10
5278498|NCT00560066|18209197|P1|Overall Study|Lost to Follow-up|4
5278499|NCT00560066|18209196|P2|Overall Study|Withdrawal by Subject|3
5278500|NCT00560066|18209197|P1|Overall Study|Withdrawal by Subject|0
5278501|NCT00560066|18209196|P2|Overall Study|Death|1
5278502|NCT00560066|18209197|P1|Overall Study|Death|2
5278503|NCT00559988|18209229|P2|Overall Study|ICD device explanted|17
5278504|NCT00559988|18209230|P1|Overall Study|ICD device explanted|10
5278505|NCT00559988|18209229|P2|Overall Study|Lost to Follow-up|56
5278506|NCT00559988|18209230|P1|Overall Study|Lost to Follow-up|42
5278507|NCT00559988|18209229|P2|Overall Study|Withdrawal by Subject|139
5278508|NCT00559988|18209230|P1|Overall Study|Withdrawal by Subject|152
5278509|NCT00559988|18209229|P2|Overall Study|Death|140
5278510|NCT00559988|18209230|P1|Overall Study|Death|147
5278511|NCT00559962|18209260|P8|Overall Study|Inclusion/exclusion criteria not met|0
5278512|NCT00559962|18209261|P7|Overall Study|Inclusion/exclusion criteria not met|1
5278513|NCT00559962|18209262|P6|Overall Study|Inclusion/exclusion criteria not met|0
5278514|NCT00559962|18209263|P5|Overall Study|Inclusion/exclusion criteria not met|0
5278515|NCT00559962|18209264|P4|Overall Study|Inclusion/exclusion criteria not met|0
5278516|NCT00559962|18209265|P3|Overall Study|Inclusion/exclusion criteria not met|0
5278517|NCT00559962|18209266|P2|Overall Study|Inclusion/exclusion criteria not met|0
5278518|NCT00559962|18209267|P1|Overall Study|Inclusion/exclusion criteria not met|0
5278519|NCT00559962|18209260|P8|Overall Study|Withdrawal by Subject|2
5278520|NCT00559962|18209261|P7|Overall Study|Withdrawal by Subject|0
5278521|NCT00559962|18209262|P6|Overall Study|Withdrawal by Subject|1
5278522|NCT00559962|18209263|P5|Overall Study|Withdrawal by Subject|3
5278523|NCT00559962|18209264|P4|Overall Study|Withdrawal by Subject|0
5278524|NCT00559962|18209265|P3|Overall Study|Withdrawal by Subject|2
5278525|NCT00559962|18209266|P2|Overall Study|Withdrawal by Subject|1
5278526|NCT00559962|18209267|P1|Overall Study|Withdrawal by Subject|1
5278527|NCT00559962|18209260|P8|Overall Study|Lost to Follow-up|0
5278528|NCT00559962|18209261|P7|Overall Study|Lost to Follow-up|0
5278529|NCT00559962|18209262|P6|Overall Study|Lost to Follow-up|0
5278530|NCT00559962|18209263|P5|Overall Study|Lost to Follow-up|0
5278531|NCT00559962|18209264|P4|Overall Study|Lost to Follow-up|0
5278532|NCT00559962|18209265|P3|Overall Study|Lost to Follow-up|0
5278533|NCT00559962|18209266|P2|Overall Study|Lost to Follow-up|1
5278534|NCT00559962|18209267|P1|Overall Study|Lost to Follow-up|0
5278535|NCT00559962|18209260|P8|Overall Study|Adverse Event|2
5278536|NCT00559962|18209261|P7|Overall Study|Adverse Event|4
5278537|NCT00559962|18209262|P6|Overall Study|Adverse Event|4
5278538|NCT00559962|18209263|P5|Overall Study|Adverse Event|11
5278539|NCT00559962|18209264|P4|Overall Study|Adverse Event|5
5278540|NCT00559962|18209265|P3|Overall Study|Adverse Event|8
5278541|NCT00559962|18209266|P2|Overall Study|Adverse Event|7
5278542|NCT00559962|18209267|P1|Overall Study|Adverse Event|1
5278543|NCT00559949|18209287|P1|Overall Study|No disease evaluation per protocol|1
5278544|NCT00559949|18209287|P1|Overall Study|Withdrawal by Subject|4
5278545|NCT00559949|18209287|P1|Overall Study|Adverse Event|1
5278546|NCT00559949|18209287|P1|Overall Study|Progressive Disease during cycle 1|1
5278547|NCT00559845|18209303|P1|Overall Study|Premature Surgery-Investigator Decision|1
5278548|NCT00559845|18209303|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
5278549|NCT00559845|18209303|P1|Overall Study|Adverse Event|3
5278550|NCT00559845|18209303|P1|Overall Study|Disease Progression|1
5278551|NCT00559845|18209303|P1|Overall Study|Withdrew Consent|1
5278552|NCT00559754|18209312|P1|Overall Study|Withdrawal by Subject|2
5278553|NCT00559754|18209312|P1|Overall Study|Investigator criteria|2
5278554|NCT00559754|18209312|P1|Overall Study|Protocol Violation|1
5278555|NCT00559754|18209312|P1|Overall Study|Adverse Event|5
5278556|NCT00559754|18209312|P1|Overall Study|Disease progression|1
5278557|NCT00559637|18209336|P1|Overall Study|Inclusion or exclusion criteria violated|2
5278558|NCT00559637|18209336|P1|Overall Study|Change of home|1
5278559|NCT00559637|18209336|P1|Overall Study|Change of center|1
5278560|NCT00559637|18209336|P1|Overall Study|Delayed administration of C.E.R.A|1
5278561|NCT00559637|18209336|P1|Overall Study|Participation in another study|1
5278562|NCT00559637|18209336|P1|Overall Study|Suspected lung cancer|1
5278563|NCT00559637|18209336|P1|Overall Study|Started requiring dialysis after month 7|2
5278564|NCT00559637|18209336|P1|Overall Study|Insufficient response|3
5278565|NCT00559637|18209336|P1|Overall Study|Failure to return|6
5278566|NCT00559637|18209336|P1|Overall Study|Withdrawal criteria fulfilled|4
5278567|NCT00559637|18209336|P1|Overall Study|Protocol Violation|6
5278568|NCT00559637|18209336|P1|Overall Study|Withdrawal by Subject|4
5278569|NCT00559637|18209336|P1|Overall Study|Adverse Event|22
5278570|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
5278571|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
5278572|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|non-specified|0
5278573|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|non-specified|71
5278574|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
5278575|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
5278576|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
5278577|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
5278578|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
5278579|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
5278580|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Death|0
5278581|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Death|20
5278582|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
5278583|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
5278584|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
5278585|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
5278586|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
5278587|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
5278588|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
5278589|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
5278590|NCT00559585|18209349|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
5278591|NCT00559585|18209350|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
5278592|NCT00559585|18209349|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
5278593|NCT00559585|18209350|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
5278594|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
5278595|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
5278596|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Investigator Decision|1
5278597|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Investigator Decision|0
5278598|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
5278599|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
5278600|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
5278601|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
5278602|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Early Discontinuation|1
5278603|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Early Discontinuation|0
5278604|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
5278605|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
5278606|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
5278607|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
5278608|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Missed Doses|1
5278609|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Missed Doses|0
5278610|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
5278611|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
5278612|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
5278613|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
5278614|NCT00559585|18209349|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
5278615|NCT00559585|18209350|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
5278616|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Death|1
5278617|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Death|1
5278618|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
5278619|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
5278620|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
5278621|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
5278622|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
5278623|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
5278624|NCT00559585|18209349|P2|Double Blind ST Period Main Study|Adverse Event|25
5278625|NCT00559585|18209350|P1|Double Blind ST Period Main Study|Adverse Event|17
5278626|NCT00559507|18209410|P1|Overall Study|Not treated, patient ineligible|3
5278627|NCT00559377|18209429|P1|Overall Study|Withdrawal by Subject|9
5278628|NCT00559364|18209439|P2|Overall Study|Inclusion/exclusion criteria failure|0
5278629|NCT00559364|18209440|P1|Overall Study|Inclusion/exclusion criteria failure|1
5278630|NCT00559273|18209452|P2|Evaluation Period (8 Weeks)|Physician Decision|1
5278631|NCT00559273|18209453|P1|Evaluation Period (8 Weeks)|Physician Decision|0
5278632|NCT00559273|18209452|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
5278633|NCT00559273|18209453|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
5278634|NCT00559273|18209452|P2|Evaluation Period (8 Weeks)|Adverse Event|1
5278635|NCT00559273|18209453|P1|Evaluation Period (8 Weeks)|Adverse Event|0
5278636|NCT00559273|18209452|P2|Evaluation Period (8 Weeks)|Death|3
5278637|NCT00559273|18209453|P1|Evaluation Period (8 Weeks)|Death|1
5278638|NCT00559273|18209452|P2|Correction Period (20 Weeks)|Did not received study treatment|0
5278639|NCT00559273|18209453|P1|Correction Period (20 Weeks)|Did not received study treatment|2
5278640|NCT00559273|18209452|P2|Correction Period (20 Weeks)|Participant treated by another center|1
5278641|NCT00559273|18209453|P1|Correction Period (20 Weeks)|Participant treated by another center|0
5278642|NCT00559273|18209452|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
5278643|NCT00559273|18209453|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
5278644|NCT00559273|18209452|P2|Correction Period (20 Weeks)|Adverse Event|1
5278645|NCT00559273|18209453|P1|Correction Period (20 Weeks)|Adverse Event|2
5278646|NCT00559273|18209452|P2|Correction Period (20 Weeks)|Death|4
5278647|NCT00559273|18209453|P1|Correction Period (20 Weeks)|Death|3
5278648|NCT00559104|18209475|P2|Overall Study|Lack of Efficacy|0
5278649|NCT00559104|18209476|P1|Overall Study|Lack of Efficacy|9
5278650|NCT00558896|18209497|P7|Overall Study|Continues on treatment|6
5278651|NCT00558896|18209498|P6|Overall Study|Continues on treatment|25
5278652|NCT00558896|18209499|P5|Overall Study|Continues on treatment|9
5278653|NCT00558896|18209500|P4|Overall Study|Continues on treatment|1
5278654|NCT00558896|18209501|P3|Overall Study|Continues on treatment|0
5278655|NCT00558896|18209502|P2|Overall Study|Continues on treatment|1
5278656|NCT00558896|18209503|P1|Overall Study|Continues on treatment|10
5278657|NCT00558896|18209497|P7|Overall Study|Physician discretion|3
5278658|NCT00558896|18209498|P6|Overall Study|Physician discretion|3
5278659|NCT00558896|18209499|P5|Overall Study|Physician discretion|1
5278660|NCT00558896|18209500|P4|Overall Study|Physician discretion|2
5278661|NCT00558896|18209501|P3|Overall Study|Physician discretion|1
5278662|NCT00558896|18209502|P2|Overall Study|Physician discretion|2
5278663|NCT00558896|18209503|P1|Overall Study|Physician discretion|3
5278664|NCT00558896|18209497|P7|Overall Study|Alternative Treatment|1
5278665|NCT00558896|18209498|P6|Overall Study|Alternative Treatment|7
5278666|NCT00558896|18209499|P5|Overall Study|Alternative Treatment|6
5278667|NCT00558896|18209500|P4|Overall Study|Alternative Treatment|2
5278668|NCT00558896|18209501|P3|Overall Study|Alternative Treatment|0
5278669|NCT00558896|18209502|P2|Overall Study|Alternative Treatment|2
5278670|NCT00558896|18209503|P1|Overall Study|Alternative Treatment|2
5278671|NCT00558896|18209497|P7|Overall Study|Withdrawal by Subject|5
5278672|NCT00558896|18209498|P6|Overall Study|Withdrawal by Subject|5
5278673|NCT00558896|18209499|P5|Overall Study|Withdrawal by Subject|1
5278674|NCT00558896|18209500|P4|Overall Study|Withdrawal by Subject|1
5278675|NCT00558896|18209501|P3|Overall Study|Withdrawal by Subject|1
5278676|NCT00558896|18209502|P2|Overall Study|Withdrawal by Subject|1
5278677|NCT00558896|18209503|P1|Overall Study|Withdrawal by Subject|2
5278678|NCT00558896|18209497|P7|Overall Study|Death|6
5278679|NCT00558896|18209498|P6|Overall Study|Death|2
5278680|NCT00558896|18209499|P5|Overall Study|Death|2
5278681|NCT00558896|18209500|P4|Overall Study|Death|3
5278682|NCT00558896|18209501|P3|Overall Study|Death|2
5278683|NCT00558896|18209502|P2|Overall Study|Death|0
5278684|NCT00558896|18209503|P1|Overall Study|Death|3
5278685|NCT00558896|18209497|P7|Overall Study|Adverse Event|3
5278686|NCT00558896|18209498|P6|Overall Study|Adverse Event|10
5278687|NCT00558896|18209499|P5|Overall Study|Adverse Event|4
5278688|NCT00558896|18209500|P4|Overall Study|Adverse Event|3
5278689|NCT00558896|18209501|P3|Overall Study|Adverse Event|1
5278690|NCT00558896|18209502|P2|Overall Study|Adverse Event|1
5278691|NCT00558896|18209503|P1|Overall Study|Adverse Event|1
5278692|NCT00558831|18209605|P1|Overall Study|Lost to Follow-up|1
5278693|NCT00558753|18209662|P2|Overall Study|Lost to Follow-up|7
5278694|NCT00558753|18209663|P1|Overall Study|Lost to Follow-up|5
5278695|NCT00558701|18209675|P2|Overall Study|Protocol Deviations|4
5278696|NCT00558701|18209676|P1|Overall Study|Protocol Deviations|1
5278697|NCT00558636|18209684|P2|Follow-up|Premature termination of the study|7
5278698|NCT00558636|18209685|P1|Follow-up|Premature termination of the study|12
5278699|NCT00558636|18209684|P2|Treatment|Disease progression|5
5278700|NCT00558636|18209685|P1|Treatment|Disease progression|1
5278701|NCT00558636|18209684|P2|Treatment|Premature termination of the study|37
5278702|NCT00558636|18209685|P1|Treatment|Premature termination of the study|35
5278703|NCT00558636|18209684|P2|Treatment|Withdrawal by Subject|0
5278704|NCT00558636|18209685|P1|Treatment|Withdrawal by Subject|2
5278705|NCT00558636|18209684|P2|Treatment|Adverse Event|2
5278706|NCT00558636|18209685|P1|Treatment|Adverse Event|9
5278707|NCT00558558|18209785|P1|Overall Study|Lack of Efficacy|4
5278708|NCT00558558|18209785|P1|Overall Study|Withdrawal by Subject|1
5278709|NCT00558558|18209785|P1|Overall Study|Unable to swallow|1
5278710|NCT00558519|18209789|P1|Overall Study|Never received treatment|1
5278711|NCT00558519|18209789|P1|Overall Study|Insufficient data|1
5278712|NCT00558519|18209789|P1|Overall Study|Ineligible|1
5278713|NCT00558519|18209789|P1|Overall Study|Ph+|20
5278714|NCT00558467|18209799|P2|Overall Study|Patient moving out of state|1
5278715|NCT00558467|18209800|P1|Overall Study|Patient moving out of state|0
5278716|NCT00558467|18209799|P2|Overall Study|Lack of Efficacy|1
5278717|NCT00558467|18209800|P1|Overall Study|Lack of Efficacy|0
5278718|NCT00558467|18209799|P2|Overall Study|Adverse Event|2
5278719|NCT00558467|18209800|P1|Overall Study|Adverse Event|1
5278720|NCT00558428|18209860|P4|Overall Study|Other|1
5278721|NCT00558428|18209861|P3|Overall Study|Other|0
5278722|NCT00558428|18209862|P2|Overall Study|Other|0
5278723|NCT00558428|18209863|P1|Overall Study|Other|3
5278724|NCT00558428|18209860|P4|Overall Study|Consent withdrawn|1
5278725|NCT00558428|18209861|P3|Overall Study|Consent withdrawn|0
5278726|NCT00558428|18209862|P2|Overall Study|Consent withdrawn|1
5278727|NCT00558428|18209863|P1|Overall Study|Consent withdrawn|2
5278728|NCT00558428|18209860|P4|Overall Study|Non compliant with protocol|3
5278729|NCT00558428|18209861|P3|Overall Study|Non compliant with protocol|0
5278730|NCT00558428|18209862|P2|Overall Study|Non compliant with protocol|0
5278731|NCT00558428|18209863|P1|Overall Study|Non compliant with protocol|1
5278732|NCT00558428|18209860|P4|Overall Study|Lack of Efficacy|2
5278733|NCT00558428|18209861|P3|Overall Study|Lack of Efficacy|1
5278734|NCT00558428|18209862|P2|Overall Study|Lack of Efficacy|0
5278735|NCT00558428|18209863|P1|Overall Study|Lack of Efficacy|0
5278736|NCT00558428|18209860|P4|Overall Study|Lost to Follow-up|0
5278737|NCT00558428|18209861|P3|Overall Study|Lost to Follow-up|0
5278738|NCT00558428|18209862|P2|Overall Study|Lost to Follow-up|1
5278739|NCT00558428|18209863|P1|Overall Study|Lost to Follow-up|0
5278740|NCT00558428|18209860|P4|Overall Study|Adverse Event|4
5278741|NCT00558428|18209861|P3|Overall Study|Adverse Event|3
5278742|NCT00558428|18209862|P2|Overall Study|Adverse Event|22
5278743|NCT00558428|18209863|P1|Overall Study|Adverse Event|6
5278744|NCT00558363|18209903|P2|Overall Study|Hospitalized; Unable to Continue|1
5278745|NCT00558363|18209904|P1|Overall Study|Hospitalized; Unable to Continue|0
5278746|NCT00558363|18209903|P2|Overall Study|Randomized in Error|2
5278747|NCT00558363|18209904|P1|Overall Study|Randomized in Error|1
5278748|NCT00558363|18209903|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
5278749|NCT00558363|18209904|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
5278750|NCT00558363|18209903|P2|Overall Study|Lost to Follow-up|1
5278751|NCT00558363|18209904|P1|Overall Study|Lost to Follow-up|0
5278752|NCT00558363|18209903|P2|Overall Study|Protocol Violation|1
5278753|NCT00558363|18209904|P1|Overall Study|Protocol Violation|2
5278754|NCT00558363|18209903|P2|Overall Study|Lack of Efficacy|2
5278755|NCT00558363|18209904|P1|Overall Study|Lack of Efficacy|2
5278756|NCT00558363|18209903|P2|Overall Study|Adverse Event|5
5278757|NCT00558363|18209904|P1|Overall Study|Adverse Event|5
5278758|NCT00558363|18209903|P2|Overall Study|Withdrawal by Subject|4
5278759|NCT00558363|18209904|P1|Overall Study|Withdrawal by Subject|11
5278760|NCT00558363|18209903|P2|Overall Study|Physician Decision|4
5278761|NCT00558363|18209904|P1|Overall Study|Physician Decision|18
5278762|NCT00558285|18209959|P5|Overall Study|Protocol deviation|0
5278763|NCT00558285|18209960|P4|Overall Study|Protocol deviation|1
5278764|NCT00558285|18209961|P3|Overall Study|Protocol deviation|0
5278765|NCT00558285|18209962|P2|Overall Study|Protocol deviation|1
5278766|NCT00558285|18209963|P1|Overall Study|Protocol deviation|1
5278767|NCT00558285|18209959|P5|Overall Study|Administrative problems|1
5278768|NCT00558285|18209960|P4|Overall Study|Administrative problems|1
5278769|NCT00558285|18209961|P3|Overall Study|Administrative problems|0
5278770|NCT00558285|18209962|P2|Overall Study|Administrative problems|0
5278771|NCT00558285|18209963|P1|Overall Study|Administrative problems|0
5278772|NCT00558285|18209959|P5|Overall Study|Lost to Follow-up|0
5278773|NCT00558285|18209960|P4|Overall Study|Lost to Follow-up|0
5278774|NCT00558285|18209961|P3|Overall Study|Lost to Follow-up|0
5278775|NCT00558285|18209962|P2|Overall Study|Lost to Follow-up|1
5278776|NCT00558285|18209963|P1|Overall Study|Lost to Follow-up|1
5278777|NCT00558285|18209959|P5|Overall Study|Subject withdrew consent|1
5278778|NCT00558285|18209960|P4|Overall Study|Subject withdrew consent|1
5278779|NCT00558285|18209961|P3|Overall Study|Subject withdrew consent|1
5278780|NCT00558285|18209962|P2|Overall Study|Subject withdrew consent|0
5278781|NCT00558285|18209963|P1|Overall Study|Subject withdrew consent|2
5278782|NCT00558285|18209959|P5|Overall Study|Abnormal test procedure result(s)|0
5278783|NCT00558285|18209960|P4|Overall Study|Abnormal test procedure result(s)|0
5278784|NCT00558285|18209961|P3|Overall Study|Abnormal test procedure result(s)|0
5278785|NCT00558285|18209962|P2|Overall Study|Abnormal test procedure result(s)|0
5278786|NCT00558285|18209963|P1|Overall Study|Abnormal test procedure result(s)|1
5278787|NCT00558285|18209959|P5|Overall Study|Adverse Event|2
5278788|NCT00558285|18209960|P4|Overall Study|Adverse Event|1
5278789|NCT00558285|18209961|P3|Overall Study|Adverse Event|4
5278790|NCT00558285|18209962|P2|Overall Study|Adverse Event|1
5278791|NCT00558285|18209963|P1|Overall Study|Adverse Event|1
5278792|NCT00558272|18210007|P2|Overall Study|Withdrawal by Subject|1
5278793|NCT00558272|18210008|P1|Overall Study|Withdrawal by Subject|0
5278794|NCT00558272|18210007|P2|Overall Study|Incorrectly enrolled|0
5278795|NCT00558272|18210008|P1|Overall Study|Incorrectly enrolled|1
5278796|NCT00558272|18210007|P2|Overall Study|AZ study team decision|1
5278797|NCT00558272|18210008|P1|Overall Study|AZ study team decision|0
5278798|NCT00558272|18210007|P2|Overall Study|Dev. of study specific discon. criteria|0
5278799|NCT00558272|18210008|P1|Overall Study|Dev. of study specific discon. criteria|1
5278800|NCT00558272|18210007|P2|Overall Study|Death|0
5278801|NCT00558272|18210008|P1|Overall Study|Death|1
5278802|NCT00558272|18210007|P2|Overall Study|Adverse Event|0
5278803|NCT00558272|18210008|P1|Overall Study|Adverse Event|10
5278804|NCT00558259|18210048|P2|Overall Study|Withdrawal by Subject|13
5278805|NCT00558259|18210049|P1|Overall Study|Withdrawal by Subject|12
5278806|NCT00558259|18210048|P2|Overall Study|Protocol Violation|5
5278807|NCT00558259|18210049|P1|Overall Study|Protocol Violation|9
5278808|NCT00558259|18210048|P2|Overall Study|Adverse Event|81
5278809|NCT00558259|18210049|P1|Overall Study|Adverse Event|50
5278810|NCT00558103|18210089|P6|Monotherapy Extension Phase|Disease Progression|8
5278811|NCT00558103|18210090|P5|Monotherapy Extension Phase|Disease Progression|0
5278812|NCT00558103|18210091|P4|Monotherapy Extension Phase|Disease Progression|0
5278813|NCT00558103|18210092|P3|Monotherapy Extension Phase|Disease Progression|0
5278814|NCT00558103|18210093|P2|Monotherapy Extension Phase|Disease Progression|0
5278815|NCT00558103|18210094|P1|Monotherapy Extension Phase|Disease Progression|0
5278816|NCT00558103|18210089|P6|Monotherapy Extension Phase|Protocol Violation|1
5278817|NCT00558103|18210090|P5|Monotherapy Extension Phase|Protocol Violation|0
5278818|NCT00558103|18210091|P4|Monotherapy Extension Phase|Protocol Violation|0
5278819|NCT00558103|18210092|P3|Monotherapy Extension Phase|Protocol Violation|0
5278820|NCT00558103|18210093|P2|Monotherapy Extension Phase|Protocol Violation|0
5278821|NCT00558103|18210094|P1|Monotherapy Extension Phase|Protocol Violation|0
5278822|NCT00558103|18210089|P6|Randomized Treatment Phase|Adverse Event|0
5278823|NCT00558103|18210090|P5|Randomized Treatment Phase|Adverse Event|1
5278824|NCT00558103|18210091|P4|Randomized Treatment Phase|Adverse Event|1
5278825|NCT00558103|18210092|P3|Randomized Treatment Phase|Adverse Event|0
5278826|NCT00558103|18210093|P2|Randomized Treatment Phase|Adverse Event|0
5278827|NCT00558103|18210094|P1|Randomized Treatment Phase|Adverse Event|0
5278828|NCT00558103|18210089|P6|Randomized Treatment Phase|Disease Progression|0
5278829|NCT00558103|18210090|P5|Randomized Treatment Phase|Disease Progression|0
5278830|NCT00558103|18210091|P4|Randomized Treatment Phase|Disease Progression|0
5278831|NCT00558103|18210092|P3|Randomized Treatment Phase|Disease Progression|1
5278832|NCT00558103|18210093|P2|Randomized Treatment Phase|Disease Progression|0
5278833|NCT00558103|18210094|P1|Randomized Treatment Phase|Disease Progression|1
5278834|NCT00558103|18210089|P6|Randomized Treatment Phase|Withdrawal by Subject|0
5278835|NCT00558103|18210090|P5|Randomized Treatment Phase|Withdrawal by Subject|1
5278836|NCT00558103|18210091|P4|Randomized Treatment Phase|Withdrawal by Subject|0
5278837|NCT00558103|18210092|P3|Randomized Treatment Phase|Withdrawal by Subject|0
5278838|NCT00558103|18210093|P2|Randomized Treatment Phase|Withdrawal by Subject|2
5278839|NCT00558103|18210094|P1|Randomized Treatment Phase|Withdrawal by Subject|2
5278840|NCT00558103|18210089|P6|Randomized Treatment Phase|Lost to Follow-up|0
5278841|NCT00558103|18210090|P5|Randomized Treatment Phase|Lost to Follow-up|3
5278842|NCT00558103|18210091|P4|Randomized Treatment Phase|Lost to Follow-up|1
5278843|NCT00558103|18210092|P3|Randomized Treatment Phase|Lost to Follow-up|2
5278844|NCT00558103|18210093|P2|Randomized Treatment Phase|Lost to Follow-up|2
5278845|NCT00558103|18210094|P1|Randomized Treatment Phase|Lost to Follow-up|2
5278846|NCT00558064|18210124|P2|Overall Study|No visit within allowance period|0
5278847|NCT00558064|18210125|P1|Overall Study|No visit within allowance period|1
5278848|NCT00558064|18210124|P2|Overall Study|Withdrawal by Subject|1
5278849|NCT00558064|18210125|P1|Overall Study|Withdrawal by Subject|0
5278850|NCT00558064|18210124|P2|Overall Study|Lost to Follow-up|1
5278851|NCT00558064|18210125|P1|Overall Study|Lost to Follow-up|0
5278852|NCT00558064|18210124|P2|Overall Study|Protocol Violation|0
5278853|NCT00558064|18210125|P1|Overall Study|Protocol Violation|1
5278854|NCT00558064|18210124|P2|Overall Study|Lack of Efficacy|1
5278855|NCT00558064|18210125|P1|Overall Study|Lack of Efficacy|0
5278856|NCT00558064|18210124|P2|Overall Study|Adverse Event|2
5278857|NCT00558064|18210125|P1|Overall Study|Adverse Event|3
5278858|NCT00558025|18210147|P2|Overall Study|Protocol Violation|0
5278859|NCT00558025|18210148|P1|Overall Study|Protocol Violation|1
5278860|NCT00558025|18210147|P2|Overall Study|Withdrawal by Subject|2
5278861|NCT00558025|18210148|P1|Overall Study|Withdrawal by Subject|2
5278862|NCT00558025|18210147|P2|Overall Study|Adverse Event|1
5278863|NCT00558025|18210148|P1|Overall Study|Adverse Event|1
5278864|NCT00557856|18210204|P9|Part 2: Exploratory Phase|global deterioration of health status|1
5278865|NCT00557856|18210205|P8|Part 2: Exploratory Phase|global deterioration of health status|0
5278866|NCT00557856|18210206|P7|Part 2: Exploratory Phase|global deterioration of health status|0
5278867|NCT00557856|18210207|P6|Part 2: Exploratory Phase|global deterioration of health status|0
5278868|NCT00557856|18210208|P5|Part 2: Exploratory Phase|global deterioration of health status|0
5278869|NCT00557856|18210209|P4|Part 2: Exploratory Phase|global deterioration of health status|0
5278870|NCT00557856|18210210|P3|Part 2: Exploratory Phase|global deterioration of health status|0
5278871|NCT00557856|18210211|P2|Part 2: Exploratory Phase|global deterioration of health status|0
5278872|NCT00557856|18210212|P1|Part 2: Exploratory Phase|global deterioration of health status|0
5278873|NCT00557856|18210204|P9|Part 2: Exploratory Phase|Death|2
5278874|NCT00557856|18210205|P8|Part 2: Exploratory Phase|Death|0
5278875|NCT00557856|18210206|P7|Part 2: Exploratory Phase|Death|0
5278876|NCT00557856|18210207|P6|Part 2: Exploratory Phase|Death|0
5278877|NCT00557856|18210208|P5|Part 2: Exploratory Phase|Death|0
5278878|NCT00557856|18210209|P4|Part 2: Exploratory Phase|Death|0
5278879|NCT00557856|18210210|P3|Part 2: Exploratory Phase|Death|0
5278880|NCT00557856|18210211|P2|Part 2: Exploratory Phase|Death|0
5278881|NCT00557856|18210212|P1|Part 2: Exploratory Phase|Death|0
5278882|NCT00557856|18210204|P9|Part 2: Exploratory Phase|Other|1
5278883|NCT00557856|18210205|P8|Part 2: Exploratory Phase|Other|0
5278884|NCT00557856|18210206|P7|Part 2: Exploratory Phase|Other|0
5278885|NCT00557856|18210207|P6|Part 2: Exploratory Phase|Other|0
5278886|NCT00557856|18210208|P5|Part 2: Exploratory Phase|Other|0
5278887|NCT00557856|18210209|P4|Part 2: Exploratory Phase|Other|0
5278888|NCT00557856|18210210|P3|Part 2: Exploratory Phase|Other|0
5278889|NCT00557856|18210211|P2|Part 2: Exploratory Phase|Other|0
5278890|NCT00557856|18210212|P1|Part 2: Exploratory Phase|Other|0
5278891|NCT00557856|18210204|P9|Part 2: Exploratory Phase|Adverse Event|4
5278892|NCT00557856|18210205|P8|Part 2: Exploratory Phase|Adverse Event|0
5278893|NCT00557856|18210206|P7|Part 2: Exploratory Phase|Adverse Event|0
5278894|NCT00557856|18210207|P6|Part 2: Exploratory Phase|Adverse Event|0
5278895|NCT00557856|18210208|P5|Part 2: Exploratory Phase|Adverse Event|0
5278896|NCT00557856|18210209|P4|Part 2: Exploratory Phase|Adverse Event|0
5278897|NCT00557856|18210210|P3|Part 2: Exploratory Phase|Adverse Event|0
5278898|NCT00557856|18210211|P2|Part 2: Exploratory Phase|Adverse Event|0
5278899|NCT00557856|18210212|P1|Part 2: Exploratory Phase|Adverse Event|0
5278900|NCT00557856|18210204|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
5278901|NCT00557856|18210205|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278902|NCT00557856|18210206|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278903|NCT00557856|18210207|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278904|NCT00557856|18210208|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278905|NCT00557856|18210209|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278906|NCT00557856|18210210|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278907|NCT00557856|18210211|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278908|NCT00557856|18210212|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
5278909|NCT00557856|18210204|P9|Part 2: Exploratory Phase|objective progression or relapse|15
5278910|NCT00557856|18210205|P8|Part 2: Exploratory Phase|objective progression or relapse|0
5278911|NCT00557856|18210206|P7|Part 2: Exploratory Phase|objective progression or relapse|0
5278912|NCT00557856|18210207|P6|Part 2: Exploratory Phase|objective progression or relapse|0
5278913|NCT00557856|18210208|P5|Part 2: Exploratory Phase|objective progression or relapse|0
5278914|NCT00557856|18210209|P4|Part 2: Exploratory Phase|objective progression or relapse|0
5278915|NCT00557856|18210210|P3|Part 2: Exploratory Phase|objective progression or relapse|0
5278916|NCT00557856|18210211|P2|Part 2: Exploratory Phase|objective progression or relapse|0
5278917|NCT00557856|18210212|P1|Part 2: Exploratory Phase|objective progression or relapse|0
5278918|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
5278919|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
5278920|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
5278921|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
5278922|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
5278923|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
5278924|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
5278925|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
5278926|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
5278927|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278928|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278929|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
5278930|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
5278931|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278932|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278933|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278934|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278935|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
5278936|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|Death|0
5278937|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|Death|0
5278938|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|Death|0
5278939|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|Death|1
5278940|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|Death|0
5278941|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|Death|0
5278942|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|Death|0
5278943|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|Death|0
5278944|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|Death|0
5278945|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|Other|0
5278946|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|Other|1
5278947|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|Other|0
5278948|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|Other|0
5278949|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|Other|0
5278950|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|Other|1
5278951|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|Other|1
5278952|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|Other|0
5278953|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|Other|0
5278954|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|Adverse Event|0
5278955|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|Adverse Event|2
5278956|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|Adverse Event|1
5278957|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|Adverse Event|3
5278958|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|Adverse Event|1
5278959|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|Adverse Event|1
5278960|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|Adverse Event|1
5278961|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|Adverse Event|0
5278962|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|Adverse Event|1
5278963|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278964|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278965|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278966|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278967|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278968|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278969|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
5278970|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5278971|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
5278972|NCT00557856|18210204|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
5278973|NCT00557856|18210205|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
5278974|NCT00557856|18210206|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
5278975|NCT00557856|18210207|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
5278976|NCT00557856|18210208|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
5278977|NCT00557856|18210209|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
5278978|NCT00557856|18210210|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
5278979|NCT00557856|18210211|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
5278980|NCT00557856|18210212|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
5278981|NCT00557830|18210411|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
5278982|NCT00557830|18210412|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
5278983|NCT00557830|18210413|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
5278984|NCT00557830|18210411|P3|Screening Treatment Phase|Adverse Event|0
5278985|NCT00557830|18210412|P2|Screening Treatment Phase|Adverse Event|0
5278986|NCT00557830|18210413|P1|Screening Treatment Phase|Adverse Event|2
5278987|NCT00557830|18210411|P3|Screening Treatment Phase|Withdrawal by Subject|0
5278988|NCT00557830|18210412|P2|Screening Treatment Phase|Withdrawal by Subject|0
5278989|NCT00557830|18210413|P1|Screening Treatment Phase|Withdrawal by Subject|1
5278990|NCT00557622|18210435|P2|12-Week Treatment Phase|Lost to Follow-up|1
5278991|NCT00557622|18210436|P1|12-Week Treatment Phase|Lost to Follow-up|0
5278992|NCT00557622|18210435|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
5278993|NCT00557622|18210436|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
5278994|NCT00557622|18210435|P2|4-Week Run-in Phase|Withdrawal by Subject|0
5278995|NCT00557622|18210436|P1|4-Week Run-in Phase|Withdrawal by Subject|1
5278996|NCT00557505|18210465|P9|Overall Study|Withdrawal by Subject|1
5278997|NCT00557505|18210466|P8|Overall Study|Withdrawal by Subject|0
5278998|NCT00557505|18210467|P7|Overall Study|Withdrawal by Subject|0
5278999|NCT00557505|18210468|P6|Overall Study|Withdrawal by Subject|0
5279000|NCT00557505|18210469|P5|Overall Study|Withdrawal by Subject|0
5279001|NCT00557505|18210470|P4|Overall Study|Withdrawal by Subject|1
5279002|NCT00557505|18210471|P3|Overall Study|Withdrawal by Subject|0
5279003|NCT00557505|18210472|P2|Overall Study|Withdrawal by Subject|0
5279004|NCT00557505|18210473|P1|Overall Study|Withdrawal by Subject|0
5279005|NCT00557505|18210465|P9|Overall Study|Objective progression or relapse|15
5279006|NCT00557505|18210466|P8|Overall Study|Objective progression or relapse|5
5279007|NCT00557505|18210467|P7|Overall Study|Objective progression or relapse|2
5279008|NCT00557505|18210468|P6|Overall Study|Objective progression or relapse|3
5279009|NCT00557505|18210469|P5|Overall Study|Objective progression or relapse|2
5279010|NCT00557505|18210470|P4|Overall Study|Objective progression or relapse|2
5279011|NCT00557505|18210471|P3|Overall Study|Objective progression or relapse|3
5279012|NCT00557505|18210472|P2|Overall Study|Objective progression or relapse|3
5279013|NCT00557505|18210473|P1|Overall Study|Objective progression or relapse|2
5279014|NCT00557505|18210465|P9|Overall Study|Global deterioration of health|0
5279015|NCT00557505|18210466|P8|Overall Study|Global deterioration of health|0
5279016|NCT00557505|18210467|P7|Overall Study|Global deterioration of health|0
5279017|NCT00557505|18210468|P6|Overall Study|Global deterioration of health|0
5279018|NCT00557505|18210469|P5|Overall Study|Global deterioration of health|0
5279019|NCT00557505|18210470|P4|Overall Study|Global deterioration of health|0
5279020|NCT00557505|18210471|P3|Overall Study|Global deterioration of health|0
5279021|NCT00557505|18210472|P2|Overall Study|Global deterioration of health|0
5279022|NCT00557505|18210473|P1|Overall Study|Global deterioration of health|1
5279023|NCT00557505|18210465|P9|Overall Study|Adverse Event|0
5279024|NCT00557505|18210466|P8|Overall Study|Adverse Event|0
5279025|NCT00557505|18210467|P7|Overall Study|Adverse Event|1
5279026|NCT00557505|18210468|P6|Overall Study|Adverse Event|0
5279027|NCT00557505|18210469|P5|Overall Study|Adverse Event|0
5279028|NCT00557505|18210470|P4|Overall Study|Adverse Event|0
5279029|NCT00557505|18210471|P3|Overall Study|Adverse Event|1
5279030|NCT00557505|18210472|P2|Overall Study|Adverse Event|0
5279031|NCT00557505|18210473|P1|Overall Study|Adverse Event|0
5279032|NCT00557505|18210465|P9|Overall Study|Death|1
5279033|NCT00557505|18210466|P8|Overall Study|Death|0
5279034|NCT00557505|18210467|P7|Overall Study|Death|0
5279035|NCT00557505|18210468|P6|Overall Study|Death|0
5279036|NCT00557505|18210469|P5|Overall Study|Death|0
5279037|NCT00557505|18210470|P4|Overall Study|Death|0
5279038|NCT00557505|18210471|P3|Overall Study|Death|0
5279039|NCT00557505|18210472|P2|Overall Study|Death|0
5279040|NCT00557505|18210473|P1|Overall Study|Death|0
5279041|NCT00557492|18210637|P1|Overall Study|Change in health insurance|1
5279042|NCT00557466|18210655|P6|Overall Study|Lost to Follow-up|0
5279043|NCT00557466|18210656|P5|Overall Study|Lost to Follow-up|0
5279044|NCT00557466|18210657|P4|Overall Study|Lost to Follow-up|1
5279045|NCT00557466|18210658|P3|Overall Study|Lost to Follow-up|0
5279046|NCT00557466|18210659|P2|Overall Study|Lost to Follow-up|0
5279047|NCT00557466|18210660|P1|Overall Study|Lost to Follow-up|0
5279048|NCT00557466|18210655|P6|Overall Study|Abnormal test procedure results|0
5279049|NCT00557466|18210656|P5|Overall Study|Abnormal test procedure results|0
5279050|NCT00557466|18210657|P4|Overall Study|Abnormal test procedure results|0
5279051|NCT00557466|18210658|P3|Overall Study|Abnormal test procedure results|1
5279052|NCT00557466|18210659|P2|Overall Study|Abnormal test procedure results|0
5279053|NCT00557466|18210660|P1|Overall Study|Abnormal test procedure results|0
5279054|NCT00557466|18210655|P6|Overall Study|Administrative problems|0
5279055|NCT00557466|18210656|P5|Overall Study|Administrative problems|0
5279056|NCT00557466|18210657|P4|Overall Study|Administrative problems|0
5279057|NCT00557466|18210658|P3|Overall Study|Administrative problems|1
5279058|NCT00557466|18210659|P2|Overall Study|Administrative problems|1
5279059|NCT00557466|18210660|P1|Overall Study|Administrative problems|0
5279060|NCT00557466|18210655|P6|Overall Study|Subject withdrew consent|2
5279061|NCT00557466|18210656|P5|Overall Study|Subject withdrew consent|1
5279062|NCT00557466|18210657|P4|Overall Study|Subject withdrew consent|0
5279063|NCT00557466|18210658|P3|Overall Study|Subject withdrew consent|0
5279064|NCT00557466|18210659|P2|Overall Study|Subject withdrew consent|0
5279065|NCT00557466|18210660|P1|Overall Study|Subject withdrew consent|0
5279066|NCT00557466|18210655|P6|Overall Study|Protocol deviation|0
5279067|NCT00557466|18210656|P5|Overall Study|Protocol deviation|0
5279068|NCT00557466|18210657|P4|Overall Study|Protocol deviation|2
5279069|NCT00557466|18210658|P3|Overall Study|Protocol deviation|0
5279070|NCT00557466|18210659|P2|Overall Study|Protocol deviation|1
5279071|NCT00557466|18210660|P1|Overall Study|Protocol deviation|0
5279072|NCT00557466|18210655|P6|Overall Study|Abnormal laboratory value(s)|0
5279073|NCT00557466|18210656|P5|Overall Study|Abnormal laboratory value(s)|0
5279074|NCT00557466|18210657|P4|Overall Study|Abnormal laboratory value(s)|0
5279075|NCT00557466|18210658|P3|Overall Study|Abnormal laboratory value(s)|0
5279076|NCT00557466|18210659|P2|Overall Study|Abnormal laboratory value(s)|2
5279077|NCT00557466|18210660|P1|Overall Study|Abnormal laboratory value(s)|1
5279078|NCT00557466|18210655|P6|Overall Study|Adverse Event|4
5279079|NCT00557466|18210656|P5|Overall Study|Adverse Event|2
5279080|NCT00557466|18210657|P4|Overall Study|Adverse Event|1
5279081|NCT00557466|18210658|P3|Overall Study|Adverse Event|4
5279082|NCT00557466|18210659|P2|Overall Study|Adverse Event|1
5279083|NCT00557466|18210660|P1|Overall Study|Adverse Event|3
5279084|NCT00557440|18210713|P3|Treatment Period 1|Adverse Event|1
5279085|NCT00557440|18210714|P2|Treatment Period 1|Adverse Event|0
5279086|NCT00557440|18210715|P1|Treatment Period 1|Adverse Event|0
5279087|NCT00557323|18210769|P1|Overall Study|Administrative change|2
5279088|NCT00557323|18210769|P1|Overall Study|Withdrawal by Subject|2
5279089|NCT00557323|18210769|P1|Overall Study|Death|3
5279090|NCT00557310|18210774|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
5279091|NCT00557310|18210774|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
5279092|NCT00557310|18210774|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
5279093|NCT00557310|18210774|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
5279094|NCT00557310|18210774|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
5279095|NCT00557310|18210774|P1|Main Study (0 - 18 Months)|Adverse Event|4
5279096|NCT00557245|18210820|P3|Overall Study|Ineligible|2
5279097|NCT00557245|18210821|P2|Overall Study|Ineligible|4
5279098|NCT00557245|18210822|P1|Overall Study|Ineligible|5
5279099|NCT00557245|18210820|P3|Overall Study|Lost to Follow-up|10
5279100|NCT00557245|18210821|P2|Overall Study|Lost to Follow-up|8
5279101|NCT00557245|18210822|P1|Overall Study|Lost to Follow-up|7
5279102|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
5279103|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
5279104|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
5279105|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
5279106|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
5279107|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
5279108|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5279109|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5279110|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5279111|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
5279112|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5279113|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5279114|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5279115|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5279116|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5279117|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
5279118|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5279119|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5279120|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Relapse|20
5279121|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Relapse|1
5279122|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Relapse|3
5279123|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Relapse|16
5279124|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Relapse|5
5279125|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Relapse|0
5279126|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
5279127|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
5279128|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
5279129|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
5279130|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
5279131|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
5279132|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
5279133|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
5279134|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
5279135|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
5279136|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
5279137|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
5279138|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Death|2
5279139|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Death|2
5279140|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Death|0
5279141|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Death|2
5279142|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Death|0
5279143|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Death|0
5279144|NCT00557193|18210860|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
5279145|NCT00557193|18210861|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
5279146|NCT00557193|18210862|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
5279147|NCT00557193|18210863|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
5279148|NCT00557193|18210864|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
5279149|NCT00557193|18210865|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
5279150|NCT00557193|18210860|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
5279151|NCT00557193|18210861|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
5279152|NCT00557193|18210862|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
5279153|NCT00557193|18210863|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
5279154|NCT00557193|18210864|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
5279155|NCT00557193|18210865|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
5279156|NCT00557193|18210860|P6|Induction|Inevaluable for post Induction|0
5279157|NCT00557193|18210861|P5|Induction|Inevaluable for post Induction|0
5279158|NCT00557193|18210862|P4|Induction|Inevaluable for post Induction|0
5279159|NCT00557193|18210863|P3|Induction|Inevaluable for post Induction|0
5279160|NCT00557193|18210864|P2|Induction|Inevaluable for post Induction|0
5279161|NCT00557193|18210865|P1|Induction|Inevaluable for post Induction|2
5279162|NCT00557193|18210860|P6|Induction|Ineligible|0
5279163|NCT00557193|18210861|P5|Induction|Ineligible|0
5279164|NCT00557193|18210862|P4|Induction|Ineligible|0
5279165|NCT00557193|18210863|P3|Induction|Ineligible|0
5279166|NCT00557193|18210864|P2|Induction|Ineligible|0
5279167|NCT00557193|18210865|P1|Induction|Ineligible|8
5279168|NCT00557193|18210860|P6|Induction|Refusal of Further Protocol Therapy|0
5279169|NCT00557193|18210861|P5|Induction|Refusal of Further Protocol Therapy|0
5279170|NCT00557193|18210862|P4|Induction|Refusal of Further Protocol Therapy|0
5279171|NCT00557193|18210863|P3|Induction|Refusal of Further Protocol Therapy|0
5279172|NCT00557193|18210864|P2|Induction|Refusal of Further Protocol Therapy|0
5279173|NCT00557193|18210865|P1|Induction|Refusal of Further Protocol Therapy|2
5279174|NCT00557193|18210860|P6|Induction|Withdrawal by Subject|0
5279175|NCT00557193|18210861|P5|Induction|Withdrawal by Subject|0
5279176|NCT00557193|18210862|P4|Induction|Withdrawal by Subject|0
5279177|NCT00557193|18210863|P3|Induction|Withdrawal by Subject|0
5279178|NCT00557193|18210864|P2|Induction|Withdrawal by Subject|0
5279179|NCT00557193|18210865|P1|Induction|Withdrawal by Subject|1
5279180|NCT00557193|18210860|P6|Induction|Physician Decision|0
5279181|NCT00557193|18210861|P5|Induction|Physician Decision|0
5279182|NCT00557193|18210862|P4|Induction|Physician Decision|0
5279183|NCT00557193|18210863|P3|Induction|Physician Decision|0
5279184|NCT00557193|18210864|P2|Induction|Physician Decision|0
5279185|NCT00557193|18210865|P1|Induction|Physician Decision|3
5279186|NCT00557193|18210860|P6|Induction|Death|0
5279187|NCT00557193|18210861|P5|Induction|Death|0
5279188|NCT00557193|18210862|P4|Induction|Death|0
5279189|NCT00557193|18210863|P3|Induction|Death|0
5279190|NCT00557193|18210864|P2|Induction|Death|0
5279191|NCT00557193|18210865|P1|Induction|Death|6
5279192|NCT00557193|18210860|P6|Induction|Adverse Event|0
5279193|NCT00557193|18210861|P5|Induction|Adverse Event|0
5279194|NCT00557193|18210862|P4|Induction|Adverse Event|0
5279195|NCT00557193|18210863|P3|Induction|Adverse Event|0
5279196|NCT00557193|18210864|P2|Induction|Adverse Event|0
5279197|NCT00557193|18210865|P1|Induction|Adverse Event|2
5279198|NCT00557076|18210905|P2|Overall Study|Unblinding|1
5279199|NCT00557076|18210906|P1|Overall Study|Unblinding|0
5279200|NCT00556998|18210914|P1|Voriconazole Oral|Intolerant of oral treatment|1
5279201|NCT00556998|18210914|P1|Voriconazole Oral|Adverse Event|1
5279202|NCT00556998|18210914|P1|Voriconazole Intravenous (IV)|Other|4
5279203|NCT00556998|18210914|P1|Voriconazole Intravenous (IV)|Adverse Event|1
5279204|NCT00556933|18210949|P4|CNI Withdrawal vs. Minimization|Death|1
5279205|NCT00556933|18210950|P3|CNI Withdrawal vs. Minimization|Death|0
5279206|NCT00556933|18210951|P2|CNI Withdrawal vs. Minimization|Death|0
5279207|NCT00556933|18210952|P1|CNI Withdrawal vs. Minimization|Death|0
5279208|NCT00556933|18210949|P4|CNI Withdrawal vs. Minimization|Graft loss|0
5279209|NCT00556933|18210950|P3|CNI Withdrawal vs. Minimization|Graft loss|2
5279210|NCT00556933|18210951|P2|CNI Withdrawal vs. Minimization|Graft loss|1
5279211|NCT00556933|18210952|P1|CNI Withdrawal vs. Minimization|Graft loss|0
5279212|NCT00556933|18210949|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
5279213|NCT00556933|18210950|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
5279214|NCT00556933|18210951|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
5279215|NCT00556933|18210952|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
5279216|NCT00556933|18210949|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
5279217|NCT00556933|18210950|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
5279218|NCT00556933|18210951|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
5279219|NCT00556933|18210952|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
5279220|NCT00556933|18210949|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
5279221|NCT00556933|18210950|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
5279222|NCT00556933|18210951|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
5279223|NCT00556933|18210952|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
5279224|NCT00556933|18210949|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
5279225|NCT00556933|18210950|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
5279226|NCT00556933|18210951|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
5279227|NCT00556933|18210952|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
5279228|NCT00556933|18210949|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
5279229|NCT00556933|18210950|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
5279230|NCT00556933|18210951|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
5279231|NCT00556933|18210952|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
5279232|NCT00556933|18210949|P4|Single vs. Divided-dose rATG Induction|Death|0
5279233|NCT00556933|18210950|P3|Single vs. Divided-dose rATG Induction|Death|0
5279234|NCT00556933|18210951|P2|Single vs. Divided-dose rATG Induction|Death|1
5279235|NCT00556933|18210952|P1|Single vs. Divided-dose rATG Induction|Death|0
5279236|NCT00556933|18210949|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
5279237|NCT00556933|18210950|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
5279238|NCT00556933|18210951|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
5279239|NCT00556933|18210952|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
5279240|NCT00556933|18210949|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
5279241|NCT00556933|18210950|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
5279242|NCT00556933|18210951|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
5279243|NCT00556933|18210952|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
5279244|NCT00556933|18210949|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
5279245|NCT00556933|18210950|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
5279246|NCT00556933|18210951|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
5279247|NCT00556933|18210952|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
5279248|NCT00556894|18211009|P3|Overall Study|Withdrawal by Subject|1
5279249|NCT00556894|18211010|P2|Overall Study|Withdrawal by Subject|1
5279250|NCT00556894|18211011|P1|Overall Study|Withdrawal by Subject|1
5279251|NCT00556894|18211009|P3|Overall Study|Change in therapy|2
5279252|NCT00556894|18211010|P2|Overall Study|Change in therapy|1
5279253|NCT00556894|18211011|P1|Overall Study|Change in therapy|2
5279254|NCT00556894|18211009|P3|Overall Study|regulatory decision in Bulgaria|13
5279255|NCT00556894|18211010|P2|Overall Study|regulatory decision in Bulgaria|14
5279256|NCT00556894|18211011|P1|Overall Study|regulatory decision in Bulgaria|10
5279257|NCT00556894|18211009|P3|Overall Study|Death|0
5279258|NCT00556894|18211010|P2|Overall Study|Death|0
5279259|NCT00556894|18211011|P1|Overall Study|Death|1
5279260|NCT00556894|18211009|P3|Overall Study|Adverse Event|3
5279261|NCT00556894|18211010|P2|Overall Study|Adverse Event|3
5279262|NCT00556894|18211011|P1|Overall Study|Adverse Event|2
5279263|NCT00556712|18211040|P2|Overall Study|Ongoing at Data Cutoff|66
5279264|NCT00556712|18211041|P1|Overall Study|Ongoing at Data Cutoff|32
5279265|NCT00556712|18211040|P2|Overall Study|Other|2
5279266|NCT00556712|18211041|P1|Overall Study|Other|2
5279267|NCT00556712|18211040|P2|Overall Study|Failure to Return|3
5279268|NCT00556712|18211041|P1|Overall Study|Failure to Return|2
5279269|NCT00556712|18211040|P2|Overall Study|Refused Treatment|16
5279270|NCT00556712|18211041|P1|Overall Study|Refused Treatment|17
5279271|NCT00556712|18211040|P2|Overall Study|Protocol Violation|2
5279272|NCT00556712|18211041|P1|Overall Study|Protocol Violation|3
5279273|NCT00556712|18211040|P2|Overall Study|Progressive Disease|320
5279274|NCT00556712|18211041|P1|Overall Study|Progressive Disease|383
5279275|NCT00556712|18211040|P2|Overall Study|Death|10
5279276|NCT00556712|18211041|P1|Overall Study|Death|5
5279277|NCT00556712|18211040|P2|Overall Study|Adverse Event|19
5279278|NCT00556712|18211041|P1|Overall Study|Adverse Event|7
5279279|NCT00556673|18211119|P2|Overall Study|Protocol deviation|2
5279280|NCT00556673|18211120|P1|Overall Study|Protocol deviation|3
5279281|NCT00556439|18211256|P4|After Week 12 (Randomized Study Period)|Severe infection|0
5279282|NCT00556439|18211257|P3|After Week 12 (Randomized Study Period)|Severe infection|0
5279283|NCT00556439|18211258|P2|After Week 12 (Randomized Study Period)|Severe infection|0
5279284|NCT00556439|18211259|P1|After Week 12 (Randomized Study Period)|Severe infection|1
5279285|NCT00556439|18211256|P4|After Week 12 (Randomized Study Period)|Malignancy|1
5279286|NCT00556439|18211257|P3|After Week 12 (Randomized Study Period)|Malignancy|0
5279287|NCT00556439|18211258|P2|After Week 12 (Randomized Study Period)|Malignancy|1
5279288|NCT00556439|18211259|P1|After Week 12 (Randomized Study Period)|Malignancy|0
5279289|NCT00556439|18211256|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
5279290|NCT00556439|18211257|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
5279291|NCT00556439|18211258|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
5279292|NCT00556439|18211259|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
5279293|NCT00556439|18211256|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
5279294|NCT00556439|18211257|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
5279295|NCT00556439|18211258|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
5279296|NCT00556439|18211259|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
5279297|NCT00556439|18211256|P4|Study Entry to Week 12|Malignancy|0
5279298|NCT00556439|18211257|P3|Study Entry to Week 12|Malignancy|1
5279299|NCT00556439|18211258|P2|Study Entry to Week 12|Malignancy|0
5279300|NCT00556439|18211259|P1|Study Entry to Week 12|Malignancy|0
5279301|NCT00556439|18211256|P4|Study Entry to Week 12|Recurrent infection|0
5279302|NCT00556439|18211257|P3|Study Entry to Week 12|Recurrent infection|0
5279303|NCT00556439|18211258|P2|Study Entry to Week 12|Recurrent infection|0
5279304|NCT00556439|18211259|P1|Study Entry to Week 12|Recurrent infection|1
5279305|NCT00556439|18211256|P4|Study Entry to Week 12|Withdrawal by Subject|0
5279306|NCT00556439|18211257|P3|Study Entry to Week 12|Withdrawal by Subject|1
5279307|NCT00556439|18211258|P2|Study Entry to Week 12|Withdrawal by Subject|0
5279308|NCT00556439|18211259|P1|Study Entry to Week 12|Withdrawal by Subject|1
5279309|NCT00556439|18211256|P4|Study Entry to Week 12|Physician Decision|0
5279310|NCT00556439|18211257|P3|Study Entry to Week 12|Physician Decision|0
5279311|NCT00556439|18211258|P2|Study Entry to Week 12|Physician Decision|0
5279312|NCT00556439|18211259|P1|Study Entry to Week 12|Physician Decision|1
5279313|NCT00556439|18211256|P4|Study Entry to Week 12|Lack of Efficacy|0
5279314|NCT00556439|18211257|P3|Study Entry to Week 12|Lack of Efficacy|6
5279315|NCT00556439|18211258|P2|Study Entry to Week 12|Lack of Efficacy|0
5279316|NCT00556439|18211259|P1|Study Entry to Week 12|Lack of Efficacy|5
5279317|NCT00556426|18211269|P1|Overall Study|Death|6
5279318|NCT00556426|18211269|P1|Overall Study|Withdrawal by Subject|3
5279319|NCT00556374|18211291|P2|Overall Study|Lost to Follow-up|5
5279320|NCT00556374|18211292|P1|Overall Study|Lost to Follow-up|7
5279321|NCT00556374|18211291|P2|Overall Study|Death|43
5279322|NCT00556374|18211292|P1|Overall Study|Death|50
5279323|NCT00556374|18211291|P2|Overall Study|Withdrawal by Subject|172
5279324|NCT00556374|18211292|P1|Overall Study|Withdrawal by Subject|190
5279325|NCT00556322|18211312|P2|Overall Study|Death|14
5279326|NCT00556322|18211313|P1|Overall Study|Death|20
5279327|NCT00556322|18211312|P2|Overall Study|Ongoing at data cutoff|5
5279328|NCT00556322|18211313|P1|Overall Study|Ongoing at data cutoff|3
5279329|NCT00556322|18211312|P2|Overall Study|Protocol Violation|1
5279330|NCT00556322|18211313|P1|Overall Study|Protocol Violation|5
5279331|NCT00556322|18211312|P2|Overall Study|Withdrawal by Subject|7
5279332|NCT00556322|18211313|P1|Overall Study|Withdrawal by Subject|19
5279333|NCT00556322|18211312|P2|Overall Study|Lost to Follow-up|3
5279334|NCT00556322|18211313|P1|Overall Study|Lost to Follow-up|5
5279335|NCT00556322|18211312|P2|Overall Study|Other|1
5279336|NCT00556322|18211313|P1|Overall Study|Other|4
5279337|NCT00556322|18211312|P2|Overall Study|Adverse Event|4
5279338|NCT00556322|18211313|P1|Overall Study|Adverse Event|7
5279339|NCT00556322|18211312|P2|Overall Study|Insufficient therapeutic response|168
5279340|NCT00556322|18211313|P1|Overall Study|Insufficient therapeutic response|158
5279341|NCT00556166|18211361|P1|Overall Study|Withdrawal by Subject|1
5279342|NCT00556075|18211374|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
5279343|NCT00556075|18211375|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
5279344|NCT00556075|18211376|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
5279345|NCT00556075|18211374|P3|Overall Study|Personal issues|0
5279346|NCT00556075|18211375|P2|Overall Study|Personal issues|1
5279347|NCT00556075|18211376|P1|Overall Study|Personal issues|4
5279348|NCT00556075|18211374|P3|Overall Study|Adverse Event|0
5279349|NCT00556075|18211375|P2|Overall Study|Adverse Event|2
5279350|NCT00556075|18211376|P1|Overall Study|Adverse Event|1
5279351|NCT00556075|18211374|P3|Overall Study|Not eligible|2
5279352|NCT00556075|18211375|P2|Overall Study|Not eligible|1
5279353|NCT00556075|18211376|P1|Overall Study|Not eligible|1
5279354|NCT00556075|18211374|P3|Overall Study|Protocol Violation|3
5279355|NCT00556075|18211375|P2|Overall Study|Protocol Violation|1
5279356|NCT00556075|18211376|P1|Overall Study|Protocol Violation|1
5279357|NCT00556075|18211374|P3|Overall Study|Withdrawal by Subject|0
5279358|NCT00556075|18211375|P2|Overall Study|Withdrawal by Subject|3
5279359|NCT00556075|18211376|P1|Overall Study|Withdrawal by Subject|3
5279360|NCT00556075|18211374|P3|Overall Study|Lost to Follow-up|3
5279361|NCT00556075|18211375|P2|Overall Study|Lost to Follow-up|0
5279362|NCT00556075|18211376|P1|Overall Study|Lost to Follow-up|3
5279363|NCT00555971|18211427|P2|Overall Study|Adverse Event|1
5279364|NCT00555971|18211428|P1|Overall Study|Adverse Event|1
5279365|NCT00555906|18211439|P5|Phase 2|Randomized but not Treated|2
5279366|NCT00555906|18211440|P4|Phase 2|Randomized but not Treated|0
5279367|NCT00555906|18211441|P3|Phase 2|Randomized but not Treated|0
5279368|NCT00555906|18211442|P2|Phase 2|Randomized but not Treated|0
5279369|NCT00555906|18211443|P1|Phase 2|Randomized but not Treated|0
5279370|NCT00555906|18211439|P5|Phase 2|Other|6
5279371|NCT00555906|18211440|P4|Phase 2|Other|0
5279372|NCT00555906|18211441|P3|Phase 2|Other|0
5279373|NCT00555906|18211442|P2|Phase 2|Other|0
5279374|NCT00555906|18211443|P1|Phase 2|Other|0
5279375|NCT00555906|18211439|P5|Phase 2|Withdrawal by Subject|2
5279376|NCT00555906|18211440|P4|Phase 2|Withdrawal by Subject|0
5279377|NCT00555906|18211441|P3|Phase 2|Withdrawal by Subject|0
5279378|NCT00555906|18211442|P2|Phase 2|Withdrawal by Subject|0
5279379|NCT00555906|18211443|P1|Phase 2|Withdrawal by Subject|0
5279380|NCT00555906|18211439|P5|Phase 2|Objective Progression or Relapse|16
5279381|NCT00555906|18211440|P4|Phase 2|Objective Progression or Relapse|0
5279382|NCT00555906|18211441|P3|Phase 2|Objective Progression or Relapse|0
5279383|NCT00555906|18211442|P2|Phase 2|Objective Progression or Relapse|0
5279384|NCT00555906|18211443|P1|Phase 2|Objective Progression or Relapse|0
5279385|NCT00555906|18211439|P5|Phase 2|Global Deterioration of Health Status|2
5279386|NCT00555906|18211440|P4|Phase 2|Global Deterioration of Health Status|0
5279387|NCT00555906|18211441|P3|Phase 2|Global Deterioration of Health Status|0
5279388|NCT00555906|18211442|P2|Phase 2|Global Deterioration of Health Status|0
5279389|NCT00555906|18211443|P1|Phase 2|Global Deterioration of Health Status|0
5279390|NCT00555906|18211439|P5|Phase 2|Adverse Event|4
5279391|NCT00555906|18211440|P4|Phase 2|Adverse Event|0
5279392|NCT00555906|18211441|P3|Phase 2|Adverse Event|0
5279393|NCT00555906|18211442|P2|Phase 2|Adverse Event|0
5279394|NCT00555906|18211443|P1|Phase 2|Adverse Event|0
5279395|NCT00555906|18211439|P5|Phase 1|Withdrawal by Subject|0
5279396|NCT00555906|18211440|P4|Phase 1|Withdrawal by Subject|1
5279397|NCT00555906|18211441|P3|Phase 1|Withdrawal by Subject|0
5279398|NCT00555906|18211442|P2|Phase 1|Withdrawal by Subject|0
5279399|NCT00555906|18211443|P1|Phase 1|Withdrawal by Subject|0
5279400|NCT00555906|18211439|P5|Phase 1|Adverse Event|0
5279401|NCT00555906|18211440|P4|Phase 1|Adverse Event|2
5279402|NCT00555906|18211441|P3|Phase 1|Adverse Event|3
5279403|NCT00555906|18211442|P2|Phase 1|Adverse Event|0
5279404|NCT00555906|18211443|P1|Phase 1|Adverse Event|0
5279405|NCT00555906|18211439|P5|Phase 1|Global Deterioration of Health Status|0
5279406|NCT00555906|18211440|P4|Phase 1|Global Deterioration of Health Status|1
5279407|NCT00555906|18211441|P3|Phase 1|Global Deterioration of Health Status|1
5279408|NCT00555906|18211442|P2|Phase 1|Global Deterioration of Health Status|1
5279409|NCT00555906|18211443|P1|Phase 1|Global Deterioration of Health Status|0
5279410|NCT00555906|18211439|P5|Phase 1|Objective Progression or Relapse|0
5279411|NCT00555906|18211440|P4|Phase 1|Objective Progression or Relapse|1
5279412|NCT00555906|18211441|P3|Phase 1|Objective Progression or Relapse|3
5279413|NCT00555906|18211442|P2|Phase 1|Objective Progression or Relapse|5
5279414|NCT00555906|18211443|P1|Phase 1|Objective Progression or Relapse|3
5279415|NCT00555672|18211565|P2|Overall Study|Participant refused|0
5279416|NCT00555672|18211566|P1|Overall Study|Participant refused|2
5279417|NCT00555672|18211565|P2|Overall Study|Other|1
5279418|NCT00555672|18211566|P1|Overall Study|Other|3
5279419|NCT00555672|18211565|P2|Overall Study|Objective progression or relapse|5
5279420|NCT00555672|18211566|P1|Overall Study|Objective progression or relapse|11
5279421|NCT00555672|18211565|P2|Overall Study|Adverse Event|2
5279422|NCT00555672|18211566|P1|Overall Study|Adverse Event|8
5279423|NCT00555672|18211565|P2|Overall Study|Death|2
5279424|NCT00555672|18211566|P1|Overall Study|Death|0
5279425|NCT00555620|18211591|P6|Overall Study|Other|3
5279426|NCT00555620|18211592|P5|Overall Study|Other|0
5279427|NCT00555620|18211593|P4|Overall Study|Other|1
5279428|NCT00555620|18211594|P3|Overall Study|Other|0
5279429|NCT00555620|18211595|P2|Overall Study|Other|0
5279430|NCT00555620|18211596|P1|Overall Study|Other|0
5279431|NCT00555620|18211591|P6|Overall Study|Participant refused treatment|1
5279432|NCT00555620|18211592|P5|Overall Study|Participant refused treatment|0
5279433|NCT00555620|18211593|P4|Overall Study|Participant refused treatment|0
5279434|NCT00555620|18211594|P3|Overall Study|Participant refused treatment|1
5279435|NCT00555620|18211595|P2|Overall Study|Participant refused treatment|1
5279436|NCT00555620|18211596|P1|Overall Study|Participant refused treatment|0
5279437|NCT00555620|18211591|P6|Overall Study|Objective progression or relapse|16
5279438|NCT00555620|18211592|P5|Overall Study|Objective progression or relapse|3
5279439|NCT00555620|18211593|P4|Overall Study|Objective progression or relapse|17
5279440|NCT00555620|18211594|P3|Overall Study|Objective progression or relapse|12
5279441|NCT00555620|18211595|P2|Overall Study|Objective progression or relapse|5
5279442|NCT00555620|18211596|P1|Overall Study|Objective progression or relapse|6
5279443|NCT00555620|18211591|P6|Overall Study|Adverse Event|1
5279444|NCT00555620|18211592|P5|Overall Study|Adverse Event|0
5279445|NCT00555620|18211593|P4|Overall Study|Adverse Event|5
5279446|NCT00555620|18211594|P3|Overall Study|Adverse Event|1
5279447|NCT00555620|18211595|P2|Overall Study|Adverse Event|0
5279448|NCT00555620|18211596|P1|Overall Study|Adverse Event|0
5279449|NCT00555620|18211591|P6|Overall Study|Study terminated by sponsor|0
5279450|NCT00555620|18211592|P5|Overall Study|Study terminated by sponsor|0
5279451|NCT00555620|18211593|P4|Overall Study|Study terminated by sponsor|0
5279452|NCT00555620|18211594|P3|Overall Study|Study terminated by sponsor|1
5279453|NCT00555620|18211595|P2|Overall Study|Study terminated by sponsor|0
5279454|NCT00555620|18211596|P1|Overall Study|Study terminated by sponsor|0
5279455|NCT00555620|18211591|P6|Overall Study|Death|1
5279456|NCT00555620|18211592|P5|Overall Study|Death|0
5279457|NCT00555620|18211593|P4|Overall Study|Death|0
5279458|NCT00555620|18211594|P3|Overall Study|Death|0
5279459|NCT00555620|18211595|P2|Overall Study|Death|1
5279460|NCT00555620|18211596|P1|Overall Study|Death|0
5279461|NCT00555568|18211720|P3|Overall Study|Lost to Follow-up|16
5279462|NCT00555568|18211721|P2|Overall Study|Lost to Follow-up|16
5279463|NCT00555568|18211722|P1|Overall Study|Lost to Follow-up|26
5279464|NCT00555477|18211744|P2|Overall Study|Physician Decision|2
5279465|NCT00555477|18211745|P1|Overall Study|Physician Decision|1
5279466|NCT00555477|18211744|P2|Overall Study|Withdrawal by Subject|2
5279467|NCT00555477|18211745|P1|Overall Study|Withdrawal by Subject|1
5279468|NCT00555477|18211744|P2|Overall Study|Adverse Event|9
5279469|NCT00555477|18211745|P1|Overall Study|Adverse Event|0
5279470|NCT00555438|18211761|P1|Between 10 Days and 30 Days Postoperativ|Death|5
5279471|NCT00555438|18211761|P1|10 Days Post-operative|Death|4
5279472|NCT00555425|18211771|P2|Overall Study|Became pregnant and transferred care|1
5279473|NCT00555425|18211772|P1|Overall Study|Became pregnant and transferred care|0
5279474|NCT00555425|18211771|P2|Overall Study|Met criteria for protective transfer|3
5279475|NCT00555425|18211772|P1|Overall Study|Met criteria for protective transfer|16
5279476|NCT00555425|18211771|P2|Overall Study|Missed 3 physician management visits|0
5279477|NCT00555425|18211772|P1|Overall Study|Missed 3 physician management visits|1
5279478|NCT00555425|18211771|P2|Overall Study|Missed Medication > 1 wk|15
5279479|NCT00555425|18211772|P1|Overall Study|Missed Medication > 1 wk|34
5279480|NCT00555321|18211808|P5|Long-term Extension Phase|Other Reason|0
5279481|NCT00555321|18211809|P4|Long-term Extension Phase|Other Reason|0
5279482|NCT00555321|18211810|P3|Long-term Extension Phase|Other Reason|2
5279483|NCT00555321|18211811|P2|Long-term Extension Phase|Other Reason|0
5279484|NCT00555321|18211812|P1|Long-term Extension Phase|Other Reason|1
5279485|NCT00555321|18211808|P5|Long-term Extension Phase|Participant did not meet study criteria|1
5279486|NCT00555321|18211809|P4|Long-term Extension Phase|Participant did not meet study criteria|0
5279487|NCT00555321|18211810|P3|Long-term Extension Phase|Participant did not meet study criteria|0
5279488|NCT00555321|18211811|P2|Long-term Extension Phase|Participant did not meet study criteria|0
5279489|NCT00555321|18211812|P1|Long-term Extension Phase|Participant did not meet study criteria|0
5279490|NCT00555321|18211808|P5|Long-term Extension Phase|Death|0
5279491|NCT00555321|18211809|P4|Long-term Extension Phase|Death|3
5279492|NCT00555321|18211810|P3|Long-term Extension Phase|Death|0
5279493|NCT00555321|18211811|P2|Long-term Extension Phase|Death|0
5279494|NCT00555321|18211812|P1|Long-term Extension Phase|Death|2
5279495|NCT00555321|18211808|P5|Long-term Extension Phase|Administrative reason by sponsor|23
5279496|NCT00555321|18211809|P4|Long-term Extension Phase|Administrative reason by sponsor|31
5279497|NCT00555321|18211810|P3|Long-term Extension Phase|Administrative reason by sponsor|18
5279498|NCT00555321|18211811|P2|Long-term Extension Phase|Administrative reason by sponsor|21
5279499|NCT00555321|18211812|P1|Long-term Extension Phase|Administrative reason by sponsor|23
5279500|NCT00555321|18211808|P5|Long-term Extension Phase|Withdrawal by Subject|2
5279501|NCT00555321|18211809|P4|Long-term Extension Phase|Withdrawal by Subject|3
5279502|NCT00555321|18211810|P3|Long-term Extension Phase|Withdrawal by Subject|2
5279503|NCT00555321|18211811|P2|Long-term Extension Phase|Withdrawal by Subject|1
5279504|NCT00555321|18211812|P1|Long-term Extension Phase|Withdrawal by Subject|2
5279505|NCT00555321|18211808|P5|Long-term Extension Phase|Adverse Event|0
5279506|NCT00555321|18211809|P4|Long-term Extension Phase|Adverse Event|1
5279507|NCT00555321|18211810|P3|Long-term Extension Phase|Adverse Event|2
5279508|NCT00555321|18211811|P2|Long-term Extension Phase|Adverse Event|5
5279509|NCT00555321|18211812|P1|Long-term Extension Phase|Adverse Event|2
5279510|NCT00555321|18211808|P5|Treatment Phase up to 12-months|Never treated|4
5279511|NCT00555321|18211809|P4|Treatment Phase up to 12-months|Never treated|0
5279512|NCT00555321|18211810|P3|Treatment Phase up to 12-months|Never treated|1
5279513|NCT00555321|18211811|P2|Treatment Phase up to 12-months|Never treated|3
5279514|NCT00555321|18211812|P1|Treatment Phase up to 12-months|Never treated|2
5279515|NCT00555321|18211808|P5|Treatment Phase up to 12-months|Other Reason|0
5279516|NCT00555321|18211809|P4|Treatment Phase up to 12-months|Other Reason|0
5279517|NCT00555321|18211810|P3|Treatment Phase up to 12-months|Other Reason|2
5279518|NCT00555321|18211811|P2|Treatment Phase up to 12-months|Other Reason|3
5279519|NCT00555321|18211812|P1|Treatment Phase up to 12-months|Other Reason|1
5279520|NCT00555321|18211808|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
5279521|NCT00555321|18211809|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
5279522|NCT00555321|18211810|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
5279523|NCT00555321|18211811|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
5279524|NCT00555321|18211812|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
5279525|NCT00555321|18211808|P5|Treatment Phase up to 12-months|Death|0
5279526|NCT00555321|18211809|P4|Treatment Phase up to 12-months|Death|0
5279527|NCT00555321|18211810|P3|Treatment Phase up to 12-months|Death|4
5279528|NCT00555321|18211811|P2|Treatment Phase up to 12-months|Death|1
5279529|NCT00555321|18211812|P1|Treatment Phase up to 12-months|Death|2
5279530|NCT00555321|18211808|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
5279531|NCT00555321|18211809|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
5279532|NCT00555321|18211810|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
5279533|NCT00555321|18211811|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
5279534|NCT00555321|18211812|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
5279535|NCT00555321|18211808|P5|Treatment Phase up to 12-months|Adverse Event|18
5279536|NCT00555321|18211809|P4|Treatment Phase up to 12-months|Adverse Event|7
5279537|NCT00555321|18211810|P3|Treatment Phase up to 12-months|Adverse Event|11
5279538|NCT00555321|18211811|P2|Treatment Phase up to 12-months|Adverse Event|7
5279539|NCT00555321|18211812|P1|Treatment Phase up to 12-months|Adverse Event|6
5279540|NCT00555217|18212116|P2|Overall Study|close out sites|17
5279541|NCT00555217|18212117|P1|Overall Study|close out sites|21
5279542|NCT00555217|18212116|P2|Overall Study|Lost to Follow-up|20
5279543|NCT00555217|18212117|P1|Overall Study|Lost to Follow-up|19
5279544|NCT00555217|18212116|P2|Overall Study|Withdrawal by Subject|31
5279545|NCT00555217|18212117|P1|Overall Study|Withdrawal by Subject|35
5279546|NCT00555061|18212154|P1|Overall Study|Participant enrolled, but never treated|1
5279547|NCT00555061|18212154|P1|Overall Study|Withdrawal by Subject|2
5279548|NCT00555061|18212154|P1|Overall Study|Lost to Follow-up|2
5279549|NCT00555061|18212154|P1|Overall Study|Protocol Violation|1
5279550|NCT00555061|18212154|P1|Overall Study|Adverse Event|3
5279551|NCT00555009|18212173|P2|Overall Study|Terminated by Sponsor|5
5279552|NCT00555009|18212174|P1|Overall Study|Terminated by Sponsor|2
5279553|NCT00555009|18212173|P2|Overall Study|Withdrawal by Subject|1
5279554|NCT00555009|18212174|P1|Overall Study|Withdrawal by Subject|0
5279555|NCT00554840|18212254|P2|Overall Study|Physician Decision|1
5279556|NCT00554840|18212255|P1|Overall Study|Physician Decision|0
5279557|NCT00554801|18212273|P2|Overall Study|Withdrawal by Subject|0
5279558|NCT00554801|18212274|P1|Overall Study|Withdrawal by Subject|14
5279559|NCT00554801|18212273|P2|Overall Study|left area before completion|0
5279560|NCT00554801|18212274|P1|Overall Study|left area before completion|5
5279561|NCT00554788|18212285|P3|Overall Study|Ineligible|1
5279562|NCT00554788|18212286|P2|Overall Study|Ineligible|0
5279563|NCT00554788|18212287|P1|Overall Study|Ineligible|2
5279564|NCT00554788|18212285|P3|Overall Study|Progressive disease|3
5279565|NCT00554788|18212286|P2|Overall Study|Progressive disease|0
5279566|NCT00554788|18212287|P1|Overall Study|Progressive disease|0
5279567|NCT00554788|18212285|P3|Overall Study|Refusal of further protocol therapy|1
5279568|NCT00554788|18212286|P2|Overall Study|Refusal of further protocol therapy|1
5279569|NCT00554788|18212287|P1|Overall Study|Refusal of further protocol therapy|0
5279570|NCT00554788|18212285|P3|Overall Study|Withdrawal by Subject|1
5279571|NCT00554788|18212286|P2|Overall Study|Withdrawal by Subject|0
5279572|NCT00554788|18212287|P1|Overall Study|Withdrawal by Subject|0
5279573|NCT00554788|18212285|P3|Overall Study|Physician Decision|3
5279574|NCT00554788|18212286|P2|Overall Study|Physician Decision|1
5279575|NCT00554788|18212287|P1|Overall Study|Physician Decision|1
5279576|NCT00554788|18212285|P3|Overall Study|Lost to Follow-up|3
5279577|NCT00554788|18212286|P2|Overall Study|Lost to Follow-up|3
5279578|NCT00554788|18212287|P1|Overall Study|Lost to Follow-up|4
5279579|NCT00554788|18212285|P3|Overall Study|Adverse Event|2
5279580|NCT00554788|18212286|P2|Overall Study|Adverse Event|1
5279581|NCT00554788|18212287|P1|Overall Study|Adverse Event|0
5279582|NCT00554619|18212319|P1|Overall Study|Liver Function Test Abnormality|1
5279583|NCT00554619|18212319|P1|Overall Study|Physician Decision|1
5279584|NCT00554619|18212319|P1|Overall Study|Adverse Event|1
5279585|NCT00554515|18212331|P1|Overall Study|Misc|15
5279586|NCT00554515|18212331|P1|Overall Study|Other|1
5279587|NCT00554515|18212331|P1|Overall Study|Achieved Stable Disease|7
5279588|NCT00554515|18212331|P1|Overall Study|Death|2
5279589|NCT00554515|18212331|P1|Overall Study|Adverse Event|9
5279590|NCT00554515|18212331|P1|Overall Study|Withdrawal by Subject|11
5279591|NCT00554515|18212331|P1|Overall Study|Physician Decision|18
5279592|NCT00554515|18212331|P1|Overall Study|Disease progression|52
5279593|NCT00554515|18212331|P1|Overall Study|Withdrawal by Subject|3
5279594|NCT00554229|18212394|P2|Overall Study|Randomised but no treatment received|0
5279595|NCT00554229|18212395|P1|Overall Study|Randomised but no treatment received|1
5279596|NCT00554229|18212394|P2|Overall Study|Reason not otherwise captured, eg; death|140
5279597|NCT00554229|18212395|P1|Overall Study|Reason not otherwise captured, eg; death|119
5279598|NCT00554229|18212394|P2|Overall Study|Protocol Violation|3
5279599|NCT00554229|18212395|P1|Overall Study|Protocol Violation|3
5279600|NCT00554229|18212394|P2|Overall Study|Adverse Event|39
5279601|NCT00554229|18212395|P1|Overall Study|Adverse Event|71
5279602|NCT00554229|18212394|P2|Overall Study|Withdrawal by Subject|37
5279603|NCT00554229|18212395|P1|Overall Study|Withdrawal by Subject|29
5279604|NCT00554229|18212394|P2|Overall Study|Lost to Follow-up|6
5279605|NCT00554229|18212395|P1|Overall Study|Lost to Follow-up|3
5279606|NCT00554216|18212420|P3|Overall Study|Lack of Efficacy|0
5279607|NCT00554216|18212421|P2|Overall Study|Lack of Efficacy|3
5279608|NCT00554216|18212422|P1|Overall Study|Lack of Efficacy|15
5279609|NCT00554216|18212420|P3|Overall Study|Other|10
5279610|NCT00554216|18212421|P2|Overall Study|Other|7
5279611|NCT00554216|18212422|P1|Overall Study|Other|12
5279612|NCT00554216|18212420|P3|Overall Study|Restricted med|1
5279613|NCT00554216|18212421|P2|Overall Study|Restricted med|1
5279614|NCT00554216|18212422|P1|Overall Study|Restricted med|3
5279615|NCT00554216|18212420|P3|Overall Study|Pregnancy|14
5279616|NCT00554216|18212421|P2|Overall Study|Pregnancy|1
5279617|NCT00554216|18212422|P1|Overall Study|Pregnancy|2
5279618|NCT00554216|18212420|P3|Overall Study|Non compliance|5
5279619|NCT00554216|18212421|P2|Overall Study|Non compliance|4
5279620|NCT00554216|18212422|P1|Overall Study|Non compliance|10
5279621|NCT00554216|18212420|P3|Overall Study|Withdrawal by Subject|43
5279622|NCT00554216|18212421|P2|Overall Study|Withdrawal by Subject|31
5279623|NCT00554216|18212422|P1|Overall Study|Withdrawal by Subject|92
5279624|NCT00554216|18212420|P3|Overall Study|Adverse Event|36
5279625|NCT00554216|18212421|P2|Overall Study|Adverse Event|16
5279626|NCT00554216|18212422|P1|Overall Study|Adverse Event|16
5279627|NCT00554216|18212420|P3|Overall Study|Lost to Follow-up|63
5279628|NCT00554216|18212421|P2|Overall Study|Lost to Follow-up|31
5279629|NCT00554216|18212422|P1|Overall Study|Lost to Follow-up|92
5279630|NCT00554190|18212433|P1|Overall Study|Termination forms not completed|10
5279631|NCT00554099|18212442|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
5279632|NCT00554099|18212443|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
5279633|NCT00554099|18212444|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
5279634|NCT00554099|18212442|P3|Non-Treatment Phase (9 Months)|Relapse|1
5279635|NCT00554099|18212443|P2|Non-Treatment Phase (9 Months)|Relapse|1
5279636|NCT00554099|18212444|P1|Non-Treatment Phase (9 Months)|Relapse|2
5279637|NCT00554099|18212442|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
5279638|NCT00554099|18212443|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
5279639|NCT00554099|18212444|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
5279640|NCT00554099|18212442|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
5279641|NCT00554099|18212443|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
5279642|NCT00554099|18212444|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
5279643|NCT00554099|18212442|P3|Treatment Period (12 Weeks)|Protocol Violation|2
5279644|NCT00554099|18212443|P2|Treatment Period (12 Weeks)|Protocol Violation|0
5279645|NCT00554099|18212444|P1|Treatment Period (12 Weeks)|Protocol Violation|0
5279646|NCT00554099|18212442|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
5279647|NCT00554099|18212443|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
5279648|NCT00554099|18212444|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
5279649|NCT00554099|18212442|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
5279650|NCT00554099|18212443|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
5279651|NCT00554099|18212444|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
5279652|NCT00554099|18212442|P3|Treatment Period (12 Weeks)|Physician Decision|0
5279653|NCT00554099|18212443|P2|Treatment Period (12 Weeks)|Physician Decision|0
5279654|NCT00554099|18212444|P1|Treatment Period (12 Weeks)|Physician Decision|3
5279655|NCT00554099|18212442|P3|Treatment Period (12 Weeks)|Adverse Event|1
5279656|NCT00554099|18212443|P2|Treatment Period (12 Weeks)|Adverse Event|5
5279657|NCT00554099|18212444|P1|Treatment Period (12 Weeks)|Adverse Event|3
5279658|NCT00553787|18212499|P3|Overall Study|Other|13
5279659|NCT00553787|18212500|P2|Overall Study|Other|10
5279660|NCT00553787|18212501|P1|Overall Study|Other|18
5279661|NCT00553787|18212499|P3|Overall Study|Requirement for restricted medication|5
5279662|NCT00553787|18212500|P2|Overall Study|Requirement for restricted medication|7
5279663|NCT00553787|18212501|P1|Overall Study|Requirement for restricted medication|8
5279664|NCT00553787|18212499|P3|Overall Study|non compliance|11
5279665|NCT00553787|18212500|P2|Overall Study|non compliance|0
5279666|NCT00553787|18212501|P1|Overall Study|non compliance|4
5279667|NCT00553787|18212499|P3|Overall Study|Pregnancy|2
5279668|NCT00553787|18212500|P2|Overall Study|Pregnancy|1
5279669|NCT00553787|18212501|P1|Overall Study|Pregnancy|0
5279670|NCT00553787|18212499|P3|Overall Study|Lack of Efficacy|3
5279671|NCT00553787|18212500|P2|Overall Study|Lack of Efficacy|1
5279672|NCT00553787|18212501|P1|Overall Study|Lack of Efficacy|31
5279673|NCT00553787|18212499|P3|Overall Study|Withdrawal by Subject|83
5279674|NCT00553787|18212500|P2|Overall Study|Withdrawal by Subject|40
5279675|NCT00553787|18212501|P1|Overall Study|Withdrawal by Subject|151
5279676|NCT00553787|18212499|P3|Overall Study|Lost to Follow-up|78
5279677|NCT00553787|18212500|P2|Overall Study|Lost to Follow-up|44
5279678|NCT00553787|18212501|P1|Overall Study|Lost to Follow-up|132
5279679|NCT00553787|18212499|P3|Overall Study|Adverse Event|67
5279680|NCT00553787|18212500|P2|Overall Study|Adverse Event|21
5279681|NCT00553787|18212501|P1|Overall Study|Adverse Event|34
5279682|NCT00553696|18212533|P4|Overall Study|Withdrawal by Subject|0
5279683|NCT00553696|18212534|P3|Overall Study|Withdrawal by Subject|0
5279684|NCT00553696|18212535|P2|Overall Study|Withdrawal by Subject|1
5279685|NCT00553696|18212536|P1|Overall Study|Withdrawal by Subject|0
5279686|NCT00553696|18212533|P4|Overall Study|Objective progression or relapse|0
5279687|NCT00553696|18212534|P3|Overall Study|Objective progression or relapse|6
5279688|NCT00553696|18212535|P2|Overall Study|Objective progression or relapse|9
5279689|NCT00553696|18212536|P1|Overall Study|Objective progression or relapse|2
5279690|NCT00553696|18212533|P4|Overall Study|Global deterioration of health status|0
5279691|NCT00553696|18212534|P3|Overall Study|Global deterioration of health status|0
5279692|NCT00553696|18212535|P2|Overall Study|Global deterioration of health status|2
5279693|NCT00553696|18212536|P1|Overall Study|Global deterioration of health status|0
5279694|NCT00553696|18212533|P4|Overall Study|Adverse Event|1
5279695|NCT00553696|18212534|P3|Overall Study|Adverse Event|0
5279696|NCT00553696|18212535|P2|Overall Study|Adverse Event|4
5279697|NCT00553696|18212536|P1|Overall Study|Adverse Event|2
5279698|NCT00553644|18212574|P1|Overall Study|Alternative therapy|6
5279699|NCT00553644|18212574|P1|Overall Study|Physician Decision|1
5279700|NCT00553644|18212574|P1|Overall Study|Withdrawal by Subject|4
5279701|NCT00553644|18212574|P1|Overall Study|Adverse Event|17
5279702|NCT00553631|18212583|P2|Overall Study|Lost to Follow-up|0
5279703|NCT00553631|18212584|P1|Overall Study|Lost to Follow-up|1
5279704|NCT00553631|18212583|P2|Overall Study|Withdrawal by Subject|1
5279705|NCT00553631|18212584|P1|Overall Study|Withdrawal by Subject|0
5279706|NCT00553605|18212606|P2|Overall Study|Randomized but not treated|0
5279707|NCT00553605|18212607|P1|Overall Study|Randomized but not treated|2
5279708|NCT00553605|18212606|P2|Overall Study|Did not receive full dose|0
5279709|NCT00553605|18212607|P1|Overall Study|Did not receive full dose|1
5279710|NCT00553605|18212606|P2|Overall Study|Did not meet entrance criteria|3
5279711|NCT00553605|18212607|P1|Overall Study|Did not meet entrance criteria|1
5279712|NCT00553540|18212633|P2|Overall Study|discharged after first visit|5
5279713|NCT00553540|18212634|P1|Overall Study|discharged after first visit|2
5279714|NCT00553514|18212645|P5|Overall Study|Other|1
5279715|NCT00553514|18212646|P4|Overall Study|Other|0
5279716|NCT00553514|18212647|P3|Overall Study|Other|0
5279717|NCT00553514|18212648|P2|Overall Study|Other|1
5279718|NCT00553514|18212649|P1|Overall Study|Other|1
5279719|NCT00553514|18212645|P5|Overall Study|Risk of multiple pregnancy|0
5279720|NCT00553514|18212646|P4|Overall Study|Risk of multiple pregnancy|1
5279721|NCT00553514|18212647|P3|Overall Study|Risk of multiple pregnancy|0
5279722|NCT00553514|18212648|P2|Overall Study|Risk of multiple pregnancy|2
5279723|NCT00553514|18212649|P1|Overall Study|Risk of multiple pregnancy|0
5279724|NCT00553514|18212645|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
5279725|NCT00553514|18212646|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
5279726|NCT00553514|18212647|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
5279727|NCT00553514|18212648|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
5279728|NCT00553514|18212649|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
5279729|NCT00553514|18212645|P5|Overall Study|Lack of ovarian response|6
5279730|NCT00553514|18212646|P4|Overall Study|Lack of ovarian response|5
5279731|NCT00553514|18212647|P3|Overall Study|Lack of ovarian response|5
5279732|NCT00553514|18212648|P2|Overall Study|Lack of ovarian response|5
5279733|NCT00553514|18212649|P1|Overall Study|Lack of ovarian response|4
5279734|NCT00553514|18212645|P5|Overall Study|Protocol deviation|0
5279735|NCT00553514|18212646|P4|Overall Study|Protocol deviation|1
5279736|NCT00553514|18212647|P3|Overall Study|Protocol deviation|0
5279737|NCT00553514|18212648|P2|Overall Study|Protocol deviation|0
5279738|NCT00553514|18212649|P1|Overall Study|Protocol deviation|0
5279739|NCT00553501|18212686|P1|Overall Study|Progression|1
5279740|NCT00553501|18212686|P1|Overall Study|Death|1
5279741|NCT00553501|18212686|P1|Overall Study|Adverse Event|2
5279742|NCT00553475|18212695|P3|Overall Study|Due to moving|0
5279743|NCT00553475|18212696|P2|Overall Study|Due to moving|1
5279744|NCT00553475|18212697|P1|Overall Study|Due to moving|0
5279745|NCT00553475|18212695|P3|Overall Study|Physician Decision|0
5279746|NCT00553475|18212696|P2|Overall Study|Physician Decision|0
5279747|NCT00553475|18212697|P1|Overall Study|Physician Decision|1
5279748|NCT00553475|18212695|P3|Overall Study|Withdrawal by Subject|0
5279749|NCT00553475|18212696|P2|Overall Study|Withdrawal by Subject|1
5279750|NCT00553475|18212697|P1|Overall Study|Withdrawal by Subject|1
5279751|NCT00553475|18212695|P3|Overall Study|Lack of Efficacy|0
5279752|NCT00553475|18212696|P2|Overall Study|Lack of Efficacy|1
5279753|NCT00553475|18212697|P1|Overall Study|Lack of Efficacy|7
5279754|NCT00553475|18212695|P3|Overall Study|Adverse Event|13
5279755|NCT00553475|18212696|P2|Overall Study|Adverse Event|17
5279756|NCT00553475|18212697|P1|Overall Study|Adverse Event|7
5279757|NCT00553462|18212819|P1|Overall Study|Physician Decision|1
5279758|NCT00553462|18212819|P1|Overall Study|Withdrawal by Subject|5
5279759|NCT00553462|18212819|P1|Overall Study|Progression|4
5279760|NCT00553462|18212819|P1|Overall Study|Adverse Event|4
5279761|NCT00553436|18212825|P1|Overall Study|Conversion to another procedure|1
5279762|NCT00553358|18212849|P3|Overall Study|Other: Reason Not Specified|20
5279763|NCT00553358|18212850|P2|Overall Study|Other: Reason Not Specified|4
5279764|NCT00553358|18212851|P1|Overall Study|Other: Reason Not Specified|15
5279765|NCT00553358|18212849|P3|Overall Study|Missing|1
5279766|NCT00553358|18212850|P2|Overall Study|Missing|1
5279767|NCT00553358|18212851|P1|Overall Study|Missing|1
5279768|NCT00553358|18212849|P3|Overall Study|Participant Withdrawal from Drug|3
5279769|NCT00553358|18212850|P2|Overall Study|Participant Withdrawal from Drug|0
5279770|NCT00553358|18212851|P1|Overall Study|Participant Withdrawal from Drug|0
5279771|NCT00553358|18212849|P3|Overall Study|Recurrence of Disease|1
5279772|NCT00553358|18212850|P2|Overall Study|Recurrence of Disease|4
5279773|NCT00553358|18212851|P1|Overall Study|Recurrence of Disease|3
5279774|NCT00553358|18212849|P3|Overall Study|Withdrawal by Subject|1
5279775|NCT00553358|18212850|P2|Overall Study|Withdrawal by Subject|0
5279776|NCT00553358|18212851|P1|Overall Study|Withdrawal by Subject|5
5279777|NCT00553358|18212849|P3|Overall Study|Protocol Violation|1
5279778|NCT00553358|18212850|P2|Overall Study|Protocol Violation|1
5279779|NCT00553358|18212851|P1|Overall Study|Protocol Violation|0
5279780|NCT00553358|18212849|P3|Overall Study|Lost to Follow-up|1
5279781|NCT00553358|18212850|P2|Overall Study|Lost to Follow-up|0
5279782|NCT00553358|18212851|P1|Overall Study|Lost to Follow-up|0
5279783|NCT00553358|18212849|P3|Overall Study|Adverse Event|32
5279784|NCT00553358|18212850|P2|Overall Study|Adverse Event|2
5279785|NCT00553358|18212851|P1|Overall Study|Adverse Event|29
5279786|NCT00553332|18212877|P1|Overall Study|ineligible, incorrect diagnosis|1
5279787|NCT00553319|18212889|P3|Overall Study|moved|1
5279788|NCT00553319|18212890|P2|Overall Study|moved|0
5279789|NCT00553319|18212891|P1|Overall Study|moved|1
5279790|NCT00553319|18212889|P3|Overall Study|incarceration|0
5279791|NCT00553319|18212890|P2|Overall Study|incarceration|0
5279792|NCT00553319|18212891|P1|Overall Study|incarceration|1
5279793|NCT00553319|18212889|P3|Overall Study|non-compliance|2
5279794|NCT00553319|18212890|P2|Overall Study|non-compliance|0
5279795|NCT00553319|18212891|P1|Overall Study|non-compliance|0
5279796|NCT00553319|18212889|P3|Overall Study|wanted treatment elsewhere|1
5279797|NCT00553319|18212890|P2|Overall Study|wanted treatment elsewhere|1
5279798|NCT00553319|18212891|P1|Overall Study|wanted treatment elsewhere|2
5279799|NCT00553319|18212889|P3|Overall Study|Lost to Follow-up|5
5279800|NCT00553319|18212890|P2|Overall Study|Lost to Follow-up|9
5279801|NCT00553319|18212891|P1|Overall Study|Lost to Follow-up|10
5279802|NCT00553280|18212902|P1|Overall Study|Physician Decision|1
5279803|NCT00553280|18212902|P1|Overall Study|Withdrawal by Subject|3
5279804|NCT00553280|18212902|P1|Overall Study|Lack of Efficacy|3
5279805|NCT00553280|18212902|P1|Overall Study|Adverse Event|19
5279806|NCT00553267|18212914|P3|Overall Study|Specified category|1
5279807|NCT00553267|18212915|P2|Overall Study|Specified category|2
5279808|NCT00553267|18212916|P1|Overall Study|Specified category|1
5279809|NCT00553267|18212914|P3|Overall Study|Consent withdrawn|1
5279810|NCT00553267|18212915|P2|Overall Study|Consent withdrawn|3
5279811|NCT00553267|18212916|P1|Overall Study|Consent withdrawn|2
5279812|NCT00553267|18212914|P3|Overall Study|Lost to Follow-up|1
5279813|NCT00553267|18212915|P2|Overall Study|Lost to Follow-up|0
5279814|NCT00553267|18212916|P1|Overall Study|Lost to Follow-up|0
5279815|NCT00553267|18212914|P3|Overall Study|Non compliant with protocol|2
5279816|NCT00553267|18212915|P2|Overall Study|Non compliant with protocol|3
5279817|NCT00553267|18212916|P1|Overall Study|Non compliant with protocol|3
5279818|NCT00553267|18212914|P3|Overall Study|Adverse Event|5
5279819|NCT00553267|18212915|P2|Overall Study|Adverse Event|10
5279820|NCT00553267|18212916|P1|Overall Study|Adverse Event|8
5279821|NCT00553254|18212953|P3|Overall Study|Other|13
5279822|NCT00553254|18212954|P2|Overall Study|Other|0
5279823|NCT00553254|18212955|P1|Overall Study|Other|1
5279824|NCT00553254|18212953|P3|Overall Study|Study terminated by Sponsor|1
5279825|NCT00553254|18212954|P2|Overall Study|Study terminated by Sponsor|0
5279826|NCT00553254|18212955|P1|Overall Study|Study terminated by Sponsor|0
5279827|NCT00553254|18212953|P3|Overall Study|Withdrawal by Subject|2
5279828|NCT00553254|18212954|P2|Overall Study|Withdrawal by Subject|0
5279829|NCT00553254|18212955|P1|Overall Study|Withdrawal by Subject|2
5279830|NCT00553254|18212953|P3|Overall Study|Lost to Follow-up|2
5279831|NCT00553254|18212954|P2|Overall Study|Lost to Follow-up|0
5279832|NCT00553254|18212955|P1|Overall Study|Lost to Follow-up|0
5279833|NCT00553254|18212953|P3|Overall Study|Death|25
5279834|NCT00553254|18212954|P2|Overall Study|Death|6
5279835|NCT00553254|18212955|P1|Overall Study|Death|3
5279836|NCT00553202|18212997|P1|Overall Study|Fails to meet organ function|6
5279837|NCT00553202|18212997|P1|Overall Study|No donor identified|16
5279838|NCT00553202|18212997|P1|Overall Study|Withdrawal by Subject|1
5279839|NCT00553202|18212997|P1|Overall Study|Physician Decision|28
5279840|NCT00553202|18212997|P1|Overall Study|Lost to Follow-up|1
5279841|NCT00553202|18212997|P1|Overall Study|Death|16
5279842|NCT00553150|18213024|P4|Overall Study|Ineligible|1
5279843|NCT00553150|18213025|P3|Overall Study|Ineligible|0
5279844|NCT00553150|18213026|P2|Overall Study|Ineligible|0
5279845|NCT00553150|18213027|P1|Overall Study|Ineligible|0
5279846|NCT00553150|18213024|P4|Overall Study|Protocol Violation|1
5279847|NCT00553150|18213025|P3|Overall Study|Protocol Violation|0
5279848|NCT00553150|18213026|P2|Overall Study|Protocol Violation|0
5279849|NCT00553150|18213027|P1|Overall Study|Protocol Violation|0
5279850|NCT00553150|18213024|P4|Overall Study|Withdrawal by Subject|2
5279851|NCT00553150|18213025|P3|Overall Study|Withdrawal by Subject|0
5279852|NCT00553150|18213026|P2|Overall Study|Withdrawal by Subject|0
5279853|NCT00553150|18213027|P1|Overall Study|Withdrawal by Subject|0
5279854|NCT00553059|18213055|P2|Overall Study|Drug supply not available|1
5279855|NCT00553059|18213056|P1|Overall Study|Drug supply not available|0
5279856|NCT00553059|18213055|P2|Overall Study|Deemed ineligible|1
5279857|NCT00553059|18213056|P1|Overall Study|Deemed ineligible|1
5279858|NCT00552929|18213084|P10|Overall Study|Not Eligible|0
5279859|NCT00552929|18213085|P9|Overall Study|Not Eligible|0
5279860|NCT00552929|18213086|P8|Overall Study|Not Eligible|0
5279861|NCT00552929|18213087|P7|Overall Study|Not Eligible|0
5279862|NCT00552929|18213088|P6|Overall Study|Not Eligible|1
5279863|NCT00552929|18213089|P5|Overall Study|Not Eligible|0
5279864|NCT00552929|18213090|P4|Overall Study|Not Eligible|0
5279865|NCT00552929|18213091|P3|Overall Study|Not Eligible|0
5279866|NCT00552929|18213092|P2|Overall Study|Not Eligible|0
5279867|NCT00552929|18213093|P1|Overall Study|Not Eligible|0
5279868|NCT00552929|18213084|P10|Overall Study|Lost to Follow-up|0
5279869|NCT00552929|18213085|P9|Overall Study|Lost to Follow-up|1
5279870|NCT00552929|18213086|P8|Overall Study|Lost to Follow-up|0
5279871|NCT00552929|18213087|P7|Overall Study|Lost to Follow-up|0
5279872|NCT00552929|18213088|P6|Overall Study|Lost to Follow-up|0
5279873|NCT00552929|18213089|P5|Overall Study|Lost to Follow-up|0
5279874|NCT00552929|18213090|P4|Overall Study|Lost to Follow-up|0
5279875|NCT00552929|18213091|P3|Overall Study|Lost to Follow-up|0
5279876|NCT00552929|18213092|P2|Overall Study|Lost to Follow-up|0
5279877|NCT00552929|18213093|P1|Overall Study|Lost to Follow-up|0
5279878|NCT00552760|18213164|P2|Overall Study|Medication Change|0
5279879|NCT00552760|18213165|P1|Overall Study|Medication Change|1
5279880|NCT00552760|18213164|P2|Overall Study|Withdrawal by Subject|0
5279881|NCT00552760|18213165|P1|Overall Study|Withdrawal by Subject|3
5279882|NCT00552760|18213164|P2|Overall Study|Medical Condition|1
5279883|NCT00552760|18213165|P1|Overall Study|Medical Condition|1
5279884|NCT00552760|18213164|P2|Overall Study|Non-compliance|1
5279885|NCT00552760|18213165|P1|Overall Study|Non-compliance|1
5279886|NCT00552760|18213164|P2|Overall Study|Lost to Follow-up|1
5279887|NCT00552760|18213165|P1|Overall Study|Lost to Follow-up|1
5279888|NCT00552760|18213164|P2|Overall Study|Protocol Violation|1
5279889|NCT00552760|18213165|P1|Overall Study|Protocol Violation|0
5279890|NCT00552760|18213164|P2|Overall Study|Relapsed- Mixed Event|5
5279891|NCT00552760|18213165|P1|Overall Study|Relapsed- Mixed Event|3
5279892|NCT00552760|18213164|P2|Overall Study|Relapse- Manic Event|3
5279893|NCT00552760|18213165|P1|Overall Study|Relapse- Manic Event|3
5279894|NCT00552760|18213164|P2|Overall Study|Relapsed- Depressed Event|16
5279895|NCT00552760|18213165|P1|Overall Study|Relapsed- Depressed Event|10
5279896|NCT00552760|18213164|P2|Overall Study|Adverse Event|5
5279897|NCT00552760|18213165|P1|Overall Study|Adverse Event|3
5279898|NCT00552669|18213192|P2|Overall Study|Death|7
5279899|NCT00552669|18213193|P1|Overall Study|Death|3
5279900|NCT00552617|18213213|P10|Overall Study|Lost to Follow-up|0
5279901|NCT00552617|18213214|P9|Overall Study|Lost to Follow-up|2
5279902|NCT00552617|18213215|P8|Overall Study|Lost to Follow-up|0
5279903|NCT00552617|18213216|P7|Overall Study|Lost to Follow-up|0
5279904|NCT00552617|18213217|P6|Overall Study|Lost to Follow-up|2
5279905|NCT00552617|18213218|P5|Overall Study|Lost to Follow-up|0
5279906|NCT00552617|18213219|P4|Overall Study|Lost to Follow-up|1
5279907|NCT00552617|18213220|P3|Overall Study|Lost to Follow-up|0
5279908|NCT00552617|18213221|P2|Overall Study|Lost to Follow-up|0
5279909|NCT00552617|18213222|P1|Overall Study|Lost to Follow-up|0
5279910|NCT00552617|18213213|P10|Overall Study|Not Treated|1
5279911|NCT00552617|18213214|P9|Overall Study|Not Treated|0
5279912|NCT00552617|18213215|P8|Overall Study|Not Treated|0
5279913|NCT00552617|18213216|P7|Overall Study|Not Treated|0
5279914|NCT00552617|18213217|P6|Overall Study|Not Treated|0
5279915|NCT00552617|18213218|P5|Overall Study|Not Treated|0
5279916|NCT00552617|18213219|P4|Overall Study|Not Treated|0
5279917|NCT00552617|18213220|P3|Overall Study|Not Treated|1
5279918|NCT00552617|18213221|P2|Overall Study|Not Treated|0
5279919|NCT00552617|18213222|P1|Overall Study|Not Treated|0
5279920|NCT00552578|18213266|P2|Overall Study|Lost to Follow-up|1
5279921|NCT00552578|18213267|P1|Overall Study|Lost to Follow-up|1
5279922|NCT00552513|18213279|P2|Overall Study|Lost to Follow-up|1
5279923|NCT00552513|18213280|P1|Overall Study|Lost to Follow-up|5
5279924|NCT00552396|18213325|P7|Overall Study|protocol withdrawal criteria|9
5279925|NCT00552396|18213326|P6|Overall Study|protocol withdrawal criteria|3
5279926|NCT00552396|18213327|P5|Overall Study|protocol withdrawal criteria|3
5279927|NCT00552396|18213328|P4|Overall Study|protocol withdrawal criteria|6
5279928|NCT00552396|18213329|P3|Overall Study|protocol withdrawal criteria|3
5279929|NCT00552396|18213330|P2|Overall Study|protocol withdrawal criteria|3
5279930|NCT00552396|18213331|P1|Overall Study|protocol withdrawal criteria|3
5279931|NCT00552344|18213368|P1|Overall Study|Other Reason|22
5279932|NCT00552344|18213368|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
5279933|NCT00552344|18213368|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
5279934|NCT00552344|18213368|P1|Overall Study|AE, non-serious non-fatal|38
5279935|NCT00552344|18213368|P1|Overall Study|SAE, non-fatal|6
5279936|NCT00552344|18213368|P1|Overall Study|Withdrawal by Subject|48
5279937|NCT00552344|18213368|P1|Overall Study|Lost to Follow-up|8
5279938|NCT00552344|18213368|P1|Overall Study|Loss of efficacy|75
5279939|NCT00552344|18213368|P1|Overall Study|Lack of Efficacy|55
5279940|NCT00552305|18213377|P1|Overall Study|Other: Subject went to rehab|1
5279941|NCT00552305|18213377|P1|Overall Study|Other: Subject incarcerated|1
5279942|NCT00552305|18213377|P1|Overall Study|Other: Subject moved from area|2
5279943|NCT00552305|18213377|P1|Overall Study|Other: Health problems, not drug related|1
5279944|NCT00552305|18213377|P1|Overall Study|Other: Subject became pregnant|1
5279945|NCT00552305|18213377|P1|Overall Study|Other: Subject underwent surgery|4
5279946|NCT00552305|18213377|P1|Overall Study|Other: Unable to attend visits|1
5279947|NCT00552305|18213377|P1|Overall Study|Other: Personal problems|1
5279948|NCT00552305|18213377|P1|Overall Study|Other: Site closed|4
5279949|NCT00552305|18213377|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
5279950|NCT00552305|18213377|P1|Overall Study|AE/Other: prohibited drug required|1
5279951|NCT00552305|18213377|P1|Overall Study|Poor compliance/lost to follow-up|1
5279952|NCT00552305|18213377|P1|Overall Study|Unsatisfactory compliance|11
5279953|NCT00552305|18213377|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
5279954|NCT00552305|18213377|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
5279955|NCT00552305|18213377|P1|Overall Study|Lack of efficacy/withdrew consent|1
5279956|NCT00552305|18213377|P1|Overall Study|Withdrawal by Subject|44
5279957|NCT00552305|18213377|P1|Overall Study|Protocol Violation|3
5279958|NCT00552305|18213377|P1|Overall Study|Lost to Follow-up|4
5279959|NCT00552305|18213377|P1|Overall Study|Lack of Efficacy|120
5279960|NCT00552305|18213377|P1|Overall Study|Adverse Event|43
5279961|NCT00552279|18213387|P2|Overall Study|Other|1
5279962|NCT00552279|18213388|P1|Overall Study|Other|1
5279963|NCT00552279|18213387|P2|Overall Study|Lost to Follow-up|0
5279964|NCT00552279|18213388|P1|Overall Study|Lost to Follow-up|1
5279965|NCT00552279|18213387|P2|Overall Study|Withdrawal by Subject|1
5279966|NCT00552279|18213388|P1|Overall Study|Withdrawal by Subject|12
5279967|NCT00552279|18213387|P2|Overall Study|Adverse Event|1
5279968|NCT00552279|18213388|P1|Overall Study|Adverse Event|0
5279969|NCT00552240|18213414|P2|Overall Study|Other|0
5279970|NCT00552240|18213415|P1|Overall Study|Other|1
5279971|NCT00552240|18213414|P2|Overall Study|Lack of Efficacy|0
5279972|NCT00552240|18213415|P1|Overall Study|Lack of Efficacy|6
5279973|NCT00552240|18213414|P2|Overall Study|Withdrawal by Subject|2
5279974|NCT00552240|18213415|P1|Overall Study|Withdrawal by Subject|2
5279975|NCT00552240|18213414|P2|Overall Study|Lost to Follow-up|6
5279976|NCT00552240|18213415|P1|Overall Study|Lost to Follow-up|5
5279977|NCT00552240|18213414|P2|Overall Study|Protocol Violation|1
5279978|NCT00552240|18213415|P1|Overall Study|Protocol Violation|1
5279979|NCT00552240|18213414|P2|Overall Study|Adverse Event|9
5279980|NCT00552240|18213415|P1|Overall Study|Adverse Event|9
5279981|NCT00552188|18213517|P2|Overall Study|Subject returned to home country|1
5279982|NCT00552188|18213518|P1|Overall Study|Subject returned to home country|0
5279983|NCT00552188|18213517|P2|Overall Study|Withdrawal of consent|1
5279984|NCT00552188|18213518|P1|Overall Study|Withdrawal of consent|0
5279985|NCT00552188|18213517|P2|Overall Study|Lost to Follow-up|1
5279986|NCT00552188|18213518|P1|Overall Study|Lost to Follow-up|2
5279987|NCT00552188|18213517|P2|Overall Study|Adverse Event|2
5279988|NCT00552188|18213518|P1|Overall Study|Adverse Event|0
5279989|NCT00552175|18213529|P3|Overall Study|Reason Not Specified|1
5279990|NCT00552175|18213530|P2|Overall Study|Reason Not Specified|1
5279991|NCT00552175|18213531|P1|Overall Study|Reason Not Specified|3
5279992|NCT00552175|18213529|P3|Overall Study|Entry Criteria Not Met|0
5279993|NCT00552175|18213530|P2|Overall Study|Entry Criteria Not Met|1
5279994|NCT00552175|18213531|P1|Overall Study|Entry Criteria Not Met|1
5279995|NCT00552175|18213529|P3|Overall Study|Lost to Follow-up|1
5279996|NCT00552175|18213530|P2|Overall Study|Lost to Follow-up|0
5279997|NCT00552175|18213531|P1|Overall Study|Lost to Follow-up|0
5279998|NCT00552175|18213529|P3|Overall Study|Withdrawal by Subject|1
5279999|NCT00552175|18213530|P2|Overall Study|Withdrawal by Subject|2
5280000|NCT00552175|18213531|P1|Overall Study|Withdrawal by Subject|2
5280001|NCT00552175|18213529|P3|Overall Study|Adverse Event|10
5280002|NCT00552175|18213530|P2|Overall Study|Adverse Event|9
5280003|NCT00552175|18213531|P1|Overall Study|Adverse Event|9
5280004|NCT00552175|18213529|P3|Overall Study|Lack of Efficacy|1
5280005|NCT00552175|18213530|P2|Overall Study|Lack of Efficacy|0
5280006|NCT00552175|18213531|P1|Overall Study|Lack of Efficacy|2
5280007|NCT00552110|18213571|P5|Overall Study|Nonserious Adverse Event (AE)|0
5280008|NCT00552110|18213572|P4|Overall Study|Nonserious Adverse Event (AE)|1
5280009|NCT00552110|18213573|P3|Overall Study|Nonserious Adverse Event (AE)|0
5280010|NCT00552110|18213574|P2|Overall Study|Nonserious Adverse Event (AE)|0
5280011|NCT00552110|18213575|P1|Overall Study|Nonserious Adverse Event (AE)|1
5280012|NCT00552110|18213571|P5|Overall Study|Increased Blood Pressure at Visit 2|0
5280013|NCT00552110|18213572|P4|Overall Study|Increased Blood Pressure at Visit 2|1
5280014|NCT00552110|18213573|P3|Overall Study|Increased Blood Pressure at Visit 2|0
5280015|NCT00552110|18213574|P2|Overall Study|Increased Blood Pressure at Visit 2|0
5280016|NCT00552110|18213575|P1|Overall Study|Increased Blood Pressure at Visit 2|0
5280017|NCT00552110|18213571|P5|Overall Study|Delay of Study due to Relabeling|0
5280018|NCT00552110|18213572|P4|Overall Study|Delay of Study due to Relabeling|1
5280019|NCT00552110|18213573|P3|Overall Study|Delay of Study due to Relabeling|0
5280020|NCT00552110|18213574|P2|Overall Study|Delay of Study due to Relabeling|0
5280021|NCT00552110|18213575|P1|Overall Study|Delay of Study due to Relabeling|0
5280022|NCT00552110|18213571|P5|Overall Study|Use of Prohibited Medication|0
5280023|NCT00552110|18213572|P4|Overall Study|Use of Prohibited Medication|0
5280024|NCT00552110|18213573|P3|Overall Study|Use of Prohibited Medication|0
5280025|NCT00552110|18213574|P2|Overall Study|Use of Prohibited Medication|1
5280026|NCT00552110|18213575|P1|Overall Study|Use of Prohibited Medication|1
5280027|NCT00552110|18213571|P5|Overall Study|Withdrawn per Sponsor|1
5280028|NCT00552110|18213572|P4|Overall Study|Withdrawn per Sponsor|0
5280029|NCT00552110|18213573|P3|Overall Study|Withdrawn per Sponsor|0
5280030|NCT00552110|18213574|P2|Overall Study|Withdrawn per Sponsor|1
5280031|NCT00552110|18213575|P1|Overall Study|Withdrawn per Sponsor|0
5280032|NCT00552110|18213571|P5|Overall Study|Failed to Comply With Study Requirements|1
5280033|NCT00552110|18213572|P4|Overall Study|Failed to Comply With Study Requirements|0
5280034|NCT00552110|18213573|P3|Overall Study|Failed to Comply With Study Requirements|1
5280035|NCT00552110|18213574|P2|Overall Study|Failed to Comply With Study Requirements|1
5280036|NCT00552110|18213575|P1|Overall Study|Failed to Comply With Study Requirements|1
5280037|NCT00552110|18213571|P5|Overall Study|Lost to Follow-up|1
5280038|NCT00552110|18213572|P4|Overall Study|Lost to Follow-up|1
5280039|NCT00552110|18213573|P3|Overall Study|Lost to Follow-up|0
5280040|NCT00552110|18213574|P2|Overall Study|Lost to Follow-up|0
5280041|NCT00552110|18213575|P1|Overall Study|Lost to Follow-up|0
5280042|NCT00552110|18213571|P5|Overall Study|Withdrawal by Subject|2
5280043|NCT00552110|18213572|P4|Overall Study|Withdrawal by Subject|3
5280044|NCT00552110|18213573|P3|Overall Study|Withdrawal by Subject|0
5280045|NCT00552110|18213574|P2|Overall Study|Withdrawal by Subject|2
5280046|NCT00552110|18213575|P1|Overall Study|Withdrawal by Subject|0
5280047|NCT00552110|18213571|P5|Overall Study|Lack of Efficacy|4
5280048|NCT00552110|18213572|P4|Overall Study|Lack of Efficacy|1
5280049|NCT00552110|18213573|P3|Overall Study|Lack of Efficacy|0
5280050|NCT00552110|18213574|P2|Overall Study|Lack of Efficacy|0
5280051|NCT00552110|18213575|P1|Overall Study|Lack of Efficacy|1
5280052|NCT00552110|18213571|P5|Overall Study|Serious or Life-Threatening AE|0
5280053|NCT00552110|18213572|P4|Overall Study|Serious or Life-Threatening AE|0
5280054|NCT00552110|18213573|P3|Overall Study|Serious or Life-Threatening AE|1
5280055|NCT00552110|18213574|P2|Overall Study|Serious or Life-Threatening AE|0
5280056|NCT00552110|18213575|P1|Overall Study|Serious or Life-Threatening AE|0
5280057|NCT00552084|18213594|P2|Overall Study|change in anti-arrythmic drug|1
5280058|NCT00552084|18213595|P1|Overall Study|change in anti-arrythmic drug|1
5280059|NCT00552084|18213594|P2|Overall Study|Protocol Violation|0
5280060|NCT00552084|18213595|P1|Overall Study|Protocol Violation|1
5280061|NCT00552084|18213594|P2|Overall Study|Withdrawal by Subject|5
5280062|NCT00552084|18213595|P1|Overall Study|Withdrawal by Subject|4
5280063|NCT00552084|18213594|P2|Overall Study|Adverse Event|3
5280064|NCT00552084|18213595|P1|Overall Study|Adverse Event|2
5280065|NCT00552071|18213603|P2|Overall Study|Withdrawal by Subject|1
5280066|NCT00552071|18213604|P1|Overall Study|Withdrawal by Subject|0
5280067|NCT00552071|18213603|P2|Overall Study|Death|1
5280068|NCT00552071|18213604|P1|Overall Study|Death|0
5280069|NCT00552071|18213603|P2|Overall Study|Pregnancy|0
5280070|NCT00552071|18213604|P1|Overall Study|Pregnancy|1
5280071|NCT00552071|18213603|P2|Overall Study|Physician Decision|0
5280072|NCT00552071|18213604|P1|Overall Study|Physician Decision|1
5280073|NCT00552071|18213603|P2|Overall Study|Lack of Efficacy|0
5280074|NCT00552071|18213604|P1|Overall Study|Lack of Efficacy|1
5280075|NCT00552071|18213603|P2|Overall Study|Adverse Event|0
5280076|NCT00552071|18213604|P1|Overall Study|Adverse Event|1
5280077|NCT00552058|18213614|P2|Overall Study|Other: Early Roll Over|0
5280078|NCT00552058|18213615|P1|Overall Study|Other: Early Roll Over|1
5280079|NCT00552058|18213614|P2|Overall Study|Other: Sponsors Decision|1
5280080|NCT00552058|18213615|P1|Overall Study|Other: Sponsors Decision|0
5280081|NCT00552058|18213614|P2|Overall Study|Other: Randomized in error|1
5280082|NCT00552058|18213615|P1|Overall Study|Other: Randomized in error|0
5280083|NCT00552058|18213614|P2|Overall Study|Other: Positive Stool Result|1
5280084|NCT00552058|18213615|P1|Overall Study|Other: Positive Stool Result|0
5280085|NCT00552058|18213614|P2|Overall Study|Other: Low CDAI score, entry violation|1
5280086|NCT00552058|18213615|P1|Overall Study|Other: Low CDAI score, entry violation|0
5280087|NCT00552058|18213614|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
5280088|NCT00552058|18213615|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
5280089|NCT00552058|18213614|P2|Overall Study|Other: Non Compliance|2
5280090|NCT00552058|18213615|P1|Overall Study|Other: Non Compliance|1
5280091|NCT00552058|18213614|P2|Overall Study|Other: Protocol Violation|1
5280092|NCT00552058|18213615|P1|Overall Study|Other: Protocol Violation|0
5280093|NCT00552058|18213614|P2|Overall Study|Withdrawal by Subject|4
5280094|NCT00552058|18213615|P1|Overall Study|Withdrawal by Subject|4
5280095|NCT00552058|18213614|P2|Overall Study|Lost to Follow-up|0
5280096|NCT00552058|18213615|P1|Overall Study|Lost to Follow-up|1
5280097|NCT00552058|18213614|P2|Overall Study|Lack of Efficacy|5
5280098|NCT00552058|18213615|P1|Overall Study|Lack of Efficacy|1
5280099|NCT00552058|18213614|P2|Overall Study|Adverse Event|7
5280100|NCT00552058|18213615|P1|Overall Study|Adverse Event|8
5280101|NCT00552032|18213655|P2|Overall Study|Lost to Follow-up|5
5280102|NCT00552032|18213656|P1|Overall Study|Lost to Follow-up|8
5280103|NCT00552032|18213655|P2|Overall Study|Protocol Violation|12
5280104|NCT00552032|18213656|P1|Overall Study|Protocol Violation|7
5280105|NCT00552032|18213655|P2|Overall Study|Withdrawal by Subject|2
5280106|NCT00552032|18213656|P1|Overall Study|Withdrawal by Subject|2
5280107|NCT00551759|18213700|P1|Overall Study|Ineligible|1
5280108|NCT00551759|18213700|P1|Overall Study|Death|5
5280109|NCT00551759|18213700|P1|Overall Study|Adverse Event|7
5280110|NCT00551642|18213741|P2|Overall Study|Inclusion/Exclusion criteria|4
5280111|NCT00551642|18213742|P1|Overall Study|Inclusion/Exclusion criteria|4
5280112|NCT00551642|18213741|P2|Overall Study|Delivery device failure|3
5280113|NCT00551642|18213742|P1|Overall Study|Delivery device failure|1
5280114|NCT00551642|18213741|P2|Overall Study|Physician Decision|1
5280115|NCT00551642|18213742|P1|Overall Study|Physician Decision|0
5280116|NCT00551642|18213741|P2|Overall Study|Protocol Violation|11
5280117|NCT00551642|18213742|P1|Overall Study|Protocol Violation|6
5280118|NCT00551642|18213741|P2|Overall Study|Death|31
5280119|NCT00551642|18213742|P1|Overall Study|Death|33
5280120|NCT00551642|18213741|P2|Overall Study|Adverse Event|12
5280121|NCT00551642|18213742|P1|Overall Study|Adverse Event|15
5280122|NCT00551642|18213741|P2|Overall Study|Withdrawal by Subject|1
5280123|NCT00551642|18213742|P1|Overall Study|Withdrawal by Subject|2
5280124|NCT00551525|18213748|P1|Overall Study|Protocol Violation|5
5280125|NCT00551460|18213757|P1|Overall Study|Not analyzable (did not start treatment)|4
5280126|NCT00551460|18213757|P1|Overall Study|Ineligible|4
5280127|NCT00551460|18213757|P1|Overall Study|Death|7
5280128|NCT00551460|18213757|P1|Overall Study|Physician Decision|1
5280129|NCT00551460|18213757|P1|Overall Study|Withdrawal by Subject|1
5280130|NCT00551460|18213757|P1|Overall Study|Adverse Event|1
5280131|NCT00551421|18213763|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
5280132|NCT00551369|18213770|P1|Overall Study|Not treated per protocol and re|1
5280133|NCT00551369|18213770|P1|Overall Study|Withdrawal by Subject|1
5280134|NCT00551369|18213770|P1|Overall Study|Protocol Violation|5
5280135|NCT00551291|18213779|P1|Overall Study|Physician Decision|1
5280136|NCT00551213|18213787|P2|Overall Study|Not Treated|2
5280137|NCT00551213|18213788|P1|Overall Study|Not Treated|1
5280138|NCT00551213|18213787|P2|Overall Study|Withdrawal by Subject|0
5280139|NCT00551213|18213788|P1|Overall Study|Withdrawal by Subject|2
5280140|NCT00551213|18213787|P2|Overall Study|Progressive Disease|12
5280141|NCT00551213|18213788|P1|Overall Study|Progressive Disease|41
5280142|NCT00551213|18213787|P2|Overall Study|Adverse Event|3
5280143|NCT00551213|18213788|P1|Overall Study|Adverse Event|6
5280144|NCT00551161|18213832|P1|Overall Study|Withdrawal by Subject|1
5280145|NCT00551135|18213840|P4|Overall Study|Withdrawal by Subject|1
5280146|NCT00551135|18213841|P3|Overall Study|Withdrawal by Subject|3
5280147|NCT00551135|18213842|P2|Overall Study|Withdrawal by Subject|0
5280148|NCT00551135|18213843|P1|Overall Study|Withdrawal by Subject|1
5280149|NCT00551135|18213840|P4|Overall Study|Other|2
5280150|NCT00551135|18213841|P3|Overall Study|Other|1
5280151|NCT00551135|18213842|P2|Overall Study|Other|2
5280152|NCT00551135|18213843|P1|Overall Study|Other|3
5280153|NCT00551135|18213840|P4|Overall Study|Lost to Follow-up|1
5280154|NCT00551135|18213841|P3|Overall Study|Lost to Follow-up|0
5280155|NCT00551135|18213842|P2|Overall Study|Lost to Follow-up|0
5280156|NCT00551135|18213843|P1|Overall Study|Lost to Follow-up|0
5280157|NCT00551135|18213840|P4|Overall Study|Adverse Event|1
5280158|NCT00551135|18213841|P3|Overall Study|Adverse Event|1
5280159|NCT00551135|18213842|P2|Overall Study|Adverse Event|0
5280160|NCT00551135|18213843|P1|Overall Study|Adverse Event|1
5280161|NCT00551031|18213972|P5|Overall Study|Did not receive vaccine|0
5280162|NCT00551031|18213973|P4|Overall Study|Did not receive vaccine|0
5280163|NCT00551031|18213974|P3|Overall Study|Did not receive vaccine|0
5280164|NCT00551031|18213975|P2|Overall Study|Did not receive vaccine|2
5280165|NCT00551031|18213976|P1|Overall Study|Did not receive vaccine|1
5280166|NCT00551031|18213972|P5|Overall Study|Serious Adverse Event|0
5280167|NCT00551031|18213973|P4|Overall Study|Serious Adverse Event|0
5280168|NCT00551031|18213974|P3|Overall Study|Serious Adverse Event|1
5280169|NCT00551031|18213975|P2|Overall Study|Serious Adverse Event|2
5280170|NCT00551031|18213976|P1|Overall Study|Serious Adverse Event|0
5280171|NCT00551031|18213972|P5|Overall Study|Withdrawal by Subject|0
5280172|NCT00551031|18213973|P4|Overall Study|Withdrawal by Subject|2
5280173|NCT00551031|18213974|P3|Overall Study|Withdrawal by Subject|1
5280174|NCT00551031|18213975|P2|Overall Study|Withdrawal by Subject|4
5280175|NCT00551031|18213976|P1|Overall Study|Withdrawal by Subject|0
5280176|NCT00551031|18213972|P5|Overall Study|Lost to Follow-up|1
5280177|NCT00551031|18213973|P4|Overall Study|Lost to Follow-up|1
5280178|NCT00551031|18213974|P3|Overall Study|Lost to Follow-up|0
5280179|NCT00551031|18213975|P2|Overall Study|Lost to Follow-up|1
5280180|NCT00551031|18213976|P1|Overall Study|Lost to Follow-up|0
5280181|NCT00551031|18213972|P5|Overall Study|Protocol Violation|0
5280182|NCT00551031|18213973|P4|Overall Study|Protocol Violation|0
5280183|NCT00551031|18213974|P3|Overall Study|Protocol Violation|0
5280184|NCT00551031|18213975|P2|Overall Study|Protocol Violation|1
5280185|NCT00551031|18213976|P1|Overall Study|Protocol Violation|1
5280186|NCT00551031|18213972|P5|Overall Study|Adverse Event|0
5280187|NCT00551031|18213973|P4|Overall Study|Adverse Event|0
5280188|NCT00551031|18213974|P3|Overall Study|Adverse Event|0
5280189|NCT00551031|18213975|P2|Overall Study|Adverse Event|1
5280190|NCT00551031|18213976|P1|Overall Study|Adverse Event|0
5280191|NCT00550953|18214005|P2|Overall Study|Not able to visit the site|3
5280192|NCT00550953|18214006|P1|Overall Study|Not able to visit the site|2
5280193|NCT00550953|18214005|P2|Overall Study|Adverse Event|3
5280194|NCT00550953|18214006|P1|Overall Study|Adverse Event|4
5280195|NCT00550836|18214053|P2|Overall Study|Withdrawal by Subject|9
5280196|NCT00550836|18214054|P1|Overall Study|Withdrawal by Subject|3
5280197|NCT00550771|18214070|P2|Overall Study|Protocol Violation|5
5280198|NCT00550771|18214071|P1|Overall Study|Protocol Violation|4
5280199|NCT00550771|18214070|P2|Overall Study|Withdrawal by Subject|1
5280200|NCT00550771|18214071|P1|Overall Study|Withdrawal by Subject|0
5280201|NCT00550771|18214070|P2|Overall Study|Physician Decision|0
5280202|NCT00550771|18214071|P1|Overall Study|Physician Decision|2
5280203|NCT00550771|18214070|P2|Overall Study|Discontinued for study-related reasons|1
5280204|NCT00550771|18214071|P1|Overall Study|Discontinued for study-related reasons|0
5280205|NCT00550771|18214070|P2|Overall Study|Adverse Event|3
5280206|NCT00550771|18214071|P1|Overall Study|Adverse Event|11
5280207|NCT00550745|18214085|P2|Overall Study|Screen failure|0
5280208|NCT00550745|18214086|P1|Overall Study|Screen failure|1
5280209|NCT00550745|18214085|P2|Overall Study|Withdrawal by Subject|10
5280210|NCT00550745|18214086|P1|Overall Study|Withdrawal by Subject|17
5280211|NCT00550745|18214085|P2|Overall Study|Protocol Violation|2
5280212|NCT00550745|18214086|P1|Overall Study|Protocol Violation|4
5280213|NCT00550745|18214085|P2|Overall Study|Physician Decision|2
5280214|NCT00550745|18214086|P1|Overall Study|Physician Decision|0
5280215|NCT00550745|18214085|P2|Overall Study|Lost to Follow-up|30
5280216|NCT00550745|18214086|P1|Overall Study|Lost to Follow-up|45
5280217|NCT00550745|18214085|P2|Overall Study|Death|16
5280218|NCT00550745|18214086|P1|Overall Study|Death|20
5280219|NCT00550732|18214094|P1|Overall Study|Adverse Event|1
5280220|NCT00550732|18214094|P1|Overall Study|Palliative care|1
5280221|NCT00550732|18214094|P1|Overall Study|Lost to Follow-up|1
5280222|NCT00550732|18214094|P1|Overall Study|Physician Decision|2
5280223|NCT00550732|18214094|P1|Overall Study|Withdrawal by Subject|2
5280224|NCT00550732|18214094|P1|Overall Study|Death|4
5280225|NCT00550680|18214105|P1|Overall Study|Screen Failure|6
5280226|NCT00550680|18214105|P1|Overall Study|Refused Treatment|19
5280227|NCT00550680|18214105|P1|Overall Study|Protocol Violation|7
5280228|NCT00550680|18214105|P1|Overall Study|Other|10
5280229|NCT00550680|18214105|P1|Overall Study|Lack of Efficacy|1
5280230|NCT00550680|18214105|P1|Overall Study|Lost to Follow-up|3
5280231|NCT00550680|18214105|P1|Overall Study|Early Improvement|1
5280232|NCT00550680|18214105|P1|Overall Study|Death|3
5280233|NCT00550680|18214105|P1|Overall Study|Adverse Event|5
5280234|NCT00550680|18214105|P1|Overall Study|Administrative Reasons|1
5280235|NCT00550615|18214126|P4|Overall Study|Not evaluable|7
5280236|NCT00550615|18214127|P3|Overall Study|Not evaluable|2
5280237|NCT00550615|18214128|P2|Overall Study|Not evaluable|0
5280238|NCT00550615|18214129|P1|Overall Study|Not evaluable|0
5280239|NCT00550615|18214126|P4|Overall Study|Withdrawal by Subject|3
5280240|NCT00550615|18214127|P3|Overall Study|Withdrawal by Subject|2
5280241|NCT00550615|18214128|P2|Overall Study|Withdrawal by Subject|0
5280242|NCT00550615|18214129|P1|Overall Study|Withdrawal by Subject|0
5280243|NCT00550550|18214148|P2|Overall Study|Randomized But Not Treated|0
5280244|NCT00550550|18214149|P1|Overall Study|Randomized But Not Treated|1
5280245|NCT00550550|18214148|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5280246|NCT00550550|18214149|P1|Overall Study|Did Not Meet Protocol Eligibility|1
5280247|NCT00550550|18214148|P2|Overall Study|Protocol Violation|14
5280248|NCT00550550|18214149|P1|Overall Study|Protocol Violation|5
5280249|NCT00550550|18214148|P2|Overall Study|Withdrawal by Subject|8
5280250|NCT00550550|18214149|P1|Overall Study|Withdrawal by Subject|10
5280251|NCT00550550|18214148|P2|Overall Study|Lost to Follow-up|0
5280252|NCT00550550|18214149|P1|Overall Study|Lost to Follow-up|4
5280253|NCT00550550|18214148|P2|Overall Study|Treatment Failure|1
5280254|NCT00550550|18214149|P1|Overall Study|Treatment Failure|0
5280255|NCT00550550|18214148|P2|Overall Study|Adverse Event|5
5280256|NCT00550550|18214149|P1|Overall Study|Adverse Event|13
5280257|NCT00550537|18214161|P1|Overall Study|Treated closer to home|4
5280258|NCT00550537|18214161|P1|Overall Study|Declining performance status|2
5280259|NCT00550537|18214161|P1|Overall Study|Other complicating ilness|3
5280260|NCT00550537|18214161|P1|Overall Study|Change in treatment plan|4
5280261|NCT00550537|18214161|P1|Overall Study|Withdrawal by Subject|7
5280262|NCT00550537|18214161|P1|Overall Study|Disease progression before|46
5280263|NCT00550537|18214161|P1|Overall Study|Adverse Event|20
5280264|NCT00550537|18214161|P1|Overall Study|Death|18
5280265|NCT00550459|18214178|P2|Overall Study|Withdrawal by Subject|1
5280266|NCT00550459|18214179|P1|Overall Study|Withdrawal by Subject|1
5280267|NCT00550459|18214178|P2|Overall Study|Adverse Event|2
5280268|NCT00550459|18214179|P1|Overall Study|Adverse Event|0
5280269|NCT00550446|18214248|P11|Post Week 12|Other|0
5280270|NCT00550446|18214249|P10|Post Week 12|Other|1
5280271|NCT00550446|18214250|P9|Post Week 12|Other|1
5280272|NCT00550446|18214251|P8|Post Week 12|Other|0
5280273|NCT00550446|18214252|P7|Post Week 12|Other|1
5280274|NCT00550446|18214253|P6|Post Week 12|Other|0
5280275|NCT00550446|18214254|P5|Post Week 12|Other|0
5280276|NCT00550446|18214255|P4|Post Week 12|Other|1
5280277|NCT00550446|18214256|P3|Post Week 12|Other|0
5280278|NCT00550446|18214257|P2|Post Week 12|Other|1
5280279|NCT00550446|18214258|P1|Post Week 12|Other|1
5280280|NCT00550446|18214248|P11|Post Week 12|Withdrawal by Subject|0
5280281|NCT00550446|18214249|P10|Post Week 12|Withdrawal by Subject|0
5280282|NCT00550446|18214250|P9|Post Week 12|Withdrawal by Subject|0
5280283|NCT00550446|18214251|P8|Post Week 12|Withdrawal by Subject|0
5280284|NCT00550446|18214252|P7|Post Week 12|Withdrawal by Subject|0
5280285|NCT00550446|18214253|P6|Post Week 12|Withdrawal by Subject|0
5280286|NCT00550446|18214254|P5|Post Week 12|Withdrawal by Subject|1
5280287|NCT00550446|18214255|P4|Post Week 12|Withdrawal by Subject|0
5280288|NCT00550446|18214256|P3|Post Week 12|Withdrawal by Subject|0
5280289|NCT00550446|18214257|P2|Post Week 12|Withdrawal by Subject|0
5280290|NCT00550446|18214258|P1|Post Week 12|Withdrawal by Subject|0
5280291|NCT00550446|18214248|P11|Post Week 12|Lost to Follow-up|0
5280292|NCT00550446|18214249|P10|Post Week 12|Lost to Follow-up|0
5280293|NCT00550446|18214250|P9|Post Week 12|Lost to Follow-up|0
5280294|NCT00550446|18214251|P8|Post Week 12|Lost to Follow-up|0
5280295|NCT00550446|18214252|P7|Post Week 12|Lost to Follow-up|1
5280296|NCT00550446|18214253|P6|Post Week 12|Lost to Follow-up|0
5280297|NCT00550446|18214254|P5|Post Week 12|Lost to Follow-up|0
5280298|NCT00550446|18214255|P4|Post Week 12|Lost to Follow-up|1
5280299|NCT00550446|18214256|P3|Post Week 12|Lost to Follow-up|1
5280300|NCT00550446|18214257|P2|Post Week 12|Lost to Follow-up|0
5280301|NCT00550446|18214258|P1|Post Week 12|Lost to Follow-up|0
5280302|NCT00550446|18214248|P11|Post Week 12|Lack of Efficacy|1
5280303|NCT00550446|18214249|P10|Post Week 12|Lack of Efficacy|2
5280304|NCT00550446|18214250|P9|Post Week 12|Lack of Efficacy|1
5280305|NCT00550446|18214251|P8|Post Week 12|Lack of Efficacy|1
5280306|NCT00550446|18214252|P7|Post Week 12|Lack of Efficacy|0
5280307|NCT00550446|18214253|P6|Post Week 12|Lack of Efficacy|0
5280308|NCT00550446|18214254|P5|Post Week 12|Lack of Efficacy|0
5280309|NCT00550446|18214255|P4|Post Week 12|Lack of Efficacy|0
5280310|NCT00550446|18214256|P3|Post Week 12|Lack of Efficacy|1
5280311|NCT00550446|18214257|P2|Post Week 12|Lack of Efficacy|0
5280312|NCT00550446|18214258|P1|Post Week 12|Lack of Efficacy|0
5280313|NCT00550446|18214248|P11|Post Week 12|Adverse Event|0
5280314|NCT00550446|18214249|P10|Post Week 12|Adverse Event|4
5280315|NCT00550446|18214250|P9|Post Week 12|Adverse Event|0
5280316|NCT00550446|18214251|P8|Post Week 12|Adverse Event|0
5280317|NCT00550446|18214252|P7|Post Week 12|Adverse Event|0
5280318|NCT00550446|18214253|P6|Post Week 12|Adverse Event|1
5280319|NCT00550446|18214254|P5|Post Week 12|Adverse Event|1
5280320|NCT00550446|18214255|P4|Post Week 12|Adverse Event|1
5280321|NCT00550446|18214256|P3|Post Week 12|Adverse Event|1
5280322|NCT00550446|18214257|P2|Post Week 12|Adverse Event|1
5280323|NCT00550446|18214258|P1|Post Week 12|Adverse Event|2
5280324|NCT00550446|18214248|P11|Up To Week 12|Randomized not treated|0
5280325|NCT00550446|18214249|P10|Up To Week 12|Randomized not treated|0
5280326|NCT00550446|18214250|P9|Up To Week 12|Randomized not treated|0
5280327|NCT00550446|18214251|P8|Up To Week 12|Randomized not treated|0
5280328|NCT00550446|18214252|P7|Up To Week 12|Randomized not treated|0
5280329|NCT00550446|18214253|P6|Up To Week 12|Randomized not treated|0
5280330|NCT00550446|18214254|P5|Up To Week 12|Randomized not treated|0
5280331|NCT00550446|18214255|P4|Up To Week 12|Randomized not treated|0
5280332|NCT00550446|18214256|P3|Up To Week 12|Randomized not treated|1
5280333|NCT00550446|18214257|P2|Up To Week 12|Randomized not treated|1
5280334|NCT00550446|18214258|P1|Up To Week 12|Randomized not treated|0
5280335|NCT00550446|18214248|P11|Up To Week 12|Other|0
5280336|NCT00550446|18214249|P10|Up To Week 12|Other|0
5280337|NCT00550446|18214250|P9|Up To Week 12|Other|0
5280338|NCT00550446|18214251|P8|Up To Week 12|Other|0
5280339|NCT00550446|18214252|P7|Up To Week 12|Other|4
5280340|NCT00550446|18214253|P6|Up To Week 12|Other|1
5280341|NCT00550446|18214254|P5|Up To Week 12|Other|0
5280342|NCT00550446|18214255|P4|Up To Week 12|Other|0
5280343|NCT00550446|18214256|P3|Up To Week 12|Other|0
5280344|NCT00550446|18214257|P2|Up To Week 12|Other|0
5280345|NCT00550446|18214258|P1|Up To Week 12|Other|3
5280346|NCT00550446|18214248|P11|Up To Week 12|Withdrawal by Subject|0
5280347|NCT00550446|18214249|P10|Up To Week 12|Withdrawal by Subject|0
5280348|NCT00550446|18214250|P9|Up To Week 12|Withdrawal by Subject|0
5280349|NCT00550446|18214251|P8|Up To Week 12|Withdrawal by Subject|0
5280350|NCT00550446|18214252|P7|Up To Week 12|Withdrawal by Subject|3
5280351|NCT00550446|18214253|P6|Up To Week 12|Withdrawal by Subject|1
5280352|NCT00550446|18214254|P5|Up To Week 12|Withdrawal by Subject|0
5280353|NCT00550446|18214255|P4|Up To Week 12|Withdrawal by Subject|2
5280354|NCT00550446|18214256|P3|Up To Week 12|Withdrawal by Subject|3
5280355|NCT00550446|18214257|P2|Up To Week 12|Withdrawal by Subject|0
5280356|NCT00550446|18214258|P1|Up To Week 12|Withdrawal by Subject|2
5280357|NCT00550446|18214248|P11|Up To Week 12|Lost to Follow-up|0
5280358|NCT00550446|18214249|P10|Up To Week 12|Lost to Follow-up|0
5280359|NCT00550446|18214250|P9|Up To Week 12|Lost to Follow-up|0
5280360|NCT00550446|18214251|P8|Up To Week 12|Lost to Follow-up|0
5280361|NCT00550446|18214252|P7|Up To Week 12|Lost to Follow-up|2
5280362|NCT00550446|18214253|P6|Up To Week 12|Lost to Follow-up|1
5280363|NCT00550446|18214254|P5|Up To Week 12|Lost to Follow-up|1
5280364|NCT00550446|18214255|P4|Up To Week 12|Lost to Follow-up|0
5280365|NCT00550446|18214256|P3|Up To Week 12|Lost to Follow-up|0
5280366|NCT00550446|18214257|P2|Up To Week 12|Lost to Follow-up|1
5280367|NCT00550446|18214258|P1|Up To Week 12|Lost to Follow-up|0
5280368|NCT00550446|18214248|P11|Up To Week 12|Lack of Efficacy|0
5280369|NCT00550446|18214249|P10|Up To Week 12|Lack of Efficacy|0
5280370|NCT00550446|18214250|P9|Up To Week 12|Lack of Efficacy|0
5280371|NCT00550446|18214251|P8|Up To Week 12|Lack of Efficacy|0
5280372|NCT00550446|18214252|P7|Up To Week 12|Lack of Efficacy|3
5280373|NCT00550446|18214253|P6|Up To Week 12|Lack of Efficacy|3
5280374|NCT00550446|18214254|P5|Up To Week 12|Lack of Efficacy|0
5280375|NCT00550446|18214255|P4|Up To Week 12|Lack of Efficacy|1
5280376|NCT00550446|18214256|P3|Up To Week 12|Lack of Efficacy|0
5280377|NCT00550446|18214257|P2|Up To Week 12|Lack of Efficacy|1
5280378|NCT00550446|18214258|P1|Up To Week 12|Lack of Efficacy|3
5280379|NCT00550446|18214248|P11|Up To Week 12|Adverse Event|0
5280380|NCT00550446|18214249|P10|Up To Week 12|Adverse Event|0
5280381|NCT00550446|18214250|P9|Up To Week 12|Adverse Event|0
5280382|NCT00550446|18214251|P8|Up To Week 12|Adverse Event|0
5280383|NCT00550446|18214252|P7|Up To Week 12|Adverse Event|1
5280384|NCT00550446|18214253|P6|Up To Week 12|Adverse Event|2
5280385|NCT00550446|18214254|P5|Up To Week 12|Adverse Event|2
5280386|NCT00550446|18214255|P4|Up To Week 12|Adverse Event|0
5280387|NCT00550446|18214256|P3|Up To Week 12|Adverse Event|0
5280388|NCT00550446|18214257|P2|Up To Week 12|Adverse Event|2
5280389|NCT00550446|18214258|P1|Up To Week 12|Adverse Event|2
5280390|NCT00550420|18214690|P1|Overall Study|Prohibited medicine|1
5280391|NCT00550420|18214690|P1|Overall Study|Exclusion criteria|1
5280392|NCT00550420|18214690|P1|Overall Study|Out of Electrocardiogram criteria|1
5280393|NCT00550420|18214690|P1|Overall Study|Caregiver's decision to withdraw|1
5280394|NCT00550420|18214690|P1|Overall Study|Unethical stop of enrollment|2
5280395|NCT00550420|18214690|P1|Overall Study|Lack of curative effect|1
5280396|NCT00550420|18214690|P1|Overall Study|Investigators opinion|1
5280397|NCT00550420|18214690|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
5280398|NCT00550420|18214690|P1|Overall Study|Missing|2
5280399|NCT00550420|18214690|P1|Overall Study|Still in study at termination|206
5280400|NCT00550420|18214690|P1|Overall Study|Withdrawal by Subject|30
5280401|NCT00550420|18214690|P1|Overall Study|Protocol Violation|11
5280402|NCT00550420|18214690|P1|Overall Study|Lost to Follow-up|8
5280403|NCT00550420|18214690|P1|Overall Study|Adverse Event|28
5280404|NCT00550407|18214713|P3|26-Week Randomized Phase|Withdrawal by Subject|3
5280405|NCT00550407|18214714|P2|26-Week Randomized Phase|Withdrawal by Subject|1
5280406|NCT00550407|18214715|P1|26-Week Randomized Phase|Withdrawal by Subject|0
5280407|NCT00550407|18214713|P3|26-Week Randomized Phase|Investigator Discretion|0
5280408|NCT00550407|18214714|P2|26-Week Randomized Phase|Investigator Discretion|1
5280409|NCT00550407|18214715|P1|26-Week Randomized Phase|Investigator Discretion|0
5280410|NCT00550407|18214713|P3|26-Week Randomized Phase|Lack of Efficacy|19
5280411|NCT00550407|18214714|P2|26-Week Randomized Phase|Lack of Efficacy|36
5280412|NCT00550407|18214715|P1|26-Week Randomized Phase|Lack of Efficacy|0
5280413|NCT00550407|18214713|P3|26-Week Randomized Phase|Adverse Event|2
5280414|NCT00550407|18214714|P2|26-Week Randomized Phase|Adverse Event|5
5280415|NCT00550407|18214715|P1|26-Week Randomized Phase|Adverse Event|0
5280416|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
5280417|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
5280418|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
5280419|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
5280420|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
5280421|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
5280422|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
5280423|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
5280424|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
5280425|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
5280426|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
5280427|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
5280428|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
5280429|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
5280430|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
5280431|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
5280432|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
5280433|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
5280434|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
5280435|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
5280436|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
5280437|NCT00550407|18214713|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
5280438|NCT00550407|18214714|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
5280439|NCT00550407|18214715|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
5280440|NCT00550238|18214787|P1|Overall Study|Sponsor decision|55
5280441|NCT00550238|18214787|P1|Overall Study|Lost to Follow-up|13
5280442|NCT00550238|18214787|P1|Overall Study|Patient noncompliance|25
5280443|NCT00550238|18214787|P1|Overall Study|Physician Decision|31
5280444|NCT00550238|18214787|P1|Overall Study|Withdrawal by Subject|167
5280445|NCT00550238|18214787|P1|Overall Study|Disease progression|46
5280446|NCT00550238|18214787|P1|Overall Study|Death|34
5280447|NCT00550238|18214787|P1|Overall Study|Adverse Event|88
5280448|NCT00550173|18214794|P3|Overall Study|Lost to Follow-up|3
5280449|NCT00550173|18214795|P2|Overall Study|Lost to Follow-up|4
5280450|NCT00550173|18214796|P1|Overall Study|Lost to Follow-up|4
5280451|NCT00550173|18214794|P3|Overall Study|Sponsor Decision|1
5280452|NCT00550173|18214795|P2|Overall Study|Sponsor Decision|7
5280453|NCT00550173|18214796|P1|Overall Study|Sponsor Decision|13
5280454|NCT00550173|18214794|P3|Overall Study|Withdrawal by Subject|17
5280455|NCT00550173|18214795|P2|Overall Study|Withdrawal by Subject|12
5280456|NCT00550173|18214796|P1|Overall Study|Withdrawal by Subject|9
5280457|NCT00550173|18214794|P3|Overall Study|Physician Decision|2
5280458|NCT00550173|18214795|P2|Overall Study|Physician Decision|2
5280459|NCT00550173|18214796|P1|Overall Study|Physician Decision|1
5280460|NCT00550173|18214794|P3|Overall Study|Death|50
5280461|NCT00550173|18214795|P2|Overall Study|Death|38
5280462|NCT00550173|18214796|P1|Overall Study|Death|45
5280463|NCT00550147|18214825|P1|Quetiapine Addition Treatment Period|Moved out of state|1
5280464|NCT00550147|18214825|P1|Quetiapine Addition Treatment Period|Noncompliance|2
5280465|NCT00550147|18214825|P1|Quetiapine Addition Treatment Period|Adverse Event|3
5280466|NCT00550147|18214825|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
5280467|NCT00550147|18214825|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
5280468|NCT00550043|18214848|P5|Overall Study|Other Reasons- Unspecified|0
5280469|NCT00550043|18214849|P4|Overall Study|Other Reasons- Unspecified|1
5280470|NCT00550043|18214850|P3|Overall Study|Other Reasons- Unspecified|0
5280471|NCT00550043|18214851|P2|Overall Study|Other Reasons- Unspecified|1
5280472|NCT00550043|18214852|P1|Overall Study|Other Reasons- Unspecified|0
5280473|NCT00550043|18214848|P5|Overall Study|Subject Withdrew Consent|0
5280474|NCT00550043|18214849|P4|Overall Study|Subject Withdrew Consent|0
5280475|NCT00550043|18214850|P3|Overall Study|Subject Withdrew Consent|1
5280476|NCT00550043|18214851|P2|Overall Study|Subject Withdrew Consent|2
5280477|NCT00550043|18214852|P1|Overall Study|Subject Withdrew Consent|0
5280478|NCT00550043|18214848|P5|Overall Study|Adverse Event|1
5280479|NCT00550043|18214849|P4|Overall Study|Adverse Event|1
5280480|NCT00550043|18214850|P3|Overall Study|Adverse Event|0
5280481|NCT00550043|18214851|P2|Overall Study|Adverse Event|0
5280482|NCT00550043|18214852|P1|Overall Study|Adverse Event|0
5280483|NCT00549939|18214907|P3|40-week Open Label Treatment Period|Other|4
5280484|NCT00549939|18214908|P2|40-week Open Label Treatment Period|Other|1
5280485|NCT00549939|18214909|P1|40-week Open Label Treatment Period|Other|0
5280486|NCT00549939|18214907|P3|40-week Open Label Treatment Period|Protocol Violation|0
5280487|NCT00549939|18214908|P2|40-week Open Label Treatment Period|Protocol Violation|1
5280488|NCT00549939|18214909|P1|40-week Open Label Treatment Period|Protocol Violation|0
5280489|NCT00549939|18214907|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
5280490|NCT00549939|18214908|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
5280491|NCT00549939|18214909|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
5280492|NCT00549939|18214907|P3|40-week Open Label Treatment Period|Adverse Event|1
5280493|NCT00549939|18214908|P2|40-week Open Label Treatment Period|Adverse Event|2
5280494|NCT00549939|18214909|P1|40-week Open Label Treatment Period|Adverse Event|0
5280495|NCT00549939|18214907|P3|12-week Double Blind Treatment Period|Too many blood draws|0
5280496|NCT00549939|18214908|P2|12-week Double Blind Treatment Period|Too many blood draws|1
5280497|NCT00549939|18214909|P1|12-week Double Blind Treatment Period|Too many blood draws|0
5280498|NCT00549939|18214907|P3|12-week Double Blind Treatment Period|Adverse Event|2
5280499|NCT00549939|18214908|P2|12-week Double Blind Treatment Period|Adverse Event|1
5280500|NCT00549939|18214909|P1|12-week Double Blind Treatment Period|Adverse Event|1
5280501|NCT00549900|18214936|P1|Overall Study|Adverse Event|1
5280502|NCT00549770|18214992|P8|Overall Study|Adverse Event|4
5280503|NCT00549770|18214993|P7|Overall Study|Adverse Event|5
5280504|NCT00549770|18214994|P6|Overall Study|Adverse Event|0
5280505|NCT00549770|18214995|P5|Overall Study|Adverse Event|1
5280506|NCT00549770|18214996|P4|Overall Study|Adverse Event|2
5280507|NCT00549770|18214997|P3|Overall Study|Adverse Event|1
5280508|NCT00549770|18214998|P2|Overall Study|Adverse Event|3
5280509|NCT00549770|18214999|P1|Overall Study|Adverse Event|1
5280510|NCT00549770|18214992|P8|Overall Study|Abnormal laboratory values|0
5280511|NCT00549770|18214993|P7|Overall Study|Abnormal laboratory values|0
5280512|NCT00549770|18214994|P6|Overall Study|Abnormal laboratory values|1
5280513|NCT00549770|18214995|P5|Overall Study|Abnormal laboratory values|0
5280514|NCT00549770|18214996|P4|Overall Study|Abnormal laboratory values|0
5280515|NCT00549770|18214997|P3|Overall Study|Abnormal laboratory values|0
5280516|NCT00549770|18214998|P2|Overall Study|Abnormal laboratory values|0
5280517|NCT00549770|18214999|P1|Overall Study|Abnormal laboratory values|0
5280518|NCT00549770|18214992|P8|Overall Study|Abnormal test procedure results|1
5280519|NCT00549770|18214993|P7|Overall Study|Abnormal test procedure results|1
5280520|NCT00549770|18214994|P6|Overall Study|Abnormal test procedure results|1
5280521|NCT00549770|18214995|P5|Overall Study|Abnormal test procedure results|0
5280522|NCT00549770|18214996|P4|Overall Study|Abnormal test procedure results|2
5280523|NCT00549770|18214997|P3|Overall Study|Abnormal test procedure results|0
5280524|NCT00549770|18214998|P2|Overall Study|Abnormal test procedure results|0
5280525|NCT00549770|18214999|P1|Overall Study|Abnormal test procedure results|0
5280526|NCT00549770|18214992|P8|Overall Study|Lack of Efficacy|8
5280527|NCT00549770|18214993|P7|Overall Study|Lack of Efficacy|3
5280528|NCT00549770|18214994|P6|Overall Study|Lack of Efficacy|1
5280529|NCT00549770|18214995|P5|Overall Study|Lack of Efficacy|5
5280530|NCT00549770|18214996|P4|Overall Study|Lack of Efficacy|3
5280531|NCT00549770|18214997|P3|Overall Study|Lack of Efficacy|2
5280532|NCT00549770|18214998|P2|Overall Study|Lack of Efficacy|0
5280533|NCT00549770|18214999|P1|Overall Study|Lack of Efficacy|1
5280534|NCT00549770|18214992|P8|Overall Study|Withdrawal by Subject|9
5280535|NCT00549770|18214993|P7|Overall Study|Withdrawal by Subject|4
5280536|NCT00549770|18214994|P6|Overall Study|Withdrawal by Subject|6
5280537|NCT00549770|18214995|P5|Overall Study|Withdrawal by Subject|6
5280538|NCT00549770|18214996|P4|Overall Study|Withdrawal by Subject|5
5280539|NCT00549770|18214997|P3|Overall Study|Withdrawal by Subject|4
5280540|NCT00549770|18214998|P2|Overall Study|Withdrawal by Subject|6
5280541|NCT00549770|18214999|P1|Overall Study|Withdrawal by Subject|4
5280542|NCT00549770|18214992|P8|Overall Study|Lost to Follow-up|0
5280543|NCT00549770|18214993|P7|Overall Study|Lost to Follow-up|0
5280544|NCT00549770|18214994|P6|Overall Study|Lost to Follow-up|2
5280545|NCT00549770|18214995|P5|Overall Study|Lost to Follow-up|3
5280546|NCT00549770|18214996|P4|Overall Study|Lost to Follow-up|2
5280547|NCT00549770|18214997|P3|Overall Study|Lost to Follow-up|2
5280548|NCT00549770|18214998|P2|Overall Study|Lost to Follow-up|0
5280549|NCT00549770|18214999|P1|Overall Study|Lost to Follow-up|0
5280550|NCT00549770|18214992|P8|Overall Study|Administrative problems|1
5280551|NCT00549770|18214993|P7|Overall Study|Administrative problems|0
5280552|NCT00549770|18214994|P6|Overall Study|Administrative problems|0
5280553|NCT00549770|18214995|P5|Overall Study|Administrative problems|0
5280554|NCT00549770|18214996|P4|Overall Study|Administrative problems|0
5280555|NCT00549770|18214997|P3|Overall Study|Administrative problems|0
5280556|NCT00549770|18214998|P2|Overall Study|Administrative problems|1
5280557|NCT00549770|18214999|P1|Overall Study|Administrative problems|0
5280558|NCT00549770|18214992|P8|Overall Study|Protocol deviation|2
5280559|NCT00549770|18214993|P7|Overall Study|Protocol deviation|1
5280560|NCT00549770|18214994|P6|Overall Study|Protocol deviation|2
5280561|NCT00549770|18214995|P5|Overall Study|Protocol deviation|2
5280562|NCT00549770|18214996|P4|Overall Study|Protocol deviation|2
5280563|NCT00549770|18214997|P3|Overall Study|Protocol deviation|1
5280564|NCT00549770|18214998|P2|Overall Study|Protocol deviation|1
5280565|NCT00549770|18214999|P1|Overall Study|Protocol deviation|1
5280566|NCT00549757|18215083|P2|Extension Period (in Average 9 Months)|Patient's request|436
5280567|NCT00549757|18215084|P1|Extension Period (in Average 9 Months)|Patient's request|421
5280568|NCT00549757|18215083|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
5280569|NCT00549757|18215084|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
5280570|NCT00549757|18215083|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
5280571|NCT00549757|18215084|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
5280572|NCT00549757|18215083|P2|Extension Period (in Average 9 Months)|Death|136
5280573|NCT00549757|18215084|P1|Extension Period (in Average 9 Months)|Death|143
5280574|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
5280575|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
5280576|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
5280577|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
5280578|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
5280579|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
5280580|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Death|200
5280581|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Death|188
5280582|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
5280583|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
5280584|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
5280585|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
5280586|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
5280587|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
5280588|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
5280589|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
5280590|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
5280591|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
5280592|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
5280593|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
5280594|NCT00549757|18215083|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
5280595|NCT00549757|18215084|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
5280596|NCT00549718|18215146|P4|Overall Study|Administrative|1
5280597|NCT00549718|18215147|P3|Overall Study|Administrative|2
5280598|NCT00549718|18215148|P2|Overall Study|Administrative|2
5280599|NCT00549718|18215149|P1|Overall Study|Administrative|2
5280600|NCT00549718|18215146|P4|Overall Study|Withdrawal by Subject|13
5280601|NCT00549718|18215147|P3|Overall Study|Withdrawal by Subject|12
5280602|NCT00549718|18215148|P2|Overall Study|Withdrawal by Subject|18
5280603|NCT00549718|18215149|P1|Overall Study|Withdrawal by Subject|9
5280604|NCT00549718|18215146|P4|Overall Study|Lost to Follow-up|6
5280605|NCT00549718|18215147|P3|Overall Study|Lost to Follow-up|0
5280606|NCT00549718|18215148|P2|Overall Study|Lost to Follow-up|2
5280607|NCT00549718|18215149|P1|Overall Study|Lost to Follow-up|4
5280608|NCT00549718|18215146|P4|Overall Study|Adverse Event|3
5280609|NCT00549718|18215147|P3|Overall Study|Adverse Event|7
5280610|NCT00549718|18215148|P2|Overall Study|Adverse Event|8
5280611|NCT00549718|18215149|P1|Overall Study|Adverse Event|6
5280612|NCT00549718|18215146|P4|Overall Study|Insufficient clinical response|32
5280613|NCT00549718|18215147|P3|Overall Study|Insufficient clinical response|18
5280614|NCT00549718|18215148|P2|Overall Study|Insufficient clinical response|7
5280615|NCT00549718|18215149|P1|Overall Study|Insufficient clinical response|20
5280616|NCT00549640|18215165|P2|Overall Study|Lost to Follow-up|4
5280617|NCT00549640|18215166|P1|Overall Study|Lost to Follow-up|7
5280618|NCT00549640|18215165|P2|Overall Study|Adverse Event|0
5280619|NCT00549640|18215166|P1|Overall Study|Adverse Event|5
5280620|NCT00549640|18215165|P2|Overall Study|Withdrawal by Subject|12
5280621|NCT00549640|18215166|P1|Overall Study|Withdrawal by Subject|6
5280622|NCT00549601|18215179|P3|Received Study Drug|Withdrawal by Subject|1
5280623|NCT00549601|18215180|P2|Received Study Drug|Withdrawal by Subject|0
5280624|NCT00549601|18215181|P1|Received Study Drug|Withdrawal by Subject|2
5280625|NCT00549601|18215179|P3|Received Study Drug|Protocol Violation|1
5280626|NCT00549601|18215180|P2|Received Study Drug|Protocol Violation|4
5280627|NCT00549601|18215181|P1|Received Study Drug|Protocol Violation|3
5280628|NCT00549601|18215179|P3|Received Study Drug|Lost to Follow-up|1
5280629|NCT00549601|18215180|P2|Received Study Drug|Lost to Follow-up|1
5280630|NCT00549601|18215181|P1|Received Study Drug|Lost to Follow-up|0
5280631|NCT00549601|18215179|P3|Received Study Drug|Death|0
5280632|NCT00549601|18215180|P2|Received Study Drug|Death|1
5280633|NCT00549601|18215181|P1|Received Study Drug|Death|0
5280634|NCT00549601|18215179|P3|Received Study Drug|Adverse Event|1
5280635|NCT00549601|18215180|P2|Received Study Drug|Adverse Event|5
5280636|NCT00549601|18215181|P1|Received Study Drug|Adverse Event|2
5280637|NCT00549601|18215179|P3|Randomized|Withdrawal by Subject|1
5280638|NCT00549601|18215180|P2|Randomized|Withdrawal by Subject|1
5280639|NCT00549601|18215181|P1|Randomized|Withdrawal by Subject|0
5280640|NCT00549601|18215179|P3|Randomized|Protocol Violation|1
5280641|NCT00549601|18215180|P2|Randomized|Protocol Violation|0
5280642|NCT00549601|18215181|P1|Randomized|Protocol Violation|0
5280643|NCT00549562|18215203|P1|Overall Study|Lack of Efficacy|1
5280644|NCT00549562|18215203|P1|Overall Study|Adverse Event|1
5280645|NCT00549549|18215215|P4|Overall Study|Randomized but not treated|1
5280646|NCT00549549|18215216|P3|Overall Study|Randomized but not treated|1
5280647|NCT00549549|18215217|P2|Overall Study|Randomized but not treated|0
5280648|NCT00549549|18215218|P1|Overall Study|Randomized but not treated|0
5280649|NCT00549549|18215215|P4|Overall Study|Other|11
5280650|NCT00549549|18215216|P3|Overall Study|Other|9
5280651|NCT00549549|18215217|P2|Overall Study|Other|9
5280652|NCT00549549|18215218|P1|Overall Study|Other|9
5280653|NCT00549549|18215215|P4|Overall Study|Withdrawal by Subject|0
5280654|NCT00549549|18215216|P3|Overall Study|Withdrawal by Subject|1
5280655|NCT00549549|18215217|P2|Overall Study|Withdrawal by Subject|4
5280656|NCT00549549|18215218|P1|Overall Study|Withdrawal by Subject|0
5280657|NCT00549549|18215215|P4|Overall Study|Lost to Follow-up|2
5280658|NCT00549549|18215216|P3|Overall Study|Lost to Follow-up|1
5280659|NCT00549549|18215217|P2|Overall Study|Lost to Follow-up|0
5280660|NCT00549549|18215218|P1|Overall Study|Lost to Follow-up|1
5280661|NCT00549549|18215215|P4|Overall Study|Lack of Efficacy|2
5280662|NCT00549549|18215216|P3|Overall Study|Lack of Efficacy|4
5280663|NCT00549549|18215217|P2|Overall Study|Lack of Efficacy|6
5280664|NCT00549549|18215218|P1|Overall Study|Lack of Efficacy|9
5280665|NCT00549549|18215215|P4|Overall Study|Adverse Event|9
5280666|NCT00549549|18215216|P3|Overall Study|Adverse Event|1
5280667|NCT00549549|18215217|P2|Overall Study|Adverse Event|3
5280668|NCT00549549|18215218|P1|Overall Study|Adverse Event|5
5280669|NCT00549445|18215286|P2|Overall Study|Sputum & Blood Samples Not Available|17
5280670|NCT00549445|18215287|P1|Overall Study|Sputum & Blood Samples Not Available|15
5280671|NCT00549328|18215306|P1|Overall Study|Use of Prohibited Medication|1
5280672|NCT00549328|18215306|P1|Overall Study|Death|1
5280673|NCT00549328|18215306|P1|Overall Study|Disease Progression|10
5280674|NCT00549328|18215306|P1|Overall Study|Adverse Event|2
5280675|NCT00549302|18215317|P3|Open-Label|Withdrawal by Subject|6
5280676|NCT00549302|18215318|P2|Open-Label|Withdrawal by Subject|0
5280677|NCT00549302|18215319|P1|Open-Label|Withdrawal by Subject|0
5280678|NCT00549302|18215317|P3|Open-Label|New drug pulmonary atrial hypertension|2
5280679|NCT00549302|18215318|P2|Open-Label|New drug pulmonary atrial hypertension|0
5280680|NCT00549302|18215319|P1|Open-Label|New drug pulmonary atrial hypertension|0
5280681|NCT00549302|18215317|P3|Open-Label|Other|3
5280682|NCT00549302|18215318|P2|Open-Label|Other|0
5280683|NCT00549302|18215319|P1|Open-Label|Other|0
5280684|NCT00549302|18215317|P3|Open-Label|Lost to Follow-up|2
5280685|NCT00549302|18215318|P2|Open-Label|Lost to Follow-up|0
5280686|NCT00549302|18215319|P1|Open-Label|Lost to Follow-up|0
5280687|NCT00549302|18215317|P3|Open-Label|Investigator Decision|5
5280688|NCT00549302|18215318|P2|Open-Label|Investigator Decision|0
5280689|NCT00549302|18215319|P1|Open-Label|Investigator Decision|0
5280690|NCT00549302|18215317|P3|Open-Label|Death|40
5280691|NCT00549302|18215318|P2|Open-Label|Death|0
5280692|NCT00549302|18215319|P1|Open-Label|Death|0
5280693|NCT00549302|18215317|P3|Open-Label|Adverse Event|11
5280694|NCT00549302|18215318|P2|Open-Label|Adverse Event|0
5280695|NCT00549302|18215319|P1|Open-Label|Adverse Event|0
5280696|NCT00549302|18215317|P3|Double-Blind|New condition or starts new therapy|0
5280697|NCT00549302|18215318|P2|Double-Blind|New condition or starts new therapy|2
5280698|NCT00549302|18215319|P1|Double-Blind|New condition or starts new therapy|0
5280699|NCT00549302|18215317|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
5280700|NCT00549302|18215318|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
5280701|NCT00549302|18215319|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
5280702|NCT00549302|18215317|P3|Double-Blind|Lost to Follow-up|0
5280703|NCT00549302|18215318|P2|Double-Blind|Lost to Follow-up|2
5280704|NCT00549302|18215319|P1|Double-Blind|Lost to Follow-up|1
5280705|NCT00549302|18215317|P3|Double-Blind|Sponsor Decision|0
5280706|NCT00549302|18215318|P2|Double-Blind|Sponsor Decision|1
5280707|NCT00549302|18215319|P1|Double-Blind|Sponsor Decision|0
5280708|NCT00549302|18215317|P3|Double-Blind|Investigator Decision|0
5280709|NCT00549302|18215318|P2|Double-Blind|Investigator Decision|5
5280710|NCT00549302|18215319|P1|Double-Blind|Investigator Decision|1
5280711|NCT00549302|18215317|P3|Double-Blind|Withdrawal by Subject|0
5280712|NCT00549302|18215318|P2|Double-Blind|Withdrawal by Subject|8
5280713|NCT00549302|18215319|P1|Double-Blind|Withdrawal by Subject|3
5280714|NCT00549302|18215317|P3|Double-Blind|Adverse Event|0
5280715|NCT00549302|18215318|P2|Double-Blind|Adverse Event|16
5280716|NCT00549302|18215319|P1|Double-Blind|Adverse Event|3
5280717|NCT00549302|18215317|P3|Double-Blind|Death|0
5280718|NCT00549302|18215318|P2|Double-Blind|Death|9
5280719|NCT00549302|18215319|P1|Double-Blind|Death|2
5280720|NCT00549198|18215331|P2|Overall Study|Not Exposed to Study Drug|4
5280721|NCT00549198|18215332|P1|Overall Study|Not Exposed to Study Drug|3
5280722|NCT00549198|18215331|P2|Overall Study|Pregnancy|3
5280723|NCT00549198|18215332|P1|Overall Study|Pregnancy|0
5280724|NCT00549198|18215331|P2|Overall Study|No scan facilities|2
5280725|NCT00549198|18215332|P1|Overall Study|No scan facilities|0
5280726|NCT00549198|18215331|P2|Overall Study|Participant overweight, no scan possible|0
5280727|NCT00549198|18215332|P1|Overall Study|Participant overweight, no scan possible|1
5280728|NCT00549198|18215331|P2|Overall Study|Participant planning pregnancy|0
5280729|NCT00549198|18215332|P1|Overall Study|Participant planning pregnancy|1
5280730|NCT00549198|18215331|P2|Overall Study|Prohibited Medication|2
5280731|NCT00549198|18215332|P1|Overall Study|Prohibited Medication|1
5280732|NCT00549198|18215331|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
5280733|NCT00549198|18215332|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
5280734|NCT00549198|18215331|P2|Overall Study|Participant not able to perform Week 96|0
5280735|NCT00549198|18215332|P1|Overall Study|Participant not able to perform Week 96|1
5280736|NCT00549198|18215331|P2|Overall Study|Participant Moved|0
5280737|NCT00549198|18215332|P1|Overall Study|Participant Moved|2
5280738|NCT00549198|18215331|P2|Overall Study|Disease Progression|0
5280739|NCT00549198|18215332|P1|Overall Study|Disease Progression|1
5280740|NCT00549198|18215331|P2|Overall Study|Withdrawal by Subject|7
5280741|NCT00549198|18215332|P1|Overall Study|Withdrawal by Subject|7
5280742|NCT00549198|18215331|P2|Overall Study|Investigator Decision|3
5280743|NCT00549198|18215332|P1|Overall Study|Investigator Decision|4
5280744|NCT00549198|18215331|P2|Overall Study|Protocol Violation|2
5280745|NCT00549198|18215332|P1|Overall Study|Protocol Violation|7
5280746|NCT00549198|18215331|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
5280747|NCT00549198|18215332|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
5280748|NCT00549198|18215331|P2|Overall Study|Lost to Follow-up|8
5280749|NCT00549198|18215332|P1|Overall Study|Lost to Follow-up|7
5280750|NCT00549198|18215331|P2|Overall Study|Non-compliance|4
5280751|NCT00549198|18215332|P1|Overall Study|Non-compliance|2
5280752|NCT00549198|18215331|P2|Overall Study|Protocol-defined Virological Failure|0
5280753|NCT00549198|18215332|P1|Overall Study|Protocol-defined Virological Failure|7
5280754|NCT00549198|18215331|P2|Overall Study|Insufficient Viral Load Response|2
5280755|NCT00549198|18215332|P1|Overall Study|Insufficient Viral Load Response|4
5280756|NCT00549198|18215331|P2|Overall Study|Adverse Event|26
5280757|NCT00549198|18215332|P1|Overall Study|Adverse Event|28
5280758|NCT00549055|18215469|P1|Overall Study|Very low visual acuity (VA)|1
5280759|NCT00549055|18215469|P1|Overall Study|Choroidal neovascularization|1
5280760|NCT00549055|18215469|P1|Overall Study|Growth choroidal neovascularisation|1
5280761|NCT00549055|18215469|P1|Overall Study|Vitreous hemorrhage|1
5280762|NCT00549055|18215469|P1|Overall Study|Active choroidal neovascula increased|1
5280763|NCT00549055|18215469|P1|Overall Study|Decrease of size|1
5280764|NCT00549055|18215469|P1|Overall Study|Progression to fibrosis|2
5280765|NCT00549055|18215469|P1|Overall Study|Stabilization|5
5280766|NCT00549055|18215469|P1|Overall Study|Lack of Efficacy|18
5280767|NCT00549055|18215469|P1|Overall Study|Adverse Event|4
5280768|NCT00548847|18215513|P1|Overall Study|Disease progression|7
5280769|NCT00548808|18215520|P2|Overall Study|Sponsor Decision|1
5280770|NCT00548808|18215521|P1|Overall Study|Sponsor Decision|1
5280771|NCT00548808|18215520|P2|Overall Study|Lack of Efficacy|0
5280772|NCT00548808|18215521|P1|Overall Study|Lack of Efficacy|2
5280773|NCT00548808|18215520|P2|Overall Study|Entry Criteria Not Met|2
5280774|NCT00548808|18215521|P1|Overall Study|Entry Criteria Not Met|2
5280775|NCT00548808|18215520|P2|Overall Study|Death|0
5280776|NCT00548808|18215521|P1|Overall Study|Death|2
5280777|NCT00548808|18215520|P2|Overall Study|Adverse Event|5
5280778|NCT00548808|18215521|P1|Overall Study|Adverse Event|4
5280779|NCT00548808|18215520|P2|Overall Study|Physician Decision|3
5280780|NCT00548808|18215521|P1|Overall Study|Physician Decision|6
5280781|NCT00548808|18215520|P2|Overall Study|Withdrawal by Subject|4
5280782|NCT00548808|18215521|P1|Overall Study|Withdrawal by Subject|8
5280783|NCT00548808|18215520|P2|Overall Study|Protocol Violation|8
5280784|NCT00548808|18215521|P1|Overall Study|Protocol Violation|8
5280785|NCT00548808|18215520|P2|Overall Study|Lost to Follow-up|3
5280786|NCT00548808|18215521|P1|Overall Study|Lost to Follow-up|9
5280787|NCT00548717|18215545|P2|Overall Study|Alternative treatment for GVHD|0
5280788|NCT00548717|18215546|P1|Overall Study|Alternative treatment for GVHD|1
5280789|NCT00548717|18215545|P2|Overall Study|Relapse|0
5280790|NCT00548717|18215546|P1|Overall Study|Relapse|3
5280791|NCT00548717|18215545|P2|Overall Study|Death|2
5280792|NCT00548717|18215546|P1|Overall Study|Death|5
5280793|NCT00548548|18215590|P2|Overall Study|Lost to Follow-up|18
5280794|NCT00548548|18215591|P1|Overall Study|Lost to Follow-up|17
5280795|NCT00548548|18215590|P2|Overall Study|Death|348
5280796|NCT00548548|18215591|P1|Overall Study|Death|345
5280797|NCT00548405|18215634|P3|Overall Study|Randomized but not treated|0
5280798|NCT00548405|18215635|P2|Overall Study|Randomized but not treated|0
5280799|NCT00548405|18215636|P1|Overall Study|Randomized but not treated|1
5280800|NCT00548405|18215634|P3|Overall Study|Sponsor decision|0
5280801|NCT00548405|18215635|P2|Overall Study|Sponsor decision|0
5280802|NCT00548405|18215636|P1|Overall Study|Sponsor decision|1
5280803|NCT00548405|18215634|P3|Overall Study|Death|1
5280804|NCT00548405|18215635|P2|Overall Study|Death|1
5280805|NCT00548405|18215636|P1|Overall Study|Death|0
5280806|NCT00548405|18215634|P3|Overall Study|Lost to Follow-up|2
5280807|NCT00548405|18215635|P2|Overall Study|Lost to Follow-up|1
5280808|NCT00548405|18215636|P1|Overall Study|Lost to Follow-up|1
5280809|NCT00548405|18215634|P3|Overall Study|Withdrawal by Subject|5
5280810|NCT00548405|18215635|P2|Overall Study|Withdrawal by Subject|12
5280811|NCT00548405|18215636|P1|Overall Study|Withdrawal by Subject|36
5280812|NCT00548405|18215634|P3|Overall Study|Protocol Violation|0
5280813|NCT00548405|18215635|P2|Overall Study|Protocol Violation|0
5280814|NCT00548405|18215636|P1|Overall Study|Protocol Violation|1
5280815|NCT00548405|18215634|P3|Overall Study|Pregnancy|0
5280816|NCT00548405|18215635|P2|Overall Study|Pregnancy|0
5280817|NCT00548405|18215636|P1|Overall Study|Pregnancy|1
5280818|NCT00548405|18215634|P3|Overall Study|Physician Decision|1
5280819|NCT00548405|18215635|P2|Overall Study|Physician Decision|4
5280820|NCT00548405|18215636|P1|Overall Study|Physician Decision|3
5280821|NCT00548405|18215634|P3|Overall Study|Lack of Efficacy|0
5280822|NCT00548405|18215635|P2|Overall Study|Lack of Efficacy|0
5280823|NCT00548405|18215636|P1|Overall Study|Lack of Efficacy|6
5280824|NCT00548405|18215634|P3|Overall Study|Adverse Event|0
5280825|NCT00548405|18215635|P2|Overall Study|Adverse Event|2
5280826|NCT00548405|18215636|P1|Overall Study|Adverse Event|6
5280827|NCT00548340|18215657|P3|Overall Study|Other|1
5280828|NCT00548340|18215658|P2|Overall Study|Other|1
5280829|NCT00548340|18215659|P1|Overall Study|Other|1
5280830|NCT00548340|18215657|P3|Overall Study|Withdrawal by Subject|3
5280831|NCT00548340|18215658|P2|Overall Study|Withdrawal by Subject|4
5280832|NCT00548340|18215659|P1|Overall Study|Withdrawal by Subject|2
5280833|NCT00548340|18215657|P3|Overall Study|Lost to Follow-up|0
5280834|NCT00548340|18215658|P2|Overall Study|Lost to Follow-up|1
5280835|NCT00548340|18215659|P1|Overall Study|Lost to Follow-up|1
5280836|NCT00548340|18215657|P3|Overall Study|Adverse Event|2
5280837|NCT00548340|18215658|P2|Overall Study|Adverse Event|2
5280838|NCT00548340|18215659|P1|Overall Study|Adverse Event|2
5280839|NCT00548340|18215657|P3|Overall Study|Protocol Violation|3
5280840|NCT00548340|18215658|P2|Overall Study|Protocol Violation|3
5280841|NCT00548340|18215659|P1|Overall Study|Protocol Violation|2
5280842|NCT00548327|18215678|P2|Overall Study|Adverse Event|1
5280843|NCT00548327|18215679|P1|Overall Study|Adverse Event|0
5280844|NCT00548262|18215697|P1|Overall Study|Withdrawal by Subject|1
5280845|NCT00548262|18215697|P1|Overall Study|Other|3
5280846|NCT00548262|18215697|P1|Overall Study|Lost to Follow-up|1
5280847|NCT00548262|18215697|P1|Overall Study|Lack of Efficacy|4
5280848|NCT00548262|18215697|P1|Overall Study|Adverse Event|2
5280849|NCT00548262|18215697|P1|Overall Study|Death|21
5280850|NCT00548249|18215727|P5|Overall Study|Sponsor's request|0
5280851|NCT00548249|18215728|P4|Overall Study|Sponsor's request|1
5280852|NCT00548249|18215729|P3|Overall Study|Sponsor's request|0
5280853|NCT00548249|18215730|P2|Overall Study|Sponsor's request|0
5280854|NCT00548249|18215731|P1|Overall Study|Sponsor's request|0
5280855|NCT00548249|18215727|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
5280856|NCT00548249|18215728|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
5280857|NCT00548249|18215729|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
5280858|NCT00548249|18215730|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
5280859|NCT00548249|18215731|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
5280860|NCT00548249|18215727|P5|Overall Study|Withdrawal by Subject|0
5280861|NCT00548249|18215728|P4|Overall Study|Withdrawal by Subject|0
5280862|NCT00548249|18215729|P3|Overall Study|Withdrawal by Subject|0
5280863|NCT00548249|18215730|P2|Overall Study|Withdrawal by Subject|0
5280864|NCT00548249|18215731|P1|Overall Study|Withdrawal by Subject|2
5280865|NCT00548249|18215727|P5|Overall Study|Prolonged hospitalization|0
5280866|NCT00548249|18215728|P4|Overall Study|Prolonged hospitalization|1
5280867|NCT00548249|18215729|P3|Overall Study|Prolonged hospitalization|2
5280868|NCT00548249|18215730|P2|Overall Study|Prolonged hospitalization|0
5280869|NCT00548249|18215731|P1|Overall Study|Prolonged hospitalization|0
5280870|NCT00548249|18215727|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
5280871|NCT00548249|18215728|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5280872|NCT00548249|18215729|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5280873|NCT00548249|18215730|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5280874|NCT00548249|18215731|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5280875|NCT00548249|18215727|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
5280876|NCT00548249|18215728|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
5280877|NCT00548249|18215729|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
5280878|NCT00548249|18215730|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
5280879|NCT00548249|18215731|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
5280880|NCT00548249|18215727|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
5280881|NCT00548249|18215728|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
5280882|NCT00548249|18215729|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
5280883|NCT00548249|18215730|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
5280884|NCT00548249|18215731|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
5280885|NCT00548249|18215727|P5|Overall Study|Adverse Event|1
5280886|NCT00548249|18215728|P4|Overall Study|Adverse Event|1
5280887|NCT00548249|18215729|P3|Overall Study|Adverse Event|0
5280888|NCT00548249|18215730|P2|Overall Study|Adverse Event|2
5280889|NCT00548249|18215731|P1|Overall Study|Adverse Event|2
5280890|NCT00548249|18215727|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
5280891|NCT00548249|18215728|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
5280892|NCT00548249|18215729|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
5280893|NCT00548249|18215730|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
5280894|NCT00548249|18215731|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
5280895|NCT00548249|18215727|P5|Overall Study|Miscellaneous|2
5280896|NCT00548249|18215728|P4|Overall Study|Miscellaneous|0
5280897|NCT00548249|18215729|P3|Overall Study|Miscellaneous|2
5280898|NCT00548249|18215730|P2|Overall Study|Miscellaneous|3
5280899|NCT00548249|18215731|P1|Overall Study|Miscellaneous|2
5280900|NCT00548249|18215727|P5|Overall Study|Protocol Violation|3
5280901|NCT00548249|18215728|P4|Overall Study|Protocol Violation|0
5280902|NCT00548249|18215729|P3|Overall Study|Protocol Violation|4
5280903|NCT00548249|18215730|P2|Overall Study|Protocol Violation|1
5280904|NCT00548249|18215731|P1|Overall Study|Protocol Violation|1
5280905|NCT00548249|18215727|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
5280906|NCT00548249|18215728|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
5280907|NCT00548249|18215729|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
5280908|NCT00548249|18215730|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
5280909|NCT00548249|18215731|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
5280910|NCT00548249|18215727|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
5280911|NCT00548249|18215728|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
5280912|NCT00548249|18215729|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
5280913|NCT00548249|18215730|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
5280914|NCT00548249|18215731|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
5280915|NCT00548184|18215779|P1|Overall Study|Found Her2 negative|1
5280916|NCT00548184|18215779|P1|Overall Study|took other drug|1
5280917|NCT00548184|18215779|P1|Overall Study|Adverse Event|3
5280918|NCT00548145|18215827|P2|Overall Study|Physician Decision|1
5280919|NCT00548145|18215828|P1|Overall Study|Physician Decision|1
5280920|NCT00548145|18215827|P2|Overall Study|Withdrawal by Subject|2
5280921|NCT00548145|18215828|P1|Overall Study|Withdrawal by Subject|0
5280922|NCT00548145|18215827|P2|Overall Study|Death|1
5280923|NCT00548145|18215828|P1|Overall Study|Death|0
5280924|NCT00548093|18215847|P2|Overall Study|Completed post-treatment follow-up|0
5280925|NCT00548093|18215848|P1|Overall Study|Completed post-treatment follow-up|1
5280926|NCT00548093|18215847|P2|Overall Study|Withdrawal by Subject|0
5280927|NCT00548093|18215848|P1|Overall Study|Withdrawal by Subject|1
5280928|NCT00548093|18215847|P2|Overall Study|Other|1
5280929|NCT00548093|18215848|P1|Overall Study|Other|11
5280930|NCT00548093|18215847|P2|Overall Study|Objective progression or relapse|1
5280931|NCT00548093|18215848|P1|Overall Study|Objective progression or relapse|1
5280932|NCT00548093|18215847|P2|Overall Study|Lost to Follow-up|1
5280933|NCT00548093|18215848|P1|Overall Study|Lost to Follow-up|3
5280934|NCT00548093|18215847|P2|Overall Study|Death|13
5280935|NCT00548093|18215848|P1|Overall Study|Death|33
5280936|NCT00547911|18215886|P6|Overall Study|Adverse Event|0
5280937|NCT00547911|18215887|P5|Overall Study|Adverse Event|0
5280938|NCT00547911|18215888|P4|Overall Study|Adverse Event|1
5280939|NCT00547911|18215889|P3|Overall Study|Adverse Event|0
5280940|NCT00547911|18215890|P2|Overall Study|Adverse Event|0
5280941|NCT00547911|18215891|P1|Overall Study|Adverse Event|0
5280942|NCT00547703|18215941|P2|Overall Study|Lost to Follow-up|0
5280943|NCT00547703|18215942|P1|Overall Study|Lost to Follow-up|1
5280944|NCT00547534|18215988|P1|Overall Study|Disease Progression|4
5280945|NCT00547534|18215988|P1|Overall Study|Adverse Event|7
5280946|NCT00547521|18215996|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
5280947|NCT00547521|18215997|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
5280948|NCT00547521|18215996|P2|Long Term Extension (LTE) Study|Other|2
5280949|NCT00547521|18215997|P1|Long Term Extension (LTE) Study|Other|0
5280950|NCT00547521|18215996|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
5280951|NCT00547521|18215997|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
5280952|NCT00547521|18215996|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
5280953|NCT00547521|18215997|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
5280954|NCT00547521|18215996|P2|Long Term Extension (LTE) Study|Adverse Event|9
5280955|NCT00547521|18215997|P1|Long Term Extension (LTE) Study|Adverse Event|0
5280956|NCT00547521|18215996|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
5280957|NCT00547521|18215997|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
5280958|NCT00547521|18215996|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
5280959|NCT00547521|18215997|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
5280960|NCT00547521|18215996|P2|Short Term Study (4 Months)|Withdrawal of consent|1
5280961|NCT00547521|18215997|P1|Short Term Study (4 Months)|Withdrawal of consent|0
5280962|NCT00547521|18215996|P2|Short Term Study (4 Months)|Lack of Efficacy|2
5280963|NCT00547521|18215997|P1|Short Term Study (4 Months)|Lack of Efficacy|0
5280964|NCT00547521|18215996|P2|Short Term Study (4 Months)|Adverse Event|0
5280965|NCT00547521|18215997|P1|Short Term Study (4 Months)|Adverse Event|1
5280966|NCT00547378|18216074|P3|All Implanted Cohort|Other reasons|1
5280967|NCT00547378|18216075|P2|All Implanted Cohort|Other reasons|0
5280968|NCT00547378|18216076|P1|All Implanted Cohort|Other reasons|1
5280969|NCT00547378|18216074|P3|All Implanted Cohort|Site closure|1
5280970|NCT00547378|18216075|P2|All Implanted Cohort|Site closure|0
5280971|NCT00547378|18216076|P1|All Implanted Cohort|Site closure|2
5280972|NCT00547378|18216074|P3|All Implanted Cohort|Physician Decision|6
5280973|NCT00547378|18216075|P2|All Implanted Cohort|Physician Decision|2
5280974|NCT00547378|18216076|P1|All Implanted Cohort|Physician Decision|0
5280975|NCT00547378|18216074|P3|All Implanted Cohort|Death|4
5280976|NCT00547378|18216075|P2|All Implanted Cohort|Death|1
5280977|NCT00547378|18216076|P1|All Implanted Cohort|Death|3
5280978|NCT00547378|18216074|P3|All Implanted Cohort|Lost to Follow-up|14
5280979|NCT00547378|18216075|P2|All Implanted Cohort|Lost to Follow-up|1
5280980|NCT00547378|18216076|P1|All Implanted Cohort|Lost to Follow-up|0
5280981|NCT00547378|18216074|P3|All Implanted Cohort|Adverse Event|17
5280982|NCT00547378|18216075|P2|All Implanted Cohort|Adverse Event|10
5280983|NCT00547378|18216076|P1|All Implanted Cohort|Adverse Event|4
5280984|NCT00547378|18216074|P3|All Implanted Cohort|Withdrawal by Subject|27
5280985|NCT00547378|18216075|P2|All Implanted Cohort|Withdrawal by Subject|4
5280986|NCT00547378|18216076|P1|All Implanted Cohort|Withdrawal by Subject|5
5280987|NCT00547378|18216074|P3|Randomized Cohort|Other reasons|0
5280988|NCT00547378|18216075|P2|Randomized Cohort|Other reasons|0
5280989|NCT00547378|18216076|P1|Randomized Cohort|Other reasons|2
5280990|NCT00547378|18216074|P3|Randomized Cohort|Adverse Event|0
5280991|NCT00547378|18216075|P2|Randomized Cohort|Adverse Event|0
5280992|NCT00547378|18216076|P1|Randomized Cohort|Adverse Event|1
5280993|NCT00547378|18216074|P3|Randomized Cohort|Lost to Follow-up|0
5280994|NCT00547378|18216075|P2|Randomized Cohort|Lost to Follow-up|0
5280995|NCT00547378|18216076|P1|Randomized Cohort|Lost to Follow-up|1
5280996|NCT00547378|18216074|P3|Randomized Cohort|Death|0
5280997|NCT00547378|18216075|P2|Randomized Cohort|Death|1
5280998|NCT00547378|18216076|P1|Randomized Cohort|Death|0
5280999|NCT00547378|18216074|P3|Randomized Cohort|Withdrawal by Subject|0
5281000|NCT00547378|18216075|P2|Randomized Cohort|Withdrawal by Subject|5
5281001|NCT00547378|18216076|P1|Randomized Cohort|Withdrawal by Subject|7
5281002|NCT00547365|18216086|P1|Overall Study|death (not related to study)|4
5281003|NCT00547365|18216086|P1|Overall Study|Protocol Violation|2
5281004|NCT00547365|18216086|P1|Overall Study|Lost to Follow-up|1
5281005|NCT00547365|18216086|P1|Overall Study|Physician Decision|1
5281006|NCT00547300|18216093|P2|Overall Study|Did not Meet Entry Criteria|2
5281007|NCT00547300|18216094|P1|Overall Study|Did not Meet Entry Criteria|0
5281008|NCT00547300|18216093|P2|Overall Study|Study was Administratively Terminated|24
5281009|NCT00547300|18216094|P1|Overall Study|Study was Administratively Terminated|25
5281010|NCT00547248|18216108|P4|Overall Study|Withdrawal by Subject|1
5281011|NCT00547248|18216109|P3|Overall Study|Withdrawal by Subject|7
5281012|NCT00547248|18216110|P2|Overall Study|Withdrawal by Subject|0
5281013|NCT00547248|18216111|P1|Overall Study|Withdrawal by Subject|0
5281014|NCT00547248|18216108|P4|Overall Study|Migrated/moved from study area|0
5281015|NCT00547248|18216109|P3|Overall Study|Migrated/moved from study area|2
5281016|NCT00547248|18216110|P2|Overall Study|Migrated/moved from study area|0
5281017|NCT00547248|18216111|P1|Overall Study|Migrated/moved from study area|0
5281018|NCT00547248|18216108|P4|Overall Study|Protocol Violation|1
5281019|NCT00547248|18216109|P3|Overall Study|Protocol Violation|1
5281020|NCT00547248|18216110|P2|Overall Study|Protocol Violation|0
5281021|NCT00547248|18216111|P1|Overall Study|Protocol Violation|0
5281022|NCT00547157|18216229|P2|Overall Study|Lost to Follow-up|2
5281023|NCT00547157|18216230|P1|Overall Study|Lost to Follow-up|4
5281024|NCT00547157|18216229|P2|Overall Study|Administrative decision|2
5281025|NCT00547157|18216230|P1|Overall Study|Administrative decision|3
5281026|NCT00547157|18216229|P2|Overall Study|Withdrawal by Subject|1
5281027|NCT00547157|18216230|P1|Overall Study|Withdrawal by Subject|3
5281028|NCT00547157|18216229|P2|Overall Study|Death|18
5281029|NCT00547157|18216230|P1|Overall Study|Death|38
5281030|NCT00547157|18216229|P2|Overall Study|Other|0
5281031|NCT00547157|18216230|P1|Overall Study|Other|1
5281032|NCT00547118|18216248|P2|Overall Study|Study suspended|8
5281033|NCT00547118|18216249|P1|Overall Study|Study suspended|7
5281034|NCT00547118|18216248|P2|Overall Study|Did not qualify prior to starting drug|1
5281035|NCT00547118|18216249|P1|Overall Study|Did not qualify prior to starting drug|1
5281036|NCT00546910|18216293|P2|Overall Study|Withdrawal by Subject|0
5281037|NCT00546910|18216294|P1|Overall Study|Withdrawal by Subject|2
5281038|NCT00546910|18216293|P2|Overall Study|Physician Decision|1
5281039|NCT00546910|18216294|P1|Overall Study|Physician Decision|0
5281040|NCT00546910|18216293|P2|Overall Study|Lack of Efficacy|7
5281041|NCT00546910|18216294|P1|Overall Study|Lack of Efficacy|5
5281042|NCT00546910|18216293|P2|Overall Study|Adverse Event|3
5281043|NCT00546910|18216294|P1|Overall Study|Adverse Event|2
5281044|NCT00546871|18216360|P2|Study Extension Period|Withdrawal by Subject|1
5281045|NCT00546871|18216361|P1|Study Extension Period|Withdrawal by Subject|0
5281046|NCT00546871|18216360|P2|Study Extension Period|Protocol Violation|0
5281047|NCT00546871|18216361|P1|Study Extension Period|Protocol Violation|1
5281048|NCT00546871|18216360|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
5281049|NCT00546871|18216361|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
5281050|NCT00546871|18216360|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
5281051|NCT00546871|18216361|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
5281052|NCT00546871|18216360|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
5281053|NCT00546871|18216361|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
5281054|NCT00546819|18216466|P2|Overall Study|Withdrawal by Subject|2
5281055|NCT00546819|18216467|P1|Overall Study|Withdrawal by Subject|4
5281056|NCT00546819|18216466|P2|Overall Study|Lost to Follow-up|1
5281057|NCT00546819|18216467|P1|Overall Study|Lost to Follow-up|2
5281058|NCT00546819|18216466|P2|Overall Study|Adverse Event|3
5281059|NCT00546819|18216467|P1|Overall Study|Adverse Event|2
5281060|NCT00546754|18216479|P2|Overall Study|Missing|7
5281061|NCT00546754|18216480|P1|Overall Study|Missing|14
5281062|NCT00546754|18216479|P2|Overall Study|Patient's Decision|1
5281063|NCT00546754|18216480|P1|Overall Study|Patient's Decision|0
5281064|NCT00546754|18216479|P2|Overall Study|Elevated Creatinine and Potassium levels|1
5281065|NCT00546754|18216480|P1|Overall Study|Elevated Creatinine and Potassium levels|0
5281066|NCT00546754|18216479|P2|Overall Study|Missing Cooperation|0
5281067|NCT00546754|18216480|P1|Overall Study|Missing Cooperation|1
5281068|NCT00546754|18216479|P2|Overall Study|Suicide|0
5281069|NCT00546754|18216480|P1|Overall Study|Suicide|1
5281070|NCT00546754|18216479|P2|Overall Study|Hip Replacement|0
5281071|NCT00546754|18216480|P1|Overall Study|Hip Replacement|1
5281072|NCT00546754|18216479|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
5281073|NCT00546754|18216480|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
5281074|NCT00546754|18216479|P2|Overall Study|Dyspnea|0
5281075|NCT00546754|18216480|P1|Overall Study|Dyspnea|1
5281076|NCT00546754|18216479|P2|Overall Study|Withdrawal by Subject|7
5281077|NCT00546754|18216480|P1|Overall Study|Withdrawal by Subject|6
5281078|NCT00546754|18216479|P2|Overall Study|Protocol Violation|0
5281079|NCT00546754|18216480|P1|Overall Study|Protocol Violation|3
5281080|NCT00546754|18216479|P2|Overall Study|Lost to Follow-up|15
5281081|NCT00546754|18216480|P1|Overall Study|Lost to Follow-up|9
5281082|NCT00546754|18216479|P2|Overall Study|Lack of Efficacy|1
5281083|NCT00546754|18216480|P1|Overall Study|Lack of Efficacy|1
5281084|NCT00546754|18216479|P2|Overall Study|Adverse Event|16
5281085|NCT00546754|18216480|P1|Overall Study|Adverse Event|11
5281086|NCT00546754|18216479|P2|Overall Study|Serious Adverse Event|1
5281087|NCT00546754|18216480|P1|Overall Study|Serious Adverse Event|1
5281088|NCT00546715|18216523|P4|Overall Study|Withdrawal by Subject|0
5281089|NCT00546715|18216524|P3|Overall Study|Withdrawal by Subject|0
5281090|NCT00546715|18216525|P2|Overall Study|Withdrawal by Subject|1
5281091|NCT00546715|18216526|P1|Overall Study|Withdrawal by Subject|0
5281092|NCT00546637|18216581|P2|Overall Study|Randomized, but not treated|1
5281093|NCT00546637|18216582|P1|Overall Study|Randomized, but not treated|3
5281094|NCT00546637|18216581|P2|Overall Study|Withdrawal by Subject|9
5281095|NCT00546637|18216582|P1|Overall Study|Withdrawal by Subject|7
5281096|NCT00546637|18216581|P2|Overall Study|Other|12
5281097|NCT00546637|18216582|P1|Overall Study|Other|10
5281098|NCT00546637|18216581|P2|Overall Study|Lost to Follow-up|2
5281099|NCT00546637|18216582|P1|Overall Study|Lost to Follow-up|2
5281100|NCT00546637|18216581|P2|Overall Study|Lack of Efficacy|5
5281101|NCT00546637|18216582|P1|Overall Study|Lack of Efficacy|5
5281102|NCT00546637|18216581|P2|Overall Study|Adverse Event|20
5281103|NCT00546637|18216582|P1|Overall Study|Adverse Event|46
5281104|NCT00546572|18216656|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
5281105|NCT00546572|18216657|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
5281106|NCT00546572|18216656|P2|Vax 2 / Year 1|Adverse Event|0
5281107|NCT00546572|18216657|P1|Vax 2 / Year 1|Adverse Event|1
5281108|NCT00546572|18216656|P2|Vax 2 / Year 1|Other|1
5281109|NCT00546572|18216657|P1|Vax 2 / Year 1|Other|1
5281110|NCT00546572|18216656|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
5281111|NCT00546572|18216657|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
5281112|NCT00546572|18216656|P2|Vax 1 / Year 0|Lost to Follow-up|1
5281113|NCT00546572|18216657|P1|Vax 1 / Year 0|Lost to Follow-up|0
5281114|NCT00546572|18216656|P2|Vax 1 / Year 0|Adverse Event|1
5281115|NCT00546572|18216657|P1|Vax 1 / Year 0|Adverse Event|0
5281116|NCT00546572|18216656|P2|Vax 1 / Year 0|Death|2
5281117|NCT00546572|18216657|P1|Vax 1 / Year 0|Death|2
5281118|NCT00546572|18216656|P2|Vax 1 / Year 0|Protocol Violation|4
5281119|NCT00546572|18216657|P1|Vax 1 / Year 0|Protocol Violation|3
5281120|NCT00546572|18216656|P2|Vax 1 / Year 0|Withdrawal by Subject|2
5281121|NCT00546572|18216657|P1|Vax 1 / Year 0|Withdrawal by Subject|3
5281122|NCT00546572|18216656|P2|Vax 1 / Year 0|Randomized, not treated|1
5281123|NCT00546572|18216657|P1|Vax 1 / Year 0|Randomized, not treated|1
5281124|NCT00546481|18216701|P3|Maintenance Phase (CERA)|Other Reason|1
5281125|NCT00546481|18216702|P2|Maintenance Phase (CERA)|Other Reason|0
5281126|NCT00546481|18216703|P1|Maintenance Phase (CERA)|Other Reason|0
5281127|NCT00546481|18216701|P3|Maintenance Phase (CERA)|Kidney transplantation|1
5281128|NCT00546481|18216702|P2|Maintenance Phase (CERA)|Kidney transplantation|0
5281129|NCT00546481|18216703|P1|Maintenance Phase (CERA)|Kidney transplantation|0
5281130|NCT00546481|18216701|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
5281131|NCT00546481|18216702|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
5281132|NCT00546481|18216703|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
5281133|NCT00546481|18216701|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
5281134|NCT00546481|18216702|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
5281135|NCT00546481|18216703|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
5281136|NCT00546481|18216701|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
5281137|NCT00546481|18216702|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
5281138|NCT00546481|18216703|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
5281139|NCT00546481|18216701|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
5281140|NCT00546481|18216702|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
5281141|NCT00546481|18216703|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
5281142|NCT00546481|18216701|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
5281143|NCT00546481|18216702|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
5281144|NCT00546481|18216703|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
5281145|NCT00546481|18216701|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
5281146|NCT00546481|18216702|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
5281147|NCT00546481|18216703|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
5281148|NCT00546481|18216701|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
5281149|NCT00546481|18216702|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
5281150|NCT00546481|18216703|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
5281151|NCT00546377|18216741|P1|Overall Study|Adverse Event|6
5281152|NCT00546377|18216741|P1|Overall Study|Deemed ineligible|1
5281153|NCT00546364|18216749|P3|Overall Study|Sponsor decision|1
5281154|NCT00546364|18216750|P2|Overall Study|Sponsor decision|0
5281155|NCT00546364|18216751|P1|Overall Study|Sponsor decision|0
5281156|NCT00546364|18216749|P3|Overall Study|Physician Decision|1
5281157|NCT00546364|18216750|P2|Overall Study|Physician Decision|0
5281158|NCT00546364|18216751|P1|Overall Study|Physician Decision|0
5281159|NCT00546364|18216749|P3|Overall Study|Target lesions resected|0
5281160|NCT00546364|18216750|P2|Overall Study|Target lesions resected|0
5281161|NCT00546364|18216751|P1|Overall Study|Target lesions resected|1
5281162|NCT00546364|18216749|P3|Overall Study|Palliative treatment|1
5281163|NCT00546364|18216750|P2|Overall Study|Palliative treatment|0
5281164|NCT00546364|18216751|P1|Overall Study|Palliative treatment|1
5281165|NCT00546364|18216749|P3|Overall Study|Mixed response|0
5281166|NCT00546364|18216750|P2|Overall Study|Mixed response|0
5281167|NCT00546364|18216751|P1|Overall Study|Mixed response|1
5281168|NCT00546364|18216749|P3|Overall Study|Prior taxotere|0
5281169|NCT00546364|18216750|P2|Overall Study|Prior taxotere|0
5281170|NCT00546364|18216751|P1|Overall Study|Prior taxotere|1
5281171|NCT00546364|18216749|P3|Overall Study|Withdrawal by Subject|3
5281172|NCT00546364|18216750|P2|Overall Study|Withdrawal by Subject|6
5281173|NCT00546364|18216751|P1|Overall Study|Withdrawal by Subject|5
5281174|NCT00546364|18216749|P3|Overall Study|No longer meets study criteria|0
5281175|NCT00546364|18216750|P2|Overall Study|No longer meets study criteria|1
5281176|NCT00546364|18216751|P1|Overall Study|No longer meets study criteria|1
5281177|NCT00546364|18216749|P3|Overall Study|Poor compliance/noncompliance|1
5281178|NCT00546364|18216750|P2|Overall Study|Poor compliance/noncompliance|0
5281179|NCT00546364|18216751|P1|Overall Study|Poor compliance/noncompliance|0
5281180|NCT00546364|18216749|P3|Overall Study|Administrative reason by sponsor|0
5281181|NCT00546364|18216750|P2|Overall Study|Administrative reason by sponsor|0
5281182|NCT00546364|18216751|P1|Overall Study|Administrative reason by sponsor|1
5281183|NCT00546364|18216749|P3|Overall Study|Completed and off treatment|2
5281184|NCT00546364|18216750|P2|Overall Study|Completed and off treatment|0
5281185|NCT00546364|18216751|P1|Overall Study|Completed and off treatment|1
5281186|NCT00546364|18216749|P3|Overall Study|Disease progression|8
5281187|NCT00546364|18216750|P2|Overall Study|Disease progression|11
5281188|NCT00546364|18216751|P1|Overall Study|Disease progression|5
5281189|NCT00546351|18216786|P1|Overall Study|Other reasons for premature termination|17
5281190|NCT00546351|18216786|P1|Overall Study|Unsatisfactory compliance|9
5281191|NCT00546351|18216786|P1|Overall Study|Protocol Deviation|1
5281192|NCT00546351|18216786|P1|Overall Study|Lost to Follow-up|9
5281193|NCT00546351|18216786|P1|Overall Study|Withdrawal by Subject|109
5281194|NCT00546351|18216786|P1|Overall Study|Lack of Efficacy|15
5281195|NCT00546351|18216786|P1|Overall Study|Adverse Event|76
5281196|NCT00546260|18216832|P2|Overall Study|Drug not given pre diagnostic angiogr|2
5281197|NCT00546260|18216833|P1|Overall Study|Drug not given pre diagnostic angiogr|8
5281198|NCT00546117|18216855|P2|Overall Study|Inability to schedule follow-up visit|0
5281199|NCT00546117|18216856|P1|Overall Study|Inability to schedule follow-up visit|1
5281200|NCT00546117|18216855|P2|Overall Study|Withdrawal by Subject|0
5281201|NCT00546117|18216856|P1|Overall Study|Withdrawal by Subject|3
5281202|NCT00546078|18216881|P2|Overall Study|Other reason|1
5281203|NCT00546078|18216882|P1|Overall Study|Other reason|1
5281204|NCT00546078|18216881|P2|Overall Study|Withdrawal by Subject|3
5281205|NCT00546078|18216882|P1|Overall Study|Withdrawal by Subject|2
5281206|NCT00546078|18216881|P2|Overall Study|Lost to Follow-up|3
5281207|NCT00546078|18216882|P1|Overall Study|Lost to Follow-up|1
5281208|NCT00546052|18216920|P1|Overall Study|Non Compliance|7
5281209|NCT00546052|18216920|P1|Overall Study|Withdrawal by Subject|20
5281210|NCT00546052|18216920|P1|Overall Study|Protocol Violation|9
5281211|NCT00546052|18216920|P1|Overall Study|Lost to Follow-up|144
5281212|NCT00546052|18216920|P1|Overall Study|Adverse Event|47
5281213|NCT00546000|18216938|P1|Overall Study|Baseline HPA Axis Supression|2
5281214|NCT00546000|18216938|P1|Overall Study|Lost to Follow-up|1
5281215|NCT00546000|18216938|P1|Overall Study|Adverse Event|1
5281216|NCT00545948|18216963|P3|Overall Study|Not Treated|7
5281217|NCT00545948|18216964|P2|Overall Study|Not Treated|1
5281218|NCT00545948|18216965|P1|Overall Study|Not Treated|1
5281219|NCT00545844|18216975|P1|Overall Study|Withdrawal by Subject|2
5281220|NCT00545844|18216975|P1|Overall Study|Protocol Violation|1
5281221|NCT00545844|18216975|P1|Overall Study|Lost to Follow-up|9
5281222|NCT00545818|18216991|P2|Overall Study|Lost to Follow-up|6
5281223|NCT00545818|18216992|P1|Overall Study|Lost to Follow-up|1
5281224|NCT00545818|18216991|P2|Overall Study|Adverse Event|1
5281225|NCT00545818|18216992|P1|Overall Study|Adverse Event|1
5281226|NCT00545818|18216991|P2|Overall Study|Protocol Violation|0
5281227|NCT00545818|18216992|P1|Overall Study|Protocol Violation|1
5281228|NCT00545792|18217006|P1|Overall Study|Withdrawal by Subject|1
5281229|NCT00545779|18217011|P1|Overall Study|Failure to return|3
5281230|NCT00545779|18217011|P1|Overall Study|Adverse Event/intercurrent illness|5
5281231|NCT00545779|18217011|P1|Overall Study|Withdrawal by Subject|20
5281232|NCT00545779|18217011|P1|Overall Study|Did not cooperate|7
5281233|NCT00545779|18217011|P1|Overall Study|Other protocol violation|1
5281234|NCT00545779|18217011|P1|Overall Study|Violation of selection criteria at entry|8
5281235|NCT00545753|18217031|P3|Overall Study|Protocol Violation|4
5281236|NCT00545753|18217032|P2|Overall Study|Protocol Violation|1
5281237|NCT00545753|18217033|P1|Overall Study|Protocol Violation|3
5281238|NCT00545753|18217031|P3|Overall Study|Lost to Follow-up|12
5281239|NCT00545753|18217032|P2|Overall Study|Lost to Follow-up|3
5281240|NCT00545753|18217033|P1|Overall Study|Lost to Follow-up|13
5281241|NCT00545753|18217031|P3|Overall Study|Withdrawal by Subject|10
5281242|NCT00545753|18217032|P2|Overall Study|Withdrawal by Subject|1
5281243|NCT00545753|18217033|P1|Overall Study|Withdrawal by Subject|0
5281244|NCT00545740|18217046|P4|Overall Study|Husband against study|0
5281245|NCT00545740|18217047|P3|Overall Study|Husband against study|1
5281246|NCT00545740|18217048|P2|Overall Study|Husband against study|0
5281247|NCT00545740|18217049|P1|Overall Study|Husband against study|0
5281248|NCT00545740|18217046|P4|Overall Study|Patient difficulties|0
5281249|NCT00545740|18217047|P3|Overall Study|Patient difficulties|0
5281250|NCT00545740|18217048|P2|Overall Study|Patient difficulties|1
5281251|NCT00545740|18217049|P1|Overall Study|Patient difficulties|0
5281252|NCT00545740|18217046|P4|Overall Study|Non-adherence to visits|0
5281253|NCT00545740|18217047|P3|Overall Study|Non-adherence to visits|0
5281254|NCT00545740|18217048|P2|Overall Study|Non-adherence to visits|1
5281255|NCT00545740|18217049|P1|Overall Study|Non-adherence to visits|0
5281256|NCT00545740|18217046|P4|Overall Study|Lack of time|0
5281257|NCT00545740|18217047|P3|Overall Study|Lack of time|0
5281258|NCT00545740|18217048|P2|Overall Study|Lack of time|1
5281259|NCT00545740|18217049|P1|Overall Study|Lack of time|0
5281260|NCT00545740|18217046|P4|Overall Study|Sponsor decision|0
5281261|NCT00545740|18217047|P3|Overall Study|Sponsor decision|0
5281262|NCT00545740|18217048|P2|Overall Study|Sponsor decision|1
5281263|NCT00545740|18217049|P1|Overall Study|Sponsor decision|0
5281264|NCT00545740|18217046|P4|Overall Study|Accepted only monthly telephone calls|0
5281265|NCT00545740|18217047|P3|Overall Study|Accepted only monthly telephone calls|0
5281266|NCT00545740|18217048|P2|Overall Study|Accepted only monthly telephone calls|0
5281267|NCT00545740|18217049|P1|Overall Study|Accepted only monthly telephone calls|1
5281268|NCT00545740|18217046|P4|Overall Study|Physician Decision|0
5281269|NCT00545740|18217047|P3|Overall Study|Physician Decision|3
5281270|NCT00545740|18217048|P2|Overall Study|Physician Decision|0
5281271|NCT00545740|18217049|P1|Overall Study|Physician Decision|0
5281272|NCT00545740|18217046|P4|Overall Study|Missed visit|0
5281273|NCT00545740|18217047|P3|Overall Study|Missed visit|0
5281274|NCT00545740|18217048|P2|Overall Study|Missed visit|0
5281275|NCT00545740|18217049|P1|Overall Study|Missed visit|1
5281276|NCT00545740|18217046|P4|Overall Study|Site closure|0
5281277|NCT00545740|18217047|P3|Overall Study|Site closure|0
5281278|NCT00545740|18217048|P2|Overall Study|Site closure|0
5281279|NCT00545740|18217049|P1|Overall Study|Site closure|1
5281280|NCT00545740|18217046|P4|Overall Study|Suspected Diverticulitis Recurrence|1
5281281|NCT00545740|18217047|P3|Overall Study|Suspected Diverticulitis Recurrence|1
5281282|NCT00545740|18217048|P2|Overall Study|Suspected Diverticulitis Recurrence|1
5281283|NCT00545740|18217049|P1|Overall Study|Suspected Diverticulitis Recurrence|1
5281284|NCT00545740|18217046|P4|Overall Study|Diverticulitis attack|1
5281285|NCT00545740|18217047|P3|Overall Study|Diverticulitis attack|1
5281286|NCT00545740|18217048|P2|Overall Study|Diverticulitis attack|0
5281287|NCT00545740|18217049|P1|Overall Study|Diverticulitis attack|0
5281288|NCT00545740|18217046|P4|Overall Study|Moved|0
5281289|NCT00545740|18217047|P3|Overall Study|Moved|1
5281290|NCT00545740|18217048|P2|Overall Study|Moved|0
5281291|NCT00545740|18217049|P1|Overall Study|Moved|2
5281292|NCT00545740|18217046|P4|Overall Study|Non-compliance|0
5281293|NCT00545740|18217047|P3|Overall Study|Non-compliance|1
5281294|NCT00545740|18217048|P2|Overall Study|Non-compliance|2
5281295|NCT00545740|18217049|P1|Overall Study|Non-compliance|0
5281296|NCT00545740|18217046|P4|Overall Study|Protocol Violation|0
5281297|NCT00545740|18217047|P3|Overall Study|Protocol Violation|1
5281298|NCT00545740|18217048|P2|Overall Study|Protocol Violation|3
5281299|NCT00545740|18217049|P1|Overall Study|Protocol Violation|1
5281300|NCT00545740|18217046|P4|Overall Study|Lost to Follow-up|6
5281301|NCT00545740|18217047|P3|Overall Study|Lost to Follow-up|5
5281302|NCT00545740|18217048|P2|Overall Study|Lost to Follow-up|5
5281303|NCT00545740|18217049|P1|Overall Study|Lost to Follow-up|7
5281304|NCT00545740|18217046|P4|Overall Study|Adverse Event|9
5281305|NCT00545740|18217047|P3|Overall Study|Adverse Event|19
5281306|NCT00545740|18217048|P2|Overall Study|Adverse Event|18
5281307|NCT00545740|18217049|P1|Overall Study|Adverse Event|10
5281308|NCT00545740|18217046|P4|Overall Study|Withdrawal by Subject|18
5281309|NCT00545740|18217047|P3|Overall Study|Withdrawal by Subject|16
5281310|NCT00545740|18217048|P2|Overall Study|Withdrawal by Subject|15
5281311|NCT00545740|18217049|P1|Overall Study|Withdrawal by Subject|17
5281312|NCT00545740|18217046|P4|Overall Study|Lack of Efficacy|36
5281313|NCT00545740|18217047|P3|Overall Study|Lack of Efficacy|47
5281314|NCT00545740|18217048|P2|Overall Study|Lack of Efficacy|35
5281315|NCT00545740|18217049|P1|Overall Study|Lack of Efficacy|34
5281316|NCT00545714|18217083|P1|Maintenance Phase (36 Months)|Death|2
5281317|NCT00545714|18217083|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
5281318|NCT00545714|18217083|P1|Maintenance Phase (36 Months)|Protocol Violation|1
5281319|NCT00545714|18217083|P1|Maintenance Phase (36 Months)|Physician Decision|1
5281320|NCT00545714|18217083|P1|Maintenance Phase (36 Months)|Disease Progression|9
5281321|NCT00545714|18217083|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
5281322|NCT00545714|18217083|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
5281323|NCT00545714|18217083|P1|Induction Phase (6 Months)|Disease Progression|1
5281324|NCT00545714|18217083|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
5281325|NCT00545714|18217083|P1|Induction Phase (6 Months)|Physician Decision|3
5281326|NCT00545688|18217104|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
5281327|NCT00545688|18217105|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
5281328|NCT00545688|18217106|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
5281329|NCT00545688|18217107|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
5281330|NCT00545688|18217104|P4|Follow-Up Period|Unspecified Reason|8
5281331|NCT00545688|18217105|P3|Follow-Up Period|Unspecified Reason|6
5281332|NCT00545688|18217106|P2|Follow-Up Period|Unspecified Reason|5
5281333|NCT00545688|18217107|P1|Follow-Up Period|Unspecified Reason|2
5281334|NCT00545688|18217104|P4|Follow-Up Period|Lost to Follow-up|1
5281335|NCT00545688|18217105|P3|Follow-Up Period|Lost to Follow-up|3
5281336|NCT00545688|18217106|P2|Follow-Up Period|Lost to Follow-up|3
5281337|NCT00545688|18217107|P1|Follow-Up Period|Lost to Follow-up|3
5281338|NCT00545688|18217104|P4|Follow-Up Period|Refused Treatment|2
5281339|NCT00545688|18217105|P3|Follow-Up Period|Refused Treatment|0
5281340|NCT00545688|18217106|P2|Follow-Up Period|Refused Treatment|2
5281341|NCT00545688|18217107|P1|Follow-Up Period|Refused Treatment|6
5281342|NCT00545688|18217104|P4|Follow-Up Period|Disease Progression|9
5281343|NCT00545688|18217105|P3|Follow-Up Period|Disease Progression|9
5281344|NCT00545688|18217106|P2|Follow-Up Period|Disease Progression|5
5281345|NCT00545688|18217107|P1|Follow-Up Period|Disease Progression|6
5281346|NCT00545688|18217104|P4|Follow-Up Period|Death|6
5281347|NCT00545688|18217105|P3|Follow-Up Period|Death|2
5281348|NCT00545688|18217106|P2|Follow-Up Period|Death|2
5281349|NCT00545688|18217107|P1|Follow-Up Period|Death|4
5281350|NCT00545688|18217104|P4|Adjuvant Treatment Period|Unknown Reason|0
5281351|NCT00545688|18217105|P3|Adjuvant Treatment Period|Unknown Reason|0
5281352|NCT00545688|18217106|P2|Adjuvant Treatment Period|Unknown Reason|1
5281353|NCT00545688|18217107|P1|Adjuvant Treatment Period|Unknown Reason|0
5281354|NCT00545688|18217104|P4|Adjuvant Treatment Period|Adverse Event|2
5281355|NCT00545688|18217105|P3|Adjuvant Treatment Period|Adverse Event|2
5281356|NCT00545688|18217106|P2|Adjuvant Treatment Period|Adverse Event|3
5281357|NCT00545688|18217107|P1|Adjuvant Treatment Period|Adverse Event|0
5281358|NCT00545688|18217104|P4|Adjuvant Treatment Period|Lost to Follow-up|0
5281359|NCT00545688|18217105|P3|Adjuvant Treatment Period|Lost to Follow-up|1
5281360|NCT00545688|18217106|P2|Adjuvant Treatment Period|Lost to Follow-up|0
5281361|NCT00545688|18217107|P1|Adjuvant Treatment Period|Lost to Follow-up|1
5281362|NCT00545688|18217104|P4|Adjuvant Treatment Period|Refused Treatment|5
5281363|NCT00545688|18217105|P3|Adjuvant Treatment Period|Refused Treatment|1
5281364|NCT00545688|18217106|P2|Adjuvant Treatment Period|Refused Treatment|1
5281365|NCT00545688|18217107|P1|Adjuvant Treatment Period|Refused Treatment|1
5281366|NCT00545688|18217104|P4|Adjuvant Treatment Period|Disease Progression|7
5281367|NCT00545688|18217105|P3|Adjuvant Treatment Period|Disease Progression|0
5281368|NCT00545688|18217106|P2|Adjuvant Treatment Period|Disease Progression|3
5281369|NCT00545688|18217107|P1|Adjuvant Treatment Period|Disease Progression|3
5281370|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
5281371|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
5281372|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
5281373|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
5281374|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
5281375|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
5281376|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
5281377|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
5281378|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
5281379|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
5281380|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
5281381|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
5281382|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Death|0
5281383|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Death|0
5281384|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Death|1
5281385|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Death|0
5281386|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
5281387|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
5281388|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
5281389|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
5281390|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
5281391|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
5281392|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
5281393|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
5281394|NCT00545688|18217104|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
5281395|NCT00545688|18217105|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
5281396|NCT00545688|18217106|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
5281397|NCT00545688|18217107|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
5281398|NCT00545584|18217206|P3|Overall Study|Two or more reasons for discontinuation|8
5281399|NCT00545584|18217207|P2|Overall Study|Two or more reasons for discontinuation|19
5281400|NCT00545584|18217208|P1|Overall Study|Two or more reasons for discontinuation|17
5281401|NCT00545584|18217206|P3|Overall Study|Only one reason for discontinuation|48
5281402|NCT00545584|18217207|P2|Overall Study|Only one reason for discontinuation|61
5281403|NCT00545584|18217208|P1|Overall Study|Only one reason for discontinuation|62
5281404|NCT00545571|18217219|P1|Overall Study|Kidney Transplantation|3
5281405|NCT00545571|18217219|P1|Overall Study|Early Termination of Study|24
5281406|NCT00545571|18217219|P1|Overall Study|Transfusion|12
5281407|NCT00545571|18217219|P1|Overall Study|Screen Failure|16
5281408|NCT00545571|18217219|P1|Overall Study|Refused Treatment|1
5281409|NCT00545571|18217219|P1|Overall Study|Protocol Violation|2
5281410|NCT00545571|18217219|P1|Overall Study|Lack of Efficacy|1
5281411|NCT00545571|18217219|P1|Overall Study|Death|5
5281412|NCT00545571|18217219|P1|Overall Study|Adverse Event|2
5281413|NCT00545571|18217219|P1|Overall Study|Administrative Reasons|1
5281414|NCT00545532|18217234|P2|Overall Study|Death|1
5281415|NCT00545532|18217235|P1|Overall Study|Death|0
5281416|NCT00545532|18217234|P2|Overall Study|Lost to Follow-up|6
5281417|NCT00545532|18217235|P1|Overall Study|Lost to Follow-up|5
5281418|NCT00545532|18217234|P2|Overall Study|Withdrawal by Subject|3
5281419|NCT00545532|18217235|P1|Overall Study|Withdrawal by Subject|1
5281420|NCT00545441|18217326|P2|Overall Study|Patients were not treated|3
5281421|NCT00545441|18217327|P1|Overall Study|Patients were not treated|1
5281422|NCT00545441|18217326|P2|Overall Study|Persistence or recurrence of fistula|2
5281423|NCT00545441|18217327|P1|Overall Study|Persistence or recurrence of fistula|5
5281424|NCT00545441|18217326|P2|Overall Study|Withdrawal by Subject|1
5281425|NCT00545441|18217327|P1|Overall Study|Withdrawal by Subject|1
5281426|NCT00545441|18217326|P2|Overall Study|Technical failure|1
5281427|NCT00545441|18217327|P1|Overall Study|Technical failure|0
5281428|NCT00545441|18217326|P2|Overall Study|Lost to Follow-up|5
5281429|NCT00545441|18217327|P1|Overall Study|Lost to Follow-up|9
5281430|NCT00545441|18217326|P2|Overall Study|Fistula draining at 6 months|4
5281431|NCT00545441|18217327|P1|Overall Study|Fistula draining at 6 months|2
5281432|NCT00545402|18217335|P2|Overall Study|Reason not specified|1
5281433|NCT00545402|18217336|P1|Overall Study|Reason not specified|1
5281434|NCT00545402|18217335|P2|Overall Study|Protocol Violation|0
5281435|NCT00545402|18217336|P1|Overall Study|Protocol Violation|1
5281436|NCT00545402|18217335|P2|Overall Study|Withdrawal by Subject|1
5281437|NCT00545402|18217336|P1|Overall Study|Withdrawal by Subject|0
5281438|NCT00545402|18217335|P2|Overall Study|Graft loss|4
5281439|NCT00545402|18217336|P1|Overall Study|Graft loss|2
5281440|NCT00545402|18217335|P2|Overall Study|Death|7
5281441|NCT00545402|18217336|P1|Overall Study|Death|5
5281442|NCT00545402|18217335|P2|Overall Study|Use of unauthorized immunosuppressant|7
5281443|NCT00545402|18217336|P1|Overall Study|Use of unauthorized immunosuppressant|8
5281444|NCT00545402|18217335|P2|Overall Study|Discontinuation of treatment|9
5281445|NCT00545402|18217336|P1|Overall Study|Discontinuation of treatment|17
5281446|NCT00545363|18217354|P2|Overall Study|Other|1
5281447|NCT00545363|18217355|P1|Overall Study|Other|1
5281448|NCT00545363|18217354|P2|Overall Study|Lost to Follow-up|0
5281449|NCT00545363|18217355|P1|Overall Study|Lost to Follow-up|2
5281450|NCT00545363|18217354|P2|Overall Study|Did not meet entry criteria|1
5281451|NCT00545363|18217355|P1|Overall Study|Did not meet entry criteria|1
5281452|NCT00545363|18217354|P2|Overall Study|Non-compliance|1
5281453|NCT00545363|18217355|P1|Overall Study|Non-compliance|3
5281454|NCT00545363|18217354|P2|Overall Study|Withdrawal by Subject|5
5281455|NCT00545363|18217355|P1|Overall Study|Withdrawal by Subject|6
5281456|NCT00545363|18217354|P2|Overall Study|Adverse Event|7
5281457|NCT00545363|18217355|P1|Overall Study|Adverse Event|6
5281458|NCT00545298|18217370|P3|Overall Study|Issues with Standard of Care|1
5281459|NCT00545298|18217371|P2|Overall Study|Issues with Standard of Care|0
5281460|NCT00545298|18217372|P1|Overall Study|Issues with Standard of Care|2
5281461|NCT00545272|18217389|P6|Overall Study|Lost to Follow-up|0
5281462|NCT00545272|18217390|P5|Overall Study|Lost to Follow-up|1
5281463|NCT00545272|18217391|P4|Overall Study|Lost to Follow-up|0
5281464|NCT00545272|18217392|P3|Overall Study|Lost to Follow-up|0
5281465|NCT00545272|18217393|P2|Overall Study|Lost to Follow-up|0
5281466|NCT00545272|18217394|P1|Overall Study|Lost to Follow-up|0
5281467|NCT00545272|18217389|P6|Overall Study|Abnormal test procedure result(s)|0
5281468|NCT00545272|18217390|P5|Overall Study|Abnormal test procedure result(s)|1
5281469|NCT00545272|18217391|P4|Overall Study|Abnormal test procedure result(s)|0
5281470|NCT00545272|18217392|P3|Overall Study|Abnormal test procedure result(s)|0
5281471|NCT00545272|18217393|P2|Overall Study|Abnormal test procedure result(s)|0
5281472|NCT00545272|18217394|P1|Overall Study|Abnormal test procedure result(s)|0
5281473|NCT00545272|18217389|P6|Overall Study|Abnormal laboratory value(s)|1
5281474|NCT00545272|18217390|P5|Overall Study|Abnormal laboratory value(s)|0
5281475|NCT00545272|18217391|P4|Overall Study|Abnormal laboratory value(s)|0
5281476|NCT00545272|18217392|P3|Overall Study|Abnormal laboratory value(s)|0
5281477|NCT00545272|18217393|P2|Overall Study|Abnormal laboratory value(s)|0
5281478|NCT00545272|18217394|P1|Overall Study|Abnormal laboratory value(s)|0
5281479|NCT00545272|18217389|P6|Overall Study|Adverse Event|1
5281480|NCT00545272|18217390|P5|Overall Study|Adverse Event|0
5281481|NCT00545272|18217391|P4|Overall Study|Adverse Event|0
5281482|NCT00545272|18217392|P3|Overall Study|Adverse Event|1
5281483|NCT00545272|18217393|P2|Overall Study|Adverse Event|0
5281484|NCT00545272|18217394|P1|Overall Study|Adverse Event|0
5281485|NCT00545272|18217389|P6|Overall Study|Protocol deviation|1
5281486|NCT00545272|18217390|P5|Overall Study|Protocol deviation|0
5281487|NCT00545272|18217391|P4|Overall Study|Protocol deviation|1
5281488|NCT00545272|18217392|P3|Overall Study|Protocol deviation|0
5281489|NCT00545272|18217393|P2|Overall Study|Protocol deviation|1
5281490|NCT00545272|18217394|P1|Overall Study|Protocol deviation|0
5281491|NCT00545233|18217446|P2|Overall Study|Physician Decision|1
5281492|NCT00545233|18217447|P1|Overall Study|Physician Decision|2
5281493|NCT00545233|18217446|P2|Overall Study|Insufficient response|15
5281494|NCT00545233|18217447|P1|Overall Study|Insufficient response|14
5281495|NCT00545233|18217446|P2|Overall Study|Failure to Return|6
5281496|NCT00545233|18217447|P1|Overall Study|Failure to Return|4
5281497|NCT00545233|18217446|P2|Overall Study|Refused Treatment|7
5281498|NCT00545233|18217447|P1|Overall Study|Refused Treatment|9
5281499|NCT00545233|18217446|P2|Overall Study|Protocol Violation|0
5281500|NCT00545233|18217447|P1|Overall Study|Protocol Violation|2
5281501|NCT00545233|18217446|P2|Overall Study|Violation of Selection Criteria at Entry|1
5281502|NCT00545233|18217447|P1|Overall Study|Violation of Selection Criteria at Entry|5
5281503|NCT00545233|18217446|P2|Overall Study|Adverse Event|5
5281504|NCT00545233|18217447|P1|Overall Study|Adverse Event|10
5281505|NCT00545168|18217506|P3|Overall Study|Visit for Day 21 was not done in error|2
5281506|NCT00545168|18217507|P2|Overall Study|Visit for Day 21 was not done in error|0
5281507|NCT00545168|18217508|P1|Overall Study|Visit for Day 21 was not done in error|1
5281508|NCT00545168|18217506|P3|Overall Study|Protocol Violation|1
5281509|NCT00545168|18217507|P2|Overall Study|Protocol Violation|0
5281510|NCT00545168|18217508|P1|Overall Study|Protocol Violation|1
5281511|NCT00545168|18217506|P3|Overall Study|Withdrawal by Subject|13
5281512|NCT00545168|18217507|P2|Overall Study|Withdrawal by Subject|0
5281513|NCT00545168|18217508|P1|Overall Study|Withdrawal by Subject|9
5281514|NCT00545168|18217506|P3|Overall Study|Lost to Follow-up|5
5281515|NCT00545168|18217507|P2|Overall Study|Lost to Follow-up|5
5281516|NCT00545168|18217508|P1|Overall Study|Lost to Follow-up|5
5281517|NCT00545103|18217534|P4|Overall Study|Death|0
5281518|NCT00545103|18217535|P3|Overall Study|Death|0
5281519|NCT00545103|18217536|P2|Overall Study|Death|1
5281520|NCT00545103|18217537|P1|Overall Study|Death|0
5281521|NCT00545103|18217534|P4|Overall Study|Subject met endpoint under protocol v. 1|0
5281522|NCT00545103|18217535|P3|Overall Study|Subject met endpoint under protocol v. 1|1
5281523|NCT00545103|18217536|P2|Overall Study|Subject met endpoint under protocol v. 1|0
5281524|NCT00545103|18217537|P1|Overall Study|Subject met endpoint under protocol v. 1|0
5281525|NCT00545103|18217534|P4|Overall Study|Does not want to take study drug anymore|0
5281526|NCT00545103|18217535|P3|Overall Study|Does not want to take study drug anymore|1
5281527|NCT00545103|18217536|P2|Overall Study|Does not want to take study drug anymore|0
5281528|NCT00545103|18217537|P1|Overall Study|Does not want to take study drug anymore|1
5281529|NCT00545103|18217534|P4|Overall Study|Use of prohibited medication|0
5281530|NCT00545103|18217535|P3|Overall Study|Use of prohibited medication|1
5281531|NCT00545103|18217536|P2|Overall Study|Use of prohibited medication|0
5281532|NCT00545103|18217537|P1|Overall Study|Use of prohibited medication|0
5281533|NCT00545103|18217534|P4|Overall Study|Subject moved|0
5281534|NCT00545103|18217535|P3|Overall Study|Subject moved|0
5281535|NCT00545103|18217536|P2|Overall Study|Subject moved|1
5281536|NCT00545103|18217537|P1|Overall Study|Subject moved|0
5281537|NCT00545103|18217534|P4|Overall Study|Investigator decision|0
5281538|NCT00545103|18217535|P3|Overall Study|Investigator decision|1
5281539|NCT00545103|18217536|P2|Overall Study|Investigator decision|0
5281540|NCT00545103|18217537|P1|Overall Study|Investigator decision|0
5281541|NCT00545103|18217534|P4|Overall Study|Noncompliance|0
5281542|NCT00545103|18217535|P3|Overall Study|Noncompliance|0
5281543|NCT00545103|18217536|P2|Overall Study|Noncompliance|1
5281544|NCT00545103|18217537|P1|Overall Study|Noncompliance|0
5281545|NCT00545103|18217534|P4|Overall Study|Subject's decision|0
5281546|NCT00545103|18217535|P3|Overall Study|Subject's decision|0
5281547|NCT00545103|18217536|P2|Overall Study|Subject's decision|0
5281548|NCT00545103|18217537|P1|Overall Study|Subject's decision|1
5281549|NCT00545103|18217534|P4|Overall Study|Personal reasons|0
5281550|NCT00545103|18217535|P3|Overall Study|Personal reasons|0
5281551|NCT00545103|18217536|P2|Overall Study|Personal reasons|0
5281552|NCT00545103|18217537|P1|Overall Study|Personal reasons|1
5281553|NCT00545103|18217534|P4|Overall Study|Diverticulitis crisis|1
5281554|NCT00545103|18217535|P3|Overall Study|Diverticulitis crisis|0
5281555|NCT00545103|18217536|P2|Overall Study|Diverticulitis crisis|0
5281556|NCT00545103|18217537|P1|Overall Study|Diverticulitis crisis|0
5281557|NCT00545103|18217534|P4|Overall Study|Wish to start a family|1
5281558|NCT00545103|18217535|P3|Overall Study|Wish to start a family|0
5281559|NCT00545103|18217536|P2|Overall Study|Wish to start a family|0
5281560|NCT00545103|18217537|P1|Overall Study|Wish to start a family|0
5281561|NCT00545103|18217534|P4|Overall Study|Investigational product not taken|1
5281562|NCT00545103|18217535|P3|Overall Study|Investigational product not taken|0
5281563|NCT00545103|18217536|P2|Overall Study|Investigational product not taken|0
5281564|NCT00545103|18217537|P1|Overall Study|Investigational product not taken|1
5281565|NCT00545103|18217534|P4|Overall Study|Difficult to open package|1
5281566|NCT00545103|18217535|P3|Overall Study|Difficult to open package|0
5281567|NCT00545103|18217536|P2|Overall Study|Difficult to open package|0
5281568|NCT00545103|18217537|P1|Overall Study|Difficult to open package|0
5281569|NCT00545103|18217534|P4|Overall Study|Suspected recurrence of diverticulitis|3
5281570|NCT00545103|18217535|P3|Overall Study|Suspected recurrence of diverticulitis|0
5281571|NCT00545103|18217536|P2|Overall Study|Suspected recurrence of diverticulitis|0
5281572|NCT00545103|18217537|P1|Overall Study|Suspected recurrence of diverticulitis|1
5281573|NCT00545103|18217534|P4|Overall Study|Protocol Violation|0
5281574|NCT00545103|18217535|P3|Overall Study|Protocol Violation|3
5281575|NCT00545103|18217536|P2|Overall Study|Protocol Violation|2
5281576|NCT00545103|18217537|P1|Overall Study|Protocol Violation|1
5281577|NCT00545103|18217534|P4|Overall Study|Lost to Follow-up|4
5281578|NCT00545103|18217535|P3|Overall Study|Lost to Follow-up|3
5281579|NCT00545103|18217536|P2|Overall Study|Lost to Follow-up|6
5281580|NCT00545103|18217537|P1|Overall Study|Lost to Follow-up|4
5281581|NCT00545103|18217534|P4|Overall Study|Adverse Event|10
5281582|NCT00545103|18217535|P3|Overall Study|Adverse Event|17
5281583|NCT00545103|18217536|P2|Overall Study|Adverse Event|12
5281584|NCT00545103|18217537|P1|Overall Study|Adverse Event|11
5281585|NCT00545103|18217534|P4|Overall Study|Withdrawal by Subject|22
5281586|NCT00545103|18217535|P3|Overall Study|Withdrawal by Subject|18
5281587|NCT00545103|18217536|P2|Overall Study|Withdrawal by Subject|10
5281588|NCT00545103|18217537|P1|Overall Study|Withdrawal by Subject|6
5281589|NCT00545103|18217534|P4|Overall Study|Lack of Efficacy|27
5281590|NCT00545103|18217535|P3|Overall Study|Lack of Efficacy|31
5281591|NCT00545103|18217536|P2|Overall Study|Lack of Efficacy|45
5281592|NCT00545103|18217537|P1|Overall Study|Lack of Efficacy|48
5281593|NCT00545077|18217573|P2|Overall Study|Death|8
5281594|NCT00545077|18217574|P1|Overall Study|Death|0
5281595|NCT00545077|18217573|P2|Overall Study|Adverse Event|31
5281596|NCT00545077|18217574|P1|Overall Study|Adverse Event|0
5281597|NCT00545077|18217573|P2|Overall Study|Protocol Violation|0
5281598|NCT00545077|18217574|P1|Overall Study|Protocol Violation|1
5281599|NCT00545077|18217573|P2|Overall Study|Lost to Follow-up|0
5281600|NCT00545077|18217574|P1|Overall Study|Lost to Follow-up|2
5281601|NCT00545077|18217573|P2|Overall Study|Physician Decision|3
5281602|NCT00545077|18217574|P1|Overall Study|Physician Decision|6
5281603|NCT00545077|18217573|P2|Overall Study|Withdrawal by Subject|14
5281604|NCT00545077|18217574|P1|Overall Study|Withdrawal by Subject|3
5281605|NCT00545077|18217573|P2|Overall Study|Disease Progression|98
5281606|NCT00545077|18217574|P1|Overall Study|Disease Progression|131
5281607|NCT00545077|18217573|P2|Overall Study|Treatment not received|1
5281608|NCT00545077|18217574|P1|Overall Study|Treatment not received|5
5281609|NCT00545064|18217590|P1|Overall Study|inclement weather|1
5281610|NCT00545064|18217590|P1|Overall Study|cancel all appointments, no rebooking|1
5281611|NCT00545064|18217590|P1|Overall Study|did not complete course of treatment|1
5281612|NCT00545064|18217590|P1|Overall Study|Withdrawal by Subject|2
5281613|NCT00545064|18217590|P1|Overall Study|Lost to Follow-up|3
5281614|NCT00545051|18217601|P2|Overall Study|Administrative reasons|1
5281615|NCT00545051|18217602|P1|Overall Study|Administrative reasons|0
5281616|NCT00545051|18217601|P2|Overall Study|Withdrawal by Subject|1
5281617|NCT00545051|18217602|P1|Overall Study|Withdrawal by Subject|0
5281618|NCT00545051|18217601|P2|Overall Study|Protocol Violation|0
5281619|NCT00545051|18217602|P1|Overall Study|Protocol Violation|1
5281620|NCT00545051|18217601|P2|Overall Study|Violation of inclusion/exclusion|2
5281621|NCT00545051|18217602|P1|Overall Study|Violation of inclusion/exclusion|0
5281622|NCT00545051|18217601|P2|Overall Study|Death|0
5281623|NCT00545051|18217602|P1|Overall Study|Death|1
5281624|NCT00545051|18217601|P2|Overall Study|Adverse Event|3
5281625|NCT00545051|18217602|P1|Overall Study|Adverse Event|7
5281626|NCT00544882|18217646|P3|Cycle 3: Follow-up|Pregnancy|0
5281627|NCT00544882|18217647|P2|Cycle 3: Follow-up|Pregnancy|1
5281628|NCT00544882|18217648|P1|Cycle 3: Follow-up|Pregnancy|0
5281629|NCT00544882|18217646|P3|Cycle 3: Follow-up|Noncompliance|0
5281630|NCT00544882|18217647|P2|Cycle 3: Follow-up|Noncompliance|1
5281631|NCT00544882|18217648|P1|Cycle 3: Follow-up|Noncompliance|0
5281632|NCT00544882|18217646|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
5281633|NCT00544882|18217647|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
5281634|NCT00544882|18217648|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
5281635|NCT00544882|18217646|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
5281636|NCT00544882|18217647|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
5281637|NCT00544882|18217648|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
5281638|NCT00544882|18217646|P3|Cycle 1: Run-in Cycle|Adverse Event|0
5281639|NCT00544882|18217647|P2|Cycle 1: Run-in Cycle|Adverse Event|0
5281640|NCT00544882|18217648|P1|Cycle 1: Run-in Cycle|Adverse Event|1
5281641|NCT00544882|18217646|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
5281642|NCT00544882|18217647|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
5281643|NCT00544882|18217648|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
5281644|NCT00544869|18217673|P3|Overall Study|Physician Decision|0
5281645|NCT00544869|18217674|P2|Overall Study|Physician Decision|0
5281646|NCT00544869|18217675|P1|Overall Study|Physician Decision|2
5281647|NCT00544869|18217673|P3|Overall Study|Lack of Efficacy|0
5281648|NCT00544869|18217674|P2|Overall Study|Lack of Efficacy|1
5281649|NCT00544869|18217675|P1|Overall Study|Lack of Efficacy|1
5281650|NCT00544869|18217673|P3|Overall Study|Adverse Event|0
5281651|NCT00544869|18217674|P2|Overall Study|Adverse Event|1
5281652|NCT00544869|18217675|P1|Overall Study|Adverse Event|6
5281653|NCT00544869|18217673|P3|Overall Study|Rsolution of congenitive symptoms|0
5281654|NCT00544869|18217674|P2|Overall Study|Rsolution of congenitive symptoms|0
5281655|NCT00544869|18217675|P1|Overall Study|Rsolution of congenitive symptoms|3
5281656|NCT00544817|18217683|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
5281657|NCT00544817|18217683|P1|Follow-up Systemic Therapy|Physician Decision|3
5281658|NCT00544817|18217683|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
5281659|NCT00544817|18217683|P1|No Treatment Interval|Adverse Event|1
5281660|NCT00544817|18217683|P1|No Treatment Interval|Physician Decision|3
5281661|NCT00544817|18217683|P1|No Treatment Interval|Lack of Efficacy|8
5281662|NCT00544817|18217683|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
5281663|NCT00544817|18217683|P1|Combined Modality|Adverse Event|2
5281664|NCT00544817|18217683|P1|Combined Modality|Worsening Neurologic Symptoms|2
5281665|NCT00544817|18217683|P1|Combined Modality|Lack of Efficacy|2
5281666|NCT00544648|18217732|P2|Overall Study|progression of disease|0
5281667|NCT00544648|18217733|P1|Overall Study|progression of disease|1
5281668|NCT00544648|18217732|P2|Overall Study|Adverse Event|1
5281669|NCT00544648|18217733|P1|Overall Study|Adverse Event|1
5281670|NCT00544648|18217732|P2|Overall Study|Withdrawal by Subject|0
5281671|NCT00544648|18217733|P1|Overall Study|Withdrawal by Subject|1
5281672|NCT00544557|18217747|P1|Overall Study|Other|98
5281673|NCT00544557|18217747|P1|Overall Study|Lack of Efficacy|196
5281674|NCT00544557|18217747|P1|Overall Study|Adverse Event|140
5281675|NCT00544544|18217778|P1|Overall Study|Lost to Follow-up|1
5281676|NCT00544544|18217778|P1|Overall Study|Adverse Event|1
5281677|NCT00544544|18217778|P1|Overall Study|Withdrawal by Subject|1
5281678|NCT00544440|18217785|P1|Overall Study|Other|5
5281679|NCT00544440|18217785|P1|Overall Study|Progressive Disease|47
5281680|NCT00544440|18217785|P1|Overall Study|Subject Non-compliance|1
5281681|NCT00544440|18217785|P1|Overall Study|Withdrawal by Subject|2
5281682|NCT00544440|18217785|P1|Overall Study|Adverse Event|1
5281683|NCT00544440|18217785|P1|Overall Study|Other|1
5281684|NCT00544167|18217792|P1|Overall Study|Physician Decision|8
5281685|NCT00544167|18217792|P1|Overall Study|Adverse Event|21
5281686|NCT00543985|18217818|P1|Overall Study|Withdrawal by Subject|4
5281687|NCT00543855|18217829|P4|Overall Study|Protocol Violation|0
5281688|NCT00543855|18217830|P3|Overall Study|Protocol Violation|0
5281689|NCT00543855|18217831|P2|Overall Study|Protocol Violation|0
5281690|NCT00543855|18217832|P1|Overall Study|Protocol Violation|1
5281691|NCT00543855|18217829|P4|Overall Study|Withdrawal by Subject|0
5281692|NCT00543855|18217830|P3|Overall Study|Withdrawal by Subject|2
5281693|NCT00543855|18217831|P2|Overall Study|Withdrawal by Subject|1
5281694|NCT00543855|18217832|P1|Overall Study|Withdrawal by Subject|0
5281695|NCT00543855|18217829|P4|Overall Study|Lost to Follow-up|0
5281696|NCT00543855|18217830|P3|Overall Study|Lost to Follow-up|1
5281697|NCT00543855|18217831|P2|Overall Study|Lost to Follow-up|0
5281698|NCT00543855|18217832|P1|Overall Study|Lost to Follow-up|0
5281699|NCT00543855|18217829|P4|Overall Study|Adverse Event|4
5281700|NCT00543855|18217830|P3|Overall Study|Adverse Event|3
5281701|NCT00543855|18217831|P2|Overall Study|Adverse Event|1
5281702|NCT00543855|18217832|P1|Overall Study|Adverse Event|3
5281703|NCT00543803|18217854|P1|Overall Study|Other|86
5281704|NCT00543803|18217854|P1|Overall Study|Lost to Follow-up|20
5281705|NCT00543803|18217854|P1|Overall Study|Lack of Efficacy|22
5281706|NCT00543803|18217854|P1|Overall Study|Adverse Event|14
5281707|NCT00543725|18217882|P2|Overall Study|Other|3
5281708|NCT00543725|18217883|P1|Overall Study|Other|3
5281709|NCT00543725|18217882|P2|Overall Study|Lost to Follow-up|11
5281710|NCT00543725|18217883|P1|Overall Study|Lost to Follow-up|15
5281711|NCT00543725|18217882|P2|Overall Study|Withdrawal by Subject|13
5281712|NCT00543725|18217883|P1|Overall Study|Withdrawal by Subject|4
5281713|NCT00543725|18217882|P2|Overall Study|Protocol Violation|1
5281714|NCT00543725|18217883|P1|Overall Study|Protocol Violation|0
5281715|NCT00543725|18217882|P2|Overall Study|Subject Reached A Virologic Endpoint|14
5281716|NCT00543725|18217883|P1|Overall Study|Subject Reached A Virologic Endpoint|22
5281717|NCT00543725|18217882|P2|Overall Study|Subject Ineligible To Continue The Trial|0
5281718|NCT00543725|18217883|P1|Overall Study|Subject Ineligible To Continue The Trial|2
5281719|NCT00543725|18217882|P2|Overall Study|Subject Non-Compliant|4
5281720|NCT00543725|18217883|P1|Overall Study|Subject Non-Compliant|4
5281721|NCT00543725|18217882|P2|Overall Study|Sponsor's Decision|1
5281722|NCT00543725|18217883|P1|Overall Study|Sponsor's Decision|0
5281723|NCT00543725|18217882|P2|Overall Study|Adverse Event|27
5281724|NCT00543725|18217883|P1|Overall Study|Adverse Event|18
5281725|NCT00543569|18217909|P4|Overall Study|Randomized but never received study drug|3
5281726|NCT00543569|18217910|P3|Overall Study|Randomized but never received study drug|5
5281727|NCT00543569|18217911|P2|Overall Study|Randomized but never received study drug|3
5281728|NCT00543569|18217912|P1|Overall Study|Randomized but never received study drug|3
5281729|NCT00543569|18217909|P4|Overall Study|Miscellaneous Reasons|4
5281730|NCT00543569|18217910|P3|Overall Study|Miscellaneous Reasons|11
5281731|NCT00543569|18217911|P2|Overall Study|Miscellaneous Reasons|3
5281732|NCT00543569|18217912|P1|Overall Study|Miscellaneous Reasons|7
5281733|NCT00543569|18217909|P4|Overall Study|Lost to Follow-up|1
5281734|NCT00543569|18217910|P3|Overall Study|Lost to Follow-up|1
5281735|NCT00543569|18217911|P2|Overall Study|Lost to Follow-up|0
5281736|NCT00543569|18217912|P1|Overall Study|Lost to Follow-up|0
5281737|NCT00543569|18217909|P4|Overall Study|Death|1
5281738|NCT00543569|18217910|P3|Overall Study|Death|3
5281739|NCT00543569|18217911|P2|Overall Study|Death|2
5281740|NCT00543569|18217912|P1|Overall Study|Death|2
5281741|NCT00543543|18218018|P4|Extension Study|Withdrawal by Subject|120
5281742|NCT00543543|18218019|P3|Extension Study|Withdrawal by Subject|0
5281743|NCT00543543|18218020|P2|Extension Study|Withdrawal by Subject|0
5281744|NCT00543543|18218021|P1|Extension Study|Withdrawal by Subject|0
5281745|NCT00543543|18218018|P4|Extension Study|Protocol Violation|11
5281746|NCT00543543|18218019|P3|Extension Study|Protocol Violation|0
5281747|NCT00543543|18218020|P2|Extension Study|Protocol Violation|0
5281748|NCT00543543|18218021|P1|Extension Study|Protocol Violation|0
5281749|NCT00543543|18218018|P4|Extension Study|Pregnancy|6
5281750|NCT00543543|18218019|P3|Extension Study|Pregnancy|0
5281751|NCT00543543|18218020|P2|Extension Study|Pregnancy|0
5281752|NCT00543543|18218021|P1|Extension Study|Pregnancy|0
5281753|NCT00543543|18218018|P4|Extension Study|Physician Decision|7
5281754|NCT00543543|18218019|P3|Extension Study|Physician Decision|0
5281755|NCT00543543|18218020|P2|Extension Study|Physician Decision|0
5281756|NCT00543543|18218021|P1|Extension Study|Physician Decision|0
5281757|NCT00543543|18218018|P4|Extension Study|Lost to Follow-up|77
5281758|NCT00543543|18218019|P3|Extension Study|Lost to Follow-up|0
5281759|NCT00543543|18218020|P2|Extension Study|Lost to Follow-up|0
5281760|NCT00543543|18218021|P1|Extension Study|Lost to Follow-up|0
5281761|NCT00543543|18218018|P4|Extension Study|Adverse Event|5
5281762|NCT00543543|18218019|P3|Extension Study|Adverse Event|0
5281763|NCT00543543|18218020|P2|Extension Study|Adverse Event|0
5281764|NCT00543543|18218021|P1|Extension Study|Adverse Event|0
5281765|NCT00543543|18218018|P4|Base Study|Withdrawal by Subject|503
5281766|NCT00543543|18218019|P3|Base Study|Withdrawal by Subject|5
5281767|NCT00543543|18218020|P2|Base Study|Withdrawal by Subject|482
5281768|NCT00543543|18218021|P1|Base Study|Withdrawal by Subject|7
5281769|NCT00543543|18218018|P4|Base Study|Protocol Violation|6
5281770|NCT00543543|18218019|P3|Base Study|Protocol Violation|0
5281771|NCT00543543|18218020|P2|Base Study|Protocol Violation|6
5281772|NCT00543543|18218021|P1|Base Study|Protocol Violation|0
5281773|NCT00543543|18218018|P4|Base Study|Physician Decision|7
5281774|NCT00543543|18218019|P3|Base Study|Physician Decision|0
5281775|NCT00543543|18218020|P2|Base Study|Physician Decision|4
5281776|NCT00543543|18218021|P1|Base Study|Physician Decision|0
5281777|NCT00543543|18218018|P4|Base Study|Lost to Follow-up|701
5281778|NCT00543543|18218019|P3|Base Study|Lost to Follow-up|9
5281779|NCT00543543|18218020|P2|Base Study|Lost to Follow-up|749
5281780|NCT00543543|18218021|P1|Base Study|Lost to Follow-up|12
5281781|NCT00543543|18218018|P4|Base Study|Adverse Event|5
5281782|NCT00543543|18218019|P3|Base Study|Adverse Event|0
5281783|NCT00543543|18218020|P2|Base Study|Adverse Event|11
5281784|NCT00543543|18218021|P1|Base Study|Adverse Event|1
5281785|NCT00543439|18218065|P3|Period 2|Adverse Event|1
5281786|NCT00543439|18218066|P2|Period 2|Adverse Event|1
5281787|NCT00543439|18218067|P1|Period 2|Adverse Event|0
5281788|NCT00543439|18218065|P3|Period 2|Protocol Violation|1
5281789|NCT00543439|18218066|P2|Period 2|Protocol Violation|0
5281790|NCT00543439|18218067|P1|Period 2|Protocol Violation|1
5281791|NCT00543439|18218065|P3|Period 1|Physician Decision|1
5281792|NCT00543439|18218066|P2|Period 1|Physician Decision|0
5281793|NCT00543439|18218067|P1|Period 1|Physician Decision|0
5281794|NCT00543439|18218065|P3|Period 1|Withdrawal by Subject|0
5281795|NCT00543439|18218066|P2|Period 1|Withdrawal by Subject|1
5281796|NCT00543439|18218067|P1|Period 1|Withdrawal by Subject|1
5281797|NCT00543439|18218065|P3|Period 1|Adverse Event|1
5281798|NCT00543439|18218066|P2|Period 1|Adverse Event|2
5281799|NCT00543439|18218067|P1|Period 1|Adverse Event|0
5281800|NCT00543387|18218136|P11|Crossover Participants|Study Terminated by Sponsor|1
5281801|NCT00543387|18218137|P10|Crossover Participants|Study Terminated by Sponsor|0
5281802|NCT00543387|18218138|P9|Crossover Participants|Study Terminated by Sponsor|0
5281803|NCT00543387|18218139|P8|Crossover Participants|Study Terminated by Sponsor|0
5281804|NCT00543387|18218140|P7|Crossover Participants|Study Terminated by Sponsor|0
5281805|NCT00543387|18218141|P6|Crossover Participants|Study Terminated by Sponsor|0
5281806|NCT00543387|18218142|P5|Crossover Participants|Study Terminated by Sponsor|0
5281807|NCT00543387|18218143|P4|Crossover Participants|Study Terminated by Sponsor|0
5281808|NCT00543387|18218144|P3|Crossover Participants|Study Terminated by Sponsor|0
5281809|NCT00543387|18218145|P2|Crossover Participants|Study Terminated by Sponsor|0
5281810|NCT00543387|18218146|P1|Crossover Participants|Study Terminated by Sponsor|0
5281811|NCT00543387|18218136|P11|Crossover Participants|Progressive Disease|2
5281812|NCT00543387|18218137|P10|Crossover Participants|Progressive Disease|1
5281813|NCT00543387|18218138|P9|Crossover Participants|Progressive Disease|0
5281814|NCT00543387|18218139|P8|Crossover Participants|Progressive Disease|0
5281815|NCT00543387|18218140|P7|Crossover Participants|Progressive Disease|0
5281816|NCT00543387|18218141|P6|Crossover Participants|Progressive Disease|0
5281817|NCT00543387|18218142|P5|Crossover Participants|Progressive Disease|0
5281818|NCT00543387|18218143|P4|Crossover Participants|Progressive Disease|0
5281819|NCT00543387|18218144|P3|Crossover Participants|Progressive Disease|0
5281820|NCT00543387|18218145|P2|Crossover Participants|Progressive Disease|0
5281821|NCT00543387|18218146|P1|Crossover Participants|Progressive Disease|0
5281822|NCT00543387|18218136|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
5281823|NCT00543387|18218137|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
5281824|NCT00543387|18218138|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
5281825|NCT00543387|18218139|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
5281826|NCT00543387|18218140|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
5281827|NCT00543387|18218141|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
5281828|NCT00543387|18218142|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
5281829|NCT00543387|18218143|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
5281830|NCT00543387|18218144|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
5281831|NCT00543387|18218145|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
5281832|NCT00543387|18218146|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
5281833|NCT00543387|18218136|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
5281834|NCT00543387|18218137|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
5281835|NCT00543387|18218138|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
5281836|NCT00543387|18218139|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
5281837|NCT00543387|18218140|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
5281838|NCT00543387|18218141|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
5281839|NCT00543387|18218142|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
5281840|NCT00543387|18218143|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
5281841|NCT00543387|18218144|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
5281842|NCT00543387|18218145|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
5281843|NCT00543387|18218146|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
5281844|NCT00543387|18218136|P11|Panel 1 + Panel 2|Physician Decision|0
5281845|NCT00543387|18218137|P10|Panel 1 + Panel 2|Physician Decision|0
5281846|NCT00543387|18218138|P9|Panel 1 + Panel 2|Physician Decision|0
5281847|NCT00543387|18218139|P8|Panel 1 + Panel 2|Physician Decision|1
5281848|NCT00543387|18218140|P7|Panel 1 + Panel 2|Physician Decision|0
5281849|NCT00543387|18218141|P6|Panel 1 + Panel 2|Physician Decision|0
5281850|NCT00543387|18218142|P5|Panel 1 + Panel 2|Physician Decision|0
5281851|NCT00543387|18218143|P4|Panel 1 + Panel 2|Physician Decision|0
5281852|NCT00543387|18218144|P3|Panel 1 + Panel 2|Physician Decision|1
5281853|NCT00543387|18218145|P2|Panel 1 + Panel 2|Physician Decision|0
5281854|NCT00543387|18218146|P1|Panel 1 + Panel 2|Physician Decision|0
5281855|NCT00543387|18218136|P11|Panel 1 + Panel 2|Adverse Event|0
5281856|NCT00543387|18218137|P10|Panel 1 + Panel 2|Adverse Event|0
5281857|NCT00543387|18218138|P9|Panel 1 + Panel 2|Adverse Event|1
5281858|NCT00543387|18218139|P8|Panel 1 + Panel 2|Adverse Event|1
5281859|NCT00543387|18218140|P7|Panel 1 + Panel 2|Adverse Event|0
5281860|NCT00543387|18218141|P6|Panel 1 + Panel 2|Adverse Event|0
5281861|NCT00543387|18218142|P5|Panel 1 + Panel 2|Adverse Event|0
5281862|NCT00543387|18218143|P4|Panel 1 + Panel 2|Adverse Event|0
5281863|NCT00543387|18218144|P3|Panel 1 + Panel 2|Adverse Event|0
5281864|NCT00543387|18218145|P2|Panel 1 + Panel 2|Adverse Event|1
5281865|NCT00543387|18218146|P1|Panel 1 + Panel 2|Adverse Event|0
5281866|NCT00543309|18218184|P3|Overall Study|Physician Decision|0
5281867|NCT00543309|18218185|P2|Overall Study|Physician Decision|1
5281868|NCT00543309|18218186|P1|Overall Study|Physician Decision|0
5281869|NCT00543296|18218236|P1|Overall Study|Physician Decision|7
5281870|NCT00543140|18218243|P1|Overall Study|Conversion to different procedure|1
5281871|NCT00543140|18218243|P1|Overall Study|Subject moved|1
5281872|NCT00543140|18218243|P1|Overall Study|Death|1
5281873|NCT00543140|18218243|P1|Overall Study|SAE leading to explant of SAGB|3
5281874|NCT00543140|18218243|P1|Overall Study|Insufficient weight loss|10
5281875|NCT00543140|18218243|P1|Overall Study|Protocol Violation|10
5281876|NCT00543140|18218243|P1|Overall Study|Withdrawal by Subject|13
5281877|NCT00543140|18218243|P1|Overall Study|Lost to Follow-up|33
5281878|NCT00543062|18218281|P4|Overall Study|Protocol Violation|0
5281879|NCT00543062|18218282|P3|Overall Study|Protocol Violation|0
5281880|NCT00543062|18218283|P2|Overall Study|Protocol Violation|0
5281881|NCT00543062|18218284|P1|Overall Study|Protocol Violation|1
5281882|NCT00543062|18218281|P4|Overall Study|Adverse Event|1
5281883|NCT00543062|18218282|P3|Overall Study|Adverse Event|1
5281884|NCT00543062|18218283|P2|Overall Study|Adverse Event|1
5281885|NCT00543062|18218284|P1|Overall Study|Adverse Event|0
5281886|NCT00543062|18218281|P4|Overall Study|Withdrawal by Subject|0
5281887|NCT00543062|18218282|P3|Overall Study|Withdrawal by Subject|2
5281888|NCT00543062|18218283|P2|Overall Study|Withdrawal by Subject|0
5281889|NCT00543062|18218284|P1|Overall Study|Withdrawal by Subject|1
5281890|NCT00542997|18218306|P1|Efficacy Period|Adverse Event|3
5281891|NCT00542997|18218306|P1|Wash in / Wash Out Period|Adverse Event|3
5281892|NCT00542997|18218306|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
5281893|NCT00542919|18218329|P3|Overall Study|Lost to Follow-up|1
5281894|NCT00542919|18218330|P2|Overall Study|Lost to Follow-up|0
5281895|NCT00542919|18218331|P1|Overall Study|Lost to Follow-up|2
5281896|NCT00542919|18218329|P3|Overall Study|Sponsor Decision|0
5281897|NCT00542919|18218330|P2|Overall Study|Sponsor Decision|0
5281898|NCT00542919|18218331|P1|Overall Study|Sponsor Decision|1
5281899|NCT00542919|18218329|P3|Overall Study|Physician Decision|1
5281900|NCT00542919|18218330|P2|Overall Study|Physician Decision|2
5281901|NCT00542919|18218331|P1|Overall Study|Physician Decision|2
5281902|NCT00542919|18218329|P3|Overall Study|Withdrawal by Subject|3
5281903|NCT00542919|18218330|P2|Overall Study|Withdrawal by Subject|0
5281904|NCT00542919|18218331|P1|Overall Study|Withdrawal by Subject|1
5281905|NCT00542919|18218329|P3|Overall Study|Adverse Event|1
5281906|NCT00542919|18218330|P2|Overall Study|Adverse Event|5
5281907|NCT00542919|18218331|P1|Overall Study|Adverse Event|1
5281908|NCT00542880|18218376|P2|Period 3|Adverse Event|2
5281909|NCT00542880|18218377|P1|Period 3|Adverse Event|0
5281910|NCT00542880|18218376|P2|Period 2|Other|1
5281911|NCT00542880|18218377|P1|Period 2|Other|0
5281912|NCT00542880|18218376|P2|Period 2|Severe non-compliance|1
5281913|NCT00542880|18218377|P1|Period 2|Severe non-compliance|0
5281914|NCT00542880|18218376|P2|Period 2|Discontinuation criteria|0
5281915|NCT00542880|18218377|P1|Period 2|Discontinuation criteria|2
5281916|NCT00542880|18218376|P2|Period 2|Eligibility not fulfilled|1
5281917|NCT00542880|18218377|P1|Period 2|Eligibility not fulfilled|0
5281918|NCT00542880|18218376|P2|Period 2|Adverse Event|7
5281919|NCT00542880|18218377|P1|Period 2|Adverse Event|5
5281920|NCT00542880|18218376|P2|Period 1|Protocol Violation|1
5281921|NCT00542880|18218377|P1|Period 1|Protocol Violation|0
5281922|NCT00542880|18218376|P2|Period 1|Withdrawal by Subject|1
5281923|NCT00542880|18218377|P1|Period 1|Withdrawal by Subject|1
5281924|NCT00542880|18218376|P2|Period 1|Development of study-specific criteria|2
5281925|NCT00542880|18218377|P1|Period 1|Development of study-specific criteria|1
5281926|NCT00542880|18218376|P2|Period 1|Adverse Event|2
5281927|NCT00542880|18218377|P1|Period 1|Adverse Event|2
5281928|NCT00542880|18218376|P2|Period 1|Eligibility criteria not fulfilled|6
5281929|NCT00542880|18218377|P1|Period 1|Eligibility criteria not fulfilled|2
5281930|NCT00542828|18218413|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
5281931|NCT00542828|18218413|P1|Overall Study|Study Prematurely Discontinued|7
5281932|NCT00542828|18218413|P1|Overall Study|Need for Prohibited Treatment|3
5281933|NCT00542828|18218413|P1|Overall Study|Physician Decision|1
5281934|NCT00542815|18218431|P3|Overall Study|Other reasons|10
5281935|NCT00542815|18218432|P2|Overall Study|Other reasons|10
5281936|NCT00542815|18218433|P1|Overall Study|Other reasons|24
5281937|NCT00542815|18218431|P3|Overall Study|Withdrawal by Subject|8
5281938|NCT00542815|18218432|P2|Overall Study|Withdrawal by Subject|5
5281939|NCT00542815|18218433|P1|Overall Study|Withdrawal by Subject|41
5281940|NCT00542815|18218431|P3|Overall Study|Protocol Violation|2
5281941|NCT00542815|18218432|P2|Overall Study|Protocol Violation|1
5281942|NCT00542815|18218433|P1|Overall Study|Protocol Violation|1
5281943|NCT00542815|18218431|P3|Overall Study|Physician Decision|0
5281944|NCT00542815|18218432|P2|Overall Study|Physician Decision|1
5281945|NCT00542815|18218433|P1|Overall Study|Physician Decision|2
5281946|NCT00542815|18218431|P3|Overall Study|Lack of Efficacy|0
5281947|NCT00542815|18218432|P2|Overall Study|Lack of Efficacy|2
5281948|NCT00542815|18218433|P1|Overall Study|Lack of Efficacy|9
5281949|NCT00542815|18218431|P3|Overall Study|Death|3
5281950|NCT00542815|18218432|P2|Overall Study|Death|7
5281951|NCT00542815|18218433|P1|Overall Study|Death|10
5281952|NCT00542815|18218431|P3|Overall Study|Adverse Event|9
5281953|NCT00542815|18218432|P2|Overall Study|Adverse Event|6
5281954|NCT00542815|18218433|P1|Overall Study|Adverse Event|19
5281955|NCT00542789|18218446|P2|Overall Study|Recurrence of Gastric Ulcer|57
5281956|NCT00542789|18218447|P1|Overall Study|Recurrence of Gastric Ulcer|8
5281957|NCT00542789|18218446|P2|Overall Study|Protocol Violation|1
5281958|NCT00542789|18218447|P1|Overall Study|Protocol Violation|8
5281959|NCT00542789|18218446|P2|Overall Study|Withdrawal by Subject|3
5281960|NCT00542789|18218447|P1|Overall Study|Withdrawal by Subject|7
5281961|NCT00542789|18218446|P2|Overall Study|Adverse Event|17
5281962|NCT00542789|18218447|P1|Overall Study|Adverse Event|18
5281963|NCT00542425|18218547|P5|Extended 24 Weeks of Treatment|Other|1
5281964|NCT00542425|18218548|P4|Extended 24 Weeks of Treatment|Other|0
5281965|NCT00542425|18218549|P3|Extended 24 Weeks of Treatment|Other|0
5281966|NCT00542425|18218550|P2|Extended 24 Weeks of Treatment|Other|1
5281967|NCT00542425|18218551|P1|Extended 24 Weeks of Treatment|Other|1
5281968|NCT00542425|18218547|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
5281969|NCT00542425|18218548|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
5281970|NCT00542425|18218549|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
5281971|NCT00542425|18218550|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
5281972|NCT00542425|18218551|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
5281973|NCT00542425|18218547|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
5281974|NCT00542425|18218548|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
5281975|NCT00542425|18218549|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
5281976|NCT00542425|18218550|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
5281977|NCT00542425|18218551|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
5281978|NCT00542425|18218547|P5|Extended 24 Weeks of Treatment|Adverse Event|0
5281979|NCT00542425|18218548|P4|Extended 24 Weeks of Treatment|Adverse Event|1
5281980|NCT00542425|18218549|P3|Extended 24 Weeks of Treatment|Adverse Event|1
5281981|NCT00542425|18218550|P2|Extended 24 Weeks of Treatment|Adverse Event|0
5281982|NCT00542425|18218551|P1|Extended 24 Weeks of Treatment|Adverse Event|0
5281983|NCT00542425|18218547|P5|Initial 24 Weeks|Other|0
5281984|NCT00542425|18218548|P4|Initial 24 Weeks|Other|0
5281985|NCT00542425|18218549|P3|Initial 24 Weeks|Other|1
5281986|NCT00542425|18218550|P2|Initial 24 Weeks|Other|2
5281987|NCT00542425|18218551|P1|Initial 24 Weeks|Other|0
5281988|NCT00542425|18218547|P5|Initial 24 Weeks|Refusal of treatment|1
5281989|NCT00542425|18218548|P4|Initial 24 Weeks|Refusal of treatment|4
5281990|NCT00542425|18218549|P3|Initial 24 Weeks|Refusal of treatment|1
5281991|NCT00542425|18218550|P2|Initial 24 Weeks|Refusal of treatment|2
5281992|NCT00542425|18218551|P1|Initial 24 Weeks|Refusal of treatment|2
5281993|NCT00542425|18218547|P5|Initial 24 Weeks|Protocol Violation|0
5281994|NCT00542425|18218548|P4|Initial 24 Weeks|Protocol Violation|1
5281995|NCT00542425|18218549|P3|Initial 24 Weeks|Protocol Violation|0
5281996|NCT00542425|18218550|P2|Initial 24 Weeks|Protocol Violation|0
5281997|NCT00542425|18218551|P1|Initial 24 Weeks|Protocol Violation|0
5281998|NCT00542425|18218547|P5|Initial 24 Weeks|Non-compliance|1
5281999|NCT00542425|18218548|P4|Initial 24 Weeks|Non-compliance|1
5282000|NCT00542425|18218549|P3|Initial 24 Weeks|Non-compliance|0
5282001|NCT00542425|18218550|P2|Initial 24 Weeks|Non-compliance|0
5282002|NCT00542425|18218551|P1|Initial 24 Weeks|Non-compliance|0
5282003|NCT00542425|18218547|P5|Initial 24 Weeks|Lost to Follow-up|0
5282004|NCT00542425|18218548|P4|Initial 24 Weeks|Lost to Follow-up|0
5282005|NCT00542425|18218549|P3|Initial 24 Weeks|Lost to Follow-up|1
5282006|NCT00542425|18218550|P2|Initial 24 Weeks|Lost to Follow-up|2
5282007|NCT00542425|18218551|P1|Initial 24 Weeks|Lost to Follow-up|2
5282008|NCT00542425|18218547|P5|Initial 24 Weeks|Inability to complete procedures|2
5282009|NCT00542425|18218548|P4|Initial 24 Weeks|Inability to complete procedures|1
5282010|NCT00542425|18218549|P3|Initial 24 Weeks|Inability to complete procedures|2
5282011|NCT00542425|18218550|P2|Initial 24 Weeks|Inability to complete procedures|3
5282012|NCT00542425|18218551|P1|Initial 24 Weeks|Inability to complete procedures|0
5282013|NCT00542425|18218547|P5|Initial 24 Weeks|Adverse Event|2
5282014|NCT00542425|18218548|P4|Initial 24 Weeks|Adverse Event|3
5282015|NCT00542425|18218549|P3|Initial 24 Weeks|Adverse Event|1
5282016|NCT00542425|18218550|P2|Initial 24 Weeks|Adverse Event|1
5282017|NCT00542425|18218551|P1|Initial 24 Weeks|Adverse Event|0
5282018|NCT00542425|18218547|P5|Initial 24 Weeks|Administrative reasons|0
5282019|NCT00542425|18218548|P4|Initial 24 Weeks|Administrative reasons|1
5282020|NCT00542425|18218549|P3|Initial 24 Weeks|Administrative reasons|1
5282021|NCT00542425|18218550|P2|Initial 24 Weeks|Administrative reasons|0
5282022|NCT00542425|18218551|P1|Initial 24 Weeks|Administrative reasons|0
5282023|NCT00542386|18218589|P6|Overall Study|Other Reasons|2
5282024|NCT00542386|18218590|P5|Overall Study|Other Reasons|4
5282025|NCT00542386|18218591|P4|Overall Study|Other Reasons|3
5282026|NCT00542386|18218592|P3|Overall Study|Other Reasons|4
5282027|NCT00542386|18218593|P2|Overall Study|Other Reasons|1
5282028|NCT00542386|18218594|P1|Overall Study|Other Reasons|4
5282029|NCT00542386|18218589|P6|Overall Study|Withdrawal by Subject|7
5282030|NCT00542386|18218590|P5|Overall Study|Withdrawal by Subject|15
5282031|NCT00542386|18218591|P4|Overall Study|Withdrawal by Subject|11
5282032|NCT00542386|18218592|P3|Overall Study|Withdrawal by Subject|10
5282033|NCT00542386|18218593|P2|Overall Study|Withdrawal by Subject|8
5282034|NCT00542386|18218594|P1|Overall Study|Withdrawal by Subject|5
5282035|NCT00542386|18218589|P6|Overall Study|Protocol Violation|4
5282036|NCT00542386|18218590|P5|Overall Study|Protocol Violation|0
5282037|NCT00542386|18218591|P4|Overall Study|Protocol Violation|0
5282038|NCT00542386|18218592|P3|Overall Study|Protocol Violation|1
5282039|NCT00542386|18218593|P2|Overall Study|Protocol Violation|0
5282040|NCT00542386|18218594|P1|Overall Study|Protocol Violation|0
5282041|NCT00542386|18218589|P6|Overall Study|Physician Decision|0
5282042|NCT00542386|18218590|P5|Overall Study|Physician Decision|0
5282043|NCT00542386|18218591|P4|Overall Study|Physician Decision|1
5282044|NCT00542386|18218592|P3|Overall Study|Physician Decision|0
5282045|NCT00542386|18218593|P2|Overall Study|Physician Decision|0
5282046|NCT00542386|18218594|P1|Overall Study|Physician Decision|1
5282047|NCT00542386|18218589|P6|Overall Study|Lack of Efficacy|31
5282048|NCT00542386|18218590|P5|Overall Study|Lack of Efficacy|7
5282049|NCT00542386|18218591|P4|Overall Study|Lack of Efficacy|13
5282050|NCT00542386|18218592|P3|Overall Study|Lack of Efficacy|10
5282051|NCT00542386|18218593|P2|Overall Study|Lack of Efficacy|12
5282052|NCT00542386|18218594|P1|Overall Study|Lack of Efficacy|32
5282053|NCT00542386|18218589|P6|Overall Study|Death|2
5282054|NCT00542386|18218590|P5|Overall Study|Death|1
5282055|NCT00542386|18218591|P4|Overall Study|Death|2
5282056|NCT00542386|18218592|P3|Overall Study|Death|1
5282057|NCT00542386|18218593|P2|Overall Study|Death|0
5282058|NCT00542386|18218594|P1|Overall Study|Death|0
5282059|NCT00542386|18218589|P6|Overall Study|Adverse Event|4
5282060|NCT00542386|18218590|P5|Overall Study|Adverse Event|13
5282061|NCT00542386|18218591|P4|Overall Study|Adverse Event|8
5282062|NCT00542386|18218592|P3|Overall Study|Adverse Event|7
5282063|NCT00542386|18218593|P2|Overall Study|Adverse Event|7
5282064|NCT00542386|18218594|P1|Overall Study|Adverse Event|1
5282065|NCT00542321|18218616|P2|Overall Study|Death|1
5282066|NCT00542321|18218617|P1|Overall Study|Death|0
5282067|NCT00542269|18218639|P3|Overall Study|Administrative problems|1
5282068|NCT00542269|18218640|P2|Overall Study|Administrative problems|1
5282069|NCT00542269|18218641|P1|Overall Study|Administrative problems|1
5282070|NCT00542269|18218639|P3|Overall Study|Withdrawal by Subject|0
5282071|NCT00542269|18218640|P2|Overall Study|Withdrawal by Subject|0
5282072|NCT00542269|18218641|P1|Overall Study|Withdrawal by Subject|1
5282073|NCT00542269|18218639|P3|Overall Study|Protocol Violation|0
5282074|NCT00542269|18218640|P2|Overall Study|Protocol Violation|1
5282075|NCT00542269|18218641|P1|Overall Study|Protocol Violation|1
5282076|NCT00542269|18218639|P3|Overall Study|Adverse Event|5
5282077|NCT00542269|18218640|P2|Overall Study|Adverse Event|4
5282078|NCT00542269|18218641|P1|Overall Study|Adverse Event|10
5282079|NCT00542191|18218670|P1|Overall Study|Death|3
5282080|NCT00542178|18218680|P8|Overall Study|did not complete year 4 follow-up|85
5282081|NCT00542178|18218681|P7|Overall Study|did not complete year 4 follow-up|87
5282082|NCT00542178|18218682|P6|Overall Study|did not complete year 4 follow-up|89
5282083|NCT00542178|18218683|P5|Overall Study|did not complete year 4 follow-up|64
5282084|NCT00542178|18218684|P4|Overall Study|did not complete year 4 follow-up|62
5282085|NCT00542178|18218685|P3|Overall Study|did not complete year 4 follow-up|74
5282086|NCT00542178|18218686|P2|Overall Study|did not complete year 4 follow-up|80
5282087|NCT00542178|18218687|P1|Overall Study|did not complete year 4 follow-up|75
5282088|NCT00541970|18218723|P4|Month 60|Protocol Violation|72
5282089|NCT00541970|18218724|P3|Month 60|Protocol Violation|82
5282090|NCT00541970|18218725|P2|Month 60|Protocol Violation|77
5282091|NCT00541970|18218726|P1|Month 60|Protocol Violation|78
5282092|NCT00541970|18218723|P4|Month 48|Lost to Follow-up|73
5282093|NCT00541970|18218724|P3|Month 48|Lost to Follow-up|68
5282094|NCT00541970|18218725|P2|Month 48|Lost to Follow-up|68
5282095|NCT00541970|18218726|P1|Month 48|Lost to Follow-up|66
5282096|NCT00541970|18218723|P4|Month 48|Other|0
5282097|NCT00541970|18218724|P3|Month 48|Other|1
5282098|NCT00541970|18218725|P2|Month 48|Other|1
5282099|NCT00541970|18218726|P1|Month 48|Other|3
5282100|NCT00541970|18218723|P4|Month 48|Withdrawal by Subject|2
5282101|NCT00541970|18218724|P3|Month 48|Withdrawal by Subject|4
5282102|NCT00541970|18218725|P2|Month 48|Withdrawal by Subject|4
5282103|NCT00541970|18218726|P1|Month 48|Withdrawal by Subject|2
5282104|NCT00541970|18218723|P4|Month 36|Protocol Violation|60
5282105|NCT00541970|18218724|P3|Month 36|Protocol Violation|66
5282106|NCT00541970|18218725|P2|Month 36|Protocol Violation|66
5282107|NCT00541970|18218726|P1|Month 36|Protocol Violation|61
5282108|NCT00541970|18218723|P4|Month 24|Protocol Violation|21
5282109|NCT00541970|18218724|P3|Month 24|Protocol Violation|31
5282110|NCT00541970|18218725|P2|Month 24|Protocol Violation|31
5282111|NCT00541970|18218726|P1|Month 24|Protocol Violation|29
5282112|NCT00541970|18218723|P4|Month 24|Adverse Event|1
5282113|NCT00541970|18218724|P3|Month 24|Adverse Event|1
5282114|NCT00541970|18218725|P2|Month 24|Adverse Event|1
5282115|NCT00541970|18218726|P1|Month 24|Adverse Event|0
5282116|NCT00541970|18218723|P4|Month 18|Protocol Violation|16
5282117|NCT00541970|18218724|P3|Month 18|Protocol Violation|24
5282118|NCT00541970|18218725|P2|Month 18|Protocol Violation|23
5282119|NCT00541970|18218726|P1|Month 18|Protocol Violation|14
5282120|NCT00541970|18218723|P4|Month 18|Adverse Event|1
5282121|NCT00541970|18218724|P3|Month 18|Adverse Event|1
5282122|NCT00541970|18218725|P2|Month 18|Adverse Event|1
5282123|NCT00541970|18218726|P1|Month 18|Adverse Event|0
5282124|NCT00541970|18218723|P4|Month 12|Protocol Violation|15
5282125|NCT00541970|18218724|P3|Month 12|Protocol Violation|20
5282126|NCT00541970|18218725|P2|Month 12|Protocol Violation|21
5282127|NCT00541970|18218726|P1|Month 12|Protocol Violation|12
5282128|NCT00541970|18218723|P4|Month 12|Adverse Event|1
5282129|NCT00541970|18218724|P3|Month 12|Adverse Event|1
5282130|NCT00541970|18218725|P2|Month 12|Adverse Event|1
5282131|NCT00541970|18218726|P1|Month 12|Adverse Event|0
5282132|NCT00541970|18218723|P4|Month 7|Protocol Violation|5
5282133|NCT00541970|18218724|P3|Month 7|Protocol Violation|11
5282134|NCT00541970|18218725|P2|Month 7|Protocol Violation|13
5282135|NCT00541970|18218726|P1|Month 7|Protocol Violation|9
5282136|NCT00541931|18218877|P2|Overall Study|Transportation Issue|1
5282137|NCT00541931|18218878|P1|Overall Study|Transportation Issue|0
5282138|NCT00541931|18218877|P2|Overall Study|Withdrawal by Subject|0
5282139|NCT00541931|18218878|P1|Overall Study|Withdrawal by Subject|1
5282140|NCT00541931|18218877|P2|Overall Study|Lost to Follow-up|3
5282141|NCT00541931|18218878|P1|Overall Study|Lost to Follow-up|3
5282142|NCT00541931|18218877|P2|Overall Study|Adverse Event|0
5282143|NCT00541931|18218878|P1|Overall Study|Adverse Event|1
5282144|NCT00541866|18218891|P5|Overall Study|Physician Decision|0
5282145|NCT00541866|18218892|P4|Overall Study|Physician Decision|1
5282146|NCT00541866|18218893|P3|Overall Study|Physician Decision|2
5282147|NCT00541866|18218894|P2|Overall Study|Physician Decision|0
5282148|NCT00541866|18218895|P1|Overall Study|Physician Decision|0
5282149|NCT00541866|18218891|P5|Overall Study|Not Reported or Other|1
5282150|NCT00541866|18218892|P4|Overall Study|Not Reported or Other|3
5282151|NCT00541866|18218893|P3|Overall Study|Not Reported or Other|3
5282152|NCT00541866|18218894|P2|Overall Study|Not Reported or Other|3
5282153|NCT00541866|18218895|P1|Overall Study|Not Reported or Other|11
5282154|NCT00541866|18218891|P5|Overall Study|Lack of Efficacy|14
5282155|NCT00541866|18218892|P4|Overall Study|Lack of Efficacy|12
5282156|NCT00541866|18218893|P3|Overall Study|Lack of Efficacy|10
5282157|NCT00541866|18218894|P2|Overall Study|Lack of Efficacy|15
5282158|NCT00541866|18218895|P1|Overall Study|Lack of Efficacy|19
5282159|NCT00541866|18218891|P5|Overall Study|Death|0
5282160|NCT00541866|18218892|P4|Overall Study|Death|0
5282161|NCT00541866|18218893|P3|Overall Study|Death|0
5282162|NCT00541866|18218894|P2|Overall Study|Death|0
5282163|NCT00541866|18218895|P1|Overall Study|Death|1
5282164|NCT00541866|18218891|P5|Overall Study|Adverse Event|0
5282165|NCT00541866|18218892|P4|Overall Study|Adverse Event|0
5282166|NCT00541866|18218893|P3|Overall Study|Adverse Event|0
5282167|NCT00541866|18218894|P2|Overall Study|Adverse Event|0
5282168|NCT00541866|18218895|P1|Overall Study|Adverse Event|3
5282169|NCT00541775|18218936|P3|Overall Study|Withdrawal by Subject and Other|2
5282170|NCT00541775|18218937|P2|Overall Study|Withdrawal by Subject and Other|0
5282171|NCT00541775|18218938|P1|Overall Study|Withdrawal by Subject and Other|5
5282172|NCT00541775|18218936|P3|Overall Study|Protocol Violation|0
5282173|NCT00541775|18218937|P2|Overall Study|Protocol Violation|0
5282174|NCT00541775|18218938|P1|Overall Study|Protocol Violation|1
5282175|NCT00541775|18218936|P3|Overall Study|Lost to Follow-up|2
5282176|NCT00541775|18218937|P2|Overall Study|Lost to Follow-up|0
5282177|NCT00541775|18218938|P1|Overall Study|Lost to Follow-up|0
5282178|NCT00541775|18218936|P3|Overall Study|Lack of Efficacy|3
5282179|NCT00541775|18218937|P2|Overall Study|Lack of Efficacy|0
5282180|NCT00541775|18218938|P1|Overall Study|Lack of Efficacy|0
5282181|NCT00541775|18218936|P3|Overall Study|Adverse Event|1
5282182|NCT00541775|18218937|P2|Overall Study|Adverse Event|2
5282183|NCT00541775|18218938|P1|Overall Study|Adverse Event|3
5282184|NCT00541658|18218964|P3|Overall Study|Took No Study Drug|0
5282185|NCT00541658|18218965|P2|Overall Study|Took No Study Drug|0
5282186|NCT00541658|18218966|P1|Overall Study|Took No Study Drug|1
5282187|NCT00541658|18218964|P3|Overall Study|Withdrawal by Subject|32
5282188|NCT00541658|18218965|P2|Overall Study|Withdrawal by Subject|32
5282189|NCT00541658|18218966|P1|Overall Study|Withdrawal by Subject|28
5282190|NCT00541658|18218964|P3|Overall Study|Protocol Violation|1
5282191|NCT00541658|18218965|P2|Overall Study|Protocol Violation|1
5282192|NCT00541658|18218966|P1|Overall Study|Protocol Violation|0
5282193|NCT00541658|18218964|P3|Overall Study|Lost to Follow-up|6
5282194|NCT00541658|18218965|P2|Overall Study|Lost to Follow-up|3
5282195|NCT00541658|18218966|P1|Overall Study|Lost to Follow-up|3
5282196|NCT00541658|18218964|P3|Overall Study|Physician Decision|4
5282197|NCT00541658|18218965|P2|Overall Study|Physician Decision|0
5282198|NCT00541658|18218966|P1|Overall Study|Physician Decision|0
5282199|NCT00541658|18218964|P3|Overall Study|Adverse Event|25
5282200|NCT00541658|18218965|P2|Overall Study|Adverse Event|37
5282201|NCT00541658|18218966|P1|Overall Study|Adverse Event|28
5282202|NCT00541450|18219129|P2|Phase B|Withdrawal by Subject|6
5282203|NCT00541450|18219130|P1|Phase B|Withdrawal by Subject|8
5282204|NCT00541450|18219129|P2|Phase B|Protocol Violation|3
5282205|NCT00541450|18219130|P1|Phase B|Protocol Violation|3
5282206|NCT00541450|18219129|P2|Phase B|Pregnancy|1
5282207|NCT00541450|18219130|P1|Phase B|Pregnancy|0
5282208|NCT00541450|18219129|P2|Phase B|Physician Decision|2
5282209|NCT00541450|18219130|P1|Phase B|Physician Decision|4
5282210|NCT00541450|18219129|P2|Phase B|Lost to Follow-up|4
5282211|NCT00541450|18219130|P1|Phase B|Lost to Follow-up|6
5282212|NCT00541450|18219129|P2|Phase B|Hyperglycemia|9
5282213|NCT00541450|18219130|P1|Phase B|Hyperglycemia|10
5282214|NCT00541450|18219129|P2|Phase B|Adverse Event|6
5282215|NCT00541450|18219130|P1|Phase B|Adverse Event|6
5282216|NCT00541450|18219129|P2|Phase A|Withdrawal by Subject|7
5282217|NCT00541450|18219130|P1|Phase A|Withdrawal by Subject|7
5282218|NCT00541450|18219129|P2|Phase A|Protocol Violation|3
5282219|NCT00541450|18219130|P1|Phase A|Protocol Violation|2
5282220|NCT00541450|18219129|P2|Phase A|Physician Decision|0
5282221|NCT00541450|18219130|P1|Phase A|Physician Decision|2
5282222|NCT00541450|18219129|P2|Phase A|Lost to Follow-up|4
5282223|NCT00541450|18219130|P1|Phase A|Lost to Follow-up|6
5282224|NCT00541450|18219129|P2|Phase A|Hyperglycemia|1
5282225|NCT00541450|18219130|P1|Phase A|Hyperglycemia|0
5282226|NCT00541450|18219129|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
5282227|NCT00541450|18219130|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
5282228|NCT00541450|18219129|P2|Phase A|Adverse Event|0
5282229|NCT00541450|18219130|P1|Phase A|Adverse Event|3
5282230|NCT00541346|18219148|P1|Follow-up|Adverse Event|1
5282231|NCT00541307|18219162|P1|Overall Study|Surgical Bypass|5
5282232|NCT00541307|18219162|P1|Overall Study|Subject returned early (outside window)|1
5282233|NCT00541307|18219162|P1|Overall Study|Lost to Follow-up|4
5282234|NCT00541307|18219162|P1|Overall Study|Withdrawal by Subject|6
5282235|NCT00541307|18219162|P1|Overall Study|Physician Decision|3
5282236|NCT00541307|18219162|P1|Overall Study|Death|5
5282237|NCT00541229|18219187|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5282238|NCT00541229|18219188|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5282239|NCT00541229|18219189|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5282240|NCT00541229|18219190|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
5282241|NCT00541229|18219191|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5282242|NCT00541229|18219192|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5282243|NCT00541229|18219187|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
5282244|NCT00541229|18219188|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5282245|NCT00541229|18219189|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5282246|NCT00541229|18219190|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5282247|NCT00541229|18219191|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5282248|NCT00541229|18219192|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5282249|NCT00541229|18219187|P6|Treatment Period III (Week 11)|Adverse Event|0
5282250|NCT00541229|18219188|P5|Treatment Period III (Week 11)|Adverse Event|1
5282251|NCT00541229|18219189|P4|Treatment Period III (Week 11)|Adverse Event|0
5282252|NCT00541229|18219190|P3|Treatment Period III (Week 11)|Adverse Event|0
5282253|NCT00541229|18219191|P2|Treatment Period III (Week 11)|Adverse Event|0
5282254|NCT00541229|18219192|P1|Treatment Period III (Week 11)|Adverse Event|0
5282255|NCT00541229|18219187|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
5282256|NCT00541229|18219188|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
5282257|NCT00541229|18219189|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
5282258|NCT00541229|18219190|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
5282259|NCT00541229|18219191|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
5282260|NCT00541229|18219192|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
5282261|NCT00541229|18219187|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5282262|NCT00541229|18219188|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
5282263|NCT00541229|18219189|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5282264|NCT00541229|18219190|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5282265|NCT00541229|18219191|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5282266|NCT00541229|18219192|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5282267|NCT00541229|18219187|P6|Washout Period II (Week 7-10)|Protocol Violation|0
5282268|NCT00541229|18219188|P5|Washout Period II (Week 7-10)|Protocol Violation|0
5282269|NCT00541229|18219189|P4|Washout Period II (Week 7-10)|Protocol Violation|0
5282270|NCT00541229|18219190|P3|Washout Period II (Week 7-10)|Protocol Violation|0
5282271|NCT00541229|18219191|P2|Washout Period II (Week 7-10)|Protocol Violation|0
5282272|NCT00541229|18219192|P1|Washout Period II (Week 7-10)|Protocol Violation|1
5282273|NCT00541229|18219187|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
5282274|NCT00541229|18219188|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5282275|NCT00541229|18219189|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5282276|NCT00541229|18219190|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5282277|NCT00541229|18219191|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5282278|NCT00541229|18219192|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
5282279|NCT00541229|18219187|P6|Treatment Period II (Week 6)|Protocol Violation|1
5282280|NCT00541229|18219188|P5|Treatment Period II (Week 6)|Protocol Violation|1
5282281|NCT00541229|18219189|P4|Treatment Period II (Week 6)|Protocol Violation|0
5282282|NCT00541229|18219190|P3|Treatment Period II (Week 6)|Protocol Violation|0
5282283|NCT00541229|18219191|P2|Treatment Period II (Week 6)|Protocol Violation|0
5282284|NCT00541229|18219192|P1|Treatment Period II (Week 6)|Protocol Violation|0
5282285|NCT00541229|18219187|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
5282286|NCT00541229|18219188|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
5282287|NCT00541229|18219189|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
5282288|NCT00541229|18219190|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
5282289|NCT00541229|18219191|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
5282290|NCT00541229|18219192|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
5282291|NCT00541229|18219187|P6|Washout Period I (Week 2-5)|Protocol Violation|1
5282292|NCT00541229|18219188|P5|Washout Period I (Week 2-5)|Protocol Violation|0
5282293|NCT00541229|18219189|P4|Washout Period I (Week 2-5)|Protocol Violation|0
5282294|NCT00541229|18219190|P3|Washout Period I (Week 2-5)|Protocol Violation|0
5282295|NCT00541229|18219191|P2|Washout Period I (Week 2-5)|Protocol Violation|0
5282296|NCT00541229|18219192|P1|Washout Period I (Week 2-5)|Protocol Violation|0
5282297|NCT00541229|18219187|P6|Washout Period I (Week 2-5)|Physician Decision|0
5282298|NCT00541229|18219188|P5|Washout Period I (Week 2-5)|Physician Decision|0
5282299|NCT00541229|18219189|P4|Washout Period I (Week 2-5)|Physician Decision|1
5282300|NCT00541229|18219190|P3|Washout Period I (Week 2-5)|Physician Decision|0
5282301|NCT00541229|18219191|P2|Washout Period I (Week 2-5)|Physician Decision|0
5282302|NCT00541229|18219192|P1|Washout Period I (Week 2-5)|Physician Decision|0
5282303|NCT00541229|18219187|P6|Washout Period I (Week 2-5)|Adverse Event|0
5282304|NCT00541229|18219188|P5|Washout Period I (Week 2-5)|Adverse Event|0
5282305|NCT00541229|18219189|P4|Washout Period I (Week 2-5)|Adverse Event|0
5282306|NCT00541229|18219190|P3|Washout Period I (Week 2-5)|Adverse Event|1
5282307|NCT00541229|18219191|P2|Washout Period I (Week 2-5)|Adverse Event|0
5282308|NCT00541229|18219192|P1|Washout Period I (Week 2-5)|Adverse Event|1
5282309|NCT00541229|18219187|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
5282310|NCT00541229|18219188|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
5282311|NCT00541229|18219189|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
5282312|NCT00541229|18219190|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
5282313|NCT00541229|18219191|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
5282314|NCT00541229|18219192|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
5282315|NCT00541229|18219187|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
5282316|NCT00541229|18219188|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5282317|NCT00541229|18219189|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5282318|NCT00541229|18219190|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5282319|NCT00541229|18219191|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5282320|NCT00541229|18219192|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5282321|NCT00541229|18219187|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
5282322|NCT00541229|18219188|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
5282323|NCT00541229|18219189|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
5282324|NCT00541229|18219190|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
5282325|NCT00541229|18219191|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
5282326|NCT00541229|18219192|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
5282327|NCT00541229|18219187|P6|Treatment Period I (Week 1)|Physician Decision|0
5282328|NCT00541229|18219188|P5|Treatment Period I (Week 1)|Physician Decision|0
5282329|NCT00541229|18219189|P4|Treatment Period I (Week 1)|Physician Decision|0
5282330|NCT00541229|18219190|P3|Treatment Period I (Week 1)|Physician Decision|1
5282331|NCT00541229|18219191|P2|Treatment Period I (Week 1)|Physician Decision|0
5282332|NCT00541229|18219192|P1|Treatment Period I (Week 1)|Physician Decision|0
5282333|NCT00541099|18219211|P1|Overall Study|Ineligible|3
5282334|NCT00541034|18219219|P1|Overall Study|Non-Compliance|3
5282335|NCT00540644|18219268|P2|Overall Study|Noncomplilance|0
5282336|NCT00540644|18219269|P1|Overall Study|Noncomplilance|1
5282337|NCT00540644|18219268|P2|Overall Study|Withdrawal by Subject|2
5282338|NCT00540644|18219269|P1|Overall Study|Withdrawal by Subject|2
5282339|NCT00540644|18219268|P2|Overall Study|Physician Decision|5
5282340|NCT00540644|18219269|P1|Overall Study|Physician Decision|0
5282341|NCT00540644|18219268|P2|Overall Study|Disease Progression|1
5282342|NCT00540644|18219269|P1|Overall Study|Disease Progression|3
5282343|NCT00540644|18219268|P2|Overall Study|Adverse Event|1
5282344|NCT00540644|18219269|P1|Overall Study|Adverse Event|3
5282345|NCT00540592|18219289|P10|Overall Study|Withdrawal by Subject|0
5282346|NCT00540592|18219290|P9|Overall Study|Withdrawal by Subject|0
5282347|NCT00540592|18219291|P8|Overall Study|Withdrawal by Subject|0
5282348|NCT00540592|18219292|P7|Overall Study|Withdrawal by Subject|0
5282349|NCT00540592|18219293|P6|Overall Study|Withdrawal by Subject|0
5282350|NCT00540592|18219294|P5|Overall Study|Withdrawal by Subject|0
5282351|NCT00540592|18219295|P4|Overall Study|Withdrawal by Subject|1
5282352|NCT00540592|18219296|P3|Overall Study|Withdrawal by Subject|1
5282353|NCT00540592|18219297|P2|Overall Study|Withdrawal by Subject|0
5282354|NCT00540592|18219298|P1|Overall Study|Withdrawal by Subject|0
5282355|NCT00540592|18219289|P10|Overall Study|Lost to Follow-up|0
5282356|NCT00540592|18219290|P9|Overall Study|Lost to Follow-up|0
5282357|NCT00540592|18219291|P8|Overall Study|Lost to Follow-up|0
5282358|NCT00540592|18219292|P7|Overall Study|Lost to Follow-up|0
5282359|NCT00540592|18219293|P6|Overall Study|Lost to Follow-up|0
5282360|NCT00540592|18219294|P5|Overall Study|Lost to Follow-up|0
5282361|NCT00540592|18219295|P4|Overall Study|Lost to Follow-up|0
5282362|NCT00540592|18219296|P3|Overall Study|Lost to Follow-up|0
5282363|NCT00540592|18219297|P2|Overall Study|Lost to Follow-up|0
5282364|NCT00540592|18219298|P1|Overall Study|Lost to Follow-up|2
5282365|NCT00540592|18219289|P10|Overall Study|Adverse Event|2
5282366|NCT00540592|18219290|P9|Overall Study|Adverse Event|1
5282367|NCT00540592|18219291|P8|Overall Study|Adverse Event|1
5282368|NCT00540592|18219292|P7|Overall Study|Adverse Event|0
5282369|NCT00540592|18219293|P6|Overall Study|Adverse Event|0
5282370|NCT00540592|18219294|P5|Overall Study|Adverse Event|1
5282371|NCT00540592|18219295|P4|Overall Study|Adverse Event|0
5282372|NCT00540592|18219296|P3|Overall Study|Adverse Event|0
5282373|NCT00540592|18219297|P2|Overall Study|Adverse Event|1
5282374|NCT00540592|18219298|P1|Overall Study|Adverse Event|0
5282375|NCT00540514|18219537|P2|Overall Study|Paclitaxel not available|2
5282376|NCT00540514|18219538|P1|Overall Study|Paclitaxel not available|0
5282377|NCT00540514|18219537|P2|Overall Study|Excluded prior to treatment|7
5282378|NCT00540514|18219538|P1|Overall Study|Excluded prior to treatment|7
5282379|NCT00540514|18219537|P2|Overall Study|Withdrawal by Subject|67
5282380|NCT00540514|18219538|P1|Overall Study|Withdrawal by Subject|65
5282381|NCT00540514|18219537|P2|Overall Study|Lost to Follow-up|1
5282382|NCT00540514|18219538|P1|Overall Study|Lost to Follow-up|1
5282383|NCT00540514|18219537|P2|Overall Study|Protocol Deviation|4
5282384|NCT00540514|18219538|P1|Overall Study|Protocol Deviation|3
5282385|NCT00540514|18219537|P2|Overall Study|Physician Decision|99
5282386|NCT00540514|18219538|P1|Overall Study|Physician Decision|86
5282387|NCT00540514|18219537|P2|Overall Study|Adverse Event|24
5282388|NCT00540514|18219538|P1|Overall Study|Adverse Event|20
5282389|NCT00540514|18219537|P2|Overall Study|Unacceptable Toxicity|62
5282390|NCT00540514|18219538|P1|Overall Study|Unacceptable Toxicity|61
5282391|NCT00540514|18219537|P2|Overall Study|Still on treatment|0
5282392|NCT00540514|18219538|P1|Overall Study|Still on treatment|3
5282393|NCT00540449|18219570|P2|Overall Study|Other|4
5282394|NCT00540449|18219571|P1|Overall Study|Other|1
5282395|NCT00540449|18219570|P2|Overall Study|Withdrawal by Subject|10
5282396|NCT00540449|18219571|P1|Overall Study|Withdrawal by Subject|10
5282397|NCT00540449|18219570|P2|Overall Study|Subject Reached A Virologic Endpoint|8
5282398|NCT00540449|18219571|P1|Overall Study|Subject Reached A Virologic Endpoint|32
5282399|NCT00540449|18219570|P2|Overall Study|Subject Non-Compliant|5
5282400|NCT00540449|18219571|P1|Overall Study|Subject Non-Compliant|7
5282401|NCT00540449|18219570|P2|Overall Study|Lost to Follow-up|17
5282402|NCT00540449|18219571|P1|Overall Study|Lost to Follow-up|19
5282403|NCT00540449|18219570|P2|Overall Study|Subject Ineligible To Continue The Trial|1
5282404|NCT00540449|18219571|P1|Overall Study|Subject Ineligible To Continue The Trial|2
5282405|NCT00540449|18219570|P2|Overall Study|Sponsor's Decision|1
5282406|NCT00540449|18219571|P1|Overall Study|Sponsor's Decision|1
5282407|NCT00540449|18219570|P2|Overall Study|Adverse Event|32
5282408|NCT00540449|18219571|P1|Overall Study|Adverse Event|12
5282409|NCT00540436|18219593|P1|Second 12-Week Treatment Period|Adverse Event|1
5282410|NCT00540436|18219593|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
5282411|NCT00540436|18219593|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
5282412|NCT00540436|18219593|P1|First 12-Week Treatment Period|Adverse Event|1
5282413|NCT00540423|18219608|P3|Open-Label Treatment Period|Lack of Efficacy|2
5282414|NCT00540423|18219609|P2|Open-Label Treatment Period|Lack of Efficacy|0
5282415|NCT00540423|18219610|P1|Open-Label Treatment Period|Lack of Efficacy|0
5282416|NCT00540423|18219608|P3|Double-Blind Treatment Period|Adverse Event|0
5282417|NCT00540423|18219609|P2|Double-Blind Treatment Period|Adverse Event|1
5282418|NCT00540423|18219610|P1|Double-Blind Treatment Period|Adverse Event|0
5282419|NCT00540293|18219660|P1|Overall Study|Protocol violation, & subject schedule|12
5282420|NCT00540293|18219660|P1|Overall Study|Withdrawal by Subject|6
5282421|NCT00540293|18219660|P1|Overall Study|Adverse event not related to study drug|7
5282422|NCT00540293|18219660|P1|Overall Study|Adverse event related to study drug|10
5282423|NCT00540228|18219708|P5|Overall Study|Lost to Follow-up|0
5282424|NCT00540228|18219709|P4|Overall Study|Lost to Follow-up|0
5282425|NCT00540228|18219710|P3|Overall Study|Lost to Follow-up|0
5282426|NCT00540228|18219711|P2|Overall Study|Lost to Follow-up|1
5282427|NCT00540228|18219712|P1|Overall Study|Lost to Follow-up|1
5282428|NCT00540228|18219708|P5|Overall Study|Adverse Event|0
5282429|NCT00540228|18219709|P4|Overall Study|Adverse Event|0
5282430|NCT00540228|18219710|P3|Overall Study|Adverse Event|0
5282431|NCT00540228|18219711|P2|Overall Study|Adverse Event|0
5282432|NCT00540228|18219712|P1|Overall Study|Adverse Event|2
5282433|NCT00540124|18219782|P3|Overall Study|Withdrawal by Subject|0
5282434|NCT00540124|18219783|P2|Overall Study|Withdrawal by Subject|1
5282435|NCT00540124|18219784|P1|Overall Study|Withdrawal by Subject|1
5282436|NCT00540124|18219782|P3|Overall Study|Lack of Efficacy|0
5282437|NCT00540124|18219783|P2|Overall Study|Lack of Efficacy|0
5282438|NCT00540124|18219784|P1|Overall Study|Lack of Efficacy|1
5282439|NCT00540124|18219782|P3|Overall Study|Entry Criteria Not Met|0
5282440|NCT00540124|18219783|P2|Overall Study|Entry Criteria Not Met|0
5282441|NCT00540124|18219784|P1|Overall Study|Entry Criteria Not Met|2
5282442|NCT00540124|18219782|P3|Overall Study|Adverse Event|1
5282443|NCT00540124|18219783|P2|Overall Study|Adverse Event|2
5282444|NCT00540124|18219784|P1|Overall Study|Adverse Event|0
5282445|NCT00540046|18219830|P2|Overall Study|Lost to Follow-up|23
5282446|NCT00540046|18219831|P1|Overall Study|Lost to Follow-up|33
5282447|NCT00539994|18219867|P3|Overall Study|Physician Decision|1
5282448|NCT00539994|18219868|P2|Overall Study|Physician Decision|0
5282449|NCT00539994|18219869|P1|Overall Study|Physician Decision|0
5282450|NCT00539994|18219867|P3|Overall Study|Withdrawal by Subject|1
5282451|NCT00539994|18219868|P2|Overall Study|Withdrawal by Subject|0
5282452|NCT00539994|18219869|P1|Overall Study|Withdrawal by Subject|1
5282453|NCT00539994|18219867|P3|Overall Study|Lost to Follow-up|0
5282454|NCT00539994|18219868|P2|Overall Study|Lost to Follow-up|1
5282455|NCT00539994|18219869|P1|Overall Study|Lost to Follow-up|2
5282456|NCT00539864|18219919|P2|Overall Study|Withdrawal by Subject|1
5282457|NCT00539864|18219920|P1|Overall Study|Withdrawal by Subject|1
5282458|NCT00539864|18219919|P2|Overall Study|Lost to Follow-up|1
5282459|NCT00539864|18219920|P1|Overall Study|Lost to Follow-up|0
5282460|NCT00539838|18219935|P3|Overall Study|Administrative|8
5282461|NCT00539838|18219936|P2|Overall Study|Administrative|0
5282462|NCT00539838|18219937|P1|Overall Study|Administrative|4
5282463|NCT00539838|18219935|P3|Overall Study|Did not cooperate|1
5282464|NCT00539838|18219936|P2|Overall Study|Did not cooperate|0
5282465|NCT00539838|18219937|P1|Overall Study|Did not cooperate|1
5282466|NCT00539838|18219935|P3|Overall Study|Death|0
5282467|NCT00539838|18219936|P2|Overall Study|Death|2
5282468|NCT00539838|18219937|P1|Overall Study|Death|0
5282469|NCT00539838|18219935|P3|Overall Study|Withdrawal by Subject|0
5282470|NCT00539838|18219936|P2|Overall Study|Withdrawal by Subject|4
5282471|NCT00539838|18219937|P1|Overall Study|Withdrawal by Subject|0
5282472|NCT00539838|18219935|P3|Overall Study|Fail to return|0
5282473|NCT00539838|18219936|P2|Overall Study|Fail to return|0
5282474|NCT00539838|18219937|P1|Overall Study|Fail to return|2
5282475|NCT00539734|18219987|P1|Overall Study|Protocol Violation|1
5282476|NCT00539591|18220013|P3|Overall Study|Disease progression|3
5282477|NCT00539591|18220014|P2|Overall Study|Disease progression|2
5282478|NCT00539591|18220015|P1|Overall Study|Disease progression|2
5282479|NCT00539591|18220013|P3|Overall Study|Toxicity|0
5282480|NCT00539591|18220014|P2|Overall Study|Toxicity|0
5282481|NCT00539591|18220015|P1|Overall Study|Toxicity|3
5282482|NCT00539513|18220167|P2|Overall Study|Lost to Follow-up|1
5282483|NCT00539513|18220168|P1|Overall Study|Lost to Follow-up|0
5282484|NCT00539513|18220167|P2|Overall Study|Withdrawal by Subject|1
5282485|NCT00539513|18220168|P1|Overall Study|Withdrawal by Subject|2
5282486|NCT00539500|18220180|P1|Overall Study|Lost to Follow-up|2
5282487|NCT00539500|18220180|P1|Overall Study|Disease Progression|1
5282488|NCT00539305|18220188|P2|Overall Study|Withdrawal by Subject|1
5282489|NCT00539305|18220189|P1|Overall Study|Withdrawal by Subject|0
5282490|NCT00539305|18220188|P2|Overall Study|Substance Use|1
5282491|NCT00539305|18220189|P1|Overall Study|Substance Use|0
5282492|NCT00539305|18220188|P2|Overall Study|Adverse Event|0
5282493|NCT00539305|18220189|P1|Overall Study|Adverse Event|1
5282494|NCT00539279|18220203|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
5282495|NCT00539279|18220204|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
5282496|NCT00539279|18220203|P2|Post-Treatment Assessment|Lost to Follow-up|9
5282497|NCT00539279|18220204|P1|Post-Treatment Assessment|Lost to Follow-up|12
5282498|NCT00539279|18220203|P2|Treatment|Death|0
5282499|NCT00539279|18220204|P1|Treatment|Death|1
5282500|NCT00539279|18220203|P2|Treatment|Withdrawal by Subject|8
5282501|NCT00539279|18220204|P1|Treatment|Withdrawal by Subject|10
5282502|NCT00539240|18220230|P3|Overall Study|Adverse Event|10
5282503|NCT00539240|18220231|P2|Overall Study|Adverse Event|1
5282504|NCT00539240|18220232|P1|Overall Study|Adverse Event|3
5282505|NCT00539240|18220230|P3|Overall Study|Lost to Follow-up|1
5282506|NCT00539240|18220231|P2|Overall Study|Lost to Follow-up|3
5282507|NCT00539240|18220232|P1|Overall Study|Lost to Follow-up|2
5282508|NCT00539240|18220230|P3|Overall Study|Protocol Violation|4
5282509|NCT00539240|18220231|P2|Overall Study|Protocol Violation|1
5282510|NCT00539240|18220232|P1|Overall Study|Protocol Violation|1
5282511|NCT00539240|18220230|P3|Overall Study|Withdrawal by Subject|0
5282512|NCT00539240|18220231|P2|Overall Study|Withdrawal by Subject|2
5282513|NCT00539240|18220232|P1|Overall Study|Withdrawal by Subject|0
5282514|NCT00539188|18220251|P2|Overall Study|Lost to Follow-up|1
5282515|NCT00539188|18220252|P1|Overall Study|Lost to Follow-up|2
5282516|NCT00539188|18220251|P2|Overall Study|Withdrawal by Subject|0
5282517|NCT00539188|18220252|P1|Overall Study|Withdrawal by Subject|1
5282518|NCT00539032|18220275|P2|Overall Study|Withdrawal by Subject|1
5282519|NCT00539032|18220276|P1|Overall Study|Withdrawal by Subject|2
5282520|NCT00539006|18220290|P4|Treatment Period 2|Other|0
5282521|NCT00539006|18220291|P3|Treatment Period 2|Other|0
5282522|NCT00539006|18220292|P2|Treatment Period 2|Other|1
5282523|NCT00539006|18220293|P1|Treatment Period 2|Other|0
5282524|NCT00539006|18220290|P4|Treatment Period 2|Protocol Violation|0
5282525|NCT00539006|18220291|P3|Treatment Period 2|Protocol Violation|0
5282526|NCT00539006|18220292|P2|Treatment Period 2|Protocol Violation|0
5282527|NCT00539006|18220293|P1|Treatment Period 2|Protocol Violation|1
5282528|NCT00539006|18220290|P4|Washout|Other|3
5282529|NCT00539006|18220291|P3|Washout|Other|2
5282530|NCT00539006|18220292|P2|Washout|Other|1
5282531|NCT00539006|18220293|P1|Washout|Other|1
5282532|NCT00539006|18220290|P4|Washout|Failed to meet continuation criteria|6
5282533|NCT00539006|18220291|P3|Washout|Failed to meet continuation criteria|14
5282534|NCT00539006|18220292|P2|Washout|Failed to meet continuation criteria|5
5282535|NCT00539006|18220293|P1|Washout|Failed to meet continuation criteria|16
5282536|NCT00539006|18220290|P4|Washout|Withdrawal by Subject|0
5282537|NCT00539006|18220291|P3|Washout|Withdrawal by Subject|0
5282538|NCT00539006|18220292|P2|Washout|Withdrawal by Subject|2
5282539|NCT00539006|18220293|P1|Washout|Withdrawal by Subject|0
5282540|NCT00539006|18220290|P4|Washout|Protocol Violation|0
5282541|NCT00539006|18220291|P3|Washout|Protocol Violation|0
5282542|NCT00539006|18220292|P2|Washout|Protocol Violation|1
5282543|NCT00539006|18220293|P1|Washout|Protocol Violation|1
5282544|NCT00539006|18220290|P4|Washout|Adverse Event|0
5282545|NCT00539006|18220291|P3|Washout|Adverse Event|0
5282546|NCT00539006|18220292|P2|Washout|Adverse Event|1
5282547|NCT00539006|18220293|P1|Washout|Adverse Event|2
5282548|NCT00539006|18220290|P4|Treatment Period 1|Lack of Efficacy|1
5282549|NCT00539006|18220291|P3|Treatment Period 1|Lack of Efficacy|0
5282550|NCT00539006|18220292|P2|Treatment Period 1|Lack of Efficacy|0
5282551|NCT00539006|18220293|P1|Treatment Period 1|Lack of Efficacy|0
5282552|NCT00539006|18220290|P4|Treatment Period 1|Protocol Violation|0
5282553|NCT00539006|18220291|P3|Treatment Period 1|Protocol Violation|1
5282554|NCT00539006|18220292|P2|Treatment Period 1|Protocol Violation|0
5282555|NCT00539006|18220293|P1|Treatment Period 1|Protocol Violation|0
5282556|NCT00539006|18220290|P4|Treatment Period 1|Lost to Follow-up|0
5282557|NCT00539006|18220291|P3|Treatment Period 1|Lost to Follow-up|1
5282558|NCT00539006|18220292|P2|Treatment Period 1|Lost to Follow-up|0
5282559|NCT00539006|18220293|P1|Treatment Period 1|Lost to Follow-up|0
5282560|NCT00539006|18220290|P4|Pre-treatment|Other|0
5282561|NCT00539006|18220291|P3|Pre-treatment|Other|0
5282562|NCT00539006|18220292|P2|Pre-treatment|Other|1
5282563|NCT00539006|18220293|P1|Pre-treatment|Other|0
5282564|NCT00538902|18220338|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
5282565|NCT00538902|18220339|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
5282566|NCT00538902|18220340|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
5282567|NCT00538902|18220338|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
5282568|NCT00538902|18220339|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
5282569|NCT00538902|18220340|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
5282570|NCT00538902|18220338|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
5282571|NCT00538902|18220339|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
5282572|NCT00538902|18220340|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
5282573|NCT00538902|18220338|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
5282574|NCT00538902|18220339|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
5282575|NCT00538902|18220340|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
5282576|NCT00538902|18220338|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
5282577|NCT00538902|18220339|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
5282578|NCT00538902|18220340|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
5282579|NCT00538902|18220338|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
5282580|NCT00538902|18220339|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
5282581|NCT00538902|18220340|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
5282582|NCT00538902|18220338|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
5282583|NCT00538902|18220339|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
5282584|NCT00538902|18220340|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
5282585|NCT00538902|18220338|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
5282586|NCT00538902|18220339|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
5282587|NCT00538902|18220340|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
5282588|NCT00538785|18220401|P2|Overall Study|Lost to Follow-up|0
5282589|NCT00538785|18220402|P1|Overall Study|Lost to Follow-up|1
5282590|NCT00538785|18220401|P2|Overall Study|Withdrawal of consent|7
5282591|NCT00538785|18220402|P1|Overall Study|Withdrawal of consent|9
5282592|NCT00538785|18220401|P2|Overall Study|Death|10
5282593|NCT00538785|18220402|P1|Overall Study|Death|9
5282594|NCT00538733|18220444|P1|Overall Study|still on therapy|1
5282595|NCT00538733|18220444|P1|Overall Study|declined to participate|2
5282596|NCT00538733|18220444|P1|Overall Study|Death|1
5282597|NCT00538733|18220444|P1|Overall Study|Adverse Event|8
5282598|NCT00538681|18220456|P4|Overall Study|Investigator Decision|1
5282599|NCT00538681|18220457|P3|Overall Study|Investigator Decision|0
5282600|NCT00538681|18220458|P2|Overall Study|Investigator Decision|0
5282601|NCT00538681|18220459|P1|Overall Study|Investigator Decision|0
5282602|NCT00538681|18220456|P4|Overall Study|Death|1
5282603|NCT00538681|18220457|P3|Overall Study|Death|1
5282604|NCT00538681|18220458|P2|Overall Study|Death|0
5282605|NCT00538681|18220459|P1|Overall Study|Death|0
5282606|NCT00538681|18220456|P4|Overall Study|Adverse Event|0
5282607|NCT00538681|18220457|P3|Overall Study|Adverse Event|1
5282608|NCT00538681|18220458|P2|Overall Study|Adverse Event|1
5282609|NCT00538681|18220459|P1|Overall Study|Adverse Event|1
5282610|NCT00538681|18220456|P4|Overall Study|Sponsor Decision|9
5282611|NCT00538681|18220457|P3|Overall Study|Sponsor Decision|8
5282612|NCT00538681|18220458|P2|Overall Study|Sponsor Decision|3
5282613|NCT00538681|18220459|P1|Overall Study|Sponsor Decision|1
5282614|NCT00538681|18220456|P4|Overall Study|Progressive Disease|0
5282615|NCT00538681|18220457|P3|Overall Study|Progressive Disease|1
5282616|NCT00538681|18220458|P2|Overall Study|Progressive Disease|0
5282617|NCT00538681|18220459|P1|Overall Study|Progressive Disease|7
5282618|NCT00538629|18220525|P1|Overall Study|Subject's untimely distrust of medicine|1
5282619|NCT00538629|18220525|P1|Overall Study|Lost to Follow-up|6
5282620|NCT00538629|18220525|P1|Overall Study|Lack of Efficacy|12
5282621|NCT00538629|18220525|P1|Overall Study|Adverse Event|2
5282622|NCT00538629|18220525|P1|Overall Study|At subject's request|1
5282623|NCT00538590|18220581|P2|Overall Study|Death|0
5282624|NCT00538590|18220582|P1|Overall Study|Death|1
5282625|NCT00538473|18220620|P2|Overall Study|Adverse Event|0
5282626|NCT00538473|18220621|P1|Overall Study|Adverse Event|1
5282627|NCT00538291|18220701|P1|Overall Study|Withdrawal by Subject|1
5282628|NCT00538291|18220701|P1|Overall Study|Adverse Event|2
5282629|NCT00537979|18220759|P2|Overall Study|Heart failure|1
5282630|NCT00537979|18220760|P1|Overall Study|Heart failure|0
5282631|NCT00537979|18220759|P2|Overall Study|Kidney transplant|3
5282632|NCT00537979|18220760|P1|Overall Study|Kidney transplant|0
5282633|NCT00537979|18220759|P2|Overall Study|Death|3
5282634|NCT00537979|18220760|P1|Overall Study|Death|0
5282635|NCT00537979|18220759|P2|Overall Study|Non-compliance with treatment/procedure|2
5282636|NCT00537979|18220760|P1|Overall Study|Non-compliance with treatment/procedure|2
5282637|NCT00537979|18220759|P2|Overall Study|Lack of Efficacy|1
5282638|NCT00537979|18220760|P1|Overall Study|Lack of Efficacy|0
5282639|NCT00537979|18220759|P2|Overall Study|Lost to Follow-up|4
5282640|NCT00537979|18220760|P1|Overall Study|Lost to Follow-up|1
5282641|NCT00537979|18220759|P2|Overall Study|Withdrawal by Subject|4
5282642|NCT00537979|18220760|P1|Overall Study|Withdrawal by Subject|1
5282643|NCT00537979|18220759|P2|Overall Study|Adverse Event|2
5282644|NCT00537979|18220760|P1|Overall Study|Adverse Event|2
5282645|NCT00537940|18220776|P2|Overall Study|Other|12
5282646|NCT00537940|18220777|P1|Overall Study|Other|10
5282647|NCT00537940|18220776|P2|Overall Study|Study terminated by sponsor|3
5282648|NCT00537940|18220777|P1|Overall Study|Study terminated by sponsor|2
5282649|NCT00537940|18220776|P2|Overall Study|Pregnancy|1
5282650|NCT00537940|18220777|P1|Overall Study|Pregnancy|1
5282651|NCT00537940|18220776|P2|Overall Study|Protocol Violation|4
5282652|NCT00537940|18220777|P1|Overall Study|Protocol Violation|6
5282653|NCT00537940|18220776|P2|Overall Study|Withdrawal by Subject|95
5282654|NCT00537940|18220777|P1|Overall Study|Withdrawal by Subject|113
5282655|NCT00537940|18220776|P2|Overall Study|Lost to Follow-up|29
5282656|NCT00537940|18220777|P1|Overall Study|Lost to Follow-up|23
5282657|NCT00537940|18220776|P2|Overall Study|Lack of Efficacy|16
5282658|NCT00537940|18220777|P1|Overall Study|Lack of Efficacy|8
5282659|NCT00537940|18220776|P2|Overall Study|Adverse Event|19
5282660|NCT00537940|18220777|P1|Overall Study|Adverse Event|20
5282661|NCT00537823|18220801|P2|Overall Study|Adverse Event|0
5282662|NCT00537823|18220802|P1|Overall Study|Adverse Event|2
5282663|NCT00537810|18220828|P4|Overall Study|Medically withdrawn|1
5282664|NCT00537810|18220829|P3|Overall Study|Medically withdrawn|0
5282665|NCT00537810|18220830|P2|Overall Study|Medically withdrawn|2
5282666|NCT00537810|18220831|P1|Overall Study|Medically withdrawn|2
5282667|NCT00537810|18220828|P4|Overall Study|Withdrawal by Subject|3
5282668|NCT00537810|18220829|P3|Overall Study|Withdrawal by Subject|4
5282669|NCT00537810|18220830|P2|Overall Study|Withdrawal by Subject|11
5282670|NCT00537810|18220831|P1|Overall Study|Withdrawal by Subject|4
5282671|NCT00537771|18220847|P2|Overall Study|Severe Non-Compliance to Protocol|2
5282672|NCT00537771|18220848|P1|Overall Study|Severe Non-Compliance to Protocol|4
5282673|NCT00537771|18220847|P2|Overall Study|Protocol Violation|6
5282674|NCT00537771|18220848|P1|Overall Study|Protocol Violation|2
5282675|NCT00537771|18220847|P2|Overall Study|Lost to Follow-up|15
5282676|NCT00537771|18220848|P1|Overall Study|Lost to Follow-up|9
5282677|NCT00537771|18220847|P2|Overall Study|Adverse Event|15
5282678|NCT00537771|18220848|P1|Overall Study|Adverse Event|8
5282679|NCT00537771|18220847|P2|Overall Study|Withdrawal by Subject|23
5282680|NCT00537771|18220848|P1|Overall Study|Withdrawal by Subject|6
5282681|NCT00537745|18220858|P1|Overall Study|Subject unable to provide Interlock info|1
5282682|NCT00537745|18220858|P1|Overall Study|Withdrawal by Subject|2
5282683|NCT00537745|18220858|P1|Overall Study|Did not meet eligibility criteria|2
5282684|NCT00537485|18220940|P2|Overall Study|Physician Decision|0
5282685|NCT00537485|18220941|P1|Overall Study|Physician Decision|1
5282686|NCT00537485|18220940|P2|Overall Study|Withdrawal by Subject|3
5282687|NCT00537485|18220941|P1|Overall Study|Withdrawal by Subject|1
5282688|NCT00537485|18220940|P2|Overall Study|Withdrawal by Subject|2
5282689|NCT00537485|18220941|P1|Overall Study|Withdrawal by Subject|3
5282690|NCT00537485|18220940|P2|Overall Study|Adverse Event|5
5282691|NCT00537485|18220941|P1|Overall Study|Adverse Event|10
5282692|NCT00537394|18221024|P3|2nd Year of Follow-up|Clinic site closure|0
5282693|NCT00537394|18221025|P2|2nd Year of Follow-up|Clinic site closure|0
5282694|NCT00537394|18221026|P1|2nd Year of Follow-up|Clinic site closure|1
5282695|NCT00537394|18221024|P3|2nd Year of Follow-up|Lost to Follow-up|2
5282696|NCT00537394|18221025|P2|2nd Year of Follow-up|Lost to Follow-up|7
5282697|NCT00537394|18221026|P1|2nd Year of Follow-up|Lost to Follow-up|6
5282698|NCT00537394|18221024|P3|2nd Year of Follow-up|Withdrawal by Subject|2
5282699|NCT00537394|18221025|P2|2nd Year of Follow-up|Withdrawal by Subject|1
5282700|NCT00537394|18221026|P1|2nd Year of Follow-up|Withdrawal by Subject|0
5282701|NCT00537394|18221024|P3|2nd Year of Follow-up|Death|2
5282702|NCT00537394|18221025|P2|2nd Year of Follow-up|Death|1
5282703|NCT00537394|18221026|P1|2nd Year of Follow-up|Death|4
5282704|NCT00537394|18221024|P3|First Year of Follow-up|Lost to Follow-up|1
5282705|NCT00537394|18221025|P2|First Year of Follow-up|Lost to Follow-up|5
5282706|NCT00537394|18221026|P1|First Year of Follow-up|Lost to Follow-up|1
5282707|NCT00537394|18221024|P3|First Year of Follow-up|Withdrawal by Subject|1
5282708|NCT00537394|18221025|P2|First Year of Follow-up|Withdrawal by Subject|6
5282709|NCT00537394|18221026|P1|First Year of Follow-up|Withdrawal by Subject|3
5282710|NCT00537394|18221024|P3|First Year of Follow-up|Severe debilitation|1
5282711|NCT00537394|18221025|P2|First Year of Follow-up|Severe debilitation|0
5282712|NCT00537394|18221026|P1|First Year of Follow-up|Severe debilitation|1
5282713|NCT00537394|18221024|P3|First Year of Follow-up|Death|0
5282714|NCT00537394|18221025|P2|First Year of Follow-up|Death|0
5282715|NCT00537394|18221026|P1|First Year of Follow-up|Death|7
5282716|NCT00537381|18221062|P2|Overall Study|Other|3
5282717|NCT00537381|18221063|P1|Overall Study|Other|5
5282718|NCT00537381|18221062|P2|Overall Study|Sponsor decision|9
5282719|NCT00537381|18221063|P1|Overall Study|Sponsor decision|14
5282720|NCT00537381|18221062|P2|Overall Study|Disease Progression|18
5282721|NCT00537381|18221063|P1|Overall Study|Disease Progression|9
5282722|NCT00537381|18221062|P2|Overall Study|Physician Decision|6
5282723|NCT00537381|18221063|P1|Overall Study|Physician Decision|7
5282724|NCT00537381|18221062|P2|Overall Study|Withdrawal by Subject|14
5282725|NCT00537381|18221063|P1|Overall Study|Withdrawal by Subject|5
5282726|NCT00537381|18221062|P2|Overall Study|Death|3
5282727|NCT00537381|18221063|P1|Overall Study|Death|3
5282728|NCT00537381|18221062|P2|Overall Study|Adverse Event|9
5282729|NCT00537381|18221063|P1|Overall Study|Adverse Event|13
5282730|NCT00537329|18221083|P1|Overall Study|Other|1
5282731|NCT00537329|18221083|P1|Overall Study|Withdrawal by Subject|4
5282732|NCT00537329|18221083|P1|Overall Study|Lost to Follow-up|6
5282733|NCT00537329|18221083|P1|Overall Study|Lack of Efficacy|2
5282734|NCT00537329|18221083|P1|Overall Study|Adverse Event|3
5282735|NCT00537329|18221083|P1|Overall Study|Death|10
5282736|NCT00537316|18221103|P7|Part 2|Administrative|1
5282737|NCT00537316|18221104|P6|Part 2|Administrative|4
5282738|NCT00537316|18221105|P5|Part 2|Administrative|1
5282739|NCT00537316|18221106|P4|Part 2|Administrative|3
5282740|NCT00537316|18221107|P3|Part 2|Administrative|24
5282741|NCT00537316|18221108|P2|Part 2|Administrative|8
5282742|NCT00537316|18221109|P1|Part 2|Administrative|16
5282743|NCT00537316|18221103|P7|Part 2|Withdrawal by Subject|0
5282744|NCT00537316|18221104|P6|Part 2|Withdrawal by Subject|0
5282745|NCT00537316|18221105|P5|Part 2|Withdrawal by Subject|0
5282746|NCT00537316|18221106|P4|Part 2|Withdrawal by Subject|0
5282747|NCT00537316|18221107|P3|Part 2|Withdrawal by Subject|4
5282748|NCT00537316|18221108|P2|Part 2|Withdrawal by Subject|1
5282749|NCT00537316|18221109|P1|Part 2|Withdrawal by Subject|5
5282750|NCT00537316|18221103|P7|Part 2|Lost to Follow-up|0
5282751|NCT00537316|18221104|P6|Part 2|Lost to Follow-up|0
5282752|NCT00537316|18221105|P5|Part 2|Lost to Follow-up|0
5282753|NCT00537316|18221106|P4|Part 2|Lost to Follow-up|0
5282754|NCT00537316|18221107|P3|Part 2|Lost to Follow-up|2
5282755|NCT00537316|18221108|P2|Part 2|Lost to Follow-up|0
5282756|NCT00537316|18221109|P1|Part 2|Lost to Follow-up|1
5282757|NCT00537316|18221103|P7|Part 2|Adverse Event|0
5282758|NCT00537316|18221104|P6|Part 2|Adverse Event|0
5282759|NCT00537316|18221105|P5|Part 2|Adverse Event|0
5282760|NCT00537316|18221106|P4|Part 2|Adverse Event|0
5282761|NCT00537316|18221107|P3|Part 2|Adverse Event|2
5282762|NCT00537316|18221108|P2|Part 2|Adverse Event|0
5282763|NCT00537316|18221109|P1|Part 2|Adverse Event|4
5282764|NCT00537316|18221103|P7|Part 2|Never entered follow-up|1
5282765|NCT00537316|18221104|P6|Part 2|Never entered follow-up|0
5282766|NCT00537316|18221105|P5|Part 2|Never entered follow-up|0
5282767|NCT00537316|18221106|P4|Part 2|Never entered follow-up|0
5282768|NCT00537316|18221107|P3|Part 2|Never entered follow-up|0
5282769|NCT00537316|18221108|P2|Part 2|Never entered follow-up|0
5282770|NCT00537316|18221109|P1|Part 2|Never entered follow-up|0
5282771|NCT00537316|18221103|P7|Part 1|Administrative|0
5282772|NCT00537316|18221104|P6|Part 1|Administrative|0
5282773|NCT00537316|18221105|P5|Part 1|Administrative|0
5282774|NCT00537316|18221106|P4|Part 1|Administrative|0
5282775|NCT00537316|18221107|P3|Part 1|Administrative|2
5282776|NCT00537316|18221108|P2|Part 1|Administrative|0
5282777|NCT00537316|18221109|P1|Part 1|Administrative|0
5282778|NCT00537316|18221103|P7|Part 1|Did not meet protocol eligibility|0
5282779|NCT00537316|18221104|P6|Part 1|Did not meet protocol eligibility|0
5282780|NCT00537316|18221105|P5|Part 1|Did not meet protocol eligibility|0
5282781|NCT00537316|18221106|P4|Part 1|Did not meet protocol eligibility|0
5282782|NCT00537316|18221107|P3|Part 1|Did not meet protocol eligibility|2
5282783|NCT00537316|18221108|P2|Part 1|Did not meet protocol eligibility|3
5282784|NCT00537316|18221109|P1|Part 1|Did not meet protocol eligibility|1
5282785|NCT00537316|18221103|P7|Part 1|Protocol Violation|0
5282786|NCT00537316|18221104|P6|Part 1|Protocol Violation|0
5282787|NCT00537316|18221105|P5|Part 1|Protocol Violation|0
5282788|NCT00537316|18221106|P4|Part 1|Protocol Violation|0
5282789|NCT00537316|18221107|P3|Part 1|Protocol Violation|1
5282790|NCT00537316|18221108|P2|Part 1|Protocol Violation|5
5282791|NCT00537316|18221109|P1|Part 1|Protocol Violation|1
5282792|NCT00537316|18221103|P7|Part 1|Withdrawal by Subject|0
5282793|NCT00537316|18221104|P6|Part 1|Withdrawal by Subject|0
5282794|NCT00537316|18221105|P5|Part 1|Withdrawal by Subject|0
5282795|NCT00537316|18221106|P4|Part 1|Withdrawal by Subject|0
5282796|NCT00537316|18221107|P3|Part 1|Withdrawal by Subject|4
5282797|NCT00537316|18221108|P2|Part 1|Withdrawal by Subject|8
5282798|NCT00537316|18221109|P1|Part 1|Withdrawal by Subject|3
5282799|NCT00537316|18221103|P7|Part 1|Lost to Follow-up|0
5282800|NCT00537316|18221104|P6|Part 1|Lost to Follow-up|0
5282801|NCT00537316|18221105|P5|Part 1|Lost to Follow-up|0
5282802|NCT00537316|18221106|P4|Part 1|Lost to Follow-up|0
5282803|NCT00537316|18221107|P3|Part 1|Lost to Follow-up|0
5282804|NCT00537316|18221108|P2|Part 1|Lost to Follow-up|0
5282805|NCT00537316|18221109|P1|Part 1|Lost to Follow-up|1
5282806|NCT00537316|18221103|P7|Part 1|Protocol defined clinical event|0
5282807|NCT00537316|18221104|P6|Part 1|Protocol defined clinical event|0
5282808|NCT00537316|18221105|P5|Part 1|Protocol defined clinical event|0
5282809|NCT00537316|18221106|P4|Part 1|Protocol defined clinical event|0
5282810|NCT00537316|18221107|P3|Part 1|Protocol defined clinical event|0
5282811|NCT00537316|18221108|P2|Part 1|Protocol defined clinical event|0
5282812|NCT00537316|18221109|P1|Part 1|Protocol defined clinical event|1
5282813|NCT00537316|18221103|P7|Part 1|Adverse Event|0
5282814|NCT00537316|18221104|P6|Part 1|Adverse Event|0
5282815|NCT00537316|18221105|P5|Part 1|Adverse Event|0
5282816|NCT00537316|18221106|P4|Part 1|Adverse Event|0
5282817|NCT00537316|18221107|P3|Part 1|Adverse Event|8
5282818|NCT00537316|18221108|P2|Part 1|Adverse Event|11
5282819|NCT00537316|18221109|P1|Part 1|Adverse Event|7
5282820|NCT00537303|18221136|P2|Overall Study|Unclassified|7
5282821|NCT00537303|18221137|P1|Overall Study|Unclassified|8
5282822|NCT00537303|18221136|P2|Overall Study|Withdrawal criteria|3
5282823|NCT00537303|18221137|P1|Overall Study|Withdrawal criteria|3
5282824|NCT00537303|18221136|P2|Overall Study|Protocol Violation|4
5282825|NCT00537303|18221137|P1|Overall Study|Protocol Violation|8
5282826|NCT00537303|18221136|P2|Overall Study|Lack of Efficacy|7
5282827|NCT00537303|18221137|P1|Overall Study|Lack of Efficacy|6
5282828|NCT00537303|18221136|P2|Overall Study|Adverse Event|4
5282829|NCT00537303|18221137|P1|Overall Study|Adverse Event|1
5282830|NCT00537277|18221158|P1|Overall Study|Non-compliance with trial procedures|15
5282831|NCT00537277|18221158|P1|Overall Study|Inability to tolerate trial medication|4
5282832|NCT00537277|18221158|P1|Overall Study|Unclassified|4
5282833|NCT00537277|18221158|P1|Overall Study|Protocol Violation|11
5282834|NCT00537277|18221158|P1|Overall Study|Lost to Follow-up|12
5282835|NCT00537277|18221158|P1|Overall Study|Lack of Efficacy|2
5282836|NCT00537277|18221158|P1|Overall Study|Adverse Event|1
5282837|NCT00537238|18221169|P2|Overall Study|Other|52
5282838|NCT00537238|18221170|P1|Overall Study|Other|44
5282839|NCT00537238|18221169|P2|Overall Study|Does not meet entrance criteria|2
5282840|NCT00537238|18221170|P1|Overall Study|Does not meet entrance criteria|0
5282841|NCT00537238|18221169|P2|Overall Study|Protocol Violation|19
5282842|NCT00537238|18221170|P1|Overall Study|Protocol Violation|15
5282843|NCT00537238|18221169|P2|Overall Study|Withdrawal by Subject|47
5282844|NCT00537238|18221170|P1|Overall Study|Withdrawal by Subject|51
5282845|NCT00537238|18221169|P2|Overall Study|Lost to Follow-up|8
5282846|NCT00537238|18221170|P1|Overall Study|Lost to Follow-up|12
5282847|NCT00537238|18221169|P2|Overall Study|Lack of Efficacy|21
5282848|NCT00537238|18221170|P1|Overall Study|Lack of Efficacy|20
5282849|NCT00537238|18221169|P2|Overall Study|Adverse Event|22
5282850|NCT00537238|18221170|P1|Overall Study|Adverse Event|31
5282851|NCT00537238|18221169|P2|Overall Study|Death|2
5282852|NCT00537238|18221170|P1|Overall Study|Death|1
5282853|NCT00537199|18221190|P1|Overall Study|Study Terminated|1
5282854|NCT00537095|18221196|P2|Overall Study|Incorrect enrolment|1
5282855|NCT00537095|18221197|P1|Overall Study|Incorrect enrolment|0
5282856|NCT00537095|18221196|P2|Overall Study|subjective disease progression|1
5282857|NCT00537095|18221197|P1|Overall Study|subjective disease progression|0
5282858|NCT00537095|18221196|P2|Overall Study|Withdrawal by Subject|2
5282859|NCT00537095|18221197|P1|Overall Study|Withdrawal by Subject|2
5282860|NCT00537095|18221196|P2|Overall Study|Death|1
5282861|NCT00537095|18221197|P1|Overall Study|Death|3
5282862|NCT00537095|18221196|P2|Overall Study|disease progression|48
5282863|NCT00537095|18221197|P1|Overall Study|disease progression|21
5282864|NCT00537095|18221196|P2|Overall Study|Adverse Event|4
5282865|NCT00537095|18221197|P1|Overall Study|Adverse Event|24
5282866|NCT00537095|18221196|P2|Overall Study|surgery|0
5282867|NCT00537095|18221197|P1|Overall Study|surgery|1
5282868|NCT00537082|18221212|P3|Overall Study|Discontinued before initiating treatment|0
5282869|NCT00537082|18221213|P2|Overall Study|Discontinued before initiating treatment|0
5282870|NCT00537082|18221214|P1|Overall Study|Discontinued before initiating treatment|3
5282871|NCT00537082|18221212|P3|Overall Study|Withdrawal by Subject|0
5282872|NCT00537082|18221213|P2|Overall Study|Withdrawal by Subject|1
5282873|NCT00537082|18221214|P1|Overall Study|Withdrawal by Subject|0
5282874|NCT00537082|18221212|P3|Overall Study|Lack of Efficacy|2
5282875|NCT00537082|18221213|P2|Overall Study|Lack of Efficacy|0
5282876|NCT00537082|18221214|P1|Overall Study|Lack of Efficacy|0
5282877|NCT00537082|18221212|P3|Overall Study|Protocol Violation|1
5282878|NCT00537082|18221213|P2|Overall Study|Protocol Violation|2
5282879|NCT00537082|18221214|P1|Overall Study|Protocol Violation|0
5282880|NCT00537082|18221212|P3|Overall Study|Adverse Event|3
5282881|NCT00537082|18221213|P2|Overall Study|Adverse Event|6
5282882|NCT00537082|18221214|P1|Overall Study|Adverse Event|6
5282883|NCT00537056|18221231|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
5282884|NCT00537030|18221243|P1|Overall Study|Inevaluable|2
5282885|NCT00537030|18221243|P1|Overall Study|Ineligible|2
5282886|NCT00537030|18221243|P1|Overall Study|Disease progression/ relapse during Tx|1
5282887|NCT00537030|18221243|P1|Overall Study|≥ Grade 2 allergy|7
5282888|NCT00537030|18221243|P1|Overall Study|Withdrawal by Subject|2
5282889|NCT00537030|18221243|P1|Overall Study|Physician Decision|2
5282890|NCT00537017|18221250|P1|Follow-up Phase|Withdrawal by Subject|9
5282891|NCT00537017|18221250|P1|Treatment Phase|Protocol Violation|2
5282892|NCT00537017|18221250|P1|Treatment Phase|Withdrawal by Subject|13
5282893|NCT00537017|18221250|P1|Treatment Phase|Adverse Event|19
5282894|NCT00536991|18221261|P1|Overall Study|patient ineligible|2
5282895|NCT00536991|18221261|P1|Overall Study|Physician Decision|1
5282896|NCT00536991|18221261|P1|Overall Study|Withdrawal by Subject|10
5282897|NCT00536978|18221268|P1|Overall Study|Not eligible for Adback Infusion|22
5282898|NCT00536939|18221272|P2|Overall Study|Other Complicating Disease|0
5282899|NCT00536939|18221273|P1|Overall Study|Other Complicating Disease|1
5282900|NCT00536939|18221272|P2|Overall Study|Withdrawal by Subject|0
5282901|NCT00536939|18221273|P1|Overall Study|Withdrawal by Subject|1
5282902|NCT00536874|18221304|P1|Overall Study|Withdrawal by Subject|1
5282903|NCT00536874|18221304|P1|Overall Study|Death|2
5282904|NCT00536874|18221304|P1|Overall Study|Adverse Event|1
5282905|NCT00536809|18221314|P1|Phase II|Referred for surgical resection|1
5282906|NCT00536809|18221314|P1|Phase II|Adverse Event|1
5282907|NCT00536744|18221337|P2|Overall Study|PI tried alternative treatment|3
5282908|NCT00536744|18221338|P1|Overall Study|PI tried alternative treatment|1
5282909|NCT00536744|18221337|P2|Overall Study|Withdrawal by Subject|8
5282910|NCT00536744|18221338|P1|Overall Study|Withdrawal by Subject|7
5282911|NCT00536744|18221337|P2|Overall Study|Lost to Follow-up|5
5282912|NCT00536744|18221338|P1|Overall Study|Lost to Follow-up|3
5282913|NCT00536744|18221337|P2|Overall Study|Physician Decision|1
5282914|NCT00536744|18221338|P1|Overall Study|Physician Decision|3
5282915|NCT00536744|18221337|P2|Overall Study|Death|1
5282916|NCT00536744|18221338|P1|Overall Study|Death|2
5282917|NCT00536744|18221337|P2|Overall Study|Adverse Event|10
5282918|NCT00536744|18221338|P1|Overall Study|Adverse Event|13
5282919|NCT00536731|18221347|P3|Overall Study|Other|0
5282920|NCT00536731|18221348|P2|Overall Study|Other|1
5282921|NCT00536731|18221349|P1|Overall Study|Other|1
5282922|NCT00536731|18221347|P3|Overall Study|Safety reasons|1
5282923|NCT00536731|18221348|P2|Overall Study|Safety reasons|0
5282924|NCT00536731|18221349|P1|Overall Study|Safety reasons|0
5282925|NCT00536731|18221347|P3|Overall Study|Intake of prohibited conc. medication|1
5282926|NCT00536731|18221348|P2|Overall Study|Intake of prohibited conc. medication|0
5282927|NCT00536731|18221349|P1|Overall Study|Intake of prohibited conc. medication|0
5282928|NCT00536731|18221347|P3|Overall Study|Withdrawal by Subject|0
5282929|NCT00536731|18221348|P2|Overall Study|Withdrawal by Subject|2
5282930|NCT00536731|18221349|P1|Overall Study|Withdrawal by Subject|0
5282931|NCT00536731|18221347|P3|Overall Study|Adverse Event|3
5282932|NCT00536731|18221348|P2|Overall Study|Adverse Event|2
5282933|NCT00536731|18221349|P1|Overall Study|Adverse Event|3
5282934|NCT00536575|18221393|P1|Overall Study|Death|1
5282935|NCT00536575|18221393|P1|Overall Study|Withdrawal by Subject|1
5282936|NCT00536510|18221399|P2|Overall Study|Patient Discontinued for Other Reasons|2
5282937|NCT00536510|18221400|P1|Overall Study|Patient Discontinued for Other Reasons|2
5282938|NCT00536510|18221399|P2|Overall Study|Laboratory Adverse Event|1
5282939|NCT00536510|18221400|P1|Overall Study|Laboratory Adverse Event|2
5282940|NCT00536510|18221399|P2|Overall Study|Flushing with Product|0
5282941|NCT00536510|18221400|P1|Overall Study|Flushing with Product|20
5282942|NCT00536510|18221399|P2|Overall Study|Withdrawal by Subject|9
5282943|NCT00536510|18221400|P1|Overall Study|Withdrawal by Subject|16
5282944|NCT00536510|18221399|P2|Overall Study|Protocol Violation|5
5282945|NCT00536510|18221400|P1|Overall Study|Protocol Violation|4
5282946|NCT00536510|18221399|P2|Overall Study|Lost to Follow-up|8
5282947|NCT00536510|18221400|P1|Overall Study|Lost to Follow-up|11
5282948|NCT00536510|18221399|P2|Overall Study|Adverse Event|4
5282949|NCT00536510|18221400|P1|Overall Study|Adverse Event|27
5282950|NCT00536484|18221410|P2|Overall Study|Other|0
5282951|NCT00536484|18221411|P1|Overall Study|Other|4
5282952|NCT00536484|18221410|P2|Overall Study|Lack of Efficacy|5
5282953|NCT00536484|18221411|P1|Overall Study|Lack of Efficacy|16
5282954|NCT00536484|18221410|P2|Overall Study|Lost to Follow-up|6
5282955|NCT00536484|18221411|P1|Overall Study|Lost to Follow-up|8
5282956|NCT00536484|18221410|P2|Overall Study|Withdrawal by Subject|11
5282957|NCT00536484|18221411|P1|Overall Study|Withdrawal by Subject|11
5282958|NCT00536484|18221410|P2|Overall Study|Adverse Event|34
5282959|NCT00536484|18221411|P1|Overall Study|Adverse Event|21
5282960|NCT00536471|18221445|P4|Overall Study|Sponsor Decision|2
5282961|NCT00536471|18221446|P3|Overall Study|Sponsor Decision|3
5282962|NCT00536471|18221447|P2|Overall Study|Sponsor Decision|1
5282963|NCT00536471|18221448|P1|Overall Study|Sponsor Decision|0
5282964|NCT00536471|18221445|P4|Overall Study|Death|2
5282965|NCT00536471|18221446|P3|Overall Study|Death|1
5282966|NCT00536471|18221447|P2|Overall Study|Death|0
5282967|NCT00536471|18221448|P1|Overall Study|Death|0
5282968|NCT00536471|18221445|P4|Overall Study|Physician Decision|2
5282969|NCT00536471|18221446|P3|Overall Study|Physician Decision|3
5282970|NCT00536471|18221447|P2|Overall Study|Physician Decision|1
5282971|NCT00536471|18221448|P1|Overall Study|Physician Decision|11
5282972|NCT00536471|18221445|P4|Overall Study|Protocol Violation|3
5282973|NCT00536471|18221446|P3|Overall Study|Protocol Violation|2
5282974|NCT00536471|18221447|P2|Overall Study|Protocol Violation|1
5282975|NCT00536471|18221448|P1|Overall Study|Protocol Violation|8
5282976|NCT00536471|18221445|P4|Overall Study|Lack of Efficacy|9
5282977|NCT00536471|18221446|P3|Overall Study|Lack of Efficacy|11
5282978|NCT00536471|18221447|P2|Overall Study|Lack of Efficacy|18
5282979|NCT00536471|18221448|P1|Overall Study|Lack of Efficacy|17
5282980|NCT00536471|18221445|P4|Overall Study|Withdrawal by Subject|21
5282981|NCT00536471|18221446|P3|Overall Study|Withdrawal by Subject|43
5282982|NCT00536471|18221447|P2|Overall Study|Withdrawal by Subject|24
5282983|NCT00536471|18221448|P1|Overall Study|Withdrawal by Subject|40
5282984|NCT00536471|18221445|P4|Overall Study|Adverse Event|13
5282985|NCT00536471|18221446|P3|Overall Study|Adverse Event|28
5282986|NCT00536471|18221447|P2|Overall Study|Adverse Event|16
5282987|NCT00536471|18221448|P1|Overall Study|Adverse Event|32
5282988|NCT00536471|18221445|P4|Overall Study|Lost to Follow-up|22
5282989|NCT00536471|18221446|P3|Overall Study|Lost to Follow-up|48
5282990|NCT00536471|18221447|P2|Overall Study|Lost to Follow-up|23
5282991|NCT00536471|18221448|P1|Overall Study|Lost to Follow-up|48
5282992|NCT00536380|18221693|P3|Overall Study|Administrative|1
5282993|NCT00536380|18221694|P2|Overall Study|Administrative|0
5282994|NCT00536380|18221695|P1|Overall Study|Administrative|0
5282995|NCT00536380|18221693|P3|Overall Study|Did not meet protocol eligibility|1
5282996|NCT00536380|18221694|P2|Overall Study|Did not meet protocol eligibility|0
5282997|NCT00536380|18221695|P1|Overall Study|Did not meet protocol eligibility|0
5282998|NCT00536380|18221693|P3|Overall Study|Noncompliance with protocol|2
5282999|NCT00536380|18221694|P2|Overall Study|Noncompliance with protocol|2
5283000|NCT00536380|18221695|P1|Overall Study|Noncompliance with protocol|3
5283001|NCT00536380|18221693|P3|Overall Study|Withdrawal related to study drug|2
5283002|NCT00536380|18221694|P2|Overall Study|Withdrawal related to study drug|5
5283003|NCT00536380|18221695|P1|Overall Study|Withdrawal related to study drug|7
5283004|NCT00536380|18221693|P3|Overall Study|Withdrawal unrelated to study drug|1
5283005|NCT00536380|18221694|P2|Overall Study|Withdrawal unrelated to study drug|0
5283006|NCT00536380|18221695|P1|Overall Study|Withdrawal unrelated to study drug|2
5283007|NCT00536380|18221693|P3|Overall Study|Lost to Follow-up|1
5283008|NCT00536380|18221694|P2|Overall Study|Lost to Follow-up|0
5283009|NCT00536380|18221695|P1|Overall Study|Lost to Follow-up|0
5283010|NCT00536380|18221693|P3|Overall Study|Adverse Event|2
5283011|NCT00536380|18221694|P2|Overall Study|Adverse Event|2
5283012|NCT00536380|18221695|P1|Overall Study|Adverse Event|0
5283013|NCT00536263|18221719|P3|Overall Study|Did not meet protocol eligibility|2
5283014|NCT00536263|18221720|P2|Overall Study|Did not meet protocol eligibility|2
5283015|NCT00536263|18221721|P1|Overall Study|Did not meet protocol eligibility|1
5283016|NCT00536263|18221719|P3|Overall Study|Noncompliance with protocol|1
5283017|NCT00536263|18221720|P2|Overall Study|Noncompliance with protocol|0
5283018|NCT00536263|18221721|P1|Overall Study|Noncompliance with protocol|0
5283019|NCT00536263|18221719|P3|Overall Study|Subject withdrew - treatment related|2
5283020|NCT00536263|18221720|P2|Overall Study|Subject withdrew - treatment related|3
5283021|NCT00536263|18221721|P1|Overall Study|Subject withdrew - treatment related|0
5283022|NCT00536263|18221719|P3|Overall Study|Subject withdrew - not treatment related|5
5283023|NCT00536263|18221720|P2|Overall Study|Subject withdrew - not treatment related|0
5283024|NCT00536263|18221721|P1|Overall Study|Subject withdrew - not treatment related|2
5283025|NCT00536263|18221719|P3|Overall Study|Lost to Follow-up|4
5283026|NCT00536263|18221720|P2|Overall Study|Lost to Follow-up|4
5283027|NCT00536263|18221721|P1|Overall Study|Lost to Follow-up|3
5283028|NCT00536263|18221719|P3|Overall Study|Adverse Event|7
5283029|NCT00536263|18221720|P2|Overall Study|Adverse Event|5
5283030|NCT00536263|18221721|P1|Overall Study|Adverse Event|5
5283031|NCT00536198|18221761|P2|Overall Study|Protocol Violation|1
5283032|NCT00536198|18221762|P1|Overall Study|Protocol Violation|0
5283033|NCT00536198|18221761|P2|Overall Study|Pregnancy|1
5283034|NCT00536198|18221762|P1|Overall Study|Pregnancy|1
5283035|NCT00536198|18221761|P2|Overall Study|Rescue|9
5283036|NCT00536198|18221762|P1|Overall Study|Rescue|3
5283037|NCT00536198|18221761|P2|Overall Study|Adverse Event|2
5283038|NCT00536198|18221762|P1|Overall Study|Adverse Event|2
5283039|NCT00536198|18221761|P2|Overall Study|Withdrawal by Subject|12
5283040|NCT00536198|18221762|P1|Overall Study|Withdrawal by Subject|16
5283041|NCT00536198|18221761|P2|Overall Study|Lost to Follow-up|14
5283042|NCT00536198|18221762|P1|Overall Study|Lost to Follow-up|15
5283043|NCT00536120|18221801|P2|Overall Study|Missed Study Visit|1
5283044|NCT00536120|18221802|P1|Overall Study|Missed Study Visit|0
5283045|NCT00536120|18221801|P2|Overall Study|Steroid Use|2
5283046|NCT00536120|18221802|P1|Overall Study|Steroid Use|0
5283047|NCT00536120|18221801|P2|Overall Study|Sponsor Decision Due to Lab Values|0
5283048|NCT00536120|18221802|P1|Overall Study|Sponsor Decision Due to Lab Values|1
5283049|NCT00536120|18221801|P2|Overall Study|Non-compliance|0
5283050|NCT00536120|18221802|P1|Overall Study|Non-compliance|1
5283051|NCT00536120|18221801|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
5283052|NCT00536120|18221802|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
5283053|NCT00536120|18221801|P2|Overall Study|Lost to Follow-up|0
5283054|NCT00536120|18221802|P1|Overall Study|Lost to Follow-up|1
5283055|NCT00536107|18221816|P2|Overall Study|Study Termination|4
5283056|NCT00536107|18221817|P1|Overall Study|Study Termination|2
5283057|NCT00536107|18221816|P2|Overall Study|Withdrawal by Subject|1
5283058|NCT00536107|18221817|P1|Overall Study|Withdrawal by Subject|0
5283059|NCT00536107|18221816|P2|Overall Study|Incorrect enrolment|0
5283060|NCT00536107|18221817|P1|Overall Study|Incorrect enrolment|1
5283061|NCT00536107|18221816|P2|Overall Study|Death|1
5283062|NCT00536107|18221817|P1|Overall Study|Death|5
5283063|NCT00535847|18221882|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
5283064|NCT00535847|18221883|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
5283065|NCT00535847|18221884|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
5283066|NCT00535847|18221882|P3|Overall Study|Non compliance|0
5283067|NCT00535847|18221883|P2|Overall Study|Non compliance|1
5283068|NCT00535847|18221884|P1|Overall Study|Non compliance|1
5283069|NCT00535847|18221882|P3|Overall Study|Adverse Event|2
5283070|NCT00535847|18221883|P2|Overall Study|Adverse Event|3
5283071|NCT00535847|18221884|P1|Overall Study|Adverse Event|5
5283072|NCT00535730|18222119|P2|Overall Study|Withdrawal by Subject|4
5283073|NCT00535730|18222120|P1|Overall Study|Withdrawal by Subject|0
5283074|NCT00535730|18222119|P2|Overall Study|Protocol Violation|0
5283075|NCT00535730|18222120|P1|Overall Study|Protocol Violation|1
5283076|NCT00535730|18222119|P2|Overall Study|Physician Decision|1
5283077|NCT00535730|18222120|P1|Overall Study|Physician Decision|0
5283078|NCT00535730|18222119|P2|Overall Study|Lost to Follow-up|1
5283079|NCT00535730|18222120|P1|Overall Study|Lost to Follow-up|0
5283080|NCT00535730|18222119|P2|Overall Study|Adverse Event|1
5283081|NCT00535730|18222120|P1|Overall Study|Adverse Event|1
5283082|NCT00535626|18222141|P1|Overall Study|Unable to return|2
5283083|NCT00535626|18222141|P1|Overall Study|Subject terminated|31
5283084|NCT00535626|18222141|P1|Overall Study|Removal/revision of study component|8
5283085|NCT00535626|18222141|P1|Overall Study|Withdrawal by Subject|20
5283086|NCT00535626|18222141|P1|Overall Study|Lost to Follow-up|29
5283087|NCT00535626|18222141|P1|Overall Study|Death|15
5283088|NCT00535496|18222181|P4|Overall Study|Not treated with sugammadex|0
5283089|NCT00535496|18222182|P3|Overall Study|Not treated with sugammadex|0
5283090|NCT00535496|18222183|P2|Overall Study|Not treated with sugammadex|1
5283091|NCT00535496|18222184|P1|Overall Study|Not treated with sugammadex|0
5283092|NCT00535496|18222181|P4|Overall Study|Lost to Follow-up|0
5283093|NCT00535496|18222182|P3|Overall Study|Lost to Follow-up|0
5283094|NCT00535496|18222183|P2|Overall Study|Lost to Follow-up|1
5283095|NCT00535496|18222184|P1|Overall Study|Lost to Follow-up|0
5283096|NCT00535405|18222204|P5|Overall Study|Withdrawal by Subject|8
5283097|NCT00535405|18222205|P4|Overall Study|Withdrawal by Subject|10
5283098|NCT00535405|18222206|P3|Overall Study|Withdrawal by Subject|10
5283099|NCT00535405|18222207|P2|Overall Study|Withdrawal by Subject|11
5283100|NCT00535405|18222208|P1|Overall Study|Withdrawal by Subject|5
5283101|NCT00535405|18222204|P5|Overall Study|Protocol Violation|0
5283102|NCT00535405|18222205|P4|Overall Study|Protocol Violation|1
5283103|NCT00535405|18222206|P3|Overall Study|Protocol Violation|2
5283104|NCT00535405|18222207|P2|Overall Study|Protocol Violation|2
5283105|NCT00535405|18222208|P1|Overall Study|Protocol Violation|2
5283106|NCT00535405|18222204|P5|Overall Study|Physician Decision|1
5283107|NCT00535405|18222205|P4|Overall Study|Physician Decision|1
5283108|NCT00535405|18222206|P3|Overall Study|Physician Decision|0
5283109|NCT00535405|18222207|P2|Overall Study|Physician Decision|2
5283110|NCT00535405|18222208|P1|Overall Study|Physician Decision|3
5283111|NCT00535405|18222204|P5|Overall Study|Lost to Follow-up|1
5283112|NCT00535405|18222205|P4|Overall Study|Lost to Follow-up|2
5283113|NCT00535405|18222206|P3|Overall Study|Lost to Follow-up|3
5283114|NCT00535405|18222207|P2|Overall Study|Lost to Follow-up|3
5283115|NCT00535405|18222208|P1|Overall Study|Lost to Follow-up|1
5283116|NCT00535405|18222204|P5|Overall Study|Adverse Event|6
5283117|NCT00535405|18222205|P4|Overall Study|Adverse Event|8
5283118|NCT00535405|18222206|P3|Overall Study|Adverse Event|3
5283119|NCT00535405|18222207|P2|Overall Study|Adverse Event|8
5283120|NCT00535405|18222208|P1|Overall Study|Adverse Event|6
5283121|NCT00535288|18222269|P5|Overall Study|Other|1
5283122|NCT00535288|18222270|P4|Overall Study|Other|2
5283123|NCT00535288|18222271|P3|Overall Study|Other|1
5283124|NCT00535288|18222272|P2|Overall Study|Other|1
5283125|NCT00535288|18222273|P1|Overall Study|Other|2
5283126|NCT00535288|18222269|P5|Overall Study|Unwilling to cooperate|4
5283127|NCT00535288|18222270|P4|Overall Study|Unwilling to cooperate|3
5283128|NCT00535288|18222271|P3|Overall Study|Unwilling to cooperate|3
5283129|NCT00535288|18222272|P2|Overall Study|Unwilling to cooperate|6
5283130|NCT00535288|18222273|P1|Overall Study|Unwilling to cooperate|6
5283131|NCT00535288|18222269|P5|Overall Study|Lack of Efficacy|7
5283132|NCT00535288|18222270|P4|Overall Study|Lack of Efficacy|4
5283133|NCT00535288|18222271|P3|Overall Study|Lack of Efficacy|4
5283134|NCT00535288|18222272|P2|Overall Study|Lack of Efficacy|3
5283135|NCT00535288|18222273|P1|Overall Study|Lack of Efficacy|26
5283136|NCT00535288|18222269|P5|Overall Study|Lost to Follow-up|0
5283137|NCT00535288|18222270|P4|Overall Study|Lost to Follow-up|0
5283138|NCT00535288|18222271|P3|Overall Study|Lost to Follow-up|0
5283139|NCT00535288|18222272|P2|Overall Study|Lost to Follow-up|3
5283140|NCT00535288|18222273|P1|Overall Study|Lost to Follow-up|0
5283141|NCT00535288|18222269|P5|Overall Study|Adverse Event|30
5283142|NCT00535288|18222270|P4|Overall Study|Adverse Event|20
5283143|NCT00535288|18222271|P3|Overall Study|Adverse Event|25
5283144|NCT00535288|18222272|P2|Overall Study|Adverse Event|19
5283145|NCT00535288|18222273|P1|Overall Study|Adverse Event|20
5283146|NCT00535262|18222350|P1|Overall Study|No funding|3
5283147|NCT00535236|18222364|P10|Overall Study|Withdrawal by Subject|2
5283148|NCT00535236|18222365|P9|Overall Study|Withdrawal by Subject|4
5283149|NCT00535236|18222366|P8|Overall Study|Withdrawal by Subject|0
5283150|NCT00535236|18222367|P7|Overall Study|Withdrawal by Subject|5
5283151|NCT00535236|18222368|P6|Overall Study|Withdrawal by Subject|1
5283152|NCT00535236|18222369|P5|Overall Study|Withdrawal by Subject|6
5283153|NCT00535236|18222370|P4|Overall Study|Withdrawal by Subject|1
5283154|NCT00535236|18222371|P3|Overall Study|Withdrawal by Subject|2
5283155|NCT00535236|18222372|P2|Overall Study|Withdrawal by Subject|0
5283156|NCT00535236|18222373|P1|Overall Study|Withdrawal by Subject|3
5283157|NCT00535236|18222364|P10|Overall Study|Protocol Violation|0
5283158|NCT00535236|18222365|P9|Overall Study|Protocol Violation|1
5283159|NCT00535236|18222366|P8|Overall Study|Protocol Violation|0
5283160|NCT00535236|18222367|P7|Overall Study|Protocol Violation|0
5283161|NCT00535236|18222368|P6|Overall Study|Protocol Violation|0
5283162|NCT00535236|18222369|P5|Overall Study|Protocol Violation|0
5283163|NCT00535236|18222370|P4|Overall Study|Protocol Violation|0
5283164|NCT00535236|18222371|P3|Overall Study|Protocol Violation|1
5283165|NCT00535236|18222372|P2|Overall Study|Protocol Violation|0
5283166|NCT00535236|18222373|P1|Overall Study|Protocol Violation|2
5283167|NCT00535236|18222364|P10|Overall Study|Physician Decision|0
5283168|NCT00535236|18222365|P9|Overall Study|Physician Decision|0
5283169|NCT00535236|18222366|P8|Overall Study|Physician Decision|0
5283170|NCT00535236|18222367|P7|Overall Study|Physician Decision|1
5283171|NCT00535236|18222368|P6|Overall Study|Physician Decision|0
5283172|NCT00535236|18222369|P5|Overall Study|Physician Decision|1
5283173|NCT00535236|18222370|P4|Overall Study|Physician Decision|0
5283174|NCT00535236|18222371|P3|Overall Study|Physician Decision|0
5283175|NCT00535236|18222372|P2|Overall Study|Physician Decision|0
5283176|NCT00535236|18222373|P1|Overall Study|Physician Decision|0
5283177|NCT00535236|18222364|P10|Overall Study|Lost to Follow-up|1
5283178|NCT00535236|18222365|P9|Overall Study|Lost to Follow-up|6
5283179|NCT00535236|18222366|P8|Overall Study|Lost to Follow-up|0
5283180|NCT00535236|18222367|P7|Overall Study|Lost to Follow-up|0
5283181|NCT00535236|18222368|P6|Overall Study|Lost to Follow-up|0
5283182|NCT00535236|18222369|P5|Overall Study|Lost to Follow-up|2
5283183|NCT00535236|18222370|P4|Overall Study|Lost to Follow-up|0
5283184|NCT00535236|18222371|P3|Overall Study|Lost to Follow-up|0
5283185|NCT00535236|18222372|P2|Overall Study|Lost to Follow-up|2
5283186|NCT00535236|18222373|P1|Overall Study|Lost to Follow-up|1
5283187|NCT00535236|18222364|P10|Overall Study|Adverse Event|1
5283188|NCT00535236|18222365|P9|Overall Study|Adverse Event|2
5283189|NCT00535236|18222366|P8|Overall Study|Adverse Event|1
5283190|NCT00535236|18222367|P7|Overall Study|Adverse Event|5
5283191|NCT00535236|18222368|P6|Overall Study|Adverse Event|0
5283192|NCT00535236|18222369|P5|Overall Study|Adverse Event|3
5283193|NCT00535236|18222370|P4|Overall Study|Adverse Event|3
5283194|NCT00535236|18222371|P3|Overall Study|Adverse Event|9
5283195|NCT00535236|18222372|P2|Overall Study|Adverse Event|0
5283196|NCT00535236|18222373|P1|Overall Study|Adverse Event|1
5283197|NCT00535223|18222433|P2|Overall Study|Withdrawal by Subject|1
5283198|NCT00535223|18222434|P1|Overall Study|Withdrawal by Subject|4
5283199|NCT00535145|18222442|P1|Phase II|Subject non-compliance|2
5283200|NCT00535145|18222442|P1|Phase II|Withdrawal by Subject|5
5283201|NCT00535145|18222442|P1|Phase II|Lost to Follow-up|5
5283202|NCT00535145|18222442|P1|Phase II|Lack of Efficacy|1
5283203|NCT00535145|18222442|P1|Phase II|Adverse Event|2
5283204|NCT00535145|18222442|P1|Phase I|(diagnosis)|3
5283205|NCT00535145|18222442|P1|Phase I|(PI decision)|1
5283206|NCT00535145|18222442|P1|Phase I|(protocol violation)|1
5283207|NCT00535145|18222442|P1|Phase I|(eligibility)|8
5283208|NCT00535145|18222442|P1|Phase I|Withdrawal by Subject|6
5283209|NCT00535145|18222442|P1|Phase I|Lost to Follow-up|7
5283210|NCT00535145|18222442|P1|Phase I|Adverse Event|3
5283211|NCT00535132|18222454|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
5283212|NCT00535132|18222455|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
5283213|NCT00535132|18222454|P2|Safety Analysis Set|Did Not Receive Study Medication|2
5283214|NCT00535132|18222455|P1|Safety Analysis Set|Did Not Receive Study Medication|2
5283215|NCT00534976|18222536|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
5283216|NCT00534976|18222537|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
5283217|NCT00534976|18222536|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
5283218|NCT00534976|18222537|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
5283219|NCT00534976|18222536|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
5283220|NCT00534976|18222537|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
5283221|NCT00534638|18222617|P2|Overall Study|Other|902
5283222|NCT00534638|18222618|P1|Overall Study|Other|1685
5283223|NCT00534638|18222617|P2|Overall Study|Lost to follow-up, complete vaccination|10757
5283224|NCT00534638|18222618|P1|Overall Study|Lost to follow-up, complete vaccination|4707
5283225|NCT00534638|18222617|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
5283226|NCT00534638|18222618|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
5283227|NCT00534638|18222617|P2|Overall Study|Migrated/moved from study area|11
5283228|NCT00534638|18222618|P1|Overall Study|Migrated/moved from study area|13
5283229|NCT00534638|18222617|P2|Overall Study|Withdrawal by Subject|4
5283230|NCT00534638|18222618|P1|Overall Study|Withdrawal by Subject|3
5283231|NCT00534599|18222656|P2|Overall Study|Other|0
5283232|NCT00534599|18222657|P1|Overall Study|Other|7
5283233|NCT00534599|18222656|P2|Overall Study|Withdrawal by Subject|6
5283234|NCT00534599|18222657|P1|Overall Study|Withdrawal by Subject|4
5283235|NCT00534599|18222656|P2|Overall Study|Lost to Follow-up|14
5283236|NCT00534599|18222657|P1|Overall Study|Lost to Follow-up|11
5283237|NCT00534599|18222656|P2|Overall Study|Protocol Violation|3
5283238|NCT00534599|18222657|P1|Overall Study|Protocol Violation|1
5283239|NCT00534599|18222656|P2|Overall Study|Generalized anxiety disorder worsened|1
5283240|NCT00534599|18222657|P1|Overall Study|Generalized anxiety disorder worsened|0
5283241|NCT00534599|18222656|P2|Overall Study|Lack of Efficacy|1
5283242|NCT00534599|18222657|P1|Overall Study|Lack of Efficacy|0
5283243|NCT00534599|18222656|P2|Overall Study|Developed study-specific d/c criteria|0
5283244|NCT00534599|18222657|P1|Overall Study|Developed study-specific d/c criteria|5
5283245|NCT00534599|18222656|P2|Overall Study|Mis-randomization|2
5283246|NCT00534599|18222657|P1|Overall Study|Mis-randomization|2
5283247|NCT00534599|18222656|P2|Overall Study|Incorrect enrollment|1
5283248|NCT00534599|18222657|P1|Overall Study|Incorrect enrollment|2
5283249|NCT00534599|18222656|P2|Overall Study|Adverse Event|4
5283250|NCT00534599|18222657|P1|Overall Study|Adverse Event|25
5283251|NCT00534495|18222693|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
5283252|NCT00534495|18222694|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
5283253|NCT00534495|18222695|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
5283254|NCT00534495|18222693|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
5283255|NCT00534495|18222694|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
5283256|NCT00534495|18222695|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
5283257|NCT00534495|18222693|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
5283258|NCT00534495|18222694|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
5283259|NCT00534495|18222695|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
5283260|NCT00534495|18222693|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
5283261|NCT00534495|18222694|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
5283262|NCT00534495|18222695|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
5283263|NCT00534495|18222693|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
5283264|NCT00534495|18222694|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
5283265|NCT00534495|18222695|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
5283266|NCT00534495|18222693|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
5283267|NCT00534495|18222694|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
5283268|NCT00534495|18222695|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
5283269|NCT00534495|18222693|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
5283270|NCT00534495|18222694|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
5283271|NCT00534495|18222695|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
5283272|NCT00534495|18222693|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
5283273|NCT00534495|18222694|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
5283274|NCT00534495|18222695|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
5283275|NCT00534495|18222693|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
5283276|NCT00534495|18222694|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
5283277|NCT00534495|18222695|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
5283278|NCT00534404|18222733|P3|Overall Study|Lost to Follow-up|201
5283279|NCT00534404|18222734|P2|Overall Study|Lost to Follow-up|138
5283280|NCT00534404|18222735|P1|Overall Study|Lost to Follow-up|170
5283281|NCT00534404|18222733|P3|Overall Study|Removed by study staff|1
5283282|NCT00534404|18222734|P2|Overall Study|Removed by study staff|3
5283283|NCT00534404|18222735|P1|Overall Study|Removed by study staff|2
5283284|NCT00534404|18222733|P3|Overall Study|Withdrawal by Subject|38
5283285|NCT00534404|18222734|P2|Overall Study|Withdrawal by Subject|2
5283286|NCT00534404|18222735|P1|Overall Study|Withdrawal by Subject|8
5283287|NCT00534404|18222733|P3|Overall Study|Death|2
5283288|NCT00534404|18222734|P2|Overall Study|Death|0
5283289|NCT00534404|18222735|P1|Overall Study|Death|0
5283290|NCT00534352|18222766|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
5283291|NCT00534352|18222766|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
5283292|NCT00534352|18222766|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
5283293|NCT00534352|18222766|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
5283294|NCT00534352|18222766|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
5283295|NCT00534352|18222766|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
5283296|NCT00534313|18222810|P4|Long-term Period|Other|2
5283297|NCT00534313|18222811|P3|Long-term Period|Other|2
5283298|NCT00534313|18222812|P2|Long-term Period|Other|2
5283299|NCT00534313|18222813|P1|Long-term Period|Other|1
5283300|NCT00534313|18222810|P4|Long-term Period|Administrative reason by sponsor|18
5283301|NCT00534313|18222811|P3|Long-term Period|Administrative reason by sponsor|26
5283302|NCT00534313|18222812|P2|Long-term Period|Administrative reason by sponsor|15
5283303|NCT00534313|18222813|P1|Long-term Period|Administrative reason by sponsor|17
5283304|NCT00534313|18222810|P4|Long-term Period|Poor compliance/noncompliance|0
5283305|NCT00534313|18222811|P3|Long-term Period|Poor compliance/noncompliance|1
5283306|NCT00534313|18222812|P2|Long-term Period|Poor compliance/noncompliance|1
5283307|NCT00534313|18222813|P1|Long-term Period|Poor compliance/noncompliance|0
5283308|NCT00534313|18222810|P4|Long-term Period|No longer meets study criteria|0
5283309|NCT00534313|18222811|P3|Long-term Period|No longer meets study criteria|0
5283310|NCT00534313|18222812|P2|Long-term Period|No longer meets study criteria|1
5283311|NCT00534313|18222813|P1|Long-term Period|No longer meets study criteria|0
5283312|NCT00534313|18222810|P4|Long-term Period|Withdrawal by Subject|0
5283313|NCT00534313|18222811|P3|Long-term Period|Withdrawal by Subject|0
5283314|NCT00534313|18222812|P2|Long-term Period|Withdrawal by Subject|2
5283315|NCT00534313|18222813|P1|Long-term Period|Withdrawal by Subject|2
5283316|NCT00534313|18222810|P4|Long-term Period|Lost to Follow-up|0
5283317|NCT00534313|18222811|P3|Long-term Period|Lost to Follow-up|0
5283318|NCT00534313|18222812|P2|Long-term Period|Lost to Follow-up|2
5283319|NCT00534313|18222813|P1|Long-term Period|Lost to Follow-up|1
5283320|NCT00534313|18222810|P4|Long-term Period|Lack of Efficacy|12
5283321|NCT00534313|18222811|P3|Long-term Period|Lack of Efficacy|14
5283322|NCT00534313|18222812|P2|Long-term Period|Lack of Efficacy|10
5283323|NCT00534313|18222813|P1|Long-term Period|Lack of Efficacy|14
5283324|NCT00534313|18222810|P4|Long-term Period|Adverse Event|1
5283325|NCT00534313|18222811|P3|Long-term Period|Adverse Event|0
5283326|NCT00534313|18222812|P2|Long-term Period|Adverse Event|1
5283327|NCT00534313|18222813|P1|Long-term Period|Adverse Event|2
5283328|NCT00534313|18222810|P4|Short-term Period|Pregnancy|0
5283329|NCT00534313|18222811|P3|Short-term Period|Pregnancy|1
5283330|NCT00534313|18222812|P2|Short-term Period|Pregnancy|0
5283331|NCT00534313|18222813|P1|Short-term Period|Pregnancy|0
5283332|NCT00534313|18222810|P4|Short-term Period|Participant withdrew consent|2
5283333|NCT00534313|18222811|P3|Short-term Period|Participant withdrew consent|0
5283334|NCT00534313|18222812|P2|Short-term Period|Participant withdrew consent|0
5283335|NCT00534313|18222813|P1|Short-term Period|Participant withdrew consent|2
5283336|NCT00534313|18222810|P4|Short-term Period|Participant not meeting study criteria|1
5283337|NCT00534313|18222811|P3|Short-term Period|Participant not meeting study criteria|0
5283338|NCT00534313|18222812|P2|Short-term Period|Participant not meeting study criteria|0
5283339|NCT00534313|18222813|P1|Short-term Period|Participant not meeting study criteria|0
5283340|NCT00534313|18222810|P4|Short-term Period|Lack of Efficacy|3
5283341|NCT00534313|18222811|P3|Short-term Period|Lack of Efficacy|0
5283342|NCT00534313|18222812|P2|Short-term Period|Lack of Efficacy|4
5283343|NCT00534313|18222813|P1|Short-term Period|Lack of Efficacy|3
5283344|NCT00534313|18222810|P4|Short-term Period|Adverse Event|3
5283345|NCT00534313|18222811|P3|Short-term Period|Adverse Event|1
5283346|NCT00534313|18222812|P2|Short-term Period|Adverse Event|2
5283347|NCT00534313|18222813|P1|Short-term Period|Adverse Event|1
5283348|NCT00534248|18222908|P2|Overall Study|Withdrawal by Subject|255
5283349|NCT00534248|18222909|P1|Overall Study|Withdrawal by Subject|263
5283350|NCT00534248|18222908|P2|Overall Study|Protocol Violation|4
5283351|NCT00534248|18222909|P1|Overall Study|Protocol Violation|3
5283352|NCT00534248|18222908|P2|Overall Study|Physician Decision|7
5283353|NCT00534248|18222909|P1|Overall Study|Physician Decision|10
5283354|NCT00534248|18222908|P2|Overall Study|Other protocol specified criteria|3
5283355|NCT00534248|18222909|P1|Overall Study|Other protocol specified criteria|13
5283356|NCT00534248|18222908|P2|Overall Study|Lost to Follow-up|375
5283357|NCT00534248|18222909|P1|Overall Study|Lost to Follow-up|353
5283358|NCT00534248|18222908|P2|Overall Study|Adverse Event|29
5283359|NCT00534248|18222909|P1|Overall Study|Adverse Event|19
5283360|NCT00534105|18223079|P2|Overall Study|Lost to Follow-up|39
5283361|NCT00534105|18223080|P1|Overall Study|Lost to Follow-up|23
5283362|NCT00534092|18223094|P2|Overall Study|personal reasons/family concerns|0
5283363|NCT00534092|18223095|P1|Overall Study|personal reasons/family concerns|1
5283364|NCT00534092|18223094|P2|Overall Study|Lost to Follow-up|0
5283365|NCT00534092|18223095|P1|Overall Study|Lost to Follow-up|1
5283366|NCT00533949|18223133|P4|Overall Study|Withdrawal by Subject|1
5283367|NCT00533949|18223134|P3|Overall Study|Withdrawal by Subject|1
5283368|NCT00533949|18223135|P2|Overall Study|Withdrawal by Subject|2
5283369|NCT00533949|18223136|P1|Overall Study|Withdrawal by Subject|3
5283370|NCT00533949|18223133|P4|Overall Study|Protocol Violation|9
5283371|NCT00533949|18223134|P3|Overall Study|Protocol Violation|9
5283372|NCT00533949|18223135|P2|Overall Study|Protocol Violation|12
5283373|NCT00533949|18223136|P1|Overall Study|Protocol Violation|12
5283374|NCT00533897|18223177|P8|Long Term Extension (LTE)|Other|6
5283375|NCT00533897|18223178|P7|Long Term Extension (LTE)|Other|1
5283376|NCT00533897|18223179|P6|Long Term Extension (LTE)|Other|0
5283377|NCT00533897|18223180|P5|Long Term Extension (LTE)|Other|0
5283378|NCT00533897|18223181|P4|Long Term Extension (LTE)|Other|0
5283379|NCT00533897|18223182|P3|Long Term Extension (LTE)|Other|0
5283380|NCT00533897|18223183|P2|Long Term Extension (LTE)|Other|0
5283381|NCT00533897|18223184|P1|Long Term Extension (LTE)|Other|0
5283382|NCT00533897|18223177|P8|Long Term Extension (LTE)|Lost to Follow-up|1
5283383|NCT00533897|18223178|P7|Long Term Extension (LTE)|Lost to Follow-up|1
5283384|NCT00533897|18223179|P6|Long Term Extension (LTE)|Lost to Follow-up|0
5283385|NCT00533897|18223180|P5|Long Term Extension (LTE)|Lost to Follow-up|0
5283386|NCT00533897|18223181|P4|Long Term Extension (LTE)|Lost to Follow-up|0
5283387|NCT00533897|18223182|P3|Long Term Extension (LTE)|Lost to Follow-up|0
5283388|NCT00533897|18223183|P2|Long Term Extension (LTE)|Lost to Follow-up|0
5283389|NCT00533897|18223184|P1|Long Term Extension (LTE)|Lost to Follow-up|0
5283390|NCT00533897|18223177|P8|Long Term Extension (LTE)|Pregnancy|2
5283391|NCT00533897|18223178|P7|Long Term Extension (LTE)|Pregnancy|0
5283392|NCT00533897|18223179|P6|Long Term Extension (LTE)|Pregnancy|0
5283393|NCT00533897|18223180|P5|Long Term Extension (LTE)|Pregnancy|0
5283394|NCT00533897|18223181|P4|Long Term Extension (LTE)|Pregnancy|0
5283395|NCT00533897|18223182|P3|Long Term Extension (LTE)|Pregnancy|0
5283396|NCT00533897|18223183|P2|Long Term Extension (LTE)|Pregnancy|0
5283397|NCT00533897|18223184|P1|Long Term Extension (LTE)|Pregnancy|0
5283398|NCT00533897|18223177|P8|Long Term Extension (LTE)|Adverse Event|5
5283399|NCT00533897|18223178|P7|Long Term Extension (LTE)|Adverse Event|2
5283400|NCT00533897|18223179|P6|Long Term Extension (LTE)|Adverse Event|0
5283401|NCT00533897|18223180|P5|Long Term Extension (LTE)|Adverse Event|0
5283402|NCT00533897|18223181|P4|Long Term Extension (LTE)|Adverse Event|0
5283403|NCT00533897|18223182|P3|Long Term Extension (LTE)|Adverse Event|0
5283404|NCT00533897|18223183|P2|Long Term Extension (LTE)|Adverse Event|0
5283405|NCT00533897|18223184|P1|Long Term Extension (LTE)|Adverse Event|0
5283406|NCT00533897|18223177|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
5283407|NCT00533897|18223178|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
5283408|NCT00533897|18223179|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
5283409|NCT00533897|18223180|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
5283410|NCT00533897|18223181|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
5283411|NCT00533897|18223182|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
5283412|NCT00533897|18223183|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
5283413|NCT00533897|18223184|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
5283414|NCT00533897|18223177|P8|Long Term Extension (LTE)|Lack of Efficacy|3
5283415|NCT00533897|18223178|P7|Long Term Extension (LTE)|Lack of Efficacy|5
5283416|NCT00533897|18223179|P6|Long Term Extension (LTE)|Lack of Efficacy|0
5283417|NCT00533897|18223180|P5|Long Term Extension (LTE)|Lack of Efficacy|0
5283418|NCT00533897|18223181|P4|Long Term Extension (LTE)|Lack of Efficacy|0
5283419|NCT00533897|18223182|P3|Long Term Extension (LTE)|Lack of Efficacy|0
5283420|NCT00533897|18223183|P2|Long Term Extension (LTE)|Lack of Efficacy|0
5283421|NCT00533897|18223184|P1|Long Term Extension (LTE)|Lack of Efficacy|0
5283422|NCT00533897|18223177|P8|Long Term Extension (LTE)|Death|3
5283423|NCT00533897|18223178|P7|Long Term Extension (LTE)|Death|1
5283424|NCT00533897|18223179|P6|Long Term Extension (LTE)|Death|0
5283425|NCT00533897|18223180|P5|Long Term Extension (LTE)|Death|0
5283426|NCT00533897|18223181|P4|Long Term Extension (LTE)|Death|0
5283427|NCT00533897|18223182|P3|Long Term Extension (LTE)|Death|0
5283428|NCT00533897|18223183|P2|Long Term Extension (LTE)|Death|0
5283429|NCT00533897|18223184|P1|Long Term Extension (LTE)|Death|0
5283430|NCT00533897|18223177|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
5283431|NCT00533897|18223178|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
5283432|NCT00533897|18223179|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
5283433|NCT00533897|18223180|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
5283434|NCT00533897|18223181|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
5283435|NCT00533897|18223182|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
5283436|NCT00533897|18223183|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
5283437|NCT00533897|18223184|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
5283438|NCT00533897|18223177|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283439|NCT00533897|18223178|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283440|NCT00533897|18223179|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
5283441|NCT00533897|18223180|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283442|NCT00533897|18223181|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283443|NCT00533897|18223182|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283444|NCT00533897|18223183|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283445|NCT00533897|18223184|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5283446|NCT00533897|18223177|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283447|NCT00533897|18223178|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283448|NCT00533897|18223179|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
5283449|NCT00533897|18223180|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283450|NCT00533897|18223181|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283451|NCT00533897|18223182|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283452|NCT00533897|18223183|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283453|NCT00533897|18223184|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5283454|NCT00533897|18223177|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283455|NCT00533897|18223178|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283456|NCT00533897|18223179|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283457|NCT00533897|18223180|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283458|NCT00533897|18223181|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283459|NCT00533897|18223182|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
5283460|NCT00533897|18223183|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283461|NCT00533897|18223184|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5283462|NCT00533897|18223177|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5283463|NCT00533897|18223178|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5283464|NCT00533897|18223179|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5283465|NCT00533897|18223180|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5283466|NCT00533897|18223181|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5283467|NCT00533897|18223182|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
5283468|NCT00533897|18223183|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
5283469|NCT00533897|18223184|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5283470|NCT00533897|18223177|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283471|NCT00533897|18223178|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283472|NCT00533897|18223179|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283473|NCT00533897|18223180|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283474|NCT00533897|18223181|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283475|NCT00533897|18223182|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283476|NCT00533897|18223183|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5283477|NCT00533897|18223184|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
5283478|NCT00533897|18223177|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
5283479|NCT00533897|18223178|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
5283480|NCT00533897|18223179|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
5283481|NCT00533897|18223180|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
5283482|NCT00533897|18223181|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
5283483|NCT00533897|18223182|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
5283484|NCT00533897|18223183|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
5283485|NCT00533897|18223184|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
5283486|NCT00533897|18223177|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283487|NCT00533897|18223178|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283488|NCT00533897|18223179|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283489|NCT00533897|18223180|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283490|NCT00533897|18223181|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283491|NCT00533897|18223182|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283492|NCT00533897|18223183|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5283493|NCT00533897|18223184|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
5283494|NCT00533897|18223177|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
5283495|NCT00533897|18223178|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
5283496|NCT00533897|18223179|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
5283497|NCT00533897|18223180|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
5283498|NCT00533897|18223181|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
5283499|NCT00533897|18223182|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
5283500|NCT00533897|18223183|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
5283501|NCT00533897|18223184|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
5283502|NCT00533897|18223177|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283503|NCT00533897|18223178|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283504|NCT00533897|18223179|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283505|NCT00533897|18223180|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283506|NCT00533897|18223181|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283507|NCT00533897|18223182|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283508|NCT00533897|18223183|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5283509|NCT00533897|18223184|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
5283510|NCT00533897|18223177|P8|Lead-in (LI) Period 1|Adverse Event|0
5283511|NCT00533897|18223178|P7|Lead-in (LI) Period 1|Adverse Event|0
5283512|NCT00533897|18223179|P6|Lead-in (LI) Period 1|Adverse Event|0
5283513|NCT00533897|18223180|P5|Lead-in (LI) Period 1|Adverse Event|0
5283514|NCT00533897|18223181|P4|Lead-in (LI) Period 1|Adverse Event|0
5283515|NCT00533897|18223182|P3|Lead-in (LI) Period 1|Adverse Event|0
5283516|NCT00533897|18223183|P2|Lead-in (LI) Period 1|Adverse Event|0
5283517|NCT00533897|18223184|P1|Lead-in (LI) Period 1|Adverse Event|1
5283518|NCT00533845|18223324|P2|Overall Study|Physician Decision|0
5283519|NCT00533845|18223325|P1|Overall Study|Physician Decision|1
5283520|NCT00533702|18223333|P2|Overall Study|Found ineligible after randomization|1
5283521|NCT00533702|18223334|P1|Overall Study|Found ineligible after randomization|2
5283522|NCT00533702|18223333|P2|Overall Study|Withdrawal by Subject|1
5283523|NCT00533702|18223334|P1|Overall Study|Withdrawal by Subject|3
5283524|NCT00533507|18223365|P1|Overall Study|Withdrawal by Subject|1
5283525|NCT00533273|18223410|P2|Open-label|Withdrawal by Subject|0
5283526|NCT00533273|18223411|P1|Open-label|Withdrawal by Subject|6
5283527|NCT00533273|18223410|P2|Double-blind|Withdrew consent|2
5283528|NCT00533273|18223411|P1|Double-blind|Withdrew consent|0
5283529|NCT00532948|18223462|P3|Overall Study|Failure to return|0
5283530|NCT00532948|18223463|P2|Overall Study|Failure to return|1
5283531|NCT00532948|18223464|P1|Overall Study|Failure to return|0
5283532|NCT00532948|18223462|P3|Overall Study|Violation of selection criteria at entry|0
5283533|NCT00532948|18223463|P2|Overall Study|Violation of selection criteria at entry|1
5283534|NCT00532948|18223464|P1|Overall Study|Violation of selection criteria at entry|0
5283535|NCT00532948|18223462|P3|Overall Study|Death|4
5283536|NCT00532948|18223463|P2|Overall Study|Death|3
5283537|NCT00532948|18223464|P1|Overall Study|Death|3
5283538|NCT00532948|18223462|P3|Overall Study|Protocol Violation|0
5283539|NCT00532948|18223463|P2|Overall Study|Protocol Violation|0
5283540|NCT00532948|18223464|P1|Overall Study|Protocol Violation|1
5283541|NCT00532935|18223496|P2|Overall Study|Protocol Specific Criteria|15
5283542|NCT00532935|18223497|P1|Overall Study|Protocol Specific Criteria|11
5283543|NCT00532935|18223496|P2|Overall Study|Withdrawal by Subject|9
5283544|NCT00532935|18223497|P1|Overall Study|Withdrawal by Subject|10
5283545|NCT00532935|18223496|P2|Overall Study|Protocol Violation|2
5283546|NCT00532935|18223497|P1|Overall Study|Protocol Violation|4
5283547|NCT00532935|18223496|P2|Overall Study|Pregnancy|0
5283548|NCT00532935|18223497|P1|Overall Study|Pregnancy|1
5283549|NCT00532935|18223496|P2|Overall Study|Physician Decision|5
5283550|NCT00532935|18223497|P1|Overall Study|Physician Decision|4
5283551|NCT00532935|18223496|P2|Overall Study|Lost to Follow-up|6
5283552|NCT00532935|18223497|P1|Overall Study|Lost to Follow-up|10
5283553|NCT00532935|18223496|P2|Overall Study|Lack of Efficacy|3
5283554|NCT00532935|18223497|P1|Overall Study|Lack of Efficacy|0
5283555|NCT00532935|18223496|P2|Overall Study|Adverse Event|12
5283556|NCT00532935|18223497|P1|Overall Study|Adverse Event|11
5283557|NCT00532883|18223515|P4|Overall Study|Early Study Termination|4
5283558|NCT00532883|18223516|P3|Overall Study|Early Study Termination|1
5283559|NCT00532883|18223517|P2|Overall Study|Early Study Termination|4
5283560|NCT00532883|18223518|P1|Overall Study|Early Study Termination|4
5283561|NCT00532883|18223515|P4|Overall Study|Subject was Nonadherent|0
5283562|NCT00532883|18223516|P3|Overall Study|Subject was Nonadherent|1
5283563|NCT00532883|18223517|P2|Overall Study|Subject was Nonadherent|1
5283564|NCT00532883|18223518|P1|Overall Study|Subject was Nonadherent|0
5283565|NCT00532883|18223515|P4|Overall Study|Withdrawal by Subject|0
5283566|NCT00532883|18223516|P3|Overall Study|Withdrawal by Subject|1
5283567|NCT00532883|18223517|P2|Overall Study|Withdrawal by Subject|1
5283568|NCT00532883|18223518|P1|Overall Study|Withdrawal by Subject|0
5283569|NCT00532883|18223515|P4|Overall Study|Lost to Follow-up|0
5283570|NCT00532883|18223516|P3|Overall Study|Lost to Follow-up|1
5283571|NCT00532883|18223517|P2|Overall Study|Lost to Follow-up|1
5283572|NCT00532883|18223518|P1|Overall Study|Lost to Follow-up|1
5283573|NCT00532883|18223515|P4|Overall Study|Adverse Event|1
5283574|NCT00532883|18223516|P3|Overall Study|Adverse Event|0
5283575|NCT00532883|18223517|P2|Overall Study|Adverse Event|0
5283576|NCT00532883|18223518|P1|Overall Study|Adverse Event|1
5283577|NCT00532779|18223531|P3|Overall Study|Drug noncompliance, moved, other|29
5283578|NCT00532779|18223532|P2|Overall Study|Drug noncompliance, moved, other|23
5283579|NCT00532779|18223533|P1|Overall Study|Drug noncompliance, moved, other|14
5283580|NCT00532779|18223531|P3|Overall Study|Death|0
5283581|NCT00532779|18223532|P2|Overall Study|Death|1
5283582|NCT00532779|18223533|P1|Overall Study|Death|0
5283583|NCT00532779|18223531|P3|Overall Study|Pregnancy|3
5283584|NCT00532779|18223532|P2|Overall Study|Pregnancy|5
5283585|NCT00532779|18223533|P1|Overall Study|Pregnancy|2
5283586|NCT00532779|18223531|P3|Overall Study|Protocol Violation|7
5283587|NCT00532779|18223532|P2|Overall Study|Protocol Violation|9
5283588|NCT00532779|18223533|P1|Overall Study|Protocol Violation|5
5283589|NCT00532779|18223531|P3|Overall Study|Lack of Efficacy|40
5283590|NCT00532779|18223532|P2|Overall Study|Lack of Efficacy|12
5283591|NCT00532779|18223533|P1|Overall Study|Lack of Efficacy|12
5283592|NCT00532779|18223531|P3|Overall Study|Withdrawal by Subject|90
5283593|NCT00532779|18223532|P2|Overall Study|Withdrawal by Subject|60
5283594|NCT00532779|18223533|P1|Overall Study|Withdrawal by Subject|63
5283595|NCT00532779|18223531|P3|Overall Study|Lost to Follow-up|66
5283596|NCT00532779|18223532|P2|Overall Study|Lost to Follow-up|65
5283597|NCT00532779|18223533|P1|Overall Study|Lost to Follow-up|76
5283598|NCT00532779|18223531|P3|Overall Study|Adverse Event|56
5283599|NCT00532779|18223532|P2|Overall Study|Adverse Event|112
5283600|NCT00532779|18223533|P1|Overall Study|Adverse Event|122
5283601|NCT00532493|18223594|P2|Overall Study|Contraindicative Medication|0
5283602|NCT00532493|18223595|P1|Overall Study|Contraindicative Medication|1
5283603|NCT00532493|18223594|P2|Overall Study|Subject Moved Away|1
5283604|NCT00532493|18223595|P1|Overall Study|Subject Moved Away|3
5283605|NCT00532493|18223594|P2|Overall Study|Protocol Deviation|0
5283606|NCT00532493|18223595|P1|Overall Study|Protocol Deviation|1
5283607|NCT00532493|18223594|P2|Overall Study|Adverse Event|5
5283608|NCT00532493|18223595|P1|Overall Study|Adverse Event|6
5283609|NCT00532493|18223594|P2|Overall Study|Physician Decision|6
5283610|NCT00532493|18223595|P1|Overall Study|Physician Decision|1
5283611|NCT00532493|18223594|P2|Overall Study|Withdrawal by Subject|9
5283612|NCT00532493|18223595|P1|Overall Study|Withdrawal by Subject|7
5283613|NCT00532493|18223594|P2|Overall Study|Lost to Follow-up|7
5283614|NCT00532493|18223595|P1|Overall Study|Lost to Follow-up|10
5283615|NCT00532493|18223594|P2|Overall Study|Death|1
5283616|NCT00532493|18223595|P1|Overall Study|Death|1
5283617|NCT00532441|18223629|P2|Overall Study|Death|0
5283618|NCT00532441|18223630|P1|Overall Study|Death|1
5283619|NCT00532298|18223645|P6|Overall Study|Lost to Follow-up|1
5283620|NCT00532298|18223646|P5|Overall Study|Lost to Follow-up|0
5283621|NCT00532298|18223647|P4|Overall Study|Lost to Follow-up|0
5283622|NCT00532298|18223648|P3|Overall Study|Lost to Follow-up|1
5283623|NCT00532298|18223649|P2|Overall Study|Lost to Follow-up|1
5283624|NCT00532298|18223650|P1|Overall Study|Lost to Follow-up|1
5283625|NCT00532298|18223645|P6|Overall Study|Adverse Event|1
5283626|NCT00532298|18223646|P5|Overall Study|Adverse Event|1
5283627|NCT00532298|18223647|P4|Overall Study|Adverse Event|0
5283628|NCT00532298|18223648|P3|Overall Study|Adverse Event|0
5283629|NCT00532298|18223649|P2|Overall Study|Adverse Event|0
5283630|NCT00532298|18223650|P1|Overall Study|Adverse Event|1
5283631|NCT00532259|18223730|P1|Overall Study|Protocol Violation|1
5283632|NCT00532259|18223730|P1|Overall Study|Physician Decision|3
5283633|NCT00532259|18223730|P1|Overall Study|Lost to Follow-up|3
5283634|NCT00532259|18223730|P1|Overall Study|Lack of Efficacy|21
5283635|NCT00532259|18223730|P1|Overall Study|Death|1
5283636|NCT00532259|18223730|P1|Overall Study|Adverse Event|1
5283637|NCT00532259|18223730|P1|Overall Study|Withdrawal by Subject|2
5283638|NCT00532155|18223737|P2|Overall Study|Did not receive study medication|6
5283639|NCT00532155|18223738|P1|Overall Study|Did not receive study medication|2
5283640|NCT00532155|18223737|P2|Overall Study|Study termination stop further treatment|0
5283641|NCT00532155|18223738|P1|Overall Study|Study termination stop further treatment|4
5283642|NCT00532155|18223737|P2|Overall Study|Study terminated by sponsor|0
5283643|NCT00532155|18223738|P1|Overall Study|Study terminated by sponsor|1
5283644|NCT00532155|18223737|P2|Overall Study|Study stopped|0
5283645|NCT00532155|18223738|P1|Overall Study|Study stopped|1
5283646|NCT00532155|18223737|P2|Overall Study|Had brain metastasis, was mis-randomized|0
5283647|NCT00532155|18223738|P1|Overall Study|Had brain metastasis, was mis-randomized|1
5283648|NCT00532155|18223737|P2|Overall Study|Progressive disease (by incorrect scan)|1
5283649|NCT00532155|18223738|P1|Overall Study|Progressive disease (by incorrect scan)|0
5283650|NCT00532155|18223737|P2|Overall Study|Promotor ended study|0
5283651|NCT00532155|18223738|P1|Overall Study|Promotor ended study|1
5283652|NCT00532155|18223737|P2|Overall Study|Occurence of a secondary cancer|1
5283653|NCT00532155|18223738|P1|Overall Study|Occurence of a secondary cancer|0
5283654|NCT00532155|18223737|P2|Overall Study|Occurence of a second cancer|1
5283655|NCT00532155|18223738|P1|Overall Study|Occurence of a second cancer|0
5283656|NCT00532155|18223737|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
5283657|NCT00532155|18223738|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
5283658|NCT00532155|18223737|P2|Overall Study|Moved|0
5283659|NCT00532155|18223738|P1|Overall Study|Moved|1
5283660|NCT00532155|18223737|P2|Overall Study|Consent withdrawn|7
5283661|NCT00532155|18223738|P1|Overall Study|Consent withdrawn|5
5283662|NCT00532155|18223737|P2|Overall Study|Withdrawal by Subject|44
5283663|NCT00532155|18223738|P1|Overall Study|Withdrawal by Subject|23
5283664|NCT00532155|18223737|P2|Overall Study|Physician Decision|15
5283665|NCT00532155|18223738|P1|Overall Study|Physician Decision|16
5283666|NCT00532155|18223737|P2|Overall Study|Lost to Follow-up|0
5283667|NCT00532155|18223738|P1|Overall Study|Lost to Follow-up|2
5283668|NCT00532155|18223737|P2|Overall Study|Protocol Violation|3
5283669|NCT00532155|18223738|P1|Overall Study|Protocol Violation|1
5283670|NCT00532155|18223737|P2|Overall Study|Lack of Efficacy|255
5283671|NCT00532155|18223738|P1|Overall Study|Lack of Efficacy|332
5283672|NCT00532155|18223737|P2|Overall Study|Adverse Event|123
5283673|NCT00532155|18223738|P1|Overall Study|Adverse Event|66
5283674|NCT00532129|18223752|P1|Follow-up Period|Other|6
5283675|NCT00532129|18223752|P1|Follow-up Period|Lost to Follow-up|1
5283676|NCT00532129|18223752|P1|Follow-up Period|Disease progression|57
5283677|NCT00532129|18223752|P1|Follow-up Period|Adverse event/Serious adverse event|1
5283678|NCT00532129|18223752|P1|Treatment Period|Other|5
5283679|NCT00532129|18223752|P1|Treatment Period|Protocol Violation|1
5283680|NCT00532129|18223752|P1|Treatment Period|Disease progression|3
5283681|NCT00532129|18223752|P1|Treatment Period|Physician Decision|15
5283682|NCT00532129|18223752|P1|Treatment Period|Adverse event/Serious adverse event|25
5283683|NCT00531960|18223772|P2|Overall Study|Other|10
5283684|NCT00531960|18223773|P1|Overall Study|Other|4
5283685|NCT00531960|18223772|P2|Overall Study|Refused Treatment|6
5283686|NCT00531960|18223773|P1|Overall Study|Refused Treatment|5
5283687|NCT00531960|18223772|P2|Overall Study|Violation of Selection Criteria|0
5283688|NCT00531960|18223773|P1|Overall Study|Violation of Selection Criteria|2
5283689|NCT00531960|18223772|P2|Overall Study|Lack of Efficacy|41
5283690|NCT00531960|18223773|P1|Overall Study|Lack of Efficacy|42
5283691|NCT00531960|18223772|P2|Overall Study|Death|2
5283692|NCT00531960|18223773|P1|Overall Study|Death|3
5283693|NCT00531960|18223772|P2|Overall Study|Adverse Event|4
5283694|NCT00531960|18223773|P1|Overall Study|Adverse Event|5
5283695|NCT00531947|18223791|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
5283696|NCT00531947|18223792|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
5283697|NCT00531947|18223791|P2|Overall Study|Non-Compliance|7
5283698|NCT00531947|18223792|P1|Overall Study|Non-Compliance|4
5283699|NCT00531947|18223791|P2|Overall Study|Protocol Violation|1
5283700|NCT00531947|18223792|P1|Overall Study|Protocol Violation|2
5283701|NCT00531947|18223791|P2|Overall Study|Withdrawal by Subject|19
5283702|NCT00531947|18223792|P1|Overall Study|Withdrawal by Subject|14
5283703|NCT00531947|18223791|P2|Overall Study|Lost to Follow-up|9
5283704|NCT00531947|18223792|P1|Overall Study|Lost to Follow-up|12
5283705|NCT00531947|18223791|P2|Overall Study|Adverse Event|10
5283706|NCT00531947|18223792|P1|Overall Study|Adverse Event|5
5283707|NCT00531934|18223836|P2|Overall Study|Other|2
5283708|NCT00531934|18223837|P1|Overall Study|Other|2
5283709|NCT00531934|18223836|P2|Overall Study|Withdrawal by Subject|1
5283710|NCT00531934|18223837|P1|Overall Study|Withdrawal by Subject|1
5283711|NCT00531934|18223836|P2|Overall Study|Death|10
5283712|NCT00531934|18223837|P1|Overall Study|Death|7
5283713|NCT00531934|18223836|P2|Overall Study|Progression|42
5283714|NCT00531934|18223837|P1|Overall Study|Progression|52
5283715|NCT00531934|18223836|P2|Overall Study|Adverse Event|8
5283716|NCT00531934|18223837|P1|Overall Study|Adverse Event|4
5283717|NCT00531752|18223965|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
5283718|NCT00531752|18223966|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
5283719|NCT00531752|18223967|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
5283720|NCT00531752|18223968|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
5283721|NCT00531752|18223965|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
5283722|NCT00531752|18223966|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
5283723|NCT00531752|18223967|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
5283724|NCT00531752|18223968|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
5283725|NCT00531752|18223965|P4|Second Double-blind Intervention Period|Other|0
5283726|NCT00531752|18223966|P3|Second Double-blind Intervention Period|Other|0
5283727|NCT00531752|18223967|P2|Second Double-blind Intervention Period|Other|1
5283728|NCT00531752|18223968|P1|Second Double-blind Intervention Period|Other|1
5283729|NCT00531752|18223965|P4|Second Double-blind Intervention Period|Adverse Event|0
5283730|NCT00531752|18223966|P3|Second Double-blind Intervention Period|Adverse Event|0
5283731|NCT00531752|18223967|P2|Second Double-blind Intervention Period|Adverse Event|1
5283732|NCT00531752|18223968|P1|Second Double-blind Intervention Period|Adverse Event|1
5283733|NCT00531752|18223965|P4|First Double-blind Intervention Period|Randomized but not treated|0
5283734|NCT00531752|18223966|P3|First Double-blind Intervention Period|Randomized but not treated|0
5283735|NCT00531752|18223967|P2|First Double-blind Intervention Period|Randomized but not treated|0
5283736|NCT00531752|18223968|P1|First Double-blind Intervention Period|Randomized but not treated|1
5283737|NCT00531752|18223965|P4|First Double-blind Intervention Period|Lost to Follow-up|1
5283738|NCT00531752|18223966|P3|First Double-blind Intervention Period|Lost to Follow-up|1
5283739|NCT00531752|18223967|P2|First Double-blind Intervention Period|Lost to Follow-up|0
5283740|NCT00531752|18223968|P1|First Double-blind Intervention Period|Lost to Follow-up|0
5283741|NCT00531752|18223965|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
5283742|NCT00531752|18223966|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
5283743|NCT00531752|18223967|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
5283744|NCT00531752|18223968|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
5283745|NCT00531752|18223965|P4|First Double-blind Intervention Period|Other|0
5283746|NCT00531752|18223966|P3|First Double-blind Intervention Period|Other|4
5283747|NCT00531752|18223967|P2|First Double-blind Intervention Period|Other|4
5283748|NCT00531752|18223968|P1|First Double-blind Intervention Period|Other|1
5283749|NCT00531752|18223965|P4|First Double-blind Intervention Period|Adverse Event|1
5283750|NCT00531752|18223966|P3|First Double-blind Intervention Period|Adverse Event|1
5283751|NCT00531752|18223967|P2|First Double-blind Intervention Period|Adverse Event|0
5283752|NCT00531752|18223968|P1|First Double-blind Intervention Period|Adverse Event|2
5283753|NCT00531479|18224079|P2|Overall Study|Did not receive treatment|3
5283754|NCT00531479|18224080|P1|Overall Study|Did not receive treatment|2
5283755|NCT00531479|18224079|P2|Overall Study|Withdrawal by Subject|6
5283756|NCT00531479|18224080|P1|Overall Study|Withdrawal by Subject|6
5283757|NCT00531479|18224079|P2|Overall Study|Other|1
5283758|NCT00531479|18224080|P1|Overall Study|Other|0
5283759|NCT00531479|18224079|P2|Overall Study|Lost to Follow-up|2
5283760|NCT00531479|18224080|P1|Overall Study|Lost to Follow-up|0
5283761|NCT00531479|18224079|P2|Overall Study|Death|71
5283762|NCT00531479|18224080|P1|Overall Study|Death|68
5283763|NCT00531427|18224111|P2|Overall Study|Administrative|9
5283764|NCT00531427|18224112|P1|Overall Study|Administrative|4
5283765|NCT00531427|18224111|P2|Overall Study|Lack of Efficacy|39
5283766|NCT00531427|18224112|P1|Overall Study|Lack of Efficacy|14
5283767|NCT00531427|18224111|P2|Overall Study|Lost to Follow-up|3
5283768|NCT00531427|18224112|P1|Overall Study|Lost to Follow-up|4
5283769|NCT00531427|18224111|P2|Overall Study|Adverse Event|30
5283770|NCT00531427|18224112|P1|Overall Study|Adverse Event|44
5283771|NCT00531427|18224111|P2|Overall Study|Withdrawal by Subject|13
5283772|NCT00531427|18224112|P1|Overall Study|Withdrawal by Subject|7
5283773|NCT00531284|18224140|P17|Overall Study|Other|0
5283774|NCT00531284|18224141|P16|Overall Study|Other|0
5283775|NCT00531284|18224142|P15|Overall Study|Other|1
5283776|NCT00531284|18224143|P14|Overall Study|Other|0
5283777|NCT00531284|18224144|P13|Overall Study|Other|0
5283778|NCT00531284|18224145|P12|Overall Study|Other|2
5283779|NCT00531284|18224146|P11|Overall Study|Other|0
5283780|NCT00531284|18224147|P10|Overall Study|Other|1
5283781|NCT00531284|18224148|P9|Overall Study|Other|2
5283782|NCT00531284|18224149|P8|Overall Study|Other|0
5283783|NCT00531284|18224150|P7|Overall Study|Other|0
5283784|NCT00531284|18224151|P6|Overall Study|Other|1
5283785|NCT00531284|18224152|P5|Overall Study|Other|2
5283786|NCT00531284|18224153|P4|Overall Study|Other|10
5283787|NCT00531284|18224154|P3|Overall Study|Other|0
5283788|NCT00531284|18224155|P2|Overall Study|Other|0
5283789|NCT00531284|18224156|P1|Overall Study|Other|1
5283790|NCT00531284|18224140|P17|Overall Study|Withdrawal by Subject|1
5283791|NCT00531284|18224141|P16|Overall Study|Withdrawal by Subject|1
5283792|NCT00531284|18224142|P15|Overall Study|Withdrawal by Subject|0
5283793|NCT00531284|18224143|P14|Overall Study|Withdrawal by Subject|1
5283794|NCT00531284|18224144|P13|Overall Study|Withdrawal by Subject|0
5283795|NCT00531284|18224145|P12|Overall Study|Withdrawal by Subject|3
5283796|NCT00531284|18224146|P11|Overall Study|Withdrawal by Subject|0
5283797|NCT00531284|18224147|P10|Overall Study|Withdrawal by Subject|0
5283798|NCT00531284|18224148|P9|Overall Study|Withdrawal by Subject|0
5283799|NCT00531284|18224149|P8|Overall Study|Withdrawal by Subject|0
5283800|NCT00531284|18224150|P7|Overall Study|Withdrawal by Subject|0
5283801|NCT00531284|18224151|P6|Overall Study|Withdrawal by Subject|0
5283802|NCT00531284|18224152|P5|Overall Study|Withdrawal by Subject|0
5283803|NCT00531284|18224153|P4|Overall Study|Withdrawal by Subject|4
5283804|NCT00531284|18224154|P3|Overall Study|Withdrawal by Subject|0
5283805|NCT00531284|18224155|P2|Overall Study|Withdrawal by Subject|0
5283806|NCT00531284|18224156|P1|Overall Study|Withdrawal by Subject|1
5283807|NCT00531284|18224140|P17|Overall Study|Adverse Event|2
5283808|NCT00531284|18224141|P16|Overall Study|Adverse Event|0
5283809|NCT00531284|18224142|P15|Overall Study|Adverse Event|1
5283810|NCT00531284|18224143|P14|Overall Study|Adverse Event|1
5283811|NCT00531284|18224144|P13|Overall Study|Adverse Event|0
5283812|NCT00531284|18224145|P12|Overall Study|Adverse Event|5
5283813|NCT00531284|18224146|P11|Overall Study|Adverse Event|0
5283814|NCT00531284|18224147|P10|Overall Study|Adverse Event|0
5283815|NCT00531284|18224148|P9|Overall Study|Adverse Event|3
5283816|NCT00531284|18224149|P8|Overall Study|Adverse Event|2
5283817|NCT00531284|18224150|P7|Overall Study|Adverse Event|3
5283818|NCT00531284|18224151|P6|Overall Study|Adverse Event|2
5283819|NCT00531284|18224152|P5|Overall Study|Adverse Event|0
5283820|NCT00531284|18224153|P4|Overall Study|Adverse Event|7
5283821|NCT00531284|18224154|P3|Overall Study|Adverse Event|1
5283822|NCT00531284|18224155|P2|Overall Study|Adverse Event|1
5283823|NCT00531284|18224156|P1|Overall Study|Adverse Event|0
5283824|NCT00531284|18224140|P17|Overall Study|Progressive Disease|5
5283825|NCT00531284|18224141|P16|Overall Study|Progressive Disease|11
5283826|NCT00531284|18224142|P15|Overall Study|Progressive Disease|2
5283827|NCT00531284|18224143|P14|Overall Study|Progressive Disease|1
5283828|NCT00531284|18224144|P13|Overall Study|Progressive Disease|2
5283829|NCT00531284|18224145|P12|Overall Study|Progressive Disease|14
5283830|NCT00531284|18224146|P11|Overall Study|Progressive Disease|3
5283831|NCT00531284|18224147|P10|Overall Study|Progressive Disease|3
5283832|NCT00531284|18224148|P9|Overall Study|Progressive Disease|6
5283833|NCT00531284|18224149|P8|Overall Study|Progressive Disease|8
5283834|NCT00531284|18224150|P7|Overall Study|Progressive Disease|3
5283835|NCT00531284|18224151|P6|Overall Study|Progressive Disease|4
5283836|NCT00531284|18224152|P5|Overall Study|Progressive Disease|4
5283837|NCT00531284|18224153|P4|Overall Study|Progressive Disease|42
5283838|NCT00531284|18224154|P3|Overall Study|Progressive Disease|5
5283839|NCT00531284|18224155|P2|Overall Study|Progressive Disease|3
5283840|NCT00531284|18224156|P1|Overall Study|Progressive Disease|1
5283841|NCT00531206|18224306|P1|Overall Study|including non-related adverse events|8
5283842|NCT00531206|18224306|P1|Overall Study|Lost to Follow-up|5
5283843|NCT00531206|18224306|P1|Overall Study|Lack of Efficacy|2
5283844|NCT00531206|18224306|P1|Overall Study|Adverse Event related|5
5283845|NCT00531050|18224336|P6|Part 2: Period 3|Abnormal test procedure|1
5283846|NCT00531050|18224337|P5|Part 2: Period 3|Abnormal test procedure|0
5283847|NCT00531050|18224338|P4|Part 2: Period 3|Abnormal test procedure|0
5283848|NCT00531050|18224339|P3|Part 2: Period 3|Abnormal test procedure|0
5283849|NCT00531050|18224340|P2|Part 2: Period 3|Abnormal test procedure|0
5283850|NCT00531050|18224341|P1|Part 2: Period 3|Abnormal test procedure|1
5283851|NCT00531050|18224336|P6|Part 2: Period 1|Adverse Event|1
5283852|NCT00531050|18224337|P5|Part 2: Period 1|Adverse Event|0
5283853|NCT00531050|18224338|P4|Part 2: Period 1|Adverse Event|0
5283854|NCT00531050|18224339|P3|Part 2: Period 1|Adverse Event|0
5283855|NCT00531050|18224340|P2|Part 2: Period 1|Adverse Event|0
5283856|NCT00531050|18224341|P1|Part 2: Period 1|Adverse Event|0
5283857|NCT00531050|18224336|P6|Part 1: Period 3|Adverse Event|0
5283858|NCT00531050|18224337|P5|Part 1: Period 3|Adverse Event|0
5283859|NCT00531050|18224338|P4|Part 1: Period 3|Adverse Event|0
5283860|NCT00531050|18224339|P3|Part 1: Period 3|Adverse Event|0
5283861|NCT00531050|18224340|P2|Part 1: Period 3|Adverse Event|0
5283862|NCT00531050|18224341|P1|Part 1: Period 3|Adverse Event|1
5283863|NCT00531050|18224336|P6|Part 1: Period 1|Protocol Deviation|0
5283864|NCT00531050|18224337|P5|Part 1: Period 1|Protocol Deviation|0
5283865|NCT00531050|18224338|P4|Part 1: Period 1|Protocol Deviation|1
5283866|NCT00531050|18224339|P3|Part 1: Period 1|Protocol Deviation|0
5283867|NCT00531050|18224340|P2|Part 1: Period 1|Protocol Deviation|0
5283868|NCT00531050|18224341|P1|Part 1: Period 1|Protocol Deviation|0
5283869|NCT00531050|18224336|P6|Part 1: Period 1|Adverse Event|0
5283870|NCT00531050|18224337|P5|Part 1: Period 1|Adverse Event|0
5283871|NCT00531050|18224338|P4|Part 1: Period 1|Adverse Event|0
5283872|NCT00531050|18224339|P3|Part 1: Period 1|Adverse Event|0
5283873|NCT00531050|18224340|P2|Part 1: Period 1|Adverse Event|1
5283874|NCT00531050|18224341|P1|Part 1: Period 1|Adverse Event|0
5283875|NCT00531011|18224370|P2|Overall Study|Physician Decision|3
5283876|NCT00531011|18224371|P1|Overall Study|Physician Decision|0
5283877|NCT00531011|18224370|P2|Overall Study|Lost to Follow-up|0
5283878|NCT00531011|18224371|P1|Overall Study|Lost to Follow-up|1
5283879|NCT00531011|18224370|P2|Overall Study|Death|0
5283880|NCT00531011|18224371|P1|Overall Study|Death|1
5283881|NCT00531011|18224370|P2|Overall Study|Withdrawal by Subject|4
5283882|NCT00531011|18224371|P1|Overall Study|Withdrawal by Subject|2
5283883|NCT00530946|18224417|P4|Overall Study|Noncompliance|0
5283884|NCT00530946|18224418|P3|Overall Study|Noncompliance|0
5283885|NCT00530946|18224419|P2|Overall Study|Noncompliance|0
5283886|NCT00530946|18224420|P1|Overall Study|Noncompliance|1
5283887|NCT00530946|18224417|P4|Overall Study|Protocol Violation|1
5283888|NCT00530946|18224418|P3|Overall Study|Protocol Violation|0
5283889|NCT00530946|18224419|P2|Overall Study|Protocol Violation|0
5283890|NCT00530946|18224420|P1|Overall Study|Protocol Violation|0
5283891|NCT00530946|18224417|P4|Overall Study|Adverse Event|1
5283892|NCT00530946|18224418|P3|Overall Study|Adverse Event|1
5283893|NCT00530946|18224419|P2|Overall Study|Adverse Event|2
5283894|NCT00530946|18224420|P1|Overall Study|Adverse Event|1
5283895|NCT00530920|18224473|P3|Overall Study|Withdrawal by Subject|1
5283896|NCT00530920|18224474|P2|Overall Study|Withdrawal by Subject|0
5283897|NCT00530920|18224475|P1|Overall Study|Withdrawal by Subject|0
5283898|NCT00530920|18224473|P3|Overall Study|Adverse Event|3
5283899|NCT00530920|18224474|P2|Overall Study|Adverse Event|0
5283900|NCT00530920|18224475|P1|Overall Study|Adverse Event|0
5283901|NCT00530920|18224473|P3|Overall Study|Randomized but not treated|0
5283902|NCT00530920|18224474|P2|Overall Study|Randomized but not treated|2
5283903|NCT00530920|18224475|P1|Overall Study|Randomized but not treated|0
5283904|NCT00530894|18224535|P4|Overall Study|Alive and censored prior to 1 year|0
5283905|NCT00530894|18224536|P3|Overall Study|Alive and censored prior to 1 year|0
5283906|NCT00530894|18224537|P2|Overall Study|Alive and censored prior to 1 year|0
5283907|NCT00530894|18224538|P1|Overall Study|Alive and censored prior to 1 year|2
5283908|NCT00530894|18224535|P4|Overall Study|Withdrawal by Subject|5
5283909|NCT00530894|18224536|P3|Overall Study|Withdrawal by Subject|0
5283910|NCT00530894|18224537|P2|Overall Study|Withdrawal by Subject|23
5283911|NCT00530894|18224538|P1|Overall Study|Withdrawal by Subject|1
5283912|NCT00530894|18224535|P4|Overall Study|Lost to Follow-up|0
5283913|NCT00530894|18224536|P3|Overall Study|Lost to Follow-up|0
5283914|NCT00530894|18224537|P2|Overall Study|Lost to Follow-up|3
5283915|NCT00530894|18224538|P1|Overall Study|Lost to Follow-up|1
5283916|NCT00530894|18224535|P4|Overall Study|Death|89
5283917|NCT00530894|18224536|P3|Overall Study|Death|55
5283918|NCT00530894|18224537|P2|Overall Study|Death|89
5283919|NCT00530894|18224538|P1|Overall Study|Death|84
5283920|NCT00530855|18224566|P1|Overall Study|Other reason for premature termination|17
5283921|NCT00530855|18224566|P1|Overall Study|Lost to Follow-up|9
5283922|NCT00530855|18224566|P1|Overall Study|Unsatisfactory compliance of subject|11
5283923|NCT00530855|18224566|P1|Overall Study|Protocol Violation|3
5283924|NCT00530855|18224566|P1|Overall Study|Non Fatal Non Serious AE|12
5283925|NCT00530855|18224566|P1|Overall Study|Non Fatal Serious AE|7
5283926|NCT00530855|18224566|P1|Overall Study|Fatal Serious AE|3
5283927|NCT00530855|18224566|P1|Overall Study|Withdrawal by Subject|30
5283928|NCT00530855|18224566|P1|Overall Study|Lack of Efficacy|20
5283929|NCT00530842|18224575|P2|Period 2|Individual different reasons|0
5283930|NCT00530842|18224576|P1|Period 2|Individual different reasons|2
5283931|NCT00530842|18224575|P2|Period 2|Withdrawal by Subject|2
5283932|NCT00530842|18224576|P1|Period 2|Withdrawal by Subject|1
5283933|NCT00530842|18224575|P2|Period 2|Protocol Violation|0
5283934|NCT00530842|18224576|P1|Period 2|Protocol Violation|1
5283935|NCT00530842|18224575|P2|Period 2|Lost to Follow-up|4
5283936|NCT00530842|18224576|P1|Period 2|Lost to Follow-up|0
5283937|NCT00530842|18224575|P2|Period 2|Lack of Efficacy|0
5283938|NCT00530842|18224576|P1|Period 2|Lack of Efficacy|1
5283939|NCT00530842|18224575|P2|Period 2|Adverse Event|3
5283940|NCT00530842|18224576|P1|Period 2|Adverse Event|3
5283941|NCT00530842|18224575|P2|Period 1|Individual different reasons|3
5283942|NCT00530842|18224576|P1|Period 1|Individual different reasons|2
5283943|NCT00530842|18224575|P2|Period 1|Withdrawal by Subject|3
5283944|NCT00530842|18224576|P1|Period 1|Withdrawal by Subject|2
5283945|NCT00530842|18224575|P2|Period 1|Protocol Violation|1
5283946|NCT00530842|18224576|P1|Period 1|Protocol Violation|2
5283947|NCT00530842|18224575|P2|Period 1|Lack of Efficacy|1
5283948|NCT00530842|18224576|P1|Period 1|Lack of Efficacy|1
5283949|NCT00530842|18224575|P2|Period 1|Adverse Event|3
5283950|NCT00530842|18224576|P1|Period 1|Adverse Event|7
5283951|NCT00530842|18224575|P2|Overall Study|Individual different reasons|3
5283952|NCT00530842|18224576|P1|Overall Study|Individual different reasons|4
5283953|NCT00530842|18224575|P2|Overall Study|Withdrawal by Subject|5
5283954|NCT00530842|18224576|P1|Overall Study|Withdrawal by Subject|4
5283955|NCT00530842|18224575|P2|Overall Study|Protocol Violation|2
5283956|NCT00530842|18224576|P1|Overall Study|Protocol Violation|3
5283957|NCT00530842|18224575|P2|Overall Study|Lost to Follow-up|4
5283958|NCT00530842|18224576|P1|Overall Study|Lost to Follow-up|0
5283959|NCT00530842|18224575|P2|Overall Study|Lack of Efficacy|1
5283960|NCT00530842|18224576|P1|Overall Study|Lack of Efficacy|2
5283961|NCT00530842|18224575|P2|Overall Study|Adverse Event|6
5283962|NCT00530842|18224576|P1|Overall Study|Adverse Event|10
5283963|NCT00530816|18224703|P3|Overall Study|Withdrawal by Subject|6
5283964|NCT00530816|18224704|P2|Overall Study|Withdrawal by Subject|2
5283965|NCT00530816|18224705|P1|Overall Study|Withdrawal by Subject|1
5283966|NCT00530816|18224703|P3|Overall Study|Other|4
5283967|NCT00530816|18224704|P2|Overall Study|Other|3
5283968|NCT00530816|18224705|P1|Overall Study|Other|3
5283969|NCT00530816|18224703|P3|Overall Study|Adverse Event|7
5283970|NCT00530816|18224704|P2|Overall Study|Adverse Event|13
5283971|NCT00530816|18224705|P1|Overall Study|Adverse Event|6
5283972|NCT00530816|18224703|P3|Overall Study|Progressive Disease|24
5283973|NCT00530816|18224704|P2|Overall Study|Progressive Disease|24
5283974|NCT00530816|18224705|P1|Overall Study|Progressive Disease|16
5283975|NCT00530790|18224748|P1|Overall Study|Physician Decision|1
5283976|NCT00530790|18224748|P1|Overall Study|Withdrawal by Subject|2
5283977|NCT00530790|18224748|P1|Overall Study|Adverse Event|2
5283978|NCT00530777|18224770|P2|Overall Study|Unable to adhere to visit schedule|1
5283979|NCT00530777|18224771|P1|Overall Study|Unable to adhere to visit schedule|5
5283980|NCT00530777|18224770|P2|Overall Study|Withdrawal by Subject|1
5283981|NCT00530777|18224771|P1|Overall Study|Withdrawal by Subject|0
5283982|NCT00530777|18224770|P2|Overall Study|Physician Decision|0
5283983|NCT00530777|18224771|P1|Overall Study|Physician Decision|1
5283984|NCT00530777|18224770|P2|Overall Study|Death|2
5283985|NCT00530777|18224771|P1|Overall Study|Death|1
5283986|NCT00530777|18224770|P2|Overall Study|Lost to Follow-up|1
5283987|NCT00530777|18224771|P1|Overall Study|Lost to Follow-up|0
5283988|NCT00530712|18224828|P1|12 Month Follow-up Visit|Death|9
5283989|NCT00530712|18224828|P1|12 Month Follow-up Visit|Lost to Follow-up|7
5283990|NCT00530712|18224828|P1|12 Month Follow-up Visit|Missed Visit|3
5283991|NCT00530712|18224828|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
5283992|NCT00530712|18224828|P1|6 Month Follow-up Visit|Death|2
5283993|NCT00530712|18224828|P1|6 Month Follow-up Visit|Lost to Follow-up|3
5283994|NCT00530712|18224828|P1|6 Month Follow-up Visit|Missed Visit|3
5283995|NCT00530712|18224828|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
5283996|NCT00530712|18224828|P1|30 Day Follow-up Visit|Missed Visit|5
5283997|NCT00530712|18224828|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
5283998|NCT00530621|18224851|P2|Overall Study|Not Treated Due to PD Prior to Dosing|0
5283999|NCT00530621|18224852|P1|Overall Study|Not Treated Due to PD Prior to Dosing|1
5284000|NCT00530621|18224851|P2|Overall Study|Death|6
5284001|NCT00530621|18224852|P1|Overall Study|Death|3
5284002|NCT00530621|18224851|P2|Overall Study|Subject Decision|7
5284003|NCT00530621|18224852|P1|Overall Study|Subject Decision|4
5284004|NCT00530621|18224851|P2|Overall Study|Sponsor Decision|15
5284005|NCT00530621|18224852|P1|Overall Study|Sponsor Decision|12
5284006|NCT00530621|18224851|P2|Overall Study|Progressive Disease (PD)|40
5284007|NCT00530621|18224852|P1|Overall Study|Progressive Disease (PD)|47
5284008|NCT00530621|18224851|P2|Overall Study|Physician Decision|4
5284009|NCT00530621|18224852|P1|Overall Study|Physician Decision|2
5284010|NCT00530621|18224851|P2|Overall Study|Adverse Event|8
5284011|NCT00530621|18224852|P1|Overall Study|Adverse Event|11
5284012|NCT00530504|18224873|P1|Overall Study|Exited study due to other reasons|33
5284013|NCT00530504|18224873|P1|Overall Study|Withdrawal by Subject|39
5284014|NCT00530504|18224873|P1|Overall Study|Lost to Follow-up|26
5284015|NCT00530504|18224873|P1|Overall Study|Death|54
5284016|NCT00530439|18224879|P2|Overall Study|Severe malformation/abortion|3
5284017|NCT00530439|18224880|P1|Overall Study|Severe malformation/abortion|0
5284018|NCT00530439|18224879|P2|Overall Study|Twin pregnancy|2
5284019|NCT00530439|18224880|P1|Overall Study|Twin pregnancy|0
5284020|NCT00530439|18224879|P2|Overall Study|Misclassification|0
5284021|NCT00530439|18224880|P1|Overall Study|Misclassification|2
5284022|NCT00530439|18224879|P2|Overall Study|Missed abortion|4
5284023|NCT00530439|18224880|P1|Overall Study|Missed abortion|1
5284024|NCT00530439|18224879|P2|Overall Study|Withdraw|14
5284025|NCT00530439|18224880|P1|Overall Study|Withdraw|18
5284026|NCT00530439|18224879|P2|Overall Study|GDM|3
5284027|NCT00530439|18224880|P1|Overall Study|GDM|9
5284028|NCT00530348|18224888|P2|Overall Study|Noncompliance with inclusion criterion 3|1
5284029|NCT00530348|18224889|P1|Overall Study|Noncompliance with inclusion criterion 3|0
5284030|NCT00530348|18224888|P2|Overall Study|Randomised in error|0
5284031|NCT00530348|18224889|P1|Overall Study|Randomised in error|1
5284032|NCT00530348|18224888|P2|Overall Study|Withdrawal by Subject|12
5284033|NCT00530348|18224889|P1|Overall Study|Withdrawal by Subject|12
5284034|NCT00530348|18224888|P2|Overall Study|Pregnancy|0
5284035|NCT00530348|18224889|P1|Overall Study|Pregnancy|1
5284036|NCT00530348|18224888|P2|Overall Study|Physician Decision|2
5284037|NCT00530348|18224889|P1|Overall Study|Physician Decision|1
5284038|NCT00530348|18224888|P2|Overall Study|Lost to Follow-up|2
5284039|NCT00530348|18224889|P1|Overall Study|Lost to Follow-up|0
5284040|NCT00530348|18224888|P2|Overall Study|Lack of Efficacy|0
5284041|NCT00530348|18224889|P1|Overall Study|Lack of Efficacy|2
5284042|NCT00530348|18224888|P2|Overall Study|Death|1
5284043|NCT00530348|18224889|P1|Overall Study|Death|0
5284044|NCT00530348|18224888|P2|Overall Study|Adverse Event|1
5284045|NCT00530348|18224889|P1|Overall Study|Adverse Event|5
5284046|NCT00530335|18224905|P1|Overall Study|Physician Decision|1
5284047|NCT00530335|18224905|P1|Overall Study|Withdrawal by Subject|1
5284048|NCT00530335|18224905|P1|Overall Study|Protocol Violation|1
5284049|NCT00530335|18224905|P1|Overall Study|Adverse Event|3
5284050|NCT00530270|18224922|P2|Overall Study|Protocol Violation|0
5284051|NCT00530270|18224923|P1|Overall Study|Protocol Violation|1
5284052|NCT00530257|18224937|P1|Overall Study|Lost to Follow-up|1
5284053|NCT00530218|18224965|P1|Overall Study|Death|12
5284054|NCT00530218|18224965|P1|Overall Study|CMV Not Detected|13
5284055|NCT00530088|18224972|P1|Overall Study|Other Not Specified|2
5284056|NCT00530088|18224972|P1|Overall Study|Physician Decision|4
5284057|NCT00530088|18224972|P1|Overall Study|Disease Progression|4
5284058|NCT00530075|18224977|P1|Overall Study|Withdrawal by Subject|1
5284059|NCT00530075|18224977|P1|Overall Study|Protocol Violation|1
5284060|NCT00530075|18224977|P1|Overall Study|Lack of Efficacy|3
5284061|NCT00530075|18224977|P1|Overall Study|Death|1
5284062|NCT00530075|18224977|P1|Overall Study|Adverse Event|1
5284063|NCT00530023|18224990|P2|Overall Study|Withdrawal by Subject|1
5284064|NCT00530023|18224991|P1|Overall Study|Withdrawal by Subject|0
5284065|NCT00529958|18225008|P3|5-Year Follow-up|Withdrawal by Subject|0
5284066|NCT00529958|18225009|P2|5-Year Follow-up|Withdrawal by Subject|0
5284067|NCT00529958|18225010|P1|5-Year Follow-up|Withdrawal by Subject|1
5284068|NCT00529958|18225008|P3|5-Year Follow-up|Lost to Follow-up|1
5284069|NCT00529958|18225009|P2|5-Year Follow-up|Lost to Follow-up|3
5284070|NCT00529958|18225010|P1|5-Year Follow-up|Lost to Follow-up|2
5284071|NCT00529958|18225008|P3|2-Year Follow-up|Withdrawal by Subject|0
5284072|NCT00529958|18225009|P2|2-Year Follow-up|Withdrawal by Subject|0
5284073|NCT00529958|18225010|P1|2-Year Follow-up|Withdrawal by Subject|3
5284074|NCT00529958|18225008|P3|2-Year Follow-up|Lost to Follow-up|2
5284075|NCT00529958|18225009|P2|2-Year Follow-up|Lost to Follow-up|2
5284076|NCT00529958|18225010|P1|2-Year Follow-up|Lost to Follow-up|1
5284077|NCT00529802|18225051|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
5284078|NCT00529802|18225051|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
5284079|NCT00529802|18225051|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
5284080|NCT00529802|18225051|P1|Evaluable for Primary Endpoint|Death|1
5284081|NCT00529802|18225051|P1|Evaluable for Primary Endpoint|Adverse Event|2
5284082|NCT00529802|18225051|P1|Evaluable for Primary Endpoint|Worsening performance status|2
5284083|NCT00529802|18225051|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
5284084|NCT00529789|18225057|P1|Study Period IV|Lost to Follow-up|3
5284085|NCT00529789|18225057|P1|Study Period IV|Lack of Efficacy|1
5284086|NCT00529789|18225057|P1|Study Period IV|Adverse Event|1
5284087|NCT00529789|18225057|P1|Study Period IV|Parent/Caregiver Decision|1
5284088|NCT00529789|18225057|P1|Study Period II/III|Lost to Follow-up|3
5284089|NCT00529789|18225057|P1|Study Period II/III|Physician Decision|3
5284090|NCT00529789|18225057|P1|Study Period II/III|Protocol Violation|3
5284091|NCT00529789|18225057|P1|Study Period II/III|Withdrawal by Subject|1
5284092|NCT00529789|18225057|P1|Study Period II/III|Lack of Efficacy|2
5284093|NCT00529789|18225057|P1|Study Period II/III|Adverse Event|3
5284094|NCT00529789|18225057|P1|Study Period II/III|Parent/Caregiver Decision|9
5284095|NCT00529763|18225082|P3|Overall Study|Patient Withdrew Consent|2
5284096|NCT00529763|18225083|P2|Overall Study|Patient Withdrew Consent|3
5284097|NCT00529763|18225084|P1|Overall Study|Patient Withdrew Consent|2
5284098|NCT00529763|18225082|P3|Overall Study|Study Drug Toxicity|1
5284099|NCT00529763|18225083|P2|Overall Study|Study Drug Toxicity|6
5284100|NCT00529763|18225084|P1|Overall Study|Study Drug Toxicity|1
5284101|NCT00529763|18225082|P3|Overall Study|Stem Cell Transplant|0
5284102|NCT00529763|18225083|P2|Overall Study|Stem Cell Transplant|3
5284103|NCT00529763|18225084|P1|Overall Study|Stem Cell Transplant|0
5284104|NCT00529763|18225082|P3|Overall Study|Lost to Follow-up|1
5284105|NCT00529763|18225083|P2|Overall Study|Lost to Follow-up|1
5284106|NCT00529763|18225084|P1|Overall Study|Lost to Follow-up|0
5284107|NCT00529763|18225082|P3|Overall Study|Disease Progression|1
5284108|NCT00529763|18225083|P2|Overall Study|Disease Progression|16
5284109|NCT00529763|18225084|P1|Overall Study|Disease Progression|6
5284110|NCT00529763|18225082|P3|Overall Study|Death|1
5284111|NCT00529763|18225083|P2|Overall Study|Death|1
5284112|NCT00529763|18225084|P1|Overall Study|Death|0
5284113|NCT00529763|18225082|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
5284114|NCT00529763|18225083|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5284115|NCT00529763|18225084|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
5284116|NCT00529659|18225122|P2|Overall Study|Withdrawal by Subject|6
5284117|NCT00529659|18225123|P1|Overall Study|Withdrawal by Subject|1
5284118|NCT00529659|18225122|P2|Overall Study|Protocol Violation|6
5284119|NCT00529659|18225123|P1|Overall Study|Protocol Violation|2
5284120|NCT00529659|18225122|P2|Overall Study|Physician Decision|2
5284121|NCT00529659|18225123|P1|Overall Study|Physician Decision|0
5284122|NCT00529659|18225122|P2|Overall Study|Lost to Follow-up|2
5284123|NCT00529659|18225123|P1|Overall Study|Lost to Follow-up|0
5284124|NCT00529659|18225122|P2|Overall Study|Adverse Event|7
5284125|NCT00529659|18225123|P1|Overall Study|Adverse Event|8
5284126|NCT00529633|18225141|P2|Overall Study|Withdrawal by Subject|1
5284127|NCT00529633|18225142|P1|Overall Study|Withdrawal by Subject|1
5284128|NCT00529568|18225154|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
5284129|NCT00529568|18225155|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
5284130|NCT00529568|18225156|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
5284131|NCT00529568|18225154|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
5284132|NCT00529568|18225155|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
5284133|NCT00529568|18225156|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
5284134|NCT00529568|18225154|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
5284135|NCT00529568|18225155|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
5284136|NCT00529568|18225156|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
5284137|NCT00529568|18225154|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
5284138|NCT00529568|18225155|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
5284139|NCT00529568|18225156|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
5284140|NCT00529568|18225154|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
5284141|NCT00529568|18225155|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
5284142|NCT00529568|18225156|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
5284143|NCT00529568|18225154|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
5284144|NCT00529568|18225155|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
5284145|NCT00529568|18225156|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
5284146|NCT00529568|18225154|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
5284147|NCT00529568|18225155|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
5284148|NCT00529568|18225156|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
5284149|NCT00529568|18225154|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
5284150|NCT00529568|18225155|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
5284151|NCT00529568|18225156|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
5284152|NCT00529568|18225154|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
5284153|NCT00529568|18225155|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
5284154|NCT00529568|18225156|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
5284155|NCT00529568|18225154|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
5284156|NCT00529568|18225155|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
5284157|NCT00529568|18225156|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
5284158|NCT00529568|18225154|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
5284159|NCT00529568|18225155|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
5284160|NCT00529568|18225156|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
5284161|NCT00529542|18225219|P2|Overall Study|Lost to Follow-up|1
5284162|NCT00529542|18225220|P1|Overall Study|Lost to Follow-up|0
5284163|NCT00529542|18225219|P2|Overall Study|Withdrawal by Subject|0
5284164|NCT00529542|18225220|P1|Overall Study|Withdrawal by Subject|1
5284165|NCT00529529|18225263|P3|Overall Study|Administrative problems|3
5284166|NCT00529529|18225264|P2|Overall Study|Administrative problems|0
5284167|NCT00529529|18225265|P1|Overall Study|Administrative problems|1
5284168|NCT00529529|18225263|P3|Overall Study|Abnormal test procedure result(s)|0
5284169|NCT00529529|18225264|P2|Overall Study|Abnormal test procedure result(s)|0
5284170|NCT00529529|18225265|P1|Overall Study|Abnormal test procedure result(s)|1
5284171|NCT00529529|18225263|P3|Overall Study|Death|0
5284172|NCT00529529|18225264|P2|Overall Study|Death|0
5284173|NCT00529529|18225265|P1|Overall Study|Death|2
5284174|NCT00529529|18225263|P3|Overall Study|Unsatisfactory therapeutic effect|2
5284175|NCT00529529|18225264|P2|Overall Study|Unsatisfactory therapeutic effect|2
5284176|NCT00529529|18225265|P1|Overall Study|Unsatisfactory therapeutic effect|2
5284177|NCT00529529|18225263|P3|Overall Study|Lost to Follow-up|1
5284178|NCT00529529|18225264|P2|Overall Study|Lost to Follow-up|3
5284179|NCT00529529|18225265|P1|Overall Study|Lost to Follow-up|5
5284180|NCT00529529|18225263|P3|Overall Study|Protocol deviation|5
5284181|NCT00529529|18225264|P2|Overall Study|Protocol deviation|12
5284182|NCT00529529|18225265|P1|Overall Study|Protocol deviation|8
5284183|NCT00529529|18225263|P3|Overall Study|Subject withdrew consent|12
5284184|NCT00529529|18225264|P2|Overall Study|Subject withdrew consent|9
5284185|NCT00529529|18225265|P1|Overall Study|Subject withdrew consent|12
5284186|NCT00529529|18225263|P3|Overall Study|Adverse Event|8
5284187|NCT00529529|18225264|P2|Overall Study|Adverse Event|17
5284188|NCT00529529|18225265|P1|Overall Study|Adverse Event|12
5284189|NCT00529516|18225324|P3|Overall Study|Lost to Follow-up|1
5284190|NCT00529516|18225325|P2|Overall Study|Lost to Follow-up|0
5284191|NCT00529516|18225326|P1|Overall Study|Lost to Follow-up|0
5284192|NCT00529516|18225324|P3|Overall Study|Withdrawal by Subject|0
5284193|NCT00529516|18225325|P2|Overall Study|Withdrawal by Subject|1
5284194|NCT00529516|18225326|P1|Overall Study|Withdrawal by Subject|1
5284195|NCT00529516|18225324|P3|Overall Study|Adverse Event|0
5284196|NCT00529516|18225325|P2|Overall Study|Adverse Event|1
5284197|NCT00529516|18225326|P1|Overall Study|Adverse Event|2
5284198|NCT00529451|18225411|P4|Overall Study|Administrative problems|2
5284199|NCT00529451|18225412|P3|Overall Study|Administrative problems|0
5284200|NCT00529451|18225413|P2|Overall Study|Administrative problems|1
5284201|NCT00529451|18225414|P1|Overall Study|Administrative problems|1
5284202|NCT00529451|18225411|P4|Overall Study|Protocol deviation|1
5284203|NCT00529451|18225412|P3|Overall Study|Protocol deviation|4
5284204|NCT00529451|18225413|P2|Overall Study|Protocol deviation|1
5284205|NCT00529451|18225414|P1|Overall Study|Protocol deviation|1
5284206|NCT00529451|18225411|P4|Overall Study|Lost to Follow-up|4
5284207|NCT00529451|18225412|P3|Overall Study|Lost to Follow-up|4
5284208|NCT00529451|18225413|P2|Overall Study|Lost to Follow-up|7
5284209|NCT00529451|18225414|P1|Overall Study|Lost to Follow-up|4
5284210|NCT00529451|18225411|P4|Overall Study|Unsatisfactory therapeutic response|4
5284211|NCT00529451|18225412|P3|Overall Study|Unsatisfactory therapeutic response|5
5284212|NCT00529451|18225413|P2|Overall Study|Unsatisfactory therapeutic response|2
5284213|NCT00529451|18225414|P1|Overall Study|Unsatisfactory therapeutic response|6
5284214|NCT00529451|18225411|P4|Overall Study|Adverse Event|8
5284215|NCT00529451|18225412|P3|Overall Study|Adverse Event|14
5284216|NCT00529451|18225413|P2|Overall Study|Adverse Event|16
5284217|NCT00529451|18225414|P1|Overall Study|Adverse Event|9
5284218|NCT00529451|18225411|P4|Overall Study|Subject withdrew consent|12
5284219|NCT00529451|18225412|P3|Overall Study|Subject withdrew consent|13
5284220|NCT00529451|18225413|P2|Overall Study|Subject withdrew consent|21
5284221|NCT00529451|18225414|P1|Overall Study|Subject withdrew consent|16
5284222|NCT00529399|18225441|P3|Overall Study|Non-compliant|0
5284223|NCT00529399|18225442|P2|Overall Study|Non-compliant|1
5284224|NCT00529399|18225443|P1|Overall Study|Non-compliant|0
5284225|NCT00529399|18225441|P3|Overall Study|Withdrawal by Subject|1
5284226|NCT00529399|18225442|P2|Overall Study|Withdrawal by Subject|0
5284227|NCT00529399|18225443|P1|Overall Study|Withdrawal by Subject|1
5284228|NCT00529399|18225441|P3|Overall Study|Lost to Follow-up|1
5284229|NCT00529399|18225442|P2|Overall Study|Lost to Follow-up|0
5284230|NCT00529399|18225443|P1|Overall Study|Lost to Follow-up|1
5284231|NCT00529386|18225451|P1|Overall Study|Lost to Follow-up|1
5284232|NCT00529373|18225457|P2|Second Extension Study|Status Missing|5
5284233|NCT00529373|18225458|P1|Second Extension Study|Status Missing|5
5284234|NCT00529373|18225457|P2|Second Extension Study|Withdrawal by Subject|75
5284235|NCT00529373|18225458|P1|Second Extension Study|Withdrawal by Subject|97
5284236|NCT00529373|18225457|P2|Second Extension Study|Protocol Violation|1
5284237|NCT00529373|18225458|P1|Second Extension Study|Protocol Violation|2
5284238|NCT00529373|18225457|P2|Second Extension Study|Physician Decision|26
5284239|NCT00529373|18225458|P1|Second Extension Study|Physician Decision|63
5284240|NCT00529373|18225457|P2|Second Extension Study|Other|12
5284241|NCT00529373|18225458|P1|Second Extension Study|Other|7
5284242|NCT00529373|18225457|P2|Second Extension Study|Lost to Follow-up|12
5284243|NCT00529373|18225458|P1|Second Extension Study|Lost to Follow-up|18
5284244|NCT00529373|18225457|P2|Second Extension Study|Lack of Efficacy|15
5284245|NCT00529373|18225458|P1|Second Extension Study|Lack of Efficacy|7
5284246|NCT00529373|18225457|P2|Second Extension Study|Adverse Event|51
5284247|NCT00529373|18225458|P1|Second Extension Study|Adverse Event|101
5284248|NCT00529373|18225457|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
5284249|NCT00529373|18225458|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
5284250|NCT00529373|18225457|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
5284251|NCT00529373|18225458|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
5284252|NCT00529373|18225457|P2|First Extension Study|Discontinued after 5 years completion|346
5284253|NCT00529373|18225458|P1|First Extension Study|Discontinued after 5 years completion|208
5284254|NCT00529373|18225457|P2|First Extension Study|Disposition record non-existing|1
5284255|NCT00529373|18225458|P1|First Extension Study|Disposition record non-existing|0
5284256|NCT00529373|18225457|P2|First Extension Study|Withdrawal by Subject|287
5284257|NCT00529373|18225458|P1|First Extension Study|Withdrawal by Subject|296
5284258|NCT00529373|18225457|P2|First Extension Study|Protocol Violation|13
5284259|NCT00529373|18225458|P1|First Extension Study|Protocol Violation|16
5284260|NCT00529373|18225457|P2|First Extension Study|Physician Decision|45
5284261|NCT00529373|18225458|P1|First Extension Study|Physician Decision|50
5284262|NCT00529373|18225457|P2|First Extension Study|Other|47
5284263|NCT00529373|18225458|P1|First Extension Study|Other|27
5284264|NCT00529373|18225457|P2|First Extension Study|Lost to Follow-up|37
5284265|NCT00529373|18225458|P1|First Extension Study|Lost to Follow-up|41
5284266|NCT00529373|18225457|P2|First Extension Study|Lack of Efficacy|427
5284267|NCT00529373|18225458|P1|First Extension Study|Lack of Efficacy|65
5284268|NCT00529373|18225457|P2|First Extension Study|Adverse Event|142
5284269|NCT00529373|18225458|P1|First Extension Study|Adverse Event|162
5284270|NCT00529373|18225457|P2|Base Study|Did not continue into Extension|2238
5284271|NCT00529373|18225458|P1|Base Study|Did not continue into Extension|1795
5284272|NCT00529373|18225457|P2|Base Study|Withdrawal by Subject|967
5284273|NCT00529373|18225458|P1|Base Study|Withdrawal by Subject|1062
5284274|NCT00529373|18225457|P2|Base Study|Protocol Violation|38
5284275|NCT00529373|18225458|P1|Base Study|Protocol Violation|48
5284276|NCT00529373|18225457|P2|Base Study|Physician Decision|52
5284277|NCT00529373|18225458|P1|Base Study|Physician Decision|60
5284278|NCT00529373|18225457|P2|Base Study|Other Protocol Specified Criteria|20
5284279|NCT00529373|18225458|P1|Base Study|Other Protocol Specified Criteria|19
5284280|NCT00529373|18225457|P2|Base Study|Lost to Follow-up|208
5284281|NCT00529373|18225458|P1|Base Study|Lost to Follow-up|221
5284282|NCT00529373|18225457|P2|Base Study|Lack of Efficacy|75
5284283|NCT00529373|18225458|P1|Base Study|Lack of Efficacy|16
5284284|NCT00529373|18225457|P2|Base Study|Adverse Event|470
5284285|NCT00529373|18225458|P1|Base Study|Adverse Event|525
5284286|NCT00529308|18225652|P2|Overall Study|Withdrawal by Subject|1
5284287|NCT00529308|18225653|P1|Overall Study|Withdrawal by Subject|1
5284288|NCT00529243|18225682|P1|Overall Study|Relocated|1
5284289|NCT00529243|18225682|P1|Overall Study|Death|1
5284290|NCT00529243|18225682|P1|Overall Study|Adverse Event|1
5284291|NCT00529217|18225687|P1|Overall Study|Unable to adhere to study schedule|2
5284292|NCT00529217|18225687|P1|Overall Study|Lack of Efficacy|2
5284293|NCT00529152|18225723|P1|Overall Study|Lost to Follow-up|1
5284294|NCT00529152|18225723|P1|Overall Study|Withdrawal by Subject|2
5284295|NCT00529152|18225723|P1|Overall Study|Adverse Event|2
5284296|NCT00529100|18225747|P2|Overall Study|Participant Ineligibility|1
5284297|NCT00529100|18225748|P1|Overall Study|Participant Ineligibility|0
5284298|NCT00529100|18225747|P2|Overall Study|Withdrawal by Subject|1
5284299|NCT00529100|18225748|P1|Overall Study|Withdrawal by Subject|0
5284300|NCT00529100|18225747|P2|Overall Study|Progressive Disease|1
5284301|NCT00529100|18225748|P1|Overall Study|Progressive Disease|0
5284302|NCT00529100|18225747|P2|Overall Study|Protocol Violation|1
5284303|NCT00529100|18225748|P1|Overall Study|Protocol Violation|0
5284304|NCT00529100|18225747|P2|Overall Study|Adverse Event|5
5284305|NCT00529100|18225748|P1|Overall Study|Adverse Event|0
5284306|NCT00529087|18225765|P3|Overall Study|Protocol deviation|2
5284307|NCT00529087|18225766|P2|Overall Study|Protocol deviation|1
5284308|NCT00529087|18225767|P1|Overall Study|Protocol deviation|1
5284309|NCT00529087|18225765|P3|Overall Study|Withdrawal by Subject|3
5284310|NCT00529087|18225766|P2|Overall Study|Withdrawal by Subject|3
5284311|NCT00529087|18225767|P1|Overall Study|Withdrawal by Subject|3
5284312|NCT00529087|18225765|P3|Overall Study|Protocol Violation|6
5284313|NCT00529087|18225766|P2|Overall Study|Protocol Violation|7
5284314|NCT00529087|18225767|P1|Overall Study|Protocol Violation|8
5284315|NCT00529087|18225765|P3|Overall Study|Lost to Follow-up|1
5284316|NCT00529087|18225766|P2|Overall Study|Lost to Follow-up|4
5284317|NCT00529087|18225767|P1|Overall Study|Lost to Follow-up|6
5284318|NCT00529087|18225765|P3|Overall Study|Adverse Event|4
5284319|NCT00529087|18225766|P2|Overall Study|Adverse Event|13
5284320|NCT00529087|18225767|P1|Overall Study|Adverse Event|10
5284321|NCT00529035|18225831|P1|Overall Study|Withdrawal by Subject|1
5284322|NCT00528970|18225845|P3|Overall Study|Randomized but not treated|1
5284323|NCT00528970|18225846|P2|Overall Study|Randomized but not treated|0
5284324|NCT00528970|18225847|P1|Overall Study|Randomized but not treated|0
5284325|NCT00528970|18225845|P3|Overall Study|Withdrawal by Subject|5
5284326|NCT00528970|18225846|P2|Overall Study|Withdrawal by Subject|3
5284327|NCT00528970|18225847|P1|Overall Study|Withdrawal by Subject|4
5284328|NCT00528970|18225845|P3|Overall Study|Lack of Efficacy|1
5284329|NCT00528970|18225846|P2|Overall Study|Lack of Efficacy|0
5284330|NCT00528970|18225847|P1|Overall Study|Lack of Efficacy|0
5284331|NCT00528970|18225845|P3|Overall Study|Protocol Violation|4
5284332|NCT00528970|18225846|P2|Overall Study|Protocol Violation|1
5284333|NCT00528970|18225847|P1|Overall Study|Protocol Violation|2
5284334|NCT00528970|18225845|P3|Overall Study|Other than specified|3
5284335|NCT00528970|18225846|P2|Overall Study|Other than specified|3
5284336|NCT00528970|18225847|P1|Overall Study|Other than specified|2
5284337|NCT00528970|18225845|P3|Overall Study|Lost to Follow-up|1
5284338|NCT00528970|18225846|P2|Overall Study|Lost to Follow-up|0
5284339|NCT00528970|18225847|P1|Overall Study|Lost to Follow-up|0
5284340|NCT00528970|18225845|P3|Overall Study|Adverse Event|5
5284341|NCT00528970|18225846|P2|Overall Study|Adverse Event|8
5284342|NCT00528970|18225847|P1|Overall Study|Adverse Event|6
5284343|NCT00528957|18225866|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
5284344|NCT00528957|18225867|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
5284345|NCT00528957|18225866|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
5284346|NCT00528957|18225867|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
5284347|NCT00528957|18225866|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
5284348|NCT00528957|18225867|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
5284349|NCT00528957|18225866|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
5284350|NCT00528957|18225867|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
5284351|NCT00528957|18225866|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
5284352|NCT00528957|18225867|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
5284353|NCT00528957|18225866|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
5284354|NCT00528957|18225867|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
5284355|NCT00528957|18225866|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
5284356|NCT00528957|18225867|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
5284357|NCT00528957|18225866|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
5284358|NCT00528957|18225867|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
5284359|NCT00528957|18225866|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
5284360|NCT00528957|18225867|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
5284361|NCT00528957|18225866|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
5284362|NCT00528957|18225867|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
5284363|NCT00528957|18225866|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
5284364|NCT00528957|18225867|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
5284365|NCT00528957|18225866|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
5284366|NCT00528957|18225867|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
5284367|NCT00528957|18225866|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
5284368|NCT00528957|18225867|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
5284369|NCT00528957|18225866|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
5284370|NCT00528957|18225867|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
5284371|NCT00528957|18225866|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
5284372|NCT00528957|18225867|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
5284373|NCT00528957|18225866|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
5284374|NCT00528957|18225867|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
5284375|NCT00528931|18226008|P1|Overall Study|Lost to Follow-up|1
5284376|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
5284377|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
5284378|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
5284379|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
5284380|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
5284381|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
5284382|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
5284383|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
5284384|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
5284385|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
5284386|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
5284387|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
5284388|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
5284389|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
5284390|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
5284391|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
5284392|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Death|0
5284393|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Death|0
5284394|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Death|1
5284395|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Death|0
5284396|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
5284397|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
5284398|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
5284399|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
5284400|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
5284401|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
5284402|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
5284403|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
5284404|NCT00528879|18226020|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
5284405|NCT00528879|18226021|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
5284406|NCT00528879|18226022|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
5284407|NCT00528879|18226023|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
5284408|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Other|1
5284409|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Other|1
5284410|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Other|0
5284411|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Other|0
5284412|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
5284413|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
5284414|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
5284415|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
5284416|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
5284417|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
5284418|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
5284419|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
5284420|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
5284421|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
5284422|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
5284423|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
5284424|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
5284425|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5284426|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5284427|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
5284428|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
5284429|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
5284430|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
5284431|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
5284432|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
5284433|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
5284434|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
5284435|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
5284436|NCT00528879|18226020|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
5284437|NCT00528879|18226021|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
5284438|NCT00528879|18226022|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
5284439|NCT00528879|18226023|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
5284440|NCT00528866|18226089|P1|Overall Study|Protocol Violation|6
5284441|NCT00528840|18226102|P1|Overall Study|Other|2
5284442|NCT00528840|18226102|P1|Overall Study|Administrative Reasons|1
5284443|NCT00528840|18226102|P1|Overall Study|Death|2
5284444|NCT00528840|18226102|P1|Overall Study|Withdrawal by Subject|17
5284445|NCT00528840|18226102|P1|Overall Study|Adverse Event|1
5284446|NCT00528840|18226102|P1|Overall Study|Lost to Follow-up|10
5284447|NCT00528801|18226116|P2|Overall Study|Administrative Reasons|1
5284448|NCT00528801|18226117|P1|Overall Study|Administrative Reasons|0
5284449|NCT00528801|18226116|P2|Overall Study|Lost to Follow-up|4
5284450|NCT00528801|18226117|P1|Overall Study|Lost to Follow-up|15
5284451|NCT00528801|18226116|P2|Overall Study|Protocol Violation|5
5284452|NCT00528801|18226117|P1|Overall Study|Protocol Violation|11
5284453|NCT00528801|18226116|P2|Overall Study|Withdrawal by Subject|1
5284454|NCT00528801|18226117|P1|Overall Study|Withdrawal by Subject|1
5284455|NCT00528775|18226131|P1|Overall Study|Other not specified|1
5284456|NCT00528645|18226139|P1|Overall Study|Adverse Event|3
5284457|NCT00528606|18226148|P2|Overall Study|Other|0
5284458|NCT00528606|18226149|P1|Overall Study|Other|2
5284459|NCT00528606|18226148|P2|Overall Study|Adverse Event|0
5284460|NCT00528606|18226149|P1|Overall Study|Adverse Event|3
5284461|NCT00528606|18226148|P2|Overall Study|Lost to Follow-up|1
5284462|NCT00528606|18226149|P1|Overall Study|Lost to Follow-up|4
5284463|NCT00528606|18226148|P2|Overall Study|Withdrew consent|3
5284464|NCT00528606|18226149|P1|Overall Study|Withdrew consent|4
5284465|NCT00528567|18226182|P2|Overall Study|Administrative/Other|75
5284466|NCT00528567|18226183|P1|Overall Study|Administrative/Other|22
5284467|NCT00528567|18226182|P2|Overall Study|Other Protocol Violation|21
5284468|NCT00528567|18226183|P1|Overall Study|Other Protocol Violation|5
5284469|NCT00528567|18226182|P2|Overall Study|Failure to Return|4
5284470|NCT00528567|18226183|P1|Overall Study|Failure to Return|1
5284471|NCT00528567|18226182|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
5284472|NCT00528567|18226183|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
5284473|NCT00528567|18226182|P2|Overall Study|Withdrew Consent|55
5284474|NCT00528567|18226183|P1|Overall Study|Withdrew Consent|59
5284475|NCT00528567|18226182|P2|Overall Study|Violation Criteria at Entry|17
5284476|NCT00528567|18226183|P1|Overall Study|Violation Criteria at Entry|3
5284477|NCT00528567|18226182|P2|Overall Study|Adverse Event/Intermittent Illness|29
5284478|NCT00528567|18226183|P1|Overall Study|Adverse Event/Intermittent Illness|255
5284479|NCT00528567|18226182|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
5284480|NCT00528567|18226183|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
5284481|NCT00528567|18226182|P2|Overall Study|Death|5
5284482|NCT00528567|18226183|P1|Overall Study|Death|4
5284483|NCT00528528|18226250|P4|Overall Study|Ongoing participant|0
5284484|NCT00528528|18226251|P3|Overall Study|Ongoing participant|1
5284485|NCT00528528|18226252|P2|Overall Study|Ongoing participant|0
5284486|NCT00528528|18226253|P1|Overall Study|Ongoing participant|0
5284487|NCT00528528|18226250|P4|Overall Study|Withdrawal by Subject|1
5284488|NCT00528528|18226251|P3|Overall Study|Withdrawal by Subject|1
5284489|NCT00528528|18226252|P2|Overall Study|Withdrawal by Subject|2
5284490|NCT00528528|18226253|P1|Overall Study|Withdrawal by Subject|3
5284491|NCT00528528|18226250|P4|Overall Study|Other|0
5284492|NCT00528528|18226251|P3|Overall Study|Other|0
5284493|NCT00528528|18226252|P2|Overall Study|Other|1
5284494|NCT00528528|18226253|P1|Overall Study|Other|0
5284495|NCT00528528|18226250|P4|Overall Study|Ineligible to continue the trial|1
5284496|NCT00528528|18226251|P3|Overall Study|Ineligible to continue the trial|0
5284497|NCT00528528|18226252|P2|Overall Study|Ineligible to continue the trial|0
5284498|NCT00528528|18226253|P1|Overall Study|Ineligible to continue the trial|0
5284499|NCT00528528|18226250|P4|Overall Study|Lost to Follow-up|1
5284500|NCT00528528|18226251|P3|Overall Study|Lost to Follow-up|1
5284501|NCT00528528|18226252|P2|Overall Study|Lost to Follow-up|0
5284502|NCT00528528|18226253|P1|Overall Study|Lost to Follow-up|0
5284503|NCT00528424|18226291|P1|Overall Study|Other|12
5284504|NCT00528424|18226291|P1|Overall Study|Administrative reason|2
5284505|NCT00528424|18226291|P1|Overall Study|Withdrew consent|2
5284506|NCT00528424|18226291|P1|Overall Study|Lost to Follow-up|13
5284507|NCT00528411|18226306|P3|Overall Study|Prior commitment medication|0
5284508|NCT00528411|18226307|P2|Overall Study|Prior commitment medication|1
5284509|NCT00528411|18226308|P1|Overall Study|Prior commitment medication|0
5284510|NCT00528411|18226306|P3|Overall Study|Severe non-compliance to protocol|0
5284511|NCT00528411|18226307|P2|Overall Study|Severe non-compliance to protocol|1
5284512|NCT00528411|18226308|P1|Overall Study|Severe non-compliance to protocol|0
5284513|NCT00528411|18226306|P3|Overall Study|Incorrect Enrolment|0
5284514|NCT00528411|18226307|P2|Overall Study|Incorrect Enrolment|1
5284515|NCT00528411|18226308|P1|Overall Study|Incorrect Enrolment|1
5284516|NCT00528411|18226306|P3|Overall Study|Adverse Event|1
5284517|NCT00528411|18226307|P2|Overall Study|Adverse Event|0
5284518|NCT00528411|18226308|P1|Overall Study|Adverse Event|4
5284519|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
5284520|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
5284521|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
5284522|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
5284523|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
5284524|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
5284525|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
5284526|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
5284527|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
5284528|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
5284529|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5284530|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
5284531|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5284532|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5284533|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5284534|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5284535|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
5284536|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5284537|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284538|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284539|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284540|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
5284541|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
5284542|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284543|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284544|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284545|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5284546|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5284547|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5284548|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5284549|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5284550|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5284551|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5284552|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5284553|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5284554|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5284555|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
5284556|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
5284557|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
5284558|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
5284559|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
5284560|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
5284561|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
5284562|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
5284563|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
5284564|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
5284565|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
5284566|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
5284567|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
5284568|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
5284569|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
5284570|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
5284571|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
5284572|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
5284573|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
5284574|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
5284575|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
5284576|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
5284577|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
5284578|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
5284579|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
5284580|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
5284581|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
5284582|NCT00528372|18226445|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
5284583|NCT00528372|18226446|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
5284584|NCT00528372|18226447|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
5284585|NCT00528372|18226448|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
5284586|NCT00528372|18226449|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
5284587|NCT00528372|18226450|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
5284588|NCT00528372|18226451|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
5284589|NCT00528372|18226452|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
5284590|NCT00528372|18226453|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
5284591|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
5284592|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
5284593|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
5284594|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
5284595|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
5284596|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
5284597|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
5284598|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
5284599|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
5284600|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5284601|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5284602|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5284603|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
5284604|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5284605|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5284606|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
5284607|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5284608|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
5284609|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284610|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284611|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284612|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
5284613|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284614|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
5284615|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284616|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284617|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5284618|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
5284619|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
5284620|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
5284621|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
5284622|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
5284623|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
5284624|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
5284625|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
5284626|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
5284627|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
5284628|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
5284629|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
5284630|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
5284631|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
5284632|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
5284633|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
5284634|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
5284635|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
5284636|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5284637|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5284638|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
5284639|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
5284640|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5284641|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
5284642|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
5284643|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
5284644|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5284645|NCT00528372|18226445|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284646|NCT00528372|18226446|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284647|NCT00528372|18226447|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284648|NCT00528372|18226448|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284649|NCT00528372|18226449|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284650|NCT00528372|18226450|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284651|NCT00528372|18226451|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284652|NCT00528372|18226452|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5284653|NCT00528372|18226453|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
5284654|NCT00528112|18226585|P2|Extension Phase|Protocol Violation|2
5284655|NCT00528112|18226586|P1|Extension Phase|Protocol Violation|0
5284656|NCT00528112|18226585|P2|Extension Phase|Adverse Event|36
5284657|NCT00528112|18226586|P1|Extension Phase|Adverse Event|0
5284658|NCT00528112|18226585|P2|Extension Phase|Death|1
5284659|NCT00528112|18226586|P1|Extension Phase|Death|0
5284660|NCT00528112|18226585|P2|Extension Phase|Lost to Follow-up|12
5284661|NCT00528112|18226586|P1|Extension Phase|Lost to Follow-up|0
5284662|NCT00528112|18226585|P2|Extension Phase|Pregnancy|3
5284663|NCT00528112|18226586|P1|Extension Phase|Pregnancy|0
5284664|NCT00528112|18226585|P2|Extension Phase|Other reasons|100
5284665|NCT00528112|18226586|P1|Extension Phase|Other reasons|0
5284666|NCT00528112|18226585|P2|Extension Phase|Withdrawal by Subject|3
5284667|NCT00528112|18226586|P1|Extension Phase|Withdrawal by Subject|0
5284668|NCT00528112|18226585|P2|Treatment up to 3 Years|Other reasons|186
5284669|NCT00528112|18226586|P1|Treatment up to 3 Years|Other reasons|186
5284670|NCT00528112|18226585|P2|Treatment up to 3 Years|Pregnancy|10
5284671|NCT00528112|18226586|P1|Treatment up to 3 Years|Pregnancy|9
5284672|NCT00528112|18226585|P2|Treatment up to 3 Years|Lost to Follow-up|61
5284673|NCT00528112|18226586|P1|Treatment up to 3 Years|Lost to Follow-up|63
5284674|NCT00528112|18226585|P2|Treatment up to 3 Years|Death|1
5284675|NCT00528112|18226586|P1|Treatment up to 3 Years|Death|0
5284676|NCT00528112|18226585|P2|Treatment up to 3 Years|Protocol Violation|16
5284677|NCT00528112|18226586|P1|Treatment up to 3 Years|Protocol Violation|16
5284678|NCT00528112|18226585|P2|Treatment up to 3 Years|Withdrawal by Subject|31
5284679|NCT00528112|18226586|P1|Treatment up to 3 Years|Withdrawal by Subject|26
5284680|NCT00528112|18226585|P2|Treatment up to 3 Years|Adverse Event|278
5284681|NCT00528112|18226586|P1|Treatment up to 3 Years|Adverse Event|313
5284682|NCT00528021|18226644|P4|Overall Study|Lack of Efficacy|9
5284683|NCT00528021|18226645|P3|Overall Study|Lack of Efficacy|7
5284684|NCT00528021|18226646|P2|Overall Study|Lack of Efficacy|13
5284685|NCT00528021|18226647|P1|Overall Study|Lack of Efficacy|17
5284686|NCT00527982|18226659|P2|Overall Study|Physician Decision|0
5284687|NCT00527982|18226660|P1|Overall Study|Physician Decision|1
5284688|NCT00527904|18226701|P1|Overall Study|misc|22
5284689|NCT00527904|18226701|P1|Overall Study|Lost to Follow-up|8
5284690|NCT00527904|18226701|P1|Overall Study|Withdrawal by Subject|21
5284691|NCT00527904|18226701|P1|Overall Study|Adverse Event|45
5284692|NCT00527826|18226720|P2|Overall Study|Participant moved away|1
5284693|NCT00527826|18226721|P1|Overall Study|Participant moved away|0
5284694|NCT00527826|18226720|P2|Overall Study|Additional Intake of Viani forte|1
5284695|NCT00527826|18226721|P1|Overall Study|Additional Intake of Viani forte|0
5284696|NCT00527826|18226720|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
5284697|NCT00527826|18226721|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
5284698|NCT00527826|18226720|P2|Overall Study|Inclusion Criteria Not Met|3
5284699|NCT00527826|18226721|P1|Overall Study|Inclusion Criteria Not Met|3
5284700|NCT00527826|18226720|P2|Overall Study|Withdrawal by Subject|8
5284701|NCT00527826|18226721|P1|Overall Study|Withdrawal by Subject|5
5284702|NCT00527826|18226720|P2|Overall Study|Lost to Follow-up|2
5284703|NCT00527826|18226721|P1|Overall Study|Lost to Follow-up|3
5284704|NCT00527826|18226720|P2|Overall Study|Adverse Event|10
5284705|NCT00527826|18226721|P1|Overall Study|Adverse Event|10
5284706|NCT00527787|18226770|P2|Overall Study|misc|2
5284707|NCT00527787|18226771|P1|Overall Study|misc|5
5284708|NCT00527787|18226770|P2|Overall Study|Duodenal Ulcer|10
5284709|NCT00527787|18226771|P1|Overall Study|Duodenal Ulcer|1
5284710|NCT00527787|18226770|P2|Overall Study|Lost to Follow-up|2
5284711|NCT00527787|18226771|P1|Overall Study|Lost to Follow-up|5
5284712|NCT00527787|18226770|P2|Overall Study|Withdrawal by Subject|25
5284713|NCT00527787|18226771|P1|Overall Study|Withdrawal by Subject|13
5284714|NCT00527787|18226770|P2|Overall Study|Adverse Event|24
5284715|NCT00527787|18226771|P1|Overall Study|Adverse Event|14
5284716|NCT00527748|18226793|P1|Overall Study|Other|3
5284717|NCT00527735|18226800|P3|Overall Study|Completed treatment during maintenance|1
5284718|NCT00527735|18226801|P2|Overall Study|Completed treatment during maintenance|2
5284719|NCT00527735|18226802|P1|Overall Study|Completed treatment during maintenance|2
5284720|NCT00527735|18226800|P3|Overall Study|Poor compliance or noncompliance|1
5284721|NCT00527735|18226801|P2|Overall Study|Poor compliance or noncompliance|1
5284722|NCT00527735|18226802|P1|Overall Study|Poor compliance or noncompliance|0
5284723|NCT00527735|18226800|P3|Overall Study|Lost to Follow-up|3
5284724|NCT00527735|18226801|P2|Overall Study|Lost to Follow-up|0
5284725|NCT00527735|18226802|P1|Overall Study|Lost to Follow-up|0
5284726|NCT00527735|18226800|P3|Overall Study|No longer met study criteria|1
5284727|NCT00527735|18226801|P2|Overall Study|No longer met study criteria|2
5284728|NCT00527735|18226802|P1|Overall Study|No longer met study criteria|2
5284729|NCT00527735|18226800|P3|Overall Study|Withdrawal by Subject|3
5284730|NCT00527735|18226801|P2|Overall Study|Withdrawal by Subject|4
5284731|NCT00527735|18226802|P1|Overall Study|Withdrawal by Subject|5
5284732|NCT00527735|18226800|P3|Overall Study|Not identified|5
5284733|NCT00527735|18226801|P2|Overall Study|Not identified|5
5284734|NCT00527735|18226802|P1|Overall Study|Not identified|5
5284735|NCT00527735|18226800|P3|Overall Study|Adverse Event|7
5284736|NCT00527735|18226801|P2|Overall Study|Adverse Event|6
5284737|NCT00527735|18226802|P1|Overall Study|Adverse Event|10
5284738|NCT00527735|18226800|P3|Overall Study|Completed treatment in treatment phase|18
5284739|NCT00527735|18226801|P2|Overall Study|Completed treatment in treatment phase|13
5284740|NCT00527735|18226802|P1|Overall Study|Completed treatment in treatment phase|14
5284741|NCT00527735|18226800|P3|Overall Study|Death|15
5284742|NCT00527735|18226801|P2|Overall Study|Death|13
5284743|NCT00527735|18226802|P1|Overall Study|Death|23
5284744|NCT00527735|18226800|P3|Overall Study|Disease progression|53
5284745|NCT00527735|18226801|P2|Overall Study|Disease progression|61
5284746|NCT00527735|18226802|P1|Overall Study|Disease progression|47
5284747|NCT00527618|18226888|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
5284748|NCT00527618|18226889|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
5284749|NCT00527618|18226888|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
5284750|NCT00527618|18226889|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
5284751|NCT00527618|18226888|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
5284752|NCT00527618|18226889|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
5284753|NCT00527618|18226888|P2|Week 13-14 (Washout)|Lost to Follow-up|0
5284754|NCT00527618|18226889|P1|Week 13-14 (Washout)|Lost to Follow-up|1
5284755|NCT00527618|18226888|P2|Week 1-12 (First Intervention)|Adverse Event|1
5284756|NCT00527618|18226889|P1|Week 1-12 (First Intervention)|Adverse Event|0
5284757|NCT00527618|18226888|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
5284758|NCT00527618|18226889|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
5284759|NCT00527605|18226904|P2|Overall Study|Protocol Violation|2
5284760|NCT00527605|18226905|P1|Overall Study|Protocol Violation|1
5284761|NCT00527605|18226904|P2|Overall Study|Lost to Follow-up|2
5284762|NCT00527605|18226905|P1|Overall Study|Lost to Follow-up|6
5284763|NCT00527605|18226904|P2|Overall Study|Withdrawal by Subject|7
5284764|NCT00527605|18226905|P1|Overall Study|Withdrawal by Subject|3
5284765|NCT00527605|18226904|P2|Overall Study|Adverse Event|0
5284766|NCT00527605|18226905|P1|Overall Study|Adverse Event|3
5284767|NCT00527514|18226956|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
5284768|NCT00527514|18226956|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
5284769|NCT00527514|18226956|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
5284770|NCT00527514|18226956|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
5284771|NCT00527514|18226956|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
5284772|NCT00527514|18226956|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
5284773|NCT00527514|18226956|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
5284774|NCT00527488|18226972|P4|Overall Study|Withdrawn prior to dosing|0
5284775|NCT00527488|18226973|P3|Overall Study|Withdrawn prior to dosing|1
5284776|NCT00527488|18226974|P2|Overall Study|Withdrawn prior to dosing|1
5284777|NCT00527488|18226975|P1|Overall Study|Withdrawn prior to dosing|0
5284778|NCT00527423|18227058|P1|Overall Study|Death|9
5284779|NCT00527423|18227058|P1|Overall Study|OTHER|4
5284780|NCT00527423|18227058|P1|Overall Study|Lost to Follow-up|4
5284781|NCT00527423|18227058|P1|Overall Study|Withdrawal by Subject|10
5284782|NCT00527423|18227058|P1|Overall Study|Physician Decision|4
5284783|NCT00527423|18227058|P1|Overall Study|Adverse Event|5
5284784|NCT00527423|18227058|P1|Overall Study|Protocol Violation|1
5284785|NCT00527397|18227064|P1|Overall Study|Study terminated by sponsor|13
5284786|NCT00527397|18227064|P1|Overall Study|Withdrawal by Subject|6
5284787|NCT00527397|18227064|P1|Overall Study|Protocol Violation|1
5284788|NCT00527397|18227064|P1|Overall Study|Lack of Efficacy|1
5284789|NCT00527397|18227064|P1|Overall Study|Adverse Event|3
5284790|NCT00527332|18227090|P2|Overall Study|Withdrew consent|1
5284791|NCT00527332|18227091|P1|Overall Study|Withdrew consent|5
5284792|NCT00527332|18227090|P2|Overall Study|Protocol Violation|8
5284793|NCT00527332|18227091|P1|Overall Study|Protocol Violation|4
5284794|NCT00527319|18227100|P3|Overall Study|Adverse Event|1
5284795|NCT00527319|18227101|P2|Overall Study|Adverse Event|0
5284796|NCT00527319|18227102|P1|Overall Study|Adverse Event|0
5284797|NCT00527319|18227100|P3|Overall Study|Intercurrent Medical Illness|3
5284798|NCT00527319|18227101|P2|Overall Study|Intercurrent Medical Illness|1
5284799|NCT00527319|18227102|P1|Overall Study|Intercurrent Medical Illness|0
5284800|NCT00527319|18227100|P3|Overall Study|Death|1
5284801|NCT00527319|18227101|P2|Overall Study|Death|3
5284802|NCT00527319|18227102|P1|Overall Study|Death|0
5284803|NCT00527319|18227100|P3|Overall Study|Lost to Follow-up|0
5284804|NCT00527319|18227101|P2|Overall Study|Lost to Follow-up|0
5284805|NCT00527319|18227102|P1|Overall Study|Lost to Follow-up|1
5284806|NCT00527319|18227100|P3|Overall Study|Withdrawal by Subject|1
5284807|NCT00527319|18227101|P2|Overall Study|Withdrawal by Subject|0
5284808|NCT00527319|18227102|P1|Overall Study|Withdrawal by Subject|5
5284809|NCT00527111|18227132|P2|Overall Study|Other|2
5284810|NCT00527111|18227133|P1|Overall Study|Other|2
5284811|NCT00527111|18227132|P2|Overall Study|Patient Request|5
5284812|NCT00527111|18227133|P1|Overall Study|Patient Request|2
5284813|NCT00527111|18227132|P2|Overall Study|Investigator Request|1
5284814|NCT00527111|18227133|P1|Overall Study|Investigator Request|2
5284815|NCT00527111|18227132|P2|Overall Study|Death|1
5284816|NCT00527111|18227133|P1|Overall Study|Death|0
5284817|NCT00527111|18227132|P2|Overall Study|Adverse Event|13
5284818|NCT00527111|18227133|P1|Overall Study|Adverse Event|14
5284819|NCT00527072|18227155|P1|Overall Study|Withdrawal by Subject|7
5284820|NCT00527072|18227155|P1|Overall Study|Protocol Violation|2
5284821|NCT00527072|18227155|P1|Overall Study|Lost to Follow-up|3
5284822|NCT00527072|18227155|P1|Overall Study|Lack of Efficacy|11
5284823|NCT00527072|18227155|P1|Overall Study|Adverse Event|13
5284824|NCT00526994|18227164|P3|Overall Study|incarcerated, impaired, incomplete|3
5284825|NCT00526994|18227165|P2|Overall Study|incarcerated, impaired, incomplete|3
5284826|NCT00526994|18227166|P1|Overall Study|incarcerated, impaired, incomplete|4
5284827|NCT00526994|18227164|P3|Overall Study|Withdrawal by Subject|5
5284828|NCT00526994|18227165|P2|Overall Study|Withdrawal by Subject|7
5284829|NCT00526994|18227166|P1|Overall Study|Withdrawal by Subject|2
5284830|NCT00526994|18227164|P3|Overall Study|Death|3
5284831|NCT00526994|18227165|P2|Overall Study|Death|3
5284832|NCT00526994|18227166|P1|Overall Study|Death|4
5284833|NCT00526994|18227164|P3|Overall Study|Lost to Follow-up|96
5284834|NCT00526994|18227165|P2|Overall Study|Lost to Follow-up|108
5284835|NCT00526994|18227166|P1|Overall Study|Lost to Follow-up|98
5284836|NCT00526890|18227183|P1|Overall Study|Adverse Event|2
5284837|NCT00526799|18227195|P2|Overall Study|Intercurrent Complicating Disease|1
5284838|NCT00526799|18227196|P1|Overall Study|Intercurrent Complicating Disease|0
5284839|NCT00526799|18227195|P2|Overall Study|Withdrawal by Subject|0
5284840|NCT00526799|18227196|P1|Overall Study|Withdrawal by Subject|1
5284841|NCT00526669|18227204|P2|Combined Treatment Phase|Death|2
5284842|NCT00526669|18227205|P1|Combined Treatment Phase|Death|0
5284843|NCT00526669|18227204|P2|Combined Treatment Phase|Sponsor Terminated Study|2
5284844|NCT00526669|18227205|P1|Combined Treatment Phase|Sponsor Terminated Study|0
5284845|NCT00526669|18227204|P2|Combined Treatment Phase|Withdrawal by Subject|2
5284846|NCT00526669|18227205|P1|Combined Treatment Phase|Withdrawal by Subject|0
5284847|NCT00526669|18227204|P2|Combined Treatment Phase|Lost to Follow-up|2
5284848|NCT00526669|18227205|P1|Combined Treatment Phase|Lost to Follow-up|0
5284849|NCT00526656|18227234|P1|Overall Study|Refused surgery|1
5284850|NCT00526656|18227234|P1|Overall Study|Death|1
5284851|NCT00526630|18227240|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
5284852|NCT00526630|18227241|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
5284853|NCT00526630|18227240|P2|First Intervention Period - 12 Weeks|Withdrawn|3
5284854|NCT00526630|18227241|P1|First Intervention Period - 12 Weeks|Withdrawn|0
5284855|NCT00526331|18227353|P1|Overall Study|Sponsor Termination|55
5284856|NCT00526227|18227361|P1|Overall Study|Death|1
5284857|NCT00526227|18227361|P1|Overall Study|Device not implanted|1
5284858|NCT00526162|18227372|P1|Overall Study|Device not implanted|3
5284859|NCT00526110|18227405|P2|Overall Study|Poor Tolerance|5
5284860|NCT00526110|18227406|P1|Overall Study|Poor Tolerance|0
5284861|NCT00526110|18227405|P2|Overall Study|Withdrawal by Subject|2
5284862|NCT00526110|18227406|P1|Overall Study|Withdrawal by Subject|0
5284863|NCT00526110|18227405|P2|Overall Study|Maximal Response|6
5284864|NCT00526110|18227406|P1|Overall Study|Maximal Response|0
5284865|NCT00526110|18227405|P2|Overall Study|Disease Progression|19
5284866|NCT00526110|18227406|P1|Overall Study|Disease Progression|0
5284867|NCT00526110|18227405|P2|Overall Study|Adverse Event|9
5284868|NCT00526110|18227406|P1|Overall Study|Adverse Event|2
5284869|NCT00526097|18227415|P2|Overall Study|Other|1
5284870|NCT00526097|18227416|P1|Overall Study|Other|2
5284871|NCT00526097|18227415|P2|Overall Study|Withdrawal by Subject|1
5284872|NCT00526097|18227416|P1|Overall Study|Withdrawal by Subject|3
5284873|NCT00526097|18227415|P2|Overall Study|Protocol Violation|10
5284874|NCT00526097|18227416|P1|Overall Study|Protocol Violation|4
5284875|NCT00526097|18227415|P2|Overall Study|Adverse Event|44
5284876|NCT00526097|18227416|P1|Overall Study|Adverse Event|6
5284877|NCT00526071|18227592|P1|Overall Study|Lack of Response to Study Drug|4
5284878|NCT00526071|18227592|P1|Overall Study|Withdrawal by Subject|1
5284879|NCT00526071|18227592|P1|Overall Study|Adverse Event|1
5284880|NCT00525915|18227618|P2|Overall Study|Unrelated illness|0
5284881|NCT00525915|18227619|P1|Overall Study|Unrelated illness|1
5284882|NCT00525915|18227618|P2|Overall Study|Refused Surgery|2
5284883|NCT00525915|18227619|P1|Overall Study|Refused Surgery|1
5284884|NCT00525915|18227618|P2|Overall Study|Withdrawal by Subject|0
5284885|NCT00525915|18227619|P1|Overall Study|Withdrawal by Subject|1
5284886|NCT00525915|18227618|P2|Overall Study|Disease Progression|6
5284887|NCT00525915|18227619|P1|Overall Study|Disease Progression|5
5284888|NCT00525915|18227618|P2|Overall Study|Non-Compliance|1
5284889|NCT00525915|18227619|P1|Overall Study|Non-Compliance|0
5284890|NCT00525902|18227625|P1|Overall Study|Lack of Efficacy|1
5284891|NCT00525824|18227649|P4|Overall Study|Other|1
5284892|NCT00525824|18227650|P3|Overall Study|Other|3
5284893|NCT00525824|18227651|P2|Overall Study|Other|3
5284894|NCT00525824|18227652|P1|Overall Study|Other|1
5284895|NCT00525824|18227649|P4|Overall Study|Safety reasons|0
5284896|NCT00525824|18227650|P3|Overall Study|Safety reasons|1
5284897|NCT00525824|18227651|P2|Overall Study|Safety reasons|0
5284898|NCT00525824|18227652|P1|Overall Study|Safety reasons|1
5284899|NCT00525824|18227649|P4|Overall Study|Severe non-compliance|1
5284900|NCT00525824|18227650|P3|Overall Study|Severe non-compliance|1
5284901|NCT00525824|18227651|P2|Overall Study|Severe non-compliance|1
5284902|NCT00525824|18227652|P1|Overall Study|Severe non-compliance|0
5284903|NCT00525824|18227649|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
5284904|NCT00525824|18227650|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
5284905|NCT00525824|18227651|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
5284906|NCT00525824|18227652|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
5284907|NCT00525824|18227649|P4|Overall Study|Lost to Follow-up|0
5284908|NCT00525824|18227650|P3|Overall Study|Lost to Follow-up|4
5284909|NCT00525824|18227651|P2|Overall Study|Lost to Follow-up|2
5284910|NCT00525824|18227652|P1|Overall Study|Lost to Follow-up|4
5284911|NCT00525824|18227649|P4|Overall Study|Withdrawal by Subject|4
5284912|NCT00525824|18227650|P3|Overall Study|Withdrawal by Subject|3
5284913|NCT00525824|18227651|P2|Overall Study|Withdrawal by Subject|9
5284914|NCT00525824|18227652|P1|Overall Study|Withdrawal by Subject|5
5284915|NCT00525824|18227649|P4|Overall Study|Adverse Event|7
5284916|NCT00525824|18227650|P3|Overall Study|Adverse Event|6
5284917|NCT00525824|18227651|P2|Overall Study|Adverse Event|11
5284918|NCT00525824|18227652|P1|Overall Study|Adverse Event|7
5284919|NCT00525785|18227725|P1|Overall Study|Physician Decision|1
5284920|NCT00525785|18227725|P1|Overall Study|Lack of Efficacy|1
5284921|NCT00525785|18227725|P1|Overall Study|Withdrawal by Subject|1
5284922|NCT00525590|18227749|P1|Overall Study|Other|13
5284923|NCT00525590|18227749|P1|Overall Study|Death|9
5284924|NCT00525590|18227749|P1|Overall Study|Lost to Follow-up|1
5284925|NCT00525590|18227749|P1|Overall Study|Withdrawal by Subject|16
5284926|NCT00525590|18227749|P1|Overall Study|Physician Decision|3
5284927|NCT00525590|18227749|P1|Overall Study|Adverse Event|3
5284928|NCT00525512|18227777|P4|Open-Label Phase|Other reason (not specified)|5
5284929|NCT00525512|18227778|P3|Open-Label Phase|Other reason (not specified)|4
5284930|NCT00525512|18227779|P2|Open-Label Phase|Other reason (not specified)|0
5284931|NCT00525512|18227780|P1|Open-Label Phase|Other reason (not specified)|0
5284932|NCT00525512|18227777|P4|Open-Label Phase|Lost to Follow-up|0
5284933|NCT00525512|18227778|P3|Open-Label Phase|Lost to Follow-up|1
5284934|NCT00525512|18227779|P2|Open-Label Phase|Lost to Follow-up|0
5284935|NCT00525512|18227780|P1|Open-Label Phase|Lost to Follow-up|0
5284936|NCT00525512|18227777|P4|Open-Label Phase|Adverse Event|0
5284937|NCT00525512|18227778|P3|Open-Label Phase|Adverse Event|1
5284938|NCT00525512|18227779|P2|Open-Label Phase|Adverse Event|0
5284939|NCT00525512|18227780|P1|Open-Label Phase|Adverse Event|0
5284940|NCT00525512|18227777|P4|Double-Blind Phase|Other reason (not specified)|0
5284941|NCT00525512|18227778|P3|Double-Blind Phase|Other reason (not specified)|0
5284942|NCT00525512|18227779|P2|Double-Blind Phase|Other reason (not specified)|13
5284943|NCT00525512|18227780|P1|Double-Blind Phase|Other reason (not specified)|12
5284944|NCT00525512|18227777|P4|Double-Blind Phase|Lack of Efficacy|0
5284945|NCT00525512|18227778|P3|Double-Blind Phase|Lack of Efficacy|0
5284946|NCT00525512|18227779|P2|Double-Blind Phase|Lack of Efficacy|5
5284947|NCT00525512|18227780|P1|Double-Blind Phase|Lack of Efficacy|13
5284948|NCT00525512|18227777|P4|Double-Blind Phase|Withdrawal by Subject|0
5284949|NCT00525512|18227778|P3|Double-Blind Phase|Withdrawal by Subject|0
5284950|NCT00525512|18227779|P2|Double-Blind Phase|Withdrawal by Subject|12
5284951|NCT00525512|18227780|P1|Double-Blind Phase|Withdrawal by Subject|17
5284952|NCT00525512|18227777|P4|Double-Blind Phase|Lost to Follow-up|0
5284953|NCT00525512|18227778|P3|Double-Blind Phase|Lost to Follow-up|0
5284954|NCT00525512|18227779|P2|Double-Blind Phase|Lost to Follow-up|7
5284955|NCT00525512|18227780|P1|Double-Blind Phase|Lost to Follow-up|3
5284956|NCT00525512|18227777|P4|Double-Blind Phase|Protocol Violation|0
5284957|NCT00525512|18227778|P3|Double-Blind Phase|Protocol Violation|0
5284958|NCT00525512|18227779|P2|Double-Blind Phase|Protocol Violation|1
5284959|NCT00525512|18227780|P1|Double-Blind Phase|Protocol Violation|3
5284960|NCT00525512|18227777|P4|Double-Blind Phase|Adverse Event|0
5284961|NCT00525512|18227778|P3|Double-Blind Phase|Adverse Event|0
5284962|NCT00525512|18227779|P2|Double-Blind Phase|Adverse Event|28
5284963|NCT00525512|18227780|P1|Double-Blind Phase|Adverse Event|48
5284964|NCT00525499|18227922|P4|Overall Study|Protocol Violation|0
5284965|NCT00525499|18227923|P3|Overall Study|Protocol Violation|1
5284966|NCT00525499|18227924|P2|Overall Study|Protocol Violation|1
5284967|NCT00525499|18227925|P1|Overall Study|Protocol Violation|0
5284968|NCT00525499|18227922|P4|Overall Study|Withdrawal by Subject|2
5284969|NCT00525499|18227923|P3|Overall Study|Withdrawal by Subject|5
5284970|NCT00525499|18227924|P2|Overall Study|Withdrawal by Subject|1
5284971|NCT00525499|18227925|P1|Overall Study|Withdrawal by Subject|5
5284972|NCT00525499|18227922|P4|Overall Study|Adverse Event|1
5284973|NCT00525499|18227923|P3|Overall Study|Adverse Event|0
5284974|NCT00525499|18227924|P2|Overall Study|Adverse Event|1
5284975|NCT00525499|18227925|P1|Overall Study|Adverse Event|0
5284976|NCT00525499|18227922|P4|Overall Study|Lost to Follow-up|4
5284977|NCT00525499|18227923|P3|Overall Study|Lost to Follow-up|1
5284978|NCT00525499|18227924|P2|Overall Study|Lost to Follow-up|4
5284979|NCT00525499|18227925|P1|Overall Study|Lost to Follow-up|2
5284980|NCT00525265|18227952|P2|Overall Study|Protocol Violation|0
5284981|NCT00525265|18227953|P1|Overall Study|Protocol Violation|1
5284982|NCT00525161|18228010|P1|Overall Study|Adverse Event|1
5284983|NCT00525148|18228020|P4|Overall Study|Other than stated|3
5284984|NCT00525148|18228021|P3|Overall Study|Other than stated|0
5284985|NCT00525148|18228022|P2|Overall Study|Other than stated|1
5284986|NCT00525148|18228023|P1|Overall Study|Other than stated|2
5284987|NCT00525148|18228020|P4|Overall Study|Refused continuation of study medication|1
5284988|NCT00525148|18228021|P3|Overall Study|Refused continuation of study medication|0
5284989|NCT00525148|18228022|P2|Overall Study|Refused continuation of study medication|2
5284990|NCT00525148|18228023|P1|Overall Study|Refused continuation of study medication|0
5284991|NCT00525148|18228020|P4|Overall Study|Progressive disease|49
5284992|NCT00525148|18228021|P3|Overall Study|Progressive disease|6
5284993|NCT00525148|18228022|P2|Overall Study|Progressive disease|30
5284994|NCT00525148|18228023|P1|Overall Study|Progressive disease|18
5284995|NCT00525148|18228020|P4|Overall Study|Other Adverse Event|8
5284996|NCT00525148|18228021|P3|Overall Study|Other Adverse Event|1
5284997|NCT00525148|18228022|P2|Overall Study|Other Adverse Event|5
5284998|NCT00525148|18228023|P1|Overall Study|Other Adverse Event|3
5284999|NCT00525044|18228051|P2|Overall Study|Lost to Follow-up|1
5285000|NCT00525044|18228052|P1|Overall Study|Lost to Follow-up|0
5285001|NCT00525031|18228068|P2|Overall Study|Disease Progression|1
5285002|NCT00525031|18228069|P1|Overall Study|Disease Progression|1
5285003|NCT00524771|18228083|P2|Overall Study|Protocol Violation|585
5285004|NCT00524771|18228084|P1|Overall Study|Protocol Violation|220
5285005|NCT00524745|18228098|P4|Overall Study|subject withdrawal or lost to follow up|22
5285006|NCT00524745|18228099|P3|Overall Study|subject withdrawal or lost to follow up|29
5285007|NCT00524745|18228100|P2|Overall Study|subject withdrawal or lost to follow up|13
5285008|NCT00524745|18228101|P1|Overall Study|subject withdrawal or lost to follow up|34
5285009|NCT00524680|18228127|P4|Overall Study|Withdrawal by Subject|1
5285010|NCT00524680|18228128|P3|Overall Study|Withdrawal by Subject|1
5285011|NCT00524680|18228129|P2|Overall Study|Withdrawal by Subject|0
5285012|NCT00524680|18228130|P1|Overall Study|Withdrawal by Subject|1
5285013|NCT00524680|18228127|P4|Overall Study|Other|3
5285014|NCT00524680|18228128|P3|Overall Study|Other|2
5285015|NCT00524680|18228129|P2|Overall Study|Other|1
5285016|NCT00524680|18228130|P1|Overall Study|Other|0
5285017|NCT00524680|18228127|P4|Overall Study|Adverse Event|1
5285018|NCT00524680|18228128|P3|Overall Study|Adverse Event|0
5285019|NCT00524680|18228129|P2|Overall Study|Adverse Event|0
5285020|NCT00524680|18228130|P1|Overall Study|Adverse Event|2
5285021|NCT00524680|18228127|P4|Overall Study|progression|1
5285022|NCT00524680|18228128|P3|Overall Study|progression|0
5285023|NCT00524680|18228129|P2|Overall Study|progression|0
5285024|NCT00524680|18228130|P1|Overall Study|progression|0
5285025|NCT00524589|18228152|P1|Overall Study|Disease Progression|16
5285026|NCT00524589|18228152|P1|Overall Study|Withdrawal by Subject|2
5285027|NCT00524485|18228203|P1|Overall Study|Withdrawal by Subject|5
5285028|NCT00524459|18228232|P1|Overall Study|Other|1
5285029|NCT00524459|18228232|P1|Overall Study|Withdrawal by Subject|1
5285030|NCT00524420|18228242|P2|Overall Study|Lack of Efficacy|0
5285031|NCT00524420|18228243|P1|Overall Study|Lack of Efficacy|1
5285032|NCT00524368|18228261|P2|Overall Study|Other|2
5285033|NCT00524368|18228262|P1|Overall Study|Other|3
5285034|NCT00524368|18228261|P2|Overall Study|Ineligible to Continue the study|5
5285035|NCT00524368|18228262|P1|Overall Study|Ineligible to Continue the study|2
5285036|NCT00524368|18228261|P2|Overall Study|Sponsor's Decision|0
5285037|NCT00524368|18228262|P1|Overall Study|Sponsor's Decision|2
5285038|NCT00524368|18228261|P2|Overall Study|Reached a Virologic Endpoint|2
5285039|NCT00524368|18228262|P1|Overall Study|Reached a Virologic Endpoint|3
5285040|NCT00524368|18228261|P2|Overall Study|Non-compliant|9
5285041|NCT00524368|18228262|P1|Overall Study|Non-compliant|8
5285042|NCT00524368|18228261|P2|Overall Study|Withdrawal by Subject|5
5285043|NCT00524368|18228262|P1|Overall Study|Withdrawal by Subject|4
5285044|NCT00524368|18228261|P2|Overall Study|Lost to Follow-up|13
5285045|NCT00524368|18228262|P1|Overall Study|Lost to Follow-up|9
5285046|NCT00524368|18228261|P2|Overall Study|Adverse Event|12
5285047|NCT00524368|18228262|P1|Overall Study|Adverse Event|10
5285048|NCT00524316|18228296|P1|Overall Study|Disease Progression|7
5285049|NCT00524316|18228296|P1|Overall Study|Adverse Event|7
5285050|NCT00524316|18228296|P1|Overall Study|Withdrawal by Subject|2
5285051|NCT00524303|18228308|P3|Overall Study|Completed 5 years|1
5285052|NCT00524303|18228309|P2|Overall Study|Completed 5 years|0
5285053|NCT00524303|18228310|P1|Overall Study|Completed 5 years|0
5285054|NCT00524303|18228308|P3|Overall Study|Physician Decision|1
5285055|NCT00524303|18228309|P2|Overall Study|Physician Decision|0
5285056|NCT00524303|18228310|P1|Overall Study|Physician Decision|0
5285057|NCT00524303|18228308|P3|Overall Study|Sponsor Request|1
5285058|NCT00524303|18228309|P2|Overall Study|Sponsor Request|0
5285059|NCT00524303|18228310|P1|Overall Study|Sponsor Request|0
5285060|NCT00524303|18228308|P3|Overall Study|Disease Recurrence|0
5285061|NCT00524303|18228309|P2|Overall Study|Disease Recurrence|1
5285062|NCT00524303|18228310|P1|Overall Study|Disease Recurrence|0
5285063|NCT00524303|18228308|P3|Overall Study|Disease Progression|1
5285064|NCT00524303|18228309|P2|Overall Study|Disease Progression|4
5285065|NCT00524303|18228310|P1|Overall Study|Disease Progression|0
5285066|NCT00524303|18228308|P3|Overall Study|Worsening Peripheral Neuropathy|0
5285067|NCT00524303|18228309|P2|Overall Study|Worsening Peripheral Neuropathy|0
5285068|NCT00524303|18228310|P1|Overall Study|Worsening Peripheral Neuropathy|1
5285069|NCT00524303|18228308|P3|Overall Study|Did not Complete Study Dosing|0
5285070|NCT00524303|18228309|P2|Overall Study|Did not Complete Study Dosing|0
5285071|NCT00524303|18228310|P1|Overall Study|Did not Complete Study Dosing|1
5285072|NCT00524303|18228308|P3|Overall Study|Adverse Event|3
5285073|NCT00524303|18228309|P2|Overall Study|Adverse Event|2
5285074|NCT00524303|18228310|P1|Overall Study|Adverse Event|1
5285075|NCT00524303|18228308|P3|Overall Study|Death|3
5285076|NCT00524303|18228309|P2|Overall Study|Death|2
5285077|NCT00524303|18228310|P1|Overall Study|Death|0
5285078|NCT00524303|18228308|P3|Overall Study|Withdrawal by Subject|4
5285079|NCT00524303|18228309|P2|Overall Study|Withdrawal by Subject|0
5285080|NCT00524303|18228310|P1|Overall Study|Withdrawal by Subject|3
5285081|NCT00524303|18228308|P3|Overall Study|Protocol Violation|1
5285082|NCT00524303|18228309|P2|Overall Study|Protocol Violation|1
5285083|NCT00524303|18228310|P1|Overall Study|Protocol Violation|0
5285084|NCT00524303|18228308|P3|Overall Study|Lost to Follow-up|3
5285085|NCT00524303|18228309|P2|Overall Study|Lost to Follow-up|0
5285086|NCT00524303|18228310|P1|Overall Study|Lost to Follow-up|6
5285087|NCT00524173|18228362|P2|Overall Study|Had not reached endpoint at study close|1
5285088|NCT00524173|18228363|P1|Overall Study|Had not reached endpoint at study close|4
5285089|NCT00524173|18228362|P2|Overall Study|Death|0
5285090|NCT00524173|18228363|P1|Overall Study|Death|1
5285091|NCT00524173|18228362|P2|Overall Study|Lost to Follow-up|1
5285092|NCT00524173|18228363|P1|Overall Study|Lost to Follow-up|0
5285093|NCT00524134|18228375|P1|Overall Study|Physician Decision|1
5285094|NCT00524134|18228375|P1|Overall Study|Withdrawal by Subject|1
5285095|NCT00524121|18228382|P1|Overall Study|Not treated (changed mind)|1
5285096|NCT00524121|18228382|P1|Overall Study|Not treated (became ineligible)|4
5285097|NCT00524121|18228382|P1|Overall Study|Death|1
5285098|NCT00524121|18228382|P1|Overall Study|Other|1
5285099|NCT00524121|18228382|P1|Overall Study|Patient refused|2
5285100|NCT00524121|18228382|P1|Overall Study|Adverse Event|4
5285101|NCT00524121|18228382|P1|Overall Study|Disease progression|6
5285102|NCT00524043|18228402|P3|Overall Study|Various (eg, incarceration)|0
5285103|NCT00524043|18228403|P2|Overall Study|Various (eg, incarceration)|1
5285104|NCT00524043|18228404|P1|Overall Study|Various (eg, incarceration)|2
5285105|NCT00524043|18228402|P3|Overall Study|Lost to Follow-up|3
5285106|NCT00524043|18228403|P2|Overall Study|Lost to Follow-up|5
5285107|NCT00524043|18228404|P1|Overall Study|Lost to Follow-up|3
5285108|NCT00524043|18228402|P3|Overall Study|Adverse Event|7
5285109|NCT00524043|18228403|P2|Overall Study|Adverse Event|2
5285110|NCT00524043|18228404|P1|Overall Study|Adverse Event|5
5285111|NCT00524043|18228402|P3|Overall Study|Withdrawal by Subject|7
5285112|NCT00524043|18228403|P2|Overall Study|Withdrawal by Subject|7
5285113|NCT00524043|18228404|P1|Overall Study|Withdrawal by Subject|5
5285114|NCT00524043|18228402|P3|Overall Study|Lack of Efficacy|14
5285115|NCT00524043|18228403|P2|Overall Study|Lack of Efficacy|13
5285116|NCT00524043|18228404|P1|Overall Study|Lack of Efficacy|15
5285117|NCT00524030|18228426|P2|Overall Study|Death|1
5285118|NCT00524030|18228427|P1|Overall Study|Death|0
5285119|NCT00524030|18228426|P2|Overall Study|Adverse Event|21
5285120|NCT00524030|18228427|P1|Overall Study|Adverse Event|3
5285121|NCT00524030|18228426|P2|Overall Study|Pregnancy|0
5285122|NCT00524030|18228427|P1|Overall Study|Pregnancy|1
5285123|NCT00524030|18228426|P2|Overall Study|Protocol Violation|1
5285124|NCT00524030|18228427|P1|Overall Study|Protocol Violation|0
5285125|NCT00524030|18228426|P2|Overall Study|Noncompliance/Investigator discretion|2
5285126|NCT00524030|18228427|P1|Overall Study|Noncompliance/Investigator discretion|0
5285127|NCT00524030|18228426|P2|Overall Study|Withdrawal by Subject|8
5285128|NCT00524030|18228427|P1|Overall Study|Withdrawal by Subject|3
5285129|NCT00524030|18228426|P2|Overall Study|Lost to Follow-up|2
5285130|NCT00524030|18228427|P1|Overall Study|Lost to Follow-up|0
5285131|NCT00524030|18228426|P2|Overall Study|Lack of Efficacy|24
5285132|NCT00524030|18228427|P1|Overall Study|Lack of Efficacy|10
5285133|NCT00523991|18228466|P2|Overall Study|Other reason (not specified)|0
5285134|NCT00523991|18228467|P1|Overall Study|Other reason (not specified)|3
5285135|NCT00523991|18228466|P2|Overall Study|Withdrawal by Subject|17
5285136|NCT00523991|18228467|P1|Overall Study|Withdrawal by Subject|7
5285137|NCT00523991|18228466|P2|Overall Study|Lost to Follow-up|1
5285138|NCT00523991|18228467|P1|Overall Study|Lost to Follow-up|4
5285139|NCT00523991|18228466|P2|Overall Study|Protocol Violation|4
5285140|NCT00523991|18228467|P1|Overall Study|Protocol Violation|1
5285141|NCT00523991|18228466|P2|Overall Study|Adverse Event|5
5285142|NCT00523991|18228467|P1|Overall Study|Adverse Event|6
5285143|NCT00523978|18228747|P2|Overall Study|Death|0
5285144|NCT00523978|18228748|P1|Overall Study|Death|1
5285145|NCT00523978|18228747|P2|Overall Study|Screen Failures|1
5285146|NCT00523978|18228748|P1|Overall Study|Screen Failures|5
5285147|NCT00523978|18228747|P2|Overall Study|Withdrawal by Subject|7
5285148|NCT00523978|18228748|P1|Overall Study|Withdrawal by Subject|3
5285149|NCT00523848|18228770|P1|Overall Study|Other, unspecified|4
5285150|NCT00523848|18228770|P1|Overall Study|Disease Progression|5
5285151|NCT00523848|18228770|P1|Overall Study|NOT TREATED (Became ineligible)|2
5285152|NCT00523848|18228770|P1|Overall Study|Withdrawal by Subject|2
5285153|NCT00523848|18228770|P1|Overall Study|Adverse Event|11
5285154|NCT00523744|18228780|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
5285155|NCT00523744|18228780|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
5285156|NCT00523744|18228780|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
5285157|NCT00523744|18228780|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
5285158|NCT00523744|18228780|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
5285159|NCT00523744|18228780|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
5285160|NCT00523718|18228799|P2|Overall Study|Protocol Violation|0
5285161|NCT00523718|18228800|P1|Overall Study|Protocol Violation|2
5285162|NCT00523718|18228799|P2|Overall Study|Withdrawal by Subject|0
5285163|NCT00523718|18228800|P1|Overall Study|Withdrawal by Subject|1
5285164|NCT00523705|18228814|P2|Overall Study|No time for study.|1
5285165|NCT00523705|18228815|P1|Overall Study|No time for study.|0
5285166|NCT00523640|18228827|P1|Overall Study|Death|1
5285167|NCT00523549|18228844|P2|Overall Study|Lost to Follow-up|5
5285168|NCT00523549|18228845|P1|Overall Study|Lost to Follow-up|3
5285169|NCT00523549|18228844|P2|Overall Study|Patient withdrew consent|6
5285170|NCT00523549|18228845|P1|Overall Study|Patient withdrew consent|7
5285171|NCT00523549|18228844|P2|Overall Study|Protocol Deviation|1
5285172|NCT00523549|18228845|P1|Overall Study|Protocol Deviation|3
5285173|NCT00523549|18228844|P2|Overall Study|Unsatisfactory therapeutic effect|1
5285174|NCT00523549|18228845|P1|Overall Study|Unsatisfactory therapeutic effect|0
5285175|NCT00523549|18228844|P2|Overall Study|Adverse Event|3
5285176|NCT00523549|18228845|P1|Overall Study|Adverse Event|6
5285177|NCT00523419|18228863|P1|Overall Study|Death due to Adverse Event|2
5285178|NCT00523419|18228863|P1|Overall Study|Death due to Study Disease|4
5285179|NCT00523419|18228863|P1|Overall Study|Progressive Disease|22
5285180|NCT00523419|18228863|P1|Overall Study|Physician Decision|2
5285181|NCT00523419|18228863|P1|Overall Study|Withdrawal by Subject|1
5285182|NCT00523419|18228863|P1|Overall Study|Adverse Event|1
5285183|NCT00523367|18228873|P1|Overall Study|4 Withdrawn by PI|4
5285184|NCT00523367|18228873|P1|Overall Study|19 screen failures|19
5285185|NCT00523341|18228879|P2|Overall Study|Disease Progression|0
5285186|NCT00523341|18228880|P1|Overall Study|Disease Progression|1
5285187|NCT00523341|18228879|P2|Overall Study|Ineligibility Determined|4
5285188|NCT00523341|18228880|P1|Overall Study|Ineligibility Determined|3
5285189|NCT00523341|18228879|P2|Overall Study|Protocol Deviation|5
5285190|NCT00523341|18228880|P1|Overall Study|Protocol Deviation|6
5285191|NCT00523341|18228879|P2|Overall Study|Requirement for Alternative Therapy|14
5285192|NCT00523341|18228880|P1|Overall Study|Requirement for Alternative Therapy|4
5285193|NCT00523341|18228879|P2|Overall Study|Physician Decision|13
5285194|NCT00523341|18228880|P1|Overall Study|Physician Decision|14
5285195|NCT00523341|18228879|P2|Overall Study|Non-compliance|13
5285196|NCT00523341|18228880|P1|Overall Study|Non-compliance|20
5285197|NCT00523341|18228879|P2|Overall Study|Lost to Follow-up|61
5285198|NCT00523341|18228880|P1|Overall Study|Lost to Follow-up|73
5285199|NCT00523341|18228879|P2|Overall Study|Death|110
5285200|NCT00523341|18228880|P1|Overall Study|Death|101
5285201|NCT00523341|18228879|P2|Overall Study|Adverse Event|155
5285202|NCT00523341|18228880|P1|Overall Study|Adverse Event|122
5285203|NCT00523341|18228879|P2|Overall Study|Other|198
5285204|NCT00523341|18228880|P1|Overall Study|Other|181
5285205|NCT00523341|18228879|P2|Overall Study|Withdrawal by Subject|427
5285206|NCT00523341|18228880|P1|Overall Study|Withdrawal by Subject|399
5285207|NCT00522951|18228997|P2|Period 2|residual contrast medium|1
5285208|NCT00522951|18228998|P1|Period 2|residual contrast medium|1
5285209|NCT00522951|18228997|P2|Period 2|Withdrawal by Subject|0
5285210|NCT00522951|18228998|P1|Period 2|Withdrawal by Subject|1
5285211|NCT00522951|18228997|P2|Washout Period|Death|1
5285212|NCT00522951|18228998|P1|Washout Period|Death|0
5285213|NCT00522951|18228997|P2|Washout Period|Adverse Event|1
5285214|NCT00522951|18228998|P1|Washout Period|Adverse Event|0
5285215|NCT00522951|18228997|P2|Period 1|body motion|1
5285216|NCT00522951|18228998|P1|Period 1|body motion|0
5285217|NCT00522873|18229053|P2|Overall Study|Never Received Medication|0
5285218|NCT00522873|18229054|P1|Overall Study|Never Received Medication|1
5285219|NCT00522873|18229053|P2|Overall Study|Medication Errors|1
5285220|NCT00522873|18229054|P1|Overall Study|Medication Errors|1
5285221|NCT00522873|18229053|P2|Overall Study|Personal Reasons|1
5285222|NCT00522873|18229054|P1|Overall Study|Personal Reasons|8
5285223|NCT00522873|18229053|P2|Overall Study|Lost to Follow-up|3
5285224|NCT00522873|18229054|P1|Overall Study|Lost to Follow-up|11
5285225|NCT00522873|18229053|P2|Overall Study|Protocol Violation|4
5285226|NCT00522873|18229054|P1|Overall Study|Protocol Violation|14
5285227|NCT00522873|18229053|P2|Overall Study|Withdrawal by Subject|9
5285228|NCT00522873|18229054|P1|Overall Study|Withdrawal by Subject|20
5285229|NCT00522873|18229053|P2|Overall Study|Adverse Event|26
5285230|NCT00522873|18229054|P1|Overall Study|Adverse Event|41
5285231|NCT00522626|18229067|P1|Overall Study|Lost to Follow-up|7
5285232|NCT00522548|18229073|P2|Overall Study|Withdrawal by Subject|2
5285233|NCT00522548|18229074|P1|Overall Study|Withdrawal by Subject|0
5285234|NCT00522548|18229073|P2|Overall Study|Adverse Event|2
5285235|NCT00522548|18229074|P1|Overall Study|Adverse Event|2
5285236|NCT00522457|18229102|P1|Overall Study|Adverse Event|2
5285237|NCT00522457|18229102|P1|Overall Study|Due to disease progression|16
5285238|NCT00522431|18229108|P1|Overall Study|Other/unknown|1
5285239|NCT00522431|18229108|P1|Overall Study|Subject non-compliance|1
5285240|NCT00522431|18229108|P1|Overall Study|Withdrawal by Subject|2
5285241|NCT00522431|18229108|P1|Overall Study|Protocol Violation|2
5285242|NCT00522431|18229108|P1|Overall Study|Adverse Event|5
5285243|NCT00522418|18229115|P2|Overall Study|Lack of Efficacy|1
5285244|NCT00522418|18229116|P1|Overall Study|Lack of Efficacy|0
5285245|NCT00522418|18229115|P2|Overall Study|Consent Withdraw|2
5285246|NCT00522418|18229116|P1|Overall Study|Consent Withdraw|1
5285247|NCT00522418|18229115|P2|Overall Study|Reason Not Specified|1
5285248|NCT00522418|18229116|P1|Overall Study|Reason Not Specified|3
5285249|NCT00522418|18229115|P2|Overall Study|Noncompliance|2
5285250|NCT00522418|18229116|P1|Overall Study|Noncompliance|2
5285251|NCT00522418|18229115|P2|Overall Study|Early Study Termination|47
5285252|NCT00522418|18229116|P1|Overall Study|Early Study Termination|46
5285253|NCT00522418|18229115|P2|Overall Study|Local IRB Consent Violation|5
5285254|NCT00522418|18229116|P1|Overall Study|Local IRB Consent Violation|5
5285255|NCT00522392|18229164|P2|Overall Study|Non-compliance|1
5285256|NCT00522392|18229165|P1|Overall Study|Non-compliance|0
5285257|NCT00522392|18229164|P2|Overall Study|Physician Decision|1
5285258|NCT00522392|18229165|P1|Overall Study|Physician Decision|0
5285259|NCT00522392|18229164|P2|Overall Study|Withdrawal by Subject|1
5285260|NCT00522392|18229165|P1|Overall Study|Withdrawal by Subject|1
5285261|NCT00522392|18229164|P2|Overall Study|Adverse Event|7
5285262|NCT00522392|18229165|P1|Overall Study|Adverse Event|7
5285263|NCT00522392|18229164|P2|Overall Study|Disease progression|3
5285264|NCT00522392|18229165|P1|Overall Study|Disease progression|0
5285265|NCT00522379|18229182|P5|Overall Study|Subject Withdrawal|0
5285266|NCT00522379|18229183|P4|Overall Study|Subject Withdrawal|1
5285267|NCT00522379|18229184|P3|Overall Study|Subject Withdrawal|0
5285268|NCT00522379|18229185|P2|Overall Study|Subject Withdrawal|0
5285269|NCT00522379|18229186|P1|Overall Study|Subject Withdrawal|0
5285270|NCT00522379|18229182|P5|Overall Study|Site Closed|0
5285271|NCT00522379|18229183|P4|Overall Study|Site Closed|1
5285272|NCT00522379|18229184|P3|Overall Study|Site Closed|0
5285273|NCT00522379|18229185|P2|Overall Study|Site Closed|0
5285274|NCT00522379|18229186|P1|Overall Study|Site Closed|0
5285275|NCT00522379|18229182|P5|Overall Study|Family Problem|0
5285276|NCT00522379|18229183|P4|Overall Study|Family Problem|0
5285277|NCT00522379|18229184|P3|Overall Study|Family Problem|1
5285278|NCT00522379|18229185|P2|Overall Study|Family Problem|0
5285279|NCT00522379|18229186|P1|Overall Study|Family Problem|0
5285280|NCT00522379|18229182|P5|Overall Study|Sponsor Request|0
5285281|NCT00522379|18229183|P4|Overall Study|Sponsor Request|0
5285282|NCT00522379|18229184|P3|Overall Study|Sponsor Request|0
5285283|NCT00522379|18229185|P2|Overall Study|Sponsor Request|1
5285284|NCT00522379|18229186|P1|Overall Study|Sponsor Request|0
5285285|NCT00522379|18229182|P5|Overall Study|Subject Moved|0
5285286|NCT00522379|18229183|P4|Overall Study|Subject Moved|0
5285287|NCT00522379|18229184|P3|Overall Study|Subject Moved|0
5285288|NCT00522379|18229185|P2|Overall Study|Subject Moved|1
5285289|NCT00522379|18229186|P1|Overall Study|Subject Moved|1
5285290|NCT00522379|18229182|P5|Overall Study|Dispensing error|0
5285291|NCT00522379|18229183|P4|Overall Study|Dispensing error|1
5285292|NCT00522379|18229184|P3|Overall Study|Dispensing error|0
5285293|NCT00522379|18229185|P2|Overall Study|Dispensing error|0
5285294|NCT00522379|18229186|P1|Overall Study|Dispensing error|1
5285295|NCT00522379|18229182|P5|Overall Study|Randomization error|1
5285296|NCT00522379|18229183|P4|Overall Study|Randomization error|0
5285297|NCT00522379|18229184|P3|Overall Study|Randomization error|0
5285298|NCT00522379|18229185|P2|Overall Study|Randomization error|0
5285299|NCT00522379|18229186|P1|Overall Study|Randomization error|0
5285300|NCT00522379|18229182|P5|Overall Study|Lost to Follow-up|2
5285301|NCT00522379|18229183|P4|Overall Study|Lost to Follow-up|2
5285302|NCT00522379|18229184|P3|Overall Study|Lost to Follow-up|4
5285303|NCT00522379|18229185|P2|Overall Study|Lost to Follow-up|0
5285304|NCT00522379|18229186|P1|Overall Study|Lost to Follow-up|1
5285305|NCT00522379|18229182|P5|Overall Study|Unsatisfactory Subject Compliance|0
5285306|NCT00522379|18229183|P4|Overall Study|Unsatisfactory Subject Compliance|0
5285307|NCT00522379|18229184|P3|Overall Study|Unsatisfactory Subject Compliance|0
5285308|NCT00522379|18229185|P2|Overall Study|Unsatisfactory Subject Compliance|2
5285309|NCT00522379|18229186|P1|Overall Study|Unsatisfactory Subject Compliance|1
5285310|NCT00522379|18229182|P5|Overall Study|Protocol Violation|0
5285311|NCT00522379|18229183|P4|Overall Study|Protocol Violation|0
5285312|NCT00522379|18229184|P3|Overall Study|Protocol Violation|2
5285313|NCT00522379|18229185|P2|Overall Study|Protocol Violation|1
5285314|NCT00522379|18229186|P1|Overall Study|Protocol Violation|1
5285315|NCT00522379|18229182|P5|Overall Study|Withdrawal by Subject|0
5285316|NCT00522379|18229183|P4|Overall Study|Withdrawal by Subject|2
5285317|NCT00522379|18229184|P3|Overall Study|Withdrawal by Subject|1
5285318|NCT00522379|18229185|P2|Overall Study|Withdrawal by Subject|3
5285319|NCT00522379|18229186|P1|Overall Study|Withdrawal by Subject|2
5285320|NCT00522379|18229182|P5|Overall Study|Lack of Efficacy|7
5285321|NCT00522379|18229183|P4|Overall Study|Lack of Efficacy|2
5285322|NCT00522379|18229184|P3|Overall Study|Lack of Efficacy|2
5285323|NCT00522379|18229185|P2|Overall Study|Lack of Efficacy|0
5285324|NCT00522379|18229186|P1|Overall Study|Lack of Efficacy|3
5285325|NCT00522379|18229182|P5|Overall Study|Adverse Event|17
5285326|NCT00522379|18229183|P4|Overall Study|Adverse Event|5
5285327|NCT00522379|18229184|P3|Overall Study|Adverse Event|12
5285328|NCT00522379|18229185|P2|Overall Study|Adverse Event|15
5285329|NCT00522379|18229186|P1|Overall Study|Adverse Event|12
5285330|NCT00522301|18229288|P1|Overall Study|Adverse Event|5
5285331|NCT00522301|18229288|P1|Overall Study|Withdrawal by Subject|1
5285332|NCT00522275|18229292|P1|Overall Study|Other: Subject had surgery for epilepsy|2
5285333|NCT00522275|18229292|P1|Overall Study|Other: Subject ran out of medication|1
5285334|NCT00522275|18229292|P1|Overall Study|Other: Sponsor request|2
5285335|NCT00522275|18229292|P1|Overall Study|Other: Travel to / from site difficulty|3
5285336|NCT00522275|18229292|P1|Overall Study|Other: Site / clinic closed|4
5285337|NCT00522275|18229292|P1|Overall Study|Other: Subject arrested|1
5285338|NCT00522275|18229292|P1|Overall Study|Other: Subject relocated|2
5285339|NCT00522275|18229292|P1|Overall Study|Other: Subject is pregnant|2
5285340|NCT00522275|18229292|P1|Overall Study|Other: Subject wants to become pregnant|2
5285341|NCT00522275|18229292|P1|Overall Study|Lost to Follow-up|8
5285342|NCT00522275|18229292|P1|Overall Study|Unsatisfactory compliance|11
5285343|NCT00522275|18229292|P1|Overall Study|Protocol deviation|1
5285344|NCT00522275|18229292|P1|Overall Study|Subject withdrew consent|16
5285345|NCT00522275|18229292|P1|Overall Study|Lack of Efficacy|80
5285346|NCT00522275|18229292|P1|Overall Study|Adverse Event|35
5285347|NCT00522041|18229313|P2|Overall Study|Did not receive treatment|1
5285348|NCT00522041|18229314|P1|Overall Study|Did not receive treatment|0
5285349|NCT00522041|18229313|P2|Overall Study|Voluntary withdrawal|4
5285350|NCT00522041|18229314|P1|Overall Study|Voluntary withdrawal|5
5285351|NCT00522041|18229313|P2|Overall Study|Lost to Follow-up|4
5285352|NCT00522041|18229314|P1|Overall Study|Lost to Follow-up|1
5285353|NCT00522041|18229313|P2|Overall Study|Protocol Violation|0
5285354|NCT00522041|18229314|P1|Overall Study|Protocol Violation|2
5285355|NCT00522041|18229313|P2|Overall Study|Adverse Event|3
5285356|NCT00522041|18229314|P1|Overall Study|Adverse Event|9
5285357|NCT00521599|18229373|P3|Overall Study|Did not meet protocol eligibility|1
5285358|NCT00521599|18229374|P2|Overall Study|Did not meet protocol eligibility|2
5285359|NCT00521599|18229375|P1|Overall Study|Did not meet protocol eligibility|2
5285360|NCT00521599|18229373|P3|Overall Study|Protocol Violation|2
5285361|NCT00521599|18229374|P2|Overall Study|Protocol Violation|4
5285362|NCT00521599|18229375|P1|Overall Study|Protocol Violation|2
5285363|NCT00521599|18229373|P3|Overall Study|Withdrawal by subject treatment related|2
5285364|NCT00521599|18229374|P2|Overall Study|Withdrawal by subject treatment related|1
5285365|NCT00521599|18229375|P1|Overall Study|Withdrawal by subject treatment related|3
5285366|NCT00521599|18229373|P3|Overall Study|Withdrawal by Subject|1
5285367|NCT00521599|18229374|P2|Overall Study|Withdrawal by Subject|5
5285368|NCT00521599|18229375|P1|Overall Study|Withdrawal by Subject|3
5285369|NCT00521599|18229373|P3|Overall Study|Lost to Follow-up|2
5285370|NCT00521599|18229374|P2|Overall Study|Lost to Follow-up|1
5285371|NCT00521599|18229375|P1|Overall Study|Lost to Follow-up|2
5285372|NCT00521599|18229373|P3|Overall Study|Treatment Failure|22
5285373|NCT00521599|18229374|P2|Overall Study|Treatment Failure|9
5285374|NCT00521599|18229375|P1|Overall Study|Treatment Failure|8
5285375|NCT00521599|18229373|P3|Overall Study|Adverse Event|6
5285376|NCT00521599|18229374|P2|Overall Study|Adverse Event|7
5285377|NCT00521599|18229375|P1|Overall Study|Adverse Event|5
5285378|NCT00521586|18229386|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
5285379|NCT00521586|18229387|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
5285380|NCT00521586|18229386|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
5285381|NCT00521586|18229387|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
5285382|NCT00521586|18229386|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
5285383|NCT00521586|18229387|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
5285384|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
5285385|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
5285386|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
5285387|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
5285388|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
5285389|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
5285390|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
5285391|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
5285392|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
5285393|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
5285394|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
5285395|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
5285396|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
5285397|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
5285398|NCT00521586|18229386|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
5285399|NCT00521586|18229387|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
5285400|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Failed to return|1
5285401|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Failed to return|0
5285402|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Death|0
5285403|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Death|1
5285404|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Adverse Event|1
5285405|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Adverse Event|0
5285406|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Investigator request|0
5285407|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Investigator request|2
5285408|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Other, unspecified|1
5285409|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Other, unspecified|3
5285410|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Protocol Violation|5
5285411|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Protocol Violation|2
5285412|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
5285413|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
5285414|NCT00521586|18229386|P2|Initial Vaccination (Year 0)|Subject request|11
5285415|NCT00521586|18229387|P1|Initial Vaccination (Year 0)|Subject request|8
5285416|NCT00521365|18229460|P1|Overall Study|Usage of not allowed drugs|6
5285417|NCT00521365|18229460|P1|Overall Study|Drug compliance|3
5285418|NCT00521365|18229460|P1|Overall Study|Protocol deviation|2
5285419|NCT00521365|18229460|P1|Overall Study|Lost to Follow-up|6
5285420|NCT00521365|18229460|P1|Overall Study|Adverse Event|3
5285421|NCT00521339|18229490|P3|Treatment Extension Phase|Death|1
5285422|NCT00521339|18229491|P2|Treatment Extension Phase|Death|0
5285423|NCT00521339|18229492|P1|Treatment Extension Phase|Death|0
5285424|NCT00521339|18229490|P3|Treatment Extension Phase|Withdrawal by Subject|2
5285425|NCT00521339|18229491|P2|Treatment Extension Phase|Withdrawal by Subject|0
5285426|NCT00521339|18229492|P1|Treatment Extension Phase|Withdrawal by Subject|0
5285427|NCT00521339|18229490|P3|Treatment Phase|Protocol Violation|0
5285428|NCT00521339|18229491|P2|Treatment Phase|Protocol Violation|0
5285429|NCT00521339|18229492|P1|Treatment Phase|Protocol Violation|1
5285430|NCT00521339|18229490|P3|Treatment Phase|Lost to Follow-up|0
5285431|NCT00521339|18229491|P2|Treatment Phase|Lost to Follow-up|0
5285432|NCT00521339|18229492|P1|Treatment Phase|Lost to Follow-up|1
5285433|NCT00521339|18229490|P3|Treatment Phase|Withdrawal by Subject|0
5285434|NCT00521339|18229491|P2|Treatment Phase|Withdrawal by Subject|0
5285435|NCT00521339|18229492|P1|Treatment Phase|Withdrawal by Subject|3
5285436|NCT00521339|18229490|P3|Treatment Phase|Lack of Efficacy|0
5285437|NCT00521339|18229491|P2|Treatment Phase|Lack of Efficacy|0
5285438|NCT00521339|18229492|P1|Treatment Phase|Lack of Efficacy|3
5285439|NCT00521339|18229490|P3|Treatment Phase|Intolerability to study drug|0
5285440|NCT00521339|18229491|P2|Treatment Phase|Intolerability to study drug|0
5285441|NCT00521339|18229492|P1|Treatment Phase|Intolerability to study drug|2
5285442|NCT00521339|18229490|P3|Treatment Phase|Adverse Event|0
5285443|NCT00521339|18229491|P2|Treatment Phase|Adverse Event|0
5285444|NCT00521339|18229492|P1|Treatment Phase|Adverse Event|2
5285445|NCT00521144|18229560|P5|Overall Study|Progressive Disease|6
5285446|NCT00521144|18229561|P4|Overall Study|Progressive Disease|0
5285447|NCT00521144|18229562|P3|Overall Study|Progressive Disease|2
5285448|NCT00521144|18229563|P2|Overall Study|Progressive Disease|2
5285449|NCT00521144|18229564|P1|Overall Study|Progressive Disease|4
5285450|NCT00521144|18229560|P5|Overall Study|Adverse Event|1
5285451|NCT00521144|18229561|P4|Overall Study|Adverse Event|0
5285452|NCT00521144|18229562|P3|Overall Study|Adverse Event|0
5285453|NCT00521144|18229563|P2|Overall Study|Adverse Event|1
5285454|NCT00521144|18229564|P1|Overall Study|Adverse Event|0
5285455|NCT00521144|18229560|P5|Overall Study|Not Treated|0
5285456|NCT00521144|18229561|P4|Overall Study|Not Treated|1
5285457|NCT00521144|18229562|P3|Overall Study|Not Treated|0
5285458|NCT00521144|18229563|P2|Overall Study|Not Treated|0
5285459|NCT00521144|18229564|P1|Overall Study|Not Treated|0
5285460|NCT00521079|18229578|P2|Overall Study|Withdrawal by Subject|3
5285461|NCT00521079|18229579|P1|Overall Study|Withdrawal by Subject|5
5285462|NCT00521079|18229578|P2|Overall Study|Lost to Follow-up|1
5285463|NCT00521079|18229579|P1|Overall Study|Lost to Follow-up|2
5285464|NCT00521079|18229578|P2|Overall Study|Adverse Event|1
5285465|NCT00521079|18229579|P1|Overall Study|Adverse Event|7
5285466|NCT00521053|18229589|P1|Observation Phase|Physician Decision|1
5285467|NCT00521053|18229589|P1|Observation Phase|Other non-study melanoma treatment|1
5285468|NCT00521053|18229589|P1|Observation Phase|Adverse Event|1
5285469|NCT00521053|18229589|P1|Observation Phase|Death|2
5285470|NCT00521053|18229589|P1|Observation Phase|Additional PV-10 via alternate protocol|8
5285471|NCT00521053|18229589|P1|Observation Phase|Disease Progression|55
5285472|NCT00521014|18229599|P1|Overall Study|Inevaluable, not treated|1
5285473|NCT00521001|18229603|P1|Overall Study|Ineligible|1
5285474|NCT00520975|18229612|P2|Overall Study|Not start protocol therapy|2
5285475|NCT00520975|18229613|P1|Overall Study|Not start protocol therapy|1
5285476|NCT00520975|18229612|P2|Overall Study|Other reasons|2
5285477|NCT00520975|18229613|P1|Overall Study|Other reasons|4
5285478|NCT00520975|18229612|P2|Overall Study|Other therapy|4
5285479|NCT00520975|18229613|P1|Overall Study|Other therapy|2
5285480|NCT00520975|18229612|P2|Overall Study|Withdrawal by Subject|5
5285481|NCT00520975|18229613|P1|Overall Study|Withdrawal by Subject|3
5285482|NCT00520975|18229612|P2|Overall Study|Death|2
5285483|NCT00520975|18229613|P1|Overall Study|Death|0
5285484|NCT00520975|18229612|P2|Overall Study|Adverse Event|10
5285485|NCT00520975|18229613|P1|Overall Study|Adverse Event|7
5285486|NCT00520975|18229612|P2|Overall Study|Disease progression|23
5285487|NCT00520975|18229613|P1|Overall Study|Disease progression|31
5285488|NCT00520936|18229645|P8|Overall Study|Protocol Violation|0
5285489|NCT00520936|18229646|P7|Overall Study|Protocol Violation|1
5285490|NCT00520936|18229647|P6|Overall Study|Protocol Violation|0
5285491|NCT00520936|18229648|P5|Overall Study|Protocol Violation|1
5285492|NCT00520936|18229649|P4|Overall Study|Protocol Violation|0
5285493|NCT00520936|18229650|P3|Overall Study|Protocol Violation|1
5285494|NCT00520936|18229651|P2|Overall Study|Protocol Violation|1
5285495|NCT00520936|18229652|P1|Overall Study|Protocol Violation|0
5285496|NCT00520936|18229645|P8|Overall Study|Death|0
5285497|NCT00520936|18229646|P7|Overall Study|Death|1
5285498|NCT00520936|18229647|P6|Overall Study|Death|0
5285499|NCT00520936|18229648|P5|Overall Study|Death|0
5285500|NCT00520936|18229649|P4|Overall Study|Death|0
5285501|NCT00520936|18229650|P3|Overall Study|Death|0
5285502|NCT00520936|18229651|P2|Overall Study|Death|0
5285503|NCT00520936|18229652|P1|Overall Study|Death|0
5285504|NCT00520936|18229645|P8|Overall Study|Toxicity Requiring Removal from Study|0
5285505|NCT00520936|18229646|P7|Overall Study|Toxicity Requiring Removal from Study|2
5285506|NCT00520936|18229647|P6|Overall Study|Toxicity Requiring Removal from Study|0
5285507|NCT00520936|18229648|P5|Overall Study|Toxicity Requiring Removal from Study|0
5285508|NCT00520936|18229649|P4|Overall Study|Toxicity Requiring Removal from Study|0
5285509|NCT00520936|18229650|P3|Overall Study|Toxicity Requiring Removal from Study|0
5285510|NCT00520936|18229651|P2|Overall Study|Toxicity Requiring Removal from Study|1
5285511|NCT00520936|18229652|P1|Overall Study|Toxicity Requiring Removal from Study|0
5285512|NCT00520936|18229645|P8|Overall Study|Withdrawal by Subject|1
5285513|NCT00520936|18229646|P7|Overall Study|Withdrawal by Subject|0
5285514|NCT00520936|18229647|P6|Overall Study|Withdrawal by Subject|0
5285515|NCT00520936|18229648|P5|Overall Study|Withdrawal by Subject|0
5285516|NCT00520936|18229649|P4|Overall Study|Withdrawal by Subject|0
5285517|NCT00520936|18229650|P3|Overall Study|Withdrawal by Subject|0
5285518|NCT00520936|18229651|P2|Overall Study|Withdrawal by Subject|0
5285519|NCT00520936|18229652|P1|Overall Study|Withdrawal by Subject|0
5285520|NCT00520936|18229645|P8|Overall Study|Physician Decision|0
5285521|NCT00520936|18229646|P7|Overall Study|Physician Decision|0
5285522|NCT00520936|18229647|P6|Overall Study|Physician Decision|0
5285523|NCT00520936|18229648|P5|Overall Study|Physician Decision|0
5285524|NCT00520936|18229649|P4|Overall Study|Physician Decision|0
5285525|NCT00520936|18229650|P3|Overall Study|Physician Decision|1
5285526|NCT00520936|18229651|P2|Overall Study|Physician Decision|2
5285527|NCT00520936|18229652|P1|Overall Study|Physician Decision|0
5285528|NCT00520845|18229707|P1|Overall Study|Alternative Therapy|1
5285529|NCT00520845|18229707|P1|Overall Study|Withdrawal by Subject|1
5285530|NCT00520845|18229707|P1|Overall Study|Disease Progression, relapse|13
5285531|NCT00520845|18229707|P1|Overall Study|Adverse Event|4
5285532|NCT00520845|18229707|P1|Overall Study|Death|3
5285533|NCT00520767|18229715|P1|Overall Study|Death|2
5285534|NCT00520741|18229721|P2|Overall Study|Other reasons for premature termination|6
5285535|NCT00520741|18229722|P1|Overall Study|Other reasons for premature termination|0
5285536|NCT00520741|18229721|P2|Overall Study|Lost to Follow-up|4
5285537|NCT00520741|18229722|P1|Overall Study|Lost to Follow-up|4
5285538|NCT00520741|18229721|P2|Overall Study|Unsatisfactory compliance of subject|3
5285539|NCT00520741|18229722|P1|Overall Study|Unsatisfactory compliance of subject|4
5285540|NCT00520741|18229721|P2|Overall Study|Protocol Violation|15
5285541|NCT00520741|18229722|P1|Overall Study|Protocol Violation|2
5285542|NCT00520741|18229721|P2|Overall Study|Withdrawal by Subject|11
5285543|NCT00520741|18229722|P1|Overall Study|Withdrawal by Subject|0
5285544|NCT00520741|18229721|P2|Overall Study|Lack of Efficacy|30
5285545|NCT00520741|18229722|P1|Overall Study|Lack of Efficacy|11
5285546|NCT00520741|18229721|P2|Overall Study|Adverse Event|56
5285547|NCT00520741|18229722|P1|Overall Study|Adverse Event|16
5285548|NCT00520676|18229740|P2|Overall Study|Withdrawal by Subject|11
5285549|NCT00520676|18229741|P1|Overall Study|Withdrawal by Subject|7
5285550|NCT00520676|18229740|P2|Overall Study|Physician Decision|1
5285551|NCT00520676|18229741|P1|Overall Study|Physician Decision|4
5285552|NCT00520676|18229740|P2|Overall Study|Lost to Follow-up|10
5285553|NCT00520676|18229741|P1|Overall Study|Lost to Follow-up|6
5285554|NCT00520676|18229740|P2|Overall Study|Death|81
5285555|NCT00520676|18229741|P1|Overall Study|Death|84
5285556|NCT00520572|18229767|P6|Overall Study|Did not receive Treatment|0
5285557|NCT00520572|18229768|P5|Overall Study|Did not receive Treatment|0
5285558|NCT00520572|18229769|P4|Overall Study|Did not receive Treatment|0
5285559|NCT00520572|18229770|P3|Overall Study|Did not receive Treatment|1
5285560|NCT00520572|18229771|P2|Overall Study|Did not receive Treatment|0
5285561|NCT00520572|18229772|P1|Overall Study|Did not receive Treatment|1
5285562|NCT00520572|18229767|P6|Overall Study|Long break in taking Medication|0
5285563|NCT00520572|18229768|P5|Overall Study|Long break in taking Medication|0
5285564|NCT00520572|18229769|P4|Overall Study|Long break in taking Medication|1
5285565|NCT00520572|18229770|P3|Overall Study|Long break in taking Medication|0
5285566|NCT00520572|18229771|P2|Overall Study|Long break in taking Medication|0
5285567|NCT00520572|18229772|P1|Overall Study|Long break in taking Medication|0
5285568|NCT00520572|18229767|P6|Overall Study|Oral corticotherapy for acute urticaria|0
5285569|NCT00520572|18229768|P5|Overall Study|Oral corticotherapy for acute urticaria|0
5285570|NCT00520572|18229769|P4|Overall Study|Oral corticotherapy for acute urticaria|0
5285571|NCT00520572|18229770|P3|Overall Study|Oral corticotherapy for acute urticaria|0
5285572|NCT00520572|18229771|P2|Overall Study|Oral corticotherapy for acute urticaria|1
5285573|NCT00520572|18229772|P1|Overall Study|Oral corticotherapy for acute urticaria|0
5285574|NCT00520572|18229767|P6|Overall Study|Incorrect enrollment|0
5285575|NCT00520572|18229768|P5|Overall Study|Incorrect enrollment|1
5285576|NCT00520572|18229769|P4|Overall Study|Incorrect enrollment|0
5285577|NCT00520572|18229770|P3|Overall Study|Incorrect enrollment|1
5285578|NCT00520572|18229771|P2|Overall Study|Incorrect enrollment|0
5285579|NCT00520572|18229772|P1|Overall Study|Incorrect enrollment|1
5285580|NCT00520572|18229767|P6|Overall Study|Lost to Follow-up|0
5285581|NCT00520572|18229768|P5|Overall Study|Lost to Follow-up|1
5285582|NCT00520572|18229769|P4|Overall Study|Lost to Follow-up|0
5285583|NCT00520572|18229770|P3|Overall Study|Lost to Follow-up|0
5285584|NCT00520572|18229771|P2|Overall Study|Lost to Follow-up|0
5285585|NCT00520572|18229772|P1|Overall Study|Lost to Follow-up|0
5285586|NCT00520572|18229767|P6|Overall Study|Lack of Efficacy|0
5285587|NCT00520572|18229768|P5|Overall Study|Lack of Efficacy|1
5285588|NCT00520572|18229769|P4|Overall Study|Lack of Efficacy|2
5285589|NCT00520572|18229770|P3|Overall Study|Lack of Efficacy|1
5285590|NCT00520572|18229771|P2|Overall Study|Lack of Efficacy|1
5285591|NCT00520572|18229772|P1|Overall Study|Lack of Efficacy|1
5285592|NCT00520572|18229767|P6|Overall Study|Protocol Violation|0
5285593|NCT00520572|18229768|P5|Overall Study|Protocol Violation|0
5285594|NCT00520572|18229769|P4|Overall Study|Protocol Violation|0
5285595|NCT00520572|18229770|P3|Overall Study|Protocol Violation|1
5285596|NCT00520572|18229771|P2|Overall Study|Protocol Violation|0
5285597|NCT00520572|18229772|P1|Overall Study|Protocol Violation|0
5285598|NCT00520572|18229767|P6|Overall Study|Withdrawal by Subject|0
5285599|NCT00520572|18229768|P5|Overall Study|Withdrawal by Subject|2
5285600|NCT00520572|18229769|P4|Overall Study|Withdrawal by Subject|2
5285601|NCT00520572|18229770|P3|Overall Study|Withdrawal by Subject|5
5285602|NCT00520572|18229771|P2|Overall Study|Withdrawal by Subject|9
5285603|NCT00520572|18229772|P1|Overall Study|Withdrawal by Subject|0
5285604|NCT00520572|18229767|P6|Overall Study|Adverse Event|2
5285605|NCT00520572|18229768|P5|Overall Study|Adverse Event|7
5285606|NCT00520572|18229769|P4|Overall Study|Adverse Event|9
5285607|NCT00520572|18229770|P3|Overall Study|Adverse Event|6
5285608|NCT00520572|18229771|P2|Overall Study|Adverse Event|3
5285609|NCT00520572|18229772|P1|Overall Study|Adverse Event|9
5285610|NCT00520546|18229810|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
5285611|NCT00520546|18229810|P1|Overall Study|Withdrawal by Subject|1
5285612|NCT00520494|18229825|P1|Overall Study|Withdrawal by Subject|1
5285613|NCT00520481|18229850|P2|Overall Study|Withdrawal by Subject|0
5285614|NCT00520481|18229851|P1|Overall Study|Withdrawal by Subject|3
5285615|NCT00520481|18229850|P2|Overall Study|Adverse Event|1
5285616|NCT00520481|18229851|P1|Overall Study|Adverse Event|4
5285617|NCT00520403|18229875|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
5285618|NCT00520403|18229875|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
5285619|NCT00520403|18229875|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
5285620|NCT00520403|18229875|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
5285621|NCT00520403|18229875|P1|Bevacizumab + IFN/Vinblastine|Death|2
5285622|NCT00520403|18229875|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
5285623|NCT00520403|18229875|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
5285624|NCT00520403|18229875|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
5285625|NCT00520351|18229884|P2|First Intervention|Withdrawal by Subject|1
5285626|NCT00520351|18229885|P1|First Intervention|Withdrawal by Subject|1
5285627|NCT00520299|18229900|P3|Overall Study|Progressive disease|4
5285628|NCT00520299|18229901|P2|Overall Study|Progressive disease|3
5285629|NCT00520299|18229902|P1|Overall Study|Progressive disease|0
5285630|NCT00520299|18229900|P3|Overall Study|Withdrawal by Subject|2
5285631|NCT00520299|18229901|P2|Overall Study|Withdrawal by Subject|0
5285632|NCT00520299|18229902|P1|Overall Study|Withdrawal by Subject|0
5285633|NCT00520130|18229957|P2|Overall Study|Physician Decision|1
5285634|NCT00520130|18229958|P1|Overall Study|Physician Decision|1
5285635|NCT00520130|18229957|P2|Overall Study|Disease progression on study|0
5285636|NCT00520130|18229958|P1|Overall Study|Disease progression on study|4
5285637|NCT00520039|18230000|P2|Overall Study|Exclusion criteria met at first visit|5
5285638|NCT00520039|18230001|P1|Overall Study|Exclusion criteria met at first visit|7
5285639|NCT00520013|18230014|P3|Overall Study|Physician Decision|3
5285640|NCT00520013|18230015|P2|Overall Study|Physician Decision|0
5285641|NCT00520013|18230016|P1|Overall Study|Physician Decision|0
5285642|NCT00520013|18230014|P3|Overall Study|Death|0
5285643|NCT00520013|18230015|P2|Overall Study|Death|1
5285644|NCT00520013|18230016|P1|Overall Study|Death|0
5285645|NCT00520013|18230014|P3|Overall Study|Clinical Progression|0
5285646|NCT00520013|18230015|P2|Overall Study|Clinical Progression|1
5285647|NCT00520013|18230016|P1|Overall Study|Clinical Progression|3
5285648|NCT00520013|18230014|P3|Overall Study|Progressive Disease|0
5285649|NCT00520013|18230015|P2|Overall Study|Progressive Disease|3
5285650|NCT00520013|18230016|P1|Overall Study|Progressive Disease|7
5285651|NCT00520013|18230014|P3|Overall Study|Adverse Event|7
5285652|NCT00520013|18230015|P2|Overall Study|Adverse Event|10
5285653|NCT00520013|18230016|P1|Overall Study|Adverse Event|2
5285654|NCT00520013|18230014|P3|Overall Study|Withdrawal by Subject|1
5285655|NCT00520013|18230015|P2|Overall Study|Withdrawal by Subject|0
5285656|NCT00520013|18230016|P1|Overall Study|Withdrawal by Subject|0
5285657|NCT00519896|18230026|P1|Overall Study|Adverse Event|1
5285658|NCT00519896|18230026|P1|Overall Study|Protocol Violation|1
5285659|NCT00519831|18230032|P1|Overall Study|Adverse Event|3
5285660|NCT00519779|18230049|P2|Overall Study|Withdrawal by Subject|1
5285661|NCT00519779|18230050|P1|Overall Study|Withdrawal by Subject|0
5285662|NCT00519649|18230066|P1|Overall Study|Withdrawal by Subject|1
5285663|NCT00519636|18230079|P4|Post Study Period|Subject randomized in error|1
5285664|NCT00519636|18230080|P3|Post Study Period|Subject randomized in error|0
5285665|NCT00519636|18230081|P2|Post Study Period|Subject randomized in error|0
5285666|NCT00519636|18230082|P1|Post Study Period|Subject randomized in error|0
5285667|NCT00519636|18230079|P4|Treatment Period 2|Subject misrandomized|1
5285668|NCT00519636|18230080|P3|Treatment Period 2|Subject misrandomized|0
5285669|NCT00519636|18230081|P2|Treatment Period 2|Subject misrandomized|0
5285670|NCT00519636|18230082|P1|Treatment Period 2|Subject misrandomized|0
5285671|NCT00519636|18230079|P4|Treatment Period 2|Per doctors request|0
5285672|NCT00519636|18230080|P3|Treatment Period 2|Per doctors request|1
5285673|NCT00519636|18230081|P2|Treatment Period 2|Per doctors request|0
5285674|NCT00519636|18230082|P1|Treatment Period 2|Per doctors request|0
5285675|NCT00519636|18230079|P4|Treatment Period 2|Subject randomized in error|0
5285676|NCT00519636|18230080|P3|Treatment Period 2|Subject randomized in error|0
5285677|NCT00519636|18230081|P2|Treatment Period 2|Subject randomized in error|1
5285678|NCT00519636|18230082|P1|Treatment Period 2|Subject randomized in error|0
5285679|NCT00519636|18230079|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
5285764|NCT00519376|18230191|P3|Treatment Period 4|Lost to Follow-up|1
5285680|NCT00519636|18230080|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
5285681|NCT00519636|18230081|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
5285682|NCT00519636|18230082|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
5285683|NCT00519636|18230079|P4|Washout Period|Prohibited medications|0
5285684|NCT00519636|18230080|P3|Washout Period|Prohibited medications|1
5285685|NCT00519636|18230081|P2|Washout Period|Prohibited medications|0
5285686|NCT00519636|18230082|P1|Washout Period|Prohibited medications|0
5285687|NCT00519636|18230079|P4|Washout Period|Subject randomized in error|0
5285688|NCT00519636|18230080|P3|Washout Period|Subject randomized in error|1
5285689|NCT00519636|18230081|P2|Washout Period|Subject randomized in error|0
5285690|NCT00519636|18230082|P1|Washout Period|Subject randomized in error|0
5285691|NCT00519636|18230079|P4|Washout Period|Per doctors request|0
5285692|NCT00519636|18230080|P3|Washout Period|Per doctors request|0
5285693|NCT00519636|18230081|P2|Washout Period|Per doctors request|1
5285694|NCT00519636|18230082|P1|Washout Period|Per doctors request|0
5285695|NCT00519636|18230079|P4|Washout Period|Non-compliant|0
5285696|NCT00519636|18230080|P3|Washout Period|Non-compliant|0
5285697|NCT00519636|18230081|P2|Washout Period|Non-compliant|1
5285698|NCT00519636|18230082|P1|Washout Period|Non-compliant|0
5285699|NCT00519636|18230079|P4|Washout Period|Participating in study at another site|0
5285700|NCT00519636|18230080|P3|Washout Period|Participating in study at another site|0
5285701|NCT00519636|18230081|P2|Washout Period|Participating in study at another site|0
5285702|NCT00519636|18230082|P1|Washout Period|Participating in study at another site|1
5285703|NCT00519636|18230079|P4|Washout Period|Out of pollen area > 48 hours|0
5285704|NCT00519636|18230080|P3|Washout Period|Out of pollen area > 48 hours|0
5285705|NCT00519636|18230081|P2|Washout Period|Out of pollen area > 48 hours|0
5285706|NCT00519636|18230082|P1|Washout Period|Out of pollen area > 48 hours|1
5285707|NCT00519636|18230079|P4|Washout Period|Failed to meet continuation criteria|3
5285708|NCT00519636|18230080|P3|Washout Period|Failed to meet continuation criteria|9
5285709|NCT00519636|18230081|P2|Washout Period|Failed to meet continuation criteria|11
5285710|NCT00519636|18230082|P1|Washout Period|Failed to meet continuation criteria|14
5285711|NCT00519636|18230079|P4|Washout Period|Withdrawal by Subject|0
5285712|NCT00519636|18230080|P3|Washout Period|Withdrawal by Subject|1
5285713|NCT00519636|18230081|P2|Washout Period|Withdrawal by Subject|0
5285714|NCT00519636|18230082|P1|Washout Period|Withdrawal by Subject|1
5285715|NCT00519636|18230079|P4|Washout Period|Protocol Violation|2
5285716|NCT00519636|18230080|P3|Washout Period|Protocol Violation|1
5285717|NCT00519636|18230081|P2|Washout Period|Protocol Violation|0
5285718|NCT00519636|18230082|P1|Washout Period|Protocol Violation|0
5285719|NCT00519636|18230079|P4|Washout Period|Lost to Follow-up|0
5285720|NCT00519636|18230080|P3|Washout Period|Lost to Follow-up|0
5285721|NCT00519636|18230081|P2|Washout Period|Lost to Follow-up|0
5285722|NCT00519636|18230082|P1|Washout Period|Lost to Follow-up|1
5285723|NCT00519636|18230079|P4|Washout Period|Adverse Event|0
5285724|NCT00519636|18230080|P3|Washout Period|Adverse Event|1
5285725|NCT00519636|18230081|P2|Washout Period|Adverse Event|1
5285726|NCT00519636|18230082|P1|Washout Period|Adverse Event|2
5285727|NCT00519636|18230079|P4|Treatment Period 1|Sponsor request due to missed visit|0
5285728|NCT00519636|18230080|P3|Treatment Period 1|Sponsor request due to missed visit|0
5285729|NCT00519636|18230081|P2|Treatment Period 1|Sponsor request due to missed visit|0
5285730|NCT00519636|18230082|P1|Treatment Period 1|Sponsor request due to missed visit|1
5285731|NCT00519636|18230079|P4|Treatment Period 1|Adverse Event|0
5285732|NCT00519636|18230080|P3|Treatment Period 1|Adverse Event|1
5285733|NCT00519636|18230081|P2|Treatment Period 1|Adverse Event|0
5285734|NCT00519636|18230082|P1|Treatment Period 1|Adverse Event|1
5285735|NCT00519623|18230112|P1|Overall Study|Adverse Event|1
5285736|NCT00519532|18230146|P1|Overall Study|Lost to Follow-up|2
5285737|NCT00519532|18230146|P1|Overall Study|Withdrawal by Subject|5
5285738|NCT00519532|18230146|P1|Overall Study|Adverse Event|11
5285739|NCT00519428|18230156|P3|Overall Study|unstated|2
5285740|NCT00519428|18230157|P2|Overall Study|unstated|3
5285741|NCT00519428|18230158|P1|Overall Study|unstated|1
5285742|NCT00519428|18230156|P3|Overall Study|Withdrawal by Subject|7
5285743|NCT00519428|18230157|P2|Overall Study|Withdrawal by Subject|3
5285744|NCT00519428|18230158|P1|Overall Study|Withdrawal by Subject|8
5285745|NCT00519428|18230156|P3|Overall Study|Lost to Follow-up|6
5285746|NCT00519428|18230157|P2|Overall Study|Lost to Follow-up|7
5285747|NCT00519428|18230158|P1|Overall Study|Lost to Follow-up|7
5285748|NCT00519428|18230156|P3|Overall Study|Adverse Event|10
5285749|NCT00519428|18230157|P2|Overall Study|Adverse Event|2
5285750|NCT00519428|18230158|P1|Overall Study|Adverse Event|5
5285751|NCT00519376|18230178|P16|Treatment Period 4|Lost to Follow-up|0
5285752|NCT00519376|18230179|P15|Treatment Period 4|Lost to Follow-up|0
5285753|NCT00519376|18230180|P14|Treatment Period 4|Lost to Follow-up|0
5285754|NCT00519376|18230181|P13|Treatment Period 4|Lost to Follow-up|0
5285755|NCT00519376|18230182|P12|Treatment Period 4|Lost to Follow-up|0
5285756|NCT00519376|18230183|P11|Treatment Period 4|Lost to Follow-up|0
5285757|NCT00519376|18230184|P10|Treatment Period 4|Lost to Follow-up|0
5285758|NCT00519376|18230185|P9|Treatment Period 4|Lost to Follow-up|0
5285759|NCT00519376|18230186|P8|Treatment Period 4|Lost to Follow-up|0
5285760|NCT00519376|18230187|P7|Treatment Period 4|Lost to Follow-up|0
5285761|NCT00519376|18230188|P6|Treatment Period 4|Lost to Follow-up|0
5285762|NCT00519376|18230189|P5|Treatment Period 4|Lost to Follow-up|0
5285763|NCT00519376|18230190|P4|Treatment Period 4|Lost to Follow-up|0
5285765|NCT00519376|18230192|P2|Treatment Period 4|Lost to Follow-up|0
5285766|NCT00519376|18230193|P1|Treatment Period 4|Lost to Follow-up|0
5285767|NCT00519376|18230178|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285768|NCT00519376|18230179|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285769|NCT00519376|18230180|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285770|NCT00519376|18230181|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
5285771|NCT00519376|18230182|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285772|NCT00519376|18230183|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285773|NCT00519376|18230184|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285774|NCT00519376|18230185|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285775|NCT00519376|18230186|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285776|NCT00519376|18230187|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285777|NCT00519376|18230188|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285778|NCT00519376|18230189|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285779|NCT00519376|18230190|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285780|NCT00519376|18230191|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285781|NCT00519376|18230192|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285782|NCT00519376|18230193|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5285783|NCT00519285|18230317|P2|Overall Study|Treatment ongoing|2
5285784|NCT00519285|18230318|P1|Overall Study|Treatment ongoing|1
5285785|NCT00519285|18230317|P2|Overall Study|Not treated|7
5285786|NCT00519285|18230318|P1|Overall Study|Not treated|8
5285787|NCT00519285|18230317|P2|Overall Study|Reason unspecified|8
5285788|NCT00519285|18230318|P1|Overall Study|Reason unspecified|5
5285789|NCT00519285|18230317|P2|Overall Study|Poor compliance to protocol|7
5285790|NCT00519285|18230318|P1|Overall Study|Poor compliance to protocol|5
5285791|NCT00519285|18230317|P2|Overall Study|Consent withdrawn|5
5285792|NCT00519285|18230318|P1|Overall Study|Consent withdrawn|4
5285793|NCT00519285|18230317|P2|Overall Study|Participant's request|84
5285794|NCT00519285|18230318|P1|Overall Study|Participant's request|53
5285795|NCT00519285|18230317|P2|Overall Study|Physician Decision|47
5285796|NCT00519285|18230318|P1|Overall Study|Physician Decision|75
5285797|NCT00519285|18230317|P2|Overall Study|Disease progression|186
5285798|NCT00519285|18230318|P1|Overall Study|Disease progression|334
5285799|NCT00519285|18230317|P2|Overall Study|Adverse Event|266
5285800|NCT00519285|18230318|P1|Overall Study|Adverse Event|127
5285801|NCT00519194|18230344|P1|Overall Study|Lost to Follow-up|3
5285802|NCT00519194|18230344|P1|Overall Study|Death|9
5285803|NCT00519194|18230344|P1|Overall Study|Withdrawal by Subject|9
5285804|NCT00519077|18230359|P1|Overall Study|Other|2
5285805|NCT00519077|18230359|P1|Overall Study|Death|6
5285806|NCT00518986|18230366|P2|Overall Study|Non-Specific|1
5285807|NCT00518986|18230367|P1|Overall Study|Non-Specific|2
5285808|NCT00518986|18230366|P2|Overall Study|Withdrawal by Subject|4
5285809|NCT00518986|18230367|P1|Overall Study|Withdrawal by Subject|4
5285810|NCT00518986|18230366|P2|Overall Study|Protocol Violation|7
5285811|NCT00518986|18230367|P1|Overall Study|Protocol Violation|5
5285812|NCT00518986|18230366|P2|Overall Study|Physician Decision|3
5285813|NCT00518986|18230367|P1|Overall Study|Physician Decision|0
5285814|NCT00518986|18230366|P2|Overall Study|Lost to Follow-up|2
5285815|NCT00518986|18230367|P1|Overall Study|Lost to Follow-up|3
5285816|NCT00518986|18230366|P2|Overall Study|Lack of Efficacy|2
5285817|NCT00518986|18230367|P1|Overall Study|Lack of Efficacy|0
5285818|NCT00518986|18230366|P2|Overall Study|Adverse Event|7
5285819|NCT00518986|18230367|P1|Overall Study|Adverse Event|12
5285820|NCT00518973|18230493|P2|Overall Study|Withdrawal by Subject|2
5285821|NCT00518973|18230494|P1|Overall Study|Withdrawal by Subject|3
5285822|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
5285823|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
5285824|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Subject decision|0
5285825|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Subject decision|2
5285826|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
5285827|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
5285828|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
5285829|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
5285830|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Creatine increased|0
5285831|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Creatine increased|1
5285832|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Change in treatment|1
5285833|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Change in treatment|1
5285834|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
5285835|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
5285836|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
5285837|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
5285838|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
5285839|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
5285840|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
5285841|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
5285842|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
5285843|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
5285844|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
5285928|NCT00518336|18230794|P2|Year 8|Could not attend in time|1
5285845|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
5285846|NCT00518882|18230510|P2|Open-Label Extension, Week 26-78|Adverse Event|9
5285847|NCT00518882|18230511|P1|Open-Label Extension, Week 26-78|Adverse Event|3
5285848|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Mutual consent|1
5285849|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Mutual consent|0
5285850|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
5285851|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
5285852|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
5285853|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
5285854|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Loss of trust|1
5285855|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Loss of trust|0
5285856|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
5285857|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
5285858|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Subject decision|1
5285859|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Subject decision|1
5285860|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Lost to follow up|1
5285861|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Lost to follow up|2
5285862|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
5285863|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
5285864|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Protocol Violation|3
5285865|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Protocol Violation|4
5285866|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
5285867|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
5285868|NCT00518882|18230510|P2|Double-Blind, Week 0-26|Adverse Event|31
5285869|NCT00518882|18230511|P1|Double-Blind, Week 0-26|Adverse Event|23
5285870|NCT00518687|18230692|P2|Overall Study|Withdrawal by Subject|110
5285871|NCT00518687|18230693|P1|Overall Study|Withdrawal by Subject|110
5285872|NCT00518687|18230692|P2|Overall Study|Study terminated by sponsor|918
5285873|NCT00518687|18230693|P1|Overall Study|Study terminated by sponsor|930
5285874|NCT00518687|18230692|P2|Overall Study|Protocol Violation|10
5285875|NCT00518687|18230693|P1|Overall Study|Protocol Violation|8
5285876|NCT00518687|18230692|P2|Overall Study|Progressive disease|2
5285877|NCT00518687|18230693|P1|Overall Study|Progressive disease|2
5285878|NCT00518687|18230692|P2|Overall Study|Physician Decision|48
5285879|NCT00518687|18230693|P1|Overall Study|Physician Decision|42
5285880|NCT00518687|18230692|P2|Overall Study|Lost to Follow-up|155
5285881|NCT00518687|18230693|P1|Overall Study|Lost to Follow-up|144
5285882|NCT00518687|18230692|P2|Overall Study|Adverse Event|177
5285883|NCT00518687|18230693|P1|Overall Study|Adverse Event|201
5285884|NCT00518622|18230713|P8|Overall Study|Study medication taken incorrectly|0
5285885|NCT00518622|18230714|P7|Overall Study|Study medication taken incorrectly|0
5285886|NCT00518622|18230715|P6|Overall Study|Study medication taken incorrectly|0
5285887|NCT00518622|18230716|P5|Overall Study|Study medication taken incorrectly|0
5285888|NCT00518622|18230717|P4|Overall Study|Study medication taken incorrectly|0
5285889|NCT00518622|18230718|P3|Overall Study|Study medication taken incorrectly|0
5285890|NCT00518622|18230719|P2|Overall Study|Study medication taken incorrectly|1
5285891|NCT00518622|18230720|P1|Overall Study|Study medication taken incorrectly|0
5285892|NCT00518622|18230713|P8|Overall Study|Lost to Follow-up|0
5285893|NCT00518622|18230714|P7|Overall Study|Lost to Follow-up|0
5285894|NCT00518622|18230715|P6|Overall Study|Lost to Follow-up|0
5285895|NCT00518622|18230716|P5|Overall Study|Lost to Follow-up|0
5285896|NCT00518622|18230717|P4|Overall Study|Lost to Follow-up|0
5285897|NCT00518622|18230718|P3|Overall Study|Lost to Follow-up|1
5285898|NCT00518622|18230719|P2|Overall Study|Lost to Follow-up|0
5285899|NCT00518622|18230720|P1|Overall Study|Lost to Follow-up|0
5285900|NCT00518531|18230748|P2|Treatment Period 2|Non-compliance|2
5285901|NCT00518531|18230749|P1|Treatment Period 2|Non-compliance|1
5285902|NCT00518531|18230748|P2|Treatment Period 2|Protocol-specified criteria|1
5285903|NCT00518531|18230749|P1|Treatment Period 2|Protocol-specified criteria|0
5285904|NCT00518531|18230748|P2|Treatment Period 2|Adverse Event|7
5285905|NCT00518531|18230749|P1|Treatment Period 2|Adverse Event|1
5285906|NCT00518531|18230748|P2|Treatment Period 2|Complete out of scheduled visit window|2
5285907|NCT00518531|18230749|P1|Treatment Period 2|Complete out of scheduled visit window|1
5285908|NCT00518531|18230748|P2|Treatment Period 2|Withdrawal by Subject|8
5285909|NCT00518531|18230749|P1|Treatment Period 2|Withdrawal by Subject|0
5285910|NCT00518531|18230748|P2|Treatment Period 1|Early crossover|3
5285911|NCT00518531|18230749|P1|Treatment Period 1|Early crossover|1
5285912|NCT00518531|18230748|P2|Treatment Period 1|Withdrawal by Subject|6
5285913|NCT00518531|18230749|P1|Treatment Period 1|Withdrawal by Subject|4
5285914|NCT00518531|18230748|P2|Treatment Period 1|Protocol Violation|0
5285915|NCT00518531|18230749|P1|Treatment Period 1|Protocol Violation|2
5285916|NCT00518531|18230748|P2|Treatment Period 1|Physician Decision|0
5285917|NCT00518531|18230749|P1|Treatment Period 1|Physician Decision|1
5285918|NCT00518531|18230748|P2|Treatment Period 1|Lost to Follow-up|3
5285919|NCT00518531|18230749|P1|Treatment Period 1|Lost to Follow-up|5
5285920|NCT00518531|18230748|P2|Treatment Period 1|Adverse Event|0
5285921|NCT00518531|18230749|P1|Treatment Period 1|Adverse Event|5
5285922|NCT00518336|18230794|P2|Year 9|Personal reasons|0
5285923|NCT00518336|18230795|P1|Year 9|Personal reasons|1
5285924|NCT00518336|18230794|P2|Year 9|Lost to Follow-up|0
5285925|NCT00518336|18230795|P1|Year 9|Lost to Follow-up|3
5285926|NCT00518336|18230794|P2|Year 9|Migrated/moved from study area|1
5285927|NCT00518336|18230795|P1|Year 9|Migrated/moved from study area|1
5285929|NCT00518336|18230795|P1|Year 8|Could not attend in time|0
5285930|NCT00518336|18230794|P2|Year 8|Lost to Follow-up|1
5285931|NCT00518336|18230795|P1|Year 8|Lost to Follow-up|1
5285932|NCT00518336|18230794|P2|Year 7|Could not attend in time|3
5285933|NCT00518336|18230795|P1|Year 7|Could not attend in time|0
5285934|NCT00518336|18230794|P2|Year 7|Lost to Follow-up|0
5285935|NCT00518336|18230795|P1|Year 7|Lost to Follow-up|2
5285936|NCT00518323|18230961|P4|Overall Study|Prohibited medication and others|0
5285937|NCT00518323|18230962|P3|Overall Study|Prohibited medication and others|1
5285938|NCT00518323|18230963|P2|Overall Study|Prohibited medication and others|1
5285939|NCT00518323|18230964|P1|Overall Study|Prohibited medication and others|3
5285940|NCT00518323|18230961|P4|Overall Study|Adverse Event|0
5285941|NCT00518323|18230962|P3|Overall Study|Adverse Event|1
5285942|NCT00518323|18230963|P2|Overall Study|Adverse Event|1
5285943|NCT00518323|18230964|P1|Overall Study|Adverse Event|1
5285944|NCT00518323|18230961|P4|Overall Study|Lost to Follow-up|3
5285945|NCT00518323|18230962|P3|Overall Study|Lost to Follow-up|1
5285946|NCT00518323|18230963|P2|Overall Study|Lost to Follow-up|2
5285947|NCT00518323|18230964|P1|Overall Study|Lost to Follow-up|0
5285948|NCT00518323|18230961|P4|Overall Study|Withdrawal by Subject|2
5285949|NCT00518323|18230962|P3|Overall Study|Withdrawal by Subject|4
5285950|NCT00518323|18230963|P2|Overall Study|Withdrawal by Subject|2
5285951|NCT00518323|18230964|P1|Overall Study|Withdrawal by Subject|1
5285952|NCT00518323|18230961|P4|Overall Study|Lack of Efficacy|20
5285953|NCT00518323|18230962|P3|Overall Study|Lack of Efficacy|4
5285954|NCT00518323|18230963|P2|Overall Study|Lack of Efficacy|2
5285955|NCT00518323|18230964|P1|Overall Study|Lack of Efficacy|14
5285956|NCT00518284|18230994|P4|Overall Study|Study Termination|2
5285957|NCT00518284|18230995|P3|Overall Study|Study Termination|1
5285958|NCT00518284|18230996|P2|Overall Study|Study Termination|2
5285959|NCT00518284|18230997|P1|Overall Study|Study Termination|0
5285960|NCT00518284|18230994|P4|Overall Study|Adverse Event|0
5285961|NCT00518284|18230995|P3|Overall Study|Adverse Event|0
5285962|NCT00518284|18230996|P2|Overall Study|Adverse Event|1
5285963|NCT00518284|18230997|P1|Overall Study|Adverse Event|0
5285964|NCT00518206|18231053|P2|Overall Study|Completion Status Unknown|0
5285965|NCT00518206|18231054|P1|Overall Study|Completion Status Unknown|1
5285966|NCT00518206|18231053|P2|Overall Study|Reason Unknown|0
5285967|NCT00518206|18231054|P1|Overall Study|Reason Unknown|1
5285968|NCT00518206|18231053|P2|Overall Study|Drug Supply Issue|0
5285969|NCT00518206|18231054|P1|Overall Study|Drug Supply Issue|1
5285970|NCT00518206|18231053|P2|Overall Study|Withdrawal by Subject|0
5285971|NCT00518206|18231054|P1|Overall Study|Withdrawal by Subject|2
5285972|NCT00518206|18231053|P2|Overall Study|Disease Progression Requiring Therapy|6
5285973|NCT00518206|18231054|P1|Overall Study|Disease Progression Requiring Therapy|6
5285974|NCT00518180|18231071|P3|Overall Study|Adverse Event|0
5285975|NCT00518180|18231072|P2|Overall Study|Adverse Event|0
5285976|NCT00518180|18231073|P1|Overall Study|Adverse Event|1
5285977|NCT00518180|18231071|P3|Overall Study|Unable to classify|0
5285978|NCT00518180|18231072|P2|Overall Study|Unable to classify|2
5285979|NCT00518180|18231073|P1|Overall Study|Unable to classify|0
5285980|NCT00518180|18231071|P3|Overall Study|Protocol Violation|4
5285981|NCT00518180|18231072|P2|Overall Study|Protocol Violation|7
5285982|NCT00518180|18231073|P1|Overall Study|Protocol Violation|5
5285983|NCT00518180|18231071|P3|Overall Study|Administrative reason|2
5285984|NCT00518180|18231072|P2|Overall Study|Administrative reason|2
5285985|NCT00518180|18231073|P1|Overall Study|Administrative reason|0
5285986|NCT00518180|18231071|P3|Overall Study|Lost to Follow-up|34
5285987|NCT00518180|18231072|P2|Overall Study|Lost to Follow-up|28
5285988|NCT00518180|18231073|P1|Overall Study|Lost to Follow-up|30
5285989|NCT00518180|18231071|P3|Overall Study|Withdrawal by Subject|42
5285990|NCT00518180|18231072|P2|Overall Study|Withdrawal by Subject|30
5285991|NCT00518180|18231073|P1|Overall Study|Withdrawal by Subject|29
5285992|NCT00518115|18231129|P10|Overall Study|Moved Out of State|1
5285993|NCT00518115|18231130|P9|Overall Study|Moved Out of State|0
5285994|NCT00518115|18231131|P8|Overall Study|Moved Out of State|0
5285995|NCT00518115|18231132|P7|Overall Study|Moved Out of State|0
5285996|NCT00518115|18231133|P6|Overall Study|Moved Out of State|0
5285997|NCT00518115|18231134|P5|Overall Study|Moved Out of State|0
5285998|NCT00518115|18231135|P4|Overall Study|Moved Out of State|0
5285999|NCT00518115|18231136|P3|Overall Study|Moved Out of State|0
5286000|NCT00518115|18231137|P2|Overall Study|Moved Out of State|0
5286001|NCT00518115|18231138|P1|Overall Study|Moved Out of State|0
5286002|NCT00518115|18231129|P10|Overall Study|Withdrew Consent|0
5286003|NCT00518115|18231130|P9|Overall Study|Withdrew Consent|0
5286004|NCT00518115|18231131|P8|Overall Study|Withdrew Consent|0
5286005|NCT00518115|18231132|P7|Overall Study|Withdrew Consent|0
5286006|NCT00518115|18231133|P6|Overall Study|Withdrew Consent|1
5286007|NCT00518115|18231134|P5|Overall Study|Withdrew Consent|0
5286008|NCT00518115|18231135|P4|Overall Study|Withdrew Consent|0
5286009|NCT00518115|18231136|P3|Overall Study|Withdrew Consent|0
5286010|NCT00518115|18231137|P2|Overall Study|Withdrew Consent|0
5286011|NCT00518115|18231138|P1|Overall Study|Withdrew Consent|0
5286012|NCT00518115|18231129|P10|Overall Study|Family Emergency; Had to Go to England|0
5286013|NCT00518115|18231130|P9|Overall Study|Family Emergency; Had to Go to England|0
5286014|NCT00518115|18231131|P8|Overall Study|Family Emergency; Had to Go to England|0
5286015|NCT00518115|18231132|P7|Overall Study|Family Emergency; Had to Go to England|0
5286016|NCT00518115|18231133|P6|Overall Study|Family Emergency; Had to Go to England|0
5286017|NCT00518115|18231134|P5|Overall Study|Family Emergency; Had to Go to England|1
5286018|NCT00518115|18231135|P4|Overall Study|Family Emergency; Had to Go to England|0
5286019|NCT00518115|18231136|P3|Overall Study|Family Emergency; Had to Go to England|0
5286020|NCT00518115|18231137|P2|Overall Study|Family Emergency; Had to Go to England|0
5286021|NCT00518115|18231138|P1|Overall Study|Family Emergency; Had to Go to England|0
5286022|NCT00518115|18231129|P10|Overall Study|Violation of Exclusion Criteria|0
5286023|NCT00518115|18231130|P9|Overall Study|Violation of Exclusion Criteria|0
5286024|NCT00518115|18231131|P8|Overall Study|Violation of Exclusion Criteria|0
5286025|NCT00518115|18231132|P7|Overall Study|Violation of Exclusion Criteria|1
5286026|NCT00518115|18231133|P6|Overall Study|Violation of Exclusion Criteria|0
5286027|NCT00518115|18231134|P5|Overall Study|Violation of Exclusion Criteria|0
5286028|NCT00518115|18231135|P4|Overall Study|Violation of Exclusion Criteria|1
5286029|NCT00518115|18231136|P3|Overall Study|Violation of Exclusion Criteria|0
5286030|NCT00518115|18231137|P2|Overall Study|Violation of Exclusion Criteria|0
5286031|NCT00518115|18231138|P1|Overall Study|Violation of Exclusion Criteria|0
5286032|NCT00518115|18231129|P10|Overall Study|Wrong Monotherapy Administered|0
5286033|NCT00518115|18231130|P9|Overall Study|Wrong Monotherapy Administered|0
5286034|NCT00518115|18231131|P8|Overall Study|Wrong Monotherapy Administered|0
5286035|NCT00518115|18231132|P7|Overall Study|Wrong Monotherapy Administered|1
5286036|NCT00518115|18231133|P6|Overall Study|Wrong Monotherapy Administered|0
5286037|NCT00518115|18231134|P5|Overall Study|Wrong Monotherapy Administered|0
5286038|NCT00518115|18231135|P4|Overall Study|Wrong Monotherapy Administered|0
5286039|NCT00518115|18231136|P3|Overall Study|Wrong Monotherapy Administered|1
5286040|NCT00518115|18231137|P2|Overall Study|Wrong Monotherapy Administered|0
5286041|NCT00518115|18231138|P1|Overall Study|Wrong Monotherapy Administered|0
5286042|NCT00518115|18231129|P10|Overall Study|Different Monotherapy Diabetic Drug|0
5286043|NCT00518115|18231130|P9|Overall Study|Different Monotherapy Diabetic Drug|1
5286044|NCT00518115|18231131|P8|Overall Study|Different Monotherapy Diabetic Drug|0
5286045|NCT00518115|18231132|P7|Overall Study|Different Monotherapy Diabetic Drug|0
5286046|NCT00518115|18231133|P6|Overall Study|Different Monotherapy Diabetic Drug|0
5286047|NCT00518115|18231134|P5|Overall Study|Different Monotherapy Diabetic Drug|0
5286048|NCT00518115|18231135|P4|Overall Study|Different Monotherapy Diabetic Drug|0
5286049|NCT00518115|18231136|P3|Overall Study|Different Monotherapy Diabetic Drug|1
5286050|NCT00518115|18231137|P2|Overall Study|Different Monotherapy Diabetic Drug|0
5286051|NCT00518115|18231138|P1|Overall Study|Different Monotherapy Diabetic Drug|0
5286052|NCT00518115|18231129|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286053|NCT00518115|18231130|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286054|NCT00518115|18231131|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286055|NCT00518115|18231132|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286056|NCT00518115|18231133|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286057|NCT00518115|18231134|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286058|NCT00518115|18231135|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286059|NCT00518115|18231136|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286060|NCT00518115|18231137|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
5286061|NCT00518115|18231138|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
5286062|NCT00518115|18231129|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
5286063|NCT00518115|18231130|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
5286064|NCT00518115|18231131|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
5286065|NCT00518115|18231132|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
5286066|NCT00518115|18231133|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
5286067|NCT00518115|18231134|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
5286068|NCT00518115|18231135|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
5286069|NCT00518115|18231136|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
5286070|NCT00518115|18231137|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
5286071|NCT00518115|18231138|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
5286072|NCT00518115|18231129|P10|Overall Study|Non-Compliance|1
5286073|NCT00518115|18231130|P9|Overall Study|Non-Compliance|0
5286074|NCT00518115|18231131|P8|Overall Study|Non-Compliance|1
5286075|NCT00518115|18231132|P7|Overall Study|Non-Compliance|1
5286076|NCT00518115|18231133|P6|Overall Study|Non-Compliance|1
5286077|NCT00518115|18231134|P5|Overall Study|Non-Compliance|1
5286078|NCT00518115|18231135|P4|Overall Study|Non-Compliance|0
5286079|NCT00518115|18231136|P3|Overall Study|Non-Compliance|1
5286080|NCT00518115|18231137|P2|Overall Study|Non-Compliance|0
5286081|NCT00518115|18231138|P1|Overall Study|Non-Compliance|1
5286082|NCT00518115|18231129|P10|Overall Study|Lack of Efficacy|0
5286083|NCT00518115|18231130|P9|Overall Study|Lack of Efficacy|0
5286084|NCT00518115|18231131|P8|Overall Study|Lack of Efficacy|1
5286085|NCT00518115|18231132|P7|Overall Study|Lack of Efficacy|0
5286086|NCT00518115|18231133|P6|Overall Study|Lack of Efficacy|0
5286087|NCT00518115|18231134|P5|Overall Study|Lack of Efficacy|0
5286088|NCT00518115|18231135|P4|Overall Study|Lack of Efficacy|1
5286089|NCT00518115|18231136|P3|Overall Study|Lack of Efficacy|1
5286090|NCT00518115|18231137|P2|Overall Study|Lack of Efficacy|0
5286091|NCT00518115|18231138|P1|Overall Study|Lack of Efficacy|1
5286092|NCT00518115|18231129|P10|Overall Study|Withdrawal by Subject|3
5286093|NCT00518115|18231130|P9|Overall Study|Withdrawal by Subject|1
5286094|NCT00518115|18231131|P8|Overall Study|Withdrawal by Subject|2
5286095|NCT00518115|18231132|P7|Overall Study|Withdrawal by Subject|0
5286096|NCT00518115|18231133|P6|Overall Study|Withdrawal by Subject|1
5286097|NCT00518115|18231134|P5|Overall Study|Withdrawal by Subject|2
5286098|NCT00518115|18231135|P4|Overall Study|Withdrawal by Subject|0
5286099|NCT00518115|18231136|P3|Overall Study|Withdrawal by Subject|5
5286100|NCT00518115|18231137|P2|Overall Study|Withdrawal by Subject|1
5286101|NCT00518115|18231138|P1|Overall Study|Withdrawal by Subject|1
5286102|NCT00518115|18231129|P10|Overall Study|Protocol Violation|0
5286103|NCT00518115|18231130|P9|Overall Study|Protocol Violation|0
5286104|NCT00518115|18231131|P8|Overall Study|Protocol Violation|0
5286105|NCT00518115|18231132|P7|Overall Study|Protocol Violation|0
5286106|NCT00518115|18231133|P6|Overall Study|Protocol Violation|0
5286107|NCT00518115|18231134|P5|Overall Study|Protocol Violation|0
5286108|NCT00518115|18231135|P4|Overall Study|Protocol Violation|0
5286109|NCT00518115|18231136|P3|Overall Study|Protocol Violation|1
5286110|NCT00518115|18231137|P2|Overall Study|Protocol Violation|3
5286111|NCT00518115|18231138|P1|Overall Study|Protocol Violation|1
5286112|NCT00518115|18231129|P10|Overall Study|Lost to Follow-up|1
5286113|NCT00518115|18231130|P9|Overall Study|Lost to Follow-up|1
5286114|NCT00518115|18231131|P8|Overall Study|Lost to Follow-up|1
5286115|NCT00518115|18231132|P7|Overall Study|Lost to Follow-up|0
5286116|NCT00518115|18231133|P6|Overall Study|Lost to Follow-up|3
5286117|NCT00518115|18231134|P5|Overall Study|Lost to Follow-up|1
5286118|NCT00518115|18231135|P4|Overall Study|Lost to Follow-up|3
5286119|NCT00518115|18231136|P3|Overall Study|Lost to Follow-up|2
5286120|NCT00518115|18231137|P2|Overall Study|Lost to Follow-up|0
5286121|NCT00518115|18231138|P1|Overall Study|Lost to Follow-up|0
5286122|NCT00518115|18231129|P10|Overall Study|Adverse Event|9
5286123|NCT00518115|18231130|P9|Overall Study|Adverse Event|2
5286124|NCT00518115|18231131|P8|Overall Study|Adverse Event|10
5286125|NCT00518115|18231132|P7|Overall Study|Adverse Event|5
5286126|NCT00518115|18231133|P6|Overall Study|Adverse Event|5
5286127|NCT00518115|18231134|P5|Overall Study|Adverse Event|5
5286128|NCT00518115|18231135|P4|Overall Study|Adverse Event|6
5286129|NCT00518115|18231136|P3|Overall Study|Adverse Event|5
5286130|NCT00518115|18231137|P2|Overall Study|Adverse Event|1
5286131|NCT00518115|18231138|P1|Overall Study|Adverse Event|6
5286132|NCT00518011|18231313|P2|Overall Study|Withdrawal by Subject|0
5286133|NCT00518011|18231314|P1|Overall Study|Withdrawal by Subject|1
5286134|NCT00518011|18231313|P2|Overall Study|Other Reasons|2
5286135|NCT00518011|18231314|P1|Overall Study|Other Reasons|3
5286136|NCT00518011|18231313|P2|Overall Study|Disease Progression|2
5286137|NCT00518011|18231314|P1|Overall Study|Disease Progression|2
5286138|NCT00518011|18231313|P2|Overall Study|Adverse Event|3
5286139|NCT00518011|18231314|P1|Overall Study|Adverse Event|2
5286140|NCT00518011|18231313|P2|Overall Study|Death|1
5286141|NCT00518011|18231314|P1|Overall Study|Death|1
5286142|NCT00517933|18231336|P2|Period 2|Underwent lung transplant|2
5286143|NCT00517933|18231337|P1|Period 2|Underwent lung transplant|0
5286144|NCT00517933|18231336|P2|Period 2|Withdrawal by Subject|3
5286145|NCT00517933|18231337|P1|Period 2|Withdrawal by Subject|1
5286146|NCT00517933|18231336|P2|Period 2|Physician Decision|0
5286147|NCT00517933|18231337|P1|Period 2|Physician Decision|1
5286148|NCT00517933|18231336|P2|Period 2|Adverse Event|4
5286149|NCT00517933|18231337|P1|Period 2|Adverse Event|2
5286150|NCT00517933|18231336|P2|Period 2|Death|4
5286151|NCT00517933|18231337|P1|Period 2|Death|2
5286152|NCT00517933|18231336|P2|Period 1|Underwent lung transplant|1
5286153|NCT00517933|18231337|P1|Period 1|Underwent lung transplant|0
5286154|NCT00517933|18231336|P2|Period 1|Lost to Follow-up|0
5286155|NCT00517933|18231337|P1|Period 1|Lost to Follow-up|2
5286156|NCT00517933|18231336|P2|Period 1|Adverse Event|4
5286157|NCT00517933|18231337|P1|Period 1|Adverse Event|4
5286158|NCT00517933|18231336|P2|Period 1|Death|1
5286159|NCT00517933|18231337|P1|Period 1|Death|2
5286160|NCT00517881|18231401|P1|Overall Study|Renal transplantation|2
5286161|NCT00517881|18231401|P1|Overall Study|Adverse Event|1
5286162|NCT00517881|18231401|P1|Overall Study|Protocol Violation|2
5286163|NCT00517829|18231413|P2|Overall Study|Other|1
5286164|NCT00517829|18231414|P1|Overall Study|Other|3
5286165|NCT00517829|18231413|P2|Overall Study|Investigator Request|3
5286166|NCT00517829|18231414|P1|Overall Study|Investigator Request|5
5286167|NCT00517829|18231413|P2|Overall Study|Patient Request|5
5286168|NCT00517829|18231414|P1|Overall Study|Patient Request|6
5286169|NCT00517829|18231413|P2|Overall Study|Disease Progression|32
5286170|NCT00517829|18231414|P1|Overall Study|Disease Progression|39
5286171|NCT00517829|18231413|P2|Overall Study|Adverse Event|34
5286172|NCT00517829|18231414|P1|Overall Study|Adverse Event|22
5286173|NCT00517751|18231428|P1|Overall Study|Missing|3
5286174|NCT00517751|18231428|P1|Overall Study|Patient not due for visit|76
5286175|NCT00517751|18231428|P1|Overall Study|patient not over due|6
5286176|NCT00517751|18231428|P1|Overall Study|Lost to Follow-up|4
5286177|NCT00517751|18231428|P1|Overall Study|Withdrawal by Subject|37
5286178|NCT00517751|18231428|P1|Overall Study|Death|3
5286179|NCT00517699|18231451|P1|Overall Study|Study terminated by Sponsor|2
5286180|NCT00517699|18231451|P1|Overall Study|Administrative error|1
5286181|NCT00517699|18231451|P1|Overall Study|Lack of Efficacy|1
5286182|NCT00517699|18231451|P1|Overall Study|Withdrawal by Subject|1
5286183|NCT00517634|18231459|P6|Second Treatment Period|Withdrawal by Subject|0
5286184|NCT00517634|18231460|P5|Second Treatment Period|Withdrawal by Subject|1
5286185|NCT00517634|18231461|P4|Second Treatment Period|Withdrawal by Subject|0
5286186|NCT00517634|18231462|P3|Second Treatment Period|Withdrawal by Subject|0
5286187|NCT00517634|18231463|P2|Second Treatment Period|Withdrawal by Subject|0
5286188|NCT00517634|18231464|P1|Second Treatment Period|Withdrawal by Subject|0
5286189|NCT00517413|18231566|P1|Overall Study|Other-Reasons|23
5286190|NCT00517413|18231566|P1|Overall Study|Failure to return|1
5286191|NCT00517413|18231566|P1|Overall Study|Withdrawal by Subject|2
5286192|NCT00517413|18231566|P1|Overall Study|Protocol Violation|15
5286193|NCT00517413|18231566|P1|Overall Study|Death|13
5286194|NCT00517413|18231566|P1|Overall Study|Adverse Event|7
5286195|NCT00517361|18231587|P1|Overall Study|The study was terminated|5
5286196|NCT00517361|18231587|P1|Overall Study|Death|6
5286197|NCT00517296|18231596|P2|Overall Study|Withdrawal by Subject|0
5286198|NCT00517296|18231597|P1|Overall Study|Withdrawal by Subject|1
5286199|NCT00517192|18231609|P2|Overall Study|Early termination of the trial|18
5286200|NCT00517192|18231610|P1|Overall Study|Early termination of the trial|16
5286201|NCT00517192|18231609|P2|Overall Study|Withdrawal by Subject|0
5286202|NCT00517192|18231610|P1|Overall Study|Withdrawal by Subject|1
5286203|NCT00517192|18231609|P2|Overall Study|Lost to Follow-up|1
5286204|NCT00517192|18231610|P1|Overall Study|Lost to Follow-up|1
5286205|NCT00517192|18231609|P2|Overall Study|Adverse Event|1
5286206|NCT00517192|18231610|P1|Overall Study|Adverse Event|1
5286207|NCT00516906|18231717|P2|Overall Study|Final Dressing Removal Data not captured|2
5286208|NCT00516906|18231718|P1|Overall Study|Final Dressing Removal Data not captured|6
5286209|NCT00516893|18231728|P1|Overall Study|Received Medication From Another Study|1
5286210|NCT00516893|18231728|P1|Overall Study|Pregnancy|1
5286211|NCT00516893|18231728|P1|Overall Study|Relocated|1
5286212|NCT00516893|18231728|P1|Overall Study|Persistent Antibodies per Protocol|6
5286213|NCT00516893|18231728|P1|Overall Study|Death|1
5286214|NCT00516893|18231728|P1|Overall Study|Noncompliance|2
5286215|NCT00516893|18231728|P1|Overall Study|Withdrawal by Subject|2
5286216|NCT00516893|18231728|P1|Overall Study|Adverse Event|3
5286217|NCT00516893|18231728|P1|Overall Study|Lost to Follow-up|4
5286218|NCT00516737|18231737|P2|Overall Study|Lack of Qualifying Event|6
5286219|NCT00516737|18231738|P1|Overall Study|Lack of Qualifying Event|9
5286220|NCT00516737|18231737|P2|Overall Study|Withdrawal by Subject|1
5286221|NCT00516737|18231738|P1|Overall Study|Withdrawal by Subject|0
5286222|NCT00516737|18231737|P2|Overall Study|Physician Decision|1
5286223|NCT00516737|18231738|P1|Overall Study|Physician Decision|0
5286224|NCT00516737|18231737|P2|Overall Study|Lost to Follow-up|0
5286225|NCT00516737|18231738|P1|Overall Study|Lost to Follow-up|2
5286226|NCT00516386|18231777|P1|Overall Study|Lost to Follow-up|2
5286227|NCT00516386|18231777|P1|Overall Study|not interested in the study|4
5286228|NCT00516321|18231784|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
5286229|NCT00516321|18231785|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
5286230|NCT00516321|18231786|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
5286231|NCT00516321|18231784|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
5286232|NCT00516321|18231785|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
5286233|NCT00516321|18231786|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
5286234|NCT00516321|18231784|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
5286235|NCT00516321|18231785|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
5286236|NCT00516321|18231786|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
5286237|NCT00516321|18231784|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
5286238|NCT00516321|18231785|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
5286239|NCT00516321|18231786|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
5286240|NCT00516321|18231784|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
5286241|NCT00516321|18231785|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
5286242|NCT00516321|18231786|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
5286243|NCT00516321|18231784|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
5286244|NCT00516321|18231785|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
5286245|NCT00516321|18231786|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
5286246|NCT00516321|18231784|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
5286247|NCT00516321|18231785|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
5286248|NCT00516321|18231786|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
5286249|NCT00516321|18231784|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
5286250|NCT00516321|18231785|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
5286251|NCT00516321|18231786|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
5286252|NCT00516321|18231784|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
5286253|NCT00516321|18231785|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
5286254|NCT00516321|18231786|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
5286255|NCT00516321|18231784|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
5286256|NCT00516321|18231785|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
5286257|NCT00516321|18231786|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
5286258|NCT00516321|18231784|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
5286259|NCT00516321|18231785|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
5286260|NCT00516321|18231786|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
5286261|NCT00516295|18231837|P3|Overall Study|Ineligible|0
5286262|NCT00516295|18231838|P2|Overall Study|Ineligible|0
5286263|NCT00516295|18231839|P1|Overall Study|Ineligible|1
5286264|NCT00516295|18231837|P3|Overall Study|Lack of Efficacy|0
5286265|NCT00516295|18231838|P2|Overall Study|Lack of Efficacy|0
5286266|NCT00516295|18231839|P1|Overall Study|Lack of Efficacy|2
5286267|NCT00516269|18231852|P2|Overall Study|Protocol Violation|1
5286268|NCT00516269|18231853|P1|Overall Study|Protocol Violation|0
5286269|NCT00516269|18231852|P2|Overall Study|Lost to Follow-up|1
5286270|NCT00516269|18231853|P1|Overall Study|Lost to Follow-up|0
5286271|NCT00516269|18231852|P2|Overall Study|Adverse Event|1
5286272|NCT00516269|18231853|P1|Overall Study|Adverse Event|2
5286273|NCT00516139|18231874|P1|Overall Study|Lack of Efficacy|1
5286274|NCT00516139|18231874|P1|Overall Study|Withdrawal by Subject|8
5286275|NCT00516139|18231874|P1|Overall Study|Protocol Violation|1
5286276|NCT00516139|18231874|P1|Overall Study|Lost to Follow-up|1
5286277|NCT00516139|18231874|P1|Overall Study|Adverse Event|27
5286278|NCT00516074|18231905|P2|Overall Study|Loss of Glucose Control|0
5286279|NCT00516074|18231906|P1|Overall Study|Loss of Glucose Control|2
5286280|NCT00516074|18231905|P2|Overall Study|Subject Decision|2
5286281|NCT00516074|18231906|P1|Overall Study|Subject Decision|4
5286282|NCT00516074|18231905|P2|Overall Study|Adverse Event|1
5286283|NCT00516074|18231906|P1|Overall Study|Adverse Event|0
5286284|NCT00516048|18231924|P3|Overall Study|Subject Decision|0
5286285|NCT00516048|18231925|P2|Overall Study|Subject Decision|2
5286286|NCT00516048|18231926|P1|Overall Study|Subject Decision|0
5286287|NCT00516048|18231924|P3|Overall Study|Death|1
5286288|NCT00516048|18231925|P2|Overall Study|Death|0
5286289|NCT00516048|18231926|P1|Overall Study|Death|0
5286290|NCT00515827|18231961|P2|Second Intervention (12 Weeks)|Consent withdraw|0
5286291|NCT00515827|18231962|P1|Second Intervention (12 Weeks)|Consent withdraw|1
5286292|NCT00515827|18231961|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
5286293|NCT00515827|18231962|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
5286294|NCT00515671|18232020|P2|Overall Study|incarcerated|2
5286295|NCT00515671|18232021|P1|Overall Study|incarcerated|1
5286296|NCT00515671|18232020|P2|Overall Study|Withdrawal by Subject|5
5286297|NCT00515671|18232021|P1|Overall Study|Withdrawal by Subject|3
5286298|NCT00515671|18232020|P2|Overall Study|Lost to Follow-up|10
5286299|NCT00515671|18232021|P1|Overall Study|Lost to Follow-up|13
5286300|NCT00515619|18232029|P1|Overall Study|Other: Subject interested in other AED|1
5286301|NCT00515619|18232029|P1|Overall Study|Other: Drug available on license|1
5286302|NCT00515619|18232029|P1|Overall Study|Other: Request from sponsor|1
5286303|NCT00515619|18232029|P1|Overall Study|Other: Subject became pregnant|1
5286304|NCT00515619|18232029|P1|Overall Study|Other: Investigator decision|1
5286305|NCT00515619|18232029|P1|Overall Study|Other: Subject moved to another country|1
5286306|NCT00515619|18232029|P1|Overall Study|Other: Subject required surgery|1
5286307|NCT00515619|18232029|P1|Overall Study|Other: Subject cannot attend visits|2
5286308|NCT00515619|18232029|P1|Overall Study|Other: Site discontinuing trials|2
5286309|NCT00515619|18232029|P1|Overall Study|Unsatisfactory compliance|6
5286310|NCT00515619|18232029|P1|Overall Study|Lost to Follow-up|4
5286311|NCT00515619|18232029|P1|Overall Study|Protocol Violation|3
5286312|NCT00515619|18232029|P1|Overall Study|Withdrawal by Subject|66
5286313|NCT00515619|18232029|P1|Overall Study|Lack of Efficacy|92
5286314|NCT00515619|18232029|P1|Overall Study|Adverse Event|34
5286315|NCT00515541|18232041|P4|Overall Study|Withdrawal by Subject|2
5286316|NCT00515541|18232042|P3|Overall Study|Withdrawal by Subject|0
5286317|NCT00515541|18232043|P2|Overall Study|Withdrawal by Subject|2
5286318|NCT00515541|18232044|P1|Overall Study|Withdrawal by Subject|0
5286319|NCT00515541|18232041|P4|Overall Study|No show for appointments|2
5286320|NCT00515541|18232042|P3|Overall Study|No show for appointments|0
5286321|NCT00515541|18232043|P2|Overall Study|No show for appointments|1
5286322|NCT00515541|18232044|P1|Overall Study|No show for appointments|0
5286323|NCT00515541|18232041|P4|Overall Study|Physician Decision|1
5286324|NCT00515541|18232042|P3|Overall Study|Physician Decision|0
5286325|NCT00515541|18232043|P2|Overall Study|Physician Decision|2
5286326|NCT00515541|18232044|P1|Overall Study|Physician Decision|0
5286327|NCT00515502|18232075|P12|Treatment Period 2|Adverse Event|0
5286328|NCT00515502|18232076|P11|Treatment Period 2|Adverse Event|0
5286329|NCT00515502|18232077|P10|Treatment Period 2|Adverse Event|0
5286330|NCT00515502|18232078|P9|Treatment Period 2|Adverse Event|0
5286331|NCT00515502|18232079|P8|Treatment Period 2|Adverse Event|0
5286332|NCT00515502|18232080|P7|Treatment Period 2|Adverse Event|0
5286333|NCT00515502|18232081|P6|Treatment Period 2|Adverse Event|0
5286334|NCT00515502|18232082|P5|Treatment Period 2|Adverse Event|0
5286335|NCT00515502|18232083|P4|Treatment Period 2|Adverse Event|0
5286336|NCT00515502|18232084|P3|Treatment Period 2|Adverse Event|0
5286337|NCT00515502|18232085|P2|Treatment Period 2|Adverse Event|1
5286338|NCT00515502|18232086|P1|Treatment Period 2|Adverse Event|0
5286339|NCT00515502|18232075|P12|Treatment Period 1|Adverse Event|1
5286340|NCT00515502|18232076|P11|Treatment Period 1|Adverse Event|0
5286341|NCT00515502|18232077|P10|Treatment Period 1|Adverse Event|0
5286342|NCT00515502|18232078|P9|Treatment Period 1|Adverse Event|1
5286343|NCT00515502|18232079|P8|Treatment Period 1|Adverse Event|0
5286344|NCT00515502|18232080|P7|Treatment Period 1|Adverse Event|1
5286345|NCT00515502|18232081|P6|Treatment Period 1|Adverse Event|0
5286346|NCT00515502|18232082|P5|Treatment Period 1|Adverse Event|0
5286347|NCT00515502|18232083|P4|Treatment Period 1|Adverse Event|0
5286348|NCT00515502|18232084|P3|Treatment Period 1|Adverse Event|0
5286349|NCT00515502|18232085|P2|Treatment Period 1|Adverse Event|0
5286350|NCT00515502|18232086|P1|Treatment Period 1|Adverse Event|0
5286351|NCT00515463|18232246|P2|Overall Study|Other|1
5286352|NCT00515463|18232247|P1|Overall Study|Other|0
5286353|NCT00515463|18232246|P2|Overall Study|Lost to Follow-up|5
5286354|NCT00515463|18232247|P1|Overall Study|Lost to Follow-up|6
5286355|NCT00515463|18232246|P2|Overall Study|Withdrawal by Subject|4
5286356|NCT00515463|18232247|P1|Overall Study|Withdrawal by Subject|3
5286357|NCT00515463|18232246|P2|Overall Study|Adverse Event|2
5286358|NCT00515463|18232247|P1|Overall Study|Adverse Event|1
5286359|NCT00515463|18232246|P2|Overall Study|Physician Decision|2
5286360|NCT00515463|18232247|P1|Overall Study|Physician Decision|4
5286361|NCT00515294|18232446|P4|Overall Study|Caffeine amount inaccurate|0
5286362|NCT00515294|18232447|P3|Overall Study|Caffeine amount inaccurate|7
5286363|NCT00515294|18232448|P2|Overall Study|Caffeine amount inaccurate|0
5286364|NCT00515294|18232449|P1|Overall Study|Caffeine amount inaccurate|5
5286365|NCT00515294|18232446|P4|Overall Study|Driver simulator problems|3
5286366|NCT00515294|18232447|P3|Overall Study|Driver simulator problems|1
5286367|NCT00515294|18232448|P2|Overall Study|Driver simulator problems|1
5286368|NCT00515294|18232449|P1|Overall Study|Driver simulator problems|1
5286369|NCT00515294|18232446|P4|Overall Study|Lost to Follow-up|1
5286370|NCT00515294|18232447|P3|Overall Study|Lost to Follow-up|3
5286371|NCT00515294|18232448|P2|Overall Study|Lost to Follow-up|2
5286372|NCT00515294|18232449|P1|Overall Study|Lost to Follow-up|3
5286373|NCT00515216|18232463|P1|Overall Study|Withdrawal by Subject|1
5286374|NCT00515112|18232525|P2|Overall Study|The study was terminated|2
5286375|NCT00515112|18232526|P1|Overall Study|The study was terminated|3
5286376|NCT00515112|18232525|P2|Overall Study|Death|1
5286377|NCT00515112|18232526|P1|Overall Study|Death|0
5286378|NCT00515099|18232536|P2|Overall Study|IRB Recommendation|0
5286379|NCT00515099|18232537|P1|Overall Study|IRB Recommendation|1
5286380|NCT00515099|18232536|P2|Overall Study|Withdrawal by Subject|0
5286381|NCT00515099|18232537|P1|Overall Study|Withdrawal by Subject|2
5286382|NCT00515099|18232536|P2|Overall Study|Lost to Follow-up|4
5286383|NCT00515099|18232537|P1|Overall Study|Lost to Follow-up|0
5286384|NCT00515086|18232559|P4|Overall Study|Death|0
5286385|NCT00515086|18232560|P3|Overall Study|Death|0
5286386|NCT00515086|18232561|P2|Overall Study|Death|0
5286387|NCT00515086|18232562|P1|Overall Study|Death|2
5286388|NCT00515086|18232559|P4|Overall Study|Study drug no longer required|0
5286389|NCT00515086|18232560|P3|Overall Study|Study drug no longer required|0
5286390|NCT00515086|18232561|P2|Overall Study|Study drug no longer required|1
5286391|NCT00515086|18232562|P1|Overall Study|Study drug no longer required|0
5286392|NCT00515086|18232559|P4|Overall Study|Lost to Follow-up|0
5286393|NCT00515086|18232560|P3|Overall Study|Lost to Follow-up|0
5286394|NCT00515086|18232561|P2|Overall Study|Lost to Follow-up|0
5286395|NCT00515086|18232562|P1|Overall Study|Lost to Follow-up|1
5286396|NCT00515086|18232559|P4|Overall Study|Unsatisfactory therapeutic effect|2
5286397|NCT00515086|18232560|P3|Overall Study|Unsatisfactory therapeutic effect|3
5286398|NCT00515086|18232561|P2|Overall Study|Unsatisfactory therapeutic effect|3
5286399|NCT00515086|18232562|P1|Overall Study|Unsatisfactory therapeutic effect|18
5286400|NCT00515086|18232559|P4|Overall Study|Withdrawal by Subject|1
5286401|NCT00515086|18232560|P3|Overall Study|Withdrawal by Subject|0
5286402|NCT00515086|18232561|P2|Overall Study|Withdrawal by Subject|0
5286403|NCT00515086|18232562|P1|Overall Study|Withdrawal by Subject|1
5286404|NCT00515086|18232559|P4|Overall Study|Administrative|0
5286405|NCT00515086|18232560|P3|Overall Study|Administrative|0
5286406|NCT00515086|18232561|P2|Overall Study|Administrative|1
5286407|NCT00515086|18232562|P1|Overall Study|Administrative|1
5286408|NCT00515086|18232559|P4|Overall Study|Adverse Event|3
5286409|NCT00515086|18232560|P3|Overall Study|Adverse Event|2
5286410|NCT00515086|18232561|P2|Overall Study|Adverse Event|1
5286411|NCT00515086|18232562|P1|Overall Study|Adverse Event|1
5286412|NCT00515073|18232589|P1|Overall Study|Physician Decision|1
5286413|NCT00515073|18232589|P1|Overall Study|Withdrawal by Subject|1
5286414|NCT00515034|18232597|P4|Overall Study|Other|1
5286415|NCT00515034|18232598|P3|Overall Study|Other|2
5286416|NCT00515034|18232599|P2|Overall Study|Other|0
5286417|NCT00515034|18232600|P1|Overall Study|Other|1
5286418|NCT00515034|18232597|P4|Overall Study|Physician Decision|1
5286419|NCT00515034|18232598|P3|Overall Study|Physician Decision|1
5286420|NCT00515034|18232599|P2|Overall Study|Physician Decision|0
5286421|NCT00515034|18232600|P1|Overall Study|Physician Decision|0
5286422|NCT00515034|18232597|P4|Overall Study|Withdrawal by Subject|0
5286423|NCT00515034|18232598|P3|Overall Study|Withdrawal by Subject|3
5286424|NCT00515034|18232599|P2|Overall Study|Withdrawal by Subject|0
5286425|NCT00515034|18232600|P1|Overall Study|Withdrawal by Subject|1
5286426|NCT00515034|18232597|P4|Overall Study|Death|3
5286427|NCT00515034|18232598|P3|Overall Study|Death|1
5286428|NCT00515034|18232599|P2|Overall Study|Death|2
5286429|NCT00515034|18232600|P1|Overall Study|Death|4
5286430|NCT00515034|18232597|P4|Overall Study|Adverse Event|0
5286431|NCT00515034|18232598|P3|Overall Study|Adverse Event|1
5286432|NCT00515034|18232599|P2|Overall Study|Adverse Event|0
5286433|NCT00515034|18232600|P1|Overall Study|Adverse Event|2
5286434|NCT00515008|18232631|P2|Overall Study|Scheduling conflict|0
5286435|NCT00515008|18232632|P1|Overall Study|Scheduling conflict|1
5286436|NCT00515008|18232631|P2|Overall Study|Left the Boston Area|1
5286437|NCT00515008|18232632|P1|Overall Study|Left the Boston Area|1
5286438|NCT00515008|18232631|P2|Overall Study|Declined|3
5286439|NCT00515008|18232632|P1|Overall Study|Declined|0
5286440|NCT00515008|18232631|P2|Overall Study|Lost to Follow-up|0
5286441|NCT00515008|18232632|P1|Overall Study|Lost to Follow-up|1
5286442|NCT00514943|18232656|P2|Stage 2|Other than stated above|2
5286443|NCT00514943|18232657|P1|Stage 2|Other than stated above|0
5286444|NCT00514943|18232656|P2|Stage 2|Patient refused to continue study meds|0
5286445|NCT00514943|18232657|P1|Stage 2|Patient refused to continue study meds|2
5286446|NCT00514943|18232656|P2|Stage 2|Other Adverse Event|10
5286447|NCT00514943|18232657|P1|Stage 2|Other Adverse Event|3
5286448|NCT00514943|18232656|P2|Stage 2|Progressive disease|24
5286449|NCT00514943|18232657|P1|Stage 2|Progressive disease|27
5286450|NCT00514943|18232656|P2|Stage 1|Other than stated above|7
5286451|NCT00514943|18232657|P1|Stage 1|Other than stated above|1
5286452|NCT00514943|18232656|P2|Stage 1|Patient refused to continue study meds|3
5286453|NCT00514943|18232657|P1|Stage 1|Patient refused to continue study meds|8
5286454|NCT00514943|18232656|P2|Stage 1|Not treated|2
5286455|NCT00514943|18232657|P1|Stage 1|Not treated|1
5286456|NCT00514943|18232656|P2|Stage 1|Other Adverse Event|6
5286457|NCT00514943|18232657|P1|Stage 1|Other Adverse Event|16
5286458|NCT00514943|18232656|P2|Stage 1|Progressive disease|8
5286459|NCT00514943|18232657|P1|Stage 1|Progressive disease|4
5286460|NCT00514917|18232715|P2|Overall Study|Undefined|5
5286461|NCT00514917|18232716|P1|Overall Study|Undefined|11
5286462|NCT00514917|18232715|P2|Overall Study|Discontinued due to study closure|81
5286463|NCT00514917|18232716|P1|Overall Study|Discontinued due to study closure|88
5286464|NCT00514917|18232715|P2|Overall Study|Withdrawal by Subject|16
5286465|NCT00514917|18232716|P1|Overall Study|Withdrawal by Subject|18
5286466|NCT00514917|18232715|P2|Overall Study|Lost to Follow-up|3
5286467|NCT00514917|18232716|P1|Overall Study|Lost to Follow-up|4
5286468|NCT00514917|18232715|P2|Overall Study|Protocol Violation|0
5286469|NCT00514917|18232716|P1|Overall Study|Protocol Violation|1
5286470|NCT00514917|18232715|P2|Overall Study|Death|10
5286471|NCT00514917|18232716|P1|Overall Study|Death|4
5286472|NCT00514904|18232744|P2|Overall Study|Lost to Follow-up|3
5286473|NCT00514904|18232745|P1|Overall Study|Lost to Follow-up|21
5286474|NCT00514904|18232744|P2|Overall Study|Withdrawal by Subject|2
5286475|NCT00514904|18232745|P1|Overall Study|Withdrawal by Subject|3
5286476|NCT00514813|18232810|P4|Overall Study|Death|2
5286477|NCT00514813|18232811|P3|Overall Study|Death|3
5286478|NCT00514813|18232812|P2|Overall Study|Death|2
5286479|NCT00514813|18232813|P1|Overall Study|Death|0
5286480|NCT00514813|18232810|P4|Overall Study|Kidney transplant|0
5286481|NCT00514813|18232811|P3|Overall Study|Kidney transplant|2
5286482|NCT00514813|18232812|P2|Overall Study|Kidney transplant|6
5286483|NCT00514813|18232813|P1|Overall Study|Kidney transplant|0
5286484|NCT00514813|18232810|P4|Overall Study|Lack of Efficacy|0
5286485|NCT00514813|18232811|P3|Overall Study|Lack of Efficacy|0
5286486|NCT00514813|18232812|P2|Overall Study|Lack of Efficacy|1
5286487|NCT00514813|18232813|P1|Overall Study|Lack of Efficacy|0
5286488|NCT00514813|18232810|P4|Overall Study|Withdrawal by Subject|0
5286489|NCT00514813|18232811|P3|Overall Study|Withdrawal by Subject|0
5286490|NCT00514813|18232812|P2|Overall Study|Withdrawal by Subject|1
5286491|NCT00514813|18232813|P1|Overall Study|Withdrawal by Subject|0
5286492|NCT00514813|18232810|P4|Overall Study|Protocol Violation|0
5286493|NCT00514813|18232811|P3|Overall Study|Protocol Violation|0
5286494|NCT00514813|18232812|P2|Overall Study|Protocol Violation|0
5286495|NCT00514813|18232813|P1|Overall Study|Protocol Violation|1
5286496|NCT00514813|18232810|P4|Overall Study|Adverse Event|0
5286497|NCT00514813|18232811|P3|Overall Study|Adverse Event|2
5286498|NCT00514813|18232812|P2|Overall Study|Adverse Event|2
5286499|NCT00514813|18232813|P1|Overall Study|Adverse Event|0
5286500|NCT00514813|18232810|P4|Overall Study|Study terminated|2
5286501|NCT00514813|18232811|P3|Overall Study|Study terminated|40
5286502|NCT00514813|18232812|P2|Overall Study|Study terminated|74
5286503|NCT00514813|18232813|P1|Overall Study|Study terminated|14
5286504|NCT00514735|18232833|P2|Overall Study|Lost to Follow-up|1
5286505|NCT00514735|18232834|P1|Overall Study|Lost to Follow-up|0
5286506|NCT00514735|18232833|P2|Overall Study|Death|0
5286507|NCT00514735|18232834|P1|Overall Study|Death|1
5286508|NCT00514735|18232833|P2|Overall Study|Withdrawal by Subject|5
5286509|NCT00514735|18232834|P1|Overall Study|Withdrawal by Subject|13
5286510|NCT00514683|18232870|P5|Overall Study|Reason other than listed above|1
5286511|NCT00514683|18232871|P4|Overall Study|Reason other than listed above|0
5286512|NCT00514683|18232872|P3|Overall Study|Reason other than listed above|2
5286513|NCT00514683|18232873|P2|Overall Study|Reason other than listed above|1
5286514|NCT00514683|18232874|P1|Overall Study|Reason other than listed above|0
5286515|NCT00514683|18232870|P5|Overall Study|Withdrawal by Subject|4
5286516|NCT00514683|18232871|P4|Overall Study|Withdrawal by Subject|0
5286517|NCT00514683|18232872|P3|Overall Study|Withdrawal by Subject|1
5286518|NCT00514683|18232873|P2|Overall Study|Withdrawal by Subject|2
5286519|NCT00514683|18232874|P1|Overall Study|Withdrawal by Subject|2
5286520|NCT00514683|18232870|P5|Overall Study|Protocol Violation|0
5286521|NCT00514683|18232871|P4|Overall Study|Protocol Violation|1
5286522|NCT00514683|18232872|P3|Overall Study|Protocol Violation|0
5286523|NCT00514683|18232873|P2|Overall Study|Protocol Violation|1
5286524|NCT00514683|18232874|P1|Overall Study|Protocol Violation|1
5286525|NCT00514683|18232870|P5|Overall Study|Adverse Event|27
5286526|NCT00514683|18232871|P4|Overall Study|Adverse Event|13
5286527|NCT00514683|18232872|P3|Overall Study|Adverse Event|15
5286528|NCT00514683|18232873|P2|Overall Study|Adverse Event|20
5286529|NCT00514683|18232874|P1|Overall Study|Adverse Event|21
5286530|NCT00514683|18232870|P5|Overall Study|Not treated|1
5286531|NCT00514683|18232871|P4|Overall Study|Not treated|0
5286532|NCT00514683|18232872|P3|Overall Study|Not treated|0
5286533|NCT00514683|18232873|P2|Overall Study|Not treated|1
5286534|NCT00514683|18232874|P1|Overall Study|Not treated|2
5286535|NCT00514540|18233070|P1|Second-Line|Physician/Patient Decision|31
5286536|NCT00514540|18233070|P1|First-Line Chemo|Protocol Violation|7
5286537|NCT00514540|18233070|P1|First-Line Chemo|Withdrawal by Subject|1
5286538|NCT00514514|18233081|P3|Extension - 4 Years|Adverse Event|3
5286539|NCT00514514|18233082|P2|Extension - 4 Years|Adverse Event|6
5286540|NCT00514514|18233083|P1|Extension - 4 Years|Adverse Event|9
5286541|NCT00514514|18233081|P3|Extension - 4 Years|Death|6
5286542|NCT00514514|18233082|P2|Extension - 4 Years|Death|3
5286543|NCT00514514|18233083|P1|Extension - 4 Years|Death|8
5286544|NCT00514514|18233081|P3|Extension - 4 Years|Administrative problems|1
5286545|NCT00514514|18233082|P2|Extension - 4 Years|Administrative problems|1
5286546|NCT00514514|18233083|P1|Extension - 4 Years|Administrative problems|3
5286547|NCT00514514|18233081|P3|Extension - 4 Years|Lost to Follow-up|9
5286548|NCT00514514|18233082|P2|Extension - 4 Years|Lost to Follow-up|10
5286549|NCT00514514|18233083|P1|Extension - 4 Years|Lost to Follow-up|12
5286550|NCT00514514|18233081|P3|Extension - 4 Years|Withdrawal by Subject|2
5286551|NCT00514514|18233082|P2|Extension - 4 Years|Withdrawal by Subject|2
5286552|NCT00514514|18233083|P1|Extension - 4 Years|Withdrawal by Subject|5
5286553|NCT00514514|18233081|P3|Randomized - 9 Month|Adverse Event|27
5286554|NCT00514514|18233082|P2|Randomized - 9 Month|Adverse Event|44
5286555|NCT00514514|18233083|P1|Randomized - 9 Month|Adverse Event|25
5286556|NCT00514514|18233081|P3|Randomized - 9 Month|Abnormal laboratory values|1
5286557|NCT00514514|18233082|P2|Randomized - 9 Month|Abnormal laboratory values|3
5286558|NCT00514514|18233083|P1|Randomized - 9 Month|Abnormal laboratory values|0
5286559|NCT00514514|18233081|P3|Randomized - 9 Month|Lack of Efficacy|1
5286560|NCT00514514|18233082|P2|Randomized - 9 Month|Lack of Efficacy|3
5286561|NCT00514514|18233083|P1|Randomized - 9 Month|Lack of Efficacy|2
5286562|NCT00514514|18233081|P3|Randomized - 9 Month|Protocol Violation|0
5286563|NCT00514514|18233082|P2|Randomized - 9 Month|Protocol Violation|1
5286564|NCT00514514|18233083|P1|Randomized - 9 Month|Protocol Violation|1
5286565|NCT00514514|18233081|P3|Randomized - 9 Month|Withdrawal by Subject|5
5286566|NCT00514514|18233082|P2|Randomized - 9 Month|Withdrawal by Subject|7
5286567|NCT00514514|18233083|P1|Randomized - 9 Month|Withdrawal by Subject|7
5286568|NCT00514514|18233081|P3|Randomized - 9 Month|Administrative problems|2
5286569|NCT00514514|18233082|P2|Randomized - 9 Month|Administrative problems|1
5286570|NCT00514514|18233083|P1|Randomized - 9 Month|Administrative problems|1
5286571|NCT00514514|18233081|P3|Randomized - 9 Month|Death|2
5286572|NCT00514514|18233082|P2|Randomized - 9 Month|Death|2
5286573|NCT00514514|18233083|P1|Randomized - 9 Month|Death|3
5286574|NCT00514514|18233081|P3|Pre-phase|Withdrawal by Subject|0
5286575|NCT00514514|18233082|P2|Pre-phase|Withdrawal by Subject|0
5286576|NCT00514514|18233083|P1|Pre-phase|Withdrawal by Subject|66
5286577|NCT00514514|18233081|P3|Pre-phase|Adverse Event|0
5286578|NCT00514514|18233082|P2|Pre-phase|Adverse Event|0
5286579|NCT00514514|18233083|P1|Pre-phase|Adverse Event|137
5286580|NCT00514514|18233081|P3|Pre-phase|Lack of Efficacy|0
5286581|NCT00514514|18233082|P2|Pre-phase|Lack of Efficacy|0
5286582|NCT00514514|18233083|P1|Pre-phase|Lack of Efficacy|35
5286583|NCT00514514|18233081|P3|Pre-phase|abnormal lab values|0
5286584|NCT00514514|18233082|P2|Pre-phase|abnormal lab values|0
5286585|NCT00514514|18233083|P1|Pre-phase|abnormal lab values|23
5286586|NCT00514514|18233081|P3|Pre-phase|Lost to Follow-up|0
5286587|NCT00514514|18233082|P2|Pre-phase|Lost to Follow-up|0
5286588|NCT00514514|18233083|P1|Pre-phase|Lost to Follow-up|2
5286589|NCT00514514|18233081|P3|Pre-phase|abnormal test procedure results|0
5286590|NCT00514514|18233082|P2|Pre-phase|abnormal test procedure results|0
5286591|NCT00514514|18233083|P1|Pre-phase|abnormal test procedure results|15
5286592|NCT00514514|18233081|P3|Pre-phase|condition no longer requires study drug|0
5286593|NCT00514514|18233082|P2|Pre-phase|condition no longer requires study drug|0
5286594|NCT00514514|18233083|P1|Pre-phase|condition no longer requires study drug|7
5286595|NCT00514514|18233081|P3|Pre-phase|Protocol Violation|0
5286596|NCT00514514|18233082|P2|Pre-phase|Protocol Violation|0
5286597|NCT00514514|18233083|P1|Pre-phase|Protocol Violation|6
5286598|NCT00514514|18233081|P3|Pre-phase|administrative problems|0
5286599|NCT00514514|18233082|P2|Pre-phase|administrative problems|0
5286600|NCT00514514|18233083|P1|Pre-phase|administrative problems|2
5286601|NCT00514514|18233081|P3|Pre-phase|Death|0
5286602|NCT00514514|18233082|P2|Pre-phase|Death|0
5286603|NCT00514514|18233083|P1|Pre-phase|Death|10
5286604|NCT00514449|18233135|P2|Overall Study|Lost to Follow-up|0
5286605|NCT00514449|18233136|P1|Overall Study|Lost to Follow-up|1
5286606|NCT00514449|18233135|P2|Overall Study|Protocol Violation|2
5286607|NCT00514449|18233136|P1|Overall Study|Protocol Violation|1
5286608|NCT00514449|18233135|P2|Overall Study|Withdrawal by Subject|2
5286609|NCT00514449|18233136|P1|Overall Study|Withdrawal by Subject|1
5286610|NCT00514020|18233160|P1|Overall Study|"patients moved to the no tx group"|6
5286611|NCT00514020|18233160|P1|Overall Study|patient went to radiation treatment|1
5286612|NCT00514020|18233160|P1|Overall Study|other complicating disease|2
5286613|NCT00514020|18233160|P1|Overall Study|disease progression|9
5286614|NCT00514020|18233160|P1|Overall Study|Physician Decision|1
5286615|NCT00514020|18233160|P1|Overall Study|Withdrawal by Subject|3
5286616|NCT00514020|18233160|P1|Overall Study|Adverse Event|6
5286617|NCT00513708|18233214|P3|Overall Study|Lost to Follow-up|4
5286618|NCT00513708|18233215|P2|Overall Study|Lost to Follow-up|4
5286619|NCT00513708|18233216|P1|Overall Study|Lost to Follow-up|4
5286620|NCT00513695|18233230|P1|Overall Study|Progression prior to surgery|3
5286621|NCT00513695|18233230|P1|Overall Study|Discontinued therapy|2
5286622|NCT00513682|18233239|P1|Washout Phase|Adverse Event|2
5286623|NCT00513604|18233269|P5|Overall Study|Death during treatment|0
5286624|NCT00513604|18233270|P4|Overall Study|Death during treatment|0
5286625|NCT00513604|18233271|P3|Overall Study|Death during treatment|2
5286626|NCT00513604|18233272|P2|Overall Study|Death during treatment|3
5286627|NCT00513604|18233273|P1|Overall Study|Death during treatment|0
5286628|NCT00513604|18233269|P5|Overall Study|Not treated|0
5286629|NCT00513604|18233270|P4|Overall Study|Not treated|0
5286630|NCT00513604|18233271|P3|Overall Study|Not treated|1
5286631|NCT00513604|18233272|P2|Overall Study|Not treated|0
5286632|NCT00513604|18233273|P1|Overall Study|Not treated|2
5286633|NCT00513500|18233307|P2|Overall Study|Hospitalized|14
5286634|NCT00513500|18233308|P1|Overall Study|Hospitalized|4
5286635|NCT00513500|18233307|P2|Overall Study|Death|1
5286636|NCT00513500|18233308|P1|Overall Study|Death|2
5286637|NCT00513500|18233307|P2|Overall Study|Lost to Follow-up|39
5286638|NCT00513500|18233308|P1|Overall Study|Lost to Follow-up|35
5286639|NCT00513474|18233320|P2|Overall Study|Participant Withdrew Consent|0
5286640|NCT00513474|18233321|P1|Overall Study|Participant Withdrew Consent|1
5286641|NCT00513474|18233320|P2|Overall Study|Death|9
5286642|NCT00513474|18233321|P1|Overall Study|Death|6
5286643|NCT00513409|18233377|P2|Overall Study|Visit 3 not done|2
5286644|NCT00513409|18233378|P1|Overall Study|Visit 3 not done|1
5286645|NCT00513409|18233377|P2|Overall Study|Physician Decision|0
5286646|NCT00513409|18233378|P1|Overall Study|Physician Decision|1
5286647|NCT00513409|18233377|P2|Overall Study|Lost to Follow-up|1
5286648|NCT00513409|18233378|P1|Overall Study|Lost to Follow-up|0
5286649|NCT00513409|18233377|P2|Overall Study|Withdrawal by Subject|2
5286650|NCT00513409|18233378|P1|Overall Study|Withdrawal by Subject|0
5286651|NCT00513409|18233377|P2|Overall Study|Adverse Event|1
5286652|NCT00513409|18233378|P1|Overall Study|Adverse Event|0
5286653|NCT00513357|18233434|P2|Overall Study|Disease Progression|1
5286654|NCT00513357|18233435|P1|Overall Study|Disease Progression|2
5286655|NCT00513357|18233434|P2|Overall Study|Withdrawal by Subject|4
5286656|NCT00513357|18233435|P1|Overall Study|Withdrawal by Subject|5
5286657|NCT00513357|18233434|P2|Overall Study|Death|0
5286658|NCT00513357|18233435|P1|Overall Study|Death|2
5286659|NCT00513357|18233434|P2|Overall Study|Adverse Event|2
5286660|NCT00513357|18233435|P1|Overall Study|Adverse Event|4
5286661|NCT00513357|18233434|P2|Overall Study|did not receive allocated placebo|3
5286662|NCT00513357|18233435|P1|Overall Study|did not receive allocated placebo|2
5286663|NCT00513305|18233454|P2|Overall Study|Sponsor Decision|2
5286664|NCT00513305|18233455|P1|Overall Study|Sponsor Decision|0
5286665|NCT00513305|18233454|P2|Overall Study|Persistent hypocellularity|1
5286666|NCT00513305|18233455|P1|Overall Study|Persistent hypocellularity|0
5286667|NCT00513305|18233454|P2|Overall Study|Physician Decision|0
5286668|NCT00513305|18233455|P1|Overall Study|Physician Decision|1
5286669|NCT00513305|18233454|P2|Overall Study|Hematologic counts did not recover|0
5286670|NCT00513305|18233455|P1|Overall Study|Hematologic counts did not recover|1
5286671|NCT00513305|18233454|P2|Overall Study|Eligible for stem cell transplant|0
5286672|NCT00513305|18233455|P1|Overall Study|Eligible for stem cell transplant|1
5286673|NCT00513305|18233454|P2|Overall Study|Disease progression|5
5286674|NCT00513305|18233455|P1|Overall Study|Disease progression|8
5286675|NCT00513305|18233454|P2|Overall Study|Withdrawal by Subject|2
5286676|NCT00513305|18233455|P1|Overall Study|Withdrawal by Subject|1
5286677|NCT00513305|18233454|P2|Overall Study|Lack of Efficacy|13
5286678|NCT00513305|18233455|P1|Overall Study|Lack of Efficacy|8
5286679|NCT00513305|18233454|P2|Overall Study|Death (through Consolidation Treatment)|2
5286680|NCT00513305|18233455|P1|Overall Study|Death (through Consolidation Treatment)|2
5286681|NCT00513305|18233454|P2|Overall Study|Adverse Event|2
5286682|NCT00513305|18233455|P1|Overall Study|Adverse Event|6
5286683|NCT00513240|18233498|P2|Overall Study|Withdrawal by Subject|4
5286684|NCT00513240|18233499|P1|Overall Study|Withdrawal by Subject|7
5286685|NCT00513240|18233498|P2|Overall Study|Death|3
5286686|NCT00513240|18233499|P1|Overall Study|Death|3
5286687|NCT00513240|18233498|P2|Overall Study|Did not have intended surgery|0
5286688|NCT00513240|18233499|P1|Overall Study|Did not have intended surgery|3
5286689|NCT00513071|18233512|P1|Overall Study|Physician Decision|3
5286690|NCT00513071|18233512|P1|Overall Study|Withdrawal by Subject|1
5286691|NCT00513071|18233512|P1|Overall Study|Adverse Event|1
5286692|NCT00513019|18233524|P2|Overall Study|Withdrawal by Subject|5
5286693|NCT00513019|18233525|P1|Overall Study|Withdrawal by Subject|4
5286694|NCT00513019|18233524|P2|Overall Study|Adverse Event|0
5286695|NCT00513019|18233525|P1|Overall Study|Adverse Event|1
5286696|NCT00512902|18233531|P1|Overall Study|Lost to Follow-up|1
5286697|NCT00512902|18233531|P1|Overall Study|Adverse Event|7
5286698|NCT00512798|18233546|P2|Overall Study|Withdrawal by Subject|0
5286699|NCT00512798|18233547|P1|Overall Study|Withdrawal by Subject|3
5286700|NCT00512798|18233546|P2|Overall Study|Progression of disease|20
5286701|NCT00512798|18233547|P1|Overall Study|Progression of disease|14
5286702|NCT00512798|18233546|P2|Overall Study|Adverse Event|4
5286703|NCT00512798|18233547|P1|Overall Study|Adverse Event|2
5286704|NCT00512798|18233546|P2|Overall Study|Death|3
5286705|NCT00512798|18233547|P1|Overall Study|Death|0
5286706|NCT00512707|18233558|P2|Overall Study|Unable to tolerate the smell of the gel|0
5286707|NCT00512707|18233559|P1|Overall Study|Unable to tolerate the smell of the gel|1
5286708|NCT00512707|18233558|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
5286709|NCT00512707|18233559|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
5286710|NCT00512707|18233558|P2|Overall Study|Developed skin irritation|1
5286711|NCT00512707|18233559|P1|Overall Study|Developed skin irritation|2
5286712|NCT00512707|18233558|P2|Overall Study|Lost to Follow-up|11
5286713|NCT00512707|18233559|P1|Overall Study|Lost to Follow-up|5
5286714|NCT00512252|18233609|P3|Overall Study|Death|1
5286715|NCT00512252|18233610|P2|Overall Study|Death|0
5286716|NCT00512252|18233611|P1|Overall Study|Death|0
5286717|NCT00512252|18233609|P3|Overall Study|Protocol Violation|1
5286718|NCT00512252|18233610|P2|Overall Study|Protocol Violation|0
5286719|NCT00512252|18233611|P1|Overall Study|Protocol Violation|0
5286720|NCT00512252|18233609|P3|Overall Study|Lost to Follow-up|1
5286721|NCT00512252|18233610|P2|Overall Study|Lost to Follow-up|0
5286722|NCT00512252|18233611|P1|Overall Study|Lost to Follow-up|0
5286723|NCT00512148|18233639|P1|Primay Study Period|Withdrawal by Subject|1
5286724|NCT00512096|18233645|P1|Overall Study|Lack of Efficacy|3
5286725|NCT00512096|18233645|P1|Overall Study|Withdrawal by Subject|2
5286726|NCT00512096|18233645|P1|Overall Study|Adverse Event|2
5286727|NCT00511901|18233673|P2|Overall Study|Withdrawal by Subject|3
5286728|NCT00511901|18233674|P1|Overall Study|Withdrawal by Subject|1
5286729|NCT00511875|18233696|P2|Overall Study|Missing variables|0
5286730|NCT00511875|18233697|P1|Overall Study|Missing variables|1
5286731|NCT00511875|18233696|P2|Overall Study|Lost to Follow-up|0
5286732|NCT00511875|18233697|P1|Overall Study|Lost to Follow-up|4
5286733|NCT00511836|18233737|P2|Double-blind Period|Lost to Follow-up|0
5286734|NCT00511836|18233738|P1|Double-blind Period|Lost to Follow-up|1
5286735|NCT00511810|18233755|P2|Overall Study|Refused second scn|1
5286736|NCT00511810|18233756|P1|Overall Study|Refused second scn|0
5286737|NCT00511810|18233755|P2|Overall Study|Lack of Efficacy|2
5286738|NCT00511810|18233756|P1|Overall Study|Lack of Efficacy|0
5286739|NCT00511810|18233755|P2|Overall Study|Lost to Follow-up|2
5286740|NCT00511810|18233756|P1|Overall Study|Lost to Follow-up|1
5286741|NCT00511797|18233766|P4|Overall Study|Other (moving etc)|2
5286742|NCT00511797|18233767|P3|Overall Study|Other (moving etc)|1
5286743|NCT00511797|18233768|P2|Overall Study|Other (moving etc)|0
5286744|NCT00511797|18233769|P1|Overall Study|Other (moving etc)|1
5286745|NCT00511797|18233766|P4|Overall Study|Partially missing diary|0
5286746|NCT00511797|18233767|P3|Overall Study|Partially missing diary|1
5286747|NCT00511797|18233768|P2|Overall Study|Partially missing diary|0
5286748|NCT00511797|18233769|P1|Overall Study|Partially missing diary|0
5286749|NCT00511797|18233766|P4|Overall Study|Study drug not taken|1
5286750|NCT00511797|18233767|P3|Overall Study|Study drug not taken|0
5286751|NCT00511797|18233768|P2|Overall Study|Study drug not taken|1
5286752|NCT00511797|18233769|P1|Overall Study|Study drug not taken|0
5286753|NCT00511797|18233766|P4|Overall Study|Never dispensed|3
5286754|NCT00511797|18233767|P3|Overall Study|Never dispensed|1
5286755|NCT00511797|18233768|P2|Overall Study|Never dispensed|0
5286756|NCT00511797|18233769|P1|Overall Study|Never dispensed|1
5286757|NCT00511797|18233766|P4|Overall Study|Withdrawal by Subject|2
5286758|NCT00511797|18233767|P3|Overall Study|Withdrawal by Subject|4
5286759|NCT00511797|18233768|P2|Overall Study|Withdrawal by Subject|3
5286760|NCT00511797|18233769|P1|Overall Study|Withdrawal by Subject|3
5286761|NCT00511797|18233766|P4|Overall Study|Protocol Violation|3
5286762|NCT00511797|18233767|P3|Overall Study|Protocol Violation|2
5286763|NCT00511797|18233768|P2|Overall Study|Protocol Violation|2
5286764|NCT00511797|18233769|P1|Overall Study|Protocol Violation|0
5286765|NCT00511797|18233766|P4|Overall Study|Pregnancy|1
5286766|NCT00511797|18233767|P3|Overall Study|Pregnancy|0
5286767|NCT00511797|18233768|P2|Overall Study|Pregnancy|0
5286768|NCT00511797|18233769|P1|Overall Study|Pregnancy|0
5286769|NCT00511797|18233766|P4|Overall Study|Lost to Follow-up|1
5286770|NCT00511797|18233767|P3|Overall Study|Lost to Follow-up|0
5286771|NCT00511797|18233768|P2|Overall Study|Lost to Follow-up|0
5286772|NCT00511797|18233769|P1|Overall Study|Lost to Follow-up|1
5286773|NCT00511797|18233766|P4|Overall Study|Adverse Event|2
5286774|NCT00511797|18233767|P3|Overall Study|Adverse Event|2
5286775|NCT00511797|18233768|P2|Overall Study|Adverse Event|2
5286776|NCT00511797|18233769|P1|Overall Study|Adverse Event|1
5286777|NCT00511667|18233888|P2|Overall Study|Other|1
5286778|NCT00511667|18233889|P1|Overall Study|Other|2
5286779|NCT00511667|18233888|P2|Overall Study|Site terminated|1
5286780|NCT00511667|18233889|P1|Overall Study|Site terminated|6
5286781|NCT00511667|18233888|P2|Overall Study|Withdrawal by Subject|0
5286782|NCT00511667|18233889|P1|Overall Study|Withdrawal by Subject|2
5286783|NCT00511667|18233888|P2|Overall Study|Protocol Violation|1
5286784|NCT00511667|18233889|P1|Overall Study|Protocol Violation|1
5286785|NCT00511667|18233888|P2|Overall Study|Adverse Event|0
5286786|NCT00511667|18233889|P1|Overall Study|Adverse Event|1
5286787|NCT00511472|18233924|P2|Overall Study|Not reported|2
5286788|NCT00511472|18233925|P1|Overall Study|Not reported|2
5286789|NCT00511472|18233924|P2|Overall Study|Laboratory Adverse Event|2
5286790|NCT00511472|18233925|P1|Overall Study|Laboratory Adverse Event|0
5286791|NCT00511472|18233924|P2|Overall Study|Clinical Adverse Event|2
5286792|NCT00511472|18233925|P1|Overall Study|Clinical Adverse Event|1
5286793|NCT00511433|18233944|P2|Overall Study|Other Reason|1
5286794|NCT00511433|18233945|P1|Overall Study|Other Reason|1
5286795|NCT00511433|18233944|P2|Overall Study|Adverse Event|0
5286796|NCT00511433|18233945|P1|Overall Study|Adverse Event|5
5286797|NCT00511355|18233985|P2|Overall Study|Other reason pre-treatment|1
5286798|NCT00511355|18233986|P1|Overall Study|Other reason pre-treatment|0
5286799|NCT00511355|18233985|P2|Overall Study|Withdrawal of informed consent|1
5286800|NCT00511355|18233986|P1|Overall Study|Withdrawal of informed consent|0
5286801|NCT00511355|18233985|P2|Overall Study|Pre-treatment (serious) adverse event|1
5286802|NCT00511355|18233986|P1|Overall Study|Pre-treatment (serious) adverse event|0
5286803|NCT00511355|18233985|P2|Overall Study|Other Reason|1
5286804|NCT00511355|18233986|P1|Overall Study|Other Reason|0
5286805|NCT00511355|18233985|P2|Overall Study|Lost to Follow-up|1
5286806|NCT00511355|18233986|P1|Overall Study|Lost to Follow-up|2
5286807|NCT00511355|18233985|P2|Overall Study|Pregnancy Wish|0
5286808|NCT00511355|18233986|P1|Overall Study|Pregnancy Wish|1
5286809|NCT00511355|18233985|P2|Overall Study|Adverse Event|4
5286810|NCT00511355|18233986|P1|Overall Study|Adverse Event|4
5286811|NCT00511342|18234086|P2|Overall Study|Other Reason|2
5286812|NCT00511342|18234087|P1|Overall Study|Other Reason|2
5286813|NCT00511342|18234086|P2|Overall Study|Lost to Follow-up|5
5286814|NCT00511342|18234087|P1|Overall Study|Lost to Follow-up|1
5286815|NCT00511342|18234086|P2|Overall Study|Pregnancy wish|1
5286816|NCT00511342|18234087|P1|Overall Study|Pregnancy wish|0
5286817|NCT00511342|18234086|P2|Overall Study|Pregnancy|1
5286818|NCT00511342|18234087|P1|Overall Study|Pregnancy|0
5286819|NCT00511342|18234086|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
5286820|NCT00511342|18234087|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
5286821|NCT00511342|18234086|P2|Overall Study|Unacceptable vaginal bleeding|1
5286822|NCT00511342|18234087|P1|Overall Study|Unacceptable vaginal bleeding|2
5286823|NCT00511238|18234118|P2|Overall Study|various reasons|14
5286824|NCT00511238|18234119|P1|Overall Study|various reasons|4
5286825|NCT00511238|18234118|P2|Overall Study|Progressive Disease|157
5286826|NCT00511238|18234119|P1|Overall Study|Progressive Disease|23
5286827|NCT00511238|18234118|P2|Overall Study|Withdrawal by Subject|22
5286828|NCT00511238|18234119|P1|Overall Study|Withdrawal by Subject|2
5286829|NCT00511238|18234118|P2|Overall Study|Adverse Event|33
5286830|NCT00511238|18234119|P1|Overall Study|Adverse Event|13
5286831|NCT00511199|18234138|P2|Overall Study|Other Reason|37
5286832|NCT00511199|18234139|P1|Overall Study|Other Reason|78
5286833|NCT00511199|18234138|P2|Overall Study|Lost to Follow-up|17
5286834|NCT00511199|18234139|P1|Overall Study|Lost to Follow-up|40
5286835|NCT00511199|18234138|P2|Overall Study|Pregnancy Wish|8
5286836|NCT00511199|18234139|P1|Overall Study|Pregnancy Wish|16
5286837|NCT00511199|18234138|P2|Overall Study|Pregnancy|3
5286838|NCT00511199|18234139|P1|Overall Study|Pregnancy|6
5286839|NCT00511199|18234138|P2|Overall Study|Withdrawal of Informed Consent|4
5286840|NCT00511199|18234139|P1|Overall Study|Withdrawal of Informed Consent|19
5286841|NCT00511199|18234138|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
5286842|NCT00511199|18234139|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
5286843|NCT00511199|18234138|P2|Overall Study|Unacceptable Vaginal Bleeding|4
5286844|NCT00511199|18234139|P1|Overall Study|Unacceptable Vaginal Bleeding|63
5286845|NCT00511147|18234168|P1|Overall Study|Required platelet transfusion|1
5286846|NCT00511147|18234168|P1|Overall Study|Disease progression|5
5286847|NCT00511147|18234168|P1|Overall Study|Withdrawal by Subject|1
5286848|NCT00511134|18234177|P2|Overall Study|Withdrawal by Subject|2
5286849|NCT00511134|18234178|P1|Overall Study|Withdrawal by Subject|0
5286850|NCT00511108|18234190|P4|Overall Study|Withdrawal by Subject|2
5286851|NCT00511108|18234191|P3|Overall Study|Withdrawal by Subject|3
5286852|NCT00511108|18234192|P2|Overall Study|Withdrawal by Subject|0
5286853|NCT00511108|18234193|P1|Overall Study|Withdrawal by Subject|4
5286854|NCT00511108|18234190|P4|Overall Study|Physician Decision|1
5286855|NCT00511108|18234191|P3|Overall Study|Physician Decision|0
5286856|NCT00511108|18234192|P2|Overall Study|Physician Decision|0
5286857|NCT00511108|18234193|P1|Overall Study|Physician Decision|0
5286858|NCT00511108|18234190|P4|Overall Study|Lost to Follow-up|0
5286859|NCT00511108|18234191|P3|Overall Study|Lost to Follow-up|1
5286860|NCT00511108|18234192|P2|Overall Study|Lost to Follow-up|2
5286861|NCT00511108|18234193|P1|Overall Study|Lost to Follow-up|0
5286862|NCT00511108|18234190|P4|Overall Study|Adverse Event|2
5286863|NCT00511108|18234191|P3|Overall Study|Adverse Event|1
5286864|NCT00511108|18234192|P2|Overall Study|Adverse Event|0
5286865|NCT00511108|18234193|P1|Overall Study|Adverse Event|2
5286866|NCT00511004|18234224|P3|Overall Study|Lost to Follow-up|4
5286867|NCT00511004|18234225|P2|Overall Study|Lost to Follow-up|0
5286868|NCT00511004|18234226|P1|Overall Study|Lost to Follow-up|0
5286869|NCT00510952|18234245|P2|Overall Study|Did Not Receive Study Drug|0
5286870|NCT00510952|18234246|P1|Overall Study|Did Not Receive Study Drug|2
5286871|NCT00510952|18234245|P2|Overall Study|Withdrawal by Subject|7
5286872|NCT00510952|18234246|P1|Overall Study|Withdrawal by Subject|6
5286873|NCT00510952|18234245|P2|Overall Study|Sponsor Decision|0
5286874|NCT00510952|18234246|P1|Overall Study|Sponsor Decision|1
5286875|NCT00510952|18234245|P2|Overall Study|Protocol Violation|4
5286876|NCT00510952|18234246|P1|Overall Study|Protocol Violation|7
5286877|NCT00510952|18234245|P2|Overall Study|Physician Decision|1
5286878|NCT00510952|18234246|P1|Overall Study|Physician Decision|1
5286879|NCT00510952|18234245|P2|Overall Study|Lost to Follow-up|3
5286880|NCT00510952|18234246|P1|Overall Study|Lost to Follow-up|5
5286881|NCT00510952|18234245|P2|Overall Study|Entry Criteria Not Met|1
5286882|NCT00510952|18234246|P1|Overall Study|Entry Criteria Not Met|3
5286883|NCT00510952|18234245|P2|Overall Study|Adverse Event|0
5286884|NCT00510952|18234246|P1|Overall Study|Adverse Event|1
5286885|NCT00510887|18234272|P1|Overall Study|Lost to Follow-up|1
5286886|NCT00510874|18234288|P7|Overall Study|Lost to Follow-up|1
5286887|NCT00510874|18234289|P6|Overall Study|Lost to Follow-up|0
5286888|NCT00510874|18234290|P5|Overall Study|Lost to Follow-up|4
5286889|NCT00510874|18234291|P4|Overall Study|Lost to Follow-up|3
5286890|NCT00510874|18234292|P3|Overall Study|Lost to Follow-up|1
5286891|NCT00510874|18234293|P2|Overall Study|Lost to Follow-up|3
5286892|NCT00510874|18234294|P1|Overall Study|Lost to Follow-up|2
5286893|NCT00510874|18234288|P7|Overall Study|Withdrawal by Subject|0
5286894|NCT00510874|18234289|P6|Overall Study|Withdrawal by Subject|0
5286895|NCT00510874|18234290|P5|Overall Study|Withdrawal by Subject|3
5286896|NCT00510874|18234291|P4|Overall Study|Withdrawal by Subject|0
5286897|NCT00510874|18234292|P3|Overall Study|Withdrawal by Subject|0
5286898|NCT00510874|18234293|P2|Overall Study|Withdrawal by Subject|1
5286899|NCT00510874|18234294|P1|Overall Study|Withdrawal by Subject|1
5286900|NCT00510835|18234397|P3|Overall Study|Withdrawal by Subject|2
5286901|NCT00510835|18234398|P2|Overall Study|Withdrawal by Subject|2
5286902|NCT00510835|18234399|P1|Overall Study|Withdrawal by Subject|6
5286903|NCT00510783|18234425|P2|Overall Study|Protocol Violation|1
5286904|NCT00510783|18234426|P1|Overall Study|Protocol Violation|0
5286905|NCT00510783|18234425|P2|Overall Study|Withdrawal by Subject|3
5286906|NCT00510783|18234426|P1|Overall Study|Withdrawal by Subject|2
5286907|NCT00510783|18234425|P2|Overall Study|Lost to Follow-up|25
5286908|NCT00510783|18234426|P1|Overall Study|Lost to Follow-up|29
5286909|NCT00510718|18234443|P2|Multiple Dose Period: 12 Weeks|Other|1
5286910|NCT00510718|18234444|P1|Multiple Dose Period: 12 Weeks|Other|1
5286911|NCT00510718|18234443|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
5286912|NCT00510718|18234444|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
5286913|NCT00510718|18234443|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
5286914|NCT00510718|18234444|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
5286915|NCT00510718|18234443|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
5286916|NCT00510718|18234444|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
5286917|NCT00510718|18234443|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
5286918|NCT00510718|18234444|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
5286919|NCT00510718|18234443|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
5286920|NCT00510718|18234444|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
5286921|NCT00510692|18234570|P2|Overall Study|Withdrawal by Subject|0
5286922|NCT00510692|18234571|P1|Overall Study|Withdrawal by Subject|1
5286923|NCT00510692|18234570|P2|Overall Study|Adverse Event|3
5286924|NCT00510692|18234571|P1|Overall Study|Adverse Event|1
5286925|NCT00510653|18234585|P1|Overall Study|Monetary|3
5286926|NCT00510653|18234585|P1|Overall Study|Withdrawal by Subject|8
5286927|NCT00510510|18234592|P3|Overall Study|Protocol Violation|4
5286928|NCT00510510|18234593|P2|Overall Study|Protocol Violation|3
5286929|NCT00510510|18234594|P1|Overall Study|Protocol Violation|0
5286930|NCT00510510|18234592|P3|Overall Study|Lost to Follow-up|1
5286931|NCT00510510|18234593|P2|Overall Study|Lost to Follow-up|0
5286932|NCT00510510|18234594|P1|Overall Study|Lost to Follow-up|0
5286933|NCT00510510|18234592|P3|Overall Study|Withdrawal by Subject|3
5286934|NCT00510510|18234593|P2|Overall Study|Withdrawal by Subject|2
5286935|NCT00510510|18234594|P1|Overall Study|Withdrawal by Subject|1
5286936|NCT00510510|18234592|P3|Overall Study|Subjects no longer requires study drug|2
5286937|NCT00510510|18234593|P2|Overall Study|Subjects no longer requires study drug|0
5286938|NCT00510510|18234594|P1|Overall Study|Subjects no longer requires study drug|0
5286939|NCT00510510|18234592|P3|Overall Study|Lack of Efficacy|1
5286940|NCT00510510|18234593|P2|Overall Study|Lack of Efficacy|1
5286941|NCT00510510|18234594|P1|Overall Study|Lack of Efficacy|0
5286942|NCT00510510|18234592|P3|Overall Study|Adverse Event|6
5286943|NCT00510510|18234593|P2|Overall Study|Adverse Event|3
5286944|NCT00510510|18234594|P1|Overall Study|Adverse Event|4
5286945|NCT00510484|18234612|P2|Wash-out Period|Adverse Event|1
5286946|NCT00510484|18234613|P1|Wash-out Period|Adverse Event|0
5286947|NCT00510458|18234633|P1|Overall Study|Revision|2
5286948|NCT00510458|18234633|P1|Overall Study|Withdrawal by Subject|3
5286949|NCT00510458|18234633|P1|Overall Study|Lost to Follow-up|6
5286950|NCT00510458|18234633|P1|Overall Study|Terminated|14
5286951|NCT00510458|18234633|P1|Overall Study|Death|1
5286952|NCT00510458|18234633|P1|Overall Study|5 year not evaluable/missed|21
5286953|NCT00510289|18234646|P1|Overall Study|Progressed prior to starting drug|2
5286954|NCT00510289|18234646|P1|Overall Study|Lost to Follow-up|1
5286955|NCT00510289|18234646|P1|Overall Study|Refused bone marrow biopsy|2
5286956|NCT00510289|18234646|P1|Overall Study|Withdrawal by Subject|7
5286957|NCT00510276|18234656|P2|Extension Open-Label Phase|Subject Decision|9
5286958|NCT00510276|18234657|P1|Extension Open-Label Phase|Subject Decision|7
5286959|NCT00510276|18234656|P2|Extension Open-Label Phase|Sponsor Decision|0
5286960|NCT00510276|18234657|P1|Extension Open-Label Phase|Sponsor Decision|1
5286961|NCT00510276|18234656|P2|Extension Open-Label Phase|Protocol Violation|1
5286962|NCT00510276|18234657|P1|Extension Open-Label Phase|Protocol Violation|0
5286963|NCT00510276|18234656|P2|Extension Open-Label Phase|Physician Decision|3
5286964|NCT00510276|18234657|P1|Extension Open-Label Phase|Physician Decision|2
5286965|NCT00510276|18234656|P2|Extension Open-Label Phase|Lost to Follow-up|10
5286966|NCT00510276|18234657|P1|Extension Open-Label Phase|Lost to Follow-up|12
5286967|NCT00510276|18234656|P2|Extension Open-Label Phase|Lack of Efficacy|7
5286968|NCT00510276|18234657|P1|Extension Open-Label Phase|Lack of Efficacy|2
5286969|NCT00510276|18234656|P2|Extension Open-Label Phase|Adverse Event|18
5286970|NCT00510276|18234657|P1|Extension Open-Label Phase|Adverse Event|9
5286971|NCT00510276|18234656|P2|Acute Double-Blind Phase|Subject Decision|28
5286972|NCT00510276|18234657|P1|Acute Double-Blind Phase|Subject Decision|26
5286973|NCT00510276|18234656|P2|Acute Double-Blind Phase|Sponsor Decision|1
5286974|NCT00510276|18234657|P1|Acute Double-Blind Phase|Sponsor Decision|2
5286975|NCT00510276|18234656|P2|Acute Double-Blind Phase|Protocol Violation|3
5286976|NCT00510276|18234657|P1|Acute Double-Blind Phase|Protocol Violation|4
5286977|NCT00510276|18234656|P2|Acute Double-Blind Phase|Physician Decision|3
5286978|NCT00510276|18234657|P1|Acute Double-Blind Phase|Physician Decision|0
5286979|NCT00510276|18234656|P2|Acute Double-Blind Phase|Lost to Follow-up|49
5286980|NCT00510276|18234657|P1|Acute Double-Blind Phase|Lost to Follow-up|48
5286981|NCT00510276|18234656|P2|Acute Double-Blind Phase|Lack of Efficacy|4
5286982|NCT00510276|18234657|P1|Acute Double-Blind Phase|Lack of Efficacy|3
5286983|NCT00510276|18234656|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
5286984|NCT00510276|18234657|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
5286985|NCT00510276|18234656|P2|Acute Double-Blind Phase|Adverse Event|6
5286986|NCT00510276|18234657|P1|Acute Double-Blind Phase|Adverse Event|21
5286987|NCT00510198|18234751|P2|Overall Study|Withdrawal by Subject|4
5286988|NCT00510198|18234752|P1|Overall Study|Withdrawal by Subject|5
5286989|NCT00510146|18234766|P2|Open-Label Treatment|Sponsor Decision|0
5286990|NCT00510146|18234767|P1|Open-Label Treatment|Sponsor Decision|2
5286991|NCT00510146|18234766|P2|Open-Label Treatment|Clinical Relapse|1
5286992|NCT00510146|18234767|P1|Open-Label Treatment|Clinical Relapse|1
5286993|NCT00510146|18234766|P2|Open-Label Treatment|Withdrawal by Subject|12
5286994|NCT00510146|18234767|P1|Open-Label Treatment|Withdrawal by Subject|24
5286995|NCT00510146|18234766|P2|Open-Label Treatment|Protocol Violation|2
5286996|NCT00510146|18234767|P1|Open-Label Treatment|Protocol Violation|4
5286997|NCT00510146|18234766|P2|Open-Label Treatment|Physician Decision|1
5286998|NCT00510146|18234767|P1|Open-Label Treatment|Physician Decision|3
5286999|NCT00510146|18234766|P2|Open-Label Treatment|Lost to Follow-up|1
5287000|NCT00510146|18234767|P1|Open-Label Treatment|Lost to Follow-up|10
5287001|NCT00510146|18234766|P2|Open-Label Treatment|Lack of Efficacy|0
5287002|NCT00510146|18234767|P1|Open-Label Treatment|Lack of Efficacy|4
5287003|NCT00510146|18234766|P2|Open-Label Treatment|Death|1
5287004|NCT00510146|18234767|P1|Open-Label Treatment|Death|1
5287005|NCT00510146|18234766|P2|Open-Label Treatment|Adverse Event|8
5287006|NCT00510146|18234767|P1|Open-Label Treatment|Adverse Event|22
5287007|NCT00510146|18234766|P2|Double-Blind Treatment|Entry Criteria Not Met|0
5287008|NCT00510146|18234767|P1|Double-Blind Treatment|Entry Criteria Not Met|3
5287009|NCT00510146|18234766|P2|Double-Blind Treatment|Clinical Relapse|1
5287010|NCT00510146|18234767|P1|Double-Blind Treatment|Clinical Relapse|0
5287011|NCT00510146|18234766|P2|Double-Blind Treatment|Withdrawal by Subject|13
5287012|NCT00510146|18234767|P1|Double-Blind Treatment|Withdrawal by Subject|27
5287013|NCT00510146|18234766|P2|Double-Blind Treatment|Protocol Violation|2
5287014|NCT00510146|18234767|P1|Double-Blind Treatment|Protocol Violation|1
5287015|NCT00510146|18234766|P2|Double-Blind Treatment|Physician Decision|0
5287016|NCT00510146|18234767|P1|Double-Blind Treatment|Physician Decision|6
5287017|NCT00510146|18234766|P2|Double-Blind Treatment|Lost to Follow-up|7
5287018|NCT00510146|18234767|P1|Double-Blind Treatment|Lost to Follow-up|3
5287019|NCT00510146|18234766|P2|Double-Blind Treatment|Lack of Efficacy|13
5287020|NCT00510146|18234767|P1|Double-Blind Treatment|Lack of Efficacy|6
5287021|NCT00510146|18234766|P2|Double-Blind Treatment|Adverse Event|13
5287022|NCT00510146|18234767|P1|Double-Blind Treatment|Adverse Event|30
5287023|NCT00510068|18234856|P2|Open-label Period|Abnormal laboratory value (s)|0
5287024|NCT00510068|18234857|P1|Open-label Period|Abnormal laboratory value (s)|1
5287025|NCT00510068|18234856|P2|Open-label Period|Protocol Violation|0
5287026|NCT00510068|18234857|P1|Open-label Period|Protocol Violation|2
5287027|NCT00510068|18234856|P2|Open-label Period|New cancer therapy|0
5287028|NCT00510068|18234857|P1|Open-label Period|New cancer therapy|7
5287029|NCT00510068|18234856|P2|Open-label Period|Death|0
5287030|NCT00510068|18234857|P1|Open-label Period|Death|7
5287031|NCT00510068|18234856|P2|Open-label Period|Administrative problems|0
5287032|NCT00510068|18234857|P1|Open-label Period|Administrative problems|17
5287033|NCT00510068|18234856|P2|Open-label Period|Withdrawal by Subject|0
5287034|NCT00510068|18234857|P1|Open-label Period|Withdrawal by Subject|21
5287035|NCT00510068|18234856|P2|Open-label Period|Adverse Event|0
5287036|NCT00510068|18234857|P1|Open-label Period|Adverse Event|46
5287037|NCT00510068|18234856|P2|Open-label Period|Disease Progression|0
5287038|NCT00510068|18234857|P1|Open-label Period|Disease Progression|124
5287039|NCT00510068|18234856|P2|Double-blind Period|Protocol Violation|0
5287040|NCT00510068|18234857|P1|Double-blind Period|Protocol Violation|6
5287041|NCT00510068|18234856|P2|Double-blind Period|Lost to Follow-up|0
5287042|NCT00510068|18234857|P1|Double-blind Period|Lost to Follow-up|1
5287043|NCT00510068|18234856|P2|Double-blind Period|Abnormal test result (s)|0
5287044|NCT00510068|18234857|P1|Double-blind Period|Abnormal test result (s)|1
5287045|NCT00510068|18234856|P2|Double-blind Period|Death|3
5287046|NCT00510068|18234857|P1|Double-blind Period|Death|4
5287047|NCT00510068|18234856|P2|Double-blind Period|Withdrawal by Subject|6
5287048|NCT00510068|18234857|P1|Double-blind Period|Withdrawal by Subject|8
5287049|NCT00510068|18234856|P2|Double-blind Period|Adverse Event|7
5287050|NCT00510068|18234857|P1|Double-blind Period|Adverse Event|37
5287051|NCT00510068|18234856|P2|Double-blind Period|Final primary analysis|18
5287052|NCT00510068|18234857|P1|Double-blind Period|Final primary analysis|52
5287053|NCT00510068|18234856|P2|Double-blind Period|Disease progression|169
5287054|NCT00510068|18234857|P1|Double-blind Period|Disease progression|98
5287055|NCT00509925|18234898|P2|Overall Study|Personal reasons|1
5287056|NCT00509925|18234899|P1|Overall Study|Personal reasons|0
5287057|NCT00509899|18234947|P8|Overall Study|Lack of Efficacy|0
5287058|NCT00509899|18234948|P7|Overall Study|Lack of Efficacy|0
5287059|NCT00509899|18234949|P6|Overall Study|Lack of Efficacy|1
5287060|NCT00509899|18234950|P5|Overall Study|Lack of Efficacy|0
5287061|NCT00509899|18234951|P4|Overall Study|Lack of Efficacy|0
5287062|NCT00509899|18234952|P3|Overall Study|Lack of Efficacy|2
5287063|NCT00509899|18234953|P2|Overall Study|Lack of Efficacy|0
5287064|NCT00509899|18234954|P1|Overall Study|Lack of Efficacy|1
5287065|NCT00509899|18234947|P8|Overall Study|Death|1
5287066|NCT00509899|18234948|P7|Overall Study|Death|1
5287067|NCT00509899|18234949|P6|Overall Study|Death|1
5287068|NCT00509899|18234950|P5|Overall Study|Death|1
5287069|NCT00509899|18234951|P4|Overall Study|Death|0
5287070|NCT00509899|18234952|P3|Overall Study|Death|3
5287071|NCT00509899|18234953|P2|Overall Study|Death|2
5287072|NCT00509899|18234954|P1|Overall Study|Death|2
5287073|NCT00509899|18234947|P8|Overall Study|Intercurrent Illness|0
5287074|NCT00509899|18234948|P7|Overall Study|Intercurrent Illness|0
5287075|NCT00509899|18234949|P6|Overall Study|Intercurrent Illness|1
5287076|NCT00509899|18234950|P5|Overall Study|Intercurrent Illness|0
5287077|NCT00509899|18234951|P4|Overall Study|Intercurrent Illness|1
5287078|NCT00509899|18234952|P3|Overall Study|Intercurrent Illness|0
5287079|NCT00509899|18234953|P2|Overall Study|Intercurrent Illness|0
5287080|NCT00509899|18234954|P1|Overall Study|Intercurrent Illness|1
5287081|NCT00509899|18234947|P8|Overall Study|Physician Decision|0
5287082|NCT00509899|18234948|P7|Overall Study|Physician Decision|0
5287083|NCT00509899|18234949|P6|Overall Study|Physician Decision|4
5287084|NCT00509899|18234950|P5|Overall Study|Physician Decision|1
5287085|NCT00509899|18234951|P4|Overall Study|Physician Decision|0
5287086|NCT00509899|18234952|P3|Overall Study|Physician Decision|7
5287087|NCT00509899|18234953|P2|Overall Study|Physician Decision|2
5287088|NCT00509899|18234954|P1|Overall Study|Physician Decision|4
5287089|NCT00509899|18234947|P8|Overall Study|Withdrawal by Subject|0
5287090|NCT00509899|18234948|P7|Overall Study|Withdrawal by Subject|0
5287091|NCT00509899|18234949|P6|Overall Study|Withdrawal by Subject|2
5287092|NCT00509899|18234950|P5|Overall Study|Withdrawal by Subject|3
5287093|NCT00509899|18234951|P4|Overall Study|Withdrawal by Subject|0
5287094|NCT00509899|18234952|P3|Overall Study|Withdrawal by Subject|3
5287095|NCT00509899|18234953|P2|Overall Study|Withdrawal by Subject|2
5287096|NCT00509899|18234954|P1|Overall Study|Withdrawal by Subject|6
5287097|NCT00509899|18234947|P8|Overall Study|Unacceptable Toxicity|0
5287098|NCT00509899|18234948|P7|Overall Study|Unacceptable Toxicity|0
5287099|NCT00509899|18234949|P6|Overall Study|Unacceptable Toxicity|0
5287100|NCT00509899|18234950|P5|Overall Study|Unacceptable Toxicity|0
5287101|NCT00509899|18234951|P4|Overall Study|Unacceptable Toxicity|2
5287102|NCT00509899|18234952|P3|Overall Study|Unacceptable Toxicity|0
5287103|NCT00509899|18234953|P2|Overall Study|Unacceptable Toxicity|0
5287104|NCT00509899|18234954|P1|Overall Study|Unacceptable Toxicity|1
5287105|NCT00509899|18234947|P8|Overall Study|Progressive disease|0
5287106|NCT00509899|18234948|P7|Overall Study|Progressive disease|0
5287107|NCT00509899|18234949|P6|Overall Study|Progressive disease|1
5287108|NCT00509899|18234950|P5|Overall Study|Progressive disease|0
5287109|NCT00509899|18234951|P4|Overall Study|Progressive disease|1
5287110|NCT00509899|18234952|P3|Overall Study|Progressive disease|5
5287111|NCT00509899|18234953|P2|Overall Study|Progressive disease|3
5287112|NCT00509899|18234954|P1|Overall Study|Progressive disease|1
5287113|NCT00509821|18235011|P2|Study Period 1 (Induction)|Progressive Disease|1
5287114|NCT00509821|18235012|P1|Study Period 1 (Induction)|Progressive Disease|0
5287115|NCT00509821|18235011|P2|Study Period 1 (Induction)|Adverse Event|2
5287116|NCT00509821|18235012|P1|Study Period 1 (Induction)|Adverse Event|0
5287117|NCT00509821|18235011|P2|Study Period 1 (Induction)|Death|1
5287118|NCT00509821|18235012|P1|Study Period 1 (Induction)|Death|0
5287119|NCT00509795|18235030|P4|Overall Study|Withdrawal by Subject|8
5287120|NCT00509795|18235031|P3|Overall Study|Withdrawal by Subject|7
5287121|NCT00509795|18235032|P2|Overall Study|Withdrawal by Subject|5
5287122|NCT00509795|18235033|P1|Overall Study|Withdrawal by Subject|10
5287123|NCT00509795|18235030|P4|Overall Study|Protocol Violation|1
5287124|NCT00509795|18235031|P3|Overall Study|Protocol Violation|3
5287125|NCT00509795|18235032|P2|Overall Study|Protocol Violation|0
5287126|NCT00509795|18235033|P1|Overall Study|Protocol Violation|3
5287127|NCT00509795|18235030|P4|Overall Study|OTHER|1
5287128|NCT00509795|18235031|P3|Overall Study|OTHER|4
5287129|NCT00509795|18235032|P2|Overall Study|OTHER|0
5287130|NCT00509795|18235033|P1|Overall Study|OTHER|1
5287131|NCT00509795|18235030|P4|Overall Study|Lost to Follow-up|4
5287132|NCT00509795|18235031|P3|Overall Study|Lost to Follow-up|4
5287133|NCT00509795|18235032|P2|Overall Study|Lost to Follow-up|2
5287134|NCT00509795|18235033|P1|Overall Study|Lost to Follow-up|1
5287135|NCT00509795|18235030|P4|Overall Study|Lack of Efficacy|2
5287136|NCT00509795|18235031|P3|Overall Study|Lack of Efficacy|2
5287137|NCT00509795|18235032|P2|Overall Study|Lack of Efficacy|0
5287138|NCT00509795|18235033|P1|Overall Study|Lack of Efficacy|0
5287139|NCT00509795|18235030|P4|Overall Study|Death|7
5287140|NCT00509795|18235031|P3|Overall Study|Death|2
5287141|NCT00509795|18235032|P2|Overall Study|Death|1
5287142|NCT00509795|18235033|P1|Overall Study|Death|3
5287143|NCT00509795|18235030|P4|Overall Study|Adverse Event|4
5287144|NCT00509795|18235031|P3|Overall Study|Adverse Event|5
5287145|NCT00509795|18235032|P2|Overall Study|Adverse Event|3
5287146|NCT00509795|18235033|P1|Overall Study|Adverse Event|4
5287147|NCT00509769|18235064|P1|Overall Study|Use of prohibited therapies during study|1
5287148|NCT00509769|18235064|P1|Overall Study|Physician Decision|8
5287149|NCT00509769|18235064|P1|Overall Study|Patient's decision|1
5287150|NCT00509769|18235064|P1|Overall Study|Adverse Event|4
5287151|NCT00509769|18235064|P1|Overall Study|Progressive disease|77
5287152|NCT00509600|18235083|P1|Overall Study|Adverse Event|1
5287153|NCT00509366|18235162|P5|Overall Study|Not Treated (Screen Failure)|0
5287154|NCT00509366|18235163|P4|Overall Study|Not Treated (Screen Failure)|0
5287155|NCT00509366|18235164|P3|Overall Study|Not Treated (Screen Failure)|1
5287156|NCT00509366|18235165|P2|Overall Study|Not Treated (Screen Failure)|1
5287157|NCT00509366|18235166|P1|Overall Study|Not Treated (Screen Failure)|1
5287158|NCT00509262|18235190|P2|Overall Study|Withdrawal by Subject|11
5287159|NCT00509262|18235191|P1|Overall Study|Withdrawal by Subject|24
5287160|NCT00509262|18235190|P2|Overall Study|Protocol Violation|2
5287161|NCT00509262|18235191|P1|Overall Study|Protocol Violation|2
5287162|NCT00509262|18235190|P2|Overall Study|Physician Decision|3
5287163|NCT00509262|18235191|P1|Overall Study|Physician Decision|1
5287164|NCT00509262|18235190|P2|Overall Study|Lost to Follow-up|6
5287165|NCT00509262|18235191|P1|Overall Study|Lost to Follow-up|1
5287166|NCT00509262|18235190|P2|Overall Study|Lack of Efficacy|0
5287167|NCT00509262|18235191|P1|Overall Study|Lack of Efficacy|1
5287168|NCT00509262|18235190|P2|Overall Study|Other|2
5287169|NCT00509262|18235191|P1|Overall Study|Other|2
5287170|NCT00509262|18235190|P2|Overall Study|Adverse Event|18
5287171|NCT00509262|18235191|P1|Overall Study|Adverse Event|16
5287172|NCT00509236|18235209|P2|Overall Study|Scheduled Kidney Transplant|0
5287173|NCT00509236|18235210|P1|Overall Study|Scheduled Kidney Transplant|1
5287174|NCT00509236|18235209|P2|Overall Study|Excluded Medication|1
5287175|NCT00509236|18235210|P1|Overall Study|Excluded Medication|1
5287176|NCT00509236|18235209|P2|Overall Study|Protocol Violation|0
5287177|NCT00509236|18235210|P1|Overall Study|Protocol Violation|3
5287178|NCT00509236|18235209|P2|Overall Study|Withdrawal by Subject|10
5287179|NCT00509236|18235210|P1|Overall Study|Withdrawal by Subject|5
5287180|NCT00509236|18235209|P2|Overall Study|Adverse Event|9
5287181|NCT00509236|18235210|P1|Overall Study|Adverse Event|7
5287182|NCT00509223|18235225|P2|Overall Study|Did not meet revised inclusion criteria|62
5287183|NCT00509223|18235226|P1|Overall Study|Did not meet revised inclusion criteria|56
5287184|NCT00509223|18235225|P2|Overall Study|Including: subject change of address|2
5287185|NCT00509223|18235226|P1|Overall Study|Including: subject change of address|5
5287186|NCT00509223|18235225|P2|Overall Study|Withdrawal by Subject|6
5287187|NCT00509223|18235226|P1|Overall Study|Withdrawal by Subject|25
5287188|NCT00509223|18235225|P2|Overall Study|Adverse Event|1
5287189|NCT00509223|18235226|P1|Overall Study|Adverse Event|1
5287190|NCT00509223|18235225|P2|Overall Study|Lost to Follow-up|1
5287191|NCT00509223|18235226|P1|Overall Study|Lost to Follow-up|1
5287192|NCT00509106|18235258|P2|Overall Study|Death|6
5287193|NCT00509106|18235259|P1|Overall Study|Death|6
5287194|NCT00509106|18235258|P2|Overall Study|Other|0
5287195|NCT00509106|18235259|P1|Overall Study|Other|1
5287196|NCT00509106|18235258|P2|Overall Study|Lost to Follow-up|10
5287197|NCT00509106|18235259|P1|Overall Study|Lost to Follow-up|16
5287198|NCT00509106|18235258|P2|Overall Study|Withdrew consent|8
5287199|NCT00509106|18235259|P1|Overall Study|Withdrew consent|4
5287200|NCT00509106|18235258|P2|Overall Study|At the request of sponsor/investigator|2
5287201|NCT00509106|18235259|P1|Overall Study|At the request of sponsor/investigator|1
5287202|NCT00509106|18235258|P2|Overall Study|Noncompliance|1
5287203|NCT00509106|18235259|P1|Overall Study|Noncompliance|0
5287204|NCT00509106|18235258|P2|Overall Study|Adverse Event|2
5287205|NCT00509106|18235259|P1|Overall Study|Adverse Event|3
5287206|NCT00509093|18235265|P1|Overall Study|Physician Decision|1
5287207|NCT00509093|18235265|P1|Overall Study|Withdrawal by Subject|3
5287208|NCT00509093|18235265|P1|Overall Study|Transformed into MDS|1
5287209|NCT00509093|18235265|P1|Overall Study|Disease Progression|9
5287210|NCT00509093|18235265|P1|Overall Study|Adverse Event|10
5287211|NCT00509067|18235275|P2|Overall Study|Protocol Violation|3
5287212|NCT00509067|18235276|P1|Overall Study|Protocol Violation|0
5287213|NCT00509067|18235275|P2|Overall Study|Adverse Event|1
5287214|NCT00509067|18235276|P1|Overall Study|Adverse Event|3
5287215|NCT00509067|18235275|P2|Overall Study|Lost to Follow-up|1
5287216|NCT00509067|18235276|P1|Overall Study|Lost to Follow-up|1
5287217|NCT00509028|18235295|P2|Overall Study|Non-compliance|1
5287218|NCT00509028|18235296|P1|Overall Study|Non-compliance|2
5287219|NCT00509028|18235295|P2|Overall Study|Protocol Violation|2
5287220|NCT00509028|18235296|P1|Overall Study|Protocol Violation|4
5287221|NCT00509028|18235295|P2|Overall Study|Lost to Follow-up|1
5287222|NCT00509028|18235296|P1|Overall Study|Lost to Follow-up|0
5287223|NCT00509028|18235295|P2|Overall Study|Withdrawal by Subject|3
5287224|NCT00509028|18235296|P1|Overall Study|Withdrawal by Subject|4
5287225|NCT00509028|18235295|P2|Overall Study|Adverse Event|0
5287226|NCT00509028|18235296|P1|Overall Study|Adverse Event|2
5287227|NCT00508924|18235336|P4|Overall Study|Protocol Violation|1
5287228|NCT00508924|18235337|P3|Overall Study|Protocol Violation|1
5287229|NCT00508924|18235338|P2|Overall Study|Protocol Violation|0
5287230|NCT00508924|18235339|P1|Overall Study|Protocol Violation|0
5287231|NCT00508872|18235353|P1|Overall Study|Physician Decision|1
5287232|NCT00508872|18235353|P1|Overall Study|Lost to Follow-up|1
5287233|NCT00508820|18235359|P2|Overall Study|Protocol-specified Criteria|12
5287234|NCT00508820|18235360|P1|Overall Study|Protocol-specified Criteria|3
5287235|NCT00508820|18235359|P2|Overall Study|Requirement for alternative therapy|15
5287236|NCT00508820|18235360|P1|Overall Study|Requirement for alternative therapy|7
5287237|NCT00508820|18235359|P2|Overall Study|Noncompliance|0
5287238|NCT00508820|18235360|P1|Overall Study|Noncompliance|1
5287239|NCT00508820|18235359|P2|Overall Study|Other|2
5287240|NCT00508820|18235360|P1|Overall Study|Other|11
5287241|NCT00508820|18235359|P2|Overall Study|Withdrawal by Subject|12
5287242|NCT00508820|18235360|P1|Overall Study|Withdrawal by Subject|10
5287243|NCT00508820|18235359|P2|Overall Study|Protocol Violation|0
5287244|NCT00508820|18235360|P1|Overall Study|Protocol Violation|2
5287245|NCT00508820|18235359|P2|Overall Study|Pregnancy|2
5287246|NCT00508820|18235360|P1|Overall Study|Pregnancy|0
5287247|NCT00508820|18235359|P2|Overall Study|Physician Decision|2
5287248|NCT00508820|18235360|P1|Overall Study|Physician Decision|8
5287249|NCT00508820|18235359|P2|Overall Study|Lost to Follow-up|1
5287250|NCT00508820|18235360|P1|Overall Study|Lost to Follow-up|1
5287251|NCT00508820|18235359|P2|Overall Study|Death|8
5287252|NCT00508820|18235360|P1|Overall Study|Death|6
5287253|NCT00508820|18235359|P2|Overall Study|Adverse Event|10
5287254|NCT00508820|18235360|P1|Overall Study|Adverse Event|6
5287255|NCT00508755|18235370|P1|Overall Study|Withdrawal by Subject|1
5287256|NCT00508742|18235378|P2|Period 3: Toddler Dose|Other|4
5287257|NCT00508742|18235379|P1|Period 3: Toddler Dose|Other|5
5287258|NCT00508742|18235378|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
5287259|NCT00508742|18235379|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
5287260|NCT00508742|18235378|P2|Period 3: Toddler Dose|Lost to Follow-up|3
5287261|NCT00508742|18235379|P1|Period 3: Toddler Dose|Lost to Follow-up|2
5287262|NCT00508742|18235378|P2|Period 3: Toddler Dose|Adverse Event|0
5287263|NCT00508742|18235379|P1|Period 3: Toddler Dose|Adverse Event|1
5287264|NCT00508742|18235378|P2|Period 2: After Infant Series|Other|1
5287265|NCT00508742|18235379|P1|Period 2: After Infant Series|Other|2
5287266|NCT00508742|18235378|P2|Period 2: After Infant Series|Failed to Return|0
5287267|NCT00508742|18235379|P1|Period 2: After Infant Series|Failed to Return|1
5287268|NCT00508742|18235378|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
5287269|NCT00508742|18235379|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
5287270|NCT00508742|18235378|P2|Period 2: After Infant Series|Protocol Violation|0
5287271|NCT00508742|18235379|P1|Period 2: After Infant Series|Protocol Violation|1
5287272|NCT00508742|18235378|P2|Period 2: After Infant Series|Lost to Follow-up|1
5287273|NCT00508742|18235379|P1|Period 2: After Infant Series|Lost to Follow-up|1
5287274|NCT00508742|18235378|P2|Period 2: After Infant Series|Adverse Event|6
5287275|NCT00508742|18235379|P1|Period 2: After Infant Series|Adverse Event|2
5287276|NCT00508742|18235378|P2|Period 1: Infant Series|Other|1
5287277|NCT00508742|18235379|P1|Period 1: Infant Series|Other|4
5287278|NCT00508742|18235378|P2|Period 1: Infant Series|Physician Decision|0
5287279|NCT00508742|18235379|P1|Period 1: Infant Series|Physician Decision|1
5287280|NCT00508742|18235378|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
5287281|NCT00508742|18235379|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
5287282|NCT00508742|18235378|P2|Period 1: Infant Series|Protocol Violation|0
5287283|NCT00508742|18235379|P1|Period 1: Infant Series|Protocol Violation|1
5287284|NCT00508742|18235378|P2|Period 1: Infant Series|Adverse Event|4
5287285|NCT00508742|18235379|P1|Period 1: Infant Series|Adverse Event|5
5287286|NCT00508651|18235404|P2|Overall Study|Withdrawal by Subject|1
5287287|NCT00508651|18235405|P1|Overall Study|Withdrawal by Subject|1
5287288|NCT00508651|18235404|P2|Overall Study|Lost to Follow-up|1
5287289|NCT00508651|18235405|P1|Overall Study|Lost to Follow-up|3
5287290|NCT00508482|18235486|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
5287291|NCT00508482|18235487|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
5287292|NCT00508482|18235488|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
5287293|NCT00508482|18235486|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
5287294|NCT00508482|18235487|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
5287295|NCT00508482|18235488|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
5287296|NCT00508482|18235486|P3|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
5287297|NCT00508482|18235487|P2|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
5287298|NCT00508482|18235488|P1|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
5287299|NCT00508404|18235532|P1|Overall Study|Other - Not Specified|3
5287300|NCT00508404|18235532|P1|Overall Study|Lost to Follow-up|2
5287301|NCT00508404|18235532|P1|Overall Study|Protocol-specified Criteria|2
5287302|NCT00508404|18235532|P1|Overall Study|Withdrawal by Subject|3
5287303|NCT00508404|18235532|P1|Overall Study|Physician Decision|2
5287304|NCT00508404|18235532|P1|Overall Study|Death|16
5287305|NCT00508404|18235532|P1|Overall Study|Adverse Event|2
5287306|NCT00508404|18235532|P1|Overall Study|Ongoing at Data Cut-off|12
5287307|NCT00508391|18235559|P2|Second Treatment|Withdrawal by Subject|0
5287308|NCT00508391|18235560|P1|Second Treatment|Withdrawal by Subject|2
5287309|NCT00508391|18235559|P2|First Treatment|Withdrawal by Subject|3
5287310|NCT00508391|18235560|P1|First Treatment|Withdrawal by Subject|6
5287311|NCT00508274|18235580|P1|Overall Study|Withdrawal by Subject|1
5287312|NCT00508274|18235580|P1|Overall Study|Adverse Event|1
5287313|NCT00508261|18235593|P4|Overall Study|Lost to Follow-up|1
5287314|NCT00508261|18235594|P3|Overall Study|Lost to Follow-up|1
5287315|NCT00508261|18235595|P2|Overall Study|Lost to Follow-up|1
5287316|NCT00508261|18235596|P1|Overall Study|Lost to Follow-up|0
5287317|NCT00508261|18235593|P4|Overall Study|Migrated/ moved from study area|0
5287318|NCT00508261|18235594|P3|Overall Study|Migrated/ moved from study area|0
5287319|NCT00508261|18235595|P2|Overall Study|Migrated/ moved from study area|1
5287320|NCT00508261|18235596|P1|Overall Study|Migrated/ moved from study area|0
5287321|NCT00508261|18235593|P4|Overall Study|Withdrawal by Subject|0
5287322|NCT00508261|18235594|P3|Overall Study|Withdrawal by Subject|4
5287323|NCT00508261|18235595|P2|Overall Study|Withdrawal by Subject|4
5287324|NCT00508261|18235596|P1|Overall Study|Withdrawal by Subject|3
5287325|NCT00508261|18235593|P4|Overall Study|Serious Adverse Event|0
5287326|NCT00508261|18235594|P3|Overall Study|Serious Adverse Event|0
5287327|NCT00508261|18235595|P2|Overall Study|Serious Adverse Event|1
5287328|NCT00508261|18235596|P1|Overall Study|Serious Adverse Event|0
5287329|NCT00508261|18235593|P4|Overall Study|Other|0
5287330|NCT00508261|18235594|P3|Overall Study|Other|1
5287331|NCT00508261|18235595|P2|Overall Study|Other|1
5287332|NCT00508261|18235596|P1|Overall Study|Other|0
5287333|NCT00508157|18235736|P2|Overall Study|Other known cause|1
5287334|NCT00508157|18235737|P1|Overall Study|Other known cause|0
5287335|NCT00508157|18235736|P2|Overall Study|Subject no longer met study criteria|1
5287336|NCT00508157|18235737|P1|Overall Study|Subject no longer met study criteria|0
5287337|NCT00508157|18235736|P2|Overall Study|Lost to Follow-up|0
5287338|NCT00508157|18235737|P1|Overall Study|Lost to Follow-up|1
5287339|NCT00508157|18235736|P2|Overall Study|Subject Withdrew Consent|0
5287340|NCT00508157|18235737|P1|Overall Study|Subject Withdrew Consent|1
5287341|NCT00508157|18235736|P2|Overall Study|Adverse Event|1
5287342|NCT00508157|18235737|P1|Overall Study|Adverse Event|0
5287343|NCT00508144|18235759|P1|Overall Study|Death|5
5287344|NCT00508144|18235759|P1|Overall Study|Not eligible|6
5287345|NCT00508027|18235798|P1|Dose Level 2|Withdrawal by Subject|2
5287346|NCT00508027|18235798|P1|Dose Level 2|Lost to Follow-up|2
5287347|NCT00508027|18235798|P1|Dose Level 1|Physician Decision|2
5287348|NCT00508027|18235798|P1|Dose Level 1|Withdrawal by Subject|2
5287349|NCT00508027|18235798|P1|Dose Level 1|Lost to Follow-up|4
5287350|NCT00508001|18235839|P3|Overall Study|Withdrawal by Subject|1
5287351|NCT00508001|18235840|P2|Overall Study|Withdrawal by Subject|4
5287352|NCT00508001|18235841|P1|Overall Study|Withdrawal by Subject|4
5287353|NCT00508001|18235839|P3|Overall Study|Death|1
5287354|NCT00508001|18235840|P2|Overall Study|Death|1
5287355|NCT00508001|18235841|P1|Overall Study|Death|0
5287356|NCT00508001|18235839|P3|Overall Study|condition under investigation worsened|1
5287357|NCT00508001|18235840|P2|Overall Study|condition under investigation worsened|7
5287358|NCT00508001|18235841|P1|Overall Study|condition under investigation worsened|13
5287359|NCT00508001|18235839|P3|Overall Study|Adverse Event|4
5287360|NCT00508001|18235840|P2|Overall Study|Adverse Event|0
5287361|NCT00508001|18235841|P1|Overall Study|Adverse Event|2
5287362|NCT00507819|18235858|P2|Washout (6 Weeks)|Withdrawal by Subject|0
5287363|NCT00507819|18235859|P1|Washout (6 Weeks)|Withdrawal by Subject|1
5287364|NCT00507689|18235878|P2|Randomized Period|Withdrawal by Subject|1
5287365|NCT00507689|18235879|P1|Randomized Period|Withdrawal by Subject|0
5287366|NCT00507689|18235878|P2|Randomized Period|Adverse Event|1
5287367|NCT00507689|18235879|P1|Randomized Period|Adverse Event|1
5287368|NCT00507689|18235878|P2|Pre-Randomization Period|Withdrawal by Subject|0
5287369|NCT00507689|18235879|P1|Pre-Randomization Period|Withdrawal by Subject|1
5287370|NCT00507689|18235878|P2|Pre-Randomization Period|Physician Decision|0
5287371|NCT00507689|18235879|P1|Pre-Randomization Period|Physician Decision|1
5287372|NCT00507689|18235878|P2|Pre-Randomization Period|Adverse Event|0
5287373|NCT00507689|18235879|P1|Pre-Randomization Period|Adverse Event|1
5287374|NCT00507546|18235911|P2|Overall Study|Physician Decision|1
5287375|NCT00507546|18235912|P1|Overall Study|Physician Decision|0
5287376|NCT00507546|18235911|P2|Overall Study|Protocol Violation|0
5287377|NCT00507546|18235912|P1|Overall Study|Protocol Violation|1
5287378|NCT00507546|18235911|P2|Overall Study|Withdrawal by Subject|0
5287379|NCT00507546|18235912|P1|Overall Study|Withdrawal by Subject|1
5287380|NCT00507507|18235922|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
5287381|NCT00507507|18235923|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
5287382|NCT00507507|18235922|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
5287383|NCT00507507|18235923|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
5287384|NCT00507507|18235922|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
5287385|NCT00507507|18235923|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
5287386|NCT00507507|18235922|P2|Treatment Period|Withdrawal by Subject|47
5287387|NCT00507507|18235923|P1|Treatment Period|Withdrawal by Subject|46
5287388|NCT00507507|18235922|P2|Treatment Period|Adverse Event|1
5287389|NCT00507507|18235923|P1|Treatment Period|Adverse Event|1
5287390|NCT00507507|18235922|P2|Treatment Period|Protocol Violation|2
5287391|NCT00507507|18235923|P1|Treatment Period|Protocol Violation|1
5287392|NCT00507507|18235922|P2|Treatment Period|Physician Decision|1
5287393|NCT00507507|18235923|P1|Treatment Period|Physician Decision|4
5287394|NCT00507507|18235922|P2|Treatment Period|Lost to Follow-up|2
5287395|NCT00507507|18235923|P1|Treatment Period|Lost to Follow-up|0
5287396|NCT00507455|18235958|P3|Overall Study|Other - miscellaneous reason|1
5287397|NCT00507455|18235959|P2|Overall Study|Other - miscellaneous reason|0
5287398|NCT00507455|18235960|P1|Overall Study|Other - miscellaneous reason|1
5287399|NCT00507455|18235958|P3|Overall Study|Lack of Efficacy|0
5287400|NCT00507455|18235959|P2|Overall Study|Lack of Efficacy|1
5287401|NCT00507455|18235960|P1|Overall Study|Lack of Efficacy|0
5287402|NCT00507455|18235958|P3|Overall Study|Lost to Follow-up|2
5287403|NCT00507455|18235959|P2|Overall Study|Lost to Follow-up|0
5287404|NCT00507455|18235960|P1|Overall Study|Lost to Follow-up|2
5287405|NCT00507455|18235958|P3|Overall Study|Protocol Violation|1
5287406|NCT00507455|18235959|P2|Overall Study|Protocol Violation|1
5287407|NCT00507455|18235960|P1|Overall Study|Protocol Violation|4
5287408|NCT00507455|18235958|P3|Overall Study|Withdrawal by Subject|2
5287409|NCT00507455|18235959|P2|Overall Study|Withdrawal by Subject|1
5287410|NCT00507455|18235960|P1|Overall Study|Withdrawal by Subject|2
5287411|NCT00507455|18235958|P3|Overall Study|Adverse Event|6
5287412|NCT00507455|18235959|P2|Overall Study|Adverse Event|3
5287413|NCT00507455|18235960|P1|Overall Study|Adverse Event|3
5287414|NCT00507442|18236023|P4|Overall Study|Other|2
5287415|NCT00507442|18236024|P3|Overall Study|Other|2
5287416|NCT00507442|18236025|P2|Overall Study|Other|5
5287417|NCT00507442|18236026|P1|Overall Study|Other|2
5287418|NCT00507442|18236023|P4|Overall Study|Withdrawal by Subject|1
5287419|NCT00507442|18236024|P3|Overall Study|Withdrawal by Subject|2
5287420|NCT00507442|18236025|P2|Overall Study|Withdrawal by Subject|4
5287421|NCT00507442|18236026|P1|Overall Study|Withdrawal by Subject|4
5287422|NCT00507442|18236023|P4|Overall Study|Progressive Disease|0
5287423|NCT00507442|18236024|P3|Overall Study|Progressive Disease|2
5287424|NCT00507442|18236025|P2|Overall Study|Progressive Disease|4
5287425|NCT00507442|18236026|P1|Overall Study|Progressive Disease|2
5287426|NCT00507442|18236023|P4|Overall Study|Physician Decision|1
5287427|NCT00507442|18236024|P3|Overall Study|Physician Decision|4
5287428|NCT00507442|18236025|P2|Overall Study|Physician Decision|2
5287429|NCT00507442|18236026|P1|Overall Study|Physician Decision|0
5287430|NCT00507442|18236023|P4|Overall Study|Lost to Follow-up|0
5287431|NCT00507442|18236024|P3|Overall Study|Lost to Follow-up|1
5287432|NCT00507442|18236025|P2|Overall Study|Lost to Follow-up|0
5287433|NCT00507442|18236026|P1|Overall Study|Lost to Follow-up|0
5287434|NCT00507442|18236023|P4|Overall Study|Protocol Violation|0
5287435|NCT00507442|18236024|P3|Overall Study|Protocol Violation|0
5287436|NCT00507442|18236025|P2|Overall Study|Protocol Violation|1
5287437|NCT00507442|18236026|P1|Overall Study|Protocol Violation|0
5287438|NCT00507442|18236023|P4|Overall Study|Adverse Event|1
5287439|NCT00507442|18236024|P3|Overall Study|Adverse Event|4
5287440|NCT00507442|18236025|P2|Overall Study|Adverse Event|11
5287441|NCT00507442|18236026|P1|Overall Study|Adverse Event|8
5287442|NCT00507429|18236078|P2|Maintenance Phase|Progressive Disease|0
5287443|NCT00507429|18236079|P1|Maintenance Phase|Progressive Disease|14
5287444|NCT00507429|18236078|P2|Treatment Phase|Other|3
5287445|NCT00507429|18236079|P1|Treatment Phase|Other|6
5287446|NCT00507429|18236078|P2|Treatment Phase|Physician Decision|2
5287447|NCT00507429|18236079|P1|Treatment Phase|Physician Decision|4
5287448|NCT00507429|18236078|P2|Treatment Phase|Withdrawal by Subject|3
5287449|NCT00507429|18236079|P1|Treatment Phase|Withdrawal by Subject|3
5287450|NCT00507429|18236078|P2|Treatment Phase|Adverse Event|5
5287451|NCT00507429|18236079|P1|Treatment Phase|Adverse Event|12
5287452|NCT00507429|18236078|P2|Treatment Phase|Disease Progression|5
5287453|NCT00507429|18236079|P1|Treatment Phase|Disease Progression|12
5287454|NCT00507416|18236090|P3|Overall Study|Did not Receive Study Treatment|4
5287455|NCT00507416|18236091|P2|Overall Study|Did not Receive Study Treatment|9
5287456|NCT00507416|18236092|P1|Overall Study|Did not Receive Study Treatment|3
5287457|NCT00507416|18236090|P3|Overall Study|Other|13
5287458|NCT00507416|18236091|P2|Overall Study|Other|16
5287459|NCT00507416|18236092|P1|Overall Study|Other|11
5287460|NCT00507416|18236090|P3|Overall Study|Patient declined further treatment|11
5287461|NCT00507416|18236091|P2|Overall Study|Patient declined further treatment|14
5287462|NCT00507416|18236092|P1|Overall Study|Patient declined further treatment|18
5287463|NCT00507416|18236090|P3|Overall Study|Progressive Disease|13
5287464|NCT00507416|18236091|P2|Overall Study|Progressive Disease|10
5287465|NCT00507416|18236092|P1|Overall Study|Progressive Disease|20
5287466|NCT00507416|18236090|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
5287467|NCT00507416|18236091|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
5287468|NCT00507416|18236092|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
5287469|NCT00507416|18236090|P3|Overall Study|Protocol Violation|0
5287470|NCT00507416|18236091|P2|Overall Study|Protocol Violation|2
5287471|NCT00507416|18236092|P1|Overall Study|Protocol Violation|1
5287472|NCT00507416|18236090|P3|Overall Study|Adverse Event|65
5287473|NCT00507416|18236091|P2|Overall Study|Adverse Event|67
5287474|NCT00507416|18236092|P1|Overall Study|Adverse Event|58
5287475|NCT00507130|18236134|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
5287476|NCT00507130|18236135|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
5287477|NCT00507130|18236136|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
5287478|NCT00507130|18236137|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
5287479|NCT00507130|18236134|P4|Overall Study|Lost to Follow-up|1
5287480|NCT00507130|18236135|P3|Overall Study|Lost to Follow-up|1
5287481|NCT00507130|18236136|P2|Overall Study|Lost to Follow-up|0
5287482|NCT00507130|18236137|P1|Overall Study|Lost to Follow-up|0
5287483|NCT00506948|18236179|P1|Overall Study|Physician Decision|1
5287484|NCT00506948|18236179|P1|Overall Study|Adverse Event|5
5287485|NCT00506948|18236179|P1|Overall Study|Death|4
5287486|NCT00506922|18236188|P5|Overall Study|Withdrawal by Subject|1
5287487|NCT00506922|18236189|P4|Overall Study|Withdrawal by Subject|0
5287488|NCT00506922|18236190|P3|Overall Study|Withdrawal by Subject|0
5287489|NCT00506922|18236191|P2|Overall Study|Withdrawal by Subject|0
5287490|NCT00506922|18236192|P1|Overall Study|Withdrawal by Subject|0
5287491|NCT00506922|18236188|P5|Overall Study|Physician Decision|0
5287492|NCT00506922|18236189|P4|Overall Study|Physician Decision|2
5287493|NCT00506922|18236190|P3|Overall Study|Physician Decision|0
5287494|NCT00506922|18236191|P2|Overall Study|Physician Decision|0
5287495|NCT00506922|18236192|P1|Overall Study|Physician Decision|0
5287496|NCT00506883|18236219|P3|Overall Study|Other|1
5287497|NCT00506883|18236220|P2|Overall Study|Other|1
5287498|NCT00506883|18236221|P1|Overall Study|Other|5
5287499|NCT00506883|18236219|P3|Overall Study|Lack of Efficacy|1
5287500|NCT00506883|18236220|P2|Overall Study|Lack of Efficacy|1
5287501|NCT00506883|18236221|P1|Overall Study|Lack of Efficacy|0
5287502|NCT00506883|18236219|P3|Overall Study|Withdrawal by Subject|1
5287503|NCT00506883|18236220|P2|Overall Study|Withdrawal by Subject|0
5287504|NCT00506883|18236221|P1|Overall Study|Withdrawal by Subject|1
5287505|NCT00506883|18236219|P3|Overall Study|Lost to Follow-up|1
5287506|NCT00506883|18236220|P2|Overall Study|Lost to Follow-up|1
5287507|NCT00506883|18236221|P1|Overall Study|Lost to Follow-up|1
5287508|NCT00506831|18236234|P1|Overall Study|Withdrawal by Subject|1
5287509|NCT00506831|18236234|P1|Overall Study|Death|1
5287510|NCT00506779|18236247|P4|Overall Study|Adverse Event|1
5287511|NCT00506779|18236248|P3|Overall Study|Adverse Event|1
5287512|NCT00506779|18236249|P2|Overall Study|Adverse Event|1
5287513|NCT00506779|18236250|P1|Overall Study|Adverse Event|0
5287514|NCT00506779|18236247|P4|Overall Study|Withdrawal by Subject|0
5287515|NCT00506779|18236248|P3|Overall Study|Withdrawal by Subject|1
5287516|NCT00506779|18236249|P2|Overall Study|Withdrawal by Subject|0
5287517|NCT00506779|18236250|P1|Overall Study|Withdrawal by Subject|1
5287518|NCT00506753|18236265|P2|Overall Study|Lost to Follow-up|15
5287519|NCT00506753|18236266|P1|Overall Study|Lost to Follow-up|21
5287520|NCT00506662|18236304|P2|Overall Study|Not recorded|6
5287521|NCT00506662|18236305|P1|Overall Study|Not recorded|4
5287522|NCT00506662|18236304|P2|Overall Study|Trial terminated|16
5287523|NCT00506662|18236305|P1|Overall Study|Trial terminated|10
5287524|NCT00506662|18236304|P2|Overall Study|Protocol Violation|4
5287525|NCT00506662|18236305|P1|Overall Study|Protocol Violation|2
5287526|NCT00506662|18236304|P2|Overall Study|Lack of Efficacy|0
5287527|NCT00506662|18236305|P1|Overall Study|Lack of Efficacy|1
5287528|NCT00506662|18236304|P2|Overall Study|Adverse Event|2
5287529|NCT00506662|18236305|P1|Overall Study|Adverse Event|0
5287530|NCT00506493|18236339|P1|Overall Study|Withdrawal by Subject|5
5287531|NCT00506493|18236339|P1|Overall Study|Death|6
5287532|NCT00506454|18236348|P2|Overall Study|Withdrawal by Subject|1
5287533|NCT00506454|18236349|P1|Overall Study|Withdrawal by Subject|1
5287534|NCT00506441|18236355|P2|Period 2; Double-blind Period|Other Reason|1
5287535|NCT00506441|18236356|P1|Period 2; Double-blind Period|Other Reason|1
5287536|NCT00506441|18236355|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
5287537|NCT00506441|18236356|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
5287538|NCT00506441|18236355|P2|Period 2; Double-blind Period|Physician Decision|1
5287539|NCT00506441|18236356|P1|Period 2; Double-blind Period|Physician Decision|1
5287540|NCT00506441|18236355|P2|Period 2; Double-blind Period|Lack of Efficacy|2
5287541|NCT00506441|18236356|P1|Period 2; Double-blind Period|Lack of Efficacy|0
5287542|NCT00506441|18236355|P2|Period 2; Double-blind Period|Adverse Event|1
5287543|NCT00506441|18236356|P1|Period 2; Double-blind Period|Adverse Event|0
5287544|NCT00506441|18236355|P2|Period 1; Open-label Period|Other Reasons|0
5287545|NCT00506441|18236356|P1|Period 1; Open-label Period|Other Reasons|13
5287546|NCT00506441|18236355|P2|Period 1; Open-label Period|Withdrawal by Subject|0
5287547|NCT00506441|18236356|P1|Period 1; Open-label Period|Withdrawal by Subject|13
5287548|NCT00506441|18236355|P2|Period 1; Open-label Period|Protocol Violation|0
5287549|NCT00506441|18236356|P1|Period 1; Open-label Period|Protocol Violation|9
5287550|NCT00506441|18236355|P2|Period 1; Open-label Period|Physician Decision|0
5287551|NCT00506441|18236356|P1|Period 1; Open-label Period|Physician Decision|5
5287552|NCT00506441|18236355|P2|Period 1; Open-label Period|Lost to Follow-up|0
5287553|NCT00506441|18236356|P1|Period 1; Open-label Period|Lost to Follow-up|2
5287554|NCT00506441|18236355|P2|Period 1; Open-label Period|Lack of Efficacy|0
5287555|NCT00506441|18236356|P1|Period 1; Open-label Period|Lack of Efficacy|13
5287556|NCT00506441|18236355|P2|Period 1; Open-label Period|Adverse Event|0
5287557|NCT00506441|18236356|P1|Period 1; Open-label Period|Adverse Event|21
5287558|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
5287559|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
5287560|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
5287561|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
5287562|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
5287563|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5287564|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5287565|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5287566|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
5287567|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
5287568|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
5287569|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
5287570|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
5287571|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5287572|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5287573|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5287574|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
5287575|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5287576|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5287577|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5287578|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
5287579|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
5287580|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
5287581|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
5287582|NCT00506415|18236364|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
5287583|NCT00506415|18236365|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
5287584|NCT00506415|18236366|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
5287585|NCT00506415|18236367|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
5287586|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
5287587|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
5287588|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
5287589|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
5287590|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
5287591|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
5287592|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
5287593|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
5287594|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
5287595|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
5287596|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
5287597|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
5287598|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
5287599|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
5287600|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
5287601|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
5287602|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
5287603|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
5287604|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
5287605|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
5287606|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
5287607|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
5287608|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
5287609|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
5287610|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Death|0
5287611|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Death|3
5287612|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Death|5
5287613|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Death|0
5287614|NCT00506415|18236364|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
5287615|NCT00506415|18236365|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
5287616|NCT00506415|18236366|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
5287617|NCT00506415|18236367|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
5287618|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
5287619|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
5287620|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
5287621|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
5287622|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
5287623|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
5287624|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
5287625|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
5287626|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
5287627|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
5287628|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
5287629|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
5287630|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5287631|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5287632|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5287633|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
5287634|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5287635|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5287636|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5287637|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
5287638|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5287639|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5287640|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5287641|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
5287642|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
5287643|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
5287644|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
5287645|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
5287646|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
5287647|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
5287648|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
5287649|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
5287650|NCT00506415|18236364|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
5287651|NCT00506415|18236365|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
5287652|NCT00506415|18236366|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
5287653|NCT00506415|18236367|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
5287654|NCT00506389|18236392|P3|In-treatment Period|Randomized but not treated|1
5287655|NCT00506389|18236393|P2|In-treatment Period|Randomized but not treated|1
5287656|NCT00506389|18236394|P1|In-treatment Period|Randomized but not treated|4
5287657|NCT00506389|18236392|P3|In-treatment Period|Adverse Event|2
5287658|NCT00506389|18236393|P2|In-treatment Period|Adverse Event|5
5287659|NCT00506389|18236394|P1|In-treatment Period|Adverse Event|11
5287660|NCT00506389|18236392|P3|In-treatment Period|Lack of Efficacy|0
5287661|NCT00506389|18236393|P2|In-treatment Period|Lack of Efficacy|2
5287662|NCT00506389|18236394|P1|In-treatment Period|Lack of Efficacy|0
5287663|NCT00506389|18236392|P3|In-treatment Period|Withdrawal by Subject|4
5287664|NCT00506389|18236393|P2|In-treatment Period|Withdrawal by Subject|3
5287665|NCT00506389|18236394|P1|In-treatment Period|Withdrawal by Subject|3
5287666|NCT00506389|18236392|P3|In-treatment Period|Reasons not related to trial|0
5287667|NCT00506389|18236393|P2|In-treatment Period|Reasons not related to trial|1
5287668|NCT00506389|18236394|P1|In-treatment Period|Reasons not related to trial|4
5287669|NCT00506389|18236392|P3|In-treatment Period|Lack of compliance|0
5287670|NCT00506389|18236393|P2|In-treatment Period|Lack of compliance|0
5287671|NCT00506389|18236394|P1|In-treatment Period|Lack of compliance|1
5287672|NCT00506389|18236392|P3|In-treatment Period|Lost to Follow-up|1
5287673|NCT00506389|18236393|P2|In-treatment Period|Lost to Follow-up|0
5287674|NCT00506389|18236394|P1|In-treatment Period|Lost to Follow-up|0
5287675|NCT00506389|18236392|P3|In-treatment Period|Other|4
5287676|NCT00506389|18236393|P2|In-treatment Period|Other|3
5287677|NCT00506389|18236394|P1|In-treatment Period|Other|3
5287678|NCT00506350|18236420|P9|Overall Study|Other|2
5287679|NCT00506350|18236421|P8|Overall Study|Other|2
5287680|NCT00506350|18236422|P7|Overall Study|Other|0
5287681|NCT00506350|18236423|P6|Overall Study|Other|0
5287682|NCT00506350|18236424|P5|Overall Study|Other|3
5287683|NCT00506350|18236425|P4|Overall Study|Other|0
5287684|NCT00506350|18236426|P3|Overall Study|Other|3
5287685|NCT00506350|18236427|P2|Overall Study|Other|1
5287686|NCT00506350|18236428|P1|Overall Study|Other|1
5287687|NCT00506350|18236420|P9|Overall Study|Medical Reason|0
5287688|NCT00506350|18236421|P8|Overall Study|Medical Reason|0
5287689|NCT00506350|18236422|P7|Overall Study|Medical Reason|0
5287690|NCT00506350|18236423|P6|Overall Study|Medical Reason|0
5287691|NCT00506350|18236424|P5|Overall Study|Medical Reason|1
5287692|NCT00506350|18236425|P4|Overall Study|Medical Reason|0
5287693|NCT00506350|18236426|P3|Overall Study|Medical Reason|0
5287694|NCT00506350|18236427|P2|Overall Study|Medical Reason|0
5287695|NCT00506350|18236428|P1|Overall Study|Medical Reason|0
5287696|NCT00506350|18236420|P9|Overall Study|Lost to Follow-up|2
5287697|NCT00506350|18236421|P8|Overall Study|Lost to Follow-up|0
5287698|NCT00506350|18236422|P7|Overall Study|Lost to Follow-up|0
5287699|NCT00506350|18236423|P6|Overall Study|Lost to Follow-up|1
5287700|NCT00506350|18236424|P5|Overall Study|Lost to Follow-up|2
5287701|NCT00506350|18236425|P4|Overall Study|Lost to Follow-up|1
5287702|NCT00506350|18236426|P3|Overall Study|Lost to Follow-up|1
5287703|NCT00506350|18236427|P2|Overall Study|Lost to Follow-up|1
5287704|NCT00506350|18236428|P1|Overall Study|Lost to Follow-up|1
5287705|NCT00506350|18236420|P9|Overall Study|Withdrawal by Subject|0
5287706|NCT00506350|18236421|P8|Overall Study|Withdrawal by Subject|2
5287707|NCT00506350|18236422|P7|Overall Study|Withdrawal by Subject|1
5287708|NCT00506350|18236423|P6|Overall Study|Withdrawal by Subject|1
5287709|NCT00506350|18236424|P5|Overall Study|Withdrawal by Subject|4
5287710|NCT00506350|18236425|P4|Overall Study|Withdrawal by Subject|1
5287711|NCT00506350|18236426|P3|Overall Study|Withdrawal by Subject|1
5287712|NCT00506350|18236427|P2|Overall Study|Withdrawal by Subject|1
5287713|NCT00506350|18236428|P1|Overall Study|Withdrawal by Subject|0
5287714|NCT00506350|18236420|P9|Overall Study|Protocol Violation|0
5287715|NCT00506350|18236421|P8|Overall Study|Protocol Violation|0
5287716|NCT00506350|18236422|P7|Overall Study|Protocol Violation|1
5287717|NCT00506350|18236423|P6|Overall Study|Protocol Violation|0
5287718|NCT00506350|18236424|P5|Overall Study|Protocol Violation|0
5287719|NCT00506350|18236425|P4|Overall Study|Protocol Violation|0
5287720|NCT00506350|18236426|P3|Overall Study|Protocol Violation|1
5287721|NCT00506350|18236427|P2|Overall Study|Protocol Violation|0
5287722|NCT00506350|18236428|P1|Overall Study|Protocol Violation|0
5287723|NCT00506350|18236420|P9|Overall Study|Adverse Event|1
5287724|NCT00506350|18236421|P8|Overall Study|Adverse Event|1
5287725|NCT00506350|18236422|P7|Overall Study|Adverse Event|0
5287726|NCT00506350|18236423|P6|Overall Study|Adverse Event|0
5287727|NCT00506350|18236424|P5|Overall Study|Adverse Event|0
5287728|NCT00506350|18236425|P4|Overall Study|Adverse Event|0
5287729|NCT00506350|18236426|P3|Overall Study|Adverse Event|0
5287730|NCT00506350|18236427|P2|Overall Study|Adverse Event|0
5287731|NCT00506350|18236428|P1|Overall Study|Adverse Event|0
5287732|NCT00506350|18236420|P9|Overall Study|Serious Adverse Event|0
5287733|NCT00506350|18236421|P8|Overall Study|Serious Adverse Event|0
5287734|NCT00506350|18236422|P7|Overall Study|Serious Adverse Event|0
5287735|NCT00506350|18236423|P6|Overall Study|Serious Adverse Event|0
5287736|NCT00506350|18236424|P5|Overall Study|Serious Adverse Event|0
5287737|NCT00506350|18236425|P4|Overall Study|Serious Adverse Event|0
5287738|NCT00506350|18236426|P3|Overall Study|Serious Adverse Event|0
5287739|NCT00506350|18236427|P2|Overall Study|Serious Adverse Event|0
5287740|NCT00506350|18236428|P1|Overall Study|Serious Adverse Event|1
5287741|NCT00506285|18236575|P2|6-month Open Label Phase|Withdrawal by Subject|5
5287742|NCT00506285|18236576|P1|6-month Open Label Phase|Withdrawal by Subject|9
5287743|NCT00506285|18236575|P2|6-month Open Label Phase|Lost to Follow-up|7
5287744|NCT00506285|18236576|P1|6-month Open Label Phase|Lost to Follow-up|1
5287745|NCT00506285|18236575|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
5287746|NCT00506285|18236576|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
5287747|NCT00506285|18236575|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
5287748|NCT00506285|18236576|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
5287749|NCT00506285|18236575|P2|3 Week Screening Phase|Withdrawal by Subject|10
5287750|NCT00506285|18236576|P1|3 Week Screening Phase|Withdrawal by Subject|17
5287751|NCT00506142|18236591|P2|Overall Study|New health condition|0
5287752|NCT00506142|18236592|P1|Overall Study|New health condition|1
5287753|NCT00506142|18236591|P2|Overall Study|Physician Decision|0
5287754|NCT00506142|18236592|P1|Overall Study|Physician Decision|1
5287755|NCT00506142|18236591|P2|Overall Study|Withdrawal by Subject|5
5287756|NCT00506142|18236592|P1|Overall Study|Withdrawal by Subject|4
5287757|NCT00506142|18236591|P2|Overall Study|Lack of Efficacy|7
5287758|NCT00506142|18236592|P1|Overall Study|Lack of Efficacy|21
5287759|NCT00506142|18236591|P2|Overall Study|Adverse Event|7
5287760|NCT00506142|18236592|P1|Overall Study|Adverse Event|8
5287761|NCT00506077|18236600|P2|Treatment Period 2|Withdrawal by Subject|0
5287762|NCT00506077|18236601|P1|Treatment Period 2|Withdrawal by Subject|1
5287763|NCT00506077|18236600|P2|Treatment Period 2|Adverse Event|1
5287764|NCT00506077|18236601|P1|Treatment Period 2|Adverse Event|0
5287765|NCT00506077|18236600|P2|Treatment Period 1|Withdrawal by Subject|0
5287766|NCT00506077|18236601|P1|Treatment Period 1|Withdrawal by Subject|2
5287767|NCT00506077|18236600|P2|Treatment Period 1|Lost to Follow-up|2
5287768|NCT00506077|18236601|P1|Treatment Period 1|Lost to Follow-up|0
5287769|NCT00506077|18236600|P2|Treatment Period 1|Adverse Event|1
5287770|NCT00506077|18236601|P1|Treatment Period 1|Adverse Event|2
5287771|NCT00505934|18236643|P1|Overall Study|Other: IV dose needed to be changed|1
5287772|NCT00505934|18236643|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
5287773|NCT00505934|18236643|P1|Overall Study|Adverse Event|1
5287774|NCT00505921|18236649|P1|Overall Study|Failed to Mobilize|8
5287775|NCT00505921|18236649|P1|Overall Study|Ineligible|1
5287776|NCT00505778|18236666|P2|Overall Study|Took No Study Drug|2
5287777|NCT00505778|18236667|P1|Overall Study|Took No Study Drug|2
5287778|NCT00505778|18236666|P2|Overall Study|Relapse|65
5287779|NCT00505778|18236667|P1|Overall Study|Relapse|65
5287780|NCT00505778|18236666|P2|Overall Study|Withdrawal by Subject|14
5287781|NCT00505778|18236667|P1|Overall Study|Withdrawal by Subject|29
5287782|NCT00505778|18236666|P2|Overall Study|Protocol Violation|9
5287783|NCT00505778|18236667|P1|Overall Study|Protocol Violation|7
5287784|NCT00505778|18236666|P2|Overall Study|Unable to Meet Protocol Criteria|1
5287785|NCT00505778|18236667|P1|Overall Study|Unable to Meet Protocol Criteria|4
5287786|NCT00505778|18236666|P2|Overall Study|Lost to Follow-up|23
5287787|NCT00505778|18236667|P1|Overall Study|Lost to Follow-up|17
5287788|NCT00505778|18236666|P2|Overall Study|Physician Decision|14
5287789|NCT00505778|18236667|P1|Overall Study|Physician Decision|8
5287790|NCT00505778|18236666|P2|Overall Study|Adverse Event|7
5287791|NCT00505778|18236667|P1|Overall Study|Adverse Event|2
5287792|NCT00505765|18236686|P3|Overall Study|Noncompliance|3
5287793|NCT00505765|18236687|P2|Overall Study|Noncompliance|1
5287794|NCT00505765|18236688|P1|Overall Study|Noncompliance|0
5287795|NCT00505765|18236686|P3|Overall Study|Adverse Event|0
5287796|NCT00505765|18236687|P2|Overall Study|Adverse Event|2
5287797|NCT00505765|18236688|P1|Overall Study|Adverse Event|1
5287798|NCT00505765|18236686|P3|Overall Study|Withdrawal by Subject|0
5287799|NCT00505765|18236687|P2|Overall Study|Withdrawal by Subject|0
5287800|NCT00505765|18236688|P1|Overall Study|Withdrawal by Subject|1
5287801|NCT00505752|18236715|P4|Overall Study|Other|2
5287802|NCT00505752|18236716|P3|Overall Study|Other|1
5287803|NCT00505752|18236717|P2|Overall Study|Other|2
5287804|NCT00505752|18236718|P1|Overall Study|Other|1
5287805|NCT00505752|18236715|P4|Overall Study|All embryos/blastocysts discarded|1
5287806|NCT00505752|18236716|P3|Overall Study|All embryos/blastocysts discarded|1
5287807|NCT00505752|18236717|P2|Overall Study|All embryos/blastocysts discarded|0
5287808|NCT00505752|18236718|P1|Overall Study|All embryos/blastocysts discarded|0
5287809|NCT00505752|18236715|P4|Overall Study|No Fertilization|1
5287810|NCT00505752|18236716|P3|Overall Study|No Fertilization|2
5287811|NCT00505752|18236717|P2|Overall Study|No Fertilization|1
5287812|NCT00505752|18236718|P1|Overall Study|No Fertilization|1
5287813|NCT00505752|18236715|P4|Overall Study|No oocytes retrieved|1
5287814|NCT00505752|18236716|P3|Overall Study|No oocytes retrieved|0
5287815|NCT00505752|18236717|P2|Overall Study|No oocytes retrieved|2
5287816|NCT00505752|18236718|P1|Overall Study|No oocytes retrieved|0
5287817|NCT00505752|18236715|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
5287818|NCT00505752|18236716|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
5287819|NCT00505752|18236717|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
5287820|NCT00505752|18236718|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
5287821|NCT00505752|18236715|P4|Overall Study|Lack of ovarian response|0
5287822|NCT00505752|18236716|P3|Overall Study|Lack of ovarian response|0
5287823|NCT00505752|18236717|P2|Overall Study|Lack of ovarian response|3
5287824|NCT00505752|18236718|P1|Overall Study|Lack of ovarian response|1
5287825|NCT00505752|18236715|P4|Overall Study|Lost to Follow-up|0
5287826|NCT00505752|18236716|P3|Overall Study|Lost to Follow-up|0
5287827|NCT00505752|18236717|P2|Overall Study|Lost to Follow-up|0
5287828|NCT00505752|18236718|P1|Overall Study|Lost to Follow-up|1
5287829|NCT00505752|18236715|P4|Overall Study|Adverse Event|0
5287830|NCT00505752|18236716|P3|Overall Study|Adverse Event|1
5287831|NCT00505752|18236717|P2|Overall Study|Adverse Event|0
5287832|NCT00505752|18236718|P1|Overall Study|Adverse Event|1
5287833|NCT00505687|18236732|P1|Overall Study|Other: As Per Sponsor|8
5287834|NCT00505687|18236732|P1|Overall Study|Other: Disease Progression|1
5287835|NCT00505687|18236732|P1|Overall Study|Other: Neupro Given In Hospital|1
5287836|NCT00505687|18236732|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
5287837|NCT00505687|18236732|P1|Overall Study|Other: Prolonged Hospitalization|1
5287838|NCT00505687|18236732|P1|Overall Study|Other: Scheduled DBS Surgery|1
5287839|NCT00505687|18236732|P1|Overall Study|Other: Underwent Implantation Of DBS|1
5287840|NCT00505687|18236732|P1|Overall Study|Lost to Follow-up|1
5287841|NCT00505687|18236732|P1|Overall Study|Subject withdrew consent|15
5287842|NCT00505687|18236732|P1|Overall Study|Adverse Event|48
5287843|NCT00505687|18236732|P1|Overall Study|Lack of Efficacy|15
5287844|NCT00505687|18236732|P1|Overall Study|Important protocol violation|2
5287845|NCT00505661|18236738|P1|Overall Study|Not Eligible|4
5287846|NCT00505622|18236749|P3|Overall Study|Study termination by sponsor|90
5287847|NCT00505622|18236750|P2|Overall Study|Study termination by sponsor|98
5287848|NCT00505622|18236751|P1|Overall Study|Study termination by sponsor|115
5287849|NCT00505622|18236749|P3|Overall Study|Withdrawal by Subject|2
5287850|NCT00505622|18236750|P2|Overall Study|Withdrawal by Subject|3
5287851|NCT00505622|18236751|P1|Overall Study|Withdrawal by Subject|0
5287852|NCT00505622|18236749|P3|Overall Study|Protocol Violation|0
5287853|NCT00505622|18236750|P2|Overall Study|Protocol Violation|1
5287854|NCT00505622|18236751|P1|Overall Study|Protocol Violation|1
5287855|NCT00505622|18236749|P3|Overall Study|Adverse Event|4
5287856|NCT00505622|18236750|P2|Overall Study|Adverse Event|6
5287857|NCT00505622|18236751|P1|Overall Study|Adverse Event|5
5287858|NCT00505414|18236776|P5|Maintenance Phase|underlying disease and therapy required|0
5287859|NCT00505414|18236777|P4|Maintenance Phase|underlying disease and therapy required|0
5287860|NCT00505414|18236778|P3|Maintenance Phase|underlying disease and therapy required|2
5287861|NCT00505414|18236779|P2|Maintenance Phase|underlying disease and therapy required|2
5287862|NCT00505414|18236780|P1|Maintenance Phase|underlying disease and therapy required|0
5287863|NCT00505414|18236776|P5|Maintenance Phase|Withdrawal by Subject|0
5287864|NCT00505414|18236777|P4|Maintenance Phase|Withdrawal by Subject|0
5287865|NCT00505414|18236778|P3|Maintenance Phase|Withdrawal by Subject|1
5287866|NCT00505414|18236779|P2|Maintenance Phase|Withdrawal by Subject|0
5287867|NCT00505414|18236780|P1|Maintenance Phase|Withdrawal by Subject|0
5287868|NCT00505414|18236776|P5|Maintenance Phase|Lack of Efficacy|0
5287869|NCT00505414|18236777|P4|Maintenance Phase|Lack of Efficacy|0
5287870|NCT00505414|18236778|P3|Maintenance Phase|Lack of Efficacy|1
5287871|NCT00505414|18236779|P2|Maintenance Phase|Lack of Efficacy|1
5287872|NCT00505414|18236780|P1|Maintenance Phase|Lack of Efficacy|2
5287873|NCT00505414|18236776|P5|Maintenance Phase|Death|0
5287874|NCT00505414|18236777|P4|Maintenance Phase|Death|0
5287875|NCT00505414|18236778|P3|Maintenance Phase|Death|1
5287876|NCT00505414|18236779|P2|Maintenance Phase|Death|0
5287877|NCT00505414|18236780|P1|Maintenance Phase|Death|2
5287878|NCT00505414|18236776|P5|Maintenance Phase|Adverse Event|0
5287879|NCT00505414|18236777|P4|Maintenance Phase|Adverse Event|0
5287880|NCT00505414|18236778|P3|Maintenance Phase|Adverse Event|3
5287881|NCT00505414|18236779|P2|Maintenance Phase|Adverse Event|2
5287882|NCT00505414|18236780|P1|Maintenance Phase|Adverse Event|2
5287883|NCT00505414|18236776|P5|Titration Phase|Underlying disease and therapy required|3
5287884|NCT00505414|18236777|P4|Titration Phase|Underlying disease and therapy required|7
5287885|NCT00505414|18236778|P3|Titration Phase|Underlying disease and therapy required|0
5287886|NCT00505414|18236779|P2|Titration Phase|Underlying disease and therapy required|0
5287887|NCT00505414|18236780|P1|Titration Phase|Underlying disease and therapy required|0
5287888|NCT00505414|18236776|P5|Titration Phase|Withdrawal by Subject|4
5287889|NCT00505414|18236777|P4|Titration Phase|Withdrawal by Subject|3
5287890|NCT00505414|18236778|P3|Titration Phase|Withdrawal by Subject|0
5287891|NCT00505414|18236779|P2|Titration Phase|Withdrawal by Subject|0
5287892|NCT00505414|18236780|P1|Titration Phase|Withdrawal by Subject|0
5287893|NCT00505414|18236776|P5|Titration Phase|Protocol Violation|1
5287894|NCT00505414|18236777|P4|Titration Phase|Protocol Violation|0
5287895|NCT00505414|18236778|P3|Titration Phase|Protocol Violation|0
5287896|NCT00505414|18236779|P2|Titration Phase|Protocol Violation|0
5287897|NCT00505414|18236780|P1|Titration Phase|Protocol Violation|0
5287898|NCT00505414|18236776|P5|Titration Phase|Lack of Efficacy|1
5287899|NCT00505414|18236777|P4|Titration Phase|Lack of Efficacy|10
5287900|NCT00505414|18236778|P3|Titration Phase|Lack of Efficacy|0
5287901|NCT00505414|18236779|P2|Titration Phase|Lack of Efficacy|0
5287902|NCT00505414|18236780|P1|Titration Phase|Lack of Efficacy|0
5287903|NCT00505414|18236776|P5|Titration Phase|Death|0
5287904|NCT00505414|18236777|P4|Titration Phase|Death|2
5287905|NCT00505414|18236778|P3|Titration Phase|Death|0
5287906|NCT00505414|18236779|P2|Titration Phase|Death|0
5287907|NCT00505414|18236780|P1|Titration Phase|Death|0
5287908|NCT00505414|18236776|P5|Titration Phase|Adverse Event|3
5287909|NCT00505414|18236777|P4|Titration Phase|Adverse Event|8
5287910|NCT00505414|18236778|P3|Titration Phase|Adverse Event|0
5287911|NCT00505414|18236779|P2|Titration Phase|Adverse Event|0
5287912|NCT00505414|18236780|P1|Titration Phase|Adverse Event|0
5287913|NCT00505375|18236797|P2|Overall Study|Travel issues|1
5287914|NCT00505375|18236798|P1|Overall Study|Travel issues|0
5287915|NCT00505375|18236797|P2|Overall Study|Pregnancy|0
5287916|NCT00505375|18236798|P1|Overall Study|Pregnancy|1
5287917|NCT00505375|18236797|P2|Overall Study|Lost to Follow-up|2
5287918|NCT00505375|18236798|P1|Overall Study|Lost to Follow-up|0
5287919|NCT00505375|18236797|P2|Overall Study|Withdrawal by Subject|2
5287920|NCT00505375|18236798|P1|Overall Study|Withdrawal by Subject|2
5287921|NCT00505375|18236797|P2|Overall Study|Death|0
5287922|NCT00505375|18236798|P1|Overall Study|Death|1
5287923|NCT00505284|18236820|P5|Overall Study|Other|4
5287924|NCT00505284|18236821|P4|Overall Study|Other|4
5287925|NCT00505284|18236822|P3|Overall Study|Other|0
5287926|NCT00505284|18236823|P2|Overall Study|Other|0
5287927|NCT00505284|18236824|P1|Overall Study|Other|5
5287928|NCT00505284|18236820|P5|Overall Study|Physician Decision|0
5287929|NCT00505284|18236821|P4|Overall Study|Physician Decision|0
5287930|NCT00505284|18236822|P3|Overall Study|Physician Decision|0
5287931|NCT00505284|18236823|P2|Overall Study|Physician Decision|1
5287932|NCT00505284|18236824|P1|Overall Study|Physician Decision|0
5287933|NCT00505284|18236820|P5|Overall Study|Lack of Efficacy|1
5287934|NCT00505284|18236821|P4|Overall Study|Lack of Efficacy|1
5287935|NCT00505284|18236822|P3|Overall Study|Lack of Efficacy|1
5287936|NCT00505284|18236823|P2|Overall Study|Lack of Efficacy|1
5287937|NCT00505284|18236824|P1|Overall Study|Lack of Efficacy|0
5287938|NCT00505284|18236820|P5|Overall Study|Withdrawal by Subject|6
5287939|NCT00505284|18236821|P4|Overall Study|Withdrawal by Subject|0
5287940|NCT00505284|18236822|P3|Overall Study|Withdrawal by Subject|1
5287941|NCT00505284|18236823|P2|Overall Study|Withdrawal by Subject|6
5287942|NCT00505284|18236824|P1|Overall Study|Withdrawal by Subject|2
5287943|NCT00505284|18236820|P5|Overall Study|Protocol Violation|0
5287944|NCT00505284|18236821|P4|Overall Study|Protocol Violation|0
5287945|NCT00505284|18236822|P3|Overall Study|Protocol Violation|1
5287946|NCT00505284|18236823|P2|Overall Study|Protocol Violation|1
5287947|NCT00505284|18236824|P1|Overall Study|Protocol Violation|0
5287948|NCT00505284|18236820|P5|Overall Study|Adverse Event|22
5287949|NCT00505284|18236821|P4|Overall Study|Adverse Event|14
5287950|NCT00505284|18236822|P3|Overall Study|Adverse Event|9
5287951|NCT00505284|18236823|P2|Overall Study|Adverse Event|7
5287952|NCT00505284|18236824|P1|Overall Study|Adverse Event|3
5287953|NCT00505076|18236894|P3|Overall Study|Withdrawal by Subject|2
5287954|NCT00505076|18236895|P2|Overall Study|Withdrawal by Subject|1
5287955|NCT00505076|18236896|P1|Overall Study|Withdrawal by Subject|0
5287956|NCT00505076|18236894|P3|Overall Study|Protocol Violation|2
5287957|NCT00505076|18236895|P2|Overall Study|Protocol Violation|1
5287958|NCT00505076|18236896|P1|Overall Study|Protocol Violation|2
5287959|NCT00505076|18236894|P3|Overall Study|Adverse Event|1
5287960|NCT00505076|18236895|P2|Overall Study|Adverse Event|0
5287961|NCT00505076|18236896|P1|Overall Study|Adverse Event|1
5287962|NCT00504881|18236925|P2|Overall Study|AE of unknown type|0
5287963|NCT00504881|18236926|P1|Overall Study|AE of unknown type|1
5287964|NCT00504881|18236925|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
5287965|NCT00504881|18236926|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5287966|NCT00504881|18236925|P2|Overall Study|AE, non-serious non-fatal|14
5287967|NCT00504881|18236926|P1|Overall Study|AE, non-serious non-fatal|4
5287968|NCT00504881|18236925|P2|Overall Study|SAE, non-fatal|6
5287969|NCT00504881|18236926|P1|Overall Study|SAE, non-fatal|2
5287970|NCT00504881|18236925|P2|Overall Study|AE, serious fatal|1
5287971|NCT00504881|18236926|P1|Overall Study|AE, serious fatal|0
5287972|NCT00504881|18236925|P2|Overall Study|Safety Visit not performed|1
5287973|NCT00504881|18236926|P1|Overall Study|Safety Visit not performed|0
5287974|NCT00504881|18236925|P2|Overall Study|No Birth Control|1
5287975|NCT00504881|18236926|P1|Overall Study|No Birth Control|0
5287976|NCT00504881|18236925|P2|Overall Study|Non-Compliance|0
5287977|NCT00504881|18236926|P1|Overall Study|Non-Compliance|1
5287978|NCT00504881|18236925|P2|Overall Study|Withdrawal by Subject|4
5287979|NCT00504881|18236926|P1|Overall Study|Withdrawal by Subject|1
5287980|NCT00504881|18236925|P2|Overall Study|Lost to Follow-up|2
5287981|NCT00504881|18236926|P1|Overall Study|Lost to Follow-up|0
5287982|NCT00504881|18236925|P2|Overall Study|Lack of Efficacy|5
5287983|NCT00504881|18236926|P1|Overall Study|Lack of Efficacy|1
5287984|NCT00504829|18236979|P3|Overall Study|Protocol Violation|10
5287985|NCT00504829|18236980|P2|Overall Study|Protocol Violation|4
5287986|NCT00504829|18236981|P1|Overall Study|Protocol Violation|6
5287987|NCT00504777|18236990|P1|Overall Study|Adverse Event|1
5287988|NCT00504725|18237003|P2|Overall Study|Protocol Violation|0
5287989|NCT00504725|18237004|P1|Overall Study|Protocol Violation|1
5287990|NCT00504595|18237027|P4|Overall Study|Other|0
5287991|NCT00504595|18237028|P3|Overall Study|Other|2
5287992|NCT00504595|18237029|P2|Overall Study|Other|0
5287993|NCT00504595|18237030|P1|Overall Study|Other|0
5287994|NCT00504595|18237027|P4|Overall Study|Lack of Efficacy|0
5287995|NCT00504595|18237028|P3|Overall Study|Lack of Efficacy|0
5287996|NCT00504595|18237029|P2|Overall Study|Lack of Efficacy|0
5287997|NCT00504595|18237030|P1|Overall Study|Lack of Efficacy|1
5287998|NCT00504556|18237047|P5|Overall Study|not in safety analysis set|1
5287999|NCT00504556|18237048|P4|Overall Study|not in safety analysis set|0
5288000|NCT00504556|18237049|P3|Overall Study|not in safety analysis set|1
5288001|NCT00504556|18237050|P2|Overall Study|not in safety analysis set|1
5288002|NCT00504556|18237051|P1|Overall Study|not in safety analysis set|0
5288003|NCT00504556|18237047|P5|Overall Study|Other|0
5288004|NCT00504556|18237048|P4|Overall Study|Other|3
5288005|NCT00504556|18237049|P3|Overall Study|Other|2
5288006|NCT00504556|18237050|P2|Overall Study|Other|2
5288007|NCT00504556|18237051|P1|Overall Study|Other|2
5288008|NCT00504556|18237047|P5|Overall Study|data monitor committee decision|0
5288009|NCT00504556|18237048|P4|Overall Study|data monitor committee decision|100
5288010|NCT00504556|18237049|P3|Overall Study|data monitor committee decision|0
5288011|NCT00504556|18237050|P2|Overall Study|data monitor committee decision|0
5288012|NCT00504556|18237051|P1|Overall Study|data monitor committee decision|0
5288013|NCT00504556|18237047|P5|Overall Study|did not meet entry criteria|0
5288014|NCT00504556|18237048|P4|Overall Study|did not meet entry criteria|1
5288015|NCT00504556|18237049|P3|Overall Study|did not meet entry criteria|1
5288016|NCT00504556|18237050|P2|Overall Study|did not meet entry criteria|0
5288017|NCT00504556|18237051|P1|Overall Study|did not meet entry criteria|2
5288018|NCT00504556|18237047|P5|Overall Study|administrative reasons|2
5288019|NCT00504556|18237048|P4|Overall Study|administrative reasons|1
5288020|NCT00504556|18237049|P3|Overall Study|administrative reasons|2
5288021|NCT00504556|18237050|P2|Overall Study|administrative reasons|2
5288022|NCT00504556|18237051|P1|Overall Study|administrative reasons|0
5288023|NCT00504556|18237047|P5|Overall Study|Withdrawal by Subject|12
5288024|NCT00504556|18237048|P4|Overall Study|Withdrawal by Subject|8
5288025|NCT00504556|18237049|P3|Overall Study|Withdrawal by Subject|7
5288026|NCT00504556|18237050|P2|Overall Study|Withdrawal by Subject|16
5288027|NCT00504556|18237051|P1|Overall Study|Withdrawal by Subject|16
5288028|NCT00504556|18237047|P5|Overall Study|Lost to Follow-up|1
5288029|NCT00504556|18237048|P4|Overall Study|Lost to Follow-up|1
5288030|NCT00504556|18237049|P3|Overall Study|Lost to Follow-up|1
5288031|NCT00504556|18237050|P2|Overall Study|Lost to Follow-up|0
5288032|NCT00504556|18237051|P1|Overall Study|Lost to Follow-up|0
5288033|NCT00504556|18237047|P5|Overall Study|Protocol Violation|2
5288034|NCT00504556|18237048|P4|Overall Study|Protocol Violation|1
5288035|NCT00504556|18237049|P3|Overall Study|Protocol Violation|2
5288036|NCT00504556|18237050|P2|Overall Study|Protocol Violation|3
5288037|NCT00504556|18237051|P1|Overall Study|Protocol Violation|1
5288038|NCT00504556|18237047|P5|Overall Study|Death|2
5288039|NCT00504556|18237048|P4|Overall Study|Death|0
5288040|NCT00504556|18237049|P3|Overall Study|Death|1
5288041|NCT00504556|18237050|P2|Overall Study|Death|3
5288042|NCT00504556|18237051|P1|Overall Study|Death|3
5288043|NCT00504556|18237047|P5|Overall Study|Adverse Event|5
5288044|NCT00504556|18237048|P4|Overall Study|Adverse Event|13
5288045|NCT00504556|18237049|P3|Overall Study|Adverse Event|14
5288046|NCT00504556|18237050|P2|Overall Study|Adverse Event|11
5288047|NCT00504556|18237051|P1|Overall Study|Adverse Event|11
5288048|NCT00504426|18237119|P4|Overall Study|Withdrawal by Subject|0
5288049|NCT00504426|18237120|P3|Overall Study|Withdrawal by Subject|0
5288050|NCT00504426|18237121|P2|Overall Study|Withdrawal by Subject|0
5288051|NCT00504426|18237122|P1|Overall Study|Withdrawal by Subject|2
5288052|NCT00504426|18237119|P4|Overall Study|Protocol Violation|0
5288053|NCT00504426|18237120|P3|Overall Study|Protocol Violation|2
5288054|NCT00504426|18237121|P2|Overall Study|Protocol Violation|1
5288055|NCT00504426|18237122|P1|Overall Study|Protocol Violation|1
5288056|NCT00504426|18237119|P4|Overall Study|Adverse Event|0
5288057|NCT00504426|18237120|P3|Overall Study|Adverse Event|2
5288058|NCT00504426|18237121|P2|Overall Study|Adverse Event|0
5288059|NCT00504426|18237122|P1|Overall Study|Adverse Event|0
5288060|NCT00504348|18237136|P1|Overall Study|Physician Decision|1
5288061|NCT00504348|18237136|P1|Overall Study|Lack of Efficacy|4
5288062|NCT00504348|18237136|P1|Overall Study|Adverse Event|3
5288063|NCT00504309|18237147|P6|Overall Study|Withdrawal by Subject|0
5288064|NCT00504309|18237148|P5|Overall Study|Withdrawal by Subject|0
5288065|NCT00504309|18237149|P4|Overall Study|Withdrawal by Subject|0
5288066|NCT00504309|18237150|P3|Overall Study|Withdrawal by Subject|1
5288067|NCT00504309|18237151|P2|Overall Study|Withdrawal by Subject|0
5288068|NCT00504309|18237152|P1|Overall Study|Withdrawal by Subject|0
5288069|NCT00504309|18237147|P6|Overall Study|Death|0
5288070|NCT00504309|18237148|P5|Overall Study|Death|1
5288071|NCT00504309|18237149|P4|Overall Study|Death|0
5288072|NCT00504309|18237150|P3|Overall Study|Death|0
5288073|NCT00504309|18237151|P2|Overall Study|Death|0
5288074|NCT00504309|18237152|P1|Overall Study|Death|0
5288075|NCT00504257|18237190|P1|Overall Study|ineligible histology|2
5288076|NCT00504257|18237190|P1|Overall Study|Withdrawal by Subject|2
5288077|NCT00504231|18237202|P4|Overall Study|Discrepant chart documentation re route|0
5288078|NCT00504231|18237203|P3|Overall Study|Discrepant chart documentation re route|1
5288079|NCT00504231|18237204|P2|Overall Study|Discrepant chart documentation re route|0
5288080|NCT00504231|18237205|P1|Overall Study|Discrepant chart documentation re route|0
5288081|NCT00504166|18237225|P2|Overall Study|Lost to Follow-up|3
5288082|NCT00504166|18237226|P1|Overall Study|Lost to Follow-up|1
5288083|NCT00504166|18237225|P2|Overall Study|Physician Decision|1
5288084|NCT00504166|18237226|P1|Overall Study|Physician Decision|1
5288085|NCT00504166|18237225|P2|Overall Study|Withdrawal by Subject|6
5288086|NCT00504166|18237226|P1|Overall Study|Withdrawal by Subject|3
5288087|NCT00504166|18237225|P2|Overall Study|Adverse Event|4
5288088|NCT00504166|18237226|P1|Overall Study|Adverse Event|1
5288089|NCT00504153|18237232|P1|Overall Study|Death|1
5288090|NCT00504153|18237232|P1|Overall Study|Adverse Event|4
5288091|NCT00504153|18237232|P1|Overall Study|Withdrawal by Subject|1
5288092|NCT00504075|18237240|P1|Overall Study|Required other therapeutic intervention|1
5288093|NCT00504075|18237240|P1|Overall Study|Withdrawal by Subject|1
5288094|NCT00504075|18237240|P1|Overall Study|Lost to Follow-up|5
5288095|NCT00504075|18237240|P1|Overall Study|Adverse Event|1
5288096|NCT00503997|18237250|P1|Overall Study|Withdrawal by Subject|1
5288097|NCT00503997|18237250|P1|Overall Study|Death|1
5288098|NCT00503997|18237250|P1|Overall Study|Adverse Event|5
5288099|NCT00503997|18237250|P1|Overall Study|disease progression|1
5288100|NCT00503984|18237256|P6|Overall Study|Death|0
5288101|NCT00503984|18237257|P5|Overall Study|Death|1
5288102|NCT00503984|18237258|P4|Overall Study|Death|0
5288103|NCT00503984|18237259|P3|Overall Study|Death|0
5288104|NCT00503984|18237260|P2|Overall Study|Death|0
5288105|NCT00503984|18237261|P1|Overall Study|Death|0
5288106|NCT00503984|18237256|P6|Overall Study|Adverse Event|0
5288107|NCT00503984|18237257|P5|Overall Study|Adverse Event|0
5288108|NCT00503984|18237258|P4|Overall Study|Adverse Event|0
5288109|NCT00503984|18237259|P3|Overall Study|Adverse Event|0
5288110|NCT00503984|18237260|P2|Overall Study|Adverse Event|1
5288111|NCT00503984|18237261|P1|Overall Study|Adverse Event|0
5288112|NCT00503984|18237256|P6|Overall Study|Protocol Violation|0
5288113|NCT00503984|18237257|P5|Overall Study|Protocol Violation|0
5288114|NCT00503984|18237258|P4|Overall Study|Protocol Violation|0
5288115|NCT00503984|18237259|P3|Overall Study|Protocol Violation|0
5288116|NCT00503984|18237260|P2|Overall Study|Protocol Violation|1
5288117|NCT00503984|18237261|P1|Overall Study|Protocol Violation|0
5288118|NCT00503906|18237287|P1|Overall Study|Withdrawal by Subject|1
5288119|NCT00503841|18237309|P1|Overall Study|All screen failures|44
5288120|NCT00503776|18237320|P4|Overall Study|Physician Decision|1
5288121|NCT00503776|18237321|P3|Overall Study|Physician Decision|1
5288122|NCT00503776|18237322|P2|Overall Study|Physician Decision|0
5288123|NCT00503776|18237323|P1|Overall Study|Physician Decision|0
5288124|NCT00503776|18237320|P4|Overall Study|Withdrawal by Subject|1
5288125|NCT00503776|18237321|P3|Overall Study|Withdrawal by Subject|1
5288126|NCT00503776|18237322|P2|Overall Study|Withdrawal by Subject|0
5288127|NCT00503776|18237323|P1|Overall Study|Withdrawal by Subject|1
5288128|NCT00503698|18237356|P2|Overall Study|Not exposed to trial drug|6
5288129|NCT00503698|18237357|P1|Overall Study|Not exposed to trial drug|11
5288130|NCT00503698|18237356|P2|Overall Study|Unclassified|32
5288131|NCT00503698|18237357|P1|Overall Study|Unclassified|48
5288132|NCT00503698|18237356|P2|Overall Study|Critically ill|0
5288133|NCT00503698|18237357|P1|Overall Study|Critically ill|2
5288134|NCT00503698|18237356|P2|Overall Study|Move to nonparticipating dialysis center|1
5288135|NCT00503698|18237357|P1|Overall Study|Move to nonparticipating dialysis center|2
5288136|NCT00503698|18237356|P2|Overall Study|Switch to peritoneal or home dialysis|2
5288137|NCT00503698|18237357|P1|Overall Study|Switch to peritoneal or home dialysis|2
5288138|NCT00503698|18237356|P2|Overall Study|Any condition in exclusion criteria|6
5288139|NCT00503698|18237357|P1|Overall Study|Any condition in exclusion criteria|4
5288140|NCT00503698|18237356|P2|Overall Study|Pregnancy/intention to become pregnant|0
5288141|NCT00503698|18237357|P1|Overall Study|Pregnancy/intention to become pregnant|1
5288142|NCT00503698|18237356|P2|Overall Study|End hemodialysis due to renal transplant|4
5288143|NCT00503698|18237357|P1|Overall Study|End hemodialysis due to renal transplant|10
5288144|NCT00503698|18237356|P2|Overall Study|Trial terminated|253
5288145|NCT00503698|18237357|P1|Overall Study|Trial terminated|216
5288146|NCT00503698|18237356|P2|Overall Study|Lack of Efficacy|4
5288147|NCT00503698|18237357|P1|Overall Study|Lack of Efficacy|3
5288148|NCT00503698|18237356|P2|Overall Study|Death|0
5288149|NCT00503698|18237357|P1|Overall Study|Death|1
5288150|NCT00503698|18237356|P2|Overall Study|Adverse Event|41
5288151|NCT00503698|18237357|P1|Overall Study|Adverse Event|52
5288152|NCT00503698|18237356|P2|Overall Study|Protocol Violation|6
5288153|NCT00503698|18237357|P1|Overall Study|Protocol Violation|5
5288154|NCT00503685|18237374|P3|Overall Study|Eligibility Criteria Not Met|0
5288155|NCT00503685|18237375|P2|Overall Study|Eligibility Criteria Not Met|1
5288156|NCT00503685|18237376|P1|Overall Study|Eligibility Criteria Not Met|0
5288157|NCT00503685|18237374|P3|Overall Study|Protocol Violation|0
5288158|NCT00503685|18237375|P2|Overall Study|Protocol Violation|1
5288159|NCT00503685|18237376|P1|Overall Study|Protocol Violation|0
5288160|NCT00503685|18237374|P3|Overall Study|Withdrawal by Subject|0
5288161|NCT00503685|18237375|P2|Overall Study|Withdrawal by Subject|1
5288162|NCT00503685|18237376|P1|Overall Study|Withdrawal by Subject|0
5288163|NCT00503685|18237374|P3|Overall Study|Adverse Event|2
5288164|NCT00503685|18237375|P2|Overall Study|Adverse Event|0
5288165|NCT00503685|18237376|P1|Overall Study|Adverse Event|0
5288166|NCT00503581|18237421|P3|Overall Study|Study closed|2
5288167|NCT00503581|18237422|P2|Overall Study|Study closed|4
5288168|NCT00503581|18237423|P1|Overall Study|Study closed|3
5288169|NCT00503425|18237434|P1|Overall Study|Missing Data/Unknown|4
5288170|NCT00503425|18237434|P1|Overall Study|Death|3
5288171|NCT00503425|18237434|P1|Overall Study|Lost to Follow-up|3
5288172|NCT00503425|18237434|P1|Overall Study|Withdrawal by Subject|8
5288173|NCT00503425|18237434|P1|Overall Study|Lack of Efficacy|25
5288174|NCT00503425|18237434|P1|Overall Study|Adverse Event|5
5288175|NCT00503425|18237434|P1|Overall Study|Participant files lost|6
5288176|NCT00503399|18237444|P2|Overall Study|Lost to Follow-up|2
5288177|NCT00503399|18237445|P1|Overall Study|Lost to Follow-up|0
5288178|NCT00503399|18237444|P2|Overall Study|Adverse Event|3
5288179|NCT00503399|18237445|P1|Overall Study|Adverse Event|0
5288180|NCT00503399|18237444|P2|Overall Study|Withdrawal by Subject|2
5288181|NCT00503399|18237445|P1|Overall Study|Withdrawal by Subject|4
5288182|NCT00503399|18237444|P2|Overall Study|Protocol Violation|0
5288183|NCT00503399|18237445|P1|Overall Study|Protocol Violation|1
5288184|NCT00503399|18237444|P2|Overall Study|Death|1
5288185|NCT00503399|18237445|P1|Overall Study|Death|2
5288186|NCT00503308|18237469|P2|Overall Study|Protocol Violation|1
5288187|NCT00503308|18237470|P1|Overall Study|Protocol Violation|2
5288188|NCT00503139|18237476|P1|Overall Study|Protocol Violation|4
5288189|NCT00503139|18237476|P1|Overall Study|Case Report Forms were not collected|4
5288190|NCT00503009|18237524|P3|Overall Study|Physician Decision|1
5288191|NCT00503009|18237525|P2|Overall Study|Physician Decision|1
5288192|NCT00503009|18237526|P1|Overall Study|Physician Decision|0
5288193|NCT00503009|18237524|P3|Overall Study|Withdrawal by Subject|1
5288194|NCT00503009|18237525|P2|Overall Study|Withdrawal by Subject|1
5288195|NCT00503009|18237526|P1|Overall Study|Withdrawal by Subject|0
5288196|NCT00503009|18237524|P3|Overall Study|Protocol Violation|1
5288197|NCT00503009|18237525|P2|Overall Study|Protocol Violation|0
5288198|NCT00503009|18237526|P1|Overall Study|Protocol Violation|1
5288199|NCT00502996|18237543|P1|Overall Study|Adverse Event|2
5288200|NCT00502996|18237543|P1|Overall Study|Withdrawal Informed Consent|6
5288201|NCT00502996|18237543|P1|Overall Study|Treatment failure|25
5288202|NCT00502996|18237543|P1|Overall Study|Protocol Violation|2
5288203|NCT00502996|18237543|P1|Overall Study|Lost to Follow-up|9
5288204|NCT00502840|18237611|P1|Overall Study|Other|20
5288205|NCT00502840|18237611|P1|Overall Study|Administrative problems|1
5288206|NCT00502840|18237611|P1|Overall Study|Lost to Follow-up|6
5288207|NCT00502840|18237611|P1|Overall Study|Withdrawal by Subject|5
5288208|NCT00502840|18237611|P1|Overall Study|Protocol Violation|4
5288209|NCT00502840|18237611|P1|Overall Study|Lack of Efficacy|11
5288210|NCT00502840|18237611|P1|Overall Study|Additional or changed therapy|48
5288211|NCT00502840|18237611|P1|Overall Study|Adverse Event|5
5288212|NCT00502801|18237639|P1|End of Therapy to Test of Cure|OTHER|2
5288213|NCT00502801|18237639|P1|End of Therapy to Test of Cure|Death|3
5288214|NCT00502801|18237639|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
5288215|NCT00502801|18237639|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
5288216|NCT00502801|18237639|P1|Treatment Period|OTHER|30
5288217|NCT00502801|18237639|P1|Treatment Period|Death|14
5288218|NCT00502801|18237639|P1|Treatment Period|Adverse Event|7
5288219|NCT00502801|18237639|P1|Treatment Period|Withdrawal by Subject|3
5288220|NCT00502775|18237647|P3|Overall Study|Subject took disallowed drug|1
5288221|NCT00502775|18237648|P2|Overall Study|Subject took disallowed drug|0
5288222|NCT00502775|18237649|P1|Overall Study|Subject took disallowed drug|0
5288223|NCT00502775|18237647|P3|Overall Study|Subject in jail|0
5288224|NCT00502775|18237648|P2|Overall Study|Subject in jail|1
5288225|NCT00502775|18237649|P1|Overall Study|Subject in jail|0
5288226|NCT00502775|18237647|P3|Overall Study|Declining pollen counts|1
5288227|NCT00502775|18237648|P2|Overall Study|Declining pollen counts|1
5288228|NCT00502775|18237649|P1|Overall Study|Declining pollen counts|0
5288229|NCT00502775|18237647|P3|Overall Study|Outside pollen area more than 48 hours|0
5288230|NCT00502775|18237648|P2|Overall Study|Outside pollen area more than 48 hours|1
5288231|NCT00502775|18237649|P1|Overall Study|Outside pollen area more than 48 hours|0
5288232|NCT00502775|18237647|P3|Overall Study|Non-compliance|2
5288233|NCT00502775|18237648|P2|Overall Study|Non-compliance|2
5288234|NCT00502775|18237649|P1|Overall Study|Non-compliance|0
5288235|NCT00502775|18237647|P3|Overall Study|Randomized in error|1
5288236|NCT00502775|18237648|P2|Overall Study|Randomized in error|1
5288237|NCT00502775|18237649|P1|Overall Study|Randomized in error|0
5288238|NCT00502775|18237647|P3|Overall Study|Logpad compliance <80%|0
5288239|NCT00502775|18237648|P2|Overall Study|Logpad compliance <80%|0
5288240|NCT00502775|18237649|P1|Overall Study|Logpad compliance <80%|1
5288241|NCT00502775|18237647|P3|Overall Study|Subject unable to swallow capsule|1
5288242|NCT00502775|18237648|P2|Overall Study|Subject unable to swallow capsule|0
5288243|NCT00502775|18237649|P1|Overall Study|Subject unable to swallow capsule|1
5288244|NCT00502775|18237647|P3|Overall Study|Non-compliance with eDiary|1
5288245|NCT00502775|18237648|P2|Overall Study|Non-compliance with eDiary|1
5288246|NCT00502775|18237649|P1|Overall Study|Non-compliance with eDiary|4
5288247|NCT00502775|18237647|P3|Overall Study|Sponsor Terminated Study|1
5288248|NCT00502775|18237648|P2|Overall Study|Sponsor Terminated Study|0
5288249|NCT00502775|18237649|P1|Overall Study|Sponsor Terminated Study|1
5288250|NCT00502775|18237647|P3|Overall Study|Withdrawal by Subject|2
5288251|NCT00502775|18237648|P2|Overall Study|Withdrawal by Subject|1
5288252|NCT00502775|18237649|P1|Overall Study|Withdrawal by Subject|1
5288253|NCT00502775|18237647|P3|Overall Study|Protocol Violation|2
5288254|NCT00502775|18237648|P2|Overall Study|Protocol Violation|5
5288255|NCT00502775|18237649|P1|Overall Study|Protocol Violation|1
5288256|NCT00502775|18237647|P3|Overall Study|Adverse Event|1
5288257|NCT00502775|18237648|P2|Overall Study|Adverse Event|2
5288258|NCT00502775|18237649|P1|Overall Study|Adverse Event|1
5288259|NCT00502697|18237692|P2|Overall Study|did not meet assignment criteria|2
5288260|NCT00502697|18237693|P1|Overall Study|did not meet assignment criteria|4
5288261|NCT00502697|18237692|P2|Overall Study|found not to meet eligibility criteria|4
5288262|NCT00502697|18237693|P1|Overall Study|found not to meet eligibility criteria|3
5288263|NCT00502697|18237692|P2|Overall Study|disenrolled due to pregnancy loss|5
5288264|NCT00502697|18237693|P1|Overall Study|disenrolled due to pregnancy loss|3
5288265|NCT00502697|18237692|P2|Overall Study|Withdrawal by Subject|1
5288266|NCT00502697|18237693|P1|Overall Study|Withdrawal by Subject|3
5288267|NCT00502671|18237701|P1|Overall Study|Adverse Event|19
5288268|NCT00502671|18237701|P1|Overall Study|Protocol Violation|16
5288269|NCT00502671|18237701|P1|Overall Study|Lost to Follow-up|7
5288270|NCT00502671|18237701|P1|Overall Study|Personal Reasons|22
5288271|NCT00502671|18237701|P1|Overall Study|Disease Progression|13
5288272|NCT00502593|18237718|P12|Overall Study|Lost to Follow-up|0
5288273|NCT00502593|18237719|P11|Overall Study|Lost to Follow-up|1
5288274|NCT00502593|18237720|P10|Overall Study|Lost to Follow-up|0
5288275|NCT00502593|18237721|P9|Overall Study|Lost to Follow-up|3
5288276|NCT00502593|18237722|P8|Overall Study|Lost to Follow-up|0
5288277|NCT00502593|18237723|P7|Overall Study|Lost to Follow-up|0
5288278|NCT00502593|18237724|P6|Overall Study|Lost to Follow-up|0
5288279|NCT00502593|18237725|P5|Overall Study|Lost to Follow-up|0
5288280|NCT00502593|18237726|P4|Overall Study|Lost to Follow-up|1
5288281|NCT00502593|18237727|P3|Overall Study|Lost to Follow-up|1
5288282|NCT00502593|18237728|P2|Overall Study|Lost to Follow-up|1
5288283|NCT00502593|18237729|P1|Overall Study|Lost to Follow-up|2
5288284|NCT00502593|18237718|P12|Overall Study|Withdrawal by Subject|0
5288285|NCT00502593|18237719|P11|Overall Study|Withdrawal by Subject|1
5288286|NCT00502593|18237720|P10|Overall Study|Withdrawal by Subject|0
5288287|NCT00502593|18237721|P9|Overall Study|Withdrawal by Subject|3
5288288|NCT00502593|18237722|P8|Overall Study|Withdrawal by Subject|0
5288289|NCT00502593|18237723|P7|Overall Study|Withdrawal by Subject|3
5288290|NCT00502593|18237724|P6|Overall Study|Withdrawal by Subject|0
5288291|NCT00502593|18237725|P5|Overall Study|Withdrawal by Subject|2
5288292|NCT00502593|18237726|P4|Overall Study|Withdrawal by Subject|2
5288293|NCT00502593|18237727|P3|Overall Study|Withdrawal by Subject|6
5288294|NCT00502593|18237728|P2|Overall Study|Withdrawal by Subject|0
5288295|NCT00502593|18237729|P1|Overall Study|Withdrawal by Subject|0
5288296|NCT00502593|18237718|P12|Overall Study|Withdrawn unspecified reason|0
5288297|NCT00502593|18237719|P11|Overall Study|Withdrawn unspecified reason|0
5288298|NCT00502593|18237720|P10|Overall Study|Withdrawn unspecified reason|0
5288299|NCT00502593|18237721|P9|Overall Study|Withdrawn unspecified reason|0
5288300|NCT00502593|18237722|P8|Overall Study|Withdrawn unspecified reason|0
5288301|NCT00502593|18237723|P7|Overall Study|Withdrawn unspecified reason|2
5288302|NCT00502593|18237724|P6|Overall Study|Withdrawn unspecified reason|0
5288303|NCT00502593|18237725|P5|Overall Study|Withdrawn unspecified reason|2
5288304|NCT00502593|18237726|P4|Overall Study|Withdrawn unspecified reason|1
5288305|NCT00502593|18237727|P3|Overall Study|Withdrawn unspecified reason|3
5288306|NCT00502593|18237728|P2|Overall Study|Withdrawn unspecified reason|1
5288307|NCT00502593|18237729|P1|Overall Study|Withdrawn unspecified reason|1
5288308|NCT00502320|18238245|P2|Overall Study|Adverse Event|5
5288309|NCT00502320|18238246|P1|Overall Study|Adverse Event|3
5288310|NCT00502320|18238245|P2|Overall Study|Screen Failure|1
5288311|NCT00502320|18238246|P1|Overall Study|Screen Failure|0
5288312|NCT00502320|18238245|P2|Overall Study|No longer met criteria|0
5288313|NCT00502320|18238246|P1|Overall Study|No longer met criteria|1
5288314|NCT00502320|18238245|P2|Overall Study|Withdrew Consent|0
5288315|NCT00502320|18238246|P1|Overall Study|Withdrew Consent|1
5288316|NCT00502320|18238245|P2|Overall Study|Lost to Follow-up|1
5288317|NCT00502320|18238246|P1|Overall Study|Lost to Follow-up|1
5288318|NCT00502307|18238256|P3|Maintenance Period|Discontinued due to other reasons|0
5288319|NCT00502307|18238257|P2|Maintenance Period|Discontinued due to other reasons|0
5288320|NCT00502307|18238258|P1|Maintenance Period|Discontinued due to other reasons|68
5288321|NCT00502307|18238256|P3|Maintenance Period|Progressive disease|0
5288322|NCT00502307|18238257|P2|Maintenance Period|Progressive disease|0
5288323|NCT00502307|18238258|P1|Maintenance Period|Progressive disease|80
5288324|NCT00502307|18238256|P3|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
5288325|NCT00502307|18238257|P2|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
5288326|NCT00502307|18238258|P1|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
5288327|NCT00502307|18238256|P3|Double-Blind Period (12 Weeks)|Progressive disease|2
5288328|NCT00502307|18238257|P2|Double-Blind Period (12 Weeks)|Progressive disease|23
5288329|NCT00502307|18238258|P1|Double-Blind Period (12 Weeks)|Progressive disease|0
5288330|NCT00502307|18238256|P3|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
5288331|NCT00502307|18238257|P2|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
5288332|NCT00502307|18238258|P1|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
5288333|NCT00502307|18238256|P3|Open Label Period (16 Weeks)|Progressive disease|0
5288334|NCT00502307|18238257|P2|Open Label Period (16 Weeks)|Progressive disease|0
5288335|NCT00502307|18238258|P1|Open Label Period (16 Weeks)|Progressive disease|50
5288336|NCT00502242|18238285|P2|Overall Study|Withdrawal by Subject|7
5288337|NCT00502242|18238286|P1|Overall Study|Withdrawal by Subject|6
5288338|NCT00502242|18238285|P2|Overall Study|Protocol Violation|1
5288339|NCT00502242|18238286|P1|Overall Study|Protocol Violation|3
5288340|NCT00502242|18238285|P2|Overall Study|Other - Unspecified|14
5288341|NCT00502242|18238286|P1|Overall Study|Other - Unspecified|8
5288342|NCT00502242|18238285|P2|Overall Study|Physician Decision|3
5288343|NCT00502242|18238286|P1|Overall Study|Physician Decision|2
5288344|NCT00502242|18238285|P2|Overall Study|Adverse Event|20
5288345|NCT00502242|18238286|P1|Overall Study|Adverse Event|31
5288346|NCT00502242|18238285|P2|Overall Study|Lack of Efficacy|11
5288347|NCT00502242|18238286|P1|Overall Study|Lack of Efficacy|1
5288348|NCT00502203|18238350|P1|Overall Study|Inevaluable|1
5288349|NCT00501969|18238359|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
5288350|NCT00501969|18238359|P1|Overall Study|Other: Admin Request from the Sponsor|3
5288351|NCT00501969|18238359|P1|Overall Study|Other: As Required by Local EC|2
5288352|NCT00501969|18238359|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
5288353|NCT00501969|18238359|P1|Overall Study|Other: Pat Pending Surgery for PD|1
5288354|NCT00501969|18238359|P1|Overall Study|Other: Patient is Going to Have DBS|1
5288355|NCT00501969|18238359|P1|Overall Study|Other: Patients + Investigator Agreement|1
5288356|NCT00501969|18238359|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
5288357|NCT00501969|18238359|P1|Overall Study|Other: Sponsor Stopped Study|12
5288358|NCT00501969|18238359|P1|Overall Study|Other: Sponsor Termination at Site|1
5288359|NCT00501969|18238359|P1|Overall Study|Other: Sponsors Request|10
5288360|NCT00501969|18238359|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
5288361|NCT00501969|18238359|P1|Overall Study|Lost to Follow-up|4
5288362|NCT00501969|18238359|P1|Overall Study|Subject withdrew consent|51
5288363|NCT00501969|18238359|P1|Overall Study|Unsatisfactory compliance of subject|7
5288364|NCT00501969|18238359|P1|Overall Study|Adverse Event|76
5288365|NCT00501969|18238359|P1|Overall Study|Lack of Efficacy|29
5288366|NCT00501969|18238359|P1|Overall Study|Major Protocol Violation|4
5288367|NCT00501852|18238391|P1|Overall Study|Withdrawal by Subject|2
5288368|NCT00501852|18238391|P1|Overall Study|Adverse Event|3
5288369|NCT00501644|18238411|P1|Overall Study|Withdrawal by Subject|1
5288370|NCT00501644|18238411|P1|Overall Study|Adverse Event|4
5288371|NCT00501540|18238440|P1|Overall Study|Death|5
5288372|NCT00501293|18238452|P2|Maintenance Period|Application site reaction|0
5288373|NCT00501293|18238453|P1|Maintenance Period|Application site reaction|1
5288374|NCT00501293|18238452|P2|Maintenance Period|Would not wear patch|0
5288375|NCT00501293|18238453|P1|Maintenance Period|Would not wear patch|1
5288376|NCT00501293|18238452|P2|Maintenance Period|Went into rehabilitation|0
5288377|NCT00501293|18238453|P1|Maintenance Period|Went into rehabilitation|1
5288378|NCT00501293|18238452|P2|Maintenance Period|Noncompliant with study medication|0
5288379|NCT00501293|18238453|P1|Maintenance Period|Noncompliant with study medication|5
5288380|NCT00501293|18238452|P2|Maintenance Period|Lack of Efficacy|1
5288381|NCT00501293|18238453|P1|Maintenance Period|Lack of Efficacy|4
5288382|NCT00501293|18238452|P2|Maintenance Period|Protocol Violation|1
5288383|NCT00501293|18238453|P1|Maintenance Period|Protocol Violation|2
5288384|NCT00501293|18238452|P2|Maintenance Period|Adverse Event|6
5288385|NCT00501293|18238453|P1|Maintenance Period|Adverse Event|6
5288386|NCT00501293|18238452|P2|Maintenance Period|Lost to Follow-up|7
5288387|NCT00501293|18238453|P1|Maintenance Period|Lost to Follow-up|12
5288388|NCT00501293|18238452|P2|Maintenance Period|Withdrawal by Subject|13
5288389|NCT00501293|18238453|P1|Maintenance Period|Withdrawal by Subject|14
5288390|NCT00501293|18238452|P2|Optimization Period|Enrolled in error|0
5288391|NCT00501293|18238453|P1|Optimization Period|Enrolled in error|1
5288392|NCT00501228|18238480|P1|Overall Study|Withdrawal by Subject|1
5288393|NCT00501085|18238484|P1|Overall Study|Other loss to follow-up|32
5288394|NCT00501085|18238484|P1|Overall Study|Study closed by sponsor|109
5288395|NCT00501085|18238484|P1|Overall Study|Non-Compliance|24
5288396|NCT00501085|18238484|P1|Overall Study|Adverse Event|4
5288397|NCT00501085|18238484|P1|Overall Study|Explantation Surgery|26
5288398|NCT00501085|18238484|P1|Overall Study|Revision Surgery|7
5288399|NCT00501085|18238484|P1|Overall Study|Subject Decision|1
5288400|NCT00501085|18238484|P1|Overall Study|Withdrawal by Subject|34
5288401|NCT00501085|18238484|P1|Overall Study|Lost to Follow-up|195
5288402|NCT00501059|18238494|P2|Overall Study|Not treated|17
5288403|NCT00501059|18238495|P1|Overall Study|Not treated|25
5288404|NCT00501059|18238494|P2|Overall Study|Lost to Follow-up|198
5288405|NCT00501059|18238495|P1|Overall Study|Lost to Follow-up|210
5288406|NCT00501059|18238494|P2|Overall Study|Adverse Event|122
5288407|NCT00501059|18238495|P1|Overall Study|Adverse Event|129
5288408|NCT00501059|18238494|P2|Overall Study|Reason not given|1
5288409|NCT00501059|18238495|P1|Overall Study|Reason not given|3
5288410|NCT00501059|18238494|P2|Overall Study|Non-compliant with study treatment|16
5288411|NCT00501059|18238495|P1|Overall Study|Non-compliant with study treatment|23
5288412|NCT00501059|18238494|P2|Overall Study|Consent withdrawn by subject|873
5288413|NCT00501059|18238495|P1|Overall Study|Consent withdrawn by subject|817
5288414|NCT00501059|18238494|P2|Overall Study|Insufficient therapeutic effect|5
5288415|NCT00501059|18238495|P1|Overall Study|Insufficient therapeutic effect|4
5288416|NCT00501059|18238494|P2|Overall Study|Clinical endpoint reached|123
5288417|NCT00501059|18238495|P1|Overall Study|Clinical endpoint reached|110
5288418|NCT00501059|18238494|P2|Overall Study|Missing end-of-study page|92
5288419|NCT00501059|18238495|P1|Overall Study|Missing end-of-study page|91
5288420|NCT00501059|18238494|P2|Overall Study|Other|239
5288421|NCT00501059|18238495|P1|Overall Study|Other|236
5288422|NCT00501059|18238494|P2|Overall Study|Death|137
5288423|NCT00501059|18238495|P1|Overall Study|Death|140
5288424|NCT00501059|18238494|P2|Overall Study|Protocol Violation|69
5288425|NCT00501059|18238495|P1|Overall Study|Protocol Violation|80
5288426|NCT00501046|18238519|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
5288427|NCT00501046|18238520|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
5288428|NCT00501046|18238519|P2|Overall Study|Withdrawal by Subject|83
5288429|NCT00501046|18238520|P1|Overall Study|Withdrawal by Subject|84
5288430|NCT00501046|18238519|P2|Overall Study|Protocol Violation|1
5288431|NCT00501046|18238520|P1|Overall Study|Protocol Violation|2
5288432|NCT00501046|18238519|P2|Overall Study|Pregnancy|3
5288433|NCT00501046|18238520|P1|Overall Study|Pregnancy|0
5288434|NCT00501046|18238519|P2|Overall Study|Physician Decision|2
5288435|NCT00501046|18238520|P1|Overall Study|Physician Decision|7
5288436|NCT00501046|18238519|P2|Overall Study|Lost to Follow-up|13
5288437|NCT00501046|18238520|P1|Overall Study|Lost to Follow-up|14
5288438|NCT00501046|18238519|P2|Overall Study|Death|30
5288439|NCT00501046|18238520|P1|Overall Study|Death|23
5288440|NCT00501046|18238519|P2|Overall Study|Adverse Event|25
5288441|NCT00501046|18238520|P1|Overall Study|Adverse Event|21
5288442|NCT00501007|18238526|P2|Overall Study|Inclusion criteria not met.|25
5288443|NCT00501007|18238527|P1|Overall Study|Inclusion criteria not met.|29
5288444|NCT00500903|18238536|P3|Overall Study|Reason Not Specified|2
5288445|NCT00500903|18238537|P2|Overall Study|Reason Not Specified|0
5288446|NCT00500903|18238538|P1|Overall Study|Reason Not Specified|10
5288447|NCT00500903|18238536|P3|Overall Study|Symptomatic Deterioration|0
5288448|NCT00500903|18238537|P2|Overall Study|Symptomatic Deterioration|0
5288449|NCT00500903|18238538|P1|Overall Study|Symptomatic Deterioration|2
5288450|NCT00500903|18238536|P3|Overall Study|Patient Declined Further Treatment|3
5288451|NCT00500903|18238537|P2|Overall Study|Patient Declined Further Treatment|0
5288452|NCT00500903|18238538|P1|Overall Study|Patient Declined Further Treatment|0
5288453|NCT00500903|18238536|P3|Overall Study|Progressive Disease|15
5288454|NCT00500903|18238537|P2|Overall Study|Progressive Disease|2
5288455|NCT00500903|18238538|P1|Overall Study|Progressive Disease|41
5288456|NCT00500903|18238536|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5288457|NCT00500903|18238537|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5288458|NCT00500903|18238538|P1|Overall Study|Unsatisfactory Therapeutic Response|2
5288459|NCT00500903|18238536|P3|Overall Study|Occurrence of Adverse Event(s)|0
5288460|NCT00500903|18238537|P2|Overall Study|Occurrence of Adverse Event(s)|0
5288461|NCT00500903|18238538|P1|Overall Study|Occurrence of Adverse Event(s)|10
5288462|NCT00500760|18238734|P2|Overall Study|Other|2
5288463|NCT00500760|18238735|P1|Overall Study|Other|1
5288464|NCT00500760|18238734|P2|Overall Study|Lost to Follow-up|0
5288465|NCT00500760|18238735|P1|Overall Study|Lost to Follow-up|3
5288466|NCT00500760|18238734|P2|Overall Study|Administrative decision|0
5288467|NCT00500760|18238735|P1|Overall Study|Administrative decision|2
5288468|NCT00500760|18238734|P2|Overall Study|Withdrawal by Subject|7
5288469|NCT00500760|18238735|P1|Overall Study|Withdrawal by Subject|5
5288470|NCT00500760|18238734|P2|Overall Study|Death|15
5288471|NCT00500760|18238735|P1|Overall Study|Death|32
5288472|NCT00500682|18238755|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
5288473|NCT00500682|18238756|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
5288474|NCT00500682|18238755|P2|Overall Study|Withdrawal by Subject|74
5288475|NCT00500682|18238756|P1|Overall Study|Withdrawal by Subject|80
5288476|NCT00500682|18238755|P2|Overall Study|Protocol Violation|3
5288477|NCT00500682|18238756|P1|Overall Study|Protocol Violation|1
5288478|NCT00500682|18238755|P2|Overall Study|Pregnancy|0
5288479|NCT00500682|18238756|P1|Overall Study|Pregnancy|2
5288480|NCT00500682|18238755|P2|Overall Study|Physician Decision|10
5288481|NCT00500682|18238756|P1|Overall Study|Physician Decision|6
5288482|NCT00500682|18238755|P2|Overall Study|Lost to Follow-up|11
5288483|NCT00500682|18238756|P1|Overall Study|Lost to Follow-up|11
5288484|NCT00500682|18238755|P2|Overall Study|Death|16
5288485|NCT00500682|18238756|P1|Overall Study|Death|25
5288486|NCT00500682|18238755|P2|Overall Study|Adverse Event|29
5288487|NCT00500682|18238756|P1|Overall Study|Adverse Event|37
5288488|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Missing|3
5288489|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
5288490|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Death|1
5288491|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Administrative problems|1
5288492|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
5288493|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
5288494|NCT00500539|18238790|P1|Follow-up Period (16 Weeks)|Adverse Event|1
5288495|NCT00500539|18238790|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
5288496|NCT00500539|18238790|P1|Treatment Period (24 Weeks)|Administrative problems|2
5288497|NCT00500539|18238790|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
5288498|NCT00500539|18238790|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
5288499|NCT00500539|18238790|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
5288500|NCT00500539|18238790|P1|Treatment Period (24 Weeks)|Adverse Event|4
5288501|NCT00500370|18238816|P2|Overall Study|Subject Decision|17
5288502|NCT00500370|18238817|P1|Overall Study|Subject Decision|10
5288503|NCT00500370|18238816|P2|Overall Study|Sponsor Decision|0
5288504|NCT00500370|18238817|P1|Overall Study|Sponsor Decision|2
5288505|NCT00500370|18238816|P2|Overall Study|Protocol Violation|4
5288506|NCT00500370|18238817|P1|Overall Study|Protocol Violation|2
5288507|NCT00500370|18238816|P2|Overall Study|Lost to Follow-up|10
5288508|NCT00500370|18238817|P1|Overall Study|Lost to Follow-up|10
5288509|NCT00500370|18238816|P2|Overall Study|Adverse Event|3
5288510|NCT00500370|18238817|P1|Overall Study|Adverse Event|9
5288511|NCT00500357|18238853|P1|Overall Study|Death|1
5288512|NCT00500331|18238879|P7|Overall Study|Protocol violated|0
5288513|NCT00500331|18238880|P6|Overall Study|Protocol violated|0
5288514|NCT00500331|18238881|P5|Overall Study|Protocol violated|0
5288515|NCT00500331|18238882|P4|Overall Study|Protocol violated|1
5288516|NCT00500331|18238883|P3|Overall Study|Protocol violated|0
5288517|NCT00500331|18238884|P2|Overall Study|Protocol violated|0
5288518|NCT00500331|18238885|P1|Overall Study|Protocol violated|0
5288519|NCT00500331|18238879|P7|Overall Study|State ban of biological samples export|0
5288520|NCT00500331|18238880|P6|Overall Study|State ban of biological samples export|0
5288521|NCT00500331|18238881|P5|Overall Study|State ban of biological samples export|0
5288522|NCT00500331|18238882|P4|Overall Study|State ban of biological samples export|1
5288523|NCT00500331|18238883|P3|Overall Study|State ban of biological samples export|0
5288524|NCT00500331|18238884|P2|Overall Study|State ban of biological samples export|0
5288525|NCT00500331|18238885|P1|Overall Study|State ban of biological samples export|0
5288526|NCT00500331|18238879|P7|Overall Study|Diabetologist nurse in the study|0
5288527|NCT00500331|18238880|P6|Overall Study|Diabetologist nurse in the study|0
5288528|NCT00500331|18238881|P5|Overall Study|Diabetologist nurse in the study|0
5288529|NCT00500331|18238882|P4|Overall Study|Diabetologist nurse in the study|0
5288530|NCT00500331|18238883|P3|Overall Study|Diabetologist nurse in the study|1
5288531|NCT00500331|18238884|P2|Overall Study|Diabetologist nurse in the study|0
5288532|NCT00500331|18238885|P1|Overall Study|Diabetologist nurse in the study|0
5288533|NCT00500331|18238879|P7|Overall Study|Participant was randomized by mistake|0
5288534|NCT00500331|18238880|P6|Overall Study|Participant was randomized by mistake|0
5288535|NCT00500331|18238881|P5|Overall Study|Participant was randomized by mistake|0
5288536|NCT00500331|18238882|P4|Overall Study|Participant was randomized by mistake|0
5288537|NCT00500331|18238883|P3|Overall Study|Participant was randomized by mistake|0
5288538|NCT00500331|18238884|P2|Overall Study|Participant was randomized by mistake|0
5288539|NCT00500331|18238885|P1|Overall Study|Participant was randomized by mistake|1
5288540|NCT00500331|18238879|P7|Overall Study|Sponsor decided to withdraw participant|0
5288541|NCT00500331|18238880|P6|Overall Study|Sponsor decided to withdraw participant|0
5288542|NCT00500331|18238881|P5|Overall Study|Sponsor decided to withdraw participant|0
5288543|NCT00500331|18238882|P4|Overall Study|Sponsor decided to withdraw participant|0
5288544|NCT00500331|18238883|P3|Overall Study|Sponsor decided to withdraw participant|0
5288545|NCT00500331|18238884|P2|Overall Study|Sponsor decided to withdraw participant|0
5288546|NCT00500331|18238885|P1|Overall Study|Sponsor decided to withdraw participant|1
5288547|NCT00500331|18238879|P7|Overall Study|Exclusion citeria not met on Visit 4|0
5288548|NCT00500331|18238880|P6|Overall Study|Exclusion citeria not met on Visit 4|0
5288549|NCT00500331|18238881|P5|Overall Study|Exclusion citeria not met on Visit 4|0
5288550|NCT00500331|18238882|P4|Overall Study|Exclusion citeria not met on Visit 4|0
5288551|NCT00500331|18238883|P3|Overall Study|Exclusion citeria not met on Visit 4|0
5288552|NCT00500331|18238884|P2|Overall Study|Exclusion citeria not met on Visit 4|0
5288553|NCT00500331|18238885|P1|Overall Study|Exclusion citeria not met on Visit 4|1
5288554|NCT00500331|18238879|P7|Overall Study|Didn't return for continuation of study|0
5288555|NCT00500331|18238880|P6|Overall Study|Didn't return for continuation of study|0
5288556|NCT00500331|18238881|P5|Overall Study|Didn't return for continuation of study|0
5288557|NCT00500331|18238882|P4|Overall Study|Didn't return for continuation of study|0
5288558|NCT00500331|18238883|P3|Overall Study|Didn't return for continuation of study|0
5288559|NCT00500331|18238884|P2|Overall Study|Didn't return for continuation of study|0
5288560|NCT00500331|18238885|P1|Overall Study|Didn't return for continuation of study|1
5288561|NCT00500331|18238879|P7|Overall Study|Increased serum creatinine from Baseline|0
5288562|NCT00500331|18238880|P6|Overall Study|Increased serum creatinine from Baseline|1
5288563|NCT00500331|18238881|P5|Overall Study|Increased serum creatinine from Baseline|0
5288564|NCT00500331|18238882|P4|Overall Study|Increased serum creatinine from Baseline|0
5288565|NCT00500331|18238883|P3|Overall Study|Increased serum creatinine from Baseline|0
5288566|NCT00500331|18238884|P2|Overall Study|Increased serum creatinine from Baseline|0
5288567|NCT00500331|18238885|P1|Overall Study|Increased serum creatinine from Baseline|0
5288568|NCT00500331|18238879|P7|Overall Study|Liver function test abnormality|0
5288569|NCT00500331|18238880|P6|Overall Study|Liver function test abnormality|0
5288570|NCT00500331|18238881|P5|Overall Study|Liver function test abnormality|0
5288571|NCT00500331|18238882|P4|Overall Study|Liver function test abnormality|0
5288572|NCT00500331|18238883|P3|Overall Study|Liver function test abnormality|1
5288573|NCT00500331|18238884|P2|Overall Study|Liver function test abnormality|0
5288574|NCT00500331|18238885|P1|Overall Study|Liver function test abnormality|0
5288575|NCT00500331|18238879|P7|Overall Study|Lack of Efficacy|0
5288576|NCT00500331|18238880|P6|Overall Study|Lack of Efficacy|0
5288577|NCT00500331|18238881|P5|Overall Study|Lack of Efficacy|0
5288578|NCT00500331|18238882|P4|Overall Study|Lack of Efficacy|0
5288579|NCT00500331|18238883|P3|Overall Study|Lack of Efficacy|0
5288580|NCT00500331|18238884|P2|Overall Study|Lack of Efficacy|1
5288581|NCT00500331|18238885|P1|Overall Study|Lack of Efficacy|3
5288582|NCT00500331|18238879|P7|Overall Study|Withdrawal by Subject|1
5288583|NCT00500331|18238880|P6|Overall Study|Withdrawal by Subject|1
5288584|NCT00500331|18238881|P5|Overall Study|Withdrawal by Subject|0
5288585|NCT00500331|18238882|P4|Overall Study|Withdrawal by Subject|5
5288586|NCT00500331|18238883|P3|Overall Study|Withdrawal by Subject|1
5288587|NCT00500331|18238884|P2|Overall Study|Withdrawal by Subject|0
5288588|NCT00500331|18238885|P1|Overall Study|Withdrawal by Subject|4
5288589|NCT00500331|18238879|P7|Overall Study|Protocol Violation|1
5288590|NCT00500331|18238880|P6|Overall Study|Protocol Violation|1
5288591|NCT00500331|18238881|P5|Overall Study|Protocol Violation|1
5288592|NCT00500331|18238882|P4|Overall Study|Protocol Violation|0
5288593|NCT00500331|18238883|P3|Overall Study|Protocol Violation|1
5288594|NCT00500331|18238884|P2|Overall Study|Protocol Violation|1
5288595|NCT00500331|18238885|P1|Overall Study|Protocol Violation|3
5288596|NCT00500331|18238879|P7|Overall Study|Lost to Follow-up|0
5288597|NCT00500331|18238880|P6|Overall Study|Lost to Follow-up|0
5288598|NCT00500331|18238881|P5|Overall Study|Lost to Follow-up|1
5288599|NCT00500331|18238882|P4|Overall Study|Lost to Follow-up|2
5288600|NCT00500331|18238883|P3|Overall Study|Lost to Follow-up|1
5288601|NCT00500331|18238884|P2|Overall Study|Lost to Follow-up|1
5288602|NCT00500331|18238885|P1|Overall Study|Lost to Follow-up|1
5288603|NCT00500331|18238879|P7|Overall Study|Adverse Event|0
5288604|NCT00500331|18238880|P6|Overall Study|Adverse Event|2
5288605|NCT00500331|18238881|P5|Overall Study|Adverse Event|2
5288606|NCT00500331|18238882|P4|Overall Study|Adverse Event|1
5288607|NCT00500331|18238883|P3|Overall Study|Adverse Event|0
5288608|NCT00500331|18238884|P2|Overall Study|Adverse Event|2
5288609|NCT00500331|18238885|P1|Overall Study|Adverse Event|0
5288610|NCT00500318|18239022|P2|Overall Study|Other Reason|1
5288611|NCT00500318|18239023|P1|Overall Study|Other Reason|0
5288612|NCT00500318|18239022|P2|Overall Study|Lack of Efficacy|3
5288613|NCT00500318|18239023|P1|Overall Study|Lack of Efficacy|0
5288614|NCT00500318|18239022|P2|Overall Study|Withdrawal by Subject|2
5288615|NCT00500318|18239023|P1|Overall Study|Withdrawal by Subject|1
5288616|NCT00500318|18239022|P2|Overall Study|Protocol Violation|3
5288617|NCT00500318|18239023|P1|Overall Study|Protocol Violation|1
5288618|NCT00500318|18239022|P2|Overall Study|Adverse Event|8
5288619|NCT00500318|18239023|P1|Overall Study|Adverse Event|3
5288620|NCT00500292|18239040|P3|Overall Study|Other|4
5288621|NCT00500292|18239041|P2|Overall Study|Other|1
5288622|NCT00500292|18239042|P1|Overall Study|Other|1
5288623|NCT00500292|18239040|P3|Overall Study|Withdrawal by Subject|0
5288624|NCT00500292|18239041|P2|Overall Study|Withdrawal by Subject|1
5288625|NCT00500292|18239042|P1|Overall Study|Withdrawal by Subject|0
5288626|NCT00500292|18239040|P3|Overall Study|Condition under investigation worsened|19
5288627|NCT00500292|18239041|P2|Overall Study|Condition under investigation worsened|23
5288628|NCT00500292|18239042|P1|Overall Study|Condition under investigation worsened|21
5288629|NCT00500292|18239040|P3|Overall Study|Adverse Event|4
5288630|NCT00500292|18239041|P2|Overall Study|Adverse Event|6
5288631|NCT00500292|18239042|P1|Overall Study|Adverse Event|3
5288632|NCT00500149|18239063|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
5288633|NCT00500149|18239064|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
5288634|NCT00500149|18239063|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
5288635|NCT00500149|18239064|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
5288636|NCT00500149|18239063|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
5288637|NCT00500149|18239064|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
5288638|NCT00500149|18239063|P2|First Intervention (Cross-over Phase)|Adverse Event|1
5288639|NCT00500149|18239064|P1|First Intervention (Cross-over Phase)|Adverse Event|0
5288640|NCT00500149|18239063|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
5288641|NCT00500149|18239064|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
5288642|NCT00500149|18239063|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
5288643|NCT00500149|18239064|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
5288644|NCT00500149|18239063|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
5288645|NCT00500149|18239064|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
5288646|NCT00500110|18239072|P1|Overall Study|Withdrawal by Subject|3
5288647|NCT00500071|18239076|P1|30-day Safety Follow-up|Lost to Follow-up|17
5288648|NCT00500071|18239076|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
5288649|NCT00500071|18239076|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
5288650|NCT00500071|18239076|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
5288651|NCT00500071|18239076|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
5288652|NCT00500071|18239076|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
5288653|NCT00500071|18239076|P1|Screening and Washout Phase|Protocol Violation|1
5288654|NCT00499889|18239099|P1|Overall Study|Infection prior to treatment|1
5288655|NCT00499863|18239107|P2|Overall Study|Lost to Follow-up|1
5288656|NCT00499863|18239108|P1|Overall Study|Lost to Follow-up|1
5288657|NCT00499863|18239107|P2|Overall Study|Sponsor decision|2
5288658|NCT00499863|18239108|P1|Overall Study|Sponsor decision|2
5288659|NCT00499863|18239107|P2|Overall Study|Adverse Event|2
5288660|NCT00499863|18239108|P1|Overall Study|Adverse Event|8
5288661|NCT00499863|18239107|P2|Overall Study|Withdrawal by Subject|4
5288662|NCT00499863|18239108|P1|Overall Study|Withdrawal by Subject|6
5288663|NCT00499863|18239107|P2|Overall Study|Protocol Violation|7
5288664|NCT00499863|18239108|P1|Overall Study|Protocol Violation|12
5288665|NCT00499863|18239107|P2|Overall Study|Lack of Efficacy|27
5288666|NCT00499863|18239108|P1|Overall Study|Lack of Efficacy|21
5288667|NCT00500266|18239136|P1|Overall Study|Assigned, not treated|4
5288668|NCT00500266|18239136|P1|Overall Study|Withdrawal by Subject|3
5288669|NCT00500266|18239136|P1|Overall Study|Lost to Follow-up|3
5288670|NCT00500266|18239136|P1|Overall Study|Death|3
5288671|NCT00499746|18239143|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
5288672|NCT00499746|18239143|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
5288673|NCT00499746|18239143|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
5288674|NCT00499746|18239143|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
5288675|NCT00499694|18239212|P1|Overall Study|Patient never received treatment.|1
5288676|NCT00499681|18239221|P2|Overall Study|disease progression|1
5288677|NCT00499681|18239222|P1|Overall Study|disease progression|0
5288678|NCT00499681|18239221|P2|Overall Study|toxicity|1
5288679|NCT00499681|18239222|P1|Overall Study|toxicity|0
5288680|NCT00499616|18239249|P4|Overall Study|Patient/Parent Refusal|0
5288681|NCT00499616|18239250|P3|Overall Study|Patient/Parent Refusal|3
5288682|NCT00499616|18239251|P2|Overall Study|Patient/Parent Refusal|5
5288683|NCT00499616|18239252|P1|Overall Study|Patient/Parent Refusal|1
5288684|NCT00499616|18239249|P4|Overall Study|Not evaluable|41
5288685|NCT00499616|18239250|P3|Overall Study|Not evaluable|0
5288686|NCT00499616|18239251|P2|Overall Study|Not evaluable|0
5288687|NCT00499616|18239252|P1|Overall Study|Not evaluable|0
5288688|NCT00499616|18239249|P4|Overall Study|Ineligible|15
5288689|NCT00499616|18239250|P3|Overall Study|Ineligible|0
5288690|NCT00499616|18239251|P2|Overall Study|Ineligible|2
5288691|NCT00499616|18239252|P1|Overall Study|Ineligible|1
5288692|NCT00499616|18239249|P4|Overall Study|Withdrawal by Subject|0
5288693|NCT00499616|18239250|P3|Overall Study|Withdrawal by Subject|1
5288694|NCT00499616|18239251|P2|Overall Study|Withdrawal by Subject|0
5288695|NCT00499616|18239252|P1|Overall Study|Withdrawal by Subject|1
5288696|NCT00499616|18239249|P4|Overall Study|Physician Decision|0
5288697|NCT00499616|18239250|P3|Overall Study|Physician Decision|9
5288698|NCT00499616|18239251|P2|Overall Study|Physician Decision|16
5288699|NCT00499616|18239252|P1|Overall Study|Physician Decision|6
5288700|NCT00499616|18239249|P4|Overall Study|Lost to Follow-up|0
5288701|NCT00499616|18239250|P3|Overall Study|Lost to Follow-up|1
5288702|NCT00499616|18239251|P2|Overall Study|Lost to Follow-up|0
5288703|NCT00499616|18239252|P1|Overall Study|Lost to Follow-up|0
5288704|NCT00499616|18239249|P4|Overall Study|Lack of Efficacy|0
5288705|NCT00499616|18239250|P3|Overall Study|Lack of Efficacy|19
5288706|NCT00499616|18239251|P2|Overall Study|Lack of Efficacy|0
5288707|NCT00499616|18239252|P1|Overall Study|Lack of Efficacy|5
5288708|NCT00499616|18239249|P4|Overall Study|Death|1
5288709|NCT00499616|18239250|P3|Overall Study|Death|3
5288710|NCT00499616|18239251|P2|Overall Study|Death|5
5288711|NCT00499616|18239252|P1|Overall Study|Death|1
5288712|NCT00499603|18239297|P2|Overall Study|Adverse Event|1
5288713|NCT00499603|18239298|P1|Overall Study|Adverse Event|0
5288714|NCT00499590|18239311|P3|Overall Study|Not treated|1
5288715|NCT00499590|18239312|P2|Overall Study|Not treated|0
5288716|NCT00499590|18239313|P1|Overall Study|Not treated|1
5288717|NCT00499590|18239311|P3|Overall Study|Study Terminated|112
5288718|NCT00499590|18239312|P2|Overall Study|Study Terminated|112
5288719|NCT00499590|18239313|P1|Overall Study|Study Terminated|112
5288720|NCT00499486|18239324|P1|Overall Study|Withdrawal by Subject|16
5288721|NCT00499460|18239351|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
5288722|NCT00499460|18239352|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
5288723|NCT00499460|18239351|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
5288724|NCT00499460|18239352|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
5288725|NCT00499460|18239351|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
5288726|NCT00499460|18239352|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
5288727|NCT00499369|18239385|P5|Overall Study|Ineligible|0
5288728|NCT00499369|18239386|P4|Overall Study|Ineligible|1
5288729|NCT00499369|18239387|P3|Overall Study|Ineligible|1
5288730|NCT00499369|18239388|P2|Overall Study|Ineligible|2
5288731|NCT00499369|18239389|P1|Overall Study|Ineligible|2
5288732|NCT00499369|18239385|P5|Overall Study|Not protocol specified|0
5288733|NCT00499369|18239386|P4|Overall Study|Not protocol specified|1
5288734|NCT00499369|18239387|P3|Overall Study|Not protocol specified|3
5288735|NCT00499369|18239388|P2|Overall Study|Not protocol specified|0
5288736|NCT00499369|18239389|P1|Overall Study|Not protocol specified|2
5288737|NCT00499369|18239385|P5|Overall Study|Death|0
5288738|NCT00499369|18239386|P4|Overall Study|Death|0
5288739|NCT00499369|18239387|P3|Overall Study|Death|0
5288740|NCT00499369|18239388|P2|Overall Study|Death|1
5288741|NCT00499369|18239389|P1|Overall Study|Death|0
5288742|NCT00499369|18239385|P5|Overall Study|Progression|10
5288743|NCT00499369|18239386|P4|Overall Study|Progression|6
5288744|NCT00499369|18239387|P3|Overall Study|Progression|9
5288745|NCT00499369|18239388|P2|Overall Study|Progression|12
5288746|NCT00499369|18239389|P1|Overall Study|Progression|10
5288747|NCT00499369|18239385|P5|Overall Study|Withdrawal by Subject|0
5288748|NCT00499369|18239386|P4|Overall Study|Withdrawal by Subject|0
5288749|NCT00499369|18239387|P3|Overall Study|Withdrawal by Subject|1
5288750|NCT00499369|18239388|P2|Overall Study|Withdrawal by Subject|1
5288751|NCT00499369|18239389|P1|Overall Study|Withdrawal by Subject|0
5288752|NCT00499369|18239385|P5|Overall Study|Adverse Event|2
5288753|NCT00499369|18239386|P4|Overall Study|Adverse Event|1
5288754|NCT00499369|18239387|P3|Overall Study|Adverse Event|3
5288755|NCT00499369|18239388|P2|Overall Study|Adverse Event|2
5288756|NCT00499369|18239389|P1|Overall Study|Adverse Event|2
5288757|NCT00499252|18239425|P1|Overall Study|<no further label>|3
5288758|NCT00499252|18239425|P1|Overall Study|Ineligible|4
5288759|NCT00499252|18239425|P1|Overall Study|Refused further treatment|2
5288760|NCT00499252|18239425|P1|Overall Study|Adverse Event|3
5288761|NCT00499122|18239435|P1|Overall Study|Withdrawal by Subject|2
5288762|NCT00499083|18239478|P1|Overall Study|Not evaluable|3
5288763|NCT00499031|18239485|P1|Overall Study|Never treated|1
5288764|NCT00499031|18239485|P1|Overall Study|Required test not done|1
5288765|NCT00499031|18239485|P1|Overall Study|Improper pre-protocol treatment|1
5288766|NCT00498797|18239508|P2|Overall Study|Other|1
5288767|NCT00498797|18239509|P1|Overall Study|Other|3
5288768|NCT00498797|18239508|P2|Overall Study|Condition under investigation worsened|21
5288769|NCT00498797|18239509|P1|Overall Study|Condition under investigation worsened|19
5288770|NCT00498797|18239508|P2|Overall Study|Adverse Event|5
5288771|NCT00498797|18239509|P1|Overall Study|Adverse Event|12
5288772|NCT00498797|18239508|P2|Overall Study|Withdrawal by Subject|2
5288773|NCT00498797|18239509|P1|Overall Study|Withdrawal by Subject|4
5288774|NCT00498602|18239593|P7|Overall Study|Other|0
5288775|NCT00498602|18239594|P6|Overall Study|Other|3
5288776|NCT00498602|18239595|P5|Overall Study|Other|0
5288777|NCT00498602|18239596|P4|Overall Study|Other|0
5288778|NCT00498602|18239597|P3|Overall Study|Other|1
5288779|NCT00498602|18239598|P2|Overall Study|Other|3
5288780|NCT00498602|18239599|P1|Overall Study|Other|2
5288781|NCT00498602|18239593|P7|Overall Study|Subject Request|1
5288782|NCT00498602|18239594|P6|Overall Study|Subject Request|4
5288783|NCT00498602|18239595|P5|Overall Study|Subject Request|1
5288784|NCT00498602|18239596|P4|Overall Study|Subject Request|1
5288785|NCT00498602|18239597|P3|Overall Study|Subject Request|1
5288786|NCT00498602|18239598|P2|Overall Study|Subject Request|0
5288787|NCT00498602|18239599|P1|Overall Study|Subject Request|3
5288788|NCT00498602|18239593|P7|Overall Study|Investigator Request|0
5288789|NCT00498602|18239594|P6|Overall Study|Investigator Request|0
5288790|NCT00498602|18239595|P5|Overall Study|Investigator Request|0
5288791|NCT00498602|18239596|P4|Overall Study|Investigator Request|0
5288792|NCT00498602|18239597|P3|Overall Study|Investigator Request|1
5288793|NCT00498602|18239598|P2|Overall Study|Investigator Request|0
5288794|NCT00498602|18239599|P1|Overall Study|Investigator Request|0
5288795|NCT00498602|18239593|P7|Overall Study|Caregiver Request|0
5288796|NCT00498602|18239594|P6|Overall Study|Caregiver Request|2
5288797|NCT00498602|18239595|P5|Overall Study|Caregiver Request|1
5288798|NCT00498602|18239596|P4|Overall Study|Caregiver Request|0
5288799|NCT00498602|18239597|P3|Overall Study|Caregiver Request|2
5288800|NCT00498602|18239598|P2|Overall Study|Caregiver Request|2
5288801|NCT00498602|18239599|P1|Overall Study|Caregiver Request|2
5288802|NCT00498602|18239593|P7|Overall Study|AE not related to Study Drug|1
5288803|NCT00498602|18239594|P6|Overall Study|AE not related to Study Drug|2
5288804|NCT00498602|18239595|P5|Overall Study|AE not related to Study Drug|2
5288805|NCT00498602|18239596|P4|Overall Study|AE not related to Study Drug|0
5288806|NCT00498602|18239597|P3|Overall Study|AE not related to Study Drug|0
5288807|NCT00498602|18239598|P2|Overall Study|AE not related to Study Drug|3
5288808|NCT00498602|18239599|P1|Overall Study|AE not related to Study Drug|1
5288809|NCT00498602|18239593|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
5288810|NCT00498602|18239594|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
5288811|NCT00498602|18239595|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
5288812|NCT00498602|18239596|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
5288813|NCT00498602|18239597|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
5288814|NCT00498602|18239598|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
5288815|NCT00498602|18239599|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
5288816|NCT00498602|18239593|P7|Overall Study|Lost to Follow-up|0
5288817|NCT00498602|18239594|P6|Overall Study|Lost to Follow-up|0
5288818|NCT00498602|18239595|P5|Overall Study|Lost to Follow-up|0
5288819|NCT00498602|18239596|P4|Overall Study|Lost to Follow-up|2
5288820|NCT00498602|18239597|P3|Overall Study|Lost to Follow-up|0
5288821|NCT00498602|18239598|P2|Overall Study|Lost to Follow-up|2
5288822|NCT00498602|18239599|P1|Overall Study|Lost to Follow-up|0
5288823|NCT00498602|18239593|P7|Overall Study|Lack of Efficacy|0
5288824|NCT00498602|18239594|P6|Overall Study|Lack of Efficacy|0
5288825|NCT00498602|18239595|P5|Overall Study|Lack of Efficacy|0
5288826|NCT00498602|18239596|P4|Overall Study|Lack of Efficacy|0
5288827|NCT00498602|18239597|P3|Overall Study|Lack of Efficacy|0
5288828|NCT00498602|18239598|P2|Overall Study|Lack of Efficacy|0
5288829|NCT00498602|18239599|P1|Overall Study|Lack of Efficacy|1
5288830|NCT00498602|18239593|P7|Overall Study|Death|0
5288831|NCT00498602|18239594|P6|Overall Study|Death|1
5288832|NCT00498602|18239595|P5|Overall Study|Death|0
5288833|NCT00498602|18239596|P4|Overall Study|Death|0
5288834|NCT00498602|18239597|P3|Overall Study|Death|0
5288835|NCT00498602|18239598|P2|Overall Study|Death|0
5288836|NCT00498602|18239599|P1|Overall Study|Death|0
5288837|NCT00498485|18239647|P2|Overall Study|Adverse Event|5
5288838|NCT00498485|18239648|P1|Overall Study|Adverse Event|1
5288839|NCT00498433|18239659|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
5288840|NCT00498433|18239660|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
5288841|NCT00498433|18239661|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
5288842|NCT00498433|18239659|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
5288843|NCT00498433|18239660|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
5288844|NCT00498433|18239661|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
5288845|NCT00498433|18239659|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
5288846|NCT00498433|18239660|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
5288847|NCT00498433|18239661|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
5288848|NCT00498433|18239659|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
5288849|NCT00498433|18239660|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
5288850|NCT00498433|18239661|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
5288851|NCT00498368|18239706|P2|Overall Study|Withdrawal by Subject|2
5288852|NCT00498368|18239707|P1|Overall Study|Withdrawal by Subject|3
5288853|NCT00498355|18239719|P1|Overall Study|Lost to Follow-up|1
5288854|NCT00498186|18239727|P1|Overall Study|Other|10
5288855|NCT00498186|18239727|P1|Overall Study|Lost to Follow-up|3
5288856|NCT00498186|18239727|P1|Overall Study|Withdrawal by Subject|18
5288857|NCT00498186|18239727|P1|Overall Study|Unsatisfactory compliance of subject|12
5288858|NCT00498186|18239727|P1|Overall Study|Adverse Event|89
5288859|NCT00498186|18239727|P1|Overall Study|Lack of Efficacy|31
5288860|NCT00498186|18239727|P1|Overall Study|Protocol Violation|10
5288861|NCT00498173|18239734|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
5288862|NCT00498173|18239735|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
5288863|NCT00498173|18239736|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
5288864|NCT00497874|18239766|P2|Overall Study|Unable to schedule|24
5288865|NCT00497874|18239767|P1|Overall Study|Unable to schedule|37
5288866|NCT00497874|18239766|P2|Overall Study|Unable to contact|67
5288867|NCT00497874|18239767|P1|Overall Study|Unable to contact|52
5288868|NCT00497874|18239766|P2|Overall Study|Death|4
5288869|NCT00497874|18239767|P1|Overall Study|Death|2
5288870|NCT00497874|18239766|P2|Overall Study|Illness|4
5288871|NCT00497874|18239767|P1|Overall Study|Illness|8
5288872|NCT00497874|18239766|P2|Overall Study|Withdrawal by Subject|17
5288873|NCT00497874|18239767|P1|Overall Study|Withdrawal by Subject|48
5288874|NCT00497796|18239785|P2|Overall Study|Not applicable (randomized not treated)|4
5288875|NCT00497796|18239786|P1|Overall Study|Not applicable (randomized not treated)|0
5288876|NCT00497796|18239785|P2|Overall Study|Lost to Follow-up|1
5288877|NCT00497796|18239786|P1|Overall Study|Lost to Follow-up|0
5288878|NCT00497796|18239785|P2|Overall Study|Investigator/sponsor discretion|34
5288879|NCT00497796|18239786|P1|Overall Study|Investigator/sponsor discretion|31
5288880|NCT00497796|18239785|P2|Overall Study|Consent withdrawn|3
5288881|NCT00497796|18239786|P1|Overall Study|Consent withdrawn|10
5288882|NCT00497796|18239785|P2|Overall Study|CMV infection or disease treatment|4
5288883|NCT00497796|18239786|P1|Overall Study|CMV infection or disease treatment|30
5288884|NCT00497796|18239785|P2|Overall Study|Adverse event (related)|4
5288885|NCT00497796|18239786|P1|Overall Study|Adverse event (related)|5
5288886|NCT00497796|18239785|P2|Overall Study|Adverse event (not related)|9
5288887|NCT00497796|18239786|P1|Overall Study|Adverse event (not related)|9
5288888|NCT00497198|18239873|P2|Overall Study|Withdrawal by Subject|1
5288889|NCT00497198|18239874|P1|Overall Study|Withdrawal by Subject|0
5288890|NCT00497198|18239873|P2|Overall Study|Physician Decision|2
5288891|NCT00497198|18239874|P1|Overall Study|Physician Decision|1
5288892|NCT00497198|18239873|P2|Overall Study|Adverse Event|2
5288893|NCT00497198|18239874|P1|Overall Study|Adverse Event|4
5288894|NCT00497146|18239890|P2|Long-term Follow-up Period|Other|1
5288895|NCT00497146|18239891|P1|Long-term Follow-up Period|Other|0
5288896|NCT00497146|18239890|P2|Long-term Follow-up Period|Lost to Follow-up|1
5288897|NCT00497146|18239891|P1|Long-term Follow-up Period|Lost to Follow-up|5
5288898|NCT00497146|18239890|P2|Long-term Follow-up Period|Withdrawal by Subject|2
5288899|NCT00497146|18239891|P1|Long-term Follow-up Period|Withdrawal by Subject|8
5288900|NCT00497146|18239890|P2|Long-term Follow-up Period|Adverse Event|2
5288901|NCT00497146|18239891|P1|Long-term Follow-up Period|Adverse Event|2
5288902|NCT00497146|18239890|P2|Treatment Period|Other Reason|3
5288903|NCT00497146|18239891|P1|Treatment Period|Other Reason|2
5288904|NCT00497146|18239890|P2|Treatment Period|Unable to dose reduce per protocol|1
5288905|NCT00497146|18239891|P1|Treatment Period|Unable to dose reduce per protocol|4
5288906|NCT00497146|18239890|P2|Treatment Period|Change in RAAS inhibitor therapy|2
5288907|NCT00497146|18239891|P1|Treatment Period|Change in RAAS inhibitor therapy|5
5288908|NCT00497146|18239890|P2|Treatment Period|Required dialysis|1
5288909|NCT00497146|18239891|P1|Treatment Period|Required dialysis|4
5288910|NCT00497146|18239890|P2|Treatment Period|Lost to Follow-up|3
5288911|NCT00497146|18239891|P1|Treatment Period|Lost to Follow-up|1
5288912|NCT00497146|18239890|P2|Treatment Period|Withdrawal by Subject|9
5288913|NCT00497146|18239891|P1|Treatment Period|Withdrawal by Subject|5
5288914|NCT00497146|18239890|P2|Treatment Period|Adverse Event|2
5288915|NCT00497146|18239891|P1|Treatment Period|Adverse Event|6
5288916|NCT00496964|18239959|P2|Overall Study|Withdrawal by Subject|1
5288917|NCT00496964|18239960|P1|Overall Study|Withdrawal by Subject|0
5288918|NCT00496873|18239978|P1|Overall Study|Withdrawal by Subject|3
5288919|NCT00496873|18239978|P1|Overall Study|Death|2
5288920|NCT00496873|18239978|P1|Overall Study|Ineligible|2
5288921|NCT00496834|18240011|P2|Overall Study|Blood Pressure control failure|1
5288922|NCT00496834|18240012|P1|Overall Study|Blood Pressure control failure|2
5288923|NCT00496834|18240011|P2|Overall Study|Lost to Follow-up|0
5288924|NCT00496834|18240012|P1|Overall Study|Lost to Follow-up|2
5288925|NCT00496834|18240011|P2|Overall Study|IP administration violation|0
5288926|NCT00496834|18240012|P1|Overall Study|IP administration violation|2
5288927|NCT00496834|18240011|P2|Overall Study|Adverse Event|3
5288928|NCT00496834|18240012|P1|Overall Study|Adverse Event|5
5288929|NCT00496834|18240011|P2|Overall Study|Inclusion/exclusion criteria not met|2
5288930|NCT00496834|18240012|P1|Overall Study|Inclusion/exclusion criteria not met|3
5288931|NCT00496834|18240011|P2|Overall Study|Contraindicated medication administered|1
5288932|NCT00496834|18240012|P1|Overall Study|Contraindicated medication administered|0
5288933|NCT00496834|18240011|P2|Overall Study|Withdrawal by Subject|6
5288934|NCT00496834|18240012|P1|Overall Study|Withdrawal by Subject|4
5288935|NCT00496782|18240031|P2|Overall Study|Protocol Violation|2
5288936|NCT00496782|18240032|P1|Overall Study|Protocol Violation|1
5288937|NCT00496769|18240066|P3|Open Label|>=1 reason assigned per patient|1011
5288938|NCT00496769|18240067|P2|Open Label|>=1 reason assigned per patient|0
5288939|NCT00496769|18240068|P1|Open Label|>=1 reason assigned per patient|0
5288940|NCT00496769|18240066|P3|Double Blind|>=1 reason assigned per patient|0
5288941|NCT00496769|18240067|P2|Double Blind|>=1 reason assigned per patient|649
5288942|NCT00496769|18240068|P1|Double Blind|>=1 reason assigned per patient|558
5288943|NCT00496730|18240098|P2|Overall Study|Withdrawal by Subject|2
5288944|NCT00496730|18240099|P1|Overall Study|Withdrawal by Subject|2
5288945|NCT00496730|18240098|P2|Overall Study|Lost to Follow-up|3
5288946|NCT00496730|18240099|P1|Overall Study|Lost to Follow-up|4
5288947|NCT00496626|18240111|P2|Overall Study|Relocated|1
5288948|NCT00496626|18240112|P1|Overall Study|Relocated|0
5288949|NCT00496626|18240111|P2|Overall Study|Withdrawal by Subject|4
5288950|NCT00496626|18240112|P1|Overall Study|Withdrawal by Subject|5
5288951|NCT00496626|18240111|P2|Overall Study|Protocol Violation|0
5288952|NCT00496626|18240112|P1|Overall Study|Protocol Violation|1
5288953|NCT00496626|18240111|P2|Overall Study|Lost to Follow-up|1
5288954|NCT00496626|18240112|P1|Overall Study|Lost to Follow-up|0
5288955|NCT00496587|18240124|P1|Overall Study|Complications unrelated|2
5288956|NCT00496587|18240124|P1|Overall Study|Death|1
5288957|NCT00496587|18240124|P1|Overall Study|Withdrawal by Subject|2
5288958|NCT00496587|18240124|P1|Overall Study|Progressive Disease|24
5288959|NCT00496587|18240124|P1|Overall Study|Adverse Event|2
5288960|NCT00496483|18240130|P1|Overall Study|Lack of Efficacy|1
5288961|NCT00496483|18240130|P1|Overall Study|Adverse Event|2
5288962|NCT00496483|18240130|P1|Overall Study|Not dosed|9
5288963|NCT00496470|18240147|P2|Overall Study|Other reason|2
5288964|NCT00496470|18240148|P1|Overall Study|Other reason|0
5288965|NCT00496470|18240147|P2|Overall Study|Incorrectly enrolled|5
5288966|NCT00496470|18240148|P1|Overall Study|Incorrectly enrolled|13
5288967|NCT00496470|18240147|P2|Overall Study|Withdrawal by Subject|12
5288968|NCT00496470|18240148|P1|Overall Study|Withdrawal by Subject|5
5288969|NCT00496470|18240147|P2|Overall Study|Adverse Event|10
5288970|NCT00496470|18240148|P1|Overall Study|Adverse Event|8
5288971|NCT00496366|18240234|P1|Overall Study|Death|1
5288972|NCT00496197|18240265|P1|Overall Study|Protocol Violation|8
5288973|NCT00496197|18240265|P1|Overall Study|Other|14
5288974|NCT00496197|18240265|P1|Overall Study|Pathogen not isolated baseline specimen|4
5288975|NCT00496197|18240265|P1|Overall Study|Withdrawal by Subject|11
5288976|NCT00496197|18240265|P1|Overall Study|Lost to Follow-up|11
5288977|NCT00496197|18240265|P1|Overall Study|Insufficient bacteriological response|10
5288978|NCT00496197|18240265|P1|Overall Study|Insufficient clinical response|3
5288979|NCT00496197|18240265|P1|Overall Study|Does not meet entrance criteria|5
5288980|NCT00496197|18240265|P1|Overall Study|Adverse Event|13
5288981|NCT00496197|18240265|P1|Overall Study|Discontinued study due to death|43
5288982|NCT00496080|18240292|P1|Overall Study|Physician Decision|6
5288983|NCT00496080|18240292|P1|Overall Study|Withdrawal by Subject|5
5288984|NCT00496080|18240292|P1|Overall Study|Surgical re-intervention|7
5288985|NCT00496080|18240292|P1|Overall Study|Lost to Follow-up|9
5288986|NCT00496054|18240302|P1|Overall Study|Lost to Follow-up|7
5288987|NCT00496054|18240302|P1|Overall Study|Adverse Event|1
5288988|NCT00496015|18240334|P5|Overall Study|Other|0
5288989|NCT00496015|18240335|P4|Overall Study|Other|1
5288990|NCT00496015|18240336|P3|Overall Study|Other|0
5288991|NCT00496015|18240337|P2|Overall Study|Other|0
5288992|NCT00496015|18240338|P1|Overall Study|Other|1
5288993|NCT00495820|18240462|P2|Overall Study|Adverse Event|1
5288994|NCT00495820|18240463|P1|Overall Study|Adverse Event|1
5288995|NCT00495794|18240475|P2|Overall Study|Pharmacist did not activate patient|0
5288996|NCT00495794|18240476|P1|Overall Study|Pharmacist did not activate patient|522
5288997|NCT00495755|18240486|P1|Overall Study|Adverse Event|3
5288998|NCT00495677|18240507|P7|Stage 1 (25 Days)|Adverse Event|0
5288999|NCT00495677|18240508|P6|Stage 1 (25 Days)|Adverse Event|0
5289000|NCT00495677|18240509|P5|Stage 1 (25 Days)|Adverse Event|0
5289001|NCT00495677|18240510|P4|Stage 1 (25 Days)|Adverse Event|0
5289002|NCT00495677|18240511|P3|Stage 1 (25 Days)|Adverse Event|1
5289003|NCT00495677|18240512|P2|Stage 1 (25 Days)|Adverse Event|0
5289004|NCT00495677|18240513|P1|Stage 1 (25 Days)|Adverse Event|0
5289005|NCT00495625|18240568|P1|Overall Study|Did not complete at least 1 42 day cycle|10
5289006|NCT00495612|18240579|P2|Overall Study|Subject's Decision to Withdraw|0
5289007|NCT00495612|18240580|P1|Overall Study|Subject's Decision to Withdraw|3
5289008|NCT00495612|18240579|P2|Overall Study|Lost to Follow-up|0
5289009|NCT00495612|18240580|P1|Overall Study|Lost to Follow-up|1
5289010|NCT00495586|18240598|P2|Overall Study|Withdrawal by Subject|4
5289011|NCT00495586|18240599|P1|Overall Study|Withdrawal by Subject|4
5289012|NCT00495521|18240609|P2|Overall Study|Physician Decision|1
5289013|NCT00495521|18240610|P1|Overall Study|Physician Decision|0
5289014|NCT00495495|18240640|P1|Overall Study|Protocol Violation|99
5289015|NCT00495469|18240660|P7|Overall Study|ST depression at randomisation in ECG|0
5289016|NCT00495469|18240661|P6|Overall Study|ST depression at randomisation in ECG|0
5289017|NCT00495469|18240662|P5|Overall Study|ST depression at randomisation in ECG|0
5289018|NCT00495469|18240663|P4|Overall Study|ST depression at randomisation in ECG|0
5289019|NCT00495469|18240664|P3|Overall Study|ST depression at randomisation in ECG|0
5289020|NCT00495469|18240665|P2|Overall Study|ST depression at randomisation in ECG|1
5289021|NCT00495469|18240666|P1|Overall Study|ST depression at randomisation in ECG|0
5289022|NCT00495469|18240660|P7|Overall Study|Liver function test abnormality|0
5289023|NCT00495469|18240661|P6|Overall Study|Liver function test abnormality|0
5289024|NCT00495469|18240662|P5|Overall Study|Liver function test abnormality|0
5289025|NCT00495469|18240663|P4|Overall Study|Liver function test abnormality|0
5289026|NCT00495469|18240664|P3|Overall Study|Liver function test abnormality|0
5289027|NCT00495469|18240665|P2|Overall Study|Liver function test abnormality|1
5289028|NCT00495469|18240666|P1|Overall Study|Liver function test abnormality|0
5289029|NCT00495469|18240660|P7|Overall Study|Lack of Efficacy|1
5289030|NCT00495469|18240661|P6|Overall Study|Lack of Efficacy|0
5289031|NCT00495469|18240662|P5|Overall Study|Lack of Efficacy|0
5289032|NCT00495469|18240663|P4|Overall Study|Lack of Efficacy|0
5289033|NCT00495469|18240664|P3|Overall Study|Lack of Efficacy|0
5289034|NCT00495469|18240665|P2|Overall Study|Lack of Efficacy|0
5289035|NCT00495469|18240666|P1|Overall Study|Lack of Efficacy|0
5289036|NCT00495469|18240660|P7|Overall Study|Withdrawal by Subject|3
5289037|NCT00495469|18240661|P6|Overall Study|Withdrawal by Subject|2
5289038|NCT00495469|18240662|P5|Overall Study|Withdrawal by Subject|3
5289039|NCT00495469|18240663|P4|Overall Study|Withdrawal by Subject|3
5289040|NCT00495469|18240664|P3|Overall Study|Withdrawal by Subject|1
5289041|NCT00495469|18240665|P2|Overall Study|Withdrawal by Subject|3
5289042|NCT00495469|18240666|P1|Overall Study|Withdrawal by Subject|5
5289043|NCT00495469|18240660|P7|Overall Study|Protocol Violation|0
5289044|NCT00495469|18240661|P6|Overall Study|Protocol Violation|2
5289045|NCT00495469|18240662|P5|Overall Study|Protocol Violation|1
5289046|NCT00495469|18240663|P4|Overall Study|Protocol Violation|0
5289047|NCT00495469|18240664|P3|Overall Study|Protocol Violation|0
5289048|NCT00495469|18240665|P2|Overall Study|Protocol Violation|0
5289049|NCT00495469|18240666|P1|Overall Study|Protocol Violation|0
5289050|NCT00495469|18240660|P7|Overall Study|Lost to Follow-up|0
5289051|NCT00495469|18240661|P6|Overall Study|Lost to Follow-up|0
5289052|NCT00495469|18240662|P5|Overall Study|Lost to Follow-up|0
5289053|NCT00495469|18240663|P4|Overall Study|Lost to Follow-up|1
5289054|NCT00495469|18240664|P3|Overall Study|Lost to Follow-up|3
5289055|NCT00495469|18240665|P2|Overall Study|Lost to Follow-up|1
5289056|NCT00495469|18240666|P1|Overall Study|Lost to Follow-up|1
5289057|NCT00495469|18240660|P7|Overall Study|Adverse Event|1
5289058|NCT00495469|18240661|P6|Overall Study|Adverse Event|1
5289059|NCT00495469|18240662|P5|Overall Study|Adverse Event|1
5289060|NCT00495469|18240663|P4|Overall Study|Adverse Event|0
5289061|NCT00495469|18240664|P3|Overall Study|Adverse Event|3
5289062|NCT00495469|18240665|P2|Overall Study|Adverse Event|1
5289063|NCT00495469|18240666|P1|Overall Study|Adverse Event|0
5289064|NCT00495391|18240810|P2|Overall Study|Withdrawal by Subject|3
5289065|NCT00495391|18240811|P1|Overall Study|Withdrawal by Subject|2
5289066|NCT00495391|18240810|P2|Overall Study|Lack of Efficacy|18
5289067|NCT00495391|18240811|P1|Overall Study|Lack of Efficacy|34
5289068|NCT00495170|18240834|P1|Overall Study|Inappropriate staging|8
5289069|NCT00495170|18240834|P1|Overall Study|Withdrawal by Subject|3
5289070|NCT00495170|18240834|P1|Overall Study|Lost to Follow-up|9
5289071|NCT00495131|18240853|P2|Overall Study|Withdrawal by Subject|0
5289072|NCT00495131|18240854|P1|Overall Study|Withdrawal by Subject|1
5289073|NCT00495131|18240853|P2|Overall Study|Lost to Follow-up|2
5289074|NCT00495131|18240854|P1|Overall Study|Lost to Follow-up|0
5289075|NCT00495131|18240853|P2|Overall Study|Lack of Efficacy|2
5289076|NCT00495131|18240854|P1|Overall Study|Lack of Efficacy|0
5289077|NCT00495131|18240853|P2|Overall Study|Adverse Event|2
5289078|NCT00495131|18240854|P1|Overall Study|Adverse Event|6
5289079|NCT00495040|18240871|P1|Overall Study|Withdrawal by Subject|3
5289080|NCT00494871|18240886|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
5289081|NCT00494871|18240887|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
5289082|NCT00494871|18240886|P2|Follow-up (FU) Period|Withdrawal by Subject|5
5289083|NCT00494871|18240887|P1|Follow-up (FU) Period|Withdrawal by Subject|5
5289084|NCT00494871|18240886|P2|Follow-up (FU) Period|Protocol Violation|0
5289085|NCT00494871|18240887|P1|Follow-up (FU) Period|Protocol Violation|1
5289086|NCT00494871|18240886|P2|Follow-up (FU) Period|Physician Decision|1
5289087|NCT00494871|18240887|P1|Follow-up (FU) Period|Physician Decision|0
5289088|NCT00494871|18240886|P2|Follow-up (FU) Period|Lost to Follow-up|2
5289089|NCT00494871|18240887|P1|Follow-up (FU) Period|Lost to Follow-up|6
5289090|NCT00494871|18240886|P2|Follow-up (FU) Period|Death|12
5289091|NCT00494871|18240887|P1|Follow-up (FU) Period|Death|13
5289092|NCT00494871|18240886|P2|Follow-up (FU) Period|Adverse Event|1
5289093|NCT00494871|18240887|P1|Follow-up (FU) Period|Adverse Event|1
5289094|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
5289095|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
5289096|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
5289097|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
5289098|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
5289099|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
5289100|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
5289101|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
5289102|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
5289103|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
5289104|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
5289105|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
5289106|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
5289107|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
5289108|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
5289109|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
5289110|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Physician Decision|13
5289111|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Physician Decision|4
5289112|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Death|3
5289113|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Death|8
5289114|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
5289115|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
5289116|NCT00494871|18240886|P2|Double-blind (DB) Treatment Period|Adverse Event|70
5289117|NCT00494871|18240887|P1|Double-blind (DB) Treatment Period|Adverse Event|73
5289118|NCT00494780|18240928|P2|Overall Study|Insurance Issues|1
5289119|NCT00494780|18240929|P1|Overall Study|Insurance Issues|0
5289120|NCT00494780|18240928|P2|Overall Study|Residual Tumour Mass|1
5289121|NCT00494780|18240929|P1|Overall Study|Residual Tumour Mass|0
5289122|NCT00494780|18240928|P2|Overall Study|Non-compliance|0
5289123|NCT00494780|18240929|P1|Overall Study|Non-compliance|1
5289124|NCT00494780|18240928|P2|Overall Study|New Treatment|2
5289125|NCT00494780|18240929|P1|Overall Study|New Treatment|2
5289126|NCT00494780|18240928|P2|Overall Study|Progression of Study Disease|8
5289127|NCT00494780|18240929|P1|Overall Study|Progression of Study Disease|7
5289128|NCT00494780|18240928|P2|Overall Study|Withdrew before Dosed|1
5289129|NCT00494780|18240929|P1|Overall Study|Withdrew before Dosed|0
5289130|NCT00494780|18240928|P2|Overall Study|Adverse Event|0
5289131|NCT00494780|18240929|P1|Overall Study|Adverse Event|1
5289132|NCT00494676|18240967|P2|Second Intervention|Withdrawal by Subject|1
5289133|NCT00494676|18240968|P1|Second Intervention|Withdrawal by Subject|1
5289134|NCT00494676|18240967|P2|First Intervention|Withdrawal by Subject|3
5289135|NCT00494676|18240968|P1|First Intervention|Withdrawal by Subject|1
5289136|NCT00494676|18240967|P2|Allocation|Withdrawal by Subject|4
5289137|NCT00494676|18240968|P1|Allocation|Withdrawal by Subject|2
5289138|NCT00494507|18240983|P4|Open-Label Phase|Worsening Disease|2
5289139|NCT00494507|18240984|P3|Open-Label Phase|Worsening Disease|0
5289140|NCT00494507|18240985|P2|Open-Label Phase|Worsening Disease|0
5289141|NCT00494507|18240986|P1|Open-Label Phase|Worsening Disease|0
5289142|NCT00494507|18240983|P4|Open-Label Phase|Adverse Event|3
5289143|NCT00494507|18240984|P3|Open-Label Phase|Adverse Event|5
5289144|NCT00494507|18240985|P2|Open-Label Phase|Adverse Event|1
5289145|NCT00494507|18240986|P1|Open-Label Phase|Adverse Event|0
5289146|NCT00494507|18240983|P4|Double-Blind Phase|Negative DNA test|1
5289147|NCT00494507|18240984|P3|Double-Blind Phase|Negative DNA test|0
5289148|NCT00494507|18240985|P2|Double-Blind Phase|Negative DNA test|0
5289149|NCT00494507|18240986|P1|Double-Blind Phase|Negative DNA test|0
5289150|NCT00494507|18240983|P4|Double-Blind Phase|Subject Non-compliance|0
5289151|NCT00494507|18240984|P3|Double-Blind Phase|Subject Non-compliance|1
5289152|NCT00494507|18240985|P2|Double-Blind Phase|Subject Non-compliance|0
5289153|NCT00494507|18240986|P1|Double-Blind Phase|Subject Non-compliance|0
5289154|NCT00494507|18240983|P4|Double-Blind Phase|Withdrawal by Subject|0
5289155|NCT00494507|18240984|P3|Double-Blind Phase|Withdrawal by Subject|0
5289156|NCT00494507|18240985|P2|Double-Blind Phase|Withdrawal by Subject|0
5289157|NCT00494507|18240986|P1|Double-Blind Phase|Withdrawal by Subject|1
5289158|NCT00494507|18240983|P4|Double-Blind Phase|Adverse Event|0
5289159|NCT00494507|18240984|P3|Double-Blind Phase|Adverse Event|1
5289160|NCT00494507|18240985|P2|Double-Blind Phase|Adverse Event|0
5289161|NCT00494507|18240986|P1|Double-Blind Phase|Adverse Event|2
5289162|NCT00494481|18241053|P2|Overall Study|Never received IP|0
5289163|NCT00494481|18241054|P1|Overall Study|Never received IP|2
5289164|NCT00494481|18241053|P2|Overall Study|Other|0
5289165|NCT00494481|18241054|P1|Overall Study|Other|1
5289166|NCT00494481|18241053|P2|Overall Study|Adverse Event|11
5289167|NCT00494481|18241054|P1|Overall Study|Adverse Event|15
5289168|NCT00494481|18241053|P2|Overall Study|Condition under investigation worsened|13
5289169|NCT00494481|18241054|P1|Overall Study|Condition under investigation worsened|11
5289170|NCT00494442|18241062|P2|Overall Study|Intercurrent illness|1
5289171|NCT00494442|18241063|P1|Overall Study|Intercurrent illness|0
5289172|NCT00494442|18241062|P2|Overall Study|Non-compliance|1
5289173|NCT00494442|18241063|P1|Overall Study|Non-compliance|0
5289174|NCT00494442|18241062|P2|Overall Study|Physician Decision|1
5289175|NCT00494442|18241063|P1|Overall Study|Physician Decision|0
5289176|NCT00494442|18241062|P2|Overall Study|Adverse Event|2
5289177|NCT00494442|18241063|P1|Overall Study|Adverse Event|0
5289178|NCT00494442|18241062|P2|Overall Study|Lack of Efficacy|10
5289179|NCT00494442|18241063|P1|Overall Study|Lack of Efficacy|16
5289180|NCT00494442|18241062|P2|Overall Study|Death|1
5289181|NCT00494442|18241063|P1|Overall Study|Death|1
5289182|NCT00494299|18241079|P2|Overall Study|Protocol Driven Decision Point|22
5289183|NCT00494299|18241080|P1|Overall Study|Protocol Driven Decision Point|11
5289184|NCT00494299|18241079|P2|Overall Study|Site Closed by Sponsor|0
5289185|NCT00494299|18241080|P1|Overall Study|Site Closed by Sponsor|6
5289186|NCT00494299|18241079|P2|Overall Study|Participant Did Not Take Study Drug|2
5289187|NCT00494299|18241080|P1|Overall Study|Participant Did Not Take Study Drug|0
5289188|NCT00494299|18241079|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
5289189|NCT00494299|18241080|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
5289190|NCT00494299|18241079|P2|Overall Study|Withdrawal by Subject|3
5289191|NCT00494299|18241080|P1|Overall Study|Withdrawal by Subject|8
5289192|NCT00494299|18241079|P2|Overall Study|Protocol Violation|2
5289193|NCT00494299|18241080|P1|Overall Study|Protocol Violation|1
5289194|NCT00494299|18241079|P2|Overall Study|Physician Decision|2
5289195|NCT00494299|18241080|P1|Overall Study|Physician Decision|0
5289196|NCT00494299|18241079|P2|Overall Study|Lost to Follow-up|0
5289197|NCT00494299|18241080|P1|Overall Study|Lost to Follow-up|1
5289198|NCT00494299|18241079|P2|Overall Study|Adverse Event|13
5289199|NCT00494299|18241080|P1|Overall Study|Adverse Event|93
5289200|NCT00494234|18241092|P2|Overall Study|Death|1
5289201|NCT00494234|18241093|P1|Overall Study|Death|2
5289202|NCT00494234|18241092|P2|Overall Study|Withdrawal by Subject|0
5289203|NCT00494234|18241093|P1|Overall Study|Withdrawal by Subject|1
5289204|NCT00494234|18241092|P2|Overall Study|Lack of Efficacy|9
5289205|NCT00494234|18241093|P1|Overall Study|Lack of Efficacy|12
5289206|NCT00494221|18241112|P3|Overall Study|Withdrawal by Subject|0
5289207|NCT00494221|18241113|P2|Overall Study|Withdrawal by Subject|2
5289208|NCT00494221|18241114|P1|Overall Study|Withdrawal by Subject|1
5289209|NCT00494221|18241112|P3|Overall Study|Death|14
5289210|NCT00494221|18241113|P2|Overall Study|Death|9
5289211|NCT00494221|18241114|P1|Overall Study|Death|15
5289212|NCT00494091|18241155|P2|Overall Study|Withdrawal by Subject|7
5289213|NCT00494091|18241156|P1|Overall Study|Withdrawal by Subject|0
5289214|NCT00494091|18241155|P2|Overall Study|Other|11
5289215|NCT00494091|18241156|P1|Overall Study|Other|1
5289216|NCT00494091|18241155|P2|Overall Study|Lost to Follow-up|4
5289217|NCT00494091|18241156|P1|Overall Study|Lost to Follow-up|0
5289218|NCT00494091|18241155|P2|Overall Study|Death|54
5289219|NCT00494091|18241156|P1|Overall Study|Death|5
5289220|NCT00494026|18241178|P1|Overall Study|Sponsor Decision|4
5289221|NCT00494013|18241188|P2|Overall Study|Sponsor Decision|1
5289222|NCT00494013|18241189|P1|Overall Study|Sponsor Decision|0
5289223|NCT00494013|18241188|P2|Overall Study|Withdrawal by Subject|14
5289224|NCT00494013|18241189|P1|Overall Study|Withdrawal by Subject|13
5289225|NCT00494013|18241188|P2|Overall Study|Protocol Violation|5
5289226|NCT00494013|18241189|P1|Overall Study|Protocol Violation|8
5289227|NCT00494013|18241188|P2|Overall Study|Physician Decision|5
5289228|NCT00494013|18241189|P1|Overall Study|Physician Decision|3
5289229|NCT00494013|18241188|P2|Overall Study|Lost to Follow-up|6
5289230|NCT00494013|18241189|P1|Overall Study|Lost to Follow-up|5
5289231|NCT00494013|18241188|P2|Overall Study|Entry Criteria Not Met|4
5289232|NCT00494013|18241189|P1|Overall Study|Entry Criteria Not Met|1
5289233|NCT00494013|18241188|P2|Overall Study|Adverse Event|1
5289234|NCT00494013|18241189|P1|Overall Study|Adverse Event|0
5289235|NCT00493974|18241219|P2|Overall Study|Lost to Follow-up|6
5289236|NCT00493974|18241220|P1|Overall Study|Lost to Follow-up|4
5289237|NCT00493974|18241219|P2|Overall Study|Withdrawal by Subject|6
5289238|NCT00493974|18241220|P1|Overall Study|Withdrawal by Subject|8
5289239|NCT00493974|18241219|P2|Overall Study|Death|2
5289240|NCT00493974|18241220|P1|Overall Study|Death|1
5289241|NCT00493779|18241247|P1|Overall Study|Logistical issue at site|1
5289242|NCT00493649|18241254|P1|Overall Study|Other|13
5289243|NCT00493649|18241254|P1|Overall Study|Lost to Follow-up|1
5289244|NCT00493649|18241254|P1|Overall Study|Disease Progression|1
5289245|NCT00493649|18241254|P1|Overall Study|Investigator Request|2
5289246|NCT00493649|18241254|P1|Overall Study|Patient Request|21
5289247|NCT00493649|18241254|P1|Overall Study|Adverse Event|44
5289248|NCT00493636|18241267|P2|Overall Study|Mis-randomization|1
5289249|NCT00493636|18241268|P1|Overall Study|Mis-randomization|1
5289250|NCT00493636|18241267|P2|Overall Study|Disease progression/recurrence/relapse|1
5289251|NCT00493636|18241268|P1|Overall Study|Disease progression/recurrence/relapse|0
5289252|NCT00493636|18241267|P2|Overall Study|Withdrawal by Subject|0
5289253|NCT00493636|18241268|P1|Overall Study|Withdrawal by Subject|1
5289254|NCT00493467|18241282|P1|Overall Study|Death|1
5289255|NCT00493454|18241287|P1|Overall Study|Withdrawal by Subject|1
5289256|NCT00493311|18241293|P2|Overall Study|Need for rescue medication|2
5289257|NCT00493311|18241294|P1|Overall Study|Need for rescue medication|2
5289258|NCT00493285|18241314|P6|Overall Study|Lost to Follow-up|0
5289259|NCT00493285|18241315|P5|Overall Study|Lost to Follow-up|1
5289260|NCT00493285|18241316|P4|Overall Study|Lost to Follow-up|0
5289261|NCT00493285|18241317|P3|Overall Study|Lost to Follow-up|0
5289262|NCT00493285|18241318|P2|Overall Study|Lost to Follow-up|0
5289263|NCT00493285|18241319|P1|Overall Study|Lost to Follow-up|0
5289264|NCT00493246|18241551|P8|Overall Study|Lost to Follow-up|0
5289265|NCT00493246|18241552|P7|Overall Study|Lost to Follow-up|1
5289266|NCT00493246|18241553|P6|Overall Study|Lost to Follow-up|0
5289267|NCT00493246|18241554|P5|Overall Study|Lost to Follow-up|0
5289268|NCT00493246|18241555|P4|Overall Study|Lost to Follow-up|0
5289269|NCT00493246|18241556|P3|Overall Study|Lost to Follow-up|0
5289270|NCT00493246|18241557|P2|Overall Study|Lost to Follow-up|0
5289271|NCT00493246|18241558|P1|Overall Study|Lost to Follow-up|0
5289272|NCT00493246|18241551|P8|Overall Study|No access to draw blood|0
5289273|NCT00493246|18241552|P7|Overall Study|No access to draw blood|0
5289274|NCT00493246|18241553|P6|Overall Study|No access to draw blood|1
5289275|NCT00493246|18241554|P5|Overall Study|No access to draw blood|0
5289276|NCT00493246|18241555|P4|Overall Study|No access to draw blood|0
5289277|NCT00493246|18241556|P3|Overall Study|No access to draw blood|0
5289278|NCT00493246|18241557|P2|Overall Study|No access to draw blood|0
5289279|NCT00493246|18241558|P1|Overall Study|No access to draw blood|0
5289280|NCT00493246|18241551|P8|Overall Study|Withdrawal by Subject|0
5289281|NCT00493246|18241552|P7|Overall Study|Withdrawal by Subject|0
5289282|NCT00493246|18241553|P6|Overall Study|Withdrawal by Subject|0
5289283|NCT00493246|18241554|P5|Overall Study|Withdrawal by Subject|1
5289284|NCT00493246|18241555|P4|Overall Study|Withdrawal by Subject|0
5289285|NCT00493246|18241556|P3|Overall Study|Withdrawal by Subject|0
5289286|NCT00493246|18241557|P2|Overall Study|Withdrawal by Subject|0
5289287|NCT00493246|18241558|P1|Overall Study|Withdrawal by Subject|0
5289288|NCT00493220|18241622|P6|Third Intervention|Withdrawal by Subject|0
5289289|NCT00493220|18241623|P5|Third Intervention|Withdrawal by Subject|0
5289290|NCT00493220|18241624|P4|Third Intervention|Withdrawal by Subject|0
5289291|NCT00493220|18241625|P3|Third Intervention|Withdrawal by Subject|0
5289292|NCT00493220|18241626|P2|Third Intervention|Withdrawal by Subject|0
5289293|NCT00493220|18241627|P1|Third Intervention|Withdrawal by Subject|1
5289294|NCT00493038|18241655|P2|Follow-up|Lost to Follow-up|0
5289295|NCT00493038|18241656|P1|Follow-up|Lost to Follow-up|1
5289296|NCT00493038|18241655|P2|Treatment|Other|1
5289297|NCT00493038|18241656|P1|Treatment|Other|0
5289298|NCT00493038|18241655|P2|Treatment|Withdrawal by Subject|12
5289299|NCT00493038|18241656|P1|Treatment|Withdrawal by Subject|11
5289300|NCT00493038|18241655|P2|Treatment|Lost to Follow-up|3
5289301|NCT00493038|18241656|P1|Treatment|Lost to Follow-up|5
5289302|NCT00493038|18241655|P2|Treatment|Adverse Event|4
5289303|NCT00493038|18241656|P1|Treatment|Adverse Event|8
5289304|NCT00493025|18241670|P1|Overall Study|Physician Decision|19
5289305|NCT00493012|18241681|P2|Overall Study|Lost to Follow-up|17
5289306|NCT00493012|18241682|P1|Overall Study|Lost to Follow-up|18
5289307|NCT00492921|18241725|P3|Overall Study|Death|1
5289308|NCT00492921|18241726|P2|Overall Study|Death|0
5289309|NCT00492921|18241727|P1|Overall Study|Death|1
5289310|NCT00492856|18241738|P4|Post-consolidation|Observation Arm|0
5289311|NCT00492856|18241739|P3|Post-consolidation|Observation Arm|27
5289312|NCT00492856|18241740|P2|Post-consolidation|Observation Arm|0
5289313|NCT00492856|18241741|P1|Post-consolidation|Observation Arm|0
5289314|NCT00492856|18241738|P4|Post-consolidation|Lost to Follow-up|0
5289315|NCT00492856|18241739|P3|Post-consolidation|Lost to Follow-up|0
5289316|NCT00492856|18241740|P2|Post-consolidation|Lost to Follow-up|2
5289317|NCT00492856|18241741|P1|Post-consolidation|Lost to Follow-up|0
5289318|NCT00492856|18241738|P4|Post-consolidation|Not protocol specified|0
5289319|NCT00492856|18241739|P3|Post-consolidation|Not protocol specified|0
5289320|NCT00492856|18241740|P2|Post-consolidation|Not protocol specified|1
5289321|NCT00492856|18241741|P1|Post-consolidation|Not protocol specified|0
5289322|NCT00492856|18241738|P4|Post-consolidation|Death|0
5289323|NCT00492856|18241739|P3|Post-consolidation|Death|0
5289324|NCT00492856|18241740|P2|Post-consolidation|Death|1
5289325|NCT00492856|18241741|P1|Post-consolidation|Death|0
5289326|NCT00492856|18241738|P4|Post-consolidation|Withdrawal by Subject|0
5289327|NCT00492856|18241739|P3|Post-consolidation|Withdrawal by Subject|0
5289328|NCT00492856|18241740|P2|Post-consolidation|Withdrawal by Subject|4
5289329|NCT00492856|18241741|P1|Post-consolidation|Withdrawal by Subject|0
5289330|NCT00492856|18241738|P4|Post-consolidation|Adverse Event|1
5289331|NCT00492856|18241739|P3|Post-consolidation|Adverse Event|0
5289332|NCT00492856|18241740|P2|Post-consolidation|Adverse Event|4
5289333|NCT00492856|18241741|P1|Post-consolidation|Adverse Event|0
5289334|NCT00492856|18241738|P4|Consolidation|Lost to Follow-up|0
5289335|NCT00492856|18241739|P3|Consolidation|Lost to Follow-up|0
5289336|NCT00492856|18241740|P2|Consolidation|Lost to Follow-up|0
5289337|NCT00492856|18241741|P1|Consolidation|Lost to Follow-up|1
5289338|NCT00492856|18241738|P4|Consolidation|Not protocol specified|0
5289339|NCT00492856|18241739|P3|Consolidation|Not protocol specified|0
5289340|NCT00492856|18241740|P2|Consolidation|Not protocol specified|0
5289341|NCT00492856|18241741|P1|Consolidation|Not protocol specified|2
5289342|NCT00492856|18241738|P4|Consolidation|Adverse Event|0
5289343|NCT00492856|18241739|P3|Consolidation|Adverse Event|0
5289344|NCT00492856|18241740|P2|Consolidation|Adverse Event|0
5289345|NCT00492856|18241741|P1|Consolidation|Adverse Event|6
5289346|NCT00492856|18241738|P4|Induction|Death|0
5289347|NCT00492856|18241739|P3|Induction|Death|0
5289348|NCT00492856|18241740|P2|Induction|Death|0
5289349|NCT00492856|18241741|P1|Induction|Death|3
5289350|NCT00492856|18241738|P4|Induction|Withdrawal by Subject|0
5289351|NCT00492856|18241739|P3|Induction|Withdrawal by Subject|0
5289352|NCT00492856|18241740|P2|Induction|Withdrawal by Subject|0
5289353|NCT00492856|18241741|P1|Induction|Withdrawal by Subject|1
5289354|NCT00492856|18241738|P4|Induction|Adverse Event|0
5289355|NCT00492856|18241739|P3|Induction|Adverse Event|0
5289356|NCT00492856|18241740|P2|Induction|Adverse Event|0
5289357|NCT00492856|18241741|P1|Induction|Adverse Event|2
5289358|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
5289359|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
5289360|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
5289361|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
5289362|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
5289363|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
5289364|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
5289365|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
5289366|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
5289367|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
5289368|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
5289369|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
5289370|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
5289371|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
5289372|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
5289373|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
5289374|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
5289375|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
5289376|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
5289377|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
5289378|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
5289379|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
5289380|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
5289381|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
5289382|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Death|1
5289383|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Death|45
5289384|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Death|5
5289385|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Death|75
5289386|NCT00492752|18241755|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
5289387|NCT00492752|18241756|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
5289388|NCT00492752|18241757|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
5289389|NCT00492752|18241758|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
5289390|NCT00492752|18241755|P4|Double Blind Treatment|Protocol Violation|0
5289391|NCT00492752|18241756|P3|Double Blind Treatment|Protocol Violation|1
5289392|NCT00492752|18241757|P2|Double Blind Treatment|Protocol Violation|0
5289393|NCT00492752|18241758|P1|Double Blind Treatment|Protocol Violation|0
5289394|NCT00492752|18241755|P4|Double Blind Treatment|Adverse Event|0
5289395|NCT00492752|18241756|P3|Double Blind Treatment|Adverse Event|0
5289396|NCT00492752|18241757|P2|Double Blind Treatment|Adverse Event|0
5289397|NCT00492752|18241758|P1|Double Blind Treatment|Adverse Event|1
5289398|NCT00492752|18241755|P4|Double Blind Treatment|Death|0
5289399|NCT00492752|18241756|P3|Double Blind Treatment|Death|2
5289400|NCT00492752|18241757|P2|Double Blind Treatment|Death|0
5289401|NCT00492752|18241758|P1|Double Blind Treatment|Death|13
5289402|NCT00492726|18241793|P2|Overall Study|Non compliant with study medication|3
5289403|NCT00492726|18241794|P1|Overall Study|Non compliant with study medication|0
5289404|NCT00492726|18241793|P2|Overall Study|Withdrawal by Subject|3
5289405|NCT00492726|18241794|P1|Overall Study|Withdrawal by Subject|6
5289406|NCT00492726|18241793|P2|Overall Study|Physician Decision|1
5289407|NCT00492726|18241794|P1|Overall Study|Physician Decision|0
5289408|NCT00492726|18241793|P2|Overall Study|Lost to Follow-up|19
5289409|NCT00492726|18241794|P1|Overall Study|Lost to Follow-up|27
5289410|NCT00492726|18241793|P2|Overall Study|Lack of Efficacy|2
5289411|NCT00492726|18241794|P1|Overall Study|Lack of Efficacy|0
5289412|NCT00492726|18241793|P2|Overall Study|Death|2
5289413|NCT00492726|18241794|P1|Overall Study|Death|7
5289414|NCT00492726|18241793|P2|Overall Study|Adverse Event|6
5289415|NCT00492726|18241794|P1|Overall Study|Adverse Event|10
5289416|NCT00492648|18241820|P2|Month 30 (109671 Study)|Protocol Violation|1
5289417|NCT00492648|18241821|P1|Month 30 (109671 Study)|Protocol Violation|0
5289418|NCT00492557|18241868|P2|Overall Study|Lost to Follow-up|1
5289419|NCT00492557|18241869|P1|Overall Study|Lost to Follow-up|0
5289420|NCT00492557|18241868|P2|Overall Study|Failed to return|0
5289421|NCT00492557|18241869|P1|Overall Study|Failed to return|1
5289422|NCT00492557|18241868|P2|Overall Study|Adverse Event|0
5289423|NCT00492557|18241869|P1|Overall Study|Adverse Event|1
5289424|NCT00492557|18241868|P2|Overall Study|Death|1
5289425|NCT00492557|18241869|P1|Overall Study|Death|1
5289426|NCT00492557|18241868|P2|Overall Study|Other|2
5289427|NCT00492557|18241869|P1|Overall Study|Other|2
5289428|NCT00492557|18241868|P2|Overall Study|Protocol Violation|8
5289429|NCT00492557|18241869|P1|Overall Study|Protocol Violation|7
5289430|NCT00492557|18241868|P2|Overall Study|Subject request|11
5289431|NCT00492557|18241869|P1|Overall Study|Subject request|12
5289432|NCT00492531|18241899|P2|Overall Study|Withdrawn(More than one reason selected)|23
5289433|NCT00492531|18241900|P1|Overall Study|Withdrawn(More than one reason selected)|22
5289434|NCT00492297|18241973|P1|Survival Only Follow-up|Study terminated by sponsor|12
5289435|NCT00492297|18241973|P1|Survival Only Follow-up|Lack of Efficacy|1
5289436|NCT00492297|18241973|P1|Survival Only Follow-up|Death|46
5289437|NCT00492297|18241973|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
5289438|NCT00492297|18241973|P1|Active Follow-up 30(+4) Days Duration|Death|17
5289439|NCT00492297|18241973|P1|Treatment|Study terminated by sponsor|3
5289440|NCT00492297|18241973|P1|Treatment|Death|2
5289441|NCT00492284|18241991|P4|Overall Study|Withdrawal by Subject|2
5289442|NCT00492284|18241992|P3|Overall Study|Withdrawal by Subject|0
5289443|NCT00492284|18241993|P2|Overall Study|Withdrawal by Subject|0
5289444|NCT00492284|18241994|P1|Overall Study|Withdrawal by Subject|1
5289445|NCT00492284|18241991|P4|Overall Study|Death|5
5289446|NCT00492284|18241992|P3|Overall Study|Death|2
5289447|NCT00492284|18241993|P2|Overall Study|Death|3
5289448|NCT00492284|18241994|P1|Overall Study|Death|0
5289449|NCT00492284|18241991|P4|Overall Study|Lost to Follow-up|1
5289450|NCT00492284|18241992|P3|Overall Study|Lost to Follow-up|3
5289451|NCT00492284|18241993|P2|Overall Study|Lost to Follow-up|0
5289452|NCT00492284|18241994|P1|Overall Study|Lost to Follow-up|0
5289453|NCT00492284|18241991|P4|Overall Study|Adverse Event|2
5289454|NCT00492284|18241992|P3|Overall Study|Adverse Event|1
5289455|NCT00492284|18241993|P2|Overall Study|Adverse Event|1
5289456|NCT00492284|18241994|P1|Overall Study|Adverse Event|0
5289457|NCT00492232|18242038|P2|Open-Label Treatment|Withdrawal by Subject|0
5289458|NCT00492232|18242039|P1|Open-Label Treatment|Withdrawal by Subject|1
5289459|NCT00492232|18242038|P2|Double-Blind Treatment|Randomized not treated|0
5289460|NCT00492232|18242039|P1|Double-Blind Treatment|Randomized not treated|1
5289461|NCT00492232|18242038|P2|Double-Blind Treatment|Other|5
5289462|NCT00492232|18242039|P1|Double-Blind Treatment|Other|6
5289463|NCT00492232|18242038|P2|Double-Blind Treatment|Lack of Efficacy|0
5289464|NCT00492232|18242039|P1|Double-Blind Treatment|Lack of Efficacy|1
5289465|NCT00492232|18242038|P2|Double-Blind Treatment|Withdrawal by Subject|8
5289466|NCT00492232|18242039|P1|Double-Blind Treatment|Withdrawal by Subject|4
5289467|NCT00492232|18242038|P2|Double-Blind Treatment|Lost to Follow-up|3
5289468|NCT00492232|18242039|P1|Double-Blind Treatment|Lost to Follow-up|2
5289469|NCT00492232|18242038|P2|Double-Blind Treatment|Protocol Violation|7
5289470|NCT00492232|18242039|P1|Double-Blind Treatment|Protocol Violation|3
5289471|NCT00492232|18242038|P2|Double-Blind Treatment|Adverse Event|2
5289472|NCT00492232|18242039|P1|Double-Blind Treatment|Adverse Event|1
5289473|NCT00492232|18242038|P2|Placebo Run-in|Missing|2
5289474|NCT00492232|18242039|P1|Placebo Run-in|Missing|0
5289475|NCT00492232|18242038|P2|Placebo Run-in|Other|6
5289476|NCT00492232|18242039|P1|Placebo Run-in|Other|0
5289477|NCT00492232|18242038|P2|Placebo Run-in|Entrance criteria not met|45
5289478|NCT00492232|18242039|P1|Placebo Run-in|Entrance criteria not met|0
5289479|NCT00492232|18242038|P2|Placebo Run-in|Pregnancy|1
5289480|NCT00492232|18242039|P1|Placebo Run-in|Pregnancy|0
5289481|NCT00492232|18242038|P2|Placebo Run-in|Withdrawal by Subject|8
5289482|NCT00492232|18242039|P1|Placebo Run-in|Withdrawal by Subject|0
5289483|NCT00492232|18242038|P2|Placebo Run-in|Lost to Follow-up|3
5289484|NCT00492232|18242039|P1|Placebo Run-in|Lost to Follow-up|0
5289485|NCT00492232|18242038|P2|Placebo Run-in|Protocol Violation|3
5289486|NCT00492232|18242039|P1|Placebo Run-in|Protocol Violation|0
5289487|NCT00492232|18242038|P2|Placebo Run-in|Adverse Event|2
5289488|NCT00492232|18242039|P1|Placebo Run-in|Adverse Event|0
5289489|NCT00492115|18242080|P2|Overall Study|Withdrawal by Subject|4
5289490|NCT00492115|18242081|P1|Overall Study|Withdrawal by Subject|3
5289491|NCT00492063|18242102|P4|Overall Study|Protocol Violation|1
5289492|NCT00492063|18242103|P3|Overall Study|Protocol Violation|0
5289493|NCT00492063|18242104|P2|Overall Study|Protocol Violation|0
5289494|NCT00492063|18242105|P1|Overall Study|Protocol Violation|0
5289495|NCT00492063|18242102|P4|Overall Study|Lost to Follow-up|3
5289496|NCT00492063|18242103|P3|Overall Study|Lost to Follow-up|5
5289497|NCT00492063|18242104|P2|Overall Study|Lost to Follow-up|11
5289498|NCT00492063|18242105|P1|Overall Study|Lost to Follow-up|6
5289499|NCT00492063|18242102|P4|Overall Study|Withdrawal by Subject|4
5289500|NCT00492063|18242103|P3|Overall Study|Withdrawal by Subject|5
5289501|NCT00492063|18242104|P2|Overall Study|Withdrawal by Subject|3
5289502|NCT00492063|18242105|P1|Overall Study|Withdrawal by Subject|4
5289503|NCT00492063|18242102|P4|Overall Study|Death|2
5289504|NCT00492063|18242103|P3|Overall Study|Death|1
5289505|NCT00492063|18242104|P2|Overall Study|Death|0
5289506|NCT00492063|18242105|P1|Overall Study|Death|0
5289507|NCT00492024|18242129|P2|Follow up|Lost to Follow-up|1
5289508|NCT00492024|18242130|P1|Follow up|Lost to Follow-up|1
5289509|NCT00492024|18242129|P2|Follow up|Lack of Efficacy|1
5289510|NCT00492024|18242130|P1|Follow up|Lack of Efficacy|0
5289511|NCT00492024|18242129|P2|Treatment|Withdrawal by Subject|0
5289512|NCT00492024|18242130|P1|Treatment|Withdrawal by Subject|2
5289513|NCT00492024|18242129|P2|Treatment|Lost to Follow-up|1
5289514|NCT00492024|18242130|P1|Treatment|Lost to Follow-up|3
5289515|NCT00492024|18242129|P2|Treatment|Lack of Efficacy|20
5289516|NCT00492024|18242130|P1|Treatment|Lack of Efficacy|21
5289517|NCT00492024|18242129|P2|Treatment|Adverse Event|1
5289518|NCT00492024|18242130|P1|Treatment|Adverse Event|3
5289519|NCT00491894|18242146|P1|Overall Study|Other-Intake of prohibited medication|1
5289520|NCT00491894|18242146|P1|Overall Study|Protocol Violation|2
5289521|NCT00491894|18242146|P1|Overall Study|Physician Decision|2
5289522|NCT00491894|18242146|P1|Overall Study|Other-Failed to meet any criteria|2
5289523|NCT00491894|18242146|P1|Overall Study|Lack of Efficacy|2
5289524|NCT00491894|18242146|P1|Overall Study|Lost to Follow-up|3
5289525|NCT00491894|18242146|P1|Overall Study|Death|3
5289526|NCT00491894|18242146|P1|Overall Study|Withdrawal by Subject|5
5289527|NCT00491894|18242146|P1|Overall Study|Adverse Event|14
5289528|NCT00491764|18242173|P6|Overall Study|Administrative|0
5289529|NCT00491764|18242174|P5|Overall Study|Administrative|0
5289530|NCT00491764|18242175|P4|Overall Study|Administrative|1
5289531|NCT00491764|18242176|P3|Overall Study|Administrative|2
5289532|NCT00491764|18242177|P2|Overall Study|Administrative|0
5289533|NCT00491764|18242178|P1|Overall Study|Administrative|1
5289534|NCT00491764|18242173|P6|Overall Study|Did not Meet Protocol Eligibility|1
5289535|NCT00491764|18242174|P5|Overall Study|Did not Meet Protocol Eligibility|1
5289536|NCT00491764|18242175|P4|Overall Study|Did not Meet Protocol Eligibility|0
5289537|NCT00491764|18242176|P3|Overall Study|Did not Meet Protocol Eligibility|1
5289538|NCT00491764|18242177|P2|Overall Study|Did not Meet Protocol Eligibility|1
5289539|NCT00491764|18242178|P1|Overall Study|Did not Meet Protocol Eligibility|0
5289540|NCT00491764|18242173|P6|Overall Study|Non Compliance with the Protocol|0
5289541|NCT00491764|18242174|P5|Overall Study|Non Compliance with the Protocol|0
5289542|NCT00491764|18242175|P4|Overall Study|Non Compliance with the Protocol|0
5289543|NCT00491764|18242176|P3|Overall Study|Non Compliance with the Protocol|0
5289544|NCT00491764|18242177|P2|Overall Study|Non Compliance with the Protocol|0
5289545|NCT00491764|18242178|P1|Overall Study|Non Compliance with the Protocol|1
5289546|NCT00491764|18242173|P6|Overall Study|Withdrawal by Subject|4
5289547|NCT00491764|18242174|P5|Overall Study|Withdrawal by Subject|2
5289548|NCT00491764|18242175|P4|Overall Study|Withdrawal by Subject|2
5289549|NCT00491764|18242176|P3|Overall Study|Withdrawal by Subject|1
5289550|NCT00491764|18242177|P2|Overall Study|Withdrawal by Subject|3
5289551|NCT00491764|18242178|P1|Overall Study|Withdrawal by Subject|2
5289552|NCT00491764|18242173|P6|Overall Study|Lost to Follow-up|3
5289553|NCT00491764|18242174|P5|Overall Study|Lost to Follow-up|0
5289554|NCT00491764|18242175|P4|Overall Study|Lost to Follow-up|1
5289555|NCT00491764|18242176|P3|Overall Study|Lost to Follow-up|0
5289556|NCT00491764|18242177|P2|Overall Study|Lost to Follow-up|1
5289557|NCT00491764|18242178|P1|Overall Study|Lost to Follow-up|0
5289558|NCT00491764|18242173|P6|Overall Study|Adverse Event|1
5289559|NCT00491764|18242174|P5|Overall Study|Adverse Event|0
5289560|NCT00491764|18242175|P4|Overall Study|Adverse Event|4
5289561|NCT00491764|18242176|P3|Overall Study|Adverse Event|4
5289562|NCT00491764|18242177|P2|Overall Study|Adverse Event|2
5289563|NCT00491764|18242178|P1|Overall Study|Adverse Event|1
5289564|NCT00491608|18242226|P1|Overall Study|Withdrawal by Subject|1
5289565|NCT00491608|18242226|P1|Overall Study|Death|2
5289566|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
5289567|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
5289568|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
5289569|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
5289570|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
5289571|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
5289572|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
5289573|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
5289574|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
5289575|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
5289576|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
5289577|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
5289578|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
5289579|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
5289580|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
5289581|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
5289582|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
5289583|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
5289584|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
5289585|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
5289586|NCT00491556|18242237|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
5289587|NCT00491556|18242238|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
5289588|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
5289589|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
5289590|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
5289591|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
5289592|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
5289593|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
5289594|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
5289595|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
5289596|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
5289597|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
5289598|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
5289599|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
5289600|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
5289601|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
5289602|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
5289603|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
5289604|NCT00491556|18242237|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
5289605|NCT00491556|18242238|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
5289606|NCT00491530|18242297|P3|Overall Study|Use of Prohibited Medication|1
5289607|NCT00491530|18242298|P2|Overall Study|Use of Prohibited Medication|0
5289608|NCT00491530|18242299|P1|Overall Study|Use of Prohibited Medication|0
5289609|NCT00491530|18242297|P3|Overall Study|Patient Request|0
5289610|NCT00491530|18242298|P2|Overall Study|Patient Request|1
5289611|NCT00491530|18242299|P1|Overall Study|Patient Request|0
5289612|NCT00491530|18242297|P3|Overall Study|Investigator Discretion|0
5289613|NCT00491530|18242298|P2|Overall Study|Investigator Discretion|1
5289614|NCT00491530|18242299|P1|Overall Study|Investigator Discretion|0
5289615|NCT00491530|18242297|P3|Overall Study|Lack of Efficacy|0
5289616|NCT00491530|18242298|P2|Overall Study|Lack of Efficacy|1
5289617|NCT00491530|18242299|P1|Overall Study|Lack of Efficacy|0
5289618|NCT00491530|18242297|P3|Overall Study|Lost to Follow-up|2
5289619|NCT00491530|18242298|P2|Overall Study|Lost to Follow-up|2
5289620|NCT00491530|18242299|P1|Overall Study|Lost to Follow-up|3
5289621|NCT00491530|18242297|P3|Overall Study|Withdrawal by Subject|0
5289622|NCT00491530|18242298|P2|Overall Study|Withdrawal by Subject|0
5289623|NCT00491530|18242299|P1|Overall Study|Withdrawal by Subject|3
5289624|NCT00491530|18242297|P3|Overall Study|Adverse Event|2
5289625|NCT00491530|18242298|P2|Overall Study|Adverse Event|1
5289626|NCT00491530|18242299|P1|Overall Study|Adverse Event|6
5289627|NCT00491504|18242329|P4|Overall Study|Protocol Violation|2
5289628|NCT00491504|18242330|P3|Overall Study|Protocol Violation|3
5289629|NCT00491504|18242331|P2|Overall Study|Protocol Violation|0
5289630|NCT00491504|18242332|P1|Overall Study|Protocol Violation|0
5289631|NCT00491504|18242329|P4|Overall Study|Withdrawal by Subject|2
5289632|NCT00491504|18242330|P3|Overall Study|Withdrawal by Subject|1
5289633|NCT00491504|18242331|P2|Overall Study|Withdrawal by Subject|0
5289634|NCT00491504|18242332|P1|Overall Study|Withdrawal by Subject|0
5289635|NCT00491504|18242329|P4|Overall Study|Adverse Event|0
5289636|NCT00491504|18242330|P3|Overall Study|Adverse Event|0
5289637|NCT00491504|18242331|P2|Overall Study|Adverse Event|1
5289638|NCT00491504|18242332|P1|Overall Study|Adverse Event|0
5289639|NCT00491400|18242361|P2|Overall Study|Withdrawal by Subject|4
5289640|NCT00491400|18242362|P1|Overall Study|Withdrawal by Subject|5
5289641|NCT00491387|18242370|P1|Overall Study|study terminated|20
5289642|NCT00491322|18242385|P2|Overall Study|Pregnancy|1
5289643|NCT00491322|18242386|P1|Overall Study|Pregnancy|0
5289644|NCT00491322|18242385|P2|Overall Study|Protocol Violation|0
5289645|NCT00491322|18242386|P1|Overall Study|Protocol Violation|1
5289646|NCT00491179|18242405|P2|Overall Study|Withdrawal by Subject|1
5289647|NCT00491179|18242406|P1|Overall Study|Withdrawal by Subject|2
5289648|NCT00491179|18242405|P2|Overall Study|Adverse Event|1
5289649|NCT00491179|18242406|P1|Overall Study|Adverse Event|5
5289650|NCT00491075|18242414|P1|Overall Study|Physician Decision|1
5289651|NCT00491075|18242414|P1|Overall Study|Withdrawal by Subject|1
5289652|NCT00490971|18242420|P5|Maintenance|Other|3
5289653|NCT00490971|18242421|P4|Maintenance|Other|9
5289654|NCT00490971|18242422|P3|Maintenance|Other|11
5289655|NCT00490971|18242423|P2|Maintenance|Other|0
5289656|NCT00490971|18242424|P1|Maintenance|Other|0
5289657|NCT00490971|18242420|P5|Maintenance|Withdrawal by Subject|18
5289658|NCT00490971|18242421|P4|Maintenance|Withdrawal by Subject|28
5289659|NCT00490971|18242422|P3|Maintenance|Withdrawal by Subject|26
5289660|NCT00490971|18242423|P2|Maintenance|Withdrawal by Subject|0
5289661|NCT00490971|18242424|P1|Maintenance|Withdrawal by Subject|0
5289662|NCT00490971|18242420|P5|Maintenance|Protocol Violation|1
5289663|NCT00490971|18242421|P4|Maintenance|Protocol Violation|1
5289664|NCT00490971|18242422|P3|Maintenance|Protocol Violation|4
5289665|NCT00490971|18242423|P2|Maintenance|Protocol Violation|0
5289666|NCT00490971|18242424|P1|Maintenance|Protocol Violation|0
5289667|NCT00490971|18242420|P5|Maintenance|Pregnancy|0
5289668|NCT00490971|18242421|P4|Maintenance|Pregnancy|0
5289669|NCT00490971|18242422|P3|Maintenance|Pregnancy|1
5289670|NCT00490971|18242423|P2|Maintenance|Pregnancy|0
5289671|NCT00490971|18242424|P1|Maintenance|Pregnancy|0
5289672|NCT00490971|18242420|P5|Maintenance|Lost to Follow-up|10
5289673|NCT00490971|18242421|P4|Maintenance|Lost to Follow-up|8
5289674|NCT00490971|18242422|P3|Maintenance|Lost to Follow-up|5
5289675|NCT00490971|18242423|P2|Maintenance|Lost to Follow-up|0
5289676|NCT00490971|18242424|P1|Maintenance|Lost to Follow-up|0
5289677|NCT00490971|18242420|P5|Maintenance|Death|0
5289678|NCT00490971|18242421|P4|Maintenance|Death|2
5289679|NCT00490971|18242422|P3|Maintenance|Death|0
5289680|NCT00490971|18242423|P2|Maintenance|Death|0
5289681|NCT00490971|18242424|P1|Maintenance|Death|0
5289682|NCT00490971|18242420|P5|Maintenance|Adverse Event|7
5289683|NCT00490971|18242421|P4|Maintenance|Adverse Event|5
5289684|NCT00490971|18242422|P3|Maintenance|Adverse Event|4
5289685|NCT00490971|18242423|P2|Maintenance|Adverse Event|0
5289686|NCT00490971|18242424|P1|Maintenance|Adverse Event|0
5289687|NCT00490971|18242420|P5|Acute/Continuation|Other|0
5289688|NCT00490971|18242421|P4|Acute/Continuation|Other|0
5289689|NCT00490971|18242422|P3|Acute/Continuation|Other|0
5289690|NCT00490971|18242423|P2|Acute/Continuation|Other|4
5289691|NCT00490971|18242424|P1|Acute/Continuation|Other|11
5289692|NCT00490971|18242420|P5|Acute/Continuation|Withdrawal by Subject|0
5289693|NCT00490971|18242421|P4|Acute/Continuation|Withdrawal by Subject|0
5289694|NCT00490971|18242422|P3|Acute/Continuation|Withdrawal by Subject|0
5289695|NCT00490971|18242423|P2|Acute/Continuation|Withdrawal by Subject|24
5289696|NCT00490971|18242424|P1|Acute/Continuation|Withdrawal by Subject|92
5289697|NCT00490971|18242420|P5|Acute/Continuation|Protocol Violation|0
5289698|NCT00490971|18242421|P4|Acute/Continuation|Protocol Violation|0
5289699|NCT00490971|18242422|P3|Acute/Continuation|Protocol Violation|0
5289700|NCT00490971|18242423|P2|Acute/Continuation|Protocol Violation|2
5289701|NCT00490971|18242424|P1|Acute/Continuation|Protocol Violation|10
5289702|NCT00490971|18242420|P5|Acute/Continuation|Lost to Follow-up|0
5289703|NCT00490971|18242421|P4|Acute/Continuation|Lost to Follow-up|0
5289704|NCT00490971|18242422|P3|Acute/Continuation|Lost to Follow-up|0
5289705|NCT00490971|18242423|P2|Acute/Continuation|Lost to Follow-up|7
5289706|NCT00490971|18242424|P1|Acute/Continuation|Lost to Follow-up|23
5289707|NCT00490971|18242420|P5|Acute/Continuation|Lack of Efficacy|0
5289708|NCT00490971|18242421|P4|Acute/Continuation|Lack of Efficacy|0
5289709|NCT00490971|18242422|P3|Acute/Continuation|Lack of Efficacy|0
5289710|NCT00490971|18242423|P2|Acute/Continuation|Lack of Efficacy|12
5289711|NCT00490971|18242424|P1|Acute/Continuation|Lack of Efficacy|106
5289712|NCT00490971|18242420|P5|Acute/Continuation|Death|0
5289713|NCT00490971|18242421|P4|Acute/Continuation|Death|0
5289714|NCT00490971|18242422|P3|Acute/Continuation|Death|0
5289715|NCT00490971|18242423|P2|Acute/Continuation|Death|0
5289716|NCT00490971|18242424|P1|Acute/Continuation|Death|2
5289717|NCT00490971|18242420|P5|Acute/Continuation|Adverse Event|0
5289718|NCT00490971|18242421|P4|Acute/Continuation|Adverse Event|0
5289719|NCT00490971|18242422|P3|Acute/Continuation|Adverse Event|0
5289720|NCT00490971|18242423|P2|Acute/Continuation|Adverse Event|13
5289721|NCT00490971|18242424|P1|Acute/Continuation|Adverse Event|62
5289722|NCT00490945|18242471|P5|Overall Study|Adverse Event|0
5289723|NCT00490945|18242472|P4|Overall Study|Adverse Event|0
5289724|NCT00490945|18242473|P3|Overall Study|Adverse Event|0
5289725|NCT00490945|18242474|P2|Overall Study|Adverse Event|1
5289726|NCT00490945|18242475|P1|Overall Study|Adverse Event|0
5289727|NCT00490919|18242511|P3|Double-blind Phase|Administrative|6
5289728|NCT00490919|18242512|P2|Double-blind Phase|Administrative|6
5289729|NCT00490919|18242513|P1|Double-blind Phase|Administrative|0
5289730|NCT00490919|18242511|P3|Double-blind Phase|Lack of Efficacy|36
5289731|NCT00490919|18242512|P2|Double-blind Phase|Lack of Efficacy|22
5289732|NCT00490919|18242513|P1|Double-blind Phase|Lack of Efficacy|0
5289733|NCT00490919|18242511|P3|Double-blind Phase|Lost to Follow-up|11
5289734|NCT00490919|18242512|P2|Double-blind Phase|Lost to Follow-up|8
5289735|NCT00490919|18242513|P1|Double-blind Phase|Lost to Follow-up|0
5289736|NCT00490919|18242511|P3|Double-blind Phase|Withdrawal by Subject|11
5289737|NCT00490919|18242512|P2|Double-blind Phase|Withdrawal by Subject|10
5289738|NCT00490919|18242513|P1|Double-blind Phase|Withdrawal by Subject|0
5289739|NCT00490919|18242511|P3|Double-blind Phase|Adverse Event|20
5289740|NCT00490919|18242512|P2|Double-blind Phase|Adverse Event|40
5289741|NCT00490919|18242513|P1|Double-blind Phase|Adverse Event|0
5289742|NCT00490919|18242511|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
5289743|NCT00490919|18242512|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
5289744|NCT00490919|18242513|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
5289745|NCT00490919|18242511|P3|Open-label Run-in Period|Administrative|0
5289746|NCT00490919|18242512|P2|Open-label Run-in Period|Administrative|0
5289747|NCT00490919|18242513|P1|Open-label Run-in Period|Administrative|40
5289748|NCT00490919|18242511|P3|Open-label Run-in Period|Lack of Efficacy|0
5289749|NCT00490919|18242512|P2|Open-label Run-in Period|Lack of Efficacy|0
5289750|NCT00490919|18242513|P1|Open-label Run-in Period|Lack of Efficacy|143
5289751|NCT00490919|18242511|P3|Open-label Run-in Period|Lost to Follow-up|0
5289752|NCT00490919|18242512|P2|Open-label Run-in Period|Lost to Follow-up|0
5289753|NCT00490919|18242513|P1|Open-label Run-in Period|Lost to Follow-up|21
5289754|NCT00490919|18242511|P3|Open-label Run-in Period|Withdrawal by Subject|0
5289755|NCT00490919|18242512|P2|Open-label Run-in Period|Withdrawal by Subject|0
5289756|NCT00490919|18242513|P1|Open-label Run-in Period|Withdrawal by Subject|37
5289757|NCT00490919|18242511|P3|Open-label Run-in Period|Adverse Event|0
5289758|NCT00490919|18242512|P2|Open-label Run-in Period|Adverse Event|0
5289759|NCT00490919|18242513|P1|Open-label Run-in Period|Adverse Event|239
5289760|NCT00490841|18242524|P1|Overall Study|30 day f/u, only non-study stent used|3
5289761|NCT00490841|18242524|P1|Overall Study|Lost to Follow-up|1
5289762|NCT00490841|18242524|P1|Overall Study|Withdrawal by Subject|4
5289763|NCT00490841|18242524|P1|Overall Study|Death|5
5289764|NCT00490815|18242546|P2|Overall Study|Death|3
5289765|NCT00490815|18242547|P1|Overall Study|Death|1
5289766|NCT00490815|18242546|P2|Overall Study|Lost to Follow-up|3
5289767|NCT00490815|18242547|P1|Overall Study|Lost to Follow-up|1
5289768|NCT00490815|18242546|P2|Overall Study|Withdrawal by Subject|0
5289769|NCT00490815|18242547|P1|Overall Study|Withdrawal by Subject|4
5289770|NCT00490815|18242546|P2|Overall Study|Adverse Event|3
5289771|NCT00490815|18242547|P1|Overall Study|Adverse Event|2
5289772|NCT00490724|18242575|P3|Period II|Treatment Discontinuation|3
5289773|NCT00490724|18242576|P2|Period II|Treatment Discontinuation|1
5289774|NCT00490724|18242577|P1|Period II|Treatment Discontinuation|3
5289775|NCT00490724|18242575|P3|Period I|Physician Decision|1
5289776|NCT00490724|18242576|P2|Period I|Physician Decision|0
5289777|NCT00490724|18242577|P1|Period I|Physician Decision|0
5289778|NCT00490698|18242642|P1|Overall Study|Physician Decision|2
5289779|NCT00490698|18242642|P1|Overall Study|Disease Progression|7
5289780|NCT00490698|18242642|P1|Overall Study|Withdrawal by Subject|1
5289781|NCT00490646|18242648|P2|Overall Study|Never Treated (withdrew consent)|1
5289782|NCT00490646|18242649|P1|Overall Study|Never Treated (withdrew consent)|0
5289783|NCT00490646|18242648|P2|Overall Study|Never Treated (had an adverse event)|0
5289784|NCT00490646|18242649|P1|Overall Study|Never Treated (had an adverse event)|1
5289785|NCT00490646|18242648|P2|Overall Study|Still on trastuzumab monotherapy|1
5289786|NCT00490646|18242649|P1|Overall Study|Still on trastuzumab monotherapy|1
5289787|NCT00490568|18242669|P1|Overall Study|Participant withdrawal due to surgery|1
5289788|NCT00490568|18242669|P1|Overall Study|Participant died|1
5289789|NCT00490568|18242669|P1|Overall Study|Efficacy related|3
5289790|NCT00490568|18242669|P1|Overall Study|Non-Compliance|7
5289791|NCT00490568|18242669|P1|Overall Study|Investigator decision|3
5289792|NCT00490568|18242669|P1|Overall Study|Unmet inclusion-exclusion criteria|5
5289793|NCT00490568|18242669|P1|Overall Study|Disease progression|4
5289794|NCT00490568|18242669|P1|Overall Study|Legal representative withdrew consent|1
5289795|NCT00490568|18242669|P1|Overall Study|Participant refused follow-up|9
5289796|NCT00490568|18242669|P1|Overall Study|Abnormal ECG|25
5289797|NCT00490568|18242669|P1|Overall Study|Caregiver related|20
5289798|NCT00490568|18242669|P1|Overall Study|Exclusion criteria met|1
5289799|NCT00490568|18242669|P1|Overall Study|Other|1
5289800|NCT00490568|18242669|P1|Overall Study|Still in the study at termination|974
5289801|NCT00490568|18242669|P1|Overall Study|Withdrawal by Subject|135
5289802|NCT00490568|18242669|P1|Overall Study|Protocol Violation|45
5289803|NCT00490568|18242669|P1|Overall Study|Lost to Follow-up|13
5289804|NCT00490568|18242669|P1|Overall Study|Adverse Event|116
5289805|NCT00490555|18242693|P4|Overall Study|noncompliant with drug administration|0
5289806|NCT00490555|18242694|P3|Overall Study|noncompliant with drug administration|2
5289807|NCT00490555|18242695|P2|Overall Study|noncompliant with drug administration|0
5289808|NCT00490555|18242696|P1|Overall Study|noncompliant with drug administration|0
5289809|NCT00490542|18242724|P2|Overall Study|Lack of Efficacy|1
5289810|NCT00490542|18242725|P1|Overall Study|Lack of Efficacy|1
5289811|NCT00490542|18242724|P2|Overall Study|Adverse Event|3
5289812|NCT00490542|18242725|P1|Overall Study|Adverse Event|3
5289813|NCT00490542|18242724|P2|Overall Study|Lost to Follow-up|0
5289814|NCT00490542|18242725|P1|Overall Study|Lost to Follow-up|3
5289815|NCT00490529|18242731|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
5289816|NCT00490529|18242731|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
5289817|NCT00490529|18242731|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
5289818|NCT00490529|18242731|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
5289819|NCT00490529|18242731|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
5289820|NCT00490529|18242731|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
5289821|NCT00490490|18242739|P1|Completed Assessment for TTP|Lost to Follow-up|2
5289822|NCT00490490|18242739|P1|Completed Assessment for TTP|Withdrawal by Subject|1
5289823|NCT00490451|18242756|P2|Overall Study|Progressive Disease|34
5289824|NCT00490451|18242757|P1|Overall Study|Progressive Disease|53
5289825|NCT00490451|18242756|P2|Overall Study|Protocol Violation|0
5289826|NCT00490451|18242757|P1|Overall Study|Protocol Violation|1
5289827|NCT00490451|18242756|P2|Overall Study|Investigator Decision|0
5289828|NCT00490451|18242757|P1|Overall Study|Investigator Decision|1
5289829|NCT00490451|18242756|P2|Overall Study|Withdrawal by Subject|0
5289830|NCT00490451|18242757|P1|Overall Study|Withdrawal by Subject|2
5289831|NCT00490451|18242756|P2|Overall Study|Death|1
5289832|NCT00490451|18242757|P1|Overall Study|Death|3
5289833|NCT00490451|18242756|P2|Overall Study|Adverse Event|3
5289834|NCT00490451|18242757|P1|Overall Study|Adverse Event|3
5289835|NCT00490139|18242799|P4|Overall Study|Participant Withdrew Consent|116
5289836|NCT00490139|18242800|P3|Overall Study|Participant Withdrew Consent|208
5289837|NCT00490139|18242801|P2|Overall Study|Participant Withdrew Consent|110
5289838|NCT00490139|18242802|P1|Overall Study|Participant Withdrew Consent|146
5289839|NCT00490139|18242799|P4|Overall Study|Lost to Follow-up|56
5289840|NCT00490139|18242800|P3|Overall Study|Lost to Follow-up|58
5289841|NCT00490139|18242801|P2|Overall Study|Lost to Follow-up|46
5289842|NCT00490139|18242802|P1|Overall Study|Lost to Follow-up|56
5289843|NCT00490139|18242799|P4|Overall Study|Death|135
5289844|NCT00490139|18242800|P3|Overall Study|Death|168
5289845|NCT00490139|18242801|P2|Overall Study|Death|119
5289846|NCT00490139|18242802|P1|Overall Study|Death|106
5289847|NCT00490061|18242837|P1|Overall Study|Physician Decision|1
5289848|NCT00490035|18242846|P4|Overall Study|AE of unknown type|0
5289849|NCT00490035|18242847|P3|Overall Study|AE of unknown type|2
5289850|NCT00490035|18242848|P2|Overall Study|AE of unknown type|0
5289851|NCT00490035|18242849|P1|Overall Study|AE of unknown type|0
5289852|NCT00490035|18242846|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
5289853|NCT00490035|18242847|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
5289854|NCT00490035|18242848|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
5289855|NCT00490035|18242849|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
5289856|NCT00490035|18242846|P4|Overall Study|AE, serious fatal|0
5289857|NCT00490035|18242847|P3|Overall Study|AE, serious fatal|0
5289858|NCT00490035|18242848|P2|Overall Study|AE, serious fatal|0
5289859|NCT00490035|18242849|P1|Overall Study|AE, serious fatal|1
5289860|NCT00490035|18242846|P4|Overall Study|Other reason|1
5289861|NCT00490035|18242847|P3|Overall Study|Other reason|3
5289862|NCT00490035|18242848|P2|Overall Study|Other reason|1
5289863|NCT00490035|18242849|P1|Overall Study|Other reason|0
5289864|NCT00490035|18242846|P4|Overall Study|Withdrawal by Subject|0
5289865|NCT00490035|18242847|P3|Overall Study|Withdrawal by Subject|1
5289866|NCT00490035|18242848|P2|Overall Study|Withdrawal by Subject|1
5289867|NCT00490035|18242849|P1|Overall Study|Withdrawal by Subject|2
5289868|NCT00490035|18242846|P4|Overall Study|Lost to Follow-up|0
5289869|NCT00490035|18242847|P3|Overall Study|Lost to Follow-up|1
5289870|NCT00490035|18242848|P2|Overall Study|Lost to Follow-up|0
5289871|NCT00490035|18242849|P1|Overall Study|Lost to Follow-up|2
5289872|NCT00490035|18242846|P4|Overall Study|AE, non-serious non-fatal|5
5289873|NCT00490035|18242847|P3|Overall Study|AE, non-serious non-fatal|4
5289874|NCT00490035|18242848|P2|Overall Study|AE, non-serious non-fatal|4
5289875|NCT00490035|18242849|P1|Overall Study|AE, non-serious non-fatal|3
5289876|NCT00490022|18242949|P2|Overall Study|Subject failed to disclose concommitant|1
5289877|NCT00490022|18242950|P1|Overall Study|Subject failed to disclose concommitant|0
5289878|NCT00490022|18242949|P2|Overall Study|Withdrawal by Subject|0
5289879|NCT00490022|18242950|P1|Overall Study|Withdrawal by Subject|1
5289880|NCT00490022|18242949|P2|Overall Study|Adverse Event|2
5289881|NCT00490022|18242950|P1|Overall Study|Adverse Event|0
5289882|NCT00489970|18242967|P3|Persistence Year 9|Other|2
5289883|NCT00489970|18242968|P2|Persistence Year 9|Other|0
5289884|NCT00489970|18242969|P1|Persistence Year 9|Other|1
5289885|NCT00489970|18242967|P3|Persistence Year 9|Lost to Follow-up|3
5289886|NCT00489970|18242968|P2|Persistence Year 9|Lost to Follow-up|2
5289887|NCT00489970|18242969|P1|Persistence Year 9|Lost to Follow-up|2
5289888|NCT00489918|18243073|P5|Overall Study|Physician Decision|0
5289889|NCT00489918|18243074|P4|Overall Study|Physician Decision|0
5289890|NCT00489918|18243075|P3|Overall Study|Physician Decision|1
5289891|NCT00489918|18243076|P2|Overall Study|Physician Decision|0
5289892|NCT00489918|18243077|P1|Overall Study|Physician Decision|0
5289893|NCT00489918|18243073|P5|Overall Study|Lost to Follow-up|0
5289894|NCT00489918|18243074|P4|Overall Study|Lost to Follow-up|1
5289895|NCT00489918|18243075|P3|Overall Study|Lost to Follow-up|1
5289896|NCT00489918|18243076|P2|Overall Study|Lost to Follow-up|0
5289897|NCT00489918|18243077|P1|Overall Study|Lost to Follow-up|0
5289898|NCT00489918|18243073|P5|Overall Study|Adverse Event|0
5289899|NCT00489918|18243074|P4|Overall Study|Adverse Event|0
5289900|NCT00489918|18243075|P3|Overall Study|Adverse Event|1
5289901|NCT00489918|18243076|P2|Overall Study|Adverse Event|1
5289902|NCT00489918|18243077|P1|Overall Study|Adverse Event|0
5289903|NCT00489918|18243073|P5|Overall Study|Withdrawal by Subject|1
5289904|NCT00489918|18243074|P4|Overall Study|Withdrawal by Subject|0
5289905|NCT00489918|18243075|P3|Overall Study|Withdrawal by Subject|1
5289906|NCT00489918|18243076|P2|Overall Study|Withdrawal by Subject|1
5289907|NCT00489918|18243077|P1|Overall Study|Withdrawal by Subject|2
5289908|NCT00489853|18243126|P3|Treatment Period 3|Study specific discontinuation criteria|0
5289909|NCT00489853|18243127|P2|Treatment Period 3|Study specific discontinuation criteria|1
5289910|NCT00489853|18243128|P1|Treatment Period 3|Study specific discontinuation criteria|0
5289911|NCT00489853|18243126|P3|Wash-out Period 2|Study specific discontinuation criteria|2
5289912|NCT00489853|18243127|P2|Wash-out Period 2|Study specific discontinuation criteria|2
5289913|NCT00489853|18243128|P1|Wash-out Period 2|Study specific discontinuation criteria|3
5289914|NCT00489853|18243126|P3|Wash-out Period 2|Adverse Event|0
5289915|NCT00489853|18243127|P2|Wash-out Period 2|Adverse Event|1
5289916|NCT00489853|18243128|P1|Wash-out Period 2|Adverse Event|1
5289917|NCT00489853|18243126|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
5289918|NCT00489853|18243127|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
5289919|NCT00489853|18243128|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
5289920|NCT00489853|18243126|P3|Wash-out Period 1|Protocol Violation|1
5289921|NCT00489853|18243127|P2|Wash-out Period 1|Protocol Violation|1
5289922|NCT00489853|18243128|P1|Wash-out Period 1|Protocol Violation|0
5289923|NCT00489853|18243126|P3|Wash-out Period 1|Adverse Event|1
5289924|NCT00489853|18243127|P2|Wash-out Period 1|Adverse Event|1
5289925|NCT00489853|18243128|P1|Wash-out Period 1|Adverse Event|0
5289926|NCT00489853|18243126|P3|Wash-out Period 1|Withdrawal by Subject|0
5289927|NCT00489853|18243127|P2|Wash-out Period 1|Withdrawal by Subject|0
5289928|NCT00489853|18243128|P1|Wash-out Period 1|Withdrawal by Subject|1
5289929|NCT00489827|18243225|P2|Overall Study|Intraoperative exclusion criteria|1
5289930|NCT00489827|18243226|P1|Overall Study|Intraoperative exclusion criteria|1
5289931|NCT00489827|18243225|P2|Overall Study|Intraoperative exclusion criteria|1
5289932|NCT00489827|18243226|P1|Overall Study|Intraoperative exclusion criteria|1
5289933|NCT00489736|18243250|P2|Overall Study|Not coded/ Not pre-specified|8
5289934|NCT00489736|18243251|P1|Overall Study|Not coded/ Not pre-specified|5
5289935|NCT00489736|18243250|P2|Overall Study|Poor compliance|2
5289936|NCT00489736|18243251|P1|Overall Study|Poor compliance|6
5289937|NCT00489736|18243250|P2|Overall Study|Adverse Event|45
5289938|NCT00489736|18243251|P1|Overall Study|Adverse Event|32
5289939|NCT00489736|18243250|P2|Overall Study|Lack of Efficacy|14
5289940|NCT00489736|18243251|P1|Overall Study|Lack of Efficacy|53
5289941|NCT00489554|18243261|P1|Overall Study|Lost to Follow-up|1
5289942|NCT00489554|18243261|P1|Overall Study|Withdrawal by Subject|1
5289943|NCT00489554|18243261|P1|Overall Study|Adverse Event|2
5289944|NCT00489541|18243281|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
5289945|NCT00489541|18243282|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
5289946|NCT00489541|18243281|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
5289947|NCT00489541|18243282|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
5289948|NCT00489541|18243281|P2|12-Month Clinical Follow-up|Death|2
5289949|NCT00489541|18243282|P1|12-Month Clinical Follow-up|Death|3
5289950|NCT00489541|18243281|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
5289951|NCT00489541|18243282|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
5289952|NCT00489541|18243281|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
5289953|NCT00489541|18243282|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
5289954|NCT00489541|18243281|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
5289955|NCT00489541|18243282|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
5289956|NCT00489489|18243293|P3|Overall Study|Other than above|0
5289957|NCT00489489|18243294|P2|Overall Study|Other than above|1
5289958|NCT00489489|18243295|P1|Overall Study|Other than above|0
5289959|NCT00489489|18243293|P3|Overall Study|Participant did not wish to continue|0
5289960|NCT00489489|18243294|P2|Overall Study|Participant did not wish to continue|1
5289961|NCT00489489|18243295|P1|Overall Study|Participant did not wish to continue|1
5289962|NCT00489489|18243293|P3|Overall Study|Progressive disease|0
5289963|NCT00489489|18243294|P2|Overall Study|Progressive disease|1
5289964|NCT00489489|18243295|P1|Overall Study|Progressive disease|0
5289965|NCT00489489|18243293|P3|Overall Study|Protocol Violation|1
5289966|NCT00489489|18243294|P2|Overall Study|Protocol Violation|0
5289967|NCT00489489|18243295|P1|Overall Study|Protocol Violation|1
5289968|NCT00489489|18243293|P3|Overall Study|Adverse Event|1
5289969|NCT00489489|18243294|P2|Overall Study|Adverse Event|1
5289970|NCT00489489|18243295|P1|Overall Study|Adverse Event|1
5289971|NCT00489489|18243293|P3|Overall Study|Not treated due to protocol violation|1
5289972|NCT00489489|18243294|P2|Overall Study|Not treated due to protocol violation|1
5289973|NCT00489489|18243295|P1|Overall Study|Not treated due to protocol violation|0
5289974|NCT00489476|18243327|P4|Overall Study|Lost to Follow-up|0
5289975|NCT00489476|18243328|P3|Overall Study|Lost to Follow-up|0
5289976|NCT00489476|18243329|P2|Overall Study|Lost to Follow-up|1
5289977|NCT00489476|18243330|P1|Overall Study|Lost to Follow-up|0
5289978|NCT00489424|18243351|P3|Overall Study|Administrative problems|1
5289979|NCT00489424|18243352|P2|Overall Study|Administrative problems|2
5289980|NCT00489424|18243353|P1|Overall Study|Administrative problems|0
5289981|NCT00489424|18243351|P3|Overall Study|Lack of Efficacy|0
5289982|NCT00489424|18243352|P2|Overall Study|Lack of Efficacy|0
5289983|NCT00489424|18243353|P1|Overall Study|Lack of Efficacy|1
5289984|NCT00489424|18243351|P3|Overall Study|Adverse Event|4
5289985|NCT00489424|18243352|P2|Overall Study|Adverse Event|3
5289986|NCT00489424|18243353|P1|Overall Study|Adverse Event|3
5289987|NCT00489411|18243384|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
5289988|NCT00489411|18243385|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
5289989|NCT00489411|18243384|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
5289990|NCT00489411|18243385|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
5289991|NCT00489411|18243384|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
5289992|NCT00489411|18243385|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
5289993|NCT00489411|18243384|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
5289994|NCT00489411|18243385|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
5289995|NCT00489411|18243384|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
5289996|NCT00489411|18243385|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
5289997|NCT00489359|18243399|P2|Overall Study|Adverse Event|16
5289998|NCT00489359|18243400|P1|Overall Study|Adverse Event|0
5289999|NCT00489359|18243399|P2|Overall Study|Withdrawal by Subject|5
5290000|NCT00489359|18243400|P1|Overall Study|Withdrawal by Subject|1
5290001|NCT00489359|18243399|P2|Overall Study|Lost to Follow-up|0
5290002|NCT00489359|18243400|P1|Overall Study|Lost to Follow-up|1
5290003|NCT00489359|18243399|P2|Overall Study|Progressive Disease|6
5290004|NCT00489359|18243400|P1|Overall Study|Progressive Disease|5
5290005|NCT00489359|18243399|P2|Overall Study|Death|2
5290006|NCT00489359|18243400|P1|Overall Study|Death|0
5290007|NCT00489255|18243476|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
5290008|NCT00489255|18243477|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
5290009|NCT00489255|18243476|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
5290010|NCT00489255|18243477|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
5290011|NCT00489255|18243476|P2|Period 3: Days 57 to 84|Adverse Event|3
5290012|NCT00489255|18243477|P1|Period 3: Days 57 to 84|Adverse Event|3
5290013|NCT00489255|18243476|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
5290014|NCT00489255|18243477|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
5290015|NCT00489255|18243476|P2|Period 2: Days 29 to 56|Adverse Event|1
5290016|NCT00489255|18243477|P1|Period 2: Days 29 to 56|Adverse Event|3
5290017|NCT00489255|18243476|P2|Period 1: Days 1 to 28|Noncompliance|0
5290018|NCT00489255|18243477|P1|Period 1: Days 1 to 28|Noncompliance|2
5290019|NCT00489255|18243476|P2|Period 1: Days 1 to 28|Physician Decision|4
5290020|NCT00489255|18243477|P1|Period 1: Days 1 to 28|Physician Decision|1
5290021|NCT00489255|18243476|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
5290022|NCT00489255|18243477|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
5290023|NCT00489255|18243476|P2|Period 1: Days 1 to 28|Adverse Event|8
5290024|NCT00489255|18243477|P1|Period 1: Days 1 to 28|Adverse Event|21
5290025|NCT00489255|18243476|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
5290026|NCT00489255|18243477|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
5290027|NCT00489216|18243525|P1|Overall Study|Adverse Event|1
5290028|NCT00488982|18243542|P3|Course 1|Adverse Event|6
5290029|NCT00488982|18243543|P2|Course 1|Adverse Event|0
5290030|NCT00488982|18243544|P1|Course 1|Adverse Event|0
5290031|NCT00488982|18243542|P3|Course 1|nonprotocol therapy|2
5290032|NCT00488982|18243543|P2|Course 1|nonprotocol therapy|2
5290033|NCT00488982|18243544|P1|Course 1|nonprotocol therapy|0
5290034|NCT00488982|18243542|P3|Course 1|Withdrawal by Subject|2
5290035|NCT00488982|18243543|P2|Course 1|Withdrawal by Subject|8
5290036|NCT00488982|18243544|P1|Course 1|Withdrawal by Subject|0
5290037|NCT00488982|18243542|P3|Course 1|Physician Decision|4
5290038|NCT00488982|18243543|P2|Course 1|Physician Decision|2
5290039|NCT00488982|18243544|P1|Course 1|Physician Decision|0
5290040|NCT00488826|18243567|P3|Overall Study|Protocol Deviations|1
5290041|NCT00488826|18243568|P2|Overall Study|Protocol Deviations|1
5290042|NCT00488826|18243569|P1|Overall Study|Protocol Deviations|2
5290043|NCT00488826|18243567|P3|Overall Study|Lost to Follow-up|0
5290044|NCT00488826|18243568|P2|Overall Study|Lost to Follow-up|1
5290045|NCT00488826|18243569|P1|Overall Study|Lost to Follow-up|5
5290046|NCT00488826|18243567|P3|Overall Study|Adverse Event|4
5290047|NCT00488826|18243568|P2|Overall Study|Adverse Event|15
5290048|NCT00488826|18243569|P1|Overall Study|Adverse Event|9
5290049|NCT00488826|18243567|P3|Overall Study|Protocol Violation|2
5290050|NCT00488826|18243568|P2|Overall Study|Protocol Violation|0
5290051|NCT00488826|18243569|P1|Overall Study|Protocol Violation|0
5290052|NCT00488826|18243567|P3|Overall Study|Withdrawal by Subject|19
5290053|NCT00488826|18243568|P2|Overall Study|Withdrawal by Subject|35
5290054|NCT00488826|18243569|P1|Overall Study|Withdrawal by Subject|40
5290055|NCT00488774|18243584|P4|Overall Study|Lost to Follow-up|1
5290056|NCT00488774|18243585|P3|Overall Study|Lost to Follow-up|1
5290057|NCT00488774|18243586|P2|Overall Study|Lost to Follow-up|0
5290058|NCT00488774|18243587|P1|Overall Study|Lost to Follow-up|0
5290059|NCT00488774|18243584|P4|Overall Study|Other|2
5290060|NCT00488774|18243585|P3|Overall Study|Other|2
5290061|NCT00488774|18243586|P2|Overall Study|Other|3
5290062|NCT00488774|18243587|P1|Overall Study|Other|6
5290063|NCT00488774|18243584|P4|Overall Study|Withdrawal of consent|0
5290064|NCT00488774|18243585|P3|Overall Study|Withdrawal of consent|2
5290065|NCT00488774|18243586|P2|Overall Study|Withdrawal of consent|2
5290066|NCT00488774|18243587|P1|Overall Study|Withdrawal of consent|2
5290067|NCT00488683|18243604|P3|Overall Study|Unable to Classify|0
5290068|NCT00488683|18243605|P2|Overall Study|Unable to Classify|0
5290069|NCT00488683|18243606|P1|Overall Study|Unable to Classify|1
5290070|NCT00488683|18243604|P3|Overall Study|Protocol Violation|0
5290071|NCT00488683|18243605|P2|Overall Study|Protocol Violation|1
5290072|NCT00488683|18243606|P1|Overall Study|Protocol Violation|5
5290073|NCT00488683|18243604|P3|Overall Study|Lost to Follow-up|0
5290074|NCT00488683|18243605|P2|Overall Study|Lost to Follow-up|3
5290075|NCT00488683|18243606|P1|Overall Study|Lost to Follow-up|5
5290076|NCT00488683|18243604|P3|Overall Study|Withdrawal by Subject|2
5290077|NCT00488683|18243605|P2|Overall Study|Withdrawal by Subject|2
5290078|NCT00488683|18243606|P1|Overall Study|Withdrawal by Subject|1
5290079|NCT00488644|18243665|P1|Overall Study|Not Evaluable|1
5290080|NCT00488644|18243665|P1|Overall Study|Not Eligible|1
5290081|NCT00488631|18243675|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290082|NCT00488631|18243676|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
5290083|NCT00488631|18243677|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
5290084|NCT00488631|18243678|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
5290085|NCT00488631|18243679|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290086|NCT00488631|18243680|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290087|NCT00488631|18243681|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290088|NCT00488631|18243682|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290089|NCT00488631|18243683|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290090|NCT00488631|18243684|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5290091|NCT00488631|18243675|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290092|NCT00488631|18243676|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
5290093|NCT00488631|18243677|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290094|NCT00488631|18243678|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
5290095|NCT00488631|18243679|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290096|NCT00488631|18243680|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290097|NCT00488631|18243681|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290098|NCT00488631|18243682|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290099|NCT00488631|18243683|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290100|NCT00488631|18243684|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5290101|NCT00488631|18243675|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
5290102|NCT00488631|18243676|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
5290103|NCT00488631|18243677|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
5290104|NCT00488631|18243678|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
5290105|NCT00488631|18243679|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5290106|NCT00488631|18243680|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5290107|NCT00488631|18243681|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5290108|NCT00488631|18243682|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5290109|NCT00488631|18243683|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5290110|NCT00488631|18243684|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5290111|NCT00488631|18243675|P10|Open Label Study Extension (Week 54-228)|Death|0
5290112|NCT00488631|18243676|P9|Open Label Study Extension (Week 54-228)|Death|1
5290113|NCT00488631|18243677|P8|Open Label Study Extension (Week 54-228)|Death|0
5290114|NCT00488631|18243678|P7|Open Label Study Extension (Week 54-228)|Death|0
5290115|NCT00488631|18243679|P6|Open Label Study Extension (Week 54-228)|Death|0
5290116|NCT00488631|18243680|P5|Open Label Study Extension (Week 54-228)|Death|0
5290117|NCT00488631|18243681|P4|Open Label Study Extension (Week 54-228)|Death|0
5290118|NCT00488631|18243682|P3|Open Label Study Extension (Week 54-228)|Death|0
5290119|NCT00488631|18243683|P2|Open Label Study Extension (Week 54-228)|Death|0
5290120|NCT00488631|18243684|P1|Open Label Study Extension (Week 54-228)|Death|0
5290121|NCT00488631|18243675|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290122|NCT00488631|18243676|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
5290123|NCT00488631|18243677|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
5290124|NCT00488631|18243678|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
5290125|NCT00488631|18243679|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290126|NCT00488631|18243680|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290127|NCT00488631|18243681|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290128|NCT00488631|18243682|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290129|NCT00488631|18243683|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290130|NCT00488631|18243684|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
5290131|NCT00488631|18243675|P10|Double Blind Period (Week 0-54)|Other|0
5290132|NCT00488631|18243676|P9|Double Blind Period (Week 0-54)|Other|0
5290133|NCT00488631|18243677|P8|Double Blind Period (Week 0-54)|Other|0
5290134|NCT00488631|18243678|P7|Double Blind Period (Week 0-54)|Other|0
5290135|NCT00488631|18243679|P6|Double Blind Period (Week 0-54)|Other|34
5290136|NCT00488631|18243680|P5|Double Blind Period (Week 0-54)|Other|14
5290137|NCT00488631|18243681|P4|Double Blind Period (Week 0-54)|Other|11
5290138|NCT00488631|18243682|P3|Double Blind Period (Week 0-54)|Other|10
5290139|NCT00488631|18243683|P2|Double Blind Period (Week 0-54)|Other|12
5290140|NCT00488631|18243684|P1|Double Blind Period (Week 0-54)|Other|6
5290141|NCT00488631|18243675|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5290142|NCT00488631|18243676|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5290143|NCT00488631|18243677|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5290144|NCT00488631|18243678|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5290145|NCT00488631|18243679|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
5290146|NCT00488631|18243680|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
5290147|NCT00488631|18243681|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5290148|NCT00488631|18243682|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
5290149|NCT00488631|18243683|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
5290150|NCT00488631|18243684|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
5290151|NCT00488631|18243675|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5290152|NCT00488631|18243676|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5290153|NCT00488631|18243677|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5290154|NCT00488631|18243678|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5290155|NCT00488631|18243679|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
5290156|NCT00488631|18243680|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
5290157|NCT00488631|18243681|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
5290158|NCT00488631|18243682|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
5290159|NCT00488631|18243683|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
5290160|NCT00488631|18243684|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
5290161|NCT00488631|18243675|P10|Double Blind Period (Week 0-54)|Death|0
5290162|NCT00488631|18243676|P9|Double Blind Period (Week 0-54)|Death|0
5290163|NCT00488631|18243677|P8|Double Blind Period (Week 0-54)|Death|0
5290164|NCT00488631|18243678|P7|Double Blind Period (Week 0-54)|Death|0
5290165|NCT00488631|18243679|P6|Double Blind Period (Week 0-54)|Death|1
5290166|NCT00488631|18243680|P5|Double Blind Period (Week 0-54)|Death|0
5290167|NCT00488631|18243681|P4|Double Blind Period (Week 0-54)|Death|0
5290168|NCT00488631|18243682|P3|Double Blind Period (Week 0-54)|Death|0
5290169|NCT00488631|18243683|P2|Double Blind Period (Week 0-54)|Death|0
5290170|NCT00488631|18243684|P1|Double Blind Period (Week 0-54)|Death|0
5290171|NCT00488631|18243675|P10|Double Blind Period (Week 0-54)|Adverse Event|0
5290172|NCT00488631|18243676|P9|Double Blind Period (Week 0-54)|Adverse Event|0
5290173|NCT00488631|18243677|P8|Double Blind Period (Week 0-54)|Adverse Event|0
5290174|NCT00488631|18243678|P7|Double Blind Period (Week 0-54)|Adverse Event|0
5290175|NCT00488631|18243679|P6|Double Blind Period (Week 0-54)|Adverse Event|50
5290176|NCT00488631|18243680|P5|Double Blind Period (Week 0-54)|Adverse Event|30
5290177|NCT00488631|18243681|P4|Double Blind Period (Week 0-54)|Adverse Event|12
5290178|NCT00488631|18243682|P3|Double Blind Period (Week 0-54)|Adverse Event|12
5290179|NCT00488631|18243683|P2|Double Blind Period (Week 0-54)|Adverse Event|12
5290180|NCT00488631|18243684|P1|Double Blind Period (Week 0-54)|Adverse Event|17
5290181|NCT00488618|18243721|P2|Overall Study|Lost to Follow-up|0
5290182|NCT00488618|18243722|P1|Overall Study|Lost to Follow-up|1
5290183|NCT00488618|18243721|P2|Overall Study|Withdrawal of Consent|13
5290184|NCT00488618|18243722|P1|Overall Study|Withdrawal of Consent|15
5290185|NCT00488618|18243721|P2|Overall Study|Protocol Violation|2
5290186|NCT00488618|18243722|P1|Overall Study|Protocol Violation|0
5290187|NCT00488618|18243721|P2|Overall Study|Insufficient Therapeutic Response|11
5290188|NCT00488618|18243722|P1|Overall Study|Insufficient Therapeutic Response|18
5290189|NCT00488618|18243721|P2|Overall Study|Adverse Event|17
5290190|NCT00488618|18243722|P1|Overall Study|Adverse Event|13
5290191|NCT00488592|18243730|P1|Overall Study|Enrolled but not treated|1
5290192|NCT00488592|18243730|P1|Overall Study|Disease progression|1
5290193|NCT00488592|18243730|P1|Overall Study|Withdrawal by Subject|1
5290194|NCT00488514|18243734|P1|Overall Study|Increased use of concomitant medication|1
5290195|NCT00488514|18243734|P1|Overall Study|Increase in number of migraines|2
5290196|NCT00488514|18243734|P1|Overall Study|Participant had too few migraines|5
5290197|NCT00488514|18243734|P1|Overall Study|Investigator decision|1
5290198|NCT00488514|18243734|P1|Overall Study|Withdrawn per medical monitor decision|2
5290199|NCT00488514|18243734|P1|Overall Study|Postive drug screen|1
5290200|NCT00488514|18243734|P1|Overall Study|Did not meet criteria for treatment|30
5290201|NCT00488514|18243734|P1|Overall Study|Lack of Efficacy|28
5290202|NCT00488514|18243734|P1|Overall Study|Withdrawal by Subject|106
5290203|NCT00488514|18243734|P1|Overall Study|Protocol Violation|32
5290204|NCT00488514|18243734|P1|Overall Study|Lost to Follow-up|44
5290205|NCT00488514|18243734|P1|Overall Study|Adverse Event|41
5290206|NCT00488475|18243822|P1|Overall Study|Other|1754
5290207|NCT00488345|18243851|P3|Overall Study|Parent/legal guardian request|1
5290208|NCT00488345|18243852|P2|Overall Study|Parent/legal guardian request|1
5290209|NCT00488345|18243853|P1|Overall Study|Parent/legal guardian request|0
5290210|NCT00488345|18243851|P3|Overall Study|Surgical team recommendation|0
5290211|NCT00488345|18243852|P2|Overall Study|Surgical team recommendation|1
5290212|NCT00488345|18243853|P1|Overall Study|Surgical team recommendation|0
5290213|NCT00488345|18243851|P3|Overall Study|Institutional Review Board review|1
5290214|NCT00488345|18243852|P2|Overall Study|Institutional Review Board review|0
5290215|NCT00488345|18243853|P1|Overall Study|Institutional Review Board review|0
5290216|NCT00488345|18243851|P3|Overall Study|Unable to administer antibiotics at home|0
5290217|NCT00488345|18243852|P2|Overall Study|Unable to administer antibiotics at home|1
5290218|NCT00488345|18243853|P1|Overall Study|Unable to administer antibiotics at home|0
5290219|NCT00488345|18243851|P3|Overall Study|Adverse Event|1
5290220|NCT00488345|18243852|P2|Overall Study|Adverse Event|1
5290221|NCT00488345|18243853|P1|Overall Study|Adverse Event|0
5290222|NCT00488319|18243879|P3|Overall Study|Other reasons for withdrawal|12
5290223|NCT00488319|18243880|P2|Overall Study|Other reasons for withdrawal|4
5290224|NCT00488319|18243881|P1|Overall Study|Other reasons for withdrawal|0
5290225|NCT00488319|18243879|P3|Overall Study|Withdrawal by Subject|44
5290226|NCT00488319|18243880|P2|Overall Study|Withdrawal by Subject|20
5290227|NCT00488319|18243881|P1|Overall Study|Withdrawal by Subject|5
5290228|NCT00488319|18243879|P3|Overall Study|Lost to Follow-up|16
5290229|NCT00488319|18243880|P2|Overall Study|Lost to Follow-up|5
5290230|NCT00488319|18243881|P1|Overall Study|Lost to Follow-up|3
5290231|NCT00488319|18243879|P3|Overall Study|Lack of Efficacy|27
5290232|NCT00488319|18243880|P2|Overall Study|Lack of Efficacy|12
5290233|NCT00488319|18243881|P1|Overall Study|Lack of Efficacy|6
5290234|NCT00488319|18243879|P3|Overall Study|Adverse Event|23
5290235|NCT00488319|18243880|P2|Overall Study|Adverse Event|2
5290236|NCT00488319|18243881|P1|Overall Study|Adverse Event|1
5290237|NCT00488293|18243968|P2|Overall Study|Misrandomization/Other Unspecified|1
5290238|NCT00488293|18243969|P1|Overall Study|Misrandomization/Other Unspecified|1
5290239|NCT00488293|18243968|P2|Overall Study|Death|1
5290240|NCT00488293|18243969|P1|Overall Study|Death|2
5290241|NCT00488293|18243968|P2|Overall Study|Withdrawal by Subject|3
5290242|NCT00488293|18243969|P1|Overall Study|Withdrawal by Subject|5
5290243|NCT00488293|18243968|P2|Overall Study|Lost to Follow-up|25
5290244|NCT00488293|18243969|P1|Overall Study|Lost to Follow-up|28
5290245|NCT00488033|18244014|P2|Overall Study|Withdrawal by Subject|0
5290246|NCT00488033|18244015|P1|Overall Study|Withdrawal by Subject|1
5290247|NCT00487981|18244031|P1|Overall Study|Hypothyroidism diagnosis|1
5290248|NCT00487942|18244039|P4|Overall Study|Withdrawal by Subject|0
5290249|NCT00487942|18244040|P3|Overall Study|Withdrawal by Subject|2
5290250|NCT00487942|18244041|P2|Overall Study|Withdrawal by Subject|1
5290251|NCT00487942|18244042|P1|Overall Study|Withdrawal by Subject|0
5290252|NCT00487942|18244039|P4|Overall Study|Protocol Violation|0
5290253|NCT00487942|18244040|P3|Overall Study|Protocol Violation|0
5290254|NCT00487942|18244041|P2|Overall Study|Protocol Violation|1
5290255|NCT00487942|18244042|P1|Overall Study|Protocol Violation|1
5290256|NCT00487942|18244039|P4|Overall Study|Lost to Follow-up|1
5290257|NCT00487942|18244040|P3|Overall Study|Lost to Follow-up|0
5290258|NCT00487942|18244041|P2|Overall Study|Lost to Follow-up|0
5290259|NCT00487942|18244042|P1|Overall Study|Lost to Follow-up|1
5290260|NCT00487942|18244039|P4|Overall Study|Adverse Event|1
5290261|NCT00487942|18244040|P3|Overall Study|Adverse Event|1
5290262|NCT00487942|18244041|P2|Overall Study|Adverse Event|1
5290263|NCT00487942|18244042|P1|Overall Study|Adverse Event|1
5290264|NCT00487825|18244426|P2|Overall Study|Other|2
5290265|NCT00487825|18244427|P1|Overall Study|Other|3
5290266|NCT00487825|18244426|P2|Overall Study|Lack of Efficacy|1
5290267|NCT00487825|18244427|P1|Overall Study|Lack of Efficacy|1
5290268|NCT00487825|18244426|P2|Overall Study|Adverse Event|2
5290269|NCT00487825|18244427|P1|Overall Study|Adverse Event|2
5290270|NCT00487747|18244439|P1|Overall Study|Lack of Efficacy|1
5290271|NCT00487747|18244439|P1|Overall Study|Lost to Follow-up|9
5290272|NCT00487747|18244439|P1|Overall Study|Adverse Event|1
5290273|NCT00487695|18244456|P2|Second Procedure|Withdrawal by Subject|2
5290274|NCT00487695|18244457|P1|Second Procedure|Withdrawal by Subject|1
5290275|NCT00487695|18244456|P2|Second Procedure|active wheezing|1
5290276|NCT00487695|18244457|P1|Second Procedure|active wheezing|0
5290277|NCT00487695|18244456|P2|First Procedure|esophageal stricture found (excl crit)|0
5290278|NCT00487695|18244457|P1|First Procedure|esophageal stricture found (excl crit)|1
5290279|NCT00487695|18244456|P2|First Procedure|active wheezing (did not have procedure)|0
5290280|NCT00487695|18244457|P1|First Procedure|active wheezing (did not have procedure)|1
5290281|NCT00487695|18244456|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
5290282|NCT00487695|18244457|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
5290283|NCT00487578|18244485|P2|Overall Study|Lost to Follow-up|1
5290284|NCT00487578|18244486|P1|Overall Study|Lost to Follow-up|0
5290285|NCT00487578|18244485|P2|Overall Study|Lack of Efficacy|1
5290286|NCT00487578|18244486|P1|Overall Study|Lack of Efficacy|0
5290287|NCT00487578|18244485|P2|Overall Study|Adverse Event|2
5290288|NCT00487578|18244486|P1|Overall Study|Adverse Event|1
5290289|NCT00487552|18244506|P1|Overall Study|Stent not placed|1
5290290|NCT00487552|18244506|P1|Overall Study|Death due to progressive malignancy|2
5290291|NCT00487552|18244506|P1|Overall Study|Unsuccessful magnet placements|3
5290292|NCT00487539|18244515|P4|Overall Study|Other|2
5290293|NCT00487539|18244516|P3|Overall Study|Other|2
5290294|NCT00487539|18244517|P2|Overall Study|Other|1
5290295|NCT00487539|18244518|P1|Overall Study|Other|3
5290296|NCT00487539|18244515|P4|Overall Study|Unsatisfactory therapeutic effect|1
5290297|NCT00487539|18244516|P3|Overall Study|Unsatisfactory therapeutic effect|0
5290298|NCT00487539|18244517|P2|Overall Study|Unsatisfactory therapeutic effect|0
5290299|NCT00487539|18244518|P1|Overall Study|Unsatisfactory therapeutic effect|1
5290300|NCT00487539|18244515|P4|Overall Study|Adverse Event|1
5290301|NCT00487539|18244516|P3|Overall Study|Adverse Event|1
5290302|NCT00487539|18244517|P2|Overall Study|Adverse Event|2
5290303|NCT00487539|18244518|P1|Overall Study|Adverse Event|3
5290304|NCT00487435|18244552|P1|Overall Study|Other|83
5290305|NCT00487435|18244552|P1|Overall Study|Study Medication Non-Compliant|32
5290306|NCT00487435|18244552|P1|Overall Study|Resolution Of Pain|1
5290307|NCT00487435|18244552|P1|Overall Study|Withdrawal by Subject|132
5290308|NCT00487435|18244552|P1|Overall Study|Pregnancy|2
5290309|NCT00487435|18244552|P1|Overall Study|Lost to Follow-up|54
5290310|NCT00487435|18244552|P1|Overall Study|Lack of Efficacy|33
5290311|NCT00487435|18244552|P1|Overall Study|Death|2
5290312|NCT00487435|18244552|P1|Overall Study|Adverse Event|146
5290313|NCT00487279|18244568|P2|Overall Study|Withdrawal by Subject|2
5290314|NCT00487279|18244569|P1|Overall Study|Withdrawal by Subject|0
5290315|NCT00487279|18244568|P2|Overall Study|Death|0
5290316|NCT00487279|18244569|P1|Overall Study|Death|1
5290317|NCT00487240|18244579|P2|Overall Study|Physician Decision|0
5290318|NCT00487240|18244580|P1|Overall Study|Physician Decision|2
5290319|NCT00487240|18244579|P2|Overall Study|Sponsor Decision|1
5290320|NCT00487240|18244580|P1|Overall Study|Sponsor Decision|2
5290321|NCT00487240|18244579|P2|Overall Study|Entry Criteria Not Met|4
5290322|NCT00487240|18244580|P1|Overall Study|Entry Criteria Not Met|3
5290323|NCT00487240|18244579|P2|Overall Study|Protocol Violation|5
5290324|NCT00487240|18244580|P1|Overall Study|Protocol Violation|5
5290325|NCT00487240|18244579|P2|Overall Study|Adverse Event|4
5290326|NCT00487240|18244580|P1|Overall Study|Adverse Event|0
5290327|NCT00487240|18244579|P2|Overall Study|Lost to Follow-up|6
5290328|NCT00487240|18244580|P1|Overall Study|Lost to Follow-up|7
5290329|NCT00487240|18244579|P2|Overall Study|Withdrawal by Subject|6
5290330|NCT00487240|18244580|P1|Overall Study|Withdrawal by Subject|12
5290331|NCT00487188|18244608|P3|Maintenance Phase|Administrative|1
5290332|NCT00487188|18244609|P2|Maintenance Phase|Administrative|0
5290333|NCT00487188|18244610|P1|Maintenance Phase|Administrative|0
5290334|NCT00487188|18244608|P3|Maintenance Phase|Lost to Follow-up|0
5290335|NCT00487188|18244609|P2|Maintenance Phase|Lost to Follow-up|0
5290336|NCT00487188|18244610|P1|Maintenance Phase|Lost to Follow-up|1
5290337|NCT00487188|18244608|P3|Maintenance Phase|Death|0
5290338|NCT00487188|18244609|P2|Maintenance Phase|Death|0
5290339|NCT00487188|18244610|P1|Maintenance Phase|Death|1
5290340|NCT00487188|18244608|P3|Maintenance Phase|Adverse Event|0
5290341|NCT00487188|18244609|P2|Maintenance Phase|Adverse Event|0
5290342|NCT00487188|18244610|P1|Maintenance Phase|Adverse Event|1
5290343|NCT00487188|18244608|P3|Induction Phase|Administrative|0
5290344|NCT00487188|18244609|P2|Induction Phase|Administrative|1
5290345|NCT00487188|18244610|P1|Induction Phase|Administrative|0
5290346|NCT00487188|18244608|P3|Induction Phase|Lost to Follow-up|0
5290347|NCT00487188|18244609|P2|Induction Phase|Lost to Follow-up|2
5290348|NCT00487188|18244610|P1|Induction Phase|Lost to Follow-up|2
5290349|NCT00487188|18244608|P3|Induction Phase|Refused Treatment|0
5290350|NCT00487188|18244609|P2|Induction Phase|Refused Treatment|2
5290351|NCT00487188|18244610|P1|Induction Phase|Refused Treatment|1
5290352|NCT00487188|18244608|P3|Induction Phase|Protocol Violation|0
5290353|NCT00487188|18244609|P2|Induction Phase|Protocol Violation|0
5290354|NCT00487188|18244610|P1|Induction Phase|Protocol Violation|1
5290355|NCT00487188|18244608|P3|Induction Phase|Lack of Efficacy|0
5290356|NCT00487188|18244609|P2|Induction Phase|Lack of Efficacy|1
5290357|NCT00487188|18244610|P1|Induction Phase|Lack of Efficacy|0
5290358|NCT00487188|18244608|P3|Induction Phase|Adverse Event|0
5290359|NCT00487188|18244609|P2|Induction Phase|Adverse Event|0
5290360|NCT00487188|18244610|P1|Induction Phase|Adverse Event|5
5290361|NCT00487188|18244608|P3|Induction Phase|Abnormality of Laboratory Test|0
5290362|NCT00487188|18244609|P2|Induction Phase|Abnormality of Laboratory Test|1
5290363|NCT00487188|18244610|P1|Induction Phase|Abnormality of Laboratory Test|0
5290364|NCT00487162|18244649|P2|Overall Study|Withdrawal by Subject|3
5290365|NCT00487162|18244650|P1|Overall Study|Withdrawal by Subject|2
5290366|NCT00487162|18244649|P2|Overall Study|Physician Decision|1
5290367|NCT00487162|18244650|P1|Overall Study|Physician Decision|0
5290368|NCT00487162|18244649|P2|Overall Study|Adverse Event|1
5290369|NCT00487162|18244650|P1|Overall Study|Adverse Event|0
5290370|NCT00487084|18244661|P3|Overall Study|Did not receive intervention|5
5290371|NCT00487084|18244662|P2|Overall Study|Did not receive intervention|3
5290372|NCT00487084|18244663|P1|Overall Study|Did not receive intervention|4
5290373|NCT00486954|18244684|P5|Randomized Part|Sponsor Terminated Study|13
5290374|NCT00486954|18244685|P4|Randomized Part|Sponsor Terminated Study|19
5290375|NCT00486954|18244686|P3|Randomized Part|Sponsor Terminated Study|0
5290376|NCT00486954|18244687|P2|Randomized Part|Sponsor Terminated Study|0
5290377|NCT00486954|18244688|P1|Randomized Part|Sponsor Terminated Study|0
5290378|NCT00486954|18244684|P5|Randomized Part|Withdrawal by Subject|0
5290379|NCT00486954|18244685|P4|Randomized Part|Withdrawal by Subject|1
5290380|NCT00486954|18244686|P3|Randomized Part|Withdrawal by Subject|0
5290381|NCT00486954|18244687|P2|Randomized Part|Withdrawal by Subject|0
5290382|NCT00486954|18244688|P1|Randomized Part|Withdrawal by Subject|0
5290383|NCT00486954|18244684|P5|Randomized Part|Lost to Follow-up|1
5290384|NCT00486954|18244685|P4|Randomized Part|Lost to Follow-up|0
5290385|NCT00486954|18244686|P3|Randomized Part|Lost to Follow-up|0
5290386|NCT00486954|18244687|P2|Randomized Part|Lost to Follow-up|0
5290387|NCT00486954|18244688|P1|Randomized Part|Lost to Follow-up|0
5290388|NCT00486954|18244684|P5|Pilot Part|Disease Progression|0
5290389|NCT00486954|18244685|P4|Pilot Part|Disease Progression|0
5290390|NCT00486954|18244686|P3|Pilot Part|Disease Progression|1
5290391|NCT00486954|18244687|P2|Pilot Part|Disease Progression|0
5290392|NCT00486954|18244688|P1|Pilot Part|Disease Progression|2
5290393|NCT00486954|18244684|P5|Pilot Part|Adverse Event|0
5290394|NCT00486954|18244685|P4|Pilot Part|Adverse Event|0
5290395|NCT00486954|18244686|P3|Pilot Part|Adverse Event|5
5290396|NCT00486954|18244687|P2|Pilot Part|Adverse Event|0
5290397|NCT00486954|18244688|P1|Pilot Part|Adverse Event|4
5290398|NCT00486902|18244786|P2|Overall Study|No toradol due to hemmorhage or allergy|1
5290399|NCT00486902|18244787|P1|Overall Study|No toradol due to hemmorhage or allergy|3
5290400|NCT00486902|18244786|P2|Overall Study|Did not meet inclusion criteria|0
5290401|NCT00486902|18244787|P1|Overall Study|Did not meet inclusion criteria|1
5290402|NCT00486902|18244786|P2|Overall Study|spinal anesthetic protocal violation|1
5290403|NCT00486902|18244787|P1|Overall Study|spinal anesthetic protocal violation|1
5290404|NCT00486902|18244786|P2|Overall Study|decision for postpartum tubal ligation|1
5290405|NCT00486902|18244787|P1|Overall Study|decision for postpartum tubal ligation|3
5290406|NCT00486902|18244786|P2|Overall Study|Withdrawal by Subject|2
5290407|NCT00486902|18244787|P1|Overall Study|Withdrawal by Subject|1
5290408|NCT00486837|18244854|P2|Overall Study|No sputum, devise issues, exacerbation|4
5290409|NCT00486837|18244855|P1|Overall Study|No sputum, devise issues, exacerbation|3
5290410|NCT00486837|18244854|P2|Overall Study|Protocol Violation|2
5290411|NCT00486837|18244855|P1|Overall Study|Protocol Violation|4
5290412|NCT00486837|18244854|P2|Overall Study|Adverse Event|1
5290413|NCT00486837|18244855|P1|Overall Study|Adverse Event|1
5290414|NCT00486837|18244854|P2|Overall Study|Withdrawal by Subject|0
5290415|NCT00486837|18244855|P1|Overall Study|Withdrawal by Subject|1
5290416|NCT00486811|18244895|P3|Overall Study|All other|7
5290417|NCT00486811|18244896|P2|Overall Study|All other|11
5290418|NCT00486811|18244897|P1|Overall Study|All other|18
5290419|NCT00486811|18244895|P3|Overall Study|Study drug non-compliant|3
5290420|NCT00486811|18244896|P2|Overall Study|Study drug non-compliant|6
5290421|NCT00486811|18244897|P1|Overall Study|Study drug non-compliant|5
5290422|NCT00486811|18244895|P3|Overall Study|Withdrawal by Subject|58
5290423|NCT00486811|18244896|P2|Overall Study|Withdrawal by Subject|44
5290424|NCT00486811|18244897|P1|Overall Study|Withdrawal by Subject|33
5290425|NCT00486811|18244895|P3|Overall Study|Lost to Follow-up|4
5290426|NCT00486811|18244896|P2|Overall Study|Lost to Follow-up|6
5290427|NCT00486811|18244897|P1|Overall Study|Lost to Follow-up|4
5290428|NCT00486811|18244895|P3|Overall Study|Lack of Efficacy|7
5290429|NCT00486811|18244896|P2|Overall Study|Lack of Efficacy|14
5290430|NCT00486811|18244897|P1|Overall Study|Lack of Efficacy|34
5290431|NCT00486811|18244895|P3|Overall Study|Adverse Event|135
5290432|NCT00486811|18244896|P2|Overall Study|Adverse Event|60
5290433|NCT00486811|18244897|P1|Overall Study|Adverse Event|28
5290434|NCT00486759|18244940|P2|Safety Follow-up|Adverse event/intercurrent illness|0
5290435|NCT00486759|18244941|P1|Safety Follow-up|Adverse event/intercurrent illness|4
5290436|NCT00486759|18244940|P2|Safety Follow-up|Refused treatment/did not cooperate|4
5290437|NCT00486759|18244941|P1|Safety Follow-up|Refused treatment/did not cooperate|6
5290438|NCT00486759|18244940|P2|Safety Follow-up|Administrative/not specified|6
5290439|NCT00486759|18244941|P1|Safety Follow-up|Administrative/not specified|8
5290440|NCT00486759|18244940|P2|Safety Follow-up|Failure to return|6
5290441|NCT00486759|18244941|P1|Safety Follow-up|Failure to return|9
5290442|NCT00486759|18244940|P2|Safety Follow-up|Withdrew consent|23
5290443|NCT00486759|18244941|P1|Safety Follow-up|Withdrew consent|32
5290444|NCT00486759|18244940|P2|Safety Follow-up|Death|29
5290445|NCT00486759|18244941|P1|Safety Follow-up|Death|40
5290446|NCT00486759|18244940|P2|Safety Follow-up|Insufficient therapeutic response|50
5290447|NCT00486759|18244941|P1|Safety Follow-up|Insufficient therapeutic response|40
5290448|NCT00486759|18244940|P2|Treatment|Failure to return|1
5290449|NCT00486759|18244941|P1|Treatment|Failure to return|1
5290450|NCT00486759|18244940|P2|Treatment|Other protocol violation|5
5290451|NCT00486759|18244941|P1|Treatment|Other protocol violation|1
5290452|NCT00486759|18244940|P2|Treatment|Violation of selection criteria at entry|3
5290453|NCT00486759|18244941|P1|Treatment|Violation of selection criteria at entry|3
5290454|NCT00486759|18244940|P2|Treatment|Refused treatment|7
5290455|NCT00486759|18244941|P1|Treatment|Refused treatment|10
5290456|NCT00486759|18244940|P2|Treatment|Administrative/reason not specified|21
5290457|NCT00486759|18244941|P1|Treatment|Administrative/reason not specified|17
5290458|NCT00486759|18244940|P2|Treatment|Withdrew consent|12
5290459|NCT00486759|18244941|P1|Treatment|Withdrew consent|15
5290460|NCT00486759|18244940|P2|Treatment|Death|10
5290461|NCT00486759|18244941|P1|Treatment|Death|17
5290462|NCT00486759|18244940|P2|Treatment|Insufficient therapeutic response|39
5290463|NCT00486759|18244941|P1|Treatment|Insufficient therapeutic response|37
5290464|NCT00486759|18244940|P2|Treatment|Adverse event/intercurrent illness|39
5290465|NCT00486759|18244941|P1|Treatment|Adverse event/intercurrent illness|86
5290466|NCT00486720|18244953|P2|Overall Study|Progressive Disease|1
5290467|NCT00486720|18244954|P1|Overall Study|Progressive Disease|0
5290468|NCT00486720|18244953|P2|Overall Study|Withdrawal by Subject|1
5290469|NCT00486720|18244954|P1|Overall Study|Withdrawal by Subject|3
5290470|NCT00486720|18244953|P2|Overall Study|Protocol Violation|0
5290471|NCT00486720|18244954|P1|Overall Study|Protocol Violation|1
5290472|NCT00486720|18244953|P2|Overall Study|Physician Decision|2
5290473|NCT00486720|18244954|P1|Overall Study|Physician Decision|1
5290474|NCT00486720|18244953|P2|Overall Study|Lack of Efficacy|6
5290475|NCT00486720|18244954|P1|Overall Study|Lack of Efficacy|4
5290476|NCT00486720|18244953|P2|Overall Study|Adverse Event|2
5290477|NCT00486720|18244954|P1|Overall Study|Adverse Event|1
5290478|NCT00486603|18244989|P5|Overall Study|Physician Decision|0
5290479|NCT00486603|18244990|P4|Overall Study|Physician Decision|0
5290480|NCT00486603|18244991|P3|Overall Study|Physician Decision|0
5290481|NCT00486603|18244992|P2|Overall Study|Physician Decision|1
5290482|NCT00486603|18244993|P1|Overall Study|Physician Decision|0
5290483|NCT00486603|18244989|P5|Overall Study|Withdrawal by Subject|0
5290484|NCT00486603|18244990|P4|Overall Study|Withdrawal by Subject|0
5290485|NCT00486603|18244991|P3|Overall Study|Withdrawal by Subject|0
5290486|NCT00486603|18244992|P2|Overall Study|Withdrawal by Subject|0
5290487|NCT00486603|18244993|P1|Overall Study|Withdrawal by Subject|1
5290488|NCT00486434|18245041|P2|Overall Study|Personal reasons|6
5290489|NCT00486434|18245042|P1|Overall Study|Personal reasons|5
5290490|NCT00486434|18245041|P2|Overall Study|Death|2
5290491|NCT00486434|18245042|P1|Overall Study|Death|1
5290492|NCT00486434|18245041|P2|Overall Study|Lost to Follow-up|3
5290493|NCT00486434|18245042|P1|Overall Study|Lost to Follow-up|2
5290494|NCT00486434|18245041|P2|Overall Study|Lack of Efficacy|19
5290495|NCT00486434|18245042|P1|Overall Study|Lack of Efficacy|12
5290496|NCT00486434|18245041|P2|Overall Study|Protocol Violation|21
5290497|NCT00486434|18245042|P1|Overall Study|Protocol Violation|22
5290498|NCT00486434|18245041|P2|Overall Study|Adverse Event|44
5290499|NCT00486434|18245042|P1|Overall Study|Adverse Event|118
5290500|NCT00486434|18245041|P2|Overall Study|Withdrawal by Subject|39
5290501|NCT00486434|18245042|P1|Overall Study|Withdrawal by Subject|34
5290502|NCT00486330|18245061|P1|Overall Study|Adverse Event|2
5290503|NCT00486291|18245067|P2|Overall Study|requirement for restricted medication|3
5290504|NCT00486291|18245068|P1|Overall Study|requirement for restricted medication|0
5290505|NCT00486291|18245067|P2|Overall Study|protocol non-compliance|15
5290506|NCT00486291|18245068|P1|Overall Study|protocol non-compliance|10
5290507|NCT00486291|18245067|P2|Overall Study|Lost to Follow-up|7
5290508|NCT00486291|18245068|P1|Overall Study|Lost to Follow-up|3
5290509|NCT00486291|18245067|P2|Overall Study|Adverse Event|4
5290510|NCT00486291|18245068|P1|Overall Study|Adverse Event|3
5290511|NCT00486278|18245076|P1|Overall Study|Physician Decision|2
5290512|NCT00486278|18245076|P1|Overall Study|Withdrawal by Subject|2
5290513|NCT00486278|18245076|P1|Overall Study|Adverse Event|5
5290514|NCT00486265|18245210|P1|Overall Study|Lack of Efficacy|8
5290515|NCT00486265|18245210|P1|Overall Study|Adverse Event|1
5290516|NCT00486252|18245214|P1|Overall Study|Other|18
5290517|NCT00486252|18245214|P1|Overall Study|Lost to Follow-up|24
5290518|NCT00486252|18245214|P1|Overall Study|Lack of Efficacy|9
5290519|NCT00486252|18245214|P1|Overall Study|Adverse Event|7
5290520|NCT00486226|18245229|P1|Overall Study|Lost to Follow-up|8
5290521|NCT00486226|18245229|P1|Overall Study|Withdrawal by Subject|1
5290522|NCT00486226|18245229|P1|Overall Study|Adverse Event|1
5290523|NCT00486226|18245229|P1|Overall Study|Death|3
5290524|NCT00486044|18245239|P2|Overall Study|Lost to Follow-up|1
5290525|NCT00486044|18245240|P1|Overall Study|Lost to Follow-up|0
5290526|NCT00486044|18245239|P2|Overall Study|Adverse Event|1
5290527|NCT00486044|18245240|P1|Overall Study|Adverse Event|0
5290528|NCT00486044|18245239|P2|Overall Study|Withdrawal by Subject|1
5290529|NCT00486044|18245240|P1|Overall Study|Withdrawal by Subject|2
5290530|NCT00485758|18245334|P2|Overall Study|Study Terminated by Sponsor|0
5290531|NCT00485758|18245335|P1|Overall Study|Study Terminated by Sponsor|3
5290532|NCT00485758|18245334|P2|Overall Study|Withdrawal by Subject|27
5290533|NCT00485758|18245335|P1|Overall Study|Withdrawal by Subject|32
5290534|NCT00485758|18245334|P2|Overall Study|Protocol Violation|2
5290535|NCT00485758|18245335|P1|Overall Study|Protocol Violation|11
5290536|NCT00485758|18245334|P2|Overall Study|Physician Decision|3
5290537|NCT00485758|18245335|P1|Overall Study|Physician Decision|3
5290538|NCT00485758|18245334|P2|Overall Study|Lost to Follow-up|1
5290539|NCT00485758|18245335|P1|Overall Study|Lost to Follow-up|5
5290540|NCT00485758|18245334|P2|Overall Study|Death|1
5290541|NCT00485758|18245335|P1|Overall Study|Death|0
5290542|NCT00485758|18245334|P2|Overall Study|Adverse Event|31
5290543|NCT00485758|18245335|P1|Overall Study|Adverse Event|102
5290544|NCT00485732|18245347|P2|Overall Study|Lost to Follow-up|2
5290545|NCT00485732|18245348|P1|Overall Study|Lost to Follow-up|2
5290546|NCT00485732|18245347|P2|Overall Study|Withdrawal by Subject|4
5290547|NCT00485732|18245348|P1|Overall Study|Withdrawal by Subject|5
5290548|NCT00485732|18245347|P2|Overall Study|Protocol Violation|3
5290549|NCT00485732|18245348|P1|Overall Study|Protocol Violation|1
5290550|NCT00485589|18245383|P3|Overall Study|Adverse Event|10
5290551|NCT00485589|18245384|P2|Overall Study|Adverse Event|3
5290552|NCT00485589|18245385|P1|Overall Study|Adverse Event|3
5290553|NCT00485589|18245383|P3|Overall Study|Withdrawal by Subject|2
5290554|NCT00485589|18245384|P2|Overall Study|Withdrawal by Subject|2
5290555|NCT00485589|18245385|P1|Overall Study|Withdrawal by Subject|3
5290556|NCT00485589|18245383|P3|Overall Study|Refused treatment/did not cooperate|2
5290557|NCT00485589|18245384|P2|Overall Study|Refused treatment/did not cooperate|0
5290558|NCT00485589|18245385|P1|Overall Study|Refused treatment/did not cooperate|1
5290559|NCT00485589|18245383|P3|Overall Study|Insufficient therapeutic response|1
5290560|NCT00485589|18245384|P2|Overall Study|Insufficient therapeutic response|3
5290561|NCT00485589|18245385|P1|Overall Study|Insufficient therapeutic response|10
5290562|NCT00485589|18245383|P3|Overall Study|Administrative/Other|1
5290563|NCT00485589|18245384|P2|Overall Study|Administrative/Other|2
5290564|NCT00485589|18245385|P1|Overall Study|Administrative/Other|1
5290565|NCT00485589|18245383|P3|Overall Study|Violation of selection criteria at entry|1
5290566|NCT00485589|18245384|P2|Overall Study|Violation of selection criteria at entry|3
5290567|NCT00485589|18245385|P1|Overall Study|Violation of selection criteria at entry|0
5290568|NCT00485589|18245383|P3|Overall Study|Protocol Violation|0
5290569|NCT00485589|18245384|P2|Overall Study|Protocol Violation|0
5290570|NCT00485589|18245385|P1|Overall Study|Protocol Violation|1
5290571|NCT00485589|18245383|P3|Overall Study|Failure to return|1
5290572|NCT00485589|18245384|P2|Overall Study|Failure to return|5
5290573|NCT00485589|18245385|P1|Overall Study|Failure to return|6
5290574|NCT00485589|18245383|P3|Overall Study|Death|0
5290575|NCT00485589|18245384|P2|Overall Study|Death|2
5290576|NCT00485589|18245385|P1|Overall Study|Death|2
5290577|NCT00485472|18245417|P2|Overall Study|Lost to Follow-up|1
5290578|NCT00485472|18245418|P1|Overall Study|Lost to Follow-up|0
5290579|NCT00485472|18245417|P2|Overall Study|Other|1
5290580|NCT00485472|18245418|P1|Overall Study|Other|2
5290581|NCT00485472|18245417|P2|Overall Study|Protocol Violation|1
5290582|NCT00485472|18245418|P1|Overall Study|Protocol Violation|0
5290583|NCT00485472|18245417|P2|Overall Study|Withdrawal by Subject|0
5290584|NCT00485472|18245418|P1|Overall Study|Withdrawal by Subject|1
5290585|NCT00485472|18245417|P2|Overall Study|Lack of Efficacy|4
5290586|NCT00485472|18245418|P1|Overall Study|Lack of Efficacy|5
5290587|NCT00485472|18245417|P2|Overall Study|Adverse Event|5
5290588|NCT00485472|18245418|P1|Overall Study|Adverse Event|8
5290589|NCT00485303|18245455|P1|Overall Study|Treatment ongoing at cutoff date|2
5290590|NCT00485303|18245455|P1|Overall Study|Initiation of new anti-cancer treatment|2
5290591|NCT00485303|18245455|P1|Overall Study|Other|3
5290592|NCT00485303|18245455|P1|Overall Study|Progressive Disease|44
5290593|NCT00485303|18245455|P1|Overall Study|Adverse Event|5
5290594|NCT00485264|18245473|P6|Overall Study|Other Reason|0
5290595|NCT00485264|18245474|P5|Overall Study|Other Reason|0
5290596|NCT00485264|18245475|P4|Overall Study|Other Reason|0
5290597|NCT00485264|18245476|P3|Overall Study|Other Reason|0
5290598|NCT00485264|18245477|P2|Overall Study|Other Reason|0
5290599|NCT00485264|18245478|P1|Overall Study|Other Reason|3
5290600|NCT00485264|18245473|P6|Overall Study|Lost to Follow-up|1
5290601|NCT00485264|18245474|P5|Overall Study|Lost to Follow-up|0
5290602|NCT00485264|18245475|P4|Overall Study|Lost to Follow-up|0
5290603|NCT00485264|18245476|P3|Overall Study|Lost to Follow-up|1
5290604|NCT00485264|18245477|P2|Overall Study|Lost to Follow-up|1
5290605|NCT00485264|18245478|P1|Overall Study|Lost to Follow-up|2
5290606|NCT00485264|18245473|P6|Overall Study|Non-Compliant|0
5290607|NCT00485264|18245474|P5|Overall Study|Non-Compliant|1
5290608|NCT00485264|18245475|P4|Overall Study|Non-Compliant|0
5290609|NCT00485264|18245476|P3|Overall Study|Non-Compliant|1
5290610|NCT00485264|18245477|P2|Overall Study|Non-Compliant|2
5290611|NCT00485264|18245478|P1|Overall Study|Non-Compliant|17
5290612|NCT00485264|18245473|P6|Overall Study|Not Able to Attend Clinic|2
5290613|NCT00485264|18245474|P5|Overall Study|Not Able to Attend Clinic|1
5290614|NCT00485264|18245475|P4|Overall Study|Not Able to Attend Clinic|1
5290615|NCT00485264|18245476|P3|Overall Study|Not Able to Attend Clinic|0
5290616|NCT00485264|18245477|P2|Overall Study|Not Able to Attend Clinic|0
5290617|NCT00485264|18245478|P1|Overall Study|Not Able to Attend Clinic|5
5290618|NCT00485264|18245473|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
5290619|NCT00485264|18245474|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
5290620|NCT00485264|18245475|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
5290621|NCT00485264|18245476|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
5290622|NCT00485264|18245477|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
5290623|NCT00485264|18245478|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
5290624|NCT00485264|18245473|P6|Overall Study|Physician Decision|0
5290625|NCT00485264|18245474|P5|Overall Study|Physician Decision|0
5290626|NCT00485264|18245475|P4|Overall Study|Physician Decision|0
5290627|NCT00485264|18245476|P3|Overall Study|Physician Decision|0
5290628|NCT00485264|18245477|P2|Overall Study|Physician Decision|2
5290629|NCT00485264|18245478|P1|Overall Study|Physician Decision|0
5290630|NCT00485264|18245473|P6|Overall Study|Guardian Consent Withdrawn|0
5290631|NCT00485264|18245474|P5|Overall Study|Guardian Consent Withdrawn|1
5290632|NCT00485264|18245475|P4|Overall Study|Guardian Consent Withdrawn|0
5290633|NCT00485264|18245476|P3|Overall Study|Guardian Consent Withdrawn|0
5290634|NCT00485264|18245477|P2|Overall Study|Guardian Consent Withdrawn|0
5290635|NCT00485264|18245478|P1|Overall Study|Guardian Consent Withdrawn|1
5290636|NCT00485264|18245473|P6|Overall Study|Lack of Efficacy|0
5290637|NCT00485264|18245474|P5|Overall Study|Lack of Efficacy|0
5290638|NCT00485264|18245475|P4|Overall Study|Lack of Efficacy|0
5290639|NCT00485264|18245476|P3|Overall Study|Lack of Efficacy|0
5290640|NCT00485264|18245477|P2|Overall Study|Lack of Efficacy|1
5290641|NCT00485264|18245478|P1|Overall Study|Lack of Efficacy|0
5290642|NCT00485264|18245473|P6|Overall Study|Number/Volume/Timing of Study Meds|0
5290643|NCT00485264|18245474|P5|Overall Study|Number/Volume/Timing of Study Meds|0
5290644|NCT00485264|18245475|P4|Overall Study|Number/Volume/Timing of Study Meds|0
5290645|NCT00485264|18245476|P3|Overall Study|Number/Volume/Timing of Study Meds|1
5290646|NCT00485264|18245477|P2|Overall Study|Number/Volume/Timing of Study Meds|1
5290647|NCT00485264|18245478|P1|Overall Study|Number/Volume/Timing of Study Meds|2
5290648|NCT00485264|18245473|P6|Overall Study|Disallowed Medication|1
5290649|NCT00485264|18245474|P5|Overall Study|Disallowed Medication|0
5290650|NCT00485264|18245475|P4|Overall Study|Disallowed Medication|0
5290651|NCT00485264|18245476|P3|Overall Study|Disallowed Medication|0
5290652|NCT00485264|18245477|P2|Overall Study|Disallowed Medication|0
5290653|NCT00485264|18245478|P1|Overall Study|Disallowed Medication|0
5290654|NCT00485264|18245473|P6|Overall Study|Pregnancy|0
5290655|NCT00485264|18245474|P5|Overall Study|Pregnancy|0
5290656|NCT00485264|18245475|P4|Overall Study|Pregnancy|0
5290657|NCT00485264|18245476|P3|Overall Study|Pregnancy|0
5290658|NCT00485264|18245477|P2|Overall Study|Pregnancy|0
5290659|NCT00485264|18245478|P1|Overall Study|Pregnancy|4
5290660|NCT00485264|18245473|P6|Overall Study|Adverse Event|3
5290661|NCT00485264|18245474|P5|Overall Study|Adverse Event|1
5290662|NCT00485264|18245475|P4|Overall Study|Adverse Event|3
5290663|NCT00485264|18245476|P3|Overall Study|Adverse Event|2
5290664|NCT00485264|18245477|P2|Overall Study|Adverse Event|0
5290665|NCT00485264|18245478|P1|Overall Study|Adverse Event|1
5290666|NCT00485264|18245473|P6|Overall Study|Death|0
5290667|NCT00485264|18245474|P5|Overall Study|Death|1
5290668|NCT00485264|18245475|P4|Overall Study|Death|0
5290669|NCT00485264|18245476|P3|Overall Study|Death|0
5290670|NCT00485264|18245477|P2|Overall Study|Death|0
5290671|NCT00485264|18245478|P1|Overall Study|Death|1
5290672|NCT00485264|18245473|P6|Overall Study|Enrolled But Not Given Treatment|0
5290673|NCT00485264|18245474|P5|Overall Study|Enrolled But Not Given Treatment|1
5290674|NCT00485264|18245475|P4|Overall Study|Enrolled But Not Given Treatment|0
5290675|NCT00485264|18245476|P3|Overall Study|Enrolled But Not Given Treatment|0
5290676|NCT00485264|18245477|P2|Overall Study|Enrolled But Not Given Treatment|0
5290677|NCT00485264|18245478|P1|Overall Study|Enrolled But Not Given Treatment|0
5290678|NCT00485173|18245566|P2|Overall Study|Lost to Follow-up|61
5290679|NCT00485173|18245567|P1|Overall Study|Lost to Follow-up|32
5290680|NCT00485173|18245566|P2|Overall Study|Death|3
5290681|NCT00485173|18245567|P1|Overall Study|Death|4
5290682|NCT00485134|18245615|P8|Overall Study|Pregnancy|0
5290683|NCT00485134|18245616|P7|Overall Study|Pregnancy|1
5290684|NCT00485134|18245617|P6|Overall Study|Pregnancy|0
5290685|NCT00485134|18245618|P5|Overall Study|Pregnancy|0
5290686|NCT00485134|18245619|P4|Overall Study|Pregnancy|0
5290687|NCT00485134|18245620|P3|Overall Study|Pregnancy|0
5290688|NCT00485134|18245621|P2|Overall Study|Pregnancy|0
5290689|NCT00485134|18245622|P1|Overall Study|Pregnancy|0
5290690|NCT00485134|18245615|P8|Overall Study|Unable to comply with study schedule|1
5290691|NCT00485134|18245616|P7|Overall Study|Unable to comply with study schedule|0
5290692|NCT00485134|18245617|P6|Overall Study|Unable to comply with study schedule|0
5290693|NCT00485134|18245618|P5|Overall Study|Unable to comply with study schedule|0
5290694|NCT00485134|18245619|P4|Overall Study|Unable to comply with study schedule|0
5290695|NCT00485134|18245620|P3|Overall Study|Unable to comply with study schedule|0
5290696|NCT00485134|18245621|P2|Overall Study|Unable to comply with study schedule|0
5290697|NCT00485134|18245622|P1|Overall Study|Unable to comply with study schedule|0
5290698|NCT00485134|18245615|P8|Overall Study|Non-compliance|0
5290699|NCT00485134|18245616|P7|Overall Study|Non-compliance|2
5290700|NCT00485134|18245617|P6|Overall Study|Non-compliance|2
5290701|NCT00485134|18245618|P5|Overall Study|Non-compliance|1
5290702|NCT00485134|18245619|P4|Overall Study|Non-compliance|0
5290703|NCT00485134|18245620|P3|Overall Study|Non-compliance|0
5290704|NCT00485134|18245621|P2|Overall Study|Non-compliance|0
5290705|NCT00485134|18245622|P1|Overall Study|Non-compliance|0
5290706|NCT00485134|18245615|P8|Overall Study|Positive drug test|0
5290707|NCT00485134|18245616|P7|Overall Study|Positive drug test|0
5290708|NCT00485134|18245617|P6|Overall Study|Positive drug test|1
5290709|NCT00485134|18245618|P5|Overall Study|Positive drug test|2
5290710|NCT00485134|18245619|P4|Overall Study|Positive drug test|0
5290711|NCT00485134|18245620|P3|Overall Study|Positive drug test|0
5290712|NCT00485134|18245621|P2|Overall Study|Positive drug test|0
5290713|NCT00485134|18245622|P1|Overall Study|Positive drug test|0
5290714|NCT00485134|18245615|P8|Overall Study|Withdrew for adverse event|0
5290715|NCT00485134|18245616|P7|Overall Study|Withdrew for adverse event|0
5290716|NCT00485134|18245617|P6|Overall Study|Withdrew for adverse event|0
5290717|NCT00485134|18245618|P5|Overall Study|Withdrew for adverse event|0
5290718|NCT00485134|18245619|P4|Overall Study|Withdrew for adverse event|0
5290719|NCT00485134|18245620|P3|Overall Study|Withdrew for adverse event|1
5290720|NCT00485134|18245621|P2|Overall Study|Withdrew for adverse event|0
5290721|NCT00485134|18245622|P1|Overall Study|Withdrew for adverse event|0
5290722|NCT00485134|18245615|P8|Overall Study|Change in health status|0
5290723|NCT00485134|18245616|P7|Overall Study|Change in health status|0
5290724|NCT00485134|18245617|P6|Overall Study|Change in health status|1
5290725|NCT00485134|18245618|P5|Overall Study|Change in health status|0
5290726|NCT00485134|18245619|P4|Overall Study|Change in health status|1
5290727|NCT00485134|18245620|P3|Overall Study|Change in health status|2
5290728|NCT00485134|18245621|P2|Overall Study|Change in health status|1
5290729|NCT00485134|18245622|P1|Overall Study|Change in health status|0
5290730|NCT00485134|18245615|P8|Overall Study|Withdrawal by Subject|0
5290731|NCT00485134|18245616|P7|Overall Study|Withdrawal by Subject|0
5290732|NCT00485134|18245617|P6|Overall Study|Withdrawal by Subject|0
5290733|NCT00485134|18245618|P5|Overall Study|Withdrawal by Subject|0
5290734|NCT00485134|18245619|P4|Overall Study|Withdrawal by Subject|0
5290735|NCT00485134|18245620|P3|Overall Study|Withdrawal by Subject|0
5290736|NCT00485134|18245621|P2|Overall Study|Withdrawal by Subject|1
5290737|NCT00485134|18245622|P1|Overall Study|Withdrawal by Subject|0
5290738|NCT00485134|18245615|P8|Overall Study|Lost to Follow-up|0
5290739|NCT00485134|18245616|P7|Overall Study|Lost to Follow-up|0
5290740|NCT00485134|18245617|P6|Overall Study|Lost to Follow-up|0
5290741|NCT00485134|18245618|P5|Overall Study|Lost to Follow-up|0
5290742|NCT00485134|18245619|P4|Overall Study|Lost to Follow-up|0
5290743|NCT00485134|18245620|P3|Overall Study|Lost to Follow-up|0
5290744|NCT00485134|18245621|P2|Overall Study|Lost to Follow-up|0
5290745|NCT00485134|18245622|P1|Overall Study|Lost to Follow-up|1
5290746|NCT00485069|18245644|P2|Overall Study|Withdrawal by Subject|6
5290747|NCT00485069|18245645|P1|Overall Study|Withdrawal by Subject|6
5290748|NCT00485069|18245644|P2|Overall Study|Protocol Violation|1
5290749|NCT00485069|18245645|P1|Overall Study|Protocol Violation|0
5290750|NCT00485069|18245644|P2|Overall Study|Lack of Efficacy|1
5290751|NCT00485069|18245645|P1|Overall Study|Lack of Efficacy|2
5290752|NCT00485069|18245644|P2|Overall Study|Adverse Event|4
5290753|NCT00485069|18245645|P1|Overall Study|Adverse Event|10
5290754|NCT00484939|18245690|P2|Overall Study|Reason Not Specified|6
5290755|NCT00484939|18245691|P1|Overall Study|Reason Not Specified|11
5290756|NCT00484939|18245690|P2|Overall Study|Screen Failure|2
5290757|NCT00484939|18245691|P1|Overall Study|Screen Failure|2
5290758|NCT00484939|18245690|P2|Overall Study|Disease progression|88
5290759|NCT00484939|18245691|P1|Overall Study|Disease progression|67
5290760|NCT00484939|18245690|P2|Overall Study|Discretion of Investigator or Sponsor|3
5290761|NCT00484939|18245691|P1|Overall Study|Discretion of Investigator or Sponsor|7
5290762|NCT00484939|18245690|P2|Overall Study|Lost to Follow-up|3
5290763|NCT00484939|18245691|P1|Overall Study|Lost to Follow-up|0
5290764|NCT00484939|18245690|P2|Overall Study|Protocol Violation|3
5290765|NCT00484939|18245691|P1|Overall Study|Protocol Violation|3
5290766|NCT00484939|18245690|P2|Overall Study|Patient Withdrew Consent|10
5290767|NCT00484939|18245691|P1|Overall Study|Patient Withdrew Consent|19
5290768|NCT00484939|18245690|P2|Overall Study|Adverse Event|12
5290769|NCT00484939|18245691|P1|Overall Study|Adverse Event|22
5290770|NCT00484939|18245690|P2|Overall Study|Death|13
5290771|NCT00484939|18245691|P1|Overall Study|Death|9
5290772|NCT00484679|18245718|P1|Overall Study|Withdrawal by Subject|3
5290773|NCT00484419|18245725|P3|Overall Study|sponsor decision, randomized in error|2
5290774|NCT00484419|18245726|P2|Overall Study|sponsor decision, randomized in error|0
5290775|NCT00484419|18245727|P1|Overall Study|sponsor decision, randomized in error|0
5290776|NCT00484419|18245725|P3|Overall Study|subject relocated|0
5290777|NCT00484419|18245726|P2|Overall Study|subject relocated|1
5290778|NCT00484419|18245727|P1|Overall Study|subject relocated|0
5290779|NCT00484419|18245725|P3|Overall Study|subject unable to receive medication|0
5290780|NCT00484419|18245726|P2|Overall Study|subject unable to receive medication|0
5290781|NCT00484419|18245727|P1|Overall Study|subject unable to receive medication|1
5290782|NCT00484419|18245725|P3|Overall Study|Physician Decision|1
5290783|NCT00484419|18245726|P2|Overall Study|Physician Decision|1
5290784|NCT00484419|18245727|P1|Overall Study|Physician Decision|1
5290785|NCT00484419|18245725|P3|Overall Study|required restricted medication|1
5290786|NCT00484419|18245726|P2|Overall Study|required restricted medication|0
5290787|NCT00484419|18245727|P1|Overall Study|required restricted medication|1
5290788|NCT00484419|18245725|P3|Overall Study|subject met discontinuation criteria|4
5290789|NCT00484419|18245726|P2|Overall Study|subject met discontinuation criteria|2
5290790|NCT00484419|18245727|P1|Overall Study|subject met discontinuation criteria|2
5290791|NCT00484419|18245725|P3|Overall Study|Withdrawal by Subject|1
5290792|NCT00484419|18245726|P2|Overall Study|Withdrawal by Subject|1
5290793|NCT00484419|18245727|P1|Overall Study|Withdrawal by Subject|3
5290794|NCT00484419|18245725|P3|Overall Study|Lost to Follow-up|2
5290795|NCT00484419|18245726|P2|Overall Study|Lost to Follow-up|0
5290796|NCT00484419|18245727|P1|Overall Study|Lost to Follow-up|1
5290797|NCT00484419|18245725|P3|Overall Study|Adverse Event|0
5290798|NCT00484419|18245726|P2|Overall Study|Adverse Event|0
5290799|NCT00484419|18245727|P1|Overall Study|Adverse Event|3
5290800|NCT00484315|18245811|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
5290801|NCT00484315|18245812|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
5290802|NCT00484315|18245811|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
5290803|NCT00484315|18245812|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
5290804|NCT00484315|18245811|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
5290805|NCT00484315|18245812|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
5290806|NCT00484315|18245811|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
5290807|NCT00484315|18245812|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
5290808|NCT00484315|18245811|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
5290809|NCT00484315|18245812|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
5290810|NCT00484315|18245811|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
5290811|NCT00484315|18245812|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
5290812|NCT00484315|18245811|P2|12-Month Clinical Follow-up|Death|2
5290813|NCT00484315|18245812|P1|12-Month Clinical Follow-up|Death|6
5290814|NCT00484289|18245823|P3|Post Marketing Phase|Adverse Event|0
5290815|NCT00484289|18245824|P2|Post Marketing Phase|Adverse Event|1
5290816|NCT00484289|18245825|P1|Post Marketing Phase|Adverse Event|0
5290817|NCT00484289|18245823|P3|Long Term Phase|Other Reason|1
5290818|NCT00484289|18245824|P2|Long Term Phase|Other Reason|5
5290819|NCT00484289|18245825|P1|Long Term Phase|Other Reason|0
5290820|NCT00484289|18245823|P3|Long Term Phase|Inadequate response|4
5290821|NCT00484289|18245824|P2|Long Term Phase|Inadequate response|7
5290822|NCT00484289|18245825|P1|Long Term Phase|Inadequate response|2
5290823|NCT00484289|18245823|P3|Long Term Phase|Withdrawal by Subject|6
5290824|NCT00484289|18245824|P2|Long Term Phase|Withdrawal by Subject|7
5290825|NCT00484289|18245825|P1|Long Term Phase|Withdrawal by Subject|0
5290826|NCT00484289|18245823|P3|Long Term Phase|Adverse Event|5
5290827|NCT00484289|18245824|P2|Long Term Phase|Adverse Event|17
5290828|NCT00484289|18245825|P1|Long Term Phase|Adverse Event|1
5290829|NCT00484185|18245897|P1|Overall Study|Death|2
5290830|NCT00484185|18245897|P1|Overall Study|Randomized but not treated|5
5290831|NCT00484185|18245897|P1|Overall Study|Other|20
5290832|NCT00484185|18245897|P1|Overall Study|Lost to Follow-up|44
5290833|NCT00484159|18245919|P3|Overall Study|Lost to Follow-up|0
5290834|NCT00484159|18245920|P2|Overall Study|Lost to Follow-up|1
5290835|NCT00484159|18245921|P1|Overall Study|Lost to Follow-up|1
5290836|NCT00484094|18245932|P1|Overall Study|Other|3
5290837|NCT00484094|18245932|P1|Overall Study|Discontinued|39
5290838|NCT00483938|18245948|P7|Overall Study|Other|32
5290839|NCT00483938|18245949|P6|Overall Study|Other|4
5290840|NCT00483938|18245950|P5|Overall Study|Other|0
5290841|NCT00483938|18245951|P4|Overall Study|Other|4
5290842|NCT00483938|18245952|P3|Overall Study|Other|0
5290843|NCT00483938|18245953|P2|Overall Study|Other|9
5290844|NCT00483938|18245954|P1|Overall Study|Other|3
5290845|NCT00483938|18245948|P7|Overall Study|Death|0
5290846|NCT00483938|18245949|P6|Overall Study|Death|0
5290847|NCT00483938|18245950|P5|Overall Study|Death|0
5290848|NCT00483938|18245951|P4|Overall Study|Death|0
5290849|NCT00483938|18245952|P3|Overall Study|Death|0
5290850|NCT00483938|18245953|P2|Overall Study|Death|2
5290851|NCT00483938|18245954|P1|Overall Study|Death|0
5290852|NCT00483938|18245948|P7|Overall Study|Lost to Follow-up|3
5290853|NCT00483938|18245949|P6|Overall Study|Lost to Follow-up|1
5290854|NCT00483938|18245950|P5|Overall Study|Lost to Follow-up|1
5290855|NCT00483938|18245951|P4|Overall Study|Lost to Follow-up|2
5290856|NCT00483938|18245952|P3|Overall Study|Lost to Follow-up|0
5290857|NCT00483938|18245953|P2|Overall Study|Lost to Follow-up|2
5290858|NCT00483938|18245954|P1|Overall Study|Lost to Follow-up|1
5290859|NCT00483938|18245948|P7|Overall Study|Withdrawal by Subject|2
5290860|NCT00483938|18245949|P6|Overall Study|Withdrawal by Subject|3
5290861|NCT00483938|18245950|P5|Overall Study|Withdrawal by Subject|1
5290862|NCT00483938|18245951|P4|Overall Study|Withdrawal by Subject|0
5290863|NCT00483938|18245952|P3|Overall Study|Withdrawal by Subject|0
5290864|NCT00483938|18245953|P2|Overall Study|Withdrawal by Subject|6
5290865|NCT00483938|18245954|P1|Overall Study|Withdrawal by Subject|1
5290866|NCT00483938|18245948|P7|Overall Study|Protocol Violation|3
5290867|NCT00483938|18245949|P6|Overall Study|Protocol Violation|0
5290868|NCT00483938|18245950|P5|Overall Study|Protocol Violation|0
5290869|NCT00483938|18245951|P4|Overall Study|Protocol Violation|0
5290870|NCT00483938|18245952|P3|Overall Study|Protocol Violation|0
5290871|NCT00483938|18245953|P2|Overall Study|Protocol Violation|0
5290872|NCT00483938|18245954|P1|Overall Study|Protocol Violation|0
5290873|NCT00483756|18245978|P3|Overall Study|Randomized, Not Treated|4
5290874|NCT00483756|18245979|P2|Overall Study|Randomized, Not Treated|4
5290875|NCT00483756|18245980|P1|Overall Study|Randomized, Not Treated|1
5290876|NCT00483756|18245978|P3|Overall Study|Other|3
5290877|NCT00483756|18245979|P2|Overall Study|Other|4
5290878|NCT00483756|18245980|P1|Overall Study|Other|2
5290879|NCT00483756|18245978|P3|Overall Study|Withdrawal by Subject|4
5290880|NCT00483756|18245979|P2|Overall Study|Withdrawal by Subject|3
5290881|NCT00483756|18245980|P1|Overall Study|Withdrawal by Subject|5
5290882|NCT00483756|18245978|P3|Overall Study|Lost to Follow-up|0
5290883|NCT00483756|18245979|P2|Overall Study|Lost to Follow-up|1
5290884|NCT00483756|18245980|P1|Overall Study|Lost to Follow-up|3
5290885|NCT00483756|18245978|P3|Overall Study|Lack of Efficacy|0
5290886|NCT00483756|18245979|P2|Overall Study|Lack of Efficacy|0
5290887|NCT00483756|18245980|P1|Overall Study|Lack of Efficacy|1
5290888|NCT00483756|18245978|P3|Overall Study|Adverse Event|40
5290889|NCT00483756|18245979|P2|Overall Study|Adverse Event|38
5290890|NCT00483756|18245980|P1|Overall Study|Adverse Event|19
5290891|NCT00483756|18245978|P3|Overall Study|Death|1
5290892|NCT00483756|18245979|P2|Overall Study|Death|0
5290893|NCT00483756|18245980|P1|Overall Study|Death|2
5290894|NCT00483717|18246044|P2|Overall Study|Withdrawal by Subject|0
5290895|NCT00483717|18246045|P1|Overall Study|Withdrawal by Subject|1
5290896|NCT00483717|18246044|P2|Overall Study|Lost to Follow-up|0
5290897|NCT00483717|18246045|P1|Overall Study|Lost to Follow-up|1
5290898|NCT00483717|18246044|P2|Overall Study|No treatment for migraine|13
5290899|NCT00483717|18246045|P1|Overall Study|No treatment for migraine|16
5290900|NCT00483717|18246044|P2|Overall Study|Time of dosing missing|1
5290901|NCT00483717|18246045|P1|Overall Study|Time of dosing missing|1
5290902|NCT00483717|18246044|P2|Overall Study|Protocol Violation|7
5290903|NCT00483717|18246045|P1|Overall Study|Protocol Violation|5
5290904|NCT00483704|18246068|P3|Treatment|Physician Decision|4
5290905|NCT00483704|18246069|P2|Treatment|Physician Decision|1
5290906|NCT00483704|18246070|P1|Treatment|Physician Decision|0
5290907|NCT00483704|18246068|P3|Treatment|Pregnancy|0
5290908|NCT00483704|18246069|P2|Treatment|Pregnancy|1
5290909|NCT00483704|18246070|P1|Treatment|Pregnancy|0
5290910|NCT00483704|18246068|P3|Treatment|Lack of Efficacy|1
5290911|NCT00483704|18246069|P2|Treatment|Lack of Efficacy|1
5290912|NCT00483704|18246070|P1|Treatment|Lack of Efficacy|1
5290913|NCT00483704|18246068|P3|Treatment|Lost to Follow-up|5
5290914|NCT00483704|18246069|P2|Treatment|Lost to Follow-up|7
5290915|NCT00483704|18246070|P1|Treatment|Lost to Follow-up|2
5290916|NCT00483704|18246068|P3|Treatment|Protocol Violation|5
5290917|NCT00483704|18246069|P2|Treatment|Protocol Violation|3
5290918|NCT00483704|18246070|P1|Treatment|Protocol Violation|6
5290919|NCT00483704|18246068|P3|Treatment|Withdrawal by Subject|21
5290920|NCT00483704|18246069|P2|Treatment|Withdrawal by Subject|12
5290921|NCT00483704|18246070|P1|Treatment|Withdrawal by Subject|16
5290922|NCT00483704|18246068|P3|Treatment|Adverse Event|4
5290923|NCT00483704|18246069|P2|Treatment|Adverse Event|5
5290924|NCT00483704|18246070|P1|Treatment|Adverse Event|3
5290925|NCT00483704|18246068|P3|Treatment|Lack of qualifying migraines|116
5290926|NCT00483704|18246069|P2|Treatment|Lack of qualifying migraines|99
5290927|NCT00483704|18246070|P1|Treatment|Lack of qualifying migraines|101
5290928|NCT00483704|18246068|P3|Randomization|Lack of qualifying migraines|31
5290929|NCT00483704|18246069|P2|Randomization|Lack of qualifying migraines|25
5290930|NCT00483704|18246070|P1|Randomization|Lack of qualifying migraines|21
5290931|NCT00483704|18246068|P3|Randomization|Progressive disease|1
5290932|NCT00483704|18246069|P2|Randomization|Progressive disease|0
5290933|NCT00483704|18246070|P1|Randomization|Progressive disease|0
5290934|NCT00483704|18246068|P3|Randomization|Physician Decision|0
5290935|NCT00483704|18246069|P2|Randomization|Physician Decision|4
5290936|NCT00483704|18246070|P1|Randomization|Physician Decision|2
5290937|NCT00483704|18246068|P3|Randomization|Pregnancy|0
5290938|NCT00483704|18246069|P2|Randomization|Pregnancy|0
5290939|NCT00483704|18246070|P1|Randomization|Pregnancy|1
5290940|NCT00483704|18246068|P3|Randomization|Lost to Follow-up|19
5290941|NCT00483704|18246069|P2|Randomization|Lost to Follow-up|14
5290942|NCT00483704|18246070|P1|Randomization|Lost to Follow-up|14
5290943|NCT00483704|18246068|P3|Randomization|Protocol Violation|22
5290944|NCT00483704|18246069|P2|Randomization|Protocol Violation|25
5290945|NCT00483704|18246070|P1|Randomization|Protocol Violation|14
5290946|NCT00483704|18246068|P3|Randomization|Withdrawal by Subject|18
5290947|NCT00483704|18246069|P2|Randomization|Withdrawal by Subject|28
5290948|NCT00483704|18246070|P1|Randomization|Withdrawal by Subject|19
5290949|NCT00483652|18246116|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
5290950|NCT00483652|18246117|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
5290951|NCT00483652|18246116|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
5290952|NCT00483652|18246117|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
5290953|NCT00483652|18246116|P2|Double-blind Treatment Period|Adverse Event|4
5290954|NCT00483652|18246117|P1|Double-blind Treatment Period|Adverse Event|3
5290955|NCT00483652|18246116|P2|Double-blind Treatment Period|Protocol Violation|1
5290956|NCT00483652|18246117|P1|Double-blind Treatment Period|Protocol Violation|2
5290957|NCT00483574|18246127|P2|Overall Study|Withdrawal by Subject|0
5290958|NCT00483574|18246128|P1|Overall Study|Withdrawal by Subject|52
5290959|NCT00483574|18246127|P2|Overall Study|Lost to Follow-up|4
5290960|NCT00483574|18246128|P1|Overall Study|Lost to Follow-up|16
5290961|NCT00483574|18246127|P2|Overall Study|Protocol Violation|9
5290962|NCT00483574|18246128|P1|Overall Study|Protocol Violation|28
5290963|NCT00483574|18246127|P2|Overall Study|Adverse Event|0
5290964|NCT00483574|18246128|P1|Overall Study|Adverse Event|6
5290965|NCT00483548|18246143|P2|Overall Study|Withdrawal by Subject|2
5290966|NCT00483548|18246144|P1|Overall Study|Withdrawal by Subject|5
5290967|NCT00483548|18246143|P2|Overall Study|Lost to Follow-up|4
5290968|NCT00483548|18246144|P1|Overall Study|Lost to Follow-up|3
5290969|NCT00483548|18246143|P2|Overall Study|Non-compliance with medication|0
5290970|NCT00483548|18246144|P1|Overall Study|Non-compliance with medication|2
5290971|NCT00483548|18246143|P2|Overall Study|Unable to comply with protocol schedule|0
5290972|NCT00483548|18246144|P1|Overall Study|Unable to comply with protocol schedule|1
5290973|NCT00483548|18246143|P2|Overall Study|Protocol required discontinuation|6
5290974|NCT00483548|18246144|P1|Overall Study|Protocol required discontinuation|6
5290975|NCT00483548|18246143|P2|Overall Study|Pregnancy|0
5290976|NCT00483548|18246144|P1|Overall Study|Pregnancy|1
5290977|NCT00483548|18246143|P2|Overall Study|Protocol Violation|7
5290978|NCT00483548|18246144|P1|Overall Study|Protocol Violation|11
5290979|NCT00483548|18246143|P2|Overall Study|Lack of Efficacy|8
5290980|NCT00483548|18246144|P1|Overall Study|Lack of Efficacy|4
5290981|NCT00483548|18246143|P2|Overall Study|Laboratory abnormality|2
5290982|NCT00483548|18246144|P1|Overall Study|Laboratory abnormality|1
5290983|NCT00483548|18246143|P2|Overall Study|Adverse Event|14
5290984|NCT00483548|18246144|P1|Overall Study|Adverse Event|25
5290985|NCT00483548|18246143|P2|Overall Study|Randomized; not treated with study drug|3
5290986|NCT00483548|18246144|P1|Overall Study|Randomized; not treated with study drug|1
5290987|NCT00483405|18246202|P1|Overall Study|Other complicating disease|1
5290988|NCT00483405|18246202|P1|Overall Study|Withdrawal by Subject|2
5290989|NCT00483405|18246202|P1|Overall Study|Death|3
5290990|NCT00483405|18246202|P1|Overall Study|Lack of Efficacy|14
5290991|NCT00483405|18246202|P1|Overall Study|Adverse Event|8
5290992|NCT00483379|18246211|P2|Treatment Period|Withdrawal by Subject|0
5290993|NCT00483379|18246212|P1|Treatment Period|Withdrawal by Subject|1
5290994|NCT00483379|18246211|P2|Treatment Period|Adverse Event|0
5290995|NCT00483379|18246212|P1|Treatment Period|Adverse Event|1
5290996|NCT00483327|18246248|P1|Overall Study|Patient Non Compliance|2
5290997|NCT00483327|18246248|P1|Overall Study|Lost to Follow-up|4
5290998|NCT00483327|18246248|P1|Overall Study|Withdrawal by Subject|3
5290999|NCT00483327|18246248|P1|Overall Study|Adverse Event|1
5291000|NCT00483184|18246280|P3|Overall Study|Protocol Violation|1
5291001|NCT00483184|18246281|P2|Overall Study|Protocol Violation|0
5291002|NCT00483184|18246282|P1|Overall Study|Protocol Violation|1
5291003|NCT00483184|18246280|P3|Overall Study|Adverse Event|2
5291004|NCT00483184|18246281|P2|Overall Study|Adverse Event|2
5291005|NCT00483184|18246282|P1|Overall Study|Adverse Event|1
5291006|NCT00483184|18246280|P3|Overall Study|Lost to Follow-up|0
5291007|NCT00483184|18246281|P2|Overall Study|Lost to Follow-up|0
5291008|NCT00483184|18246282|P1|Overall Study|Lost to Follow-up|1
5291009|NCT00483184|18246280|P3|Overall Study|Withdrawal by Subject|0
5291010|NCT00483184|18246281|P2|Overall Study|Withdrawal by Subject|2
5291011|NCT00483184|18246282|P1|Overall Study|Withdrawal by Subject|2
5291012|NCT00483119|18246292|P2|Overall Study|Physician Decision|0
5291013|NCT00483119|18246293|P1|Overall Study|Physician Decision|1
5291014|NCT00483119|18246292|P2|Overall Study|Adverse Event|1
5291015|NCT00483119|18246293|P1|Overall Study|Adverse Event|0
5291016|NCT00483041|18246307|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
5291017|NCT00483041|18246308|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
5291018|NCT00483002|18246338|P1|Overall Study|Other|967
5291019|NCT00483002|18246338|P1|Overall Study|Other|2
5291020|NCT00483002|18246338|P1|Overall Study|Lost to Follow-up|962
5291021|NCT00483002|18246338|P1|Overall Study|Lack of Efficacy|555
5291022|NCT00483002|18246338|P1|Overall Study|Adverse Event|68
5291023|NCT00482729|18246363|P2|Overall Study|Withdrawal by Subject|69
5291024|NCT00482729|18246364|P1|Overall Study|Withdrawal by Subject|67
5291025|NCT00482729|18246363|P2|Overall Study|Protocol Violation|18
5291026|NCT00482729|18246364|P1|Overall Study|Protocol Violation|10
5291027|NCT00482729|18246363|P2|Overall Study|Pregnancy|2
5291028|NCT00482729|18246364|P1|Overall Study|Pregnancy|4
5291029|NCT00482729|18246363|P2|Overall Study|Physician Decision|7
5291030|NCT00482729|18246364|P1|Overall Study|Physician Decision|10
5291031|NCT00482729|18246363|P2|Overall Study|Lost to Follow-up|66
5291032|NCT00482729|18246364|P1|Overall Study|Lost to Follow-up|86
5291033|NCT00482729|18246363|P2|Overall Study|Lack of Efficacy|16
5291034|NCT00482729|18246364|P1|Overall Study|Lack of Efficacy|4
5291035|NCT00482729|18246363|P2|Overall Study|Hyperglycemia Criteria|5
5291036|NCT00482729|18246364|P1|Overall Study|Hyperglycemia Criteria|7
5291037|NCT00482729|18246363|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
5291038|NCT00482729|18246364|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
5291039|NCT00482729|18246363|P2|Overall Study|Adverse Event|33
5291040|NCT00482729|18246364|P1|Overall Study|Adverse Event|29
5291041|NCT00482703|18246380|P2|Overall Study|Poor compliance|0
5291042|NCT00482703|18246381|P1|Overall Study|Poor compliance|1
5291043|NCT00482612|18246452|P4|Follow-up Period|Reasons not related to trial|3
5291044|NCT00482612|18246453|P3|Follow-up Period|Reasons not related to trial|1
5291045|NCT00482612|18246454|P2|Follow-up Period|Reasons not related to trial|0
5291046|NCT00482612|18246455|P1|Follow-up Period|Reasons not related to trial|1
5291047|NCT00482612|18246452|P4|Follow-up Period|Withdrawal by Subject|2
5291048|NCT00482612|18246453|P3|Follow-up Period|Withdrawal by Subject|7
5291049|NCT00482612|18246454|P2|Follow-up Period|Withdrawal by Subject|5
5291050|NCT00482612|18246455|P1|Follow-up Period|Withdrawal by Subject|3
5291051|NCT00482612|18246452|P4|Follow-up Period|Lack of Efficacy|0
5291052|NCT00482612|18246453|P3|Follow-up Period|Lack of Efficacy|1
5291053|NCT00482612|18246454|P2|Follow-up Period|Lack of Efficacy|0
5291054|NCT00482612|18246455|P1|Follow-up Period|Lack of Efficacy|2
5291055|NCT00482612|18246452|P4|Follow-up Period|Adverse Event|0
5291056|NCT00482612|18246453|P3|Follow-up Period|Adverse Event|9
5291057|NCT00482612|18246454|P2|Follow-up Period|Adverse Event|7
5291058|NCT00482612|18246455|P1|Follow-up Period|Adverse Event|4
5291059|NCT00482612|18246452|P4|Follow-up Period|Lost to Follow-up|1
5291060|NCT00482612|18246453|P3|Follow-up Period|Lost to Follow-up|2
5291061|NCT00482612|18246454|P2|Follow-up Period|Lost to Follow-up|4
5291062|NCT00482612|18246455|P1|Follow-up Period|Lost to Follow-up|0
5291063|NCT00482612|18246452|P4|Follow-up Period|Lack of compliance|0
5291064|NCT00482612|18246453|P3|Follow-up Period|Lack of compliance|1
5291065|NCT00482612|18246454|P2|Follow-up Period|Lack of compliance|0
5291066|NCT00482612|18246455|P1|Follow-up Period|Lack of compliance|0
5291067|NCT00482612|18246452|P4|Follow-up Period|Other|2
5291068|NCT00482612|18246453|P3|Follow-up Period|Other|1
5291069|NCT00482612|18246454|P2|Follow-up Period|Other|2
5291070|NCT00482612|18246455|P1|Follow-up Period|Other|4
5291071|NCT00482612|18246452|P4|In-treatment Period|No study medication administered|0
5291072|NCT00482612|18246453|P3|In-treatment Period|No study medication administered|1
5291073|NCT00482612|18246454|P2|In-treatment Period|No study medication administered|0
5291074|NCT00482612|18246455|P1|In-treatment Period|No study medication administered|0
5291075|NCT00482391|18246504|P1|Overall Study|Death|1
5291076|NCT00482391|18246504|P1|Overall Study|Adverse Event|1
5291077|NCT00482391|18246504|P1|Overall Study|Withdrawal by Subject|1
5291078|NCT00482274|18246509|P1|Overall Study|Adverse Event|1
5291079|NCT00482170|18246519|P2|Overall Study|Unspecified reason|2
5291080|NCT00482170|18246520|P1|Overall Study|Unspecified reason|0
5291081|NCT00482170|18246519|P2|Overall Study|Lost to Follow-up|0
5291082|NCT00482170|18246520|P1|Overall Study|Lost to Follow-up|2
5291083|NCT00482170|18246519|P2|Overall Study|Protocol Violation|3
5291084|NCT00482170|18246520|P1|Overall Study|Protocol Violation|2
5291085|NCT00482170|18246519|P2|Overall Study|Withdrawal by Subject|1
5291086|NCT00482170|18246520|P1|Overall Study|Withdrawal by Subject|6
5291087|NCT00482170|18246519|P2|Overall Study|Adverse Event|14
5291088|NCT00482170|18246520|P1|Overall Study|Adverse Event|5
5291089|NCT00482053|18246638|P1|Inter-treatment Period|Disease progression|1
5291090|NCT00482014|18246652|P4|Overall Study|Sponsor Decision|1
5291091|NCT00482014|18246653|P3|Overall Study|Sponsor Decision|1
5291092|NCT00482014|18246654|P2|Overall Study|Sponsor Decision|2
5291093|NCT00482014|18246655|P1|Overall Study|Sponsor Decision|1
5291094|NCT00482014|18246652|P4|Overall Study|Lack of Efficacy|6
5291095|NCT00482014|18246653|P3|Overall Study|Lack of Efficacy|4
5291096|NCT00482014|18246654|P2|Overall Study|Lack of Efficacy|0
5291097|NCT00482014|18246655|P1|Overall Study|Lack of Efficacy|1
5291098|NCT00482014|18246652|P4|Overall Study|Death|4
5291099|NCT00482014|18246653|P3|Overall Study|Death|1
5291100|NCT00482014|18246654|P2|Overall Study|Death|2
5291101|NCT00482014|18246655|P1|Overall Study|Death|1
5291102|NCT00482014|18246652|P4|Overall Study|Adverse Event|8
5291103|NCT00482014|18246653|P3|Overall Study|Adverse Event|2
5291104|NCT00482014|18246654|P2|Overall Study|Adverse Event|0
5291105|NCT00482014|18246655|P1|Overall Study|Adverse Event|3
5291106|NCT00482014|18246652|P4|Overall Study|Withdrawal by Subject|4
5291107|NCT00482014|18246653|P3|Overall Study|Withdrawal by Subject|3
5291108|NCT00482014|18246654|P2|Overall Study|Withdrawal by Subject|2
5291109|NCT00482014|18246655|P1|Overall Study|Withdrawal by Subject|1
5291110|NCT00482001|18246679|P2|Overall Study|Protocol Violation|1
5291111|NCT00482001|18246680|P1|Overall Study|Protocol Violation|1
5291112|NCT00481988|18246700|P2|Overall Study|Withdrawal by Subject|1
5291113|NCT00481988|18246701|P1|Overall Study|Withdrawal by Subject|1
5291114|NCT00481871|18246714|P5|Overall Study|Progressive Disease - pt withdrew|0
5291115|NCT00481871|18246715|P4|Overall Study|Progressive Disease - pt withdrew|0
5291116|NCT00481871|18246716|P3|Overall Study|Progressive Disease - pt withdrew|1
5291117|NCT00481871|18246717|P2|Overall Study|Progressive Disease - pt withdrew|0
5291118|NCT00481871|18246718|P1|Overall Study|Progressive Disease - pt withdrew|0
5291119|NCT00481832|18246743|P1|Inter-transplant Period|Lack of allogeneic donor|5
5291120|NCT00481832|18246743|P1|Inter-transplant Period|Disease relapse|11
5291121|NCT00481832|18246743|P1|Inter-transplant Period|Physician Decision|4
5291122|NCT00481832|18246743|P1|Inter-transplant Period|Death|3
5291123|NCT00481832|18246743|P1|Inter-transplant Period|Adverse Event|4
5291124|NCT00481832|18246743|P1|Enrollment|Unable to collect enough stem cells|2
5291125|NCT00481832|18246743|P1|Enrollment|Physician Decision|8
5291126|NCT00481767|18246758|P2|Overall Study|Lost to Follow-up|10
5291127|NCT00481767|18246759|P1|Overall Study|Lost to Follow-up|16
5291128|NCT00481767|18246758|P2|Overall Study|Withdrawal by Subject|11
5291129|NCT00481767|18246759|P1|Overall Study|Withdrawal by Subject|16
5291130|NCT00481676|18246793|P2|Overall Study|Administrative problem|0
5291131|NCT00481676|18246794|P1|Overall Study|Administrative problem|1
5291132|NCT00481676|18246793|P2|Overall Study|Unsatisfactory therapeutic effect|4
5291133|NCT00481676|18246794|P1|Overall Study|Unsatisfactory therapeutic effect|1
5291134|NCT00481676|18246793|P2|Overall Study|Adverse Event|1
5291135|NCT00481676|18246794|P1|Overall Study|Adverse Event|0
5291136|NCT00481247|18246846|P2|Overall Study|Did not receive treatment|2
5291137|NCT00481247|18246847|P1|Overall Study|Did not receive treatment|1
5291138|NCT00481247|18246846|P2|Overall Study|Varied|15
5291139|NCT00481247|18246847|P1|Overall Study|Varied|6
5291140|NCT00481247|18246846|P2|Overall Study|Administrative reason by sponsor|162
5291141|NCT00481247|18246847|P1|Overall Study|Administrative reason by sponsor|157
5291142|NCT00481247|18246846|P2|Overall Study|Poor compliance/noncompliance|7
5291143|NCT00481247|18246847|P1|Overall Study|Poor compliance/noncompliance|1
5291144|NCT00481247|18246846|P2|Overall Study|Lost to Follow-up|2
5291145|NCT00481247|18246847|P1|Overall Study|Lost to Follow-up|1
5291146|NCT00481247|18246846|P2|Overall Study|Pregnancy|1
5291147|NCT00481247|18246847|P1|Overall Study|Pregnancy|2
5291148|NCT00481247|18246846|P2|Overall Study|Withdrawal by Subject|13
5291149|NCT00481247|18246847|P1|Overall Study|Withdrawal by Subject|8
5291150|NCT00481247|18246846|P2|Overall Study|AE unrelated to study drug|4
5291151|NCT00481247|18246847|P1|Overall Study|AE unrelated to study drug|13
5291152|NCT00481247|18246846|P2|Overall Study|Treatment failure|14
5291153|NCT00481247|18246847|P1|Overall Study|Treatment failure|10
5291154|NCT00481247|18246846|P2|Overall Study|Intolerance|17
5291155|NCT00481247|18246847|P1|Overall Study|Intolerance|42
5291156|NCT00481247|18246846|P2|Overall Study|Disease progression|22
5291157|NCT00481247|18246847|P1|Overall Study|Disease progression|18
5291158|NCT00481247|18246846|P2|Overall Study|Death|1
5291159|NCT00481247|18246847|P1|Overall Study|Death|0
5291160|NCT00481195|18246871|P2|Overall Study|Miscellaneous|2
5291161|NCT00481195|18246872|P1|Overall Study|Miscellaneous|2
5291162|NCT00481195|18246871|P2|Overall Study|Withdrawal by Subject|9
5291163|NCT00481195|18246872|P1|Overall Study|Withdrawal by Subject|3
5291164|NCT00481195|18246871|P2|Overall Study|Protocol Violation|7
5291165|NCT00481195|18246872|P1|Overall Study|Protocol Violation|10
5291166|NCT00481195|18246871|P2|Overall Study|Physician Decision|1
5291167|NCT00481195|18246872|P1|Overall Study|Physician Decision|3
5291168|NCT00481195|18246871|P2|Overall Study|Lost to Follow-up|6
5291169|NCT00481195|18246872|P1|Overall Study|Lost to Follow-up|4
5291170|NCT00481195|18246871|P2|Overall Study|Lack of Efficacy|3
5291171|NCT00481195|18246872|P1|Overall Study|Lack of Efficacy|1
5291172|NCT00481195|18246871|P2|Overall Study|Adverse Event|11
5291173|NCT00481195|18246872|P1|Overall Study|Adverse Event|16
5291174|NCT00481078|18246958|P2|Overall Study|Brain metastasis|1
5291175|NCT00481078|18246959|P1|Overall Study|Brain metastasis|0
5291176|NCT00481078|18246958|P2|Overall Study|Received other treatment|1
5291177|NCT00481078|18246959|P1|Overall Study|Received other treatment|2
5291178|NCT00481078|18246958|P2|Overall Study|Information not available|0
5291179|NCT00481078|18246959|P1|Overall Study|Information not available|1
5291180|NCT00481078|18246958|P2|Overall Study|Withdrawal by Subject|1
5291181|NCT00481078|18246959|P1|Overall Study|Withdrawal by Subject|7
5291182|NCT00481078|18246958|P2|Overall Study|Intercurrent illness|0
5291183|NCT00481078|18246959|P1|Overall Study|Intercurrent illness|1
5291184|NCT00481078|18246958|P2|Overall Study|Death|3
5291185|NCT00481078|18246959|P1|Overall Study|Death|5
5291186|NCT00481078|18246958|P2|Overall Study|Adverse Event|3
5291187|NCT00481078|18246959|P1|Overall Study|Adverse Event|15
5291188|NCT00481078|18246958|P2|Overall Study|Progression of disease|11
5291189|NCT00481078|18246959|P1|Overall Study|Progression of disease|11
5291190|NCT00481065|18246977|P8|Overall Study|Unable to classify|0
5291191|NCT00481065|18246978|P7|Overall Study|Unable to classify|0
5291192|NCT00481065|18246979|P6|Overall Study|Unable to classify|0
5291193|NCT00481065|18246980|P5|Overall Study|Unable to classify|1
5291194|NCT00481065|18246981|P4|Overall Study|Unable to classify|0
5291195|NCT00481065|18246982|P3|Overall Study|Unable to classify|2
5291196|NCT00481065|18246983|P2|Overall Study|Unable to classify|1
5291197|NCT00481065|18246984|P1|Overall Study|Unable to classify|0
5291198|NCT00481065|18246977|P8|Overall Study|Protocol Violation|2
5291199|NCT00481065|18246978|P7|Overall Study|Protocol Violation|3
5291200|NCT00481065|18246979|P6|Overall Study|Protocol Violation|6
5291201|NCT00481065|18246980|P5|Overall Study|Protocol Violation|2
5291202|NCT00481065|18246981|P4|Overall Study|Protocol Violation|1
5291203|NCT00481065|18246982|P3|Overall Study|Protocol Violation|1
5291204|NCT00481065|18246983|P2|Overall Study|Protocol Violation|1
5291205|NCT00481065|18246984|P1|Overall Study|Protocol Violation|2
5291206|NCT00481065|18246977|P8|Overall Study|Administrative reason|0
5291207|NCT00481065|18246978|P7|Overall Study|Administrative reason|1
5291208|NCT00481065|18246979|P6|Overall Study|Administrative reason|2
5291209|NCT00481065|18246980|P5|Overall Study|Administrative reason|0
5291210|NCT00481065|18246981|P4|Overall Study|Administrative reason|0
5291211|NCT00481065|18246982|P3|Overall Study|Administrative reason|0
5291212|NCT00481065|18246983|P2|Overall Study|Administrative reason|0
5291213|NCT00481065|18246984|P1|Overall Study|Administrative reason|0
5291214|NCT00481065|18246977|P8|Overall Study|Inappropriate enrollment|1
5291215|NCT00481065|18246978|P7|Overall Study|Inappropriate enrollment|0
5291216|NCT00481065|18246979|P6|Overall Study|Inappropriate enrollment|1
5291217|NCT00481065|18246980|P5|Overall Study|Inappropriate enrollment|2
5291218|NCT00481065|18246981|P4|Overall Study|Inappropriate enrollment|0
5291219|NCT00481065|18246982|P3|Overall Study|Inappropriate enrollment|2
5291220|NCT00481065|18246983|P2|Overall Study|Inappropriate enrollment|0
5291221|NCT00481065|18246984|P1|Overall Study|Inappropriate enrollment|4
5291222|NCT00481065|18246977|P8|Overall Study|Lost to Follow-up|5
5291223|NCT00481065|18246978|P7|Overall Study|Lost to Follow-up|2
5291224|NCT00481065|18246979|P6|Overall Study|Lost to Follow-up|3
5291225|NCT00481065|18246980|P5|Overall Study|Lost to Follow-up|3
5291226|NCT00481065|18246981|P4|Overall Study|Lost to Follow-up|3
5291227|NCT00481065|18246982|P3|Overall Study|Lost to Follow-up|4
5291228|NCT00481065|18246983|P2|Overall Study|Lost to Follow-up|2
5291229|NCT00481065|18246984|P1|Overall Study|Lost to Follow-up|4
5291230|NCT00481065|18246977|P8|Overall Study|Withdrawal by Subject|10
5291231|NCT00481065|18246978|P7|Overall Study|Withdrawal by Subject|9
5291232|NCT00481065|18246979|P6|Overall Study|Withdrawal by Subject|12
5291233|NCT00481065|18246980|P5|Overall Study|Withdrawal by Subject|13
5291234|NCT00481065|18246981|P4|Overall Study|Withdrawal by Subject|11
5291235|NCT00481065|18246982|P3|Overall Study|Withdrawal by Subject|7
5291236|NCT00481065|18246983|P2|Overall Study|Withdrawal by Subject|12
5291237|NCT00481065|18246984|P1|Overall Study|Withdrawal by Subject|11
5291238|NCT00481065|18246977|P8|Overall Study|Adverse event or death|1
5291239|NCT00481065|18246978|P7|Overall Study|Adverse event or death|1
5291240|NCT00481065|18246979|P6|Overall Study|Adverse event or death|0
5291241|NCT00481065|18246980|P5|Overall Study|Adverse event or death|2
5291242|NCT00481065|18246981|P4|Overall Study|Adverse event or death|0
5291243|NCT00481065|18246982|P3|Overall Study|Adverse event or death|3
5291244|NCT00481065|18246983|P2|Overall Study|Adverse event or death|1
5291245|NCT00481065|18246984|P1|Overall Study|Adverse event or death|1
5291246|NCT00480857|18247074|P1|Overall Study|Lack of Efficacy|2
5291247|NCT00480779|18247084|P2|Overall Study|Job and Health-related|3
5291248|NCT00480779|18247085|P1|Overall Study|Job and Health-related|0
5291249|NCT00480779|18247084|P2|Overall Study|Other|0
5291250|NCT00480779|18247085|P1|Overall Study|Other|2
5291251|NCT00480636|18247122|P1|Overall Study|Lost to follow-up; subsequently died|1
5291252|NCT00480636|18247122|P1|Overall Study|Other|2
5291253|NCT00480636|18247122|P1|Overall Study|Lost to Follow-up|4
5291254|NCT00480636|18247122|P1|Overall Study|Death|12
5291255|NCT00480532|18247134|P4|Overall Study|Protocol Violation|0
5291256|NCT00480532|18247135|P3|Overall Study|Protocol Violation|1
5291257|NCT00480532|18247136|P2|Overall Study|Protocol Violation|0
5291258|NCT00480532|18247137|P1|Overall Study|Protocol Violation|0
5291259|NCT00480532|18247134|P4|Overall Study|Withdrawal by Subject|1
5291260|NCT00480532|18247135|P3|Overall Study|Withdrawal by Subject|3
5291261|NCT00480532|18247136|P2|Overall Study|Withdrawal by Subject|4
5291262|NCT00480532|18247137|P1|Overall Study|Withdrawal by Subject|2
5291263|NCT00480493|18247157|P2|Overall Study|moved|7
5291264|NCT00480493|18247158|P1|Overall Study|moved|2
5291265|NCT00480441|18247170|P3|Randomization|Lost to Follow-up|2
5291266|NCT00480441|18247171|P2|Randomization|Lost to Follow-up|7
5291267|NCT00480441|18247172|P1|Randomization|Lost to Follow-up|0
5291268|NCT00480441|18247170|P3|Baseline Functional MRI|physical contraindication|0
5291269|NCT00480441|18247171|P2|Baseline Functional MRI|physical contraindication|0
5291270|NCT00480441|18247172|P1|Baseline Functional MRI|physical contraindication|4
5291271|NCT00480441|18247170|P3|Baseline Functional MRI|Lost to Follow-up|0
5291272|NCT00480441|18247171|P2|Baseline Functional MRI|Lost to Follow-up|0
5291273|NCT00480441|18247172|P1|Baseline Functional MRI|Lost to Follow-up|4
5291274|NCT00480441|18247170|P3|Baseline Functional MRI|Functional MRI data not usable|0
5291275|NCT00480441|18247171|P2|Baseline Functional MRI|Functional MRI data not usable|0
5291276|NCT00480441|18247172|P1|Baseline Functional MRI|Functional MRI data not usable|4
5291277|NCT00480441|18247170|P3|Screening|Not Eligible|0
5291278|NCT00480441|18247171|P2|Screening|Not Eligible|0
5291279|NCT00480441|18247172|P1|Screening|Not Eligible|37
5291280|NCT00480324|18247181|P2|Overall Study|Subject's mother pregnant|1
5291281|NCT00480324|18247182|P1|Overall Study|Subject's mother pregnant|0
5291282|NCT00480324|18247181|P2|Overall Study|Lost to Follow-up|8
5291283|NCT00480324|18247182|P1|Overall Study|Lost to Follow-up|17
5291284|NCT00480324|18247181|P2|Overall Study|Withdrawal by Subject|5
5291285|NCT00480324|18247182|P1|Overall Study|Withdrawal by Subject|14
5291286|NCT00480324|18247181|P2|Overall Study|Protocol Violation|1
5291287|NCT00480324|18247182|P1|Overall Study|Protocol Violation|0
5291288|NCT00480324|18247181|P2|Overall Study|Adverse Event|1
5291289|NCT00480324|18247182|P1|Overall Study|Adverse Event|1
5291290|NCT00480077|18247210|P2|Overall Study|early exit|11
5291291|NCT00480077|18247211|P1|Overall Study|early exit|12
5291292|NCT00480077|18247210|P2|Overall Study|Death|15
5291293|NCT00480077|18247211|P1|Overall Study|Death|19
5291294|NCT00480025|18247219|P2|Overall Study|SAE including intercurrent illness|42
5291295|NCT00480025|18247220|P1|Overall Study|SAE including intercurrent illness|76
5291296|NCT00480025|18247219|P2|Overall Study|Other|29
5291297|NCT00480025|18247220|P1|Overall Study|Other|70
5291298|NCT00480025|18247219|P2|Overall Study|Adverse Event|12
5291299|NCT00480025|18247220|P1|Overall Study|Adverse Event|44
5291300|NCT00480025|18247219|P2|Overall Study|Disease Progression / Recurrence|224
5291301|NCT00480025|18247220|P1|Overall Study|Disease Progression / Recurrence|449
5291302|NCT00480025|18247219|P2|Overall Study|Patients remaining ongoing at Data Lock|55
5291303|NCT00480025|18247220|P1|Overall Study|Patients remaining ongoing at Data Lock|101
5291304|NCT00480025|18247219|P2|Overall Study|Protocol Violation|7
5291305|NCT00480025|18247220|P1|Overall Study|Protocol Violation|12
5291306|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
5291307|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
5291308|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
5291309|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
5291310|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
5291311|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
5291312|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
5291313|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
5291314|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
5291315|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
5291316|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
5291317|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
5291318|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Other|2
5291319|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Other|2
5291320|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Other|0
5291321|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Other|5
5291322|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
5291323|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
5291324|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
5291325|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
5291326|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
5291327|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
5291328|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
5291329|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
5291330|NCT00479882|18247292|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
5291331|NCT00479882|18247293|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
5291332|NCT00479882|18247294|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
5291333|NCT00479882|18247295|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
5291334|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
5291335|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
5291336|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
5291337|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
5291338|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
5291339|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
5291340|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
5291341|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
5291342|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
5291343|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
5291344|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
5291345|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
5291346|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
5291347|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
5291348|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
5291349|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
5291350|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
5291351|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
5291352|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
5291353|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
5291354|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
5291355|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
5291356|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
5291357|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
5291358|NCT00479882|18247292|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
5291359|NCT00479882|18247293|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
5291360|NCT00479882|18247294|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
5291361|NCT00479882|18247295|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
5291362|NCT00479856|18247425|P1|Overall Study|Physician Decision|1
5291363|NCT00479856|18247425|P1|Overall Study|Withdrawal by Subject|1
5291364|NCT00479856|18247425|P1|Overall Study|Adverse Event|1
5291365|NCT00479765|18247434|P1|Overall Study|study terminated|4
5291366|NCT00479713|18247440|P2|Overall Study|Withdrawal by Subject|1
5291367|NCT00479713|18247441|P1|Overall Study|Withdrawal by Subject|4
5291368|NCT00479713|18247440|P2|Overall Study|Protocol Violation|1
5291369|NCT00479713|18247441|P1|Overall Study|Protocol Violation|0
5291370|NCT00479713|18247440|P2|Overall Study|Lost to Follow-up|1
5291371|NCT00479713|18247441|P1|Overall Study|Lost to Follow-up|0
5291372|NCT00479713|18247440|P2|Overall Study|Death|0
5291373|NCT00479713|18247441|P1|Overall Study|Death|1
5291374|NCT00479713|18247440|P2|Overall Study|Adverse Event|6
5291375|NCT00479713|18247441|P1|Overall Study|Adverse Event|8
5291376|NCT00479674|18247465|P1|Overall Study|none provided|3
5291377|NCT00479674|18247465|P1|Overall Study|Physician Decision|14
5291378|NCT00479674|18247465|P1|Overall Study|Withdrawal by Subject|6
5291379|NCT00479674|18247465|P1|Overall Study|Adverse Event|18
5291380|NCT00479557|18247480|P7|Overall Study|Other|0
5291381|NCT00479557|18247481|P6|Overall Study|Other|3
5291382|NCT00479557|18247482|P5|Overall Study|Other|0
5291383|NCT00479557|18247483|P4|Overall Study|Other|0
5291384|NCT00479557|18247484|P3|Overall Study|Other|1
5291385|NCT00479557|18247485|P2|Overall Study|Other|3
5291386|NCT00479557|18247486|P1|Overall Study|Other|2
5291387|NCT00479557|18247480|P7|Overall Study|Subject Request|1
5291388|NCT00479557|18247481|P6|Overall Study|Subject Request|4
5291389|NCT00479557|18247482|P5|Overall Study|Subject Request|1
5291390|NCT00479557|18247483|P4|Overall Study|Subject Request|1
5291391|NCT00479557|18247484|P3|Overall Study|Subject Request|1
5291392|NCT00479557|18247485|P2|Overall Study|Subject Request|0
5291393|NCT00479557|18247486|P1|Overall Study|Subject Request|3
5291394|NCT00479557|18247480|P7|Overall Study|Investigator Request|0
5291395|NCT00479557|18247481|P6|Overall Study|Investigator Request|0
5291396|NCT00479557|18247482|P5|Overall Study|Investigator Request|0
5291397|NCT00479557|18247483|P4|Overall Study|Investigator Request|0
5291398|NCT00479557|18247484|P3|Overall Study|Investigator Request|1
5291399|NCT00479557|18247485|P2|Overall Study|Investigator Request|0
5291400|NCT00479557|18247486|P1|Overall Study|Investigator Request|0
5291401|NCT00479557|18247480|P7|Overall Study|Caregiver Request|0
5291402|NCT00479557|18247481|P6|Overall Study|Caregiver Request|2
5291403|NCT00479557|18247482|P5|Overall Study|Caregiver Request|1
5291404|NCT00479557|18247483|P4|Overall Study|Caregiver Request|0
5291405|NCT00479557|18247484|P3|Overall Study|Caregiver Request|2
5291406|NCT00479557|18247485|P2|Overall Study|Caregiver Request|2
5291407|NCT00479557|18247486|P1|Overall Study|Caregiver Request|2
5291408|NCT00479557|18247480|P7|Overall Study|AE not related to Study Drug|1
5291409|NCT00479557|18247481|P6|Overall Study|AE not related to Study Drug|2
5291410|NCT00479557|18247482|P5|Overall Study|AE not related to Study Drug|2
5291411|NCT00479557|18247483|P4|Overall Study|AE not related to Study Drug|0
5291412|NCT00479557|18247484|P3|Overall Study|AE not related to Study Drug|0
5291413|NCT00479557|18247485|P2|Overall Study|AE not related to Study Drug|3
5291414|NCT00479557|18247486|P1|Overall Study|AE not related to Study Drug|1
5291504|NCT00479401|18247564|P2|Overall Study|Lack of Efficacy|2
5291415|NCT00479557|18247480|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
5291416|NCT00479557|18247481|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
5291417|NCT00479557|18247482|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
5291418|NCT00479557|18247483|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
5291419|NCT00479557|18247484|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
5291420|NCT00479557|18247485|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
5291421|NCT00479557|18247486|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
5291422|NCT00479557|18247480|P7|Overall Study|Lost to Follow-up|0
5291423|NCT00479557|18247481|P6|Overall Study|Lost to Follow-up|0
5291424|NCT00479557|18247482|P5|Overall Study|Lost to Follow-up|0
5291425|NCT00479557|18247483|P4|Overall Study|Lost to Follow-up|2
5291426|NCT00479557|18247484|P3|Overall Study|Lost to Follow-up|0
5291427|NCT00479557|18247485|P2|Overall Study|Lost to Follow-up|2
5291428|NCT00479557|18247486|P1|Overall Study|Lost to Follow-up|0
5291429|NCT00479557|18247480|P7|Overall Study|Lack of Efficacy|0
5291430|NCT00479557|18247481|P6|Overall Study|Lack of Efficacy|0
5291431|NCT00479557|18247482|P5|Overall Study|Lack of Efficacy|0
5291432|NCT00479557|18247483|P4|Overall Study|Lack of Efficacy|0
5291433|NCT00479557|18247484|P3|Overall Study|Lack of Efficacy|0
5291434|NCT00479557|18247485|P2|Overall Study|Lack of Efficacy|0
5291435|NCT00479557|18247486|P1|Overall Study|Lack of Efficacy|1
5291436|NCT00479557|18247480|P7|Overall Study|Death|0
5291437|NCT00479557|18247481|P6|Overall Study|Death|1
5291438|NCT00479557|18247482|P5|Overall Study|Death|0
5291439|NCT00479557|18247483|P4|Overall Study|Death|0
5291440|NCT00479557|18247484|P3|Overall Study|Death|0
5291441|NCT00479557|18247485|P2|Overall Study|Death|0
5291442|NCT00479557|18247486|P1|Overall Study|Death|0
5291443|NCT00479466|18247529|P6|Overall Study|Withdrawal by Subject|1
5291444|NCT00479466|18247530|P5|Overall Study|Withdrawal by Subject|3
5291445|NCT00479466|18247531|P4|Overall Study|Withdrawal by Subject|2
5291446|NCT00479466|18247532|P3|Overall Study|Withdrawal by Subject|0
5291447|NCT00479466|18247533|P2|Overall Study|Withdrawal by Subject|5
5291448|NCT00479466|18247534|P1|Overall Study|Withdrawal by Subject|3
5291449|NCT00479466|18247529|P6|Overall Study|Protocol Violation|0
5291450|NCT00479466|18247530|P5|Overall Study|Protocol Violation|0
5291451|NCT00479466|18247531|P4|Overall Study|Protocol Violation|0
5291452|NCT00479466|18247532|P3|Overall Study|Protocol Violation|0
5291453|NCT00479466|18247533|P2|Overall Study|Protocol Violation|0
5291454|NCT00479466|18247534|P1|Overall Study|Protocol Violation|1
5291455|NCT00479466|18247529|P6|Overall Study|Pregnancy|0
5291456|NCT00479466|18247530|P5|Overall Study|Pregnancy|1
5291457|NCT00479466|18247531|P4|Overall Study|Pregnancy|0
5291458|NCT00479466|18247532|P3|Overall Study|Pregnancy|0
5291459|NCT00479466|18247533|P2|Overall Study|Pregnancy|0
5291460|NCT00479466|18247534|P1|Overall Study|Pregnancy|0
5291461|NCT00479466|18247529|P6|Overall Study|Physician Decision|0
5291462|NCT00479466|18247530|P5|Overall Study|Physician Decision|0
5291463|NCT00479466|18247531|P4|Overall Study|Physician Decision|0
5291464|NCT00479466|18247532|P3|Overall Study|Physician Decision|1
5291465|NCT00479466|18247533|P2|Overall Study|Physician Decision|1
5291466|NCT00479466|18247534|P1|Overall Study|Physician Decision|2
5291467|NCT00479466|18247529|P6|Overall Study|Lost to Follow-up|2
5291468|NCT00479466|18247530|P5|Overall Study|Lost to Follow-up|2
5291469|NCT00479466|18247531|P4|Overall Study|Lost to Follow-up|0
5291470|NCT00479466|18247532|P3|Overall Study|Lost to Follow-up|1
5291471|NCT00479466|18247533|P2|Overall Study|Lost to Follow-up|1
5291472|NCT00479466|18247534|P1|Overall Study|Lost to Follow-up|0
5291473|NCT00479466|18247529|P6|Overall Study|Lack of Efficacy|0
5291474|NCT00479466|18247530|P5|Overall Study|Lack of Efficacy|0
5291475|NCT00479466|18247531|P4|Overall Study|Lack of Efficacy|0
5291476|NCT00479466|18247532|P3|Overall Study|Lack of Efficacy|1
5291477|NCT00479466|18247533|P2|Overall Study|Lack of Efficacy|0
5291478|NCT00479466|18247534|P1|Overall Study|Lack of Efficacy|2
5291479|NCT00479466|18247529|P6|Overall Study|Hyperglycemia|1
5291480|NCT00479466|18247530|P5|Overall Study|Hyperglycemia|0
5291481|NCT00479466|18247531|P4|Overall Study|Hyperglycemia|0
5291482|NCT00479466|18247532|P3|Overall Study|Hyperglycemia|0
5291483|NCT00479466|18247533|P2|Overall Study|Hyperglycemia|0
5291484|NCT00479466|18247534|P1|Overall Study|Hyperglycemia|0
5291485|NCT00479466|18247529|P6|Overall Study|Adverse Event|0
5291486|NCT00479466|18247530|P5|Overall Study|Adverse Event|2
5291487|NCT00479466|18247531|P4|Overall Study|Adverse Event|1
5291488|NCT00479466|18247532|P3|Overall Study|Adverse Event|0
5291489|NCT00479466|18247533|P2|Overall Study|Adverse Event|1
5291490|NCT00479466|18247534|P1|Overall Study|Adverse Event|5
5291491|NCT00479401|18247563|P3|Overall Study|Exclusion criteria, relocation|0
5291492|NCT00479401|18247564|P2|Overall Study|Exclusion criteria, relocation|3
5291493|NCT00479401|18247565|P1|Overall Study|Exclusion criteria, relocation|4
5291494|NCT00479401|18247563|P3|Overall Study|Withdrawal by Subject|2
5291495|NCT00479401|18247564|P2|Overall Study|Withdrawal by Subject|10
5291496|NCT00479401|18247565|P1|Overall Study|Withdrawal by Subject|16
5291497|NCT00479401|18247563|P3|Overall Study|Lost to Follow-up|1
5291498|NCT00479401|18247564|P2|Overall Study|Lost to Follow-up|1
5291499|NCT00479401|18247565|P1|Overall Study|Lost to Follow-up|1
5291500|NCT00479401|18247563|P3|Overall Study|Protocol Violation|1
5291501|NCT00479401|18247564|P2|Overall Study|Protocol Violation|1
5291502|NCT00479401|18247565|P1|Overall Study|Protocol Violation|2
5291503|NCT00479401|18247563|P3|Overall Study|Lack of Efficacy|4
5291505|NCT00479401|18247565|P1|Overall Study|Lack of Efficacy|2
5291506|NCT00479401|18247563|P3|Overall Study|Adverse Event|4
5291507|NCT00479401|18247564|P2|Overall Study|Adverse Event|20
5291508|NCT00479401|18247565|P1|Overall Study|Adverse Event|24
5291509|NCT00479388|18247620|P2|Overall Study|Withdrawal by Subject|17
5291510|NCT00479388|18247621|P1|Overall Study|Withdrawal by Subject|32
5291511|NCT00479388|18247620|P2|Overall Study|Protocol Violation|9
5291512|NCT00479388|18247621|P1|Overall Study|Protocol Violation|10
5291513|NCT00479388|18247620|P2|Overall Study|Lost to Follow-up|2
5291514|NCT00479388|18247621|P1|Overall Study|Lost to Follow-up|0
5291515|NCT00479388|18247620|P2|Overall Study|Adverse Event|45
5291516|NCT00479388|18247621|P1|Overall Study|Adverse Event|90
5291517|NCT00479336|18247635|P4|Overall Study|Resolution of all hepatic edema findings|0
5291518|NCT00479336|18247636|P3|Overall Study|Resolution of all hepatic edema findings|0
5291519|NCT00479336|18247637|P2|Overall Study|Resolution of all hepatic edema findings|1
5291520|NCT00479336|18247638|P1|Overall Study|Resolution of all hepatic edema findings|1
5291521|NCT00479336|18247635|P4|Overall Study|Physician Decision|2
5291522|NCT00479336|18247636|P3|Overall Study|Physician Decision|0
5291523|NCT00479336|18247637|P2|Overall Study|Physician Decision|1
5291524|NCT00479336|18247638|P1|Overall Study|Physician Decision|0
5291525|NCT00479336|18247635|P4|Overall Study|Withdrawal by Subject|0
5291526|NCT00479336|18247636|P3|Overall Study|Withdrawal by Subject|0
5291527|NCT00479336|18247637|P2|Overall Study|Withdrawal by Subject|2
5291528|NCT00479336|18247638|P1|Overall Study|Withdrawal by Subject|1
5291529|NCT00479336|18247635|P4|Overall Study|Protocol Violation|0
5291530|NCT00479336|18247636|P3|Overall Study|Protocol Violation|0
5291531|NCT00479336|18247637|P2|Overall Study|Protocol Violation|1
5291532|NCT00479336|18247638|P1|Overall Study|Protocol Violation|0
5291533|NCT00479336|18247635|P4|Overall Study|Lack of Efficacy|0
5291534|NCT00479336|18247636|P3|Overall Study|Lack of Efficacy|0
5291535|NCT00479336|18247637|P2|Overall Study|Lack of Efficacy|0
5291536|NCT00479336|18247638|P1|Overall Study|Lack of Efficacy|1
5291537|NCT00479336|18247635|P4|Overall Study|Adverse Event|3
5291538|NCT00479336|18247636|P3|Overall Study|Adverse Event|1
5291539|NCT00479336|18247637|P2|Overall Study|Adverse Event|1
5291540|NCT00479336|18247638|P1|Overall Study|Adverse Event|1
5291541|NCT00479232|18247661|P6|Overall Study|Withdrew Consent|3
5291542|NCT00479232|18247662|P5|Overall Study|Withdrew Consent|1
5291543|NCT00479232|18247663|P4|Overall Study|Withdrew Consent|0
5291544|NCT00479232|18247664|P3|Overall Study|Withdrew Consent|6
5291545|NCT00479232|18247665|P2|Overall Study|Withdrew Consent|2
5291546|NCT00479232|18247666|P1|Overall Study|Withdrew Consent|0
5291547|NCT00479232|18247661|P6|Overall Study|Progressive Disease|12
5291548|NCT00479232|18247662|P5|Overall Study|Progressive Disease|3
5291549|NCT00479232|18247663|P4|Overall Study|Progressive Disease|3
5291550|NCT00479232|18247664|P3|Overall Study|Progressive Disease|12
5291551|NCT00479232|18247665|P2|Overall Study|Progressive Disease|1
5291552|NCT00479232|18247666|P1|Overall Study|Progressive Disease|3
5291553|NCT00479232|18247661|P6|Overall Study|Physician Decision|1
5291554|NCT00479232|18247662|P5|Overall Study|Physician Decision|0
5291555|NCT00479232|18247663|P4|Overall Study|Physician Decision|0
5291556|NCT00479232|18247664|P3|Overall Study|Physician Decision|2
5291557|NCT00479232|18247665|P2|Overall Study|Physician Decision|0
5291558|NCT00479232|18247666|P1|Overall Study|Physician Decision|0
5291559|NCT00479232|18247661|P6|Overall Study|Lack of Efficacy|4
5291560|NCT00479232|18247662|P5|Overall Study|Lack of Efficacy|0
5291561|NCT00479232|18247663|P4|Overall Study|Lack of Efficacy|0
5291562|NCT00479232|18247664|P3|Overall Study|Lack of Efficacy|2
5291563|NCT00479232|18247665|P2|Overall Study|Lack of Efficacy|0
5291564|NCT00479232|18247666|P1|Overall Study|Lack of Efficacy|0
5291565|NCT00479232|18247661|P6|Overall Study|Deviation from Protocol|0
5291566|NCT00479232|18247662|P5|Overall Study|Deviation from Protocol|0
5291567|NCT00479232|18247663|P4|Overall Study|Deviation from Protocol|0
5291568|NCT00479232|18247664|P3|Overall Study|Deviation from Protocol|1
5291569|NCT00479232|18247665|P2|Overall Study|Deviation from Protocol|0
5291570|NCT00479232|18247666|P1|Overall Study|Deviation from Protocol|0
5291571|NCT00479232|18247661|P6|Overall Study|Adverse Event|10
5291572|NCT00479232|18247662|P5|Overall Study|Adverse Event|0
5291573|NCT00479232|18247663|P4|Overall Study|Adverse Event|0
5291574|NCT00479232|18247664|P3|Overall Study|Adverse Event|5
5291575|NCT00479232|18247665|P2|Overall Study|Adverse Event|0
5291576|NCT00479232|18247666|P1|Overall Study|Adverse Event|0
5291577|NCT00478933|18247728|P1|Overall Study|Inadequate data available|53
5291578|NCT00478933|18247728|P1|Overall Study|Informed consent not verified|3
5291579|NCT00478933|18247728|P1|Overall Study|Protocol Violation|22
5291580|NCT00478881|18247754|P2|Overall Study|Non-Compliance with Study Medication|2
5291581|NCT00478881|18247755|P1|Overall Study|Non-Compliance with Study Medication|0
5291582|NCT00478881|18247754|P2|Overall Study|Withdrawal by Subject|2
5291583|NCT00478881|18247755|P1|Overall Study|Withdrawal by Subject|6
5291584|NCT00478881|18247754|P2|Overall Study|Protocol Violation|2
5291585|NCT00478881|18247755|P1|Overall Study|Protocol Violation|2
5291586|NCT00478881|18247754|P2|Overall Study|Lost to Follow-up|1
5291587|NCT00478881|18247755|P1|Overall Study|Lost to Follow-up|0
5291588|NCT00478881|18247754|P2|Overall Study|Lack of Efficacy|3
5291589|NCT00478881|18247755|P1|Overall Study|Lack of Efficacy|0
5291590|NCT00478881|18247754|P2|Overall Study|Adverse Event|12
5291591|NCT00478881|18247755|P1|Overall Study|Adverse Event|31
5291592|NCT00478777|18247779|P1|Overall Study|Not treated with lenalidomide|6
5291593|NCT00478777|18247779|P1|Overall Study|End of therapy|2
5291594|NCT00478777|18247779|P1|Overall Study|Lymphocytes infusion|1
5291595|NCT00478777|18247779|P1|Overall Study|Lack of compliance|1
5291596|NCT00478777|18247779|P1|Overall Study|Intolerance of therapy|1
5291597|NCT00478777|18247779|P1|Overall Study|Physician Decision|1
5291598|NCT00478777|18247779|P1|Overall Study|Lost to Follow-up|3
5291599|NCT00478777|18247779|P1|Overall Study|Protocol Violation|3
5291600|NCT00478777|18247779|P1|Overall Study|Death|3
5291601|NCT00478777|18247779|P1|Overall Study|Withdrawal by Subject|4
5291602|NCT00478777|18247779|P1|Overall Study|Lack of Efficacy|23
5291603|NCT00478777|18247779|P1|Overall Study|Adverse Event|29
5291604|NCT00478673|18247786|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
5291605|NCT00478673|18247786|P1|12-Months Post-Procedure|Missed Visit|25
5291606|NCT00478673|18247786|P1|12-Months Post-Procedure|Withdrawal by Subject|6
5291607|NCT00478673|18247786|P1|12-Months Post-Procedure|Lost to Follow-up|4
5291608|NCT00478673|18247786|P1|12-Months Post-Procedure|Death|23
5291609|NCT00478673|18247786|P1|30-Days Post-Procedure|Missed Visit|7
5291610|NCT00478673|18247786|P1|30-Days Post-Procedure|Withdrawal by Subject|1
5291611|NCT00478673|18247786|P1|30-Days Post-Procedure|Death|2
5291612|NCT00478647|18247791|P1|Overall Study|Withdrawal by Subject|1
5291613|NCT00478647|18247791|P1|Overall Study|Adverse Event|1
5291614|NCT00478608|18247799|P1|Overall Study|Protocol Violation|3
5291615|NCT00478608|18247799|P1|Overall Study|Withdrawal by Subject|2
5291616|NCT00478608|18247799|P1|Overall Study|Serious Adverse Event|14
5291617|NCT00478608|18247799|P1|Overall Study|Adverse Event|1
5291618|NCT00478426|18247832|P1|Overall Study|Withdrawal by Subject|1
5291619|NCT00478257|18247857|P2|Overall Study|Withdrawal by Subject|3
5291620|NCT00478257|18247858|P1|Overall Study|Withdrawal by Subject|8
5291621|NCT00478244|18247864|P1|Overall Study|Did not receive transplant|1
5291622|NCT00478231|18247877|P1|Overall Study|Randomized, not treated|3
5291623|NCT00478231|18247877|P1|Overall Study|Adverse Event|5
5291624|NCT00478231|18247877|P1|Overall Study|Other|9
5291625|NCT00478231|18247877|P1|Overall Study|Withdrawal by Subject|6
5291626|NCT00478231|18247877|P1|Overall Study|Lost to Follow-up|7
5291627|NCT00478231|18247877|P1|Overall Study|Lack of Efficacy|47
5291628|NCT00478231|18247877|P1|Overall Study|Death|7
5291629|NCT00478205|18247913|P2|Overall Study|Other|12
5291630|NCT00478205|18247914|P1|Overall Study|Other|24
5291631|NCT00478205|18247913|P2|Overall Study|Lack of Efficacy|0
5291632|NCT00478205|18247914|P1|Overall Study|Lack of Efficacy|1
5291633|NCT00478205|18247913|P2|Overall Study|Withdrawal by Subject|22
5291634|NCT00478205|18247914|P1|Overall Study|Withdrawal by Subject|61
5291635|NCT00478205|18247913|P2|Overall Study|Request of Investigator or Sponsor|5
5291636|NCT00478205|18247914|P1|Overall Study|Request of Investigator or Sponsor|4
5291637|NCT00478205|18247913|P2|Overall Study|Protocol Violation|5
5291638|NCT00478205|18247914|P1|Overall Study|Protocol Violation|15
5291639|NCT00478205|18247913|P2|Overall Study|Medication Non-compliance|4
5291640|NCT00478205|18247914|P1|Overall Study|Medication Non-compliance|9
5291641|NCT00478205|18247913|P2|Overall Study|Adverse Event|39
5291642|NCT00478205|18247914|P1|Overall Study|Adverse Event|182
5291643|NCT00478140|18247958|P1|Overall Study|Clinical Disease Progression|1
5291644|NCT00478023|18247990|P5|Overall Study|Lack of pain, Technical difficulties|3
5291645|NCT00478023|18247991|P4|Overall Study|Lack of pain, Technical difficulties|6
5291646|NCT00478023|18247992|P3|Overall Study|Lack of pain, Technical difficulties|5
5291647|NCT00478023|18247993|P2|Overall Study|Lack of pain, Technical difficulties|3
5291648|NCT00478023|18247994|P1|Overall Study|Lack of pain, Technical difficulties|7
5291649|NCT00478023|18247990|P5|Overall Study|Withdrawal by Subject|5
5291650|NCT00478023|18247991|P4|Overall Study|Withdrawal by Subject|4
5291651|NCT00478023|18247992|P3|Overall Study|Withdrawal by Subject|2
5291652|NCT00478023|18247993|P2|Overall Study|Withdrawal by Subject|3
5291653|NCT00478023|18247994|P1|Overall Study|Withdrawal by Subject|2
5291654|NCT00478023|18247990|P5|Overall Study|Lost to Follow-up|0
5291655|NCT00478023|18247991|P4|Overall Study|Lost to Follow-up|1
5291656|NCT00478023|18247992|P3|Overall Study|Lost to Follow-up|1
5291657|NCT00478023|18247993|P2|Overall Study|Lost to Follow-up|1
5291658|NCT00478023|18247994|P1|Overall Study|Lost to Follow-up|3
5291659|NCT00478023|18247990|P5|Overall Study|Lack of Efficacy|41
5291660|NCT00478023|18247991|P4|Overall Study|Lack of Efficacy|5
5291661|NCT00478023|18247992|P3|Overall Study|Lack of Efficacy|4
5291662|NCT00478023|18247993|P2|Overall Study|Lack of Efficacy|10
5291663|NCT00478023|18247994|P1|Overall Study|Lack of Efficacy|11
5291664|NCT00478023|18247990|P5|Overall Study|Death|0
5291665|NCT00478023|18247991|P4|Overall Study|Death|0
5291666|NCT00478023|18247992|P3|Overall Study|Death|0
5291667|NCT00478023|18247993|P2|Overall Study|Death|0
5291668|NCT00478023|18247994|P1|Overall Study|Death|1
5291669|NCT00478023|18247990|P5|Overall Study|Adverse Event|6
5291670|NCT00478023|18247991|P4|Overall Study|Adverse Event|14
5291671|NCT00478023|18247992|P3|Overall Study|Adverse Event|8
5291672|NCT00478023|18247993|P2|Overall Study|Adverse Event|7
5291673|NCT00478023|18247994|P1|Overall Study|Adverse Event|11
5291674|NCT00477971|18248013|P2|Overall Study|Alternative treatment|1
5291675|NCT00477971|18248014|P1|Overall Study|Alternative treatment|3
5291676|NCT00477971|18248013|P2|Overall Study|Death|4
5291677|NCT00477971|18248014|P1|Overall Study|Death|2
5291678|NCT00477971|18248013|P2|Overall Study|Adverse Event|0
5291679|NCT00477971|18248014|P1|Overall Study|Adverse Event|3
5291680|NCT00477971|18248013|P2|Overall Study|Withdrawal by Subject|1
5291681|NCT00477971|18248014|P1|Overall Study|Withdrawal by Subject|3
5291682|NCT00477971|18248013|P2|Overall Study|Disease progression|0
5291683|NCT00477971|18248014|P1|Overall Study|Disease progression|6
5291684|NCT00477750|18248026|P1|Overall Study|Currently Receiving Treatment|11
5291685|NCT00477672|18248042|P3|Overall Study|Discretion of Sponsor|0
5291686|NCT00477672|18248043|P2|Overall Study|Discretion of Sponsor|2
5291687|NCT00477672|18248044|P1|Overall Study|Discretion of Sponsor|1
5291688|NCT00477672|18248042|P3|Overall Study|Consent withdrawn|10
5291689|NCT00477672|18248043|P2|Overall Study|Consent withdrawn|5
5291690|NCT00477672|18248044|P1|Overall Study|Consent withdrawn|2
5291691|NCT00477672|18248042|P3|Overall Study|Protocol noncompliance|0
5291692|NCT00477672|18248043|P2|Overall Study|Protocol noncompliance|2
5291693|NCT00477672|18248044|P1|Overall Study|Protocol noncompliance|0
5291694|NCT00477672|18248042|P3|Overall Study|Physician Decision|0
5291695|NCT00477672|18248043|P2|Overall Study|Physician Decision|0
5291696|NCT00477672|18248044|P1|Overall Study|Physician Decision|1
5291697|NCT00477672|18248042|P3|Overall Study|Disease progression|0
5291698|NCT00477672|18248043|P2|Overall Study|Disease progression|1
5291699|NCT00477672|18248044|P1|Overall Study|Disease progression|0
5291700|NCT00477672|18248042|P3|Overall Study|Death|0
5291701|NCT00477672|18248043|P2|Overall Study|Death|1
5291702|NCT00477672|18248044|P1|Overall Study|Death|0
5291703|NCT00477672|18248042|P3|Overall Study|Adverse Event|6
5291704|NCT00477672|18248043|P2|Overall Study|Adverse Event|5
5291705|NCT00477672|18248044|P1|Overall Study|Adverse Event|3
5291706|NCT00477633|18248055|P1|Overall Study|Various (Moving, Enrollment closed)|75
5291707|NCT00477633|18248055|P1|Overall Study|Protocol Violation|25
5291708|NCT00477633|18248055|P1|Overall Study|Withdrawal by Subject|149
5291709|NCT00477633|18248055|P1|Overall Study|Lost to Follow-up|271
5291710|NCT00477633|18248055|P1|Overall Study|Pregnancy|23
5291711|NCT00477633|18248055|P1|Overall Study|Adverse Event|143
5291712|NCT00477633|18248055|P1|Overall Study|Did not receive treatment|23
5291713|NCT00477607|18248063|P2|Overall Study|Lost to Follow-up|7
5291714|NCT00477607|18248064|P1|Overall Study|Lost to Follow-up|7
5291715|NCT00477594|18248076|P2|Follow-up Period|Other|0
5291716|NCT00477594|18248077|P1|Follow-up Period|Other|1
5291717|NCT00477594|18248076|P2|Follow-up Period|Withdrawal by Subject|1
5291718|NCT00477594|18248077|P1|Follow-up Period|Withdrawal by Subject|2
5291719|NCT00477594|18248076|P2|Year 3|Withdrawal by Subject|0
5291720|NCT00477594|18248077|P1|Year 3|Withdrawal by Subject|1
5291721|NCT00477594|18248076|P2|Year 3|Adverse Event|0
5291722|NCT00477594|18248077|P1|Year 3|Adverse Event|1
5291723|NCT00477594|18248076|P2|Year 1 and Year 2|Other|0
5291724|NCT00477594|18248077|P1|Year 1 and Year 2|Other|1
5291725|NCT00477594|18248076|P2|Year 1 and Year 2|Withdrawal by Subject|1
5291726|NCT00477594|18248077|P1|Year 1 and Year 2|Withdrawal by Subject|2
5291727|NCT00477594|18248076|P2|Year 1 and Year 2|Physician Decision|1
5291728|NCT00477594|18248077|P1|Year 1 and Year 2|Physician Decision|2
5291729|NCT00477594|18248076|P2|Year 1 and Year 2|Adverse Event|2
5291730|NCT00477594|18248077|P1|Year 1 and Year 2|Adverse Event|4
5291731|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
5291732|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
5291733|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
5291734|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
5291735|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
5291736|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
5291737|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
5291738|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
5291739|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
5291740|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
5291741|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
5291742|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
5291743|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
5291744|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
5291745|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
5291746|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
5291747|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
5291748|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
5291749|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291750|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291751|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291752|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291753|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291754|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291755|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291756|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
5291757|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5291758|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
5291759|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
5291760|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5291761|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5291762|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
5291763|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5291764|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5291765|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5291766|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5291767|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5291768|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5291769|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
5291770|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5291771|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
5291772|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5291773|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
5291774|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
5291775|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5291776|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
5291777|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5291778|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5291779|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5291780|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5291781|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5291782|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
5291783|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
5291784|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
5291785|NCT00477490|18248138|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
5291786|NCT00477490|18248139|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
5291787|NCT00477490|18248140|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
5291788|NCT00477490|18248141|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
5291789|NCT00477490|18248142|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
5291790|NCT00477490|18248143|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
5291791|NCT00477490|18248144|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
5291792|NCT00477490|18248145|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
5291793|NCT00477490|18248146|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
5291794|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Not Reported|0
5291795|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Not Reported|0
5291796|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Not Reported|0
5291797|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Not Reported|0
5291798|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Not Reported|1
5291799|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Not Reported|0
5291800|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Not Reported|3
5291801|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Not Reported|2
5291802|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Not Reported|1
5291803|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Other, not specified|0
5291804|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Other, not specified|0
5291805|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Other, not specified|0
5291806|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Other, not specified|0
5291807|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Other, not specified|1
5291808|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Other, not specified|1
5291809|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Other, not specified|0
5291810|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Other, not specified|4
5291811|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Other, not specified|2
5291812|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
5291813|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
5291814|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
5291815|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
5291816|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
5291817|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
5291818|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
5291819|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
5291820|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
5291821|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5291822|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5291823|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5291824|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5291825|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
5291826|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
5291827|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
5291828|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
5291829|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
5291830|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Protocol Violation|0
5291831|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Protocol Violation|0
5291832|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Protocol Violation|0
5291833|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Protocol Violation|0
5291834|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Protocol Violation|1
5291835|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Protocol Violation|0
5291836|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Protocol Violation|0
5291837|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Protocol Violation|0
5291838|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Protocol Violation|2
5291839|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5291840|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5291841|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5291842|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5291843|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
5291844|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
5291845|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5291846|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5291847|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
5291848|NCT00477490|18248138|P9|Part I: 4 Week Efficacy|Adverse Event|0
5291849|NCT00477490|18248139|P8|Part I: 4 Week Efficacy|Adverse Event|0
5291850|NCT00477490|18248140|P7|Part I: 4 Week Efficacy|Adverse Event|0
5291851|NCT00477490|18248141|P6|Part I: 4 Week Efficacy|Adverse Event|0
5291852|NCT00477490|18248142|P5|Part I: 4 Week Efficacy|Adverse Event|6
5291853|NCT00477490|18248143|P4|Part I: 4 Week Efficacy|Adverse Event|5
5291854|NCT00477490|18248144|P3|Part I: 4 Week Efficacy|Adverse Event|0
5291855|NCT00477490|18248145|P2|Part I: 4 Week Efficacy|Adverse Event|4
5291856|NCT00477490|18248146|P1|Part I: 4 Week Efficacy|Adverse Event|1
5291857|NCT00477464|18248230|P1|Overall Study|Completion of protocol-defined follow-up|14
5291858|NCT00477464|18248230|P1|Overall Study|Death|36
5291859|NCT00477464|18248230|P1|Overall Study|Lost to Follow-up|1
5291860|NCT00477386|18248274|P2|Overall Study|Withdrawal by Subject|0
5291861|NCT00477386|18248275|P1|Overall Study|Withdrawal by Subject|1
5291862|NCT00477386|18248274|P2|Overall Study|Physician Decision|0
5291863|NCT00477386|18248275|P1|Overall Study|Physician Decision|1
5291864|NCT00477386|18248274|P2|Overall Study|Other|2
5291865|NCT00477386|18248275|P1|Overall Study|Other|1
5291866|NCT00477386|18248274|P2|Overall Study|Disease progression, refractory|3
5291867|NCT00477386|18248275|P1|Overall Study|Disease progression, refractory|1
5291868|NCT00477386|18248274|P2|Overall Study|Disease progression, relapse|4
5291869|NCT00477386|18248275|P1|Overall Study|Disease progression, relapse|3
5291870|NCT00477386|18248274|P2|Overall Study|Adverse Event|8
5291871|NCT00477386|18248275|P1|Overall Study|Adverse Event|4
5291872|NCT00477334|18248285|P2|Overall Study|Protocol Violation|1
5291873|NCT00477334|18248286|P1|Overall Study|Protocol Violation|7
5291874|NCT00477334|18248285|P2|Overall Study|Administrative Problems|15
5291875|NCT00477334|18248286|P1|Overall Study|Administrative Problems|39
5291876|NCT00477334|18248285|P2|Overall Study|Lost to Follow-up|4
5291877|NCT00477334|18248286|P1|Overall Study|Lost to Follow-up|15
5291878|NCT00477334|18248285|P2|Overall Study|Withdrawal by Subject|1
5291879|NCT00477334|18248286|P1|Overall Study|Withdrawal by Subject|2
5291880|NCT00477334|18248285|P2|Overall Study|Adverse Event|2
5291881|NCT00477334|18248286|P1|Overall Study|Adverse Event|1
5291882|NCT00477334|18248285|P2|Overall Study|Discontinued prior to taking study drug|53
5291883|NCT00477334|18248286|P1|Overall Study|Discontinued prior to taking study drug|106
5291884|NCT00477295|18248312|P2|Overall Study|Other|3
5291885|NCT00477295|18248313|P1|Overall Study|Other|4
5291886|NCT00477295|18248312|P2|Overall Study|Lost to Follow-up|11
5291887|NCT00477295|18248313|P1|Overall Study|Lost to Follow-up|21
5291888|NCT00477295|18248312|P2|Overall Study|Physician Decision|5
5291889|NCT00477295|18248313|P1|Overall Study|Physician Decision|4
5291890|NCT00477295|18248312|P2|Overall Study|Protocol Violation|8
5291891|NCT00477295|18248313|P1|Overall Study|Protocol Violation|3
5291892|NCT00477295|18248312|P2|Overall Study|Lack of Efficacy|23
5291893|NCT00477295|18248313|P1|Overall Study|Lack of Efficacy|23
5291894|NCT00477295|18248312|P2|Overall Study|Withdrawal by Subject|24
5291895|NCT00477295|18248313|P1|Overall Study|Withdrawal by Subject|35
5291896|NCT00477295|18248312|P2|Overall Study|Adverse Event|35
5291897|NCT00477295|18248313|P1|Overall Study|Adverse Event|31
5291898|NCT00477269|18248341|P3|Open Label Extension|Death|4
5291899|NCT00477269|18248342|P2|Open Label Extension|Death|0
5291900|NCT00477269|18248343|P1|Open Label Extension|Death|0
5291901|NCT00477269|18248341|P3|Open Label Extension|Adminiatrative problems|2
5291902|NCT00477269|18248342|P2|Open Label Extension|Adminiatrative problems|0
5291903|NCT00477269|18248343|P1|Open Label Extension|Adminiatrative problems|0
5291904|NCT00477269|18248341|P3|Open Label Extension|unsatisfactory therapeutic effects|2
5291905|NCT00477269|18248342|P2|Open Label Extension|unsatisfactory therapeutic effects|0
5291906|NCT00477269|18248343|P1|Open Label Extension|unsatisfactory therapeutic effects|0
5291907|NCT00477269|18248341|P3|Open Label Extension|Abnormal laboratory values|1
5291908|NCT00477269|18248342|P2|Open Label Extension|Abnormal laboratory values|0
5291909|NCT00477269|18248343|P1|Open Label Extension|Abnormal laboratory values|0
5291910|NCT00477269|18248341|P3|Open Label Extension|Adverse Event|4
5291911|NCT00477269|18248342|P2|Open Label Extension|Adverse Event|0
5291912|NCT00477269|18248343|P1|Open Label Extension|Adverse Event|0
5291913|NCT00477269|18248341|P3|Core Study|Withdrawn Consent|0
5291914|NCT00477269|18248342|P2|Core Study|Withdrawn Consent|1
5291915|NCT00477269|18248343|P1|Core Study|Withdrawn Consent|0
5291916|NCT00477269|18248341|P3|Core Study|Death|0
5291917|NCT00477269|18248342|P2|Core Study|Death|3
5291918|NCT00477269|18248343|P1|Core Study|Death|3
5291919|NCT00477269|18248341|P3|Core Study|Adverse Event|0
5291920|NCT00477269|18248342|P2|Core Study|Adverse Event|4
5291921|NCT00477269|18248343|P1|Core Study|Adverse Event|6
5291922|NCT00477165|18248422|P2|Overall Study|Adverse Event|2
5291923|NCT00477165|18248423|P1|Overall Study|Adverse Event|7
5291924|NCT00477152|18248435|P1|Overall Study|Adverse Event|1
5291925|NCT00477152|18248435|P1|Overall Study|Parent withdrew consent|2
5291926|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Early termination of the study|578
5291927|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Early termination of the study|0
5291928|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Early termination of the study|0
5291929|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Early termination of the study|0
5291930|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
5291931|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
5291932|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
5291933|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
5291934|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
5291935|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
5291936|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
5291937|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
5291938|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
5291939|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
5291940|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
5291941|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
5291942|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Death|7
5291943|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Death|0
5291944|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Death|0
5291945|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Death|0
5291946|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Adverse Event|8
5291947|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Adverse Event|0
5291948|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Adverse Event|0
5291949|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Adverse Event|0
5291950|NCT00476996|18248451|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
5291951|NCT00476996|18248452|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
5291952|NCT00476996|18248453|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
5291953|NCT00476996|18248454|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
5291954|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
5291955|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
5291956|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
5291957|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
5291958|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Death|0
5291959|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Death|1
5291960|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Death|1
5291961|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Death|2
5291962|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
5291963|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
5291964|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
5291965|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
5291966|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
5291967|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
5291968|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
5291969|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
5291970|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
5291971|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
5291972|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
5291973|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
5291974|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
5291975|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
5291976|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
5291977|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
5291978|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
5291979|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
5291980|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
5291981|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
5291982|NCT00476996|18248451|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
5291983|NCT00476996|18248452|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
5291984|NCT00476996|18248453|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
5291985|NCT00476996|18248454|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
5291986|NCT00476957|18248486|P2|Overall Study|Lost to Follow-up|193
5291987|NCT00476957|18248487|P1|Overall Study|Lost to Follow-up|176
5291988|NCT00476593|18248551|P4|Overall Study|Lost to Follow-up|22
5291989|NCT00476593|18248552|P3|Overall Study|Lost to Follow-up|8
5291990|NCT00476593|18248553|P2|Overall Study|Lost to Follow-up|2
5291991|NCT00476593|18248554|P1|Overall Study|Lost to Follow-up|10
5291992|NCT00476476|18248566|P2|Overall Study|Progressive Disease|17
5291993|NCT00476476|18248567|P1|Overall Study|Progressive Disease|0
5291994|NCT00476476|18248566|P2|Overall Study|Adverse Event|7
5291995|NCT00476476|18248567|P1|Overall Study|Adverse Event|2
5291996|NCT00476229|18248585|P1|Overall Study|Progressive shortness of breath|1
5291997|NCT00476151|18248591|P2|Overall Study|Physician Decision|2
5291998|NCT00476151|18248592|P1|Overall Study|Physician Decision|0
5291999|NCT00476151|18248591|P2|Overall Study|Withdrawal by Subject|0
5292000|NCT00476151|18248592|P1|Overall Study|Withdrawal by Subject|2
5292001|NCT00476151|18248591|P2|Overall Study|Protocol Violation|3
5292002|NCT00476151|18248592|P1|Overall Study|Protocol Violation|1
5292003|NCT00476151|18248591|P2|Overall Study|Adverse Event|2
5292004|NCT00476151|18248592|P1|Overall Study|Adverse Event|0
5292005|NCT00476086|18248598|P1|Overall Study|Progressive Disease|4
5292006|NCT00476086|18248598|P1|Overall Study|Alternative therapy|1
5292007|NCT00476047|18248604|P1|Overall Study|Lost to Follow-up|1
5292008|NCT00476008|18248630|P2|Overall Study|Death|0
5292009|NCT00476008|18248631|P1|Overall Study|Death|1
5292010|NCT00476008|18248630|P2|Overall Study|Withdrawal by Subject|1
5292011|NCT00476008|18248631|P1|Overall Study|Withdrawal by Subject|0
5292012|NCT00476008|18248630|P2|Overall Study|Physician Decision: Medication Noncompli|1
5292013|NCT00476008|18248631|P1|Overall Study|Physician Decision: Medication Noncompli|2
5292014|NCT00476008|18248630|P2|Overall Study|Placebo concerns|2
5292015|NCT00476008|18248631|P1|Overall Study|Placebo concerns|2
5292016|NCT00476008|18248630|P2|Overall Study|Adverse Event|4
5292017|NCT00476008|18248631|P1|Overall Study|Adverse Event|4
5292018|NCT00475982|18248657|P2|Overall Study|surgery rescheduled|3
5292019|NCT00475982|18248658|P1|Overall Study|surgery rescheduled|7
5292020|NCT00475865|18248706|P3|Overall Study|Other than above|0
5292021|NCT00475865|18248707|P2|Overall Study|Other than above|1
5292022|NCT00475865|18248708|P1|Overall Study|Other than above|0
5292023|NCT00475865|18248706|P3|Overall Study|Participant did not wish to continue|0
5292024|NCT00475865|18248707|P2|Overall Study|Participant did not wish to continue|0
5292025|NCT00475865|18248708|P1|Overall Study|Participant did not wish to continue|1
5292026|NCT00475865|18248706|P3|Overall Study|Progressive disease|2
5292027|NCT00475865|18248707|P2|Overall Study|Progressive disease|1
5292028|NCT00475865|18248708|P1|Overall Study|Progressive disease|0
5292029|NCT00475865|18248706|P3|Overall Study|Lack of Efficacy|0
5292030|NCT00475865|18248707|P2|Overall Study|Lack of Efficacy|0
5292031|NCT00475865|18248708|P1|Overall Study|Lack of Efficacy|1
5292032|NCT00475865|18248706|P3|Overall Study|Adverse Event|4
5292033|NCT00475865|18248707|P2|Overall Study|Adverse Event|3
5292034|NCT00475865|18248708|P1|Overall Study|Adverse Event|0
5292035|NCT00475852|18248738|P2|Overall Study|Lost to Follow-up|68
5292036|NCT00475852|18248739|P1|Overall Study|Lost to Follow-up|54
5292037|NCT00475852|18248738|P2|Overall Study|Withdrawal by Subject|24
5292038|NCT00475852|18248739|P1|Overall Study|Withdrawal by Subject|19
5292039|NCT00475852|18248738|P2|Overall Study|Death|456
5292040|NCT00475852|18248739|P1|Overall Study|Death|444
5292041|NCT00475735|18248790|P6|Treatment Period 2|Withdrawal by Subject|0
5292042|NCT00475735|18248791|P5|Treatment Period 2|Withdrawal by Subject|1
5292043|NCT00475735|18248792|P4|Treatment Period 2|Withdrawal by Subject|0
5292044|NCT00475735|18248793|P3|Treatment Period 2|Withdrawal by Subject|0
5292045|NCT00475735|18248794|P2|Treatment Period 2|Withdrawal by Subject|0
5292046|NCT00475735|18248795|P1|Treatment Period 2|Withdrawal by Subject|0
5292047|NCT00475735|18248790|P6|Treatment Period 2|Lack of Efficacy|1
5292048|NCT00475735|18248791|P5|Treatment Period 2|Lack of Efficacy|0
5292049|NCT00475735|18248792|P4|Treatment Period 2|Lack of Efficacy|0
5292050|NCT00475735|18248793|P3|Treatment Period 2|Lack of Efficacy|0
5292051|NCT00475735|18248794|P2|Treatment Period 2|Lack of Efficacy|0
5292052|NCT00475735|18248795|P1|Treatment Period 2|Lack of Efficacy|0
5292053|NCT00475735|18248790|P6|Treatment Period 2|Adverse Event|0
5292054|NCT00475735|18248791|P5|Treatment Period 2|Adverse Event|0
5292055|NCT00475735|18248792|P4|Treatment Period 2|Adverse Event|2
5292056|NCT00475735|18248793|P3|Treatment Period 2|Adverse Event|0
5292057|NCT00475735|18248794|P2|Treatment Period 2|Adverse Event|1
5292058|NCT00475735|18248795|P1|Treatment Period 2|Adverse Event|0
5292059|NCT00475735|18248790|P6|Treatment Washout|Protocol Violation|0
5292060|NCT00475735|18248791|P5|Treatment Washout|Protocol Violation|0
5292061|NCT00475735|18248792|P4|Treatment Washout|Protocol Violation|0
5292062|NCT00475735|18248793|P3|Treatment Washout|Protocol Violation|0
5292063|NCT00475735|18248794|P2|Treatment Washout|Protocol Violation|1
5292064|NCT00475735|18248795|P1|Treatment Washout|Protocol Violation|0
5292065|NCT00475735|18248790|P6|Treatment Washout|Lost to Follow-up|0
5292066|NCT00475735|18248791|P5|Treatment Washout|Lost to Follow-up|0
5292067|NCT00475735|18248792|P4|Treatment Washout|Lost to Follow-up|0
5292068|NCT00475735|18248793|P3|Treatment Washout|Lost to Follow-up|0
5292069|NCT00475735|18248794|P2|Treatment Washout|Lost to Follow-up|1
5292070|NCT00475735|18248795|P1|Treatment Washout|Lost to Follow-up|0
5292071|NCT00475735|18248790|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
5292072|NCT00475735|18248791|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
5292073|NCT00475735|18248792|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
5292074|NCT00475735|18248793|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
5292075|NCT00475735|18248794|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
5292076|NCT00475735|18248795|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
5292077|NCT00475735|18248790|P6|Treatment Period 1|DC due to AE but continuing|2
5292078|NCT00475735|18248791|P5|Treatment Period 1|DC due to AE but continuing|2
5292079|NCT00475735|18248792|P4|Treatment Period 1|DC due to AE but continuing|1
5292080|NCT00475735|18248793|P3|Treatment Period 1|DC due to AE but continuing|0
5292081|NCT00475735|18248794|P2|Treatment Period 1|DC due to AE but continuing|0
5292082|NCT00475735|18248795|P1|Treatment Period 1|DC due to AE but continuing|0
5292083|NCT00475735|18248790|P6|Treatment Period 1|Withdrawal by Subject|0
5292084|NCT00475735|18248791|P5|Treatment Period 1|Withdrawal by Subject|0
5292085|NCT00475735|18248792|P4|Treatment Period 1|Withdrawal by Subject|0
5292086|NCT00475735|18248793|P3|Treatment Period 1|Withdrawal by Subject|0
5292087|NCT00475735|18248794|P2|Treatment Period 1|Withdrawal by Subject|1
5292088|NCT00475735|18248795|P1|Treatment Period 1|Withdrawal by Subject|1
5292089|NCT00475735|18248790|P6|Treatment Period 1|Protocol Violation|0
5292090|NCT00475735|18248791|P5|Treatment Period 1|Protocol Violation|0
5292091|NCT00475735|18248792|P4|Treatment Period 1|Protocol Violation|1
5292092|NCT00475735|18248793|P3|Treatment Period 1|Protocol Violation|0
5292093|NCT00475735|18248794|P2|Treatment Period 1|Protocol Violation|0
5292094|NCT00475735|18248795|P1|Treatment Period 1|Protocol Violation|0
5292095|NCT00475735|18248790|P6|Treatment Period 1|Lost to Follow-up|1
5292096|NCT00475735|18248791|P5|Treatment Period 1|Lost to Follow-up|0
5292097|NCT00475735|18248792|P4|Treatment Period 1|Lost to Follow-up|0
5292098|NCT00475735|18248793|P3|Treatment Period 1|Lost to Follow-up|0
5292099|NCT00475735|18248794|P2|Treatment Period 1|Lost to Follow-up|0
5292100|NCT00475735|18248795|P1|Treatment Period 1|Lost to Follow-up|0
5292101|NCT00475735|18248790|P6|Treatment Period 1|Lack of Efficacy|0
5292102|NCT00475735|18248791|P5|Treatment Period 1|Lack of Efficacy|0
5292103|NCT00475735|18248792|P4|Treatment Period 1|Lack of Efficacy|0
5292104|NCT00475735|18248793|P3|Treatment Period 1|Lack of Efficacy|0
5292105|NCT00475735|18248794|P2|Treatment Period 1|Lack of Efficacy|0
5292106|NCT00475735|18248795|P1|Treatment Period 1|Lack of Efficacy|1
5292107|NCT00475735|18248790|P6|Treatment Period 1|Adverse Event|0
5292108|NCT00475735|18248791|P5|Treatment Period 1|Adverse Event|0
5292109|NCT00475735|18248792|P4|Treatment Period 1|Adverse Event|0
5292110|NCT00475735|18248793|P3|Treatment Period 1|Adverse Event|0
5292111|NCT00475735|18248794|P2|Treatment Period 1|Adverse Event|0
5292112|NCT00475735|18248795|P1|Treatment Period 1|Adverse Event|2
5292113|NCT00475722|18248808|P2|Overall Study|Protocol Violation|0
5292114|NCT00475722|18248809|P1|Overall Study|Protocol Violation|3
5292115|NCT00475722|18248808|P2|Overall Study|Withdrawal by Subject|12
5292116|NCT00475722|18248809|P1|Overall Study|Withdrawal by Subject|12
5292117|NCT00475709|18248815|P1|Overall Study|Lost to Follow-up|21
5292118|NCT00475709|18248815|P1|Overall Study|Device Explant|6
5292119|NCT00475709|18248815|P1|Overall Study|Death|41
5292120|NCT00475709|18248815|P1|Overall Study|Did not meet eligibility criteria|8
5292121|NCT00475670|18248823|P2|Overall Study|Other|3
5292122|NCT00475670|18248824|P1|Overall Study|Other|0
5292123|NCT00475670|18248823|P2|Overall Study|Failure to Return|1
5292124|NCT00475670|18248824|P1|Overall Study|Failure to Return|0
5292125|NCT00475670|18248823|P2|Overall Study|Refused treatment|2
5292126|NCT00475670|18248824|P1|Overall Study|Refused treatment|0
5292127|NCT00475670|18248823|P2|Overall Study|Lack of Efficacy|34
5292128|NCT00475670|18248824|P1|Overall Study|Lack of Efficacy|3
5292129|NCT00475670|18248823|P2|Overall Study|Death|1
5292130|NCT00475670|18248824|P1|Overall Study|Death|0
5292131|NCT00475657|18248848|P1|Overall Study|Sponsor's Decision|3
5292132|NCT00475657|18248848|P1|Overall Study|Death|1
5292133|NCT00475644|18248856|P1|Overall Study|Protocol Violation|13
5292134|NCT00475423|18248921|P1|Overall Study|Lost to Follow-up|7
5292135|NCT00475423|18248921|P1|Overall Study|Reason not specified|1
5292136|NCT00475423|18248921|P1|Overall Study|Death|1
5292137|NCT00475423|18248921|P1|Overall Study|Lack of Efficacy|8
5292138|NCT00475423|18248921|P1|Overall Study|Withdrawal by Subject|6
5292139|NCT00475423|18248921|P1|Overall Study|Adverse Event|4
5292140|NCT00475423|18248921|P1|Overall Study|Protocol Violation|5
5292141|NCT00475306|18248967|P4|Overall Study|Protocol Violation|1
5292142|NCT00475306|18248968|P3|Overall Study|Protocol Violation|0
5292143|NCT00475306|18248969|P2|Overall Study|Protocol Violation|1
5292144|NCT00475306|18248970|P1|Overall Study|Protocol Violation|1
5292145|NCT00475228|18249001|P2|Overall Study|Lost to Follow-up|17
5292146|NCT00475228|18249002|P1|Overall Study|Lost to Follow-up|17
5292147|NCT00475176|18249041|P1|Overall Study|Protocol Violation|1
5292148|NCT00475176|18249041|P1|Overall Study|Withdrawal by Subject|1
5292149|NCT00475176|18249041|P1|Overall Study|Adverse Event|2
5292150|NCT00475033|18249081|P2|Toddler Dose|Lost to Follow-up|0
5292151|NCT00475033|18249082|P1|Toddler Dose|Lost to Follow-up|1
5292152|NCT00475033|18249081|P2|Toddler Dose|Failed to return|0
5292153|NCT00475033|18249082|P1|Toddler Dose|Failed to return|1
5292154|NCT00475033|18249081|P2|Toddler Dose|Parent or legal guardian request|0
5292155|NCT00475033|18249082|P1|Toddler Dose|Parent or legal guardian request|2
5292156|NCT00475033|18249081|P2|After the Infant Series|Other|1
5292157|NCT00475033|18249082|P1|After the Infant Series|Other|0
5292158|NCT00475033|18249081|P2|After the Infant Series|Lost to Follow-up|0
5292159|NCT00475033|18249082|P1|After the Infant Series|Lost to Follow-up|1
5292160|NCT00475033|18249081|P2|After the Infant Series|Protocol Violation|0
5292161|NCT00475033|18249082|P1|After the Infant Series|Protocol Violation|1
5292162|NCT00475033|18249081|P2|After the Infant Series|Failed to return|1
5292163|NCT00475033|18249082|P1|After the Infant Series|Failed to return|2
5292164|NCT00475033|18249081|P2|After the Infant Series|Parent or legal guardian request|2
5292165|NCT00475033|18249082|P1|After the Infant Series|Parent or legal guardian request|2
5292166|NCT00475033|18249081|P2|After the Infant Series|Adverse Event|4
5292167|NCT00475033|18249082|P1|After the Infant Series|Adverse Event|0
5292168|NCT00475033|18249081|P2|Infant Series|Adverse Event|2
5292169|NCT00475033|18249082|P1|Infant Series|Adverse Event|0
5292170|NCT00475033|18249081|P2|Infant Series|Lost to Follow-up|0
5292171|NCT00475033|18249082|P1|Infant Series|Lost to Follow-up|2
5292172|NCT00475033|18249081|P2|Infant Series|Protocol Violation|2
5292173|NCT00475033|18249082|P1|Infant Series|Protocol Violation|1
5292174|NCT00475033|18249081|P2|Infant Series|Parent or legal guardian request|5
5292175|NCT00475033|18249082|P1|Infant Series|Parent or legal guardian request|1
5292176|NCT00475033|18249081|P2|Infant Series|Failed to return|4
5292177|NCT00475033|18249082|P1|Infant Series|Failed to return|3
5292178|NCT00475020|18249130|P1|Overall Study|Donor not able to donate the last minute|1
5292179|NCT00475020|18249130|P1|Overall Study|Insurance Denial|1
5292180|NCT00475020|18249130|P1|Overall Study|Physician Decision|3
5292181|NCT00474994|18249135|P1|Overall Study|Patient found to be ineligible|1
5292182|NCT00474994|18249135|P1|Overall Study|Patient evaluable for toxicity only|3
5292183|NCT00474994|18249135|P1|Overall Study|Patient Not treated|1
5292184|NCT00474968|18249141|P2|Overall Study|Sample not collected|1
5292185|NCT00474968|18249142|P1|Overall Study|Sample not collected|1
5292186|NCT00474968|18249141|P2|Overall Study|Protocol Violation|8
5292187|NCT00474968|18249142|P1|Overall Study|Protocol Violation|9
5292188|NCT00474968|18249141|P2|Overall Study|Withdrawal by Subject|7
5292189|NCT00474968|18249142|P1|Overall Study|Withdrawal by Subject|8
5292190|NCT00474955|18249152|P1|Overall Study|Personal reasons|5
5292191|NCT00474955|18249152|P1|Overall Study|Drug unavailability|1
5292192|NCT00474955|18249152|P1|Overall Study|Adverse Event|2
5292193|NCT00474929|18249168|P5|Overall Study|Physician Decision|0
5292194|NCT00474929|18249169|P4|Overall Study|Physician Decision|2
5292195|NCT00474929|18249170|P3|Overall Study|Physician Decision|1
5292196|NCT00474929|18249171|P2|Overall Study|Physician Decision|0
5292197|NCT00474929|18249172|P1|Overall Study|Physician Decision|0
5292198|NCT00474929|18249168|P5|Overall Study|Unrelated medical condition|0
5292199|NCT00474929|18249169|P4|Overall Study|Unrelated medical condition|0
5292200|NCT00474929|18249170|P3|Overall Study|Unrelated medical condition|1
5292201|NCT00474929|18249171|P2|Overall Study|Unrelated medical condition|0
5292202|NCT00474929|18249172|P1|Overall Study|Unrelated medical condition|0
5292203|NCT00474929|18249168|P5|Overall Study|Withdrawal by Subject|0
5292204|NCT00474929|18249169|P4|Overall Study|Withdrawal by Subject|0
5292205|NCT00474929|18249170|P3|Overall Study|Withdrawal by Subject|0
5292206|NCT00474929|18249171|P2|Overall Study|Withdrawal by Subject|1
5292207|NCT00474929|18249172|P1|Overall Study|Withdrawal by Subject|0
5292208|NCT00474903|18249189|P3|Overall Study|Protocol Violation|2
5292209|NCT00474903|18249190|P2|Overall Study|Protocol Violation|5
5292210|NCT00474903|18249191|P1|Overall Study|Protocol Violation|1
5292211|NCT00474812|18249213|P1|Overall Study|No Initiation of treatment|2
5292212|NCT00474812|18249213|P1|Overall Study|Withdrawal by Subject|5
5292213|NCT00474786|18249223|P2|Overall Study|Other|0
5292214|NCT00474786|18249224|P1|Overall Study|Other|5
5292215|NCT00474786|18249223|P2|Overall Study|Withdrawal by Subject|15
5292216|NCT00474786|18249224|P1|Overall Study|Withdrawal by Subject|15
5292217|NCT00474786|18249223|P2|Overall Study|Protocol Violation|0
5292218|NCT00474786|18249224|P1|Overall Study|Protocol Violation|2
5292219|NCT00474786|18249223|P2|Overall Study|Lost to Follow-up|7
5292220|NCT00474786|18249224|P1|Overall Study|Lost to Follow-up|4
5292221|NCT00474786|18249223|P2|Overall Study|Discontinuation of Study by Sponsor|59
5292222|NCT00474786|18249224|P1|Overall Study|Discontinuation of Study by Sponsor|42
5292223|NCT00474786|18249223|P2|Overall Study|Death|170
5292224|NCT00474786|18249224|P1|Overall Study|Death|189
5292225|NCT00474786|18249223|P2|Overall Study|Investigator Request|1
5292226|NCT00474786|18249224|P1|Overall Study|Investigator Request|2
5292227|NCT00474786|18249223|P2|Overall Study|Not Meeting Study Criteria|1
5292228|NCT00474786|18249224|P1|Overall Study|Not Meeting Study Criteria|0
5292229|NCT00474760|18249249|P7|Overall Study|Terminated by sponsor|2
5292230|NCT00474760|18249250|P6|Overall Study|Terminated by sponsor|0
5292231|NCT00474760|18249251|P5|Overall Study|Terminated by sponsor|0
5292232|NCT00474760|18249252|P4|Overall Study|Terminated by sponsor|0
5292233|NCT00474760|18249253|P3|Overall Study|Terminated by sponsor|0
5292234|NCT00474760|18249254|P2|Overall Study|Terminated by sponsor|0
5292235|NCT00474760|18249255|P1|Overall Study|Terminated by sponsor|0
5292236|NCT00474760|18249249|P7|Overall Study|Progressive disease|7
5292237|NCT00474760|18249250|P6|Overall Study|Progressive disease|20
5292238|NCT00474760|18249251|P5|Overall Study|Progressive disease|8
5292239|NCT00474760|18249252|P4|Overall Study|Progressive disease|2
5292240|NCT00474760|18249253|P3|Overall Study|Progressive disease|3
5292241|NCT00474760|18249254|P2|Overall Study|Progressive disease|2
5292242|NCT00474760|18249255|P1|Overall Study|Progressive disease|3
5292243|NCT00474760|18249249|P7|Overall Study|Other|0
5292244|NCT00474760|18249250|P6|Overall Study|Other|0
5292245|NCT00474760|18249251|P5|Overall Study|Other|1
5292246|NCT00474760|18249252|P4|Overall Study|Other|0
5292247|NCT00474760|18249253|P3|Overall Study|Other|0
5292248|NCT00474760|18249254|P2|Overall Study|Other|1
5292249|NCT00474760|18249255|P1|Overall Study|Other|0
5292250|NCT00474760|18249249|P7|Overall Study|Withdrawal by Subject|1
5292251|NCT00474760|18249250|P6|Overall Study|Withdrawal by Subject|1
5292252|NCT00474760|18249251|P5|Overall Study|Withdrawal by Subject|0
5292253|NCT00474760|18249252|P4|Overall Study|Withdrawal by Subject|1
5292254|NCT00474760|18249253|P3|Overall Study|Withdrawal by Subject|0
5292255|NCT00474760|18249254|P2|Overall Study|Withdrawal by Subject|0
5292256|NCT00474760|18249255|P1|Overall Study|Withdrawal by Subject|0
5292257|NCT00474760|18249249|P7|Overall Study|Laboratory abnormality|0
5292258|NCT00474760|18249250|P6|Overall Study|Laboratory abnormality|1
5292259|NCT00474760|18249251|P5|Overall Study|Laboratory abnormality|0
5292260|NCT00474760|18249252|P4|Overall Study|Laboratory abnormality|0
5292261|NCT00474760|18249253|P3|Overall Study|Laboratory abnormality|0
5292262|NCT00474760|18249254|P2|Overall Study|Laboratory abnormality|0
5292263|NCT00474760|18249255|P1|Overall Study|Laboratory abnormality|0
5292264|NCT00474760|18249249|P7|Overall Study|Adverse Event|0
5292265|NCT00474760|18249250|P6|Overall Study|Adverse Event|7
5292266|NCT00474760|18249251|P5|Overall Study|Adverse Event|1
5292267|NCT00474760|18249252|P4|Overall Study|Adverse Event|0
5292268|NCT00474760|18249253|P3|Overall Study|Adverse Event|0
5292269|NCT00474760|18249254|P2|Overall Study|Adverse Event|0
5292270|NCT00474760|18249255|P1|Overall Study|Adverse Event|0
5292271|NCT00474760|18249249|P7|Overall Study|Death|0
5292272|NCT00474760|18249250|P6|Overall Study|Death|0
5292273|NCT00474760|18249251|P5|Overall Study|Death|2
5292274|NCT00474760|18249252|P4|Overall Study|Death|0
5292275|NCT00474760|18249253|P3|Overall Study|Death|0
5292276|NCT00474760|18249254|P2|Overall Study|Death|0
5292277|NCT00474760|18249255|P1|Overall Study|Death|0
5292278|NCT00474708|18249362|P2|Overall Study|Physician Decision|6
5292279|NCT00474708|18249363|P1|Overall Study|Physician Decision|9
5292280|NCT00474708|18249362|P2|Overall Study|Lost to Follow-up|9
5292281|NCT00474708|18249363|P1|Overall Study|Lost to Follow-up|18
5292282|NCT00474708|18249362|P2|Overall Study|Lack of compliance|4
5292283|NCT00474708|18249363|P1|Overall Study|Lack of compliance|12
5292284|NCT00474708|18249362|P2|Overall Study|Withdrawal by Subject|0
5292285|NCT00474708|18249363|P1|Overall Study|Withdrawal by Subject|7
5292286|NCT00474708|18249362|P2|Overall Study|Suicide ideation/behavior|1
5292287|NCT00474708|18249363|P1|Overall Study|Suicide ideation/behavior|0
5292288|NCT00474708|18249362|P2|Overall Study|Lack of Efficacy|5
5292289|NCT00474708|18249363|P1|Overall Study|Lack of Efficacy|11
5292290|NCT00474630|18249373|P2|Overall Study|Drug noncompliance, other|4
5292291|NCT00474630|18249374|P1|Overall Study|Drug noncompliance, other|11
5292292|NCT00474630|18249373|P2|Overall Study|Lack of Efficacy|6
5292293|NCT00474630|18249374|P1|Overall Study|Lack of Efficacy|5
5292294|NCT00474630|18249373|P2|Overall Study|Protocol Violation|4
5292295|NCT00474630|18249374|P1|Overall Study|Protocol Violation|3
5292296|NCT00474630|18249373|P2|Overall Study|Withdrawal by Subject|15
5292297|NCT00474630|18249374|P1|Overall Study|Withdrawal by Subject|21
5292298|NCT00474630|18249373|P2|Overall Study|Lost to Follow-up|15
5292299|NCT00474630|18249374|P1|Overall Study|Lost to Follow-up|22
5292300|NCT00474630|18249373|P2|Overall Study|Adverse Event|26
5292301|NCT00474630|18249374|P1|Overall Study|Adverse Event|98
5292302|NCT00474539|18249467|P2|Toddler Dose|Protocol Violation|0
5292303|NCT00474539|18249468|P1|Toddler Dose|Protocol Violation|1
5292304|NCT00474539|18249467|P2|After Infant Series|Withdrawal by Subject|0
5292305|NCT00474539|18249468|P1|After Infant Series|Withdrawal by Subject|1
5292306|NCT00474539|18249467|P2|After Infant Series|Lost to Follow-up|0
5292307|NCT00474539|18249468|P1|After Infant Series|Lost to Follow-up|3
5292308|NCT00474539|18249467|P2|Infant Series|Protocol Violation|1
5292309|NCT00474539|18249468|P1|Infant Series|Protocol Violation|0
5292310|NCT00474539|18249467|P2|Infant Series|Lost to Follow-up|1
5292311|NCT00474539|18249468|P1|Infant Series|Lost to Follow-up|2
5292312|NCT00474539|18249467|P2|Infant Series|Randomization error|0
5292313|NCT00474539|18249468|P1|Infant Series|Randomization error|5
5292314|NCT00474539|18249467|P2|Infant Series|Withdrawal by Subject|4
5292315|NCT00474539|18249468|P1|Infant Series|Withdrawal by Subject|3
5292316|NCT00474526|18249533|P17|Overall Study|Withdrawal by Subject|1
5292317|NCT00474526|18249534|P16|Overall Study|Withdrawal by Subject|1
5292318|NCT00474526|18249535|P15|Overall Study|Withdrawal by Subject|22
5292319|NCT00474526|18249536|P14|Overall Study|Withdrawal by Subject|37
5292320|NCT00474526|18249537|P13|Overall Study|Withdrawal by Subject|4
5292321|NCT00474526|18249538|P12|Overall Study|Withdrawal by Subject|4
5292322|NCT00474526|18249539|P11|Overall Study|Withdrawal by Subject|5
5292323|NCT00474526|18249540|P10|Overall Study|Withdrawal by Subject|13
5292324|NCT00474526|18249541|P9|Overall Study|Withdrawal by Subject|4
5292325|NCT00474526|18249542|P8|Overall Study|Withdrawal by Subject|4
5292326|NCT00474526|18249543|P7|Overall Study|Withdrawal by Subject|12
5292327|NCT00474526|18249544|P6|Overall Study|Withdrawal by Subject|6
5292328|NCT00474526|18249545|P5|Overall Study|Withdrawal by Subject|38
5292329|NCT00474526|18249546|P4|Overall Study|Withdrawal by Subject|52
5292330|NCT00474526|18249547|P3|Overall Study|Withdrawal by Subject|21
5292331|NCT00474526|18249548|P2|Overall Study|Withdrawal by Subject|24
5292332|NCT00474526|18249549|P1|Overall Study|Withdrawal by Subject|9
5292333|NCT00474526|18249533|P17|Overall Study|UNABLE TO CLASSIFY|1
5292334|NCT00474526|18249534|P16|Overall Study|UNABLE TO CLASSIFY|6
5292335|NCT00474526|18249535|P15|Overall Study|UNABLE TO CLASSIFY|12
5292336|NCT00474526|18249536|P14|Overall Study|UNABLE TO CLASSIFY|20
5292337|NCT00474526|18249537|P13|Overall Study|UNABLE TO CLASSIFY|0
5292338|NCT00474526|18249538|P12|Overall Study|UNABLE TO CLASSIFY|0
5292339|NCT00474526|18249539|P11|Overall Study|UNABLE TO CLASSIFY|0
5292340|NCT00474526|18249540|P10|Overall Study|UNABLE TO CLASSIFY|3
5292341|NCT00474526|18249541|P9|Overall Study|UNABLE TO CLASSIFY|0
5292342|NCT00474526|18249542|P8|Overall Study|UNABLE TO CLASSIFY|1
5292343|NCT00474526|18249543|P7|Overall Study|UNABLE TO CLASSIFY|0
5292344|NCT00474526|18249544|P6|Overall Study|UNABLE TO CLASSIFY|2
5292345|NCT00474526|18249545|P5|Overall Study|UNABLE TO CLASSIFY|3
5292346|NCT00474526|18249546|P4|Overall Study|UNABLE TO CLASSIFY|1
5292347|NCT00474526|18249547|P3|Overall Study|UNABLE TO CLASSIFY|0
5292348|NCT00474526|18249548|P2|Overall Study|UNABLE TO CLASSIFY|0
5292349|NCT00474526|18249549|P1|Overall Study|UNABLE TO CLASSIFY|1
5292350|NCT00474526|18249533|P17|Overall Study|Protocol Violation|2
5292351|NCT00474526|18249534|P16|Overall Study|Protocol Violation|6
5292352|NCT00474526|18249535|P15|Overall Study|Protocol Violation|9
5292353|NCT00474526|18249536|P14|Overall Study|Protocol Violation|19
5292354|NCT00474526|18249537|P13|Overall Study|Protocol Violation|4
5292355|NCT00474526|18249538|P12|Overall Study|Protocol Violation|2
5292356|NCT00474526|18249539|P11|Overall Study|Protocol Violation|2
5292357|NCT00474526|18249540|P10|Overall Study|Protocol Violation|4
5292358|NCT00474526|18249541|P9|Overall Study|Protocol Violation|0
5292359|NCT00474526|18249542|P8|Overall Study|Protocol Violation|0
5292360|NCT00474526|18249543|P7|Overall Study|Protocol Violation|3
5292361|NCT00474526|18249544|P6|Overall Study|Protocol Violation|1
5292362|NCT00474526|18249545|P5|Overall Study|Protocol Violation|3
5292363|NCT00474526|18249546|P4|Overall Study|Protocol Violation|12
5292364|NCT00474526|18249547|P3|Overall Study|Protocol Violation|4
5292365|NCT00474526|18249548|P2|Overall Study|Protocol Violation|6
5292366|NCT00474526|18249549|P1|Overall Study|Protocol Violation|2
5292367|NCT00474526|18249533|P17|Overall Study|Lost to Follow-up|5
5292368|NCT00474526|18249534|P16|Overall Study|Lost to Follow-up|4
5292369|NCT00474526|18249535|P15|Overall Study|Lost to Follow-up|29
5292370|NCT00474526|18249536|P14|Overall Study|Lost to Follow-up|74
5292371|NCT00474526|18249537|P13|Overall Study|Lost to Follow-up|6
5292372|NCT00474526|18249538|P12|Overall Study|Lost to Follow-up|4
5292373|NCT00474526|18249539|P11|Overall Study|Lost to Follow-up|2
5292374|NCT00474526|18249540|P10|Overall Study|Lost to Follow-up|6
5292375|NCT00474526|18249541|P9|Overall Study|Lost to Follow-up|0
5292376|NCT00474526|18249542|P8|Overall Study|Lost to Follow-up|1
5292377|NCT00474526|18249543|P7|Overall Study|Lost to Follow-up|8
5292378|NCT00474526|18249544|P6|Overall Study|Lost to Follow-up|5
5292379|NCT00474526|18249545|P5|Overall Study|Lost to Follow-up|11
5292380|NCT00474526|18249546|P4|Overall Study|Lost to Follow-up|29
5292381|NCT00474526|18249547|P3|Overall Study|Lost to Follow-up|13
5292382|NCT00474526|18249548|P2|Overall Study|Lost to Follow-up|6
5292383|NCT00474526|18249549|P1|Overall Study|Lost to Follow-up|8
5292384|NCT00474526|18249533|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292385|NCT00474526|18249534|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292386|NCT00474526|18249535|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
5292387|NCT00474526|18249536|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
5292388|NCT00474526|18249537|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292389|NCT00474526|18249538|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292390|NCT00474526|18249539|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292391|NCT00474526|18249540|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292392|NCT00474526|18249541|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292393|NCT00474526|18249542|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292394|NCT00474526|18249543|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292395|NCT00474526|18249544|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292396|NCT00474526|18249545|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
5292397|NCT00474526|18249546|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
5292398|NCT00474526|18249547|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292399|NCT00474526|18249548|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
5292400|NCT00474526|18249549|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
5292401|NCT00474526|18249533|P17|Overall Study|Death|0
5292402|NCT00474526|18249534|P16|Overall Study|Death|0
5292403|NCT00474526|18249535|P15|Overall Study|Death|0
5292404|NCT00474526|18249536|P14|Overall Study|Death|3
5292405|NCT00474526|18249537|P13|Overall Study|Death|0
5292406|NCT00474526|18249538|P12|Overall Study|Death|0
5292407|NCT00474526|18249539|P11|Overall Study|Death|0
5292408|NCT00474526|18249540|P10|Overall Study|Death|0
5292409|NCT00474526|18249541|P9|Overall Study|Death|0
5292410|NCT00474526|18249542|P8|Overall Study|Death|0
5292411|NCT00474526|18249543|P7|Overall Study|Death|0
5292412|NCT00474526|18249544|P6|Overall Study|Death|0
5292413|NCT00474526|18249545|P5|Overall Study|Death|0
5292414|NCT00474526|18249546|P4|Overall Study|Death|0
5292415|NCT00474526|18249547|P3|Overall Study|Death|0
5292416|NCT00474526|18249548|P2|Overall Study|Death|0
5292417|NCT00474526|18249549|P1|Overall Study|Death|0
5292418|NCT00474526|18249533|P17|Overall Study|Adverse Event|0
5292419|NCT00474526|18249534|P16|Overall Study|Adverse Event|1
5292420|NCT00474526|18249535|P15|Overall Study|Adverse Event|1
5292421|NCT00474526|18249536|P14|Overall Study|Adverse Event|0
5292422|NCT00474526|18249537|P13|Overall Study|Adverse Event|0
5292423|NCT00474526|18249538|P12|Overall Study|Adverse Event|0
5292424|NCT00474526|18249539|P11|Overall Study|Adverse Event|0
5292425|NCT00474526|18249540|P10|Overall Study|Adverse Event|0
5292426|NCT00474526|18249541|P9|Overall Study|Adverse Event|0
5292427|NCT00474526|18249542|P8|Overall Study|Adverse Event|0
5292428|NCT00474526|18249543|P7|Overall Study|Adverse Event|1
5292429|NCT00474526|18249544|P6|Overall Study|Adverse Event|1
5292430|NCT00474526|18249545|P5|Overall Study|Adverse Event|2
5292431|NCT00474526|18249546|P4|Overall Study|Adverse Event|4
5292432|NCT00474526|18249547|P3|Overall Study|Adverse Event|2
5292433|NCT00474526|18249548|P2|Overall Study|Adverse Event|0
5292434|NCT00474526|18249549|P1|Overall Study|Adverse Event|2
5292435|NCT00474526|18249533|P17|Overall Study|ADMINISTRATIVE REASON|0
5292436|NCT00474526|18249534|P16|Overall Study|ADMINISTRATIVE REASON|0
5292437|NCT00474526|18249535|P15|Overall Study|ADMINISTRATIVE REASON|2
5292438|NCT00474526|18249536|P14|Overall Study|ADMINISTRATIVE REASON|1
5292439|NCT00474526|18249537|P13|Overall Study|ADMINISTRATIVE REASON|1
5292440|NCT00474526|18249538|P12|Overall Study|ADMINISTRATIVE REASON|1
5292441|NCT00474526|18249539|P11|Overall Study|ADMINISTRATIVE REASON|1
5292442|NCT00474526|18249540|P10|Overall Study|ADMINISTRATIVE REASON|1
5292443|NCT00474526|18249541|P9|Overall Study|ADMINISTRATIVE REASON|2
5292444|NCT00474526|18249542|P8|Overall Study|ADMINISTRATIVE REASON|0
5292445|NCT00474526|18249543|P7|Overall Study|ADMINISTRATIVE REASON|1
5292446|NCT00474526|18249544|P6|Overall Study|ADMINISTRATIVE REASON|1
5292447|NCT00474526|18249545|P5|Overall Study|ADMINISTRATIVE REASON|9
5292448|NCT00474526|18249546|P4|Overall Study|ADMINISTRATIVE REASON|20
5292449|NCT00474526|18249547|P3|Overall Study|ADMINISTRATIVE REASON|9
5292450|NCT00474526|18249548|P2|Overall Study|ADMINISTRATIVE REASON|9
5292451|NCT00474526|18249549|P1|Overall Study|ADMINISTRATIVE REASON|11
5292452|NCT00474487|18249714|P4|Overall Study|Death|0
5292453|NCT00474487|18249715|P3|Overall Study|Death|0
5292454|NCT00474487|18249716|P2|Overall Study|Death|1
5292455|NCT00474487|18249717|P1|Overall Study|Death|0
5292456|NCT00474487|18249714|P4|Overall Study|Inappropriate enrollment|0
5292457|NCT00474487|18249715|P3|Overall Study|Inappropriate enrollment|7
5292458|NCT00474487|18249716|P2|Overall Study|Inappropriate enrollment|0
5292459|NCT00474487|18249717|P1|Overall Study|Inappropriate enrollment|4
5292460|NCT00474487|18249714|P4|Overall Study|Lost to Follow-up|0
5292461|NCT00474487|18249715|P3|Overall Study|Lost to Follow-up|7
5292462|NCT00474487|18249716|P2|Overall Study|Lost to Follow-up|1
5292463|NCT00474487|18249717|P1|Overall Study|Lost to Follow-up|20
5292464|NCT00474487|18249714|P4|Overall Study|Withdrawal by Subject|0
5292465|NCT00474487|18249715|P3|Overall Study|Withdrawal by Subject|0
5292466|NCT00474487|18249716|P2|Overall Study|Withdrawal by Subject|0
5292467|NCT00474487|18249717|P1|Overall Study|Withdrawal by Subject|6
5292468|NCT00474383|18249737|P2|Extension|Progressive Disease|5
5292469|NCT00474383|18249738|P1|Extension|Progressive Disease|0
5292470|NCT00474383|18249737|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
5292471|NCT00474383|18249738|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
5292472|NCT00474383|18249737|P2|Main Study|Other|0
5292473|NCT00474383|18249738|P1|Main Study|Other|1
5292474|NCT00474383|18249737|P2|Main Study|Progressive Disease|0
5292475|NCT00474383|18249738|P1|Main Study|Progressive Disease|23
5292476|NCT00474383|18249737|P2|Main Study|Symptomatic Deterioration|0
5292477|NCT00474383|18249738|P1|Main Study|Symptomatic Deterioration|1
5292478|NCT00474383|18249737|P2|Main Study|Adverse Event|0
5292479|NCT00474383|18249738|P1|Main Study|Adverse Event|11
5292480|NCT00474266|18249753|P4|Overall Study|Withdrawal by Subject|7
5292481|NCT00474266|18249754|P3|Overall Study|Withdrawal by Subject|4
5292482|NCT00474266|18249755|P2|Overall Study|Withdrawal by Subject|20
5292483|NCT00474266|18249756|P1|Overall Study|Withdrawal by Subject|7
5292484|NCT00474253|18249860|P2|Overall Study|Discharged prior to study completion|1
5292485|NCT00474253|18249861|P1|Overall Study|Discharged prior to study completion|0
5292486|NCT00474253|18249860|P2|Overall Study|Lost to Follow-up|0
5292487|NCT00474253|18249861|P1|Overall Study|Lost to Follow-up|1
5292488|NCT00474253|18249860|P2|Overall Study|Withdrew due to surgery-related issues|3
5292489|NCT00474253|18249861|P1|Overall Study|Withdrew due to surgery-related issues|0
5292490|NCT00474253|18249860|P2|Overall Study|Withdrew consent|0
5292491|NCT00474253|18249861|P1|Overall Study|Withdrew consent|2
5292492|NCT00474240|18249885|P6|Overall Study|Removed due to lab value|1
5292493|NCT00474240|18249886|P5|Overall Study|Removed due to lab value|0
5292494|NCT00474240|18249887|P4|Overall Study|Removed due to lab value|0
5292495|NCT00474240|18249888|P3|Overall Study|Removed due to lab value|0
5292496|NCT00474240|18249889|P2|Overall Study|Removed due to lab value|0
5292497|NCT00474240|18249890|P1|Overall Study|Removed due to lab value|0
5292498|NCT00474240|18249885|P6|Overall Study|Adverse Event|16
5292499|NCT00474240|18249886|P5|Overall Study|Adverse Event|5
5292500|NCT00474240|18249887|P4|Overall Study|Adverse Event|14
5292501|NCT00474240|18249888|P3|Overall Study|Adverse Event|9
5292502|NCT00474240|18249889|P2|Overall Study|Adverse Event|0
5292503|NCT00474240|18249890|P1|Overall Study|Adverse Event|0
5292504|NCT00474240|18249885|P6|Overall Study|Withdrawal by Subject|1
5292505|NCT00474240|18249886|P5|Overall Study|Withdrawal by Subject|3
5292506|NCT00474240|18249887|P4|Overall Study|Withdrawal by Subject|2
5292507|NCT00474240|18249888|P3|Overall Study|Withdrawal by Subject|0
5292508|NCT00474240|18249889|P2|Overall Study|Withdrawal by Subject|1
5292509|NCT00474240|18249890|P1|Overall Study|Withdrawal by Subject|1
5292510|NCT00474188|18249915|P1|Overall Study|Study discontinued by sponsor|5
5292511|NCT00474188|18249915|P1|Overall Study|Withdrawal by Subject|1
5292512|NCT00474175|18249925|P3|Overall Study|Administrative|0
5292513|NCT00474175|18249926|P2|Overall Study|Administrative|1
5292514|NCT00474175|18249927|P1|Overall Study|Administrative|0
5292515|NCT00474175|18249925|P3|Overall Study|Protocol Violation|1
5292516|NCT00474175|18249926|P2|Overall Study|Protocol Violation|2
5292517|NCT00474175|18249927|P1|Overall Study|Protocol Violation|0
5292518|NCT00474175|18249925|P3|Overall Study|Ineligible|1
5292519|NCT00474175|18249926|P2|Overall Study|Ineligible|3
5292520|NCT00474175|18249927|P1|Overall Study|Ineligible|1
5292521|NCT00474175|18249925|P3|Overall Study|Withdrawal by Subject|1
5292522|NCT00474175|18249926|P2|Overall Study|Withdrawal by Subject|1
5292523|NCT00474175|18249927|P1|Overall Study|Withdrawal by Subject|0
5292524|NCT00474175|18249925|P3|Overall Study|Lack of Efficacy|1
5292525|NCT00474175|18249926|P2|Overall Study|Lack of Efficacy|0
5292526|NCT00474175|18249927|P1|Overall Study|Lack of Efficacy|0
5292527|NCT00474058|18249991|P2|Overall Study|Other|0
5292528|NCT00474058|18249992|P1|Overall Study|Other|2
5292529|NCT00474058|18249991|P2|Overall Study|Withdrawal by Subject|7
5292530|NCT00474058|18249992|P1|Overall Study|Withdrawal by Subject|11
5292531|NCT00474058|18249991|P2|Overall Study|Lack of Efficacy|4
5292532|NCT00474058|18249992|P1|Overall Study|Lack of Efficacy|0
5292533|NCT00474058|18249991|P2|Overall Study|Adverse Event|6
5292534|NCT00474058|18249992|P1|Overall Study|Adverse Event|11
5292535|NCT00474045|18250006|P2|Overall Study|Withdrawal criteria|50
5292536|NCT00474045|18250007|P1|Overall Study|Withdrawal criteria|60
5292537|NCT00474045|18250006|P2|Overall Study|Withdrawal by Subject|18
5292538|NCT00474045|18250007|P1|Overall Study|Withdrawal by Subject|16
5292539|NCT00474045|18250006|P2|Overall Study|Protocol Violation|12
5292540|NCT00474045|18250007|P1|Overall Study|Protocol Violation|10
5292541|NCT00474045|18250006|P2|Overall Study|Lost to Follow-up|1
5292542|NCT00474045|18250007|P1|Overall Study|Lost to Follow-up|1
5292543|NCT00474045|18250006|P2|Overall Study|Lack of Efficacy|9
5292544|NCT00474045|18250007|P1|Overall Study|Lack of Efficacy|0
5292545|NCT00474045|18250006|P2|Overall Study|Unclassified|3
5292546|NCT00474045|18250007|P1|Overall Study|Unclassified|1
5292547|NCT00474045|18250006|P2|Overall Study|Adverse Event|8
5292548|NCT00474045|18250007|P1|Overall Study|Adverse Event|18
5292549|NCT00473889|18250107|P2|Overall Study|Withdrawal by Subject|0
5292550|NCT00473889|18250108|P1|Overall Study|Withdrawal by Subject|5
5292551|NCT00473889|18250107|P2|Overall Study|Trial Terminated|6
5292552|NCT00473889|18250108|P1|Overall Study|Trial Terminated|3
5292553|NCT00473889|18250107|P2|Overall Study|Physician Decision|5
5292554|NCT00473889|18250108|P1|Overall Study|Physician Decision|10
5292555|NCT00473889|18250107|P2|Overall Study|Lost to Follow-up|1
5292556|NCT00473889|18250108|P1|Overall Study|Lost to Follow-up|2
5292557|NCT00473889|18250107|P2|Overall Study|Lack of Efficacy|29
5292558|NCT00473889|18250108|P1|Overall Study|Lack of Efficacy|28
5292559|NCT00473889|18250107|P2|Overall Study|Protocol Violation|2
5292560|NCT00473889|18250108|P1|Overall Study|Protocol Violation|4
5292561|NCT00473889|18250107|P2|Overall Study|Adverse Event|17
5292562|NCT00473889|18250108|P1|Overall Study|Adverse Event|30
5292563|NCT00473889|18250107|P2|Overall Study|Did not receive study medication|4
5292564|NCT00473889|18250108|P1|Overall Study|Did not receive study medication|1
5292565|NCT00473876|18250120|P2|Overall Study|Lost to Follow-up|1
5292566|NCT00473876|18250121|P1|Overall Study|Lost to Follow-up|3
5292567|NCT00473824|18250140|P2|Overall Study|Withdrawal by physician|0
5292568|NCT00473824|18250141|P1|Overall Study|Withdrawal by physician|1
5292569|NCT00473824|18250140|P2|Overall Study|Lost to Follow-up|0
5292570|NCT00473824|18250141|P1|Overall Study|Lost to Follow-up|1
5292571|NCT00473824|18250140|P2|Overall Study|Death|0
5292572|NCT00473824|18250141|P1|Overall Study|Death|1
5292573|NCT00473824|18250140|P2|Overall Study|Adverse Event|0
5292574|NCT00473824|18250141|P1|Overall Study|Adverse Event|1
5292575|NCT00473824|18250140|P2|Overall Study|Virologic Breakthrough|0
5292576|NCT00473824|18250141|P1|Overall Study|Virologic Breakthrough|1
5292577|NCT00473746|18250152|P5|Period 2 (Phase 2)|Reason not specified|3
5292578|NCT00473746|18250153|P4|Period 2 (Phase 2)|Reason not specified|0
5292579|NCT00473746|18250154|P3|Period 2 (Phase 2)|Reason not specified|0
5292580|NCT00473746|18250155|P2|Period 2 (Phase 2)|Reason not specified|0
5292581|NCT00473746|18250156|P1|Period 2 (Phase 2)|Reason not specified|0
5292582|NCT00473746|18250152|P5|Period 2 (Phase 2)|Progressive Disease|20
5292583|NCT00473746|18250153|P4|Period 2 (Phase 2)|Progressive Disease|0
5292584|NCT00473746|18250154|P3|Period 2 (Phase 2)|Progressive Disease|0
5292585|NCT00473746|18250155|P2|Period 2 (Phase 2)|Progressive Disease|0
5292586|NCT00473746|18250156|P1|Period 2 (Phase 2)|Progressive Disease|0
5292587|NCT00473746|18250152|P5|Period 2 (Phase 2)|Death|1
5292588|NCT00473746|18250153|P4|Period 2 (Phase 2)|Death|0
5292589|NCT00473746|18250154|P3|Period 2 (Phase 2)|Death|0
5292590|NCT00473746|18250155|P2|Period 2 (Phase 2)|Death|0
5292591|NCT00473746|18250156|P1|Period 2 (Phase 2)|Death|0
5292592|NCT00473746|18250152|P5|Period 2 (Phase 2)|Adverse Event|3
5292593|NCT00473746|18250153|P4|Period 2 (Phase 2)|Adverse Event|0
5292594|NCT00473746|18250154|P3|Period 2 (Phase 2)|Adverse Event|0
5292595|NCT00473746|18250155|P2|Period 2 (Phase 2)|Adverse Event|0
5292596|NCT00473746|18250156|P1|Period 2 (Phase 2)|Adverse Event|0
5292597|NCT00473746|18250152|P5|Period 1 (Phase 1)|Reason not specified|0
5292598|NCT00473746|18250153|P4|Period 1 (Phase 1)|Reason not specified|0
5292599|NCT00473746|18250154|P3|Period 1 (Phase 1)|Reason not specified|0
5292600|NCT00473746|18250155|P2|Period 1 (Phase 1)|Reason not specified|1
5292601|NCT00473746|18250156|P1|Period 1 (Phase 1)|Reason not specified|0
5292602|NCT00473746|18250152|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
5292603|NCT00473746|18250153|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
5292604|NCT00473746|18250154|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
5292605|NCT00473746|18250155|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
5292606|NCT00473746|18250156|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
5292607|NCT00473746|18250152|P5|Period 1 (Phase 1)|Progressive Disease|0
5292608|NCT00473746|18250153|P4|Period 1 (Phase 1)|Progressive Disease|10
5292609|NCT00473746|18250154|P3|Period 1 (Phase 1)|Progressive Disease|6
5292610|NCT00473746|18250155|P2|Period 1 (Phase 1)|Progressive Disease|6
5292611|NCT00473746|18250156|P1|Period 1 (Phase 1)|Progressive Disease|5
5292612|NCT00473746|18250152|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
5292613|NCT00473746|18250153|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
5292614|NCT00473746|18250154|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
5292615|NCT00473746|18250155|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
5292616|NCT00473746|18250156|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
5292617|NCT00473746|18250152|P5|Period 1 (Phase 1)|Adverse Event|0
5292618|NCT00473746|18250153|P4|Period 1 (Phase 1)|Adverse Event|0
5292619|NCT00473746|18250154|P3|Period 1 (Phase 1)|Adverse Event|0
5292620|NCT00473746|18250155|P2|Period 1 (Phase 1)|Adverse Event|0
5292621|NCT00473746|18250156|P1|Period 1 (Phase 1)|Adverse Event|1
5292622|NCT00473694|18250205|P4|Overall Study|Lost to Follow-up|1
5292623|NCT00473694|18250206|P3|Overall Study|Lost to Follow-up|0
5292624|NCT00473694|18250207|P2|Overall Study|Lost to Follow-up|0
5292625|NCT00473694|18250208|P1|Overall Study|Lost to Follow-up|0
5292626|NCT00473694|18250205|P4|Overall Study|Participants did not receive treatment|6
5292627|NCT00473694|18250206|P3|Overall Study|Participants did not receive treatment|5
5292628|NCT00473694|18250207|P2|Overall Study|Participants did not receive treatment|3
5292629|NCT00473694|18250208|P1|Overall Study|Participants did not receive treatment|11
5292630|NCT00473694|18250205|P4|Overall Study|Adverse Event|0
5292631|NCT00473694|18250206|P3|Overall Study|Adverse Event|0
5292632|NCT00473694|18250207|P2|Overall Study|Adverse Event|1
5292633|NCT00473694|18250208|P1|Overall Study|Adverse Event|0
5292634|NCT00473668|18250249|P3|Overall Study|Other|4
5292635|NCT00473668|18250250|P2|Overall Study|Other|3
5292636|NCT00473668|18250251|P1|Overall Study|Other|2
5292637|NCT00473668|18250249|P3|Overall Study|Lost to Follow-up|6
5292638|NCT00473668|18250250|P2|Overall Study|Lost to Follow-up|4
5292639|NCT00473668|18250251|P1|Overall Study|Lost to Follow-up|0
5292640|NCT00473668|18250249|P3|Overall Study|Migrated/moved from study area|0
5292641|NCT00473668|18250250|P2|Overall Study|Migrated/moved from study area|2
5292642|NCT00473668|18250251|P1|Overall Study|Migrated/moved from study area|3
5292643|NCT00473668|18250249|P3|Overall Study|Withdrawal by Subject|0
5292644|NCT00473668|18250250|P2|Overall Study|Withdrawal by Subject|2
5292645|NCT00473668|18250251|P1|Overall Study|Withdrawal by Subject|0
5292646|NCT00473655|18250304|P3|Overall Study|Lost to Follow-up|8
5292647|NCT00473655|18250305|P2|Overall Study|Lost to Follow-up|5
5292648|NCT00473655|18250306|P1|Overall Study|Lost to Follow-up|9
5292649|NCT00473590|18250367|P2|Overall Study|Other|1
5292650|NCT00473590|18250368|P1|Overall Study|Other|0
5292651|NCT00473590|18250367|P2|Overall Study|Withdrawal by Subject|3
5292652|NCT00473590|18250368|P1|Overall Study|Withdrawal by Subject|5
5292653|NCT00473590|18250367|P2|Overall Study|Physician Decision|4
5292654|NCT00473590|18250368|P1|Overall Study|Physician Decision|2
5292655|NCT00473590|18250367|P2|Overall Study|Non-protocol-specified therapy|5
5292656|NCT00473590|18250368|P1|Overall Study|Non-protocol-specified therapy|7
5292657|NCT00473590|18250367|P2|Overall Study|Progression not resulting in death|20
5292658|NCT00473590|18250368|P1|Overall Study|Progression not resulting in death|24
5292659|NCT00473590|18250367|P2|Overall Study|Death|2
5292660|NCT00473590|18250368|P1|Overall Study|Death|4
5292661|NCT00473590|18250367|P2|Overall Study|Adverse Event|3
5292662|NCT00473590|18250368|P1|Overall Study|Adverse Event|3
5292663|NCT00473564|18250384|P1|Overall Study|robot surgery aborted in OR|23
5292664|NCT00473512|18250394|P5|Period 2 (Phase 2)|Other|0
5292665|NCT00473512|18250395|P4|Period 2 (Phase 2)|Other|3
5292666|NCT00473512|18250396|P3|Period 2 (Phase 2)|Other|0
5292667|NCT00473512|18250397|P2|Period 2 (Phase 2)|Other|0
5292668|NCT00473512|18250398|P1|Period 2 (Phase 2)|Other|1
5292669|NCT00473512|18250394|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
5292670|NCT00473512|18250395|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
5292671|NCT00473512|18250396|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
5292672|NCT00473512|18250397|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
5292673|NCT00473512|18250398|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
5292674|NCT00473512|18250394|P5|Period 2 (Phase 2)|Disease Progression|1
5292675|NCT00473512|18250395|P4|Period 2 (Phase 2)|Disease Progression|17
5292676|NCT00473512|18250396|P3|Period 2 (Phase 2)|Disease Progression|2
5292677|NCT00473512|18250397|P2|Period 2 (Phase 2)|Disease Progression|2
5292678|NCT00473512|18250398|P1|Period 2 (Phase 2)|Disease Progression|0
5292679|NCT00473512|18250394|P5|Period 2 (Phase 2)|Death|1
5292680|NCT00473512|18250395|P4|Period 2 (Phase 2)|Death|1
5292681|NCT00473512|18250396|P3|Period 2 (Phase 2)|Death|0
5292682|NCT00473512|18250397|P2|Period 2 (Phase 2)|Death|0
5292683|NCT00473512|18250398|P1|Period 2 (Phase 2)|Death|0
5292684|NCT00473512|18250394|P5|Period 2 (Phase 2)|Adverse Event|0
5292685|NCT00473512|18250395|P4|Period 2 (Phase 2)|Adverse Event|1
5292686|NCT00473512|18250396|P3|Period 2 (Phase 2)|Adverse Event|0
5292687|NCT00473512|18250397|P2|Period 2 (Phase 2)|Adverse Event|0
5292688|NCT00473512|18250398|P1|Period 2 (Phase 2)|Adverse Event|0
5292689|NCT00473512|18250394|P5|Period 1 (Phase 1)|Other|0
5292690|NCT00473512|18250395|P4|Period 1 (Phase 1)|Other|1
5292691|NCT00473512|18250396|P3|Period 1 (Phase 1)|Other|0
5292692|NCT00473512|18250397|P2|Period 1 (Phase 1)|Other|0
5292693|NCT00473512|18250398|P1|Period 1 (Phase 1)|Other|0
5292694|NCT00473512|18250394|P5|Period 1 (Phase 1)|Disease Progression|1
5292695|NCT00473512|18250395|P4|Period 1 (Phase 1)|Disease Progression|10
5292696|NCT00473512|18250396|P3|Period 1 (Phase 1)|Disease Progression|0
5292697|NCT00473512|18250397|P2|Period 1 (Phase 1)|Disease Progression|1
5292698|NCT00473512|18250398|P1|Period 1 (Phase 1)|Disease Progression|1
5292699|NCT00473512|18250394|P5|Period 1 (Phase 1)|Death|0
5292700|NCT00473512|18250395|P4|Period 1 (Phase 1)|Death|1
5292701|NCT00473512|18250396|P3|Period 1 (Phase 1)|Death|0
5292702|NCT00473512|18250397|P2|Period 1 (Phase 1)|Death|0
5292703|NCT00473512|18250398|P1|Period 1 (Phase 1)|Death|0
5292704|NCT00473512|18250394|P5|Period 1 (Phase 1)|Adverse Event|0
5292705|NCT00473512|18250395|P4|Period 1 (Phase 1)|Adverse Event|5
5292706|NCT00473512|18250396|P3|Period 1 (Phase 1)|Adverse Event|0
5292707|NCT00473512|18250397|P2|Period 1 (Phase 1)|Adverse Event|0
5292708|NCT00473512|18250398|P1|Period 1 (Phase 1)|Adverse Event|0
5292709|NCT00473434|18250456|P1|Overall Study|No longer required|1
5292710|NCT00473434|18250456|P1|Overall Study|Switching to trial medication|1
5292711|NCT00473434|18250456|P1|Overall Study|Ceased in favor of Paliperidone|1
5292712|NCT00473434|18250456|P1|Overall Study|Reason not specified|6
5292713|NCT00473434|18250456|P1|Overall Study|Safety evaluation|1
5292714|NCT00473434|18250456|P1|Overall Study|Patient was selling medication to others|1
5292715|NCT00473434|18250456|P1|Overall Study|Adverse Event|3
5292716|NCT00473434|18250456|P1|Overall Study|Lack of Efficacy|3
5292717|NCT00473434|18250456|P1|Overall Study|Compliance|3
5292718|NCT00473434|18250456|P1|Overall Study|Withdrawal by Subject|9
5292719|NCT00473434|18250456|P1|Overall Study|Physician Decision|3
5292720|NCT00473382|18250521|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
5292721|NCT00473382|18250522|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
5292722|NCT00473382|18250523|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
5292723|NCT00473382|18250521|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
5292724|NCT00473382|18250522|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
5292725|NCT00473382|18250523|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
5292726|NCT00473382|18250521|P3|Open-label Extension Through Month 60|Subject's Decision|6
5292727|NCT00473382|18250522|P2|Open-label Extension Through Month 60|Subject's Decision|1
5292728|NCT00473382|18250523|P1|Open-label Extension Through Month 60|Subject's Decision|7
5292729|NCT00473382|18250521|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
5292730|NCT00473382|18250522|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
5292731|NCT00473382|18250523|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
5292732|NCT00473382|18250521|P3|Open-label Extension Through Month 60|Death|4
5292733|NCT00473382|18250522|P2|Open-label Extension Through Month 60|Death|7
5292734|NCT00473382|18250523|P1|Open-label Extension Through Month 60|Death|1
5292735|NCT00473382|18250521|P3|Open-label Extension Through Month 60|Adverse Event|2
5292736|NCT00473382|18250522|P2|Open-label Extension Through Month 60|Adverse Event|0
5292737|NCT00473382|18250523|P1|Open-label Extension Through Month 60|Adverse Event|0
5292738|NCT00473382|18250521|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
5292739|NCT00473382|18250522|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
5292740|NCT00473382|18250523|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
5292741|NCT00473382|18250521|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
5292742|NCT00473382|18250522|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
5292743|NCT00473382|18250523|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
5292744|NCT00473382|18250521|P3|Open-label Extension Through Month 48|Subject's Decision|6
5292745|NCT00473382|18250522|P2|Open-label Extension Through Month 48|Subject's Decision|1
5292746|NCT00473382|18250523|P1|Open-label Extension Through Month 48|Subject's Decision|5
5292747|NCT00473382|18250521|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
5292748|NCT00473382|18250522|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
5292749|NCT00473382|18250523|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
5292750|NCT00473382|18250521|P3|Open-label Extension Through Month 48|Death|3
5292751|NCT00473382|18250522|P2|Open-label Extension Through Month 48|Death|3
5292752|NCT00473382|18250523|P1|Open-label Extension Through Month 48|Death|1
5292753|NCT00473382|18250521|P3|Open-label Extension Through Month 48|Adverse Event|1
5292754|NCT00473382|18250522|P2|Open-label Extension Through Month 48|Adverse Event|0
5292755|NCT00473382|18250523|P1|Open-label Extension Through Month 48|Adverse Event|0
5292756|NCT00473382|18250521|P3|Core Study|Subject's decision|10
5292757|NCT00473382|18250522|P2|Core Study|Subject's decision|11
5292758|NCT00473382|18250523|P1|Core Study|Subject's decision|12
5292759|NCT00473382|18250521|P3|Core Study|Subject needed other treatment|2
5292760|NCT00473382|18250522|P2|Core Study|Subject needed other treatment|3
5292761|NCT00473382|18250523|P1|Core Study|Subject needed other treatment|1
5292762|NCT00473382|18250521|P3|Core Study|Subject non-compliance|1
5292763|NCT00473382|18250522|P2|Core Study|Subject non-compliance|2
5292764|NCT00473382|18250523|P1|Core Study|Subject non-compliance|5
5292765|NCT00473382|18250521|P3|Core Study|Physician Decision|2
5292766|NCT00473382|18250522|P2|Core Study|Physician Decision|2
5292767|NCT00473382|18250523|P1|Core Study|Physician Decision|1
5292768|NCT00473382|18250521|P3|Core Study|Lost to Follow-up|3
5292769|NCT00473382|18250522|P2|Core Study|Lost to Follow-up|3
5292770|NCT00473382|18250523|P1|Core Study|Lost to Follow-up|3
5292771|NCT00473382|18250521|P3|Core Study|Death|10
5292772|NCT00473382|18250522|P2|Core Study|Death|5
5292773|NCT00473382|18250523|P1|Core Study|Death|3
5292774|NCT00473382|18250521|P3|Core Study|Adverse Event|1
5292775|NCT00473382|18250522|P2|Core Study|Adverse Event|1
5292776|NCT00473382|18250523|P1|Core Study|Adverse Event|3
5292777|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
5292778|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
5292779|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
5292780|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
5292781|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
5292782|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
5292783|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
5292784|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
5292785|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
5292786|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Subject's Decision|4
5292787|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Subject's Decision|3
5292788|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Subject's Decision|1
5292789|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Physician's Decision|3
5292790|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Physician's Decision|1
5292791|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Physician's Decision|2
5292792|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
5292793|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
5292794|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
5292795|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Death|1
5292796|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Death|2
5292797|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Death|2
5292798|NCT00473330|18250581|P3|Open-label Extension Through Month 60|Adverse Event|2
5292799|NCT00473330|18250582|P2|Open-label Extension Through Month 60|Adverse Event|0
5292800|NCT00473330|18250583|P1|Open-label Extension Through Month 60|Adverse Event|0
5292801|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
5292802|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
5292803|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
5292804|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
5292805|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
5292806|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
5292807|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
5292808|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
5292809|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
5292810|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Subject's Decision|3
5292811|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Subject's Decision|3
5292812|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Subject's Decision|1
5292813|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Physician's Decision|3
5292814|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Physician's Decision|1
5292815|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Physician's Decision|2
5292816|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
5292817|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
5292818|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
5292819|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Death|0
5292820|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Death|0
5292821|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Death|2
5292822|NCT00473330|18250581|P3|Open-label Extension Through Month 48|Adverse Event|2
5292823|NCT00473330|18250582|P2|Open-label Extension Through Month 48|Adverse Event|0
5292824|NCT00473330|18250583|P1|Open-label Extension Through Month 48|Adverse Event|0
5292825|NCT00473330|18250581|P3|Core Study|Subject's Decision|19
5292826|NCT00473330|18250582|P2|Core Study|Subject's Decision|8
5292827|NCT00473330|18250583|P1|Core Study|Subject's Decision|9
5292828|NCT00473330|18250581|P3|Core Study|Subject Required Other Therapy|3
5292829|NCT00473330|18250582|P2|Core Study|Subject Required Other Therapy|1
5292830|NCT00473330|18250583|P1|Core Study|Subject Required Other Therapy|0
5292831|NCT00473330|18250581|P3|Core Study|Subject Non-compliance|1
5292832|NCT00473330|18250582|P2|Core Study|Subject Non-compliance|2
5292833|NCT00473330|18250583|P1|Core Study|Subject Non-compliance|1
5292834|NCT00473330|18250581|P3|Core Study|Physician Decision|3
5292835|NCT00473330|18250582|P2|Core Study|Physician Decision|1
5292836|NCT00473330|18250583|P1|Core Study|Physician Decision|2
5292837|NCT00473330|18250581|P3|Core Study|Lost to Follow-up|10
5292838|NCT00473330|18250582|P2|Core Study|Lost to Follow-up|5
5292839|NCT00473330|18250583|P1|Core Study|Lost to Follow-up|5
5292840|NCT00473330|18250581|P3|Core Study|Death|4
5292841|NCT00473330|18250582|P2|Core Study|Death|4
5292842|NCT00473330|18250583|P1|Core Study|Death|6
5292843|NCT00473330|18250581|P3|Core Study|Adverse Event|1
5292844|NCT00473330|18250582|P2|Core Study|Adverse Event|4
5292845|NCT00473330|18250583|P1|Core Study|Adverse Event|4
5292846|NCT00473265|18250638|P1|Overall Study|Off treatment early|15
5292847|NCT00473265|18250638|P1|Overall Study|Unrelated adverse event|5
5292848|NCT00473083|18250650|P3|Overall Study|Adverse Event|0
5292849|NCT00473083|18250651|P2|Overall Study|Adverse Event|0
5292850|NCT00473083|18250652|P1|Overall Study|Adverse Event|1
5292851|NCT00472641|18250727|P1|Overall Study|Lost to Follow-up|1
5292852|NCT00472641|18250727|P1|Overall Study|Adverse Event|3
5292853|NCT00472641|18250727|P1|Overall Study|Lack of Efficacy|3
5292854|NCT00472446|18250747|P4|Overall Study|Questionnaires not returned|4
5292855|NCT00472446|18250748|P3|Overall Study|Questionnaires not returned|6
5292856|NCT00472446|18250749|P2|Overall Study|Questionnaires not returned|6
5292857|NCT00472446|18250750|P1|Overall Study|Questionnaires not returned|5
5292858|NCT00472446|18250747|P4|Overall Study|Reintervention|1
5292859|NCT00472446|18250748|P3|Overall Study|Reintervention|1
5292860|NCT00472446|18250749|P2|Overall Study|Reintervention|0
5292861|NCT00472446|18250750|P1|Overall Study|Reintervention|0
5292862|NCT00472446|18250747|P4|Overall Study|Protocol Violation|1
5292863|NCT00472446|18250748|P3|Overall Study|Protocol Violation|0
5292864|NCT00472446|18250749|P2|Overall Study|Protocol Violation|0
5292865|NCT00472446|18250750|P1|Overall Study|Protocol Violation|0
5292866|NCT00472420|18250780|P1|Follow-up Period|Protocol Violation|1
5292867|NCT00472420|18250780|P1|Follow-up Period|Lost to Follow-up|2
5292868|NCT00472420|18250780|P1|Follow-up Period|Physician Decision|9
5292869|NCT00472420|18250780|P1|Follow-up Period|Death|5
5292870|NCT00472420|18250780|P1|Induction Treatment Period|Death|3
5292871|NCT00472420|18250780|P1|Induction Treatment Period|Non-compliance|1
5292872|NCT00472420|18250780|P1|Induction Treatment Period|Adverse Event|3
5292873|NCT00472420|18250780|P1|Induction Treatment Period|Physician Decision|9
5292874|NCT00472303|18250788|P3|Maintenance Phase|Other|0
5292875|NCT00472303|18250789|P2|Maintenance Phase|Other|1
5292876|NCT00472303|18250790|P1|Maintenance Phase|Other|1
5292877|NCT00472303|18250788|P3|Maintenance Phase|Resolution of pain|1
5292878|NCT00472303|18250789|P2|Maintenance Phase|Resolution of pain|0
5292879|NCT00472303|18250790|P1|Maintenance Phase|Resolution of pain|0
5292880|NCT00472303|18250788|P3|Maintenance Phase|Trial medication non-compliant|1
5292881|NCT00472303|18250789|P2|Maintenance Phase|Trial medication non-compliant|0
5292882|NCT00472303|18250790|P1|Maintenance Phase|Trial medication non-compliant|0
5292883|NCT00472303|18250788|P3|Maintenance Phase|Withdrawal by Subject|3
5292884|NCT00472303|18250789|P2|Maintenance Phase|Withdrawal by Subject|7
5292885|NCT00472303|18250790|P1|Maintenance Phase|Withdrawal by Subject|6
5292886|NCT00472303|18250788|P3|Maintenance Phase|Lack of Efficacy|4
5292887|NCT00472303|18250789|P2|Maintenance Phase|Lack of Efficacy|2
5292888|NCT00472303|18250790|P1|Maintenance Phase|Lack of Efficacy|2
5292889|NCT00472303|18250788|P3|Maintenance Phase|Death|2
5292890|NCT00472303|18250789|P2|Maintenance Phase|Death|0
5292891|NCT00472303|18250790|P1|Maintenance Phase|Death|3
5292892|NCT00472303|18250788|P3|Maintenance Phase|Adverse Event|6
5292893|NCT00472303|18250789|P2|Maintenance Phase|Adverse Event|6
5292894|NCT00472303|18250790|P1|Maintenance Phase|Adverse Event|5
5292895|NCT00472303|18250788|P3|Discontinuations After Titration Phase|Other|0
5292896|NCT00472303|18250789|P2|Discontinuations After Titration Phase|Other|0
5292897|NCT00472303|18250790|P1|Discontinuations After Titration Phase|Other|5
5292898|NCT00472303|18250788|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
5292899|NCT00472303|18250789|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
5292900|NCT00472303|18250790|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
5292901|NCT00472303|18250788|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
5292902|NCT00472303|18250789|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
5292903|NCT00472303|18250790|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
5292904|NCT00472303|18250788|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
5292905|NCT00472303|18250789|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
5292906|NCT00472303|18250790|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
5292907|NCT00472303|18250788|P3|Discontinuations After Titration Phase|Adverse Event|0
5292908|NCT00472303|18250789|P2|Discontinuations After Titration Phase|Adverse Event|0
5292909|NCT00472303|18250790|P1|Discontinuations After Titration Phase|Adverse Event|6
5292910|NCT00472303|18250788|P3|Titration Phase|Other|0
5292911|NCT00472303|18250789|P2|Titration Phase|Other|1
5292912|NCT00472303|18250790|P1|Titration Phase|Other|3
5292913|NCT00472303|18250788|P3|Titration Phase|Trial Medication non-compliant|0
5292914|NCT00472303|18250789|P2|Titration Phase|Trial Medication non-compliant|1
5292915|NCT00472303|18250790|P1|Titration Phase|Trial Medication non-compliant|4
5292916|NCT00472303|18250788|P3|Titration Phase|Withdrawal by Subject|0
5292917|NCT00472303|18250789|P2|Titration Phase|Withdrawal by Subject|13
5292918|NCT00472303|18250790|P1|Titration Phase|Withdrawal by Subject|16
5292919|NCT00472303|18250788|P3|Titration Phase|Lack of Efficacy|0
5292920|NCT00472303|18250789|P2|Titration Phase|Lack of Efficacy|0
5292921|NCT00472303|18250790|P1|Titration Phase|Lack of Efficacy|10
5292922|NCT00472303|18250788|P3|Titration Phase|Death|0
5292923|NCT00472303|18250789|P2|Titration Phase|Death|2
5292924|NCT00472303|18250790|P1|Titration Phase|Death|4
5292925|NCT00472303|18250788|P3|Titration Phase|Adverse Event|0
5292926|NCT00472303|18250789|P2|Titration Phase|Adverse Event|12
5292927|NCT00472303|18250790|P1|Titration Phase|Adverse Event|22
5292928|NCT00472290|18250853|P1|Overall Study|Requirement for alternative therapy|7
5292929|NCT00472290|18250853|P1|Overall Study|Adverse Event|6
5292930|NCT00472290|18250853|P1|Overall Study|Withdrawal by Subject|5
5292931|NCT00472290|18250853|P1|Overall Study|Disease Progression|4
5292932|NCT00472290|18250853|P1|Overall Study|Lack of Efficacy|1
5292933|NCT00472290|18250853|P1|Overall Study|Lost to Follow-up|1
5292934|NCT00472290|18250853|P1|Overall Study|Death|3
5292935|NCT00472290|18250853|P1|Overall Study|Administrative Decision|37
5292936|NCT00472290|18250853|P1|Overall Study|Protocol Specified Criteria|7
5292937|NCT00472290|18250853|P1|Overall Study|Progression of Therapy-Related MDS|1
5292938|NCT00472199|18250865|P2|Overall Study|patient was asymptomatic|0
5292939|NCT00472199|18250866|P1|Overall Study|patient was asymptomatic|1
5292940|NCT00472199|18250865|P2|Overall Study|personal reason|1
5292941|NCT00472199|18250866|P1|Overall Study|personal reason|0
5292942|NCT00472199|18250865|P2|Overall Study|Withdrawal by Subject|5
5292943|NCT00472199|18250866|P1|Overall Study|Withdrawal by Subject|6
5292944|NCT00472199|18250865|P2|Overall Study|Protocol Violation|2
5292945|NCT00472199|18250866|P1|Overall Study|Protocol Violation|3
5292946|NCT00472199|18250865|P2|Overall Study|Lost to Follow-up|4
5292947|NCT00472199|18250866|P1|Overall Study|Lost to Follow-up|2
5292948|NCT00472199|18250865|P2|Overall Study|Lack of Efficacy|25
5292949|NCT00472199|18250866|P1|Overall Study|Lack of Efficacy|4
5292950|NCT00472199|18250865|P2|Overall Study|Adverse Event|23
5292951|NCT00472199|18250866|P1|Overall Study|Adverse Event|19
5292952|NCT00472082|18250932|P1|Overall Study|Study prematurely terminated|5
5292953|NCT00472030|18250954|P2|Overall Study|Physician Decision|0
5292954|NCT00472030|18250955|P1|Overall Study|Physician Decision|1
5292955|NCT00471887|18250971|P1|Overall Study|Adverse Event|9
5292956|NCT00471822|18250980|P1|Overall Study|Protocol Violation|2
5292957|NCT00471718|18250988|P1|Overall Study|Withdrawal by Subject|1
5292958|NCT00471718|18250988|P1|Overall Study|disease progression|22
5292959|NCT00471718|18250988|P1|Overall Study|other complicating disease|1
5292960|NCT00471718|18250988|P1|Overall Study|Adverse Event|3
5292961|NCT00471536|18251016|P1|Overall Study|Withdrawal by Subject|1
5292962|NCT00471497|18251028|P3|Extension Phase|Protocol Violation|0
5292963|NCT00471497|18251029|P2|Extension Phase|Protocol Violation|2
5292964|NCT00471497|18251030|P1|Extension Phase|Protocol Violation|2
5292965|NCT00471497|18251028|P3|Extension Phase|Disease progression|0
5292966|NCT00471497|18251029|P2|Extension Phase|Disease progression|0
5292967|NCT00471497|18251030|P1|Extension Phase|Disease progression|2
5292968|NCT00471497|18251028|P3|Extension Phase|Death|0
5292969|NCT00471497|18251029|P2|Extension Phase|Death|0
5292970|NCT00471497|18251030|P1|Extension Phase|Death|1
5292971|NCT00471497|18251028|P3|Extension Phase|Lost to Follow-up|0
5292972|NCT00471497|18251029|P2|Extension Phase|Lost to Follow-up|0
5292973|NCT00471497|18251030|P1|Extension Phase|Lost to Follow-up|2
5292974|NCT00471497|18251028|P3|Extension Phase|Withdrawal by Subject|0
5292975|NCT00471497|18251029|P2|Extension Phase|Withdrawal by Subject|1
5292976|NCT00471497|18251030|P1|Extension Phase|Withdrawal by Subject|3
5292977|NCT00471497|18251028|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5292978|NCT00471497|18251029|P2|Extension Phase|Unsatisfactory therapeutic effect|6
5292979|NCT00471497|18251030|P1|Extension Phase|Unsatisfactory therapeutic effect|8
5292980|NCT00471497|18251028|P3|Extension Phase|Adverse Event|1
5292981|NCT00471497|18251029|P2|Extension Phase|Adverse Event|5
5292982|NCT00471497|18251030|P1|Extension Phase|Adverse Event|9
5292983|NCT00471497|18251028|P3|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
5292984|NCT00471497|18251029|P2|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
5292985|NCT00471497|18251030|P1|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
5292986|NCT00471497|18251028|P3|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
5292987|NCT00471497|18251029|P2|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
5292988|NCT00471497|18251030|P1|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
5292989|NCT00471497|18251028|P3|Core Treatment Phase|Adverse Event|89
5292990|NCT00471497|18251029|P2|Core Treatment Phase|Adverse Event|53
5292991|NCT00471497|18251030|P1|Core Treatment Phase|Adverse Event|43
5292992|NCT00471497|18251028|P3|Core Treatment Phase|Administrative problems|12
5292993|NCT00471497|18251029|P2|Core Treatment Phase|Administrative problems|14
5292994|NCT00471497|18251030|P1|Core Treatment Phase|Administrative problems|14
5292995|NCT00471497|18251028|P3|Core Treatment Phase|Sub optimal response or treat. failure|13
5292996|NCT00471497|18251029|P2|Core Treatment Phase|Sub optimal response or treat. failure|11
5292997|NCT00471497|18251030|P1|Core Treatment Phase|Sub optimal response or treat. failure|19
5292998|NCT00471497|18251028|P3|Core Treatment Phase|Protocol Violation|11
5292999|NCT00471497|18251029|P2|Core Treatment Phase|Protocol Violation|15
5293000|NCT00471497|18251030|P1|Core Treatment Phase|Protocol Violation|6
5293001|NCT00471497|18251028|P3|Core Treatment Phase|Disease Progression|4
5293002|NCT00471497|18251029|P2|Core Treatment Phase|Disease Progression|2
5293003|NCT00471497|18251030|P1|Core Treatment Phase|Disease Progression|10
5293004|NCT00471497|18251028|P3|Core Treatment Phase|Death|3
5293005|NCT00471497|18251029|P2|Core Treatment Phase|Death|9
5293006|NCT00471497|18251030|P1|Core Treatment Phase|Death|3
5293007|NCT00471497|18251028|P3|Core Treatment Phase|Lost to Follow-up|3
5293008|NCT00471497|18251029|P2|Core Treatment Phase|Lost to Follow-up|6
5293009|NCT00471497|18251030|P1|Core Treatment Phase|Lost to Follow-up|6
5293010|NCT00471497|18251028|P3|Core Treatment Phase|Withdrawal by Subject|34
5293011|NCT00471497|18251029|P2|Core Treatment Phase|Withdrawal by Subject|29
5293012|NCT00471497|18251030|P1|Core Treatment Phase|Withdrawal by Subject|31
5293013|NCT00471497|18251028|P3|Core Treatment Phase|Condition no longer requires study drug|0
5293014|NCT00471497|18251029|P2|Core Treatment Phase|Condition no longer requires study drug|1
5293015|NCT00471497|18251030|P1|Core Treatment Phase|Condition no longer requires study drug|0
5293016|NCT00471497|18251028|P3|Core Treatment Phase|Abnormal Test Procedures|1
5293017|NCT00471497|18251029|P2|Core Treatment Phase|Abnormal Test Procedures|0
5293018|NCT00471497|18251030|P1|Core Treatment Phase|Abnormal Test Procedures|1
5293019|NCT00471497|18251028|P3|Core Treatment Phase|Abnormal Laboratory Values|9
5293020|NCT00471497|18251029|P2|Core Treatment Phase|Abnormal Laboratory Values|9
5293021|NCT00471497|18251030|P1|Core Treatment Phase|Abnormal Laboratory Values|3
5293022|NCT00471445|18251126|P2|Overall Study|Protocol Violation|1
5293023|NCT00471445|18251127|P1|Overall Study|Protocol Violation|0
5293024|NCT00471445|18251126|P2|Overall Study|Ineligible|0
5293025|NCT00471445|18251127|P1|Overall Study|Ineligible|1
5293026|NCT00471445|18251126|P2|Overall Study|Withdrawal by Subject|1
5293027|NCT00471445|18251127|P1|Overall Study|Withdrawal by Subject|1
5293028|NCT00471354|18251140|P1|Overall Study|Patient/Caregiver Decision|12
5293029|NCT00471354|18251140|P1|Overall Study|Lack of Efficacy|5
5293030|NCT00471354|18251140|P1|Overall Study|Lost to Follow-up|3
5293031|NCT00471354|18251140|P1|Overall Study|Sponsor Decision|1
5293032|NCT00471354|18251140|P1|Overall Study|Physician Decision|4
5293033|NCT00471354|18251140|P1|Overall Study|Withdrawal by Subject|1
5293034|NCT00471354|18251140|P1|Overall Study|Protocol Violation|12
5293035|NCT00471354|18251140|P1|Overall Study|Adverse Event|13
5293036|NCT00471354|18251140|P1|Overall Study|Protocol Entry Criteria Not Met|1
5293037|NCT00471328|18251152|P2|Extension Phase|Administrative Problem|0
5293038|NCT00471328|18251153|P1|Extension Phase|Administrative Problem|1
5293039|NCT00471328|18251152|P2|Extension Phase|New cancer Therapy|0
5293040|NCT00471328|18251153|P1|Extension Phase|New cancer Therapy|1
5293041|NCT00471328|18251152|P2|Extension Phase|Disease Progression|44
5293042|NCT00471328|18251153|P1|Extension Phase|Disease Progression|32
5293043|NCT00471328|18251152|P2|Extension Phase|Treatment duration as per protocol|1
5293044|NCT00471328|18251153|P1|Extension Phase|Treatment duration as per protocol|0
5293045|NCT00471328|18251152|P2|Extension Phase|Protocol Deviation|1
5293046|NCT00471328|18251153|P1|Extension Phase|Protocol Deviation|3
5293047|NCT00471328|18251152|P2|Extension Phase|Death|7
5293048|NCT00471328|18251153|P1|Extension Phase|Death|1
5293049|NCT00471328|18251152|P2|Extension Phase|Withdrawal by Subject|2
5293050|NCT00471328|18251153|P1|Extension Phase|Withdrawal by Subject|0
5293051|NCT00471328|18251152|P2|Extension Phase|Adverse Event|12
5293052|NCT00471328|18251153|P1|Extension Phase|Adverse Event|3
5293053|NCT00471328|18251152|P2|Core Phase|Protocol Deviation|1
5293054|NCT00471328|18251153|P1|Core Phase|Protocol Deviation|0
5293055|NCT00471328|18251152|P2|Core Phase|Administrative Problem|1
5293056|NCT00471328|18251153|P1|Core Phase|Administrative Problem|0
5293057|NCT00471328|18251152|P2|Core Phase|Disease Progression|53
5293058|NCT00471328|18251153|P1|Core Phase|Disease Progression|78
5293059|NCT00471328|18251152|P2|Core Phase|Abnormal laboratory value|0
5293060|NCT00471328|18251153|P1|Core Phase|Abnormal laboratory value|1
5293061|NCT00471328|18251152|P2|Core Phase|Withdrawal by Subject|2
5293062|NCT00471328|18251153|P1|Core Phase|Withdrawal by Subject|2
5293063|NCT00471328|18251152|P2|Core Phase|Death|4
5293064|NCT00471328|18251153|P1|Core Phase|Death|8
5293065|NCT00471328|18251152|P2|Core Phase|Adverse Event|6
5293066|NCT00471328|18251153|P1|Core Phase|Adverse Event|18
5293067|NCT00471315|18251172|P1|Overall Study|Withdrawal by Subject|1
5293068|NCT00471315|18251172|P1|Overall Study|Adverse Event|7
5293069|NCT00471276|18251177|P1|Overall Study|Refused treatment|6
5293070|NCT00471276|18251177|P1|Overall Study|Other|3
5293071|NCT00471276|18251177|P1|Overall Study|Global deterioration of health status|1
5293072|NCT00471276|18251177|P1|Overall Study|Objective progression or relapse|54
5293073|NCT00471276|18251177|P1|Overall Study|Protocol Violation|1
5293074|NCT00471276|18251177|P1|Overall Study|Adverse Event|16
5293075|NCT00471276|18251177|P1|Overall Study|Death|2
5293076|NCT00471237|18251207|P7|Overall Study|Participant's decision|0
5293077|NCT00471237|18251208|P6|Overall Study|Participant's decision|1
5293078|NCT00471237|18251209|P5|Overall Study|Participant's decision|0
5293079|NCT00471237|18251210|P4|Overall Study|Participant's decision|0
5293080|NCT00471237|18251211|P3|Overall Study|Participant's decision|0
5293081|NCT00471237|18251212|P2|Overall Study|Participant's decision|0
5293082|NCT00471237|18251213|P1|Overall Study|Participant's decision|0
5293083|NCT00471237|18251207|P7|Overall Study|Participant shifted residence|0
5293084|NCT00471237|18251208|P6|Overall Study|Participant shifted residence|0
5293085|NCT00471237|18251209|P5|Overall Study|Participant shifted residence|1
5293086|NCT00471237|18251210|P4|Overall Study|Participant shifted residence|0
5293087|NCT00471237|18251211|P3|Overall Study|Participant shifted residence|0
5293088|NCT00471237|18251212|P2|Overall Study|Participant shifted residence|0
5293089|NCT00471237|18251213|P1|Overall Study|Participant shifted residence|0
5293090|NCT00471237|18251207|P7|Overall Study|Administration of prohibited medicine|0
5293091|NCT00471237|18251208|P6|Overall Study|Administration of prohibited medicine|0
5293092|NCT00471237|18251209|P5|Overall Study|Administration of prohibited medicine|1
5293093|NCT00471237|18251210|P4|Overall Study|Administration of prohibited medicine|0
5293094|NCT00471237|18251211|P3|Overall Study|Administration of prohibited medicine|0
5293095|NCT00471237|18251212|P2|Overall Study|Administration of prohibited medicine|0
5293096|NCT00471237|18251213|P1|Overall Study|Administration of prohibited medicine|0
5293097|NCT00471237|18251207|P7|Overall Study|Participant lost medication|0
5293098|NCT00471237|18251208|P6|Overall Study|Participant lost medication|0
5293099|NCT00471237|18251209|P5|Overall Study|Participant lost medication|1
5293100|NCT00471237|18251210|P4|Overall Study|Participant lost medication|0
5293101|NCT00471237|18251211|P3|Overall Study|Participant lost medication|0
5293102|NCT00471237|18251212|P2|Overall Study|Participant lost medication|0
5293103|NCT00471237|18251213|P1|Overall Study|Participant lost medication|0
5293104|NCT00471237|18251207|P7|Overall Study|High parathyroid hormone|0
5293105|NCT00471237|18251208|P6|Overall Study|High parathyroid hormone|0
5293106|NCT00471237|18251209|P5|Overall Study|High parathyroid hormone|0
5293107|NCT00471237|18251210|P4|Overall Study|High parathyroid hormone|0
5293108|NCT00471237|18251211|P3|Overall Study|High parathyroid hormone|1
5293109|NCT00471237|18251212|P2|Overall Study|High parathyroid hormone|0
5293110|NCT00471237|18251213|P1|Overall Study|High parathyroid hormone|0
5293111|NCT00471237|18251207|P7|Overall Study|Participant planned to travel to abraod|0
5293112|NCT00471237|18251208|P6|Overall Study|Participant planned to travel to abraod|1
5293113|NCT00471237|18251209|P5|Overall Study|Participant planned to travel to abraod|0
5293114|NCT00471237|18251210|P4|Overall Study|Participant planned to travel to abraod|0
5293115|NCT00471237|18251211|P3|Overall Study|Participant planned to travel to abraod|0
5293116|NCT00471237|18251212|P2|Overall Study|Participant planned to travel to abraod|0
5293117|NCT00471237|18251213|P1|Overall Study|Participant planned to travel to abraod|1
5293118|NCT00471237|18251207|P7|Overall Study|Early stopping due to non-efficacy|0
5293119|NCT00471237|18251208|P6|Overall Study|Early stopping due to non-efficacy|0
5293120|NCT00471237|18251209|P5|Overall Study|Early stopping due to non-efficacy|1
5293121|NCT00471237|18251210|P4|Overall Study|Early stopping due to non-efficacy|0
5293122|NCT00471237|18251211|P3|Overall Study|Early stopping due to non-efficacy|0
5293123|NCT00471237|18251212|P2|Overall Study|Early stopping due to non-efficacy|0
5293124|NCT00471237|18251213|P1|Overall Study|Early stopping due to non-efficacy|1
5293125|NCT00471237|18251207|P7|Overall Study|Met serum creatinine withdrawal criteria|0
5293126|NCT00471237|18251208|P6|Overall Study|Met serum creatinine withdrawal criteria|0
5293127|NCT00471237|18251209|P5|Overall Study|Met serum creatinine withdrawal criteria|0
5293128|NCT00471237|18251210|P4|Overall Study|Met serum creatinine withdrawal criteria|2
5293129|NCT00471237|18251211|P3|Overall Study|Met serum creatinine withdrawal criteria|2
5293130|NCT00471237|18251212|P2|Overall Study|Met serum creatinine withdrawal criteria|0
5293131|NCT00471237|18251213|P1|Overall Study|Met serum creatinine withdrawal criteria|1
5293132|NCT00471237|18251207|P7|Overall Study|Non-compliance|0
5293133|NCT00471237|18251208|P6|Overall Study|Non-compliance|0
5293134|NCT00471237|18251209|P5|Overall Study|Non-compliance|0
5293135|NCT00471237|18251210|P4|Overall Study|Non-compliance|1
5293136|NCT00471237|18251211|P3|Overall Study|Non-compliance|0
5293137|NCT00471237|18251212|P2|Overall Study|Non-compliance|1
5293138|NCT00471237|18251213|P1|Overall Study|Non-compliance|0
5293139|NCT00471237|18251207|P7|Overall Study|Sponsor terminated study|0
5293140|NCT00471237|18251208|P6|Overall Study|Sponsor terminated study|24
5293141|NCT00471237|18251209|P5|Overall Study|Sponsor terminated study|18
5293142|NCT00471237|18251210|P4|Overall Study|Sponsor terminated study|22
5293143|NCT00471237|18251211|P3|Overall Study|Sponsor terminated study|19
5293144|NCT00471237|18251212|P2|Overall Study|Sponsor terminated study|23
5293145|NCT00471237|18251213|P1|Overall Study|Sponsor terminated study|20
5293146|NCT00471237|18251207|P7|Overall Study|Withdrawal by Subject|2
5293147|NCT00471237|18251208|P6|Overall Study|Withdrawal by Subject|4
5293148|NCT00471237|18251209|P5|Overall Study|Withdrawal by Subject|7
5293149|NCT00471237|18251210|P4|Overall Study|Withdrawal by Subject|8
5293150|NCT00471237|18251211|P3|Overall Study|Withdrawal by Subject|5
5293151|NCT00471237|18251212|P2|Overall Study|Withdrawal by Subject|6
5293152|NCT00471237|18251213|P1|Overall Study|Withdrawal by Subject|8
5293153|NCT00471237|18251207|P7|Overall Study|Protocol Violation|1
5293154|NCT00471237|18251208|P6|Overall Study|Protocol Violation|4
5293155|NCT00471237|18251209|P5|Overall Study|Protocol Violation|2
5293156|NCT00471237|18251210|P4|Overall Study|Protocol Violation|2
5293157|NCT00471237|18251211|P3|Overall Study|Protocol Violation|3
5293158|NCT00471237|18251212|P2|Overall Study|Protocol Violation|6
5293159|NCT00471237|18251213|P1|Overall Study|Protocol Violation|3
5293160|NCT00471237|18251207|P7|Overall Study|Lost to Follow-up|0
5293161|NCT00471237|18251208|P6|Overall Study|Lost to Follow-up|0
5293162|NCT00471237|18251209|P5|Overall Study|Lost to Follow-up|3
5293163|NCT00471237|18251210|P4|Overall Study|Lost to Follow-up|2
5293164|NCT00471237|18251211|P3|Overall Study|Lost to Follow-up|0
5293165|NCT00471237|18251212|P2|Overall Study|Lost to Follow-up|1
5293166|NCT00471237|18251213|P1|Overall Study|Lost to Follow-up|1
5293167|NCT00471237|18251207|P7|Overall Study|Adverse Event|0
5293168|NCT00471237|18251208|P6|Overall Study|Adverse Event|5
5293169|NCT00471237|18251209|P5|Overall Study|Adverse Event|7
5293170|NCT00471237|18251210|P4|Overall Study|Adverse Event|8
5293171|NCT00471237|18251211|P3|Overall Study|Adverse Event|4
5293172|NCT00471237|18251212|P2|Overall Study|Adverse Event|5
5293173|NCT00471237|18251213|P1|Overall Study|Adverse Event|6
5293174|NCT00471146|18251363|P2|Overall Study|Other|5
5293175|NCT00471146|18251364|P1|Overall Study|Other|4
5293176|NCT00471146|18251363|P2|Overall Study|Randomized but not treated|8
5293177|NCT00471146|18251364|P1|Overall Study|Randomized but not treated|9
5293178|NCT00471146|18251363|P2|Overall Study|Global deterioration of health status|14
5293179|NCT00471146|18251364|P1|Overall Study|Global deterioration of health status|12
5293180|NCT00471146|18251363|P2|Overall Study|Objective progression or relapse|87
5293181|NCT00471146|18251364|P1|Overall Study|Objective progression or relapse|84
5293182|NCT00471146|18251363|P2|Overall Study|Protocol Violation|2
5293183|NCT00471146|18251364|P1|Overall Study|Protocol Violation|2
5293184|NCT00471146|18251363|P2|Overall Study|Lost to Follow-up|2
5293185|NCT00471146|18251364|P1|Overall Study|Lost to Follow-up|4
5293186|NCT00471146|18251363|P2|Overall Study|Death|12
5293187|NCT00471146|18251364|P1|Overall Study|Death|11
5293188|NCT00471146|18251363|P2|Overall Study|Withdrawal by Subject|11
5293189|NCT00471146|18251364|P1|Overall Study|Withdrawal by Subject|14
5293190|NCT00471146|18251363|P2|Overall Study|Adverse Event|33
5293191|NCT00471146|18251364|P1|Overall Study|Adverse Event|32
5293192|NCT00471107|18251389|P3|Overall Study|Technical problems/data loss|3
5293193|NCT00471107|18251390|P2|Overall Study|Technical problems/data loss|1
5293194|NCT00471107|18251391|P1|Overall Study|Technical problems/data loss|3
5293195|NCT00471081|18251401|P2|Extended Safety Follow-Up|Missing confirmed|1
5293196|NCT00471081|18251402|P1|Extended Safety Follow-Up|Missing confirmed|0
5293197|NCT00471081|18251401|P2|Extended Safety Follow-Up|Lost to Follow-up|8
5293198|NCT00471081|18251402|P1|Extended Safety Follow-Up|Lost to Follow-up|1
5293199|NCT00471081|18251401|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
5293200|NCT00471081|18251402|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
5293201|NCT00471081|18251401|P2|Active Phase|Lost health plan/insurance|8
5293202|NCT00471081|18251402|P1|Active Phase|Lost health plan/insurance|1
5293203|NCT00471081|18251401|P2|Active Phase|Lost to Follow-up|1
5293204|NCT00471081|18251402|P1|Active Phase|Lost to Follow-up|0
5293205|NCT00471081|18251401|P2|Active Phase|Withdrawal by Subject|3
5293206|NCT00471081|18251402|P1|Active Phase|Withdrawal by Subject|0
5293207|NCT00471081|18251401|P2|Active Phase|Protocol Violation|1
5293208|NCT00471081|18251402|P1|Active Phase|Protocol Violation|1
5293209|NCT00470847|18251448|P1|Overall Study|Pt still receiving treatment|1
5293210|NCT00470834|18251461|P2|Extension Period (24 Months)|Disease Progression|1
5293211|NCT00470834|18251462|P1|Extension Period (24 Months)|Disease Progression|0
5293212|NCT00470834|18251461|P2|Extension Period (24 Months)|Non-compliance|1
5293213|NCT00470834|18251462|P1|Extension Period (24 Months)|Non-compliance|0
5293214|NCT00470834|18251461|P2|Extension Period (24 Months)|Lost to Follow-up|1
5293215|NCT00470834|18251462|P1|Extension Period (24 Months)|Lost to Follow-up|0
5293216|NCT00470834|18251461|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
5293217|NCT00470834|18251462|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
5293218|NCT00470834|18251461|P2|Extension Period (24 Months)|Physician Decision|3
5293219|NCT00470834|18251462|P1|Extension Period (24 Months)|Physician Decision|4
5293220|NCT00470834|18251461|P2|Extension Period (24 Months)|Withdrawal by Subject|5
5293221|NCT00470834|18251462|P1|Extension Period (24 Months)|Withdrawal by Subject|2
5293222|NCT00470834|18251461|P2|Extension Period (24 Months)|Adverse Event|4
5293223|NCT00470834|18251462|P1|Extension Period (24 Months)|Adverse Event|3
5293224|NCT00470834|18251461|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
5293225|NCT00470834|18251462|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
5293226|NCT00470834|18251461|P2|Treatment Period (18 Months)|Lack of Efficacy|0
5293227|NCT00470834|18251462|P1|Treatment Period (18 Months)|Lack of Efficacy|1
5293228|NCT00470834|18251461|P2|Treatment Period (18 Months)|Non-compliance|0
5293229|NCT00470834|18251462|P1|Treatment Period (18 Months)|Non-compliance|1
5293230|NCT00470834|18251461|P2|Treatment Period (18 Months)|Lost to Follow-up|0
5293231|NCT00470834|18251462|P1|Treatment Period (18 Months)|Lost to Follow-up|1
5293232|NCT00470834|18251461|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
5293233|NCT00470834|18251462|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
5293234|NCT00470834|18251461|P2|Treatment Period (18 Months)|Protocol Violation|1
5293235|NCT00470834|18251462|P1|Treatment Period (18 Months)|Protocol Violation|3
5293236|NCT00470834|18251461|P2|Treatment Period (18 Months)|Physician Decision|4
5293237|NCT00470834|18251462|P1|Treatment Period (18 Months)|Physician Decision|4
5293238|NCT00470834|18251461|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
5293239|NCT00470834|18251462|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
5293240|NCT00470834|18251461|P2|Treatment Period (18 Months)|Adverse Event|6
5293241|NCT00470834|18251462|P1|Treatment Period (18 Months)|Adverse Event|7
5293242|NCT00470834|18251461|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
5293243|NCT00470834|18251462|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
5293244|NCT00470626|18251476|P1|Overall Study|Withdrawal by Subject|7
5293245|NCT00470626|18251476|P1|Overall Study|Lost to Follow-up|10
5293246|NCT00470535|18251524|P1|Overall Study|Other|2
5293247|NCT00470535|18251524|P1|Overall Study|Death|1
5293248|NCT00470535|18251524|P1|Overall Study|Adverse Event|1
5293249|NCT00470535|18251524|P1|Overall Study|Withdrawal by Subject|1
5293250|NCT00470535|18251524|P1|Overall Study|Disease Progression|13
5293251|NCT00470470|18251533|P1|Overall Study|Not treated|1
5293252|NCT00470470|18251533|P1|Overall Study|Death|2
5293253|NCT00470470|18251533|P1|Overall Study|Adverse Event|2
5293254|NCT00470418|18251540|P2|Overall Study|Withdrawal by Subject|0
5293255|NCT00470418|18251541|P1|Overall Study|Withdrawal by Subject|1
5293256|NCT00470366|18251562|P1|Overall Study|Poor compliance|1
5293257|NCT00470366|18251562|P1|Overall Study|Adverse Event|3
5293258|NCT00470275|18251573|P1|Overall Study|Withdrawal by Subject|2
5293259|NCT00470275|18251573|P1|Overall Study|Lack of Efficacy|7
5293260|NCT00470275|18251573|P1|Overall Study|Death|1
5293261|NCT00470262|18251579|P2|Overall Study|Withdrawal by Subject|0
5293262|NCT00470262|18251580|P1|Overall Study|Withdrawal by Subject|2
5293263|NCT00470184|18251588|P1|Overall Study|recurrence|1
5293264|NCT00470184|18251588|P1|Overall Study|other|5
5293265|NCT00470184|18251588|P1|Overall Study|Withdrawal by Subject|4
5293266|NCT00470184|18251588|P1|Overall Study|Adverse Event|3
5293267|NCT00470184|18251588|P1|Overall Study|disease Progression|4
5293268|NCT00470184|18251588|P1|Overall Study|Not treated (other)|1
5293269|NCT00470184|18251588|P1|Overall Study|Not Treated(became ineligible)|4
5293270|NCT00470158|18251600|P5|Overall Study|Protocol Violation|0
5293271|NCT00470158|18251601|P4|Overall Study|Protocol Violation|0
5293272|NCT00470158|18251602|P3|Overall Study|Protocol Violation|0
5293273|NCT00470158|18251603|P2|Overall Study|Protocol Violation|0
5293274|NCT00470158|18251604|P1|Overall Study|Protocol Violation|1
5293275|NCT00470158|18251600|P5|Overall Study|Lost to Follow-up|4
5293276|NCT00470158|18251601|P4|Overall Study|Lost to Follow-up|5
5293277|NCT00470158|18251602|P3|Overall Study|Lost to Follow-up|8
5293278|NCT00470158|18251603|P2|Overall Study|Lost to Follow-up|8
5293279|NCT00470158|18251604|P1|Overall Study|Lost to Follow-up|7
5293280|NCT00470158|18251600|P5|Overall Study|Death|2
5293281|NCT00470158|18251601|P4|Overall Study|Death|0
5293282|NCT00470158|18251602|P3|Overall Study|Death|0
5293283|NCT00470158|18251603|P2|Overall Study|Death|0
5293284|NCT00470158|18251604|P1|Overall Study|Death|0
5293285|NCT00470093|18251637|P1|Overall Study|Adverse Event|2
5293286|NCT00470067|18251644|P1|Overall Study|Disease Progression|6
5293287|NCT00470067|18251644|P1|Overall Study|Death|1
5293288|NCT00470054|18251648|P1|Overall Study|Ineligible|1
5293289|NCT00469898|18251664|P1|Overall Study|Decreased performance status|1
5293290|NCT00469898|18251664|P1|Overall Study|Disease progression|9
5293291|NCT00469898|18251664|P1|Overall Study|Death|4
5293292|NCT00469898|18251664|P1|Overall Study|Withdrawal by Subject|4
5293293|NCT00469898|18251664|P1|Overall Study|Adverse Event|7
5293294|NCT00469859|18251673|P2|Overall Study|Inevaluable|2
5293295|NCT00469859|18251674|P1|Overall Study|Inevaluable|0
5293296|NCT00469833|18251682|P1|Overall Study|No IV access|2
5293297|NCT00469612|18251694|P2|Overall Study|Study terminated before data collected|0
5293298|NCT00469612|18251695|P1|Overall Study|Study terminated before data collected|2
5293299|NCT00469456|18251722|P2|Overall Study|Withdrawal by Subject|1
5293300|NCT00469456|18251723|P1|Overall Study|Withdrawal by Subject|4
5293301|NCT00469456|18251722|P2|Overall Study|Protocol Violation|0
5293302|NCT00469456|18251723|P1|Overall Study|Protocol Violation|1
5293303|NCT00469456|18251722|P2|Overall Study|Adverse Event|3
5293304|NCT00469456|18251723|P1|Overall Study|Adverse Event|4
5293305|NCT00469209|18251752|P3|Overall Study|Adverse Event|1
5293306|NCT00469209|18251753|P2|Overall Study|Adverse Event|0
5293307|NCT00469209|18251754|P1|Overall Study|Adverse Event|1
5293308|NCT00469092|18251764|P2|Overall Study|Use of Corticosteroid|0
5293309|NCT00469092|18251765|P1|Overall Study|Use of Corticosteroid|1
5293310|NCT00469092|18251764|P2|Overall Study|Abnormal lab value|0
5293311|NCT00469092|18251765|P1|Overall Study|Abnormal lab value|1
5293312|NCT00469092|18251764|P2|Overall Study|Hypoglycaemic Episodes|1
5293313|NCT00469092|18251765|P1|Overall Study|Hypoglycaemic Episodes|1
5293314|NCT00469092|18251764|P2|Overall Study|Use of lipid lowering drug|0
5293315|NCT00469092|18251765|P1|Overall Study|Use of lipid lowering drug|1
5293316|NCT00469092|18251764|P2|Overall Study|Contraindication metformin/glimepiride|0
5293317|NCT00469092|18251765|P1|Overall Study|Contraindication metformin/glimepiride|1
5293318|NCT00469092|18251764|P2|Overall Study|Incorrectly Randomised|3
5293319|NCT00469092|18251765|P1|Overall Study|Incorrectly Randomised|4
5293320|NCT00469092|18251764|P2|Overall Study|Withdrawal Criteria|4
5293321|NCT00469092|18251765|P1|Overall Study|Withdrawal Criteria|3
5293322|NCT00469092|18251764|P2|Overall Study|Withdrawal by Subject|4
5293323|NCT00469092|18251765|P1|Overall Study|Withdrawal by Subject|4
5293324|NCT00469092|18251764|P2|Overall Study|Protocol Violation|3
5293325|NCT00469092|18251765|P1|Overall Study|Protocol Violation|3
5293326|NCT00469092|18251764|P2|Overall Study|Lost to Follow-up|2
5293327|NCT00469092|18251765|P1|Overall Study|Lost to Follow-up|1
5293328|NCT00469092|18251764|P2|Overall Study|Lack of Efficacy|0
5293329|NCT00469092|18251765|P1|Overall Study|Lack of Efficacy|1
5293330|NCT00469092|18251764|P2|Overall Study|Adverse Event|4
5293331|NCT00469092|18251765|P1|Overall Study|Adverse Event|5
5293332|NCT00469079|18251784|P3|Overall Study|Ineligible|0
5293333|NCT00469079|18251785|P2|Overall Study|Ineligible|1
5293334|NCT00469079|18251786|P1|Overall Study|Ineligible|0
5293335|NCT00469079|18251784|P3|Overall Study|Withdrawal by Subject|2
5293336|NCT00469079|18251785|P2|Overall Study|Withdrawal by Subject|2
5293337|NCT00469079|18251786|P1|Overall Study|Withdrawal by Subject|1
5293338|NCT00469079|18251784|P3|Overall Study|Lost to Follow-up|10
5293339|NCT00469079|18251785|P2|Overall Study|Lost to Follow-up|8
5293340|NCT00469079|18251786|P1|Overall Study|Lost to Follow-up|4
5293341|NCT00469079|18251784|P3|Overall Study|Adverse Event|2
5293342|NCT00469079|18251785|P2|Overall Study|Adverse Event|3
5293343|NCT00469079|18251786|P1|Overall Study|Adverse Event|1
5293344|NCT00469079|18251784|P3|Overall Study|Lack of Efficacy|5
5293345|NCT00469079|18251785|P2|Overall Study|Lack of Efficacy|8
5293346|NCT00469079|18251786|P1|Overall Study|Lack of Efficacy|3
5293347|NCT00468910|18251805|P2|Overall Study|Medical Contraindication|1
5293348|NCT00468910|18251806|P1|Overall Study|Medical Contraindication|0
5293349|NCT00468910|18251805|P2|Overall Study|Withdrawal by Subject|1
5293350|NCT00468910|18251806|P1|Overall Study|Withdrawal by Subject|2
5293351|NCT00468910|18251805|P2|Overall Study|Lost to Follow-up|1
5293352|NCT00468910|18251806|P1|Overall Study|Lost to Follow-up|2
5293353|NCT00468858|18251825|P3|Overall Study|Other|1
5293354|NCT00468858|18251826|P2|Overall Study|Other|0
5293355|NCT00468858|18251827|P1|Overall Study|Other|0
5293356|NCT00468858|18251825|P3|Overall Study|Lost to Follow-up|5
5293357|NCT00468858|18251826|P2|Overall Study|Lost to Follow-up|2
5293358|NCT00468858|18251827|P1|Overall Study|Lost to Follow-up|1
5293359|NCT00468858|18251825|P3|Overall Study|Relocation|3
5293360|NCT00468858|18251826|P2|Overall Study|Relocation|3
5293361|NCT00468858|18251827|P1|Overall Study|Relocation|1
5293362|NCT00468858|18251825|P3|Overall Study|Withdrawal by Subject|5
5293363|NCT00468858|18251826|P2|Overall Study|Withdrawal by Subject|4
5293364|NCT00468858|18251827|P1|Overall Study|Withdrawal by Subject|7
5293365|NCT00468858|18251825|P3|Overall Study|Adverse Event|0
5293366|NCT00468858|18251826|P2|Overall Study|Adverse Event|1
5293367|NCT00468858|18251827|P1|Overall Study|Adverse Event|0
5293368|NCT00468845|18251948|P3|Overall Study|Randomized, not treated|2
5293369|NCT00468845|18251949|P2|Overall Study|Randomized, not treated|4
5293370|NCT00468845|18251950|P1|Overall Study|Randomized, not treated|1
5293454|NCT00468546|18252293|P2|Week 24 Analysis|Due to clinical hold|0
5293371|NCT00468845|18251948|P3|Overall Study|No longer willing to participate|10
5293372|NCT00468845|18251949|P2|Overall Study|No longer willing to participate|6
5293373|NCT00468845|18251950|P1|Overall Study|No longer willing to participate|5
5293374|NCT00468845|18251948|P3|Overall Study|Other|5
5293375|NCT00468845|18251949|P2|Overall Study|Other|9
5293376|NCT00468845|18251950|P1|Overall Study|Other|4
5293377|NCT00468845|18251948|P3|Overall Study|Lost to Follow-up|2
5293378|NCT00468845|18251949|P2|Overall Study|Lost to Follow-up|1
5293379|NCT00468845|18251950|P1|Overall Study|Lost to Follow-up|2
5293380|NCT00468845|18251948|P3|Overall Study|Adverse Event|11
5293381|NCT00468845|18251949|P2|Overall Study|Adverse Event|14
5293382|NCT00468845|18251950|P1|Overall Study|Adverse Event|9
5293383|NCT00468819|18252087|P3|Overall Study|Drop-outs (Treatment never received)|0
5293384|NCT00468819|18252088|P2|Overall Study|Drop-outs (Treatment never received)|0
5293385|NCT00468819|18252089|P1|Overall Study|Drop-outs (Treatment never received)|2
5293386|NCT00468819|18252087|P3|Overall Study|Lost to Follow-up|1
5293387|NCT00468819|18252088|P2|Overall Study|Lost to Follow-up|0
5293388|NCT00468819|18252089|P1|Overall Study|Lost to Follow-up|0
5293389|NCT00468819|18252087|P3|Overall Study|Withdrawal by Subject|1
5293390|NCT00468819|18252088|P2|Overall Study|Withdrawal by Subject|0
5293391|NCT00468819|18252089|P1|Overall Study|Withdrawal by Subject|4
5293392|NCT00468728|18252169|P2|Follow-up|mITT failure|31
5293393|NCT00468728|18252170|P1|Follow-up|mITT failure|34
5293394|NCT00468728|18252169|P2|Treatment|criteria for mITT population|11
5293395|NCT00468728|18252170|P1|Treatment|criteria for mITT population|4
5293396|NCT00468676|18252182|P2|Overall Study|Death|1
5293397|NCT00468676|18252183|P1|Overall Study|Death|2
5293398|NCT00468676|18252182|P2|Overall Study|Lost to Follow-up|11
5293399|NCT00468676|18252183|P1|Overall Study|Lost to Follow-up|14
5293400|NCT00468650|18252200|P1|Overall Study|Protocol Violation|1
5293401|NCT00468650|18252200|P1|Overall Study|Withdrawal by Subject|2
5293402|NCT00468650|18252200|P1|Overall Study|Lost to Follow-up|4
5293403|NCT00468585|18252248|P4|Overall Study|Withdrawal by Subject|1
5293404|NCT00468585|18252249|P3|Overall Study|Withdrawal by Subject|2
5293405|NCT00468585|18252250|P2|Overall Study|Withdrawal by Subject|0
5293406|NCT00468585|18252251|P1|Overall Study|Withdrawal by Subject|0
5293407|NCT00468585|18252248|P4|Overall Study|Adverse Event|0
5293408|NCT00468585|18252249|P3|Overall Study|Adverse Event|1
5293409|NCT00468585|18252250|P2|Overall Study|Adverse Event|0
5293410|NCT00468585|18252251|P1|Overall Study|Adverse Event|0
5293411|NCT00468585|18252248|P4|Overall Study|Patient found to be ineligible|0
5293412|NCT00468585|18252249|P3|Overall Study|Patient found to be ineligible|1
5293413|NCT00468585|18252250|P2|Overall Study|Patient found to be ineligible|0
5293414|NCT00468585|18252251|P1|Overall Study|Patient found to be ineligible|0
5293415|NCT00468585|18252248|P4|Overall Study|Patient not treated|0
5293416|NCT00468585|18252249|P3|Overall Study|Patient not treated|1
5293417|NCT00468585|18252250|P2|Overall Study|Patient not treated|0
5293418|NCT00468585|18252251|P1|Overall Study|Patient not treated|1
5293419|NCT00468559|18252263|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
5293420|NCT00468559|18252264|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
5293421|NCT00468559|18252265|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
5293422|NCT00468559|18252263|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
5293423|NCT00468559|18252264|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
5293424|NCT00468559|18252265|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
5293425|NCT00468559|18252263|P3|Open-label Treatment Phase|Withdrawal by Subject|0
5293426|NCT00468559|18252264|P2|Open-label Treatment Phase|Withdrawal by Subject|0
5293427|NCT00468559|18252265|P1|Open-label Treatment Phase|Withdrawal by Subject|4
5293428|NCT00468559|18252263|P3|Open-label Treatment Phase|Lack of Efficacy|0
5293429|NCT00468559|18252264|P2|Open-label Treatment Phase|Lack of Efficacy|0
5293430|NCT00468559|18252265|P1|Open-label Treatment Phase|Lack of Efficacy|9
5293431|NCT00468559|18252263|P3|Open-label Treatment Phase|Adverse Event|0
5293432|NCT00468559|18252264|P2|Open-label Treatment Phase|Adverse Event|0
5293433|NCT00468559|18252265|P1|Open-label Treatment Phase|Adverse Event|5
5293434|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Other|14
5293435|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Other|17
5293436|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
5293437|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
5293438|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Failure to return|2
5293439|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Failure to return|1
5293440|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Refused treatment|7
5293441|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Refused treatment|4
5293442|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
5293443|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
5293444|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
5293445|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
5293446|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Death|0
5293447|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Death|1
5293448|NCT00468546|18252293|P2|Week 24 to Week 104 Analysis|Adverse Event|5
5293449|NCT00468546|18252294|P1|Week 24 to Week 104 Analysis|Adverse Event|2
5293450|NCT00468546|18252293|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
5293451|NCT00468546|18252294|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
5293452|NCT00468546|18252293|P2|Week 24 Analysis|Went onto rescue therapy|0
5293453|NCT00468546|18252294|P1|Week 24 Analysis|Went onto rescue therapy|1
5293455|NCT00468546|18252294|P1|Week 24 Analysis|Due to clinical hold|1
5293456|NCT00468546|18252293|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
5293457|NCT00468546|18252294|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
5293458|NCT00468546|18252293|P2|Week 24 Analysis|Rescue therapy|0
5293459|NCT00468546|18252294|P1|Week 24 Analysis|Rescue therapy|2
5293460|NCT00468546|18252293|P2|Week 24 Analysis|Failure to return|4
5293461|NCT00468546|18252294|P1|Week 24 Analysis|Failure to return|3
5293462|NCT00468546|18252293|P2|Week 24 Analysis|Adverse Event|8
5293463|NCT00468546|18252294|P1|Week 24 Analysis|Adverse Event|1
5293464|NCT00468546|18252293|P2|Week 24 Analysis|Refused treatment|5
5293465|NCT00468546|18252294|P1|Week 24 Analysis|Refused treatment|5
5293466|NCT00468546|18252293|P2|Week 24 Analysis|Lack of Efficacy|37
5293467|NCT00468546|18252294|P1|Week 24 Analysis|Lack of Efficacy|83
5293468|NCT00468481|18252324|P2|Overall Study|Other|0
5293469|NCT00468481|18252325|P1|Overall Study|Other|6
5293470|NCT00468481|18252324|P2|Overall Study|Non-Compliance|0
5293471|NCT00468481|18252325|P1|Overall Study|Non-Compliance|5
5293472|NCT00468481|18252324|P2|Overall Study|Moved out of area|1
5293473|NCT00468481|18252325|P1|Overall Study|Moved out of area|4
5293474|NCT00468481|18252324|P2|Overall Study|Egg Donor|0
5293475|NCT00468481|18252325|P1|Overall Study|Egg Donor|1
5293476|NCT00468481|18252324|P2|Overall Study|Prohibited Medication|1
5293477|NCT00468481|18252325|P1|Overall Study|Prohibited Medication|1
5293478|NCT00468481|18252324|P2|Overall Study|susp/diag malignant/premalignant disease|0
5293479|NCT00468481|18252325|P1|Overall Study|susp/diag malignant/premalignant disease|1
5293480|NCT00468481|18252324|P2|Overall Study|Withdrawal by Subject|3
5293481|NCT00468481|18252325|P1|Overall Study|Withdrawal by Subject|12
5293482|NCT00468481|18252324|P2|Overall Study|Protocol Violation|8
5293483|NCT00468481|18252325|P1|Overall Study|Protocol Violation|18
5293484|NCT00468481|18252324|P2|Overall Study|Pregnancy|0
5293485|NCT00468481|18252325|P1|Overall Study|Pregnancy|2
5293486|NCT00468481|18252324|P2|Overall Study|Lost to Follow-up|8
5293487|NCT00468481|18252325|P1|Overall Study|Lost to Follow-up|25
5293488|NCT00468481|18252324|P2|Overall Study|Adverse Event|3
5293489|NCT00468481|18252325|P1|Overall Study|Adverse Event|13
5293490|NCT00468312|18252425|P2|Overall Study|Did not meet protocol eligibility|1
5293491|NCT00468312|18252426|P1|Overall Study|Did not meet protocol eligibility|0
5293492|NCT00468312|18252425|P2|Overall Study|Protocol Violation|1
5293493|NCT00468312|18252426|P1|Overall Study|Protocol Violation|2
5293494|NCT00468312|18252425|P2|Overall Study|Withdrawal by Subject|1
5293495|NCT00468312|18252426|P1|Overall Study|Withdrawal by Subject|0
5293496|NCT00468312|18252425|P2|Overall Study|Lack of Efficacy|1
5293497|NCT00468312|18252426|P1|Overall Study|Lack of Efficacy|0
5293498|NCT00468312|18252425|P2|Overall Study|Adverse Event|1
5293499|NCT00468312|18252426|P1|Overall Study|Adverse Event|2
5293500|NCT00468299|18252442|P2|Overall Study|Withdrawal by Subject|1
5293501|NCT00468299|18252443|P1|Overall Study|Withdrawal by Subject|0
5293502|NCT00468286|18252453|P2|Overall Study|Physician Decision|1
5293503|NCT00468286|18252454|P1|Overall Study|Physician Decision|0
5293504|NCT00468286|18252453|P2|Overall Study|Withdrawal by Subject|3
5293505|NCT00468286|18252454|P1|Overall Study|Withdrawal by Subject|4
5293506|NCT00468286|18252453|P2|Overall Study|Protocol Violation|2
5293507|NCT00468286|18252454|P1|Overall Study|Protocol Violation|2
5293508|NCT00468286|18252453|P2|Overall Study|Adverse Event|6
5293509|NCT00468286|18252454|P1|Overall Study|Adverse Event|1
5293510|NCT00468169|18252486|P2|Overall Study|Withdrawal by Subject|0
5293511|NCT00468169|18252487|P1|Overall Study|Withdrawal by Subject|1
5293512|NCT00468143|18252503|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
5293513|NCT00468143|18252504|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
5293514|NCT00468143|18252503|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
5293515|NCT00468143|18252504|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
5293516|NCT00468104|18252518|P2|Second Intervention|discarded for malposition of chest tube|2
5293517|NCT00468104|18252519|P1|Second Intervention|discarded for malposition of chest tube|0
5293518|NCT00468104|18252518|P2|Second Intervention|Withdrawal by Subject|2
5293519|NCT00468104|18252519|P1|Second Intervention|Withdrawal by Subject|5
5293520|NCT00468104|18252518|P2|First Intervention|trapped lung|0
5293521|NCT00468104|18252519|P1|First Intervention|trapped lung|1
5293522|NCT00468104|18252518|P2|First Intervention|associated prolonged pneumothorax|0
5293523|NCT00468104|18252519|P1|First Intervention|associated prolonged pneumothorax|1
5293524|NCT00468104|18252518|P2|First Intervention|large lung mass with minimal effusion|0
5293525|NCT00468104|18252519|P1|First Intervention|large lung mass with minimal effusion|1
5293526|NCT00468104|18252518|P2|First Intervention|malposition/blocked chest tube tube|0
5293527|NCT00468104|18252519|P1|First Intervention|malposition/blocked chest tube tube|2
5293528|NCT00468104|18252518|P2|First Intervention|died within 3 weeks|0
5293529|NCT00468104|18252519|P1|First Intervention|died within 3 weeks|1
5293530|NCT00468104|18252518|P2|First Intervention|bleeding at chest tube site--first dose|0
5293531|NCT00468104|18252519|P1|First Intervention|bleeding at chest tube site--first dose|1
5293532|NCT00468104|18252518|P2|First Intervention|Protocol Violation|1
5293533|NCT00468104|18252519|P1|First Intervention|Protocol Violation|2
5293534|NCT00468052|18252536|P2|Overall Study|Protocol Violation|8
5293535|NCT00468052|18252537|P1|Overall Study|Protocol Violation|7
5293536|NCT00467961|18252555|P1|Overall Study|Disease Progression|2
5293537|NCT00467961|18252555|P1|Overall Study|Technical Failures|5
5293538|NCT00467896|18252559|P1|Overall Study|Patient had no improvement|1
5293539|NCT00467896|18252559|P1|Overall Study|Started inhaled Remodulin|1
5293540|NCT00467896|18252559|P1|Overall Study|Started intravenous prostacyclin|1
5293541|NCT00467896|18252559|P1|Overall Study|Mainly used Prodose not I-neb® device|1
5293542|NCT00467896|18252559|P1|Overall Study|Patient weaned off iloprost|1
5293543|NCT00467896|18252559|P1|Overall Study|Patient had atrial septostomy|1
5293544|NCT00467896|18252559|P1|Overall Study|Patient received transplant|2
5293545|NCT00467896|18252559|P1|Overall Study|Changed therapy|2
5293546|NCT00467896|18252559|P1|Overall Study|Non-compliance|3
5293547|NCT00467896|18252559|P1|Overall Study|Serious Adverse Event|13
5293548|NCT00467896|18252559|P1|Overall Study|Adverse Event|7
5293549|NCT00467896|18252559|P1|Overall Study|Consent Withdrawal|18
5293550|NCT00467870|18252585|P6|Overall Study|Other/Unknown|0
5293551|NCT00467870|18252586|P5|Overall Study|Other/Unknown|4
5293552|NCT00467870|18252587|P4|Overall Study|Other/Unknown|5
5293553|NCT00467870|18252588|P3|Overall Study|Other/Unknown|1
5293554|NCT00467870|18252589|P2|Overall Study|Other/Unknown|5
5293555|NCT00467870|18252590|P1|Overall Study|Other/Unknown|8
5293556|NCT00467870|18252585|P6|Overall Study|Subject Non-compliance|0
5293557|NCT00467870|18252586|P5|Overall Study|Subject Non-compliance|5
5293558|NCT00467870|18252587|P4|Overall Study|Subject Non-compliance|1
5293559|NCT00467870|18252588|P3|Overall Study|Subject Non-compliance|0
5293560|NCT00467870|18252589|P2|Overall Study|Subject Non-compliance|4
5293561|NCT00467870|18252590|P1|Overall Study|Subject Non-compliance|3
5293562|NCT00467870|18252585|P6|Overall Study|Lost to Follow-up|0
5293563|NCT00467870|18252586|P5|Overall Study|Lost to Follow-up|3
5293564|NCT00467870|18252587|P4|Overall Study|Lost to Follow-up|1
5293565|NCT00467870|18252588|P3|Overall Study|Lost to Follow-up|1
5293566|NCT00467870|18252589|P2|Overall Study|Lost to Follow-up|3
5293567|NCT00467870|18252590|P1|Overall Study|Lost to Follow-up|5
5293568|NCT00467870|18252585|P6|Overall Study|Withdrawal by Subject|1
5293569|NCT00467870|18252586|P5|Overall Study|Withdrawal by Subject|10
5293570|NCT00467870|18252587|P4|Overall Study|Withdrawal by Subject|9
5293571|NCT00467870|18252588|P3|Overall Study|Withdrawal by Subject|0
5293572|NCT00467870|18252589|P2|Overall Study|Withdrawal by Subject|21
5293573|NCT00467870|18252590|P1|Overall Study|Withdrawal by Subject|14
5293574|NCT00467870|18252585|P6|Overall Study|Protocol Violation|0
5293575|NCT00467870|18252586|P5|Overall Study|Protocol Violation|0
5293576|NCT00467870|18252587|P4|Overall Study|Protocol Violation|2
5293577|NCT00467870|18252588|P3|Overall Study|Protocol Violation|1
5293578|NCT00467870|18252589|P2|Overall Study|Protocol Violation|1
5293579|NCT00467870|18252590|P1|Overall Study|Protocol Violation|2
5293580|NCT00467870|18252585|P6|Overall Study|Adverse Event|1
5293581|NCT00467870|18252586|P5|Overall Study|Adverse Event|15
5293582|NCT00467870|18252587|P4|Overall Study|Adverse Event|15
5293583|NCT00467870|18252588|P3|Overall Study|Adverse Event|1
5293584|NCT00467870|18252589|P2|Overall Study|Adverse Event|9
5293585|NCT00467870|18252590|P1|Overall Study|Adverse Event|13
5293586|NCT00467857|18252633|P2|Overall Study|Discontinuation reason missing|3
5293587|NCT00467857|18252634|P1|Overall Study|Discontinuation reason missing|0
5293588|NCT00467857|18252633|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
5293589|NCT00467857|18252634|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
5293590|NCT00467857|18252633|P2|Overall Study|Emergency care required|1
5293591|NCT00467857|18252634|P1|Overall Study|Emergency care required|0
5293592|NCT00467857|18252633|P2|Overall Study|Discharged from court service|1
5293593|NCT00467857|18252634|P1|Overall Study|Discharged from court service|0
5293594|NCT00467857|18252633|P2|Overall Study|Death|1
5293595|NCT00467857|18252634|P1|Overall Study|Death|0
5293596|NCT00467857|18252633|P2|Overall Study|Withdrew consent|0
5293597|NCT00467857|18252634|P1|Overall Study|Withdrew consent|2
5293598|NCT00467857|18252633|P2|Overall Study|Adverse Event|0
5293599|NCT00467857|18252634|P1|Overall Study|Adverse Event|1
5293600|NCT00467831|18252682|P1|Overall Study|Withdrawal by Subject|1
5293601|NCT00467831|18252682|P1|Overall Study|Death|2
5293602|NCT00467779|18252701|P15|Stage 3|Unspecified Reason|5
5293603|NCT00467779|18252702|P14|Stage 3|Unspecified Reason|0
5293604|NCT00467779|18252703|P13|Stage 3|Unspecified Reason|0
5293605|NCT00467779|18252704|P12|Stage 3|Unspecified Reason|0
5293606|NCT00467779|18252705|P11|Stage 3|Unspecified Reason|0
5293607|NCT00467779|18252706|P10|Stage 3|Unspecified Reason|0
5293608|NCT00467779|18252707|P9|Stage 3|Unspecified Reason|0
5293609|NCT00467779|18252708|P8|Stage 3|Unspecified Reason|0
5293610|NCT00467779|18252709|P7|Stage 3|Unspecified Reason|0
5293611|NCT00467779|18252710|P6|Stage 3|Unspecified Reason|0
5293612|NCT00467779|18252711|P5|Stage 3|Unspecified Reason|0
5293613|NCT00467779|18252712|P4|Stage 3|Unspecified Reason|0
5293614|NCT00467779|18252713|P3|Stage 3|Unspecified Reason|0
5293615|NCT00467779|18252714|P2|Stage 3|Unspecified Reason|0
5293616|NCT00467779|18252715|P1|Stage 3|Unspecified Reason|0
5293617|NCT00467779|18252701|P15|Stage 3|Disease Progression|9
5293618|NCT00467779|18252702|P14|Stage 3|Disease Progression|0
5293619|NCT00467779|18252703|P13|Stage 3|Disease Progression|0
5293620|NCT00467779|18252704|P12|Stage 3|Disease Progression|0
5293621|NCT00467779|18252705|P11|Stage 3|Disease Progression|0
5293622|NCT00467779|18252706|P10|Stage 3|Disease Progression|0
5293623|NCT00467779|18252707|P9|Stage 3|Disease Progression|0
5293624|NCT00467779|18252708|P8|Stage 3|Disease Progression|0
5293625|NCT00467779|18252709|P7|Stage 3|Disease Progression|0
5293626|NCT00467779|18252710|P6|Stage 3|Disease Progression|0
5293627|NCT00467779|18252711|P5|Stage 3|Disease Progression|0
5293628|NCT00467779|18252712|P4|Stage 3|Disease Progression|0
5293629|NCT00467779|18252713|P3|Stage 3|Disease Progression|0
5293630|NCT00467779|18252714|P2|Stage 3|Disease Progression|0
5293631|NCT00467779|18252715|P1|Stage 3|Disease Progression|0
5293632|NCT00467779|18252701|P15|Stage 3|Death|1
5293633|NCT00467779|18252702|P14|Stage 3|Death|0
5293634|NCT00467779|18252703|P13|Stage 3|Death|0
5293635|NCT00467779|18252704|P12|Stage 3|Death|0
5293636|NCT00467779|18252705|P11|Stage 3|Death|0
5293637|NCT00467779|18252706|P10|Stage 3|Death|0
5293638|NCT00467779|18252707|P9|Stage 3|Death|0
5293639|NCT00467779|18252708|P8|Stage 3|Death|0
5293640|NCT00467779|18252709|P7|Stage 3|Death|0
5293641|NCT00467779|18252710|P6|Stage 3|Death|0
5293642|NCT00467779|18252711|P5|Stage 3|Death|0
5293643|NCT00467779|18252712|P4|Stage 3|Death|0
5293644|NCT00467779|18252713|P3|Stage 3|Death|0
5293645|NCT00467779|18252714|P2|Stage 3|Death|0
5293646|NCT00467779|18252715|P1|Stage 3|Death|0
5293647|NCT00467779|18252701|P15|Stage 3|Adverse Event|2
5293648|NCT00467779|18252702|P14|Stage 3|Adverse Event|0
5293649|NCT00467779|18252703|P13|Stage 3|Adverse Event|0
5293650|NCT00467779|18252704|P12|Stage 3|Adverse Event|0
5293651|NCT00467779|18252705|P11|Stage 3|Adverse Event|0
5293652|NCT00467779|18252706|P10|Stage 3|Adverse Event|0
5293653|NCT00467779|18252707|P9|Stage 3|Adverse Event|0
5293654|NCT00467779|18252708|P8|Stage 3|Adverse Event|0
5293655|NCT00467779|18252709|P7|Stage 3|Adverse Event|0
5293656|NCT00467779|18252710|P6|Stage 3|Adverse Event|0
5293657|NCT00467779|18252711|P5|Stage 3|Adverse Event|0
5293658|NCT00467779|18252712|P4|Stage 3|Adverse Event|0
5293659|NCT00467779|18252713|P3|Stage 3|Adverse Event|0
5293660|NCT00467779|18252714|P2|Stage 3|Adverse Event|0
5293661|NCT00467779|18252715|P1|Stage 3|Adverse Event|0
5293662|NCT00467779|18252701|P15|Stage 2A|Withdrawal by Subject|0
5293663|NCT00467779|18252702|P14|Stage 2A|Withdrawal by Subject|1
5293664|NCT00467779|18252703|P13|Stage 2A|Withdrawal by Subject|0
5293665|NCT00467779|18252704|P12|Stage 2A|Withdrawal by Subject|0
5293666|NCT00467779|18252705|P11|Stage 2A|Withdrawal by Subject|0
5293667|NCT00467779|18252706|P10|Stage 2A|Withdrawal by Subject|0
5293668|NCT00467779|18252707|P9|Stage 2A|Withdrawal by Subject|0
5293669|NCT00467779|18252708|P8|Stage 2A|Withdrawal by Subject|0
5293670|NCT00467779|18252709|P7|Stage 2A|Withdrawal by Subject|0
5293671|NCT00467779|18252710|P6|Stage 2A|Withdrawal by Subject|0
5293672|NCT00467779|18252711|P5|Stage 2A|Withdrawal by Subject|0
5293673|NCT00467779|18252712|P4|Stage 2A|Withdrawal by Subject|0
5293674|NCT00467779|18252713|P3|Stage 2A|Withdrawal by Subject|0
5293675|NCT00467779|18252714|P2|Stage 2A|Withdrawal by Subject|0
5293676|NCT00467779|18252715|P1|Stage 2A|Withdrawal by Subject|0
5293677|NCT00467779|18252701|P15|Stage 2A|Unspecified Reason|0
5293678|NCT00467779|18252702|P14|Stage 2A|Unspecified Reason|7
5293679|NCT00467779|18252703|P13|Stage 2A|Unspecified Reason|0
5293680|NCT00467779|18252704|P12|Stage 2A|Unspecified Reason|0
5293681|NCT00467779|18252705|P11|Stage 2A|Unspecified Reason|0
5293682|NCT00467779|18252706|P10|Stage 2A|Unspecified Reason|0
5293683|NCT00467779|18252707|P9|Stage 2A|Unspecified Reason|0
5293684|NCT00467779|18252708|P8|Stage 2A|Unspecified Reason|0
5293685|NCT00467779|18252709|P7|Stage 2A|Unspecified Reason|0
5293686|NCT00467779|18252710|P6|Stage 2A|Unspecified Reason|0
5293687|NCT00467779|18252711|P5|Stage 2A|Unspecified Reason|0
5293688|NCT00467779|18252712|P4|Stage 2A|Unspecified Reason|0
5293689|NCT00467779|18252713|P3|Stage 2A|Unspecified Reason|0
5293690|NCT00467779|18252714|P2|Stage 2A|Unspecified Reason|0
5293691|NCT00467779|18252715|P1|Stage 2A|Unspecified Reason|0
5293692|NCT00467779|18252701|P15|Stage 2A|Disease Progression|0
5293693|NCT00467779|18252702|P14|Stage 2A|Disease Progression|10
5293694|NCT00467779|18252703|P13|Stage 2A|Disease Progression|0
5293695|NCT00467779|18252704|P12|Stage 2A|Disease Progression|0
5293696|NCT00467779|18252705|P11|Stage 2A|Disease Progression|0
5293697|NCT00467779|18252706|P10|Stage 2A|Disease Progression|0
5293698|NCT00467779|18252707|P9|Stage 2A|Disease Progression|0
5293699|NCT00467779|18252708|P8|Stage 2A|Disease Progression|0
5293700|NCT00467779|18252709|P7|Stage 2A|Disease Progression|0
5293701|NCT00467779|18252710|P6|Stage 2A|Disease Progression|0
5293702|NCT00467779|18252711|P5|Stage 2A|Disease Progression|0
5293703|NCT00467779|18252712|P4|Stage 2A|Disease Progression|0
5293704|NCT00467779|18252713|P3|Stage 2A|Disease Progression|0
5293705|NCT00467779|18252714|P2|Stage 2A|Disease Progression|0
5293706|NCT00467779|18252715|P1|Stage 2A|Disease Progression|0
5293707|NCT00467779|18252701|P15|Stage 2A|Death|0
5293708|NCT00467779|18252702|P14|Stage 2A|Death|1
5293709|NCT00467779|18252703|P13|Stage 2A|Death|0
5293710|NCT00467779|18252704|P12|Stage 2A|Death|0
5293711|NCT00467779|18252705|P11|Stage 2A|Death|0
5293712|NCT00467779|18252706|P10|Stage 2A|Death|0
5293713|NCT00467779|18252707|P9|Stage 2A|Death|0
5293714|NCT00467779|18252708|P8|Stage 2A|Death|0
5293715|NCT00467779|18252709|P7|Stage 2A|Death|0
5293716|NCT00467779|18252710|P6|Stage 2A|Death|0
5293717|NCT00467779|18252711|P5|Stage 2A|Death|0
5293718|NCT00467779|18252712|P4|Stage 2A|Death|0
5293719|NCT00467779|18252713|P3|Stage 2A|Death|0
5293720|NCT00467779|18252714|P2|Stage 2A|Death|0
5293721|NCT00467779|18252715|P1|Stage 2A|Death|0
5293722|NCT00467779|18252701|P15|Stage 2A|Adverse Event|0
5293723|NCT00467779|18252702|P14|Stage 2A|Adverse Event|2
5293724|NCT00467779|18252703|P13|Stage 2A|Adverse Event|0
5293725|NCT00467779|18252704|P12|Stage 2A|Adverse Event|0
5293726|NCT00467779|18252705|P11|Stage 2A|Adverse Event|0
5293727|NCT00467779|18252706|P10|Stage 2A|Adverse Event|0
5293728|NCT00467779|18252707|P9|Stage 2A|Adverse Event|0
5293729|NCT00467779|18252708|P8|Stage 2A|Adverse Event|0
5293730|NCT00467779|18252709|P7|Stage 2A|Adverse Event|0
5293731|NCT00467779|18252710|P6|Stage 2A|Adverse Event|0
5293732|NCT00467779|18252711|P5|Stage 2A|Adverse Event|0
5293733|NCT00467779|18252712|P4|Stage 2A|Adverse Event|0
5293734|NCT00467779|18252713|P3|Stage 2A|Adverse Event|0
5293735|NCT00467779|18252714|P2|Stage 2A|Adverse Event|0
5293736|NCT00467779|18252715|P1|Stage 2A|Adverse Event|0
5293737|NCT00467779|18252701|P15|Stage 2|Unspecified Reason|0
5293738|NCT00467779|18252702|P14|Stage 2|Unspecified Reason|0
5293739|NCT00467779|18252703|P13|Stage 2|Unspecified Reason|0
5293740|NCT00467779|18252704|P12|Stage 2|Unspecified Reason|0
5293741|NCT00467779|18252705|P11|Stage 2|Unspecified Reason|0
5293742|NCT00467779|18252706|P10|Stage 2|Unspecified Reason|0
5293743|NCT00467779|18252707|P9|Stage 2|Unspecified Reason|3
5293744|NCT00467779|18252708|P8|Stage 2|Unspecified Reason|0
5293745|NCT00467779|18252709|P7|Stage 2|Unspecified Reason|0
5293746|NCT00467779|18252710|P6|Stage 2|Unspecified Reason|0
5293747|NCT00467779|18252711|P5|Stage 2|Unspecified Reason|0
5293748|NCT00467779|18252712|P4|Stage 2|Unspecified Reason|0
5293749|NCT00467779|18252713|P3|Stage 2|Unspecified Reason|0
5293750|NCT00467779|18252714|P2|Stage 2|Unspecified Reason|0
5293751|NCT00467779|18252715|P1|Stage 2|Unspecified Reason|0
5293752|NCT00467779|18252701|P15|Stage 2|Disease Progression|0
5293753|NCT00467779|18252702|P14|Stage 2|Disease Progression|0
5293754|NCT00467779|18252703|P13|Stage 2|Disease Progression|0
5293755|NCT00467779|18252704|P12|Stage 2|Disease Progression|0
5293756|NCT00467779|18252705|P11|Stage 2|Disease Progression|0
5293757|NCT00467779|18252706|P10|Stage 2|Disease Progression|0
5293758|NCT00467779|18252707|P9|Stage 2|Disease Progression|16
5293759|NCT00467779|18252708|P8|Stage 2|Disease Progression|0
5293760|NCT00467779|18252709|P7|Stage 2|Disease Progression|0
5293761|NCT00467779|18252710|P6|Stage 2|Disease Progression|0
5293762|NCT00467779|18252711|P5|Stage 2|Disease Progression|0
5293763|NCT00467779|18252712|P4|Stage 2|Disease Progression|0
5293764|NCT00467779|18252713|P3|Stage 2|Disease Progression|0
5293765|NCT00467779|18252714|P2|Stage 2|Disease Progression|0
5293766|NCT00467779|18252715|P1|Stage 2|Disease Progression|0
5293767|NCT00467779|18252701|P15|Stage 2|Death|0
5293768|NCT00467779|18252702|P14|Stage 2|Death|0
5293769|NCT00467779|18252703|P13|Stage 2|Death|0
5293770|NCT00467779|18252704|P12|Stage 2|Death|0
5293771|NCT00467779|18252705|P11|Stage 2|Death|0
5293772|NCT00467779|18252706|P10|Stage 2|Death|0
5293773|NCT00467779|18252707|P9|Stage 2|Death|1
5293774|NCT00467779|18252708|P8|Stage 2|Death|0
5293775|NCT00467779|18252709|P7|Stage 2|Death|0
5293776|NCT00467779|18252710|P6|Stage 2|Death|0
5293777|NCT00467779|18252711|P5|Stage 2|Death|0
5293778|NCT00467779|18252712|P4|Stage 2|Death|0
5293779|NCT00467779|18252713|P3|Stage 2|Death|0
5293780|NCT00467779|18252714|P2|Stage 2|Death|0
5293781|NCT00467779|18252715|P1|Stage 2|Death|0
5293782|NCT00467779|18252701|P15|Stage 2|Adverse Event|0
5293783|NCT00467779|18252702|P14|Stage 2|Adverse Event|0
5293784|NCT00467779|18252703|P13|Stage 2|Adverse Event|0
5293785|NCT00467779|18252704|P12|Stage 2|Adverse Event|0
5293786|NCT00467779|18252705|P11|Stage 2|Adverse Event|0
5293787|NCT00467779|18252706|P10|Stage 2|Adverse Event|0
5293788|NCT00467779|18252707|P9|Stage 2|Adverse Event|1
5293789|NCT00467779|18252708|P8|Stage 2|Adverse Event|0
5293790|NCT00467779|18252709|P7|Stage 2|Adverse Event|0
5293791|NCT00467779|18252710|P6|Stage 2|Adverse Event|0
5293792|NCT00467779|18252711|P5|Stage 2|Adverse Event|0
5293793|NCT00467779|18252712|P4|Stage 2|Adverse Event|0
5293794|NCT00467779|18252713|P3|Stage 2|Adverse Event|0
5293795|NCT00467779|18252714|P2|Stage 2|Adverse Event|0
5293796|NCT00467779|18252715|P1|Stage 2|Adverse Event|0
5293797|NCT00467779|18252701|P15|Stage 1A|Unspecified Reason|0
5293798|NCT00467779|18252702|P14|Stage 1A|Unspecified Reason|0
5293799|NCT00467779|18252703|P13|Stage 1A|Unspecified Reason|1
5293800|NCT00467779|18252704|P12|Stage 1A|Unspecified Reason|1
5293801|NCT00467779|18252705|P11|Stage 1A|Unspecified Reason|0
5293802|NCT00467779|18252706|P10|Stage 1A|Unspecified Reason|0
5293803|NCT00467779|18252707|P9|Stage 1A|Unspecified Reason|0
5293804|NCT00467779|18252708|P8|Stage 1A|Unspecified Reason|0
5293805|NCT00467779|18252709|P7|Stage 1A|Unspecified Reason|0
5293806|NCT00467779|18252710|P6|Stage 1A|Unspecified Reason|0
5293807|NCT00467779|18252711|P5|Stage 1A|Unspecified Reason|0
5293808|NCT00467779|18252712|P4|Stage 1A|Unspecified Reason|0
5293809|NCT00467779|18252713|P3|Stage 1A|Unspecified Reason|0
5293810|NCT00467779|18252714|P2|Stage 1A|Unspecified Reason|0
5293811|NCT00467779|18252715|P1|Stage 1A|Unspecified Reason|0
5293812|NCT00467779|18252701|P15|Stage 1A|Withdrawal by Subject|0
5293813|NCT00467779|18252702|P14|Stage 1A|Withdrawal by Subject|0
5293814|NCT00467779|18252703|P13|Stage 1A|Withdrawal by Subject|1
5293815|NCT00467779|18252704|P12|Stage 1A|Withdrawal by Subject|1
5293816|NCT00467779|18252705|P11|Stage 1A|Withdrawal by Subject|1
5293817|NCT00467779|18252706|P10|Stage 1A|Withdrawal by Subject|0
5293818|NCT00467779|18252707|P9|Stage 1A|Withdrawal by Subject|0
5293819|NCT00467779|18252708|P8|Stage 1A|Withdrawal by Subject|0
5293820|NCT00467779|18252709|P7|Stage 1A|Withdrawal by Subject|0
5293821|NCT00467779|18252710|P6|Stage 1A|Withdrawal by Subject|0
5293822|NCT00467779|18252711|P5|Stage 1A|Withdrawal by Subject|0
5293823|NCT00467779|18252712|P4|Stage 1A|Withdrawal by Subject|0
5293824|NCT00467779|18252713|P3|Stage 1A|Withdrawal by Subject|0
5293825|NCT00467779|18252714|P2|Stage 1A|Withdrawal by Subject|0
5293826|NCT00467779|18252715|P1|Stage 1A|Withdrawal by Subject|0
5293827|NCT00467779|18252701|P15|Stage 1A|Physician Decision|0
5293828|NCT00467779|18252702|P14|Stage 1A|Physician Decision|0
5293829|NCT00467779|18252703|P13|Stage 1A|Physician Decision|0
5293830|NCT00467779|18252704|P12|Stage 1A|Physician Decision|0
5293831|NCT00467779|18252705|P11|Stage 1A|Physician Decision|0
5293832|NCT00467779|18252706|P10|Stage 1A|Physician Decision|1
5293833|NCT00467779|18252707|P9|Stage 1A|Physician Decision|0
5293834|NCT00467779|18252708|P8|Stage 1A|Physician Decision|0
5293835|NCT00467779|18252709|P7|Stage 1A|Physician Decision|0
5293836|NCT00467779|18252710|P6|Stage 1A|Physician Decision|0
5293837|NCT00467779|18252711|P5|Stage 1A|Physician Decision|0
5293838|NCT00467779|18252712|P4|Stage 1A|Physician Decision|0
5293839|NCT00467779|18252713|P3|Stage 1A|Physician Decision|0
5293840|NCT00467779|18252714|P2|Stage 1A|Physician Decision|0
5293841|NCT00467779|18252715|P1|Stage 1A|Physician Decision|0
5293842|NCT00467779|18252701|P15|Stage 1A|Disease Progression|0
5293843|NCT00467779|18252702|P14|Stage 1A|Disease Progression|0
5293844|NCT00467779|18252703|P13|Stage 1A|Disease Progression|2
5293845|NCT00467779|18252704|P12|Stage 1A|Disease Progression|5
5293846|NCT00467779|18252705|P11|Stage 1A|Disease Progression|2
5293847|NCT00467779|18252706|P10|Stage 1A|Disease Progression|2
5293848|NCT00467779|18252707|P9|Stage 1A|Disease Progression|0
5293849|NCT00467779|18252708|P8|Stage 1A|Disease Progression|0
5293850|NCT00467779|18252709|P7|Stage 1A|Disease Progression|0
5293851|NCT00467779|18252710|P6|Stage 1A|Disease Progression|0
5293852|NCT00467779|18252711|P5|Stage 1A|Disease Progression|0
5293853|NCT00467779|18252712|P4|Stage 1A|Disease Progression|0
5293854|NCT00467779|18252713|P3|Stage 1A|Disease Progression|0
5293855|NCT00467779|18252714|P2|Stage 1A|Disease Progression|0
5293856|NCT00467779|18252715|P1|Stage 1A|Disease Progression|0
5293857|NCT00467779|18252701|P15|Stage 1A|Death|0
5293858|NCT00467779|18252702|P14|Stage 1A|Death|0
5293859|NCT00467779|18252703|P13|Stage 1A|Death|1
5293860|NCT00467779|18252704|P12|Stage 1A|Death|1
5293861|NCT00467779|18252705|P11|Stage 1A|Death|0
5293862|NCT00467779|18252706|P10|Stage 1A|Death|0
5293863|NCT00467779|18252707|P9|Stage 1A|Death|0
5293864|NCT00467779|18252708|P8|Stage 1A|Death|0
5293865|NCT00467779|18252709|P7|Stage 1A|Death|0
5293866|NCT00467779|18252710|P6|Stage 1A|Death|0
5293867|NCT00467779|18252711|P5|Stage 1A|Death|0
5293868|NCT00467779|18252712|P4|Stage 1A|Death|0
5293869|NCT00467779|18252713|P3|Stage 1A|Death|0
5293870|NCT00467779|18252714|P2|Stage 1A|Death|0
5293871|NCT00467779|18252715|P1|Stage 1A|Death|0
5293872|NCT00467779|18252701|P15|Stage 1A|Adverse Event|0
5293873|NCT00467779|18252702|P14|Stage 1A|Adverse Event|0
5293874|NCT00467779|18252703|P13|Stage 1A|Adverse Event|1
5293875|NCT00467779|18252704|P12|Stage 1A|Adverse Event|0
5293876|NCT00467779|18252705|P11|Stage 1A|Adverse Event|0
5293877|NCT00467779|18252706|P10|Stage 1A|Adverse Event|0
5293878|NCT00467779|18252707|P9|Stage 1A|Adverse Event|0
5293879|NCT00467779|18252708|P8|Stage 1A|Adverse Event|0
5293880|NCT00467779|18252709|P7|Stage 1A|Adverse Event|0
5293881|NCT00467779|18252710|P6|Stage 1A|Adverse Event|0
5293882|NCT00467779|18252711|P5|Stage 1A|Adverse Event|0
5293883|NCT00467779|18252712|P4|Stage 1A|Adverse Event|0
5293884|NCT00467779|18252713|P3|Stage 1A|Adverse Event|0
5293885|NCT00467779|18252714|P2|Stage 1A|Adverse Event|0
5293886|NCT00467779|18252715|P1|Stage 1A|Adverse Event|0
5293887|NCT00467779|18252701|P15|Stage 1|Withdrawal by Subject|0
5293888|NCT00467779|18252702|P14|Stage 1|Withdrawal by Subject|0
5293889|NCT00467779|18252703|P13|Stage 1|Withdrawal by Subject|0
5293890|NCT00467779|18252704|P12|Stage 1|Withdrawal by Subject|0
5293891|NCT00467779|18252705|P11|Stage 1|Withdrawal by Subject|0
5293892|NCT00467779|18252706|P10|Stage 1|Withdrawal by Subject|0
5293893|NCT00467779|18252707|P9|Stage 1|Withdrawal by Subject|0
5293894|NCT00467779|18252708|P8|Stage 1|Withdrawal by Subject|1
5293895|NCT00467779|18252709|P7|Stage 1|Withdrawal by Subject|1
5293896|NCT00467779|18252710|P6|Stage 1|Withdrawal by Subject|0
5293897|NCT00467779|18252711|P5|Stage 1|Withdrawal by Subject|0
5293898|NCT00467779|18252712|P4|Stage 1|Withdrawal by Subject|0
5293899|NCT00467779|18252713|P3|Stage 1|Withdrawal by Subject|0
5293900|NCT00467779|18252714|P2|Stage 1|Withdrawal by Subject|0
5293901|NCT00467779|18252715|P1|Stage 1|Withdrawal by Subject|0
5293902|NCT00467779|18252701|P15|Stage 1|Physician Decision|0
5293903|NCT00467779|18252702|P14|Stage 1|Physician Decision|0
5293904|NCT00467779|18252703|P13|Stage 1|Physician Decision|0
5293905|NCT00467779|18252704|P12|Stage 1|Physician Decision|0
5293906|NCT00467779|18252705|P11|Stage 1|Physician Decision|0
5293907|NCT00467779|18252706|P10|Stage 1|Physician Decision|0
5293908|NCT00467779|18252707|P9|Stage 1|Physician Decision|0
5293909|NCT00467779|18252708|P8|Stage 1|Physician Decision|0
5293910|NCT00467779|18252709|P7|Stage 1|Physician Decision|0
5293911|NCT00467779|18252710|P6|Stage 1|Physician Decision|0
5293912|NCT00467779|18252711|P5|Stage 1|Physician Decision|0
5293913|NCT00467779|18252712|P4|Stage 1|Physician Decision|0
5293914|NCT00467779|18252713|P3|Stage 1|Physician Decision|0
5293915|NCT00467779|18252714|P2|Stage 1|Physician Decision|1
5293916|NCT00467779|18252715|P1|Stage 1|Physician Decision|0
5293917|NCT00467779|18252701|P15|Stage 1|Unspecified Reason|0
5293918|NCT00467779|18252702|P14|Stage 1|Unspecified Reason|0
5293919|NCT00467779|18252703|P13|Stage 1|Unspecified Reason|0
5293920|NCT00467779|18252704|P12|Stage 1|Unspecified Reason|0
5293921|NCT00467779|18252705|P11|Stage 1|Unspecified Reason|0
5293922|NCT00467779|18252706|P10|Stage 1|Unspecified Reason|0
5293923|NCT00467779|18252707|P9|Stage 1|Unspecified Reason|0
5293924|NCT00467779|18252708|P8|Stage 1|Unspecified Reason|0
5293925|NCT00467779|18252709|P7|Stage 1|Unspecified Reason|0
5293926|NCT00467779|18252710|P6|Stage 1|Unspecified Reason|2
5293927|NCT00467779|18252711|P5|Stage 1|Unspecified Reason|1
5293928|NCT00467779|18252712|P4|Stage 1|Unspecified Reason|0
5293929|NCT00467779|18252713|P3|Stage 1|Unspecified Reason|1
5293930|NCT00467779|18252714|P2|Stage 1|Unspecified Reason|0
5293931|NCT00467779|18252715|P1|Stage 1|Unspecified Reason|1
5293932|NCT00467779|18252701|P15|Stage 1|Disease Progression|0
5293933|NCT00467779|18252702|P14|Stage 1|Disease Progression|0
5293934|NCT00467779|18252703|P13|Stage 1|Disease Progression|0
5293935|NCT00467779|18252704|P12|Stage 1|Disease Progression|0
5293936|NCT00467779|18252705|P11|Stage 1|Disease Progression|0
5293937|NCT00467779|18252706|P10|Stage 1|Disease Progression|0
5293938|NCT00467779|18252707|P9|Stage 1|Disease Progression|0
5293939|NCT00467779|18252708|P8|Stage 1|Disease Progression|5
5293940|NCT00467779|18252709|P7|Stage 1|Disease Progression|4
5293941|NCT00467779|18252710|P6|Stage 1|Disease Progression|2
5293942|NCT00467779|18252711|P5|Stage 1|Disease Progression|2
5293943|NCT00467779|18252712|P4|Stage 1|Disease Progression|3
5293944|NCT00467779|18252713|P3|Stage 1|Disease Progression|2
5293945|NCT00467779|18252714|P2|Stage 1|Disease Progression|2
5293946|NCT00467779|18252715|P1|Stage 1|Disease Progression|2
5293947|NCT00467779|18252701|P15|Stage 1|Adverse Event|0
5293948|NCT00467779|18252702|P14|Stage 1|Adverse Event|0
5293949|NCT00467779|18252703|P13|Stage 1|Adverse Event|0
5293950|NCT00467779|18252704|P12|Stage 1|Adverse Event|0
5293951|NCT00467779|18252705|P11|Stage 1|Adverse Event|0
5293952|NCT00467779|18252706|P10|Stage 1|Adverse Event|0
5293953|NCT00467779|18252707|P9|Stage 1|Adverse Event|0
5293954|NCT00467779|18252708|P8|Stage 1|Adverse Event|1
5293955|NCT00467779|18252709|P7|Stage 1|Adverse Event|2
5293956|NCT00467779|18252710|P6|Stage 1|Adverse Event|1
5293957|NCT00467779|18252711|P5|Stage 1|Adverse Event|0
5293958|NCT00467779|18252712|P4|Stage 1|Adverse Event|0
5293959|NCT00467779|18252713|P3|Stage 1|Adverse Event|0
5293960|NCT00467779|18252714|P2|Stage 1|Adverse Event|0
5293961|NCT00467779|18252715|P1|Stage 1|Adverse Event|1
5293962|NCT00467753|18252889|P2|Overall Study|Adverse Event|0
5293963|NCT00467753|18252890|P1|Overall Study|Adverse Event|2
5293964|NCT00467753|18252889|P2|Overall Study|Lost to Follow-up|2
5293965|NCT00467753|18252890|P1|Overall Study|Lost to Follow-up|1
5293966|NCT00467740|18252901|P5|Overall Study|Lack of Efficacy|0
5293967|NCT00467740|18252902|P4|Overall Study|Lack of Efficacy|0
5293968|NCT00467740|18252903|P3|Overall Study|Lack of Efficacy|0
5293969|NCT00467740|18252904|P2|Overall Study|Lack of Efficacy|1
5293970|NCT00467740|18252905|P1|Overall Study|Lack of Efficacy|0
5293971|NCT00467740|18252901|P5|Overall Study|Withdrawal by Subject|0
5293972|NCT00467740|18252902|P4|Overall Study|Withdrawal by Subject|1
5293973|NCT00467740|18252903|P3|Overall Study|Withdrawal by Subject|0
5293974|NCT00467740|18252904|P2|Overall Study|Withdrawal by Subject|1
5293975|NCT00467740|18252905|P1|Overall Study|Withdrawal by Subject|1
5293976|NCT00467740|18252901|P5|Overall Study|Lost to Follow-up|0
5293977|NCT00467740|18252902|P4|Overall Study|Lost to Follow-up|0
5293978|NCT00467740|18252903|P3|Overall Study|Lost to Follow-up|0
5293979|NCT00467740|18252904|P2|Overall Study|Lost to Follow-up|1
5293980|NCT00467740|18252905|P1|Overall Study|Lost to Follow-up|0
5293981|NCT00467740|18252901|P5|Overall Study|Protocol Violation|0
5293982|NCT00467740|18252902|P4|Overall Study|Protocol Violation|0
5293983|NCT00467740|18252903|P3|Overall Study|Protocol Violation|1
5293984|NCT00467740|18252904|P2|Overall Study|Protocol Violation|0
5293985|NCT00467740|18252905|P1|Overall Study|Protocol Violation|0
5293986|NCT00467740|18252901|P5|Overall Study|Adverse Event|0
5293987|NCT00467740|18252902|P4|Overall Study|Adverse Event|0
5293988|NCT00467740|18252903|P3|Overall Study|Adverse Event|1
5293989|NCT00467740|18252904|P2|Overall Study|Adverse Event|0
5293990|NCT00467740|18252905|P1|Overall Study|Adverse Event|0
5293991|NCT00467649|18253094|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
5293992|NCT00467649|18253095|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5293993|NCT00467649|18253096|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5293994|NCT00467649|18253097|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5293995|NCT00467649|18253098|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5293996|NCT00467649|18253099|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5293997|NCT00467649|18253094|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5293998|NCT00467649|18253095|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5293999|NCT00467649|18253096|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
5294000|NCT00467649|18253097|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5294001|NCT00467649|18253098|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5294002|NCT00467649|18253099|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5294003|NCT00467649|18253094|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5294004|NCT00467649|18253095|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5294005|NCT00467649|18253096|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
5294006|NCT00467649|18253097|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5294007|NCT00467649|18253098|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5294008|NCT00467649|18253099|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5294088|NCT00466726|18253539|P1|Overall Study|Not evaluable for response|14
5294009|NCT00467649|18253094|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5294010|NCT00467649|18253095|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5294011|NCT00467649|18253096|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5294012|NCT00467649|18253097|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5294013|NCT00467649|18253098|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
5294014|NCT00467649|18253099|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
5294015|NCT00467649|18253094|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
5294016|NCT00467649|18253095|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
5294017|NCT00467649|18253096|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
5294018|NCT00467649|18253097|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
5294019|NCT00467649|18253098|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
5294020|NCT00467649|18253099|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
5294021|NCT00467649|18253094|P6|Phase 1 (Randomized Population)|Investigator Decision|0
5294022|NCT00467649|18253095|P5|Phase 1 (Randomized Population)|Investigator Decision|0
5294023|NCT00467649|18253096|P4|Phase 1 (Randomized Population)|Investigator Decision|0
5294024|NCT00467649|18253097|P3|Phase 1 (Randomized Population)|Investigator Decision|0
5294025|NCT00467649|18253098|P2|Phase 1 (Randomized Population)|Investigator Decision|0
5294026|NCT00467649|18253099|P1|Phase 1 (Randomized Population)|Investigator Decision|1
5294027|NCT00467649|18253094|P6|Phase 1 (Randomized Population)|Adverse Event|0
5294028|NCT00467649|18253095|P5|Phase 1 (Randomized Population)|Adverse Event|0
5294029|NCT00467649|18253096|P4|Phase 1 (Randomized Population)|Adverse Event|0
5294030|NCT00467649|18253097|P3|Phase 1 (Randomized Population)|Adverse Event|0
5294031|NCT00467649|18253098|P2|Phase 1 (Randomized Population)|Adverse Event|0
5294032|NCT00467649|18253099|P1|Phase 1 (Randomized Population)|Adverse Event|2
5294033|NCT00467610|18253139|P1|Overall Study|Withdrawal by Subject|1
5294034|NCT00467597|18253150|P2|Overall Study|Withdrawal by Subject|0
5294035|NCT00467597|18253151|P1|Overall Study|Withdrawal by Subject|2
5294036|NCT00467584|18253164|P3|Overall Study|Withdrawal by Subject|1
5294037|NCT00467584|18253165|P2|Overall Study|Withdrawal by Subject|5
5294038|NCT00467584|18253166|P1|Overall Study|Withdrawal by Subject|4
5294039|NCT00467558|18253176|P2|Overall Study|Lost to Follow-up|0
5294040|NCT00467558|18253177|P1|Overall Study|Lost to Follow-up|2
5294041|NCT00467519|18253187|P2|Overall Study|Withdrawal by Subject|10
5294042|NCT00467519|18253188|P1|Overall Study|Withdrawal by Subject|4
5294043|NCT00467519|18253187|P2|Overall Study|Lost to Follow-up|9
5294044|NCT00467519|18253188|P1|Overall Study|Lost to Follow-up|2
5294045|NCT00467519|18253187|P2|Overall Study|Protocol Violation|4
5294046|NCT00467519|18253188|P1|Overall Study|Protocol Violation|8
5294047|NCT00467363|18253217|P2|Overall Study|Lost to Follow-up|70
5294048|NCT00467363|18253218|P1|Overall Study|Lost to Follow-up|80
5294049|NCT00467285|18253274|P2|Overall Study|Lost to Follow-up|4
5294050|NCT00467285|18253275|P1|Overall Study|Lost to Follow-up|4
5294051|NCT00467259|18253295|P2|Overall Study|Site Closed|1
5294052|NCT00467259|18253296|P1|Overall Study|Site Closed|2
5294053|NCT00467259|18253295|P2|Overall Study|Lost to Follow-up|34
5294054|NCT00467259|18253296|P1|Overall Study|Lost to Follow-up|14
5294055|NCT00467259|18253295|P2|Overall Study|Physician Decision|2
5294056|NCT00467259|18253296|P1|Overall Study|Physician Decision|0
5294057|NCT00467259|18253295|P2|Overall Study|Withdrawal by Subject|108
5294058|NCT00467259|18253296|P1|Overall Study|Withdrawal by Subject|34
5294059|NCT00467259|18253295|P2|Overall Study|Protocol Violation|7
5294060|NCT00467259|18253296|P1|Overall Study|Protocol Violation|1
5294061|NCT00467259|18253295|P2|Overall Study|Adverse Event|90
5294062|NCT00467259|18253296|P1|Overall Study|Adverse Event|24
5294063|NCT00467051|18253313|P1|Overall Study|Adverse Event|2
5294064|NCT00466947|18253340|P2|Study End Analysis Period|Other - Unconformity in team's treatment|1
5294065|NCT00466947|18253341|P1|Study End Analysis Period|Other - Unconformity in team's treatment|0
5294066|NCT00466947|18253340|P2|Study End Analysis Period|Other - Subject without a legal guardian|0
5294067|NCT00466947|18253341|P1|Study End Analysis Period|Other - Subject without a legal guardian|1
5294068|NCT00466947|18253340|P2|Study End Analysis Period|Other - Forbidden vaccination|10
5294069|NCT00466947|18253341|P1|Study End Analysis Period|Other - Forbidden vaccination|21
5294070|NCT00466947|18253340|P2|Study End Analysis Period|Withdrawal by Subject|1267
5294071|NCT00466947|18253341|P1|Study End Analysis Period|Withdrawal by Subject|1264
5294072|NCT00466947|18253340|P2|Study End Analysis Period|Protocol Violation|17
5294073|NCT00466947|18253341|P1|Study End Analysis Period|Protocol Violation|9
5294074|NCT00466947|18253340|P2|Study End Analysis Period|Physician Decision|29
5294075|NCT00466947|18253341|P1|Study End Analysis Period|Physician Decision|29
5294076|NCT00466947|18253340|P2|Study End Analysis Period|Lost to Follow-up|1167
5294077|NCT00466947|18253341|P1|Study End Analysis Period|Lost to Follow-up|1137
5294078|NCT00466947|18253340|P2|Study End Analysis Period|Adverse Event|43
5294079|NCT00466947|18253341|P1|Study End Analysis Period|Adverse Event|35
5294080|NCT00466947|18253340|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
5294081|NCT00466947|18253341|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
5294082|NCT00466921|18253463|P1|Follow up for a Minimum of 1 Year|Death|6
5294083|NCT00466921|18253463|P1|Completed 4 Cycles/Reached 1st Response|Uknown|1
5294084|NCT00466921|18253463|P1|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
5294085|NCT00466921|18253463|P1|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
5294086|NCT00466921|18253463|P1|First 3 Cycles of Treatment|Withdrawal by Subject|5
5294087|NCT00466921|18253463|P1|First 3 Cycles of Treatment|Adverse Event|2
5294089|NCT00466687|18253545|P1|Overall Study|Disease progression|29
5294090|NCT00466687|18253545|P1|Overall Study|Withdrawal by Subject|1
5294091|NCT00466687|18253545|P1|Overall Study|Other complicating illness|3
5294092|NCT00466687|18253545|P1|Overall Study|Adverse Event|1
5294093|NCT00466505|18253577|P1|Overall Study|Adverse Event|4
5294094|NCT00466505|18253577|P1|Overall Study|disease progression|13
5294095|NCT00466440|18253592|P3|Overall Study|Sponsor decision|1
5294096|NCT00466440|18253593|P2|Overall Study|Sponsor decision|0
5294097|NCT00466440|18253594|P1|Overall Study|Sponsor decision|0
5294098|NCT00466440|18253592|P3|Overall Study|Withdrawal by Subject|0
5294099|NCT00466440|18253593|P2|Overall Study|Withdrawal by Subject|1
5294100|NCT00466440|18253594|P1|Overall Study|Withdrawal by Subject|0
5294101|NCT00466440|18253592|P3|Overall Study|Protocol entry criteria not met|4
5294102|NCT00466440|18253593|P2|Overall Study|Protocol entry criteria not met|0
5294103|NCT00466440|18253594|P1|Overall Study|Protocol entry criteria not met|0
5294104|NCT00466440|18253592|P3|Overall Study|Physician Decision|2
5294105|NCT00466440|18253593|P2|Overall Study|Physician Decision|1
5294106|NCT00466440|18253594|P1|Overall Study|Physician Decision|0
5294107|NCT00466440|18253592|P3|Overall Study|Lost to Follow-up|0
5294108|NCT00466440|18253593|P2|Overall Study|Lost to Follow-up|1
5294109|NCT00466440|18253594|P1|Overall Study|Lost to Follow-up|0
5294110|NCT00466440|18253592|P3|Overall Study|Progressive disease|4
5294111|NCT00466440|18253593|P2|Overall Study|Progressive disease|5
5294112|NCT00466440|18253594|P1|Overall Study|Progressive disease|13
5294113|NCT00466440|18253592|P3|Overall Study|Death|0
5294114|NCT00466440|18253593|P2|Overall Study|Death|1
5294115|NCT00466440|18253594|P1|Overall Study|Death|1
5294116|NCT00466440|18253592|P3|Overall Study|Adverse Event|1
5294117|NCT00466440|18253593|P2|Overall Study|Adverse Event|3
5294118|NCT00466440|18253594|P1|Overall Study|Adverse Event|0
5294119|NCT00466193|18253669|P2|Overall Study|Patient refused Visit 4 procedures|0
5294120|NCT00466193|18253670|P1|Overall Study|Patient refused Visit 4 procedures|1
5294121|NCT00466193|18253669|P2|Overall Study|Withdrawal by Subject|2
5294122|NCT00466193|18253670|P1|Overall Study|Withdrawal by Subject|7
5294123|NCT00466193|18253669|P2|Overall Study|Protocol Violation|1
5294124|NCT00466193|18253670|P1|Overall Study|Protocol Violation|1
5294125|NCT00466193|18253669|P2|Overall Study|Physician Decision|0
5294126|NCT00466193|18253670|P1|Overall Study|Physician Decision|1
5294127|NCT00466193|18253669|P2|Overall Study|Lost to Follow-up|4
5294128|NCT00466193|18253670|P1|Overall Study|Lost to Follow-up|2
5294129|NCT00466193|18253669|P2|Overall Study|Adverse Event|1
5294130|NCT00466193|18253670|P1|Overall Study|Adverse Event|0
5294131|NCT00466167|18253697|P3|Overall Study|Not treated|0
5294132|NCT00466167|18253698|P2|Overall Study|Not treated|0
5294133|NCT00466167|18253699|P1|Overall Study|Not treated|1
5294134|NCT00466167|18253697|P3|Overall Study|patient did not meet inclusion criteria|1
5294135|NCT00466167|18253698|P2|Overall Study|patient did not meet inclusion criteria|0
5294136|NCT00466167|18253699|P1|Overall Study|patient did not meet inclusion criteria|1
5294137|NCT00466167|18253697|P3|Overall Study|Withdrawal by Subject|6
5294138|NCT00466167|18253698|P2|Overall Study|Withdrawal by Subject|1
5294139|NCT00466167|18253699|P1|Overall Study|Withdrawal by Subject|4
5294140|NCT00466167|18253697|P3|Overall Study|Lost to Follow-up|2
5294141|NCT00466167|18253698|P2|Overall Study|Lost to Follow-up|2
5294142|NCT00466167|18253699|P1|Overall Study|Lost to Follow-up|3
5294143|NCT00466167|18253697|P3|Overall Study|Protocol Violation|2
5294144|NCT00466167|18253698|P2|Overall Study|Protocol Violation|1
5294145|NCT00466167|18253699|P1|Overall Study|Protocol Violation|1
5294146|NCT00466167|18253697|P3|Overall Study|Lack of Efficacy|3
5294147|NCT00466167|18253698|P2|Overall Study|Lack of Efficacy|0
5294148|NCT00466167|18253699|P1|Overall Study|Lack of Efficacy|2
5294149|NCT00466167|18253697|P3|Overall Study|Adverse Event|7
5294150|NCT00466167|18253698|P2|Overall Study|Adverse Event|8
5294151|NCT00466167|18253699|P1|Overall Study|Adverse Event|8
5294152|NCT00465985|18253760|P2|Part III - Open-label Treatment Period|Adverse Event|0
5294153|NCT00465985|18253761|P1|Part III - Open-label Treatment Period|Adverse Event|1
5294154|NCT00465985|18253760|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
5294155|NCT00465985|18253761|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
5294156|NCT00465985|18253760|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
5294157|NCT00465985|18253761|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
5294158|NCT00465985|18253760|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
5294159|NCT00465985|18253761|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
5294160|NCT00465972|18253784|P2|Overall Study|Withdrawal by Subject|1
5294161|NCT00465972|18253785|P1|Overall Study|Withdrawal by Subject|2
5294162|NCT00465894|18253795|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
5294163|NCT00465894|18253796|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
5294164|NCT00465894|18253795|P2|Treatment For 12 Weeks|Family Issues|1
5294165|NCT00465894|18253796|P1|Treatment For 12 Weeks|Family Issues|1
5294166|NCT00465894|18253795|P2|Treatment For 12 Weeks|Lost to Follow-up|1
5294167|NCT00465894|18253796|P1|Treatment For 12 Weeks|Lost to Follow-up|4
5294168|NCT00465816|18253829|P3|Overall Study|Lost to Follow-up|2
5294169|NCT00465816|18253830|P2|Overall Study|Lost to Follow-up|0
5294170|NCT00465816|18253831|P1|Overall Study|Lost to Follow-up|0
5294171|NCT00465738|18253894|P2|Overall Study|Other|5
5294172|NCT00465738|18253895|P1|Overall Study|Other|2
5294173|NCT00465738|18253894|P2|Overall Study|Withdrawal by Subject|0
5294174|NCT00465738|18253895|P1|Overall Study|Withdrawal by Subject|2
5294175|NCT00465738|18253894|P2|Overall Study|Adverse Event|1
5294176|NCT00465738|18253895|P1|Overall Study|Adverse Event|0
5294177|NCT00465738|18253894|P2|Overall Study|Lost to Follow-up|0
5294178|NCT00465738|18253895|P1|Overall Study|Lost to Follow-up|2
5294179|NCT00465647|18253989|P4|Overall Study|"The other reasons included loss of IV"|2
5294180|NCT00465647|18253990|P3|Overall Study|"The other reasons included loss of IV"|3
5294181|NCT00465647|18253991|P2|Overall Study|"The other reasons included loss of IV"|4
5294182|NCT00465647|18253992|P1|Overall Study|"The other reasons included loss of IV"|8
5294183|NCT00465647|18253989|P4|Overall Study|Withdrawal by Subject|7
5294184|NCT00465647|18253990|P3|Overall Study|Withdrawal by Subject|2
5294185|NCT00465647|18253991|P2|Overall Study|Withdrawal by Subject|2
5294186|NCT00465647|18253992|P1|Overall Study|Withdrawal by Subject|1
5294187|NCT00465647|18253989|P4|Overall Study|Adverse Event|2
5294188|NCT00465647|18253990|P3|Overall Study|Adverse Event|3
5294189|NCT00465647|18253991|P2|Overall Study|Adverse Event|0
5294190|NCT00465647|18253992|P1|Overall Study|Adverse Event|2
5294191|NCT00465647|18253989|P4|Overall Study|Administrative|2
5294192|NCT00465647|18253990|P3|Overall Study|Administrative|3
5294193|NCT00465647|18253991|P2|Overall Study|Administrative|2
5294194|NCT00465647|18253992|P1|Overall Study|Administrative|2
5294195|NCT00465569|18254040|P2|Overall Study|persistent eczema during dose escalation|0
5294196|NCT00465569|18254041|P1|Overall Study|persistent eczema during dose escalation|1
5294197|NCT00465361|18254064|P1|Baseline Assessment|Personal Issues/Scheduling|4
5294198|NCT00465270|18254070|P2|Overall Study|Investigator request|4
5294199|NCT00465270|18254071|P1|Overall Study|Investigator request|3
5294200|NCT00465270|18254070|P2|Overall Study|Lost to Follow-up|67
5294201|NCT00465270|18254071|P1|Overall Study|Lost to Follow-up|60
5294202|NCT00465270|18254070|P2|Overall Study|Withdrawal by Subject|78
5294203|NCT00465270|18254071|P1|Overall Study|Withdrawal by Subject|34
5294204|NCT00465270|18254070|P2|Overall Study|Death|11
5294205|NCT00465270|18254071|P1|Overall Study|Death|7
5294206|NCT00465179|18254080|P1|Overall Study|Progression of Disease|47
5294207|NCT00465179|18254080|P1|Overall Study|Withdrawal by Subject|2
5294208|NCT00465179|18254080|P1|Overall Study|Adverse Event|4
5294209|NCT00465101|18254086|P1|Overall Study|Withdrew consent prior to procedure|3
5294210|NCT00465101|18254086|P1|Overall Study|Physician Decision|1
5294211|NCT00465101|18254086|P1|Overall Study|Withdrawal by Subject|25
5294212|NCT00465101|18254086|P1|Overall Study|Death|3
5294213|NCT00465101|18254086|P1|Overall Study|Unable to obtain IRB approval|1
5294214|NCT00465101|18254086|P1|Overall Study|Site closed due to IRB expiration|1
5294215|NCT00465101|18254086|P1|Overall Study|Patient postponed procedure|1
5294216|NCT00465101|18254086|P1|Overall Study|Pt. Insurance not accepted at center|2
5294217|NCT00465101|18254086|P1|Overall Study|Other|6
5294218|NCT00465101|18254086|P1|Overall Study|Lost to Follow-up|5
5294219|NCT00465101|18254086|P1|Overall Study|Did not meet study criteria|4
5294220|NCT00465101|18254086|P1|Overall Study|Change in health precluded follow up|4
5294221|NCT00465101|18254086|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
5294222|NCT00464945|18254156|P2|Toddler Dose|Lost to Follow-up|1
5294223|NCT00464945|18254157|P1|Toddler Dose|Lost to Follow-up|0
5294224|NCT00464945|18254156|P2|After Infant Series|Withdrawal by Subject|2
5294225|NCT00464945|18254157|P1|After Infant Series|Withdrawal by Subject|0
5294226|NCT00464945|18254156|P2|Infant Series|Lost to Follow-up|0
5294227|NCT00464945|18254157|P1|Infant Series|Lost to Follow-up|1
5294228|NCT00464945|18254156|P2|Infant Series|Protocol Violation|0
5294229|NCT00464945|18254157|P1|Infant Series|Protocol Violation|1
5294230|NCT00464945|18254156|P2|Infant Series|Withdrawal by parent/guardian request|1
5294231|NCT00464945|18254157|P1|Infant Series|Withdrawal by parent/guardian request|2
5294232|NCT00464815|18254187|P2|Overall Study|Withdrawal by Subject|3
5294233|NCT00464815|18254188|P1|Overall Study|Withdrawal by Subject|6
5294234|NCT00464737|18254221|P3|Overall Study|Other: Subject's disability per sponsor|1
5294235|NCT00464737|18254222|P2|Overall Study|Other: Subject's disability per sponsor|0
5294236|NCT00464737|18254223|P1|Overall Study|Other: Subject's disability per sponsor|0
5294237|NCT00464737|18254221|P3|Overall Study|Other: Personal family reasons|1
5294238|NCT00464737|18254222|P2|Overall Study|Other: Personal family reasons|0
5294239|NCT00464737|18254223|P1|Overall Study|Other: Personal family reasons|0
5294240|NCT00464737|18254221|P3|Overall Study|Other: Study demands too great|0
5294241|NCT00464737|18254222|P2|Overall Study|Other: Study demands too great|1
5294242|NCT00464737|18254223|P1|Overall Study|Other: Study demands too great|0
5294243|NCT00464737|18254221|P3|Overall Study|Other: Subject left town; family illness|0
5294244|NCT00464737|18254222|P2|Overall Study|Other: Subject left town; family illness|0
5294245|NCT00464737|18254223|P1|Overall Study|Other: Subject left town; family illness|1
5294246|NCT00464737|18254221|P3|Overall Study|Other: Subject's schedule doesn't permit|0
5294247|NCT00464737|18254222|P2|Overall Study|Other: Subject's schedule doesn't permit|0
5294248|NCT00464737|18254223|P1|Overall Study|Other: Subject's schedule doesn't permit|1
5294249|NCT00464737|18254221|P3|Overall Study|Lost to Follow-up|5
5294250|NCT00464737|18254222|P2|Overall Study|Lost to Follow-up|2
5294251|NCT00464737|18254223|P1|Overall Study|Lost to Follow-up|5
5294252|NCT00464737|18254221|P3|Overall Study|Non-compliance|1
5294253|NCT00464737|18254222|P2|Overall Study|Non-compliance|1
5294254|NCT00464737|18254223|P1|Overall Study|Non-compliance|0
5294255|NCT00464737|18254221|P3|Overall Study|Protocol Violation|5
5294256|NCT00464737|18254222|P2|Overall Study|Protocol Violation|1
5294257|NCT00464737|18254223|P1|Overall Study|Protocol Violation|1
5294258|NCT00464737|18254221|P3|Overall Study|Withdrawal by Subject|5
5294259|NCT00464737|18254222|P2|Overall Study|Withdrawal by Subject|3
5294260|NCT00464737|18254223|P1|Overall Study|Withdrawal by Subject|5
5294261|NCT00464737|18254221|P3|Overall Study|Lack of Efficacy|4
5294262|NCT00464737|18254222|P2|Overall Study|Lack of Efficacy|7
5294263|NCT00464737|18254223|P1|Overall Study|Lack of Efficacy|7
5294264|NCT00464737|18254221|P3|Overall Study|Adverse Event|33
5294265|NCT00464737|18254222|P2|Overall Study|Adverse Event|17
5294266|NCT00464737|18254223|P1|Overall Study|Adverse Event|12
5294267|NCT00464672|18254303|P6|Overall Study|Lost to Follow-up|0
5294268|NCT00464672|18254304|P5|Overall Study|Lost to Follow-up|1
5294269|NCT00464672|18254305|P4|Overall Study|Lost to Follow-up|0
5294270|NCT00464672|18254306|P3|Overall Study|Lost to Follow-up|0
5294271|NCT00464672|18254307|P2|Overall Study|Lost to Follow-up|10
5294272|NCT00464672|18254308|P1|Overall Study|Lost to Follow-up|25
5294273|NCT00464672|18254303|P6|Overall Study|withdrawal of consent|4
5294274|NCT00464672|18254304|P5|Overall Study|withdrawal of consent|9
5294275|NCT00464672|18254305|P4|Overall Study|withdrawal of consent|1
5294276|NCT00464672|18254306|P3|Overall Study|withdrawal of consent|0
5294277|NCT00464672|18254307|P2|Overall Study|withdrawal of consent|0
5294278|NCT00464672|18254308|P1|Overall Study|withdrawal of consent|0
5294279|NCT00464620|18254387|P3|Overall Study|Use of prohibited concomitant medication|2
5294280|NCT00464620|18254388|P2|Overall Study|Use of prohibited concomitant medication|0
5294281|NCT00464620|18254389|P1|Overall Study|Use of prohibited concomitant medication|0
5294282|NCT00464620|18254387|P3|Overall Study|Ineligible sarcoma subtype|2
5294283|NCT00464620|18254388|P2|Overall Study|Ineligible sarcoma subtype|2
5294284|NCT00464620|18254389|P1|Overall Study|Ineligible sarcoma subtype|0
5294285|NCT00464620|18254387|P3|Overall Study|Withdrawal by Subject|3
5294286|NCT00464620|18254388|P2|Overall Study|Withdrawal by Subject|0
5294287|NCT00464620|18254389|P1|Overall Study|Withdrawal by Subject|1
5294288|NCT00464620|18254387|P3|Overall Study|Physician Decision|0
5294289|NCT00464620|18254388|P2|Overall Study|Physician Decision|0
5294290|NCT00464620|18254389|P1|Overall Study|Physician Decision|1
5294291|NCT00464568|18254416|P1|Overall Study|Adverse Event|2
5294292|NCT00464542|18254489|P1|Pre-treatment|Withdrawal by Subject|2
5294293|NCT00464490|18254496|P2|Overall Study|Physician Decision|11
5294294|NCT00464490|18254497|P1|Overall Study|Physician Decision|11
5294295|NCT00464334|18254544|P11|Overall Study|Withdrawal by Subject|0
5294296|NCT00464334|18254545|P10|Overall Study|Withdrawal by Subject|0
5294297|NCT00464334|18254546|P9|Overall Study|Withdrawal by Subject|3
5294298|NCT00464334|18254547|P8|Overall Study|Withdrawal by Subject|1
5294299|NCT00464334|18254548|P7|Overall Study|Withdrawal by Subject|2
5294300|NCT00464334|18254549|P6|Overall Study|Withdrawal by Subject|2
5294301|NCT00464334|18254550|P5|Overall Study|Withdrawal by Subject|2
5294302|NCT00464334|18254551|P4|Overall Study|Withdrawal by Subject|2
5294303|NCT00464334|18254552|P3|Overall Study|Withdrawal by Subject|4
5294304|NCT00464334|18254553|P2|Overall Study|Withdrawal by Subject|7
5294305|NCT00464334|18254554|P1|Overall Study|Withdrawal by Subject|1
5294306|NCT00464334|18254544|P11|Overall Study|Study Terminated by Sponsor|0
5294307|NCT00464334|18254545|P10|Overall Study|Study Terminated by Sponsor|0
5294308|NCT00464334|18254546|P9|Overall Study|Study Terminated by Sponsor|0
5294309|NCT00464334|18254547|P8|Overall Study|Study Terminated by Sponsor|0
5294310|NCT00464334|18254548|P7|Overall Study|Study Terminated by Sponsor|0
5294311|NCT00464334|18254549|P6|Overall Study|Study Terminated by Sponsor|0
5294312|NCT00464334|18254550|P5|Overall Study|Study Terminated by Sponsor|0
5294313|NCT00464334|18254551|P4|Overall Study|Study Terminated by Sponsor|1
5294314|NCT00464334|18254552|P3|Overall Study|Study Terminated by Sponsor|0
5294315|NCT00464334|18254553|P2|Overall Study|Study Terminated by Sponsor|0
5294316|NCT00464334|18254554|P1|Overall Study|Study Terminated by Sponsor|0
5294317|NCT00464334|18254544|P11|Overall Study|Progressive Disease|0
5294318|NCT00464334|18254545|P10|Overall Study|Progressive Disease|0
5294319|NCT00464334|18254546|P9|Overall Study|Progressive Disease|1
5294320|NCT00464334|18254547|P8|Overall Study|Progressive Disease|0
5294321|NCT00464334|18254548|P7|Overall Study|Progressive Disease|0
5294322|NCT00464334|18254549|P6|Overall Study|Progressive Disease|1
5294323|NCT00464334|18254550|P5|Overall Study|Progressive Disease|0
5294324|NCT00464334|18254551|P4|Overall Study|Progressive Disease|0
5294325|NCT00464334|18254552|P3|Overall Study|Progressive Disease|0
5294326|NCT00464334|18254553|P2|Overall Study|Progressive Disease|0
5294327|NCT00464334|18254554|P1|Overall Study|Progressive Disease|0
5294328|NCT00464334|18254544|P11|Overall Study|Lost to Follow-up|2
5294329|NCT00464334|18254545|P10|Overall Study|Lost to Follow-up|0
5294330|NCT00464334|18254546|P9|Overall Study|Lost to Follow-up|0
5294331|NCT00464334|18254547|P8|Overall Study|Lost to Follow-up|0
5294332|NCT00464334|18254548|P7|Overall Study|Lost to Follow-up|1
5294333|NCT00464334|18254549|P6|Overall Study|Lost to Follow-up|0
5294334|NCT00464334|18254550|P5|Overall Study|Lost to Follow-up|1
5294335|NCT00464334|18254551|P4|Overall Study|Lost to Follow-up|0
5294336|NCT00464334|18254552|P3|Overall Study|Lost to Follow-up|1
5294337|NCT00464334|18254553|P2|Overall Study|Lost to Follow-up|0
5294338|NCT00464334|18254554|P1|Overall Study|Lost to Follow-up|0
5294339|NCT00464334|18254544|P11|Overall Study|Lack of Efficacy|0
5294340|NCT00464334|18254545|P10|Overall Study|Lack of Efficacy|0
5294341|NCT00464334|18254546|P9|Overall Study|Lack of Efficacy|0
5294342|NCT00464334|18254547|P8|Overall Study|Lack of Efficacy|0
5294343|NCT00464334|18254548|P7|Overall Study|Lack of Efficacy|0
5294344|NCT00464334|18254549|P6|Overall Study|Lack of Efficacy|0
5294345|NCT00464334|18254550|P5|Overall Study|Lack of Efficacy|0
5294346|NCT00464334|18254551|P4|Overall Study|Lack of Efficacy|0
5294347|NCT00464334|18254552|P3|Overall Study|Lack of Efficacy|0
5294348|NCT00464334|18254553|P2|Overall Study|Lack of Efficacy|1
5294349|NCT00464334|18254554|P1|Overall Study|Lack of Efficacy|0
5294350|NCT00464334|18254544|P11|Overall Study|Adverse Event|2
5294351|NCT00464334|18254545|P10|Overall Study|Adverse Event|1
5294352|NCT00464334|18254546|P9|Overall Study|Adverse Event|2
5294353|NCT00464334|18254547|P8|Overall Study|Adverse Event|0
5294354|NCT00464334|18254548|P7|Overall Study|Adverse Event|0
5294355|NCT00464334|18254549|P6|Overall Study|Adverse Event|1
5294356|NCT00464334|18254550|P5|Overall Study|Adverse Event|1
5294357|NCT00464334|18254551|P4|Overall Study|Adverse Event|1
5294358|NCT00464334|18254552|P3|Overall Study|Adverse Event|0
5294359|NCT00464334|18254553|P2|Overall Study|Adverse Event|0
5294360|NCT00464334|18254554|P1|Overall Study|Adverse Event|0
5294361|NCT00464308|18254614|P3|Overall Study|Physician Decision|0
5294362|NCT00464308|18254615|P2|Overall Study|Physician Decision|0
5294363|NCT00464308|18254616|P1|Overall Study|Physician Decision|1
5294364|NCT00464308|18254614|P3|Overall Study|Patient discontinued and other reasons|23
5294365|NCT00464308|18254615|P2|Overall Study|Patient discontinued and other reasons|17
5294366|NCT00464308|18254616|P1|Overall Study|Patient discontinued and other reasons|17
5294367|NCT00464308|18254614|P3|Overall Study|Lost to Follow-up|20
5294368|NCT00464308|18254615|P2|Overall Study|Lost to Follow-up|19
5294369|NCT00464308|18254616|P1|Overall Study|Lost to Follow-up|29
5294370|NCT00464308|18254614|P3|Overall Study|Adverse Event|16
5294371|NCT00464308|18254615|P2|Overall Study|Adverse Event|27
5294372|NCT00464308|18254616|P1|Overall Study|Adverse Event|22
5294373|NCT00464269|18254646|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5294374|NCT00464269|18254647|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5294375|NCT00464269|18254648|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5294376|NCT00464269|18254649|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5294377|NCT00464269|18254646|P4|Overall Study|AE, non-serious non-fatal|4
5294378|NCT00464269|18254647|P3|Overall Study|AE, non-serious non-fatal|3
5294379|NCT00464269|18254648|P2|Overall Study|AE, non-serious non-fatal|8
5294380|NCT00464269|18254649|P1|Overall Study|AE, non-serious non-fatal|2
5294381|NCT00464269|18254646|P4|Overall Study|SAE, non-fatal|1
5294382|NCT00464269|18254647|P3|Overall Study|SAE, non-fatal|0
5294383|NCT00464269|18254648|P2|Overall Study|SAE, non-fatal|0
5294384|NCT00464269|18254649|P1|Overall Study|SAE, non-fatal|0
5294385|NCT00464269|18254646|P4|Overall Study|AE, serious fatal|1
5294386|NCT00464269|18254647|P3|Overall Study|AE, serious fatal|1
5294387|NCT00464269|18254648|P2|Overall Study|AE, serious fatal|0
5294388|NCT00464269|18254649|P1|Overall Study|AE, serious fatal|0
5294389|NCT00464269|18254646|P4|Overall Study|Other reason|1
5294390|NCT00464269|18254647|P3|Overall Study|Other reason|1
5294391|NCT00464269|18254648|P2|Overall Study|Other reason|3
5294392|NCT00464269|18254649|P1|Overall Study|Other reason|3
5294393|NCT00464269|18254646|P4|Overall Study|Withdrawal by Subject|1
5294394|NCT00464269|18254647|P3|Overall Study|Withdrawal by Subject|1
5294395|NCT00464269|18254648|P2|Overall Study|Withdrawal by Subject|2
5294396|NCT00464269|18254649|P1|Overall Study|Withdrawal by Subject|0
5294397|NCT00464269|18254646|P4|Overall Study|Lost to Follow-up|1
5294398|NCT00464269|18254647|P3|Overall Study|Lost to Follow-up|0
5294399|NCT00464269|18254648|P2|Overall Study|Lost to Follow-up|4
5294400|NCT00464269|18254649|P1|Overall Study|Lost to Follow-up|0
5294401|NCT00464269|18254646|P4|Overall Study|Lack of Efficacy|0
5294402|NCT00464269|18254647|P3|Overall Study|Lack of Efficacy|0
5294403|NCT00464269|18254648|P2|Overall Study|Lack of Efficacy|0
5294404|NCT00464269|18254649|P1|Overall Study|Lack of Efficacy|1
5294405|NCT00464087|18254787|P3|Overall Study|No PCI per inclusion criteria|29
5294406|NCT00464087|18254788|P2|Overall Study|No PCI per inclusion criteria|0
5294407|NCT00464087|18254789|P1|Overall Study|No PCI per inclusion criteria|0
5294408|NCT00463866|18254807|P2|Overall Study|Other|22
5294409|NCT00463866|18254808|P1|Overall Study|Other|22
5294410|NCT00463866|18254807|P2|Overall Study|Mis-Randomization of subject|1
5294411|NCT00463866|18254808|P1|Overall Study|Mis-Randomization of subject|0
5294412|NCT00463866|18254807|P2|Overall Study|Safety Reason|3
5294413|NCT00463866|18254808|P1|Overall Study|Safety Reason|1
5294414|NCT00463866|18254807|P2|Overall Study|Severe Non-Compliance to Protocol|21
5294415|NCT00463866|18254808|P1|Overall Study|Severe Non-Compliance to Protocol|25
5294416|NCT00463866|18254807|P2|Overall Study|Incorrect Enrolment|66
5294417|NCT00463866|18254808|P1|Overall Study|Incorrect Enrolment|64
5294418|NCT00463866|18254807|P2|Overall Study|Lost to Follow-up|55
5294419|NCT00463866|18254808|P1|Overall Study|Lost to Follow-up|46
5294420|NCT00463866|18254807|P2|Overall Study|Withdrawal by Subject|79
5294421|NCT00463866|18254808|P1|Overall Study|Withdrawal by Subject|81
5294422|NCT00463866|18254807|P2|Overall Study|Adverse Event|93
5294423|NCT00463866|18254808|P1|Overall Study|Adverse Event|70
5294424|NCT00463840|18254828|P1|Overall Study|Adverse Event|3
5294425|NCT00463840|18254828|P1|Overall Study|Withdrawal by Subject|2
5294426|NCT00463840|18254828|P1|Overall Study|Disease progression|7
5294427|NCT00463801|18254833|P1|Overall Study|No longer require therapy|1
5294428|NCT00463801|18254833|P1|Overall Study|Lost to Follow-up|5
5294429|NCT00463801|18254833|P1|Overall Study|Adverse Event|4
5294430|NCT00463801|18254833|P1|Overall Study|Lack of Efficacy|2
5294431|NCT00463801|18254833|P1|Overall Study|Protocol Violation|1
5294432|NCT00463788|18254839|P2|Overall Study|Randomized but not treated|1
5294433|NCT00463788|18254840|P1|Overall Study|Randomized but not treated|1
5294434|NCT00463788|18254839|P2|Overall Study|Other|0
5294435|NCT00463788|18254840|P1|Overall Study|Other|3
5294436|NCT00463788|18254839|P2|Overall Study|Protocol Violation|1
5294437|NCT00463788|18254840|P1|Overall Study|Protocol Violation|0
5294438|NCT00463788|18254839|P2|Overall Study|Lost to Follow-up|0
5294439|NCT00463788|18254840|P1|Overall Study|Lost to Follow-up|1
5294440|NCT00463788|18254839|P2|Overall Study|Symptomatic Deterioration|3
5294441|NCT00463788|18254840|P1|Overall Study|Symptomatic Deterioration|2
5294442|NCT00463788|18254839|P2|Overall Study|Death|3
5294443|NCT00463788|18254840|P1|Overall Study|Death|4
5294444|NCT00463788|18254839|P2|Overall Study|Withdrawal by Subject|2
5294445|NCT00463788|18254840|P1|Overall Study|Withdrawal by Subject|6
5294446|NCT00463788|18254839|P2|Overall Study|Adverse Event|2
5294447|NCT00463788|18254840|P1|Overall Study|Adverse Event|6
5294448|NCT00463788|18254839|P2|Overall Study|Progressive Disease|42
5294449|NCT00463788|18254840|P1|Overall Study|Progressive Disease|86
5294450|NCT00463684|18254855|P1|Overall Study|Lost to Follow-up|3
5294451|NCT00463684|18254855|P1|Overall Study|Withdrawal by Subject|1
5294452|NCT00463606|18254873|P3|Overall Study|Protocol Violation|1
5294453|NCT00463606|18254874|P2|Overall Study|Protocol Violation|0
5294454|NCT00463606|18254875|P1|Overall Study|Protocol Violation|0
5294455|NCT00463606|18254873|P3|Overall Study|Participation in another ABT-335 trial|0
5294456|NCT00463606|18254874|P2|Overall Study|Participation in another ABT-335 trial|0
5294457|NCT00463606|18254875|P1|Overall Study|Participation in another ABT-335 trial|1
5294458|NCT00463606|18254873|P3|Overall Study|Patient randomized in error|0
5294459|NCT00463606|18254874|P2|Overall Study|Patient randomized in error|0
5294460|NCT00463606|18254875|P1|Overall Study|Patient randomized in error|1
5294461|NCT00463606|18254873|P3|Overall Study|Coordinator error|0
5294462|NCT00463606|18254874|P2|Overall Study|Coordinator error|0
5294463|NCT00463606|18254875|P1|Overall Study|Coordinator error|1
5294464|NCT00463606|18254873|P3|Overall Study|Exclusion criteria violation|0
5294465|NCT00463606|18254874|P2|Overall Study|Exclusion criteria violation|0
5294466|NCT00463606|18254875|P1|Overall Study|Exclusion criteria violation|2
5294467|NCT00463606|18254873|P3|Overall Study|Sponsor request|0
5294468|NCT00463606|18254874|P2|Overall Study|Sponsor request|1
5294469|NCT00463606|18254875|P1|Overall Study|Sponsor request|0
5294470|NCT00463606|18254873|P3|Overall Study|Physician Decision|0
5294471|NCT00463606|18254874|P2|Overall Study|Physician Decision|1
5294472|NCT00463606|18254875|P1|Overall Study|Physician Decision|0
5294473|NCT00463606|18254873|P3|Overall Study|Subject moved out of town|0
5294474|NCT00463606|18254874|P2|Overall Study|Subject moved out of town|0
5294475|NCT00463606|18254875|P1|Overall Study|Subject moved out of town|1
5294476|NCT00463606|18254873|P3|Overall Study|Subject noncompliance|0
5294477|NCT00463606|18254874|P2|Overall Study|Subject noncompliance|1
5294478|NCT00463606|18254875|P1|Overall Study|Subject noncompliance|1
5294479|NCT00463606|18254873|P3|Overall Study|Lost to Follow-up|3
5294480|NCT00463606|18254874|P2|Overall Study|Lost to Follow-up|2
5294481|NCT00463606|18254875|P1|Overall Study|Lost to Follow-up|2
5294482|NCT00463606|18254873|P3|Overall Study|Withdrawal by Subject|5
5294483|NCT00463606|18254874|P2|Overall Study|Withdrawal by Subject|11
5294484|NCT00463606|18254875|P1|Overall Study|Withdrawal by Subject|11
5294485|NCT00463606|18254873|P3|Overall Study|Adverse Event|11
5294486|NCT00463606|18254874|P2|Overall Study|Adverse Event|18
5294487|NCT00463606|18254875|P1|Overall Study|Adverse Event|21
5294488|NCT00463580|18254900|P2|Overall Study|Medical/psychiatric complications|2
5294489|NCT00463580|18254901|P1|Overall Study|Medical/psychiatric complications|0
5294490|NCT00463580|18254900|P2|Overall Study|Schedule conflict|0
5294491|NCT00463580|18254901|P1|Overall Study|Schedule conflict|2
5294492|NCT00463580|18254900|P2|Overall Study|Lost to Follow-up|0
5294493|NCT00463580|18254901|P1|Overall Study|Lost to Follow-up|1
5294494|NCT00463567|18254934|P7|Overall Study|Death|0
5294495|NCT00463567|18254935|P6|Overall Study|Death|0
5294496|NCT00463567|18254936|P5|Overall Study|Death|0
5294497|NCT00463567|18254937|P4|Overall Study|Death|0
5294498|NCT00463567|18254938|P3|Overall Study|Death|2
5294499|NCT00463567|18254939|P2|Overall Study|Death|0
5294500|NCT00463567|18254940|P1|Overall Study|Death|1
5294501|NCT00463567|18254934|P7|Overall Study|Abnormal test procedure result(s)|0
5294502|NCT00463567|18254935|P6|Overall Study|Abnormal test procedure result(s)|2
5294503|NCT00463567|18254936|P5|Overall Study|Abnormal test procedure result(s)|0
5294504|NCT00463567|18254937|P4|Overall Study|Abnormal test procedure result(s)|2
5294505|NCT00463567|18254938|P3|Overall Study|Abnormal test procedure result(s)|6
5294506|NCT00463567|18254939|P2|Overall Study|Abnormal test procedure result(s)|1
5294507|NCT00463567|18254940|P1|Overall Study|Abnormal test procedure result(s)|1
5294508|NCT00463567|18254934|P7|Overall Study|Abnormal lab value(s)|0
5294509|NCT00463567|18254935|P6|Overall Study|Abnormal lab value(s)|0
5294510|NCT00463567|18254936|P5|Overall Study|Abnormal lab value(s)|1
5294511|NCT00463567|18254937|P4|Overall Study|Abnormal lab value(s)|1
5294512|NCT00463567|18254938|P3|Overall Study|Abnormal lab value(s)|2
5294513|NCT00463567|18254939|P2|Overall Study|Abnormal lab value(s)|1
5294514|NCT00463567|18254940|P1|Overall Study|Abnormal lab value(s)|1
5294515|NCT00463567|18254934|P7|Overall Study|Lack of Efficacy|1
5294516|NCT00463567|18254935|P6|Overall Study|Lack of Efficacy|0
5294517|NCT00463567|18254936|P5|Overall Study|Lack of Efficacy|1
5294518|NCT00463567|18254937|P4|Overall Study|Lack of Efficacy|17
5294519|NCT00463567|18254938|P3|Overall Study|Lack of Efficacy|9
5294520|NCT00463567|18254939|P2|Overall Study|Lack of Efficacy|9
5294521|NCT00463567|18254940|P1|Overall Study|Lack of Efficacy|4
5294522|NCT00463567|18254934|P7|Overall Study|Administrative problems|2
5294523|NCT00463567|18254935|P6|Overall Study|Administrative problems|2
5294524|NCT00463567|18254936|P5|Overall Study|Administrative problems|3
5294525|NCT00463567|18254937|P4|Overall Study|Administrative problems|9
5294526|NCT00463567|18254938|P3|Overall Study|Administrative problems|6
5294527|NCT00463567|18254939|P2|Overall Study|Administrative problems|3
5294528|NCT00463567|18254940|P1|Overall Study|Administrative problems|5
5294529|NCT00463567|18254934|P7|Overall Study|Lost to Follow-up|1
5294530|NCT00463567|18254935|P6|Overall Study|Lost to Follow-up|1
5294531|NCT00463567|18254936|P5|Overall Study|Lost to Follow-up|1
5294532|NCT00463567|18254937|P4|Overall Study|Lost to Follow-up|8
5294533|NCT00463567|18254938|P3|Overall Study|Lost to Follow-up|13
5294534|NCT00463567|18254939|P2|Overall Study|Lost to Follow-up|6
5294535|NCT00463567|18254940|P1|Overall Study|Lost to Follow-up|12
5294536|NCT00463567|18254934|P7|Overall Study|Protocol Deviation|2
5294537|NCT00463567|18254935|P6|Overall Study|Protocol Deviation|1
5294538|NCT00463567|18254936|P5|Overall Study|Protocol Deviation|1
5294539|NCT00463567|18254937|P4|Overall Study|Protocol Deviation|11
5294540|NCT00463567|18254938|P3|Overall Study|Protocol Deviation|14
5294541|NCT00463567|18254939|P2|Overall Study|Protocol Deviation|9
5294542|NCT00463567|18254940|P1|Overall Study|Protocol Deviation|13
5294543|NCT00463567|18254934|P7|Overall Study|Withdrawal by Subject|1
5294544|NCT00463567|18254935|P6|Overall Study|Withdrawal by Subject|5
5294545|NCT00463567|18254936|P5|Overall Study|Withdrawal by Subject|6
5294546|NCT00463567|18254937|P4|Overall Study|Withdrawal by Subject|37
5294547|NCT00463567|18254938|P3|Overall Study|Withdrawal by Subject|20
5294548|NCT00463567|18254939|P2|Overall Study|Withdrawal by Subject|22
5294549|NCT00463567|18254940|P1|Overall Study|Withdrawal by Subject|29
5294550|NCT00463567|18254934|P7|Overall Study|Adverse Event|4
5294551|NCT00463567|18254935|P6|Overall Study|Adverse Event|10
5294552|NCT00463567|18254936|P5|Overall Study|Adverse Event|10
5294553|NCT00463567|18254937|P4|Overall Study|Adverse Event|46
5294554|NCT00463567|18254938|P3|Overall Study|Adverse Event|17
5294555|NCT00463567|18254939|P2|Overall Study|Adverse Event|26
5294556|NCT00463567|18254940|P1|Overall Study|Adverse Event|29
5294557|NCT00463476|18254973|P2|Overall Study|Lost to Follow-up|1
5294558|NCT00463476|18254974|P1|Overall Study|Lost to Follow-up|1
5294559|NCT00463476|18254973|P2|Overall Study|Withdrawal by Subject|2
5294560|NCT00463476|18254974|P1|Overall Study|Withdrawal by Subject|1
5294561|NCT00463385|18255063|P4|Overall Study|1 participant received commercial drug|0
5294562|NCT00463385|18255064|P3|Overall Study|1 participant received commercial drug|0
5294563|NCT00463385|18255065|P2|Overall Study|1 participant received commercial drug|1
5294564|NCT00463385|18255066|P1|Overall Study|1 participant received commercial drug|0
5294565|NCT00463385|18255063|P4|Overall Study|Missing|2
5294566|NCT00463385|18255064|P3|Overall Study|Missing|0
5294567|NCT00463385|18255065|P2|Overall Study|Missing|0
5294568|NCT00463385|18255066|P1|Overall Study|Missing|2
5294569|NCT00463385|18255063|P4|Overall Study|Death|0
5294570|NCT00463385|18255064|P3|Overall Study|Death|2
5294571|NCT00463385|18255065|P2|Overall Study|Death|1
5294572|NCT00463385|18255066|P1|Overall Study|Death|2
5294573|NCT00463385|18255063|P4|Overall Study|Lost to Follow-up|1
5294574|NCT00463385|18255064|P3|Overall Study|Lost to Follow-up|0
5294575|NCT00463385|18255065|P2|Overall Study|Lost to Follow-up|0
5294576|NCT00463385|18255066|P1|Overall Study|Lost to Follow-up|0
5294577|NCT00463385|18255063|P4|Overall Study|Withdrawal by Subject|4
5294578|NCT00463385|18255064|P3|Overall Study|Withdrawal by Subject|3
5294579|NCT00463385|18255065|P2|Overall Study|Withdrawal by Subject|3
5294580|NCT00463385|18255066|P1|Overall Study|Withdrawal by Subject|3
5294581|NCT00463385|18255063|P4|Overall Study|Lack of Efficacy|9
5294582|NCT00463385|18255064|P3|Overall Study|Lack of Efficacy|7
5294583|NCT00463385|18255065|P2|Overall Study|Lack of Efficacy|6
5294584|NCT00463385|18255066|P1|Overall Study|Lack of Efficacy|6
5294585|NCT00463385|18255063|P4|Overall Study|Adverse Event|2
5294586|NCT00463385|18255064|P3|Overall Study|Adverse Event|4
5294587|NCT00463385|18255065|P2|Overall Study|Adverse Event|8
5294588|NCT00463385|18255066|P1|Overall Study|Adverse Event|5
5294589|NCT00463385|18255063|P4|Overall Study|Other|4
5294590|NCT00463385|18255064|P3|Overall Study|Other|6
5294591|NCT00463385|18255065|P2|Overall Study|Other|3
5294592|NCT00463385|18255066|P1|Overall Study|Other|4
5294593|NCT00463346|18255118|P2|Overall Study|Withdrawal by Subject|3
5294594|NCT00463346|18255119|P1|Overall Study|Withdrawal by Subject|3
5294595|NCT00463229|18255129|P2|Overall Study|Death|3
5294596|NCT00463229|18255130|P1|Overall Study|Death|4
5294597|NCT00463229|18255129|P2|Overall Study|Lost to Follow-up|7
5294598|NCT00463229|18255130|P1|Overall Study|Lost to Follow-up|5
5294599|NCT00463060|18255150|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
5294600|NCT00463060|18255150|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
5294601|NCT00463047|18255164|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
5294602|NCT00463047|18255165|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
5294603|NCT00463047|18255164|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
5294604|NCT00463047|18255165|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
5294605|NCT00463047|18255164|P2|Double-Blind Treatment Period 2|Adverse Event|1
5294606|NCT00463047|18255165|P1|Double-Blind Treatment Period 2|Adverse Event|0
5294607|NCT00463047|18255164|P2|Double-Blind Treatment Period 1|Other|0
5294608|NCT00463047|18255165|P1|Double-Blind Treatment Period 1|Other|1
5294609|NCT00463047|18255164|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
5294610|NCT00463047|18255165|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
5294611|NCT00463047|18255164|P2|Double-Blind Treatment Period 1|Protocol Violation|2
5294612|NCT00463047|18255165|P1|Double-Blind Treatment Period 1|Protocol Violation|1
5294613|NCT00463047|18255164|P2|Double-Blind Treatment Period 1|Adverse Event|2
5294614|NCT00463047|18255165|P1|Double-Blind Treatment Period 1|Adverse Event|0
5294615|NCT00463047|18255164|P2|Titration Period 2|Other|2
5294616|NCT00463047|18255165|P1|Titration Period 2|Other|3
5294617|NCT00463047|18255164|P2|Titration Period 2|Non-compliance procedures|1
5294618|NCT00463047|18255165|P1|Titration Period 2|Non-compliance procedures|4
5294619|NCT00463047|18255164|P2|Titration Period 2|Non-compliance study medication|2
5294620|NCT00463047|18255165|P1|Titration Period 2|Non-compliance study medication|4
5294621|NCT00463047|18255164|P2|Titration Period 2|Lost to Follow-up|2
5294622|NCT00463047|18255165|P1|Titration Period 2|Lost to Follow-up|1
5294623|NCT00463047|18255164|P2|Titration Period 2|Protocol Violation|3
5294624|NCT00463047|18255165|P1|Titration Period 2|Protocol Violation|2
5294625|NCT00463047|18255164|P2|Titration Period 2|Withdrawal by Subject|0
5294626|NCT00463047|18255165|P1|Titration Period 2|Withdrawal by Subject|1
5294627|NCT00463047|18255164|P2|Titration Period 2|Lack of Efficacy|4
5294628|NCT00463047|18255165|P1|Titration Period 2|Lack of Efficacy|6
5294629|NCT00463047|18255164|P2|Titration Period 2|Adverse Event|9
5294630|NCT00463047|18255165|P1|Titration Period 2|Adverse Event|9
5294631|NCT00463047|18255164|P2|Titration Period 1|Other|2
5294632|NCT00463047|18255165|P1|Titration Period 1|Other|0
5294633|NCT00463047|18255164|P2|Titration Period 1|Non-compliance procedures|10
5294634|NCT00463047|18255165|P1|Titration Period 1|Non-compliance procedures|4
5294635|NCT00463047|18255164|P2|Titration Period 1|Withdrawal by Subject|5
5294636|NCT00463047|18255165|P1|Titration Period 1|Withdrawal by Subject|3
5294637|NCT00463047|18255164|P2|Titration Period 1|Protocol Violation|5
5294638|NCT00463047|18255165|P1|Titration Period 1|Protocol Violation|5
5294639|NCT00463047|18255164|P2|Titration Period 1|Non-compliance with study medication|5
5294640|NCT00463047|18255165|P1|Titration Period 1|Non-compliance with study medication|3
5294641|NCT00463047|18255164|P2|Titration Period 1|Lost to Follow-up|0
5294642|NCT00463047|18255165|P1|Titration Period 1|Lost to Follow-up|2
5294643|NCT00463047|18255164|P2|Titration Period 1|Lack of Efficacy|4
5294644|NCT00463047|18255165|P1|Titration Period 1|Lack of Efficacy|10
5294645|NCT00463047|18255164|P2|Titration Period 1|Adverse Event|8
5294646|NCT00463047|18255165|P1|Titration Period 1|Adverse Event|10
5294647|NCT00462982|18255250|P1|Overall Study|Patient Not Treated|2
5294648|NCT00462982|18255250|P1|Overall Study|Adverse Event|1
5294649|NCT00462943|18255257|P3|Overall Study|Withdrawal by Subject|0
5294650|NCT00462943|18255258|P2|Overall Study|Withdrawal by Subject|1
5294651|NCT00462943|18255259|P1|Overall Study|Withdrawal by Subject|0
5294652|NCT00462943|18255257|P3|Overall Study|Physician Decision|0
5294653|NCT00462943|18255258|P2|Overall Study|Physician Decision|0
5294654|NCT00462943|18255259|P1|Overall Study|Physician Decision|1
5294655|NCT00462943|18255257|P3|Overall Study|Transplant - not specified|1
5294656|NCT00462943|18255258|P2|Overall Study|Transplant - not specified|0
5294657|NCT00462943|18255259|P1|Overall Study|Transplant - not specified|1
5294658|NCT00462943|18255257|P3|Overall Study|Required Lymphocyte Infusion|0
5294659|NCT00462943|18255258|P2|Overall Study|Required Lymphocyte Infusion|0
5294660|NCT00462943|18255259|P1|Overall Study|Required Lymphocyte Infusion|1
5294661|NCT00462943|18255257|P3|Overall Study|Bone Marrow Transplant|0
5294662|NCT00462943|18255258|P2|Overall Study|Bone Marrow Transplant|0
5294663|NCT00462943|18255259|P1|Overall Study|Bone Marrow Transplant|1
5294664|NCT00462943|18255257|P3|Overall Study|Stem Cell Transplant|0
5294665|NCT00462943|18255258|P2|Overall Study|Stem Cell Transplant|1
5294666|NCT00462943|18255259|P1|Overall Study|Stem Cell Transplant|1
5294667|NCT00462943|18255257|P3|Overall Study|Death|7
5294668|NCT00462943|18255258|P2|Overall Study|Death|2
5294669|NCT00462943|18255259|P1|Overall Study|Death|5
5294670|NCT00462943|18255257|P3|Overall Study|Disease Progression|9
5294671|NCT00462943|18255258|P2|Overall Study|Disease Progression|15
5294672|NCT00462943|18255259|P1|Overall Study|Disease Progression|15
5294673|NCT00462943|18255257|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
5294674|NCT00462943|18255258|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
5294675|NCT00462943|18255259|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
5294676|NCT00462943|18255257|P3|Overall Study|Protocol Violation|0
5294677|NCT00462943|18255258|P2|Overall Study|Protocol Violation|0
5294678|NCT00462943|18255259|P1|Overall Study|Protocol Violation|1
5294679|NCT00462943|18255257|P3|Overall Study|Adverse Event|1
5294680|NCT00462943|18255258|P2|Overall Study|Adverse Event|4
5294681|NCT00462943|18255259|P1|Overall Study|Adverse Event|6
5294682|NCT00462943|18255257|P3|Overall Study|Failure to achieve a response|1
5294683|NCT00462943|18255258|P2|Overall Study|Failure to achieve a response|5
5294684|NCT00462943|18255259|P1|Overall Study|Failure to achieve a response|5
5294685|NCT00462904|18255351|P1|Overall Study|Lost to Follow-up|1
5294686|NCT00462865|18255356|P1|Overall Study|Adverse Event|1
5294687|NCT00462826|18255376|P1|Overall Study|Never treated|1
5294688|NCT00462826|18255376|P1|Overall Study|Ineligible - wrong primary|2
5294689|NCT00462826|18255376|P1|Overall Study|Ineligible - wrong cell type|1
5294690|NCT00462826|18255376|P1|Overall Study|Ineligible - second primary|1
5294691|NCT00462761|18255389|P1|Overall Study|Other|1
5294692|NCT00462761|18255389|P1|Overall Study|Death|12
5294693|NCT00462761|18255389|P1|Overall Study|Disease progression|43
5294694|NCT00462761|18255389|P1|Overall Study|Physician Decision|5
5294695|NCT00462761|18255389|P1|Overall Study|Withdrawal by Subject|9
5294696|NCT00462761|18255389|P1|Overall Study|Adverse Event|6
5294697|NCT00462748|18255464|P3|Overall Study|Discontinued after 41 days Rx|0
5294698|NCT00462748|18255465|P2|Overall Study|Discontinued after 41 days Rx|0
5294699|NCT00462748|18255466|P1|Overall Study|Discontinued after 41 days Rx|1
5294700|NCT00462748|18255464|P3|Overall Study|Lost to Follow-up|1
5294701|NCT00462748|18255465|P2|Overall Study|Lost to Follow-up|1
5294702|NCT00462748|18255466|P1|Overall Study|Lost to Follow-up|1
5294703|NCT00462748|18255464|P3|Overall Study|Withdrew consent|0
5294704|NCT00462748|18255465|P2|Overall Study|Withdrew consent|3
5294705|NCT00462748|18255466|P1|Overall Study|Withdrew consent|3
5294706|NCT00462748|18255464|P3|Overall Study|Protocol Violation|1
5294707|NCT00462748|18255465|P2|Overall Study|Protocol Violation|2
5294708|NCT00462748|18255466|P1|Overall Study|Protocol Violation|0
5294709|NCT00462748|18255464|P3|Overall Study|Adverse Event|9
5294710|NCT00462748|18255465|P2|Overall Study|Adverse Event|5
5294711|NCT00462748|18255466|P1|Overall Study|Adverse Event|7
5294712|NCT00462709|18255519|P1|Overall Study|Withdrew to start treatment with Cetor|1
5294713|NCT00462709|18255519|P1|Overall Study|Physician Decision|1
5294714|NCT00462709|18255519|P1|Overall Study|Logistical reasons|2
5294715|NCT00462709|18255519|P1|Overall Study|Death|2
5294716|NCT00462709|18255519|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
5294717|NCT00462709|18255519|P1|Overall Study|Withdrawal by Subject|8
5294718|NCT00462709|18255519|P1|Overall Study|Lost to Follow-up|10
5294719|NCT00462709|18255519|P1|Overall Study|Transitioned to commercial C1INH-nf|40
5294720|NCT00462670|18255528|P2|Overall Study|Resolution of signs and symptoms|2
5294721|NCT00462670|18255529|P1|Overall Study|Resolution of signs and symptoms|0
5294722|NCT00462670|18255528|P2|Overall Study|Protocol Violation|0
5294723|NCT00462670|18255529|P1|Overall Study|Protocol Violation|1
5294724|NCT00462670|18255528|P2|Overall Study|Lack of Efficacy|0
5294725|NCT00462670|18255529|P1|Overall Study|Lack of Efficacy|1
5294726|NCT00462670|18255528|P2|Overall Study|Adverse Event|5
5294727|NCT00462670|18255529|P1|Overall Study|Adverse Event|3
5294728|NCT00462501|18255566|P1|Overall Study|Adverse Event|2
5294729|NCT00462501|18255566|P1|Overall Study|Not treated|3
5294730|NCT00462488|18255572|P2|Overall Study|Lack of Efficacy|17
5294731|NCT00462488|18255573|P1|Overall Study|Lack of Efficacy|19
5294732|NCT00462488|18255572|P2|Overall Study|Protocol Violation|0
5294733|NCT00462488|18255573|P1|Overall Study|Protocol Violation|1
5294734|NCT00462462|18255581|P2|Overall Study|Physician Decision|1
5294735|NCT00462462|18255582|P1|Overall Study|Physician Decision|0
5294736|NCT00462384|18255610|P1|Overall Study|Other|4
5294737|NCT00462384|18255610|P1|Overall Study|Withdrawal by Subject|1
5294738|NCT00462384|18255610|P1|Overall Study|Death|2
5294739|NCT00462384|18255610|P1|Overall Study|Adverse Event|2
5294740|NCT00462345|18255618|P1|Overall Study|Did not complete second course|1
5294741|NCT00462345|18255618|P1|Overall Study|Withdrawal by Subject|2
5294742|NCT00462306|18255653|P2|Overall Study|insufficient data|13
5294743|NCT00462306|18255654|P1|Overall Study|insufficient data|0
5294744|NCT00461981|18255785|P2|Overall Study|Withdrawal by Subject|3
5294745|NCT00461981|18255786|P1|Overall Study|Withdrawal by Subject|2
5294746|NCT00461981|18255785|P2|Overall Study|Lost to Follow-up|6
5294747|NCT00461981|18255786|P1|Overall Study|Lost to Follow-up|9
5294748|NCT00461812|18255902|P1|Overall Study|study terminated|10
5294749|NCT00461786|18255907|P1|Overall Study|Inevaluable (Never Treated)|1
5294750|NCT00461786|18255907|P1|Overall Study|Entry Criteria Not Met|2
5294751|NCT00461708|18255952|P2|Overall Study|Death|1
5294752|NCT00461708|18255953|P1|Overall Study|Death|8
5294753|NCT00461708|18255952|P2|Overall Study|Other|4
5294754|NCT00461708|18255953|P1|Overall Study|Other|4
5294755|NCT00461708|18255952|P2|Overall Study|Withdrawal by Subject|2
5294756|NCT00461708|18255953|P1|Overall Study|Withdrawal by Subject|8
5294757|NCT00461708|18255952|P2|Overall Study|Physician Decision|4
5294758|NCT00461708|18255953|P1|Overall Study|Physician Decision|10
5294759|NCT00461708|18255952|P2|Overall Study|Lack of Efficacy|20
5294760|NCT00461708|18255953|P1|Overall Study|Lack of Efficacy|68
5294761|NCT00461708|18255952|P2|Overall Study|Adverse Event|7
5294762|NCT00461708|18255953|P1|Overall Study|Adverse Event|17
5294763|NCT00461682|18255979|P1|Overall Study|Protocol Violation|1
5294764|NCT00461630|18256007|P2|Overall Study|Lost to Follow-up|95
5294765|NCT00461630|18256008|P1|Overall Study|Lost to Follow-up|108
5294766|NCT00461630|18256007|P2|Overall Study|Death|732
5294767|NCT00461630|18256008|P1|Overall Study|Death|798
5294768|NCT00461552|18256047|P2|Overall Study|Drug Dispensing error|2
5294769|NCT00461552|18256048|P1|Overall Study|Drug Dispensing error|0
5294770|NCT00461500|18256071|P2|Overall Study|Lost to Follow-up|2
5294771|NCT00461500|18256072|P1|Overall Study|Lost to Follow-up|2
5294772|NCT00461500|18256071|P2|Overall Study|No Longer Willing to Take Part in Study|0
5294773|NCT00461500|18256072|P1|Overall Study|No Longer Willing to Take Part in Study|1
5294774|NCT00461500|18256071|P2|Overall Study|Drug Treatment Misuse|0
5294775|NCT00461500|18256072|P1|Overall Study|Drug Treatment Misuse|1
5294776|NCT00461500|18256071|P2|Overall Study|Study Stopped|2
5294777|NCT00461500|18256072|P1|Overall Study|Study Stopped|1
5294778|NCT00461500|18256071|P2|Overall Study|Expired Drug Treatment|1
5294779|NCT00461500|18256072|P1|Overall Study|Expired Drug Treatment|1
5294780|NCT00461500|18256071|P2|Overall Study|Lack of Efficacy|1
5294781|NCT00461500|18256072|P1|Overall Study|Lack of Efficacy|0
5294782|NCT00461500|18256071|P2|Overall Study|Adverse Event|0
5294783|NCT00461500|18256072|P1|Overall Study|Adverse Event|1
5294784|NCT00461305|18256115|P2|Continued Treatment|Other (missing drug etc)|0
5294785|NCT00461305|18256116|P1|Continued Treatment|Other (missing drug etc)|2
5294786|NCT00461305|18256115|P2|Continued Treatment|Partially missing diary|0
5294787|NCT00461305|18256116|P1|Continued Treatment|Partially missing diary|2
5294788|NCT00461305|18256115|P2|Continued Treatment|Withdrawal by Subject|0
5294789|NCT00461305|18256116|P1|Continued Treatment|Withdrawal by Subject|48
5294790|NCT00461305|18256115|P2|Continued Treatment|Protocol Violation|0
5294791|NCT00461305|18256116|P1|Continued Treatment|Protocol Violation|13
5294792|NCT00461305|18256115|P2|Continued Treatment|Lost to Follow-up|0
5294793|NCT00461305|18256116|P1|Continued Treatment|Lost to Follow-up|4
5294794|NCT00461305|18256115|P2|Continued Treatment|Adverse Event|0
5294795|NCT00461305|18256116|P1|Continued Treatment|Adverse Event|26
5294796|NCT00461305|18256115|P2|Treatment|Other (missing drug etc)|0
5294797|NCT00461305|18256116|P1|Treatment|Other (missing drug etc)|2
5294798|NCT00461305|18256115|P2|Treatment|Partially missing diary|0
5294799|NCT00461305|18256116|P1|Treatment|Partially missing diary|2
5294800|NCT00461305|18256115|P2|Treatment|Study drug not taken|0
5294801|NCT00461305|18256116|P1|Treatment|Study drug not taken|1
5294802|NCT00461305|18256115|P2|Treatment|Never dispensed|0
5294803|NCT00461305|18256116|P1|Treatment|Never dispensed|5
5294804|NCT00461305|18256115|P2|Treatment|Withdrawal by Subject|2
5294805|NCT00461305|18256116|P1|Treatment|Withdrawal by Subject|48
5294806|NCT00461305|18256115|P2|Treatment|Protocol Violation|2
5294807|NCT00461305|18256116|P1|Treatment|Protocol Violation|13
5294808|NCT00461305|18256115|P2|Treatment|Lost to Follow-up|2
5294809|NCT00461305|18256116|P1|Treatment|Lost to Follow-up|4
5294810|NCT00461305|18256115|P2|Treatment|Adverse Event|3
5294811|NCT00461305|18256116|P1|Treatment|Adverse Event|26
5294812|NCT00461253|18256200|P2|Overall Study|administrative|7773
5294813|NCT00461253|18256201|P1|Overall Study|administrative|773
5294814|NCT00461253|18256200|P2|Overall Study|no response|11789
5294815|NCT00461253|18256201|P1|Overall Study|no response|2609
5294816|NCT00461253|18256200|P2|Overall Study|Protocol Violation|236
5294817|NCT00461253|18256201|P1|Overall Study|Protocol Violation|613
5294818|NCT00461253|18256200|P2|Overall Study|Death|0
5294819|NCT00461253|18256201|P1|Overall Study|Death|985
5294820|NCT00461175|18256209|P2|Overall Study|Protocol Violation|365
5294821|NCT00461175|18256210|P1|Overall Study|Protocol Violation|522
5294822|NCT00461123|18256220|P2|Overall Study|Withdrawal by Subject|3
5294823|NCT00461123|18256221|P1|Overall Study|Withdrawal by Subject|1
5294824|NCT00461123|18256220|P2|Overall Study|Protocol Violation|2
5294825|NCT00461123|18256221|P1|Overall Study|Protocol Violation|3
5294826|NCT00461123|18256220|P2|Overall Study|Lost to Follow-up|1
5294827|NCT00461123|18256221|P1|Overall Study|Lost to Follow-up|1
5294828|NCT00461123|18256220|P2|Overall Study|Adverse Event|0
5294829|NCT00461123|18256221|P1|Overall Study|Adverse Event|1
5294830|NCT00461032|18256266|P2|Overall Study|Other|5
5294831|NCT00461032|18256267|P1|Overall Study|Other|7
5294832|NCT00461032|18256266|P2|Overall Study|Patient Moved or Relocated|1
5294833|NCT00461032|18256267|P1|Overall Study|Patient Moved or Relocated|2
5294834|NCT00461032|18256266|P2|Overall Study|Withdrawal by Subject|15
5294835|NCT00461032|18256267|P1|Overall Study|Withdrawal by Subject|7
5294836|NCT00461032|18256266|P2|Overall Study|Protocol Violation|4
5294837|NCT00461032|18256267|P1|Overall Study|Protocol Violation|4
5294838|NCT00461032|18256266|P2|Overall Study|Lost to Follow-up|12
5294839|NCT00461032|18256267|P1|Overall Study|Lost to Follow-up|7
5294840|NCT00461032|18256266|P2|Overall Study|Lack of Efficacy|1
5294841|NCT00461032|18256267|P1|Overall Study|Lack of Efficacy|5
5294842|NCT00461032|18256266|P2|Overall Study|Adverse Event|6
5294843|NCT00461032|18256267|P1|Overall Study|Adverse Event|5
5294844|NCT00460811|18256293|P5|Overall Study|Lost to Follow-up|6
5294845|NCT00460811|18256294|P4|Overall Study|Lost to Follow-up|3
5294846|NCT00460811|18256295|P3|Overall Study|Lost to Follow-up|5
5294847|NCT00460811|18256296|P2|Overall Study|Lost to Follow-up|2
5294848|NCT00460811|18256297|P1|Overall Study|Lost to Follow-up|3
5294849|NCT00460811|18256293|P5|Overall Study|Physician Decision|0
5294850|NCT00460811|18256294|P4|Overall Study|Physician Decision|0
5294851|NCT00460811|18256295|P3|Overall Study|Physician Decision|0
5294852|NCT00460811|18256296|P2|Overall Study|Physician Decision|0
5294853|NCT00460811|18256297|P1|Overall Study|Physician Decision|1
5294854|NCT00460811|18256293|P5|Overall Study|Withdrawal by Subject|11
5294855|NCT00460811|18256294|P4|Overall Study|Withdrawal by Subject|3
5294856|NCT00460811|18256295|P3|Overall Study|Withdrawal by Subject|6
5294857|NCT00460811|18256296|P2|Overall Study|Withdrawal by Subject|7
5294858|NCT00460811|18256297|P1|Overall Study|Withdrawal by Subject|7
5294859|NCT00460811|18256293|P5|Overall Study|Noncompliance|1
5294860|NCT00460811|18256294|P4|Overall Study|Noncompliance|2
5294861|NCT00460811|18256295|P3|Overall Study|Noncompliance|0
5294862|NCT00460811|18256296|P2|Overall Study|Noncompliance|0
5294863|NCT00460811|18256297|P1|Overall Study|Noncompliance|1
5294864|NCT00460811|18256293|P5|Overall Study|Adverse Event|2
5294865|NCT00460811|18256294|P4|Overall Study|Adverse Event|10
5294866|NCT00460811|18256295|P3|Overall Study|Adverse Event|3
5294867|NCT00460811|18256296|P2|Overall Study|Adverse Event|6
5294868|NCT00460811|18256297|P1|Overall Study|Adverse Event|4
5294869|NCT00460798|18256339|P1|Overall Study|Missing/Incomplete Dosing Information|27
5294870|NCT00460798|18256339|P1|Overall Study|Ongoing at Date of Cut-Off|82
5294871|NCT00460798|18256339|P1|Overall Study|Other|27
5294872|NCT00460798|18256339|P1|Overall Study|Progressive Disease|99
5294873|NCT00460798|18256339|P1|Overall Study|Lost to Follow-up|19
5294874|NCT00460798|18256339|P1|Overall Study|Adverse Event|27
5294875|NCT00460798|18256339|P1|Overall Study|Death|59
5294876|NCT00460746|18256347|P1|Overall Study|Lost to Follow-up|1
5294877|NCT00460746|18256347|P1|Overall Study|Adverse Event|1
5294878|NCT00460655|18256362|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
5294879|NCT00460655|18256363|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
5294880|NCT00460655|18256364|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
5294881|NCT00460655|18256365|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
5294882|NCT00460655|18256362|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
5294883|NCT00460655|18256363|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
5294884|NCT00460655|18256364|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5294885|NCT00460655|18256365|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5294886|NCT00460655|18256362|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
5294887|NCT00460655|18256363|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
5294888|NCT00460655|18256364|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
5294889|NCT00460655|18256365|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
5294890|NCT00460655|18256362|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
5294891|NCT00460655|18256363|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
5294892|NCT00460655|18256364|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
5294893|NCT00460655|18256365|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
5294894|NCT00460655|18256362|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5294895|NCT00460655|18256363|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5294896|NCT00460655|18256364|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5294897|NCT00460655|18256365|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
5294898|NCT00460655|18256362|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
5294899|NCT00460655|18256363|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
5294900|NCT00460655|18256364|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
5294901|NCT00460655|18256365|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
5294902|NCT00460603|18256409|P12|Phase 2|Randomized, but not treated|0
5294903|NCT00460603|18256410|P11|Phase 2|Randomized, but not treated|0
5294904|NCT00460603|18256411|P10|Phase 2|Randomized, but not treated|3
5294905|NCT00460603|18256412|P9|Phase 2|Randomized, but not treated|0
5294906|NCT00460603|18256413|P8|Phase 2|Randomized, but not treated|0
5294907|NCT00460603|18256414|P7|Phase 2|Randomized, but not treated|0
5294908|NCT00460603|18256415|P6|Phase 2|Randomized, but not treated|0
5294909|NCT00460603|18256416|P5|Phase 2|Randomized, but not treated|0
5294910|NCT00460603|18256417|P4|Phase 2|Randomized, but not treated|0
5294911|NCT00460603|18256418|P3|Phase 2|Randomized, but not treated|0
5294912|NCT00460603|18256419|P2|Phase 2|Randomized, but not treated|0
5294913|NCT00460603|18256420|P1|Phase 2|Randomized, but not treated|0
5294914|NCT00460603|18256409|P12|Phase 2|Withdrawal by Subject|5
5294915|NCT00460603|18256410|P11|Phase 2|Withdrawal by Subject|4
5294916|NCT00460603|18256411|P10|Phase 2|Withdrawal by Subject|5
5294917|NCT00460603|18256412|P9|Phase 2|Withdrawal by Subject|0
5294918|NCT00460603|18256413|P8|Phase 2|Withdrawal by Subject|0
5294919|NCT00460603|18256414|P7|Phase 2|Withdrawal by Subject|0
5294920|NCT00460603|18256415|P6|Phase 2|Withdrawal by Subject|0
5294921|NCT00460603|18256416|P5|Phase 2|Withdrawal by Subject|0
5294922|NCT00460603|18256417|P4|Phase 2|Withdrawal by Subject|0
5294923|NCT00460603|18256418|P3|Phase 2|Withdrawal by Subject|0
5294924|NCT00460603|18256419|P2|Phase 2|Withdrawal by Subject|0
5294925|NCT00460603|18256420|P1|Phase 2|Withdrawal by Subject|0
5294926|NCT00460603|18256409|P12|Phase 2|Global Deterioration of Health Status|0
5294927|NCT00460603|18256410|P11|Phase 2|Global Deterioration of Health Status|1
5294928|NCT00460603|18256411|P10|Phase 2|Global Deterioration of Health Status|0
5294929|NCT00460603|18256412|P9|Phase 2|Global Deterioration of Health Status|0
5294930|NCT00460603|18256413|P8|Phase 2|Global Deterioration of Health Status|0
5294931|NCT00460603|18256414|P7|Phase 2|Global Deterioration of Health Status|0
5294932|NCT00460603|18256415|P6|Phase 2|Global Deterioration of Health Status|0
5294933|NCT00460603|18256416|P5|Phase 2|Global Deterioration of Health Status|0
5294934|NCT00460603|18256417|P4|Phase 2|Global Deterioration of Health Status|0
5294935|NCT00460603|18256418|P3|Phase 2|Global Deterioration of Health Status|0
5294936|NCT00460603|18256419|P2|Phase 2|Global Deterioration of Health Status|0
5294937|NCT00460603|18256420|P1|Phase 2|Global Deterioration of Health Status|0
5294938|NCT00460603|18256409|P12|Phase 2|Objective Progression or Relapse|17
5294939|NCT00460603|18256410|P11|Phase 2|Objective Progression or Relapse|10
5294940|NCT00460603|18256411|P10|Phase 2|Objective Progression or Relapse|9
5294941|NCT00460603|18256412|P9|Phase 2|Objective Progression or Relapse|0
5294942|NCT00460603|18256413|P8|Phase 2|Objective Progression or Relapse|0
5294943|NCT00460603|18256414|P7|Phase 2|Objective Progression or Relapse|0
5294944|NCT00460603|18256415|P6|Phase 2|Objective Progression or Relapse|0
5294945|NCT00460603|18256416|P5|Phase 2|Objective Progression or Relapse|0
5294946|NCT00460603|18256417|P4|Phase 2|Objective Progression or Relapse|0
5294947|NCT00460603|18256418|P3|Phase 2|Objective Progression or Relapse|0
5294948|NCT00460603|18256419|P2|Phase 2|Objective Progression or Relapse|0
5294949|NCT00460603|18256420|P1|Phase 2|Objective Progression or Relapse|0
5294950|NCT00460603|18256409|P12|Phase 2|Other|7
5294951|NCT00460603|18256410|P11|Phase 2|Other|16
5294952|NCT00460603|18256411|P10|Phase 2|Other|6
5294953|NCT00460603|18256412|P9|Phase 2|Other|0
5294954|NCT00460603|18256413|P8|Phase 2|Other|0
5294955|NCT00460603|18256414|P7|Phase 2|Other|0
5294956|NCT00460603|18256415|P6|Phase 2|Other|0
5294957|NCT00460603|18256416|P5|Phase 2|Other|0
5294958|NCT00460603|18256417|P4|Phase 2|Other|0
5294959|NCT00460603|18256418|P3|Phase 2|Other|0
5294960|NCT00460603|18256419|P2|Phase 2|Other|0
5294961|NCT00460603|18256420|P1|Phase 2|Other|0
5294962|NCT00460603|18256409|P12|Phase 2|Lost to Follow-up|0
5294963|NCT00460603|18256410|P11|Phase 2|Lost to Follow-up|0
5294964|NCT00460603|18256411|P10|Phase 2|Lost to Follow-up|1
5294965|NCT00460603|18256412|P9|Phase 2|Lost to Follow-up|0
5294966|NCT00460603|18256413|P8|Phase 2|Lost to Follow-up|0
5294967|NCT00460603|18256414|P7|Phase 2|Lost to Follow-up|0
5294968|NCT00460603|18256415|P6|Phase 2|Lost to Follow-up|0
5294969|NCT00460603|18256416|P5|Phase 2|Lost to Follow-up|0
5294970|NCT00460603|18256417|P4|Phase 2|Lost to Follow-up|0
5294971|NCT00460603|18256418|P3|Phase 2|Lost to Follow-up|0
5294972|NCT00460603|18256419|P2|Phase 2|Lost to Follow-up|0
5294973|NCT00460603|18256420|P1|Phase 2|Lost to Follow-up|0
5294974|NCT00460603|18256409|P12|Phase 2|Protocol Violation|0
5294975|NCT00460603|18256410|P11|Phase 2|Protocol Violation|1
5294976|NCT00460603|18256411|P10|Phase 2|Protocol Violation|1
5294977|NCT00460603|18256412|P9|Phase 2|Protocol Violation|0
5294978|NCT00460603|18256413|P8|Phase 2|Protocol Violation|0
5294979|NCT00460603|18256414|P7|Phase 2|Protocol Violation|0
5294980|NCT00460603|18256415|P6|Phase 2|Protocol Violation|0
5294981|NCT00460603|18256416|P5|Phase 2|Protocol Violation|0
5294982|NCT00460603|18256417|P4|Phase 2|Protocol Violation|0
5294983|NCT00460603|18256418|P3|Phase 2|Protocol Violation|0
5294984|NCT00460603|18256419|P2|Phase 2|Protocol Violation|0
5294985|NCT00460603|18256420|P1|Phase 2|Protocol Violation|0
5294986|NCT00460603|18256409|P12|Phase 2|Death|2
5294987|NCT00460603|18256410|P11|Phase 2|Death|2
5294988|NCT00460603|18256411|P10|Phase 2|Death|4
5294989|NCT00460603|18256412|P9|Phase 2|Death|0
5294990|NCT00460603|18256413|P8|Phase 2|Death|0
5294991|NCT00460603|18256414|P7|Phase 2|Death|0
5294992|NCT00460603|18256415|P6|Phase 2|Death|0
5294993|NCT00460603|18256416|P5|Phase 2|Death|0
5294994|NCT00460603|18256417|P4|Phase 2|Death|0
5294995|NCT00460603|18256418|P3|Phase 2|Death|0
5294996|NCT00460603|18256419|P2|Phase 2|Death|0
5294997|NCT00460603|18256420|P1|Phase 2|Death|0
5294998|NCT00460603|18256409|P12|Phase 2|Adverse Event|10
5294999|NCT00460603|18256410|P11|Phase 2|Adverse Event|9
5295000|NCT00460603|18256411|P10|Phase 2|Adverse Event|12
5295001|NCT00460603|18256412|P9|Phase 2|Adverse Event|0
5295002|NCT00460603|18256413|P8|Phase 2|Adverse Event|0
5295003|NCT00460603|18256414|P7|Phase 2|Adverse Event|0
5295004|NCT00460603|18256415|P6|Phase 2|Adverse Event|0
5295005|NCT00460603|18256416|P5|Phase 2|Adverse Event|0
5295006|NCT00460603|18256417|P4|Phase 2|Adverse Event|0
5295007|NCT00460603|18256418|P3|Phase 2|Adverse Event|0
5295008|NCT00460603|18256419|P2|Phase 2|Adverse Event|0
5295009|NCT00460603|18256420|P1|Phase 2|Adverse Event|0
5295010|NCT00460603|18256409|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295011|NCT00460603|18256410|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295012|NCT00460603|18256411|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
5295013|NCT00460603|18256412|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295014|NCT00460603|18256413|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295015|NCT00460603|18256414|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295016|NCT00460603|18256415|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295017|NCT00460603|18256416|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295018|NCT00460603|18256417|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295019|NCT00460603|18256418|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295020|NCT00460603|18256419|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295021|NCT00460603|18256420|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5295022|NCT00460603|18256409|P12|Phase 1|Other|0
5295023|NCT00460603|18256410|P11|Phase 1|Other|0
5295024|NCT00460603|18256411|P10|Phase 1|Other|0
5295025|NCT00460603|18256412|P9|Phase 1|Other|0
5295026|NCT00460603|18256413|P8|Phase 1|Other|1
5295027|NCT00460603|18256414|P7|Phase 1|Other|0
5295028|NCT00460603|18256415|P6|Phase 1|Other|2
5295029|NCT00460603|18256416|P5|Phase 1|Other|1
5295030|NCT00460603|18256417|P4|Phase 1|Other|1
5295031|NCT00460603|18256418|P3|Phase 1|Other|1
5295032|NCT00460603|18256419|P2|Phase 1|Other|3
5295033|NCT00460603|18256420|P1|Phase 1|Other|0
5295034|NCT00460603|18256409|P12|Phase 1|Withdrawal by Subject|0
5295035|NCT00460603|18256410|P11|Phase 1|Withdrawal by Subject|0
5295036|NCT00460603|18256411|P10|Phase 1|Withdrawal by Subject|0
5295037|NCT00460603|18256412|P9|Phase 1|Withdrawal by Subject|2
5295038|NCT00460603|18256413|P8|Phase 1|Withdrawal by Subject|0
5295039|NCT00460603|18256414|P7|Phase 1|Withdrawal by Subject|1
5295040|NCT00460603|18256415|P6|Phase 1|Withdrawal by Subject|0
5295041|NCT00460603|18256416|P5|Phase 1|Withdrawal by Subject|3
5295042|NCT00460603|18256417|P4|Phase 1|Withdrawal by Subject|1
5295043|NCT00460603|18256418|P3|Phase 1|Withdrawal by Subject|1
5295044|NCT00460603|18256419|P2|Phase 1|Withdrawal by Subject|2
5295045|NCT00460603|18256420|P1|Phase 1|Withdrawal by Subject|1
5295046|NCT00460603|18256409|P12|Phase 1|Lack of Efficacy|0
5295047|NCT00460603|18256410|P11|Phase 1|Lack of Efficacy|0
5295048|NCT00460603|18256411|P10|Phase 1|Lack of Efficacy|0
5295049|NCT00460603|18256412|P9|Phase 1|Lack of Efficacy|11
5295050|NCT00460603|18256413|P8|Phase 1|Lack of Efficacy|2
5295051|NCT00460603|18256414|P7|Phase 1|Lack of Efficacy|2
5295052|NCT00460603|18256415|P6|Phase 1|Lack of Efficacy|2
5295053|NCT00460603|18256416|P5|Phase 1|Lack of Efficacy|2
5295054|NCT00460603|18256417|P4|Phase 1|Lack of Efficacy|2
5295055|NCT00460603|18256418|P3|Phase 1|Lack of Efficacy|1
5295056|NCT00460603|18256419|P2|Phase 1|Lack of Efficacy|0
5295057|NCT00460603|18256420|P1|Phase 1|Lack of Efficacy|1
5295058|NCT00460603|18256409|P12|Phase 1|Adverse Event|0
5295059|NCT00460603|18256410|P11|Phase 1|Adverse Event|0
5295060|NCT00460603|18256411|P10|Phase 1|Adverse Event|0
5295061|NCT00460603|18256412|P9|Phase 1|Adverse Event|4
5295062|NCT00460603|18256413|P8|Phase 1|Adverse Event|0
5295063|NCT00460603|18256414|P7|Phase 1|Adverse Event|3
5295064|NCT00460603|18256415|P6|Phase 1|Adverse Event|0
5295065|NCT00460603|18256416|P5|Phase 1|Adverse Event|0
5295066|NCT00460603|18256417|P4|Phase 1|Adverse Event|2
5295067|NCT00460603|18256418|P3|Phase 1|Adverse Event|1
5295068|NCT00460603|18256419|P2|Phase 1|Adverse Event|1
5295069|NCT00460603|18256420|P1|Phase 1|Adverse Event|3
5295070|NCT00460603|18256409|P12|Phase 1|Death|0
5295071|NCT00460603|18256410|P11|Phase 1|Death|0
5295072|NCT00460603|18256411|P10|Phase 1|Death|0
5295073|NCT00460603|18256412|P9|Phase 1|Death|1
5295074|NCT00460603|18256413|P8|Phase 1|Death|0
5295075|NCT00460603|18256414|P7|Phase 1|Death|0
5295076|NCT00460603|18256415|P6|Phase 1|Death|0
5295077|NCT00460603|18256416|P5|Phase 1|Death|0
5295078|NCT00460603|18256417|P4|Phase 1|Death|2
5295079|NCT00460603|18256418|P3|Phase 1|Death|0
5295080|NCT00460603|18256419|P2|Phase 1|Death|0
5295081|NCT00460603|18256420|P1|Phase 1|Death|1
5295082|NCT00460577|18256514|P2|Overall Study|Protocol Violation|6
5295083|NCT00460577|18256515|P1|Overall Study|Protocol Violation|2
5295084|NCT00460564|18256533|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295085|NCT00460564|18256534|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295086|NCT00460564|18256535|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295087|NCT00460564|18256536|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
5295088|NCT00460564|18256537|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295089|NCT00460564|18256538|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295090|NCT00460564|18256539|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295091|NCT00460564|18256540|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5295092|NCT00460564|18256533|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5295093|NCT00460564|18256534|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5295094|NCT00460564|18256535|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
5295095|NCT00460564|18256536|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
5295096|NCT00460564|18256537|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5295097|NCT00460564|18256538|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5295098|NCT00460564|18256539|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5295099|NCT00460564|18256540|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5295100|NCT00460564|18256533|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
5295101|NCT00460564|18256534|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
5295102|NCT00460564|18256535|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
5295103|NCT00460564|18256536|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
5295104|NCT00460564|18256537|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
5295105|NCT00460564|18256538|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
5295106|NCT00460564|18256539|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
5295107|NCT00460564|18256540|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
5295108|NCT00460564|18256533|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295109|NCT00460564|18256534|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295110|NCT00460564|18256535|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295111|NCT00460564|18256536|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295112|NCT00460564|18256537|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295113|NCT00460564|18256538|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295114|NCT00460564|18256539|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5295115|NCT00460564|18256540|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
5295116|NCT00460564|18256533|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
5295117|NCT00460564|18256534|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
5295118|NCT00460564|18256535|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
5295119|NCT00460564|18256536|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
5295120|NCT00460564|18256537|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
5295121|NCT00460564|18256538|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
5295122|NCT00460564|18256539|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
5295123|NCT00460564|18256540|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
5295124|NCT00460434|18256684|P2|Overall Study|Lost to Follow-up|7
5295125|NCT00460434|18256685|P1|Overall Study|Lost to Follow-up|3
5295126|NCT00460408|18256764|P4|Overall Study|Other|0
5295127|NCT00460408|18256765|P3|Overall Study|Other|0
5295128|NCT00460408|18256766|P2|Overall Study|Other|2
5295129|NCT00460408|18256767|P1|Overall Study|Other|12
5295130|NCT00460408|18256764|P4|Overall Study|Insufficient clinical response|0
5295131|NCT00460408|18256765|P3|Overall Study|Insufficient clinical response|5
5295132|NCT00460408|18256766|P2|Overall Study|Insufficient clinical response|1
5295133|NCT00460408|18256767|P1|Overall Study|Insufficient clinical response|5
5295134|NCT00460408|18256764|P4|Overall Study|Withdrawal by Subject|0
5295135|NCT00460408|18256765|P3|Overall Study|Withdrawal by Subject|0
5295136|NCT00460408|18256766|P2|Overall Study|Withdrawal by Subject|0
5295137|NCT00460408|18256767|P1|Overall Study|Withdrawal by Subject|31
5295138|NCT00460408|18256764|P4|Overall Study|Lost to Follow-up|0
5295139|NCT00460408|18256765|P3|Overall Study|Lost to Follow-up|1
5295140|NCT00460408|18256766|P2|Overall Study|Lost to Follow-up|0
5295141|NCT00460408|18256767|P1|Overall Study|Lost to Follow-up|11
5295142|NCT00460408|18256764|P4|Overall Study|Death|0
5295143|NCT00460408|18256765|P3|Overall Study|Death|0
5295144|NCT00460408|18256766|P2|Overall Study|Death|0
5295145|NCT00460408|18256767|P1|Overall Study|Death|7
5295146|NCT00460408|18256764|P4|Overall Study|Adverse Event|0
5295147|NCT00460408|18256765|P3|Overall Study|Adverse Event|0
5295148|NCT00460408|18256766|P2|Overall Study|Adverse Event|0
5295149|NCT00460408|18256767|P1|Overall Study|Adverse Event|1
5295150|NCT00460265|18256804|P2|Overall Study|Ongoing|47
5295151|NCT00460265|18256805|P1|Overall Study|Ongoing|60
5295152|NCT00460265|18256804|P2|Overall Study|Withdrawal by Subject|25
5295153|NCT00460265|18256805|P1|Overall Study|Withdrawal by Subject|10
5295154|NCT00460265|18256804|P2|Overall Study|Physician Decision|2
5295155|NCT00460265|18256805|P1|Overall Study|Physician Decision|1
5295156|NCT00460265|18256804|P2|Overall Study|Lost to Follow-up|15
5295157|NCT00460265|18256805|P1|Overall Study|Lost to Follow-up|14
5295158|NCT00460239|18256821|P9|Overall Study|Withdrawal by Subject|0
5295159|NCT00460239|18256822|P8|Overall Study|Withdrawal by Subject|0
5295160|NCT00460239|18256823|P7|Overall Study|Withdrawal by Subject|0
5295161|NCT00460239|18256824|P6|Overall Study|Withdrawal by Subject|1
5295162|NCT00460239|18256825|P5|Overall Study|Withdrawal by Subject|0
5295163|NCT00460239|18256826|P4|Overall Study|Withdrawal by Subject|0
5295164|NCT00460239|18256827|P3|Overall Study|Withdrawal by Subject|0
5295165|NCT00460239|18256828|P2|Overall Study|Withdrawal by Subject|0
5295166|NCT00460239|18256829|P1|Overall Study|Withdrawal by Subject|0
5295167|NCT00460239|18256821|P9|Overall Study|Physician Decision|0
5295168|NCT00460239|18256822|P8|Overall Study|Physician Decision|0
5295169|NCT00460239|18256823|P7|Overall Study|Physician Decision|0
5295170|NCT00460239|18256824|P6|Overall Study|Physician Decision|2
5295171|NCT00460239|18256825|P5|Overall Study|Physician Decision|0
5295172|NCT00460239|18256826|P4|Overall Study|Physician Decision|0
5295173|NCT00460239|18256827|P3|Overall Study|Physician Decision|0
5295174|NCT00460239|18256828|P2|Overall Study|Physician Decision|1
5295175|NCT00460239|18256829|P1|Overall Study|Physician Decision|0
5295176|NCT00460109|18256898|P1|Overall Study|Death|1
5295177|NCT00460031|18256906|P1|Overall Study|Death|1
5295178|NCT00460031|18256906|P1|Overall Study|Withdrawal by Subject|5
5295179|NCT00460031|18256906|P1|Overall Study|Adverse Event|5
5295180|NCT00459979|18256914|P1|Overall Study|Protocol Violation|1
5295181|NCT00459979|18256914|P1|Overall Study|Withdrawal by Subject|1
5295182|NCT00459953|18256926|P2|Overall Study|not analyzed-household member in study|1
5295183|NCT00459953|18256927|P1|Overall Study|not analyzed-household member in study|1
5295184|NCT00459875|18256933|P1|Overall Study|Adverse Event|2
5295185|NCT00459875|18256933|P1|Overall Study|Ineligible participant|1
5295186|NCT00459706|18256969|P2|Overall Study|Other|1
5295187|NCT00459706|18256970|P1|Overall Study|Other|0
5295188|NCT00459706|18256969|P2|Overall Study|Failed to Return|0
5295189|NCT00459706|18256970|P1|Overall Study|Failed to Return|1
5295190|NCT00459706|18256969|P2|Overall Study|Protocol Violation|1
5295191|NCT00459706|18256970|P1|Overall Study|Protocol Violation|2
5295192|NCT00459706|18256969|P2|Overall Study|Discontinuation of Study by Sponsor|0
5295193|NCT00459706|18256970|P1|Overall Study|Discontinuation of Study by Sponsor|1
5295194|NCT00459706|18256969|P2|Overall Study|Physician Decision|0
5295195|NCT00459706|18256970|P1|Overall Study|Physician Decision|2
5295196|NCT00459706|18256969|P2|Overall Study|Withdrawal by Subject|6
5295197|NCT00459706|18256970|P1|Overall Study|Withdrawal by Subject|1
5295198|NCT00459706|18256969|P2|Overall Study|Adverse Event|13
5295199|NCT00459706|18256970|P1|Overall Study|Adverse Event|19
5295200|NCT00459667|18257113|P3|Overall Study|No treatment administered|1
5295201|NCT00459667|18257114|P2|Overall Study|No treatment administered|3
5295202|NCT00459667|18257115|P1|Overall Study|No treatment administered|6
5295203|NCT00459667|18257113|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
5295204|NCT00459667|18257114|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
5295205|NCT00459667|18257115|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
5295206|NCT00459667|18257113|P3|Overall Study|Other disease modifying treatment|1
5295207|NCT00459667|18257114|P2|Overall Study|Other disease modifying treatment|2
5295208|NCT00459667|18257115|P1|Overall Study|Other disease modifying treatment|1
5295209|NCT00459667|18257113|P3|Overall Study|Withdrawal by Subject|5
5295210|NCT00459667|18257114|P2|Overall Study|Withdrawal by Subject|5
5295211|NCT00459667|18257115|P1|Overall Study|Withdrawal by Subject|3
5295212|NCT00459667|18257113|P3|Overall Study|Protocol Violation|0
5295213|NCT00459667|18257114|P2|Overall Study|Protocol Violation|0
5295214|NCT00459667|18257115|P1|Overall Study|Protocol Violation|1
5295215|NCT00459667|18257113|P3|Overall Study|Pregnancy|1
5295216|NCT00459667|18257114|P2|Overall Study|Pregnancy|1
5295217|NCT00459667|18257115|P1|Overall Study|Pregnancy|1
5295218|NCT00459667|18257113|P3|Overall Study|Lost to Follow-up|3
5295219|NCT00459667|18257114|P2|Overall Study|Lost to Follow-up|9
5295220|NCT00459667|18257115|P1|Overall Study|Lost to Follow-up|5
5295221|NCT00459667|18257113|P3|Overall Study|Adverse Event|8
5295222|NCT00459667|18257114|P2|Overall Study|Adverse Event|12
5295223|NCT00459667|18257115|P1|Overall Study|Adverse Event|9
5295224|NCT00459537|18257137|P2|Overall Study|Missing|0
5295225|NCT00459537|18257138|P1|Overall Study|Missing|1
5295226|NCT00459537|18257137|P2|Overall Study|Protocol Violation|3
5295227|NCT00459537|18257138|P1|Overall Study|Protocol Violation|4
5295228|NCT00459537|18257137|P2|Overall Study|Administrative problems|0
5295229|NCT00459537|18257138|P1|Overall Study|Administrative problems|3
5295230|NCT00459537|18257137|P2|Overall Study|Lost to Follow-up|30
5295231|NCT00459537|18257138|P1|Overall Study|Lost to Follow-up|27
5295232|NCT00459537|18257137|P2|Overall Study|Withdrawal by Subject|26
5295233|NCT00459537|18257138|P1|Overall Study|Withdrawal by Subject|20
5295234|NCT00459537|18257137|P2|Overall Study|Lack of Efficacy|11
5295235|NCT00459537|18257138|P1|Overall Study|Lack of Efficacy|10
5295236|NCT00459537|18257137|P2|Overall Study|Adverse Event|6
5295237|NCT00459537|18257138|P1|Overall Study|Adverse Event|1
5295238|NCT00459355|18257173|P2|Overall Study|Subject no longer met inc criteria|18
5295239|NCT00459355|18257174|P1|Overall Study|Subject no longer met inc criteria|20
5295240|NCT00459342|18257186|P1|Overall Study|Not eligible|1
5295241|NCT00459316|18257199|P3|Step 3|Withdrawal by Subject|1
5295242|NCT00459316|18257200|P2|Step 3|Withdrawal by Subject|0
5295243|NCT00459316|18257201|P1|Step 3|Withdrawal by Subject|3
5295244|NCT00459316|18257199|P3|Steps 1 & 2|Lost to Follow-up|2
5295245|NCT00459316|18257200|P2|Steps 1 & 2|Lost to Follow-up|0
5295246|NCT00459316|18257201|P1|Steps 1 & 2|Lost to Follow-up|5
5295247|NCT00459316|18257199|P3|Steps 1 & 2|Not willing to adhere to regulations|0
5295248|NCT00459316|18257200|P2|Steps 1 & 2|Not willing to adhere to regulations|0
5295249|NCT00459316|18257201|P1|Steps 1 & 2|Not willing to adhere to regulations|1
5295250|NCT00459316|18257199|P3|Steps 1 & 2|Withdrawal by Subject|0
5295251|NCT00459316|18257200|P2|Steps 1 & 2|Withdrawal by Subject|1
5295252|NCT00459316|18257201|P1|Steps 1 & 2|Withdrawal by Subject|6
5295253|NCT00459316|18257199|P3|Steps 1 & 2|Not able to get to clinic|0
5295254|NCT00459316|18257200|P2|Steps 1 & 2|Not able to get to clinic|4
5295255|NCT00459316|18257201|P1|Steps 1 & 2|Not able to get to clinic|7
5295256|NCT00459316|18257199|P3|Steps 1 & 2|Death|0
5295257|NCT00459316|18257200|P2|Steps 1 & 2|Death|1
5295258|NCT00459316|18257201|P1|Steps 1 & 2|Death|1
5295259|NCT00459316|18257199|P3|Steps 1 & 2|Other eligibility failure|0
5295260|NCT00459316|18257200|P2|Steps 1 & 2|Other eligibility failure|1
5295261|NCT00459316|18257201|P1|Steps 1 & 2|Other eligibility failure|1
5295262|NCT00459290|18257266|P1|Overall Study|Ineligible|2
5295263|NCT00459290|18257266|P1|Overall Study|Adverse Event|3
5295264|NCT00459186|18257281|P1|PET Imaging and Assessment|Adverse Event|3
5295265|NCT00459186|18257281|P1|Single Agent RAD001|Withdrawal by Subject|1
5295266|NCT00459134|18257288|P2|Overall Study|Multiple Reasons|3
5295267|NCT00459134|18257289|P1|Overall Study|Multiple Reasons|2
5295268|NCT00459134|18257288|P2|Overall Study|Progression|0
5295269|NCT00459134|18257289|P1|Overall Study|Progression|1
5295270|NCT00459134|18257288|P2|Overall Study|Toxicity|5
5295271|NCT00459134|18257289|P1|Overall Study|Toxicity|4
5295272|NCT00459134|18257288|P2|Overall Study|Surgery|2
5295273|NCT00459134|18257289|P1|Overall Study|Surgery|1
5295274|NCT00459134|18257288|P2|Overall Study|Lost to Follow-up|7
5295275|NCT00459134|18257289|P1|Overall Study|Lost to Follow-up|6
5295276|NCT00459134|18257288|P2|Overall Study|Withdrawal by Subject|7
5295277|NCT00459134|18257289|P1|Overall Study|Withdrawal by Subject|8
5295278|NCT00459134|18257288|P2|Overall Study|Physician Decision|1
5295279|NCT00459134|18257289|P1|Overall Study|Physician Decision|1
5295280|NCT00459108|18257305|P1|Overall Study|Progression|1
5295281|NCT00459108|18257305|P1|Overall Study|Death|2
5295282|NCT00459108|18257305|P1|Overall Study|Adverse Event|3
5295283|NCT00459108|18257305|P1|Overall Study|Withdrawal by Subject|5
5295284|NCT00459056|18257315|P2|First Intervention (First Three Months)|Lost to Follow-up|1
5295285|NCT00459056|18257316|P1|First Intervention (First Three Months)|Lost to Follow-up|1
5295286|NCT00459043|18257324|P2|Overall Study|Withdrawal by Subject|0
5295287|NCT00459043|18257325|P1|Overall Study|Withdrawal by Subject|1
5295288|NCT00458705|18257352|P1|Overall Study|Not Treated|1
5295289|NCT00458705|18257352|P1|Overall Study|Adverse Event|4
5295290|NCT00458536|18257356|P1|Overall Study|Progressive disease during treatment|2
5295291|NCT00458536|18257356|P1|Overall Study|Withdrawal by Subject|1
5295292|NCT00458536|18257356|P1|Overall Study|Ineligible due to toxicity|1
5295293|NCT00458536|18257356|P1|Overall Study|Patient did not have surgery|1
5295294|NCT00458536|18257356|P1|Overall Study|Did not have renal cell carcinoma|2
5295295|NCT00458536|18257356|P1|Overall Study|No measurable disease after surgery|2
5295296|NCT00458536|18257356|P1|Overall Study|Unable to make vaccine|3
5295297|NCT00458536|18257356|P1|Overall Study|Disease progression prior to treatment|7
5295298|NCT00458484|18257367|P7|Overall Study|Not eligible b/c prior radiation history|0
5295299|NCT00458484|18257368|P6|Overall Study|Not eligible b/c prior radiation history|1
5295300|NCT00458484|18257369|P5|Overall Study|Not eligible b/c prior radiation history|0
5295301|NCT00458484|18257370|P4|Overall Study|Not eligible b/c prior radiation history|0
5295302|NCT00458484|18257371|P3|Overall Study|Not eligible b/c prior radiation history|0
5295303|NCT00458484|18257372|P2|Overall Study|Not eligible b/c prior radiation history|0
5295304|NCT00458484|18257373|P1|Overall Study|Not eligible b/c prior radiation history|0
5295305|NCT00458393|18257439|P2|Overall Study|Sites marked other on the form.|20
5295306|NCT00458393|18257440|P1|Overall Study|Sites marked other on the form.|19
5295307|NCT00458393|18257439|P2|Overall Study|Lost to Follow-up|92
5295308|NCT00458393|18257440|P1|Overall Study|Lost to Follow-up|115
5295309|NCT00458393|18257439|P2|Overall Study|Relocated|81
5295310|NCT00458393|18257440|P1|Overall Study|Relocated|77
5295311|NCT00458393|18257439|P2|Overall Study|Physician Decision|22
5295312|NCT00458393|18257440|P1|Overall Study|Physician Decision|31
5295313|NCT00458393|18257439|P2|Overall Study|Withdrawal by Subject|80
5295314|NCT00458393|18257440|P1|Overall Study|Withdrawal by Subject|67
5295315|NCT00458341|18257488|P2|Cycle 1|Adverse Event|0
5295316|NCT00458341|18257489|P1|Cycle 1|Adverse Event|1
5295317|NCT00458302|18257529|P2|Overall Study|Other|2
5295318|NCT00458302|18257530|P1|Overall Study|Other|4
5295319|NCT00458302|18257529|P2|Overall Study|Lost to Follow-up|0
5295320|NCT00458302|18257530|P1|Overall Study|Lost to Follow-up|2
5295321|NCT00458302|18257529|P2|Overall Study|Study Termination By Sponsor|0
5295322|NCT00458302|18257530|P1|Overall Study|Study Termination By Sponsor|1
5295323|NCT00458302|18257529|P2|Overall Study|Inc/Exc Criteria Not Met|1
5295324|NCT00458302|18257530|P1|Overall Study|Inc/Exc Criteria Not Met|1
5295325|NCT00458302|18257529|P2|Overall Study|Withdrawal by Subject|4
5295326|NCT00458302|18257530|P1|Overall Study|Withdrawal by Subject|6
5295327|NCT00458302|18257529|P2|Overall Study|Protocol Violation|2
5295328|NCT00458302|18257530|P1|Overall Study|Protocol Violation|0
5295329|NCT00458302|18257529|P2|Overall Study|Pregnancy|1
5295330|NCT00458302|18257530|P1|Overall Study|Pregnancy|2
5295331|NCT00458302|18257529|P2|Overall Study|Adverse Event|14
5295332|NCT00458302|18257530|P1|Overall Study|Adverse Event|4
5295333|NCT00458211|18257575|P1|Overall Study|Protocol Violation|2
5295334|NCT00458211|18257575|P1|Overall Study|Withdrawal by Subject|2
5295335|NCT00458211|18257575|P1|Overall Study|Lack of Efficacy|12
5295336|NCT00457821|18257625|P8|Part 2|Withdrawal by Subject|1
5295337|NCT00457821|18257626|P7|Part 2|Withdrawal by Subject|0
5295338|NCT00457821|18257627|P6|Part 2|Withdrawal by Subject|0
5295339|NCT00457821|18257628|P5|Part 2|Withdrawal by Subject|0
5295340|NCT00457821|18257629|P4|Part 2|Withdrawal by Subject|0
5295341|NCT00457821|18257630|P3|Part 2|Withdrawal by Subject|0
5295342|NCT00457821|18257631|P2|Part 2|Withdrawal by Subject|0
5295343|NCT00457821|18257632|P1|Part 2|Withdrawal by Subject|0
5295344|NCT00457743|18257671|P3|Overall Study|Lack of Efficacy|3
5295345|NCT00457743|18257672|P2|Overall Study|Lack of Efficacy|23
5295346|NCT00457743|18257673|P1|Overall Study|Lack of Efficacy|3
5295347|NCT00457743|18257671|P3|Overall Study|Adverse Event|0
5295348|NCT00457743|18257672|P2|Overall Study|Adverse Event|4
5295349|NCT00457743|18257673|P1|Overall Study|Adverse Event|0
5295350|NCT00457691|18257730|P2|Overall Study|Disease progression, study terminated|196
5295351|NCT00457691|18257731|P1|Overall Study|Disease progression, study terminated|180
5295352|NCT00457691|18257730|P2|Overall Study|Subject refused (reason other than AE)|19
5295353|NCT00457691|18257731|P1|Overall Study|Subject refused (reason other than AE)|14
5295354|NCT00457691|18257730|P2|Overall Study|Study terminated by Sponsor|1
5295355|NCT00457691|18257731|P1|Overall Study|Study terminated by Sponsor|1
5295356|NCT00457691|18257730|P2|Overall Study|Lost to Follow-up|14
5295357|NCT00457691|18257731|P1|Overall Study|Lost to Follow-up|23
5295358|NCT00457691|18257730|P2|Overall Study|Protocol Violation|3
5295359|NCT00457691|18257731|P1|Overall Study|Protocol Violation|1
5295360|NCT00457691|18257730|P2|Overall Study|Death|148
5295361|NCT00457691|18257731|P1|Overall Study|Death|163
5295362|NCT00457691|18257730|P2|Overall Study|Adverse Event|1
5295363|NCT00457691|18257731|P1|Overall Study|Adverse Event|4
5295364|NCT00457665|18257753|P2|24 Months|Abnormal liver function tests|5
5295365|NCT00457665|18257754|P1|24 Months|Abnormal liver function tests|1
5295366|NCT00457665|18257753|P2|24 Months|Lipodystrophy|1
5295367|NCT00457665|18257754|P1|24 Months|Lipodystrophy|1
5295368|NCT00457665|18257753|P2|24 Months|Withdrawal by Subject|2
5295369|NCT00457665|18257754|P1|24 Months|Withdrawal by Subject|3
5295370|NCT00457665|18257753|P2|12 Months|Abnormal Liver function tests|5
5295371|NCT00457665|18257754|P1|12 Months|Abnormal Liver function tests|0
5295372|NCT00457665|18257753|P2|12 Months|Withdrawal by Subject|2
5295373|NCT00457665|18257754|P1|12 Months|Withdrawal by Subject|0
5295374|NCT00457665|18257753|P2|12 Months|Lipodystrophy|0
5295375|NCT00457665|18257754|P1|12 Months|Lipodystrophy|2
5295376|NCT00457665|18257753|P2|12 Months|High HIV viral load|1
5295377|NCT00457665|18257754|P1|12 Months|High HIV viral load|5
5295378|NCT00457665|18257753|P2|12 Months|Drug allergy|1
5295379|NCT00457665|18257754|P1|12 Months|Drug allergy|1
5295380|NCT00457639|18257760|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
5295381|NCT00457639|18257761|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
5295382|NCT00457639|18257760|P2|Intervention 1 (6 Months)|unrelated illness|2
5295383|NCT00457639|18257761|P1|Intervention 1 (6 Months)|unrelated illness|0
5295384|NCT00457639|18257760|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
5295385|NCT00457639|18257761|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
5295386|NCT00457418|18257769|P1|Post PK Maintenance|Lost to Follow-up|1
5295387|NCT00457418|18257769|P1|Post PK Maintenance|Withdrawal by Subject|11
5295388|NCT00457418|18257769|P1|Post PK Maintenance|Progression of Disease|6
5295389|NCT00457418|18257769|P1|Post PK Maintenance|Adverse Event|10
5295390|NCT00457418|18257769|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
5295391|NCT00457418|18257769|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
5295392|NCT00457418|18257769|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
5295393|NCT00457392|18257781|P2|Overall Study|Randomized, Not Treated|3
5295394|NCT00457392|18257782|P1|Overall Study|Randomized, Not Treated|7
5295395|NCT00457392|18257781|P2|Overall Study|Study Terminated by Sponsor|4
5295396|NCT00457392|18257782|P1|Overall Study|Study Terminated by Sponsor|1
5295397|NCT00457392|18257781|P2|Overall Study|Other|4
5295398|NCT00457392|18257782|P1|Overall Study|Other|7
5295399|NCT00457392|18257781|P2|Overall Study|Protocol Violation|3
5295400|NCT00457392|18257782|P1|Overall Study|Protocol Violation|4
5295401|NCT00457392|18257781|P2|Overall Study|Lost to Follow-up|7
5295402|NCT00457392|18257782|P1|Overall Study|Lost to Follow-up|6
5295403|NCT00457392|18257781|P2|Overall Study|Withdrawal by Subject|8
5295404|NCT00457392|18257782|P1|Overall Study|Withdrawal by Subject|14
5295405|NCT00457392|18257781|P2|Overall Study|Global Deterioration of Health Status|8
5295406|NCT00457392|18257782|P1|Overall Study|Global Deterioration of Health Status|22
5295407|NCT00457392|18257781|P2|Overall Study|Adverse Event|41
5295408|NCT00457392|18257782|P1|Overall Study|Adverse Event|84
5295409|NCT00457392|18257781|P2|Overall Study|Death|106
5295410|NCT00457392|18257782|P1|Overall Study|Death|106
5295411|NCT00457392|18257781|P2|Overall Study|Objective Progression or Relapse|296
5295412|NCT00457392|18257782|P1|Overall Study|Objective Progression or Relapse|229
5295413|NCT00457301|18257809|P2|Overall Study|Death|7
5295414|NCT00457301|18257810|P1|Overall Study|Death|5
5295415|NCT00457301|18257809|P2|Overall Study|Censored out of the study|14
5295416|NCT00457301|18257810|P1|Overall Study|Censored out of the study|15
5295417|NCT00457301|18257809|P2|Overall Study|Withdrawal by Subject|3
5295418|NCT00457301|18257810|P1|Overall Study|Withdrawal by Subject|3
5295419|NCT00457249|18257824|P2|Overall Study|Serious Adverse Events|0
5295420|NCT00457249|18257825|P1|Overall Study|Serious Adverse Events|2
5295421|NCT00457249|18257824|P2|Overall Study|Withdrawal by Subject|1
5295422|NCT00457249|18257825|P1|Overall Study|Withdrawal by Subject|3
5295423|NCT00457249|18257824|P2|Overall Study|Protocol Violation|1
5295424|NCT00457249|18257825|P1|Overall Study|Protocol Violation|4
5295425|NCT00457249|18257824|P2|Overall Study|Lost to Follow-up|0
5295426|NCT00457249|18257825|P1|Overall Study|Lost to Follow-up|3
5295427|NCT00457015|18257864|P2|Overall Study|Left study site against medical advice|1
5295428|NCT00457015|18257865|P1|Overall Study|Left study site against medical advice|0
5295429|NCT00457002|18257881|P2|Overall Study|treated for 1 day; missing status/reason|0
5295430|NCT00457002|18257882|P1|Overall Study|treated for 1 day; missing status/reason|1
5295431|NCT00457002|18257881|P2|Overall Study|non-specified|38
5295432|NCT00457002|18257882|P1|Overall Study|non-specified|29
5295433|NCT00457002|18257881|P2|Overall Study|Administrative reason by Sponsor|0
5295434|NCT00457002|18257882|P1|Overall Study|Administrative reason by Sponsor|1
5295435|NCT00457002|18257881|P2|Overall Study|No longer met criteria|37
5295436|NCT00457002|18257882|P1|Overall Study|No longer met criteria|41
5295437|NCT00457002|18257881|P2|Overall Study|Poor/Non-compliance|33
5295438|NCT00457002|18257882|P1|Overall Study|Poor/Non-compliance|46
5295439|NCT00457002|18257881|P2|Overall Study|Lost to Follow-up|71
5295440|NCT00457002|18257882|P1|Overall Study|Lost to Follow-up|72
5295441|NCT00457002|18257881|P2|Overall Study|Withdrawal by Subject|271
5295442|NCT00457002|18257882|P1|Overall Study|Withdrawal by Subject|299
5295443|NCT00457002|18257881|P2|Overall Study|Adverse Event|260
5295444|NCT00457002|18257882|P1|Overall Study|Adverse Event|284
5295445|NCT00457002|18257881|P2|Overall Study|Death|47
5295446|NCT00457002|18257882|P1|Overall Study|Death|40
5295447|NCT00456846|18257987|P2|Overall Study|Other|2
5295448|NCT00456846|18257988|P1|Overall Study|Other|0
5295449|NCT00456846|18257987|P2|Overall Study|Participant Discretion|5
5295450|NCT00456846|18257988|P1|Overall Study|Participant Discretion|1
5295451|NCT00456846|18257987|P2|Overall Study|Protocol Deviation|0
5295452|NCT00456846|18257988|P1|Overall Study|Protocol Deviation|2
5295453|NCT00456846|18257987|P2|Overall Study|Physician Decision|6
5295454|NCT00456846|18257988|P1|Overall Study|Physician Decision|11
5295455|NCT00456846|18257987|P2|Overall Study|Adverse Event|15
5295456|NCT00456846|18257988|P1|Overall Study|Adverse Event|2
5295457|NCT00456755|18258029|P2|Overall Study|Lost to Follow-up|1
5295458|NCT00456755|18258030|P1|Overall Study|Lost to Follow-up|2
5295459|NCT00456612|18258044|P1|Overall Study|Withdrawal by Subject|3
5295460|NCT00456599|18258049|P1|Overall Study|Withdrawal by Subject|2
5295461|NCT00456599|18258049|P1|Overall Study|Non-compliance|1
5295462|NCT00456521|18258072|P2|Overall Study|Drug non-compliance, moved, other|11
5295463|NCT00456521|18258073|P1|Overall Study|Drug non-compliance, moved, other|26
5295464|NCT00456521|18258072|P2|Overall Study|Pregnancy|1
5295465|NCT00456521|18258073|P1|Overall Study|Pregnancy|1
5295466|NCT00456521|18258072|P2|Overall Study|Protocol Violation|0
5295467|NCT00456521|18258073|P1|Overall Study|Protocol Violation|4
5295468|NCT00456521|18258072|P2|Overall Study|Lack of Efficacy|6
5295469|NCT00456521|18258073|P1|Overall Study|Lack of Efficacy|3
5295470|NCT00456521|18258072|P2|Overall Study|Lost to Follow-up|17
5295471|NCT00456521|18258073|P1|Overall Study|Lost to Follow-up|22
5295472|NCT00456521|18258072|P2|Overall Study|Withdrawal by Subject|24
5295473|NCT00456521|18258073|P1|Overall Study|Withdrawal by Subject|43
5295474|NCT00456521|18258072|P2|Overall Study|Adverse Event|25
5295475|NCT00456521|18258073|P1|Overall Study|Adverse Event|150
5295476|NCT00456495|18258119|P1|Overall Study|Physician Decision|2
5295477|NCT00456365|18258126|P2|Overall Study|oncologic diagnosis|1
5295478|NCT00456365|18258127|P1|Overall Study|oncologic diagnosis|1
5295479|NCT00456365|18258126|P2|Overall Study|Pregnancy|1
5295480|NCT00456365|18258127|P1|Overall Study|Pregnancy|1
5295481|NCT00456365|18258126|P2|Overall Study|Withdrawal by Subject|7
5295482|NCT00456365|18258127|P1|Overall Study|Withdrawal by Subject|4
5295483|NCT00456365|18258126|P2|Overall Study|Lost to Follow-up|3
5295484|NCT00456365|18258127|P1|Overall Study|Lost to Follow-up|1
5295485|NCT00456300|18258139|P2|Overall Study|Adverse Event|0
5295486|NCT00456300|18258140|P1|Overall Study|Adverse Event|1
5295487|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Other|0
5295488|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Other|0
5295489|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Other|1
5295490|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Other|0
5295491|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Other|1
5295492|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
5295493|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
5295494|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
5295495|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
5295496|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
5295497|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
5295498|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
5295499|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
5295500|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
5295501|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
5295502|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
5295503|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
5295504|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
5295505|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
5295506|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
5295507|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
5295508|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
5295509|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
5295510|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
5295511|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
5295512|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
5295513|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
5295514|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
5295515|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
5295516|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
5295517|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5295518|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5295519|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5295520|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5295521|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
5295522|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
5295523|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
5295524|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
5295525|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
5295526|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
5295527|NCT00456092|18258164|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
5295528|NCT00456092|18258165|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
5295529|NCT00456092|18258166|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
5295530|NCT00456092|18258167|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
5295531|NCT00456092|18258168|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
5295532|NCT00456092|18258164|P5|Extension Phase|Other|1
5295533|NCT00456092|18258165|P4|Extension Phase|Other|1
5295534|NCT00456092|18258166|P3|Extension Phase|Other|0
5295535|NCT00456092|18258167|P2|Extension Phase|Other|0
5295536|NCT00456092|18258168|P1|Extension Phase|Other|2
5295537|NCT00456092|18258164|P5|Extension Phase|Lost to Follow-up|1
5295538|NCT00456092|18258165|P4|Extension Phase|Lost to Follow-up|0
5295539|NCT00456092|18258166|P3|Extension Phase|Lost to Follow-up|0
5295540|NCT00456092|18258167|P2|Extension Phase|Lost to Follow-up|1
5295541|NCT00456092|18258168|P1|Extension Phase|Lost to Follow-up|1
5295542|NCT00456092|18258164|P5|Extension Phase|Withdrew Consent|0
5295543|NCT00456092|18258165|P4|Extension Phase|Withdrew Consent|0
5295544|NCT00456092|18258166|P3|Extension Phase|Withdrew Consent|0
5295545|NCT00456092|18258167|P2|Extension Phase|Withdrew Consent|0
5295546|NCT00456092|18258168|P1|Extension Phase|Withdrew Consent|2
5295547|NCT00456092|18258164|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
5295548|NCT00456092|18258165|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
5295549|NCT00456092|18258166|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
5295550|NCT00456092|18258167|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
5295551|NCT00456092|18258168|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
5295552|NCT00456092|18258164|P5|Extension Phase|Flare of Psoriatic Arthritis|1
5295553|NCT00456092|18258165|P4|Extension Phase|Flare of Psoriatic Arthritis|0
5295554|NCT00456092|18258166|P3|Extension Phase|Flare of Psoriatic Arthritis|0
5295555|NCT00456092|18258167|P2|Extension Phase|Flare of Psoriatic Arthritis|0
5295556|NCT00456092|18258168|P1|Extension Phase|Flare of Psoriatic Arthritis|1
5295557|NCT00456092|18258164|P5|Extension Phase|Grade 2 or Greater AE|2
5295558|NCT00456092|18258165|P4|Extension Phase|Grade 2 or Greater AE|0
5295559|NCT00456092|18258166|P3|Extension Phase|Grade 2 or Greater AE|0
5295560|NCT00456092|18258167|P2|Extension Phase|Grade 2 or Greater AE|2
5295561|NCT00456092|18258168|P1|Extension Phase|Grade 2 or Greater AE|2
5295562|NCT00455923|18258350|P2|Overall Study|Other|1
5295563|NCT00455923|18258351|P1|Overall Study|Other|3
5295564|NCT00455923|18258350|P2|Overall Study|Pregnancy|2
5295565|NCT00455923|18258351|P1|Overall Study|Pregnancy|0
5295566|NCT00455858|18258367|P1|Overall Study|Withdrawal|1
5295567|NCT00455858|18258367|P1|Overall Study|Well controlled FPG without insulin|1
5295568|NCT00455858|18258367|P1|Overall Study|Lack of Efficacy|1
5295569|NCT00455858|18258367|P1|Overall Study|Protocol Violation|1
5295570|NCT00455858|18258367|P1|Overall Study|Lost to Follow-up|2
5295571|NCT00455741|18258377|P2|Overall Study|Physician Decision|1
5295572|NCT00455741|18258378|P1|Overall Study|Physician Decision|0
5295573|NCT00455533|18258474|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
5295574|NCT00455533|18258475|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
5295575|NCT00455533|18258476|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
5295576|NCT00455533|18258474|P3|Period Two: Randomized Period|Study Drug Toxicity|0
5295577|NCT00455533|18258475|P2|Period Two: Randomized Period|Study Drug Toxicity|2
5295578|NCT00455533|18258476|P1|Period Two: Randomized Period|Study Drug Toxicity|0
5295579|NCT00455533|18258474|P3|Period Two: Randomized Period|Other - need reasons|0
5295580|NCT00455533|18258475|P2|Period Two: Randomized Period|Other - need reasons|1
5295581|NCT00455533|18258476|P1|Period Two: Randomized Period|Other - need reasons|0
5295582|NCT00455533|18258474|P3|Period Two: Randomized Period|Lost to Follow-up|1
5295583|NCT00455533|18258475|P2|Period Two: Randomized Period|Lost to Follow-up|0
5295584|NCT00455533|18258476|P1|Period Two: Randomized Period|Lost to Follow-up|0
5295585|NCT00455533|18258474|P3|Period Two: Randomized Period|Disease Progression|1
5295586|NCT00455533|18258475|P2|Period Two: Randomized Period|Disease Progression|1
5295587|NCT00455533|18258476|P1|Period Two: Randomized Period|Disease Progression|0
5295588|NCT00455533|18258474|P3|Period Two: Randomized Period|Death|3
5295589|NCT00455533|18258475|P2|Period Two: Randomized Period|Death|0
5295590|NCT00455533|18258476|P1|Period Two: Randomized Period|Death|0
5295591|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
5295592|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
5295593|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
5295594|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
5295595|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
5295596|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
5295597|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
5295598|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
5295599|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
5295600|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
5295601|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
5295602|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
5295603|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
5295604|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
5295605|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
5295606|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Not Reported|0
5295607|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Not Reported|0
5295608|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Not Reported|1
5295609|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
5295610|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
5295611|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
5295612|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Disease Progression|0
5295613|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Disease Progression|0
5295614|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Disease Progression|5
5295615|NCT00455533|18258474|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
5295616|NCT00455533|18258475|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
5295617|NCT00455533|18258476|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
5295618|NCT00455520|18258525|P2|Double Blind Tapentadol ER vs Placebo|All other|6
5295619|NCT00455520|18258526|P1|Double Blind Tapentadol ER vs Placebo|All other|4
5295620|NCT00455520|18258525|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
5295621|NCT00455520|18258526|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
5295622|NCT00455520|18258525|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
5295623|NCT00455520|18258526|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
5295624|NCT00455520|18258525|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
5295625|NCT00455520|18258526|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
5295626|NCT00455520|18258525|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
5295627|NCT00455520|18258526|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
5295628|NCT00455520|18258525|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
5295629|NCT00455520|18258526|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
5295630|NCT00455520|18258525|P2|Open Label Tapentadol Extended Release|All other|0
5295631|NCT00455520|18258526|P1|Open Label Tapentadol Extended Release|All other|33
5295632|NCT00455520|18258525|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
5295633|NCT00455520|18258526|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
5295634|NCT00455520|18258525|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
5295635|NCT00455520|18258526|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
5295636|NCT00455520|18258525|P2|Open Label Tapentadol Extended Release|Adverse Event|0
5295637|NCT00455520|18258526|P1|Open Label Tapentadol Extended Release|Adverse Event|100
5295638|NCT00455520|18258525|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
5295639|NCT00455520|18258526|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
5295640|NCT00455520|18258525|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
5295641|NCT00455520|18258526|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
5295642|NCT00455455|18258542|P2|Washout|Withdrawal by Subject|0
5295643|NCT00455455|18258543|P1|Washout|Withdrawal by Subject|1
5295644|NCT00455455|18258542|P2|Washout|Withdrawal by Subject|1
5295645|NCT00455455|18258543|P1|Washout|Withdrawal by Subject|0
5295646|NCT00455429|18258563|P4|Overall Study|Other|1
5295647|NCT00455429|18258564|P3|Overall Study|Other|0
5295648|NCT00455429|18258565|P2|Overall Study|Other|2
5295649|NCT00455429|18258566|P1|Overall Study|Other|0
5295650|NCT00455429|18258563|P4|Overall Study|Non-compliance|1
5295651|NCT00455429|18258564|P3|Overall Study|Non-compliance|0
5295652|NCT00455429|18258565|P2|Overall Study|Non-compliance|0
5295653|NCT00455429|18258566|P1|Overall Study|Non-compliance|0
5295654|NCT00455429|18258563|P4|Overall Study|Personal Reason|0
5295655|NCT00455429|18258564|P3|Overall Study|Personal Reason|0
5295656|NCT00455429|18258565|P2|Overall Study|Personal Reason|0
5295657|NCT00455429|18258566|P1|Overall Study|Personal Reason|1
5295658|NCT00455429|18258563|P4|Overall Study|Randomly assigned but not treated|2
5295659|NCT00455429|18258564|P3|Overall Study|Randomly assigned but not treated|0
5295660|NCT00455429|18258565|P2|Overall Study|Randomly assigned but not treated|0
5295661|NCT00455429|18258566|P1|Overall Study|Randomly assigned but not treated|0
5295662|NCT00455429|18258563|P4|Overall Study|Adverse Event|3
5295663|NCT00455429|18258564|P3|Overall Study|Adverse Event|0
5295664|NCT00455429|18258565|P2|Overall Study|Adverse Event|1
5295665|NCT00455429|18258566|P1|Overall Study|Adverse Event|0
5295666|NCT00455429|18258563|P4|Overall Study|Lack of Efficacy|1
5295667|NCT00455429|18258564|P3|Overall Study|Lack of Efficacy|0
5295668|NCT00455429|18258565|P2|Overall Study|Lack of Efficacy|1
5295669|NCT00455429|18258566|P1|Overall Study|Lack of Efficacy|0
5295670|NCT00455429|18258563|P4|Overall Study|Withdrawal by Subject|0
5295671|NCT00455429|18258564|P3|Overall Study|Withdrawal by Subject|1
5295672|NCT00455429|18258565|P2|Overall Study|Withdrawal by Subject|1
5295673|NCT00455429|18258566|P1|Overall Study|Withdrawal by Subject|0
5295674|NCT00455429|18258563|P4|Overall Study|Lost to Follow-up|3
5295675|NCT00455429|18258564|P3|Overall Study|Lost to Follow-up|0
5295676|NCT00455429|18258565|P2|Overall Study|Lost to Follow-up|0
5295677|NCT00455429|18258566|P1|Overall Study|Lost to Follow-up|1
5295678|NCT00455429|18258563|P4|Overall Study|Study Terminated by Sponsor|3
5295679|NCT00455429|18258564|P3|Overall Study|Study Terminated by Sponsor|0
5295680|NCT00455429|18258565|P2|Overall Study|Study Terminated by Sponsor|0
5295681|NCT00455429|18258566|P1|Overall Study|Study Terminated by Sponsor|0
5295682|NCT00455312|18258625|P2|Overall Study|Death|1
5295683|NCT00455312|18258626|P1|Overall Study|Death|0
5295684|NCT00455195|18258652|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
5295685|NCT00455195|18258653|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
5295686|NCT00455195|18258652|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
5295687|NCT00455195|18258653|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
5295688|NCT00455195|18258652|P2|Double-blind Study AGLU02704|Death|0
5295689|NCT00455195|18258653|P1|Double-blind Study AGLU02704|Death|1
5295690|NCT00455195|18258652|P2|Double-blind Study AGLU02704|Adverse Event|1
5295691|NCT00455195|18258653|P1|Double-blind Study AGLU02704|Adverse Event|2
5295692|NCT00455143|18258667|P1|Overall Study|Surgical time, staff not available|1
5295693|NCT00455143|18258667|P1|Overall Study|No longer met Inclusion Criteria|1
5295694|NCT00455143|18258667|P1|Overall Study|Staff was not avail to follow patient|2
5295695|NCT00455143|18258667|P1|Overall Study|Withdrawal by Subject|1
5295696|NCT00455143|18258667|P1|Overall Study|Physician Decision|1
5295697|NCT00455013|18258691|P3|Long Term Extension (LTE)|non-specified|1
5295698|NCT00455013|18258692|P2|Long Term Extension (LTE)|non-specified|0
5295699|NCT00455013|18258693|P1|Long Term Extension (LTE)|non-specified|0
5295700|NCT00455013|18258691|P3|Long Term Extension (LTE)|Poor non-compliance|0
5295701|NCT00455013|18258692|P2|Long Term Extension (LTE)|Poor non-compliance|1
5295702|NCT00455013|18258693|P1|Long Term Extension (LTE)|Poor non-compliance|0
5295703|NCT00455013|18258691|P3|Long Term Extension (LTE)|Subject Request or refused|3
5295704|NCT00455013|18258692|P2|Long Term Extension (LTE)|Subject Request or refused|0
5295705|NCT00455013|18258693|P1|Long Term Extension (LTE)|Subject Request or refused|0
5295706|NCT00455013|18258691|P3|Long Term Extension (LTE)|No longer met criteria|1
5295707|NCT00455013|18258692|P2|Long Term Extension (LTE)|No longer met criteria|0
5295708|NCT00455013|18258693|P1|Long Term Extension (LTE)|No longer met criteria|0
5295709|NCT00455013|18258691|P3|Long Term Extension (LTE)|Death|0
5295710|NCT00455013|18258692|P2|Long Term Extension (LTE)|Death|1
5295711|NCT00455013|18258693|P1|Long Term Extension (LTE)|Death|1
5295712|NCT00455013|18258691|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
5295713|NCT00455013|18258692|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
5295714|NCT00455013|18258693|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
5295715|NCT00455013|18258691|P3|Long Term Extension (LTE)|Adverse Event|1
5295716|NCT00455013|18258692|P2|Long Term Extension (LTE)|Adverse Event|1
5295717|NCT00455013|18258693|P1|Long Term Extension (LTE)|Adverse Event|0
5295718|NCT00455013|18258691|P3|Short Term Period|Other|1
5295719|NCT00455013|18258692|P2|Short Term Period|Other|0
5295720|NCT00455013|18258693|P1|Short Term Period|Other|0
5295721|NCT00455013|18258691|P3|Short Term Period|Lack of Efficacy|0
5295722|NCT00455013|18258692|P2|Short Term Period|Lack of Efficacy|0
5295723|NCT00455013|18258693|P1|Short Term Period|Lack of Efficacy|4
5295724|NCT00455013|18258691|P3|Short Term Period|Withdrawal by Subject|1
5295725|NCT00455013|18258692|P2|Short Term Period|Withdrawal by Subject|0
5295726|NCT00455013|18258693|P1|Short Term Period|Withdrawal by Subject|0
5295727|NCT00455013|18258691|P3|Short Term Period|Adverse Event|0
5295728|NCT00455013|18258692|P2|Short Term Period|Adverse Event|5
5295729|NCT00455013|18258693|P1|Short Term Period|Adverse Event|2
5295730|NCT00454987|18258761|P3|Booster Period (NCT00258700)|Lost to Follow-up|0
5295731|NCT00454987|18258762|P2|Booster Period (NCT00258700)|Lost to Follow-up|0
5295732|NCT00454987|18258763|P1|Booster Period (NCT00258700)|Lost to Follow-up|1
5295733|NCT00454987|18258761|P3|Booster Period (NCT00258700)|Withdrawal by Subject|0
5295734|NCT00454987|18258762|P2|Booster Period (NCT00258700)|Withdrawal by Subject|1
5295735|NCT00454987|18258763|P1|Booster Period (NCT00258700)|Withdrawal by Subject|0
5295736|NCT00454987|18258761|P3|Booster Period (NCT00258700)|Adverse Event|0
5295737|NCT00454987|18258762|P2|Booster Period (NCT00258700)|Adverse Event|0
5295738|NCT00454987|18258763|P1|Booster Period (NCT00258700)|Adverse Event|1
5295739|NCT00454909|18258837|P3|Overall Study|Others|0
5295740|NCT00454909|18258838|P2|Overall Study|Others|0
5295741|NCT00454909|18258839|P1|Overall Study|Others|1
5295742|NCT00454909|18258837|P3|Overall Study|Lost to follow-up (complete vaccination)|1
5295743|NCT00454909|18258838|P2|Overall Study|Lost to follow-up (complete vaccination)|3
5295744|NCT00454909|18258839|P1|Overall Study|Lost to follow-up (complete vaccination)|5
5295745|NCT00454909|18258837|P3|Overall Study|Migrated/moved from study area|1
5295746|NCT00454909|18258838|P2|Overall Study|Migrated/moved from study area|0
5295747|NCT00454909|18258839|P1|Overall Study|Migrated/moved from study area|0
5295748|NCT00454909|18258837|P3|Overall Study|Withdrawal by Subject|0
5295749|NCT00454909|18258838|P2|Overall Study|Withdrawal by Subject|0
5295750|NCT00454909|18258839|P1|Overall Study|Withdrawal by Subject|1
5295751|NCT00454857|18258877|P1|Overall Study|Reason unknown|1
5295752|NCT00454857|18258877|P1|Overall Study|Other|11
5295753|NCT00454857|18258877|P1|Overall Study|Death|5
5295754|NCT00454857|18258877|P1|Overall Study|Noncompliance|6
5295755|NCT00454857|18258877|P1|Overall Study|Lost to Follow-up|16
5295756|NCT00454857|18258877|P1|Overall Study|Withdrawal by Subject|15
5295757|NCT00454818|18258902|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
5295758|NCT00454818|18258903|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
5295759|NCT00454818|18258904|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
5295760|NCT00454818|18258905|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
5295761|NCT00454818|18258906|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
5295762|NCT00454818|18258902|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
5295763|NCT00454818|18258903|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
5295764|NCT00454818|18258904|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
5295765|NCT00454818|18258905|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
5295766|NCT00454818|18258906|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
5295767|NCT00454818|18258902|P5|Phase 2: Randomized Double-blind|Death|1
5295768|NCT00454818|18258903|P4|Phase 2: Randomized Double-blind|Death|0
5295769|NCT00454818|18258904|P3|Phase 2: Randomized Double-blind|Death|0
5295770|NCT00454818|18258905|P2|Phase 2: Randomized Double-blind|Death|1
5295771|NCT00454818|18258906|P1|Phase 2: Randomized Double-blind|Death|0
5295772|NCT00454818|18258902|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
5295773|NCT00454818|18258903|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
5295774|NCT00454818|18258904|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
5295775|NCT00454818|18258905|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
5295776|NCT00454818|18258906|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
5295777|NCT00454818|18258902|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
5295778|NCT00454818|18258903|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
5295779|NCT00454818|18258904|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
5295780|NCT00454818|18258905|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
5295781|NCT00454818|18258906|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
5295782|NCT00454818|18258902|P5|Phase I: Open-label Dose-escalation|Death|0
5295783|NCT00454818|18258903|P4|Phase I: Open-label Dose-escalation|Death|0
5295784|NCT00454818|18258904|P3|Phase I: Open-label Dose-escalation|Death|0
5295785|NCT00454818|18258905|P2|Phase I: Open-label Dose-escalation|Death|1
5295786|NCT00454818|18258906|P1|Phase I: Open-label Dose-escalation|Death|0
5295787|NCT00454818|18258902|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
5295788|NCT00454818|18258903|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
5295789|NCT00454818|18258904|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
5295790|NCT00454818|18258905|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
5295791|NCT00454818|18258906|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
5295792|NCT00454805|18258985|P2|Overall Study|In order to begin radiotherapy|0
5295793|NCT00454805|18258986|P1|Overall Study|In order to begin radiotherapy|1
5295794|NCT00454805|18258985|P2|Overall Study|Disease progression|19
5295795|NCT00454805|18258986|P1|Overall Study|Disease progression|16
5295796|NCT00454805|18258985|P2|Overall Study|Death|2
5295797|NCT00454805|18258986|P1|Overall Study|Death|0
5295798|NCT00454805|18258985|P2|Overall Study|Withdrawal by Subject|2
5295799|NCT00454805|18258986|P1|Overall Study|Withdrawal by Subject|9
5295800|NCT00454779|18259002|P2|Second-line Treatment Phase|Ongoing|1
5295801|NCT00454779|18259003|P1|Second-line Treatment Phase|Ongoing|0
5295802|NCT00454779|18259002|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
5295803|NCT00454779|18259003|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
5295804|NCT00454779|18259002|P2|Second-line Treatment Phase|Withdrawal by Subject|1
5295805|NCT00454779|18259003|P1|Second-line Treatment Phase|Withdrawal by Subject|0
5295806|NCT00454779|18259002|P2|First-line Treatment Phase|Ongoing|0
5295807|NCT00454779|18259003|P1|First-line Treatment Phase|Ongoing|1
5295808|NCT00454779|18259002|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
5295809|NCT00454779|18259003|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
5295810|NCT00454779|18259002|P2|First-line Treatment Phase|Protocol Violation|1
5295811|NCT00454779|18259003|P1|First-line Treatment Phase|Protocol Violation|0
5295812|NCT00454779|18259002|P2|First-line Treatment Phase|Lost to Follow-up|0
5295813|NCT00454779|18259003|P1|First-line Treatment Phase|Lost to Follow-up|1
5295814|NCT00454779|18259002|P2|First-line Treatment Phase|Withdrawal by Subject|4
5295815|NCT00454779|18259003|P1|First-line Treatment Phase|Withdrawal by Subject|2
5295816|NCT00454779|18259002|P2|First-line Treatment Phase|Lack of Efficacy|2
5295817|NCT00454779|18259003|P1|First-line Treatment Phase|Lack of Efficacy|0
5295818|NCT00454649|18259041|P10|Overall Study|Withdrawal by Subject|0
5295819|NCT00454649|18259042|P9|Overall Study|Withdrawal by Subject|1
5295820|NCT00454649|18259043|P8|Overall Study|Withdrawal by Subject|2
5295821|NCT00454649|18259044|P7|Overall Study|Withdrawal by Subject|0
5295822|NCT00454649|18259045|P6|Overall Study|Withdrawal by Subject|1
5295823|NCT00454649|18259046|P5|Overall Study|Withdrawal by Subject|0
5295824|NCT00454649|18259047|P4|Overall Study|Withdrawal by Subject|0
5295825|NCT00454649|18259048|P3|Overall Study|Withdrawal by Subject|0
5295826|NCT00454649|18259049|P2|Overall Study|Withdrawal by Subject|0
5295827|NCT00454649|18259050|P1|Overall Study|Withdrawal by Subject|0
5295828|NCT00454649|18259041|P10|Overall Study|Other|1
5295829|NCT00454649|18259042|P9|Overall Study|Other|3
5295830|NCT00454649|18259043|P8|Overall Study|Other|0
5295831|NCT00454649|18259044|P7|Overall Study|Other|0
5295832|NCT00454649|18259045|P6|Overall Study|Other|0
5295833|NCT00454649|18259046|P5|Overall Study|Other|0
5295834|NCT00454649|18259047|P4|Overall Study|Other|3
5295835|NCT00454649|18259048|P3|Overall Study|Other|5
5295836|NCT00454649|18259049|P2|Overall Study|Other|1
5295837|NCT00454649|18259050|P1|Overall Study|Other|1
5295838|NCT00454649|18259041|P10|Overall Study|Lost to Follow-up|0
5295839|NCT00454649|18259042|P9|Overall Study|Lost to Follow-up|0
5295840|NCT00454649|18259043|P8|Overall Study|Lost to Follow-up|0
5295841|NCT00454649|18259044|P7|Overall Study|Lost to Follow-up|1
5295842|NCT00454649|18259045|P6|Overall Study|Lost to Follow-up|0
5295843|NCT00454649|18259046|P5|Overall Study|Lost to Follow-up|0
5295844|NCT00454649|18259047|P4|Overall Study|Lost to Follow-up|0
5295845|NCT00454649|18259048|P3|Overall Study|Lost to Follow-up|1
5295846|NCT00454649|18259049|P2|Overall Study|Lost to Follow-up|0
5295847|NCT00454649|18259050|P1|Overall Study|Lost to Follow-up|0
5295848|NCT00454649|18259041|P10|Overall Study|Adverse Event|2
5295849|NCT00454649|18259042|P9|Overall Study|Adverse Event|6
5295850|NCT00454649|18259043|P8|Overall Study|Adverse Event|4
5295851|NCT00454649|18259044|P7|Overall Study|Adverse Event|3
5295852|NCT00454649|18259045|P6|Overall Study|Adverse Event|2
5295853|NCT00454649|18259046|P5|Overall Study|Adverse Event|1
5295854|NCT00454649|18259047|P4|Overall Study|Adverse Event|0
5295855|NCT00454649|18259048|P3|Overall Study|Adverse Event|3
5295856|NCT00454649|18259049|P2|Overall Study|Adverse Event|1
5295857|NCT00454649|18259050|P1|Overall Study|Adverse Event|0
5295858|NCT00454649|18259041|P10|Overall Study|Lack of Efficacy|2
5295859|NCT00454649|18259042|P9|Overall Study|Lack of Efficacy|10
5295860|NCT00454649|18259043|P8|Overall Study|Lack of Efficacy|13
5295861|NCT00454649|18259044|P7|Overall Study|Lack of Efficacy|5
5295862|NCT00454649|18259045|P6|Overall Study|Lack of Efficacy|4
5295863|NCT00454649|18259046|P5|Overall Study|Lack of Efficacy|0
5295864|NCT00454649|18259047|P4|Overall Study|Lack of Efficacy|3
5295865|NCT00454649|18259048|P3|Overall Study|Lack of Efficacy|10
5295866|NCT00454649|18259049|P2|Overall Study|Lack of Efficacy|2
5295867|NCT00454649|18259050|P1|Overall Study|Lack of Efficacy|2
5295868|NCT00454636|18259179|P4|Overall Study|Lost to Follow-up|0
5295869|NCT00454636|18259180|P3|Overall Study|Lost to Follow-up|0
5295870|NCT00454636|18259181|P2|Overall Study|Lost to Follow-up|1
5295871|NCT00454636|18259182|P1|Overall Study|Lost to Follow-up|0
5295872|NCT00454636|18259179|P4|Overall Study|Patient refusal|2
5295873|NCT00454636|18259180|P3|Overall Study|Patient refusal|3
5295874|NCT00454636|18259181|P2|Overall Study|Patient refusal|1
5295875|NCT00454636|18259182|P1|Overall Study|Patient refusal|1
5295876|NCT00454636|18259179|P4|Overall Study|Death|1
5295877|NCT00454636|18259180|P3|Overall Study|Death|1
5295878|NCT00454636|18259181|P2|Overall Study|Death|1
5295879|NCT00454636|18259182|P1|Overall Study|Death|6
5295880|NCT00454636|18259179|P4|Overall Study|Protocol Violation|3
5295881|NCT00454636|18259180|P3|Overall Study|Protocol Violation|3
5295882|NCT00454636|18259181|P2|Overall Study|Protocol Violation|2
5295883|NCT00454636|18259182|P1|Overall Study|Protocol Violation|3
5295884|NCT00454636|18259179|P4|Overall Study|Disease Progression|11
5295885|NCT00454636|18259180|P3|Overall Study|Disease Progression|4
5295886|NCT00454636|18259181|P2|Overall Study|Disease Progression|12
5295887|NCT00454636|18259182|P1|Overall Study|Disease Progression|11
5295888|NCT00454636|18259179|P4|Overall Study|Adverse Event|15
5295889|NCT00454636|18259180|P3|Overall Study|Adverse Event|9
5295890|NCT00454636|18259181|P2|Overall Study|Adverse Event|6
5295891|NCT00454636|18259182|P1|Overall Study|Adverse Event|10
5295892|NCT00454584|18259215|P6|After Controlled Period|Other|17
5295893|NCT00454584|18259216|P5|After Controlled Period|Other|5
5295894|NCT00454584|18259217|P4|After Controlled Period|Other|13
5295895|NCT00454584|18259218|P3|After Controlled Period|Other|0
5295896|NCT00454584|18259219|P2|After Controlled Period|Other|0
5295897|NCT00454584|18259220|P1|After Controlled Period|Other|0
5295898|NCT00454584|18259215|P6|After Controlled Period|Other|0
5295899|NCT00454584|18259216|P5|After Controlled Period|Other|0
5295900|NCT00454584|18259217|P4|After Controlled Period|Other|1
5295901|NCT00454584|18259218|P3|After Controlled Period|Other|0
5295902|NCT00454584|18259219|P2|After Controlled Period|Other|0
5295903|NCT00454584|18259220|P1|After Controlled Period|Other|0
5295904|NCT00454584|18259215|P6|After Controlled Period|Lost to Follow-up|6
5295905|NCT00454584|18259216|P5|After Controlled Period|Lost to Follow-up|4
5295906|NCT00454584|18259217|P4|After Controlled Period|Lost to Follow-up|2
5295907|NCT00454584|18259218|P3|After Controlled Period|Lost to Follow-up|0
5295908|NCT00454584|18259219|P2|After Controlled Period|Lost to Follow-up|0
5295909|NCT00454584|18259220|P1|After Controlled Period|Lost to Follow-up|0
5295910|NCT00454584|18259215|P6|After Controlled Period|Lack of Efficacy|0
5295911|NCT00454584|18259216|P5|After Controlled Period|Lack of Efficacy|0
5295912|NCT00454584|18259217|P4|After Controlled Period|Lack of Efficacy|1
5295913|NCT00454584|18259218|P3|After Controlled Period|Lack of Efficacy|0
5295914|NCT00454584|18259219|P2|After Controlled Period|Lack of Efficacy|0
5295915|NCT00454584|18259220|P1|After Controlled Period|Lack of Efficacy|0
5295916|NCT00454584|18259215|P6|After Controlled Period|Adverse Event|9
5295917|NCT00454584|18259216|P5|After Controlled Period|Adverse Event|3
5295918|NCT00454584|18259217|P4|After Controlled Period|Adverse Event|9
5295919|NCT00454584|18259218|P3|After Controlled Period|Adverse Event|0
5295920|NCT00454584|18259219|P2|After Controlled Period|Adverse Event|0
5295921|NCT00454584|18259220|P1|After Controlled Period|Adverse Event|0
5295922|NCT00454584|18259215|P6|Controlled Period|Other|0
5295923|NCT00454584|18259216|P5|Controlled Period|Other|0
5295924|NCT00454584|18259217|P4|Controlled Period|Other|0
5295925|NCT00454584|18259218|P3|Controlled Period|Other|2
5295926|NCT00454584|18259219|P2|Controlled Period|Other|4
5295927|NCT00454584|18259220|P1|Controlled Period|Other|5
5295928|NCT00454584|18259215|P6|Controlled Period|Lost to Follow-up|0
5295929|NCT00454584|18259216|P5|Controlled Period|Lost to Follow-up|0
5295930|NCT00454584|18259217|P4|Controlled Period|Lost to Follow-up|0
5295931|NCT00454584|18259218|P3|Controlled Period|Lost to Follow-up|2
5295932|NCT00454584|18259219|P2|Controlled Period|Lost to Follow-up|2
5295933|NCT00454584|18259220|P1|Controlled Period|Lost to Follow-up|1
5295934|NCT00454584|18259215|P6|Controlled Period|Adverse Event|0
5295935|NCT00454584|18259216|P5|Controlled Period|Adverse Event|0
5295936|NCT00454584|18259217|P4|Controlled Period|Adverse Event|0
5295937|NCT00454584|18259218|P3|Controlled Period|Adverse Event|1
5295938|NCT00454584|18259219|P2|Controlled Period|Adverse Event|2
5295939|NCT00454584|18259220|P1|Controlled Period|Adverse Event|5
5295940|NCT00454571|18259242|P2|Overall Study|Withdrawal by Subject|5
5295941|NCT00454571|18259243|P1|Overall Study|Withdrawal by Subject|10
5295942|NCT00454571|18259242|P2|Overall Study|Protocol Violation|0
5295943|NCT00454571|18259243|P1|Overall Study|Protocol Violation|1
5295944|NCT00454571|18259242|P2|Overall Study|Physician Decision|1
5295945|NCT00454571|18259243|P1|Overall Study|Physician Decision|0
5295946|NCT00454571|18259242|P2|Overall Study|Adverse Event|0
5295947|NCT00454571|18259243|P1|Overall Study|Adverse Event|2
5295948|NCT00454363|18259278|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
5295949|NCT00454363|18259279|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
5295950|NCT00454363|18259278|P2|Overall Study|Adverse Event|2
5295951|NCT00454363|18259279|P1|Overall Study|Adverse Event|1
5295952|NCT00454246|18259308|P3|Overall Study|Early termination of study|9
5295953|NCT00454246|18259309|P2|Overall Study|Early termination of study|26
5295954|NCT00454246|18259310|P1|Overall Study|Early termination of study|62
5295955|NCT00454246|18259308|P3|Overall Study|Failure to return|0
5295956|NCT00454246|18259309|P2|Overall Study|Failure to return|0
5295957|NCT00454246|18259310|P1|Overall Study|Failure to return|1
5295958|NCT00454246|18259308|P3|Overall Study|Refused Treatment|0
5295959|NCT00454246|18259309|P2|Overall Study|Refused Treatment|1
5295960|NCT00454246|18259310|P1|Overall Study|Refused Treatment|1
5295961|NCT00454246|18259308|P3|Overall Study|Protocol Violation|0
5295962|NCT00454246|18259309|P2|Overall Study|Protocol Violation|0
5295963|NCT00454246|18259310|P1|Overall Study|Protocol Violation|1
5295964|NCT00454246|18259308|P3|Overall Study|Violation of selection criteria at entry|0
5295965|NCT00454246|18259309|P2|Overall Study|Violation of selection criteria at entry|0
5295966|NCT00454246|18259310|P1|Overall Study|Violation of selection criteria at entry|6
5295967|NCT00454246|18259308|P3|Overall Study|Adverse Event|0
5295968|NCT00454246|18259309|P2|Overall Study|Adverse Event|2
5295969|NCT00454246|18259310|P1|Overall Study|Adverse Event|2
5295970|NCT00454207|18259326|P2|Overall Study|Protocol Violation|1
5295971|NCT00454207|18259327|P1|Overall Study|Protocol Violation|0
5295972|NCT00454207|18259326|P2|Overall Study|Lack of Efficacy|0
5295973|NCT00454207|18259327|P1|Overall Study|Lack of Efficacy|1
5295974|NCT00454207|18259326|P2|Overall Study|Adverse Event|1
5295975|NCT00454207|18259327|P1|Overall Study|Adverse Event|3
5295976|NCT00454194|18259372|P2|Overall Study|Other Unspecified Reason|2
5295977|NCT00454194|18259373|P1|Overall Study|Other Unspecified Reason|2
5295978|NCT00454194|18259372|P2|Overall Study|Other Medical Problems|2
5295979|NCT00454194|18259373|P1|Overall Study|Other Medical Problems|1
5295980|NCT00454194|18259372|P2|Overall Study|Withdrawal by Subject|8
5295981|NCT00454194|18259373|P1|Overall Study|Withdrawal by Subject|12
5295982|NCT00454194|18259372|P2|Overall Study|Adverse Event|2
5295983|NCT00454194|18259373|P1|Overall Study|Adverse Event|7
5295984|NCT00454181|18259391|P2|Overall Study|Withdrawal by Subject|0
5295985|NCT00454181|18259392|P1|Overall Study|Withdrawal by Subject|2
5295986|NCT00454181|18259391|P2|Overall Study|Protocol Violation|1
5295987|NCT00454181|18259392|P1|Overall Study|Protocol Violation|1
5295988|NCT00454181|18259391|P2|Overall Study|Lost to Follow-up|1
5295989|NCT00454181|18259392|P1|Overall Study|Lost to Follow-up|11
5295990|NCT00454181|18259391|P2|Overall Study|Adverse Event|1
5295991|NCT00454181|18259392|P1|Overall Study|Adverse Event|1
5295992|NCT00454142|18259408|P1|Overall Study|Withdrawal by Subject|1
5295993|NCT00454116|18259426|P3|Overall Study|Other|0
5295994|NCT00454116|18259427|P2|Overall Study|Other|2
5295995|NCT00454116|18259428|P1|Overall Study|Other|2
5295996|NCT00454116|18259426|P3|Overall Study|Withdrawal by Subject|1
5295997|NCT00454116|18259427|P2|Overall Study|Withdrawal by Subject|3
5295998|NCT00454116|18259428|P1|Overall Study|Withdrawal by Subject|3
5295999|NCT00454116|18259426|P3|Overall Study|Condition under investigation worsened|18
5296000|NCT00454116|18259427|P2|Overall Study|Condition under investigation worsened|13
5296001|NCT00454116|18259428|P1|Overall Study|Condition under investigation worsened|17
5296002|NCT00454116|18259426|P3|Overall Study|Adverse Event|9
5296003|NCT00454116|18259427|P2|Overall Study|Adverse Event|11
5296004|NCT00454116|18259428|P1|Overall Study|Adverse Event|5
5296005|NCT00454051|18259438|P2|Overall Study|Protocol Violation|1
5296006|NCT00454051|18259439|P1|Overall Study|Protocol Violation|1
5296007|NCT00454051|18259438|P2|Overall Study|Withdrawal by Subject|0
5296008|NCT00454051|18259439|P1|Overall Study|Withdrawal by Subject|1
5296009|NCT00454051|18259438|P2|Overall Study|Adverse Event|2
5296010|NCT00454051|18259439|P1|Overall Study|Adverse Event|1
5296011|NCT00453999|18259472|P3|Overall Study|Subject Request|0
5296012|NCT00453999|18259473|P2|Overall Study|Subject Request|1
5296013|NCT00453999|18259474|P1|Overall Study|Subject Request|2
5296014|NCT00453999|18259472|P3|Overall Study|Withdrawal by Subject|1
5296015|NCT00453999|18259473|P2|Overall Study|Withdrawal by Subject|1
5296016|NCT00453999|18259474|P1|Overall Study|Withdrawal by Subject|2
5296017|NCT00453999|18259472|P3|Overall Study|Lost to Follow-up|1
5296018|NCT00453999|18259473|P2|Overall Study|Lost to Follow-up|1
5296019|NCT00453999|18259474|P1|Overall Study|Lost to Follow-up|0
5296020|NCT00453999|18259472|P3|Overall Study|Adverse Event|1
5296021|NCT00453999|18259473|P2|Overall Study|Adverse Event|2
5296022|NCT00453999|18259474|P1|Overall Study|Adverse Event|1
5296023|NCT00453986|18259502|P5|Overall Study|Lost to Follow-up|0
5296024|NCT00453986|18259503|P4|Overall Study|Lost to Follow-up|2
5296025|NCT00453986|18259504|P3|Overall Study|Lost to Follow-up|6
5296026|NCT00453986|18259505|P2|Overall Study|Lost to Follow-up|5
5296027|NCT00453986|18259506|P1|Overall Study|Lost to Follow-up|6
5296028|NCT00453973|18259599|P2|Overall Study|Sponsor Decision to Terminate Study|30
5296029|NCT00453973|18259600|P1|Overall Study|Sponsor Decision to Terminate Study|35
5296030|NCT00453973|18259599|P2|Overall Study|Site closed by sponsor|0
5296031|NCT00453973|18259600|P1|Overall Study|Site closed by sponsor|3
5296032|NCT00453973|18259599|P2|Overall Study|Renal transplant|1
5296033|NCT00453973|18259600|P1|Overall Study|Renal transplant|1
5296034|NCT00453973|18259599|P2|Overall Study|Relocation|0
5296035|NCT00453973|18259600|P1|Overall Study|Relocation|1
5296036|NCT00453973|18259599|P2|Overall Study|PI Decision|2
5296037|NCT00453973|18259600|P1|Overall Study|PI Decision|0
5296038|NCT00453973|18259599|P2|Overall Study|Withdrawal by Subject|6
5296039|NCT00453973|18259600|P1|Overall Study|Withdrawal by Subject|7
5296040|NCT00453973|18259599|P2|Overall Study|Adverse Event|9
5296041|NCT00453973|18259600|P1|Overall Study|Adverse Event|4
5296042|NCT00453921|18259610|P4|Overall Study|Lost to Follow-up|0
5296043|NCT00453921|18259611|P3|Overall Study|Lost to Follow-up|1
5296044|NCT00453921|18259612|P2|Overall Study|Lost to Follow-up|0
5296045|NCT00453921|18259613|P1|Overall Study|Lost to Follow-up|0
5296046|NCT00453921|18259610|P4|Overall Study|Withdrawal by Subject|1
5296047|NCT00453921|18259611|P3|Overall Study|Withdrawal by Subject|1
5296048|NCT00453921|18259612|P2|Overall Study|Withdrawal by Subject|1
5296049|NCT00453921|18259613|P1|Overall Study|Withdrawal by Subject|1
5296050|NCT00453362|18259760|P1|Overall Study|Screening Failure|14
5296051|NCT00453362|18259760|P1|Overall Study|Progression of disease|56
5296052|NCT00453362|18259760|P1|Overall Study|Withdrawal by Subject|3
5296053|NCT00453362|18259760|P1|Overall Study|Physician Decision|2
5296054|NCT00453362|18259760|P1|Overall Study|Death|7
5296055|NCT00453362|18259760|P1|Overall Study|Adverse Event|5
5296056|NCT00453349|18259786|P2|Completed Study|Lost to follow up after study treatment|11
5296057|NCT00453349|18259787|P1|Completed Study|Lost to follow up after study treatment|2
5296058|NCT00453349|18259786|P2|Completed Study|Withdrawal by Subject|5
5296059|NCT00453349|18259787|P1|Completed Study|Withdrawal by Subject|3
5296060|NCT00453349|18259786|P2|Completed Study|Protocol Violation|1
5296061|NCT00453349|18259787|P1|Completed Study|Protocol Violation|1
5296062|NCT00453349|18259786|P2|Completed Study|Lost to Follow-up|5
5296063|NCT00453349|18259787|P1|Completed Study|Lost to Follow-up|7
5296064|NCT00453349|18259786|P2|Completed Study|Lack of Efficacy|1
5296065|NCT00453349|18259787|P1|Completed Study|Lack of Efficacy|2
5296066|NCT00453349|18259786|P2|Completed Study|Adverse Event|11
5296067|NCT00453349|18259787|P1|Completed Study|Adverse Event|12
5296068|NCT00453349|18259786|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
5296069|NCT00453349|18259787|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
5296070|NCT00453349|18259786|P2|Randomized|Withdrawal by Subject|5
5296071|NCT00453349|18259787|P1|Randomized|Withdrawal by Subject|3
5296072|NCT00453349|18259786|P2|Randomized|Protocol Violation|1
5296073|NCT00453349|18259787|P1|Randomized|Protocol Violation|1
5296074|NCT00453349|18259786|P2|Randomized|Lost to Follow-up|5
5296075|NCT00453349|18259787|P1|Randomized|Lost to Follow-up|7
5296076|NCT00453349|18259786|P2|Randomized|Lack of Efficacy|1
5296077|NCT00453349|18259787|P1|Randomized|Lack of Efficacy|2
5296078|NCT00453349|18259786|P2|Randomized|Adverse Event|11
5296079|NCT00453349|18259787|P1|Randomized|Adverse Event|12
5296080|NCT00453310|18259818|P1|Overall Study|Progression of Disease|10
5296081|NCT00453206|18259822|P1|Overall Study|Death|1
5296082|NCT00453180|18259832|P2|Overall Study|Adverse Event|2
5296083|NCT00453180|18259833|P1|Overall Study|Adverse Event|1
5296084|NCT00453180|18259832|P2|Overall Study|Lost to Follow-up|1
5296085|NCT00453180|18259833|P1|Overall Study|Lost to Follow-up|2
5296086|NCT00453154|18259852|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
5296087|NCT00453154|18259853|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
5296088|NCT00453154|18259854|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
5296089|NCT00453154|18259855|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
5296090|NCT00453154|18259852|P4|Double BIind Maintenance|Medical Issues|1
5296091|NCT00453154|18259853|P3|Double BIind Maintenance|Medical Issues|3
5296092|NCT00453154|18259854|P2|Double BIind Maintenance|Medical Issues|0
5296093|NCT00453154|18259855|P1|Double BIind Maintenance|Medical Issues|0
5296094|NCT00453154|18259852|P4|Double BIind Maintenance|Progression|26
5296095|NCT00453154|18259853|P3|Double BIind Maintenance|Progression|29
5296096|NCT00453154|18259854|P2|Double BIind Maintenance|Progression|0
5296097|NCT00453154|18259855|P1|Double BIind Maintenance|Progression|0
5296098|NCT00453154|18259852|P4|Double BIind Maintenance|Withdrawal by Subject|4
5296099|NCT00453154|18259853|P3|Double BIind Maintenance|Withdrawal by Subject|4
5296100|NCT00453154|18259854|P2|Double BIind Maintenance|Withdrawal by Subject|0
5296101|NCT00453154|18259855|P1|Double BIind Maintenance|Withdrawal by Subject|0
5296102|NCT00453154|18259852|P4|Double BIind Maintenance|Death|1
5296103|NCT00453154|18259853|P3|Double BIind Maintenance|Death|2
5296104|NCT00453154|18259854|P2|Double BIind Maintenance|Death|0
5296105|NCT00453154|18259855|P1|Double BIind Maintenance|Death|0
5296106|NCT00453154|18259852|P4|Double BIind Maintenance|Adverse Event|12
5296107|NCT00453154|18259853|P3|Double BIind Maintenance|Adverse Event|3
5296108|NCT00453154|18259854|P2|Double BIind Maintenance|Adverse Event|0
5296109|NCT00453154|18259855|P1|Double BIind Maintenance|Adverse Event|0
5296110|NCT00453102|18259868|P1|Overall Study|Withdrawal by Subject|2
5296111|NCT00453063|18259879|P2|Overall Study|Protocol Violation|0
5296112|NCT00453063|18259880|P1|Overall Study|Protocol Violation|1
5296113|NCT00453063|18259879|P2|Overall Study|Withdrawal by Subject|1
5296114|NCT00453063|18259880|P1|Overall Study|Withdrawal by Subject|1
5296115|NCT00453063|18259879|P2|Overall Study|Adverse Event|2
5296116|NCT00453063|18259880|P1|Overall Study|Adverse Event|1
5296117|NCT00452790|18259900|P2|Toddler Dose|Parent/legal guardian request|1
5296118|NCT00452790|18259901|P1|Toddler Dose|Parent/legal guardian request|0
5296119|NCT00452790|18259900|P2|Toddler Dose|Failed to return|1
5296120|NCT00452790|18259901|P1|Toddler Dose|Failed to return|0
5296121|NCT00452790|18259900|P2|After Infant Series|Other reasons|0
5296122|NCT00452790|18259901|P1|After Infant Series|Other reasons|1
5296123|NCT00452790|18259900|P2|After Infant Series|Failed to return|0
5296124|NCT00452790|18259901|P1|After Infant Series|Failed to return|1
5296125|NCT00452790|18259900|P2|After Infant Series|Lost to Follow-up|0
5296126|NCT00452790|18259901|P1|After Infant Series|Lost to Follow-up|4
5296127|NCT00452790|18259900|P2|After Infant Series|Parent/legal guardian request|3
5296128|NCT00452790|18259901|P1|After Infant Series|Parent/legal guardian request|1
5296129|NCT00452790|18259900|P2|After Infant Series|Adverse Event|1
5296130|NCT00452790|18259901|P1|After Infant Series|Adverse Event|4
5296131|NCT00452790|18259900|P2|After Infant Series|Investigator request|10
5296132|NCT00452790|18259901|P1|After Infant Series|Investigator request|10
5296133|NCT00452790|18259900|P2|Infant Series|Death|1
5296134|NCT00452790|18259901|P1|Infant Series|Death|0
5296135|NCT00452790|18259900|P2|Infant Series|Investigator request|1
5296136|NCT00452790|18259901|P1|Infant Series|Investigator request|0
5296137|NCT00452790|18259900|P2|Infant Series|Other reasons|2
5296138|NCT00452790|18259901|P1|Infant Series|Other reasons|1
5296139|NCT00452790|18259900|P2|Infant Series|Adverse Event|2
5296140|NCT00452790|18259901|P1|Infant Series|Adverse Event|1
5296141|NCT00452790|18259900|P2|Infant Series|Lost to Follow-up|2
5296142|NCT00452790|18259901|P1|Infant Series|Lost to Follow-up|2
5296143|NCT00452790|18259900|P2|Infant Series|Protocol Violation|3
5296144|NCT00452790|18259901|P1|Infant Series|Protocol Violation|1
5296145|NCT00452790|18259900|P2|Infant Series|Failed to return|1
5296146|NCT00452790|18259901|P1|Infant Series|Failed to return|4
5296147|NCT00452790|18259900|P2|Infant Series|Parent/legal guardian request|6
5296148|NCT00452790|18259901|P1|Infant Series|Parent/legal guardian request|8
5296149|NCT00452790|18259900|P2|Infant Series|Clinical hold - consent withdrawn|123
5296150|NCT00452790|18259901|P1|Infant Series|Clinical hold - consent withdrawn|118
5296151|NCT00452699|18259937|P2|Overall Study|Other|7
5296152|NCT00452699|18259938|P1|Overall Study|Other|12
5296153|NCT00452699|18259937|P2|Overall Study|Withdrawal by Subject|25
5296154|NCT00452699|18259938|P1|Overall Study|Withdrawal by Subject|26
5296155|NCT00452699|18259937|P2|Overall Study|Protocol Violation|25
5296156|NCT00452699|18259938|P1|Overall Study|Protocol Violation|21
5296157|NCT00452699|18259937|P2|Overall Study|Lost to Follow-up|9
5296158|NCT00452699|18259938|P1|Overall Study|Lost to Follow-up|6
5296159|NCT00452699|18259937|P2|Overall Study|Lack of Efficacy|4
5296160|NCT00452699|18259938|P1|Overall Study|Lack of Efficacy|6
5296161|NCT00452699|18259937|P2|Overall Study|Adverse Event|3
5296162|NCT00452699|18259938|P1|Overall Study|Adverse Event|10
5296163|NCT00452673|18259954|P5|Dose Expansion Period|Other|2
5296164|NCT00452673|18259955|P4|Dose Expansion Period|Other|0
5296165|NCT00452673|18259956|P3|Dose Expansion Period|Other|0
5296166|NCT00452673|18259957|P2|Dose Expansion Period|Other|0
5296167|NCT00452673|18259958|P1|Dose Expansion Period|Other|0
5296168|NCT00452673|18259954|P5|Dose Expansion Period|Disease Progression|19
5296169|NCT00452673|18259955|P4|Dose Expansion Period|Disease Progression|0
5296170|NCT00452673|18259956|P3|Dose Expansion Period|Disease Progression|0
5296171|NCT00452673|18259957|P2|Dose Expansion Period|Disease Progression|0
5296172|NCT00452673|18259958|P1|Dose Expansion Period|Disease Progression|0
5296173|NCT00452673|18259954|P5|Dose Escalation Period|Withdrawal by Subject|0
5296174|NCT00452673|18259955|P4|Dose Escalation Period|Withdrawal by Subject|1
5296175|NCT00452673|18259956|P3|Dose Escalation Period|Withdrawal by Subject|0
5296176|NCT00452673|18259957|P2|Dose Escalation Period|Withdrawal by Subject|0
5296177|NCT00452673|18259958|P1|Dose Escalation Period|Withdrawal by Subject|0
5296178|NCT00452673|18259954|P5|Dose Escalation Period|Adverse Event|0
5296179|NCT00452673|18259955|P4|Dose Escalation Period|Adverse Event|1
5296180|NCT00452673|18259956|P3|Dose Escalation Period|Adverse Event|0
5296181|NCT00452673|18259957|P2|Dose Escalation Period|Adverse Event|0
5296182|NCT00452673|18259958|P1|Dose Escalation Period|Adverse Event|0
5296183|NCT00452673|18259954|P5|Dose Escalation Period|Other|0
5296184|NCT00452673|18259955|P4|Dose Escalation Period|Other|0
5296185|NCT00452673|18259956|P3|Dose Escalation Period|Other|1
5296186|NCT00452673|18259957|P2|Dose Escalation Period|Other|0
5296187|NCT00452673|18259958|P1|Dose Escalation Period|Other|0
5296188|NCT00452673|18259954|P5|Dose Escalation Period|study drug toxicity|0
5296189|NCT00452673|18259955|P4|Dose Escalation Period|study drug toxicity|1
5296190|NCT00452673|18259956|P3|Dose Escalation Period|study drug toxicity|3
5296191|NCT00452673|18259957|P2|Dose Escalation Period|study drug toxicity|3
5296192|NCT00452673|18259958|P1|Dose Escalation Period|study drug toxicity|1
5296193|NCT00452673|18259954|P5|Dose Escalation Period|Disease Progression|0
5296194|NCT00452673|18259955|P4|Dose Escalation Period|Disease Progression|6
5296195|NCT00452673|18259956|P3|Dose Escalation Period|Disease Progression|2
5296196|NCT00452673|18259957|P2|Dose Escalation Period|Disease Progression|6
5296197|NCT00452673|18259958|P1|Dose Escalation Period|Disease Progression|6
5296198|NCT00452530|18260005|P2|Overall Study|Other|11
5296199|NCT00452530|18260006|P1|Overall Study|Other|7
5296200|NCT00452530|18260005|P2|Overall Study|No longer met study criteria|22
5296201|NCT00452530|18260006|P1|Overall Study|No longer met study criteria|18
5296202|NCT00452530|18260005|P2|Overall Study|Poor compliance/noncompliance|2
5296203|NCT00452530|18260006|P1|Overall Study|Poor compliance/noncompliance|1
5296204|NCT00452530|18260005|P2|Overall Study|Lost to Follow-up|0
5296205|NCT00452530|18260006|P1|Overall Study|Lost to Follow-up|1
5296206|NCT00452530|18260005|P2|Overall Study|Withdrawal by Subject|57
5296207|NCT00452530|18260006|P1|Overall Study|Withdrawal by Subject|68
5296208|NCT00452530|18260005|P2|Overall Study|Adverse Event|44
5296209|NCT00452530|18260006|P1|Overall Study|Adverse Event|40
5296210|NCT00452530|18260005|P2|Overall Study|Death|0
5296211|NCT00452530|18260006|P1|Overall Study|Death|1
5296212|NCT00452452|18260027|P3|Overall Study|Lost to Follow-up|0
5296213|NCT00452452|18260028|P2|Overall Study|Lost to Follow-up|0
5296214|NCT00452452|18260029|P1|Overall Study|Lost to Follow-up|1
5296215|NCT00452452|18260027|P3|Overall Study|Withdrawal by Subject|0
5296216|NCT00452452|18260028|P2|Overall Study|Withdrawal by Subject|0
5296217|NCT00452452|18260029|P1|Overall Study|Withdrawal by Subject|1
5296218|NCT00452452|18260027|P3|Overall Study|Protocol Violation|1
5296219|NCT00452452|18260028|P2|Overall Study|Protocol Violation|0
5296220|NCT00452452|18260029|P1|Overall Study|Protocol Violation|0
5296221|NCT00452400|18260074|P5|Overall Study|Other reasons not listed above|1
5296222|NCT00452400|18260075|P4|Overall Study|Other reasons not listed above|1
5296223|NCT00452400|18260076|P3|Overall Study|Other reasons not listed above|0
5296224|NCT00452400|18260077|P2|Overall Study|Other reasons not listed above|0
5296225|NCT00452400|18260078|P1|Overall Study|Other reasons not listed above|0
5296226|NCT00452400|18260074|P5|Overall Study|Lack of Efficacy|0
5296227|NCT00452400|18260075|P4|Overall Study|Lack of Efficacy|0
5296228|NCT00452400|18260076|P3|Overall Study|Lack of Efficacy|0
5296229|NCT00452400|18260077|P2|Overall Study|Lack of Efficacy|0
5296230|NCT00452400|18260078|P1|Overall Study|Lack of Efficacy|2
5296231|NCT00452400|18260074|P5|Overall Study|Withdrawal by Subject|0
5296232|NCT00452400|18260075|P4|Overall Study|Withdrawal by Subject|0
5296233|NCT00452400|18260076|P3|Overall Study|Withdrawal by Subject|1
5296234|NCT00452400|18260077|P2|Overall Study|Withdrawal by Subject|0
5296235|NCT00452400|18260078|P1|Overall Study|Withdrawal by Subject|1
5296236|NCT00452400|18260074|P5|Overall Study|Lost to Follow-up|0
5296237|NCT00452400|18260075|P4|Overall Study|Lost to Follow-up|0
5296238|NCT00452400|18260076|P3|Overall Study|Lost to Follow-up|0
5296239|NCT00452400|18260077|P2|Overall Study|Lost to Follow-up|0
5296240|NCT00452400|18260078|P1|Overall Study|Lost to Follow-up|1
5296241|NCT00452400|18260074|P5|Overall Study|Protocol Violation|0
5296242|NCT00452400|18260075|P4|Overall Study|Protocol Violation|0
5296243|NCT00452400|18260076|P3|Overall Study|Protocol Violation|1
5296244|NCT00452400|18260077|P2|Overall Study|Protocol Violation|0
5296245|NCT00452400|18260078|P1|Overall Study|Protocol Violation|0
5296246|NCT00452400|18260074|P5|Overall Study|Adverse Event|2
5296247|NCT00452400|18260075|P4|Overall Study|Adverse Event|0
5296248|NCT00452400|18260076|P3|Overall Study|Adverse Event|5
5296249|NCT00452400|18260077|P2|Overall Study|Adverse Event|1
5296250|NCT00452400|18260078|P1|Overall Study|Adverse Event|1
5296251|NCT00452361|18260265|P2|Overall Study|Premature termination|9
5296252|NCT00452361|18260266|P1|Overall Study|Premature termination|13
5296253|NCT00452361|18260265|P2|Overall Study|Withdrawal by Subject|1
5296254|NCT00452361|18260266|P1|Overall Study|Withdrawal by Subject|0
5296255|NCT00452361|18260265|P2|Overall Study|Adverse Event|0
5296256|NCT00452361|18260266|P1|Overall Study|Adverse Event|8
5296257|NCT00452348|18260310|P2|Overall Study|Other|9
5296258|NCT00452348|18260311|P1|Overall Study|Other|9
5296259|NCT00452348|18260310|P2|Overall Study|Withdrawal by Subject|21
5296260|NCT00452348|18260311|P1|Overall Study|Withdrawal by Subject|18
5296261|NCT00452348|18260310|P2|Overall Study|Protocol Violation|28
5296262|NCT00452348|18260311|P1|Overall Study|Protocol Violation|22
5296263|NCT00452348|18260310|P2|Overall Study|Lost to Follow-up|8
5296264|NCT00452348|18260311|P1|Overall Study|Lost to Follow-up|14
5296265|NCT00452348|18260310|P2|Overall Study|Lack of Efficacy|9
5296266|NCT00452348|18260311|P1|Overall Study|Lack of Efficacy|10
5296267|NCT00452348|18260310|P2|Overall Study|Adverse Event|9
5296268|NCT00452348|18260311|P1|Overall Study|Adverse Event|6
5296269|NCT00452114|18260365|P2|Overall Study|Physician Decision|3
5296270|NCT00452114|18260366|P1|Overall Study|Physician Decision|3
5296271|NCT00451958|18260382|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
5296272|NCT00451958|18260383|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
5296273|NCT00451958|18260384|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
5296274|NCT00451958|18260385|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
5296275|NCT00451958|18260386|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
5296276|NCT00451958|18260382|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
5296277|NCT00451958|18260383|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
5296278|NCT00451958|18260384|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
5296279|NCT00451958|18260385|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
5296280|NCT00451958|18260386|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
5296281|NCT00451958|18260382|P5|CS21A (NCT00451958)|Physician Decision|0
5296282|NCT00451958|18260383|P4|CS21A (NCT00451958)|Physician Decision|4
5296283|NCT00451958|18260384|P3|CS21A (NCT00451958)|Physician Decision|4
5296284|NCT00451958|18260385|P2|CS21A (NCT00451958)|Physician Decision|4
5296285|NCT00451958|18260386|P1|CS21A (NCT00451958)|Physician Decision|2
5296286|NCT00451958|18260382|P5|CS21A (NCT00451958)|Protocol Violation|0
5296287|NCT00451958|18260383|P4|CS21A (NCT00451958)|Protocol Violation|0
5296288|NCT00451958|18260384|P3|CS21A (NCT00451958)|Protocol Violation|2
5296289|NCT00451958|18260385|P2|CS21A (NCT00451958)|Protocol Violation|3
5296290|NCT00451958|18260386|P1|CS21A (NCT00451958)|Protocol Violation|1
5296291|NCT00451958|18260382|P5|CS21A (NCT00451958)|Lost to Follow-up|0
5296292|NCT00451958|18260383|P4|CS21A (NCT00451958)|Lost to Follow-up|1
5296293|NCT00451958|18260384|P3|CS21A (NCT00451958)|Lost to Follow-up|1
5296294|NCT00451958|18260385|P2|CS21A (NCT00451958)|Lost to Follow-up|5
5296295|NCT00451958|18260386|P1|CS21A (NCT00451958)|Lost to Follow-up|6
5296296|NCT00451958|18260382|P5|CS21A (NCT00451958)|Adverse Event|0
5296297|NCT00451958|18260383|P4|CS21A (NCT00451958)|Adverse Event|17
5296298|NCT00451958|18260384|P3|CS21A (NCT00451958)|Adverse Event|14
5296299|NCT00451958|18260385|P2|CS21A (NCT00451958)|Adverse Event|34
5296300|NCT00451958|18260386|P1|CS21A (NCT00451958)|Adverse Event|21
5296301|NCT00451906|18260416|P1|Overall Study|Did not complete final visit|4
5296302|NCT00451906|18260416|P1|Overall Study|Other Reasons|121
5296303|NCT00451906|18260416|P1|Overall Study|Termination of the study|108
5296304|NCT00451906|18260416|P1|Overall Study|Progressive disease|1328
5296305|NCT00451906|18260416|P1|Overall Study|Protocol Violation|21
5296306|NCT00451906|18260416|P1|Overall Study|Withdrawal by Subject|111
5296307|NCT00451906|18260416|P1|Overall Study|Lost to Follow-up|31
5296308|NCT00451906|18260416|P1|Overall Study|Adverse Event|515
5296309|NCT00451555|18260444|P2|Overall Study|Physician Decision|1
5296310|NCT00451555|18260445|P1|Overall Study|Physician Decision|2
5296311|NCT00451555|18260444|P2|Overall Study|Withdrawal by Subject|0
5296312|NCT00451555|18260445|P1|Overall Study|Withdrawal by Subject|6
5296313|NCT00451555|18260444|P2|Overall Study|Adverse Event|1
5296314|NCT00451555|18260445|P1|Overall Study|Adverse Event|3
5296315|NCT00451555|18260444|P2|Overall Study|Protocol Violation|2
5296316|NCT00451555|18260445|P1|Overall Study|Protocol Violation|2
5296317|NCT00451451|18260479|P4|Overall Study|Other Reasons for Not Completing Study|14
5296318|NCT00451451|18260480|P3|Overall Study|Other Reasons for Not Completing Study|17
5296319|NCT00451451|18260481|P2|Overall Study|Other Reasons for Not Completing Study|30
5296320|NCT00451451|18260482|P1|Overall Study|Other Reasons for Not Completing Study|34
5296321|NCT00451451|18260479|P4|Overall Study|Death|1
5296322|NCT00451451|18260480|P3|Overall Study|Death|0
5296323|NCT00451451|18260481|P2|Overall Study|Death|0
5296324|NCT00451451|18260482|P1|Overall Study|Death|1
5296325|NCT00451451|18260479|P4|Overall Study|Subject Non-Compliance|3
5296326|NCT00451451|18260480|P3|Overall Study|Subject Non-Compliance|3
5296327|NCT00451451|18260481|P2|Overall Study|Subject Non-Compliance|4
5296328|NCT00451451|18260482|P1|Overall Study|Subject Non-Compliance|8
5296329|NCT00451451|18260479|P4|Overall Study|Investigator Decision|2
5296330|NCT00451451|18260480|P3|Overall Study|Investigator Decision|1
5296331|NCT00451451|18260481|P2|Overall Study|Investigator Decision|2
5296332|NCT00451451|18260482|P1|Overall Study|Investigator Decision|6
5296333|NCT00451451|18260479|P4|Overall Study|Consent Withdrawn|17
5296334|NCT00451451|18260480|P3|Overall Study|Consent Withdrawn|17
5296335|NCT00451451|18260481|P2|Overall Study|Consent Withdrawn|9
5296336|NCT00451451|18260482|P1|Overall Study|Consent Withdrawn|14
5296337|NCT00451451|18260479|P4|Overall Study|Lost to Follow-up|11
5296338|NCT00451451|18260480|P3|Overall Study|Lost to Follow-up|8
5296339|NCT00451451|18260481|P2|Overall Study|Lost to Follow-up|9
5296340|NCT00451451|18260482|P1|Overall Study|Lost to Follow-up|11
5296341|NCT00451451|18260479|P4|Overall Study|Adverse Event|10
5296342|NCT00451451|18260480|P3|Overall Study|Adverse Event|26
5296343|NCT00451451|18260481|P2|Overall Study|Adverse Event|21
5296344|NCT00451451|18260482|P1|Overall Study|Adverse Event|11
5296345|NCT00451321|18260517|P8|Overall Study|Sponsor decision to amend protocol|3
5296346|NCT00451321|18260518|P7|Overall Study|Sponsor decision to amend protocol|1
5296347|NCT00451321|18260519|P6|Overall Study|Sponsor decision to amend protocol|1
5296348|NCT00451321|18260520|P5|Overall Study|Sponsor decision to amend protocol|0
5296349|NCT00451321|18260521|P4|Overall Study|Sponsor decision to amend protocol|0
5296350|NCT00451321|18260522|P3|Overall Study|Sponsor decision to amend protocol|0
5296351|NCT00451321|18260523|P2|Overall Study|Sponsor decision to amend protocol|0
5296352|NCT00451321|18260524|P1|Overall Study|Sponsor decision to amend protocol|0
5296353|NCT00451321|18260517|P8|Overall Study|Study closed/terminated|3
5296354|NCT00451321|18260518|P7|Overall Study|Study closed/terminated|5
5296355|NCT00451321|18260519|P6|Overall Study|Study closed/terminated|7
5296356|NCT00451321|18260520|P5|Overall Study|Study closed/terminated|7
5296357|NCT00451321|18260521|P4|Overall Study|Study closed/terminated|5
5296358|NCT00451321|18260522|P3|Overall Study|Study closed/terminated|17
5296359|NCT00451321|18260523|P2|Overall Study|Study closed/terminated|1
5296360|NCT00451321|18260524|P1|Overall Study|Study closed/terminated|1
5296361|NCT00451321|18260517|P8|Overall Study|Withdrawal by Subject|0
5296362|NCT00451321|18260518|P7|Overall Study|Withdrawal by Subject|0
5296363|NCT00451321|18260519|P6|Overall Study|Withdrawal by Subject|0
5296364|NCT00451321|18260520|P5|Overall Study|Withdrawal by Subject|0
5296365|NCT00451321|18260521|P4|Overall Study|Withdrawal by Subject|4
5296366|NCT00451321|18260522|P3|Overall Study|Withdrawal by Subject|0
5296367|NCT00451321|18260523|P2|Overall Study|Withdrawal by Subject|1
5296368|NCT00451321|18260524|P1|Overall Study|Withdrawal by Subject|3
5296369|NCT00451321|18260517|P8|Overall Study|Lost to Follow-up|0
5296370|NCT00451321|18260518|P7|Overall Study|Lost to Follow-up|0
5296371|NCT00451321|18260519|P6|Overall Study|Lost to Follow-up|1
5296372|NCT00451321|18260520|P5|Overall Study|Lost to Follow-up|0
5296373|NCT00451321|18260521|P4|Overall Study|Lost to Follow-up|3
5296374|NCT00451321|18260522|P3|Overall Study|Lost to Follow-up|1
5296375|NCT00451321|18260523|P2|Overall Study|Lost to Follow-up|3
5296376|NCT00451321|18260524|P1|Overall Study|Lost to Follow-up|3
5296377|NCT00451282|18260696|P2|Overall Study|Lost to Follow-up|5
5296378|NCT00451282|18260697|P1|Overall Study|Lost to Follow-up|6
5296379|NCT00451217|18260713|P4|Overall Study|Not Treated|4
5296380|NCT00451217|18260714|P3|Overall Study|Not Treated|3
5296381|NCT00451217|18260715|P2|Overall Study|Not Treated|1
5296382|NCT00451217|18260716|P1|Overall Study|Not Treated|1
5296383|NCT00451217|18260713|P4|Overall Study|Withdrawal by Subject|0
5296384|NCT00451217|18260714|P3|Overall Study|Withdrawal by Subject|0
5296385|NCT00451217|18260715|P2|Overall Study|Withdrawal by Subject|0
5296386|NCT00451217|18260716|P1|Overall Study|Withdrawal by Subject|1
5296387|NCT00451217|18260713|P4|Overall Study|Lost to Follow-up|1
5296388|NCT00451217|18260714|P3|Overall Study|Lost to Follow-up|1
5296389|NCT00451217|18260715|P2|Overall Study|Lost to Follow-up|1
5296390|NCT00451217|18260716|P1|Overall Study|Lost to Follow-up|0
5296391|NCT00451204|18260744|P2|Overall Study|Other|2
5296392|NCT00451204|18260745|P1|Overall Study|Other|1
5296393|NCT00451204|18260744|P2|Overall Study|Patient refusal|4
5296394|NCT00451204|18260745|P1|Overall Study|Patient refusal|8
5296395|NCT00451204|18260744|P2|Overall Study|Protocol Violation|0
5296396|NCT00451204|18260745|P1|Overall Study|Protocol Violation|1
5296397|NCT00451204|18260744|P2|Overall Study|Lost to Follow-up|4
5296398|NCT00451204|18260745|P1|Overall Study|Lost to Follow-up|4
5296399|NCT00451204|18260744|P2|Overall Study|Lack of Efficacy|4
5296400|NCT00451204|18260745|P1|Overall Study|Lack of Efficacy|4
5296401|NCT00451204|18260744|P2|Overall Study|Adverse Event|6
5296402|NCT00451204|18260745|P1|Overall Study|Adverse Event|4
5296403|NCT00451191|18260763|P2|Overall Study|withdrawal or received alternate tx|11
5296404|NCT00451191|18260764|P1|Overall Study|withdrawal or received alternate tx|15
5296405|NCT00451178|18260772|P2|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
5296406|NCT00451178|18260773|P1|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
5296407|NCT00451178|18260772|P2|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
5296408|NCT00451178|18260773|P1|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
5296409|NCT00451178|18260772|P2|Maintenance Therapy (up to 3 Years)|PD|0
5296410|NCT00451178|18260773|P1|Maintenance Therapy (up to 3 Years)|PD|10
5296411|NCT00451178|18260772|P2|Maintenance Therapy (up to 3 Years)|Death|0
5296412|NCT00451178|18260773|P1|Maintenance Therapy (up to 3 Years)|Death|1
5296413|NCT00451178|18260772|P2|Maintenance Therapy (up to 3 Years)|Physician Decision|0
5296414|NCT00451178|18260773|P1|Maintenance Therapy (up to 3 Years)|Physician Decision|1
5296415|NCT00451178|18260772|P2|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
5296416|NCT00451178|18260773|P1|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
5296417|NCT00451178|18260772|P2|Maintenance Therapy (up to 3 Years)|Adverse Event|0
5296418|NCT00451178|18260773|P1|Maintenance Therapy (up to 3 Years)|Adverse Event|4
5296419|NCT00451178|18260772|P2|Prior to Maintenance Therapy|PD|0
5296420|NCT00451178|18260773|P1|Prior to Maintenance Therapy|PD|2
5296421|NCT00451178|18260772|P2|Prior to Maintenance Therapy|Physician Decision|0
5296422|NCT00451178|18260773|P1|Prior to Maintenance Therapy|Physician Decision|2
5296423|NCT00451178|18260772|P2|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
5296424|NCT00451178|18260773|P1|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
5296425|NCT00451178|18260772|P2|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
5296426|NCT00451178|18260773|P1|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
5296427|NCT00451178|18260772|P2|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
5296428|NCT00451178|18260773|P1|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
5296429|NCT00451178|18260772|P2|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
5296430|NCT00451178|18260773|P1|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
5296431|NCT00451178|18260772|P2|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
5296432|NCT00451178|18260773|P1|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
5296433|NCT00451178|18260772|P2|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
5296434|NCT00451178|18260773|P1|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
5296435|NCT00450866|18260820|P2|Overall Study|Physician Decision|0
5296436|NCT00450866|18260821|P1|Overall Study|Physician Decision|1
5296437|NCT00450866|18260820|P2|Overall Study|Death|0
5296438|NCT00450866|18260821|P1|Overall Study|Death|1
5296439|NCT00450866|18260820|P2|Overall Study|Withdrawal by Subject|2
5296440|NCT00450866|18260821|P1|Overall Study|Withdrawal by Subject|5
5296441|NCT00450866|18260820|P2|Overall Study|Adverse Event|1
5296442|NCT00450866|18260821|P1|Overall Study|Adverse Event|0
5296443|NCT00450814|18260841|P11|Overall Study|Patient withdrawal prior to treatment|0
5296444|NCT00450814|18260842|P10|Overall Study|Patient withdrawal prior to treatment|1
5296445|NCT00450814|18260843|P9|Overall Study|Patient withdrawal prior to treatment|0
5296446|NCT00450814|18260844|P8|Overall Study|Patient withdrawal prior to treatment|0
5296447|NCT00450814|18260845|P7|Overall Study|Patient withdrawal prior to treatment|0
5296448|NCT00450814|18260846|P6|Overall Study|Patient withdrawal prior to treatment|0
5296449|NCT00450814|18260847|P5|Overall Study|Patient withdrawal prior to treatment|0
5296450|NCT00450814|18260848|P4|Overall Study|Patient withdrawal prior to treatment|0
5296451|NCT00450814|18260849|P3|Overall Study|Patient withdrawal prior to treatment|0
5296452|NCT00450814|18260850|P2|Overall Study|Patient withdrawal prior to treatment|0
5296453|NCT00450814|18260851|P1|Overall Study|Patient withdrawal prior to treatment|0
5296454|NCT00450814|18260841|P11|Overall Study|Failed to complete the initial therapy|0
5296455|NCT00450814|18260842|P10|Overall Study|Failed to complete the initial therapy|0
5296456|NCT00450814|18260843|P9|Overall Study|Failed to complete the initial therapy|0
5296457|NCT00450814|18260844|P8|Overall Study|Failed to complete the initial therapy|0
5296458|NCT00450814|18260845|P7|Overall Study|Failed to complete the initial therapy|0
5296459|NCT00450814|18260846|P6|Overall Study|Failed to complete the initial therapy|1
5296460|NCT00450814|18260847|P5|Overall Study|Failed to complete the initial therapy|1
5296461|NCT00450814|18260848|P4|Overall Study|Failed to complete the initial therapy|1
5296462|NCT00450814|18260849|P3|Overall Study|Failed to complete the initial therapy|0
5296463|NCT00450814|18260850|P2|Overall Study|Failed to complete the initial therapy|0
5296464|NCT00450814|18260851|P1|Overall Study|Failed to complete the initial therapy|0
5296465|NCT00450801|18260885|P1|Overall Study|Death|1
5296466|NCT00450749|18260899|P3|Overall Study|Noncompliant|0
5296467|NCT00450749|18260900|P2|Overall Study|Noncompliant|1
5296468|NCT00450749|18260901|P1|Overall Study|Noncompliant|0
5296469|NCT00450749|18260899|P3|Overall Study|Withdrawal by Subject|2
5296470|NCT00450749|18260900|P2|Overall Study|Withdrawal by Subject|0
5296471|NCT00450749|18260901|P1|Overall Study|Withdrawal by Subject|0
5296472|NCT00450723|18260939|P1|Overall Study|Physician Decision|5
5296473|NCT00450658|18260947|P2|Overall Study|misc|10
5296474|NCT00450658|18260948|P1|Overall Study|misc|21
5296475|NCT00450658|18260947|P2|Overall Study|UGI ulcer|34
5296476|NCT00450658|18260948|P1|Overall Study|UGI ulcer|33
5296477|NCT00450658|18260947|P2|Overall Study|Lost to Follow-up|5
5296478|NCT00450658|18260948|P1|Overall Study|Lost to Follow-up|22
5296479|NCT00450658|18260947|P2|Overall Study|Withdrawal by Subject|26
5296480|NCT00450658|18260948|P1|Overall Study|Withdrawal by Subject|43
5296481|NCT00450658|18260947|P2|Overall Study|Adverse Event|15
5296482|NCT00450658|18260948|P1|Overall Study|Adverse Event|24
5296483|NCT00450619|18260962|P2|Overall Study|Adverse Event|0
5296484|NCT00450619|18260963|P1|Overall Study|Adverse Event|1
5296485|NCT00450619|18260962|P2|Overall Study|did not progress; refused further trmt|1
5296486|NCT00450619|18260963|P1|Overall Study|did not progress; refused further trmt|1
5296487|NCT00450619|18260962|P2|Overall Study|refused treatment after randomization|0
5296488|NCT00450619|18260963|P1|Overall Study|refused treatment after randomization|2
5296489|NCT00450580|18260989|P2|Overall Study|Withdrawal due to pregnancy|1
5296490|NCT00450580|18260990|P1|Overall Study|Withdrawal due to pregnancy|0
5296491|NCT00450580|18260989|P2|Overall Study|Patient could not swallow Norvir|0
5296492|NCT00450580|18260990|P1|Overall Study|Patient could not swallow Norvir|1
5296493|NCT00450580|18260989|P2|Overall Study|Patient went to Brazil|0
5296494|NCT00450580|18260990|P1|Overall Study|Patient went to Brazil|1
5296495|NCT00450580|18260989|P2|Overall Study|Could not comply with scheduled visits|0
5296496|NCT00450580|18260990|P1|Overall Study|Could not comply with scheduled visits|1
5296497|NCT00450580|18260989|P2|Overall Study|Protocol-defined virologic failure|0
5296498|NCT00450580|18260990|P1|Overall Study|Protocol-defined virologic failure|1
5296499|NCT00450580|18260989|P2|Overall Study|Protocol Violation|1
5296500|NCT00450580|18260990|P1|Overall Study|Protocol Violation|1
5296501|NCT00450580|18260989|P2|Overall Study|Withdrawal by Subject|2
5296502|NCT00450580|18260990|P1|Overall Study|Withdrawal by Subject|2
5296503|NCT00450580|18260989|P2|Overall Study|Lost to Follow-up|5
5296504|NCT00450580|18260990|P1|Overall Study|Lost to Follow-up|4
5296505|NCT00450580|18260989|P2|Overall Study|Adverse Event|7
5296506|NCT00450580|18260990|P1|Overall Study|Adverse Event|5
5296507|NCT00450450|18261027|P2|Overall Study|Missing Data|0
5296508|NCT00450450|18261028|P1|Overall Study|Missing Data|2
5296509|NCT00450450|18261027|P2|Overall Study|Relapse|0
5296510|NCT00450450|18261028|P1|Overall Study|Relapse|2
5296511|NCT00450450|18261027|P2|Overall Study|Death|3
5296512|NCT00450450|18261028|P1|Overall Study|Death|1
5296513|NCT00450437|18261052|P4|Overall Study|Unable to Classify|0
5296514|NCT00450437|18261053|P3|Overall Study|Unable to Classify|1
5296515|NCT00450437|18261054|P2|Overall Study|Unable to Classify|0
5296516|NCT00450437|18261055|P1|Overall Study|Unable to Classify|1
5296517|NCT00450437|18261052|P4|Overall Study|Administrative reason|0
5296518|NCT00450437|18261053|P3|Overall Study|Administrative reason|1
5296519|NCT00450437|18261054|P2|Overall Study|Administrative reason|0
5296520|NCT00450437|18261055|P1|Overall Study|Administrative reason|0
5296521|NCT00450437|18261052|P4|Overall Study|Inappropriate enrollment|0
5296522|NCT00450437|18261053|P3|Overall Study|Inappropriate enrollment|3
5296523|NCT00450437|18261054|P2|Overall Study|Inappropriate enrollment|1
5296524|NCT00450437|18261055|P1|Overall Study|Inappropriate enrollment|4
5296525|NCT00450437|18261052|P4|Overall Study|Protocol Violation|1
5296526|NCT00450437|18261053|P3|Overall Study|Protocol Violation|0
5296527|NCT00450437|18261054|P2|Overall Study|Protocol Violation|1
5296528|NCT00450437|18261055|P1|Overall Study|Protocol Violation|0
5296529|NCT00450437|18261052|P4|Overall Study|Lost to Follow-up|9
5296530|NCT00450437|18261053|P3|Overall Study|Lost to Follow-up|19
5296531|NCT00450437|18261054|P2|Overall Study|Lost to Follow-up|12
5296532|NCT00450437|18261055|P1|Overall Study|Lost to Follow-up|31
5296533|NCT00450437|18261052|P4|Overall Study|Withdrawal by Subject|1
5296534|NCT00450437|18261053|P3|Overall Study|Withdrawal by Subject|0
5296535|NCT00450437|18261054|P2|Overall Study|Withdrawal by Subject|2
5296536|NCT00450437|18261055|P1|Overall Study|Withdrawal by Subject|10
5296537|NCT00450411|18261086|P1|Overall Study|No protocol treatment|2
5296538|NCT00450411|18261086|P1|Overall Study|Protocol Violation|6
5296539|NCT00450385|18261091|P1|Overall Study|Other|3
5296540|NCT00450385|18261091|P1|Overall Study|Physician Decision|1
5296541|NCT00450385|18261091|P1|Overall Study|Adverse Event|1
5296542|NCT00450385|18261091|P1|Overall Study|Lack of Efficacy|2
5296543|NCT00450385|18261091|P1|Overall Study|Withdrawal by Subject|2
5296544|NCT00450385|18261091|P1|Overall Study|Protocol Violation|1
5296545|NCT00450385|18261091|P1|Overall Study|Death|3
5296546|NCT00450372|18261100|P1|Overall Study|Physician Decision|1
5296547|NCT00450333|18261113|P4|Overall Study|Death|2
5296548|NCT00450333|18261114|P3|Overall Study|Death|2
5296549|NCT00450333|18261115|P2|Overall Study|Death|2
5296550|NCT00450333|18261116|P1|Overall Study|Death|3
5296551|NCT00450333|18261113|P4|Overall Study|Kidney transplant|3
5296552|NCT00450333|18261114|P3|Overall Study|Kidney transplant|1
5296553|NCT00450333|18261115|P2|Overall Study|Kidney transplant|0
5296554|NCT00450333|18261116|P1|Overall Study|Kidney transplant|1
5296555|NCT00450333|18261113|P4|Overall Study|Withdrawal by Subject|0
5296556|NCT00450333|18261114|P3|Overall Study|Withdrawal by Subject|3
5296557|NCT00450333|18261115|P2|Overall Study|Withdrawal by Subject|0
5296558|NCT00450333|18261116|P1|Overall Study|Withdrawal by Subject|1
5296559|NCT00450333|18261113|P4|Overall Study|Protocol Violation|0
5296560|NCT00450333|18261114|P3|Overall Study|Protocol Violation|1
5296561|NCT00450333|18261115|P2|Overall Study|Protocol Violation|0
5296562|NCT00450333|18261116|P1|Overall Study|Protocol Violation|1
5296563|NCT00450333|18261113|P4|Overall Study|Adverse Event|2
5296564|NCT00450333|18261114|P3|Overall Study|Adverse Event|2
5296565|NCT00450333|18261115|P2|Overall Study|Adverse Event|7
5296566|NCT00450333|18261116|P1|Overall Study|Adverse Event|1
5296567|NCT00450333|18261113|P4|Overall Study|Study terminated|21
5296568|NCT00450333|18261114|P3|Overall Study|Study terminated|16
5296569|NCT00450333|18261115|P2|Overall Study|Study terminated|54
5296570|NCT00450333|18261116|P1|Overall Study|Study terminated|47
5296571|NCT00450255|18261139|P1|Overall Study|Prior RFA ablation of liver|1
5296572|NCT00450216|18261164|P2|Overall Study|misc|20
5296573|NCT00450216|18261165|P1|Overall Study|misc|21
5296574|NCT00450216|18261164|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
5296575|NCT00450216|18261165|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
5296576|NCT00450216|18261164|P2|Overall Study|Lost to Follow-up|9
5296577|NCT00450216|18261165|P1|Overall Study|Lost to Follow-up|16
5296578|NCT00450216|18261164|P2|Overall Study|Withdrawal by Subject|26
5296579|NCT00450216|18261165|P1|Overall Study|Withdrawal by Subject|48
5296580|NCT00450216|18261164|P2|Overall Study|Adverse Event|23
5296581|NCT00450216|18261165|P1|Overall Study|Adverse Event|38
5296582|NCT00450190|18261177|P1|Overall Study|Withdrawal by Subject|2
5296583|NCT00450177|18261187|P2|Overall Study|Withdrawal by Primary Team|1
5296584|NCT00450177|18261188|P1|Overall Study|Withdrawal by Primary Team|1
5296585|NCT00450177|18261187|P2|Overall Study|Withdrawal by Subject|6
5296586|NCT00450177|18261188|P1|Overall Study|Withdrawal by Subject|1
5296587|NCT00450177|18261187|P2|Overall Study|Adverse Event|4
5296588|NCT00450177|18261188|P1|Overall Study|Adverse Event|7
5296589|NCT00450112|18261214|P2|Overall Study|Others|3
5296590|NCT00450112|18261215|P1|Overall Study|Others|2
5296591|NCT00450112|18261214|P2|Overall Study|Lost to Follow-up|1
5296592|NCT00450112|18261215|P1|Overall Study|Lost to Follow-up|2
5296593|NCT00450112|18261214|P2|Overall Study|Withdrawal by Subject|1
5296594|NCT00450112|18261215|P1|Overall Study|Withdrawal by Subject|4
5296595|NCT00450112|18261214|P2|Overall Study|Other Treatment Required|1
5296596|NCT00450112|18261215|P1|Overall Study|Other Treatment Required|5
5296597|NCT00449956|18261253|P3|Overall Study|Physician Decision|1
5296598|NCT00449956|18261254|P2|Overall Study|Physician Decision|1
5296599|NCT00449956|18261255|P1|Overall Study|Physician Decision|2
5296600|NCT00449956|18261253|P3|Overall Study|Withdrawal by Subject|0
5296601|NCT00449956|18261254|P2|Overall Study|Withdrawal by Subject|1
5296602|NCT00449956|18261255|P1|Overall Study|Withdrawal by Subject|0
5296603|NCT00449956|18261253|P3|Overall Study|Protocol Violation|1
5296604|NCT00449956|18261254|P2|Overall Study|Protocol Violation|1
5296605|NCT00449956|18261255|P1|Overall Study|Protocol Violation|1
5296606|NCT00449956|18261253|P3|Overall Study|Lack of Efficacy|1
5296607|NCT00449956|18261254|P2|Overall Study|Lack of Efficacy|0
5296608|NCT00449956|18261255|P1|Overall Study|Lack of Efficacy|0
5296609|NCT00449956|18261253|P3|Overall Study|Adverse Event|6
5296610|NCT00449956|18261254|P2|Overall Study|Adverse Event|1
5296611|NCT00449956|18261255|P1|Overall Study|Adverse Event|7
5296612|NCT00449930|18261271|P2|Overall Study|Glycemic discontinuation criteria|1
5296613|NCT00449930|18261272|P1|Overall Study|Glycemic discontinuation criteria|1
5296614|NCT00449930|18261271|P2|Overall Study|Withdrawal by Subject|23
5296615|NCT00449930|18261272|P1|Overall Study|Withdrawal by Subject|16
5296616|NCT00449930|18261271|P2|Overall Study|Protocol Violation|15
5296617|NCT00449930|18261272|P1|Overall Study|Protocol Violation|14
5296618|NCT00449930|18261271|P2|Overall Study|Physician Decision|2
5296619|NCT00449930|18261272|P1|Overall Study|Physician Decision|1
5296620|NCT00449930|18261271|P2|Overall Study|Lost to Follow-up|14
5296621|NCT00449930|18261272|P1|Overall Study|Lost to Follow-up|9
5296622|NCT00449930|18261271|P2|Overall Study|Lack of Efficacy|1
5296623|NCT00449930|18261272|P1|Overall Study|Lack of Efficacy|10
5296624|NCT00449930|18261271|P2|Overall Study|Trial Terminated ( Site Closed)|0
5296625|NCT00449930|18261272|P1|Overall Study|Trial Terminated ( Site Closed)|1
5296626|NCT00449930|18261271|P2|Overall Study|Adverse Event|19
5296627|NCT00449930|18261272|P1|Overall Study|Adverse Event|9
5296628|NCT00449865|18261288|P2|Overall Study|Study was stopped|328
5296629|NCT00449865|18261289|P1|Overall Study|Study was stopped|324
5296630|NCT00449865|18261288|P2|Overall Study|Protocol Violation|7
5296631|NCT00449865|18261289|P1|Overall Study|Protocol Violation|8
5296632|NCT00449865|18261288|P2|Overall Study|Death|40
5296633|NCT00449865|18261289|P1|Overall Study|Death|31
5296634|NCT00449865|18261288|P2|Overall Study|Physician Decision|12
5296635|NCT00449865|18261289|P1|Overall Study|Physician Decision|13
5296636|NCT00449865|18261288|P2|Overall Study|Lost to Follow-up|37
5296637|NCT00449865|18261289|P1|Overall Study|Lost to Follow-up|36
5296638|NCT00449865|18261288|P2|Overall Study|Withdrawal by Subject|110
5296639|NCT00449865|18261289|P1|Overall Study|Withdrawal by Subject|110
5296640|NCT00449787|18261297|P2|Overall Study|Did not require medication|92
5296641|NCT00449787|18261298|P1|Overall Study|Did not require medication|95
5296642|NCT00449787|18261297|P2|Overall Study|Lost to Follow-up|8
5296643|NCT00449787|18261298|P1|Overall Study|Lost to Follow-up|10
5296644|NCT00449696|18261314|P2|Overall Study|Others|0
5296645|NCT00449696|18261315|P1|Overall Study|Others|7
5296646|NCT00449696|18261314|P2|Overall Study|Lost to Follow-up|3
5296647|NCT00449696|18261315|P1|Overall Study|Lost to Follow-up|2
5296648|NCT00449696|18261314|P2|Overall Study|Withdrawal by Subject|5
5296649|NCT00449696|18261315|P1|Overall Study|Withdrawal by Subject|5
5296650|NCT00449696|18261314|P2|Overall Study|Other Treatment Required|1
5296651|NCT00449696|18261315|P1|Overall Study|Other Treatment Required|6
5296652|NCT00449670|18261339|P2|Booster Phase (Study no.109873)|Other|2
5296653|NCT00449670|18261340|P1|Booster Phase (Study no.109873)|Other|0
5296654|NCT00449670|18261339|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
5296655|NCT00449670|18261340|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
5296656|NCT00449670|18261339|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
5296657|NCT00449670|18261340|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
5296658|NCT00449670|18261339|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
5296659|NCT00449670|18261340|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
5296660|NCT00449670|18261339|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
5296661|NCT00449670|18261340|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
5296662|NCT00449670|18261339|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
5296663|NCT00449670|18261340|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
5296664|NCT00449644|18261453|P4|Overall Study|Rolled-over to treatment with TMC207|1
5296665|NCT00449644|18261454|P3|Overall Study|Rolled-over to treatment with TMC207|0
5296666|NCT00449644|18261455|P2|Overall Study|Rolled-over to treatment with TMC207|0
5296667|NCT00449644|18261456|P1|Overall Study|Rolled-over to treatment with TMC207|0
5296668|NCT00449644|18261453|P4|Overall Study|Other|0
5296669|NCT00449644|18261454|P3|Overall Study|Other|1
5296670|NCT00449644|18261455|P2|Overall Study|Other|4
5296671|NCT00449644|18261456|P1|Overall Study|Other|1
5296672|NCT00449644|18261453|P4|Overall Study|Inclusion/exclusion criteria not met|6
5296673|NCT00449644|18261454|P3|Overall Study|Inclusion/exclusion criteria not met|2
5296674|NCT00449644|18261455|P2|Overall Study|Inclusion/exclusion criteria not met|0
5296675|NCT00449644|18261456|P1|Overall Study|Inclusion/exclusion criteria not met|0
5296676|NCT00449644|18261453|P4|Overall Study|Withdrawal by Subject|7
5296677|NCT00449644|18261454|P3|Overall Study|Withdrawal by Subject|6
5296678|NCT00449644|18261455|P2|Overall Study|Withdrawal by Subject|4
5296679|NCT00449644|18261456|P1|Overall Study|Withdrawal by Subject|3
5296680|NCT00449644|18261453|P4|Overall Study|Protocol Violation|7
5296681|NCT00449644|18261454|P3|Overall Study|Protocol Violation|3
5296682|NCT00449644|18261455|P2|Overall Study|Protocol Violation|4
5296683|NCT00449644|18261456|P1|Overall Study|Protocol Violation|4
5296684|NCT00449644|18261453|P4|Overall Study|Pregnancy|2
5296685|NCT00449644|18261454|P3|Overall Study|Pregnancy|3
5296686|NCT00449644|18261455|P2|Overall Study|Pregnancy|0
5296687|NCT00449644|18261456|P1|Overall Study|Pregnancy|0
5296688|NCT00449644|18261453|P4|Overall Study|Lost to Follow-up|3
5296689|NCT00449644|18261454|P3|Overall Study|Lost to Follow-up|5
5296690|NCT00449644|18261455|P2|Overall Study|Lost to Follow-up|1
5296691|NCT00449644|18261456|P1|Overall Study|Lost to Follow-up|1
5296692|NCT00449644|18261453|P4|Overall Study|Death|1
5296693|NCT00449644|18261454|P3|Overall Study|Death|6
5296694|NCT00449644|18261455|P2|Overall Study|Death|0
5296695|NCT00449644|18261456|P1|Overall Study|Death|1
5296696|NCT00449644|18261453|P4|Overall Study|Adverse Event|5
5296697|NCT00449644|18261454|P3|Overall Study|Adverse Event|3
5296698|NCT00449644|18261455|P2|Overall Study|Adverse Event|0
5296699|NCT00449644|18261456|P1|Overall Study|Adverse Event|0
5296700|NCT00449540|18261476|P3|Treatment Phase|did not experience or treat migraine|17
5296701|NCT00449540|18261477|P2|Treatment Phase|did not experience or treat migraine|20
5296702|NCT00449540|18261478|P1|Treatment Phase|did not experience or treat migraine|0
5296703|NCT00449540|18261476|P3|Pretreatment Phase|No migraine experienced|0
5296704|NCT00449540|18261477|P2|Pretreatment Phase|No migraine experienced|0
5296705|NCT00449540|18261478|P1|Pretreatment Phase|No migraine experienced|66
5296706|NCT00449176|18261495|P3|Overall Study|all other|20
5296707|NCT00449176|18261496|P2|Overall Study|all other|19
5296708|NCT00449176|18261497|P1|Overall Study|all other|22
5296709|NCT00449176|18261495|P3|Overall Study|Study drug non-compliant|11
5296710|NCT00449176|18261496|P2|Overall Study|Study drug non-compliant|11
5296711|NCT00449176|18261497|P1|Overall Study|Study drug non-compliant|14
5296712|NCT00449176|18261495|P3|Overall Study|Lack of Efficacy|50
5296713|NCT00449176|18261496|P2|Overall Study|Lack of Efficacy|7
5296714|NCT00449176|18261497|P1|Overall Study|Lack of Efficacy|13
5296715|NCT00449176|18261495|P3|Overall Study|Adverse Event|15
5296716|NCT00449176|18261496|P2|Overall Study|Adverse Event|107
5296717|NCT00449176|18261497|P1|Overall Study|Adverse Event|51
5296718|NCT00449176|18261495|P3|Overall Study|Lost to Follow-up|12
5296719|NCT00449176|18261496|P2|Overall Study|Lost to Follow-up|8
5296720|NCT00449176|18261497|P1|Overall Study|Lost to Follow-up|13
5296721|NCT00449176|18261495|P3|Overall Study|Withdrawal by Subject|59
5296722|NCT00449176|18261496|P2|Overall Study|Withdrawal by Subject|43
5296723|NCT00449176|18261497|P1|Overall Study|Withdrawal by Subject|39
5296724|NCT00449163|18261523|P1|Overall Study|Physician Decision|3
5296725|NCT00449150|18261533|P3|Overall Study|Protocol Violation|1
5296726|NCT00449150|18261534|P2|Overall Study|Protocol Violation|2
5296727|NCT00449150|18261535|P1|Overall Study|Protocol Violation|1
5296728|NCT00449150|18261533|P3|Overall Study|Withdrawal by Subject|21
5296729|NCT00449150|18261534|P2|Overall Study|Withdrawal by Subject|18
5296730|NCT00449150|18261535|P1|Overall Study|Withdrawal by Subject|17
5296731|NCT00449150|18261533|P3|Overall Study|Other|14
5296732|NCT00449150|18261534|P2|Overall Study|Other|13
5296733|NCT00449150|18261535|P1|Overall Study|Other|16
5296734|NCT00449150|18261533|P3|Overall Study|Lack of Efficacy|2
5296735|NCT00449150|18261534|P2|Overall Study|Lack of Efficacy|2
5296736|NCT00449150|18261535|P1|Overall Study|Lack of Efficacy|1
5296737|NCT00449150|18261533|P3|Overall Study|Adverse Event|9
5296738|NCT00449150|18261534|P2|Overall Study|Adverse Event|18
5296739|NCT00449150|18261535|P1|Overall Study|Adverse Event|11
5296740|NCT00449072|18261548|P2|Overall Study|Relocation|2
5296741|NCT00449072|18261549|P1|Overall Study|Relocation|3
5296742|NCT00449072|18261548|P2|Overall Study|Sponsor decision|3
5296743|NCT00449072|18261549|P1|Overall Study|Sponsor decision|1
5296744|NCT00449072|18261548|P2|Overall Study|Non-compliance|5
5296745|NCT00449072|18261549|P1|Overall Study|Non-compliance|2
5296746|NCT00449072|18261548|P2|Overall Study|Excluded medication|2
5296747|NCT00449072|18261549|P1|Overall Study|Excluded medication|0
5296748|NCT00449072|18261548|P2|Overall Study|Not treated|1
5296749|NCT00449072|18261549|P1|Overall Study|Not treated|0
5296750|NCT00449072|18261548|P2|Overall Study|Physician Decision|0
5296751|NCT00449072|18261549|P1|Overall Study|Physician Decision|1
5296752|NCT00449072|18261548|P2|Overall Study|Lack of Efficacy|1
5296753|NCT00449072|18261549|P1|Overall Study|Lack of Efficacy|1
5296754|NCT00449072|18261548|P2|Overall Study|Withdrawal by Subject|8
5296755|NCT00449072|18261549|P1|Overall Study|Withdrawal by Subject|11
5296756|NCT00449072|18261548|P2|Overall Study|Lost to Follow-up|7
5296757|NCT00449072|18261549|P1|Overall Study|Lost to Follow-up|5
5296758|NCT00449072|18261548|P2|Overall Study|Protocol Violation|12
5296759|NCT00449072|18261549|P1|Overall Study|Protocol Violation|14
5296760|NCT00449072|18261548|P2|Overall Study|Adverse Event|1
5296761|NCT00449072|18261549|P1|Overall Study|Adverse Event|3
5296762|NCT00449033|18261586|P2|Follow-up Period|Reason Missing|113
5296763|NCT00449033|18261587|P1|Follow-up Period|Reason Missing|120
5296764|NCT00449033|18261586|P2|Follow-up Period|Lost to Follow-up|10
5296765|NCT00449033|18261587|P1|Follow-up Period|Lost to Follow-up|6
5296766|NCT00449033|18261586|P2|Follow-up Period|Death|311
5296767|NCT00449033|18261587|P1|Follow-up Period|Death|299
5296768|NCT00449033|18261586|P2|Treatment Period|Treatment Ongoing|4
5296769|NCT00449033|18261587|P1|Treatment Period|Treatment Ongoing|6
5296770|NCT00449033|18261586|P2|Treatment Period|Reason Missing|4
5296771|NCT00449033|18261587|P1|Treatment Period|Reason Missing|0
5296772|NCT00449033|18261586|P2|Treatment Period|Second Malignancy|1
5296773|NCT00449033|18261587|P1|Treatment Period|Second Malignancy|0
5296774|NCT00449033|18261586|P2|Treatment Period|Non-compliance|8
5296775|NCT00449033|18261587|P1|Treatment Period|Non-compliance|7
5296776|NCT00449033|18261586|P2|Treatment Period|Amended Protocol Criteria|18
5296777|NCT00449033|18261587|P1|Treatment Period|Amended Protocol Criteria|22
5296778|NCT00449033|18261586|P2|Treatment Period|Consent Withdrawn|20
5296779|NCT00449033|18261587|P1|Treatment Period|Consent Withdrawn|36
5296780|NCT00449033|18261586|P2|Treatment Period|Disease Progression|288
5296781|NCT00449033|18261587|P1|Treatment Period|Disease Progression|231
5296782|NCT00449033|18261586|P2|Treatment Period|Protocol Violation|7
5296783|NCT00449033|18261587|P1|Treatment Period|Protocol Violation|8
5296784|NCT00449033|18261586|P2|Treatment Period|Physician Decision|5
5296785|NCT00449033|18261587|P1|Treatment Period|Physician Decision|4
5296786|NCT00449033|18261586|P2|Treatment Period|Lost to Follow-up|2
5296787|NCT00449033|18261587|P1|Treatment Period|Lost to Follow-up|0
5296788|NCT00449033|18261586|P2|Treatment Period|Death|12
5296789|NCT00449033|18261587|P1|Treatment Period|Death|21
5296790|NCT00449033|18261586|P2|Treatment Period|Adverse Event|83
5296791|NCT00449033|18261587|P1|Treatment Period|Adverse Event|117
5296792|NCT00448916|18261625|P4|Overall Study|Protocol Violation|1
5296793|NCT00448916|18261626|P3|Overall Study|Protocol Violation|0
5296794|NCT00448916|18261627|P2|Overall Study|Protocol Violation|0
5296795|NCT00448916|18261628|P1|Overall Study|Protocol Violation|0
5296796|NCT00448916|18261625|P4|Overall Study|Lost to Follow-up|1
5296797|NCT00448916|18261626|P3|Overall Study|Lost to Follow-up|0
5296798|NCT00448916|18261627|P2|Overall Study|Lost to Follow-up|1
5296799|NCT00448916|18261628|P1|Overall Study|Lost to Follow-up|0
5296800|NCT00448916|18261625|P4|Overall Study|Other|0
5296801|NCT00448916|18261626|P3|Overall Study|Other|0
5296802|NCT00448916|18261627|P2|Overall Study|Other|0
5296803|NCT00448916|18261628|P1|Overall Study|Other|1
5296804|NCT00448916|18261625|P4|Overall Study|Withdrawal by Subject|1
5296805|NCT00448916|18261626|P3|Overall Study|Withdrawal by Subject|1
5296806|NCT00448916|18261627|P2|Overall Study|Withdrawal by Subject|3
5296807|NCT00448916|18261628|P1|Overall Study|Withdrawal by Subject|3
5296808|NCT00448916|18261625|P4|Overall Study|Lack of Efficacy|1
5296809|NCT00448916|18261626|P3|Overall Study|Lack of Efficacy|2
5296810|NCT00448916|18261627|P2|Overall Study|Lack of Efficacy|0
5296811|NCT00448916|18261628|P1|Overall Study|Lack of Efficacy|1
5296812|NCT00448916|18261625|P4|Overall Study|Adverse Event|2
5296813|NCT00448916|18261626|P3|Overall Study|Adverse Event|3
5296814|NCT00448916|18261627|P2|Overall Study|Adverse Event|2
5296815|NCT00448916|18261628|P1|Overall Study|Adverse Event|2
5296816|NCT00448864|18261702|P3|Overall Study|Protocol Violation|0
5296817|NCT00448864|18261703|P2|Overall Study|Protocol Violation|2
5296818|NCT00448864|18261704|P1|Overall Study|Protocol Violation|0
5296819|NCT00448864|18261702|P3|Overall Study|Withdrawal by Subject|0
5296820|NCT00448864|18261703|P2|Overall Study|Withdrawal by Subject|2
5296821|NCT00448864|18261704|P1|Overall Study|Withdrawal by Subject|0
5296822|NCT00448864|18261702|P3|Overall Study|Physician Decision|1
5296823|NCT00448864|18261703|P2|Overall Study|Physician Decision|0
5296824|NCT00448864|18261704|P1|Overall Study|Physician Decision|1
5296825|NCT00448864|18261702|P3|Overall Study|Lost to Follow-up|0
5296826|NCT00448864|18261703|P2|Overall Study|Lost to Follow-up|1
5296827|NCT00448864|18261704|P1|Overall Study|Lost to Follow-up|3
5296828|NCT00448864|18261702|P3|Overall Study|Death|0
5296829|NCT00448864|18261703|P2|Overall Study|Death|0
5296830|NCT00448864|18261704|P1|Overall Study|Death|1
5296831|NCT00448760|18261720|P1|Overall Study|Death|3
5296832|NCT00448747|18261729|P2|Overall Study|collapsed veins|0
5296833|NCT00448747|18261730|P1|Overall Study|collapsed veins|1
5296834|NCT00448708|18261748|P2|Overall Study|not listed|2
5296835|NCT00448708|18261749|P1|Overall Study|not listed|0
5296836|NCT00448708|18261748|P2|Overall Study|Lost to Follow-up|8
5296837|NCT00448708|18261749|P1|Overall Study|Lost to Follow-up|6
5296838|NCT00448708|18261748|P2|Overall Study|Withdrawal by Subject|4
5296839|NCT00448708|18261749|P1|Overall Study|Withdrawal by Subject|8
5296840|NCT00448708|18261748|P2|Overall Study|Death|17
5296841|NCT00448708|18261749|P1|Overall Study|Death|21
5296842|NCT00448669|18261765|P2|Overall Study|Never started drug|7
5296843|NCT00448669|18261766|P1|Overall Study|Never started drug|9
5296844|NCT00448669|18261765|P2|Overall Study|HIV-infected at enrollment|2
5296845|NCT00448669|18261766|P1|Overall Study|HIV-infected at enrollment|1
5296846|NCT00448669|18261765|P2|Overall Study|Had other reasons|6
5296847|NCT00448669|18261766|P1|Overall Study|Had other reasons|5
5296848|NCT00448669|18261765|P2|Overall Study|Death|4
5296849|NCT00448669|18261766|P1|Overall Study|Death|2
5296850|NCT00448669|18261765|P2|Overall Study|Were withdrawn by investigator|6
5296851|NCT00448669|18261766|P1|Overall Study|Were withdrawn by investigator|10
5296852|NCT00448669|18261765|P2|Overall Study|Relocated|36
5296853|NCT00448669|18261766|P1|Overall Study|Relocated|49
5296854|NCT00448669|18261765|P2|Overall Study|Withdrawal by Subject|74
5296855|NCT00448669|18261766|P1|Overall Study|Withdrawal by Subject|90
5296856|NCT00448669|18261765|P2|Overall Study|Lost to Follow-up|63
5296857|NCT00448669|18261766|P1|Overall Study|Lost to Follow-up|52
5296858|NCT00448591|18261827|P1|Overall Study|Termination of Study|70
5296859|NCT00448591|18261827|P1|Overall Study|Other|154
5296860|NCT00448591|18261827|P1|Overall Study|Treatment Regimen Completed|70
5296861|NCT00448591|18261827|P1|Overall Study|Lost to Follow-up|19
5296862|NCT00448591|18261827|P1|Overall Study|Protocol Violation|41
5296863|NCT00448591|18261827|P1|Overall Study|Adverse Event|382
5296864|NCT00448591|18261827|P1|Overall Study|Progressive Disease|1382
5296865|NCT00448591|18261827|P1|Overall Study|Withdrawal by Subject|178
5296866|NCT00448539|18261838|P2|Overall Study|Lost to Follow-up|3
5296867|NCT00448539|18261839|P1|Overall Study|Lost to Follow-up|1
5296868|NCT00448539|18261838|P2|Overall Study|Change of meds|3
5296869|NCT00448539|18261839|P1|Overall Study|Change of meds|2
5296870|NCT00448539|18261838|P2|Overall Study|Miscellaneous|1
5296871|NCT00448539|18261839|P1|Overall Study|Miscellaneous|2
5296872|NCT00448539|18261838|P2|Overall Study|Lack of Efficacy|40
5296873|NCT00448539|18261839|P1|Overall Study|Lack of Efficacy|27
5296874|NCT00448539|18261838|P2|Overall Study|Adverse Event|26
5296875|NCT00448539|18261839|P1|Overall Study|Adverse Event|9
5296876|NCT00448539|18261838|P2|Overall Study|Diary non-compliance|0
5296877|NCT00448539|18261839|P1|Overall Study|Diary non-compliance|1
5296878|NCT00448539|18261838|P2|Overall Study|Withdrawal by Subject|24
5296879|NCT00448539|18261839|P1|Overall Study|Withdrawal by Subject|20
5296880|NCT00448539|18261838|P2|Overall Study|Request of the investigator or sponsor|54
5296881|NCT00448539|18261839|P1|Overall Study|Request of the investigator or sponsor|67
5296882|NCT00448539|18261838|P2|Overall Study|Protocol Violation|0
5296883|NCT00448539|18261839|P1|Overall Study|Protocol Violation|1
5296884|NCT00448539|18261838|P2|Overall Study|Medication non-compliance|1
5296885|NCT00448539|18261839|P1|Overall Study|Medication non-compliance|4
5296886|NCT00448448|18261847|P2|Overall Study|Signed consent lost|1
5296887|NCT00448448|18261848|P1|Overall Study|Signed consent lost|0
5296888|NCT00448448|18261847|P2|Overall Study|Wrong diagnosis (n=3) or other|1
5296889|NCT00448448|18261848|P1|Overall Study|Wrong diagnosis (n=3) or other|2
5296890|NCT00448448|18261847|P2|Overall Study|Lost to Follow-up|1
5296891|NCT00448448|18261848|P1|Overall Study|Lost to Follow-up|2
5296892|NCT00448448|18261847|P2|Overall Study|On protocol when study ended|36
5296893|NCT00448448|18261848|P1|Overall Study|On protocol when study ended|83
5296894|NCT00448448|18261847|P2|Overall Study|Withdrawal by Subject|2
5296895|NCT00448448|18261848|P1|Overall Study|Withdrawal by Subject|13
5296896|NCT00448435|18261854|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
5296897|NCT00448435|18261855|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
5296898|NCT00448344|18261906|P2|Overall Study|Physician Decision|2
5296899|NCT00448344|18261907|P1|Overall Study|Physician Decision|1
5296900|NCT00448344|18261906|P2|Overall Study|Death|4
5296901|NCT00448344|18261907|P1|Overall Study|Death|3
5296902|NCT00448344|18261906|P2|Overall Study|Withdrawal by Subject|8
5296903|NCT00448344|18261907|P1|Overall Study|Withdrawal by Subject|6
5296904|NCT00448344|18261906|P2|Overall Study|Lost to Follow-up|22
5296905|NCT00448344|18261907|P1|Overall Study|Lost to Follow-up|20
5296906|NCT00448279|18261917|P2|Overall Study|Protocol Violation|1
5296907|NCT00448279|18261918|P1|Overall Study|Protocol Violation|0
5296908|NCT00448279|18261917|P2|Overall Study|Other|4
5296909|NCT00448279|18261918|P1|Overall Study|Other|6
5296910|NCT00448279|18261917|P2|Overall Study|Withdrawal by Subject|3
5296911|NCT00448279|18261918|P1|Overall Study|Withdrawal by Subject|4
5296912|NCT00448279|18261917|P2|Overall Study|Disease progression|18
5296913|NCT00448279|18261918|P1|Overall Study|Disease progression|16
5296914|NCT00448279|18261917|P2|Overall Study|Adverse Event|1
5296915|NCT00448279|18261918|P1|Overall Study|Adverse Event|1
5296916|NCT00448279|18261917|P2|Overall Study|Lost to Follow-up|2
5296917|NCT00448279|18261918|P1|Overall Study|Lost to Follow-up|2
5296918|NCT00448136|18261981|P2|Overall Study|Investigator's decision (progression)|0
5296919|NCT00448136|18261982|P1|Overall Study|Investigator's decision (progression)|1
5296920|NCT00448136|18261981|P2|Overall Study|Death|8
5296921|NCT00448136|18261982|P1|Overall Study|Death|3
5296922|NCT00448123|18262020|P2|Overall Study|Physician Decision|6
5296923|NCT00448123|18262021|P1|Overall Study|Physician Decision|6
5296924|NCT00448123|18262020|P2|Overall Study|Lost to Follow-up|6
5296925|NCT00448123|18262021|P1|Overall Study|Lost to Follow-up|9
5296926|NCT00448019|18262031|P1|Overall Study|Insurance Issues|1
5296927|NCT00448019|18262031|P1|Overall Study|Death|2
5296928|NCT00448019|18262031|P1|Overall Study|Disease progression|1
5296929|NCT00448019|18262031|P1|Overall Study|Withdrawal by Subject|3
5296930|NCT00447902|18262039|P2|Overall Study|Lack of Efficacy|1
5296931|NCT00447902|18262040|P1|Overall Study|Lack of Efficacy|2
5296932|NCT00447902|18262039|P2|Overall Study|included patients who discontinued|1
5296933|NCT00447902|18262040|P1|Overall Study|included patients who discontinued|1
5296934|NCT00447902|18262039|P2|Overall Study|Withdrawal by Subject|1
5296935|NCT00447902|18262040|P1|Overall Study|Withdrawal by Subject|0
5296936|NCT00447902|18262039|P2|Overall Study|Protocol Violation|0
5296937|NCT00447902|18262040|P1|Overall Study|Protocol Violation|1
5296938|NCT00447902|18262039|P2|Overall Study|Adverse Event|3
5296939|NCT00447902|18262040|P1|Overall Study|Adverse Event|0
5296940|NCT00447876|18262082|P2|Overall Study|Deterioration of symptomology|0
5296941|NCT00447876|18262083|P1|Overall Study|Deterioration of symptomology|1
5296942|NCT00447876|18262082|P2|Overall Study|Lost to Follow-up|0
5296943|NCT00447876|18262083|P1|Overall Study|Lost to Follow-up|1
5296944|NCT00447876|18262082|P2|Overall Study|Withdrawal by Subject|4
5296945|NCT00447876|18262083|P1|Overall Study|Withdrawal by Subject|1
5296946|NCT00447772|18262113|P1|Overall Study|Premature re-injection required|1
5296947|NCT00447772|18262113|P1|Overall Study|Chemotherapy for lung cancer|1
5296948|NCT00447772|18262113|P1|Overall Study|Incomplete documentation at visit 1|1
5296949|NCT00447772|18262113|P1|Overall Study|Patient relocated|1
5296950|NCT00447772|18262113|P1|Overall Study|Adverse Event|1
5296951|NCT00447772|18262113|P1|Overall Study|Unable to attend all study visits|2
5296952|NCT00447772|18262113|P1|Overall Study|Withdrawal by Subject|1
5296953|NCT00447772|18262113|P1|Overall Study|Lost to Follow-up|9
5296954|NCT00447772|18262113|P1|Overall Study|Discontinuation of drug therapy|1
5296955|NCT00447772|18262113|P1|Overall Study|Insufficient compliance|6
5296956|NCT00447772|18262113|P1|Overall Study|Lack of Efficacy|3
5296957|NCT00447603|18262133|P3|Filter Period|Study terminated by Sponsor|10
5296958|NCT00447603|18262134|P2|Filter Period|Study terminated by Sponsor|1
5296959|NCT00447603|18262135|P1|Filter Period|Study terminated by Sponsor|0
5296960|NCT00447603|18262133|P3|Filter Period|Screen Failure|4
5296961|NCT00447603|18262134|P2|Filter Period|Screen Failure|3
5296962|NCT00447603|18262135|P1|Filter Period|Screen Failure|0
5296963|NCT00447603|18262133|P3|Filter Period|Adverse Event|1
5296964|NCT00447603|18262134|P2|Filter Period|Adverse Event|0
5296965|NCT00447603|18262135|P1|Filter Period|Adverse Event|0
5296966|NCT00447603|18262133|P3|Screening|Study Terminated by Sponsor|0
5296967|NCT00447603|18262134|P2|Screening|Study Terminated by Sponsor|0
5296968|NCT00447603|18262135|P1|Screening|Study Terminated by Sponsor|15
5296969|NCT00447603|18262133|P3|Screening|Screen Failure|0
5296970|NCT00447603|18262134|P2|Screening|Screen Failure|0
5296971|NCT00447603|18262135|P1|Screening|Screen Failure|4
5296972|NCT00447603|18262133|P3|Screening|Protocol Violation|0
5296973|NCT00447603|18262134|P2|Screening|Protocol Violation|0
5296974|NCT00447603|18262135|P1|Screening|Protocol Violation|1
5296975|NCT00447603|18262133|P3|Screening|Withdrawal by Subject|0
5296976|NCT00447603|18262134|P2|Screening|Withdrawal by Subject|0
5296977|NCT00447603|18262135|P1|Screening|Withdrawal by Subject|1
5296978|NCT00447590|18262155|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
5296979|NCT00447590|18262155|P1|Overall Study|Lost to Follow-up|24
5296980|NCT00447590|18262155|P1|Overall Study|Withdrawal by Subject|26
5296981|NCT00447499|18262164|P1|Overall Study|Physician Decision|1
5296982|NCT00447499|18262164|P1|Overall Study|Sponsor Decision|1
5296983|NCT00447499|18262164|P1|Overall Study|Patient Decision|4
5296984|NCT00447499|18262164|P1|Overall Study|Adverse Event|1
5296985|NCT00447421|18262174|P1|Overall Study|Sponsor Decision|2
5296986|NCT00447421|18262174|P1|Overall Study|Adverse Event|3
5296987|NCT00447421|18262174|P1|Overall Study|Lack of Efficacy|1
5296988|NCT00447382|18262186|P2|Overall Study|Unclassified|5
5296989|NCT00447382|18262187|P1|Overall Study|Unclassified|2
5296990|NCT00447382|18262186|P2|Overall Study|Protocol Violation|0
5296991|NCT00447382|18262187|P1|Overall Study|Protocol Violation|2
5296992|NCT00447382|18262186|P2|Overall Study|Lack of Efficacy|0
5296993|NCT00447382|18262187|P1|Overall Study|Lack of Efficacy|1
5296994|NCT00447382|18262186|P2|Overall Study|Adverse Event|1
5296995|NCT00447382|18262187|P1|Overall Study|Adverse Event|1
5296996|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
5296997|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
5296998|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
5296999|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
5297000|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
5297001|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
5297002|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
5297003|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
5297004|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
5297005|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
5297006|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
5297007|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
5297008|NCT00447278|18262248|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
5297009|NCT00447278|18262249|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
5297010|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
5297011|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
5297012|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
5297013|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
5297014|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Physician Decision|1
5297015|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Physician Decision|4
5297016|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
5297017|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
5297018|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Protocol Violation|7
5297019|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Protocol Violation|10
5297020|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
5297021|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
5297022|NCT00447278|18262248|P2|Period II (6 Month Open-Label)|Adverse Event|3
5297023|NCT00447278|18262249|P1|Period II (6 Month Open-Label)|Adverse Event|7
5297024|NCT00447265|18262270|P2|Overall Study|Physician Decision|0
5297025|NCT00447265|18262271|P1|Overall Study|Physician Decision|1
5297026|NCT00447226|18262284|P2|Double-blind Phase|Disease Progression|3
5297027|NCT00447226|18262285|P1|Double-blind Phase|Disease Progression|4
5297028|NCT00447226|18262284|P2|12-Week Open-label Phase|Physician Decision|1
5297029|NCT00447226|18262285|P1|12-Week Open-label Phase|Physician Decision|0
5297030|NCT00447226|18262284|P2|12-Week Open-label Phase|Disease Progression|20
5297031|NCT00447226|18262285|P1|12-Week Open-label Phase|Disease Progression|0
5297032|NCT00447226|18262284|P2|12-Week Open-label Phase|Protocol Violation|1
5297033|NCT00447226|18262285|P1|12-Week Open-label Phase|Protocol Violation|0
5297034|NCT00447226|18262284|P2|12-Week Open-label Phase|Adverse Event|3
5297035|NCT00447226|18262285|P1|12-Week Open-label Phase|Adverse Event|0
5297036|NCT00447057|18262328|P4|Overall Study|Death, study drug related|0
5297037|NCT00447057|18262329|P3|Overall Study|Death, study drug related|0
5297038|NCT00447057|18262330|P2|Overall Study|Death, study drug related|1
5297039|NCT00447057|18262331|P1|Overall Study|Death, study drug related|0
5297040|NCT00447057|18262328|P4|Overall Study|Death due to adverse event|2
5297041|NCT00447057|18262329|P3|Overall Study|Death due to adverse event|1
5297042|NCT00447057|18262330|P2|Overall Study|Death due to adverse event|0
5297043|NCT00447057|18262331|P1|Overall Study|Death due to adverse event|0
5297044|NCT00447057|18262328|P4|Overall Study|Progressive disease|18
5297045|NCT00447057|18262329|P3|Overall Study|Progressive disease|13
5297046|NCT00447057|18262330|P2|Overall Study|Progressive disease|43
5297047|NCT00447057|18262331|P1|Overall Study|Progressive disease|58
5297048|NCT00447057|18262328|P4|Overall Study|Sponsor decision|0
5297049|NCT00447057|18262329|P3|Overall Study|Sponsor decision|0
5297050|NCT00447057|18262330|P2|Overall Study|Sponsor decision|1
5297051|NCT00447057|18262331|P1|Overall Study|Sponsor decision|1
5297052|NCT00447057|18262328|P4|Overall Study|Physician Decision|1
5297053|NCT00447057|18262329|P3|Overall Study|Physician Decision|3
5297054|NCT00447057|18262330|P2|Overall Study|Physician Decision|6
5297055|NCT00447057|18262331|P1|Overall Study|Physician Decision|9
5297056|NCT00447057|18262328|P4|Overall Study|Withdrawal by Subject|1
5297057|NCT00447057|18262329|P3|Overall Study|Withdrawal by Subject|1
5297058|NCT00447057|18262330|P2|Overall Study|Withdrawal by Subject|5
5297059|NCT00447057|18262331|P1|Overall Study|Withdrawal by Subject|4
5297060|NCT00447057|18262328|P4|Overall Study|Protocol Violation|0
5297061|NCT00447057|18262329|P3|Overall Study|Protocol Violation|0
5297062|NCT00447057|18262330|P2|Overall Study|Protocol Violation|1
5297063|NCT00447057|18262331|P1|Overall Study|Protocol Violation|0
5297064|NCT00447057|18262328|P4|Overall Study|Entry criteria not met|0
5297065|NCT00447057|18262329|P3|Overall Study|Entry criteria not met|0
5297066|NCT00447057|18262330|P2|Overall Study|Entry criteria not met|1
5297067|NCT00447057|18262331|P1|Overall Study|Entry criteria not met|1
5297068|NCT00447057|18262328|P4|Overall Study|Lost to Follow-up|0
5297069|NCT00447057|18262329|P3|Overall Study|Lost to Follow-up|0
5297070|NCT00447057|18262330|P2|Overall Study|Lost to Follow-up|1
5297071|NCT00447057|18262331|P1|Overall Study|Lost to Follow-up|0
5297072|NCT00447057|18262328|P4|Overall Study|Death due to study disease|1
5297073|NCT00447057|18262329|P3|Overall Study|Death due to study disease|1
5297074|NCT00447057|18262330|P2|Overall Study|Death due to study disease|4
5297075|NCT00447057|18262331|P1|Overall Study|Death due to study disease|6
5297076|NCT00447057|18262328|P4|Overall Study|Adverse Event|3
5297077|NCT00447057|18262329|P3|Overall Study|Adverse Event|0
5297078|NCT00447057|18262330|P2|Overall Study|Adverse Event|10
5297079|NCT00447057|18262331|P1|Overall Study|Adverse Event|4
5297080|NCT00447005|18262349|P1|Overall Study|Lack of Efficacy|11
5297081|NCT00447005|18262349|P1|Overall Study|Adverse Event|1
5297082|NCT00446992|18262363|P1|Overall Study|Lost to Follow-up|5
5297083|NCT00446992|18262363|P1|Overall Study|Adverse Event|11
5297084|NCT00446966|18262377|P2|Overall Study|Lost to Follow-up|7
5297085|NCT00446966|18262378|P1|Overall Study|Lost to Follow-up|10
5297086|NCT00446849|18262384|P1|Maintenance Phase|concomitant medication use|1
5297087|NCT00446849|18262384|P1|Maintenance Phase|hydrocodone use|1
5297088|NCT00446849|18262384|P1|Maintenance Phase|study closure|1
5297089|NCT00446849|18262384|P1|Maintenance Phase|antibiotic use|1
5297090|NCT00446849|18262384|P1|Maintenance Phase|prohibited medication use|2
5297091|NCT00446849|18262384|P1|Maintenance Phase|noncompliance|2
5297092|NCT00446849|18262384|P1|Maintenance Phase|Pregnancy|1
5297093|NCT00446849|18262384|P1|Maintenance Phase|Lost to Follow-up|3
5297094|NCT00446849|18262384|P1|Maintenance Phase|Consent withdrawn|5
5297095|NCT00446849|18262384|P1|Maintenance Phase|Adverse Event|6
5297096|NCT00446849|18262384|P1|Maintenance Phase|Protocol Violation|7
5297097|NCT00446849|18262384|P1|Maintenance Phase|Lack of Efficacy|40
5297098|NCT00446849|18262384|P1|Acute Phase|noncompliance|1
5297099|NCT00446849|18262384|P1|Acute Phase|Physician Decision|1
5297100|NCT00446849|18262384|P1|Acute Phase|Lost to Follow-up|2
5297101|NCT00446849|18262384|P1|Acute Phase|Consent withdrawn|4
5297102|NCT00446849|18262384|P1|Acute Phase|Protocol Violation|10
5297103|NCT00446849|18262384|P1|Acute Phase|Lack of Efficacy|64
5297104|NCT00446797|18262396|P2|Overall Study|did not meet entrance criteria|1
5297105|NCT00446797|18262397|P1|Overall Study|did not meet entrance criteria|0
5297106|NCT00446797|18262396|P2|Overall Study|subject entered at another site|1
5297107|NCT00446797|18262397|P1|Overall Study|subject entered at another site|0
5297108|NCT00446797|18262396|P2|Overall Study|Protocol Violation|3
5297109|NCT00446797|18262397|P1|Overall Study|Protocol Violation|1
5297110|NCT00446797|18262396|P2|Overall Study|Withdrawal by Subject|2
5297111|NCT00446797|18262397|P1|Overall Study|Withdrawal by Subject|2
5297112|NCT00446797|18262396|P2|Overall Study|Lost to Follow-up|3
5297113|NCT00446797|18262397|P1|Overall Study|Lost to Follow-up|5
5297114|NCT00446797|18262396|P2|Overall Study|Lack of Efficacy|2
5297115|NCT00446797|18262397|P1|Overall Study|Lack of Efficacy|0
5297116|NCT00446654|18262443|P2|Overall Study|Adverse Event|0
5297117|NCT00446654|18262444|P1|Overall Study|Adverse Event|1
5297118|NCT00446654|18262443|P2|Overall Study|Withdrawal by Subject|0
5297119|NCT00446654|18262444|P1|Overall Study|Withdrawal by Subject|1
5297120|NCT00446641|18262452|P2|Overall Study|Lost to Follow-up|1
5297121|NCT00446641|18262453|P1|Overall Study|Lost to Follow-up|1
5297122|NCT00446641|18262452|P2|Overall Study|poor compliance|6
5297123|NCT00446641|18262453|P1|Overall Study|poor compliance|8
5297124|NCT00446641|18262452|P2|Overall Study|Withdrawal by Subject|3
5297125|NCT00446641|18262453|P1|Overall Study|Withdrawal by Subject|8
5297126|NCT00446563|18262473|P2|Overall Study|Administrative problems|1
5297127|NCT00446563|18262474|P1|Overall Study|Administrative problems|0
5297128|NCT00446563|18262473|P2|Overall Study|Withdrawal by Subject|1
5297129|NCT00446563|18262474|P1|Overall Study|Withdrawal by Subject|2
5297130|NCT00446563|18262473|P2|Overall Study|Unsatisfactory therapeutic effect|3
5297131|NCT00446563|18262474|P1|Overall Study|Unsatisfactory therapeutic effect|0
5297132|NCT00446563|18262473|P2|Overall Study|Abnormal test procedure result(s)|0
5297133|NCT00446563|18262474|P1|Overall Study|Abnormal test procedure result(s)|1
5297134|NCT00446563|18262473|P2|Overall Study|Abnormal laboratory value(s)|1
5297135|NCT00446563|18262474|P1|Overall Study|Abnormal laboratory value(s)|0
5297136|NCT00446563|18262473|P2|Overall Study|Adverse Event|3
5297137|NCT00446563|18262474|P1|Overall Study|Adverse Event|4
5297138|NCT00446550|18262510|P2|Overall Study|Adverse Event|0
5297139|NCT00446550|18262511|P1|Overall Study|Adverse Event|1
5297140|NCT00446511|18262523|P4|Overall Study|Administrative Problems|1
5297141|NCT00446511|18262524|P3|Overall Study|Administrative Problems|4
5297142|NCT00446511|18262525|P2|Overall Study|Administrative Problems|0
5297143|NCT00446511|18262526|P1|Overall Study|Administrative Problems|3
5297144|NCT00446511|18262523|P4|Overall Study|Withdrawal by Subject|3
5297145|NCT00446511|18262524|P3|Overall Study|Withdrawal by Subject|0
5297146|NCT00446511|18262525|P2|Overall Study|Withdrawal by Subject|0
5297147|NCT00446511|18262526|P1|Overall Study|Withdrawal by Subject|0
5297148|NCT00446511|18262523|P4|Overall Study|Protocol Violation|1
5297149|NCT00446511|18262524|P3|Overall Study|Protocol Violation|0
5297150|NCT00446511|18262525|P2|Overall Study|Protocol Violation|0
5297151|NCT00446511|18262526|P1|Overall Study|Protocol Violation|0
5297152|NCT00446511|18262523|P4|Overall Study|Adverse Event|1
5297153|NCT00446511|18262524|P3|Overall Study|Adverse Event|3
5297154|NCT00446511|18262525|P2|Overall Study|Adverse Event|2
5297155|NCT00446511|18262526|P1|Overall Study|Adverse Event|7
5297156|NCT00446459|18262550|P1|12 Months|14 subjects to MMF + Rituximab Study|14
5297157|NCT00446459|18262550|P1|12 Months|Protocol Violation|4
5297158|NCT00446459|18262550|P1|8 Months|Protocol Violation|12
5297159|NCT00446446|18262558|P1|Overall Study|On Treatment at Time of Data Cut-off|1
5297160|NCT00446446|18262558|P1|Overall Study|Adverse Event|1
5297161|NCT00446446|18262558|P1|Overall Study|Disease Progession|2
5297162|NCT00446446|18262558|P1|Overall Study|Other|4
5297163|NCT00446446|18262558|P1|Overall Study|Withdrawal by Subject|6
5297164|NCT00446446|18262558|P1|Overall Study|Death|10
5297165|NCT00446251|18262582|P1|Overall Study|Lost to Follow-up|1
5297166|NCT00446251|18262582|P1|Overall Study|Rituximab Infusion Reaction|2
5297167|NCT00446251|18262582|P1|Overall Study|On-study Transplants|2
5297168|NCT00446199|18262592|P4|Overall Study|Move|0
5297169|NCT00446199|18262593|P3|Overall Study|Move|0
5297170|NCT00446199|18262594|P2|Overall Study|Move|1
5297171|NCT00446199|18262595|P1|Overall Study|Move|0
5297172|NCT00446199|18262592|P4|Overall Study|In-/Exclusion criterion violated|1
5297173|NCT00446199|18262593|P3|Overall Study|In-/Exclusion criterion violated|2
5297174|NCT00446199|18262594|P2|Overall Study|In-/Exclusion criterion violated|1
5297175|NCT00446199|18262595|P1|Overall Study|In-/Exclusion criterion violated|2
5297176|NCT00446199|18262592|P4|Overall Study|Lost interest in study participation|0
5297177|NCT00446199|18262593|P3|Overall Study|Lost interest in study participation|0
5297178|NCT00446199|18262594|P2|Overall Study|Lost interest in study participation|1
5297179|NCT00446199|18262595|P1|Overall Study|Lost interest in study participation|0
5297180|NCT00446199|18262592|P4|Overall Study|Hormone fear|1
5297181|NCT00446199|18262593|P3|Overall Study|Hormone fear|0
5297182|NCT00446199|18262594|P2|Overall Study|Hormone fear|0
5297183|NCT00446199|18262595|P1|Overall Study|Hormone fear|0
5297184|NCT00446199|18262592|P4|Overall Study|Non-compliant with visit schedule|2
5297185|NCT00446199|18262593|P3|Overall Study|Non-compliant with visit schedule|1
5297186|NCT00446199|18262594|P2|Overall Study|Non-compliant with visit schedule|1
5297187|NCT00446199|18262595|P1|Overall Study|Non-compliant with visit schedule|1
5297188|NCT00446199|18262592|P4|Overall Study|Non-compliant with study drug|0
5297189|NCT00446199|18262593|P3|Overall Study|Non-compliant with study drug|5
5297190|NCT00446199|18262594|P2|Overall Study|Non-compliant with study drug|0
5297191|NCT00446199|18262595|P1|Overall Study|Non-compliant with study drug|1
5297192|NCT00446199|18262592|P4|Overall Study|Lack of Efficacy|1
5297193|NCT00446199|18262593|P3|Overall Study|Lack of Efficacy|0
5297194|NCT00446199|18262594|P2|Overall Study|Lack of Efficacy|0
5297195|NCT00446199|18262595|P1|Overall Study|Lack of Efficacy|1
5297196|NCT00446199|18262592|P4|Overall Study|Randomization in Error|1
5297197|NCT00446199|18262593|P3|Overall Study|Randomization in Error|1
5297198|NCT00446199|18262594|P2|Overall Study|Randomization in Error|0
5297199|NCT00446199|18262595|P1|Overall Study|Randomization in Error|2
5297200|NCT00446199|18262592|P4|Overall Study|Site termination|1
5297201|NCT00446199|18262593|P3|Overall Study|Site termination|0
5297202|NCT00446199|18262594|P2|Overall Study|Site termination|0
5297203|NCT00446199|18262595|P1|Overall Study|Site termination|2
5297204|NCT00446199|18262592|P4|Overall Study|Withdrawal by Subject|10
5297205|NCT00446199|18262593|P3|Overall Study|Withdrawal by Subject|9
5297206|NCT00446199|18262594|P2|Overall Study|Withdrawal by Subject|5
5297207|NCT00446199|18262595|P1|Overall Study|Withdrawal by Subject|2
5297208|NCT00446199|18262592|P4|Overall Study|Protocol Violation|3
5297209|NCT00446199|18262593|P3|Overall Study|Protocol Violation|1
5297210|NCT00446199|18262594|P2|Overall Study|Protocol Violation|2
5297211|NCT00446199|18262595|P1|Overall Study|Protocol Violation|1
5297212|NCT00446199|18262592|P4|Overall Study|Lost to Follow-up|6
5297213|NCT00446199|18262593|P3|Overall Study|Lost to Follow-up|2
5297214|NCT00446199|18262594|P2|Overall Study|Lost to Follow-up|5
5297215|NCT00446199|18262595|P1|Overall Study|Lost to Follow-up|4
5297216|NCT00446199|18262592|P4|Overall Study|Adverse Event|4
5297217|NCT00446199|18262593|P3|Overall Study|Adverse Event|6
5297218|NCT00446199|18262594|P2|Overall Study|Adverse Event|4
5297219|NCT00446199|18262595|P1|Overall Study|Adverse Event|7
5297220|NCT00446134|18262688|P4|Overall Study|Reason Not Completed|2
5297221|NCT00446134|18262689|P3|Overall Study|Reason Not Completed|1
5297222|NCT00446134|18262690|P2|Overall Study|Reason Not Completed|0
5297223|NCT00446134|18262691|P1|Overall Study|Reason Not Completed|3
5297224|NCT00446134|18262688|P4|Overall Study|Adverse Event-Diarrhea|0
5297225|NCT00446134|18262689|P3|Overall Study|Adverse Event-Diarrhea|2
5297226|NCT00446134|18262690|P2|Overall Study|Adverse Event-Diarrhea|1
5297227|NCT00446134|18262691|P1|Overall Study|Adverse Event-Diarrhea|1
5297228|NCT00446134|18262688|P4|Overall Study|Physician Decision|2
5297229|NCT00446134|18262689|P3|Overall Study|Physician Decision|0
5297230|NCT00446134|18262690|P2|Overall Study|Physician Decision|0
5297231|NCT00446134|18262691|P1|Overall Study|Physician Decision|0
5297232|NCT00446134|18262688|P4|Overall Study|Withdrawal by Subject|3
5297233|NCT00446134|18262689|P3|Overall Study|Withdrawal by Subject|1
5297234|NCT00446134|18262690|P2|Overall Study|Withdrawal by Subject|3
5297235|NCT00446134|18262691|P1|Overall Study|Withdrawal by Subject|3
5297236|NCT00446134|18262688|P4|Overall Study|Lost to Follow-up|1
5297237|NCT00446134|18262689|P3|Overall Study|Lost to Follow-up|1
5297238|NCT00446134|18262690|P2|Overall Study|Lost to Follow-up|3
5297239|NCT00446134|18262691|P1|Overall Study|Lost to Follow-up|1
5297240|NCT00446134|18262688|P4|Overall Study|Protocol Violation|0
5297241|NCT00446134|18262689|P3|Overall Study|Protocol Violation|1
5297242|NCT00446134|18262690|P2|Overall Study|Protocol Violation|2
5297243|NCT00446134|18262691|P1|Overall Study|Protocol Violation|0
5297244|NCT00446134|18262688|P4|Overall Study|Lack of Efficacy|19
5297245|NCT00446134|18262689|P3|Overall Study|Lack of Efficacy|24
5297246|NCT00446134|18262690|P2|Overall Study|Lack of Efficacy|19
5297247|NCT00446134|18262691|P1|Overall Study|Lack of Efficacy|19
5297248|NCT00446134|18262688|P4|Overall Study|Adverse Event|18
5297249|NCT00446134|18262689|P3|Overall Study|Adverse Event|13
5297250|NCT00446134|18262690|P2|Overall Study|Adverse Event|17
5297251|NCT00446134|18262691|P1|Overall Study|Adverse Event|7
5297252|NCT00446095|18262718|P5|Phase I (28 Days)|Lack of Efficacy|3
5297253|NCT00446095|18262719|P4|Phase I (28 Days)|Lack of Efficacy|0
5297254|NCT00446095|18262720|P3|Phase I (28 Days)|Lack of Efficacy|0
5297255|NCT00446095|18262721|P2|Phase I (28 Days)|Lack of Efficacy|0
5297256|NCT00446095|18262722|P1|Phase I (28 Days)|Lack of Efficacy|0
5297257|NCT00446095|18262718|P5|Phase I (28 Days)|Adverse Event|0
5297258|NCT00446095|18262719|P4|Phase I (28 Days)|Adverse Event|1
5297259|NCT00446095|18262720|P3|Phase I (28 Days)|Adverse Event|0
5297260|NCT00446095|18262721|P2|Phase I (28 Days)|Adverse Event|0
5297261|NCT00446095|18262722|P1|Phase I (28 Days)|Adverse Event|0
5297262|NCT00446095|18262718|P5|Phase II (8 Weeks)|Ongoing|0
5297263|NCT00446095|18262719|P4|Phase II (8 Weeks)|Ongoing|0
5297264|NCT00446095|18262720|P3|Phase II (8 Weeks)|Ongoing|1
5297265|NCT00446095|18262721|P2|Phase II (8 Weeks)|Ongoing|0
5297266|NCT00446095|18262722|P1|Phase II (8 Weeks)|Ongoing|0
5297267|NCT00446095|18262718|P5|Phase II (8 Weeks)|Lack of Efficacy|0
5297268|NCT00446095|18262719|P4|Phase II (8 Weeks)|Lack of Efficacy|0
5297269|NCT00446095|18262720|P3|Phase II (8 Weeks)|Lack of Efficacy|1
5297270|NCT00446095|18262721|P2|Phase II (8 Weeks)|Lack of Efficacy|2
5297271|NCT00446095|18262722|P1|Phase II (8 Weeks)|Lack of Efficacy|9
5297272|NCT00446095|18262718|P5|Phase II (8 Weeks)|Physician Decision|0
5297273|NCT00446095|18262719|P4|Phase II (8 Weeks)|Physician Decision|0
5297274|NCT00446095|18262720|P3|Phase II (8 Weeks)|Physician Decision|0
5297275|NCT00446095|18262721|P2|Phase II (8 Weeks)|Physician Decision|0
5297276|NCT00446095|18262722|P1|Phase II (8 Weeks)|Physician Decision|1
5297277|NCT00446095|18262718|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
5297278|NCT00446095|18262719|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
5297279|NCT00446095|18262720|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
5297280|NCT00446095|18262721|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
5297281|NCT00446095|18262722|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
5297282|NCT00446095|18262718|P5|Phase II (8 Weeks)|Adverse Event|0
5297283|NCT00446095|18262719|P4|Phase II (8 Weeks)|Adverse Event|0
5297284|NCT00446095|18262720|P3|Phase II (8 Weeks)|Adverse Event|1
5297285|NCT00446095|18262721|P2|Phase II (8 Weeks)|Adverse Event|1
5297286|NCT00446095|18262722|P1|Phase II (8 Weeks)|Adverse Event|0
5297287|NCT00446095|18262718|P5|Phase II (8 Weeks)|Lost to Follow-up|0
5297288|NCT00446095|18262719|P4|Phase II (8 Weeks)|Lost to Follow-up|0
5297289|NCT00446095|18262720|P3|Phase II (8 Weeks)|Lost to Follow-up|0
5297290|NCT00446095|18262721|P2|Phase II (8 Weeks)|Lost to Follow-up|0
5297291|NCT00446095|18262722|P1|Phase II (8 Weeks)|Lost to Follow-up|1
5297292|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
5297293|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
5297294|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
5297295|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
5297296|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
5297297|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
5297298|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
5297299|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
5297300|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
5297301|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
5297302|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
5297303|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
5297304|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
5297305|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
5297306|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Death|2
5297307|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Death|2
5297308|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
5297309|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
5297310|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
5297311|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
5297312|NCT00446030|18262745|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
5297313|NCT00446030|18262746|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
5297314|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
5297315|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
5297316|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
5297317|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
5297318|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
5297319|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
5297320|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
5297321|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
5297322|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
5297323|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
5297324|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
5297325|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
5297326|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
5297327|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
5297328|NCT00446030|18262745|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
5297329|NCT00446030|18262746|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
5297330|NCT00445939|18262757|P4|Period B - Week 4 - Week 8|Adverse Event|1
5297331|NCT00445939|18262758|P3|Period B - Week 4 - Week 8|Adverse Event|0
5297332|NCT00445939|18262759|P2|Period B - Week 4 - Week 8|Adverse Event|0
5297333|NCT00445939|18262760|P1|Period B - Week 4 - Week 8|Adverse Event|2
5297334|NCT00445939|18262757|P4|Period A - Week 0 - Week 4|Adverse Event|0
5297335|NCT00445939|18262758|P3|Period A - Week 0 - Week 4|Adverse Event|0
5297336|NCT00445939|18262759|P2|Period A - Week 0 - Week 4|Adverse Event|2
5297337|NCT00445939|18262760|P1|Period A - Week 0 - Week 4|Adverse Event|1
5297338|NCT00445848|18262808|P1|Overall Study|Other-Not protocol specified|5
5297339|NCT00445848|18262808|P1|Overall Study|Progression|62
5297340|NCT00445848|18262808|P1|Overall Study|Withdrawal by Subject|4
5297341|NCT00445848|18262808|P1|Overall Study|Adverse Event|14
5297342|NCT00445770|18262818|P3|Overall Study|Other|6
5297343|NCT00445770|18262819|P2|Overall Study|Other|5
5297344|NCT00445770|18262820|P1|Overall Study|Other|6
5297345|NCT00445770|18262818|P3|Overall Study|Lost to Follow-up|0
5297346|NCT00445770|18262819|P2|Overall Study|Lost to Follow-up|2
5297347|NCT00445770|18262820|P1|Overall Study|Lost to Follow-up|0
5297348|NCT00445770|18262818|P3|Overall Study|Lack of Efficacy|6
5297349|NCT00445770|18262819|P2|Overall Study|Lack of Efficacy|13
5297350|NCT00445770|18262820|P1|Overall Study|Lack of Efficacy|38
5297351|NCT00445770|18262818|P3|Overall Study|Adverse Event|19
5297352|NCT00445770|18262819|P2|Overall Study|Adverse Event|15
5297353|NCT00445770|18262820|P1|Overall Study|Adverse Event|9
5297354|NCT00445692|18262921|P1|Overall Study|Lack of Efficacy|5
5297355|NCT00445692|18262921|P1|Overall Study|Adverse Event|11
5297356|NCT00445679|18262931|P4|Overall Study|Lack of Efficacy|0
5297357|NCT00445679|18262932|P3|Overall Study|Lack of Efficacy|2
5297358|NCT00445679|18262933|P2|Overall Study|Lack of Efficacy|6
5297359|NCT00445679|18262934|P1|Overall Study|Lack of Efficacy|2
5297360|NCT00445679|18262931|P4|Overall Study|Withdrawal by Subject|18
5297361|NCT00445679|18262932|P3|Overall Study|Withdrawal by Subject|20
5297362|NCT00445679|18262933|P2|Overall Study|Withdrawal by Subject|14
5297363|NCT00445679|18262934|P1|Overall Study|Withdrawal by Subject|8
5297364|NCT00445679|18262931|P4|Overall Study|Protocol Violation|1
5297365|NCT00445679|18262932|P3|Overall Study|Protocol Violation|3
5297366|NCT00445679|18262933|P2|Overall Study|Protocol Violation|3
5297367|NCT00445679|18262934|P1|Overall Study|Protocol Violation|2
5297368|NCT00445679|18262931|P4|Overall Study|Withdrawal of Informed Consent|0
5297369|NCT00445679|18262932|P3|Overall Study|Withdrawal of Informed Consent|1
5297370|NCT00445679|18262933|P2|Overall Study|Withdrawal of Informed Consent|0
5297371|NCT00445679|18262934|P1|Overall Study|Withdrawal of Informed Consent|0
5297372|NCT00445679|18262931|P4|Overall Study|Compliance|2
5297373|NCT00445679|18262932|P3|Overall Study|Compliance|1
5297374|NCT00445679|18262933|P2|Overall Study|Compliance|2
5297375|NCT00445679|18262934|P1|Overall Study|Compliance|3
5297376|NCT00445679|18262931|P4|Overall Study|Lost to Follow-up|5
5297377|NCT00445679|18262932|P3|Overall Study|Lost to Follow-up|6
5297378|NCT00445679|18262933|P2|Overall Study|Lost to Follow-up|6
5297379|NCT00445679|18262934|P1|Overall Study|Lost to Follow-up|10
5297380|NCT00445679|18262931|P4|Overall Study|Physician Decision|0
5297381|NCT00445679|18262932|P3|Overall Study|Physician Decision|1
5297382|NCT00445679|18262933|P2|Overall Study|Physician Decision|0
5297383|NCT00445679|18262934|P1|Overall Study|Physician Decision|0
5297384|NCT00445679|18262931|P4|Overall Study|Failed to return|2
5297385|NCT00445679|18262932|P3|Overall Study|Failed to return|2
5297386|NCT00445679|18262933|P2|Overall Study|Failed to return|3
5297387|NCT00445679|18262934|P1|Overall Study|Failed to return|1
5297388|NCT00445679|18262931|P4|Overall Study|Adverse Event|19
5297389|NCT00445679|18262932|P3|Overall Study|Adverse Event|30
5297390|NCT00445679|18262933|P2|Overall Study|Adverse Event|12
5297391|NCT00445679|18262934|P1|Overall Study|Adverse Event|22
5297392|NCT00445601|18262970|P2|Overall Study|Death prior to TURBT|1
5297393|NCT00445601|18262971|P1|Overall Study|Death prior to TURBT|0
5297394|NCT00445601|18262970|P2|Overall Study|Adverse Event|0
5297395|NCT00445601|18262971|P1|Overall Study|Adverse Event|2
5297396|NCT00445601|18262970|P2|Overall Study|Drug Delivery Issue|2
5297397|NCT00445601|18262971|P1|Overall Study|Drug Delivery Issue|2
5297398|NCT00445601|18262970|P2|Overall Study|Incorrect Disease Status|6
5297399|NCT00445601|18262971|P1|Overall Study|Incorrect Disease Status|6
5297400|NCT00445601|18262970|P2|Overall Study|TURBT Complication|8
5297401|NCT00445601|18262971|P1|Overall Study|TURBT Complication|12
5297402|NCT00445601|18262970|P2|Overall Study|Withdrawal by Subject|11
5297403|NCT00445601|18262971|P1|Overall Study|Withdrawal by Subject|11
5297404|NCT00445549|18262988|P1|Overall Study|progressive disease|12
5297405|NCT00445458|18263012|P4|Overall Study|Surgery|0
5297406|NCT00445458|18263013|P3|Overall Study|Surgery|1
5297407|NCT00445458|18263014|P2|Overall Study|Surgery|0
5297408|NCT00445458|18263015|P1|Overall Study|Surgery|0
5297409|NCT00445458|18263012|P4|Overall Study|Physician Decision|1
5297410|NCT00445458|18263013|P3|Overall Study|Physician Decision|1
5297411|NCT00445458|18263014|P2|Overall Study|Physician Decision|0
5297412|NCT00445458|18263015|P1|Overall Study|Physician Decision|0
5297413|NCT00445458|18263012|P4|Overall Study|Death|0
5297414|NCT00445458|18263013|P3|Overall Study|Death|2
5297415|NCT00445458|18263014|P2|Overall Study|Death|1
5297416|NCT00445458|18263015|P1|Overall Study|Death|0
5297417|NCT00445458|18263012|P4|Overall Study|Adverse Event|0
5297418|NCT00445458|18263013|P3|Overall Study|Adverse Event|3
5297419|NCT00445458|18263014|P2|Overall Study|Adverse Event|0
5297420|NCT00445458|18263015|P1|Overall Study|Adverse Event|0
5297421|NCT00445458|18263012|P4|Overall Study|Withdrawal by Subject|0
5297422|NCT00445458|18263013|P3|Overall Study|Withdrawal by Subject|7
5297423|NCT00445458|18263014|P2|Overall Study|Withdrawal by Subject|0
5297424|NCT00445458|18263015|P1|Overall Study|Withdrawal by Subject|0
5297425|NCT00445458|18263012|P4|Overall Study|Disease Progression|27
5297426|NCT00445458|18263013|P3|Overall Study|Disease Progression|54
5297427|NCT00445458|18263014|P2|Overall Study|Disease Progression|4
5297428|NCT00445458|18263015|P1|Overall Study|Disease Progression|3
5297429|NCT00445432|18263033|P4|148 Weeks of Adalimumab Treatment|Other|9
5297430|NCT00445432|18263034|P3|148 Weeks of Adalimumab Treatment|Other|0
5297431|NCT00445432|18263035|P2|148 Weeks of Adalimumab Treatment|Other|0
5297432|NCT00445432|18263036|P1|148 Weeks of Adalimumab Treatment|Other|0
5297433|NCT00445432|18263033|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
5297434|NCT00445432|18263034|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
5297435|NCT00445432|18263035|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
5297436|NCT00445432|18263036|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
5297437|NCT00445432|18263033|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
5297438|NCT00445432|18263034|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
5297439|NCT00445432|18263035|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
5297440|NCT00445432|18263036|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
5297441|NCT00445432|18263033|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
5297442|NCT00445432|18263034|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
5297443|NCT00445432|18263035|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
5297444|NCT00445432|18263036|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
5297445|NCT00445432|18263033|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
5297446|NCT00445432|18263034|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
5297447|NCT00445432|18263035|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
5297448|NCT00445432|18263036|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
5297449|NCT00445432|18263033|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
5297450|NCT00445432|18263034|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
5297451|NCT00445432|18263035|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
5297452|NCT00445432|18263036|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
5297453|NCT00445432|18263033|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
5297454|NCT00445432|18263034|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
5297455|NCT00445432|18263035|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
5297456|NCT00445432|18263036|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
5297457|NCT00445341|18263069|P1|Overall Study|taken off treatment too early|1
5297458|NCT00445341|18263069|P1|Overall Study|refused further treatment|1
5297459|NCT00445328|18263076|P2|Overall Study|Protocol Violation|0
5297460|NCT00445328|18263077|P1|Overall Study|Protocol Violation|1
5297461|NCT00445328|18263076|P2|Overall Study|Withdrawal by Subject|0
5297462|NCT00445328|18263077|P1|Overall Study|Withdrawal by Subject|2
5297463|NCT00445328|18263076|P2|Overall Study|Other|2
5297464|NCT00445328|18263077|P1|Overall Study|Other|0
5297465|NCT00445328|18263076|P2|Overall Study|Adverse Event|3
5297466|NCT00445328|18263077|P1|Overall Study|Adverse Event|0
5297467|NCT00445328|18263076|P2|Overall Study|Death|1
5297468|NCT00445328|18263077|P1|Overall Study|Death|0
5297469|NCT00445224|18263238|P2|Specific Exercises|Withdrawal by Subject|0
5297470|NCT00445224|18263239|P1|Specific Exercises|Withdrawal by Subject|1
5297471|NCT00445224|18263238|P2|Specific Exercises|Withdrawal by Subject|3
5297472|NCT00445224|18263239|P1|Specific Exercises|Withdrawal by Subject|3
5297473|NCT00445146|18263266|P1|Overall Study|Pregnancy|1
5297474|NCT00445146|18263266|P1|Overall Study|Protocol Violation|4
5297475|NCT00445146|18263266|P1|Overall Study|Death|9
5297476|NCT00445146|18263266|P1|Overall Study|Lost to Follow-up|13
5297477|NCT00445146|18263266|P1|Overall Study|Adverse Event|13
5297478|NCT00445146|18263266|P1|Overall Study|Investigator's Discretion|22
5297479|NCT00445146|18263266|P1|Overall Study|Lack of Efficacy|28
5297480|NCT00445146|18263266|P1|Overall Study|Withdrew Consent|29
5297481|NCT00445003|18263288|P3|Overall Study|Dropped|2
5297482|NCT00445003|18263289|P2|Overall Study|Dropped|3
5297483|NCT00445003|18263290|P1|Overall Study|Dropped|1
5297484|NCT00445003|18263288|P3|Overall Study|Missed Visit|1
5297485|NCT00445003|18263289|P2|Overall Study|Missed Visit|5
5297486|NCT00445003|18263290|P1|Overall Study|Missed Visit|3
5297487|NCT00445003|18263288|P3|Overall Study|Death|1
5297488|NCT00445003|18263289|P2|Overall Study|Death|2
5297489|NCT00445003|18263290|P1|Overall Study|Death|1
5297490|NCT00444951|18263322|P3|Overall Study|Withdrawal by Subject|3
5297491|NCT00444951|18263323|P2|Overall Study|Withdrawal by Subject|5
5297492|NCT00444951|18263324|P1|Overall Study|Withdrawal by Subject|4
5297493|NCT00444951|18263322|P3|Overall Study|Lost to Follow-up|0
5297494|NCT00444951|18263323|P2|Overall Study|Lost to Follow-up|1
5297495|NCT00444951|18263324|P1|Overall Study|Lost to Follow-up|1
5297496|NCT00444925|18263341|P3|Double-blind Treatment Period|Other|12
5297497|NCT00444925|18263342|P2|Double-blind Treatment Period|Other|7
5297498|NCT00444925|18263343|P1|Double-blind Treatment Period|Other|7
5297499|NCT00444925|18263341|P3|Double-blind Treatment Period|Withdrawal by Subject|7
5297500|NCT00444925|18263342|P2|Double-blind Treatment Period|Withdrawal by Subject|8
5297501|NCT00444925|18263343|P1|Double-blind Treatment Period|Withdrawal by Subject|6
5297502|NCT00444925|18263341|P3|Double-blind Treatment Period|Lost to Follow-up|5
5297503|NCT00444925|18263342|P2|Double-blind Treatment Period|Lost to Follow-up|8
5297504|NCT00444925|18263343|P1|Double-blind Treatment Period|Lost to Follow-up|4
5297505|NCT00444925|18263341|P3|Double-blind Treatment Period|Lack of Efficacy|13
5297506|NCT00444925|18263342|P2|Double-blind Treatment Period|Lack of Efficacy|5
5297507|NCT00444925|18263343|P1|Double-blind Treatment Period|Lack of Efficacy|5
5297508|NCT00444925|18263341|P3|Double-blind Treatment Period|Adverse Event|44
5297509|NCT00444925|18263342|P2|Double-blind Treatment Period|Adverse Event|28
5297510|NCT00444925|18263343|P1|Double-blind Treatment Period|Adverse Event|6
5297511|NCT00444925|18263341|P3|Double-blind Treatment Period|Death|0
5297512|NCT00444925|18263342|P2|Double-blind Treatment Period|Death|0
5297513|NCT00444925|18263343|P1|Double-blind Treatment Period|Death|2
5297514|NCT00444925|18263341|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
5297515|NCT00444925|18263342|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
5297516|NCT00444925|18263343|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
5297517|NCT00444912|18263407|P2|Overall Study|Participant Failed Mobilization|0
5297518|NCT00444912|18263408|P1|Overall Study|Participant Failed Mobilization|1
5297519|NCT00444912|18263407|P2|Overall Study|Lost to Follow-up|0
5297520|NCT00444912|18263408|P1|Overall Study|Lost to Follow-up|1
5297521|NCT00444912|18263407|P2|Overall Study|Death|2
5297522|NCT00444912|18263408|P1|Overall Study|Death|1
5297523|NCT00444795|18263449|P1|Overall Study|Treated Prior to the Contract Date|2
5297524|NCT00444795|18263449|P1|Overall Study|Not Treated|1
5297525|NCT00444678|18263454|P1|Overall Study|Withdrawal by Subject|2
5297526|NCT00444678|18263454|P1|Overall Study|Physician Decision|3
5297527|NCT00444678|18263454|P1|Overall Study|Death|3
5297528|NCT00444678|18263454|P1|Overall Study|Disease Progression|12
5297529|NCT00444678|18263454|P1|Overall Study|Toxicity|11
5297530|NCT00444626|18263461|P1|Initial Treatment Period|Lost to Follow-up|9
5297531|NCT00444626|18263461|P1|Initial Treatment Period|Adverse Event|1
5297532|NCT00444626|18263461|P1|Initial Treatment Period|Withdrawal by Subject|2
5297533|NCT00444600|18263491|P4|Overall Study|Missed visit|1
5297534|NCT00444600|18263492|P3|Overall Study|Missed visit|0
5297535|NCT00444600|18263493|P2|Overall Study|Missed visit|0
5297536|NCT00444600|18263494|P1|Overall Study|Missed visit|1
5297537|NCT00444600|18263491|P4|Overall Study|Dropped|7
5297538|NCT00444600|18263492|P3|Overall Study|Dropped|7
5297539|NCT00444600|18263493|P2|Overall Study|Dropped|11
5297540|NCT00444600|18263494|P1|Overall Study|Dropped|11
5297541|NCT00444600|18263491|P4|Overall Study|Death|2
5297542|NCT00444600|18263492|P3|Overall Study|Death|3
5297543|NCT00444600|18263493|P2|Overall Study|Death|5
5297544|NCT00444600|18263494|P1|Overall Study|Death|7
5297545|NCT00444587|18263586|P2|Overall Study|Missing|5
5297546|NCT00444587|18263587|P1|Overall Study|Missing|0
5297547|NCT00444587|18263586|P2|Overall Study|Protocol Violation|0
5297548|NCT00444587|18263587|P1|Overall Study|Protocol Violation|1
5297549|NCT00444587|18263586|P2|Overall Study|Investigator decision|0
5297550|NCT00444587|18263587|P1|Overall Study|Investigator decision|3
5297551|NCT00444587|18263586|P2|Overall Study|Refused treatment/did not cooperate|1
5297552|NCT00444587|18263587|P1|Overall Study|Refused treatment/did not cooperate|4
5297553|NCT00444587|18263586|P2|Overall Study|Progression of the disease|8
5297554|NCT00444587|18263587|P1|Overall Study|Progression of the disease|73
5297555|NCT00444587|18263586|P2|Overall Study|Death|1
5297556|NCT00444587|18263587|P1|Overall Study|Death|2
5297557|NCT00444535|18263608|P1|Overall Study|Adverse Event|3
5297558|NCT00444535|18263608|P1|Overall Study|Investigator decision|2
5297559|NCT00444535|18263608|P1|Overall Study|Withdrawal by Subject|3
5297560|NCT00444535|18263608|P1|Overall Study|Treatment is ongoing|16
5297561|NCT00444457|18263619|P4|Toddler Dose|Protocol Violation|1
5297562|NCT00444457|18263620|P3|Toddler Dose|Protocol Violation|0
5297563|NCT00444457|18263621|P2|Toddler Dose|Protocol Violation|0
5297564|NCT00444457|18263622|P1|Toddler Dose|Protocol Violation|1
5297565|NCT00444457|18263619|P4|Toddler Dose|Parent or legal guardian request|1
5297566|NCT00444457|18263620|P3|Toddler Dose|Parent or legal guardian request|2
5297567|NCT00444457|18263621|P2|Toddler Dose|Parent or legal guardian request|3
5297568|NCT00444457|18263622|P1|Toddler Dose|Parent or legal guardian request|0
5297569|NCT00444457|18263619|P4|Toddler Dose|Failed to return|3
5297570|NCT00444457|18263620|P3|Toddler Dose|Failed to return|1
5297571|NCT00444457|18263621|P2|Toddler Dose|Failed to return|2
5297572|NCT00444457|18263622|P1|Toddler Dose|Failed to return|2
5297573|NCT00444457|18263619|P4|Toddler Dose|Lost to Follow-up|3
5297574|NCT00444457|18263620|P3|Toddler Dose|Lost to Follow-up|1
5297575|NCT00444457|18263621|P2|Toddler Dose|Lost to Follow-up|1
5297576|NCT00444457|18263622|P1|Toddler Dose|Lost to Follow-up|4
5297577|NCT00444457|18263619|P4|After Infant Series|Other|0
5297578|NCT00444457|18263620|P3|After Infant Series|Other|0
5297579|NCT00444457|18263621|P2|After Infant Series|Other|1
5297580|NCT00444457|18263622|P1|After Infant Series|Other|0
5297581|NCT00444457|18263619|P4|After Infant Series|Investigator request|1
5297582|NCT00444457|18263620|P3|After Infant Series|Investigator request|0
5297583|NCT00444457|18263621|P2|After Infant Series|Investigator request|0
5297584|NCT00444457|18263622|P1|After Infant Series|Investigator request|0
5297585|NCT00444457|18263619|P4|After Infant Series|Adverse Event|0
5297586|NCT00444457|18263620|P3|After Infant Series|Adverse Event|0
5297587|NCT00444457|18263621|P2|After Infant Series|Adverse Event|2
5297588|NCT00444457|18263622|P1|After Infant Series|Adverse Event|2
5297589|NCT00444457|18263619|P4|After Infant Series|Protocol Violation|2
5297590|NCT00444457|18263620|P3|After Infant Series|Protocol Violation|2
5297591|NCT00444457|18263621|P2|After Infant Series|Protocol Violation|4
5297592|NCT00444457|18263622|P1|After Infant Series|Protocol Violation|2
5297593|NCT00444457|18263619|P4|After Infant Series|Lost to Follow-up|2
5297594|NCT00444457|18263620|P3|After Infant Series|Lost to Follow-up|5
5297595|NCT00444457|18263621|P2|After Infant Series|Lost to Follow-up|5
5297596|NCT00444457|18263622|P1|After Infant Series|Lost to Follow-up|5
5297597|NCT00444457|18263619|P4|After Infant Series|Failed to return|1
5297598|NCT00444457|18263620|P3|After Infant Series|Failed to return|5
5297599|NCT00444457|18263621|P2|After Infant Series|Failed to return|6
5297600|NCT00444457|18263622|P1|After Infant Series|Failed to return|7
5297601|NCT00444457|18263619|P4|After Infant Series|Parent or legal guardian request|3
5297602|NCT00444457|18263620|P3|After Infant Series|Parent or legal guardian request|6
5297603|NCT00444457|18263621|P2|After Infant Series|Parent or legal guardian request|11
5297604|NCT00444457|18263622|P1|After Infant Series|Parent or legal guardian request|4
5297605|NCT00444457|18263619|P4|After Infant Series|Other|1
5297606|NCT00444457|18263620|P3|After Infant Series|Other|1
5297607|NCT00444457|18263621|P2|After Infant Series|Other|1
5297608|NCT00444457|18263622|P1|After Infant Series|Other|0
5297609|NCT00444457|18263619|P4|Infant Series|Death|1
5297610|NCT00444457|18263620|P3|Infant Series|Death|1
5297611|NCT00444457|18263621|P2|Infant Series|Death|1
5297612|NCT00444457|18263622|P1|Infant Series|Death|0
5297613|NCT00444457|18263619|P4|Infant Series|Adverse Event|0
5297614|NCT00444457|18263620|P3|Infant Series|Adverse Event|2
5297615|NCT00444457|18263621|P2|Infant Series|Adverse Event|2
5297616|NCT00444457|18263622|P1|Infant Series|Adverse Event|1
5297617|NCT00444457|18263619|P4|Infant Series|Other|0
5297618|NCT00444457|18263620|P3|Infant Series|Other|4
5297619|NCT00444457|18263621|P2|Infant Series|Other|2
5297620|NCT00444457|18263622|P1|Infant Series|Other|0
5297621|NCT00444457|18263619|P4|Infant Series|Investigator request|2
5297622|NCT00444457|18263620|P3|Infant Series|Investigator request|3
5297623|NCT00444457|18263621|P2|Infant Series|Investigator request|3
5297624|NCT00444457|18263622|P1|Infant Series|Investigator request|4
5297625|NCT00444457|18263619|P4|Infant Series|Failed to return|2
5297626|NCT00444457|18263620|P3|Infant Series|Failed to return|4
5297627|NCT00444457|18263621|P2|Infant Series|Failed to return|4
5297628|NCT00444457|18263622|P1|Infant Series|Failed to return|5
5297629|NCT00444457|18263619|P4|Infant Series|Protocol Violation|3
5297630|NCT00444457|18263620|P3|Infant Series|Protocol Violation|6
5297631|NCT00444457|18263621|P2|Infant Series|Protocol Violation|8
5297632|NCT00444457|18263622|P1|Infant Series|Protocol Violation|16
5297633|NCT00444457|18263619|P4|Infant Series|Lost to Follow-up|6
5297634|NCT00444457|18263620|P3|Infant Series|Lost to Follow-up|7
5297635|NCT00444457|18263621|P2|Infant Series|Lost to Follow-up|11
5297636|NCT00444457|18263622|P1|Infant Series|Lost to Follow-up|10
5297637|NCT00444457|18263619|P4|Infant Series|Parent or legal guardian request|14
5297638|NCT00444457|18263620|P3|Infant Series|Parent or legal guardian request|34
5297639|NCT00444457|18263621|P2|Infant Series|Parent or legal guardian request|29
5297640|NCT00444457|18263622|P1|Infant Series|Parent or legal guardian request|18
5297641|NCT00444457|18263619|P4|Infant Series|Other|0
5297642|NCT00444457|18263620|P3|Infant Series|Other|0
5297643|NCT00444457|18263621|P2|Infant Series|Other|1
5297644|NCT00444457|18263622|P1|Infant Series|Other|0
5297645|NCT00444275|18263687|P5|Maintenance Treatment Phase|Ineffectiveness|14
5297646|NCT00444275|18263688|P4|Maintenance Treatment Phase|Ineffectiveness|3
5297647|NCT00444275|18263689|P3|Maintenance Treatment Phase|Ineffectiveness|5
5297648|NCT00444275|18263690|P2|Maintenance Treatment Phase|Ineffectiveness|0
5297649|NCT00444275|18263691|P1|Maintenance Treatment Phase|Ineffectiveness|0
5297650|NCT00444275|18263687|P5|Maintenance Treatment Phase|Protocol Violation|87
5297651|NCT00444275|18263688|P4|Maintenance Treatment Phase|Protocol Violation|88
5297652|NCT00444275|18263689|P3|Maintenance Treatment Phase|Protocol Violation|103
5297653|NCT00444275|18263690|P2|Maintenance Treatment Phase|Protocol Violation|0
5297654|NCT00444275|18263691|P1|Maintenance Treatment Phase|Protocol Violation|0
5297655|NCT00444275|18263687|P5|Maintenance Treatment Phase|Patient's wish|20
5297656|NCT00444275|18263688|P4|Maintenance Treatment Phase|Patient's wish|9
5297657|NCT00444275|18263689|P3|Maintenance Treatment Phase|Patient's wish|19
5297658|NCT00444275|18263690|P2|Maintenance Treatment Phase|Patient's wish|0
5297659|NCT00444275|18263691|P1|Maintenance Treatment Phase|Patient's wish|0
5297660|NCT00444275|18263687|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
5297661|NCT00444275|18263688|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
5297662|NCT00444275|18263689|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
5297663|NCT00444275|18263690|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
5297664|NCT00444275|18263691|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
5297665|NCT00444275|18263687|P5|Maintenance Treatment Phase|Adverse Event|13
5297666|NCT00444275|18263688|P4|Maintenance Treatment Phase|Adverse Event|2
5297667|NCT00444275|18263689|P3|Maintenance Treatment Phase|Adverse Event|3
5297668|NCT00444275|18263690|P2|Maintenance Treatment Phase|Adverse Event|0
5297669|NCT00444275|18263691|P1|Maintenance Treatment Phase|Adverse Event|0
5297670|NCT00444275|18263687|P5|Maintenance Treatment Phase|Lost to Follow-up|10
5297671|NCT00444275|18263688|P4|Maintenance Treatment Phase|Lost to Follow-up|14
5297672|NCT00444275|18263689|P3|Maintenance Treatment Phase|Lost to Follow-up|8
5297673|NCT00444275|18263690|P2|Maintenance Treatment Phase|Lost to Follow-up|0
5297674|NCT00444275|18263691|P1|Maintenance Treatment Phase|Lost to Follow-up|0
5297675|NCT00444275|18263687|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
5297676|NCT00444275|18263688|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
5297677|NCT00444275|18263689|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
5297678|NCT00444275|18263690|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
5297679|NCT00444275|18263691|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
5297680|NCT00444145|18263741|P1|Overall Study|Screen Failures|5
5297681|NCT00444145|18263741|P1|Overall Study|non-compliant|11
5297682|NCT00444145|18263741|P1|Overall Study|Lost to Follow-up|1
5297683|NCT00444145|18263741|P1|Overall Study|Withdrawal by Subject|2
5297684|NCT00444106|18263748|P3|Overall Study|Abnormal Test Procedure Results|1
5297685|NCT00444106|18263749|P2|Overall Study|Abnormal Test Procedure Results|0
5297686|NCT00444106|18263750|P1|Overall Study|Abnormal Test Procedure Results|0
5297687|NCT00444106|18263748|P3|Overall Study|Lost to Follow-up|0
5297688|NCT00444106|18263749|P2|Overall Study|Lost to Follow-up|1
5297689|NCT00444106|18263750|P1|Overall Study|Lost to Follow-up|2
5297690|NCT00444067|18263782|P2|Overall Study|Lost to Follow-up|1
5297691|NCT00444067|18263783|P1|Overall Study|Lost to Follow-up|0
5297692|NCT00443898|18263846|P4|Overall Study|Death|0
5297693|NCT00443898|18263847|P3|Overall Study|Death|0
5297694|NCT00443898|18263848|P2|Overall Study|Death|1
5297695|NCT00443898|18263849|P1|Overall Study|Death|0
5297696|NCT00443898|18263846|P4|Overall Study|Lost to Follow-up|10
5297697|NCT00443898|18263847|P3|Overall Study|Lost to Follow-up|14
5297698|NCT00443898|18263848|P2|Overall Study|Lost to Follow-up|10
5297699|NCT00443898|18263849|P1|Overall Study|Lost to Follow-up|10
5297700|NCT00443898|18263846|P4|Overall Study|Withdrawal by Subject|6
5297701|NCT00443898|18263847|P3|Overall Study|Withdrawal by Subject|10
5297702|NCT00443898|18263848|P2|Overall Study|Withdrawal by Subject|10
5297703|NCT00443898|18263849|P1|Overall Study|Withdrawal by Subject|11
5297704|NCT00443898|18263846|P4|Overall Study|Protocol Violation|0
5297705|NCT00443898|18263847|P3|Overall Study|Protocol Violation|1
5297706|NCT00443898|18263848|P2|Overall Study|Protocol Violation|1
5297707|NCT00443898|18263849|P1|Overall Study|Protocol Violation|1
5297708|NCT00443898|18263846|P4|Overall Study|Lack of Efficacy|1
5297709|NCT00443898|18263847|P3|Overall Study|Lack of Efficacy|3
5297710|NCT00443898|18263848|P2|Overall Study|Lack of Efficacy|3
5297711|NCT00443898|18263849|P1|Overall Study|Lack of Efficacy|2
5297712|NCT00443898|18263846|P4|Overall Study|Adverse Event|1
5297713|NCT00443898|18263847|P3|Overall Study|Adverse Event|1
5297714|NCT00443898|18263848|P2|Overall Study|Adverse Event|0
5297715|NCT00443898|18263849|P1|Overall Study|Adverse Event|0
5297716|NCT00443872|18263871|P1|Overall Study|Adverse Event|8
5297717|NCT00443872|18263871|P1|Overall Study|Lost to Follow-up|2
5297718|NCT00443872|18263871|P1|Overall Study|Protocol Violation|7
5297719|NCT00443846|18263886|P2|Overall Study|Lost to Follow-up|2
5297720|NCT00443846|18263887|P1|Overall Study|Lost to Follow-up|1
5297721|NCT00443846|18263886|P2|Overall Study|Personal reason|3
5297722|NCT00443846|18263887|P1|Overall Study|Personal reason|8
5297723|NCT00443846|18263886|P2|Overall Study|Adverse Event|1
5297724|NCT00443846|18263887|P1|Overall Study|Adverse Event|0
5297725|NCT00443846|18263886|P2|Overall Study|Not vaccinated, no blood sample drawn|0
5297726|NCT00443846|18263887|P1|Overall Study|Not vaccinated, no blood sample drawn|1
5297727|NCT00443846|18263886|P2|Overall Study|Withdrawn due to intercurrent disease|0
5297728|NCT00443846|18263887|P1|Overall Study|Withdrawn due to intercurrent disease|1
5297729|NCT00443820|18263897|P4|Overall Study|Death|0
5297730|NCT00443820|18263898|P3|Overall Study|Death|1
5297731|NCT00443820|18263899|P2|Overall Study|Death|0
5297732|NCT00443820|18263900|P1|Overall Study|Death|0
5297733|NCT00443820|18263897|P4|Overall Study|Administrative problems|1
5297734|NCT00443820|18263898|P3|Overall Study|Administrative problems|0
5297735|NCT00443820|18263899|P2|Overall Study|Administrative problems|0
5297736|NCT00443820|18263900|P1|Overall Study|Administrative problems|0
5297737|NCT00443820|18263897|P4|Overall Study|Lost to Follow-up|5
5297738|NCT00443820|18263898|P3|Overall Study|Lost to Follow-up|6
5297739|NCT00443820|18263899|P2|Overall Study|Lost to Follow-up|8
5297740|NCT00443820|18263900|P1|Overall Study|Lost to Follow-up|9
5297741|NCT00443820|18263897|P4|Overall Study|Withdrawal by Subject|9
5297742|NCT00443820|18263898|P3|Overall Study|Withdrawal by Subject|8
5297743|NCT00443820|18263899|P2|Overall Study|Withdrawal by Subject|7
5297744|NCT00443820|18263900|P1|Overall Study|Withdrawal by Subject|6
5297745|NCT00443820|18263897|P4|Overall Study|Protocol Violation|1
5297746|NCT00443820|18263898|P3|Overall Study|Protocol Violation|2
5297747|NCT00443820|18263899|P2|Overall Study|Protocol Violation|1
5297748|NCT00443820|18263900|P1|Overall Study|Protocol Violation|2
5297749|NCT00443820|18263897|P4|Overall Study|Lack of Efficacy|1
5297750|NCT00443820|18263898|P3|Overall Study|Lack of Efficacy|1
5297751|NCT00443820|18263899|P2|Overall Study|Lack of Efficacy|2
5297752|NCT00443820|18263900|P1|Overall Study|Lack of Efficacy|3
5297753|NCT00443820|18263897|P4|Overall Study|Adverse Event|0
5297754|NCT00443820|18263898|P3|Overall Study|Adverse Event|0
5297755|NCT00443820|18263899|P2|Overall Study|Adverse Event|1
5297756|NCT00443820|18263900|P1|Overall Study|Adverse Event|1
5297757|NCT00443781|18263922|P1|Overall Study|PD/FAD not done|1
5297758|NCT00443781|18263922|P1|Overall Study|Insurance not covered|2
5297759|NCT00443781|18263922|P1|Overall Study|Investigator terminated participation|1
5297760|NCT00443781|18263922|P1|Overall Study|Unable to comply with study follow up|2
5297761|NCT00443781|18263922|P1|Overall Study|Withdrawal by Subject|6
5297762|NCT00443781|18263922|P1|Overall Study|Protocol Violation|1
5297763|NCT00443781|18263922|P1|Overall Study|Physician Decision|2
5297764|NCT00443781|18263922|P1|Overall Study|Lost to Follow-up|10
5297765|NCT00443755|18263928|P2|Overall Study|Withdrawal by Subject|1
5297766|NCT00443755|18263929|P1|Overall Study|Withdrawal by Subject|2
5297767|NCT00443729|18263963|P2|Overall Study|Withdrawal by Subject|1
5297768|NCT00443729|18263964|P1|Overall Study|Withdrawal by Subject|3
5297769|NCT00443729|18263963|P2|Overall Study|Protocol Violation|1
5297770|NCT00443729|18263964|P1|Overall Study|Protocol Violation|1
5297771|NCT00443729|18263963|P2|Overall Study|Physician Decision|1
5297772|NCT00443729|18263964|P1|Overall Study|Physician Decision|2
5297773|NCT00443729|18263963|P2|Overall Study|Lost to Follow-up|1
5297774|NCT00443729|18263964|P1|Overall Study|Lost to Follow-up|0
5297775|NCT00443729|18263963|P2|Overall Study|Lack of Efficacy|2
5297776|NCT00443729|18263964|P1|Overall Study|Lack of Efficacy|4
5297777|NCT00443729|18263963|P2|Overall Study|Never Treated|1
5297778|NCT00443729|18263964|P1|Overall Study|Never Treated|0
5297779|NCT00443703|18264012|P2|Overall Study|Progressive Disease|0
5297780|NCT00443703|18264013|P1|Overall Study|Progressive Disease|1
5297781|NCT00443703|18264012|P2|Overall Study|Withdrawal by Subject|6
5297782|NCT00443703|18264013|P1|Overall Study|Withdrawal by Subject|9
5297783|NCT00443703|18264012|P2|Overall Study|Protocol Violation|1
5297784|NCT00443703|18264013|P1|Overall Study|Protocol Violation|1
5297785|NCT00443703|18264012|P2|Overall Study|Physician Decision|2
5297786|NCT00443703|18264013|P1|Overall Study|Physician Decision|4
5297787|NCT00443703|18264012|P2|Overall Study|Lost to Follow-up|4
5297788|NCT00443703|18264013|P1|Overall Study|Lost to Follow-up|0
5297789|NCT00443703|18264012|P2|Overall Study|Lack of Efficacy|1
5297790|NCT00443703|18264013|P1|Overall Study|Lack of Efficacy|3
5297791|NCT00443703|18264012|P2|Overall Study|Adverse Event|3
5297792|NCT00443703|18264013|P1|Overall Study|Adverse Event|7
5297793|NCT00443703|18264012|P2|Overall Study|Never Treated|1
5297794|NCT00443703|18264013|P1|Overall Study|Never Treated|3
5297795|NCT00443651|18264065|P2|Overall Study|Pregnancy|1
5297796|NCT00443651|18264066|P1|Overall Study|Pregnancy|0
5297797|NCT00443651|18264065|P2|Overall Study|Physician Decision|4
5297798|NCT00443651|18264066|P1|Overall Study|Physician Decision|13
5297799|NCT00443651|18264065|P2|Overall Study|Patient's/Guardian's Decision|30
5297800|NCT00443651|18264066|P1|Overall Study|Patient's/Guardian's Decision|58
5297801|NCT00443651|18264065|P2|Overall Study|Lost to Follow-up|12
5297802|NCT00443651|18264066|P1|Overall Study|Lost to Follow-up|18
5297803|NCT00443651|18264065|P2|Overall Study|Adverse Event|6
5297804|NCT00443651|18264066|P1|Overall Study|Adverse Event|5
5297805|NCT00443651|18264065|P2|Overall Study|Death|5
5297806|NCT00443651|18264066|P1|Overall Study|Death|1
5297807|NCT00443599|18264086|P2|Overall Study|Cardiopulmonary bypass canceled|1
5297808|NCT00443599|18264087|P1|Overall Study|Cardiopulmonary bypass canceled|3
5297809|NCT00443599|18264086|P2|Overall Study|Death|1
5297810|NCT00443599|18264087|P1|Overall Study|Death|1
5297811|NCT00443599|18264086|P2|Overall Study|Physician Decision|1
5297812|NCT00443599|18264087|P1|Overall Study|Physician Decision|2
5297813|NCT00443560|18264121|P2|Overall Study|Multiple pregnancies or fetal demise|4
5297814|NCT00443560|18264122|P1|Overall Study|Multiple pregnancies or fetal demise|2
5297815|NCT00443560|18264121|P2|Overall Study|No intrathecal dose|26
5297816|NCT00443560|18264122|P1|Overall Study|No intrathecal dose|58
5297817|NCT00443534|18264157|P1|Overall Study|Enrolled, Not Treated|1
5297818|NCT00443534|18264157|P1|Overall Study|Other|10
5297819|NCT00443534|18264157|P1|Overall Study|Study Terminated by Sponsor|12
5297820|NCT00443534|18264157|P1|Overall Study|Withdrawal by Subject|8
5297821|NCT00443534|18264157|P1|Overall Study|Death|9
5297822|NCT00443534|18264157|P1|Overall Study|Adverse Event|16
5297823|NCT00443534|18264157|P1|Overall Study|Lack of Efficacy|67
5297824|NCT00443456|18264164|P1|Overall Study|Withdrawal by Subject|1
5297825|NCT00443456|18264164|P1|Overall Study|Move|1
5297826|NCT00443456|18264164|P1|Overall Study|Adverse Event|16
5297827|NCT00443430|18264199|P2|Overall Study|Adverse Event|1
5297828|NCT00443430|18264200|P1|Overall Study|Adverse Event|1
5297829|NCT00443430|18264199|P2|Overall Study|Lack of Efficacy|3
5297830|NCT00443430|18264200|P1|Overall Study|Lack of Efficacy|3
5297831|NCT00443261|18264214|P1|Overall Study|Death|1
5297832|NCT00443209|18264220|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
5297833|NCT00443209|18264221|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
5297834|NCT00443209|18264220|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
5297835|NCT00443209|18264221|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
5297836|NCT00443209|18264220|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
5297837|NCT00443209|18264221|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
5297838|NCT00443209|18264220|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
5297839|NCT00443209|18264221|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
5297840|NCT00443209|18264220|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
5297841|NCT00443209|18264221|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
5297842|NCT00443209|18264220|P2|Months 13 to 18 Treatment Period|Adverse Event|0
5297843|NCT00443209|18264221|P1|Months 13 to 18 Treatment Period|Adverse Event|1
5297844|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Not Treated|43
5297845|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Not Treated|71
5297846|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Missing|1
5297847|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Missing|2
5297848|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
5297849|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
5297850|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
5297851|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
5297852|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Pregnancy|4
5297853|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Pregnancy|3
5297854|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Physician Decision|4
5297855|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Physician Decision|8
5297856|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
5297857|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
5297858|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
5297859|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
5297860|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
5297861|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
5297862|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
5297863|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
5297864|NCT00443209|18264220|P2|Months 1 to 12 Treatment Period|Adverse Event|11
5297865|NCT00443209|18264221|P1|Months 1 to 12 Treatment Period|Adverse Event|22
5297866|NCT00443118|18264238|P3|Overall Study|Withdrawal by Subject|0
5297867|NCT00443118|18264239|P2|Overall Study|Withdrawal by Subject|0
5297868|NCT00443118|18264240|P1|Overall Study|Withdrawal by Subject|1
5297869|NCT00443118|18264238|P3|Overall Study|unknown primary outcome|0
5297870|NCT00443118|18264239|P2|Overall Study|unknown primary outcome|1
5297871|NCT00443118|18264240|P1|Overall Study|unknown primary outcome|3
5297872|NCT00443053|18264289|P2|Overall Study|Physician Decision|4
5297873|NCT00443053|18264290|P1|Overall Study|Physician Decision|0
5297874|NCT00443053|18264289|P2|Overall Study|Other|4
5297875|NCT00443053|18264290|P1|Overall Study|Other|3
5297876|NCT00443053|18264289|P2|Overall Study|Noncompliance|1
5297877|NCT00443053|18264290|P1|Overall Study|Noncompliance|2
5297878|NCT00443053|18264289|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5297879|NCT00443053|18264290|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5297880|NCT00443053|18264289|P2|Overall Study|Lost to Follow-up|5
5297881|NCT00443053|18264290|P1|Overall Study|Lost to Follow-up|4
5297882|NCT00443053|18264289|P2|Overall Study|Withdrawal by Subject|18
5297883|NCT00443053|18264290|P1|Overall Study|Withdrawal by Subject|9
5297884|NCT00443053|18264289|P2|Overall Study|Adverse Event|1
5297885|NCT00443053|18264290|P1|Overall Study|Adverse Event|2
5297886|NCT00443040|18264311|P3|Overall Study|Converted to an open laparotomy|1
5297887|NCT00443040|18264312|P2|Overall Study|Converted to an open laparotomy|0
5297888|NCT00443040|18264313|P1|Overall Study|Converted to an open laparotomy|3
5297889|NCT00443040|18264311|P3|Overall Study|Withdrawal by Subject|0
5297890|NCT00443040|18264312|P2|Overall Study|Withdrawal by Subject|0
5297891|NCT00443040|18264313|P1|Overall Study|Withdrawal by Subject|1
5297892|NCT00442962|18264321|P1|Overall Study|Lost to Follow-up|7
5297893|NCT00442962|18264321|P1|Overall Study|Pregnancy|1
5297894|NCT00442936|18264339|P4|Overall Study|Protocol Violation|1
5297895|NCT00442936|18264340|P3|Overall Study|Protocol Violation|1
5297896|NCT00442936|18264341|P2|Overall Study|Protocol Violation|0
5297897|NCT00442936|18264342|P1|Overall Study|Protocol Violation|1
5297898|NCT00442897|18264390|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
5297899|NCT00442897|18264391|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
5297900|NCT00442897|18264390|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
5297901|NCT00442897|18264391|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
5297902|NCT00442897|18264390|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
5297903|NCT00442897|18264391|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
5297904|NCT00442897|18264390|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
5297905|NCT00442897|18264391|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
5297906|NCT00442897|18264390|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
5297907|NCT00442897|18264391|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
5297908|NCT00442897|18264390|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
5297909|NCT00442897|18264391|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
5297910|NCT00442897|18264390|P2|Base Study (12 Week Follow-up)|Death|1
5297911|NCT00442897|18264391|P1|Base Study (12 Week Follow-up)|Death|0
5297912|NCT00442897|18264390|P2|Base Study (12 Week Follow-up)|Adverse Event|0
5297913|NCT00442897|18264391|P1|Base Study (12 Week Follow-up)|Adverse Event|1
5297914|NCT00442702|18264409|P2|Evaluation Period|Site closure|1
5297915|NCT00442702|18264410|P1|Evaluation Period|Site closure|0
5297916|NCT00442702|18264409|P2|Evaluation Period|Failure to return|0
5297917|NCT00442702|18264410|P1|Evaluation Period|Failure to return|1
5297918|NCT00442702|18264409|P2|Evaluation Period|Renal transplant|1
5297919|NCT00442702|18264410|P1|Evaluation Period|Renal transplant|0
5297920|NCT00442702|18264409|P2|Evaluation Period|Refused treatment|1
5297921|NCT00442702|18264410|P1|Evaluation Period|Refused treatment|1
5297922|NCT00442702|18264409|P2|Evaluation Period|Insufficient Therapeutic Response|0
5297923|NCT00442702|18264410|P1|Evaluation Period|Insufficient Therapeutic Response|1
5297924|NCT00442702|18264409|P2|Evaluation Period|Death|1
5297925|NCT00442702|18264410|P1|Evaluation Period|Death|1
5297926|NCT00442702|18264409|P2|Evaluation Period|Adverse Event|0
5297927|NCT00442702|18264410|P1|Evaluation Period|Adverse Event|1
5297928|NCT00442702|18264409|P2|Titration Period|Hospitalized in another hospital|0
5297929|NCT00442702|18264410|P1|Titration Period|Hospitalized in another hospital|1
5297930|NCT00442702|18264409|P2|Titration Period|Failure to return|0
5297931|NCT00442702|18264410|P1|Titration Period|Failure to return|1
5297932|NCT00442702|18264409|P2|Titration Period|Refused Treatment|1
5297933|NCT00442702|18264410|P1|Titration Period|Refused Treatment|4
5297934|NCT00442702|18264409|P2|Titration Period|Insufficient Therapeutic Response|0
5297935|NCT00442702|18264410|P1|Titration Period|Insufficient Therapeutic Response|1
5297936|NCT00442702|18264409|P2|Titration Period|Death|2
5297937|NCT00442702|18264410|P1|Titration Period|Death|3
5297938|NCT00442702|18264409|P2|Titration Period|Adverse Event|0
5297939|NCT00442702|18264410|P1|Titration Period|Adverse Event|2
5297940|NCT00442598|18264475|P3|Overall Study|Death|0
5297941|NCT00442598|18264476|P2|Overall Study|Death|1
5297942|NCT00442598|18264477|P1|Overall Study|Death|0
5297943|NCT00442598|18264475|P3|Overall Study|Reduced creatinine clearance|0
5297944|NCT00442598|18264476|P2|Overall Study|Reduced creatinine clearance|0
5297945|NCT00442598|18264477|P1|Overall Study|Reduced creatinine clearance|1
5297946|NCT00442598|18264475|P3|Overall Study|CA125 progression|0
5297947|NCT00442598|18264476|P2|Overall Study|CA125 progression|1
5297948|NCT00442598|18264477|P1|Overall Study|CA125 progression|0
5297949|NCT00442598|18264475|P3|Overall Study|Clinical deterioration|0
5297950|NCT00442598|18264476|P2|Overall Study|Clinical deterioration|2
5297951|NCT00442598|18264477|P1|Overall Study|Clinical deterioration|1
5297952|NCT00442598|18264475|P3|Overall Study|Tumor progression|0
5297953|NCT00442598|18264476|P2|Overall Study|Tumor progression|4
5297954|NCT00442598|18264477|P1|Overall Study|Tumor progression|3
5297955|NCT00442598|18264475|P3|Overall Study|Adverse Event|0
5297956|NCT00442598|18264476|P2|Overall Study|Adverse Event|0
5297957|NCT00442598|18264477|P1|Overall Study|Adverse Event|1
5297958|NCT00442572|18264495|P2|Overall Study|Withdrawal by Subject|1
5297959|NCT00442572|18264496|P1|Overall Study|Withdrawal by Subject|0
5297960|NCT00442572|18264495|P2|Overall Study|Lost to Follow-up|1
5297961|NCT00442572|18264496|P1|Overall Study|Lost to Follow-up|0
5297962|NCT00442572|18264495|P2|Overall Study|Relapse|1
5297963|NCT00442572|18264496|P1|Overall Study|Relapse|8
5297964|NCT00442559|18264536|P2|Overall Study|Withdrawal by Subject|0
5297965|NCT00442559|18264537|P1|Overall Study|Withdrawal by Subject|1
5297966|NCT00442559|18264536|P2|Overall Study|Protocol Violation|1
5297967|NCT00442559|18264537|P1|Overall Study|Protocol Violation|1
5297968|NCT00442559|18264536|P2|Overall Study|Lost to Follow-up|34
5297969|NCT00442559|18264537|P1|Overall Study|Lost to Follow-up|32
5297970|NCT00442546|18264552|P3|Overall Study|Randomized But Not Treated|6
5297971|NCT00442546|18264553|P2|Overall Study|Randomized But Not Treated|4
5297972|NCT00442546|18264554|P1|Overall Study|Randomized But Not Treated|5
5297973|NCT00442546|18264552|P3|Overall Study|Withdrawal by Subject|7
5297974|NCT00442546|18264553|P2|Overall Study|Withdrawal by Subject|5
5297975|NCT00442546|18264554|P1|Overall Study|Withdrawal by Subject|5
5297976|NCT00442546|18264552|P3|Overall Study|Other|6
5297977|NCT00442546|18264553|P2|Overall Study|Other|9
5297978|NCT00442546|18264554|P1|Overall Study|Other|4
5297979|NCT00442546|18264552|P3|Overall Study|Lost to Follow-up|1
5297980|NCT00442546|18264553|P2|Overall Study|Lost to Follow-up|2
5297981|NCT00442546|18264554|P1|Overall Study|Lost to Follow-up|1
5297982|NCT00442546|18264552|P3|Overall Study|Adverse Event|13
5297983|NCT00442546|18264553|P2|Overall Study|Adverse Event|17
5297984|NCT00442546|18264554|P1|Overall Study|Adverse Event|11
5297985|NCT00442468|18264683|P1|Overall Study|Did not complete all study procedures|88
5297986|NCT00442468|18264683|P1|Overall Study|Withdrawal by Subject|91
5297987|NCT00442468|18264683|P1|Overall Study|Adverse Event|4
5297988|NCT00442416|18264713|P2|Overall Study|Administrative/Other|33
5297989|NCT00442416|18264714|P1|Overall Study|Administrative/Other|27
5297990|NCT00442416|18264713|P2|Overall Study|Withdrew consent|2
5297991|NCT00442416|18264714|P1|Overall Study|Withdrew consent|1
5297992|NCT00442416|18264713|P2|Overall Study|Protocol Violation|3
5297993|NCT00442416|18264714|P1|Overall Study|Protocol Violation|2
5297994|NCT00442416|18264713|P2|Overall Study|Lack of Efficacy|0
5297995|NCT00442416|18264714|P1|Overall Study|Lack of Efficacy|2
5297996|NCT00442416|18264713|P2|Overall Study|Death|0
5297997|NCT00442416|18264714|P1|Overall Study|Death|1
5297998|NCT00442416|18264713|P2|Overall Study|Adverse Event|1
5297999|NCT00442416|18264714|P1|Overall Study|Adverse Event|4
5298000|NCT00442351|18264753|P2|Overall Study|Other|1
5298001|NCT00442351|18264754|P1|Overall Study|Other|0
5298002|NCT00442351|18264753|P2|Overall Study|Did not meet protocol eligibility|0
5298003|NCT00442351|18264754|P1|Overall Study|Did not meet protocol eligibility|1
5298004|NCT00442351|18264753|P2|Overall Study|Administrative|5
5298005|NCT00442351|18264754|P1|Overall Study|Administrative|6
5298006|NCT00442286|18264776|P2|Overall Study|Patient Injury|0
5298007|NCT00442286|18264777|P1|Overall Study|Patient Injury|1
5298008|NCT00442286|18264776|P2|Overall Study|System explanted|0
5298009|NCT00442286|18264777|P1|Overall Study|System explanted|1
5298010|NCT00442286|18264776|P2|Overall Study|Withdrawal by Subject|0
5298011|NCT00442286|18264777|P1|Overall Study|Withdrawal by Subject|2
5298012|NCT00442286|18264776|P2|Overall Study|Lost to Follow-up|0
5298013|NCT00442286|18264777|P1|Overall Study|Lost to Follow-up|1
5298014|NCT00442286|18264776|P2|Overall Study|Death|2
5298015|NCT00442286|18264777|P1|Overall Study|Death|2
5298016|NCT00442117|18264839|P2|Overall Study|Met Withdrawal Criteria|1
5298017|NCT00442117|18264840|P1|Overall Study|Met Withdrawal Criteria|2
5298018|NCT00442117|18264839|P2|Overall Study|Non compliance with protocol|5
5298019|NCT00442117|18264840|P1|Overall Study|Non compliance with protocol|3
5298020|NCT00442117|18264839|P2|Overall Study|Major Deviation|20
5298021|NCT00442117|18264840|P1|Overall Study|Major Deviation|25
5298022|NCT00442117|18264839|P2|Overall Study|Withdrawal by Subject|2
5298023|NCT00442117|18264840|P1|Overall Study|Withdrawal by Subject|2
5298024|NCT00442117|18264839|P2|Overall Study|Lost to Follow-up|2
5298025|NCT00442117|18264840|P1|Overall Study|Lost to Follow-up|1
5298026|NCT00442117|18264839|P2|Overall Study|Lack of Efficacy|6
5298027|NCT00442117|18264840|P1|Overall Study|Lack of Efficacy|2
5298028|NCT00442117|18264839|P2|Overall Study|Adverse Event|2
5298029|NCT00442117|18264840|P1|Overall Study|Adverse Event|3
5298030|NCT00441974|18264871|P1|Overall Study|Protocol Violation|7
5298031|NCT00441974|18264871|P1|Overall Study|Lost to Follow-up|80
5298032|NCT00441974|18264871|P1|Overall Study|Consent Withdrawn|35
5298033|NCT00441974|18264871|P1|Overall Study|Adverse Event|6
5298034|NCT00441792|18264918|P2|Overall Study|Lost to Follow-up|2
5298035|NCT00441792|18264919|P1|Overall Study|Lost to Follow-up|0
5298036|NCT00441727|18264959|P3|Overall Study|Various reason specified|5
5298037|NCT00441727|18264960|P2|Overall Study|Various reason specified|8
5298038|NCT00441727|18264961|P1|Overall Study|Various reason specified|6
5298039|NCT00441727|18264959|P3|Overall Study|Safety Reasons|3
5298040|NCT00441727|18264960|P2|Overall Study|Safety Reasons|1
5298041|NCT00441727|18264961|P1|Overall Study|Safety Reasons|3
5298042|NCT00441727|18264959|P3|Overall Study|Lost to Follow-up|5
5298043|NCT00441727|18264960|P2|Overall Study|Lost to Follow-up|6
5298044|NCT00441727|18264961|P1|Overall Study|Lost to Follow-up|5
5298045|NCT00441727|18264959|P3|Overall Study|Withdrawal by Subject|47
5298046|NCT00441727|18264960|P2|Overall Study|Withdrawal by Subject|34
5298047|NCT00441727|18264961|P1|Overall Study|Withdrawal by Subject|40
5298048|NCT00441727|18264959|P3|Overall Study|Lack of Efficacy|48
5298049|NCT00441727|18264960|P2|Overall Study|Lack of Efficacy|8
5298050|NCT00441727|18264961|P1|Overall Study|Lack of Efficacy|7
5298051|NCT00441727|18264959|P3|Overall Study|Adverse Event|28
5298052|NCT00441727|18264960|P2|Overall Study|Adverse Event|33
5298053|NCT00441727|18264961|P1|Overall Study|Adverse Event|26
5298054|NCT00441727|18264959|P3|Overall Study|Protocol Violation|32
5298055|NCT00441727|18264960|P2|Overall Study|Protocol Violation|28
5298056|NCT00441727|18264961|P1|Overall Study|Protocol Violation|19
5298057|NCT00441701|18264994|P10|Overall Study|Withdrawal by Subject|0
5298058|NCT00441701|18264995|P9|Overall Study|Withdrawal by Subject|0
5298059|NCT00441701|18264996|P8|Overall Study|Withdrawal by Subject|0
5298060|NCT00441701|18264997|P7|Overall Study|Withdrawal by Subject|0
5298061|NCT00441701|18264998|P6|Overall Study|Withdrawal by Subject|0
5298062|NCT00441701|18264999|P5|Overall Study|Withdrawal by Subject|0
5298063|NCT00441701|18265000|P4|Overall Study|Withdrawal by Subject|1
5298064|NCT00441701|18265001|P3|Overall Study|Withdrawal by Subject|1
5298065|NCT00441701|18265002|P2|Overall Study|Withdrawal by Subject|2
5298066|NCT00441701|18265003|P1|Overall Study|Withdrawal by Subject|0
5298067|NCT00441701|18264994|P10|Overall Study|Lack of Efficacy|0
5298068|NCT00441701|18264995|P9|Overall Study|Lack of Efficacy|0
5298069|NCT00441701|18264996|P8|Overall Study|Lack of Efficacy|0
5298070|NCT00441701|18264997|P7|Overall Study|Lack of Efficacy|0
5298071|NCT00441701|18264998|P6|Overall Study|Lack of Efficacy|1
5298072|NCT00441701|18264999|P5|Overall Study|Lack of Efficacy|0
5298073|NCT00441701|18265000|P4|Overall Study|Lack of Efficacy|2
5298074|NCT00441701|18265001|P3|Overall Study|Lack of Efficacy|2
5298075|NCT00441701|18265002|P2|Overall Study|Lack of Efficacy|0
5298076|NCT00441701|18265003|P1|Overall Study|Lack of Efficacy|2
5298077|NCT00441701|18264994|P10|Overall Study|Adverse Event|0
5298078|NCT00441701|18264995|P9|Overall Study|Adverse Event|0
5298079|NCT00441701|18264996|P8|Overall Study|Adverse Event|0
5298080|NCT00441701|18264997|P7|Overall Study|Adverse Event|0
5298081|NCT00441701|18264998|P6|Overall Study|Adverse Event|2
5298082|NCT00441701|18264999|P5|Overall Study|Adverse Event|2
5298083|NCT00441701|18265000|P4|Overall Study|Adverse Event|0
5298084|NCT00441701|18265001|P3|Overall Study|Adverse Event|1
5298085|NCT00441701|18265002|P2|Overall Study|Adverse Event|2
5298086|NCT00441701|18265003|P1|Overall Study|Adverse Event|3
5298087|NCT00441584|18265085|P1|Overall Study|Failure to meet eligibility criteria|3
5298088|NCT00441584|18265085|P1|Overall Study|Lost to Follow-up|4
5298089|NCT00441584|18265085|P1|Overall Study|Protocol Violation|5
5298090|NCT00441584|18265085|P1|Overall Study|Adverse Event|6
5298091|NCT00441584|18265085|P1|Overall Study|Withdrawal by Subject|8
5298092|NCT00441584|18265085|P1|Overall Study|Lack of Efficacy|79
5298093|NCT00441545|18265093|P2|Second Intervention|Subject moved|1
5298094|NCT00441545|18265094|P1|Second Intervention|Subject moved|0
5298095|NCT00441545|18265093|P2|Second Intervention|Subject exceeded safety criteria|0
5298096|NCT00441545|18265094|P1|Second Intervention|Subject exceeded safety criteria|1
5298097|NCT00441545|18265093|P2|Second Intervention|Lack of Efficacy|1
5298098|NCT00441545|18265094|P1|Second Intervention|Lack of Efficacy|0
5298099|NCT00441545|18265093|P2|Second Intervention|Kidney Transplant|1
5298100|NCT00441545|18265094|P1|Second Intervention|Kidney Transplant|1
5298101|NCT00441545|18265093|P2|Second Intervention|Withdrawal by Subject|1
5298102|NCT00441545|18265094|P1|Second Intervention|Withdrawal by Subject|1
5298103|NCT00441545|18265093|P2|Second Intervention|Protocol Violation|1
5298104|NCT00441545|18265094|P1|Second Intervention|Protocol Violation|4
5298105|NCT00441545|18265093|P2|Second Intervention|Adverse Event|2
5298106|NCT00441545|18265094|P1|Second Intervention|Adverse Event|5
5298107|NCT00441545|18265093|P2|First Intervention|Sponsor's request|0
5298108|NCT00441545|18265094|P1|First Intervention|Sponsor's request|1
5298109|NCT00441545|18265093|P2|First Intervention|Site error|0
5298110|NCT00441545|18265094|P1|First Intervention|Site error|1
5298111|NCT00441545|18265093|P2|First Intervention|Extended hospitalization|0
5298112|NCT00441545|18265094|P1|First Intervention|Extended hospitalization|1
5298113|NCT00441545|18265093|P2|First Intervention|Subject met an exclusionary criteria|0
5298114|NCT00441545|18265094|P1|First Intervention|Subject met an exclusionary criteria|1
5298115|NCT00441545|18265093|P2|First Intervention|Subject exceeded safety criteria|1
5298116|NCT00441545|18265094|P1|First Intervention|Subject exceeded safety criteria|0
5298117|NCT00441545|18265093|P2|First Intervention|Lack of Efficacy|0
5298118|NCT00441545|18265094|P1|First Intervention|Lack of Efficacy|2
5298119|NCT00441545|18265093|P2|First Intervention|Kidney transplant|1
5298120|NCT00441545|18265094|P1|First Intervention|Kidney transplant|1
5298121|NCT00441545|18265093|P2|First Intervention|Withdrawal by Subject|3
5298122|NCT00441545|18265094|P1|First Intervention|Withdrawal by Subject|3
5298123|NCT00441545|18265093|P2|First Intervention|Protocol Violation|2
5298124|NCT00441545|18265094|P1|First Intervention|Protocol Violation|2
5298125|NCT00441545|18265093|P2|First Intervention|Adverse Event|5
5298126|NCT00441545|18265094|P1|First Intervention|Adverse Event|6
5298127|NCT00441480|18265108|P2|Overall Study|Withdrawal by Subject|3
5298128|NCT00441480|18265109|P1|Overall Study|Withdrawal by Subject|2
5298129|NCT00441480|18265108|P2|Overall Study|Protocol Violation|1
5298130|NCT00441480|18265109|P1|Overall Study|Protocol Violation|1
5298131|NCT00441467|18265141|P1|Overall Study|Progressive disease|9
5298132|NCT00441467|18265141|P1|Overall Study|Withdrawal by Subject|3
5298133|NCT00441467|18265141|P1|Overall Study|Adverse Event|6
5298134|NCT00441441|18265149|P2|Overall Study|Other|3
5298135|NCT00441441|18265150|P1|Overall Study|Other|3
5298136|NCT00441441|18265149|P2|Overall Study|Withdrawal by Subject|2
5298137|NCT00441441|18265150|P1|Overall Study|Withdrawal by Subject|1
5298138|NCT00441441|18265149|P2|Overall Study|Exacerbation of asthma|2
5298139|NCT00441441|18265150|P1|Overall Study|Exacerbation of asthma|1
5298140|NCT00441441|18265149|P2|Overall Study|Protocol Violation|6
5298141|NCT00441441|18265150|P1|Overall Study|Protocol Violation|4
5298142|NCT00441441|18265149|P2|Overall Study|Adverse Event|1
5298143|NCT00441441|18265150|P1|Overall Study|Adverse Event|2
5298144|NCT00441363|18265210|P2|Overall Study|Other|0
5298145|NCT00441363|18265211|P1|Overall Study|Other|2
5298146|NCT00441363|18265210|P2|Overall Study|Lost to Follow-up|2
5298147|NCT00441363|18265211|P1|Overall Study|Lost to Follow-up|2
5298148|NCT00441363|18265210|P2|Overall Study|Physician Decision|7
5298149|NCT00441363|18265211|P1|Overall Study|Physician Decision|6
5298150|NCT00441363|18265210|P2|Overall Study|Withdrawal by Subject|4
5298151|NCT00441363|18265211|P1|Overall Study|Withdrawal by Subject|3
5298152|NCT00441363|18265210|P2|Overall Study|Adverse Event|2
5298153|NCT00441363|18265211|P1|Overall Study|Adverse Event|4
5298154|NCT00441337|18265223|P4|Overall Study|Did not meet inclusion criteria|0
5298155|NCT00441337|18265224|P3|Overall Study|Did not meet inclusion criteria|1
5298156|NCT00441337|18265225|P2|Overall Study|Did not meet inclusion criteria|0
5298157|NCT00441337|18265226|P1|Overall Study|Did not meet inclusion criteria|0
5298158|NCT00441337|18265223|P4|Overall Study|Sponsor Decision|2
5298159|NCT00441337|18265224|P3|Overall Study|Sponsor Decision|1
5298160|NCT00441337|18265225|P2|Overall Study|Sponsor Decision|0
5298161|NCT00441337|18265226|P1|Overall Study|Sponsor Decision|0
5298162|NCT00441337|18265223|P4|Overall Study|Lost to Follow-up|1
5298163|NCT00441337|18265224|P3|Overall Study|Lost to Follow-up|0
5298164|NCT00441337|18265225|P2|Overall Study|Lost to Follow-up|0
5298165|NCT00441337|18265226|P1|Overall Study|Lost to Follow-up|0
5298166|NCT00441337|18265223|P4|Overall Study|Disease Progression|18
5298167|NCT00441337|18265224|P3|Overall Study|Disease Progression|4
5298168|NCT00441337|18265225|P2|Overall Study|Disease Progression|6
5298169|NCT00441337|18265226|P1|Overall Study|Disease Progression|6
5298170|NCT00441272|18265339|P2|Overall Study|Study terminated prior to enrollment|25
5298171|NCT00441272|18265340|P1|Overall Study|Study terminated prior to enrollment|25
5298172|NCT00441168|18265367|P2|Follow-up Period|Other|3
5298173|NCT00441168|18265368|P1|Follow-up Period|Other|1
5298174|NCT00441168|18265367|P2|Follow-up Period|Withdrawal by Subject|0
5298175|NCT00441168|18265368|P1|Follow-up Period|Withdrawal by Subject|3
5298176|NCT00441168|18265367|P2|Follow-up Period|Lost to Follow-up|6
5298177|NCT00441168|18265368|P1|Follow-up Period|Lost to Follow-up|5
5298178|NCT00441168|18265367|P2|Follow-up Period|Death|0
5298179|NCT00441168|18265368|P1|Follow-up Period|Death|3
5298180|NCT00441168|18265367|P2|Treatment Period|refractory disease|0
5298181|NCT00441168|18265368|P1|Treatment Period|refractory disease|1
5298182|NCT00441168|18265367|P2|Treatment Period|qualified for stem-cell transplantation|0
5298183|NCT00441168|18265368|P1|Treatment Period|qualified for stem-cell transplantation|3
5298184|NCT00441168|18265367|P2|Treatment Period|Withdrawal by Subject|0
5298185|NCT00441168|18265368|P1|Treatment Period|Withdrawal by Subject|3
5298186|NCT00441168|18265367|P2|Treatment Period|Lost to Follow-up|1
5298187|NCT00441168|18265368|P1|Treatment Period|Lost to Follow-up|0
5298188|NCT00441168|18265367|P2|Treatment Period|Protocol Violation|1
5298189|NCT00441168|18265368|P1|Treatment Period|Protocol Violation|0
5298190|NCT00441168|18265367|P2|Treatment Period|Progressive Disease|2
5298191|NCT00441168|18265368|P1|Treatment Period|Progressive Disease|0
5298192|NCT00441168|18265367|P2|Treatment Period|Adverse Event|2
5298193|NCT00441168|18265368|P1|Treatment Period|Adverse Event|1
5298194|NCT00441168|18265367|P2|Treatment Period|Death|0
5298195|NCT00441168|18265368|P1|Treatment Period|Death|3
5298196|NCT00441142|18265382|P4|Overall Study|Death|1
5298197|NCT00441142|18265383|P3|Overall Study|Death|0
5298198|NCT00441142|18265384|P2|Overall Study|Death|0
5298199|NCT00441142|18265385|P1|Overall Study|Death|0
5298200|NCT00441142|18265382|P4|Overall Study|Physician Decision|1
5298201|NCT00441142|18265383|P3|Overall Study|Physician Decision|0
5298202|NCT00441142|18265384|P2|Overall Study|Physician Decision|1
5298203|NCT00441142|18265385|P1|Overall Study|Physician Decision|0
5298204|NCT00441142|18265382|P4|Overall Study|Patient still receiving active study tx|2
5298205|NCT00441142|18265383|P3|Overall Study|Patient still receiving active study tx|0
5298206|NCT00441142|18265384|P2|Overall Study|Patient still receiving active study tx|0
5298207|NCT00441142|18265385|P1|Overall Study|Patient still receiving active study tx|1
5298208|NCT00441142|18265382|P4|Overall Study|Withdrawal by Subject|10
5298209|NCT00441142|18265383|P3|Overall Study|Withdrawal by Subject|2
5298210|NCT00441142|18265384|P2|Overall Study|Withdrawal by Subject|0
5298211|NCT00441142|18265385|P1|Overall Study|Withdrawal by Subject|0
5298212|NCT00441142|18265382|P4|Overall Study|Lack of Efficacy|32
5298213|NCT00441142|18265383|P3|Overall Study|Lack of Efficacy|17
5298214|NCT00441142|18265384|P2|Overall Study|Lack of Efficacy|3
5298215|NCT00441142|18265385|P1|Overall Study|Lack of Efficacy|3
5298216|NCT00441142|18265382|P4|Overall Study|Adverse Event|22
5298217|NCT00441142|18265383|P3|Overall Study|Adverse Event|3
5298218|NCT00441142|18265384|P2|Overall Study|Adverse Event|3
5298219|NCT00441142|18265385|P1|Overall Study|Adverse Event|2
5298220|NCT00441129|18265407|P2|Overall Study|Withdrawal by Subject|14
5298221|NCT00441129|18265408|P1|Overall Study|Withdrawal by Subject|6
5298222|NCT00441116|18265420|P2|Overall Study|Did not meet Eligibility Criteria|1
5298223|NCT00441116|18265421|P1|Overall Study|Did not meet Eligibility Criteria|1
5298224|NCT00441116|18265420|P2|Overall Study|Withdrawal by Subject|0
5298225|NCT00441116|18265421|P1|Overall Study|Withdrawal by Subject|1
5298226|NCT00441116|18265420|P2|Overall Study|Adverse Event|1
5298227|NCT00441116|18265421|P1|Overall Study|Adverse Event|1
5298228|NCT00441103|18265489|P2|Overall Study|Participant decided to stop|1
5298229|NCT00441103|18265490|P1|Overall Study|Participant decided to stop|0
5298230|NCT00441103|18265489|P2|Overall Study|Participant's reason|1
5298231|NCT00441103|18265490|P1|Overall Study|Participant's reason|0
5298232|NCT00441103|18265489|P2|Overall Study|Participant decided to withdraw|0
5298233|NCT00441103|18265490|P1|Overall Study|Participant decided to withdraw|1
5298234|NCT00441103|18265489|P2|Overall Study|Non-compliant|1
5298235|NCT00441103|18265490|P1|Overall Study|Non-compliant|0
5298236|NCT00441103|18265489|P2|Overall Study|Inclusion criteria absent|0
5298237|NCT00441103|18265490|P1|Overall Study|Inclusion criteria absent|1
5298238|NCT00441103|18265489|P2|Overall Study|Participant refused MRI|0
5298239|NCT00441103|18265490|P1|Overall Study|Participant refused MRI|1
5298240|NCT00441103|18265489|P2|Overall Study|Participant unable to use Rebiject II|0
5298241|NCT00441103|18265490|P1|Overall Study|Participant unable to use Rebiject II|1
5298242|NCT00441103|18265489|P2|Overall Study|Protocol Violation|0
5298243|NCT00441103|18265490|P1|Overall Study|Protocol Violation|1
5298244|NCT00441103|18265489|P2|Overall Study|Lost to Follow-up|0
5298245|NCT00441103|18265490|P1|Overall Study|Lost to Follow-up|1
5298246|NCT00441103|18265489|P2|Overall Study|Disease Progression|0
5298247|NCT00441103|18265490|P1|Overall Study|Disease Progression|2
5298248|NCT00441103|18265489|P2|Overall Study|Death|0
5298249|NCT00441103|18265490|P1|Overall Study|Death|1
5298250|NCT00441103|18265489|P2|Overall Study|Adverse Event|1
5298251|NCT00441103|18265490|P1|Overall Study|Adverse Event|2
5298252|NCT00441090|18265506|P5|Overall Study|Lack of Efficacy|0
5298253|NCT00441090|18265507|P4|Overall Study|Lack of Efficacy|0
5298254|NCT00441090|18265508|P3|Overall Study|Lack of Efficacy|0
5298255|NCT00441090|18265509|P2|Overall Study|Lack of Efficacy|0
5298256|NCT00441090|18265510|P1|Overall Study|Lack of Efficacy|1
5298257|NCT00441090|18265506|P5|Overall Study|Withdrawal by Subject|0
5298258|NCT00441090|18265507|P4|Overall Study|Withdrawal by Subject|0
5298259|NCT00441090|18265508|P3|Overall Study|Withdrawal by Subject|1
5298260|NCT00441090|18265509|P2|Overall Study|Withdrawal by Subject|0
5298261|NCT00441090|18265510|P1|Overall Study|Withdrawal by Subject|1
5298262|NCT00441090|18265506|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
5298263|NCT00441090|18265507|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
5298264|NCT00441090|18265508|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
5298265|NCT00441090|18265509|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
5298266|NCT00441090|18265510|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
5298267|NCT00441090|18265506|P5|Overall Study|Adverse Event|0
5298268|NCT00441090|18265507|P4|Overall Study|Adverse Event|0
5298269|NCT00441090|18265508|P3|Overall Study|Adverse Event|1
5298270|NCT00441090|18265509|P2|Overall Study|Adverse Event|1
5298271|NCT00441090|18265510|P1|Overall Study|Adverse Event|0
5298272|NCT00441064|18265554|P2|Overall Study|Patient withdrew consent|2
5298273|NCT00441064|18265555|P1|Overall Study|Patient withdrew consent|5
5298274|NCT00441064|18265554|P2|Overall Study|Protocol Deviation|2
5298275|NCT00441064|18265555|P1|Overall Study|Protocol Deviation|3
5298276|NCT00441064|18265554|P2|Overall Study|Unsatisfactory therapeutic effect|0
5298277|NCT00441064|18265555|P1|Overall Study|Unsatisfactory therapeutic effect|1
5298278|NCT00441064|18265554|P2|Overall Study|Abnormal test procedure results|1
5298279|NCT00441064|18265555|P1|Overall Study|Abnormal test procedure results|0
5298280|NCT00441064|18265554|P2|Overall Study|Abnormal laboratory values|2
5298281|NCT00441064|18265555|P1|Overall Study|Abnormal laboratory values|0
5298282|NCT00441064|18265554|P2|Overall Study|Adverse Event|0
5298283|NCT00441064|18265555|P1|Overall Study|Adverse Event|1
5298284|NCT00441012|18265567|P2|Overall Study|Subject Randomized but Not Vaccinated|0
5298285|NCT00441012|18265568|P1|Overall Study|Subject Randomized but Not Vaccinated|1
5298286|NCT00441012|18265567|P2|Overall Study|Withdrawal by Subject|0
5298287|NCT00441012|18265568|P1|Overall Study|Withdrawal by Subject|4
5298288|NCT00441012|18265567|P2|Overall Study|Protocol Violation|9
5298289|NCT00441012|18265568|P1|Overall Study|Protocol Violation|10
5298290|NCT00441012|18265567|P2|Overall Study|Lost to Follow-up|3
5298291|NCT00441012|18265568|P1|Overall Study|Lost to Follow-up|3
5298292|NCT00441012|18265567|P2|Overall Study|Adverse Event|1
5298293|NCT00441012|18265568|P1|Overall Study|Adverse Event|0
5298294|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
5298295|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5298296|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5298297|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5298298|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5298299|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Physician Decision|1
5298300|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Physician Decision|0
5298301|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Physician Decision|0
5298302|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Physician Decision|0
5298303|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Physician Decision|0
5298304|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Other|0
5298305|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Other|1
5298306|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Other|0
5298307|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Other|0
5298308|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Other|0
5298309|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
5298310|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
5298311|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
5298312|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
5298313|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
5298314|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Sponsor Request|1
5298315|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Sponsor Request|1
5298316|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Sponsor Request|0
5298317|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Sponsor Request|0
5298318|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Sponsor Request|0
5298319|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Participant Moved|1
5298320|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Participant Moved|1
5298321|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Participant Moved|0
5298322|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Participant Moved|0
5298323|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Participant Moved|0
5298324|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Pregnancy|0
5298325|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Pregnancy|3
5298326|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Pregnancy|0
5298327|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Pregnancy|0
5298328|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Pregnancy|0
5298329|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
5298330|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
5298331|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
5298332|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
5298333|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
5298334|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Protocol Violation|0
5298335|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Protocol Violation|1
5298336|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Protocol Violation|0
5298337|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Protocol Violation|0
5298338|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Protocol Violation|0
5298339|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
5298340|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
5298341|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
5298342|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
5298343|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
5298344|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Non-compliance|1
5298345|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Non-compliance|1
5298346|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Non-compliance|0
5298347|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Non-compliance|0
5298348|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Non-compliance|0
5298349|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
5298350|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
5298351|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
5298352|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
5298353|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
5298354|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
5298355|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
5298356|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
5298357|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
5298358|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
5298359|NCT00440947|18265582|P5|Optional 60-Week Extension Phase|Adverse Event|3
5298360|NCT00440947|18265583|P4|Optional 60-Week Extension Phase|Adverse Event|1
5298361|NCT00440947|18265584|P3|Optional 60-Week Extension Phase|Adverse Event|0
5298362|NCT00440947|18265585|P2|Optional 60-Week Extension Phase|Adverse Event|0
5298363|NCT00440947|18265586|P1|Optional 60-Week Extension Phase|Adverse Event|0
5298364|NCT00440947|18265582|P5|48-Week Randomization Phase|Physician Decision|0
5298365|NCT00440947|18265583|P4|48-Week Randomization Phase|Physician Decision|0
5298366|NCT00440947|18265584|P3|48-Week Randomization Phase|Physician Decision|0
5298367|NCT00440947|18265585|P2|48-Week Randomization Phase|Physician Decision|2
5298368|NCT00440947|18265586|P1|48-Week Randomization Phase|Physician Decision|0
5298369|NCT00440947|18265582|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
5298370|NCT00440947|18265583|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
5298371|NCT00440947|18265584|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
5298372|NCT00440947|18265585|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
5298373|NCT00440947|18265586|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
5298374|NCT00440947|18265582|P5|48-Week Randomization Phase|Incarceration|0
5298375|NCT00440947|18265583|P4|48-Week Randomization Phase|Incarceration|0
5298376|NCT00440947|18265584|P3|48-Week Randomization Phase|Incarceration|0
5298377|NCT00440947|18265585|P2|48-Week Randomization Phase|Incarceration|3
5298378|NCT00440947|18265586|P1|48-Week Randomization Phase|Incarceration|0
5298379|NCT00440947|18265582|P5|48-Week Randomization Phase|Pregnancy|0
5298380|NCT00440947|18265583|P4|48-Week Randomization Phase|Pregnancy|0
5298381|NCT00440947|18265584|P3|48-Week Randomization Phase|Pregnancy|1
5298382|NCT00440947|18265585|P2|48-Week Randomization Phase|Pregnancy|0
5298383|NCT00440947|18265586|P1|48-Week Randomization Phase|Pregnancy|0
5298384|NCT00440947|18265582|P5|48-Week Randomization Phase|Withdrawal by Subject|0
5298385|NCT00440947|18265583|P4|48-Week Randomization Phase|Withdrawal by Subject|0
5298386|NCT00440947|18265584|P3|48-Week Randomization Phase|Withdrawal by Subject|4
5298387|NCT00440947|18265585|P2|48-Week Randomization Phase|Withdrawal by Subject|2
5298388|NCT00440947|18265586|P1|48-Week Randomization Phase|Withdrawal by Subject|0
5298389|NCT00440947|18265582|P5|48-Week Randomization Phase|Protocol Violation|0
5298390|NCT00440947|18265583|P4|48-Week Randomization Phase|Protocol Violation|0
5298391|NCT00440947|18265584|P3|48-Week Randomization Phase|Protocol Violation|1
5298392|NCT00440947|18265585|P2|48-Week Randomization Phase|Protocol Violation|0
5298393|NCT00440947|18265586|P1|48-Week Randomization Phase|Protocol Violation|0
5298394|NCT00440947|18265582|P5|48-Week Randomization Phase|Lost to Follow-up|0
5298395|NCT00440947|18265583|P4|48-Week Randomization Phase|Lost to Follow-up|0
5298396|NCT00440947|18265584|P3|48-Week Randomization Phase|Lost to Follow-up|8
5298397|NCT00440947|18265585|P2|48-Week Randomization Phase|Lost to Follow-up|2
5298398|NCT00440947|18265586|P1|48-Week Randomization Phase|Lost to Follow-up|0
5298399|NCT00440947|18265582|P5|48-Week Randomization Phase|Non-compliance|0
5298400|NCT00440947|18265583|P4|48-Week Randomization Phase|Non-compliance|0
5298401|NCT00440947|18265584|P3|48-Week Randomization Phase|Non-compliance|4
5298402|NCT00440947|18265585|P2|48-Week Randomization Phase|Non-compliance|3
5298403|NCT00440947|18265586|P1|48-Week Randomization Phase|Non-compliance|0
5298404|NCT00440947|18265582|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
5298405|NCT00440947|18265583|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
5298406|NCT00440947|18265584|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
5298407|NCT00440947|18265585|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
5298408|NCT00440947|18265586|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
5298409|NCT00440947|18265582|P5|48-Week Randomization Phase|Adverse Event|0
5298410|NCT00440947|18265583|P4|48-Week Randomization Phase|Adverse Event|0
5298411|NCT00440947|18265584|P3|48-Week Randomization Phase|Adverse Event|5
5298412|NCT00440947|18265585|P2|48-Week Randomization Phase|Adverse Event|2
5298413|NCT00440947|18265586|P1|48-Week Randomization Phase|Adverse Event|0
5298414|NCT00440947|18265582|P5|36-Week Induction Phase|Pregnancy|0
5298415|NCT00440947|18265583|P4|36-Week Induction Phase|Pregnancy|0
5298416|NCT00440947|18265584|P3|36-Week Induction Phase|Pregnancy|0
5298417|NCT00440947|18265585|P2|36-Week Induction Phase|Pregnancy|0
5298418|NCT00440947|18265586|P1|36-Week Induction Phase|Pregnancy|1
5298419|NCT00440947|18265582|P5|36-Week Induction Phase|Incarceration|0
5298420|NCT00440947|18265583|P4|36-Week Induction Phase|Incarceration|0
5298421|NCT00440947|18265584|P3|36-Week Induction Phase|Incarceration|0
5298422|NCT00440947|18265585|P2|36-Week Induction Phase|Incarceration|0
5298423|NCT00440947|18265586|P1|36-Week Induction Phase|Incarceration|3
5298424|NCT00440947|18265582|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5298425|NCT00440947|18265583|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5298426|NCT00440947|18265584|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5298427|NCT00440947|18265585|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5298428|NCT00440947|18265586|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
5298429|NCT00440947|18265582|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5298430|NCT00440947|18265583|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5298431|NCT00440947|18265584|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5298432|NCT00440947|18265585|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5298433|NCT00440947|18265586|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
5298434|NCT00440947|18265582|P5|36-Week Induction Phase|Took Exclusionary Medications|0
5298435|NCT00440947|18265583|P4|36-Week Induction Phase|Took Exclusionary Medications|0
5298436|NCT00440947|18265584|P3|36-Week Induction Phase|Took Exclusionary Medications|0
5298437|NCT00440947|18265585|P2|36-Week Induction Phase|Took Exclusionary Medications|0
5298438|NCT00440947|18265586|P1|36-Week Induction Phase|Took Exclusionary Medications|1
5298439|NCT00440947|18265582|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5298440|NCT00440947|18265583|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5298441|NCT00440947|18265584|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5298442|NCT00440947|18265585|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5298443|NCT00440947|18265586|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
5298444|NCT00440947|18265582|P5|36-Week Induction Phase|Withdrawal by Subject|0
5298445|NCT00440947|18265583|P4|36-Week Induction Phase|Withdrawal by Subject|0
5298446|NCT00440947|18265584|P3|36-Week Induction Phase|Withdrawal by Subject|0
5298447|NCT00440947|18265585|P2|36-Week Induction Phase|Withdrawal by Subject|0
5298448|NCT00440947|18265586|P1|36-Week Induction Phase|Withdrawal by Subject|7
5298449|NCT00440947|18265582|P5|36-Week Induction Phase|Lost to Follow-up|0
5298450|NCT00440947|18265583|P4|36-Week Induction Phase|Lost to Follow-up|0
5298451|NCT00440947|18265584|P3|36-Week Induction Phase|Lost to Follow-up|0
5298452|NCT00440947|18265585|P2|36-Week Induction Phase|Lost to Follow-up|0
5298453|NCT00440947|18265586|P1|36-Week Induction Phase|Lost to Follow-up|16
5298454|NCT00440947|18265582|P5|36-Week Induction Phase|Non-compliance|0
5298455|NCT00440947|18265583|P4|36-Week Induction Phase|Non-compliance|0
5298456|NCT00440947|18265584|P3|36-Week Induction Phase|Non-compliance|0
5298457|NCT00440947|18265585|P2|36-Week Induction Phase|Non-compliance|0
5298458|NCT00440947|18265586|P1|36-Week Induction Phase|Non-compliance|10
5298459|NCT00440947|18265582|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5298460|NCT00440947|18265583|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5298461|NCT00440947|18265584|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5298462|NCT00440947|18265585|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5298463|NCT00440947|18265586|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
5298464|NCT00440947|18265582|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
5298465|NCT00440947|18265583|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
5298466|NCT00440947|18265584|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
5298467|NCT00440947|18265585|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
5298468|NCT00440947|18265586|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
5298469|NCT00440947|18265582|P5|36-Week Induction Phase|Adverse Event|0
5298470|NCT00440947|18265583|P4|36-Week Induction Phase|Adverse Event|0
5298471|NCT00440947|18265584|P3|36-Week Induction Phase|Adverse Event|0
5298472|NCT00440947|18265585|P2|36-Week Induction Phase|Adverse Event|0
5298473|NCT00440947|18265586|P1|36-Week Induction Phase|Adverse Event|16
5298474|NCT00440726|18265661|P3|Phase 2|Adverse Event|1
5298475|NCT00440726|18265662|P2|Phase 2|Adverse Event|0
5298476|NCT00440726|18265663|P1|Phase 2|Adverse Event|0
5298477|NCT00440726|18265661|P3|Phase 2|Death|1
5298478|NCT00440726|18265662|P2|Phase 2|Death|0
5298479|NCT00440726|18265663|P1|Phase 2|Death|0
5298480|NCT00440726|18265661|P3|Phase 1|Physician Decision|0
5298481|NCT00440726|18265662|P2|Phase 1|Physician Decision|0
5298482|NCT00440726|18265663|P1|Phase 1|Physician Decision|1
5298483|NCT00440726|18265661|P3|Phase 1|Dose-Limiting Toxicity|0
5298484|NCT00440726|18265662|P2|Phase 1|Dose-Limiting Toxicity|1
5298485|NCT00440726|18265663|P1|Phase 1|Dose-Limiting Toxicity|0
5298486|NCT00440700|18265677|P3|Overall Study|Withdrawal by Subject|4
5298487|NCT00440700|18265678|P2|Overall Study|Withdrawal by Subject|8
5298488|NCT00440700|18265679|P1|Overall Study|Withdrawal by Subject|8
5298489|NCT00440557|18265713|P3|Overall Study|Patient had surgery|0
5298490|NCT00440557|18265714|P2|Overall Study|Patient had surgery|0
5298491|NCT00440557|18265715|P1|Overall Study|Patient had surgery|1
5298492|NCT00440557|18265713|P3|Overall Study|Patient transferred to nursing home|0
5298493|NCT00440557|18265714|P2|Overall Study|Patient transferred to nursing home|1
5298494|NCT00440557|18265715|P1|Overall Study|Patient transferred to nursing home|0
5298495|NCT00440557|18265713|P3|Overall Study|Principal Investigator's office closed|4
5298496|NCT00440557|18265714|P2|Overall Study|Principal Investigator's office closed|6
5298497|NCT00440557|18265715|P1|Overall Study|Principal Investigator's office closed|3
5298498|NCT00440557|18265713|P3|Overall Study|Patient moved|1
5298499|NCT00440557|18265714|P2|Overall Study|Patient moved|2
5298500|NCT00440557|18265715|P1|Overall Study|Patient moved|1
5298501|NCT00440557|18265713|P3|Overall Study|Principal Investigator decision|1
5298502|NCT00440557|18265714|P2|Overall Study|Principal Investigator decision|3
5298503|NCT00440557|18265715|P1|Overall Study|Principal Investigator decision|0
5298504|NCT00440557|18265713|P3|Overall Study|Began Dialysis|4
5298505|NCT00440557|18265714|P2|Overall Study|Began Dialysis|1
5298506|NCT00440557|18265715|P1|Overall Study|Began Dialysis|4
5298507|NCT00440557|18265713|P3|Overall Study|Death|3
5298508|NCT00440557|18265714|P2|Overall Study|Death|6
5298509|NCT00440557|18265715|P1|Overall Study|Death|2
5298510|NCT00440557|18265713|P3|Overall Study|Adverse Event|5
5298511|NCT00440557|18265714|P2|Overall Study|Adverse Event|3
5298512|NCT00440557|18265715|P1|Overall Study|Adverse Event|3
5298513|NCT00440557|18265713|P3|Overall Study|Lost to Follow-up|6
5298514|NCT00440557|18265714|P2|Overall Study|Lost to Follow-up|2
5298515|NCT00440557|18265715|P1|Overall Study|Lost to Follow-up|1
5298516|NCT00440557|18265713|P3|Overall Study|Withdrawal by Subject|11
5298517|NCT00440557|18265714|P2|Overall Study|Withdrawal by Subject|5
5298518|NCT00440557|18265715|P1|Overall Study|Withdrawal by Subject|10
5298519|NCT00440531|18265747|P3|Overall Study|see pre-assignment details|0
5298520|NCT00440531|18265748|P2|Overall Study|see pre-assignment details|0
5298521|NCT00440531|18265749|P1|Overall Study|see pre-assignment details|2
5298522|NCT00440531|18265747|P3|Overall Study|Lost to Follow-up|5
5298523|NCT00440531|18265748|P2|Overall Study|Lost to Follow-up|3
5298524|NCT00440531|18265749|P1|Overall Study|Lost to Follow-up|4
5298525|NCT00440531|18265747|P3|Overall Study|Protocol Violation|0
5298526|NCT00440531|18265748|P2|Overall Study|Protocol Violation|2
5298527|NCT00440531|18265749|P1|Overall Study|Protocol Violation|1
5298528|NCT00440531|18265747|P3|Overall Study|Withdrawal by Subject|0
5298529|NCT00440531|18265748|P2|Overall Study|Withdrawal by Subject|0
5298530|NCT00440531|18265749|P1|Overall Study|Withdrawal by Subject|2
5298531|NCT00440531|18265747|P3|Overall Study|Adverse Event|2
5298532|NCT00440531|18265748|P2|Overall Study|Adverse Event|0
5298533|NCT00440531|18265749|P1|Overall Study|Adverse Event|1
5298534|NCT00440518|18265766|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
5298535|NCT00440518|18265767|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
5298536|NCT00440518|18265768|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
5298537|NCT00440518|18265766|P3|Maintenance and Safety Follow-up Periods|Other|2
5298538|NCT00440518|18265767|P2|Maintenance and Safety Follow-up Periods|Other|0
5298539|NCT00440518|18265768|P1|Maintenance and Safety Follow-up Periods|Other|0
5298540|NCT00440518|18265766|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
5298541|NCT00440518|18265767|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
5298542|NCT00440518|18265768|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
5298543|NCT00440518|18265766|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
5298544|NCT00440518|18265767|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
5298545|NCT00440518|18265768|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
5298546|NCT00440518|18265766|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
5298547|NCT00440518|18265767|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
5298548|NCT00440518|18265768|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
5298549|NCT00440518|18265766|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
5298550|NCT00440518|18265767|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
5298551|NCT00440518|18265768|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
5298552|NCT00440518|18265766|P3|Randomized /Titration Period|Adverse Event|0
5298553|NCT00440518|18265767|P2|Randomized /Titration Period|Adverse Event|3
5298554|NCT00440518|18265768|P1|Randomized /Titration Period|Adverse Event|2
5298555|NCT00440518|18265766|P3|Randomized /Titration Period|Lost to Follow-up|1
5298556|NCT00440518|18265767|P2|Randomized /Titration Period|Lost to Follow-up|2
5298557|NCT00440518|18265768|P1|Randomized /Titration Period|Lost to Follow-up|2
5298558|NCT00440518|18265766|P3|Randomized /Titration Period|Other|0
5298559|NCT00440518|18265767|P2|Randomized /Titration Period|Other|0
5298560|NCT00440518|18265768|P1|Randomized /Titration Period|Other|1
5298561|NCT00440518|18265766|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
5298562|NCT00440518|18265767|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
5298563|NCT00440518|18265768|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
5298564|NCT00440518|18265766|P3|Randomized /Titration Period|Protocol Deviation|0
5298565|NCT00440518|18265767|P2|Randomized /Titration Period|Protocol Deviation|0
5298566|NCT00440518|18265768|P1|Randomized /Titration Period|Protocol Deviation|1
5298567|NCT00440518|18265766|P3|Randomized /Titration Period|Subject Withdrew Consent|0
5298568|NCT00440518|18265767|P2|Randomized /Titration Period|Subject Withdrew Consent|1
5298569|NCT00440518|18265768|P1|Randomized /Titration Period|Subject Withdrew Consent|4
5298570|NCT00440518|18265766|P3|Randomized /Titration Period|Lack of Efficacy|1
5298571|NCT00440518|18265767|P2|Randomized /Titration Period|Lack of Efficacy|0
5298572|NCT00440518|18265768|P1|Randomized /Titration Period|Lack of Efficacy|1
5298573|NCT00440466|18265813|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
5298574|NCT00440466|18265814|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
5298575|NCT00440466|18265815|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
5298576|NCT00440466|18265813|P3|Overall Study|Began Dialysis|1
5298577|NCT00440466|18265814|P2|Overall Study|Began Dialysis|0
5298578|NCT00440466|18265815|P1|Overall Study|Began Dialysis|0
5298579|NCT00440466|18265813|P3|Overall Study|Withdrawal by Subject|9
5298580|NCT00440466|18265814|P2|Overall Study|Withdrawal by Subject|5
5298581|NCT00440466|18265815|P1|Overall Study|Withdrawal by Subject|2
5298582|NCT00440466|18265813|P3|Overall Study|Protocol Violation|4
5298583|NCT00440466|18265814|P2|Overall Study|Protocol Violation|0
5298584|NCT00440466|18265815|P1|Overall Study|Protocol Violation|2
5298585|NCT00440466|18265813|P3|Overall Study|Physician Decision|1
5298586|NCT00440466|18265814|P2|Overall Study|Physician Decision|0
5298587|NCT00440466|18265815|P1|Overall Study|Physician Decision|2
5298588|NCT00440466|18265813|P3|Overall Study|Lost to Follow-up|2
5298589|NCT00440466|18265814|P2|Overall Study|Lost to Follow-up|0
5298590|NCT00440466|18265815|P1|Overall Study|Lost to Follow-up|1
5298591|NCT00440466|18265813|P3|Overall Study|Adverse Event|11
5298592|NCT00440466|18265814|P2|Overall Study|Adverse Event|4
5298593|NCT00440466|18265815|P1|Overall Study|Adverse Event|3
5298594|NCT00440466|18265813|P3|Overall Study|Death|9
5298595|NCT00440466|18265814|P2|Overall Study|Death|2
5298596|NCT00440466|18265815|P1|Overall Study|Death|3
5298597|NCT00440401|18265849|P2|Overall Study|Other|5
5298598|NCT00440401|18265850|P1|Overall Study|Other|2
5298599|NCT00440401|18265849|P2|Overall Study|Adverse Event|1
5298600|NCT00440401|18265850|P1|Overall Study|Adverse Event|2
5298601|NCT00440310|18265860|P2|Overall Study|Status Unknown|3
5298602|NCT00440310|18265861|P1|Overall Study|Status Unknown|1
5298603|NCT00440310|18265860|P2|Overall Study|Other|0
5298604|NCT00440310|18265861|P1|Overall Study|Other|1
5298605|NCT00440310|18265860|P2|Overall Study|No Reply at EOS|7
5298606|NCT00440310|18265861|P1|Overall Study|No Reply at EOS|7
5298607|NCT00440310|18265860|P2|Overall Study|Withdrawal by Subject|14
5298608|NCT00440310|18265861|P1|Overall Study|Withdrawal by Subject|15
5298609|NCT00440310|18265860|P2|Overall Study|Protocol Violation|1
5298610|NCT00440310|18265861|P1|Overall Study|Protocol Violation|0
5298611|NCT00440310|18265860|P2|Overall Study|Lost to Follow-up|5
5298612|NCT00440310|18265861|P1|Overall Study|Lost to Follow-up|4
5298613|NCT00440297|18265869|P2|Overall Study|Randomized by mistake|0
5298614|NCT00440297|18265870|P1|Overall Study|Randomized by mistake|1
5298615|NCT00440297|18265869|P2|Overall Study|Withdrawal by Subject|6
5298616|NCT00440297|18265870|P1|Overall Study|Withdrawal by Subject|1
5298617|NCT00440297|18265869|P2|Overall Study|Protocol Violation|7
5298618|NCT00440297|18265870|P1|Overall Study|Protocol Violation|11
5298619|NCT00440297|18265869|P2|Overall Study|Physician Decision|0
5298620|NCT00440297|18265870|P1|Overall Study|Physician Decision|1
5298621|NCT00440297|18265869|P2|Overall Study|Lost to Follow-up|0
5298622|NCT00440297|18265870|P1|Overall Study|Lost to Follow-up|1
5298623|NCT00440297|18265869|P2|Overall Study|Adverse Event|5
5298624|NCT00440297|18265870|P1|Overall Study|Adverse Event|8
5298625|NCT00440271|18265886|P2|Overall Study|Other|0
5298626|NCT00440271|18265887|P1|Overall Study|Other|2
5298627|NCT00440271|18265886|P2|Overall Study|Due to closure of trial|10
5298628|NCT00440271|18265887|P1|Overall Study|Due to closure of trial|8
5298629|NCT00440271|18265886|P2|Overall Study|Lack of Efficacy|1
5298630|NCT00440271|18265887|P1|Overall Study|Lack of Efficacy|0
5298631|NCT00440271|18265886|P2|Overall Study|Withdrawal by Subject|2
5298632|NCT00440271|18265887|P1|Overall Study|Withdrawal by Subject|0
5298633|NCT00440271|18265886|P2|Overall Study|Lost to Follow-up|0
5298634|NCT00440271|18265887|P1|Overall Study|Lost to Follow-up|1
5298635|NCT00440271|18265886|P2|Overall Study|Adverse Event|1
5298636|NCT00440271|18265887|P1|Overall Study|Adverse Event|0
5298637|NCT00440271|18265886|P2|Overall Study|Protocol Violation|1
5298638|NCT00440271|18265887|P1|Overall Study|Protocol Violation|1
5298639|NCT00440232|18265921|P2|Overall Study|Onset of headache within 4 hours of fast|2
5298640|NCT00440232|18265922|P1|Overall Study|Onset of headache within 4 hours of fast|2
5298641|NCT00440232|18265921|P2|Overall Study|Unable to treat within allowed time|1
5298642|NCT00440232|18265922|P1|Overall Study|Unable to treat within allowed time|0
5298643|NCT00440232|18265921|P2|Overall Study|Lost to Follow-up|1
5298644|NCT00440232|18265922|P1|Overall Study|Lost to Follow-up|1
5298645|NCT00440193|18265932|P2|Observational Period|Participant convenience|0
5298646|NCT00440193|18265933|P1|Observational Period|Participant convenience|2
5298647|NCT00440193|18265932|P2|Observational Period|Clinical endpoint reached|0
5298648|NCT00440193|18265933|P1|Observational Period|Clinical endpoint reached|1
5298649|NCT00440193|18265932|P2|Observational Period|Physician Decision|0
5298650|NCT00440193|18265933|P1|Observational Period|Physician Decision|1
5298651|NCT00440193|18265932|P2|Observational Period|Withdrawal by Subject|8
5298652|NCT00440193|18265933|P1|Observational Period|Withdrawal by Subject|11
5298653|NCT00440193|18265932|P2|Observational Period|Protocol Violation|0
5298654|NCT00440193|18265933|P1|Observational Period|Protocol Violation|1
5298655|NCT00440193|18265932|P2|Observational Period|Lost to Follow-up|8
5298656|NCT00440193|18265933|P1|Observational Period|Lost to Follow-up|12
5298657|NCT00440193|18265932|P2|Observational Period|Death|20
5298658|NCT00440193|18265933|P1|Observational Period|Death|15
5298659|NCT00440193|18265932|P2|Observational Period|Adverse Event|2
5298660|NCT00440193|18265933|P1|Observational Period|Adverse Event|2
5298661|NCT00440193|18265932|P2|Treatment Period|Site closed by investigator|2
5298662|NCT00440193|18265933|P1|Treatment Period|Site closed by investigator|0
5298663|NCT00440193|18265932|P2|Treatment Period|Participant did not receive treatment|13
5298664|NCT00440193|18265933|P1|Treatment Period|Participant did not receive treatment|7
5298665|NCT00440193|18265932|P2|Treatment Period|Participant convenience|2
5298666|NCT00440193|18265933|P1|Treatment Period|Participant convenience|5
5298667|NCT00440193|18265932|P2|Treatment Period|Technical problems|1
5298668|NCT00440193|18265933|P1|Treatment Period|Technical problems|1
5298669|NCT00440193|18265932|P2|Treatment Period|Switch to commercial drug|2
5298670|NCT00440193|18265933|P1|Treatment Period|Switch to commercial drug|0
5298671|NCT00440193|18265932|P2|Treatment Period|Protocol driven decision point|2
5298672|NCT00440193|18265933|P1|Treatment Period|Protocol driven decision point|2
5298673|NCT00440193|18265932|P2|Treatment Period|Study terminated by sponsor|94
5298674|NCT00440193|18265933|P1|Treatment Period|Study terminated by sponsor|102
5298675|NCT00440193|18265932|P2|Treatment Period|Clinical endpoint reached|25
5298676|NCT00440193|18265933|P1|Treatment Period|Clinical endpoint reached|28
5298677|NCT00440193|18265932|P2|Treatment Period|Withdrawal by Subject|77
5298678|NCT00440193|18265933|P1|Treatment Period|Withdrawal by Subject|36
5298679|NCT00440193|18265932|P2|Treatment Period|Protocol Violation|19
5298680|NCT00440193|18265933|P1|Treatment Period|Protocol Violation|16
5298681|NCT00440193|18265932|P2|Treatment Period|Physician Decision|6
5298682|NCT00440193|18265933|P1|Treatment Period|Physician Decision|3
5298683|NCT00440193|18265932|P2|Treatment Period|Lost to Follow-up|18
5298684|NCT00440193|18265933|P1|Treatment Period|Lost to Follow-up|12
5298685|NCT00440193|18265932|P2|Treatment Period|Lack of Efficacy|1
5298686|NCT00440193|18265933|P1|Treatment Period|Lack of Efficacy|0
5298687|NCT00440193|18265932|P2|Treatment Period|Death|22
5298688|NCT00440193|18265933|P1|Treatment Period|Death|19
5298689|NCT00440193|18265932|P2|Treatment Period|Adverse Event|67
5298690|NCT00440193|18265933|P1|Treatment Period|Adverse Event|74
5298691|NCT00440115|18265979|P3|Overall Study|Incarceration|1
5298692|NCT00440115|18265980|P2|Overall Study|Incarceration|2
5298693|NCT00440115|18265981|P1|Overall Study|Incarceration|0
5298694|NCT00440115|18265979|P3|Overall Study|Death|5
5298695|NCT00440115|18265980|P2|Overall Study|Death|9
5298696|NCT00440115|18265981|P1|Overall Study|Death|7
5298697|NCT00440037|18266010|P1|Overall Study|Administrative decision|3
5298698|NCT00440037|18266010|P1|Overall Study|Withdrawal by Subject|6
5298699|NCT00440011|18266020|P2|Overall Study|Withdrawal by Subject|0
5298700|NCT00440011|18266021|P1|Overall Study|Withdrawal by Subject|1
5298701|NCT00440011|18266020|P2|Overall Study|Protocol Violation|1
5298702|NCT00440011|18266021|P1|Overall Study|Protocol Violation|1
5298703|NCT00440011|18266020|P2|Overall Study|Lost to Follow-up|2
5298704|NCT00440011|18266021|P1|Overall Study|Lost to Follow-up|0
5298705|NCT00440011|18266020|P2|Overall Study|Adverse Event|0
5298706|NCT00440011|18266021|P1|Overall Study|Adverse Event|2
5298707|NCT00439777|18266048|P2|Observational Period|Technical problems|1
5298708|NCT00439777|18266049|P1|Observational Period|Technical problems|0
5298709|NCT00439777|18266048|P2|Observational Period|Lack of Efficacy|0
5298710|NCT00439777|18266049|P1|Observational Period|Lack of Efficacy|1
5298711|NCT00439777|18266048|P2|Observational Period|Protocol driven decision point|1
5298712|NCT00439777|18266049|P1|Observational Period|Protocol driven decision point|0
5298713|NCT00439777|18266048|P2|Observational Period|Study terminated by sponsor|1
5298714|NCT00439777|18266049|P1|Observational Period|Study terminated by sponsor|3
5298715|NCT00439777|18266048|P2|Observational Period|Death|20
5298716|NCT00439777|18266049|P1|Observational Period|Death|27
5298717|NCT00439777|18266048|P2|Observational Period|Lost to Follow-up|11
5298718|NCT00439777|18266049|P1|Observational Period|Lost to Follow-up|1
5298719|NCT00439777|18266048|P2|Observational Period|Withdrawal by Subject|5
5298720|NCT00439777|18266049|P1|Observational Period|Withdrawal by Subject|9
5298721|NCT00439777|18266048|P2|Observational Period|Protocol Violation|2
5298722|NCT00439777|18266049|P1|Observational Period|Protocol Violation|0
5298723|NCT00439777|18266048|P2|Treatment Period|Participant convenience|8
5298724|NCT00439777|18266049|P1|Treatment Period|Participant convenience|12
5298725|NCT00439777|18266048|P2|Treatment Period|Technical problems|1
5298726|NCT00439777|18266049|P1|Treatment Period|Technical problems|3
5298727|NCT00439777|18266048|P2|Treatment Period|Clinical endpoint reached|13
5298728|NCT00439777|18266049|P1|Treatment Period|Clinical endpoint reached|26
5298729|NCT00439777|18266048|P2|Treatment Period|Physician Decision|18
5298730|NCT00439777|18266049|P1|Treatment Period|Physician Decision|7
5298731|NCT00439777|18266048|P2|Treatment Period|Protocol driven decision point|3
5298732|NCT00439777|18266049|P1|Treatment Period|Protocol driven decision point|1
5298733|NCT00439777|18266048|P2|Treatment Period|Lost to Follow-up|10
5298734|NCT00439777|18266049|P1|Treatment Period|Lost to Follow-up|8
5298735|NCT00439777|18266048|P2|Treatment Period|Lack of Efficacy|4
5298736|NCT00439777|18266049|P1|Treatment Period|Lack of Efficacy|1
5298737|NCT00439777|18266048|P2|Treatment Period|Withdrawal by Subject|118
5298738|NCT00439777|18266049|P1|Treatment Period|Withdrawal by Subject|66
5298739|NCT00439777|18266048|P2|Treatment Period|Protocol Violation|30
5298740|NCT00439777|18266049|P1|Treatment Period|Protocol Violation|23
5298741|NCT00439777|18266048|P2|Treatment Period|Adverse Event|92
5298742|NCT00439777|18266049|P1|Treatment Period|Adverse Event|111
5298743|NCT00439777|18266048|P2|Treatment Period|Did not take study treatment|8
5298744|NCT00439777|18266049|P1|Treatment Period|Did not take study treatment|7
5298745|NCT00439777|18266048|P2|Treatment Period|Site closed by investigator|1
5298746|NCT00439777|18266049|P1|Treatment Period|Site closed by investigator|0
5298747|NCT00439777|18266048|P2|Treatment Period|Study terminated by sponsor|132
5298748|NCT00439777|18266049|P1|Treatment Period|Study terminated by sponsor|125
5298749|NCT00439777|18266048|P2|Treatment Period|Death|21
5298750|NCT00439777|18266049|P1|Treatment Period|Death|29
5298751|NCT00439738|18266087|P2|Overall Study|Abnormal Lab Values|0
5298752|NCT00439738|18266088|P1|Overall Study|Abnormal Lab Values|1
5298753|NCT00439738|18266087|P2|Overall Study|Lack of Efficacy|2
5298754|NCT00439738|18266088|P1|Overall Study|Lack of Efficacy|2
5298755|NCT00439738|18266087|P2|Overall Study|Protocol Violation|3
5298756|NCT00439738|18266088|P1|Overall Study|Protocol Violation|6
5298757|NCT00439738|18266087|P2|Overall Study|Lost to Follow-up|6
5298758|NCT00439738|18266088|P1|Overall Study|Lost to Follow-up|5
5298759|NCT00439738|18266087|P2|Overall Study|Adverse Event|4
5298760|NCT00439738|18266088|P1|Overall Study|Adverse Event|6
5298761|NCT00439738|18266087|P2|Overall Study|Withdrawal by Subject|13
5298762|NCT00439738|18266088|P1|Overall Study|Withdrawal by Subject|16
5298763|NCT00439725|18266106|P2|Observational Period|Participant convenience|0
5298764|NCT00439725|18266107|P1|Observational Period|Participant convenience|1
5298765|NCT00439725|18266106|P2|Observational Period|Technical problems|0
5298766|NCT00439725|18266107|P1|Observational Period|Technical problems|1
5298767|NCT00439725|18266106|P2|Observational Period|Clinical endpoint reached|1
5298768|NCT00439725|18266107|P1|Observational Period|Clinical endpoint reached|3
5298769|NCT00439725|18266106|P2|Observational Period|Study termination by sponsor|1
5298770|NCT00439725|18266107|P1|Observational Period|Study termination by sponsor|1
5298771|NCT00439725|18266106|P2|Observational Period|Death|2
5298772|NCT00439725|18266107|P1|Observational Period|Death|0
5298773|NCT00439725|18266106|P2|Observational Period|Lost to Follow-up|1
5298774|NCT00439725|18266107|P1|Observational Period|Lost to Follow-up|0
5298775|NCT00439725|18266106|P2|Observational Period|Withdrawal by Subject|2
5298776|NCT00439725|18266107|P1|Observational Period|Withdrawal by Subject|2
5298777|NCT00439725|18266106|P2|Treatment Period|Participant did not receive treatment|4
5298778|NCT00439725|18266107|P1|Treatment Period|Participant did not receive treatment|4
5298779|NCT00439725|18266106|P2|Treatment Period|Death|1
5298780|NCT00439725|18266107|P1|Treatment Period|Death|1
5298781|NCT00439725|18266106|P2|Treatment Period|Protocol driven decision point|1
5298782|NCT00439725|18266107|P1|Treatment Period|Protocol driven decision point|1
5298783|NCT00439725|18266106|P2|Treatment Period|Participant convenience|0
5298784|NCT00439725|18266107|P1|Treatment Period|Participant convenience|1
5298785|NCT00439725|18266106|P2|Treatment Period|Lost to Follow-up|1
5298786|NCT00439725|18266107|P1|Treatment Period|Lost to Follow-up|1
5298787|NCT00439725|18266106|P2|Treatment Period|Technical problems|0
5298788|NCT00439725|18266107|P1|Treatment Period|Technical problems|1
5298789|NCT00439725|18266106|P2|Treatment Period|Clinical endpoint reached|50
5298790|NCT00439725|18266107|P1|Treatment Period|Clinical endpoint reached|6
5298791|NCT00439725|18266106|P2|Treatment Period|Protocol Violation|1
5298792|NCT00439725|18266107|P1|Treatment Period|Protocol Violation|2
5298793|NCT00439725|18266106|P2|Treatment Period|Physician Decision|1
5298794|NCT00439725|18266107|P1|Treatment Period|Physician Decision|1
5298795|NCT00439725|18266106|P2|Treatment Period|Adverse Event|18
5298796|NCT00439725|18266107|P1|Treatment Period|Adverse Event|39
5298797|NCT00439725|18266106|P2|Treatment Period|Site closed by investigator|2
5298798|NCT00439725|18266107|P1|Treatment Period|Site closed by investigator|1
5298799|NCT00439725|18266106|P2|Treatment Period|Study terminated by sponsor|148
5298800|NCT00439725|18266107|P1|Treatment Period|Study terminated by sponsor|156
5298801|NCT00439725|18266106|P2|Treatment Period|Withdrawal by Subject|19
5298802|NCT00439725|18266107|P1|Treatment Period|Withdrawal by Subject|22
5298803|NCT00439647|18266158|P2|Overall Study|Lack of Efficacy|4
5298804|NCT00439647|18266159|P1|Overall Study|Lack of Efficacy|0
5298805|NCT00439647|18266158|P2|Overall Study|Protocol Violation|4
5298806|NCT00439647|18266159|P1|Overall Study|Protocol Violation|3
5298807|NCT00439647|18266158|P2|Overall Study|Lost to Follow-up|12
5298808|NCT00439647|18266159|P1|Overall Study|Lost to Follow-up|4
5298809|NCT00439647|18266158|P2|Overall Study|Adverse Event|11
5298810|NCT00439647|18266159|P1|Overall Study|Adverse Event|11
5298811|NCT00439647|18266158|P2|Overall Study|Death|18
5298812|NCT00439647|18266159|P1|Overall Study|Death|15
5298813|NCT00439647|18266158|P2|Overall Study|Withdrawal by Subject|22
5298814|NCT00439647|18266159|P1|Overall Study|Withdrawal by Subject|25
5298815|NCT00439569|18266196|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
5298816|NCT00439569|18266196|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
5298817|NCT00439569|18266196|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
5298818|NCT00439556|18266210|P3|Overall Study|Patient was taken off study for non-comp|0
5298819|NCT00439556|18266211|P2|Overall Study|Patient was taken off study for non-comp|1
5298820|NCT00439556|18266212|P1|Overall Study|Patient was taken off study for non-comp|0
5298821|NCT00439517|18266225|P2|Overall Study|Subject in survival follow-up|0
5298822|NCT00439517|18266226|P1|Overall Study|Subject in survival follow-up|1
5298823|NCT00439517|18266225|P2|Overall Study|Subject on treatment|0
5298824|NCT00439517|18266226|P1|Overall Study|Subject on treatment|1
5298825|NCT00439309|18266365|P2|Follow-Up|Late response by subject|1
5298826|NCT00439309|18266366|P1|Follow-Up|Late response by subject|0
5298827|NCT00439309|18266365|P2|Follow-Up|Withdrawal by Subject|1
5298828|NCT00439309|18266366|P1|Follow-Up|Withdrawal by Subject|0
5298829|NCT00439309|18266365|P2|Follow-Up|Lost to Follow-up|0
5298830|NCT00439309|18266366|P1|Follow-Up|Lost to Follow-up|2
5298831|NCT00439309|18266365|P2|Follow-Up|Death|0
5298832|NCT00439309|18266366|P1|Follow-Up|Death|1
5298833|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5298834|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
5298835|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5298836|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5298837|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5298838|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5298839|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
5298840|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5298841|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5298842|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5298843|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5298844|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
5298845|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5298846|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5298847|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5298848|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
5298849|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
5298850|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
5298851|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
5298852|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
5298853|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5298854|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
5298855|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5298856|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5298857|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5298858|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
5298859|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
5298860|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
5298861|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
5298862|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
5298863|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5298864|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
5298865|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5298866|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5298867|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5298868|NCT00439270|18266398|P5|Phase 2 (51.6 Months)|Disease progression|0
5298869|NCT00439270|18266399|P4|Phase 2 (51.6 Months)|Disease progression|18
5298870|NCT00439270|18266400|P3|Phase 2 (51.6 Months)|Disease progression|0
5298871|NCT00439270|18266401|P2|Phase 2 (51.6 Months)|Disease progression|0
5298872|NCT00439270|18266402|P1|Phase 2 (51.6 Months)|Disease progression|0
5298873|NCT00439270|18266398|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
5298874|NCT00439270|18266399|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
5298875|NCT00439270|18266400|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
5298876|NCT00439270|18266401|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
5298877|NCT00439270|18266402|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
5298878|NCT00439270|18266398|P5|Phase 1 (18.1 Months)|Disease progression|3
5298879|NCT00439270|18266399|P4|Phase 1 (18.1 Months)|Disease progression|0
5298880|NCT00439270|18266400|P3|Phase 1 (18.1 Months)|Disease progression|3
5298881|NCT00439270|18266401|P2|Phase 1 (18.1 Months)|Disease progression|2
5298882|NCT00439270|18266402|P1|Phase 1 (18.1 Months)|Disease progression|3
5298883|NCT00439244|18266444|P3|Overall Study|Administrative problems|0
5298884|NCT00439244|18266445|P2|Overall Study|Administrative problems|0
5298885|NCT00439244|18266446|P1|Overall Study|Administrative problems|1
5298886|NCT00439244|18266444|P3|Overall Study|Protocol Violation|0
5298887|NCT00439244|18266445|P2|Overall Study|Protocol Violation|1
5298888|NCT00439244|18266446|P1|Overall Study|Protocol Violation|0
5298889|NCT00439244|18266444|P3|Overall Study|Death|0
5298890|NCT00439244|18266445|P2|Overall Study|Death|1
5298891|NCT00439244|18266446|P1|Overall Study|Death|0
5298892|NCT00439244|18266444|P3|Overall Study|Lost to Follow-up|2
5298893|NCT00439244|18266445|P2|Overall Study|Lost to Follow-up|1
5298894|NCT00439244|18266446|P1|Overall Study|Lost to Follow-up|2
5298895|NCT00439244|18266444|P3|Overall Study|Withdrawal by Subject|2
5298896|NCT00439244|18266445|P2|Overall Study|Withdrawal by Subject|1
5298897|NCT00439244|18266446|P1|Overall Study|Withdrawal by Subject|3
5298898|NCT00439244|18266444|P3|Overall Study|Adverse Event|3
5298899|NCT00439244|18266445|P2|Overall Study|Adverse Event|2
5298900|NCT00439244|18266446|P1|Overall Study|Adverse Event|5
5298901|NCT00439231|18266466|P1|Overall Study|Lack of Efficacy|28
5298902|NCT00439218|18266470|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
5298903|NCT00439179|18266485|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
5298904|NCT00439179|18266486|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
5298905|NCT00439179|18266487|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
5298906|NCT00439179|18266488|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
5298907|NCT00439140|18266505|P3|Treatment Cycle 2|Lost to Follow-up|0
5298908|NCT00439140|18266506|P2|Treatment Cycle 2|Lost to Follow-up|1
5298909|NCT00439140|18266507|P1|Treatment Cycle 2|Lost to Follow-up|1
5298910|NCT00439140|18266505|P3|Treatment Cycle 2|Withdrawal by Subject|0
5298911|NCT00439140|18266506|P2|Treatment Cycle 2|Withdrawal by Subject|0
5298912|NCT00439140|18266507|P1|Treatment Cycle 2|Withdrawal by Subject|1
5298913|NCT00439140|18266505|P3|Treatment Cycle 1|Withdrawal by Subject|0
5298914|NCT00439140|18266506|P2|Treatment Cycle 1|Withdrawal by Subject|1
5298915|NCT00439140|18266507|P1|Treatment Cycle 1|Withdrawal by Subject|0
5298916|NCT00439140|18266505|P3|Treatment Cycle 1|Personal reasons|0
5298917|NCT00439140|18266506|P2|Treatment Cycle 1|Personal reasons|2
5298918|NCT00439140|18266507|P1|Treatment Cycle 1|Personal reasons|0
5298919|NCT00439140|18266505|P3|Treatment Cycle 1|Lost to Follow-up|1
5298920|NCT00439140|18266506|P2|Treatment Cycle 1|Lost to Follow-up|1
5298921|NCT00439140|18266507|P1|Treatment Cycle 1|Lost to Follow-up|1
5298922|NCT00438815|18266590|P1|Overall Study|Death|1
5298923|NCT00438815|18266590|P1|Overall Study|Withdrawal by Subject|6
5298924|NCT00438815|18266590|P1|Overall Study|Lost to Follow-up|6
5298925|NCT00438815|18266590|P1|Overall Study|Transitioned to commercial C1INH-nf|6
5298926|NCT00438815|18266590|P1|Overall Study|Noncompliance with protocol requirements|9
5298927|NCT00438815|18266590|P1|Overall Study|3-month follow-up no longer required|12
5298928|NCT00438815|18266590|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
5298929|NCT00438672|18266640|P2|Overall Study|Lost to Follow-up|9
5298930|NCT00438672|18266641|P1|Overall Study|Lost to Follow-up|7
5298931|NCT00438659|18266651|P2|Overall Study|Cancel|2
5298932|NCT00438659|18266652|P1|Overall Study|Cancel|5
5298933|NCT00438659|18266651|P2|Overall Study|Discontinued Mometasone/Placebo|2
5298934|NCT00438659|18266652|P1|Overall Study|Discontinued Mometasone/Placebo|1
5298935|NCT00438633|18266676|P2|Overall Study|Lost to Follow-up|17
5298936|NCT00438633|18266677|P1|Overall Study|Lost to Follow-up|15
5298937|NCT00438633|18266676|P2|Overall Study|Withdrawal by Subject|0
5298938|NCT00438633|18266677|P1|Overall Study|Withdrawal by Subject|1
5298939|NCT00438464|18266708|P2|Overall Study|Incomplete data submission|2
5298940|NCT00438464|18266709|P1|Overall Study|Incomplete data submission|0
5298941|NCT00438464|18266708|P2|Overall Study|Terminated Early|5
5298942|NCT00438464|18266709|P1|Overall Study|Terminated Early|14
5298943|NCT00438399|18266810|P6|Overall Study|Patien stopped study at visit 4 by error|0
5298944|NCT00438399|18266811|P5|Overall Study|Patien stopped study at visit 4 by error|0
5298945|NCT00438399|18266812|P4|Overall Study|Patien stopped study at visit 4 by error|0
5298946|NCT00438399|18266813|P3|Overall Study|Patien stopped study at visit 4 by error|0
5298947|NCT00438399|18266814|P2|Overall Study|Patien stopped study at visit 4 by error|0
5298948|NCT00438399|18266815|P1|Overall Study|Patien stopped study at visit 4 by error|1
5298949|NCT00438399|18266810|P6|Overall Study|Pregnancy|1
5298950|NCT00438399|18266811|P5|Overall Study|Pregnancy|0
5298951|NCT00438399|18266812|P4|Overall Study|Pregnancy|0
5298952|NCT00438399|18266813|P3|Overall Study|Pregnancy|0
5298953|NCT00438399|18266814|P2|Overall Study|Pregnancy|0
5298954|NCT00438399|18266815|P1|Overall Study|Pregnancy|0
5298955|NCT00438399|18266810|P6|Overall Study|Subje stopped study|0
5298956|NCT00438399|18266811|P5|Overall Study|Subje stopped study|0
5298957|NCT00438399|18266812|P4|Overall Study|Subje stopped study|0
5298958|NCT00438399|18266813|P3|Overall Study|Subje stopped study|1
5298959|NCT00438399|18266814|P2|Overall Study|Subje stopped study|0
5298960|NCT00438399|18266815|P1|Overall Study|Subje stopped study|0
5298961|NCT00438399|18266810|P6|Overall Study|Protocol Violation|1
5298962|NCT00438399|18266811|P5|Overall Study|Protocol Violation|0
5298963|NCT00438399|18266812|P4|Overall Study|Protocol Violation|0
5298964|NCT00438399|18266813|P3|Overall Study|Protocol Violation|1
5298965|NCT00438399|18266814|P2|Overall Study|Protocol Violation|0
5298966|NCT00438399|18266815|P1|Overall Study|Protocol Violation|0
5298967|NCT00438399|18266810|P6|Overall Study|Withdrawal by Subject|2
5298968|NCT00438399|18266811|P5|Overall Study|Withdrawal by Subject|2
5298969|NCT00438399|18266812|P4|Overall Study|Withdrawal by Subject|2
5298970|NCT00438399|18266813|P3|Overall Study|Withdrawal by Subject|3
5298971|NCT00438399|18266814|P2|Overall Study|Withdrawal by Subject|6
5298972|NCT00438399|18266815|P1|Overall Study|Withdrawal by Subject|5
5298973|NCT00438399|18266810|P6|Overall Study|Adverse Event|1
5298974|NCT00438399|18266811|P5|Overall Study|Adverse Event|0
5298975|NCT00438399|18266812|P4|Overall Study|Adverse Event|1
5298976|NCT00438399|18266813|P3|Overall Study|Adverse Event|1
5298977|NCT00438399|18266814|P2|Overall Study|Adverse Event|0
5298978|NCT00438399|18266815|P1|Overall Study|Adverse Event|0
5298979|NCT00438399|18266810|P6|Overall Study|Lost to Follow-up|1
5298980|NCT00438399|18266811|P5|Overall Study|Lost to Follow-up|1
5298981|NCT00438399|18266812|P4|Overall Study|Lost to Follow-up|1
5298982|NCT00438399|18266813|P3|Overall Study|Lost to Follow-up|1
5298983|NCT00438399|18266814|P2|Overall Study|Lost to Follow-up|2
5298984|NCT00438399|18266815|P1|Overall Study|Lost to Follow-up|2
5298985|NCT00438360|18266826|P2|Overall Study|Other|15
5298986|NCT00438360|18266827|P1|Overall Study|Other|24
5298987|NCT00438360|18266826|P2|Overall Study|Lack of Efficacy|27
5298988|NCT00438360|18266827|P1|Overall Study|Lack of Efficacy|42
5298989|NCT00438360|18266826|P2|Overall Study|Adverse Event|1
5298990|NCT00438360|18266827|P1|Overall Study|Adverse Event|6
5298991|NCT00438256|18266841|P4|Overall Study|Excluded final Diagnosis|2
5298992|NCT00438256|18266842|P3|Overall Study|Excluded final Diagnosis|0
5298993|NCT00438256|18266843|P2|Overall Study|Excluded final Diagnosis|0
5298994|NCT00438256|18266844|P1|Overall Study|Excluded final Diagnosis|0
5298995|NCT00438256|18266841|P4|Overall Study|Ineligible for Resection|7
5298996|NCT00438256|18266842|P3|Overall Study|Ineligible for Resection|1
5298997|NCT00438256|18266843|P2|Overall Study|Ineligible for Resection|1
5298998|NCT00438256|18266844|P1|Overall Study|Ineligible for Resection|2
5298999|NCT00437983|18266894|P2|Overall Study|Withdrawal by Subject|6
5299000|NCT00437983|18266895|P1|Overall Study|Withdrawal by Subject|5
5299001|NCT00437983|18266894|P2|Overall Study|Protocol Violation|1
5299002|NCT00437983|18266895|P1|Overall Study|Protocol Violation|2
5299003|NCT00437983|18266894|P2|Overall Study|Adverse Event|6
5299004|NCT00437983|18266895|P1|Overall Study|Adverse Event|6
5299005|NCT00437658|18266908|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
5299006|NCT00437658|18266909|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
5299007|NCT00437658|18266910|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
5299008|NCT00437658|18266908|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
5299009|NCT00437658|18266909|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
5299010|NCT00437658|18266910|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
5299011|NCT00437658|18266908|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
5299012|NCT00437658|18266909|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
5299013|NCT00437658|18266910|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
5299014|NCT00437658|18266908|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
5299015|NCT00437658|18266909|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
5299016|NCT00437658|18266910|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
5299017|NCT00437658|18266908|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
5299018|NCT00437658|18266909|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
5299019|NCT00437658|18266910|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
5299020|NCT00437658|18266908|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
5299021|NCT00437658|18266909|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
5299022|NCT00437658|18266910|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
5299023|NCT00437658|18266908|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
5299024|NCT00437658|18266909|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
5299025|NCT00437658|18266910|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
5299026|NCT00437658|18266908|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
5299027|NCT00437658|18266909|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
5299028|NCT00437658|18266910|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
5299029|NCT00437658|18266908|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
5299030|NCT00437658|18266909|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
5299031|NCT00437658|18266910|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
5299032|NCT00437658|18266908|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
5299033|NCT00437658|18266909|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
5299034|NCT00437658|18266910|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
5299035|NCT00437658|18266908|P3|Treatment Period (24 Weeks)|Non-compliance|4
5299036|NCT00437658|18266909|P2|Treatment Period (24 Weeks)|Non-compliance|1
5299037|NCT00437658|18266910|P1|Treatment Period (24 Weeks)|Non-compliance|1
5299038|NCT00437658|18266908|P3|Treatment Period (24 Weeks)|Adverse Event|14
5299039|NCT00437658|18266909|P2|Treatment Period (24 Weeks)|Adverse Event|7
5299040|NCT00437658|18266910|P1|Treatment Period (24 Weeks)|Adverse Event|4
5299041|NCT00437645|18267004|P2|Overall Study|Condition no longer requires study drug|1
5299042|NCT00437645|18267005|P1|Overall Study|Condition no longer requires study drug|1
5299043|NCT00437645|18267004|P2|Overall Study|Lack of Efficacy|1
5299044|NCT00437645|18267005|P1|Overall Study|Lack of Efficacy|2
5299045|NCT00437645|18267004|P2|Overall Study|Administrative problems|1
5299046|NCT00437645|18267005|P1|Overall Study|Administrative problems|2
5299047|NCT00437645|18267004|P2|Overall Study|Lost to Follow-up|3
5299048|NCT00437645|18267005|P1|Overall Study|Lost to Follow-up|2
5299049|NCT00437645|18267004|P2|Overall Study|Protocol Violation|3
5299050|NCT00437645|18267005|P1|Overall Study|Protocol Violation|3
5299051|NCT00437645|18267004|P2|Overall Study|Withdrawal by Subject|22
5299052|NCT00437645|18267005|P1|Overall Study|Withdrawal by Subject|10
5299053|NCT00437645|18267004|P2|Overall Study|Adverse Event|84
5299054|NCT00437645|18267005|P1|Overall Study|Adverse Event|15
5299055|NCT00437489|18267021|P2|Overall Study|Lost to Follow-up|1
5299056|NCT00437489|18267022|P1|Overall Study|Lost to Follow-up|0
5299057|NCT00437489|18267021|P2|Overall Study|Study terminated by sponsor|21
5299058|NCT00437489|18267022|P1|Overall Study|Study terminated by sponsor|23
5299059|NCT00437294|18267041|P2|Overall Study|Entry criteria not met|1
5299060|NCT00437294|18267042|P1|Overall Study|Entry criteria not met|1
5299061|NCT00437294|18267041|P2|Overall Study|Protocol Violation|1
5299062|NCT00437294|18267042|P1|Overall Study|Protocol Violation|0
5299063|NCT00437294|18267041|P2|Overall Study|Sponsor Decision|9
5299064|NCT00437294|18267042|P1|Overall Study|Sponsor Decision|8
5299065|NCT00437294|18267041|P2|Overall Study|Progressive Disease|23
5299066|NCT00437294|18267042|P1|Overall Study|Progressive Disease|19
5299067|NCT00437294|18267041|P2|Overall Study|Withdrawal by Subject|0
5299068|NCT00437294|18267042|P1|Overall Study|Withdrawal by Subject|5
5299069|NCT00437294|18267041|P2|Overall Study|Physician Decision|3
5299070|NCT00437294|18267042|P1|Overall Study|Physician Decision|0
5299071|NCT00437294|18267041|P2|Overall Study|Death|2
5299072|NCT00437294|18267042|P1|Overall Study|Death|5
5299073|NCT00437294|18267041|P2|Overall Study|Adverse Event|4
5299074|NCT00437294|18267042|P1|Overall Study|Adverse Event|5
5299075|NCT00437281|18267083|P20|Overall Study|Lost to Follow-up|1
5299076|NCT00437281|18267084|P19|Overall Study|Lost to Follow-up|0
5299077|NCT00437281|18267085|P18|Overall Study|Lost to Follow-up|0
5299078|NCT00437281|18267086|P17|Overall Study|Lost to Follow-up|0
5299079|NCT00437281|18267087|P16|Overall Study|Lost to Follow-up|0
5299080|NCT00437281|18267088|P15|Overall Study|Lost to Follow-up|0
5299081|NCT00437281|18267089|P14|Overall Study|Lost to Follow-up|0
5299082|NCT00437281|18267090|P13|Overall Study|Lost to Follow-up|0
5299083|NCT00437281|18267091|P12|Overall Study|Lost to Follow-up|0
5299084|NCT00437281|18267092|P11|Overall Study|Lost to Follow-up|0
5299085|NCT00437281|18267093|P10|Overall Study|Lost to Follow-up|0
5299086|NCT00437281|18267094|P9|Overall Study|Lost to Follow-up|0
5299087|NCT00437281|18267095|P8|Overall Study|Lost to Follow-up|0
5299088|NCT00437281|18267096|P7|Overall Study|Lost to Follow-up|0
5299089|NCT00437281|18267097|P6|Overall Study|Lost to Follow-up|0
5299090|NCT00437281|18267098|P5|Overall Study|Lost to Follow-up|0
5299091|NCT00437281|18267099|P4|Overall Study|Lost to Follow-up|0
5299092|NCT00437281|18267100|P3|Overall Study|Lost to Follow-up|0
5299093|NCT00437281|18267101|P2|Overall Study|Lost to Follow-up|0
5299094|NCT00437281|18267102|P1|Overall Study|Lost to Follow-up|0
5299095|NCT00437281|18267083|P20|Overall Study|Adverse Event|0
5299096|NCT00437281|18267084|P19|Overall Study|Adverse Event|1
5299097|NCT00437281|18267085|P18|Overall Study|Adverse Event|0
5299098|NCT00437281|18267086|P17|Overall Study|Adverse Event|0
5299099|NCT00437281|18267087|P16|Overall Study|Adverse Event|0
5299100|NCT00437281|18267088|P15|Overall Study|Adverse Event|1
5299101|NCT00437281|18267089|P14|Overall Study|Adverse Event|1
5299102|NCT00437281|18267090|P13|Overall Study|Adverse Event|0
5299103|NCT00437281|18267091|P12|Overall Study|Adverse Event|0
5299104|NCT00437281|18267092|P11|Overall Study|Adverse Event|0
5299105|NCT00437281|18267093|P10|Overall Study|Adverse Event|1
5299106|NCT00437281|18267094|P9|Overall Study|Adverse Event|0
5299107|NCT00437281|18267095|P8|Overall Study|Adverse Event|0
5299108|NCT00437281|18267096|P7|Overall Study|Adverse Event|0
5299109|NCT00437281|18267097|P6|Overall Study|Adverse Event|1
5299110|NCT00437281|18267098|P5|Overall Study|Adverse Event|0
5299111|NCT00437281|18267099|P4|Overall Study|Adverse Event|1
5299112|NCT00437281|18267100|P3|Overall Study|Adverse Event|0
5299113|NCT00437281|18267101|P2|Overall Study|Adverse Event|0
5299114|NCT00437281|18267102|P1|Overall Study|Adverse Event|0
5299115|NCT00437268|18267398|P2|Overall Study|Death|1
5299116|NCT00437268|18267399|P1|Overall Study|Death|0
5299117|NCT00437268|18267398|P2|Overall Study|Physician Decision|0
5299118|NCT00437268|18267399|P1|Overall Study|Physician Decision|1
5299119|NCT00437268|18267398|P2|Overall Study|Progressive disease|9
5299120|NCT00437268|18267399|P1|Overall Study|Progressive disease|9
5299121|NCT00437268|18267398|P2|Overall Study|Withdrawal by Subject|2
5299122|NCT00437268|18267399|P1|Overall Study|Withdrawal by Subject|2
5299123|NCT00437268|18267398|P2|Overall Study|Adverse Event|1
5299124|NCT00437268|18267399|P1|Overall Study|Adverse Event|1
5299125|NCT00437203|18267425|P10|Overall Study|Other|0
5299126|NCT00437203|18267426|P9|Overall Study|Other|0
5299127|NCT00437203|18267427|P8|Overall Study|Other|0
5299128|NCT00437203|18267428|P7|Overall Study|Other|1
5299129|NCT00437203|18267429|P6|Overall Study|Other|0
5299130|NCT00437203|18267430|P5|Overall Study|Other|0
5299131|NCT00437203|18267431|P4|Overall Study|Other|0
5299132|NCT00437203|18267432|P3|Overall Study|Other|0
5299133|NCT00437203|18267433|P2|Overall Study|Other|1
5299134|NCT00437203|18267434|P1|Overall Study|Other|0
5299559|NCT00434967|18268596|P4|Overall Study|Lost to Follow-up|0
5299135|NCT00437203|18267425|P10|Overall Study|Objective progression or relapse|2
5299136|NCT00437203|18267426|P9|Overall Study|Objective progression or relapse|2
5299137|NCT00437203|18267427|P8|Overall Study|Objective progression or relapse|1
5299138|NCT00437203|18267428|P7|Overall Study|Objective progression or relapse|6
5299139|NCT00437203|18267429|P6|Overall Study|Objective progression or relapse|3
5299140|NCT00437203|18267430|P5|Overall Study|Objective progression or relapse|3
5299141|NCT00437203|18267431|P4|Overall Study|Objective progression or relapse|3
5299142|NCT00437203|18267432|P3|Overall Study|Objective progression or relapse|2
5299143|NCT00437203|18267433|P2|Overall Study|Objective progression or relapse|6
5299144|NCT00437203|18267434|P1|Overall Study|Objective progression or relapse|5
5299145|NCT00437203|18267425|P10|Overall Study|Study terminated by sponsor|0
5299146|NCT00437203|18267426|P9|Overall Study|Study terminated by sponsor|1
5299147|NCT00437203|18267427|P8|Overall Study|Study terminated by sponsor|0
5299148|NCT00437203|18267428|P7|Overall Study|Study terminated by sponsor|0
5299149|NCT00437203|18267429|P6|Overall Study|Study terminated by sponsor|0
5299150|NCT00437203|18267430|P5|Overall Study|Study terminated by sponsor|0
5299151|NCT00437203|18267431|P4|Overall Study|Study terminated by sponsor|0
5299152|NCT00437203|18267432|P3|Overall Study|Study terminated by sponsor|0
5299153|NCT00437203|18267433|P2|Overall Study|Study terminated by sponsor|0
5299154|NCT00437203|18267434|P1|Overall Study|Study terminated by sponsor|0
5299155|NCT00437203|18267425|P10|Overall Study|Adverse Event|1
5299156|NCT00437203|18267426|P9|Overall Study|Adverse Event|0
5299157|NCT00437203|18267427|P8|Overall Study|Adverse Event|1
5299158|NCT00437203|18267428|P7|Overall Study|Adverse Event|0
5299159|NCT00437203|18267429|P6|Overall Study|Adverse Event|0
5299160|NCT00437203|18267430|P5|Overall Study|Adverse Event|0
5299161|NCT00437203|18267431|P4|Overall Study|Adverse Event|0
5299162|NCT00437203|18267432|P3|Overall Study|Adverse Event|0
5299163|NCT00437203|18267433|P2|Overall Study|Adverse Event|1
5299164|NCT00437203|18267434|P1|Overall Study|Adverse Event|1
5299165|NCT00437203|18267425|P10|Overall Study|Death|1
5299166|NCT00437203|18267426|P9|Overall Study|Death|0
5299167|NCT00437203|18267427|P8|Overall Study|Death|1
5299168|NCT00437203|18267428|P7|Overall Study|Death|0
5299169|NCT00437203|18267429|P6|Overall Study|Death|0
5299170|NCT00437203|18267430|P5|Overall Study|Death|0
5299171|NCT00437203|18267431|P4|Overall Study|Death|0
5299172|NCT00437203|18267432|P3|Overall Study|Death|1
5299173|NCT00437203|18267433|P2|Overall Study|Death|0
5299174|NCT00437203|18267434|P1|Overall Study|Death|0
5299175|NCT00437125|18267538|P1|Overall Study|Physician Decision|1
5299176|NCT00437125|18267538|P1|Overall Study|Withdrawal by Caregiver|2
5299177|NCT00437125|18267538|P1|Overall Study|Withdrawal by Subject|13
5299178|NCT00437125|18267538|P1|Overall Study|Lost to Follow-up|1
5299179|NCT00437125|18267538|P1|Overall Study|Lack of Efficacy|1
5299180|NCT00437125|18267538|P1|Overall Study|Clinical Relapse|1
5299181|NCT00437125|18267538|P1|Overall Study|Death|1
5299182|NCT00437125|18267538|P1|Overall Study|Adverse Event|12
5299183|NCT00437073|18267559|P2|Overall Study|Physician Decision|1
5299184|NCT00437073|18267560|P1|Overall Study|Physician Decision|0
5299185|NCT00437073|18267559|P2|Overall Study|Sponsor Terminated Study|0
5299186|NCT00437073|18267560|P1|Overall Study|Sponsor Terminated Study|1
5299187|NCT00437034|18267588|P1|Overall Study|Disease progression during treatment|5
5299188|NCT00437034|18267588|P1|Overall Study|Adverse Event|1
5299189|NCT00436982|18267594|P2|Overall Study|no RSA data|2
5299190|NCT00436982|18267595|P1|Overall Study|no RSA data|1
5299191|NCT00436982|18267594|P2|Overall Study|Did not receive allocated intervention|1
5299192|NCT00436982|18267595|P1|Overall Study|Did not receive allocated intervention|0
5299193|NCT00436982|18267594|P2|Overall Study|Withdrawal by Subject|1
5299194|NCT00436982|18267595|P1|Overall Study|Withdrawal by Subject|3
5299195|NCT00436956|18267666|P2|Overall Study|Not evaluable|0
5299196|NCT00436956|18267667|P1|Overall Study|Not evaluable|1
5299197|NCT00436917|18267681|P1|Overall Study|Personal conflicts of patient|1
5299198|NCT00436917|18267681|P1|Overall Study|Increased creatinine|1
5299199|NCT00436917|18267681|P1|Overall Study|Treatment for polymyalgia rheumatic|1
5299200|NCT00436917|18267681|P1|Overall Study|Lost to Follow-up|1
5299201|NCT00436917|18267681|P1|Overall Study|Death|1
5299202|NCT00436917|18267681|P1|Overall Study|Physician Decision|1
5299203|NCT00436917|18267681|P1|Overall Study|Adverse Event|2
5299204|NCT00436917|18267681|P1|Overall Study|Withdrawal by Subject|13
5299205|NCT00436852|18267707|P2|Overall Study|Ineligible|0
5299206|NCT00436852|18267708|P1|Overall Study|Ineligible|1
5299207|NCT00436852|18267707|P2|Overall Study|Withdrawal by Subject|4
5299208|NCT00436852|18267708|P1|Overall Study|Withdrawal by Subject|2
5299209|NCT00436852|18267707|P2|Overall Study|Lack of Efficacy|7
5299210|NCT00436852|18267708|P1|Overall Study|Lack of Efficacy|9
5299211|NCT00436852|18267707|P2|Overall Study|Death|34
5299212|NCT00436852|18267708|P1|Overall Study|Death|23
5299213|NCT00436826|18267727|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
5299214|NCT00436826|18267728|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
5299215|NCT00436826|18267729|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5299216|NCT00436826|18267730|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5299217|NCT00436826|18267731|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5299218|NCT00436826|18267732|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5299219|NCT00436826|18267727|P6|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5299220|NCT00436826|18267728|P5|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5299221|NCT00436826|18267729|P4|Ext. Period (With Cladribine Treatment)|Other un-specified|25
5299222|NCT00436826|18267730|P3|Ext. Period (With Cladribine Treatment)|Other un-specified|46
5299223|NCT00436826|18267731|P2|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5299224|NCT00436826|18267732|P1|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5299225|NCT00436826|18267727|P6|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5299226|NCT00436826|18267728|P5|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5299227|NCT00436826|18267729|P4|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
5299228|NCT00436826|18267730|P3|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5299229|NCT00436826|18267731|P2|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5299230|NCT00436826|18267732|P1|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5299231|NCT00436826|18267727|P6|Double Blind Period (DBP)|Other|0
5299232|NCT00436826|18267728|P5|Double Blind Period (DBP)|Other|0
5299233|NCT00436826|18267729|P4|Double Blind Period (DBP)|Other|0
5299234|NCT00436826|18267730|P3|Double Blind Period (DBP)|Other|0
5299235|NCT00436826|18267731|P2|Double Blind Period (DBP)|Other|11
5299236|NCT00436826|18267732|P1|Double Blind Period (DBP)|Other|10
5299237|NCT00436826|18267727|P6|Double Blind Period (DBP)|Protocol Violation|0
5299238|NCT00436826|18267728|P5|Double Blind Period (DBP)|Protocol Violation|0
5299239|NCT00436826|18267729|P4|Double Blind Period (DBP)|Protocol Violation|0
5299240|NCT00436826|18267730|P3|Double Blind Period (DBP)|Protocol Violation|0
5299241|NCT00436826|18267731|P2|Double Blind Period (DBP)|Protocol Violation|0
5299242|NCT00436826|18267732|P1|Double Blind Period (DBP)|Protocol Violation|1
5299243|NCT00436826|18267727|P6|Double Blind Period (DBP)|Adverse Event|0
5299244|NCT00436826|18267728|P5|Double Blind Period (DBP)|Adverse Event|0
5299245|NCT00436826|18267729|P4|Double Blind Period (DBP)|Adverse Event|0
5299246|NCT00436826|18267730|P3|Double Blind Period (DBP)|Adverse Event|0
5299247|NCT00436826|18267731|P2|Double Blind Period (DBP)|Adverse Event|0
5299248|NCT00436826|18267732|P1|Double Blind Period (DBP)|Adverse Event|2
5299249|NCT00436748|18267830|P2|Overall Study|Other|0
5299250|NCT00436748|18267831|P1|Overall Study|Other|3
5299251|NCT00436748|18267830|P2|Overall Study|Protocol-specified Criteria|4
5299252|NCT00436748|18267831|P1|Overall Study|Protocol-specified Criteria|5
5299253|NCT00436748|18267830|P2|Overall Study|Lost to Follow-up|1
5299254|NCT00436748|18267831|P1|Overall Study|Lost to Follow-up|0
5299255|NCT00436748|18267830|P2|Overall Study|Administrative Decision|0
5299256|NCT00436748|18267831|P1|Overall Study|Administrative Decision|1
5299257|NCT00436748|18267830|P2|Overall Study|Consent Withdrawn|4
5299258|NCT00436748|18267831|P1|Overall Study|Consent Withdrawn|1
5299259|NCT00436748|18267830|P2|Overall Study|Adverse Event|2
5299260|NCT00436748|18267831|P1|Overall Study|Adverse Event|0
5299261|NCT00436748|18267830|P2|Overall Study|Ineligibility Determined|1
5299262|NCT00436748|18267831|P1|Overall Study|Ineligibility Determined|1
5299263|NCT00436644|18267865|P1|Overall Study|Death|1
5299264|NCT00436644|18267865|P1|Overall Study|Adverse Event|2
5299265|NCT00436618|18267875|P3|Overall Study|Still on treatment|7
5299266|NCT00436618|18267876|P2|Overall Study|Still on treatment|2
5299267|NCT00436618|18267877|P1|Overall Study|Still on treatment|1
5299268|NCT00436618|18267875|P3|Overall Study|New Primary or Other Reasons|12
5299269|NCT00436618|18267876|P2|Overall Study|New Primary or Other Reasons|2
5299270|NCT00436618|18267877|P1|Overall Study|New Primary or Other Reasons|6
5299271|NCT00436618|18267875|P3|Overall Study|Death|3
5299272|NCT00436618|18267876|P2|Overall Study|Death|2
5299273|NCT00436618|18267877|P1|Overall Study|Death|4
5299274|NCT00436618|18267875|P3|Overall Study|Other Medical Problems|7
5299275|NCT00436618|18267876|P2|Overall Study|Other Medical Problems|1
5299276|NCT00436618|18267877|P1|Overall Study|Other Medical Problems|3
5299277|NCT00436618|18267875|P3|Overall Study|Alternate Treatment|12
5299278|NCT00436618|18267876|P2|Overall Study|Alternate Treatment|4
5299279|NCT00436618|18267877|P1|Overall Study|Alternate Treatment|3
5299280|NCT00436618|18267875|P3|Overall Study|Adverse Event|9
5299281|NCT00436618|18267876|P2|Overall Study|Adverse Event|8
5299282|NCT00436618|18267877|P1|Overall Study|Adverse Event|8
5299283|NCT00436618|18267875|P3|Overall Study|Withdrawal by Subject|11
5299284|NCT00436618|18267876|P2|Overall Study|Withdrawal by Subject|8
5299285|NCT00436618|18267877|P1|Overall Study|Withdrawal by Subject|5
5299286|NCT00436605|18267894|P1|Overall Study|Protocol Violation|3
5299287|NCT00436566|18267899|P1|Overall Study|Protocol Violation|1
5299288|NCT00436566|18267899|P1|Overall Study|Withdrawal by Subject|2
5299289|NCT00436553|18267906|P3|Overall Study|Withdrawal by Subject|3
5299290|NCT00436553|18267907|P2|Overall Study|Withdrawal by Subject|6
5299291|NCT00436553|18267908|P1|Overall Study|Withdrawal by Subject|5
5299292|NCT00436553|18267906|P3|Overall Study|Protocol Violation|0
5299293|NCT00436553|18267907|P2|Overall Study|Protocol Violation|0
5299294|NCT00436553|18267908|P1|Overall Study|Protocol Violation|1
5299295|NCT00436553|18267906|P3|Overall Study|Lost to Follow-up|0
5299296|NCT00436553|18267907|P2|Overall Study|Lost to Follow-up|2
5299297|NCT00436553|18267908|P1|Overall Study|Lost to Follow-up|0
5299298|NCT00436553|18267906|P3|Overall Study|Death|3
5299299|NCT00436553|18267907|P2|Overall Study|Death|1
5299300|NCT00436553|18267908|P1|Overall Study|Death|3
5299301|NCT00436553|18267906|P3|Overall Study|Adverse Event|4
5299302|NCT00436553|18267907|P2|Overall Study|Adverse Event|3
5299303|NCT00436553|18267908|P1|Overall Study|Adverse Event|4
5299304|NCT00436501|18267929|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
5299305|NCT00436501|18267930|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
5299560|NCT00434967|18268597|P3|Overall Study|Lost to Follow-up|1
5299306|NCT00436501|18267929|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
5299307|NCT00436501|18267930|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
5299308|NCT00436436|18267966|P1|Overall Study|Death|6
5299309|NCT00436436|18267966|P1|Overall Study|Adverse Event|2
5299310|NCT00436436|18267966|P1|Overall Study|Progression|4
5299311|NCT00436345|18267977|P2|Overall Study|ICU resident beyond follow-up period|0
5299312|NCT00436345|18267978|P1|Overall Study|ICU resident beyond follow-up period|3
5299313|NCT00436332|18268031|P1|Overall Study|Never Received Treatment|3
5299314|NCT00436332|18268031|P1|Overall Study|Ineligible|2
5299315|NCT00436332|18268031|P1|Overall Study|Not Protocol Specified|6
5299316|NCT00436332|18268031|P1|Overall Study|Death|2
5299317|NCT00436332|18268031|P1|Overall Study|Progression|59
5299318|NCT00436332|18268031|P1|Overall Study|Withdrawal by Subject|2
5299319|NCT00436332|18268031|P1|Overall Study|Adverse Event|9
5299320|NCT00436280|18268038|P1|Period 3: Maintenance|Progressive Disease|12
5299321|NCT00436280|18268038|P1|Period 3: Maintenance|Adverse Event|6
5299322|NCT00436280|18268038|P1|Period 2: Consolidation|Death|1
5299323|NCT00436280|18268038|P1|Period 2: Consolidation|Withdrawal by Subject|2
5299324|NCT00436280|18268038|P1|Period 2: Consolidation|Physician Decision|2
5299325|NCT00436280|18268038|P1|Period 2: Consolidation|Stable Disease|1
5299326|NCT00436280|18268038|P1|Period 2: Consolidation|Progressive Disease|10
5299327|NCT00436280|18268038|P1|Period 2: Consolidation|Adverse Event|1
5299328|NCT00436280|18268038|P1|Period 1: Induction|Death|1
5299329|NCT00436280|18268038|P1|Period 1: Induction|Withdrawal by Subject|1
5299330|NCT00436280|18268038|P1|Period 1: Induction|Stable Disease|6
5299331|NCT00436280|18268038|P1|Period 1: Induction|Progressive Disease|12
5299332|NCT00436280|18268038|P1|Period 1: Induction|Adverse Event|8
5299333|NCT00436215|18268052|P1|Overall Study|Small bowel obstruction|1
5299334|NCT00436215|18268052|P1|Overall Study|Refused further treatment|3
5299335|NCT00436163|18268058|P1|Overall Study|Adverse Event|1
5299336|NCT00436163|18268058|P1|Overall Study|Lost to Follow-up|2
5299337|NCT00436007|18268106|P3|Overall Study|Other|1
5299338|NCT00436007|18268107|P2|Overall Study|Other|0
5299339|NCT00436007|18268108|P1|Overall Study|Other|0
5299340|NCT00436007|18268106|P3|Overall Study|Death|3
5299341|NCT00436007|18268107|P2|Overall Study|Death|1
5299342|NCT00436007|18268108|P1|Overall Study|Death|0
5299343|NCT00436007|18268106|P3|Overall Study|Physician Decision|2
5299344|NCT00436007|18268107|P2|Overall Study|Physician Decision|0
5299345|NCT00436007|18268108|P1|Overall Study|Physician Decision|0
5299346|NCT00436007|18268106|P3|Overall Study|Lost to Follow-up|13
5299347|NCT00436007|18268107|P2|Overall Study|Lost to Follow-up|10
5299348|NCT00436007|18268108|P1|Overall Study|Lost to Follow-up|14
5299349|NCT00436007|18268106|P3|Overall Study|Withdrawal by Subject|4
5299350|NCT00436007|18268107|P2|Overall Study|Withdrawal by Subject|3
5299351|NCT00436007|18268108|P1|Overall Study|Withdrawal by Subject|5
5299352|NCT00435994|18268156|P3|Overall Study|Lost to Follow-up|0
5299353|NCT00435994|18268157|P2|Overall Study|Lost to Follow-up|0
5299354|NCT00435994|18268158|P1|Overall Study|Lost to Follow-up|7
5299355|NCT00435942|18268169|P2|Overall Study|Other|1
5299356|NCT00435942|18268170|P1|Overall Study|Other|0
5299357|NCT00435942|18268169|P2|Overall Study|Technical Failure|0
5299358|NCT00435942|18268170|P1|Overall Study|Technical Failure|3
5299359|NCT00435942|18268169|P2|Overall Study|Conversion to Open Repair|0
5299360|NCT00435942|18268170|P1|Overall Study|Conversion to Open Repair|1
5299361|NCT00435942|18268169|P2|Overall Study|Lost to Follow-up|16
5299362|NCT00435942|18268170|P1|Overall Study|Lost to Follow-up|0
5299363|NCT00435942|18268169|P2|Overall Study|Withdrawal by Subject|0
5299364|NCT00435942|18268170|P1|Overall Study|Withdrawal by Subject|2
5299365|NCT00435942|18268169|P2|Overall Study|Death|10
5299366|NCT00435942|18268170|P1|Overall Study|Death|17
5299367|NCT00435825|18268210|P4|Overall Study|Did not complete full follow-up period|5
5299368|NCT00435825|18268211|P3|Overall Study|Did not complete full follow-up period|4
5299369|NCT00435825|18268212|P2|Overall Study|Did not complete full follow-up period|6
5299370|NCT00435825|18268213|P1|Overall Study|Did not complete full follow-up period|6
5299371|NCT00435825|18268210|P4|Overall Study|Did not enter follow-up|3
5299372|NCT00435825|18268211|P3|Overall Study|Did not enter follow-up|1
5299373|NCT00435825|18268212|P2|Overall Study|Did not enter follow-up|4
5299374|NCT00435825|18268213|P1|Overall Study|Did not enter follow-up|0
5299375|NCT00435825|18268210|P4|Overall Study|Did not receive study drug|0
5299376|NCT00435825|18268211|P3|Overall Study|Did not receive study drug|2
5299377|NCT00435825|18268212|P2|Overall Study|Did not receive study drug|0
5299378|NCT00435825|18268213|P1|Overall Study|Did not receive study drug|1
5299379|NCT00435825|18268210|P4|Overall Study|Failure to return|0
5299380|NCT00435825|18268211|P3|Overall Study|Failure to return|4
5299381|NCT00435825|18268212|P2|Overall Study|Failure to return|0
5299382|NCT00435825|18268213|P1|Overall Study|Failure to return|5
5299383|NCT00435825|18268210|P4|Overall Study|Refused treatment|5
5299384|NCT00435825|18268211|P3|Overall Study|Refused treatment|0
5299385|NCT00435825|18268212|P2|Overall Study|Refused treatment|0
5299386|NCT00435825|18268213|P1|Overall Study|Refused treatment|2
5299387|NCT00435825|18268210|P4|Overall Study|Other Protocol Violation|0
5299388|NCT00435825|18268211|P3|Overall Study|Other Protocol Violation|0
5299389|NCT00435825|18268212|P2|Overall Study|Other Protocol Violation|0
5299390|NCT00435825|18268213|P1|Overall Study|Other Protocol Violation|1
5299391|NCT00435825|18268210|P4|Overall Study|Insufficient Therapeutic Response|3
5299392|NCT00435825|18268211|P3|Overall Study|Insufficient Therapeutic Response|0
5299393|NCT00435825|18268212|P2|Overall Study|Insufficient Therapeutic Response|1
5299394|NCT00435825|18268213|P1|Overall Study|Insufficient Therapeutic Response|3
5299395|NCT00435825|18268210|P4|Overall Study|Abnormality of Laboratory Test|0
5299396|NCT00435825|18268211|P3|Overall Study|Abnormality of Laboratory Test|0
5299397|NCT00435825|18268212|P2|Overall Study|Abnormality of Laboratory Test|1
5299398|NCT00435825|18268213|P1|Overall Study|Abnormality of Laboratory Test|0
5299399|NCT00435487|18268336|P2|Overall Study|Received Drug in Other Treatment Group|1
5299400|NCT00435487|18268337|P1|Overall Study|Received Drug in Other Treatment Group|0
5299401|NCT00435487|18268336|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
5299402|NCT00435487|18268337|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
5299403|NCT00435487|18268336|P2|Overall Study|Withdrawal by Subject|1
5299404|NCT00435487|18268337|P1|Overall Study|Withdrawal by Subject|2
5299405|NCT00435487|18268336|P2|Overall Study|Other|2
5299406|NCT00435487|18268337|P1|Overall Study|Other|5
5299407|NCT00435487|18268336|P2|Overall Study|Lost to Follow-up|2
5299408|NCT00435487|18268337|P1|Overall Study|Lost to Follow-up|2
5299409|NCT00435487|18268336|P2|Overall Study|Adverse Event|3
5299410|NCT00435487|18268337|P1|Overall Study|Adverse Event|0
5299411|NCT00435487|18268336|P2|Overall Study|Death|4
5299412|NCT00435487|18268337|P1|Overall Study|Death|3
5299413|NCT00435461|18268356|P3|Overall Study|Lost to Follow-up|2
5299414|NCT00435461|18268357|P2|Overall Study|Lost to Follow-up|1
5299415|NCT00435461|18268358|P1|Overall Study|Lost to Follow-up|1
5299416|NCT00435461|18268356|P3|Overall Study|Non-Compliance of diary|1
5299417|NCT00435461|18268357|P2|Overall Study|Non-Compliance of diary|0
5299418|NCT00435461|18268358|P1|Overall Study|Non-Compliance of diary|2
5299419|NCT00435461|18268356|P3|Overall Study|Adverse Event|6
5299420|NCT00435461|18268357|P2|Overall Study|Adverse Event|2
5299421|NCT00435461|18268358|P1|Overall Study|Adverse Event|1
5299422|NCT00435461|18268356|P3|Overall Study|Noncompliance with study requirements|1
5299423|NCT00435461|18268357|P2|Overall Study|Noncompliance with study requirements|1
5299424|NCT00435461|18268358|P1|Overall Study|Noncompliance with study requirements|1
5299425|NCT00435461|18268356|P3|Overall Study|Participant ended study one day early|0
5299426|NCT00435461|18268357|P2|Overall Study|Participant ended study one day early|0
5299427|NCT00435461|18268358|P1|Overall Study|Participant ended study one day early|1
5299428|NCT00435461|18268356|P3|Overall Study|Participant moved eDiary,studymedication|0
5299429|NCT00435461|18268357|P2|Overall Study|Participant moved eDiary,studymedication|0
5299430|NCT00435461|18268358|P1|Overall Study|Participant moved eDiary,studymedication|1
5299431|NCT00435461|18268356|P3|Overall Study|Pregnancy|0
5299432|NCT00435461|18268357|P2|Overall Study|Pregnancy|0
5299433|NCT00435461|18268358|P1|Overall Study|Pregnancy|2
5299434|NCT00435461|18268356|P3|Overall Study|Participant could not swallow capsule|1
5299435|NCT00435461|18268357|P2|Overall Study|Participant could not swallow capsule|0
5299436|NCT00435461|18268358|P1|Overall Study|Participant could not swallow capsule|0
5299437|NCT00435461|18268356|P3|Overall Study|Participant could not tolerate symptoms|1
5299438|NCT00435461|18268357|P2|Overall Study|Participant could not tolerate symptoms|0
5299439|NCT00435461|18268358|P1|Overall Study|Participant could not tolerate symptoms|0
5299440|NCT00435461|18268356|P3|Overall Study|Randomized in error|0
5299441|NCT00435461|18268357|P2|Overall Study|Randomized in error|0
5299442|NCT00435461|18268358|P1|Overall Study|Randomized in error|1
5299443|NCT00435461|18268356|P3|Overall Study|Withdrawal by Subject|2
5299444|NCT00435461|18268357|P2|Overall Study|Withdrawal by Subject|0
5299445|NCT00435461|18268358|P1|Overall Study|Withdrawal by Subject|1
5299446|NCT00435461|18268356|P3|Overall Study|Lack of Efficacy|0
5299447|NCT00435461|18268357|P2|Overall Study|Lack of Efficacy|1
5299448|NCT00435461|18268358|P1|Overall Study|Lack of Efficacy|2
5299449|NCT00435461|18268356|P3|Overall Study|In error, two study medications switched|0
5299450|NCT00435461|18268357|P2|Overall Study|In error, two study medications switched|0
5299451|NCT00435461|18268358|P1|Overall Study|In error, two study medications switched|1
5299452|NCT00435461|18268356|P3|Overall Study|Compliance less than 80 percent|0
5299453|NCT00435461|18268357|P2|Overall Study|Compliance less than 80 percent|0
5299454|NCT00435461|18268358|P1|Overall Study|Compliance less than 80 percent|1
5299455|NCT00435461|18268356|P3|Overall Study|Participant randomized(inadequate score)|0
5299456|NCT00435461|18268357|P2|Overall Study|Participant randomized(inadequate score)|0
5299457|NCT00435461|18268358|P1|Overall Study|Participant randomized(inadequate score)|1
5299458|NCT00435461|18268356|P3|Overall Study|Protocol Violation|10
5299459|NCT00435461|18268357|P2|Overall Study|Protocol Violation|9
5299460|NCT00435461|18268358|P1|Overall Study|Protocol Violation|6
5299461|NCT00435461|18268356|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
5299462|NCT00435461|18268357|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
5299463|NCT00435461|18268358|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
5299464|NCT00435409|18268395|P3|Overall Study|Sponsor decision|0
5299465|NCT00435409|18268396|P2|Overall Study|Sponsor decision|3
5299466|NCT00435409|18268397|P1|Overall Study|Sponsor decision|0
5299467|NCT00435409|18268395|P3|Overall Study|Adverse Event|8
5299468|NCT00435409|18268396|P2|Overall Study|Adverse Event|0
5299469|NCT00435409|18268397|P1|Overall Study|Adverse Event|0
5299470|NCT00435409|18268395|P3|Overall Study|Other|1
5299471|NCT00435409|18268396|P2|Overall Study|Other|30
5299472|NCT00435409|18268397|P1|Overall Study|Other|45
5299473|NCT00435409|18268395|P3|Overall Study|Withdrawal by Subject|1
5299474|NCT00435409|18268396|P2|Overall Study|Withdrawal by Subject|7
5299475|NCT00435409|18268397|P1|Overall Study|Withdrawal by Subject|8
5299476|NCT00435409|18268395|P3|Overall Study|Global deterioration of health status|4
5299477|NCT00435409|18268396|P2|Overall Study|Global deterioration of health status|0
5299478|NCT00435409|18268397|P1|Overall Study|Global deterioration of health status|0
5299479|NCT00435409|18268395|P3|Overall Study|Objective progression or relapse|58
5299480|NCT00435409|18268396|P2|Overall Study|Objective progression or relapse|93
5299481|NCT00435409|18268397|P1|Overall Study|Objective progression or relapse|158
5299482|NCT00435409|18268395|P3|Overall Study|Death|6
5299483|NCT00435409|18268396|P2|Overall Study|Death|6
5299484|NCT00435409|18268397|P1|Overall Study|Death|8
5299485|NCT00435409|18268395|P3|Overall Study|Lost to Follow-up|0
5299486|NCT00435409|18268396|P2|Overall Study|Lost to Follow-up|2
5299487|NCT00435409|18268397|P1|Overall Study|Lost to Follow-up|1
5299488|NCT00435409|18268395|P3|Overall Study|Protocol Violation|0
5299489|NCT00435409|18268396|P2|Overall Study|Protocol Violation|2
5299490|NCT00435409|18268397|P1|Overall Study|Protocol Violation|1
5299491|NCT00435370|18268419|P2|Overall Study|Antipsychotic medication changed|2
5299492|NCT00435370|18268420|P1|Overall Study|Antipsychotic medication changed|4
5299493|NCT00435370|18268419|P2|Overall Study|Withdrawal by Subject|10
5299494|NCT00435370|18268420|P1|Overall Study|Withdrawal by Subject|10
5299495|NCT00435370|18268419|P2|Overall Study|Adverse Event|8
5299496|NCT00435370|18268420|P1|Overall Study|Adverse Event|8
5299497|NCT00435188|18268428|P2|Overall Study|Lost to Follow-up|6
5299498|NCT00435188|18268429|P1|Overall Study|Lost to Follow-up|5
5299499|NCT00435188|18268428|P2|Overall Study|Withdrawal by Subject|11
5299500|NCT00435188|18268429|P1|Overall Study|Withdrawal by Subject|16
5299501|NCT00435188|18268428|P2|Overall Study|Death|6
5299502|NCT00435188|18268429|P1|Overall Study|Death|1
5299503|NCT00435162|18268472|P6|Period 2 (2 Weeks)|Adverse Event|0
5299504|NCT00435162|18268473|P5|Period 2 (2 Weeks)|Adverse Event|0
5299505|NCT00435162|18268474|P4|Period 2 (2 Weeks)|Adverse Event|0
5299506|NCT00435162|18268475|P3|Period 2 (2 Weeks)|Adverse Event|0
5299507|NCT00435162|18268476|P2|Period 2 (2 Weeks)|Adverse Event|1
5299508|NCT00435162|18268477|P1|Period 2 (2 Weeks)|Adverse Event|0
5299509|NCT00435045|18268497|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
5299510|NCT00435045|18268498|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
5299511|NCT00435045|18268497|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
5299512|NCT00435045|18268498|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
5299513|NCT00435045|18268497|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
5299514|NCT00435045|18268498|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
5299515|NCT00435045|18268497|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
5299516|NCT00435045|18268498|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
5299517|NCT00435045|18268497|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
5299518|NCT00435045|18268498|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
5299519|NCT00435045|18268497|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
5299520|NCT00435045|18268498|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
5299521|NCT00435045|18268497|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
5299522|NCT00435045|18268498|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
5299523|NCT00435045|18268497|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
5299524|NCT00435045|18268498|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
5299525|NCT00435045|18268497|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
5299526|NCT00435045|18268498|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
5299527|NCT00435045|18268497|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
5299528|NCT00435045|18268498|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
5299529|NCT00435045|18268497|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
5299530|NCT00435045|18268498|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
5299531|NCT00435019|18268554|P2|Overall Study|Personal reasons for withdrawal|7
5299532|NCT00435019|18268555|P1|Overall Study|Personal reasons for withdrawal|8
5299533|NCT00435019|18268554|P2|Overall Study|Protocol Violation|1
5299534|NCT00435019|18268555|P1|Overall Study|Protocol Violation|3
5299535|NCT00435019|18268554|P2|Overall Study|Lack of Efficacy|2
5299536|NCT00435019|18268555|P1|Overall Study|Lack of Efficacy|1
5299537|NCT00435019|18268554|P2|Overall Study|Adverse Event|0
5299538|NCT00435019|18268555|P1|Overall Study|Adverse Event|1
5299539|NCT00434967|18268596|P4|Overall Study|Patient Disposition Challenges|3
5299540|NCT00434967|18268597|P3|Overall Study|Patient Disposition Challenges|0
5299541|NCT00434967|18268598|P2|Overall Study|Patient Disposition Challenges|0
5299542|NCT00434967|18268599|P1|Overall Study|Patient Disposition Challenges|2
5299543|NCT00434967|18268596|P4|Overall Study|Physician Decision|0
5299544|NCT00434967|18268597|P3|Overall Study|Physician Decision|1
5299545|NCT00434967|18268598|P2|Overall Study|Physician Decision|1
5299546|NCT00434967|18268599|P1|Overall Study|Physician Decision|1
5299547|NCT00434967|18268596|P4|Overall Study|Protocol Violation|1
5299548|NCT00434967|18268597|P3|Overall Study|Protocol Violation|0
5299549|NCT00434967|18268598|P2|Overall Study|Protocol Violation|1
5299550|NCT00434967|18268599|P1|Overall Study|Protocol Violation|0
5299551|NCT00434967|18268596|P4|Overall Study|Randomized in error|1
5299552|NCT00434967|18268597|P3|Overall Study|Randomized in error|0
5299553|NCT00434967|18268598|P2|Overall Study|Randomized in error|0
5299554|NCT00434967|18268599|P1|Overall Study|Randomized in error|0
5299555|NCT00434967|18268596|P4|Overall Study|Withdrawal by Subject|6
5299556|NCT00434967|18268597|P3|Overall Study|Withdrawal by Subject|4
5299557|NCT00434967|18268598|P2|Overall Study|Withdrawal by Subject|2
5299558|NCT00434967|18268599|P1|Overall Study|Withdrawal by Subject|2
5299561|NCT00434967|18268598|P2|Overall Study|Lost to Follow-up|0
5299562|NCT00434967|18268599|P1|Overall Study|Lost to Follow-up|0
5299563|NCT00434967|18268596|P4|Overall Study|Adverse Event|3
5299564|NCT00434967|18268597|P3|Overall Study|Adverse Event|3
5299565|NCT00434967|18268598|P2|Overall Study|Adverse Event|4
5299566|NCT00434967|18268599|P1|Overall Study|Adverse Event|2
5299567|NCT00434954|18268619|P2|Overall Study|Subject decision|22
5299568|NCT00434954|18268620|P1|Overall Study|Subject decision|8
5299569|NCT00434954|18268619|P2|Overall Study|Sponsor decision|0
5299570|NCT00434954|18268620|P1|Overall Study|Sponsor decision|1
5299571|NCT00434954|18268619|P2|Overall Study|Protocol Violation|27
5299572|NCT00434954|18268620|P1|Overall Study|Protocol Violation|36
5299573|NCT00434954|18268619|P2|Overall Study|Physician Decision|3
5299574|NCT00434954|18268620|P1|Overall Study|Physician Decision|6
5299575|NCT00434954|18268619|P2|Overall Study|Lost to Follow-up|1
5299576|NCT00434954|18268620|P1|Overall Study|Lost to Follow-up|0
5299577|NCT00434954|18268619|P2|Overall Study|Entry criteria not met|16
5299578|NCT00434954|18268620|P1|Overall Study|Entry criteria not met|14
5299579|NCT00434954|18268619|P2|Overall Study|Adverse Event|2
5299580|NCT00434954|18268620|P1|Overall Study|Adverse Event|17
5299581|NCT00434876|18268650|P2|Overall Study|Lost to Follow-up|1
5299582|NCT00434876|18268651|P1|Overall Study|Lost to Follow-up|1
5299583|NCT00434759|18268665|P2|Overall Study|family affairs|0
5299584|NCT00434759|18268666|P1|Overall Study|family affairs|2
5299585|NCT00434759|18268665|P2|Overall Study|Withdrawal by Subject|1
5299586|NCT00434759|18268666|P1|Overall Study|Withdrawal by Subject|17
5299587|NCT00434759|18268665|P2|Overall Study|Lack of Efficacy|4
5299588|NCT00434759|18268666|P1|Overall Study|Lack of Efficacy|5
5299589|NCT00434642|18268682|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
5299590|NCT00434642|18268683|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
5299591|NCT00434642|18268682|P2|Open-label Treatment Phase|Adverse Event|5
5299592|NCT00434642|18268683|P1|Open-label Treatment Phase|Adverse Event|0
5299593|NCT00434642|18268682|P2|Blinded Treatment Phase|Did not Receive Treatment|1
5299594|NCT00434642|18268683|P1|Blinded Treatment Phase|Did not Receive Treatment|4
5299595|NCT00434642|18268682|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
5299596|NCT00434642|18268683|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
5299597|NCT00434642|18268682|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
5299598|NCT00434642|18268683|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
5299599|NCT00434642|18268682|P2|Blinded Treatment Phase|Physician Decision|27
5299600|NCT00434642|18268683|P1|Blinded Treatment Phase|Physician Decision|19
5299601|NCT00434642|18268682|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
5299602|NCT00434642|18268683|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
5299603|NCT00434642|18268682|P2|Blinded Treatment Phase|Clinical Disease Progression|5
5299604|NCT00434642|18268683|P1|Blinded Treatment Phase|Clinical Disease Progression|4
5299605|NCT00434642|18268682|P2|Blinded Treatment Phase|Adverse Event|58
5299606|NCT00434642|18268683|P1|Blinded Treatment Phase|Adverse Event|12
5299607|NCT00434590|18268701|P2|Overall Study|Administrative problems|5
5299608|NCT00434590|18268702|P1|Overall Study|Administrative problems|5
5299609|NCT00434577|18268713|P5|Months 0-3|Withdrawal by Subject|1
5299610|NCT00434577|18268714|P4|Months 0-3|Withdrawal by Subject|1
5299611|NCT00434577|18268715|P3|Months 0-3|Withdrawal by Subject|1
5299612|NCT00434577|18268716|P2|Months 0-3|Withdrawal by Subject|1
5299613|NCT00434577|18268717|P1|Months 0-3|Withdrawal by Subject|2
5299614|NCT00434577|18268713|P5|Months 0-3|Protocol Violation|0
5299615|NCT00434577|18268714|P4|Months 0-3|Protocol Violation|0
5299616|NCT00434577|18268715|P3|Months 0-3|Protocol Violation|1
5299617|NCT00434577|18268716|P2|Months 0-3|Protocol Violation|0
5299618|NCT00434577|18268717|P1|Months 0-3|Protocol Violation|1
5299619|NCT00434577|18268713|P5|Months 0-3|Lost to Follow-up|2
5299620|NCT00434577|18268714|P4|Months 0-3|Lost to Follow-up|0
5299621|NCT00434577|18268715|P3|Months 0-3|Lost to Follow-up|0
5299622|NCT00434577|18268716|P2|Months 0-3|Lost to Follow-up|0
5299623|NCT00434577|18268717|P1|Months 0-3|Lost to Follow-up|0
5299624|NCT00434577|18268713|P5|Months 0-3|Adverse Event|0
5299625|NCT00434577|18268714|P4|Months 0-3|Adverse Event|0
5299626|NCT00434577|18268715|P3|Months 0-3|Adverse Event|1
5299627|NCT00434577|18268716|P2|Months 0-3|Adverse Event|1
5299628|NCT00434577|18268717|P1|Months 0-3|Adverse Event|0
5299629|NCT00434577|18268713|P5|Months 0-3|Serious Adverse Event|0
5299630|NCT00434577|18268714|P4|Months 0-3|Serious Adverse Event|0
5299631|NCT00434577|18268715|P3|Months 0-3|Serious Adverse Event|1
5299632|NCT00434577|18268716|P2|Months 0-3|Serious Adverse Event|0
5299633|NCT00434577|18268717|P1|Months 0-3|Serious Adverse Event|0
5299634|NCT00434512|18268895|P6|Overall Study|Other|0
5299635|NCT00434512|18268896|P5|Overall Study|Other|0
5299636|NCT00434512|18268897|P4|Overall Study|Other|0
5299637|NCT00434512|18268898|P3|Overall Study|Other|0
5299638|NCT00434512|18268899|P2|Overall Study|Other|1
5299639|NCT00434512|18268900|P1|Overall Study|Other|0
5299640|NCT00434512|18268895|P6|Overall Study|Migrated/moved from study area|1
5299641|NCT00434512|18268896|P5|Overall Study|Migrated/moved from study area|1
5299642|NCT00434512|18268897|P4|Overall Study|Migrated/moved from study area|1
5299643|NCT00434512|18268898|P3|Overall Study|Migrated/moved from study area|0
5299644|NCT00434512|18268899|P2|Overall Study|Migrated/moved from study area|0
5299645|NCT00434512|18268900|P1|Overall Study|Migrated/moved from study area|0
5299646|NCT00434421|18269014|P1|Overall Study|Non-compliance with study treatment|1
5299647|NCT00434421|18269014|P1|Overall Study|Withdrawal by Subject|1
5299648|NCT00434330|18269042|P6|Overall Study|Subject Not Compliant With Study|0
5299649|NCT00434330|18269043|P5|Overall Study|Subject Not Compliant With Study|0
5299650|NCT00434330|18269044|P4|Overall Study|Subject Not Compliant With Study|0
5299651|NCT00434330|18269045|P3|Overall Study|Subject Not Compliant With Study|1
5299652|NCT00434330|18269046|P2|Overall Study|Subject Not Compliant With Study|0
5299653|NCT00434330|18269047|P1|Overall Study|Subject Not Compliant With Study|0
5299654|NCT00434330|18269042|P6|Overall Study|Renal transplant|0
5299655|NCT00434330|18269043|P5|Overall Study|Renal transplant|0
5299656|NCT00434330|18269044|P4|Overall Study|Renal transplant|1
5299657|NCT00434330|18269045|P3|Overall Study|Renal transplant|0
5299658|NCT00434330|18269046|P2|Overall Study|Renal transplant|0
5299659|NCT00434330|18269047|P1|Overall Study|Renal transplant|0
5299660|NCT00434330|18269042|P6|Overall Study|Withdrawal by Subject|0
5299661|NCT00434330|18269043|P5|Overall Study|Withdrawal by Subject|0
5299662|NCT00434330|18269044|P4|Overall Study|Withdrawal by Subject|1
5299663|NCT00434330|18269045|P3|Overall Study|Withdrawal by Subject|1
5299664|NCT00434330|18269046|P2|Overall Study|Withdrawal by Subject|0
5299665|NCT00434330|18269047|P1|Overall Study|Withdrawal by Subject|0
5299666|NCT00434330|18269042|P6|Overall Study|Death|1
5299667|NCT00434330|18269043|P5|Overall Study|Death|1
5299668|NCT00434330|18269044|P4|Overall Study|Death|0
5299669|NCT00434330|18269045|P3|Overall Study|Death|0
5299670|NCT00434330|18269046|P2|Overall Study|Death|0
5299671|NCT00434330|18269047|P1|Overall Study|Death|1
5299672|NCT00434330|18269042|P6|Overall Study|Adverse Event|0
5299673|NCT00434330|18269043|P5|Overall Study|Adverse Event|0
5299674|NCT00434330|18269044|P4|Overall Study|Adverse Event|0
5299675|NCT00434330|18269045|P3|Overall Study|Adverse Event|1
5299676|NCT00434330|18269046|P2|Overall Study|Adverse Event|0
5299677|NCT00434330|18269047|P1|Overall Study|Adverse Event|0
5299678|NCT00434304|18269079|P1|Overall Study|Withdrawal by Subject|4
5299679|NCT00434304|18269079|P1|Overall Study|Lack of Efficacy|2
5299680|NCT00434304|18269079|P1|Overall Study|Adverse Event|14
5299681|NCT00434252|18269128|P2|Overall Study|Withdrawal by Subject|7
5299682|NCT00434252|18269129|P1|Overall Study|Withdrawal by Subject|3
5299683|NCT00434252|18269128|P2|Overall Study|Physician Decision|8
5299684|NCT00434252|18269129|P1|Overall Study|Physician Decision|4
5299685|NCT00434252|18269128|P2|Overall Study|Lost to Follow-up|1
5299686|NCT00434252|18269129|P1|Overall Study|Lost to Follow-up|0
5299687|NCT00434252|18269128|P2|Overall Study|Death|2
5299688|NCT00434252|18269129|P1|Overall Study|Death|1
5299689|NCT00434252|18269128|P2|Overall Study|Adverse Event|13
5299690|NCT00434252|18269129|P1|Overall Study|Adverse Event|6
5299691|NCT00434252|18269128|P2|Overall Study|Lack of Efficacy|100
5299692|NCT00434252|18269129|P1|Overall Study|Lack of Efficacy|50
5299693|NCT00434213|18269163|P1|Overall Study|Non-compliant to study schedule|1
5299694|NCT00434213|18269163|P1|Overall Study|Application site reaction|1
5299695|NCT00434213|18269163|P1|Overall Study|Unable to comply with study visit window|2
5299696|NCT00434213|18269163|P1|Overall Study|Protocol Violation|3
5299697|NCT00434213|18269163|P1|Overall Study|Withdrawal by Subject|7
5299698|NCT00434213|18269163|P1|Overall Study|Lost to Follow-up|14
5299699|NCT00434213|18269163|P1|Overall Study|Lack of Efficacy|9
5299700|NCT00434213|18269163|P1|Overall Study|Adverse Event|12
5299701|NCT00434161|18269171|P3|Overall Study|Logistical error study assessments|3
5299702|NCT00434161|18269172|P2|Overall Study|Logistical error study assessments|0
5299703|NCT00434161|18269173|P1|Overall Study|Logistical error study assessments|1
5299704|NCT00434161|18269171|P3|Overall Study|Withdrawal by Subject|3
5299705|NCT00434161|18269172|P2|Overall Study|Withdrawal by Subject|0
5299706|NCT00434161|18269173|P1|Overall Study|Withdrawal by Subject|2
5299707|NCT00434161|18269171|P3|Overall Study|Non-Compliance|0
5299708|NCT00434161|18269172|P2|Overall Study|Non-Compliance|1
5299709|NCT00434161|18269173|P1|Overall Study|Non-Compliance|1
5299710|NCT00434161|18269171|P3|Overall Study|Death|1
5299711|NCT00434161|18269172|P2|Overall Study|Death|0
5299712|NCT00434161|18269173|P1|Overall Study|Death|1
5299713|NCT00434161|18269171|P3|Overall Study|Lost to Follow-up|0
5299714|NCT00434161|18269172|P2|Overall Study|Lost to Follow-up|1
5299715|NCT00434161|18269173|P1|Overall Study|Lost to Follow-up|0
5299716|NCT00434161|18269171|P3|Overall Study|Adverse Event|4
5299717|NCT00434161|18269172|P2|Overall Study|Adverse Event|1
5299718|NCT00434161|18269173|P1|Overall Study|Adverse Event|5
5299719|NCT00434148|18269217|P2|Overall Study|Abnormal test procedure result|1
5299720|NCT00434148|18269218|P1|Overall Study|Abnormal test procedure result|0
5299721|NCT00434148|18269217|P2|Overall Study|Condition no longer requires study drug|0
5299722|NCT00434148|18269218|P1|Overall Study|Condition no longer requires study drug|1
5299723|NCT00434148|18269217|P2|Overall Study|Lost to Follow-up|1
5299724|NCT00434148|18269218|P1|Overall Study|Lost to Follow-up|0
5299725|NCT00434148|18269217|P2|Overall Study|Administrative problems|10
5299726|NCT00434148|18269218|P1|Overall Study|Administrative problems|6
5299727|NCT00434148|18269217|P2|Overall Study|Protocol Violation|0
5299728|NCT00434148|18269218|P1|Overall Study|Protocol Violation|4
5299729|NCT00434148|18269217|P2|Overall Study|Withdrawal by Subject|15
5299730|NCT00434148|18269218|P1|Overall Study|Withdrawal by Subject|15
5299731|NCT00434148|18269217|P2|Overall Study|Lack of Efficacy|28
5299732|NCT00434148|18269218|P1|Overall Study|Lack of Efficacy|25
5299733|NCT00434148|18269217|P2|Overall Study|Adverse Event|18
5299734|NCT00434148|18269218|P1|Overall Study|Adverse Event|18
5299735|NCT00434122|18269254|P2|Overall Study|Travelling of subject.|0
5299736|NCT00434122|18269255|P1|Overall Study|Travelling of subject.|1
5299737|NCT00434122|18269254|P2|Overall Study|Low follicular response.|2
5299738|NCT00434122|18269255|P1|Overall Study|Low follicular response.|1
5299739|NCT00434122|18269254|P2|Overall Study|Large follicle size|2
5299740|NCT00434122|18269255|P1|Overall Study|Large follicle size|2
5299741|NCT00434122|18269254|P2|Overall Study|Personal reasons|1
5299742|NCT00434122|18269255|P1|Overall Study|Personal reasons|1
5299743|NCT00434122|18269254|P2|Overall Study|loss of subject contact|1
5299744|NCT00434122|18269255|P1|Overall Study|loss of subject contact|1
5299745|NCT00434122|18269254|P2|Overall Study|Non-compliance with protocol|1
5299746|NCT00434122|18269255|P1|Overall Study|Non-compliance with protocol|0
5299747|NCT00434109|18269264|P1|Overall Study|had embolism, did not receive sunitinib|3
5299748|NCT00434109|18269264|P1|Overall Study|Protocol Violation|1
5299749|NCT00434109|18269264|P1|Overall Study|Adverse Event|5
5299750|NCT00434109|18269264|P1|Overall Study|Physician Decision|9
5299751|NCT00434057|18269273|P1|Overall Study|Withdrawal by Subject|1
5299752|NCT00433966|18269311|P4|Stent Intervention/Randomization|Lost to Follow-up|47
5299753|NCT00433966|18269312|P3|Stent Intervention/Randomization|Lost to Follow-up|113
5299754|NCT00433966|18269313|P2|Stent Intervention/Randomization|Lost to Follow-up|0
5299755|NCT00433966|18269314|P1|Stent Intervention/Randomization|Lost to Follow-up|0
5299756|NCT00433966|18269311|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
5299757|NCT00433966|18269312|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
5299758|NCT00433966|18269313|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
5299759|NCT00433966|18269314|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
5299760|NCT00433966|18269311|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
5299761|NCT00433966|18269312|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
5299762|NCT00433966|18269313|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
5299763|NCT00433966|18269314|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
5299764|NCT00433966|18269311|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
5299765|NCT00433966|18269312|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
5299766|NCT00433966|18269313|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
5299767|NCT00433966|18269314|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
5299768|NCT00433966|18269311|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
5299769|NCT00433966|18269312|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
5299770|NCT00433966|18269313|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
5299771|NCT00433966|18269314|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
5299772|NCT00433914|18269336|P2|Overall Study|Lost to Follow-up|1
5299773|NCT00433914|18269337|P1|Overall Study|Lost to Follow-up|0
5299774|NCT00433914|18269336|P2|Overall Study|Withdrawal by Subject|2
5299775|NCT00433914|18269337|P1|Overall Study|Withdrawal by Subject|0
5299776|NCT00433836|18269357|P2|Overall Study|Abnormal laboratory values|1
5299777|NCT00433836|18269358|P1|Overall Study|Abnormal laboratory values|0
5299778|NCT00433836|18269357|P2|Overall Study|Condition no longer requires study drug|1
5299779|NCT00433836|18269358|P1|Overall Study|Condition no longer requires study drug|0
5299780|NCT00433836|18269357|P2|Overall Study|Protocol Violation|2
5299781|NCT00433836|18269358|P1|Overall Study|Protocol Violation|0
5299782|NCT00433836|18269357|P2|Overall Study|Unsatisfactory therapeutic effect|1
5299783|NCT00433836|18269358|P1|Overall Study|Unsatisfactory therapeutic effect|1
5299784|NCT00433836|18269357|P2|Overall Study|Withdrawal by Subject|1
5299785|NCT00433836|18269358|P1|Overall Study|Withdrawal by Subject|2
5299786|NCT00433836|18269357|P2|Overall Study|Lost to Follow-up|0
5299787|NCT00433836|18269358|P1|Overall Study|Lost to Follow-up|3
5299788|NCT00433836|18269357|P2|Overall Study|Adverse Event|0
5299789|NCT00433836|18269358|P1|Overall Study|Adverse Event|7
5299790|NCT00433771|18269370|P1|Overall Study|Failure to deploy stent|1
5299791|NCT00433771|18269370|P1|Overall Study|Death|2
5299792|NCT00433771|18269370|P1|Overall Study|Treated and later found to be ineligible|2
5299793|NCT00433771|18269370|P1|Overall Study|screen fail|14
5299794|NCT00433654|18269393|P2|Overall Study|Withdrawal by Subject|2
5299795|NCT00433654|18269394|P1|Overall Study|Withdrawal by Subject|1
5299796|NCT00433654|18269393|P2|Overall Study|Subject not yet due for visit|0
5299797|NCT00433654|18269394|P1|Overall Study|Subject not yet due for visit|4
5299798|NCT00433654|18269393|P2|Overall Study|Missed visit|3
5299799|NCT00433654|18269394|P1|Overall Study|Missed visit|6
5299800|NCT00433654|18269393|P2|Overall Study|Death|0
5299801|NCT00433654|18269394|P1|Overall Study|Death|4
5299802|NCT00433537|18269440|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
5299803|NCT00433537|18269441|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
5299804|NCT00433537|18269442|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
5299805|NCT00433537|18269440|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
5299806|NCT00433537|18269441|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
5299807|NCT00433537|18269442|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
5299808|NCT00433537|18269440|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
5299809|NCT00433537|18269441|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
5299810|NCT00433537|18269442|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
5299811|NCT00433537|18269440|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
5299812|NCT00433537|18269441|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
5299813|NCT00433537|18269442|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
5299979|NCT00433147|18269650|P4|Overall Study|Adverse Event|0
5299814|NCT00433537|18269440|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
5299815|NCT00433537|18269441|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
5299816|NCT00433537|18269442|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
5299817|NCT00433537|18269440|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
5299818|NCT00433537|18269441|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
5299819|NCT00433537|18269442|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
5299820|NCT00433537|18269440|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
5299821|NCT00433537|18269441|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
5299822|NCT00433537|18269442|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
5299823|NCT00433537|18269440|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
5299824|NCT00433537|18269441|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
5299825|NCT00433537|18269442|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
5299826|NCT00433537|18269440|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
5299827|NCT00433537|18269441|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
5299828|NCT00433537|18269442|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
5299829|NCT00433511|18269454|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
5299830|NCT00433511|18269455|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
5299831|NCT00433511|18269456|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
5299832|NCT00433511|18269454|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
5299833|NCT00433511|18269455|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
5299834|NCT00433511|18269456|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
5299835|NCT00433511|18269454|P3|Step 2 (Arm D)|Suspected recurrence|1
5299836|NCT00433511|18269455|P2|Step 2 (Arm D)|Suspected recurrence|0
5299837|NCT00433511|18269456|P1|Step 2 (Arm D)|Suspected recurrence|0
5299838|NCT00433511|18269454|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
5299839|NCT00433511|18269455|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
5299840|NCT00433511|18269456|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
5299841|NCT00433511|18269454|P3|Step 2 (Arm D)|Other complicating disease|3
5299842|NCT00433511|18269455|P2|Step 2 (Arm D)|Other complicating disease|0
5299843|NCT00433511|18269456|P1|Step 2 (Arm D)|Other complicating disease|0
5299844|NCT00433511|18269454|P3|Step 2 (Arm D)|Disease progression, relapse|7
5299845|NCT00433511|18269455|P2|Step 2 (Arm D)|Disease progression, relapse|0
5299846|NCT00433511|18269456|P1|Step 2 (Arm D)|Disease progression, relapse|0
5299847|NCT00433511|18269454|P3|Step 2 (Arm D)|Physician Decision|9
5299848|NCT00433511|18269455|P2|Step 2 (Arm D)|Physician Decision|0
5299849|NCT00433511|18269456|P1|Step 2 (Arm D)|Physician Decision|0
5299850|NCT00433511|18269454|P3|Step 2 (Arm D)|Never started protocol therapy|148
5299851|NCT00433511|18269455|P2|Step 2 (Arm D)|Never started protocol therapy|0
5299852|NCT00433511|18269456|P1|Step 2 (Arm D)|Never started protocol therapy|0
5299853|NCT00433511|18269454|P3|Step 2 (Arm D)|Withdrawal by Subject|181
5299854|NCT00433511|18269455|P2|Step 2 (Arm D)|Withdrawal by Subject|0
5299855|NCT00433511|18269456|P1|Step 2 (Arm D)|Withdrawal by Subject|0
5299856|NCT00433511|18269454|P3|Step 2 (Arm D)|Adverse Event|135
5299857|NCT00433511|18269455|P2|Step 2 (Arm D)|Adverse Event|0
5299858|NCT00433511|18269456|P1|Step 2 (Arm D)|Adverse Event|0
5299859|NCT00433511|18269454|P3|Step 1|Patient moved|1
5299860|NCT00433511|18269455|P2|Step 1|Patient moved|0
5299861|NCT00433511|18269456|P1|Step 1|Patient moved|0
5299862|NCT00433511|18269454|P3|Step 1|Insurance/drug distribution issues|2
5299863|NCT00433511|18269455|P2|Step 1|Insurance/drug distribution issues|1
5299864|NCT00433511|18269456|P1|Step 1|Insurance/drug distribution issues|0
5299865|NCT00433511|18269454|P3|Step 1|Suspected recurrence|0
5299866|NCT00433511|18269455|P2|Step 1|Suspected recurrence|1
5299867|NCT00433511|18269456|P1|Step 1|Suspected recurrence|0
5299868|NCT00433511|18269454|P3|Step 1|Non-breast cancer surgery/wound issues|1
5299869|NCT00433511|18269455|P2|Step 1|Non-breast cancer surgery/wound issues|4
5299870|NCT00433511|18269456|P1|Step 1|Non-breast cancer surgery/wound issues|0
5299871|NCT00433511|18269454|P3|Step 1|Other complicating disease|3
5299872|NCT00433511|18269455|P2|Step 1|Other complicating disease|6
5299873|NCT00433511|18269456|P1|Step 1|Other complicating disease|2
5299874|NCT00433511|18269454|P3|Step 1|Disease progression, relapse|3
5299875|NCT00433511|18269455|P2|Step 1|Disease progression, relapse|3
5299876|NCT00433511|18269456|P1|Step 1|Disease progression, relapse|5
5299877|NCT00433511|18269454|P3|Step 1|Alternative therapy|3
5299878|NCT00433511|18269455|P2|Step 1|Alternative therapy|1
5299879|NCT00433511|18269456|P1|Step 1|Alternative therapy|2
5299880|NCT00433511|18269454|P3|Step 1|Never started protocol therapy|66
5299881|NCT00433511|18269455|P2|Step 1|Never started protocol therapy|64
5299882|NCT00433511|18269456|P1|Step 1|Never started protocol therapy|28
5299883|NCT00433511|18269454|P3|Step 1|Physician Decision|3
5299884|NCT00433511|18269455|P2|Step 1|Physician Decision|4
5299885|NCT00433511|18269456|P1|Step 1|Physician Decision|1
5299886|NCT00433511|18269454|P3|Step 1|Death|1
5299887|NCT00433511|18269455|P2|Step 1|Death|1
5299888|NCT00433511|18269456|P1|Step 1|Death|3
5299889|NCT00433511|18269454|P3|Step 1|Withdrawal by Subject|154
5299890|NCT00433511|18269455|P2|Step 1|Withdrawal by Subject|143
5299891|NCT00433511|18269456|P1|Step 1|Withdrawal by Subject|45
5299892|NCT00433511|18269454|P3|Step 1|Adverse Event|153
5299893|NCT00433511|18269455|P2|Step 1|Adverse Event|157
5299894|NCT00433511|18269456|P1|Step 1|Adverse Event|50
5299895|NCT00433446|18269470|P1|Overall Study|Ineligible|9
5299896|NCT00433446|18269470|P1|Overall Study|Other - Not Protocol specified|3
5299897|NCT00433446|18269470|P1|Overall Study|Progression|44
5299898|NCT00433446|18269470|P1|Overall Study|Refusal Unrelated to Adverse Event|1
5299899|NCT00433446|18269470|P1|Overall Study|Adverse Event|4
5299900|NCT00433381|18269480|P2|Overall Study|Ineligible / no protocol treatment|3
5299901|NCT00433381|18269481|P1|Overall Study|Ineligible / no protocol treatment|3
5299902|NCT00433329|18269500|P1|Overall Study|Physician Decision|1
5299903|NCT00433329|18269500|P1|Overall Study|Lost to Follow-up|1
5299904|NCT00433329|18269500|P1|Overall Study|Moved out of state|1
5299905|NCT00433329|18269500|P1|Overall Study|Discontinued sildenafil|2
5299906|NCT00433329|18269500|P1|Overall Study|Withdrew consent|3
5299907|NCT00433329|18269500|P1|Overall Study|Death|4
5299908|NCT00433329|18269500|P1|Overall Study|Adverse Event|9
5299909|NCT00433290|18269506|P2|Overall Study|Lost to Follow-up|0
5299910|NCT00433290|18269507|P1|Overall Study|Lost to Follow-up|1
5299911|NCT00433290|18269506|P2|Overall Study|Entry Criteria Not Met|1
5299912|NCT00433290|18269507|P1|Overall Study|Entry Criteria Not Met|0
5299913|NCT00433290|18269506|P2|Overall Study|Physician Decision|0
5299914|NCT00433290|18269507|P1|Overall Study|Physician Decision|2
5299915|NCT00433290|18269506|P2|Overall Study|Protocol Violation|2
5299916|NCT00433290|18269507|P1|Overall Study|Protocol Violation|3
5299917|NCT00433290|18269506|P2|Overall Study|Withdrawal by Subject|2
5299918|NCT00433290|18269507|P1|Overall Study|Withdrawal by Subject|4
5299919|NCT00433290|18269506|P2|Overall Study|Lack of Efficacy|5
5299920|NCT00433290|18269507|P1|Overall Study|Lack of Efficacy|1
5299921|NCT00433290|18269506|P2|Overall Study|Adverse Event|7
5299922|NCT00433290|18269507|P1|Overall Study|Adverse Event|24
5299923|NCT00433199|18269576|P2|Open-Label Period|Administrative|1
5299924|NCT00433199|18269577|P1|Open-Label Period|Administrative|0
5299925|NCT00433199|18269576|P2|Open-Label Period|Protocol Violation|2
5299926|NCT00433199|18269577|P1|Open-Label Period|Protocol Violation|0
5299927|NCT00433199|18269576|P2|Open-Label Period|Withdrawal by Subject|7
5299928|NCT00433199|18269577|P1|Open-Label Period|Withdrawal by Subject|0
5299929|NCT00433199|18269576|P2|Open-Label Period|Lost to Follow-up|3
5299930|NCT00433199|18269577|P1|Open-Label Period|Lost to Follow-up|0
5299931|NCT00433199|18269576|P2|Open-Label Period|Lack of Efficacy|2
5299932|NCT00433199|18269577|P1|Open-Label Period|Lack of Efficacy|0
5299933|NCT00433199|18269576|P2|Open-Label Period|Adverse Event|19
5299934|NCT00433199|18269577|P1|Open-Label Period|Adverse Event|0
5299935|NCT00433199|18269576|P2|Double-Blind Period|Administrative|5
5299936|NCT00433199|18269577|P1|Double-Blind Period|Administrative|1
5299937|NCT00433199|18269576|P2|Double-Blind Period|Protocol Violation|10
5299938|NCT00433199|18269577|P1|Double-Blind Period|Protocol Violation|1
5299939|NCT00433199|18269576|P2|Double-Blind Period|Withdrawal by Subject|19
5299940|NCT00433199|18269577|P1|Double-Blind Period|Withdrawal by Subject|8
5299941|NCT00433199|18269576|P2|Double-Blind Period|Lost to Follow-up|5
5299942|NCT00433199|18269577|P1|Double-Blind Period|Lost to Follow-up|2
5299943|NCT00433199|18269576|P2|Double-Blind Period|Lack of Efficacy|2
5299944|NCT00433199|18269577|P1|Double-Blind Period|Lack of Efficacy|0
5299945|NCT00433199|18269576|P2|Double-Blind Period|Adverse Event|25
5299946|NCT00433199|18269577|P1|Double-Blind Period|Adverse Event|0
5299947|NCT00433160|18269597|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
5299948|NCT00433160|18269598|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
5299949|NCT00433160|18269597|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
5299950|NCT00433160|18269598|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
5299951|NCT00433160|18269597|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
5299952|NCT00433160|18269598|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
5299953|NCT00433160|18269597|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
5299954|NCT00433160|18269598|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
5299955|NCT00433160|18269597|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
5299956|NCT00433160|18269598|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
5299957|NCT00433160|18269597|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
5299958|NCT00433160|18269598|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
5299959|NCT00433160|18269597|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
5299960|NCT00433160|18269598|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
5299961|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
5299962|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
5299963|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
5299964|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
5299965|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
5299966|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
5299967|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
5299968|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
5299969|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
5299970|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
5299971|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
5299972|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
5299973|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
5299974|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
5299975|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Death|0
5299976|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Death|0
5299977|NCT00433160|18269597|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
5299978|NCT00433160|18269598|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
5299980|NCT00433147|18269651|P3|Overall Study|Adverse Event|0
5299981|NCT00433147|18269652|P2|Overall Study|Adverse Event|1
5299982|NCT00433147|18269653|P1|Overall Study|Adverse Event|0
5299983|NCT00433017|18269669|P2|Overall Study|Subject no longer requires study drug|1
5299984|NCT00433017|18269670|P1|Overall Study|Subject no longer requires study drug|1
5299985|NCT00433017|18269669|P2|Overall Study|Death|2
5299986|NCT00433017|18269670|P1|Overall Study|Death|2
5299987|NCT00433017|18269669|P2|Overall Study|Protocol Violation|0
5299988|NCT00433017|18269670|P1|Overall Study|Protocol Violation|1
5299989|NCT00433017|18269669|P2|Overall Study|Administrative problems|86
5299990|NCT00433017|18269670|P1|Overall Study|Administrative problems|80
5299991|NCT00433017|18269669|P2|Overall Study|Lost to Follow-up|4
5299992|NCT00433017|18269670|P1|Overall Study|Lost to Follow-up|3
5299993|NCT00433017|18269669|P2|Overall Study|Withdrawal by Subject|5
5299994|NCT00433017|18269670|P1|Overall Study|Withdrawal by Subject|4
5299995|NCT00433017|18269669|P2|Overall Study|Adverse Event|3
5299996|NCT00433017|18269670|P1|Overall Study|Adverse Event|5
5299997|NCT00433004|18269686|P2|Overall Study|Lost to Follow-up|7
5299998|NCT00433004|18269687|P1|Overall Study|Lost to Follow-up|5
5299999|NCT00432991|18269699|P2|Overall Study|Protocol Violation|12
5300000|NCT00432991|18269700|P1|Overall Study|Protocol Violation|7
5300001|NCT00432965|18269712|P2|Overall Study|Incomplete Data|3
5300002|NCT00432965|18269713|P1|Overall Study|Incomplete Data|4
5300003|NCT00432965|18269712|P2|Overall Study|Exclusionary Methods|2
5300004|NCT00432965|18269713|P1|Overall Study|Exclusionary Methods|1
5300005|NCT00432965|18269712|P2|Overall Study|Death|4
5300006|NCT00432965|18269713|P1|Overall Study|Death|3
5300007|NCT00432965|18269712|P2|Overall Study|Adverse Event|19
5300008|NCT00432965|18269713|P1|Overall Study|Adverse Event|22
5300009|NCT00432965|18269712|P2|Overall Study|Non-compliance|0
5300010|NCT00432965|18269713|P1|Overall Study|Non-compliance|7
5300011|NCT00432965|18269712|P2|Overall Study|Lack of Efficacy|13
5300012|NCT00432965|18269713|P1|Overall Study|Lack of Efficacy|8
5300013|NCT00432965|18269712|P2|Overall Study|Physician Decision|13
5300014|NCT00432965|18269713|P1|Overall Study|Physician Decision|14
5300015|NCT00432965|18269712|P2|Overall Study|Withdrawal by Subject|13
5300016|NCT00432965|18269713|P1|Overall Study|Withdrawal by Subject|13
5300017|NCT00432965|18269712|P2|Overall Study|Lost to Follow-up|19
5300018|NCT00432965|18269713|P1|Overall Study|Lost to Follow-up|22
5300019|NCT00432835|18269721|P2|Overall Study|Adverse event: lead dislodgement.|7
5300020|NCT00432835|18269722|P1|Overall Study|Adverse event: lead dislodgement.|6
5300021|NCT00432809|18269735|P3|1 Year Follow-up|Withdrawal by Subject|1
5300022|NCT00432809|18269736|P2|1 Year Follow-up|Withdrawal by Subject|0
5300023|NCT00432809|18269737|P1|1 Year Follow-up|Withdrawal by Subject|7
5300024|NCT00432809|18269735|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
5300025|NCT00432809|18269736|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
5300026|NCT00432809|18269737|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
5300027|NCT00432744|18269810|P2|Months 7 - 12|Too disabled to score|1
5300028|NCT00432744|18269811|P1|Months 7 - 12|Too disabled to score|0
5300029|NCT00432744|18269810|P2|Months 7 - 12|Withdrawal by Subject|0
5300030|NCT00432744|18269811|P1|Months 7 - 12|Withdrawal by Subject|1
5300031|NCT00432744|18269810|P2|Months 0-6|Too disabled to score|0
5300032|NCT00432744|18269811|P1|Months 0-6|Too disabled to score|1
5300033|NCT00432744|18269810|P2|Months 0-6|Withdrawal by Subject|4
5300034|NCT00432744|18269811|P1|Months 0-6|Withdrawal by Subject|4
5300035|NCT00432679|18269823|P2|Overall Study|Withdrawal by Subject|2
5300036|NCT00432679|18269824|P1|Overall Study|Withdrawal by Subject|3
5300037|NCT00432679|18269823|P2|Overall Study|Adverse Event|1
5300038|NCT00432679|18269824|P1|Overall Study|Adverse Event|2
5300039|NCT00432666|18269848|P2|Open-Label Extension Period|Physician Decision|0
5300040|NCT00432666|18269849|P1|Open-Label Extension Period|Physician Decision|3
5300041|NCT00432666|18269848|P2|Open-Label Extension Period|Consent withdrawn|0
5300042|NCT00432666|18269849|P1|Open-Label Extension Period|Consent withdrawn|10
5300043|NCT00432666|18269848|P2|Open-Label Extension Period|Adverse Event|0
5300044|NCT00432666|18269849|P1|Open-Label Extension Period|Adverse Event|5
5300045|NCT00432666|18269848|P2|Open-Label Extension Period|Lack of Efficacy|0
5300046|NCT00432666|18269849|P1|Open-Label Extension Period|Lack of Efficacy|6
5300047|NCT00432666|18269848|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
5300048|NCT00432666|18269849|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
5300049|NCT00432666|18269848|P2|Main Period|Consent Withdrawn|0
5300050|NCT00432666|18269849|P1|Main Period|Consent Withdrawn|1
5300051|NCT00432666|18269848|P2|Main Period|Adverse Event|1
5300052|NCT00432666|18269849|P1|Main Period|Adverse Event|1
5300053|NCT00432562|18270022|P2|Overall Study|Death|0
5300054|NCT00432562|18270023|P1|Overall Study|Death|3
5300055|NCT00432380|18270075|P3|Overall Study|Adverse Event|0
5300056|NCT00432380|18270076|P2|Overall Study|Adverse Event|0
5300057|NCT00432380|18270077|P1|Overall Study|Adverse Event|1
5300058|NCT00432380|18270075|P3|Overall Study|Migrated/moved from study area|1
5300059|NCT00432380|18270076|P2|Overall Study|Migrated/moved from study area|4
5300060|NCT00432380|18270077|P1|Overall Study|Migrated/moved from study area|3
5300061|NCT00432276|18270130|P2|Overall Study|Other|3
5300062|NCT00432276|18270131|P1|Overall Study|Other|2
5300063|NCT00432276|18270130|P2|Overall Study|Physician Decision|8
5300064|NCT00432276|18270131|P1|Overall Study|Physician Decision|6
5300065|NCT00432276|18270130|P2|Overall Study|Withdrawal by Subject|20
5300066|NCT00432276|18270131|P1|Overall Study|Withdrawal by Subject|25
5300067|NCT00432276|18270130|P2|Overall Study|Lost to Follow-up|2
5300068|NCT00432276|18270131|P1|Overall Study|Lost to Follow-up|6
5300069|NCT00432276|18270130|P2|Overall Study|Protocol Violation|20
5300070|NCT00432276|18270131|P1|Overall Study|Protocol Violation|25
5300071|NCT00432276|18270130|P2|Overall Study|Adverse Event|16
5300072|NCT00432276|18270131|P1|Overall Study|Adverse Event|13
5300073|NCT00432276|18270130|P2|Overall Study|Hyperglycemic Rescue|87
5300074|NCT00432276|18270131|P1|Overall Study|Hyperglycemic Rescue|44
5300075|NCT00432237|18270221|P4|Overall Study|Lack of Qualifying Event|84
5300076|NCT00432237|18270222|P3|Overall Study|Lack of Qualifying Event|69
5300077|NCT00432237|18270223|P2|Overall Study|Lack of Qualifying Event|71
5300078|NCT00432237|18270224|P1|Overall Study|Lack of Qualifying Event|38
5300079|NCT00432237|18270221|P4|Overall Study|Withdrawal by Subject|11
5300080|NCT00432237|18270222|P3|Overall Study|Withdrawal by Subject|9
5300081|NCT00432237|18270223|P2|Overall Study|Withdrawal by Subject|6
5300082|NCT00432237|18270224|P1|Overall Study|Withdrawal by Subject|5
5300083|NCT00432237|18270221|P4|Overall Study|Protocol Violation|8
5300084|NCT00432237|18270222|P3|Overall Study|Protocol Violation|11
5300085|NCT00432237|18270223|P2|Overall Study|Protocol Violation|10
5300086|NCT00432237|18270224|P1|Overall Study|Protocol Violation|13
5300087|NCT00432237|18270221|P4|Overall Study|Pregnancy|0
5300088|NCT00432237|18270222|P3|Overall Study|Pregnancy|0
5300089|NCT00432237|18270223|P2|Overall Study|Pregnancy|1
5300090|NCT00432237|18270224|P1|Overall Study|Pregnancy|0
5300091|NCT00432237|18270221|P4|Overall Study|Physician Decision|1
5300092|NCT00432237|18270222|P3|Overall Study|Physician Decision|2
5300093|NCT00432237|18270223|P2|Overall Study|Physician Decision|3
5300094|NCT00432237|18270224|P1|Overall Study|Physician Decision|1
5300095|NCT00432237|18270221|P4|Overall Study|Lost to Follow-up|18
5300096|NCT00432237|18270222|P3|Overall Study|Lost to Follow-up|18
5300097|NCT00432237|18270223|P2|Overall Study|Lost to Follow-up|10
5300098|NCT00432237|18270224|P1|Overall Study|Lost to Follow-up|10
5300099|NCT00432237|18270221|P4|Overall Study|Lack of Efficacy|1
5300100|NCT00432237|18270222|P3|Overall Study|Lack of Efficacy|0
5300101|NCT00432237|18270223|P2|Overall Study|Lack of Efficacy|0
5300102|NCT00432237|18270224|P1|Overall Study|Lack of Efficacy|0
5300103|NCT00432237|18270221|P4|Overall Study|Adverse Event|1
5300104|NCT00432237|18270222|P3|Overall Study|Adverse Event|0
5300105|NCT00432237|18270223|P2|Overall Study|Adverse Event|0
5300106|NCT00432237|18270224|P1|Overall Study|Adverse Event|0
5300107|NCT00432172|18270266|P4|Overall Study|No treatment received|1
5300108|NCT00432172|18270267|P3|Overall Study|No treatment received|0
5300109|NCT00432172|18270268|P2|Overall Study|No treatment received|2
5300110|NCT00432172|18270269|P1|Overall Study|No treatment received|2
5300111|NCT00432172|18270266|P4|Overall Study|Withdrawal by Subject|2
5300112|NCT00432172|18270267|P3|Overall Study|Withdrawal by Subject|0
5300113|NCT00432172|18270268|P2|Overall Study|Withdrawal by Subject|1
5300114|NCT00432172|18270269|P1|Overall Study|Withdrawal by Subject|0
5300115|NCT00432172|18270266|P4|Overall Study|Disease progression|1
5300116|NCT00432172|18270267|P3|Overall Study|Disease progression|5
5300117|NCT00432172|18270268|P2|Overall Study|Disease progression|2
5300118|NCT00432172|18270269|P1|Overall Study|Disease progression|0
5300119|NCT00432172|18270266|P4|Overall Study|Adverse Event|3
5300120|NCT00432172|18270267|P3|Overall Study|Adverse Event|4
5300121|NCT00432172|18270268|P2|Overall Study|Adverse Event|2
5300122|NCT00432172|18270269|P1|Overall Study|Adverse Event|4
5300123|NCT00432172|18270266|P4|Overall Study|Physician Decision|0
5300124|NCT00432172|18270267|P3|Overall Study|Physician Decision|2
5300125|NCT00432172|18270268|P2|Overall Study|Physician Decision|0
5300126|NCT00432172|18270269|P1|Overall Study|Physician Decision|0
5300127|NCT00432159|18270294|P5|Overall Study|Missing NDI and/or neuro. assessment|7
5300128|NCT00432159|18270295|P4|Overall Study|Missing NDI and/or neuro. assessment|3
5300129|NCT00432159|18270296|P3|Overall Study|Missing NDI and/or neuro. assessment|1
5300130|NCT00432159|18270297|P2|Overall Study|Missing NDI and/or neuro. assessment|24
5300131|NCT00432159|18270298|P1|Overall Study|Missing NDI and/or neuro. assessment|13
5300132|NCT00432159|18270294|P5|Overall Study|Failure|3
5300133|NCT00432159|18270295|P4|Overall Study|Failure|2
5300134|NCT00432159|18270296|P3|Overall Study|Failure|3
5300135|NCT00432159|18270297|P2|Overall Study|Failure|5
5300136|NCT00432159|18270298|P1|Overall Study|Failure|9
5300137|NCT00432159|18270294|P5|Overall Study|Death|0
5300138|NCT00432159|18270295|P4|Overall Study|Death|0
5300139|NCT00432159|18270296|P3|Overall Study|Death|0
5300140|NCT00432159|18270297|P2|Overall Study|Death|1
5300141|NCT00432159|18270298|P1|Overall Study|Death|0
5300142|NCT00432042|18270405|P3|Overall Study|Lost to Follow-up|0
5300143|NCT00432042|18270406|P2|Overall Study|Lost to Follow-up|1
5300144|NCT00432042|18270407|P1|Overall Study|Lost to Follow-up|5
5300145|NCT00432042|18270405|P3|Overall Study|Withdrawal by Subject|2
5300146|NCT00432042|18270406|P2|Overall Study|Withdrawal by Subject|0
5300147|NCT00432042|18270407|P1|Overall Study|Withdrawal by Subject|0
5300148|NCT00432042|18270405|P3|Overall Study|Protocol Violation|0
5300149|NCT00432042|18270406|P2|Overall Study|Protocol Violation|0
5300150|NCT00432042|18270407|P1|Overall Study|Protocol Violation|2
5300151|NCT00431964|18270420|P2|Overall Study|Due to Unstable Health|1
5300152|NCT00431964|18270421|P1|Overall Study|Due to Unstable Health|0
5300153|NCT00431964|18270420|P2|Overall Study|Parental Consent Withdrawn|2
5300154|NCT00431964|18270421|P1|Overall Study|Parental Consent Withdrawn|0
5300155|NCT00431964|18270420|P2|Overall Study|Withdrawal by Subject|1
5300156|NCT00431964|18270421|P1|Overall Study|Withdrawal by Subject|2
5300157|NCT00431964|18270420|P2|Overall Study|Physician Decision|2
5300158|NCT00431964|18270421|P1|Overall Study|Physician Decision|2
5300159|NCT00431964|18270420|P2|Overall Study|Lost to Follow-up|2
5300160|NCT00431964|18270421|P1|Overall Study|Lost to Follow-up|1
5300161|NCT00431964|18270420|P2|Overall Study|Adverse Event|0
5300162|NCT00431964|18270421|P1|Overall Study|Adverse Event|1
5300163|NCT00431951|18270431|P4|Overall Study|Adverse Event|0
5300164|NCT00431951|18270432|P3|Overall Study|Adverse Event|1
5300165|NCT00431951|18270433|P2|Overall Study|Adverse Event|0
5300166|NCT00431951|18270434|P1|Overall Study|Adverse Event|0
5300167|NCT00431951|18270431|P4|Overall Study|Withdrawal by Subject|0
5300168|NCT00431951|18270432|P3|Overall Study|Withdrawal by Subject|0
5300169|NCT00431951|18270433|P2|Overall Study|Withdrawal by Subject|1
5300170|NCT00431951|18270434|P1|Overall Study|Withdrawal by Subject|0
5300171|NCT00431951|18270431|P4|Overall Study|Lost to Follow-up|0
5300172|NCT00431951|18270432|P3|Overall Study|Lost to Follow-up|0
5300173|NCT00431951|18270433|P2|Overall Study|Lost to Follow-up|1
5300174|NCT00431951|18270434|P1|Overall Study|Lost to Follow-up|0
5300175|NCT00431951|18270431|P4|Overall Study|Inability to follow study procedures|2
5300176|NCT00431951|18270432|P3|Overall Study|Inability to follow study procedures|1
5300177|NCT00431951|18270433|P2|Overall Study|Inability to follow study procedures|0
5300178|NCT00431951|18270434|P1|Overall Study|Inability to follow study procedures|1
5300179|NCT00431847|18270496|P5|Overall Study|Protocol Violation|1
5300180|NCT00431847|18270497|P4|Overall Study|Protocol Violation|0
5300181|NCT00431847|18270498|P3|Overall Study|Protocol Violation|0
5300182|NCT00431847|18270499|P2|Overall Study|Protocol Violation|0
5300183|NCT00431847|18270500|P1|Overall Study|Protocol Violation|0
5300184|NCT00431847|18270496|P5|Overall Study|completion of less than two study visits|0
5300185|NCT00431847|18270497|P4|Overall Study|completion of less than two study visits|14
5300186|NCT00431847|18270498|P3|Overall Study|completion of less than two study visits|4
5300187|NCT00431847|18270499|P2|Overall Study|completion of less than two study visits|3
5300188|NCT00431847|18270500|P1|Overall Study|completion of less than two study visits|6
5300189|NCT00431834|18270574|P1|Overall Study|Lost to Follow-up|1
5300190|NCT00431834|18270574|P1|Overall Study|Missed Endpoint Visit|2
5300191|NCT00431834|18270574|P1|Overall Study|Death|3
5300192|NCT00431834|18270574|P1|Overall Study|Withdrawal by Subject|7
5300193|NCT00431496|18270590|P1|Overall Study|Protocol-specified criteria|5
5300194|NCT00431496|18270590|P1|Overall Study|Withdrawal by Subject|2
5300195|NCT00431496|18270590|P1|Overall Study|Lost to Follow-up|1
5300196|NCT00431496|18270590|P1|Overall Study|Adverse Event|3
5300197|NCT00431444|18270601|P2|Overall Study|Administrative Problems|1
5300198|NCT00431444|18270602|P1|Overall Study|Administrative Problems|0
5300199|NCT00431444|18270601|P2|Overall Study|Lost to Follow-up|0
5300200|NCT00431444|18270602|P1|Overall Study|Lost to Follow-up|1
5300201|NCT00431444|18270601|P2|Overall Study|Withdrawal by Subject|1
5300202|NCT00431444|18270602|P1|Overall Study|Withdrawal by Subject|1
5300203|NCT00431444|18270601|P2|Overall Study|Adverse Event|1
5300204|NCT00431444|18270602|P1|Overall Study|Adverse Event|2
5300205|NCT00431444|18270601|P2|Overall Study|Protocol Violation|4
5300206|NCT00431444|18270602|P1|Overall Study|Protocol Violation|1
5300207|NCT00431067|18270642|P1|Overall Study|Non-compliance,lost to follow-up|2
5300208|NCT00431067|18270642|P1|Overall Study|Progressive disease|30
5300209|NCT00431067|18270642|P1|Overall Study|Other Adverse Event|9
5300210|NCT00430989|18270667|P2|Overall Study|Not eligible|6
5300211|NCT00430989|18270668|P1|Overall Study|Not eligible|13
5300212|NCT00430989|18270667|P2|Overall Study|Protocol Violation|37
5300213|NCT00430989|18270668|P1|Overall Study|Protocol Violation|30
5300214|NCT00430989|18270667|P2|Overall Study|Withdrawal by Subject|14
5300215|NCT00430989|18270668|P1|Overall Study|Withdrawal by Subject|15
5300216|NCT00430989|18270667|P2|Overall Study|Lost to Follow-up|3
5300217|NCT00430989|18270668|P1|Overall Study|Lost to Follow-up|2
5300218|NCT00430950|18270688|P2|Overall Study|concomitant medication,etc.|7
5300219|NCT00430950|18270689|P1|Overall Study|concomitant medication,etc.|5
5300220|NCT00430950|18270688|P2|Overall Study|Withdrawal by Subject|0
5300221|NCT00430950|18270689|P1|Overall Study|Withdrawal by Subject|1
5300222|NCT00430950|18270688|P2|Overall Study|Adverse Event|6
5300223|NCT00430950|18270689|P1|Overall Study|Adverse Event|7
5300224|NCT00430937|18270703|P2|Overall Study|Unable to classify|1
5300225|NCT00430937|18270704|P1|Overall Study|Unable to classify|0
5300226|NCT00430937|18270703|P2|Overall Study|Protocol discontinuation criteria met|2
5300227|NCT00430937|18270704|P1|Overall Study|Protocol discontinuation criteria met|1
5300228|NCT00430937|18270703|P2|Overall Study|Administrative reasons|0
5300229|NCT00430937|18270704|P1|Overall Study|Administrative reasons|1
5300230|NCT00430937|18270703|P2|Overall Study|Inappropriate enrollment|1
5300231|NCT00430937|18270704|P1|Overall Study|Inappropriate enrollment|2
5300232|NCT00430937|18270703|P2|Overall Study|Lack of Efficacy|5
5300233|NCT00430937|18270704|P1|Overall Study|Lack of Efficacy|6
5300234|NCT00430937|18270703|P2|Overall Study|Protocol Violation|2
5300235|NCT00430937|18270704|P1|Overall Study|Protocol Violation|3
5300236|NCT00430937|18270703|P2|Overall Study|Withdrawal by Subject|2
5300237|NCT00430937|18270704|P1|Overall Study|Withdrawal by Subject|5
5300238|NCT00430937|18270703|P2|Overall Study|Lost to Follow-up|6
5300239|NCT00430937|18270704|P1|Overall Study|Lost to Follow-up|6
5300240|NCT00430937|18270703|P2|Overall Study|Death|1
5300241|NCT00430937|18270704|P1|Overall Study|Death|0
5300242|NCT00430937|18270703|P2|Overall Study|Adverse Event|8
5300243|NCT00430937|18270704|P1|Overall Study|Adverse Event|3
5300244|NCT00430781|18270715|P3|End-of-Study Analysis; 28 July 2011|Other|0
5300245|NCT00430781|18270716|P2|End-of-Study Analysis; 28 July 2011|Other|1
5300246|NCT00430781|18270717|P1|End-of-Study Analysis; 28 July 2011|Other|4
5300247|NCT00430781|18270715|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
5300248|NCT00430781|18270716|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
5300249|NCT00430781|18270717|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
5300250|NCT00430781|18270715|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
5300251|NCT00430781|18270716|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
5300252|NCT00430781|18270717|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
5300253|NCT00430781|18270715|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
5300254|NCT00430781|18270716|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
5300255|NCT00430781|18270717|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
5300256|NCT00430781|18270715|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
5300257|NCT00430781|18270716|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
5300258|NCT00430781|18270717|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
5300259|NCT00430781|18270715|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
5300260|NCT00430781|18270716|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
5300261|NCT00430781|18270717|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
5300262|NCT00430781|18270715|P3|Final Analysis; 31 July 2008|Ongoing|32
5300263|NCT00430781|18270716|P2|Final Analysis; 31 July 2008|Ongoing|29
5300264|NCT00430781|18270717|P1|Final Analysis; 31 July 2008|Ongoing|0
5300265|NCT00430781|18270715|P3|Final Analysis; 31 July 2008|Other|0
5300266|NCT00430781|18270716|P2|Final Analysis; 31 July 2008|Other|1
5300267|NCT00430781|18270717|P1|Final Analysis; 31 July 2008|Other|0
5300268|NCT00430781|18270715|P3|Final Analysis; 31 July 2008|Physician Decision|6
5300269|NCT00430781|18270716|P2|Final Analysis; 31 July 2008|Physician Decision|6
5300270|NCT00430781|18270717|P1|Final Analysis; 31 July 2008|Physician Decision|0
5300271|NCT00430781|18270715|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
5300272|NCT00430781|18270716|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
5300273|NCT00430781|18270717|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
5300274|NCT00430781|18270715|P3|Final Analysis; 31 July 2008|Protocol Violation|0
5300275|NCT00430781|18270716|P2|Final Analysis; 31 July 2008|Protocol Violation|1
5300276|NCT00430781|18270717|P1|Final Analysis; 31 July 2008|Protocol Violation|0
5300277|NCT00430781|18270715|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
5300278|NCT00430781|18270716|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
5300279|NCT00430781|18270717|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
5300280|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Ongoing|25
5300281|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Ongoing|20
5300282|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Ongoing|23
5300283|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Physician Decision|3
5300284|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Physician Decision|3
5300285|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Physician Decision|2
5300286|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
5300287|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
5300288|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
5300289|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Death|0
5300290|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Death|1
5300291|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Death|0
5300292|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Disease Progression|22
5300293|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Disease Progression|30
5300294|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Disease Progression|16
5300295|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
5300296|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
5300297|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
5300298|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
5300299|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
5300300|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
5300301|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
5300302|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
5300303|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
5300304|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
5300305|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
5300306|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
5300307|NCT00430781|18270715|P3|Interim Analysis; 11 February 2008|Adverse Event|7
5300308|NCT00430781|18270716|P2|Interim Analysis; 11 February 2008|Adverse Event|3
5300309|NCT00430781|18270717|P1|Interim Analysis; 11 February 2008|Adverse Event|10
5300310|NCT00430755|18270759|P1|Overall Study|Withdrawal by Subject|53
5300311|NCT00430716|18270766|P3|Open Label Phase|Study terminated by sponsor|4
5300312|NCT00430716|18270767|P2|Open Label Phase|Study terminated by sponsor|5
5300313|NCT00430716|18270768|P1|Open Label Phase|Study terminated by sponsor|4
5300314|NCT00430716|18270766|P3|Open Label Phase|Protocol Violation|0
5300315|NCT00430716|18270767|P2|Open Label Phase|Protocol Violation|0
5300316|NCT00430716|18270768|P1|Open Label Phase|Protocol Violation|1
5300317|NCT00430716|18270766|P3|Open Label Phase|Other|1
5300318|NCT00430716|18270767|P2|Open Label Phase|Other|1
5300319|NCT00430716|18270768|P1|Open Label Phase|Other|3
5300320|NCT00430716|18270766|P3|Open Label Phase|No longer willing to participate|1
5300321|NCT00430716|18270767|P2|Open Label Phase|No longer willing to participate|1
5300322|NCT00430716|18270768|P1|Open Label Phase|No longer willing to participate|0
5300323|NCT00430716|18270766|P3|Open Label Phase|Lost to Follow-up|1
5300324|NCT00430716|18270767|P2|Open Label Phase|Lost to Follow-up|0
5300325|NCT00430716|18270768|P1|Open Label Phase|Lost to Follow-up|1
5300326|NCT00430716|18270766|P3|Double Blind Phase|Not treated|0
5300327|NCT00430716|18270767|P2|Double Blind Phase|Not treated|0
5300328|NCT00430716|18270768|P1|Double Blind Phase|Not treated|1
5300329|NCT00430716|18270766|P3|Double Blind Phase|Adverse Event|3
5300330|NCT00430716|18270767|P2|Double Blind Phase|Adverse Event|1
5300331|NCT00430716|18270768|P1|Double Blind Phase|Adverse Event|1
5300332|NCT00430716|18270766|P3|Double Blind Phase|Study terminated by sponsor|2
5300333|NCT00430716|18270767|P2|Double Blind Phase|Study terminated by sponsor|1
5300334|NCT00430716|18270768|P1|Double Blind Phase|Study terminated by sponsor|1
5300335|NCT00430716|18270766|P3|Double Blind Phase|Other|0
5300336|NCT00430716|18270767|P2|Double Blind Phase|Other|2
5300337|NCT00430716|18270768|P1|Double Blind Phase|Other|0
5300338|NCT00430716|18270766|P3|Double Blind Phase|No longer willing to participate|1
5300339|NCT00430716|18270767|P2|Double Blind Phase|No longer willing to participate|1
5300340|NCT00430716|18270768|P1|Double Blind Phase|No longer willing to participate|2
5300341|NCT00430716|18270766|P3|Double Blind Phase|Death|0
5300342|NCT00430716|18270767|P2|Double Blind Phase|Death|0
5300343|NCT00430716|18270768|P1|Double Blind Phase|Death|1
5300344|NCT00430677|18270800|P3|Long-term Extension Period|Poor compliance/noncompliance|0
5300345|NCT00430677|18270801|P2|Long-term Extension Period|Poor compliance/noncompliance|0
5300346|NCT00430677|18270802|P1|Long-term Extension Period|Poor compliance/noncompliance|1
5300347|NCT00430677|18270800|P3|Long-term Extension Period|Other|1
5300348|NCT00430677|18270801|P2|Long-term Extension Period|Other|1
5300349|NCT00430677|18270802|P1|Long-term Extension Period|Other|2
5300350|NCT00430677|18270800|P3|Long-term Extension Period|Administrative reason by sponsor|46
5300351|NCT00430677|18270801|P2|Long-term Extension Period|Administrative reason by sponsor|49
5300352|NCT00430677|18270802|P1|Long-term Extension Period|Administrative reason by sponsor|41
5300353|NCT00430677|18270800|P3|Long-term Extension Period|Pregnancy|0
5300354|NCT00430677|18270801|P2|Long-term Extension Period|Pregnancy|1
5300355|NCT00430677|18270802|P1|Long-term Extension Period|Pregnancy|1
5300356|NCT00430677|18270800|P3|Long-term Extension Period|Withdrawal by Subject|2
5300357|NCT00430677|18270801|P2|Long-term Extension Period|Withdrawal by Subject|1
5300358|NCT00430677|18270802|P1|Long-term Extension Period|Withdrawal by Subject|5
5300359|NCT00430677|18270800|P3|Long-term Extension Period|Lost to Follow-up|1
5300360|NCT00430677|18270801|P2|Long-term Extension Period|Lost to Follow-up|1
5300361|NCT00430677|18270802|P1|Long-term Extension Period|Lost to Follow-up|1
5300362|NCT00430677|18270800|P3|Long-term Extension Period|Lack of Efficacy|8
5300363|NCT00430677|18270801|P2|Long-term Extension Period|Lack of Efficacy|3
5300364|NCT00430677|18270802|P1|Long-term Extension Period|Lack of Efficacy|5
5300365|NCT00430677|18270800|P3|Long-term Extension Period|Adverse Event|5
5300366|NCT00430677|18270801|P2|Long-term Extension Period|Adverse Event|2
5300367|NCT00430677|18270802|P1|Long-term Extension Period|Adverse Event|3
5300368|NCT00430677|18270800|P3|Long-term Extension Period|Death|0
5300369|NCT00430677|18270801|P2|Long-term Extension Period|Death|0
5300370|NCT00430677|18270802|P1|Long-term Extension Period|Death|1
5300371|NCT00430677|18270800|P3|Short-term Period|Pregnancy|0
5300372|NCT00430677|18270801|P2|Short-term Period|Pregnancy|2
5300373|NCT00430677|18270802|P1|Short-term Period|Pregnancy|0
5300374|NCT00430677|18270800|P3|Short-term Period|Poor compliance/ noncompliance|0
5300375|NCT00430677|18270801|P2|Short-term Period|Poor compliance/ noncompliance|1
5300376|NCT00430677|18270802|P1|Short-term Period|Poor compliance/ noncompliance|0
5300377|NCT00430677|18270800|P3|Short-term Period|Participant no longer met study criteria|2
5300378|NCT00430677|18270801|P2|Short-term Period|Participant no longer met study criteria|1
5300379|NCT00430677|18270802|P1|Short-term Period|Participant no longer met study criteria|1
5300380|NCT00430677|18270800|P3|Short-term Period|Withdrawal by Subject|2
5300381|NCT00430677|18270801|P2|Short-term Period|Withdrawal by Subject|1
5300382|NCT00430677|18270802|P1|Short-term Period|Withdrawal by Subject|1
5300383|NCT00430677|18270800|P3|Short-term Period|Lack of Efficacy|4
5300384|NCT00430677|18270801|P2|Short-term Period|Lack of Efficacy|6
5300385|NCT00430677|18270802|P1|Short-term Period|Lack of Efficacy|5
5300386|NCT00430677|18270800|P3|Short-term Period|Adverse Event|9
5300387|NCT00430677|18270801|P2|Short-term Period|Adverse Event|13
5300388|NCT00430677|18270802|P1|Short-term Period|Adverse Event|15
5300389|NCT00430677|18270800|P3|Short-term Period|Death|5
5300390|NCT00430677|18270801|P2|Short-term Period|Death|1
5300391|NCT00430677|18270802|P1|Short-term Period|Death|1
5300392|NCT00430638|18270925|P2|Overall Study|Other|2
5300393|NCT00430638|18270926|P1|Overall Study|Other|2
5300394|NCT00430638|18270925|P2|Overall Study|Non-compliant|1
5300395|NCT00430638|18270926|P1|Overall Study|Non-compliant|2
5300396|NCT00430638|18270925|P2|Overall Study|Withdrawal by Subject|6
5300397|NCT00430638|18270926|P1|Overall Study|Withdrawal by Subject|4
5300398|NCT00430638|18270925|P2|Overall Study|Protocol Violation|4
5300399|NCT00430638|18270926|P1|Overall Study|Protocol Violation|6
5300400|NCT00430638|18270925|P2|Overall Study|Lost to Follow-up|7
5300401|NCT00430638|18270926|P1|Overall Study|Lost to Follow-up|1
5300402|NCT00430638|18270925|P2|Overall Study|Uncontrolled blood pressure|13
5300403|NCT00430638|18270926|P1|Overall Study|Uncontrolled blood pressure|48
5300404|NCT00430638|18270925|P2|Overall Study|Adverse Event|15
5300405|NCT00430638|18270926|P1|Overall Study|Adverse Event|15
5300406|NCT00430573|18270961|P1|Overall Study|Withdrawal by Subject|5
5300407|NCT00430521|18270974|P8|Overall Study|Withdrawal by Subject|2
5300408|NCT00430521|18270975|P7|Overall Study|Withdrawal by Subject|0
5300409|NCT00430521|18270976|P6|Overall Study|Withdrawal by Subject|0
5300410|NCT00430521|18270977|P5|Overall Study|Withdrawal by Subject|0
5300411|NCT00430521|18270978|P4|Overall Study|Withdrawal by Subject|3
5300412|NCT00430521|18270979|P3|Overall Study|Withdrawal by Subject|0
5300413|NCT00430521|18270980|P2|Overall Study|Withdrawal by Subject|1
5300414|NCT00430521|18270981|P1|Overall Study|Withdrawal by Subject|3
5300415|NCT00430521|18270974|P8|Overall Study|Protocol Violation|0
5300416|NCT00430521|18270975|P7|Overall Study|Protocol Violation|0
5300417|NCT00430521|18270976|P6|Overall Study|Protocol Violation|0
5300418|NCT00430521|18270977|P5|Overall Study|Protocol Violation|0
5300419|NCT00430521|18270978|P4|Overall Study|Protocol Violation|0
5300420|NCT00430521|18270979|P3|Overall Study|Protocol Violation|0
5300421|NCT00430521|18270980|P2|Overall Study|Protocol Violation|0
5300422|NCT00430521|18270981|P1|Overall Study|Protocol Violation|1
5300423|NCT00430521|18270974|P8|Overall Study|Vaccine Expired|0
5300424|NCT00430521|18270975|P7|Overall Study|Vaccine Expired|0
5300425|NCT00430521|18270976|P6|Overall Study|Vaccine Expired|1
5300426|NCT00430521|18270977|P5|Overall Study|Vaccine Expired|0
5300427|NCT00430521|18270978|P4|Overall Study|Vaccine Expired|0
5300428|NCT00430521|18270979|P3|Overall Study|Vaccine Expired|0
5300429|NCT00430521|18270980|P2|Overall Study|Vaccine Expired|0
5300430|NCT00430521|18270981|P1|Overall Study|Vaccine Expired|0
5300431|NCT00430521|18270974|P8|Overall Study|Pregnancy|0
5300432|NCT00430521|18270975|P7|Overall Study|Pregnancy|1
5300433|NCT00430521|18270976|P6|Overall Study|Pregnancy|0
5300434|NCT00430521|18270977|P5|Overall Study|Pregnancy|0
5300435|NCT00430521|18270978|P4|Overall Study|Pregnancy|0
5300436|NCT00430521|18270979|P3|Overall Study|Pregnancy|0
5300437|NCT00430521|18270980|P2|Overall Study|Pregnancy|0
5300438|NCT00430521|18270981|P1|Overall Study|Pregnancy|0
5300439|NCT00430521|18270974|P8|Overall Study|Lost to Follow-up|10
5300440|NCT00430521|18270975|P7|Overall Study|Lost to Follow-up|8
5300441|NCT00430521|18270976|P6|Overall Study|Lost to Follow-up|2
5300442|NCT00430521|18270977|P5|Overall Study|Lost to Follow-up|5
5300443|NCT00430521|18270978|P4|Overall Study|Lost to Follow-up|5
5300444|NCT00430521|18270979|P3|Overall Study|Lost to Follow-up|3
5300445|NCT00430521|18270980|P2|Overall Study|Lost to Follow-up|8
5300446|NCT00430521|18270981|P1|Overall Study|Lost to Follow-up|7
5300447|NCT00430521|18270974|P8|Overall Study|Adverse Event|0
5300448|NCT00430521|18270975|P7|Overall Study|Adverse Event|1
5300449|NCT00430521|18270976|P6|Overall Study|Adverse Event|2
5300450|NCT00430521|18270977|P5|Overall Study|Adverse Event|0
5300451|NCT00430521|18270978|P4|Overall Study|Adverse Event|0
5300452|NCT00430521|18270979|P3|Overall Study|Adverse Event|0
5300453|NCT00430521|18270980|P2|Overall Study|Adverse Event|0
5300454|NCT00430521|18270981|P1|Overall Study|Adverse Event|0
5300455|NCT00430508|18271223|P4|Overall Study|Other|0
5300456|NCT00430508|18271224|P3|Overall Study|Other|3
5300457|NCT00430508|18271225|P2|Overall Study|Other|1
5300458|NCT00430508|18271226|P1|Overall Study|Other|1
5300459|NCT00430508|18271223|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
5300460|NCT00430508|18271224|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
5300461|NCT00430508|18271225|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
5300462|NCT00430508|18271226|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
5300463|NCT00430508|18271223|P4|Overall Study|responder at visit 4|0
5300464|NCT00430508|18271224|P3|Overall Study|responder at visit 4|2
5300465|NCT00430508|18271225|P2|Overall Study|responder at visit 4|0
5300466|NCT00430508|18271226|P1|Overall Study|responder at visit 4|0
5300467|NCT00430508|18271223|P4|Overall Study|Withdrawal by Subject|1
5300468|NCT00430508|18271224|P3|Overall Study|Withdrawal by Subject|1
5300469|NCT00430508|18271225|P2|Overall Study|Withdrawal by Subject|1
5300470|NCT00430508|18271226|P1|Overall Study|Withdrawal by Subject|0
5300471|NCT00430508|18271223|P4|Overall Study|Adverse Event|3
5300472|NCT00430508|18271224|P3|Overall Study|Adverse Event|5
5300473|NCT00430508|18271225|P2|Overall Study|Adverse Event|3
5300474|NCT00430508|18271226|P1|Overall Study|Adverse Event|2
5300475|NCT00430495|18271264|P4|Overall Study|Randomized but not Treated|0
5300476|NCT00430495|18271265|P3|Overall Study|Randomized but not Treated|0
5300477|NCT00430495|18271266|P2|Overall Study|Randomized but not Treated|0
5300478|NCT00430495|18271267|P1|Overall Study|Randomized but not Treated|2
5300479|NCT00430495|18271264|P4|Overall Study|Other|4
5300480|NCT00430495|18271265|P3|Overall Study|Other|5
5300481|NCT00430495|18271266|P2|Overall Study|Other|2
5300482|NCT00430495|18271267|P1|Overall Study|Other|8
5300483|NCT00430495|18271264|P4|Overall Study|Disease Progression|0
5300484|NCT00430495|18271265|P3|Overall Study|Disease Progression|0
5300485|NCT00430495|18271266|P2|Overall Study|Disease Progression|1
5300486|NCT00430495|18271267|P1|Overall Study|Disease Progression|1
5300487|NCT00430495|18271264|P4|Overall Study|Protocol Violation|0
5300488|NCT00430495|18271265|P3|Overall Study|Protocol Violation|1
5300489|NCT00430495|18271266|P2|Overall Study|Protocol Violation|0
5300490|NCT00430495|18271267|P1|Overall Study|Protocol Violation|1
5300491|NCT00430495|18271264|P4|Overall Study|Lost to Follow-up|0
5300492|NCT00430495|18271265|P3|Overall Study|Lost to Follow-up|4
5300493|NCT00430495|18271266|P2|Overall Study|Lost to Follow-up|1
5300494|NCT00430495|18271267|P1|Overall Study|Lost to Follow-up|0
5300495|NCT00430495|18271264|P4|Overall Study|Death|0
5300496|NCT00430495|18271265|P3|Overall Study|Death|1
5300497|NCT00430495|18271266|P2|Overall Study|Death|0
5300498|NCT00430495|18271267|P1|Overall Study|Death|0
5300499|NCT00430495|18271264|P4|Overall Study|Adverse Event|0
5300500|NCT00430495|18271265|P3|Overall Study|Adverse Event|2
5300501|NCT00430495|18271266|P2|Overall Study|Adverse Event|3
5300502|NCT00430495|18271267|P1|Overall Study|Adverse Event|2
5300503|NCT00430482|18271307|P2|Completed Treatment|Insufficient Treatment|11
5300504|NCT00430482|18271308|P1|Completed Treatment|Insufficient Treatment|7
5300505|NCT00430352|18271316|P1|Overall Study|Other|48
5300506|NCT00430352|18271316|P1|Overall Study|Death|5
5300507|NCT00430352|18271316|P1|Overall Study|Adverse Event|16
5300508|NCT00430352|18271316|P1|Overall Study|Withdrawal by Subject|11
5300509|NCT00430352|18271316|P1|Overall Study|Disease progression|58
5300510|NCT00430300|18271334|P4|Overall Study|Other|1
5300511|NCT00430300|18271335|P3|Overall Study|Other|0
5300512|NCT00430300|18271336|P2|Overall Study|Other|0
5300513|NCT00430300|18271337|P1|Overall Study|Other|0
5300514|NCT00430300|18271334|P4|Overall Study|Laboratory abnormality|0
5300515|NCT00430300|18271335|P3|Overall Study|Laboratory abnormality|0
5300516|NCT00430300|18271336|P2|Overall Study|Laboratory abnormality|0
5300517|NCT00430300|18271337|P1|Overall Study|Laboratory abnormality|1
5300518|NCT00430300|18271334|P4|Overall Study|Withdrawal by Subject|0
5300519|NCT00430300|18271335|P3|Overall Study|Withdrawal by Subject|5
5300520|NCT00430300|18271336|P2|Overall Study|Withdrawal by Subject|0
5300521|NCT00430300|18271337|P1|Overall Study|Withdrawal by Subject|1
5300522|NCT00430300|18271334|P4|Overall Study|Adverse Event|1
5300523|NCT00430300|18271335|P3|Overall Study|Adverse Event|1
5300524|NCT00430300|18271336|P2|Overall Study|Adverse Event|2
5300525|NCT00430300|18271337|P1|Overall Study|Adverse Event|0
5300526|NCT00430248|18271442|P3|Overall Study|Reason Not Specified|11
5300527|NCT00430248|18271443|P2|Overall Study|Reason Not Specified|8
5300528|NCT00430248|18271444|P1|Overall Study|Reason Not Specified|8
5300529|NCT00430248|18271442|P3|Overall Study|Gout Flare|2
5300530|NCT00430248|18271443|P2|Overall Study|Gout Flare|7
5300531|NCT00430248|18271444|P1|Overall Study|Gout Flare|3
5300532|NCT00430248|18271442|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5300533|NCT00430248|18271443|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
5300534|NCT00430248|18271444|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5300535|NCT00430248|18271442|P3|Overall Study|Withdrawal by Subject|16
5300536|NCT00430248|18271443|P2|Overall Study|Withdrawal by Subject|20
5300537|NCT00430248|18271444|P1|Overall Study|Withdrawal by Subject|14
5300538|NCT00430248|18271442|P3|Overall Study|Therapeutic Failure|1
5300539|NCT00430248|18271443|P2|Overall Study|Therapeutic Failure|1
5300540|NCT00430248|18271444|P1|Overall Study|Therapeutic Failure|1
5300541|NCT00430248|18271442|P3|Overall Study|Lost to Follow-up|28
5300542|NCT00430248|18271443|P2|Overall Study|Lost to Follow-up|33
5300543|NCT00430248|18271444|P1|Overall Study|Lost to Follow-up|28
5300544|NCT00430248|18271442|P3|Overall Study|Personal Reasons|9
5300545|NCT00430248|18271443|P2|Overall Study|Personal Reasons|24
5300546|NCT00430248|18271444|P1|Overall Study|Personal Reasons|12
5300547|NCT00430248|18271442|P3|Overall Study|Protocol Violation|4
5300548|NCT00430248|18271443|P2|Overall Study|Protocol Violation|2
5300549|NCT00430248|18271444|P1|Overall Study|Protocol Violation|10
5300550|NCT00430248|18271442|P3|Overall Study|Adverse Event|64
5300551|NCT00430248|18271443|P2|Overall Study|Adverse Event|61
5300552|NCT00430248|18271444|P1|Overall Study|Adverse Event|49
5300553|NCT00430092|18271512|P3|Overall Study|Withdrawal by Subject|1
5300554|NCT00430092|18271513|P2|Overall Study|Withdrawal by Subject|1
5300555|NCT00430092|18271514|P1|Overall Study|Withdrawal by Subject|0
5300556|NCT00430092|18271512|P3|Overall Study|Protocol Violation|1
5300557|NCT00430092|18271513|P2|Overall Study|Protocol Violation|1
5300558|NCT00430092|18271514|P1|Overall Study|Protocol Violation|0
5300559|NCT00430092|18271512|P3|Overall Study|Lost to Follow-up|0
5300560|NCT00430092|18271513|P2|Overall Study|Lost to Follow-up|0
5300561|NCT00430092|18271514|P1|Overall Study|Lost to Follow-up|1
5300562|NCT00430092|18271512|P3|Overall Study|Lack of Efficacy|54
5300563|NCT00430092|18271513|P2|Overall Study|Lack of Efficacy|2
5300564|NCT00430092|18271514|P1|Overall Study|Lack of Efficacy|5
5300565|NCT00430092|18271512|P3|Overall Study|Adverse Event|1
5300566|NCT00430092|18271513|P2|Overall Study|Adverse Event|0
5300567|NCT00430092|18271514|P1|Overall Study|Adverse Event|0
5300568|NCT00430027|18271519|P1|Overall Study|Study terminated|8
5300569|NCT00429923|18271536|P3|Overall Study|Early Termination|0
5300570|NCT00429923|18271537|P2|Overall Study|Early Termination|1
5300571|NCT00429923|18271538|P1|Overall Study|Early Termination|0
5300572|NCT00429923|18271536|P3|Overall Study|Withdrew Consent|1
5300573|NCT00429923|18271537|P2|Overall Study|Withdrew Consent|0
5300574|NCT00429923|18271538|P1|Overall Study|Withdrew Consent|1
5300575|NCT00429923|18271536|P3|Overall Study|Lost to Follow-up|2
5300576|NCT00429923|18271537|P2|Overall Study|Lost to Follow-up|0
5300577|NCT00429923|18271538|P1|Overall Study|Lost to Follow-up|0
5300578|NCT00429923|18271536|P3|Overall Study|Lack of Efficacy|33
5300579|NCT00429923|18271537|P2|Overall Study|Lack of Efficacy|1
5300580|NCT00429923|18271538|P1|Overall Study|Lack of Efficacy|4
5300581|NCT00429923|18271536|P3|Overall Study|Adverse Event|3
5300582|NCT00429923|18271537|P2|Overall Study|Adverse Event|2
5300583|NCT00429923|18271538|P1|Overall Study|Adverse Event|0
5300584|NCT00429858|18271543|P1|Overall Study|Study Termination|1
5300585|NCT00429858|18271543|P1|Overall Study|Withdrawal by Subject|1
5300586|NCT00429793|18271554|P1|Overall Study|Non-measurable|1
5300587|NCT00429793|18271554|P1|Overall Study|Never treated|1
5300588|NCT00429793|18271554|P1|Overall Study|Required test not done|1
5300589|NCT00429793|18271554|P1|Overall Study|Improper pre-protocol treatment|3
5300590|NCT00429663|18271581|P2|Overall Study|Death|0
5300591|NCT00429663|18271582|P1|Overall Study|Death|4
5300592|NCT00429663|18271581|P2|Overall Study|Withdrawal by Subject|5
5300593|NCT00429663|18271582|P1|Overall Study|Withdrawal by Subject|2
5300594|NCT00429663|18271581|P2|Overall Study|Physician Decision|3
5300595|NCT00429663|18271582|P1|Overall Study|Physician Decision|6
5300596|NCT00429663|18271581|P2|Overall Study|Lost to Follow-up|31
5300597|NCT00429663|18271582|P1|Overall Study|Lost to Follow-up|24
5300598|NCT00429572|18271596|P1|Overall Study|Disease progression|1
5300599|NCT00429494|18271608|P1|Overall Study|Death|6
5300600|NCT00429494|18271608|P1|Overall Study|Withdrawal by Subject|9
5300601|NCT00429416|18271612|P1|Overall Study|Death|1
5300602|NCT00429364|18271631|P2|Overall Study|Pregnancy|1
5300603|NCT00429364|18271632|P1|Overall Study|Pregnancy|0
5300604|NCT00429364|18271631|P2|Overall Study|Underwent aortic root surgery|18
5300605|NCT00429364|18271632|P1|Overall Study|Underwent aortic root surgery|10
5300606|NCT00429364|18271631|P2|Overall Study|Death|1
5300607|NCT00429364|18271632|P1|Overall Study|Death|0
5300608|NCT00429364|18271631|P2|Overall Study|Lost to Follow-up|6
5300609|NCT00429364|18271632|P1|Overall Study|Lost to Follow-up|7
5300610|NCT00429364|18271631|P2|Overall Study|Physician Decision|2
5300611|NCT00429364|18271632|P1|Overall Study|Physician Decision|4
5300612|NCT00429364|18271631|P2|Overall Study|Withdrawal by Subject|5
5300613|NCT00429364|18271632|P1|Overall Study|Withdrawal by Subject|11
5300614|NCT00429299|18271691|P3|Overall Study|Withdrawal by Subject|3
5300615|NCT00429299|18271692|P2|Overall Study|Withdrawal by Subject|1
5300616|NCT00429299|18271693|P1|Overall Study|Withdrawal by Subject|0
5300617|NCT00429299|18271691|P3|Overall Study|Protocol Violation|0
5300618|NCT00429299|18271692|P2|Overall Study|Protocol Violation|0
5300619|NCT00429299|18271693|P1|Overall Study|Protocol Violation|1
5300620|NCT00429299|18271691|P3|Overall Study|Adverse Event|1
5300621|NCT00429299|18271692|P2|Overall Study|Adverse Event|5
5300622|NCT00429299|18271693|P1|Overall Study|Adverse Event|2
5300623|NCT00429299|18271691|P3|Overall Study|Disease Progression|0
5300624|NCT00429299|18271692|P2|Overall Study|Disease Progression|1
5300625|NCT00429299|18271693|P1|Overall Study|Disease Progression|1
5300626|NCT00429273|18271725|P3|Overall Study|Adverse Event|2
5300627|NCT00429273|18271726|P2|Overall Study|Adverse Event|1
5300628|NCT00429273|18271727|P1|Overall Study|Adverse Event|1
5300629|NCT00429273|18271725|P3|Overall Study|Physician Decision|5
5300630|NCT00429273|18271726|P2|Overall Study|Physician Decision|5
5300631|NCT00429273|18271727|P1|Overall Study|Physician Decision|6
5300632|NCT00429273|18271725|P3|Overall Study|Lost to Follow-up|2
5300633|NCT00429273|18271726|P2|Overall Study|Lost to Follow-up|2
5300634|NCT00429273|18271727|P1|Overall Study|Lost to Follow-up|1
5300635|NCT00429182|18271735|P1|Overall Study|Not eligible|5
5300636|NCT00429182|18271735|P1|Overall Study|Not evaluable, Disease Progression|2
5300637|NCT00429169|18271742|P2|Overall Study|Ineligibility discovered after entry|1
5300638|NCT00429169|18271743|P1|Overall Study|Ineligibility discovered after entry|2
5300639|NCT00429169|18271742|P2|Overall Study|Lost to Follow-up|1
5300640|NCT00429169|18271743|P1|Overall Study|Lost to Follow-up|0
5300641|NCT00429104|18271763|P1|Overall Study|Protocol Violation|1
5300642|NCT00429026|18271768|P1|Overall Study|Inevaluable for response.|40
5300643|NCT00428948|18271795|P2|Overall Study|Protocol Deviation|1
5300644|NCT00428948|18271796|P1|Overall Study|Protocol Deviation|1
5300645|NCT00428948|18271795|P2|Overall Study|Subject Withdrew Consent|30
5300646|NCT00428948|18271796|P1|Overall Study|Subject Withdrew Consent|50
5300647|NCT00428948|18271795|P2|Overall Study|Investigator Withdrew Subject|4
5300648|NCT00428948|18271796|P1|Overall Study|Investigator Withdrew Subject|3
5300649|NCT00428948|18271795|P2|Overall Study|Subject Met Withdrawal Criteria|0
5300650|NCT00428948|18271796|P1|Overall Study|Subject Met Withdrawal Criteria|4
5300651|NCT00428948|18271795|P2|Overall Study|Adverse Event|24
5300652|NCT00428948|18271796|P1|Overall Study|Adverse Event|148
5300653|NCT00428948|18271795|P2|Overall Study|Lost to Follow-up|8
5300654|NCT00428948|18271796|P1|Overall Study|Lost to Follow-up|15
5300655|NCT00428844|18271824|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
5300656|NCT00428844|18271825|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
5300657|NCT00428844|18271826|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
5300658|NCT00428844|18271824|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
5300659|NCT00428844|18271825|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
5300660|NCT00428844|18271826|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
5300661|NCT00428844|18271824|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
5300662|NCT00428844|18271825|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
5300663|NCT00428844|18271826|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
5300664|NCT00428844|18271824|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
5300665|NCT00428844|18271825|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
5300666|NCT00428844|18271826|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
5300667|NCT00428844|18271824|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
5300668|NCT00428844|18271825|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
5300754|NCT00428389|18272007|P1|Core Phase|Protocol deviation|0
5300669|NCT00428844|18271826|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
5300670|NCT00428844|18271824|P3|Completed Study Drug Treatment|Randomized Not Treated|1
5300671|NCT00428844|18271825|P2|Completed Study Drug Treatment|Randomized Not Treated|0
5300672|NCT00428844|18271826|P1|Completed Study Drug Treatment|Randomized Not Treated|0
5300673|NCT00428844|18271824|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
5300674|NCT00428844|18271825|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
5300675|NCT00428844|18271826|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
5300676|NCT00428844|18271824|P3|Completed Study Drug Treatment|Protocol Violation|1
5300677|NCT00428844|18271825|P2|Completed Study Drug Treatment|Protocol Violation|1
5300678|NCT00428844|18271826|P1|Completed Study Drug Treatment|Protocol Violation|0
5300679|NCT00428844|18271824|P3|Completed Study Drug Treatment|Adverse Event|4
5300680|NCT00428844|18271825|P2|Completed Study Drug Treatment|Adverse Event|4
5300681|NCT00428844|18271826|P1|Completed Study Drug Treatment|Adverse Event|2
5300682|NCT00428792|18271849|P2|Overall Study|Lost to Follow-up|1
5300683|NCT00428792|18271850|P1|Overall Study|Lost to Follow-up|0
5300684|NCT00428792|18271849|P2|Overall Study|Lack of Efficacy|3
5300685|NCT00428792|18271850|P1|Overall Study|Lack of Efficacy|1
5300686|NCT00428714|18271876|P2|Overall Study|Death due to other then PD|0
5300687|NCT00428714|18271877|P1|Overall Study|Death due to other then PD|1
5300688|NCT00428714|18271876|P2|Overall Study|Death due to Progressive Disease (PD)|0
5300689|NCT00428714|18271877|P1|Overall Study|Death due to Progressive Disease (PD)|1
5300690|NCT00428714|18271876|P2|Overall Study|Physician Decision|1
5300691|NCT00428714|18271877|P1|Overall Study|Physician Decision|1
5300692|NCT00428714|18271876|P2|Overall Study|Adverse Event|2
5300693|NCT00428714|18271877|P1|Overall Study|Adverse Event|0
5300694|NCT00428714|18271876|P2|Overall Study|Withdrawal by Subject|3
5300695|NCT00428714|18271877|P1|Overall Study|Withdrawal by Subject|0
5300696|NCT00428714|18271876|P2|Overall Study|Progressive Disease|36
5300697|NCT00428714|18271877|P1|Overall Study|Progressive Disease|28
5300698|NCT00428610|18271896|P3|Overall Study|Withdrawal by Subject|0
5300699|NCT00428610|18271897|P2|Overall Study|Withdrawal by Subject|0
5300700|NCT00428610|18271898|P1|Overall Study|Withdrawal by Subject|4
5300701|NCT00428610|18271896|P3|Overall Study|Progressive Disease|22
5300702|NCT00428610|18271897|P2|Overall Study|Progressive Disease|14
5300703|NCT00428610|18271898|P1|Overall Study|Progressive Disease|42
5300704|NCT00428610|18271896|P3|Overall Study|Investigator Decision|1
5300705|NCT00428610|18271897|P2|Overall Study|Investigator Decision|1
5300706|NCT00428610|18271898|P1|Overall Study|Investigator Decision|2
5300707|NCT00428610|18271896|P3|Overall Study|Adverse Event|2
5300708|NCT00428610|18271897|P2|Overall Study|Adverse Event|3
5300709|NCT00428610|18271898|P1|Overall Study|Adverse Event|2
5300710|NCT00428610|18271896|P3|Overall Study|Death Due to Progressive Disease|2
5300711|NCT00428610|18271897|P2|Overall Study|Death Due to Progressive Disease|0
5300712|NCT00428610|18271898|P1|Overall Study|Death Due to Progressive Disease|0
5300713|NCT00428610|18271896|P3|Overall Study|Death Due to Adverse Event|5
5300714|NCT00428610|18271897|P2|Overall Study|Death Due to Adverse Event|0
5300715|NCT00428610|18271898|P1|Overall Study|Death Due to Adverse Event|3
5300716|NCT00428597|18271932|P2|Overall Study|Death|3
5300717|NCT00428597|18271933|P1|Overall Study|Death|1
5300718|NCT00428597|18271932|P2|Overall Study|Pregnancy|0
5300719|NCT00428597|18271933|P1|Overall Study|Pregnancy|1
5300720|NCT00428597|18271932|P2|Overall Study|Lost to Follow-up|1
5300721|NCT00428597|18271933|P1|Overall Study|Lost to Follow-up|0
5300722|NCT00428597|18271932|P2|Overall Study|Other|1
5300723|NCT00428597|18271933|P1|Overall Study|Other|1
5300724|NCT00428597|18271932|P2|Overall Study|Withdrawal by Subject|1
5300725|NCT00428597|18271933|P1|Overall Study|Withdrawal by Subject|2
5300726|NCT00428597|18271932|P2|Overall Study|Protocol Violation|1
5300727|NCT00428597|18271933|P1|Overall Study|Protocol Violation|2
5300728|NCT00428597|18271932|P2|Overall Study|Global Deterioration of Health Status|5
5300729|NCT00428597|18271933|P1|Overall Study|Global Deterioration of Health Status|1
5300730|NCT00428597|18271932|P2|Overall Study|Adverse Event|7
5300731|NCT00428597|18271933|P1|Overall Study|Adverse Event|15
5300732|NCT00428597|18271932|P2|Overall Study|Study Terminated by Sponsor|16
5300733|NCT00428597|18271933|P1|Overall Study|Study Terminated by Sponsor|41
5300734|NCT00428597|18271932|P2|Overall Study|Objective Progression or Relapse|47
5300735|NCT00428597|18271933|P1|Overall Study|Objective Progression or Relapse|19
5300736|NCT00428597|18271932|P2|Overall Study|Randomized but not treated|3
5300737|NCT00428597|18271933|P1|Overall Study|Randomized but not treated|3
5300738|NCT00428441|18272000|P1|Overall Study|Lost to Follow-up|1
5300739|NCT00428389|18272006|P2|Extension Phase|Administrative problems|1
5300740|NCT00428389|18272007|P1|Extension Phase|Administrative problems|1
5300741|NCT00428389|18272006|P2|Extension Phase|Protocol Violation|2
5300742|NCT00428389|18272007|P1|Extension Phase|Protocol Violation|3
5300743|NCT00428389|18272006|P2|Extension Phase|Death|0
5300744|NCT00428389|18272007|P1|Extension Phase|Death|1
5300745|NCT00428389|18272006|P2|Extension Phase|Lost to Follow-up|3
5300746|NCT00428389|18272007|P1|Extension Phase|Lost to Follow-up|0
5300747|NCT00428389|18272006|P2|Extension Phase|Withdrawal by Subject|6
5300748|NCT00428389|18272007|P1|Extension Phase|Withdrawal by Subject|6
5300749|NCT00428389|18272006|P2|Extension Phase|Lack of Efficacy|3
5300750|NCT00428389|18272007|P1|Extension Phase|Lack of Efficacy|4
5300751|NCT00428389|18272006|P2|Extension Phase|Adverse Event|11
5300752|NCT00428389|18272007|P1|Extension Phase|Adverse Event|17
5300753|NCT00428389|18272006|P2|Core Phase|Protocol deviation|2
5300755|NCT00428389|18272006|P2|Core Phase|Withdrawal by Subject|4
5300756|NCT00428389|18272007|P1|Core Phase|Withdrawal by Subject|3
5300757|NCT00428389|18272006|P2|Core Phase|Abnormal test procedure result(s)|1
5300758|NCT00428389|18272007|P1|Core Phase|Abnormal test procedure result(s)|0
5300759|NCT00428389|18272006|P2|Core Phase|Lack of Efficacy|0
5300760|NCT00428389|18272007|P1|Core Phase|Lack of Efficacy|2
5300761|NCT00428389|18272006|P2|Core Phase|Adverse Event|4
5300762|NCT00428389|18272007|P1|Core Phase|Adverse Event|6
5300763|NCT00428246|18272041|P3|Overall Study|Adverse Event|0
5300764|NCT00428246|18272042|P2|Overall Study|Adverse Event|0
5300765|NCT00428246|18272043|P1|Overall Study|Adverse Event|1
5300766|NCT00428246|18272041|P3|Overall Study|Withdrawal by Subject|1
5300767|NCT00428246|18272042|P2|Overall Study|Withdrawal by Subject|0
5300768|NCT00428246|18272043|P1|Overall Study|Withdrawal by Subject|0
5300769|NCT00428220|18272051|P1|Overall Study|Other|23
5300770|NCT00428220|18272051|P1|Overall Study|Adverse Event|51
5300771|NCT00428220|18272051|P1|Overall Study|Participant refused continued treatment|7
5300772|NCT00428220|18272051|P1|Overall Study|Objective progression or relapse|123
5300773|NCT00428220|18272051|P1|Overall Study|Lost to Follow-up|4
5300774|NCT00428220|18272051|P1|Overall Study|Global deterioration of health status|7
5300775|NCT00428220|18272051|P1|Overall Study|Participant died|8
5300776|NCT00428116|18272076|P2|Overall Study|Lost to Follow-up|0
5300777|NCT00428116|18272077|P1|Overall Study|Lost to Follow-up|1
5300778|NCT00428116|18272076|P2|Overall Study|Withdrawal by Subject|0
5300779|NCT00428116|18272077|P1|Overall Study|Withdrawal by Subject|1
5300780|NCT00428116|18272076|P2|Overall Study|Death|0
5300781|NCT00428116|18272077|P1|Overall Study|Death|1
5300782|NCT00428090|18272089|P4|Overall Study|Raised Creatinine Value|1
5300783|NCT00428090|18272090|P3|Overall Study|Raised Creatinine Value|0
5300784|NCT00428090|18272091|P2|Overall Study|Raised Creatinine Value|0
5300785|NCT00428090|18272092|P1|Overall Study|Raised Creatinine Value|0
5300786|NCT00428090|18272089|P4|Overall Study|Excluded for heart insufficiency|0
5300787|NCT00428090|18272090|P3|Overall Study|Excluded for heart insufficiency|1
5300788|NCT00428090|18272091|P2|Overall Study|Excluded for heart insufficiency|0
5300789|NCT00428090|18272092|P1|Overall Study|Excluded for heart insufficiency|0
5300790|NCT00428090|18272089|P4|Overall Study|Serious adverse event|0
5300791|NCT00428090|18272090|P3|Overall Study|Serious adverse event|1
5300792|NCT00428090|18272091|P2|Overall Study|Serious adverse event|0
5300793|NCT00428090|18272092|P1|Overall Study|Serious adverse event|0
5300794|NCT00428090|18272089|P4|Overall Study|Deterioration of cognitive status|0
5300795|NCT00428090|18272090|P3|Overall Study|Deterioration of cognitive status|1
5300796|NCT00428090|18272091|P2|Overall Study|Deterioration of cognitive status|0
5300797|NCT00428090|18272092|P1|Overall Study|Deterioration of cognitive status|0
5300798|NCT00428090|18272089|P4|Overall Study|High MMSE scores|0
5300799|NCT00428090|18272090|P3|Overall Study|High MMSE scores|1
5300800|NCT00428090|18272091|P2|Overall Study|High MMSE scores|0
5300801|NCT00428090|18272092|P1|Overall Study|High MMSE scores|0
5300802|NCT00428090|18272089|P4|Overall Study|Insufficient AD documentation|0
5300803|NCT00428090|18272090|P3|Overall Study|Insufficient AD documentation|1
5300804|NCT00428090|18272091|P2|Overall Study|Insufficient AD documentation|0
5300805|NCT00428090|18272092|P1|Overall Study|Insufficient AD documentation|0
5300806|NCT00428090|18272089|P4|Overall Study|Excluded for concerning QTc value|0
5300807|NCT00428090|18272090|P3|Overall Study|Excluded for concerning QTc value|1
5300808|NCT00428090|18272091|P2|Overall Study|Excluded for concerning QTc value|0
5300809|NCT00428090|18272092|P1|Overall Study|Excluded for concerning QTc value|0
5300810|NCT00428090|18272089|P4|Overall Study|Worsening of AD|0
5300811|NCT00428090|18272090|P3|Overall Study|Worsening of AD|1
5300812|NCT00428090|18272091|P2|Overall Study|Worsening of AD|0
5300813|NCT00428090|18272092|P1|Overall Study|Worsening of AD|0
5300814|NCT00428090|18272089|P4|Overall Study|Mental status of par. was|0
5300815|NCT00428090|18272090|P3|Overall Study|Mental status of par. was|0
5300816|NCT00428090|18272091|P2|Overall Study|Mental status of par. was|1
5300817|NCT00428090|18272092|P1|Overall Study|Mental status of par. was|0
5300818|NCT00428090|18272089|P4|Overall Study|Medical monitor terminated par.|0
5300819|NCT00428090|18272090|P3|Overall Study|Medical monitor terminated par.|0
5300820|NCT00428090|18272091|P2|Overall Study|Medical monitor terminated par.|1
5300821|NCT00428090|18272092|P1|Overall Study|Medical monitor terminated par.|0
5300822|NCT00428090|18272089|P4|Overall Study|Visit 7 exceed the visit window|0
5300823|NCT00428090|18272090|P3|Overall Study|Visit 7 exceed the visit window|0
5300824|NCT00428090|18272091|P2|Overall Study|Visit 7 exceed the visit window|1
5300825|NCT00428090|18272092|P1|Overall Study|Visit 7 exceed the visit window|0
5300826|NCT00428090|18272089|P4|Overall Study|Death of par.|0
5300827|NCT00428090|18272090|P3|Overall Study|Death of par.|1
5300828|NCT00428090|18272091|P2|Overall Study|Death of par.|0
5300829|NCT00428090|18272092|P1|Overall Study|Death of par.|1
5300830|NCT00428090|18272089|P4|Overall Study|Prohibited medication used for SAE|0
5300831|NCT00428090|18272090|P3|Overall Study|Prohibited medication used for SAE|0
5300832|NCT00428090|18272091|P2|Overall Study|Prohibited medication used for SAE|0
5300833|NCT00428090|18272092|P1|Overall Study|Prohibited medication used for SAE|1
5300834|NCT00428090|18272089|P4|Overall Study|Follow-Up visit not possible|0
5300835|NCT00428090|18272090|P3|Overall Study|Follow-Up visit not possible|0
5300836|NCT00428090|18272091|P2|Overall Study|Follow-Up visit not possible|0
5300837|NCT00428090|18272092|P1|Overall Study|Follow-Up visit not possible|1
5300838|NCT00428090|18272089|P4|Overall Study|Par. did not returned to visit|1
5300839|NCT00428090|18272090|P3|Overall Study|Par. did not returned to visit|0
5300840|NCT00428090|18272091|P2|Overall Study|Par. did not returned to visit|0
5300841|NCT00428090|18272092|P1|Overall Study|Par. did not returned to visit|1
5300842|NCT00428090|18272089|P4|Overall Study|Non-compliance|3
5300843|NCT00428090|18272090|P3|Overall Study|Non-compliance|1
5300844|NCT00428090|18272091|P2|Overall Study|Non-compliance|0
5300845|NCT00428090|18272092|P1|Overall Study|Non-compliance|4
5300846|NCT00428090|18272089|P4|Overall Study|Sponsor terminated study|0
5300847|NCT00428090|18272090|P3|Overall Study|Sponsor terminated study|0
5300848|NCT00428090|18272091|P2|Overall Study|Sponsor terminated study|1
5300849|NCT00428090|18272092|P1|Overall Study|Sponsor terminated study|0
5300850|NCT00428090|18272089|P4|Overall Study|Withdrawal by Subject|5
5300851|NCT00428090|18272090|P3|Overall Study|Withdrawal by Subject|15
5300852|NCT00428090|18272091|P2|Overall Study|Withdrawal by Subject|12
5300853|NCT00428090|18272092|P1|Overall Study|Withdrawal by Subject|10
5300854|NCT00428090|18272089|P4|Overall Study|Protocol Violation|3
5300855|NCT00428090|18272090|P3|Overall Study|Protocol Violation|3
5300856|NCT00428090|18272091|P2|Overall Study|Protocol Violation|1
5300857|NCT00428090|18272092|P1|Overall Study|Protocol Violation|3
5300858|NCT00428090|18272089|P4|Overall Study|Lost to Follow-up|4
5300859|NCT00428090|18272090|P3|Overall Study|Lost to Follow-up|1
5300860|NCT00428090|18272091|P2|Overall Study|Lost to Follow-up|6
5300861|NCT00428090|18272092|P1|Overall Study|Lost to Follow-up|3
5300862|NCT00428090|18272089|P4|Overall Study|Adverse Event|11
5300863|NCT00428090|18272090|P3|Overall Study|Adverse Event|10
5300864|NCT00428090|18272091|P2|Overall Study|Adverse Event|8
5300865|NCT00428090|18272092|P1|Overall Study|Adverse Event|10
5300866|NCT00427999|18272210|P1|Overall Study|Death|1
5300867|NCT00427999|18272210|P1|Overall Study|Withdrawal by Subject|9
5300868|NCT00427999|18272210|P1|Overall Study|Protocol Violation|2
5300869|NCT00427999|18272210|P1|Overall Study|Unsatisfactory therapeutic effect|13
5300870|NCT00427999|18272210|P1|Overall Study|Abnormal laboratory values|1
5300871|NCT00427999|18272210|P1|Overall Study|Adverse Event|6
5300872|NCT00427960|18272228|P2|Overall Study|Other|1
5300873|NCT00427960|18272229|P1|Overall Study|Other|0
5300874|NCT00427960|18272228|P2|Overall Study|Withdrawal by Subject|3
5300875|NCT00427960|18272229|P1|Overall Study|Withdrawal by Subject|0
5300876|NCT00427960|18272228|P2|Overall Study|Adverse Event|0
5300877|NCT00427960|18272229|P1|Overall Study|Adverse Event|2
5300878|NCT00427934|18272267|P4|Overall Study|Withdrawal by Subject|3
5300879|NCT00427934|18272268|P3|Overall Study|Withdrawal by Subject|1
5300880|NCT00427934|18272269|P2|Overall Study|Withdrawal by Subject|0
5300881|NCT00427934|18272270|P1|Overall Study|Withdrawal by Subject|0
5300882|NCT00427934|18272267|P4|Overall Study|Other|5
5300883|NCT00427934|18272268|P3|Overall Study|Other|11
5300884|NCT00427934|18272269|P2|Overall Study|Other|0
5300885|NCT00427934|18272270|P1|Overall Study|Other|0
5300886|NCT00427934|18272267|P4|Overall Study|Randomized But Did Not Receive Treatment|1
5300887|NCT00427934|18272268|P3|Overall Study|Randomized But Did Not Receive Treatment|1
5300888|NCT00427934|18272269|P2|Overall Study|Randomized But Did Not Receive Treatment|0
5300889|NCT00427934|18272270|P1|Overall Study|Randomized But Did Not Receive Treatment|0
5300890|NCT00427934|18272267|P4|Overall Study|Lack of Efficacy|2
5300891|NCT00427934|18272268|P3|Overall Study|Lack of Efficacy|5
5300892|NCT00427934|18272269|P2|Overall Study|Lack of Efficacy|0
5300893|NCT00427934|18272270|P1|Overall Study|Lack of Efficacy|0
5300894|NCT00427934|18272267|P4|Overall Study|Adverse Event|4
5300895|NCT00427934|18272268|P3|Overall Study|Adverse Event|5
5300896|NCT00427934|18272269|P2|Overall Study|Adverse Event|0
5300897|NCT00427934|18272270|P1|Overall Study|Adverse Event|1
5300898|NCT00427921|18272338|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
5300899|NCT00427921|18272338|P1|Overall Study|Adverse Event + Withdrawn from Study|1
5300900|NCT00427921|18272338|P1|Overall Study|Adverse Event + Lost Response|1
5300901|NCT00427921|18272338|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
5300902|NCT00427921|18272338|P1|Overall Study|Adverse Event + Worsening of CD|1
5300903|NCT00427921|18272338|P1|Overall Study|Adverse Event + No Response|1
5300904|NCT00427921|18272338|P1|Overall Study|Adverse Event + Withdrew Consent|1
5300905|NCT00427921|18272338|P1|Overall Study|Adverse Event + Hospitalization|1
5300906|NCT00427921|18272338|P1|Overall Study|Other reason not specified|10
5300907|NCT00427921|18272338|P1|Overall Study|Lost to Follow-up|2
5300908|NCT00427921|18272338|P1|Overall Study|Withdrawal by Subject|4
5300909|NCT00427921|18272338|P1|Overall Study|Adverse Event|26
5300910|NCT00427908|18272361|P4|Primary Phase|Adverse Event|0
5300911|NCT00427908|18272362|P3|Primary Phase|Adverse Event|0
5300912|NCT00427908|18272363|P2|Primary Phase|Adverse Event|1
5300913|NCT00427908|18272364|P1|Primary Phase|Adverse Event|0
5300914|NCT00427908|18272361|P4|Primary Phase|Withdrawal by Subject|0
5300915|NCT00427908|18272362|P3|Primary Phase|Withdrawal by Subject|1
5300916|NCT00427908|18272363|P2|Primary Phase|Withdrawal by Subject|2
5300917|NCT00427908|18272364|P1|Primary Phase|Withdrawal by Subject|1
5300918|NCT00427908|18272361|P4|Primary Phase|Lost to Follow-up|0
5300919|NCT00427908|18272362|P3|Primary Phase|Lost to Follow-up|2
5300920|NCT00427908|18272363|P2|Primary Phase|Lost to Follow-up|0
5300921|NCT00427908|18272364|P1|Primary Phase|Lost to Follow-up|4
5300922|NCT00427895|18272564|P8|Vax 2/Year 3 to 4|Failed to Return|0
5300923|NCT00427895|18272565|P7|Vax 2/Year 3 to 4|Failed to Return|0
5300924|NCT00427895|18272566|P6|Vax 2/Year 3 to 4|Failed to Return|0
5300925|NCT00427895|18272567|P5|Vax 2/Year 3 to 4|Failed to Return|1
5300926|NCT00427895|18272568|P4|Vax 2/Year 3 to 4|Failed to Return|0
5300927|NCT00427895|18272569|P3|Vax 2/Year 3 to 4|Failed to Return|0
5300928|NCT00427895|18272570|P2|Vax 2/Year 3 to 4|Failed to Return|0
5300929|NCT00427895|18272571|P1|Vax 2/Year 3 to 4|Failed to Return|0
5300930|NCT00427895|18272564|P8|Vax 2/Year 3 to 4|Protocol Violation|1
5300931|NCT00427895|18272565|P7|Vax 2/Year 3 to 4|Protocol Violation|0
5300932|NCT00427895|18272566|P6|Vax 2/Year 3 to 4|Protocol Violation|0
5300933|NCT00427895|18272567|P5|Vax 2/Year 3 to 4|Protocol Violation|0
5300934|NCT00427895|18272568|P4|Vax 2/Year 3 to 4|Protocol Violation|0
5300935|NCT00427895|18272569|P3|Vax 2/Year 3 to 4|Protocol Violation|0
5300936|NCT00427895|18272570|P2|Vax 2/Year 3 to 4|Protocol Violation|0
5300937|NCT00427895|18272571|P1|Vax 2/Year 3 to 4|Protocol Violation|0
5300938|NCT00427895|18272564|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
5300939|NCT00427895|18272565|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300940|NCT00427895|18272566|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300941|NCT00427895|18272567|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300942|NCT00427895|18272568|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300943|NCT00427895|18272569|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300944|NCT00427895|18272570|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300945|NCT00427895|18272571|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
5300946|NCT00427895|18272564|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5300947|NCT00427895|18272565|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5300948|NCT00427895|18272566|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5300949|NCT00427895|18272567|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5300950|NCT00427895|18272568|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
5300951|NCT00427895|18272569|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
5300952|NCT00427895|18272570|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
5300953|NCT00427895|18272571|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
5300954|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Other|0
5300955|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Other|0
5300956|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Other|0
5300957|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Other|0
5300958|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Other|2
5300959|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Other|0
5300960|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Other|0
5300961|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Other|0
5300962|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
5300963|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
5300964|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
5300965|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
5300966|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
5300967|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
5300968|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
5300969|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
5300970|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Death|0
5300971|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Death|0
5300972|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Death|0
5300973|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Death|0
5300974|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Death|0
5300975|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Death|0
5300976|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Death|0
5300977|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Death|1
5300978|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
5300979|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
5300980|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
5300981|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
5300982|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
5300983|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
5300984|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
5300985|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
5300986|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5300987|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5300988|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5300989|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5300990|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
5300991|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
5300992|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
5300993|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
5300994|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
5300995|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
5300996|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
5300997|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
5300998|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
5300999|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
5301000|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
5301001|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
5301002|NCT00427895|18272564|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5301003|NCT00427895|18272565|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5301004|NCT00427895|18272566|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5301005|NCT00427895|18272567|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5301006|NCT00427895|18272568|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
5301007|NCT00427895|18272569|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
5301008|NCT00427895|18272570|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
5301009|NCT00427895|18272571|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5301010|NCT00427895|18272564|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301011|NCT00427895|18272565|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301012|NCT00427895|18272566|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301013|NCT00427895|18272567|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301014|NCT00427895|18272568|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
5301015|NCT00427895|18272569|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301016|NCT00427895|18272570|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301017|NCT00427895|18272571|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5301018|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
5301019|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
5301020|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
5301021|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
5301022|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
5301023|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
5301024|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
5301025|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
5301026|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5301027|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5301028|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5301029|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5301030|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
5301031|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
5301032|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
5301033|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
5301034|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301035|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301036|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301037|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301038|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
5301039|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301040|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301041|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5301042|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5301043|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5301044|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5301045|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5301046|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
5301047|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
5301048|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
5301049|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
5301050|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5301051|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5301052|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5301053|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5301054|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5301055|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5301056|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
5301057|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
5301058|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5301059|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5301060|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5301061|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5301062|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
5301063|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
5301064|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5301065|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
5301066|NCT00427895|18272564|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5301067|NCT00427895|18272565|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5301068|NCT00427895|18272566|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5301069|NCT00427895|18272567|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5301070|NCT00427895|18272568|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
5301071|NCT00427895|18272569|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
5301072|NCT00427895|18272570|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
5301073|NCT00427895|18272571|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5301074|NCT00427778|18272646|P2|First Intervention (4 Weeks)|anxious about using ring|0
5301075|NCT00427778|18272647|P1|First Intervention (4 Weeks)|anxious about using ring|1
5301076|NCT00427778|18272646|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
5301077|NCT00427778|18272647|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
5301078|NCT00427778|18272646|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
5301079|NCT00427778|18272647|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
5301080|NCT00427778|18272646|P2|First Intervention (4 Weeks)|no longer interested|0
5301081|NCT00427778|18272647|P1|First Intervention (4 Weeks)|no longer interested|1
5301082|NCT00427700|18272672|P2|Overall Study|Pregnancy|2
5301083|NCT00427700|18272673|P1|Overall Study|Pregnancy|0
5301084|NCT00427700|18272672|P2|Overall Study|no induction of menses|4
5301085|NCT00427700|18272673|P1|Overall Study|no induction of menses|1
5301086|NCT00427700|18272672|P2|Overall Study|Lost to Follow-up|5
5301087|NCT00427700|18272673|P1|Overall Study|Lost to Follow-up|2
5301088|NCT00427648|18272689|P2|Overall Study|Adverse Event|1
5301089|NCT00427648|18272690|P1|Overall Study|Adverse Event|0
5301090|NCT00427648|18272689|P2|Overall Study|Protocol Violation|2
5301091|NCT00427648|18272690|P1|Overall Study|Protocol Violation|1
5301092|NCT00427635|18272710|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
5301093|NCT00427635|18272711|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
5301094|NCT00427635|18272710|P2|Treatment Phase|Withdrawal by Subject|0
5301095|NCT00427635|18272711|P1|Treatment Phase|Withdrawal by Subject|1
5301096|NCT00427349|18272743|P1|Overall Study|Never started therapy|1
5301097|NCT00427349|18272743|P1|Overall Study|Ineligible|1
5301098|NCT00427349|18272743|P1|Overall Study|Other|2
5301099|NCT00427349|18272743|P1|Overall Study|Alternative therapy|1
5301100|NCT00427349|18272743|P1|Overall Study|Withdrawal by Subject|3
5301101|NCT00427349|18272743|P1|Overall Study|Death|1
5301102|NCT00427349|18272743|P1|Overall Study|Adverse Event|14
5301103|NCT00427349|18272743|P1|Overall Study|Lack of Efficacy|23
5301104|NCT00427011|18272800|P1|Overall Study|Other|12
5301105|NCT00427011|18272800|P1|Overall Study|Lack of Efficacy|2
5301106|NCT00427011|18272800|P1|Overall Study|Withdrawal by Subject|1
5301107|NCT00427011|18272800|P1|Overall Study|Adverse Event|10
5301108|NCT00426842|18272815|P1|Overall Study|Lost to Follow-up|1
5301109|NCT00426764|18272821|P1|Overall Study|Other Reasons (Miscellaneous)|10
5301110|NCT00426764|18272821|P1|Overall Study|Death|1
5301111|NCT00426764|18272821|P1|Overall Study|Other|1
5301112|NCT00426764|18272821|P1|Overall Study|Adverse Event|24
5301113|NCT00426764|18272821|P1|Overall Study|Progressive Disease|83
5301114|NCT00426764|18272821|P1|Overall Study|Compassionate Use|1
5301115|NCT00426764|18272821|P1|Overall Study|Physician Decision|6
5301116|NCT00426764|18272821|P1|Overall Study|Withdrawal by Subject|4
5301117|NCT00426764|18272821|P1|Overall Study|Protocol Violation|1
5301118|NCT00426751|18272838|P2|Overall Study|Other Reasons|12
5301119|NCT00426751|18272839|P1|Overall Study|Other Reasons|7
5301120|NCT00426751|18272838|P2|Overall Study|Consent Withdrawn|1
5301121|NCT00426751|18272839|P1|Overall Study|Consent Withdrawn|0
5301122|NCT00426751|18272838|P2|Overall Study|Lost to Follow-up|6
5301123|NCT00426751|18272839|P1|Overall Study|Lost to Follow-up|7
5301124|NCT00426751|18272838|P2|Overall Study|Adverse Event|1
5301125|NCT00426751|18272839|P1|Overall Study|Adverse Event|8
5301126|NCT00426660|18272883|P1|Overall Study|Enrolled Not Treated|15
5301127|NCT00426660|18272883|P1|Overall Study|Protocol Violation|1
5301128|NCT00426660|18272883|P1|Overall Study|Withdrawal by Subject|18
5301129|NCT00426660|18272883|P1|Overall Study|Other|23
5301130|NCT00426660|18272883|P1|Overall Study|Lost to Follow-up|15
5301131|NCT00426660|18272883|P1|Overall Study|Insufficient Clinical Response|22
5301132|NCT00426660|18272883|P1|Overall Study|Adverse Event|23
5301133|NCT00426660|18272883|P1|Overall Study|Death|14
5301134|NCT00426556|18272914|P4|Phase II - Extension Phase|Adverse Event|2
5301135|NCT00426556|18272915|P3|Phase II - Extension Phase|Adverse Event|0
5301136|NCT00426556|18272916|P2|Phase II - Extension Phase|Adverse Event|0
5301137|NCT00426556|18272917|P1|Phase II - Extension Phase|Adverse Event|0
5301138|NCT00426556|18272914|P4|Phase II - Extension Phase|Disease Progression|21
5301139|NCT00426556|18272915|P3|Phase II - Extension Phase|Disease Progression|0
5301140|NCT00426556|18272916|P2|Phase II - Extension Phase|Disease Progression|0
5301141|NCT00426556|18272917|P1|Phase II - Extension Phase|Disease Progression|0
5301142|NCT00426556|18272914|P4|Phase II - Core Phase|Adverse Event|8
5301143|NCT00426556|18272915|P3|Phase II - Core Phase|Adverse Event|0
5301144|NCT00426556|18272916|P2|Phase II - Core Phase|Adverse Event|0
5301145|NCT00426556|18272917|P1|Phase II - Core Phase|Adverse Event|0
5301146|NCT00426556|18272914|P4|Phase II - Core Phase|Disease Progression|16
5301147|NCT00426556|18272915|P3|Phase II - Core Phase|Disease Progression|0
5301148|NCT00426556|18272916|P2|Phase II - Core Phase|Disease Progression|0
5301149|NCT00426556|18272917|P1|Phase II - Core Phase|Disease Progression|0
5301150|NCT00426556|18272914|P4|Phase II - Core Phase|Withdrawal by Subject|3
5301151|NCT00426556|18272915|P3|Phase II - Core Phase|Withdrawal by Subject|0
5301152|NCT00426556|18272916|P2|Phase II - Core Phase|Withdrawal by Subject|0
5301153|NCT00426556|18272917|P1|Phase II - Core Phase|Withdrawal by Subject|0
5301154|NCT00426556|18272914|P4|Phase I - Extension Phase|Disease Progression|0
5301155|NCT00426556|18272915|P3|Phase I - Extension Phase|Disease Progression|6
5301156|NCT00426556|18272916|P2|Phase I - Extension Phase|Disease Progression|5
5301157|NCT00426556|18272917|P1|Phase I - Extension Phase|Disease Progression|5
5301158|NCT00426556|18272914|P4|Phase I - Extension Phase|Adverse Event|0
5301159|NCT00426556|18272915|P3|Phase I - Extension Phase|Adverse Event|1
5301160|NCT00426556|18272916|P2|Phase I - Extension Phase|Adverse Event|1
5301161|NCT00426556|18272917|P1|Phase I - Extension Phase|Adverse Event|0
5301162|NCT00426556|18272914|P4|Phase I - Core Phase|Death|0
5301163|NCT00426556|18272915|P3|Phase I - Core Phase|Death|0
5301164|NCT00426556|18272916|P2|Phase I - Core Phase|Death|1
5301165|NCT00426556|18272917|P1|Phase I - Core Phase|Death|0
5301166|NCT00426556|18272914|P4|Phase I - Core Phase|Adverse Event|0
5301167|NCT00426556|18272915|P3|Phase I - Core Phase|Adverse Event|1
5301168|NCT00426556|18272916|P2|Phase I - Core Phase|Adverse Event|3
5301169|NCT00426556|18272917|P1|Phase I - Core Phase|Adverse Event|1
5301170|NCT00426556|18272914|P4|Phase I - Core Phase|Disease Progression|0
5301171|NCT00426556|18272915|P3|Phase I - Core Phase|Disease Progression|2
5301172|NCT00426556|18272916|P2|Phase I - Core Phase|Disease Progression|6
5301173|NCT00426556|18272917|P1|Phase I - Core Phase|Disease Progression|0
5301174|NCT00426361|18272942|P3|Overall Study|Withdrawal by Subject|0
5301175|NCT00426361|18272943|P2|Overall Study|Withdrawal by Subject|3
5301176|NCT00426361|18272944|P1|Overall Study|Withdrawal by Subject|1
5301177|NCT00426361|18272942|P3|Overall Study|Lost to Follow-up|5
5301178|NCT00426361|18272943|P2|Overall Study|Lost to Follow-up|2
5301179|NCT00426361|18272944|P1|Overall Study|Lost to Follow-up|3
5301180|NCT00426270|18273011|P1|Overall Study|Adverse Event|5
5301181|NCT00426270|18273011|P1|Overall Study|Incorrectly Enrolled in the Study|1
5301182|NCT00426231|18273021|P2|Overall Study|Withdrawal by Subject|12
5301183|NCT00426231|18273022|P1|Overall Study|Withdrawal by Subject|9
5301184|NCT00426127|18273045|P1|Overall Study|Removed due to disease progression|1
5301185|NCT00426127|18273045|P1|Overall Study|Adverse Event|1
5301186|NCT00425945|18273053|P2|Overall Study|Moved from area|1
5301187|NCT00425945|18273054|P1|Overall Study|Moved from area|0
5301188|NCT00425945|18273053|P2|Overall Study|Began cancer treatments|0
5301189|NCT00425945|18273054|P1|Overall Study|Began cancer treatments|1
5301190|NCT00425945|18273053|P2|Overall Study|Began hypertension medication|0
5301191|NCT00425945|18273054|P1|Overall Study|Began hypertension medication|1
5301192|NCT00425945|18273053|P2|Overall Study|Lost to Follow-up|2
5301193|NCT00425945|18273054|P1|Overall Study|Lost to Follow-up|0
5301194|NCT00425945|18273053|P2|Overall Study|Inconvenience|2
5301195|NCT00425945|18273054|P1|Overall Study|Inconvenience|0
5301196|NCT00425945|18273053|P2|Overall Study|Concern about Supplement|0
5301197|NCT00425945|18273054|P1|Overall Study|Concern about Supplement|2
5301198|NCT00425854|18273092|P2|Overall Study|Other Adverse Event|2
5301199|NCT00425854|18273093|P1|Overall Study|Other Adverse Event|2
5301200|NCT00425854|18273092|P2|Overall Study|Dose reduction toxicity AE|7
5301201|NCT00425854|18273093|P1|Overall Study|Dose reduction toxicity AE|8
5301202|NCT00425854|18273092|P2|Overall Study|Progressive Disease|12
5301203|NCT00425854|18273093|P1|Overall Study|Progressive Disease|19
5301204|NCT00425750|18273126|P1|Overall Study|Progression of disease|18
5301205|NCT00425750|18273126|P1|Overall Study|Adverse Event|3
5301206|NCT00425750|18273126|P1|Overall Study|Withdrawal by Subject|3
5301207|NCT00425750|18273126|P1|Overall Study|Death|1
5301208|NCT00425698|18273134|P2|Overall Study|Withdrawal by Subject|1
5301209|NCT00425698|18273135|P1|Overall Study|Withdrawal by Subject|0
5301210|NCT00425698|18273134|P2|Overall Study|Adverse Event|1
5301211|NCT00425698|18273135|P1|Overall Study|Adverse Event|3
5301212|NCT00425607|18273150|P1|Overall Study|Withdrawal by Subject|1
5301213|NCT00425607|18273150|P1|Overall Study|Death|1
5301214|NCT00425503|18273154|P1|Overall Study|Protocol Violation|1
5301215|NCT00425503|18273154|P1|Overall Study|Adverse Event|2
5301216|NCT00425438|18273166|P2|Overall Study|Termination by Sponsor|27
5301217|NCT00425438|18273167|P1|Overall Study|Termination by Sponsor|25
5301218|NCT00425373|18273201|P9|Overall Study|Lack of Efficacy|5
5301219|NCT00425373|18273202|P8|Overall Study|Lack of Efficacy|0
5301220|NCT00425373|18273203|P7|Overall Study|Lack of Efficacy|3
5301221|NCT00425373|18273204|P6|Overall Study|Lack of Efficacy|3
5301222|NCT00425373|18273205|P5|Overall Study|Lack of Efficacy|1
5301223|NCT00425373|18273206|P4|Overall Study|Lack of Efficacy|0
5301224|NCT00425373|18273207|P3|Overall Study|Lack of Efficacy|0
5301225|NCT00425373|18273208|P2|Overall Study|Lack of Efficacy|0
5301226|NCT00425373|18273209|P1|Overall Study|Lack of Efficacy|0
5301227|NCT00425373|18273201|P9|Overall Study|Withdrawal by Subject|2
5301228|NCT00425373|18273202|P8|Overall Study|Withdrawal by Subject|2
5301229|NCT00425373|18273203|P7|Overall Study|Withdrawal by Subject|2
5301230|NCT00425373|18273204|P6|Overall Study|Withdrawal by Subject|0
5301231|NCT00425373|18273205|P5|Overall Study|Withdrawal by Subject|4
5301232|NCT00425373|18273206|P4|Overall Study|Withdrawal by Subject|1
5301233|NCT00425373|18273207|P3|Overall Study|Withdrawal by Subject|2
5301234|NCT00425373|18273208|P2|Overall Study|Withdrawal by Subject|0
5301235|NCT00425373|18273209|P1|Overall Study|Withdrawal by Subject|2
5301236|NCT00425373|18273201|P9|Overall Study|Protocol Violation|3
5301237|NCT00425373|18273202|P8|Overall Study|Protocol Violation|5
5301238|NCT00425373|18273203|P7|Overall Study|Protocol Violation|0
5301239|NCT00425373|18273204|P6|Overall Study|Protocol Violation|0
5301240|NCT00425373|18273205|P5|Overall Study|Protocol Violation|0
5301241|NCT00425373|18273206|P4|Overall Study|Protocol Violation|0
5301242|NCT00425373|18273207|P3|Overall Study|Protocol Violation|1
5301243|NCT00425373|18273208|P2|Overall Study|Protocol Violation|0
5301244|NCT00425373|18273209|P1|Overall Study|Protocol Violation|1
5301245|NCT00425373|18273201|P9|Overall Study|Lost to Follow-up|0
5301246|NCT00425373|18273202|P8|Overall Study|Lost to Follow-up|0
5301247|NCT00425373|18273203|P7|Overall Study|Lost to Follow-up|0
5301248|NCT00425373|18273204|P6|Overall Study|Lost to Follow-up|0
5301249|NCT00425373|18273205|P5|Overall Study|Lost to Follow-up|1
5301250|NCT00425373|18273206|P4|Overall Study|Lost to Follow-up|0
5301251|NCT00425373|18273207|P3|Overall Study|Lost to Follow-up|0
5301252|NCT00425373|18273208|P2|Overall Study|Lost to Follow-up|1
5301253|NCT00425373|18273209|P1|Overall Study|Lost to Follow-up|0
5301254|NCT00425373|18273201|P9|Overall Study|Adverse Event|8
5301255|NCT00425373|18273202|P8|Overall Study|Adverse Event|3
5301256|NCT00425373|18273203|P7|Overall Study|Adverse Event|2
5301257|NCT00425373|18273204|P6|Overall Study|Adverse Event|6
5301258|NCT00425373|18273205|P5|Overall Study|Adverse Event|4
5301259|NCT00425373|18273206|P4|Overall Study|Adverse Event|1
5301260|NCT00425373|18273207|P3|Overall Study|Adverse Event|0
5301261|NCT00425373|18273208|P2|Overall Study|Adverse Event|2
5301262|NCT00425373|18273209|P1|Overall Study|Adverse Event|2
5301263|NCT00425308|18273267|P2|Overall Study|Death|0
5301264|NCT00425308|18273268|P1|Overall Study|Death|1
5301265|NCT00425308|18273267|P2|Overall Study|Withdrawal by Subject|0
5301266|NCT00425308|18273268|P1|Overall Study|Withdrawal by Subject|1
5301267|NCT00425308|18273267|P2|Overall Study|Adverse Event|1
5301268|NCT00425308|18273268|P1|Overall Study|Adverse Event|2
5301269|NCT00425269|18273298|P2|Overall Study|moved or medical reason|4
5301270|NCT00425269|18273299|P1|Overall Study|moved or medical reason|5
5301271|NCT00425269|18273298|P2|Overall Study|Lost to Follow-up|9
5301272|NCT00425269|18273299|P1|Overall Study|Lost to Follow-up|9
5301273|NCT00425269|18273298|P2|Overall Study|Pregnancy|7
5301274|NCT00425269|18273299|P1|Overall Study|Pregnancy|5
5301275|NCT00425113|18273377|P2|Overall Study|Withdrawal by Subject|0
5301276|NCT00425113|18273378|P1|Overall Study|Withdrawal by Subject|1
5301277|NCT00425113|18273377|P2|Overall Study|missing study drug more than 14 days|1
5301278|NCT00425113|18273378|P1|Overall Study|missing study drug more than 14 days|0
5301279|NCT00425113|18273377|P2|Overall Study|diagnosis of abdominal TB|1
5301280|NCT00425113|18273378|P1|Overall Study|diagnosis of abdominal TB|0
5301281|NCT00425113|18273377|P2|Overall Study|uncontrolled diabetes mellitus|0
5301282|NCT00425113|18273378|P1|Overall Study|uncontrolled diabetes mellitus|1
5301283|NCT00425100|18273386|P1|Overall Study|Withdrawal by Subject|7
5301284|NCT00425100|18273386|P1|Overall Study|Protocol Violation|4
5301285|NCT00425100|18273386|P1|Overall Study|Lost to Follow-up|2
5301286|NCT00425100|18273386|P1|Overall Study|Lack of Efficacy|4
5301287|NCT00425100|18273386|P1|Overall Study|Adverse Event|36
5301288|NCT00425061|18273430|P7|Overall Study|Other|1
5301289|NCT00425061|18273431|P6|Overall Study|Other|0
5301290|NCT00425061|18273432|P5|Overall Study|Other|3
5301291|NCT00425061|18273433|P4|Overall Study|Other|0
5301292|NCT00425061|18273434|P3|Overall Study|Other|0
5301293|NCT00425061|18273435|P2|Overall Study|Other|0
5301294|NCT00425061|18273436|P1|Overall Study|Other|0
5301295|NCT00425061|18273430|P7|Overall Study|Physician Decision|0
5301296|NCT00425061|18273431|P6|Overall Study|Physician Decision|0
5301297|NCT00425061|18273432|P5|Overall Study|Physician Decision|1
5301298|NCT00425061|18273433|P4|Overall Study|Physician Decision|0
5301299|NCT00425061|18273434|P3|Overall Study|Physician Decision|0
5301300|NCT00425061|18273435|P2|Overall Study|Physician Decision|0
5301301|NCT00425061|18273436|P1|Overall Study|Physician Decision|0
5301302|NCT00425061|18273430|P7|Overall Study|Sponsor's request|15
5301303|NCT00425061|18273431|P6|Overall Study|Sponsor's request|4
5301304|NCT00425061|18273432|P5|Overall Study|Sponsor's request|19
5301305|NCT00425061|18273433|P4|Overall Study|Sponsor's request|0
5301306|NCT00425061|18273434|P3|Overall Study|Sponsor's request|0
5301307|NCT00425061|18273435|P2|Overall Study|Sponsor's request|0
5301308|NCT00425061|18273436|P1|Overall Study|Sponsor's request|0
5301309|NCT00425061|18273430|P7|Overall Study|Withdrawal by Subject|3
5301310|NCT00425061|18273431|P6|Overall Study|Withdrawal by Subject|0
5301311|NCT00425061|18273432|P5|Overall Study|Withdrawal by Subject|1
5301312|NCT00425061|18273433|P4|Overall Study|Withdrawal by Subject|0
5301313|NCT00425061|18273434|P3|Overall Study|Withdrawal by Subject|0
5301314|NCT00425061|18273435|P2|Overall Study|Withdrawal by Subject|1
5301315|NCT00425061|18273436|P1|Overall Study|Withdrawal by Subject|0
5301316|NCT00425061|18273430|P7|Overall Study|Protocol Violation|0
5301317|NCT00425061|18273431|P6|Overall Study|Protocol Violation|0
5301318|NCT00425061|18273432|P5|Overall Study|Protocol Violation|0
5301319|NCT00425061|18273433|P4|Overall Study|Protocol Violation|0
5301320|NCT00425061|18273434|P3|Overall Study|Protocol Violation|0
5301321|NCT00425061|18273435|P2|Overall Study|Protocol Violation|0
5301322|NCT00425061|18273436|P1|Overall Study|Protocol Violation|1
5301323|NCT00425061|18273430|P7|Overall Study|Lost to Follow-up|0
5301324|NCT00425061|18273431|P6|Overall Study|Lost to Follow-up|0
5301325|NCT00425061|18273432|P5|Overall Study|Lost to Follow-up|0
5301326|NCT00425061|18273433|P4|Overall Study|Lost to Follow-up|0
5301327|NCT00425061|18273434|P3|Overall Study|Lost to Follow-up|0
5301328|NCT00425061|18273435|P2|Overall Study|Lost to Follow-up|1
5301329|NCT00425061|18273436|P1|Overall Study|Lost to Follow-up|0
5301330|NCT00425061|18273430|P7|Overall Study|Adverse Event|0
5301331|NCT00425061|18273431|P6|Overall Study|Adverse Event|0
5301332|NCT00425061|18273432|P5|Overall Study|Adverse Event|2
5301333|NCT00425061|18273433|P4|Overall Study|Adverse Event|2
5301334|NCT00425061|18273434|P3|Overall Study|Adverse Event|0
5301335|NCT00425061|18273435|P2|Overall Study|Adverse Event|0
5301336|NCT00425061|18273436|P1|Overall Study|Adverse Event|1
5301337|NCT00424827|18273560|P1|Overall Study|Adverse Event|1
5301338|NCT00424775|18273568|P2|Overall Study|Lack of Efficacy|0
5301339|NCT00424775|18273569|P1|Overall Study|Lack of Efficacy|1
5301340|NCT00424775|18273568|P2|Overall Study|Adverse Event|0
5301341|NCT00424775|18273569|P1|Overall Study|Adverse Event|2
5301342|NCT00424762|18273579|P2|Overall Study|Lost to Follow-up|3
5301343|NCT00424762|18273580|P1|Overall Study|Lost to Follow-up|2
5301344|NCT00424762|18273579|P2|Overall Study|Withdrawal by Subject|19
5301345|NCT00424762|18273580|P1|Overall Study|Withdrawal by Subject|18
5301346|NCT00424749|18273590|P1|Overall Study|Withdrawal by Subject|1
5301347|NCT00424645|18273597|P2|Overall Study|Death|0
5301348|NCT00424645|18273598|P1|Overall Study|Death|1
5301349|NCT00424632|18273606|P10|Overall Study|Other|0
5301350|NCT00424632|18273607|P9|Overall Study|Other|1
5301351|NCT00424632|18273608|P8|Overall Study|Other|0
5301352|NCT00424632|18273609|P7|Overall Study|Other|0
5301353|NCT00424632|18273610|P6|Overall Study|Other|0
5301354|NCT00424632|18273611|P5|Overall Study|Other|0
5301355|NCT00424632|18273612|P4|Overall Study|Other|1
5301356|NCT00424632|18273613|P3|Overall Study|Other|0
5301357|NCT00424632|18273614|P2|Overall Study|Other|0
5301358|NCT00424632|18273615|P1|Overall Study|Other|0
5301359|NCT00424632|18273606|P10|Overall Study|Objective progression or relapse|4
5301360|NCT00424632|18273607|P9|Overall Study|Objective progression or relapse|12
5301361|NCT00424632|18273608|P8|Overall Study|Objective progression or relapse|3
5301362|NCT00424632|18273609|P7|Overall Study|Objective progression or relapse|7
5301363|NCT00424632|18273610|P6|Overall Study|Objective progression or relapse|13
5301364|NCT00424632|18273611|P5|Overall Study|Objective progression or relapse|2
5301365|NCT00424632|18273612|P4|Overall Study|Objective progression or relapse|2
5301366|NCT00424632|18273613|P3|Overall Study|Objective progression or relapse|1
5301367|NCT00424632|18273614|P2|Overall Study|Objective progression or relapse|1
5301368|NCT00424632|18273615|P1|Overall Study|Objective progression or relapse|1
5301369|NCT00424632|18273606|P10|Overall Study|Global deterioration of health status|0
5301370|NCT00424632|18273607|P9|Overall Study|Global deterioration of health status|0
5301371|NCT00424632|18273608|P8|Overall Study|Global deterioration of health status|0
5301372|NCT00424632|18273609|P7|Overall Study|Global deterioration of health status|0
5301373|NCT00424632|18273610|P6|Overall Study|Global deterioration of health status|0
5301374|NCT00424632|18273611|P5|Overall Study|Global deterioration of health status|1
5301375|NCT00424632|18273612|P4|Overall Study|Global deterioration of health status|1
5301376|NCT00424632|18273613|P3|Overall Study|Global deterioration of health status|0
5301377|NCT00424632|18273614|P2|Overall Study|Global deterioration of health status|0
5301378|NCT00424632|18273615|P1|Overall Study|Global deterioration of health status|0
5301379|NCT00424632|18273606|P10|Overall Study|Adverse Event|2
5301380|NCT00424632|18273607|P9|Overall Study|Adverse Event|3
5301381|NCT00424632|18273608|P8|Overall Study|Adverse Event|0
5301382|NCT00424632|18273609|P7|Overall Study|Adverse Event|0
5301383|NCT00424632|18273610|P6|Overall Study|Adverse Event|0
5301384|NCT00424632|18273611|P5|Overall Study|Adverse Event|0
5301385|NCT00424632|18273612|P4|Overall Study|Adverse Event|0
5301386|NCT00424632|18273613|P3|Overall Study|Adverse Event|0
5301387|NCT00424632|18273614|P2|Overall Study|Adverse Event|0
5301388|NCT00424632|18273615|P1|Overall Study|Adverse Event|0
5301389|NCT00424632|18273606|P10|Overall Study|Death|0
5301390|NCT00424632|18273607|P9|Overall Study|Death|0
5301391|NCT00424632|18273608|P8|Overall Study|Death|0
5301392|NCT00424632|18273609|P7|Overall Study|Death|0
5301393|NCT00424632|18273610|P6|Overall Study|Death|2
5301394|NCT00424632|18273611|P5|Overall Study|Death|0
5301395|NCT00424632|18273612|P4|Overall Study|Death|0
5301396|NCT00424632|18273613|P3|Overall Study|Death|0
5301397|NCT00424632|18273614|P2|Overall Study|Death|0
5301398|NCT00424632|18273615|P1|Overall Study|Death|0
5301399|NCT00424593|18273785|P2|Dose-Blind Extension Period|Physician Decision|0
5301400|NCT00424593|18273786|P1|Dose-Blind Extension Period|Physician Decision|3
5301401|NCT00424593|18273785|P2|Dose-Blind Extension Period|Lost to Follow-up|0
5301402|NCT00424593|18273786|P1|Dose-Blind Extension Period|Lost to Follow-up|6
5301403|NCT00424593|18273785|P2|Dose-Blind Extension Period|Protocol Violation|0
5301404|NCT00424593|18273786|P1|Dose-Blind Extension Period|Protocol Violation|9
5301405|NCT00424593|18273785|P2|Dose-Blind Extension Period|Lack of Efficacy|0
5301406|NCT00424593|18273786|P1|Dose-Blind Extension Period|Lack of Efficacy|9
5301407|NCT00424593|18273785|P2|Dose-Blind Extension Period|Adverse Event|0
5301408|NCT00424593|18273786|P1|Dose-Blind Extension Period|Adverse Event|18
5301409|NCT00424593|18273785|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
5301410|NCT00424593|18273786|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
5301411|NCT00424593|18273785|P2|Acute Double-Blind Period|Lack of Efficacy|1
5301412|NCT00424593|18273786|P1|Acute Double-Blind Period|Lack of Efficacy|0
5301413|NCT00424593|18273785|P2|Acute Double-Blind Period|Lost to Follow-up|1
5301414|NCT00424593|18273786|P1|Acute Double-Blind Period|Lost to Follow-up|1
5301415|NCT00424593|18273785|P2|Acute Double-Blind Period|Physician Decision|2
5301416|NCT00424593|18273786|P1|Acute Double-Blind Period|Physician Decision|1
5301417|NCT00424593|18273785|P2|Acute Double-Blind Period|Protocol Violation|2
5301418|NCT00424593|18273786|P1|Acute Double-Blind Period|Protocol Violation|2
5301419|NCT00424593|18273785|P2|Acute Double-Blind Period|Withdrawal by Subject|10
5301420|NCT00424593|18273786|P1|Acute Double-Blind Period|Withdrawal by Subject|11
5301421|NCT00424593|18273785|P2|Acute Double-Blind Period|Adverse Event|7
5301422|NCT00424593|18273786|P1|Acute Double-Blind Period|Adverse Event|16
5301423|NCT00424528|18273850|P3|Overall Study|noncompliance with study requirements|2
5301424|NCT00424528|18273851|P2|Overall Study|noncompliance with study requirements|1
5301425|NCT00424528|18273852|P1|Overall Study|noncompliance with study requirements|2
5301426|NCT00424528|18273850|P3|Overall Study|Lost to Follow-up|0
5301427|NCT00424528|18273851|P2|Overall Study|Lost to Follow-up|1
5301428|NCT00424528|18273852|P1|Overall Study|Lost to Follow-up|0
5301429|NCT00424528|18273850|P3|Overall Study|Protocol Violation|0
5301430|NCT00424528|18273851|P2|Overall Study|Protocol Violation|1
5301431|NCT00424528|18273852|P1|Overall Study|Protocol Violation|1
5301432|NCT00424528|18273850|P3|Overall Study|Adverse Event|2
5301433|NCT00424528|18273851|P2|Overall Study|Adverse Event|1
5301434|NCT00424528|18273852|P1|Overall Study|Adverse Event|2
5301435|NCT00424515|18273907|P2|Overall Study|Withdrawal by Subject|0
5301436|NCT00424515|18273908|P1|Overall Study|Withdrawal by Subject|1
5301437|NCT00424515|18273907|P2|Overall Study|Intercurrent Illness|1
5301438|NCT00424515|18273908|P1|Overall Study|Intercurrent Illness|0
5301439|NCT00424515|18273907|P2|Overall Study|Adverse Event|1
5301440|NCT00424515|18273908|P1|Overall Study|Adverse Event|0
5301441|NCT00424515|18273907|P2|Overall Study|Progressive Disease|11
5301442|NCT00424515|18273908|P1|Overall Study|Progressive Disease|10
5301443|NCT00424489|18273927|P1|Overall Study|Death|3
5301444|NCT00424476|18273934|P3|Overall Study|Other|9
5301445|NCT00424476|18273935|P2|Overall Study|Other|3
5301446|NCT00424476|18273936|P1|Overall Study|Other|4
5301447|NCT00424476|18273934|P3|Overall Study|Physician Decision|3
5301448|NCT00424476|18273935|P2|Overall Study|Physician Decision|2
5301449|NCT00424476|18273936|P1|Overall Study|Physician Decision|3
5301450|NCT00424476|18273934|P3|Overall Study|Protocol Violation|3
5301451|NCT00424476|18273935|P2|Overall Study|Protocol Violation|2
5301452|NCT00424476|18273936|P1|Overall Study|Protocol Violation|7
5301453|NCT00424476|18273934|P3|Overall Study|Lost to Follow-up|3
5301454|NCT00424476|18273935|P2|Overall Study|Lost to Follow-up|6
5301455|NCT00424476|18273936|P1|Overall Study|Lost to Follow-up|4
5301456|NCT00424476|18273934|P3|Overall Study|Lack of Compliance|1
5301457|NCT00424476|18273935|P2|Overall Study|Lack of Compliance|1
5301458|NCT00424476|18273936|P1|Overall Study|Lack of Compliance|1
5301459|NCT00424476|18273934|P3|Overall Study|Lack of Efficacy|12
5301460|NCT00424476|18273935|P2|Overall Study|Lack of Efficacy|12
5301461|NCT00424476|18273936|P1|Overall Study|Lack of Efficacy|16
5301462|NCT00424476|18273934|P3|Overall Study|Adverse Event|15
5301463|NCT00424476|18273935|P2|Overall Study|Adverse Event|16
5301464|NCT00424476|18273936|P1|Overall Study|Adverse Event|19
5301465|NCT00424476|18273934|P3|Overall Study|Withdrawal by Subject|3
5301466|NCT00424476|18273935|P2|Overall Study|Withdrawal by Subject|6
5301467|NCT00424476|18273936|P1|Overall Study|Withdrawal by Subject|7
5301468|NCT00424463|18273962|P3|Overall Study|Patient's convenience|1
5301469|NCT00424463|18273963|P2|Overall Study|Patient's convenience|0
5301470|NCT00424463|18273964|P1|Overall Study|Patient's convenience|0
5301471|NCT00424463|18273962|P3|Overall Study|Tracheotomy due to worsening of ALS|6
5301472|NCT00424463|18273963|P2|Overall Study|Tracheotomy due to worsening of ALS|7
5301473|NCT00424463|18273964|P1|Overall Study|Tracheotomy due to worsening of ALS|1
5301474|NCT00424463|18273962|P3|Overall Study|Withdrawal by Subject|5
5301475|NCT00424463|18273963|P2|Overall Study|Withdrawal by Subject|2
5301476|NCT00424463|18273964|P1|Overall Study|Withdrawal by Subject|4
5301477|NCT00424463|18273962|P3|Overall Study|Physician Decision|2
5301478|NCT00424463|18273963|P2|Overall Study|Physician Decision|2
5301479|NCT00424463|18273964|P1|Overall Study|Physician Decision|0
5301480|NCT00424463|18273962|P3|Overall Study|Adverse Event|2
5301481|NCT00424463|18273963|P2|Overall Study|Adverse Event|3
5301482|NCT00424463|18273964|P1|Overall Study|Adverse Event|2
5301483|NCT00424398|18273993|P3|Overall Study|Subject met exclusion criteria|0
5301484|NCT00424398|18273994|P2|Overall Study|Subject met exclusion criteria|0
5301485|NCT00424398|18273995|P1|Overall Study|Subject met exclusion criteria|1
5301486|NCT00424398|18273993|P3|Overall Study|Withdrawal by Subject|0
5301487|NCT00424398|18273994|P2|Overall Study|Withdrawal by Subject|1
5301488|NCT00424398|18273995|P1|Overall Study|Withdrawal by Subject|2
5301489|NCT00424385|18274039|P1|Cohort 1|Withdrawal by Subject|1
5301490|NCT00424385|18274039|P1|Cohort 0|Physician Decision|1
5301491|NCT00424385|18274039|P1|Cohort 0|Withdrawal by Subject|5
5301492|NCT00424372|18274046|P1|Overall Study|Lack of Efficacy|6
5301493|NCT00424372|18274046|P1|Overall Study|Protocol Violation|1
5301494|NCT00424372|18274046|P1|Overall Study|Withdrawal by Subject|4
5301495|NCT00424372|18274046|P1|Overall Study|Health deterioration|1
5301496|NCT00424372|18274046|P1|Overall Study|Adverse Event|18
5301497|NCT00424372|18274046|P1|Overall Study|Death|1
5301498|NCT00424346|18274058|P4|Extension Phase|Protocol Violation|0
5301499|NCT00424346|18274059|P3|Extension Phase|Protocol Violation|1
5301500|NCT00424346|18274060|P2|Extension Phase|Protocol Violation|1
5301501|NCT00424346|18274061|P1|Extension Phase|Protocol Violation|0
5301502|NCT00424346|18274058|P4|Extension Phase|Death|1
5301503|NCT00424346|18274059|P3|Extension Phase|Death|0
5301504|NCT00424346|18274060|P2|Extension Phase|Death|0
5301505|NCT00424346|18274061|P1|Extension Phase|Death|0
5301506|NCT00424346|18274058|P4|Extension Phase|Administrative Problems|35
5301507|NCT00424346|18274059|P3|Extension Phase|Administrative Problems|32
5301508|NCT00424346|18274060|P2|Extension Phase|Administrative Problems|69
5301509|NCT00424346|18274061|P1|Extension Phase|Administrative Problems|0
5301510|NCT00424346|18274058|P4|Extension Phase|Lost to Follow-up|0
5301511|NCT00424346|18274059|P3|Extension Phase|Lost to Follow-up|0
5301512|NCT00424346|18274060|P2|Extension Phase|Lost to Follow-up|2
5301513|NCT00424346|18274061|P1|Extension Phase|Lost to Follow-up|0
5301514|NCT00424346|18274058|P4|Extension Phase|Withdrawal by Subject|4
5301515|NCT00424346|18274059|P3|Extension Phase|Withdrawal by Subject|3
5301516|NCT00424346|18274060|P2|Extension Phase|Withdrawal by Subject|5
5301517|NCT00424346|18274061|P1|Extension Phase|Withdrawal by Subject|0
5301518|NCT00424346|18274058|P4|Extension Phase|Lack of Efficacy|11
5301519|NCT00424346|18274059|P3|Extension Phase|Lack of Efficacy|14
5301520|NCT00424346|18274060|P2|Extension Phase|Lack of Efficacy|16
5301521|NCT00424346|18274061|P1|Extension Phase|Lack of Efficacy|0
5301522|NCT00424346|18274058|P4|Extension Phase|Adverse Event|4
5301523|NCT00424346|18274059|P3|Extension Phase|Adverse Event|5
5301524|NCT00424346|18274060|P2|Extension Phase|Adverse Event|9
5301525|NCT00424346|18274061|P1|Extension Phase|Adverse Event|0
5301526|NCT00424346|18274058|P4|Core Study|Protocol Violation|0
5301527|NCT00424346|18274059|P3|Core Study|Protocol Violation|2
5301528|NCT00424346|18274060|P2|Core Study|Protocol Violation|0
5301529|NCT00424346|18274061|P1|Core Study|Protocol Violation|0
5301530|NCT00424346|18274058|P4|Core Study|Administrative Problems|0
5301531|NCT00424346|18274059|P3|Core Study|Administrative Problems|1
5301532|NCT00424346|18274060|P2|Core Study|Administrative Problems|0
5301533|NCT00424346|18274061|P1|Core Study|Administrative Problems|1
5301534|NCT00424346|18274058|P4|Core Study|Lost to Follow-up|0
5301535|NCT00424346|18274059|P3|Core Study|Lost to Follow-up|0
5301536|NCT00424346|18274060|P2|Core Study|Lost to Follow-up|1
5301537|NCT00424346|18274061|P1|Core Study|Lost to Follow-up|1
5301538|NCT00424346|18274058|P4|Core Study|Withdrawal by Subject|2
5301539|NCT00424346|18274059|P3|Core Study|Withdrawal by Subject|0
5301540|NCT00424346|18274060|P2|Core Study|Withdrawal by Subject|0
5301541|NCT00424346|18274061|P1|Core Study|Withdrawal by Subject|1
5301542|NCT00424346|18274058|P4|Core Study|Lack of Efficacy|4
5301543|NCT00424346|18274059|P3|Core Study|Lack of Efficacy|0
5301544|NCT00424346|18274060|P2|Core Study|Lack of Efficacy|3
5301545|NCT00424346|18274061|P1|Core Study|Lack of Efficacy|1
5301546|NCT00424346|18274058|P4|Core Study|Abnormal Laboratory Values|0
5301547|NCT00424346|18274059|P3|Core Study|Abnormal Laboratory Values|0
5301548|NCT00424346|18274060|P2|Core Study|Abnormal Laboratory Values|1
5301549|NCT00424346|18274061|P1|Core Study|Abnormal Laboratory Values|0
5301550|NCT00424346|18274058|P4|Core Study|Adverse Event|1
5301551|NCT00424346|18274059|P3|Core Study|Adverse Event|1
5301552|NCT00424346|18274060|P2|Core Study|Adverse Event|3
5301553|NCT00424346|18274061|P1|Core Study|Adverse Event|5
5301554|NCT00424294|18274176|P2|Overall Study|Randomized but not Treated|0
5301555|NCT00424294|18274177|P1|Overall Study|Randomized but not Treated|1
5301556|NCT00424294|18274176|P2|Overall Study|Other|2
5301557|NCT00424294|18274177|P1|Overall Study|Other|0
5301558|NCT00424294|18274176|P2|Overall Study|Withdrawal by Subject|2
5301559|NCT00424294|18274177|P1|Overall Study|Withdrawal by Subject|1
5301560|NCT00424294|18274176|P2|Overall Study|Lack of Efficacy|1
5301561|NCT00424294|18274177|P1|Overall Study|Lack of Efficacy|2
5301562|NCT00424294|18274176|P2|Overall Study|Adverse Event|10
5301563|NCT00424294|18274177|P1|Overall Study|Adverse Event|4
5301564|NCT00424255|18274244|P2|Overall Study|Sponsor Terminated Study|167
5301565|NCT00424255|18274245|P1|Overall Study|Sponsor Terminated Study|161
5301566|NCT00424255|18274244|P2|Overall Study|Disease Progression|2
5301567|NCT00424255|18274245|P1|Overall Study|Disease Progression|0
5301568|NCT00424255|18274244|P2|Overall Study|Fatigue|0
5301569|NCT00424255|18274245|P1|Overall Study|Fatigue|1
5301570|NCT00424255|18274244|P2|Overall Study|Non-compliance by Participants|0
5301571|NCT00424255|18274245|P1|Overall Study|Non-compliance by Participants|1
5301572|NCT00424255|18274244|P2|Overall Study|Cognitive Disturbance|0
5301573|NCT00424255|18274245|P1|Overall Study|Cognitive Disturbance|1
5301574|NCT00424255|18274244|P2|Overall Study|Physician Decision|7
5301575|NCT00424255|18274245|P1|Overall Study|Physician Decision|3
5301576|NCT00424255|18274244|P2|Overall Study|Withdrawal by Subject|38
5301577|NCT00424255|18274245|P1|Overall Study|Withdrawal by Subject|34
5301578|NCT00424255|18274244|P2|Overall Study|Protocol Violation|1
5301579|NCT00424255|18274245|P1|Overall Study|Protocol Violation|0
5301580|NCT00424255|18274244|P2|Overall Study|Lost to Follow-up|20
5301581|NCT00424255|18274245|P1|Overall Study|Lost to Follow-up|26
5301582|NCT00424255|18274244|P2|Overall Study|Death|111
5301583|NCT00424255|18274245|P1|Overall Study|Death|115
5301584|NCT00424190|18274293|P2|Overall Study|Other|21
5301585|NCT00424190|18274294|P1|Overall Study|Other|15
5301586|NCT00424190|18274293|P2|Overall Study|Diagnosis of osteomyelitis|1
5301587|NCT00424190|18274294|P1|Overall Study|Diagnosis of osteomyelitis|0
5301588|NCT00424190|18274293|P2|Overall Study|Request of sponsor or investigator|2
5301589|NCT00424190|18274294|P1|Overall Study|Request of sponsor or investigator|0
5301590|NCT00424190|18274293|P2|Overall Study|Noncompliance|2
5301591|NCT00424190|18274294|P1|Overall Study|Noncompliance|1
5301592|NCT00424190|18274293|P2|Overall Study|Death|0
5301593|NCT00424190|18274294|P1|Overall Study|Death|3
5301594|NCT00424190|18274293|P2|Overall Study|Withdrew consent|4
5301595|NCT00424190|18274294|P1|Overall Study|Withdrew consent|3
5301596|NCT00424177|18274300|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
5301597|NCT00424177|18274300|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
5301598|NCT00424177|18274300|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
5301599|NCT00424177|18274300|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
5301600|NCT00424177|18274300|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
5301601|NCT00424177|18274300|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
5301602|NCT00424177|18274300|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
5301603|NCT00424177|18274300|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
5301604|NCT00424177|18274300|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
5301605|NCT00424177|18274300|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
5301606|NCT00424047|18274329|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
5301607|NCT00424047|18274330|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
5301608|NCT00424047|18274329|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
5301609|NCT00424047|18274330|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
5301610|NCT00424047|18274329|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
5301611|NCT00424047|18274330|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
5301612|NCT00424047|18274329|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
5301613|NCT00424047|18274330|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
5301614|NCT00424047|18274329|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
5301615|NCT00424047|18274330|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
5301616|NCT00424047|18274329|P2|On Study at Time of Unblinding|Other|4
5301617|NCT00424047|18274330|P1|On Study at Time of Unblinding|Other|5
5301618|NCT00424047|18274329|P2|On Study at Time of Unblinding|Death|11
5301619|NCT00424047|18274330|P1|On Study at Time of Unblinding|Death|11
5301620|NCT00424047|18274329|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
5301621|NCT00424047|18274330|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
5301622|NCT00424047|18274329|P2|On Study at Time of Unblinding|Lack of Efficacy|3
5301623|NCT00424047|18274330|P1|On Study at Time of Unblinding|Lack of Efficacy|1
5301624|NCT00424047|18274329|P2|On Study at Time of Unblinding|Progression of disease|128
5301625|NCT00424047|18274330|P1|On Study at Time of Unblinding|Progression of disease|92
5301626|NCT00424047|18274329|P2|On Study at Time of Unblinding|Adverse Event|12
5301627|NCT00424047|18274330|P1|On Study at Time of Unblinding|Adverse Event|22
5301628|NCT00424047|18274329|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
5301629|NCT00424047|18274330|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
5301630|NCT00424047|18274329|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
5301631|NCT00424047|18274330|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
5301632|NCT00424047|18274329|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
5301633|NCT00424047|18274330|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
5301634|NCT00424047|18274329|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
5301635|NCT00424047|18274330|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
5301636|NCT00424047|18274329|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
5301637|NCT00424047|18274330|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
5301638|NCT00424047|18274329|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
5301639|NCT00424047|18274330|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
5301640|NCT00424021|18274362|P4|AMB-220-E Study Period|Physician Decision|1
5301641|NCT00424021|18274363|P3|AMB-220-E Study Period|Physician Decision|0
5301642|NCT00424021|18274364|P2|AMB-220-E Study Period|Physician Decision|0
5301643|NCT00424021|18274365|P1|AMB-220-E Study Period|Physician Decision|0
5301644|NCT00424021|18274362|P4|AMB-220-E Study Period|Lost to Follow-up|1
5301645|NCT00424021|18274363|P3|AMB-220-E Study Period|Lost to Follow-up|1
5301646|NCT00424021|18274364|P2|AMB-220-E Study Period|Lost to Follow-up|1
5301647|NCT00424021|18274365|P1|AMB-220-E Study Period|Lost to Follow-up|0
5301648|NCT00424021|18274362|P4|AMB-220-E Study Period|Death|1
5301649|NCT00424021|18274363|P3|AMB-220-E Study Period|Death|1
5301650|NCT00424021|18274364|P2|AMB-220-E Study Period|Death|0
5301651|NCT00424021|18274365|P1|AMB-220-E Study Period|Death|0
5301652|NCT00424021|18274362|P4|AMB-220-E Study Period|Adverse Event|7
5301653|NCT00424021|18274363|P3|AMB-220-E Study Period|Adverse Event|3
5301654|NCT00424021|18274364|P2|AMB-220-E Study Period|Adverse Event|1
5301655|NCT00424021|18274365|P1|AMB-220-E Study Period|Adverse Event|1
5301656|NCT00424021|18274362|P4|NCT00046319 Study Period|Lost to Follow-up|0
5301657|NCT00424021|18274363|P3|NCT00046319 Study Period|Lost to Follow-up|0
5301658|NCT00424021|18274364|P2|NCT00046319 Study Period|Lost to Follow-up|1
5301659|NCT00424021|18274365|P1|NCT00046319 Study Period|Lost to Follow-up|0
5301660|NCT00424021|18274362|P4|NCT00046319 Study Period|Sponsor discretion|0
5301661|NCT00424021|18274363|P3|NCT00046319 Study Period|Sponsor discretion|0
5301662|NCT00424021|18274364|P2|NCT00046319 Study Period|Sponsor discretion|1
5301663|NCT00424021|18274365|P1|NCT00046319 Study Period|Sponsor discretion|0
5301664|NCT00424021|18274362|P4|NCT00046319 Study Period|Withdrawal by Subject|0
5301665|NCT00424021|18274363|P3|NCT00046319 Study Period|Withdrawal by Subject|0
5301666|NCT00424021|18274364|P2|NCT00046319 Study Period|Withdrawal by Subject|1
5301667|NCT00424021|18274365|P1|NCT00046319 Study Period|Withdrawal by Subject|0
5301668|NCT00424021|18274362|P4|NCT00046319 Study Period|Adverse Event|1
5301669|NCT00424021|18274363|P3|NCT00046319 Study Period|Adverse Event|1
5301670|NCT00424021|18274364|P2|NCT00046319 Study Period|Adverse Event|0
5301671|NCT00424021|18274365|P1|NCT00046319 Study Period|Adverse Event|1
5301672|NCT00424008|18274408|P2|Overall Study|Administrative|257
5301673|NCT00424008|18274409|P1|Overall Study|Administrative|266
5301674|NCT00424008|18274408|P2|Overall Study|Did not meet protocol eligibility|21
5301675|NCT00424008|18274409|P1|Overall Study|Did not meet protocol eligibility|16
5301676|NCT00424008|18274408|P2|Overall Study|Noncompliance with protocol|7
5301677|NCT00424008|18274409|P1|Overall Study|Noncompliance with protocol|13
5301678|NCT00424008|18274408|P2|Overall Study|Withdrawal by Subject|8
5301679|NCT00424008|18274409|P1|Overall Study|Withdrawal by Subject|5
5301680|NCT00424008|18274408|P2|Overall Study|Lost to Follow-up|2
5301681|NCT00424008|18274409|P1|Overall Study|Lost to Follow-up|1
5301682|NCT00424008|18274408|P2|Overall Study|Lack of Efficacy|34
5301683|NCT00424008|18274409|P1|Overall Study|Lack of Efficacy|40
5301684|NCT00424008|18274408|P2|Overall Study|Adverse Event|6
5301685|NCT00424008|18274409|P1|Overall Study|Adverse Event|8
5301686|NCT00423943|18274424|P2|Overall Study|Withdrawal by Subject|1
5301687|NCT00423943|18274425|P1|Overall Study|Withdrawal by Subject|3
5301688|NCT00423930|18274439|P1|Overall Study|Withdrawal by Subject|2
5301689|NCT00423917|18274444|P1|Overall Study|Ineligible|1
5301690|NCT00423917|18274444|P1|Overall Study|Cancel|2
5301691|NCT00423891|18274457|P3|Post-Dosing Follow Up|Lost to Follow-up|0
5301692|NCT00423891|18274458|P2|Post-Dosing Follow Up|Lost to Follow-up|0
5301693|NCT00423891|18274459|P1|Post-Dosing Follow Up|Lost to Follow-up|2
5301694|NCT00423891|18274457|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
5301695|NCT00423891|18274458|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
5301696|NCT00423891|18274459|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
5301697|NCT00423891|18274457|P3|Treatment|Lost to Follow-up|0
5301698|NCT00423891|18274458|P2|Treatment|Lost to Follow-up|0
5301699|NCT00423891|18274459|P1|Treatment|Lost to Follow-up|1
5301700|NCT00423891|18274457|P3|Treatment|Withdrawal by Subject|0
5301701|NCT00423891|18274458|P2|Treatment|Withdrawal by Subject|0
5301702|NCT00423891|18274459|P1|Treatment|Withdrawal by Subject|1
5301703|NCT00423891|18274457|P3|Enrolled|No longer met criteria|1
5301704|NCT00423891|18274458|P2|Enrolled|No longer met criteria|2
5301705|NCT00423891|18274459|P1|Enrolled|No longer met criteria|11
5301706|NCT00423891|18274457|P3|Enrolled|Lost to Follow-up|1
5301707|NCT00423891|18274458|P2|Enrolled|Lost to Follow-up|0
5301708|NCT00423891|18274459|P1|Enrolled|Lost to Follow-up|0
5301709|NCT00423891|18274457|P3|Enrolled|Withdrawal by Subject|1
5301710|NCT00423891|18274458|P2|Enrolled|Withdrawal by Subject|0
5301711|NCT00423891|18274459|P1|Enrolled|Withdrawal by Subject|0
5301712|NCT00423852|18274537|P1|Overall Study|Removed pior to the high-dose portion|3
5301713|NCT00423813|18274545|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
5301714|NCT00423813|18274546|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
5301715|NCT00423813|18274547|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
5301716|NCT00423813|18274545|P3|Overall Study|Will start exclusionary medications|0
5301717|NCT00423813|18274546|P2|Overall Study|Will start exclusionary medications|1
5301718|NCT00423813|18274547|P1|Overall Study|Will start exclusionary medications|0
5301719|NCT00423813|18274545|P3|Overall Study|Subject started night shift work|0
5301720|NCT00423813|18274546|P2|Overall Study|Subject started night shift work|0
5301721|NCT00423813|18274547|P1|Overall Study|Subject started night shift work|1
5301722|NCT00423813|18274545|P3|Overall Study|Pregnancy|1
5301723|NCT00423813|18274546|P2|Overall Study|Pregnancy|0
5301724|NCT00423813|18274547|P1|Overall Study|Pregnancy|0
5301725|NCT00423813|18274545|P3|Overall Study|Protocol Violation|4
5301726|NCT00423813|18274546|P2|Overall Study|Protocol Violation|4
5301727|NCT00423813|18274547|P1|Overall Study|Protocol Violation|9
5301728|NCT00423813|18274545|P3|Overall Study|Sponsor Decision|0
5301729|NCT00423813|18274546|P2|Overall Study|Sponsor Decision|1
5301730|NCT00423813|18274547|P1|Overall Study|Sponsor Decision|0
5301731|NCT00423813|18274545|P3|Overall Study|Physician Decision|0
5301732|NCT00423813|18274546|P2|Overall Study|Physician Decision|0
5301733|NCT00423813|18274547|P1|Overall Study|Physician Decision|2
5301734|NCT00423813|18274545|P3|Overall Study|Lack of Efficacy|19
5301735|NCT00423813|18274546|P2|Overall Study|Lack of Efficacy|18
5301736|NCT00423813|18274547|P1|Overall Study|Lack of Efficacy|23
5301737|NCT00423813|18274545|P3|Overall Study|Lost to Follow-up|4
5301738|NCT00423813|18274546|P2|Overall Study|Lost to Follow-up|4
5301739|NCT00423813|18274547|P1|Overall Study|Lost to Follow-up|5
5301740|NCT00423813|18274545|P3|Overall Study|Withdrawal by Subject|5
5301741|NCT00423813|18274546|P2|Overall Study|Withdrawal by Subject|8
5301742|NCT00423813|18274547|P1|Overall Study|Withdrawal by Subject|6
5301743|NCT00423813|18274545|P3|Overall Study|Adverse Event|40
5301744|NCT00423813|18274546|P2|Overall Study|Adverse Event|30
5301745|NCT00423813|18274547|P1|Overall Study|Adverse Event|11
5301746|NCT00423800|18274557|P2|Overall Study|Protocol Violation|1
5301747|NCT00423800|18274558|P1|Overall Study|Protocol Violation|0
5301748|NCT00423735|18274570|P3|Overall Study|Ineligible / No protocol treatment|0
5301749|NCT00423735|18274571|P2|Overall Study|Ineligible / No protocol treatment|6
5301750|NCT00423735|18274572|P1|Overall Study|Ineligible / No protocol treatment|8
5301751|NCT00423722|18274595|P2|Overall Study|Withdrawal by Subject|2
5301752|NCT00423722|18274596|P1|Overall Study|Withdrawal by Subject|4
5301753|NCT00423722|18274595|P2|Overall Study|Unable to complete questionnaires|4
5301754|NCT00423722|18274596|P1|Overall Study|Unable to complete questionnaires|4
5301755|NCT00423722|18274595|P2|Overall Study|Declined to participate|3
5301756|NCT00423722|18274596|P1|Overall Study|Declined to participate|2
5301757|NCT00423722|18274595|P2|Overall Study|Death|4
5301758|NCT00423722|18274596|P1|Overall Study|Death|4
5301759|NCT00423670|18274638|P8|Follow-up Period|Non-compliance with protocol|2
5301760|NCT00423670|18274639|P7|Follow-up Period|Non-compliance with protocol|3
5301761|NCT00423670|18274640|P6|Follow-up Period|Non-compliance with protocol|0
5301762|NCT00423670|18274641|P5|Follow-up Period|Non-compliance with protocol|0
5301763|NCT00423670|18274642|P4|Follow-up Period|Non-compliance with protocol|1
5301764|NCT00423670|18274643|P3|Follow-up Period|Non-compliance with protocol|1
5301765|NCT00423670|18274644|P2|Follow-up Period|Non-compliance with protocol|0
5301766|NCT00423670|18274645|P1|Follow-up Period|Non-compliance with protocol|2
5301767|NCT00423670|18274638|P8|Follow-up Period|Subject withdrew (not treatment related)|1
5301768|NCT00423670|18274639|P7|Follow-up Period|Subject withdrew (not treatment related)|1
5301769|NCT00423670|18274640|P6|Follow-up Period|Subject withdrew (not treatment related)|0
5301770|NCT00423670|18274641|P5|Follow-up Period|Subject withdrew (not treatment related)|1
5301771|NCT00423670|18274642|P4|Follow-up Period|Subject withdrew (not treatment related)|1
5301772|NCT00423670|18274643|P3|Follow-up Period|Subject withdrew (not treatment related)|2
5301773|NCT00423670|18274644|P2|Follow-up Period|Subject withdrew (not treatment related)|4
5301774|NCT00423670|18274645|P1|Follow-up Period|Subject withdrew (not treatment related)|1
5301775|NCT00423670|18274638|P8|Follow-up Period|Lost to Follow-up|0
5301776|NCT00423670|18274639|P7|Follow-up Period|Lost to Follow-up|5
5301777|NCT00423670|18274640|P6|Follow-up Period|Lost to Follow-up|0
5301778|NCT00423670|18274641|P5|Follow-up Period|Lost to Follow-up|1
5301779|NCT00423670|18274642|P4|Follow-up Period|Lost to Follow-up|3
5301780|NCT00423670|18274643|P3|Follow-up Period|Lost to Follow-up|8
5301781|NCT00423670|18274644|P2|Follow-up Period|Lost to Follow-up|12
5301782|NCT00423670|18274645|P1|Follow-up Period|Lost to Follow-up|0
5301783|NCT00423670|18274638|P8|Treatment Period|Non-compliance with protocol|2
5301784|NCT00423670|18274639|P7|Treatment Period|Non-compliance with protocol|2
5301785|NCT00423670|18274640|P6|Treatment Period|Non-compliance with protocol|0
5301786|NCT00423670|18274641|P5|Treatment Period|Non-compliance with protocol|2
5301787|NCT00423670|18274642|P4|Treatment Period|Non-compliance with protocol|3
5301788|NCT00423670|18274643|P3|Treatment Period|Non-compliance with protocol|1
5301789|NCT00423670|18274644|P2|Treatment Period|Non-compliance with protocol|1
5301790|NCT00423670|18274645|P1|Treatment Period|Non-compliance with protocol|3
5301791|NCT00423670|18274638|P8|Treatment Period|Investigator decision|1
5301792|NCT00423670|18274639|P7|Treatment Period|Investigator decision|0
5301793|NCT00423670|18274640|P6|Treatment Period|Investigator decision|0
5301794|NCT00423670|18274641|P5|Treatment Period|Investigator decision|0
5301795|NCT00423670|18274642|P4|Treatment Period|Investigator decision|0
5301796|NCT00423670|18274643|P3|Treatment Period|Investigator decision|0
5301797|NCT00423670|18274644|P2|Treatment Period|Investigator decision|0
5301798|NCT00423670|18274645|P1|Treatment Period|Investigator decision|0
5301799|NCT00423670|18274638|P8|Treatment Period|Subject withdrew (not treatment related)|0
5301800|NCT00423670|18274639|P7|Treatment Period|Subject withdrew (not treatment related)|3
5301801|NCT00423670|18274640|P6|Treatment Period|Subject withdrew (not treatment related)|0
5301802|NCT00423670|18274641|P5|Treatment Period|Subject withdrew (not treatment related)|5
5301803|NCT00423670|18274642|P4|Treatment Period|Subject withdrew (not treatment related)|4
5301804|NCT00423670|18274643|P3|Treatment Period|Subject withdrew (not treatment related)|4
5301805|NCT00423670|18274644|P2|Treatment Period|Subject withdrew (not treatment related)|9
5301806|NCT00423670|18274645|P1|Treatment Period|Subject withdrew (not treatment related)|3
5301807|NCT00423670|18274638|P8|Treatment Period|Lost to Follow-up|1
5301808|NCT00423670|18274639|P7|Treatment Period|Lost to Follow-up|3
5301809|NCT00423670|18274640|P6|Treatment Period|Lost to Follow-up|0
5301810|NCT00423670|18274641|P5|Treatment Period|Lost to Follow-up|6
5301811|NCT00423670|18274642|P4|Treatment Period|Lost to Follow-up|1
5301812|NCT00423670|18274643|P3|Treatment Period|Lost to Follow-up|3
5301813|NCT00423670|18274644|P2|Treatment Period|Lost to Follow-up|1
5301814|NCT00423670|18274645|P1|Treatment Period|Lost to Follow-up|2
5301815|NCT00423670|18274638|P8|Treatment Period|Protocol-defined clinical event|15
5301816|NCT00423670|18274639|P7|Treatment Period|Protocol-defined clinical event|16
5301817|NCT00423670|18274640|P6|Treatment Period|Protocol-defined clinical event|4
5301818|NCT00423670|18274641|P5|Treatment Period|Protocol-defined clinical event|5
5301819|NCT00423670|18274642|P4|Treatment Period|Protocol-defined clinical event|12
5301820|NCT00423670|18274643|P3|Treatment Period|Protocol-defined clinical event|4
5301821|NCT00423670|18274644|P2|Treatment Period|Protocol-defined clinical event|7
5301822|NCT00423670|18274645|P1|Treatment Period|Protocol-defined clinical event|0
5301823|NCT00423670|18274638|P8|Treatment Period|Adverse Event|2
5301824|NCT00423670|18274639|P7|Treatment Period|Adverse Event|7
5301825|NCT00423670|18274640|P6|Treatment Period|Adverse Event|4
5301826|NCT00423670|18274641|P5|Treatment Period|Adverse Event|9
5301827|NCT00423670|18274642|P4|Treatment Period|Adverse Event|20
5301828|NCT00423670|18274643|P3|Treatment Period|Adverse Event|15
5301829|NCT00423670|18274644|P2|Treatment Period|Adverse Event|12
5301830|NCT00423670|18274645|P1|Treatment Period|Adverse Event|8
5301831|NCT00423670|18274638|P8|Treatment Period|Switched to Arm 8 at TW 24|0
5301832|NCT00423670|18274639|P7|Treatment Period|Switched to Arm 8 at TW 24|0
5301833|NCT00423670|18274640|P6|Treatment Period|Switched to Arm 8 at TW 24|0
5301834|NCT00423670|18274641|P5|Treatment Period|Switched to Arm 8 at TW 24|0
5301835|NCT00423670|18274642|P4|Treatment Period|Switched to Arm 8 at TW 24|0
5301836|NCT00423670|18274643|P3|Treatment Period|Switched to Arm 8 at TW 24|0
5301837|NCT00423670|18274644|P2|Treatment Period|Switched to Arm 8 at TW 24|0
5301838|NCT00423670|18274645|P1|Treatment Period|Switched to Arm 8 at TW 24|36
5301839|NCT00423657|18274703|P2|Overall Study|Request of sponsor/investigator|0
5301840|NCT00423657|18274704|P1|Overall Study|Request of sponsor/investigator|1
5301841|NCT00423657|18274703|P2|Overall Study|Other|16
5301842|NCT00423657|18274704|P1|Overall Study|Other|15
5301843|NCT00423657|18274703|P2|Overall Study|Non-compliance|1
5301844|NCT00423657|18274704|P1|Overall Study|Non-compliance|0
5301845|NCT00423657|18274703|P2|Overall Study|Withdrew consent|8
5301846|NCT00423657|18274704|P1|Overall Study|Withdrew consent|10
5301847|NCT00423605|18274710|P1|Overall Study|Not one of the pre-specified options|5
5301848|NCT00423605|18274710|P1|Overall Study|Protocol Violation|7
5301849|NCT00423605|18274710|P1|Overall Study|Physician Decision|8
5301850|NCT00423605|18274710|P1|Overall Study|Sponsor Decision|3
5301851|NCT00423605|18274710|P1|Overall Study|Lack of Efficacy|38
5301852|NCT00423605|18274710|P1|Overall Study|Lost to Follow-up|15
5301853|NCT00423605|18274710|P1|Overall Study|Withdrawal by Subject|36
5301854|NCT00423605|18274710|P1|Overall Study|Adverse Event|129
5301855|NCT00423592|18274714|P1|Overall Study|Adverse Event (post Week 12)|5
5301856|NCT00423592|18274714|P1|Overall Study|Adverse Event (through Week 12)|2
5301857|NCT00423579|18274735|P2|Overall Study|Diagnosis of diabetes|1
5301858|NCT00423579|18274736|P1|Overall Study|Diagnosis of diabetes|0
5301859|NCT00423579|18274735|P2|Overall Study|Protocol Violation|3
5301860|NCT00423579|18274736|P1|Overall Study|Protocol Violation|1
5301861|NCT00423579|18274735|P2|Overall Study|Lost to Follow-up|0
5301862|NCT00423579|18274736|P1|Overall Study|Lost to Follow-up|3
5301863|NCT00423488|18274744|P2|Overall Study|No post baseline data|0
5301864|NCT00423488|18274745|P1|Overall Study|No post baseline data|3
5301865|NCT00423488|18274744|P2|Overall Study|No evidence of study drug intake|1
5301866|NCT00423488|18274745|P1|Overall Study|No evidence of study drug intake|2
5301867|NCT00423449|18274751|P5|Overall Study|Protocol Violation|0
5301868|NCT00423449|18274752|P4|Overall Study|Protocol Violation|1
5301869|NCT00423449|18274753|P3|Overall Study|Protocol Violation|2
5301870|NCT00423449|18274754|P2|Overall Study|Protocol Violation|0
5301871|NCT00423449|18274755|P1|Overall Study|Protocol Violation|0
5301872|NCT00423449|18274751|P5|Overall Study|Other|0
5301873|NCT00423449|18274752|P4|Overall Study|Other|1
5301874|NCT00423449|18274753|P3|Overall Study|Other|0
5301875|NCT00423449|18274754|P2|Overall Study|Other|0
5301876|NCT00423449|18274755|P1|Overall Study|Other|0
5301877|NCT00423449|18274751|P5|Overall Study|Laboratory Adverse Event|0
5301878|NCT00423449|18274752|P4|Overall Study|Laboratory Adverse Event|0
5301879|NCT00423449|18274753|P3|Overall Study|Laboratory Adverse Event|2
5301880|NCT00423449|18274754|P2|Overall Study|Laboratory Adverse Event|1
5301881|NCT00423449|18274755|P1|Overall Study|Laboratory Adverse Event|0
5301882|NCT00423449|18274751|P5|Overall Study|Progressive Disease|4
5301883|NCT00423449|18274752|P4|Overall Study|Progressive Disease|11
5301884|NCT00423449|18274753|P3|Overall Study|Progressive Disease|8
5301885|NCT00423449|18274754|P2|Overall Study|Progressive Disease|3
5301886|NCT00423449|18274755|P1|Overall Study|Progressive Disease|1
5301887|NCT00423449|18274751|P5|Overall Study|Death|1
5301888|NCT00423449|18274752|P4|Overall Study|Death|1
5301889|NCT00423449|18274753|P3|Overall Study|Death|2
5301890|NCT00423449|18274754|P2|Overall Study|Death|0
5301891|NCT00423449|18274755|P1|Overall Study|Death|1
5301892|NCT00423449|18274751|P5|Overall Study|Clinical Adverse Event|2
5301893|NCT00423449|18274752|P4|Overall Study|Clinical Adverse Event|8
5301894|NCT00423449|18274753|P3|Overall Study|Clinical Adverse Event|1
5301895|NCT00423449|18274754|P2|Overall Study|Clinical Adverse Event|0
5301896|NCT00423449|18274755|P1|Overall Study|Clinical Adverse Event|1
5301897|NCT00423332|18274802|P2|Overall Study|Unblinded before 12 weeks|3
5301898|NCT00423332|18274803|P1|Overall Study|Unblinded before 12 weeks|1
5301899|NCT00423332|18274802|P2|Overall Study|Progressive at Week 6|1
5301900|NCT00423332|18274803|P1|Overall Study|Progressive at Week 6|0
5301901|NCT00423332|18274802|P2|Overall Study|Condition under investigation worsened|1
5301902|NCT00423332|18274803|P1|Overall Study|Condition under investigation worsened|1
5301903|NCT00423332|18274802|P2|Overall Study|Withdrawal by Subject|0
5301904|NCT00423332|18274803|P1|Overall Study|Withdrawal by Subject|1
5301905|NCT00423332|18274802|P2|Overall Study|Adverse Event|2
5301906|NCT00423332|18274803|P1|Overall Study|Adverse Event|6
5301907|NCT00423319|18274822|P2|Overall Study|Other|22
5301908|NCT00423319|18274823|P1|Overall Study|Other|23
5301909|NCT00423319|18274822|P2|Overall Study|No longer meets study criteria|15
5301910|NCT00423319|18274823|P1|Overall Study|No longer meets study criteria|15
5301911|NCT00423319|18274822|P2|Overall Study|Poor compliance or noncompliance|1
5301912|NCT00423319|18274823|P1|Overall Study|Poor compliance or noncompliance|1
5301913|NCT00423319|18274822|P2|Overall Study|Lost to Follow-up|3
5301914|NCT00423319|18274823|P1|Overall Study|Lost to Follow-up|4
5301915|NCT00423319|18274822|P2|Overall Study|Withdrawal by Subject|99
5301916|NCT00423319|18274823|P1|Overall Study|Withdrawal by Subject|86
5301917|NCT00423319|18274822|P2|Overall Study|Adverse Event|112
5301918|NCT00423319|18274823|P1|Overall Study|Adverse Event|93
5301919|NCT00423319|18274822|P2|Overall Study|Death|0
5301920|NCT00423319|18274823|P1|Overall Study|Death|2
5301921|NCT00423293|18274855|P1|Overall Study|Ineligible / No protocol treatment|11
5301922|NCT00423267|18274872|P2|Period A|Administrative|0
5301923|NCT00423267|18274873|P1|Period A|Administrative|1
5301924|NCT00423267|18274872|P2|Period A|Non-compliance with protocol|0
5301925|NCT00423267|18274873|P1|Period A|Non-compliance with protocol|1
5301926|NCT00423267|18274872|P2|Period A|Withdrawal by Subject|1
5301927|NCT00423267|18274873|P1|Period A|Withdrawal by Subject|0
5301928|NCT00423189|18274893|P3|Overall Study|Death|0
5301929|NCT00423189|18274894|P2|Overall Study|Death|1
5301930|NCT00423189|18274895|P1|Overall Study|Death|0
5301931|NCT00423176|18274917|P2|Overall Study|Did not meet protocol eligibility|4
5301932|NCT00423176|18274918|P1|Overall Study|Did not meet protocol eligibility|2
5301933|NCT00423176|18274917|P2|Overall Study|Protocol Violation|3
5301934|NCT00423176|18274918|P1|Overall Study|Protocol Violation|1
5301935|NCT00423176|18274917|P2|Overall Study|Withdrawal by Subject|3
5301936|NCT00423176|18274918|P1|Overall Study|Withdrawal by Subject|4
5301937|NCT00423176|18274917|P2|Overall Study|Lost to Follow-up|7
5301938|NCT00423176|18274918|P1|Overall Study|Lost to Follow-up|4
5301939|NCT00423176|18274917|P2|Overall Study|Treatment Failure|6
5301940|NCT00423176|18274918|P1|Overall Study|Treatment Failure|1
5301941|NCT00423176|18274917|P2|Overall Study|Adverse Event|6
5301942|NCT00423176|18274918|P1|Overall Study|Adverse Event|4
5301943|NCT00423150|18274926|P1|Overall Study|Administrative|4
5301944|NCT00423150|18274926|P1|Overall Study|Non-compliance with protocol|1
5301945|NCT00423150|18274926|P1|Overall Study|Withdrawal by Subject|1
5301946|NCT00423150|18274926|P1|Overall Study|Progression of disease being studied|69
5301947|NCT00423150|18274926|P1|Overall Study|Adverse Event|11
5301948|NCT00423098|18274932|P2|Overall Study|Death|0
5301949|NCT00423098|18274933|P1|Overall Study|Death|2
5301950|NCT00423098|18274932|P2|Overall Study|Administrative problems|1
5301951|NCT00423098|18274933|P1|Overall Study|Administrative problems|0
5301952|NCT00423098|18274932|P2|Overall Study|Unsatisfactory therapeutic effect|1
5301953|NCT00423098|18274933|P1|Overall Study|Unsatisfactory therapeutic effect|0
5301954|NCT00423098|18274932|P2|Overall Study|Adverse Event|2
5301955|NCT00423098|18274933|P1|Overall Study|Adverse Event|1
5301956|NCT00423085|18274960|P4|52-Week Open-Label Extension Phase|Death|2
5301957|NCT00423085|18274961|P3|52-Week Open-Label Extension Phase|Death|0
5301958|NCT00423085|18274962|P2|52-Week Open-Label Extension Phase|Death|0
5301959|NCT00423085|18274963|P1|52-Week Open-Label Extension Phase|Death|0
5301960|NCT00423085|18274960|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
5301961|NCT00423085|18274961|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
5301962|NCT00423085|18274962|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
5301963|NCT00423085|18274963|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
5301964|NCT00423085|18274960|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
5301965|NCT00423085|18274961|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
5301966|NCT00423085|18274962|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
5301967|NCT00423085|18274963|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
5301968|NCT00423085|18274960|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
5301969|NCT00423085|18274961|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
5301970|NCT00423085|18274962|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
5301971|NCT00423085|18274963|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
5301972|NCT00423085|18274960|P4|52-Week Open-Label Extension Phase|Adverse Event|97
5301973|NCT00423085|18274961|P3|52-Week Open-Label Extension Phase|Adverse Event|0
5301974|NCT00423085|18274962|P2|52-Week Open-Label Extension Phase|Adverse Event|0
5301975|NCT00423085|18274963|P1|52-Week Open-Label Extension Phase|Adverse Event|0
5301976|NCT00423085|18274960|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
5301977|NCT00423085|18274961|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
5301978|NCT00423085|18274962|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
5301979|NCT00423085|18274963|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
5301980|NCT00423085|18274960|P4|24-Week Double-Blind Treatment Phase|Death|0
5301981|NCT00423085|18274961|P3|24-Week Double-Blind Treatment Phase|Death|0
5301982|NCT00423085|18274962|P2|24-Week Double-Blind Treatment Phase|Death|1
5301983|NCT00423085|18274963|P1|24-Week Double-Blind Treatment Phase|Death|1
5301984|NCT00423085|18274960|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
5301985|NCT00423085|18274961|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
5301986|NCT00423085|18274962|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
5301987|NCT00423085|18274963|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
5301988|NCT00423085|18274960|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5301989|NCT00423085|18274961|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
5301990|NCT00423085|18274962|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
5301991|NCT00423085|18274963|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
5301992|NCT00423085|18274960|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
5301993|NCT00423085|18274961|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
5301994|NCT00423085|18274962|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
5301995|NCT00423085|18274963|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
5301996|NCT00423085|18274960|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
5301997|NCT00423085|18274961|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
5301998|NCT00423085|18274962|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
5301999|NCT00423085|18274963|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
5302000|NCT00423046|18274992|P2|Overall Study|Other|345
5302001|NCT00423046|18274993|P1|Overall Study|Other|340
5302002|NCT00422942|18275059|P1|Overall Study|Study terminated by Sponsor|3
5302003|NCT00422903|18275078|P2|Overall Study|Informed Consent Withdrawn|2
5302004|NCT00422903|18275079|P1|Overall Study|Informed Consent Withdrawn|1
5302005|NCT00422903|18275078|P2|Overall Study|Adverse Event|2
5302006|NCT00422903|18275079|P1|Overall Study|Adverse Event|0
5302007|NCT00422903|18275078|P2|Overall Study|Disease Progression|1
5302008|NCT00422903|18275079|P1|Overall Study|Disease Progression|3
5302009|NCT00422799|18275128|P1|Overall Study|Adverse Event|7
5302010|NCT00422799|18275128|P1|Overall Study|Withdrawal by Subject|6
5302011|NCT00422734|18275137|P2|Overall Study|Partner Decision|3
5302012|NCT00422734|18275138|P1|Overall Study|Partner Decision|0
5302013|NCT00422734|18275137|P2|Overall Study|Adverse Event|3
5302014|NCT00422734|18275138|P1|Overall Study|Adverse Event|0
5302015|NCT00422734|18275137|P2|Overall Study|Withdrawal by Subject|8
5302016|NCT00422734|18275138|P1|Overall Study|Withdrawal by Subject|12
5302017|NCT00422734|18275137|P2|Overall Study|Protocol Violation|6
5302018|NCT00422734|18275138|P1|Overall Study|Protocol Violation|1
5302019|NCT00422734|18275137|P2|Overall Study|Physician Decision|1
5302020|NCT00422734|18275138|P1|Overall Study|Physician Decision|1
5302021|NCT00422669|18275184|P3|Overall Study|The study was terminated early.|7
5302022|NCT00422669|18275185|P2|Overall Study|The study was terminated early.|100
5302023|NCT00422669|18275186|P1|Overall Study|The study was terminated early.|98
5302024|NCT00422591|18275214|P1|Overall Study|Withdrawal by Subject|2
5302025|NCT00422591|18275214|P1|Overall Study|Physician Decision|4
5302026|NCT00422513|18275222|P2|Overall Study|Death|7
5302027|NCT00422513|18275223|P1|Overall Study|Death|3
5302028|NCT00422513|18275222|P2|Overall Study|Adverse Event|4
5302029|NCT00422513|18275223|P1|Overall Study|Adverse Event|4
5302030|NCT00422513|18275222|P2|Overall Study|early termination of the study|80
5302031|NCT00422513|18275223|P1|Overall Study|early termination of the study|67
5302032|NCT00422513|18275222|P2|Overall Study|Withdrawal by Subject|1
5302033|NCT00422513|18275223|P1|Overall Study|Withdrawal by Subject|2
5302034|NCT00422513|18275222|P2|Overall Study|Refused Treatment|2
5302035|NCT00422513|18275223|P1|Overall Study|Refused Treatment|4
5302036|NCT00422513|18275222|P2|Overall Study|Protocol Violation|7
5302037|NCT00422513|18275223|P1|Overall Study|Protocol Violation|23
5302038|NCT00422513|18275222|P2|Overall Study|Lack of Efficacy|5
5302039|NCT00422513|18275223|P1|Overall Study|Lack of Efficacy|4
5302040|NCT00422422|18275240|P1|Overall Study|AE, non-serious non-fatal|5
5302041|NCT00422422|18275240|P1|Overall Study|SAE, non-fatal|1
5302042|NCT00422422|18275240|P1|Overall Study|Withdrawal by Subject|2
5302043|NCT00422422|18275240|P1|Overall Study|Protocol Violation|1
5302044|NCT00422422|18275240|P1|Overall Study|Lack of Efficacy|1
5302045|NCT00422383|18275257|P5|Overall Study|Withdrawal by Subject|1
5302046|NCT00422383|18275258|P4|Overall Study|Withdrawal by Subject|0
5302047|NCT00422383|18275259|P3|Overall Study|Withdrawal by Subject|0
5302048|NCT00422383|18275260|P2|Overall Study|Withdrawal by Subject|5
5302049|NCT00422383|18275261|P1|Overall Study|Withdrawal by Subject|5
5302050|NCT00422383|18275257|P5|Overall Study|Protocol Violation|0
5302051|NCT00422383|18275258|P4|Overall Study|Protocol Violation|0
5302052|NCT00422383|18275259|P3|Overall Study|Protocol Violation|1
5302053|NCT00422383|18275260|P2|Overall Study|Protocol Violation|1
5302054|NCT00422383|18275261|P1|Overall Study|Protocol Violation|1
5302055|NCT00422383|18275257|P5|Overall Study|Lost to Follow-up|1
5302056|NCT00422383|18275258|P4|Overall Study|Lost to Follow-up|0
5302057|NCT00422383|18275259|P3|Overall Study|Lost to Follow-up|0
5302058|NCT00422383|18275260|P2|Overall Study|Lost to Follow-up|1
5302059|NCT00422383|18275261|P1|Overall Study|Lost to Follow-up|0
5302060|NCT00422383|18275257|P5|Overall Study|Lack of Efficacy|1
5302061|NCT00422383|18275258|P4|Overall Study|Lack of Efficacy|1
5302062|NCT00422383|18275259|P3|Overall Study|Lack of Efficacy|2
5302063|NCT00422383|18275260|P2|Overall Study|Lack of Efficacy|4
5302064|NCT00422383|18275261|P1|Overall Study|Lack of Efficacy|4
5302065|NCT00422383|18275257|P5|Overall Study|Adverse Event|0
5302066|NCT00422383|18275258|P4|Overall Study|Adverse Event|1
5302067|NCT00422383|18275259|P3|Overall Study|Adverse Event|1
5302068|NCT00422383|18275260|P2|Overall Study|Adverse Event|3
5302069|NCT00422383|18275261|P1|Overall Study|Adverse Event|5
5302070|NCT00422292|18275404|P4|Overall Study|Withdrawal by Subject|13
5302071|NCT00422292|18275405|P3|Overall Study|Withdrawal by Subject|7
5302072|NCT00422292|18275406|P2|Overall Study|Withdrawal by Subject|25
5302073|NCT00422292|18275407|P1|Overall Study|Withdrawal by Subject|6
5302074|NCT00422292|18275404|P4|Overall Study|Lost to Follow-up|6
5302075|NCT00422292|18275405|P3|Overall Study|Lost to Follow-up|6
5302076|NCT00422292|18275406|P2|Overall Study|Lost to Follow-up|12
5302077|NCT00422292|18275407|P1|Overall Study|Lost to Follow-up|6
5302078|NCT00422292|18275404|P4|Overall Study|Protocol Violation|5
5302079|NCT00422292|18275405|P3|Overall Study|Protocol Violation|8
5302080|NCT00422292|18275406|P2|Overall Study|Protocol Violation|25
5302081|NCT00422292|18275407|P1|Overall Study|Protocol Violation|4
5302082|NCT00422292|18275404|P4|Overall Study|Adverse Event|0
5302083|NCT00422292|18275405|P3|Overall Study|Adverse Event|1
5302084|NCT00422292|18275406|P2|Overall Study|Adverse Event|0
5302085|NCT00422292|18275407|P1|Overall Study|Adverse Event|1
5302086|NCT00422292|18275404|P4|Overall Study|Serious adverse events|0
5302087|NCT00422292|18275405|P3|Overall Study|Serious adverse events|0
5302088|NCT00422292|18275406|P2|Overall Study|Serious adverse events|4
5302089|NCT00422292|18275407|P1|Overall Study|Serious adverse events|1
5302090|NCT00422227|18275446|P2|Overall Study|Withdrawal by Subject|4
5302091|NCT00422227|18275447|P1|Overall Study|Withdrawal by Subject|0
5302092|NCT00422227|18275446|P2|Overall Study|Lost to Follow-up|3
5302093|NCT00422227|18275447|P1|Overall Study|Lost to Follow-up|1
5302094|NCT00422227|18275446|P2|Overall Study|Adverse Event|8
5302095|NCT00422227|18275447|P1|Overall Study|Adverse Event|3
5302096|NCT00422162|18275478|P2|Overall Study|Didn't Receive Treatment|1
5302097|NCT00422162|18275479|P1|Overall Study|Didn't Receive Treatment|0
5302098|NCT00422162|18275478|P2|Overall Study|Other|1
5302099|NCT00422162|18275479|P1|Overall Study|Other|0
5302100|NCT00422162|18275478|P2|Overall Study|Non-Compliant with Protocol|1
5302101|NCT00422162|18275479|P1|Overall Study|Non-Compliant with Protocol|1
5302102|NCT00422162|18275478|P2|Overall Study|Lost to Follow-up|2
5302103|NCT00422162|18275479|P1|Overall Study|Lost to Follow-up|1
5302104|NCT00422162|18275478|P2|Overall Study|Withdrawal by Subject|6
5302105|NCT00422162|18275479|P1|Overall Study|Withdrawal by Subject|7
5302106|NCT00422162|18275478|P2|Overall Study|Lack of Efficacy|10
5302107|NCT00422162|18275479|P1|Overall Study|Lack of Efficacy|4
5302108|NCT00422162|18275478|P2|Overall Study|Adverse Event|9
5302109|NCT00422162|18275479|P1|Overall Study|Adverse Event|11
5302110|NCT00422097|18275539|P8|Dose Level 2|Still on treatment|0
5302111|NCT00422097|18275540|P7|Dose Level 2|Still on treatment|0
5302112|NCT00422097|18275541|P6|Dose Level 2|Still on treatment|0
5302113|NCT00422097|18275542|P5|Dose Level 2|Still on treatment|0
5302114|NCT00422097|18275543|P4|Dose Level 2|Still on treatment|0
5302115|NCT00422097|18275544|P3|Dose Level 2|Still on treatment|0
5302116|NCT00422097|18275545|P2|Dose Level 2|Still on treatment|1
5302117|NCT00422097|18275546|P1|Dose Level 2|Still on treatment|0
5302118|NCT00422058|18275611|P6|Open-Label Extension, Week 20-104|Other|18
5302119|NCT00422058|18275612|P5|Open-Label Extension, Week 20-104|Other|16
5302120|NCT00422058|18275613|P4|Open-Label Extension, Week 20-104|Other|13
5302121|NCT00422058|18275614|P3|Open-Label Extension, Week 20-104|Other|6
5302122|NCT00422058|18275615|P2|Open-Label Extension, Week 20-104|Other|14
5302123|NCT00422058|18275616|P1|Open-Label Extension, Week 20-104|Other|13
5302124|NCT00422058|18275611|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
5302125|NCT00422058|18275612|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
5302126|NCT00422058|18275613|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
5302127|NCT00422058|18275614|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
5302128|NCT00422058|18275615|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
5302129|NCT00422058|18275616|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
5302130|NCT00422058|18275611|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
5302131|NCT00422058|18275612|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
5302132|NCT00422058|18275613|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
5302133|NCT00422058|18275614|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
5302134|NCT00422058|18275615|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
5302135|NCT00422058|18275616|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
5302136|NCT00422058|18275611|P6|Open-Label Extension, Week 20-104|Adverse Event|0
5302137|NCT00422058|18275612|P5|Open-Label Extension, Week 20-104|Adverse Event|4
5302138|NCT00422058|18275613|P4|Open-Label Extension, Week 20-104|Adverse Event|4
5302139|NCT00422058|18275614|P3|Open-Label Extension, Week 20-104|Adverse Event|7
5302140|NCT00422058|18275615|P2|Open-Label Extension, Week 20-104|Adverse Event|4
5302141|NCT00422058|18275616|P1|Open-Label Extension, Week 20-104|Adverse Event|3
5302142|NCT00422058|18275611|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
5302143|NCT00422058|18275612|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
5302144|NCT00422058|18275613|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
5302145|NCT00422058|18275614|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
5302146|NCT00422058|18275615|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
5302147|NCT00422058|18275616|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
5302148|NCT00422058|18275611|P6|Double-Blind, Week 0-20|Other|10
5302149|NCT00422058|18275612|P5|Double-Blind, Week 0-20|Other|4
5302150|NCT00422058|18275613|P4|Double-Blind, Week 0-20|Other|8
5302151|NCT00422058|18275614|P3|Double-Blind, Week 0-20|Other|8
5302152|NCT00422058|18275615|P2|Double-Blind, Week 0-20|Other|3
5302153|NCT00422058|18275616|P1|Double-Blind, Week 0-20|Other|11
5302154|NCT00422058|18275611|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
5302155|NCT00422058|18275612|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
5302156|NCT00422058|18275613|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
5302157|NCT00422058|18275614|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
5302158|NCT00422058|18275615|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
5302159|NCT00422058|18275616|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
5302160|NCT00422058|18275611|P6|Double-Blind, Week 0-20|Protocol Violation|2
5302161|NCT00422058|18275612|P5|Double-Blind, Week 0-20|Protocol Violation|2
5302162|NCT00422058|18275613|P4|Double-Blind, Week 0-20|Protocol Violation|3
5302163|NCT00422058|18275614|P3|Double-Blind, Week 0-20|Protocol Violation|2
5302164|NCT00422058|18275615|P2|Double-Blind, Week 0-20|Protocol Violation|2
5302165|NCT00422058|18275616|P1|Double-Blind, Week 0-20|Protocol Violation|3
5302166|NCT00422058|18275611|P6|Double-Blind, Week 0-20|Adverse Event|3
5302167|NCT00422058|18275612|P5|Double-Blind, Week 0-20|Adverse Event|5
5302168|NCT00422058|18275613|P4|Double-Blind, Week 0-20|Adverse Event|9
5302169|NCT00422058|18275614|P3|Double-Blind, Week 0-20|Adverse Event|5
5302170|NCT00422058|18275615|P2|Double-Blind, Week 0-20|Adverse Event|4
5302171|NCT00422058|18275616|P1|Double-Blind, Week 0-20|Adverse Event|3
5302172|NCT00421993|18275757|P4|Overall Study|Subject transportation issues|1
5302173|NCT00421993|18275758|P3|Overall Study|Subject transportation issues|0
5302174|NCT00421993|18275759|P2|Overall Study|Subject transportation issues|0
5302175|NCT00421993|18275760|P1|Overall Study|Subject transportation issues|0
5302176|NCT00421993|18275757|P4|Overall Study|Pregnancy|2
5302177|NCT00421993|18275758|P3|Overall Study|Pregnancy|1
5302178|NCT00421993|18275759|P2|Overall Study|Pregnancy|1
5302179|NCT00421993|18275760|P1|Overall Study|Pregnancy|0
5302180|NCT00421993|18275757|P4|Overall Study|Lack of Efficacy|5
5302181|NCT00421993|18275758|P3|Overall Study|Lack of Efficacy|0
5302182|NCT00421993|18275759|P2|Overall Study|Lack of Efficacy|3
5302183|NCT00421993|18275760|P1|Overall Study|Lack of Efficacy|0
5302184|NCT00421993|18275757|P4|Overall Study|Protocol Violation|1
5302185|NCT00421993|18275758|P3|Overall Study|Protocol Violation|0
5302186|NCT00421993|18275759|P2|Overall Study|Protocol Violation|2
5302187|NCT00421993|18275760|P1|Overall Study|Protocol Violation|2
5302188|NCT00421993|18275757|P4|Overall Study|Adverse Event|4
5302189|NCT00421993|18275758|P3|Overall Study|Adverse Event|6
5302190|NCT00421993|18275759|P2|Overall Study|Adverse Event|1
5302191|NCT00421993|18275760|P1|Overall Study|Adverse Event|11
5302192|NCT00421993|18275757|P4|Overall Study|Lost to Follow-up|20
5302193|NCT00421993|18275758|P3|Overall Study|Lost to Follow-up|22
5302194|NCT00421993|18275759|P2|Overall Study|Lost to Follow-up|19
5302195|NCT00421993|18275760|P1|Overall Study|Lost to Follow-up|18
5302196|NCT00421993|18275757|P4|Overall Study|Withdrawal by Subject|24
5302197|NCT00421993|18275758|P3|Overall Study|Withdrawal by Subject|23
5302198|NCT00421993|18275759|P2|Overall Study|Withdrawal by Subject|23
5302199|NCT00421993|18275760|P1|Overall Study|Withdrawal by Subject|22
5302200|NCT00421928|18275797|P3|Overall Study|Death|0
5302201|NCT00421928|18275798|P2|Overall Study|Death|1
5302202|NCT00421928|18275799|P1|Overall Study|Death|0
5302203|NCT00421928|18275797|P3|Overall Study|All other|27
5302204|NCT00421928|18275798|P2|Overall Study|All other|21
5302205|NCT00421928|18275799|P1|Overall Study|All other|26
5302206|NCT00421928|18275797|P3|Overall Study|Study drug non-compliant|4
5302207|NCT00421928|18275798|P2|Overall Study|Study drug non-compliant|7
5302208|NCT00421928|18275799|P1|Overall Study|Study drug non-compliant|6
5302209|NCT00421928|18275797|P3|Overall Study|Lack of Efficacy|35
5302210|NCT00421928|18275798|P2|Overall Study|Lack of Efficacy|7
5302211|NCT00421928|18275799|P1|Overall Study|Lack of Efficacy|15
5302212|NCT00421928|18275797|P3|Overall Study|Withdrawal by Subject|43
5302213|NCT00421928|18275798|P2|Overall Study|Withdrawal by Subject|48
5302214|NCT00421928|18275799|P1|Overall Study|Withdrawal by Subject|50
5302215|NCT00421928|18275797|P3|Overall Study|Lost to Follow-up|3
5302216|NCT00421928|18275798|P2|Overall Study|Lost to Follow-up|0
5302217|NCT00421928|18275799|P1|Overall Study|Lost to Follow-up|5
5302218|NCT00421928|18275797|P3|Overall Study|Adverse Event|22
5302219|NCT00421928|18275798|P2|Overall Study|Adverse Event|140
5302220|NCT00421928|18275799|P1|Overall Study|Adverse Event|61
5302221|NCT00421889|18275834|P9|Overall Study|Lost to Follow-up|1
5302222|NCT00421889|18275835|P8|Overall Study|Lost to Follow-up|0
5302223|NCT00421889|18275836|P7|Overall Study|Lost to Follow-up|0
5302224|NCT00421889|18275837|P6|Overall Study|Lost to Follow-up|0
5302225|NCT00421889|18275838|P5|Overall Study|Lost to Follow-up|0
5302226|NCT00421889|18275839|P4|Overall Study|Lost to Follow-up|0
5302227|NCT00421889|18275840|P3|Overall Study|Lost to Follow-up|0
5302228|NCT00421889|18275841|P2|Overall Study|Lost to Follow-up|0
5302229|NCT00421889|18275842|P1|Overall Study|Lost to Follow-up|0
5302230|NCT00421889|18275834|P9|Overall Study|Patient/Investigator request|3
5302231|NCT00421889|18275835|P8|Overall Study|Patient/Investigator request|1
5302232|NCT00421889|18275836|P7|Overall Study|Patient/Investigator request|0
5302233|NCT00421889|18275837|P6|Overall Study|Patient/Investigator request|9
5302234|NCT00421889|18275838|P5|Overall Study|Patient/Investigator request|0
5302235|NCT00421889|18275839|P4|Overall Study|Patient/Investigator request|0
5302236|NCT00421889|18275840|P3|Overall Study|Patient/Investigator request|0
5302237|NCT00421889|18275841|P2|Overall Study|Patient/Investigator request|0
5302238|NCT00421889|18275842|P1|Overall Study|Patient/Investigator request|0
5302239|NCT00421889|18275834|P9|Overall Study|Progressive disease|5
5302240|NCT00421889|18275835|P8|Overall Study|Progressive disease|1
5302241|NCT00421889|18275836|P7|Overall Study|Progressive disease|3
5302242|NCT00421889|18275837|P6|Overall Study|Progressive disease|21
5302243|NCT00421889|18275838|P5|Overall Study|Progressive disease|2
5302244|NCT00421889|18275839|P4|Overall Study|Progressive disease|3
5302245|NCT00421889|18275840|P3|Overall Study|Progressive disease|2
5302246|NCT00421889|18275841|P2|Overall Study|Progressive disease|2
5302247|NCT00421889|18275842|P1|Overall Study|Progressive disease|3
5302248|NCT00421889|18275834|P9|Overall Study|Death|0
5302249|NCT00421889|18275835|P8|Overall Study|Death|0
5302250|NCT00421889|18275836|P7|Overall Study|Death|0
5302251|NCT00421889|18275837|P6|Overall Study|Death|1
5302252|NCT00421889|18275838|P5|Overall Study|Death|1
5302253|NCT00421889|18275839|P4|Overall Study|Death|0
5302254|NCT00421889|18275840|P3|Overall Study|Death|0
5302255|NCT00421889|18275841|P2|Overall Study|Death|0
5302256|NCT00421889|18275842|P1|Overall Study|Death|0
5302257|NCT00421889|18275834|P9|Overall Study|Withdrawal by Subject|0
5302258|NCT00421889|18275835|P8|Overall Study|Withdrawal by Subject|0
5302259|NCT00421889|18275836|P7|Overall Study|Withdrawal by Subject|0
5302260|NCT00421889|18275837|P6|Overall Study|Withdrawal by Subject|0
5302261|NCT00421889|18275838|P5|Overall Study|Withdrawal by Subject|2
5302262|NCT00421889|18275839|P4|Overall Study|Withdrawal by Subject|0
5302263|NCT00421889|18275840|P3|Overall Study|Withdrawal by Subject|0
5302264|NCT00421889|18275841|P2|Overall Study|Withdrawal by Subject|3
5302265|NCT00421889|18275842|P1|Overall Study|Withdrawal by Subject|1
5302266|NCT00421889|18275834|P9|Overall Study|Adverse Event|2
5302267|NCT00421889|18275835|P8|Overall Study|Adverse Event|0
5302268|NCT00421889|18275836|P7|Overall Study|Adverse Event|1
5302269|NCT00421889|18275837|P6|Overall Study|Adverse Event|4
5302270|NCT00421889|18275838|P5|Overall Study|Adverse Event|1
5302271|NCT00421889|18275839|P4|Overall Study|Adverse Event|1
5302272|NCT00421889|18275840|P3|Overall Study|Adverse Event|1
5302273|NCT00421889|18275841|P2|Overall Study|Adverse Event|0
5302274|NCT00421889|18275842|P1|Overall Study|Adverse Event|1
5302275|NCT00421733|18275887|P3|Overall Study|Protocol deviation|2
5302276|NCT00421733|18275888|P2|Overall Study|Protocol deviation|7
5302277|NCT00421733|18275889|P1|Overall Study|Protocol deviation|4
5302278|NCT00421733|18275887|P3|Overall Study|Sponsor request|3
5302279|NCT00421733|18275888|P2|Overall Study|Sponsor request|0
5302280|NCT00421733|18275889|P1|Overall Study|Sponsor request|1
5302281|NCT00421733|18275887|P3|Overall Study|Did not satisfy entry criteria|2
5302282|NCT00421733|18275888|P2|Overall Study|Did not satisfy entry criteria|3
5302283|NCT00421733|18275889|P1|Overall Study|Did not satisfy entry criteria|1
5302284|NCT00421733|18275887|P3|Overall Study|Administrative|0
5302285|NCT00421733|18275888|P2|Overall Study|Administrative|0
5302286|NCT00421733|18275889|P1|Overall Study|Administrative|2
5302287|NCT00421733|18275887|P3|Overall Study|Required dialysis|0
5302288|NCT00421733|18275888|P2|Overall Study|Required dialysis|0
5302289|NCT00421733|18275889|P1|Overall Study|Required dialysis|1
5302290|NCT00421733|18275887|P3|Overall Study|Death|0
5302291|NCT00421733|18275888|P2|Overall Study|Death|3
5302292|NCT00421733|18275889|P1|Overall Study|Death|0
5302293|NCT00421733|18275887|P3|Overall Study|Withdrawal by Subject|7
5302294|NCT00421733|18275888|P2|Overall Study|Withdrawal by Subject|2
5302295|NCT00421733|18275889|P1|Overall Study|Withdrawal by Subject|1
5302296|NCT00421733|18275887|P3|Overall Study|Lost to Follow-up|4
5302297|NCT00421733|18275888|P2|Overall Study|Lost to Follow-up|2
5302298|NCT00421733|18275889|P1|Overall Study|Lost to Follow-up|1
5302299|NCT00421733|18275887|P3|Overall Study|Adverse Event|2
5302300|NCT00421733|18275888|P2|Overall Study|Adverse Event|9
5302301|NCT00421733|18275889|P1|Overall Study|Adverse Event|4
5302302|NCT00421707|18275909|P2|Period 3:Treatment Period 2|Adverse Event|2
5302303|NCT00421707|18275910|P1|Period 3:Treatment Period 2|Adverse Event|0
5302304|NCT00421707|18275909|P2|Period 3:Treatment Period 2|Protocol Violation|0
5302305|NCT00421707|18275910|P1|Period 3:Treatment Period 2|Protocol Violation|1
5302306|NCT00421707|18275909|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
5302307|NCT00421707|18275910|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
5302308|NCT00421707|18275909|P2|Period 2: Washout|Other: Pregnancy|1
5302309|NCT00421707|18275910|P1|Period 2: Washout|Other: Pregnancy|0
5302310|NCT00421707|18275909|P2|Period 2: Washout|Lost to Follow-up|1
5302311|NCT00421707|18275910|P1|Period 2: Washout|Lost to Follow-up|0
5302312|NCT00421707|18275909|P2|Period 2: Washout|Withdrawal by Subject|1
5302313|NCT00421707|18275910|P1|Period 2: Washout|Withdrawal by Subject|0
5302314|NCT00421707|18275909|P2|Period 2: Washout|Adverse Event|1
5302315|NCT00421707|18275910|P1|Period 2: Washout|Adverse Event|1
5302316|NCT00421707|18275909|P2|Period 1: Treatment Period 1|Protocol Violation|0
5302317|NCT00421707|18275910|P1|Period 1: Treatment Period 1|Protocol Violation|1
5302318|NCT00421707|18275909|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
5302319|NCT00421707|18275910|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
5302320|NCT00421707|18275909|P2|Period 1: Treatment Period 1|Adverse Event|2
5302321|NCT00421707|18275910|P1|Period 1: Treatment Period 1|Adverse Event|7
5302322|NCT00421707|18275909|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
5302323|NCT00421707|18275910|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
5302324|NCT00421408|18275961|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
5302325|NCT00421408|18275962|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
5302326|NCT00421408|18275961|P2|Overall Study|Lost to Follow-up|20
5302327|NCT00421408|18275962|P1|Overall Study|Lost to Follow-up|30
5302328|NCT00421343|18275980|P1|Overall Study|Lost to Follow-up|3
5302329|NCT00421343|18275980|P1|Overall Study|Withdrawal by Subject|2
5302330|NCT00421343|18275980|P1|Overall Study|Death|1
5302331|NCT00421174|18275986|P2|Overall Study|Ineligible due to infection|0
5302332|NCT00421174|18275987|P1|Overall Study|Ineligible due to infection|2
5302333|NCT00421174|18275986|P2|Overall Study|Withdrawal by Subject|1
5302334|NCT00421174|18275987|P1|Overall Study|Withdrawal by Subject|0
5302335|NCT00421148|18276035|P20|Overall Study|Protocol Violation|0
5302336|NCT00421148|18276036|P19|Overall Study|Protocol Violation|1
5302337|NCT00421148|18276037|P18|Overall Study|Protocol Violation|0
5302338|NCT00421148|18276038|P17|Overall Study|Protocol Violation|0
5302339|NCT00421148|18276039|P16|Overall Study|Protocol Violation|0
5302340|NCT00421148|18276040|P15|Overall Study|Protocol Violation|0
5302341|NCT00421148|18276041|P14|Overall Study|Protocol Violation|0
5302342|NCT00421148|18276042|P13|Overall Study|Protocol Violation|0
5302343|NCT00421148|18276043|P12|Overall Study|Protocol Violation|0
5302344|NCT00421148|18276044|P11|Overall Study|Protocol Violation|0
5302345|NCT00421148|18276045|P10|Overall Study|Protocol Violation|0
5302346|NCT00421148|18276046|P9|Overall Study|Protocol Violation|0
5302347|NCT00421148|18276047|P8|Overall Study|Protocol Violation|0
5302348|NCT00421148|18276048|P7|Overall Study|Protocol Violation|0
5302349|NCT00421148|18276049|P6|Overall Study|Protocol Violation|1
5302350|NCT00421148|18276050|P5|Overall Study|Protocol Violation|0
5302351|NCT00421148|18276051|P4|Overall Study|Protocol Violation|0
5302352|NCT00421148|18276052|P3|Overall Study|Protocol Violation|0
5302353|NCT00421148|18276053|P2|Overall Study|Protocol Violation|0
5302354|NCT00421148|18276054|P1|Overall Study|Protocol Violation|0
5302355|NCT00421148|18276035|P20|Overall Study|Withdrawal by Subject|0
5302356|NCT00421148|18276036|P19|Overall Study|Withdrawal by Subject|0
5302357|NCT00421148|18276037|P18|Overall Study|Withdrawal by Subject|1
5302358|NCT00421148|18276038|P17|Overall Study|Withdrawal by Subject|0
5302359|NCT00421148|18276039|P16|Overall Study|Withdrawal by Subject|0
5302360|NCT00421148|18276040|P15|Overall Study|Withdrawal by Subject|0
5302361|NCT00421148|18276041|P14|Overall Study|Withdrawal by Subject|0
5302362|NCT00421148|18276042|P13|Overall Study|Withdrawal by Subject|0
5302363|NCT00421148|18276043|P12|Overall Study|Withdrawal by Subject|0
5302364|NCT00421148|18276044|P11|Overall Study|Withdrawal by Subject|0
5302365|NCT00421148|18276045|P10|Overall Study|Withdrawal by Subject|0
5302366|NCT00421148|18276046|P9|Overall Study|Withdrawal by Subject|0
5302367|NCT00421148|18276047|P8|Overall Study|Withdrawal by Subject|0
5302368|NCT00421148|18276048|P7|Overall Study|Withdrawal by Subject|0
5302369|NCT00421148|18276049|P6|Overall Study|Withdrawal by Subject|0
5302370|NCT00421148|18276050|P5|Overall Study|Withdrawal by Subject|0
5302371|NCT00421148|18276051|P4|Overall Study|Withdrawal by Subject|0
5302372|NCT00421148|18276052|P3|Overall Study|Withdrawal by Subject|0
5302373|NCT00421148|18276053|P2|Overall Study|Withdrawal by Subject|0
5302374|NCT00421148|18276054|P1|Overall Study|Withdrawal by Subject|0
5302375|NCT00421148|18276035|P20|Overall Study|Lost to Follow-up|0
5302376|NCT00421148|18276036|P19|Overall Study|Lost to Follow-up|0
5302377|NCT00421148|18276037|P18|Overall Study|Lost to Follow-up|1
5302378|NCT00421148|18276038|P17|Overall Study|Lost to Follow-up|0
5302379|NCT00421148|18276039|P16|Overall Study|Lost to Follow-up|0
5302380|NCT00421148|18276040|P15|Overall Study|Lost to Follow-up|0
5302381|NCT00421148|18276041|P14|Overall Study|Lost to Follow-up|0
5302382|NCT00421148|18276042|P13|Overall Study|Lost to Follow-up|0
5302383|NCT00421148|18276043|P12|Overall Study|Lost to Follow-up|0
5302384|NCT00421148|18276044|P11|Overall Study|Lost to Follow-up|0
5302385|NCT00421148|18276045|P10|Overall Study|Lost to Follow-up|0
5302386|NCT00421148|18276046|P9|Overall Study|Lost to Follow-up|0
5302387|NCT00421148|18276047|P8|Overall Study|Lost to Follow-up|0
5302388|NCT00421148|18276048|P7|Overall Study|Lost to Follow-up|0
5302389|NCT00421148|18276049|P6|Overall Study|Lost to Follow-up|0
5302390|NCT00421148|18276050|P5|Overall Study|Lost to Follow-up|0
5302391|NCT00421148|18276051|P4|Overall Study|Lost to Follow-up|0
5302392|NCT00421148|18276052|P3|Overall Study|Lost to Follow-up|0
5302393|NCT00421148|18276053|P2|Overall Study|Lost to Follow-up|0
5302394|NCT00421148|18276054|P1|Overall Study|Lost to Follow-up|0
5302395|NCT00420927|18276153|P7|Period 2|Took prohibited medication|0
5302396|NCT00420927|18276154|P6|Period 2|Took prohibited medication|0
5302397|NCT00420927|18276155|P5|Period 2|Took prohibited medication|1
5302398|NCT00420927|18276156|P4|Period 2|Took prohibited medication|0
5302399|NCT00420927|18276157|P3|Period 2|Took prohibited medication|0
5302400|NCT00420927|18276158|P2|Period 2|Took prohibited medication|0
5302401|NCT00420927|18276159|P1|Period 2|Took prohibited medication|0
5302402|NCT00420927|18276153|P7|Period 2|Methotrexate intolerance|1
5302403|NCT00420927|18276154|P6|Period 2|Methotrexate intolerance|0
5302404|NCT00420927|18276155|P5|Period 2|Methotrexate intolerance|0
5302405|NCT00420927|18276156|P4|Period 2|Methotrexate intolerance|0
5302406|NCT00420927|18276157|P3|Period 2|Methotrexate intolerance|0
5302407|NCT00420927|18276158|P2|Period 2|Methotrexate intolerance|0
5302408|NCT00420927|18276159|P1|Period 2|Methotrexate intolerance|0
5302409|NCT00420927|18276153|P7|Period 2|Noncompliant with study drug|2
5302410|NCT00420927|18276154|P6|Period 2|Noncompliant with study drug|0
5302411|NCT00420927|18276155|P5|Period 2|Noncompliant with study drug|0
5302412|NCT00420927|18276156|P4|Period 2|Noncompliant with study drug|1
5302413|NCT00420927|18276157|P3|Period 2|Noncompliant with study drug|0
5302414|NCT00420927|18276158|P2|Period 2|Noncompliant with study drug|0
5302415|NCT00420927|18276159|P1|Period 2|Noncompliant with study drug|0
5302416|NCT00420927|18276153|P7|Period 2|Randomization error|0
5302417|NCT00420927|18276154|P6|Period 2|Randomization error|1
5302418|NCT00420927|18276155|P5|Period 2|Randomization error|1
5302419|NCT00420927|18276156|P4|Period 2|Randomization error|0
5302420|NCT00420927|18276157|P3|Period 2|Randomization error|0
5302421|NCT00420927|18276158|P2|Period 2|Randomization error|0
5302422|NCT00420927|18276159|P1|Period 2|Randomization error|0
5302423|NCT00420927|18276153|P7|Period 2|Sponsor decision|1
5302424|NCT00420927|18276154|P6|Period 2|Sponsor decision|0
5302425|NCT00420927|18276155|P5|Period 2|Sponsor decision|0
5302426|NCT00420927|18276156|P4|Period 2|Sponsor decision|0
5302427|NCT00420927|18276157|P3|Period 2|Sponsor decision|1
5302428|NCT00420927|18276158|P2|Period 2|Sponsor decision|0
5302429|NCT00420927|18276159|P1|Period 2|Sponsor decision|0
5302430|NCT00420927|18276153|P7|Period 2|Physician Decision|0
5302431|NCT00420927|18276154|P6|Period 2|Physician Decision|1
5302432|NCT00420927|18276155|P5|Period 2|Physician Decision|1
5302433|NCT00420927|18276156|P4|Period 2|Physician Decision|0
5302434|NCT00420927|18276157|P3|Period 2|Physician Decision|0
5302435|NCT00420927|18276158|P2|Period 2|Physician Decision|0
5302436|NCT00420927|18276159|P1|Period 2|Physician Decision|0
5302437|NCT00420927|18276153|P7|Period 2|Subject unable to find transportation|1
5302438|NCT00420927|18276154|P6|Period 2|Subject unable to find transportation|0
5302439|NCT00420927|18276155|P5|Period 2|Subject unable to find transportation|0
5302440|NCT00420927|18276156|P4|Period 2|Subject unable to find transportation|0
5302441|NCT00420927|18276157|P3|Period 2|Subject unable to find transportation|0
5302442|NCT00420927|18276158|P2|Period 2|Subject unable to find transportation|0
5302443|NCT00420927|18276159|P1|Period 2|Subject unable to find transportation|0
5302444|NCT00420927|18276153|P7|Period 2|Received wrong treatment/incorrect dose|1
5302445|NCT00420927|18276154|P6|Period 2|Received wrong treatment/incorrect dose|0
5302446|NCT00420927|18276155|P5|Period 2|Received wrong treatment/incorrect dose|0
5302447|NCT00420927|18276156|P4|Period 2|Received wrong treatment/incorrect dose|0
5302448|NCT00420927|18276157|P3|Period 2|Received wrong treatment/incorrect dose|0
5302449|NCT00420927|18276158|P2|Period 2|Received wrong treatment/incorrect dose|0
5302450|NCT00420927|18276159|P1|Period 2|Received wrong treatment/incorrect dose|0
5302451|NCT00420927|18276153|P7|Period 2|Lack of efficacy/Loss of efficacy|6
5302452|NCT00420927|18276154|P6|Period 2|Lack of efficacy/Loss of efficacy|2
5302453|NCT00420927|18276155|P5|Period 2|Lack of efficacy/Loss of efficacy|6
5302454|NCT00420927|18276156|P4|Period 2|Lack of efficacy/Loss of efficacy|1
5302455|NCT00420927|18276157|P3|Period 2|Lack of efficacy/Loss of efficacy|2
5302456|NCT00420927|18276158|P2|Period 2|Lack of efficacy/Loss of efficacy|0
5302457|NCT00420927|18276159|P1|Period 2|Lack of efficacy/Loss of efficacy|0
5302458|NCT00420927|18276153|P7|Period 2|Lost to Follow-up|9
5302459|NCT00420927|18276154|P6|Period 2|Lost to Follow-up|3
5302460|NCT00420927|18276155|P5|Period 2|Lost to Follow-up|6
5302461|NCT00420927|18276156|P4|Period 2|Lost to Follow-up|2
5302462|NCT00420927|18276157|P3|Period 2|Lost to Follow-up|2
5302463|NCT00420927|18276158|P2|Period 2|Lost to Follow-up|0
5302464|NCT00420927|18276159|P1|Period 2|Lost to Follow-up|0
5302465|NCT00420927|18276153|P7|Period 2|Withdrawal by Subject|12
5302466|NCT00420927|18276154|P6|Period 2|Withdrawal by Subject|2
5302467|NCT00420927|18276155|P5|Period 2|Withdrawal by Subject|11
5302468|NCT00420927|18276156|P4|Period 2|Withdrawal by Subject|3
5302469|NCT00420927|18276157|P3|Period 2|Withdrawal by Subject|1
5302470|NCT00420927|18276158|P2|Period 2|Withdrawal by Subject|0
5302471|NCT00420927|18276159|P1|Period 2|Withdrawal by Subject|0
5302472|NCT00420927|18276153|P7|Period 2|Adverse Event|20
5302473|NCT00420927|18276154|P6|Period 2|Adverse Event|6
5302474|NCT00420927|18276155|P5|Period 2|Adverse Event|17
5302475|NCT00420927|18276156|P4|Period 2|Adverse Event|3
5302476|NCT00420927|18276157|P3|Period 2|Adverse Event|7
5302477|NCT00420927|18276158|P2|Period 2|Adverse Event|0
5302478|NCT00420927|18276159|P1|Period 2|Adverse Event|0
5302479|NCT00420927|18276153|P7|Period 1|Took prohibited medication|0
5302480|NCT00420927|18276154|P6|Period 1|Took prohibited medication|0
5302481|NCT00420927|18276155|P5|Period 1|Took prohibited medication|0
5302482|NCT00420927|18276156|P4|Period 1|Took prohibited medication|0
5302483|NCT00420927|18276157|P3|Period 1|Took prohibited medication|0
5302484|NCT00420927|18276158|P2|Period 1|Took prohibited medication|3
5302485|NCT00420927|18276159|P1|Period 1|Took prohibited medication|1
5302486|NCT00420927|18276153|P7|Period 1|Failed to meet entry criteria|0
5302487|NCT00420927|18276154|P6|Period 1|Failed to meet entry criteria|0
5302488|NCT00420927|18276155|P5|Period 1|Failed to meet entry criteria|0
5302489|NCT00420927|18276156|P4|Period 1|Failed to meet entry criteria|0
5302490|NCT00420927|18276157|P3|Period 1|Failed to meet entry criteria|0
5302491|NCT00420927|18276158|P2|Period 1|Failed to meet entry criteria|7
5302492|NCT00420927|18276159|P1|Period 1|Failed to meet entry criteria|8
5302493|NCT00420927|18276153|P7|Period 1|Received wrong treatment/incorrect dose|0
5302494|NCT00420927|18276154|P6|Period 1|Received wrong treatment/incorrect dose|0
5302495|NCT00420927|18276155|P5|Period 1|Received wrong treatment/incorrect dose|0
5302496|NCT00420927|18276156|P4|Period 1|Received wrong treatment/incorrect dose|0
5302497|NCT00420927|18276157|P3|Period 1|Received wrong treatment/incorrect dose|0
5302498|NCT00420927|18276158|P2|Period 1|Received wrong treatment/incorrect dose|1
5302499|NCT00420927|18276159|P1|Period 1|Received wrong treatment/incorrect dose|0
5302500|NCT00420927|18276153|P7|Period 1|Subject received new diagnosis|0
5302501|NCT00420927|18276154|P6|Period 1|Subject received new diagnosis|0
5302502|NCT00420927|18276155|P5|Period 1|Subject received new diagnosis|0
5302503|NCT00420927|18276156|P4|Period 1|Subject received new diagnosis|0
5302504|NCT00420927|18276157|P3|Period 1|Subject received new diagnosis|0
5302505|NCT00420927|18276158|P2|Period 1|Subject received new diagnosis|2
5302506|NCT00420927|18276159|P1|Period 1|Subject received new diagnosis|0
5302507|NCT00420927|18276153|P7|Period 1|Study site closure|0
5302508|NCT00420927|18276154|P6|Period 1|Study site closure|0
5302509|NCT00420927|18276155|P5|Period 1|Study site closure|0
5302510|NCT00420927|18276156|P4|Period 1|Study site closure|0
5302511|NCT00420927|18276157|P3|Period 1|Study site closure|0
5302512|NCT00420927|18276158|P2|Period 1|Study site closure|1
5302513|NCT00420927|18276159|P1|Period 1|Study site closure|0
5302514|NCT00420927|18276153|P7|Period 1|Suspected tuberculosis/positive test|0
5302515|NCT00420927|18276154|P6|Period 1|Suspected tuberculosis/positive test|0
5302516|NCT00420927|18276155|P5|Period 1|Suspected tuberculosis/positive test|0
5302517|NCT00420927|18276156|P4|Period 1|Suspected tuberculosis/positive test|0
5302518|NCT00420927|18276157|P3|Period 1|Suspected tuberculosis/positive test|0
5302519|NCT00420927|18276158|P2|Period 1|Suspected tuberculosis/positive test|1
5302520|NCT00420927|18276159|P1|Period 1|Suspected tuberculosis/positive test|1
5302521|NCT00420927|18276153|P7|Period 1|Randomization error|0
5302522|NCT00420927|18276154|P6|Period 1|Randomization error|0
5302523|NCT00420927|18276155|P5|Period 1|Randomization error|0
5302524|NCT00420927|18276156|P4|Period 1|Randomization error|0
5302525|NCT00420927|18276157|P3|Period 1|Randomization error|0
5302526|NCT00420927|18276158|P2|Period 1|Randomization error|0
5302527|NCT00420927|18276159|P1|Period 1|Randomization error|1
5302528|NCT00420927|18276153|P7|Period 1|Noncompliant with study drug|0
5302529|NCT00420927|18276154|P6|Period 1|Noncompliant with study drug|0
5302530|NCT00420927|18276155|P5|Period 1|Noncompliant with study drug|0
5302531|NCT00420927|18276156|P4|Period 1|Noncompliant with study drug|0
5302532|NCT00420927|18276157|P3|Period 1|Noncompliant with study drug|0
5302533|NCT00420927|18276158|P2|Period 1|Noncompliant with study drug|1
5302534|NCT00420927|18276159|P1|Period 1|Noncompliant with study drug|1
5302535|NCT00420927|18276153|P7|Period 1|Subject moved/relocated|0
5302536|NCT00420927|18276154|P6|Period 1|Subject moved/relocated|0
5302537|NCT00420927|18276155|P5|Period 1|Subject moved/relocated|0
5302538|NCT00420927|18276156|P4|Period 1|Subject moved/relocated|0
5302539|NCT00420927|18276157|P3|Period 1|Subject moved/relocated|0
5302540|NCT00420927|18276158|P2|Period 1|Subject moved/relocated|2
5302541|NCT00420927|18276159|P1|Period 1|Subject moved/relocated|0
5302542|NCT00420927|18276153|P7|Period 1|Death|0
5302543|NCT00420927|18276154|P6|Period 1|Death|0
5302544|NCT00420927|18276155|P5|Period 1|Death|0
5302545|NCT00420927|18276156|P4|Period 1|Death|0
5302546|NCT00420927|18276157|P3|Period 1|Death|0
5302547|NCT00420927|18276158|P2|Period 1|Death|0
5302548|NCT00420927|18276159|P1|Period 1|Death|2
5302549|NCT00420927|18276153|P7|Period 1|Lack of efficacy/Loss of efficacy|0
5302550|NCT00420927|18276154|P6|Period 1|Lack of efficacy/Loss of efficacy|0
5302551|NCT00420927|18276155|P5|Period 1|Lack of efficacy/Loss of efficacy|0
5302552|NCT00420927|18276156|P4|Period 1|Lack of efficacy/Loss of efficacy|0
5302553|NCT00420927|18276157|P3|Period 1|Lack of efficacy/Loss of efficacy|0
5302554|NCT00420927|18276158|P2|Period 1|Lack of efficacy/Loss of efficacy|6
5302555|NCT00420927|18276159|P1|Period 1|Lack of efficacy/Loss of efficacy|1
5302556|NCT00420927|18276153|P7|Period 1|Lost to Follow-up|0
5302557|NCT00420927|18276154|P6|Period 1|Lost to Follow-up|0
5302558|NCT00420927|18276155|P5|Period 1|Lost to Follow-up|0
5302559|NCT00420927|18276156|P4|Period 1|Lost to Follow-up|0
5302560|NCT00420927|18276157|P3|Period 1|Lost to Follow-up|0
5302561|NCT00420927|18276158|P2|Period 1|Lost to Follow-up|6
5302562|NCT00420927|18276159|P1|Period 1|Lost to Follow-up|8
5302563|NCT00420927|18276153|P7|Period 1|Withdrawal by Subject|0
5302564|NCT00420927|18276154|P6|Period 1|Withdrawal by Subject|0
5302565|NCT00420927|18276155|P5|Period 1|Withdrawal by Subject|0
5302566|NCT00420927|18276156|P4|Period 1|Withdrawal by Subject|0
5302567|NCT00420927|18276157|P3|Period 1|Withdrawal by Subject|0
5302568|NCT00420927|18276158|P2|Period 1|Withdrawal by Subject|12
5302569|NCT00420927|18276159|P1|Period 1|Withdrawal by Subject|7
5302570|NCT00420927|18276153|P7|Period 1|Adverse Event|0
5302571|NCT00420927|18276154|P6|Period 1|Adverse Event|0
5302572|NCT00420927|18276155|P5|Period 1|Adverse Event|0
5302573|NCT00420927|18276156|P4|Period 1|Adverse Event|0
5302574|NCT00420927|18276157|P3|Period 1|Adverse Event|0
5302575|NCT00420927|18276158|P2|Period 1|Adverse Event|15
5302576|NCT00420927|18276159|P1|Period 1|Adverse Event|19
5302577|NCT00420849|18276263|P1|Overall Study|Lost to Follow-up|1
5302578|NCT00420849|18276263|P1|Overall Study|Protocol Violation|1
5302579|NCT00420849|18276263|P1|Overall Study|Transplant|8
5302580|NCT00420849|18276263|P1|Overall Study|Other|14
5302581|NCT00420849|18276263|P1|Overall Study|Death|18
5302582|NCT00420849|18276263|P1|Overall Study|Withdrawal by Subject|28
5302583|NCT00420849|18276263|P1|Overall Study|Adverse Event|107
5302584|NCT00420849|18276263|P1|Overall Study|Lack of Efficacy|154
5302585|NCT00420784|18276332|P4|Overall Study|Other|5
5302586|NCT00420784|18276333|P3|Overall Study|Other|0
5302587|NCT00420784|18276334|P2|Overall Study|Other|2
5302588|NCT00420784|18276335|P1|Overall Study|Other|1
5302589|NCT00420784|18276332|P4|Overall Study|Virologic Stopping Rule|67
5302590|NCT00420784|18276333|P3|Overall Study|Virologic Stopping Rule|41
5302591|NCT00420784|18276334|P2|Overall Study|Virologic Stopping Rule|26
5302592|NCT00420784|18276335|P1|Overall Study|Virologic Stopping Rule|17
5302593|NCT00420784|18276332|P4|Overall Study|Lost to Follow-up|1
5302594|NCT00420784|18276333|P3|Overall Study|Lost to Follow-up|2
5302595|NCT00420784|18276334|P2|Overall Study|Lost to Follow-up|0
5302596|NCT00420784|18276335|P1|Overall Study|Lost to Follow-up|0
5302597|NCT00420784|18276332|P4|Overall Study|Withdrawal by Subject|0
5302598|NCT00420784|18276333|P3|Overall Study|Withdrawal by Subject|0
5302599|NCT00420784|18276334|P2|Overall Study|Withdrawal by Subject|1
5302600|NCT00420784|18276335|P1|Overall Study|Withdrawal by Subject|0
5302601|NCT00420784|18276332|P4|Overall Study|Adverse Event|5
5302602|NCT00420784|18276333|P3|Overall Study|Adverse Event|10
5302603|NCT00420784|18276334|P2|Overall Study|Adverse Event|29
5302604|NCT00420784|18276335|P1|Overall Study|Adverse Event|11
5302605|NCT00420745|18276373|P2|Overall Study|Age limit exceeded for Dose 2|0
5302606|NCT00420745|18276374|P1|Overall Study|Age limit exceeded for Dose 2|1
5302607|NCT00420745|18276373|P2|Overall Study|Recurrent pneumonia & bronchitis|1
5302608|NCT00420745|18276374|P1|Overall Study|Recurrent pneumonia & bronchitis|0
5302609|NCT00420745|18276373|P2|Overall Study|Physician Decision|1
5302610|NCT00420745|18276374|P1|Overall Study|Physician Decision|1
5302611|NCT00420745|18276373|P2|Overall Study|Protocol Violation|0
5302612|NCT00420745|18276374|P1|Overall Study|Protocol Violation|1
5302613|NCT00420745|18276373|P2|Overall Study|Lost to Follow-up|2
5302614|NCT00420745|18276374|P1|Overall Study|Lost to Follow-up|10
5302615|NCT00420745|18276373|P2|Overall Study|Adverse Event|2
5302616|NCT00420745|18276374|P1|Overall Study|Adverse Event|2
5302617|NCT00420641|18276393|P3|Overall Study|Other|3
5302618|NCT00420641|18276394|P2|Overall Study|Other|4
5302619|NCT00420641|18276395|P1|Overall Study|Other|4
5302620|NCT00420641|18276393|P3|Overall Study|Non-compliance|4
5302621|NCT00420641|18276394|P2|Overall Study|Non-compliance|5
5302622|NCT00420641|18276395|P1|Overall Study|Non-compliance|7
5302623|NCT00420641|18276393|P3|Overall Study|Lack of Efficacy|4
5302624|NCT00420641|18276394|P2|Overall Study|Lack of Efficacy|5
5302625|NCT00420641|18276395|P1|Overall Study|Lack of Efficacy|6
5302626|NCT00420641|18276393|P3|Overall Study|Withdrawal by Subject|14
5302627|NCT00420641|18276394|P2|Overall Study|Withdrawal by Subject|21
5302628|NCT00420641|18276395|P1|Overall Study|Withdrawal by Subject|15
5302629|NCT00420641|18276393|P3|Overall Study|Protocol Violation|7
5302630|NCT00420641|18276394|P2|Overall Study|Protocol Violation|8
5302631|NCT00420641|18276395|P1|Overall Study|Protocol Violation|8
5302632|NCT00420641|18276393|P3|Overall Study|Lost to Follow-up|2
5302633|NCT00420641|18276394|P2|Overall Study|Lost to Follow-up|4
5302634|NCT00420641|18276395|P1|Overall Study|Lost to Follow-up|2
5302635|NCT00420641|18276393|P3|Overall Study|Adverse Event|10
5302636|NCT00420641|18276394|P2|Overall Study|Adverse Event|25
5302637|NCT00420641|18276395|P1|Overall Study|Adverse Event|3
5302638|NCT00420628|18276471|P2|Overall Study|Adverse Event|0
5302639|NCT00420628|18276472|P1|Overall Study|Adverse Event|1
5302640|NCT00420628|18276471|P2|Overall Study|Lost to Follow-up|2
5302641|NCT00420628|18276472|P1|Overall Study|Lost to Follow-up|3
5302642|NCT00420628|18276471|P2|Overall Study|Withdrawn by parent or gaurdian|2
5302643|NCT00420628|18276472|P1|Overall Study|Withdrawn by parent or gaurdian|5
5302644|NCT00420511|18276488|P2|Overall Study|Lost to Follow-up|0
5302645|NCT00420511|18276489|P1|Overall Study|Lost to Follow-up|1
5302646|NCT00420511|18276488|P2|Overall Study|Adverse Event|1
5302647|NCT00420511|18276489|P1|Overall Study|Adverse Event|1
5302648|NCT00420420|18276510|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
5302649|NCT00420420|18276511|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
5302650|NCT00420420|18276510|P2|Overall Study|Withdrawal by Subject|0
5302651|NCT00420420|18276511|P1|Overall Study|Withdrawal by Subject|1
5302652|NCT00420420|18276510|P2|Overall Study|Protocol Violation|1
5302653|NCT00420420|18276511|P1|Overall Study|Protocol Violation|1
5302654|NCT00420420|18276510|P2|Overall Study|Adverse Event|3
5302655|NCT00420420|18276511|P1|Overall Study|Adverse Event|5
5302656|NCT00420407|18276529|P2|Overall Study|Withdrawal by Subject|2
5302657|NCT00420407|18276530|P1|Overall Study|Withdrawal by Subject|0
5302658|NCT00420407|18276529|P2|Overall Study|subject identified as Jehovah's witness|0
5302659|NCT00420407|18276530|P1|Overall Study|subject identified as Jehovah's witness|1
5302660|NCT00420407|18276529|P2|Overall Study|subject identified as detainee|0
5302661|NCT00420407|18276530|P1|Overall Study|subject identified as detainee|1
5302662|NCT00420407|18276529|P2|Overall Study|Physician Decision|1
5302663|NCT00420407|18276530|P1|Overall Study|Physician Decision|2
5302664|NCT00420407|18276529|P2|Overall Study|Lost to Follow-up|3
5302665|NCT00420407|18276530|P1|Overall Study|Lost to Follow-up|0
5302666|NCT00420342|18276540|P3|Overall Study|Withdrawal by Subject|0
5302667|NCT00420342|18276541|P2|Overall Study|Withdrawal by Subject|2
5302668|NCT00420342|18276542|P1|Overall Study|Withdrawal by Subject|0
5302669|NCT00420342|18276540|P3|Overall Study|Lost to Follow-up|1
5302670|NCT00420342|18276541|P2|Overall Study|Lost to Follow-up|0
5302671|NCT00420342|18276542|P1|Overall Study|Lost to Follow-up|1
5302672|NCT00420316|18276585|P2|Overall Study|Lost to Follow-up|8
5302673|NCT00420316|18276586|P1|Overall Study|Lost to Follow-up|12
5302674|NCT00420316|18276585|P2|Overall Study|Withdrawal by Subject|1
5302675|NCT00420316|18276586|P1|Overall Study|Withdrawal by Subject|0
5302676|NCT00420303|18276610|P2|Overall Study|Physician Decision|1
5302677|NCT00420303|18276611|P1|Overall Study|Physician Decision|0
5302678|NCT00420303|18276610|P2|Overall Study|Lack of Efficacy|3
5302679|NCT00420303|18276611|P1|Overall Study|Lack of Efficacy|0
5302680|NCT00420303|18276610|P2|Overall Study|Serious Adverse Event|0
5302681|NCT00420303|18276611|P1|Overall Study|Serious Adverse Event|1
5302682|NCT00420290|18276623|P2|Overall Study|did not meet inclusion/exclusion|1
5302683|NCT00420290|18276624|P1|Overall Study|did not meet inclusion/exclusion|1
5302684|NCT00420290|18276623|P2|Overall Study|Withdrawal by Subject|2
5302685|NCT00420290|18276624|P1|Overall Study|Withdrawal by Subject|0
5302686|NCT00420290|18276623|P2|Overall Study|Adverse Event|1
5302687|NCT00420290|18276624|P1|Overall Study|Adverse Event|3
5302688|NCT00420238|18276640|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
5302689|NCT00420238|18276641|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
5302690|NCT00420238|18276640|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
5302691|NCT00420238|18276641|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
5302692|NCT00420238|18276640|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
5302693|NCT00420238|18276641|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
5302694|NCT00420238|18276640|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
5302695|NCT00420238|18276641|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
5302696|NCT00420238|18276640|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
5302697|NCT00420238|18276641|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
5302698|NCT00420238|18276640|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
5302699|NCT00420238|18276641|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
5302700|NCT00420212|18276780|P3|Overall Study|Other-Unspecified|18
5302701|NCT00420212|18276781|P2|Overall Study|Other-Unspecified|14
5302702|NCT00420212|18276782|P1|Overall Study|Other-Unspecified|21
5302703|NCT00420212|18276780|P3|Overall Study|Death|1
5302704|NCT00420212|18276781|P2|Overall Study|Death|0
5302705|NCT00420212|18276782|P1|Overall Study|Death|0
5302706|NCT00420212|18276780|P3|Overall Study|Protocol Violation|8
5302707|NCT00420212|18276781|P2|Overall Study|Protocol Violation|4
5302708|NCT00420212|18276782|P1|Overall Study|Protocol Violation|4
5302709|NCT00420212|18276780|P3|Overall Study|Physician Decision|3
5302710|NCT00420212|18276781|P2|Overall Study|Physician Decision|4
5302711|NCT00420212|18276782|P1|Overall Study|Physician Decision|4
5302712|NCT00420212|18276780|P3|Overall Study|Withdrawal by Subject|19
5302713|NCT00420212|18276781|P2|Overall Study|Withdrawal by Subject|22
5302714|NCT00420212|18276782|P1|Overall Study|Withdrawal by Subject|31
5302715|NCT00420212|18276780|P3|Overall Study|Lost to Follow-up|11
5302716|NCT00420212|18276781|P2|Overall Study|Lost to Follow-up|11
5302717|NCT00420212|18276782|P1|Overall Study|Lost to Follow-up|9
5302718|NCT00420212|18276780|P3|Overall Study|Adverse Event|36
5302719|NCT00420212|18276781|P2|Overall Study|Adverse Event|40
5302720|NCT00420212|18276782|P1|Overall Study|Adverse Event|22
5302721|NCT00420199|18276808|P2|Overall Study|Participant no longer met study criteria|0
5302722|NCT00420199|18276809|P1|Overall Study|Participant no longer met study criteria|1
5302723|NCT00420095|18276875|P2|Overall Study|Lost to Follow-up|0
5302724|NCT00420095|18276876|P1|Overall Study|Lost to Follow-up|1
5302725|NCT00420095|18276875|P2|Overall Study|Protocol Violation|1
5302726|NCT00420095|18276876|P1|Overall Study|Protocol Violation|1
5302727|NCT00420095|18276875|P2|Overall Study|Adverse Event|0
5302728|NCT00420095|18276876|P1|Overall Study|Adverse Event|1
5302729|NCT00420056|18276894|P1|Overall Study|Objective progression or relapse|17
5302730|NCT00420004|18276934|P3|Overall Study|Sponsor Decision|1
5302731|NCT00420004|18276935|P2|Overall Study|Sponsor Decision|3
5302732|NCT00420004|18276936|P1|Overall Study|Sponsor Decision|3
5302733|NCT00420004|18276934|P3|Overall Study|Withdrawal by Subject|14
5302734|NCT00420004|18276935|P2|Overall Study|Withdrawal by Subject|42
5302735|NCT00420004|18276936|P1|Overall Study|Withdrawal by Subject|67
5302736|NCT00420004|18276934|P3|Overall Study|Protocol Violation|3
5302737|NCT00420004|18276935|P2|Overall Study|Protocol Violation|4
5302738|NCT00420004|18276936|P1|Overall Study|Protocol Violation|5
5302739|NCT00420004|18276934|P3|Overall Study|Physician Decision|2
5302740|NCT00420004|18276935|P2|Overall Study|Physician Decision|4
5302741|NCT00420004|18276936|P1|Overall Study|Physician Decision|14
5302742|NCT00420004|18276934|P3|Overall Study|Entry Criteria Not Met|0
5302743|NCT00420004|18276935|P2|Overall Study|Entry Criteria Not Met|1
5302744|NCT00420004|18276936|P1|Overall Study|Entry Criteria Not Met|0
5302745|NCT00420004|18276934|P3|Overall Study|Lost to Follow-up|10
5302746|NCT00420004|18276935|P2|Overall Study|Lost to Follow-up|12
5302747|NCT00420004|18276936|P1|Overall Study|Lost to Follow-up|31
5302748|NCT00420004|18276934|P3|Overall Study|Lack of Efficacy|1
5302749|NCT00420004|18276935|P2|Overall Study|Lack of Efficacy|4
5302750|NCT00420004|18276936|P1|Overall Study|Lack of Efficacy|5
5302751|NCT00420004|18276934|P3|Overall Study|Adverse Event|1
5302752|NCT00420004|18276935|P2|Overall Study|Adverse Event|1
5302753|NCT00420004|18276936|P1|Overall Study|Adverse Event|4
5302754|NCT00419952|18277001|P2|Overall Study|Abnormal ECG|0
5302755|NCT00419952|18277002|P1|Overall Study|Abnormal ECG|1
5302756|NCT00419952|18277001|P2|Overall Study|Diary or medication non-compliance|4
5302757|NCT00419952|18277002|P1|Overall Study|Diary or medication non-compliance|2
5302758|NCT00419952|18277001|P2|Overall Study|Occurence of 2 or more exacerbations|0
5302759|NCT00419952|18277002|P1|Overall Study|Occurence of 2 or more exacerbations|2
5302760|NCT00419952|18277001|P2|Overall Study|Intake of prohibited medication|2
5302761|NCT00419952|18277002|P1|Overall Study|Intake of prohibited medication|2
5302762|NCT00419952|18277001|P2|Overall Study|Incorrectly enrolled|3
5302763|NCT00419952|18277002|P1|Overall Study|Incorrectly enrolled|10
5302764|NCT00419952|18277001|P2|Overall Study|Physician Decision|3
5302765|NCT00419952|18277002|P1|Overall Study|Physician Decision|1
5302766|NCT00419952|18277001|P2|Overall Study|Pregnancy|2
5302767|NCT00419952|18277002|P1|Overall Study|Pregnancy|4
5302768|NCT00419952|18277001|P2|Overall Study|Protocol Violation|24
5302769|NCT00419952|18277002|P1|Overall Study|Protocol Violation|32
5302770|NCT00419952|18277001|P2|Overall Study|Lost to Follow-up|34
5302771|NCT00419952|18277002|P1|Overall Study|Lost to Follow-up|43
5302772|NCT00419952|18277001|P2|Overall Study|Withdrawal by Subject|43
5302773|NCT00419952|18277002|P1|Overall Study|Withdrawal by Subject|44
5302774|NCT00419952|18277001|P2|Overall Study|Adverse Event|10
5302775|NCT00419952|18277002|P1|Overall Study|Adverse Event|8
5302776|NCT00419926|18277036|P2|Overall Study|Death|1
5302777|NCT00419926|18277037|P1|Overall Study|Death|2
5302778|NCT00419926|18277036|P2|Overall Study|Lost to Follow-up|2
5302779|NCT00419926|18277037|P1|Overall Study|Lost to Follow-up|1
5302780|NCT00419926|18277036|P2|Overall Study|Administrative Problem|4
5302781|NCT00419926|18277037|P1|Overall Study|Administrative Problem|4
5302782|NCT00419926|18277036|P2|Overall Study|Withdrawal by Subject|3
5302783|NCT00419926|18277037|P1|Overall Study|Withdrawal by Subject|7
5302784|NCT00419770|18277053|P2|Overall Study|Withdrawal by Subject|1
5302785|NCT00419770|18277054|P1|Overall Study|Withdrawal by Subject|5
5302786|NCT00419757|18277062|P2|Overall Study|Multiple reasons|1
5302787|NCT00419757|18277063|P1|Overall Study|Multiple reasons|3
5302788|NCT00419757|18277062|P2|Overall Study|Study specific discontinuation criteria|8
5302789|NCT00419757|18277063|P1|Overall Study|Study specific discontinuation criteria|4
5302790|NCT00419757|18277062|P2|Overall Study|Protocol Violation|3
5302791|NCT00419757|18277063|P1|Overall Study|Protocol Violation|2
5302792|NCT00419757|18277062|P2|Overall Study|Withdrawal by Subject|1
5302793|NCT00419757|18277063|P1|Overall Study|Withdrawal by Subject|7
5302794|NCT00419757|18277062|P2|Overall Study|Lost to Follow-up|4
5302795|NCT00419757|18277063|P1|Overall Study|Lost to Follow-up|1
5302796|NCT00419757|18277062|P2|Overall Study|Adverse Event|4
5302797|NCT00419757|18277063|P1|Overall Study|Adverse Event|1
5302798|NCT00419744|18277102|P3|Overall Study|Incorrect medication kit dispensed|1
5302799|NCT00419744|18277103|P2|Overall Study|Incorrect medication kit dispensed|0
5302800|NCT00419744|18277104|P1|Overall Study|Incorrect medication kit dispensed|0
5302801|NCT00419744|18277102|P3|Overall Study|Spirometry mouthpiece issues|2
5302802|NCT00419744|18277103|P2|Overall Study|Spirometry mouthpiece issues|1
5302803|NCT00419744|18277104|P1|Overall Study|Spirometry mouthpiece issues|0
5302804|NCT00419744|18277102|P3|Overall Study|Physician Decision|6
5302805|NCT00419744|18277103|P2|Overall Study|Physician Decision|5
5302806|NCT00419744|18277104|P1|Overall Study|Physician Decision|10
5302807|NCT00419744|18277102|P3|Overall Study|Moving out of state|1
5302808|NCT00419744|18277103|P2|Overall Study|Moving out of state|0
5302809|NCT00419744|18277104|P1|Overall Study|Moving out of state|2
5302810|NCT00419744|18277102|P3|Overall Study|Randomized in error|7
5302811|NCT00419744|18277103|P2|Overall Study|Randomized in error|6
5302812|NCT00419744|18277104|P1|Overall Study|Randomized in error|9
5302813|NCT00419744|18277102|P3|Overall Study|Protocol Violation|8
5302814|NCT00419744|18277103|P2|Overall Study|Protocol Violation|7
5302815|NCT00419744|18277104|P1|Overall Study|Protocol Violation|4
5302816|NCT00419744|18277102|P3|Overall Study|Lost to Follow-up|6
5302817|NCT00419744|18277103|P2|Overall Study|Lost to Follow-up|10
5302818|NCT00419744|18277104|P1|Overall Study|Lost to Follow-up|8
5302819|NCT00419744|18277102|P3|Overall Study|Withdrawal by Subject|52
5302820|NCT00419744|18277103|P2|Overall Study|Withdrawal by Subject|49
5302821|NCT00419744|18277104|P1|Overall Study|Withdrawal by Subject|45
5302822|NCT00419744|18277102|P3|Overall Study|Adverse Event|50
5302823|NCT00419744|18277103|P2|Overall Study|Adverse Event|40
5302824|NCT00419744|18277104|P1|Overall Study|Adverse Event|39
5302825|NCT00419562|18277147|P2|Overall Study|Participant Institutionalized|0
5302826|NCT00419562|18277148|P1|Overall Study|Participant Institutionalized|1
5302827|NCT00419562|18277147|P2|Overall Study|Withdrawal by Subject|18
5302828|NCT00419562|18277148|P1|Overall Study|Withdrawal by Subject|20
5302829|NCT00419562|18277147|P2|Overall Study|Lost to Follow-up|13
5302830|NCT00419562|18277148|P1|Overall Study|Lost to Follow-up|12
5302831|NCT00419393|18277171|P1|Overall Study|Other: Investigator decision|1
5302832|NCT00419393|18277171|P1|Overall Study|Other: Other health problems|1
5302833|NCT00419393|18277171|P1|Overall Study|Other: Site closure|1
5302834|NCT00419393|18277171|P1|Overall Study|Other: Subject had temporal lobectomy|1
5302835|NCT00419393|18277171|P1|Overall Study|Other: Sponsor request|3
5302836|NCT00419393|18277171|P1|Overall Study|Withdrawal by Subject|7
5302837|NCT00419393|18277171|P1|Overall Study|Protocol Violation|5
5302838|NCT00419393|18277171|P1|Overall Study|Adverse Event|5
5302839|NCT00419380|18277181|P2|Overall Study|Withdrawal by Subject|1
5302840|NCT00419380|18277182|P1|Overall Study|Withdrawal by Subject|0
5302841|NCT00419380|18277181|P2|Overall Study|Lost to Follow-up|1
5302842|NCT00419380|18277182|P1|Overall Study|Lost to Follow-up|0
5302843|NCT00419380|18277181|P2|Overall Study|Physician Decision|1
5302844|NCT00419380|18277182|P1|Overall Study|Physician Decision|0
5302845|NCT00419380|18277181|P2|Overall Study|Lack of Efficacy|7
5302846|NCT00419380|18277182|P1|Overall Study|Lack of Efficacy|1
5302847|NCT00419341|18277190|P1|Efficacy Period|Termination of study site|1
5302848|NCT00419341|18277190|P1|Efficacy Period|Non-compliance|1
5302849|NCT00419341|18277190|P1|Efficacy Period|Lost to Follow-up|1
5302850|NCT00419341|18277190|P1|Efficacy Period|Protocol Violation|1
5302851|NCT00419341|18277190|P1|Efficacy Period|Withdrawal by Subject|6
5302852|NCT00419341|18277190|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
5302853|NCT00419341|18277190|P1|Wash in/Wash Out Period|Adverse Event|2
5302854|NCT00419341|18277190|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
5302855|NCT00419263|18277225|P3|Overall Study|Withdrawal by Subject|1
5302856|NCT00419263|18277226|P2|Overall Study|Withdrawal by Subject|0
5302857|NCT00419263|18277227|P1|Overall Study|Withdrawal by Subject|0
5302858|NCT00419263|18277225|P3|Overall Study|Adverse Event|1
5302859|NCT00419263|18277226|P2|Overall Study|Adverse Event|0
5302860|NCT00419263|18277227|P1|Overall Study|Adverse Event|0
5302861|NCT00419263|18277225|P3|Overall Study|Randomized in Error, Not Treated|0
5302862|NCT00419263|18277226|P2|Overall Study|Randomized in Error, Not Treated|1
5302863|NCT00419263|18277227|P1|Overall Study|Randomized in Error, Not Treated|1
5302864|NCT00419263|18277225|P3|Overall Study|Lost to Follow-up|1
5302865|NCT00419263|18277226|P2|Overall Study|Lost to Follow-up|1
5302866|NCT00419263|18277227|P1|Overall Study|Lost to Follow-up|2
5302867|NCT00419159|18277256|P2|Overall Study|Disease progression|76
5302868|NCT00419159|18277257|P1|Overall Study|Disease progression|79
5302869|NCT00419159|18277256|P2|Overall Study|Death|2
5302870|NCT00419159|18277257|P1|Overall Study|Death|2
5302871|NCT00419159|18277256|P2|Overall Study|Lost to Follow-up|1
5302872|NCT00419159|18277257|P1|Overall Study|Lost to Follow-up|0
5302873|NCT00419159|18277256|P2|Overall Study|Withdrawal by Subject|3
5302874|NCT00419159|18277257|P1|Overall Study|Withdrawal by Subject|10
5302875|NCT00419159|18277256|P2|Overall Study|Protocol Violation|0
5302876|NCT00419159|18277257|P1|Overall Study|Protocol Violation|1
5302877|NCT00419159|18277256|P2|Overall Study|Subject's no longer requires study drug|1
5302878|NCT00419159|18277257|P1|Overall Study|Subject's no longer requires study drug|0
5302879|NCT00419159|18277256|P2|Overall Study|Abnormal laboratory value(s)|2
5302880|NCT00419159|18277257|P1|Overall Study|Abnormal laboratory value(s)|0
5302881|NCT00419159|18277256|P2|Overall Study|Adverse Event|15
5302882|NCT00419159|18277257|P1|Overall Study|Adverse Event|7
5302883|NCT00419120|18277287|P1|Long Term Follow up Period|study ongoing|10
5302884|NCT00419094|18277294|P2|Overall Study|Other: No contact for extended period|1
5302885|NCT00419094|18277295|P1|Overall Study|Other: No contact for extended period|0
5302886|NCT00419094|18277294|P2|Overall Study|Other: Patient non-compliant|1
5302887|NCT00419094|18277295|P1|Overall Study|Other: Patient non-compliant|0
5302888|NCT00419094|18277294|P2|Overall Study|Other: Error determining exit criteria|0
5302889|NCT00419094|18277295|P1|Overall Study|Other: Error determining exit criteria|1
5302890|NCT00419094|18277294|P2|Overall Study|Withdrawal of consent|5
5302891|NCT00419094|18277295|P1|Overall Study|Withdrawal of consent|1
5302892|NCT00419094|18277294|P2|Overall Study|Protocol Violation|14
5302893|NCT00419094|18277295|P1|Overall Study|Protocol Violation|1
5302894|NCT00419094|18277294|P2|Overall Study|Lost to Follow-up|2
5302895|NCT00419094|18277295|P1|Overall Study|Lost to Follow-up|0
5302896|NCT00419094|18277294|P2|Overall Study|Lack of Efficacy|0
5302897|NCT00419094|18277295|P1|Overall Study|Lack of Efficacy|1
5302898|NCT00419094|18277294|P2|Overall Study|Adverse Event|7
5302899|NCT00419094|18277295|P1|Overall Study|Adverse Event|3
5302900|NCT00419003|18277309|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
5302901|NCT00419003|18277310|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
5302902|NCT00419003|18277309|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
5302903|NCT00419003|18277310|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
5302904|NCT00418938|18277364|P2|Overall Study|Ineligibility Determined|0
5302905|NCT00418938|18277365|P1|Overall Study|Ineligibility Determined|1
5302906|NCT00418938|18277364|P2|Overall Study|On-going|1
5302907|NCT00418938|18277365|P1|Overall Study|On-going|1
5302908|NCT00418938|18277364|P2|Overall Study|Adverse Event|1
5302909|NCT00418938|18277365|P1|Overall Study|Adverse Event|1
5302910|NCT00418938|18277364|P2|Overall Study|Lost to Follow-up|3
5302911|NCT00418938|18277365|P1|Overall Study|Lost to Follow-up|1
5302912|NCT00418938|18277364|P2|Overall Study|Withdrawal by Subject|15
5302913|NCT00418938|18277365|P1|Overall Study|Withdrawal by Subject|16
5302914|NCT00418938|18277364|P2|Overall Study|Administrative decision|3
5302915|NCT00418938|18277365|P1|Overall Study|Administrative decision|3
5302916|NCT00418938|18277364|P2|Overall Study|Reimbursement|0
5302917|NCT00418938|18277365|P1|Overall Study|Reimbursement|1
5302918|NCT00418886|18277385|P2|Overall Study|randomised but no treatment received|1
5302919|NCT00418886|18277386|P1|Overall Study|randomised but no treatment received|0
5302920|NCT00418886|18277385|P2|Overall Study|withdrawn due to other reason|0
5302921|NCT00418886|18277386|P1|Overall Study|withdrawn due to other reason|1
5302922|NCT00418886|18277385|P2|Overall Study|Lost to Follow-up|6
5302923|NCT00418886|18277386|P1|Overall Study|Lost to Follow-up|4
5302924|NCT00418886|18277385|P2|Overall Study|Withdrawal by Subject|10
5302925|NCT00418886|18277386|P1|Overall Study|Withdrawal by Subject|9
5302926|NCT00418886|18277385|P2|Overall Study|Death|147
5302927|NCT00418886|18277386|P1|Overall Study|Death|122
5302928|NCT00418886|18277385|P2|Overall Study|discontinue treatment survival follow up|91
5302929|NCT00418886|18277386|P1|Overall Study|discontinue treatment survival follow up|90
5302930|NCT00418834|18277412|P2|Overall Study|Withdrawal by Subject|7
5302931|NCT00418834|18277413|P1|Overall Study|Withdrawal by Subject|3
5302932|NCT00418834|18277412|P2|Overall Study|Protocol Violation|3
5302933|NCT00418834|18277413|P1|Overall Study|Protocol Violation|4
5302934|NCT00418834|18277412|P2|Overall Study|Lost to Follow-up|1
5302935|NCT00418834|18277413|P1|Overall Study|Lost to Follow-up|0
5302936|NCT00418834|18277412|P2|Overall Study|Adverse Event|9
5302937|NCT00418834|18277413|P1|Overall Study|Adverse Event|16
5302938|NCT00418717|18277473|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
5302939|NCT00418717|18277473|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
5302940|NCT00418691|18277481|P3|Overall Study|Progressive Disease|1
5302941|NCT00418691|18277482|P2|Overall Study|Progressive Disease|0
5302942|NCT00418691|18277483|P1|Overall Study|Progressive Disease|1
5302943|NCT00418691|18277481|P3|Overall Study|Started new medication voiding entry|1
5302944|NCT00418691|18277482|P2|Overall Study|Started new medication voiding entry|0
5302945|NCT00418691|18277483|P1|Overall Study|Started new medication voiding entry|0
5302946|NCT00418691|18277481|P3|Overall Study|Lost to Follow-up|3
5302947|NCT00418691|18277482|P2|Overall Study|Lost to Follow-up|2
5302948|NCT00418691|18277483|P1|Overall Study|Lost to Follow-up|1
5302949|NCT00418665|18277494|P3|Treatment Extension|Death|1
5302950|NCT00418665|18277495|P2|Treatment Extension|Death|0
5302951|NCT00418665|18277496|P1|Treatment Extension|Death|0
5302952|NCT00418665|18277494|P3|Treatment Extension|Physician Decision|1
5302953|NCT00418665|18277495|P2|Treatment Extension|Physician Decision|2
5302954|NCT00418665|18277496|P1|Treatment Extension|Physician Decision|2
5302955|NCT00418665|18277494|P3|Treatment Extension|Requirement for alternative therapy|0
5302956|NCT00418665|18277495|P2|Treatment Extension|Requirement for alternative therapy|2
5302957|NCT00418665|18277496|P1|Treatment Extension|Requirement for alternative therapy|2
5302958|NCT00418665|18277494|P3|Treatment Extension|Withdrawal by Subject|0
5302959|NCT00418665|18277495|P2|Treatment Extension|Withdrawal by Subject|0
5302960|NCT00418665|18277496|P1|Treatment Extension|Withdrawal by Subject|1
5302961|NCT00418665|18277494|P3|Treatment Extension|Adverse Event|0
5302962|NCT00418665|18277495|P2|Treatment Extension|Adverse Event|0
5302963|NCT00418665|18277496|P1|Treatment Extension|Adverse Event|1
5302964|NCT00418665|18277494|P3|Treatment Period|Physician Decision|3
5302965|NCT00418665|18277495|P2|Treatment Period|Physician Decision|0
5302966|NCT00418665|18277496|P1|Treatment Period|Physician Decision|1
5302967|NCT00418665|18277494|P3|Treatment Period|Requirement for alternative therapy|0
5302968|NCT00418665|18277495|P2|Treatment Period|Requirement for alternative therapy|0
5302969|NCT00418665|18277496|P1|Treatment Period|Requirement for alternative therapy|1
5302970|NCT00418665|18277494|P3|Treatment Period|Withdrawal by Subject|1
5302971|NCT00418665|18277495|P2|Treatment Period|Withdrawal by Subject|3
5302972|NCT00418665|18277496|P1|Treatment Period|Withdrawal by Subject|0
5302973|NCT00418665|18277494|P3|Treatment Period|Adverse Event|0
5302974|NCT00418665|18277495|P2|Treatment Period|Adverse Event|2
5302975|NCT00418665|18277496|P1|Treatment Period|Adverse Event|2
5302976|NCT00418665|18277494|P3|Treatment Period|Ineligibility determined|0
5302977|NCT00418665|18277495|P2|Treatment Period|Ineligibility determined|1
5302978|NCT00418665|18277496|P1|Treatment Period|Ineligibility determined|1
5302979|NCT00418561|18277530|P3|Overall Study|Participant's (guardian's) decision|0
5302980|NCT00418561|18277531|P2|Overall Study|Participant's (guardian's) decision|1
5302981|NCT00418561|18277532|P1|Overall Study|Participant's (guardian's) decision|0
5302982|NCT00418522|18277602|P2|Overall Study|Randomized but did not receive treatment|4
5302983|NCT00418522|18277603|P1|Overall Study|Randomized but did not receive treatment|7
5302984|NCT00418522|18277602|P2|Overall Study|Other|23
5302985|NCT00418522|18277603|P1|Overall Study|Other|27
5302986|NCT00418522|18277602|P2|Overall Study|Withdrawal by Subject|7
5302987|NCT00418522|18277603|P1|Overall Study|Withdrawal by Subject|31
5302988|NCT00418522|18277602|P2|Overall Study|Lost to Follow-up|4
5302989|NCT00418522|18277603|P1|Overall Study|Lost to Follow-up|10
5302990|NCT00418522|18277602|P2|Overall Study|Lack of Efficacy|3
5302991|NCT00418522|18277603|P1|Overall Study|Lack of Efficacy|1
5302992|NCT00418522|18277602|P2|Overall Study|Adverse Event|1
5302993|NCT00418522|18277603|P1|Overall Study|Adverse Event|7
5302994|NCT00418379|18277667|P3|Year 5|Any other reason not above-mentioned|3
5302995|NCT00418379|18277668|P2|Year 5|Any other reason not above-mentioned|4
5302996|NCT00418379|18277669|P1|Year 5|Any other reason not above-mentioned|2
5302997|NCT00418379|18277667|P3|Year 5|Adverse Event|0
5302998|NCT00418379|18277668|P2|Year 5|Adverse Event|1
5302999|NCT00418379|18277669|P1|Year 5|Adverse Event|0
5303000|NCT00418379|18277667|P3|Year 4|Any other reason not above-mentioned|0
5303001|NCT00418379|18277668|P2|Year 4|Any other reason not above-mentioned|1
5303002|NCT00418379|18277669|P1|Year 4|Any other reason not above-mentioned|1
5303003|NCT00418379|18277667|P3|Year 4|Withdrawal by Subject|2
5303004|NCT00418379|18277668|P2|Year 4|Withdrawal by Subject|3
5303005|NCT00418379|18277669|P1|Year 4|Withdrawal by Subject|2
5303006|NCT00418379|18277667|P3|Year 4|Adverse Event|0
5303007|NCT00418379|18277668|P2|Year 4|Adverse Event|1
5303008|NCT00418379|18277669|P1|Year 4|Adverse Event|0
5303009|NCT00418379|18277667|P3|Year 3|Any other reason not above-mentioned|1
5303010|NCT00418379|18277668|P2|Year 3|Any other reason not above-mentioned|1
5303011|NCT00418379|18277669|P1|Year 3|Any other reason not above-mentioned|2
5303012|NCT00418379|18277667|P3|Year 3|Withdrawal by Subject|2
5303013|NCT00418379|18277668|P2|Year 3|Withdrawal by Subject|1
5303014|NCT00418379|18277669|P1|Year 3|Withdrawal by Subject|1
5303015|NCT00418379|18277667|P3|Year 2|Any other reason not above-mentioned|6
5303016|NCT00418379|18277668|P2|Year 2|Any other reason not above-mentioned|1
5303017|NCT00418379|18277669|P1|Year 2|Any other reason not above-mentioned|2
5303018|NCT00418379|18277667|P3|Year 2|Withdrawal by Subject|3
5303019|NCT00418379|18277668|P2|Year 2|Withdrawal by Subject|1
5303020|NCT00418379|18277669|P1|Year 2|Withdrawal by Subject|1
5303021|NCT00418379|18277667|P3|Year 2|Adverse Event|1
5303022|NCT00418379|18277668|P2|Year 2|Adverse Event|2
5303023|NCT00418379|18277669|P1|Year 2|Adverse Event|5
5303024|NCT00418379|18277667|P3|Year 1|Any other reason not above-mentioned|7
5303025|NCT00418379|18277668|P2|Year 1|Any other reason not above-mentioned|5
5303026|NCT00418379|18277669|P1|Year 1|Any other reason not above-mentioned|2
5303027|NCT00418379|18277667|P3|Year 1|Withdrawal by Subject|5
5303028|NCT00418379|18277668|P2|Year 1|Withdrawal by Subject|8
5303029|NCT00418379|18277669|P1|Year 1|Withdrawal by Subject|7
5303030|NCT00418379|18277667|P3|Year 1|Adverse Event|3
5303031|NCT00418379|18277668|P2|Year 1|Adverse Event|15
5303032|NCT00418379|18277669|P1|Year 1|Adverse Event|9
5303033|NCT00418314|18277679|P2|Overall Study|Withdrawal by Subject|2
5303034|NCT00418314|18277680|P1|Overall Study|Withdrawal by Subject|1
5303035|NCT00418184|18277710|P2|Double-blind Phase|Poor compliance|1
5303036|NCT00418184|18277711|P1|Double-blind Phase|Poor compliance|3
5303037|NCT00418184|18277710|P2|Double-blind Phase|Adverse Event|1
5303038|NCT00418184|18277711|P1|Double-blind Phase|Adverse Event|2
5303039|NCT00418184|18277710|P2|Double-blind Phase|Withdrawal by Subject|9
5303040|NCT00418184|18277711|P1|Double-blind Phase|Withdrawal by Subject|22
5303041|NCT00418145|18277719|P1|Overall Study|study terminated|6
5303042|NCT00417989|18277794|P2|Overall Study|Physician Decision|2
5303043|NCT00417989|18277795|P1|Overall Study|Physician Decision|5
5303044|NCT00417989|18277794|P2|Overall Study|Death|1
5303045|NCT00417989|18277795|P1|Overall Study|Death|0
5303046|NCT00417989|18277794|P2|Overall Study|Protocol Violation|0
5303047|NCT00417989|18277795|P1|Overall Study|Protocol Violation|1
5303048|NCT00417989|18277794|P2|Overall Study|Lost to Follow-up|6
5303049|NCT00417989|18277795|P1|Overall Study|Lost to Follow-up|1
5303050|NCT00417989|18277794|P2|Overall Study|Withdrawal by Subject|13
5303051|NCT00417989|18277795|P1|Overall Study|Withdrawal by Subject|13
5303052|NCT00417976|18277817|P1|Overall Study|Treatment -related toxicity|2
5303053|NCT00417976|18277817|P1|Overall Study|Non compliance unrelated to toxicity|1
5303054|NCT00417963|18277822|P1|Overall Study|Study device could not be deployed|3
5303055|NCT00417963|18277822|P1|Overall Study|Death|17
5303056|NCT00417963|18277822|P1|Overall Study|Withdrawal by Subject|18
5303057|NCT00417963|18277822|P1|Overall Study|Lost to Follow-up|3
5303058|NCT00417885|18277839|P1|Overall Study|Transferred to Another Sunitinib Study|2
5303059|NCT00417885|18277839|P1|Overall Study|Objective Progression or Relapse|3
5303060|NCT00417885|18277839|P1|Overall Study|Adverse Event|1
5303061|NCT00417612|18277865|P2|Overall Study|Lost to Follow-up|0
5303062|NCT00417612|18277866|P1|Overall Study|Lost to Follow-up|1
5303063|NCT00417612|18277865|P2|Overall Study|Protocol Violation|2
5303064|NCT00417612|18277866|P1|Overall Study|Protocol Violation|0
5303065|NCT00417612|18277865|P2|Overall Study|Adverse Event|0
5303066|NCT00417612|18277866|P1|Overall Study|Adverse Event|2
5303067|NCT00417612|18277865|P2|Overall Study|Errant diagnosis|1
5303068|NCT00417612|18277866|P1|Overall Study|Errant diagnosis|0
5303069|NCT00417482|18277892|P3|Phase B 2nd 16 Weeks|Death|0
5303070|NCT00417482|18277893|P2|Phase B 2nd 16 Weeks|Death|1
5303071|NCT00417482|18277894|P1|Phase B 2nd 16 Weeks|Death|1
5303072|NCT00417482|18277892|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
5303073|NCT00417482|18277893|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
5303074|NCT00417482|18277894|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
5303075|NCT00417482|18277892|P3|Phase B 2nd 16 Weeks|Adverse Event|1
5303076|NCT00417482|18277893|P2|Phase B 2nd 16 Weeks|Adverse Event|0
5303077|NCT00417482|18277894|P1|Phase B 2nd 16 Weeks|Adverse Event|0
5303078|NCT00417482|18277892|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
5303079|NCT00417482|18277893|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
5303080|NCT00417482|18277894|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
5303081|NCT00417482|18277892|P3|Phase B 1st 16 Weeks|Death|0
5303082|NCT00417482|18277893|P2|Phase B 1st 16 Weeks|Death|0
5303083|NCT00417482|18277894|P1|Phase B 1st 16 Weeks|Death|1
5303084|NCT00417482|18277892|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
5303085|NCT00417482|18277893|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
5303086|NCT00417482|18277894|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
5303087|NCT00417482|18277892|P3|Phase B 1st 16 Weeks|Adverse Event|1
5303088|NCT00417482|18277893|P2|Phase B 1st 16 Weeks|Adverse Event|0
5303089|NCT00417482|18277894|P1|Phase B 1st 16 Weeks|Adverse Event|2
5303090|NCT00417482|18277892|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
5303091|NCT00417482|18277893|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
5303092|NCT00417482|18277894|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
5303093|NCT00417248|18277933|P1|Overall Study|Lack of Efficacy|1
5303094|NCT00417248|18277933|P1|Overall Study|Death|1
5303095|NCT00417248|18277933|P1|Overall Study|Study Terminated|6
5303096|NCT00417170|18277940|P2|Overall Study|Lost to Follow-up|1
5303097|NCT00417170|18277941|P1|Overall Study|Lost to Follow-up|0
5303098|NCT00417170|18277940|P2|Overall Study|Withdrawal by Subject|1
5303099|NCT00417170|18277941|P1|Overall Study|Withdrawal by Subject|1
5303100|NCT00417170|18277940|P2|Overall Study|Adverse Event|1
5303101|NCT00417170|18277941|P1|Overall Study|Adverse Event|1
5303102|NCT00417079|18277957|P2|Overall Study|abnormal liver function tests|1
5303103|NCT00417079|18277958|P1|Overall Study|abnormal liver function tests|0
5303104|NCT00417079|18277957|P2|Overall Study|Patient unable to come to the clinic|1
5303105|NCT00417079|18277958|P1|Overall Study|Patient unable to come to the clinic|0
5303106|NCT00417079|18277957|P2|Overall Study|Withdrawal by subject's family|1
5303107|NCT00417079|18277958|P1|Overall Study|Withdrawal by subject's family|0
5303108|NCT00417079|18277957|P2|Overall Study|Screening error|1
5303109|NCT00417079|18277958|P1|Overall Study|Screening error|2
5303110|NCT00417079|18277957|P2|Overall Study|Clinical deterioration|0
5303111|NCT00417079|18277958|P1|Overall Study|Clinical deterioration|1
5303112|NCT00417079|18277957|P2|Overall Study|Non-confirmed Disease progression|1
5303113|NCT00417079|18277958|P1|Overall Study|Non-confirmed Disease progression|1
5303114|NCT00417079|18277957|P2|Overall Study|Investigator's decision|4
5303115|NCT00417079|18277958|P1|Overall Study|Investigator's decision|1
5303116|NCT00417079|18277957|P2|Overall Study|Screened failure|1
5303117|NCT00417079|18277958|P1|Overall Study|Screened failure|2
5303118|NCT00417079|18277957|P2|Overall Study|Not treated|7
5303119|NCT00417079|18277958|P1|Overall Study|Not treated|6
5303120|NCT00417079|18277957|P2|Overall Study|Withdrawal by Subject|8
5303121|NCT00417079|18277958|P1|Overall Study|Withdrawal by Subject|17
5303122|NCT00417079|18277957|P2|Overall Study|Lost to Follow-up|0
5303123|NCT00417079|18277958|P1|Overall Study|Lost to Follow-up|2
5303124|NCT00417079|18277957|P2|Overall Study|Non-compliance to protocol|1
5303125|NCT00417079|18277958|P1|Overall Study|Non-compliance to protocol|0
5303126|NCT00417079|18277957|P2|Overall Study|Adverse Event|67
5303127|NCT00417079|18277958|P1|Overall Study|Adverse Event|32
5303128|NCT00417079|18277957|P2|Overall Study|Disease progression|180
5303129|NCT00417079|18277958|P1|Overall Study|Disease progression|267
5303130|NCT00417027|18277981|P3|Overall Study|Protocol Violation|5
5303131|NCT00417027|18277982|P2|Overall Study|Protocol Violation|5
5303132|NCT00417027|18277983|P1|Overall Study|Protocol Violation|0
5303133|NCT00416949|18278009|P1|Overall Study|Patients refused to participate|5
5303134|NCT00416884|18278013|P1|Overall Study|Study terminated due to low accrual|1
5303135|NCT00416715|18278022|P1|Overall Study|Vitamin D levels not evaluable|8
5303136|NCT00416715|18278022|P1|Overall Study|Not evaluable for joint aches|7
5303137|NCT00416624|18278033|P4|Overall Study|Cancel|0
5303138|NCT00416624|18278034|P3|Overall Study|Cancel|0
5303139|NCT00416624|18278035|P2|Overall Study|Cancel|0
5303140|NCT00416624|18278036|P1|Overall Study|Cancel|1
5303141|NCT00416624|18278033|P4|Overall Study|Other|5
5303142|NCT00416624|18278034|P3|Overall Study|Other|5
5303143|NCT00416624|18278035|P2|Overall Study|Other|11
5303144|NCT00416624|18278036|P1|Overall Study|Other|8
5303145|NCT00416624|18278033|P4|Overall Study|Adverse Event|2
5303146|NCT00416624|18278034|P3|Overall Study|Adverse Event|2
5303147|NCT00416624|18278035|P2|Overall Study|Adverse Event|3
5303148|NCT00416624|18278036|P1|Overall Study|Adverse Event|8
5303149|NCT00416624|18278033|P4|Overall Study|Death|1
5303150|NCT00416624|18278034|P3|Overall Study|Death|7
5303151|NCT00416624|18278035|P2|Overall Study|Death|7
5303152|NCT00416624|18278036|P1|Overall Study|Death|4
5303153|NCT00416624|18278033|P4|Overall Study|Withdrawal by Subject|9
5303154|NCT00416624|18278034|P3|Overall Study|Withdrawal by Subject|4
5303155|NCT00416624|18278035|P2|Overall Study|Withdrawal by Subject|6
5303156|NCT00416624|18278036|P1|Overall Study|Withdrawal by Subject|1
5303157|NCT00416598|18278090|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
5303158|NCT00416598|18278090|P1|Decitabine Maintenance|Alternative treatment|2
5303159|NCT00416598|18278090|P1|Decitabine Maintenance|Progression/relapse|38
5303160|NCT00416598|18278090|P1|Decitabine Maintenance|Withdrawal by Subject|18
5303161|NCT00416598|18278090|P1|Decitabine Maintenance|Adverse Event|5
5303162|NCT00416598|18278090|P1|Induction & Intensification|Failed induction|87
5303163|NCT00416598|18278090|P1|Induction & Intensification|Relapse/progression|29
5303164|NCT00416598|18278090|P1|Induction & Intensification|Physician discretion/other medical issue|45
5303165|NCT00416598|18278090|P1|Induction & Intensification|Alternative Treatment|135
5303166|NCT00416598|18278090|P1|Induction & Intensification|Withdrawal by Subject|46
5303167|NCT00416598|18278090|P1|Induction & Intensification|Death|32
5303168|NCT00416598|18278090|P1|Induction & Intensification|Adverse Event|38
5303169|NCT00416520|18278116|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
5303170|NCT00416520|18278117|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
5303171|NCT00416520|18278118|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
5303172|NCT00416520|18278119|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
5303173|NCT00416520|18278116|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
5303174|NCT00416520|18278117|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
5303175|NCT00416520|18278118|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
5303176|NCT00416520|18278119|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
5303177|NCT00416520|18278116|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
5303178|NCT00416520|18278117|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
5303179|NCT00416520|18278118|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
5303180|NCT00416520|18278119|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
5303181|NCT00416520|18278116|P4|Open-label Period|Other Reasons|0
5303182|NCT00416520|18278117|P3|Open-label Period|Other Reasons|0
5303183|NCT00416520|18278118|P2|Open-label Period|Other Reasons|12
5303184|NCT00416520|18278119|P1|Open-label Period|Other Reasons|3
5303185|NCT00416520|18278116|P4|Open-label Period|Withdrawal by Subject|0
5303186|NCT00416520|18278117|P3|Open-label Period|Withdrawal by Subject|0
5303187|NCT00416520|18278118|P2|Open-label Period|Withdrawal by Subject|5
5303188|NCT00416520|18278119|P1|Open-label Period|Withdrawal by Subject|16
5303189|NCT00416520|18278116|P4|Open-label Period|Protocol Violation|0
5303190|NCT00416520|18278117|P3|Open-label Period|Protocol Violation|0
5303191|NCT00416520|18278118|P2|Open-label Period|Protocol Violation|3
5303192|NCT00416520|18278119|P1|Open-label Period|Protocol Violation|3
5303193|NCT00416520|18278116|P4|Open-label Period|Lack of Efficacy|0
5303194|NCT00416520|18278117|P3|Open-label Period|Lack of Efficacy|0
5303195|NCT00416520|18278118|P2|Open-label Period|Lack of Efficacy|1
5303196|NCT00416520|18278119|P1|Open-label Period|Lack of Efficacy|8
5303197|NCT00416520|18278116|P4|Open-label Period|Death|0
5303198|NCT00416520|18278117|P3|Open-label Period|Death|0
5303199|NCT00416520|18278118|P2|Open-label Period|Death|1
5303200|NCT00416520|18278119|P1|Open-label Period|Death|2
5303201|NCT00416520|18278116|P4|Open-label Period|Adverse Event|0
5303202|NCT00416520|18278117|P3|Open-label Period|Adverse Event|0
5303203|NCT00416520|18278118|P2|Open-label Period|Adverse Event|10
5303204|NCT00416520|18278119|P1|Open-label Period|Adverse Event|28
5303205|NCT00416455|18278148|P2|Overall Study|Inadequate pathology|2
5303206|NCT00416455|18278149|P1|Overall Study|Inadequate pathology|11
5303207|NCT00416455|18278148|P2|Overall Study|PET / CT poor quality|1
5303208|NCT00416455|18278149|P1|Overall Study|PET / CT poor quality|2
5303209|NCT00416455|18278148|P2|Overall Study|PET / CT not done|5
5303210|NCT00416455|18278149|P1|Overall Study|PET / CT not done|3
5303211|NCT00416312|18278184|P1|Overall Study|tumors not visible on imaging|2
5303212|NCT00416195|18278190|P2|Overall Study|Other|1
5303213|NCT00416195|18278191|P1|Overall Study|Other|0
5303214|NCT00416195|18278190|P2|Overall Study|Protocol Violation|1
5303215|NCT00416195|18278191|P1|Overall Study|Protocol Violation|1
5303216|NCT00416195|18278190|P2|Overall Study|Adverse Event|2
5303217|NCT00416195|18278191|P1|Overall Study|Adverse Event|1
5303218|NCT00416078|18278216|P2|Overall Study|Lost to Follow-up|2
5303219|NCT00416078|18278217|P1|Overall Study|Lost to Follow-up|4
5303220|NCT00416078|18278216|P2|Overall Study|Physician Decision|0
5303221|NCT00416078|18278217|P1|Overall Study|Physician Decision|1
5303222|NCT00416078|18278216|P2|Overall Study|Withdrawal by Subject|2
5303223|NCT00416078|18278217|P1|Overall Study|Withdrawal by Subject|3
5303224|NCT00416078|18278216|P2|Overall Study|Death|4
5303225|NCT00416078|18278217|P1|Overall Study|Death|3
5303226|NCT00415909|18278233|P1|Overall Study|Death|1
5303227|NCT00415909|18278233|P1|Overall Study|Withdrawal by Subject|2
5303228|NCT00415636|18278267|P6|Overall Study|Disease progression|1
5303229|NCT00415636|18278268|P5|Overall Study|Disease progression|0
5303230|NCT00415636|18278269|P4|Overall Study|Disease progression|3
5303231|NCT00415636|18278270|P3|Overall Study|Disease progression|0
5303232|NCT00415636|18278271|P2|Overall Study|Disease progression|0
5303233|NCT00415636|18278272|P1|Overall Study|Disease progression|0
5303234|NCT00415636|18278267|P6|Overall Study|Withdrawal by Subject|0
5303235|NCT00415636|18278268|P5|Overall Study|Withdrawal by Subject|1
5303236|NCT00415636|18278269|P4|Overall Study|Withdrawal by Subject|0
5303237|NCT00415636|18278270|P3|Overall Study|Withdrawal by Subject|0
5303238|NCT00415636|18278271|P2|Overall Study|Withdrawal by Subject|0
5303239|NCT00415636|18278272|P1|Overall Study|Withdrawal by Subject|0
5303240|NCT00415636|18278267|P6|Overall Study|Adverse Event|0
5303241|NCT00415636|18278268|P5|Overall Study|Adverse Event|1
5303242|NCT00415636|18278269|P4|Overall Study|Adverse Event|1
5303243|NCT00415636|18278270|P3|Overall Study|Adverse Event|0
5303244|NCT00415636|18278271|P2|Overall Study|Adverse Event|0
5303245|NCT00415636|18278272|P1|Overall Study|Adverse Event|0
5303246|NCT00415636|18278267|P6|Overall Study|Symptomatic deterioration|1
5303247|NCT00415636|18278268|P5|Overall Study|Symptomatic deterioration|0
5303248|NCT00415636|18278269|P4|Overall Study|Symptomatic deterioration|2
5303249|NCT00415636|18278270|P3|Overall Study|Symptomatic deterioration|1
5303250|NCT00415636|18278271|P2|Overall Study|Symptomatic deterioration|0
5303251|NCT00415636|18278272|P1|Overall Study|Symptomatic deterioration|1
5303252|NCT00415623|18278306|P2|Overall Study|Withdrawal by Subject|1
5303253|NCT00415623|18278307|P1|Overall Study|Withdrawal by Subject|1
5303254|NCT00415623|18278306|P2|Overall Study|Death|0
5303255|NCT00415623|18278307|P1|Overall Study|Death|1
5303256|NCT00415623|18278306|P2|Overall Study|Adverse Event|4
5303257|NCT00415623|18278307|P1|Overall Study|Adverse Event|3
5303258|NCT00415610|18278334|P3|Overall Study|Death|5
5303259|NCT00415610|18278335|P2|Overall Study|Death|2
5303260|NCT00415610|18278336|P1|Overall Study|Death|3
5303261|NCT00415597|18278356|P1|Treatment|Multiple Reasons|1
5303262|NCT00415597|18278356|P1|Treatment|Sponsor Decision|1
5303263|NCT00415597|18278356|P1|Treatment|Administrative|3
5303264|NCT00415597|18278356|P1|Treatment|Drug Screen|2
5303265|NCT00415597|18278356|P1|Treatment|Lost to Follow-up|28
5303266|NCT00415597|18278356|P1|Treatment|Withdrawal by Subject|51
5303267|NCT00415597|18278356|P1|Treatment|Physician Decision|3
5303268|NCT00415597|18278356|P1|Treatment|Protocol Violation|67
5303269|NCT00415597|18278356|P1|Treatment|Lack of Efficacy|39
5303270|NCT00415597|18278356|P1|Treatment|Adverse Event|110
5303271|NCT00415597|18278356|P1|Enrollment|Protocol Violation|1
5303272|NCT00415597|18278356|P1|Enrollment|Withdrawal by Subject|1
5303273|NCT00415532|18278364|P2|Safety Follow Up Period|Requirement for alternative therapy|1
5303274|NCT00415532|18278365|P1|Safety Follow Up Period|Requirement for alternative therapy|0
5303275|NCT00415532|18278364|P2|Safety Follow Up Period|Noncompliance|0
5303276|NCT00415532|18278365|P1|Safety Follow Up Period|Noncompliance|1
5303277|NCT00415532|18278364|P2|Safety Follow Up Period|Ineligibility determined|1
5303278|NCT00415532|18278365|P1|Safety Follow Up Period|Ineligibility determined|1
5303279|NCT00415532|18278364|P2|Safety Follow Up Period|Other|4
5303280|NCT00415532|18278365|P1|Safety Follow Up Period|Other|1
5303281|NCT00415532|18278364|P2|Safety Follow Up Period|Withdrawal by Subject|3
5303282|NCT00415532|18278365|P1|Safety Follow Up Period|Withdrawal by Subject|2
5303283|NCT00415532|18278364|P2|Safety Follow Up Period|Death|0
5303284|NCT00415532|18278365|P1|Safety Follow Up Period|Death|3
5303285|NCT00415532|18278364|P2|Safety Follow Up Period|Adverse Event|3
5303286|NCT00415532|18278365|P1|Safety Follow Up Period|Adverse Event|1
5303287|NCT00415532|18278364|P2|Treatment Period|Requirement for alternative therapy|0
5303288|NCT00415532|18278365|P1|Treatment Period|Requirement for alternative therapy|1
5303289|NCT00415532|18278364|P2|Treatment Period|Noncompliance|1
5303290|NCT00415532|18278365|P1|Treatment Period|Noncompliance|1
5303291|NCT00415532|18278364|P2|Treatment Period|Ineligibility determined|1
5303292|NCT00415532|18278365|P1|Treatment Period|Ineligibility determined|1
5303293|NCT00415532|18278364|P2|Treatment Period|Other|2
5303294|NCT00415532|18278365|P1|Treatment Period|Other|2
5303295|NCT00415532|18278364|P2|Treatment Period|Withdrawal by Subject|6
5303296|NCT00415532|18278365|P1|Treatment Period|Withdrawal by Subject|6
5303297|NCT00415532|18278364|P2|Treatment Period|Protocol Violation|0
5303298|NCT00415532|18278365|P1|Treatment Period|Protocol Violation|1
5303299|NCT00415532|18278364|P2|Treatment Period|Lost to Follow-up|1
5303300|NCT00415532|18278365|P1|Treatment Period|Lost to Follow-up|1
5303301|NCT00415532|18278364|P2|Treatment Period|Death|1
5303302|NCT00415532|18278365|P1|Treatment Period|Death|2
5303303|NCT00415532|18278364|P2|Treatment Period|Adverse Event|3
5303304|NCT00415532|18278365|P1|Treatment Period|Adverse Event|2
5303305|NCT00415519|18278387|P2|Overall Study|Patient's convenience|0
5303306|NCT00415519|18278388|P1|Overall Study|Patient's convenience|1
5303307|NCT00415519|18278387|P2|Overall Study|Withdrawal by Subject|0
5303308|NCT00415519|18278388|P1|Overall Study|Withdrawal by Subject|2
5303309|NCT00415519|18278387|P2|Overall Study|Adverse Event|0
5303310|NCT00415519|18278388|P1|Overall Study|Adverse Event|1
5303311|NCT00415363|18278428|P2|Overall Study|Progressive disease|32
5303312|NCT00415363|18278429|P1|Overall Study|Progressive disease|26
5303313|NCT00415363|18278428|P2|Overall Study|Death|12
5303314|NCT00415363|18278429|P1|Overall Study|Death|16
5303315|NCT00415363|18278428|P2|Overall Study|Physician Decision|1
5303316|NCT00415363|18278429|P1|Overall Study|Physician Decision|3
5303317|NCT00415363|18278428|P2|Overall Study|Lost to Follow-up|1
5303318|NCT00415363|18278429|P1|Overall Study|Lost to Follow-up|2
5303319|NCT00415363|18278428|P2|Overall Study|Adverse Event|4
5303320|NCT00415363|18278429|P1|Overall Study|Adverse Event|4
5303321|NCT00415363|18278428|P2|Overall Study|Withdrawal by Subject|4
5303322|NCT00415363|18278429|P1|Overall Study|Withdrawal by Subject|4
5303323|NCT00415194|18278459|P2|Overall Study|Death Due to AE (Other Causes)|15
5303324|NCT00415194|18278460|P1|Overall Study|Death Due to AE (Other Causes)|27
5303325|NCT00415194|18278459|P2|Overall Study|Death Due to Procedural Related AE|1
5303326|NCT00415194|18278460|P1|Overall Study|Death Due to Procedural Related AE|0
5303327|NCT00415194|18278459|P2|Overall Study|Death Due to Study Drug Related AE|1
5303328|NCT00415194|18278460|P1|Overall Study|Death Due to Study Drug Related AE|11
5303329|NCT00415194|18278459|P2|Overall Study|Death Due to Study Disease|29
5303330|NCT00415194|18278460|P1|Overall Study|Death Due to Study Disease|26
5303331|NCT00415194|18278459|P2|Overall Study|Withdrawal by Subject|21
5303332|NCT00415194|18278460|P1|Overall Study|Withdrawal by Subject|28
5303333|NCT00415194|18278459|P2|Overall Study|Protocol Violation|2
5303334|NCT00415194|18278460|P1|Overall Study|Protocol Violation|4
5303335|NCT00415194|18278459|P2|Overall Study|Progressive Disease|217
5303336|NCT00415194|18278460|P1|Overall Study|Progressive Disease|180
5303337|NCT00415194|18278459|P2|Overall Study|Physician Decision|16
5303338|NCT00415194|18278460|P1|Overall Study|Physician Decision|10
5303339|NCT00415194|18278459|P2|Overall Study|Lost to Follow-up|0
5303340|NCT00415194|18278460|P1|Overall Study|Lost to Follow-up|1
5303341|NCT00415194|18278459|P2|Overall Study|Entry Criteria Not Met|8
5303342|NCT00415194|18278460|P1|Overall Study|Entry Criteria Not Met|4
5303343|NCT00415194|18278459|P2|Overall Study|Adverse Event|32
5303344|NCT00415194|18278460|P1|Overall Study|Adverse Event|37
5303345|NCT00415168|18278476|P1|Overall Study|Withdrawal by Subject|6
5303346|NCT00415168|18278476|P1|Overall Study|Sponsor Decision|4
5303347|NCT00415168|18278476|P1|Overall Study|Physician Decision|13
5303348|NCT00415168|18278476|P1|Overall Study|Lost to Follow-up|3
5303349|NCT00415168|18278476|P1|Overall Study|Death|26
5303350|NCT00415051|18278486|P1|Overall Study|Protocol Violation|1
5303351|NCT00414973|18278497|P4|Overall Study|Death|0
5303352|NCT00414973|18278498|P3|Overall Study|Death|1
5303353|NCT00414973|18278499|P2|Overall Study|Death|0
5303354|NCT00414973|18278500|P1|Overall Study|Death|0
5303355|NCT00414973|18278497|P4|Overall Study|Sponsor Decision|0
5303356|NCT00414973|18278498|P3|Overall Study|Sponsor Decision|0
5303357|NCT00414973|18278499|P2|Overall Study|Sponsor Decision|0
5303358|NCT00414973|18278500|P1|Overall Study|Sponsor Decision|1
5303359|NCT00414973|18278497|P4|Overall Study|Lost to Follow-up|0
5303360|NCT00414973|18278498|P3|Overall Study|Lost to Follow-up|0
5303361|NCT00414973|18278499|P2|Overall Study|Lost to Follow-up|2
5303362|NCT00414973|18278500|P1|Overall Study|Lost to Follow-up|0
5303363|NCT00414973|18278497|P4|Overall Study|Protocol Violation|0
5303364|NCT00414973|18278498|P3|Overall Study|Protocol Violation|0
5303365|NCT00414973|18278499|P2|Overall Study|Protocol Violation|4
5303366|NCT00414973|18278500|P1|Overall Study|Protocol Violation|3
5303367|NCT00414973|18278497|P4|Overall Study|Adverse Event|0
5303368|NCT00414973|18278498|P3|Overall Study|Adverse Event|1
5303369|NCT00414973|18278499|P2|Overall Study|Adverse Event|0
5303370|NCT00414973|18278500|P1|Overall Study|Adverse Event|10
5303371|NCT00414973|18278497|P4|Overall Study|Withdrawal by Subject|0
5303372|NCT00414973|18278498|P3|Overall Study|Withdrawal by Subject|1
5303373|NCT00414973|18278499|P2|Overall Study|Withdrawal by Subject|4
5303374|NCT00414973|18278500|P1|Overall Study|Withdrawal by Subject|14
5303375|NCT00414960|18278520|P2|Overall Study|Physician Decision|1
5303376|NCT00414960|18278521|P1|Overall Study|Physician Decision|0
5303377|NCT00414960|18278520|P2|Overall Study|Withdrawal by Subject|0
5303378|NCT00414960|18278521|P1|Overall Study|Withdrawal by Subject|3
5303379|NCT00414960|18278520|P2|Overall Study|Adverse Event|0
5303380|NCT00414960|18278521|P1|Overall Study|Adverse Event|4
5303381|NCT00414908|18278531|P2|Overall Study|Protocol Violation|1
5303382|NCT00414908|18278532|P1|Overall Study|Protocol Violation|1
5303383|NCT00414726|18278569|P2|Overall Study|Withdrawal by Subject|1
5303384|NCT00414726|18278570|P1|Overall Study|Withdrawal by Subject|0
5303385|NCT00414661|18278605|P4|Overall Study|Other|0
5303386|NCT00414661|18278606|P3|Overall Study|Other|0
5303387|NCT00414661|18278607|P2|Overall Study|Other|3
5303388|NCT00414661|18278608|P1|Overall Study|Other|6
5303389|NCT00414661|18278605|P4|Overall Study|Withdrawal by Subject|2
5303390|NCT00414661|18278606|P3|Overall Study|Withdrawal by Subject|2
5303391|NCT00414661|18278607|P2|Overall Study|Withdrawal by Subject|2
5303392|NCT00414661|18278608|P1|Overall Study|Withdrawal by Subject|5
5303393|NCT00414661|18278605|P4|Overall Study|Lost to Follow-up|1
5303394|NCT00414661|18278606|P3|Overall Study|Lost to Follow-up|0
5303395|NCT00414661|18278607|P2|Overall Study|Lost to Follow-up|4
5303396|NCT00414661|18278608|P1|Overall Study|Lost to Follow-up|1
5303397|NCT00414661|18278605|P4|Overall Study|Death|0
5303398|NCT00414661|18278606|P3|Overall Study|Death|0
5303399|NCT00414661|18278607|P2|Overall Study|Death|5
5303400|NCT00414661|18278608|P1|Overall Study|Death|2
5303401|NCT00414609|18278653|P3|Extension Study|Death|17
5303402|NCT00414609|18278654|P2|Extension Study|Death|0
5303403|NCT00414609|18278655|P1|Extension Study|Death|0
5303404|NCT00414609|18278653|P3|Extension Study|Administrative problems|1
5303405|NCT00414609|18278654|P2|Extension Study|Administrative problems|0
5303406|NCT00414609|18278655|P1|Extension Study|Administrative problems|0
5303407|NCT00414609|18278653|P3|Extension Study|Lost to Follow-up|10
5303408|NCT00414609|18278654|P2|Extension Study|Lost to Follow-up|0
5303409|NCT00414609|18278655|P1|Extension Study|Lost to Follow-up|0
5303410|NCT00414609|18278653|P3|Extension Study|Withdrawal by Subject|13
5303411|NCT00414609|18278654|P2|Extension Study|Withdrawal by Subject|0
5303412|NCT00414609|18278655|P1|Extension Study|Withdrawal by Subject|0
5303413|NCT00414609|18278653|P3|Extension Study|Unsatisfactory therapeutic effect|2
5303414|NCT00414609|18278654|P2|Extension Study|Unsatisfactory therapeutic effect|0
5303415|NCT00414609|18278655|P1|Extension Study|Unsatisfactory therapeutic effect|0
5303416|NCT00414609|18278653|P3|Extension Study|Adverse Event|14
5303417|NCT00414609|18278654|P2|Extension Study|Adverse Event|0
5303418|NCT00414609|18278655|P1|Extension Study|Adverse Event|0
5303419|NCT00414609|18278653|P3|Core Study|Death|0
5303420|NCT00414609|18278654|P2|Core Study|Death|14
5303421|NCT00414609|18278655|P1|Core Study|Death|7
5303422|NCT00414609|18278653|P3|Core Study|Administrative problems|0
5303423|NCT00414609|18278654|P2|Core Study|Administrative problems|2
5303424|NCT00414609|18278655|P1|Core Study|Administrative problems|0
5303425|NCT00414609|18278653|P3|Core Study|Lost to Follow-up|0
5303426|NCT00414609|18278654|P2|Core Study|Lost to Follow-up|4
5303427|NCT00414609|18278655|P1|Core Study|Lost to Follow-up|7
5303428|NCT00414609|18278653|P3|Core Study|Patient withdrew consent|0
5303429|NCT00414609|18278654|P2|Core Study|Patient withdrew consent|11
5303430|NCT00414609|18278655|P1|Core Study|Patient withdrew consent|10
5303431|NCT00414609|18278653|P3|Core Study|Protocol deviation|0
5303432|NCT00414609|18278654|P2|Core Study|Protocol deviation|1
5303433|NCT00414609|18278655|P1|Core Study|Protocol deviation|0
5303434|NCT00414609|18278653|P3|Core Study|Abnormal test procedure results|0
5303435|NCT00414609|18278654|P2|Core Study|Abnormal test procedure results|1
5303436|NCT00414609|18278655|P1|Core Study|Abnormal test procedure results|1
5303437|NCT00414609|18278653|P3|Core Study|Abnormal laboratory values|0
5303438|NCT00414609|18278654|P2|Core Study|Abnormal laboratory values|1
5303439|NCT00414609|18278655|P1|Core Study|Abnormal laboratory values|0
5303440|NCT00414609|18278653|P3|Core Study|Adverse Event|0
5303441|NCT00414609|18278654|P2|Core Study|Adverse Event|11
5303442|NCT00414609|18278655|P1|Core Study|Adverse Event|9
5303443|NCT00414596|18278678|P1|Overall Study|Protocol Violation|2
5303444|NCT00414544|18278687|P1|Overall Study|Lost to Follow-up|14
5303445|NCT00414466|18278710|P4|Overall Study|Withdrawn by Sponsor|0
5303446|NCT00414466|18278711|P3|Overall Study|Withdrawn by Sponsor|0
5303447|NCT00414466|18278712|P2|Overall Study|Withdrawn by Sponsor|0
5303448|NCT00414466|18278713|P1|Overall Study|Withdrawn by Sponsor|1
5303449|NCT00414466|18278710|P4|Overall Study|Lack of Efficacy|0
5303450|NCT00414466|18278711|P3|Overall Study|Lack of Efficacy|0
5303451|NCT00414466|18278712|P2|Overall Study|Lack of Efficacy|0
5303452|NCT00414466|18278713|P1|Overall Study|Lack of Efficacy|1
5303453|NCT00414466|18278710|P4|Overall Study|Adverse Event|1
5303454|NCT00414466|18278711|P3|Overall Study|Adverse Event|1
5303455|NCT00414466|18278712|P2|Overall Study|Adverse Event|0
5303456|NCT00414466|18278713|P1|Overall Study|Adverse Event|0
5303457|NCT00414453|18278731|P1|Overall Study|Abnormal lab work|16
5303458|NCT00414440|18278779|P2|Extension Period|Not included in follow up period|8
5303459|NCT00414440|18278780|P1|Extension Period|Not included in follow up period|18
5303460|NCT00414440|18278779|P2|Extension Period|Withdrawal by Subject|7
5303461|NCT00414440|18278780|P1|Extension Period|Withdrawal by Subject|9
5303462|NCT00414440|18278779|P2|Extension Period|Death|2
5303463|NCT00414440|18278780|P1|Extension Period|Death|1
5303464|NCT00414440|18278779|P2|Extension Period|Administrative|16
5303465|NCT00414440|18278780|P1|Extension Period|Administrative|16
5303466|NCT00414440|18278779|P2|Extension Period|Other|1
5303467|NCT00414440|18278780|P1|Extension Period|Other|1
5303468|NCT00414440|18278779|P2|Extension Period|Did not consent to continue follow up|54
5303469|NCT00414440|18278780|P1|Extension Period|Did not consent to continue follow up|61
5303470|NCT00414440|18278779|P2|Extension Period|Lost to Follow-up|52
5303471|NCT00414440|18278780|P1|Extension Period|Lost to Follow-up|44
5303472|NCT00414440|18278779|P2|Core Period|Withdrawal by Subject|32
5303473|NCT00414440|18278780|P1|Core Period|Withdrawal by Subject|70
5303474|NCT00414388|18278794|P1|Overall Study|Adverse Event|1
5303475|NCT00414310|18278802|P2|Overall Study|Not treated|0
5303476|NCT00414310|18278803|P1|Overall Study|Not treated|1
5303477|NCT00414076|18278847|P2|Overall Study|Adverse Event|0
5303478|NCT00414076|18278848|P1|Overall Study|Adverse Event|1
5303479|NCT00414076|18278847|P2|Overall Study|Withdrawal by Subject|3
5303480|NCT00414076|18278848|P1|Overall Study|Withdrawal by Subject|1
5303481|NCT00414076|18278847|P2|Overall Study|Progression|2
5303482|NCT00414076|18278848|P1|Overall Study|Progression|1
5303483|NCT00414050|18278858|P4|Overall Study|Subject Moved|1
5303484|NCT00414050|18278859|P3|Overall Study|Subject Moved|0
5303485|NCT00414050|18278860|P2|Overall Study|Subject Moved|0
5303486|NCT00414050|18278861|P1|Overall Study|Subject Moved|0
5303487|NCT00414050|18278858|P4|Overall Study|Subject discontinued for other reason|1
5303488|NCT00414050|18278859|P3|Overall Study|Subject discontinued for other reason|2
5303489|NCT00414050|18278860|P2|Overall Study|Subject discontinued for other reason|2
5303490|NCT00414050|18278861|P1|Overall Study|Subject discontinued for other reason|1
5303491|NCT00414050|18278858|P4|Overall Study|Withdrawal by Subject|4
5303492|NCT00414050|18278859|P3|Overall Study|Withdrawal by Subject|2
5303493|NCT00414050|18278860|P2|Overall Study|Withdrawal by Subject|3
5303494|NCT00414050|18278861|P1|Overall Study|Withdrawal by Subject|5
5303495|NCT00414050|18278858|P4|Overall Study|Lost to Follow-up|1
5303496|NCT00414050|18278859|P3|Overall Study|Lost to Follow-up|1
5303497|NCT00414050|18278860|P2|Overall Study|Lost to Follow-up|2
5303498|NCT00414050|18278861|P1|Overall Study|Lost to Follow-up|2
5303499|NCT00414050|18278858|P4|Overall Study|Adverse Event|1
5303500|NCT00414050|18278859|P3|Overall Study|Adverse Event|1
5303501|NCT00414050|18278860|P2|Overall Study|Adverse Event|1
5303502|NCT00414050|18278861|P1|Overall Study|Adverse Event|1
5303503|NCT00414011|18278875|P1|Overall Study|Withdrawal by Subject|2
5303504|NCT00414011|18278875|P1|Overall Study|Physician Decision|3
5303505|NCT00413972|18278884|P4|Overall Study|Other|1
5303506|NCT00413972|18278885|P3|Overall Study|Other|0
5303507|NCT00413972|18278886|P2|Overall Study|Other|0
5303508|NCT00413972|18278887|P1|Overall Study|Other|0
5303509|NCT00413972|18278884|P4|Overall Study|Protocol Violation|0
5303510|NCT00413972|18278885|P3|Overall Study|Protocol Violation|2
5303511|NCT00413972|18278886|P2|Overall Study|Protocol Violation|0
5303512|NCT00413972|18278887|P1|Overall Study|Protocol Violation|0
5303513|NCT00413972|18278884|P4|Overall Study|Withdrawal by Subject|2
5303514|NCT00413972|18278885|P3|Overall Study|Withdrawal by Subject|7
5303515|NCT00413972|18278886|P2|Overall Study|Withdrawal by Subject|5
5303516|NCT00413972|18278887|P1|Overall Study|Withdrawal by Subject|4
5303517|NCT00413972|18278884|P4|Overall Study|Lost to Follow-up|0
5303518|NCT00413972|18278885|P3|Overall Study|Lost to Follow-up|1
5303519|NCT00413972|18278886|P2|Overall Study|Lost to Follow-up|2
5303520|NCT00413972|18278887|P1|Overall Study|Lost to Follow-up|1
5303521|NCT00413972|18278884|P4|Overall Study|Adverse Event|0
5303522|NCT00413972|18278885|P3|Overall Study|Adverse Event|0
5303523|NCT00413972|18278886|P2|Overall Study|Adverse Event|1
5303524|NCT00413972|18278887|P1|Overall Study|Adverse Event|2
5303525|NCT00413959|18278897|P1|Overall Study|Pt had only one cycle.|1
5303526|NCT00413920|18278904|P2|Overall Study|Graft Loss|3
5303527|NCT00413920|18278905|P1|Overall Study|Graft Loss|5
5303528|NCT00413920|18278904|P2|Overall Study|Death|5
5303529|NCT00413920|18278905|P1|Overall Study|Death|3
5303530|NCT00413920|18278904|P2|Overall Study|Lack of Efficacy|9
5303531|NCT00413920|18278905|P1|Overall Study|Lack of Efficacy|11
5303532|NCT00413920|18278904|P2|Overall Study|Adverse Event|11
5303533|NCT00413920|18278905|P1|Overall Study|Adverse Event|9
5303534|NCT00413894|18278920|P1|Overall Study|Other|18
5303535|NCT00413894|18278920|P1|Overall Study|Protocol Violation|11
5303536|NCT00413894|18278920|P1|Overall Study|Adverse Event|28
5303537|NCT00413894|18278920|P1|Overall Study|Hb <10 grams/deciliter|12
5303538|NCT00413894|18278920|P1|Overall Study|Administrative Reasons|1
5303539|NCT00413894|18278920|P1|Overall Study|Withdrawal by Subject|10
5303540|NCT00413777|18278937|P2|Fixed-dose Period|Withdrew Consent|1
5303541|NCT00413777|18278938|P1|Fixed-dose Period|Withdrew Consent|0
5303542|NCT00413777|18278937|P2|Fixed-dose Period|Met Withdrawal Criteria|0
5303543|NCT00413777|18278938|P1|Fixed-dose Period|Met Withdrawal Criteria|1
5303544|NCT00413777|18278937|P2|Fixed-dose Period|Adverse Event|1
5303545|NCT00413777|18278938|P1|Fixed-dose Period|Adverse Event|2
5303546|NCT00413777|18278937|P2|Fixed-dose Period|Lost to Follow-up|1
5303547|NCT00413777|18278938|P1|Fixed-dose Period|Lost to Follow-up|1
5303548|NCT00413699|18278986|P3|Extension Period|Adverse Event|2
5303549|NCT00413699|18278987|P2|Extension Period|Adverse Event|0
5303550|NCT00413699|18278988|P1|Extension Period|Adverse Event|0
5303551|NCT00413699|18278986|P3|Extension Period|Protocol Violation|1
5303552|NCT00413699|18278987|P2|Extension Period|Protocol Violation|0
5303553|NCT00413699|18278988|P1|Extension Period|Protocol Violation|0
5303554|NCT00413699|18278986|P3|Extension Period|No Longer Willing to Participate|2
5303555|NCT00413699|18278987|P2|Extension Period|No Longer Willing to Participate|0
5303556|NCT00413699|18278988|P1|Extension Period|No Longer Willing to Participate|0
5303557|NCT00413699|18278986|P3|Initial Period|No longer willing to participate|0
5303558|NCT00413699|18278987|P2|Initial Period|No longer willing to participate|368
5303559|NCT00413699|18278988|P1|Initial Period|No longer willing to participate|116
5303560|NCT00413699|18278986|P3|Initial Period|Missing end of study page|0
5303561|NCT00413699|18278987|P2|Initial Period|Missing end of study page|4
5303562|NCT00413699|18278988|P1|Initial Period|Missing end of study page|0
5303563|NCT00413699|18278986|P3|Initial Period|Adverse event not related to study drug|0
5303564|NCT00413699|18278987|P2|Initial Period|Adverse event not related to study drug|248
5303565|NCT00413699|18278988|P1|Initial Period|Adverse event not related to study drug|113
5303566|NCT00413699|18278986|P3|Initial Period|Adverse event related to study drug|0
5303567|NCT00413699|18278987|P2|Initial Period|Adverse event related to study drug|527
5303568|NCT00413699|18278988|P1|Initial Period|Adverse event related to study drug|178
5303569|NCT00413699|18278986|P3|Initial Period|Other|0
5303570|NCT00413699|18278987|P2|Initial Period|Other|211
5303571|NCT00413699|18278988|P1|Initial Period|Other|67
5303572|NCT00413699|18278986|P3|Initial Period|Study terminated by Sponsor|0
5303573|NCT00413699|18278987|P2|Initial Period|Study terminated by Sponsor|1
5303574|NCT00413699|18278988|P1|Initial Period|Study terminated by Sponsor|0
5303575|NCT00413699|18278986|P3|Initial Period|Medication error without adverse event|0
5303576|NCT00413699|18278987|P2|Initial Period|Medication error without adverse event|1
5303577|NCT00413699|18278988|P1|Initial Period|Medication error without adverse event|0
5303578|NCT00413699|18278986|P3|Initial Period|Did not meet entrance criteria|0
5303579|NCT00413699|18278987|P2|Initial Period|Did not meet entrance criteria|2
5303580|NCT00413699|18278988|P1|Initial Period|Did not meet entrance criteria|2
5303581|NCT00413699|18278986|P3|Initial Period|Pregnancy|0
5303582|NCT00413699|18278987|P2|Initial Period|Pregnancy|8
5303583|NCT00413699|18278988|P1|Initial Period|Pregnancy|10
5303584|NCT00413699|18278986|P3|Initial Period|Protocol Violation|0
5303585|NCT00413699|18278987|P2|Initial Period|Protocol Violation|89
5303586|NCT00413699|18278988|P1|Initial Period|Protocol Violation|38
5303587|NCT00413699|18278986|P3|Initial Period|Lost to Follow-up|0
5303588|NCT00413699|18278987|P2|Initial Period|Lost to Follow-up|101
5303589|NCT00413699|18278988|P1|Initial Period|Lost to Follow-up|31
5303590|NCT00413699|18278986|P3|Initial Period|Lack of Efficacy|0
5303591|NCT00413699|18278987|P2|Initial Period|Lack of Efficacy|115
5303592|NCT00413699|18278988|P1|Initial Period|Lack of Efficacy|59
5303593|NCT00413699|18278986|P3|Initial Period|Death|0
5303594|NCT00413699|18278987|P2|Initial Period|Death|30
5303595|NCT00413699|18278988|P1|Initial Period|Death|25
5303596|NCT00413660|18279070|P11|Post Week 12|Other|0
5303597|NCT00413660|18279071|P10|Post Week 12|Other|0
5303598|NCT00413660|18279072|P9|Post Week 12|Other|0
5303599|NCT00413660|18279073|P8|Post Week 12|Other|0
5303600|NCT00413660|18279074|P7|Post Week 12|Other|1
5303601|NCT00413660|18279075|P6|Post Week 12|Other|1
5303602|NCT00413660|18279076|P5|Post Week 12|Other|1
5303603|NCT00413660|18279077|P4|Post Week 12|Other|0
5303604|NCT00413660|18279078|P3|Post Week 12|Other|3
5303605|NCT00413660|18279079|P2|Post Week 12|Other|2
5303606|NCT00413660|18279080|P1|Post Week 12|Other|1
5303607|NCT00413660|18279070|P11|Post Week 12|Withdrawal by Subject|1
5303608|NCT00413660|18279071|P10|Post Week 12|Withdrawal by Subject|0
5303609|NCT00413660|18279072|P9|Post Week 12|Withdrawal by Subject|0
5303610|NCT00413660|18279073|P8|Post Week 12|Withdrawal by Subject|0
5303611|NCT00413660|18279074|P7|Post Week 12|Withdrawal by Subject|0
5303612|NCT00413660|18279075|P6|Post Week 12|Withdrawal by Subject|0
5303613|NCT00413660|18279076|P5|Post Week 12|Withdrawal by Subject|1
5303614|NCT00413660|18279077|P4|Post Week 12|Withdrawal by Subject|0
5303615|NCT00413660|18279078|P3|Post Week 12|Withdrawal by Subject|1
5303616|NCT00413660|18279079|P2|Post Week 12|Withdrawal by Subject|1
5303617|NCT00413660|18279080|P1|Post Week 12|Withdrawal by Subject|0
5303618|NCT00413660|18279070|P11|Post Week 12|Lost to Follow-up|0
5303619|NCT00413660|18279071|P10|Post Week 12|Lost to Follow-up|0
5303620|NCT00413660|18279072|P9|Post Week 12|Lost to Follow-up|0
5303621|NCT00413660|18279073|P8|Post Week 12|Lost to Follow-up|0
5303622|NCT00413660|18279074|P7|Post Week 12|Lost to Follow-up|0
5303623|NCT00413660|18279075|P6|Post Week 12|Lost to Follow-up|0
5303624|NCT00413660|18279076|P5|Post Week 12|Lost to Follow-up|0
5303625|NCT00413660|18279077|P4|Post Week 12|Lost to Follow-up|0
5303626|NCT00413660|18279078|P3|Post Week 12|Lost to Follow-up|1
5303627|NCT00413660|18279079|P2|Post Week 12|Lost to Follow-up|1
5303628|NCT00413660|18279080|P1|Post Week 12|Lost to Follow-up|0
5303629|NCT00413660|18279070|P11|Post Week 12|Lack of Efficacy|0
5303630|NCT00413660|18279071|P10|Post Week 12|Lack of Efficacy|1
5303631|NCT00413660|18279072|P9|Post Week 12|Lack of Efficacy|0
5303632|NCT00413660|18279073|P8|Post Week 12|Lack of Efficacy|0
5303633|NCT00413660|18279074|P7|Post Week 12|Lack of Efficacy|0
5303634|NCT00413660|18279075|P6|Post Week 12|Lack of Efficacy|0
5303635|NCT00413660|18279076|P5|Post Week 12|Lack of Efficacy|0
5303636|NCT00413660|18279077|P4|Post Week 12|Lack of Efficacy|0
5303637|NCT00413660|18279078|P3|Post Week 12|Lack of Efficacy|1
5303638|NCT00413660|18279079|P2|Post Week 12|Lack of Efficacy|0
5303639|NCT00413660|18279080|P1|Post Week 12|Lack of Efficacy|0
5303640|NCT00413660|18279070|P11|Post Week 12|Adverse Event|0
5303641|NCT00413660|18279071|P10|Post Week 12|Adverse Event|0
5303642|NCT00413660|18279072|P9|Post Week 12|Adverse Event|0
5303643|NCT00413660|18279073|P8|Post Week 12|Adverse Event|0
5303644|NCT00413660|18279074|P7|Post Week 12|Adverse Event|2
5303645|NCT00413660|18279075|P6|Post Week 12|Adverse Event|2
5303646|NCT00413660|18279076|P5|Post Week 12|Adverse Event|4
5303647|NCT00413660|18279077|P4|Post Week 12|Adverse Event|1
5303648|NCT00413660|18279078|P3|Post Week 12|Adverse Event|2
5303649|NCT00413660|18279079|P2|Post Week 12|Adverse Event|0
5303650|NCT00413660|18279080|P1|Post Week 12|Adverse Event|2
5303651|NCT00413660|18279070|P11|Up To Week 12|Other|0
5303652|NCT00413660|18279071|P10|Up To Week 12|Other|0
5303653|NCT00413660|18279072|P9|Up To Week 12|Other|0
5303654|NCT00413660|18279073|P8|Up To Week 12|Other|0
5303655|NCT00413660|18279074|P7|Up To Week 12|Other|3
5303656|NCT00413660|18279075|P6|Up To Week 12|Other|4
5303657|NCT00413660|18279076|P5|Up To Week 12|Other|2
5303658|NCT00413660|18279077|P4|Up To Week 12|Other|1
5303659|NCT00413660|18279078|P3|Up To Week 12|Other|6
5303660|NCT00413660|18279079|P2|Up To Week 12|Other|1
5303661|NCT00413660|18279080|P1|Up To Week 12|Other|3
5303662|NCT00413660|18279070|P11|Up To Week 12|Randomized, Not Treated|0
5303663|NCT00413660|18279071|P10|Up To Week 12|Randomized, Not Treated|0
5303664|NCT00413660|18279072|P9|Up To Week 12|Randomized, Not Treated|0
5303665|NCT00413660|18279073|P8|Up To Week 12|Randomized, Not Treated|0
5303666|NCT00413660|18279074|P7|Up To Week 12|Randomized, Not Treated|0
5303667|NCT00413660|18279075|P6|Up To Week 12|Randomized, Not Treated|0
5303668|NCT00413660|18279076|P5|Up To Week 12|Randomized, Not Treated|0
5303669|NCT00413660|18279077|P4|Up To Week 12|Randomized, Not Treated|1
5303670|NCT00413660|18279078|P3|Up To Week 12|Randomized, Not Treated|0
5303671|NCT00413660|18279079|P2|Up To Week 12|Randomized, Not Treated|0
5303672|NCT00413660|18279080|P1|Up To Week 12|Randomized, Not Treated|1
5303673|NCT00413660|18279070|P11|Up To Week 12|Withdrawal by Subject|0
5303674|NCT00413660|18279071|P10|Up To Week 12|Withdrawal by Subject|0
5303675|NCT00413660|18279072|P9|Up To Week 12|Withdrawal by Subject|0
5303676|NCT00413660|18279073|P8|Up To Week 12|Withdrawal by Subject|0
5303677|NCT00413660|18279074|P7|Up To Week 12|Withdrawal by Subject|2
5303678|NCT00413660|18279075|P6|Up To Week 12|Withdrawal by Subject|2
5303679|NCT00413660|18279076|P5|Up To Week 12|Withdrawal by Subject|0
5303680|NCT00413660|18279077|P4|Up To Week 12|Withdrawal by Subject|2
5303681|NCT00413660|18279078|P3|Up To Week 12|Withdrawal by Subject|0
5303682|NCT00413660|18279079|P2|Up To Week 12|Withdrawal by Subject|2
5303683|NCT00413660|18279080|P1|Up To Week 12|Withdrawal by Subject|0
5303684|NCT00413660|18279070|P11|Up To Week 12|Lost to Follow-up|0
5303685|NCT00413660|18279071|P10|Up To Week 12|Lost to Follow-up|0
5303686|NCT00413660|18279072|P9|Up To Week 12|Lost to Follow-up|0
5303687|NCT00413660|18279073|P8|Up To Week 12|Lost to Follow-up|0
5303688|NCT00413660|18279074|P7|Up To Week 12|Lost to Follow-up|0
5303689|NCT00413660|18279075|P6|Up To Week 12|Lost to Follow-up|0
5303690|NCT00413660|18279076|P5|Up To Week 12|Lost to Follow-up|1
5303691|NCT00413660|18279077|P4|Up To Week 12|Lost to Follow-up|0
5303692|NCT00413660|18279078|P3|Up To Week 12|Lost to Follow-up|0
5303693|NCT00413660|18279079|P2|Up To Week 12|Lost to Follow-up|1
5303694|NCT00413660|18279080|P1|Up To Week 12|Lost to Follow-up|0
5303695|NCT00413660|18279070|P11|Up To Week 12|Lack of Efficacy|0
5303696|NCT00413660|18279071|P10|Up To Week 12|Lack of Efficacy|0
5303697|NCT00413660|18279072|P9|Up To Week 12|Lack of Efficacy|0
5303698|NCT00413660|18279073|P8|Up To Week 12|Lack of Efficacy|0
5303699|NCT00413660|18279074|P7|Up To Week 12|Lack of Efficacy|5
5303700|NCT00413660|18279075|P6|Up To Week 12|Lack of Efficacy|0
5303701|NCT00413660|18279076|P5|Up To Week 12|Lack of Efficacy|0
5303702|NCT00413660|18279077|P4|Up To Week 12|Lack of Efficacy|0
5303703|NCT00413660|18279078|P3|Up To Week 12|Lack of Efficacy|0
5303704|NCT00413660|18279079|P2|Up To Week 12|Lack of Efficacy|0
5303705|NCT00413660|18279080|P1|Up To Week 12|Lack of Efficacy|2
5303706|NCT00413660|18279070|P11|Up To Week 12|Adverse Event|0
5303707|NCT00413660|18279071|P10|Up To Week 12|Adverse Event|0
5303708|NCT00413660|18279072|P9|Up To Week 12|Adverse Event|0
5303709|NCT00413660|18279073|P8|Up To Week 12|Adverse Event|0
5303710|NCT00413660|18279074|P7|Up To Week 12|Adverse Event|1
5303711|NCT00413660|18279075|P6|Up To Week 12|Adverse Event|4
5303712|NCT00413660|18279076|P5|Up To Week 12|Adverse Event|6
5303713|NCT00413660|18279077|P4|Up To Week 12|Adverse Event|4
5303714|NCT00413660|18279078|P3|Up To Week 12|Adverse Event|1
5303715|NCT00413660|18279079|P2|Up To Week 12|Adverse Event|3
5303716|NCT00413660|18279080|P1|Up To Week 12|Adverse Event|1
5303717|NCT00413413|18279483|P3|Double-Blind|Lost to Follow-up|2
5303718|NCT00413413|18279484|P2|Double-Blind|Lost to Follow-up|4
5303719|NCT00413413|18279485|P1|Double-Blind|Lost to Follow-up|3
5303720|NCT00413413|18279483|P3|Double-Blind|Subject withdrew consent|9
5303721|NCT00413413|18279484|P2|Double-Blind|Subject withdrew consent|6
5303722|NCT00413413|18279485|P1|Double-Blind|Subject withdrew consent|4
5303723|NCT00413413|18279483|P3|Double-Blind|Protocol deviation|1
5303724|NCT00413413|18279484|P2|Double-Blind|Protocol deviation|2
5303725|NCT00413413|18279485|P1|Double-Blind|Protocol deviation|1
5303726|NCT00413413|18279483|P3|Double-Blind|Unsatisfactory therapeutic effect|1
5303727|NCT00413413|18279484|P2|Double-Blind|Unsatisfactory therapeutic effect|2
5303728|NCT00413413|18279485|P1|Double-Blind|Unsatisfactory therapeutic effect|1
5303729|NCT00413413|18279483|P3|Double-Blind|Adverse Event|5
5303730|NCT00413413|18279484|P2|Double-Blind|Adverse Event|0
5303731|NCT00413413|18279485|P1|Double-Blind|Adverse Event|6
5303732|NCT00413413|18279483|P3|Single-Blind|Lost to Follow-up|0
5303733|NCT00413413|18279484|P2|Single-Blind|Lost to Follow-up|8
5303734|NCT00413413|18279485|P1|Single-Blind|Lost to Follow-up|0
5303735|NCT00413413|18279483|P3|Single-Blind|Withdrawal by Subject|0
5303736|NCT00413413|18279484|P2|Single-Blind|Withdrawal by Subject|27
5303737|NCT00413413|18279485|P1|Single-Blind|Withdrawal by Subject|0
5303738|NCT00413413|18279483|P3|Single-Blind|Protocol Violation|0
5303739|NCT00413413|18279484|P2|Single-Blind|Protocol Violation|16
5303740|NCT00413413|18279485|P1|Single-Blind|Protocol Violation|0
5303741|NCT00413413|18279483|P3|Single-Blind|Subject no longer requires study drug|0
5303742|NCT00413413|18279484|P2|Single-Blind|Subject no longer requires study drug|151
5303743|NCT00413413|18279485|P1|Single-Blind|Subject no longer requires study drug|0
5303744|NCT00413413|18279483|P3|Single-Blind|Lack of Efficacy|0
5303745|NCT00413413|18279484|P2|Single-Blind|Lack of Efficacy|5
5303746|NCT00413413|18279485|P1|Single-Blind|Lack of Efficacy|0
5303747|NCT00413413|18279483|P3|Single-Blind|Adverse Event|0
5303748|NCT00413413|18279484|P2|Single-Blind|Adverse Event|9
5303749|NCT00413413|18279485|P1|Single-Blind|Adverse Event|0
5303750|NCT00413374|18279538|P2|Overall Study|Surgery|0
5303751|NCT00413374|18279539|P1|Overall Study|Surgery|1
5303752|NCT00413374|18279538|P2|Overall Study|Lost to Follow-up|0
5303753|NCT00413374|18279539|P1|Overall Study|Lost to Follow-up|1
5303754|NCT00413374|18279538|P2|Overall Study|Adverse Event|0
5303755|NCT00413374|18279539|P1|Overall Study|Adverse Event|1
5303756|NCT00413374|18279538|P2|Overall Study|Ineligible due to screening criteria.|0
5303757|NCT00413374|18279539|P1|Overall Study|Ineligible due to screening criteria.|3
5303758|NCT00413283|18279570|P4|Overall Study|Other|0
5303759|NCT00413283|18279571|P3|Overall Study|Other|1
5303760|NCT00413283|18279572|P2|Overall Study|Other|0
5303761|NCT00413283|18279573|P1|Overall Study|Other|0
5303762|NCT00413283|18279570|P4|Overall Study|Requirement for alternative therapy|0
5303763|NCT00413283|18279571|P3|Overall Study|Requirement for alternative therapy|0
5303764|NCT00413283|18279572|P2|Overall Study|Requirement for alternative therapy|2
5303765|NCT00413283|18279573|P1|Overall Study|Requirement for alternative therapy|0
5303766|NCT00413283|18279570|P4|Overall Study|Protocol deviation|0
5303767|NCT00413283|18279571|P3|Overall Study|Protocol deviation|0
5303768|NCT00413283|18279572|P2|Overall Study|Protocol deviation|1
5303769|NCT00413283|18279573|P1|Overall Study|Protocol deviation|0
5303770|NCT00413283|18279570|P4|Overall Study|Ineligibility determined|1
5303771|NCT00413283|18279571|P3|Overall Study|Ineligibility determined|0
5303772|NCT00413283|18279572|P2|Overall Study|Ineligibility determined|0
5303773|NCT00413283|18279573|P1|Overall Study|Ineligibility determined|0
5303774|NCT00413283|18279570|P4|Overall Study|Adverse Event|1
5303775|NCT00413283|18279571|P3|Overall Study|Adverse Event|0
5303776|NCT00413283|18279572|P2|Overall Study|Adverse Event|0
5303777|NCT00413283|18279573|P1|Overall Study|Adverse Event|0
5303778|NCT00413283|18279570|P4|Overall Study|Death|1
5303779|NCT00413283|18279571|P3|Overall Study|Death|1
5303780|NCT00413283|18279572|P2|Overall Study|Death|0
5303781|NCT00413283|18279573|P1|Overall Study|Death|0
5303782|NCT00413283|18279570|P4|Overall Study|Withdrawal by Subject|1
5303783|NCT00413283|18279571|P3|Overall Study|Withdrawal by Subject|0
5303784|NCT00413283|18279572|P2|Overall Study|Withdrawal by Subject|0
5303785|NCT00413283|18279573|P1|Overall Study|Withdrawal by Subject|1
5303786|NCT00413244|18279605|P2|Overall Study|Withdrawal by Subject|1
5303787|NCT00413244|18279606|P1|Overall Study|Withdrawal by Subject|10
5303788|NCT00413231|18279634|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
5303789|NCT00413231|18279634|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
5303790|NCT00413231|18279634|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
5303791|NCT00413231|18279634|P1|365-day to 60-month Post Treatment|Death|36
5303792|NCT00413231|18279634|P1|30-day to 365-day Post Treatment|Death|13
5303793|NCT00413231|18279634|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
5303794|NCT00413231|18279634|P1|0 to 30-day Post Treatment|Death|5
5303795|NCT00413218|18279666|P2|Overall Study|Withdrawal by Subject|1
5303796|NCT00413218|18279667|P1|Overall Study|Withdrawal by Subject|9
5303797|NCT00413218|18279666|P2|Overall Study|Missing|0
5303798|NCT00413218|18279667|P1|Overall Study|Missing|1
5303799|NCT00413218|18279666|P2|Overall Study|Admin|14
5303800|NCT00413218|18279667|P1|Overall Study|Admin|20
5303801|NCT00413218|18279666|P2|Overall Study|Lost to Follow-up|17
5303802|NCT00413218|18279667|P1|Overall Study|Lost to Follow-up|14
5303803|NCT00413218|18279666|P2|Overall Study|Death|56
5303804|NCT00413218|18279667|P1|Overall Study|Death|57
5303805|NCT00413218|18279666|P2|Overall Study|Randomized but didn't receive study drug|8
5303806|NCT00413218|18279667|P1|Overall Study|Randomized but didn't receive study drug|2
5303807|NCT00413192|18279693|P4|Overall Study|Not treated|1
5303808|NCT00413192|18279694|P3|Overall Study|Not treated|0
5303809|NCT00413192|18279695|P2|Overall Study|Not treated|0
5303810|NCT00413192|18279696|P1|Overall Study|Not treated|0
5303811|NCT00413192|18279693|P4|Overall Study|Other|2
5303812|NCT00413192|18279694|P3|Overall Study|Other|1
5303813|NCT00413192|18279695|P2|Overall Study|Other|1
5303814|NCT00413192|18279696|P1|Overall Study|Other|5
5303815|NCT00413192|18279693|P4|Overall Study|Intercurrent death|0
5303816|NCT00413192|18279694|P3|Overall Study|Intercurrent death|0
5303817|NCT00413192|18279695|P2|Overall Study|Intercurrent death|1
5303818|NCT00413192|18279696|P1|Overall Study|Intercurrent death|0
5303819|NCT00413192|18279693|P4|Overall Study|Intercurrent illness|1
5303820|NCT00413192|18279694|P3|Overall Study|Intercurrent illness|0
5303821|NCT00413192|18279695|P2|Overall Study|Intercurrent illness|0
5303822|NCT00413192|18279696|P1|Overall Study|Intercurrent illness|0
5303823|NCT00413192|18279693|P4|Overall Study|Withdrawal by Subject|1
5303824|NCT00413192|18279694|P3|Overall Study|Withdrawal by Subject|0
5303825|NCT00413192|18279695|P2|Overall Study|Withdrawal by Subject|5
5303826|NCT00413192|18279696|P1|Overall Study|Withdrawal by Subject|3
5303827|NCT00413192|18279693|P4|Overall Study|Toxicity|2
5303828|NCT00413192|18279694|P3|Overall Study|Toxicity|2
5303829|NCT00413192|18279695|P2|Overall Study|Toxicity|2
5303830|NCT00413192|18279696|P1|Overall Study|Toxicity|3
5303831|NCT00413192|18279693|P4|Overall Study|Disease progression|25
5303832|NCT00413192|18279694|P3|Overall Study|Disease progression|16
5303833|NCT00413192|18279695|P2|Overall Study|Disease progression|31
5303834|NCT00413192|18279696|P1|Overall Study|Disease progression|26
5303835|NCT00413153|18279749|P2|Overall Study|Adverse Event|0
5303836|NCT00413153|18279750|P1|Overall Study|Adverse Event|1
5303837|NCT00413153|18279749|P2|Overall Study|Withdrawal by Subject|1
5303838|NCT00413153|18279750|P1|Overall Study|Withdrawal by Subject|1
5303839|NCT00413062|18279774|P2|Overall Study|Other reason|34
5303840|NCT00413062|18279775|P1|Overall Study|Other reason|70
5303841|NCT00413062|18279774|P2|Overall Study|Lost to Follow-up|73
5303842|NCT00413062|18279775|P1|Overall Study|Lost to Follow-up|175
5303843|NCT00413062|18279774|P2|Overall Study|Pregnancy wish|6
5303844|NCT00413062|18279775|P1|Overall Study|Pregnancy wish|17
5303845|NCT00413062|18279774|P2|Overall Study|Pregnancy|5
5303846|NCT00413062|18279775|P1|Overall Study|Pregnancy|15
5303847|NCT00413062|18279774|P2|Overall Study|Withdrawal of informed consent|36
5303848|NCT00413062|18279775|P1|Overall Study|Withdrawal of informed consent|111
5303849|NCT00413062|18279774|P2|Overall Study|Pre-treatment (serious) adverse event|0
5303850|NCT00413062|18279775|P1|Overall Study|Pre-treatment (serious) adverse event|1
5303851|NCT00413062|18279774|P2|Overall Study|Adverse event/serious adverse event|56
5303852|NCT00413062|18279775|P1|Overall Study|Adverse event/serious adverse event|289
5303853|NCT00413049|18279801|P2|Overall Study|Lack of Efficacy|0
5303854|NCT00413049|18279802|P1|Overall Study|Lack of Efficacy|1
5303855|NCT00413049|18279801|P2|Overall Study|Abnormal laboratory value(s)|0
5303856|NCT00413049|18279802|P1|Overall Study|Abnormal laboratory value(s)|1
5303857|NCT00413049|18279801|P2|Overall Study|Subject no longer requires study drug|1
5303858|NCT00413049|18279802|P1|Overall Study|Subject no longer requires study drug|0
5303859|NCT00413049|18279801|P2|Overall Study|Protocol Violation|1
5303860|NCT00413049|18279802|P1|Overall Study|Protocol Violation|3
5303861|NCT00413049|18279801|P2|Overall Study|Lost to Follow-up|3
5303862|NCT00413049|18279802|P1|Overall Study|Lost to Follow-up|2
5303863|NCT00413049|18279801|P2|Overall Study|Withdrawal by Subject|5
5303864|NCT00413049|18279802|P1|Overall Study|Withdrawal by Subject|7
5303865|NCT00413049|18279801|P2|Overall Study|Adverse Event|8
5303866|NCT00413049|18279802|P1|Overall Study|Adverse Event|10
5303867|NCT00413036|18279818|P1|Overall Study|Missing|2
5303868|NCT00413036|18279818|P1|Overall Study|Other|26
5303869|NCT00413036|18279818|P1|Overall Study|Death|9
5303870|NCT00413036|18279818|P1|Overall Study|Withdrawal by Subject|7
5303871|NCT00413036|18279818|P1|Overall Study|Lack of Efficacy|129
5303872|NCT00413036|18279818|P1|Overall Study|Adverse Event|44
5303873|NCT00413010|18279828|P2|Overall Study|Due to termination of the study|52
5303874|NCT00413010|18279829|P1|Overall Study|Due to termination of the study|54
5303875|NCT00413010|18279828|P2|Overall Study|Withdrawal by Subject|2
5303876|NCT00413010|18279829|P1|Overall Study|Withdrawal by Subject|7
5303877|NCT00413010|18279828|P2|Overall Study|Lost to Follow-up|0
5303878|NCT00413010|18279829|P1|Overall Study|Lost to Follow-up|3
5303879|NCT00413010|18279828|P2|Overall Study|Lack of Efficacy|3
5303880|NCT00413010|18279829|P1|Overall Study|Lack of Efficacy|0
5303881|NCT00413010|18279828|P2|Overall Study|Laboratory abnormality|2
5303882|NCT00413010|18279829|P1|Overall Study|Laboratory abnormality|0
5303883|NCT00413010|18279828|P2|Overall Study|Adverse Event|4
5303884|NCT00413010|18279829|P1|Overall Study|Adverse Event|8
5303885|NCT00412984|18279851|P2|Overall Study|Not Reported|12
5303886|NCT00412984|18279852|P1|Overall Study|Not Reported|11
5303887|NCT00412984|18279851|P2|Overall Study|Other Reason|92
5303888|NCT00412984|18279852|P1|Overall Study|Other Reason|80
5303889|NCT00412984|18279851|P2|Overall Study|Physician Refused to Continue Treatment|89
5303890|NCT00412984|18279852|P1|Overall Study|Physician Refused to Continue Treatment|81
5303891|NCT00412984|18279851|P2|Overall Study|Administrative Reason by Sponsor|8
5303892|NCT00412984|18279852|P1|Overall Study|Administrative Reason by Sponsor|11
5303893|NCT00412984|18279851|P2|Overall Study|Subject No Longer Meets Study Criteria|100
5303894|NCT00412984|18279852|P1|Overall Study|Subject No Longer Meets Study Criteria|87
5303895|NCT00412984|18279851|P2|Overall Study|Pregnancy|0
5303896|NCT00412984|18279852|P1|Overall Study|Pregnancy|1
5303897|NCT00412984|18279851|P2|Overall Study|Poor/Noncompliance|77
5303898|NCT00412984|18279852|P1|Overall Study|Poor/Noncompliance|57
5303899|NCT00412984|18279851|P2|Overall Study|Lost to Follow-up|39
5303900|NCT00412984|18279852|P1|Overall Study|Lost to Follow-up|51
5303901|NCT00412984|18279851|P2|Overall Study|Withdrawal by Subject|989
5303902|NCT00412984|18279852|P1|Overall Study|Withdrawal by Subject|921
5303903|NCT00412984|18279851|P2|Overall Study|Adverse Event|738
5303904|NCT00412984|18279852|P1|Overall Study|Adverse Event|679
5303905|NCT00412984|18279851|P2|Overall Study|Death|349
5303906|NCT00412984|18279852|P1|Overall Study|Death|331
5303907|NCT00412971|18279896|P2|Overall Study|Protocol Violation|1
5303908|NCT00412971|18279897|P1|Overall Study|Protocol Violation|13
5303909|NCT00412971|18279896|P2|Overall Study|Lost to Follow-up|9
5303910|NCT00412971|18279897|P1|Overall Study|Lost to Follow-up|17
5303911|NCT00412958|18279910|P4|Overall Study|Transport issue|0
5303912|NCT00412958|18279911|P3|Overall Study|Transport issue|0
5303913|NCT00412958|18279912|P2|Overall Study|Transport issue|1
5303914|NCT00412958|18279913|P1|Overall Study|Transport issue|0
5303915|NCT00412958|18279910|P4|Overall Study|Death|0
5303916|NCT00412958|18279911|P3|Overall Study|Death|0
5303917|NCT00412958|18279912|P2|Overall Study|Death|1
5303918|NCT00412958|18279913|P1|Overall Study|Death|0
5303919|NCT00412958|18279910|P4|Overall Study|Lost to Follow-up|0
5303920|NCT00412958|18279911|P3|Overall Study|Lost to Follow-up|0
5303921|NCT00412958|18279912|P2|Overall Study|Lost to Follow-up|1
5303922|NCT00412958|18279913|P1|Overall Study|Lost to Follow-up|0
5303923|NCT00412958|18279910|P4|Overall Study|Adverse Event|0
5303924|NCT00412958|18279911|P3|Overall Study|Adverse Event|0
5303925|NCT00412958|18279912|P2|Overall Study|Adverse Event|1
5303926|NCT00412958|18279913|P1|Overall Study|Adverse Event|0
5303927|NCT00412958|18279910|P4|Overall Study|Withdrawal by Subject|1
5303928|NCT00412958|18279911|P3|Overall Study|Withdrawal by Subject|0
5303929|NCT00412958|18279912|P2|Overall Study|Withdrawal by Subject|0
5303930|NCT00412958|18279913|P1|Overall Study|Withdrawal by Subject|3
5303931|NCT00412932|18279923|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
5303932|NCT00412932|18279923|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
5303933|NCT00412932|18279923|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
5303934|NCT00412932|18279923|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
5303935|NCT00412932|18279923|P1|Olmesartan 40 mg|Withdrawal by Subject|1
5303936|NCT00412932|18279923|P1|Olmesartan 40 mg|Lack of Efficacy|3
5303937|NCT00412932|18279923|P1|Olmesartan 40 mg|Adverse Event|4
5303938|NCT00412932|18279923|P1|Olmesartan (Olm) 20 mg|Other|1
5303939|NCT00412932|18279923|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
5303940|NCT00412932|18279923|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
5303941|NCT00412932|18279923|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
5303942|NCT00412932|18279923|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
5303943|NCT00412893|18279934|P2|Overall Study|Randomized but Never Received Study Drug|6
5303944|NCT00412893|18279935|P1|Overall Study|Randomized but Never Received Study Drug|5
5303945|NCT00412893|18279934|P2|Overall Study|Administrative Reason|15
5303946|NCT00412893|18279935|P1|Overall Study|Administrative Reason|12
5303947|NCT00412893|18279934|P2|Overall Study|Did Not Cooperate|9
5303948|NCT00412893|18279935|P1|Overall Study|Did Not Cooperate|12
5303949|NCT00412893|18279934|P2|Overall Study|Other Protocol Violation|6
5303950|NCT00412893|18279935|P1|Overall Study|Other Protocol Violation|10
5303951|NCT00412893|18279934|P2|Overall Study|Violation of Selection at Entry|10
5303952|NCT00412893|18279935|P1|Overall Study|Violation of Selection at Entry|17
5303953|NCT00412893|18279934|P2|Overall Study|Lost to Follow-up|1
5303954|NCT00412893|18279935|P1|Overall Study|Lost to Follow-up|2
5303955|NCT00412893|18279934|P2|Overall Study|Insufficient Therapeutic Response|23
5303956|NCT00412893|18279935|P1|Overall Study|Insufficient Therapeutic Response|39
5303957|NCT00412893|18279934|P2|Overall Study|Death|21
5303958|NCT00412893|18279935|P1|Overall Study|Death|17
5303959|NCT00412893|18279934|P2|Overall Study|Adverse Event|53
5303960|NCT00412893|18279935|P1|Overall Study|Adverse Event|31
5303961|NCT00412854|18279973|P2|Overall Study|Withdrawn for other reasons|11
5303962|NCT00412854|18279974|P1|Overall Study|Withdrawn for other reasons|13
5303963|NCT00412854|18279973|P2|Overall Study|Withdrawn due to adverse events|5
5303964|NCT00412854|18279974|P1|Overall Study|Withdrawn due to adverse events|1
5303965|NCT00412750|18280018|P3|Overall Study|Lack of Efficacy|3
5303966|NCT00412750|18280019|P2|Overall Study|Lack of Efficacy|0
5303967|NCT00412750|18280020|P1|Overall Study|Lack of Efficacy|0
5303968|NCT00412750|18280018|P3|Overall Study|Withdrawal by Subject|2
5303969|NCT00412750|18280019|P2|Overall Study|Withdrawal by Subject|1
5303970|NCT00412750|18280020|P1|Overall Study|Withdrawal by Subject|0
5303971|NCT00412750|18280018|P3|Overall Study|Lost to Follow-up|1
5303972|NCT00412750|18280019|P2|Overall Study|Lost to Follow-up|0
5303973|NCT00412750|18280020|P1|Overall Study|Lost to Follow-up|1
5303974|NCT00412750|18280018|P3|Overall Study|Adverse Event|3
5303975|NCT00412750|18280019|P2|Overall Study|Adverse Event|3
5303976|NCT00412750|18280020|P1|Overall Study|Adverse Event|8
5303977|NCT00412750|18280018|P3|Overall Study|Administrative problems|14
5303978|NCT00412750|18280019|P2|Overall Study|Administrative problems|17
5303979|NCT00412750|18280020|P1|Overall Study|Administrative problems|21
5303980|NCT00412750|18280018|P3|Overall Study|Abnormal laboratory value(s)|0
5303981|NCT00412750|18280019|P2|Overall Study|Abnormal laboratory value(s)|0
5303982|NCT00412750|18280020|P1|Overall Study|Abnormal laboratory value(s)|1
5303983|NCT00412737|18280045|P2|Overall Study|Failure to Return|2
5303984|NCT00412737|18280046|P1|Overall Study|Failure to Return|6
5303985|NCT00412737|18280045|P2|Overall Study|Refused Treatment|2
5303986|NCT00412737|18280046|P1|Overall Study|Refused Treatment|6
5303987|NCT00412737|18280045|P2|Overall Study|Adverse Event|2
5303988|NCT00412737|18280046|P1|Overall Study|Adverse Event|3
5303989|NCT00412737|18280045|P2|Overall Study|Death|0
5303990|NCT00412737|18280046|P1|Overall Study|Death|1
5303991|NCT00412607|18280064|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
5303992|NCT00412607|18280064|P1|Overall Study|Death|61
5303993|NCT00412607|18280064|P1|Overall Study|Lost to Follow-up|19
5303994|NCT00412607|18280064|P1|Overall Study|Withdrawal by Subject|9
5303995|NCT00412542|18280077|P2|Overall Study|Not Eligible|1
5303996|NCT00412542|18280078|P1|Overall Study|Not Eligible|0
5303997|NCT00412542|18280077|P2|Overall Study|Withdrawal by Subject|2
5303998|NCT00412542|18280078|P1|Overall Study|Withdrawal by Subject|0
5303999|NCT00412373|18280163|P2|Overall Study|Other|2
5304000|NCT00412373|18280164|P1|Overall Study|Other|2
5304001|NCT00412373|18280163|P2|Overall Study|Withdrawal by Subject|27
5304002|NCT00412373|18280164|P1|Overall Study|Withdrawal by Subject|8
5304003|NCT00412373|18280163|P2|Overall Study|Lost to Follow-up|13
5304004|NCT00412373|18280164|P1|Overall Study|Lost to Follow-up|7
5304005|NCT00412373|18280163|P2|Overall Study|Lack of Efficacy|22
5304006|NCT00412373|18280164|P1|Overall Study|Lack of Efficacy|16
5304007|NCT00412373|18280163|P2|Overall Study|Adverse Event|13
5304008|NCT00412373|18280164|P1|Overall Study|Adverse Event|8
5304009|NCT00412360|18280206|P2|Overall Study|Not Transplanted|2
5304010|NCT00412360|18280207|P1|Overall Study|Not Transplanted|1
5304011|NCT00412360|18280206|P2|Overall Study|Lost to Follow-up|1
5304012|NCT00412360|18280207|P1|Overall Study|Lost to Follow-up|0
5304013|NCT00412217|18280237|P2|Overall Study|Other|1
5304014|NCT00412217|18280238|P1|Overall Study|Other|1
5304015|NCT00412217|18280237|P2|Overall Study|Study Terminated by Sponsor|33
5304016|NCT00412217|18280238|P1|Overall Study|Study Terminated by Sponsor|26
5304017|NCT00412217|18280237|P2|Overall Study|Lost to Follow-up|4
5304018|NCT00412217|18280238|P1|Overall Study|Lost to Follow-up|1
5304019|NCT00412217|18280237|P2|Overall Study|Withdrawal by Subject|0
5304020|NCT00412217|18280238|P1|Overall Study|Withdrawal by Subject|2
5304021|NCT00412217|18280237|P2|Overall Study|Investigator Decision|0
5304022|NCT00412217|18280238|P1|Overall Study|Investigator Decision|1
5304023|NCT00412217|18280237|P2|Overall Study|Disease Progression|3
5304024|NCT00412217|18280238|P1|Overall Study|Disease Progression|2
5304025|NCT00412217|18280237|P2|Overall Study|Death|4
5304026|NCT00412217|18280238|P1|Overall Study|Death|5
5304027|NCT00412217|18280237|P2|Overall Study|Insufficient Data Available|3
5304028|NCT00412217|18280238|P1|Overall Study|Insufficient Data Available|8
5304029|NCT00412113|18280252|P2|Overall Study|did not receive treatment|0
5304030|NCT00412113|18280253|P1|Overall Study|did not receive treatment|1
5304031|NCT00412113|18280252|P2|Overall Study|Adverse Event|15
5304032|NCT00412113|18280253|P1|Overall Study|Adverse Event|11
5304033|NCT00412061|18280337|P2|Open Label Phase|New Cancer Therapy|1
5304034|NCT00412061|18280338|P1|Open Label Phase|New Cancer Therapy|0
5304035|NCT00412061|18280337|P2|Open Label Phase|Lost to Follow-up|2
5304036|NCT00412061|18280338|P1|Open Label Phase|Lost to Follow-up|0
5304037|NCT00412061|18280337|P2|Open Label Phase|Death|7
5304038|NCT00412061|18280338|P1|Open Label Phase|Death|0
5304039|NCT00412061|18280337|P2|Open Label Phase|Administrative Problems|13
5304040|NCT00412061|18280338|P1|Open Label Phase|Administrative Problems|0
5304041|NCT00412061|18280337|P2|Open Label Phase|Withdrawal by Subject|15
5304042|NCT00412061|18280338|P1|Open Label Phase|Withdrawal by Subject|0
5304043|NCT00412061|18280337|P2|Open Label Phase|Adverse Event|46
5304044|NCT00412061|18280338|P1|Open Label Phase|Adverse Event|0
5304045|NCT00412061|18280337|P2|Open Label Phase|Disease Progression|86
5304046|NCT00412061|18280338|P1|Open Label Phase|Disease Progression|0
5304047|NCT00412061|18280337|P2|Double Blind Phase|Lost to Follow-up|1
5304048|NCT00412061|18280338|P1|Double Blind Phase|Lost to Follow-up|0
5304049|NCT00412061|18280337|P2|Double Blind Phase|New Cander Therapy|1
5304050|NCT00412061|18280338|P1|Double Blind Phase|New Cander Therapy|1
5304051|NCT00412061|18280337|P2|Double Blind Phase|Protocol Violation|4
5304052|NCT00412061|18280338|P1|Double Blind Phase|Protocol Violation|3
5304053|NCT00412061|18280337|P2|Double Blind Phase|Death|3
5304054|NCT00412061|18280338|P1|Double Blind Phase|Death|6
5304055|NCT00412061|18280337|P2|Double Blind Phase|Withdrawal by Subject|20
5304056|NCT00412061|18280338|P1|Double Blind Phase|Withdrawal by Subject|18
5304057|NCT00412061|18280337|P2|Double Blind Phase|Final Primary Analysis|14
5304058|NCT00412061|18280338|P1|Double Blind Phase|Final Primary Analysis|26
5304059|NCT00412061|18280337|P2|Double Blind Phase|Adverse Event|16
5304060|NCT00412061|18280338|P1|Double Blind Phase|Adverse Event|61
5304061|NCT00412061|18280337|P2|Double Blind Phase|Disease Progression|154
5304062|NCT00412061|18280338|P1|Double Blind Phase|Disease Progression|101
5304063|NCT00411788|18280356|P1|Overall Study|Adverse Event|1
5304064|NCT00411788|18280356|P1|Overall Study|Protocol Violation|1
5304065|NCT00411762|18280365|P1|Overall Study|Withdrawal by Subject|5
5304066|NCT00411671|18280389|P1|Overall Study|Lost to Follow-up|3
5304067|NCT00411671|18280389|P1|Overall Study|Death|2
5304068|NCT00411671|18280389|P1|Overall Study|Adverse Event|15
5304069|NCT00411645|18280397|P2|Overall Study|Lost to Follow-up|0
5304070|NCT00411645|18280398|P1|Overall Study|Lost to Follow-up|2
5304071|NCT00411645|18280397|P2|Overall Study|Investigator/Sponsor Decision|7
5304072|NCT00411645|18280398|P1|Overall Study|Investigator/Sponsor Decision|10
5304073|NCT00411645|18280397|P2|Overall Study|Death|135
5304074|NCT00411645|18280398|P1|Overall Study|Death|56
5304075|NCT00411645|18280397|P2|Overall Study|Consent Withdrawn|22
5304076|NCT00411645|18280398|P1|Overall Study|Consent Withdrawn|13
5304077|NCT00411632|18280422|P1|Overall Study|Death|1
5304078|NCT00411554|18280433|P2|Overall Study|Patient Moved|0
5304079|NCT00411554|18280434|P1|Overall Study|Patient Moved|1
5304080|NCT00411554|18280433|P2|Overall Study|Withdrawal by Subject|0
5304081|NCT00411554|18280434|P1|Overall Study|Withdrawal by Subject|3
5304082|NCT00411554|18280433|P2|Overall Study|Lack of Efficacy|5
5304083|NCT00411554|18280434|P1|Overall Study|Lack of Efficacy|2
5304084|NCT00411554|18280433|P2|Overall Study|Adverse Event|4
5304085|NCT00411554|18280434|P1|Overall Study|Adverse Event|2
5304086|NCT00411450|18280460|P1|Overall Study|Ongoing at time of data cut-off.|3
5304087|NCT00411216|18280503|P2|Overall Study|Ten participants were entered into the c|2
5304088|NCT00411216|18280504|P1|Overall Study|Ten participants were entered into the c|0
5304089|NCT00411151|18280510|P1|Overall Study|Trial prematurely closed|4
5304090|NCT00411151|18280510|P1|Overall Study|Protocol Violation|1
5304091|NCT00411151|18280510|P1|Overall Study|Lost to Follow-up|2
5304092|NCT00411151|18280510|P1|Overall Study|Withdrawal by Subject|2
5304093|NCT00411151|18280510|P1|Overall Study|Death|38
5304094|NCT00410813|18280554|P2|Overall Study|Death|2
5304095|NCT00410813|18280555|P1|Overall Study|Death|0
5304096|NCT00410813|18280554|P2|Overall Study|Ineligible|4
5304097|NCT00410813|18280555|P1|Overall Study|Ineligible|2
5304098|NCT00410813|18280554|P2|Overall Study|Not protocol specified|4
5304099|NCT00410813|18280555|P1|Overall Study|Not protocol specified|3
5304100|NCT00410813|18280554|P2|Overall Study|Progression|21
5304101|NCT00410813|18280555|P1|Overall Study|Progression|32
5304102|NCT00410813|18280554|P2|Overall Study|Adverse Event|11
5304103|NCT00410813|18280555|P1|Overall Study|Adverse Event|6
5304104|NCT00410761|18280592|P2|Overall Study|Never received randomised treatment|1
5304105|NCT00410761|18280593|P1|Overall Study|Never received randomised treatment|0
5304106|NCT00410761|18280592|P2|Overall Study|Other|9
5304107|NCT00410761|18280593|P1|Overall Study|Other|12
5304108|NCT00410761|18280592|P2|Overall Study|Withdrawal by Subject|4
5304109|NCT00410761|18280593|P1|Overall Study|Withdrawal by Subject|8
5304110|NCT00410761|18280592|P2|Overall Study|objective disease progression|55
5304111|NCT00410761|18280593|P1|Overall Study|objective disease progression|71
5304112|NCT00410761|18280592|P2|Overall Study|Adverse Event|3
5304113|NCT00410761|18280593|P1|Overall Study|Adverse Event|29
5304114|NCT00410605|18280613|P1|Overall Study|Transferred to another Institution|1
5304115|NCT00410605|18280613|P1|Overall Study|Stopped treatmen to collect stem cells|1
5304116|NCT00410605|18280613|P1|Overall Study|Started Non-Protocol Therapy|3
5304117|NCT00410605|18280613|P1|Overall Study|Withdrawal by Subject|5
5304118|NCT00410605|18280613|P1|Overall Study|Physician Decision|3
5304119|NCT00410605|18280613|P1|Overall Study|Adverse Event|12
5304120|NCT00410514|18280625|P3|Overall Study|Non-compliant with study procedures|2
5304121|NCT00410514|18280626|P2|Overall Study|Non-compliant with study procedures|0
5304122|NCT00410514|18280627|P1|Overall Study|Non-compliant with study procedures|0
5304123|NCT00410514|18280625|P3|Overall Study|Lost to Follow-up|2
5304124|NCT00410514|18280626|P2|Overall Study|Lost to Follow-up|0
5304125|NCT00410514|18280627|P1|Overall Study|Lost to Follow-up|0
5304126|NCT00410514|18280625|P3|Overall Study|Protocol Violation|1
5304127|NCT00410514|18280626|P2|Overall Study|Protocol Violation|1
5304128|NCT00410514|18280627|P1|Overall Study|Protocol Violation|0
5304129|NCT00410514|18280625|P3|Overall Study|Adverse Event|2
5304130|NCT00410514|18280626|P2|Overall Study|Adverse Event|2
5304131|NCT00410514|18280627|P1|Overall Study|Adverse Event|2
5304132|NCT00410410|18280710|P9|Open-Label Period (OL)|Other|7
5304133|NCT00410410|18280711|P8|Open-Label Period (OL)|Other|0
5304134|NCT00410410|18280712|P7|Open-Label Period (OL)|Other|0
5304135|NCT00410410|18280713|P6|Open-Label Period (OL)|Other|0
5304136|NCT00410410|18280714|P5|Open-Label Period (OL)|Other|0
5304137|NCT00410410|18280715|P4|Open-Label Period (OL)|Other|0
5304138|NCT00410410|18280716|P3|Open-Label Period (OL)|Other|0
5304139|NCT00410410|18280717|P2|Open-Label Period (OL)|Other|0
5304140|NCT00410410|18280718|P1|Open-Label Period (OL)|Other|0
5304141|NCT00410410|18280710|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
5304142|NCT00410410|18280711|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304143|NCT00410410|18280712|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304144|NCT00410410|18280713|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304145|NCT00410410|18280714|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304146|NCT00410410|18280715|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304147|NCT00410410|18280716|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304148|NCT00410410|18280717|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304149|NCT00410410|18280718|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5304150|NCT00410410|18280710|P9|Open-Label Period (OL)|Pregnancy|1
5304151|NCT00410410|18280711|P8|Open-Label Period (OL)|Pregnancy|0
5304152|NCT00410410|18280712|P7|Open-Label Period (OL)|Pregnancy|0
5304153|NCT00410410|18280713|P6|Open-Label Period (OL)|Pregnancy|0
5304154|NCT00410410|18280714|P5|Open-Label Period (OL)|Pregnancy|0
5304155|NCT00410410|18280715|P4|Open-Label Period (OL)|Pregnancy|0
5304156|NCT00410410|18280716|P3|Open-Label Period (OL)|Pregnancy|0
5304157|NCT00410410|18280717|P2|Open-Label Period (OL)|Pregnancy|0
5304158|NCT00410410|18280718|P1|Open-Label Period (OL)|Pregnancy|0
5304159|NCT00410410|18280710|P9|Open-Label Period (OL)|Withdrawal by Subject|20
5304160|NCT00410410|18280711|P8|Open-Label Period (OL)|Withdrawal by Subject|0
5304161|NCT00410410|18280712|P7|Open-Label Period (OL)|Withdrawal by Subject|0
5304162|NCT00410410|18280713|P6|Open-Label Period (OL)|Withdrawal by Subject|0
5304163|NCT00410410|18280714|P5|Open-Label Period (OL)|Withdrawal by Subject|0
5304164|NCT00410410|18280715|P4|Open-Label Period (OL)|Withdrawal by Subject|0
5304165|NCT00410410|18280716|P3|Open-Label Period (OL)|Withdrawal by Subject|0
5304166|NCT00410410|18280717|P2|Open-Label Period (OL)|Withdrawal by Subject|0
5304167|NCT00410410|18280718|P1|Open-Label Period (OL)|Withdrawal by Subject|0
5304168|NCT00410410|18280710|P9|Open-Label Period (OL)|Lost to Follow-up|4
5304169|NCT00410410|18280711|P8|Open-Label Period (OL)|Lost to Follow-up|0
5304170|NCT00410410|18280712|P7|Open-Label Period (OL)|Lost to Follow-up|0
5304171|NCT00410410|18280713|P6|Open-Label Period (OL)|Lost to Follow-up|0
5304172|NCT00410410|18280714|P5|Open-Label Period (OL)|Lost to Follow-up|0
5304173|NCT00410410|18280715|P4|Open-Label Period (OL)|Lost to Follow-up|0
5304174|NCT00410410|18280716|P3|Open-Label Period (OL)|Lost to Follow-up|0
5304175|NCT00410410|18280717|P2|Open-Label Period (OL)|Lost to Follow-up|0
5304176|NCT00410410|18280718|P1|Open-Label Period (OL)|Lost to Follow-up|0
5304177|NCT00410410|18280710|P9|Open-Label Period (OL)|Lack of Efficacy|161
5304178|NCT00410410|18280711|P8|Open-Label Period (OL)|Lack of Efficacy|0
5304179|NCT00410410|18280712|P7|Open-Label Period (OL)|Lack of Efficacy|0
5304180|NCT00410410|18280713|P6|Open-Label Period (OL)|Lack of Efficacy|0
5304181|NCT00410410|18280714|P5|Open-Label Period (OL)|Lack of Efficacy|0
5304182|NCT00410410|18280715|P4|Open-Label Period (OL)|Lack of Efficacy|0
5304183|NCT00410410|18280716|P3|Open-Label Period (OL)|Lack of Efficacy|0
5304184|NCT00410410|18280717|P2|Open-Label Period (OL)|Lack of Efficacy|0
5304185|NCT00410410|18280718|P1|Open-Label Period (OL)|Lack of Efficacy|0
5304186|NCT00410410|18280710|P9|Open-Label Period (OL)|Adverse Event|10
5304187|NCT00410410|18280711|P8|Open-Label Period (OL)|Adverse Event|0
5304188|NCT00410410|18280712|P7|Open-Label Period (OL)|Adverse Event|0
5304189|NCT00410410|18280713|P6|Open-Label Period (OL)|Adverse Event|0
5304190|NCT00410410|18280714|P5|Open-Label Period (OL)|Adverse Event|0
5304191|NCT00410410|18280715|P4|Open-Label Period (OL)|Adverse Event|0
5304192|NCT00410410|18280716|P3|Open-Label Period (OL)|Adverse Event|0
5304193|NCT00410410|18280717|P2|Open-Label Period (OL)|Adverse Event|0
5304194|NCT00410410|18280718|P1|Open-Label Period (OL)|Adverse Event|0
5304195|NCT00410410|18280710|P9|Open-Label Period (OL)|Death|1
5304196|NCT00410410|18280711|P8|Open-Label Period (OL)|Death|0
5304197|NCT00410410|18280712|P7|Open-Label Period (OL)|Death|0
5304198|NCT00410410|18280713|P6|Open-Label Period (OL)|Death|0
5304199|NCT00410410|18280714|P5|Open-Label Period (OL)|Death|0
5304200|NCT00410410|18280715|P4|Open-Label Period (OL)|Death|0
5304201|NCT00410410|18280716|P3|Open-Label Period (OL)|Death|0
5304202|NCT00410410|18280717|P2|Open-Label Period (OL)|Death|0
5304203|NCT00410410|18280718|P1|Open-Label Period (OL)|Death|0
5304204|NCT00410410|18280710|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304205|NCT00410410|18280711|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
5304206|NCT00410410|18280712|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
5304207|NCT00410410|18280713|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304208|NCT00410410|18280714|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304209|NCT00410410|18280715|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304210|NCT00410410|18280716|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304211|NCT00410410|18280717|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304212|NCT00410410|18280718|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5304213|NCT00410410|18280710|P9|Maintenance Period (MP)|Withdrawal by Subject|0
5304214|NCT00410410|18280711|P8|Maintenance Period (MP)|Withdrawal by Subject|1
5304215|NCT00410410|18280712|P7|Maintenance Period (MP)|Withdrawal by Subject|1
5304216|NCT00410410|18280713|P6|Maintenance Period (MP)|Withdrawal by Subject|0
5304217|NCT00410410|18280714|P5|Maintenance Period (MP)|Withdrawal by Subject|0
5304218|NCT00410410|18280715|P4|Maintenance Period (MP)|Withdrawal by Subject|0
5304219|NCT00410410|18280716|P3|Maintenance Period (MP)|Withdrawal by Subject|0
5304220|NCT00410410|18280717|P2|Maintenance Period (MP)|Withdrawal by Subject|0
5304221|NCT00410410|18280718|P1|Maintenance Period (MP)|Withdrawal by Subject|0
5304222|NCT00410410|18280710|P9|Maintenance Period (MP)|Lost to Follow-up|0
5304223|NCT00410410|18280711|P8|Maintenance Period (MP)|Lost to Follow-up|2
5304224|NCT00410410|18280712|P7|Maintenance Period (MP)|Lost to Follow-up|1
5304225|NCT00410410|18280713|P6|Maintenance Period (MP)|Lost to Follow-up|0
5304226|NCT00410410|18280714|P5|Maintenance Period (MP)|Lost to Follow-up|0
5304227|NCT00410410|18280715|P4|Maintenance Period (MP)|Lost to Follow-up|0
5304228|NCT00410410|18280716|P3|Maintenance Period (MP)|Lost to Follow-up|0
5304229|NCT00410410|18280717|P2|Maintenance Period (MP)|Lost to Follow-up|0
5304230|NCT00410410|18280718|P1|Maintenance Period (MP)|Lost to Follow-up|0
5304231|NCT00410410|18280710|P9|Maintenance Period (MP)|Lack of Efficacy|0
5304232|NCT00410410|18280711|P8|Maintenance Period (MP)|Lack of Efficacy|24
5304233|NCT00410410|18280712|P7|Maintenance Period (MP)|Lack of Efficacy|25
5304234|NCT00410410|18280713|P6|Maintenance Period (MP)|Lack of Efficacy|0
5304235|NCT00410410|18280714|P5|Maintenance Period (MP)|Lack of Efficacy|0
5304236|NCT00410410|18280715|P4|Maintenance Period (MP)|Lack of Efficacy|0
5304237|NCT00410410|18280716|P3|Maintenance Period (MP)|Lack of Efficacy|0
5304238|NCT00410410|18280717|P2|Maintenance Period (MP)|Lack of Efficacy|0
5304239|NCT00410410|18280718|P1|Maintenance Period (MP)|Lack of Efficacy|0
5304240|NCT00410410|18280710|P9|Maintenance Period (MP)|Adverse Event|0
5304241|NCT00410410|18280711|P8|Maintenance Period (MP)|Adverse Event|3
5304242|NCT00410410|18280712|P7|Maintenance Period (MP)|Adverse Event|1
5304243|NCT00410410|18280713|P6|Maintenance Period (MP)|Adverse Event|0
5304244|NCT00410410|18280714|P5|Maintenance Period (MP)|Adverse Event|0
5304245|NCT00410410|18280715|P4|Maintenance Period (MP)|Adverse Event|0
5304246|NCT00410410|18280716|P3|Maintenance Period (MP)|Adverse Event|0
5304247|NCT00410410|18280717|P2|Maintenance Period (MP)|Adverse Event|0
5304248|NCT00410410|18280718|P1|Maintenance Period (MP)|Adverse Event|0
5304249|NCT00410410|18280710|P9|Maintenance Period (MP)|Death|0
5304250|NCT00410410|18280711|P8|Maintenance Period (MP)|Death|0
5304251|NCT00410410|18280712|P7|Maintenance Period (MP)|Death|1
5304252|NCT00410410|18280713|P6|Maintenance Period (MP)|Death|0
5304253|NCT00410410|18280714|P5|Maintenance Period (MP)|Death|0
5304254|NCT00410410|18280715|P4|Maintenance Period (MP)|Death|0
5304255|NCT00410410|18280716|P3|Maintenance Period (MP)|Death|0
5304256|NCT00410410|18280717|P2|Maintenance Period (MP)|Death|0
5304257|NCT00410410|18280718|P1|Maintenance Period (MP)|Death|0
5304258|NCT00410410|18280710|P9|Induction Period (IP)|Other|0
5304259|NCT00410410|18280711|P8|Induction Period (IP)|Other|0
5304260|NCT00410410|18280712|P7|Induction Period (IP)|Other|0
5304261|NCT00410410|18280713|P6|Induction Period (IP)|Other|0
5304262|NCT00410410|18280714|P5|Induction Period (IP)|Other|0
5304263|NCT00410410|18280715|P4|Induction Period (IP)|Other|0
5304264|NCT00410410|18280716|P3|Induction Period (IP)|Other|1
5304265|NCT00410410|18280717|P2|Induction Period (IP)|Other|0
5304266|NCT00410410|18280718|P1|Induction Period (IP)|Other|0
5304267|NCT00410410|18280710|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
5304268|NCT00410410|18280711|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
5304269|NCT00410410|18280712|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
5304270|NCT00410410|18280713|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
5304271|NCT00410410|18280714|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
5304272|NCT00410410|18280715|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
5304273|NCT00410410|18280716|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
5304274|NCT00410410|18280717|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
5304275|NCT00410410|18280718|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
5304276|NCT00410410|18280710|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304277|NCT00410410|18280711|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304278|NCT00410410|18280712|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304279|NCT00410410|18280713|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304280|NCT00410410|18280714|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304281|NCT00410410|18280715|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304282|NCT00410410|18280716|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
5304283|NCT00410410|18280717|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304284|NCT00410410|18280718|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5304285|NCT00410410|18280710|P9|Induction Period (IP)|Withdrawal by Subject|0
5304286|NCT00410410|18280711|P8|Induction Period (IP)|Withdrawal by Subject|0
5304287|NCT00410410|18280712|P7|Induction Period (IP)|Withdrawal by Subject|0
5304288|NCT00410410|18280713|P6|Induction Period (IP)|Withdrawal by Subject|0
5304289|NCT00410410|18280714|P5|Induction Period (IP)|Withdrawal by Subject|2
5304290|NCT00410410|18280715|P4|Induction Period (IP)|Withdrawal by Subject|5
5304291|NCT00410410|18280716|P3|Induction Period (IP)|Withdrawal by Subject|3
5304292|NCT00410410|18280717|P2|Induction Period (IP)|Withdrawal by Subject|5
5304293|NCT00410410|18280718|P1|Induction Period (IP)|Withdrawal by Subject|3
5304294|NCT00410410|18280710|P9|Induction Period (IP)|Lost to Follow-up|0
5304295|NCT00410410|18280711|P8|Induction Period (IP)|Lost to Follow-up|0
5304296|NCT00410410|18280712|P7|Induction Period (IP)|Lost to Follow-up|0
5304297|NCT00410410|18280713|P6|Induction Period (IP)|Lost to Follow-up|1
5304298|NCT00410410|18280714|P5|Induction Period (IP)|Lost to Follow-up|0
5304299|NCT00410410|18280715|P4|Induction Period (IP)|Lost to Follow-up|3
5304300|NCT00410410|18280716|P3|Induction Period (IP)|Lost to Follow-up|2
5304301|NCT00410410|18280717|P2|Induction Period (IP)|Lost to Follow-up|2
5304302|NCT00410410|18280718|P1|Induction Period (IP)|Lost to Follow-up|2
5304303|NCT00410410|18280710|P9|Induction Period (IP)|Lack of Efficacy|0
5304304|NCT00410410|18280711|P8|Induction Period (IP)|Lack of Efficacy|0
5304305|NCT00410410|18280712|P7|Induction Period (IP)|Lack of Efficacy|0
5304306|NCT00410410|18280713|P6|Induction Period (IP)|Lack of Efficacy|7
5304307|NCT00410410|18280714|P5|Induction Period (IP)|Lack of Efficacy|7
5304308|NCT00410410|18280715|P4|Induction Period (IP)|Lack of Efficacy|8
5304309|NCT00410410|18280716|P3|Induction Period (IP)|Lack of Efficacy|8
5304310|NCT00410410|18280717|P2|Induction Period (IP)|Lack of Efficacy|24
5304311|NCT00410410|18280718|P1|Induction Period (IP)|Lack of Efficacy|26
5304312|NCT00410410|18280710|P9|Induction Period (IP)|Adverse Event|0
5304313|NCT00410410|18280711|P8|Induction Period (IP)|Adverse Event|0
5304314|NCT00410410|18280712|P7|Induction Period (IP)|Adverse Event|0
5304315|NCT00410410|18280713|P6|Induction Period (IP)|Adverse Event|0
5304316|NCT00410410|18280714|P5|Induction Period (IP)|Adverse Event|1
5304317|NCT00410410|18280715|P4|Induction Period (IP)|Adverse Event|4
5304318|NCT00410410|18280716|P3|Induction Period (IP)|Adverse Event|2
5304319|NCT00410410|18280717|P2|Induction Period (IP)|Adverse Event|4
5304320|NCT00410410|18280718|P1|Induction Period (IP)|Adverse Event|3
5304321|NCT00410410|18280710|P9|Induction Period (IP)|Death|0
5304322|NCT00410410|18280711|P8|Induction Period (IP)|Death|0
5304323|NCT00410410|18280712|P7|Induction Period (IP)|Death|0
5304324|NCT00410410|18280713|P6|Induction Period (IP)|Death|0
5304325|NCT00410410|18280714|P5|Induction Period (IP)|Death|0
5304326|NCT00410410|18280715|P4|Induction Period (IP)|Death|0
5304327|NCT00410410|18280716|P3|Induction Period (IP)|Death|0
5304328|NCT00410410|18280717|P2|Induction Period (IP)|Death|0
5304329|NCT00410410|18280718|P1|Induction Period (IP)|Death|1
5304330|NCT00410384|18280879|P3|Overall Study|Other|4
5304331|NCT00410384|18280880|P2|Overall Study|Other|8
5304332|NCT00410384|18280881|P1|Overall Study|Other|3
5304333|NCT00410384|18280879|P3|Overall Study|Physician Decision|4
5304334|NCT00410384|18280880|P2|Overall Study|Physician Decision|3
5304335|NCT00410384|18280881|P1|Overall Study|Physician Decision|3
5304336|NCT00410384|18280879|P3|Overall Study|Protocol Violation|6
5304337|NCT00410384|18280880|P2|Overall Study|Protocol Violation|6
5304338|NCT00410384|18280881|P1|Overall Study|Protocol Violation|6
5304339|NCT00410384|18280879|P3|Overall Study|Lost to Follow-up|6
5304340|NCT00410384|18280880|P2|Overall Study|Lost to Follow-up|6
5304341|NCT00410384|18280881|P1|Overall Study|Lost to Follow-up|4
5304342|NCT00410384|18280879|P3|Overall Study|Lack of Compliance|2
5304343|NCT00410384|18280880|P2|Overall Study|Lack of Compliance|2
5304344|NCT00410384|18280881|P1|Overall Study|Lack of Compliance|2
5304345|NCT00410384|18280879|P3|Overall Study|Lack of Efficacy|17
5304346|NCT00410384|18280880|P2|Overall Study|Lack of Efficacy|12
5304347|NCT00410384|18280881|P1|Overall Study|Lack of Efficacy|20
5304348|NCT00410384|18280879|P3|Overall Study|Adverse Event|23
5304349|NCT00410384|18280880|P2|Overall Study|Adverse Event|18
5304350|NCT00410384|18280881|P1|Overall Study|Adverse Event|23
5304351|NCT00410384|18280879|P3|Overall Study|Withdrawal by Subject|20
5304352|NCT00410384|18280880|P2|Overall Study|Withdrawal by Subject|17
5304353|NCT00410384|18280881|P1|Overall Study|Withdrawal by Subject|28
5304354|NCT00410202|18280954|P3|Off-treatment Follow up|Lost to Follow-up|0
5304355|NCT00410202|18280955|P2|Off-treatment Follow up|Lost to Follow-up|0
5304356|NCT00410202|18280956|P1|Off-treatment Follow up|Lost to Follow-up|1
5304357|NCT00410202|18280954|P3|Off-treatment Follow up|Follow up not required per protocol|1
5304358|NCT00410202|18280955|P2|Off-treatment Follow up|Follow up not required per protocol|0
5304359|NCT00410202|18280956|P1|Off-treatment Follow up|Follow up not required per protocol|3
5304360|NCT00410202|18280954|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
5304361|NCT00410202|18280955|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
5304362|NCT00410202|18280956|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
5304363|NCT00410202|18280954|P3|On-Treatment|Other Reason|1
5304364|NCT00410202|18280955|P2|On-Treatment|Other Reason|0
5304365|NCT00410202|18280956|P1|On-Treatment|Other Reason|0
5304366|NCT00410202|18280954|P3|On-Treatment|Withdrawal by Subject|1
5304367|NCT00410202|18280955|P2|On-Treatment|Withdrawal by Subject|1
5304368|NCT00410202|18280956|P1|On-Treatment|Withdrawal by Subject|2
5304369|NCT00410202|18280954|P3|On-Treatment|Lack of Efficacy|0
5304370|NCT00410202|18280955|P2|On-Treatment|Lack of Efficacy|4
5304371|NCT00410202|18280956|P1|On-Treatment|Lack of Efficacy|1
5304372|NCT00410202|18280954|P3|On-Treatment|Lost to Follow-up|1
5304373|NCT00410202|18280955|P2|On-Treatment|Lost to Follow-up|0
5304374|NCT00410202|18280956|P1|On-Treatment|Lost to Follow-up|1
5304375|NCT00410202|18280954|P3|On-Treatment|Death|0
5304376|NCT00410202|18280955|P2|On-Treatment|Death|0
5304377|NCT00410202|18280956|P1|On-Treatment|Death|1
5304378|NCT00410202|18280954|P3|On-Treatment|Adverse Event|2
5304379|NCT00410202|18280955|P2|On-Treatment|Adverse Event|3
5304380|NCT00410202|18280956|P1|On-Treatment|Adverse Event|1
5304381|NCT00410202|18280954|P3|On-Treatment|Continuing treatment|66
5304382|NCT00410202|18280955|P2|On-Treatment|Continuing treatment|71
5304383|NCT00410202|18280956|P1|On-Treatment|Continuing treatment|69
5304384|NCT00410163|18281043|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
5304385|NCT00410163|18281044|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
5304386|NCT00410163|18281043|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
5304387|NCT00410163|18281044|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
5304388|NCT00410163|18281043|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
5304389|NCT00410163|18281044|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
5304390|NCT00410163|18281043|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
5304391|NCT00410163|18281044|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
5304392|NCT00410163|18281043|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
5304393|NCT00410163|18281044|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
5304394|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
5304395|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
5304396|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
5304397|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
5304398|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
5304399|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
5304400|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
5304401|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
5304402|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
5304403|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
5304404|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
5304405|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
5304406|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
5304407|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
5304408|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Death|1
5304409|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Death|1
5304410|NCT00410163|18281043|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
5304411|NCT00410163|18281044|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
5304412|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
5304413|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
5304414|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
5304415|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
5304416|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
5304417|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
5304418|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Death|10
5304419|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Death|2
5304420|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
5304421|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
5304422|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
5304423|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
5304424|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
5304425|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
5304426|NCT00410124|18281097|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
5304427|NCT00410124|18281098|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
5304428|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
5304429|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
5304430|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Death|4
5304431|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Death|7
5304432|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
5304433|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
5304434|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
5304435|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
5304436|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
5304437|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
5304438|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
5304439|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
5304440|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
5304441|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
5304442|NCT00410124|18281097|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
5304443|NCT00410124|18281098|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
5304444|NCT00410072|18281129|P2|After Week 48 to Week 96|Withdrawal by Subject|1
5304445|NCT00410072|18281130|P1|After Week 48 to Week 96|Withdrawal by Subject|0
5304446|NCT00410072|18281129|P2|After Week 48 to Week 96|Pregnancy|2
5304447|NCT00410072|18281130|P1|After Week 48 to Week 96|Pregnancy|0
5304448|NCT00410072|18281129|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
5304449|NCT00410072|18281130|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
5304450|NCT00410072|18281129|P2|After Week 48 to Week 96|Other|0
5304451|NCT00410072|18281130|P1|After Week 48 to Week 96|Other|2
5304452|NCT00410072|18281129|P2|After Week 48 to Week 96|Lost to Follow-up|4
5304453|NCT00410072|18281130|P1|After Week 48 to Week 96|Lost to Follow-up|2
5304454|NCT00410072|18281129|P2|After Week 48 to Week 96|Lack of Efficacy|0
5304455|NCT00410072|18281130|P1|After Week 48 to Week 96|Lack of Efficacy|1
5304456|NCT00410072|18281129|P2|After Week 48 to Week 96|Death|1
5304457|NCT00410072|18281130|P1|After Week 48 to Week 96|Death|0
5304458|NCT00410072|18281129|P2|After Week 48 to Week 96|Adverse Event|2
5304459|NCT00410072|18281130|P1|After Week 48 to Week 96|Adverse Event|1
5304460|NCT00410072|18281129|P2|Day 1 to Week 48|Withdrawal by Subject|2
5304461|NCT00410072|18281130|P1|Day 1 to Week 48|Withdrawal by Subject|0
5304462|NCT00410072|18281129|P2|Day 1 to Week 48|Pregnancy|2
5304463|NCT00410072|18281130|P1|Day 1 to Week 48|Pregnancy|0
5304464|NCT00410072|18281129|P2|Day 1 to Week 48|poor compliance/noncompliance|3
5304465|NCT00410072|18281130|P1|Day 1 to Week 48|poor compliance/noncompliance|0
5304466|NCT00410072|18281129|P2|Day 1 to Week 48|Other|1
5304467|NCT00410072|18281130|P1|Day 1 to Week 48|Other|0
5304468|NCT00410072|18281129|P2|Day 1 to Week 48|Lost to Follow-up|2
5304469|NCT00410072|18281130|P1|Day 1 to Week 48|Lost to Follow-up|5
5304470|NCT00410072|18281129|P2|Day 1 to Week 48|Adverse Event|2
5304471|NCT00410072|18281130|P1|Day 1 to Week 48|Adverse Event|1
5304472|NCT00410046|18281170|P1|Overall Study|Lost to Follow-up|1
5304473|NCT00410046|18281170|P1|Overall Study|Withdrawal by Subject|1
5304474|NCT00410046|18281170|P1|Overall Study|Adverse Event|3
5304475|NCT00409838|18281201|P2|Long-term Extension Period|Pregnancy|0
5304476|NCT00409838|18281202|P1|Long-term Extension Period|Pregnancy|1
5304477|NCT00409838|18281201|P2|Long-term Extension Period|Poor compliance/noncompliance|0
5304478|NCT00409838|18281202|P1|Long-term Extension Period|Poor compliance/noncompliance|1
5304479|NCT00409838|18281201|P2|Long-term Extension Period|Withdrawal by Subject|0
5304480|NCT00409838|18281202|P1|Long-term Extension Period|Withdrawal by Subject|3
5304481|NCT00409838|18281201|P2|Long-term Extension Period|Lack of Efficacy|0
5304482|NCT00409838|18281202|P1|Long-term Extension Period|Lack of Efficacy|2
5304483|NCT00409838|18281201|P2|Long-term Extension Period|Death|0
5304484|NCT00409838|18281202|P1|Long-term Extension Period|Death|1
5304485|NCT00409838|18281201|P2|Long-term Extension Period|Adverse Event|0
5304486|NCT00409838|18281202|P1|Long-term Extension Period|Adverse Event|10
5304487|NCT00409838|18281201|P2|Short-term Period|Never Treated|0
5304488|NCT00409838|18281202|P1|Short-term Period|Never Treated|1
5304489|NCT00409838|18281201|P2|Short-term Period|Withdrawal by Subject|3
5304490|NCT00409838|18281202|P1|Short-term Period|Withdrawal by Subject|2
5304491|NCT00409838|18281201|P2|Short-term Period|Lost to Follow-up|1
5304492|NCT00409838|18281202|P1|Short-term Period|Lost to Follow-up|0
5304493|NCT00409838|18281201|P2|Short-term Period|Adverse Event|1
5304494|NCT00409838|18281202|P1|Short-term Period|Adverse Event|0
5304495|NCT00409786|18281267|P1|Overall Study|Withdrawal by Subject|3
5304496|NCT00409773|18281276|P5|Overall Study|Lack of Eligibility|1
5304497|NCT00409773|18281277|P4|Overall Study|Lack of Eligibility|0
5304498|NCT00409773|18281278|P3|Overall Study|Lack of Eligibility|0
5304499|NCT00409773|18281279|P2|Overall Study|Lack of Eligibility|0
5304500|NCT00409773|18281280|P1|Overall Study|Lack of Eligibility|0
5304501|NCT00409773|18281276|P5|Overall Study|Withdrawal by Subject|1
5304502|NCT00409773|18281277|P4|Overall Study|Withdrawal by Subject|2
5304503|NCT00409773|18281278|P3|Overall Study|Withdrawal by Subject|0
5304504|NCT00409773|18281279|P2|Overall Study|Withdrawal by Subject|0
5304505|NCT00409773|18281280|P1|Overall Study|Withdrawal by Subject|0
5304506|NCT00409773|18281276|P5|Overall Study|Protocol Violation|1
5304507|NCT00409773|18281277|P4|Overall Study|Protocol Violation|3
5304508|NCT00409773|18281278|P3|Overall Study|Protocol Violation|3
5304509|NCT00409773|18281279|P2|Overall Study|Protocol Violation|2
5304510|NCT00409773|18281280|P1|Overall Study|Protocol Violation|0
5304511|NCT00409773|18281276|P5|Overall Study|Physician Decision|0
5304512|NCT00409773|18281277|P4|Overall Study|Physician Decision|2
5304513|NCT00409773|18281278|P3|Overall Study|Physician Decision|0
5304514|NCT00409773|18281279|P2|Overall Study|Physician Decision|0
5304515|NCT00409773|18281280|P1|Overall Study|Physician Decision|0
5304516|NCT00409773|18281276|P5|Overall Study|Lost to Follow-up|1
5304517|NCT00409773|18281277|P4|Overall Study|Lost to Follow-up|3
5304518|NCT00409773|18281278|P3|Overall Study|Lost to Follow-up|2
5304519|NCT00409773|18281279|P2|Overall Study|Lost to Follow-up|1
5304520|NCT00409773|18281280|P1|Overall Study|Lost to Follow-up|6
5304521|NCT00409773|18281276|P5|Overall Study|Adverse Event|6
5304522|NCT00409773|18281277|P4|Overall Study|Adverse Event|2
5304523|NCT00409773|18281278|P3|Overall Study|Adverse Event|4
5304524|NCT00409773|18281279|P2|Overall Study|Adverse Event|4
5304525|NCT00409773|18281280|P1|Overall Study|Adverse Event|3
5304526|NCT00409747|18281362|P1|Overall Study|Withdrawal by Subject|1
5304527|NCT00409708|18281369|P2|Washout|Lost to Follow-up|3
5304528|NCT00409708|18281370|P1|Washout|Lost to Follow-up|1
5304529|NCT00409708|18281369|P2|Washout|Withdrawal by Subject|5
5304530|NCT00409708|18281370|P1|Washout|Withdrawal by Subject|11
5304531|NCT00409708|18281369|P2|Washout|Protocol Violation|1
5304532|NCT00409708|18281370|P1|Washout|Protocol Violation|0
5304533|NCT00409708|18281369|P2|Washout|Lack of Efficacy|1
5304534|NCT00409708|18281370|P1|Washout|Lack of Efficacy|9
5304535|NCT00409708|18281369|P2|Treatment|Administrative problems|0
5304536|NCT00409708|18281370|P1|Treatment|Administrative problems|5
5304537|NCT00409708|18281369|P2|Treatment|Lost to Follow-up|6
5304538|NCT00409708|18281370|P1|Treatment|Lost to Follow-up|0
5304539|NCT00409708|18281369|P2|Treatment|Withdrawal by Subject|8
5304540|NCT00409708|18281370|P1|Treatment|Withdrawal by Subject|3
5304541|NCT00409708|18281369|P2|Treatment|Protocol Violation|2
5304542|NCT00409708|18281370|P1|Treatment|Protocol Violation|6
5304543|NCT00409708|18281369|P2|Treatment|Lack of Efficacy|1
5304544|NCT00409708|18281370|P1|Treatment|Lack of Efficacy|0
5304545|NCT00409708|18281369|P2|Treatment|Abnormal test procedure result(s)|0
5304546|NCT00409708|18281370|P1|Treatment|Abnormal test procedure result(s)|1
5304547|NCT00409682|18281391|P3|EOW Double-blind Maintenance Period|Non-compliance|1
5304548|NCT00409682|18281392|P2|EOW Double-blind Maintenance Period|Non-compliance|0
5304549|NCT00409682|18281393|P1|EOW Double-blind Maintenance Period|Non-compliance|0
5304550|NCT00409682|18281391|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
5304551|NCT00409682|18281392|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
5304552|NCT00409682|18281393|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
5304553|NCT00409682|18281391|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
5304554|NCT00409682|18281392|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
5304555|NCT00409682|18281393|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
5304556|NCT00409682|18281391|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
5304557|NCT00409682|18281392|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
5304558|NCT00409682|18281393|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
5304559|NCT00409682|18281391|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
5304560|NCT00409682|18281392|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
5304561|NCT00409682|18281393|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
5304562|NCT00409682|18281391|P3|EOW Double-blind Maintenance Period|Adverse Event|12
5304563|NCT00409682|18281392|P2|EOW Double-blind Maintenance Period|Adverse Event|10
5304564|NCT00409682|18281393|P1|EOW Double-blind Maintenance Period|Adverse Event|0
5304565|NCT00409682|18281391|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
5304566|NCT00409682|18281392|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
5304567|NCT00409682|18281393|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
5304568|NCT00409682|18281391|P3|Open-label Induction Period|Protocol Violation|0
5304569|NCT00409682|18281392|P2|Open-label Induction Period|Protocol Violation|0
5304570|NCT00409682|18281393|P1|Open-label Induction Period|Protocol Violation|1
5304571|NCT00409682|18281391|P3|Open-label Induction Period|Lack of Efficacy|0
5304572|NCT00409682|18281392|P2|Open-label Induction Period|Lack of Efficacy|0
5304573|NCT00409682|18281393|P1|Open-label Induction Period|Lack of Efficacy|1
5304574|NCT00409682|18281391|P3|Open-label Induction Period|Adverse Event|0
5304575|NCT00409682|18281392|P2|Open-label Induction Period|Adverse Event|0
5304576|NCT00409682|18281393|P1|Open-label Induction Period|Adverse Event|1
5304577|NCT00409617|18281410|P1|Overall Study|Not described|14
5304578|NCT00409617|18281410|P1|Overall Study|Administrative reasons|1
5304579|NCT00409617|18281410|P1|Overall Study|Withdrawal by Subject|8
5304580|NCT00409617|18281410|P1|Overall Study|Protocol Violation|24
5304581|NCT00409617|18281410|P1|Overall Study|Lost to Follow-up|2
5304582|NCT00409617|18281410|P1|Overall Study|Lack of Efficacy|54
5304583|NCT00409617|18281410|P1|Overall Study|Adverse Event|57
5304584|NCT00409578|18281426|P4|Overall Study|Missing|1
5304585|NCT00409578|18281427|P3|Overall Study|Missing|0
5304586|NCT00409578|18281428|P2|Overall Study|Missing|1
5304587|NCT00409578|18281429|P1|Overall Study|Missing|0
5304588|NCT00409578|18281426|P4|Overall Study|Protocol Violation|1
5304589|NCT00409578|18281427|P3|Overall Study|Protocol Violation|3
5304590|NCT00409578|18281428|P2|Overall Study|Protocol Violation|2
5304591|NCT00409578|18281429|P1|Overall Study|Protocol Violation|3
5304592|NCT00409578|18281426|P4|Overall Study|Death|2
5304593|NCT00409578|18281427|P3|Overall Study|Death|4
5304594|NCT00409578|18281428|P2|Overall Study|Death|4
5304595|NCT00409578|18281429|P1|Overall Study|Death|2
5304596|NCT00409578|18281426|P4|Overall Study|Administrative problems|4
5304597|NCT00409578|18281427|P3|Overall Study|Administrative problems|2
5304598|NCT00409578|18281428|P2|Overall Study|Administrative problems|9
5304599|NCT00409578|18281429|P1|Overall Study|Administrative problems|8
5304600|NCT00409578|18281426|P4|Overall Study|Lost to Follow-up|2
5304601|NCT00409578|18281427|P3|Overall Study|Lost to Follow-up|2
5304602|NCT00409578|18281428|P2|Overall Study|Lost to Follow-up|0
5304603|NCT00409578|18281429|P1|Overall Study|Lost to Follow-up|2
5304604|NCT00409578|18281426|P4|Overall Study|Withdrawal by Subject|17
5304605|NCT00409578|18281427|P3|Overall Study|Withdrawal by Subject|16
5304606|NCT00409578|18281428|P2|Overall Study|Withdrawal by Subject|15
5304607|NCT00409578|18281429|P1|Overall Study|Withdrawal by Subject|8
5304608|NCT00409578|18281426|P4|Overall Study|Subject no longer requires study drug|1
5304609|NCT00409578|18281427|P3|Overall Study|Subject no longer requires study drug|0
5304610|NCT00409578|18281428|P2|Overall Study|Subject no longer requires study drug|0
5304611|NCT00409578|18281429|P1|Overall Study|Subject no longer requires study drug|0
5304612|NCT00409578|18281426|P4|Overall Study|Lack of Efficacy|2
5304613|NCT00409578|18281427|P3|Overall Study|Lack of Efficacy|0
5304614|NCT00409578|18281428|P2|Overall Study|Lack of Efficacy|0
5304615|NCT00409578|18281429|P1|Overall Study|Lack of Efficacy|0
5304616|NCT00409578|18281426|P4|Overall Study|Abnormal laboratory value(s)|4
5304617|NCT00409578|18281427|P3|Overall Study|Abnormal laboratory value(s)|2
5304618|NCT00409578|18281428|P2|Overall Study|Abnormal laboratory value(s)|2
5304619|NCT00409578|18281429|P1|Overall Study|Abnormal laboratory value(s)|2
5304620|NCT00409578|18281426|P4|Overall Study|Adverse Event|33
5304621|NCT00409578|18281427|P3|Overall Study|Adverse Event|25
5304622|NCT00409578|18281428|P2|Overall Study|Adverse Event|37
5304623|NCT00409578|18281429|P1|Overall Study|Adverse Event|27
5304624|NCT00409409|18281487|P2|Overall Study|Any other reason not above-mentioned|1
5304625|NCT00409409|18281488|P1|Overall Study|Any other reason not above-mentioned|0
5304626|NCT00409409|18281487|P2|Overall Study|Withdrawal by Subject|1
5304627|NCT00409409|18281488|P1|Overall Study|Withdrawal by Subject|1
5304628|NCT00409409|18281487|P2|Overall Study|Adverse Event|2
5304629|NCT00409409|18281488|P1|Overall Study|Adverse Event|7
5304630|NCT00409344|18281496|P2|Overall Study|no enrollment|0
5304631|NCT00409344|18281497|P1|Overall Study|no enrollment|0
5304632|NCT00409331|18281515|P1|Overall Study|Physician Decision|1
5304633|NCT00409188|18281537|P2|Overall Study|Ongoing at data cut-off|175
5304634|NCT00409188|18281538|P1|Overall Study|Ongoing at data cut-off|383
5304635|NCT00409175|18281554|P2|Overall Study|Liver transplantation|13
5304636|NCT00409175|18281555|P1|Overall Study|Liver transplantation|13
5304637|NCT00409175|18281554|P2|Overall Study|Negative genotype|1
5304638|NCT00409175|18281555|P1|Overall Study|Negative genotype|0
5304639|NCT00409175|18281554|P2|Overall Study|Withdrawal by Subject|2
5304640|NCT00409175|18281555|P1|Overall Study|Withdrawal by Subject|1
5304641|NCT00409175|18281554|P2|Overall Study|Adverse Event|3
5304642|NCT00409175|18281555|P1|Overall Study|Adverse Event|4
5304643|NCT00409006|18281581|P2|Overall Study|Physician Decision|2
5304644|NCT00409006|18281582|P1|Overall Study|Physician Decision|1
5304645|NCT00409006|18281581|P2|Overall Study|Withdrawal by Subject|2
5304646|NCT00409006|18281582|P1|Overall Study|Withdrawal by Subject|3
5304647|NCT00409006|18281581|P2|Overall Study|Lost to Follow-up|2
5304648|NCT00409006|18281582|P1|Overall Study|Lost to Follow-up|1
5304649|NCT00409006|18281581|P2|Overall Study|Death|6
5304650|NCT00409006|18281582|P1|Overall Study|Death|15
5304651|NCT00408993|18281598|P2|Overall Study|Withdrawal by Subject|3
5304652|NCT00408993|18281599|P1|Overall Study|Withdrawal by Subject|2
5304653|NCT00408993|18281598|P2|Overall Study|Lack of Efficacy|4
5304654|NCT00408993|18281599|P1|Overall Study|Lack of Efficacy|1
5304655|NCT00408993|18281598|P2|Overall Study|Protocol Violation|6
5304656|NCT00408993|18281599|P1|Overall Study|Protocol Violation|1
5304657|NCT00408993|18281598|P2|Overall Study|Adverse Event|4
5304658|NCT00408993|18281599|P1|Overall Study|Adverse Event|15
5304659|NCT00408928|18281631|P1|Overall Study|Infection indistinguishable from GVHD|1
5304660|NCT00408928|18281631|P1|Overall Study|Death|1
5304661|NCT00408928|18281631|P1|Overall Study|Withdrawal by Subject|1
5304662|NCT00408902|18281636|P1|Overall Study|Adverse Event|3
5304663|NCT00408902|18281636|P1|Overall Study|Lack of Efficacy|7
5304664|NCT00408876|18281646|P4|Overall Study|Physician Decision|0
5304665|NCT00408876|18281647|P3|Overall Study|Physician Decision|3
5304666|NCT00408876|18281648|P2|Overall Study|Physician Decision|0
5304667|NCT00408876|18281649|P1|Overall Study|Physician Decision|1
5304668|NCT00408876|18281646|P4|Overall Study|Protocol Violation|3
5304669|NCT00408876|18281647|P3|Overall Study|Protocol Violation|4
5304670|NCT00408876|18281648|P2|Overall Study|Protocol Violation|3
5304671|NCT00408876|18281649|P1|Overall Study|Protocol Violation|0
5304672|NCT00408876|18281646|P4|Overall Study|Lost to Follow-up|2
5304673|NCT00408876|18281647|P3|Overall Study|Lost to Follow-up|5
5304674|NCT00408876|18281648|P2|Overall Study|Lost to Follow-up|6
5304675|NCT00408876|18281649|P1|Overall Study|Lost to Follow-up|1
5304676|NCT00408876|18281646|P4|Overall Study|Lack of Efficacy|6
5304677|NCT00408876|18281647|P3|Overall Study|Lack of Efficacy|5
5304678|NCT00408876|18281648|P2|Overall Study|Lack of Efficacy|4
5304679|NCT00408876|18281649|P1|Overall Study|Lack of Efficacy|2
5304680|NCT00408876|18281646|P4|Overall Study|Withdrawal by Subject|14
5304681|NCT00408876|18281647|P3|Overall Study|Withdrawal by Subject|6
5304682|NCT00408876|18281648|P2|Overall Study|Withdrawal by Subject|6
5304683|NCT00408876|18281649|P1|Overall Study|Withdrawal by Subject|3
5304684|NCT00408876|18281646|P4|Overall Study|Adverse Event|10
5304685|NCT00408876|18281647|P3|Overall Study|Adverse Event|27
5304686|NCT00408876|18281648|P2|Overall Study|Adverse Event|17
5304687|NCT00408876|18281649|P1|Overall Study|Adverse Event|9
5304688|NCT00408694|18281899|P1|Overall Study|No protocol treatment|1
5304689|NCT00408694|18281899|P1|Overall Study|Ineligible|1
5304690|NCT00408681|18281911|P1|Overall Study|Adverse Event|7
5304691|NCT00408681|18281911|P1|Overall Study|Lack of Efficacy|2
5304692|NCT00408629|18281930|P2|Overall Study|Miscellaneous|15
5304693|NCT00408629|18281931|P1|Overall Study|Miscellaneous|11
5304694|NCT00408629|18281930|P2|Overall Study|Protocol Violation|5
5304695|NCT00408629|18281931|P1|Overall Study|Protocol Violation|1
5304696|NCT00408629|18281930|P2|Overall Study|Lack of Efficacy|73
5304697|NCT00408629|18281931|P1|Overall Study|Lack of Efficacy|63
5304698|NCT00408629|18281930|P2|Overall Study|Lost to Follow-up|1
5304699|NCT00408629|18281931|P1|Overall Study|Lost to Follow-up|1
5304700|NCT00408629|18281930|P2|Overall Study|Withdrawal by Subject|4
5304701|NCT00408629|18281931|P1|Overall Study|Withdrawal by Subject|8
5304702|NCT00408629|18281930|P2|Overall Study|Adverse Event|27
5304703|NCT00408629|18281931|P1|Overall Study|Adverse Event|13
5304704|NCT00408499|18282027|P5|Phase II- MTD Expansion|treatment delay|3
5304705|NCT00408499|18282028|P4|Phase II- MTD Expansion|treatment delay|0
5304706|NCT00408499|18282029|P3|Phase II- MTD Expansion|treatment delay|0
5304707|NCT00408499|18282030|P2|Phase II- MTD Expansion|treatment delay|0
5304708|NCT00408499|18282031|P1|Phase II- MTD Expansion|treatment delay|0
5304709|NCT00408499|18282027|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
5304710|NCT00408499|18282028|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
5304711|NCT00408499|18282029|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
5304712|NCT00408499|18282030|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
5304713|NCT00408499|18282031|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
5304714|NCT00408499|18282027|P5|Phase II- MTD Expansion|Physician Decision|1
5304715|NCT00408499|18282028|P4|Phase II- MTD Expansion|Physician Decision|0
5304716|NCT00408499|18282029|P3|Phase II- MTD Expansion|Physician Decision|0
5304717|NCT00408499|18282030|P2|Phase II- MTD Expansion|Physician Decision|0
5304718|NCT00408499|18282031|P1|Phase II- MTD Expansion|Physician Decision|0
5304719|NCT00408499|18282027|P5|Phase II- MTD Expansion|Death|2
5304720|NCT00408499|18282028|P4|Phase II- MTD Expansion|Death|0
5304721|NCT00408499|18282029|P3|Phase II- MTD Expansion|Death|0
5304722|NCT00408499|18282030|P2|Phase II- MTD Expansion|Death|0
5304723|NCT00408499|18282031|P1|Phase II- MTD Expansion|Death|0
5304724|NCT00408499|18282027|P5|Phase II- MTD Expansion|Adverse Event|9
5304725|NCT00408499|18282028|P4|Phase II- MTD Expansion|Adverse Event|0
5304726|NCT00408499|18282029|P3|Phase II- MTD Expansion|Adverse Event|0
5304727|NCT00408499|18282030|P2|Phase II- MTD Expansion|Adverse Event|0
5304728|NCT00408499|18282031|P1|Phase II- MTD Expansion|Adverse Event|0
5304729|NCT00408499|18282027|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
5304730|NCT00408499|18282028|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
5304731|NCT00408499|18282029|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
5304732|NCT00408499|18282030|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
5304733|NCT00408499|18282031|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
5304734|NCT00408499|18282027|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
5304735|NCT00408499|18282028|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
5304736|NCT00408499|18282029|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
5304737|NCT00408499|18282030|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
5304738|NCT00408499|18282031|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
5304739|NCT00408499|18282027|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
5304740|NCT00408499|18282028|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
5304741|NCT00408499|18282029|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
5304742|NCT00408499|18282030|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
5304743|NCT00408499|18282031|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
5304744|NCT00408434|18282053|P7|Overall Study|Terminated by Investigator|0
5304745|NCT00408434|18282054|P6|Overall Study|Terminated by Investigator|1
5304746|NCT00408434|18282055|P5|Overall Study|Terminated by Investigator|1
5304747|NCT00408434|18282056|P4|Overall Study|Terminated by Investigator|0
5304748|NCT00408434|18282057|P3|Overall Study|Terminated by Investigator|0
5304749|NCT00408434|18282058|P2|Overall Study|Terminated by Investigator|0
5304750|NCT00408434|18282059|P1|Overall Study|Terminated by Investigator|0
5304751|NCT00408434|18282053|P7|Overall Study|Other|0
5304752|NCT00408434|18282054|P6|Overall Study|Other|1
5304753|NCT00408434|18282055|P5|Overall Study|Other|2
5304754|NCT00408434|18282056|P4|Overall Study|Other|0
5304755|NCT00408434|18282057|P3|Overall Study|Other|1
5304756|NCT00408434|18282058|P2|Overall Study|Other|0
5304757|NCT00408434|18282059|P1|Overall Study|Other|0
5304758|NCT00408434|18282053|P7|Overall Study|Progressive disease|4
5304759|NCT00408434|18282054|P6|Overall Study|Progressive disease|1
5304760|NCT00408434|18282055|P5|Overall Study|Progressive disease|3
5304761|NCT00408434|18282056|P4|Overall Study|Progressive disease|3
5304762|NCT00408434|18282057|P3|Overall Study|Progressive disease|4
5304763|NCT00408434|18282058|P2|Overall Study|Progressive disease|3
5304764|NCT00408434|18282059|P1|Overall Study|Progressive disease|6
5304765|NCT00408434|18282053|P7|Overall Study|Adverse Event|0
5304766|NCT00408434|18282054|P6|Overall Study|Adverse Event|0
5304767|NCT00408434|18282055|P5|Overall Study|Adverse Event|0
5304768|NCT00408434|18282056|P4|Overall Study|Adverse Event|0
5304769|NCT00408434|18282057|P3|Overall Study|Adverse Event|1
5304770|NCT00408434|18282058|P2|Overall Study|Adverse Event|0
5304771|NCT00408434|18282059|P1|Overall Study|Adverse Event|0
5304772|NCT00408421|18282106|P3|Treatment Re-Randomization|Withdrawal by Subject|0
5304773|NCT00408421|18282107|P2|Treatment Re-Randomization|Withdrawal by Subject|1
5304774|NCT00408421|18282108|P1|Treatment Re-Randomization|Withdrawal by Subject|2
5304775|NCT00408421|18282106|P3|Treatment Re-Randomization|Protocol Violation|0
5304776|NCT00408421|18282107|P2|Treatment Re-Randomization|Protocol Violation|1
5304777|NCT00408421|18282108|P1|Treatment Re-Randomization|Protocol Violation|1
5304778|NCT00408421|18282106|P3|Treatment Re-Randomization|Physician Decision|0
5304779|NCT00408421|18282107|P2|Treatment Re-Randomization|Physician Decision|3
5304780|NCT00408421|18282108|P1|Treatment Re-Randomization|Physician Decision|1
5304781|NCT00408421|18282106|P3|Treatment Re-Randomization|Lost to Follow-up|1
5304782|NCT00408421|18282107|P2|Treatment Re-Randomization|Lost to Follow-up|0
5304783|NCT00408421|18282108|P1|Treatment Re-Randomization|Lost to Follow-up|0
5304784|NCT00408421|18282106|P3|Treatment Re-Randomization|Lack of Efficacy|0
5304785|NCT00408421|18282107|P2|Treatment Re-Randomization|Lack of Efficacy|0
5304786|NCT00408421|18282108|P1|Treatment Re-Randomization|Lack of Efficacy|1
5304787|NCT00408421|18282106|P3|Treatment Re-Randomization|Adverse Event|4
5304788|NCT00408421|18282107|P2|Treatment Re-Randomization|Adverse Event|2
5304789|NCT00408421|18282108|P1|Treatment Re-Randomization|Adverse Event|2
5304790|NCT00408421|18282106|P3|Treatment Initial Randomization|Sponsor Decision|0
5304791|NCT00408421|18282107|P2|Treatment Initial Randomization|Sponsor Decision|0
5304792|NCT00408421|18282108|P1|Treatment Initial Randomization|Sponsor Decision|1
5304793|NCT00408421|18282106|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
5304794|NCT00408421|18282107|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
5304795|NCT00408421|18282108|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
5304796|NCT00408421|18282106|P3|Treatment Initial Randomization|Withdrawal by Subject|0
5304797|NCT00408421|18282107|P2|Treatment Initial Randomization|Withdrawal by Subject|7
5304798|NCT00408421|18282108|P1|Treatment Initial Randomization|Withdrawal by Subject|7
5304799|NCT00408421|18282106|P3|Treatment Initial Randomization|Protocol Violation|0
5304800|NCT00408421|18282107|P2|Treatment Initial Randomization|Protocol Violation|1
5304801|NCT00408421|18282108|P1|Treatment Initial Randomization|Protocol Violation|0
5304802|NCT00408421|18282106|P3|Treatment Initial Randomization|Physician Decision|0
5304803|NCT00408421|18282107|P2|Treatment Initial Randomization|Physician Decision|0
5304804|NCT00408421|18282108|P1|Treatment Initial Randomization|Physician Decision|1
5304805|NCT00408421|18282106|P3|Treatment Initial Randomization|Lost to Follow-up|0
5304806|NCT00408421|18282107|P2|Treatment Initial Randomization|Lost to Follow-up|3
5304807|NCT00408421|18282108|P1|Treatment Initial Randomization|Lost to Follow-up|0
5304808|NCT00408421|18282106|P3|Treatment Initial Randomization|Lack of Efficacy|0
5304809|NCT00408421|18282107|P2|Treatment Initial Randomization|Lack of Efficacy|2
5304810|NCT00408421|18282108|P1|Treatment Initial Randomization|Lack of Efficacy|2
5304811|NCT00408421|18282106|P3|Treatment Initial Randomization|Adverse Event|0
5304812|NCT00408421|18282107|P2|Treatment Initial Randomization|Adverse Event|9
5304813|NCT00408421|18282108|P1|Treatment Initial Randomization|Adverse Event|5
5304814|NCT00408408|18282188|P6|Overall Study|No follow up data|3
5304815|NCT00408408|18282189|P5|Overall Study|No follow up data|5
5304816|NCT00408408|18282190|P4|Overall Study|No follow up data|7
5304817|NCT00408408|18282191|P3|Overall Study|No follow up data|0
5304818|NCT00408408|18282192|P2|Overall Study|No follow up data|3
5304819|NCT00408408|18282193|P1|Overall Study|No follow up data|2
5304820|NCT00408317|18282255|P2|Second Intervention Period|Withdrawal of consent|1
5304821|NCT00408317|18282256|P1|Second Intervention Period|Withdrawal of consent|0
5304822|NCT00408317|18282255|P2|Second Intervention Period|Protocol Violation|1
5304823|NCT00408317|18282256|P1|Second Intervention Period|Protocol Violation|0
5304824|NCT00408317|18282255|P2|Second Intervention Period|Adverse Event|0
5304825|NCT00408317|18282256|P1|Second Intervention Period|Adverse Event|2
5304826|NCT00408317|18282255|P2|First Intervention Period|Adverse Event|1
5304827|NCT00408317|18282256|P1|First Intervention Period|Adverse Event|0
5304828|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
5304829|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
5304830|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
5304831|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
5304832|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
5304833|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
5304834|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
5304835|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
5304836|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
5304837|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
5304838|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
5304839|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
5304840|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
5304841|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
5304842|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
5304843|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
5304844|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5304845|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5304846|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
5304847|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
5304848|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5304849|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5304850|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5304851|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5304852|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5304853|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5304854|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
5304855|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
5304856|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
5304857|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
5304858|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5304859|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5304860|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304861|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304862|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
5304863|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304864|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304865|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304866|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304867|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
5304868|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
5304869|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
5304870|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5304871|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
5304872|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5304873|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5304874|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5304875|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5304876|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5304877|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
5304878|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5304879|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
5304880|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
5304881|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
5304882|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5304883|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5304884|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304885|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304886|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304887|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
5304888|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304889|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304890|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304891|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5304892|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
5304893|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
5304894|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
5304895|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
5304896|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
5304897|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
5304898|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
5304899|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
5304900|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5304901|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5304902|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
5304903|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5304904|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
5304905|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
5304906|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5304907|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5304908|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
5304909|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
5304910|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
5304911|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
5304912|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
5304913|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
5304914|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
5304915|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
5304916|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5304917|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5304918|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5304919|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
5304920|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5304921|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
5304922|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5304923|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5304924|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Death|1
5304925|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Death|3
5304926|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Death|5
5304927|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Death|5
5304928|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Death|0
5304929|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Death|3
5304930|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Death|0
5304931|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Death|0
5304932|NCT00408005|18282289|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
5304933|NCT00408005|18282290|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
5304934|NCT00408005|18282291|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
5304935|NCT00408005|18282292|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
5304936|NCT00408005|18282293|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
5304937|NCT00408005|18282294|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
5304938|NCT00408005|18282295|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
5304939|NCT00408005|18282296|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
5304940|NCT00408005|18282289|P8|Induction|Recurrent leukemia|0
5304941|NCT00408005|18282290|P7|Induction|Recurrent leukemia|0
5304942|NCT00408005|18282291|P6|Induction|Recurrent leukemia|0
5304943|NCT00408005|18282292|P5|Induction|Recurrent leukemia|0
5304944|NCT00408005|18282293|P4|Induction|Recurrent leukemia|0
5304945|NCT00408005|18282294|P3|Induction|Recurrent leukemia|0
5304946|NCT00408005|18282295|P2|Induction|Recurrent leukemia|0
5304947|NCT00408005|18282296|P1|Induction|Recurrent leukemia|1
5304948|NCT00408005|18282289|P8|Induction|Hematopoietic Stem Cell Transplantation|0
5304949|NCT00408005|18282290|P7|Induction|Hematopoietic Stem Cell Transplantation|0
5304950|NCT00408005|18282291|P6|Induction|Hematopoietic Stem Cell Transplantation|0
5304951|NCT00408005|18282292|P5|Induction|Hematopoietic Stem Cell Transplantation|0
5304952|NCT00408005|18282293|P4|Induction|Hematopoietic Stem Cell Transplantation|0
5304953|NCT00408005|18282294|P3|Induction|Hematopoietic Stem Cell Transplantation|0
5304954|NCT00408005|18282295|P2|Induction|Hematopoietic Stem Cell Transplantation|0
5304955|NCT00408005|18282296|P1|Induction|Hematopoietic Stem Cell Transplantation|1
5304956|NCT00408005|18282289|P8|Induction|Protocol Deviation|0
5304957|NCT00408005|18282290|P7|Induction|Protocol Deviation|0
5304958|NCT00408005|18282291|P6|Induction|Protocol Deviation|0
5304959|NCT00408005|18282292|P5|Induction|Protocol Deviation|0
5304960|NCT00408005|18282293|P4|Induction|Protocol Deviation|0
5304961|NCT00408005|18282294|P3|Induction|Protocol Deviation|0
5304962|NCT00408005|18282295|P2|Induction|Protocol Deviation|1
5304963|NCT00408005|18282296|P1|Induction|Protocol Deviation|3
5304964|NCT00408005|18282289|P8|Induction|Failed to Complete Randomization|0
5304965|NCT00408005|18282290|P7|Induction|Failed to Complete Randomization|0
5304966|NCT00408005|18282291|P6|Induction|Failed to Complete Randomization|0
5304967|NCT00408005|18282292|P5|Induction|Failed to Complete Randomization|0
5304968|NCT00408005|18282293|P4|Induction|Failed to Complete Randomization|0
5304969|NCT00408005|18282294|P3|Induction|Failed to Complete Randomization|0
5304970|NCT00408005|18282295|P2|Induction|Failed to Complete Randomization|2
5304971|NCT00408005|18282296|P1|Induction|Failed to Complete Randomization|3
5304972|NCT00408005|18282289|P8|Induction|Inevaluable|0
5304973|NCT00408005|18282290|P7|Induction|Inevaluable|0
5304974|NCT00408005|18282291|P6|Induction|Inevaluable|0
5304975|NCT00408005|18282292|P5|Induction|Inevaluable|0
5304976|NCT00408005|18282293|P4|Induction|Inevaluable|0
5304977|NCT00408005|18282294|P3|Induction|Inevaluable|0
5304978|NCT00408005|18282295|P2|Induction|Inevaluable|14
5304979|NCT00408005|18282296|P1|Induction|Inevaluable|18
5304980|NCT00408005|18282289|P8|Induction|Progressive Disease|0
5304981|NCT00408005|18282290|P7|Induction|Progressive Disease|0
5304982|NCT00408005|18282291|P6|Induction|Progressive Disease|0
5304983|NCT00408005|18282292|P5|Induction|Progressive Disease|0
5304984|NCT00408005|18282293|P4|Induction|Progressive Disease|0
5304985|NCT00408005|18282294|P3|Induction|Progressive Disease|0
5304986|NCT00408005|18282295|P2|Induction|Progressive Disease|1
5304987|NCT00408005|18282296|P1|Induction|Progressive Disease|0
5304988|NCT00408005|18282289|P8|Induction|Identified as Philadelphia Chr. Positive|0
5304989|NCT00408005|18282290|P7|Induction|Identified as Philadelphia Chr. Positive|0
5304990|NCT00408005|18282291|P6|Induction|Identified as Philadelphia Chr. Positive|0
5304991|NCT00408005|18282292|P5|Induction|Identified as Philadelphia Chr. Positive|0
5304992|NCT00408005|18282293|P4|Induction|Identified as Philadelphia Chr. Positive|0
5304993|NCT00408005|18282294|P3|Induction|Identified as Philadelphia Chr. Positive|0
5304994|NCT00408005|18282295|P2|Induction|Identified as Philadelphia Chr. Positive|0
5304995|NCT00408005|18282296|P1|Induction|Identified as Philadelphia Chr. Positive|6
5304996|NCT00408005|18282289|P8|Induction|Patient transferred Tx to Non-COG Site|0
5304997|NCT00408005|18282290|P7|Induction|Patient transferred Tx to Non-COG Site|0
5304998|NCT00408005|18282291|P6|Induction|Patient transferred Tx to Non-COG Site|0
5304999|NCT00408005|18282292|P5|Induction|Patient transferred Tx to Non-COG Site|0
5305000|NCT00408005|18282293|P4|Induction|Patient transferred Tx to Non-COG Site|0
5305001|NCT00408005|18282294|P3|Induction|Patient transferred Tx to Non-COG Site|0
5305002|NCT00408005|18282295|P2|Induction|Patient transferred Tx to Non-COG Site|2
5305003|NCT00408005|18282296|P1|Induction|Patient transferred Tx to Non-COG Site|3
5305004|NCT00408005|18282289|P8|Induction|Entered another COG therapeutic protocol|0
5305005|NCT00408005|18282290|P7|Induction|Entered another COG therapeutic protocol|0
5305006|NCT00408005|18282291|P6|Induction|Entered another COG therapeutic protocol|0
5305007|NCT00408005|18282292|P5|Induction|Entered another COG therapeutic protocol|0
5305008|NCT00408005|18282293|P4|Induction|Entered another COG therapeutic protocol|0
5305009|NCT00408005|18282294|P3|Induction|Entered another COG therapeutic protocol|0
5305010|NCT00408005|18282295|P2|Induction|Entered another COG therapeutic protocol|0
5305011|NCT00408005|18282296|P1|Induction|Entered another COG therapeutic protocol|4
5305012|NCT00408005|18282289|P8|Induction|Refusal of Further Protocol Therapy|0
5305013|NCT00408005|18282290|P7|Induction|Refusal of Further Protocol Therapy|0
5305014|NCT00408005|18282291|P6|Induction|Refusal of Further Protocol Therapy|0
5305015|NCT00408005|18282292|P5|Induction|Refusal of Further Protocol Therapy|0
5305016|NCT00408005|18282293|P4|Induction|Refusal of Further Protocol Therapy|0
5305017|NCT00408005|18282294|P3|Induction|Refusal of Further Protocol Therapy|0
5305018|NCT00408005|18282295|P2|Induction|Refusal of Further Protocol Therapy|44
5305019|NCT00408005|18282296|P1|Induction|Refusal of Further Protocol Therapy|225
5305020|NCT00408005|18282289|P8|Induction|Ineligible|0
5305021|NCT00408005|18282290|P7|Induction|Ineligible|0
5305022|NCT00408005|18282291|P6|Induction|Ineligible|0
5305023|NCT00408005|18282292|P5|Induction|Ineligible|0
5305024|NCT00408005|18282293|P4|Induction|Ineligible|0
5305025|NCT00408005|18282294|P3|Induction|Ineligible|0
5305026|NCT00408005|18282295|P2|Induction|Ineligible|14
5305027|NCT00408005|18282296|P1|Induction|Ineligible|33
5305028|NCT00408005|18282289|P8|Induction|Withdrawal by Subject|0
5305029|NCT00408005|18282290|P7|Induction|Withdrawal by Subject|0
5305030|NCT00408005|18282291|P6|Induction|Withdrawal by Subject|0
5305031|NCT00408005|18282292|P5|Induction|Withdrawal by Subject|0
5305032|NCT00408005|18282293|P4|Induction|Withdrawal by Subject|0
5305033|NCT00408005|18282294|P3|Induction|Withdrawal by Subject|0
5305034|NCT00408005|18282295|P2|Induction|Withdrawal by Subject|4
5305035|NCT00408005|18282296|P1|Induction|Withdrawal by Subject|2
5305036|NCT00408005|18282289|P8|Induction|Physician Decision|0
5305037|NCT00408005|18282290|P7|Induction|Physician Decision|0
5305038|NCT00408005|18282291|P6|Induction|Physician Decision|0
5305039|NCT00408005|18282292|P5|Induction|Physician Decision|0
5305040|NCT00408005|18282293|P4|Induction|Physician Decision|0
5305041|NCT00408005|18282294|P3|Induction|Physician Decision|0
5305042|NCT00408005|18282295|P2|Induction|Physician Decision|9
5305043|NCT00408005|18282296|P1|Induction|Physician Decision|83
5305044|NCT00408005|18282289|P8|Induction|Death|0
5305045|NCT00408005|18282290|P7|Induction|Death|0
5305046|NCT00408005|18282291|P6|Induction|Death|0
5305047|NCT00408005|18282292|P5|Induction|Death|0
5305048|NCT00408005|18282293|P4|Induction|Death|0
5305049|NCT00408005|18282294|P3|Induction|Death|0
5305050|NCT00408005|18282295|P2|Induction|Death|0
5305051|NCT00408005|18282296|P1|Induction|Death|6
5305052|NCT00408005|18282289|P8|Induction|Adverse Event|0
5305053|NCT00408005|18282290|P7|Induction|Adverse Event|0
5305054|NCT00408005|18282291|P6|Induction|Adverse Event|0
5305055|NCT00408005|18282292|P5|Induction|Adverse Event|0
5305056|NCT00408005|18282293|P4|Induction|Adverse Event|0
5305057|NCT00408005|18282294|P3|Induction|Adverse Event|0
5305058|NCT00408005|18282295|P2|Induction|Adverse Event|3
5305059|NCT00408005|18282296|P1|Induction|Adverse Event|19
5305060|NCT00407797|18282338|P1|Overall Study|Withdrawal by Subject|3
5305061|NCT00407797|18282338|P1|Overall Study|Other|7
5305062|NCT00407797|18282338|P1|Overall Study|Adverse Event|6
5305063|NCT00407797|18282338|P1|Overall Study|Lost to Follow-up|2
5305064|NCT00407758|18282353|P1|Overall Study|ineligible -improper prior treatment|1
5305065|NCT00407745|18282366|P2|Overall Study|Randomized, unknown if treated|1
5305066|NCT00407745|18282367|P1|Overall Study|Randomized, unknown if treated|0
5305067|NCT00407745|18282366|P2|Overall Study|Other|0
5305068|NCT00407745|18282367|P1|Overall Study|Other|2
5305069|NCT00407745|18282366|P2|Overall Study|Adverse Event|8
5305070|NCT00407745|18282367|P1|Overall Study|Adverse Event|8
5305071|NCT00407745|18282366|P2|Overall Study|Protocol Violation|3
5305072|NCT00407745|18282367|P1|Overall Study|Protocol Violation|5
5305073|NCT00407745|18282366|P2|Overall Study|Withdrawal by Subject|3
5305074|NCT00407745|18282367|P1|Overall Study|Withdrawal by Subject|3
5305075|NCT00407745|18282366|P2|Overall Study|Lack of Efficacy|2
5305076|NCT00407745|18282367|P1|Overall Study|Lack of Efficacy|1
5305077|NCT00407563|18282453|P1|Overall Study|Patient continues on treatment|1
5305078|NCT00407550|18282463|P2|Overall Study|Insurance or Other medical condition|1
5305079|NCT00407550|18282464|P1|Overall Study|Insurance or Other medical condition|2
5305080|NCT00407550|18282463|P2|Overall Study|Death|0
5305081|NCT00407550|18282464|P1|Overall Study|Death|1
5305082|NCT00407550|18282463|P2|Overall Study|Withdrawal by Subject|2
5305083|NCT00407550|18282464|P1|Overall Study|Withdrawal by Subject|0
5305084|NCT00407550|18282463|P2|Overall Study|Adverse Event|1
5305085|NCT00407550|18282464|P1|Overall Study|Adverse Event|0
5305086|NCT00407537|18282478|P2|Overall Study|Withdrawal by Subject|16
5305087|NCT00407537|18282479|P1|Overall Study|Withdrawal by Subject|34
5305088|NCT00407537|18282478|P2|Overall Study|Other|7
5305089|NCT00407537|18282479|P1|Overall Study|Other|6
5305090|NCT00407537|18282478|P2|Overall Study|Lost to Follow-up|19
5305091|NCT00407537|18282479|P1|Overall Study|Lost to Follow-up|12
5305092|NCT00407537|18282478|P2|Overall Study|Adverse Event|0
5305093|NCT00407537|18282479|P1|Overall Study|Adverse Event|36
5305094|NCT00407537|18282478|P2|Overall Study|Death|2
5305095|NCT00407537|18282479|P1|Overall Study|Death|5
5305096|NCT00407511|18282527|P1|Overall Study|Withdrawal by Subject|4
5305097|NCT00407511|18282527|P1|Overall Study|Other|5
5305098|NCT00407511|18282527|P1|Overall Study|Lost to Follow-up|4
5305099|NCT00407511|18282527|P1|Overall Study|Adverse Event|9
5305100|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Physician Decision|0
5305101|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Physician Decision|2
5305102|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Physician Decision|1
5305103|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Patient Decision|0
5305104|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Patient Decision|2
5305105|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Patient Decision|1
5305106|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
5305107|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
5305108|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
5305109|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
5305110|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
5305111|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
5305112|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Adverse Event|0
5305113|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Adverse Event|0
5305114|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Adverse Event|1
5305115|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
5305116|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
5305117|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
5305118|NCT00407030|18282588|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
5305119|NCT00407030|18282589|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
5305120|NCT00407030|18282590|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
5305121|NCT00407030|18282588|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
5305122|NCT00407030|18282589|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
5305123|NCT00407030|18282590|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
5305124|NCT00407030|18282588|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
5305125|NCT00407030|18282589|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
5305126|NCT00407030|18282590|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
5305127|NCT00407030|18282588|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
5305128|NCT00407030|18282589|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
5305129|NCT00407030|18282590|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
5305130|NCT00407030|18282588|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
5305131|NCT00407030|18282589|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
5305132|NCT00407030|18282590|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
5305133|NCT00407030|18282588|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
5305134|NCT00407030|18282589|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
5305135|NCT00407030|18282590|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
5305136|NCT00407030|18282588|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
5305137|NCT00407030|18282589|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
5305138|NCT00407030|18282590|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
5305139|NCT00406848|18282618|P2|Overall Study|Sponsor Decision|1
5305140|NCT00406848|18282619|P1|Overall Study|Sponsor Decision|1
5305141|NCT00406848|18282618|P2|Overall Study|Physician Decision|2
5305142|NCT00406848|18282619|P1|Overall Study|Physician Decision|2
5305143|NCT00406848|18282618|P2|Overall Study|Lost to Follow-up|2
5305144|NCT00406848|18282619|P1|Overall Study|Lost to Follow-up|6
5305145|NCT00406848|18282618|P2|Overall Study|Protocol Violation|6
5305146|NCT00406848|18282619|P1|Overall Study|Protocol Violation|10
5305147|NCT00406848|18282618|P2|Overall Study|Lack of Efficacy|14
5305148|NCT00406848|18282619|P1|Overall Study|Lack of Efficacy|9
5305149|NCT00406848|18282618|P2|Overall Study|Adverse Event|7
5305150|NCT00406848|18282619|P1|Overall Study|Adverse Event|38
5305151|NCT00406848|18282618|P2|Overall Study|Withdrawal by Subject|22
5305152|NCT00406848|18282619|P1|Overall Study|Withdrawal by Subject|27
5305153|NCT00406783|18282683|P2|Overall Study|Protocol Violation|4
5305154|NCT00406783|18282684|P1|Overall Study|Protocol Violation|4
5305155|NCT00406783|18282683|P2|Overall Study|Withdrawal by Subject|4
5305156|NCT00406783|18282684|P1|Overall Study|Withdrawal by Subject|1
5305157|NCT00406783|18282683|P2|Overall Study|Lost to Follow-up|0
5305158|NCT00406783|18282684|P1|Overall Study|Lost to Follow-up|3
5305159|NCT00406783|18282683|P2|Overall Study|Treatment Failure|3
5305160|NCT00406783|18282684|P1|Overall Study|Treatment Failure|2
5305161|NCT00406783|18282683|P2|Overall Study|Adverse Event|4
5305162|NCT00406783|18282684|P1|Overall Study|Adverse Event|4
5305163|NCT00406718|18282699|P3|Overall Study|Lost to Follow-up|4
5305164|NCT00406718|18282700|P2|Overall Study|Lost to Follow-up|5
5305165|NCT00406718|18282701|P1|Overall Study|Lost to Follow-up|2
5305166|NCT00406718|18282699|P3|Overall Study|Withdrawal by Subject|4
5305167|NCT00406718|18282700|P2|Overall Study|Withdrawal by Subject|9
5305168|NCT00406718|18282701|P1|Overall Study|Withdrawal by Subject|2
5305169|NCT00406692|18282715|P1|Overall Study|Lack of Efficacy|1
5305170|NCT00406692|18282715|P1|Overall Study|Adverse Event|1
5305171|NCT00406692|18282715|P1|Overall Study|Physician Decision|1
5305172|NCT00406692|18282715|P1|Overall Study|Withdrawal by Subject|4
5305173|NCT00406653|18282725|P7|Open-Label Period|Refused followup|1
5305174|NCT00406653|18282726|P6|Open-Label Period|Refused followup|0
5305175|NCT00406653|18282727|P5|Open-Label Period|Refused followup|0
5305176|NCT00406653|18282728|P4|Open-Label Period|Refused followup|0
5305177|NCT00406653|18282729|P3|Open-Label Period|Refused followup|0
5305178|NCT00406653|18282730|P2|Open-Label Period|Refused followup|0
5305179|NCT00406653|18282731|P1|Open-Label Period|Refused followup|0
5305180|NCT00406653|18282725|P7|Open-Label Period|Discontinued by Sponsor|1
5305181|NCT00406653|18282726|P6|Open-Label Period|Discontinued by Sponsor|0
5305182|NCT00406653|18282727|P5|Open-Label Period|Discontinued by Sponsor|0
5305183|NCT00406653|18282728|P4|Open-Label Period|Discontinued by Sponsor|0
5305184|NCT00406653|18282729|P3|Open-Label Period|Discontinued by Sponsor|0
5305185|NCT00406653|18282730|P2|Open-Label Period|Discontinued by Sponsor|0
5305186|NCT00406653|18282731|P1|Open-Label Period|Discontinued by Sponsor|0
5305187|NCT00406653|18282725|P7|Open-Label Period|Declined participation but followup done|8
5305188|NCT00406653|18282726|P6|Open-Label Period|Declined participation but followup done|0
5305189|NCT00406653|18282727|P5|Open-Label Period|Declined participation but followup done|0
5305190|NCT00406653|18282728|P4|Open-Label Period|Declined participation but followup done|0
5305191|NCT00406653|18282729|P3|Open-Label Period|Declined participation but followup done|0
5305192|NCT00406653|18282730|P2|Open-Label Period|Declined participation but followup done|0
5305193|NCT00406653|18282731|P1|Open-Label Period|Declined participation but followup done|0
5305194|NCT00406653|18282725|P7|Open-Label Period|Administrative Reason By Sponsor|115
5305195|NCT00406653|18282726|P6|Open-Label Period|Administrative Reason By Sponsor|0
5305196|NCT00406653|18282727|P5|Open-Label Period|Administrative Reason By Sponsor|0
5305197|NCT00406653|18282728|P4|Open-Label Period|Administrative Reason By Sponsor|0
5305198|NCT00406653|18282729|P3|Open-Label Period|Administrative Reason By Sponsor|0
5305199|NCT00406653|18282730|P2|Open-Label Period|Administrative Reason By Sponsor|0
5305200|NCT00406653|18282731|P1|Open-Label Period|Administrative Reason By Sponsor|0
5305201|NCT00406653|18282725|P7|Open-Label Period|Pregnancy|2
5305202|NCT00406653|18282726|P6|Open-Label Period|Pregnancy|0
5305203|NCT00406653|18282727|P5|Open-Label Period|Pregnancy|0
5305204|NCT00406653|18282728|P4|Open-Label Period|Pregnancy|0
5305205|NCT00406653|18282729|P3|Open-Label Period|Pregnancy|0
5305206|NCT00406653|18282730|P2|Open-Label Period|Pregnancy|0
5305207|NCT00406653|18282731|P1|Open-Label Period|Pregnancy|0
5305208|NCT00406653|18282725|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
5305209|NCT00406653|18282726|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
5305210|NCT00406653|18282727|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
5305211|NCT00406653|18282728|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
5305212|NCT00406653|18282729|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
5305213|NCT00406653|18282730|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
5305214|NCT00406653|18282731|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
5305215|NCT00406653|18282725|P7|Open-Label Period|Withdrawal of Consent|11
5305216|NCT00406653|18282726|P6|Open-Label Period|Withdrawal of Consent|0
5305217|NCT00406653|18282727|P5|Open-Label Period|Withdrawal of Consent|0
5305218|NCT00406653|18282728|P4|Open-Label Period|Withdrawal of Consent|0
5305219|NCT00406653|18282729|P3|Open-Label Period|Withdrawal of Consent|0
5305220|NCT00406653|18282730|P2|Open-Label Period|Withdrawal of Consent|0
5305221|NCT00406653|18282731|P1|Open-Label Period|Withdrawal of Consent|0
5305222|NCT00406653|18282725|P7|Open-Label Period|Lost to Follow-up|6
5305223|NCT00406653|18282726|P6|Open-Label Period|Lost to Follow-up|0
5305224|NCT00406653|18282727|P5|Open-Label Period|Lost to Follow-up|0
5305225|NCT00406653|18282728|P4|Open-Label Period|Lost to Follow-up|0
5305226|NCT00406653|18282729|P3|Open-Label Period|Lost to Follow-up|0
5305227|NCT00406653|18282730|P2|Open-Label Period|Lost to Follow-up|0
5305228|NCT00406653|18282731|P1|Open-Label Period|Lost to Follow-up|0
5305229|NCT00406653|18282725|P7|Open-Label Period|Lack of Efficacy|160
5305230|NCT00406653|18282726|P6|Open-Label Period|Lack of Efficacy|0
5305231|NCT00406653|18282727|P5|Open-Label Period|Lack of Efficacy|0
5305232|NCT00406653|18282728|P4|Open-Label Period|Lack of Efficacy|0
5305233|NCT00406653|18282729|P3|Open-Label Period|Lack of Efficacy|0
5305234|NCT00406653|18282730|P2|Open-Label Period|Lack of Efficacy|0
5305235|NCT00406653|18282731|P1|Open-Label Period|Lack of Efficacy|0
5305236|NCT00406653|18282725|P7|Open-Label Period|Adverse Event|18
5305237|NCT00406653|18282726|P6|Open-Label Period|Adverse Event|0
5305238|NCT00406653|18282727|P5|Open-Label Period|Adverse Event|0
5305239|NCT00406653|18282728|P4|Open-Label Period|Adverse Event|0
5305240|NCT00406653|18282729|P3|Open-Label Period|Adverse Event|0
5305241|NCT00406653|18282730|P2|Open-Label Period|Adverse Event|0
5305242|NCT00406653|18282731|P1|Open-Label Period|Adverse Event|0
5305243|NCT00406653|18282725|P7|Open-Label Period|Death|1
5305244|NCT00406653|18282726|P6|Open-Label Period|Death|0
5305245|NCT00406653|18282727|P5|Open-Label Period|Death|0
5305246|NCT00406653|18282728|P4|Open-Label Period|Death|0
5305247|NCT00406653|18282729|P3|Open-Label Period|Death|0
5305248|NCT00406653|18282730|P2|Open-Label Period|Death|0
5305249|NCT00406653|18282731|P1|Open-Label Period|Death|0
5305250|NCT00406653|18282725|P7|Maintenance Period|Error in disease score evaluation|0
5305251|NCT00406653|18282726|P6|Maintenance Period|Error in disease score evaluation|0
5305252|NCT00406653|18282727|P5|Maintenance Period|Error in disease score evaluation|1
5305253|NCT00406653|18282728|P4|Maintenance Period|Error in disease score evaluation|0
5305254|NCT00406653|18282729|P3|Maintenance Period|Error in disease score evaluation|0
5305255|NCT00406653|18282730|P2|Maintenance Period|Error in disease score evaluation|0
5305256|NCT00406653|18282731|P1|Maintenance Period|Error in disease score evaluation|0
5305257|NCT00406653|18282725|P7|Maintenance Period|Administrative Reason By Sponsor|0
5305258|NCT00406653|18282726|P6|Maintenance Period|Administrative Reason By Sponsor|7
5305259|NCT00406653|18282727|P5|Maintenance Period|Administrative Reason By Sponsor|4
5305260|NCT00406653|18282728|P4|Maintenance Period|Administrative Reason By Sponsor|0
5305261|NCT00406653|18282729|P3|Maintenance Period|Administrative Reason By Sponsor|0
5305262|NCT00406653|18282730|P2|Maintenance Period|Administrative Reason By Sponsor|0
5305263|NCT00406653|18282731|P1|Maintenance Period|Administrative Reason By Sponsor|0
5305264|NCT00406653|18282725|P7|Maintenance Period|Pregnancy|0
5305265|NCT00406653|18282726|P6|Maintenance Period|Pregnancy|1
5305266|NCT00406653|18282727|P5|Maintenance Period|Pregnancy|0
5305267|NCT00406653|18282728|P4|Maintenance Period|Pregnancy|0
5305268|NCT00406653|18282729|P3|Maintenance Period|Pregnancy|0
5305269|NCT00406653|18282730|P2|Maintenance Period|Pregnancy|0
5305270|NCT00406653|18282731|P1|Maintenance Period|Pregnancy|0
5305271|NCT00406653|18282725|P7|Maintenance Period|Withdrawal of Consent|0
5305272|NCT00406653|18282726|P6|Maintenance Period|Withdrawal of Consent|0
5305273|NCT00406653|18282727|P5|Maintenance Period|Withdrawal of Consent|2
5305274|NCT00406653|18282728|P4|Maintenance Period|Withdrawal of Consent|0
5305275|NCT00406653|18282729|P3|Maintenance Period|Withdrawal of Consent|0
5305276|NCT00406653|18282730|P2|Maintenance Period|Withdrawal of Consent|0
5305277|NCT00406653|18282731|P1|Maintenance Period|Withdrawal of Consent|0
5305278|NCT00406653|18282725|P7|Maintenance Period|Lost to Follow-up|0
5305279|NCT00406653|18282726|P6|Maintenance Period|Lost to Follow-up|1
5305280|NCT00406653|18282727|P5|Maintenance Period|Lost to Follow-up|2
5305281|NCT00406653|18282728|P4|Maintenance Period|Lost to Follow-up|0
5305282|NCT00406653|18282729|P3|Maintenance Period|Lost to Follow-up|0
5305283|NCT00406653|18282730|P2|Maintenance Period|Lost to Follow-up|0
5305284|NCT00406653|18282731|P1|Maintenance Period|Lost to Follow-up|0
5305285|NCT00406653|18282725|P7|Maintenance Period|Lack of Efficacy|0
5305286|NCT00406653|18282726|P6|Maintenance Period|Lack of Efficacy|26
5305287|NCT00406653|18282727|P5|Maintenance Period|Lack of Efficacy|20
5305288|NCT00406653|18282728|P4|Maintenance Period|Lack of Efficacy|0
5305289|NCT00406653|18282729|P3|Maintenance Period|Lack of Efficacy|0
5305290|NCT00406653|18282730|P2|Maintenance Period|Lack of Efficacy|0
5305291|NCT00406653|18282731|P1|Maintenance Period|Lack of Efficacy|0
5305292|NCT00406653|18282725|P7|Maintenance Period|Adverse Event|0
5305293|NCT00406653|18282726|P6|Maintenance Period|Adverse Event|1
5305294|NCT00406653|18282727|P5|Maintenance Period|Adverse Event|1
5305295|NCT00406653|18282728|P4|Maintenance Period|Adverse Event|0
5305296|NCT00406653|18282729|P3|Maintenance Period|Adverse Event|0
5305297|NCT00406653|18282730|P2|Maintenance Period|Adverse Event|0
5305298|NCT00406653|18282731|P1|Maintenance Period|Adverse Event|0
5305299|NCT00406653|18282725|P7|Induction Period|Patient relocated|0
5305300|NCT00406653|18282726|P6|Induction Period|Patient relocated|0
5305301|NCT00406653|18282727|P5|Induction Period|Patient relocated|0
5305302|NCT00406653|18282728|P4|Induction Period|Patient relocated|0
5305303|NCT00406653|18282729|P3|Induction Period|Patient relocated|1
5305304|NCT00406653|18282730|P2|Induction Period|Patient relocated|0
5305305|NCT00406653|18282731|P1|Induction Period|Patient relocated|0
5305306|NCT00406653|18282725|P7|Induction Period|Incarcerated|0
5305307|NCT00406653|18282726|P6|Induction Period|Incarcerated|0
5305308|NCT00406653|18282727|P5|Induction Period|Incarcerated|0
5305309|NCT00406653|18282728|P4|Induction Period|Incarcerated|0
5305310|NCT00406653|18282729|P3|Induction Period|Incarcerated|1
5305311|NCT00406653|18282730|P2|Induction Period|Incarcerated|0
5305312|NCT00406653|18282731|P1|Induction Period|Incarcerated|0
5305313|NCT00406653|18282725|P7|Induction Period|Given prohibited drug|0
5305314|NCT00406653|18282726|P6|Induction Period|Given prohibited drug|0
5305315|NCT00406653|18282727|P5|Induction Period|Given prohibited drug|0
5305316|NCT00406653|18282728|P4|Induction Period|Given prohibited drug|0
5305317|NCT00406653|18282729|P3|Induction Period|Given prohibited drug|2
5305318|NCT00406653|18282730|P2|Induction Period|Given prohibited drug|1
5305319|NCT00406653|18282731|P1|Induction Period|Given prohibited drug|0
5305320|NCT00406653|18282725|P7|Induction Period|Declined participation but followup done|0
5305321|NCT00406653|18282726|P6|Induction Period|Declined participation but followup done|0
5305322|NCT00406653|18282727|P5|Induction Period|Declined participation but followup done|0
5305323|NCT00406653|18282728|P4|Induction Period|Declined participation but followup done|1
5305324|NCT00406653|18282729|P3|Induction Period|Declined participation but followup done|1
5305325|NCT00406653|18282730|P2|Induction Period|Declined participation but followup done|2
5305326|NCT00406653|18282731|P1|Induction Period|Declined participation but followup done|0
5305327|NCT00406653|18282725|P7|Induction Period|Pregnancy|0
5305328|NCT00406653|18282726|P6|Induction Period|Pregnancy|0
5305329|NCT00406653|18282727|P5|Induction Period|Pregnancy|0
5305330|NCT00406653|18282728|P4|Induction Period|Pregnancy|0
5305331|NCT00406653|18282729|P3|Induction Period|Pregnancy|0
5305332|NCT00406653|18282730|P2|Induction Period|Pregnancy|0
5305333|NCT00406653|18282731|P1|Induction Period|Pregnancy|1
5305334|NCT00406653|18282725|P7|Induction Period|Subject No Longer Meets Study Criteria|0
5305335|NCT00406653|18282726|P6|Induction Period|Subject No Longer Meets Study Criteria|0
5305336|NCT00406653|18282727|P5|Induction Period|Subject No Longer Meets Study Criteria|0
5305337|NCT00406653|18282728|P4|Induction Period|Subject No Longer Meets Study Criteria|2
5305338|NCT00406653|18282729|P3|Induction Period|Subject No Longer Meets Study Criteria|0
5305339|NCT00406653|18282730|P2|Induction Period|Subject No Longer Meets Study Criteria|0
5305340|NCT00406653|18282731|P1|Induction Period|Subject No Longer Meets Study Criteria|0
5305341|NCT00406653|18282725|P7|Induction Period|Withdrawal of Consent|0
5305342|NCT00406653|18282726|P6|Induction Period|Withdrawal of Consent|0
5305343|NCT00406653|18282727|P5|Induction Period|Withdrawal of Consent|0
5305344|NCT00406653|18282728|P4|Induction Period|Withdrawal of Consent|2
5305345|NCT00406653|18282729|P3|Induction Period|Withdrawal of Consent|1
5305346|NCT00406653|18282730|P2|Induction Period|Withdrawal of Consent|5
5305347|NCT00406653|18282731|P1|Induction Period|Withdrawal of Consent|2
5305348|NCT00406653|18282725|P7|Induction Period|Lost to Follow-up|0
5305349|NCT00406653|18282726|P6|Induction Period|Lost to Follow-up|0
5305350|NCT00406653|18282727|P5|Induction Period|Lost to Follow-up|0
5305351|NCT00406653|18282728|P4|Induction Period|Lost to Follow-up|0
5305352|NCT00406653|18282729|P3|Induction Period|Lost to Follow-up|0
5305353|NCT00406653|18282730|P2|Induction Period|Lost to Follow-up|2
5305354|NCT00406653|18282731|P1|Induction Period|Lost to Follow-up|0
5305355|NCT00406653|18282725|P7|Induction Period|Lack of Efficacy|0
5305356|NCT00406653|18282726|P6|Induction Period|Lack of Efficacy|0
5305357|NCT00406653|18282727|P5|Induction Period|Lack of Efficacy|0
5305358|NCT00406653|18282728|P4|Induction Period|Lack of Efficacy|10
5305359|NCT00406653|18282729|P3|Induction Period|Lack of Efficacy|8
5305360|NCT00406653|18282730|P2|Induction Period|Lack of Efficacy|14
5305361|NCT00406653|18282731|P1|Induction Period|Lack of Efficacy|11
5305362|NCT00406653|18282725|P7|Induction Period|Adverse Event|0
5305363|NCT00406653|18282726|P6|Induction Period|Adverse Event|0
5305364|NCT00406653|18282727|P5|Induction Period|Adverse Event|0
5305365|NCT00406653|18282728|P4|Induction Period|Adverse Event|11
5305366|NCT00406653|18282729|P3|Induction Period|Adverse Event|4
5305367|NCT00406653|18282730|P2|Induction Period|Adverse Event|10
5305368|NCT00406653|18282731|P1|Induction Period|Adverse Event|1
5305369|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
5305370|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
5305371|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
5305372|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
5305373|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|non-compliance|2
5305374|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|non-compliance|3
5305375|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
5305376|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
5305377|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|Physician Decision|0
5305378|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|Physician Decision|1
5305379|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|Failed to Return|0
5305380|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|Failed to Return|1
5305381|NCT00406640|18282812|P2|OL Extension Phase for Non-Responders|Adverse Event|6
5305382|NCT00406640|18282813|P1|OL Extension Phase for Non-Responders|Adverse Event|6
5305383|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
5305384|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
5305385|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
5305386|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
5305387|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Protocol Violation|2
5305388|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Protocol Violation|2
5305389|NCT00406640|18282812|P2|DB Continuation Phase for Responders|non-compliance|5
5305390|NCT00406640|18282813|P1|DB Continuation Phase for Responders|non-compliance|7
5305391|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
5305392|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
5305393|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Physician Decision|3
5305394|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Physician Decision|2
5305395|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Failed to Return|2
5305396|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Failed to Return|0
5305397|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Death|0
5305398|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Death|1
5305399|NCT00406640|18282812|P2|DB Continuation Phase for Responders|Adverse Event|11
5305400|NCT00406640|18282813|P1|DB Continuation Phase for Responders|Adverse Event|11
5305401|NCT00406640|18282812|P2|Acute Phase|Lack of Efficacy|3
5305402|NCT00406640|18282813|P1|Acute Phase|Lack of Efficacy|3
5305403|NCT00406640|18282812|P2|Acute Phase|Withdrawal by Subject|9
5305404|NCT00406640|18282813|P1|Acute Phase|Withdrawal by Subject|11
5305405|NCT00406640|18282812|P2|Acute Phase|Protocol Violation|2
5305406|NCT00406640|18282813|P1|Acute Phase|Protocol Violation|3
5305407|NCT00406640|18282812|P2|Acute Phase|Protocol deviation|10
5305408|NCT00406640|18282813|P1|Acute Phase|Protocol deviation|4
5305409|NCT00406640|18282812|P2|Acute Phase|Lost to Follow-up|4
5305410|NCT00406640|18282813|P1|Acute Phase|Lost to Follow-up|7
5305411|NCT00406640|18282812|P2|Acute Phase|Physician Decision|1
5305412|NCT00406640|18282813|P1|Acute Phase|Physician Decision|0
5305413|NCT00406640|18282812|P2|Acute Phase|Failed to Return|1
5305414|NCT00406640|18282813|P1|Acute Phase|Failed to Return|5
5305415|NCT00406640|18282812|P2|Acute Phase|Adverse Event|13
5305416|NCT00406640|18282813|P1|Acute Phase|Adverse Event|18
5305417|NCT00406419|18282846|P3|Overall Study|Lost to Follow-up|5
5305418|NCT00406419|18282847|P2|Overall Study|Lost to Follow-up|10
5305419|NCT00406419|18282848|P1|Overall Study|Lost to Follow-up|11
5305420|NCT00406419|18282846|P3|Overall Study|Adverse Event|16
5305421|NCT00406419|18282847|P2|Overall Study|Adverse Event|12
5305422|NCT00406419|18282848|P1|Overall Study|Adverse Event|10
5305423|NCT00406419|18282846|P3|Overall Study|Non-Compliance with Study Drug|3
5305424|NCT00406419|18282847|P2|Overall Study|Non-Compliance with Study Drug|6
5305425|NCT00406419|18282848|P1|Overall Study|Non-Compliance with Study Drug|5
5305426|NCT00406419|18282846|P3|Overall Study|Lack of Efficacy|6
5305427|NCT00406419|18282847|P2|Overall Study|Lack of Efficacy|1
5305428|NCT00406419|18282848|P1|Overall Study|Lack of Efficacy|12
5305429|NCT00406419|18282846|P3|Overall Study|Withdrawal by Subject|26
5305430|NCT00406419|18282847|P2|Overall Study|Withdrawal by Subject|24
5305431|NCT00406419|18282848|P1|Overall Study|Withdrawal by Subject|17
5305432|NCT00406419|18282846|P3|Overall Study|Study Terminated by Sponsor|282
5305433|NCT00406419|18282847|P2|Overall Study|Study Terminated by Sponsor|288
5305434|NCT00406419|18282848|P1|Overall Study|Study Terminated by Sponsor|260
5305435|NCT00406419|18282846|P3|Overall Study|Protocol Violation|5
5305436|NCT00406419|18282847|P2|Overall Study|Protocol Violation|2
5305437|NCT00406419|18282848|P1|Overall Study|Protocol Violation|6
5305438|NCT00406419|18282846|P3|Overall Study|Death|4
5305439|NCT00406419|18282847|P2|Overall Study|Death|1
5305440|NCT00406419|18282848|P1|Overall Study|Death|3
5305441|NCT00406393|18282933|P2|Overall Study|Did not undergo transplantation|1
5305442|NCT00406393|18282934|P1|Overall Study|Did not undergo transplantation|2
5305443|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
5305444|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
5305445|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
5305446|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
5305447|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
5305448|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
5305449|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
5305450|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
5305451|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
5305452|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
5305453|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
5305454|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
5305455|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
5305456|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
5305457|NCT00406367|18282964|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
5305458|NCT00406367|18282965|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
5305459|NCT00406367|18282964|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
5305460|NCT00406367|18282965|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
5305461|NCT00406367|18282964|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
5305462|NCT00406367|18282965|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
5305463|NCT00406367|18282964|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
5305464|NCT00406367|18282965|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
5305465|NCT00406367|18282964|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
5305466|NCT00406367|18282965|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
5305467|NCT00406354|18282980|P3|All Randomized and Treated Patients|Physician Decision|1
5305468|NCT00406354|18282981|P2|All Randomized and Treated Patients|Physician Decision|0
5305469|NCT00406354|18282982|P1|All Randomized and Treated Patients|Physician Decision|0
5305470|NCT00406354|18282980|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
5305471|NCT00406354|18282981|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
5305472|NCT00406354|18282982|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
5305473|NCT00406354|18282980|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
5305474|NCT00406354|18282981|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
5305475|NCT00406354|18282982|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
5305476|NCT00406354|18282980|P3|All Randomized and Treated Patients|Adverse Event|1
5305477|NCT00406354|18282981|P2|All Randomized and Treated Patients|Adverse Event|2
5305478|NCT00406354|18282982|P1|All Randomized and Treated Patients|Adverse Event|6
5305479|NCT00406354|18282980|P3|All Randomized and Treated Patients|Lack of Efficacy|17
5305480|NCT00406354|18282981|P2|All Randomized and Treated Patients|Lack of Efficacy|4
5305481|NCT00406354|18282982|P1|All Randomized and Treated Patients|Lack of Efficacy|7
5305482|NCT00406354|18282980|P3|All Randomized Patients|Protocol Violation|1
5305483|NCT00406354|18282981|P2|All Randomized Patients|Protocol Violation|0
5305484|NCT00406354|18282982|P1|All Randomized Patients|Protocol Violation|0
5305485|NCT00406315|18283053|P1|Overall Study|Withdrawal by Subject|30
5305486|NCT00406315|18283053|P1|Overall Study|Lost to Follow-up|21
5305487|NCT00406315|18283053|P1|Overall Study|Other|33
5305488|NCT00406315|18283053|P1|Overall Study|Lack of Efficacy|13
5305489|NCT00406315|18283053|P1|Overall Study|Laboratory Abnormality|4
5305490|NCT00406315|18283053|P1|Overall Study|Adverse Event|39
5305491|NCT00406315|18283053|P1|Overall Study|Death|1
5305492|NCT00406029|18283163|P5|Overall Study|Randomized in Error|1
5305493|NCT00406029|18283164|P4|Overall Study|Randomized in Error|3
5305494|NCT00406029|18283165|P3|Overall Study|Randomized in Error|2
5305495|NCT00406029|18283166|P2|Overall Study|Randomized in Error|0
5305496|NCT00406029|18283167|P1|Overall Study|Randomized in Error|0
5305497|NCT00406029|18283163|P5|Overall Study|Did Not Meet Eligibility Criteria|0
5305498|NCT00406029|18283164|P4|Overall Study|Did Not Meet Eligibility Criteria|0
5305499|NCT00406029|18283165|P3|Overall Study|Did Not Meet Eligibility Criteria|1
5305500|NCT00406029|18283166|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5305501|NCT00406029|18283167|P1|Overall Study|Did Not Meet Eligibility Criteria|0
5305502|NCT00406029|18283163|P5|Overall Study|Protocol Violation|0
5305503|NCT00406029|18283164|P4|Overall Study|Protocol Violation|2
5305504|NCT00406029|18283165|P3|Overall Study|Protocol Violation|0
5305505|NCT00406029|18283166|P2|Overall Study|Protocol Violation|2
5305506|NCT00406029|18283167|P1|Overall Study|Protocol Violation|1
5305507|NCT00406029|18283163|P5|Overall Study|Withdrawal by Subject|0
5305508|NCT00406029|18283164|P4|Overall Study|Withdrawal by Subject|2
5305509|NCT00406029|18283165|P3|Overall Study|Withdrawal by Subject|2
5305510|NCT00406029|18283166|P2|Overall Study|Withdrawal by Subject|4
5305511|NCT00406029|18283167|P1|Overall Study|Withdrawal by Subject|3
5305512|NCT00406029|18283163|P5|Overall Study|Adverse Event|7
5305513|NCT00406029|18283164|P4|Overall Study|Adverse Event|10
5305514|NCT00406029|18283165|P3|Overall Study|Adverse Event|5
5305515|NCT00406029|18283166|P2|Overall Study|Adverse Event|2
5305516|NCT00406029|18283167|P1|Overall Study|Adverse Event|12
5305517|NCT00405964|18283271|P2|Overall Study|Protocol Violation|6
5305518|NCT00405964|18283272|P1|Overall Study|Protocol Violation|11
5305519|NCT00405964|18283271|P2|Overall Study|Withdrawal by Subject|23
5305520|NCT00405964|18283272|P1|Overall Study|Withdrawal by Subject|19
5305521|NCT00405964|18283271|P2|Overall Study|Lost to Follow-up|5
5305522|NCT00405964|18283272|P1|Overall Study|Lost to Follow-up|5
5305523|NCT00405964|18283271|P2|Overall Study|Adverse Event|16
5305524|NCT00405964|18283272|P1|Overall Study|Adverse Event|7
5305525|NCT00405964|18283271|P2|Overall Study|Treatment Failure|45
5305526|NCT00405964|18283272|P1|Overall Study|Treatment Failure|17
5305527|NCT00405912|18283294|P3|Overall Study|Lost to Follow-up|4
5305528|NCT00405912|18283295|P2|Overall Study|Lost to Follow-up|8
5305529|NCT00405912|18283296|P1|Overall Study|Lost to Follow-up|4
5305530|NCT00405912|18283294|P3|Overall Study|Withdrawal by Subject|12
5305531|NCT00405912|18283295|P2|Overall Study|Withdrawal by Subject|11
5305532|NCT00405912|18283296|P1|Overall Study|Withdrawal by Subject|12
5305533|NCT00405821|18283309|P2|Overall Study|initiated ART|8
5305534|NCT00405821|18283310|P1|Overall Study|initiated ART|9
5305535|NCT00405821|18283309|P2|Overall Study|Protocol Violation|0
5305536|NCT00405821|18283310|P1|Overall Study|Protocol Violation|1
5305537|NCT00405821|18283309|P2|Overall Study|Lost to Follow-up|7
5305538|NCT00405821|18283310|P1|Overall Study|Lost to Follow-up|7
5305539|NCT00405821|18283309|P2|Overall Study|Death|7
5305540|NCT00405821|18283310|P1|Overall Study|Death|5
5305541|NCT00405756|18283323|P3|Follow-up|Lost to Follow-up|4
5305542|NCT00405756|18283324|P2|Follow-up|Lost to Follow-up|8
5305543|NCT00405756|18283325|P1|Follow-up|Lost to Follow-up|2
5305544|NCT00405756|18283323|P3|Follow-up|Death|24
5305545|NCT00405756|18283324|P2|Follow-up|Death|31
5305546|NCT00405756|18283325|P1|Follow-up|Death|21
5305547|NCT00405756|18283323|P3|Follow-up|Ongoing in Follow-up Period|60
5305548|NCT00405756|18283324|P2|Follow-up|Ongoing in Follow-up Period|51
5305549|NCT00405756|18283325|P1|Follow-up|Ongoing in Follow-up Period|52
5305550|NCT00405756|18283323|P3|Open-label Extension|Other|7
5305551|NCT00405756|18283324|P2|Open-label Extension|Other|1
5305552|NCT00405756|18283325|P1|Open-label Extension|Other|0
5305553|NCT00405756|18283323|P3|Open-label Extension|Death|4
5305554|NCT00405756|18283324|P2|Open-label Extension|Death|2
5305555|NCT00405756|18283325|P1|Open-label Extension|Death|1
5305556|NCT00405756|18283323|P3|Open-label Extension|Withdrawal by Subject|3
5305557|NCT00405756|18283324|P2|Open-label Extension|Withdrawal by Subject|3
5305558|NCT00405756|18283325|P1|Open-label Extension|Withdrawal by Subject|2
5305559|NCT00405756|18283323|P3|Open-label Extension|Disease Progression|26
5305560|NCT00405756|18283324|P2|Open-label Extension|Disease Progression|23
5305561|NCT00405756|18283325|P1|Open-label Extension|Disease Progression|8
5305562|NCT00405756|18283323|P3|Open-label Extension|Adverse Event|7
5305563|NCT00405756|18283324|P2|Open-label Extension|Adverse Event|3
5305564|NCT00405756|18283325|P1|Open-label Extension|Adverse Event|1
5305565|NCT00405756|18283323|P3|Open-label Extension|Ongoing in Open Label Period|25
5305566|NCT00405756|18283324|P2|Open-label Extension|Ongoing in Open Label Period|15
5305567|NCT00405756|18283325|P1|Open-label Extension|Ongoing in Open Label Period|7
5305568|NCT00405756|18283323|P3|Double-blind Treatment|Other|4
5305569|NCT00405756|18283324|P2|Double-blind Treatment|Other|4
5305570|NCT00405756|18283325|P1|Double-blind Treatment|Other|7
5305571|NCT00405756|18283323|P3|Double-blind Treatment|Protocol Violation|2
5305572|NCT00405756|18283324|P2|Double-blind Treatment|Protocol Violation|0
5305573|NCT00405756|18283325|P1|Double-blind Treatment|Protocol Violation|1
5305574|NCT00405756|18283323|P3|Double-blind Treatment|Death|4
5305575|NCT00405756|18283324|P2|Double-blind Treatment|Death|4
5305576|NCT00405756|18283325|P1|Double-blind Treatment|Death|4
5305577|NCT00405756|18283323|P3|Double-blind Treatment|Lost to Follow-up|0
5305578|NCT00405756|18283324|P2|Double-blind Treatment|Lost to Follow-up|0
5305579|NCT00405756|18283325|P1|Double-blind Treatment|Lost to Follow-up|1
5305580|NCT00405756|18283323|P3|Double-blind Treatment|Withdrawal by Subject|10
5305581|NCT00405756|18283324|P2|Double-blind Treatment|Withdrawal by Subject|9
5305582|NCT00405756|18283325|P1|Double-blind Treatment|Withdrawal by Subject|15
5305583|NCT00405756|18283323|P3|Double-blind Treatment|Lack of Efficacy|2
5305584|NCT00405756|18283324|P2|Double-blind Treatment|Lack of Efficacy|4
5305585|NCT00405756|18283325|P1|Double-blind Treatment|Lack of Efficacy|1
5305586|NCT00405756|18283323|P3|Double-blind Treatment|Disease Progression|102
5305587|NCT00405756|18283324|P2|Double-blind Treatment|Disease Progression|81
5305588|NCT00405756|18283325|P1|Double-blind Treatment|Disease Progression|47
5305589|NCT00405756|18283323|P3|Double-blind Treatment|Adverse Event|12
5305590|NCT00405756|18283324|P2|Double-blind Treatment|Adverse Event|27
5305591|NCT00405756|18283325|P1|Double-blind Treatment|Adverse Event|31
5305592|NCT00405756|18283323|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
5305593|NCT00405756|18283324|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
5305594|NCT00405756|18283325|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
5305595|NCT00405652|18283436|P1|Overall Study|Adverse Event|4
5305596|NCT00405639|18283443|P2|Overall Study|Seizure prior to receiving BNP|0
5305597|NCT00405639|18283444|P1|Overall Study|Seizure prior to receiving BNP|1
5305598|NCT00405639|18283443|P2|Overall Study|Adverse Event|0
5305599|NCT00405639|18283444|P1|Overall Study|Adverse Event|1
5305600|NCT00405639|18283443|P2|Overall Study|Withdrawal by Subject|0
5305601|NCT00405639|18283444|P1|Overall Study|Withdrawal by Subject|1
5305602|NCT00405587|18283460|P4|Overall Study|Participant not dosed|0
5305603|NCT00405587|18283461|P3|Overall Study|Participant not dosed|0
5305604|NCT00405587|18283462|P2|Overall Study|Participant not dosed|1
5305605|NCT00405587|18283463|P1|Overall Study|Participant not dosed|0
5305606|NCT00405587|18283460|P4|Overall Study|Withdrawal by Subject|2
5305607|NCT00405587|18283461|P3|Overall Study|Withdrawal by Subject|0
5305608|NCT00405587|18283462|P2|Overall Study|Withdrawal by Subject|0
5305609|NCT00405587|18283463|P1|Overall Study|Withdrawal by Subject|0
5305610|NCT00405587|18283460|P4|Overall Study|Radiation induced necrosis|0
5305611|NCT00405587|18283461|P3|Overall Study|Radiation induced necrosis|0
5305612|NCT00405587|18283462|P2|Overall Study|Radiation induced necrosis|1
5305613|NCT00405587|18283463|P1|Overall Study|Radiation induced necrosis|0
5305614|NCT00405587|18283460|P4|Overall Study|Lost to Follow-up|0
5305615|NCT00405587|18283461|P3|Overall Study|Lost to Follow-up|1
5305616|NCT00405587|18283462|P2|Overall Study|Lost to Follow-up|1
5305617|NCT00405587|18283463|P1|Overall Study|Lost to Follow-up|0
5305618|NCT00405587|18283460|P4|Overall Study|Adverse Event|0
5305619|NCT00405587|18283461|P3|Overall Study|Adverse Event|0
5305620|NCT00405587|18283462|P2|Overall Study|Adverse Event|0
5305621|NCT00405587|18283463|P1|Overall Study|Adverse Event|1
5305622|NCT00405587|18283460|P4|Overall Study|Physician Decision|0
5305623|NCT00405587|18283461|P3|Overall Study|Physician Decision|0
5305624|NCT00405587|18283462|P2|Overall Study|Physician Decision|2
5305625|NCT00405587|18283463|P1|Overall Study|Physician Decision|3
5305626|NCT00405587|18283460|P4|Overall Study|Disease Progression|17
5305627|NCT00405587|18283461|P3|Overall Study|Disease Progression|21
5305628|NCT00405587|18283462|P2|Overall Study|Disease Progression|23
5305629|NCT00405587|18283463|P1|Overall Study|Disease Progression|22
5305630|NCT00405587|18283460|P4|Overall Study|Death|1
5305631|NCT00405587|18283461|P3|Overall Study|Death|0
5305632|NCT00405587|18283462|P2|Overall Study|Death|0
5305633|NCT00405587|18283463|P1|Overall Study|Death|0
5305634|NCT00405548|18283581|P2|Overall Study|Withdrawal by Subject|0
5305635|NCT00405548|18283582|P1|Overall Study|Withdrawal by Subject|1
5305636|NCT00405548|18283581|P2|Overall Study|Venous access failed during study day|0
5305637|NCT00405548|18283582|P1|Overall Study|Venous access failed during study day|1
5305638|NCT00405548|18283581|P2|Overall Study|Unable to self-administer shots|0
5305639|NCT00405548|18283582|P1|Overall Study|Unable to self-administer shots|1
5305640|NCT00405548|18283581|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
5305641|NCT00405548|18283582|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
5305642|NCT00405548|18283581|P2|Overall Study|Cognitive Memory problems on study day|0
5305643|NCT00405548|18283582|P1|Overall Study|Cognitive Memory problems on study day|1
5305644|NCT00405392|18283626|P2|Overall Study|Other|5
5305645|NCT00405392|18283627|P1|Overall Study|Other|1
5305646|NCT00405392|18283626|P2|Overall Study|Non-compliance|1
5305647|NCT00405392|18283627|P1|Overall Study|Non-compliance|0
5305648|NCT00405392|18283626|P2|Overall Study|Data missing|0
5305649|NCT00405392|18283627|P1|Overall Study|Data missing|2
5305650|NCT00405392|18283626|P2|Overall Study|Lost to Follow-up|2
5305651|NCT00405392|18283627|P1|Overall Study|Lost to Follow-up|1
5305652|NCT00405392|18283626|P2|Overall Study|Withdrawal by Subject|3
5305653|NCT00405392|18283627|P1|Overall Study|Withdrawal by Subject|4
5305654|NCT00405392|18283626|P2|Overall Study|Did not meet Eligibility criteria|2
5305655|NCT00405392|18283627|P1|Overall Study|Did not meet Eligibility criteria|7
5305656|NCT00405392|18283626|P2|Overall Study|Adverse Event|14
5305657|NCT00405392|18283627|P1|Overall Study|Adverse Event|15
5305658|NCT00405275|18283674|P2|Overall Study|Unwilling to continue|9
5305659|NCT00405275|18283675|P1|Overall Study|Unwilling to continue|10
5305660|NCT00405275|18283674|P2|Overall Study|Withdrawal by Subject|9
5305661|NCT00405275|18283675|P1|Overall Study|Withdrawal by Subject|7
5305662|NCT00405275|18283674|P2|Overall Study|Lost to Follow-up|1
5305663|NCT00405275|18283675|P1|Overall Study|Lost to Follow-up|5
5305664|NCT00405275|18283674|P2|Overall Study|Death|0
5305665|NCT00405275|18283675|P1|Overall Study|Death|1
5305666|NCT00405067|18283684|P3|Overall Study|Lost to Follow-up|1
5305667|NCT00405067|18283685|P2|Overall Study|Lost to Follow-up|0
5305668|NCT00405067|18283686|P1|Overall Study|Lost to Follow-up|0
5305669|NCT00405067|18283684|P3|Overall Study|Adverse Event|4
5305670|NCT00405067|18283685|P2|Overall Study|Adverse Event|9
5305671|NCT00405067|18283686|P1|Overall Study|Adverse Event|4
5305672|NCT00404924|18283723|P2|Overall Study|Randomised but not received treatment|1
5305673|NCT00404924|18283724|P1|Overall Study|Randomised but not received treatment|1
5305674|NCT00404924|18283723|P2|Overall Study|Other|11
5305675|NCT00404924|18283724|P1|Overall Study|Other|25
5305676|NCT00404924|18283723|P2|Overall Study|Withdrawal by Subject|13
5305677|NCT00404924|18283724|P1|Overall Study|Withdrawal by Subject|26
5305678|NCT00404924|18283723|P2|Overall Study|Lost to Follow-up|1
5305679|NCT00404924|18283724|P1|Overall Study|Lost to Follow-up|1
5305680|NCT00404924|18283723|P2|Overall Study|Condition under investigation worsened|264
5305681|NCT00404924|18283724|P1|Overall Study|Condition under investigation worsened|475
5305682|NCT00404924|18283723|P2|Overall Study|Adverse Event|16
5305683|NCT00404924|18283724|P1|Overall Study|Adverse Event|75
5305684|NCT00404820|18283742|P2|Overall Study|Other|2
5305685|NCT00404820|18283743|P1|Overall Study|Other|0
5305686|NCT00404820|18283742|P2|Overall Study|Death|0
5305687|NCT00404820|18283743|P1|Overall Study|Death|1
5305688|NCT00404820|18283742|P2|Overall Study|Administrative problems|0
5305689|NCT00404820|18283743|P1|Overall Study|Administrative problems|2
5305690|NCT00404820|18283742|P2|Overall Study|Lost to Follow-up|3
5305691|NCT00404820|18283743|P1|Overall Study|Lost to Follow-up|7
5305692|NCT00404820|18283742|P2|Overall Study|Withdrawal by Subject|3
5305693|NCT00404820|18283743|P1|Overall Study|Withdrawal by Subject|5
5305694|NCT00404820|18283742|P2|Overall Study|Adverse Event|16
5305695|NCT00404820|18283743|P1|Overall Study|Adverse Event|4
5305696|NCT00404768|18283765|P4|Part C|Researcher suspended study medication|1
5305697|NCT00404768|18283766|P3|Part C|Researcher suspended study medication|0
5305698|NCT00404768|18283767|P2|Part C|Researcher suspended study medication|0
5305699|NCT00404768|18283768|P1|Part C|Researcher suspended study medication|0
5305700|NCT00404768|18283765|P4|Part C|Investigator discretion|1
5305701|NCT00404768|18283766|P3|Part C|Investigator discretion|0
5305702|NCT00404768|18283767|P2|Part C|Investigator discretion|0
5305703|NCT00404768|18283768|P1|Part C|Investigator discretion|0
5305704|NCT00404768|18283765|P4|Part C|Treatment failure|1
5305705|NCT00404768|18283766|P3|Part C|Treatment failure|0
5305706|NCT00404768|18283767|P2|Part C|Treatment failure|0
5305707|NCT00404768|18283768|P1|Part C|Treatment failure|0
5305708|NCT00404768|18283765|P4|Part C|Lack of Efficacy|2
5305709|NCT00404768|18283766|P3|Part C|Lack of Efficacy|0
5305710|NCT00404768|18283767|P2|Part C|Lack of Efficacy|0
5305711|NCT00404768|18283768|P1|Part C|Lack of Efficacy|0
5305712|NCT00404768|18283765|P4|Part C|Active labor|1
5305713|NCT00404768|18283766|P3|Part C|Active labor|0
5305714|NCT00404768|18283767|P2|Part C|Active labor|0
5305715|NCT00404768|18283768|P1|Part C|Active labor|0
5305716|NCT00404768|18283765|P4|Part C|Unsatisfactory uterine response to IP|1
5305717|NCT00404768|18283766|P3|Part C|Unsatisfactory uterine response to IP|0
5305718|NCT00404768|18283767|P2|Part C|Unsatisfactory uterine response to IP|0
5305719|NCT00404768|18283768|P1|Part C|Unsatisfactory uterine response to IP|0
5305720|NCT00404768|18283765|P4|Part C|Participant delivered baby|1
5305721|NCT00404768|18283766|P3|Part C|Participant delivered baby|0
5305722|NCT00404768|18283767|P2|Part C|Participant delivered baby|0
5305723|NCT00404768|18283768|P1|Part C|Participant delivered baby|0
5305724|NCT00404768|18283765|P4|Part C|Physician withdrew the study medication|0
5305725|NCT00404768|18283766|P3|Part C|Physician withdrew the study medication|1
5305726|NCT00404768|18283767|P2|Part C|Physician withdrew the study medication|0
5305727|NCT00404768|18283768|P1|Part C|Physician withdrew the study medication|0
5305728|NCT00404768|18283765|P4|Part C|Participant did not respond to therapy|1
5305729|NCT00404768|18283766|P3|Part C|Participant did not respond to therapy|1
5305730|NCT00404768|18283767|P2|Part C|Participant did not respond to therapy|0
5305731|NCT00404768|18283768|P1|Part C|Participant did not respond to therapy|0
5305732|NCT00404768|18283765|P4|Part C|Early withdrawal from study medication|0
5305733|NCT00404768|18283766|P3|Part C|Early withdrawal from study medication|1
5305734|NCT00404768|18283767|P2|Part C|Early withdrawal from study medication|0
5305735|NCT00404768|18283768|P1|Part C|Early withdrawal from study medication|0
5305736|NCT00404768|18283765|P4|Part C|Withdrawal by Subject|1
5305737|NCT00404768|18283766|P3|Part C|Withdrawal by Subject|2
5305738|NCT00404768|18283767|P2|Part C|Withdrawal by Subject|0
5305739|NCT00404768|18283768|P1|Part C|Withdrawal by Subject|0
5305740|NCT00404768|18283765|P4|Part C|Lost to Follow-up|1
5305741|NCT00404768|18283766|P3|Part C|Lost to Follow-up|3
5305742|NCT00404768|18283767|P2|Part C|Lost to Follow-up|0
5305743|NCT00404768|18283768|P1|Part C|Lost to Follow-up|0
5305744|NCT00404768|18283765|P4|Part C|Adverse Event|3
5305745|NCT00404768|18283766|P3|Part C|Adverse Event|0
5305746|NCT00404768|18283767|P2|Part C|Adverse Event|0
5305747|NCT00404768|18283768|P1|Part C|Adverse Event|0
5305748|NCT00404768|18283765|P4|Part A and B|Withdrawn as delivery imminemnt|0
5305749|NCT00404768|18283766|P3|Part A and B|Withdrawn as delivery imminemnt|0
5305750|NCT00404768|18283767|P2|Part A and B|Withdrawn as delivery imminemnt|1
5305751|NCT00404768|18283768|P1|Part A and B|Withdrawn as delivery imminemnt|0
5305752|NCT00404768|18283765|P4|Part A and B|Withdrawn due to labor progression|0
5305753|NCT00404768|18283766|P3|Part A and B|Withdrawn due to labor progression|0
5305754|NCT00404768|18283767|P2|Part A and B|Withdrawn due to labor progression|0
5305755|NCT00404768|18283768|P1|Part A and B|Withdrawn due to labor progression|1
5305756|NCT00404755|18283829|P1|Phase II (Escitalopram)|Lost to Follow-up|2
5305757|NCT00404755|18283829|P1|Phase I (Bupropion)|Other|1
5305758|NCT00404755|18283829|P1|Phase I (Bupropion)|Adverse Event|3
5305759|NCT00404651|18283844|P4|Overall Study|Withdrawal by Subject|6
5305760|NCT00404651|18283845|P3|Overall Study|Withdrawal by Subject|16
5305761|NCT00404651|18283846|P2|Overall Study|Withdrawal by Subject|12
5305762|NCT00404651|18283847|P1|Overall Study|Withdrawal by Subject|14
5305763|NCT00404651|18283844|P4|Overall Study|Lost to Follow-up|10
5305764|NCT00404651|18283845|P3|Overall Study|Lost to Follow-up|13
5305765|NCT00404651|18283846|P2|Overall Study|Lost to Follow-up|11
5305766|NCT00404651|18283847|P1|Overall Study|Lost to Follow-up|15
5305767|NCT00404651|18283844|P4|Overall Study|Protocol Violation|5
5305768|NCT00404651|18283845|P3|Overall Study|Protocol Violation|14
5305769|NCT00404651|18283846|P2|Overall Study|Protocol Violation|5
5305770|NCT00404651|18283847|P1|Overall Study|Protocol Violation|10
5305771|NCT00404651|18283844|P4|Overall Study|Serious Adverse Event|0
5305772|NCT00404651|18283845|P3|Overall Study|Serious Adverse Event|2
5305773|NCT00404651|18283846|P2|Overall Study|Serious Adverse Event|0
5305774|NCT00404651|18283847|P1|Overall Study|Serious Adverse Event|0
5305775|NCT00404547|18283875|P2|Overall Study|Reason not stated|6
5305776|NCT00404547|18283876|P1|Overall Study|Reason not stated|3
5305777|NCT00404547|18283875|P2|Overall Study|Other|0
5305778|NCT00404547|18283876|P1|Overall Study|Other|4
5305779|NCT00404547|18283875|P2|Overall Study|Lack of compliance|1
5305780|NCT00404547|18283876|P1|Overall Study|Lack of compliance|5
5305781|NCT00404547|18283875|P2|Overall Study|Lost to Follow-up|9
5305782|NCT00404547|18283876|P1|Overall Study|Lost to Follow-up|20
5305783|NCT00404547|18283875|P2|Overall Study|Protocol Violation|1
5305784|NCT00404547|18283876|P1|Overall Study|Protocol Violation|0
5305785|NCT00404547|18283875|P2|Overall Study|Withdrawal by Subject|2
5305786|NCT00404547|18283876|P1|Overall Study|Withdrawal by Subject|19
5305787|NCT00404547|18283875|P2|Overall Study|Adverse Event|6
5305788|NCT00404547|18283876|P1|Overall Study|Adverse Event|39
5305789|NCT00404495|18283886|P2|Overall Study|Withdrawal by Subject|0
5305790|NCT00404495|18283887|P1|Overall Study|Withdrawal by Subject|1
5305791|NCT00404495|18283886|P2|Overall Study|Other|0
5305792|NCT00404495|18283887|P1|Overall Study|Other|1
5305793|NCT00404495|18283886|P2|Overall Study|Lost to Follow-up|0
5305794|NCT00404495|18283887|P1|Overall Study|Lost to Follow-up|5
5305795|NCT00404495|18283886|P2|Overall Study|Death|11
5305796|NCT00404495|18283887|P1|Overall Study|Death|37
5305797|NCT00404352|18283906|P9|Open Label Extension (up to 36 Months)|Other|2
5305798|NCT00404352|18283907|P8|Open Label Extension (up to 36 Months)|Other|0
5305799|NCT00404352|18283908|P7|Open Label Extension (up to 36 Months)|Other|0
5305800|NCT00404352|18283909|P6|Open Label Extension (up to 36 Months)|Other|0
5305801|NCT00404352|18283910|P5|Open Label Extension (up to 36 Months)|Other|0
5305802|NCT00404352|18283911|P4|Open Label Extension (up to 36 Months)|Other|0
5305803|NCT00404352|18283912|P3|Open Label Extension (up to 36 Months)|Other|0
5305804|NCT00404352|18283913|P2|Open Label Extension (up to 36 Months)|Other|0
5305805|NCT00404352|18283914|P1|Open Label Extension (up to 36 Months)|Other|0
5305806|NCT00404352|18283906|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
5305807|NCT00404352|18283907|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
5305808|NCT00404352|18283908|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
5305809|NCT00404352|18283909|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
5305810|NCT00404352|18283910|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
5305811|NCT00404352|18283911|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
5305812|NCT00404352|18283912|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
5305813|NCT00404352|18283913|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
5305814|NCT00404352|18283914|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
5305815|NCT00404352|18283906|P9|Open Label (up to 24 Month)|Disease progression|0
5305816|NCT00404352|18283907|P8|Open Label (up to 24 Month)|Disease progression|0
5305817|NCT00404352|18283908|P7|Open Label (up to 24 Month)|Disease progression|0
5305818|NCT00404352|18283909|P6|Open Label (up to 24 Month)|Disease progression|0
5305819|NCT00404352|18283910|P5|Open Label (up to 24 Month)|Disease progression|0
5305820|NCT00404352|18283911|P4|Open Label (up to 24 Month)|Disease progression|1
5305821|NCT00404352|18283912|P3|Open Label (up to 24 Month)|Disease progression|0
5305822|NCT00404352|18283913|P2|Open Label (up to 24 Month)|Disease progression|0
5305823|NCT00404352|18283914|P1|Open Label (up to 24 Month)|Disease progression|0
5305824|NCT00404352|18283906|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305825|NCT00404352|18283907|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305826|NCT00404352|18283908|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305827|NCT00404352|18283909|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
5305828|NCT00404352|18283910|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305829|NCT00404352|18283911|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305830|NCT00404352|18283912|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305831|NCT00404352|18283913|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305832|NCT00404352|18283914|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
5305833|NCT00404352|18283906|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
5305834|NCT00404352|18283907|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
5305835|NCT00404352|18283908|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
5305836|NCT00404352|18283909|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
5305837|NCT00404352|18283910|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
5305838|NCT00404352|18283911|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
5305839|NCT00404352|18283912|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
5305840|NCT00404352|18283913|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
5305841|NCT00404352|18283914|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
5305842|NCT00404352|18283906|P9|Open Label (up to 24 Month)|Pregnancy|0
5305843|NCT00404352|18283907|P8|Open Label (up to 24 Month)|Pregnancy|0
5305844|NCT00404352|18283908|P7|Open Label (up to 24 Month)|Pregnancy|0
5305845|NCT00404352|18283909|P6|Open Label (up to 24 Month)|Pregnancy|1
5305846|NCT00404352|18283910|P5|Open Label (up to 24 Month)|Pregnancy|0
5305847|NCT00404352|18283911|P4|Open Label (up to 24 Month)|Pregnancy|0
5305848|NCT00404352|18283912|P3|Open Label (up to 24 Month)|Pregnancy|0
5305849|NCT00404352|18283913|P2|Open Label (up to 24 Month)|Pregnancy|0
5305850|NCT00404352|18283914|P1|Open Label (up to 24 Month)|Pregnancy|0
5305851|NCT00404352|18283906|P9|Open Label (up to 24 Month)|Adverse Event|0
5305852|NCT00404352|18283907|P8|Open Label (up to 24 Month)|Adverse Event|0
5305853|NCT00404352|18283908|P7|Open Label (up to 24 Month)|Adverse Event|0
5305854|NCT00404352|18283909|P6|Open Label (up to 24 Month)|Adverse Event|1
5305855|NCT00404352|18283910|P5|Open Label (up to 24 Month)|Adverse Event|1
5305856|NCT00404352|18283911|P4|Open Label (up to 24 Month)|Adverse Event|2
5305857|NCT00404352|18283912|P3|Open Label (up to 24 Month)|Adverse Event|0
5305858|NCT00404352|18283913|P2|Open Label (up to 24 Month)|Adverse Event|0
5305859|NCT00404352|18283914|P1|Open Label (up to 24 Month)|Adverse Event|0
5305860|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Other|0
5305861|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Other|0
5305862|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Other|0
5305863|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Other|0
5305864|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Other|0
5305865|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Other|0
5305866|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Other|0
5305867|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Other|1
5305868|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Other|0
5305869|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Physician Decision|0
5305870|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Physician Decision|0
5305871|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Physician Decision|0
5305872|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Physician Decision|0
5305873|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Physician Decision|0
5305874|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Physician Decision|0
5305875|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Physician Decision|1
5305876|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Physician Decision|0
5305877|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Physician Decision|0
5305878|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
5305879|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
5305880|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
5305881|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
5305882|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
5305883|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
5305884|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
5305885|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
5305886|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
5305887|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
5305888|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
5305889|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
5305890|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
5305891|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
5305892|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
5305893|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
5305894|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
5305895|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
5305896|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Poor compliance|0
5305897|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Poor compliance|0
5305898|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Poor compliance|0
5305899|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Poor compliance|0
5305900|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Poor compliance|0
5305901|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Poor compliance|0
5305902|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Poor compliance|0
5305903|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Poor compliance|0
5305904|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Poor compliance|1
5305905|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Disease progression|0
5305906|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Disease progression|0
5305907|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Disease progression|0
5305908|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Disease progression|0
5305909|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Disease progression|0
5305910|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Disease progression|0
5305911|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Disease progression|2
5305912|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Disease progression|0
5305913|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Disease progression|3
5305914|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5305915|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5305916|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5305917|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5305918|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5305919|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5305920|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
5305921|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
5305922|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
5305923|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
5305924|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
5305925|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
5305926|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
5305927|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
5305928|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
5305929|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
5305930|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
5305931|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
5305932|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Death|0
5305933|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Death|0
5305934|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Death|0
5305935|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Death|0
5305936|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Death|0
5305937|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Death|0
5305938|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Death|1
5305939|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Death|0
5305940|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Death|0
5305941|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Pregnancy|0
5305942|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Pregnancy|0
5305943|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Pregnancy|0
5305944|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Pregnancy|0
5305945|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Pregnancy|0
5305946|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Pregnancy|0
5305947|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Pregnancy|2
5305948|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Pregnancy|0
5305949|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Pregnancy|0
5305950|NCT00404352|18283906|P9|Double Blind (up to 24 Month)|Adverse Event|0
5305951|NCT00404352|18283907|P8|Double Blind (up to 24 Month)|Adverse Event|0
5305952|NCT00404352|18283908|P7|Double Blind (up to 24 Month)|Adverse Event|0
5305953|NCT00404352|18283909|P6|Double Blind (up to 24 Month)|Adverse Event|0
5305954|NCT00404352|18283910|P5|Double Blind (up to 24 Month)|Adverse Event|0
5305955|NCT00404352|18283911|P4|Double Blind (up to 24 Month)|Adverse Event|0
5305956|NCT00404352|18283912|P3|Double Blind (up to 24 Month)|Adverse Event|6
5305957|NCT00404352|18283913|P2|Double Blind (up to 24 Month)|Adverse Event|4
5305958|NCT00404352|18283914|P1|Double Blind (up to 24 Month)|Adverse Event|5
5305959|NCT00404248|18283949|P9|Overall Study|pts declining status|0
5305960|NCT00404248|18283950|P8|Overall Study|pts declining status|0
5305961|NCT00404248|18283951|P7|Overall Study|pts declining status|0
5305962|NCT00404248|18283952|P6|Overall Study|pts declining status|0
5305963|NCT00404248|18283953|P5|Overall Study|pts declining status|0
5305964|NCT00404248|18283954|P4|Overall Study|pts declining status|0
5305965|NCT00404248|18283955|P3|Overall Study|pts declining status|0
5305966|NCT00404248|18283956|P2|Overall Study|pts declining status|1
5305967|NCT00404248|18283957|P1|Overall Study|pts declining status|0
5305968|NCT00404235|18283990|P2|Overall Study|Withdrawal by Subject|2
5305969|NCT00404235|18283991|P1|Overall Study|Withdrawal by Subject|1
5305970|NCT00404092|18284009|P4|Overall Study|Adverse Event|0
5305971|NCT00404092|18284010|P3|Overall Study|Adverse Event|1
5305972|NCT00404092|18284011|P2|Overall Study|Adverse Event|0
5305973|NCT00404092|18284012|P1|Overall Study|Adverse Event|0
5305974|NCT00404092|18284009|P4|Overall Study|Death|0
5305975|NCT00404092|18284010|P3|Overall Study|Death|0
5305976|NCT00404092|18284011|P2|Overall Study|Death|0
5305977|NCT00404092|18284012|P1|Overall Study|Death|1
5305978|NCT00404079|18284028|P2|Overall Study|Lost to follow up, adverse event etc|20
5305979|NCT00404079|18284029|P1|Overall Study|Lost to follow up, adverse event etc|22
5305980|NCT00404066|18284035|P1|Overall Study|Withdrawal by Subject - Adverse event|2
5305981|NCT00404066|18284035|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
5305982|NCT00403845|18284040|P4|Treatment Period 3|Adverse Event|1
5305983|NCT00403845|18284041|P3|Treatment Period 3|Adverse Event|0
5305984|NCT00403845|18284042|P2|Treatment Period 3|Adverse Event|0
5305985|NCT00403845|18284043|P1|Treatment Period 3|Adverse Event|0
5305986|NCT00403845|18284040|P4|Treatment Period 3|Subject withdrew consent|1
5305987|NCT00403845|18284041|P3|Treatment Period 3|Subject withdrew consent|0
5305988|NCT00403845|18284042|P2|Treatment Period 3|Subject withdrew consent|0
5305989|NCT00403845|18284043|P1|Treatment Period 3|Subject withdrew consent|0
5305990|NCT00403845|18284040|P4|Treatment Period 2|Subject withdrew consent|0
5305991|NCT00403845|18284041|P3|Treatment Period 2|Subject withdrew consent|0
5305992|NCT00403845|18284042|P2|Treatment Period 2|Subject withdrew consent|0
5305993|NCT00403845|18284043|P1|Treatment Period 2|Subject withdrew consent|1
5305994|NCT00403845|18284040|P4|Treatment Period 1|Subject no longer needs study drug|1
5305995|NCT00403845|18284041|P3|Treatment Period 1|Subject no longer needs study drug|0
5305996|NCT00403845|18284042|P2|Treatment Period 1|Subject no longer needs study drug|0
5305997|NCT00403845|18284043|P1|Treatment Period 1|Subject no longer needs study drug|0
5305998|NCT00403845|18284040|P4|Treatment Period 1|Subject withdrew consent|0
5305999|NCT00403845|18284041|P3|Treatment Period 1|Subject withdrew consent|0
5306000|NCT00403845|18284042|P2|Treatment Period 1|Subject withdrew consent|0
5306001|NCT00403845|18284043|P1|Treatment Period 1|Subject withdrew consent|1
5306002|NCT00403767|18284067|P2|Overall Study|Missing/incomplete data|1
5306003|NCT00403767|18284068|P1|Overall Study|Missing/incomplete data|1
5306004|NCT00403767|18284067|P2|Overall Study|Study terminated by sponsor|69
5306005|NCT00403767|18284068|P1|Overall Study|Study terminated by sponsor|82
5306006|NCT00403767|18284067|P2|Overall Study|Clinical efficacy endpoint reached|332
5306007|NCT00403767|18284068|P1|Overall Study|Clinical efficacy endpoint reached|300
5306008|NCT00403767|18284067|P2|Overall Study|Protocol Violation|124
5306009|NCT00403767|18284068|P1|Overall Study|Protocol Violation|142
5306010|NCT00403767|18284067|P2|Overall Study|Lost to Follow-up|8
5306011|NCT00403767|18284068|P1|Overall Study|Lost to Follow-up|6
5306012|NCT00403767|18284067|P2|Overall Study|Investigator dec./not protocol-related|178
5306013|NCT00403767|18284068|P1|Overall Study|Investigator dec./not protocol-related|191
5306014|NCT00403767|18284067|P2|Overall Study|Consent withdrawn|673
5306015|NCT00403767|18284068|P1|Overall Study|Consent withdrawn|671
5306016|NCT00403767|18284067|P2|Overall Study|Non-compliant with study medication|164
5306017|NCT00403767|18284068|P1|Overall Study|Non-compliant with study medication|134
5306018|NCT00403767|18284067|P2|Overall Study|Adverse Event|919
5306019|NCT00403767|18284068|P1|Overall Study|Adverse Event|993
5306020|NCT00403754|18284092|P4|Core Treatment Period 2|Lack of Efficacy|0
5306021|NCT00403754|18284093|P3|Core Treatment Period 2|Lack of Efficacy|1
5306022|NCT00403754|18284094|P2|Core Treatment Period 2|Lack of Efficacy|0
5306023|NCT00403754|18284095|P1|Core Treatment Period 2|Lack of Efficacy|0
5306024|NCT00403754|18284092|P4|Core Treatment Period 1|Withdrawal by Subject|0
5306025|NCT00403754|18284093|P3|Core Treatment Period 1|Withdrawal by Subject|0
5306026|NCT00403754|18284094|P2|Core Treatment Period 1|Withdrawal by Subject|1
5306027|NCT00403754|18284095|P1|Core Treatment Period 1|Withdrawal by Subject|0
5306028|NCT00403585|18284122|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
5306029|NCT00403585|18284122|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
5306030|NCT00403585|18284122|P1|Initial Treatment Phase|Lost to Follow-up|2
5306031|NCT00403546|18284133|P3|Randomized Trial|Early Terminations|16
5306032|NCT00403546|18284134|P2|Randomized Trial|Early Terminations|17
5306033|NCT00403546|18284135|P1|Randomized Trial|Early Terminations|0
5306034|NCT00403546|18284133|P3|Screening Phase|Terminated Prior to Randomization|0
5306035|NCT00403546|18284134|P2|Screening Phase|Terminated Prior to Randomization|0
5306036|NCT00403546|18284135|P1|Screening Phase|Terminated Prior to Randomization|5
5306037|NCT00403546|18284133|P3|Screening Phase|Adverse Event|0
5306038|NCT00403546|18284134|P2|Screening Phase|Adverse Event|0
5306039|NCT00403546|18284135|P1|Screening Phase|Adverse Event|1
5306040|NCT00403546|18284133|P3|Screening Phase|Screening Failure|0
5306041|NCT00403546|18284134|P2|Screening Phase|Screening Failure|0
5306042|NCT00403546|18284135|P1|Screening Phase|Screening Failure|22
5306043|NCT00403546|18284133|P3|Signed Informed Consent/Open-Label|Adverse Event|0
5306044|NCT00403546|18284134|P2|Signed Informed Consent/Open-Label|Adverse Event|0
5306045|NCT00403546|18284135|P1|Signed Informed Consent/Open-Label|Adverse Event|5
5306046|NCT00403546|18284133|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
5306047|NCT00403546|18284134|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
5306048|NCT00403546|18284135|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
5306049|NCT00403546|18284133|P3|Signed Informed Consent/Open-Label|Early Termination|0
5306050|NCT00403546|18284134|P2|Signed Informed Consent/Open-Label|Early Termination|0
5306051|NCT00403546|18284135|P1|Signed Informed Consent/Open-Label|Early Termination|8
5306052|NCT00403546|18284133|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
5306053|NCT00403546|18284134|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
5306054|NCT00403546|18284135|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
5306055|NCT00403481|18284175|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
5306056|NCT00403481|18284175|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
5306057|NCT00403481|18284175|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
5306058|NCT00403481|18284175|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
5306059|NCT00403481|18284175|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
5306060|NCT00403481|18284175|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
5306061|NCT00403481|18284175|P1|Olm 40 mg|Other|1
5306062|NCT00403481|18284175|P1|Olm 40 mg|Withdrawal by Subject|1
5306063|NCT00403481|18284175|P1|Olm 40 mg|Protocol Violation|1
5306064|NCT00403481|18284175|P1|Olm 40 mg|Adverse Event|2
5306065|NCT00403481|18284175|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
5306066|NCT00403481|18284175|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
5306067|NCT00403481|18284175|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
5306068|NCT00403481|18284175|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
5306069|NCT00403455|18284190|P1|Overall Study|Withdrawal by Subject|1
5306070|NCT00403390|18284213|P2|Overall Study|non-compliant|0
5306071|NCT00403390|18284214|P1|Overall Study|non-compliant|1
5306072|NCT00403390|18284213|P2|Overall Study|samples lost|0
5306073|NCT00403390|18284214|P1|Overall Study|samples lost|1
5306074|NCT00403390|18284213|P2|Overall Study|Withdrawal by Subject|0
5306075|NCT00403390|18284214|P1|Overall Study|Withdrawal by Subject|1
5306076|NCT00403273|18284222|P2|Overall Study|pt. wanted to have a surgical procedure|1
5306077|NCT00403273|18284223|P1|Overall Study|pt. wanted to have a surgical procedure|0
5306078|NCT00403273|18284222|P2|Overall Study|Physician Decision|1
5306079|NCT00403273|18284223|P1|Overall Study|Physician Decision|0
5306080|NCT00403273|18284222|P2|Overall Study|Lost to Follow-up|2
5306081|NCT00403273|18284223|P1|Overall Study|Lost to Follow-up|3
5306082|NCT00403234|18284265|P4|Overall Study|Adverse Event|0
5306083|NCT00403234|18284266|P3|Overall Study|Adverse Event|1
5306084|NCT00403234|18284267|P2|Overall Study|Adverse Event|0
5306085|NCT00403234|18284268|P1|Overall Study|Adverse Event|1
5306086|NCT00403234|18284265|P4|Overall Study|Withdrawal by Subject|0
5306087|NCT00403234|18284266|P3|Overall Study|Withdrawal by Subject|0
5306088|NCT00403234|18284267|P2|Overall Study|Withdrawal by Subject|1
5306089|NCT00403234|18284268|P1|Overall Study|Withdrawal by Subject|0
5306090|NCT00403130|18284278|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
5306091|NCT00403130|18284278|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
5306092|NCT00403130|18284278|P1|2 Years From Start of Treatment|Lost to Follow up|1
5306093|NCT00403130|18284278|P1|2 Years From Start of Treatment|Not Eligible|3
5306094|NCT00402987|18284331|P4|Overall Study|Lack of Efficacy|0
5306095|NCT00402987|18284332|P3|Overall Study|Lack of Efficacy|1
5306096|NCT00402987|18284333|P2|Overall Study|Lack of Efficacy|0
5306097|NCT00402987|18284334|P1|Overall Study|Lack of Efficacy|0
5306098|NCT00402831|18284506|P2|Overall Study|Non-compliance with protocol|1
5306099|NCT00402831|18284507|P1|Overall Study|Non-compliance with protocol|0
5306100|NCT00402831|18284506|P2|Overall Study|Lost to Follow-up|2
5306101|NCT00402831|18284507|P1|Overall Study|Lost to Follow-up|1
5306102|NCT00402779|18284541|P2|Overall Study|Screen Failure|76
5306103|NCT00402779|18284542|P1|Overall Study|Screen Failure|77
5306104|NCT00402740|18284548|P1|Overall Study|Subject disposition unknown.|1
5306105|NCT00402740|18284548|P1|Overall Study|No stent. Completed FU at 30 days.|5
5306106|NCT00402740|18284548|P1|Overall Study|Lost to Follow-up|6
5306107|NCT00402740|18284548|P1|Overall Study|Death|50
5306108|NCT00402740|18284548|P1|Overall Study|Withdrawal by Subject|18
5306109|NCT00402727|18284560|P2|Overall Study|non-compliance|1
5306110|NCT00402727|18284561|P1|Overall Study|non-compliance|0
5306111|NCT00402727|18284560|P2|Overall Study|supply problems|1
5306112|NCT00402727|18284561|P1|Overall Study|supply problems|2
5306113|NCT00402727|18284560|P2|Overall Study|Withdrawal by Subject|7
5306114|NCT00402727|18284561|P1|Overall Study|Withdrawal by Subject|3
5306115|NCT00402727|18284560|P2|Overall Study|Protocol Violation|4
5306116|NCT00402727|18284561|P1|Overall Study|Protocol Violation|0
5306117|NCT00402727|18284560|P2|Overall Study|Physician Decision|1
5306118|NCT00402727|18284561|P1|Overall Study|Physician Decision|1
5306119|NCT00402727|18284560|P2|Overall Study|Lost to Follow-up|11
5306120|NCT00402727|18284561|P1|Overall Study|Lost to Follow-up|24
5306121|NCT00402727|18284560|P2|Overall Study|Lack of Efficacy|3
5306122|NCT00402727|18284561|P1|Overall Study|Lack of Efficacy|1
5306123|NCT00402727|18284560|P2|Overall Study|Death|0
5306124|NCT00402727|18284561|P1|Overall Study|Death|1
5306125|NCT00402727|18284560|P2|Overall Study|Adverse Event|6
5306126|NCT00402727|18284561|P1|Overall Study|Adverse Event|10
5306127|NCT00402688|18284603|P3|Overall Study|Patient Left Town and Forgot Medication|1
5306128|NCT00402688|18284604|P2|Overall Study|Patient Left Town and Forgot Medication|0
5306129|NCT00402688|18284605|P1|Overall Study|Patient Left Town and Forgot Medication|0
5306130|NCT00402688|18284603|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
5306131|NCT00402688|18284604|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
5306132|NCT00402688|18284605|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
5306133|NCT00402688|18284603|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
5306134|NCT00402688|18284604|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
5306135|NCT00402688|18284605|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
5306136|NCT00402688|18284603|P3|Overall Study|Lost to Follow-up|2
5306137|NCT00402688|18284604|P2|Overall Study|Lost to Follow-up|0
5306138|NCT00402688|18284605|P1|Overall Study|Lost to Follow-up|1
5306139|NCT00402688|18284603|P3|Overall Study|Protocol Violation|1
5306140|NCT00402688|18284604|P2|Overall Study|Protocol Violation|1
5306141|NCT00402688|18284605|P1|Overall Study|Protocol Violation|1
5306142|NCT00402688|18284603|P3|Overall Study|Lack of Efficacy|5
5306143|NCT00402688|18284604|P2|Overall Study|Lack of Efficacy|4
5306144|NCT00402688|18284605|P1|Overall Study|Lack of Efficacy|4
5306145|NCT00402688|18284603|P3|Overall Study|Physician Decision|1
5306146|NCT00402688|18284604|P2|Overall Study|Physician Decision|0
5306147|NCT00402688|18284605|P1|Overall Study|Physician Decision|0
5306148|NCT00402688|18284603|P3|Overall Study|Withdrawal by Subject|1
5306149|NCT00402688|18284604|P2|Overall Study|Withdrawal by Subject|1
5306150|NCT00402688|18284605|P1|Overall Study|Withdrawal by Subject|3
5306151|NCT00402688|18284603|P3|Overall Study|Adverse Event|3
5306152|NCT00402688|18284604|P2|Overall Study|Adverse Event|9
5306153|NCT00402688|18284605|P1|Overall Study|Adverse Event|12
5306154|NCT00402649|18284628|P1|Overall Study|Withdrawal by Subject|1
5306155|NCT00402649|18284628|P1|Overall Study|Lost to Follow-up|1
5306156|NCT00402597|18284643|P5|Overall Study|reason not specified|20
5306157|NCT00402597|18284644|P4|Overall Study|reason not specified|14
5306158|NCT00402597|18284645|P3|Overall Study|reason not specified|27
5306159|NCT00402597|18284646|P2|Overall Study|reason not specified|4
5306160|NCT00402597|18284647|P1|Overall Study|reason not specified|30
5306161|NCT00402597|18284643|P5|Overall Study|Withdrawal by Subject|24
5306162|NCT00402597|18284644|P4|Overall Study|Withdrawal by Subject|15
5306163|NCT00402597|18284645|P3|Overall Study|Withdrawal by Subject|65
5306164|NCT00402597|18284646|P2|Overall Study|Withdrawal by Subject|16
5306165|NCT00402597|18284647|P1|Overall Study|Withdrawal by Subject|57
5306166|NCT00402597|18284643|P5|Overall Study|Lost to Follow-up|3
5306167|NCT00402597|18284644|P4|Overall Study|Lost to Follow-up|2
5306168|NCT00402597|18284645|P3|Overall Study|Lost to Follow-up|8
5306169|NCT00402597|18284646|P2|Overall Study|Lost to Follow-up|1
5306170|NCT00402597|18284647|P1|Overall Study|Lost to Follow-up|8
5306171|NCT00402597|18284643|P5|Overall Study|Adverse Event|71
5306172|NCT00402597|18284644|P4|Overall Study|Adverse Event|39
5306173|NCT00402597|18284645|P3|Overall Study|Adverse Event|106
5306174|NCT00402597|18284646|P2|Overall Study|Adverse Event|18
5306175|NCT00402597|18284647|P1|Overall Study|Adverse Event|81
5306176|NCT00402597|18284643|P5|Overall Study|Death|6
5306177|NCT00402597|18284644|P4|Overall Study|Death|4
5306178|NCT00402597|18284645|P3|Overall Study|Death|6
5306179|NCT00402597|18284646|P2|Overall Study|Death|7
5306180|NCT00402597|18284647|P1|Overall Study|Death|15
5306181|NCT00402363|18284688|P4|Overall Study|"Captured as Other"|2
5306182|NCT00402363|18284689|P3|Overall Study|"Captured as Other"|2
5306183|NCT00402363|18284690|P2|Overall Study|"Captured as Other"|2
5306184|NCT00402363|18284691|P1|Overall Study|"Captured as Other"|6
5306185|NCT00402363|18284688|P4|Overall Study|Lost to Follow-up|2
5306186|NCT00402363|18284689|P3|Overall Study|Lost to Follow-up|0
5306187|NCT00402363|18284690|P2|Overall Study|Lost to Follow-up|4
5306188|NCT00402363|18284691|P1|Overall Study|Lost to Follow-up|5
5306189|NCT00402363|18284688|P4|Overall Study|Protocol Violation|3
5306190|NCT00402363|18284689|P3|Overall Study|Protocol Violation|0
5306191|NCT00402363|18284690|P2|Overall Study|Protocol Violation|5
5306192|NCT00402363|18284691|P1|Overall Study|Protocol Violation|3
5306193|NCT00402363|18284688|P4|Overall Study|Withdrew Consent|1
5306194|NCT00402363|18284689|P3|Overall Study|Withdrew Consent|2
5306195|NCT00402363|18284690|P2|Overall Study|Withdrew Consent|5
5306196|NCT00402363|18284691|P1|Overall Study|Withdrew Consent|10
5306197|NCT00402363|18284688|P4|Overall Study|Adverse Event|2
5306198|NCT00402363|18284689|P3|Overall Study|Adverse Event|2
5306199|NCT00402363|18284690|P2|Overall Study|Adverse Event|14
5306200|NCT00402363|18284691|P1|Overall Study|Adverse Event|9
5306201|NCT00402337|18284754|P5|Overall Study|Other Reason|0
5306202|NCT00402337|18284755|P4|Overall Study|Other Reason|0
5306203|NCT00402337|18284756|P3|Overall Study|Other Reason|0
5306204|NCT00402337|18284757|P2|Overall Study|Other Reason|1
5306205|NCT00402337|18284758|P1|Overall Study|Other Reason|0
5306206|NCT00402337|18284754|P5|Overall Study|Physician Decision|0
5306207|NCT00402337|18284755|P4|Overall Study|Physician Decision|1
5306208|NCT00402337|18284756|P3|Overall Study|Physician Decision|0
5306209|NCT00402337|18284757|P2|Overall Study|Physician Decision|0
5306210|NCT00402337|18284758|P1|Overall Study|Physician Decision|0
5306211|NCT00402337|18284754|P5|Overall Study|Lost to Follow-up|0
5306212|NCT00402337|18284755|P4|Overall Study|Lost to Follow-up|2
5306213|NCT00402337|18284756|P3|Overall Study|Lost to Follow-up|1
5306214|NCT00402337|18284757|P2|Overall Study|Lost to Follow-up|0
5306215|NCT00402337|18284758|P1|Overall Study|Lost to Follow-up|0
5306216|NCT00402337|18284754|P5|Overall Study|Withdrawal by Subject|4
5306217|NCT00402337|18284755|P4|Overall Study|Withdrawal by Subject|6
5306218|NCT00402337|18284756|P3|Overall Study|Withdrawal by Subject|1
5306219|NCT00402337|18284757|P2|Overall Study|Withdrawal by Subject|3
5306220|NCT00402337|18284758|P1|Overall Study|Withdrawal by Subject|5
5306221|NCT00402337|18284754|P5|Overall Study|Noncompliance|2
5306222|NCT00402337|18284755|P4|Overall Study|Noncompliance|0
5306223|NCT00402337|18284756|P3|Overall Study|Noncompliance|0
5306224|NCT00402337|18284757|P2|Overall Study|Noncompliance|0
5306225|NCT00402337|18284758|P1|Overall Study|Noncompliance|0
5306226|NCT00402337|18284754|P5|Overall Study|Adverse Event|2
5306227|NCT00402337|18284755|P4|Overall Study|Adverse Event|3
5306228|NCT00402337|18284756|P3|Overall Study|Adverse Event|2
5306229|NCT00402337|18284757|P2|Overall Study|Adverse Event|2
5306230|NCT00402337|18284758|P1|Overall Study|Adverse Event|0
5306231|NCT00402324|18284797|P2|Overall Study|Death|0
5306232|NCT00402324|18284798|P1|Overall Study|Death|1
5306233|NCT00402324|18284797|P2|Overall Study|Adverse Event|4
5306234|NCT00402324|18284798|P1|Overall Study|Adverse Event|6
5306235|NCT00402324|18284797|P2|Overall Study|Lack of Efficacy|4
5306236|NCT00402324|18284798|P1|Overall Study|Lack of Efficacy|1
5306237|NCT00402324|18284797|P2|Overall Study|Sponsor Decision|5
5306238|NCT00402324|18284798|P1|Overall Study|Sponsor Decision|4
5306239|NCT00402324|18284797|P2|Overall Study|Physician Decision|4
5306240|NCT00402324|18284798|P1|Overall Study|Physician Decision|2
5306241|NCT00402324|18284797|P2|Overall Study|Withdrawal by Subject|2
5306242|NCT00402324|18284798|P1|Overall Study|Withdrawal by Subject|5
5306243|NCT00402324|18284797|P2|Overall Study|Protocol Violation|7
5306244|NCT00402324|18284798|P1|Overall Study|Protocol Violation|8
5306245|NCT00402324|18284797|P2|Overall Study|Protocol Entry Criteria Not Met|4
5306246|NCT00402324|18284798|P1|Overall Study|Protocol Entry Criteria Not Met|5
5306247|NCT00402324|18284797|P2|Overall Study|Lost to Follow-up|11
5306248|NCT00402324|18284798|P1|Overall Study|Lost to Follow-up|11
5306249|NCT00402285|18284831|P3|Overall Study|insufficient RNA quality|2
5306250|NCT00402285|18284832|P2|Overall Study|insufficient RNA quality|6
5306251|NCT00402285|18284833|P1|Overall Study|insufficient RNA quality|7
5306252|NCT00402246|18284841|P2|Overall Study|Deterioriating Condition|2
5306253|NCT00402246|18284842|P1|Overall Study|Deterioriating Condition|3
5306254|NCT00402246|18284841|P2|Overall Study|Center Closure|3
5306255|NCT00402246|18284842|P1|Overall Study|Center Closure|5
5306256|NCT00402246|18284841|P2|Overall Study|Patient's device explanted|2
5306257|NCT00402246|18284842|P1|Overall Study|Patient's device explanted|6
5306258|NCT00402246|18284841|P2|Overall Study|Heart Transplant|1
5306259|NCT00402246|18284842|P1|Overall Study|Heart Transplant|0
5306260|NCT00402246|18284841|P2|Overall Study|Insurance Issues|1
5306261|NCT00402246|18284842|P1|Overall Study|Insurance Issues|2
5306262|NCT00402246|18284841|P2|Overall Study|Missed Final Visit|2
5306263|NCT00402246|18284842|P1|Overall Study|Missed Final Visit|1
5306264|NCT00402246|18284841|P2|Overall Study|Protocol Violation|24
5306265|NCT00402246|18284842|P1|Overall Study|Protocol Violation|25
5306266|NCT00402246|18284841|P2|Overall Study|Physician Decision|26
5306267|NCT00402246|18284842|P1|Overall Study|Physician Decision|24
5306268|NCT00402246|18284841|P2|Overall Study|Withdrawal by Subject|87
5306269|NCT00402246|18284842|P1|Overall Study|Withdrawal by Subject|72
5306270|NCT00402246|18284841|P2|Overall Study|Lost to Follow-up|28
5306271|NCT00402246|18284842|P1|Overall Study|Lost to Follow-up|20
5306272|NCT00402246|18284841|P2|Overall Study|Death|58
5306273|NCT00402246|18284842|P1|Overall Study|Death|62
5306274|NCT00402233|18284876|P4|Overall Study|Worsening of other pre-existing disease|0
5306275|NCT00402233|18284877|P3|Overall Study|Worsening of other pre-existing disease|0
5306276|NCT00402233|18284878|P2|Overall Study|Worsening of other pre-existing disease|1
5306277|NCT00402233|18284879|P1|Overall Study|Worsening of other pre-existing disease|0
5306278|NCT00402233|18284876|P4|Overall Study|Worsening of disease under study|0
5306279|NCT00402233|18284877|P3|Overall Study|Worsening of disease under study|0
5306280|NCT00402233|18284878|P2|Overall Study|Worsening of disease under study|0
5306281|NCT00402233|18284879|P1|Overall Study|Worsening of disease under study|2
5306282|NCT00402233|18284876|P4|Overall Study|Withdrawal by Subject|2
5306283|NCT00402233|18284877|P3|Overall Study|Withdrawal by Subject|2
5306284|NCT00402233|18284878|P2|Overall Study|Withdrawal by Subject|1
5306285|NCT00402233|18284879|P1|Overall Study|Withdrawal by Subject|2
5306286|NCT00402233|18284876|P4|Overall Study|Protocol Violation|0
5306287|NCT00402233|18284877|P3|Overall Study|Protocol Violation|0
5306288|NCT00402233|18284878|P2|Overall Study|Protocol Violation|1
5306289|NCT00402233|18284879|P1|Overall Study|Protocol Violation|0
5306290|NCT00402233|18284876|P4|Overall Study|Adverse Event|9
5306291|NCT00402233|18284877|P3|Overall Study|Adverse Event|9
5306292|NCT00402233|18284878|P2|Overall Study|Adverse Event|7
5306293|NCT00402233|18284879|P1|Overall Study|Adverse Event|1
5306294|NCT00402168|18284914|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
5306295|NCT00402168|18284915|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
5306296|NCT00402168|18284914|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
5306297|NCT00402168|18284915|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
5306298|NCT00402168|18284914|P2|Long Term (LT)|non-specified|2
5306299|NCT00402168|18284915|P1|Long Term (LT)|non-specified|1
5306300|NCT00402168|18284914|P2|Long Term (LT)|Lack of Efficacy|2
5306301|NCT00402168|18284915|P1|Long Term (LT)|Lack of Efficacy|0
5306302|NCT00402168|18284914|P2|Long Term (LT)|Death|0
5306303|NCT00402168|18284915|P1|Long Term (LT)|Death|4
5306304|NCT00402168|18284914|P2|Long Term (LT)|Lost to Follow-up|0
5306305|NCT00402168|18284915|P1|Long Term (LT)|Lost to Follow-up|1
5306306|NCT00402168|18284914|P2|Long Term (LT)|Pregnancy|1
5306307|NCT00402168|18284915|P1|Long Term (LT)|Pregnancy|0
5306308|NCT00402168|18284914|P2|Long Term (LT)|Withdrawal by Subject|7
5306309|NCT00402168|18284915|P1|Long Term (LT)|Withdrawal by Subject|4
5306310|NCT00402168|18284914|P2|Long Term (LT)|Adverse Event|5
5306311|NCT00402168|18284915|P1|Long Term (LT)|Adverse Event|1
5306312|NCT00402168|18284914|P2|Treatment (up to 12 Months)|non-specified|1
5306313|NCT00402168|18284915|P1|Treatment (up to 12 Months)|non-specified|0
5306314|NCT00402168|18284914|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
5306315|NCT00402168|18284915|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
5306316|NCT00402168|18284914|P2|Treatment (up to 12 Months)|Death|1
5306317|NCT00402168|18284915|P1|Treatment (up to 12 Months)|Death|0
5306318|NCT00402168|18284914|P2|Randomized|Withdrawal by Subject|1
5306319|NCT00402168|18284915|P1|Randomized|Withdrawal by Subject|0
5306320|NCT00402168|18284914|P2|Randomized|Lost to Follow-up|0
5306321|NCT00402168|18284915|P1|Randomized|Lost to Follow-up|1
5306322|NCT00402116|18284973|P3|Overall Study|Adverse Event|6
5306323|NCT00402116|18284974|P2|Overall Study|Adverse Event|1
5306324|NCT00402116|18284975|P1|Overall Study|Adverse Event|0
5306325|NCT00402116|18284973|P3|Overall Study|decline related hyponatremia/tumor|1
5306326|NCT00402116|18284974|P2|Overall Study|decline related hyponatremia/tumor|0
5306327|NCT00402116|18284975|P1|Overall Study|decline related hyponatremia/tumor|0
5306328|NCT00402116|18284973|P3|Overall Study|mistaken thrombocytopenia|1
5306329|NCT00402116|18284974|P2|Overall Study|mistaken thrombocytopenia|0
5306330|NCT00402116|18284975|P1|Overall Study|mistaken thrombocytopenia|0
5306331|NCT00402116|18284973|P3|Overall Study|Disease Progression|38
5306332|NCT00402116|18284974|P2|Overall Study|Disease Progression|4
5306333|NCT00402116|18284975|P1|Overall Study|Disease Progression|0
5306334|NCT00402116|18284973|P3|Overall Study|other complicating disease|2
5306335|NCT00402116|18284974|P2|Overall Study|other complicating disease|0
5306336|NCT00402116|18284975|P1|Overall Study|other complicating disease|0
5306337|NCT00402116|18284973|P3|Overall Study|Treatment completed per protocol|2
5306338|NCT00402116|18284974|P2|Overall Study|Treatment completed per protocol|1
5306339|NCT00402116|18284975|P1|Overall Study|Treatment completed per protocol|1
5306340|NCT00402116|18284973|P3|Overall Study|Withdrawal by Subject|5
5306341|NCT00402116|18284974|P2|Overall Study|Withdrawal by Subject|0
5306342|NCT00402116|18284975|P1|Overall Study|Withdrawal by Subject|1
5306343|NCT00402116|18284973|P3|Overall Study|Jaw infection after surgery-other|0
5306344|NCT00402116|18284974|P2|Overall Study|Jaw infection after surgery-other|0
5306345|NCT00402116|18284975|P1|Overall Study|Jaw infection after surgery-other|1
5306346|NCT00402103|18285005|P2|Overall Study|Administrative problems|0
5306347|NCT00402103|18285006|P1|Overall Study|Administrative problems|2
5306348|NCT00402103|18285005|P2|Overall Study|Lost to Follow-up|3
5306349|NCT00402103|18285006|P1|Overall Study|Lost to Follow-up|6
5306350|NCT00402103|18285005|P2|Overall Study|Patient withdrew consent|1
5306351|NCT00402103|18285006|P1|Overall Study|Patient withdrew consent|12
5306352|NCT00402103|18285005|P2|Overall Study|Protocol Deviation|0
5306353|NCT00402103|18285006|P1|Overall Study|Protocol Deviation|8
5306354|NCT00402103|18285005|P2|Overall Study|Condition no longer requires study drug|0
5306355|NCT00402103|18285006|P1|Overall Study|Condition no longer requires study drug|2
5306356|NCT00402103|18285005|P2|Overall Study|Unsatisfactory therapeutic effect|2
5306357|NCT00402103|18285006|P1|Overall Study|Unsatisfactory therapeutic effect|1
5306358|NCT00402103|18285005|P2|Overall Study|Adverse Event|7
5306359|NCT00402103|18285006|P1|Overall Study|Adverse Event|60
5306360|NCT00402051|18285022|P2|Overall Study|Lost to Follow-up|0
5306361|NCT00402051|18285023|P1|Overall Study|Lost to Follow-up|1
5306362|NCT00402051|18285022|P2|Overall Study|Death Due to Adverse Event|2
5306363|NCT00402051|18285023|P1|Overall Study|Death Due to Adverse Event|0
5306364|NCT00402051|18285022|P2|Overall Study|Death Due to Study Disease|1
5306365|NCT00402051|18285023|P1|Overall Study|Death Due to Study Disease|2
5306366|NCT00402051|18285022|P2|Overall Study|Death - Related to Study Drug|2
5306367|NCT00402051|18285023|P1|Overall Study|Death - Related to Study Drug|1
5306368|NCT00402051|18285022|P2|Overall Study|Withdrawal by Subject|3
5306369|NCT00402051|18285023|P1|Overall Study|Withdrawal by Subject|3
5306370|NCT00402051|18285022|P2|Overall Study|Physician Decision|3
5306371|NCT00402051|18285023|P1|Overall Study|Physician Decision|7
5306372|NCT00402051|18285022|P2|Overall Study|Adverse Event|4
5306373|NCT00402051|18285023|P1|Overall Study|Adverse Event|11
5306374|NCT00402051|18285022|P2|Overall Study|Progressive Disease|20
5306375|NCT00402051|18285023|P1|Overall Study|Progressive Disease|13
5306376|NCT00402025|18285040|P3|Overall Study|Participant Decision|1
5306377|NCT00402025|18285041|P2|Overall Study|Participant Decision|0
5306378|NCT00402025|18285042|P1|Overall Study|Participant Decision|0
5306379|NCT00402025|18285040|P3|Overall Study|Physician Decision|0
5306380|NCT00402025|18285041|P2|Overall Study|Physician Decision|1
5306381|NCT00402025|18285042|P1|Overall Study|Physician Decision|1
5306382|NCT00402025|18285040|P3|Overall Study|Disease Progression|2
5306383|NCT00402025|18285041|P2|Overall Study|Disease Progression|1
5306384|NCT00402025|18285042|P1|Overall Study|Disease Progression|1
5306385|NCT00402025|18285040|P3|Overall Study|Death|5
5306386|NCT00402025|18285041|P2|Overall Study|Death|1
5306387|NCT00402025|18285042|P1|Overall Study|Death|0
5306388|NCT00402025|18285040|P3|Overall Study|Adverse Event|2
5306389|NCT00402025|18285041|P2|Overall Study|Adverse Event|0
5306390|NCT00402025|18285042|P1|Overall Study|Adverse Event|0
5306391|NCT00401973|18285068|P3|Overall Study|Withdrawal by Subject|9
5306392|NCT00401973|18285069|P2|Overall Study|Withdrawal by Subject|12
5306393|NCT00401973|18285070|P1|Overall Study|Withdrawal by Subject|4
5306394|NCT00401973|18285068|P3|Overall Study|Sponsor Decision|0
5306395|NCT00401973|18285069|P2|Overall Study|Sponsor Decision|1
5306396|NCT00401973|18285070|P1|Overall Study|Sponsor Decision|0
5306397|NCT00401973|18285068|P3|Overall Study|Protocol Violation|3
5306398|NCT00401973|18285069|P2|Overall Study|Protocol Violation|2
5306399|NCT00401973|18285070|P1|Overall Study|Protocol Violation|1
5306400|NCT00401973|18285068|P3|Overall Study|Physician Decision|1
5306401|NCT00401973|18285069|P2|Overall Study|Physician Decision|0
5306402|NCT00401973|18285070|P1|Overall Study|Physician Decision|2
5306403|NCT00401973|18285068|P3|Overall Study|Lost to Follow-up|2
5306404|NCT00401973|18285069|P2|Overall Study|Lost to Follow-up|2
5306405|NCT00401973|18285070|P1|Overall Study|Lost to Follow-up|2
5306406|NCT00401973|18285068|P3|Overall Study|Lack of Efficacy|3
5306407|NCT00401973|18285069|P2|Overall Study|Lack of Efficacy|0
5306408|NCT00401973|18285070|P1|Overall Study|Lack of Efficacy|0
5306409|NCT00401973|18285068|P3|Overall Study|Clinical Relapse|1
5306410|NCT00401973|18285069|P2|Overall Study|Clinical Relapse|1
5306411|NCT00401973|18285070|P1|Overall Study|Clinical Relapse|0
5306412|NCT00401973|18285068|P3|Overall Study|Adverse Event|4
5306413|NCT00401973|18285069|P2|Overall Study|Adverse Event|8
5306414|NCT00401973|18285070|P1|Overall Study|Adverse Event|2
5306415|NCT00401960|18285109|P2|Overall Study|Death|0
5306416|NCT00401960|18285110|P1|Overall Study|Death|2
5306417|NCT00401960|18285109|P2|Overall Study|Lost to Follow-up|0
5306418|NCT00401960|18285110|P1|Overall Study|Lost to Follow-up|3
5306419|NCT00401843|18285140|P3|Overall Study|Received incorrect treatment|0
5306420|NCT00401843|18285141|P2|Overall Study|Received incorrect treatment|3
5306421|NCT00401843|18285142|P1|Overall Study|Received incorrect treatment|0
5306422|NCT00401843|18285140|P3|Overall Study|Randomized but not Treated|3
5306423|NCT00401843|18285141|P2|Overall Study|Randomized but not Treated|2
5306424|NCT00401843|18285142|P1|Overall Study|Randomized but not Treated|0
5306425|NCT00401843|18285140|P3|Overall Study|Withdrawal of consent to study agent|17
5306426|NCT00401843|18285141|P2|Overall Study|Withdrawal of consent to study agent|15
5306427|NCT00401843|18285142|P1|Overall Study|Withdrawal of consent to study agent|1
5306428|NCT00401843|18285140|P3|Overall Study|Withdrawal by Subject|5
5306429|NCT00401843|18285141|P2|Overall Study|Withdrawal by Subject|5
5306430|NCT00401843|18285142|P1|Overall Study|Withdrawal by Subject|1
5306431|NCT00401843|18285140|P3|Overall Study|Protocol Violation|1
5306432|NCT00401843|18285141|P2|Overall Study|Protocol Violation|0
5306433|NCT00401843|18285142|P1|Overall Study|Protocol Violation|0
5306434|NCT00401843|18285140|P3|Overall Study|Physician Decision|10
5306435|NCT00401843|18285141|P2|Overall Study|Physician Decision|16
5306436|NCT00401843|18285142|P1|Overall Study|Physician Decision|0
5306437|NCT00401843|18285140|P3|Overall Study|Other Unspecified|5
5306438|NCT00401843|18285141|P2|Overall Study|Other Unspecified|3
5306439|NCT00401843|18285142|P1|Overall Study|Other Unspecified|0
5306440|NCT00401843|18285140|P3|Overall Study|Lost to Follow-up|2
5306441|NCT00401843|18285141|P2|Overall Study|Lost to Follow-up|0
5306442|NCT00401843|18285142|P1|Overall Study|Lost to Follow-up|0
5306443|NCT00401843|18285140|P3|Overall Study|End of Study|2
5306444|NCT00401843|18285141|P2|Overall Study|End of Study|1
5306445|NCT00401843|18285142|P1|Overall Study|End of Study|1
5306446|NCT00401843|18285140|P3|Overall Study|Disease progression|49
5306447|NCT00401843|18285141|P2|Overall Study|Disease progression|60
5306448|NCT00401843|18285142|P1|Overall Study|Disease progression|10
5306449|NCT00401843|18285140|P3|Overall Study|Death|10
5306450|NCT00401843|18285141|P2|Overall Study|Death|8
5306451|NCT00401843|18285142|P1|Overall Study|Death|0
5306452|NCT00401843|18285140|P3|Overall Study|Adverse Event|27
5306453|NCT00401843|18285141|P2|Overall Study|Adverse Event|26
5306454|NCT00401843|18285142|P1|Overall Study|Adverse Event|7
5306455|NCT00401843|18285140|P3|Overall Study|Achieved Complete Response|11
5306456|NCT00401843|18285141|P2|Overall Study|Achieved Complete Response|5
5306457|NCT00401843|18285142|P1|Overall Study|Achieved Complete Response|1
5306458|NCT00401830|18285160|P2|Overall Study|Other: Personal / Family problems|0
5306459|NCT00401830|18285161|P1|Overall Study|Other: Personal / Family problems|1
5306460|NCT00401830|18285160|P2|Overall Study|Lost to Follow-up|3
5306461|NCT00401830|18285161|P1|Overall Study|Lost to Follow-up|1
5306462|NCT00401830|18285160|P2|Overall Study|Non-compliance with drug study|0
5306463|NCT00401830|18285161|P1|Overall Study|Non-compliance with drug study|1
5306464|NCT00401830|18285160|P2|Overall Study|Protocol Violation|3
5306465|NCT00401830|18285161|P1|Overall Study|Protocol Violation|3
5306466|NCT00401830|18285160|P2|Overall Study|Withdrawal by Subject|3
5306467|NCT00401830|18285161|P1|Overall Study|Withdrawal by Subject|4
5306468|NCT00401830|18285160|P2|Overall Study|Lack of Efficacy|5
5306469|NCT00401830|18285161|P1|Overall Study|Lack of Efficacy|11
5306470|NCT00401830|18285160|P2|Overall Study|Adverse Event|18
5306471|NCT00401830|18285161|P1|Overall Study|Adverse Event|10
5306472|NCT00401752|18285219|P2|Overall Study|Physician Decision|1
5306473|NCT00401752|18285220|P1|Overall Study|Physician Decision|1
5306474|NCT00401752|18285219|P2|Overall Study|Development of any exclusion criteria|2
5306475|NCT00401752|18285220|P1|Overall Study|Development of any exclusion criteria|4
5306476|NCT00401752|18285219|P2|Overall Study|Lost to Follow-up|4
5306477|NCT00401752|18285220|P1|Overall Study|Lost to Follow-up|1
5306478|NCT00401752|18285219|P2|Overall Study|Withdrawal by Subject|6
5306479|NCT00401752|18285220|P1|Overall Study|Withdrawal by Subject|2
5306480|NCT00401752|18285219|P2|Overall Study|Adverse Event|5
5306481|NCT00401752|18285220|P1|Overall Study|Adverse Event|2
5306482|NCT00401726|18285238|P2|Overall Study|Protocol Deviation|4
5306483|NCT00401726|18285239|P1|Overall Study|Protocol Deviation|9
5306484|NCT00401726|18285238|P2|Overall Study|Lack of Efficacy|6
5306485|NCT00401726|18285239|P1|Overall Study|Lack of Efficacy|4
5306486|NCT00401726|18285238|P2|Overall Study|Withdrawal by Subject|24
5306487|NCT00401726|18285239|P1|Overall Study|Withdrawal by Subject|18
5306488|NCT00401726|18285238|P2|Overall Study|Protocol Violation|3
5306489|NCT00401726|18285239|P1|Overall Study|Protocol Violation|6
5306490|NCT00401726|18285238|P2|Overall Study|Lost to Follow-up|20
5306491|NCT00401726|18285239|P1|Overall Study|Lost to Follow-up|23
5306492|NCT00401726|18285238|P2|Overall Study|Physician Decision|6
5306493|NCT00401726|18285239|P1|Overall Study|Physician Decision|3
5306494|NCT00401726|18285238|P2|Overall Study|Sponsor Request|1
5306495|NCT00401726|18285239|P1|Overall Study|Sponsor Request|0
5306496|NCT00401726|18285238|P2|Overall Study|Death|3
5306497|NCT00401726|18285239|P1|Overall Study|Death|0
5306498|NCT00401726|18285238|P2|Overall Study|Adverse Event|45
5306499|NCT00401726|18285239|P1|Overall Study|Adverse Event|34
5306500|NCT00401544|18285274|P4|Overall Study|Other|2
5306501|NCT00401544|18285275|P3|Overall Study|Other|2
5306502|NCT00401544|18285276|P2|Overall Study|Other|0
5306503|NCT00401544|18285277|P1|Overall Study|Other|0
5306504|NCT00401544|18285274|P4|Overall Study|Disease progression|0
5306505|NCT00401544|18285275|P3|Overall Study|Disease progression|0
5306506|NCT00401544|18285276|P2|Overall Study|Disease progression|1
5306507|NCT00401544|18285277|P1|Overall Study|Disease progression|0
5306508|NCT00401544|18285274|P4|Overall Study|Ineligibility determined|2
5306509|NCT00401544|18285275|P3|Overall Study|Ineligibility determined|0
5306510|NCT00401544|18285276|P2|Overall Study|Ineligibility determined|1
5306511|NCT00401544|18285277|P1|Overall Study|Ineligibility determined|0
5306512|NCT00401544|18285274|P4|Overall Study|Physician Decision|0
5306513|NCT00401544|18285275|P3|Overall Study|Physician Decision|0
5306514|NCT00401544|18285276|P2|Overall Study|Physician Decision|3
5306515|NCT00401544|18285277|P1|Overall Study|Physician Decision|1
5306516|NCT00401544|18285274|P4|Overall Study|Withdrawal by Subject|5
5306517|NCT00401544|18285275|P3|Overall Study|Withdrawal by Subject|6
5306518|NCT00401544|18285276|P2|Overall Study|Withdrawal by Subject|6
5306519|NCT00401544|18285277|P1|Overall Study|Withdrawal by Subject|7
5306520|NCT00401544|18285274|P4|Overall Study|Lost to Follow-up|1
5306521|NCT00401544|18285275|P3|Overall Study|Lost to Follow-up|1
5306522|NCT00401544|18285276|P2|Overall Study|Lost to Follow-up|0
5306523|NCT00401544|18285277|P1|Overall Study|Lost to Follow-up|2
5306524|NCT00401544|18285274|P4|Overall Study|Death|5
5306525|NCT00401544|18285275|P3|Overall Study|Death|2
5306526|NCT00401544|18285276|P2|Overall Study|Death|6
5306527|NCT00401544|18285277|P1|Overall Study|Death|3
5306528|NCT00401544|18285274|P4|Overall Study|Adverse Event|1
5306529|NCT00401544|18285275|P3|Overall Study|Adverse Event|1
5306530|NCT00401544|18285276|P2|Overall Study|Adverse Event|1
5306531|NCT00401544|18285277|P1|Overall Study|Adverse Event|5
5306532|NCT00401531|18285317|P2|Overall Study|Withdrawal by Subject|2
5306533|NCT00401531|18285318|P1|Overall Study|Withdrawal by Subject|3
5306534|NCT00401531|18285317|P2|Overall Study|Lost to Follow-up|1
5306535|NCT00401531|18285318|P1|Overall Study|Lost to Follow-up|1
5306536|NCT00401531|18285317|P2|Overall Study|Protocol Violation|7
5306537|NCT00401531|18285318|P1|Overall Study|Protocol Violation|3
5306538|NCT00401531|18285317|P2|Overall Study|Adverse Event|0
5306539|NCT00401531|18285318|P1|Overall Study|Adverse Event|2
5306540|NCT00401375|18285422|P3|Overall Study|Randomized but not treated|3
5306541|NCT00401375|18285423|P2|Overall Study|Randomized but not treated|3
5306542|NCT00401375|18285424|P1|Overall Study|Randomized but not treated|3
5306543|NCT00401375|18285422|P3|Overall Study|Other than specified|3
5306544|NCT00401375|18285423|P2|Overall Study|Other than specified|1
5306545|NCT00401375|18285424|P1|Overall Study|Other than specified|2
5306546|NCT00401375|18285422|P3|Overall Study|Lost to Follow-up|1
5306547|NCT00401375|18285423|P2|Overall Study|Lost to Follow-up|1
5306548|NCT00401375|18285424|P1|Overall Study|Lost to Follow-up|0
5306549|NCT00401375|18285422|P3|Overall Study|Withdrawal by Subject|7
5306550|NCT00401375|18285423|P2|Overall Study|Withdrawal by Subject|7
5306551|NCT00401375|18285424|P1|Overall Study|Withdrawal by Subject|9
5306552|NCT00401375|18285422|P3|Overall Study|Adverse Event|10
5306553|NCT00401375|18285423|P2|Overall Study|Adverse Event|11
5306554|NCT00401375|18285424|P1|Overall Study|Adverse Event|6
5306555|NCT00401375|18285422|P3|Overall Study|Protocol Violation|1
5306556|NCT00401375|18285423|P2|Overall Study|Protocol Violation|2
5306557|NCT00401375|18285424|P1|Overall Study|Protocol Violation|2
5306558|NCT00401258|18285441|P1|Overall Study|Adverse Event|7
5306559|NCT00401245|18285456|P8|Double Blind Tapering Phase|Lack of Efficacy|0
5306560|NCT00401245|18285457|P7|Double Blind Tapering Phase|Lack of Efficacy|0
5306561|NCT00401245|18285458|P6|Double Blind Tapering Phase|Lack of Efficacy|1
5306562|NCT00401245|18285459|P5|Double Blind Tapering Phase|Lack of Efficacy|0
5306563|NCT00401245|18285460|P4|Double Blind Tapering Phase|Lack of Efficacy|0
5306564|NCT00401245|18285461|P3|Double Blind Tapering Phase|Lack of Efficacy|0
5306565|NCT00401245|18285462|P2|Double Blind Tapering Phase|Lack of Efficacy|0
5306566|NCT00401245|18285463|P1|Double Blind Tapering Phase|Lack of Efficacy|0
5306567|NCT00401245|18285456|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
5306568|NCT00401245|18285457|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
5306569|NCT00401245|18285458|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
5306570|NCT00401245|18285459|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
5306571|NCT00401245|18285460|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
5306572|NCT00401245|18285461|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
5306573|NCT00401245|18285462|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
5306574|NCT00401245|18285463|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
5306575|NCT00401245|18285456|P8|Double Blind Tapering Phase|Other|2
5306576|NCT00401245|18285457|P7|Double Blind Tapering Phase|Other|2
5306577|NCT00401245|18285458|P6|Double Blind Tapering Phase|Other|0
5306578|NCT00401245|18285459|P5|Double Blind Tapering Phase|Other|1
5306579|NCT00401245|18285460|P4|Double Blind Tapering Phase|Other|0
5306580|NCT00401245|18285461|P3|Double Blind Tapering Phase|Other|0
5306581|NCT00401245|18285462|P2|Double Blind Tapering Phase|Other|0
5306582|NCT00401245|18285463|P1|Double Blind Tapering Phase|Other|0
5306583|NCT00401245|18285456|P8|Double Blind Tapering Phase|Investigator request|1
5306584|NCT00401245|18285457|P7|Double Blind Tapering Phase|Investigator request|0
5306585|NCT00401245|18285458|P6|Double Blind Tapering Phase|Investigator request|0
5306586|NCT00401245|18285459|P5|Double Blind Tapering Phase|Investigator request|0
5306587|NCT00401245|18285460|P4|Double Blind Tapering Phase|Investigator request|0
5306588|NCT00401245|18285461|P3|Double Blind Tapering Phase|Investigator request|0
5306589|NCT00401245|18285462|P2|Double Blind Tapering Phase|Investigator request|0
5306590|NCT00401245|18285463|P1|Double Blind Tapering Phase|Investigator request|0
5306591|NCT00401245|18285456|P8|Double Blind Tapering Phase|Adverse Event|4
5306592|NCT00401245|18285457|P7|Double Blind Tapering Phase|Adverse Event|2
5306593|NCT00401245|18285458|P6|Double Blind Tapering Phase|Adverse Event|1
5306594|NCT00401245|18285459|P5|Double Blind Tapering Phase|Adverse Event|1
5306595|NCT00401245|18285460|P4|Double Blind Tapering Phase|Adverse Event|0
5306596|NCT00401245|18285461|P3|Double Blind Tapering Phase|Adverse Event|0
5306597|NCT00401245|18285462|P2|Double Blind Tapering Phase|Adverse Event|0
5306598|NCT00401245|18285463|P1|Double Blind Tapering Phase|Adverse Event|0
5306599|NCT00401245|18285456|P8|Open Label Phase|Lack of Efficacy|0
5306600|NCT00401245|18285457|P7|Open Label Phase|Lack of Efficacy|0
5306601|NCT00401245|18285458|P6|Open Label Phase|Lack of Efficacy|0
5306602|NCT00401245|18285459|P5|Open Label Phase|Lack of Efficacy|0
5306603|NCT00401245|18285460|P4|Open Label Phase|Lack of Efficacy|0
5306604|NCT00401245|18285461|P3|Open Label Phase|Lack of Efficacy|3
5306605|NCT00401245|18285462|P2|Open Label Phase|Lack of Efficacy|2
5306606|NCT00401245|18285463|P1|Open Label Phase|Lack of Efficacy|4
5306607|NCT00401245|18285456|P8|Open Label Phase|Withdrawal by Subject|0
5306608|NCT00401245|18285457|P7|Open Label Phase|Withdrawal by Subject|0
5306609|NCT00401245|18285458|P6|Open Label Phase|Withdrawal by Subject|0
5306610|NCT00401245|18285459|P5|Open Label Phase|Withdrawal by Subject|0
5306611|NCT00401245|18285460|P4|Open Label Phase|Withdrawal by Subject|1
5306612|NCT00401245|18285461|P3|Open Label Phase|Withdrawal by Subject|2
5306613|NCT00401245|18285462|P2|Open Label Phase|Withdrawal by Subject|3
5306614|NCT00401245|18285463|P1|Open Label Phase|Withdrawal by Subject|3
5306615|NCT00401245|18285456|P8|Open Label Phase|Protocol Violation|0
5306616|NCT00401245|18285457|P7|Open Label Phase|Protocol Violation|0
5306617|NCT00401245|18285458|P6|Open Label Phase|Protocol Violation|0
5306618|NCT00401245|18285459|P5|Open Label Phase|Protocol Violation|0
5306619|NCT00401245|18285460|P4|Open Label Phase|Protocol Violation|1
5306620|NCT00401245|18285461|P3|Open Label Phase|Protocol Violation|0
5306621|NCT00401245|18285462|P2|Open Label Phase|Protocol Violation|1
5306622|NCT00401245|18285463|P1|Open Label Phase|Protocol Violation|0
5306623|NCT00401245|18285456|P8|Open Label Phase|Other|0
5306624|NCT00401245|18285457|P7|Open Label Phase|Other|0
5306625|NCT00401245|18285458|P6|Open Label Phase|Other|0
5306626|NCT00401245|18285459|P5|Open Label Phase|Other|0
5306627|NCT00401245|18285460|P4|Open Label Phase|Other|8
5306628|NCT00401245|18285461|P3|Open Label Phase|Other|7
5306629|NCT00401245|18285462|P2|Open Label Phase|Other|8
5306630|NCT00401245|18285463|P1|Open Label Phase|Other|4
5306631|NCT00401245|18285456|P8|Open Label Phase|Lost to Follow-up|0
5306632|NCT00401245|18285457|P7|Open Label Phase|Lost to Follow-up|0
5306633|NCT00401245|18285458|P6|Open Label Phase|Lost to Follow-up|0
5306634|NCT00401245|18285459|P5|Open Label Phase|Lost to Follow-up|0
5306635|NCT00401245|18285460|P4|Open Label Phase|Lost to Follow-up|4
5306636|NCT00401245|18285461|P3|Open Label Phase|Lost to Follow-up|5
5306637|NCT00401245|18285462|P2|Open Label Phase|Lost to Follow-up|7
5306638|NCT00401245|18285463|P1|Open Label Phase|Lost to Follow-up|5
5306639|NCT00401245|18285456|P8|Open Label Phase|Adverse Event|0
5306640|NCT00401245|18285457|P7|Open Label Phase|Adverse Event|0
5306641|NCT00401245|18285458|P6|Open Label Phase|Adverse Event|0
5306642|NCT00401245|18285459|P5|Open Label Phase|Adverse Event|0
5306643|NCT00401245|18285460|P4|Open Label Phase|Adverse Event|7
5306644|NCT00401245|18285461|P3|Open Label Phase|Adverse Event|6
5306645|NCT00401245|18285462|P2|Open Label Phase|Adverse Event|14
5306646|NCT00401245|18285463|P1|Open Label Phase|Adverse Event|5
5306647|NCT00401245|18285456|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
5306648|NCT00401245|18285457|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
5306649|NCT00401245|18285458|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
5306650|NCT00401245|18285459|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
5306651|NCT00401245|18285460|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
5306652|NCT00401245|18285461|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
5306653|NCT00401245|18285462|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
5306654|NCT00401245|18285463|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
5306655|NCT00401245|18285456|P8|Double Blind Titration Phase|Withdrawal by Subject|0
5306656|NCT00401245|18285457|P7|Double Blind Titration Phase|Withdrawal by Subject|0
5306657|NCT00401245|18285458|P6|Double Blind Titration Phase|Withdrawal by Subject|0
5306658|NCT00401245|18285459|P5|Double Blind Titration Phase|Withdrawal by Subject|0
5306659|NCT00401245|18285460|P4|Double Blind Titration Phase|Withdrawal by Subject|2
5306660|NCT00401245|18285461|P3|Double Blind Titration Phase|Withdrawal by Subject|0
5306661|NCT00401245|18285462|P2|Double Blind Titration Phase|Withdrawal by Subject|1
5306662|NCT00401245|18285463|P1|Double Blind Titration Phase|Withdrawal by Subject|1
5306663|NCT00401245|18285456|P8|Double Blind Titration Phase|Protocol Violation|0
5306664|NCT00401245|18285457|P7|Double Blind Titration Phase|Protocol Violation|0
5306665|NCT00401245|18285458|P6|Double Blind Titration Phase|Protocol Violation|0
5306666|NCT00401245|18285459|P5|Double Blind Titration Phase|Protocol Violation|0
5306667|NCT00401245|18285460|P4|Double Blind Titration Phase|Protocol Violation|1
5306668|NCT00401245|18285461|P3|Double Blind Titration Phase|Protocol Violation|0
5306669|NCT00401245|18285462|P2|Double Blind Titration Phase|Protocol Violation|0
5306670|NCT00401245|18285463|P1|Double Blind Titration Phase|Protocol Violation|0
5306671|NCT00401245|18285456|P8|Double Blind Titration Phase|Other|0
5306672|NCT00401245|18285457|P7|Double Blind Titration Phase|Other|0
5306673|NCT00401245|18285458|P6|Double Blind Titration Phase|Other|0
5306674|NCT00401245|18285459|P5|Double Blind Titration Phase|Other|0
5306675|NCT00401245|18285460|P4|Double Blind Titration Phase|Other|0
5306676|NCT00401245|18285461|P3|Double Blind Titration Phase|Other|1
5306677|NCT00401245|18285462|P2|Double Blind Titration Phase|Other|0
5306678|NCT00401245|18285463|P1|Double Blind Titration Phase|Other|0
5306679|NCT00401245|18285456|P8|Double Blind Titration Phase|Adverse Event|0
5306680|NCT00401245|18285457|P7|Double Blind Titration Phase|Adverse Event|0
5306681|NCT00401245|18285458|P6|Double Blind Titration Phase|Adverse Event|0
5306682|NCT00401245|18285459|P5|Double Blind Titration Phase|Adverse Event|0
5306683|NCT00401245|18285460|P4|Double Blind Titration Phase|Adverse Event|12
5306684|NCT00401245|18285461|P3|Double Blind Titration Phase|Adverse Event|5
5306685|NCT00401245|18285462|P2|Double Blind Titration Phase|Adverse Event|2
5306686|NCT00401245|18285463|P1|Double Blind Titration Phase|Adverse Event|3
5306687|NCT00401193|18285531|P3|Overall Study|Other Event|2
5306688|NCT00401193|18285532|P2|Overall Study|Other Event|2
5306689|NCT00401193|18285533|P1|Overall Study|Other Event|3
5306690|NCT00401193|18285531|P3|Overall Study|Withdrawal by Subject|1
5306691|NCT00401193|18285532|P2|Overall Study|Withdrawal by Subject|0
5306692|NCT00401193|18285533|P1|Overall Study|Withdrawal by Subject|2
5306693|NCT00401193|18285531|P3|Overall Study|Lost to Follow-up|1
5306694|NCT00401193|18285532|P2|Overall Study|Lost to Follow-up|5
5306695|NCT00401193|18285533|P1|Overall Study|Lost to Follow-up|6
5306696|NCT00401193|18285531|P3|Overall Study|Protocol Violation|1
5306697|NCT00401193|18285532|P2|Overall Study|Protocol Violation|1
5306698|NCT00401193|18285533|P1|Overall Study|Protocol Violation|3
5306699|NCT00401193|18285531|P3|Overall Study|Adverse Event|1
5306700|NCT00401193|18285532|P2|Overall Study|Adverse Event|3
5306701|NCT00401193|18285533|P1|Overall Study|Adverse Event|1
5306702|NCT00400985|18285551|P1|Overall Study|Lost to Follow-up|9
5306703|NCT00400985|18285551|P1|Overall Study|Death|30
5306704|NCT00400985|18285551|P1|Overall Study|system modification|8
5306705|NCT00400985|18285551|P1|Overall Study|Withdrawal by Subject|5
5306706|NCT00400946|18285560|P5|Overall Study|Other|1
5306707|NCT00400946|18285561|P4|Overall Study|Other|0
5306708|NCT00400946|18285562|P3|Overall Study|Other|0
5306709|NCT00400946|18285563|P2|Overall Study|Other|0
5306710|NCT00400946|18285564|P1|Overall Study|Other|0
5306711|NCT00400946|18285560|P5|Overall Study|Clinical|9
5306712|NCT00400946|18285561|P4|Overall Study|Clinical|2
5306713|NCT00400946|18285562|P3|Overall Study|Clinical|0
5306714|NCT00400946|18285563|P2|Overall Study|Clinical|2
5306715|NCT00400946|18285564|P1|Overall Study|Clinical|1
5306716|NCT00400946|18285560|P5|Overall Study|Withdrawal by Subject|8
5306717|NCT00400946|18285561|P4|Overall Study|Withdrawal by Subject|5
5306718|NCT00400946|18285562|P3|Overall Study|Withdrawal by Subject|1
5306719|NCT00400946|18285563|P2|Overall Study|Withdrawal by Subject|5
5306720|NCT00400946|18285564|P1|Overall Study|Withdrawal by Subject|2
5306721|NCT00400946|18285560|P5|Overall Study|Transplant in CR1|1
5306722|NCT00400946|18285561|P4|Overall Study|Transplant in CR1|10
5306723|NCT00400946|18285562|P3|Overall Study|Transplant in CR1|0
5306724|NCT00400946|18285563|P2|Overall Study|Transplant in CR1|0
5306725|NCT00400946|18285564|P1|Overall Study|Transplant in CR1|0
5306726|NCT00400946|18285560|P5|Overall Study|Relapse|5
5306727|NCT00400946|18285561|P4|Overall Study|Relapse|1
5306728|NCT00400946|18285562|P3|Overall Study|Relapse|1
5306729|NCT00400946|18285563|P2|Overall Study|Relapse|2
5306730|NCT00400946|18285564|P1|Overall Study|Relapse|9
5306731|NCT00400946|18285560|P5|Overall Study|Remission Death|1
5306732|NCT00400946|18285561|P4|Overall Study|Remission Death|0
5306733|NCT00400946|18285562|P3|Overall Study|Remission Death|0
5306734|NCT00400946|18285563|P2|Overall Study|Remission Death|1
5306735|NCT00400946|18285564|P1|Overall Study|Remission Death|1
5306736|NCT00400946|18285560|P5|Overall Study|Lost to Follow-up|1
5306737|NCT00400946|18285561|P4|Overall Study|Lost to Follow-up|0
5306738|NCT00400946|18285562|P3|Overall Study|Lost to Follow-up|0
5306739|NCT00400946|18285563|P2|Overall Study|Lost to Follow-up|1
5306740|NCT00400946|18285564|P1|Overall Study|Lost to Follow-up|1
5306741|NCT00400946|18285560|P5|Overall Study|Induction Death|3
5306742|NCT00400946|18285561|P4|Overall Study|Induction Death|13
5306743|NCT00400946|18285562|P3|Overall Study|Induction Death|0
5306744|NCT00400946|18285563|P2|Overall Study|Induction Death|0
5306745|NCT00400946|18285564|P1|Overall Study|Induction Death|0
5306746|NCT00400946|18285560|P5|Overall Study|Induction Failure|8
5306747|NCT00400946|18285561|P4|Overall Study|Induction Failure|11
5306748|NCT00400946|18285562|P3|Overall Study|Induction Failure|0
5306749|NCT00400946|18285563|P2|Overall Study|Induction Failure|0
5306750|NCT00400946|18285564|P1|Overall Study|Induction Failure|0
5306751|NCT00400946|18285560|P5|Overall Study|Ineligible|1
5306752|NCT00400946|18285561|P4|Overall Study|Ineligible|5
5306753|NCT00400946|18285562|P3|Overall Study|Ineligible|0
5306754|NCT00400946|18285563|P2|Overall Study|Ineligible|0
5306755|NCT00400946|18285564|P1|Overall Study|Ineligible|0
5306756|NCT00400764|18285623|P5|Phase II|Withdrawal by Subject|0
5306757|NCT00400764|18285624|P4|Phase II|Withdrawal by Subject|1
5306758|NCT00400764|18285625|P3|Phase II|Withdrawal by Subject|1
5306759|NCT00400764|18285626|P2|Phase II|Withdrawal by Subject|0
5306760|NCT00400764|18285627|P1|Phase II|Withdrawal by Subject|0
5306761|NCT00400764|18285623|P5|Phase II|Patient began new, non-protocol, therapy|0
5306762|NCT00400764|18285624|P4|Phase II|Patient began new, non-protocol, therapy|0
5306763|NCT00400764|18285625|P3|Phase II|Patient began new, non-protocol, therapy|1
5306764|NCT00400764|18285626|P2|Phase II|Patient began new, non-protocol, therapy|0
5306765|NCT00400764|18285627|P1|Phase II|Patient began new, non-protocol, therapy|0
5306766|NCT00400764|18285623|P5|Phase II|Sponsor's decision to terminate|11
5306767|NCT00400764|18285624|P4|Phase II|Sponsor's decision to terminate|22
5306768|NCT00400764|18285625|P3|Phase II|Sponsor's decision to terminate|18
5306769|NCT00400764|18285626|P2|Phase II|Sponsor's decision to terminate|0
5306770|NCT00400764|18285627|P1|Phase II|Sponsor's decision to terminate|0
5306771|NCT00400764|18285623|P5|Phase II|Physician Decision|0
5306772|NCT00400764|18285624|P4|Phase II|Physician Decision|1
5306773|NCT00400764|18285625|P3|Phase II|Physician Decision|1
5306774|NCT00400764|18285626|P2|Phase II|Physician Decision|0
5306775|NCT00400764|18285627|P1|Phase II|Physician Decision|0
5306776|NCT00400764|18285623|P5|Phase II|Lost to Follow-up|0
5306777|NCT00400764|18285624|P4|Phase II|Lost to Follow-up|0
5306778|NCT00400764|18285625|P3|Phase II|Lost to Follow-up|1
5306779|NCT00400764|18285626|P2|Phase II|Lost to Follow-up|0
5306780|NCT00400764|18285627|P1|Phase II|Lost to Follow-up|0
5306781|NCT00400764|18285623|P5|Phase II|Death|0
5306782|NCT00400764|18285624|P4|Phase II|Death|2
5306783|NCT00400764|18285625|P3|Phase II|Death|1
5306784|NCT00400764|18285626|P2|Phase II|Death|0
5306785|NCT00400764|18285627|P1|Phase II|Death|0
5306786|NCT00400764|18285623|P5|Phase Ib|Disease Progression|0
5306787|NCT00400764|18285624|P4|Phase Ib|Disease Progression|0
5306788|NCT00400764|18285625|P3|Phase Ib|Disease Progression|0
5306789|NCT00400764|18285626|P2|Phase Ib|Disease Progression|4
5306790|NCT00400764|18285627|P1|Phase Ib|Disease Progression|4
5306791|NCT00400764|18285623|P5|Phase Ib|Death|0
5306792|NCT00400764|18285624|P4|Phase Ib|Death|0
5306793|NCT00400764|18285625|P3|Phase Ib|Death|0
5306794|NCT00400764|18285626|P2|Phase Ib|Death|0
5306795|NCT00400764|18285627|P1|Phase Ib|Death|1
5306796|NCT00400764|18285623|P5|Phase Ib|Adverse Event|0
5306797|NCT00400764|18285624|P4|Phase Ib|Adverse Event|0
5306798|NCT00400764|18285625|P3|Phase Ib|Adverse Event|0
5306799|NCT00400764|18285626|P2|Phase Ib|Adverse Event|0
5306800|NCT00400764|18285627|P1|Phase Ib|Adverse Event|1
5306801|NCT00400712|18285680|P2|Overall Study|Physician Decision|4
5306802|NCT00400712|18285681|P1|Overall Study|Physician Decision|5
5306803|NCT00400712|18285680|P2|Overall Study|Withdrawal by Subject|12
5306804|NCT00400712|18285681|P1|Overall Study|Withdrawal by Subject|11
5306805|NCT00400712|18285680|P2|Overall Study|Death|0
5306806|NCT00400712|18285681|P1|Overall Study|Death|1
5306807|NCT00400569|18285716|P1|Overall Study|Death|1
5306808|NCT00400517|18285727|P1|Overall Study|Physician Decision|1
5306809|NCT00400517|18285727|P1|Overall Study|Withdrawal by Subject|1
5306810|NCT00400400|18285747|P2|Overall Study|Did not receive study drug|3
5306811|NCT00400400|18285748|P1|Overall Study|Did not receive study drug|1
5306812|NCT00400400|18285747|P2|Overall Study|Lost to Follow-up|1
5306813|NCT00400400|18285748|P1|Overall Study|Lost to Follow-up|0
5306814|NCT00400400|18285747|P2|Overall Study|Administrative Problem|0
5306815|NCT00400400|18285748|P1|Overall Study|Administrative Problem|1
5306816|NCT00400400|18285747|P2|Overall Study|Withdrawal by Subject|3
5306817|NCT00400400|18285748|P1|Overall Study|Withdrawal by Subject|1
5306818|NCT00400400|18285747|P2|Overall Study|Protocol Violation|0
5306819|NCT00400400|18285748|P1|Overall Study|Protocol Violation|2
5306820|NCT00400400|18285747|P2|Overall Study|Adverse Event|8
5306821|NCT00400400|18285748|P1|Overall Study|Adverse Event|9
5306822|NCT00400179|18285773|P2|Overall Study|Randomization error/patient ineligible|6
5306823|NCT00400179|18285774|P1|Overall Study|Randomization error/patient ineligible|1
5306824|NCT00400179|18285773|P2|Overall Study|Investigator judgment|1
5306825|NCT00400179|18285774|P1|Overall Study|Investigator judgment|0
5306826|NCT00400179|18285773|P2|Overall Study|Intercurrent illness|1
5306827|NCT00400179|18285774|P1|Overall Study|Intercurrent illness|0
5306828|NCT00400179|18285773|P2|Overall Study|Disease progression|1
5306829|NCT00400179|18285774|P1|Overall Study|Disease progression|1
5306830|NCT00400179|18285773|P2|Overall Study|Withdrew Consent|5
5306831|NCT00400179|18285774|P1|Overall Study|Withdrew Consent|1
5306832|NCT00400179|18285773|P2|Overall Study|Death|2
5306833|NCT00400179|18285774|P1|Overall Study|Death|1
5306834|NCT00400179|18285773|P2|Overall Study|Adverse Event|2
5306835|NCT00400179|18285774|P1|Overall Study|Adverse Event|2
5306836|NCT00400153|18285791|P3|Overall Study|Other reasons - not mentioned above|3
5306837|NCT00400153|18285792|P2|Overall Study|Other reasons - not mentioned above|5
5306838|NCT00400153|18285793|P1|Overall Study|Other reasons - not mentioned above|8
5306839|NCT00400153|18285791|P3|Overall Study|Withdrawal by Subject|10
5306840|NCT00400153|18285792|P2|Overall Study|Withdrawal by Subject|11
5306841|NCT00400153|18285793|P1|Overall Study|Withdrawal by Subject|12
5306842|NCT00400153|18285791|P3|Overall Study|Lost to Follow-up|4
5306843|NCT00400153|18285792|P2|Overall Study|Lost to Follow-up|1
5306844|NCT00400153|18285793|P1|Overall Study|Lost to Follow-up|2
5306845|NCT00400153|18285791|P3|Overall Study|Protocol Violation|9
5306846|NCT00400153|18285792|P2|Overall Study|Protocol Violation|4
5306847|NCT00400153|18285793|P1|Overall Study|Protocol Violation|7
5306848|NCT00400153|18285791|P3|Overall Study|AE due to other condition|15
5306849|NCT00400153|18285792|P2|Overall Study|AE due to other condition|14
5306850|NCT00400153|18285793|P1|Overall Study|AE due to other condition|3
5306851|NCT00400153|18285791|P3|Overall Study|AE due to other disease worsening|0
5306852|NCT00400153|18285792|P2|Overall Study|AE due to other disease worsening|1
5306853|NCT00400153|18285793|P1|Overall Study|AE due to other disease worsening|2
5306854|NCT00400153|18285791|P3|Overall Study|AE due to study disease worsening|20
5306855|NCT00400153|18285792|P2|Overall Study|AE due to study disease worsening|19
5306856|NCT00400153|18285793|P1|Overall Study|AE due to study disease worsening|14
5306857|NCT00399893|18286040|P2|Overall Study|Withdrawal by Subject|0
5306858|NCT00399893|18286041|P1|Overall Study|Withdrawal by Subject|1
5306859|NCT00399802|18286080|P2|Overall Study|Participant discontinued by mistake|1
5306860|NCT00399802|18286081|P1|Overall Study|Participant discontinued by mistake|0
5306861|NCT00399802|18286080|P2|Overall Study|Adverse Event|2
5306862|NCT00399802|18286081|P1|Overall Study|Adverse Event|0
5306863|NCT00399763|18286095|P2|Overall Study|Lost to Follow-up|3
5306864|NCT00399763|18286096|P1|Overall Study|Lost to Follow-up|2
5306865|NCT00399568|18286108|P2|Overall Study|Lost to Follow-up|2
5306866|NCT00399568|18286109|P1|Overall Study|Lost to Follow-up|2
5306867|NCT00399568|18286108|P2|Overall Study|Protocol non-compliance|2
5306868|NCT00399568|18286109|P1|Overall Study|Protocol non-compliance|2
5306869|NCT00399568|18286108|P2|Overall Study|Withdrawal by Subject|3
5306870|NCT00399568|18286109|P1|Overall Study|Withdrawal by Subject|7
5306871|NCT00399568|18286108|P2|Overall Study|Adverse Event|2
5306872|NCT00399568|18286109|P1|Overall Study|Adverse Event|1
5306873|NCT00399542|18286123|P2|Overall Study|Physician Decision|1
5306874|NCT00399542|18286124|P1|Overall Study|Physician Decision|0
5306875|NCT00399542|18286123|P2|Overall Study|Other|0
5306876|NCT00399542|18286124|P1|Overall Study|Other|1
5306877|NCT00399542|18286123|P2|Overall Study|Lost to Follow-up|6
5306878|NCT00399542|18286124|P1|Overall Study|Lost to Follow-up|6
5306879|NCT00399542|18286123|P2|Overall Study|Lack of Efficacy|8
5306880|NCT00399542|18286124|P1|Overall Study|Lack of Efficacy|18
5306881|NCT00399542|18286123|P2|Overall Study|Withdrawal by Subject|10
5306882|NCT00399542|18286124|P1|Overall Study|Withdrawal by Subject|28
5306883|NCT00399542|18286123|P2|Overall Study|Protocol Violation|3
5306884|NCT00399542|18286124|P1|Overall Study|Protocol Violation|13
5306885|NCT00399542|18286123|P2|Overall Study|Adverse Event|15
5306886|NCT00399542|18286124|P1|Overall Study|Adverse Event|18
5306887|NCT00399529|18286186|P1|Overall Study|Off Study Prior to Treatment|2
5306888|NCT00399516|18286192|P1|Overall Study|Lost to Follow-up|2
5306889|NCT00399360|18286200|P4|Overall Study|Withdrawal by Subject|2
5306890|NCT00399360|18286201|P3|Overall Study|Withdrawal by Subject|0
5306891|NCT00399360|18286202|P2|Overall Study|Withdrawal by Subject|2
5306892|NCT00399360|18286203|P1|Overall Study|Withdrawal by Subject|0
5306893|NCT00399360|18286200|P4|Overall Study|Adverse Event|0
5306894|NCT00399360|18286201|P3|Overall Study|Adverse Event|1
5306895|NCT00399360|18286202|P2|Overall Study|Adverse Event|0
5306896|NCT00399360|18286203|P1|Overall Study|Adverse Event|0
5306897|NCT00399360|18286200|P4|Overall Study|Lost to Follow-up|4
5306898|NCT00399360|18286201|P3|Overall Study|Lost to Follow-up|2
5306899|NCT00399360|18286202|P2|Overall Study|Lost to Follow-up|1
5306900|NCT00399360|18286203|P1|Overall Study|Lost to Follow-up|2
5306901|NCT00399035|18286274|P3|Overall Study|Severe non-compliance with protocol|0
5306902|NCT00399035|18286275|P2|Overall Study|Severe non-compliance with protocol|1
5306903|NCT00399035|18286276|P1|Overall Study|Severe non-compliance with protocol|2
5306904|NCT00399035|18286274|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
5306905|NCT00399035|18286275|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
5306906|NCT00399035|18286276|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
5306907|NCT00399035|18286274|P3|Overall Study|Withdrawal by Subject|12
5306908|NCT00399035|18286275|P2|Overall Study|Withdrawal by Subject|15
5306909|NCT00399035|18286276|P1|Overall Study|Withdrawal by Subject|19
5306910|NCT00399035|18286274|P3|Overall Study|Lost to Follow-up|5
5306911|NCT00399035|18286275|P2|Overall Study|Lost to Follow-up|1
5306912|NCT00399035|18286276|P1|Overall Study|Lost to Follow-up|2
5306913|NCT00399035|18286274|P3|Overall Study|Death|234
5306914|NCT00399035|18286275|P2|Overall Study|Death|141
5306915|NCT00399035|18286276|P1|Overall Study|Death|289
5306916|NCT00398866|18286312|P3|Overall Study|Unable to complete requirements of study|1
5306917|NCT00398866|18286313|P2|Overall Study|Unable to complete requirements of study|1
5306918|NCT00398866|18286314|P1|Overall Study|Unable to complete requirements of study|1
5306919|NCT00398866|18286312|P3|Overall Study|Withdrawal by Subject|2
5306920|NCT00398866|18286313|P2|Overall Study|Withdrawal by Subject|1
5306921|NCT00398866|18286314|P1|Overall Study|Withdrawal by Subject|5
5306922|NCT00398866|18286312|P3|Overall Study|Lost to Follow-up|4
5306923|NCT00398866|18286313|P2|Overall Study|Lost to Follow-up|6
5306924|NCT00398866|18286314|P1|Overall Study|Lost to Follow-up|7
5306925|NCT00398866|18286312|P3|Overall Study|Lack of Efficacy|1
5306926|NCT00398866|18286313|P2|Overall Study|Lack of Efficacy|0
5306927|NCT00398866|18286314|P1|Overall Study|Lack of Efficacy|0
5306928|NCT00398866|18286312|P3|Overall Study|Adverse Event|0
5306929|NCT00398866|18286313|P2|Overall Study|Adverse Event|0
5306930|NCT00398866|18286314|P1|Overall Study|Adverse Event|1
5306931|NCT00398632|18286325|P1|Overall Study|Lack of Efficacy|1
5306932|NCT00398632|18286325|P1|Overall Study|Withdrawal by Subject|1
5306933|NCT00398567|18286333|P3|Overall Study|Protocol Violation|1
5306934|NCT00398567|18286334|P2|Overall Study|Protocol Violation|0
5306935|NCT00398567|18286335|P1|Overall Study|Protocol Violation|0
5306936|NCT00398567|18286333|P3|Overall Study|Adverse Event|2
5306937|NCT00398567|18286334|P2|Overall Study|Adverse Event|0
5306938|NCT00398567|18286335|P1|Overall Study|Adverse Event|0
5306939|NCT00398567|18286333|P3|Overall Study|Withdrawal by Subject|4
5306940|NCT00398567|18286334|P2|Overall Study|Withdrawal by Subject|0
5306941|NCT00398567|18286335|P1|Overall Study|Withdrawal by Subject|1
5306942|NCT00398567|18286333|P3|Overall Study|Disease Progression|27
5306943|NCT00398567|18286334|P2|Overall Study|Disease Progression|4
5306944|NCT00398567|18286335|P1|Overall Study|Disease Progression|3
5306945|NCT00398411|18286389|P2|Overall Study|Death|1
5306946|NCT00398411|18286390|P1|Overall Study|Death|0
5306947|NCT00398320|18286413|P1|Overall Study|Physician Decision|1
5306948|NCT00398320|18286413|P1|Overall Study|Adverse Event|4
5306949|NCT00398320|18286413|P1|Overall Study|Death|1
5306950|NCT00398216|18286426|P5|Overall Study|entrance criteria|2
5306951|NCT00398216|18286427|P4|Overall Study|entrance criteria|0
5306952|NCT00398216|18286428|P3|Overall Study|entrance criteria|0
5306953|NCT00398216|18286429|P2|Overall Study|entrance criteria|0
5306954|NCT00398216|18286430|P1|Overall Study|entrance criteria|0
5306955|NCT00398216|18286426|P5|Overall Study|administrative reasons|3
5306956|NCT00398216|18286427|P4|Overall Study|administrative reasons|3
5306957|NCT00398216|18286428|P3|Overall Study|administrative reasons|4
5306958|NCT00398216|18286429|P2|Overall Study|administrative reasons|4
5306959|NCT00398216|18286430|P1|Overall Study|administrative reasons|3
5306960|NCT00398216|18286426|P5|Overall Study|Withdrawal by Subject|2
5306961|NCT00398216|18286427|P4|Overall Study|Withdrawal by Subject|1
5306962|NCT00398216|18286428|P3|Overall Study|Withdrawal by Subject|3
5306963|NCT00398216|18286429|P2|Overall Study|Withdrawal by Subject|0
5306964|NCT00398216|18286430|P1|Overall Study|Withdrawal by Subject|1
5306965|NCT00398216|18286426|P5|Overall Study|Death|0
5306966|NCT00398216|18286427|P4|Overall Study|Death|0
5306967|NCT00398216|18286428|P3|Overall Study|Death|0
5306968|NCT00398216|18286429|P2|Overall Study|Death|3
5306969|NCT00398216|18286430|P1|Overall Study|Death|0
5306970|NCT00398216|18286426|P5|Overall Study|Lost to Follow-up|1
5306971|NCT00398216|18286427|P4|Overall Study|Lost to Follow-up|4
5306972|NCT00398216|18286428|P3|Overall Study|Lost to Follow-up|4
5306973|NCT00398216|18286429|P2|Overall Study|Lost to Follow-up|6
5306974|NCT00398216|18286430|P1|Overall Study|Lost to Follow-up|1
5306975|NCT00398216|18286426|P5|Overall Study|Protocol Violation|5
5306976|NCT00398216|18286427|P4|Overall Study|Protocol Violation|7
5306977|NCT00398216|18286428|P3|Overall Study|Protocol Violation|5
5306978|NCT00398216|18286429|P2|Overall Study|Protocol Violation|4
5306979|NCT00398216|18286430|P1|Overall Study|Protocol Violation|2
5306980|NCT00398216|18286426|P5|Overall Study|Adverse Event|2
5306981|NCT00398216|18286427|P4|Overall Study|Adverse Event|7
5306982|NCT00398216|18286428|P3|Overall Study|Adverse Event|5
5306983|NCT00398216|18286429|P2|Overall Study|Adverse Event|2
5306984|NCT00398216|18286430|P1|Overall Study|Adverse Event|4
5306985|NCT00398138|18286457|P1|Overall Study|Adverse Event|2
5306986|NCT00398112|18286462|P1|Overall Study|Death|1
5306987|NCT00398112|18286462|P1|Overall Study|Withdrawal by Subject|3
5306988|NCT00398112|18286462|P1|Overall Study|Alternative treatment|1
5306989|NCT00398112|18286462|P1|Overall Study|Disease progression|9
5306990|NCT00398112|18286462|P1|Overall Study|Adverse Event|4
5306991|NCT00398086|18286473|P3|Overall Study|Withdrawal by Subject|0
5306992|NCT00398086|18286474|P2|Overall Study|Withdrawal by Subject|7
5306993|NCT00398086|18286475|P1|Overall Study|Withdrawal by Subject|5
5306994|NCT00398086|18286473|P3|Overall Study|Physician Decision|0
5306995|NCT00398086|18286474|P2|Overall Study|Physician Decision|4
5306996|NCT00398086|18286475|P1|Overall Study|Physician Decision|1
5306997|NCT00398086|18286473|P3|Overall Study|Adverse Event|0
5306998|NCT00398086|18286474|P2|Overall Study|Adverse Event|4
5306999|NCT00398086|18286475|P1|Overall Study|Adverse Event|1
5307000|NCT00398086|18286473|P3|Overall Study|Unacceptable Toxicity|2
5307001|NCT00398086|18286474|P2|Overall Study|Unacceptable Toxicity|8
5307002|NCT00398086|18286475|P1|Overall Study|Unacceptable Toxicity|2
5307003|NCT00398073|18286509|P2|Overall Study|Withdrawal by Subject|0
5307004|NCT00398073|18286510|P1|Overall Study|Withdrawal by Subject|1
5307005|NCT00398047|18286520|P1|Overall Study|all patient progressed before completion|3
5307006|NCT00397982|18286530|P1|Overall Study|Unrelated health issues|1
5307007|NCT00397982|18286530|P1|Overall Study|noncompliance|1
5307008|NCT00397982|18286530|P1|Overall Study|Adverse Event|1
5307009|NCT00397982|18286530|P1|Overall Study|Withdrawal by Subject|1
5307010|NCT00397943|18286544|P5|Overall Study|Unspecified reasons|0
5307011|NCT00397943|18286545|P4|Overall Study|Unspecified reasons|0
5307012|NCT00397943|18286546|P3|Overall Study|Unspecified reasons|0
5307013|NCT00397943|18286547|P2|Overall Study|Unspecified reasons|9
5307014|NCT00397943|18286548|P1|Overall Study|Unspecified reasons|12
5307015|NCT00397930|18286704|P2|Overall Study|Missing data|4
5307016|NCT00397930|18286705|P1|Overall Study|Missing data|0
5307017|NCT00397930|18286704|P2|Overall Study|Withdrawal by Subject|8
5307018|NCT00397930|18286705|P1|Overall Study|Withdrawal by Subject|0
5307019|NCT00397930|18286704|P2|Overall Study|Did not want to be in control group|1
5307020|NCT00397930|18286705|P1|Overall Study|Did not want to be in control group|0
5307021|NCT00397930|18286704|P2|Overall Study|Started own yoga program|1
5307022|NCT00397930|18286705|P1|Overall Study|Started own yoga program|1
5307023|NCT00397930|18286704|P2|Overall Study|Too time-consuming|9
5307024|NCT00397930|18286705|P1|Overall Study|Too time-consuming|2
5307025|NCT00397930|18286704|P2|Overall Study|Noncompliant|2
5307026|NCT00397930|18286705|P1|Overall Study|Noncompliant|3
5307027|NCT00397930|18286704|P2|Overall Study|Unknown reasons|14
5307028|NCT00397930|18286705|P1|Overall Study|Unknown reasons|9
5307029|NCT00397930|18286704|P2|Overall Study|Other medical|4
5307030|NCT00397930|18286705|P1|Overall Study|Other medical|9
5307031|NCT00397930|18286704|P2|Overall Study|Personal reasons|8
5307032|NCT00397930|18286705|P1|Overall Study|Personal reasons|14
5307033|NCT00397891|18286720|P5|Overall Study|Withdrawal by Subject|1
5307034|NCT00397891|18286721|P4|Overall Study|Withdrawal by Subject|0
5307035|NCT00397891|18286722|P3|Overall Study|Withdrawal by Subject|0
5307036|NCT00397891|18286723|P2|Overall Study|Withdrawal by Subject|0
5307037|NCT00397891|18286724|P1|Overall Study|Withdrawal by Subject|1
5307038|NCT00397631|18286897|P2|Overall Study|protocol discontinuation criteria|4
5307039|NCT00397631|18286898|P1|Overall Study|protocol discontinuation criteria|1
5307040|NCT00397631|18286897|P2|Overall Study|Withdrawal by Subject|14
5307041|NCT00397631|18286898|P1|Overall Study|Withdrawal by Subject|7
5307042|NCT00397631|18286897|P2|Overall Study|Protocol Violation|1
5307043|NCT00397631|18286898|P1|Overall Study|Protocol Violation|0
5307044|NCT00397631|18286897|P2|Overall Study|Physician Decision|0
5307045|NCT00397631|18286898|P1|Overall Study|Physician Decision|2
5307046|NCT00397631|18286897|P2|Overall Study|Lost to Follow-up|9
5307047|NCT00397631|18286898|P1|Overall Study|Lost to Follow-up|8
5307048|NCT00397631|18286897|P2|Overall Study|Lack of Efficacy|10
5307049|NCT00397631|18286898|P1|Overall Study|Lack of Efficacy|7
5307050|NCT00397631|18286897|P2|Overall Study|Adverse Event|6
5307051|NCT00397631|18286898|P1|Overall Study|Adverse Event|5
5307052|NCT00397540|18286914|P2|Overall Study|short follow-up duration < 12 months|0
5307053|NCT00397540|18286915|P1|Overall Study|short follow-up duration < 12 months|1
5307054|NCT00397514|18286923|P1|Overall Study|poor echocardiographic windows|1
5307055|NCT00397514|18286923|P1|Overall Study|early extubation|2
5307056|NCT00397514|18286923|P1|Overall Study|Not able to capture & pace LV intraoper.|4
5307057|NCT00397514|18286923|P1|Overall Study|Pacing wire malfunction|1
5307058|NCT00397514|18286923|P1|Overall Study|Withdrawal by Subject|1
5307059|NCT00397488|18286933|P1|Overall Study|Death|1
5307060|NCT00397488|18286933|P1|Overall Study|Adverse Event|3
5307061|NCT00397488|18286933|P1|Overall Study|Withdrawal by Subject|3
5307062|NCT00397254|18286953|P2|Overall Study|Lost to Follow-up|2
5307063|NCT00397254|18286954|P1|Overall Study|Lost to Follow-up|2
5307064|NCT00397215|18286976|P4|Month 6 (Day 180)|Other|0
5307065|NCT00397215|18286977|P3|Month 6 (Day 180)|Other|3
5307066|NCT00397215|18286978|P2|Month 6 (Day 180)|Other|0
5307067|NCT00397215|18286979|P1|Month 6 (Day 180)|Other|2
5307068|NCT00397215|18286976|P4|Month 6 (Day 180)|Adverse Event|0
5307069|NCT00397215|18286977|P3|Month 6 (Day 180)|Adverse Event|2
5307070|NCT00397215|18286978|P2|Month 6 (Day 180)|Adverse Event|3
5307071|NCT00397215|18286979|P1|Month 6 (Day 180)|Adverse Event|0
5307072|NCT00397215|18286976|P4|Month 0 (Day 0)|Other|3
5307073|NCT00397215|18286977|P3|Month 0 (Day 0)|Other|3
5307074|NCT00397215|18286978|P2|Month 0 (Day 0)|Other|1
5307075|NCT00397215|18286979|P1|Month 0 (Day 0)|Other|4
5307076|NCT00397215|18286976|P4|Month 0 (Day 0)|Withdrawal by Subject|1
5307077|NCT00397215|18286977|P3|Month 0 (Day 0)|Withdrawal by Subject|3
5307078|NCT00397215|18286978|P2|Month 0 (Day 0)|Withdrawal by Subject|3
5307079|NCT00397215|18286979|P1|Month 0 (Day 0)|Withdrawal by Subject|3
5307080|NCT00397215|18286976|P4|Month 0 (Day 0)|Adverse Event|0
5307081|NCT00397215|18286977|P3|Month 0 (Day 0)|Adverse Event|0
5307082|NCT00397215|18286978|P2|Month 0 (Day 0)|Adverse Event|1
5307083|NCT00397215|18286979|P1|Month 0 (Day 0)|Adverse Event|0
5307084|NCT00397189|18287115|P2|3 Weeks Period|Other|2
5307085|NCT00397189|18287116|P1|3 Weeks Period|Other|0
5307086|NCT00397189|18287115|P2|3 Weeks Period|Protocol Violation|3
5307087|NCT00397189|18287116|P1|3 Weeks Period|Protocol Violation|0
5307088|NCT00397189|18287115|P2|3 Weeks Period|Physician Decision|2
5307089|NCT00397189|18287116|P1|3 Weeks Period|Physician Decision|0
5307090|NCT00397189|18287115|P2|3 Weeks Period|Withdrawal by Subject|9
5307091|NCT00397189|18287116|P1|3 Weeks Period|Withdrawal by Subject|13
5307092|NCT00397189|18287115|P2|3 Weeks Period|Adverse Event|2
5307093|NCT00397189|18287116|P1|3 Weeks Period|Adverse Event|3
5307094|NCT00397189|18287115|P2|3 Weeks Period|Lost to Follow-up|4
5307095|NCT00397189|18287116|P1|3 Weeks Period|Lost to Follow-up|5
5307096|NCT00397046|18287143|P4|Overall Study|Disease Progression|5
5307097|NCT00397046|18287144|P3|Overall Study|Disease Progression|10
5307098|NCT00397046|18287145|P2|Overall Study|Disease Progression|3
5307099|NCT00397046|18287146|P1|Overall Study|Disease Progression|3
5307100|NCT00397033|18287168|P3|Overall Study|Other|2
5307101|NCT00397033|18287169|P2|Overall Study|Other|5
5307102|NCT00397033|18287170|P1|Overall Study|Other|0
5307103|NCT00397033|18287168|P3|Overall Study|Withdrawal by Subject|5
5307104|NCT00397033|18287169|P2|Overall Study|Withdrawal by Subject|7
5307105|NCT00397033|18287170|P1|Overall Study|Withdrawal by Subject|12
5307106|NCT00397033|18287168|P3|Overall Study|Lost to Follow-up|3
5307107|NCT00397033|18287169|P2|Overall Study|Lost to Follow-up|3
5307108|NCT00397033|18287170|P1|Overall Study|Lost to Follow-up|3
5307109|NCT00397033|18287168|P3|Overall Study|Lack of Efficacy|9
5307110|NCT00397033|18287169|P2|Overall Study|Lack of Efficacy|12
5307111|NCT00397033|18287170|P1|Overall Study|Lack of Efficacy|22
5307112|NCT00397033|18287168|P3|Overall Study|Adverse Event|4
5307113|NCT00397033|18287169|P2|Overall Study|Adverse Event|10
5307114|NCT00397033|18287170|P1|Overall Study|Adverse Event|7
5307115|NCT00396877|18287261|P2|Overall Study|Parent(s)/guardian(s)'s request|7
5307116|NCT00396877|18287262|P1|Overall Study|Parent(s)/guardian(s)'s request|4
5307117|NCT00396877|18287261|P2|Overall Study|Lost to Follow-up|1
5307118|NCT00396877|18287262|P1|Overall Study|Lost to Follow-up|2
5307119|NCT00396812|18287272|P1|Overall Study|Physician Decision|1
5307120|NCT00396656|18287284|P2|Second Treatment Period|Adverse Event|1
5307121|NCT00396656|18287285|P1|Second Treatment Period|Adverse Event|0
5307122|NCT00396656|18287284|P2|First Treatment Period|Withdrawal by Subject|2
5307123|NCT00396656|18287285|P1|First Treatment Period|Withdrawal by Subject|0
5307124|NCT00396630|18287303|P2|Overall Study|Not vaccinated at Visit 3|3
5307125|NCT00396630|18287304|P1|Overall Study|Not vaccinated at Visit 3|3
5307126|NCT00396630|18287303|P2|Overall Study|Withdrawal by Subject|1
5307127|NCT00396630|18287304|P1|Overall Study|Withdrawal by Subject|1
5307128|NCT00396630|18287303|P2|Overall Study|Lost to Follow-up|1
5307129|NCT00396630|18287304|P1|Overall Study|Lost to Follow-up|1
5307130|NCT00396591|18287324|P1|Overall Study|Participant request|1
5307131|NCT00396591|18287324|P1|Overall Study|Adverse Event|2
5307132|NCT00396591|18287324|P1|Overall Study|Disease Progression|13
5307133|NCT00396565|18287337|P3|Overall Study|Lack of Efficacy|11
5307134|NCT00396565|18287338|P2|Overall Study|Lack of Efficacy|64
5307135|NCT00396565|18287339|P1|Overall Study|Lack of Efficacy|32
5307136|NCT00396565|18287337|P3|Overall Study|Withdrawal by Subject|1
5307137|NCT00396565|18287338|P2|Overall Study|Withdrawal by Subject|13
5307138|NCT00396565|18287339|P1|Overall Study|Withdrawal by Subject|8
5307139|NCT00396565|18287337|P3|Overall Study|Adverse Event|3
5307140|NCT00396565|18287338|P2|Overall Study|Adverse Event|13
5307141|NCT00396565|18287339|P1|Overall Study|Adverse Event|5
5307142|NCT00396565|18287337|P3|Overall Study|Physician Decision|2
5307143|NCT00396565|18287338|P2|Overall Study|Physician Decision|1
5307144|NCT00396565|18287339|P1|Overall Study|Physician Decision|3
5307145|NCT00396409|18287364|P2|Period 2 - 2008|Lost to Follow-up|1
5307146|NCT00396409|18287365|P1|Period 2 - 2008|Lost to Follow-up|3
5307147|NCT00396409|18287364|P2|Period 2 - 2008|Withdrawal by Subject|1
5307148|NCT00396409|18287365|P1|Period 2 - 2008|Withdrawal by Subject|3
5307149|NCT00396409|18287364|P2|Period 2 - 2008|Protocol Violation|0
5307150|NCT00396409|18287365|P1|Period 2 - 2008|Protocol Violation|1
5307151|NCT00396409|18287364|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
5307152|NCT00396409|18287365|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
5307153|NCT00396409|18287364|P2|Period 1 - 2007|Lost to Follow-up|3
5307154|NCT00396409|18287365|P1|Period 1 - 2007|Lost to Follow-up|2
5307155|NCT00396409|18287364|P2|Period 1 - 2007|Withdrawal by Subject|1
5307156|NCT00396409|18287365|P1|Period 1 - 2007|Withdrawal by Subject|1
5307157|NCT00396409|18287364|P2|Period 1 - 2007|Lack of Efficacy|1
5307158|NCT00396409|18287365|P1|Period 1 - 2007|Lack of Efficacy|0
5307159|NCT00396409|18287364|P2|Period 1 - 2007|Adverse Event|1
5307160|NCT00396409|18287365|P1|Period 1 - 2007|Adverse Event|0
5307161|NCT00396383|18287395|P1|Overall Study|Lost to Follow-up|1
5307162|NCT00396383|18287395|P1|Overall Study|Death|2
5307163|NCT00396331|18287408|P1|Overall Study|Death|16
5307164|NCT00396331|18287408|P1|Overall Study|Lost to Follow-up|3
5307165|NCT00396331|18287408|P1|Overall Study|Did not go on to transplant|5
5307166|NCT00396331|18287408|P1|Overall Study|Failed to mobilize - no transplant|8
5307167|NCT00396318|18287461|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
5307168|NCT00396279|18287481|P1|Overall Study|Physician Decision|1
5307169|NCT00396279|18287481|P1|Overall Study|Withdrawal by Subject|1
5307170|NCT00396279|18287481|P1|Overall Study|Disease progression|2
5307171|NCT00396279|18287481|P1|Overall Study|Ongoing in study|26
5307172|NCT00396253|18287514|P1|Overall Study|Change in eligibility status|1
5307173|NCT00396253|18287514|P1|Overall Study|Physician Decision|1
5307174|NCT00396253|18287514|P1|Overall Study|Death|3
5307175|NCT00396253|18287514|P1|Overall Study|Withdrawal by Subject|7
5307176|NCT00396253|18287514|P1|Overall Study|Protocol Violation|1
5307177|NCT00396162|18287545|P2|Overall Study|Withdrawal by Subject|3
5307178|NCT00396162|18287546|P1|Overall Study|Withdrawal by Subject|2
5307179|NCT00396136|18287558|P1|Overall Study|Study device explanted|8
5307180|NCT00396136|18287558|P1|Overall Study|Lost to Follow-up|15
5307181|NCT00396136|18287558|P1|Overall Study|Withdrawal by Subject|59
5307182|NCT00396136|18287558|P1|Overall Study|Death|43
5307183|NCT00396097|18287565|P2|Overall Study|Insufficient Clinical Response|4
5307184|NCT00396097|18287566|P1|Overall Study|Insufficient Clinical Response|1
5307185|NCT00396097|18287565|P2|Overall Study|Adverse Event|5
5307186|NCT00396097|18287566|P1|Overall Study|Adverse Event|1
5307187|NCT00396097|18287565|P2|Overall Study|Protocol Violation|6
5307188|NCT00396097|18287566|P1|Overall Study|Protocol Violation|0
5307189|NCT00396097|18287565|P2|Overall Study|Other|5
5307190|NCT00396097|18287566|P1|Overall Study|Other|3
5307191|NCT00396097|18287565|P2|Overall Study|Lost to Follow-up|9
5307192|NCT00396097|18287566|P1|Overall Study|Lost to Follow-up|4
5307193|NCT00396097|18287565|P2|Overall Study|Withdrawal by Subject|17
5307194|NCT00396097|18287566|P1|Overall Study|Withdrawal by Subject|17
5307195|NCT00396084|18287594|P6|Overall Study|Withdrawal by Subject|0
5307196|NCT00396084|18287595|P5|Overall Study|Withdrawal by Subject|0
5307197|NCT00396084|18287596|P4|Overall Study|Withdrawal by Subject|1
5307198|NCT00396084|18287597|P3|Overall Study|Withdrawal by Subject|0
5307199|NCT00396084|18287598|P2|Overall Study|Withdrawal by Subject|0
5307200|NCT00396084|18287599|P1|Overall Study|Withdrawal by Subject|0
5307201|NCT00396084|18287594|P6|Overall Study|Adverse Event|2
5307202|NCT00396084|18287595|P5|Overall Study|Adverse Event|1
5307203|NCT00396084|18287596|P4|Overall Study|Adverse Event|0
5307204|NCT00396084|18287597|P3|Overall Study|Adverse Event|0
5307205|NCT00396084|18287598|P2|Overall Study|Adverse Event|0
5307206|NCT00396084|18287599|P1|Overall Study|Adverse Event|0
5307207|NCT00395967|18287728|P1|Follow-up Period|Lost to Follow-up|1
5307208|NCT00395967|18287728|P1|Follow-up Period|Death|1
5307209|NCT00395967|18287728|P1|Treatment Period|Failed Mobilization|1
5307210|NCT00395863|18287768|P2|Overall Study|Patients did not complete both exams|3
5307211|NCT00395863|18287769|P1|Overall Study|Patients did not complete both exams|2
5307212|NCT00395850|18287804|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
5307213|NCT00395850|18287805|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
5307214|NCT00395850|18287806|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
5307215|NCT00395850|18287807|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
5307216|NCT00395850|18287804|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
5307217|NCT00395850|18287805|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
5307218|NCT00395850|18287806|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
5307219|NCT00395850|18287807|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
5307220|NCT00395850|18287804|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
5307221|NCT00395850|18287805|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
5307222|NCT00395850|18287806|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
5307223|NCT00395850|18287807|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
5307224|NCT00395850|18287804|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
5307225|NCT00395850|18287805|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
5307226|NCT00395850|18287806|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
5307227|NCT00395850|18287807|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
5307228|NCT00395850|18287804|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
5307229|NCT00395850|18287805|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
5307230|NCT00395850|18287806|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
5307403|NCT00395304|18288292|P3|Treatment Period 3|Other|0
5307231|NCT00395850|18287807|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
5307232|NCT00395850|18287804|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
5307233|NCT00395850|18287805|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
5307234|NCT00395850|18287806|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
5307235|NCT00395850|18287807|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
5307236|NCT00395850|18287804|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
5307237|NCT00395850|18287805|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
5307238|NCT00395850|18287806|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
5307239|NCT00395850|18287807|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
5307240|NCT00395746|18287824|P3|Overall Study|Unable to visit site on schedule|0
5307241|NCT00395746|18287825|P2|Overall Study|Unable to visit site on schedule|0
5307242|NCT00395746|18287826|P1|Overall Study|Unable to visit site on schedule|1
5307243|NCT00395746|18287824|P3|Overall Study|Difficultulty in use of device|1
5307244|NCT00395746|18287825|P2|Overall Study|Difficultulty in use of device|0
5307245|NCT00395746|18287826|P1|Overall Study|Difficultulty in use of device|0
5307246|NCT00395746|18287824|P3|Overall Study|Withdrawal of consent|1
5307247|NCT00395746|18287825|P2|Overall Study|Withdrawal of consent|0
5307248|NCT00395746|18287826|P1|Overall Study|Withdrawal of consent|0
5307249|NCT00395746|18287824|P3|Overall Study|Subject decision|1
5307250|NCT00395746|18287825|P2|Overall Study|Subject decision|0
5307251|NCT00395746|18287826|P1|Overall Study|Subject decision|0
5307252|NCT00395746|18287824|P3|Overall Study|Hypoglycaemia|0
5307253|NCT00395746|18287825|P2|Overall Study|Hypoglycaemia|1
5307254|NCT00395746|18287826|P1|Overall Study|Hypoglycaemia|2
5307255|NCT00395746|18287824|P3|Overall Study|Lack of Efficacy|17
5307256|NCT00395746|18287825|P2|Overall Study|Lack of Efficacy|0
5307257|NCT00395746|18287826|P1|Overall Study|Lack of Efficacy|2
5307258|NCT00395746|18287824|P3|Overall Study|Protocol Violation|0
5307259|NCT00395746|18287825|P2|Overall Study|Protocol Violation|1
5307260|NCT00395746|18287826|P1|Overall Study|Protocol Violation|0
5307261|NCT00395746|18287824|P3|Overall Study|Adverse Event|2
5307262|NCT00395746|18287825|P2|Overall Study|Adverse Event|2
5307263|NCT00395746|18287826|P1|Overall Study|Adverse Event|5
5307264|NCT00395733|18287872|P2|Period 2|Technical problems|0
5307265|NCT00395733|18287873|P1|Period 2|Technical problems|1
5307266|NCT00395733|18287872|P2|Period 2|Adverse Event|2
5307267|NCT00395733|18287873|P1|Period 2|Adverse Event|0
5307268|NCT00395733|18287872|P2|Period 2|Protocol Violation|1
5307269|NCT00395733|18287873|P1|Period 2|Protocol Violation|0
5307270|NCT00395733|18287872|P2|Period 2|Withdrawal by Subject|2
5307271|NCT00395733|18287873|P1|Period 2|Withdrawal by Subject|1
5307272|NCT00395694|18287897|P2|Continuation Phase|Withdrawal by Subject|2
5307273|NCT00395694|18287898|P1|Continuation Phase|Withdrawal by Subject|0
5307274|NCT00395694|18287897|P2|Continuation Phase|Poor Compliance|0
5307275|NCT00395694|18287898|P1|Continuation Phase|Poor Compliance|1
5307276|NCT00395694|18287897|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
5307277|NCT00395694|18287898|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
5307278|NCT00395694|18287897|P2|Continuation Phase|Lack of Efficacy|11
5307279|NCT00395694|18287898|P1|Continuation Phase|Lack of Efficacy|12
5307280|NCT00395694|18287897|P2|Continuation Phase|Adverse Event|0
5307281|NCT00395694|18287898|P1|Continuation Phase|Adverse Event|1
5307282|NCT00395694|18287897|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
5307283|NCT00395694|18287898|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
5307284|NCT00395642|18287929|P1|Overall Study|Withdrawal by Subject|1
5307285|NCT00395642|18287929|P1|Overall Study|Physician Decision|7
5307286|NCT00395642|18287929|P1|Overall Study|Lost to Follow-up|1
5307287|NCT00395642|18287929|P1|Overall Study|Death|4
5307288|NCT00395629|18287936|P3|Extension Study|Administrative problems|1
5307289|NCT00395629|18287937|P2|Extension Study|Administrative problems|0
5307290|NCT00395629|18287938|P1|Extension Study|Administrative problems|0
5307291|NCT00395629|18287936|P3|Extension Study|Adverse Event|2
5307292|NCT00395629|18287937|P2|Extension Study|Adverse Event|0
5307293|NCT00395629|18287938|P1|Extension Study|Adverse Event|0
5307294|NCT00395629|18287936|P3|Core Study|Lost to Follow-up|1
5307295|NCT00395629|18287937|P2|Core Study|Lost to Follow-up|0
5307296|NCT00395629|18287938|P1|Core Study|Lost to Follow-up|0
5307297|NCT00395629|18287936|P3|Core Study|Withdrawal by Subject|1
5307298|NCT00395629|18287937|P2|Core Study|Withdrawal by Subject|1
5307299|NCT00395629|18287938|P1|Core Study|Withdrawal by Subject|0
5307300|NCT00395629|18287936|P3|Core Study|Protocol Violation|0
5307301|NCT00395629|18287937|P2|Core Study|Protocol Violation|0
5307302|NCT00395629|18287938|P1|Core Study|Protocol Violation|1
5307303|NCT00395629|18287936|P3|Core Study|Abnormal laboratory value(s)|1
5307304|NCT00395629|18287937|P2|Core Study|Abnormal laboratory value(s)|0
5307305|NCT00395629|18287938|P1|Core Study|Abnormal laboratory value(s)|0
5307306|NCT00395629|18287936|P3|Core Study|Adverse Event|4
5307307|NCT00395629|18287937|P2|Core Study|Adverse Event|3
5307308|NCT00395629|18287938|P1|Core Study|Adverse Event|0
5307309|NCT00395538|18287955|P3|Overall Study|Participant elected to discontinue|1
5307310|NCT00395538|18287956|P2|Overall Study|Participant elected to discontinue|0
5307311|NCT00395538|18287957|P1|Overall Study|Participant elected to discontinue|0
5307312|NCT00395538|18287955|P3|Overall Study|Partial recovery of parathyroid function|1
5307313|NCT00395538|18287956|P2|Overall Study|Partial recovery of parathyroid function|0
5307404|NCT00395304|18288293|P2|Treatment Period 3|Other|0
5307314|NCT00395538|18287957|P1|Overall Study|Partial recovery of parathyroid function|0
5307315|NCT00395538|18287955|P3|Overall Study|Pregnancy|0
5307316|NCT00395538|18287956|P2|Overall Study|Pregnancy|0
5307317|NCT00395538|18287957|P1|Overall Study|Pregnancy|1
5307318|NCT00395538|18287955|P3|Overall Study|PTH resistance|1
5307319|NCT00395538|18287956|P2|Overall Study|PTH resistance|0
5307320|NCT00395538|18287957|P1|Overall Study|PTH resistance|0
5307321|NCT00395538|18287955|P3|Overall Study|Non-compliance with study protocol|0
5307322|NCT00395538|18287956|P2|Overall Study|Non-compliance with study protocol|1
5307323|NCT00395538|18287957|P1|Overall Study|Non-compliance with study protocol|0
5307324|NCT00395538|18287955|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
5307325|NCT00395538|18287956|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
5307326|NCT00395538|18287957|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
5307327|NCT00395538|18287955|P3|Overall Study|Adverse Event|2
5307328|NCT00395538|18287956|P2|Overall Study|Adverse Event|0
5307329|NCT00395538|18287957|P1|Overall Study|Adverse Event|1
5307330|NCT00395538|18287955|P3|Overall Study|Switch to Natpara|3
5307331|NCT00395538|18287956|P2|Overall Study|Switch to Natpara|0
5307332|NCT00395538|18287957|P1|Overall Study|Switch to Natpara|0
5307333|NCT00395538|18287955|P3|Overall Study|Failed screening|4
5307334|NCT00395538|18287956|P2|Overall Study|Failed screening|0
5307335|NCT00395538|18287957|P1|Overall Study|Failed screening|0
5307336|NCT00395538|18287955|P3|Overall Study|FDA partial hold on PTH|11
5307337|NCT00395538|18287956|P2|Overall Study|FDA partial hold on PTH|0
5307338|NCT00395538|18287957|P1|Overall Study|FDA partial hold on PTH|0
5307339|NCT00395538|18287955|P3|Overall Study|Did not re-consent to revised protocol|0
5307340|NCT00395538|18287956|P2|Overall Study|Did not re-consent to revised protocol|10
5307341|NCT00395538|18287957|P1|Overall Study|Did not re-consent to revised protocol|1
5307342|NCT00395512|18288030|P4|Overall Study|Hyperglycemic Rescue|6
5307343|NCT00395512|18288031|P3|Overall Study|Hyperglycemic Rescue|4
5307344|NCT00395512|18288032|P2|Overall Study|Hyperglycemic Rescue|10
5307345|NCT00395512|18288033|P1|Overall Study|Hyperglycemic Rescue|18
5307346|NCT00395512|18288030|P4|Overall Study|Other|0
5307347|NCT00395512|18288031|P3|Overall Study|Other|0
5307348|NCT00395512|18288032|P2|Overall Study|Other|1
5307349|NCT00395512|18288033|P1|Overall Study|Other|1
5307350|NCT00395512|18288030|P4|Overall Study|Physician Decision|2
5307351|NCT00395512|18288031|P3|Overall Study|Physician Decision|2
5307352|NCT00395512|18288032|P2|Overall Study|Physician Decision|4
5307353|NCT00395512|18288033|P1|Overall Study|Physician Decision|6
5307354|NCT00395512|18288030|P4|Overall Study|Withdrawal by Subject|12
5307355|NCT00395512|18288031|P3|Overall Study|Withdrawal by Subject|5
5307356|NCT00395512|18288032|P2|Overall Study|Withdrawal by Subject|5
5307357|NCT00395512|18288033|P1|Overall Study|Withdrawal by Subject|6
5307358|NCT00395512|18288030|P4|Overall Study|Lost to Follow-up|5
5307359|NCT00395512|18288031|P3|Overall Study|Lost to Follow-up|5
5307360|NCT00395512|18288032|P2|Overall Study|Lost to Follow-up|6
5307361|NCT00395512|18288033|P1|Overall Study|Lost to Follow-up|2
5307362|NCT00395512|18288030|P4|Overall Study|Protocol Violation|7
5307363|NCT00395512|18288031|P3|Overall Study|Protocol Violation|6
5307364|NCT00395512|18288032|P2|Overall Study|Protocol Violation|3
5307365|NCT00395512|18288033|P1|Overall Study|Protocol Violation|2
5307366|NCT00395512|18288030|P4|Overall Study|Adverse Event|6
5307367|NCT00395512|18288031|P3|Overall Study|Adverse Event|6
5307368|NCT00395512|18288032|P2|Overall Study|Adverse Event|8
5307369|NCT00395512|18288033|P1|Overall Study|Adverse Event|3
5307370|NCT00395486|18288205|P2|Overall Study|Lost to Follow-up|1
5307371|NCT00395486|18288206|P1|Overall Study|Lost to Follow-up|0
5307372|NCT00395486|18288205|P2|Overall Study|Withdrawal by Subject|2
5307373|NCT00395486|18288206|P1|Overall Study|Withdrawal by Subject|5
5307374|NCT00395486|18288205|P2|Overall Study|Adverse Event|2
5307375|NCT00395486|18288206|P1|Overall Study|Adverse Event|1
5307376|NCT00395460|18288236|P2|Overall Study|Withdrawal by Subject|0
5307377|NCT00395460|18288237|P1|Overall Study|Withdrawal by Subject|1
5307378|NCT00395447|18288261|P2|Overall Study|Withdrawl - Other (not subject)|17
5307379|NCT00395447|18288262|P1|Overall Study|Withdrawl - Other (not subject)|8
5307380|NCT00395447|18288261|P2|Overall Study|Withdrawal by Subject|19
5307381|NCT00395447|18288262|P1|Overall Study|Withdrawal by Subject|24
5307382|NCT00395447|18288261|P2|Overall Study|Lost to Follow-up|43
5307383|NCT00395447|18288262|P1|Overall Study|Lost to Follow-up|52
5307384|NCT00395447|18288261|P2|Overall Study|Death|32
5307385|NCT00395447|18288262|P1|Overall Study|Death|37
5307386|NCT00395343|18288270|P2|Overall Study|Other|2
5307387|NCT00395343|18288271|P1|Overall Study|Other|5
5307388|NCT00395343|18288270|P2|Overall Study|Withdrawal by Subject|12
5307389|NCT00395343|18288271|P1|Overall Study|Withdrawal by Subject|11
5307390|NCT00395343|18288270|P2|Overall Study|Protocol Violation|8
5307391|NCT00395343|18288271|P1|Overall Study|Protocol Violation|6
5307392|NCT00395343|18288270|P2|Overall Study|Physician Decision|4
5307393|NCT00395343|18288271|P1|Overall Study|Physician Decision|2
5307394|NCT00395343|18288270|P2|Overall Study|Lost to Follow-up|4
5307395|NCT00395343|18288271|P1|Overall Study|Lost to Follow-up|4
5307396|NCT00395343|18288270|P2|Overall Study|Lack of Efficacy|1
5307397|NCT00395343|18288271|P1|Overall Study|Lack of Efficacy|0
5307398|NCT00395343|18288270|P2|Overall Study|Adverse Event|5
5307399|NCT00395343|18288271|P1|Overall Study|Adverse Event|13
5307400|NCT00395304|18288289|P6|Treatment Period 3|Other|0
5307401|NCT00395304|18288290|P5|Treatment Period 3|Other|0
5307402|NCT00395304|18288291|P4|Treatment Period 3|Other|1
5307405|NCT00395304|18288294|P1|Treatment Period 3|Other|0
5307406|NCT00395304|18288289|P6|Treatment Period 3|Physician Decision|0
5307407|NCT00395304|18288290|P5|Treatment Period 3|Physician Decision|0
5307408|NCT00395304|18288291|P4|Treatment Period 3|Physician Decision|0
5307409|NCT00395304|18288292|P3|Treatment Period 3|Physician Decision|0
5307410|NCT00395304|18288293|P2|Treatment Period 3|Physician Decision|1
5307411|NCT00395304|18288294|P1|Treatment Period 3|Physician Decision|0
5307412|NCT00395304|18288289|P6|Treatment Period 3|Lost to Follow-up|0
5307413|NCT00395304|18288290|P5|Treatment Period 3|Lost to Follow-up|0
5307414|NCT00395304|18288291|P4|Treatment Period 3|Lost to Follow-up|0
5307415|NCT00395304|18288292|P3|Treatment Period 3|Lost to Follow-up|0
5307416|NCT00395304|18288293|P2|Treatment Period 3|Lost to Follow-up|1
5307417|NCT00395304|18288294|P1|Treatment Period 3|Lost to Follow-up|1
5307418|NCT00395304|18288289|P6|Treatment Period 3|Withdrawal by Subject|1
5307419|NCT00395304|18288290|P5|Treatment Period 3|Withdrawal by Subject|0
5307420|NCT00395304|18288291|P4|Treatment Period 3|Withdrawal by Subject|1
5307421|NCT00395304|18288292|P3|Treatment Period 3|Withdrawal by Subject|0
5307422|NCT00395304|18288293|P2|Treatment Period 3|Withdrawal by Subject|0
5307423|NCT00395304|18288294|P1|Treatment Period 3|Withdrawal by Subject|0
5307424|NCT00395304|18288289|P6|Treatment Period 2|Other|0
5307425|NCT00395304|18288290|P5|Treatment Period 2|Other|0
5307426|NCT00395304|18288291|P4|Treatment Period 2|Other|0
5307427|NCT00395304|18288292|P3|Treatment Period 2|Other|0
5307428|NCT00395304|18288293|P2|Treatment Period 2|Other|1
5307429|NCT00395304|18288294|P1|Treatment Period 2|Other|0
5307430|NCT00395304|18288289|P6|Treatment Period 2|Physician Decision|0
5307431|NCT00395304|18288290|P5|Treatment Period 2|Physician Decision|0
5307432|NCT00395304|18288291|P4|Treatment Period 2|Physician Decision|0
5307433|NCT00395304|18288292|P3|Treatment Period 2|Physician Decision|1
5307434|NCT00395304|18288293|P2|Treatment Period 2|Physician Decision|0
5307435|NCT00395304|18288294|P1|Treatment Period 2|Physician Decision|0
5307436|NCT00395304|18288289|P6|Treatment Period 2|Lost to Follow-up|0
5307437|NCT00395304|18288290|P5|Treatment Period 2|Lost to Follow-up|0
5307438|NCT00395304|18288291|P4|Treatment Period 2|Lost to Follow-up|0
5307439|NCT00395304|18288292|P3|Treatment Period 2|Lost to Follow-up|0
5307440|NCT00395304|18288293|P2|Treatment Period 2|Lost to Follow-up|3
5307441|NCT00395304|18288294|P1|Treatment Period 2|Lost to Follow-up|0
5307442|NCT00395304|18288289|P6|Treatment Period 2|Withdrawal by Subject|2
5307443|NCT00395304|18288290|P5|Treatment Period 2|Withdrawal by Subject|0
5307444|NCT00395304|18288291|P4|Treatment Period 2|Withdrawal by Subject|1
5307445|NCT00395304|18288292|P3|Treatment Period 2|Withdrawal by Subject|0
5307446|NCT00395304|18288293|P2|Treatment Period 2|Withdrawal by Subject|0
5307447|NCT00395304|18288294|P1|Treatment Period 2|Withdrawal by Subject|0
5307448|NCT00395304|18288289|P6|Treatment Period 1|Physician Decision|0
5307449|NCT00395304|18288290|P5|Treatment Period 1|Physician Decision|0
5307450|NCT00395304|18288291|P4|Treatment Period 1|Physician Decision|0
5307451|NCT00395304|18288292|P3|Treatment Period 1|Physician Decision|0
5307452|NCT00395304|18288293|P2|Treatment Period 1|Physician Decision|1
5307453|NCT00395304|18288294|P1|Treatment Period 1|Physician Decision|0
5307454|NCT00395304|18288289|P6|Treatment Period 1|Lost to Follow-up|1
5307455|NCT00395304|18288290|P5|Treatment Period 1|Lost to Follow-up|0
5307456|NCT00395304|18288291|P4|Treatment Period 1|Lost to Follow-up|1
5307457|NCT00395304|18288292|P3|Treatment Period 1|Lost to Follow-up|0
5307458|NCT00395304|18288293|P2|Treatment Period 1|Lost to Follow-up|0
5307459|NCT00395304|18288294|P1|Treatment Period 1|Lost to Follow-up|1
5307460|NCT00395304|18288289|P6|Treatment Period 1|Withdrawal by Subject|1
5307461|NCT00395304|18288290|P5|Treatment Period 1|Withdrawal by Subject|1
5307462|NCT00395304|18288291|P4|Treatment Period 1|Withdrawal by Subject|2
5307463|NCT00395304|18288292|P3|Treatment Period 1|Withdrawal by Subject|0
5307464|NCT00395304|18288293|P2|Treatment Period 1|Withdrawal by Subject|3
5307465|NCT00395304|18288294|P1|Treatment Period 1|Withdrawal by Subject|0
5307466|NCT00395226|18288370|P2|Overall Study|Lost to Follow-up|1
5307467|NCT00395226|18288371|P1|Overall Study|Lost to Follow-up|0
5307468|NCT00395226|18288370|P2|Overall Study|Withdrawal by Subject|1
5307469|NCT00395226|18288371|P1|Overall Study|Withdrawal by Subject|0
5307470|NCT00395226|18288370|P2|Overall Study|Adverse Event|3
5307471|NCT00395226|18288371|P1|Overall Study|Adverse Event|4
5307472|NCT00395083|18288418|P2|Overall Study|Developed another disease|3
5307473|NCT00395083|18288419|P1|Overall Study|Developed another disease|4
5307474|NCT00395083|18288418|P2|Overall Study|Withdrawal by Subject|5
5307475|NCT00395083|18288419|P1|Overall Study|Withdrawal by Subject|6
5307476|NCT00395018|18288485|P1|Off-Treatment Follow-up|Poor/non-compliance|1
5307477|NCT00395018|18288485|P1|Off-Treatment Follow-up|Lost to Follow-up|2
5307478|NCT00395018|18288485|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
5307479|NCT00395018|18288485|P1|On-Treatment|Subject no longer meets study criteria|2
5307480|NCT00395018|18288485|P1|On-Treatment|Poor/non-compliance|2
5307481|NCT00395018|18288485|P1|On-Treatment|Other Reason|2
5307482|NCT00395018|18288485|P1|On-Treatment|Death|4
5307483|NCT00394953|18288506|P2|Second Treatment Period|Not defined|8
5307484|NCT00394953|18288507|P1|Second Treatment Period|Not defined|3
5307485|NCT00394953|18288506|P2|Second Treatment Period|Renal transplant|6
5307486|NCT00394953|18288507|P1|Second Treatment Period|Renal transplant|4
5307487|NCT00394953|18288506|P2|Second Treatment Period|Lost to Follow-up|1
5307488|NCT00394953|18288507|P1|Second Treatment Period|Lost to Follow-up|0
5307489|NCT00394953|18288506|P2|Second Treatment Period|Withdrawal by Subject|3
5307490|NCT00394953|18288507|P1|Second Treatment Period|Withdrawal by Subject|3
5307491|NCT00394953|18288506|P2|Second Treatment Period|Lack of Efficacy|47
5307492|NCT00394953|18288507|P1|Second Treatment Period|Lack of Efficacy|9
5307493|NCT00394953|18288506|P2|Second Treatment Period|Death|4
5307494|NCT00394953|18288507|P1|Second Treatment Period|Death|8
5307495|NCT00394953|18288506|P2|Second Treatment Period|Adverse Event|5
5307496|NCT00394953|18288507|P1|Second Treatment Period|Adverse Event|2
5307497|NCT00394953|18288506|P2|First Treatment Period|Not defined|1
5307498|NCT00394953|18288507|P1|First Treatment Period|Not defined|4
5307499|NCT00394953|18288506|P2|First Treatment Period|Renal transplant|7
5307500|NCT00394953|18288507|P1|First Treatment Period|Renal transplant|11
5307501|NCT00394953|18288506|P2|First Treatment Period|Lost to Follow-up|1
5307502|NCT00394953|18288507|P1|First Treatment Period|Lost to Follow-up|0
5307503|NCT00394953|18288506|P2|First Treatment Period|Withdrawal by Subject|3
5307504|NCT00394953|18288507|P1|First Treatment Period|Withdrawal by Subject|6
5307505|NCT00394953|18288506|P2|First Treatment Period|Lack of Efficacy|1
5307506|NCT00394953|18288507|P1|First Treatment Period|Lack of Efficacy|1
5307507|NCT00394953|18288506|P2|First Treatment Period|Death|7
5307508|NCT00394953|18288507|P1|First Treatment Period|Death|6
5307509|NCT00394953|18288506|P2|First Treatment Period|Adverse Event|2
5307510|NCT00394953|18288507|P1|First Treatment Period|Adverse Event|1
5307511|NCT00394914|18288525|P3|Treatment Period|Did not meet protocol eligibility|1
5307512|NCT00394914|18288526|P2|Treatment Period|Did not meet protocol eligibility|1
5307513|NCT00394914|18288527|P1|Treatment Period|Did not meet protocol eligibility|0
5307514|NCT00394914|18288525|P3|Treatment Period|Noncompliance with protocol|2
5307515|NCT00394914|18288526|P2|Treatment Period|Noncompliance with protocol|3
5307516|NCT00394914|18288527|P1|Treatment Period|Noncompliance with protocol|0
5307517|NCT00394914|18288525|P3|Treatment Period|Withdrawal by Subject|2
5307518|NCT00394914|18288526|P2|Treatment Period|Withdrawal by Subject|2
5307519|NCT00394914|18288527|P1|Treatment Period|Withdrawal by Subject|0
5307520|NCT00394914|18288525|P3|Treatment Period|Lost to Follow-up|0
5307521|NCT00394914|18288526|P2|Treatment Period|Lost to Follow-up|1
5307522|NCT00394914|18288527|P1|Treatment Period|Lost to Follow-up|0
5307523|NCT00394914|18288525|P3|Treatment Period|Adverse Event|1
5307524|NCT00394914|18288526|P2|Treatment Period|Adverse Event|3
5307525|NCT00394914|18288527|P1|Treatment Period|Adverse Event|0
5307526|NCT00394901|18288555|P4|Double-blind Phase|Found not to meet entrance criteria|1
5307527|NCT00394901|18288556|P3|Double-blind Phase|Found not to meet entrance criteria|0
5307528|NCT00394901|18288557|P2|Double-blind Phase|Found not to meet entrance criteria|0
5307529|NCT00394901|18288558|P1|Double-blind Phase|Found not to meet entrance criteria|0
5307530|NCT00394901|18288555|P4|Double-blind Phase|Entry into another study was found|0
5307531|NCT00394901|18288556|P3|Double-blind Phase|Entry into another study was found|1
5307532|NCT00394901|18288557|P2|Double-blind Phase|Entry into another study was found|0
5307533|NCT00394901|18288558|P1|Double-blind Phase|Entry into another study was found|0
5307534|NCT00394901|18288555|P4|Double-blind Phase|Lack of Compliance|0
5307535|NCT00394901|18288556|P3|Double-blind Phase|Lack of Compliance|0
5307536|NCT00394901|18288557|P2|Double-blind Phase|Lack of Compliance|3
5307537|NCT00394901|18288558|P1|Double-blind Phase|Lack of Compliance|0
5307538|NCT00394901|18288555|P4|Double-blind Phase|Subject's Personal Reason|1
5307539|NCT00394901|18288556|P3|Double-blind Phase|Subject's Personal Reason|0
5307540|NCT00394901|18288557|P2|Double-blind Phase|Subject's Personal Reason|0
5307541|NCT00394901|18288558|P1|Double-blind Phase|Subject's Personal Reason|1
5307542|NCT00394901|18288555|P4|Double-blind Phase|Death|0
5307543|NCT00394901|18288556|P3|Double-blind Phase|Death|0
5307544|NCT00394901|18288557|P2|Double-blind Phase|Death|0
5307545|NCT00394901|18288558|P1|Double-blind Phase|Death|1
5307546|NCT00394901|18288555|P4|Double-blind Phase|Protocol Violation|1
5307547|NCT00394901|18288556|P3|Double-blind Phase|Protocol Violation|0
5307548|NCT00394901|18288557|P2|Double-blind Phase|Protocol Violation|0
5307549|NCT00394901|18288558|P1|Double-blind Phase|Protocol Violation|0
5307550|NCT00394901|18288555|P4|Double-blind Phase|Lost to Follow-up|1
5307551|NCT00394901|18288556|P3|Double-blind Phase|Lost to Follow-up|0
5307552|NCT00394901|18288557|P2|Double-blind Phase|Lost to Follow-up|0
5307553|NCT00394901|18288558|P1|Double-blind Phase|Lost to Follow-up|0
5307554|NCT00394901|18288555|P4|Double-blind Phase|Withdrawal by Subject|0
5307555|NCT00394901|18288556|P3|Double-blind Phase|Withdrawal by Subject|0
5307556|NCT00394901|18288557|P2|Double-blind Phase|Withdrawal by Subject|0
5307557|NCT00394901|18288558|P1|Double-blind Phase|Withdrawal by Subject|2
5307558|NCT00394901|18288555|P4|Double-blind Phase|Lack of Efficacy|3
5307559|NCT00394901|18288556|P3|Double-blind Phase|Lack of Efficacy|1
5307560|NCT00394901|18288557|P2|Double-blind Phase|Lack of Efficacy|4
5307561|NCT00394901|18288558|P1|Double-blind Phase|Lack of Efficacy|6
5307562|NCT00394901|18288555|P4|Double-blind Phase|Adverse Event|20
5307563|NCT00394901|18288556|P3|Double-blind Phase|Adverse Event|16
5307564|NCT00394901|18288557|P2|Double-blind Phase|Adverse Event|7
5307565|NCT00394901|18288558|P1|Double-blind Phase|Adverse Event|5
5307566|NCT00394901|18288555|P4|Baseline Phase|Protocol Violation|0
5307567|NCT00394901|18288556|P3|Baseline Phase|Protocol Violation|1
5307568|NCT00394901|18288557|P2|Baseline Phase|Protocol Violation|0
5307569|NCT00394901|18288558|P1|Baseline Phase|Protocol Violation|0
5307570|NCT00394836|18288801|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
5307571|NCT00394836|18288802|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
5307655|NCT00394589|18289027|P2|Overall Study|Adverse Event|1
5307572|NCT00394836|18288801|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
5307573|NCT00394836|18288802|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
5307574|NCT00394836|18288801|P2|Extended Follow-up Phase (2-5 Years)|Death|1
5307575|NCT00394836|18288802|P1|Extended Follow-up Phase (2-5 Years)|Death|0
5307576|NCT00394836|18288801|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
5307577|NCT00394836|18288802|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
5307578|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Non compliance|1
5307579|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Non compliance|0
5307580|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
5307581|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
5307582|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Physician Decision|1
5307583|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Physician Decision|0
5307584|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
5307585|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
5307586|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Started alternative treatment|6
5307587|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Started alternative treatment|0
5307588|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
5307589|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
5307590|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Death|1
5307591|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Death|0
5307592|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Patient Refusal|2
5307593|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Patient Refusal|1
5307594|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Disease Progression|60
5307595|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Disease Progression|27
5307596|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Protocol Violation|2
5307597|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Protocol Violation|0
5307598|NCT00394836|18288801|P2|Teatment or Follow-up Phase|Adverse Event|2
5307599|NCT00394836|18288802|P1|Teatment or Follow-up Phase|Adverse Event|0
5307600|NCT00394771|18288848|P4|Overall Study|Other|0
5307601|NCT00394771|18288849|P3|Overall Study|Other|1
5307602|NCT00394771|18288850|P2|Overall Study|Other|3
5307603|NCT00394771|18288851|P1|Overall Study|Other|3
5307604|NCT00394771|18288848|P4|Overall Study|Lost to Follow-up|10
5307605|NCT00394771|18288849|P3|Overall Study|Lost to Follow-up|13
5307606|NCT00394771|18288850|P2|Overall Study|Lost to Follow-up|15
5307607|NCT00394771|18288851|P1|Overall Study|Lost to Follow-up|15
5307608|NCT00394771|18288848|P4|Overall Study|Participant pregnant|2
5307609|NCT00394771|18288849|P3|Overall Study|Participant pregnant|2
5307610|NCT00394771|18288850|P2|Overall Study|Participant pregnant|1
5307611|NCT00394771|18288851|P1|Overall Study|Participant pregnant|0
5307612|NCT00394771|18288848|P4|Overall Study|Adverse Event|8
5307613|NCT00394771|18288849|P3|Overall Study|Adverse Event|12
5307614|NCT00394771|18288850|P2|Overall Study|Adverse Event|5
5307615|NCT00394771|18288851|P1|Overall Study|Adverse Event|10
5307616|NCT00394771|18288848|P4|Overall Study|Withdrawal by Subject|12
5307617|NCT00394771|18288849|P3|Overall Study|Withdrawal by Subject|8
5307618|NCT00394771|18288850|P2|Overall Study|Withdrawal by Subject|6
5307619|NCT00394771|18288851|P1|Overall Study|Withdrawal by Subject|10
5307620|NCT00394771|18288848|P4|Overall Study|Protocol Violation|7
5307621|NCT00394771|18288849|P3|Overall Study|Protocol Violation|9
5307622|NCT00394771|18288850|P2|Overall Study|Protocol Violation|4
5307623|NCT00394771|18288851|P1|Overall Study|Protocol Violation|2
5307624|NCT00394771|18288848|P4|Overall Study|Did not meet protocol requirements|0
5307625|NCT00394771|18288849|P3|Overall Study|Did not meet protocol requirements|2
5307626|NCT00394771|18288850|P2|Overall Study|Did not meet protocol requirements|0
5307627|NCT00394771|18288851|P1|Overall Study|Did not meet protocol requirements|1
5307628|NCT00394706|18288921|P8|Overall Study|Lost to Follow-up|0
5307629|NCT00394706|18288922|P7|Overall Study|Lost to Follow-up|2
5307630|NCT00394706|18288923|P6|Overall Study|Lost to Follow-up|5
5307631|NCT00394706|18288924|P5|Overall Study|Lost to Follow-up|2
5307632|NCT00394706|18288925|P4|Overall Study|Lost to Follow-up|1
5307633|NCT00394706|18288926|P3|Overall Study|Lost to Follow-up|8
5307634|NCT00394706|18288927|P2|Overall Study|Lost to Follow-up|2
5307635|NCT00394706|18288928|P1|Overall Study|Lost to Follow-up|2
5307636|NCT00394706|18288921|P8|Overall Study|Withdrawal by Subject|0
5307637|NCT00394706|18288922|P7|Overall Study|Withdrawal by Subject|1
5307638|NCT00394706|18288923|P6|Overall Study|Withdrawal by Subject|2
5307639|NCT00394706|18288924|P5|Overall Study|Withdrawal by Subject|0
5307640|NCT00394706|18288925|P4|Overall Study|Withdrawal by Subject|0
5307641|NCT00394706|18288926|P3|Overall Study|Withdrawal by Subject|1
5307642|NCT00394706|18288927|P2|Overall Study|Withdrawal by Subject|0
5307643|NCT00394706|18288928|P1|Overall Study|Withdrawal by Subject|2
5307644|NCT00394654|18288960|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
5307645|NCT00394654|18288961|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
5307646|NCT00394654|18288960|P2|Overall Study|Lost to Follow-up|0
5307647|NCT00394654|18288961|P1|Overall Study|Lost to Follow-up|1
5307648|NCT00394589|18289026|P3|Overall Study|Protocol Violation|2
5307649|NCT00394589|18289027|P2|Overall Study|Protocol Violation|0
5307650|NCT00394589|18289028|P1|Overall Study|Protocol Violation|4
5307651|NCT00394589|18289026|P3|Overall Study|Lack of Efficacy|3
5307652|NCT00394589|18289027|P2|Overall Study|Lack of Efficacy|2
5307653|NCT00394589|18289028|P1|Overall Study|Lack of Efficacy|2
5307654|NCT00394589|18289026|P3|Overall Study|Adverse Event|2
5307656|NCT00394589|18289028|P1|Overall Study|Adverse Event|2
5307657|NCT00394524|18289038|P2|Overall Study|Withdrawal by Subject|1
5307658|NCT00394524|18289039|P1|Overall Study|Withdrawal by Subject|0
5307659|NCT00394524|18289038|P2|Overall Study|Death|0
5307660|NCT00394524|18289039|P1|Overall Study|Death|1
5307661|NCT00394524|18289038|P2|Overall Study|Protocol Violation|3
5307662|NCT00394524|18289039|P1|Overall Study|Protocol Violation|2
5307663|NCT00394472|18289053|P2|Overall Study|Lost to Follow-up|1
5307664|NCT00394472|18289054|P1|Overall Study|Lost to Follow-up|0
5307665|NCT00394472|18289053|P2|Overall Study|Physician Decision|1
5307666|NCT00394472|18289054|P1|Overall Study|Physician Decision|0
5307667|NCT00394472|18289053|P2|Overall Study|Withdrawal by Subject|2
5307668|NCT00394472|18289054|P1|Overall Study|Withdrawal by Subject|0
5307669|NCT00394472|18289053|P2|Overall Study|Adverse Event|2
5307670|NCT00394472|18289054|P1|Overall Study|Adverse Event|4
5307671|NCT00394472|18289053|P2|Overall Study|incorrect enrolment|2
5307672|NCT00394472|18289054|P1|Overall Study|incorrect enrolment|4
5307673|NCT00394472|18289053|P2|Overall Study|Protocol Violation|3
5307674|NCT00394472|18289054|P1|Overall Study|Protocol Violation|1
5307675|NCT00394433|18289062|P1|Overall Study|Alternative Therapy|1
5307676|NCT00394433|18289062|P1|Overall Study|Adverse Event|2
5307677|NCT00394355|18289073|P4|Overall Study|Lack of Efficacy|3
5307678|NCT00394355|18289074|P3|Overall Study|Lack of Efficacy|2
5307679|NCT00394355|18289075|P2|Overall Study|Lack of Efficacy|0
5307680|NCT00394355|18289076|P1|Overall Study|Lack of Efficacy|0
5307681|NCT00394355|18289073|P4|Overall Study|Administrative|1
5307682|NCT00394355|18289074|P3|Overall Study|Administrative|1
5307683|NCT00394355|18289075|P2|Overall Study|Administrative|1
5307684|NCT00394355|18289076|P1|Overall Study|Administrative|0
5307685|NCT00394355|18289073|P4|Overall Study|Noncompliance with protocol|8
5307686|NCT00394355|18289074|P3|Overall Study|Noncompliance with protocol|10
5307687|NCT00394355|18289075|P2|Overall Study|Noncompliance with protocol|3
5307688|NCT00394355|18289076|P1|Overall Study|Noncompliance with protocol|4
5307689|NCT00394355|18289073|P4|Overall Study|Lost to Follow-up|3
5307690|NCT00394355|18289074|P3|Overall Study|Lost to Follow-up|4
5307691|NCT00394355|18289075|P2|Overall Study|Lost to Follow-up|5
5307692|NCT00394355|18289076|P1|Overall Study|Lost to Follow-up|7
5307693|NCT00394355|18289073|P4|Overall Study|Subject withdrawal - related to drug|0
5307694|NCT00394355|18289074|P3|Overall Study|Subject withdrawal - related to drug|0
5307695|NCT00394355|18289075|P2|Overall Study|Subject withdrawal - related to drug|0
5307696|NCT00394355|18289076|P1|Overall Study|Subject withdrawal - related to drug|1
5307697|NCT00394355|18289073|P4|Overall Study|Subject withdrawal - unrelated to drug|6
5307698|NCT00394355|18289074|P3|Overall Study|Subject withdrawal - unrelated to drug|10
5307699|NCT00394355|18289075|P2|Overall Study|Subject withdrawal - unrelated to drug|14
5307700|NCT00394355|18289076|P1|Overall Study|Subject withdrawal - unrelated to drug|12
5307701|NCT00394355|18289073|P4|Overall Study|Did not meet protocol eligibility|2
5307702|NCT00394355|18289074|P3|Overall Study|Did not meet protocol eligibility|4
5307703|NCT00394355|18289075|P2|Overall Study|Did not meet protocol eligibility|5
5307704|NCT00394355|18289076|P1|Overall Study|Did not meet protocol eligibility|1
5307705|NCT00394355|18289073|P4|Overall Study|Adverse Event|8
5307706|NCT00394355|18289074|P3|Overall Study|Adverse Event|7
5307707|NCT00394355|18289075|P2|Overall Study|Adverse Event|6
5307708|NCT00394355|18289076|P1|Overall Study|Adverse Event|10
5307709|NCT00394251|18289182|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
5307710|NCT00394251|18289183|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
5307711|NCT00394251|18289182|P2|Overall Study|Withdrawal by Subject|11
5307712|NCT00394251|18289183|P1|Overall Study|Withdrawal by Subject|7
5307713|NCT00394251|18289182|P2|Overall Study|Protocol Violation|1
5307714|NCT00394251|18289183|P1|Overall Study|Protocol Violation|0
5307715|NCT00394251|18289182|P2|Overall Study|Physician Decision|1
5307716|NCT00394251|18289183|P1|Overall Study|Physician Decision|1
5307717|NCT00394251|18289182|P2|Overall Study|Unacceptable Toxicity|18
5307718|NCT00394251|18289183|P1|Overall Study|Unacceptable Toxicity|20
5307719|NCT00394251|18289182|P2|Overall Study|Adverse Event|5
5307720|NCT00394251|18289183|P1|Overall Study|Adverse Event|7
5307721|NCT00394212|18289211|P2|Overall Study|Withdrawal by Subject|1
5307722|NCT00394212|18289212|P1|Overall Study|Withdrawal by Subject|4
5307723|NCT00394212|18289211|P2|Overall Study|Lost to Follow-up|0
5307724|NCT00394212|18289212|P1|Overall Study|Lost to Follow-up|3
5307725|NCT00394095|18289226|P2|Overall Study|Adverse Event|0
5307726|NCT00394095|18289227|P1|Overall Study|Adverse Event|1
5307727|NCT00394082|18289235|P1|Overall Study|Other|1
5307728|NCT00394082|18289235|P1|Overall Study|Withdrawal by Subject|2
5307729|NCT00394082|18289235|P1|Overall Study|Physician Decision|4
5307730|NCT00394082|18289235|P1|Overall Study|Adverse Event|4
5307731|NCT00394082|18289235|P1|Overall Study|Unacceptable toxicity|15
5307732|NCT00393939|18289257|P2|Overall Study|Other|45
5307733|NCT00393939|18289258|P1|Overall Study|Other|37
5307734|NCT00393939|18289257|P2|Overall Study|Withdrawal by Subject|7
5307735|NCT00393939|18289258|P1|Overall Study|Withdrawal by Subject|2
5307736|NCT00393939|18289257|P2|Overall Study|Objective progression or relapse|223
5307737|NCT00393939|18289258|P1|Overall Study|Objective progression or relapse|239
5307738|NCT00393939|18289257|P2|Overall Study|Sponsor|13
5307739|NCT00393939|18289258|P1|Overall Study|Sponsor|5
5307740|NCT00393939|18289257|P2|Overall Study|Death|4
5307741|NCT00393939|18289258|P1|Overall Study|Death|10
5307742|NCT00393939|18289257|P2|Overall Study|Lost to Follow-up|4
5307743|NCT00393939|18289258|P1|Overall Study|Lost to Follow-up|2
5307744|NCT00393939|18289257|P2|Overall Study|Protocol Violation|1
5307745|NCT00393939|18289258|P1|Overall Study|Protocol Violation|1
5307746|NCT00393913|18289276|P1|CPAP|TEchnical problem with CPAP|3
5307747|NCT00393913|18289276|P1|CPAP|Physician Decision|1
5307748|NCT00393913|18289276|P1|CPAP|Withdrawal by Subject|3
5307749|NCT00393913|18289276|P1|Initial Assessment|Withdrawal by Subject|16
5307750|NCT00393913|18289276|P1|Initial Assessment|diagnosed with other sleep disorder|21
5307751|NCT00393887|18289284|P2|Overall Study|Lost to Follow-up|9
5307752|NCT00393887|18289285|P1|Overall Study|Lost to Follow-up|11
5307753|NCT00393887|18289284|P2|Overall Study|Physician Decision|0
5307754|NCT00393887|18289285|P1|Overall Study|Physician Decision|5
5307755|NCT00393861|18289313|P1|Overall Study|Disease Progression|24
5307756|NCT00393861|18289313|P1|Overall Study|Adverse Event|2
5307757|NCT00393848|18289324|P4|Overall Study|Personal reasons|0
5307758|NCT00393848|18289325|P3|Overall Study|Personal reasons|2
5307759|NCT00393848|18289326|P2|Overall Study|Personal reasons|0
5307760|NCT00393848|18289327|P1|Overall Study|Personal reasons|0
5307761|NCT00393848|18289324|P4|Overall Study|Surgical schedule|1
5307762|NCT00393848|18289325|P3|Overall Study|Surgical schedule|0
5307763|NCT00393848|18289326|P2|Overall Study|Surgical schedule|0
5307764|NCT00393848|18289327|P1|Overall Study|Surgical schedule|0
5307765|NCT00393718|18289350|P2|Overall Study|Move|0
5307766|NCT00393718|18289351|P1|Overall Study|Move|1
5307767|NCT00393718|18289350|P2|Overall Study|Missed measurement|0
5307768|NCT00393718|18289351|P1|Overall Study|Missed measurement|1
5307769|NCT00393718|18289350|P2|Overall Study|Withdrawal of consent|1
5307770|NCT00393718|18289351|P1|Overall Study|Withdrawal of consent|2
5307771|NCT00393718|18289350|P2|Overall Study|Subject decision|0
5307772|NCT00393718|18289351|P1|Overall Study|Subject decision|5
5307773|NCT00393718|18289350|P2|Overall Study|Hypoglycaemia|2
5307774|NCT00393718|18289351|P1|Overall Study|Hypoglycaemia|3
5307775|NCT00393718|18289350|P2|Overall Study|Lack of Efficacy|9
5307776|NCT00393718|18289351|P1|Overall Study|Lack of Efficacy|10
5307777|NCT00393718|18289350|P2|Overall Study|Protocol Violation|2
5307778|NCT00393718|18289351|P1|Overall Study|Protocol Violation|1
5307779|NCT00393718|18289350|P2|Overall Study|Adverse Event|8
5307780|NCT00393718|18289351|P1|Overall Study|Adverse Event|20
5307781|NCT00393705|18289383|P2|Overall Study|Physician Decision|2
5307782|NCT00393705|18289384|P1|Overall Study|Physician Decision|2
5307783|NCT00393705|18289383|P2|Overall Study|Withdrawal by Subject|3
5307784|NCT00393705|18289384|P1|Overall Study|Withdrawal by Subject|5
5307785|NCT00393705|18289383|P2|Overall Study|Protocol Violation|3
5307786|NCT00393705|18289384|P1|Overall Study|Protocol Violation|4
5307787|NCT00393705|18289383|P2|Overall Study|Entry Criteria Not Met|10
5307788|NCT00393705|18289384|P1|Overall Study|Entry Criteria Not Met|10
5307789|NCT00393705|18289383|P2|Overall Study|Lost to Follow-up|2
5307790|NCT00393705|18289384|P1|Overall Study|Lost to Follow-up|2
5307791|NCT00393705|18289383|P2|Overall Study|Death|1
5307792|NCT00393705|18289384|P1|Overall Study|Death|0
5307793|NCT00393705|18289383|P2|Overall Study|Adverse Event|2
5307794|NCT00393705|18289384|P1|Overall Study|Adverse Event|0
5307795|NCT00393523|18289413|P5|Overall Study|Vaccine supply issue|0
5307796|NCT00393523|18289414|P4|Overall Study|Vaccine supply issue|0
5307797|NCT00393523|18289415|P3|Overall Study|Vaccine supply issue|1
5307798|NCT00393523|18289416|P2|Overall Study|Vaccine supply issue|0
5307799|NCT00393523|18289417|P1|Overall Study|Vaccine supply issue|0
5307800|NCT00393523|18289413|P5|Overall Study|Difficulties in specimen collection|0
5307801|NCT00393523|18289414|P4|Overall Study|Difficulties in specimen collection|0
5307802|NCT00393523|18289415|P3|Overall Study|Difficulties in specimen collection|1
5307803|NCT00393523|18289416|P2|Overall Study|Difficulties in specimen collection|0
5307804|NCT00393523|18289417|P1|Overall Study|Difficulties in specimen collection|0
5307805|NCT00393523|18289413|P5|Overall Study|Withdrawal by Subject|0
5307806|NCT00393523|18289414|P4|Overall Study|Withdrawal by Subject|3
5307807|NCT00393523|18289415|P3|Overall Study|Withdrawal by Subject|2
5307808|NCT00393523|18289416|P2|Overall Study|Withdrawal by Subject|7
5307809|NCT00393523|18289417|P1|Overall Study|Withdrawal by Subject|6
5307810|NCT00393523|18289413|P5|Overall Study|Protocol Violation|0
5307811|NCT00393523|18289414|P4|Overall Study|Protocol Violation|1
5307812|NCT00393523|18289415|P3|Overall Study|Protocol Violation|0
5307813|NCT00393523|18289416|P2|Overall Study|Protocol Violation|2
5307814|NCT00393523|18289417|P1|Overall Study|Protocol Violation|6
5307815|NCT00393523|18289413|P5|Overall Study|Lost to Follow-up|1
5307816|NCT00393523|18289414|P4|Overall Study|Lost to Follow-up|2
5307817|NCT00393523|18289415|P3|Overall Study|Lost to Follow-up|0
5307818|NCT00393523|18289416|P2|Overall Study|Lost to Follow-up|0
5307819|NCT00393523|18289417|P1|Overall Study|Lost to Follow-up|0
5307820|NCT00393510|18289434|P2|Overall Study|Physician Decision|9
5307821|NCT00393510|18289435|P1|Overall Study|Physician Decision|3
5307822|NCT00393484|18289447|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
5307823|NCT00393484|18289448|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
5307824|NCT00393484|18289447|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
5307825|NCT00393484|18289448|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
5307826|NCT00393484|18289447|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
5307827|NCT00393484|18289448|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
5307828|NCT00393484|18289447|P2|Open-label Period (Weeks 96 to 240)|Death|0
5307829|NCT00393484|18289448|P1|Open-label Period (Weeks 96 to 240)|Death|1
5307830|NCT00393484|18289447|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
5307831|NCT00393484|18289448|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
5307832|NCT00393484|18289447|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
5307833|NCT00393484|18289448|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
5307834|NCT00393484|18289447|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
5307835|NCT00393484|18289448|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
5307836|NCT00393484|18289447|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
5307837|NCT00393484|18289448|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
5307838|NCT00393484|18289447|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
5307839|NCT00393484|18289448|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
5307840|NCT00393484|18289447|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
5307841|NCT00393484|18289448|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
5307842|NCT00393458|18289484|P4|Overall Study|Subject no longer requires study drug|0
5307843|NCT00393458|18289485|P3|Overall Study|Subject no longer requires study drug|0
5307844|NCT00393458|18289486|P2|Overall Study|Subject no longer requires study drug|1
5307845|NCT00393458|18289487|P1|Overall Study|Subject no longer requires study drug|0
5307846|NCT00393458|18289484|P4|Overall Study|Abnormal test procedure result(s)|2
5307847|NCT00393458|18289485|P3|Overall Study|Abnormal test procedure result(s)|1
5307848|NCT00393458|18289486|P2|Overall Study|Abnormal test procedure result(s)|1
5307849|NCT00393458|18289487|P1|Overall Study|Abnormal test procedure result(s)|0
5307850|NCT00393458|18289484|P4|Overall Study|Death|5
5307851|NCT00393458|18289485|P3|Overall Study|Death|5
5307852|NCT00393458|18289486|P2|Overall Study|Death|1
5307853|NCT00393458|18289487|P1|Overall Study|Death|1
5307854|NCT00393458|18289484|P4|Overall Study|Abnormal laboratory value(s)|0
5307855|NCT00393458|18289485|P3|Overall Study|Abnormal laboratory value(s)|0
5307856|NCT00393458|18289486|P2|Overall Study|Abnormal laboratory value(s)|1
5307857|NCT00393458|18289487|P1|Overall Study|Abnormal laboratory value(s)|1
5307858|NCT00393458|18289484|P4|Overall Study|Lost to Follow-up|3
5307859|NCT00393458|18289485|P3|Overall Study|Lost to Follow-up|5
5307860|NCT00393458|18289486|P2|Overall Study|Lost to Follow-up|6
5307861|NCT00393458|18289487|P1|Overall Study|Lost to Follow-up|5
5307862|NCT00393458|18289484|P4|Overall Study|Administrative problems|2
5307863|NCT00393458|18289485|P3|Overall Study|Administrative problems|5
5307864|NCT00393458|18289486|P2|Overall Study|Administrative problems|8
5307865|NCT00393458|18289487|P1|Overall Study|Administrative problems|7
5307866|NCT00393458|18289484|P4|Overall Study|Protocol deviation|10
5307867|NCT00393458|18289485|P3|Overall Study|Protocol deviation|11
5307868|NCT00393458|18289486|P2|Overall Study|Protocol deviation|11
5307869|NCT00393458|18289487|P1|Overall Study|Protocol deviation|11
5307870|NCT00393458|18289484|P4|Overall Study|Unsatisfactory therapeutic effect|30
5307871|NCT00393458|18289485|P3|Overall Study|Unsatisfactory therapeutic effect|12
5307872|NCT00393458|18289486|P2|Overall Study|Unsatisfactory therapeutic effect|9
5307873|NCT00393458|18289487|P1|Overall Study|Unsatisfactory therapeutic effect|12
5307874|NCT00393458|18289484|P4|Overall Study|Subject withdrew consent|50
5307875|NCT00393458|18289485|P3|Overall Study|Subject withdrew consent|33
5307876|NCT00393458|18289486|P2|Overall Study|Subject withdrew consent|40
5307877|NCT00393458|18289487|P1|Overall Study|Subject withdrew consent|27
5307878|NCT00393458|18289484|P4|Overall Study|Adverse Event|35
5307879|NCT00393458|18289485|P3|Overall Study|Adverse Event|40
5307880|NCT00393458|18289486|P2|Overall Study|Adverse Event|24
5307881|NCT00393458|18289487|P1|Overall Study|Adverse Event|35
5307882|NCT00393367|18289514|P2|Overall Study|Withdrawal by Subject|2
5307883|NCT00393367|18289515|P1|Overall Study|Withdrawal by Subject|0
5307884|NCT00393367|18289514|P2|Overall Study|Protocol Violation|5
5307885|NCT00393367|18289515|P1|Overall Study|Protocol Violation|2
5307886|NCT00393094|18289543|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
5307887|NCT00393094|18289543|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
5307888|NCT00393042|18289554|P2|Second Intervetion|Protocol Violation|1
5307889|NCT00393042|18289555|P1|Second Intervetion|Protocol Violation|1
5307890|NCT00393042|18289554|P2|Second Intervetion|Lost to Follow-up|2
5307891|NCT00393042|18289555|P1|Second Intervetion|Lost to Follow-up|0
5307892|NCT00393042|18289554|P2|Second Intervetion|Lack of Efficacy|0
5307893|NCT00393042|18289555|P1|Second Intervetion|Lack of Efficacy|1
5307894|NCT00393042|18289554|P2|Second Intervetion|Withdrawal by Subject|2
5307895|NCT00393042|18289555|P1|Second Intervetion|Withdrawal by Subject|0
5307896|NCT00393042|18289554|P2|Second Intervetion|Adverse Event|3
5307897|NCT00393042|18289555|P1|Second Intervetion|Adverse Event|0
5307898|NCT00393042|18289554|P2|First Intervention|Adverse Event|1
5307899|NCT00393042|18289555|P1|First Intervention|Adverse Event|0
5307900|NCT00393042|18289554|P2|First Intervention|Protocol Violation|0
5307901|NCT00393042|18289555|P1|First Intervention|Protocol Violation|1
5307902|NCT00393042|18289554|P2|First Intervention|Lost to Follow-up|3
5307903|NCT00393042|18289555|P1|First Intervention|Lost to Follow-up|3
5307904|NCT00393042|18289554|P2|First Intervention|Withdrawal by Subject|2
5307905|NCT00393042|18289555|P1|First Intervention|Withdrawal by Subject|1
5307906|NCT00393029|18289627|P2|Overall Study|Not treated|1
5307907|NCT00393029|18289628|P1|Overall Study|Not treated|0
5307908|NCT00392990|18289639|P2|Follow up for 2 Years|Death|0
5307909|NCT00392990|18289640|P1|Follow up for 2 Years|Death|4
5307910|NCT00392990|18289639|P2|Treatment on Study|Adverse Event|1
5307911|NCT00392990|18289640|P1|Treatment on Study|Adverse Event|3
5307912|NCT00392925|18289664|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
5307913|NCT00392925|18289665|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
5307914|NCT00392925|18289666|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
5307915|NCT00392925|18289667|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
5307916|NCT00392925|18289664|P4|Randomization to Treatment Group Period|Protocol Violation|1
5307917|NCT00392925|18289665|P3|Randomization to Treatment Group Period|Protocol Violation|2
5307918|NCT00392925|18289666|P2|Randomization to Treatment Group Period|Protocol Violation|0
5307919|NCT00392925|18289667|P1|Randomization to Treatment Group Period|Protocol Violation|0
5307920|NCT00392925|18289664|P4|Randomization to Treatment Group Period|Adverse Event|5
5307921|NCT00392925|18289665|P3|Randomization to Treatment Group Period|Adverse Event|3
5307922|NCT00392925|18289666|P2|Randomization to Treatment Group Period|Adverse Event|3
5307923|NCT00392925|18289667|P1|Randomization to Treatment Group Period|Adverse Event|0
5307924|NCT00392925|18289664|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
5307925|NCT00392925|18289665|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
5307926|NCT00392925|18289666|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
5307927|NCT00392925|18289667|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
5307928|NCT00392925|18289664|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
5307929|NCT00392925|18289665|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
5307930|NCT00392925|18289666|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
5307931|NCT00392925|18289667|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
5307932|NCT00392925|18289664|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
5307933|NCT00392925|18289665|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
5307934|NCT00392925|18289666|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
5307935|NCT00392925|18289667|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
5307936|NCT00392925|18289664|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
5307937|NCT00392925|18289665|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
5307938|NCT00392925|18289666|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
5307939|NCT00392925|18289667|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
5307940|NCT00392925|18289664|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
5307941|NCT00392925|18289665|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
5307942|NCT00392925|18289666|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
5307943|NCT00392925|18289667|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
5307944|NCT00392925|18289664|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
5307945|NCT00392925|18289665|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
5307946|NCT00392925|18289666|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
5307947|NCT00392925|18289667|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
5307948|NCT00392808|18289781|P4|Overall Study|Unable to withdraw blood|2
5307949|NCT00392808|18289782|P3|Overall Study|Unable to withdraw blood|1
5307950|NCT00392808|18289783|P2|Overall Study|Unable to withdraw blood|1
5307951|NCT00392808|18289784|P1|Overall Study|Unable to withdraw blood|3
5307952|NCT00392808|18289781|P4|Overall Study|Lost to Follow-up|2
5307953|NCT00392808|18289782|P3|Overall Study|Lost to Follow-up|1
5307954|NCT00392808|18289783|P2|Overall Study|Lost to Follow-up|2
5307955|NCT00392808|18289784|P1|Overall Study|Lost to Follow-up|3
5307956|NCT00392769|18289808|P1|Overall Study|Adverse Event|1
5307957|NCT00392769|18289808|P1|Overall Study|Clinical Deterioration|9
5307958|NCT00392665|18289860|P2|Overall Study|Lost to Follow-up|1
5307959|NCT00392665|18289861|P1|Overall Study|Lost to Follow-up|1
5307960|NCT00392665|18289860|P2|Overall Study|Death|14
5307961|NCT00392665|18289861|P1|Overall Study|Death|16
5307962|NCT00392379|18289887|P2|Overall Study|Adverse Event|1
5307963|NCT00392379|18289888|P1|Overall Study|Adverse Event|1
5307964|NCT00392379|18289887|P2|Overall Study|Lost to Follow-up|9
5307965|NCT00392379|18289888|P1|Overall Study|Lost to Follow-up|4
5307966|NCT00392379|18289887|P2|Overall Study|Withdrawal by Subject|28
5307967|NCT00392379|18289888|P1|Overall Study|Withdrawal by Subject|17
5307968|NCT00392327|18289906|P8|Overall Study|Ineligible|0
5307969|NCT00392327|18289907|P7|Overall Study|Ineligible|0
5307970|NCT00392327|18289908|P6|Overall Study|Ineligible|0
5307971|NCT00392327|18289909|P5|Overall Study|Ineligible|0
5307972|NCT00392327|18289910|P4|Overall Study|Ineligible|2
5307973|NCT00392327|18289911|P3|Overall Study|Ineligible|3
5307974|NCT00392327|18289912|P2|Overall Study|Ineligible|4
5307975|NCT00392327|18289913|P1|Overall Study|Ineligible|0
5307976|NCT00392327|18289906|P8|Overall Study|Withdrawal by Subject|5
5307977|NCT00392327|18289907|P7|Overall Study|Withdrawal by Subject|1
5307978|NCT00392327|18289908|P6|Overall Study|Withdrawal by Subject|1
5307979|NCT00392327|18289909|P5|Overall Study|Withdrawal by Subject|0
5307980|NCT00392327|18289910|P4|Overall Study|Withdrawal by Subject|6
5307981|NCT00392327|18289911|P3|Overall Study|Withdrawal by Subject|4
5307982|NCT00392327|18289912|P2|Overall Study|Withdrawal by Subject|2
5307983|NCT00392327|18289913|P1|Overall Study|Withdrawal by Subject|3
5307984|NCT00392327|18289906|P8|Overall Study|Protocol Violation|0
5307985|NCT00392327|18289907|P7|Overall Study|Protocol Violation|0
5307986|NCT00392327|18289908|P6|Overall Study|Protocol Violation|0
5307987|NCT00392327|18289909|P5|Overall Study|Protocol Violation|0
5307988|NCT00392327|18289910|P4|Overall Study|Protocol Violation|0
5307989|NCT00392327|18289911|P3|Overall Study|Protocol Violation|1
5307990|NCT00392327|18289912|P2|Overall Study|Protocol Violation|0
5307991|NCT00392327|18289913|P1|Overall Study|Protocol Violation|0
5307992|NCT00392327|18289906|P8|Overall Study|Physician Decision|3
5307993|NCT00392327|18289907|P7|Overall Study|Physician Decision|5
5307994|NCT00392327|18289908|P6|Overall Study|Physician Decision|1
5307995|NCT00392327|18289909|P5|Overall Study|Physician Decision|0
5307996|NCT00392327|18289910|P4|Overall Study|Physician Decision|2
5307997|NCT00392327|18289911|P3|Overall Study|Physician Decision|2
5307998|NCT00392327|18289912|P2|Overall Study|Physician Decision|5
5307999|NCT00392327|18289913|P1|Overall Study|Physician Decision|3
5308000|NCT00392327|18289906|P8|Overall Study|Lack of Efficacy|3
5308001|NCT00392327|18289907|P7|Overall Study|Lack of Efficacy|3
5308002|NCT00392327|18289908|P6|Overall Study|Lack of Efficacy|3
5308003|NCT00392327|18289909|P5|Overall Study|Lack of Efficacy|3
5308004|NCT00392327|18289910|P4|Overall Study|Lack of Efficacy|6
5308005|NCT00392327|18289911|P3|Overall Study|Lack of Efficacy|9
5308006|NCT00392327|18289912|P2|Overall Study|Lack of Efficacy|8
5308007|NCT00392327|18289913|P1|Overall Study|Lack of Efficacy|8
5308008|NCT00392327|18289906|P8|Overall Study|Death|0
5308009|NCT00392327|18289907|P7|Overall Study|Death|0
5308010|NCT00392327|18289908|P6|Overall Study|Death|0
5308011|NCT00392327|18289909|P5|Overall Study|Death|0
5308012|NCT00392327|18289910|P4|Overall Study|Death|0
5308013|NCT00392327|18289911|P3|Overall Study|Death|1
5308014|NCT00392327|18289912|P2|Overall Study|Death|0
5308015|NCT00392327|18289913|P1|Overall Study|Death|1
5308016|NCT00392288|18289982|P3|Overall Study|Other|1
5308017|NCT00392288|18289983|P2|Overall Study|Other|4
5308018|NCT00392288|18289984|P1|Overall Study|Other|3
5308019|NCT00392288|18289982|P3|Overall Study|Parent/legal guardian withdrawal|1
5308020|NCT00392288|18289983|P2|Overall Study|Parent/legal guardian withdrawal|2
5308021|NCT00392288|18289984|P1|Overall Study|Parent/legal guardian withdrawal|1
5308022|NCT00392288|18289982|P3|Overall Study|Withdrawal by Subject|2
5308023|NCT00392288|18289983|P2|Overall Study|Withdrawal by Subject|0
5308024|NCT00392288|18289984|P1|Overall Study|Withdrawal by Subject|1
5308025|NCT00392288|18289982|P3|Overall Study|Lost to Follow-up|1
5308026|NCT00392288|18289983|P2|Overall Study|Lost to Follow-up|1
5308027|NCT00392288|18289984|P1|Overall Study|Lost to Follow-up|1
5308028|NCT00392288|18289982|P3|Overall Study|Protocol Violation|1
5308029|NCT00392288|18289983|P2|Overall Study|Protocol Violation|3
5308030|NCT00392288|18289984|P1|Overall Study|Protocol Violation|1
5308031|NCT00392288|18289982|P3|Overall Study|Lack of Efficacy|3
5308032|NCT00392288|18289983|P2|Overall Study|Lack of Efficacy|5
5308033|NCT00392288|18289984|P1|Overall Study|Lack of Efficacy|8
5308034|NCT00392288|18289982|P3|Overall Study|Adverse Event|8
5308035|NCT00392288|18289983|P2|Overall Study|Adverse Event|7
5308036|NCT00392288|18289984|P1|Overall Study|Adverse Event|17
5308037|NCT00392223|18290009|P2|Overall Study|Withdrawal by Subject|2
5308038|NCT00392223|18290010|P1|Overall Study|Withdrawal by Subject|3
5308039|NCT00392223|18290009|P2|Overall Study|Protocol Violation|3
5308040|NCT00392223|18290010|P1|Overall Study|Protocol Violation|0
5308041|NCT00392223|18290009|P2|Overall Study|Lost to Follow-up|4
5308042|NCT00392223|18290010|P1|Overall Study|Lost to Follow-up|1
5308043|NCT00392223|18290009|P2|Overall Study|Adverse Event|4
5308044|NCT00392223|18290010|P1|Overall Study|Adverse Event|5
5308045|NCT00392210|18290028|P2|First Voiding Trial|Physician Decision|2
5308046|NCT00392210|18290029|P1|First Voiding Trial|Physician Decision|2
5308047|NCT00392197|18290037|P2|Overall Study|Withdrawal by Subject|6
5308048|NCT00392197|18290038|P1|Overall Study|Withdrawal by Subject|4
5308049|NCT00392197|18290037|P2|Overall Study|Protocol Violation|5
5308050|NCT00392197|18290038|P1|Overall Study|Protocol Violation|7
5308051|NCT00392197|18290037|P2|Overall Study|Physician Decision|2
5308052|NCT00392197|18290038|P1|Overall Study|Physician Decision|3
5308053|NCT00392197|18290037|P2|Overall Study|Lost to Follow-up|1
5308054|NCT00392197|18290038|P1|Overall Study|Lost to Follow-up|0
5308055|NCT00392197|18290037|P2|Overall Study|Lack of Efficacy|4
5308056|NCT00392197|18290038|P1|Overall Study|Lack of Efficacy|3
5308057|NCT00392197|18290037|P2|Overall Study|Adverse Event|12
5308058|NCT00392197|18290038|P1|Overall Study|Adverse Event|4
5308059|NCT00392171|18290046|P1|Overall Study|Disease progression|101
5308060|NCT00392171|18290046|P1|Overall Study|Did not meet inclusion criteria|4
5308061|NCT00391976|18290080|P3|Overall Study|Positive P. aeruginosa antibody test|31
5308062|NCT00391976|18290081|P2|Overall Study|Positive P. aeruginosa antibody test|0
5308063|NCT00391976|18290082|P1|Overall Study|Positive P. aeruginosa antibody test|0
5308064|NCT00391976|18290080|P3|Overall Study|Unable to classify|1
5308065|NCT00391976|18290081|P2|Overall Study|Unable to classify|0
5308066|NCT00391976|18290082|P1|Overall Study|Unable to classify|0
5308067|NCT00391976|18290080|P3|Overall Study|Recurrence/no eradication of infection|0
5308068|NCT00391976|18290081|P2|Overall Study|Recurrence/no eradication of infection|19
5308069|NCT00391976|18290082|P1|Overall Study|Recurrence/no eradication of infection|21
5308070|NCT00391976|18290080|P3|Overall Study|Protocol deviation/violation|1
5308071|NCT00391976|18290081|P2|Overall Study|Protocol deviation/violation|2
5308072|NCT00391976|18290082|P1|Overall Study|Protocol deviation/violation|4
5308073|NCT00391976|18290080|P3|Overall Study|Inappropriate enrollment|0
5308074|NCT00391976|18290081|P2|Overall Study|Inappropriate enrollment|1
5308075|NCT00391976|18290082|P1|Overall Study|Inappropriate enrollment|1
5308076|NCT00391976|18290080|P3|Overall Study|Lost to Follow-up|0
5308077|NCT00391976|18290081|P2|Overall Study|Lost to Follow-up|2
5308078|NCT00391976|18290082|P1|Overall Study|Lost to Follow-up|1
5308079|NCT00391976|18290080|P3|Overall Study|Withdrawal of consent|1
5308080|NCT00391976|18290081|P2|Overall Study|Withdrawal of consent|1
5308081|NCT00391976|18290082|P1|Overall Study|Withdrawal of consent|0
5308082|NCT00391976|18290080|P3|Overall Study|Adverse Event|1
5308083|NCT00391976|18290081|P2|Overall Study|Adverse Event|0
5308084|NCT00391976|18290082|P1|Overall Study|Adverse Event|0
5308085|NCT00391898|18290106|P2|Overall Study|Other|10
5308086|NCT00391898|18290107|P1|Overall Study|Other|8
5308087|NCT00391898|18290106|P2|Overall Study|Adverse Event|0
5308088|NCT00391898|18290107|P1|Overall Study|Adverse Event|3
5308089|NCT00391872|18290127|P2|Overall Study|Lost to Follow-up|0
5308090|NCT00391872|18290128|P1|Overall Study|Lost to Follow-up|2
5308091|NCT00391872|18290127|P2|Overall Study|Reason unknown|4
5308092|NCT00391872|18290128|P1|Overall Study|Reason unknown|2
5308093|NCT00391872|18290127|P2|Overall Study|Withdrawal by Subject|249
5308094|NCT00391872|18290128|P1|Overall Study|Withdrawal by Subject|296
5308095|NCT00391872|18290127|P2|Overall Study|Protocol Violation|2
5308096|NCT00391872|18290128|P1|Overall Study|Protocol Violation|7
5308097|NCT00391846|18290166|P2|Overall Study|Developed study specific DC criteria|1
5308098|NCT00391846|18290167|P1|Overall Study|Developed study specific DC criteria|0
5308099|NCT00391846|18290166|P2|Overall Study|Withdrawal by Subject|3
5308100|NCT00391846|18290167|P1|Overall Study|Withdrawal by Subject|2
5308101|NCT00391846|18290166|P2|Overall Study|Did not meet the required elig. crit|2
5308102|NCT00391846|18290167|P1|Overall Study|Did not meet the required elig. crit|2
5308103|NCT00391846|18290166|P2|Overall Study|Adverse Event|1
5308104|NCT00391846|18290167|P1|Overall Study|Adverse Event|4
5308105|NCT00391807|18290187|P1|Overall Study|Various|96
5308106|NCT00391807|18290187|P1|Overall Study|Protocol Violation|20
5308107|NCT00391807|18290187|P1|Overall Study|Withdrawal by Subject|147
5308108|NCT00391807|18290187|P1|Overall Study|Lost to Follow-up|227
5308109|NCT00391807|18290187|P1|Overall Study|Pregnancy|25
5308110|NCT00391807|18290187|P1|Overall Study|Adverse Event|177
5308111|NCT00391807|18290187|P1|Overall Study|Did not receive study medication|23
5308112|NCT00391768|18290214|P7|Overall Study|Lost to Follow-up|3
5308113|NCT00391768|18290215|P6|Overall Study|Lost to Follow-up|2
5308114|NCT00391768|18290216|P5|Overall Study|Lost to Follow-up|2
5308115|NCT00391768|18290217|P4|Overall Study|Lost to Follow-up|1
5308116|NCT00391768|18290218|P3|Overall Study|Lost to Follow-up|0
5308117|NCT00391768|18290219|P2|Overall Study|Lost to Follow-up|0
5308118|NCT00391768|18290220|P1|Overall Study|Lost to Follow-up|0
5308119|NCT00391768|18290214|P7|Overall Study|Withdrawal by Subject|1
5308120|NCT00391768|18290215|P6|Overall Study|Withdrawal by Subject|1
5308121|NCT00391768|18290216|P5|Overall Study|Withdrawal by Subject|0
5308122|NCT00391768|18290217|P4|Overall Study|Withdrawal by Subject|0
5308123|NCT00391768|18290218|P3|Overall Study|Withdrawal by Subject|1
5308124|NCT00391768|18290219|P2|Overall Study|Withdrawal by Subject|0
5308125|NCT00391768|18290220|P1|Overall Study|Withdrawal by Subject|0
5308126|NCT00391625|18290307|P1|Month 50|Physician Decision|1
5308127|NCT00391625|18290307|P1|Month 14|Withdrawal by Subject|1
5308128|NCT00391586|18290360|P1|Overall Study|Death|4
5308129|NCT00391586|18290360|P1|Overall Study|Physician Decision|2
5308130|NCT00391586|18290360|P1|Overall Study|Adverse Event|5
5308131|NCT00391586|18290360|P1|Overall Study|Progressive disease|13
5308132|NCT00391391|18290397|P4|Overall Study|Withdrawal by Subject|7
5308133|NCT00391391|18290398|P3|Overall Study|Withdrawal by Subject|10
5308134|NCT00391391|18290399|P2|Overall Study|Withdrawal by Subject|4
5308135|NCT00391391|18290400|P1|Overall Study|Withdrawal by Subject|6
5308136|NCT00391391|18290397|P4|Overall Study|Protocol Violation|7
5308137|NCT00391391|18290398|P3|Overall Study|Protocol Violation|6
5308138|NCT00391391|18290399|P2|Overall Study|Protocol Violation|3
5308139|NCT00391391|18290400|P1|Overall Study|Protocol Violation|2
5308140|NCT00391391|18290397|P4|Overall Study|Lost to Follow-up|4
5308141|NCT00391391|18290398|P3|Overall Study|Lost to Follow-up|7
5308142|NCT00391391|18290399|P2|Overall Study|Lost to Follow-up|3
5308143|NCT00391391|18290400|P1|Overall Study|Lost to Follow-up|1
5308144|NCT00391391|18290397|P4|Overall Study|Adverse Event|1
5308145|NCT00391391|18290398|P3|Overall Study|Adverse Event|0
5308146|NCT00391391|18290399|P2|Overall Study|Adverse Event|0
5308147|NCT00391391|18290400|P1|Overall Study|Adverse Event|0
5308148|NCT00391274|18290445|P2|Overall Study|Death Not Study Related|1
5308149|NCT00391274|18290446|P1|Overall Study|Death Not Study Related|0
5308150|NCT00391274|18290445|P2|Overall Study|Death Due to Indeterminate Cause|0
5308151|NCT00391274|18290446|P1|Overall Study|Death Due to Indeterminate Cause|1
5308152|NCT00391274|18290445|P2|Overall Study|Death Due to Adverse Event|3
5308153|NCT00391274|18290446|P1|Overall Study|Death Due to Adverse Event|1
5308154|NCT00391274|18290445|P2|Overall Study|Withdrawal by Subject|3
5308155|NCT00391274|18290446|P1|Overall Study|Withdrawal by Subject|0
5308156|NCT00391274|18290445|P2|Overall Study|Physician Decision|2
5308157|NCT00391274|18290446|P1|Overall Study|Physician Decision|4
5308158|NCT00391274|18290445|P2|Overall Study|Lost to Follow-up|3
5308159|NCT00391274|18290446|P1|Overall Study|Lost to Follow-up|0
5308160|NCT00391274|18290445|P2|Overall Study|Death Due to Study Disease|45
5308161|NCT00391274|18290446|P1|Overall Study|Death Due to Study Disease|55
5308162|NCT00391222|18290465|P4|Period III (Double-Blind Treatment)|Other|0
5308163|NCT00391222|18290466|P3|Period III (Double-Blind Treatment)|Other|6
5308164|NCT00391222|18290467|P2|Period III (Double-Blind Treatment)|Other|1
5308165|NCT00391222|18290468|P1|Period III (Double-Blind Treatment)|Other|6
5308166|NCT00391222|18290465|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
5308167|NCT00391222|18290466|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
5308168|NCT00391222|18290467|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
5308169|NCT00391222|18290468|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
5308170|NCT00391222|18290465|P4|Period III (Double-Blind Treatment)|Pregnancy|0
5308171|NCT00391222|18290466|P3|Period III (Double-Blind Treatment)|Pregnancy|0
5308172|NCT00391222|18290467|P2|Period III (Double-Blind Treatment)|Pregnancy|2
5308173|NCT00391222|18290468|P1|Period III (Double-Blind Treatment)|Pregnancy|0
5308174|NCT00391222|18290465|P4|Period III (Double-Blind Treatment)|Adverse Event|0
5308175|NCT00391222|18290466|P3|Period III (Double-Blind Treatment)|Adverse Event|4
5308176|NCT00391222|18290467|P2|Period III (Double-Blind Treatment)|Adverse Event|2
5308177|NCT00391222|18290468|P1|Period III (Double-Blind Treatment)|Adverse Event|5
5308178|NCT00391222|18290465|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
5308179|NCT00391222|18290466|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
5308180|NCT00391222|18290467|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
5308181|NCT00391222|18290468|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
5308182|NCT00391222|18290465|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
5308183|NCT00391222|18290466|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
5308184|NCT00391222|18290467|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
5308185|NCT00391222|18290468|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
5308186|NCT00391222|18290465|P4|Period II (Open-label Risperidone LAI)|Other|24
5308187|NCT00391222|18290466|P3|Period II (Open-label Risperidone LAI)|Other|0
5308188|NCT00391222|18290467|P2|Period II (Open-label Risperidone LAI)|Other|0
5308189|NCT00391222|18290468|P1|Period II (Open-label Risperidone LAI)|Other|0
5308190|NCT00391222|18290465|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
5308191|NCT00391222|18290466|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
5308192|NCT00391222|18290467|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
5308193|NCT00391222|18290468|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
5308194|NCT00391222|18290465|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
5308195|NCT00391222|18290466|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
5308196|NCT00391222|18290467|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
5308197|NCT00391222|18290468|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
5308198|NCT00391222|18290465|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
5308199|NCT00391222|18290466|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
5308200|NCT00391222|18290467|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
5308201|NCT00391222|18290468|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
5308202|NCT00391222|18290465|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
5308203|NCT00391222|18290466|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
5308204|NCT00391222|18290467|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
5308205|NCT00391222|18290468|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
5308206|NCT00391118|18290495|P3|Overall Study|Protocol Violation|0
5308207|NCT00391118|18290496|P2|Overall Study|Protocol Violation|0
5308208|NCT00391118|18290497|P1|Overall Study|Protocol Violation|1
5308209|NCT00391118|18290495|P3|Overall Study|Sponsor Decision|3
5308210|NCT00391118|18290496|P2|Overall Study|Sponsor Decision|1
5308211|NCT00391118|18290497|P1|Overall Study|Sponsor Decision|0
5308212|NCT00391118|18290495|P3|Overall Study|Progressive Disease|43
5308213|NCT00391118|18290496|P2|Overall Study|Progressive Disease|26
5308214|NCT00391118|18290497|P1|Overall Study|Progressive Disease|7
5308215|NCT00391118|18290495|P3|Overall Study|Protocol Entry Criteria Not Met|1
5308216|NCT00391118|18290496|P2|Overall Study|Protocol Entry Criteria Not Met|3
5308217|NCT00391118|18290497|P1|Overall Study|Protocol Entry Criteria Not Met|0
5308218|NCT00391118|18290495|P3|Overall Study|Physician Decision|0
5308219|NCT00391118|18290496|P2|Overall Study|Physician Decision|3
5308220|NCT00391118|18290497|P1|Overall Study|Physician Decision|0
5308221|NCT00391118|18290495|P3|Overall Study|Death|0
5308222|NCT00391118|18290496|P2|Overall Study|Death|1
5308223|NCT00391118|18290497|P1|Overall Study|Death|0
5308224|NCT00391118|18290495|P3|Overall Study|Withdrawal by Subject|1
5308225|NCT00391118|18290496|P2|Overall Study|Withdrawal by Subject|9
5308226|NCT00391118|18290497|P1|Overall Study|Withdrawal by Subject|0
5308227|NCT00391118|18290495|P3|Overall Study|Lost to Follow-up|3
5308228|NCT00391118|18290496|P2|Overall Study|Lost to Follow-up|2
5308229|NCT00391118|18290497|P1|Overall Study|Lost to Follow-up|0
5308230|NCT00391118|18290495|P3|Overall Study|Adverse Event|7
5308231|NCT00391118|18290496|P2|Overall Study|Adverse Event|10
5308232|NCT00391118|18290497|P1|Overall Study|Adverse Event|3
5308233|NCT00391092|18290523|P2|Overall Study|Alive in follow-up|84
5308234|NCT00391092|18290524|P1|Overall Study|Alive in follow-up|88
5308235|NCT00391092|18290523|P2|Overall Study|Alive on treatment|33
5308236|NCT00391092|18290524|P1|Overall Study|Alive on treatment|29
5308237|NCT00391092|18290523|P2|Overall Study|Lost to Follow-up|18
5308238|NCT00391092|18290524|P1|Overall Study|Lost to Follow-up|13
5308239|NCT00391092|18290523|P2|Overall Study|Death|81
5308240|NCT00391092|18290524|P1|Overall Study|Death|78
5308241|NCT00391053|18290567|P4|Overall Study|Withdrawal by Subject|1
5308242|NCT00391053|18290568|P3|Overall Study|Withdrawal by Subject|1
5308243|NCT00391053|18290569|P2|Overall Study|Withdrawal by Subject|1
5308244|NCT00391053|18290570|P1|Overall Study|Withdrawal by Subject|5
5308245|NCT00391053|18290567|P4|Overall Study|Lost to Follow-up|5
5308246|NCT00391053|18290568|P3|Overall Study|Lost to Follow-up|0
5308247|NCT00391053|18290569|P2|Overall Study|Lost to Follow-up|0
5308248|NCT00391053|18290570|P1|Overall Study|Lost to Follow-up|1
5308249|NCT00391053|18290567|P4|Overall Study|Protocol Violation|0
5308250|NCT00391053|18290568|P3|Overall Study|Protocol Violation|0
5308251|NCT00391053|18290569|P2|Overall Study|Protocol Violation|0
5308252|NCT00391053|18290570|P1|Overall Study|Protocol Violation|2
5308253|NCT00391053|18290567|P4|Overall Study|Serious Adverse Events|4
5308254|NCT00391053|18290568|P3|Overall Study|Serious Adverse Events|1
5308255|NCT00391053|18290569|P2|Overall Study|Serious Adverse Events|0
5308256|NCT00391053|18290570|P1|Overall Study|Serious Adverse Events|1
5308257|NCT00391027|18290594|P2|Overall Study|Other|3
5308258|NCT00391027|18290595|P1|Overall Study|Other|4
5308259|NCT00391027|18290594|P2|Overall Study|Withdrawal by Subject|1
5308260|NCT00391027|18290595|P1|Overall Study|Withdrawal by Subject|10
5308261|NCT00391027|18290594|P2|Overall Study|Lack of Efficacy|0
5308262|NCT00391027|18290595|P1|Overall Study|Lack of Efficacy|3
5308263|NCT00391027|18290594|P2|Overall Study|Adverse Event|8
5308264|NCT00391027|18290595|P1|Overall Study|Adverse Event|8
5308265|NCT00390910|18290645|P3|Overall Study|Migrated/moved from study area|3
5308266|NCT00390910|18290646|P2|Overall Study|Migrated/moved from study area|0
5308267|NCT00390910|18290647|P1|Overall Study|Migrated/moved from study area|0
5308268|NCT00390910|18290645|P3|Overall Study|Withdrawal by Subject|2
5308269|NCT00390910|18290646|P2|Overall Study|Withdrawal by Subject|3
5308270|NCT00390910|18290647|P1|Overall Study|Withdrawal by Subject|1
5308271|NCT00390910|18290645|P3|Overall Study|Lost to Follow-up|5
5308272|NCT00390910|18290646|P2|Overall Study|Lost to Follow-up|1
5308273|NCT00390910|18290647|P1|Overall Study|Lost to Follow-up|0
5308274|NCT00390910|18290645|P3|Overall Study|Adverse Event|0
5308275|NCT00390910|18290646|P2|Overall Study|Adverse Event|0
5308276|NCT00390910|18290647|P1|Overall Study|Adverse Event|1
5308277|NCT00390884|18290735|P2|Overall Study|Withdrawal by Subject|2
5308278|NCT00390884|18290736|P1|Overall Study|Withdrawal by Subject|2
5308279|NCT00390858|18290748|P2|Overall Study|Withdrawal by Subject|4
5308280|NCT00390858|18290749|P1|Overall Study|Withdrawal by Subject|3
5308281|NCT00390858|18290748|P2|Overall Study|Lack of Efficacy|1
5308282|NCT00390858|18290749|P1|Overall Study|Lack of Efficacy|0
5308283|NCT00390858|18290748|P2|Overall Study|Adverse Event|2
5308284|NCT00390858|18290749|P1|Overall Study|Adverse Event|6
5308285|NCT00390806|18290763|P2|Overall Study|Ongoing|2
5308286|NCT00390806|18290764|P1|Overall Study|Ongoing|4
5308287|NCT00390806|18290763|P2|Overall Study|Physician Decision|1
5308288|NCT00390806|18290764|P1|Overall Study|Physician Decision|0
5308289|NCT00390806|18290763|P2|Overall Study|Death|0
5308290|NCT00390806|18290764|P1|Overall Study|Death|1
5308291|NCT00390806|18290763|P2|Overall Study|Investigator Decision|6
5308292|NCT00390806|18290764|P1|Overall Study|Investigator Decision|4
5308293|NCT00390806|18290763|P2|Overall Study|Withdrawal by Subject|15
5308294|NCT00390806|18290764|P1|Overall Study|Withdrawal by Subject|12
5308295|NCT00390806|18290763|P2|Overall Study|Protocol Violation|2
5308296|NCT00390806|18290764|P1|Overall Study|Protocol Violation|2
5308297|NCT00390806|18290763|P2|Overall Study|Lost to Follow-up|6
5308298|NCT00390806|18290764|P1|Overall Study|Lost to Follow-up|7
5308299|NCT00390780|18290832|P2|Overall Study|SAE, death|1
5308300|NCT00390780|18290833|P1|Overall Study|SAE, death|0
5308301|NCT00390780|18290832|P2|Overall Study|Investigator decision, SAE, other reason|1
5308302|NCT00390780|18290833|P1|Overall Study|Investigator decision, SAE, other reason|0
5308303|NCT00390780|18290832|P2|Overall Study|Lost to follow up and other reasons|1
5308304|NCT00390780|18290833|P1|Overall Study|Lost to follow up and other reasons|0
5308305|NCT00390780|18290832|P2|Overall Study|Inclusion criteria not satisfied|2
5308306|NCT00390780|18290833|P1|Overall Study|Inclusion criteria not satisfied|0
5308307|NCT00390780|18290832|P2|Overall Study|Withdrawal by Subject|2
5308308|NCT00390780|18290833|P1|Overall Study|Withdrawal by Subject|1
5308309|NCT00390780|18290832|P2|Overall Study|Death|3
5308310|NCT00390780|18290833|P1|Overall Study|Death|1
5308311|NCT00390780|18290832|P2|Overall Study|Adverse Event|3
5308312|NCT00390780|18290833|P1|Overall Study|Adverse Event|2
5308313|NCT00390780|18290832|P2|Overall Study|Lost to Follow-up|6
5308314|NCT00390780|18290833|P1|Overall Study|Lost to Follow-up|3
5308315|NCT00390780|18290832|P2|Overall Study|Protocol Violation|4
5308316|NCT00390780|18290833|P1|Overall Study|Protocol Violation|6
5308317|NCT00390780|18290832|P2|Overall Study|Not completed|4
5308318|NCT00390780|18290833|P1|Overall Study|Not completed|10
5308319|NCT00390689|18290866|P3|Overall Study|Investigator's judgement|0
5308320|NCT00390689|18290867|P2|Overall Study|Investigator's judgement|0
5308321|NCT00390689|18290868|P1|Overall Study|Investigator's judgement|2
5308322|NCT00390689|18290866|P3|Overall Study|Protocol Violation|0
5308323|NCT00390689|18290867|P2|Overall Study|Protocol Violation|0
5308324|NCT00390689|18290868|P1|Overall Study|Protocol Violation|1
5308325|NCT00390689|18290866|P3|Overall Study|Lack of Efficacy|1
5308326|NCT00390689|18290867|P2|Overall Study|Lack of Efficacy|0
5308327|NCT00390689|18290868|P1|Overall Study|Lack of Efficacy|0
5308328|NCT00390689|18290866|P3|Overall Study|Adverse Event|2
5308329|NCT00390689|18290867|P2|Overall Study|Adverse Event|5
5308330|NCT00390689|18290868|P1|Overall Study|Adverse Event|2
5308331|NCT00390572|18290943|P2|Overall Study|health condition|1
5308332|NCT00390572|18290944|P1|Overall Study|health condition|0
5308333|NCT00390572|18290943|P2|Overall Study|Lost to Follow-up|4
5308334|NCT00390572|18290944|P1|Overall Study|Lost to Follow-up|8
5308335|NCT00390546|18290970|P2|Overall Study|Physician Decision|5
5308336|NCT00390546|18290971|P1|Overall Study|Physician Decision|5
5308337|NCT00390546|18290970|P2|Overall Study|Renal impairment|0
5308338|NCT00390546|18290971|P1|Overall Study|Renal impairment|1
5308339|NCT00390468|18290981|P1|Overall Study|Lack of Efficacy|1
5308340|NCT00390468|18290981|P1|Overall Study|Protocol Violation|2
5308341|NCT00390455|18290987|P2|Overall Study|Other Medical Reasons|11
5308342|NCT00390455|18290988|P1|Overall Study|Other Medical Reasons|7
5308343|NCT00390455|18290987|P2|Overall Study|Alternate Treatment|1
5308344|NCT00390455|18290988|P1|Overall Study|Alternate Treatment|0
5308345|NCT00390455|18290987|P2|Overall Study|Withdrawal by Subject|8
5308346|NCT00390455|18290988|P1|Overall Study|Withdrawal by Subject|8
5308347|NCT00390455|18290987|P2|Overall Study|Adverse Event|3
5308348|NCT00390455|18290988|P1|Overall Study|Adverse Event|17
5308349|NCT00390416|18291033|P1|Overall Study|Not treated|3
5308350|NCT00390416|18291033|P1|Overall Study|Withdrawal by Subject|1
5308351|NCT00390299|18291071|P5|Overall Study|Cancellation|0
5308352|NCT00390299|18291072|P4|Overall Study|Cancellation|0
5308353|NCT00390299|18291073|P3|Overall Study|Cancellation|0
5308354|NCT00390299|18291074|P2|Overall Study|Cancellation|0
5308355|NCT00390299|18291075|P1|Overall Study|Cancellation|1
5308356|NCT00390221|18291106|P3|Overall Study|Other|2
5308357|NCT00390221|18291107|P2|Overall Study|Other|4
5308358|NCT00390221|18291108|P1|Overall Study|Other|3
5308359|NCT00390221|18291106|P3|Overall Study|Subject Non-compliance|2
5308360|NCT00390221|18291107|P2|Overall Study|Subject Non-compliance|0
5308361|NCT00390221|18291108|P1|Overall Study|Subject Non-compliance|1
5308362|NCT00390221|18291106|P3|Overall Study|Withdrawal by Subject|7
5308363|NCT00390221|18291107|P2|Overall Study|Withdrawal by Subject|9
5308364|NCT00390221|18291108|P1|Overall Study|Withdrawal by Subject|13
5308365|NCT00390221|18291106|P3|Overall Study|Investigator Decision|1
5308366|NCT00390221|18291107|P2|Overall Study|Investigator Decision|0
5308367|NCT00390221|18291108|P1|Overall Study|Investigator Decision|0
5308368|NCT00390221|18291106|P3|Overall Study|Adverse Event|3
5308369|NCT00390221|18291107|P2|Overall Study|Adverse Event|4
5308370|NCT00390221|18291108|P1|Overall Study|Adverse Event|1
5308371|NCT00390221|18291106|P3|Overall Study|Lost to Follow-up|0
5308372|NCT00390221|18291107|P2|Overall Study|Lost to Follow-up|3
5308373|NCT00390221|18291108|P1|Overall Study|Lost to Follow-up|0
5308374|NCT00390013|18291138|P4|Phase 2 First Treatment|Withdrawal by Subject|0
5308375|NCT00390013|18291139|P3|Phase 2 First Treatment|Withdrawal by Subject|0
5308376|NCT00390013|18291140|P2|Phase 2 First Treatment|Withdrawal by Subject|1
5308377|NCT00390013|18291141|P1|Phase 2 First Treatment|Withdrawal by Subject|0
5308378|NCT00390013|18291138|P4|Phase 2 First Treatment|tired|0
5308379|NCT00390013|18291139|P3|Phase 2 First Treatment|tired|0
5308380|NCT00390013|18291140|P2|Phase 2 First Treatment|tired|0
5308381|NCT00390013|18291141|P1|Phase 2 First Treatment|tired|1
5308382|NCT00390013|18291138|P4|Phase 1|tired|1
5308383|NCT00390013|18291139|P3|Phase 1|tired|0
5308384|NCT00390013|18291140|P2|Phase 1|tired|0
5308385|NCT00390013|18291141|P1|Phase 1|tired|0
5308386|NCT00389831|18291166|P2|Overall Study|Lost to Follow-up|1
5308387|NCT00389831|18291167|P1|Overall Study|Lost to Follow-up|0
5308388|NCT00389831|18291166|P2|Overall Study|Other reasons|2
5308389|NCT00389831|18291167|P1|Overall Study|Other reasons|0
5308390|NCT00389831|18291166|P2|Overall Study|Did not receive treatment.|2
5308391|NCT00389831|18291167|P1|Overall Study|Did not receive treatment.|0
5308392|NCT00389831|18291166|P2|Overall Study|Lack of Efficacy|2
5308393|NCT00389831|18291167|P1|Overall Study|Lack of Efficacy|0
5308394|NCT00389597|18291230|P4|Overall Study|Lost to Follow-up|6
5308395|NCT00389597|18291231|P3|Overall Study|Lost to Follow-up|4
5308396|NCT00389597|18291232|P2|Overall Study|Lost to Follow-up|6
5308397|NCT00389597|18291233|P1|Overall Study|Lost to Follow-up|8
5308398|NCT00389519|18291258|P4|Treated|Reason not specified|2
5308399|NCT00389519|18291259|P3|Treated|Reason not specified|0
5308400|NCT00389519|18291260|P2|Treated|Reason not specified|1
5308401|NCT00389519|18291261|P1|Treated|Reason not specified|1
5308402|NCT00389519|18291258|P4|Treated|Adverse Event|2
5308403|NCT00389519|18291259|P3|Treated|Adverse Event|0
5308404|NCT00389519|18291260|P2|Treated|Adverse Event|0
5308405|NCT00389519|18291261|P1|Treated|Adverse Event|1
5308406|NCT00389519|18291258|P4|Randomized|Did not receive study drug|0
5308407|NCT00389519|18291259|P3|Randomized|Did not receive study drug|0
5308408|NCT00389519|18291260|P2|Randomized|Did not receive study drug|0
5308409|NCT00389519|18291261|P1|Randomized|Did not receive study drug|2
5308410|NCT00389519|18291258|P4|Placebo Run-In|Reason not specified|0
5308411|NCT00389519|18291259|P3|Placebo Run-In|Reason not specified|0
5308412|NCT00389519|18291260|P2|Placebo Run-In|Reason not specified|0
5308413|NCT00389519|18291261|P1|Placebo Run-In|Reason not specified|40
5308414|NCT00389519|18291258|P4|Placebo Run-In|Withdrawal by Subject|0
5308415|NCT00389519|18291259|P3|Placebo Run-In|Withdrawal by Subject|0
5308416|NCT00389519|18291260|P2|Placebo Run-In|Withdrawal by Subject|0
5308417|NCT00389519|18291261|P1|Placebo Run-In|Withdrawal by Subject|19
5308418|NCT00389519|18291258|P4|Placebo Run-In|Did not meet blood pressure criteria|0
5308419|NCT00389519|18291259|P3|Placebo Run-In|Did not meet blood pressure criteria|0
5308420|NCT00389519|18291260|P2|Placebo Run-In|Did not meet blood pressure criteria|0
5308421|NCT00389519|18291261|P1|Placebo Run-In|Did not meet blood pressure criteria|119
5308422|NCT00389441|18291338|P1|Overall Study|Clinical progression|1
5308423|NCT00389441|18291338|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
5308424|NCT00389441|18291338|P1|Overall Study|Objective progression or relapse|26
5308425|NCT00389441|18291338|P1|Overall Study|Global deterioration of health status|4
5308426|NCT00389441|18291338|P1|Overall Study|Protocol Violation|1
5308427|NCT00389441|18291338|P1|Overall Study|Physician Decision|1
5308428|NCT00389441|18291338|P1|Overall Study|Withdrawal by Subject|4
5308429|NCT00389441|18291338|P1|Overall Study|Lost to Follow-up|2
5308430|NCT00389441|18291338|P1|Overall Study|Death|4
5308431|NCT00389441|18291338|P1|Overall Study|Adverse Event|7
5308432|NCT00389324|18291347|P1|Subcutaneous Phase|Lost to Follow-up|1
5308433|NCT00389324|18291347|P1|Subcutaneous Phase|Withdrawal by Subject|2
5308434|NCT00389324|18291347|P1|Subcutaneous Phase|Non-compliance with study medication|2
5308435|NCT00389324|18291347|P1|Subcutaneous Phase|Adverse Event|2
5308436|NCT00389324|18291347|P1|Run-In Phase|Withdrawal by Subject|1
5308437|NCT00389324|18291347|P1|Run-In Phase|Lost to Follow-up|1
5308438|NCT00389324|18291347|P1|Run-In Phase|Adverse Event|1
5308439|NCT00389207|18291357|P3|Overall Study|Other|9
5308440|NCT00389207|18291358|P2|Overall Study|Other|23
5308441|NCT00389207|18291359|P1|Overall Study|Other|17
5308442|NCT00389207|18291357|P3|Overall Study|Withdrawal by Subject|11
5308443|NCT00389207|18291358|P2|Overall Study|Withdrawal by Subject|7
5308444|NCT00389207|18291359|P1|Overall Study|Withdrawal by Subject|5
5308445|NCT00389207|18291357|P3|Overall Study|Lost to Follow-up|7
5308446|NCT00389207|18291358|P2|Overall Study|Lost to Follow-up|9
5308447|NCT00389207|18291359|P1|Overall Study|Lost to Follow-up|12
5308448|NCT00389207|18291357|P3|Overall Study|Protocol Violation|4
5308449|NCT00389207|18291358|P2|Overall Study|Protocol Violation|1
5308450|NCT00389207|18291359|P1|Overall Study|Protocol Violation|3
5308451|NCT00389207|18291357|P3|Overall Study|Adverse Event|10
5308452|NCT00389207|18291358|P2|Overall Study|Adverse Event|32
5308453|NCT00389207|18291359|P1|Overall Study|Adverse Event|26
5308454|NCT00389064|18291482|P2|Overall Study|Multiple Reasons|11
5308455|NCT00389064|18291483|P1|Overall Study|Multiple Reasons|9
5308456|NCT00389064|18291482|P2|Overall Study|Protocol Violation|0
5308457|NCT00389064|18291483|P1|Overall Study|Protocol Violation|2
5308458|NCT00389064|18291482|P2|Overall Study|Lost to Follow-up|2
5308459|NCT00389064|18291483|P1|Overall Study|Lost to Follow-up|1
5308460|NCT00389064|18291482|P2|Overall Study|Physician Decision|2
5308461|NCT00389064|18291483|P1|Overall Study|Physician Decision|2
5308462|NCT00389064|18291482|P2|Overall Study|Withdrawal by Subject|27
5308463|NCT00389064|18291483|P1|Overall Study|Withdrawal by Subject|17
5308464|NCT00389064|18291482|P2|Overall Study|Lack of Efficacy|14
5308465|NCT00389064|18291483|P1|Overall Study|Lack of Efficacy|3
5308466|NCT00389064|18291482|P2|Overall Study|Adverse Event|3
5308467|NCT00389064|18291483|P1|Overall Study|Adverse Event|11
5308468|NCT00388973|18291511|P2|Overall Study|Did not complete 2-week follow-up visit|17
5308469|NCT00388973|18291512|P1|Overall Study|Did not complete 2-week follow-up visit|17
5308470|NCT00388973|18291511|P2|Overall Study|Left region|1
5308471|NCT00388973|18291512|P1|Overall Study|Left region|0
5308472|NCT00388973|18291511|P2|Overall Study|Did not complete 61 days of treatment|4
5308473|NCT00388973|18291512|P1|Overall Study|Did not complete 61 days of treatment|5
5308474|NCT00388973|18291511|P2|Overall Study|Study specific Discontinuation Criteria|1
5308475|NCT00388973|18291512|P1|Overall Study|Study specific Discontinuation Criteria|0
5308476|NCT00388973|18291511|P2|Overall Study|Withdrawal by Subject|17
5308477|NCT00388973|18291512|P1|Overall Study|Withdrawal by Subject|14
5308478|NCT00388973|18291511|P2|Overall Study|Protocol Violation|0
5308479|NCT00388973|18291512|P1|Overall Study|Protocol Violation|3
5308480|NCT00388973|18291511|P2|Overall Study|Lack of Efficacy|12
5308481|NCT00388973|18291512|P1|Overall Study|Lack of Efficacy|1
5308482|NCT00388973|18291511|P2|Overall Study|Adverse Event|6
5308483|NCT00388973|18291512|P1|Overall Study|Adverse Event|16
5308484|NCT00388947|18291532|P1|Overall Study|Protocol Violation|47
5308485|NCT00388726|18291548|P2|Overall Study|Death|2
5308486|NCT00388726|18291549|P1|Overall Study|Death|3
5308487|NCT00388726|18291548|P2|Overall Study|Physician Decision|13
5308488|NCT00388726|18291549|P1|Overall Study|Physician Decision|18
5308489|NCT00388726|18291548|P2|Overall Study|Administrative|9
5308490|NCT00388726|18291549|P1|Overall Study|Administrative|6
5308491|NCT00388726|18291548|P2|Overall Study|Withdrawal by Subject|7
5308492|NCT00388726|18291549|P1|Overall Study|Withdrawal by Subject|10
5308493|NCT00388726|18291548|P2|Overall Study|Clinical Progression|36
5308494|NCT00388726|18291549|P1|Overall Study|Clinical Progression|61
5308495|NCT00388726|18291548|P2|Overall Study|Progressive Disease|153
5308496|NCT00388726|18291549|P1|Overall Study|Progressive Disease|336
5308497|NCT00388726|18291548|P2|Overall Study|Adverse Event|24
5308498|NCT00388726|18291549|P1|Overall Study|Adverse Event|50
5308499|NCT00388674|18291565|P2|End of Study|Not Reported|1
5308500|NCT00388674|18291566|P1|End of Study|Not Reported|0
5308501|NCT00388674|18291565|P2|End of Study|No Off-Treatment Status Data|30
5308502|NCT00388674|18291566|P1|End of Study|No Off-Treatment Status Data|22
5308503|NCT00388674|18291565|P2|End of Study|Participant Withdrew Consent|673
5308504|NCT00388674|18291566|P1|End of Study|Participant Withdrew Consent|437
5308505|NCT00388674|18291565|P2|End of Study|Not Defined|214
5308506|NCT00388674|18291566|P1|End of Study|Not Defined|135
5308507|NCT00388674|18291565|P2|End of Study|Non-Study Related Comorbidities|4
5308508|NCT00388674|18291566|P1|End of Study|Non-Study Related Comorbidities|3
5308509|NCT00388674|18291565|P2|End of Study|Malignancy (Non-HCC)|1
5308510|NCT00388674|18291566|P1|End of Study|Malignancy (Non-HCC)|1
5308511|NCT00388674|18291565|P2|End of Study|Lost to Follow-up|715
5308512|NCT00388674|18291566|P1|End of Study|Lost to Follow-up|587
5308513|NCT00388674|18291565|P2|End of Study|HCC|7
5308514|NCT00388674|18291566|P1|End of Study|HCC|8
5308515|NCT00388674|18291565|P2|End of Study|HBV Disease Progression (Non-HCC)|9
5308516|NCT00388674|18291566|P1|End of Study|HBV Disease Progression (Non-HCC)|3
5308517|NCT00388674|18291565|P2|End of Study|Death|262
5308518|NCT00388674|18291566|P1|End of Study|Death|239
5308519|NCT00388674|18291565|P2|End of Study|Administrative Reason By Sponsor|253
5308520|NCT00388674|18291566|P1|End of Study|Administrative Reason By Sponsor|299
5308521|NCT00388674|18291565|P2|Initial Treatment|Not Reported|12
5308522|NCT00388674|18291566|P1|Initial Treatment|Not Reported|10
5308523|NCT00388674|18291565|P2|Initial Treatment|No Off-Treatment Status Data|13
5308524|NCT00388674|18291566|P1|Initial Treatment|No Off-Treatment Status Data|11
5308525|NCT00388674|18291565|P2|Initial Treatment|Participant Request|673
5308526|NCT00388674|18291566|P1|Initial Treatment|Participant Request|501
5308527|NCT00388674|18291565|P2|Initial Treatment|Study Drug Toxicity|92
5308528|NCT00388674|18291566|P1|Initial Treatment|Study Drug Toxicity|5
5308529|NCT00388674|18291565|P2|Initial Treatment|Pregnancy|16
5308530|NCT00388674|18291566|P1|Initial Treatment|Pregnancy|26
5308531|NCT00388674|18291565|P2|Initial Treatment|Partial or inadequate Treatment|472
5308532|NCT00388674|18291566|P1|Initial Treatment|Partial or inadequate Treatment|112
5308533|NCT00388674|18291565|P2|Initial Treatment|Not Defined|172
5308534|NCT00388674|18291566|P1|Initial Treatment|Not Defined|125
5308535|NCT00388674|18291565|P2|Initial Treatment|Non-Study related Comorbidities|4
5308536|NCT00388674|18291566|P1|Initial Treatment|Non-Study related Comorbidities|3
5308537|NCT00388674|18291565|P2|Initial Treatment|Never Treated with Study Medication|7
5308538|NCT00388674|18291566|P1|Initial Treatment|Never Treated with Study Medication|1
5308539|NCT00388674|18291565|P2|Initial Treatment|Malignancy (Non-HCC)|3
5308540|NCT00388674|18291566|P1|Initial Treatment|Malignancy (Non-HCC)|7
5308541|NCT00388674|18291565|P2|Initial Treatment|Lost to Follow-up|624
5308542|NCT00388674|18291566|P1|Initial Treatment|Lost to Follow-up|526
5308543|NCT00388674|18291565|P2|Initial Treatment|HCC|20
5308544|NCT00388674|18291566|P1|Initial Treatment|HCC|12
5308545|NCT00388674|18291565|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
5308546|NCT00388674|18291566|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
5308547|NCT00388674|18291565|P2|Initial Treatment|Death|216
5308548|NCT00388674|18291566|P1|Initial Treatment|Death|215
5308549|NCT00388674|18291565|P2|Initial Treatment|Adverse Event|87
5308550|NCT00388674|18291566|P1|Initial Treatment|Adverse Event|22
5308551|NCT00388674|18291565|P2|Initial Treatment|Administrative Reason by Sponsor|158
5308552|NCT00388674|18291566|P1|Initial Treatment|Administrative Reason by Sponsor|241
5308553|NCT00388583|18291584|P2|Overall Study|Did not receive vaccine|1
5308554|NCT00388583|18291585|P1|Overall Study|Did not receive vaccine|0
5308555|NCT00388583|18291584|P2|Overall Study|Serious Adverse Event|0
5308556|NCT00388583|18291585|P1|Overall Study|Serious Adverse Event|2
5308557|NCT00388583|18291584|P2|Overall Study|Withdrawal by Subject|3
5308558|NCT00388583|18291585|P1|Overall Study|Withdrawal by Subject|3
5308559|NCT00388583|18291584|P2|Overall Study|Protocol Violation|0
5308560|NCT00388583|18291585|P1|Overall Study|Protocol Violation|1
5308561|NCT00388505|18291599|P2|Overall Study|Unable to classify|3
5308562|NCT00388505|18291600|P1|Overall Study|Unable to classify|4
5308563|NCT00388505|18291599|P2|Overall Study|Protocol Violation|5
5308564|NCT00388505|18291600|P1|Overall Study|Protocol Violation|6
5308565|NCT00388505|18291599|P2|Overall Study|Administrative Reason|0
5308566|NCT00388505|18291600|P1|Overall Study|Administrative Reason|1
5308567|NCT00388505|18291599|P2|Overall Study|Inappropriate Enrollment|1
5308568|NCT00388505|18291600|P1|Overall Study|Inappropriate Enrollment|0
5308569|NCT00388505|18291599|P2|Overall Study|Lost to Follow-up|3
5308570|NCT00388505|18291600|P1|Overall Study|Lost to Follow-up|5
5308571|NCT00388505|18291599|P2|Overall Study|Withdrawal by Subject|9
5308572|NCT00388505|18291600|P1|Overall Study|Withdrawal by Subject|24
5308573|NCT00388505|18291599|P2|Overall Study|Adverse Event or Death|17
5308574|NCT00388505|18291600|P1|Overall Study|Adverse Event or Death|43
5308575|NCT00388362|18291655|P1|Remained on Study Median of 514 Days|Death|2
5308576|NCT00388362|18291655|P1|Enrolled|Withdrawal by Subject|1
5308577|NCT00388362|18291655|P1|Enrolled|Loss insurance|1
5308578|NCT00388362|18291655|P1|Enrolled|Death|1
5308579|NCT00388362|18291655|P1|Enrolled|Adverse Event|9
5308580|NCT00388362|18291655|P1|Enrolled|Ineligible|1
5308581|NCT00388349|18291660|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
5308582|NCT00388349|18291661|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
5308583|NCT00388297|18291674|P4|Overall Study|Lost to Follow-up|8
5308584|NCT00388297|18291675|P3|Overall Study|Lost to Follow-up|11
5308585|NCT00388297|18291676|P2|Overall Study|Lost to Follow-up|12
5308586|NCT00388297|18291677|P1|Overall Study|Lost to Follow-up|16
5308587|NCT00388154|18291787|P1|Overall Study|Withdrawal by Subject|1
5308588|NCT00388037|18291792|P1|Overall Study|Protocol Violation|1
5308589|NCT00387894|18291800|P1|Overall Study|Withdrawal by Subject|1
5308590|NCT00387881|18291807|P2|Overall Study|Not otherwise specified|7
5308591|NCT00387881|18291808|P1|Overall Study|Not otherwise specified|11
5308592|NCT00387881|18291807|P2|Overall Study|No opportunity to treat headache|34
5308593|NCT00387881|18291808|P1|Overall Study|No opportunity to treat headache|32
5308594|NCT00387881|18291807|P2|Overall Study|Not eligible|7
5308595|NCT00387881|18291808|P1|Overall Study|Not eligible|6
5308596|NCT00387881|18291807|P2|Overall Study|Sponsor terminated Study|1
5308597|NCT00387881|18291808|P1|Overall Study|Sponsor terminated Study|0
5308598|NCT00387881|18291807|P2|Overall Study|Withdrawal by Subject|18
5308599|NCT00387881|18291808|P1|Overall Study|Withdrawal by Subject|15
5308600|NCT00387881|18291807|P2|Overall Study|Protocol Violation|12
5308601|NCT00387881|18291808|P1|Overall Study|Protocol Violation|2
5308602|NCT00387881|18291807|P2|Overall Study|Lost to Follow-up|23
5308603|NCT00387881|18291808|P1|Overall Study|Lost to Follow-up|23
5308604|NCT00387790|18291841|P1|Overall Study|Ineligible for study|2
5308605|NCT00387790|18291841|P1|Overall Study|Withdrawal by Subject|3
5308606|NCT00387790|18291841|P1|Overall Study|Physician Decision|2
5308607|NCT00387790|18291841|P1|Overall Study|Lack of Efficacy|2
5308608|NCT00387790|18291841|P1|Overall Study|Adverse Event|5
5308609|NCT00387764|18291847|P1|Overall Study|Death|7
5308610|NCT00387764|18291847|P1|Overall Study|Other|2
5308611|NCT00387764|18291847|P1|Overall Study|Physician Decision|1
5308612|NCT00387764|18291847|P1|Overall Study|Sponsor Terminated Study|1
5308613|NCT00387764|18291847|P1|Overall Study|Withdrawal by Subject|8
5308614|NCT00387764|18291847|P1|Overall Study|Adverse Event|12
5308615|NCT00387725|18291875|P4|Overall Study|Parent/legal guardian request|1
5308616|NCT00387725|18291876|P3|Overall Study|Parent/legal guardian request|1
5308617|NCT00387725|18291877|P2|Overall Study|Parent/legal guardian request|0
5308618|NCT00387725|18291878|P1|Overall Study|Parent/legal guardian request|0
5308619|NCT00387725|18291875|P4|Overall Study|Withdrawal by Subject|0
5308620|NCT00387725|18291876|P3|Overall Study|Withdrawal by Subject|1
5308621|NCT00387725|18291877|P2|Overall Study|Withdrawal by Subject|0
5308622|NCT00387725|18291878|P1|Overall Study|Withdrawal by Subject|1
5308623|NCT00387725|18291875|P4|Overall Study|Protocol Violation|0
5308624|NCT00387725|18291876|P3|Overall Study|Protocol Violation|0
5308625|NCT00387725|18291877|P2|Overall Study|Protocol Violation|1
5308626|NCT00387725|18291878|P1|Overall Study|Protocol Violation|0
5308627|NCT00387725|18291875|P4|Overall Study|Adverse Event|1
5308628|NCT00387725|18291876|P3|Overall Study|Adverse Event|0
5308629|NCT00387725|18291877|P2|Overall Study|Adverse Event|0
5308630|NCT00387725|18291878|P1|Overall Study|Adverse Event|0
5308631|NCT00387712|18291898|P2|Overall Study|Withdrawal by Subject|12
5308632|NCT00387712|18291899|P1|Overall Study|Withdrawal by Subject|6
5308633|NCT00387712|18291898|P2|Overall Study|Lost to Follow-up|20
5308634|NCT00387712|18291899|P1|Overall Study|Lost to Follow-up|17
5308635|NCT00387712|18291898|P2|Overall Study|Physician Decision|4
5308636|NCT00387712|18291899|P1|Overall Study|Physician Decision|6
5308637|NCT00387647|18291930|P1|Overall Study|Death|18
5308638|NCT00387465|18291973|P3|Overall Study|Withdrawal by Subject|0
5308639|NCT00387465|18291974|P2|Overall Study|Withdrawal by Subject|1
5308640|NCT00387465|18291975|P1|Overall Study|Withdrawal by Subject|0
5308641|NCT00387426|18291992|P1|Overall Study|Disease Progression|3
5308642|NCT00387426|18291992|P1|Overall Study|Toxicities|4
5308643|NCT00387426|18291992|P1|Overall Study|Lack of Response|7
5308644|NCT00387348|18291999|P3|Overall Study|Adverse Event|1
5308645|NCT00387348|18292000|P2|Overall Study|Adverse Event|0
5308646|NCT00387348|18292001|P1|Overall Study|Adverse Event|1
5308647|NCT00387348|18291999|P3|Overall Study|Withdrawal by Subject|2
5308648|NCT00387348|18292000|P2|Overall Study|Withdrawal by Subject|2
5308649|NCT00387348|18292001|P1|Overall Study|Withdrawal by Subject|0
5308650|NCT00387348|18291999|P3|Overall Study|Physician Decision|1
5308651|NCT00387348|18292000|P2|Overall Study|Physician Decision|0
5308652|NCT00387348|18292001|P1|Overall Study|Physician Decision|1
5308653|NCT00387348|18291999|P3|Overall Study|Death|0
5308654|NCT00387348|18292000|P2|Overall Study|Death|1
5308655|NCT00387348|18292001|P1|Overall Study|Death|1
5308656|NCT00387153|18292030|P1|Overall Study|Lack of Response|4
5308657|NCT00387153|18292030|P1|Overall Study|Disease Progression|3
5308658|NCT00387153|18292030|P1|Overall Study|Adverse Event|1
5308659|NCT00387127|18292036|P2|Overall Study|Sponsor Unblinded|0
5308660|NCT00387127|18292037|P1|Overall Study|Sponsor Unblinded|1
5308661|NCT00387127|18292036|P2|Overall Study|Serious Adverse Event|1
5308662|NCT00387127|18292037|P1|Overall Study|Serious Adverse Event|1
5308663|NCT00387127|18292036|P2|Overall Study|Required by Protocol Amendment #4|10
5308664|NCT00387127|18292037|P1|Overall Study|Required by Protocol Amendment #4|12
5308665|NCT00387127|18292036|P2|Overall Study|Withdrawal by Subject|2
5308666|NCT00387127|18292037|P1|Overall Study|Withdrawal by Subject|3
5308667|NCT00387127|18292036|P2|Overall Study|Physician Decision|1
5308668|NCT00387127|18292037|P1|Overall Study|Physician Decision|0
5308669|NCT00387127|18292036|P2|Overall Study|Death|16
5308670|NCT00387127|18292037|P1|Overall Study|Death|16
5308671|NCT00387127|18292036|P2|Overall Study|Lost to Follow-up|4
5308672|NCT00387127|18292037|P1|Overall Study|Lost to Follow-up|0
5308673|NCT00387088|18292079|P2|Overall Study|Other|52
5308674|NCT00387088|18292080|P1|Overall Study|Other|58
5308675|NCT00387088|18292079|P2|Overall Study|Lost to Follow-up|28
5308676|NCT00387088|18292080|P1|Overall Study|Lost to Follow-up|22
5308677|NCT00387088|18292079|P2|Overall Study|Lack of Efficacy|67
5308678|NCT00387088|18292080|P1|Overall Study|Lack of Efficacy|28
5308679|NCT00387088|18292079|P2|Overall Study|Withdrawal by Subject|35
5308680|NCT00387088|18292080|P1|Overall Study|Withdrawal by Subject|20
5308681|NCT00387088|18292079|P2|Overall Study|Protocol Violation|35
5308682|NCT00387088|18292080|P1|Overall Study|Protocol Violation|47
5308683|NCT00387088|18292079|P2|Overall Study|Adverse Event|156
5308684|NCT00387088|18292080|P1|Overall Study|Adverse Event|143
5308685|NCT00387010|18292137|P1|Treatment Period|Participant reported study drug stolen|1
5308686|NCT00387010|18292137|P1|Treatment Period|Noncompliance with study procedures|3
5308687|NCT00387010|18292137|P1|Treatment Period|Noncompliance with study medication|2
5308688|NCT00387010|18292137|P1|Treatment Period|Withdrawal by Subject|1
5308689|NCT00387010|18292137|P1|Treatment Period|Adverse Event|4
5308777|NCT00386152|18292470|P2|Overall Study|Completed chemotherapy|5
5308690|NCT00387010|18292137|P1|Dose Titration Period|Noncompliance with study procedures|7
5308691|NCT00387010|18292137|P1|Dose Titration Period|Noncompliance with study medication|8
5308692|NCT00387010|18292137|P1|Dose Titration Period|Lost to Follow-up|2
5308693|NCT00387010|18292137|P1|Dose Titration Period|Protocol Violation|1
5308694|NCT00387010|18292137|P1|Dose Titration Period|Withdrawal by Subject|3
5308695|NCT00387010|18292137|P1|Dose Titration Period|Lack of Efficacy|5
5308696|NCT00387010|18292137|P1|Dose Titration Period|Adverse Event|12
5308697|NCT00386776|18292164|P1|Overall Study|Withdrawal by Subject|8
5308698|NCT00386607|18292174|P2|Extension|Unsatisfactory therapeutic effect|1
5308699|NCT00386607|18292175|P1|Extension|Unsatisfactory therapeutic effect|0
5308700|NCT00386607|18292174|P2|Extension|Patient withdrew consent|5
5308701|NCT00386607|18292175|P1|Extension|Patient withdrew consent|0
5308702|NCT00386607|18292174|P2|Extension|Lost to Follow-up|3
5308703|NCT00386607|18292175|P1|Extension|Lost to Follow-up|0
5308704|NCT00386607|18292174|P2|Extension|Administrative problems|1
5308705|NCT00386607|18292175|P1|Extension|Administrative problems|0
5308706|NCT00386607|18292174|P2|Extension|Abnormal laboratory value(s)|1
5308707|NCT00386607|18292175|P1|Extension|Abnormal laboratory value(s)|0
5308708|NCT00386607|18292174|P2|Extension|Adverse Event|6
5308709|NCT00386607|18292175|P1|Extension|Adverse Event|0
5308710|NCT00386607|18292174|P2|Core|Protocol Deviation|0
5308711|NCT00386607|18292175|P1|Core|Protocol Deviation|6
5308712|NCT00386607|18292174|P2|Core|Administrative problems|0
5308713|NCT00386607|18292175|P1|Core|Administrative problems|1
5308714|NCT00386607|18292174|P2|Core|Lost to Follow-up|0
5308715|NCT00386607|18292175|P1|Core|Lost to Follow-up|23
5308716|NCT00386607|18292174|P2|Core|Patient withdrew consent|0
5308717|NCT00386607|18292175|P1|Core|Patient withdrew consent|15
5308718|NCT00386607|18292174|P2|Core|Condition no longer requires study drug|0
5308719|NCT00386607|18292175|P1|Core|Condition no longer requires study drug|4
5308720|NCT00386607|18292174|P2|Core|Unsatisfactory therapeutic effect|0
5308721|NCT00386607|18292175|P1|Core|Unsatisfactory therapeutic effect|23
5308722|NCT00386607|18292174|P2|Core|Abnormal laboratory value(s)|0
5308723|NCT00386607|18292175|P1|Core|Abnormal laboratory value(s)|3
5308724|NCT00386607|18292174|P2|Core|Adverse Event|0
5308725|NCT00386607|18292175|P1|Core|Adverse Event|40
5308726|NCT00386425|18292203|P3|Overall Study|Withdrawal by Subject|0
5308727|NCT00386425|18292204|P2|Overall Study|Withdrawal by Subject|1
5308728|NCT00386425|18292205|P1|Overall Study|Withdrawal by Subject|0
5308729|NCT00386425|18292203|P3|Overall Study|Physician Decision|0
5308730|NCT00386425|18292204|P2|Overall Study|Physician Decision|0
5308731|NCT00386425|18292205|P1|Overall Study|Physician Decision|3
5308732|NCT00386360|18292231|P2|Overall Study|Did not take any study medication|2
5308733|NCT00386360|18292232|P1|Overall Study|Did not take any study medication|0
5308734|NCT00386360|18292231|P2|Overall Study|Withdrawal by Subject|6
5308735|NCT00386360|18292232|P1|Overall Study|Withdrawal by Subject|3
5308736|NCT00386360|18292231|P2|Overall Study|Protocol Violation|3
5308737|NCT00386360|18292232|P1|Overall Study|Protocol Violation|0
5308738|NCT00386360|18292231|P2|Overall Study|Lost to Follow-up|2
5308739|NCT00386360|18292232|P1|Overall Study|Lost to Follow-up|0
5308740|NCT00386360|18292231|P2|Overall Study|Physician Decision|2
5308741|NCT00386360|18292232|P1|Overall Study|Physician Decision|2
5308742|NCT00386360|18292231|P2|Overall Study|Adverse Event|2
5308743|NCT00386360|18292232|P1|Overall Study|Adverse Event|4
5308744|NCT00386334|18292266|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
5308745|NCT00386334|18292267|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
5308746|NCT00386334|18292266|P2|Double Blind Period|Other|3
5308747|NCT00386334|18292267|P1|Double Blind Period|Other|3
5308748|NCT00386334|18292266|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
5308749|NCT00386334|18292267|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
5308750|NCT00386334|18292266|P2|Double Blind Period|Lack of Efficacy|11
5308751|NCT00386334|18292267|P1|Double Blind Period|Lack of Efficacy|20
5308752|NCT00386334|18292266|P2|Double Blind Period|Withdrawal by Subject|13
5308753|NCT00386334|18292267|P1|Double Blind Period|Withdrawal by Subject|9
5308754|NCT00386334|18292266|P2|Double Blind Period|Protocol Violation|1
5308755|NCT00386334|18292267|P1|Double Blind Period|Protocol Violation|1
5308756|NCT00386334|18292266|P2|Double Blind Period|Adverse Event|14
5308757|NCT00386334|18292267|P1|Double Blind Period|Adverse Event|9
5308758|NCT00386308|18292411|P2|Overall Study|Other Event|1
5308759|NCT00386308|18292412|P1|Overall Study|Other Event|8
5308760|NCT00386308|18292411|P2|Overall Study|Withdrawal by Subject|2
5308761|NCT00386308|18292412|P1|Overall Study|Withdrawal by Subject|6
5308762|NCT00386308|18292411|P2|Overall Study|Lost to Follow-up|6
5308763|NCT00386308|18292412|P1|Overall Study|Lost to Follow-up|10
5308764|NCT00386308|18292411|P2|Overall Study|Lack of Efficacy|2
5308765|NCT00386308|18292412|P1|Overall Study|Lack of Efficacy|0
5308766|NCT00386308|18292411|P2|Overall Study|Protocol Violation|5
5308767|NCT00386308|18292412|P1|Overall Study|Protocol Violation|2
5308768|NCT00386308|18292411|P2|Overall Study|Adverse Event|3
5308769|NCT00386308|18292412|P1|Overall Study|Adverse Event|3
5308770|NCT00386152|18292469|P3|Overall Study|Withdrawal by Subject|10
5308771|NCT00386152|18292470|P2|Overall Study|Withdrawal by Subject|6
5308772|NCT00386152|18292471|P1|Overall Study|Withdrawal by Subject|3
5308773|NCT00386152|18292469|P3|Overall Study|Protocol Violation|2
5308774|NCT00386152|18292470|P2|Overall Study|Protocol Violation|5
5308775|NCT00386152|18292471|P1|Overall Study|Protocol Violation|3
5308776|NCT00386152|18292469|P3|Overall Study|Completed chemotherapy|1
5308778|NCT00386152|18292471|P1|Overall Study|Completed chemotherapy|4
5308779|NCT00386152|18292469|P3|Overall Study|Lost to Follow-up|0
5308780|NCT00386152|18292470|P2|Overall Study|Lost to Follow-up|0
5308781|NCT00386152|18292471|P1|Overall Study|Lost to Follow-up|1
5308782|NCT00386152|18292469|P3|Overall Study|Physician Decision|4
5308783|NCT00386152|18292470|P2|Overall Study|Physician Decision|10
5308784|NCT00386152|18292471|P1|Overall Study|Physician Decision|13
5308785|NCT00386152|18292469|P3|Overall Study|Disease progression|5
5308786|NCT00386152|18292470|P2|Overall Study|Disease progression|4
5308787|NCT00386152|18292471|P1|Overall Study|Disease progression|7
5308788|NCT00386152|18292469|P3|Overall Study|Death|1
5308789|NCT00386152|18292470|P2|Overall Study|Death|0
5308790|NCT00386152|18292471|P1|Overall Study|Death|3
5308791|NCT00386152|18292469|P3|Overall Study|Chang from original chemo stratification|6
5308792|NCT00386152|18292470|P2|Overall Study|Chang from original chemo stratification|5
5308793|NCT00386152|18292471|P1|Overall Study|Chang from original chemo stratification|4
5308794|NCT00386152|18292469|P3|Overall Study|Adverse Event|4
5308795|NCT00386152|18292470|P2|Overall Study|Adverse Event|5
5308796|NCT00386152|18292471|P1|Overall Study|Adverse Event|6
5308797|NCT00386100|18292490|P2|Overall Study|Participant randomized in error|0
5308798|NCT00386100|18292491|P1|Overall Study|Participant randomized in error|1
5308799|NCT00386100|18292490|P2|Overall Study|Hb1Ac >8%|1
5308800|NCT00386100|18292491|P1|Overall Study|Hb1Ac >8%|0
5308801|NCT00386100|18292490|P2|Overall Study|Out of country for 5 months|0
5308802|NCT00386100|18292491|P1|Overall Study|Out of country for 5 months|1
5308803|NCT00386100|18292490|P2|Overall Study|Positive pregnancy test|3
5308804|NCT00386100|18292491|P1|Overall Study|Positive pregnancy test|1
5308805|NCT00386100|18292490|P2|Overall Study|Osteoporosis|1
5308806|NCT00386100|18292491|P1|Overall Study|Osteoporosis|0
5308807|NCT00386100|18292490|P2|Overall Study|7.6% bone loss|0
5308808|NCT00386100|18292491|P1|Overall Study|7.6% bone loss|1
5308809|NCT00386100|18292490|P2|Overall Study|DBP 93 mmHg at randomization|0
5308810|NCT00386100|18292491|P1|Overall Study|DBP 93 mmHg at randomization|1
5308811|NCT00386100|18292490|P2|Overall Study|Bone loss by DXA bone scan|0
5308812|NCT00386100|18292491|P1|Overall Study|Bone loss by DXA bone scan|1
5308813|NCT00386100|18292490|P2|Overall Study|Bad metabolic control & patient security|0
5308814|NCT00386100|18292491|P1|Overall Study|Bad metabolic control & patient security|1
5308815|NCT00386100|18292490|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
5308816|NCT00386100|18292491|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
5308817|NCT00386100|18292490|P2|Overall Study|Participant's PCP wanted to stop drug|0
5308818|NCT00386100|18292491|P1|Overall Study|Participant's PCP wanted to stop drug|1
5308819|NCT00386100|18292490|P2|Overall Study|Didn't meet entry criteria|1
5308820|NCT00386100|18292491|P1|Overall Study|Didn't meet entry criteria|1
5308821|NCT00386100|18292490|P2|Overall Study|Excessive bone loss vs. baseline value|1
5308822|NCT00386100|18292491|P1|Overall Study|Excessive bone loss vs. baseline value|0
5308823|NCT00386100|18292490|P2|Overall Study|Participant moving out of state|0
5308824|NCT00386100|18292491|P1|Overall Study|Participant moving out of state|2
5308825|NCT00386100|18292490|P2|Overall Study|Participant's concern due to CPK levels|0
5308826|NCT00386100|18292491|P1|Overall Study|Participant's concern due to CPK levels|1
5308827|NCT00386100|18292490|P2|Overall Study|Laboratory findings|0
5308828|NCT00386100|18292491|P1|Overall Study|Laboratory findings|1
5308829|NCT00386100|18292490|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
5308830|NCT00386100|18292491|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
5308831|NCT00386100|18292490|P2|Overall Study|Consecutive elevated Hba1C|0
5308832|NCT00386100|18292491|P1|Overall Study|Consecutive elevated Hba1C|1
5308833|NCT00386100|18292490|P2|Overall Study|BMD <2.5|0
5308834|NCT00386100|18292491|P1|Overall Study|BMD <2.5|1
5308835|NCT00386100|18292490|P2|Overall Study|Bone mass density (BMD) loss >6%|4
5308836|NCT00386100|18292491|P1|Overall Study|Bone mass density (BMD) loss >6%|4
5308837|NCT00386100|18292490|P2|Overall Study|Withdrawal by Subject|31
5308838|NCT00386100|18292491|P1|Overall Study|Withdrawal by Subject|32
5308839|NCT00386100|18292490|P2|Overall Study|Protocol Violation|3
5308840|NCT00386100|18292491|P1|Overall Study|Protocol Violation|5
5308841|NCT00386100|18292490|P2|Overall Study|Non-compliance|19
5308842|NCT00386100|18292491|P1|Overall Study|Non-compliance|18
5308843|NCT00386100|18292490|P2|Overall Study|Lost to Follow-up|29
5308844|NCT00386100|18292491|P1|Overall Study|Lost to Follow-up|29
5308845|NCT00386100|18292490|P2|Overall Study|Insufficient therapeutic effect|6
5308846|NCT00386100|18292491|P1|Overall Study|Insufficient therapeutic effect|30
5308847|NCT00386100|18292490|P2|Overall Study|Death|1
5308848|NCT00386100|18292491|P1|Overall Study|Death|0
5308849|NCT00386100|18292490|P2|Overall Study|Adverse Event|25
5308850|NCT00386100|18292491|P1|Overall Study|Adverse Event|15
5308851|NCT00386100|18292490|P2|Overall Study|Did not receive study medication|4
5308852|NCT00386100|18292491|P1|Overall Study|Did not receive study medication|6
5308853|NCT00386022|18292555|P2|Plus Estrogen|Adverse Event|1
5308854|NCT00386022|18292556|P1|Plus Estrogen|Adverse Event|0
5308855|NCT00386022|18292555|P2|Plus Estrogen|Lost to Follow-up|0
5308856|NCT00386022|18292556|P1|Plus Estrogen|Lost to Follow-up|2
5308857|NCT00386009|18292566|P2|Overall Study|Withdrawal by Subject|4
5308858|NCT00386009|18292567|P1|Overall Study|Withdrawal by Subject|5
5308859|NCT00386009|18292566|P2|Overall Study|Sponsor Decision|1
5308860|NCT00386009|18292567|P1|Overall Study|Sponsor Decision|1
5308861|NCT00386009|18292566|P2|Overall Study|Protocol Violation|0
5308862|NCT00386009|18292567|P1|Overall Study|Protocol Violation|1
5308863|NCT00386009|18292566|P2|Overall Study|Lost to Follow-up|1
5308864|NCT00386009|18292567|P1|Overall Study|Lost to Follow-up|1
5308865|NCT00386009|18292566|P2|Overall Study|Entry Criteria Not Met|2
5308866|NCT00386009|18292567|P1|Overall Study|Entry Criteria Not Met|0
5308867|NCT00386009|18292566|P2|Overall Study|Death|0
5308868|NCT00386009|18292567|P1|Overall Study|Death|1
5308869|NCT00386009|18292566|P2|Overall Study|Adverse Event|2
5308870|NCT00386009|18292567|P1|Overall Study|Adverse Event|0
5308871|NCT00385944|18292614|P3|2nd Maintenance Dose Period|Invalid PD Data|0
5308872|NCT00385944|18292615|P2|2nd Maintenance Dose Period|Invalid PD Data|3
5308873|NCT00385944|18292616|P1|2nd Maintenance Dose Period|Invalid PD Data|2
5308874|NCT00385944|18292614|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
5308875|NCT00385944|18292615|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
5308876|NCT00385944|18292616|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
5308877|NCT00385944|18292614|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
5308878|NCT00385944|18292615|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
5308879|NCT00385944|18292616|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
5308880|NCT00385944|18292614|P3|1st Maintenance Dose Period|Physician Decision|0
5308881|NCT00385944|18292615|P2|1st Maintenance Dose Period|Physician Decision|0
5308882|NCT00385944|18292616|P1|1st Maintenance Dose Period|Physician Decision|1
5308883|NCT00385918|18292659|P3|Intervention Phase After Randomization|Lost to Follow-up|0
5308884|NCT00385918|18292660|P2|Intervention Phase After Randomization|Lost to Follow-up|0
5308885|NCT00385918|18292661|P1|Intervention Phase After Randomization|Lost to Follow-up|1
5308886|NCT00385918|18292659|P3|Intervention Phase After Randomization|Physician Decision|0
5308887|NCT00385918|18292660|P2|Intervention Phase After Randomization|Physician Decision|0
5308888|NCT00385918|18292661|P1|Intervention Phase After Randomization|Physician Decision|1
5308889|NCT00385918|18292659|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
5308890|NCT00385918|18292660|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
5308891|NCT00385918|18292661|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
5308892|NCT00385918|18292659|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
5308893|NCT00385918|18292660|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
5308894|NCT00385918|18292661|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
5308895|NCT00385918|18292659|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
5308896|NCT00385918|18292660|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
5308897|NCT00385918|18292661|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
5308898|NCT00385918|18292659|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
5308899|NCT00385918|18292660|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
5308900|NCT00385918|18292661|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
5308901|NCT00385840|18292685|P2|Overall Study|Lost to Follow-up|13
5308902|NCT00385840|18292686|P1|Overall Study|Lost to Follow-up|3
5308903|NCT00385840|18292685|P2|Overall Study|Adverse Event|1
5308904|NCT00385840|18292686|P1|Overall Study|Adverse Event|1
5308905|NCT00385827|18292709|P3|Part 2|Other|21
5308906|NCT00385827|18292710|P2|Part 2|Other|11
5308907|NCT00385827|18292711|P1|Part 2|Other|0
5308908|NCT00385827|18292709|P3|Part 2|Randomized but not treated|2
5308909|NCT00385827|18292710|P2|Part 2|Randomized but not treated|2
5308910|NCT00385827|18292711|P1|Part 2|Randomized but not treated|0
5308911|NCT00385827|18292709|P3|Part 2|Lack of Efficacy|13
5308912|NCT00385827|18292710|P2|Part 2|Lack of Efficacy|14
5308913|NCT00385827|18292711|P1|Part 2|Lack of Efficacy|0
5308914|NCT00385827|18292709|P3|Part 2|Death|2
5308915|NCT00385827|18292710|P2|Part 2|Death|0
5308916|NCT00385827|18292711|P1|Part 2|Death|0
5308917|NCT00385827|18292709|P3|Part 2|Adverse Event|10
5308918|NCT00385827|18292710|P2|Part 2|Adverse Event|6
5308919|NCT00385827|18292711|P1|Part 2|Adverse Event|0
5308920|NCT00385827|18292709|P3|Part 1|Other|0
5308921|NCT00385827|18292710|P2|Part 1|Other|0
5308922|NCT00385827|18292711|P1|Part 1|Other|1
5308923|NCT00385827|18292709|P3|Part 1|Lack of Efficacy|0
5308924|NCT00385827|18292710|P2|Part 1|Lack of Efficacy|0
5308925|NCT00385827|18292711|P1|Part 1|Lack of Efficacy|5
5308926|NCT00385827|18292709|P3|Part 1|Death|0
5308927|NCT00385827|18292710|P2|Part 1|Death|0
5308928|NCT00385827|18292711|P1|Part 1|Death|2
5308929|NCT00385827|18292709|P3|Part 1|Adverse Event|0
5308930|NCT00385827|18292710|P2|Part 1|Adverse Event|0
5308931|NCT00385827|18292711|P1|Part 1|Adverse Event|1
5308932|NCT00385762|18292755|P1|Overall Study|Lost to Follow-up|1
5308933|NCT00385762|18292755|P1|Overall Study|Adverse Event|1
5308934|NCT00385736|18292765|P3|Safety Analysis Set|Other|4
5308935|NCT00385736|18292766|P2|Safety Analysis Set|Other|4
5308936|NCT00385736|18292767|P1|Safety Analysis Set|Other|1
5308937|NCT00385736|18292765|P3|Safety Analysis Set|Protocol Violation|6
5308938|NCT00385736|18292766|P2|Safety Analysis Set|Protocol Violation|1
5308939|NCT00385736|18292767|P1|Safety Analysis Set|Protocol Violation|2
5308940|NCT00385736|18292765|P3|Safety Analysis Set|Lack of Efficacy|31
5308941|NCT00385736|18292766|P2|Safety Analysis Set|Lack of Efficacy|16
5308942|NCT00385736|18292767|P1|Safety Analysis Set|Lack of Efficacy|38
5308943|NCT00385736|18292765|P3|Safety Analysis Set|Lost to Follow-up|2
5308944|NCT00385736|18292766|P2|Safety Analysis Set|Lost to Follow-up|2
5308945|NCT00385736|18292767|P1|Safety Analysis Set|Lost to Follow-up|0
5308946|NCT00385736|18292765|P3|Safety Analysis Set|Withdrawal by Subject|14
5308947|NCT00385736|18292766|P2|Safety Analysis Set|Withdrawal by Subject|6
5308948|NCT00385736|18292767|P1|Safety Analysis Set|Withdrawal by Subject|6
5308949|NCT00385736|18292765|P3|Safety Analysis Set|Adverse Event|23
5308950|NCT00385736|18292766|P2|Safety Analysis Set|Adverse Event|15
5308951|NCT00385736|18292767|P1|Safety Analysis Set|Adverse Event|23
5308952|NCT00385736|18292765|P3|Efficacy Analysis Set - Maintenance|Other|4
5308953|NCT00385736|18292766|P2|Efficacy Analysis Set - Maintenance|Other|4
5308954|NCT00385736|18292767|P1|Efficacy Analysis Set - Maintenance|Other|0
5308955|NCT00385736|18292765|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
5308956|NCT00385736|18292766|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
5308957|NCT00385736|18292767|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
5308958|NCT00385736|18292765|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
5308959|NCT00385736|18292766|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
5308960|NCT00385736|18292767|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
5308961|NCT00385736|18292765|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
5308962|NCT00385736|18292766|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
5308963|NCT00385736|18292767|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
5308964|NCT00385736|18292765|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
5308965|NCT00385736|18292766|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
5308966|NCT00385736|18292767|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
5308967|NCT00385736|18292765|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
5308968|NCT00385736|18292766|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
5308969|NCT00385736|18292767|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
5308970|NCT00385736|18292765|P3|Efficacy Analysis Set - Induction|Other|1
5308971|NCT00385736|18292766|P2|Efficacy Analysis Set - Induction|Other|0
5308972|NCT00385736|18292767|P1|Efficacy Analysis Set - Induction|Other|0
5308973|NCT00385736|18292765|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
5308974|NCT00385736|18292766|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
5308975|NCT00385736|18292767|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
5308976|NCT00385736|18292765|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
5308977|NCT00385736|18292766|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
5308978|NCT00385736|18292767|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
5308979|NCT00385736|18292765|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
5308980|NCT00385736|18292766|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
5308981|NCT00385736|18292767|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
5308982|NCT00385736|18292765|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
5308983|NCT00385736|18292766|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
5308984|NCT00385736|18292767|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
5308985|NCT00385736|18292765|P3|Efficacy Analysis Set - Induction|Adverse Event|4
5308986|NCT00385736|18292766|P2|Efficacy Analysis Set - Induction|Adverse Event|6
5308987|NCT00385736|18292767|P1|Efficacy Analysis Set - Induction|Adverse Event|5
5308988|NCT00385723|18292812|P3|Overall Study|Withdrawal by Subject|2
5308989|NCT00385723|18292813|P2|Overall Study|Withdrawal by Subject|0
5308990|NCT00385723|18292814|P1|Overall Study|Withdrawal by Subject|1
5308991|NCT00385723|18292812|P3|Overall Study|Lost to Follow-up|0
5308992|NCT00385723|18292813|P2|Overall Study|Lost to Follow-up|1
5308993|NCT00385723|18292814|P1|Overall Study|Lost to Follow-up|1
5308994|NCT00385684|18292828|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
5308995|NCT00385684|18292829|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
5308996|NCT00385684|18292828|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
5308997|NCT00385684|18292829|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
5308998|NCT00385684|18292828|P2|FIRST INTERVENTION OF PHASE A|Death|0
5308999|NCT00385684|18292829|P1|FIRST INTERVENTION OF PHASE A|Death|1
5309000|NCT00385671|18292838|P3|Overall Study|Withdrawal by Subject|4
5309001|NCT00385671|18292839|P2|Overall Study|Withdrawal by Subject|4
5309002|NCT00385671|18292840|P1|Overall Study|Withdrawal by Subject|4
5309003|NCT00385671|18292838|P3|Overall Study|Sponsor Decision|1
5309004|NCT00385671|18292839|P2|Overall Study|Sponsor Decision|2
5309005|NCT00385671|18292840|P1|Overall Study|Sponsor Decision|2
5309006|NCT00385671|18292838|P3|Overall Study|Protocol Violation|1
5309007|NCT00385671|18292839|P2|Overall Study|Protocol Violation|2
5309008|NCT00385671|18292840|P1|Overall Study|Protocol Violation|5
5309009|NCT00385671|18292838|P3|Overall Study|Physician Decision|2
5309010|NCT00385671|18292839|P2|Overall Study|Physician Decision|1
5309011|NCT00385671|18292840|P1|Overall Study|Physician Decision|2
5309012|NCT00385671|18292838|P3|Overall Study|Lost to Follow-up|5
5309013|NCT00385671|18292839|P2|Overall Study|Lost to Follow-up|6
5309014|NCT00385671|18292840|P1|Overall Study|Lost to Follow-up|6
5309015|NCT00385671|18292838|P3|Overall Study|Lack of Efficacy|5
5309016|NCT00385671|18292839|P2|Overall Study|Lack of Efficacy|9
5309017|NCT00385671|18292840|P1|Overall Study|Lack of Efficacy|5
5309018|NCT00385671|18292838|P3|Overall Study|Adverse Event|18
5309019|NCT00385671|18292839|P2|Overall Study|Adverse Event|27
5309020|NCT00385671|18292840|P1|Overall Study|Adverse Event|14
5309021|NCT00385593|18292996|P2|Overall Study|Incorrect randomization|1
5309022|NCT00385593|18292997|P1|Overall Study|Incorrect randomization|0
5309023|NCT00385593|18292996|P2|Overall Study|Incorrect inclusion|0
5309024|NCT00385593|18292997|P1|Overall Study|Incorrect inclusion|2
5309025|NCT00385593|18292996|P2|Overall Study|Several reasons|15
5309026|NCT00385593|18292997|P1|Overall Study|Several reasons|17
5309027|NCT00385593|18292996|P2|Overall Study|Protocol Violation|4
5309028|NCT00385593|18292997|P1|Overall Study|Protocol Violation|7
5309029|NCT00385593|18292996|P2|Overall Study|Lost to Follow-up|8
5309030|NCT00385593|18292997|P1|Overall Study|Lost to Follow-up|12
5309031|NCT00385593|18292996|P2|Overall Study|Withdrawal by Subject|7
5309032|NCT00385593|18292997|P1|Overall Study|Withdrawal by Subject|17
5309033|NCT00385593|18292996|P2|Overall Study|Adverse Event|2
5309034|NCT00385593|18292997|P1|Overall Study|Adverse Event|3
5309035|NCT00385541|18293107|P2|Overall Study|severe pain, clinician requested unblind|1
5309036|NCT00385541|18293108|P1|Overall Study|severe pain, clinician requested unblind|0
5309037|NCT00385255|18293142|P2|Overall Study|Lost to Follow-up|58
5309038|NCT00385255|18293143|P1|Overall Study|Lost to Follow-up|20
5309039|NCT00385255|18293142|P2|Overall Study|Migrated/moved from study area|1
5309040|NCT00385255|18293143|P1|Overall Study|Migrated/moved from study area|0
5309041|NCT00385255|18293142|P2|Overall Study|Withdrawal by Subject|8
5309042|NCT00385255|18293143|P1|Overall Study|Withdrawal by Subject|0
5309043|NCT00385255|18293142|P2|Overall Study|Protocol Violation|4
5309044|NCT00385255|18293143|P1|Overall Study|Protocol Violation|0
5309045|NCT00385255|18293142|P2|Overall Study|Serious Adverse Event|2
5309046|NCT00385255|18293143|P1|Overall Study|Serious Adverse Event|1
5309047|NCT00385203|18293222|P2|Overall Study|Incorrect enrollment|0
5309048|NCT00385203|18293223|P1|Overall Study|Incorrect enrollment|2
5309049|NCT00385203|18293222|P2|Overall Study|Condition under investigation worsened|3
5309050|NCT00385203|18293223|P1|Overall Study|Condition under investigation worsened|18
5309051|NCT00385203|18293222|P2|Overall Study|Death|0
5309052|NCT00385203|18293223|P1|Overall Study|Death|1
5309053|NCT00385203|18293222|P2|Overall Study|Adverse Event|4
5309054|NCT00385203|18293223|P1|Overall Study|Adverse Event|5
5309055|NCT00384956|18293311|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
5309056|NCT00384930|18293328|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
5309057|NCT00384930|18293329|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
5309058|NCT00384930|18293330|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
5309059|NCT00384930|18293331|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
5309060|NCT00384930|18293332|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
5309061|NCT00384930|18293328|P5|Overall Study|Withdrawal by Subject|16
5309062|NCT00384930|18293329|P4|Overall Study|Withdrawal by Subject|6
5309063|NCT00384930|18293330|P3|Overall Study|Withdrawal by Subject|7
5309064|NCT00384930|18293331|P2|Overall Study|Withdrawal by Subject|7
5309065|NCT00384930|18293332|P1|Overall Study|Withdrawal by Subject|9
5309066|NCT00384930|18293328|P5|Overall Study|Sponsor Decision|0
5309067|NCT00384930|18293329|P4|Overall Study|Sponsor Decision|5
5309068|NCT00384930|18293330|P3|Overall Study|Sponsor Decision|0
5309069|NCT00384930|18293331|P2|Overall Study|Sponsor Decision|4
5309070|NCT00384930|18293332|P1|Overall Study|Sponsor Decision|3
5309071|NCT00384930|18293328|P5|Overall Study|Protocol Violation|4
5309072|NCT00384930|18293329|P4|Overall Study|Protocol Violation|6
5309073|NCT00384930|18293330|P3|Overall Study|Protocol Violation|1
5309074|NCT00384930|18293331|P2|Overall Study|Protocol Violation|0
5309075|NCT00384930|18293332|P1|Overall Study|Protocol Violation|1
5309076|NCT00384930|18293328|P5|Overall Study|Physician Decision|1
5309077|NCT00384930|18293329|P4|Overall Study|Physician Decision|0
5309078|NCT00384930|18293330|P3|Overall Study|Physician Decision|1
5309079|NCT00384930|18293331|P2|Overall Study|Physician Decision|1
5309080|NCT00384930|18293332|P1|Overall Study|Physician Decision|0
5309081|NCT00384930|18293328|P5|Overall Study|Lost to Follow-up|6
5309082|NCT00384930|18293329|P4|Overall Study|Lost to Follow-up|4
5309083|NCT00384930|18293330|P3|Overall Study|Lost to Follow-up|0
5309084|NCT00384930|18293331|P2|Overall Study|Lost to Follow-up|3
5309085|NCT00384930|18293332|P1|Overall Study|Lost to Follow-up|5
5309086|NCT00384930|18293328|P5|Overall Study|Lack of Efficacy|2
5309087|NCT00384930|18293329|P4|Overall Study|Lack of Efficacy|1
5309088|NCT00384930|18293330|P3|Overall Study|Lack of Efficacy|2
5309089|NCT00384930|18293331|P2|Overall Study|Lack of Efficacy|1
5309090|NCT00384930|18293332|P1|Overall Study|Lack of Efficacy|1
5309091|NCT00384930|18293328|P5|Overall Study|Entry Criteria Not Met|4
5309092|NCT00384930|18293329|P4|Overall Study|Entry Criteria Not Met|8
5309093|NCT00384930|18293330|P3|Overall Study|Entry Criteria Not Met|7
5309094|NCT00384930|18293331|P2|Overall Study|Entry Criteria Not Met|6
5309095|NCT00384930|18293332|P1|Overall Study|Entry Criteria Not Met|2
5309096|NCT00384930|18293328|P5|Overall Study|Adverse Event|14
5309097|NCT00384930|18293329|P4|Overall Study|Adverse Event|11
5309098|NCT00384930|18293330|P3|Overall Study|Adverse Event|12
5309099|NCT00384930|18293331|P2|Overall Study|Adverse Event|4
5309100|NCT00384930|18293332|P1|Overall Study|Adverse Event|5
5309101|NCT00384839|18293411|P1|Overall Study|Ineligible|2
5309102|NCT00384839|18293411|P1|Overall Study|Patient Request|1
5309103|NCT00384839|18293411|P1|Overall Study|Investigator Request|1
5309104|NCT00384839|18293411|P1|Overall Study|Adverse Event|4
5309105|NCT00384397|18293544|P3|Overall Study|Withdrawal by Subject|15
5309106|NCT00384397|18293545|P2|Overall Study|Withdrawal by Subject|17
5309107|NCT00384397|18293546|P1|Overall Study|Withdrawal by Subject|14
5309108|NCT00384397|18293544|P3|Overall Study|Lost to Follow-up|3
5309109|NCT00384397|18293545|P2|Overall Study|Lost to Follow-up|13
5309110|NCT00384397|18293546|P1|Overall Study|Lost to Follow-up|11
5309111|NCT00384397|18293544|P3|Overall Study|Protocol Violation|13
5309112|NCT00384397|18293545|P2|Overall Study|Protocol Violation|15
5309113|NCT00384397|18293546|P1|Overall Study|Protocol Violation|7
5309114|NCT00384397|18293544|P3|Overall Study|Adverse Event|2
5309115|NCT00384397|18293545|P2|Overall Study|Adverse Event|1
5309116|NCT00384397|18293546|P1|Overall Study|Adverse Event|0
5309117|NCT00384332|18293565|P2|Overall Study|Lost to Follow-up|0
5309118|NCT00384332|18293566|P1|Overall Study|Lost to Follow-up|4
5309119|NCT00384293|18293576|P3|Post-randomization Period|Patient Randomized in Error|1
5309120|NCT00384293|18293577|P2|Post-randomization Period|Patient Randomized in Error|0
5309121|NCT00384293|18293578|P1|Post-randomization Period|Patient Randomized in Error|0
5309122|NCT00384293|18293576|P3|Post-randomization Period|Trial Termination|204
5309123|NCT00384293|18293577|P2|Post-randomization Period|Trial Termination|180
5309124|NCT00384293|18293578|P1|Post-randomization Period|Trial Termination|0
5309125|NCT00384293|18293576|P3|Post-randomization Period|Withdrawal by Subject|6
5309126|NCT00384293|18293577|P2|Post-randomization Period|Withdrawal by Subject|8
5309127|NCT00384293|18293578|P1|Post-randomization Period|Withdrawal by Subject|0
5309128|NCT00384293|18293576|P3|Post-randomization Period|Protocol Violation|0
5309129|NCT00384293|18293577|P2|Post-randomization Period|Protocol Violation|1
5309130|NCT00384293|18293578|P1|Post-randomization Period|Protocol Violation|0
5309131|NCT00384293|18293576|P3|Post-randomization Period|Lost to Follow-up|1
5309132|NCT00384293|18293577|P2|Post-randomization Period|Lost to Follow-up|2
5309133|NCT00384293|18293578|P1|Post-randomization Period|Lost to Follow-up|0
5309134|NCT00384293|18293576|P3|Post-randomization Period|Adverse Event|7
5309135|NCT00384293|18293577|P2|Post-randomization Period|Adverse Event|23
5309136|NCT00384293|18293578|P1|Post-randomization Period|Adverse Event|0
5309137|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
5309138|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
5309139|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
5309140|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
5309141|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
5309142|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
5309143|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
5309144|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
5309145|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
5309146|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
5309147|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
5309148|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
5309149|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
5309150|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
5309151|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
5309152|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
5309153|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
5309154|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
5309155|NCT00384293|18293576|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
5309156|NCT00384293|18293577|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
5309157|NCT00384293|18293578|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
5309158|NCT00384189|18293602|P4|Overall Study|Reason Not Specified|40
5309159|NCT00384189|18293603|P3|Overall Study|Reason Not Specified|58
5309160|NCT00384189|18293604|P2|Overall Study|Reason Not Specified|57
5309161|NCT00384189|18293605|P1|Overall Study|Reason Not Specified|50
5309162|NCT00384176|18293666|P3|Overall Study|Liver metastases, colon resec. planned|0
5309163|NCT00384176|18293667|P2|Overall Study|Liver metastases, colon resec. planned|0
5309164|NCT00384176|18293668|P1|Overall Study|Liver metastases, colon resec. planned|1
5309165|NCT00384176|18293666|P3|Overall Study|Physician Decision|0
5309166|NCT00384176|18293667|P2|Overall Study|Physician Decision|2
5309167|NCT00384176|18293668|P1|Overall Study|Physician Decision|0
5309168|NCT00384176|18293666|P3|Overall Study|Did not receive study treatment|1
5309169|NCT00384176|18293667|P2|Overall Study|Did not receive study treatment|1
5309170|NCT00384176|18293668|P1|Overall Study|Did not receive study treatment|0
5309171|NCT00384176|18293666|P3|Overall Study|Toxicity of treatment|0
5309172|NCT00384176|18293667|P2|Overall Study|Toxicity of treatment|0
5309173|NCT00384176|18293668|P1|Overall Study|Toxicity of treatment|1
5309174|NCT00384176|18293666|P3|Overall Study|Longer QTC as Visit 1|0
5309175|NCT00384176|18293667|P2|Overall Study|Longer QTC as Visit 1|0
5309176|NCT00384176|18293668|P1|Overall Study|Longer QTC as Visit 1|1
5309177|NCT00384176|18293666|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
5309178|NCT00384176|18293667|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
5309179|NCT00384176|18293668|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
5309180|NCT00384176|18293666|P3|Overall Study|Lost to Follow-up|4
5309181|NCT00384176|18293667|P2|Overall Study|Lost to Follow-up|18
5309182|NCT00384176|18293668|P1|Overall Study|Lost to Follow-up|16
5309183|NCT00384176|18293666|P3|Overall Study|Withdrawal by Subject|22
5309184|NCT00384176|18293667|P2|Overall Study|Withdrawal by Subject|48
5309185|NCT00384176|18293668|P1|Overall Study|Withdrawal by Subject|52
5309186|NCT00384176|18293666|P3|Overall Study|Death|105
5309187|NCT00384176|18293667|P2|Overall Study|Death|247
5309188|NCT00384176|18293668|P1|Overall Study|Death|239
5309189|NCT00384085|18293694|P3|Overall Study|Patient required surgery|0
5309190|NCT00384085|18293695|P2|Overall Study|Patient required surgery|1
5309191|NCT00384085|18293696|P1|Overall Study|Patient required surgery|0
5309192|NCT00384085|18293694|P3|Overall Study|Patient moved|1
5309193|NCT00384085|18293695|P2|Overall Study|Patient moved|0
5309194|NCT00384085|18293696|P1|Overall Study|Patient moved|1
5309195|NCT00384085|18293694|P3|Overall Study|Sponsor decision|1
5309196|NCT00384085|18293695|P2|Overall Study|Sponsor decision|2
5309197|NCT00384085|18293696|P1|Overall Study|Sponsor decision|1
5309198|NCT00384085|18293694|P3|Overall Study|Loss of site personnel|1
5309199|NCT00384085|18293695|P2|Overall Study|Loss of site personnel|0
5309200|NCT00384085|18293696|P1|Overall Study|Loss of site personnel|1
5309201|NCT00384085|18293694|P3|Overall Study|Physician Decision|0
5309202|NCT00384085|18293695|P2|Overall Study|Physician Decision|0
5309203|NCT00384085|18293696|P1|Overall Study|Physician Decision|1
5309204|NCT00384085|18293694|P3|Overall Study|Patient non-compliant|5
5309205|NCT00384085|18293695|P2|Overall Study|Patient non-compliant|4
5309206|NCT00384085|18293696|P1|Overall Study|Patient non-compliant|4
5309207|NCT00384085|18293694|P3|Overall Study|Withdrawal by Subject|29
5309208|NCT00384085|18293695|P2|Overall Study|Withdrawal by Subject|19
5309209|NCT00384085|18293696|P1|Overall Study|Withdrawal by Subject|14
5309210|NCT00384085|18293694|P3|Overall Study|Progressive Disease|0
5309211|NCT00384085|18293695|P2|Overall Study|Progressive Disease|1
5309212|NCT00384085|18293696|P1|Overall Study|Progressive Disease|0
5309213|NCT00384085|18293694|P3|Overall Study|Lost to Follow-up|10
5309214|NCT00384085|18293695|P2|Overall Study|Lost to Follow-up|9
5309215|NCT00384085|18293696|P1|Overall Study|Lost to Follow-up|9
5309216|NCT00384085|18293694|P3|Overall Study|Protocol Violation|2
5309217|NCT00384085|18293695|P2|Overall Study|Protocol Violation|2
5309218|NCT00384085|18293696|P1|Overall Study|Protocol Violation|2
5309219|NCT00384085|18293694|P3|Overall Study|No longer Requires Study Treatment|1
5309220|NCT00384085|18293695|P2|Overall Study|No longer Requires Study Treatment|0
5309221|NCT00384085|18293696|P1|Overall Study|No longer Requires Study Treatment|1
5309222|NCT00384085|18293694|P3|Overall Study|Lack of Efficacy|2
5309223|NCT00384085|18293695|P2|Overall Study|Lack of Efficacy|3
5309224|NCT00384085|18293696|P1|Overall Study|Lack of Efficacy|0
5309225|NCT00384085|18293694|P3|Overall Study|Adverse Event|4
5309226|NCT00384085|18293695|P2|Overall Study|Adverse Event|5
5309227|NCT00384085|18293696|P1|Overall Study|Adverse Event|5
5309228|NCT00384059|18293722|P2|Toddler Dose|Failed to return|1
5309229|NCT00384059|18293723|P1|Toddler Dose|Failed to return|0
5309230|NCT00384059|18293722|P2|Toddler Dose|Lost to Follow-up|1
5309231|NCT00384059|18293723|P1|Toddler Dose|Lost to Follow-up|1
5309232|NCT00384059|18293722|P2|After Infant Series|Lost to Follow-up|1
5309233|NCT00384059|18293723|P1|After Infant Series|Lost to Follow-up|0
5309234|NCT00384059|18293722|P2|After Infant Series|Physician Decision|1
5309235|NCT00384059|18293723|P1|After Infant Series|Physician Decision|0
5309236|NCT00384059|18293722|P2|After Infant Series|Adverse Event|1
5309237|NCT00384059|18293723|P1|After Infant Series|Adverse Event|0
5309238|NCT00384059|18293722|P2|After Infant Series|Failed to Return|2
5309239|NCT00384059|18293723|P1|After Infant Series|Failed to Return|0
5309240|NCT00384059|18293722|P2|After Infant Series|Withdrawal by Subject|2
5309241|NCT00384059|18293723|P1|After Infant Series|Withdrawal by Subject|2
5309242|NCT00384059|18293722|P2|After Infant Series|Protocol Violation|3
5309243|NCT00384059|18293723|P1|After Infant Series|Protocol Violation|2
5309244|NCT00384059|18293722|P2|Infant Series|Lost to Follow-up|1
5309245|NCT00384059|18293723|P1|Infant Series|Lost to Follow-up|0
5309246|NCT00384059|18293722|P2|Infant Series|Protocol Violation|2
5309247|NCT00384059|18293723|P1|Infant Series|Protocol Violation|1
5309248|NCT00384059|18293722|P2|Infant Series|Adverse Event|2
5309249|NCT00384059|18293723|P1|Infant Series|Adverse Event|1
5309250|NCT00384059|18293722|P2|Infant Series|Withdrawal by Subject|2
5309251|NCT00384059|18293723|P1|Infant Series|Withdrawal by Subject|2
5309252|NCT00384059|18293722|P2|Infant Series|Not consented|6
5309253|NCT00384059|18293723|P1|Infant Series|Not consented|2
5309254|NCT00384033|18293773|P4|Overall Study|Randomized but not treated|2
5309255|NCT00384033|18293774|P3|Overall Study|Randomized but not treated|10
5309256|NCT00384033|18293775|P2|Overall Study|Randomized but not treated|7
5309257|NCT00384033|18293776|P1|Overall Study|Randomized but not treated|3
5309258|NCT00384033|18293773|P4|Overall Study|Lack of Efficacy|1
5309259|NCT00384033|18293774|P3|Overall Study|Lack of Efficacy|3
5309260|NCT00384033|18293775|P2|Overall Study|Lack of Efficacy|3
5309261|NCT00384033|18293776|P1|Overall Study|Lack of Efficacy|7
5309262|NCT00384033|18293773|P4|Overall Study|Withdrawal by Subject|2
5309263|NCT00384033|18293774|P3|Overall Study|Withdrawal by Subject|5
5309264|NCT00384033|18293775|P2|Overall Study|Withdrawal by Subject|2
5309265|NCT00384033|18293776|P1|Overall Study|Withdrawal by Subject|6
5309266|NCT00384033|18293773|P4|Overall Study|Protocol Violation|6
5309267|NCT00384033|18293774|P3|Overall Study|Protocol Violation|5
5309268|NCT00384033|18293775|P2|Overall Study|Protocol Violation|0
5309269|NCT00384033|18293776|P1|Overall Study|Protocol Violation|5
5309270|NCT00384033|18293773|P4|Overall Study|Other|0
5309271|NCT00384033|18293774|P3|Overall Study|Other|0
5309272|NCT00384033|18293775|P2|Overall Study|Other|0
5309273|NCT00384033|18293776|P1|Overall Study|Other|2
5309274|NCT00384033|18293773|P4|Overall Study|Lost to Follow-up|7
5309275|NCT00384033|18293774|P3|Overall Study|Lost to Follow-up|7
5309276|NCT00384033|18293775|P2|Overall Study|Lost to Follow-up|12
5309277|NCT00384033|18293776|P1|Overall Study|Lost to Follow-up|6
5309278|NCT00384033|18293773|P4|Overall Study|Physician Decision|0
5309279|NCT00384033|18293774|P3|Overall Study|Physician Decision|0
5309280|NCT00384033|18293775|P2|Overall Study|Physician Decision|0
5309281|NCT00384033|18293776|P1|Overall Study|Physician Decision|1
5309282|NCT00384033|18293773|P4|Overall Study|Failed to return|2
5309283|NCT00384033|18293774|P3|Overall Study|Failed to return|2
5309284|NCT00384033|18293775|P2|Overall Study|Failed to return|3
5309285|NCT00384033|18293776|P1|Overall Study|Failed to return|1
5309286|NCT00384033|18293773|P4|Overall Study|Adverse Event|20
5309287|NCT00384033|18293774|P3|Overall Study|Adverse Event|11
5309288|NCT00384033|18293775|P2|Overall Study|Adverse Event|8
5309289|NCT00384033|18293776|P1|Overall Study|Adverse Event|10
5309290|NCT00383786|18293829|P2|Overall Study|Physician Decision|1
5309291|NCT00383786|18293830|P1|Overall Study|Physician Decision|0
5309292|NCT00383786|18293829|P2|Overall Study|Withdrawal by Subject|5
5309293|NCT00383786|18293830|P1|Overall Study|Withdrawal by Subject|2
5309294|NCT00383786|18293829|P2|Overall Study|Protocol Violation|6
5309295|NCT00383786|18293830|P1|Overall Study|Protocol Violation|2
5309296|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Administrative|0
5309297|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Administrative|1
5309298|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Administrative|3
5309299|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Administrative|2
5309300|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Administrative|1
5309301|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5309302|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5309303|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5309304|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5309305|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5309306|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
5309307|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
5309308|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5309309|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5309310|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
5309311|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
5309312|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
5309313|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
5309314|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
5309315|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
5309316|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
5309317|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
5309318|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
5309319|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
5309320|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
5309321|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
5309322|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
5309323|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
5309324|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
5309325|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
5309326|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
5309327|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
5309328|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
5309329|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
5309330|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
5309331|NCT00383721|18293880|P5|26-Week Treatment Safety Extension|Adverse Event|0
5309332|NCT00383721|18293881|P4|26-Week Treatment Safety Extension|Adverse Event|1
5309333|NCT00383721|18293882|P3|26-Week Treatment Safety Extension|Adverse Event|10
5309334|NCT00383721|18293883|P2|26-Week Treatment Safety Extension|Adverse Event|7
5309335|NCT00383721|18293884|P1|26-Week Treatment Safety Extension|Adverse Event|6
5309336|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Ongoing|0
5309337|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Ongoing|0
5309338|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Ongoing|0
5309339|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Ongoing|0
5309340|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Ongoing|1
5309341|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Administrative|3
5309342|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Administrative|3
5309343|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Administrative|3
5309344|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Administrative|3
5309345|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Administrative|1
5309346|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
5309347|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
5309348|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
5309349|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
5309350|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
5309351|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
5309352|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
5309353|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
5309354|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
5309355|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
5309356|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
5309357|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
5309358|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
5309359|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
5309360|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
5309361|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
5309362|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
5309363|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
5309364|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
5309365|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
5309366|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
5309367|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
5309368|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
5309369|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
5309370|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
5309371|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
5309372|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
5309373|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5309374|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5309375|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
5309376|NCT00383721|18293880|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
5309377|NCT00383721|18293881|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
5309378|NCT00383721|18293882|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
5309379|NCT00383721|18293883|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
5309380|NCT00383721|18293884|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
5309381|NCT00383708|18293921|P1|Co-administration Period|Adverse Event|5
5309382|NCT00383708|18293921|P1|Run-in Period|Claustrophobia|1
5309383|NCT00383708|18293921|P1|Run-in Period|Adverse Event|2
5309384|NCT00383708|18293921|P1|Run-in Period|Protocol Violation|4
5309385|NCT00383708|18293921|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
5309386|NCT00383708|18293921|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
5309387|NCT00383552|18293996|P4|Overall Study|Administrative|1
5309388|NCT00383552|18293997|P3|Overall Study|Administrative|1
5309389|NCT00383552|18293998|P2|Overall Study|Administrative|0
5309390|NCT00383552|18293999|P1|Overall Study|Administrative|1
5309391|NCT00383552|18293996|P4|Overall Study|Did not meet protocol eligibility|3
5309392|NCT00383552|18293997|P3|Overall Study|Did not meet protocol eligibility|2
5309393|NCT00383552|18293998|P2|Overall Study|Did not meet protocol eligibility|6
5309394|NCT00383552|18293999|P1|Overall Study|Did not meet protocol eligibility|8
5309395|NCT00383552|18293996|P4|Overall Study|Noncompliance with the protocol|10
5309396|NCT00383552|18293997|P3|Overall Study|Noncompliance with the protocol|8
5309397|NCT00383552|18293998|P2|Overall Study|Noncompliance with the protocol|6
5309398|NCT00383552|18293999|P1|Overall Study|Noncompliance with the protocol|11
5309399|NCT00383552|18293996|P4|Overall Study|Did not wish to continue (related)|3
5309400|NCT00383552|18293997|P3|Overall Study|Did not wish to continue (related)|2
5309401|NCT00383552|18293998|P2|Overall Study|Did not wish to continue (related)|0
5309402|NCT00383552|18293999|P1|Overall Study|Did not wish to continue (related)|1
5309403|NCT00383552|18293996|P4|Overall Study|Did not wish to continue (unrelated)|6
5309404|NCT00383552|18293997|P3|Overall Study|Did not wish to continue (unrelated)|5
5309405|NCT00383552|18293998|P2|Overall Study|Did not wish to continue (unrelated)|9
5309406|NCT00383552|18293999|P1|Overall Study|Did not wish to continue (unrelated)|4
5309407|NCT00383552|18293996|P4|Overall Study|Lost to Follow-up|1
5309408|NCT00383552|18293997|P3|Overall Study|Lost to Follow-up|5
5309409|NCT00383552|18293998|P2|Overall Study|Lost to Follow-up|1
5309410|NCT00383552|18293999|P1|Overall Study|Lost to Follow-up|0
5309411|NCT00383552|18293996|P4|Overall Study|Lack of Efficacy|42
5309412|NCT00383552|18293997|P3|Overall Study|Lack of Efficacy|29
5309413|NCT00383552|18293998|P2|Overall Study|Lack of Efficacy|13
5309414|NCT00383552|18293999|P1|Overall Study|Lack of Efficacy|4
5309415|NCT00383552|18293996|P4|Overall Study|Adverse Event|6
5309416|NCT00383552|18293997|P3|Overall Study|Adverse Event|9
5309417|NCT00383552|18293998|P2|Overall Study|Adverse Event|6
5309418|NCT00383552|18293999|P1|Overall Study|Adverse Event|7
5309419|NCT00383500|18294041|P3|Overall Study|Lost to Follow-up|2
5309420|NCT00383500|18294042|P2|Overall Study|Lost to Follow-up|0
5309421|NCT00383500|18294043|P1|Overall Study|Lost to Follow-up|0
5309422|NCT00383500|18294041|P3|Overall Study|Withdrawal by Subject|0
5309423|NCT00383500|18294042|P2|Overall Study|Withdrawal by Subject|3
5309424|NCT00383500|18294043|P1|Overall Study|Withdrawal by Subject|8
5309425|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Administrative|0
5309426|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Administrative|1
5309427|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Administrative|0
5309428|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Administrative|1
5309429|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Administrative|1
5309430|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5309582|NCT00383123|18294269|P2|Overall Study|Withdrawal by Subject|18
5309431|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5309432|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5309433|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5309434|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5309435|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
5309436|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5309437|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5309438|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5309439|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
5309440|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
5309441|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
5309442|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
5309443|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
5309444|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
5309445|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
5309446|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
5309447|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
5309448|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
5309449|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
5309450|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
5309451|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
5309452|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
5309453|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
5309454|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
5309455|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
5309456|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
5309457|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
5309458|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
5309459|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
5309460|NCT00383435|18294067|P5|26-Week Treatment Safety Extension|Adverse Event|1
5309461|NCT00383435|18294068|P4|26-Week Treatment Safety Extension|Adverse Event|5
5309462|NCT00383435|18294069|P3|26-Week Treatment Safety Extension|Adverse Event|5
5309463|NCT00383435|18294070|P2|26-Week Treatment Safety Extension|Adverse Event|2
5309464|NCT00383435|18294071|P1|26-Week Treatment Safety Extension|Adverse Event|4
5309465|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Administrative|1
5309466|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Administrative|1
5309467|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Administrative|1
5309468|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Administrative|3
5309469|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Administrative|5
5309470|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
5309471|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
5309472|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
5309473|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
5309474|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
5309475|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
5309476|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
5309477|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
5309478|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
5309479|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
5309480|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
5309481|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
5309482|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
5309483|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
5309484|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
5309485|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
5309486|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
5309487|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
5309488|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
5309489|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
5309490|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
5309491|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
5309492|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
5309493|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
5309494|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
5309495|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
5309496|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
5309497|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5309498|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
5309499|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5309500|NCT00383435|18294067|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
5309501|NCT00383435|18294068|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
5309502|NCT00383435|18294069|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
5309503|NCT00383435|18294070|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
5309504|NCT00383435|18294071|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
5309505|NCT00383331|18294110|P2|Overall Study|Protocol Violation|1
5309506|NCT00383331|18294111|P1|Overall Study|Protocol Violation|0
5309507|NCT00383292|18294130|P3|Overall Study|Other|0
5309508|NCT00383292|18294131|P2|Overall Study|Other|0
5309509|NCT00383292|18294132|P1|Overall Study|Other|1
5309510|NCT00383292|18294130|P3|Overall Study|Withdrawal by Subject|2
5309511|NCT00383292|18294131|P2|Overall Study|Withdrawal by Subject|2
5309512|NCT00383292|18294132|P1|Overall Study|Withdrawal by Subject|3
5309513|NCT00383292|18294130|P3|Overall Study|Physician Decision|1
5309514|NCT00383292|18294131|P2|Overall Study|Physician Decision|0
5309515|NCT00383292|18294132|P1|Overall Study|Physician Decision|4
5309516|NCT00383292|18294130|P3|Overall Study|Death|3
5309517|NCT00383292|18294131|P2|Overall Study|Death|3
5309518|NCT00383292|18294132|P1|Overall Study|Death|3
5309519|NCT00383292|18294130|P3|Overall Study|Adverse Event|2
5309520|NCT00383292|18294131|P2|Overall Study|Adverse Event|1
5309521|NCT00383292|18294132|P1|Overall Study|Adverse Event|4
5309522|NCT00383240|18294173|P4|Overall Study|Administrative|0
5309523|NCT00383240|18294174|P3|Overall Study|Administrative|0
5309524|NCT00383240|18294175|P2|Overall Study|Administrative|1
5309525|NCT00383240|18294176|P1|Overall Study|Administrative|1
5309526|NCT00383240|18294173|P4|Overall Study|Did not meet protocol eligibility|3
5309527|NCT00383240|18294174|P3|Overall Study|Did not meet protocol eligibility|9
5309528|NCT00383240|18294175|P2|Overall Study|Did not meet protocol eligibility|4
5309529|NCT00383240|18294176|P1|Overall Study|Did not meet protocol eligibility|9
5309530|NCT00383240|18294173|P4|Overall Study|Protocol Violation|6
5309531|NCT00383240|18294174|P3|Overall Study|Protocol Violation|9
5309532|NCT00383240|18294175|P2|Overall Study|Protocol Violation|5
5309533|NCT00383240|18294176|P1|Overall Study|Protocol Violation|4
5309534|NCT00383240|18294173|P4|Overall Study|Withdrawal by subjects, reasons related|5
5309535|NCT00383240|18294174|P3|Overall Study|Withdrawal by subjects, reasons related|3
5309536|NCT00383240|18294175|P2|Overall Study|Withdrawal by subjects, reasons related|1
5309537|NCT00383240|18294176|P1|Overall Study|Withdrawal by subjects, reasons related|0
5309538|NCT00383240|18294173|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
5309539|NCT00383240|18294174|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
5309540|NCT00383240|18294175|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
5309541|NCT00383240|18294176|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
5309542|NCT00383240|18294173|P4|Overall Study|Lost to Follow-up|2
5309543|NCT00383240|18294174|P3|Overall Study|Lost to Follow-up|0
5309544|NCT00383240|18294175|P2|Overall Study|Lost to Follow-up|0
5309545|NCT00383240|18294176|P1|Overall Study|Lost to Follow-up|3
5309546|NCT00383240|18294173|P4|Overall Study|Treatment Failure|46
5309547|NCT00383240|18294174|P3|Overall Study|Treatment Failure|47
5309548|NCT00383240|18294175|P2|Overall Study|Treatment Failure|13
5309549|NCT00383240|18294176|P1|Overall Study|Treatment Failure|8
5309550|NCT00383240|18294173|P4|Overall Study|Adverse Event|7
5309551|NCT00383240|18294174|P3|Overall Study|Adverse Event|9
5309552|NCT00383240|18294175|P2|Overall Study|Adverse Event|6
5309553|NCT00383240|18294176|P1|Overall Study|Adverse Event|4
5309554|NCT00383162|18294207|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
5309555|NCT00383162|18294208|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
5309556|NCT00383162|18294207|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
5309557|NCT00383162|18294208|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
5309558|NCT00383162|18294207|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
5309559|NCT00383162|18294208|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
5309560|NCT00383162|18294207|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
5309561|NCT00383162|18294208|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
5309562|NCT00383162|18294207|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
5309563|NCT00383162|18294208|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
5309564|NCT00383162|18294207|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
5309565|NCT00383162|18294208|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
5309566|NCT00383162|18294207|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
5309567|NCT00383162|18294208|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
5309568|NCT00383162|18294207|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
5309569|NCT00383162|18294208|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
5309570|NCT00383162|18294207|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
5309571|NCT00383162|18294208|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
5309572|NCT00383149|18294250|P1|Overall Study|Participant Withdrew Consent|1
5309573|NCT00383149|18294250|P1|Overall Study|Request to Discontinue Treatment|4
5309574|NCT00383149|18294250|P1|Overall Study|Study Drug Toxicity|4
5309575|NCT00383149|18294250|P1|Overall Study|Other|1
5309576|NCT00383149|18294250|P1|Overall Study|Lost to Follow-up|1
5309577|NCT00383149|18294250|P1|Overall Study|Disease Progression|38
5309578|NCT00383149|18294250|P1|Overall Study|Death|2
5309579|NCT00383149|18294250|P1|Overall Study|Adverse Event not Related to Study Drug|3
5309580|NCT00383123|18294269|P2|Overall Study|Other reason|6
5309581|NCT00383123|18294270|P1|Overall Study|Other reason|10
5309583|NCT00383123|18294270|P1|Overall Study|Withdrawal by Subject|27
5309584|NCT00383123|18294269|P2|Overall Study|Protocol Violation|1
5309585|NCT00383123|18294270|P1|Overall Study|Protocol Violation|5
5309586|NCT00383123|18294269|P2|Overall Study|Lost to Follow-up|61
5309587|NCT00383123|18294270|P1|Overall Study|Lost to Follow-up|68
5309588|NCT00383123|18294269|P2|Overall Study|Adverse Event|0
5309589|NCT00383123|18294270|P1|Overall Study|Adverse Event|1
5309590|NCT00383084|18294311|P2|Overall Study|Withdrawal by Subject|10
5309591|NCT00383084|18294312|P1|Overall Study|Withdrawal by Subject|12
5309592|NCT00383019|18294343|P2|Overall Study|Withdrawal by Subject|1
5309593|NCT00383019|18294344|P1|Overall Study|Withdrawal by Subject|0
5309594|NCT00383019|18294343|P2|Overall Study|Adverse Event|1
5309595|NCT00383019|18294344|P1|Overall Study|Adverse Event|5
5309596|NCT00382993|18294366|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
5309597|NCT00382993|18294367|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
5309598|NCT00382993|18294366|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
5309599|NCT00382993|18294367|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
5309600|NCT00382993|18294366|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
5309601|NCT00382993|18294367|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
5309602|NCT00382993|18294366|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
5309603|NCT00382993|18294367|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
5309604|NCT00382993|18294366|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
5309605|NCT00382993|18294367|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
5309606|NCT00382993|18294366|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
5309607|NCT00382993|18294367|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
5309608|NCT00382993|18294366|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
5309609|NCT00382993|18294367|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
5309610|NCT00382993|18294366|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
5309611|NCT00382993|18294367|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
5309612|NCT00382993|18294366|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
5309613|NCT00382993|18294367|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
5309614|NCT00382993|18294366|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
5309615|NCT00382993|18294367|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
5309616|NCT00382967|18294411|P2|Overall Study|Protocol Violation|1
5309617|NCT00382967|18294412|P1|Overall Study|Protocol Violation|1
5309618|NCT00382863|18294437|P2|Overall Study|Withdrawal by Subject|25
5309619|NCT00382863|18294438|P1|Overall Study|Withdrawal by Subject|5
5309620|NCT00382863|18294437|P2|Overall Study|Lost to Follow-up|2
5309621|NCT00382863|18294438|P1|Overall Study|Lost to Follow-up|1
5309622|NCT00382863|18294437|P2|Overall Study|Death|9
5309623|NCT00382863|18294438|P1|Overall Study|Death|9
5309624|NCT00382733|18294522|P5|Overall Study|Withdrawal by Subject|0
5309625|NCT00382733|18294523|P4|Overall Study|Withdrawal by Subject|0
5309626|NCT00382733|18294524|P3|Overall Study|Withdrawal by Subject|0
5309627|NCT00382733|18294525|P2|Overall Study|Withdrawal by Subject|1
5309628|NCT00382733|18294526|P1|Overall Study|Withdrawal by Subject|0
5309629|NCT00382720|18294547|P3|Overall Study|Discontinued at end of study|2
5309630|NCT00382720|18294548|P2|Overall Study|Discontinued at end of study|1
5309631|NCT00382720|18294549|P1|Overall Study|Discontinued at end of study|0
5309632|NCT00382720|18294547|P3|Overall Study|Investigator/Clinical decision|6
5309633|NCT00382720|18294548|P2|Overall Study|Investigator/Clinical decision|6
5309634|NCT00382720|18294549|P1|Overall Study|Investigator/Clinical decision|5
5309635|NCT00382720|18294547|P3|Overall Study|Good prognosis|0
5309636|NCT00382720|18294548|P2|Overall Study|Good prognosis|1
5309637|NCT00382720|18294549|P1|Overall Study|Good prognosis|0
5309638|NCT00382720|18294547|P3|Overall Study|Clinically progressive disease|0
5309639|NCT00382720|18294548|P2|Overall Study|Clinically progressive disease|1
5309640|NCT00382720|18294549|P1|Overall Study|Clinically progressive disease|0
5309641|NCT00382720|18294547|P3|Overall Study|Patient did not receive study medication|4
5309642|NCT00382720|18294548|P2|Overall Study|Patient did not receive study medication|1
5309643|NCT00382720|18294549|P1|Overall Study|Patient did not receive study medication|1
5309644|NCT00382720|18294547|P3|Overall Study|Surgery|4
5309645|NCT00382720|18294548|P2|Overall Study|Surgery|1
5309646|NCT00382720|18294549|P1|Overall Study|Surgery|1
5309647|NCT00382720|18294547|P3|Overall Study|Withdrawal by Subject|12
5309648|NCT00382720|18294548|P2|Overall Study|Withdrawal by Subject|20
5309649|NCT00382720|18294549|P1|Overall Study|Withdrawal by Subject|11
5309650|NCT00382720|18294547|P3|Overall Study|Withdrew consent|2
5309651|NCT00382720|18294548|P2|Overall Study|Withdrew consent|1
5309652|NCT00382720|18294549|P1|Overall Study|Withdrew consent|1
5309653|NCT00382720|18294547|P3|Overall Study|Progressive disease|38
5309654|NCT00382720|18294548|P2|Overall Study|Progressive disease|28
5309655|NCT00382720|18294549|P1|Overall Study|Progressive disease|37
5309656|NCT00382720|18294547|P3|Overall Study|Death|2
5309657|NCT00382720|18294548|P2|Overall Study|Death|1
5309658|NCT00382720|18294549|P1|Overall Study|Death|0
5309659|NCT00382720|18294547|P3|Overall Study|Protocol Violation|1
5309660|NCT00382720|18294548|P2|Overall Study|Protocol Violation|5
5309661|NCT00382720|18294549|P1|Overall Study|Protocol Violation|2
5309662|NCT00382720|18294547|P3|Overall Study|Adverse Event|15
5309663|NCT00382720|18294548|P2|Overall Study|Adverse Event|23
5309664|NCT00382720|18294549|P1|Overall Study|Adverse Event|21
5309665|NCT00382408|18294574|P2|Overall Study|Other|35
5309666|NCT00382408|18294575|P1|Overall Study|Other|100
5309667|NCT00382408|18294574|P2|Overall Study|Lost to Follow-up|8
5309668|NCT00382408|18294575|P1|Overall Study|Lost to Follow-up|19
5309669|NCT00382408|18294574|P2|Overall Study|Pregnancy|0
5309670|NCT00382408|18294575|P1|Overall Study|Pregnancy|2
5309671|NCT00382408|18294574|P2|Overall Study|Withdrawal by Subject|6
5309672|NCT00382408|18294575|P1|Overall Study|Withdrawal by Subject|17
5309673|NCT00382408|18294574|P2|Overall Study|Physician Decision|0
5309674|NCT00382408|18294575|P1|Overall Study|Physician Decision|1
5309675|NCT00382408|18294574|P2|Overall Study|Protocol Violation|2
5309676|NCT00382408|18294575|P1|Overall Study|Protocol Violation|2
5309677|NCT00382408|18294574|P2|Overall Study|Did not meet protocol requirement|3
5309678|NCT00382408|18294575|P1|Overall Study|Did not meet protocol requirement|3
5309679|NCT00382291|18294602|P3|Overall Study|Lack of Efficacy|1
5309680|NCT00382291|18294603|P2|Overall Study|Lack of Efficacy|0
5309681|NCT00382291|18294604|P1|Overall Study|Lack of Efficacy|0
5309682|NCT00382291|18294602|P3|Overall Study|Physician Decision|0
5309683|NCT00382291|18294603|P2|Overall Study|Physician Decision|1
5309684|NCT00382291|18294604|P1|Overall Study|Physician Decision|0
5309685|NCT00382291|18294602|P3|Overall Study|Withdrawal by Subject|0
5309686|NCT00382291|18294603|P2|Overall Study|Withdrawal by Subject|2
5309687|NCT00382291|18294604|P1|Overall Study|Withdrawal by Subject|0
5309688|NCT00382291|18294602|P3|Overall Study|Temporary study suspension|5
5309689|NCT00382291|18294603|P2|Overall Study|Temporary study suspension|2
5309690|NCT00382291|18294604|P1|Overall Study|Temporary study suspension|2
5309691|NCT00382291|18294602|P3|Overall Study|Protocol Violation|0
5309692|NCT00382291|18294603|P2|Overall Study|Protocol Violation|0
5309693|NCT00382291|18294604|P1|Overall Study|Protocol Violation|1
5309694|NCT00382291|18294602|P3|Overall Study|Adverse Event|2
5309695|NCT00382291|18294603|P2|Overall Study|Adverse Event|2
5309696|NCT00382291|18294604|P1|Overall Study|Adverse Event|1
5309697|NCT00382174|18294636|P3|Overall Study|Wounds merged|2
5309698|NCT00382174|18294637|P2|Overall Study|Wounds merged|2
5309699|NCT00382174|18294638|P1|Overall Study|Wounds merged|0
5309700|NCT00382174|18294636|P3|Overall Study|Failed to meet criteria|1
5309701|NCT00382174|18294637|P2|Overall Study|Failed to meet criteria|1
5309702|NCT00382174|18294638|P1|Overall Study|Failed to meet criteria|0
5309703|NCT00382174|18294636|P3|Overall Study|Physician Decision|2
5309704|NCT00382174|18294637|P2|Overall Study|Physician Decision|2
5309705|NCT00382174|18294638|P1|Overall Study|Physician Decision|0
5309706|NCT00382174|18294636|P3|Overall Study|Non compliance|1
5309707|NCT00382174|18294637|P2|Overall Study|Non compliance|0
5309708|NCT00382174|18294638|P1|Overall Study|Non compliance|1
5309709|NCT00382174|18294636|P3|Overall Study|Withdrawal by Subject|5
5309710|NCT00382174|18294637|P2|Overall Study|Withdrawal by Subject|4
5309711|NCT00382174|18294638|P1|Overall Study|Withdrawal by Subject|1
5309712|NCT00382174|18294636|P3|Overall Study|Adverse Event|5
5309713|NCT00382174|18294637|P2|Overall Study|Adverse Event|4
5309714|NCT00382174|18294638|P1|Overall Study|Adverse Event|1
5309715|NCT00382174|18294636|P3|Overall Study|Lost to Follow-up|5
5309716|NCT00382174|18294637|P2|Overall Study|Lost to Follow-up|4
5309717|NCT00382174|18294638|P1|Overall Study|Lost to Follow-up|1
5309718|NCT00382109|18294666|P2|Overall Study|consent withdrawal|1
5309719|NCT00382109|18294667|P1|Overall Study|consent withdrawal|0
5309720|NCT00382109|18294666|P2|Overall Study|Other|2
5309721|NCT00382109|18294667|P1|Overall Study|Other|0
5309722|NCT00382109|18294666|P2|Overall Study|ineligible|0
5309723|NCT00382109|18294667|P1|Overall Study|ineligible|2
5309724|NCT00382109|18294666|P2|Overall Study|Withdrawal by Subject|0
5309725|NCT00382109|18294667|P1|Overall Study|Withdrawal by Subject|1
5309726|NCT00382109|18294666|P2|Overall Study|Physician Decision|1
5309727|NCT00382109|18294667|P1|Overall Study|Physician Decision|6
5309728|NCT00382109|18294666|P2|Overall Study|Adverse Event|0
5309729|NCT00382109|18294667|P1|Overall Study|Adverse Event|3
5309730|NCT00382018|18294706|P4|Overall Study|Other, not protocol specified|1
5309731|NCT00382018|18294707|P3|Overall Study|Other, not protocol specified|3
5309732|NCT00382018|18294708|P2|Overall Study|Other, not protocol specified|16
5309733|NCT00382018|18294709|P1|Overall Study|Other, not protocol specified|0
5309734|NCT00382018|18294706|P4|Overall Study|Withdrawal by Subject|4
5309735|NCT00382018|18294707|P3|Overall Study|Withdrawal by Subject|3
5309736|NCT00382018|18294708|P2|Overall Study|Withdrawal by Subject|4
5309737|NCT00382018|18294709|P1|Overall Study|Withdrawal by Subject|0
5309738|NCT00382018|18294706|P4|Overall Study|Death|11
5309739|NCT00382018|18294707|P3|Overall Study|Death|7
5309740|NCT00382018|18294708|P2|Overall Study|Death|9
5309741|NCT00382018|18294709|P1|Overall Study|Death|0
5309742|NCT00382018|18294706|P4|Overall Study|Progression|43
5309743|NCT00382018|18294707|P3|Overall Study|Progression|51
5309744|NCT00382018|18294708|P2|Overall Study|Progression|136
5309745|NCT00382018|18294709|P1|Overall Study|Progression|0
5309746|NCT00381940|18294732|P1|Overall Study|Ineligible|1
5309747|NCT00381940|18294732|P1|Overall Study|Protocol Violation|1
5309748|NCT00381940|18294732|P1|Overall Study|Lack of Efficacy|3
5309749|NCT00381888|18294736|P1|Overall Study|Adverse Event|1
5309750|NCT00381888|18294736|P1|Overall Study|Surgery was cancelled|2
5309751|NCT00381888|18294736|P1|Overall Study|Had laparoscopic surgery|2
5309752|NCT00381888|18294736|P1|Overall Study|Protocol Violation|9
5309753|NCT00381888|18294736|P1|Overall Study|Physician Decision|1
5309754|NCT00381888|18294736|P1|Overall Study|Withdrawal by Subject|1
5309755|NCT00381888|18294736|P1|Overall Study|Death|1
5309756|NCT00381849|18294747|P2|Wash Out|Withdrawal by Subject|1
5309757|NCT00381849|18294748|P1|Wash Out|Withdrawal by Subject|0
5309758|NCT00381797|18294775|P5|Overall Study|Ineligible|0
5309759|NCT00381797|18294776|P4|Overall Study|Ineligible|1
5309760|NCT00381797|18294777|P3|Overall Study|Ineligible|0
5309761|NCT00381797|18294778|P2|Overall Study|Ineligible|0
5309762|NCT00381797|18294779|P1|Overall Study|Ineligible|0
5309763|NCT00381797|18294775|P5|Overall Study|Withdrawal by Subject|2
5309764|NCT00381797|18294776|P4|Overall Study|Withdrawal by Subject|0
5309765|NCT00381797|18294777|P3|Overall Study|Withdrawal by Subject|0
5309766|NCT00381797|18294778|P2|Overall Study|Withdrawal by Subject|1
5309767|NCT00381797|18294779|P1|Overall Study|Withdrawal by Subject|1
5309768|NCT00381706|18294854|P3|Overall Study|Never treated|1
5309769|NCT00381706|18294855|P2|Overall Study|Never treated|2
5309770|NCT00381706|18294856|P1|Overall Study|Never treated|7
5309771|NCT00381693|18294879|P1|Overall Study|Progression|2
5309772|NCT00381693|18294879|P1|Overall Study|Patient Choice|1
5309773|NCT00381693|18294879|P1|Overall Study|Adverse Event|4
5309774|NCT00381693|18294879|P1|Overall Study|Death|1
5309775|NCT00381680|18294888|P2|Overall Study|Ineligible|1
5309776|NCT00381680|18294889|P1|Overall Study|Ineligible|3
5309777|NCT00381680|18294888|P2|Overall Study|Other not otherwise specified|2
5309778|NCT00381680|18294889|P1|Overall Study|Other not otherwise specified|7
5309779|NCT00381680|18294888|P2|Overall Study|Progression|1
5309780|NCT00381680|18294889|P1|Overall Study|Progression|1
5309781|NCT00381680|18294888|P2|Overall Study|Induction Failure|1
5309782|NCT00381680|18294889|P1|Overall Study|Induction Failure|4
5309783|NCT00381680|18294888|P2|Overall Study|Relapse|9
5309784|NCT00381680|18294889|P1|Overall Study|Relapse|18
5309785|NCT00381680|18294888|P2|Overall Study|Stem Cell Transplant|10
5309786|NCT00381680|18294889|P1|Overall Study|Stem Cell Transplant|26
5309787|NCT00381680|18294888|P2|Overall Study|Delay initiation|0
5309788|NCT00381680|18294889|P1|Overall Study|Delay initiation|1
5309789|NCT00381680|18294888|P2|Overall Study|Secondary Malignancy|0
5309790|NCT00381680|18294889|P1|Overall Study|Secondary Malignancy|3
5309791|NCT00381680|18294888|P2|Overall Study|Alternative Therapy|5
5309792|NCT00381680|18294889|P1|Overall Study|Alternative Therapy|11
5309793|NCT00381680|18294888|P2|Overall Study|Entry onto another COG Trial|2
5309794|NCT00381680|18294889|P1|Overall Study|Entry onto another COG Trial|1
5309795|NCT00381680|18294888|P2|Overall Study|Withdrawal by Subject|1
5309796|NCT00381680|18294889|P1|Overall Study|Withdrawal by Subject|3
5309797|NCT00381680|18294888|P2|Overall Study|Physician Decision|6
5309798|NCT00381680|18294889|P1|Overall Study|Physician Decision|25
5309799|NCT00381680|18294888|P2|Overall Study|Lost to Follow-up|2
5309800|NCT00381680|18294889|P1|Overall Study|Lost to Follow-up|3
5309801|NCT00381680|18294888|P2|Overall Study|Death|7
5309802|NCT00381680|18294889|P1|Overall Study|Death|10
5309803|NCT00381680|18294888|P2|Overall Study|Adverse Event|3
5309804|NCT00381680|18294889|P1|Overall Study|Adverse Event|9
5309805|NCT00381641|18294906|P2|Overall Study|Withdrawal by Subject|2
5309806|NCT00381641|18294907|P1|Overall Study|Withdrawal by Subject|0
5309807|NCT00381615|18294940|P4|Overall Study|Protocol Violation|0
5309808|NCT00381615|18294941|P3|Overall Study|Protocol Violation|1
5309809|NCT00381615|18294942|P2|Overall Study|Protocol Violation|0
5309810|NCT00381615|18294943|P1|Overall Study|Protocol Violation|0
5309811|NCT00381615|18294940|P4|Overall Study|Lost to Follow-up|1
5309812|NCT00381615|18294941|P3|Overall Study|Lost to Follow-up|0
5309813|NCT00381615|18294942|P2|Overall Study|Lost to Follow-up|2
5309814|NCT00381615|18294943|P1|Overall Study|Lost to Follow-up|3
5309815|NCT00381615|18294940|P4|Overall Study|Withdrawal by Subject|1
5309816|NCT00381615|18294941|P3|Overall Study|Withdrawal by Subject|0
5309817|NCT00381615|18294942|P2|Overall Study|Withdrawal by Subject|3
5309818|NCT00381615|18294943|P1|Overall Study|Withdrawal by Subject|1
5309819|NCT00381563|18294995|P2|Overall Study|Protocol Violation|1
5309820|NCT00381563|18294996|P1|Overall Study|Protocol Violation|0
5309821|NCT00381563|18294995|P2|Overall Study|Lost to Follow-up|0
5309822|NCT00381563|18294996|P1|Overall Study|Lost to Follow-up|2
5309823|NCT00381563|18294995|P2|Overall Study|Withdrawal by Subject|5
5309824|NCT00381563|18294996|P1|Overall Study|Withdrawal by Subject|5
5309825|NCT00381485|18295011|P4|Double-Blind Treatment Period|Administrative|1
5309826|NCT00381485|18295012|P3|Double-Blind Treatment Period|Administrative|0
5309827|NCT00381485|18295013|P2|Double-Blind Treatment Period|Administrative|1
5309828|NCT00381485|18295014|P1|Double-Blind Treatment Period|Administrative|0
5309829|NCT00381485|18295011|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
5309830|NCT00381485|18295012|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
5309831|NCT00381485|18295013|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
5309832|NCT00381485|18295014|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
5309833|NCT00381485|18295011|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
5309834|NCT00381485|18295012|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
5309835|NCT00381485|18295013|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
5309836|NCT00381485|18295014|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
5309837|NCT00381485|18295011|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
5309838|NCT00381485|18295012|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
5309839|NCT00381485|18295013|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
5309840|NCT00381485|18295014|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
5309841|NCT00381485|18295011|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
5309842|NCT00381485|18295012|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
5309843|NCT00381485|18295013|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
5309844|NCT00381485|18295014|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
5309845|NCT00381485|18295011|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5309846|NCT00381485|18295012|P3|Double-Blind Treatment Period|Lost to Follow-up|1
5309847|NCT00381485|18295013|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5309848|NCT00381485|18295014|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5309849|NCT00381485|18295011|P4|Double-Blind Treatment Period|Lack of Efficacy|13
5309850|NCT00381485|18295012|P3|Double-Blind Treatment Period|Lack of Efficacy|11
5309851|NCT00381485|18295013|P2|Double-Blind Treatment Period|Lack of Efficacy|8
5309852|NCT00381485|18295014|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5309853|NCT00381485|18295011|P4|Double-Blind Treatment Period|Adverse Event|5
5309854|NCT00381485|18295012|P3|Double-Blind Treatment Period|Adverse Event|2
5309855|NCT00381485|18295013|P2|Double-Blind Treatment Period|Adverse Event|2
5309856|NCT00381485|18295014|P1|Double-Blind Treatment Period|Adverse Event|0
5309857|NCT00381485|18295011|P4|Open-Label Run-In Period|Treatment failure|0
5309858|NCT00381485|18295012|P3|Open-Label Run-In Period|Treatment failure|0
5309859|NCT00381485|18295013|P2|Open-Label Run-In Period|Treatment failure|0
5309860|NCT00381485|18295014|P1|Open-Label Run-In Period|Treatment failure|1
5309861|NCT00381485|18295011|P4|Open-Label Run-In Period|Lost to Follow-up|0
5309862|NCT00381485|18295012|P3|Open-Label Run-In Period|Lost to Follow-up|0
5309863|NCT00381485|18295013|P2|Open-Label Run-In Period|Lost to Follow-up|0
5309864|NCT00381485|18295014|P1|Open-Label Run-In Period|Lost to Follow-up|3
5309865|NCT00381485|18295011|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
5309866|NCT00381485|18295012|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
5309867|NCT00381485|18295013|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
5309868|NCT00381485|18295014|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
5309869|NCT00381485|18295011|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
5309870|NCT00381485|18295012|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
5309871|NCT00381485|18295013|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
5309872|NCT00381485|18295014|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
5309873|NCT00381485|18295011|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
5309874|NCT00381485|18295012|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
5309875|NCT00381485|18295013|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
5309876|NCT00381485|18295014|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
5309877|NCT00381485|18295011|P4|Open-Label Run-In Period|Adverse Event|0
5309878|NCT00381485|18295012|P3|Open-Label Run-In Period|Adverse Event|0
5309879|NCT00381485|18295013|P2|Open-Label Run-In Period|Adverse Event|0
5309880|NCT00381485|18295014|P1|Open-Label Run-In Period|Adverse Event|9
5309881|NCT00381381|18295032|P1|Overall Study|Withdrawal by Subject|9
5309882|NCT00381381|18295032|P1|Overall Study|Lost to Follow-up|52
5309883|NCT00381381|18295032|P1|Overall Study|Adverse Event|3
5309884|NCT00381303|18295041|P2|Overall Study|Subject primary physician's decision|0
5309885|NCT00381303|18295042|P1|Overall Study|Subject primary physician's decision|1
5309886|NCT00381303|18295041|P2|Overall Study|Subject did not continue visits|0
5309887|NCT00381303|18295042|P1|Overall Study|Subject did not continue visits|1
5309888|NCT00381303|18295041|P2|Overall Study|Subject was too busy for appointments|0
5309889|NCT00381303|18295042|P1|Overall Study|Subject was too busy for appointments|1
5309890|NCT00381303|18295041|P2|Overall Study|No virologic response by week 12|0
5309891|NCT00381303|18295042|P1|Overall Study|No virologic response by week 12|1
5309892|NCT00381303|18295041|P2|Overall Study|Subject taking too many different meds|0
5309893|NCT00381303|18295042|P1|Overall Study|Subject taking too many different meds|1
5309894|NCT00381303|18295041|P2|Overall Study|Subject moved out of state|0
5309895|NCT00381303|18295042|P1|Overall Study|Subject moved out of state|2
5309896|NCT00381303|18295041|P2|Overall Study|Physician's decision to close the site|1
5309897|NCT00381303|18295042|P1|Overall Study|Physician's decision to close the site|3
5309898|NCT00381303|18295041|P2|Overall Study|Physician Decision|0
5309899|NCT00381303|18295042|P1|Overall Study|Physician Decision|1
5309900|NCT00381303|18295041|P2|Overall Study|Pregnancy|0
5309901|NCT00381303|18295042|P1|Overall Study|Pregnancy|2
5309902|NCT00381303|18295041|P2|Overall Study|Ineligible to continue the trial|1
5309903|NCT00381303|18295042|P1|Overall Study|Ineligible to continue the trial|2
5309904|NCT00381303|18295041|P2|Overall Study|Virologic failure|4
5309905|NCT00381303|18295042|P1|Overall Study|Virologic failure|6
5309906|NCT00381303|18295041|P2|Overall Study|Withdrawal by Subject|6
5309907|NCT00381303|18295042|P1|Overall Study|Withdrawal by Subject|13
5309908|NCT00381303|18295041|P2|Overall Study|Non-Adherence|6
5309909|NCT00381303|18295042|P1|Overall Study|Non-Adherence|13
5309910|NCT00381303|18295041|P2|Overall Study|AE/HIV-related event|6
5309911|NCT00381303|18295042|P1|Overall Study|AE/HIV-related event|22
5309912|NCT00381303|18295041|P2|Overall Study|Lost to Follow-up|9
5309913|NCT00381303|18295042|P1|Overall Study|Lost to Follow-up|25
5309914|NCT00381238|18295102|P1|Overall Study|Disease progression|1
5309915|NCT00381238|18295102|P1|Overall Study|Withdrew by physician|1
5309916|NCT00381238|18295102|P1|Overall Study|Lack of Efficacy|2
5309917|NCT00381238|18295102|P1|Overall Study|Withdrawal by Subject|4
5309918|NCT00381238|18295102|P1|Overall Study|Protocol Violation|1
5309919|NCT00381238|18295102|P1|Overall Study|Adverse Event|3
5309920|NCT00381095|18295118|P2|Overall Study|Adverse Event|7
5309921|NCT00381095|18295119|P1|Overall Study|Adverse Event|2
5309922|NCT00381095|18295118|P2|Overall Study|Withdrawal by Subject|3
5309923|NCT00381095|18295119|P1|Overall Study|Withdrawal by Subject|3
5309924|NCT00381095|18295118|P2|Overall Study|Protocol Violation|1
5309925|NCT00381095|18295119|P1|Overall Study|Protocol Violation|1
5309926|NCT00381095|18295118|P2|Overall Study|Other|2
5309927|NCT00381095|18295119|P1|Overall Study|Other|2
5309928|NCT00381095|18295118|P2|Overall Study|Lack of Efficacy|4
5309929|NCT00381095|18295119|P1|Overall Study|Lack of Efficacy|2
5309930|NCT00381095|18295118|P2|Overall Study|Death|4
5309931|NCT00381095|18295119|P1|Overall Study|Death|3
5309932|NCT00381043|18295151|P2|Overall Study|incarcerated|0
5309933|NCT00381043|18295152|P1|Overall Study|incarcerated|1
5309934|NCT00381043|18295151|P2|Overall Study|wanted more care|1
5309935|NCT00381043|18295152|P1|Overall Study|wanted more care|0
5309936|NCT00381043|18295151|P2|Overall Study|Withdrawal by Subject|1
5309937|NCT00381043|18295152|P1|Overall Study|Withdrawal by Subject|3
5309938|NCT00381043|18295151|P2|Overall Study|Lost to Follow-up|6
5309939|NCT00381043|18295152|P1|Overall Study|Lost to Follow-up|8
5309940|NCT00380978|18295178|P2|Overall Study|Parous patient|0
5309941|NCT00380978|18295179|P1|Overall Study|Parous patient|1
5309942|NCT00380978|18295178|P2|Overall Study|Allocation prior to analgesia request|2
5309943|NCT00380978|18295179|P1|Overall Study|Allocation prior to analgesia request|1
5309944|NCT00380978|18295178|P2|Overall Study|Wrong study envelope|2
5309945|NCT00380978|18295179|P1|Overall Study|Wrong study envelope|0
5309946|NCT00380978|18295178|P2|Overall Study|Refused allocated intervention|6
5309947|NCT00380978|18295179|P1|Overall Study|Refused allocated intervention|0
5309948|NCT00380874|18295201|P2|Overall Study|Not related to study drug|2
5309949|NCT00380874|18295202|P1|Overall Study|Not related to study drug|3
5309950|NCT00380874|18295201|P2|Overall Study|Withdrawal by Subject|1
5309951|NCT00380874|18295202|P1|Overall Study|Withdrawal by Subject|2
5309952|NCT00380874|18295201|P2|Overall Study|Death|0
5309953|NCT00380874|18295202|P1|Overall Study|Death|1
5309954|NCT00380874|18295201|P2|Overall Study|Adverse Event|7
5309955|NCT00380874|18295202|P1|Overall Study|Adverse Event|7
5309956|NCT00380744|18295234|P7|Overall Study|Withdrawal by Subject|0
5309957|NCT00380744|18295235|P6|Overall Study|Withdrawal by Subject|0
5309958|NCT00380744|18295236|P5|Overall Study|Withdrawal by Subject|0
5309959|NCT00380744|18295237|P4|Overall Study|Withdrawal by Subject|0
5309960|NCT00380744|18295238|P3|Overall Study|Withdrawal by Subject|0
5309961|NCT00380744|18295239|P2|Overall Study|Withdrawal by Subject|0
5309962|NCT00380744|18295240|P1|Overall Study|Withdrawal by Subject|1
5309963|NCT00380744|18295234|P7|Overall Study|Death|1
5309964|NCT00380744|18295235|P6|Overall Study|Death|0
5309965|NCT00380744|18295236|P5|Overall Study|Death|0
5309966|NCT00380744|18295237|P4|Overall Study|Death|0
5309967|NCT00380744|18295238|P3|Overall Study|Death|0
5309968|NCT00380744|18295239|P2|Overall Study|Death|0
5309969|NCT00380744|18295240|P1|Overall Study|Death|0
5309970|NCT00380718|18295290|P1|Overall Study|Death after 30-day post-therapy followup|17
5309971|NCT00380718|18295290|P1|Overall Study|Adverse Event|1
5309972|NCT00380692|18295302|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
5309973|NCT00380692|18295303|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
5309974|NCT00380692|18295302|P2|Study Period III - Open Label|Lack of Efficacy|4
5309975|NCT00380692|18295303|P1|Study Period III - Open Label|Lack of Efficacy|0
5309976|NCT00380692|18295302|P2|Study Period III - Open Label|Physician Decision|3
5309977|NCT00380692|18295303|P1|Study Period III - Open Label|Physician Decision|0
5309978|NCT00380692|18295302|P2|Study Period III - Open Label|Withdrawal by Subject|1
5309979|NCT00380692|18295303|P1|Study Period III - Open Label|Withdrawal by Subject|0
5309980|NCT00380692|18295302|P2|Study Period III - Open Label|Protocol Violation|0
5309981|NCT00380692|18295303|P1|Study Period III - Open Label|Protocol Violation|0
5309982|NCT00380692|18295302|P2|Study Period III - Open Label|Adverse Event|3
5309983|NCT00380692|18295303|P1|Study Period III - Open Label|Adverse Event|5
5309984|NCT00380692|18295302|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
5309985|NCT00380692|18295303|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
5309986|NCT00380692|18295302|P2|Study Period II - Double Blind|Lack of Efficacy|0
5309987|NCT00380692|18295303|P1|Study Period II - Double Blind|Lack of Efficacy|1
5309988|NCT00380692|18295302|P2|Study Period II - Double Blind|Physician Decision|1
5309989|NCT00380692|18295303|P1|Study Period II - Double Blind|Physician Decision|0
5309990|NCT00380692|18295302|P2|Study Period II - Double Blind|Withdrawal by Subject|0
5309991|NCT00380692|18295303|P1|Study Period II - Double Blind|Withdrawal by Subject|0
5309992|NCT00380692|18295302|P2|Study Period II - Double Blind|Protocol Violation|2
5309993|NCT00380692|18295303|P1|Study Period II - Double Blind|Protocol Violation|2
5309994|NCT00380692|18295302|P2|Study Period II - Double Blind|Adverse Event|0
5309995|NCT00380692|18295303|P1|Study Period II - Double Blind|Adverse Event|1
5309996|NCT00380588|18295351|P2|Overall Study|Physician Decision|0
5309997|NCT00380588|18295352|P1|Overall Study|Physician Decision|2
5309998|NCT00380588|18295351|P2|Overall Study|Withdrawal by Subject|3
5309999|NCT00380588|18295352|P1|Overall Study|Withdrawal by Subject|1
5310000|NCT00380588|18295351|P2|Overall Study|Adverse Event|3
5310001|NCT00380588|18295352|P1|Overall Study|Adverse Event|7
5310002|NCT00380588|18295351|P2|Overall Study|Next Cycle Not Started|0
5310003|NCT00380588|18295352|P1|Overall Study|Next Cycle Not Started|4
5310004|NCT00380588|18295351|P2|Overall Study|Unequivocal Disease Progression|34
5310005|NCT00380588|18295352|P1|Overall Study|Unequivocal Disease Progression|25
5310006|NCT00380393|18295366|P2|Month 14|Others|6
5310007|NCT00380393|18295367|P1|Month 14|Others|6
5310008|NCT00380393|18295366|P2|Month 14|Protocol Violation|0
5310009|NCT00380393|18295367|P1|Month 14|Protocol Violation|2
5310010|NCT00380393|18295366|P2|Month 14|Migrated/moved from study area|42
5310011|NCT00380393|18295367|P1|Month 14|Migrated/moved from study area|39
5310012|NCT00380393|18295366|P2|Month 14|Lost to Follow-up|1
5310013|NCT00380393|18295367|P1|Month 14|Lost to Follow-up|0
5310014|NCT00380393|18295366|P2|Month 14|Death|0
5310015|NCT00380393|18295367|P1|Month 14|Death|1
5310016|NCT00380393|18295366|P2|Month 14|Withdrawal by Subject|7
5310017|NCT00380393|18295367|P1|Month 14|Withdrawal by Subject|9
5310018|NCT00380393|18295366|P2|Month 8 (Cross-sectional Visit)|Others|4
5310019|NCT00380393|18295367|P1|Month 8 (Cross-sectional Visit)|Others|5
5310020|NCT00380393|18295366|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
5310021|NCT00380393|18295367|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
5310022|NCT00380393|18295366|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
5310023|NCT00380393|18295367|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
5310024|NCT00380393|18295366|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
5310025|NCT00380393|18295367|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
5310026|NCT00380393|18295366|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
5310027|NCT00380393|18295367|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
5310028|NCT00380367|18295415|P1|Overall Study|Withdrawal by Subject|1
5310029|NCT00380367|18295415|P1|Overall Study|Lost to Follow-up|1
5310030|NCT00380250|18295422|P2|Overall Study|Physician Decision|0
5310031|NCT00380250|18295423|P1|Overall Study|Physician Decision|1
5310032|NCT00380250|18295422|P2|Overall Study|Lost to Follow-up|5
5310033|NCT00380250|18295423|P1|Overall Study|Lost to Follow-up|14
5310034|NCT00380250|18295422|P2|Overall Study|Protocol Violation|5
5310035|NCT00380250|18295423|P1|Overall Study|Protocol Violation|15
5310036|NCT00380250|18295422|P2|Overall Study|Lack of Efficacy|8
5310037|NCT00380250|18295423|P1|Overall Study|Lack of Efficacy|10
5310038|NCT00380250|18295422|P2|Overall Study|Adverse Event|9
5310039|NCT00380250|18295423|P1|Overall Study|Adverse Event|20
5310040|NCT00380250|18295422|P2|Overall Study|Withdrawal by Subject|28
5310041|NCT00380250|18295423|P1|Overall Study|Withdrawal by Subject|39
5310042|NCT00380081|18295491|P6|Overall Study|Family Emergency|1
5310043|NCT00380081|18295492|P5|Overall Study|Family Emergency|0
5310044|NCT00380081|18295493|P4|Overall Study|Family Emergency|0
5310045|NCT00380081|18295494|P3|Overall Study|Family Emergency|0
5310046|NCT00380081|18295495|P2|Overall Study|Family Emergency|0
5310047|NCT00380081|18295496|P1|Overall Study|Family Emergency|0
5310048|NCT00380081|18295491|P6|Overall Study|Withdrawal by Subject|0
5310049|NCT00380081|18295492|P5|Overall Study|Withdrawal by Subject|1
5310050|NCT00380081|18295493|P4|Overall Study|Withdrawal by Subject|0
5310051|NCT00380081|18295494|P3|Overall Study|Withdrawal by Subject|0
5310052|NCT00380081|18295495|P2|Overall Study|Withdrawal by Subject|0
5310053|NCT00380081|18295496|P1|Overall Study|Withdrawal by Subject|0
5310054|NCT00380068|18295546|P1|Overall Study|Lack of Efficacy|5
5310055|NCT00380068|18295546|P1|Overall Study|Partipant moved away|1
5310056|NCT00380068|18295546|P1|Overall Study|Physician Decision|2
5310057|NCT00380068|18295546|P1|Overall Study|Lung transplant|3
5310058|NCT00380068|18295546|P1|Overall Study|Addition of other PAH therapeutic agent|1
5310059|NCT00380068|18295546|P1|Overall Study|Lost to Follow-up|1
5310060|NCT00380068|18295546|P1|Overall Study|Not compliant|6
5310061|NCT00380068|18295546|P1|Overall Study|Withdrawal by Subject|10
5310062|NCT00380068|18295546|P1|Overall Study|Adverse Event|40
5310063|NCT00379912|18295578|P2|Overall Study|Lack of Efficacy|0
5310064|NCT00379912|18295579|P1|Overall Study|Lack of Efficacy|1
5310065|NCT00379899|18295601|P2|Overall Study|Other|1
5310066|NCT00379899|18295602|P1|Overall Study|Other|3
5310067|NCT00379899|18295601|P2|Overall Study|Other protocol-specified criteria|4
5310068|NCT00379899|18295602|P1|Overall Study|Other protocol-specified criteria|3
5310069|NCT00379899|18295601|P2|Overall Study|Coronary artery bypass graft|1
5310070|NCT00379899|18295602|P1|Overall Study|Coronary artery bypass graft|1
5310071|NCT00379899|18295601|P2|Overall Study|Renal transplantation|4
5310072|NCT00379899|18295602|P1|Overall Study|Renal transplantation|5
5310073|NCT00379899|18295601|P2|Overall Study|Parathyroidectomy|2
5310074|NCT00379899|18295602|P1|Overall Study|Parathyroidectomy|0
5310075|NCT00379899|18295601|P2|Overall Study|Noncompliance|1
5310076|NCT00379899|18295602|P1|Overall Study|Noncompliance|1
5310077|NCT00379899|18295601|P2|Overall Study|Ineligibility determined|1
5310078|NCT00379899|18295602|P1|Overall Study|Ineligibility determined|0
5310079|NCT00379899|18295601|P2|Overall Study|Withdrawal by Subject|5
5310080|NCT00379899|18295602|P1|Overall Study|Withdrawal by Subject|5
5310081|NCT00379899|18295601|P2|Overall Study|Physician Decision|4
5310082|NCT00379899|18295602|P1|Overall Study|Physician Decision|3
5310083|NCT00379899|18295601|P2|Overall Study|Lost to Follow-up|4
5310084|NCT00379899|18295602|P1|Overall Study|Lost to Follow-up|2
5310085|NCT00379899|18295601|P2|Overall Study|Death|10
5310086|NCT00379899|18295602|P1|Overall Study|Death|10
5310087|NCT00379899|18295601|P2|Overall Study|Adverse Event|3
5310088|NCT00379899|18295602|P1|Overall Study|Adverse Event|7
5310089|NCT00379834|18295630|P1|Overall Study|Time constraints|2
5310090|NCT00379808|18295782|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
5310091|NCT00379808|18295783|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
5310092|NCT00379795|18295804|P5|Overall Study|Sponsor's decision|10
5310093|NCT00379795|18295805|P4|Overall Study|Sponsor's decision|47
5310094|NCT00379795|18295806|P3|Overall Study|Sponsor's decision|54
5310095|NCT00379795|18295807|P2|Overall Study|Sponsor's decision|17
5310096|NCT00379795|18295808|P1|Overall Study|Sponsor's decision|257
5310097|NCT00379795|18295804|P5|Overall Study|Subjects condition mandated intervention|7
5310098|NCT00379795|18295805|P4|Overall Study|Subjects condition mandated intervention|5
5310099|NCT00379795|18295806|P3|Overall Study|Subjects condition mandated intervention|7
5310100|NCT00379795|18295807|P2|Overall Study|Subjects condition mandated intervention|9
5310101|NCT00379795|18295808|P1|Overall Study|Subjects condition mandated intervention|34
5310102|NCT00379795|18295804|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
5310103|NCT00379795|18295805|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
5310104|NCT00379795|18295806|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
5310105|NCT00379795|18295807|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
5310106|NCT00379795|18295808|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
5310107|NCT00379795|18295804|P5|Overall Study|Subject non-compliance|1
5310108|NCT00379795|18295805|P4|Overall Study|Subject non-compliance|0
5310109|NCT00379795|18295806|P3|Overall Study|Subject non-compliance|0
5310110|NCT00379795|18295807|P2|Overall Study|Subject non-compliance|2
5310111|NCT00379795|18295808|P1|Overall Study|Subject non-compliance|7
5310112|NCT00379795|18295804|P5|Overall Study|Withdrawal by Subject|14
5310113|NCT00379795|18295805|P4|Overall Study|Withdrawal by Subject|7
5310114|NCT00379795|18295806|P3|Overall Study|Withdrawal by Subject|19
5310115|NCT00379795|18295807|P2|Overall Study|Withdrawal by Subject|11
5310116|NCT00379795|18295808|P1|Overall Study|Withdrawal by Subject|94
5310117|NCT00379795|18295804|P5|Overall Study|Physician Decision|2
5310118|NCT00379795|18295805|P4|Overall Study|Physician Decision|2
5310119|NCT00379795|18295806|P3|Overall Study|Physician Decision|2
5310120|NCT00379795|18295807|P2|Overall Study|Physician Decision|0
5310121|NCT00379795|18295808|P1|Overall Study|Physician Decision|25
5310122|NCT00379795|18295804|P5|Overall Study|Lost to Follow-up|4
5310123|NCT00379795|18295805|P4|Overall Study|Lost to Follow-up|1
5310124|NCT00379795|18295806|P3|Overall Study|Lost to Follow-up|2
5310125|NCT00379795|18295807|P2|Overall Study|Lost to Follow-up|1
5310126|NCT00379795|18295808|P1|Overall Study|Lost to Follow-up|8
5310127|NCT00379795|18295804|P5|Overall Study|Adverse Event|4
5310128|NCT00379795|18295805|P4|Overall Study|Adverse Event|1
5310129|NCT00379795|18295806|P3|Overall Study|Adverse Event|3
5310130|NCT00379795|18295807|P2|Overall Study|Adverse Event|3
5310131|NCT00379795|18295808|P1|Overall Study|Adverse Event|17
5310132|NCT00379795|18295804|P5|Overall Study|Death|7
5310133|NCT00379795|18295805|P4|Overall Study|Death|4
5310134|NCT00379795|18295806|P3|Overall Study|Death|6
5310135|NCT00379795|18295807|P2|Overall Study|Death|8
5310136|NCT00379795|18295808|P1|Overall Study|Death|31
5310137|NCT00379769|18295838|P6|Observational Follow-up|Unknown; Reason Not Provided|1
5310138|NCT00379769|18295839|P5|Observational Follow-up|Unknown; Reason Not Provided|1
5310139|NCT00379769|18295840|P4|Observational Follow-up|Unknown; Reason Not Provided|0
5310140|NCT00379769|18295841|P3|Observational Follow-up|Unknown; Reason Not Provided|0
5310141|NCT00379769|18295842|P2|Observational Follow-up|Unknown; Reason Not Provided|0
5310142|NCT00379769|18295843|P1|Observational Follow-up|Unknown; Reason Not Provided|0
5310143|NCT00379769|18295838|P6|Observational Follow-up|Participant Moved|1
5310144|NCT00379769|18295839|P5|Observational Follow-up|Participant Moved|0
5310145|NCT00379769|18295840|P4|Observational Follow-up|Participant Moved|0
5310146|NCT00379769|18295841|P3|Observational Follow-up|Participant Moved|0
5310147|NCT00379769|18295842|P2|Observational Follow-up|Participant Moved|0
5310148|NCT00379769|18295843|P1|Observational Follow-up|Participant Moved|0
5310149|NCT00379769|18295838|P6|Observational Follow-up|Site Closed Early|7
5310150|NCT00379769|18295839|P5|Observational Follow-up|Site Closed Early|6
5310151|NCT00379769|18295840|P4|Observational Follow-up|Site Closed Early|0
5310152|NCT00379769|18295841|P3|Observational Follow-up|Site Closed Early|0
5310153|NCT00379769|18295842|P2|Observational Follow-up|Site Closed Early|0
5310154|NCT00379769|18295843|P1|Observational Follow-up|Site Closed Early|0
5310155|NCT00379769|18295838|P6|Observational Follow-up|Physician Decision|8
5310156|NCT00379769|18295839|P5|Observational Follow-up|Physician Decision|8
5310157|NCT00379769|18295840|P4|Observational Follow-up|Physician Decision|0
5310158|NCT00379769|18295841|P3|Observational Follow-up|Physician Decision|0
5310159|NCT00379769|18295842|P2|Observational Follow-up|Physician Decision|0
5310160|NCT00379769|18295843|P1|Observational Follow-up|Physician Decision|0
5310161|NCT00379769|18295838|P6|Observational Follow-up|Entered into Another Clinical Trial|22
5310162|NCT00379769|18295839|P5|Observational Follow-up|Entered into Another Clinical Trial|18
5310163|NCT00379769|18295840|P4|Observational Follow-up|Entered into Another Clinical Trial|0
5310164|NCT00379769|18295841|P3|Observational Follow-up|Entered into Another Clinical Trial|0
5310165|NCT00379769|18295842|P2|Observational Follow-up|Entered into Another Clinical Trial|0
5310166|NCT00379769|18295843|P1|Observational Follow-up|Entered into Another Clinical Trial|0
5310167|NCT00379769|18295838|P6|Observational Follow-up|Withdrawal by Subject|12
5310168|NCT00379769|18295839|P5|Observational Follow-up|Withdrawal by Subject|12
5310169|NCT00379769|18295840|P4|Observational Follow-up|Withdrawal by Subject|0
5310170|NCT00379769|18295841|P3|Observational Follow-up|Withdrawal by Subject|0
5310171|NCT00379769|18295842|P2|Observational Follow-up|Withdrawal by Subject|0
5310172|NCT00379769|18295843|P1|Observational Follow-up|Withdrawal by Subject|0
5310173|NCT00379769|18295838|P6|Observational Follow-up|Lost to Follow-up|27
5310174|NCT00379769|18295839|P5|Observational Follow-up|Lost to Follow-up|25
5310175|NCT00379769|18295840|P4|Observational Follow-up|Lost to Follow-up|0
5310176|NCT00379769|18295841|P3|Observational Follow-up|Lost to Follow-up|0
5310177|NCT00379769|18295842|P2|Observational Follow-up|Lost to Follow-up|0
5310178|NCT00379769|18295843|P1|Observational Follow-up|Lost to Follow-up|0
5310179|NCT00379769|18295838|P6|Observational Follow-up|Adverse Event|0
5310180|NCT00379769|18295839|P5|Observational Follow-up|Adverse Event|1
5310181|NCT00379769|18295840|P4|Observational Follow-up|Adverse Event|0
5310182|NCT00379769|18295841|P3|Observational Follow-up|Adverse Event|0
5310183|NCT00379769|18295842|P2|Observational Follow-up|Adverse Event|0
5310184|NCT00379769|18295843|P1|Observational Follow-up|Adverse Event|0
5310185|NCT00379769|18295838|P6|Observational Follow-up|Death|70
5310186|NCT00379769|18295839|P5|Observational Follow-up|Death|78
5310187|NCT00379769|18295840|P4|Observational Follow-up|Death|0
5310188|NCT00379769|18295841|P3|Observational Follow-up|Death|0
5310189|NCT00379769|18295842|P2|Observational Follow-up|Death|0
5310190|NCT00379769|18295843|P1|Observational Follow-up|Death|0
5310191|NCT00379769|18295838|P6|Main Study|Reason unspecified|0
5310192|NCT00379769|18295839|P5|Main Study|Reason unspecified|0
5310193|NCT00379769|18295840|P4|Main Study|Reason unspecified|0
5310194|NCT00379769|18295841|P3|Main Study|Reason unspecified|1
5310195|NCT00379769|18295842|P2|Main Study|Reason unspecified|0
5310196|NCT00379769|18295843|P1|Main Study|Reason unspecified|0
5310197|NCT00379769|18295838|P6|Main Study|Investigator refused to log temperature|0
5310198|NCT00379769|18295839|P5|Main Study|Investigator refused to log temperature|0
5310199|NCT00379769|18295840|P4|Main Study|Investigator refused to log temperature|0
5310200|NCT00379769|18295841|P3|Main Study|Investigator refused to log temperature|1
5310201|NCT00379769|18295842|P2|Main Study|Investigator refused to log temperature|0
5310202|NCT00379769|18295843|P1|Main Study|Investigator refused to log temperature|0
5310203|NCT00379769|18295838|P6|Main Study|Risk of heart failure|0
5310204|NCT00379769|18295839|P5|Main Study|Risk of heart failure|0
5310205|NCT00379769|18295840|P4|Main Study|Risk of heart failure|0
5310206|NCT00379769|18295841|P3|Main Study|Risk of heart failure|0
5310207|NCT00379769|18295842|P2|Main Study|Risk of heart failure|1
5310208|NCT00379769|18295843|P1|Main Study|Risk of heart failure|0
5310209|NCT00379769|18295838|P6|Main Study|Personal reasons|0
5310210|NCT00379769|18295839|P5|Main Study|Personal reasons|0
5310211|NCT00379769|18295840|P4|Main Study|Personal reasons|0
5310212|NCT00379769|18295841|P3|Main Study|Personal reasons|0
5310213|NCT00379769|18295842|P2|Main Study|Personal reasons|0
5310214|NCT00379769|18295843|P1|Main Study|Personal reasons|1
5310215|NCT00379769|18295838|P6|Main Study|Participant completed study at visit 27|0
5310216|NCT00379769|18295839|P5|Main Study|Participant completed study at visit 27|0
5310217|NCT00379769|18295840|P4|Main Study|Participant completed study at visit 27|0
5310218|NCT00379769|18295841|P3|Main Study|Participant completed study at visit 27|0
5310219|NCT00379769|18295842|P2|Main Study|Participant completed study at visit 27|0
5310220|NCT00379769|18295843|P1|Main Study|Participant completed study at visit 27|1
5310221|NCT00379769|18295838|P6|Main Study|Physician Decision|0
5310222|NCT00379769|18295839|P5|Main Study|Physician Decision|0
5310223|NCT00379769|18295840|P4|Main Study|Physician Decision|1
5310224|NCT00379769|18295841|P3|Main Study|Physician Decision|1
5310225|NCT00379769|18295842|P2|Main Study|Physician Decision|2
5310226|NCT00379769|18295843|P1|Main Study|Physician Decision|2
5310227|NCT00379769|18295838|P6|Main Study|Participant did not take study drug|0
5310228|NCT00379769|18295839|P5|Main Study|Participant did not take study drug|0
5310229|NCT00379769|18295840|P4|Main Study|Participant did not take study drug|0
5310230|NCT00379769|18295841|P3|Main Study|Participant did not take study drug|1
5310231|NCT00379769|18295842|P2|Main Study|Participant did not take study drug|0
5310232|NCT00379769|18295843|P1|Main Study|Participant did not take study drug|0
5310233|NCT00379769|18295838|P6|Main Study|Entry criteria violation|0
5310234|NCT00379769|18295839|P5|Main Study|Entry criteria violation|0
5310235|NCT00379769|18295840|P4|Main Study|Entry criteria violation|1
5310236|NCT00379769|18295841|P3|Main Study|Entry criteria violation|1
5310237|NCT00379769|18295842|P2|Main Study|Entry criteria violation|0
5310238|NCT00379769|18295843|P1|Main Study|Entry criteria violation|0
5310239|NCT00379769|18295838|P6|Main Study|Site closed|0
5310240|NCT00379769|18295839|P5|Main Study|Site closed|0
5310241|NCT00379769|18295840|P4|Main Study|Site closed|8
5310242|NCT00379769|18295841|P3|Main Study|Site closed|4
5310243|NCT00379769|18295842|P2|Main Study|Site closed|4
5310244|NCT00379769|18295843|P1|Main Study|Site closed|4
5310245|NCT00379769|18295838|P6|Main Study|Prohibited glucose lowering medication|0
5310246|NCT00379769|18295839|P5|Main Study|Prohibited glucose lowering medication|0
5310247|NCT00379769|18295840|P4|Main Study|Prohibited glucose lowering medication|1
5310248|NCT00379769|18295841|P3|Main Study|Prohibited glucose lowering medication|0
5310249|NCT00379769|18295842|P2|Main Study|Prohibited glucose lowering medication|3
5310250|NCT00379769|18295843|P1|Main Study|Prohibited glucose lowering medication|0
5310251|NCT00379769|18295838|P6|Main Study|Poor compliance|0
5310252|NCT00379769|18295839|P5|Main Study|Poor compliance|0
5310253|NCT00379769|18295840|P4|Main Study|Poor compliance|1
5310254|NCT00379769|18295841|P3|Main Study|Poor compliance|2
5310255|NCT00379769|18295842|P2|Main Study|Poor compliance|2
5310256|NCT00379769|18295843|P1|Main Study|Poor compliance|3
5310257|NCT00379769|18295838|P6|Main Study|Participant moved|0
5310258|NCT00379769|18295839|P5|Main Study|Participant moved|0
5310259|NCT00379769|18295840|P4|Main Study|Participant moved|3
5310260|NCT00379769|18295841|P3|Main Study|Participant moved|3
5310261|NCT00379769|18295842|P2|Main Study|Participant moved|2
5310262|NCT00379769|18295843|P1|Main Study|Participant moved|3
5310263|NCT00379769|18295838|P6|Main Study|Moved to survival status follow-up only|0
5310264|NCT00379769|18295839|P5|Main Study|Moved to survival status follow-up only|0
5310265|NCT00379769|18295840|P4|Main Study|Moved to survival status follow-up only|36
5310266|NCT00379769|18295841|P3|Main Study|Moved to survival status follow-up only|32
5310267|NCT00379769|18295842|P2|Main Study|Moved to survival status follow-up only|25
5310268|NCT00379769|18295843|P1|Main Study|Moved to survival status follow-up only|27
5310269|NCT00379769|18295838|P6|Main Study|Withdrawal by Subject|0
5310270|NCT00379769|18295839|P5|Main Study|Withdrawal by Subject|0
5310271|NCT00379769|18295840|P4|Main Study|Withdrawal by Subject|70
5310272|NCT00379769|18295841|P3|Main Study|Withdrawal by Subject|72
5310273|NCT00379769|18295842|P2|Main Study|Withdrawal by Subject|56
5310274|NCT00379769|18295843|P1|Main Study|Withdrawal by Subject|46
5310275|NCT00379769|18295838|P6|Main Study|Lost to Follow-up|0
5310276|NCT00379769|18295839|P5|Main Study|Lost to Follow-up|0
5310277|NCT00379769|18295840|P4|Main Study|Lost to Follow-up|26
5310278|NCT00379769|18295841|P3|Main Study|Lost to Follow-up|25
5310279|NCT00379769|18295842|P2|Main Study|Lost to Follow-up|29
5310280|NCT00379769|18295843|P1|Main Study|Lost to Follow-up|29
5310281|NCT00379769|18295838|P6|Main Study|Adverse Event|0
5310282|NCT00379769|18295839|P5|Main Study|Adverse Event|0
5310283|NCT00379769|18295840|P4|Main Study|Adverse Event|11
5310284|NCT00379769|18295841|P3|Main Study|Adverse Event|10
5310285|NCT00379769|18295842|P2|Main Study|Adverse Event|8
5310286|NCT00379769|18295843|P1|Main Study|Adverse Event|5
5310287|NCT00379769|18295838|P6|Main Study|Death|0
5310288|NCT00379769|18295839|P5|Main Study|Death|0
5310289|NCT00379769|18295840|P4|Main Study|Death|72
5310290|NCT00379769|18295841|P3|Main Study|Death|54
5310291|NCT00379769|18295842|P2|Main Study|Death|67
5310292|NCT00379769|18295843|P1|Main Study|Death|57
5310293|NCT00379639|18296002|P5|Overall Study|Other|0
5310294|NCT00379639|18296003|P4|Overall Study|Other|0
5310295|NCT00379639|18296004|P3|Overall Study|Other|3
5310296|NCT00379639|18296005|P2|Overall Study|Other|0
5310297|NCT00379639|18296006|P1|Overall Study|Other|0
5310298|NCT00379639|18296002|P5|Overall Study|Lost to Follow-up|0
5310299|NCT00379639|18296003|P4|Overall Study|Lost to Follow-up|1
5310300|NCT00379639|18296004|P3|Overall Study|Lost to Follow-up|0
5310301|NCT00379639|18296005|P2|Overall Study|Lost to Follow-up|0
5310302|NCT00379639|18296006|P1|Overall Study|Lost to Follow-up|0
5310303|NCT00379639|18296002|P5|Overall Study|Adverse Event|1
5310304|NCT00379639|18296003|P4|Overall Study|Adverse Event|0
5310305|NCT00379639|18296004|P3|Overall Study|Adverse Event|1
5310306|NCT00379639|18296005|P2|Overall Study|Adverse Event|0
5310307|NCT00379639|18296006|P1|Overall Study|Adverse Event|0
5310308|NCT00379639|18296002|P5|Overall Study|Symptomatic Deterioration|1
5310309|NCT00379639|18296003|P4|Overall Study|Symptomatic Deterioration|0
5310310|NCT00379639|18296004|P3|Overall Study|Symptomatic Deterioration|1
5310311|NCT00379639|18296005|P2|Overall Study|Symptomatic Deterioration|0
5310312|NCT00379639|18296006|P1|Overall Study|Symptomatic Deterioration|0
5310313|NCT00379639|18296002|P5|Overall Study|Physician Decision|0
5310314|NCT00379639|18296003|P4|Overall Study|Physician Decision|1
5310315|NCT00379639|18296004|P3|Overall Study|Physician Decision|1
5310316|NCT00379639|18296005|P2|Overall Study|Physician Decision|2
5310317|NCT00379639|18296006|P1|Overall Study|Physician Decision|0
5310318|NCT00379639|18296002|P5|Overall Study|Disease Progression|4
5310319|NCT00379639|18296003|P4|Overall Study|Disease Progression|4
5310320|NCT00379639|18296004|P3|Overall Study|Disease Progression|3
5310321|NCT00379639|18296005|P2|Overall Study|Disease Progression|3
5310322|NCT00379639|18296006|P1|Overall Study|Disease Progression|3
5310323|NCT00379587|18296028|P1|Overall Study|Lost to Follow-up|2
5310324|NCT00379353|18296042|P2|Overall Study|Conflicting drug treatment|1
5310325|NCT00379353|18296043|P1|Overall Study|Conflicting drug treatment|0
5310326|NCT00379353|18296042|P2|Overall Study|Non-compliance|0
5310327|NCT00379353|18296043|P1|Overall Study|Non-compliance|1
5310328|NCT00379353|18296042|P2|Overall Study|Cardiac Tamponade|0
5310329|NCT00379353|18296043|P1|Overall Study|Cardiac Tamponade|1
5310330|NCT00379353|18296042|P2|Overall Study|Death|0
5310331|NCT00379353|18296043|P1|Overall Study|Death|1
5310332|NCT00379353|18296042|P2|Overall Study|Withdrawal by Subject|2
5310333|NCT00379353|18296043|P1|Overall Study|Withdrawal by Subject|5
5310334|NCT00379353|18296042|P2|Overall Study|Hospitalization|3
5310335|NCT00379353|18296043|P1|Overall Study|Hospitalization|3
5310336|NCT00379340|18296078|P5|Overall Study|Delayed nephrectomy and anaplasia|1
5310337|NCT00379340|18296079|P4|Overall Study|Delayed nephrectomy and anaplasia|1
5310338|NCT00379340|18296080|P3|Overall Study|Delayed nephrectomy and anaplasia|0
5310339|NCT00379340|18296081|P2|Overall Study|Delayed nephrectomy and anaplasia|0
5310340|NCT00379340|18296082|P1|Overall Study|Delayed nephrectomy and anaplasia|0
5310341|NCT00379340|18296078|P5|Overall Study|On more than 1 tumor therapeutic study|0
5310342|NCT00379340|18296079|P4|Overall Study|On more than 1 tumor therapeutic study|2
5310343|NCT00379340|18296080|P3|Overall Study|On more than 1 tumor therapeutic study|0
5310344|NCT00379340|18296081|P2|Overall Study|On more than 1 tumor therapeutic study|0
5310345|NCT00379340|18296082|P1|Overall Study|On more than 1 tumor therapeutic study|0
5310346|NCT00379340|18296078|P5|Overall Study|Refusal of further protocol therapy|7
5310347|NCT00379340|18296079|P4|Overall Study|Refusal of further protocol therapy|1
5310348|NCT00379340|18296080|P3|Overall Study|Refusal of further protocol therapy|1
5310349|NCT00379340|18296081|P2|Overall Study|Refusal of further protocol therapy|0
5310350|NCT00379340|18296082|P1|Overall Study|Refusal of further protocol therapy|1
5310351|NCT00379340|18296078|P5|Overall Study|Withdrawal by Subject|0
5310352|NCT00379340|18296079|P4|Overall Study|Withdrawal by Subject|1
5310353|NCT00379340|18296080|P3|Overall Study|Withdrawal by Subject|0
5310354|NCT00379340|18296081|P2|Overall Study|Withdrawal by Subject|0
5310355|NCT00379340|18296082|P1|Overall Study|Withdrawal by Subject|0
5310356|NCT00379340|18296078|P5|Overall Study|Physician Decision|3
5310357|NCT00379340|18296079|P4|Overall Study|Physician Decision|2
5310358|NCT00379340|18296080|P3|Overall Study|Physician Decision|1
5310359|NCT00379340|18296081|P2|Overall Study|Physician Decision|2
5310360|NCT00379340|18296082|P1|Overall Study|Physician Decision|6
5310361|NCT00379340|18296078|P5|Overall Study|Lack of Efficacy|3
5310362|NCT00379340|18296079|P4|Overall Study|Lack of Efficacy|4
5310363|NCT00379340|18296080|P3|Overall Study|Lack of Efficacy|0
5310364|NCT00379340|18296081|P2|Overall Study|Lack of Efficacy|1
5310365|NCT00379340|18296082|P1|Overall Study|Lack of Efficacy|6
5310366|NCT00379340|18296078|P5|Overall Study|Death|0
5310367|NCT00379340|18296079|P4|Overall Study|Death|2
5310368|NCT00379340|18296080|P3|Overall Study|Death|0
5310369|NCT00379340|18296081|P2|Overall Study|Death|0
5310370|NCT00379340|18296082|P1|Overall Study|Death|0
5310371|NCT00379288|18296099|P4|Overall Study|Administrative|1
5310372|NCT00379288|18296100|P3|Overall Study|Administrative|0
5310373|NCT00379288|18296101|P2|Overall Study|Administrative|2
5310374|NCT00379288|18296102|P1|Overall Study|Administrative|2
5310375|NCT00379288|18296099|P4|Overall Study|Did not meet protocol eligibility|2
5310376|NCT00379288|18296100|P3|Overall Study|Did not meet protocol eligibility|0
5310377|NCT00379288|18296101|P2|Overall Study|Did not meet protocol eligibility|1
5310378|NCT00379288|18296102|P1|Overall Study|Did not meet protocol eligibility|0
5310379|NCT00379288|18296099|P4|Overall Study|Noncompliance with protocol|1
5310380|NCT00379288|18296100|P3|Overall Study|Noncompliance with protocol|2
5310381|NCT00379288|18296101|P2|Overall Study|Noncompliance with protocol|6
5310382|NCT00379288|18296102|P1|Overall Study|Noncompliance with protocol|8
5310383|NCT00379288|18296099|P4|Overall Study|Subject withdrew-related to study drug|1
5310384|NCT00379288|18296100|P3|Overall Study|Subject withdrew-related to study drug|0
5310385|NCT00379288|18296101|P2|Overall Study|Subject withdrew-related to study drug|0
5310386|NCT00379288|18296102|P1|Overall Study|Subject withdrew-related to study drug|1
5310387|NCT00379288|18296099|P4|Overall Study|Subject withdrew-unrelated to study drug|2
5310388|NCT00379288|18296100|P3|Overall Study|Subject withdrew-unrelated to study drug|4
5310389|NCT00379288|18296101|P2|Overall Study|Subject withdrew-unrelated to study drug|3
5310390|NCT00379288|18296102|P1|Overall Study|Subject withdrew-unrelated to study drug|0
5310391|NCT00379288|18296099|P4|Overall Study|Lost to Follow-up|0
5310392|NCT00379288|18296100|P3|Overall Study|Lost to Follow-up|2
5310393|NCT00379288|18296101|P2|Overall Study|Lost to Follow-up|3
5310394|NCT00379288|18296102|P1|Overall Study|Lost to Follow-up|3
5310395|NCT00379288|18296099|P4|Overall Study|Treatment Failure|1
5310396|NCT00379288|18296100|P3|Overall Study|Treatment Failure|0
5310397|NCT00379288|18296101|P2|Overall Study|Treatment Failure|1
5310398|NCT00379288|18296102|P1|Overall Study|Treatment Failure|0
5310399|NCT00379288|18296099|P4|Overall Study|Adverse Event|0
5310400|NCT00379288|18296100|P3|Overall Study|Adverse Event|2
5310401|NCT00379288|18296101|P2|Overall Study|Adverse Event|6
5310402|NCT00379288|18296102|P1|Overall Study|Adverse Event|5
5310403|NCT00379236|18296114|P3|Open-label Extension|Other|7
5310404|NCT00379236|18296115|P2|Open-label Extension|Other|0
5310405|NCT00379236|18296116|P1|Open-label Extension|Other|0
5310406|NCT00379236|18296114|P3|Open-label Extension|Use of exclusionary medication|3
5310407|NCT00379236|18296115|P2|Open-label Extension|Use of exclusionary medication|0
5310408|NCT00379236|18296116|P1|Open-label Extension|Use of exclusionary medication|0
5310409|NCT00379236|18296114|P3|Open-label Extension|Lost to Follow-up|12
5310410|NCT00379236|18296115|P2|Open-label Extension|Lost to Follow-up|0
5310411|NCT00379236|18296116|P1|Open-label Extension|Lost to Follow-up|0
5310412|NCT00379236|18296114|P3|Open-label Extension|Withdrawal by Subject|13
5310413|NCT00379236|18296115|P2|Open-label Extension|Withdrawal by Subject|0
5310414|NCT00379236|18296116|P1|Open-label Extension|Withdrawal by Subject|0
5310415|NCT00379236|18296114|P3|Open-label Extension|Protocol Violation|7
5310416|NCT00379236|18296115|P2|Open-label Extension|Protocol Violation|0
5310417|NCT00379236|18296116|P1|Open-label Extension|Protocol Violation|0
5310418|NCT00379236|18296114|P3|Open-label Extension|Adverse Event|13
5310419|NCT00379236|18296115|P2|Open-label Extension|Adverse Event|0
5310420|NCT00379236|18296116|P1|Open-label Extension|Adverse Event|0
5310421|NCT00379236|18296114|P3|Double-blind|Data could not be retrieved|0
5310422|NCT00379236|18296115|P2|Double-blind|Data could not be retrieved|2
5310423|NCT00379236|18296116|P1|Double-blind|Data could not be retrieved|2
5310424|NCT00379236|18296114|P3|Double-blind|Other|0
5310425|NCT00379236|18296115|P2|Double-blind|Other|7
5310426|NCT00379236|18296116|P1|Double-blind|Other|3
5310427|NCT00379236|18296114|P3|Double-blind|Use of exclusionary medication|0
5310428|NCT00379236|18296115|P2|Double-blind|Use of exclusionary medication|2
5310429|NCT00379236|18296116|P1|Double-blind|Use of exclusionary medication|1
5310430|NCT00379236|18296114|P3|Double-blind|Lost to Follow-up|0
5310431|NCT00379236|18296115|P2|Double-blind|Lost to Follow-up|3
5310432|NCT00379236|18296116|P1|Double-blind|Lost to Follow-up|4
5310433|NCT00379236|18296114|P3|Double-blind|Withdrawal by Subject|0
5310434|NCT00379236|18296115|P2|Double-blind|Withdrawal by Subject|13
5310435|NCT00379236|18296116|P1|Double-blind|Withdrawal by Subject|12
5310436|NCT00379236|18296114|P3|Double-blind|Protocol Violation|0
5310437|NCT00379236|18296115|P2|Double-blind|Protocol Violation|3
5310438|NCT00379236|18296116|P1|Double-blind|Protocol Violation|3
5310439|NCT00379236|18296114|P3|Double-blind|Adverse Event|0
5310440|NCT00379236|18296115|P2|Double-blind|Adverse Event|6
5310441|NCT00379236|18296116|P1|Double-blind|Adverse Event|11
5310442|NCT00379210|18296161|P2|Overall Study|Withdrawal by Subject|7
5310443|NCT00379210|18296162|P1|Overall Study|Withdrawal by Subject|10
5310444|NCT00379080|18296185|P3|Overall Study|Withdrawal by Subject|0
5310445|NCT00379080|18296186|P2|Overall Study|Withdrawal by Subject|4
5310446|NCT00379080|18296187|P1|Overall Study|Withdrawal by Subject|0
5310447|NCT00378898|18296232|P2|Overall Study|Protocol Violation|1
5310448|NCT00378898|18296233|P1|Overall Study|Protocol Violation|1
5310449|NCT00378898|18296232|P2|Overall Study|Withdrawal by Subject|5
5310450|NCT00378898|18296233|P1|Overall Study|Withdrawal by Subject|10
5310451|NCT00378703|18296245|P4|Overall Study|Other|3
5310452|NCT00378703|18296246|P3|Overall Study|Other|2
5310453|NCT00378703|18296247|P2|Overall Study|Other|1
5310454|NCT00378703|18296248|P1|Overall Study|Other|1
5310455|NCT00378703|18296245|P4|Overall Study|Never started treatment|0
5310456|NCT00378703|18296246|P3|Overall Study|Never started treatment|0
5310457|NCT00378703|18296247|P2|Overall Study|Never started treatment|4
5310458|NCT00378703|18296248|P1|Overall Study|Never started treatment|1
5310459|NCT00378703|18296245|P4|Overall Study|Ineligible|7
5310460|NCT00378703|18296246|P3|Overall Study|Ineligible|7
5310461|NCT00378703|18296247|P2|Overall Study|Ineligible|7
5310462|NCT00378703|18296248|P1|Overall Study|Ineligible|4
5310463|NCT00378703|18296245|P4|Overall Study|Relocation|0
5310464|NCT00378703|18296246|P3|Overall Study|Relocation|1
5310465|NCT00378703|18296247|P2|Overall Study|Relocation|0
5310466|NCT00378703|18296248|P1|Overall Study|Relocation|0
5310467|NCT00378703|18296245|P4|Overall Study|Adverse events and progressive disease|1
5310468|NCT00378703|18296246|P3|Overall Study|Adverse events and progressive disease|0
5310469|NCT00378703|18296247|P2|Overall Study|Adverse events and progressive disease|0
5310470|NCT00378703|18296248|P1|Overall Study|Adverse events and progressive disease|0
5310471|NCT00378703|18296245|P4|Overall Study|Joint decision of physician and patient|0
5310472|NCT00378703|18296246|P3|Overall Study|Joint decision of physician and patient|0
5310473|NCT00378703|18296247|P2|Overall Study|Joint decision of physician and patient|0
5310474|NCT00378703|18296248|P1|Overall Study|Joint decision of physician and patient|1
5310475|NCT00378703|18296245|P4|Overall Study|Surgery|1
5310476|NCT00378703|18296246|P3|Overall Study|Surgery|0
5310477|NCT00378703|18296247|P2|Overall Study|Surgery|0
5310478|NCT00378703|18296248|P1|Overall Study|Surgery|1
5310479|NCT00378703|18296245|P4|Overall Study|Symptomatic deterioration|2
5310480|NCT00378703|18296246|P3|Overall Study|Symptomatic deterioration|0
5310481|NCT00378703|18296247|P2|Overall Study|Symptomatic deterioration|1
5310482|NCT00378703|18296248|P1|Overall Study|Symptomatic deterioration|0
5310483|NCT00378703|18296245|P4|Overall Study|Other complicated disease|0
5310484|NCT00378703|18296246|P3|Overall Study|Other complicated disease|2
5310485|NCT00378703|18296247|P2|Overall Study|Other complicated disease|2
5310486|NCT00378703|18296248|P1|Overall Study|Other complicated disease|0
5310487|NCT00378703|18296245|P4|Overall Study|Alternative therapy|0
5310488|NCT00378703|18296246|P3|Overall Study|Alternative therapy|0
5310489|NCT00378703|18296247|P2|Overall Study|Alternative therapy|2
5310490|NCT00378703|18296248|P1|Overall Study|Alternative therapy|4
5310491|NCT00378703|18296245|P4|Overall Study|Physician Decision|0
5310492|NCT00378703|18296246|P3|Overall Study|Physician Decision|1
5310493|NCT00378703|18296247|P2|Overall Study|Physician Decision|4
5310494|NCT00378703|18296248|P1|Overall Study|Physician Decision|1
5310495|NCT00378703|18296245|P4|Overall Study|Withdrawal by Subject|7
5310496|NCT00378703|18296246|P3|Overall Study|Withdrawal by Subject|5
5310497|NCT00378703|18296247|P2|Overall Study|Withdrawal by Subject|8
5310498|NCT00378703|18296248|P1|Overall Study|Withdrawal by Subject|4
5310499|NCT00378703|18296245|P4|Overall Study|Death|3
5310500|NCT00378703|18296246|P3|Overall Study|Death|4
5310501|NCT00378703|18296247|P2|Overall Study|Death|2
5310502|NCT00378703|18296248|P1|Overall Study|Death|2
5310503|NCT00378703|18296245|P4|Overall Study|Adverse Event|18
5310504|NCT00378703|18296246|P3|Overall Study|Adverse Event|20
5310505|NCT00378703|18296247|P2|Overall Study|Adverse Event|17
5310506|NCT00378703|18296248|P1|Overall Study|Adverse Event|11
5310507|NCT00378703|18296245|P4|Overall Study|Disease progression|49
5310508|NCT00378703|18296246|P3|Overall Study|Disease progression|48
5310509|NCT00378703|18296247|P2|Overall Study|Disease progression|43
5310510|NCT00378703|18296248|P1|Overall Study|Disease progression|59
5310511|NCT00378599|18296270|P1|Overall Study|Withdrawal by Subject|5
5310512|NCT00378599|18296270|P1|Overall Study|Treatment failure|7
5310513|NCT00378599|18296270|P1|Overall Study|Protocol Violation|2
5310514|NCT00378599|18296270|P1|Overall Study|Adverse Event|38
5310515|NCT00378573|18296274|P1|Follow-up|Withdrawal by Subject|1
5310516|NCT00378573|18296274|P1|Follow-up|Lost to Follow-up|1
5310517|NCT00378573|18296274|P1|Follow-up|Death|12
5310518|NCT00378573|18296274|P1|Treatment Period|Sponsor decision to close study|1
5310519|NCT00378573|18296274|P1|Treatment Period|Disease Progression|4
5310520|NCT00378573|18296274|P1|Treatment Period|Withdrawal by Subject|2
5310521|NCT00378573|18296274|P1|Treatment Period|Physician Decision|1
5310522|NCT00378573|18296274|P1|Treatment Period|Adverse Event|9
5310693|NCT00377637|18296585|P2|Maintenance Phase|Adverse Event|0
5310523|NCT00378560|18296282|P2|Overall Study|Laboratory test values abnormal|0
5310524|NCT00378560|18296283|P1|Overall Study|Laboratory test values abnormal|1
5310525|NCT00378560|18296282|P2|Overall Study|Pregnancy|5
5310526|NCT00378560|18296283|P1|Overall Study|Pregnancy|7
5310527|NCT00378560|18296282|P2|Overall Study|Moved|3
5310528|NCT00378560|18296283|P1|Overall Study|Moved|4
5310529|NCT00378560|18296282|P2|Overall Study|Withdrawal by Subject|21
5310530|NCT00378560|18296283|P1|Overall Study|Withdrawal by Subject|17
5310531|NCT00378560|18296282|P2|Overall Study|Protocol Violation|0
5310532|NCT00378560|18296283|P1|Overall Study|Protocol Violation|2
5310533|NCT00378560|18296282|P2|Overall Study|Lost to Follow-up|29
5310534|NCT00378560|18296283|P1|Overall Study|Lost to Follow-up|24
5310535|NCT00378560|18296282|P2|Overall Study|Adverse Event|0
5310536|NCT00378560|18296283|P1|Overall Study|Adverse Event|1
5310537|NCT00378534|18296297|P1|Overall Study|Subjects did not receive a transplant|3
5310538|NCT00378534|18296297|P1|Overall Study|Donors|57
5310539|NCT00378508|18296303|P2|Overall Study|Lost to Follow-up|0
5310540|NCT00378508|18296304|P1|Overall Study|Lost to Follow-up|1
5310541|NCT00378508|18296303|P2|Overall Study|Withdrawal by Subject|3
5310542|NCT00378508|18296304|P1|Overall Study|Withdrawal by Subject|1
5310543|NCT00378378|18296323|P3|Overall Study|Non-compliance with protocol|1
5310544|NCT00378378|18296324|P2|Overall Study|Non-compliance with protocol|0
5310545|NCT00378378|18296325|P1|Overall Study|Non-compliance with protocol|0
5310546|NCT00378378|18296323|P3|Overall Study|Treatment Failure|1
5310547|NCT00378378|18296324|P2|Overall Study|Treatment Failure|0
5310548|NCT00378378|18296325|P1|Overall Study|Treatment Failure|0
5310549|NCT00378378|18296323|P3|Overall Study|Withdrawal by Subject|0
5310550|NCT00378378|18296324|P2|Overall Study|Withdrawal by Subject|1
5310551|NCT00378378|18296325|P1|Overall Study|Withdrawal by Subject|0
5310552|NCT00378209|18296371|P1|Overall Study|Treatment delay|1
5310553|NCT00378209|18296371|P1|Overall Study|Death|1
5310554|NCT00378209|18296371|P1|Overall Study|Physician Decision|3
5310555|NCT00378209|18296371|P1|Overall Study|Initiation of non-protocol therapy|3
5310556|NCT00378209|18296371|P1|Overall Study|Adverse Event|3
5310557|NCT00378209|18296371|P1|Overall Study|Progressive disease|11
5310558|NCT00378105|18296381|P2|Overall Study|necessity to increase lenalidomide dose|1
5310559|NCT00378105|18296382|P1|Overall Study|necessity to increase lenalidomide dose|0
5310560|NCT00378105|18296381|P2|Overall Study|Going non-protocol therapy|1
5310561|NCT00378105|18296382|P1|Overall Study|Going non-protocol therapy|0
5310562|NCT00378105|18296381|P2|Overall Study|Physician Decision|2
5310563|NCT00378105|18296382|P1|Overall Study|Physician Decision|0
5310564|NCT00378105|18296381|P2|Overall Study|remain on study|11
5310565|NCT00378105|18296382|P1|Overall Study|remain on study|3
5310566|NCT00378105|18296381|P2|Overall Study|Progressive disease|3
5310567|NCT00378105|18296382|P1|Overall Study|Progressive disease|3
5310568|NCT00378105|18296381|P2|Overall Study|Going to transplant|8
5310569|NCT00378105|18296382|P1|Overall Study|Going to transplant|7
5310570|NCT00378105|18296381|P2|Overall Study|Death|0
5310571|NCT00378105|18296382|P1|Overall Study|Death|1
5310572|NCT00378105|18296381|P2|Overall Study|Withdrawal by Subject|3
5310573|NCT00378105|18296382|P1|Overall Study|Withdrawal by Subject|3
5310574|NCT00378105|18296381|P2|Overall Study|Adverse Event|1
5310575|NCT00378105|18296382|P1|Overall Study|Adverse Event|3
5310576|NCT00378079|18296394|P3|Overall Study|Lost to Follow-up|0
5310577|NCT00378079|18296395|P2|Overall Study|Lost to Follow-up|1
5310578|NCT00378079|18296396|P1|Overall Study|Lost to Follow-up|6
5310579|NCT00378014|18296418|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
5310580|NCT00378014|18296419|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
5310581|NCT00378014|18296418|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
5310582|NCT00378014|18296419|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
5310583|NCT00378014|18296418|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
5310584|NCT00378014|18296419|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
5310585|NCT00378014|18296418|P2|Extension (Month 12 to Month 59)|Administrative problems|0
5310586|NCT00378014|18296419|P1|Extension (Month 12 to Month 59)|Administrative problems|1
5310587|NCT00378014|18296418|P2|Extension (Month 12 to Month 59)|Death|2
5310588|NCT00378014|18296419|P1|Extension (Month 12 to Month 59)|Death|1
5310589|NCT00378014|18296418|P2|Extension (Month 12 to Month 59)|Adverse Event|7
5310590|NCT00378014|18296419|P1|Extension (Month 12 to Month 59)|Adverse Event|8
5310591|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
5310592|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
5310593|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Protocol deviation|1
5310594|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Protocol deviation|0
5310595|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
5310596|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
5310597|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
5310598|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
5310599|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Administrative Problems|2
5310600|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Administrative Problems|2
5310601|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Death|3
5310602|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Death|5
5310603|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Graft loss|2
5310604|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Graft loss|1
5310605|NCT00378014|18296418|P2|Core (Randomization to Month 11)|Adverse Event|0
5310606|NCT00378014|18296419|P1|Core (Randomization to Month 11)|Adverse Event|1
5310607|NCT00377962|18296445|P2|Extension Study: 12-24 Months|Unspecified reason|3
5310608|NCT00377962|18296446|P1|Extension Study: 12-24 Months|Unspecified reason|0
5310609|NCT00377962|18296445|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
5310610|NCT00377962|18296446|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
5310611|NCT00377962|18296445|P2|Extension Study: 12-24 Months|Adverse Event|0
5310612|NCT00377962|18296446|P1|Extension Study: 12-24 Months|Adverse Event|8
5310613|NCT00377962|18296445|P2|Extension Study: 12-24 Months|Death|1
5310614|NCT00377962|18296446|P1|Extension Study: 12-24 Months|Death|1
5310615|NCT00377962|18296445|P2|Core Study: 0-12 Months|Unspecified reasons|4
5310616|NCT00377962|18296446|P1|Core Study: 0-12 Months|Unspecified reasons|1
5310617|NCT00377962|18296445|P2|Core Study: 0-12 Months|Administrative Reason|1
5310618|NCT00377962|18296446|P1|Core Study: 0-12 Months|Administrative Reason|1
5310619|NCT00377962|18296445|P2|Core Study: 0-12 Months|Withdrew Consent|2
5310620|NCT00377962|18296446|P1|Core Study: 0-12 Months|Withdrew Consent|5
5310621|NCT00377962|18296445|P2|Core Study: 0-12 Months|Death|0
5310622|NCT00377962|18296446|P1|Core Study: 0-12 Months|Death|3
5310623|NCT00377962|18296445|P2|Core Study: 0-12 Months|Adverse Event|2
5310624|NCT00377962|18296446|P1|Core Study: 0-12 Months|Adverse Event|18
5310625|NCT00377858|18296482|P2|Overall Study|Death|3
5310626|NCT00377858|18296483|P1|Overall Study|Death|0
5310627|NCT00377858|18296482|P2|Overall Study|Sponsor Decision|2
5310628|NCT00377858|18296483|P1|Overall Study|Sponsor Decision|1
5310629|NCT00377858|18296482|P2|Overall Study|Entry Criteria Not Met|0
5310630|NCT00377858|18296483|P1|Overall Study|Entry Criteria Not Met|2
5310631|NCT00377858|18296482|P2|Overall Study|Adverse Event|1
5310632|NCT00377858|18296483|P1|Overall Study|Adverse Event|2
5310633|NCT00377858|18296482|P2|Overall Study|Protocol Violation|4
5310634|NCT00377858|18296483|P1|Overall Study|Protocol Violation|3
5310635|NCT00377858|18296482|P2|Overall Study|Physician Decision|5
5310636|NCT00377858|18296483|P1|Overall Study|Physician Decision|5
5310637|NCT00377858|18296482|P2|Overall Study|Lost to Follow-up|1
5310638|NCT00377858|18296483|P1|Overall Study|Lost to Follow-up|6
5310639|NCT00377858|18296482|P2|Overall Study|Withdrawal by Subject|11
5310640|NCT00377858|18296483|P1|Overall Study|Withdrawal by Subject|12
5310641|NCT00377819|18296536|P2|Overall Study|Protocol Violation|1
5310642|NCT00377819|18296537|P1|Overall Study|Protocol Violation|1
5310643|NCT00377819|18296536|P2|Overall Study|Lost to Follow-up|1
5310644|NCT00377819|18296537|P1|Overall Study|Lost to Follow-up|0
5310645|NCT00377819|18296536|P2|Overall Study|Death|1
5310646|NCT00377819|18296537|P1|Overall Study|Death|0
5310647|NCT00377819|18296536|P2|Overall Study|Withdrawal by Subject|4
5310648|NCT00377819|18296537|P1|Overall Study|Withdrawal by Subject|10
5310649|NCT00377819|18296536|P2|Overall Study|Adverse Event|3
5310650|NCT00377819|18296537|P1|Overall Study|Adverse Event|2
5310651|NCT00377676|18296566|P2|Overall Study|Other|58
5310652|NCT00377676|18296567|P1|Overall Study|Other|118
5310653|NCT00377676|18296566|P2|Overall Study|Lost to Follow-up|56
5310654|NCT00377676|18296567|P1|Overall Study|Lost to Follow-up|120
5310655|NCT00377676|18296566|P2|Overall Study|Withdrawal by Subject|72
5310656|NCT00377676|18296567|P1|Overall Study|Withdrawal by Subject|187
5310657|NCT00377676|18296566|P2|Overall Study|Death|2
5310658|NCT00377676|18296567|P1|Overall Study|Death|5
5310659|NCT00377676|18296566|P2|Overall Study|Protocol Violation|27
5310660|NCT00377676|18296567|P1|Overall Study|Protocol Violation|33
5310661|NCT00377676|18296566|P2|Overall Study|Adverse Event|107
5310662|NCT00377676|18296567|P1|Overall Study|Adverse Event|498
5310663|NCT00377637|18296583|P4|Maintenance Phase|Death|1
5310664|NCT00377637|18296584|P3|Maintenance Phase|Death|0
5310665|NCT00377637|18296585|P2|Maintenance Phase|Death|0
5310666|NCT00377637|18296586|P1|Maintenance Phase|Death|0
5310667|NCT00377637|18296583|P4|Maintenance Phase|Study medication stopped > 14 days|1
5310668|NCT00377637|18296584|P3|Maintenance Phase|Study medication stopped > 14 days|0
5310669|NCT00377637|18296585|P2|Maintenance Phase|Study medication stopped > 14 days|0
5310670|NCT00377637|18296586|P1|Maintenance Phase|Study medication stopped > 14 days|0
5310671|NCT00377637|18296583|P4|Maintenance Phase|Non-compliance|1
5310672|NCT00377637|18296584|P3|Maintenance Phase|Non-compliance|1
5310673|NCT00377637|18296585|P2|Maintenance Phase|Non-compliance|0
5310674|NCT00377637|18296586|P1|Maintenance Phase|Non-compliance|0
5310675|NCT00377637|18296583|P4|Maintenance Phase|Sponsor decision|3
5310676|NCT00377637|18296584|P3|Maintenance Phase|Sponsor decision|2
5310677|NCT00377637|18296585|P2|Maintenance Phase|Sponsor decision|0
5310678|NCT00377637|18296586|P1|Maintenance Phase|Sponsor decision|0
5310679|NCT00377637|18296583|P4|Maintenance Phase|Withdrawal by Subject|3
5310680|NCT00377637|18296584|P3|Maintenance Phase|Withdrawal by Subject|3
5310681|NCT00377637|18296585|P2|Maintenance Phase|Withdrawal by Subject|0
5310682|NCT00377637|18296586|P1|Maintenance Phase|Withdrawal by Subject|0
5310683|NCT00377637|18296583|P4|Maintenance Phase|Lost to Follow-up|1
5310684|NCT00377637|18296584|P3|Maintenance Phase|Lost to Follow-up|3
5310685|NCT00377637|18296585|P2|Maintenance Phase|Lost to Follow-up|0
5310686|NCT00377637|18296586|P1|Maintenance Phase|Lost to Follow-up|0
5310687|NCT00377637|18296583|P4|Maintenance Phase|Physician Decision|4
5310688|NCT00377637|18296584|P3|Maintenance Phase|Physician Decision|5
5310689|NCT00377637|18296585|P2|Maintenance Phase|Physician Decision|0
5310690|NCT00377637|18296586|P1|Maintenance Phase|Physician Decision|0
5310691|NCT00377637|18296583|P4|Maintenance Phase|Adverse Event|43
5310692|NCT00377637|18296584|P3|Maintenance Phase|Adverse Event|29
5310694|NCT00377637|18296586|P1|Maintenance Phase|Adverse Event|0
5310695|NCT00377637|18296583|P4|Induction Phase|Reason for withdrawal is not noted|0
5310696|NCT00377637|18296584|P3|Induction Phase|Reason for withdrawal is not noted|0
5310697|NCT00377637|18296585|P2|Induction Phase|Reason for withdrawal is not noted|0
5310698|NCT00377637|18296586|P1|Induction Phase|Reason for withdrawal is not noted|2
5310699|NCT00377637|18296583|P4|Induction Phase|Non-Compliance|0
5310700|NCT00377637|18296584|P3|Induction Phase|Non-Compliance|0
5310701|NCT00377637|18296585|P2|Induction Phase|Non-Compliance|0
5310702|NCT00377637|18296586|P1|Induction Phase|Non-Compliance|1
5310703|NCT00377637|18296583|P4|Induction Phase|Sponsor decision|0
5310704|NCT00377637|18296584|P3|Induction Phase|Sponsor decision|0
5310705|NCT00377637|18296585|P2|Induction Phase|Sponsor decision|2
5310706|NCT00377637|18296586|P1|Induction Phase|Sponsor decision|1
5310707|NCT00377637|18296583|P4|Induction Phase|Physician Decision|0
5310708|NCT00377637|18296584|P3|Induction Phase|Physician Decision|0
5310709|NCT00377637|18296585|P2|Induction Phase|Physician Decision|1
5310710|NCT00377637|18296586|P1|Induction Phase|Physician Decision|3
5310711|NCT00377637|18296583|P4|Induction Phase|Withdrawal by Subject|0
5310712|NCT00377637|18296584|P3|Induction Phase|Withdrawal by Subject|0
5310713|NCT00377637|18296585|P2|Induction Phase|Withdrawal by Subject|6
5310714|NCT00377637|18296586|P1|Induction Phase|Withdrawal by Subject|5
5310715|NCT00377637|18296583|P4|Induction Phase|Death|0
5310716|NCT00377637|18296584|P3|Induction Phase|Death|0
5310717|NCT00377637|18296585|P2|Induction Phase|Death|3
5310718|NCT00377637|18296586|P1|Induction Phase|Death|1
5310719|NCT00377637|18296583|P4|Induction Phase|Lost to Follow-up|0
5310720|NCT00377637|18296584|P3|Induction Phase|Lost to Follow-up|0
5310721|NCT00377637|18296585|P2|Induction Phase|Lost to Follow-up|1
5310722|NCT00377637|18296586|P1|Induction Phase|Lost to Follow-up|2
5310723|NCT00377637|18296583|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
5310724|NCT00377637|18296584|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
5310725|NCT00377637|18296585|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
5310726|NCT00377637|18296586|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
5310727|NCT00377637|18296583|P4|Induction Phase|Deterioration/serum creatinine|0
5310728|NCT00377637|18296584|P3|Induction Phase|Deterioration/serum creatinine|0
5310729|NCT00377637|18296585|P2|Induction Phase|Deterioration/serum creatinine|0
5310730|NCT00377637|18296586|P1|Induction Phase|Deterioration/serum creatinine|2
5310731|NCT00377637|18296583|P4|Induction Phase|Adverse Event|0
5310732|NCT00377637|18296584|P3|Induction Phase|Adverse Event|0
5310733|NCT00377637|18296585|P2|Induction Phase|Adverse Event|21
5310734|NCT00377637|18296586|P1|Induction Phase|Adverse Event|12
5310735|NCT00377611|18296622|P2|Overall Study|Other|3
5310736|NCT00377611|18296623|P1|Overall Study|Other|0
5310737|NCT00377611|18296622|P2|Overall Study|Lost to Follow-up|16
5310738|NCT00377611|18296623|P1|Overall Study|Lost to Follow-up|18
5310739|NCT00377611|18296622|P2|Overall Study|Withdrawal by Subject|5
5310740|NCT00377611|18296623|P1|Overall Study|Withdrawal by Subject|0
5310741|NCT00377611|18296622|P2|Overall Study|Protocol Violation|0
5310742|NCT00377611|18296623|P1|Overall Study|Protocol Violation|2
5310743|NCT00377611|18296622|P2|Overall Study|Adverse Event|9
5310744|NCT00377611|18296623|P1|Overall Study|Adverse Event|2
5310745|NCT00377520|18296725|P1|Overall Study|Ineligible (Prior radiation)|1
5310746|NCT00377455|18296730|P1|Overall Study|Withdrawal by Subject|1
5310747|NCT00377429|18296738|P1|Overall Study|Patient non-compliance|1
5310748|NCT00377429|18296738|P1|Overall Study|Physician Decision|1
5310749|NCT00377429|18296738|P1|Overall Study|Adverse Event|8
5310750|NCT00377429|18296738|P1|Overall Study|Withdrawal by Subject|5
5310751|NCT00377403|18296749|P2|Overall Study|Unable to contact for telephone intervie|7
5310752|NCT00377403|18296750|P1|Overall Study|Unable to contact for telephone intervie|4
5310753|NCT00377364|18296758|P2|Overall Study|Withdrawal by Subject|0
5310754|NCT00377364|18296759|P1|Overall Study|Withdrawal by Subject|1
5310755|NCT00377364|18296758|P2|Overall Study|Lost to Follow-up|0
5310756|NCT00377364|18296759|P1|Overall Study|Lost to Follow-up|1
5310757|NCT00377312|18296785|P2|Overall Study|Adverse Event|1
5310758|NCT00377312|18296786|P1|Overall Study|Adverse Event|1
5310759|NCT00377299|18296818|P2|Overall Study|Withdrawal by Subject|4
5310760|NCT00377299|18296819|P1|Overall Study|Withdrawal by Subject|5
5310761|NCT00377299|18296818|P2|Overall Study|Adverse Event|1
5310762|NCT00377299|18296819|P1|Overall Study|Adverse Event|0
5310763|NCT00377299|18296818|P2|Overall Study|Lost to Follow-up|19
5310764|NCT00377299|18296819|P1|Overall Study|Lost to Follow-up|14
5310765|NCT00377260|18296835|P2|Overall Study|Withdrawal by Subject|4
5310766|NCT00377260|18296836|P1|Overall Study|Withdrawal by Subject|2
5310767|NCT00377260|18296835|P2|Overall Study|Lost to Follow-up|1
5310768|NCT00377260|18296836|P1|Overall Study|Lost to Follow-up|0
5310769|NCT00377234|18296890|P2|Overall Study|Not assigned|2
5310770|NCT00377234|18296891|P1|Overall Study|Not assigned|3
5310771|NCT00377234|18296890|P2|Overall Study|Administrative|1
5310772|NCT00377234|18296891|P1|Overall Study|Administrative|2
5310773|NCT00377234|18296890|P2|Overall Study|Lost to Follow-up|2
5310774|NCT00377234|18296891|P1|Overall Study|Lost to Follow-up|4
5310775|NCT00377234|18296890|P2|Overall Study|Withdrawal by Subject|9
5310776|NCT00377234|18296891|P1|Overall Study|Withdrawal by Subject|11
5310777|NCT00377234|18296890|P2|Overall Study|Adverse Event|17
5310778|NCT00377234|18296891|P1|Overall Study|Adverse Event|14
5310779|NCT00377156|18296909|P2|Overall Study|Other|2
5310780|NCT00377156|18296910|P1|Overall Study|Other|5
5310781|NCT00377156|18296909|P2|Overall Study|Disability or language problem|1
5310782|NCT00377156|18296910|P1|Overall Study|Disability or language problem|0
5310783|NCT00377156|18296909|P2|Overall Study|Ineligible|1
5310784|NCT00377156|18296910|P1|Overall Study|Ineligible|0
5310785|NCT00377156|18296909|P2|Overall Study|Refused testing|1
5310786|NCT00377156|18296910|P1|Overall Study|Refused testing|0
5310787|NCT00377156|18296909|P2|Overall Study|Cancellation|0
5310788|NCT00377156|18296910|P1|Overall Study|Cancellation|1
5310789|NCT00377156|18296909|P2|Overall Study|Had follow-up <90 d|6
5310790|NCT00377156|18296910|P1|Overall Study|Had follow-up <90 d|3
5310791|NCT00377156|18296909|P2|Overall Study|Withdrawal by Subject|24
5310792|NCT00377156|18296910|P1|Overall Study|Withdrawal by Subject|16
5310793|NCT00377156|18296909|P2|Overall Study|Death|19
5310794|NCT00377156|18296910|P1|Overall Study|Death|23
5310795|NCT00376961|18296924|P2|Maintenance|Ineligible|3
5310796|NCT00376961|18296925|P1|Maintenance|Ineligible|0
5310797|NCT00376961|18296924|P2|Maintenance|Progression/relapse|18
5310798|NCT00376961|18296925|P1|Maintenance|Progression/relapse|0
5310799|NCT00376961|18296924|P2|Maintenance|Refusal Unrelated to Adverse Event|1
5310800|NCT00376961|18296925|P1|Maintenance|Refusal Unrelated to Adverse Event|0
5310801|NCT00376961|18296924|P2|Maintenance|Adverse Event|1
5310802|NCT00376961|18296925|P1|Maintenance|Adverse Event|0
5310803|NCT00376961|18296924|P2|Initial Registration|Ineligible|0
5310804|NCT00376961|18296925|P1|Initial Registration|Ineligible|3
5310805|NCT00376961|18296924|P2|Initial Registration|Progression/relapse|0
5310806|NCT00376961|18296925|P1|Initial Registration|Progression/relapse|1
5310807|NCT00376961|18296924|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
5310808|NCT00376961|18296925|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
5310809|NCT00376961|18296924|P2|Initial Registration|Adverse Event|0
5310810|NCT00376961|18296925|P1|Initial Registration|Adverse Event|1
5310811|NCT00376688|18296991|P1|Overall Study|Death|1
5310812|NCT00376688|18296991|P1|Overall Study|Adverse Event|3
5310813|NCT00376675|18296997|P2|Overall Study|Other Reason|7
5310814|NCT00376675|18296998|P1|Overall Study|Other Reason|1
5310815|NCT00376675|18296997|P2|Overall Study|Adverse Event|5
5310816|NCT00376675|18296998|P1|Overall Study|Adverse Event|10
5310817|NCT00376675|18296997|P2|Overall Study|Withdrawal by Subject|2
5310818|NCT00376675|18296998|P1|Overall Study|Withdrawal by Subject|9
5310819|NCT00376532|18297047|P2|Overall Study|Lack sufficient blood sample|6
5310820|NCT00376532|18297048|P1|Overall Study|Lack sufficient blood sample|6
5310821|NCT00376506|18297058|P2|Overall Study|Death|2
5310822|NCT00376506|18297059|P1|Overall Study|Death|0
5310823|NCT00376259|18297090|P2|Overall Study|Patient request|0
5310824|NCT00376259|18297091|P1|Overall Study|Patient request|1
5310825|NCT00376259|18297090|P2|Overall Study|Sponsor request - study termination|21
5310826|NCT00376259|18297091|P1|Overall Study|Sponsor request - study termination|21
5310827|NCT00376246|18297103|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
5310828|NCT00376246|18297104|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
5310829|NCT00376246|18297103|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
5310830|NCT00376246|18297104|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
5310831|NCT00376246|18297103|P2|First Intervention (2 Weeks)|Adverse Event|0
5310832|NCT00376246|18297104|P1|First Intervention (2 Weeks)|Adverse Event|2
5310833|NCT00376220|18297114|P2|Overall Study|Withdrawal by Subject|2
5310834|NCT00376220|18297115|P1|Overall Study|Withdrawal by Subject|3
5310835|NCT00376220|18297114|P2|Overall Study|Lost to Follow-up|10
5310836|NCT00376220|18297115|P1|Overall Study|Lost to Follow-up|7
5310837|NCT00376168|18297123|P2|Overall Study|Pregnancy|0
5310838|NCT00376168|18297124|P1|Overall Study|Pregnancy|1
5310839|NCT00376168|18297123|P2|Overall Study|Adverse Event|1
5310840|NCT00376168|18297124|P1|Overall Study|Adverse Event|1
5310841|NCT00375934|18297165|P2|Overall Study|Physician Decision|1
5310842|NCT00375934|18297166|P1|Overall Study|Physician Decision|0
5310843|NCT00375934|18297165|P2|Overall Study|Lack of Efficacy|2
5310844|NCT00375934|18297166|P1|Overall Study|Lack of Efficacy|0
5310845|NCT00375934|18297165|P2|Overall Study|Withdrawal by Subject|2
5310846|NCT00375934|18297166|P1|Overall Study|Withdrawal by Subject|2
5310847|NCT00375934|18297165|P2|Overall Study|Adverse Event|1
5310848|NCT00375934|18297166|P1|Overall Study|Adverse Event|1
5310849|NCT00375752|18297224|P2|Overall Study|Administrative Problems|1
5310850|NCT00375752|18297225|P1|Overall Study|Administrative Problems|0
5310851|NCT00375752|18297224|P2|Overall Study|Protocol Violation|2
5310852|NCT00375752|18297225|P1|Overall Study|Protocol Violation|0
5310853|NCT00375752|18297224|P2|Overall Study|Abnormal Laboratory Value(s)|1
5310854|NCT00375752|18297225|P1|Overall Study|Abnormal Laboratory Value(s)|1
5310855|NCT00375752|18297224|P2|Overall Study|Withdrawal by Subject|1
5310856|NCT00375752|18297225|P1|Overall Study|Withdrawal by Subject|6
5310857|NCT00375752|18297224|P2|Overall Study|Adverse Event|6
5310858|NCT00375752|18297225|P1|Overall Study|Adverse Event|1
5310859|NCT00375752|18297224|P2|Overall Study|Lack of Efficacy|4
5310860|NCT00375752|18297225|P1|Overall Study|Lack of Efficacy|4
5310861|NCT00375674|18297256|P2|Overall Study|Enrolled but not treated|2
5310862|NCT00375674|18297257|P1|Overall Study|Enrolled but not treated|3
5310863|NCT00375674|18297256|P2|Overall Study|Lost to Follow-up|15
5310864|NCT00375674|18297257|P1|Overall Study|Lost to Follow-up|17
5310865|NCT00375674|18297256|P2|Overall Study|Participants refused further follow-up|30
5310866|NCT00375674|18297257|P1|Overall Study|Participants refused further follow-up|31
5310867|NCT00375674|18297256|P2|Overall Study|Death|76
5310868|NCT00375674|18297257|P1|Overall Study|Death|67
5310869|NCT00375674|18297256|P2|Overall Study|Other|18
5310870|NCT00375674|18297257|P1|Overall Study|Other|26
5310871|NCT00375609|18297286|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
5310872|NCT00375609|18297287|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
5310873|NCT00375609|18297288|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
5310874|NCT00375609|18297286|P3|Overall Study|Withdrawal by Subject|0
5310875|NCT00375609|18297287|P2|Overall Study|Withdrawal by Subject|4
5310876|NCT00375609|18297288|P1|Overall Study|Withdrawal by Subject|1
5310877|NCT00375609|18297286|P3|Overall Study|Physician Decision|1
5310878|NCT00375609|18297287|P2|Overall Study|Physician Decision|0
5310879|NCT00375609|18297288|P1|Overall Study|Physician Decision|0
5310880|NCT00375609|18297286|P3|Overall Study|Lost to Follow-up|0
5310881|NCT00375609|18297287|P2|Overall Study|Lost to Follow-up|0
5310882|NCT00375609|18297288|P1|Overall Study|Lost to Follow-up|1
5310883|NCT00375609|18297286|P3|Overall Study|Adverse Event|0
5310884|NCT00375609|18297287|P2|Overall Study|Adverse Event|3
5310885|NCT00375609|18297288|P1|Overall Study|Adverse Event|0
5310886|NCT00375609|18297286|P3|Overall Study|Did not receive treatment|0
5310887|NCT00375609|18297287|P2|Overall Study|Did not receive treatment|0
5310888|NCT00375609|18297288|P1|Overall Study|Did not receive treatment|1
5310889|NCT00375518|18297304|P2|Overall Study|Death|1
5310890|NCT00375518|18297305|P1|Overall Study|Death|0
5310891|NCT00375518|18297304|P2|Overall Study|Patient Not Treated|6
5310892|NCT00375518|18297305|P1|Overall Study|Patient Not Treated|6
5310893|NCT00375518|18297304|P2|Overall Study|Withdrawal by Subject|10
5310894|NCT00375518|18297305|P1|Overall Study|Withdrawal by Subject|2
5310895|NCT00375505|18297313|P2|Overall Study|Adverse Event|2
5310896|NCT00375505|18297314|P1|Overall Study|Adverse Event|1
5310897|NCT00375492|18297358|P2|Overall Study|Withdrawal by Subject|6
5310898|NCT00375492|18297359|P1|Overall Study|Withdrawal by Subject|6
5310899|NCT00375492|18297358|P2|Overall Study|Sponsor Decision|1
5310900|NCT00375492|18297359|P1|Overall Study|Sponsor Decision|0
5310901|NCT00375492|18297358|P2|Overall Study|Protocol Violation|3
5310902|NCT00375492|18297359|P1|Overall Study|Protocol Violation|6
5310903|NCT00375492|18297358|P2|Overall Study|Physician Decision|4
5310904|NCT00375492|18297359|P1|Overall Study|Physician Decision|0
5310905|NCT00375492|18297358|P2|Overall Study|Lost to Follow-up|5
5310906|NCT00375492|18297359|P1|Overall Study|Lost to Follow-up|10
5310907|NCT00375492|18297358|P2|Overall Study|Loss of Glucose Control|1
5310908|NCT00375492|18297359|P1|Overall Study|Loss of Glucose Control|0
5310909|NCT00375492|18297358|P2|Overall Study|Entry Criteria Not Met|1
5310910|NCT00375492|18297359|P1|Overall Study|Entry Criteria Not Met|0
5310911|NCT00375492|18297358|P2|Overall Study|Adverse Event|5
5310912|NCT00375492|18297359|P1|Overall Study|Adverse Event|4
5310913|NCT00375427|18297389|P2|Overall Study|Death|10
5310914|NCT00375427|18297390|P1|Overall Study|Death|11
5310915|NCT00375427|18297389|P2|Overall Study|Administrative reasons|1
5310916|NCT00375427|18297390|P1|Overall Study|Administrative reasons|0
5310917|NCT00375427|18297389|P2|Overall Study|Lost to Follow-up|1
5310918|NCT00375427|18297390|P1|Overall Study|Lost to Follow-up|1
5310919|NCT00375427|18297389|P2|Overall Study|Withdrawal by Subject|13
5310920|NCT00375427|18297390|P1|Overall Study|Withdrawal by Subject|9
5310921|NCT00375427|18297389|P2|Overall Study|Protocol Violation|8
5310922|NCT00375427|18297390|P1|Overall Study|Protocol Violation|10
5310923|NCT00375427|18297389|P2|Overall Study|Patient no longer requires study drug|7
5310924|NCT00375427|18297390|P1|Overall Study|Patient no longer requires study drug|3
5310925|NCT00375427|18297389|P2|Overall Study|Unsatisfactory therapeutic effect|4
5310926|NCT00375427|18297390|P1|Overall Study|Unsatisfactory therapeutic effect|4
5310927|NCT00375427|18297389|P2|Overall Study|Abnormal laboratory value(s)|2
5310928|NCT00375427|18297390|P1|Overall Study|Abnormal laboratory value(s)|1
5310929|NCT00375427|18297389|P2|Overall Study|Abnormal test procedure result(s)|1
5310930|NCT00375427|18297390|P1|Overall Study|Abnormal test procedure result(s)|0
5310931|NCT00375427|18297389|P2|Overall Study|Adverse Event|27
5310932|NCT00375427|18297390|P1|Overall Study|Adverse Event|21
5310933|NCT00375219|18297415|P3|Overall Study|Withdrawal by Subject|0
5310934|NCT00375219|18297416|P2|Overall Study|Withdrawal by Subject|0
5310935|NCT00375219|18297417|P1|Overall Study|Withdrawal by Subject|1
5310936|NCT00375219|18297415|P3|Overall Study|Cord blood transplantation|0
5310937|NCT00375219|18297416|P2|Overall Study|Cord blood transplantation|0
5310938|NCT00375219|18297417|P1|Overall Study|Cord blood transplantation|1
5310939|NCT00375219|18297415|P3|Overall Study|Allograft|0
5310940|NCT00375219|18297416|P2|Overall Study|Allograft|0
5310941|NCT00375219|18297417|P1|Overall Study|Allograft|2
5310942|NCT00375219|18297415|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
5310943|NCT00375219|18297416|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
5310944|NCT00375219|18297417|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
5310945|NCT00375219|18297415|P3|Overall Study|Hematologic resistance|0
5310946|NCT00375219|18297416|P2|Overall Study|Hematologic resistance|0
5310947|NCT00375219|18297417|P1|Overall Study|Hematologic resistance|1
5310948|NCT00375219|18297415|P3|Overall Study|Death|7
5310949|NCT00375219|18297416|P2|Overall Study|Death|3
5310950|NCT00375219|18297417|P1|Overall Study|Death|4
5310951|NCT00375219|18297415|P3|Overall Study|Disease progression|12
5310952|NCT00375219|18297416|P2|Overall Study|Disease progression|9
5310953|NCT00375219|18297417|P1|Overall Study|Disease progression|18
5310954|NCT00375219|18297415|P3|Overall Study|Lost to Follow-up|0
5310955|NCT00375219|18297416|P2|Overall Study|Lost to Follow-up|1
5310956|NCT00375219|18297417|P1|Overall Study|Lost to Follow-up|1
5310957|NCT00375219|18297415|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
5310958|NCT00375219|18297416|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
5310959|NCT00375219|18297417|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
5310960|NCT00375219|18297415|P3|Overall Study|Protocol Violation|1
5310961|NCT00375219|18297416|P2|Overall Study|Protocol Violation|0
5310962|NCT00375219|18297417|P1|Overall Study|Protocol Violation|1
5310963|NCT00375219|18297415|P3|Overall Study|Adverse Event|1
5310964|NCT00375219|18297416|P2|Overall Study|Adverse Event|2
5310965|NCT00375219|18297417|P1|Overall Study|Adverse Event|8
5310966|NCT00375219|18297415|P3|Overall Study|Failure to achieve a response|0
5310967|NCT00375219|18297416|P2|Overall Study|Failure to achieve a response|2
5310968|NCT00375219|18297417|P1|Overall Study|Failure to achieve a response|16
5310969|NCT00374907|18297500|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
5310970|NCT00374907|18297501|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
5310971|NCT00374907|18297500|P2|116-Week Short-term + Long-term Period|Adverse Event|2
5310972|NCT00374907|18297501|P1|116-Week Short-term + Long-term Period|Adverse Event|0
5310973|NCT00374907|18297500|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
5310974|NCT00374907|18297501|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
5310975|NCT00374907|18297500|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
5310976|NCT00374907|18297501|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
5310977|NCT00374907|18297500|P2|12-Week Short-term Period|Subject Withdrew Consent|1
5310978|NCT00374907|18297501|P1|12-Week Short-term Period|Subject Withdrew Consent|3
5310979|NCT00374868|18297513|P1|Overall Study|Other - Not Specified|1
5310980|NCT00374868|18297513|P1|Overall Study|Death|2
5310981|NCT00374868|18297513|P1|Overall Study|Lost to Follow-up|1
5310982|NCT00374868|18297513|P1|Overall Study|Physician Decision|13
5310983|NCT00374868|18297513|P1|Overall Study|Progressive Disease|7
5310984|NCT00374868|18297513|P1|Overall Study|Adverse Event|12
5310985|NCT00374556|18297577|P2|Overall Study|Removed at baseline due to medical cond|1
5310986|NCT00374556|18297578|P1|Overall Study|Removed at baseline due to medical cond|0
5310987|NCT00374556|18297577|P2|Overall Study|Lost to Follow-up|0
5310988|NCT00374556|18297578|P1|Overall Study|Lost to Follow-up|1
5310989|NCT00374452|18297639|P2|Overall Study|Withdrawal by Subject|2
5310990|NCT00374452|18297640|P1|Overall Study|Withdrawal by Subject|0
5310991|NCT00374452|18297639|P2|Overall Study|Left clinic after intervention started|1
5310992|NCT00374452|18297640|P1|Overall Study|Left clinic after intervention started|1
5310993|NCT00374452|18297639|P2|Overall Study|Change in job role before intervention|1
5310994|NCT00374452|18297640|P1|Overall Study|Change in job role before intervention|0
5310995|NCT00374452|18297639|P2|Overall Study|Left clinic before intervention started|1
5310996|NCT00374452|18297640|P1|Overall Study|Left clinic before intervention started|4
5310997|NCT00374322|18297653|P2|Overall Study|Did Not Receive Study Medication|6
5310998|NCT00374322|18297654|P1|Overall Study|Did Not Receive Study Medication|8
5310999|NCT00374322|18297653|P2|Overall Study|Withdrew Consent During Follow-up|5
5311000|NCT00374322|18297654|P1|Overall Study|Withdrew Consent During Follow-up|0
5311001|NCT00374322|18297653|P2|Overall Study|Noncompliance with Study Requirements|1
5311002|NCT00374322|18297654|P1|Overall Study|Noncompliance with Study Requirements|0
5311003|NCT00374322|18297653|P2|Overall Study|Started Another Chemotherapy Regimen|1
5311004|NCT00374322|18297654|P1|Overall Study|Started Another Chemotherapy Regimen|0
5311005|NCT00374322|18297653|P2|Overall Study|Participant Changed Physician|0
5311006|NCT00374322|18297654|P1|Overall Study|Participant Changed Physician|1
5311007|NCT00374322|18297653|P2|Overall Study|Site Closed|2
5311008|NCT00374322|18297654|P1|Overall Study|Site Closed|2
5311009|NCT00374322|18297653|P2|Overall Study|Severe Toxicity|0
5311010|NCT00374322|18297654|P1|Overall Study|Severe Toxicity|1
5311011|NCT00374322|18297653|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
5311012|NCT00374322|18297654|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
5311013|NCT00374322|18297653|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
5311014|NCT00374322|18297654|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
5311015|NCT00374322|18297653|P2|Overall Study|Sponsor Decision|3
5311016|NCT00374322|18297654|P1|Overall Study|Sponsor Decision|2
5311017|NCT00374322|18297653|P2|Overall Study|Par. Consented to Survival FU Only|1
5311018|NCT00374322|18297654|P1|Overall Study|Par. Consented to Survival FU Only|3
5311019|NCT00374322|18297653|P2|Overall Study|Physician Decision|32
5311020|NCT00374322|18297654|P1|Overall Study|Physician Decision|36
5311021|NCT00374322|18297653|P2|Overall Study|Sponsor Terminated Study|990
5311022|NCT00374322|18297654|P1|Overall Study|Sponsor Terminated Study|866
5311023|NCT00374322|18297653|P2|Overall Study|Withdrawal by Subject|167
5311024|NCT00374322|18297654|P1|Overall Study|Withdrawal by Subject|235
5311025|NCT00374322|18297653|P2|Overall Study|Protocol Violation|3
5311026|NCT00374322|18297654|P1|Overall Study|Protocol Violation|8
5311027|NCT00374322|18297653|P2|Overall Study|Lost to Follow-up|90
5311028|NCT00374322|18297654|P1|Overall Study|Lost to Follow-up|92
5311029|NCT00374140|18297745|P1|Overall Study|Protocol Violation|1
5311030|NCT00374140|18297745|P1|Overall Study|Lost to Follow-up|1
5311031|NCT00374127|18297752|P1|Overall Study|Pregnancy|1
5311032|NCT00374127|18297752|P1|Overall Study|Protocol Violation|5
5311033|NCT00374127|18297752|P1|Overall Study|Blood could not be drawn.|2
5311034|NCT00374127|18297752|P1|Overall Study|Did not inhale during smoking procedure.|3
5311035|NCT00373958|18297801|P2|Toddler Dose|Withdrawn after infant series|25
5311036|NCT00373958|18297802|P1|Toddler Dose|Withdrawn after infant series|22
5311037|NCT00373958|18297801|P2|Toddler Dose|Protocol Violation|1
5311038|NCT00373958|18297802|P1|Toddler Dose|Protocol Violation|0
5311039|NCT00373958|18297801|P2|Toddler Dose|Failed to return|2
5311040|NCT00373958|18297802|P1|Toddler Dose|Failed to return|1
5311041|NCT00373958|18297801|P2|Toddler Dose|Withdrawal by Subject|2
5311042|NCT00373958|18297802|P1|Toddler Dose|Withdrawal by Subject|2
5311043|NCT00373958|18297801|P2|Toddler Dose|Lost to Follow-up|8
5311044|NCT00373958|18297802|P1|Toddler Dose|Lost to Follow-up|5
5311045|NCT00373958|18297801|P2|Infant Series|Physician Decision|1
5311046|NCT00373958|18297802|P1|Infant Series|Physician Decision|1
5311047|NCT00373958|18297801|P2|Infant Series|Adverse Event|1
5311048|NCT00373958|18297802|P1|Infant Series|Adverse Event|3
5311049|NCT00373958|18297801|P2|Infant Series|Consent was not received|0
5311050|NCT00373958|18297802|P1|Infant Series|Consent was not received|1
5311051|NCT00373958|18297801|P2|Infant Series|Child relocated|0
5311052|NCT00373958|18297802|P1|Infant Series|Child relocated|1
5311053|NCT00373958|18297801|P2|Infant Series|Lost Kaiser coverage|0
5311054|NCT00373958|18297802|P1|Infant Series|Lost Kaiser coverage|4
5311055|NCT00373958|18297801|P2|Infant Series|Protocol Violation|7
5311056|NCT00373958|18297802|P1|Infant Series|Protocol Violation|3
5311057|NCT00373958|18297801|P2|Infant Series|Lost to Follow-up|5
5311058|NCT00373958|18297802|P1|Infant Series|Lost to Follow-up|6
5311059|NCT00373958|18297801|P2|Infant Series|Failed to return|13
5311060|NCT00373958|18297802|P1|Infant Series|Failed to return|8
5311061|NCT00373958|18297801|P2|Infant Series|Withdrawal by Subject|15
5311062|NCT00373958|18297802|P1|Infant Series|Withdrawal by Subject|13
5311063|NCT00373880|18297850|P1|Overall Study|Protocol Violation|14
5311064|NCT00373880|18297850|P1|Overall Study|Arrested|1
5311065|NCT00373880|18297850|P1|Overall Study|Physician Decision|3
5311066|NCT00373685|18297895|P2|Overall Study|Randomized, not treated|77
5311067|NCT00373685|18297896|P1|Overall Study|Randomized, not treated|51
5311068|NCT00373685|18297895|P2|Overall Study|Final Status Unknown|4
5311069|NCT00373685|18297896|P1|Overall Study|Final Status Unknown|12
5311070|NCT00373685|18297895|P2|Overall Study|Protocol Violation|182
5311071|NCT00373685|18297896|P1|Overall Study|Protocol Violation|191
5311072|NCT00373685|18297895|P2|Overall Study|Other|146
5311073|NCT00373685|18297896|P1|Overall Study|Other|149
5311074|NCT00373685|18297895|P2|Overall Study|No longer willing to participate|352
5311075|NCT00373685|18297896|P1|Overall Study|No longer willing to participate|337
5311076|NCT00373685|18297895|P2|Overall Study|Lost to follow up|103
5311077|NCT00373685|18297896|P1|Overall Study|Lost to follow up|83
5311078|NCT00373685|18297895|P2|Overall Study|Did not meet entrance criteria|184
5311079|NCT00373685|18297896|P1|Overall Study|Did not meet entrance criteria|167
5311080|NCT00373685|18297895|P2|Overall Study|Insufficient clinical response|119
5311081|NCT00373685|18297896|P1|Overall Study|Insufficient clinical response|169
5311082|NCT00373685|18297895|P2|Overall Study|Adverse Event|253
5311083|NCT00373685|18297896|P1|Overall Study|Adverse Event|278
5311084|NCT00373685|18297895|P2|Overall Study|Death|1
5311085|NCT00373685|18297896|P1|Overall Study|Death|2
5311086|NCT00373529|18297930|P1|Overall Study|Consent violation|1
5311087|NCT00373529|18297930|P1|Overall Study|Failed independent confirmation of AML|3
5311088|NCT00373529|18297930|P1|Overall Study|Other|8
5311089|NCT00373529|18297930|P1|Overall Study|Need for treatment prohibited by study|1
5311090|NCT00373529|18297930|P1|Overall Study|Death|16
5311091|NCT00373529|18297930|P1|Overall Study|Disease recurrence|10
5311092|NCT00373529|18297930|P1|Overall Study|Treatment failure|36
5311093|NCT00373529|18297930|P1|Overall Study|Adverse Event|7
5311094|NCT00373529|18297930|P1|Overall Study|Withdrawal by Subject|7
5311095|NCT00373529|18297930|P1|Overall Study|Physician Decision|19
5311096|NCT00373490|18297942|P2|Overall Study|Withdrawal by Subject|1
5311097|NCT00373490|18297943|P1|Overall Study|Withdrawal by Subject|0
5311098|NCT00373490|18297942|P2|Overall Study|Lack of Efficacy|4
5311099|NCT00373490|18297943|P1|Overall Study|Lack of Efficacy|9
5311100|NCT00373490|18297942|P2|Overall Study|Adverse Event|1
5311101|NCT00373490|18297943|P1|Overall Study|Adverse Event|0
5311102|NCT00373425|18297966|P5|Overall Study|Death|0
5311103|NCT00373425|18297967|P4|Overall Study|Death|1
5311104|NCT00373425|18297968|P3|Overall Study|Death|3
5311105|NCT00373425|18297969|P2|Overall Study|Death|0
5311106|NCT00373425|18297970|P1|Overall Study|Death|7
5311107|NCT00373425|18297966|P5|Overall Study|Medical/ethical/noncompliance reason|5
5311108|NCT00373425|18297967|P4|Overall Study|Medical/ethical/noncompliance reason|2
5311109|NCT00373425|18297968|P3|Overall Study|Medical/ethical/noncompliance reason|10
5311110|NCT00373425|18297969|P2|Overall Study|Medical/ethical/noncompliance reason|9
5311111|NCT00373425|18297970|P1|Overall Study|Medical/ethical/noncompliance reason|21
5311112|NCT00373425|18297966|P5|Overall Study|Patient request|7
5311113|NCT00373425|18297967|P4|Overall Study|Patient request|6
5311114|NCT00373425|18297968|P3|Overall Study|Patient request|43
5311115|NCT00373425|18297969|P2|Overall Study|Patient request|18
5311116|NCT00373425|18297970|P1|Overall Study|Patient request|35
5311117|NCT00373425|18297966|P5|Overall Study|Adverse Event|34
5311118|NCT00373425|18297967|P4|Overall Study|Adverse Event|0
5311119|NCT00373425|18297968|P3|Overall Study|Adverse Event|59
5311120|NCT00373425|18297969|P2|Overall Study|Adverse Event|22
5311121|NCT00373425|18297970|P1|Overall Study|Adverse Event|191
5311122|NCT00373425|18297966|P5|Overall Study|Relapse of NSCLC|26
5311123|NCT00373425|18297967|P4|Overall Study|Relapse of NSCLC|2
5311124|NCT00373425|18297968|P3|Overall Study|Relapse of NSCLC|19
5311125|NCT00373425|18297969|P2|Overall Study|Relapse of NSCLC|104
5311126|NCT00373425|18297970|P1|Overall Study|Relapse of NSCLC|116
5311127|NCT00373295|18298065|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
5311128|NCT00373295|18298066|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
5311129|NCT00373295|18298067|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
5311130|NCT00373295|18298068|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
5311131|NCT00373295|18298069|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
5311132|NCT00373295|18298070|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
5311133|NCT00373256|18298091|P2|Overall Study|Study Terminated by Sponsor|13
5311134|NCT00373256|18298092|P1|Overall Study|Study Terminated by Sponsor|41
5311135|NCT00373256|18298091|P2|Overall Study|Protocol Violation|2
5311136|NCT00373256|18298092|P1|Overall Study|Protocol Violation|0
5311137|NCT00373256|18298091|P2|Overall Study|Other|107
5311138|NCT00373256|18298092|P1|Overall Study|Other|73
5311139|NCT00373256|18298091|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
5311140|NCT00373256|18298092|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
5311141|NCT00373256|18298091|P2|Overall Study|Objective Progression or Relapse|104
5311142|NCT00373256|18298092|P1|Overall Study|Objective Progression or Relapse|111
5311143|NCT00373256|18298091|P2|Overall Study|Death|8
5311144|NCT00373256|18298092|P1|Overall Study|Death|9
5311145|NCT00373256|18298091|P2|Overall Study|Lost to Follow-up|1
5311146|NCT00373256|18298092|P1|Overall Study|Lost to Follow-up|2
5311147|NCT00373256|18298091|P2|Overall Study|Adverse Event (AE)|5
5311148|NCT00373256|18298092|P1|Overall Study|Adverse Event (AE)|1
5311149|NCT00373113|18298118|P2|Overall Study|Withdrawal by Subject|15
5311150|NCT00373113|18298119|P1|Overall Study|Withdrawal by Subject|10
5311151|NCT00373113|18298118|P2|Overall Study|Protocol Violation|1
5311152|NCT00373113|18298119|P1|Overall Study|Protocol Violation|5
5311153|NCT00373113|18298118|P2|Overall Study|Other|17
5311154|NCT00373113|18298119|P1|Overall Study|Other|14
5311155|NCT00373113|18298118|P2|Overall Study|Objective progression or relapse|169
5311156|NCT00373113|18298119|P1|Overall Study|Objective progression or relapse|150
5311157|NCT00373113|18298118|P2|Overall Study|Lost to Follow-up|3
5311158|NCT00373113|18298119|P1|Overall Study|Lost to Follow-up|1
5311159|NCT00373113|18298118|P2|Overall Study|Global deterioration of health status|7
5311160|NCT00373113|18298119|P1|Overall Study|Global deterioration of health status|10
5311161|NCT00373113|18298118|P2|Overall Study|Study terminated by sponsor|1
5311162|NCT00373113|18298119|P1|Overall Study|Study terminated by sponsor|9
5311163|NCT00373113|18298118|P2|Overall Study|Adverse Event|24
5311164|NCT00373113|18298119|P1|Overall Study|Adverse Event|38
5311165|NCT00373113|18298118|P2|Overall Study|Death|7
5311166|NCT00373113|18298119|P1|Overall Study|Death|1
5311167|NCT00372996|18298141|P4|Overall Study|Other|7
5311168|NCT00372996|18298142|P3|Overall Study|Other|7
5311169|NCT00372996|18298143|P2|Overall Study|Other|2
5311170|NCT00372996|18298144|P1|Overall Study|Other|10
5311171|NCT00372996|18298141|P4|Overall Study|Study Terminated by Sponsor|0
5311172|NCT00372996|18298142|P3|Overall Study|Study Terminated by Sponsor|4
5311173|NCT00372996|18298143|P2|Overall Study|Study Terminated by Sponsor|0
5311174|NCT00372996|18298144|P1|Overall Study|Study Terminated by Sponsor|4
5311175|NCT00372996|18298141|P4|Overall Study|Withdrawal by Subject|5
5311176|NCT00372996|18298142|P3|Overall Study|Withdrawal by Subject|9
5311177|NCT00372996|18298143|P2|Overall Study|Withdrawal by Subject|6
5311178|NCT00372996|18298144|P1|Overall Study|Withdrawal by Subject|12
5311179|NCT00372996|18298141|P4|Overall Study|Lost to Follow-up|1
5311180|NCT00372996|18298142|P3|Overall Study|Lost to Follow-up|0
5311181|NCT00372996|18298143|P2|Overall Study|Lost to Follow-up|2
5311182|NCT00372996|18298144|P1|Overall Study|Lost to Follow-up|0
5311183|NCT00372996|18298141|P4|Overall Study|Death|7
5311184|NCT00372996|18298142|P3|Overall Study|Death|8
5311185|NCT00372996|18298143|P2|Overall Study|Death|4
5311186|NCT00372996|18298144|P1|Overall Study|Death|11
5311187|NCT00372905|18298229|P4|Follow up Until Relapse or Progression|Other|0
5311188|NCT00372905|18298230|P3|Follow up Until Relapse or Progression|Other|0
5311189|NCT00372905|18298231|P2|Follow up Until Relapse or Progression|Other|1
5311190|NCT00372905|18298232|P1|Follow up Until Relapse or Progression|Other|0
5311191|NCT00372905|18298229|P4|Follow up Until Relapse or Progression|Study closed|3
5311192|NCT00372905|18298230|P3|Follow up Until Relapse or Progression|Study closed|0
5311193|NCT00372905|18298231|P2|Follow up Until Relapse or Progression|Study closed|0
5311194|NCT00372905|18298232|P1|Follow up Until Relapse or Progression|Study closed|0
5311195|NCT00372905|18298229|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
5311196|NCT00372905|18298230|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
5311197|NCT00372905|18298231|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
5311198|NCT00372905|18298232|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
5311199|NCT00372905|18298229|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
5311200|NCT00372905|18298230|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
5311201|NCT00372905|18298231|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
5311202|NCT00372905|18298232|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
5311203|NCT00372905|18298229|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
5311204|NCT00372905|18298230|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
5311205|NCT00372905|18298231|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
5311206|NCT00372905|18298232|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
5311207|NCT00372905|18298229|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
5311208|NCT00372905|18298230|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
5311209|NCT00372905|18298231|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
5311210|NCT00372905|18298232|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
5311211|NCT00372775|18298244|P1|Overall Study|Not Treated|2
5311212|NCT00372775|18298244|P1|Overall Study|Other|1
5311213|NCT00372775|18298244|P1|Overall Study|Withdrawal by Subject|1
5311214|NCT00372775|18298244|P1|Overall Study|Global deterioration of health status|6
5311215|NCT00372775|18298244|P1|Overall Study|Objective progression or relapse|30
5311216|NCT00372775|18298244|P1|Overall Study|Death|15
5311217|NCT00372775|18298244|P1|Overall Study|Adverse Event|8
5311218|NCT00372697|18298266|P2|Overall Study|Protocol Violation|1
5311219|NCT00372697|18298267|P1|Overall Study|Protocol Violation|1
5311220|NCT00372619|18298292|P7|Overall Study|Inevaluable|0
5311221|NCT00372619|18298293|P6|Overall Study|Inevaluable|1
5311222|NCT00372619|18298294|P5|Overall Study|Inevaluable|0
5311223|NCT00372619|18298295|P4|Overall Study|Inevaluable|0
5311224|NCT00372619|18298296|P3|Overall Study|Inevaluable|0
5311225|NCT00372619|18298297|P2|Overall Study|Inevaluable|0
5311226|NCT00372619|18298298|P1|Overall Study|Inevaluable|0
5311227|NCT00372619|18298292|P7|Overall Study|Ineligible|0
5311228|NCT00372619|18298293|P6|Overall Study|Ineligible|2
5311229|NCT00372619|18298294|P5|Overall Study|Ineligible|0
5311230|NCT00372619|18298295|P4|Overall Study|Ineligible|0
5311231|NCT00372619|18298296|P3|Overall Study|Ineligible|0
5311232|NCT00372619|18298297|P2|Overall Study|Ineligible|0
5311233|NCT00372619|18298298|P1|Overall Study|Ineligible|0
5311234|NCT00372593|18298331|P3|Overall Study|Ineligible|1
5311235|NCT00372593|18298332|P2|Overall Study|Ineligible|21
5311236|NCT00372593|18298333|P1|Overall Study|Ineligible|20
5311237|NCT00372593|18298331|P3|Overall Study|Physician Decision|0
5311238|NCT00372593|18298332|P2|Overall Study|Physician Decision|41
5311239|NCT00372593|18298333|P1|Overall Study|Physician Decision|42
5311240|NCT00372593|18298331|P3|Overall Study|Lost to Follow-up|0
5311241|NCT00372593|18298332|P2|Overall Study|Lost to Follow-up|0
5311242|NCT00372593|18298333|P1|Overall Study|Lost to Follow-up|1
5311243|NCT00372593|18298331|P3|Overall Study|Lack of Efficacy|2
5311244|NCT00372593|18298332|P2|Overall Study|Lack of Efficacy|71
5311245|NCT00372593|18298333|P1|Overall Study|Lack of Efficacy|82
5311246|NCT00372593|18298331|P3|Overall Study|Death|1
5311247|NCT00372593|18298332|P2|Overall Study|Death|20
5311248|NCT00372593|18298333|P1|Overall Study|Death|16
5311249|NCT00372593|18298331|P3|Overall Study|Adverse Event|0
5311250|NCT00372593|18298332|P2|Overall Study|Adverse Event|45
5311251|NCT00372593|18298333|P1|Overall Study|Adverse Event|43
5311252|NCT00372567|18298362|P3|Phase 3 Study|study terminated by sponsor|5
5311253|NCT00372567|18298363|P2|Phase 3 Study|study terminated by sponsor|8
5311254|NCT00372567|18298364|P1|Phase 3 Study|study terminated by sponsor|13
5311255|NCT00372567|18298362|P3|Phase 3 Study|Other|1
5311256|NCT00372567|18298363|P2|Phase 3 Study|Other|2
5311257|NCT00372567|18298364|P1|Phase 3 Study|Other|2
5311258|NCT00372567|18298362|P3|Phase 3 Study|Global deterioration of health status|0
5311259|NCT00372567|18298363|P2|Phase 3 Study|Global deterioration of health status|1
5311260|NCT00372567|18298364|P1|Phase 3 Study|Global deterioration of health status|0
5311261|NCT00372567|18298362|P3|Phase 3 Study|Objective progression or relapse|4
5311262|NCT00372567|18298363|P2|Phase 3 Study|Objective progression or relapse|13
5311263|NCT00372567|18298364|P1|Phase 3 Study|Objective progression or relapse|10
5311264|NCT00372567|18298362|P3|Phase 3 Study|Protocol Violation|1
5311265|NCT00372567|18298363|P2|Phase 3 Study|Protocol Violation|0
5311266|NCT00372567|18298364|P1|Phase 3 Study|Protocol Violation|0
5311267|NCT00372567|18298362|P3|Phase 3 Study|Death|0
5311268|NCT00372567|18298363|P2|Phase 3 Study|Death|1
5311269|NCT00372567|18298364|P1|Phase 3 Study|Death|1
5311270|NCT00372567|18298362|P3|Phase 3 Study|Adverse Event|1
5311271|NCT00372567|18298363|P2|Phase 3 Study|Adverse Event|1
5311272|NCT00372567|18298364|P1|Phase 3 Study|Adverse Event|5
5311273|NCT00372528|18298392|P1|Overall Study|Other|1
5311274|NCT00372528|18298392|P1|Overall Study|Study Terminated by Sponsor|18
5311275|NCT00372528|18298392|P1|Overall Study|Adverse Event|1
5311276|NCT00372528|18298392|P1|Overall Study|Lack of Efficacy|1
5311277|NCT00372489|18298397|P1|Overall Study|Sponsor Decision to Terminate Study|41
5311278|NCT00372489|18298397|P1|Overall Study|Renal transplant|6
5311279|NCT00372489|18298397|P1|Overall Study|Patient Relocation|2
5311280|NCT00372489|18298397|P1|Overall Study|Withdrawal by Subject|5
5311281|NCT00372489|18298397|P1|Overall Study|Physician Decision|3
5311282|NCT00372489|18298397|P1|Overall Study|Lost to Follow-up|3
5311283|NCT00372489|18298397|P1|Overall Study|Lack of Efficacy|1
5311284|NCT00372489|18298397|P1|Overall Study|Adverse Event|18
5311285|NCT00372424|18298401|P1|Overall Study|Enrolled, Not Treated|1
5311286|NCT00372424|18298401|P1|Overall Study|Other|7
5311287|NCT00372424|18298401|P1|Overall Study|Objective Progression or Relapse|14
5311288|NCT00372424|18298401|P1|Overall Study|Death|1
5311289|NCT00372424|18298401|P1|Overall Study|Withdrawal by Subject|1
5311290|NCT00372424|18298401|P1|Overall Study|Adverse Event|2
5311291|NCT00372411|18298415|P3|Overall Study|Adverse Event|0
5311292|NCT00372411|18298416|P2|Overall Study|Adverse Event|1
5311293|NCT00372411|18298417|P1|Overall Study|Adverse Event|1
5311294|NCT00372411|18298415|P3|Overall Study|Lost to Follow-up|1
5311295|NCT00372411|18298416|P2|Overall Study|Lost to Follow-up|1
5311296|NCT00372411|18298417|P1|Overall Study|Lost to Follow-up|1
5311297|NCT00372411|18298415|P3|Overall Study|Death|1
5311298|NCT00372411|18298416|P2|Overall Study|Death|2
5311299|NCT00372411|18298417|P1|Overall Study|Death|0
5311300|NCT00372411|18298415|P3|Overall Study|Withdrawal by Subject|1
5311301|NCT00372411|18298416|P2|Overall Study|Withdrawal by Subject|4
5311302|NCT00372411|18298417|P1|Overall Study|Withdrawal by Subject|3
5311303|NCT00372385|18298441|P4|Overall Study|Virologic Stopping Rule|0
5311304|NCT00372385|18298442|P3|Overall Study|Virologic Stopping Rule|0
5311305|NCT00372385|18298443|P2|Overall Study|Virologic Stopping Rule|0
5311306|NCT00372385|18298444|P1|Overall Study|Virologic Stopping Rule|17
5311307|NCT00372385|18298441|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
5311308|NCT00372385|18298442|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
5311309|NCT00372385|18298443|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
5311310|NCT00372385|18298444|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
5311311|NCT00372385|18298441|P4|Overall Study|No Response|0
5311312|NCT00372385|18298442|P3|Overall Study|No Response|0
5311313|NCT00372385|18298443|P2|Overall Study|No Response|1
5311314|NCT00372385|18298444|P1|Overall Study|No Response|1
5311315|NCT00372385|18298441|P4|Overall Study|Refusal of Treatment|0
5311316|NCT00372385|18298442|P3|Overall Study|Refusal of Treatment|0
5311317|NCT00372385|18298443|P2|Overall Study|Refusal of Treatment|6
5311318|NCT00372385|18298444|P1|Overall Study|Refusal of Treatment|3
5311319|NCT00372385|18298441|P4|Overall Study|Withdrawal by Subject|0
5311320|NCT00372385|18298442|P3|Overall Study|Withdrawal by Subject|0
5311321|NCT00372385|18298443|P2|Overall Study|Withdrawal by Subject|1
5311322|NCT00372385|18298444|P1|Overall Study|Withdrawal by Subject|2
5311323|NCT00372385|18298441|P4|Overall Study|Lost to Follow-up|0
5311324|NCT00372385|18298442|P3|Overall Study|Lost to Follow-up|0
5311325|NCT00372385|18298443|P2|Overall Study|Lost to Follow-up|0
5311326|NCT00372385|18298444|P1|Overall Study|Lost to Follow-up|2
5311327|NCT00372385|18298441|P4|Overall Study|Physician Decision|0
5311328|NCT00372385|18298442|P3|Overall Study|Physician Decision|0
5311329|NCT00372385|18298443|P2|Overall Study|Physician Decision|0
5311330|NCT00372385|18298444|P1|Overall Study|Physician Decision|1
5311331|NCT00372385|18298441|P4|Overall Study|Noncompliance|1
5311332|NCT00372385|18298442|P3|Overall Study|Noncompliance|1
5311333|NCT00372385|18298443|P2|Overall Study|Noncompliance|1
5311334|NCT00372385|18298444|P1|Overall Study|Noncompliance|0
5311335|NCT00372385|18298441|P4|Overall Study|Adverse Event|7
5311336|NCT00372385|18298442|P3|Overall Study|Adverse Event|9
5311337|NCT00372385|18298443|P2|Overall Study|Adverse Event|11
5311338|NCT00372385|18298444|P1|Overall Study|Adverse Event|6
5311339|NCT00372255|18298473|P2|Overall Study|Withdrawn for other reasons|1
5311340|NCT00372255|18298474|P1|Overall Study|Withdrawn for other reasons|2
5311341|NCT00372229|18298496|P2|Follow-Up Phase|Lost to Follow-up|10
5311342|NCT00372229|18298497|P1|Follow-Up Phase|Lost to Follow-up|12
5311343|NCT00372229|18298496|P2|Follow-Up Phase|Reason not specified|3
5311344|NCT00372229|18298497|P1|Follow-Up Phase|Reason not specified|2
5311345|NCT00372229|18298496|P2|Follow-Up Phase|Administrative|0
5311346|NCT00372229|18298497|P1|Follow-Up Phase|Administrative|1
5311347|NCT00372229|18298496|P2|Follow-Up Phase|Death|12
5311348|NCT00372229|18298497|P1|Follow-Up Phase|Death|9
5311349|NCT00372229|18298496|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
5311350|NCT00372229|18298497|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
5311351|NCT00372229|18298496|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
5311352|NCT00372229|18298497|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
5311353|NCT00372229|18298496|P2|Follow-Up Phase|Consent withdrawn|19
5311354|NCT00372229|18298497|P1|Follow-Up Phase|Consent withdrawn|13
5311355|NCT00372229|18298496|P2|Follow-Up Phase|Graft loss|7
5311356|NCT00372229|18298497|P1|Follow-Up Phase|Graft loss|8
5311357|NCT00372229|18298496|P2|Study Phase|Lost to Follow-up|3
5311358|NCT00372229|18298497|P1|Study Phase|Lost to Follow-up|3
5311359|NCT00372229|18298496|P2|Study Phase|Reason not specified|2
5311360|NCT00372229|18298497|P1|Study Phase|Reason not specified|3
5311361|NCT00372229|18298496|P2|Study Phase|Death|2
5311362|NCT00372229|18298497|P1|Study Phase|Death|3
5311363|NCT00372229|18298496|P2|Study Phase|Refused treatment/did not cooperate|1
5311364|NCT00372229|18298497|P1|Study Phase|Refused treatment/did not cooperate|3
5311365|NCT00372229|18298496|P2|Study Phase|Consent withdrawn|14
5311366|NCT00372229|18298497|P1|Study Phase|Consent withdrawn|16
5311367|NCT00372229|18298496|P2|Study Phase|Protocol Violation|4
5311368|NCT00372229|18298497|P1|Study Phase|Protocol Violation|3
5311369|NCT00372229|18298496|P2|Study Phase|Graft loss|3
5311370|NCT00372229|18298497|P1|Study Phase|Graft loss|0
5311371|NCT00372190|18298587|P2|Overall Study|Lost to Follow-up|1
5311372|NCT00372190|18298588|P1|Overall Study|Lost to Follow-up|3
5311373|NCT00372112|18298604|P4|Overall Study|Other-protocol violation|0
5311374|NCT00372112|18298605|P3|Overall Study|Other-protocol violation|1
5311375|NCT00372112|18298606|P2|Overall Study|Other-protocol violation|0
5311376|NCT00372112|18298607|P1|Overall Study|Other-protocol violation|0
5311377|NCT00372112|18298604|P4|Overall Study|Hepatitis B|0
5311378|NCT00372112|18298605|P3|Overall Study|Hepatitis B|0
5311379|NCT00372112|18298606|P2|Overall Study|Hepatitis B|0
5311380|NCT00372112|18298607|P1|Overall Study|Hepatitis B|1
5311381|NCT00372112|18298604|P4|Overall Study|PR >240 at Visit 3|1
5311382|NCT00372112|18298605|P3|Overall Study|PR >240 at Visit 3|0
5311383|NCT00372112|18298606|P2|Overall Study|PR >240 at Visit 3|0
5311384|NCT00372112|18298607|P1|Overall Study|PR >240 at Visit 3|0
5311385|NCT00372112|18298604|P4|Overall Study|Exacerbation|1
5311386|NCT00372112|18298605|P3|Overall Study|Exacerbation|0
5311387|NCT00372112|18298606|P2|Overall Study|Exacerbation|0
5311388|NCT00372112|18298607|P1|Overall Study|Exacerbation|0
5311389|NCT00372112|18298604|P4|Overall Study|Withdrawal by Subject|1
5311390|NCT00372112|18298605|P3|Overall Study|Withdrawal by Subject|2
5311391|NCT00372112|18298606|P2|Overall Study|Withdrawal by Subject|0
5311392|NCT00372112|18298607|P1|Overall Study|Withdrawal by Subject|0
5311393|NCT00372112|18298604|P4|Overall Study|Adverse Event|1
5311394|NCT00372112|18298605|P3|Overall Study|Adverse Event|1
5311395|NCT00372112|18298606|P2|Overall Study|Adverse Event|1
5311396|NCT00372112|18298607|P1|Overall Study|Adverse Event|0
5311397|NCT00372060|18298738|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
5311398|NCT00372060|18298739|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
5311399|NCT00372060|18298738|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
5311400|NCT00372060|18298739|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
5311401|NCT00372060|18298738|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
5311402|NCT00372060|18298739|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
5311403|NCT00372060|18298738|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
5311404|NCT00372060|18298739|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
5311405|NCT00372060|18298738|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
5311406|NCT00372060|18298739|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
5311407|NCT00372060|18298738|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
5311408|NCT00372060|18298739|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
5311409|NCT00371865|18298754|P2|Overall Study|Withdrawal by Subject|10
5311410|NCT00371865|18298755|P1|Overall Study|Withdrawal by Subject|12
5311411|NCT00371865|18298754|P2|Overall Study|Protocol Violation|2
5311412|NCT00371865|18298755|P1|Overall Study|Protocol Violation|3
5311413|NCT00371865|18298754|P2|Overall Study|Lack of Efficacy|2
5311414|NCT00371865|18298755|P1|Overall Study|Lack of Efficacy|0
5311415|NCT00371839|18298772|P3|Overall Study|Lost to Follow-up|2
5311416|NCT00371839|18298773|P2|Overall Study|Lost to Follow-up|3
5311417|NCT00371839|18298774|P1|Overall Study|Lost to Follow-up|6
5311418|NCT00371839|18298772|P3|Overall Study|Withdrawal by Subject|0
5311419|NCT00371839|18298773|P2|Overall Study|Withdrawal by Subject|4
5311420|NCT00371839|18298774|P1|Overall Study|Withdrawal by Subject|7
5311421|NCT00371839|18298772|P3|Overall Study|Death|0
5311422|NCT00371839|18298773|P2|Overall Study|Death|0
5311423|NCT00371839|18298774|P1|Overall Study|Death|4
5311424|NCT00371826|18298783|P3|Extension Phase (24 Months)|Administrative problems|2
5311425|NCT00371826|18298784|P2|Extension Phase (24 Months)|Administrative problems|0
5311426|NCT00371826|18298785|P1|Extension Phase (24 Months)|Administrative problems|0
5311427|NCT00371826|18298783|P3|Extension Phase (24 Months)|Subject withdrew consent|0
5311428|NCT00371826|18298784|P2|Extension Phase (24 Months)|Subject withdrew consent|2
5311429|NCT00371826|18298785|P1|Extension Phase (24 Months)|Subject withdrew consent|1
5311430|NCT00371826|18298783|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
5311431|NCT00371826|18298784|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
5311432|NCT00371826|18298785|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
5311433|NCT00371826|18298783|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
5311434|NCT00371826|18298784|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
5311435|NCT00371826|18298785|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
5311436|NCT00371826|18298783|P3|Extension Phase (24 Months)|Adverse Event|0
5311437|NCT00371826|18298784|P2|Extension Phase (24 Months)|Adverse Event|5
5311438|NCT00371826|18298785|P1|Extension Phase (24 Months)|Adverse Event|4
5311439|NCT00371826|18298783|P3|Core Phase (12 Months)|Graft Loss|0
5311440|NCT00371826|18298784|P2|Core Phase (12 Months)|Graft Loss|1
5311441|NCT00371826|18298785|P1|Core Phase (12 Months)|Graft Loss|0
5311442|NCT00371826|18298783|P3|Core Phase (12 Months)|Administrative problems|8
5311443|NCT00371826|18298784|P2|Core Phase (12 Months)|Administrative problems|0
5311444|NCT00371826|18298785|P1|Core Phase (12 Months)|Administrative problems|1
5311445|NCT00371826|18298783|P3|Core Phase (12 Months)|Subject withdrew consent|3
5311446|NCT00371826|18298784|P2|Core Phase (12 Months)|Subject withdrew consent|0
5311447|NCT00371826|18298785|P1|Core Phase (12 Months)|Subject withdrew consent|0
5311448|NCT00371826|18298783|P3|Core Phase (12 Months)|Protocol Violation|1
5311449|NCT00371826|18298784|P2|Core Phase (12 Months)|Protocol Violation|0
5311450|NCT00371826|18298785|P1|Core Phase (12 Months)|Protocol Violation|1
5311451|NCT00371826|18298783|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
5311452|NCT00371826|18298784|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
5311453|NCT00371826|18298785|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
5311454|NCT00371826|18298783|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
5311455|NCT00371826|18298784|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
5311456|NCT00371826|18298785|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
5311457|NCT00371826|18298783|P3|Core Phase (12 Months)|Adverse Event|9
5311458|NCT00371826|18298784|P2|Core Phase (12 Months)|Adverse Event|4
5311459|NCT00371826|18298785|P1|Core Phase (12 Months)|Adverse Event|15
5311460|NCT00371787|18298909|P2|Overall Study|Withdrawal by Subject|1
5311461|NCT00371787|18298910|P1|Overall Study|Withdrawal by Subject|3
5311462|NCT00371761|18298924|P2|Overall Study|Study termination|3
5311463|NCT00371761|18298925|P1|Overall Study|Study termination|4
5311464|NCT00371761|18298924|P2|Overall Study|Investigator Judgment|3
5311465|NCT00371761|18298925|P1|Overall Study|Investigator Judgment|2
5311466|NCT00371761|18298924|P2|Overall Study|Withdrawal by Subject|3
5311467|NCT00371761|18298925|P1|Overall Study|Withdrawal by Subject|1
5311468|NCT00371761|18298924|P2|Overall Study|Adverse Event|1
5311469|NCT00371761|18298925|P1|Overall Study|Adverse Event|1
5311470|NCT00371683|18298933|P2|Follow-Up Period - Randomized Patients|non-specified|12
5311471|NCT00371683|18298934|P1|Follow-Up Period - Randomized Patients|non-specified|6
5311472|NCT00371683|18298933|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
5311473|NCT00371683|18298934|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
5311474|NCT00371683|18298933|P2|Follow-Up Period - Randomized Patients|Death|2
5311475|NCT00371683|18298934|P1|Follow-Up Period - Randomized Patients|Death|0
5311476|NCT00371683|18298933|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
5311477|NCT00371683|18298934|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
5311478|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|non-specified|8
5311479|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|non-specified|9
5311480|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
5311481|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
5311482|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
5311483|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
5311484|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
5311485|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
5311486|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
5311487|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
5311488|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
5311489|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
5311490|NCT00371683|18298933|P2|DB Treatment Period-Randomized Patients|Death|1
5311491|NCT00371683|18298934|P1|DB Treatment Period-Randomized Patients|Death|1
5311492|NCT00371566|18299002|P2|Follow Up Phase|Lost to Follow-up|0
5311493|NCT00371566|18299003|P1|Follow Up Phase|Lost to Follow-up|1
5311494|NCT00371566|18299002|P2|Follow Up Phase|Physician Decision|1
5311495|NCT00371566|18299003|P1|Follow Up Phase|Physician Decision|1
5311496|NCT00371566|18299002|P2|Follow Up Phase|Withdrawal by Subject|1
5311497|NCT00371566|18299003|P1|Follow Up Phase|Withdrawal by Subject|0
5311498|NCT00371566|18299002|P2|Follow Up Phase|Disease progression|0
5311499|NCT00371566|18299003|P1|Follow Up Phase|Disease progression|1
5311500|NCT00371566|18299002|P2|Follow Up Phase|Death|5
5311501|NCT00371566|18299003|P1|Follow Up Phase|Death|0
5311502|NCT00371566|18299002|P2|Chemoradiation Phase|Death|0
5311503|NCT00371566|18299003|P1|Chemoradiation Phase|Death|2
5311504|NCT00371566|18299002|P2|Chemoradiation Phase|Progressive Disease|1
5311505|NCT00371566|18299003|P1|Chemoradiation Phase|Progressive Disease|1
5311506|NCT00371566|18299002|P2|Chemoradiation Phase|Non compliant|1
5311507|NCT00371566|18299003|P1|Chemoradiation Phase|Non compliant|0
5311508|NCT00371566|18299002|P2|Chemoradiation Phase|Withdrawal by Subject|1
5311509|NCT00371566|18299003|P1|Chemoradiation Phase|Withdrawal by Subject|0
5311510|NCT00371566|18299002|P2|Chemoradiation Phase|Physician Decision|0
5311511|NCT00371566|18299003|P1|Chemoradiation Phase|Physician Decision|2
5311512|NCT00371566|18299002|P2|Treatment Phase|Protocol Violation|1
5311513|NCT00371566|18299003|P1|Treatment Phase|Protocol Violation|0
5311514|NCT00371566|18299002|P2|Treatment Phase|Adverse Event|1
5311515|NCT00371566|18299003|P1|Treatment Phase|Adverse Event|0
5311516|NCT00371566|18299002|P2|Treatment Phase|Withdrawal by Subject|1
5311517|NCT00371566|18299003|P1|Treatment Phase|Withdrawal by Subject|0
5311518|NCT00371462|18299088|P2|Overall Study|Other|8
5311519|NCT00371462|18299089|P1|Overall Study|Other|7
5311520|NCT00371462|18299088|P2|Overall Study|Withdrawal by Subject|0
5311521|NCT00371462|18299089|P1|Overall Study|Withdrawal by Subject|1
5311522|NCT00371397|18299113|P12|Session 1|Withdrawal by Subject|0
5311523|NCT00371397|18299114|P11|Session 1|Withdrawal by Subject|0
5311524|NCT00371397|18299115|P10|Session 1|Withdrawal by Subject|0
5311525|NCT00371397|18299116|P9|Session 1|Withdrawal by Subject|0
5311526|NCT00371397|18299117|P8|Session 1|Withdrawal by Subject|1
5311527|NCT00371397|18299118|P7|Session 1|Withdrawal by Subject|0
5311528|NCT00371397|18299119|P6|Session 1|Withdrawal by Subject|0
5311529|NCT00371397|18299120|P5|Session 1|Withdrawal by Subject|0
5311530|NCT00371397|18299121|P4|Session 1|Withdrawal by Subject|0
5311531|NCT00371397|18299122|P3|Session 1|Withdrawal by Subject|0
5311532|NCT00371397|18299123|P2|Session 1|Withdrawal by Subject|0
5311533|NCT00371397|18299124|P1|Session 1|Withdrawal by Subject|1
5311534|NCT00371345|18299132|P2|Overall Study|Participant Withdrew Consent|1
5311535|NCT00371345|18299133|P1|Overall Study|Participant Withdrew Consent|0
5311536|NCT00371345|18299132|P2|Overall Study|Participant Request|1
5311537|NCT00371345|18299133|P1|Overall Study|Participant Request|1
5311538|NCT00371345|18299132|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
5311539|NCT00371345|18299133|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
5311540|NCT00371345|18299132|P2|Overall Study|Study Drug Toxicity|7
5311541|NCT00371345|18299133|P1|Overall Study|Study Drug Toxicity|1
5311542|NCT00371345|18299132|P2|Overall Study|Disease Progression|35
5311543|NCT00371345|18299133|P1|Overall Study|Disease Progression|21
5311544|NCT00371254|18299234|P2|Overall Study|Withdrawal by Subject|1
5311545|NCT00371254|18299235|P1|Overall Study|Withdrawal by Subject|0
5311546|NCT00371254|18299234|P2|Overall Study|Lost to Follow-up|1
5311547|NCT00371254|18299235|P1|Overall Study|Lost to Follow-up|0
5311548|NCT00371254|18299234|P2|Overall Study|Adverse event unrelated to study drug|1
5311549|NCT00371254|18299235|P1|Overall Study|Adverse event unrelated to study drug|0
5311550|NCT00371254|18299234|P2|Overall Study|Investigator Decision|0
5311551|NCT00371254|18299235|P1|Overall Study|Investigator Decision|2
5311552|NCT00371254|18299234|P2|Overall Study|Subject request|0
5311553|NCT00371254|18299235|P1|Overall Study|Subject request|5
5311554|NCT00371254|18299234|P2|Overall Study|Study drug toxicity|5
5311555|NCT00371254|18299235|P1|Overall Study|Study drug toxicity|3
5311556|NCT00371254|18299234|P2|Overall Study|Disease progression|13
5311557|NCT00371254|18299235|P1|Overall Study|Disease progression|13
5311558|NCT00371150|18299318|P2|Overall Study|Lost to Follow-up|2
5311559|NCT00371150|18299319|P1|Overall Study|Lost to Follow-up|3
5311560|NCT00371137|18299354|P3|Overall Study|Protocol Violation|1
5311561|NCT00371137|18299355|P2|Overall Study|Protocol Violation|1
5311562|NCT00371137|18299356|P1|Overall Study|Protocol Violation|2
5311563|NCT00371137|18299354|P3|Overall Study|Physician Decision|1
5311564|NCT00371137|18299355|P2|Overall Study|Physician Decision|1
5311565|NCT00371137|18299356|P1|Overall Study|Physician Decision|1
5311566|NCT00371137|18299354|P3|Overall Study|Sponsor Decision|2
5311567|NCT00371137|18299355|P2|Overall Study|Sponsor Decision|1
5311568|NCT00371137|18299356|P1|Overall Study|Sponsor Decision|2
5311569|NCT00371137|18299354|P3|Overall Study|Lack of Efficacy|13
5311570|NCT00371137|18299355|P2|Overall Study|Lack of Efficacy|12
5311571|NCT00371137|18299356|P1|Overall Study|Lack of Efficacy|30
5311572|NCT00371137|18299354|P3|Overall Study|Lost to Follow-up|5
5311573|NCT00371137|18299355|P2|Overall Study|Lost to Follow-up|3
5311574|NCT00371137|18299356|P1|Overall Study|Lost to Follow-up|6
5311575|NCT00371137|18299354|P3|Overall Study|Withdrawal by Subject|15
5311576|NCT00371137|18299355|P2|Overall Study|Withdrawal by Subject|10
5311577|NCT00371137|18299356|P1|Overall Study|Withdrawal by Subject|11
5311578|NCT00371137|18299354|P3|Overall Study|Adverse Event|42
5311579|NCT00371137|18299355|P2|Overall Study|Adverse Event|35
5311580|NCT00371137|18299356|P1|Overall Study|Adverse Event|20
5311581|NCT00370682|18299399|P3|Overall Study|Lost to Follow-up|1
5311582|NCT00370682|18299400|P2|Overall Study|Lost to Follow-up|1
5311583|NCT00370682|18299401|P1|Overall Study|Lost to Follow-up|0
5311584|NCT00370682|18299399|P3|Overall Study|Moved from area|0
5311585|NCT00370682|18299400|P2|Overall Study|Moved from area|2
5311586|NCT00370682|18299401|P1|Overall Study|Moved from area|0
5311587|NCT00370552|18299443|P3|Overall Study|Planned radiation for palliation|0
5311588|NCT00370552|18299444|P2|Overall Study|Planned radiation for palliation|1
5311589|NCT00370552|18299445|P1|Overall Study|Planned radiation for palliation|0
5311590|NCT00370552|18299443|P3|Overall Study|High risk of allergic reaction|0
5311591|NCT00370552|18299444|P2|Overall Study|High risk of allergic reaction|1
5311592|NCT00370552|18299445|P1|Overall Study|High risk of allergic reaction|0
5311593|NCT00370552|18299443|P3|Overall Study|Investigator decision|0
5311594|NCT00370552|18299444|P2|Overall Study|Investigator decision|1
5311595|NCT00370552|18299445|P1|Overall Study|Investigator decision|2
5311596|NCT00370552|18299443|P3|Overall Study|Physician Decision|0
5311597|NCT00370552|18299444|P2|Overall Study|Physician Decision|1
5311598|NCT00370552|18299445|P1|Overall Study|Physician Decision|1
5311599|NCT00370552|18299443|P3|Overall Study|Never treated|0
5311600|NCT00370552|18299444|P2|Overall Study|Never treated|0
5311601|NCT00370552|18299445|P1|Overall Study|Never treated|1
5311602|NCT00370552|18299443|P3|Overall Study|Still on treatment|2
5311603|NCT00370552|18299444|P2|Overall Study|Still on treatment|3
5311604|NCT00370552|18299445|P1|Overall Study|Still on treatment|1
5311605|NCT00370552|18299443|P3|Overall Study|Withdrawal by Subject|1
5311606|NCT00370552|18299444|P2|Overall Study|Withdrawal by Subject|0
5311607|NCT00370552|18299445|P1|Overall Study|Withdrawal by Subject|2
5311608|NCT00370552|18299443|P3|Overall Study|Study drug toxicity|6
5311609|NCT00370552|18299444|P2|Overall Study|Study drug toxicity|8
5311610|NCT00370552|18299445|P1|Overall Study|Study drug toxicity|11
5311611|NCT00370552|18299443|P3|Overall Study|Poor or noncompliance|1
5311612|NCT00370552|18299444|P2|Overall Study|Poor or noncompliance|0
5311613|NCT00370552|18299445|P1|Overall Study|Poor or noncompliance|0
5311614|NCT00370552|18299443|P3|Overall Study|Maximum clinical benefit|5
5311615|NCT00370552|18299444|P2|Overall Study|Maximum clinical benefit|5
5311616|NCT00370552|18299445|P1|Overall Study|Maximum clinical benefit|3
5311617|NCT00370552|18299443|P3|Overall Study|Disease progression|15
5311618|NCT00370552|18299444|P2|Overall Study|Disease progression|23
5311619|NCT00370552|18299445|P1|Overall Study|Disease progression|23
5311620|NCT00370552|18299443|P3|Overall Study|Adverse Event|2
5311621|NCT00370552|18299444|P2|Overall Study|Adverse Event|2
5311622|NCT00370552|18299445|P1|Overall Study|Adverse Event|2
5311623|NCT00370396|18299486|P3|Overall Study|Lost to Follow-up|0
5311624|NCT00370396|18299487|P2|Overall Study|Lost to Follow-up|1
5311625|NCT00370396|18299488|P1|Overall Study|Lost to Follow-up|11
5311626|NCT00370396|18299486|P3|Overall Study|Withdrawal by Subject|1
5311627|NCT00370396|18299487|P2|Overall Study|Withdrawal by Subject|0
5311628|NCT00370396|18299488|P1|Overall Study|Withdrawal by Subject|0
5311629|NCT00370331|18299542|P2|Overall Study|Protocol Violation|1
5311630|NCT00370331|18299543|P1|Overall Study|Protocol Violation|1
5311631|NCT00370331|18299542|P2|Overall Study|Non-compliance|1
5311632|NCT00370331|18299543|P1|Overall Study|Non-compliance|0
5311633|NCT00370331|18299542|P2|Overall Study|Lack of Efficacy|1
5311634|NCT00370331|18299543|P1|Overall Study|Lack of Efficacy|0
5311635|NCT00370331|18299542|P2|Overall Study|Lost to Follow-up|3
5311636|NCT00370331|18299543|P1|Overall Study|Lost to Follow-up|0
5311637|NCT00370331|18299542|P2|Overall Study|Withdrawal by Subject|4
5311638|NCT00370331|18299543|P1|Overall Study|Withdrawal by Subject|2
5311639|NCT00370331|18299542|P2|Overall Study|Adverse Event|13
5311640|NCT00370331|18299543|P1|Overall Study|Adverse Event|4
5311641|NCT00370292|18299569|P1|Overall Study|Physician Decision|2
5311642|NCT00370292|18299569|P1|Overall Study|Adverse Event|7
5311643|NCT00370292|18299569|P1|Overall Study|Disease Progression|4
5311644|NCT00370149|18299582|P2|Overall Study|Antibiotic coated dressing placed|1
5311645|NCT00370149|18299583|P1|Overall Study|Antibiotic coated dressing placed|0
5311646|NCT00370149|18299582|P2|Overall Study|Pre-existing infection|1
5311647|NCT00370149|18299583|P1|Overall Study|Pre-existing infection|0
5311648|NCT00370149|18299582|P2|Overall Study|Catheter inserted in wrong vessel-|1
5311649|NCT00370149|18299583|P1|Overall Study|Catheter inserted in wrong vessel-|2
5311650|NCT00370149|18299582|P2|Overall Study|Protocol Violation|0
5311651|NCT00370149|18299583|P1|Overall Study|Protocol Violation|1
5311652|NCT00370149|18299582|P2|Overall Study|Physician Decision|16
5311653|NCT00370149|18299583|P1|Overall Study|Physician Decision|16
5311654|NCT00370071|18299593|P1|Overall Study|Withdrawal by Subject|2
5311655|NCT00370032|18299610|P2|Follow-up Period|Withdrawal by Subject|0
5311656|NCT00370032|18299611|P1|Follow-up Period|Withdrawal by Subject|1
5311657|NCT00370032|18299610|P2|Washout Period|Adverse Event|0
5311658|NCT00370032|18299611|P1|Washout Period|Adverse Event|1
5311659|NCT00370032|18299610|P2|Washout Period|Lost to Follow-up|1
5311660|NCT00370032|18299611|P1|Washout Period|Lost to Follow-up|0
5311661|NCT00370032|18299610|P2|Washout Period|Withdrawal by Subject|1
5311662|NCT00370032|18299611|P1|Washout Period|Withdrawal by Subject|0
5311663|NCT00370032|18299610|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
5311664|NCT00370032|18299611|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
5311665|NCT00369967|18299631|P2|Overall Study|Lost to Follow-up|12
5311666|NCT00369967|18299632|P1|Overall Study|Lost to Follow-up|23
5311667|NCT00369941|18299650|P2|Overall Study|Miscellaneous|3
5311668|NCT00369941|18299651|P1|Overall Study|Miscellaneous|3
5311669|NCT00369941|18299650|P2|Overall Study|Study Site Terminated|0
5311670|NCT00369941|18299651|P1|Overall Study|Study Site Terminated|2
5311671|NCT00369941|18299650|P2|Overall Study|Employment Interfered with Study Visits|0
5311672|NCT00369941|18299651|P1|Overall Study|Employment Interfered with Study Visits|1
5311673|NCT00369941|18299650|P2|Overall Study|Treatment with Prohibited Medication|1
5311674|NCT00369941|18299651|P1|Overall Study|Treatment with Prohibited Medication|3
5311675|NCT00369941|18299650|P2|Overall Study|Moved|5
5311676|NCT00369941|18299651|P1|Overall Study|Moved|11
5311677|NCT00369941|18299650|P2|Overall Study|Completed, Did Not Enter Extension|6
5311678|NCT00369941|18299651|P1|Overall Study|Completed, Did Not Enter Extension|5
5311679|NCT00369941|18299650|P2|Overall Study|Pregnancy|2
5311680|NCT00369941|18299651|P1|Overall Study|Pregnancy|4
5311681|NCT00369941|18299650|P2|Overall Study|Withdrawal by Subject|18
5311682|NCT00369941|18299651|P1|Overall Study|Withdrawal by Subject|5
5311683|NCT00369941|18299650|P2|Overall Study|Protocol Violation|3
5311684|NCT00369941|18299651|P1|Overall Study|Protocol Violation|5
5311685|NCT00369941|18299650|P2|Overall Study|Lost to Follow-up|22
5311686|NCT00369941|18299651|P1|Overall Study|Lost to Follow-up|12
5311687|NCT00369941|18299650|P2|Overall Study|Lack of Efficacy|10
5311688|NCT00369941|18299651|P1|Overall Study|Lack of Efficacy|6
5311689|NCT00369941|18299650|P2|Overall Study|Adverse Event|28
5311690|NCT00369941|18299651|P1|Overall Study|Adverse Event|14
5311691|NCT00369941|18299650|P2|Overall Study|Never Treated|2
5311692|NCT00369941|18299651|P1|Overall Study|Never Treated|1
5311693|NCT00369915|18299816|P2|Overall Study|W/drawl by investigators|1
5311694|NCT00369915|18299817|P1|Overall Study|W/drawl by investigators|0
5311695|NCT00369915|18299816|P2|Overall Study|Withdrawal by Subject|1
5311696|NCT00369915|18299817|P1|Overall Study|Withdrawal by Subject|4
5311697|NCT00369915|18299816|P2|Overall Study|expected side effects|1
5311698|NCT00369915|18299817|P1|Overall Study|expected side effects|2
5311699|NCT00369824|18299831|P6|Overall Study|Other|3
5311700|NCT00369824|18299832|P5|Overall Study|Other|1
5311701|NCT00369824|18299833|P4|Overall Study|Other|2
5311702|NCT00369824|18299834|P3|Overall Study|Other|0
5311703|NCT00369824|18299835|P2|Overall Study|Other|0
5311704|NCT00369824|18299836|P1|Overall Study|Other|0
5311705|NCT00369824|18299831|P6|Overall Study|Lost to Follow-up|6
5311706|NCT00369824|18299832|P5|Overall Study|Lost to Follow-up|9
5311707|NCT00369824|18299833|P4|Overall Study|Lost to Follow-up|8
5311708|NCT00369824|18299834|P3|Overall Study|Lost to Follow-up|7
5311709|NCT00369824|18299835|P2|Overall Study|Lost to Follow-up|11
5311710|NCT00369824|18299836|P1|Overall Study|Lost to Follow-up|6
5311711|NCT00369824|18299831|P6|Overall Study|Withdrawal by Subject|2
5311712|NCT00369824|18299832|P5|Overall Study|Withdrawal by Subject|6
5311713|NCT00369824|18299833|P4|Overall Study|Withdrawal by Subject|4
5311714|NCT00369824|18299834|P3|Overall Study|Withdrawal by Subject|5
5311715|NCT00369824|18299835|P2|Overall Study|Withdrawal by Subject|5
5311716|NCT00369824|18299836|P1|Overall Study|Withdrawal by Subject|9
5311717|NCT00369824|18299831|P6|Overall Study|Protocol Violation|0
5311718|NCT00369824|18299832|P5|Overall Study|Protocol Violation|1
5311719|NCT00369824|18299833|P4|Overall Study|Protocol Violation|1
5311720|NCT00369824|18299834|P3|Overall Study|Protocol Violation|0
5311721|NCT00369824|18299835|P2|Overall Study|Protocol Violation|1
5311722|NCT00369824|18299836|P1|Overall Study|Protocol Violation|0
5311723|NCT00369824|18299831|P6|Overall Study|Adverse Event|0
5311724|NCT00369824|18299832|P5|Overall Study|Adverse Event|1
5311725|NCT00369824|18299833|P4|Overall Study|Adverse Event|0
5311726|NCT00369824|18299834|P3|Overall Study|Adverse Event|0
5311727|NCT00369824|18299835|P2|Overall Study|Adverse Event|2
5311728|NCT00369824|18299836|P1|Overall Study|Adverse Event|0
5311729|NCT00369785|18299936|P2|Overall Study|Multiple reasons|5
5311730|NCT00369785|18299937|P1|Overall Study|Multiple reasons|6
5311731|NCT00369785|18299936|P2|Overall Study|Progression|4
5311732|NCT00369785|18299937|P1|Overall Study|Progression|4
5311733|NCT00369785|18299936|P2|Overall Study|Never started|2
5311734|NCT00369785|18299937|P1|Overall Study|Never started|0
5311735|NCT00369785|18299936|P2|Overall Study|Toxicity|4
5311736|NCT00369785|18299937|P1|Overall Study|Toxicity|6
5311737|NCT00369785|18299936|P2|Overall Study|Withdrawal by Subject|6
5311738|NCT00369785|18299937|P1|Overall Study|Withdrawal by Subject|7
5311739|NCT00369785|18299936|P2|Overall Study|Death|2
5311740|NCT00369785|18299937|P1|Overall Study|Death|1
5311741|NCT00369785|18299936|P2|Overall Study|Physician Decision|2
5311742|NCT00369785|18299937|P1|Overall Study|Physician Decision|3
5311743|NCT00369707|18299958|P1|Follow up for 2 Years After Treatment|Other|2
5311744|NCT00369707|18299958|P1|Follow up for 2 Years After Treatment|Death|1
5311745|NCT00369707|18299958|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
5311746|NCT00369707|18299958|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
5311747|NCT00369707|18299958|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
5311748|NCT00369707|18299958|P1|Induction Part B (2 Cycles)|Progressive disease|1
5311749|NCT00369707|18299958|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
5311750|NCT00369707|18299958|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
5311751|NCT00369707|18299958|P1|Induction Part B (2 Cycles)|Adverse Event|3
5311752|NCT00369681|18299971|P1|Overall Study|Death|1
5311753|NCT00369668|18299981|P3|Overall Study|Lack of Efficacy|7
5311754|NCT00369668|18299982|P2|Overall Study|Lack of Efficacy|5
5311755|NCT00369668|18299983|P1|Overall Study|Lack of Efficacy|4
5311756|NCT00369655|18299997|P1|Overall Study|Refusal of further treatment|2
5311757|NCT00369629|18300006|P4|Follow up for 1 Year|stopped being followed as study closed|0
5311758|NCT00369629|18300007|P3|Follow up for 1 Year|stopped being followed as study closed|2
5311759|NCT00369629|18300008|P2|Follow up for 1 Year|stopped being followed as study closed|0
5311760|NCT00369629|18300009|P1|Follow up for 1 Year|stopped being followed as study closed|0
5311761|NCT00369629|18300006|P4|Follow up for 1 Year|Lost to Follow-up|0
5311762|NCT00369629|18300007|P3|Follow up for 1 Year|Lost to Follow-up|0
5311763|NCT00369629|18300008|P2|Follow up for 1 Year|Lost to Follow-up|1
5311764|NCT00369629|18300009|P1|Follow up for 1 Year|Lost to Follow-up|0
5311765|NCT00369629|18300006|P4|Follow up for 1 Year|Death|0
5311766|NCT00369629|18300007|P3|Follow up for 1 Year|Death|1
5311767|NCT00369629|18300008|P2|Follow up for 1 Year|Death|1
5311768|NCT00369629|18300009|P1|Follow up for 1 Year|Death|2
5311769|NCT00369629|18300006|P4|Completed 4 More Cycles|Progressive disease|0
5311770|NCT00369629|18300007|P3|Completed 4 More Cycles|Progressive disease|2
5311771|NCT00369629|18300008|P2|Completed 4 More Cycles|Progressive disease|1
5311772|NCT00369629|18300009|P1|Completed 4 More Cycles|Progressive disease|2
5311773|NCT00369629|18300006|P4|Completed 4 More Cycles|Withdrawal by Subject|0
5311774|NCT00369629|18300007|P3|Completed 4 More Cycles|Withdrawal by Subject|0
5311775|NCT00369629|18300008|P2|Completed 4 More Cycles|Withdrawal by Subject|1
5311776|NCT00369629|18300009|P1|Completed 4 More Cycles|Withdrawal by Subject|2
5311777|NCT00369629|18300006|P4|Moved on to 4 More Cycles|Progressive Disease|0
5311778|NCT00369629|18300007|P3|Moved on to 4 More Cycles|Progressive Disease|1
5311779|NCT00369629|18300008|P2|Moved on to 4 More Cycles|Progressive Disease|0
5311780|NCT00369629|18300009|P1|Moved on to 4 More Cycles|Progressive Disease|0
5311781|NCT00369629|18300006|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
5311782|NCT00369629|18300007|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
5311783|NCT00369629|18300008|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
5311784|NCT00369629|18300009|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
5311785|NCT00369629|18300006|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
5311786|NCT00369629|18300007|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
5311787|NCT00369629|18300008|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
5311788|NCT00369629|18300009|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
5311789|NCT00369629|18300006|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
5311790|NCT00369629|18300007|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
5311791|NCT00369629|18300008|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
5311792|NCT00369629|18300009|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
5311793|NCT00369577|18300040|P3|Overall Study|Withdrawal by Subject|1
5311794|NCT00369577|18300041|P2|Overall Study|Withdrawal by Subject|0
5311795|NCT00369577|18300042|P1|Overall Study|Withdrawal by Subject|0
5311796|NCT00369486|18300079|P5|34-Week Visit|Dropped|3
5311797|NCT00369486|18300080|P4|34-Week Visit|Dropped|3
5311798|NCT00369486|18300081|P3|34-Week Visit|Dropped|1
5311799|NCT00369486|18300082|P2|34-Week Visit|Dropped|1
5311800|NCT00369486|18300083|P1|34-Week Visit|Dropped|0
5311801|NCT00369486|18300079|P5|17-Week Visit|Missed visit|1
5311802|NCT00369486|18300080|P4|17-Week Visit|Missed visit|1
5311803|NCT00369486|18300081|P3|17-Week Visit|Missed visit|1
5311804|NCT00369486|18300082|P2|17-Week Visit|Missed visit|0
5311805|NCT00369486|18300083|P1|17-Week Visit|Missed visit|0
5311806|NCT00369486|18300079|P5|8-Week Visit|Dropped|0
5311807|NCT00369486|18300080|P4|8-Week Visit|Dropped|1
5311808|NCT00369486|18300081|P3|8-Week Visit|Dropped|0
5311809|NCT00369486|18300082|P2|8-Week Visit|Dropped|0
5311810|NCT00369486|18300083|P1|8-Week Visit|Dropped|0
5311811|NCT00369486|18300079|P5|8-Week Visit|Missed visit|1
5311812|NCT00369486|18300080|P4|8-Week Visit|Missed visit|0
5311813|NCT00369486|18300081|P3|8-Week Visit|Missed visit|0
5311814|NCT00369486|18300082|P2|8-Week Visit|Missed visit|1
5311815|NCT00369486|18300083|P1|8-Week Visit|Missed visit|0
5311816|NCT00369486|18300079|P5|4-Week Visit|Dropped|0
5311817|NCT00369486|18300080|P4|4-Week Visit|Dropped|0
5311818|NCT00369486|18300081|P3|4-Week Visit|Dropped|1
5311819|NCT00369486|18300082|P2|4-Week Visit|Dropped|0
5311820|NCT00369486|18300083|P1|4-Week Visit|Dropped|0
5311821|NCT00369486|18300079|P5|4-Week Visit|Missed visit|1
5311822|NCT00369486|18300080|P4|4-Week Visit|Missed visit|2
5311823|NCT00369486|18300081|P3|4-Week Visit|Missed visit|0
5311824|NCT00369486|18300082|P2|4-Week Visit|Missed visit|2
5311825|NCT00369486|18300083|P1|4-Week Visit|Missed visit|2
5311826|NCT00369382|18300122|P2|Overall Study|Other|0
5311827|NCT00369382|18300123|P1|Overall Study|Other|1
5311828|NCT00369382|18300122|P2|Overall Study|Randomized, not treated|0
5311829|NCT00369382|18300123|P1|Overall Study|Randomized, not treated|2
5311830|NCT00369382|18300122|P2|Overall Study|Withdrawal by Subject|0
5311831|NCT00369382|18300123|P1|Overall Study|Withdrawal by Subject|5
5311832|NCT00369382|18300122|P2|Overall Study|Physician Decision|1
5311833|NCT00369382|18300123|P1|Overall Study|Physician Decision|2
5311834|NCT00369382|18300122|P2|Overall Study|Death|2
5311835|NCT00369382|18300123|P1|Overall Study|Death|0
5311836|NCT00369343|18300156|P2|Open-label Phase|did not take study drug|2
5311837|NCT00369343|18300157|P1|Open-label Phase|did not take study drug|1
5311838|NCT00369343|18300156|P2|Open-label Phase|Lack of continuance tolerability|4
5311839|NCT00369343|18300157|P1|Open-label Phase|Lack of continuance tolerability|3
5311840|NCT00369343|18300156|P2|Open-label Phase|Lack of Efficacy|3
5311841|NCT00369343|18300157|P1|Open-label Phase|Lack of Efficacy|4
5311842|NCT00369343|18300156|P2|Open-label Phase|Withdrawal by Subject|6
5311843|NCT00369343|18300157|P1|Open-label Phase|Withdrawal by Subject|15
5311844|NCT00369343|18300156|P2|Open-label Phase|Protocol Violation|3
5311845|NCT00369343|18300157|P1|Open-label Phase|Protocol Violation|1
5311846|NCT00369343|18300156|P2|Open-label Phase|inadvertently reported study completers|2
5311847|NCT00369343|18300157|P1|Open-label Phase|inadvertently reported study completers|3
5311848|NCT00369343|18300156|P2|Open-label Phase|Lost to Follow-up|3
5311849|NCT00369343|18300157|P1|Open-label Phase|Lost to Follow-up|5
5311850|NCT00369343|18300156|P2|Open-label Phase|Physician Decision|0
5311851|NCT00369343|18300157|P1|Open-label Phase|Physician Decision|2
5311852|NCT00369343|18300156|P2|Open-label Phase|Failed to return|0
5311853|NCT00369343|18300157|P1|Open-label Phase|Failed to return|4
5311854|NCT00369343|18300156|P2|Open-label Phase|Adverse Event|7
5311855|NCT00369343|18300157|P1|Open-label Phase|Adverse Event|19
5311856|NCT00369343|18300156|P2|Double-blind Phase|Protocol deviation|0
5311857|NCT00369343|18300157|P1|Double-blind Phase|Protocol deviation|4
5311858|NCT00369343|18300156|P2|Double-blind Phase|Lack of Efficacy|4
5311859|NCT00369343|18300157|P1|Double-blind Phase|Lack of Efficacy|0
5311860|NCT00369343|18300156|P2|Double-blind Phase|Withdrawal by Subject|6
5311861|NCT00369343|18300157|P1|Double-blind Phase|Withdrawal by Subject|8
5311862|NCT00369343|18300156|P2|Double-blind Phase|Protocol Violation|0
5311863|NCT00369343|18300157|P1|Double-blind Phase|Protocol Violation|2
5311864|NCT00369343|18300156|P2|Double-blind Phase|Lost to Follow-up|2
5311865|NCT00369343|18300157|P1|Double-blind Phase|Lost to Follow-up|9
5311866|NCT00369343|18300156|P2|Double-blind Phase|Failed to return|0
5311867|NCT00369343|18300157|P1|Double-blind Phase|Failed to return|2
5311868|NCT00369343|18300156|P2|Double-blind Phase|Adverse Event|4
5311869|NCT00369343|18300157|P1|Double-blind Phase|Adverse Event|19
5311870|NCT00369317|18300190|P1|Overall Study|Ineligible|1
5311871|NCT00369317|18300190|P1|Overall Study|Withdrawal by Subject|8
5311872|NCT00369317|18300190|P1|Overall Study|Physician Decision|2
5311873|NCT00369317|18300190|P1|Overall Study|Lack of Efficacy|5
5311874|NCT00369317|18300190|P1|Overall Study|Death|1
5311875|NCT00369317|18300190|P1|Overall Study|Adverse Event|3
5311876|NCT00369278|18300206|P2|Overall Study|Graft loss|2
5311877|NCT00369278|18300207|P1|Overall Study|Graft loss|1
5311878|NCT00369278|18300206|P2|Overall Study|Lost to Follow-up|0
5311879|NCT00369278|18300207|P1|Overall Study|Lost to Follow-up|1
5311880|NCT00369278|18300206|P2|Overall Study|Withdrawal by Subject|2
5311881|NCT00369278|18300207|P1|Overall Study|Withdrawal by Subject|2
5311882|NCT00369278|18300206|P2|Overall Study|Protocol Violation|1
5311883|NCT00369278|18300207|P1|Overall Study|Protocol Violation|2
5311884|NCT00369278|18300206|P2|Overall Study|Unsatisfactory therapeutic effect|5
5311885|NCT00369278|18300207|P1|Overall Study|Unsatisfactory therapeutic effect|4
5311886|NCT00369278|18300206|P2|Overall Study|Adverse Event|11
5311887|NCT00369278|18300207|P1|Overall Study|Adverse Event|14
5311888|NCT00369265|18300223|P2|Overall Study|Study terminated|7
5311889|NCT00369265|18300224|P1|Overall Study|Study terminated|4
5311890|NCT00369161|18300245|P2|Overall Study|Administrative Problem|2
5311891|NCT00369161|18300246|P1|Overall Study|Administrative Problem|2
5311892|NCT00369161|18300245|P2|Overall Study|Graft loss|0
5311893|NCT00369161|18300246|P1|Overall Study|Graft loss|4
5311894|NCT00369161|18300245|P2|Overall Study|Death|2
5311895|NCT00369161|18300246|P1|Overall Study|Death|1
5311896|NCT00369161|18300245|P2|Overall Study|Withdrawal by Subject|3
5311897|NCT00369161|18300246|P1|Overall Study|Withdrawal by Subject|2
5311898|NCT00369161|18300245|P2|Overall Study|Protocol Violation|2
5311899|NCT00369161|18300246|P1|Overall Study|Protocol Violation|0
5311900|NCT00369161|18300245|P2|Overall Study|Lack of Efficacy|1
5311901|NCT00369161|18300246|P1|Overall Study|Lack of Efficacy|3
5311902|NCT00369161|18300245|P2|Overall Study|Abnormal laboratory value|1
5311903|NCT00369161|18300246|P1|Overall Study|Abnormal laboratory value|0
5311904|NCT00369161|18300245|P2|Overall Study|Adverse Event|13
5311905|NCT00369161|18300246|P1|Overall Study|Adverse Event|15
5311906|NCT00369122|18300256|P1|Overall Study|No protocol treatment|1
5311907|NCT00369122|18300256|P1|Overall Study|Ineligible|10
5311908|NCT00368992|18300263|P1|Overall Study|Other|9
5311909|NCT00368992|18300263|P1|Overall Study|Death|4
5311910|NCT00368992|18300263|P1|Overall Study|Adverse Event|26
5311911|NCT00368992|18300263|P1|Overall Study|Lack of Efficacy|63
5311912|NCT00368992|18300263|P1|Overall Study|Refused treatment|3
5311913|NCT00368992|18300263|P1|Overall Study|Ineligible|5
5311914|NCT00368979|18300272|P2|Overall Study|Withdrawal by Subject|9
5311915|NCT00368979|18300273|P1|Overall Study|Withdrawal by Subject|5
5311916|NCT00368979|18300272|P2|Overall Study|Protocol Violation|1
5311917|NCT00368979|18300273|P1|Overall Study|Protocol Violation|2
5311918|NCT00368979|18300272|P2|Overall Study|Lost to Follow-up|0
5311919|NCT00368979|18300273|P1|Overall Study|Lost to Follow-up|1
5311920|NCT00368979|18300272|P2|Overall Study|Other|1
5311921|NCT00368979|18300273|P1|Overall Study|Other|3
5311922|NCT00368979|18300272|P2|Overall Study|Lack of Efficacy|3
5311923|NCT00368979|18300273|P1|Overall Study|Lack of Efficacy|5
5311924|NCT00368979|18300272|P2|Overall Study|Adverse Event|16
5311925|NCT00368979|18300273|P1|Overall Study|Adverse Event|9
5311926|NCT00368966|18300289|P2|Toddler Dose|Lost to Follow-up|2
5311927|NCT00368966|18300290|P1|Toddler Dose|Lost to Follow-up|0
5311928|NCT00368966|18300289|P2|Toddler Dose|Withdrawal by Subject|1
5311929|NCT00368966|18300290|P1|Toddler Dose|Withdrawal by Subject|1
5311930|NCT00368966|18300289|P2|After Infant|Lost to Follow-up|1
5311931|NCT00368966|18300290|P1|After Infant|Lost to Follow-up|0
5311932|NCT00368966|18300289|P2|After Infant|Death|0
5311933|NCT00368966|18300290|P1|After Infant|Death|1
5311934|NCT00368966|18300289|P2|After Infant|Withdrawal by Subject|1
5311935|NCT00368966|18300290|P1|After Infant|Withdrawal by Subject|1
5311936|NCT00368966|18300289|P2|After Infant|Adverse Event|2
5311937|NCT00368966|18300290|P1|After Infant|Adverse Event|1
5311938|NCT00368966|18300289|P2|After Infant|Failed to return|1
5311939|NCT00368966|18300290|P1|After Infant|Failed to return|3
5311940|NCT00368966|18300289|P2|Infant Series|Failed to return|0
5311941|NCT00368966|18300290|P1|Infant Series|Failed to return|1
5311942|NCT00368966|18300289|P2|Infant Series|Adverse Event|1
5311943|NCT00368966|18300290|P1|Infant Series|Adverse Event|0
5311944|NCT00368966|18300289|P2|Infant Series|Failed to meet eligibility criteria|1
5311945|NCT00368966|18300290|P1|Infant Series|Failed to meet eligibility criteria|0
5311946|NCT00368966|18300289|P2|Infant Series|Randomization error|1
5311947|NCT00368966|18300290|P1|Infant Series|Randomization error|0
5311948|NCT00368966|18300289|P2|Infant Series|Lost to Follow-up|0
5311949|NCT00368966|18300290|P1|Infant Series|Lost to Follow-up|2
5311950|NCT00368966|18300289|P2|Infant Series|Protocol Violation|1
5311951|NCT00368966|18300290|P1|Infant Series|Protocol Violation|2
5311952|NCT00368966|18300289|P2|Infant Series|Withdrawal by Subject|6
5311953|NCT00368966|18300290|P1|Infant Series|Withdrawal by Subject|11
5311954|NCT00368927|18300361|P2|Overall Study|Physician Decision|0
5311955|NCT00368927|18300362|P1|Overall Study|Physician Decision|1
5311956|NCT00368927|18300361|P2|Overall Study|Withdrawal by Subject|2
5311957|NCT00368927|18300362|P1|Overall Study|Withdrawal by Subject|1
5311958|NCT00368927|18300361|P2|Overall Study|Adverse Event|1
5311959|NCT00368927|18300362|P1|Overall Study|Adverse Event|1
5311960|NCT00368927|18300361|P2|Overall Study|Lost to Follow-up|0
5311961|NCT00368927|18300362|P1|Overall Study|Lost to Follow-up|2
5311962|NCT00368875|18300370|P2|Overall Study|Alternative Therapy|1
5311963|NCT00368875|18300371|P1|Overall Study|Alternative Therapy|1
5311964|NCT00368875|18300370|P2|Overall Study|Other Reason|2
5311965|NCT00368875|18300371|P1|Overall Study|Other Reason|0
5311966|NCT00368875|18300370|P2|Overall Study|Withdrawal by Subject|6
5311967|NCT00368875|18300371|P1|Overall Study|Withdrawal by Subject|2
5311968|NCT00368875|18300370|P2|Overall Study|Progressive disease|27
5311969|NCT00368875|18300371|P1|Overall Study|Progressive disease|3
5311970|NCT00368875|18300370|P2|Overall Study|Adverse Event|12
5311971|NCT00368875|18300371|P1|Overall Study|Adverse Event|0
5311972|NCT00368849|18300379|P2|Overall Study|Physician Decision|1
5311973|NCT00368849|18300380|P1|Overall Study|Physician Decision|0
5311974|NCT00368849|18300379|P2|Overall Study|Withdrawal by Subject|1
5311975|NCT00368849|18300380|P1|Overall Study|Withdrawal by Subject|0
5311976|NCT00368745|18300396|P2|Double-blind Treatment Period|Other|6
5311977|NCT00368745|18300397|P1|Double-blind Treatment Period|Other|7
5311978|NCT00368745|18300396|P2|Double-blind Treatment Period|Withdrawal by Subject|3
5311979|NCT00368745|18300397|P1|Double-blind Treatment Period|Withdrawal by Subject|5
5311980|NCT00368745|18300396|P2|Double-blind Treatment Period|Lost to Follow-up|0
5311981|NCT00368745|18300397|P1|Double-blind Treatment Period|Lost to Follow-up|1
5311982|NCT00368745|18300396|P2|Double-blind Treatment Period|Lack of Efficacy|16
5311983|NCT00368745|18300397|P1|Double-blind Treatment Period|Lack of Efficacy|7
5311984|NCT00368745|18300396|P2|Double-blind Treatment Period|Adverse Event|6
5311985|NCT00368745|18300397|P1|Double-blind Treatment Period|Adverse Event|6
5311986|NCT00368641|18300450|P2|Overall Study|Sponsor decision to terminate study|5
5311987|NCT00368641|18300451|P1|Overall Study|Sponsor decision to terminate study|2
5311988|NCT00368641|18300450|P2|Overall Study|Withdrawal by Subject|0
5311989|NCT00368641|18300451|P1|Overall Study|Withdrawal by Subject|1
5311990|NCT00368641|18300450|P2|Overall Study|Death|0
5311991|NCT00368641|18300451|P1|Overall Study|Death|1
5311992|NCT00368641|18300450|P2|Overall Study|Adverse Event|1
5311993|NCT00368641|18300451|P1|Overall Study|Adverse Event|2
5311994|NCT00368550|18300459|P2|Overall Study|Withdrawal by Subject|10
5311995|NCT00368550|18300460|P1|Overall Study|Withdrawal by Subject|17
5311996|NCT00368550|18300459|P2|Overall Study|Lack of Efficacy|9
5311997|NCT00368550|18300460|P1|Overall Study|Lack of Efficacy|4
5311998|NCT00368550|18300459|P2|Overall Study|Adverse Event|4
5311999|NCT00368550|18300460|P1|Overall Study|Adverse Event|7
5312000|NCT00368537|18300472|P2|Baseline Participants|Patient uncompliant|1
5312001|NCT00368537|18300473|P1|Baseline Participants|Patient uncompliant|0
5312002|NCT00368537|18300472|P2|Baseline Participants|No susceptibility|0
5312003|NCT00368537|18300473|P1|Baseline Participants|No susceptibility|1
5312004|NCT00368537|18300472|P2|Baseline Participants|Death|2
5312005|NCT00368537|18300473|P1|Baseline Participants|Death|1
5312006|NCT00368537|18300472|P2|Baseline Participants|Withdrawal by Subject|4
5312007|NCT00368537|18300473|P1|Baseline Participants|Withdrawal by Subject|6
5312008|NCT00368537|18300472|P2|Baseline Participants|Lost to Follow-up|17
5312009|NCT00368537|18300473|P1|Baseline Participants|Lost to Follow-up|16
5312010|NCT00368537|18300472|P2|Randomization|No study drug dosed|6
5312011|NCT00368537|18300473|P1|Randomization|No study drug dosed|13
5312012|NCT00368472|18300487|P1|Overall Study|Missing Final Disposition Date|1
5312013|NCT00368472|18300487|P1|Overall Study|Other|32
5312014|NCT00368472|18300487|P1|Overall Study|Diary non-compliance|1
5312015|NCT00368472|18300487|P1|Overall Study|Withdrawal by Subject|40
5312016|NCT00368472|18300487|P1|Overall Study|Request of Investigator or Sponsor|3
5312017|NCT00368472|18300487|P1|Overall Study|Protocol Violation|2
5312018|NCT00368472|18300487|P1|Overall Study|Medication non-compliance|4
5312019|NCT00368472|18300487|P1|Overall Study|Adverse Event|22
5312020|NCT00368355|18300522|P2|Overall Study|Treatment - hematopoietic cell product|0
5312021|NCT00368355|18300523|P1|Overall Study|Treatment - hematopoietic cell product|2
5312022|NCT00368355|18300522|P2|Overall Study|Subsequent transplant|3
5312023|NCT00368355|18300523|P1|Overall Study|Subsequent transplant|0
5312024|NCT00368355|18300522|P2|Overall Study|Relapse|10
5312025|NCT00368355|18300523|P1|Overall Study|Relapse|6
5312026|NCT00368355|18300522|P2|Overall Study|Death|4
5312027|NCT00368355|18300523|P1|Overall Study|Death|2
5312028|NCT00368355|18300522|P2|Overall Study|Adverse Event|0
5312029|NCT00368355|18300523|P1|Overall Study|Adverse Event|1
5312030|NCT00368277|18300563|P2|Overall Study|Lost to Follow-up|6
5312031|NCT00368277|18300564|P1|Overall Study|Lost to Follow-up|8
5312032|NCT00368277|18300563|P2|Overall Study|Patient withdrew consent|28
5312033|NCT00368277|18300564|P1|Overall Study|Patient withdrew consent|32
5312034|NCT00368277|18300563|P2|Overall Study|Protocol deviation|0
5312035|NCT00368277|18300564|P1|Overall Study|Protocol deviation|7
5312036|NCT00368277|18300563|P2|Overall Study|Unsatisfactory therapeutic effect|24
5312037|NCT00368277|18300564|P1|Overall Study|Unsatisfactory therapeutic effect|31
5312038|NCT00368277|18300563|P2|Overall Study|Death|1
5312039|NCT00368277|18300564|P1|Overall Study|Death|2
5312040|NCT00368277|18300563|P2|Overall Study|Adverse Event|49
5312041|NCT00368277|18300564|P1|Overall Study|Adverse Event|33
5312042|NCT00368251|18300579|P3|Overall Study|AE, non-serious non-fatal|1
5312043|NCT00368251|18300580|P2|Overall Study|AE, non-serious non-fatal|0
5312044|NCT00368251|18300581|P1|Overall Study|AE, non-serious non-fatal|0
5312045|NCT00368251|18300579|P3|Overall Study|SAE, non-fatal|0
5312046|NCT00368251|18300580|P2|Overall Study|SAE, non-fatal|0
5312047|NCT00368251|18300581|P1|Overall Study|SAE, non-fatal|1
5312048|NCT00368108|18300604|P3|Overall Study|Other|1
5312049|NCT00368108|18300605|P2|Overall Study|Other|7
5312050|NCT00368108|18300606|P1|Overall Study|Other|3
5312051|NCT00368108|18300604|P3|Overall Study|Physician Decision|1
5312052|NCT00368108|18300605|P2|Overall Study|Physician Decision|0
5312053|NCT00368108|18300606|P1|Overall Study|Physician Decision|2
5312054|NCT00368108|18300604|P3|Overall Study|Lack of Efficacy|5
5312055|NCT00368108|18300605|P2|Overall Study|Lack of Efficacy|8
5312056|NCT00368108|18300606|P1|Overall Study|Lack of Efficacy|7
5312057|NCT00368108|18300604|P3|Overall Study|Withdrawal by Subject|5
5312058|NCT00368108|18300605|P2|Overall Study|Withdrawal by Subject|3
5312059|NCT00368108|18300606|P1|Overall Study|Withdrawal by Subject|9
5312060|NCT00368108|18300604|P3|Overall Study|Protocol Violation|9
5312061|NCT00368108|18300605|P2|Overall Study|Protocol Violation|9
5312062|NCT00368108|18300606|P1|Overall Study|Protocol Violation|5
5312063|NCT00368108|18300604|P3|Overall Study|Abnormal Laboratory Value|3
5312064|NCT00368108|18300605|P2|Overall Study|Abnormal Laboratory Value|0
5312065|NCT00368108|18300606|P1|Overall Study|Abnormal Laboratory Value|0
5312066|NCT00368108|18300604|P3|Overall Study|Adverse Event|44
5312067|NCT00368108|18300605|P2|Overall Study|Adverse Event|26
5312068|NCT00368108|18300606|P1|Overall Study|Adverse Event|38
5312069|NCT00368069|18300625|P2|Overall Study|no blood sampling possible|1
5312070|NCT00368069|18300626|P1|Overall Study|no blood sampling possible|0
5312071|NCT00368069|18300625|P2|Overall Study|Withdrawal of Consent|1
5312072|NCT00368069|18300626|P1|Overall Study|Withdrawal of Consent|2
5312073|NCT00368069|18300625|P2|Overall Study|Protocol Violation|2
5312074|NCT00368069|18300626|P1|Overall Study|Protocol Violation|0
5312075|NCT00368069|18300625|P2|Overall Study|Lost to Follow-up|0
5312076|NCT00368069|18300626|P1|Overall Study|Lost to Follow-up|1
5312077|NCT00368069|18300625|P2|Overall Study|Lack of Efficacy|1
5312078|NCT00368069|18300626|P1|Overall Study|Lack of Efficacy|0
5312079|NCT00368069|18300625|P2|Overall Study|Adverse Event|2
5312080|NCT00368069|18300626|P1|Overall Study|Adverse Event|5
5312081|NCT00367991|18300644|P2|Overall Study|Adverse Event|1
5312082|NCT00367991|18300645|P1|Overall Study|Adverse Event|1
5312083|NCT00367991|18300644|P2|Overall Study|Withdrawal by Subject|1
5312084|NCT00367991|18300645|P1|Overall Study|Withdrawal by Subject|1
5312085|NCT00367835|18300663|P2|Overall Study|History of lead poisoning|1
5312086|NCT00367835|18300664|P1|Overall Study|History of lead poisoning|0
5312087|NCT00367835|18300663|P2|Overall Study|Did not respond to calls|0
5312088|NCT00367835|18300664|P1|Overall Study|Did not respond to calls|1
5312089|NCT00367835|18300663|P2|Overall Study|refused blood collection|0
5312090|NCT00367835|18300664|P1|Overall Study|refused blood collection|1
5312091|NCT00367835|18300663|P2|Overall Study|Subject in juvenile detention center|0
5312092|NCT00367835|18300664|P1|Overall Study|Subject in juvenile detention center|1
5312093|NCT00367835|18300663|P2|Overall Study|Lack of Efficacy|12
5312094|NCT00367835|18300664|P1|Overall Study|Lack of Efficacy|3
5312095|NCT00367835|18300663|P2|Overall Study|Lost to Follow-up|4
5312096|NCT00367835|18300664|P1|Overall Study|Lost to Follow-up|1
5312097|NCT00367835|18300663|P2|Overall Study|Withdrawal by Subject|6
5312098|NCT00367835|18300664|P1|Overall Study|Withdrawal by Subject|7
5312099|NCT00367835|18300663|P2|Overall Study|Protocol Violation|7
5312100|NCT00367835|18300664|P1|Overall Study|Protocol Violation|1
5312101|NCT00367835|18300663|P2|Overall Study|Adverse Event|1
5312102|NCT00367835|18300664|P1|Overall Study|Adverse Event|14
5312103|NCT00367770|18300690|P1|Overall Study|Withdrawal by Subject|1
5312104|NCT00367770|18300690|P1|Overall Study|Adverse Event|1
5312105|NCT00367744|18300698|P2|Overall Study|Lost to Follow-up|5
5312106|NCT00367744|18300699|P1|Overall Study|Lost to Follow-up|4
5312107|NCT00367640|18300728|P4|Overall Study|Any other reason not above-mentioned|4
5312108|NCT00367640|18300729|P3|Overall Study|Any other reason not above-mentioned|3
5312109|NCT00367640|18300730|P2|Overall Study|Any other reason not above-mentioned|5
5312110|NCT00367640|18300731|P1|Overall Study|Any other reason not above-mentioned|7
5312111|NCT00367640|18300728|P4|Overall Study|Withdrawal by Subject|6
5312112|NCT00367640|18300729|P3|Overall Study|Withdrawal by Subject|8
5312113|NCT00367640|18300730|P2|Overall Study|Withdrawal by Subject|11
5312114|NCT00367640|18300731|P1|Overall Study|Withdrawal by Subject|8
5312115|NCT00367640|18300728|P4|Overall Study|Adverse Event|0
5312116|NCT00367640|18300729|P3|Overall Study|Adverse Event|8
5312117|NCT00367640|18300730|P2|Overall Study|Adverse Event|6
5312118|NCT00367640|18300731|P1|Overall Study|Adverse Event|3
5312119|NCT00367484|18300747|P1|Overall Study|Lack of Efficacy|1
5312120|NCT00367484|18300747|P1|Overall Study|The choice of the patient|1
5312121|NCT00367484|18300747|P1|Overall Study|Protocol Violation|1
5312122|NCT00367484|18300747|P1|Overall Study|Lost to Follow-up|1
5312123|NCT00367484|18300747|P1|Overall Study|Travel to USA|1
5312124|NCT00367484|18300747|P1|Overall Study|Withdrew informed consent|5
5312125|NCT00367484|18300747|P1|Overall Study|Adverse Event|7
5312126|NCT00367458|18300753|P2|First Intervention - 8 Weeks|Adverse Event|0
5312127|NCT00367458|18300754|P1|First Intervention - 8 Weeks|Adverse Event|2
5312128|NCT00367432|18300768|P2|Second Period (up to 54 Months)|Other Reason|2
5312129|NCT00367432|18300769|P1|Second Period (up to 54 Months)|Other Reason|6
5312130|NCT00367432|18300768|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
5312131|NCT00367432|18300769|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
5312132|NCT00367432|18300768|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
5312133|NCT00367432|18300769|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
5312134|NCT00367432|18300768|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
5312135|NCT00367432|18300769|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
5312136|NCT00367432|18300768|P2|Second Period (up to 54 Months)|Adverse Event|3
5312137|NCT00367432|18300769|P1|Second Period (up to 54 Months)|Adverse Event|14
5312138|NCT00367432|18300768|P2|First Period (16 Weeks)|Other Reason|0
5312139|NCT00367432|18300769|P1|First Period (16 Weeks)|Other Reason|2
5312140|NCT00367432|18300768|P2|First Period (16 Weeks)|Withdrawal by Subject|0
5312141|NCT00367432|18300769|P1|First Period (16 Weeks)|Withdrawal by Subject|6
5312142|NCT00367432|18300768|P2|First Period (16 Weeks)|Lack of Efficacy|0
5312143|NCT00367432|18300769|P1|First Period (16 Weeks)|Lack of Efficacy|24
5312144|NCT00367432|18300768|P2|First Period (16 Weeks)|Adverse Event|0
5312145|NCT00367432|18300769|P1|First Period (16 Weeks)|Adverse Event|6
5312146|NCT00367341|18300796|P2|Overall Study|Protocol Violation|0
5312147|NCT00367341|18300797|P1|Overall Study|Protocol Violation|1
5312148|NCT00367341|18300796|P2|Overall Study|Physician Decision|0
5312149|NCT00367341|18300797|P1|Overall Study|Physician Decision|1
5312150|NCT00367237|18300807|P2|Overall Study|Protocol Violation|5
5312151|NCT00367237|18300808|P1|Overall Study|Protocol Violation|2
5312152|NCT00367237|18300807|P2|Overall Study|Withdrawal by Subject|4
5312153|NCT00367237|18300808|P1|Overall Study|Withdrawal by Subject|0
5312154|NCT00367237|18300807|P2|Overall Study|Lost to Follow-up|0
5312155|NCT00367237|18300808|P1|Overall Study|Lost to Follow-up|1
5312156|NCT00367237|18300807|P2|Overall Study|Adverse Event|2
5312157|NCT00367237|18300808|P1|Overall Study|Adverse Event|7
5312158|NCT00367133|18300817|P3|2 Years|Missed visit|4
5312159|NCT00367133|18300818|P2|2 Years|Missed visit|5
5312160|NCT00367133|18300819|P1|2 Years|Missed visit|4
5312161|NCT00367133|18300817|P3|2 Years|Dropped|33
5312162|NCT00367133|18300818|P2|2 Years|Dropped|19
5312163|NCT00367133|18300819|P1|2 Years|Dropped|34
5312164|NCT00367133|18300817|P3|2 Years|Death|12
5312165|NCT00367133|18300818|P2|2 Years|Death|12
5312166|NCT00367133|18300819|P1|2 Years|Death|20
5312167|NCT00367055|18300871|P2|Overall Study|Participant Living too Far from Hospital|1
5312168|NCT00367055|18300872|P1|Overall Study|Participant Living too Far from Hospital|0
5312169|NCT00367055|18300871|P2|Overall Study|Stopping Criterion Met|1
5312170|NCT00367055|18300872|P1|Overall Study|Stopping Criterion Met|0
5312171|NCT00367055|18300871|P2|Overall Study|Protocol Violation|1
5312172|NCT00367055|18300872|P1|Overall Study|Protocol Violation|0
5312173|NCT00367055|18300871|P2|Overall Study|Lost to Follow-up|1
5312174|NCT00367055|18300872|P1|Overall Study|Lost to Follow-up|1
5312175|NCT00367055|18300871|P2|Overall Study|Lack of Efficacy|2
5312176|NCT00367055|18300872|P1|Overall Study|Lack of Efficacy|1
5312177|NCT00367055|18300871|P2|Overall Study|Patient's Willing|2
5312178|NCT00367055|18300872|P1|Overall Study|Patient's Willing|3
5312179|NCT00367055|18300871|P2|Overall Study|Adverse Event|3
5312180|NCT00367055|18300872|P1|Overall Study|Adverse Event|6
5312181|NCT00366899|18300892|P2|Toddler Dose|Protocol Violation|0
5312182|NCT00366899|18300893|P1|Toddler Dose|Protocol Violation|1
5312183|NCT00366899|18300892|P2|Toddler Dose|Withdrawal by Subject|1
5312184|NCT00366899|18300893|P1|Toddler Dose|Withdrawal by Subject|1
5312185|NCT00366899|18300892|P2|After Infant Series|Protocol Violation|0
5312186|NCT00366899|18300893|P1|After Infant Series|Protocol Violation|1
5312187|NCT00366899|18300892|P2|After Infant Series|Adverse Event|2
5312188|NCT00366899|18300893|P1|After Infant Series|Adverse Event|1
5312189|NCT00366899|18300892|P2|After Infant Series|Withdrawal by Subject|4
5312190|NCT00366899|18300893|P1|After Infant Series|Withdrawal by Subject|1
5312191|NCT00366899|18300892|P2|After Infant Series|Lost to Follow-up|3
5312192|NCT00366899|18300893|P1|After Infant Series|Lost to Follow-up|4
5312193|NCT00366899|18300892|P2|Infant Series|Randomized but not consented|0
5312194|NCT00366899|18300893|P1|Infant Series|Randomized but not consented|1
5312195|NCT00366899|18300892|P2|Infant Series|Physician Decision|0
5312196|NCT00366899|18300893|P1|Infant Series|Physician Decision|1
5312197|NCT00366899|18300892|P2|Infant Series|Adverse Event|1
5312198|NCT00366899|18300893|P1|Infant Series|Adverse Event|0
5312199|NCT00366899|18300892|P2|Infant Series|Lost to Follow-up|2
5312200|NCT00366899|18300893|P1|Infant Series|Lost to Follow-up|0
5312201|NCT00366899|18300892|P2|Infant Series|Failed to return|1
5312202|NCT00366899|18300893|P1|Infant Series|Failed to return|1
5312203|NCT00366899|18300892|P2|Infant Series|Protocol Violation|1
5312204|NCT00366899|18300893|P1|Infant Series|Protocol Violation|2
5312205|NCT00366899|18300892|P2|Infant Series|Withdrawal by Subject|7
5312206|NCT00366899|18300893|P1|Infant Series|Withdrawal by Subject|4
5312207|NCT00366678|18300953|P3|Toddler Dose|protocol deviation|0
5312208|NCT00366678|18300954|P2|Toddler Dose|protocol deviation|0
5312209|NCT00366678|18300955|P1|Toddler Dose|protocol deviation|1
5312210|NCT00366678|18300953|P3|Toddler Dose|Withdrawal by Subject|0
5312211|NCT00366678|18300954|P2|Toddler Dose|Withdrawal by Subject|0
5312212|NCT00366678|18300955|P1|Toddler Dose|Withdrawal by Subject|1
5312213|NCT00366678|18300953|P3|Toddler Dose|Failed to return|0
5312214|NCT00366678|18300954|P2|Toddler Dose|Failed to return|0
5312215|NCT00366678|18300955|P1|Toddler Dose|Failed to return|1
5312216|NCT00366678|18300953|P3|Toddler Dose|Protocol Violation|0
5312217|NCT00366678|18300954|P2|Toddler Dose|Protocol Violation|1
5312218|NCT00366678|18300955|P1|Toddler Dose|Protocol Violation|2
5312219|NCT00366678|18300953|P3|After Infant|Protocol Violation|0
5312220|NCT00366678|18300954|P2|After Infant|Protocol Violation|0
5312221|NCT00366678|18300955|P1|After Infant|Protocol Violation|1
5312222|NCT00366678|18300953|P3|After Infant|Adverse Event|0
5312223|NCT00366678|18300954|P2|After Infant|Adverse Event|0
5312224|NCT00366678|18300955|P1|After Infant|Adverse Event|1
5312225|NCT00366678|18300953|P3|After Infant|Failed to return|0
5312226|NCT00366678|18300954|P2|After Infant|Failed to return|5
5312227|NCT00366678|18300955|P1|After Infant|Failed to return|5
5312228|NCT00366678|18300953|P3|After Infant|Lost to Follow-up|0
5312229|NCT00366678|18300954|P2|After Infant|Lost to Follow-up|1
5312230|NCT00366678|18300955|P1|After Infant|Lost to Follow-up|2
5312231|NCT00366678|18300953|P3|After Infant|Withdrawal by Subject|0
5312232|NCT00366678|18300954|P2|After Infant|Withdrawal by Subject|4
5312233|NCT00366678|18300955|P1|After Infant|Withdrawal by Subject|8
5312234|NCT00366678|18300953|P3|Infant Series|Adverse Event|0
5312235|NCT00366678|18300954|P2|Infant Series|Adverse Event|0
5312236|NCT00366678|18300955|P1|Infant Series|Adverse Event|1
5312237|NCT00366678|18300953|P3|Infant Series|Failed to return|0
5312238|NCT00366678|18300954|P2|Infant Series|Failed to return|1
5312239|NCT00366678|18300955|P1|Infant Series|Failed to return|1
5312240|NCT00366678|18300953|P3|Infant Series|Protocol Violation|0
5312241|NCT00366678|18300954|P2|Infant Series|Protocol Violation|3
5312242|NCT00366678|18300955|P1|Infant Series|Protocol Violation|4
5312243|NCT00366678|18300953|P3|Infant Series|Withdrawal by Subject|0
5312244|NCT00366678|18300954|P2|Infant Series|Withdrawal by Subject|6
5312245|NCT00366678|18300955|P1|Infant Series|Withdrawal by Subject|8
5312246|NCT00366548|18301037|P2|After Infant Series|Lost to Follow-up|0
5312247|NCT00366548|18301038|P1|After Infant Series|Lost to Follow-up|1
5312248|NCT00366548|18301037|P2|After Infant Series|Adverse Event|0
5312249|NCT00366548|18301038|P1|After Infant Series|Adverse Event|2
5312250|NCT00366548|18301037|P2|After Infant Series|Withdrawal by Subject|1
5312251|NCT00366548|18301038|P1|After Infant Series|Withdrawal by Subject|3
5312252|NCT00366548|18301037|P2|Infant Series|Withdrawal by Subject|1
5312253|NCT00366548|18301038|P1|Infant Series|Withdrawal by Subject|3
5312254|NCT00366548|18301037|P2|Infant Series|Protocol Violation|1
5312255|NCT00366548|18301038|P1|Infant Series|Protocol Violation|0
5312256|NCT00366548|18301037|P2|Infant Series|Adverse Event|3
5312257|NCT00366548|18301038|P1|Infant Series|Adverse Event|1
5312258|NCT00366535|18301074|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
5312259|NCT00366535|18301075|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
5312260|NCT00366535|18301074|P2|Second Phase: 12 Weeks|Adverse Event|1
5312261|NCT00366535|18301075|P1|Second Phase: 12 Weeks|Adverse Event|1
5312262|NCT00366535|18301074|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
5312263|NCT00366535|18301075|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
5312264|NCT00366535|18301074|P2|First Phase: 12 Weeks|Adverse Event|3
5312265|NCT00366535|18301075|P1|First Phase: 12 Weeks|Adverse Event|1
5312266|NCT00366457|18301089|P1|Overall Study|never began study therapy|2
5312267|NCT00366444|18301098|P2|Overall Study|Lack of Efficacy|1
5312268|NCT00366444|18301099|P1|Overall Study|Lack of Efficacy|0
5312269|NCT00366444|18301098|P2|Overall Study|Withdrawal by Subject|1
5312270|NCT00366444|18301099|P1|Overall Study|Withdrawal by Subject|1
5312271|NCT00366340|18301127|P2|Toddler Dose|Parent/legal guardian request|1
5312272|NCT00366340|18301128|P1|Toddler Dose|Parent/legal guardian request|0
5312273|NCT00366340|18301127|P2|Toddler Dose|Failed to return|0
5312274|NCT00366340|18301128|P1|Toddler Dose|Failed to return|1
5312275|NCT00366340|18301127|P2|After the Infant Series|Lost to Follow-up|1
5312276|NCT00366340|18301128|P1|After the Infant Series|Lost to Follow-up|0
5312277|NCT00366340|18301127|P2|After the Infant Series|Adverse Event|1
5312278|NCT00366340|18301128|P1|After the Infant Series|Adverse Event|0
5312279|NCT00366340|18301127|P2|After the Infant Series|Protocol Violation|2
5312280|NCT00366340|18301128|P1|After the Infant Series|Protocol Violation|2
5312281|NCT00366340|18301127|P2|After the Infant Series|Failed to return|1
5312282|NCT00366340|18301128|P1|After the Infant Series|Failed to return|0
5312283|NCT00366340|18301127|P2|After the Infant Series|Parent/legal guardian request|1
5312284|NCT00366340|18301128|P1|After the Infant Series|Parent/legal guardian request|1
5312285|NCT00366340|18301127|P2|Infant Series|Failure to return|0
5312286|NCT00366340|18301128|P1|Infant Series|Failure to return|1
5312287|NCT00366340|18301127|P2|Infant Series|Lost to Follow-up|1
5312288|NCT00366340|18301128|P1|Infant Series|Lost to Follow-up|1
5312289|NCT00366340|18301127|P2|Infant Series|Adverse Event|2
5312290|NCT00366340|18301128|P1|Infant Series|Adverse Event|0
5312291|NCT00366340|18301127|P2|Infant Series|Withdrawal by Subject|3
5312292|NCT00366340|18301128|P1|Infant Series|Withdrawal by Subject|3
5312293|NCT00366340|18301127|P2|Infant Series|Protocol Violation|4
5312294|NCT00366340|18301128|P1|Infant Series|Protocol Violation|3
5312295|NCT00366301|18301186|P4|Overall Study|Withdrawal by Subject|1
5312296|NCT00366301|18301187|P3|Overall Study|Withdrawal by Subject|1
5312297|NCT00366301|18301188|P2|Overall Study|Withdrawal by Subject|2
5312298|NCT00366301|18301189|P1|Overall Study|Withdrawal by Subject|4
5312299|NCT00366301|18301186|P4|Overall Study|Lost to Follow-up|7
5312300|NCT00366301|18301187|P3|Overall Study|Lost to Follow-up|3
5312301|NCT00366301|18301188|P2|Overall Study|Lost to Follow-up|4
5312302|NCT00366301|18301189|P1|Overall Study|Lost to Follow-up|4
5312303|NCT00366249|18301205|P2|Overall Study|Most due to osteomylitis status|20
5312304|NCT00366249|18301206|P1|Overall Study|Most due to osteomylitis status|31
5312305|NCT00366249|18301205|P2|Overall Study|Lack of Efficacy|21
5312306|NCT00366249|18301206|P1|Overall Study|Lack of Efficacy|21
5312307|NCT00366249|18301205|P2|Overall Study|Withdrawal by Subject|4
5312308|NCT00366249|18301206|P1|Overall Study|Withdrawal by Subject|18
5312309|NCT00366249|18301205|P2|Overall Study|Protocol Violation|2
5312310|NCT00366249|18301206|P1|Overall Study|Protocol Violation|1
5312311|NCT00366249|18301205|P2|Overall Study|Lost to Follow-up|0
5312312|NCT00366249|18301206|P1|Overall Study|Lost to Follow-up|2
5312313|NCT00366249|18301205|P2|Overall Study|Physician Decision|2
5312314|NCT00366249|18301206|P1|Overall Study|Physician Decision|5
5312315|NCT00366249|18301205|P2|Overall Study|Death|1
5312316|NCT00366249|18301206|P1|Overall Study|Death|0
5312317|NCT00366249|18301205|P2|Overall Study|Adverse Event|28
5312318|NCT00366249|18301206|P1|Overall Study|Adverse Event|53
5312319|NCT00365989|18301238|P1|Overall Study|Non-compliance|1
5312320|NCT00365989|18301238|P1|Overall Study|Withdrawal by Subject|1
5312321|NCT00365976|18301246|P2|Overall Study|Withdrawal by Subject|5
5312322|NCT00365976|18301247|P1|Overall Study|Withdrawal by Subject|1
5312323|NCT00365846|18301385|P1|Overall Study|Lost to Follow-up|1
5312324|NCT00365794|18301394|P1|Overall Study|Withdrawal by Subject|2
5312325|NCT00365716|18301423|P7|Extension 2|Withdrawal by Subject|5
5312326|NCT00365716|18301424|P6|Extension 2|Withdrawal by Subject|0
5312327|NCT00365716|18301425|P5|Extension 2|Withdrawal by Subject|0
5312328|NCT00365716|18301426|P4|Extension 2|Withdrawal by Subject|0
5312329|NCT00365716|18301427|P3|Extension 2|Withdrawal by Subject|0
5312330|NCT00365716|18301428|P2|Extension 2|Withdrawal by Subject|0
5312331|NCT00365716|18301429|P1|Extension 2|Withdrawal by Subject|0
5312332|NCT00365716|18301423|P7|Extension 2|Other|3
5312333|NCT00365716|18301424|P6|Extension 2|Other|0
5312334|NCT00365716|18301425|P5|Extension 2|Other|0
5312335|NCT00365716|18301426|P4|Extension 2|Other|0
5312336|NCT00365716|18301427|P3|Extension 2|Other|0
5312337|NCT00365716|18301428|P2|Extension 2|Other|0
5312338|NCT00365716|18301429|P1|Extension 2|Other|0
5312339|NCT00365716|18301423|P7|Extension 2|Lost to Follow-up|2
5312340|NCT00365716|18301424|P6|Extension 2|Lost to Follow-up|0
5312341|NCT00365716|18301425|P5|Extension 2|Lost to Follow-up|0
5312342|NCT00365716|18301426|P4|Extension 2|Lost to Follow-up|0
5312343|NCT00365716|18301427|P3|Extension 2|Lost to Follow-up|0
5312344|NCT00365716|18301428|P2|Extension 2|Lost to Follow-up|0
5312345|NCT00365716|18301429|P1|Extension 2|Lost to Follow-up|0
5312346|NCT00365716|18301423|P7|Extension 1|Protocol Violation|0
5312347|NCT00365716|18301424|P6|Extension 1|Protocol Violation|1
5312348|NCT00365716|18301425|P5|Extension 1|Protocol Violation|0
5312349|NCT00365716|18301426|P4|Extension 1|Protocol Violation|0
5312350|NCT00365716|18301427|P3|Extension 1|Protocol Violation|0
5312351|NCT00365716|18301428|P2|Extension 1|Protocol Violation|0
5312352|NCT00365716|18301429|P1|Extension 1|Protocol Violation|0
5312353|NCT00365716|18301423|P7|Extension 1|Pregnancy|0
5312354|NCT00365716|18301424|P6|Extension 1|Pregnancy|4
5312355|NCT00365716|18301425|P5|Extension 1|Pregnancy|0
5312356|NCT00365716|18301426|P4|Extension 1|Pregnancy|0
5312357|NCT00365716|18301427|P3|Extension 1|Pregnancy|0
5312358|NCT00365716|18301428|P2|Extension 1|Pregnancy|0
5312359|NCT00365716|18301429|P1|Extension 1|Pregnancy|0
5312360|NCT00365716|18301423|P7|Extension 1|Withdrawal by Subject|0
5312361|NCT00365716|18301424|P6|Extension 1|Withdrawal by Subject|3
5312362|NCT00365716|18301425|P5|Extension 1|Withdrawal by Subject|0
5312363|NCT00365716|18301426|P4|Extension 1|Withdrawal by Subject|0
5312364|NCT00365716|18301427|P3|Extension 1|Withdrawal by Subject|0
5312365|NCT00365716|18301428|P2|Extension 1|Withdrawal by Subject|0
5312366|NCT00365716|18301429|P1|Extension 1|Withdrawal by Subject|0
5312367|NCT00365716|18301423|P7|Extension 1|Moved|0
5312368|NCT00365716|18301424|P6|Extension 1|Moved|4
5312369|NCT00365716|18301425|P5|Extension 1|Moved|0
5312370|NCT00365716|18301426|P4|Extension 1|Moved|0
5312371|NCT00365716|18301427|P3|Extension 1|Moved|0
5312372|NCT00365716|18301428|P2|Extension 1|Moved|0
5312373|NCT00365716|18301429|P1|Extension 1|Moved|0
5312374|NCT00365716|18301423|P7|Extension 1|Other|0
5312375|NCT00365716|18301424|P6|Extension 1|Other|9
5312376|NCT00365716|18301425|P5|Extension 1|Other|0
5312377|NCT00365716|18301426|P4|Extension 1|Other|0
5312378|NCT00365716|18301427|P3|Extension 1|Other|0
5312379|NCT00365716|18301428|P2|Extension 1|Other|0
5312380|NCT00365716|18301429|P1|Extension 1|Other|0
5312381|NCT00365716|18301423|P7|Extension 1|Lost to Follow-up|0
5312382|NCT00365716|18301424|P6|Extension 1|Lost to Follow-up|1
5312383|NCT00365716|18301425|P5|Extension 1|Lost to Follow-up|0
5312384|NCT00365716|18301426|P4|Extension 1|Lost to Follow-up|0
5312385|NCT00365716|18301427|P3|Extension 1|Lost to Follow-up|0
5312386|NCT00365716|18301428|P2|Extension 1|Lost to Follow-up|0
5312387|NCT00365716|18301429|P1|Extension 1|Lost to Follow-up|0
5312388|NCT00365716|18301423|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
5312389|NCT00365716|18301424|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
5312390|NCT00365716|18301425|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
5312391|NCT00365716|18301426|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
5312392|NCT00365716|18301427|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
5312393|NCT00365716|18301428|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
5312394|NCT00365716|18301429|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
5312395|NCT00365716|18301423|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5312396|NCT00365716|18301424|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5312397|NCT00365716|18301425|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5312398|NCT00365716|18301426|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5312399|NCT00365716|18301427|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
5312400|NCT00365716|18301428|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
5312401|NCT00365716|18301429|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5312402|NCT00365716|18301423|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5312403|NCT00365716|18301424|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5312404|NCT00365716|18301425|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
5312405|NCT00365716|18301426|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5312406|NCT00365716|18301427|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5312407|NCT00365716|18301428|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5312408|NCT00365716|18301429|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
5312409|NCT00365716|18301423|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
5312410|NCT00365716|18301424|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
5312411|NCT00365716|18301425|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
5312412|NCT00365716|18301426|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
5312413|NCT00365716|18301427|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
5312414|NCT00365716|18301428|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
5312415|NCT00365716|18301429|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
5312416|NCT00365716|18301423|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
5312417|NCT00365716|18301424|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
5312418|NCT00365716|18301425|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
5312419|NCT00365716|18301426|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
5312420|NCT00365716|18301427|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
5312421|NCT00365716|18301428|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
5312422|NCT00365716|18301429|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
5312423|NCT00365716|18301423|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5312424|NCT00365716|18301424|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5312425|NCT00365716|18301425|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
5312426|NCT00365716|18301426|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
5312427|NCT00365716|18301427|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5312428|NCT00365716|18301428|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5312429|NCT00365716|18301429|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
5312430|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
5312431|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
5312432|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
5312433|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
5312434|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
5312435|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
5312436|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
5312437|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
5312438|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
5312439|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
5312440|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
5312441|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
5312442|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
5312443|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
5312444|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
5312445|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
5312446|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
5312447|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
5312448|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
5312449|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
5312450|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
5312451|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Other|0
5312452|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Other|0
5312453|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Other|0
5312454|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Other|0
5312455|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Other|0
5312456|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Other|1
5312457|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Other|0
5312458|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
5312459|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
5312460|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
5312461|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
5312462|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
5312463|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
5312464|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
5312465|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
5312466|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
5312467|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
5312468|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
5312469|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
5312470|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
5312471|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
5312472|NCT00365716|18301423|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5312473|NCT00365716|18301424|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5312474|NCT00365716|18301425|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5312475|NCT00365716|18301426|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5312476|NCT00365716|18301427|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5312477|NCT00365716|18301428|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
5312478|NCT00365716|18301429|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
5312479|NCT00365547|18301450|P1|Overall Study|Withdrawal by Subject|1
5312480|NCT00365547|18301450|P1|Overall Study|Screen failure|1
5312481|NCT00365547|18301450|P1|Overall Study|Insurance did not cover Avastin|1
5312482|NCT00365508|18301460|P2|Overall Study|Lost to Follow-up|154
5312483|NCT00365508|18301461|P1|Overall Study|Lost to Follow-up|139
5312484|NCT00365456|18301469|P2|Trial Period III (12 Months)|Other|1
5312485|NCT00365456|18301470|P1|Trial Period III (12 Months)|Other|1
5312486|NCT00365456|18301469|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
5312487|NCT00365456|18301470|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
5312488|NCT00365456|18301469|P2|Trial Period III (12 Months)|Adverse Event|3
5312489|NCT00365456|18301470|P1|Trial Period III (12 Months)|Adverse Event|13
5312490|NCT00365456|18301469|P2|Trial Period II (12 Months)|Other|1
5312491|NCT00365456|18301470|P1|Trial Period II (12 Months)|Other|0
5312492|NCT00365456|18301469|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
5312493|NCT00365456|18301470|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
5312494|NCT00365456|18301469|P2|Trial Period II (12 Months)|Non-compliance|2
5312495|NCT00365456|18301470|P1|Trial Period II (12 Months)|Non-compliance|0
5312496|NCT00365456|18301469|P2|Trial Period II (12 Months)|Adverse Event|6
5312497|NCT00365456|18301470|P1|Trial Period II (12 Months)|Adverse Event|0
5312498|NCT00365456|18301469|P2|Trial Period I (12 Months)|Other|0
5312499|NCT00365456|18301470|P1|Trial Period I (12 Months)|Other|11
5312500|NCT00365456|18301469|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
5312501|NCT00365456|18301470|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
5312502|NCT00365456|18301469|P2|Trial Period I (12 Months)|Non-compliance|0
5312503|NCT00365456|18301470|P1|Trial Period I (12 Months)|Non-compliance|3
5312504|NCT00365456|18301469|P2|Trial Period I (12 Months)|Adverse Event|0
5312505|NCT00365456|18301470|P1|Trial Period I (12 Months)|Adverse Event|84
5312506|NCT00365378|18301497|P3|Extension|Other|31
5312507|NCT00365378|18301498|P2|Extension|Other|0
5312508|NCT00365378|18301499|P1|Extension|Other|0
5312509|NCT00365378|18301497|P3|Extension|Withdrawal by Subject|98
5312510|NCT00365378|18301498|P2|Extension|Withdrawal by Subject|0
5312511|NCT00365378|18301499|P1|Extension|Withdrawal by Subject|0
5312512|NCT00365378|18301497|P3|Extension|Protocol Violation|2
5312513|NCT00365378|18301498|P2|Extension|Protocol Violation|0
5312514|NCT00365378|18301499|P1|Extension|Protocol Violation|0
5312515|NCT00365378|18301497|P3|Extension|Lost to Follow-up|57
5312516|NCT00365378|18301498|P2|Extension|Lost to Follow-up|0
5312517|NCT00365378|18301499|P1|Extension|Lost to Follow-up|0
5312518|NCT00365378|18301497|P3|Extension|Moved|8
5312519|NCT00365378|18301498|P2|Extension|Moved|0
5312520|NCT00365378|18301499|P1|Extension|Moved|0
5312521|NCT00365378|18301497|P3|Extension|Adverse Event|1
5312522|NCT00365378|18301498|P2|Extension|Adverse Event|0
5312523|NCT00365378|18301499|P1|Extension|Adverse Event|0
5312524|NCT00365378|18301497|P3|Follow-up (Month 7 Though Month 48)|Other|0
5312525|NCT00365378|18301498|P2|Follow-up (Month 7 Though Month 48)|Other|21
5312526|NCT00365378|18301499|P1|Follow-up (Month 7 Though Month 48)|Other|11
5312527|NCT00365378|18301497|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
5312528|NCT00365378|18301498|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
5312529|NCT00365378|18301499|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
5312530|NCT00365378|18301497|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
5312531|NCT00365378|18301498|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
5312532|NCT00365378|18301499|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
5312533|NCT00365378|18301497|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
5312534|NCT00365378|18301498|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
5312535|NCT00365378|18301499|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
5312536|NCT00365378|18301497|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
5312537|NCT00365378|18301498|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
5312538|NCT00365378|18301499|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
5312539|NCT00365378|18301497|P3|Follow-up (Month 7 Though Month 48)|Moved|0
5312540|NCT00365378|18301498|P2|Follow-up (Month 7 Though Month 48)|Moved|5
5312541|NCT00365378|18301499|P1|Follow-up (Month 7 Though Month 48)|Moved|6
5312542|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Other|0
5312543|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Other|9
5312544|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Other|17
5312545|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
5312546|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
5312547|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
5312548|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
5312549|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
5312550|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
5312551|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
5312552|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
5312553|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
5312554|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
5312555|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
5312556|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
5312557|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
5312558|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
5312559|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
5312560|NCT00365378|18301497|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
5312561|NCT00365378|18301498|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
5312562|NCT00365378|18301499|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
5312563|NCT00365365|18301513|P3|Overall Study|Patient/physician decision|1
5312564|NCT00365365|18301514|P2|Overall Study|Patient/physician decision|0
5312565|NCT00365365|18301515|P1|Overall Study|Patient/physician decision|0
5312566|NCT00365365|18301513|P3|Overall Study|Second malignancy|0
5312567|NCT00365365|18301514|P2|Overall Study|Second malignancy|1
5312568|NCT00365365|18301515|P1|Overall Study|Second malignancy|0
5312569|NCT00365365|18301513|P3|Overall Study|Withdrew consent|0
5312570|NCT00365365|18301514|P2|Overall Study|Withdrew consent|1
5312571|NCT00365365|18301515|P1|Overall Study|Withdrew consent|1
5312572|NCT00365365|18301513|P3|Overall Study|New cancer|0
5312573|NCT00365365|18301514|P2|Overall Study|New cancer|0
5312574|NCT00365365|18301515|P1|Overall Study|New cancer|1
5312575|NCT00365365|18301513|P3|Overall Study|Moved|0
5312576|NCT00365365|18301514|P2|Overall Study|Moved|0
5312577|NCT00365365|18301515|P1|Overall Study|Moved|2
5312578|NCT00365365|18301513|P3|Overall Study|Adverse Event|3
5312579|NCT00365365|18301514|P2|Overall Study|Adverse Event|6
5312580|NCT00365365|18301515|P1|Overall Study|Adverse Event|6
5312581|NCT00365365|18301513|P3|Overall Study|Disease progression/relapse|7
5312582|NCT00365365|18301514|P2|Overall Study|Disease progression/relapse|6
5312583|NCT00365365|18301515|P1|Overall Study|Disease progression/relapse|9
5312584|NCT00365365|18301513|P3|Overall Study|Subject's request|1
5312585|NCT00365365|18301514|P2|Overall Study|Subject's request|13
5312586|NCT00365365|18301515|P1|Overall Study|Subject's request|11
5312587|NCT00365365|18301513|P3|Overall Study|Death|0
5312588|NCT00365365|18301514|P2|Overall Study|Death|3
5312589|NCT00365365|18301515|P1|Overall Study|Death|1
5312590|NCT00365365|18301513|P3|Overall Study|Lost to Follow-up|3
5312591|NCT00365365|18301514|P2|Overall Study|Lost to Follow-up|3
5312592|NCT00365365|18301515|P1|Overall Study|Lost to Follow-up|3
5312593|NCT00365365|18301513|P3|Overall Study|Poor compliance to protocol|0
5312594|NCT00365365|18301514|P2|Overall Study|Poor compliance to protocol|1
5312595|NCT00365365|18301515|P1|Overall Study|Poor compliance to protocol|0
5312596|NCT00365365|18301513|P3|Overall Study|Randomized but not treated|0
5312597|NCT00365365|18301514|P2|Overall Study|Randomized but not treated|2
5312598|NCT00365365|18301515|P1|Overall Study|Randomized but not treated|0
5312599|NCT00365352|18301532|P3|Overall Study|Withdrawal of Participant by Sponsor|0
5312600|NCT00365352|18301533|P2|Overall Study|Withdrawal of Participant by Sponsor|0
5312601|NCT00365352|18301534|P1|Overall Study|Withdrawal of Participant by Sponsor|1
5312602|NCT00365352|18301532|P3|Overall Study|Lost to Follow-up|0
5312603|NCT00365352|18301533|P2|Overall Study|Lost to Follow-up|1
5312604|NCT00365352|18301534|P1|Overall Study|Lost to Follow-up|1
5312605|NCT00365352|18301532|P3|Overall Study|Non-Compliance (after Randomization)|1
5312606|NCT00365352|18301533|P2|Overall Study|Non-Compliance (after Randomization)|0
5312607|NCT00365352|18301534|P1|Overall Study|Non-Compliance (after Randomization)|1
5312608|NCT00365352|18301532|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
5312609|NCT00365352|18301533|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
5312610|NCT00365352|18301534|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
5312611|NCT00365352|18301532|P3|Overall Study|Lack of Efficacy|0
5312612|NCT00365352|18301533|P2|Overall Study|Lack of Efficacy|0
5312613|NCT00365352|18301534|P1|Overall Study|Lack of Efficacy|3
5312614|NCT00365352|18301532|P3|Overall Study|Participant Withdrew Consent|4
5312615|NCT00365352|18301533|P2|Overall Study|Participant Withdrew Consent|3
5312616|NCT00365352|18301534|P1|Overall Study|Participant Withdrew Consent|8
5312617|NCT00365352|18301532|P3|Overall Study|Adverse Event|8
5312618|NCT00365352|18301533|P2|Overall Study|Adverse Event|7
5312619|NCT00365352|18301534|P1|Overall Study|Adverse Event|6
5312620|NCT00365300|18301618|P2|Double-blind Phase|Lack of Efficacy|6
5312621|NCT00365300|18301619|P1|Double-blind Phase|Lack of Efficacy|6
5312622|NCT00365300|18301618|P2|Double-blind Phase|Protocol Violation|1
5312623|NCT00365300|18301619|P1|Double-blind Phase|Protocol Violation|3
5312624|NCT00365300|18301618|P2|Double-blind Phase|Withdrawal by Subject|1
5312625|NCT00365300|18301619|P1|Double-blind Phase|Withdrawal by Subject|0
5312626|NCT00365300|18301618|P2|Double-blind Phase|Noncompliance|1
5312627|NCT00365300|18301619|P1|Double-blind Phase|Noncompliance|1
5312628|NCT00365300|18301618|P2|Double-blind Phase|Failed to return|0
5312629|NCT00365300|18301619|P1|Double-blind Phase|Failed to return|1
5312630|NCT00365300|18301618|P2|Open-label Phase|Patient skipped open label phase|0
5312631|NCT00365300|18301619|P1|Open-label Phase|Patient skipped open label phase|1
5312632|NCT00365300|18301618|P2|Open-label Phase|Lack of Efficacy|0
5312633|NCT00365300|18301619|P1|Open-label Phase|Lack of Efficacy|1
5312634|NCT00365300|18301618|P2|Open-label Phase|Protocol Violation|0
5312635|NCT00365300|18301619|P1|Open-label Phase|Protocol Violation|1
5312636|NCT00365300|18301618|P2|Open-label Phase|Parent/Legal Guardian Request|0
5312637|NCT00365300|18301619|P1|Open-label Phase|Parent/Legal Guardian Request|4
5312638|NCT00365300|18301618|P2|Open-label Phase|Noncompliance|0
5312639|NCT00365300|18301619|P1|Open-label Phase|Noncompliance|9
5312640|NCT00365300|18301618|P2|Open-label Phase|Physician Decision|0
5312641|NCT00365300|18301619|P1|Open-label Phase|Physician Decision|1
5312642|NCT00365300|18301618|P2|Open-label Phase|Failed to Return|0
5312643|NCT00365300|18301619|P1|Open-label Phase|Failed to Return|1
5312644|NCT00365300|18301618|P2|Open-label Phase|Adverse Event|0
5312645|NCT00365300|18301619|P1|Open-label Phase|Adverse Event|4
5312646|NCT00365105|18301684|P2|Overall Study|Protocol Violation|8
5312647|NCT00365105|18301685|P1|Overall Study|Protocol Violation|5
5312648|NCT00364923|18301731|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
5312649|NCT00364923|18301731|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
5312650|NCT00364858|18301740|P2|Overall Study|Clinical baseline issue|1
5312651|NCT00364858|18301741|P1|Overall Study|Clinical baseline issue|0
5312652|NCT00364858|18301740|P2|Overall Study|Return to Q2 regimen|1
5312653|NCT00364858|18301741|P1|Overall Study|Return to Q2 regimen|0
5312654|NCT00364858|18301740|P2|Overall Study|Non-compliant|0
5312655|NCT00364858|18301741|P1|Overall Study|Non-compliant|1
5312656|NCT00364858|18301740|P2|Overall Study|Discontinuation at baseline|0
5312657|NCT00364858|18301741|P1|Overall Study|Discontinuation at baseline|1
5312658|NCT00364858|18301740|P2|Overall Study|Clinical failure|13
5312659|NCT00364858|18301741|P1|Overall Study|Clinical failure|2
5312660|NCT00364858|18301740|P2|Overall Study|Pregnancy|1
5312661|NCT00364858|18301741|P1|Overall Study|Pregnancy|1
5312662|NCT00364858|18301740|P2|Overall Study|Withdrawal by Subject|1
5312663|NCT00364858|18301741|P1|Overall Study|Withdrawal by Subject|1
5312664|NCT00364858|18301740|P2|Overall Study|Adverse Event|5
5312665|NCT00364858|18301741|P1|Overall Study|Adverse Event|1
5312666|NCT00364845|18301756|P2|Overall Study|Death|1
5312667|NCT00364845|18301757|P1|Overall Study|Death|0
5312668|NCT00364845|18301756|P2|Overall Study|Lost to Follow-up|1
5312669|NCT00364845|18301757|P1|Overall Study|Lost to Follow-up|0
5312670|NCT00364845|18301756|P2|Overall Study|Physician Decision|8
5312671|NCT00364845|18301757|P1|Overall Study|Physician Decision|8
5312672|NCT00364845|18301756|P2|Overall Study|Withdrawal by Subject|1
5312673|NCT00364845|18301757|P1|Overall Study|Withdrawal by Subject|2
5312674|NCT00364845|18301756|P2|Overall Study|Adverse Event|0
5312675|NCT00364845|18301757|P1|Overall Study|Adverse Event|1
5312676|NCT00364832|18301778|P12|Extension Year 2|Early Withdrawals|3
5312677|NCT00364832|18301779|P11|Extension Year 2|Early Withdrawals|5
5312678|NCT00364832|18301780|P10|Extension Year 2|Early Withdrawals|5
5312679|NCT00364832|18301781|P9|Extension Year 2|Early Withdrawals|0
5312680|NCT00364832|18301782|P8|Extension Year 2|Early Withdrawals|0
5312681|NCT00364832|18301783|P7|Extension Year 2|Early Withdrawals|0
5312682|NCT00364832|18301784|P6|Extension Year 2|Early Withdrawals|0
5312683|NCT00364832|18301785|P5|Extension Year 2|Early Withdrawals|0
5312684|NCT00364832|18301786|P4|Extension Year 2|Early Withdrawals|0
5312685|NCT00364832|18301787|P3|Extension Year 2|Early Withdrawals|0
5312686|NCT00364832|18301788|P2|Extension Year 2|Early Withdrawals|0
5312687|NCT00364832|18301789|P1|Extension Year 2|Early Withdrawals|0
5312688|NCT00364832|18301778|P12|Extension Year 1|Early Withdrawals|10
5312689|NCT00364832|18301779|P11|Extension Year 1|Early Withdrawals|2
5312690|NCT00364832|18301780|P10|Extension Year 1|Early Withdrawals|4
5312691|NCT00364832|18301781|P9|Extension Year 1|Early Withdrawals|0
5312692|NCT00364832|18301782|P8|Extension Year 1|Early Withdrawals|0
5312693|NCT00364832|18301783|P7|Extension Year 1|Early Withdrawals|0
5312694|NCT00364832|18301784|P6|Extension Year 1|Early Withdrawals|0
5312695|NCT00364832|18301785|P5|Extension Year 1|Early Withdrawals|0
5312696|NCT00364832|18301786|P4|Extension Year 1|Early Withdrawals|0
5312697|NCT00364832|18301787|P3|Extension Year 1|Early Withdrawals|0
5312698|NCT00364832|18301788|P2|Extension Year 1|Early Withdrawals|0
5312699|NCT00364832|18301789|P1|Extension Year 1|Early Withdrawals|0
5312700|NCT00364832|18301778|P12|Core Period|Early Withdrawals|0
5312701|NCT00364832|18301779|P11|Core Period|Early Withdrawals|0
5312702|NCT00364832|18301780|P10|Core Period|Early Withdrawals|0
5312703|NCT00364832|18301781|P9|Core Period|Early Withdrawals|0
5312704|NCT00364832|18301782|P8|Core Period|Early Withdrawals|1
5312705|NCT00364832|18301783|P7|Core Period|Early Withdrawals|4
5312706|NCT00364832|18301784|P6|Core Period|Early Withdrawals|0
5312707|NCT00364832|18301785|P5|Core Period|Early Withdrawals|0
5312708|NCT00364832|18301786|P4|Core Period|Early Withdrawals|1
5312709|NCT00364832|18301787|P3|Core Period|Early Withdrawals|1
5312710|NCT00364832|18301788|P2|Core Period|Early Withdrawals|2
5312711|NCT00364832|18301789|P1|Core Period|Early Withdrawals|2
5312712|NCT00364793|18301854|P4|Overall Study|Withdrawal by Subject|0
5312713|NCT00364793|18301855|P3|Overall Study|Withdrawal by Subject|0
5312714|NCT00364793|18301856|P2|Overall Study|Withdrawal by Subject|1
5312715|NCT00364793|18301857|P1|Overall Study|Withdrawal by Subject|0
5312716|NCT00364793|18301854|P4|Overall Study|No longer meets criteria|1
5312717|NCT00364793|18301855|P3|Overall Study|No longer meets criteria|0
5312718|NCT00364793|18301856|P2|Overall Study|No longer meets criteria|0
5312719|NCT00364793|18301857|P1|Overall Study|No longer meets criteria|0
5312720|NCT00364793|18301854|P4|Overall Study|Poor or non-compliance|1
5312721|NCT00364793|18301855|P3|Overall Study|Poor or non-compliance|0
5312722|NCT00364793|18301856|P2|Overall Study|Poor or non-compliance|1
5312723|NCT00364793|18301857|P1|Overall Study|Poor or non-compliance|1
5312724|NCT00364793|18301854|P4|Overall Study|Lost to Follow-up|0
5312725|NCT00364793|18301855|P3|Overall Study|Lost to Follow-up|2
5312726|NCT00364793|18301856|P2|Overall Study|Lost to Follow-up|0
5312727|NCT00364793|18301857|P1|Overall Study|Lost to Follow-up|1
5312728|NCT00364793|18301854|P4|Overall Study|Lack of Efficacy|1
5312729|NCT00364793|18301855|P3|Overall Study|Lack of Efficacy|1
5312730|NCT00364793|18301856|P2|Overall Study|Lack of Efficacy|3
5312731|NCT00364793|18301857|P1|Overall Study|Lack of Efficacy|3
5312732|NCT00364793|18301854|P4|Overall Study|Death|0
5312733|NCT00364793|18301855|P3|Overall Study|Death|1
5312734|NCT00364793|18301856|P2|Overall Study|Death|0
5312735|NCT00364793|18301857|P1|Overall Study|Death|1
5312736|NCT00364793|18301854|P4|Overall Study|Adverse Event|0
5312737|NCT00364793|18301855|P3|Overall Study|Adverse Event|0
5312738|NCT00364793|18301856|P2|Overall Study|Adverse Event|0
5312739|NCT00364793|18301857|P1|Overall Study|Adverse Event|2
5312740|NCT00364689|18301994|P1|Overall Study|Lost to Follow-up|1
5312741|NCT00364611|18302014|P2|Overall Study|Receiving Liver Ablation|1
5312742|NCT00364611|18302015|P1|Overall Study|Receiving Liver Ablation|0
5312743|NCT00364611|18302014|P2|Overall Study|Presumed CR on Study|1
5312744|NCT00364611|18302015|P1|Overall Study|Presumed CR on Study|0
5312745|NCT00364611|18302014|P2|Overall Study|Found Ineligible|0
5312746|NCT00364611|18302015|P1|Overall Study|Found Ineligible|1
5312747|NCT00364611|18302014|P2|Overall Study|Investigator decision|2
5312748|NCT00364611|18302015|P1|Overall Study|Investigator decision|2
5312749|NCT00364611|18302014|P2|Overall Study|Disease Progression|8
5312750|NCT00364611|18302015|P1|Overall Study|Disease Progression|38
5312751|NCT00364611|18302014|P2|Overall Study|Participant's Request|4
5312752|NCT00364611|18302015|P1|Overall Study|Participant's Request|3
5312753|NCT00364611|18302014|P2|Overall Study|Adverse Event|4
5312754|NCT00364611|18302015|P1|Overall Study|Adverse Event|7
5312755|NCT00364611|18302014|P2|Overall Study|Did not receive study medication|1
5312756|NCT00364611|18302015|P1|Overall Study|Did not receive study medication|0
5312757|NCT00364533|18302038|P5|Overall Study|Protocol Violation|0
5312758|NCT00364533|18302039|P4|Overall Study|Protocol Violation|0
5312759|NCT00364533|18302040|P3|Overall Study|Protocol Violation|0
5312760|NCT00364533|18302041|P2|Overall Study|Protocol Violation|1
5312761|NCT00364533|18302042|P1|Overall Study|Protocol Violation|1
5312762|NCT00364533|18302038|P5|Overall Study|Non-compliance|0
5312763|NCT00364533|18302039|P4|Overall Study|Non-compliance|0
5312764|NCT00364533|18302040|P3|Overall Study|Non-compliance|0
5312765|NCT00364533|18302041|P2|Overall Study|Non-compliance|0
5312766|NCT00364533|18302042|P1|Overall Study|Non-compliance|1
5312767|NCT00364533|18302038|P5|Overall Study|Variations in drug compliance|0
5312768|NCT00364533|18302039|P4|Overall Study|Variations in drug compliance|0
5312769|NCT00364533|18302040|P3|Overall Study|Variations in drug compliance|1
5312770|NCT00364533|18302041|P2|Overall Study|Variations in drug compliance|1
5312771|NCT00364533|18302042|P1|Overall Study|Variations in drug compliance|2
5312772|NCT00364533|18302038|P5|Overall Study|Subject discharged from hospital|1
5312773|NCT00364533|18302039|P4|Overall Study|Subject discharged from hospital|3
5312774|NCT00364533|18302040|P3|Overall Study|Subject discharged from hospital|2
5312775|NCT00364533|18302041|P2|Overall Study|Subject discharged from hospital|1
5312776|NCT00364533|18302042|P1|Overall Study|Subject discharged from hospital|4
5312777|NCT00364533|18302038|P5|Overall Study|Lack of Efficacy|42
5312778|NCT00364533|18302039|P4|Overall Study|Lack of Efficacy|17
5312779|NCT00364533|18302040|P3|Overall Study|Lack of Efficacy|21
5312780|NCT00364533|18302041|P2|Overall Study|Lack of Efficacy|22
5312781|NCT00364533|18302042|P1|Overall Study|Lack of Efficacy|22
5312782|NCT00364533|18302038|P5|Overall Study|Withdrawal by Subject|6
5312783|NCT00364533|18302039|P4|Overall Study|Withdrawal by Subject|6
5312784|NCT00364533|18302040|P3|Overall Study|Withdrawal by Subject|6
5312785|NCT00364533|18302041|P2|Overall Study|Withdrawal by Subject|8
5312786|NCT00364533|18302042|P1|Overall Study|Withdrawal by Subject|4
5312787|NCT00364533|18302038|P5|Overall Study|Adverse Event|2
5312788|NCT00364533|18302039|P4|Overall Study|Adverse Event|5
5312789|NCT00364533|18302040|P3|Overall Study|Adverse Event|15
5312790|NCT00364533|18302041|P2|Overall Study|Adverse Event|7
5312791|NCT00364533|18302042|P1|Overall Study|Adverse Event|8
5312792|NCT00364351|18302075|P2|Overall Study|Randomised treatment not started|3
5312793|NCT00364351|18302076|P1|Overall Study|Randomised treatment not started|0
5312794|NCT00364351|18302075|P2|Overall Study|Patient could not travel to site|1
5312795|NCT00364351|18302076|P1|Overall Study|Patient could not travel to site|0
5312796|NCT00364351|18302075|P2|Overall Study|Investigator error|2
5312797|NCT00364351|18302076|P1|Overall Study|Investigator error|0
5312798|NCT00364351|18302075|P2|Overall Study|Poor treatment compliance|3
5312799|NCT00364351|18302076|P1|Overall Study|Poor treatment compliance|0
5312800|NCT00364351|18302075|P2|Overall Study|Sponsor decision|0
5312801|NCT00364351|18302076|P1|Overall Study|Sponsor decision|1
5312802|NCT00364351|18302075|P2|Overall Study|Incorrect enrollment|1
5312803|NCT00364351|18302076|P1|Overall Study|Incorrect enrollment|1
5312804|NCT00364351|18302075|P2|Overall Study|Withdrawal by Subject|29
5312805|NCT00364351|18302076|P1|Overall Study|Withdrawal by Subject|30
5312806|NCT00364351|18302075|P2|Overall Study|Lost to Follow-up|1
5312807|NCT00364351|18302076|P1|Overall Study|Lost to Follow-up|1
5312808|NCT00364351|18302075|P2|Overall Study|Prohibited concomitant medication|2
5312809|NCT00364351|18302076|P1|Overall Study|Prohibited concomitant medication|0
5312810|NCT00364351|18302075|P2|Overall Study|Condition under investigation worsened|497
5312811|NCT00364351|18302076|P1|Overall Study|Condition under investigation worsened|469
5312812|NCT00364351|18302075|P2|Overall Study|Adverse Event|44
5312813|NCT00364351|18302076|P1|Overall Study|Adverse Event|90
5312814|NCT00364286|18302094|P1|Overall Study|Adverse Event|2
5312815|NCT00364286|18302094|P1|Overall Study|Withdrawal by Subject|1
5312816|NCT00364182|18302101|P3|Third Intervention|Lost to Follow-up|1
5312817|NCT00364182|18302102|P2|Third Intervention|Lost to Follow-up|0
5312818|NCT00364182|18302103|P1|Third Intervention|Lost to Follow-up|0
5312819|NCT00364182|18302101|P3|Third Intervention|non-compliance|0
5312820|NCT00364182|18302102|P2|Third Intervention|non-compliance|1
5312821|NCT00364182|18302103|P1|Third Intervention|non-compliance|0
5312822|NCT00364182|18302101|P3|Second Intervention|Adverse Event|1
5312823|NCT00364182|18302102|P2|Second Intervention|Adverse Event|0
5312824|NCT00364182|18302103|P1|Second Intervention|Adverse Event|0
5312825|NCT00364182|18302101|P3|Second Intervention|Protocol Violation|0
5312826|NCT00364182|18302102|P2|Second Intervention|Protocol Violation|1
5312827|NCT00364182|18302103|P1|Second Intervention|Protocol Violation|0
5312828|NCT00364182|18302101|P3|Second Intervention|non-compliance|1
5312829|NCT00364182|18302102|P2|Second Intervention|non-compliance|1
5312830|NCT00364182|18302103|P1|Second Intervention|non-compliance|0
5312831|NCT00364182|18302101|P3|First Intervention|Withdrawal by Subject|0
5312832|NCT00364182|18302102|P2|First Intervention|Withdrawal by Subject|0
5312833|NCT00364182|18302103|P1|First Intervention|Withdrawal by Subject|2
5312834|NCT00364182|18302101|P3|First Intervention|Secondary prophylaxis|0
5312835|NCT00364182|18302102|P2|First Intervention|Secondary prophylaxis|0
5312836|NCT00364182|18302103|P1|First Intervention|Secondary prophylaxis|1
5312837|NCT00364156|18302137|P2|Overall Study|Protocol Violation|1
5312838|NCT00364156|18302138|P1|Overall Study|Protocol Violation|6
5312839|NCT00364156|18302137|P2|Overall Study|Withdrawal by Subject|80
5312840|NCT00364156|18302138|P1|Overall Study|Withdrawal by Subject|73
5312841|NCT00364130|18302146|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
5312842|NCT00364130|18302147|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
5312843|NCT00364130|18302146|P2|Intervention Period|Withdrawal by Subject|5
5312844|NCT00364130|18302147|P1|Intervention Period|Withdrawal by Subject|4
5312845|NCT00364130|18302146|P2|Intervention Period|Pregnancy|0
5312846|NCT00364130|18302147|P1|Intervention Period|Pregnancy|1
5312847|NCT00364130|18302146|P2|Intervention Period|Lost to Follow-up|3
5312848|NCT00364130|18302147|P1|Intervention Period|Lost to Follow-up|4
5312849|NCT00364013|18302169|P2|Overall Study|Ongoing|13
5312850|NCT00364013|18302170|P1|Overall Study|Ongoing|20
5312851|NCT00364013|18302169|P2|Overall Study|Other|47
5312852|NCT00364013|18302170|P1|Overall Study|Other|41
5312853|NCT00364013|18302169|P2|Overall Study|Protocol-specified criteria|6
5312854|NCT00364013|18302170|P1|Overall Study|Protocol-specified criteria|6
5312855|NCT00364013|18302169|P2|Overall Study|Lost to Follow-up|3
5312856|NCT00364013|18302170|P1|Overall Study|Lost to Follow-up|10
5312857|NCT00364013|18302169|P2|Overall Study|Physician Decision|3
5312858|NCT00364013|18302170|P1|Overall Study|Physician Decision|3
5312859|NCT00364013|18302169|P2|Overall Study|Withdrawal by Subject|18
5312860|NCT00364013|18302170|P1|Overall Study|Withdrawal by Subject|13
5312861|NCT00364013|18302169|P2|Overall Study|Adverse Event|3
5312862|NCT00364013|18302170|P1|Overall Study|Adverse Event|4
5312863|NCT00364013|18302169|P2|Overall Study|Ineligibility determined|2
5312864|NCT00364013|18302170|P1|Overall Study|Ineligibility determined|4
5312865|NCT00363896|18302198|P2|Overall Study|Other|2
5312866|NCT00363896|18302199|P1|Overall Study|Other|1
5312867|NCT00363896|18302198|P2|Overall Study|Non-fulfilment of entry criteria|0
5312868|NCT00363896|18302199|P1|Overall Study|Non-fulfilment of entry criteria|1
5312869|NCT00363896|18302198|P2|Overall Study|Lost to Follow-up|0
5312870|NCT00363896|18302199|P1|Overall Study|Lost to Follow-up|3
5312871|NCT00363896|18302198|P2|Overall Study|Protocol Violation|1
5312872|NCT00363896|18302199|P1|Overall Study|Protocol Violation|6
5312873|NCT00363896|18302198|P2|Overall Study|Lack of Efficacy|8
5312874|NCT00363896|18302199|P1|Overall Study|Lack of Efficacy|12
5312875|NCT00363896|18302198|P2|Overall Study|COPD exacerbation|7
5312876|NCT00363896|18302199|P1|Overall Study|COPD exacerbation|13
5312877|NCT00363896|18302198|P2|Overall Study|Adverse Event|13
5312878|NCT00363896|18302199|P1|Overall Study|Adverse Event|24
5312879|NCT00363896|18302198|P2|Overall Study|Withdrawal by Subject|16
5312880|NCT00363896|18302199|P1|Overall Study|Withdrawal by Subject|29
5312881|NCT00363766|18302240|P2|Overall Study|Physician Decision|2
5312882|NCT00363766|18302241|P1|Overall Study|Physician Decision|1
5312883|NCT00363766|18302240|P2|Overall Study|Withdrawal by Subject|0
5312884|NCT00363766|18302241|P1|Overall Study|Withdrawal by Subject|2
5312885|NCT00363766|18302240|P2|Overall Study|Not Disease Related Death|4
5312886|NCT00363766|18302241|P1|Overall Study|Not Disease Related Death|3
5312887|NCT00363766|18302240|P2|Overall Study|Disease Related Death|3
5312888|NCT00363766|18302241|P1|Overall Study|Disease Related Death|1
5312889|NCT00363766|18302240|P2|Overall Study|Adverse Event|2
5312890|NCT00363766|18302241|P1|Overall Study|Adverse Event|10
5312891|NCT00363766|18302240|P2|Overall Study|Progressive Disease|9
5312892|NCT00363766|18302241|P1|Overall Study|Progressive Disease|15
5312893|NCT00363649|18302270|P2|Overall Study|Adverse Event|0
5312894|NCT00363649|18302271|P1|Overall Study|Adverse Event|6
5312895|NCT00363649|18302270|P2|Overall Study|Withdrawal by Subject|1
5312896|NCT00363649|18302271|P1|Overall Study|Withdrawal by Subject|1
5312897|NCT00363545|18302287|P2|Overall Study|Others|0
5312898|NCT00363545|18302288|P1|Overall Study|Others|1
5312899|NCT00363545|18302287|P2|Overall Study|Lost to follow-up (complete vaccination)|17
5312900|NCT00363545|18302288|P1|Overall Study|Lost to follow-up (complete vaccination)|14
5312901|NCT00363545|18302287|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
5312902|NCT00363545|18302288|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
5312903|NCT00363545|18302287|P2|Overall Study|Migrated/moved from study area|6
5312904|NCT00363545|18302288|P1|Overall Study|Migrated/moved from study area|3
5312905|NCT00363545|18302287|P2|Overall Study|Withdrawal by Subject|15
5312906|NCT00363545|18302288|P1|Overall Study|Withdrawal by Subject|12
5312907|NCT00363545|18302287|P2|Overall Study|Serious Adverse Event|1
5312908|NCT00363545|18302288|P1|Overall Study|Serious Adverse Event|0
5312909|NCT00363480|18302306|P1|Overall Study|Participant discontinued on its own|1
5312910|NCT00363480|18302306|P1|Overall Study|Non-compliance of subject|1
5312911|NCT00363480|18302306|P1|Overall Study|Withdrawal by Subject|5
5312912|NCT00363480|18302306|P1|Overall Study|Lost to Follow-up|5
5312913|NCT00363480|18302306|P1|Overall Study|Adverse Event|4
5312914|NCT00363480|18302306|P1|Overall Study|Criteria for treatment period not fulfil|1
5312915|NCT00363467|18302326|P1|Overall Study|Physician Decision|1
5312916|NCT00363415|18302336|P2|Overall Study|Protocol Violation|4
5312917|NCT00363415|18302337|P1|Overall Study|Protocol Violation|1
5312918|NCT00363415|18302336|P2|Overall Study|Lost to Follow-up|3
5312919|NCT00363415|18302337|P1|Overall Study|Lost to Follow-up|3
5312920|NCT00363415|18302336|P2|Overall Study|Withdrawal by Subject|15
5312921|NCT00363415|18302337|P1|Overall Study|Withdrawal by Subject|9
5312922|NCT00363415|18302336|P2|Overall Study|Entry Criteria Not Met|10
5312923|NCT00363415|18302337|P1|Overall Study|Entry Criteria Not Met|11
5312924|NCT00363415|18302336|P2|Overall Study|Physician Decision|35
5312925|NCT00363415|18302337|P1|Overall Study|Physician Decision|18
5312926|NCT00363415|18302336|P2|Overall Study|Adverse Event|15
5312927|NCT00363415|18302337|P1|Overall Study|Adverse Event|24
5312928|NCT00363415|18302336|P2|Overall Study|Death|29
5312929|NCT00363415|18302337|P1|Overall Study|Death|32
5312930|NCT00363415|18302336|P2|Overall Study|Sponsor Decision|31
5312931|NCT00363415|18302337|P1|Overall Study|Sponsor Decision|67
5312932|NCT00363415|18302336|P2|Overall Study|Progressive Disease|107
5312933|NCT00363415|18302337|P1|Overall Study|Progressive Disease|196
5312934|NCT00363311|18302355|P2|Overall Study|Participant Moved to Louisiana|1
5312935|NCT00363311|18302356|P1|Overall Study|Participant Moved to Louisiana|0
5312936|NCT00363311|18302355|P2|Overall Study|Withdrawn per Instructions of Monitor|1
5312937|NCT00363311|18302356|P1|Overall Study|Withdrawn per Instructions of Monitor|0
5312938|NCT00363311|18302355|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
5312939|NCT00363311|18302356|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
5312940|NCT00363311|18302355|P2|Overall Study|Participant Moved to Another Country|0
5312941|NCT00363311|18302356|P1|Overall Study|Participant Moved to Another Country|1
5312942|NCT00363311|18302355|P2|Overall Study|Participant Opted for Treatment|0
5312943|NCT00363311|18302356|P1|Overall Study|Participant Opted for Treatment|1
5312944|NCT00363311|18302355|P2|Overall Study|Prostate Volume/PSA Doubled|0
5312945|NCT00363311|18302356|P1|Overall Study|Prostate Volume/PSA Doubled|1
5312946|NCT00363311|18302355|P2|Overall Study|Participant Refused Biopsy|0
5312947|NCT00363311|18302356|P1|Overall Study|Participant Refused Biopsy|1
5312948|NCT00363311|18302355|P2|Overall Study|Non-Compliance|1
5312949|NCT00363311|18302356|P1|Overall Study|Non-Compliance|1
5312950|NCT00363311|18302355|P2|Overall Study|Disease Progression|26
5312951|NCT00363311|18302356|P1|Overall Study|Disease Progression|46
5312952|NCT00363311|18302355|P2|Overall Study|Sponsor Terminated Study|2
5312953|NCT00363311|18302356|P1|Overall Study|Sponsor Terminated Study|2
5312954|NCT00363311|18302355|P2|Overall Study|Physician Decision|1
5312955|NCT00363311|18302356|P1|Overall Study|Physician Decision|1
5312956|NCT00363311|18302355|P2|Overall Study|Withdrawal by Subject|6
5312957|NCT00363311|18302356|P1|Overall Study|Withdrawal by Subject|12
5312958|NCT00363311|18302355|P2|Overall Study|Protocol Violation|2
5312959|NCT00363311|18302356|P1|Overall Study|Protocol Violation|1
5312960|NCT00363311|18302355|P2|Overall Study|Lost to Follow-up|0
5312961|NCT00363311|18302356|P1|Overall Study|Lost to Follow-up|3
5312962|NCT00363311|18302355|P2|Overall Study|Adverse Event|4
5312963|NCT00363311|18302356|P1|Overall Study|Adverse Event|6
5312964|NCT00363298|18302422|P2|4-week Study Continuation Phase|Lack of Efficacy|0
5312965|NCT00363298|18302423|P1|4-week Study Continuation Phase|Lack of Efficacy|1
5312966|NCT00363298|18302422|P2|First Study Week|Lack of Efficacy|5
5312967|NCT00363298|18302423|P1|First Study Week|Lack of Efficacy|6
5312968|NCT00363246|18302431|P1|Overall Study|Eligibility changed due to Hospice move|5
5312969|NCT00363246|18302431|P1|Overall Study|Subject expressed security concerns|2
5312970|NCT00363246|18302431|P1|Overall Study|Stopped using wheelchair|11
5312971|NCT00363246|18302431|P1|Overall Study|Bad health|6
5312972|NCT00363246|18302431|P1|Overall Study|Lost to Follow-up|14
5312973|NCT00363246|18302431|P1|Overall Study|Withdrawal by Subject|19
5312974|NCT00363246|18302431|P1|Overall Study|Death|40
5312975|NCT00363142|18302449|P2|Overall Study|Withdrawal by Subject|1
5312976|NCT00363142|18302450|P1|Overall Study|Withdrawal by Subject|3
5312977|NCT00363142|18302449|P2|Overall Study|Non-compliance|1
5312978|NCT00363142|18302450|P1|Overall Study|Non-compliance|1
5312979|NCT00363142|18302449|P2|Overall Study|Lost to Follow-up|0
5312980|NCT00363142|18302450|P1|Overall Study|Lost to Follow-up|1
5312981|NCT00363142|18302449|P2|Overall Study|Lack of Efficacy|1
5312982|NCT00363142|18302450|P1|Overall Study|Lack of Efficacy|0
5312983|NCT00363142|18302449|P2|Overall Study|Adverse Event|0
5312984|NCT00363142|18302450|P1|Overall Study|Adverse Event|2
5312985|NCT00363129|18302479|P2|Overall Study|Other Reasons|3
5312986|NCT00363129|18302480|P1|Overall Study|Other Reasons|6
5312987|NCT00363129|18302479|P2|Overall Study|Death|1
5312988|NCT00363129|18302480|P1|Overall Study|Death|0
5312989|NCT00363129|18302479|P2|Overall Study|Other Medical Problems|4
5312990|NCT00363129|18302480|P1|Overall Study|Other Medical Problems|2
5312991|NCT00363129|18302479|P2|Overall Study|Alternate Treatment|4
5312992|NCT00363129|18302480|P1|Overall Study|Alternate Treatment|2
5312993|NCT00363129|18302479|P2|Overall Study|Adverse Event|3
5312994|NCT00363129|18302480|P1|Overall Study|Adverse Event|8
5312995|NCT00363129|18302479|P2|Overall Study|Withdrawal by Subject|18
5312996|NCT00363129|18302480|P1|Overall Study|Withdrawal by Subject|11
5312997|NCT00363051|18302523|P2|Overall Study|Death|2
5312998|NCT00363051|18302524|P1|Overall Study|Death|3
5312999|NCT00363051|18302523|P2|Overall Study|Protocol Violation|2
5313000|NCT00363051|18302524|P1|Overall Study|Protocol Violation|0
5313001|NCT00363051|18302523|P2|Overall Study|Lost to Follow-up|1
5313002|NCT00363051|18302524|P1|Overall Study|Lost to Follow-up|0
5313003|NCT00363051|18302523|P2|Overall Study|Withdrawal by Subject|3
5313004|NCT00363051|18302524|P1|Overall Study|Withdrawal by Subject|11
5313005|NCT00363051|18302523|P2|Overall Study|New Cancer Therapy|1
5313006|NCT00363051|18302524|P1|Overall Study|New Cancer Therapy|2
5313007|NCT00363051|18302523|P2|Overall Study|Adverse Event|12
5313008|NCT00363051|18302524|P1|Overall Study|Adverse Event|21
5313009|NCT00363051|18302523|P2|Overall Study|Adminstrative problems|1
5313010|NCT00363051|18302524|P1|Overall Study|Adminstrative problems|1
5313011|NCT00362648|18302573|P4|Overall Study|Withdrawal by Subject|6
5313012|NCT00362648|18302574|P3|Overall Study|Withdrawal by Subject|2
5313013|NCT00362648|18302575|P2|Overall Study|Withdrawal by Subject|42
5313014|NCT00362648|18302576|P1|Overall Study|Withdrawal by Subject|48
5313015|NCT00362648|18302573|P4|Overall Study|Protocol Violation|2
5313016|NCT00362648|18302574|P3|Overall Study|Protocol Violation|2
5313017|NCT00362648|18302575|P2|Overall Study|Protocol Violation|2
5313018|NCT00362648|18302576|P1|Overall Study|Protocol Violation|4
5313019|NCT00362648|18302573|P4|Overall Study|Lost to Follow-up|3
5313020|NCT00362648|18302574|P3|Overall Study|Lost to Follow-up|4
5313021|NCT00362648|18302575|P2|Overall Study|Lost to Follow-up|69
5313022|NCT00362648|18302576|P1|Overall Study|Lost to Follow-up|62
5313023|NCT00362648|18302573|P4|Overall Study|Adverse Event|0
5313024|NCT00362648|18302574|P3|Overall Study|Adverse Event|1
5313025|NCT00362648|18302575|P2|Overall Study|Adverse Event|21
5313026|NCT00362648|18302576|P1|Overall Study|Adverse Event|12
5313027|NCT00362609|18302594|P2|Overall Study|Protocol Violation|1
5313028|NCT00362609|18302595|P1|Overall Study|Protocol Violation|0
5313029|NCT00362609|18302594|P2|Overall Study|Withdrawal by Subject|1
5313030|NCT00362609|18302595|P1|Overall Study|Withdrawal by Subject|0
5313031|NCT00362414|18302676|P1|Overall Study|Adverse Event|1
5313032|NCT00362414|18302676|P1|Overall Study|Death|2
5313033|NCT00362375|18302705|P2|Overall Study|Lost to Follow-up|35
5313034|NCT00362375|18302706|P1|Overall Study|Lost to Follow-up|40
5313035|NCT00362336|18302723|P3|Overall Study|Withdrawal by Subject|1
5313036|NCT00362336|18302724|P2|Overall Study|Withdrawal by Subject|3
5313037|NCT00362336|18302725|P1|Overall Study|Withdrawal by Subject|3
5313038|NCT00362336|18302723|P3|Overall Study|Lost to Follow-up|0
5313039|NCT00362336|18302724|P2|Overall Study|Lost to Follow-up|4
5313040|NCT00362336|18302725|P1|Overall Study|Lost to Follow-up|6
5313041|NCT00362336|18302723|P3|Overall Study|Protocol Violation|1
5313042|NCT00362336|18302724|P2|Overall Study|Protocol Violation|0
5313043|NCT00362336|18302725|P1|Overall Study|Protocol Violation|0
5313044|NCT00362336|18302723|P3|Overall Study|Serious Adverse Event|1
5313045|NCT00362336|18302724|P2|Overall Study|Serious Adverse Event|0
5313046|NCT00362336|18302725|P1|Overall Study|Serious Adverse Event|1
5313047|NCT00362297|18302753|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
5313048|NCT00362297|18302754|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
5313049|NCT00362232|18302762|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
5313050|NCT00362232|18302763|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
5313051|NCT00362232|18302762|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
5313052|NCT00362232|18302763|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
5313053|NCT00362232|18302762|P2|Follow-up (30 (+ 5) Days)|Death|1
5313054|NCT00362232|18302763|P1|Follow-up (30 (+ 5) Days)|Death|1
5313055|NCT00362232|18302762|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
5313056|NCT00362232|18302763|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
5313057|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
5313058|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
5313059|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
5313060|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
5313061|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
5313062|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
5313063|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
5313064|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
5313065|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
5313066|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
5313067|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
5313068|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
5313069|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
5313070|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
5313071|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Death|3
5313072|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Death|1
5313073|NCT00362232|18302762|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
5313074|NCT00362232|18302763|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
5313075|NCT00362180|18302808|P9|Treated Period|Adverse Event|0
5313076|NCT00362180|18302809|P8|Treated Period|Adverse Event|1
5313077|NCT00362180|18302810|P7|Treated Period|Adverse Event|0
5313078|NCT00362180|18302811|P6|Treated Period|Adverse Event|1
5313079|NCT00362180|18302812|P5|Treated Period|Adverse Event|0
5313080|NCT00362180|18302813|P4|Treated Period|Adverse Event|0
5313081|NCT00362180|18302814|P3|Treated Period|Adverse Event|0
5313082|NCT00362180|18302815|P2|Treated Period|Adverse Event|0
5313083|NCT00362180|18302816|P1|Treated Period|Adverse Event|0
5313084|NCT00362180|18302808|P9|Treated Period|Withdrawal by Subject|0
5313085|NCT00362180|18302809|P8|Treated Period|Withdrawal by Subject|0
5313086|NCT00362180|18302810|P7|Treated Period|Withdrawal by Subject|0
5313087|NCT00362180|18302811|P6|Treated Period|Withdrawal by Subject|0
5313088|NCT00362180|18302812|P5|Treated Period|Withdrawal by Subject|0
5313089|NCT00362180|18302813|P4|Treated Period|Withdrawal by Subject|0
5313090|NCT00362180|18302814|P3|Treated Period|Withdrawal by Subject|0
5313091|NCT00362180|18302815|P2|Treated Period|Withdrawal by Subject|0
5313092|NCT00362180|18302816|P1|Treated Period|Withdrawal by Subject|1
5313093|NCT00362115|18302888|P7|Overall Study|Other|0
5313094|NCT00362115|18302889|P6|Overall Study|Other|1
5313095|NCT00362115|18302890|P5|Overall Study|Other|0
5313096|NCT00362115|18302891|P4|Overall Study|Other|1
5313097|NCT00362115|18302892|P3|Overall Study|Other|0
5313098|NCT00362115|18302893|P2|Overall Study|Other|1
5313099|NCT00362115|18302894|P1|Overall Study|Other|0
5313100|NCT00362115|18302888|P7|Overall Study|Physician Decision|3
5313101|NCT00362115|18302889|P6|Overall Study|Physician Decision|0
5313102|NCT00362115|18302890|P5|Overall Study|Physician Decision|0
5313103|NCT00362115|18302891|P4|Overall Study|Physician Decision|0
5313104|NCT00362115|18302892|P3|Overall Study|Physician Decision|0
5313105|NCT00362115|18302893|P2|Overall Study|Physician Decision|0
5313106|NCT00362115|18302894|P1|Overall Study|Physician Decision|0
5313107|NCT00362115|18302888|P7|Overall Study|Lack of Efficacy|3
5313108|NCT00362115|18302889|P6|Overall Study|Lack of Efficacy|0
5313109|NCT00362115|18302890|P5|Overall Study|Lack of Efficacy|2
5313110|NCT00362115|18302891|P4|Overall Study|Lack of Efficacy|2
5313111|NCT00362115|18302892|P3|Overall Study|Lack of Efficacy|5
5313112|NCT00362115|18302893|P2|Overall Study|Lack of Efficacy|0
5313113|NCT00362115|18302894|P1|Overall Study|Lack of Efficacy|1
5313114|NCT00362115|18302888|P7|Overall Study|Withdrawal by Subject|4
5313115|NCT00362115|18302889|P6|Overall Study|Withdrawal by Subject|3
5313116|NCT00362115|18302890|P5|Overall Study|Withdrawal by Subject|1
5313117|NCT00362115|18302891|P4|Overall Study|Withdrawal by Subject|0
5313118|NCT00362115|18302892|P3|Overall Study|Withdrawal by Subject|1
5313119|NCT00362115|18302893|P2|Overall Study|Withdrawal by Subject|3
5313120|NCT00362115|18302894|P1|Overall Study|Withdrawal by Subject|1
5313121|NCT00362115|18302888|P7|Overall Study|Lost to Follow-up|1
5313122|NCT00362115|18302889|P6|Overall Study|Lost to Follow-up|0
5313123|NCT00362115|18302890|P5|Overall Study|Lost to Follow-up|2
5313124|NCT00362115|18302891|P4|Overall Study|Lost to Follow-up|0
5313125|NCT00362115|18302892|P3|Overall Study|Lost to Follow-up|0
5313126|NCT00362115|18302893|P2|Overall Study|Lost to Follow-up|1
5313127|NCT00362115|18302894|P1|Overall Study|Lost to Follow-up|0
5313128|NCT00362115|18302888|P7|Overall Study|Protocol Violation|0
5313129|NCT00362115|18302889|P6|Overall Study|Protocol Violation|1
5313130|NCT00362115|18302890|P5|Overall Study|Protocol Violation|0
5313131|NCT00362115|18302891|P4|Overall Study|Protocol Violation|0
5313132|NCT00362115|18302892|P3|Overall Study|Protocol Violation|0
5313133|NCT00362115|18302893|P2|Overall Study|Protocol Violation|0
5313134|NCT00362115|18302894|P1|Overall Study|Protocol Violation|0
5313135|NCT00362115|18302888|P7|Overall Study|Adverse Event|1
5313136|NCT00362115|18302889|P6|Overall Study|Adverse Event|2
5313137|NCT00362115|18302890|P5|Overall Study|Adverse Event|2
5313138|NCT00362115|18302891|P4|Overall Study|Adverse Event|1
5313139|NCT00362115|18302892|P3|Overall Study|Adverse Event|1
5313140|NCT00362115|18302893|P2|Overall Study|Adverse Event|1
5313141|NCT00362115|18302894|P1|Overall Study|Adverse Event|0
5313142|NCT00361634|18303067|P1|Overall Study|Withdrawal by Subject|1
5313143|NCT00361634|18303067|P1|Overall Study|Lost to Follow-up|1
5313144|NCT00361569|18303096|P4|Overall Study|Not specified by investigator|1
5313145|NCT00361569|18303097|P3|Overall Study|Not specified by investigator|0
5313146|NCT00361569|18303098|P2|Overall Study|Not specified by investigator|0
5313147|NCT00361569|18303099|P1|Overall Study|Not specified by investigator|2
5313148|NCT00361569|18303096|P4|Overall Study|Lost to Follow-up|2
5313149|NCT00361569|18303097|P3|Overall Study|Lost to Follow-up|3
5313150|NCT00361569|18303098|P2|Overall Study|Lost to Follow-up|3
5313151|NCT00361569|18303099|P1|Overall Study|Lost to Follow-up|2
5313152|NCT00361569|18303096|P4|Overall Study|Adverse Event|2
5313153|NCT00361569|18303097|P3|Overall Study|Adverse Event|2
5313154|NCT00361569|18303098|P2|Overall Study|Adverse Event|5
5313155|NCT00361569|18303099|P1|Overall Study|Adverse Event|3
5313156|NCT00361569|18303096|P4|Overall Study|Withdrawal by Subject|14
5313157|NCT00361569|18303097|P3|Overall Study|Withdrawal by Subject|9
5313158|NCT00361569|18303098|P2|Overall Study|Withdrawal by Subject|1
5313159|NCT00361569|18303099|P1|Overall Study|Withdrawal by Subject|2
5313160|NCT00361569|18303096|P4|Overall Study|Protocol Violation|2
5313161|NCT00361569|18303097|P3|Overall Study|Protocol Violation|4
5313162|NCT00361569|18303098|P2|Overall Study|Protocol Violation|2
5313163|NCT00361569|18303099|P1|Overall Study|Protocol Violation|3
5313164|NCT00361504|18303123|P2|Overall Study|All other|3
5313165|NCT00361504|18303124|P1|Overall Study|All other|28
5313166|NCT00361504|18303123|P2|Overall Study|Study medication non compliant|15
5313167|NCT00361504|18303124|P1|Overall Study|Study medication non compliant|42
5313168|NCT00361504|18303123|P2|Overall Study|Resolution of Pain|0
5313169|NCT00361504|18303124|P1|Overall Study|Resolution of Pain|2
5313170|NCT00361504|18303123|P2|Overall Study|Lack of Efficacy|7
5313171|NCT00361504|18303124|P1|Overall Study|Lack of Efficacy|72
5313172|NCT00361504|18303123|P2|Overall Study|Adverse Event|82
5313173|NCT00361504|18303124|P1|Overall Study|Adverse Event|203
5313174|NCT00361504|18303123|P2|Overall Study|Lost to Follow-up|7
5313175|NCT00361504|18303124|P1|Overall Study|Lost to Follow-up|40
5313176|NCT00361504|18303123|P2|Overall Study|Withdrawal by Subject|31
5313177|NCT00361504|18303124|P1|Overall Study|Withdrawal by Subject|94
5313178|NCT00361335|18303165|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
5313179|NCT00361335|18303166|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5313180|NCT00361335|18303167|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5313181|NCT00361335|18303168|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5313182|NCT00361335|18303169|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
5313183|NCT00361335|18303170|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5313184|NCT00361335|18303171|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5313185|NCT00361335|18303165|P7|SC Period: Week E0 to Week E24|Other|2
5313186|NCT00361335|18303166|P6|SC Period: Week E0 to Week E24|Other|1
5313187|NCT00361335|18303167|P5|SC Period: Week E0 to Week E24|Other|0
5313188|NCT00361335|18303168|P4|SC Period: Week E0 to Week E24|Other|1
5313189|NCT00361335|18303169|P3|SC Period: Week E0 to Week E24|Other|0
5313190|NCT00361335|18303170|P2|SC Period: Week E0 to Week E24|Other|0
5313191|NCT00361335|18303171|P1|SC Period: Week E0 to Week E24|Other|1
5313192|NCT00361335|18303165|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
5313193|NCT00361335|18303166|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
5313194|NCT00361335|18303167|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
5313195|NCT00361335|18303168|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
5313196|NCT00361335|18303169|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
5313197|NCT00361335|18303170|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
5313198|NCT00361335|18303171|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
5313199|NCT00361335|18303165|P7|SC Period: Week E0 to Week E24|Death|1
5313200|NCT00361335|18303166|P6|SC Period: Week E0 to Week E24|Death|0
5313201|NCT00361335|18303167|P5|SC Period: Week E0 to Week E24|Death|0
5313202|NCT00361335|18303168|P4|SC Period: Week E0 to Week E24|Death|0
5313203|NCT00361335|18303169|P3|SC Period: Week E0 to Week E24|Death|0
5313204|NCT00361335|18303170|P2|SC Period: Week E0 to Week E24|Death|0
5313205|NCT00361335|18303171|P1|SC Period: Week E0 to Week E24|Death|0
5313206|NCT00361335|18303165|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
5313207|NCT00361335|18303166|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5313208|NCT00361335|18303167|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5313209|NCT00361335|18303168|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5313210|NCT00361335|18303169|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
5313211|NCT00361335|18303170|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5313212|NCT00361335|18303171|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
5313213|NCT00361335|18303165|P7|SC Period: Week E0 to Week E24|Adverse Event|2
5313214|NCT00361335|18303166|P6|SC Period: Week E0 to Week E24|Adverse Event|0
5313215|NCT00361335|18303167|P5|SC Period: Week E0 to Week E24|Adverse Event|0
5313216|NCT00361335|18303168|P4|SC Period: Week E0 to Week E24|Adverse Event|2
5313217|NCT00361335|18303169|P3|SC Period: Week E0 to Week E24|Adverse Event|1
5313218|NCT00361335|18303170|P2|SC Period: Week E0 to Week E24|Adverse Event|2
5313219|NCT00361335|18303171|P1|SC Period: Week E0 to Week E24|Adverse Event|0
5313220|NCT00361335|18303165|P7|IV Period: Baseline to E0|Lack of Efficacy|0
5313221|NCT00361335|18303166|P6|IV Period: Baseline to E0|Lack of Efficacy|0
5313222|NCT00361335|18303167|P5|IV Period: Baseline to E0|Lack of Efficacy|8
5313223|NCT00361335|18303168|P4|IV Period: Baseline to E0|Lack of Efficacy|7
5313224|NCT00361335|18303169|P3|IV Period: Baseline to E0|Lack of Efficacy|3
5313225|NCT00361335|18303170|P2|IV Period: Baseline to E0|Lack of Efficacy|9
5313226|NCT00361335|18303171|P1|IV Period: Baseline to E0|Lack of Efficacy|5
5313227|NCT00361335|18303165|P7|IV Period: Baseline to E0|Other|0
5313228|NCT00361335|18303166|P6|IV Period: Baseline to E0|Other|0
5313229|NCT00361335|18303167|P5|IV Period: Baseline to E0|Other|2
5313230|NCT00361335|18303168|P4|IV Period: Baseline to E0|Other|3
5313231|NCT00361335|18303169|P3|IV Period: Baseline to E0|Other|9
5313232|NCT00361335|18303170|P2|IV Period: Baseline to E0|Other|9
5313233|NCT00361335|18303171|P1|IV Period: Baseline to E0|Other|2
5313234|NCT00361335|18303165|P7|IV Period: Baseline to E0|Worsening of RA|0
5313235|NCT00361335|18303166|P6|IV Period: Baseline to E0|Worsening of RA|0
5313236|NCT00361335|18303167|P5|IV Period: Baseline to E0|Worsening of RA|2
5313237|NCT00361335|18303168|P4|IV Period: Baseline to E0|Worsening of RA|4
5313238|NCT00361335|18303169|P3|IV Period: Baseline to E0|Worsening of RA|1
5313239|NCT00361335|18303170|P2|IV Period: Baseline to E0|Worsening of RA|5
5313240|NCT00361335|18303171|P1|IV Period: Baseline to E0|Worsening of RA|0
5313241|NCT00361335|18303165|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
5313242|NCT00361335|18303166|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
5313243|NCT00361335|18303167|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
5313244|NCT00361335|18303168|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
5313245|NCT00361335|18303169|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
5313246|NCT00361335|18303170|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
5313247|NCT00361335|18303171|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
5313248|NCT00361335|18303165|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
5313249|NCT00361335|18303166|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
5313250|NCT00361335|18303167|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
5313251|NCT00361335|18303168|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
5313252|NCT00361335|18303169|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
5313253|NCT00361335|18303170|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
5313254|NCT00361335|18303171|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
5313255|NCT00361335|18303165|P7|IV Period: Baseline to E0|Death|0
5313256|NCT00361335|18303166|P6|IV Period: Baseline to E0|Death|0
5313257|NCT00361335|18303167|P5|IV Period: Baseline to E0|Death|0
5313258|NCT00361335|18303168|P4|IV Period: Baseline to E0|Death|1
5313259|NCT00361335|18303169|P3|IV Period: Baseline to E0|Death|1
5313260|NCT00361335|18303170|P2|IV Period: Baseline to E0|Death|1
5313261|NCT00361335|18303171|P1|IV Period: Baseline to E0|Death|1
5313262|NCT00361335|18303165|P7|IV Period: Baseline to E0|Lost to Follow-up|0
5313263|NCT00361335|18303166|P6|IV Period: Baseline to E0|Lost to Follow-up|0
5313264|NCT00361335|18303167|P5|IV Period: Baseline to E0|Lost to Follow-up|2
5313265|NCT00361335|18303168|P4|IV Period: Baseline to E0|Lost to Follow-up|2
5313266|NCT00361335|18303169|P3|IV Period: Baseline to E0|Lost to Follow-up|0
5313267|NCT00361335|18303170|P2|IV Period: Baseline to E0|Lost to Follow-up|0
5313268|NCT00361335|18303171|P1|IV Period: Baseline to E0|Lost to Follow-up|1
5313269|NCT00361335|18303165|P7|IV Period: Baseline to E0|Adverse Event|0
5313270|NCT00361335|18303166|P6|IV Period: Baseline to E0|Adverse Event|0
5313271|NCT00361335|18303167|P5|IV Period: Baseline to E0|Adverse Event|8
5313272|NCT00361335|18303168|P4|IV Period: Baseline to E0|Adverse Event|9
5313273|NCT00361335|18303169|P3|IV Period: Baseline to E0|Adverse Event|5
5313274|NCT00361335|18303170|P2|IV Period: Baseline to E0|Adverse Event|4
5313275|NCT00361335|18303171|P1|IV Period: Baseline to E0|Adverse Event|9
5313276|NCT00361296|18303215|P1|Overall Study|Lack of Efficacy|2
5313277|NCT00361296|18303215|P1|Overall Study|Physician Decision|1
5313278|NCT00361283|18303222|P1|Overall Study|Lost to Follow-up|27
5313279|NCT00361270|18303230|P4|Overall Study|Adverse Event|0
5313280|NCT00361270|18303231|P3|Overall Study|Adverse Event|1
5313281|NCT00361270|18303232|P2|Overall Study|Adverse Event|1
5313282|NCT00361270|18303233|P1|Overall Study|Adverse Event|0
5313283|NCT00361270|18303230|P4|Overall Study|Problems with Transportation|0
5313284|NCT00361270|18303231|P3|Overall Study|Problems with Transportation|0
5313285|NCT00361270|18303232|P2|Overall Study|Problems with Transportation|0
5313286|NCT00361270|18303233|P1|Overall Study|Problems with Transportation|4
5313287|NCT00361270|18303230|P4|Overall Study|Afraid of Hypnosis|0
5313288|NCT00361270|18303231|P3|Overall Study|Afraid of Hypnosis|0
5313289|NCT00361270|18303232|P2|Overall Study|Afraid of Hypnosis|2
5313290|NCT00361270|18303233|P1|Overall Study|Afraid of Hypnosis|1
5313291|NCT00361270|18303230|P4|Overall Study|Withdrawal by Subject|7
5313292|NCT00361270|18303231|P3|Overall Study|Withdrawal by Subject|3
5313293|NCT00361270|18303232|P2|Overall Study|Withdrawal by Subject|6
5313294|NCT00361270|18303233|P1|Overall Study|Withdrawal by Subject|6
5313295|NCT00361270|18303230|P4|Overall Study|Protocol Violation|4
5313296|NCT00361270|18303231|P3|Overall Study|Protocol Violation|5
5313297|NCT00361270|18303232|P2|Overall Study|Protocol Violation|4
5313298|NCT00361270|18303233|P1|Overall Study|Protocol Violation|9
5313299|NCT00361270|18303230|P4|Overall Study|Physician Decision|0
5313300|NCT00361270|18303231|P3|Overall Study|Physician Decision|1
5313301|NCT00361270|18303232|P2|Overall Study|Physician Decision|0
5313302|NCT00361270|18303233|P1|Overall Study|Physician Decision|0
5313303|NCT00361270|18303230|P4|Overall Study|Lost to Follow-up|0
5313304|NCT00361270|18303231|P3|Overall Study|Lost to Follow-up|0
5313305|NCT00361270|18303232|P2|Overall Study|Lost to Follow-up|1
5313306|NCT00361270|18303233|P1|Overall Study|Lost to Follow-up|4
5313307|NCT00361270|18303230|P4|Overall Study|Death|2
5313308|NCT00361270|18303231|P3|Overall Study|Death|0
5313309|NCT00361270|18303232|P2|Overall Study|Death|0
5313310|NCT00361270|18303233|P1|Overall Study|Death|0
5313311|NCT00361231|18303306|P1|Overall Study|Adverse Event|6
5313312|NCT00361231|18303306|P1|Overall Study|Withdrawal by Subject|4
5313313|NCT00361231|18303306|P1|Overall Study|Radiographic disease progression|16
5313314|NCT00361231|18303306|P1|Overall Study|Symptomatic deterioration|5
5313315|NCT00361231|18303306|P1|Overall Study|Physician Decision|3
5313316|NCT00361218|18303311|P1|Overall Study|terminated / withdrawn due to toxicity /|5
5313317|NCT00361218|18303311|P1|Overall Study|Personal Reasons|7
5313318|NCT00361218|18303311|P1|Overall Study|Lost to Follow-up|11
5313319|NCT00360698|18303390|P2|Treatment Period|Early termination by error|1
5313320|NCT00360698|18303391|P1|Treatment Period|Early termination by error|0
5313321|NCT00360698|18303390|P2|Treatment Period|Non compliance with treatment procedure|0
5313322|NCT00360698|18303391|P1|Treatment Period|Non compliance with treatment procedure|1
5313323|NCT00360698|18303390|P2|Run-In|Need of insulin with meals|1
5313324|NCT00360698|18303391|P1|Run-In|Need of insulin with meals|0
5313325|NCT00360698|18303390|P2|Run-In|Patient personal reasons|2
5313326|NCT00360698|18303391|P1|Run-In|Patient personal reasons|0
5313327|NCT00360698|18303390|P2|Run-In|Patient did not meet inclusion criteria|1
5313328|NCT00360698|18303391|P1|Run-In|Patient did not meet inclusion criteria|0
5313329|NCT00360698|18303390|P2|Run-In|Sponsor request|2
5313330|NCT00360698|18303391|P1|Run-In|Sponsor request|0
5313331|NCT00360698|18303390|P2|Run-In|Non compliance with treatment procedure|1
5313332|NCT00360698|18303391|P1|Run-In|Non compliance with treatment procedure|0
5313333|NCT00360698|18303390|P2|Run-In|Withdrawal by Subject|2
5313334|NCT00360698|18303391|P1|Run-In|Withdrawal by Subject|0
5313335|NCT00360698|18303390|P2|Run-In|Physician Decision|1
5313336|NCT00360698|18303391|P1|Run-In|Physician Decision|0
5313337|NCT00360568|18303436|P2|Overall Study|Withdrawal by Subject|3
5313338|NCT00360568|18303437|P1|Overall Study|Withdrawal by Subject|0
5313339|NCT00360568|18303436|P2|Overall Study|Lack of Efficacy|0
5313340|NCT00360568|18303437|P1|Overall Study|Lack of Efficacy|1
5313341|NCT00360568|18303436|P2|Overall Study|Adverse Event|2
5313342|NCT00360568|18303437|P1|Overall Study|Adverse Event|1
5313343|NCT00360529|18303568|P3|Overall Study|Reason discontinued not explained above|11
5313344|NCT00360529|18303569|P2|Overall Study|Reason discontinued not explained above|9
5313345|NCT00360529|18303570|P1|Overall Study|Reason discontinued not explained above|4
5313346|NCT00360529|18303568|P3|Overall Study|Lack of Efficacy|5
5313347|NCT00360529|18303569|P2|Overall Study|Lack of Efficacy|6
5313348|NCT00360529|18303570|P1|Overall Study|Lack of Efficacy|8
5313349|NCT00360529|18303568|P3|Overall Study|Withdrawal by Subject|18
5313350|NCT00360529|18303569|P2|Overall Study|Withdrawal by Subject|14
5313351|NCT00360529|18303570|P1|Overall Study|Withdrawal by Subject|22
5313352|NCT00360529|18303568|P3|Overall Study|Lost to Follow-up|13
5313353|NCT00360529|18303569|P2|Overall Study|Lost to Follow-up|10
5313354|NCT00360529|18303570|P1|Overall Study|Lost to Follow-up|14
5313355|NCT00360529|18303568|P3|Overall Study|Protocol Violation|11
5313356|NCT00360529|18303569|P2|Overall Study|Protocol Violation|3
5313357|NCT00360529|18303570|P1|Overall Study|Protocol Violation|3
5313358|NCT00360529|18303568|P3|Overall Study|Adverse Event|33
5313359|NCT00360529|18303569|P2|Overall Study|Adverse Event|23
5313360|NCT00360529|18303570|P1|Overall Study|Adverse Event|10
5313361|NCT00360490|18303598|P2|Overall Study|Withdrawal by Subject|3
5313362|NCT00360490|18303599|P1|Overall Study|Withdrawal by Subject|1
5313363|NCT00360490|18303598|P2|Overall Study|Protocol Violation|4
5313364|NCT00360490|18303599|P1|Overall Study|Protocol Violation|0
5313365|NCT00360490|18303598|P2|Overall Study|Physician Decision|1
5313366|NCT00360490|18303599|P1|Overall Study|Physician Decision|2
5313367|NCT00360490|18303598|P2|Overall Study|Lost to Follow-up|1
5313368|NCT00360490|18303599|P1|Overall Study|Lost to Follow-up|2
5313369|NCT00360490|18303598|P2|Overall Study|Adverse Event|2
5313370|NCT00360490|18303599|P1|Overall Study|Adverse Event|4
5313371|NCT00360412|18303634|P2|Overall Study|Study termination by Sponsor|469
5313372|NCT00360412|18303635|P1|Overall Study|Study termination by Sponsor|214
5313373|NCT00360412|18303634|P2|Overall Study|Other|6
5313374|NCT00360412|18303635|P1|Overall Study|Other|5
5313375|NCT00360412|18303634|P2|Overall Study|Physician Decision|4
5313376|NCT00360412|18303635|P1|Overall Study|Physician Decision|2
5313377|NCT00360412|18303634|P2|Overall Study|Lack of therapeutic efficacy|61
5313378|NCT00360412|18303635|P1|Overall Study|Lack of therapeutic efficacy|46
5313379|NCT00360412|18303634|P2|Overall Study|Patient withdrew consent|52
5313380|NCT00360412|18303635|P1|Overall Study|Patient withdrew consent|27
5313381|NCT00360412|18303634|P2|Overall Study|Protocol Violation|5
5313382|NCT00360412|18303635|P1|Overall Study|Protocol Violation|2
5313383|NCT00360412|18303634|P2|Overall Study|Adverse Event|65
5313384|NCT00360412|18303635|P1|Overall Study|Adverse Event|37
5313385|NCT00360334|18303682|P2|Overall Study|Subject decision|2
5313386|NCT00360334|18303683|P1|Overall Study|Subject decision|8
5313387|NCT00360334|18303682|P2|Overall Study|Entry criterion not met|2
5313388|NCT00360334|18303683|P1|Overall Study|Entry criterion not met|1
5313389|NCT00360334|18303682|P2|Overall Study|Lack of Efficacy|1
5313390|NCT00360334|18303683|P1|Overall Study|Lack of Efficacy|0
5313391|NCT00360334|18303682|P2|Overall Study|Physician Decision|3
5313392|NCT00360334|18303683|P1|Overall Study|Physician Decision|2
5313393|NCT00360334|18303682|P2|Overall Study|Protocol Violation|1
5313394|NCT00360334|18303683|P1|Overall Study|Protocol Violation|1
5313395|NCT00360334|18303682|P2|Overall Study|Adverse Event|4
5313396|NCT00360334|18303683|P1|Overall Study|Adverse Event|7
5313397|NCT00360308|18303746|P3|Overall Study|Study termination by sponsor|44
5313398|NCT00360308|18303747|P2|Overall Study|Study termination by sponsor|55
5313399|NCT00360308|18303748|P1|Overall Study|Study termination by sponsor|43
5313400|NCT00360308|18303746|P3|Overall Study|Other|1
5313401|NCT00360308|18303747|P2|Overall Study|Other|1
5313402|NCT00360308|18303748|P1|Overall Study|Other|2
5313403|NCT00360308|18303746|P3|Overall Study|Lack of Efficacy|2
5313404|NCT00360308|18303747|P2|Overall Study|Lack of Efficacy|0
5313405|NCT00360308|18303748|P1|Overall Study|Lack of Efficacy|3
5313406|NCT00360308|18303746|P3|Overall Study|Withdrawal by Subject|14
5313407|NCT00360308|18303747|P2|Overall Study|Withdrawal by Subject|7
5313408|NCT00360308|18303748|P1|Overall Study|Withdrawal by Subject|11
5313409|NCT00360308|18303746|P3|Overall Study|Protocol Violation|2
5313410|NCT00360308|18303747|P2|Overall Study|Protocol Violation|1
5313411|NCT00360308|18303748|P1|Overall Study|Protocol Violation|2
5313412|NCT00360308|18303746|P3|Overall Study|Abnormal Laboratory Value(s)|0
5313413|NCT00360308|18303747|P2|Overall Study|Abnormal Laboratory Value(s)|1
5313414|NCT00360308|18303748|P1|Overall Study|Abnormal Laboratory Value(s)|0
5313415|NCT00360308|18303746|P3|Overall Study|Adverse Event|25
5313416|NCT00360308|18303747|P2|Overall Study|Adverse Event|14
5313417|NCT00360308|18303748|P1|Overall Study|Adverse Event|15
5313418|NCT00360282|18303765|P4|Second Intervention|Adverse Event|0
5313419|NCT00360282|18303766|P3|Second Intervention|Adverse Event|0
5313420|NCT00360282|18303767|P2|Second Intervention|Adverse Event|1
5313421|NCT00360282|18303768|P1|Second Intervention|Adverse Event|0
5313422|NCT00360282|18303765|P4|Washout 1-3 Weeks|Lost to Follow-up|0
5313423|NCT00360282|18303766|P3|Washout 1-3 Weeks|Lost to Follow-up|1
5313424|NCT00360282|18303767|P2|Washout 1-3 Weeks|Lost to Follow-up|0
5313425|NCT00360282|18303768|P1|Washout 1-3 Weeks|Lost to Follow-up|0
5313426|NCT00360269|18303780|P2|Overall Study|Withdrawal by Subject|1
5313427|NCT00360269|18303781|P1|Overall Study|Withdrawal by Subject|1
5313428|NCT00360269|18303780|P2|Overall Study|Adverse Event|0
5313429|NCT00360269|18303781|P1|Overall Study|Adverse Event|1
5313430|NCT00360269|18303780|P2|Overall Study|Physician Decision|2
5313431|NCT00360269|18303781|P1|Overall Study|Physician Decision|1
5313432|NCT00360269|18303780|P2|Overall Study|Lost to Follow-up|9
5313433|NCT00360269|18303781|P1|Overall Study|Lost to Follow-up|7
5313434|NCT00360230|18303823|P7|Overall Study|Death|1
5313435|NCT00360230|18303824|P6|Overall Study|Death|1
5313436|NCT00360230|18303825|P5|Overall Study|Death|0
5313437|NCT00360230|18303826|P4|Overall Study|Death|0
5313438|NCT00360230|18303827|P3|Overall Study|Death|0
5313439|NCT00360230|18303828|P2|Overall Study|Death|1
5313440|NCT00360230|18303829|P1|Overall Study|Death|0
5313441|NCT00360230|18303823|P7|Overall Study|Protocol Violation|0
5313442|NCT00360230|18303824|P6|Overall Study|Protocol Violation|1
5313443|NCT00360230|18303825|P5|Overall Study|Protocol Violation|0
5313444|NCT00360230|18303826|P4|Overall Study|Protocol Violation|0
5313445|NCT00360230|18303827|P3|Overall Study|Protocol Violation|0
5313446|NCT00360230|18303828|P2|Overall Study|Protocol Violation|0
5313447|NCT00360230|18303829|P1|Overall Study|Protocol Violation|0
5313448|NCT00360230|18303823|P7|Overall Study|Other|0
5313449|NCT00360230|18303824|P6|Overall Study|Other|0
5313450|NCT00360230|18303825|P5|Overall Study|Other|0
5313451|NCT00360230|18303826|P4|Overall Study|Other|0
5313452|NCT00360230|18303827|P3|Overall Study|Other|0
5313453|NCT00360230|18303828|P2|Overall Study|Other|0
5313454|NCT00360230|18303829|P1|Overall Study|Other|1
5313455|NCT00360230|18303823|P7|Overall Study|Migrated|1
5313456|NCT00360230|18303824|P6|Overall Study|Migrated|1
5313457|NCT00360230|18303825|P5|Overall Study|Migrated|4
5313458|NCT00360230|18303826|P4|Overall Study|Migrated|1
5313459|NCT00360230|18303827|P3|Overall Study|Migrated|3
5313460|NCT00360230|18303828|P2|Overall Study|Migrated|1
5313461|NCT00360230|18303829|P1|Overall Study|Migrated|4
5313462|NCT00360230|18303823|P7|Overall Study|Withdrawal by Subject|0
5313463|NCT00360230|18303824|P6|Overall Study|Withdrawal by Subject|1
5313464|NCT00360230|18303825|P5|Overall Study|Withdrawal by Subject|1
5313465|NCT00360230|18303826|P4|Overall Study|Withdrawal by Subject|1
5313466|NCT00360230|18303827|P3|Overall Study|Withdrawal by Subject|0
5313467|NCT00360230|18303828|P2|Overall Study|Withdrawal by Subject|1
5313468|NCT00360230|18303829|P1|Overall Study|Withdrawal by Subject|1
5313469|NCT00359801|18303985|P2|Overall Study|Sponsor Decision|16
5313470|NCT00359801|18303986|P1|Overall Study|Sponsor Decision|17
5313471|NCT00359801|18303985|P2|Overall Study|Final Status Unknown: missing data|4
5313472|NCT00359801|18303986|P1|Overall Study|Final Status Unknown: missing data|7
5313473|NCT00359801|18303985|P2|Overall Study|Other|46
5313474|NCT00359801|18303986|P1|Overall Study|Other|66
5313475|NCT00359801|18303985|P2|Overall Study|Withdrawal by Subject|96
5313476|NCT00359801|18303986|P1|Overall Study|Withdrawal by Subject|143
5313477|NCT00359801|18303985|P2|Overall Study|Lost to Follow-up|58
5313478|NCT00359801|18303986|P1|Overall Study|Lost to Follow-up|72
5313479|NCT00359788|18304020|P2|Overall Study|Protocol Violation|2
5313480|NCT00359788|18304021|P1|Overall Study|Protocol Violation|4
5313481|NCT00359788|18304020|P2|Overall Study|Withdrawal by Subject|1
5313482|NCT00359788|18304021|P1|Overall Study|Withdrawal by Subject|4
5313483|NCT00359788|18304020|P2|Overall Study|Lost to Follow-up|2
5313484|NCT00359788|18304021|P1|Overall Study|Lost to Follow-up|3
5313485|NCT00359788|18304020|P2|Overall Study|Lack of Efficacy|2
5313486|NCT00359788|18304021|P1|Overall Study|Lack of Efficacy|1
5313487|NCT00359788|18304020|P2|Overall Study|Adverse Event|10
5313488|NCT00359788|18304021|P1|Overall Study|Adverse Event|11
5313489|NCT00359762|18304255|P5|Period III|Subject Decision|0
5313490|NCT00359762|18304256|P4|Period III|Subject Decision|20
5313491|NCT00359762|18304257|P3|Period III|Subject Decision|8
5313492|NCT00359762|18304258|P2|Period III|Subject Decision|7
5313493|NCT00359762|18304259|P1|Period III|Subject Decision|0
5313494|NCT00359762|18304255|P5|Period III|Entry Criteria Not Met|0
5313495|NCT00359762|18304256|P4|Period III|Entry Criteria Not Met|1
5313496|NCT00359762|18304257|P3|Period III|Entry Criteria Not Met|0
5313497|NCT00359762|18304258|P2|Period III|Entry Criteria Not Met|1
5313498|NCT00359762|18304259|P1|Period III|Entry Criteria Not Met|0
5313499|NCT00359762|18304255|P5|Period III|Lost to follow up|0
5313500|NCT00359762|18304256|P4|Period III|Lost to follow up|2
5313501|NCT00359762|18304257|P3|Period III|Lost to follow up|1
5313502|NCT00359762|18304258|P2|Period III|Lost to follow up|1
5313503|NCT00359762|18304259|P1|Period III|Lost to follow up|0
5313504|NCT00359762|18304255|P5|Period III|Lack of Efficacy|0
5313505|NCT00359762|18304256|P4|Period III|Lack of Efficacy|9
5313506|NCT00359762|18304257|P3|Period III|Lack of Efficacy|5
5313507|NCT00359762|18304258|P2|Period III|Lack of Efficacy|7
5313508|NCT00359762|18304259|P1|Period III|Lack of Efficacy|0
5313509|NCT00359762|18304255|P5|Period III|Physician Decision|0
5313510|NCT00359762|18304256|P4|Period III|Physician Decision|15
5313511|NCT00359762|18304257|P3|Period III|Physician Decision|9
5313512|NCT00359762|18304258|P2|Period III|Physician Decision|5
5313513|NCT00359762|18304259|P1|Period III|Physician Decision|0
5313514|NCT00359762|18304255|P5|Period III|Adverse Event|0
5313515|NCT00359762|18304256|P4|Period III|Adverse Event|10
5313516|NCT00359762|18304257|P3|Period III|Adverse Event|4
5313517|NCT00359762|18304258|P2|Period III|Adverse Event|3
5313518|NCT00359762|18304259|P1|Period III|Adverse Event|0
5313519|NCT00359762|18304255|P5|Period III|Protocol Violation|0
5313520|NCT00359762|18304256|P4|Period III|Protocol Violation|8
5313521|NCT00359762|18304257|P3|Period III|Protocol Violation|3
5313522|NCT00359762|18304258|P2|Period III|Protocol Violation|5
5313523|NCT00359762|18304259|P1|Period III|Protocol Violation|0
5313524|NCT00359762|18304255|P5|Period II|Subject Decision|70
5313525|NCT00359762|18304256|P4|Period II|Subject Decision|0
5313526|NCT00359762|18304257|P3|Period II|Subject Decision|0
5313527|NCT00359762|18304258|P2|Period II|Subject Decision|0
5313528|NCT00359762|18304259|P1|Period II|Subject Decision|50
5313529|NCT00359762|18304255|P5|Period II|Entry Criteria Not Met|4
5313530|NCT00359762|18304256|P4|Period II|Entry Criteria Not Met|0
5313531|NCT00359762|18304257|P3|Period II|Entry Criteria Not Met|0
5313532|NCT00359762|18304258|P2|Period II|Entry Criteria Not Met|0
5313533|NCT00359762|18304259|P1|Period II|Entry Criteria Not Met|8
5313534|NCT00359762|18304255|P5|Period II|Lost to follow up|5
5313535|NCT00359762|18304256|P4|Period II|Lost to follow up|0
5313536|NCT00359762|18304257|P3|Period II|Lost to follow up|0
5313537|NCT00359762|18304258|P2|Period II|Lost to follow up|0
5313538|NCT00359762|18304259|P1|Period II|Lost to follow up|5
5313539|NCT00359762|18304255|P5|Period II|Lack of Efficacy|8
5313540|NCT00359762|18304256|P4|Period II|Lack of Efficacy|0
5313541|NCT00359762|18304257|P3|Period II|Lack of Efficacy|0
5313542|NCT00359762|18304258|P2|Period II|Lack of Efficacy|0
5313543|NCT00359762|18304259|P1|Period II|Lack of Efficacy|11
5313544|NCT00359762|18304255|P5|Period II|Death|4
5313545|NCT00359762|18304256|P4|Period II|Death|0
5313546|NCT00359762|18304257|P3|Period II|Death|0
5313547|NCT00359762|18304258|P2|Period II|Death|0
5313548|NCT00359762|18304259|P1|Period II|Death|2
5313549|NCT00359762|18304255|P5|Period II|Physician Decision|23
5313550|NCT00359762|18304256|P4|Period II|Physician Decision|0
5313551|NCT00359762|18304257|P3|Period II|Physician Decision|0
5313552|NCT00359762|18304258|P2|Period II|Physician Decision|0
5313553|NCT00359762|18304259|P1|Period II|Physician Decision|17
5313554|NCT00359762|18304255|P5|Period II|Protocol Violation|11
5313555|NCT00359762|18304256|P4|Period II|Protocol Violation|0
5313556|NCT00359762|18304257|P3|Period II|Protocol Violation|0
5313557|NCT00359762|18304258|P2|Period II|Protocol Violation|0
5313558|NCT00359762|18304259|P1|Period II|Protocol Violation|18
5313559|NCT00359762|18304255|P5|Period II|Adverse Event|49
5313560|NCT00359762|18304256|P4|Period II|Adverse Event|0
5313561|NCT00359762|18304257|P3|Period II|Adverse Event|0
5313562|NCT00359762|18304258|P2|Period II|Adverse Event|0
5313563|NCT00359762|18304259|P1|Period II|Adverse Event|17
5313564|NCT00359632|18304333|P2|Overall Study|Non-compliance with visit schedule|0
5313565|NCT00359632|18304334|P1|Overall Study|Non-compliance with visit schedule|1
5313566|NCT00359632|18304333|P2|Overall Study|Adverse Event|0
5313567|NCT00359632|18304334|P1|Overall Study|Adverse Event|1
5313568|NCT00359632|18304333|P2|Overall Study|Death|0
5313569|NCT00359632|18304334|P1|Overall Study|Death|2
5313570|NCT00359619|18304348|P7|Overall Study|Lost to Follow-up|0
5313571|NCT00359619|18304349|P6|Overall Study|Lost to Follow-up|5
5313572|NCT00359619|18304350|P5|Overall Study|Lost to Follow-up|1
5313573|NCT00359619|18304351|P4|Overall Study|Lost to Follow-up|1
5313574|NCT00359619|18304352|P3|Overall Study|Lost to Follow-up|2
5313575|NCT00359619|18304353|P2|Overall Study|Lost to Follow-up|4
5313576|NCT00359619|18304354|P1|Overall Study|Lost to Follow-up|4
5313577|NCT00359619|18304348|P7|Overall Study|Other|0
5313578|NCT00359619|18304349|P6|Overall Study|Other|0
5313579|NCT00359619|18304350|P5|Overall Study|Other|0
5313580|NCT00359619|18304351|P4|Overall Study|Other|0
5313581|NCT00359619|18304352|P3|Overall Study|Other|0
5313582|NCT00359619|18304353|P2|Overall Study|Other|0
5313583|NCT00359619|18304354|P1|Overall Study|Other|1
5313584|NCT00359619|18304348|P7|Overall Study|Withdrawal by Subject|3
5313585|NCT00359619|18304349|P6|Overall Study|Withdrawal by Subject|0
5313586|NCT00359619|18304350|P5|Overall Study|Withdrawal by Subject|2
5313587|NCT00359619|18304351|P4|Overall Study|Withdrawal by Subject|2
5313588|NCT00359619|18304352|P3|Overall Study|Withdrawal by Subject|4
5313589|NCT00359619|18304353|P2|Overall Study|Withdrawal by Subject|1
5313590|NCT00359619|18304354|P1|Overall Study|Withdrawal by Subject|3
5313591|NCT00359619|18304348|P7|Overall Study|Adverse Event|1
5313592|NCT00359619|18304349|P6|Overall Study|Adverse Event|0
5313593|NCT00359619|18304350|P5|Overall Study|Adverse Event|0
5313594|NCT00359619|18304351|P4|Overall Study|Adverse Event|0
5313595|NCT00359619|18304352|P3|Overall Study|Adverse Event|1
5313596|NCT00359619|18304353|P2|Overall Study|Adverse Event|0
5313597|NCT00359619|18304354|P1|Overall Study|Adverse Event|0
5313598|NCT00359424|18304484|P2|Overall Study|follow up not conducted|0
5313599|NCT00359424|18304485|P1|Overall Study|follow up not conducted|2
5313600|NCT00359424|18304484|P2|Overall Study|Withdrawal by Subject|2
5313601|NCT00359424|18304485|P1|Overall Study|Withdrawal by Subject|10
5313602|NCT00359424|18304484|P2|Overall Study|Lost to Follow-up|7
5313603|NCT00359424|18304485|P1|Overall Study|Lost to Follow-up|19
5313604|NCT00359424|18304484|P2|Overall Study|Death|58
5313605|NCT00359424|18304485|P1|Overall Study|Death|99
5313606|NCT00359281|18304524|P9|Overall Study|Withdrawal by Subject|0
5313607|NCT00359281|18304525|P8|Overall Study|Withdrawal by Subject|0
5313608|NCT00359281|18304526|P7|Overall Study|Withdrawal by Subject|1
5313609|NCT00359281|18304527|P6|Overall Study|Withdrawal by Subject|0
5313610|NCT00359281|18304528|P5|Overall Study|Withdrawal by Subject|0
5313611|NCT00359281|18304529|P4|Overall Study|Withdrawal by Subject|0
5313612|NCT00359281|18304530|P3|Overall Study|Withdrawal by Subject|0
5313613|NCT00359281|18304531|P2|Overall Study|Withdrawal by Subject|0
5313614|NCT00359281|18304532|P1|Overall Study|Withdrawal by Subject|0
5313615|NCT00359281|18304524|P9|Overall Study|Adverse Event|0
5313616|NCT00359281|18304525|P8|Overall Study|Adverse Event|0
5313617|NCT00359281|18304526|P7|Overall Study|Adverse Event|1
5313618|NCT00359281|18304527|P6|Overall Study|Adverse Event|0
5313619|NCT00359281|18304528|P5|Overall Study|Adverse Event|0
5313620|NCT00359281|18304529|P4|Overall Study|Adverse Event|0
5313621|NCT00359281|18304530|P3|Overall Study|Adverse Event|0
5313622|NCT00359281|18304531|P2|Overall Study|Adverse Event|0
5313623|NCT00359281|18304532|P1|Overall Study|Adverse Event|1
5313624|NCT00359073|18304595|P2|Overall Study|developed RV16 antibody|1
5313625|NCT00359073|18304596|P1|Overall Study|developed RV16 antibody|0
5313626|NCT00359073|18304595|P2|Overall Study|Eligibility criteria no longer met|0
5313627|NCT00359073|18304596|P1|Overall Study|Eligibility criteria no longer met|3
5313628|NCT00359073|18304595|P2|Overall Study|Withdrawal by Subject|1
5313629|NCT00359073|18304596|P1|Overall Study|Withdrawal by Subject|1
5313630|NCT00359021|18304608|P2|Overall Study|Pregnancy|0
5313631|NCT00359021|18304609|P1|Overall Study|Pregnancy|1
5313632|NCT00359021|18304608|P2|Overall Study|Other|1
5313633|NCT00359021|18304609|P1|Overall Study|Other|4
5313634|NCT00359021|18304608|P2|Overall Study|Lost to Follow-up|0
5313635|NCT00359021|18304609|P1|Overall Study|Lost to Follow-up|1
5313636|NCT00359021|18304608|P2|Overall Study|Withdrawal by Subject|9
5313637|NCT00359021|18304609|P1|Overall Study|Withdrawal by Subject|2
5313638|NCT00359021|18304608|P2|Overall Study|Subject Reached A Virologic Endpoint|32
5313639|NCT00359021|18304609|P1|Overall Study|Subject Reached A Virologic Endpoint|45
5313640|NCT00359021|18304608|P2|Overall Study|Subject Ineligible To Continue The Trial|0
5313641|NCT00359021|18304609|P1|Overall Study|Subject Ineligible To Continue The Trial|1
5313642|NCT00359021|18304608|P2|Overall Study|Subject Non-Compliant|2
5313643|NCT00359021|18304609|P1|Overall Study|Subject Non-Compliant|1
5313644|NCT00359021|18304608|P2|Overall Study|Adverse Event|8
5313645|NCT00359021|18304609|P1|Overall Study|Adverse Event|26
5313646|NCT00358956|18304621|P1|Overall Study|Withdrawal by Subject|1
5313647|NCT00358956|18304621|P1|Overall Study|condition under investigation worsened|4
5313648|NCT00358956|18304621|P1|Overall Study|Adverse Event|3
5313649|NCT00358917|18304633|P2|Overall Study|Unable to Continue Participation|2
5313650|NCT00358917|18304634|P1|Overall Study|Unable to Continue Participation|2
5313651|NCT00358917|18304633|P2|Overall Study|Virologic failure|8
5313652|NCT00358917|18304634|P1|Overall Study|Virologic failure|11
5313653|NCT00358917|18304633|P2|Overall Study|Death|3
5313654|NCT00358917|18304634|P1|Overall Study|Death|2
5313655|NCT00358917|18304633|P2|Overall Study|Noncompliance|11
5313656|NCT00358917|18304634|P1|Overall Study|Noncompliance|12
5313657|NCT00358917|18304633|P2|Overall Study|Lost to Follow-up|17
5313658|NCT00358917|18304634|P1|Overall Study|Lost to Follow-up|20
5313659|NCT00358917|18304633|P2|Overall Study|Withdrawal by Subject|7
5313660|NCT00358917|18304634|P1|Overall Study|Withdrawal by Subject|5
5313661|NCT00358917|18304633|P2|Overall Study|Adverse Event|21
5313662|NCT00358917|18304634|P1|Overall Study|Adverse Event|14
5313663|NCT00358826|18304652|P8|MDCT Substudy|Withdrawal by Subject|0
5313664|NCT00358826|18304653|P7|MDCT Substudy|Withdrawal by Subject|0
5313665|NCT00358826|18304654|P6|MDCT Substudy|Withdrawal by Subject|1
5313666|NCT00358826|18304655|P5|MDCT Substudy|Withdrawal by Subject|0
5313667|NCT00358826|18304656|P4|MDCT Substudy|Withdrawal by Subject|0
5313668|NCT00358826|18304657|P3|MDCT Substudy|Withdrawal by Subject|0
5313669|NCT00358826|18304658|P2|MDCT Substudy|Withdrawal by Subject|0
5313670|NCT00358826|18304659|P1|MDCT Substudy|Withdrawal by Subject|0
5313671|NCT00358826|18304652|P8|MDCT Substudy|Lost to Follow-up|0
5313672|NCT00358826|18304653|P7|MDCT Substudy|Lost to Follow-up|0
5313673|NCT00358826|18304654|P6|MDCT Substudy|Lost to Follow-up|1
5313674|NCT00358826|18304655|P5|MDCT Substudy|Lost to Follow-up|0
5313675|NCT00358826|18304656|P4|MDCT Substudy|Lost to Follow-up|0
5313676|NCT00358826|18304657|P3|MDCT Substudy|Lost to Follow-up|0
5313677|NCT00358826|18304658|P2|MDCT Substudy|Lost to Follow-up|0
5313678|NCT00358826|18304659|P1|MDCT Substudy|Lost to Follow-up|0
5313679|NCT00358826|18304652|P8|MDCT Substudy|Adverse Event|0
5313680|NCT00358826|18304653|P7|MDCT Substudy|Adverse Event|0
5313681|NCT00358826|18304654|P6|MDCT Substudy|Adverse Event|0
5313682|NCT00358826|18304655|P5|MDCT Substudy|Adverse Event|1
5313683|NCT00358826|18304656|P4|MDCT Substudy|Adverse Event|0
5313684|NCT00358826|18304657|P3|MDCT Substudy|Adverse Event|0
5313685|NCT00358826|18304658|P2|MDCT Substudy|Adverse Event|0
5313686|NCT00358826|18304659|P1|MDCT Substudy|Adverse Event|0
5313687|NCT00358826|18304652|P8|Core Study|Physician Decision|0
5313688|NCT00358826|18304653|P7|Core Study|Physician Decision|0
5313689|NCT00358826|18304654|P6|Core Study|Physician Decision|0
5313690|NCT00358826|18304655|P5|Core Study|Physician Decision|0
5313691|NCT00358826|18304656|P4|Core Study|Physician Decision|0
5313692|NCT00358826|18304657|P3|Core Study|Physician Decision|1
5313693|NCT00358826|18304658|P2|Core Study|Physician Decision|0
5313694|NCT00358826|18304659|P1|Core Study|Physician Decision|0
5313695|NCT00358826|18304652|P8|Core Study|Lost to Follow-up|0
5313696|NCT00358826|18304653|P7|Core Study|Lost to Follow-up|0
5313697|NCT00358826|18304654|P6|Core Study|Lost to Follow-up|0
5313698|NCT00358826|18304655|P5|Core Study|Lost to Follow-up|0
5313699|NCT00358826|18304656|P4|Core Study|Lost to Follow-up|1
5313700|NCT00358826|18304657|P3|Core Study|Lost to Follow-up|0
5313701|NCT00358826|18304658|P2|Core Study|Lost to Follow-up|0
5313702|NCT00358826|18304659|P1|Core Study|Lost to Follow-up|0
5313703|NCT00358826|18304652|P8|Core Study|Withdrawal by Subject|0
5313704|NCT00358826|18304653|P7|Core Study|Withdrawal by Subject|0
5313705|NCT00358826|18304654|P6|Core Study|Withdrawal by Subject|0
5313706|NCT00358826|18304655|P5|Core Study|Withdrawal by Subject|0
5313707|NCT00358826|18304656|P4|Core Study|Withdrawal by Subject|0
5313708|NCT00358826|18304657|P3|Core Study|Withdrawal by Subject|0
5313709|NCT00358826|18304658|P2|Core Study|Withdrawal by Subject|2
5313710|NCT00358826|18304659|P1|Core Study|Withdrawal by Subject|2
5313711|NCT00358826|18304652|P8|Core Study|Adverse Event|0
5313712|NCT00358826|18304653|P7|Core Study|Adverse Event|0
5313713|NCT00358826|18304654|P6|Core Study|Adverse Event|0
5313714|NCT00358826|18304655|P5|Core Study|Adverse Event|0
5313715|NCT00358826|18304656|P4|Core Study|Adverse Event|1
5313716|NCT00358826|18304657|P3|Core Study|Adverse Event|1
5313717|NCT00358826|18304658|P2|Core Study|Adverse Event|3
5313718|NCT00358826|18304659|P1|Core Study|Adverse Event|1
5313719|NCT00358670|18304726|P2|Overall Study|Administrative|125
5313720|NCT00358670|18304727|P1|Overall Study|Administrative|153
5313721|NCT00358670|18304726|P2|Overall Study|Did Not Meet Protocol Eligibility|3
5313722|NCT00358670|18304727|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5313723|NCT00358670|18304726|P2|Overall Study|Protocol Defined Clinical Event|1
5313724|NCT00358670|18304727|P1|Overall Study|Protocol Defined Clinical Event|0
5313725|NCT00358670|18304726|P2|Overall Study|Withdrawal by Subject|24
5313726|NCT00358670|18304727|P1|Overall Study|Withdrawal by Subject|13
5313727|NCT00358670|18304726|P2|Overall Study|Lost to Follow-up|5
5313728|NCT00358670|18304727|P1|Overall Study|Lost to Follow-up|4
5313729|NCT00358670|18304726|P2|Overall Study|Protocol Violation|9
5313730|NCT00358670|18304727|P1|Overall Study|Protocol Violation|6
5313731|NCT00358670|18304726|P2|Overall Study|Lack of Efficacy|23
5313732|NCT00358670|18304727|P1|Overall Study|Lack of Efficacy|20
5313733|NCT00358670|18304726|P2|Overall Study|Adverse Event|29
5313734|NCT00358670|18304727|P1|Overall Study|Adverse Event|26
5313735|NCT00358644|18304741|P1|Overall Study|Patient not eligible for study|1
5313736|NCT00358644|18304741|P1|Overall Study|Physician Decision|6
5313737|NCT00358644|18304741|P1|Overall Study|Withdrawal by Subject|4
5313738|NCT00358644|18304741|P1|Overall Study|Death|11
5313739|NCT00358644|18304741|P1|Overall Study|Adverse Event|7
5313740|NCT00358644|18304741|P1|Overall Study|Progressive Disease|21
5313741|NCT00358527|18304764|P2|Overall Study|Administrative|1
5313742|NCT00358527|18304765|P1|Overall Study|Administrative|2
5313743|NCT00358527|18304764|P2|Overall Study|Non-compliance with protocol|1
5313744|NCT00358527|18304765|P1|Overall Study|Non-compliance with protocol|6
5313745|NCT00358527|18304764|P2|Overall Study|Withdrawal by Subject|1
5313746|NCT00358527|18304765|P1|Overall Study|Withdrawal by Subject|1
5313747|NCT00358527|18304764|P2|Overall Study|Adverse Event|0
5313748|NCT00358527|18304765|P1|Overall Study|Adverse Event|4
5313749|NCT00358449|18304815|P3|Overall Study|Steriod Inhaler was Increased|1
5313750|NCT00358449|18304816|P2|Overall Study|Steriod Inhaler was Increased|0
5313751|NCT00358449|18304817|P1|Overall Study|Steriod Inhaler was Increased|0
5313752|NCT00358449|18304815|P3|Overall Study|Lack of Efficacy|0
5313753|NCT00358449|18304816|P2|Overall Study|Lack of Efficacy|1
5313754|NCT00358449|18304817|P1|Overall Study|Lack of Efficacy|0
5313755|NCT00358449|18304815|P3|Overall Study|Withdrawal by Subject|0
5313756|NCT00358449|18304816|P2|Overall Study|Withdrawal by Subject|0
5313757|NCT00358449|18304817|P1|Overall Study|Withdrawal by Subject|2
5313758|NCT00358449|18304815|P3|Overall Study|Lost to Follow-up|0
5313759|NCT00358449|18304816|P2|Overall Study|Lost to Follow-up|0
5313760|NCT00358449|18304817|P1|Overall Study|Lost to Follow-up|1
5313761|NCT00358449|18304815|P3|Overall Study|Adverse Event|1
5313762|NCT00358449|18304816|P2|Overall Study|Adverse Event|0
5313763|NCT00358449|18304817|P1|Overall Study|Adverse Event|1
5313764|NCT00358436|18304920|P2|Overall Study|Other|1
5313765|NCT00358436|18304921|P1|Overall Study|Other|6
5313766|NCT00358436|18304920|P2|Overall Study|COPD exacerbation|10
5313767|NCT00358436|18304921|P1|Overall Study|COPD exacerbation|22
5313768|NCT00358436|18304920|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
5313769|NCT00358436|18304921|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
5313770|NCT00358436|18304920|P2|Overall Study|Withdrawal by Subject|17
5313771|NCT00358436|18304921|P1|Overall Study|Withdrawal by Subject|40
5313772|NCT00358436|18304920|P2|Overall Study|Protocol Violation|3
5313773|NCT00358436|18304921|P1|Overall Study|Protocol Violation|8
5313774|NCT00358436|18304920|P2|Overall Study|Lost to Follow-up|6
5313775|NCT00358436|18304921|P1|Overall Study|Lost to Follow-up|11
5313776|NCT00358436|18304920|P2|Overall Study|Lack of Efficacy|36
5313777|NCT00358436|18304921|P1|Overall Study|Lack of Efficacy|34
5313778|NCT00358436|18304920|P2|Overall Study|Adverse Event|13
5313779|NCT00358436|18304921|P1|Overall Study|Adverse Event|29
5313780|NCT00358215|18304992|P2|Overall Study|Did not receive investigational product|3
5313781|NCT00358215|18304993|P1|Overall Study|Did not receive investigational product|2
5313782|NCT00358215|18304992|P2|Overall Study|Other|14
5313783|NCT00358215|18304993|P1|Overall Study|Other|21
5313784|NCT00358215|18304992|P2|Overall Study|Pregnancy|0
5313785|NCT00358215|18304993|P1|Overall Study|Pregnancy|1
5313786|NCT00358215|18304992|P2|Overall Study|Protocol Violation|59
5313787|NCT00358215|18304993|P1|Overall Study|Protocol Violation|64
5313788|NCT00358215|18304992|P2|Overall Study|Death|281
5313789|NCT00358215|18304993|P1|Overall Study|Death|265
5313790|NCT00358215|18304992|P2|Overall Study|Lost to Follow-up|22
5313791|NCT00358215|18304993|P1|Overall Study|Lost to Follow-up|16
5313792|NCT00358215|18304992|P2|Overall Study|Physician Decision|39
5313793|NCT00358215|18304993|P1|Overall Study|Physician Decision|47
5313794|NCT00358215|18304992|P2|Overall Study|Participant request|64
5313795|NCT00358215|18304993|P1|Overall Study|Participant request|65
5313796|NCT00358215|18304992|P2|Overall Study|Withdrawal by Subject|102
5313797|NCT00358215|18304993|P1|Overall Study|Withdrawal by Subject|111
5313798|NCT00358215|18304992|P2|Overall Study|Adverse Event|65
5313799|NCT00358215|18304993|P1|Overall Study|Adverse Event|83
5313800|NCT00358215|18304992|P2|Overall Study|Ineligibility determined|3
5313801|NCT00358215|18304993|P1|Overall Study|Ineligibility determined|4
5313802|NCT00358150|18305007|P1|Overall Study|Undefined|3
5313803|NCT00358150|18305007|P1|Overall Study|Withdrawal by Subject|1
5313804|NCT00358150|18305007|P1|Overall Study|Adverse Event|3
5313805|NCT00357994|18305036|P2|Overall Study|Protocol Violation|0
5313806|NCT00357994|18305037|P1|Overall Study|Protocol Violation|1
5313807|NCT00357994|18305036|P2|Overall Study|Lack of Efficacy|1
5313808|NCT00357994|18305037|P1|Overall Study|Lack of Efficacy|0
5313809|NCT00357994|18305036|P2|Overall Study|Adverse Event|2
5313810|NCT00357994|18305037|P1|Overall Study|Adverse Event|1
5313811|NCT00357968|18305091|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
5313812|NCT00357968|18305092|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
5313813|NCT00357968|18305091|P2|First Maintenance Dose Phase|Not a PCI patient|42
5313814|NCT00357968|18305092|P1|First Maintenance Dose Phase|Not a PCI patient|47
5313815|NCT00357903|18305145|P2|Overall Study|Other|10
5313816|NCT00357903|18305146|P1|Overall Study|Other|49
5313817|NCT00357903|18305145|P2|Overall Study|Response status|9
5313818|NCT00357903|18305146|P1|Overall Study|Response status|61
5313819|NCT00357903|18305145|P2|Overall Study|Protocol issues|3
5313820|NCT00357903|18305146|P1|Overall Study|Protocol issues|14
5313821|NCT00357903|18305145|P2|Overall Study|Completed month 12 only|1
5313822|NCT00357903|18305146|P1|Overall Study|Completed month 12 only|0
5313823|NCT00357903|18305145|P2|Overall Study|Withdrawal by Subject|7
5313824|NCT00357903|18305146|P1|Overall Study|Withdrawal by Subject|57
5313825|NCT00357903|18305145|P2|Overall Study|Physician Decision|5
5313826|NCT00357903|18305146|P1|Overall Study|Physician Decision|39
5313827|NCT00357903|18305145|P2|Overall Study|Lost to Follow-up|4
5313828|NCT00357903|18305146|P1|Overall Study|Lost to Follow-up|23
5313829|NCT00357903|18305145|P2|Overall Study|Death|0
5313830|NCT00357903|18305146|P1|Overall Study|Death|33
5313831|NCT00357903|18305145|P2|Overall Study|Adverse Event|4
5313832|NCT00357903|18305146|P1|Overall Study|Adverse Event|87
5313833|NCT00357877|18305186|P2|Overall Study|Other|2
5313834|NCT00357877|18305187|P1|Overall Study|Other|0
5313835|NCT00357877|18305186|P2|Overall Study|Administrative withdrawal|1
5313836|NCT00357877|18305187|P1|Overall Study|Administrative withdrawal|1
5313837|NCT00357877|18305186|P2|Overall Study|Withdrawal by Subject|3
5313838|NCT00357877|18305187|P1|Overall Study|Withdrawal by Subject|3
5313839|NCT00357877|18305186|P2|Overall Study|Lost to Follow-up|23
5313840|NCT00357877|18305187|P1|Overall Study|Lost to Follow-up|20
5313841|NCT00357877|18305186|P2|Overall Study|Death|1
5313842|NCT00357877|18305187|P1|Overall Study|Death|2
5313843|NCT00357760|18305201|P2|Overall Study|To receive hospice care|1
5313844|NCT00357760|18305202|P1|Overall Study|To receive hospice care|0
5313845|NCT00357760|18305201|P2|Overall Study|Protocol Violation|1
5313846|NCT00357760|18305202|P1|Overall Study|Protocol Violation|0
5313847|NCT00357760|18305201|P2|Overall Study|Physician Decision|1
5313848|NCT00357760|18305202|P1|Overall Study|Physician Decision|2
5313849|NCT00357760|18305201|P2|Overall Study|Ineligible|2
5313850|NCT00357760|18305202|P1|Overall Study|Ineligible|0
5313851|NCT00357760|18305201|P2|Overall Study|Never started treatment|1
5313852|NCT00357760|18305202|P1|Overall Study|Never started treatment|2
5313853|NCT00357760|18305201|P2|Overall Study|Withdrawal by Subject|2
5313854|NCT00357760|18305202|P1|Overall Study|Withdrawal by Subject|0
5313855|NCT00357760|18305201|P2|Overall Study|Alternative therapy|0
5313856|NCT00357760|18305202|P1|Overall Study|Alternative therapy|1
5313857|NCT00357760|18305201|P2|Overall Study|Death|3
5313858|NCT00357760|18305202|P1|Overall Study|Death|0
5313859|NCT00357760|18305201|P2|Overall Study|Adverse Event|7
5313860|NCT00357760|18305202|P1|Overall Study|Adverse Event|10
5313861|NCT00357760|18305201|P2|Overall Study|Disease progression|17
5313862|NCT00357760|18305202|P1|Overall Study|Disease progression|44
5313863|NCT00357656|18305223|P2|Overall Study|Other, No surgery performed|3
5313864|NCT00357656|18305224|P1|Overall Study|Other, No surgery performed|0
5313865|NCT00357552|18305275|P1|Weeks 24 to 104|Not able to get to clinic|2
5313866|NCT00357552|18305275|P1|Weeks 24 to 104|Death|3
5313867|NCT00357552|18305275|P1|Weeks 0 to 24|Death|1
5313868|NCT00357552|18305275|P1|Screening|Did not meet eligibility criteria|84
5313869|NCT00357500|18305290|P1|Overall Study|Not Started Protocol Therapy|4
5313870|NCT00357500|18305290|P1|Overall Study|Progressive Disease|65
5313871|NCT00357500|18305290|P1|Overall Study|Withdrawal by Subject|5
5313872|NCT00357500|18305290|P1|Overall Study|Adverse Event|3
5313873|NCT00357396|18305299|P2|Overall Study|Adverse Event|0
5313874|NCT00357396|18305300|P1|Overall Study|Adverse Event|1
5313875|NCT00357370|18305308|P3|Cohort 2|Withdrawal by Subject|0
5313876|NCT00357370|18305309|P2|Cohort 2|Withdrawal by Subject|2
5313877|NCT00357370|18305310|P1|Cohort 2|Withdrawal by Subject|0
5313878|NCT00357370|18305308|P3|Cohort 2|non-compliance, not met criteria, etc|0
5313879|NCT00357370|18305309|P2|Cohort 2|non-compliance, not met criteria, etc|1
5313880|NCT00357370|18305310|P1|Cohort 2|non-compliance, not met criteria, etc|1
5313881|NCT00357370|18305308|P3|Cohort 2|Lost to Follow-up|0
5313882|NCT00357370|18305309|P2|Cohort 2|Lost to Follow-up|1
5313883|NCT00357370|18305310|P1|Cohort 2|Lost to Follow-up|0
5313884|NCT00357370|18305308|P3|Cohort 2|Adverse Event|1
5313885|NCT00357370|18305309|P2|Cohort 2|Adverse Event|1
5313886|NCT00357370|18305310|P1|Cohort 2|Adverse Event|1
5313887|NCT00357370|18305308|P3|Cohort 2|Lack of Efficacy|1
5313888|NCT00357370|18305309|P2|Cohort 2|Lack of Efficacy|2
5313889|NCT00357370|18305310|P1|Cohort 2|Lack of Efficacy|0
5313890|NCT00357110|18305373|P2|Overall Study|Early study termination|5
5313891|NCT00357110|18305374|P1|Overall Study|Early study termination|5
5313892|NCT00357097|18305382|P2|Overall Study|Increase of RLS Symptoms|1
5313893|NCT00357097|18305383|P1|Overall Study|Increase of RLS Symptoms|0
5313894|NCT00357097|18305382|P2|Overall Study|Other|1
5313895|NCT00357097|18305383|P1|Overall Study|Other|1
5313896|NCT00357097|18305382|P2|Overall Study|Met Exclusion Criteria|1
5313897|NCT00357097|18305383|P1|Overall Study|Met Exclusion Criteria|3
5313898|NCT00357097|18305382|P2|Overall Study|Lack of Efficacy|8
5313899|NCT00357097|18305383|P1|Overall Study|Lack of Efficacy|2
5313900|NCT00357097|18305382|P2|Overall Study|Non-compliance|2
5313901|NCT00357097|18305383|P1|Overall Study|Non-compliance|1
5313902|NCT00357097|18305382|P2|Overall Study|Withdrawal by Subject|7
5313903|NCT00357097|18305383|P1|Overall Study|Withdrawal by Subject|8
5313904|NCT00357097|18305382|P2|Overall Study|Adverse Event|6
5313905|NCT00357097|18305383|P1|Overall Study|Adverse Event|34
5313906|NCT00357097|18305382|P2|Overall Study|Did not meet inclusion criteria|3
5313907|NCT00357097|18305383|P1|Overall Study|Did not meet inclusion criteria|5
5313908|NCT00357006|18305437|P3|Overall Study|Withdrawal by Subject|2
5313909|NCT00357006|18305438|P2|Overall Study|Withdrawal by Subject|3
5313910|NCT00357006|18305439|P1|Overall Study|Withdrawal by Subject|1
5313911|NCT00357006|18305437|P3|Overall Study|Lost to Follow-up|1
5313912|NCT00357006|18305438|P2|Overall Study|Lost to Follow-up|2
5313913|NCT00357006|18305439|P1|Overall Study|Lost to Follow-up|1
5313914|NCT00356915|18305454|P3|Overall Study|Miscellaneous reasons|3
5313915|NCT00356915|18305455|P2|Overall Study|Miscellaneous reasons|8
5313916|NCT00356915|18305456|P1|Overall Study|Miscellaneous reasons|11
5313917|NCT00356915|18305454|P3|Overall Study|Adverse Event|8
5313918|NCT00356915|18305455|P2|Overall Study|Adverse Event|31
5313919|NCT00356915|18305456|P1|Overall Study|Adverse Event|21
5313920|NCT00356915|18305454|P3|Overall Study|Physician Decision|0
5313921|NCT00356915|18305455|P2|Overall Study|Physician Decision|2
5313922|NCT00356915|18305456|P1|Overall Study|Physician Decision|0
5313923|NCT00356915|18305454|P3|Overall Study|Administrative Decision|1
5313924|NCT00356915|18305455|P2|Overall Study|Administrative Decision|0
5313925|NCT00356915|18305456|P1|Overall Study|Administrative Decision|0
5313926|NCT00356915|18305454|P3|Overall Study|Lost to Follow-up|14
5313927|NCT00356915|18305455|P2|Overall Study|Lost to Follow-up|34
5313928|NCT00356915|18305456|P1|Overall Study|Lost to Follow-up|27
5313929|NCT00356915|18305454|P3|Overall Study|Lack of Efficacy|3
5313930|NCT00356915|18305455|P2|Overall Study|Lack of Efficacy|0
5313931|NCT00356915|18305456|P1|Overall Study|Lack of Efficacy|0
5313932|NCT00356915|18305454|P3|Overall Study|Withdrawal by Subject|10
5313933|NCT00356915|18305455|P2|Overall Study|Withdrawal by Subject|14
5313934|NCT00356915|18305456|P1|Overall Study|Withdrawal by Subject|14
5313935|NCT00356915|18305454|P3|Overall Study|Protocol Violation|2
5313936|NCT00356915|18305455|P2|Overall Study|Protocol Violation|3
5313937|NCT00356915|18305456|P1|Overall Study|Protocol Violation|2
5313938|NCT00356915|18305454|P3|Overall Study|Non compliance|1
5313939|NCT00356915|18305455|P2|Overall Study|Non compliance|2
5313940|NCT00356915|18305456|P1|Overall Study|Non compliance|1
5313941|NCT00356889|18305473|P1|Overall Study|Adverse Event|1
5313942|NCT00356889|18305473|P1|Overall Study|Protocol Violation|2
5313943|NCT00356863|18305482|P2|Overall Study|Lost to Follow-up|43
5313944|NCT00356863|18305483|P1|Overall Study|Lost to Follow-up|76
5313945|NCT00356863|18305482|P2|Overall Study|Death|32
5313946|NCT00356863|18305483|P1|Overall Study|Death|16
5313947|NCT00356811|18305509|P1|Overall Study|Site Closed during Follow-up|2
5313948|NCT00356811|18305509|P1|Overall Study|Study Is Terminating|3
5313949|NCT00356811|18305509|P1|Overall Study|Participant Could Not Make a Checkup|1
5313950|NCT00356811|18305509|P1|Overall Study|Withdrawal by Subject|6
5313951|NCT00356811|18305509|P1|Overall Study|Lost to Follow-up|2
5313952|NCT00356811|18305509|P1|Overall Study|Death|35
5313953|NCT00356759|18305524|P2|Overall Study|Intercurrent disease or persistent extre|2
5313954|NCT00356759|18305525|P1|Overall Study|Intercurrent disease or persistent extre|5
5313955|NCT00356759|18305524|P2|Overall Study|Lost to Follow-up|1
5313956|NCT00356759|18305525|P1|Overall Study|Lost to Follow-up|1
5313957|NCT00356759|18305524|P2|Overall Study|Adverse Event|3
5313958|NCT00356759|18305525|P1|Overall Study|Adverse Event|1
5313959|NCT00356759|18305524|P2|Overall Study|Withdrawal by Subject|2
5313960|NCT00356759|18305525|P1|Overall Study|Withdrawal by Subject|2
5313961|NCT00356759|18305524|P2|Overall Study|Death|2
5313962|NCT00356759|18305525|P1|Overall Study|Death|5
5313963|NCT00356603|18305543|P2|Overall Study|Other|3
5313964|NCT00356603|18305544|P1|Overall Study|Other|6
5313965|NCT00356590|18305558|P1|Overall Study|Other|52
5313966|NCT00356590|18305558|P1|Overall Study|Response status|28
5313967|NCT00356590|18305558|P1|Overall Study|Protocol issues|6
5313968|NCT00356590|18305558|P1|Overall Study|Completed month 12 only|2
5313969|NCT00356590|18305558|P1|Overall Study|Withdrawal by Subject|41
5313970|NCT00356590|18305558|P1|Overall Study|Physician Decision|46
5313971|NCT00356590|18305558|P1|Overall Study|Lost to Follow-up|35
5313972|NCT00356590|18305558|P1|Overall Study|Death|10
5313973|NCT00356590|18305558|P1|Overall Study|Adverse Event|54
5313974|NCT00356525|18305594|P4|Overall Study|Sponsor Decision|1
5313975|NCT00356525|18305595|P3|Overall Study|Sponsor Decision|0
5313976|NCT00356525|18305596|P2|Overall Study|Sponsor Decision|0
5313977|NCT00356525|18305597|P1|Overall Study|Sponsor Decision|0
5313978|NCT00356525|18305594|P4|Overall Study|Death|1
5313979|NCT00356525|18305595|P3|Overall Study|Death|0
5313980|NCT00356525|18305596|P2|Overall Study|Death|0
5313981|NCT00356525|18305597|P1|Overall Study|Death|0
5313982|NCT00356525|18305594|P4|Overall Study|Withdrawal by Subject|3
5313983|NCT00356525|18305595|P3|Overall Study|Withdrawal by Subject|0
5313984|NCT00356525|18305596|P2|Overall Study|Withdrawal by Subject|1
5313985|NCT00356525|18305597|P1|Overall Study|Withdrawal by Subject|1
5313986|NCT00356525|18305594|P4|Overall Study|Protocol Entry Criteria Not Met|0
5313987|NCT00356525|18305595|P3|Overall Study|Protocol Entry Criteria Not Met|0
5313988|NCT00356525|18305596|P2|Overall Study|Protocol Entry Criteria Not Met|0
5313989|NCT00356525|18305597|P1|Overall Study|Protocol Entry Criteria Not Met|1
5313990|NCT00356525|18305594|P4|Overall Study|Physician Decision|1
5313991|NCT00356525|18305595|P3|Overall Study|Physician Decision|2
5313992|NCT00356525|18305596|P2|Overall Study|Physician Decision|2
5313993|NCT00356525|18305597|P1|Overall Study|Physician Decision|2
5313994|NCT00356525|18305594|P4|Overall Study|Lost to Follow-up|0
5313995|NCT00356525|18305595|P3|Overall Study|Lost to Follow-up|0
5313996|NCT00356525|18305596|P2|Overall Study|Lost to Follow-up|0
5313997|NCT00356525|18305597|P1|Overall Study|Lost to Follow-up|1
5313998|NCT00356525|18305594|P4|Overall Study|Adverse Event|1
5313999|NCT00356525|18305595|P3|Overall Study|Adverse Event|1
5314000|NCT00356525|18305596|P2|Overall Study|Adverse Event|3
5314001|NCT00356525|18305597|P1|Overall Study|Adverse Event|1
5314002|NCT00356525|18305594|P4|Overall Study|Progressive Disease|2
5314003|NCT00356525|18305595|P3|Overall Study|Progressive Disease|4
5314004|NCT00356525|18305596|P2|Overall Study|Progressive Disease|5
5314005|NCT00356525|18305597|P1|Overall Study|Progressive Disease|8
5314006|NCT00356421|18305638|P2|Overall Study|Not related to study drug|3
5314007|NCT00356421|18305639|P1|Overall Study|Not related to study drug|5
5314008|NCT00356421|18305638|P2|Overall Study|Related to study drug|12
5314009|NCT00356421|18305639|P1|Overall Study|Related to study drug|15
5314010|NCT00356421|18305638|P2|Overall Study|Withdrawal by Subject|2
5314011|NCT00356421|18305639|P1|Overall Study|Withdrawal by Subject|9
5314012|NCT00356421|18305638|P2|Overall Study|Lack of Efficacy|0
5314013|NCT00356421|18305639|P1|Overall Study|Lack of Efficacy|3
5314014|NCT00356408|18305679|P1|Overall Study|Other: Subject chose commerical dosing|1
5314015|NCT00356408|18305679|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
5314016|NCT00356408|18305679|P1|Overall Study|Other: Azathioprine stopped|1
5314017|NCT00356408|18305679|P1|Overall Study|Other: Sponsor request|1
5314018|NCT00356408|18305679|P1|Overall Study|Other: Principal investigator discretion|3
5314019|NCT00356408|18305679|P1|Overall Study|Withdrawal by Subject|6
5314020|NCT00356408|18305679|P1|Overall Study|Lost to Follow-up|2
5314021|NCT00356408|18305679|P1|Overall Study|Lack of Efficacy|36
5314022|NCT00356408|18305679|P1|Overall Study|Adverse Event|9
5314023|NCT00356369|18305696|P2|Active Phase|Withdrawal by Subject|1
5314024|NCT00356369|18305697|P1|Active Phase|Withdrawal by Subject|2
5314025|NCT00356278|18305779|P3|Overall Study|Withdrawal by Subject|19
5314026|NCT00356278|18305780|P2|Overall Study|Withdrawal by Subject|15
5314027|NCT00356278|18305781|P1|Overall Study|Withdrawal by Subject|25
5314028|NCT00356265|18305819|P3|Overall Study|Withdrawal by Subject|1
5314029|NCT00356265|18305820|P2|Overall Study|Withdrawal by Subject|0
5314030|NCT00356265|18305821|P1|Overall Study|Withdrawal by Subject|0
5314031|NCT00356200|18305833|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
5314032|NCT00356200|18305834|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
5314033|NCT00356200|18305833|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
5314034|NCT00356200|18305834|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
5314035|NCT00356148|18305863|P2|Overall Study|Reoperation within 30 days|1
5314036|NCT00356148|18305864|P1|Overall Study|Reoperation within 30 days|2
5314037|NCT00356135|18305875|P3|Overall Study|Subject non-compliance|3
5314038|NCT00356135|18305876|P2|Overall Study|Subject non-compliance|1
5314039|NCT00356135|18305877|P1|Overall Study|Subject non-compliance|1
5314040|NCT00356135|18305875|P3|Overall Study|Physician Decision|1
5314041|NCT00356135|18305876|P2|Overall Study|Physician Decision|1
5314042|NCT00356135|18305877|P1|Overall Study|Physician Decision|1
5314043|NCT00356135|18305875|P3|Overall Study|Lost to Follow-up|1
5314044|NCT00356135|18305876|P2|Overall Study|Lost to Follow-up|0
5314045|NCT00356135|18305877|P1|Overall Study|Lost to Follow-up|0
5314046|NCT00356135|18305875|P3|Overall Study|Adverse Event|0
5314047|NCT00356135|18305876|P2|Overall Study|Adverse Event|0
5314048|NCT00356135|18305877|P1|Overall Study|Adverse Event|1
5314049|NCT00356135|18305875|P3|Overall Study|Protocol Violation|0
5314050|NCT00356135|18305876|P2|Overall Study|Protocol Violation|0
5314051|NCT00356135|18305877|P1|Overall Study|Protocol Violation|1
5314052|NCT00356122|18305899|P1|FOLLOW-UP|Other|2
5314053|NCT00356122|18305899|P1|FOLLOW-UP|Lost to Follow-up|2
5314054|NCT00356122|18305899|P1|FOLLOW-UP|Death|37
5314055|NCT00356122|18305899|P1|TREATMENT|Did not receive study medication|1
5314056|NCT00356122|18305899|P1|TREATMENT|Other|4
5314057|NCT00356122|18305899|P1|TREATMENT|Subject's request|4
5314058|NCT00356122|18305899|P1|TREATMENT|Adverse Event|10
5314059|NCT00356122|18305899|P1|TREATMENT|Lack of Efficacy|26
5314060|NCT00355784|18306007|P3|Overall Study|Withdrawal by Subject|2
5314061|NCT00355784|18306008|P2|Overall Study|Withdrawal by Subject|0
5314062|NCT00355784|18306009|P1|Overall Study|Withdrawal by Subject|0
5314063|NCT00355615|18306058|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
5314064|NCT00355615|18306059|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
5314065|NCT00355615|18306060|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
5314066|NCT00355615|18306061|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
5314067|NCT00355615|18306062|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
5314068|NCT00355615|18306058|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
5314069|NCT00355615|18306059|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5314070|NCT00355615|18306060|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5314071|NCT00355615|18306061|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5314072|NCT00355615|18306062|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5314073|NCT00355615|18306058|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
5314074|NCT00355615|18306059|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5314075|NCT00355615|18306060|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5314076|NCT00355615|18306061|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5314077|NCT00355615|18306062|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5314078|NCT00355615|18306058|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
5314079|NCT00355615|18306059|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
5314080|NCT00355615|18306060|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
5314081|NCT00355615|18306061|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
5314082|NCT00355615|18306062|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
5314083|NCT00355615|18306058|P5|Randomized Double Blind Period|Protocol Violation|0
5314084|NCT00355615|18306059|P4|Randomized Double Blind Period|Protocol Violation|1
5314085|NCT00355615|18306060|P3|Randomized Double Blind Period|Protocol Violation|1
5314086|NCT00355615|18306061|P2|Randomized Double Blind Period|Protocol Violation|0
5314087|NCT00355615|18306062|P1|Randomized Double Blind Period|Protocol Violation|0
5314088|NCT00355615|18306058|P5|Randomized Double Blind Period|Adverse Event|0
5314089|NCT00355615|18306059|P4|Randomized Double Blind Period|Adverse Event|0
5314090|NCT00355615|18306060|P3|Randomized Double Blind Period|Adverse Event|0
5314091|NCT00355615|18306061|P2|Randomized Double Blind Period|Adverse Event|0
5314092|NCT00355615|18306062|P1|Randomized Double Blind Period|Adverse Event|1
5314093|NCT00355472|18306121|P1|Overall Study|Physician Decision|1
5314094|NCT00355368|18306167|P2|Overall Study|cardiac arrest prior to intubation|2
5314095|NCT00355368|18306168|P1|Overall Study|cardiac arrest prior to intubation|2
5314096|NCT00355368|18306167|P2|Overall Study|Protocol Violation|7
5314097|NCT00355368|18306168|P1|Overall Study|Protocol Violation|8
5314098|NCT00355342|18306182|P2|Overall Study|Use of protocol excluded medication|1
5314099|NCT00355342|18306183|P1|Overall Study|Use of protocol excluded medication|0
5314100|NCT00355342|18306182|P2|Overall Study|Protocol Violation|1
5314101|NCT00355342|18306183|P1|Overall Study|Protocol Violation|0
5314102|NCT00355342|18306182|P2|Overall Study|Study management|1
5314103|NCT00355342|18306183|P1|Overall Study|Study management|0
5314104|NCT00355342|18306182|P2|Overall Study|Participant discontinued study drug|1
5314105|NCT00355342|18306183|P1|Overall Study|Participant discontinued study drug|0
5314106|NCT00355342|18306182|P2|Overall Study|Participant relocated|1
5314107|NCT00355342|18306183|P1|Overall Study|Participant relocated|0
5314108|NCT00355342|18306182|P2|Overall Study|Withdrawal by participant and physician|0
5314109|NCT00355342|18306183|P1|Overall Study|Withdrawal by participant and physician|1
5314110|NCT00355342|18306182|P2|Overall Study|Non-compliance with Dexa scans|0
5314111|NCT00355342|18306183|P1|Overall Study|Non-compliance with Dexa scans|1
5314112|NCT00355342|18306182|P2|Overall Study|Dispensed wrong study drug kit|0
5314113|NCT00355342|18306183|P1|Overall Study|Dispensed wrong study drug kit|1
5314114|NCT00355342|18306182|P2|Overall Study|COPD exacerbation|1
5314115|NCT00355342|18306183|P1|Overall Study|COPD exacerbation|1
5314116|NCT00355342|18306182|P2|Overall Study|Use of prohibited medication|0
5314117|NCT00355342|18306183|P1|Overall Study|Use of prohibited medication|1
5314118|NCT00355342|18306182|P2|Overall Study|Overcompliant-PI discretion|0
5314119|NCT00355342|18306183|P1|Overall Study|Overcompliant-PI discretion|1
5314120|NCT00355342|18306182|P2|Overall Study|Sponsor terminated study|2
5314121|NCT00355342|18306183|P1|Overall Study|Sponsor terminated study|2
5314122|NCT00355342|18306182|P2|Overall Study|Withdrawal by Subject|11
5314123|NCT00355342|18306183|P1|Overall Study|Withdrawal by Subject|14
5314124|NCT00355342|18306182|P2|Overall Study|Lost to Follow-up|2
5314125|NCT00355342|18306183|P1|Overall Study|Lost to Follow-up|4
5314126|NCT00355342|18306182|P2|Overall Study|Adverse Event|15
5314127|NCT00355342|18306183|P1|Overall Study|Adverse Event|13
5314128|NCT00355264|18306191|P1|Extension (Variable Duration)|Withdrew Consent|1
5314129|NCT00355264|18306191|P1|Extension (Variable Duration)|Adverse Event|1
5314130|NCT00355147|18306219|P2|Overall Study|Withdrawal by Subject|12
5314131|NCT00355147|18306220|P1|Overall Study|Withdrawal by Subject|8
5314132|NCT00355147|18306219|P2|Overall Study|Lost to Follow-up|8
5314133|NCT00355147|18306220|P1|Overall Study|Lost to Follow-up|10
5314134|NCT00355134|18306239|P5|Extension Phase|Protocol Violation|0
5314135|NCT00355134|18306240|P4|Extension Phase|Protocol Violation|1
5314136|NCT00355134|18306241|P3|Extension Phase|Protocol Violation|0
5314137|NCT00355134|18306242|P2|Extension Phase|Protocol Violation|0
5314138|NCT00355134|18306243|P1|Extension Phase|Protocol Violation|0
5314139|NCT00355134|18306239|P5|Extension Phase|Abnormal test procedure result(s)|1
5314140|NCT00355134|18306240|P4|Extension Phase|Abnormal test procedure result(s)|0
5314141|NCT00355134|18306241|P3|Extension Phase|Abnormal test procedure result(s)|0
5314142|NCT00355134|18306242|P2|Extension Phase|Abnormal test procedure result(s)|1
5314143|NCT00355134|18306243|P1|Extension Phase|Abnormal test procedure result(s)|0
5314144|NCT00355134|18306239|P5|Extension Phase|Unsatisfactory therapeutic effect|1
5314145|NCT00355134|18306240|P4|Extension Phase|Unsatisfactory therapeutic effect|0
5314146|NCT00355134|18306241|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5314147|NCT00355134|18306242|P2|Extension Phase|Unsatisfactory therapeutic effect|4
5314148|NCT00355134|18306243|P1|Extension Phase|Unsatisfactory therapeutic effect|3
5314149|NCT00355134|18306239|P5|Extension Phase|Administrative problems|1
5314150|NCT00355134|18306240|P4|Extension Phase|Administrative problems|1
5314151|NCT00355134|18306241|P3|Extension Phase|Administrative problems|0
5314152|NCT00355134|18306242|P2|Extension Phase|Administrative problems|4
5314153|NCT00355134|18306243|P1|Extension Phase|Administrative problems|2
5314154|NCT00355134|18306239|P5|Extension Phase|Abnormal laboratory value(s)|2
5314155|NCT00355134|18306240|P4|Extension Phase|Abnormal laboratory value(s)|2
5314156|NCT00355134|18306241|P3|Extension Phase|Abnormal laboratory value(s)|0
5314157|NCT00355134|18306242|P2|Extension Phase|Abnormal laboratory value(s)|2
5314158|NCT00355134|18306243|P1|Extension Phase|Abnormal laboratory value(s)|4
5314159|NCT00355134|18306239|P5|Extension Phase|Lost to Follow-up|4
5314160|NCT00355134|18306240|P4|Extension Phase|Lost to Follow-up|2
5314161|NCT00355134|18306241|P3|Extension Phase|Lost to Follow-up|0
5314162|NCT00355134|18306242|P2|Extension Phase|Lost to Follow-up|6
5314163|NCT00355134|18306243|P1|Extension Phase|Lost to Follow-up|2
5314164|NCT00355134|18306239|P5|Extension Phase|Adverse Event|5
5314165|NCT00355134|18306240|P4|Extension Phase|Adverse Event|3
5314166|NCT00355134|18306241|P3|Extension Phase|Adverse Event|0
5314167|NCT00355134|18306242|P2|Extension Phase|Adverse Event|9
5314168|NCT00355134|18306243|P1|Extension Phase|Adverse Event|13
5314169|NCT00355134|18306239|P5|Extension Phase|Withdrawal by Subject|5
5314170|NCT00355134|18306240|P4|Extension Phase|Withdrawal by Subject|7
5314171|NCT00355134|18306241|P3|Extension Phase|Withdrawal by Subject|0
5314172|NCT00355134|18306242|P2|Extension Phase|Withdrawal by Subject|11
5314173|NCT00355134|18306243|P1|Extension Phase|Withdrawal by Subject|7
5314174|NCT00355134|18306239|P5|Core Phase|Condition no longer requires study drug|0
5314175|NCT00355134|18306240|P4|Core Phase|Condition no longer requires study drug|0
5314176|NCT00355134|18306241|P3|Core Phase|Condition no longer requires study drug|1
5314177|NCT00355134|18306242|P2|Core Phase|Condition no longer requires study drug|0
5314178|NCT00355134|18306243|P1|Core Phase|Condition no longer requires study drug|1
5314179|NCT00355134|18306239|P5|Core Phase|Abnormal test procedure result(s)|0
5314180|NCT00355134|18306240|P4|Core Phase|Abnormal test procedure result(s)|0
5314181|NCT00355134|18306241|P3|Core Phase|Abnormal test procedure result(s)|1
5314182|NCT00355134|18306242|P2|Core Phase|Abnormal test procedure result(s)|2
5314183|NCT00355134|18306243|P1|Core Phase|Abnormal test procedure result(s)|1
5314184|NCT00355134|18306239|P5|Core Phase|Protocol Violation|0
5314185|NCT00355134|18306240|P4|Core Phase|Protocol Violation|0
5314186|NCT00355134|18306241|P3|Core Phase|Protocol Violation|2
5314187|NCT00355134|18306242|P2|Core Phase|Protocol Violation|2
5314188|NCT00355134|18306243|P1|Core Phase|Protocol Violation|3
5314189|NCT00355134|18306239|P5|Core Phase|Administrative problems|0
5314190|NCT00355134|18306240|P4|Core Phase|Administrative problems|0
5314191|NCT00355134|18306241|P3|Core Phase|Administrative problems|5
5314192|NCT00355134|18306242|P2|Core Phase|Administrative problems|3
5314193|NCT00355134|18306243|P1|Core Phase|Administrative problems|5
5314194|NCT00355134|18306239|P5|Core Phase|Unsatisfactory therapeutic effect|0
5314195|NCT00355134|18306240|P4|Core Phase|Unsatisfactory therapeutic effect|0
5314196|NCT00355134|18306241|P3|Core Phase|Unsatisfactory therapeutic effect|17
5314197|NCT00355134|18306242|P2|Core Phase|Unsatisfactory therapeutic effect|6
5314198|NCT00355134|18306243|P1|Core Phase|Unsatisfactory therapeutic effect|10
5314199|NCT00355134|18306239|P5|Core Phase|Abnormal laboratory value(s)|0
5314200|NCT00355134|18306240|P4|Core Phase|Abnormal laboratory value(s)|0
5314201|NCT00355134|18306241|P3|Core Phase|Abnormal laboratory value(s)|2
5314202|NCT00355134|18306242|P2|Core Phase|Abnormal laboratory value(s)|14
5314203|NCT00355134|18306243|P1|Core Phase|Abnormal laboratory value(s)|19
5314204|NCT00355134|18306239|P5|Core Phase|Lost to Follow-up|0
5314205|NCT00355134|18306240|P4|Core Phase|Lost to Follow-up|0
5314206|NCT00355134|18306241|P3|Core Phase|Lost to Follow-up|21
5314207|NCT00355134|18306242|P2|Core Phase|Lost to Follow-up|13
5314208|NCT00355134|18306243|P1|Core Phase|Lost to Follow-up|17
5314209|NCT00355134|18306239|P5|Core Phase|Adverse Event|0
5314210|NCT00355134|18306240|P4|Core Phase|Adverse Event|0
5314211|NCT00355134|18306241|P3|Core Phase|Adverse Event|16
5314212|NCT00355134|18306242|P2|Core Phase|Adverse Event|22
5314213|NCT00355134|18306243|P1|Core Phase|Adverse Event|28
5314214|NCT00355134|18306239|P5|Core Phase|Withdrawal by Subject|0
5314215|NCT00355134|18306240|P4|Core Phase|Withdrawal by Subject|0
5314216|NCT00355134|18306241|P3|Core Phase|Withdrawal by Subject|35
5314217|NCT00355134|18306242|P2|Core Phase|Withdrawal by Subject|24
5314218|NCT00355134|18306243|P1|Core Phase|Withdrawal by Subject|35
5314219|NCT00355121|18306286|P3|Overall Study|Serious adverse events|0
5314220|NCT00355121|18306287|P2|Overall Study|Serious adverse events|2
5314221|NCT00355121|18306288|P1|Overall Study|Serious adverse events|0
5314222|NCT00355121|18306286|P3|Overall Study|Withdrawal by Subject|2
5314223|NCT00355121|18306287|P2|Overall Study|Withdrawal by Subject|10
5314224|NCT00355121|18306288|P1|Overall Study|Withdrawal by Subject|9
5314225|NCT00355121|18306286|P3|Overall Study|Lost to Follow-up|1
5314226|NCT00355121|18306287|P2|Overall Study|Lost to Follow-up|7
5314227|NCT00355121|18306288|P1|Overall Study|Lost to Follow-up|4
5314228|NCT00355121|18306286|P3|Overall Study|Protocol Violation|1
5314229|NCT00355121|18306287|P2|Overall Study|Protocol Violation|9
5314230|NCT00355121|18306288|P1|Overall Study|Protocol Violation|7
5314231|NCT00355121|18306286|P3|Overall Study|Adverse Event|0
5314232|NCT00355121|18306287|P2|Overall Study|Adverse Event|1
5314233|NCT00355121|18306288|P1|Overall Study|Adverse Event|0
5314234|NCT00355121|18306286|P3|Overall Study|Did not receive study vaccine|1
5314235|NCT00355121|18306287|P2|Overall Study|Did not receive study vaccine|0
5314236|NCT00355121|18306288|P1|Overall Study|Did not receive study vaccine|1
5314237|NCT00355082|18306319|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
5314238|NCT00355082|18306320|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
5314239|NCT00355082|18306321|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
5314240|NCT00355082|18306319|P3|Continuation Phase|Scheduling Error|0
5314241|NCT00355082|18306320|P2|Continuation Phase|Scheduling Error|0
5314242|NCT00355082|18306321|P1|Continuation Phase|Scheduling Error|1
5314243|NCT00355082|18306319|P3|Continuation Phase|Site Closed by Sponsor|0
5314244|NCT00355082|18306320|P2|Continuation Phase|Site Closed by Sponsor|0
5314245|NCT00355082|18306321|P1|Continuation Phase|Site Closed by Sponsor|8
5314246|NCT00355082|18306319|P3|Continuation Phase|Lack of Efficacy|0
5314247|NCT00355082|18306320|P2|Continuation Phase|Lack of Efficacy|0
5314248|NCT00355082|18306321|P1|Continuation Phase|Lack of Efficacy|5
5314249|NCT00355082|18306319|P3|Continuation Phase|Withdrawal by Subject|0
5314250|NCT00355082|18306320|P2|Continuation Phase|Withdrawal by Subject|0
5314251|NCT00355082|18306321|P1|Continuation Phase|Withdrawal by Subject|4
5314252|NCT00355082|18306319|P3|Continuation Phase|Protocol Violation|1
5314253|NCT00355082|18306320|P2|Continuation Phase|Protocol Violation|0
5314254|NCT00355082|18306321|P1|Continuation Phase|Protocol Violation|1
5314255|NCT00355082|18306319|P3|Continuation Phase|Lost to Follow-up|1
5314256|NCT00355082|18306320|P2|Continuation Phase|Lost to Follow-up|0
5314257|NCT00355082|18306321|P1|Continuation Phase|Lost to Follow-up|2
5314258|NCT00355082|18306319|P3|Continuation Phase|Adverse Event|1
5314259|NCT00355082|18306320|P2|Continuation Phase|Adverse Event|0
5314260|NCT00355082|18306321|P1|Continuation Phase|Adverse Event|2
5314261|NCT00355082|18306319|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
5314262|NCT00355082|18306320|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
5314263|NCT00355082|18306321|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
5314264|NCT00355082|18306319|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
5314265|NCT00355082|18306320|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
5314266|NCT00355082|18306321|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
5314267|NCT00355082|18306319|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
5314268|NCT00355082|18306320|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
5314269|NCT00355082|18306321|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
5314270|NCT00355082|18306319|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
5314271|NCT00355082|18306320|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
5314272|NCT00355082|18306321|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
5314273|NCT00355082|18306319|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
5314274|NCT00355082|18306320|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
5314275|NCT00355082|18306321|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
5314276|NCT00355082|18306319|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
5314277|NCT00355082|18306320|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
5314278|NCT00355082|18306321|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
5314279|NCT00355056|18306343|P2|Randomization Period|Early Termination|6
5314280|NCT00355056|18306344|P1|Randomization Period|Early Termination|4
5314281|NCT00355030|18306374|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
5314282|NCT00355030|18306375|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
5314283|NCT00355030|18306374|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
5314284|NCT00355030|18306375|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
5314285|NCT00355030|18306374|P2|Study Period 1 Treatment|Other|6
5314286|NCT00355030|18306375|P1|Study Period 1 Treatment|Other|2
5314287|NCT00355030|18306374|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
5314288|NCT00355030|18306375|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
5314289|NCT00355030|18306374|P2|Study Period 1 Treatment|Sponsor Decision|32
5314290|NCT00355030|18306375|P1|Study Period 1 Treatment|Sponsor Decision|34
5314291|NCT00355030|18306374|P2|Study Period 1 Treatment|Physician Decision|1
5314292|NCT00355030|18306375|P1|Study Period 1 Treatment|Physician Decision|0
5314293|NCT00355030|18306374|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
5314294|NCT00355030|18306375|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
5314295|NCT00355030|18306374|P2|Study Period 1 Treatment|Withdrawal by Subject|1
5314296|NCT00355030|18306375|P1|Study Period 1 Treatment|Withdrawal by Subject|4
5314297|NCT00355030|18306374|P2|Study Period 1 Treatment|Lost to Follow-up|0
5314298|NCT00355030|18306375|P1|Study Period 1 Treatment|Lost to Follow-up|3
5314299|NCT00355030|18306374|P2|Study Period 1 Treatment|Adverse Event|1
5314300|NCT00355030|18306375|P1|Study Period 1 Treatment|Adverse Event|1
5314301|NCT00354835|18306414|P2|Overall Study|Refusal of further therapy|8
5314302|NCT00354835|18306415|P1|Overall Study|Refusal of further therapy|3
5314303|NCT00354835|18306414|P2|Overall Study|Adverse Event|0
5314304|NCT00354835|18306415|P1|Overall Study|Adverse Event|6
5314305|NCT00354835|18306414|P2|Overall Study|Disease progression or relapse|22
5314306|NCT00354835|18306415|P1|Overall Study|Disease progression or relapse|15
5314307|NCT00354835|18306414|P2|Overall Study|Ineligible|16
5314308|NCT00354835|18306415|P1|Overall Study|Ineligible|17
5314309|NCT00354835|18306414|P2|Overall Study|Withdrawal by Subject|1
5314310|NCT00354835|18306415|P1|Overall Study|Withdrawal by Subject|2
5314311|NCT00354835|18306414|P2|Overall Study|Physician Decision|13
5314312|NCT00354835|18306415|P1|Overall Study|Physician Decision|8
5314313|NCT00354835|18306414|P2|Overall Study|Death|1
5314314|NCT00354835|18306415|P1|Overall Study|Death|1
5314315|NCT00354744|18306454|P1|Overall Study|Withdrawal by Subject|14
5314316|NCT00354744|18306454|P1|Overall Study|Physician Decision|11
5314317|NCT00354744|18306454|P1|Overall Study|Lost to Follow-up|2
5314318|NCT00354744|18306454|P1|Overall Study|Lack of Efficacy|11
5314319|NCT00354744|18306454|P1|Overall Study|Death|2
5314320|NCT00354744|18306454|P1|Overall Study|Adverse Event|2
5314321|NCT00354679|18306460|P1|Overall Study|Patient Not Treated|1
5314322|NCT00354614|18306469|P1|Overall Study|Lack of Efficacy|28
5314323|NCT00354601|18306473|P1|Overall Study|progression|1
5314324|NCT00354601|18306473|P1|Overall Study|Protocol Violation|1
5314325|NCT00354432|18306493|P4|Overall Study|Off/Toxicity|5
5314326|NCT00354432|18306494|P3|Overall Study|Off/Toxicity|5
5314327|NCT00354432|18306495|P2|Overall Study|Off/Toxicity|7
5314328|NCT00354432|18306496|P1|Overall Study|Off/Toxicity|3
5314329|NCT00354432|18306493|P4|Overall Study|Adverse Event|5
5314330|NCT00354432|18306494|P3|Overall Study|Adverse Event|5
5314331|NCT00354432|18306495|P2|Overall Study|Adverse Event|1
5314332|NCT00354432|18306496|P1|Overall Study|Adverse Event|3
5314333|NCT00354341|18306512|P2|Overall Study|Other|2
5314334|NCT00354341|18306513|P1|Overall Study|Other|1
5314335|NCT00354341|18306512|P2|Overall Study|Failure to return|1
5314336|NCT00354341|18306513|P1|Overall Study|Failure to return|0
5314337|NCT00354341|18306512|P2|Overall Study|Refused treatment|2
5314338|NCT00354341|18306513|P1|Overall Study|Refused treatment|1
5314339|NCT00354341|18306512|P2|Overall Study|Death|2
5314340|NCT00354341|18306513|P1|Overall Study|Death|0
5314341|NCT00354341|18306512|P2|Overall Study|Adverse Event|0
5314342|NCT00354341|18306513|P1|Overall Study|Adverse Event|1
5314343|NCT00354172|18306535|P1|Overall Study|Did not receive transplant|1
5314344|NCT00354159|18306555|P2|Long-term Follow-up|Study Closed|34
5314345|NCT00354159|18306556|P1|Long-term Follow-up|Study Closed|29
5314346|NCT00354159|18306555|P2|Long-term Follow-up|Death|11
5314347|NCT00354159|18306556|P1|Long-term Follow-up|Death|14
5314348|NCT00354159|18306555|P2|Long-term Follow-up|Lost to Follow-up|0
5314349|NCT00354159|18306556|P1|Long-term Follow-up|Lost to Follow-up|1
5314350|NCT00354159|18306555|P2|Long-term Follow-up|Physician Decision|122
5314351|NCT00354159|18306556|P1|Long-term Follow-up|Physician Decision|127
5314352|NCT00354159|18306555|P2|Long-term Follow-up|Withdrawal by Subject|9
5314353|NCT00354159|18306556|P1|Long-term Follow-up|Withdrawal by Subject|9
5314354|NCT00354159|18306555|P2|Randomized Study Period|Death|9
5314355|NCT00354159|18306556|P1|Randomized Study Period|Death|7
5314356|NCT00354159|18306555|P2|Randomized Study Period|Lost to Follow-up|0
5314357|NCT00354159|18306556|P1|Randomized Study Period|Lost to Follow-up|4
5314358|NCT00354159|18306555|P2|Randomized Study Period|Physician Decision|10
5314359|NCT00354159|18306556|P1|Randomized Study Period|Physician Decision|6
5314360|NCT00354159|18306555|P2|Randomized Study Period|Withdrawal by Subject|3
5314361|NCT00354159|18306556|P1|Randomized Study Period|Withdrawal by Subject|5
5314362|NCT00354107|18306599|P1|Overall Study|Withdrawal by Subject|1
5314363|NCT00354107|18306599|P1|Overall Study|Physician Decision|2
5314364|NCT00354107|18306599|P1|Overall Study|Adverse Event|2
5314365|NCT00354029|18306609|P2|Overall Study|Protocol Violation|2
5314366|NCT00354029|18306610|P1|Overall Study|Protocol Violation|4
5314367|NCT00353873|18306622|P2|Overall Study|Withdrawal by Subject|1
5314368|NCT00353873|18306623|P1|Overall Study|Withdrawal by Subject|1
5314369|NCT00353873|18306622|P2|Overall Study|Physician Decision|0
5314370|NCT00353873|18306623|P1|Overall Study|Physician Decision|2
5314371|NCT00353873|18306622|P2|Overall Study|Adverse Event|0
5314372|NCT00353873|18306623|P1|Overall Study|Adverse Event|1
5314373|NCT00353873|18306622|P2|Overall Study|Exacerbation|0
5314374|NCT00353873|18306623|P1|Overall Study|Exacerbation|1
5314375|NCT00353873|18306622|P2|Overall Study|Protocol Violation|2
5314376|NCT00353873|18306623|P1|Overall Study|Protocol Violation|1
5314377|NCT00353704|18306652|P2|Overall Study|Protocol Violation|1
5314378|NCT00353704|18306653|P1|Overall Study|Protocol Violation|3
5314379|NCT00353496|18306723|P2|Overall Study|Not otherwise specified|2
5314380|NCT00353496|18306724|P1|Overall Study|Not otherwise specified|4
5314381|NCT00353496|18306723|P2|Overall Study|Physician Decision|9
5314382|NCT00353496|18306724|P1|Overall Study|Physician Decision|6
5314383|NCT00353496|18306723|P2|Overall Study|Withdrawal by Subject|4
5314384|NCT00353496|18306724|P1|Overall Study|Withdrawal by Subject|3
5314385|NCT00353496|18306723|P2|Overall Study|Protocol Violation|2
5314386|NCT00353496|18306724|P1|Overall Study|Protocol Violation|2
5314387|NCT00353496|18306723|P2|Overall Study|Adverse Event|0
5314388|NCT00353496|18306724|P1|Overall Study|Adverse Event|1
5314389|NCT00353366|18306777|P1|Overall Study|Other|135
5314390|NCT00353366|18306777|P1|Overall Study|Adverse Event|8
5314391|NCT00353262|18306804|P1|Overall Study|Break from Chemotherapy|1
5314392|NCT00353262|18306804|P1|Overall Study|Surgery|4
5314393|NCT00353262|18306804|P1|Overall Study|Progression|1
5314394|NCT00353262|18306804|P1|Overall Study|Insufficient Therapeutic Response|13
5314395|NCT00353262|18306804|P1|Overall Study|Withdrawal by Subject|2
5314396|NCT00353262|18306804|P1|Overall Study|Adverse Event|8
5314397|NCT00352885|18306845|P2|Overall Study|Side effects of IL-2 administration|0
5314398|NCT00352885|18306846|P1|Overall Study|Side effects of IL-2 administration|1
5314399|NCT00352885|18306845|P2|Overall Study|Progression of metastatic melanoma|3
5314400|NCT00352885|18306846|P1|Overall Study|Progression of metastatic melanoma|5
5314401|NCT00352885|18306845|P2|Overall Study|Development of major depression|1
5314402|NCT00352885|18306846|P1|Overall Study|Development of major depression|0
5314403|NCT00352885|18306845|P2|Overall Study|Withdrawal by Subject|3
5314404|NCT00352885|18306846|P1|Overall Study|Withdrawal by Subject|0
5314405|NCT00352846|18306864|P2|Overall Study|Death|1
5314406|NCT00352846|18306865|P1|Overall Study|Death|0
5314407|NCT00352846|18306864|P2|Overall Study|Non-compliance|0
5314408|NCT00352846|18306865|P1|Overall Study|Non-compliance|2
5314409|NCT00352846|18306864|P2|Overall Study|Ineligible|2
5314410|NCT00352846|18306865|P1|Overall Study|Ineligible|3
5314411|NCT00352846|18306864|P2|Overall Study|Withdrawal by Subject|8
5314412|NCT00352846|18306865|P1|Overall Study|Withdrawal by Subject|3
5314413|NCT00352846|18306864|P2|Overall Study|Disease progression|2
5314414|NCT00352846|18306865|P1|Overall Study|Disease progression|0
5314415|NCT00352755|18306880|P1|Overall Study|Adverse Event|1
5314416|NCT00352755|18306880|P1|Overall Study|Physician Decision|1
5314417|NCT00352690|18306890|P2|Overall Study|Determined to be ineligible|0
5314418|NCT00352690|18306891|P1|Overall Study|Determined to be ineligible|2
5314419|NCT00352664|18306911|P2|Overall Study|Withdrawal by Subject|0
5314420|NCT00352664|18306912|P1|Overall Study|Withdrawal by Subject|7
5314421|NCT00352534|18306929|P7|Final Risk Group Assignment|Death|0
5314422|NCT00352534|18306930|P6|Final Risk Group Assignment|Death|2
5314423|NCT00352534|18306931|P5|Final Risk Group Assignment|Death|0
5314424|NCT00352534|18306932|P4|Final Risk Group Assignment|Death|0
5314425|NCT00352534|18306933|P3|Final Risk Group Assignment|Death|0
5314426|NCT00352534|18306934|P2|Final Risk Group Assignment|Death|0
5314427|NCT00352534|18306935|P1|Final Risk Group Assignment|Death|0
5314428|NCT00352534|18306929|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
5314429|NCT00352534|18306930|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5314430|NCT00352534|18306931|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5314431|NCT00352534|18306932|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5314432|NCT00352534|18306933|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5314433|NCT00352534|18306934|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5314434|NCT00352534|18306935|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5314435|NCT00352534|18306929|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
5314436|NCT00352534|18306930|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
5314437|NCT00352534|18306931|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
5314438|NCT00352534|18306932|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
5314439|NCT00352534|18306933|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
5314440|NCT00352534|18306934|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
5314441|NCT00352534|18306935|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
5314442|NCT00352534|18306929|P7|Final Risk Group Assignment|Ineligible|0
5314443|NCT00352534|18306930|P6|Final Risk Group Assignment|Ineligible|13
5314444|NCT00352534|18306931|P5|Final Risk Group Assignment|Ineligible|0
5314445|NCT00352534|18306932|P4|Final Risk Group Assignment|Ineligible|1
5314446|NCT00352534|18306933|P3|Final Risk Group Assignment|Ineligible|3
5314447|NCT00352534|18306934|P2|Final Risk Group Assignment|Ineligible|0
5314448|NCT00352534|18306935|P1|Final Risk Group Assignment|Ineligible|0
5314449|NCT00352534|18306929|P7|Final Risk Group Assignment|Withdrawal by Subject|0
5314450|NCT00352534|18306930|P6|Final Risk Group Assignment|Withdrawal by Subject|3
5314451|NCT00352534|18306931|P5|Final Risk Group Assignment|Withdrawal by Subject|0
5314452|NCT00352534|18306932|P4|Final Risk Group Assignment|Withdrawal by Subject|0
5314453|NCT00352534|18306933|P3|Final Risk Group Assignment|Withdrawal by Subject|0
5314454|NCT00352534|18306934|P2|Final Risk Group Assignment|Withdrawal by Subject|0
5314455|NCT00352534|18306935|P1|Final Risk Group Assignment|Withdrawal by Subject|0
5314456|NCT00352534|18306929|P7|Final Risk Group Assignment|Physician Decision|0
5314457|NCT00352534|18306930|P6|Final Risk Group Assignment|Physician Decision|8
5314458|NCT00352534|18306931|P5|Final Risk Group Assignment|Physician Decision|0
5314459|NCT00352534|18306932|P4|Final Risk Group Assignment|Physician Decision|0
5314460|NCT00352534|18306933|P3|Final Risk Group Assignment|Physician Decision|0
5314461|NCT00352534|18306934|P2|Final Risk Group Assignment|Physician Decision|0
5314462|NCT00352534|18306935|P1|Final Risk Group Assignment|Physician Decision|0
5314463|NCT00352534|18306929|P7|Final Risk Group Assignment|Lack of Efficacy|0
5314464|NCT00352534|18306930|P6|Final Risk Group Assignment|Lack of Efficacy|19
5314465|NCT00352534|18306931|P5|Final Risk Group Assignment|Lack of Efficacy|1
5314466|NCT00352534|18306932|P4|Final Risk Group Assignment|Lack of Efficacy|2
5314467|NCT00352534|18306933|P3|Final Risk Group Assignment|Lack of Efficacy|0
5314468|NCT00352534|18306934|P2|Final Risk Group Assignment|Lack of Efficacy|0
5314469|NCT00352534|18306935|P1|Final Risk Group Assignment|Lack of Efficacy|0
5314470|NCT00352534|18306929|P7|Initial Staging|Ineligible|0
5314471|NCT00352534|18306930|P6|Initial Staging|Ineligible|0
5314472|NCT00352534|18306931|P5|Initial Staging|Ineligible|0
5314473|NCT00352534|18306932|P4|Initial Staging|Ineligible|0
5314474|NCT00352534|18306933|P3|Initial Staging|Ineligible|0
5314475|NCT00352534|18306934|P2|Initial Staging|Ineligible|9
5314476|NCT00352534|18306935|P1|Initial Staging|Ineligible|8
5314477|NCT00352417|18306952|P2|Overall Study|Schedule Change|1
5314478|NCT00352417|18306953|P1|Overall Study|Schedule Change|2
5314479|NCT00352417|18306952|P2|Overall Study|Lost to Follow-up|0
5314480|NCT00352417|18306953|P1|Overall Study|Lost to Follow-up|1
5314481|NCT00352417|18306952|P2|Overall Study|Withdrawal by Subject|2
5314482|NCT00352417|18306953|P1|Overall Study|Withdrawal by Subject|1
5314483|NCT00352417|18306952|P2|Overall Study|Protocol Violation|2
5314484|NCT00352417|18306953|P1|Overall Study|Protocol Violation|0
5314485|NCT00352417|18306952|P2|Overall Study|Adverse Event|0
5314486|NCT00352417|18306953|P1|Overall Study|Adverse Event|1
5314487|NCT00352365|18306967|P1|Maintenance Therapy|Not eligible|4
5314488|NCT00352365|18306967|P1|Maintenance Therapy|Not protocol specified|3
5314489|NCT00352365|18306967|P1|Maintenance Therapy|Death|2
5314490|NCT00352365|18306967|P1|Maintenance Therapy|Progression/Relapse|3
5314491|NCT00352365|18306967|P1|Induction Therapy|Death before starting protocol therapy|1
5314492|NCT00352365|18306967|P1|Induction Therapy|Not eligible|3
5314493|NCT00352365|18306967|P1|Induction Therapy|Not protocol specified|1
5314494|NCT00352365|18306967|P1|Induction Therapy|Death|7
5314495|NCT00352365|18306967|P1|Induction Therapy|Progression/Relapse|8
5314496|NCT00352365|18306967|P1|Induction Therapy|Adverse Event|7
5314497|NCT00352118|18306977|P1|Overall Study|Physician Decision|4
5314498|NCT00352105|18306987|P1|Overall Study|Protocol Violation|2
5314499|NCT00352105|18306987|P1|Overall Study|Adverse Event|19
5314500|NCT00352105|18306987|P1|Overall Study|Lack of Efficacy|9
5314501|NCT00352105|18306987|P1|Overall Study|Withdrawal by Subject|5
5314502|NCT00352105|18306987|P1|Overall Study|Death|5
5314503|NCT00352053|18306998|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
5314504|NCT00352053|18306999|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
5314505|NCT00352053|18306998|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
5314506|NCT00352053|18306999|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
5314507|NCT00352053|18306998|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
5314508|NCT00352053|18306999|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
5314509|NCT00352053|18306998|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
5314510|NCT00352053|18306999|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
5314511|NCT00352053|18306998|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
5314512|NCT00352053|18306999|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
5314513|NCT00352053|18306998|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
5314514|NCT00352053|18306999|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
5314515|NCT00352053|18306998|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
5314516|NCT00352053|18306999|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
5314517|NCT00352053|18306998|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
5314518|NCT00352053|18306999|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
5314519|NCT00352053|18306998|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
5314520|NCT00352053|18306999|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
5314521|NCT00352053|18306998|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
5314522|NCT00352053|18306999|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
5314523|NCT00352053|18306998|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
5314524|NCT00352053|18306999|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
5314525|NCT00352053|18306998|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
5314526|NCT00352053|18306999|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
5314527|NCT00352053|18306998|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
5314528|NCT00352053|18306999|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
5314529|NCT00352027|18307166|P1|Overall Study|Progressive disease|3
5314530|NCT00351819|18307465|P2|Overall Study|Enrolled in another trial|1
5314531|NCT00351819|18307466|P1|Overall Study|Enrolled in another trial|0
5314532|NCT00351819|18307465|P2|Overall Study|Incarcerated|1
5314533|NCT00351819|18307466|P1|Overall Study|Incarcerated|0
5314534|NCT00351819|18307465|P2|Overall Study|Non-compliance|1
5314535|NCT00351819|18307466|P1|Overall Study|Non-compliance|0
5314536|NCT00351819|18307465|P2|Overall Study|Unprofessional behavior|0
5314537|NCT00351819|18307466|P1|Overall Study|Unprofessional behavior|1
5314538|NCT00351819|18307465|P2|Overall Study|Traumatic ankle fracture|0
5314539|NCT00351819|18307466|P1|Overall Study|Traumatic ankle fracture|1
5314540|NCT00351819|18307465|P2|Overall Study|Elevated PSA|1
5314541|NCT00351819|18307466|P1|Overall Study|Elevated PSA|1
5314542|NCT00351819|18307465|P2|Overall Study|Withdrawal by Subject|4
5314543|NCT00351819|18307466|P1|Overall Study|Withdrawal by Subject|0
5314544|NCT00351819|18307465|P2|Overall Study|Lost to Follow-up|4
5314545|NCT00351819|18307466|P1|Overall Study|Lost to Follow-up|4
5314546|NCT00351533|18307537|P2|Overall Study|Withdrawal by Subject|1
5314547|NCT00351533|18307538|P1|Overall Study|Withdrawal by Subject|0
5314548|NCT00351533|18307537|P2|Overall Study|Physician Decision|1
5314549|NCT00351533|18307538|P1|Overall Study|Physician Decision|0
5314550|NCT00351533|18307537|P2|Overall Study|Lost to Follow-up|3
5314551|NCT00351533|18307538|P1|Overall Study|Lost to Follow-up|1
5314552|NCT00351533|18307537|P2|Overall Study|Extubated before first BAL|0
5314553|NCT00351533|18307538|P1|Overall Study|Extubated before first BAL|1
5314554|NCT00351468|18307598|P1|Overall Study|Protocol Violation|3
5314555|NCT00351468|18307598|P1|Overall Study|Lost to Follow-up|4
5314556|NCT00351468|18307598|P1|Overall Study|Non-compliance|8
5314557|NCT00351468|18307598|P1|Overall Study|Lack of Efficacy|32
5314558|NCT00351468|18307598|P1|Overall Study|Various -follow up w clinical team|39
5314559|NCT00351468|18307598|P1|Overall Study|Withdrawal by Subject|39
5314560|NCT00351468|18307598|P1|Overall Study|Adverse Event|42
5314561|NCT00351377|18307622|P1|Overall Study|Unsatisfactory therapeutic effect|1
5314562|NCT00351377|18307622|P1|Overall Study|Death|1
5314563|NCT00351377|18307622|P1|Overall Study|Adverse Event|5
5314564|NCT00351351|18307636|P2|Overall Study|surgical access pbs; device issues|4
5314565|NCT00351351|18307637|P1|Overall Study|surgical access pbs; device issues|9
5314566|NCT00351273|18307663|P3|Overall Study|Lost to Follow-up|5
5314567|NCT00351273|18307664|P2|Overall Study|Lost to Follow-up|2
5314568|NCT00351273|18307665|P1|Overall Study|Lost to Follow-up|1
5314569|NCT00350870|18307708|P4|Overall Study|Physician Decision|1
5314570|NCT00350870|18307709|P3|Overall Study|Physician Decision|1
5314571|NCT00350870|18307710|P2|Overall Study|Physician Decision|0
5314572|NCT00350870|18307711|P1|Overall Study|Physician Decision|1
5314573|NCT00350870|18307708|P4|Overall Study|Withdrawal by Subject|14
5314574|NCT00350870|18307709|P3|Overall Study|Withdrawal by Subject|15
5314575|NCT00350870|18307710|P2|Overall Study|Withdrawal by Subject|17
5314576|NCT00350870|18307711|P1|Overall Study|Withdrawal by Subject|21
5314577|NCT00350844|18307725|P1|Overall Study|Lost to Follow-up|1
5314578|NCT00350792|18307729|P1|Overall Study|Lack of Efficacy|11
5314579|NCT00350792|18307729|P1|Overall Study|Physician Decision|2
5314580|NCT00350792|18307729|P1|Overall Study|Withdrawal by Subject|4
5314581|NCT00350792|18307729|P1|Overall Study|Protocol Violation|1
5314582|NCT00350792|18307729|P1|Overall Study|Death Not Study Drug Related|2
5314583|NCT00350792|18307729|P1|Overall Study|Death from Study Drug Toxicity|1
5314584|NCT00350792|18307729|P1|Overall Study|Death from Study Disease|1
5314585|NCT00350792|18307729|P1|Overall Study|Adverse Event|11
5314586|NCT00350779|18307739|P2|Overall Study|Non-compliance with study procedures|1
5314587|NCT00350779|18307740|P1|Overall Study|Non-compliance with study procedures|0
5314588|NCT00350779|18307739|P2|Overall Study|Patient Moved|1
5314589|NCT00350779|18307740|P1|Overall Study|Patient Moved|2
5314590|NCT00350779|18307739|P2|Overall Study|Withdrawal by Subject|8
5314591|NCT00350779|18307740|P1|Overall Study|Withdrawal by Subject|9
5314592|NCT00350779|18307739|P2|Overall Study|Protocol Violation|1
5314593|NCT00350779|18307740|P1|Overall Study|Protocol Violation|3
5314594|NCT00350779|18307739|P2|Overall Study|Physician Decision|4
5314595|NCT00350779|18307740|P1|Overall Study|Physician Decision|2
5314596|NCT00350779|18307739|P2|Overall Study|Lost to Follow-up|0
5314597|NCT00350779|18307740|P1|Overall Study|Lost to Follow-up|2
5314598|NCT00350779|18307739|P2|Overall Study|Lack of Efficacy|4
5314599|NCT00350779|18307740|P1|Overall Study|Lack of Efficacy|0
5314600|NCT00350779|18307739|P2|Overall Study|Adverse Event|2
5314601|NCT00350779|18307740|P1|Overall Study|Adverse Event|4
5314602|NCT00350727|18307761|P3|Phase II|Enrolled in Rollover Study|1
5314603|NCT00350727|18307762|P2|Phase II|Enrolled in Rollover Study|0
5314604|NCT00350727|18307763|P1|Phase II|Enrolled in Rollover Study|0
5314605|NCT00350727|18307761|P3|Phase II|Sponsor Terminated Study|1
5314606|NCT00350727|18307762|P2|Phase II|Sponsor Terminated Study|0
5314607|NCT00350727|18307763|P1|Phase II|Sponsor Terminated Study|0
5314608|NCT00350727|18307761|P3|Phase II|Death|2
5314609|NCT00350727|18307762|P2|Phase II|Death|0
5314610|NCT00350727|18307763|P1|Phase II|Death|0
5314611|NCT00350727|18307761|P3|Phase II|Adverse Event|1
5314612|NCT00350727|18307762|P2|Phase II|Adverse Event|1
5314613|NCT00350727|18307763|P1|Phase II|Adverse Event|0
5314614|NCT00350727|18307761|P3|Phase II|Withdrawal by Subject|1
5314615|NCT00350727|18307762|P2|Phase II|Withdrawal by Subject|2
5314616|NCT00350727|18307763|P1|Phase II|Withdrawal by Subject|0
5314617|NCT00350727|18307761|P3|Phase II|Clinical Deterioration|0
5314618|NCT00350727|18307762|P2|Phase II|Clinical Deterioration|1
5314619|NCT00350727|18307763|P1|Phase II|Clinical Deterioration|0
5314620|NCT00350727|18307761|P3|Phase II|Disease Progression|16
5314621|NCT00350727|18307762|P2|Phase II|Disease Progression|15
5314622|NCT00350727|18307763|P1|Phase II|Disease Progression|0
5314623|NCT00350727|18307761|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
5314624|NCT00350727|18307762|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
5314625|NCT00350727|18307763|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
5314626|NCT00350727|18307761|P3|Phase I: Dose Escalation|Physician Decision|0
5314627|NCT00350727|18307762|P2|Phase I: Dose Escalation|Physician Decision|0
5314628|NCT00350727|18307763|P1|Phase I: Dose Escalation|Physician Decision|1
5314629|NCT00350727|18307761|P3|Phase I: Dose Escalation|Death|0
5314630|NCT00350727|18307762|P2|Phase I: Dose Escalation|Death|0
5314631|NCT00350727|18307763|P1|Phase I: Dose Escalation|Death|1
5314632|NCT00350727|18307761|P3|Phase I: Dose Escalation|Lack of Efficacy|0
5314633|NCT00350727|18307762|P2|Phase I: Dose Escalation|Lack of Efficacy|0
5314634|NCT00350727|18307763|P1|Phase I: Dose Escalation|Lack of Efficacy|25
5314635|NCT00350727|18307761|P3|Phase I: Dose Escalation|Adverse Event|0
5314636|NCT00350727|18307762|P2|Phase I: Dose Escalation|Adverse Event|0
5314637|NCT00350727|18307763|P1|Phase I: Dose Escalation|Adverse Event|4
5314638|NCT00350636|18307907|P2|Overall Study|Other|2
5314639|NCT00350636|18307908|P1|Overall Study|Other|1
5314640|NCT00350636|18307907|P2|Overall Study|Physician Decision|2
5314641|NCT00350636|18307908|P1|Overall Study|Physician Decision|0
5314642|NCT00350636|18307907|P2|Overall Study|Lost to Follow-up|8
5314643|NCT00350636|18307908|P1|Overall Study|Lost to Follow-up|9
5314644|NCT00350636|18307907|P2|Overall Study|Withdrawal by Subject|17
5314645|NCT00350636|18307908|P1|Overall Study|Withdrawal by Subject|13
5314646|NCT00350636|18307907|P2|Overall Study|Protocol Violation|3
5314647|NCT00350636|18307908|P1|Overall Study|Protocol Violation|1
5314648|NCT00350636|18307907|P2|Overall Study|Adverse Event|13
5314649|NCT00350636|18307908|P1|Overall Study|Adverse Event|19
5314650|NCT00350623|18307927|P3|Overall Study|patient traveling outside the country|1
5314651|NCT00350623|18307928|P2|Overall Study|patient traveling outside the country|0
5314652|NCT00350623|18307929|P1|Overall Study|patient traveling outside the country|0
5314653|NCT00350623|18307927|P3|Overall Study|Withdrawal by Subject|1
5314654|NCT00350623|18307928|P2|Overall Study|Withdrawal by Subject|1
5314655|NCT00350623|18307929|P1|Overall Study|Withdrawal by Subject|0
5314656|NCT00350623|18307927|P3|Overall Study|Lost to Follow-up|4
5314657|NCT00350623|18307928|P2|Overall Study|Lost to Follow-up|3
5314658|NCT00350623|18307929|P1|Overall Study|Lost to Follow-up|8
5314659|NCT00350545|18307937|P1|Overall Study|Withdrawal by Subject|2
5314660|NCT00350519|18307956|P2|Overall Study|Withdrawal by Subject|2
5314661|NCT00350519|18307957|P1|Overall Study|Withdrawal by Subject|3
5314662|NCT00350519|18307956|P2|Overall Study|Protocol Violation|2
5314663|NCT00350519|18307957|P1|Overall Study|Protocol Violation|1
5314664|NCT00350519|18307956|P2|Overall Study|Physician Decision|1
5314665|NCT00350519|18307957|P1|Overall Study|Physician Decision|0
5314666|NCT00350519|18307956|P2|Overall Study|Death|1
5314667|NCT00350519|18307957|P1|Overall Study|Death|0
5314668|NCT00350402|18307971|P2|Overall Study|Lost to Follow-up|1
5314669|NCT00350402|18307972|P1|Overall Study|Lost to Follow-up|1
5314670|NCT00350272|18308045|P2|Open-Label 84 Week Treatment|Sponsor decision|1
5314671|NCT00350272|18308046|P1|Open-Label 84 Week Treatment|Sponsor decision|2
5314672|NCT00350272|18308045|P2|Open-Label 84 Week Treatment|Physician Decision|2
5314673|NCT00350272|18308046|P1|Open-Label 84 Week Treatment|Physician Decision|1
5314674|NCT00350272|18308045|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
5314675|NCT00350272|18308046|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
5314676|NCT00350272|18308045|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
5314677|NCT00350272|18308046|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
5314678|NCT00350272|18308045|P2|Open-Label 84 Week Treatment|Adverse Event|1
5314679|NCT00350272|18308046|P1|Open-Label 84 Week Treatment|Adverse Event|2
5314680|NCT00350272|18308045|P2|Blinded 12 Week Treatment|Sponsor decision|1
5314681|NCT00350272|18308046|P1|Blinded 12 Week Treatment|Sponsor decision|0
5314682|NCT00350272|18308045|P2|Blinded 12 Week Treatment|Physician Decision|1
5314683|NCT00350272|18308046|P1|Blinded 12 Week Treatment|Physician Decision|2
5314684|NCT00350272|18308045|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
5314685|NCT00350272|18308046|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
5314686|NCT00350272|18308045|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
5314687|NCT00350272|18308046|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
5314688|NCT00350272|18308045|P2|Blinded 12 Week Treatment|Death|0
5314689|NCT00350272|18308046|P1|Blinded 12 Week Treatment|Death|1
5314690|NCT00350272|18308045|P2|Blinded 12 Week Treatment|Adverse Event|0
5314691|NCT00350272|18308046|P1|Blinded 12 Week Treatment|Adverse Event|1
5314692|NCT00350207|18308068|P3|Overall Study|Other|1
5314693|NCT00350207|18308069|P2|Overall Study|Other|3
5314694|NCT00350207|18308070|P1|Overall Study|Other|1
5314695|NCT00350207|18308068|P3|Overall Study|Withdrawal by Subject|1
5314696|NCT00350207|18308069|P2|Overall Study|Withdrawal by Subject|1
5314697|NCT00350207|18308070|P1|Overall Study|Withdrawal by Subject|0
5314698|NCT00350207|18308068|P3|Overall Study|Lost to Follow-up|1
5314699|NCT00350207|18308069|P2|Overall Study|Lost to Follow-up|0
5314700|NCT00350207|18308070|P1|Overall Study|Lost to Follow-up|1
5314701|NCT00350207|18308068|P3|Overall Study|Lack of Efficacy|2
5314702|NCT00350207|18308069|P2|Overall Study|Lack of Efficacy|0
5314703|NCT00350207|18308070|P1|Overall Study|Lack of Efficacy|1
5314704|NCT00350207|18308068|P3|Overall Study|Adverse Event|2
5314705|NCT00350207|18308069|P2|Overall Study|Adverse Event|2
5314706|NCT00350207|18308070|P1|Overall Study|Adverse Event|5
5314707|NCT00349973|18308282|P2|Overall Study|Withdrawal by Subject|0
5314708|NCT00349973|18308283|P1|Overall Study|Withdrawal by Subject|1
5314709|NCT00349973|18308282|P2|Overall Study|Adverse Event|3
5314710|NCT00349973|18308283|P1|Overall Study|Adverse Event|3
5314711|NCT00349921|18308297|P4|First Spinal Injection|Adverse Event|0
5314712|NCT00349921|18308298|P3|First Spinal Injection|Adverse Event|1
5314713|NCT00349921|18308299|P2|First Spinal Injection|Adverse Event|0
5314714|NCT00349921|18308300|P1|First Spinal Injection|Adverse Event|0
5314715|NCT00349921|18308297|P4|First Spinal Injection|Physician Decision|0
5314716|NCT00349921|18308298|P3|First Spinal Injection|Physician Decision|0
5314717|NCT00349921|18308299|P2|First Spinal Injection|Physician Decision|0
5314718|NCT00349921|18308300|P1|First Spinal Injection|Physician Decision|1
5314719|NCT00349908|18308311|P2|Overall Study|Withdrawal by Subject|4
5314720|NCT00349908|18308312|P1|Overall Study|Withdrawal by Subject|0
5314721|NCT00349752|18308338|P2|Overall Study|Other:History of squamous cell carcinoma|0
5314722|NCT00349752|18308339|P1|Overall Study|Other:History of squamous cell carcinoma|1
5314723|NCT00349752|18308338|P2|Overall Study|Other: Inadvertently unblinded|0
5314724|NCT00349752|18308339|P1|Overall Study|Other: Inadvertently unblinded|1
5314725|NCT00349752|18308338|P2|Overall Study|Other: Ineligible|0
5314726|NCT00349752|18308339|P1|Overall Study|Other: Ineligible|1
5314727|NCT00349752|18308338|P2|Overall Study|Other: Patient's steroid use|0
5314728|NCT00349752|18308339|P1|Overall Study|Other: Patient's steroid use|1
5314729|NCT00349752|18308338|P2|Overall Study|Other: Patient stopped steroids|1
5314730|NCT00349752|18308339|P1|Overall Study|Other: Patient stopped steroids|0
5314731|NCT00349752|18308338|P2|Overall Study|Other: Non compliance|1
5314732|NCT00349752|18308339|P1|Overall Study|Other: Non compliance|0
5314733|NCT00349752|18308338|P2|Overall Study|Other: Required exclusionary medication|1
5314734|NCT00349752|18308339|P1|Overall Study|Other: Required exclusionary medication|0
5314735|NCT00349752|18308338|P2|Overall Study|Personal reasons|5
5314736|NCT00349752|18308339|P1|Overall Study|Personal reasons|6
5314737|NCT00349752|18308338|P2|Overall Study|Lost to Follow-up|2
5314738|NCT00349752|18308339|P1|Overall Study|Lost to Follow-up|4
5314739|NCT00349752|18308338|P2|Overall Study|Lack of Efficacy|42
5314740|NCT00349752|18308339|P1|Overall Study|Lack of Efficacy|37
5314741|NCT00349752|18308338|P2|Overall Study|Adverse Event|12
5314742|NCT00349752|18308339|P1|Overall Study|Adverse Event|8
5314743|NCT00349622|18308392|P2|Overall Study|Withdrawal by Subject|9
5314744|NCT00349622|18308393|P1|Overall Study|Withdrawal by Subject|5
5314745|NCT00349622|18308392|P2|Overall Study|Lost to Follow-up|1
5314746|NCT00349622|18308393|P1|Overall Study|Lost to Follow-up|5
5314747|NCT00349622|18308392|P2|Overall Study|Death|86
5314748|NCT00349622|18308393|P1|Overall Study|Death|168
5314749|NCT00349349|18308432|P3|Overall Study|New Malignancy (Bladder Cancer)|0
5314750|NCT00349349|18308433|P2|Overall Study|New Malignancy (Bladder Cancer)|1
5314751|NCT00349349|18308434|P1|Overall Study|New Malignancy (Bladder Cancer)|0
5314752|NCT00349349|18308432|P3|Overall Study|No Response|0
5314753|NCT00349349|18308433|P2|Overall Study|No Response|3
5314754|NCT00349349|18308434|P1|Overall Study|No Response|0
5314755|NCT00349349|18308432|P3|Overall Study|Physician Decision|1
5314756|NCT00349349|18308433|P2|Overall Study|Physician Decision|2
5314757|NCT00349349|18308434|P1|Overall Study|Physician Decision|1
5314758|NCT00349349|18308432|P3|Overall Study|Participant Reduced General Condition|0
5314759|NCT00349349|18308433|P2|Overall Study|Participant Reduced General Condition|1
5314760|NCT00349349|18308434|P1|Overall Study|Participant Reduced General Condition|0
5314761|NCT00349349|18308432|P3|Overall Study|Other Treatment Selected|0
5314762|NCT00349349|18308433|P2|Overall Study|Other Treatment Selected|0
5314763|NCT00349349|18308434|P1|Overall Study|Other Treatment Selected|2
5314764|NCT00349349|18308432|P3|Overall Study|Death|1
5314765|NCT00349349|18308433|P2|Overall Study|Death|10
5314766|NCT00349349|18308434|P1|Overall Study|Death|13
5314767|NCT00349349|18308432|P3|Overall Study|Withdrawn due to Disease Progression|1
5314768|NCT00349349|18308433|P2|Overall Study|Withdrawn due to Disease Progression|37
5314769|NCT00349349|18308434|P1|Overall Study|Withdrawn due to Disease Progression|27
5314770|NCT00349349|18308432|P3|Overall Study|Withdrawal by Subject|1
5314771|NCT00349349|18308433|P2|Overall Study|Withdrawal by Subject|2
5314772|NCT00349349|18308434|P1|Overall Study|Withdrawal by Subject|5
5314773|NCT00349349|18308432|P3|Overall Study|Adverse Event|2
5314774|NCT00349349|18308433|P2|Overall Study|Adverse Event|6
5314775|NCT00349349|18308434|P1|Overall Study|Adverse Event|5
5314776|NCT00348933|18308523|P1|Overall Study|Adverse Event|7
5314777|NCT00348933|18308523|P1|Overall Study|Protocol Violation|2
5314778|NCT00348933|18308523|P1|Overall Study|Lost to Follow-up|6
5314779|NCT00348933|18308523|P1|Overall Study|Withdrawal by Subject|10
5314780|NCT00348881|18308531|P2|Overall Study|Serious Adverse Event|2
5314781|NCT00348881|18308532|P1|Overall Study|Serious Adverse Event|0
5314782|NCT00348881|18308531|P2|Overall Study|Adverse Event|0
5314783|NCT00348881|18308532|P1|Overall Study|Adverse Event|2
5314784|NCT00348881|18308531|P2|Overall Study|Withdrawal by Subject|4
5314785|NCT00348881|18308532|P1|Overall Study|Withdrawal by Subject|3
5314786|NCT00348881|18308531|P2|Overall Study|Lost to Follow-up|6
5314787|NCT00348881|18308532|P1|Overall Study|Lost to Follow-up|12
5314788|NCT00348816|18308544|P1|Overall Study|Noncompliance with radiation treatment|1
5314789|NCT00348790|18308551|P1|Completed Treatment|Unable to travel to study site|1
5314790|NCT00348790|18308551|P1|Completed Treatment|Required surgery|2
5314791|NCT00348790|18308551|P1|Completed Treatment|Adverse Event|4
5314792|NCT00348790|18308551|P1|Completed Treatment|Disease progression|14
5314793|NCT00348790|18308551|P1|Completed Treatment|Withdrawal by Subject|4
5314794|NCT00348686|18308563|P1|Overall Study|Multiple Reasons|8
5314795|NCT00348686|18308563|P1|Overall Study|Lost to Follow-up|2
5314796|NCT00348686|18308563|P1|Overall Study|Protocol Violation|6
5314797|NCT00348686|18308563|P1|Overall Study|Adverse Event|5
5314798|NCT00348686|18308563|P1|Overall Study|Withdrawal by Subject|45
5314799|NCT00348673|18308580|P9|Stage 1|Randomized but not Treated|0
5314800|NCT00348673|18308581|P8|Stage 1|Randomized but not Treated|0
5314801|NCT00348673|18308582|P7|Stage 1|Randomized but not Treated|0
5314802|NCT00348673|18308583|P6|Stage 1|Randomized but not Treated|0
5314803|NCT00348673|18308584|P5|Stage 1|Randomized but not Treated|0
5314804|NCT00348673|18308585|P4|Stage 1|Randomized but not Treated|0
5314805|NCT00348673|18308586|P3|Stage 1|Randomized but not Treated|1
5314806|NCT00348673|18308587|P2|Stage 1|Randomized but not Treated|0
5314807|NCT00348673|18308588|P1|Stage 1|Randomized but not Treated|0
5314808|NCT00348595|18308637|P2|Overall Study|Adverse Event|8
5314809|NCT00348595|18308638|P1|Overall Study|Adverse Event|5
5314810|NCT00348556|18308650|P1|Overall Study|Adverse Event|1
5314811|NCT00348374|18308657|P2|Overall Study|randomized but did not receive treatment|7
5314812|NCT00348374|18308658|P1|Overall Study|randomized but did not receive treatment|0
5314813|NCT00348374|18308657|P2|Overall Study|ongoing at date of cutoff|1
5314814|NCT00348374|18308658|P1|Overall Study|ongoing at date of cutoff|1
5314815|NCT00348374|18308657|P2|Overall Study|Other|12
5314816|NCT00348374|18308658|P1|Overall Study|Other|11
5314817|NCT00348374|18308657|P2|Overall Study|Withdrawal by Subject|5
5314818|NCT00348374|18308658|P1|Overall Study|Withdrawal by Subject|5
5314819|NCT00348374|18308657|P2|Overall Study|Lost to Follow-up|3
5314820|NCT00348374|18308658|P1|Overall Study|Lost to Follow-up|1
5314821|NCT00348374|18308657|P2|Overall Study|Adverse Event|4
5314822|NCT00348374|18308658|P1|Overall Study|Adverse Event|1
5314823|NCT00348348|18308705|P2|Overall Study|Adverse event probably related to study|0
5314824|NCT00348348|18308706|P1|Overall Study|Adverse event probably related to study|1
5314825|NCT00348348|18308705|P2|Overall Study|Worsening of BC - Unlikely related|2
5314826|NCT00348348|18308706|P1|Overall Study|Worsening of BC - Unlikely related|1
5314827|NCT00348348|18308705|P2|Overall Study|Worsening of BC - Unrelated to study|3
5314828|NCT00348348|18308706|P1|Overall Study|Worsening of BC - Unrelated to study|0
5314829|NCT00348348|18308705|P2|Overall Study|Dissallowed Meds - possibly releated|1
5314830|NCT00348348|18308706|P1|Overall Study|Dissallowed Meds - possibly releated|1
5314831|NCT00348348|18308705|P2|Overall Study|Dissallowed Meds - unlikley related|1
5314832|NCT00348348|18308706|P1|Overall Study|Dissallowed Meds - unlikley related|1
5314833|NCT00348348|18308705|P2|Overall Study|Dissallowed Meds - unrelated to study|3
5314834|NCT00348348|18308706|P1|Overall Study|Dissallowed Meds - unrelated to study|1
5314835|NCT00348348|18308705|P2|Overall Study|Other|4
5314836|NCT00348348|18308706|P1|Overall Study|Other|7
5314837|NCT00348348|18308705|P2|Overall Study|Withdrawal by Subject|1
5314838|NCT00348348|18308706|P1|Overall Study|Withdrawal by Subject|4
5314839|NCT00348348|18308705|P2|Overall Study|Lost to Follow-up|10
5314840|NCT00348348|18308706|P1|Overall Study|Lost to Follow-up|8
5314841|NCT00348348|18308705|P2|Overall Study|Lack of Efficacy|1
5314842|NCT00348348|18308706|P1|Overall Study|Lack of Efficacy|1
5314843|NCT00348348|18308705|P2|Overall Study|Adverse event - unrelated to study drug|1
5314844|NCT00348348|18308706|P1|Overall Study|Adverse event - unrelated to study drug|0
5314845|NCT00348309|18308721|P3|Overall Study|HCV career|1
5314846|NCT00348309|18308722|P2|Overall Study|HCV career|0
5314847|NCT00348309|18308723|P1|Overall Study|HCV career|0
5314848|NCT00348309|18308721|P3|Overall Study|Cardiologist recommendations|1
5314849|NCT00348309|18308722|P2|Overall Study|Cardiologist recommendations|0
5314850|NCT00348309|18308723|P1|Overall Study|Cardiologist recommendations|0
5314851|NCT00348309|18308721|P3|Overall Study|ECG abnormal|2
5314852|NCT00348309|18308722|P2|Overall Study|ECG abnormal|0
5314853|NCT00348309|18308723|P1|Overall Study|ECG abnormal|0
5314854|NCT00348309|18308721|P3|Overall Study|Adverse event not attended|1
5314855|NCT00348309|18308722|P2|Overall Study|Adverse event not attended|0
5314856|NCT00348309|18308723|P1|Overall Study|Adverse event not attended|0
5314857|NCT00348309|18308721|P3|Overall Study|Site closure|1
5314858|NCT00348309|18308722|P2|Overall Study|Site closure|0
5314859|NCT00348309|18308723|P1|Overall Study|Site closure|0
5314860|NCT00348309|18308721|P3|Overall Study|Increased dose of Aricept|1
5314861|NCT00348309|18308722|P2|Overall Study|Increased dose of Aricept|0
5314862|NCT00348309|18308723|P1|Overall Study|Increased dose of Aricept|0
5314863|NCT00348309|18308721|P3|Overall Study|Medical Monitor decision|1
5314864|NCT00348309|18308722|P2|Overall Study|Medical Monitor decision|0
5314865|NCT00348309|18308723|P1|Overall Study|Medical Monitor decision|0
5314866|NCT00348309|18308721|P3|Overall Study|Forgot often medication|0
5314867|NCT00348309|18308722|P2|Overall Study|Forgot often medication|1
5314868|NCT00348309|18308723|P1|Overall Study|Forgot often medication|0
5314869|NCT00348309|18308721|P3|Overall Study|Sponsor refuseal|1
5314870|NCT00348309|18308722|P2|Overall Study|Sponsor refuseal|1
5314871|NCT00348309|18308723|P1|Overall Study|Sponsor refuseal|0
5314872|NCT00348309|18308721|P3|Overall Study|Participant was hospitalized|0
5314873|NCT00348309|18308722|P2|Overall Study|Participant was hospitalized|1
5314874|NCT00348309|18308723|P1|Overall Study|Participant was hospitalized|0
5314875|NCT00348309|18308721|P3|Overall Study|A foul of exclusion criteria|0
5314876|NCT00348309|18308722|P2|Overall Study|A foul of exclusion criteria|1
5314877|NCT00348309|18308723|P1|Overall Study|A foul of exclusion criteria|0
5314878|NCT00348309|18308721|P3|Overall Study|Ineffectiveness of treatment|0
5314879|NCT00348309|18308722|P2|Overall Study|Ineffectiveness of treatment|1
5314880|NCT00348309|18308723|P1|Overall Study|Ineffectiveness of treatment|0
5314881|NCT00348309|18308721|P3|Overall Study|Decision of sponsor|0
5314882|NCT00348309|18308722|P2|Overall Study|Decision of sponsor|0
5314883|NCT00348309|18308723|P1|Overall Study|Decision of sponsor|1
5314884|NCT00348309|18308721|P3|Overall Study|Participant died|1
5314885|NCT00348309|18308722|P2|Overall Study|Participant died|1
5314886|NCT00348309|18308723|P1|Overall Study|Participant died|2
5314887|NCT00348309|18308721|P3|Overall Study|Did not appear in time for Visit 3|0
5314888|NCT00348309|18308722|P2|Overall Study|Did not appear in time for Visit 3|0
5314889|NCT00348309|18308723|P1|Overall Study|Did not appear in time for Visit 3|1
5314890|NCT00348309|18308721|P3|Overall Study|Worsening of alzheimer|1
5314891|NCT00348309|18308722|P2|Overall Study|Worsening of alzheimer|0
5314892|NCT00348309|18308723|P1|Overall Study|Worsening of alzheimer|1
5314893|NCT00348309|18308721|P3|Overall Study|Cognitive and behaviour worsening|0
5314894|NCT00348309|18308722|P2|Overall Study|Cognitive and behaviour worsening|0
5314895|NCT00348309|18308723|P1|Overall Study|Cognitive and behaviour worsening|2
5314896|NCT00348309|18308721|P3|Overall Study|Worsened neurodegenerative disease|0
5314897|NCT00348309|18308722|P2|Overall Study|Worsened neurodegenerative disease|0
5314898|NCT00348309|18308723|P1|Overall Study|Worsened neurodegenerative disease|1
5314899|NCT00348309|18308721|P3|Overall Study|No disponibility of medication|0
5314900|NCT00348309|18308722|P2|Overall Study|No disponibility of medication|0
5314901|NCT00348309|18308723|P1|Overall Study|No disponibility of medication|1
5314902|NCT00348309|18308721|P3|Overall Study|Principal investigator's decision|0
5314903|NCT00348309|18308722|P2|Overall Study|Principal investigator's decision|0
5314904|NCT00348309|18308723|P1|Overall Study|Principal investigator's decision|1
5314905|NCT00348309|18308721|P3|Overall Study|PI closing medical practice|0
5314906|NCT00348309|18308722|P2|Overall Study|PI closing medical practice|0
5314907|NCT00348309|18308723|P1|Overall Study|PI closing medical practice|1
5314908|NCT00348309|18308721|P3|Overall Study|Unable to complete ET visit|0
5314909|NCT00348309|18308722|P2|Overall Study|Unable to complete ET visit|0
5314910|NCT00348309|18308723|P1|Overall Study|Unable to complete ET visit|1
5314911|NCT00348309|18308721|P3|Overall Study|Caregiver withdrawal|7
5314912|NCT00348309|18308722|P2|Overall Study|Caregiver withdrawal|0
5314913|NCT00348309|18308723|P1|Overall Study|Caregiver withdrawal|3
5314914|NCT00348309|18308721|P3|Overall Study|Use of prohibited medication|2
5314915|NCT00348309|18308722|P2|Overall Study|Use of prohibited medication|2
5314916|NCT00348309|18308723|P1|Overall Study|Use of prohibited medication|5
5314917|NCT00348309|18308721|P3|Overall Study|Caregiver sick|0
5314918|NCT00348309|18308722|P2|Overall Study|Caregiver sick|0
5314919|NCT00348309|18308723|P1|Overall Study|Caregiver sick|1
5314920|NCT00348309|18308721|P3|Overall Study|Wrong bottle allocated|0
5314921|NCT00348309|18308722|P2|Overall Study|Wrong bottle allocated|0
5314922|NCT00348309|18308723|P1|Overall Study|Wrong bottle allocated|1
5314923|NCT00348309|18308721|P3|Overall Study|Lack of insight, dementia|0
5314924|NCT00348309|18308722|P2|Overall Study|Lack of insight, dementia|0
5314925|NCT00348309|18308723|P1|Overall Study|Lack of insight, dementia|1
5314926|NCT00348309|18308721|P3|Overall Study|Death of caregiver|1
5314927|NCT00348309|18308722|P2|Overall Study|Death of caregiver|0
5314928|NCT00348309|18308723|P1|Overall Study|Death of caregiver|1
5314929|NCT00348309|18308721|P3|Overall Study|Non-compliance|8
5314930|NCT00348309|18308722|P2|Overall Study|Non-compliance|6
5314931|NCT00348309|18308723|P1|Overall Study|Non-compliance|8
5314932|NCT00348309|18308721|P3|Overall Study|Withdrawal by Subject|40
5314933|NCT00348309|18308722|P2|Overall Study|Withdrawal by Subject|37
5314934|NCT00348309|18308723|P1|Overall Study|Withdrawal by Subject|33
5314935|NCT00348309|18308721|P3|Overall Study|Protocol Violation|7
5314936|NCT00348309|18308722|P2|Overall Study|Protocol Violation|12
5314937|NCT00348309|18308723|P1|Overall Study|Protocol Violation|7
5314938|NCT00348309|18308721|P3|Overall Study|Lost to Follow-up|4
5314939|NCT00348309|18308722|P2|Overall Study|Lost to Follow-up|7
5314940|NCT00348309|18308723|P1|Overall Study|Lost to Follow-up|6
5314941|NCT00348309|18308721|P3|Overall Study|Adverse Event|63
5314942|NCT00348309|18308722|P2|Overall Study|Adverse Event|28
5314943|NCT00348309|18308723|P1|Overall Study|Adverse Event|56
5314944|NCT00348283|18308796|P2|Open Label|Sponsor decision|1
5314945|NCT00348283|18308797|P1|Open Label|Sponsor decision|0
5314946|NCT00348283|18308796|P2|Open Label|Pregnancy|1
5314947|NCT00348283|18308797|P1|Open Label|Pregnancy|0
5314948|NCT00348283|18308796|P2|Open Label|Subject moved to the United States|1
5314949|NCT00348283|18308797|P1|Open Label|Subject moved to the United States|0
5314950|NCT00348283|18308796|P2|Open Label|Administrative reasons|5
5314951|NCT00348283|18308797|P1|Open Label|Administrative reasons|0
5314952|NCT00348283|18308796|P2|Open Label|Lack of Efficacy|13
5314953|NCT00348283|18308797|P1|Open Label|Lack of Efficacy|0
5314954|NCT00348283|18308796|P2|Open Label|Lost to Follow-up|1
5314955|NCT00348283|18308797|P1|Open Label|Lost to Follow-up|0
5314956|NCT00348283|18308796|P2|Open Label|Withdrawal by Subject|4
5314957|NCT00348283|18308797|P1|Open Label|Withdrawal by Subject|0
5314958|NCT00348283|18308796|P2|Open Label|Adverse Event|8
5314959|NCT00348283|18308797|P1|Open Label|Adverse Event|0
5314960|NCT00348283|18308796|P2|Double Blind|Pregnancy|1
5314961|NCT00348283|18308797|P1|Double Blind|Pregnancy|0
5314962|NCT00348283|18308796|P2|Double Blind|Lack of Efficacy|2
5314963|NCT00348283|18308797|P1|Double Blind|Lack of Efficacy|2
5314964|NCT00348283|18308796|P2|Double Blind|Protocol Violation|1
5314965|NCT00348283|18308797|P1|Double Blind|Protocol Violation|0
5314966|NCT00348283|18308796|P2|Double Blind|Withdrawal by Subject|1
5314967|NCT00348283|18308797|P1|Double Blind|Withdrawal by Subject|1
5314968|NCT00348283|18308796|P2|Double Blind|Adverse Event|5
5314969|NCT00348283|18308797|P1|Double Blind|Adverse Event|2
5314970|NCT00348283|18308796|P2|Induction|Protocol Violation|4
5314971|NCT00348283|18308797|P1|Induction|Protocol Violation|0
5314972|NCT00348283|18308796|P2|Induction|Adverse Event|2
5314973|NCT00348283|18308797|P1|Induction|Adverse Event|0
5314974|NCT00348140|18308826|P3|Overall Study|Memory declined|1
5314975|NCT00348140|18308827|P2|Overall Study|Memory declined|0
5314976|NCT00348140|18308828|P1|Overall Study|Memory declined|0
5314977|NCT00348140|18308826|P3|Overall Study|Exclusion criteria met|1
5314978|NCT00348140|18308827|P2|Overall Study|Exclusion criteria met|0
5314979|NCT00348140|18308828|P1|Overall Study|Exclusion criteria met|0
5314980|NCT00348140|18308826|P3|Overall Study|Participant died|0
5314981|NCT00348140|18308827|P2|Overall Study|Participant died|1
5314982|NCT00348140|18308828|P1|Overall Study|Participant died|0
5314983|NCT00348140|18308826|P3|Overall Study|Abnormal ECG|3
5314984|NCT00348140|18308827|P2|Overall Study|Abnormal ECG|1
5314985|NCT00348140|18308828|P1|Overall Study|Abnormal ECG|0
5314986|NCT00348140|18308826|P3|Overall Study|Serious adverse event|0
5314987|NCT00348140|18308827|P2|Overall Study|Serious adverse event|1
5314988|NCT00348140|18308828|P1|Overall Study|Serious adverse event|0
5314989|NCT00348140|18308826|P3|Overall Study|Increased risk of cardiac infarction|0
5314990|NCT00348140|18308827|P2|Overall Study|Increased risk of cardiac infarction|1
5314991|NCT00348140|18308828|P1|Overall Study|Increased risk of cardiac infarction|0
5314992|NCT00348140|18308826|P3|Overall Study|Disease progression|5
5314993|NCT00348140|18308827|P2|Overall Study|Disease progression|2
5314994|NCT00348140|18308828|P1|Overall Study|Disease progression|1
5314995|NCT00348140|18308826|P3|Overall Study|Use of prohibited drug|2
5314996|NCT00348140|18308827|P2|Overall Study|Use of prohibited drug|0
5314997|NCT00348140|18308828|P1|Overall Study|Use of prohibited drug|1
5314998|NCT00348140|18308826|P3|Overall Study|Decided to discontinue on their own|1
5314999|NCT00348140|18308827|P2|Overall Study|Decided to discontinue on their own|4
5315000|NCT00348140|18308828|P1|Overall Study|Decided to discontinue on their own|1
5315001|NCT00348140|18308826|P3|Overall Study|Investigator decided to discontinue|4
5315002|NCT00348140|18308827|P2|Overall Study|Investigator decided to discontinue|1
5315003|NCT00348140|18308828|P1|Overall Study|Investigator decided to discontinue|4
5315004|NCT00348140|18308826|P3|Overall Study|Screen failure|0
5315005|NCT00348140|18308827|P2|Overall Study|Screen failure|0
5315006|NCT00348140|18308828|P1|Overall Study|Screen failure|1
5315007|NCT00348140|18308826|P3|Overall Study|Participant unwell|0
5315008|NCT00348140|18308827|P2|Overall Study|Participant unwell|0
5315009|NCT00348140|18308828|P1|Overall Study|Participant unwell|1
5315010|NCT00348140|18308826|P3|Overall Study|Unmet inclusion-exclusion criteria|1
5315011|NCT00348140|18308827|P2|Overall Study|Unmet inclusion-exclusion criteria|0
5315012|NCT00348140|18308828|P1|Overall Study|Unmet inclusion-exclusion criteria|1
5315013|NCT00348140|18308826|P3|Overall Study|Administration related|1
5315014|NCT00348140|18308827|P2|Overall Study|Administration related|1
5315015|NCT00348140|18308828|P1|Overall Study|Administration related|3
5315016|NCT00348140|18308826|P3|Overall Study|Efficacy related|0
5315017|NCT00348140|18308827|P2|Overall Study|Efficacy related|1
5315018|NCT00348140|18308828|P1|Overall Study|Efficacy related|1
5315019|NCT00348140|18308826|P3|Overall Study|Participant hospitalised|0
5315020|NCT00348140|18308827|P2|Overall Study|Participant hospitalised|0
5315021|NCT00348140|18308828|P1|Overall Study|Participant hospitalised|3
5315022|NCT00348140|18308826|P3|Overall Study|Caregiver related|3
5315023|NCT00348140|18308827|P2|Overall Study|Caregiver related|7
5315024|NCT00348140|18308828|P1|Overall Study|Caregiver related|4
5315025|NCT00348140|18308826|P3|Overall Study|Conditional medication increased dose|0
5315026|NCT00348140|18308827|P2|Overall Study|Conditional medication increased dose|0
5315027|NCT00348140|18308828|P1|Overall Study|Conditional medication increased dose|1
5315028|NCT00348140|18308826|P3|Overall Study|Participant at risk due to study drug|0
5315029|NCT00348140|18308827|P2|Overall Study|Participant at risk due to study drug|0
5315030|NCT00348140|18308828|P1|Overall Study|Participant at risk due to study drug|2
5315031|NCT00348140|18308826|P3|Overall Study|Non-compliance|5
5315032|NCT00348140|18308827|P2|Overall Study|Non-compliance|13
5315033|NCT00348140|18308828|P1|Overall Study|Non-compliance|8
5315034|NCT00348140|18308826|P3|Overall Study|Withdrawal by Subject|40
5315035|NCT00348140|18308827|P2|Overall Study|Withdrawal by Subject|40
5315036|NCT00348140|18308828|P1|Overall Study|Withdrawal by Subject|32
5315037|NCT00348140|18308826|P3|Overall Study|Protocol Violation|14
5315038|NCT00348140|18308827|P2|Overall Study|Protocol Violation|13
5315039|NCT00348140|18308828|P1|Overall Study|Protocol Violation|12
5315040|NCT00348140|18308826|P3|Overall Study|Lost to Follow-up|4
5315041|NCT00348140|18308827|P2|Overall Study|Lost to Follow-up|4
5315042|NCT00348140|18308828|P1|Overall Study|Lost to Follow-up|4
5315043|NCT00348140|18308826|P3|Overall Study|Adverse Event|78
5315044|NCT00348140|18308827|P2|Overall Study|Adverse Event|49
5315045|NCT00348140|18308828|P1|Overall Study|Adverse Event|46
5315046|NCT00347958|18308926|P1|Overall Study|Withdrawal by Subject|1
5315047|NCT00347958|18308926|P1|Overall Study|Protocol Violation|2
5315048|NCT00347958|18308926|P1|Overall Study|Adverse Event|1
5315049|NCT00347932|18308935|P2|Overall Study|Did not meet inclusion criteria|8
5315050|NCT00347932|18308936|P1|Overall Study|Did not meet inclusion criteria|4
5315051|NCT00347932|18308935|P2|Overall Study|Withdrawal by Subject|16
5315052|NCT00347932|18308936|P1|Overall Study|Withdrawal by Subject|10
5315053|NCT00347932|18308935|P2|Overall Study|Lost to Follow-up|9
5315054|NCT00347932|18308936|P1|Overall Study|Lost to Follow-up|10
5315055|NCT00347932|18308935|P2|Overall Study|Lack of Efficacy|14
5315056|NCT00347932|18308936|P1|Overall Study|Lack of Efficacy|3
5315057|NCT00347932|18308935|P2|Overall Study|Adverse Event|5
5315058|NCT00347932|18308936|P1|Overall Study|Adverse Event|4
5315059|NCT00347919|18308951|P3|Overall Study|Missing|2
5315060|NCT00347919|18308952|P2|Overall Study|Missing|1
5315061|NCT00347919|18308953|P1|Overall Study|Missing|2
5315062|NCT00347919|18308951|P3|Overall Study|Par. Started Other Treatment|1
5315063|NCT00347919|18308952|P2|Overall Study|Par. Started Other Treatment|1
5315064|NCT00347919|18308953|P1|Overall Study|Par. Started Other Treatment|1
5315065|NCT00347919|18308951|P3|Overall Study|Death|19
5315066|NCT00347919|18308952|P2|Overall Study|Death|42
5315067|NCT00347919|18308953|P1|Overall Study|Death|35
5315068|NCT00347919|18308951|P3|Overall Study|Sponsor terminated study|16
5315069|NCT00347919|18308952|P2|Overall Study|Sponsor terminated study|10
5315070|NCT00347919|18308953|P1|Overall Study|Sponsor terminated study|15
5315071|NCT00347919|18308951|P3|Overall Study|Physician Decision|0
5315072|NCT00347919|18308952|P2|Overall Study|Physician Decision|1
5315073|NCT00347919|18308953|P1|Overall Study|Physician Decision|1
5315074|NCT00347919|18308951|P3|Overall Study|Withdrawal by Subject|0
5315075|NCT00347919|18308952|P2|Overall Study|Withdrawal by Subject|8
5315076|NCT00347919|18308953|P1|Overall Study|Withdrawal by Subject|6
5315077|NCT00347919|18308951|P3|Overall Study|Lost to Follow-up|0
5315078|NCT00347919|18308952|P2|Overall Study|Lost to Follow-up|13
5315079|NCT00347919|18308953|P1|Overall Study|Lost to Follow-up|11
5315080|NCT00347776|18308976|P3|12 Month Follow-up|Reached endpoint|9
5315081|NCT00347776|18308977|P2|12 Month Follow-up|Reached endpoint|6
5315082|NCT00347776|18308978|P1|12 Month Follow-up|Reached endpoint|13
5315083|NCT00347776|18308976|P3|12 Month Follow-up|Death|4
5315084|NCT00347776|18308977|P2|12 Month Follow-up|Death|4
5315085|NCT00347776|18308978|P1|12 Month Follow-up|Death|3
5315086|NCT00347776|18308976|P3|12 Month Follow-up|Lost to Follow-up|6
5315087|NCT00347776|18308977|P2|12 Month Follow-up|Lost to Follow-up|6
5315088|NCT00347776|18308978|P1|12 Month Follow-up|Lost to Follow-up|7
5315089|NCT00347776|18308976|P3|6 Month Follow-up|reached endpont|15
5315090|NCT00347776|18308977|P2|6 Month Follow-up|reached endpont|12
5315091|NCT00347776|18308978|P1|6 Month Follow-up|reached endpont|20
5315092|NCT00347776|18308976|P3|6 Month Follow-up|Death|3
5315093|NCT00347776|18308977|P2|6 Month Follow-up|Death|1
5315094|NCT00347776|18308978|P1|6 Month Follow-up|Death|2
5315095|NCT00347776|18308976|P3|1.5 Month Follow-up|reached the endpoint|12
5315096|NCT00347776|18308977|P2|1.5 Month Follow-up|reached the endpoint|8
5315097|NCT00347776|18308978|P1|1.5 Month Follow-up|reached the endpoint|12
5315098|NCT00347776|18308976|P3|1.5 Month Follow-up|Death|0
5315099|NCT00347776|18308977|P2|1.5 Month Follow-up|Death|0
5315100|NCT00347776|18308978|P1|1.5 Month Follow-up|Death|2
5315101|NCT00347438|18308990|P1|Overall Study|Physician Decision|1
5315102|NCT00347438|18308990|P1|Overall Study|Withdrawal by Subject|1
5315103|NCT00347360|18309012|P15|Overall Study|Visits conflicted with new job|0
5315104|NCT00347360|18309013|P14|Overall Study|Visits conflicted with new job|0
5315105|NCT00347360|18309014|P13|Overall Study|Visits conflicted with new job|0
5315106|NCT00347360|18309015|P12|Overall Study|Visits conflicted with new job|0
5315107|NCT00347360|18309016|P11|Overall Study|Visits conflicted with new job|0
5315108|NCT00347360|18309017|P10|Overall Study|Visits conflicted with new job|0
5315109|NCT00347360|18309018|P9|Overall Study|Visits conflicted with new job|0
5315110|NCT00347360|18309019|P8|Overall Study|Visits conflicted with new job|0
5315111|NCT00347360|18309020|P7|Overall Study|Visits conflicted with new job|1
5315112|NCT00347360|18309021|P6|Overall Study|Visits conflicted with new job|0
5315113|NCT00347360|18309022|P5|Overall Study|Visits conflicted with new job|0
5315114|NCT00347360|18309023|P4|Overall Study|Visits conflicted with new job|0
5315115|NCT00347360|18309024|P3|Overall Study|Visits conflicted with new job|0
5315116|NCT00347360|18309025|P2|Overall Study|Visits conflicted with new job|0
5315117|NCT00347360|18309026|P1|Overall Study|Visits conflicted with new job|0
5315118|NCT00347360|18309012|P15|Overall Study|Subject refuse to sign updated consent|1
5315119|NCT00347360|18309013|P14|Overall Study|Subject refuse to sign updated consent|0
5315120|NCT00347360|18309014|P13|Overall Study|Subject refuse to sign updated consent|0
5315121|NCT00347360|18309015|P12|Overall Study|Subject refuse to sign updated consent|0
5315122|NCT00347360|18309016|P11|Overall Study|Subject refuse to sign updated consent|0
5315123|NCT00347360|18309017|P10|Overall Study|Subject refuse to sign updated consent|0
5315124|NCT00347360|18309018|P9|Overall Study|Subject refuse to sign updated consent|0
5315125|NCT00347360|18309019|P8|Overall Study|Subject refuse to sign updated consent|0
5315126|NCT00347360|18309020|P7|Overall Study|Subject refuse to sign updated consent|0
5315127|NCT00347360|18309021|P6|Overall Study|Subject refuse to sign updated consent|0
5315128|NCT00347360|18309022|P5|Overall Study|Subject refuse to sign updated consent|0
5315129|NCT00347360|18309023|P4|Overall Study|Subject refuse to sign updated consent|0
5315130|NCT00347360|18309024|P3|Overall Study|Subject refuse to sign updated consent|0
5315131|NCT00347360|18309025|P2|Overall Study|Subject refuse to sign updated consent|0
5315132|NCT00347360|18309026|P1|Overall Study|Subject refuse to sign updated consent|0
5315133|NCT00347360|18309012|P15|Overall Study|Subject left town, ran out of study drug|0
5315134|NCT00347360|18309013|P14|Overall Study|Subject left town, ran out of study drug|1
5315135|NCT00347360|18309014|P13|Overall Study|Subject left town, ran out of study drug|0
5315136|NCT00347360|18309015|P12|Overall Study|Subject left town, ran out of study drug|0
5315137|NCT00347360|18309016|P11|Overall Study|Subject left town, ran out of study drug|0
5315138|NCT00347360|18309017|P10|Overall Study|Subject left town, ran out of study drug|0
5315139|NCT00347360|18309018|P9|Overall Study|Subject left town, ran out of study drug|0
5315140|NCT00347360|18309019|P8|Overall Study|Subject left town, ran out of study drug|0
5315141|NCT00347360|18309020|P7|Overall Study|Subject left town, ran out of study drug|0
5315142|NCT00347360|18309021|P6|Overall Study|Subject left town, ran out of study drug|0
5315143|NCT00347360|18309022|P5|Overall Study|Subject left town, ran out of study drug|0
5315144|NCT00347360|18309023|P4|Overall Study|Subject left town, ran out of study drug|0
5315145|NCT00347360|18309024|P3|Overall Study|Subject left town, ran out of study drug|0
5315146|NCT00347360|18309025|P2|Overall Study|Subject left town, ran out of study drug|0
5315147|NCT00347360|18309026|P1|Overall Study|Subject left town, ran out of study drug|0
5315148|NCT00347360|18309012|P15|Overall Study|Prolonged duration between visits|0
5315149|NCT00347360|18309013|P14|Overall Study|Prolonged duration between visits|0
5315150|NCT00347360|18309014|P13|Overall Study|Prolonged duration between visits|1
5315151|NCT00347360|18309015|P12|Overall Study|Prolonged duration between visits|0
5315152|NCT00347360|18309016|P11|Overall Study|Prolonged duration between visits|0
5315153|NCT00347360|18309017|P10|Overall Study|Prolonged duration between visits|0
5315154|NCT00347360|18309018|P9|Overall Study|Prolonged duration between visits|0
5315155|NCT00347360|18309019|P8|Overall Study|Prolonged duration between visits|0
5315156|NCT00347360|18309020|P7|Overall Study|Prolonged duration between visits|0
5315157|NCT00347360|18309021|P6|Overall Study|Prolonged duration between visits|0
5315158|NCT00347360|18309022|P5|Overall Study|Prolonged duration between visits|0
5315159|NCT00347360|18309023|P4|Overall Study|Prolonged duration between visits|0
5315160|NCT00347360|18309024|P3|Overall Study|Prolonged duration between visits|0
5315161|NCT00347360|18309025|P2|Overall Study|Prolonged duration between visits|0
5315162|NCT00347360|18309026|P1|Overall Study|Prolonged duration between visits|0
5315163|NCT00347360|18309012|P15|Overall Study|Failed inclusion criteria #4|0
5315164|NCT00347360|18309013|P14|Overall Study|Failed inclusion criteria #4|0
5315165|NCT00347360|18309014|P13|Overall Study|Failed inclusion criteria #4|0
5315166|NCT00347360|18309015|P12|Overall Study|Failed inclusion criteria #4|1
5315167|NCT00347360|18309016|P11|Overall Study|Failed inclusion criteria #4|0
5315168|NCT00347360|18309017|P10|Overall Study|Failed inclusion criteria #4|0
5315169|NCT00347360|18309018|P9|Overall Study|Failed inclusion criteria #4|0
5315170|NCT00347360|18309019|P8|Overall Study|Failed inclusion criteria #4|0
5315171|NCT00347360|18309020|P7|Overall Study|Failed inclusion criteria #4|0
5315172|NCT00347360|18309021|P6|Overall Study|Failed inclusion criteria #4|0
5315173|NCT00347360|18309022|P5|Overall Study|Failed inclusion criteria #4|0
5315174|NCT00347360|18309023|P4|Overall Study|Failed inclusion criteria #4|0
5315175|NCT00347360|18309024|P3|Overall Study|Failed inclusion criteria #4|0
5315176|NCT00347360|18309025|P2|Overall Study|Failed inclusion criteria #4|0
5315177|NCT00347360|18309026|P1|Overall Study|Failed inclusion criteria #4|0
5315178|NCT00347360|18309012|P15|Overall Study|Randomized in error|0
5315179|NCT00347360|18309013|P14|Overall Study|Randomized in error|0
5315180|NCT00347360|18309014|P13|Overall Study|Randomized in error|0
5315181|NCT00347360|18309015|P12|Overall Study|Randomized in error|1
5315182|NCT00347360|18309016|P11|Overall Study|Randomized in error|0
5315183|NCT00347360|18309017|P10|Overall Study|Randomized in error|0
5315184|NCT00347360|18309018|P9|Overall Study|Randomized in error|0
5315185|NCT00347360|18309019|P8|Overall Study|Randomized in error|0
5315186|NCT00347360|18309020|P7|Overall Study|Randomized in error|0
5315187|NCT00347360|18309021|P6|Overall Study|Randomized in error|0
5315188|NCT00347360|18309022|P5|Overall Study|Randomized in error|0
5315189|NCT00347360|18309023|P4|Overall Study|Randomized in error|0
5315190|NCT00347360|18309024|P3|Overall Study|Randomized in error|0
5315191|NCT00347360|18309025|P2|Overall Study|Randomized in error|0
5315192|NCT00347360|18309026|P1|Overall Study|Randomized in error|0
5315193|NCT00347360|18309012|P15|Overall Study|Did not meet criteria before ABPM|0
5315194|NCT00347360|18309013|P14|Overall Study|Did not meet criteria before ABPM|0
5315195|NCT00347360|18309014|P13|Overall Study|Did not meet criteria before ABPM|0
5315196|NCT00347360|18309015|P12|Overall Study|Did not meet criteria before ABPM|0
5315197|NCT00347360|18309016|P11|Overall Study|Did not meet criteria before ABPM|1
5315198|NCT00347360|18309017|P10|Overall Study|Did not meet criteria before ABPM|0
5315199|NCT00347360|18309018|P9|Overall Study|Did not meet criteria before ABPM|0
5315200|NCT00347360|18309019|P8|Overall Study|Did not meet criteria before ABPM|0
5315201|NCT00347360|18309020|P7|Overall Study|Did not meet criteria before ABPM|0
5315202|NCT00347360|18309021|P6|Overall Study|Did not meet criteria before ABPM|0
5315203|NCT00347360|18309022|P5|Overall Study|Did not meet criteria before ABPM|0
5315204|NCT00347360|18309023|P4|Overall Study|Did not meet criteria before ABPM|0
5315205|NCT00347360|18309024|P3|Overall Study|Did not meet criteria before ABPM|0
5315206|NCT00347360|18309025|P2|Overall Study|Did not meet criteria before ABPM|0
5315207|NCT00347360|18309026|P1|Overall Study|Did not meet criteria before ABPM|0
5315208|NCT00347360|18309012|P15|Overall Study|PI recommended early withdrawal|0
5315209|NCT00347360|18309013|P14|Overall Study|PI recommended early withdrawal|0
5315210|NCT00347360|18309014|P13|Overall Study|PI recommended early withdrawal|0
5315211|NCT00347360|18309015|P12|Overall Study|PI recommended early withdrawal|0
5315212|NCT00347360|18309016|P11|Overall Study|PI recommended early withdrawal|0
5315213|NCT00347360|18309017|P10|Overall Study|PI recommended early withdrawal|1
5315214|NCT00347360|18309018|P9|Overall Study|PI recommended early withdrawal|0
5315215|NCT00347360|18309019|P8|Overall Study|PI recommended early withdrawal|0
5315216|NCT00347360|18309020|P7|Overall Study|PI recommended early withdrawal|0
5315217|NCT00347360|18309021|P6|Overall Study|PI recommended early withdrawal|0
5315218|NCT00347360|18309022|P5|Overall Study|PI recommended early withdrawal|0
5315219|NCT00347360|18309023|P4|Overall Study|PI recommended early withdrawal|0
5315220|NCT00347360|18309024|P3|Overall Study|PI recommended early withdrawal|0
5315221|NCT00347360|18309025|P2|Overall Study|PI recommended early withdrawal|0
5315222|NCT00347360|18309026|P1|Overall Study|PI recommended early withdrawal|0
5315223|NCT00347360|18309012|P15|Overall Study|Abnormal lab values|0
5315224|NCT00347360|18309013|P14|Overall Study|Abnormal lab values|0
5315225|NCT00347360|18309014|P13|Overall Study|Abnormal lab values|0
5315226|NCT00347360|18309015|P12|Overall Study|Abnormal lab values|0
5315227|NCT00347360|18309016|P11|Overall Study|Abnormal lab values|0
5315228|NCT00347360|18309017|P10|Overall Study|Abnormal lab values|0
5315229|NCT00347360|18309018|P9|Overall Study|Abnormal lab values|0
5315230|NCT00347360|18309019|P8|Overall Study|Abnormal lab values|0
5315231|NCT00347360|18309020|P7|Overall Study|Abnormal lab values|1
5315232|NCT00347360|18309021|P6|Overall Study|Abnormal lab values|0
5315233|NCT00347360|18309022|P5|Overall Study|Abnormal lab values|0
5315234|NCT00347360|18309023|P4|Overall Study|Abnormal lab values|0
5315235|NCT00347360|18309024|P3|Overall Study|Abnormal lab values|0
5315236|NCT00347360|18309025|P2|Overall Study|Abnormal lab values|0
5315237|NCT00347360|18309026|P1|Overall Study|Abnormal lab values|0
5315238|NCT00347360|18309012|P15|Overall Study|Subject did not meet end of study ABPM|0
5315239|NCT00347360|18309013|P14|Overall Study|Subject did not meet end of study ABPM|1
5315240|NCT00347360|18309014|P13|Overall Study|Subject did not meet end of study ABPM|1
5315241|NCT00347360|18309015|P12|Overall Study|Subject did not meet end of study ABPM|0
5315242|NCT00347360|18309016|P11|Overall Study|Subject did not meet end of study ABPM|1
5315243|NCT00347360|18309017|P10|Overall Study|Subject did not meet end of study ABPM|0
5315244|NCT00347360|18309018|P9|Overall Study|Subject did not meet end of study ABPM|0
5315245|NCT00347360|18309019|P8|Overall Study|Subject did not meet end of study ABPM|0
5315246|NCT00347360|18309020|P7|Overall Study|Subject did not meet end of study ABPM|1
5315247|NCT00347360|18309021|P6|Overall Study|Subject did not meet end of study ABPM|0
5315248|NCT00347360|18309022|P5|Overall Study|Subject did not meet end of study ABPM|0
5315249|NCT00347360|18309023|P4|Overall Study|Subject did not meet end of study ABPM|0
5315250|NCT00347360|18309024|P3|Overall Study|Subject did not meet end of study ABPM|0
5315251|NCT00347360|18309025|P2|Overall Study|Subject did not meet end of study ABPM|0
5315252|NCT00347360|18309026|P1|Overall Study|Subject did not meet end of study ABPM|0
5315253|NCT00347360|18309012|P15|Overall Study|P.I. recommended due to blood pressure|0
5315254|NCT00347360|18309013|P14|Overall Study|P.I. recommended due to blood pressure|0
5315255|NCT00347360|18309014|P13|Overall Study|P.I. recommended due to blood pressure|0
5315256|NCT00347360|18309015|P12|Overall Study|P.I. recommended due to blood pressure|0
5315257|NCT00347360|18309016|P11|Overall Study|P.I. recommended due to blood pressure|0
5315258|NCT00347360|18309017|P10|Overall Study|P.I. recommended due to blood pressure|0
5315259|NCT00347360|18309018|P9|Overall Study|P.I. recommended due to blood pressure|0
5315260|NCT00347360|18309019|P8|Overall Study|P.I. recommended due to blood pressure|0
5315261|NCT00347360|18309020|P7|Overall Study|P.I. recommended due to blood pressure|0
5315262|NCT00347360|18309021|P6|Overall Study|P.I. recommended due to blood pressure|0
5315263|NCT00347360|18309022|P5|Overall Study|P.I. recommended due to blood pressure|1
5315264|NCT00347360|18309023|P4|Overall Study|P.I. recommended due to blood pressure|0
5315265|NCT00347360|18309024|P3|Overall Study|P.I. recommended due to blood pressure|0
5315266|NCT00347360|18309025|P2|Overall Study|P.I. recommended due to blood pressure|0
5315267|NCT00347360|18309026|P1|Overall Study|P.I. recommended due to blood pressure|0
5315268|NCT00347360|18309012|P15|Overall Study|Per sponsors instruction|0
5315269|NCT00347360|18309013|P14|Overall Study|Per sponsors instruction|0
5315270|NCT00347360|18309014|P13|Overall Study|Per sponsors instruction|0
5315271|NCT00347360|18309015|P12|Overall Study|Per sponsors instruction|0
5315272|NCT00347360|18309016|P11|Overall Study|Per sponsors instruction|0
5315273|NCT00347360|18309017|P10|Overall Study|Per sponsors instruction|0
5315274|NCT00347360|18309018|P9|Overall Study|Per sponsors instruction|0
5315275|NCT00347360|18309019|P8|Overall Study|Per sponsors instruction|0
5315276|NCT00347360|18309020|P7|Overall Study|Per sponsors instruction|0
5315277|NCT00347360|18309021|P6|Overall Study|Per sponsors instruction|0
5315278|NCT00347360|18309022|P5|Overall Study|Per sponsors instruction|0
5315279|NCT00347360|18309023|P4|Overall Study|Per sponsors instruction|0
5315280|NCT00347360|18309024|P3|Overall Study|Per sponsors instruction|0
5315281|NCT00347360|18309025|P2|Overall Study|Per sponsors instruction|1
5315282|NCT00347360|18309026|P1|Overall Study|Per sponsors instruction|0
5315283|NCT00347360|18309012|P15|Overall Study|Reason not listed/blank|0
5315284|NCT00347360|18309013|P14|Overall Study|Reason not listed/blank|1
5315285|NCT00347360|18309014|P13|Overall Study|Reason not listed/blank|0
5315286|NCT00347360|18309015|P12|Overall Study|Reason not listed/blank|0
5315287|NCT00347360|18309016|P11|Overall Study|Reason not listed/blank|0
5315288|NCT00347360|18309017|P10|Overall Study|Reason not listed/blank|0
5315289|NCT00347360|18309018|P9|Overall Study|Reason not listed/blank|0
5315290|NCT00347360|18309019|P8|Overall Study|Reason not listed/blank|0
5315291|NCT00347360|18309020|P7|Overall Study|Reason not listed/blank|1
5315292|NCT00347360|18309021|P6|Overall Study|Reason not listed/blank|0
5315293|NCT00347360|18309022|P5|Overall Study|Reason not listed/blank|0
5315294|NCT00347360|18309023|P4|Overall Study|Reason not listed/blank|0
5315295|NCT00347360|18309024|P3|Overall Study|Reason not listed/blank|0
5315296|NCT00347360|18309025|P2|Overall Study|Reason not listed/blank|0
5315297|NCT00347360|18309026|P1|Overall Study|Reason not listed/blank|1
5315298|NCT00347360|18309012|P15|Overall Study|Lack of Efficacy|0
5315299|NCT00347360|18309013|P14|Overall Study|Lack of Efficacy|0
5315300|NCT00347360|18309014|P13|Overall Study|Lack of Efficacy|0
5315301|NCT00347360|18309015|P12|Overall Study|Lack of Efficacy|0
5315302|NCT00347360|18309016|P11|Overall Study|Lack of Efficacy|0
5315303|NCT00347360|18309017|P10|Overall Study|Lack of Efficacy|0
5315304|NCT00347360|18309018|P9|Overall Study|Lack of Efficacy|1
5315305|NCT00347360|18309019|P8|Overall Study|Lack of Efficacy|1
5315306|NCT00347360|18309020|P7|Overall Study|Lack of Efficacy|0
5315307|NCT00347360|18309021|P6|Overall Study|Lack of Efficacy|1
5315308|NCT00347360|18309022|P5|Overall Study|Lack of Efficacy|0
5315309|NCT00347360|18309023|P4|Overall Study|Lack of Efficacy|1
5315310|NCT00347360|18309024|P3|Overall Study|Lack of Efficacy|3
5315311|NCT00347360|18309025|P2|Overall Study|Lack of Efficacy|1
5315312|NCT00347360|18309026|P1|Overall Study|Lack of Efficacy|1
5315313|NCT00347360|18309012|P15|Overall Study|Withdrawal by Subject|1
5315314|NCT00347360|18309013|P14|Overall Study|Withdrawal by Subject|2
5315315|NCT00347360|18309014|P13|Overall Study|Withdrawal by Subject|4
5315316|NCT00347360|18309015|P12|Overall Study|Withdrawal by Subject|3
5315317|NCT00347360|18309016|P11|Overall Study|Withdrawal by Subject|0
5315318|NCT00347360|18309017|P10|Overall Study|Withdrawal by Subject|1
5315319|NCT00347360|18309018|P9|Overall Study|Withdrawal by Subject|1
5315320|NCT00347360|18309019|P8|Overall Study|Withdrawal by Subject|1
5315321|NCT00347360|18309020|P7|Overall Study|Withdrawal by Subject|1
5315322|NCT00347360|18309021|P6|Overall Study|Withdrawal by Subject|2
5315323|NCT00347360|18309022|P5|Overall Study|Withdrawal by Subject|1
5315324|NCT00347360|18309023|P4|Overall Study|Withdrawal by Subject|4
5315325|NCT00347360|18309024|P3|Overall Study|Withdrawal by Subject|2
5315326|NCT00347360|18309025|P2|Overall Study|Withdrawal by Subject|1
5315327|NCT00347360|18309026|P1|Overall Study|Withdrawal by Subject|0
5315328|NCT00347360|18309012|P15|Overall Study|Protocol Violation|0
5315329|NCT00347360|18309013|P14|Overall Study|Protocol Violation|1
5315330|NCT00347360|18309014|P13|Overall Study|Protocol Violation|0
5315331|NCT00347360|18309015|P12|Overall Study|Protocol Violation|0
5315332|NCT00347360|18309016|P11|Overall Study|Protocol Violation|0
5315333|NCT00347360|18309017|P10|Overall Study|Protocol Violation|2
5315334|NCT00347360|18309018|P9|Overall Study|Protocol Violation|1
5315335|NCT00347360|18309019|P8|Overall Study|Protocol Violation|0
5315336|NCT00347360|18309020|P7|Overall Study|Protocol Violation|0
5315337|NCT00347360|18309021|P6|Overall Study|Protocol Violation|2
5315338|NCT00347360|18309022|P5|Overall Study|Protocol Violation|1
5315339|NCT00347360|18309023|P4|Overall Study|Protocol Violation|2
5315340|NCT00347360|18309024|P3|Overall Study|Protocol Violation|1
5315341|NCT00347360|18309025|P2|Overall Study|Protocol Violation|3
5315342|NCT00347360|18309026|P1|Overall Study|Protocol Violation|2
5315343|NCT00347360|18309012|P15|Overall Study|Lost to Follow-up|0
5315344|NCT00347360|18309013|P14|Overall Study|Lost to Follow-up|0
5315345|NCT00347360|18309014|P13|Overall Study|Lost to Follow-up|1
5315346|NCT00347360|18309015|P12|Overall Study|Lost to Follow-up|0
5315347|NCT00347360|18309016|P11|Overall Study|Lost to Follow-up|0
5315348|NCT00347360|18309017|P10|Overall Study|Lost to Follow-up|2
5315349|NCT00347360|18309018|P9|Overall Study|Lost to Follow-up|1
5315350|NCT00347360|18309019|P8|Overall Study|Lost to Follow-up|1
5315351|NCT00347360|18309020|P7|Overall Study|Lost to Follow-up|0
5315352|NCT00347360|18309021|P6|Overall Study|Lost to Follow-up|1
5315353|NCT00347360|18309022|P5|Overall Study|Lost to Follow-up|1
5315354|NCT00347360|18309023|P4|Overall Study|Lost to Follow-up|2
5315355|NCT00347360|18309024|P3|Overall Study|Lost to Follow-up|0
5315356|NCT00347360|18309025|P2|Overall Study|Lost to Follow-up|0
5315357|NCT00347360|18309026|P1|Overall Study|Lost to Follow-up|0
5315358|NCT00347360|18309012|P15|Overall Study|Adverse Event|2
5315359|NCT00347360|18309013|P14|Overall Study|Adverse Event|2
5315360|NCT00347360|18309014|P13|Overall Study|Adverse Event|3
5315361|NCT00347360|18309015|P12|Overall Study|Adverse Event|1
5315362|NCT00347360|18309016|P11|Overall Study|Adverse Event|3
5315363|NCT00347360|18309017|P10|Overall Study|Adverse Event|3
5315364|NCT00347360|18309018|P9|Overall Study|Adverse Event|2
5315365|NCT00347360|18309019|P8|Overall Study|Adverse Event|0
5315366|NCT00347360|18309020|P7|Overall Study|Adverse Event|2
5315367|NCT00347360|18309021|P6|Overall Study|Adverse Event|2
5315368|NCT00347360|18309022|P5|Overall Study|Adverse Event|1
5315369|NCT00347360|18309023|P4|Overall Study|Adverse Event|4
5315370|NCT00347360|18309024|P3|Overall Study|Adverse Event|0
5315371|NCT00347360|18309025|P2|Overall Study|Adverse Event|2
5315372|NCT00347360|18309026|P1|Overall Study|Adverse Event|1
5315373|NCT00347269|18309214|P2|Overall Study|Death|3
5315374|NCT00347269|18309215|P1|Overall Study|Death|2
5315375|NCT00347269|18309214|P2|Overall Study|Withdrawal by Subject|38
5315376|NCT00347269|18309215|P1|Overall Study|Withdrawal by Subject|18
5315377|NCT00347269|18309214|P2|Overall Study|Lost to Follow-up|65
5315378|NCT00347269|18309215|P1|Overall Study|Lost to Follow-up|74
5315379|NCT00347009|18309230|P1|Overall Study|Serious Adverse Event|1
5315380|NCT00347009|18309230|P1|Overall Study|Increased ALT/HBV DNA|1
5315381|NCT00347009|18309230|P1|Overall Study|Insufficient Viral Suppression|3
5315382|NCT00347009|18309230|P1|Overall Study|Adverse Laboratory Experience|1
5315383|NCT00347009|18309230|P1|Overall Study|Protocol Violation|2
5315384|NCT00347009|18309230|P1|Overall Study|Lost to Follow-up|4
5315385|NCT00347009|18309230|P1|Overall Study|Physician Decision|5
5315386|NCT00347009|18309230|P1|Overall Study|Withdrawal by Subject|3
5315387|NCT00347009|18309230|P1|Overall Study|Adverse Event|6
5315388|NCT00347009|18309230|P1|Overall Study|Death|1
5315389|NCT00346775|18309251|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
5315390|NCT00346775|18309252|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
5315391|NCT00346775|18309251|P2|Period 1: Intervention Period 1|Protocol Violation|2
5315392|NCT00346775|18309252|P1|Period 1: Intervention Period 1|Protocol Violation|3
5315393|NCT00346775|18309251|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
5315394|NCT00346775|18309252|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
5315395|NCT00346697|18309264|P2|Overall Study|Lost to Follow-up|1
5315396|NCT00346697|18309265|P1|Overall Study|Lost to Follow-up|0
5315397|NCT00346632|18309301|P10|Overall Study|Not Stated|1
5315398|NCT00346632|18309302|P9|Overall Study|Not Stated|2
5315399|NCT00346632|18309303|P8|Overall Study|Not Stated|2
5315400|NCT00346632|18309304|P7|Overall Study|Not Stated|0
5315401|NCT00346632|18309305|P6|Overall Study|Not Stated|0
5315402|NCT00346632|18309306|P5|Overall Study|Not Stated|0
5315403|NCT00346632|18309307|P4|Overall Study|Not Stated|0
5315404|NCT00346632|18309308|P3|Overall Study|Not Stated|0
5315405|NCT00346632|18309309|P2|Overall Study|Not Stated|1
5315406|NCT00346632|18309310|P1|Overall Study|Not Stated|1
5315407|NCT00346632|18309301|P10|Overall Study|Switched to alternative treatment|0
5315408|NCT00346632|18309302|P9|Overall Study|Switched to alternative treatment|0
5315409|NCT00346632|18309303|P8|Overall Study|Switched to alternative treatment|0
5315410|NCT00346632|18309304|P7|Overall Study|Switched to alternative treatment|0
5315411|NCT00346632|18309305|P6|Overall Study|Switched to alternative treatment|0
5315412|NCT00346632|18309306|P5|Overall Study|Switched to alternative treatment|0
5315413|NCT00346632|18309307|P4|Overall Study|Switched to alternative treatment|0
5315414|NCT00346632|18309308|P3|Overall Study|Switched to alternative treatment|1
5315415|NCT00346632|18309309|P2|Overall Study|Switched to alternative treatment|0
5315416|NCT00346632|18309310|P1|Overall Study|Switched to alternative treatment|0
5315417|NCT00346632|18309301|P10|Overall Study|Withdrawal by Subject|0
5315418|NCT00346632|18309302|P9|Overall Study|Withdrawal by Subject|0
5315419|NCT00346632|18309303|P8|Overall Study|Withdrawal by Subject|0
5315420|NCT00346632|18309304|P7|Overall Study|Withdrawal by Subject|1
5315421|NCT00346632|18309305|P6|Overall Study|Withdrawal by Subject|0
5315422|NCT00346632|18309306|P5|Overall Study|Withdrawal by Subject|0
5315423|NCT00346632|18309307|P4|Overall Study|Withdrawal by Subject|0
5315424|NCT00346632|18309308|P3|Overall Study|Withdrawal by Subject|0
5315425|NCT00346632|18309309|P2|Overall Study|Withdrawal by Subject|0
5315426|NCT00346632|18309310|P1|Overall Study|Withdrawal by Subject|0
5315427|NCT00346632|18309301|P10|Overall Study|Protocol Violation|0
5315428|NCT00346632|18309302|P9|Overall Study|Protocol Violation|0
5315429|NCT00346632|18309303|P8|Overall Study|Protocol Violation|0
5315430|NCT00346632|18309304|P7|Overall Study|Protocol Violation|1
5315431|NCT00346632|18309305|P6|Overall Study|Protocol Violation|0
5315432|NCT00346632|18309306|P5|Overall Study|Protocol Violation|0
5315433|NCT00346632|18309307|P4|Overall Study|Protocol Violation|0
5315434|NCT00346632|18309308|P3|Overall Study|Protocol Violation|0
5315435|NCT00346632|18309309|P2|Overall Study|Protocol Violation|0
5315436|NCT00346632|18309310|P1|Overall Study|Protocol Violation|0
5315437|NCT00346632|18309301|P10|Overall Study|Death|0
5315438|NCT00346632|18309302|P9|Overall Study|Death|0
5315439|NCT00346632|18309303|P8|Overall Study|Death|0
5315440|NCT00346632|18309304|P7|Overall Study|Death|0
5315441|NCT00346632|18309305|P6|Overall Study|Death|0
5315442|NCT00346632|18309306|P5|Overall Study|Death|0
5315443|NCT00346632|18309307|P4|Overall Study|Death|0
5315444|NCT00346632|18309308|P3|Overall Study|Death|1
5315445|NCT00346632|18309309|P2|Overall Study|Death|0
5315446|NCT00346632|18309310|P1|Overall Study|Death|0
5315447|NCT00346632|18309301|P10|Overall Study|Adverse Event|0
5315448|NCT00346632|18309302|P9|Overall Study|Adverse Event|0
5315449|NCT00346632|18309303|P8|Overall Study|Adverse Event|0
5315450|NCT00346632|18309304|P7|Overall Study|Adverse Event|1
5315451|NCT00346632|18309305|P6|Overall Study|Adverse Event|1
5315452|NCT00346632|18309306|P5|Overall Study|Adverse Event|1
5315453|NCT00346632|18309307|P4|Overall Study|Adverse Event|0
5315454|NCT00346632|18309308|P3|Overall Study|Adverse Event|0
5315455|NCT00346632|18309309|P2|Overall Study|Adverse Event|0
5315456|NCT00346632|18309310|P1|Overall Study|Adverse Event|0
5315457|NCT00346632|18309301|P10|Overall Study|Progressive Disease|2
5315458|NCT00346632|18309302|P9|Overall Study|Progressive Disease|2
5315459|NCT00346632|18309303|P8|Overall Study|Progressive Disease|2
5315460|NCT00346632|18309304|P7|Overall Study|Progressive Disease|2
5315461|NCT00346632|18309305|P6|Overall Study|Progressive Disease|1
5315462|NCT00346632|18309306|P5|Overall Study|Progressive Disease|3
5315463|NCT00346632|18309307|P4|Overall Study|Progressive Disease|3
5315464|NCT00346632|18309308|P3|Overall Study|Progressive Disease|4
5315465|NCT00346632|18309309|P2|Overall Study|Progressive Disease|2
5315466|NCT00346632|18309310|P1|Overall Study|Progressive Disease|2
5315467|NCT00346398|18309460|P2|Overall Study|Withdrawal by Subject|2
5315468|NCT00346398|18309461|P1|Overall Study|Withdrawal by Subject|0
5315469|NCT00346398|18309460|P2|Overall Study|Lost to Follow-up|0
5315470|NCT00346398|18309461|P1|Overall Study|Lost to Follow-up|3
5315471|NCT00346333|18309473|P2|Overall Study|unwilling or unable to continue|8
5315472|NCT00346333|18309474|P1|Overall Study|unwilling or unable to continue|4
5315473|NCT00346333|18309473|P2|Overall Study|Death|0
5315474|NCT00346333|18309474|P1|Overall Study|Death|1
5315475|NCT00346268|18309490|P2|Overall Study|Participant refused|3
5315476|NCT00346268|18309491|P1|Overall Study|Participant refused|0
5315477|NCT00346268|18309490|P2|Overall Study|Protocol Violation|0
5315478|NCT00346268|18309491|P1|Overall Study|Protocol Violation|1
5315479|NCT00346268|18309490|P2|Overall Study|Adverse Event|0
5315480|NCT00346268|18309491|P1|Overall Study|Adverse Event|1
5315481|NCT00346216|18309526|P3|Overall Study|Missing Subject Summary Status|62
5315482|NCT00346216|18309527|P2|Overall Study|Missing Subject Summary Status|61
5315483|NCT00346216|18309528|P1|Overall Study|Missing Subject Summary Status|62
5315484|NCT00346216|18309526|P3|Overall Study|Study terminated by sponsor|8
5315485|NCT00346216|18309527|P2|Overall Study|Study terminated by sponsor|4
5315486|NCT00346216|18309528|P1|Overall Study|Study terminated by sponsor|11
5315487|NCT00346216|18309526|P3|Overall Study|Death|228
5315488|NCT00346216|18309527|P2|Overall Study|Death|192
5315489|NCT00346216|18309528|P1|Overall Study|Death|189
5315490|NCT00346216|18309526|P3|Overall Study|Does not meet entrance criteria|8
5315491|NCT00346216|18309527|P2|Overall Study|Does not meet entrance criteria|10
5315492|NCT00346216|18309528|P1|Overall Study|Does not meet entrance criteria|13
5315493|NCT00346216|18309526|P3|Overall Study|Physician Decision|59
5315494|NCT00346216|18309527|P2|Overall Study|Physician Decision|76
5315495|NCT00346216|18309528|P1|Overall Study|Physician Decision|80
5315496|NCT00346216|18309526|P3|Overall Study|Lost to Follow-up|542
5315497|NCT00346216|18309527|P2|Overall Study|Lost to Follow-up|588
5315498|NCT00346216|18309528|P1|Overall Study|Lost to Follow-up|611
5315499|NCT00346216|18309526|P3|Overall Study|Withdrawal by Subject|651
5315500|NCT00346216|18309527|P2|Overall Study|Withdrawal by Subject|692
5315501|NCT00346216|18309528|P1|Overall Study|Withdrawal by Subject|661
5315502|NCT00346216|18309526|P3|Overall Study|No longer willing to participate|585
5315503|NCT00346216|18309527|P2|Overall Study|No longer willing to participate|606
5315504|NCT00346216|18309528|P1|Overall Study|No longer willing to participate|600
5315505|NCT00346216|18309526|P3|Overall Study|Other|205
5315506|NCT00346216|18309527|P2|Overall Study|Other|231
5315507|NCT00346216|18309528|P1|Overall Study|Other|181
5315508|NCT00346164|18309549|P4|Overall Study|Inability to start week 16 tx on time|11
5315509|NCT00346164|18309550|P3|Overall Study|Inability to start week 16 tx on time|0
5315510|NCT00346164|18309551|P2|Overall Study|Inability to start week 16 tx on time|0
5315511|NCT00346164|18309552|P1|Overall Study|Inability to start week 16 tx on time|0
5315512|NCT00346164|18309549|P4|Overall Study|Refusal of further protocol therapy|15
5315513|NCT00346164|18309550|P3|Overall Study|Refusal of further protocol therapy|3
5315514|NCT00346164|18309551|P2|Overall Study|Refusal of further protocol therapy|1
5315515|NCT00346164|18309552|P1|Overall Study|Refusal of further protocol therapy|0
5315516|NCT00346164|18309549|P4|Overall Study|Ineligible|23
5315517|NCT00346164|18309550|P3|Overall Study|Ineligible|2
5315518|NCT00346164|18309551|P2|Overall Study|Ineligible|2
5315519|NCT00346164|18309552|P1|Overall Study|Ineligible|11
5315520|NCT00346164|18309549|P4|Overall Study|Withdrawal by Subject|0
5315521|NCT00346164|18309550|P3|Overall Study|Withdrawal by Subject|2
5315522|NCT00346164|18309551|P2|Overall Study|Withdrawal by Subject|0
5315523|NCT00346164|18309552|P1|Overall Study|Withdrawal by Subject|0
5315524|NCT00346164|18309549|P4|Overall Study|Protocol Violation|4
5315525|NCT00346164|18309550|P3|Overall Study|Protocol Violation|10
5315526|NCT00346164|18309551|P2|Overall Study|Protocol Violation|2
5315527|NCT00346164|18309552|P1|Overall Study|Protocol Violation|6
5315528|NCT00346164|18309549|P4|Overall Study|Physician Decision|27
5315529|NCT00346164|18309550|P3|Overall Study|Physician Decision|2
5315530|NCT00346164|18309551|P2|Overall Study|Physician Decision|1
5315531|NCT00346164|18309552|P1|Overall Study|Physician Decision|0
5315532|NCT00346164|18309549|P4|Overall Study|Lack of Efficacy|25
5315533|NCT00346164|18309550|P3|Overall Study|Lack of Efficacy|7
5315534|NCT00346164|18309551|P2|Overall Study|Lack of Efficacy|1
5315535|NCT00346164|18309552|P1|Overall Study|Lack of Efficacy|0
5315536|NCT00346164|18309549|P4|Overall Study|Adverse Event|1
5315537|NCT00346164|18309550|P3|Overall Study|Adverse Event|0
5315538|NCT00346164|18309551|P2|Overall Study|Adverse Event|0
5315539|NCT00346164|18309552|P1|Overall Study|Adverse Event|0
5315540|NCT00346151|18309587|P1|Overall Study|Withdrawal by Subject|3
5315541|NCT00346073|18309607|P2|Overall Study|Lost to Follow-up|24
5315542|NCT00346073|18309608|P1|Overall Study|Lost to Follow-up|39
5315543|NCT00346073|18309607|P2|Overall Study|Serious Adverse Event|0
5315544|NCT00346073|18309608|P1|Overall Study|Serious Adverse Event|2
5315545|NCT00346034|18309642|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
5315546|NCT00346034|18309642|P1|Overall Study|Patient Stopped Taking Study Drug|1
5315547|NCT00346034|18309642|P1|Overall Study|Withdrawal by Subject|13
5315548|NCT00346034|18309642|P1|Overall Study|Lack of Efficacy|8
5315549|NCT00346034|18309642|P1|Overall Study|Adverse Event|34
5315550|NCT00345878|18309682|P2|Overall Study|Other|0
5315551|NCT00345878|18309683|P1|Overall Study|Other|1
5315552|NCT00345878|18309682|P2|Overall Study|Lost to Follow-up|1
5315553|NCT00345878|18309683|P1|Overall Study|Lost to Follow-up|2
5315554|NCT00345878|18309682|P2|Overall Study|Adverse Event|0
5315555|NCT00345878|18309683|P1|Overall Study|Adverse Event|1
5315556|NCT00345839|18309742|P2|Overall Study|Lost to Follow-up|61
5315557|NCT00345839|18309743|P1|Overall Study|Lost to Follow-up|58
5315558|NCT00345839|18309742|P2|Overall Study|Withdrawal by Subject|98
5315559|NCT00345839|18309743|P1|Overall Study|Withdrawal by Subject|91
5315560|NCT00345683|18309769|P2|Overall Study|Other|2
5315561|NCT00345683|18309770|P1|Overall Study|Other|6
5315562|NCT00345683|18309769|P2|Overall Study|Lost to Follow-up|7
5315563|NCT00345683|18309770|P1|Overall Study|Lost to Follow-up|19
5315564|NCT00345631|18309793|P3|Overall Study|Other reasons|1
5315565|NCT00345631|18309794|P2|Overall Study|Other reasons|0
5315566|NCT00345631|18309795|P1|Overall Study|Other reasons|0
5315567|NCT00345631|18309793|P3|Overall Study|Lost to Follow-up|4
5315568|NCT00345631|18309794|P2|Overall Study|Lost to Follow-up|7
5315569|NCT00345631|18309795|P1|Overall Study|Lost to Follow-up|3
5315570|NCT00345631|18309793|P3|Overall Study|Adverse Event|0
5315571|NCT00345631|18309794|P2|Overall Study|Adverse Event|1
5315572|NCT00345631|18309795|P1|Overall Study|Adverse Event|0
5315573|NCT00345631|18309793|P3|Overall Study|Withdrawal by Subject|1
5315574|NCT00345631|18309794|P2|Overall Study|Withdrawal by Subject|0
5315575|NCT00345631|18309795|P1|Overall Study|Withdrawal by Subject|1
5315576|NCT00345605|18309827|P2|Arm 2, Opposite Treatment|Adverse Event|0
5315577|NCT00345605|18309828|P1|Arm 2, Opposite Treatment|Adverse Event|1
5315578|NCT00345605|18309827|P2|Arm 1|Adverse Event|1
5315579|NCT00345605|18309828|P1|Arm 1|Adverse Event|0
5315580|NCT00345592|18309848|P2|Overall Study|Withdrawal by Subject|8
5315581|NCT00345592|18309849|P1|Overall Study|Withdrawal by Subject|11
5315582|NCT00345592|18309848|P2|Overall Study|Death|16
5315583|NCT00345592|18309849|P1|Overall Study|Death|14
5315584|NCT00345579|18309857|P2|Overall Study|Other|1
5315585|NCT00345579|18309858|P1|Overall Study|Other|9
5315586|NCT00345579|18309857|P2|Overall Study|Lost to Follow-up|36
5315587|NCT00345579|18309858|P1|Overall Study|Lost to Follow-up|82
5315588|NCT00345579|18309857|P2|Overall Study|Withdrawal by Subject|17
5315589|NCT00345579|18309858|P1|Overall Study|Withdrawal by Subject|50
5315590|NCT00345579|18309857|P2|Overall Study|Protocol Violation|5
5315591|NCT00345579|18309858|P1|Overall Study|Protocol Violation|14
5315592|NCT00345579|18309857|P2|Overall Study|Adverse Event|6
5315593|NCT00345579|18309858|P1|Overall Study|Adverse Event|9
5315594|NCT00345540|18309878|P1|Overall Study|Withdrawal by Subject|1
5315595|NCT00345397|18309884|P1|Overall Study|Death|1
5315596|NCT00345358|18309915|P4|Booster Vaccination Phase|Lost to Follow-up|0
5315597|NCT00345358|18309916|P3|Booster Vaccination Phase|Lost to Follow-up|0
5315598|NCT00345358|18309917|P2|Booster Vaccination Phase|Lost to Follow-up|0
5315599|NCT00345358|18309918|P1|Booster Vaccination Phase|Lost to Follow-up|3
5315600|NCT00345358|18309915|P4|Booster Vaccination Phase|Withdrawal by Subject|0
5315601|NCT00345358|18309916|P3|Booster Vaccination Phase|Withdrawal by Subject|0
5315602|NCT00345358|18309917|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5315603|NCT00345358|18309918|P1|Booster Vaccination Phase|Withdrawal by Subject|1
5315604|NCT00345358|18309915|P4|Primary Vaccination Phase|Lost to Follow-up|2
5315605|NCT00345358|18309916|P3|Primary Vaccination Phase|Lost to Follow-up|2
5315606|NCT00345358|18309917|P2|Primary Vaccination Phase|Lost to Follow-up|0
5315607|NCT00345358|18309918|P1|Primary Vaccination Phase|Lost to Follow-up|1
5315608|NCT00345358|18309915|P4|Primary Vaccination Phase|Withdrawal by Subject|0
5315609|NCT00345358|18309916|P3|Primary Vaccination Phase|Withdrawal by Subject|4
5315610|NCT00345358|18309917|P2|Primary Vaccination Phase|Withdrawal by Subject|2
5315611|NCT00345358|18309918|P1|Primary Vaccination Phase|Withdrawal by Subject|1
5315612|NCT00345358|18309915|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
5315613|NCT00345358|18309916|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
5315614|NCT00345358|18309917|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
5315615|NCT00345358|18309918|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
5315616|NCT00345358|18309915|P4|Primary Vaccination Phase|Other|0
5315617|NCT00345358|18309916|P3|Primary Vaccination Phase|Other|1
5315618|NCT00345358|18309917|P2|Primary Vaccination Phase|Other|1
5315619|NCT00345358|18309918|P1|Primary Vaccination Phase|Other|0
5315620|NCT00345293|18310008|P2|Overall Study|Withdrawal by Subject|0
5315621|NCT00345293|18310009|P1|Overall Study|Withdrawal by Subject|1
5315622|NCT00345293|18310008|P2|Overall Study|Unable to access line for sample|0
5315623|NCT00345293|18310009|P1|Overall Study|Unable to access line for sample|1
5315624|NCT00345046|18310055|P3|Overall Study|Protocol Violation|2
5315625|NCT00345046|18310056|P2|Overall Study|Protocol Violation|1
5315626|NCT00345046|18310057|P1|Overall Study|Protocol Violation|1
5315627|NCT00344968|18310087|P3|Overall Study|Other|0
5315628|NCT00344968|18310088|P2|Overall Study|Other|1
5315629|NCT00344968|18310089|P1|Overall Study|Other|0
5315630|NCT00344968|18310087|P3|Overall Study|Death|31
5315631|NCT00344968|18310088|P2|Overall Study|Death|27
5315632|NCT00344968|18310089|P1|Overall Study|Death|11
5315633|NCT00344968|18310087|P3|Overall Study|Lost to Follow-up|37
5315634|NCT00344968|18310088|P2|Overall Study|Lost to Follow-up|37
5315635|NCT00344968|18310089|P1|Overall Study|Lost to Follow-up|24
5315636|NCT00344968|18310087|P3|Overall Study|Withdrawal by Subject|27
5315637|NCT00344968|18310088|P2|Overall Study|Withdrawal by Subject|31
5315638|NCT00344968|18310089|P1|Overall Study|Withdrawal by Subject|14
5315639|NCT00344968|18310087|P3|Overall Study|Protocol Violation|5
5315640|NCT00344968|18310088|P2|Overall Study|Protocol Violation|2
5315641|NCT00344968|18310089|P1|Overall Study|Protocol Violation|2
5315642|NCT00344968|18310087|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
5315643|NCT00344968|18310088|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5315644|NCT00344968|18310089|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
5315645|NCT00344968|18310087|P3|Overall Study|Adverse Event|15
5315646|NCT00344968|18310088|P2|Overall Study|Adverse Event|4
5315647|NCT00344968|18310089|P1|Overall Study|Adverse Event|5
5315648|NCT00344773|18310100|P1|Overall Study|Not Eligible for the study|2
5315649|NCT00344773|18310100|P1|Overall Study|Withdrawal by Subject|1
5315650|NCT00344773|18310100|P1|Overall Study|Objective Disease Progression|16
5315651|NCT00344773|18310100|P1|Overall Study|Adverse Event|2
5315652|NCT00344500|18310123|P3|Overall Study|Not Noted|0
5315653|NCT00344500|18310124|P2|Overall Study|Not Noted|3
5315654|NCT00344500|18310125|P1|Overall Study|Not Noted|1
5315655|NCT00344500|18310123|P3|Overall Study|Protocol Violation|1
5315656|NCT00344500|18310124|P2|Overall Study|Protocol Violation|7
5315657|NCT00344500|18310125|P1|Overall Study|Protocol Violation|4
5315658|NCT00344500|18310123|P3|Overall Study|Withdrawal by Subject|0
5315659|NCT00344500|18310124|P2|Overall Study|Withdrawal by Subject|10
5315660|NCT00344500|18310125|P1|Overall Study|Withdrawal by Subject|7
5315661|NCT00344500|18310123|P3|Overall Study|Lost to Follow-up|1
5315662|NCT00344500|18310124|P2|Overall Study|Lost to Follow-up|13
5315663|NCT00344500|18310125|P1|Overall Study|Lost to Follow-up|5
5315664|NCT00344500|18310123|P3|Overall Study|Adverse Event|0
5315665|NCT00344500|18310124|P2|Overall Study|Adverse Event|2
5315666|NCT00344500|18310125|P1|Overall Study|Adverse Event|6
5315667|NCT00344487|18310136|P1|Overall Study|immunologic failure|1
5315668|NCT00344461|18310140|P1|Overall Study|Withdrawal by Subject|2
5315669|NCT00344461|18310140|P1|Overall Study|Protocol Violation|6
5315670|NCT00344461|18310140|P1|Overall Study|Physician Decision|2
5315671|NCT00344461|18310140|P1|Overall Study|Lost to Follow-up|2
5315672|NCT00344461|18310140|P1|Overall Study|Lack of Efficacy|2
5315673|NCT00344461|18310140|P1|Overall Study|Death|1
5315674|NCT00344461|18310140|P1|Overall Study|Adverse Event|6
5315675|NCT00344448|18310151|P2|Open Label|Study terminated|0
5315676|NCT00344448|18310152|P1|Open Label|Study terminated|1
5315677|NCT00344448|18310151|P2|Open Label|Withdrawal by Subject|1
5315678|NCT00344448|18310152|P1|Open Label|Withdrawal by Subject|1
5315679|NCT00344448|18310151|P2|Double Blind, Placebo Controlled|Study terminated|0
5315680|NCT00344448|18310152|P1|Double Blind, Placebo Controlled|Study terminated|1
5315681|NCT00344448|18310151|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
5315682|NCT00344448|18310152|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
5315683|NCT00344448|18310151|P2|Screening|Withdrawal by Subject|1
5315684|NCT00344448|18310152|P1|Screening|Withdrawal by Subject|0
5315685|NCT00344318|18310173|P4|Overall Study|Lost to Follow-up|0
5315686|NCT00344318|18310174|P3|Overall Study|Lost to Follow-up|1
5315687|NCT00344318|18310175|P2|Overall Study|Lost to Follow-up|0
5315688|NCT00344318|18310176|P1|Overall Study|Lost to Follow-up|2
5315689|NCT00344318|18310173|P4|Overall Study|Withdrawal by Subject|2
5315690|NCT00344318|18310174|P3|Overall Study|Withdrawal by Subject|0
5315691|NCT00344318|18310175|P2|Overall Study|Withdrawal by Subject|2
5315692|NCT00344318|18310176|P1|Overall Study|Withdrawal by Subject|2
5315693|NCT00344318|18310173|P4|Overall Study|Adverse Event|1
5315694|NCT00344318|18310174|P3|Overall Study|Adverse Event|0
5315695|NCT00344318|18310175|P2|Overall Study|Adverse Event|3
5315696|NCT00344318|18310176|P1|Overall Study|Adverse Event|0
5315697|NCT00344305|18310298|P2|Overall Study|Participant was not contacted in window|1
5315698|NCT00344305|18310299|P1|Overall Study|Participant was not contacted in window|0
5315699|NCT00344305|18310298|P2|Overall Study|Lost to Follow-up|0
5315700|NCT00344305|18310299|P1|Overall Study|Lost to Follow-up|2
5315701|NCT00344032|18310349|P2|Overall Study|Physician Decision|1
5315702|NCT00344032|18310350|P1|Overall Study|Physician Decision|4
5315703|NCT00344032|18310349|P2|Overall Study|Lost to Follow-up|6
5315704|NCT00344032|18310350|P1|Overall Study|Lost to Follow-up|4
5315705|NCT00344032|18310349|P2|Overall Study|Withdrawal by Subject|2
5315706|NCT00344032|18310350|P1|Overall Study|Withdrawal by Subject|6
5315707|NCT00344032|18310349|P2|Overall Study|Adverse Event|1
5315708|NCT00344032|18310350|P1|Overall Study|Adverse Event|0
5315709|NCT00344019|18310369|P3|Overall Study|did not meet final inclusion criteria|74
5315710|NCT00344019|18310370|P2|Overall Study|did not meet final inclusion criteria|0
5315711|NCT00344019|18310371|P1|Overall Study|did not meet final inclusion criteria|0
5315712|NCT00343915|18310389|P2|Primary Study|Other|0
5315713|NCT00343915|18310390|P1|Primary Study|Other|1
5315714|NCT00343915|18310389|P2|Primary Study|Lost to Follow-up|3
5315715|NCT00343915|18310390|P1|Primary Study|Lost to Follow-up|2
5315716|NCT00343915|18310389|P2|Primary Study|Withdrawal by Subject|0
5315717|NCT00343915|18310390|P1|Primary Study|Withdrawal by Subject|1
5315718|NCT00343889|18310416|P2|Overall Study|Protocol Violation|0
5315719|NCT00343889|18310417|P1|Overall Study|Protocol Violation|1
5315720|NCT00343889|18310416|P2|Overall Study|Withdrawal by Subject|1
5315721|NCT00343889|18310417|P1|Overall Study|Withdrawal by Subject|0
5315722|NCT00343889|18310416|P2|Overall Study|Lost to Follow-up|0
5315723|NCT00343889|18310417|P1|Overall Study|Lost to Follow-up|2
5315724|NCT00343512|18310581|P1|Overall Study|Withdrawal by Subject|2
5315725|NCT00343382|18310669|P3|Overall Study|Other Reason Not Specified|4
5315726|NCT00343382|18310670|P2|Overall Study|Other Reason Not Specified|2
5315727|NCT00343382|18310671|P1|Overall Study|Other Reason Not Specified|1
5315728|NCT00343382|18310669|P3|Overall Study|Withdrawal by Subject|6
5315729|NCT00343382|18310670|P2|Overall Study|Withdrawal by Subject|2
5315730|NCT00343382|18310671|P1|Overall Study|Withdrawal by Subject|1
5315731|NCT00343382|18310669|P3|Overall Study|Adverse Event|7
5315732|NCT00343382|18310670|P2|Overall Study|Adverse Event|10
5315733|NCT00343382|18310671|P1|Overall Study|Adverse Event|2
5315734|NCT00343291|18310690|P2|Overall Study|Other|5
5315735|NCT00343291|18310691|P1|Overall Study|Other|8
5315736|NCT00343291|18310690|P2|Overall Study|Withdrawal by Subject|2
5315737|NCT00343291|18310691|P1|Overall Study|Withdrawal by Subject|0
5315738|NCT00343291|18310690|P2|Overall Study|Progressive disease|34
5315739|NCT00343291|18310691|P1|Overall Study|Progressive disease|33
5315740|NCT00343291|18310690|P2|Overall Study|Death|2
5315741|NCT00343291|18310691|P1|Overall Study|Death|3
5315742|NCT00343291|18310690|P2|Overall Study|Adverse Event|13
5315743|NCT00343291|18310691|P1|Overall Study|Adverse Event|13
5315744|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
5315745|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
5315746|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Sponsor Decision|5
5315747|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Sponsor Decision|8
5315748|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Protocol Violation|3
5315749|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Protocol Violation|3
5315750|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Physician Decision|7
5315751|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Physician Decision|4
5315752|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
5315753|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
5315754|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
5315755|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
5315756|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
5315757|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
5315758|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Death|5
5315759|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Death|4
5315760|NCT00343252|18310707|P2|18 Months (All Treated Participants)|Adverse Event|23
5315761|NCT00343252|18310708|P1|18 Months (All Treated Participants)|Adverse Event|31
5315762|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
5315763|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
5315764|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Sponsor Decision|6
5315765|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Sponsor Decision|9
5315766|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Protocol Violation|2
5315767|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Protocol Violation|3
5315768|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Physician Decision|5
5315769|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Physician Decision|4
5315770|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
5315771|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
5315772|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
5315773|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
5315774|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
5315775|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
5315776|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Death|3
5315777|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Death|3
5315778|NCT00343252|18310707|P2|12 Months (All Treated Participants)|Adverse Event|20
5315779|NCT00343252|18310708|P1|12 Months (All Treated Participants)|Adverse Event|22
5315780|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
5315781|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
5315782|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Sponsor Decision|4
5315783|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Sponsor Decision|7
5315784|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Protocol Violation|2
5315785|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Protocol Violation|2
5315786|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Physician Decision|3
5315787|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Physician Decision|1
5315788|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
5315789|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
5315790|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
5315791|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
5315792|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
5315793|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
5315794|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Death|2
5315795|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Death|0
5315796|NCT00343252|18310707|P2|6 Months (All Treated Participants)|Adverse Event|11
5315797|NCT00343252|18310708|P1|6 Months (All Treated Participants)|Adverse Event|17
5315798|NCT00342628|18310773|P3|Overall Study|moved residence|1
5315799|NCT00342628|18310774|P2|Overall Study|moved residence|1
5315800|NCT00342628|18310775|P1|Overall Study|moved residence|0
5315801|NCT00342628|18310773|P3|Overall Study|Death|0
5315802|NCT00342628|18310774|P2|Overall Study|Death|1
5315803|NCT00342628|18310775|P1|Overall Study|Death|1
5315804|NCT00342628|18310773|P3|Overall Study|Withdrawal by Subject|18
5315805|NCT00342628|18310774|P2|Overall Study|Withdrawal by Subject|19
5315806|NCT00342628|18310775|P1|Overall Study|Withdrawal by Subject|19
5315807|NCT00340834|18310841|P5|Extension Phase of Study|Death|1
5315808|NCT00340834|18310842|P4|Extension Phase of Study|Death|0
5315809|NCT00340834|18310843|P3|Extension Phase of Study|Death|0
5315810|NCT00340834|18310844|P2|Extension Phase of Study|Death|0
5315811|NCT00340834|18310845|P1|Extension Phase of Study|Death|0
5315812|NCT00340834|18310841|P5|Extension Phase of Study|Protocol Violation|0
5315813|NCT00340834|18310842|P4|Extension Phase of Study|Protocol Violation|0
5315814|NCT00340834|18310843|P3|Extension Phase of Study|Protocol Violation|0
5315815|NCT00340834|18310844|P2|Extension Phase of Study|Protocol Violation|0
5315816|NCT00340834|18310845|P1|Extension Phase of Study|Protocol Violation|3
5315817|NCT00340834|18310841|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
5315818|NCT00340834|18310842|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
5315819|NCT00340834|18310843|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
5315820|NCT00340834|18310844|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
5315821|NCT00340834|18310845|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
5315822|NCT00340834|18310841|P5|Extension Phase of Study|Administrative problems|1
5315823|NCT00340834|18310842|P4|Extension Phase of Study|Administrative problems|1
5315824|NCT00340834|18310843|P3|Extension Phase of Study|Administrative problems|0
5315825|NCT00340834|18310844|P2|Extension Phase of Study|Administrative problems|0
5315826|NCT00340834|18310845|P1|Extension Phase of Study|Administrative problems|3
5315827|NCT00340834|18310841|P5|Extension Phase of Study|Subject no longer requires study drug|2
5315828|NCT00340834|18310842|P4|Extension Phase of Study|Subject no longer requires study drug|0
5315829|NCT00340834|18310843|P3|Extension Phase of Study|Subject no longer requires study drug|0
5315830|NCT00340834|18310844|P2|Extension Phase of Study|Subject no longer requires study drug|0
5315831|NCT00340834|18310845|P1|Extension Phase of Study|Subject no longer requires study drug|4
5315832|NCT00340834|18310841|P5|Extension Phase of Study|Lost to Follow-up|3
5315833|NCT00340834|18310842|P4|Extension Phase of Study|Lost to Follow-up|2
5315834|NCT00340834|18310843|P3|Extension Phase of Study|Lost to Follow-up|0
5315835|NCT00340834|18310844|P2|Extension Phase of Study|Lost to Follow-up|1
5315836|NCT00340834|18310845|P1|Extension Phase of Study|Lost to Follow-up|1
5315837|NCT00340834|18310841|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
5315838|NCT00340834|18310842|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
5315839|NCT00340834|18310843|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
5315840|NCT00340834|18310844|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
5315841|NCT00340834|18310845|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
5315842|NCT00340834|18310841|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
5315843|NCT00340834|18310842|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
5315844|NCT00340834|18310843|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
5315845|NCT00340834|18310844|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
5315846|NCT00340834|18310845|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
5315847|NCT00340834|18310841|P5|Extension Phase of Study|Adverse Event|7
5315848|NCT00340834|18310842|P4|Extension Phase of Study|Adverse Event|19
5315849|NCT00340834|18310843|P3|Extension Phase of Study|Adverse Event|0
5315850|NCT00340834|18310844|P2|Extension Phase of Study|Adverse Event|22
5315851|NCT00340834|18310845|P1|Extension Phase of Study|Adverse Event|21
5315852|NCT00340834|18310841|P5|Extension Phase of Study|Subject withdrew consent|15
5315853|NCT00340834|18310842|P4|Extension Phase of Study|Subject withdrew consent|12
5315854|NCT00340834|18310843|P3|Extension Phase of Study|Subject withdrew consent|0
5315855|NCT00340834|18310844|P2|Extension Phase of Study|Subject withdrew consent|31
5315856|NCT00340834|18310845|P1|Extension Phase of Study|Subject withdrew consent|26
5315857|NCT00340834|18310841|P5|Extension Phase of Study|Subject did not receive study drug|0
5315858|NCT00340834|18310842|P4|Extension Phase of Study|Subject did not receive study drug|2
5315859|NCT00340834|18310843|P3|Extension Phase of Study|Subject did not receive study drug|0
5315860|NCT00340834|18310844|P2|Extension Phase of Study|Subject did not receive study drug|1
5315861|NCT00340834|18310845|P1|Extension Phase of Study|Subject did not receive study drug|0
5315862|NCT00340834|18310841|P5|Core Phase of Study|Protocol Violation|0
5315863|NCT00340834|18310842|P4|Core Phase of Study|Protocol Violation|0
5315864|NCT00340834|18310843|P3|Core Phase of Study|Protocol Violation|2
5315865|NCT00340834|18310844|P2|Core Phase of Study|Protocol Violation|0
5315866|NCT00340834|18310845|P1|Core Phase of Study|Protocol Violation|0
5315867|NCT00340834|18310841|P5|Core Phase of Study|Death|0
5315868|NCT00340834|18310842|P4|Core Phase of Study|Death|0
5315869|NCT00340834|18310843|P3|Core Phase of Study|Death|0
5315870|NCT00340834|18310844|P2|Core Phase of Study|Death|0
5315871|NCT00340834|18310845|P1|Core Phase of Study|Death|2
5315872|NCT00340834|18310841|P5|Core Phase of Study|Lost to Follow-up|0
5315873|NCT00340834|18310842|P4|Core Phase of Study|Lost to Follow-up|0
5315874|NCT00340834|18310843|P3|Core Phase of Study|Lost to Follow-up|4
5315875|NCT00340834|18310844|P2|Core Phase of Study|Lost to Follow-up|1
5315876|NCT00340834|18310845|P1|Core Phase of Study|Lost to Follow-up|1
5315877|NCT00340834|18310841|P5|Core Phase of Study|Abnormal test procedure result(s)|0
5315878|NCT00340834|18310842|P4|Core Phase of Study|Abnormal test procedure result(s)|0
5315879|NCT00340834|18310843|P3|Core Phase of Study|Abnormal test procedure result(s)|3
5315880|NCT00340834|18310844|P2|Core Phase of Study|Abnormal test procedure result(s)|3
5315881|NCT00340834|18310845|P1|Core Phase of Study|Abnormal test procedure result(s)|4
5315882|NCT00340834|18310841|P5|Core Phase of Study|Abnormal laboratory value(s)|0
5315883|NCT00340834|18310842|P4|Core Phase of Study|Abnormal laboratory value(s)|0
5315884|NCT00340834|18310843|P3|Core Phase of Study|Abnormal laboratory value(s)|1
5315885|NCT00340834|18310844|P2|Core Phase of Study|Abnormal laboratory value(s)|6
5315886|NCT00340834|18310845|P1|Core Phase of Study|Abnormal laboratory value(s)|4
5315887|NCT00340834|18310841|P5|Core Phase of Study|Lack of Efficacy|0
5315888|NCT00340834|18310842|P4|Core Phase of Study|Lack of Efficacy|0
5315889|NCT00340834|18310843|P3|Core Phase of Study|Lack of Efficacy|7
5315890|NCT00340834|18310844|P2|Core Phase of Study|Lack of Efficacy|3
5315891|NCT00340834|18310845|P1|Core Phase of Study|Lack of Efficacy|3
5315892|NCT00340834|18310841|P5|Core Phase of Study|Administrative Problems|0
5315893|NCT00340834|18310842|P4|Core Phase of Study|Administrative Problems|0
5315894|NCT00340834|18310843|P3|Core Phase of Study|Administrative Problems|7
5315895|NCT00340834|18310844|P2|Core Phase of Study|Administrative Problems|2
5315896|NCT00340834|18310845|P1|Core Phase of Study|Administrative Problems|6
5315897|NCT00340834|18310841|P5|Core Phase of Study|Withdrawal by Subject|0
5315898|NCT00340834|18310842|P4|Core Phase of Study|Withdrawal by Subject|0
5315899|NCT00340834|18310843|P3|Core Phase of Study|Withdrawal by Subject|16
5315900|NCT00340834|18310844|P2|Core Phase of Study|Withdrawal by Subject|9
5315901|NCT00340834|18310845|P1|Core Phase of Study|Withdrawal by Subject|11
5315902|NCT00340834|18310841|P5|Core Phase of Study|Adverse Event|0
5315903|NCT00340834|18310842|P4|Core Phase of Study|Adverse Event|0
5315904|NCT00340834|18310843|P3|Core Phase of Study|Adverse Event|9
5315905|NCT00340834|18310844|P2|Core Phase of Study|Adverse Event|9
5315906|NCT00340834|18310845|P1|Core Phase of Study|Adverse Event|26
5315907|NCT00340704|18310879|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
5315908|NCT00340704|18310880|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
5315909|NCT00340704|18310881|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
5315910|NCT00340704|18310882|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
5315911|NCT00340704|18310883|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5315912|NCT00340704|18310884|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5315913|NCT00340704|18310885|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5315914|NCT00340704|18310886|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5315915|NCT00340704|18310887|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5315916|NCT00340704|18310879|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315917|NCT00340704|18310880|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315918|NCT00340704|18310881|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315919|NCT00340704|18310882|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
5315920|NCT00340704|18310883|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
5315921|NCT00340704|18310884|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315922|NCT00340704|18310885|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315923|NCT00340704|18310886|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315924|NCT00340704|18310887|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5315925|NCT00340704|18310879|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315926|NCT00340704|18310880|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315927|NCT00340704|18310881|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315928|NCT00340704|18310882|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
5315929|NCT00340704|18310883|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315930|NCT00340704|18310884|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315931|NCT00340704|18310885|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315932|NCT00340704|18310886|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315933|NCT00340704|18310887|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5315934|NCT00340704|18310879|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
5315935|NCT00340704|18310880|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
5315936|NCT00340704|18310881|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5315937|NCT00340704|18310882|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5315938|NCT00340704|18310883|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
5315939|NCT00340704|18310884|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
5315940|NCT00340704|18310885|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5315941|NCT00340704|18310886|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5315942|NCT00340704|18310887|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5315943|NCT00340704|18310879|P9|PK Study|Not treated|0
5315944|NCT00340704|18310880|P8|PK Study|Not treated|0
5315945|NCT00340704|18310881|P7|PK Study|Not treated|0
5315946|NCT00340704|18310882|P6|PK Study|Not treated|0
5315947|NCT00340704|18310883|P5|PK Study|Not treated|0
5315948|NCT00340704|18310884|P4|PK Study|Not treated|0
5315949|NCT00340704|18310885|P3|PK Study|Not treated|1
5315950|NCT00340704|18310886|P2|PK Study|Not treated|0
5315951|NCT00340704|18310887|P1|PK Study|Not treated|0
5315952|NCT00340704|18310879|P9|PK Study|Adverse Event|0
5315953|NCT00340704|18310880|P8|PK Study|Adverse Event|0
5315954|NCT00340704|18310881|P7|PK Study|Adverse Event|0
5315955|NCT00340704|18310882|P6|PK Study|Adverse Event|0
5315956|NCT00340704|18310883|P5|PK Study|Adverse Event|0
5315957|NCT00340704|18310884|P4|PK Study|Adverse Event|0
5315958|NCT00340704|18310885|P3|PK Study|Adverse Event|0
5315959|NCT00340704|18310886|P2|PK Study|Adverse Event|1
5315960|NCT00340704|18310887|P1|PK Study|Adverse Event|0
5315961|NCT00340678|18310993|P4|Overall Study|Lost to Follow-up|0
5315962|NCT00340678|18310994|P3|Overall Study|Lost to Follow-up|0
5315963|NCT00340678|18310995|P2|Overall Study|Lost to Follow-up|0
5315964|NCT00340678|18310996|P1|Overall Study|Lost to Follow-up|1
5315965|NCT00339833|18311023|P2|Overall Study|Error in data records|0
5315966|NCT00339833|18311024|P1|Overall Study|Error in data records|1
5315967|NCT00339833|18311023|P2|Overall Study|anaemia or excess drop in glycaemia|0
5315968|NCT00339833|18311024|P1|Overall Study|anaemia or excess drop in glycaemia|2
5315969|NCT00339833|18311023|P2|Overall Study|Poor venous access|2
5315970|NCT00339833|18311024|P1|Overall Study|Poor venous access|2
5315971|NCT00339833|18311023|P2|Overall Study|minor infection|1
5315972|NCT00339833|18311024|P1|Overall Study|minor infection|0
5315973|NCT00339833|18311023|P2|Overall Study|Chest pain|1
5315974|NCT00339833|18311024|P1|Overall Study|Chest pain|0
5315975|NCT00339833|18311023|P2|Overall Study|indigestion|1
5315976|NCT00339833|18311024|P1|Overall Study|indigestion|0
5315977|NCT00339833|18311023|P2|Overall Study|toothache|1
5315978|NCT00339833|18311024|P1|Overall Study|toothache|0
5315979|NCT00339833|18311023|P2|Overall Study|Withdrawal by Subject|2
5315980|NCT00339833|18311024|P1|Overall Study|Withdrawal by Subject|1
5315981|NCT00339183|18311034|P2|Overall Study|Ongoing|13
5315982|NCT00339183|18311035|P1|Overall Study|Ongoing|20
5315983|NCT00339183|18311034|P2|Overall Study|Other|40
5315984|NCT00339183|18311035|P1|Overall Study|Other|46
5315985|NCT00339183|18311034|P2|Overall Study|Missing reason|1
5315986|NCT00339183|18311035|P1|Overall Study|Missing reason|3
5315987|NCT00339183|18311034|P2|Overall Study|Protocol-specified criteria|8
5315988|NCT00339183|18311035|P1|Overall Study|Protocol-specified criteria|12
5315989|NCT00339183|18311034|P2|Overall Study|Lost to Follow-up|17
5315990|NCT00339183|18311035|P1|Overall Study|Lost to Follow-up|17
5315991|NCT00339183|18311034|P2|Overall Study|Physician Decision|4
5315992|NCT00339183|18311035|P1|Overall Study|Physician Decision|2
5315993|NCT00339183|18311034|P2|Overall Study|Withdrawal by Subject|19
5315994|NCT00339183|18311035|P1|Overall Study|Withdrawal by Subject|16
5315995|NCT00339183|18311034|P2|Overall Study|Adverse Event|3
5315996|NCT00339183|18311035|P1|Overall Study|Adverse Event|5
5315997|NCT00339144|18311064|P3|Overall Study|Participant's request to discontinuation|1
5315998|NCT00339144|18311065|P2|Overall Study|Participant's request to discontinuation|0
5315999|NCT00339144|18311066|P1|Overall Study|Participant's request to discontinuation|1
5316000|NCT00339144|18311064|P3|Overall Study|Study drug toxicity|1
5316001|NCT00339144|18311065|P2|Overall Study|Study drug toxicity|1
5316002|NCT00339144|18311066|P1|Overall Study|Study drug toxicity|3
5316003|NCT00339144|18311064|P3|Overall Study|Disease progression|2
5316004|NCT00339144|18311065|P2|Overall Study|Disease progression|2
5316005|NCT00339144|18311066|P1|Overall Study|Disease progression|5
5316006|NCT00339040|18311171|P2|Stage II|Site closing|0
5316007|NCT00339040|18311172|P1|Stage II|Site closing|2
5316008|NCT00339040|18311171|P2|Stage II|Not able to attend clinic|0
5316009|NCT00339040|18311172|P1|Stage II|Not able to attend clinic|1
5316010|NCT00339040|18311171|P2|Stage II|Protocol Violation|0
5316011|NCT00339040|18311172|P1|Stage II|Protocol Violation|3
5316012|NCT00339040|18311171|P2|Stage II|Withdrawal by Subject|2
5316013|NCT00339040|18311172|P1|Stage II|Withdrawal by Subject|1
5316014|NCT00339040|18311171|P2|Stage II|Lost to Follow-up|0
5316015|NCT00339040|18311172|P1|Stage II|Lost to Follow-up|3
5316016|NCT00339040|18311171|P2|Stage I|Protocol Violation|1
5316017|NCT00339040|18311172|P1|Stage I|Protocol Violation|1
5316018|NCT00339040|18311171|P2|Stage I|Not able to attend clinic|0
5316019|NCT00339040|18311172|P1|Stage I|Not able to attend clinic|1
5316020|NCT00338962|18311199|P4|Overall Study|Poor Compliance|0
5316021|NCT00338962|18311200|P3|Overall Study|Poor Compliance|2
5316022|NCT00338962|18311201|P2|Overall Study|Poor Compliance|0
5316023|NCT00338962|18311202|P1|Overall Study|Poor Compliance|0
5316024|NCT00338962|18311199|P4|Overall Study|Adverse Event|0
5316025|NCT00338962|18311200|P3|Overall Study|Adverse Event|2
5316026|NCT00338962|18311201|P2|Overall Study|Adverse Event|0
5316027|NCT00338962|18311202|P1|Overall Study|Adverse Event|0
5316028|NCT00338962|18311199|P4|Overall Study|Moved|0
5316029|NCT00338962|18311200|P3|Overall Study|Moved|0
5316030|NCT00338962|18311201|P2|Overall Study|Moved|1
5316031|NCT00338962|18311202|P1|Overall Study|Moved|0
5316032|NCT00338962|18311199|P4|Overall Study|Time Constraint|0
5316033|NCT00338962|18311200|P3|Overall Study|Time Constraint|0
5316034|NCT00338962|18311201|P2|Overall Study|Time Constraint|0
5316035|NCT00338962|18311202|P1|Overall Study|Time Constraint|2
5316036|NCT00338962|18311199|P4|Overall Study|No Transportation|0
5316037|NCT00338962|18311200|P3|Overall Study|No Transportation|0
5316038|NCT00338962|18311201|P2|Overall Study|No Transportation|0
5316039|NCT00338962|18311202|P1|Overall Study|No Transportation|2
5316040|NCT00338962|18311199|P4|Overall Study|Withdrawal by Subject|0
5316041|NCT00338962|18311200|P3|Overall Study|Withdrawal by Subject|0
5316042|NCT00338962|18311201|P2|Overall Study|Withdrawal by Subject|0
5316043|NCT00338962|18311202|P1|Overall Study|Withdrawal by Subject|1
5316044|NCT00338962|18311199|P4|Overall Study|Lost to Follow-up|3
5316045|NCT00338962|18311200|P3|Overall Study|Lost to Follow-up|2
5316046|NCT00338962|18311201|P2|Overall Study|Lost to Follow-up|3
5316047|NCT00338962|18311202|P1|Overall Study|Lost to Follow-up|3
5316048|NCT00338949|18311226|P2|Randomization|Adverse Event|5
5316049|NCT00338949|18311227|P1|Randomization|Adverse Event|0
5316050|NCT00338949|18311226|P2|Randomization|Withdrawal by Subject|0
5316051|NCT00338949|18311227|P1|Randomization|Withdrawal by Subject|1
5316052|NCT00338949|18311226|P2|Subject Screening|Screen failures|11
5316053|NCT00338949|18311227|P1|Subject Screening|Screen failures|11
5316054|NCT00338884|18311235|P1|Overall Study|Randomized But Did Not Receive Treatment|1
5316055|NCT00338884|18311235|P1|Overall Study|Lost to Follow-up|1
5316056|NCT00338884|18311235|P1|Overall Study|Withdrawal by Subject|3
5316057|NCT00338884|18311235|P1|Overall Study|Global Deterioration of Health Status|3
5316058|NCT00338884|18311235|P1|Overall Study|Other|4
5316059|NCT00338884|18311235|P1|Overall Study|Death|8
5316060|NCT00338884|18311235|P1|Overall Study|Adverse Event|14
5316061|NCT00338884|18311235|P1|Overall Study|Objective Disease Progression or Relapse|44
5316062|NCT00338806|18311269|P2|Follow-up|Lost to Follow-up|3
5316063|NCT00338806|18311270|P1|Follow-up|Lost to Follow-up|1
5316064|NCT00338806|18311269|P2|Acute Phase|Withdrawal by Subject|1
5316065|NCT00338806|18311270|P1|Acute Phase|Withdrawal by Subject|0
5316066|NCT00338741|18311332|P2|Overall Study|Lost to Follow-up|0
5316067|NCT00338741|18311333|P1|Overall Study|Lost to Follow-up|2
5316068|NCT00338728|18311341|P1|Overall Study|Screen Failure|14
5316069|NCT00338455|18311369|P2|Overall Study|Physician Decision|0
5316070|NCT00338455|18311370|P1|Overall Study|Physician Decision|1
5316071|NCT00338455|18311369|P2|Overall Study|Death|1
5316072|NCT00338455|18311370|P1|Overall Study|Death|2
5316073|NCT00338286|18311384|P2|Overall Study|Other|93
5316074|NCT00338286|18311385|P1|Overall Study|Other|103
5316075|NCT00338286|18311384|P2|Overall Study|Lost to Follow-up|66
5316076|NCT00338286|18311385|P1|Overall Study|Lost to Follow-up|80
5316077|NCT00338286|18311384|P2|Overall Study|Withdrawal by Subject|54
5316078|NCT00338286|18311385|P1|Overall Study|Withdrawal by Subject|50
5316079|NCT00338104|18311402|P3|Overall Study|Protocol Violation|3
5316080|NCT00338104|18311403|P2|Overall Study|Protocol Violation|1
5316081|NCT00338104|18311404|P1|Overall Study|Protocol Violation|2
5316082|NCT00337935|18311427|P2|Overall Study|Lack of Efficacy|1
5316083|NCT00337935|18311428|P1|Overall Study|Lack of Efficacy|0
5316084|NCT00337935|18311427|P2|Overall Study|Other|1
5316085|NCT00337935|18311428|P1|Overall Study|Other|0
5316086|NCT00337935|18311427|P2|Overall Study|Withdrawal by Subject|7
5316087|NCT00337935|18311428|P1|Overall Study|Withdrawal by Subject|1
5316088|NCT00337935|18311427|P2|Overall Study|Protocol Violation|3
5316089|NCT00337935|18311428|P1|Overall Study|Protocol Violation|4
5316090|NCT00337935|18311427|P2|Overall Study|Lost to Follow-up|1
5316091|NCT00337935|18311428|P1|Overall Study|Lost to Follow-up|0
5316092|NCT00337935|18311427|P2|Overall Study|Physician Decision|1
5316093|NCT00337935|18311428|P1|Overall Study|Physician Decision|1
5316094|NCT00337935|18311427|P2|Overall Study|Death|8
5316095|NCT00337935|18311428|P1|Overall Study|Death|2
5316096|NCT00337935|18311427|P2|Overall Study|Adverse Event|5
5316097|NCT00337935|18311428|P1|Overall Study|Adverse Event|2
5316098|NCT00337818|18311441|P3|Overall Study|Lost to Follow-up|107
5316099|NCT00337818|18311442|P2|Overall Study|Lost to Follow-up|91
5316100|NCT00337818|18311443|P1|Overall Study|Lost to Follow-up|289
5316101|NCT00337779|18311465|P2|Overall Study|Death|1
5316102|NCT00337779|18311466|P1|Overall Study|Death|0
5316103|NCT00337779|18311465|P2|Overall Study|Pregnancy|2
5316104|NCT00337779|18311466|P1|Overall Study|Pregnancy|3
5316105|NCT00337779|18311465|P2|Overall Study|Adverse Event|51
5316106|NCT00337779|18311466|P1|Overall Study|Adverse Event|28
5316107|NCT00337779|18311465|P2|Overall Study|Lost to Follow-up|5
5316108|NCT00337779|18311466|P1|Overall Study|Lost to Follow-up|6
5316109|NCT00337779|18311465|P2|Overall Study|Protocol Violation|1
5316110|NCT00337779|18311466|P1|Overall Study|Protocol Violation|1
5316111|NCT00337779|18311465|P2|Overall Study|Physician Decision|6
5316112|NCT00337779|18311466|P1|Overall Study|Physician Decision|3
5316113|NCT00337779|18311465|P2|Overall Study|Sponsor decision|1
5316114|NCT00337779|18311466|P1|Overall Study|Sponsor decision|1
5316115|NCT00337779|18311465|P2|Overall Study|Withdrawal by Subject|12
5316116|NCT00337779|18311466|P1|Overall Study|Withdrawal by Subject|10
5316117|NCT00337727|18311478|P2|Overall Study|Withdrawal by Subject|5
5316118|NCT00337727|18311479|P1|Overall Study|Withdrawal by Subject|3
5316119|NCT00337727|18311478|P2|Overall Study|Protocol Violation|0
5316120|NCT00337727|18311479|P1|Overall Study|Protocol Violation|4
5316121|NCT00337727|18311478|P2|Overall Study|Physician Decision|0
5316122|NCT00337727|18311479|P1|Overall Study|Physician Decision|1
5316123|NCT00337727|18311478|P2|Overall Study|Lost to Follow-up|4
5316124|NCT00337727|18311479|P1|Overall Study|Lost to Follow-up|5
5316125|NCT00337727|18311478|P2|Overall Study|Adverse Event|3
5316126|NCT00337727|18311479|P1|Overall Study|Adverse Event|5
5316127|NCT00337675|18311490|P3|Overall Study|Trial Terminated|2
5316128|NCT00337675|18311491|P2|Overall Study|Trial Terminated|0
5316129|NCT00337675|18311492|P1|Overall Study|Trial Terminated|0
5316130|NCT00337675|18311490|P3|Overall Study|Progressive Disease|0
5316131|NCT00337675|18311491|P2|Overall Study|Progressive Disease|2
5316132|NCT00337675|18311492|P1|Overall Study|Progressive Disease|0
5316133|NCT00337675|18311490|P3|Overall Study|Withdrawal by Subject|19
5316134|NCT00337675|18311491|P2|Overall Study|Withdrawal by Subject|25
5316135|NCT00337675|18311492|P1|Overall Study|Withdrawal by Subject|25
5316136|NCT00337675|18311490|P3|Overall Study|Protocol Violation|19
5316137|NCT00337675|18311491|P2|Overall Study|Protocol Violation|24
5316138|NCT00337675|18311492|P1|Overall Study|Protocol Violation|21
5316139|NCT00337675|18311490|P3|Overall Study|Physician Decision|14
5316140|NCT00337675|18311491|P2|Overall Study|Physician Decision|17
5316141|NCT00337675|18311492|P1|Overall Study|Physician Decision|9
5316142|NCT00337675|18311490|P3|Overall Study|Lost to Follow-up|17
5316143|NCT00337675|18311491|P2|Overall Study|Lost to Follow-up|19
5316144|NCT00337675|18311492|P1|Overall Study|Lost to Follow-up|22
5316145|NCT00337675|18311490|P3|Overall Study|Lack of Efficacy|9
5316146|NCT00337675|18311491|P2|Overall Study|Lack of Efficacy|7
5316147|NCT00337675|18311492|P1|Overall Study|Lack of Efficacy|10
5316148|NCT00337675|18311490|P3|Overall Study|Adverse Event|19
5316149|NCT00337675|18311491|P2|Overall Study|Adverse Event|9
5316150|NCT00337675|18311492|P1|Overall Study|Adverse Event|10
5316151|NCT00337662|18311509|P4|Study Period III|Clinical Relapse|0
5316152|NCT00337662|18311510|P3|Study Period III|Clinical Relapse|0
5316153|NCT00337662|18311511|P2|Study Period III|Clinical Relapse|0
5316154|NCT00337662|18311512|P1|Study Period III|Clinical Relapse|1
5316155|NCT00337662|18311509|P4|Study Period III|Sponsor Decision|0
5316156|NCT00337662|18311510|P3|Study Period III|Sponsor Decision|1
5316157|NCT00337662|18311511|P2|Study Period III|Sponsor Decision|0
5316158|NCT00337662|18311512|P1|Study Period III|Sponsor Decision|1
5316159|NCT00337662|18311509|P4|Study Period III|Parent/Caregiver Decision|0
5316160|NCT00337662|18311510|P3|Study Period III|Parent/Caregiver Decision|2
5316161|NCT00337662|18311511|P2|Study Period III|Parent/Caregiver Decision|0
5316162|NCT00337662|18311512|P1|Study Period III|Parent/Caregiver Decision|0
5316163|NCT00337662|18311509|P4|Study Period III|Lack of Efficacy|0
5316164|NCT00337662|18311510|P3|Study Period III|Lack of Efficacy|2
5316165|NCT00337662|18311511|P2|Study Period III|Lack of Efficacy|4
5316166|NCT00337662|18311512|P1|Study Period III|Lack of Efficacy|4
5316167|NCT00337662|18311509|P4|Study Period III|Entry Criteria Not Met|0
5316168|NCT00337662|18311510|P3|Study Period III|Entry Criteria Not Met|3
5316169|NCT00337662|18311511|P2|Study Period III|Entry Criteria Not Met|1
5316170|NCT00337662|18311512|P1|Study Period III|Entry Criteria Not Met|4
5316171|NCT00337662|18311509|P4|Study Period III|Physician Decision|0
5316172|NCT00337662|18311510|P3|Study Period III|Physician Decision|0
5316173|NCT00337662|18311511|P2|Study Period III|Physician Decision|5
5316174|NCT00337662|18311512|P1|Study Period III|Physician Decision|6
5316175|NCT00337662|18311509|P4|Study Period III|Protocol Violation|0
5316176|NCT00337662|18311510|P3|Study Period III|Protocol Violation|2
5316177|NCT00337662|18311511|P2|Study Period III|Protocol Violation|8
5316178|NCT00337662|18311512|P1|Study Period III|Protocol Violation|3
5316179|NCT00337662|18311509|P4|Study Period III|Adverse Event|0
5316180|NCT00337662|18311510|P3|Study Period III|Adverse Event|8
5316181|NCT00337662|18311511|P2|Study Period III|Adverse Event|10
5316182|NCT00337662|18311512|P1|Study Period III|Adverse Event|9
5316183|NCT00337662|18311509|P4|Study Period III|Withdrawal by Subject|0
5316184|NCT00337662|18311510|P3|Study Period III|Withdrawal by Subject|12
5316185|NCT00337662|18311511|P2|Study Period III|Withdrawal by Subject|14
5316186|NCT00337662|18311512|P1|Study Period III|Withdrawal by Subject|18
5316187|NCT00337662|18311509|P4|Study Period III|Lost to Follow-up|0
5316188|NCT00337662|18311510|P3|Study Period III|Lost to Follow-up|14
5316189|NCT00337662|18311511|P2|Study Period III|Lost to Follow-up|16
5316190|NCT00337662|18311512|P1|Study Period III|Lost to Follow-up|14
5316191|NCT00337662|18311509|P4|Study Period II|Parent/Caregiver Decision|1
5316192|NCT00337662|18311510|P3|Study Period II|Parent/Caregiver Decision|0
5316193|NCT00337662|18311511|P2|Study Period II|Parent/Caregiver Decision|0
5316194|NCT00337662|18311512|P1|Study Period II|Parent/Caregiver Decision|0
5316195|NCT00337662|18311509|P4|Study Period II|Sponsor Decision|2
5316196|NCT00337662|18311510|P3|Study Period II|Sponsor Decision|0
5316197|NCT00337662|18311511|P2|Study Period II|Sponsor Decision|0
5316198|NCT00337662|18311512|P1|Study Period II|Sponsor Decision|0
5316199|NCT00337662|18311509|P4|Study Period II|Lack of Efficacy|7
5316200|NCT00337662|18311510|P3|Study Period II|Lack of Efficacy|0
5316201|NCT00337662|18311511|P2|Study Period II|Lack of Efficacy|0
5316202|NCT00337662|18311512|P1|Study Period II|Lack of Efficacy|0
5316203|NCT00337662|18311509|P4|Study Period II|Protocol Violation|6
5316204|NCT00337662|18311510|P3|Study Period II|Protocol Violation|0
5316205|NCT00337662|18311511|P2|Study Period II|Protocol Violation|0
5316206|NCT00337662|18311512|P1|Study Period II|Protocol Violation|0
5316207|NCT00337662|18311509|P4|Study Period II|Entry Criteria Not Met|6
5316208|NCT00337662|18311510|P3|Study Period II|Entry Criteria Not Met|0
5316209|NCT00337662|18311511|P2|Study Period II|Entry Criteria Not Met|0
5316210|NCT00337662|18311512|P1|Study Period II|Entry Criteria Not Met|0
5316211|NCT00337662|18311509|P4|Study Period II|Physician Decision|13
5316212|NCT00337662|18311510|P3|Study Period II|Physician Decision|0
5316213|NCT00337662|18311511|P2|Study Period II|Physician Decision|0
5316214|NCT00337662|18311512|P1|Study Period II|Physician Decision|0
5316215|NCT00337662|18311509|P4|Study Period II|Adverse Event|16
5316216|NCT00337662|18311510|P3|Study Period II|Adverse Event|0
5316217|NCT00337662|18311511|P2|Study Period II|Adverse Event|0
5316218|NCT00337662|18311512|P1|Study Period II|Adverse Event|0
5316219|NCT00337662|18311509|P4|Study Period II|Withdrawal by Subject|20
5316220|NCT00337662|18311510|P3|Study Period II|Withdrawal by Subject|0
5316221|NCT00337662|18311511|P2|Study Period II|Withdrawal by Subject|0
5316222|NCT00337662|18311512|P1|Study Period II|Withdrawal by Subject|0
5316223|NCT00337662|18311509|P4|Study Period II|Lost to Follow-up|35
5316224|NCT00337662|18311510|P3|Study Period II|Lost to Follow-up|0
5316225|NCT00337662|18311511|P2|Study Period II|Lost to Follow-up|0
5316226|NCT00337662|18311512|P1|Study Period II|Lost to Follow-up|0
5316227|NCT00337610|18311566|P2|Overall Study|Withdrawal by Subject|5
5316228|NCT00337610|18311567|P1|Overall Study|Withdrawal by Subject|6
5316229|NCT00337610|18311566|P2|Overall Study|Lost to Follow-up|3
5316230|NCT00337610|18311567|P1|Overall Study|Lost to Follow-up|3
5316231|NCT00337610|18311566|P2|Overall Study|Lack of Efficacy|3
5316232|NCT00337610|18311567|P1|Overall Study|Lack of Efficacy|6
5316233|NCT00337610|18311566|P2|Overall Study|Death|1
5316234|NCT00337610|18311567|P1|Overall Study|Death|0
5316235|NCT00337610|18311566|P2|Overall Study|Adverse Event|2
5316236|NCT00337610|18311567|P1|Overall Study|Adverse Event|2
5316237|NCT00337571|18311583|P4|Overall Study|High Potassium level|1
5316238|NCT00337571|18311584|P3|Overall Study|High Potassium level|0
5316239|NCT00337571|18311585|P2|Overall Study|High Potassium level|0
5316240|NCT00337571|18311586|P1|Overall Study|High Potassium level|0
5316241|NCT00337571|18311583|P4|Overall Study|No longer met study criteria|0
5316242|NCT00337571|18311584|P3|Overall Study|No longer met study criteria|0
5316243|NCT00337571|18311585|P2|Overall Study|No longer met study criteria|0
5316244|NCT00337571|18311586|P1|Overall Study|No longer met study criteria|1
5316245|NCT00337571|18311583|P4|Overall Study|Poor/noncompliance|1
5316246|NCT00337571|18311584|P3|Overall Study|Poor/noncompliance|1
5316247|NCT00337571|18311585|P2|Overall Study|Poor/noncompliance|1
5316248|NCT00337571|18311586|P1|Overall Study|Poor/noncompliance|1
5316249|NCT00337571|18311583|P4|Overall Study|Lost to Follow-up|1
5316250|NCT00337571|18311584|P3|Overall Study|Lost to Follow-up|0
5316251|NCT00337571|18311585|P2|Overall Study|Lost to Follow-up|1
5316252|NCT00337571|18311586|P1|Overall Study|Lost to Follow-up|3
5316253|NCT00337571|18311583|P4|Overall Study|Withdrawal by Subject|0
5316254|NCT00337571|18311584|P3|Overall Study|Withdrawal by Subject|1
5316255|NCT00337571|18311585|P2|Overall Study|Withdrawal by Subject|2
5316256|NCT00337571|18311586|P1|Overall Study|Withdrawal by Subject|2
5316257|NCT00337571|18311583|P4|Overall Study|Adverse Event|4
5316258|NCT00337571|18311584|P3|Overall Study|Adverse Event|8
5316259|NCT00337571|18311585|P2|Overall Study|Adverse Event|5
5316260|NCT00337571|18311586|P1|Overall Study|Adverse Event|4
5316261|NCT00337571|18311583|P4|Overall Study|Lack of Efficacy|0
5316262|NCT00337571|18311584|P3|Overall Study|Lack of Efficacy|0
5316263|NCT00337571|18311585|P2|Overall Study|Lack of Efficacy|0
5316264|NCT00337571|18311586|P1|Overall Study|Lack of Efficacy|3
5316265|NCT00337467|18311624|P1|Overall Study|Subject No Longer Met Study Criteria|2
5316266|NCT00337467|18311624|P1|Overall Study|Lost to Follow-up|2
5316267|NCT00337467|18311624|P1|Overall Study|Pregnancy|1
5316268|NCT00337467|18311624|P1|Overall Study|Subject Withdrew Consent|2
5316269|NCT00337467|18311624|P1|Overall Study|Adverse Event|3
5316270|NCT00337428|18311643|P2|Overall Study|Anorexia|0
5316271|NCT00337428|18311644|P1|Overall Study|Anorexia|1
5316272|NCT00337428|18311643|P2|Overall Study|Unwilling to Continue|0
5316273|NCT00337428|18311644|P1|Overall Study|Unwilling to Continue|1
5316274|NCT00337428|18311643|P2|Overall Study|Lack of Time|1
5316275|NCT00337428|18311644|P1|Overall Study|Lack of Time|1
5316276|NCT00337428|18311643|P2|Overall Study|Withdrawal by Subject|2
5316277|NCT00337428|18311644|P1|Overall Study|Withdrawal by Subject|1
5316278|NCT00337285|18311695|P1|Overall Study|Lack of protocol compliance|7
5316279|NCT00337285|18311695|P1|Overall Study|Physician Decision|1
5316280|NCT00337285|18311695|P1|Overall Study|Death|1
5316281|NCT00337285|18311695|P1|Overall Study|Lack of Efficacy|11
5316282|NCT00337285|18311695|P1|Overall Study|Protocol Violation|27
5316283|NCT00337285|18311695|P1|Overall Study|Adverse Event|28
5316284|NCT00337285|18311695|P1|Overall Study|Lost to Follow-up|41
5316285|NCT00337285|18311695|P1|Overall Study|Withdrawal by Subject|42
5316286|NCT00337272|18311703|P2|Withdrawal Period|Non-compliance|1
5316287|NCT00337272|18311704|P1|Withdrawal Period|Non-compliance|0
5316288|NCT00337272|18311703|P2|Treatment Period|Withdrawal by Subject|1
5316289|NCT00337272|18311704|P1|Treatment Period|Withdrawal by Subject|0
5316290|NCT00337272|18311703|P2|Treatment Period|Non-compliance|1
5316291|NCT00337272|18311704|P1|Treatment Period|Non-compliance|1
5316292|NCT00337272|18311703|P2|Screening Period (Pre-randomization)|Screen failure|0
5316293|NCT00337272|18311704|P1|Screening Period (Pre-randomization)|Screen failure|3
5316294|NCT00337272|18311703|P2|Screening Period (Pre-randomization)|Non-compliance|0
5316295|NCT00337272|18311704|P1|Screening Period (Pre-randomization)|Non-compliance|1
5316296|NCT00337272|18311703|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
5316297|NCT00337272|18311704|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
5316298|NCT00337207|18311724|P1|Overall Study|Withdrawal by Subject|3
5316299|NCT00337194|18311732|P2|Overall Study|Subsequent non-protocol therapy|1
5316300|NCT00337194|18311733|P1|Overall Study|Subsequent non-protocol therapy|3
5316301|NCT00337194|18311732|P2|Overall Study|Disease progression|2
5316302|NCT00337194|18311733|P1|Overall Study|Disease progression|1
5316303|NCT00337194|18311732|P2|Overall Study|Withdrawal by Subject|0
5316304|NCT00337194|18311733|P1|Overall Study|Withdrawal by Subject|1
5316305|NCT00337194|18311732|P2|Overall Study|Death|0
5316306|NCT00337194|18311733|P1|Overall Study|Death|2
5316307|NCT00337194|18311732|P2|Overall Study|Adverse Event|1
5316308|NCT00337194|18311733|P1|Overall Study|Adverse Event|5
5316309|NCT00337168|18311757|P1|Overall Study|Did not start therapy|1
5316310|NCT00337168|18311757|P1|Overall Study|Not protocol specified|2
5316311|NCT00337168|18311757|P1|Overall Study|Death|5
5316312|NCT00337129|18311764|P1|Overall Study|not protocol specified|1
5316313|NCT00337129|18311764|P1|Overall Study|Death|2
5316314|NCT00337129|18311764|P1|Overall Study|Lack of Efficacy|32
5316315|NCT00337129|18311764|P1|Overall Study|Withdrawal by Subject|1
5316316|NCT00337129|18311764|P1|Overall Study|Adverse Event|4
5316317|NCT00337103|18311773|P2|Overall Study|Death|0
5316318|NCT00337103|18311774|P1|Overall Study|Death|1
5316319|NCT00337103|18311773|P2|Overall Study|Lost to Follow-up|2
5316320|NCT00337103|18311774|P1|Overall Study|Lost to Follow-up|1
5316321|NCT00337103|18311773|P2|Overall Study|Entry Criteria Not Met|1
5316322|NCT00337103|18311774|P1|Overall Study|Entry Criteria Not Met|4
5316323|NCT00337103|18311773|P2|Overall Study|Other|6
5316324|NCT00337103|18311774|P1|Overall Study|Other|5
5316325|NCT00337103|18311773|P2|Overall Study|Withdrawal by Subject|5
5316326|NCT00337103|18311774|P1|Overall Study|Withdrawal by Subject|8
5316327|NCT00337103|18311773|P2|Overall Study|Physician Decision|14
5316328|NCT00337103|18311774|P1|Overall Study|Physician Decision|15
5316329|NCT00337103|18311773|P2|Overall Study|Clinical Progression|24
5316330|NCT00337103|18311774|P1|Overall Study|Clinical Progression|27
5316331|NCT00337103|18311773|P2|Overall Study|Subject Choice|27
5316332|NCT00337103|18311774|P1|Overall Study|Subject Choice|34
5316333|NCT00337103|18311773|P2|Overall Study|Adverse Event|59
5316334|NCT00337103|18311774|P1|Overall Study|Adverse Event|45
5316335|NCT00337103|18311773|P2|Overall Study|Progressive Disease|410
5316336|NCT00337103|18311774|P1|Overall Study|Progressive Disease|414
5316337|NCT00337077|18311808|P3|Overall Study|Ineligible|1
5316338|NCT00337077|18311809|P2|Overall Study|Ineligible|1
5316339|NCT00337077|18311810|P1|Overall Study|Ineligible|1
5316340|NCT00337077|18311808|P3|Overall Study|Never started treatment|0
5316341|NCT00337077|18311809|P2|Overall Study|Never started treatment|1
5316342|NCT00337077|18311810|P1|Overall Study|Never started treatment|1
5316343|NCT00337077|18311808|P3|Overall Study|Physician Decision|2
5316344|NCT00337077|18311809|P2|Overall Study|Physician Decision|4
5316345|NCT00337077|18311810|P1|Overall Study|Physician Decision|1
5316346|NCT00337077|18311808|P3|Overall Study|Alternative therapy|0
5316347|NCT00337077|18311809|P2|Overall Study|Alternative therapy|0
5316348|NCT00337077|18311810|P1|Overall Study|Alternative therapy|1
5316349|NCT00337077|18311808|P3|Overall Study|Withdrawal by Subject|2
5316350|NCT00337077|18311809|P2|Overall Study|Withdrawal by Subject|2
5316351|NCT00337077|18311810|P1|Overall Study|Withdrawal by Subject|7
5316352|NCT00337077|18311808|P3|Overall Study|Death|0
5316353|NCT00337077|18311809|P2|Overall Study|Death|1
5316354|NCT00337077|18311810|P1|Overall Study|Death|0
5316355|NCT00337077|18311808|P3|Overall Study|Adverse Event|1
5316356|NCT00337077|18311809|P2|Overall Study|Adverse Event|7
5316357|NCT00337077|18311810|P1|Overall Study|Adverse Event|7
5316358|NCT00337077|18311808|P3|Overall Study|Progressive disease|19
5316359|NCT00337077|18311809|P2|Overall Study|Progressive disease|37
5316360|NCT00337077|18311810|P1|Overall Study|Progressive disease|25
5316361|NCT00336895|18311825|P1|Overall Study|screen failed|1
5316362|NCT00336895|18311825|P1|Overall Study|Physician Decision|1
5316363|NCT00336895|18311825|P1|Overall Study|nausea and upset stomach|1
5316364|NCT00336895|18311825|P1|Overall Study|diarrhea|1
5316365|NCT00336856|18311831|P1|Overall Study|Found ineligible at time of analysis|1
5316366|NCT00336856|18311831|P1|Overall Study|Withdrawal by Subject|3
5316367|NCT00336583|18311879|P1|Overall Study|Death|1
5316368|NCT00336583|18311879|P1|Overall Study|Lost to Follow-up|1
5316369|NCT00336544|18311886|P2|Overall Study|Other|5
5316370|NCT00336544|18311887|P1|Overall Study|Other|3
5316371|NCT00336544|18311886|P2|Overall Study|Withdrawal by Subject|3
5316372|NCT00336544|18311887|P1|Overall Study|Withdrawal by Subject|4
5316373|NCT00336544|18311886|P2|Overall Study|Adverse Event|9
5316374|NCT00336544|18311887|P1|Overall Study|Adverse Event|4
5316375|NCT00336544|18311886|P2|Overall Study|Lack of Efficacy|5
5316376|NCT00336544|18311887|P1|Overall Study|Lack of Efficacy|8
5316377|NCT00336505|18311901|P2|Overall Study|Other|7
5316378|NCT00336505|18311902|P1|Overall Study|Other|7
5316379|NCT00336505|18311901|P2|Overall Study|Withdrawal by Subject|3
5316380|NCT00336505|18311902|P1|Overall Study|Withdrawal by Subject|5
5316381|NCT00336505|18311901|P2|Overall Study|Lost to Follow-up|4
5316382|NCT00336505|18311902|P1|Overall Study|Lost to Follow-up|7
5316383|NCT00336505|18311901|P2|Overall Study|Lack of Efficacy|4
5316384|NCT00336505|18311902|P1|Overall Study|Lack of Efficacy|8
5316385|NCT00336505|18311901|P2|Overall Study|Adverse Event|9
5316386|NCT00336505|18311902|P1|Overall Study|Adverse Event|10
5316387|NCT00336492|18311917|P3|Overall Study|Other|1
5316388|NCT00336492|18311918|P2|Overall Study|Other|0
5316389|NCT00336492|18311919|P1|Overall Study|Other|5
5316390|NCT00336492|18311917|P3|Overall Study|Lack of Efficacy|4
5316391|NCT00336492|18311918|P2|Overall Study|Lack of Efficacy|1
5316392|NCT00336492|18311919|P1|Overall Study|Lack of Efficacy|6
5316393|NCT00336492|18311917|P3|Overall Study|Adverse Event|6
5316394|NCT00336492|18311918|P2|Overall Study|Adverse Event|3
5316395|NCT00336492|18311919|P1|Overall Study|Adverse Event|4
5316396|NCT00336479|18311931|P4|Overall Study|Virologic Stopping Rule|0
5316397|NCT00336479|18311932|P3|Overall Study|Virologic Stopping Rule|0
5316398|NCT00336479|18311933|P2|Overall Study|Virologic Stopping Rule|0
5316399|NCT00336479|18311934|P1|Overall Study|Virologic Stopping Rule|20
5316400|NCT00336479|18311931|P4|Overall Study|Other|0
5316401|NCT00336479|18311932|P3|Overall Study|Other|1
5316402|NCT00336479|18311933|P2|Overall Study|Other|0
5316403|NCT00336479|18311934|P1|Overall Study|Other|0
5316404|NCT00336479|18311931|P4|Overall Study|Withdrawal by Subject|0
5316405|NCT00336479|18311932|P3|Overall Study|Withdrawal by Subject|3
5316406|NCT00336479|18311933|P2|Overall Study|Withdrawal by Subject|2
5316407|NCT00336479|18311934|P1|Overall Study|Withdrawal by Subject|3
5316408|NCT00336479|18311931|P4|Overall Study|Lost to Follow-up|0
5316409|NCT00336479|18311932|P3|Overall Study|Lost to Follow-up|0
5316410|NCT00336479|18311933|P2|Overall Study|Lost to Follow-up|2
5316411|NCT00336479|18311934|P1|Overall Study|Lost to Follow-up|3
5316412|NCT00336479|18311931|P4|Overall Study|Physician Decision|0
5316413|NCT00336479|18311932|P3|Overall Study|Physician Decision|1
5316414|NCT00336479|18311933|P2|Overall Study|Physician Decision|3
5316415|NCT00336479|18311934|P1|Overall Study|Physician Decision|2
5316416|NCT00336479|18311931|P4|Overall Study|Noncompliant|0
5316417|NCT00336479|18311932|P3|Overall Study|Noncompliant|3
5316418|NCT00336479|18311933|P2|Overall Study|Noncompliant|7
5316419|NCT00336479|18311934|P1|Overall Study|Noncompliant|1
5316420|NCT00336479|18311931|P4|Overall Study|Adverse Event|4
5316421|NCT00336479|18311932|P3|Overall Study|Adverse Event|18
5316422|NCT00336479|18311933|P2|Overall Study|Adverse Event|11
5316423|NCT00336479|18311934|P1|Overall Study|Adverse Event|8
5316424|NCT00336284|18312023|P2|Overall Study|Withdrawal by Physician or Subject|64
5316425|NCT00336284|18312024|P1|Overall Study|Withdrawal by Physician or Subject|102
5316426|NCT00336284|18312023|P2|Overall Study|Lost to Follow-up|61
5316427|NCT00336284|18312024|P1|Overall Study|Lost to Follow-up|82
5316428|NCT00336284|18312023|P2|Overall Study|Death|26
5316429|NCT00336284|18312024|P1|Overall Study|Death|52
5316430|NCT00336024|18312042|P2|Overall Study|Ineligible|7
5316431|NCT00336024|18312043|P1|Overall Study|Ineligible|7
5316432|NCT00336024|18312042|P2|Overall Study|Progressive Disease|7
5316433|NCT00336024|18312043|P1|Overall Study|Progressive Disease|4
5316434|NCT00336024|18312042|P2|Overall Study|Failure to fulfill consolidation|1
5316435|NCT00336024|18312043|P1|Overall Study|Failure to fulfill consolidation|1
5316436|NCT00336024|18312042|P2|Overall Study|Withdrawal by Subject|2
5316437|NCT00336024|18312043|P1|Overall Study|Withdrawal by Subject|1
5316438|NCT00336024|18312042|P2|Overall Study|Protocol Violation|0
5316439|NCT00336024|18312043|P1|Overall Study|Protocol Violation|1
5316440|NCT00336024|18312042|P2|Overall Study|Physician Decision|1
5316441|NCT00336024|18312043|P1|Overall Study|Physician Decision|4
5316442|NCT00336024|18312042|P2|Overall Study|Death|1
5316443|NCT00336024|18312043|P1|Overall Study|Death|2
5316444|NCT00335972|18312079|P2|Overall Study|not given treatments|3
5316445|NCT00335972|18312080|P1|Overall Study|not given treatments|0
5316446|NCT00335959|18312090|P1|Overall Study|Ineligible|1
5316447|NCT00335959|18312090|P1|Overall Study|Adverse Event|2
5316448|NCT00335829|18312095|P1|Overall Study|Adverse Event|1
5316449|NCT00335829|18312095|P1|Overall Study|Lost to Follow-up|1
5316450|NCT00335829|18312095|P1|Overall Study|Withdrawal by Subject|1
5316451|NCT00335777|18312109|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
5316452|NCT00335777|18312109|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
5316453|NCT00335777|18312109|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
5316454|NCT00335777|18312109|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
5316455|NCT00335777|18312109|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
5316456|NCT00335764|18312119|P5|Overall Study|wrong histology|1
5316457|NCT00335764|18312120|P4|Overall Study|wrong histology|0
5316458|NCT00335764|18312121|P3|Overall Study|wrong histology|0
5316459|NCT00335764|18312122|P2|Overall Study|wrong histology|0
5316460|NCT00335764|18312123|P1|Overall Study|wrong histology|1
5316461|NCT00335738|18312172|P2|Overall Study|Ineligible|4
5316462|NCT00335738|18312173|P1|Overall Study|Ineligible|3
5316463|NCT00335738|18312172|P2|Overall Study|Withdrawal by Subject|0
5316464|NCT00335738|18312173|P1|Overall Study|Withdrawal by Subject|2
5316465|NCT00335738|18312172|P2|Overall Study|Physician Decision|0
5316466|NCT00335738|18312173|P1|Overall Study|Physician Decision|6
5316467|NCT00335556|18312205|P6|Overall Study|Refusal of further protocol therapy|0
5316468|NCT00335556|18312206|P5|Overall Study|Refusal of further protocol therapy|0
5316469|NCT00335556|18312207|P4|Overall Study|Refusal of further protocol therapy|1
5316470|NCT00335556|18312208|P3|Overall Study|Refusal of further protocol therapy|0
5316471|NCT00335556|18312209|P2|Overall Study|Refusal of further protocol therapy|4
5316472|NCT00335556|18312210|P1|Overall Study|Refusal of further protocol therapy|0
5316473|NCT00335556|18312205|P6|Overall Study|Ineligible|0
5316474|NCT00335556|18312206|P5|Overall Study|Ineligible|0
5316475|NCT00335556|18312207|P4|Overall Study|Ineligible|0
5316476|NCT00335556|18312208|P3|Overall Study|Ineligible|0
5316477|NCT00335556|18312209|P2|Overall Study|Ineligible|0
5316478|NCT00335556|18312210|P1|Overall Study|Ineligible|2
5316479|NCT00335556|18312205|P6|Overall Study|Physician Decision|0
5316480|NCT00335556|18312206|P5|Overall Study|Physician Decision|0
5316481|NCT00335556|18312207|P4|Overall Study|Physician Decision|1
5316482|NCT00335556|18312208|P3|Overall Study|Physician Decision|2
5316483|NCT00335556|18312209|P2|Overall Study|Physician Decision|6
5316484|NCT00335556|18312210|P1|Overall Study|Physician Decision|0
5316485|NCT00335556|18312205|P6|Overall Study|Lack of Efficacy|1
5316486|NCT00335556|18312206|P5|Overall Study|Lack of Efficacy|0
5316487|NCT00335556|18312207|P4|Overall Study|Lack of Efficacy|3
5316488|NCT00335556|18312208|P3|Overall Study|Lack of Efficacy|3
5316489|NCT00335556|18312209|P2|Overall Study|Lack of Efficacy|19
5316490|NCT00335556|18312210|P1|Overall Study|Lack of Efficacy|0
5316491|NCT00335556|18312205|P6|Overall Study|Death|0
5316492|NCT00335556|18312206|P5|Overall Study|Death|1
5316493|NCT00335556|18312207|P4|Overall Study|Death|0
5316494|NCT00335556|18312208|P3|Overall Study|Death|0
5316495|NCT00335556|18312209|P2|Overall Study|Death|5
5316496|NCT00335556|18312210|P1|Overall Study|Death|0
5316497|NCT00335452|18312272|P4|Overall Study|Lost to Follow-up|2
5316498|NCT00335452|18312273|P3|Overall Study|Lost to Follow-up|1
5316499|NCT00335452|18312274|P2|Overall Study|Lost to Follow-up|3
5316500|NCT00335452|18312275|P1|Overall Study|Lost to Follow-up|2
5316501|NCT00335452|18312272|P4|Overall Study|Death|129
5316502|NCT00335452|18312273|P3|Overall Study|Death|158
5316503|NCT00335452|18312274|P2|Overall Study|Death|144
5316504|NCT00335452|18312275|P1|Overall Study|Death|156
5316505|NCT00335322|18312300|P3|Overall Study|Randomised but withdrew prior to ART sta|2
5316506|NCT00335322|18312301|P2|Overall Study|Randomised but withdrew prior to ART sta|2
5316507|NCT00335322|18312302|P1|Overall Study|Randomised but withdrew prior to ART sta|1
5316508|NCT00335153|18312350|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
5316509|NCT00335153|18312350|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
5316510|NCT00335153|18312350|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
5316511|NCT00335153|18312350|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
5316512|NCT00335153|18312350|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
5316513|NCT00335153|18312350|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
5316514|NCT00335153|18312350|P1|Nasojejunal (NJ) Test Period|Administrative|1
5316515|NCT00335153|18312350|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
5316516|NCT00335153|18312350|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
5316517|NCT00335153|18312350|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
5316518|NCT00335140|18312387|P1|Overall Study|Ineligible|1
5316519|NCT00334958|18312393|P2|Overall Study|Other|2
5316520|NCT00334958|18312394|P1|Overall Study|Other|1
5316521|NCT00334958|18312393|P2|Overall Study|Adverse Event|12
5316522|NCT00334958|18312394|P1|Overall Study|Adverse Event|27
5316523|NCT00334958|18312393|P2|Overall Study|Withdrawal by Subject|4
5316524|NCT00334958|18312394|P1|Overall Study|Withdrawal by Subject|7
5316525|NCT00334958|18312393|P2|Overall Study|Request of the investigator or sponsor|1
5316526|NCT00334958|18312394|P1|Overall Study|Request of the investigator or sponsor|0
5316527|NCT00334958|18312393|P2|Overall Study|Protocol Violation|2
5316528|NCT00334958|18312394|P1|Overall Study|Protocol Violation|2
5316529|NCT00334958|18312393|P2|Overall Study|Medication Noncompliance|3
5316530|NCT00334958|18312394|P1|Overall Study|Medication Noncompliance|0
5316531|NCT00334893|18312408|P2|Overall Study|Not Treated|0
5316532|NCT00334893|18312409|P1|Overall Study|Not Treated|1
5316533|NCT00334815|18312419|P2|Overall Study|Physician Decision|4
5316534|NCT00334815|18312420|P1|Overall Study|Physician Decision|2
5316535|NCT00334815|18312419|P2|Overall Study|patient refused treatment|1
5316536|NCT00334815|18312420|P1|Overall Study|patient refused treatment|0
5316537|NCT00334815|18312419|P2|Overall Study|ineligible|1
5316538|NCT00334815|18312420|P1|Overall Study|ineligible|1
5316539|NCT00334815|18312419|P2|Overall Study|Progression|0
5316540|NCT00334815|18312420|P1|Overall Study|Progression|1
5316541|NCT00334815|18312419|P2|Overall Study|Death|2
5316542|NCT00334815|18312420|P1|Overall Study|Death|0
5316543|NCT00334815|18312419|P2|Overall Study|Adverse Event|2
5316544|NCT00334815|18312420|P1|Overall Study|Adverse Event|3
5316545|NCT00334802|18312434|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
5316546|NCT00334802|18312435|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
5316547|NCT00334802|18312434|P2|Overall Study|Adverse Event|3
5316548|NCT00334802|18312435|P1|Overall Study|Adverse Event|0
5316549|NCT00334802|18312434|P2|Overall Study|Withdrawal by Subject|4
5316550|NCT00334802|18312435|P1|Overall Study|Withdrawal by Subject|0
5316551|NCT00334802|18312434|P2|Overall Study|Physician Decision|0
5316552|NCT00334802|18312435|P1|Overall Study|Physician Decision|1
5316553|NCT00334802|18312434|P2|Overall Study|Patient Condition Aggrevated|0
5316554|NCT00334802|18312435|P1|Overall Study|Patient Condition Aggrevated|1
5316555|NCT00334802|18312434|P2|Overall Study|Lack of Efficacy|3
5316556|NCT00334802|18312435|P1|Overall Study|Lack of Efficacy|1
5316557|NCT00334802|18312434|P2|Overall Study|Toxicity|5
5316558|NCT00334802|18312435|P1|Overall Study|Toxicity|1
5316559|NCT00334802|18312434|P2|Overall Study|Progressive Disease|24
5316560|NCT00334802|18312435|P1|Overall Study|Progressive Disease|2
5316561|NCT00334737|18312455|P3|Follow up Phase|Lost to Follow-up|6
5316562|NCT00334737|18312456|P2|Follow up Phase|Lost to Follow-up|3
5316563|NCT00334737|18312457|P1|Follow up Phase|Lost to Follow-up|5
5316564|NCT00334737|18312455|P3|Hospital Phase|Did not receive study drug|0
5316565|NCT00334737|18312456|P2|Hospital Phase|Did not receive study drug|0
5316566|NCT00334737|18312457|P1|Hospital Phase|Did not receive study drug|1
5316567|NCT00334737|18312455|P3|Hospital Phase|Withdrawal by Subject|1
5316568|NCT00334737|18312456|P2|Hospital Phase|Withdrawal by Subject|0
5316569|NCT00334737|18312457|P1|Hospital Phase|Withdrawal by Subject|0
5316570|NCT00334737|18312455|P3|Hospital Phase|Death|3
5316571|NCT00334737|18312456|P2|Hospital Phase|Death|2
5316572|NCT00334737|18312457|P1|Hospital Phase|Death|1
5316573|NCT00334542|18312505|P1|Overall Study|New cancer diagnosis|1
5316574|NCT00334542|18312505|P1|Overall Study|Withdrawal by Subject|1
5316575|NCT00334542|18312505|P1|Overall Study|Adverse Event|3
5316576|NCT00334295|18312512|P1|Overall Study|Patients received fewer than 3 injection|5
5316577|NCT00334282|18312522|P2|Overall Study|Death|100
5316578|NCT00334282|18312523|P1|Overall Study|Death|194
5316579|NCT00334282|18312522|P2|Overall Study|Withdrawal by Subject|3
5316580|NCT00334282|18312523|P1|Overall Study|Withdrawal by Subject|17
5316581|NCT00334282|18312522|P2|Overall Study|Lost to Follow-up|5
5316582|NCT00334282|18312523|P1|Overall Study|Lost to Follow-up|11
5316583|NCT00334113|18312554|P2|Overall Study|Withdrawal by Subject|1
5316584|NCT00334113|18312555|P1|Overall Study|Withdrawal by Subject|0
5316585|NCT00334113|18312554|P2|Overall Study|Lost to Follow-up|2
5316586|NCT00334113|18312555|P1|Overall Study|Lost to Follow-up|2
5316587|NCT00333983|18312578|P3|Overall Study|Withdrawal by Subject|1
5316588|NCT00333983|18312579|P2|Overall Study|Withdrawal by Subject|3
5316589|NCT00333983|18312580|P1|Overall Study|Withdrawal by Subject|0
5316590|NCT00333983|18312578|P3|Overall Study|Adverse Event|1
5316591|NCT00333983|18312579|P2|Overall Study|Adverse Event|1
5316592|NCT00333983|18312580|P1|Overall Study|Adverse Event|1
5316593|NCT00333983|18312578|P3|Overall Study|Lost to Follow-up|0
5316594|NCT00333983|18312579|P2|Overall Study|Lost to Follow-up|1
5316595|NCT00333983|18312580|P1|Overall Study|Lost to Follow-up|2
5316596|NCT00333970|18312590|P2|Overall Study|Withdrawal by Subject|7
5316597|NCT00333970|18312591|P1|Overall Study|Withdrawal by Subject|13
5316598|NCT00333866|18312606|P4|Overall Study|Randomized but not Treated|1
5316599|NCT00333866|18312607|P3|Overall Study|Randomized but not Treated|2
5316600|NCT00333866|18312608|P2|Overall Study|Randomized but not Treated|3
5316601|NCT00333866|18312609|P1|Overall Study|Randomized but not Treated|5
5316602|NCT00333866|18312606|P4|Overall Study|Withdrawal by Subject|9
5316603|NCT00333866|18312607|P3|Overall Study|Withdrawal by Subject|4
5316604|NCT00333866|18312608|P2|Overall Study|Withdrawal by Subject|14
5316605|NCT00333866|18312609|P1|Overall Study|Withdrawal by Subject|8
5316606|NCT00333866|18312606|P4|Overall Study|Lost to Follow-up|2
5316607|NCT00333866|18312607|P3|Overall Study|Lost to Follow-up|2
5316608|NCT00333866|18312608|P2|Overall Study|Lost to Follow-up|2
5316609|NCT00333866|18312609|P1|Overall Study|Lost to Follow-up|1
5316610|NCT00333866|18312606|P4|Overall Study|Lack of Efficacy|5
5316611|NCT00333866|18312607|P3|Overall Study|Lack of Efficacy|3
5316612|NCT00333866|18312608|P2|Overall Study|Lack of Efficacy|6
5316613|NCT00333866|18312609|P1|Overall Study|Lack of Efficacy|8
5316614|NCT00333866|18312606|P4|Overall Study|Other|2
5316615|NCT00333866|18312607|P3|Overall Study|Other|2
5316616|NCT00333866|18312608|P2|Overall Study|Other|2
5316617|NCT00333866|18312609|P1|Overall Study|Other|3
5316618|NCT00333866|18312606|P4|Overall Study|Adverse Event|47
5316619|NCT00333866|18312607|P3|Overall Study|Adverse Event|38
5316620|NCT00333866|18312608|P2|Overall Study|Adverse Event|37
5316621|NCT00333866|18312609|P1|Overall Study|Adverse Event|23
5316622|NCT00333840|18312669|P4|Second-line Treatment Period|Death|9
5316623|NCT00333840|18312670|P3|Second-line Treatment Period|Death|0
5316624|NCT00333840|18312671|P2|Second-line Treatment Period|Death|0
5316625|NCT00333840|18312672|P1|Second-line Treatment Period|Death|0
5316626|NCT00333840|18312669|P4|Second-line Treatment Period|Administrative problems|7
5316627|NCT00333840|18312670|P3|Second-line Treatment Period|Administrative problems|0
5316628|NCT00333840|18312671|P2|Second-line Treatment Period|Administrative problems|0
5316629|NCT00333840|18312672|P1|Second-line Treatment Period|Administrative problems|0
5316630|NCT00333840|18312669|P4|Second-line Treatment Period|Lost to Follow-up|6
5316631|NCT00333840|18312670|P3|Second-line Treatment Period|Lost to Follow-up|0
5316632|NCT00333840|18312671|P2|Second-line Treatment Period|Lost to Follow-up|0
5316633|NCT00333840|18312672|P1|Second-line Treatment Period|Lost to Follow-up|0
5316634|NCT00333840|18312669|P4|Second-line Treatment Period|Subject withdrew consent|34
5316635|NCT00333840|18312670|P3|Second-line Treatment Period|Subject withdrew consent|0
5316636|NCT00333840|18312671|P2|Second-line Treatment Period|Subject withdrew consent|0
5316637|NCT00333840|18312672|P1|Second-line Treatment Period|Subject withdrew consent|0
5316638|NCT00333840|18312669|P4|Second-line Treatment Period|Protocol Violation|10
5316639|NCT00333840|18312670|P3|Second-line Treatment Period|Protocol Violation|1
5316640|NCT00333840|18312671|P2|Second-line Treatment Period|Protocol Violation|0
5316641|NCT00333840|18312672|P1|Second-line Treatment Period|Protocol Violation|0
5316642|NCT00333840|18312669|P4|Second-line Treatment Period|No longer required study drug|14
5316643|NCT00333840|18312670|P3|Second-line Treatment Period|No longer required study drug|1
5316644|NCT00333840|18312671|P2|Second-line Treatment Period|No longer required study drug|0
5316645|NCT00333840|18312672|P1|Second-line Treatment Period|No longer required study drug|0
5316646|NCT00333840|18312669|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
5316647|NCT00333840|18312670|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
5316648|NCT00333840|18312671|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
5316649|NCT00333840|18312672|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
5316650|NCT00333840|18312669|P4|Second-line Treatment Period|Abnormal procedure|1
5316651|NCT00333840|18312670|P3|Second-line Treatment Period|Abnormal procedure|0
5316652|NCT00333840|18312671|P2|Second-line Treatment Period|Abnormal procedure|0
5316653|NCT00333840|18312672|P1|Second-line Treatment Period|Abnormal procedure|0
5316654|NCT00333840|18312669|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
5316655|NCT00333840|18312670|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
5316656|NCT00333840|18312671|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
5316657|NCT00333840|18312672|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
5316658|NCT00333840|18312669|P4|Second-line Treatment Period|Adverse Event|34
5316659|NCT00333840|18312670|P3|Second-line Treatment Period|Adverse Event|3
5316660|NCT00333840|18312671|P2|Second-line Treatment Period|Adverse Event|0
5316661|NCT00333840|18312672|P1|Second-line Treatment Period|Adverse Event|0
5316662|NCT00333840|18312669|P4|First-line Treatment Period|Crossed over to other treatment arm|0
5316663|NCT00333840|18312670|P3|First-line Treatment Period|Crossed over to other treatment arm|0
5316664|NCT00333840|18312671|P2|First-line Treatment Period|Crossed over to other treatment arm|363
5316665|NCT00333840|18312672|P1|First-line Treatment Period|Crossed over to other treatment arm|14
5316666|NCT00333840|18312669|P4|First-line Treatment Period|Death|0
5316667|NCT00333840|18312670|P3|First-line Treatment Period|Death|0
5316668|NCT00333840|18312671|P2|First-line Treatment Period|Death|2
5316669|NCT00333840|18312672|P1|First-line Treatment Period|Death|19
5316670|NCT00333840|18312669|P4|First-line Treatment Period|Administrative problems|0
5316671|NCT00333840|18312670|P3|First-line Treatment Period|Administrative problems|0
5316672|NCT00333840|18312671|P2|First-line Treatment Period|Administrative problems|6
5316673|NCT00333840|18312672|P1|First-line Treatment Period|Administrative problems|12
5316674|NCT00333840|18312669|P4|First-line Treatment Period|Lost to Follow-up|0
5316675|NCT00333840|18312670|P3|First-line Treatment Period|Lost to Follow-up|0
5316676|NCT00333840|18312671|P2|First-line Treatment Period|Lost to Follow-up|6
5316677|NCT00333840|18312672|P1|First-line Treatment Period|Lost to Follow-up|15
5316678|NCT00333840|18312669|P4|First-line Treatment Period|Subject withdrew consent|0
5316679|NCT00333840|18312670|P3|First-line Treatment Period|Subject withdrew consent|0
5316680|NCT00333840|18312671|P2|First-line Treatment Period|Subject withdrew consent|77
5316681|NCT00333840|18312672|P1|First-line Treatment Period|Subject withdrew consent|57
5316682|NCT00333840|18312669|P4|First-line Treatment Period|Protocol Violation|0
5316683|NCT00333840|18312670|P3|First-line Treatment Period|Protocol Violation|0
5316684|NCT00333840|18312671|P2|First-line Treatment Period|Protocol Violation|17
5316685|NCT00333840|18312672|P1|First-line Treatment Period|Protocol Violation|17
5316686|NCT00333840|18312669|P4|First-line Treatment Period|No longer required study drug|0
5316687|NCT00333840|18312670|P3|First-line Treatment Period|No longer required study drug|0
5316688|NCT00333840|18312671|P2|First-line Treatment Period|No longer required study drug|8
5316689|NCT00333840|18312672|P1|First-line Treatment Period|No longer required study drug|21
5316690|NCT00333840|18312669|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
5316691|NCT00333840|18312670|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
5316692|NCT00333840|18312671|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
5316693|NCT00333840|18312672|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
5316694|NCT00333840|18312669|P4|First-line Treatment Period|Abnormal procedure|0
5316695|NCT00333840|18312670|P3|First-line Treatment Period|Abnormal procedure|0
5316696|NCT00333840|18312671|P2|First-line Treatment Period|Abnormal procedure|0
5316697|NCT00333840|18312672|P1|First-line Treatment Period|Abnormal procedure|2
5316698|NCT00333840|18312669|P4|First-line Treatment Period|Abnormal laboratory values|0
5316699|NCT00333840|18312670|P3|First-line Treatment Period|Abnormal laboratory values|0
5316700|NCT00333840|18312671|P2|First-line Treatment Period|Abnormal laboratory values|1
5316701|NCT00333840|18312672|P1|First-line Treatment Period|Abnormal laboratory values|3
5316702|NCT00333840|18312669|P4|First-line Treatment Period|Adverse Event|0
5316703|NCT00333840|18312670|P3|First-line Treatment Period|Adverse Event|0
5316704|NCT00333840|18312671|P2|First-line Treatment Period|Adverse Event|37
5316705|NCT00333840|18312672|P1|First-line Treatment Period|Adverse Event|38
5316706|NCT00333801|18312718|P2|Overall Study|Withdrawal by Subject|1
5316707|NCT00333801|18312719|P1|Overall Study|Withdrawal by Subject|0
5316708|NCT00333801|18312718|P2|Overall Study|Incarcerated|2
5316709|NCT00333801|18312719|P1|Overall Study|Incarcerated|1
5316710|NCT00333801|18312718|P2|Overall Study|Lost to Follow-up|0
5316711|NCT00333801|18312719|P1|Overall Study|Lost to Follow-up|2
5316712|NCT00333801|18312718|P2|Overall Study|Moved to another state|3
5316713|NCT00333801|18312719|P1|Overall Study|Moved to another state|5
5316714|NCT00333788|18312737|P1|Overall Study|Other: Signed consent for another study|1
5316715|NCT00333788|18312737|P1|Overall Study|Other: Physician decision|1
5316716|NCT00333788|18312737|P1|Overall Study|Other: Medical monitor decision|1
5316717|NCT00333788|18312737|P1|Overall Study|Other: Subject in need of an Entocort|1
5316718|NCT00333788|18312737|P1|Overall Study|Other: Sponsor decision|1
5316719|NCT00333788|18312737|P1|Overall Study|Other: Quality of life concern|1
5316720|NCT00333788|18312737|P1|Overall Study|Other: Investigator decision|1
5316721|NCT00333788|18312737|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
5316722|NCT00333788|18312737|P1|Overall Study|Other: Moved|2
5316723|NCT00333788|18312737|P1|Overall Study|Other: Non-compliance|2
5316724|NCT00333788|18312737|P1|Overall Study|Withdrawal by Subject|24
5316725|NCT00333788|18312737|P1|Overall Study|Lost to Follow-up|2
5316726|NCT00333788|18312737|P1|Overall Study|Lack of Efficacy|80
5316727|NCT00333788|18312737|P1|Overall Study|Adverse Event|44
5316728|NCT00333775|18312767|P3|Overall Study|Lost to Follow-up|8
5316729|NCT00333775|18312768|P2|Overall Study|Lost to Follow-up|7
5316730|NCT00333775|18312769|P1|Overall Study|Lost to Follow-up|10
5316731|NCT00333775|18312767|P3|Overall Study|In Follow-up When Study Stopped|96
5316732|NCT00333775|18312768|P2|Overall Study|In Follow-up When Study Stopped|92
5316733|NCT00333775|18312769|P1|Overall Study|In Follow-up When Study Stopped|87
5316734|NCT00333775|18312767|P3|Overall Study|Death|143
5316735|NCT00333775|18312768|P2|Overall Study|Death|149
5316736|NCT00333775|18312769|P1|Overall Study|Death|144
5316737|NCT00333619|18312808|P2|Overall Study|Lost to Follow-up|3
5316738|NCT00333619|18312809|P1|Overall Study|Lost to Follow-up|3
5316739|NCT00333619|18312808|P2|Overall Study|Withdrawal by Subject|1
5316740|NCT00333619|18312809|P1|Overall Study|Withdrawal by Subject|6
5316741|NCT00333619|18312808|P2|Overall Study|Death|6
5316742|NCT00333619|18312809|P1|Overall Study|Death|12
5316743|NCT00333359|18312838|P2|Overall Study|Withdrew before Receiving One Dose|6
5316744|NCT00333359|18312839|P1|Overall Study|Withdrew before Receiving One Dose|2
5316745|NCT00333359|18312838|P2|Overall Study|Treatment Failure|8
5316746|NCT00333359|18312839|P1|Overall Study|Treatment Failure|3
5316747|NCT00333359|18312838|P2|Overall Study|Termination or Withdrawal by Sponsor|1
5316748|NCT00333359|18312839|P1|Overall Study|Termination or Withdrawal by Sponsor|1
5316749|NCT00333359|18312838|P2|Overall Study|Lost to Follow-up|25
5316750|NCT00333359|18312839|P1|Overall Study|Lost to Follow-up|15
5316751|NCT00333359|18312838|P2|Overall Study|Protocol Non-compliance|8
5316752|NCT00333359|18312839|P1|Overall Study|Protocol Non-compliance|2
5316753|NCT00333359|18312838|P2|Overall Study|Physician Decision|2
5316754|NCT00333359|18312839|P1|Overall Study|Physician Decision|2
5316755|NCT00333359|18312838|P2|Overall Study|Withdrawal by Subject|37
5316756|NCT00333359|18312839|P1|Overall Study|Withdrawal by Subject|19
5316757|NCT00333359|18312838|P2|Overall Study|Adverse Event|35
5316758|NCT00333359|18312839|P1|Overall Study|Adverse Event|29
5316759|NCT00333229|18312882|P2|Overall Study|Lack of Efficacy|1
5316760|NCT00333229|18312883|P1|Overall Study|Lack of Efficacy|0
5316761|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Death|0
5316762|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Death|1
5316763|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Death|0
5316764|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
5316765|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
5316766|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
5316767|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
5316768|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
5316769|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
5316770|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
5316771|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
5316772|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
5316773|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
5316774|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
5316775|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
5316776|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
5316777|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
5316778|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
5316779|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
5316780|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
5316781|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
5316782|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
5316783|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
5316784|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
5316785|NCT00333138|18312953|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
5316786|NCT00333138|18312954|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
5316787|NCT00333138|18312955|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
5316788|NCT00333138|18312953|P3|Core Study (6 Months)|Laboratory abnormality|1
5316789|NCT00333138|18312954|P2|Core Study (6 Months)|Laboratory abnormality|0
5316790|NCT00333138|18312955|P1|Core Study (6 Months)|Laboratory abnormality|0
5316791|NCT00333138|18312953|P3|Core Study (6 Months)|Protocol Violation|1
5316792|NCT00333138|18312954|P2|Core Study (6 Months)|Protocol Violation|0
5316793|NCT00333138|18312955|P1|Core Study (6 Months)|Protocol Violation|1
5316794|NCT00333138|18312953|P3|Core Study (6 Months)|Lack of Efficacy|0
5316795|NCT00333138|18312954|P2|Core Study (6 Months)|Lack of Efficacy|0
5316796|NCT00333138|18312955|P1|Core Study (6 Months)|Lack of Efficacy|1
5316797|NCT00333138|18312953|P3|Core Study (6 Months)|Withdrawal by Subject|2
5316798|NCT00333138|18312954|P2|Core Study (6 Months)|Withdrawal by Subject|1
5316799|NCT00333138|18312955|P1|Core Study (6 Months)|Withdrawal by Subject|1
5316800|NCT00333138|18312953|P3|Core Study (6 Months)|Adverse Event|8
5316801|NCT00333138|18312954|P2|Core Study (6 Months)|Adverse Event|5
5316802|NCT00333138|18312955|P1|Core Study (6 Months)|Adverse Event|4
5316803|NCT00332839|18312994|P2|Follow-up (Months 12 - 60)|Death|1
5316804|NCT00332839|18312995|P1|Follow-up (Months 12 - 60)|Death|1
5316805|NCT00332839|18312994|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
5316806|NCT00332839|18312995|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
5316807|NCT00332839|18312994|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
5316808|NCT00332839|18312995|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
5316809|NCT00332839|18312994|P2|Core (Months 0 - 12)|Adverse Event|15
5316810|NCT00332839|18312995|P1|Core (Months 0 - 12)|Adverse Event|5
5316811|NCT00332839|18312994|P2|Core (Months 0 - 12)|Protocol deviation|1
5316812|NCT00332839|18312995|P1|Core (Months 0 - 12)|Protocol deviation|1
5316813|NCT00332839|18312994|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
5316814|NCT00332839|18312995|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
5316815|NCT00332839|18312994|P2|Core (Months 0 - 12)|Administrative problems|1
5316816|NCT00332839|18312995|P1|Core (Months 0 - 12)|Administrative problems|1
5316817|NCT00332709|18313026|P2|Overall Study|Abnormal test procedure result|0
5316818|NCT00332709|18313027|P1|Overall Study|Abnormal test procedure result|1
5316819|NCT00332709|18313026|P2|Overall Study|Administrative Problems|3
5316820|NCT00332709|18313027|P1|Overall Study|Administrative Problems|0
5316821|NCT00332709|18313026|P2|Overall Study|Lost to Follow-up|0
5316822|NCT00332709|18313027|P1|Overall Study|Lost to Follow-up|2
5316823|NCT00332709|18313026|P2|Overall Study|Withdrawal by Subject|3
5316824|NCT00332709|18313027|P1|Overall Study|Withdrawal by Subject|2
5316825|NCT00332709|18313026|P2|Overall Study|Adverse Event|14
5316826|NCT00332709|18313027|P1|Overall Study|Adverse Event|11
5316827|NCT00332696|18313051|P2|Overall Study|Withdrawal by Subject|0
5316828|NCT00332696|18313052|P1|Overall Study|Withdrawal by Subject|1
5316829|NCT00332696|18313051|P2|Overall Study|Lost to Follow-up|1
5316830|NCT00332696|18313052|P1|Overall Study|Lost to Follow-up|0
5316831|NCT00332696|18313051|P2|Overall Study|Condition does not justify treatment|2
5316832|NCT00332696|18313052|P1|Overall Study|Condition does not justify treatment|0
5316833|NCT00332696|18313051|P2|Overall Study|Adverse Event|2
5316834|NCT00332696|18313052|P1|Overall Study|Adverse Event|1
5316835|NCT00332696|18313051|P2|Overall Study|Insufficient therapeutic effect|11
5316836|NCT00332696|18313052|P1|Overall Study|Insufficient therapeutic effect|4
5316837|NCT00332696|18313051|P2|Overall Study|Death|14
5316838|NCT00332696|18313052|P1|Overall Study|Death|24
5316839|NCT00332488|18313128|P3|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
5316840|NCT00332488|18313129|P2|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
5316841|NCT00332488|18313130|P1|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
5316842|NCT00332488|18313128|P3|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
5316843|NCT00332488|18313129|P2|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
5316844|NCT00332488|18313130|P1|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
5316845|NCT00332488|18313128|P3|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
5316846|NCT00332488|18313129|P2|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
5316847|NCT00332488|18313130|P1|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
5316848|NCT00332488|18313128|P3|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
5316849|NCT00332488|18313129|P2|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
5316850|NCT00332488|18313130|P1|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
5316851|NCT00332488|18313128|P3|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
5316852|NCT00332488|18313129|P2|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
5316853|NCT00332488|18313130|P1|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
5316854|NCT00332488|18313128|P3|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
5316855|NCT00332488|18313129|P2|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
5316856|NCT00332488|18313130|P1|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
5316857|NCT00332488|18313128|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
5316858|NCT00332488|18313129|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
5316859|NCT00332488|18313130|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
5316860|NCT00332488|18313128|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
5316861|NCT00332488|18313129|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
5316862|NCT00332488|18313130|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
5316863|NCT00332488|18313128|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
5316864|NCT00332488|18313129|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
5316865|NCT00332488|18313130|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
5316866|NCT00332488|18313128|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
5316867|NCT00332488|18313129|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
5316868|NCT00332488|18313130|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
5316869|NCT00332488|18313128|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
5316870|NCT00332488|18313129|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
5316871|NCT00332488|18313130|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
5316872|NCT00332488|18313128|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
5316873|NCT00332488|18313129|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
5316874|NCT00332488|18313130|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
5316875|NCT00332462|18313142|P1|Overall Study|Graft Loss|2
5316876|NCT00332462|18313142|P1|Overall Study|Death|3
5316877|NCT00332462|18313142|P1|Overall Study|no longer requires study drug|1
5316878|NCT00332462|18313142|P1|Overall Study|Unsatisfactory therapeutic effect|4
5316879|NCT00332462|18313142|P1|Overall Study|Abnormal Lab Value|1
5316880|NCT00332462|18313142|P1|Overall Study|Adverse Event|5
5316881|NCT00332332|18313149|P1|Overall Study|Did not receive study treatment|16
5316882|NCT00332332|18313149|P1|Overall Study|Other|18
5316883|NCT00332332|18313149|P1|Overall Study|Disease progression|2
5316884|NCT00332332|18313149|P1|Overall Study|Noncompliance|2
5316885|NCT00332332|18313149|P1|Overall Study|Protocol deviation|4
5316886|NCT00332332|18313149|P1|Overall Study|Lost to Follow-up|3
5316887|NCT00332332|18313149|P1|Overall Study|Physician Decision|1
5316888|NCT00332332|18313149|P1|Overall Study|Withdrawal by Subject|8
5316889|NCT00332332|18313149|P1|Overall Study|Death|1
5316890|NCT00332332|18313149|P1|Overall Study|Adverse Event|13
5316891|NCT00332241|18313158|P2|Overall Study|Lost to Follow-up|1
5316892|NCT00332241|18313159|P1|Overall Study|Lost to Follow-up|4
5316893|NCT00332241|18313158|P2|Overall Study|Withdrawal by Subject|1
5316894|NCT00332241|18313159|P1|Overall Study|Withdrawal by Subject|2
5316895|NCT00332241|18313158|P2|Overall Study|Adverse Event|5
5316896|NCT00332241|18313159|P1|Overall Study|Adverse Event|3
5316897|NCT00332241|18313158|P2|Overall Study|Lack of Efficacy|1
5316898|NCT00332241|18313159|P1|Overall Study|Lack of Efficacy|6
5316899|NCT00332202|18313181|P2|Overall Study|Death|2
5316900|NCT00332202|18313182|P1|Overall Study|Death|5
5316901|NCT00332202|18313181|P2|Overall Study|Progressive Disease|60
5316902|NCT00332202|18313182|P1|Overall Study|Progressive Disease|106
5316903|NCT00332202|18313181|P2|Overall Study|Withdrawal by Subject|17
5316904|NCT00332202|18313182|P1|Overall Study|Withdrawal by Subject|36
5316905|NCT00332202|18313181|P2|Overall Study|Sponsor Decision|2
5316906|NCT00332202|18313182|P1|Overall Study|Sponsor Decision|1
5316907|NCT00332202|18313181|P2|Overall Study|Protocol Violation|2
5316908|NCT00332202|18313182|P1|Overall Study|Protocol Violation|7
5316909|NCT00332202|18313181|P2|Overall Study|Protocol Entry Criteria Not Met|5
5316910|NCT00332202|18313182|P1|Overall Study|Protocol Entry Criteria Not Met|6
5316911|NCT00332202|18313181|P2|Overall Study|Physician Decision|8
5316912|NCT00332202|18313182|P1|Overall Study|Physician Decision|6
5316913|NCT00332202|18313181|P2|Overall Study|Lost to Follow-up|1
5316914|NCT00332202|18313182|P1|Overall Study|Lost to Follow-up|2
5316915|NCT00332202|18313181|P2|Overall Study|Adverse Event|28
5316916|NCT00332202|18313182|P1|Overall Study|Adverse Event|72
5316917|NCT00332189|18313211|P1|Overall Study|Moved out of country|2
5316918|NCT00332189|18313211|P1|Overall Study|Lack of Efficacy|4
5316919|NCT00332189|18313211|P1|Overall Study|Withdrawal by Subject|9
5316920|NCT00332189|18313211|P1|Overall Study|Uncooperative/Noncompliant|3
5316921|NCT00332189|18313211|P1|Overall Study|Adverse Event|3
5316922|NCT00331864|18313253|P2|Overall Study|Death|0
5316923|NCT00331864|18313254|P1|Overall Study|Death|6
5316924|NCT00331864|18313253|P2|Overall Study|Administrative Problems|0
5316925|NCT00331864|18313254|P1|Overall Study|Administrative Problems|1
5316926|NCT00331864|18313253|P2|Overall Study|Lost to Follow-up|3
5316927|NCT00331864|18313254|P1|Overall Study|Lost to Follow-up|4
5316928|NCT00331864|18313253|P2|Overall Study|Withdrawal by Subject|0
5316929|NCT00331864|18313254|P1|Overall Study|Withdrawal by Subject|10
5316930|NCT00331864|18313253|P2|Overall Study|Protocol Violation|0
5316931|NCT00331864|18313254|P1|Overall Study|Protocol Violation|3
5316932|NCT00331864|18313253|P2|Overall Study|Lack of Efficacy|0
5316933|NCT00331864|18313254|P1|Overall Study|Lack of Efficacy|4
5316934|NCT00331864|18313253|P2|Overall Study|Adverse Event|1
5316935|NCT00331864|18313254|P1|Overall Study|Adverse Event|30
5316936|NCT00331799|18313273|P1|Overall Study|Sedation|1
5316937|NCT00331799|18313273|P1|Overall Study|Withdrawal by Subject|2
5316938|NCT00331773|18313279|P2|Overall Study|Protocol Violation|3
5316939|NCT00331773|18313280|P1|Overall Study|Protocol Violation|10
5316940|NCT00331773|18313279|P2|Overall Study|Withdrawal by Subject|4
5316941|NCT00331773|18313280|P1|Overall Study|Withdrawal by Subject|6
5316942|NCT00331760|18313310|P2|Overall Study|Ineligible / no protocol treatment|8
5316943|NCT00331760|18313311|P1|Overall Study|Ineligible / no protocol treatment|15
5316944|NCT00331682|18313332|P1|Overall Study|Adverse Event|1
5316945|NCT00331630|18313338|P1|Follow up for 5 Years|Data collection was stopped|24
5316946|NCT00331630|18313338|P1|Follow up for 5 Years|Death|5
5316947|NCT00331630|18313338|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
5316948|NCT00331630|18313338|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
5316949|NCT00331552|18313350|P2|Period 3: Phase II|Severe Nausea|0
5316950|NCT00331552|18313351|P1|Period 3: Phase II|Severe Nausea|1
5316951|NCT00331552|18313350|P2|Period 3: Phase II|Neurological Symptoms|0
5316952|NCT00331552|18313351|P1|Period 3: Phase II|Neurological Symptoms|1
5316953|NCT00331422|18313365|P1|Overall Study|Did not receive entire study regimen|5
5316954|NCT00331409|18313374|P1|Overall Study|Lack of Efficacy|4
5316955|NCT00331344|18313382|P9|Phase II|Death|4
5316956|NCT00331344|18313383|P8|Phase II|Death|0
5316957|NCT00331344|18313384|P7|Phase II|Death|0
5316958|NCT00331344|18313385|P6|Phase II|Death|0
5316959|NCT00331344|18313386|P5|Phase II|Death|0
5316960|NCT00331344|18313387|P4|Phase II|Death|0
5316961|NCT00331344|18313388|P3|Phase II|Death|0
5316962|NCT00331344|18313389|P2|Phase II|Death|0
5316963|NCT00331344|18313390|P1|Phase II|Death|0
5316964|NCT00331344|18313382|P9|Phase I|Adverse Event|0
5316965|NCT00331344|18313383|P8|Phase I|Adverse Event|1
5316966|NCT00331344|18313384|P7|Phase I|Adverse Event|0
5316967|NCT00331344|18313385|P6|Phase I|Adverse Event|2
5316968|NCT00331344|18313386|P5|Phase I|Adverse Event|2
5316969|NCT00331344|18313387|P4|Phase I|Adverse Event|1
5316970|NCT00331344|18313388|P3|Phase I|Adverse Event|0
5316971|NCT00331344|18313389|P2|Phase I|Adverse Event|0
5316972|NCT00331344|18313390|P1|Phase I|Adverse Event|0
5316973|NCT00331006|18313427|P1|Follow-Up Phase II|Lost to Follow-up|3
5316974|NCT00331006|18313427|P1|Follow-Up Phase I|Lost to Follow-up|1
5316975|NCT00331006|18313427|P1|Treatment Phase|Withdrawal by Subject|1
5316976|NCT00331006|18313427|P1|Screening Phase|Ineligible for treatment phase|4
5316977|NCT00331006|18313427|P1|Screening Phase|Lost to Follow-up|1
5316978|NCT00331006|18313427|P1|Screening Phase|enrollment halted|1
5316979|NCT00331006|18313427|P1|Screening Phase|Withdrawal by Subject|1
5316980|NCT00330967|18313440|P2|Overall Study|Physician Decision|9
5316981|NCT00330967|18313441|P1|Overall Study|Physician Decision|0
5316982|NCT00330967|18313440|P2|Overall Study|Withdrawal by Subject|5
5316983|NCT00330967|18313441|P1|Overall Study|Withdrawal by Subject|0
5316984|NCT00330928|18313452|P1|Overall Study|IVUS could not be performed.|1
5316985|NCT00330928|18313452|P1|Overall Study|Death|1
5316986|NCT00330928|18313452|P1|Overall Study|Physician Decision|9
5316987|NCT00330928|18313452|P1|Overall Study|Lost to Follow-up|6
5316988|NCT00330759|18313494|P2|Overall Study|Other|44
5316989|NCT00330759|18313495|P1|Overall Study|Other|36
5316990|NCT00330759|18313494|P2|Overall Study|Ineligibility determined|1
5316991|NCT00330759|18313495|P1|Overall Study|Ineligibility determined|2
5316992|NCT00330759|18313494|P2|Overall Study|Protocol deviation|2
5316993|NCT00330759|18313495|P1|Overall Study|Protocol deviation|0
5316994|NCT00330759|18313494|P2|Overall Study|Physician Decision|2
5316995|NCT00330759|18313495|P1|Overall Study|Physician Decision|1
5316996|NCT00330759|18313494|P2|Overall Study|Noncompliance|17
5316997|NCT00330759|18313495|P1|Overall Study|Noncompliance|15
5316998|NCT00330759|18313494|P2|Overall Study|Lost to Follow-up|22
5316999|NCT00330759|18313495|P1|Overall Study|Lost to Follow-up|16
5317000|NCT00330759|18313494|P2|Overall Study|Participant request|22
5317001|NCT00330759|18313495|P1|Overall Study|Participant request|31
5317002|NCT00330759|18313494|P2|Overall Study|Adverse Event|36
5317003|NCT00330759|18313495|P1|Overall Study|Adverse Event|48
5317004|NCT00330759|18313494|P2|Overall Study|Withdrawal by Subject|124
5317005|NCT00330759|18313495|P1|Overall Study|Withdrawal by Subject|143
5317006|NCT00330759|18313494|P2|Overall Study|Disease progression|126
5317007|NCT00330759|18313495|P1|Overall Study|Disease progression|104
5317008|NCT00330759|18313494|P2|Overall Study|Death|310
5317009|NCT00330759|18313495|P1|Overall Study|Death|316
5317010|NCT00330681|18313528|P2|Overall Study|Tracheotomy due to worsening of ALS|2
5317011|NCT00330681|18313529|P1|Overall Study|Tracheotomy due to worsening of ALS|1
5317012|NCT00330681|18313528|P2|Overall Study|Withdrawal by Subject|5
5317013|NCT00330681|18313529|P1|Overall Study|Withdrawal by Subject|5
5317014|NCT00330681|18313528|P2|Overall Study|Protocol Violation|1
5317015|NCT00330681|18313529|P1|Overall Study|Protocol Violation|0
5317016|NCT00330681|18313528|P2|Overall Study|Adverse Event|6
5317017|NCT00330681|18313529|P1|Overall Study|Adverse Event|3
5317018|NCT00330668|18313551|P1|QD Dosing Period|Lost to Follow-up|2
5317019|NCT00330668|18313551|P1|QD Dosing Period|Withdrawal by Subject|1
5317020|NCT00330668|18313551|P1|QD Dosing Period|Other|1
5317021|NCT00330668|18313551|P1|QD Dosing Period|Sponsor decision to terminate study|74
5317022|NCT00330668|18313551|P1|BID Dosing Period|Other|3
5317023|NCT00330668|18313551|P1|BID Dosing Period|Sponsor's decision|1
5317024|NCT00330668|18313551|P1|BID Dosing Period|Withdrawal by Subject|19
5317025|NCT00330668|18313551|P1|BID Dosing Period|Non-Compliance|5
5317026|NCT00330668|18313551|P1|BID Dosing Period|Lost to Follow-up|7
5317027|NCT00330668|18313551|P1|BID Dosing Period|Adverse Event|1
5317028|NCT00330616|18313559|P1|Overall Study|Other|1
5317029|NCT00330616|18313559|P1|Overall Study|Withdrawal by Subject|4
5317030|NCT00330616|18313559|P1|Overall Study|Lost to Follow-up|2
5317031|NCT00330616|18313559|P1|Overall Study|Lack of Efficacy|1
5317032|NCT00330616|18313559|P1|Overall Study|Adverse Event|13
5317033|NCT00330460|18313610|P2|Overall Study|Other|0
5317034|NCT00330460|18313611|P1|Overall Study|Other|1
5317035|NCT00330460|18313610|P2|Overall Study|Noncompliance|1
5317036|NCT00330460|18313611|P1|Overall Study|Noncompliance|2
5317037|NCT00330460|18313610|P2|Overall Study|Lost to Follow-up|3
5317038|NCT00330460|18313611|P1|Overall Study|Lost to Follow-up|8
5317039|NCT00330460|18313610|P2|Overall Study|Ineligibility determined|3
5317040|NCT00330460|18313611|P1|Overall Study|Ineligibility determined|1
5317041|NCT00330460|18313610|P2|Overall Study|Death|1
5317042|NCT00330460|18313611|P1|Overall Study|Death|1
5317043|NCT00330460|18313610|P2|Overall Study|Withdrawal by Subject|17
5317044|NCT00330460|18313611|P1|Overall Study|Withdrawal by Subject|18
5317045|NCT00330460|18313610|P2|Overall Study|Adverse Event|8
5317046|NCT00330460|18313611|P1|Overall Study|Adverse Event|10
5317047|NCT00330460|18313610|P2|Overall Study|Physician Decision|0
5317048|NCT00330460|18313611|P1|Overall Study|Physician Decision|1
5317049|NCT00330343|18313654|P1|Overall Study|Lost to Follow-up|5
5317050|NCT00330187|18313662|P4|Overall Study|Withdrawal by Subject|4
5317051|NCT00330187|18313663|P3|Overall Study|Withdrawal by Subject|4
5317052|NCT00330187|18313664|P2|Overall Study|Withdrawal by Subject|5
5317053|NCT00330187|18313665|P1|Overall Study|Withdrawal by Subject|8
5317054|NCT00330187|18313662|P4|Overall Study|Lost to Follow-up|10
5317055|NCT00330187|18313663|P3|Overall Study|Lost to Follow-up|14
5317056|NCT00330187|18313664|P2|Overall Study|Lost to Follow-up|13
5317057|NCT00330187|18313665|P1|Overall Study|Lost to Follow-up|12
5317058|NCT00330174|18313677|P2|Overall Study|Miscellaneous reasons|1
5317059|NCT00330174|18313678|P1|Overall Study|Miscellaneous reasons|7
5317060|NCT00330174|18313677|P2|Overall Study|Excessive missed visits|8
5317061|NCT00330174|18313678|P1|Overall Study|Excessive missed visits|3
5317062|NCT00330174|18313677|P2|Overall Study|Clinical deterioration|2
5317063|NCT00330174|18313678|P1|Overall Study|Clinical deterioration|1
5317064|NCT00330174|18313677|P2|Overall Study|Lost to Follow-up|1
5317065|NCT00330174|18313678|P1|Overall Study|Lost to Follow-up|4
5317066|NCT00330174|18313677|P2|Overall Study|Withdrawal by Subject|7
5317067|NCT00330174|18313678|P1|Overall Study|Withdrawal by Subject|7
5317068|NCT00329901|18313702|P3|Overall Study|Unable to classify|0
5317069|NCT00329901|18313703|P2|Overall Study|Unable to classify|2
5317070|NCT00329901|18313704|P1|Overall Study|Unable to classify|2
5317071|NCT00329901|18313702|P3|Overall Study|Protocol Violation|1
5317072|NCT00329901|18313703|P2|Overall Study|Protocol Violation|0
5317073|NCT00329901|18313704|P1|Overall Study|Protocol Violation|1
5317074|NCT00329901|18313702|P3|Overall Study|Lost to Follow-up|1
5317075|NCT00329901|18313703|P2|Overall Study|Lost to Follow-up|0
5317076|NCT00329901|18313704|P1|Overall Study|Lost to Follow-up|2
5317077|NCT00329901|18313702|P3|Overall Study|Withdrawal by Subject|2
5317078|NCT00329901|18313703|P2|Overall Study|Withdrawal by Subject|3
5317079|NCT00329901|18313704|P1|Overall Study|Withdrawal by Subject|4
5317080|NCT00329849|18313734|P2|Overall Study|Withdrawal by Subject|4
5317081|NCT00329849|18313735|P1|Overall Study|Withdrawal by Subject|6
5317082|NCT00329797|18313761|P2|Overall Study|Withdrawal by Subject|6
5317083|NCT00329797|18313762|P1|Overall Study|Withdrawal by Subject|6
5317084|NCT00329797|18313761|P2|Overall Study|Protocol Violation|0
5317085|NCT00329797|18313762|P1|Overall Study|Protocol Violation|1
5317086|NCT00329784|18313778|P4|Overall Study|Other|0
5317087|NCT00329784|18313779|P3|Overall Study|Other|0
5317088|NCT00329784|18313780|P2|Overall Study|Other|2
5317089|NCT00329784|18313781|P1|Overall Study|Other|1
5317090|NCT00329784|18313778|P4|Overall Study|Withdrawal by Subject|0
5317091|NCT00329784|18313779|P3|Overall Study|Withdrawal by Subject|0
5317092|NCT00329784|18313780|P2|Overall Study|Withdrawal by Subject|2
5317093|NCT00329784|18313781|P1|Overall Study|Withdrawal by Subject|4
5317094|NCT00329784|18313778|P4|Overall Study|Lost to Follow-up|0
5317095|NCT00329784|18313779|P3|Overall Study|Lost to Follow-up|0
5317096|NCT00329784|18313780|P2|Overall Study|Lost to Follow-up|1
5317097|NCT00329784|18313781|P1|Overall Study|Lost to Follow-up|0
5317098|NCT00329745|18313809|P2|Overall Study|Lost to Follow-up|101
5317099|NCT00329745|18313810|P1|Overall Study|Lost to Follow-up|86
5317100|NCT00329745|18313809|P2|Overall Study|Withdrawal by Subject|1
5317101|NCT00329745|18313810|P1|Overall Study|Withdrawal by Subject|0
5317102|NCT00329745|18313809|P2|Overall Study|Protocol Violation|0
5317103|NCT00329745|18313810|P1|Overall Study|Protocol Violation|1
5317104|NCT00329719|18313830|P4|Overall Study|Lost to Follow-up|1
5317105|NCT00329719|18313831|P3|Overall Study|Lost to Follow-up|0
5317106|NCT00329719|18313832|P2|Overall Study|Lost to Follow-up|0
5317107|NCT00329719|18313833|P1|Overall Study|Lost to Follow-up|0
5317108|NCT00329641|18313855|P1|Overall Study|Other reason, not protocol specified|1
5317109|NCT00329641|18313855|P1|Overall Study|Adverse Event|3
5317110|NCT00329641|18313855|P1|Overall Study|Not eligible|1
5317111|NCT00329641|18313855|P1|Overall Study|Did not start treatment|1
5317112|NCT00329602|18313864|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
5317113|NCT00329602|18313865|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
5317114|NCT00329602|18313866|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
5317115|NCT00329602|18313864|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
5317116|NCT00329602|18313865|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
5317117|NCT00329602|18313866|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
5317118|NCT00329602|18313864|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
5317119|NCT00329602|18313865|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
5317120|NCT00329602|18313866|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
5317121|NCT00329602|18313864|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
5317122|NCT00329602|18313865|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
5317123|NCT00329602|18313866|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
5317124|NCT00329602|18313864|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
5317125|NCT00329602|18313865|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
5317126|NCT00329602|18313866|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
5317127|NCT00329602|18313864|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
5317128|NCT00329602|18313865|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
5317129|NCT00329602|18313866|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
5317130|NCT00329550|18313904|P3|Overall Study|Due to Relocation|1
5317131|NCT00329550|18313905|P2|Overall Study|Due to Relocation|0
5317132|NCT00329550|18313906|P1|Overall Study|Due to Relocation|0
5317133|NCT00329550|18313904|P3|Overall Study|Withdrawal of Consent|1
5317134|NCT00329550|18313905|P2|Overall Study|Withdrawal of Consent|0
5317135|NCT00329550|18313906|P1|Overall Study|Withdrawal of Consent|1
5317136|NCT00329550|18313904|P3|Overall Study|Adverse Event|2
5317137|NCT00329550|18313905|P2|Overall Study|Adverse Event|4
5317138|NCT00329550|18313906|P1|Overall Study|Adverse Event|3
5317139|NCT00329420|18314175|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
5317140|NCT00329420|18314176|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
5317141|NCT00329420|18314177|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
5317142|NCT00329420|18314175|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
5317143|NCT00329420|18314176|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
5317144|NCT00329420|18314177|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
5317145|NCT00329420|18314175|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
5317146|NCT00329420|18314176|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
5317147|NCT00329420|18314177|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
5317148|NCT00329420|18314175|P3|Re-induction Phase|Did not respond to re-induction|7
5317149|NCT00329420|18314176|P2|Re-induction Phase|Did not respond to re-induction|5
5317150|NCT00329420|18314177|P1|Re-induction Phase|Did not respond to re-induction|6
5317151|NCT00329420|18314175|P3|Re-induction Phase|Withdrawal of Consent|1
5317152|NCT00329420|18314176|P2|Re-induction Phase|Withdrawal of Consent|0
5317153|NCT00329420|18314177|P1|Re-induction Phase|Withdrawal of Consent|0
5317154|NCT00329420|18314175|P3|Re-induction Phase|Lack of Efficacy|0
5317155|NCT00329420|18314176|P2|Re-induction Phase|Lack of Efficacy|1
5317156|NCT00329420|18314177|P1|Re-induction Phase|Lack of Efficacy|0
5317157|NCT00329407|18314556|P1|Overall Study|Withdrawal by Subject|1
5317158|NCT00329303|18314563|P2|Overall Study|Patient relocated|1
5317159|NCT00329303|18314564|P1|Overall Study|Patient relocated|0
5317160|NCT00329303|18314563|P2|Overall Study|Patient no longer available|0
5317161|NCT00329303|18314564|P1|Overall Study|Patient no longer available|1
5317162|NCT00329303|18314563|P2|Overall Study|Decision of the sponsor|1
5317163|NCT00329303|18314564|P1|Overall Study|Decision of the sponsor|0
5317164|NCT00329303|18314563|P2|Overall Study|Lack of Efficacy|0
5317165|NCT00329303|18314564|P1|Overall Study|Lack of Efficacy|1
5317166|NCT00329238|18314726|P2|Overall Study|Other reason (not specified)|54
5317167|NCT00329238|18314727|P1|Overall Study|Other reason (not specified)|40
5317168|NCT00329238|18314726|P2|Overall Study|Withdrawal by Subject|58
5317169|NCT00329238|18314727|P1|Overall Study|Withdrawal by Subject|64
5317170|NCT00329238|18314726|P2|Overall Study|Lost to Follow-up|6
5317171|NCT00329238|18314727|P1|Overall Study|Lost to Follow-up|2
5317172|NCT00329238|18314726|P2|Overall Study|Protocol Violation|34
5317173|NCT00329238|18314727|P1|Overall Study|Protocol Violation|23
5317174|NCT00329238|18314726|P2|Overall Study|Adverse Event|129
5317175|NCT00329238|18314727|P1|Overall Study|Adverse Event|147
5317176|NCT00329160|18314763|P1|Overall Study|Incomplete IVUS|45
5317177|NCT00329160|18314763|P1|Overall Study|Did not Receive Study Drug|1
5317178|NCT00329160|18314763|P1|Overall Study|Protocol Violation|2
5317179|NCT00329160|18314763|P1|Overall Study|Withdrawal by Subject|13
5317180|NCT00329160|18314763|P1|Overall Study|Adverse Event|27
5317181|NCT00329108|18314772|P2|Overall Study|Protocol Violation|2
5317182|NCT00329108|18314773|P1|Overall Study|Protocol Violation|0
5317183|NCT00329108|18314772|P2|Overall Study|withdrew patient after SAE resolved|0
5317184|NCT00329108|18314773|P1|Overall Study|withdrew patient after SAE resolved|1
5317185|NCT00329108|18314772|P2|Overall Study|study terminated by sponsor|0
5317186|NCT00329108|18314773|P1|Overall Study|study terminated by sponsor|1
5317187|NCT00329108|18314772|P2|Overall Study|Subject no longer willing to participate|2
5317188|NCT00329108|18314773|P1|Overall Study|Subject no longer willing to participate|2
5317189|NCT00329108|18314772|P2|Overall Study|symptomatic deterioration|1
5317190|NCT00329108|18314773|P1|Overall Study|symptomatic deterioration|1
5317191|NCT00329108|18314772|P2|Overall Study|Withdrawal by Subject|2
5317192|NCT00329108|18314773|P1|Overall Study|Withdrawal by Subject|0
5317193|NCT00329108|18314772|P2|Overall Study|Lack of Efficacy|3
5317194|NCT00329108|18314773|P1|Overall Study|Lack of Efficacy|3
5317195|NCT00329108|18314772|P2|Overall Study|Adverse Event|2
5317196|NCT00329108|18314773|P1|Overall Study|Adverse Event|2
5317197|NCT00329030|18314781|P2|Overall Study|Ineligible Pathology|1
5317198|NCT00329030|18314782|P1|Overall Study|Ineligible Pathology|1
5317199|NCT00329030|18314781|P2|Overall Study|Progressive Disease|2
5317200|NCT00329030|18314782|P1|Overall Study|Progressive Disease|6
5317201|NCT00329030|18314781|P2|Overall Study|Withdrawal by Subject|3
5317202|NCT00329030|18314782|P1|Overall Study|Withdrawal by Subject|1
5317203|NCT00328926|18314813|P3|Overall Study|Lack of ovarian response|0
5317204|NCT00328926|18314814|P2|Overall Study|Lack of ovarian response|1
5317205|NCT00328926|18314815|P1|Overall Study|Lack of ovarian response|0
5317206|NCT00328926|18314813|P3|Overall Study|In vitro fertilization treatment|1
5317207|NCT00328926|18314814|P2|Overall Study|In vitro fertilization treatment|0
5317208|NCT00328926|18314815|P1|Overall Study|In vitro fertilization treatment|0
5317209|NCT00328926|18314813|P3|Overall Study|Death|1
5317210|NCT00328926|18314814|P2|Overall Study|Death|0
5317211|NCT00328926|18314815|P1|Overall Study|Death|0
5317212|NCT00328926|18314813|P3|Overall Study|Lost to Follow-up|0
5317213|NCT00328926|18314814|P2|Overall Study|Lost to Follow-up|1
5317214|NCT00328926|18314815|P1|Overall Study|Lost to Follow-up|0
5317215|NCT00328926|18314813|P3|Overall Study|Pregnancy|0
5317216|NCT00328926|18314814|P2|Overall Study|Pregnancy|1
5317217|NCT00328926|18314815|P1|Overall Study|Pregnancy|2
5317218|NCT00328783|18314840|P1|Overall Study|Withdrawal by Subject|1
5317219|NCT00328783|18314840|P1|Overall Study|No heart in RT field|4
5317220|NCT00328783|18314840|P1|Overall Study|Could not tolerate ABC|21
5317221|NCT00328627|18314866|P12|Overall Study|Other|0
5317222|NCT00328627|18314867|P11|Overall Study|Other|1
5317223|NCT00328627|18314868|P10|Overall Study|Other|1
5317224|NCT00328627|18314869|P9|Overall Study|Other|0
5317225|NCT00328627|18314870|P8|Overall Study|Other|0
5317226|NCT00328627|18314871|P7|Overall Study|Other|1
5317227|NCT00328627|18314872|P6|Overall Study|Other|0
5317228|NCT00328627|18314873|P5|Overall Study|Other|0
5317229|NCT00328627|18314874|P4|Overall Study|Other|1
5317230|NCT00328627|18314875|P3|Overall Study|Other|0
5317231|NCT00328627|18314876|P2|Overall Study|Other|0
5317232|NCT00328627|18314877|P1|Overall Study|Other|0
5317233|NCT00328627|18314866|P12|Overall Study|Physician Decision|0
5317234|NCT00328627|18314867|P11|Overall Study|Physician Decision|1
5317235|NCT00328627|18314868|P10|Overall Study|Physician Decision|2
5317236|NCT00328627|18314869|P9|Overall Study|Physician Decision|3
5317237|NCT00328627|18314870|P8|Overall Study|Physician Decision|0
5317238|NCT00328627|18314871|P7|Overall Study|Physician Decision|1
5317239|NCT00328627|18314872|P6|Overall Study|Physician Decision|1
5317240|NCT00328627|18314873|P5|Overall Study|Physician Decision|1
5317241|NCT00328627|18314874|P4|Overall Study|Physician Decision|2
5317242|NCT00328627|18314875|P3|Overall Study|Physician Decision|1
5317243|NCT00328627|18314876|P2|Overall Study|Physician Decision|3
5317244|NCT00328627|18314877|P1|Overall Study|Physician Decision|4
5317245|NCT00328627|18314866|P12|Overall Study|Pregnancy|0
5317246|NCT00328627|18314867|P11|Overall Study|Pregnancy|0
5317247|NCT00328627|18314868|P10|Overall Study|Pregnancy|0
5317248|NCT00328627|18314869|P9|Overall Study|Pregnancy|0
5317249|NCT00328627|18314870|P8|Overall Study|Pregnancy|0
5317250|NCT00328627|18314871|P7|Overall Study|Pregnancy|0
5317251|NCT00328627|18314872|P6|Overall Study|Pregnancy|0
5317252|NCT00328627|18314873|P5|Overall Study|Pregnancy|0
5317253|NCT00328627|18314874|P4|Overall Study|Pregnancy|0
5317254|NCT00328627|18314875|P3|Overall Study|Pregnancy|0
5317255|NCT00328627|18314876|P2|Overall Study|Pregnancy|1
5317256|NCT00328627|18314877|P1|Overall Study|Pregnancy|0
5317257|NCT00328627|18314866|P12|Overall Study|Withdrawal by Subject|7
5317258|NCT00328627|18314867|P11|Overall Study|Withdrawal by Subject|2
5317259|NCT00328627|18314868|P10|Overall Study|Withdrawal by Subject|5
5317260|NCT00328627|18314869|P9|Overall Study|Withdrawal by Subject|4
5317261|NCT00328627|18314870|P8|Overall Study|Withdrawal by Subject|4
5317262|NCT00328627|18314871|P7|Overall Study|Withdrawal by Subject|4
5317263|NCT00328627|18314872|P6|Overall Study|Withdrawal by Subject|5
5317264|NCT00328627|18314873|P5|Overall Study|Withdrawal by Subject|2
5317265|NCT00328627|18314874|P4|Overall Study|Withdrawal by Subject|6
5317266|NCT00328627|18314875|P3|Overall Study|Withdrawal by Subject|5
5317267|NCT00328627|18314876|P2|Overall Study|Withdrawal by Subject|4
5317268|NCT00328627|18314877|P1|Overall Study|Withdrawal by Subject|5
5317269|NCT00328627|18314866|P12|Overall Study|Lost to Follow-up|1
5317270|NCT00328627|18314867|P11|Overall Study|Lost to Follow-up|0
5317271|NCT00328627|18314868|P10|Overall Study|Lost to Follow-up|2
5317272|NCT00328627|18314869|P9|Overall Study|Lost to Follow-up|3
5317273|NCT00328627|18314870|P8|Overall Study|Lost to Follow-up|0
5317274|NCT00328627|18314871|P7|Overall Study|Lost to Follow-up|3
5317275|NCT00328627|18314872|P6|Overall Study|Lost to Follow-up|2
5317276|NCT00328627|18314873|P5|Overall Study|Lost to Follow-up|0
5317277|NCT00328627|18314874|P4|Overall Study|Lost to Follow-up|4
5317278|NCT00328627|18314875|P3|Overall Study|Lost to Follow-up|2
5317279|NCT00328627|18314876|P2|Overall Study|Lost to Follow-up|2
5317280|NCT00328627|18314877|P1|Overall Study|Lost to Follow-up|4
5317281|NCT00328627|18314866|P12|Overall Study|Protocol Violation|2
5317282|NCT00328627|18314867|P11|Overall Study|Protocol Violation|6
5317283|NCT00328627|18314868|P10|Overall Study|Protocol Violation|4
5317284|NCT00328627|18314869|P9|Overall Study|Protocol Violation|1
5317285|NCT00328627|18314870|P8|Overall Study|Protocol Violation|2
5317286|NCT00328627|18314871|P7|Overall Study|Protocol Violation|6
5317287|NCT00328627|18314872|P6|Overall Study|Protocol Violation|5
5317288|NCT00328627|18314873|P5|Overall Study|Protocol Violation|5
5317289|NCT00328627|18314874|P4|Overall Study|Protocol Violation|8
5317290|NCT00328627|18314875|P3|Overall Study|Protocol Violation|2
5317291|NCT00328627|18314876|P2|Overall Study|Protocol Violation|2
5317292|NCT00328627|18314877|P1|Overall Study|Protocol Violation|2
5317293|NCT00328627|18314866|P12|Overall Study|Adverse Event|4
5317294|NCT00328627|18314867|P11|Overall Study|Adverse Event|5
5317295|NCT00328627|18314868|P10|Overall Study|Adverse Event|7
5317296|NCT00328627|18314869|P9|Overall Study|Adverse Event|0
5317297|NCT00328627|18314870|P8|Overall Study|Adverse Event|2
5317298|NCT00328627|18314871|P7|Overall Study|Adverse Event|1
5317299|NCT00328627|18314872|P6|Overall Study|Adverse Event|2
5317300|NCT00328627|18314873|P5|Overall Study|Adverse Event|1
5317301|NCT00328627|18314874|P4|Overall Study|Adverse Event|3
5317302|NCT00328627|18314875|P3|Overall Study|Adverse Event|2
5317303|NCT00328627|18314876|P2|Overall Study|Adverse Event|1
5317304|NCT00328627|18314877|P1|Overall Study|Adverse Event|3
5317305|NCT00328627|18314866|P12|Overall Study|Hyperglycemic Rescue|2
5317306|NCT00328627|18314867|P11|Overall Study|Hyperglycemic Rescue|3
5317307|NCT00328627|18314868|P10|Overall Study|Hyperglycemic Rescue|11
5317308|NCT00328627|18314869|P9|Overall Study|Hyperglycemic Rescue|6
5317309|NCT00328627|18314870|P8|Overall Study|Hyperglycemic Rescue|6
5317310|NCT00328627|18314871|P7|Overall Study|Hyperglycemic Rescue|19
5317311|NCT00328627|18314872|P6|Overall Study|Hyperglycemic Rescue|5
5317312|NCT00328627|18314873|P5|Overall Study|Hyperglycemic Rescue|6
5317313|NCT00328627|18314874|P4|Overall Study|Hyperglycemic Rescue|13
5317314|NCT00328627|18314875|P3|Overall Study|Hyperglycemic Rescue|16
5317315|NCT00328627|18314876|P2|Overall Study|Hyperglycemic Rescue|18
5317316|NCT00328627|18314877|P1|Overall Study|Hyperglycemic Rescue|41
5317317|NCT00328562|18316414|P1|Overall Study|Disease progression|1
5317318|NCT00328510|18316423|P2|Overall Study|Treatment changed to a single fraction|1
5317319|NCT00328510|18316424|P1|Overall Study|Treatment changed to a single fraction|1
5317320|NCT00328510|18316423|P2|Overall Study|Severe kyphosis, could not use mask|1
5317321|NCT00328510|18316424|P1|Overall Study|Severe kyphosis, could not use mask|0
5317322|NCT00328510|18316423|P2|Overall Study|Withdrawal by Subject|2
5317323|NCT00328510|18316424|P1|Overall Study|Withdrawal by Subject|4
5317324|NCT00328510|18316423|P2|Overall Study|Dentition problems, could not use frame|0
5317325|NCT00328510|18316424|P1|Overall Study|Dentition problems, could not use frame|1
5317326|NCT00328510|18316423|P2|Overall Study|Gag disorder, could not use frame|0
5317327|NCT00328510|18316424|P1|Overall Study|Gag disorder, could not use frame|4
5317328|NCT00328198|18316439|P1|Follow-up|Death|31
5317329|NCT00328198|18316439|P1|Follow-up|Lost to Follow-up|4
5317330|NCT00328198|18316439|P1|Treatment|Confirmed complete response, MRD -|3
5317331|NCT00328198|18316439|P1|Treatment|Non-compliance|1
5317332|NCT00328198|18316439|P1|Treatment|Evidence of disease progression|2
5317333|NCT00328198|18316439|P1|Treatment|Withdrawal by Subject|5
5317334|NCT00328198|18316439|P1|Treatment|Physician Decision|5
5317335|NCT00328198|18316439|P1|Treatment|Death|1
5317336|NCT00328198|18316439|P1|Treatment|Adverse Event|21
5317337|NCT00328172|18316454|P5|Overall Study|Other reason (not specified)|0
5317338|NCT00328172|18316455|P4|Overall Study|Other reason (not specified)|0
5317339|NCT00328172|18316456|P3|Overall Study|Other reason (not specified)|1
5317340|NCT00328172|18316457|P2|Overall Study|Other reason (not specified)|0
5317341|NCT00328172|18316458|P1|Overall Study|Other reason (not specified)|3
5317342|NCT00328172|18316454|P5|Overall Study|Lack of Efficacy|3
5317343|NCT00328172|18316455|P4|Overall Study|Lack of Efficacy|4
5317344|NCT00328172|18316456|P3|Overall Study|Lack of Efficacy|4
5317345|NCT00328172|18316457|P2|Overall Study|Lack of Efficacy|9
5317346|NCT00328172|18316458|P1|Overall Study|Lack of Efficacy|14
5317347|NCT00328172|18316454|P5|Overall Study|Withdrawal by Subject|0
5317348|NCT00328172|18316455|P4|Overall Study|Withdrawal by Subject|6
5317349|NCT00328172|18316456|P3|Overall Study|Withdrawal by Subject|1
5317350|NCT00328172|18316457|P2|Overall Study|Withdrawal by Subject|1
5317351|NCT00328172|18316458|P1|Overall Study|Withdrawal by Subject|1
5317352|NCT00328172|18316454|P5|Overall Study|Lost to Follow-up|1
5317353|NCT00328172|18316455|P4|Overall Study|Lost to Follow-up|1
5317354|NCT00328172|18316456|P3|Overall Study|Lost to Follow-up|2
5317355|NCT00328172|18316457|P2|Overall Study|Lost to Follow-up|1
5317356|NCT00328172|18316458|P1|Overall Study|Lost to Follow-up|1
5317357|NCT00328172|18316454|P5|Overall Study|Protocol Violation|0
5317358|NCT00328172|18316455|P4|Overall Study|Protocol Violation|0
5317359|NCT00328172|18316456|P3|Overall Study|Protocol Violation|1
5317360|NCT00328172|18316457|P2|Overall Study|Protocol Violation|1
5317361|NCT00328172|18316458|P1|Overall Study|Protocol Violation|0
5317362|NCT00328172|18316454|P5|Overall Study|Adverse Event|1
5317363|NCT00328172|18316455|P4|Overall Study|Adverse Event|2
5317364|NCT00328172|18316456|P3|Overall Study|Adverse Event|1
5317365|NCT00328172|18316457|P2|Overall Study|Adverse Event|2
5317366|NCT00328172|18316458|P1|Overall Study|Adverse Event|3
5317367|NCT00328094|18316482|P2|Overall Study|Physician Decision|3
5317368|NCT00328094|18316483|P1|Overall Study|Physician Decision|3
5317369|NCT00327717|18316517|P2|Overall Study|Withdrawal by Subject|7
5317370|NCT00327717|18316518|P1|Overall Study|Withdrawal by Subject|3
5317371|NCT00327717|18316517|P2|Overall Study|Lack of Efficacy|1
5317372|NCT00327717|18316518|P1|Overall Study|Lack of Efficacy|0
5317373|NCT00327717|18316517|P2|Overall Study|Adverse Event|6
5317374|NCT00327717|18316518|P1|Overall Study|Adverse Event|6
5317375|NCT00327470|18316544|P2|Overall Study|Death|4
5317376|NCT00327470|18316545|P1|Overall Study|Death|1
5317377|NCT00327470|18316544|P2|Overall Study|Withdrawal by Subject|12
5317378|NCT00327470|18316545|P1|Overall Study|Withdrawal by Subject|6
5317379|NCT00327470|18316544|P2|Overall Study|Lost to Follow-up|3
5317380|NCT00327470|18316545|P1|Overall Study|Lost to Follow-up|1
5317381|NCT00327470|18316544|P2|Overall Study|Other|9
5317382|NCT00327470|18316545|P1|Overall Study|Other|5
5317383|NCT00327470|18316544|P2|Overall Study|Lack of Efficacy|19
5317384|NCT00327470|18316545|P1|Overall Study|Lack of Efficacy|7
5317385|NCT00327470|18316544|P2|Overall Study|Adverse Event|14
5317386|NCT00327470|18316545|P1|Overall Study|Adverse Event|9
5317387|NCT00327470|18316544|P2|Overall Study|Randomized, but not treated|2
5317388|NCT00327470|18316545|P1|Overall Study|Randomized, but not treated|0
5317389|NCT00327444|18316565|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
5317390|NCT00327444|18316566|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
5317391|NCT00327444|18316565|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
5317392|NCT00327444|18316566|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
5317393|NCT00327444|18316565|P2|Open Label Treatment (OL) Period|Adverse Event|2
5317394|NCT00327444|18316566|P1|Open Label Treatment (OL) Period|Adverse Event|2
5317395|NCT00327444|18316565|P2|Open Label Treatment (OL) Period|Disease progression|7
5317396|NCT00327444|18316566|P1|Open Label Treatment (OL) Period|Disease progression|8
5317397|NCT00327444|18316565|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
5317398|NCT00327444|18316566|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
5317399|NCT00327444|18316565|P2|Double Blind Treatment (DB) Period|Subject request|1
5317400|NCT00327444|18316566|P1|Double Blind Treatment (DB) Period|Subject request|0
5317401|NCT00327444|18316565|P2|Double Blind Treatment (DB) Period|Adverse Event|5
5317402|NCT00327444|18316566|P1|Double Blind Treatment (DB) Period|Adverse Event|5
5317403|NCT00327444|18316565|P2|Double Blind Treatment (DB) Period|Disease progression|13
5317404|NCT00327444|18316566|P1|Double Blind Treatment (DB) Period|Disease progression|10
5317405|NCT00327340|18316584|P2|Overall Study|Adverse Event|3
5317406|NCT00327340|18316585|P1|Overall Study|Adverse Event|3
5317407|NCT00327340|18316584|P2|Overall Study|Symptomatic Disease|2
5317408|NCT00327340|18316585|P1|Overall Study|Symptomatic Disease|0
5317409|NCT00327340|18316584|P2|Overall Study|Disease Progression|19
5317410|NCT00327340|18316585|P1|Overall Study|Disease Progression|10
5317411|NCT00327340|18316584|P2|Overall Study|Physician Decision|1
5317412|NCT00327340|18316585|P1|Overall Study|Physician Decision|1
5317413|NCT00327340|18316584|P2|Overall Study|Withdrawal by Subject|5
5317414|NCT00327340|18316585|P1|Overall Study|Withdrawal by Subject|1
5317415|NCT00327171|18316599|P2|Overall Study|Other|0
5317416|NCT00327171|18316600|P1|Overall Study|Other|1
5317417|NCT00327171|18316599|P2|Overall Study|Undisclosed history of ischemia|1
5317418|NCT00327171|18316600|P1|Overall Study|Undisclosed history of ischemia|0
5317419|NCT00327171|18316599|P2|Overall Study|Clinical progression|8
5317420|NCT00327171|18316600|P1|Overall Study|Clinical progression|12
5317421|NCT00327171|18316599|P2|Overall Study|Investigator/participant request|8
5317422|NCT00327171|18316600|P1|Overall Study|Investigator/participant request|1
5317423|NCT00327171|18316599|P2|Overall Study|Disease progression/lack of efficacy|69
5317424|NCT00327171|18316600|P1|Overall Study|Disease progression/lack of efficacy|68
5317425|NCT00327171|18316599|P2|Overall Study|Adverse Event|23
5317426|NCT00327171|18316600|P1|Overall Study|Adverse Event|23
5317427|NCT00327171|18316599|P2|Overall Study|Did not receive study medication|0
5317428|NCT00327171|18316600|P1|Overall Study|Did not receive study medication|3
5317429|NCT00327015|18316632|P4|Overall Study|Administrative Reason by Sponsor|1
5317430|NCT00327015|18316633|P3|Overall Study|Administrative Reason by Sponsor|2
5317431|NCT00327015|18316634|P2|Overall Study|Administrative Reason by Sponsor|2
5317432|NCT00327015|18316635|P1|Overall Study|Administrative Reason by Sponsor|1
5317433|NCT00327015|18316632|P4|Overall Study|Pregnancy|1
5317434|NCT00327015|18316633|P3|Overall Study|Pregnancy|1
5317435|NCT00327015|18316634|P2|Overall Study|Pregnancy|2
5317436|NCT00327015|18316635|P1|Overall Study|Pregnancy|0
5317437|NCT00327015|18316632|P4|Overall Study|Death|3
5317438|NCT00327015|18316633|P3|Overall Study|Death|2
5317439|NCT00327015|18316634|P2|Overall Study|Death|2
5317440|NCT00327015|18316635|P1|Overall Study|Death|1
5317441|NCT00327015|18316632|P4|Overall Study|Physician Decision|2
5317442|NCT00327015|18316633|P3|Overall Study|Physician Decision|3
5317443|NCT00327015|18316634|P2|Overall Study|Physician Decision|1
5317444|NCT00327015|18316635|P1|Overall Study|Physician Decision|0
5317445|NCT00327015|18316632|P4|Overall Study|Poor/Noncompliance|5
5317446|NCT00327015|18316633|P3|Overall Study|Poor/Noncompliance|4
5317447|NCT00327015|18316634|P2|Overall Study|Poor/Noncompliance|8
5317448|NCT00327015|18316635|P1|Overall Study|Poor/Noncompliance|11
5317449|NCT00327015|18316632|P4|Overall Study|Subject no longer meets study criteria|7
5317450|NCT00327015|18316633|P3|Overall Study|Subject no longer meets study criteria|8
5317451|NCT00327015|18316634|P2|Overall Study|Subject no longer meets study criteria|2
5317452|NCT00327015|18316635|P1|Overall Study|Subject no longer meets study criteria|4
5317453|NCT00327015|18316632|P4|Overall Study|Adverse Event|14
5317454|NCT00327015|18316633|P3|Overall Study|Adverse Event|14
5317455|NCT00327015|18316634|P2|Overall Study|Adverse Event|10
5317456|NCT00327015|18316635|P1|Overall Study|Adverse Event|14
5317457|NCT00327015|18316632|P4|Overall Study|Lost to Follow-up|22
5317458|NCT00327015|18316633|P3|Overall Study|Lost to Follow-up|29
5317459|NCT00327015|18316634|P2|Overall Study|Lost to Follow-up|23
5317460|NCT00327015|18316635|P1|Overall Study|Lost to Follow-up|22
5317461|NCT00327015|18316632|P4|Overall Study|Withdrawal of Consent by Subject|25
5317462|NCT00327015|18316633|P3|Overall Study|Withdrawal of Consent by Subject|28
5317463|NCT00327015|18316634|P2|Overall Study|Withdrawal of Consent by Subject|24
5317464|NCT00327015|18316635|P1|Overall Study|Withdrawal of Consent by Subject|20
5317465|NCT00327015|18316632|P4|Overall Study|Lack of Efficacy|29
5317466|NCT00327015|18316633|P3|Overall Study|Lack of Efficacy|35
5317467|NCT00327015|18316634|P2|Overall Study|Lack of Efficacy|18
5317468|NCT00327015|18316635|P1|Overall Study|Lack of Efficacy|18
5317469|NCT00326963|18316677|P1|Overall Study|Administrative / other|1
5317470|NCT00326963|18316677|P1|Overall Study|Other protocol violation|1
5317471|NCT00326963|18316677|P1|Overall Study|Violation of selection criteria at entry|2
5317472|NCT00326963|18316677|P1|Overall Study|Refused treatment / did not cooperate|5
5317473|NCT00326963|18316677|P1|Overall Study|Withdrawal by Subject|10
5317474|NCT00326963|18316677|P1|Overall Study|Failure to return|10
5317475|NCT00326963|18316677|P1|Overall Study|Death|1
5317476|NCT00326963|18316677|P1|Overall Study|Injection site reaction|1
5317477|NCT00326963|18316677|P1|Overall Study|Adverse Event|2
5317478|NCT00326950|18316697|P1|Overall Study|Progressive Disease|1
5317479|NCT00326911|18316719|P2|Overall Study|Withdrawal by subject prior to treatment|1
5317480|NCT00326911|18316720|P1|Overall Study|Withdrawal by subject prior to treatment|0
5317481|NCT00326911|18316719|P2|Overall Study|Physician decision prior to treatment|0
5317482|NCT00326911|18316720|P1|Overall Study|Physician decision prior to treatment|1
5317483|NCT00326911|18316719|P2|Overall Study|Hospitalization prior to treatment|1
5317484|NCT00326911|18316720|P1|Overall Study|Hospitalization prior to treatment|0
5317485|NCT00326898|18316773|P3|Overall Study|Other/Missing/Unknown|32
5317486|NCT00326898|18316774|P2|Overall Study|Other/Missing/Unknown|28
5317487|NCT00326898|18316775|P1|Overall Study|Other/Missing/Unknown|33
5317488|NCT00326898|18316773|P3|Overall Study|Other complicating disease|4
5317489|NCT00326898|18316774|P2|Overall Study|Other complicating disease|5
5317490|NCT00326898|18316775|P1|Overall Study|Other complicating disease|5
5317491|NCT00326898|18316773|P3|Overall Study|Alternative therapy|0
5317492|NCT00326898|18316774|P2|Overall Study|Alternative therapy|0
5317493|NCT00326898|18316775|P1|Overall Study|Alternative therapy|1
5317494|NCT00326898|18316773|P3|Overall Study|Withdrawal by Subject|32
5317495|NCT00326898|18316774|P2|Overall Study|Withdrawal by Subject|128
5317496|NCT00326898|18316775|P1|Overall Study|Withdrawal by Subject|134
5317497|NCT00326898|18316773|P3|Overall Study|Death|0
5317498|NCT00326898|18316774|P2|Overall Study|Death|0
5317499|NCT00326898|18316775|P1|Overall Study|Death|2
5317500|NCT00326898|18316773|P3|Overall Study|Adverse Event|33
5317501|NCT00326898|18316774|P2|Overall Study|Adverse Event|128
5317502|NCT00326898|18316775|P1|Overall Study|Adverse Event|124
5317503|NCT00326898|18316773|P3|Overall Study|Disease progression|102
5317504|NCT00326898|18316774|P2|Overall Study|Disease progression|54
5317505|NCT00326898|18316775|P1|Overall Study|Disease progression|52
5317506|NCT00326885|18316792|P1|Overall Study|Hospice withdrew consent|2
5317507|NCT00326885|18316792|P1|Overall Study|Physician Decision|1
5317508|NCT00326885|18316792|P1|Overall Study|Withdrawal by Subject|3
5317509|NCT00326885|18316792|P1|Overall Study|Adverse Event|1
5317510|NCT00326716|18316823|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
5317511|NCT00326716|18316824|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
5317512|NCT00326716|18316825|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
5317513|NCT00326716|18316826|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
5317514|NCT00326612|18316898|P2|Overall Study|They did not have a seizure requiring tx|137
5317515|NCT00326612|18316899|P1|Overall Study|They did not have a seizure requiring tx|129
5317516|NCT00326599|18316921|P4|Overall Study|Other Unspecified Reason|1
5317517|NCT00326599|18316922|P3|Overall Study|Other Unspecified Reason|2
5317518|NCT00326599|18316923|P2|Overall Study|Other Unspecified Reason|0
5317519|NCT00326599|18316924|P1|Overall Study|Other Unspecified Reason|0
5317520|NCT00326599|18316921|P4|Overall Study|Death|2
5317521|NCT00326599|18316922|P3|Overall Study|Death|1
5317522|NCT00326599|18316923|P2|Overall Study|Death|0
5317523|NCT00326599|18316924|P1|Overall Study|Death|0
5317524|NCT00326599|18316921|P4|Overall Study|Alternate Treatment|0
5317525|NCT00326599|18316922|P3|Overall Study|Alternate Treatment|0
5317526|NCT00326599|18316923|P2|Overall Study|Alternate Treatment|0
5317527|NCT00326599|18316924|P1|Overall Study|Alternate Treatment|1
5317528|NCT00326599|18316921|P4|Overall Study|Disease Progression|11
5317529|NCT00326599|18316922|P3|Overall Study|Disease Progression|13
5317530|NCT00326599|18316923|P2|Overall Study|Disease Progression|1
5317531|NCT00326599|18316924|P1|Overall Study|Disease Progression|3
5317532|NCT00326599|18316921|P4|Overall Study|Adverse Event|3
5317533|NCT00326599|18316922|P3|Overall Study|Adverse Event|32
5317534|NCT00326599|18316923|P2|Overall Study|Adverse Event|0
5317535|NCT00326599|18316924|P1|Overall Study|Adverse Event|1
5317536|NCT00326599|18316921|P4|Overall Study|Withdrawal by Subject|2
5317537|NCT00326599|18316922|P3|Overall Study|Withdrawal by Subject|5
5317538|NCT00326599|18316923|P2|Overall Study|Withdrawal by Subject|0
5317539|NCT00326599|18316924|P1|Overall Study|Withdrawal by Subject|1
5317540|NCT00326495|18316943|P1|Overall Study|Subject off study before assessment|1
5317541|NCT00326495|18316943|P1|Overall Study|Refused further treatment|2
5317542|NCT00326495|18316943|P1|Overall Study|Disease progression before treatment|1
5317543|NCT00326495|18316943|P1|Overall Study|Switched to alternative treatment|1
5317544|NCT00326417|18316950|P4|Overall Study|Death|0
5317545|NCT00326417|18316951|P3|Overall Study|Death|0
5317546|NCT00326417|18316952|P2|Overall Study|Death|0
5317547|NCT00326417|18316953|P1|Overall Study|Death|7
5317548|NCT00326417|18316950|P4|Overall Study|Arm Closed|3
5317549|NCT00326417|18316951|P3|Overall Study|Arm Closed|0
5317550|NCT00326417|18316952|P2|Overall Study|Arm Closed|0
5317551|NCT00326417|18316953|P1|Overall Study|Arm Closed|7
5317552|NCT00326417|18316950|P4|Overall Study|Withdrawal by Subject|0
5317553|NCT00326417|18316951|P3|Overall Study|Withdrawal by Subject|1
5317554|NCT00326417|18316952|P2|Overall Study|Withdrawal by Subject|0
5317555|NCT00326417|18316953|P1|Overall Study|Withdrawal by Subject|0
5317556|NCT00326209|18316969|P1|Overall Study|Pregnancy|1
5317557|NCT00326209|18316969|P1|Overall Study|Withdrawn in error|1
5317558|NCT00326209|18316969|P1|Overall Study|Violation of entry criteria|1
5317559|NCT00326209|18316969|P1|Overall Study|Prohibited medication use|1
5317560|NCT00326209|18316969|P1|Overall Study|Sponsor closed study|173
5317561|NCT00326209|18316969|P1|Overall Study|Participant non-compliant|6
5317562|NCT00326209|18316969|P1|Overall Study|Lost to Follow-up|18
5317563|NCT00326209|18316969|P1|Overall Study|Lack of Efficacy|31
5317564|NCT00326209|18316969|P1|Overall Study|Withdrawal by Subject|22
5317565|NCT00326209|18316969|P1|Overall Study|Adverse Event|28
5317566|NCT00326183|18316987|P2|Overall Study|Adverse Event|0
5317567|NCT00326183|18316988|P1|Overall Study|Adverse Event|1
5317568|NCT00326183|18316987|P2|Overall Study|Other|13
5317569|NCT00326183|18316988|P1|Overall Study|Other|47
5317570|NCT00326183|18316987|P2|Overall Study|Subject Moved|4
5317571|NCT00326183|18316988|P1|Overall Study|Subject Moved|7
5317572|NCT00326183|18316987|P2|Overall Study|Withdrawal by Subject|7
5317573|NCT00326183|18316988|P1|Overall Study|Withdrawal by Subject|35
5317574|NCT00326183|18316987|P2|Overall Study|Protocol Violation|3
5317575|NCT00326183|18316988|P1|Overall Study|Protocol Violation|6
5317576|NCT00326183|18316987|P2|Overall Study|Lost to Follow-up|56
5317577|NCT00326183|18316988|P1|Overall Study|Lost to Follow-up|104
5317578|NCT00326118|18317020|P2|Active Phase|Withdrawal by Subject|1
5317579|NCT00326118|18317021|P1|Active Phase|Withdrawal by Subject|4
5317580|NCT00326001|18317057|P2|Overall Study|Physician Decision|3
5317581|NCT00326001|18317058|P1|Overall Study|Physician Decision|3
5317582|NCT00326001|18317057|P2|Overall Study|Adverse Event|5
5317583|NCT00326001|18317058|P1|Overall Study|Adverse Event|4
5317584|NCT00325897|18317072|P2|Overall Study|Lost to Follow-up|13
5317585|NCT00325897|18317073|P1|Overall Study|Lost to Follow-up|12
5317586|NCT00325819|18317093|P2|Overall Study|Lost to Follow-up|3
5317587|NCT00325819|18317094|P1|Overall Study|Lost to Follow-up|3
5317588|NCT00325819|18317093|P2|Overall Study|Did not take a dose of study product|9
5317589|NCT00325819|18317094|P1|Overall Study|Did not take a dose of study product|4
5317590|NCT00325819|18317093|P2|Overall Study|Study product lost in mail|1
5317591|NCT00325819|18317094|P1|Overall Study|Study product lost in mail|2
5317592|NCT00325754|18317121|P2|Overall Study|Adverse Event|1
5317593|NCT00325754|18317122|P1|Overall Study|Adverse Event|4
5317594|NCT00325468|18317177|P5|Overall Study|site closure etc|1
5317595|NCT00325468|18317178|P4|Overall Study|site closure etc|8
5317596|NCT00325468|18317179|P3|Overall Study|site closure etc|1
5317597|NCT00325468|18317180|P2|Overall Study|site closure etc|2
5317598|NCT00325468|18317181|P1|Overall Study|site closure etc|4
5317599|NCT00325468|18317177|P5|Overall Study|Withdrawal by Subject|4
5317600|NCT00325468|18317178|P4|Overall Study|Withdrawal by Subject|14
5317601|NCT00325468|18317179|P3|Overall Study|Withdrawal by Subject|0
5317602|NCT00325468|18317180|P2|Overall Study|Withdrawal by Subject|1
5317603|NCT00325468|18317181|P1|Overall Study|Withdrawal by Subject|3
5317604|NCT00325468|18317177|P5|Overall Study|Physician Decision|0
5317605|NCT00325468|18317178|P4|Overall Study|Physician Decision|1
5317606|NCT00325468|18317179|P3|Overall Study|Physician Decision|0
5317607|NCT00325468|18317180|P2|Overall Study|Physician Decision|1
5317608|NCT00325468|18317181|P1|Overall Study|Physician Decision|1
5317609|NCT00325468|18317177|P5|Overall Study|Lost to Follow-up|2
5317610|NCT00325468|18317178|P4|Overall Study|Lost to Follow-up|2
5317611|NCT00325468|18317179|P3|Overall Study|Lost to Follow-up|1
5317612|NCT00325468|18317180|P2|Overall Study|Lost to Follow-up|0
5317613|NCT00325468|18317181|P1|Overall Study|Lost to Follow-up|0
5317614|NCT00325468|18317177|P5|Overall Study|Death|0
5317615|NCT00325468|18317178|P4|Overall Study|Death|4
5317616|NCT00325468|18317179|P3|Overall Study|Death|2
5317617|NCT00325468|18317180|P2|Overall Study|Death|0
5317618|NCT00325468|18317181|P1|Overall Study|Death|2
5317619|NCT00325468|18317177|P5|Overall Study|Adverse Event|1
5317620|NCT00325468|18317178|P4|Overall Study|Adverse Event|5
5317621|NCT00325468|18317179|P3|Overall Study|Adverse Event|0
5317622|NCT00325468|18317180|P2|Overall Study|Adverse Event|1
5317623|NCT00325468|18317181|P1|Overall Study|Adverse Event|1
5317624|NCT00325416|18317264|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
5317625|NCT00325416|18317265|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
5317626|NCT00325416|18317264|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
5317627|NCT00325416|18317265|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
5317628|NCT00325416|18317264|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
5317629|NCT00325416|18317265|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
5317630|NCT00325416|18317264|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
5317631|NCT00325416|18317265|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
5317632|NCT00325416|18317264|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
5317633|NCT00325416|18317265|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
5317634|NCT00325416|18317264|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
5317635|NCT00325416|18317265|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
5317636|NCT00325234|18317318|P2|Overall Study|Progressive Disease|37
5317637|NCT00325234|18317319|P1|Overall Study|Progressive Disease|34
5317638|NCT00325234|18317318|P2|Overall Study|Physician Decision|12
5317639|NCT00325234|18317319|P1|Overall Study|Physician Decision|17
5317640|NCT00325234|18317318|P2|Overall Study|Subject Decision|8
5317641|NCT00325234|18317319|P1|Overall Study|Subject Decision|6
5317642|NCT00325234|18317318|P2|Overall Study|Entry Criteria Not Met|2
5317643|NCT00325234|18317319|P1|Overall Study|Entry Criteria Not Met|1
5317644|NCT00325234|18317318|P2|Overall Study|Death due to Study Disease|0
5317645|NCT00325234|18317319|P1|Overall Study|Death due to Study Disease|1
5317646|NCT00325234|18317318|P2|Overall Study|Adverse Event|7
5317647|NCT00325234|18317319|P1|Overall Study|Adverse Event|10
5317648|NCT00325195|18317338|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
5317649|NCT00325195|18317339|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
5317650|NCT00325195|18317340|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
5317651|NCT00325195|18317338|P3|Received Intervention: ITT Population|Lost to Follow-up|2
5317652|NCT00325195|18317339|P2|Received Intervention: ITT Population|Lost to Follow-up|0
5317653|NCT00325195|18317340|P1|Received Intervention: ITT Population|Lost to Follow-up|0
5317654|NCT00325195|18317338|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
5317655|NCT00325195|18317339|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
5317656|NCT00325195|18317340|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
5317657|NCT00325195|18317338|P3|Received Intervention: ITT Population|Death|0
5317658|NCT00325195|18317339|P2|Received Intervention: ITT Population|Death|1
5317659|NCT00325195|18317340|P1|Received Intervention: ITT Population|Death|3
5317660|NCT00325195|18317338|P3|Received Intervention: ITT Population|Adverse Event|1
5317661|NCT00325195|18317339|P2|Received Intervention: ITT Population|Adverse Event|17
5317662|NCT00325195|18317340|P1|Received Intervention: ITT Population|Adverse Event|15
5317663|NCT00325195|18317338|P3|Randomized|Not dosed|3
5317664|NCT00325195|18317339|P2|Randomized|Not dosed|5
5317665|NCT00325195|18317340|P1|Randomized|Not dosed|5
5317666|NCT00325156|18317363|P1|Overall Study|Withdrawal by Subject|31
5317667|NCT00325156|18317363|P1|Overall Study|Other|1
5317668|NCT00325156|18317363|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
5317669|NCT00325156|18317363|P1|Overall Study|Adverse event, non-fatal|3
5317670|NCT00325156|18317363|P1|Overall Study|Migrated/moved from study area|12
5317671|NCT00325156|18317363|P1|Overall Study|Lost to follow-up (complete vaccination)|41
5317672|NCT00325156|18317363|P1|Overall Study|Protocol Violation|8
5317673|NCT00325143|18317370|P1|Overall Study|Withdrawal by Subject|8
5317674|NCT00325143|18317370|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
5317675|NCT00325143|18317370|P1|Overall Study|Migrated/moved from study area|1
5317676|NCT00325143|18317370|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
5317677|NCT00325130|18317380|P2|Overall Study|Patient Discontinued for Other|0
5317678|NCT00325130|18317381|P1|Overall Study|Patient Discontinued for Other|1
5317679|NCT00325130|18317380|P2|Overall Study|Moved|1
5317680|NCT00325130|18317381|P1|Overall Study|Moved|0
5317681|NCT00325130|18317380|P2|Overall Study|Protocol Deviation|1
5317682|NCT00325130|18317381|P1|Overall Study|Protocol Deviation|0
5317683|NCT00325130|18317380|P2|Overall Study|Withdrawal by Subject|14
5317684|NCT00325130|18317381|P1|Overall Study|Withdrawal by Subject|12
5317685|NCT00325130|18317380|P2|Overall Study|Lost to Follow-up|14
5317686|NCT00325130|18317381|P1|Overall Study|Lost to Follow-up|6
5317687|NCT00325039|18317438|P2|Overall Study|Lost to Follow-up|14
5317688|NCT00325039|18317439|P1|Overall Study|Lost to Follow-up|18
5317689|NCT00324987|18317455|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
5317690|NCT00324987|18317456|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
5317691|NCT00324987|18317455|P2|Overall Study|Progression|1
5317692|NCT00324987|18317456|P1|Overall Study|Progression|1
5317693|NCT00324987|18317455|P2|Overall Study|Withdrawal by Subject|1
5317694|NCT00324987|18317456|P1|Overall Study|Withdrawal by Subject|1
5317695|NCT00324987|18317455|P2|Overall Study|Adverse Event|1
5317696|NCT00324987|18317456|P1|Overall Study|Adverse Event|2
5317697|NCT00324961|18317470|P1|Overall Study|Other|2
5317698|NCT00324961|18317470|P1|Overall Study|Protocol Violation|3
5317699|NCT00324961|18317470|P1|Overall Study|Lost to Follow-up|22
5317700|NCT00324961|18317470|P1|Overall Study|Consent Withdrawn|11
5317701|NCT00324961|18317470|P1|Overall Study|Adverse Event|5
5317702|NCT00324805|18317521|P2|Overall Study|Did not start therapy|17
5317703|NCT00324805|18317522|P1|Overall Study|Did not start therapy|12
5317704|NCT00324805|18317521|P2|Overall Study|Other|2
5317705|NCT00324805|18317522|P1|Overall Study|Other|0
5317706|NCT00324805|18317521|P2|Overall Study|Other reasons|26
5317707|NCT00324805|18317522|P1|Overall Study|Other reasons|7
5317708|NCT00324805|18317521|P2|Overall Study|Other complicating disease|9
5317709|NCT00324805|18317522|P1|Overall Study|Other complicating disease|1
5317710|NCT00324805|18317521|P2|Overall Study|Alternative therapy|8
5317711|NCT00324805|18317522|P1|Overall Study|Alternative therapy|4
5317712|NCT00324805|18317521|P2|Overall Study|Death|9
5317713|NCT00324805|18317522|P1|Overall Study|Death|6
5317714|NCT00324805|18317521|P2|Overall Study|Withdrawal by Subject|174
5317715|NCT00324805|18317522|P1|Overall Study|Withdrawal by Subject|51
5317716|NCT00324805|18317521|P2|Overall Study|Progression|35
5317717|NCT00324805|18317522|P1|Overall Study|Progression|7
5317718|NCT00324805|18317521|P2|Overall Study|Adverse Event|203
5317719|NCT00324805|18317522|P1|Overall Study|Adverse Event|62
5317720|NCT00324740|18317547|P3|Overall Study|Withdrawal by Subject|1
5317721|NCT00324740|18317548|P2|Overall Study|Withdrawal by Subject|0
5317722|NCT00324740|18317549|P1|Overall Study|Withdrawal by Subject|1
5317723|NCT00324675|18317569|P2|Overall Study|Adverse Event|0
5317724|NCT00324675|18317570|P1|Overall Study|Adverse Event|1
5317725|NCT00324649|18317578|P2|Overall Study|Noncompliance|0
5317726|NCT00324649|18317579|P1|Overall Study|Noncompliance|1
5317727|NCT00324649|18317578|P2|Overall Study|Withdrawal by Subject|1
5317728|NCT00324649|18317579|P1|Overall Study|Withdrawal by Subject|0
5317729|NCT00324649|18317578|P2|Overall Study|Adverse Event|4
5317730|NCT00324649|18317579|P1|Overall Study|Adverse Event|1
5317731|NCT00324233|18317710|P2|Second Period|Protocol Violation|6
5317732|NCT00324233|18317711|P1|Second Period|Protocol Violation|4
5317733|NCT00324233|18317710|P2|Second Period|unable to insert catheter|1
5317734|NCT00324233|18317711|P1|Second Period|unable to insert catheter|1
5317735|NCT00324233|18317710|P2|First Period|unable to insert catheter|0
5317736|NCT00324233|18317711|P1|First Period|unable to insert catheter|1
5317737|NCT00324168|18317719|P2|Overall Study|Patient did not visit in f/u window|9
5317738|NCT00324168|18317720|P1|Overall Study|Patient did not visit in f/u window|6
5317739|NCT00324168|18317719|P2|Overall Study|Death|3
5317740|NCT00324168|18317720|P1|Overall Study|Death|3
5317741|NCT00324168|18317719|P2|Overall Study|Lost to Follow-up|18
5317742|NCT00324168|18317720|P1|Overall Study|Lost to Follow-up|19
5317743|NCT00324155|18317748|P2|Follow-up Phase|On-going participants still on drug|6
5317744|NCT00324155|18317749|P1|Follow-up Phase|On-going participants still on drug|11
5317745|NCT00324155|18317748|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
5317746|NCT00324155|18317749|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
5317747|NCT00324155|18317748|P2|Received Treatment in Maintenance Phase|Adverse Event|3
5317748|NCT00324155|18317749|P1|Received Treatment in Maintenance Phase|Adverse Event|0
5317749|NCT00324155|18317748|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
5317750|NCT00324155|18317749|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
5317751|NCT00324155|18317748|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
5317752|NCT00324155|18317749|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
5317753|NCT00324155|18317748|P2|Received Treatment in Maintenance Phase|Disease Progression|41
5317754|NCT00324155|18317749|P1|Received Treatment in Maintenance Phase|Disease Progression|26
5317755|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Physician Decision|0
5317756|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Physician Decision|2
5317757|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
5317758|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
5317759|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Adverse Event|7
5317760|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Adverse Event|6
5317761|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
5317762|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
5317763|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Death|15
5317764|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Death|8
5317765|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
5317766|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
5317767|NCT00324155|18317748|P2|Received Treatment in Induction Phase|Disease Progression|152
5317768|NCT00324155|18317749|P1|Received Treatment in Induction Phase|Disease Progression|88
5317769|NCT00324155|18317748|P2|Enrolled and Randomized|Lost to Follow-up|1
5317770|NCT00324155|18317749|P1|Enrolled and Randomized|Lost to Follow-up|0
5317771|NCT00324155|18317748|P2|Enrolled and Randomized|No longer met study criteria|0
5317772|NCT00324155|18317749|P1|Enrolled and Randomized|No longer met study criteria|3
5317773|NCT00324116|18317779|P1|Overall Study|Other|5
5317774|NCT00324116|18317779|P1|Overall Study|Withdrawal by Subject|5
5317775|NCT00324116|18317779|P1|Overall Study|Lack of Efficacy|17
5317776|NCT00324116|18317779|P1|Overall Study|Adverse Event|5
5317777|NCT00324038|18317791|P2|Overall Study|Other|13
5317778|NCT00324038|18317792|P1|Overall Study|Other|6
5317779|NCT00324038|18317791|P2|Overall Study|Lost to Follow-up|2
5317780|NCT00324038|18317792|P1|Overall Study|Lost to Follow-up|0
5317781|NCT00324038|18317791|P2|Overall Study|Lack of Efficacy|13
5317782|NCT00324038|18317792|P1|Overall Study|Lack of Efficacy|5
5317783|NCT00324038|18317791|P2|Overall Study|Adverse Event|23
5317784|NCT00324038|18317792|P1|Overall Study|Adverse Event|38
5317785|NCT00323882|18317803|P5|Overall Study|Other|1
5317786|NCT00323882|18317804|P4|Overall Study|Other|1
5317787|NCT00323882|18317805|P3|Overall Study|Other|0
5317788|NCT00323882|18317806|P2|Overall Study|Other|0
5317789|NCT00323882|18317807|P1|Overall Study|Other|0
5317790|NCT00323882|18317803|P5|Overall Study|Lost to Follow-up|1
5317791|NCT00323882|18317804|P4|Overall Study|Lost to Follow-up|0
5317792|NCT00323882|18317805|P3|Overall Study|Lost to Follow-up|1
5317793|NCT00323882|18317806|P2|Overall Study|Lost to Follow-up|0
5317794|NCT00323882|18317807|P1|Overall Study|Lost to Follow-up|0
5317795|NCT00323882|18317803|P5|Overall Study|Death|5
5317796|NCT00323882|18317804|P4|Overall Study|Death|0
5317797|NCT00323882|18317805|P3|Overall Study|Death|1
5317798|NCT00323882|18317806|P2|Overall Study|Death|1
5317799|NCT00323882|18317807|P1|Overall Study|Death|0
5317800|NCT00323882|18317803|P5|Overall Study|Disease Progression|22
5317801|NCT00323882|18317804|P4|Overall Study|Disease Progression|5
5317802|NCT00323882|18317805|P3|Overall Study|Disease Progression|10
5317803|NCT00323882|18317806|P2|Overall Study|Disease Progression|4
5317804|NCT00323882|18317807|P1|Overall Study|Disease Progression|6
5317805|NCT00323882|18317803|P5|Overall Study|Adverse Event|3
5317806|NCT00323882|18317804|P4|Overall Study|Adverse Event|1
5317807|NCT00323882|18317805|P3|Overall Study|Adverse Event|1
5317808|NCT00323882|18317806|P2|Overall Study|Adverse Event|1
5317809|NCT00323882|18317807|P1|Overall Study|Adverse Event|2
5317810|NCT00323869|18317878|P1|Overall Study|Death|1
5317811|NCT00323622|18317934|P8|Overall Study|Death|2
5317812|NCT00323622|18317935|P7|Overall Study|Death|0
5317813|NCT00323622|18317936|P6|Overall Study|Death|0
5317814|NCT00323622|18317937|P5|Overall Study|Death|7
5317815|NCT00323622|18317938|P4|Overall Study|Death|0
5317816|NCT00323622|18317939|P3|Overall Study|Death|0
5317817|NCT00323622|18317940|P2|Overall Study|Death|1
5317818|NCT00323622|18317941|P1|Overall Study|Death|1
5317819|NCT00323622|18317934|P8|Overall Study|Other|13
5317820|NCT00323622|18317935|P7|Overall Study|Other|5
5317821|NCT00323622|18317936|P6|Overall Study|Other|74
5317822|NCT00323622|18317937|P5|Overall Study|Other|32
5317823|NCT00323622|18317938|P4|Overall Study|Other|12
5317824|NCT00323622|18317939|P3|Overall Study|Other|4
5317825|NCT00323622|18317940|P2|Overall Study|Other|91
5317826|NCT00323622|18317941|P1|Overall Study|Other|30
5317827|NCT00323609|18317983|P4|Overall Study|Other reason|9
5317828|NCT00323609|18317984|P3|Overall Study|Other reason|4
5317829|NCT00323609|18317985|P2|Overall Study|Other reason|8
5317830|NCT00323609|18317986|P1|Overall Study|Other reason|11
5317831|NCT00323609|18317983|P4|Overall Study|Logistical withdrawal|1
5317832|NCT00323609|18317984|P3|Overall Study|Logistical withdrawal|0
5317833|NCT00323609|18317985|P2|Overall Study|Logistical withdrawal|5
5317834|NCT00323609|18317986|P1|Overall Study|Logistical withdrawal|9
5317835|NCT00323609|18317983|P4|Overall Study|Unrelenting or severe back pain|0
5317836|NCT00323609|18317984|P3|Overall Study|Unrelenting or severe back pain|0
5317837|NCT00323609|18317985|P2|Overall Study|Unrelenting or severe back pain|1
5317838|NCT00323609|18317986|P1|Overall Study|Unrelenting or severe back pain|1
5317839|NCT00323609|18317983|P4|Overall Study|Sponsor discontinued trial|0
5317840|NCT00323609|18317984|P3|Overall Study|Sponsor discontinued trial|0
5317841|NCT00323609|18317985|P2|Overall Study|Sponsor discontinued trial|29
5317842|NCT00323609|18317986|P1|Overall Study|Sponsor discontinued trial|29
5317843|NCT00323609|18317983|P4|Overall Study|Other non-VCF-related medical condition|0
5317844|NCT00323609|18317984|P3|Overall Study|Other non-VCF-related medical condition|0
5317845|NCT00323609|18317985|P2|Overall Study|Other non-VCF-related medical condition|2
5317846|NCT00323609|18317986|P1|Overall Study|Other non-VCF-related medical condition|3
5317847|NCT00323609|18317983|P4|Overall Study|Withdrawal by Subject|4
5317848|NCT00323609|18317984|P3|Overall Study|Withdrawal by Subject|4
5317849|NCT00323609|18317985|P2|Overall Study|Withdrawal by Subject|23
5317850|NCT00323609|18317986|P1|Overall Study|Withdrawal by Subject|11
5317851|NCT00323609|18317983|P4|Overall Study|Physician Decision|1
5317852|NCT00323609|18317984|P3|Overall Study|Physician Decision|0
5317853|NCT00323609|18317985|P2|Overall Study|Physician Decision|0
5317854|NCT00323609|18317986|P1|Overall Study|Physician Decision|2
5317855|NCT00323609|18317983|P4|Overall Study|Lost to Follow-up|0
5317856|NCT00323609|18317984|P3|Overall Study|Lost to Follow-up|0
5317857|NCT00323609|18317985|P2|Overall Study|Lost to Follow-up|10
5317858|NCT00323609|18317986|P1|Overall Study|Lost to Follow-up|9
5317859|NCT00323609|18317983|P4|Overall Study|Death|0
5317860|NCT00323609|18317984|P3|Overall Study|Death|0
5317861|NCT00323609|18317985|P2|Overall Study|Death|21
5317862|NCT00323609|18317986|P1|Overall Study|Death|16
5317863|NCT00323557|18318022|P2|Overall Study|Physician Decision|0
5317864|NCT00323557|18318023|P1|Overall Study|Physician Decision|1
5317865|NCT00323492|18318032|P3|Study Phase 2|Protocol Violation|0
5317866|NCT00323492|18318033|P2|Study Phase 2|Protocol Violation|0
5317867|NCT00323492|18318034|P1|Study Phase 2|Protocol Violation|1
5317868|NCT00323492|18318032|P3|Study Phase 2|Noncompliance with study schedule|1
5317869|NCT00323492|18318033|P2|Study Phase 2|Noncompliance with study schedule|0
5317870|NCT00323492|18318034|P1|Study Phase 2|Noncompliance with study schedule|0
5317871|NCT00323492|18318032|P3|Study Phase 2|Withdrawal by Subject|0
5317872|NCT00323492|18318033|P2|Study Phase 2|Withdrawal by Subject|1
5317873|NCT00323492|18318034|P1|Study Phase 2|Withdrawal by Subject|0
5317874|NCT00323492|18318032|P3|Study Phase 2|Lost to Follow-up|0
5317875|NCT00323492|18318033|P2|Study Phase 2|Lost to Follow-up|0
5317876|NCT00323492|18318034|P1|Study Phase 2|Lost to Follow-up|1
5317877|NCT00323492|18318032|P3|Study Phase 2|Physician Decision|0
5317878|NCT00323492|18318033|P2|Study Phase 2|Physician Decision|0
5317879|NCT00323492|18318034|P1|Study Phase 2|Physician Decision|1
5317880|NCT00323492|18318032|P3|Study Phase 2|Adverse Event|0
5317881|NCT00323492|18318033|P2|Study Phase 2|Adverse Event|0
5317882|NCT00323492|18318034|P1|Study Phase 2|Adverse Event|1
5317883|NCT00323492|18318032|P3|Study Phase 1|Adverse Event|0
5317884|NCT00323492|18318033|P2|Study Phase 1|Adverse Event|0
5317885|NCT00323492|18318034|P1|Study Phase 1|Adverse Event|2
5317886|NCT00323479|18318065|P1|Overall Study|house moving|1
5317887|NCT00323479|18318065|P1|Overall Study|Protocol Violation|3
5317888|NCT00323479|18318065|P1|Overall Study|Withdrawal by Subject|2
5317889|NCT00323479|18318065|P1|Overall Study|Adverse Event|2
5317890|NCT00323414|18318098|P2|Overall Study|Withdrawal by Subject|1
5317891|NCT00323414|18318099|P1|Overall Study|Withdrawal by Subject|0
5317892|NCT00323310|18318121|P1|Overall Study|did not complete the 24-hr f-up visit|1
5317893|NCT00323310|18318121|P1|Overall Study|a parent refused blood draw|1
5317894|NCT00323310|18318121|P1|Overall Study|Withdrawal by Subject|1
5317895|NCT00323297|18318136|P2|Part B (Open-label)|Protocol Violation|1
5317896|NCT00323297|18318137|P1|Part B (Open-label)|Protocol Violation|0
5317897|NCT00323297|18318136|P2|Part B (Open-label)|Adverse Event|5
5317898|NCT00323297|18318137|P1|Part B (Open-label)|Adverse Event|5
5317899|NCT00323297|18318136|P2|Part B (Open-label)|Lack of Efficacy|1
5317900|NCT00323297|18318137|P1|Part B (Open-label)|Lack of Efficacy|3
5317901|NCT00323297|18318136|P2|Part B (Open-label)|Withdrawal by Subject|3
5317902|NCT00323297|18318137|P1|Part B (Open-label)|Withdrawal by Subject|1
5317903|NCT00323297|18318136|P2|Part B (Open-label)|Reason unspecified|1
5317904|NCT00323297|18318137|P1|Part B (Open-label)|Reason unspecified|0
5317905|NCT00323297|18318136|P2|Part B (Open-label)|Death|1
5317906|NCT00323297|18318137|P1|Part B (Open-label)|Death|0
5317907|NCT00323297|18318136|P2|Part A (Double Blind Randomized)|Related adverse event|2
5317908|NCT00323297|18318137|P1|Part A (Double Blind Randomized)|Related adverse event|2
5317909|NCT00323297|18318136|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
5317910|NCT00323297|18318137|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
5317911|NCT00323297|18318136|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
5317912|NCT00323297|18318137|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
5317913|NCT00323297|18318136|P2|Part A (Double Blind Randomized)|Protocol Violation|3
5317914|NCT00323297|18318137|P1|Part A (Double Blind Randomized)|Protocol Violation|1
5317915|NCT00323297|18318136|P2|Part A (Double Blind Randomized)|Death|1
5317916|NCT00323297|18318137|P1|Part A (Double Blind Randomized)|Death|0
5317917|NCT00323297|18318136|P2|Part A (Double Blind Randomized)|Reason unspecified|1
5317918|NCT00323297|18318137|P1|Part A (Double Blind Randomized)|Reason unspecified|0
5317919|NCT00323258|18318177|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
5317920|NCT00323258|18318178|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
5317921|NCT00323258|18318177|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
5317922|NCT00323258|18318178|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
5317923|NCT00323258|18318177|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
5317924|NCT00323258|18318178|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
5317925|NCT00323258|18318177|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
5317926|NCT00323258|18318178|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
5317927|NCT00323258|18318177|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
5317928|NCT00323258|18318178|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
5317929|NCT00323258|18318177|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
5317930|NCT00323258|18318178|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
5317931|NCT00323258|18318177|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
5317932|NCT00323258|18318178|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
5317933|NCT00323115|18318203|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
5317934|NCT00323115|18318203|P1|Vaccine Administration|Adverse Event|1
5317935|NCT00323063|18318230|P2|Overall Study|brain mets discovered prior to treatment|0
5317936|NCT00323063|18318231|P1|Overall Study|brain mets discovered prior to treatment|1
5317937|NCT00323063|18318230|P2|Overall Study|Adverse Event|0
5317938|NCT00323063|18318231|P1|Overall Study|Adverse Event|1
5317939|NCT00322881|18318248|P1|Overall Study|Disease Progression|2
5317940|NCT00322881|18318248|P1|Overall Study|Adverse Event|1
5317941|NCT00322881|18318248|P1|Overall Study|Death|2
5317942|NCT00322868|18318252|P1|Overall Study|disease progression|1
5317943|NCT00322842|18318277|P2|Overall Study|Death|0
5317944|NCT00322842|18318278|P1|Overall Study|Death|1
5317945|NCT00322842|18318277|P2|Overall Study|Refused transplant|0
5317946|NCT00322842|18318278|P1|Overall Study|Refused transplant|1
5317947|NCT00322842|18318277|P2|Overall Study|Lost to Follow-up|1
5317948|NCT00322842|18318278|P1|Overall Study|Lost to Follow-up|0
5317949|NCT00322842|18318277|P2|Overall Study|Withdrawal by Subject|1
5317950|NCT00322842|18318278|P1|Overall Study|Withdrawal by Subject|0
5317951|NCT00322712|18318316|P1|Overall Study|treated with bevacizumab not cetuximab|1
5317952|NCT00322621|18318320|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
5317953|NCT00322621|18318321|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
5317954|NCT00322621|18318322|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
5317955|NCT00322621|18318320|P3|Period III - Maintenance / Rescue Phase|Death|0
5317956|NCT00322621|18318321|P2|Period III - Maintenance / Rescue Phase|Death|1
5317957|NCT00322621|18318322|P1|Period III - Maintenance / Rescue Phase|Death|0
5317958|NCT00322621|18318320|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
5317959|NCT00322621|18318321|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
5317960|NCT00322621|18318322|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
5317961|NCT00322621|18318320|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
5317962|NCT00322621|18318321|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
5317963|NCT00322621|18318322|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
5317964|NCT00322621|18318320|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
5317965|NCT00322621|18318321|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
5317966|NCT00322621|18318322|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
5317967|NCT00322621|18318320|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
5317968|NCT00322621|18318321|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
5317969|NCT00322621|18318322|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
5317970|NCT00322621|18318320|P3|Period II - Acute Therapy Phase|Physician Decision|0
5317971|NCT00322621|18318321|P2|Period II - Acute Therapy Phase|Physician Decision|0
5317972|NCT00322621|18318322|P1|Period II - Acute Therapy Phase|Physician Decision|1
5317973|NCT00322621|18318320|P3|Period II - Acute Therapy Phase|Protocol Violation|0
5317974|NCT00322621|18318321|P2|Period II - Acute Therapy Phase|Protocol Violation|0
5317975|NCT00322621|18318322|P1|Period II - Acute Therapy Phase|Protocol Violation|2
5317976|NCT00322621|18318320|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
5317977|NCT00322621|18318321|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
5317978|NCT00322621|18318322|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
5317979|NCT00322621|18318320|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
5317980|NCT00322621|18318321|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
5317981|NCT00322621|18318322|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
5317982|NCT00322621|18318320|P3|Period II - Acute Therapy Phase|Adverse Event|0
5317983|NCT00322621|18318321|P2|Period II - Acute Therapy Phase|Adverse Event|0
5317984|NCT00322621|18318322|P1|Period II - Acute Therapy Phase|Adverse Event|20
5317985|NCT00322556|18318374|P1|Overall Study|Other Reason|7
5317986|NCT00322556|18318374|P1|Overall Study|Lost to Follow-up|3
5317987|NCT00322556|18318374|P1|Overall Study|Withdrawal by Subject|1
5317988|NCT00322556|18318374|P1|Overall Study|Adverse Event|1
5317989|NCT00322491|18318390|P2|Overall Study|Death|2
5317990|NCT00322491|18318391|P1|Overall Study|Death|1
5317991|NCT00322491|18318390|P2|Overall Study|Adverse Event|0
5317992|NCT00322491|18318391|P1|Overall Study|Adverse Event|1
5317993|NCT00322452|18318481|P2|Overall Study|Death|227
5317994|NCT00322452|18318482|P1|Overall Study|Death|223
5317995|NCT00322452|18318481|P2|Overall Study|Withdrawal by Subject|46
5317996|NCT00322452|18318482|P1|Overall Study|Withdrawal by Subject|19
5317997|NCT00322452|18318481|P2|Overall Study|Lost to Follow-up|2
5317998|NCT00322452|18318482|P1|Overall Study|Lost to Follow-up|5
5317999|NCT00322452|18318481|P2|Overall Study|Eligibility criteria not fulfilled|1
5318000|NCT00322452|18318482|P1|Overall Study|Eligibility criteria not fulfilled|0
5318001|NCT00322387|18318533|P2|Follow-up Period|Death|0
5318002|NCT00322387|18318534|P1|Follow-up Period|Death|1
5318003|NCT00322387|18318533|P2|Follow-up Period|Final assessment not done|3
5318004|NCT00322387|18318534|P1|Follow-up Period|Final assessment not done|1
5318005|NCT00322387|18318533|P2|Treatment Period|Adverse Event|1
5318006|NCT00322387|18318534|P1|Treatment Period|Adverse Event|0
5318007|NCT00322374|18318568|P4|Second Escalation|Study Drug Toxicity|0
5318008|NCT00322374|18318569|P3|Second Escalation|Study Drug Toxicity|1
5318009|NCT00322374|18318570|P2|Second Escalation|Study Drug Toxicity|0
5318010|NCT00322374|18318571|P1|Second Escalation|Study Drug Toxicity|0
5318011|NCT00322374|18318568|P4|Second Escalation|Physician Decision|0
5318012|NCT00322374|18318569|P3|Second Escalation|Physician Decision|5
5318013|NCT00322374|18318570|P2|Second Escalation|Physician Decision|0
5318014|NCT00322374|18318571|P1|Second Escalation|Physician Decision|0
5318015|NCT00322374|18318568|P4|First Escalation|Participant Request|0
5318016|NCT00322374|18318569|P3|First Escalation|Participant Request|0
5318017|NCT00322374|18318570|P2|First Escalation|Participant Request|1
5318018|NCT00322374|18318571|P1|First Escalation|Participant Request|0
5318019|NCT00322374|18318568|P4|First Escalation|Study Drug Toxicity|0
5318020|NCT00322374|18318569|P3|First Escalation|Study Drug Toxicity|0
5318021|NCT00322374|18318570|P2|First Escalation|Study Drug Toxicity|11
5318022|NCT00322374|18318571|P1|First Escalation|Study Drug Toxicity|0
5318023|NCT00322374|18318568|P4|First Escalation|Physician Decision|0
5318024|NCT00322374|18318569|P3|First Escalation|Physician Decision|0
5318025|NCT00322374|18318570|P2|First Escalation|Physician Decision|12
5318026|NCT00322374|18318571|P1|First Escalation|Physician Decision|0
5318027|NCT00322374|18318568|P4|First Escalation|Documented Disease Progression|0
5318028|NCT00322374|18318569|P3|First Escalation|Documented Disease Progression|0
5318029|NCT00322374|18318570|P2|First Escalation|Documented Disease Progression|6
5318030|NCT00322374|18318571|P1|First Escalation|Documented Disease Progression|0
5318031|NCT00322374|18318568|P4|Starting Dose|Study Drug Toxicity|0
5318032|NCT00322374|18318569|P3|Starting Dose|Study Drug Toxicity|0
5318033|NCT00322374|18318570|P2|Starting Dose|Study Drug Toxicity|0
5318034|NCT00322374|18318571|P1|Starting Dose|Study Drug Toxicity|4
5318035|NCT00322374|18318568|P4|Starting Dose|Physician Decision|0
5318036|NCT00322374|18318569|P3|Starting Dose|Physician Decision|0
5318037|NCT00322374|18318570|P2|Starting Dose|Physician Decision|0
5318038|NCT00322374|18318571|P1|Starting Dose|Physician Decision|2
5318039|NCT00322348|18318621|P2|Overall Study|Reasons not specified|1
5318040|NCT00322348|18318622|P1|Overall Study|Reasons not specified|5
5318041|NCT00322348|18318621|P2|Overall Study|Disease Progression|25
5318042|NCT00322348|18318622|P1|Overall Study|Disease Progression|30
5318043|NCT00322348|18318621|P2|Overall Study|Death|2
5318044|NCT00322348|18318622|P1|Overall Study|Death|0
5318045|NCT00322348|18318621|P2|Overall Study|Lost to Follow-up|0
5318046|NCT00322348|18318622|P1|Overall Study|Lost to Follow-up|1
5318047|NCT00322348|18318621|P2|Overall Study|Withdrawal by Subject|4
5318048|NCT00322348|18318622|P1|Overall Study|Withdrawal by Subject|1
5318049|NCT00322348|18318621|P2|Overall Study|Adverse Event|1
5318050|NCT00322348|18318622|P1|Overall Study|Adverse Event|0
5318051|NCT00322153|18318713|P2|Overall Study|Withdrawn for other reasons|4
5318052|NCT00322153|18318714|P1|Overall Study|Withdrawn for other reasons|5
5318053|NCT00322153|18318713|P2|Overall Study|Lost to Follow-up|4
5318054|NCT00322153|18318714|P1|Overall Study|Lost to Follow-up|5
5318055|NCT00322153|18318713|P2|Overall Study|Lack of Efficacy|3
5318056|NCT00322153|18318714|P1|Overall Study|Lack of Efficacy|8
5318057|NCT00322153|18318713|P2|Overall Study|Withdrawal by Subject|10
5318058|NCT00322153|18318714|P1|Overall Study|Withdrawal by Subject|18
5318059|NCT00322153|18318713|P2|Overall Study|Protocol Violation|14
5318060|NCT00322153|18318714|P1|Overall Study|Protocol Violation|6
5318061|NCT00322153|18318713|P2|Overall Study|Adverse Event|34
5318062|NCT00322153|18318714|P1|Overall Study|Adverse Event|21
5318063|NCT00322049|18318747|P4|Overall Study|Infected with Dengue during study|0
5318064|NCT00322049|18318748|P3|Overall Study|Infected with Dengue during study|0
5318065|NCT00322049|18318749|P2|Overall Study|Infected with Dengue during study|1
5318066|NCT00322049|18318750|P1|Overall Study|Infected with Dengue during study|0
5318067|NCT00322049|18318747|P4|Overall Study|Moved out of area|1
5318068|NCT00322049|18318748|P3|Overall Study|Moved out of area|0
5318069|NCT00322049|18318749|P2|Overall Study|Moved out of area|0
5318070|NCT00322049|18318750|P1|Overall Study|Moved out of area|0
5318071|NCT00322023|18318783|P3|Overall Study|various|6
5318072|NCT00322023|18318784|P2|Overall Study|various|2
5318073|NCT00322023|18318785|P1|Overall Study|various|0
5318074|NCT00321984|18318802|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
5318164|NCT00321789|18319064|P1|Overall Study|Lost to Follow-up|4
5318075|NCT00321984|18318803|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
5318076|NCT00321984|18318804|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
5318077|NCT00321984|18318802|P3|Overall Study|Per Investigator Request|0
5318078|NCT00321984|18318803|P2|Overall Study|Per Investigator Request|0
5318079|NCT00321984|18318804|P1|Overall Study|Per Investigator Request|1
5318080|NCT00321984|18318802|P3|Overall Study|Per Subject Request|0
5318081|NCT00321984|18318803|P2|Overall Study|Per Subject Request|0
5318082|NCT00321984|18318804|P1|Overall Study|Per Subject Request|1
5318083|NCT00321984|18318802|P3|Overall Study|Pregnancy|0
5318084|NCT00321984|18318803|P2|Overall Study|Pregnancy|1
5318085|NCT00321984|18318804|P1|Overall Study|Pregnancy|0
5318086|NCT00321984|18318802|P3|Overall Study|Noncompliant|2
5318087|NCT00321984|18318803|P2|Overall Study|Noncompliant|0
5318088|NCT00321984|18318804|P1|Overall Study|Noncompliant|0
5318089|NCT00321984|18318802|P3|Overall Study|Lack of Efficacy|3
5318090|NCT00321984|18318803|P2|Overall Study|Lack of Efficacy|1
5318091|NCT00321984|18318804|P1|Overall Study|Lack of Efficacy|3
5318092|NCT00321984|18318802|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
5318093|NCT00321984|18318803|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
5318094|NCT00321984|18318804|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
5318095|NCT00321984|18318802|P3|Overall Study|Withdrawal by Subject|5
5318096|NCT00321984|18318803|P2|Overall Study|Withdrawal by Subject|6
5318097|NCT00321984|18318804|P1|Overall Study|Withdrawal by Subject|8
5318098|NCT00321984|18318802|P3|Overall Study|Lost to Follow-up|2
5318099|NCT00321984|18318803|P2|Overall Study|Lost to Follow-up|4
5318100|NCT00321984|18318804|P1|Overall Study|Lost to Follow-up|2
5318101|NCT00321984|18318802|P3|Overall Study|Protocol Violation|1
5318102|NCT00321984|18318803|P2|Overall Study|Protocol Violation|1
5318103|NCT00321984|18318804|P1|Overall Study|Protocol Violation|0
5318104|NCT00321984|18318802|P3|Overall Study|Adverse Event|8
5318105|NCT00321984|18318803|P2|Overall Study|Adverse Event|6
5318106|NCT00321984|18318804|P1|Overall Study|Adverse Event|9
5318107|NCT00321932|18318832|P2|Overall Study|Missing data|1
5318108|NCT00321932|18318833|P1|Overall Study|Missing data|2
5318109|NCT00321932|18318832|P2|Overall Study|Early relapse|8
5318110|NCT00321932|18318833|P1|Overall Study|Early relapse|2
5318111|NCT00321932|18318832|P2|Overall Study|Withdrawal by Subject|6
5318112|NCT00321932|18318833|P1|Overall Study|Withdrawal by Subject|3
5318113|NCT00321932|18318832|P2|Overall Study|Death|6
5318114|NCT00321932|18318833|P1|Overall Study|Death|3
5318115|NCT00321919|18318857|P2|Overall Study|Other withdrawal reason|6
5318116|NCT00321919|18318858|P1|Overall Study|Other withdrawal reason|7
5318117|NCT00321919|18318857|P2|Overall Study|Failure to Return|1
5318118|NCT00321919|18318858|P1|Overall Study|Failure to Return|3
5318119|NCT00321919|18318857|P2|Overall Study|Other Protocol Violation|3
5318120|NCT00321919|18318858|P1|Overall Study|Other Protocol Violation|2
5318121|NCT00321919|18318857|P2|Overall Study|Refused Treatment|14
5318122|NCT00321919|18318858|P1|Overall Study|Refused Treatment|23
5318123|NCT00321919|18318857|P2|Overall Study|Violation of Selection Criteria at Entry|1
5318124|NCT00321919|18318858|P1|Overall Study|Violation of Selection Criteria at Entry|1
5318125|NCT00321919|18318857|P2|Overall Study|Insufficient Therapeutic Response|0
5318126|NCT00321919|18318858|P1|Overall Study|Insufficient Therapeutic Response|1
5318127|NCT00321919|18318857|P2|Overall Study|Death|17
5318128|NCT00321919|18318858|P1|Overall Study|Death|21
5318129|NCT00321919|18318857|P2|Overall Study|Adverse Event|10
5318130|NCT00321919|18318858|P1|Overall Study|Adverse Event|17
5318131|NCT00321906|18318900|P2|Overall Study|Withdrawal by Subject|4
5318132|NCT00321906|18318901|P1|Overall Study|Withdrawal by Subject|0
5318133|NCT00321906|18318900|P2|Overall Study|Lost to Follow-up|2
5318134|NCT00321906|18318901|P1|Overall Study|Lost to Follow-up|1
5318135|NCT00321906|18318900|P2|Overall Study|Death|6
5318136|NCT00321906|18318901|P1|Overall Study|Death|9
5318137|NCT00321906|18318900|P2|Overall Study|Adverse Event|44
5318138|NCT00321906|18318901|P1|Overall Study|Adverse Event|36
5318139|NCT00321893|18318923|P2|Overall Study|Adverse Event|3
5318140|NCT00321893|18318924|P1|Overall Study|Adverse Event|6
5318141|NCT00321893|18318923|P2|Overall Study|Lost to Follow-up|1
5318142|NCT00321893|18318924|P1|Overall Study|Lost to Follow-up|2
5318143|NCT00321893|18318923|P2|Overall Study|Non-Compliance/Refusal|10
5318144|NCT00321893|18318924|P1|Overall Study|Non-Compliance/Refusal|16
5318145|NCT00321854|18318938|P2|Overall Study|Other|1
5318146|NCT00321854|18318939|P1|Overall Study|Other|1
5318147|NCT00321854|18318938|P2|Overall Study|Withdrawal by Subject|17
5318148|NCT00321854|18318939|P1|Overall Study|Withdrawal by Subject|6
5318149|NCT00321854|18318938|P2|Overall Study|Lost to Follow-up|2
5318150|NCT00321854|18318939|P1|Overall Study|Lost to Follow-up|0
5318151|NCT00321854|18318938|P2|Overall Study|Protocol Violation|5
5318152|NCT00321854|18318939|P1|Overall Study|Protocol Violation|6
5318153|NCT00321854|18318938|P2|Overall Study|Lack of Efficacy|14
5318154|NCT00321854|18318939|P1|Overall Study|Lack of Efficacy|9
5318155|NCT00321854|18318938|P2|Overall Study|Adverse Event|43
5318156|NCT00321854|18318939|P1|Overall Study|Adverse Event|41
5318157|NCT00321828|18319057|P1|Overall Study|No follow up data|1
5318158|NCT00321828|18319057|P1|Overall Study|Ineligible|3
5318159|NCT00321789|18319063|P2|Overall Study|Protocol Violation|3
5318160|NCT00321789|18319064|P1|Overall Study|Protocol Violation|5
5318161|NCT00321789|18319063|P2|Overall Study|Withdrawal by Subject|6
5318162|NCT00321789|18319064|P1|Overall Study|Withdrawal by Subject|6
5318163|NCT00321789|18319063|P2|Overall Study|Lost to Follow-up|7
5318165|NCT00321763|18319096|P4|Overall Study|Lost to Follow-up|4
5318166|NCT00321763|18319097|P3|Overall Study|Lost to Follow-up|5
5318167|NCT00321763|18319098|P2|Overall Study|Lost to Follow-up|1
5318168|NCT00321763|18319099|P1|Overall Study|Lost to Follow-up|3
5318169|NCT00321763|18319096|P4|Overall Study|Withdrawal by Subject|0
5318170|NCT00321763|18319097|P3|Overall Study|Withdrawal by Subject|1
5318171|NCT00321763|18319098|P2|Overall Study|Withdrawal by Subject|0
5318172|NCT00321763|18319099|P1|Overall Study|Withdrawal by Subject|2
5318173|NCT00321763|18319096|P4|Overall Study|Adverse Event|1
5318174|NCT00321763|18319097|P3|Overall Study|Adverse Event|0
5318175|NCT00321763|18319098|P2|Overall Study|Adverse Event|1
5318176|NCT00321763|18319099|P1|Overall Study|Adverse Event|1
5318177|NCT00321737|18319159|P3|Overall Study|Subject Request/ Subject Unavailable|2
5318178|NCT00321737|18319160|P2|Overall Study|Subject Request/ Subject Unavailable|0
5318179|NCT00321737|18319161|P1|Overall Study|Subject Request/ Subject Unavailable|0
5318180|NCT00321737|18319159|P3|Overall Study|Noncompliance|0
5318181|NCT00321737|18319160|P2|Overall Study|Noncompliance|0
5318182|NCT00321737|18319161|P1|Overall Study|Noncompliance|2
5318183|NCT00321737|18319159|P3|Overall Study|Pregnancy|0
5318184|NCT00321737|18319160|P2|Overall Study|Pregnancy|2
5318185|NCT00321737|18319161|P1|Overall Study|Pregnancy|0
5318186|NCT00321737|18319159|P3|Overall Study|Therapeutic Failure|2
5318187|NCT00321737|18319160|P2|Overall Study|Therapeutic Failure|0
5318188|NCT00321737|18319161|P1|Overall Study|Therapeutic Failure|6
5318189|NCT00321737|18319159|P3|Overall Study|Possible Barrett's Esophagus|1
5318190|NCT00321737|18319160|P2|Overall Study|Possible Barrett's Esophagus|1
5318191|NCT00321737|18319161|P1|Overall Study|Possible Barrett's Esophagus|2
5318192|NCT00321737|18319159|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5318193|NCT00321737|18319160|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5318194|NCT00321737|18319161|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
5318195|NCT00321737|18319159|P3|Overall Study|Protocol Violation|1
5318196|NCT00321737|18319160|P2|Overall Study|Protocol Violation|0
5318197|NCT00321737|18319161|P1|Overall Study|Protocol Violation|0
5318198|NCT00321737|18319159|P3|Overall Study|Withdrawal by Subject|17
5318199|NCT00321737|18319160|P2|Overall Study|Withdrawal by Subject|12
5318200|NCT00321737|18319161|P1|Overall Study|Withdrawal by Subject|19
5318201|NCT00321737|18319159|P3|Overall Study|Lost to Follow-up|6
5318202|NCT00321737|18319160|P2|Overall Study|Lost to Follow-up|5
5318203|NCT00321737|18319161|P1|Overall Study|Lost to Follow-up|5
5318204|NCT00321737|18319159|P3|Overall Study|Adverse Event|6
5318205|NCT00321737|18319160|P2|Overall Study|Adverse Event|3
5318206|NCT00321737|18319161|P1|Overall Study|Adverse Event|11
5318207|NCT00321737|18319159|P3|Overall Study|Relapse of Erosive Esophagitis|19
5318208|NCT00321737|18319160|P2|Overall Study|Relapse of Erosive Esophagitis|25
5318209|NCT00321737|18319161|P1|Overall Study|Relapse of Erosive Esophagitis|76
5318210|NCT00321711|18319189|P5|Part B|Death|1
5318211|NCT00321711|18319190|P4|Part B|Death|2
5318212|NCT00321711|18319191|P3|Part B|Death|0
5318213|NCT00321711|18319192|P2|Part B|Death|0
5318214|NCT00321711|18319193|P1|Part B|Death|0
5318215|NCT00321711|18319189|P5|Part B|Physician Decision|2
5318216|NCT00321711|18319190|P4|Part B|Physician Decision|1
5318217|NCT00321711|18319191|P3|Part B|Physician Decision|0
5318218|NCT00321711|18319192|P2|Part B|Physician Decision|0
5318219|NCT00321711|18319193|P1|Part B|Physician Decision|0
5318220|NCT00321711|18319189|P5|Part B|Disease progression|0
5318221|NCT00321711|18319190|P4|Part B|Disease progression|1
5318222|NCT00321711|18319191|P3|Part B|Disease progression|0
5318223|NCT00321711|18319192|P2|Part B|Disease progression|0
5318224|NCT00321711|18319193|P1|Part B|Disease progression|0
5318225|NCT00321711|18319189|P5|Part B|Adverse Event|1
5318226|NCT00321711|18319190|P4|Part B|Adverse Event|2
5318227|NCT00321711|18319191|P3|Part B|Adverse Event|0
5318228|NCT00321711|18319192|P2|Part B|Adverse Event|0
5318229|NCT00321711|18319193|P1|Part B|Adverse Event|0
5318230|NCT00321711|18319189|P5|Part B|Noncompliance|1
5318231|NCT00321711|18319190|P4|Part B|Noncompliance|0
5318232|NCT00321711|18319191|P3|Part B|Noncompliance|0
5318233|NCT00321711|18319192|P2|Part B|Noncompliance|0
5318234|NCT00321711|18319193|P1|Part B|Noncompliance|0
5318235|NCT00321711|18319189|P5|Part A|Protocol deviation|0
5318236|NCT00321711|18319190|P4|Part A|Protocol deviation|0
5318237|NCT00321711|18319191|P3|Part A|Protocol deviation|1
5318238|NCT00321711|18319192|P2|Part A|Protocol deviation|0
5318239|NCT00321711|18319193|P1|Part A|Protocol deviation|0
5318240|NCT00321711|18319189|P5|Part A|Other|0
5318241|NCT00321711|18319190|P4|Part A|Other|0
5318242|NCT00321711|18319191|P3|Part A|Other|3
5318243|NCT00321711|18319192|P2|Part A|Other|2
5318244|NCT00321711|18319193|P1|Part A|Other|1
5318245|NCT00321711|18319189|P5|Part A|Physician Decision|0
5318246|NCT00321711|18319190|P4|Part A|Physician Decision|0
5318247|NCT00321711|18319191|P3|Part A|Physician Decision|3
5318248|NCT00321711|18319192|P2|Part A|Physician Decision|1
5318249|NCT00321711|18319193|P1|Part A|Physician Decision|0
5318250|NCT00321711|18319189|P5|Part A|Requirement for alternative therapy|0
5318251|NCT00321711|18319190|P4|Part A|Requirement for alternative therapy|0
5318252|NCT00321711|18319191|P3|Part A|Requirement for alternative therapy|1
5318253|NCT00321711|18319192|P2|Part A|Requirement for alternative therapy|2
5318254|NCT00321711|18319193|P1|Part A|Requirement for alternative therapy|0
5318255|NCT00321711|18319189|P5|Part A|Disease progression|0
5318256|NCT00321711|18319190|P4|Part A|Disease progression|0
5318257|NCT00321711|18319191|P3|Part A|Disease progression|0
5318258|NCT00321711|18319192|P2|Part A|Disease progression|1
5318259|NCT00321711|18319193|P1|Part A|Disease progression|0
5318260|NCT00321711|18319189|P5|Part A|Withdrawal by Subject|0
5318261|NCT00321711|18319190|P4|Part A|Withdrawal by Subject|0
5318262|NCT00321711|18319191|P3|Part A|Withdrawal by Subject|1
5318263|NCT00321711|18319192|P2|Part A|Withdrawal by Subject|1
5318264|NCT00321711|18319193|P1|Part A|Withdrawal by Subject|1
5318265|NCT00321711|18319189|P5|Part A|Adverse Event|0
5318266|NCT00321711|18319190|P4|Part A|Adverse Event|0
5318267|NCT00321711|18319191|P3|Part A|Adverse Event|2
5318268|NCT00321711|18319192|P2|Part A|Adverse Event|3
5318269|NCT00321711|18319193|P1|Part A|Adverse Event|3
5318270|NCT00321685|18319243|P1|Overall Study|Ineligible|2
5318271|NCT00321685|18319243|P1|Overall Study|Not start protocol therapy|2
5318272|NCT00321685|18319243|P1|Overall Study|Other|5
5318273|NCT00321685|18319243|P1|Overall Study|Complicating disese|1
5318274|NCT00321685|18319243|P1|Overall Study|Alternative therapy|1
5318275|NCT00321685|18319243|P1|Overall Study|Withdrawal by Subject|8
5318276|NCT00321685|18319243|P1|Overall Study|Death|2
5318277|NCT00321685|18319243|P1|Overall Study|Adverse Event|18
5318278|NCT00321672|18319255|P4|Overall Study|Extensive travel required for new job|0
5318279|NCT00321672|18319256|P3|Overall Study|Extensive travel required for new job|0
5318280|NCT00321672|18319257|P2|Overall Study|Extensive travel required for new job|1
5318281|NCT00321672|18319258|P1|Overall Study|Extensive travel required for new job|0
5318282|NCT00321672|18319255|P4|Overall Study|Diagnosis of testicular cancer|0
5318283|NCT00321672|18319256|P3|Overall Study|Diagnosis of testicular cancer|0
5318284|NCT00321672|18319257|P2|Overall Study|Diagnosis of testicular cancer|1
5318285|NCT00321672|18319258|P1|Overall Study|Diagnosis of testicular cancer|0
5318286|NCT00321672|18319255|P4|Overall Study|Protocol Violation|0
5318287|NCT00321672|18319256|P3|Overall Study|Protocol Violation|1
5318288|NCT00321672|18319257|P2|Overall Study|Protocol Violation|0
5318289|NCT00321672|18319258|P1|Overall Study|Protocol Violation|0
5318290|NCT00321672|18319255|P4|Overall Study|Moved out of state|0
5318291|NCT00321672|18319256|P3|Overall Study|Moved out of state|1
5318292|NCT00321672|18319257|P2|Overall Study|Moved out of state|1
5318293|NCT00321672|18319258|P1|Overall Study|Moved out of state|0
5318294|NCT00321672|18319255|P4|Overall Study|Incarcerated|0
5318295|NCT00321672|18319256|P3|Overall Study|Incarcerated|2
5318296|NCT00321672|18319257|P2|Overall Study|Incarcerated|0
5318297|NCT00321672|18319258|P1|Overall Study|Incarcerated|0
5318298|NCT00321672|18319255|P4|Overall Study|Too far to travel for visits|0
5318299|NCT00321672|18319256|P3|Overall Study|Too far to travel for visits|0
5318300|NCT00321672|18319257|P2|Overall Study|Too far to travel for visits|0
5318301|NCT00321672|18319258|P1|Overall Study|Too far to travel for visits|1
5318302|NCT00321672|18319255|P4|Overall Study|Death|0
5318303|NCT00321672|18319256|P3|Overall Study|Death|0
5318304|NCT00321672|18319257|P2|Overall Study|Death|0
5318305|NCT00321672|18319258|P1|Overall Study|Death|1
5318306|NCT00321672|18319255|P4|Overall Study|Lost to Follow-up|2
5318307|NCT00321672|18319256|P3|Overall Study|Lost to Follow-up|4
5318308|NCT00321672|18319257|P2|Overall Study|Lost to Follow-up|0
5318309|NCT00321672|18319258|P1|Overall Study|Lost to Follow-up|2
5318310|NCT00321672|18319255|P4|Overall Study|Lack of Efficacy|0
5318311|NCT00321672|18319256|P3|Overall Study|Lack of Efficacy|0
5318312|NCT00321672|18319257|P2|Overall Study|Lack of Efficacy|1
5318313|NCT00321672|18319258|P1|Overall Study|Lack of Efficacy|1
5318314|NCT00321672|18319255|P4|Overall Study|Adverse Event|0
5318315|NCT00321672|18319256|P3|Overall Study|Adverse Event|0
5318316|NCT00321672|18319257|P2|Overall Study|Adverse Event|1
5318317|NCT00321672|18319258|P1|Overall Study|Adverse Event|1
5318318|NCT00321672|18319255|P4|Overall Study|Noncompliance|0
5318319|NCT00321672|18319256|P3|Overall Study|Noncompliance|1
5318320|NCT00321672|18319257|P2|Overall Study|Noncompliance|2
5318321|NCT00321672|18319258|P1|Overall Study|Noncompliance|1
5318322|NCT00321672|18319255|P4|Overall Study|Withdrawal by Subject|0
5318323|NCT00321672|18319256|P3|Overall Study|Withdrawal by Subject|2
5318324|NCT00321672|18319257|P2|Overall Study|Withdrawal by Subject|1
5318325|NCT00321672|18319258|P1|Overall Study|Withdrawal by Subject|5
5318326|NCT00321646|18319284|P1|Neoadjuvant Chemotherapy|Disease progression|1
5318327|NCT00321646|18319284|P1|Neoadjuvant Chemotherapy|Adverse Event|2
5318328|NCT00321646|18319284|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
5318329|NCT00321620|18319291|P2|Overall Study|Other|33
5318330|NCT00321620|18319292|P1|Overall Study|Other|42
5318331|NCT00321620|18319291|P2|Overall Study|Participant request|52
5318332|NCT00321620|18319292|P1|Overall Study|Participant request|75
5318333|NCT00321620|18319291|P2|Overall Study|Ineligibility determined|3
5318334|NCT00321620|18319292|P1|Overall Study|Ineligibility determined|2
5318335|NCT00321620|18319291|P2|Overall Study|Protocol deviation|3
5318336|NCT00321620|18319292|P1|Overall Study|Protocol deviation|4
5318337|NCT00321620|18319291|P2|Overall Study|Noncompliance|7
5318338|NCT00321620|18319292|P1|Overall Study|Noncompliance|14
5318339|NCT00321620|18319291|P2|Overall Study|Physician Decision|1
5318340|NCT00321620|18319292|P1|Overall Study|Physician Decision|4
5318341|NCT00321620|18319291|P2|Overall Study|Lost to Follow-up|9
5318342|NCT00321620|18319292|P1|Overall Study|Lost to Follow-up|13
5318343|NCT00321620|18319291|P2|Overall Study|Adverse Event|56
5318344|NCT00321620|18319292|P1|Overall Study|Adverse Event|43
5318345|NCT00321620|18319291|P2|Overall Study|Disease progression|117
5318346|NCT00321620|18319292|P1|Overall Study|Disease progression|113
5318347|NCT00321620|18319291|P2|Overall Study|Withdrawal by Subject|147
5318348|NCT00321620|18319292|P1|Overall Study|Withdrawal by Subject|164
5318349|NCT00321620|18319291|P2|Overall Study|Death|294
5318350|NCT00321620|18319292|P1|Overall Study|Death|269
5318351|NCT00321555|18319320|P1|Overall Study|Disease progression on study|1
5318352|NCT00321555|18319320|P1|Overall Study|Physician Decision|1
5318353|NCT00321555|18319320|P1|Overall Study|Switched to alternative treatment|3
5318354|NCT00321555|18319320|P1|Overall Study|Developed antibodies|1
5318355|NCT00321464|18319328|P2|Overall Study|Other|18
5318356|NCT00321464|18319329|P1|Overall Study|Other|21
5318357|NCT00321464|18319328|P2|Overall Study|Ineligibility determined|1
5318358|NCT00321464|18319329|P1|Overall Study|Ineligibility determined|2
5318359|NCT00321464|18319328|P2|Overall Study|Protocol deviation|2
5318360|NCT00321464|18319329|P1|Overall Study|Protocol deviation|0
5318361|NCT00321464|18319328|P2|Overall Study|Lost to Follow-up|8
5318362|NCT00321464|18319329|P1|Overall Study|Lost to Follow-up|7
5318363|NCT00321464|18319328|P2|Overall Study|Noncompliance|10
5318364|NCT00321464|18319329|P1|Overall Study|Noncompliance|4
5318365|NCT00321464|18319328|P2|Overall Study|Physician Decision|14
5318366|NCT00321464|18319329|P1|Overall Study|Physician Decision|15
5318367|NCT00321464|18319328|P2|Overall Study|Adverse Event|28
5318368|NCT00321464|18319329|P1|Overall Study|Adverse Event|43
5318369|NCT00321464|18319328|P2|Overall Study|Participant request|61
5318370|NCT00321464|18319329|P1|Overall Study|Participant request|57
5318371|NCT00321464|18319328|P2|Overall Study|Withdrawal by Subject|118
5318372|NCT00321464|18319329|P1|Overall Study|Withdrawal by Subject|117
5318373|NCT00321464|18319328|P2|Overall Study|Disease progression|124
5318374|NCT00321464|18319329|P1|Overall Study|Disease progression|124
5318375|NCT00321464|18319328|P2|Overall Study|Death|174
5318376|NCT00321464|18319329|P1|Overall Study|Death|169
5318377|NCT00321373|18319342|P3|Overall Study|Other|1
5318378|NCT00321373|18319343|P2|Overall Study|Other|0
5318379|NCT00321373|18319344|P1|Overall Study|Other|0
5318380|NCT00321373|18319342|P3|Overall Study|Withdrawal by Subject|0
5318381|NCT00321373|18319343|P2|Overall Study|Withdrawal by Subject|0
5318382|NCT00321373|18319344|P1|Overall Study|Withdrawal by Subject|1
5318383|NCT00321373|18319342|P3|Overall Study|Lost to Follow-up|1
5318384|NCT00321373|18319343|P2|Overall Study|Lost to Follow-up|0
5318385|NCT00321373|18319344|P1|Overall Study|Lost to Follow-up|1
5318386|NCT00321373|18319342|P3|Overall Study|Adverse Event|1
5318387|NCT00321373|18319343|P2|Overall Study|Adverse Event|0
5318388|NCT00321373|18319344|P1|Overall Study|Adverse Event|0
5318389|NCT00321048|18319384|P2|Overall Study|Withdrawal by Subject|8
5318390|NCT00321048|18319385|P1|Overall Study|Withdrawal by Subject|6
5318391|NCT00320801|18319393|P4|Extension Phase|Lost to Follow-up|3
5318392|NCT00320801|18319394|P3|Extension Phase|Lost to Follow-up|0
5318393|NCT00320801|18319395|P2|Extension Phase|Lost to Follow-up|0
5318394|NCT00320801|18319396|P1|Extension Phase|Lost to Follow-up|0
5318395|NCT00320801|18319393|P4|Extension Phase|Lack of Efficacy|2
5318396|NCT00320801|18319394|P3|Extension Phase|Lack of Efficacy|0
5318397|NCT00320801|18319395|P2|Extension Phase|Lack of Efficacy|0
5318398|NCT00320801|18319396|P1|Extension Phase|Lack of Efficacy|0
5318399|NCT00320801|18319393|P4|Extension Phase|Administrative|29
5318400|NCT00320801|18319394|P3|Extension Phase|Administrative|0
5318401|NCT00320801|18319395|P2|Extension Phase|Administrative|0
5318402|NCT00320801|18319396|P1|Extension Phase|Administrative|0
5318403|NCT00320801|18319393|P4|Extension Phase|Adverse Event|8
5318404|NCT00320801|18319394|P3|Extension Phase|Adverse Event|0
5318405|NCT00320801|18319395|P2|Extension Phase|Adverse Event|0
5318406|NCT00320801|18319396|P1|Extension Phase|Adverse Event|0
5318407|NCT00320801|18319393|P4|Extension Phase|Withdrawal by Subject|6
5318408|NCT00320801|18319394|P3|Extension Phase|Withdrawal by Subject|0
5318409|NCT00320801|18319395|P2|Extension Phase|Withdrawal by Subject|0
5318410|NCT00320801|18319396|P1|Extension Phase|Withdrawal by Subject|0
5318411|NCT00320801|18319393|P4|Double-blind Phase|Lack of Efficacy|0
5318412|NCT00320801|18319394|P3|Double-blind Phase|Lack of Efficacy|1
5318413|NCT00320801|18319395|P2|Double-blind Phase|Lack of Efficacy|9
5318414|NCT00320801|18319396|P1|Double-blind Phase|Lack of Efficacy|0
5318415|NCT00320801|18319393|P4|Double-blind Phase|Administrative|0
5318416|NCT00320801|18319394|P3|Double-blind Phase|Administrative|4
5318417|NCT00320801|18319395|P2|Double-blind Phase|Administrative|0
5318418|NCT00320801|18319396|P1|Double-blind Phase|Administrative|0
5318419|NCT00320801|18319393|P4|Double-blind Phase|Adverse Event|0
5318420|NCT00320801|18319394|P3|Double-blind Phase|Adverse Event|8
5318421|NCT00320801|18319395|P2|Double-blind Phase|Adverse Event|2
5318422|NCT00320801|18319396|P1|Double-blind Phase|Adverse Event|0
5318423|NCT00320801|18319393|P4|Double-blind Phase|Withdrawal by Subject|0
5318424|NCT00320801|18319394|P3|Double-blind Phase|Withdrawal by Subject|1
5318425|NCT00320801|18319395|P2|Double-blind Phase|Withdrawal by Subject|0
5318426|NCT00320801|18319396|P1|Double-blind Phase|Withdrawal by Subject|0
5318427|NCT00320801|18319393|P4|Open-label Run-in Period|Did not qualify|0
5318428|NCT00320801|18319394|P3|Open-label Run-in Period|Did not qualify|0
5318429|NCT00320801|18319395|P2|Open-label Run-in Period|Did not qualify|0
5318430|NCT00320801|18319396|P1|Open-label Run-in Period|Did not qualify|1
5318431|NCT00320801|18319393|P4|Open-label Run-in Period|Lost to Follow-up|0
5318432|NCT00320801|18319394|P3|Open-label Run-in Period|Lost to Follow-up|0
5318433|NCT00320801|18319395|P2|Open-label Run-in Period|Lost to Follow-up|0
5318434|NCT00320801|18319396|P1|Open-label Run-in Period|Lost to Follow-up|2
5318435|NCT00320801|18319393|P4|Open-label Run-in Period|Lack of Efficacy|0
5318436|NCT00320801|18319394|P3|Open-label Run-in Period|Lack of Efficacy|0
5318437|NCT00320801|18319395|P2|Open-label Run-in Period|Lack of Efficacy|0
5318438|NCT00320801|18319396|P1|Open-label Run-in Period|Lack of Efficacy|44
5318439|NCT00320801|18319393|P4|Open-label Run-in Period|Administrative|0
5318440|NCT00320801|18319394|P3|Open-label Run-in Period|Administrative|0
5318441|NCT00320801|18319395|P2|Open-label Run-in Period|Administrative|0
5318442|NCT00320801|18319396|P1|Open-label Run-in Period|Administrative|10
5318443|NCT00320801|18319393|P4|Open-label Run-in Period|Adverse Event|0
5318444|NCT00320801|18319394|P3|Open-label Run-in Period|Adverse Event|0
5318445|NCT00320801|18319395|P2|Open-label Run-in Period|Adverse Event|0
5318446|NCT00320801|18319396|P1|Open-label Run-in Period|Adverse Event|33
5318447|NCT00320801|18319393|P4|Open-label Run-in Period|Withdrawal by Subject|0
5318448|NCT00320801|18319394|P3|Open-label Run-in Period|Withdrawal by Subject|0
5318449|NCT00320801|18319395|P2|Open-label Run-in Period|Withdrawal by Subject|0
5318450|NCT00320801|18319396|P1|Open-label Run-in Period|Withdrawal by Subject|2
5318451|NCT00320788|18319411|P5|Overall Study|Withdrawal by Subject|1
5318452|NCT00320788|18319412|P4|Overall Study|Withdrawal by Subject|3
5318453|NCT00320788|18319413|P3|Overall Study|Withdrawal by Subject|0
5318454|NCT00320788|18319414|P2|Overall Study|Withdrawal by Subject|0
5318455|NCT00320788|18319415|P1|Overall Study|Withdrawal by Subject|3
5318456|NCT00320788|18319411|P5|Overall Study|Protocol Violation|1
5318457|NCT00320788|18319412|P4|Overall Study|Protocol Violation|0
5318458|NCT00320788|18319413|P3|Overall Study|Protocol Violation|0
5318459|NCT00320788|18319414|P2|Overall Study|Protocol Violation|0
5318460|NCT00320788|18319415|P1|Overall Study|Protocol Violation|0
5318461|NCT00320788|18319411|P5|Overall Study|Physician Decision|0
5318462|NCT00320788|18319412|P4|Overall Study|Physician Decision|0
5318463|NCT00320788|18319413|P3|Overall Study|Physician Decision|0
5318464|NCT00320788|18319414|P2|Overall Study|Physician Decision|1
5318465|NCT00320788|18319415|P1|Overall Study|Physician Decision|1
5318466|NCT00320788|18319411|P5|Overall Study|Other|1
5318467|NCT00320788|18319412|P4|Overall Study|Other|1
5318468|NCT00320788|18319413|P3|Overall Study|Other|1
5318469|NCT00320788|18319414|P2|Overall Study|Other|2
5318470|NCT00320788|18319415|P1|Overall Study|Other|1
5318471|NCT00320788|18319411|P5|Overall Study|Decision by the Sponsor|1
5318472|NCT00320788|18319412|P4|Overall Study|Decision by the Sponsor|0
5318473|NCT00320788|18319413|P3|Overall Study|Decision by the Sponsor|0
5318474|NCT00320788|18319414|P2|Overall Study|Decision by the Sponsor|1
5318475|NCT00320788|18319415|P1|Overall Study|Decision by the Sponsor|1
5318476|NCT00320788|18319411|P5|Overall Study|Lost to Follow-up|0
5318477|NCT00320788|18319412|P4|Overall Study|Lost to Follow-up|0
5318478|NCT00320788|18319413|P3|Overall Study|Lost to Follow-up|1
5318479|NCT00320788|18319414|P2|Overall Study|Lost to Follow-up|2
5318480|NCT00320788|18319415|P1|Overall Study|Lost to Follow-up|0
5318481|NCT00320788|18319411|P5|Overall Study|Death|1
5318482|NCT00320788|18319412|P4|Overall Study|Death|0
5318483|NCT00320788|18319413|P3|Overall Study|Death|1
5318484|NCT00320788|18319414|P2|Overall Study|Death|0
5318485|NCT00320788|18319415|P1|Overall Study|Death|0
5318486|NCT00320788|18319411|P5|Overall Study|Adverse Event|0
5318487|NCT00320788|18319412|P4|Overall Study|Adverse Event|1
5318488|NCT00320788|18319413|P3|Overall Study|Adverse Event|0
5318489|NCT00320788|18319414|P2|Overall Study|Adverse Event|0
5318490|NCT00320788|18319415|P1|Overall Study|Adverse Event|0
5318491|NCT00320710|18319469|P3|Overall Study|Lost to Follow-up|0
5318492|NCT00320710|18319470|P2|Overall Study|Lost to Follow-up|0
5318493|NCT00320710|18319471|P1|Overall Study|Lost to Follow-up|1
5318494|NCT00320710|18319469|P3|Overall Study|Adverse Event|1
5318495|NCT00320710|18319470|P2|Overall Study|Adverse Event|14
5318496|NCT00320710|18319471|P1|Overall Study|Adverse Event|18
5318497|NCT00320710|18319469|P3|Overall Study|Abnormal laboratory value(s)|0
5318498|NCT00320710|18319470|P2|Overall Study|Abnormal laboratory value(s)|3
5318499|NCT00320710|18319471|P1|Overall Study|Abnormal laboratory value(s)|12
5318500|NCT00320710|18319469|P3|Overall Study|Abnormal test procedure result(s)|0
5318501|NCT00320710|18319470|P2|Overall Study|Abnormal test procedure result(s)|0
5318502|NCT00320710|18319471|P1|Overall Study|Abnormal test procedure result(s)|2
5318503|NCT00320710|18319469|P3|Overall Study|Protocol Violation|0
5318504|NCT00320710|18319470|P2|Overall Study|Protocol Violation|5
5318505|NCT00320710|18319471|P1|Overall Study|Protocol Violation|6
5318506|NCT00320710|18319469|P3|Overall Study|Withdrawal by Subject|1
5318507|NCT00320710|18319470|P2|Overall Study|Withdrawal by Subject|26
5318508|NCT00320710|18319471|P1|Overall Study|Withdrawal by Subject|20
5318509|NCT00320710|18319469|P3|Overall Study|Administrative problems|0
5318510|NCT00320710|18319470|P2|Overall Study|Administrative problems|2
5318511|NCT00320710|18319471|P1|Overall Study|Administrative problems|1
5318512|NCT00320710|18319469|P3|Overall Study|Death|1
5318513|NCT00320710|18319470|P2|Overall Study|Death|7
5318514|NCT00320710|18319471|P1|Overall Study|Death|10
5318515|NCT00320710|18319469|P3|Overall Study|Disease progression|2
5318516|NCT00320710|18319470|P2|Overall Study|Disease progression|19
5318517|NCT00320710|18319471|P1|Overall Study|Disease progression|24
5318518|NCT00320606|18319501|P1|Overall Study|Withdrawal by Subject|1
5318519|NCT00320606|18319501|P1|Overall Study|Protocol Violation|1
5318520|NCT00320606|18319501|P1|Overall Study|Adverse Event|1
5318521|NCT00320593|18319517|P2|Overall Study|Withdrawal by clinical center|0
5318522|NCT00320593|18319518|P1|Overall Study|Withdrawal by clinical center|1
5318523|NCT00320593|18319517|P2|Overall Study|Withdrawal by Subject|1
5318524|NCT00320593|18319518|P1|Overall Study|Withdrawal by Subject|2
5318525|NCT00320593|18319517|P2|Overall Study|Moved to another state|0
5318526|NCT00320593|18319518|P1|Overall Study|Moved to another state|1
5318527|NCT00320593|18319517|P2|Overall Study|Lost to Follow-up|0
5318528|NCT00320593|18319518|P1|Overall Study|Lost to Follow-up|3
5318529|NCT00320541|18319542|P2|Overall Study|Protocol Entry Criterion Not Met|0
5318530|NCT00320541|18319543|P1|Overall Study|Protocol Entry Criterion Not Met|1
5318531|NCT00320541|18319542|P2|Overall Study|Death due to Adverse Event(s)|0
5318532|NCT00320541|18319543|P1|Overall Study|Death due to Adverse Event(s)|1
5318533|NCT00320541|18319542|P2|Overall Study|Death due to Study Disease|3
5318534|NCT00320541|18319543|P1|Overall Study|Death due to Study Disease|1
5318535|NCT00320541|18319542|P2|Overall Study|Sponsor Decision|1
5318536|NCT00320541|18319543|P1|Overall Study|Sponsor Decision|2
5318537|NCT00320541|18319542|P2|Overall Study|Other|4
5318538|NCT00320541|18319543|P1|Overall Study|Other|3
5318539|NCT00320541|18319542|P2|Overall Study|Physician Decision|13
5318540|NCT00320541|18319543|P1|Overall Study|Physician Decision|9
5318541|NCT00320541|18319542|P2|Overall Study|Withdrawal by Subject|16
5318542|NCT00320541|18319543|P1|Overall Study|Withdrawal by Subject|12
5318543|NCT00320541|18319542|P2|Overall Study|Protocol Violation|1
5318544|NCT00320541|18319543|P1|Overall Study|Protocol Violation|0
5318545|NCT00320541|18319542|P2|Overall Study|Adverse Event|19
5318546|NCT00320541|18319543|P1|Overall Study|Adverse Event|21
5318547|NCT00320528|18319570|P3|Study Period III|Atomoxetine Commercially Available|90
5318548|NCT00320528|18319571|P2|Study Period III|Atomoxetine Commercially Available|25
5318549|NCT00320528|18319572|P1|Study Period III|Atomoxetine Commercially Available|68
5318550|NCT00320528|18319570|P3|Study Period III|Sponsor Decision|1
5318551|NCT00320528|18319571|P2|Study Period III|Sponsor Decision|0
5318552|NCT00320528|18319572|P1|Study Period III|Sponsor Decision|0
5318553|NCT00320528|18319570|P3|Study Period III|Physician Decision|2
5318554|NCT00320528|18319571|P2|Study Period III|Physician Decision|1
5318555|NCT00320528|18319572|P1|Study Period III|Physician Decision|0
5318556|NCT00320528|18319570|P3|Study Period III|Protocol Violation|0
5318557|NCT00320528|18319571|P2|Study Period III|Protocol Violation|1
5318558|NCT00320528|18319572|P1|Study Period III|Protocol Violation|0
5318559|NCT00320528|18319570|P3|Study Period III|Parent/Caregiver Decision|11
5318560|NCT00320528|18319571|P2|Study Period III|Parent/Caregiver Decision|3
5318561|NCT00320528|18319572|P1|Study Period III|Parent/Caregiver Decision|14
5318562|NCT00320528|18319570|P3|Study Period III|Lack of Efficacy|0
5318563|NCT00320528|18319571|P2|Study Period III|Lack of Efficacy|0
5318564|NCT00320528|18319572|P1|Study Period III|Lack of Efficacy|2
5318565|NCT00320528|18319570|P3|Study Period III|Withdrawal by Subject|2
5318566|NCT00320528|18319571|P2|Study Period III|Withdrawal by Subject|1
5318567|NCT00320528|18319572|P1|Study Period III|Withdrawal by Subject|1
5318568|NCT00320528|18319570|P3|Study Period III|Lost to Follow-up|0
5318569|NCT00320528|18319571|P2|Study Period III|Lost to Follow-up|0
5318570|NCT00320528|18319572|P1|Study Period III|Lost to Follow-up|1
5318571|NCT00320528|18319570|P3|Study Period III|Adverse Event|0
5318572|NCT00320528|18319571|P2|Study Period III|Adverse Event|0
5318573|NCT00320528|18319572|P1|Study Period III|Adverse Event|1
5318574|NCT00320528|18319570|P3|Study Period II|Entry Criteria Exclusion|2
5318575|NCT00320528|18319571|P2|Study Period II|Entry Criteria Exclusion|2
5318576|NCT00320528|18319572|P1|Study Period II|Entry Criteria Exclusion|0
5318577|NCT00320528|18319570|P3|Study Period II|Withdrawal by Subject|1
5318578|NCT00320528|18319571|P2|Study Period II|Withdrawal by Subject|1
5318579|NCT00320528|18319572|P1|Study Period II|Withdrawal by Subject|0
5318580|NCT00320528|18319570|P3|Study Period II|Parent/Caregiver Decision|11
5318581|NCT00320528|18319571|P2|Study Period II|Parent/Caregiver Decision|3
5318582|NCT00320528|18319572|P1|Study Period II|Parent/Caregiver Decision|8
5318583|NCT00320528|18319570|P3|Study Period II|Adverse Event|8
5318584|NCT00320528|18319571|P2|Study Period II|Adverse Event|4
5318585|NCT00320528|18319572|P1|Study Period II|Adverse Event|3
5318586|NCT00320515|18319607|P1|Overall Study|Withdrawal by Subject|8
5318587|NCT00320515|18319607|P1|Overall Study|Physician Decision|2
5318588|NCT00320515|18319607|P1|Overall Study|Lost to Follow-up|6
5318589|NCT00320515|18319607|P1|Overall Study|Death|33
5318590|NCT00320489|18319616|P2|Overall Study|Withdrawal by Subject|41
5318591|NCT00320489|18319617|P1|Overall Study|Withdrawal by Subject|39
5318592|NCT00320489|18319616|P2|Overall Study|Sponsor Decision|3
5318593|NCT00320489|18319617|P1|Overall Study|Sponsor Decision|3
5318594|NCT00320489|18319616|P2|Overall Study|Protocol Violation|4
5318595|NCT00320489|18319617|P1|Overall Study|Protocol Violation|4
5318596|NCT00320489|18319616|P2|Overall Study|Physician Decision|8
5318597|NCT00320489|18319617|P1|Overall Study|Physician Decision|8
5318598|NCT00320489|18319616|P2|Overall Study|Lost to Follow-up|22
5318599|NCT00320489|18319617|P1|Overall Study|Lost to Follow-up|21
5318600|NCT00320489|18319616|P2|Overall Study|Lack of Efficacy|7
5318601|NCT00320489|18319617|P1|Overall Study|Lack of Efficacy|16
5318602|NCT00320489|18319616|P2|Overall Study|Entry Criteria Exclusion|4
5318603|NCT00320489|18319617|P1|Overall Study|Entry Criteria Exclusion|2
5318604|NCT00320489|18319616|P2|Overall Study|Death|2
5318605|NCT00320489|18319617|P1|Overall Study|Death|0
5318606|NCT00320489|18319616|P2|Overall Study|Clinical Relapse|20
5318607|NCT00320489|18319617|P1|Overall Study|Clinical Relapse|26
5318608|NCT00320489|18319616|P2|Overall Study|Adverse Event|25
5318609|NCT00320489|18319617|P1|Overall Study|Adverse Event|26
5318610|NCT00320424|18319673|P1|Overall Study|Other|3
5318611|NCT00320424|18319673|P1|Overall Study|Adverse Event|3
5318612|NCT00320411|18319687|P1|Overall Study|No investigational product admin.|4
5318613|NCT00320398|18319710|P2|Overall Study|Other|0
5318614|NCT00320398|18319711|P1|Overall Study|Other|1
5318615|NCT00320398|18319710|P2|Overall Study|Adverse Event|4
5318616|NCT00320398|18319711|P1|Overall Study|Adverse Event|1
5318617|NCT00320385|18319739|P2|Overall Study|Adverse Event|1
5318618|NCT00320385|18319740|P1|Overall Study|Adverse Event|0
5318619|NCT00320385|18319739|P2|Overall Study|Withdrew Consent|0
5318620|NCT00320385|18319740|P1|Overall Study|Withdrew Consent|1
5318621|NCT00320385|18319739|P2|Overall Study|Serious Adverse Event|0
5318622|NCT00320385|18319740|P1|Overall Study|Serious Adverse Event|1
5318623|NCT00320385|18319739|P2|Overall Study|Death|2
5318624|NCT00320385|18319740|P1|Overall Study|Death|1
5318625|NCT00320385|18319739|P2|Overall Study|Investigator Decision|1
5318626|NCT00320385|18319740|P1|Overall Study|Investigator Decision|0
5318627|NCT00320385|18319739|P2|Overall Study|Sponsor Terminated Study|1
5318628|NCT00320385|18319740|P1|Overall Study|Sponsor Terminated Study|2
5318629|NCT00320385|18319739|P2|Overall Study|Withdrawal by Subject|7
5318630|NCT00320385|18319740|P1|Overall Study|Withdrawal by Subject|6
5318631|NCT00320385|18319739|P2|Overall Study|Lost to Follow-up|10
5318632|NCT00320385|18319740|P1|Overall Study|Lost to Follow-up|7
5318633|NCT00320372|18319763|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
5318634|NCT00320372|18319764|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
5318635|NCT00320372|18319763|P2|Overall Study|Did not Meet (I/E)|1
5318636|NCT00320372|18319764|P1|Overall Study|Did not Meet (I/E)|3
5318637|NCT00320372|18319763|P2|Overall Study|Non-Compliance|39
5318638|NCT00320372|18319764|P1|Overall Study|Non-Compliance|40
5318639|NCT00320372|18319763|P2|Overall Study|Withdrawal by Subject|37
5318640|NCT00320372|18319764|P1|Overall Study|Withdrawal by Subject|55
5318641|NCT00320372|18319763|P2|Overall Study|Death|8
5318642|NCT00320372|18319764|P1|Overall Study|Death|7
5318643|NCT00320372|18319763|P2|Overall Study|Physician Decision|7
5318644|NCT00320372|18319764|P1|Overall Study|Physician Decision|4
5318645|NCT00320255|18319806|P6|Overall Study|Other|0
5318646|NCT00320255|18319807|P5|Overall Study|Other|0
5318647|NCT00320255|18319808|P4|Overall Study|Other|0
5318648|NCT00320255|18319809|P3|Overall Study|Other|1
5318649|NCT00320255|18319810|P2|Overall Study|Other|2
5318650|NCT00320255|18319811|P1|Overall Study|Other|3
5318651|NCT00320255|18319806|P6|Overall Study|No longer meets study criteria|0
5318652|NCT00320255|18319807|P5|Overall Study|No longer meets study criteria|0
5318653|NCT00320255|18319808|P4|Overall Study|No longer meets study criteria|1
5318654|NCT00320255|18319809|P3|Overall Study|No longer meets study criteria|0
5318655|NCT00320255|18319810|P2|Overall Study|No longer meets study criteria|0
5318656|NCT00320255|18319811|P1|Overall Study|No longer meets study criteria|0
5318657|NCT00320255|18319806|P6|Overall Study|Poor compliance/noncompliance|0
5318658|NCT00320255|18319807|P5|Overall Study|Poor compliance/noncompliance|0
5318659|NCT00320255|18319808|P4|Overall Study|Poor compliance/noncompliance|1
5318660|NCT00320255|18319809|P3|Overall Study|Poor compliance/noncompliance|0
5318661|NCT00320255|18319810|P2|Overall Study|Poor compliance/noncompliance|1
5318662|NCT00320255|18319811|P1|Overall Study|Poor compliance/noncompliance|1
5318663|NCT00320255|18319806|P6|Overall Study|Withdrawal by Subject|0
5318664|NCT00320255|18319807|P5|Overall Study|Withdrawal by Subject|0
5318665|NCT00320255|18319808|P4|Overall Study|Withdrawal by Subject|4
5318666|NCT00320255|18319809|P3|Overall Study|Withdrawal by Subject|2
5318667|NCT00320255|18319810|P2|Overall Study|Withdrawal by Subject|2
5318668|NCT00320255|18319811|P1|Overall Study|Withdrawal by Subject|1
5318669|NCT00320255|18319806|P6|Overall Study|Adverse Event|0
5318670|NCT00320255|18319807|P5|Overall Study|Adverse Event|0
5318671|NCT00320255|18319808|P4|Overall Study|Adverse Event|2
5318672|NCT00320255|18319809|P3|Overall Study|Adverse Event|3
5318673|NCT00320255|18319810|P2|Overall Study|Adverse Event|2
5318674|NCT00320255|18319811|P1|Overall Study|Adverse Event|5
5318675|NCT00320255|18319806|P6|Overall Study|Lack of Efficacy|0
5318676|NCT00320255|18319807|P5|Overall Study|Lack of Efficacy|0
5318677|NCT00320255|18319808|P4|Overall Study|Lack of Efficacy|0
5318678|NCT00320255|18319809|P3|Overall Study|Lack of Efficacy|0
5318679|NCT00320255|18319810|P2|Overall Study|Lack of Efficacy|0
5318680|NCT00320255|18319811|P1|Overall Study|Lack of Efficacy|1
5318681|NCT00320216|18319904|P5|Overall Study|Other|3
5318682|NCT00320216|18319905|P4|Overall Study|Other|1
5318683|NCT00320216|18319906|P3|Overall Study|Other|5
5318684|NCT00320216|18319907|P2|Overall Study|Other|2
5318685|NCT00320216|18319908|P1|Overall Study|Other|7
5318686|NCT00320216|18319904|P5|Overall Study|Lost to Follow-up|0
5318687|NCT00320216|18319905|P4|Overall Study|Lost to Follow-up|0
5318688|NCT00320216|18319906|P3|Overall Study|Lost to Follow-up|0
5318689|NCT00320216|18319907|P2|Overall Study|Lost to Follow-up|0
5318690|NCT00320216|18319908|P1|Overall Study|Lost to Follow-up|3
5318691|NCT00320216|18319904|P5|Overall Study|Lack of Efficacy|1
5318692|NCT00320216|18319905|P4|Overall Study|Lack of Efficacy|0
5318693|NCT00320216|18319906|P3|Overall Study|Lack of Efficacy|1
5318694|NCT00320216|18319907|P2|Overall Study|Lack of Efficacy|2
5318695|NCT00320216|18319908|P1|Overall Study|Lack of Efficacy|6
5318696|NCT00320216|18319904|P5|Overall Study|Adverse Event|2
5318697|NCT00320216|18319905|P4|Overall Study|Adverse Event|2
5318698|NCT00320216|18319906|P3|Overall Study|Adverse Event|0
5318699|NCT00320216|18319907|P2|Overall Study|Adverse Event|6
5318700|NCT00320216|18319908|P1|Overall Study|Adverse Event|0
5318701|NCT00320190|18319942|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
5318702|NCT00320190|18319943|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
5318949|NCT00318461|18320415|P4|Double-Blind, 6 Months|Lack of Efficacy|29
5318703|NCT00320190|18319942|P2|Long-term (12-month) Extension|Lack of major molecular response|2
5318704|NCT00320190|18319943|P1|Long-term (12-month) Extension|Lack of major molecular response|1
5318705|NCT00320190|18319942|P2|Long-term (12-month) Extension|Sponsor terminated study|0
5318706|NCT00320190|18319943|P1|Long-term (12-month) Extension|Sponsor terminated study|7
5318707|NCT00320190|18319942|P2|First 12 Months|Withdrawal by Subject|1
5318708|NCT00320190|18319943|P1|First 12 Months|Withdrawal by Subject|0
5318709|NCT00320190|18319942|P2|First 12 Months|Study drug toxicity|1
5318710|NCT00320190|18319943|P1|First 12 Months|Study drug toxicity|0
5318711|NCT00320190|18319942|P2|First 12 Months|Investigator request|1
5318712|NCT00320190|18319943|P1|First 12 Months|Investigator request|0
5318713|NCT00320190|18319942|P2|First 12 Months|Adverse event unrelated to study drug|0
5318714|NCT00320190|18319943|P1|First 12 Months|Adverse event unrelated to study drug|1
5318715|NCT00320190|18319942|P2|First 12 Months|Enrollment failure|1
5318716|NCT00320190|18319943|P1|First 12 Months|Enrollment failure|0
5318717|NCT00320190|18319942|P2|First 12 Months|Lost to Follow-up|1
5318718|NCT00320190|18319943|P1|First 12 Months|Lost to Follow-up|0
5318719|NCT00320190|18319942|P2|First 12 Months|Sponsor terminated study|2
5318720|NCT00320190|18319943|P1|First 12 Months|Sponsor terminated study|2
5318721|NCT00320190|18319942|P2|First 12 Months|Completed but did not enter extension|3
5318722|NCT00320190|18319943|P1|First 12 Months|Completed but did not enter extension|5
5318723|NCT00320112|18319963|P2|Overall Study|Death|1
5318724|NCT00320112|18319964|P1|Overall Study|Death|2
5318725|NCT00320112|18319963|P2|Overall Study|Withdrawal by Subject|0
5318726|NCT00320112|18319964|P1|Overall Study|Withdrawal by Subject|3
5318727|NCT00320112|18319963|P2|Overall Study|Lost to Follow-up|4
5318728|NCT00320112|18319964|P1|Overall Study|Lost to Follow-up|3
5318729|NCT00319982|18319978|P2|Overall Study|Withdrawal by Subject|0
5318730|NCT00319982|18319979|P1|Overall Study|Withdrawal by Subject|1
5318731|NCT00319956|18319999|P2|Overall Study|Death|24
5318732|NCT00319956|18320000|P1|Overall Study|Death|20
5318733|NCT00319839|18320012|P1|Overall Study|Withdrawal by Subject|1
5318734|NCT00319839|18320012|P1|Overall Study|Adverse Event|5
5318735|NCT00319735|18320028|P1|Overall Study|Death|2
5318736|NCT00319696|18320041|P1|Overall Study|Lost to Follow-up|3
5318737|NCT00319696|18320041|P1|Overall Study|administrative|7
5318738|NCT00319696|18320041|P1|Overall Study|withdrawal of consent|14
5318739|NCT00319696|18320041|P1|Overall Study|Adverse Event|36
5318740|NCT00319592|18320078|P2|Overall Study|Physician Decision|1
5318741|NCT00319592|18320079|P1|Overall Study|Physician Decision|0
5318742|NCT00319592|18320078|P2|Overall Study|Protocol Violation|0
5318743|NCT00319592|18320079|P1|Overall Study|Protocol Violation|1
5318744|NCT00319553|18320095|P2|Overall Study|Withdrawal by Subject|1
5318745|NCT00319553|18320096|P1|Overall Study|Withdrawal by Subject|1
5318746|NCT00319553|18320095|P2|Overall Study|Lost to Follow-up|1
5318747|NCT00319553|18320096|P1|Overall Study|Lost to Follow-up|2
5318748|NCT00319553|18320095|P2|Overall Study|Protocol Violation|2
5318749|NCT00319553|18320096|P1|Overall Study|Protocol Violation|1
5318750|NCT00319501|18320110|P2|Open-label Extension Period|Withdrawal by Subject|0
5318751|NCT00319501|18320111|P1|Open-label Extension Period|Withdrawal by Subject|2
5318752|NCT00319501|18320110|P2|Open-label Extension Period|Sponsor request|0
5318753|NCT00319501|18320111|P1|Open-label Extension Period|Sponsor request|26
5318754|NCT00319501|18320110|P2|Open-label Extension Period|Principal investigator decision|0
5318755|NCT00319501|18320111|P1|Open-label Extension Period|Principal investigator decision|2
5318756|NCT00319501|18320110|P2|Open-label Extension Period|Other|0
5318757|NCT00319501|18320111|P1|Open-label Extension Period|Other|1
5318758|NCT00319501|18320110|P2|Open-label Extension Period|Did not receive treatment|0
5318759|NCT00319501|18320111|P1|Open-label Extension Period|Did not receive treatment|18
5318760|NCT00319501|18320110|P2|Open-label Extension Period|Adverse Event|0
5318761|NCT00319501|18320111|P1|Open-label Extension Period|Adverse Event|2
5318762|NCT00319501|18320110|P2|Open-label Period|Other|0
5318763|NCT00319501|18320111|P1|Open-label Period|Other|11
5318764|NCT00319501|18320110|P2|Open-label Period|Did not receive treatment|0
5318765|NCT00319501|18320111|P1|Open-label Period|Did not receive treatment|33
5318766|NCT00319501|18320110|P2|Open-label Period|Lost to Follow-up|0
5318767|NCT00319501|18320111|P1|Open-label Period|Lost to Follow-up|5
5318768|NCT00319501|18320110|P2|Open-label Period|Sponsor request|0
5318769|NCT00319501|18320111|P1|Open-label Period|Sponsor request|12
5318770|NCT00319501|18320110|P2|Open-label Period|Principal Investigator decision|0
5318771|NCT00319501|18320111|P1|Open-label Period|Principal Investigator decision|6
5318772|NCT00319501|18320110|P2|Open-label Period|Withdrawal by Subject|0
5318773|NCT00319501|18320111|P1|Open-label Period|Withdrawal by Subject|38
5318774|NCT00319501|18320110|P2|Open-label Period|Protocol Violation|0
5318775|NCT00319501|18320111|P1|Open-label Period|Protocol Violation|6
5318776|NCT00319501|18320110|P2|Open-label Period|Adverse Event|0
5318777|NCT00319501|18320111|P1|Open-label Period|Adverse Event|5
5318778|NCT00319501|18320110|P2|Double-blind Period|Did not receive treatment|29
5318779|NCT00319501|18320111|P1|Double-blind Period|Did not receive treatment|42
5318780|NCT00319501|18320110|P2|Double-blind Period|Sponsor Request|0
5318781|NCT00319501|18320111|P1|Double-blind Period|Sponsor Request|1
5318782|NCT00319501|18320110|P2|Double-blind Period|Withdrawal by Subject|3
5318783|NCT00319501|18320111|P1|Double-blind Period|Withdrawal by Subject|0
5318784|NCT00319449|18320137|P2|Overall Study|Noncompliance with the protocol|0
5318785|NCT00319449|18320138|P1|Overall Study|Noncompliance with the protocol|1
5318786|NCT00319449|18320137|P2|Overall Study|Subject did not wish to continue|0
5318787|NCT00319449|18320138|P1|Overall Study|Subject did not wish to continue|1
5318788|NCT00319436|18320150|P2|Overall Study|Withdrawal by Subject|7
5318789|NCT00319436|18320151|P1|Overall Study|Withdrawal by Subject|6
5318790|NCT00319254|18320169|P1|Overall Study|Enrolled, Not Treated|2
5318791|NCT00319254|18320169|P1|Overall Study|Lost to Follow-up|2
5318792|NCT00319254|18320169|P1|Overall Study|Death|46
5318793|NCT00319254|18320169|P1|Overall Study|Withdrawal by Subject|4
5318794|NCT00319111|18320182|P1|Overall Study|Treatment failure|1
5318795|NCT00319111|18320182|P1|Overall Study|Administrative|2
5318796|NCT00319111|18320182|P1|Overall Study|Lack of clinical improvement|4
5318797|NCT00319111|18320182|P1|Overall Study|Death|9
5318798|NCT00319111|18320182|P1|Overall Study|Withdrawal of consent|11
5318799|NCT00319111|18320182|P1|Overall Study|Adverse Event|20
5318800|NCT00319098|18320196|P2|Overall Study|Protocol Violation|1
5318801|NCT00319098|18320197|P1|Overall Study|Protocol Violation|3
5318802|NCT00319098|18320196|P2|Overall Study|Others|8
5318803|NCT00319098|18320197|P1|Overall Study|Others|33
5318804|NCT00319098|18320196|P2|Overall Study|Lost to Follow-up|13
5318805|NCT00319098|18320197|P1|Overall Study|Lost to Follow-up|37
5318806|NCT00319098|18320196|P2|Overall Study|Migrated/moved from study area|1
5318807|NCT00319098|18320197|P1|Overall Study|Migrated/moved from study area|2
5318808|NCT00319098|18320196|P2|Overall Study|Withdrawal by Subject|8
5318809|NCT00319098|18320197|P1|Overall Study|Withdrawal by Subject|37
5318810|NCT00319098|18320196|P2|Overall Study|Adverse Event|1
5318811|NCT00319098|18320197|P1|Overall Study|Adverse Event|20
5318812|NCT00319098|18320196|P2|Overall Study|Serious adverse event|0
5318813|NCT00319098|18320197|P1|Overall Study|Serious adverse event|3
5318814|NCT00319046|18320255|P1|Overall Study|administrative reason|1
5318815|NCT00319046|18320255|P1|Overall Study|withdrawal of subject's consent|7
5318816|NCT00319020|18320264|P2|Overall Study|Adverse Event|1
5318817|NCT00319020|18320265|P1|Overall Study|Adverse Event|0
5318818|NCT00319020|18320264|P2|Overall Study|Treatment failure|1
5318819|NCT00319020|18320265|P1|Overall Study|Treatment failure|0
5318820|NCT00319020|18320264|P2|Overall Study|Transplant|1
5318821|NCT00319020|18320265|P1|Overall Study|Transplant|0
5318822|NCT00319020|18320264|P2|Overall Study|Disease progression|2
5318823|NCT00319020|18320265|P1|Overall Study|Disease progression|0
5318824|NCT00319020|18320264|P2|Overall Study|Administrative reason|5
5318825|NCT00319020|18320265|P1|Overall Study|Administrative reason|0
5318826|NCT00319020|18320264|P2|Overall Study|F-1 completed but not enrolled in F-2|0
5318827|NCT00319020|18320265|P1|Overall Study|F-1 completed but not enrolled in F-2|1
5318828|NCT00319020|18320264|P2|Overall Study|Withdrawal by Subject|1
5318829|NCT00319020|18320265|P1|Overall Study|Withdrawal by Subject|4
5318830|NCT00319020|18320264|P2|Overall Study|Death|2
5318831|NCT00319020|18320265|P1|Overall Study|Death|2
5318832|NCT00318656|18320337|P2|Overall Study|Did not receive any treatment|1
5318833|NCT00318656|18320338|P1|Overall Study|Did not receive any treatment|0
5318834|NCT00318656|18320337|P2|Overall Study|Took Avandamet instead of Glim/Met|1
5318835|NCT00318656|18320338|P1|Overall Study|Took Avandamet instead of Glim/Met|0
5318836|NCT00318565|18320395|P1|Overall Study|Excluded per protocol|24
5318837|NCT00318474|18320402|P2|Overall Study|Trial terminated|7
5318838|NCT00318474|18320403|P1|Overall Study|Trial terminated|10
5318839|NCT00318474|18320402|P2|Overall Study|Post-therapy hyperflycemia|1
5318840|NCT00318474|18320403|P1|Overall Study|Post-therapy hyperflycemia|0
5318841|NCT00318474|18320402|P2|Overall Study|Fall in GFR|3
5318842|NCT00318474|18320403|P1|Overall Study|Fall in GFR|3
5318843|NCT00318474|18320402|P2|Overall Study|Withdrawal by Subject|2
5318844|NCT00318474|18320403|P1|Overall Study|Withdrawal by Subject|3
5318845|NCT00318474|18320402|P2|Overall Study|Protocol Violation|0
5318846|NCT00318474|18320403|P1|Overall Study|Protocol Violation|1
5318847|NCT00318474|18320402|P2|Overall Study|Pregnancy|2
5318848|NCT00318474|18320403|P1|Overall Study|Pregnancy|0
5318849|NCT00318474|18320402|P2|Overall Study|Lost to Follow-up|1
5318850|NCT00318474|18320403|P1|Overall Study|Lost to Follow-up|0
5318851|NCT00318474|18320402|P2|Overall Study|Adverse Event|1
5318852|NCT00318474|18320403|P1|Overall Study|Adverse Event|1
5318853|NCT00318461|18320414|P5|Open-Label Extension, 18 Months|Protocol Violation|6
5318854|NCT00318461|18320415|P4|Open-Label Extension, 18 Months|Protocol Violation|4
5318855|NCT00318461|18320416|P3|Open-Label Extension, 18 Months|Protocol Violation|3
5318856|NCT00318461|18320417|P2|Open-Label Extension, 18 Months|Protocol Violation|5
5318857|NCT00318461|18320418|P1|Open-Label Extension, 18 Months|Protocol Violation|7
5318858|NCT00318461|18320414|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
5318859|NCT00318461|18320415|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
5318860|NCT00318461|18320416|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
5318861|NCT00318461|18320417|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
5318862|NCT00318461|18320418|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
5318863|NCT00318461|18320414|P5|Open-Label Extension, 18 Months|Adverse Event|6
5318864|NCT00318461|18320415|P4|Open-Label Extension, 18 Months|Adverse Event|1
5318865|NCT00318461|18320416|P3|Open-Label Extension, 18 Months|Adverse Event|6
5318866|NCT00318461|18320417|P2|Open-Label Extension, 18 Months|Adverse Event|8
5318867|NCT00318461|18320418|P1|Open-Label Extension, 18 Months|Adverse Event|11
5318868|NCT00318461|18320414|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
5318869|NCT00318461|18320415|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
5318870|NCT00318461|18320416|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
5318871|NCT00318461|18320417|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
5318872|NCT00318461|18320418|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
5318873|NCT00318461|18320414|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
5318874|NCT00318461|18320415|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
5318875|NCT00318461|18320416|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
5318876|NCT00318461|18320417|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
5318877|NCT00318461|18320418|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
5318878|NCT00318461|18320414|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
5318879|NCT00318461|18320415|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5318880|NCT00318461|18320416|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5318881|NCT00318461|18320417|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5318882|NCT00318461|18320418|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5318883|NCT00318461|18320414|P5|Double-Blind, 6 Months|Hyperglicaemia|0
5318884|NCT00318461|18320415|P4|Double-Blind, 6 Months|Hyperglicaemia|1
5318885|NCT00318461|18320416|P3|Double-Blind, 6 Months|Hyperglicaemia|0
5318886|NCT00318461|18320417|P2|Double-Blind, 6 Months|Hyperglicaemia|0
5318887|NCT00318461|18320418|P1|Double-Blind, 6 Months|Hyperglicaemia|0
5318888|NCT00318461|18320414|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
5318889|NCT00318461|18320415|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5318890|NCT00318461|18320416|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5318891|NCT00318461|18320417|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5318892|NCT00318461|18320418|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5318893|NCT00318461|18320414|P5|Double-Blind, 6 Months|Lack of time|0
5318894|NCT00318461|18320415|P4|Double-Blind, 6 Months|Lack of time|0
5318895|NCT00318461|18320416|P3|Double-Blind, 6 Months|Lack of time|0
5318896|NCT00318461|18320417|P2|Double-Blind, 6 Months|Lack of time|0
5318897|NCT00318461|18320418|P1|Double-Blind, 6 Months|Lack of time|1
5318898|NCT00318461|18320414|P5|Double-Blind, 6 Months|Investigator decision|1
5318899|NCT00318461|18320415|P4|Double-Blind, 6 Months|Investigator decision|0
5318900|NCT00318461|18320416|P3|Double-Blind, 6 Months|Investigator decision|0
5318901|NCT00318461|18320417|P2|Double-Blind, 6 Months|Investigator decision|0
5318902|NCT00318461|18320418|P1|Double-Blind, 6 Months|Investigator decision|0
5318903|NCT00318461|18320414|P5|Double-Blind, 6 Months|Work commitment|1
5318904|NCT00318461|18320415|P4|Double-Blind, 6 Months|Work commitment|0
5318905|NCT00318461|18320416|P3|Double-Blind, 6 Months|Work commitment|0
5318906|NCT00318461|18320417|P2|Double-Blind, 6 Months|Work commitment|0
5318907|NCT00318461|18320418|P1|Double-Blind, 6 Months|Work commitment|0
5318908|NCT00318461|18320414|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
5318909|NCT00318461|18320415|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
5318910|NCT00318461|18320416|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
5318911|NCT00318461|18320417|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
5318912|NCT00318461|18320418|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
5318913|NCT00318461|18320414|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
5318914|NCT00318461|18320415|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5318915|NCT00318461|18320416|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5318916|NCT00318461|18320417|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5318917|NCT00318461|18320418|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5318918|NCT00318461|18320414|P5|Double-Blind, 6 Months|Move|0
5318919|NCT00318461|18320415|P4|Double-Blind, 6 Months|Move|0
5318920|NCT00318461|18320416|P3|Double-Blind, 6 Months|Move|0
5318921|NCT00318461|18320417|P2|Double-Blind, 6 Months|Move|1
5318922|NCT00318461|18320418|P1|Double-Blind, 6 Months|Move|0
5318923|NCT00318461|18320414|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
5318924|NCT00318461|18320415|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
5318925|NCT00318461|18320416|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
5318926|NCT00318461|18320417|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
5318927|NCT00318461|18320418|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
5318928|NCT00318461|18320414|P5|Double-Blind, 6 Months|Consent withdrawn|4
5318929|NCT00318461|18320415|P4|Double-Blind, 6 Months|Consent withdrawn|10
5318930|NCT00318461|18320416|P3|Double-Blind, 6 Months|Consent withdrawn|4
5318931|NCT00318461|18320417|P2|Double-Blind, 6 Months|Consent withdrawn|3
5318932|NCT00318461|18320418|P1|Double-Blind, 6 Months|Consent withdrawn|0
5318933|NCT00318461|18320414|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5318934|NCT00318461|18320415|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5318935|NCT00318461|18320416|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5318936|NCT00318461|18320417|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
5318937|NCT00318461|18320418|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5318938|NCT00318461|18320414|P5|Double-Blind, 6 Months|Lost to follow up|0
5318939|NCT00318461|18320415|P4|Double-Blind, 6 Months|Lost to follow up|0
5318940|NCT00318461|18320416|P3|Double-Blind, 6 Months|Lost to follow up|0
5318941|NCT00318461|18320417|P2|Double-Blind, 6 Months|Lost to follow up|1
5318942|NCT00318461|18320418|P1|Double-Blind, 6 Months|Lost to follow up|0
5318943|NCT00318461|18320414|P5|Double-Blind, 6 Months|Protocol Violation|5
5318944|NCT00318461|18320415|P4|Double-Blind, 6 Months|Protocol Violation|4
5318945|NCT00318461|18320416|P3|Double-Blind, 6 Months|Protocol Violation|4
5318946|NCT00318461|18320417|P2|Double-Blind, 6 Months|Protocol Violation|4
5318947|NCT00318461|18320418|P1|Double-Blind, 6 Months|Protocol Violation|2
5318948|NCT00318461|18320414|P5|Double-Blind, 6 Months|Lack of Efficacy|9
5318950|NCT00318461|18320416|P3|Double-Blind, 6 Months|Lack of Efficacy|13
5318951|NCT00318461|18320417|P2|Double-Blind, 6 Months|Lack of Efficacy|8
5318952|NCT00318461|18320418|P1|Double-Blind, 6 Months|Lack of Efficacy|19
5318953|NCT00318461|18320414|P5|Double-Blind, 6 Months|Adverse Event|8
5318954|NCT00318461|18320415|P4|Double-Blind, 6 Months|Adverse Event|2
5318955|NCT00318461|18320416|P3|Double-Blind, 6 Months|Adverse Event|29
5318956|NCT00318461|18320417|P2|Double-Blind, 6 Months|Adverse Event|23
5318957|NCT00318461|18320418|P1|Double-Blind, 6 Months|Adverse Event|11
5318958|NCT00318370|18320517|P3|Period 3|Other|3
5318959|NCT00318370|18320518|P2|Period 3|Other|0
5318960|NCT00318370|18320519|P1|Period 3|Other|0
5318961|NCT00318370|18320517|P3|Period 3|Withdrawal by Subject|3
5318962|NCT00318370|18320518|P2|Period 3|Withdrawal by Subject|0
5318963|NCT00318370|18320519|P1|Period 3|Withdrawal by Subject|0
5318964|NCT00318370|18320517|P3|Period 3|Physician Decision|1
5318965|NCT00318370|18320518|P2|Period 3|Physician Decision|0
5318966|NCT00318370|18320519|P1|Period 3|Physician Decision|0
5318967|NCT00318370|18320517|P3|Period 3|Death|1
5318968|NCT00318370|18320518|P2|Period 3|Death|0
5318969|NCT00318370|18320519|P1|Period 3|Death|0
5318970|NCT00318370|18320517|P3|Period 3|Lack of Efficacy|24
5318971|NCT00318370|18320518|P2|Period 3|Lack of Efficacy|0
5318972|NCT00318370|18320519|P1|Period 3|Lack of Efficacy|0
5318973|NCT00318370|18320517|P3|Period 3|Adverse Event|1
5318974|NCT00318370|18320518|P2|Period 3|Adverse Event|0
5318975|NCT00318370|18320519|P1|Period 3|Adverse Event|0
5318976|NCT00318370|18320517|P3|Period 2|Other|0
5318977|NCT00318370|18320518|P2|Period 2|Other|1
5318978|NCT00318370|18320519|P1|Period 2|Other|0
5318979|NCT00318370|18320517|P3|Period 2|Withdrawal by Subject|0
5318980|NCT00318370|18320518|P2|Period 2|Withdrawal by Subject|1
5318981|NCT00318370|18320519|P1|Period 2|Withdrawal by Subject|0
5318982|NCT00318370|18320517|P3|Period 2|Physician Decision|0
5318983|NCT00318370|18320518|P2|Period 2|Physician Decision|1
5318984|NCT00318370|18320519|P1|Period 2|Physician Decision|0
5318985|NCT00318370|18320517|P3|Period 2|Lack of Efficacy|0
5318986|NCT00318370|18320518|P2|Period 2|Lack of Efficacy|5
5318987|NCT00318370|18320519|P1|Period 2|Lack of Efficacy|0
5318988|NCT00318370|18320517|P3|Period 2|Adverse Event|0
5318989|NCT00318370|18320518|P2|Period 2|Adverse Event|3
5318990|NCT00318370|18320519|P1|Period 2|Adverse Event|0
5318991|NCT00318370|18320517|P3|Period 1|Withdrawal by Subject|0
5318992|NCT00318370|18320518|P2|Period 1|Withdrawal by Subject|0
5318993|NCT00318370|18320519|P1|Period 1|Withdrawal by Subject|1
5318994|NCT00318370|18320517|P3|Period 1|Physician Decision|0
5318995|NCT00318370|18320518|P2|Period 1|Physician Decision|0
5318996|NCT00318370|18320519|P1|Period 1|Physician Decision|1
5318997|NCT00318370|18320517|P3|Period 1|Lack of Efficacy|0
5318998|NCT00318370|18320518|P2|Period 1|Lack of Efficacy|0
5318999|NCT00318370|18320519|P1|Period 1|Lack of Efficacy|5
5319000|NCT00318149|18320553|P6|Overall Study|Adverse Event|2
5319001|NCT00318149|18320554|P5|Overall Study|Adverse Event|0
5319002|NCT00318149|18320555|P4|Overall Study|Adverse Event|0
5319003|NCT00318149|18320556|P3|Overall Study|Adverse Event|0
5319004|NCT00318149|18320557|P2|Overall Study|Adverse Event|0
5319005|NCT00318149|18320558|P1|Overall Study|Adverse Event|0
5319006|NCT00317642|18320704|P2|Overall Study|AML Not Centrally Confirmed|5
5319007|NCT00317642|18320705|P1|Overall Study|AML Not Centrally Confirmed|1
5319008|NCT00317642|18320704|P2|Overall Study|Referred For Transplantation|0
5319009|NCT00317642|18320705|P1|Overall Study|Referred For Transplantation|1
5319010|NCT00317642|18320704|P2|Overall Study|Withdrawal by Subject|1
5319011|NCT00317642|18320705|P1|Overall Study|Withdrawal by Subject|0
5319012|NCT00317642|18320704|P2|Overall Study|Not Continue to Consolidation|0
5319013|NCT00317642|18320705|P1|Overall Study|Not Continue to Consolidation|2
5319014|NCT00317642|18320704|P2|Overall Study|Death|7
5319015|NCT00317642|18320705|P1|Overall Study|Death|14
5319016|NCT00317642|18320704|P2|Overall Study|Disease Recurrence|2
5319017|NCT00317642|18320705|P1|Overall Study|Disease Recurrence|1
5319018|NCT00317642|18320704|P2|Overall Study|Treatment Failure|102
5319019|NCT00317642|18320705|P1|Overall Study|Treatment Failure|56
5319020|NCT00317642|18320704|P2|Overall Study|Adverse Event|5
5319021|NCT00317642|18320705|P1|Overall Study|Adverse Event|17
5319022|NCT00317642|18320704|P2|Overall Study|Participant declined treatment|3
5319023|NCT00317642|18320705|P1|Overall Study|Participant declined treatment|14
5319024|NCT00317642|18320704|P2|Overall Study|Physician Decision|7
5319025|NCT00317642|18320705|P1|Overall Study|Physician Decision|15
5319026|NCT00317642|18320704|P2|Overall Study|Not Received Either Study Drug|3
5319027|NCT00317642|18320705|P1|Overall Study|Not Received Either Study Drug|1
5319028|NCT00317473|18320784|P6|Overall Study|Other|0
5319029|NCT00317473|18320785|P5|Overall Study|Other|0
5319030|NCT00317473|18320786|P4|Overall Study|Other|0
5319031|NCT00317473|18320787|P3|Overall Study|Other|0
5319032|NCT00317473|18320788|P2|Overall Study|Other|2
5319033|NCT00317473|18320789|P1|Overall Study|Other|0
5319034|NCT00317473|18320784|P6|Overall Study|Death|0
5319035|NCT00317473|18320785|P5|Overall Study|Death|0
5319036|NCT00317473|18320786|P4|Overall Study|Death|0
5319037|NCT00317473|18320787|P3|Overall Study|Death|0
5319038|NCT00317473|18320788|P2|Overall Study|Death|0
5319039|NCT00317473|18320789|P1|Overall Study|Death|1
5319040|NCT00317473|18320784|P6|Overall Study|Relocation|2
5319041|NCT00317473|18320785|P5|Overall Study|Relocation|5
5319042|NCT00317473|18320786|P4|Overall Study|Relocation|1
5319043|NCT00317473|18320787|P3|Overall Study|Relocation|1
5319044|NCT00317473|18320788|P2|Overall Study|Relocation|0
5319045|NCT00317473|18320789|P1|Overall Study|Relocation|1
5319046|NCT00317473|18320784|P6|Overall Study|Withdrawal by Subject|1
5319047|NCT00317473|18320785|P5|Overall Study|Withdrawal by Subject|3
5319048|NCT00317473|18320786|P4|Overall Study|Withdrawal by Subject|1
5319049|NCT00317473|18320787|P3|Overall Study|Withdrawal by Subject|2
5319050|NCT00317473|18320788|P2|Overall Study|Withdrawal by Subject|1
5319051|NCT00317473|18320789|P1|Overall Study|Withdrawal by Subject|2
5319052|NCT00317109|18320828|P2|Overall Study|Migated/moved from study area|0
5319053|NCT00317109|18320829|P1|Overall Study|Migated/moved from study area|1
5319054|NCT00317109|18320828|P2|Overall Study|Withdrawal by Subject|0
5319055|NCT00317109|18320829|P1|Overall Study|Withdrawal by Subject|2
5319056|NCT00317044|18320866|P3|Overall Study|Multiple Reasons|6
5319057|NCT00317044|18320867|P2|Overall Study|Multiple Reasons|2
5319058|NCT00317044|18320868|P1|Overall Study|Multiple Reasons|6
5319059|NCT00317044|18320866|P3|Overall Study|Lost to Follow-up|3
5319060|NCT00317044|18320867|P2|Overall Study|Lost to Follow-up|2
5319061|NCT00317044|18320868|P1|Overall Study|Lost to Follow-up|0
5319062|NCT00317044|18320866|P3|Overall Study|Withdrawal by Subject|12
5319063|NCT00317044|18320867|P2|Overall Study|Withdrawal by Subject|7
5319064|NCT00317044|18320868|P1|Overall Study|Withdrawal by Subject|10
5319065|NCT00317044|18320866|P3|Overall Study|Adverse Event|4
5319066|NCT00317044|18320867|P2|Overall Study|Adverse Event|7
5319067|NCT00317044|18320868|P1|Overall Study|Adverse Event|4
5319068|NCT00317044|18320866|P3|Overall Study|Protocol Violation|20
5319069|NCT00317044|18320867|P2|Overall Study|Protocol Violation|22
5319070|NCT00317044|18320868|P1|Overall Study|Protocol Violation|28
5319071|NCT00316914|18320914|P2|Overall Study|Missing end of treatment documentation|15
5319072|NCT00316914|18320915|P1|Overall Study|Missing end of treatment documentation|14
5319073|NCT00316914|18320914|P2|Overall Study|Other Problems|11
5319074|NCT00316914|18320915|P1|Overall Study|Other Problems|6
5319075|NCT00316914|18320914|P2|Overall Study|Adverse Event|7
5319076|NCT00316914|18320915|P1|Overall Study|Adverse Event|8
5319077|NCT00316914|18320914|P2|Overall Study|Withdrawal by Subject|3
5319078|NCT00316914|18320915|P1|Overall Study|Withdrawal by Subject|5
5319079|NCT00316888|18320945|P2|Overall Study|Not start protocol therapy|1
5319080|NCT00316888|18320946|P1|Overall Study|Not start protocol therapy|0
5319081|NCT00316888|18320945|P2|Overall Study|Withdrawal by Subject|2
5319082|NCT00316888|18320946|P1|Overall Study|Withdrawal by Subject|2
5319083|NCT00316888|18320945|P2|Overall Study|Adverse Event|5
5319084|NCT00316888|18320946|P1|Overall Study|Adverse Event|4
5319085|NCT00316719|18320968|P2|Overall Study|Consent withdrawn|0
5319086|NCT00316719|18320969|P1|Overall Study|Consent withdrawn|2
5319087|NCT00316719|18320968|P2|Overall Study|Adverse Event|6
5319088|NCT00316719|18320969|P1|Overall Study|Adverse Event|0
5319089|NCT00316706|18320995|P2|Overall Study|Lost to Follow-up|48
5319090|NCT00316706|18320996|P1|Overall Study|Lost to Follow-up|38
5319091|NCT00316693|18321012|P2|Overall Study|Other|44
5319092|NCT00316693|18321013|P1|Overall Study|Other|38
5319093|NCT00316693|18321012|P2|Overall Study|Lost to Follow-up|34
5319094|NCT00316693|18321013|P1|Overall Study|Lost to Follow-up|26
5319095|NCT00316693|18321012|P2|Overall Study|Withdrawal by Subject|6
5319096|NCT00316693|18321013|P1|Overall Study|Withdrawal by Subject|6
5319097|NCT00316693|18321012|P2|Overall Study|Protocol Violation|0
5319098|NCT00316693|18321013|P1|Overall Study|Protocol Violation|1
5319099|NCT00316693|18321012|P2|Overall Study|Adverse Event|1
5319100|NCT00316693|18321013|P1|Overall Study|Adverse Event|6
5319101|NCT00316602|18321055|P2|Overall Study|Other|6
5319102|NCT00316602|18321056|P1|Overall Study|Other|3
5319103|NCT00316602|18321055|P2|Overall Study|Adverse Event|0
5319104|NCT00316602|18321056|P1|Overall Study|Adverse Event|1
5319105|NCT00316602|18321055|P2|Overall Study|Subject unwilling/unable to comply with|17
5319106|NCT00316602|18321056|P1|Overall Study|Subject unwilling/unable to comply with|3
5319107|NCT00316602|18321055|P2|Overall Study|Withdrawal by Subject|2
5319108|NCT00316602|18321056|P1|Overall Study|Withdrawal by Subject|3
5319109|NCT00316589|18321088|P4|Overall Study|Other reason|1
5319110|NCT00316589|18321089|P3|Overall Study|Other reason|1
5319111|NCT00316589|18321090|P2|Overall Study|Other reason|12
5319112|NCT00316589|18321091|P1|Overall Study|Other reason|0
5319113|NCT00316589|18321088|P4|Overall Study|Physician Decision|0
5319114|NCT00316589|18321089|P3|Overall Study|Physician Decision|0
5319115|NCT00316589|18321090|P2|Overall Study|Physician Decision|1
5319116|NCT00316589|18321091|P1|Overall Study|Physician Decision|0
5319117|NCT00316589|18321088|P4|Overall Study|Adverse Event|1
5319118|NCT00316589|18321089|P3|Overall Study|Adverse Event|0
5319119|NCT00316589|18321090|P2|Overall Study|Adverse Event|0
5319120|NCT00316589|18321091|P1|Overall Study|Adverse Event|1
5319121|NCT00316589|18321088|P4|Overall Study|Subject unwilling/unable to comply|2
5319122|NCT00316589|18321089|P3|Overall Study|Subject unwilling/unable to comply|0
5319123|NCT00316589|18321090|P2|Overall Study|Subject unwilling/unable to comply|6
5319124|NCT00316589|18321091|P1|Overall Study|Subject unwilling/unable to comply|0
5319125|NCT00316589|18321088|P4|Overall Study|Withdrawal by Subject|1
5319126|NCT00316589|18321089|P3|Overall Study|Withdrawal by Subject|0
5319127|NCT00316589|18321090|P2|Overall Study|Withdrawal by Subject|5
5319128|NCT00316589|18321091|P1|Overall Study|Withdrawal by Subject|0
5319129|NCT00316303|18321225|P2|Overall Study|Lost to Follow-up|16
5319130|NCT00316303|18321226|P1|Overall Study|Lost to Follow-up|11
5319131|NCT00316277|18321242|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
5319132|NCT00316277|18321243|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
5319133|NCT00316277|18321242|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
5319134|NCT00316277|18321243|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
5319135|NCT00316277|18321242|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
5319136|NCT00316277|18321243|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
5319137|NCT00316277|18321242|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
5319138|NCT00316277|18321243|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
5319139|NCT00316277|18321242|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
5319140|NCT00316277|18321243|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
5319141|NCT00316264|18321264|P3|Overall Study|Other|0
5319142|NCT00316264|18321265|P2|Overall Study|Other|1
5319143|NCT00316264|18321266|P1|Overall Study|Other|1
5319144|NCT00316264|18321264|P3|Overall Study|Death|0
5319145|NCT00316264|18321265|P2|Overall Study|Death|0
5319146|NCT00316264|18321266|P1|Overall Study|Death|2
5319147|NCT00316264|18321264|P3|Overall Study|Withdrawal of Consent|6
5319148|NCT00316264|18321265|P2|Overall Study|Withdrawal of Consent|5
5319149|NCT00316264|18321266|P1|Overall Study|Withdrawal of Consent|3
5319150|NCT00316264|18321264|P3|Overall Study|Lost to Follow-up|0
5319151|NCT00316264|18321265|P2|Overall Study|Lost to Follow-up|1
5319152|NCT00316264|18321266|P1|Overall Study|Lost to Follow-up|0
5319153|NCT00316225|18321334|P1|Overall Study|Death|2
5319154|NCT00316225|18321334|P1|Overall Study|Withdrawal by Subject|3
5319155|NCT00316225|18321334|P1|Overall Study|Progressive Disease|15
5319156|NCT00316225|18321334|P1|Overall Study|Physician Decision|3
5319157|NCT00316225|18321334|P1|Overall Study|Adverse Event|2
5319158|NCT00316199|18321343|P1|Overall Study|Lost to Follow-up|2
5319159|NCT00316199|18321343|P1|Overall Study|Death|8
5319160|NCT00316199|18321343|P1|Overall Study|Adverse Event|2
5319161|NCT00316186|18321351|P1|Overall Study|Other|1
5319162|NCT00316186|18321351|P1|Overall Study|Lost to Follow-up|1
5319163|NCT00316186|18321351|P1|Overall Study|Disease Progression|4
5319164|NCT00316186|18321351|P1|Overall Study|Adverse Event|6
5319165|NCT00316173|18321365|P2|Treatment Phase|Study Follow-up Stopped|34
5319166|NCT00316173|18321366|P1|Treatment Phase|Study Follow-up Stopped|0
5319167|NCT00316173|18321365|P2|Treatment Phase|Withdrawal by Subject|1
5319168|NCT00316173|18321366|P1|Treatment Phase|Withdrawal by Subject|0
5319169|NCT00316173|18321365|P2|Treatment Phase|Lost to Follow-up|3
5319170|NCT00316173|18321366|P1|Treatment Phase|Lost to Follow-up|0
5319171|NCT00316173|18321365|P2|Treatment Phase|Lack of Efficacy|3
5319172|NCT00316173|18321366|P1|Treatment Phase|Lack of Efficacy|0
5319173|NCT00316173|18321365|P2|Treatment Phase|Adverse Event|1
5319174|NCT00316173|18321366|P1|Treatment Phase|Adverse Event|0
5319175|NCT00316173|18321365|P2|Run-in Phase|Study Follow-up Stopped|0
5319176|NCT00316173|18321366|P1|Run-in Phase|Study Follow-up Stopped|5
5319177|NCT00316173|18321365|P2|Run-in Phase|Protocol Violation|0
5319178|NCT00316173|18321366|P1|Run-in Phase|Protocol Violation|1
5319179|NCT00316173|18321365|P2|Run-in Phase|Adverse Event|0
5319180|NCT00316173|18321366|P1|Run-in Phase|Adverse Event|1
5319181|NCT00316121|18321379|P2|Overall Study|Subject did not have 24 month visit|0
5319182|NCT00316121|18321380|P1|Overall Study|Subject did not have 24 month visit|1
5319183|NCT00316121|18321379|P2|Overall Study|Subject no show for visit x 3|0
5319184|NCT00316121|18321380|P1|Overall Study|Subject no show for visit x 3|1
5319185|NCT00316121|18321379|P2|Overall Study|Subject refused to return|0
5319186|NCT00316121|18321380|P1|Overall Study|Subject refused to return|1
5319187|NCT00316121|18321379|P2|Overall Study|Subject relocated|1
5319188|NCT00316121|18321380|P1|Overall Study|Subject relocated|1
5319189|NCT00316121|18321379|P2|Overall Study|Reason is missing|0
5319190|NCT00316121|18321380|P1|Overall Study|Reason is missing|1
5319191|NCT00316121|18321379|P2|Overall Study|Withdrawal by Subject|0
5319192|NCT00316121|18321380|P1|Overall Study|Withdrawal by Subject|2
5319193|NCT00316121|18321379|P2|Overall Study|Lost to Follow-up|8
5319194|NCT00316121|18321380|P1|Overall Study|Lost to Follow-up|14
5319195|NCT00316121|18321379|P2|Overall Study|Death|0
5319196|NCT00316121|18321380|P1|Overall Study|Death|1
5319197|NCT00316082|18321391|P5|Overall Study|Administrative reason by sponsor|0
5319198|NCT00316082|18321392|P4|Overall Study|Administrative reason by sponsor|0
5319199|NCT00316082|18321393|P3|Overall Study|Administrative reason by sponsor|1
5319200|NCT00316082|18321394|P2|Overall Study|Administrative reason by sponsor|0
5319201|NCT00316082|18321395|P1|Overall Study|Administrative reason by sponsor|0
5319202|NCT00316082|18321391|P5|Overall Study|Death|0
5319203|NCT00316082|18321392|P4|Overall Study|Death|0
5319204|NCT00316082|18321393|P3|Overall Study|Death|1
5319205|NCT00316082|18321394|P2|Overall Study|Death|0
5319206|NCT00316082|18321395|P1|Overall Study|Death|0
5319207|NCT00316082|18321391|P5|Overall Study|Physician Decision|1
5319208|NCT00316082|18321392|P4|Overall Study|Physician Decision|1
5319209|NCT00316082|18321393|P3|Overall Study|Physician Decision|2
5319210|NCT00316082|18321394|P2|Overall Study|Physician Decision|1
5319211|NCT00316082|18321395|P1|Overall Study|Physician Decision|1
5319212|NCT00316082|18321391|P5|Overall Study|Subject no longer meets study criteria|1
5319213|NCT00316082|18321392|P4|Overall Study|Subject no longer meets study criteria|2
5319214|NCT00316082|18321393|P3|Overall Study|Subject no longer meets study criteria|2
5319215|NCT00316082|18321394|P2|Overall Study|Subject no longer meets study criteria|1
5319216|NCT00316082|18321395|P1|Overall Study|Subject no longer meets study criteria|3
5319217|NCT00316082|18321391|P5|Overall Study|Adverse Event|3
5319218|NCT00316082|18321392|P4|Overall Study|Adverse Event|1
5319219|NCT00316082|18321393|P3|Overall Study|Adverse Event|5
5319220|NCT00316082|18321394|P2|Overall Study|Adverse Event|2
5319221|NCT00316082|18321395|P1|Overall Study|Adverse Event|4
5319222|NCT00316082|18321391|P5|Overall Study|Poor/noncompliance|4
5319223|NCT00316082|18321392|P4|Overall Study|Poor/noncompliance|1
5319224|NCT00316082|18321393|P3|Overall Study|Poor/noncompliance|4
5319225|NCT00316082|18321394|P2|Overall Study|Poor/noncompliance|1
5319226|NCT00316082|18321395|P1|Overall Study|Poor/noncompliance|6
5319227|NCT00316082|18321391|P5|Overall Study|Lost to Follow-up|6
5319228|NCT00316082|18321392|P4|Overall Study|Lost to Follow-up|8
5319229|NCT00316082|18321393|P3|Overall Study|Lost to Follow-up|7
5319230|NCT00316082|18321394|P2|Overall Study|Lost to Follow-up|6
5319231|NCT00316082|18321395|P1|Overall Study|Lost to Follow-up|7
5319232|NCT00316082|18321391|P5|Overall Study|Withdrawal of Consent by Subject|5
5319233|NCT00316082|18321392|P4|Overall Study|Withdrawal of Consent by Subject|9
5319234|NCT00316082|18321393|P3|Overall Study|Withdrawal of Consent by Subject|2
5319235|NCT00316082|18321394|P2|Overall Study|Withdrawal of Consent by Subject|8
5319236|NCT00316082|18321395|P1|Overall Study|Withdrawal of Consent by Subject|10
5319237|NCT00316082|18321391|P5|Overall Study|Lack of Efficacy|6
5319238|NCT00316082|18321392|P4|Overall Study|Lack of Efficacy|4
5319239|NCT00316082|18321393|P3|Overall Study|Lack of Efficacy|3
5319240|NCT00316082|18321394|P2|Overall Study|Lack of Efficacy|3
5319241|NCT00316082|18321395|P1|Overall Study|Lack of Efficacy|2
5319242|NCT00316017|18321426|P3|Overall Study|Protocol Violation|19
5319243|NCT00316017|18321427|P2|Overall Study|Protocol Violation|13
5319244|NCT00316017|18321428|P1|Overall Study|Protocol Violation|11
5319245|NCT00316004|18321502|P3|Overall Study|Subject was not given study fluid.|21
5319246|NCT00316004|18321503|P2|Overall Study|Subject was not given study fluid.|14
5319247|NCT00316004|18321504|P1|Overall Study|Subject was not given study fluid.|14
5319248|NCT00315731|18321575|P1|Overall Study|Death|5
5319249|NCT00315731|18321575|P1|Overall Study|Lost to Follow-up|1
5319250|NCT00315705|18321603|P1|Phase 2|Death|7
5319251|NCT00315705|18321603|P1|Phase 2|Other|1
5319252|NCT00315705|18321603|P1|Phase 2|Scheduled for transplant|8
5319253|NCT00315705|18321603|P1|Phase 2|Disease relapse|1
5319254|NCT00315705|18321603|P1|Phase 2|Failure to achieve response|3
5319255|NCT00315705|18321603|P1|Phase 2|Adverse Event|1
5319256|NCT00315705|18321603|P1|Phase 2|Physician Decision|4
5319257|NCT00315705|18321603|P1|Phase 1|Death|3
5319258|NCT00315705|18321603|P1|Phase 1|Scheduled for transplant|9
5319259|NCT00315705|18321603|P1|Phase 1|Disease relapse|4
5319260|NCT00315705|18321603|P1|Phase 1|Failure to achieve response|8
5319261|NCT00315705|18321603|P1|Phase 1|Refused further treatment|1
5319262|NCT00315458|18321664|P4|Overall Study|Did not qualify|0
5319263|NCT00315458|18321665|P3|Overall Study|Did not qualify|1
5319264|NCT00315458|18321666|P2|Overall Study|Did not qualify|0
5319265|NCT00315458|18321667|P1|Overall Study|Did not qualify|0
5319266|NCT00315458|18321664|P4|Overall Study|Lack of Efficacy|1
5319267|NCT00315458|18321665|P3|Overall Study|Lack of Efficacy|20
5319268|NCT00315458|18321666|P2|Overall Study|Lack of Efficacy|0
5319269|NCT00315458|18321667|P1|Overall Study|Lack of Efficacy|0
5319270|NCT00315458|18321664|P4|Overall Study|Withdrawal by Subject|2
5319271|NCT00315458|18321665|P3|Overall Study|Withdrawal by Subject|0
5319272|NCT00315458|18321666|P2|Overall Study|Withdrawal by Subject|3
5319273|NCT00315458|18321667|P1|Overall Study|Withdrawal by Subject|0
5319274|NCT00315458|18321664|P4|Overall Study|Lost to Follow-up|2
5319275|NCT00315458|18321665|P3|Overall Study|Lost to Follow-up|0
5319276|NCT00315458|18321666|P2|Overall Study|Lost to Follow-up|2
5319277|NCT00315458|18321667|P1|Overall Study|Lost to Follow-up|1
5319278|NCT00315458|18321664|P4|Overall Study|Adverse Event|3
5319279|NCT00315458|18321665|P3|Overall Study|Adverse Event|23
5319280|NCT00315458|18321666|P2|Overall Study|Adverse Event|4
5319281|NCT00315458|18321667|P1|Overall Study|Adverse Event|2
5319282|NCT00315458|18321664|P4|Overall Study|Administrative|21
5319283|NCT00315458|18321665|P3|Overall Study|Administrative|8
5319284|NCT00315458|18321666|P2|Overall Study|Administrative|3
5319285|NCT00315458|18321667|P1|Overall Study|Administrative|0
5319286|NCT00315445|18321680|P3|Overall Study|Other|0
5319287|NCT00315445|18321681|P2|Overall Study|Other|3
5319288|NCT00315445|18321682|P1|Overall Study|Other|1
5319289|NCT00315445|18321680|P3|Overall Study|Protocol Violation|1
5319290|NCT00315445|18321681|P2|Overall Study|Protocol Violation|0
5319291|NCT00315445|18321682|P1|Overall Study|Protocol Violation|2
5319292|NCT00315445|18321680|P3|Overall Study|Lost to Follow-up|1
5319293|NCT00315445|18321681|P2|Overall Study|Lost to Follow-up|0
5319294|NCT00315445|18321682|P1|Overall Study|Lost to Follow-up|1
5319295|NCT00315445|18321680|P3|Overall Study|Lack of Efficacy|7
5319296|NCT00315445|18321681|P2|Overall Study|Lack of Efficacy|1
5319297|NCT00315445|18321682|P1|Overall Study|Lack of Efficacy|16
5319298|NCT00315445|18321680|P3|Overall Study|Adverse Event|15
5319299|NCT00315445|18321681|P2|Overall Study|Adverse Event|12
5319300|NCT00315445|18321682|P1|Overall Study|Adverse Event|7
5319301|NCT00315055|18321972|P2|Overall Study|Lost to Follow-up|1
5319302|NCT00315055|18321973|P1|Overall Study|Lost to Follow-up|1
5319303|NCT00315055|18321972|P2|Overall Study|Protocol Violation|4
5319304|NCT00315055|18321973|P1|Overall Study|Protocol Violation|2
5319305|NCT00314951|18321991|P2|Follow-up|mITT failure|34
5319306|NCT00314951|18321992|P1|Follow-up|mITT failure|44
5319307|NCT00314951|18321991|P2|Treatment|Didn't meet criteria for mITT population|11
5319308|NCT00314951|18321992|P1|Treatment|Didn't meet criteria for mITT population|16
5319309|NCT00314808|18322002|P1|Overall Study|Withdrawal by Subject/PI without AE|4
5319310|NCT00314808|18322002|P1|Overall Study|Disease Progression without AE|4
5319311|NCT00314795|18322010|P1|Overall Study|Participants Withdrew Consent|2
5319312|NCT00314795|18322010|P1|Overall Study|Renal Transplant|3
5319313|NCT00314795|18322010|P1|Overall Study|Reason not Specified|3
5319314|NCT00314795|18322010|P1|Overall Study|Death|4
5319315|NCT00314795|18322010|P1|Overall Study|Adverse Event|8
5319316|NCT00314574|18322020|P2|Overall Study|Data unknown at database lock|1
5319317|NCT00314574|18322021|P1|Overall Study|Data unknown at database lock|0
5319318|NCT00314574|18322020|P2|Overall Study|Pregnancy|4
5319319|NCT00314574|18322021|P1|Overall Study|Pregnancy|6
5319320|NCT00314574|18322020|P2|Overall Study|Physician Decision|15
5319321|NCT00314574|18322021|P1|Overall Study|Physician Decision|22
5319322|NCT00314574|18322020|P2|Overall Study|Withdrawal by Subject|22
5319323|NCT00314574|18322021|P1|Overall Study|Withdrawal by Subject|33
5319324|NCT00314574|18322020|P2|Overall Study|Lost to Follow-up|25
5319325|NCT00314574|18322021|P1|Overall Study|Lost to Follow-up|19
5319326|NCT00314574|18322020|P2|Overall Study|Adverse Event|16
5319327|NCT00314574|18322021|P1|Overall Study|Adverse Event|11
5319328|NCT00314574|18322020|P2|Overall Study|Death|0
5319329|NCT00314574|18322021|P1|Overall Study|Death|3
5319330|NCT00314366|18322037|P2|Overall Study|not treated due to patient medical condi|0
5319331|NCT00314366|18322038|P1|Overall Study|not treated due to patient medical condi|1
5319332|NCT00314340|18322083|P1|Overall Study|lost interest|1
5319333|NCT00314327|18322089|P1|Overall Study|Withdrawal by Subject|1
5319334|NCT00314262|18322094|P1|Overall Study|Physician Decision|1
5319335|NCT00314262|18322094|P1|Overall Study|Withdrawal by Subject|2
5319336|NCT00314262|18322094|P1|Overall Study|Adverse Event|2
5319337|NCT00314249|18322102|P2|Overall Study|Non-Compliant|6
5319338|NCT00314249|18322103|P1|Overall Study|Non-Compliant|5
5319339|NCT00314249|18322102|P2|Overall Study|Withdrawn for other reasons|1
5319340|NCT00314249|18322103|P1|Overall Study|Withdrawn for other reasons|4
5319341|NCT00314249|18322102|P2|Overall Study|Physician Decision|1
5319342|NCT00314249|18322103|P1|Overall Study|Physician Decision|1
5319343|NCT00314249|18322102|P2|Overall Study|Lost to Follow-up|9
5319344|NCT00314249|18322103|P1|Overall Study|Lost to Follow-up|15
5319345|NCT00314249|18322102|P2|Overall Study|Withdrawal by Subject|28
5319346|NCT00314249|18322103|P1|Overall Study|Withdrawal by Subject|21
5319347|NCT00314249|18322102|P2|Overall Study|Lack of Efficacy|24
5319348|NCT00314249|18322103|P1|Overall Study|Lack of Efficacy|33
5319349|NCT00314249|18322102|P2|Overall Study|Adverse Event|94
5319350|NCT00314249|18322103|P1|Overall Study|Adverse Event|73
5319351|NCT00314145|18322136|P2|Overall Study|Sponsor Decision|0
5319352|NCT00314145|18322137|P1|Overall Study|Sponsor Decision|2
5319353|NCT00314145|18322136|P2|Overall Study|Protocol Violation|0
5319354|NCT00314145|18322137|P1|Overall Study|Protocol Violation|3
5319355|NCT00314145|18322136|P2|Overall Study|Adverse Event|3
5319356|NCT00314145|18322137|P1|Overall Study|Adverse Event|0
5319357|NCT00314145|18322136|P2|Overall Study|Physician Decision|4
5319358|NCT00314145|18322137|P1|Overall Study|Physician Decision|3
5319359|NCT00314145|18322136|P2|Overall Study|Lost to Follow-up|12
5319360|NCT00314145|18322137|P1|Overall Study|Lost to Follow-up|5
5319361|NCT00314145|18322136|P2|Overall Study|Withdrawal by Subject|10
5319362|NCT00314145|18322137|P1|Overall Study|Withdrawal by Subject|8
5319363|NCT00314132|18322151|P2|Overall Study|Physician Decision|0
5319364|NCT00314132|18322152|P1|Overall Study|Physician Decision|1
5319365|NCT00314132|18322151|P2|Overall Study|Adverse Event|0
5319366|NCT00314132|18322152|P1|Overall Study|Adverse Event|1
5319367|NCT00314132|18322151|P2|Overall Study|Withdrawal by Subject|5
5319368|NCT00314132|18322152|P1|Overall Study|Withdrawal by Subject|3
5319369|NCT00314132|18322151|P2|Overall Study|Lost to Follow-up|13
5319370|NCT00314132|18322152|P1|Overall Study|Lost to Follow-up|3
5319371|NCT00313911|18322179|P2|Overall Study|Did not meet age criteria|1
5319372|NCT00313911|18322180|P1|Overall Study|Did not meet age criteria|1
5319373|NCT00313911|18322179|P2|Overall Study|Withdrawal by Subject|12
5319374|NCT00313911|18322180|P1|Overall Study|Withdrawal by Subject|39
5319375|NCT00313911|18322179|P2|Overall Study|Lost to Follow-up|14
5319376|NCT00313911|18322180|P1|Overall Study|Lost to Follow-up|27
5319377|NCT00313911|18322179|P2|Overall Study|Protocol Violation|10
5319378|NCT00313911|18322180|P1|Overall Study|Protocol Violation|19
5319379|NCT00313911|18322179|P2|Overall Study|Adverse Event|3
5319380|NCT00313911|18322180|P1|Overall Study|Adverse Event|2
5319381|NCT00313911|18322179|P2|Overall Study|Serious adverse event|1
5319382|NCT00313911|18322180|P1|Overall Study|Serious adverse event|6
5319383|NCT00313846|18322194|P2|Overall Study|Administrative|3
5319384|NCT00313846|18322195|P1|Overall Study|Administrative|2
5319385|NCT00313846|18322194|P2|Overall Study|Adverse Event|8
5319386|NCT00313846|18322195|P1|Overall Study|Adverse Event|1
5319387|NCT00313846|18322194|P2|Overall Study|Withdrawal by Subject|0
5319388|NCT00313846|18322195|P1|Overall Study|Withdrawal by Subject|2
5319389|NCT00313820|18322206|P2|Pregabalin or Placebo Treatment Period|Other|3
5319390|NCT00313820|18322207|P1|Pregabalin or Placebo Treatment Period|Other|2
5319391|NCT00313820|18322206|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
5319392|NCT00313820|18322207|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
5319393|NCT00313820|18322206|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
5319394|NCT00313820|18322207|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
5319395|NCT00313820|18322206|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
5319396|NCT00313820|18322207|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
5319397|NCT00313820|18322206|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
5319398|NCT00313820|18322207|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
5319399|NCT00313820|18322206|P2|Assigned to Treatment|Other|0
5319400|NCT00313820|18322207|P1|Assigned to Treatment|Other|1
5319401|NCT00313781|18322245|P3|After Crossover|Other|18
5319402|NCT00313781|18322246|P2|After Crossover|Other|0
5319403|NCT00313781|18322247|P1|After Crossover|Other|0
5319404|NCT00313781|18322245|P3|After Crossover|Withdrawal by Subject|3
5319405|NCT00313781|18322246|P2|After Crossover|Withdrawal by Subject|0
5319406|NCT00313781|18322247|P1|After Crossover|Withdrawal by Subject|0
5319407|NCT00313781|18322245|P3|After Crossover|Death|6
5319408|NCT00313781|18322246|P2|After Crossover|Death|0
5319409|NCT00313781|18322247|P1|After Crossover|Death|0
5319410|NCT00313781|18322245|P3|Before Crossover|Randomized, not treated|0
5319411|NCT00313781|18322246|P2|Before Crossover|Randomized, not treated|0
5319412|NCT00313781|18322247|P1|Before Crossover|Randomized, not treated|5
5319413|NCT00313781|18322245|P3|Before Crossover|Crossover|0
5319414|NCT00313781|18322246|P2|Before Crossover|Crossover|37
5319415|NCT00313781|18322247|P1|Before Crossover|Crossover|0
5319416|NCT00313781|18322245|P3|Before Crossover|Other|0
5319417|NCT00313781|18322246|P2|Before Crossover|Other|30
5319418|NCT00313781|18322247|P1|Before Crossover|Other|45
5319419|NCT00313781|18322245|P3|Before Crossover|Withdrawal by Subject|0
5319420|NCT00313781|18322246|P2|Before Crossover|Withdrawal by Subject|1
5319421|NCT00313781|18322247|P1|Before Crossover|Withdrawal by Subject|3
5319422|NCT00313781|18322245|P3|Before Crossover|Lost to Follow-up|0
5319423|NCT00313781|18322246|P2|Before Crossover|Lost to Follow-up|3
5319424|NCT00313781|18322247|P1|Before Crossover|Lost to Follow-up|0
5319425|NCT00313781|18322245|P3|Before Crossover|Death|0
5319426|NCT00313781|18322246|P2|Before Crossover|Death|8
5319427|NCT00313781|18322247|P1|Before Crossover|Death|22
5319428|NCT00313716|18322293|P6|Overall Study|Withdrawal by Subject|0
5319429|NCT00313716|18322294|P5|Overall Study|Withdrawal by Subject|1
5319430|NCT00313716|18322295|P4|Overall Study|Withdrawal by Subject|0
5319431|NCT00313716|18322296|P3|Overall Study|Withdrawal by Subject|1
5319432|NCT00313716|18322297|P2|Overall Study|Withdrawal by Subject|1
5319433|NCT00313716|18322298|P1|Overall Study|Withdrawal by Subject|0
5319434|NCT00313716|18322293|P6|Overall Study|Lost to Follow-up|4
5319435|NCT00313716|18322294|P5|Overall Study|Lost to Follow-up|0
5319436|NCT00313716|18322295|P4|Overall Study|Lost to Follow-up|1
5319437|NCT00313716|18322296|P3|Overall Study|Lost to Follow-up|2
5319438|NCT00313716|18322297|P2|Overall Study|Lost to Follow-up|5
5319439|NCT00313716|18322298|P1|Overall Study|Lost to Follow-up|2
5319440|NCT00313716|18322293|P6|Overall Study|Death|9
5319441|NCT00313716|18322294|P5|Overall Study|Death|5
5319442|NCT00313716|18322295|P4|Overall Study|Death|3
5319443|NCT00313716|18322296|P3|Overall Study|Death|9
5319444|NCT00313716|18322297|P2|Overall Study|Death|2
5319445|NCT00313716|18322298|P1|Overall Study|Death|3
5319446|NCT00313703|18322325|P4|Overall Study|Lost to Follow-up|12
5319447|NCT00313703|18322326|P3|Overall Study|Lost to Follow-up|5
5319448|NCT00313703|18322327|P2|Overall Study|Lost to Follow-up|2
5319449|NCT00313703|18322328|P1|Overall Study|Lost to Follow-up|11
5319450|NCT00313612|18322344|P2|Overall Study|Patient never received treatment|1
5319451|NCT00313612|18322345|P1|Overall Study|Patient never received treatment|0
5319452|NCT00313586|18322357|P4|Overall Study|Death before starting treatment|0
5319453|NCT00313586|18322358|P3|Overall Study|Death before starting treatment|0
5319454|NCT00313586|18322359|P2|Overall Study|Death before starting treatment|0
5319455|NCT00313586|18322360|P1|Overall Study|Death before starting treatment|1
5319456|NCT00313586|18322357|P4|Overall Study|Moved|0
5319457|NCT00313586|18322358|P3|Overall Study|Moved|0
5319458|NCT00313586|18322359|P2|Overall Study|Moved|1
5319459|NCT00313586|18322360|P1|Overall Study|Moved|0
5319460|NCT00313586|18322357|P4|Overall Study|Lost insurance|0
5319461|NCT00313586|18322358|P3|Overall Study|Lost insurance|0
5319462|NCT00313586|18322359|P2|Overall Study|Lost insurance|1
5319463|NCT00313586|18322360|P1|Overall Study|Lost insurance|0
5319464|NCT00313586|18322357|P4|Overall Study|Absolute neutrophil count not recovered|0
5319465|NCT00313586|18322358|P3|Overall Study|Absolute neutrophil count not recovered|0
5319466|NCT00313586|18322359|P2|Overall Study|Absolute neutrophil count not recovered|1
5319467|NCT00313586|18322360|P1|Overall Study|Absolute neutrophil count not recovered|2
5319468|NCT00313586|18322357|P4|Overall Study|Physician Decision|0
5319469|NCT00313586|18322358|P3|Overall Study|Physician Decision|0
5319470|NCT00313586|18322359|P2|Overall Study|Physician Decision|1
5319471|NCT00313586|18322360|P1|Overall Study|Physician Decision|2
5319472|NCT00313586|18322357|P4|Overall Study|Did not achieve HI-major/better response|1
5319473|NCT00313586|18322358|P3|Overall Study|Did not achieve HI-major/better response|2
5319474|NCT00313586|18322359|P2|Overall Study|Did not achieve HI-major/better response|7
5319475|NCT00313586|18322360|P1|Overall Study|Did not achieve HI-major/better response|10
5319476|NCT00313586|18322357|P4|Overall Study|Other complicating disease|0
5319477|NCT00313586|18322358|P3|Overall Study|Other complicating disease|0
5319478|NCT00313586|18322359|P2|Overall Study|Other complicating disease|2
5319479|NCT00313586|18322360|P1|Overall Study|Other complicating disease|2
5319480|NCT00313586|18322357|P4|Overall Study|Alternative therapy|0
5319481|NCT00313586|18322358|P3|Overall Study|Alternative therapy|2
5319482|NCT00313586|18322359|P2|Overall Study|Alternative therapy|6
5319483|NCT00313586|18322360|P1|Overall Study|Alternative therapy|3
5319484|NCT00313586|18322357|P4|Overall Study|Withdrawal by Subject|2
5319485|NCT00313586|18322358|P3|Overall Study|Withdrawal by Subject|6
5319486|NCT00313586|18322359|P2|Overall Study|Withdrawal by Subject|6
5319487|NCT00313586|18322360|P1|Overall Study|Withdrawal by Subject|13
5319488|NCT00313586|18322357|P4|Overall Study|Death|7
5319489|NCT00313586|18322358|P3|Overall Study|Death|1
5319490|NCT00313586|18322359|P2|Overall Study|Death|8
5319491|NCT00313586|18322360|P1|Overall Study|Death|11
5319492|NCT00313586|18322357|P4|Overall Study|Adverse Event|10
5319493|NCT00313586|18322358|P3|Overall Study|Adverse Event|3
5319494|NCT00313586|18322359|P2|Overall Study|Adverse Event|18
5319495|NCT00313586|18322360|P1|Overall Study|Adverse Event|12
5319496|NCT00313586|18322357|P4|Overall Study|Disease progression|3
5319497|NCT00313586|18322358|P3|Overall Study|Disease progression|10
5319498|NCT00313586|18322359|P2|Overall Study|Disease progression|19
5319499|NCT00313586|18322360|P1|Overall Study|Disease progression|14
5319500|NCT00313313|18322388|P3|Overall Study|Subject No Longer Meets Study Criteria|2
5319501|NCT00313313|18322389|P2|Overall Study|Subject No Longer Meets Study Criteria|3
5319502|NCT00313313|18322390|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5319503|NCT00313313|18322388|P3|Overall Study|Death|2
5319504|NCT00313313|18322389|P2|Overall Study|Death|0
5319505|NCT00313313|18322390|P1|Overall Study|Death|0
5319506|NCT00313313|18322388|P3|Overall Study|Pregnancy|0
5319507|NCT00313313|18322389|P2|Overall Study|Pregnancy|2
5319508|NCT00313313|18322390|P1|Overall Study|Pregnancy|1
5319509|NCT00313313|18322388|P3|Overall Study|Poor/Noncompliance|2
5319510|NCT00313313|18322389|P2|Overall Study|Poor/Noncompliance|6
5319511|NCT00313313|18322390|P1|Overall Study|Poor/Noncompliance|3
5319512|NCT00313313|18322388|P3|Overall Study|Physician Decision|4
5319513|NCT00313313|18322389|P2|Overall Study|Physician Decision|6
5319514|NCT00313313|18322390|P1|Overall Study|Physician Decision|2
5319515|NCT00313313|18322388|P3|Overall Study|Adverse Event|12
5319516|NCT00313313|18322389|P2|Overall Study|Adverse Event|16
5319517|NCT00313313|18322390|P1|Overall Study|Adverse Event|15
5319518|NCT00313313|18322388|P3|Overall Study|Lost to Follow-up|9
5319519|NCT00313313|18322389|P2|Overall Study|Lost to Follow-up|7
5319520|NCT00313313|18322390|P1|Overall Study|Lost to Follow-up|10
5319521|NCT00313313|18322388|P3|Overall Study|Withdrawal of consent by subject|31
5319522|NCT00313313|18322389|P2|Overall Study|Withdrawal of consent by subject|17
5319523|NCT00313313|18322390|P1|Overall Study|Withdrawal of consent by subject|18
5319524|NCT00313313|18322388|P3|Overall Study|Lack of Efficacy|20
5319525|NCT00313313|18322389|P2|Overall Study|Lack of Efficacy|9
5319526|NCT00313313|18322390|P1|Overall Study|Lack of Efficacy|14
5319527|NCT00313300|18322412|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
5319528|NCT00313300|18322413|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
5319529|NCT00313300|18322414|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
5319530|NCT00313300|18322415|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
5319531|NCT00313300|18322416|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
5319532|NCT00313300|18322412|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
5319533|NCT00313300|18322413|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
5319534|NCT00313300|18322414|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
5319535|NCT00313300|18322415|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
5319536|NCT00313300|18322416|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
5319537|NCT00313300|18322412|P5|Follow-Up(30days)-Randomized Phase B|Death|0
5319538|NCT00313300|18322413|P4|Follow-Up(30days)-Randomized Phase B|Death|0
5319539|NCT00313300|18322414|P3|Follow-Up(30days)-Randomized Phase B|Death|0
5319540|NCT00313300|18322415|P2|Follow-Up(30days)-Randomized Phase B|Death|0
5319541|NCT00313300|18322416|P1|Follow-Up(30days)-Randomized Phase B|Death|1
5319542|NCT00313300|18322412|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
5319543|NCT00313300|18322413|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
5319544|NCT00313300|18322414|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
5319545|NCT00313300|18322415|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
5319546|NCT00313300|18322416|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
5319547|NCT00313300|18322412|P5|Follow-Up(30days)-Randomized Phase A|Death|0
5319548|NCT00313300|18322413|P4|Follow-Up(30days)-Randomized Phase A|Death|0
5319549|NCT00313300|18322414|P3|Follow-Up(30days)-Randomized Phase A|Death|0
5319550|NCT00313300|18322415|P2|Follow-Up(30days)-Randomized Phase A|Death|1
5319551|NCT00313300|18322416|P1|Follow-Up(30days)-Randomized Phase A|Death|0
5319552|NCT00313300|18322412|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
5319553|NCT00313300|18322413|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
5319554|NCT00313300|18322414|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
5319555|NCT00313300|18322415|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
5319556|NCT00313300|18322416|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
5319557|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|non-specified|0
5319558|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|non-specified|0
5319559|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|non-specified|0
5319560|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|non-specified|0
5319561|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|non-specified|1
5319562|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
5319563|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
5319564|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
5319565|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
5319566|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
5319567|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
5319568|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
5319569|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
5319570|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
5319571|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
5319572|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
5319573|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
5319574|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
5319575|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
5319576|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
5319577|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
5319578|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
5319579|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
5319580|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
5319581|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
5319582|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|Death|1
5319583|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|Death|0
5319584|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|Death|1
5319585|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|Death|3
5319586|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|Death|5
5319587|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
5319588|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
5319589|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
5319590|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
5319591|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
5319592|NCT00313300|18322412|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
5319593|NCT00313300|18322413|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
5319594|NCT00313300|18322414|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
5319595|NCT00313300|18322415|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
5319596|NCT00313300|18322416|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
5319597|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5319598|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5319599|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5319600|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5319601|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
5319602|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
5319603|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
5319604|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
5319605|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
5319606|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
5319607|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
5319608|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
5319609|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
5319610|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
5319611|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
5319612|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
5319613|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
5319614|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
5319615|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
5319616|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
5319617|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|Death|0
5319618|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|Death|0
5319619|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|Death|0
5319620|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|Death|4
5319621|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|Death|3
5319622|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
5319623|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
5319624|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
5319625|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
5319626|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
5319627|NCT00313300|18322412|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
5319628|NCT00313300|18322413|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
5319629|NCT00313300|18322414|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
5319630|NCT00313300|18322415|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
5319631|NCT00313300|18322416|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
5319632|NCT00313170|18322486|P3|Overall Study|Progression (investigators opinion)|0
5319633|NCT00313170|18322487|P2|Overall Study|Progression (investigators opinion)|0
5319634|NCT00313170|18322488|P1|Overall Study|Progression (investigators opinion)|1
5319635|NCT00313170|18322486|P3|Overall Study|Lost to Follow-up|1
5319636|NCT00313170|18322487|P2|Overall Study|Lost to Follow-up|0
5319637|NCT00313170|18322488|P1|Overall Study|Lost to Follow-up|0
5319638|NCT00313170|18322486|P3|Overall Study|Incorrect enrollment|1
5319639|NCT00313170|18322487|P2|Overall Study|Incorrect enrollment|2
5319640|NCT00313170|18322488|P1|Overall Study|Incorrect enrollment|0
5319641|NCT00313170|18322486|P3|Overall Study|Withdrawal by Subject|1
5319642|NCT00313170|18322487|P2|Overall Study|Withdrawal by Subject|0
5319643|NCT00313170|18322488|P1|Overall Study|Withdrawal by Subject|1
5319644|NCT00313170|18322486|P3|Overall Study|Disease progression|27
5319645|NCT00313170|18322487|P2|Overall Study|Disease progression|26
5319646|NCT00313170|18322488|P1|Overall Study|Disease progression|31
5319647|NCT00313170|18322486|P3|Overall Study|Adverse Event|0
5319648|NCT00313170|18322487|P2|Overall Study|Adverse Event|2
5319649|NCT00313170|18322488|P1|Overall Study|Adverse Event|1
5319650|NCT00313170|18322486|P3|Overall Study|Death|2
5319651|NCT00313170|18322487|P2|Overall Study|Death|4
5319652|NCT00313170|18322488|P1|Overall Study|Death|2
5319653|NCT00313144|18322507|P1|Overall Study|Due to termination of the study|66
5319654|NCT00313144|18322507|P1|Overall Study|Change to different product|1
5319655|NCT00313144|18322507|P1|Overall Study|Insurance (homecare provider) change|1
5319656|NCT00313144|18322507|P1|Overall Study|Liver transplant|1
5319657|NCT00313144|18322507|P1|Overall Study|Adverse event - transient|5
5319658|NCT00313144|18322507|P1|Overall Study|Physician Decision|4
5319659|NCT00313144|18322507|P1|Overall Study|Terminated by sponsor/ homecare provider|4
5319660|NCT00313144|18322507|P1|Overall Study|Withdrawal by Subject|4
5319661|NCT00313144|18322507|P1|Overall Study|Lost to Follow-up|5
5319662|NCT00313144|18322507|P1|Overall Study|Death|7
5319663|NCT00313144|18322507|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
5319664|NCT00313014|18322594|P3|Overall Study|Lack of Efficacy|16
5319665|NCT00313014|18322595|P2|Overall Study|Lack of Efficacy|25
5319666|NCT00313014|18322596|P1|Overall Study|Lack of Efficacy|52
5319667|NCT00313014|18322594|P3|Overall Study|Administrative|14
5319668|NCT00313014|18322595|P2|Overall Study|Administrative|6
5319669|NCT00313014|18322596|P1|Overall Study|Administrative|9
5319670|NCT00313014|18322594|P3|Overall Study|Lost to Follow-up|10
5319671|NCT00313014|18322595|P2|Overall Study|Lost to Follow-up|6
5319672|NCT00313014|18322596|P1|Overall Study|Lost to Follow-up|7
5319673|NCT00313014|18322594|P3|Overall Study|Adverse Event|16
5319674|NCT00313014|18322595|P2|Overall Study|Adverse Event|29
5319675|NCT00313014|18322596|P1|Overall Study|Adverse Event|14
5319676|NCT00313014|18322594|P3|Overall Study|Withdrawal by Subject|5
5319677|NCT00313014|18322595|P2|Overall Study|Withdrawal by Subject|7
5319678|NCT00313014|18322596|P1|Overall Study|Withdrawal by Subject|11
5319679|NCT00312897|18322627|P2|Overall Study|discontinued prior to getting treatment|3
5319680|NCT00312897|18322628|P1|Overall Study|discontinued prior to getting treatment|0
5319681|NCT00312897|18322627|P2|Overall Study|Pregnancy|0
5319682|NCT00312897|18322628|P1|Overall Study|Pregnancy|1
5319683|NCT00312897|18322627|P2|Overall Study|Withdrawal by Subject|3
5319684|NCT00312897|18322628|P1|Overall Study|Withdrawal by Subject|1
5319685|NCT00312897|18322627|P2|Overall Study|Physician Decision|0
5319686|NCT00312897|18322628|P1|Overall Study|Physician Decision|1
5319687|NCT00312897|18322627|P2|Overall Study|Lost to Follow-up|0
5319688|NCT00312897|18322628|P1|Overall Study|Lost to Follow-up|2
5319689|NCT00312897|18322627|P2|Overall Study|Adverse Event|0
5319690|NCT00312897|18322628|P1|Overall Study|Adverse Event|1
5319691|NCT00312858|18322653|P2|Overall Study|Other|12
5319692|NCT00312858|18322654|P1|Overall Study|Other|9
5319693|NCT00312858|18322653|P2|Overall Study|Participant Moved|10
5319694|NCT00312858|18322654|P1|Overall Study|Participant Moved|11
5319695|NCT00312858|18322653|P2|Overall Study|Withdraw by Participant|20
5319696|NCT00312858|18322654|P1|Overall Study|Withdraw by Participant|20
5319697|NCT00312858|18322653|P2|Overall Study|Protocol Violation|8
5319698|NCT00312858|18322654|P1|Overall Study|Protocol Violation|3
5319699|NCT00312858|18322653|P2|Overall Study|Lost to Follow-up|42
5319700|NCT00312858|18322654|P1|Overall Study|Lost to Follow-up|25
5319701|NCT00312858|18322653|P2|Overall Study|Adverse Event|1
5319702|NCT00312858|18322654|P1|Overall Study|Adverse Event|0
5319703|NCT00312845|18322708|P2|Overall Study|Other|5
5319704|NCT00312845|18322709|P1|Overall Study|Other|6
5319705|NCT00312845|18322708|P2|Overall Study|Lost to Follow-up|0
5319706|NCT00312845|18322709|P1|Overall Study|Lost to Follow-up|2
5319707|NCT00312845|18322708|P2|Overall Study|Disease Progression|77
5319708|NCT00312845|18322709|P1|Overall Study|Disease Progression|56
5319709|NCT00312845|18322708|P2|Overall Study|Withdrawal by Subject|6
5319710|NCT00312845|18322709|P1|Overall Study|Withdrawal by Subject|14
5319711|NCT00312845|18322708|P2|Overall Study|Death|2
5319712|NCT00312845|18322709|P1|Overall Study|Death|2
5319713|NCT00312845|18322708|P2|Overall Study|Adverse Event|5
5319714|NCT00312845|18322709|P1|Overall Study|Adverse Event|19
5319715|NCT00312728|18322717|P1|Overall Study|Other|1
5319716|NCT00312728|18322717|P1|Overall Study|Other|10
5319717|NCT00312728|18322717|P1|Overall Study|Protocol Violation|2
5319718|NCT00312728|18322717|P1|Overall Study|Required non-protocol cancer treatment|2
5319719|NCT00312728|18322717|P1|Overall Study|Withdrawal by Subject|10
5319720|NCT00312728|18322717|P1|Overall Study|Adverse Event|32
5319721|NCT00312728|18322717|P1|Overall Study|Progressive disease|53
5319722|NCT00312702|18322729|P3|Immunization Phase|Lost to Follow-up|0
5319723|NCT00312702|18322730|P2|Immunization Phase|Lost to Follow-up|1
5319724|NCT00312702|18322731|P1|Immunization Phase|Lost to Follow-up|0
5319725|NCT00312663|18322744|P3|Immunization Phase|Adverse Event|0
5319726|NCT00312663|18322745|P2|Immunization Phase|Adverse Event|1
5319727|NCT00312663|18322746|P1|Immunization Phase|Adverse Event|0
5319728|NCT00312572|18322759|P2|Overall Study|Lack of Efficacy|2
5319729|NCT00312572|18322760|P1|Overall Study|Lack of Efficacy|1
5319730|NCT00312572|18322759|P2|Overall Study|Administrative|2
5319731|NCT00312572|18322760|P1|Overall Study|Administrative|4
5319732|NCT00312572|18322759|P2|Overall Study|Lost to Follow-up|1
5319733|NCT00312572|18322760|P1|Overall Study|Lost to Follow-up|1
5319734|NCT00312572|18322759|P2|Overall Study|Adverse Event|16
5319735|NCT00312572|18322760|P1|Overall Study|Adverse Event|10
5319736|NCT00312494|18322771|P3|Overall Study|Other|1
5319737|NCT00312494|18322772|P2|Overall Study|Other|10
5319738|NCT00312494|18322773|P1|Overall Study|Other|10
5319739|NCT00312494|18322771|P3|Overall Study|Withdrawal by Subject|10
5319740|NCT00312494|18322772|P2|Overall Study|Withdrawal by Subject|9
5319741|NCT00312494|18322773|P1|Overall Study|Withdrawal by Subject|6
5319742|NCT00312494|18322771|P3|Overall Study|Lost to Follow-up|8
5319743|NCT00312494|18322772|P2|Overall Study|Lost to Follow-up|8
5319744|NCT00312494|18322773|P1|Overall Study|Lost to Follow-up|8
5319745|NCT00312494|18322771|P3|Overall Study|Laboratory abnormality|0
5319746|NCT00312494|18322772|P2|Overall Study|Laboratory abnormality|0
5319747|NCT00312494|18322773|P1|Overall Study|Laboratory abnormality|1
5319748|NCT00312494|18322771|P3|Overall Study|Lack of Efficacy|8
5319749|NCT00312494|18322772|P2|Overall Study|Lack of Efficacy|6
5319750|NCT00312494|18322773|P1|Overall Study|Lack of Efficacy|4
5319751|NCT00312494|18322771|P3|Overall Study|Adverse Event|11
5319752|NCT00312494|18322772|P2|Overall Study|Adverse Event|15
5319753|NCT00312494|18322773|P1|Overall Study|Adverse Event|33
5319754|NCT00312494|18322771|P3|Overall Study|Randomized; not treated with study drug|5
5319755|NCT00312494|18322772|P2|Overall Study|Randomized; not treated with study drug|10
5319756|NCT00312494|18322773|P1|Overall Study|Randomized; not treated with study drug|9
5319757|NCT00312377|18322807|P2|Overall Study|Site ended participation in study|0
5319758|NCT00312377|18322808|P1|Overall Study|Site ended participation in study|1
5319759|NCT00312377|18322807|P2|Overall Study|Discontinue treatment survival follow up|200
5319760|NCT00312377|18322808|P1|Overall Study|Discontinue treatment survival follow up|202
5319761|NCT00312377|18322807|P2|Overall Study|Randomised but never received treatment|6
5319762|NCT00312377|18322808|P1|Overall Study|Randomised but never received treatment|6
5319763|NCT00312377|18322807|P2|Overall Study|Non-compliance|2
5319764|NCT00312377|18322808|P1|Overall Study|Non-compliance|0
5319765|NCT00312377|18322807|P2|Overall Study|Lost to Follow-up|12
5319766|NCT00312377|18322808|P1|Overall Study|Lost to Follow-up|9
5319767|NCT00312377|18322807|P2|Overall Study|Withdrawal by Subject|30
5319768|NCT00312377|18322808|P1|Overall Study|Withdrawal by Subject|23
5319769|NCT00312377|18322807|P2|Overall Study|Death|418
5319770|NCT00312377|18322808|P1|Overall Study|Death|403
5319771|NCT00312338|18322832|P2|Overall Study|Subsequent infection|0
5319772|NCT00312338|18322833|P1|Overall Study|Subsequent infection|2
5319773|NCT00312338|18322832|P2|Overall Study|Withdrawal by Subject|0
5319774|NCT00312338|18322833|P1|Overall Study|Withdrawal by Subject|4
5319775|NCT00312338|18322832|P2|Overall Study|Lost to Follow-up|1
5319776|NCT00312338|18322833|P1|Overall Study|Lost to Follow-up|9
5319777|NCT00312338|18322832|P2|Overall Study|Adverse Event|2
5319778|NCT00312338|18322833|P1|Overall Study|Adverse Event|7
5319779|NCT00312221|18322846|P4|Double-blind Phase|Lack of Efficacy|10
5319780|NCT00312221|18322847|P3|Double-blind Phase|Lack of Efficacy|6
5319781|NCT00312221|18322848|P2|Double-blind Phase|Lack of Efficacy|17
5319782|NCT00312221|18322849|P1|Double-blind Phase|Lack of Efficacy|0
5319783|NCT00312221|18322846|P4|Double-blind Phase|Administrative|33
5319784|NCT00312221|18322847|P3|Double-blind Phase|Administrative|37
5319785|NCT00312221|18322848|P2|Double-blind Phase|Administrative|26
5319786|NCT00312221|18322849|P1|Double-blind Phase|Administrative|0
5319787|NCT00312221|18322846|P4|Double-blind Phase|Lost to Follow-up|2
5319788|NCT00312221|18322847|P3|Double-blind Phase|Lost to Follow-up|2
5319789|NCT00312221|18322848|P2|Double-blind Phase|Lost to Follow-up|0
5319790|NCT00312221|18322849|P1|Double-blind Phase|Lost to Follow-up|0
5319791|NCT00312221|18322846|P4|Double-blind Phase|Adverse Event|18
5319792|NCT00312221|18322847|P3|Double-blind Phase|Adverse Event|19
5319793|NCT00312221|18322848|P2|Double-blind Phase|Adverse Event|10
5319794|NCT00312221|18322849|P1|Double-blind Phase|Adverse Event|0
5319795|NCT00312221|18322846|P4|Double-blind Phase|Withdrawal by Subject|7
5319796|NCT00312221|18322847|P3|Double-blind Phase|Withdrawal by Subject|8
5319797|NCT00312221|18322848|P2|Double-blind Phase|Withdrawal by Subject|6
5319798|NCT00312221|18322849|P1|Double-blind Phase|Withdrawal by Subject|0
5319799|NCT00312221|18322846|P4|Open-label Run-in Period|Did not qualify|0
5319800|NCT00312221|18322847|P3|Open-label Run-in Period|Did not qualify|0
5319801|NCT00312221|18322848|P2|Open-label Run-in Period|Did not qualify|0
5319802|NCT00312221|18322849|P1|Open-label Run-in Period|Did not qualify|5
5319803|NCT00312221|18322846|P4|Open-label Run-in Period|Lack of Efficacy|0
5319804|NCT00312221|18322847|P3|Open-label Run-in Period|Lack of Efficacy|0
5319805|NCT00312221|18322848|P2|Open-label Run-in Period|Lack of Efficacy|0
5319806|NCT00312221|18322849|P1|Open-label Run-in Period|Lack of Efficacy|102
5319807|NCT00312221|18322846|P4|Open-label Run-in Period|Administrative|0
5319808|NCT00312221|18322847|P3|Open-label Run-in Period|Administrative|0
5319809|NCT00312221|18322848|P2|Open-label Run-in Period|Administrative|0
5319810|NCT00312221|18322849|P1|Open-label Run-in Period|Administrative|42
5319811|NCT00312221|18322846|P4|Open-label Run-in Period|Lost to Follow-up|0
5319812|NCT00312221|18322847|P3|Open-label Run-in Period|Lost to Follow-up|0
5319813|NCT00312221|18322848|P2|Open-label Run-in Period|Lost to Follow-up|0
5319814|NCT00312221|18322849|P1|Open-label Run-in Period|Lost to Follow-up|5
5319815|NCT00312221|18322846|P4|Open-label Run-in Period|Adverse Event|0
5319816|NCT00312221|18322847|P3|Open-label Run-in Period|Adverse Event|0
5319817|NCT00312221|18322848|P2|Open-label Run-in Period|Adverse Event|0
5319818|NCT00312221|18322849|P1|Open-label Run-in Period|Adverse Event|74
5319819|NCT00312221|18322846|P4|Open-label Run-in Period|Withdrawal by Subject|0
5319820|NCT00312221|18322847|P3|Open-label Run-in Period|Withdrawal by Subject|0
5319821|NCT00312221|18322848|P2|Open-label Run-in Period|Withdrawal by Subject|0
5319822|NCT00312221|18322849|P1|Open-label Run-in Period|Withdrawal by Subject|6
5319823|NCT00312208|18322869|P2|Overall Study|Other|7
5319824|NCT00312208|18322870|P1|Overall Study|Other|5
5319825|NCT00312208|18322869|P2|Overall Study|Withdrawal by Subject|42
5319826|NCT00312208|18322870|P1|Overall Study|Withdrawal by Subject|53
5319827|NCT00312208|18322869|P2|Overall Study|Lost to Follow-up|5
5319828|NCT00312208|18322870|P1|Overall Study|Lost to Follow-up|3
5319829|NCT00312208|18322869|P2|Overall Study|Lack of Efficacy|4
5319830|NCT00312208|18322870|P1|Overall Study|Lack of Efficacy|7
5319831|NCT00312208|18322869|P2|Overall Study|Death|1
5319832|NCT00312208|18322870|P1|Overall Study|Death|2
5319833|NCT00312208|18322869|P2|Overall Study|Protocol Violation|3
5319834|NCT00312208|18322870|P1|Overall Study|Protocol Violation|5
5319835|NCT00312208|18322869|P2|Overall Study|Adverse Event|61
5319836|NCT00312208|18322870|P1|Overall Study|Adverse Event|97
5319837|NCT00312195|18322880|P2|Overall Study|Protocol Violation|0
5319838|NCT00312195|18322881|P1|Overall Study|Protocol Violation|1
5319839|NCT00312195|18322880|P2|Overall Study|Lost to Follow-up|0
5319840|NCT00312195|18322881|P1|Overall Study|Lost to Follow-up|1
5319841|NCT00312195|18322880|P2|Overall Study|Adverse Event|6
5319842|NCT00312195|18322881|P1|Overall Study|Adverse Event|4
5319843|NCT00311623|18322909|P3|Overall Study|Physician Decision|2
5319844|NCT00311623|18322910|P2|Overall Study|Physician Decision|0
5319845|NCT00311623|18322911|P1|Overall Study|Physician Decision|0
5319846|NCT00311584|18322953|P2|Overall Study|ineligible|2
5319847|NCT00311584|18322954|P1|Overall Study|ineligible|2
5319848|NCT00311584|18322953|P2|Overall Study|Withdrawal by Subject|1
5319849|NCT00311584|18322954|P1|Overall Study|Withdrawal by Subject|1
5319850|NCT00311584|18322953|P2|Overall Study|Physician Decision|5
5319851|NCT00311584|18322954|P1|Overall Study|Physician Decision|4
5319852|NCT00311584|18322953|P2|Overall Study|Lack of Efficacy|15
5319853|NCT00311584|18322954|P1|Overall Study|Lack of Efficacy|12
5319854|NCT00311584|18322953|P2|Overall Study|Death|0
5319855|NCT00311584|18322954|P1|Overall Study|Death|1
5319856|NCT00311402|18322962|P2|Overall Study|IRB's rejection etc.|3
5319857|NCT00311402|18322963|P1|Overall Study|IRB's rejection etc.|10
5319858|NCT00311402|18322962|P2|Overall Study|Protocol Violation|6
5319859|NCT00311402|18322963|P1|Overall Study|Protocol Violation|7
5319860|NCT00311402|18322962|P2|Overall Study|Lack of Efficacy|42
5319861|NCT00311402|18322963|P1|Overall Study|Lack of Efficacy|58
5319862|NCT00311402|18322962|P2|Overall Study|Withdrawal by Subject|18
5319863|NCT00311402|18322963|P1|Overall Study|Withdrawal by Subject|17
5319864|NCT00311402|18322962|P2|Overall Study|Lost to Follow-up|3
5319865|NCT00311402|18322963|P1|Overall Study|Lost to Follow-up|0
5319866|NCT00311402|18322962|P2|Overall Study|Adverse Event|105
5319867|NCT00311402|18322963|P1|Overall Study|Adverse Event|118
5319868|NCT00311363|18323012|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
5319869|NCT00311363|18323013|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
5319870|NCT00311363|18323014|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
5319871|NCT00311363|18323012|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
5319872|NCT00311363|18323013|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
5319873|NCT00311363|18323014|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
5319874|NCT00311363|18323012|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
5319875|NCT00311363|18323013|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
5319876|NCT00311363|18323014|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
5319877|NCT00311363|18323012|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
5319878|NCT00311363|18323013|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
5319879|NCT00311363|18323014|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
5319880|NCT00311363|18323012|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
5319881|NCT00311363|18323013|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
5319882|NCT00311363|18323014|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
5319883|NCT00311363|18323012|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
5319884|NCT00311363|18323013|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
5319885|NCT00311363|18323014|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
5319886|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Death|0
5319887|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Death|0
5319888|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Death|1
5319889|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
5319890|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
5319891|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
5319892|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
5319893|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
5319894|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
5319895|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
5319896|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
5319897|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
5319898|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
5319899|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
5319900|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
5319901|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
5319902|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
5319903|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
5319904|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
5319905|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
5319906|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
5319907|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
5319908|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
5319909|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
5319910|NCT00311363|18323012|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
5319911|NCT00311363|18323013|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
5319912|NCT00311363|18323014|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
5319913|NCT00311311|18323074|P2|Overall Study|Lack of ancillary assistance|1
5319914|NCT00311311|18323075|P1|Overall Study|Lack of ancillary assistance|0
5319915|NCT00311311|18323074|P2|Overall Study|Death|0
5319916|NCT00311311|18323075|P1|Overall Study|Death|1
5319917|NCT00311311|18323074|P2|Overall Study|Study Termination by Sponsor|4
5319918|NCT00311311|18323075|P1|Overall Study|Study Termination by Sponsor|3
5319919|NCT00311311|18323074|P2|Overall Study|Noncompliance|1
5319920|NCT00311311|18323075|P1|Overall Study|Noncompliance|0
5319921|NCT00311311|18323074|P2|Overall Study|Withdrawal by Subject|1
5319922|NCT00311311|18323075|P1|Overall Study|Withdrawal by Subject|1
5319923|NCT00311311|18323074|P2|Overall Study|Adverse Event|2
5319924|NCT00311311|18323075|P1|Overall Study|Adverse Event|3
5319925|NCT00311181|18323133|P1|Overall Study|Final DFTs were not obtained|96
5319926|NCT00311155|18323139|P1|Overall Study|Did not meet entry criteria|55
5319927|NCT00311155|18323139|P1|Overall Study|Withdrawal by Subject|17
5319928|NCT00311155|18323139|P1|Overall Study|Adverse Event|21
5319929|NCT00310856|18323151|P3|Overall Study|Unable to classify|0
5319930|NCT00310856|18323152|P2|Overall Study|Unable to classify|0
5319931|NCT00310856|18323153|P1|Overall Study|Unable to classify|1
5319932|NCT00310856|18323151|P3|Overall Study|Inappropriate enrollment|0
5319933|NCT00310856|18323152|P2|Overall Study|Inappropriate enrollment|1
5319934|NCT00310856|18323153|P1|Overall Study|Inappropriate enrollment|1
5319935|NCT00310856|18323151|P3|Overall Study|Lost to Follow-up|6
5319936|NCT00310856|18323152|P2|Overall Study|Lost to Follow-up|2
5319937|NCT00310856|18323153|P1|Overall Study|Lost to Follow-up|1
5319938|NCT00310856|18323151|P3|Overall Study|Withdrawal by Subject|2
5319939|NCT00310856|18323152|P2|Overall Study|Withdrawal by Subject|2
5319940|NCT00310856|18323153|P1|Overall Study|Withdrawal by Subject|2
5319941|NCT00310817|18323177|P4|Overall Study|Unable to classify|0
5319942|NCT00310817|18323178|P3|Overall Study|Unable to classify|0
5319943|NCT00310817|18323179|P2|Overall Study|Unable to classify|1
5319944|NCT00310817|18323180|P1|Overall Study|Unable to classify|3
5319945|NCT00310817|18323177|P4|Overall Study|Protocol Violation|1
5319946|NCT00310817|18323178|P3|Overall Study|Protocol Violation|1
5319947|NCT00310817|18323179|P2|Overall Study|Protocol Violation|1
5319948|NCT00310817|18323180|P1|Overall Study|Protocol Violation|1
5319949|NCT00310817|18323177|P4|Overall Study|Inappropriate Enrollment|0
5319950|NCT00310817|18323178|P3|Overall Study|Inappropriate Enrollment|1
5319951|NCT00310817|18323179|P2|Overall Study|Inappropriate Enrollment|0
5319952|NCT00310817|18323180|P1|Overall Study|Inappropriate Enrollment|1
5319953|NCT00310817|18323177|P4|Overall Study|Lost to Follow-up|0
5319954|NCT00310817|18323178|P3|Overall Study|Lost to Follow-up|0
5319955|NCT00310817|18323179|P2|Overall Study|Lost to Follow-up|1
5319956|NCT00310817|18323180|P1|Overall Study|Lost to Follow-up|2
5319957|NCT00310817|18323177|P4|Overall Study|Withdrawal by Subject|7
5319958|NCT00310817|18323178|P3|Overall Study|Withdrawal by Subject|6
5319959|NCT00310817|18323179|P2|Overall Study|Withdrawal by Subject|4
5319960|NCT00310817|18323180|P1|Overall Study|Withdrawal by Subject|1
5319961|NCT00310817|18323177|P4|Overall Study|AE or Death|0
5319962|NCT00310817|18323178|P3|Overall Study|AE or Death|0
5319963|NCT00310817|18323179|P2|Overall Study|AE or Death|1
5319964|NCT00310817|18323180|P1|Overall Study|AE or Death|3
5319965|NCT00310804|18323268|P2|Overall Study|Withdrawal by Subject|0
5319966|NCT00310804|18323269|P1|Overall Study|Withdrawal by Subject|3
5319967|NCT00310804|18323268|P2|Overall Study|Lost to Follow-up|0
5319968|NCT00310804|18323269|P1|Overall Study|Lost to Follow-up|2
5319969|NCT00310440|18323328|P2|Overall Study|Missed 12 Month Visit|4
5319970|NCT00310440|18323329|P1|Overall Study|Missed 12 Month Visit|7
5319971|NCT00310440|18323328|P2|Overall Study|Withdrawal by Subject|1
5319972|NCT00310440|18323329|P1|Overall Study|Withdrawal by Subject|2
5319973|NCT00310440|18323328|P2|Overall Study|Lost to Follow-up|8
5319974|NCT00310440|18323329|P1|Overall Study|Lost to Follow-up|17
5319975|NCT00310388|18323393|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
5319976|NCT00310388|18323394|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
5319977|NCT00310388|18323393|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
5319978|NCT00310388|18323394|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
5319979|NCT00310388|18323393|P2|Safety Follow-up Continuation Phase|Adverse Event|1
5319980|NCT00310388|18323394|P1|Safety Follow-up Continuation Phase|Adverse Event|0
5319981|NCT00310388|18323393|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
5319982|NCT00310388|18323394|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
5319983|NCT00310388|18323393|P2|Primary Reporting Phase|Other|0
5319984|NCT00310388|18323394|P1|Primary Reporting Phase|Other|1
5319985|NCT00310388|18323393|P2|Primary Reporting Phase|Missing|0
5319986|NCT00310388|18323394|P1|Primary Reporting Phase|Missing|1
5319987|NCT00310388|18323393|P2|Primary Reporting Phase|Participant retired the informed consent|0
5319988|NCT00310388|18323394|P1|Primary Reporting Phase|Participant retired the informed consent|1
5319989|NCT00310388|18323393|P2|Primary Reporting Phase|Participant passed away|0
5319990|NCT00310388|18323394|P1|Primary Reporting Phase|Participant passed away|1
5319991|NCT00310388|18323393|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
5319992|NCT00310388|18323394|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
5319993|NCT00310388|18323393|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
5319994|NCT00310388|18323394|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
5319995|NCT00310388|18323393|P2|Primary Reporting Phase|Termination of study at sponsor request|0
5319996|NCT00310388|18323394|P1|Primary Reporting Phase|Termination of study at sponsor request|3
5319997|NCT00310388|18323393|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
5319998|NCT00310388|18323394|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
5319999|NCT00310388|18323393|P2|Primary Reporting Phase|Discontinuation of study|0
5320000|NCT00310388|18323394|P1|Primary Reporting Phase|Discontinuation of study|1
5320001|NCT00310388|18323393|P2|Primary Reporting Phase|Ministry of Health decision|0
5320002|NCT00310388|18323394|P1|Primary Reporting Phase|Ministry of Health decision|25
5320003|NCT00310388|18323393|P2|Primary Reporting Phase|Participant request|0
5320004|NCT00310388|18323394|P1|Primary Reporting Phase|Participant request|2
5320005|NCT00310388|18323393|P2|Primary Reporting Phase|Participant request unrelated to study|0
5320006|NCT00310388|18323394|P1|Primary Reporting Phase|Participant request unrelated to study|2
5320007|NCT00310388|18323393|P2|Primary Reporting Phase|Failed to return|0
5320008|NCT00310388|18323394|P1|Primary Reporting Phase|Failed to return|8
5320009|NCT00310388|18323393|P2|Primary Reporting Phase|Request of the sponsor|0
5320010|NCT00310388|18323394|P1|Primary Reporting Phase|Request of the sponsor|19
5320011|NCT00310388|18323393|P2|Primary Reporting Phase|Physician Decision|0
5320012|NCT00310388|18323394|P1|Primary Reporting Phase|Physician Decision|2
5320013|NCT00310388|18323393|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
5320014|NCT00310388|18323394|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
5320015|NCT00310388|18323393|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
5320016|NCT00310388|18323394|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
5320017|NCT00310388|18323393|P2|Primary Reporting Phase|Change in participant medical condition|0
5320018|NCT00310388|18323394|P1|Primary Reporting Phase|Change in participant medical condition|3
5320019|NCT00310388|18323393|P2|Primary Reporting Phase|Pregnancy|0
5320020|NCT00310388|18323394|P1|Primary Reporting Phase|Pregnancy|3
5320021|NCT00310388|18323393|P2|Primary Reporting Phase|Protocol Violation|0
5320022|NCT00310388|18323394|P1|Primary Reporting Phase|Protocol Violation|10
5320023|NCT00310388|18323393|P2|Primary Reporting Phase|Withdrawal by Subject|0
5320024|NCT00310388|18323394|P1|Primary Reporting Phase|Withdrawal by Subject|97
5320025|NCT00310388|18323393|P2|Primary Reporting Phase|Lack of Efficacy|0
5320026|NCT00310388|18323394|P1|Primary Reporting Phase|Lack of Efficacy|56
5320027|NCT00310388|18323393|P2|Primary Reporting Phase|Adverse Event|0
5320028|NCT00310388|18323394|P1|Primary Reporting Phase|Adverse Event|101
5320029|NCT00310375|18323436|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
5320030|NCT00310375|18323437|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
5320031|NCT00310375|18323438|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
5320032|NCT00310375|18323436|P3|Primary Reporting Phase|Request of Ethics Committee|0
5320033|NCT00310375|18323437|P2|Primary Reporting Phase|Request of Ethics Committee|1
5320034|NCT00310375|18323438|P1|Primary Reporting Phase|Request of Ethics Committee|0
5320035|NCT00310375|18323436|P3|Primary Reporting Phase|Par. switched to commercial product|0
5320036|NCT00310375|18323437|P2|Primary Reporting Phase|Par. switched to commercial product|1
5320037|NCT00310375|18323438|P1|Primary Reporting Phase|Par. switched to commercial product|0
5320038|NCT00310375|18323436|P3|Primary Reporting Phase|Missed study drug for 2 months|0
5320039|NCT00310375|18323437|P2|Primary Reporting Phase|Missed study drug for 2 months|0
5320040|NCT00310375|18323438|P1|Primary Reporting Phase|Missed study drug for 2 months|1
5320041|NCT00310375|18323436|P3|Primary Reporting Phase|Site closure|0
5320042|NCT00310375|18323437|P2|Primary Reporting Phase|Site closure|0
5320043|NCT00310375|18323438|P1|Primary Reporting Phase|Site closure|3
5320044|NCT00310375|18323436|P3|Primary Reporting Phase|Missed study drug >5 days|0
5320045|NCT00310375|18323437|P2|Primary Reporting Phase|Missed study drug >5 days|0
5320046|NCT00310375|18323438|P1|Primary Reporting Phase|Missed study drug >5 days|1
5320047|NCT00310375|18323436|P3|Primary Reporting Phase|Going for temporal lobectomy|0
5320048|NCT00310375|18323437|P2|Primary Reporting Phase|Going for temporal lobectomy|0
5320049|NCT00310375|18323438|P1|Primary Reporting Phase|Going for temporal lobectomy|1
5320050|NCT00310375|18323436|P3|Primary Reporting Phase|Participant request unrelated to study|0
5320051|NCT00310375|18323437|P2|Primary Reporting Phase|Participant request unrelated to study|2
5320052|NCT00310375|18323438|P1|Primary Reporting Phase|Participant request unrelated to study|1
5320053|NCT00310375|18323436|P3|Primary Reporting Phase|Failed to return|0
5320054|NCT00310375|18323437|P2|Primary Reporting Phase|Failed to return|3
5320055|NCT00310375|18323438|P1|Primary Reporting Phase|Failed to return|1
5320056|NCT00310375|18323436|P3|Primary Reporting Phase|Request of the sponsor|0
5320057|NCT00310375|18323437|P2|Primary Reporting Phase|Request of the sponsor|2
5320058|NCT00310375|18323438|P1|Primary Reporting Phase|Request of the sponsor|2
5320059|NCT00310375|18323436|P3|Primary Reporting Phase|Physician Decision|0
5320060|NCT00310375|18323437|P2|Primary Reporting Phase|Physician Decision|3
5320061|NCT00310375|18323438|P1|Primary Reporting Phase|Physician Decision|5
5320062|NCT00310375|18323436|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
5320063|NCT00310375|18323437|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
5320064|NCT00310375|18323438|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
5320065|NCT00310375|18323436|P3|Primary Reporting Phase|Change in Par medical condition|0
5320066|NCT00310375|18323437|P2|Primary Reporting Phase|Change in Par medical condition|0
5320067|NCT00310375|18323438|P1|Primary Reporting Phase|Change in Par medical condition|2
5320068|NCT00310375|18323436|P3|Primary Reporting Phase|Protocol Violation|0
5320069|NCT00310375|18323437|P2|Primary Reporting Phase|Protocol Violation|5
5320070|NCT00310375|18323438|P1|Primary Reporting Phase|Protocol Violation|8
5320071|NCT00310375|18323436|P3|Primary Reporting Phase|Withdrawal by Subject|0
5320072|NCT00310375|18323437|P2|Primary Reporting Phase|Withdrawal by Subject|7
5320073|NCT00310375|18323438|P1|Primary Reporting Phase|Withdrawal by Subject|10
5320074|NCT00310375|18323436|P3|Primary Reporting Phase|Pregnancy|0
5320075|NCT00310375|18323437|P2|Primary Reporting Phase|Pregnancy|2
5320076|NCT00310375|18323438|P1|Primary Reporting Phase|Pregnancy|2
5320077|NCT00310375|18323436|P3|Primary Reporting Phase|Lack of Efficacy|0
5320078|NCT00310375|18323437|P2|Primary Reporting Phase|Lack of Efficacy|19
5320079|NCT00310375|18323438|P1|Primary Reporting Phase|Lack of Efficacy|24
5320080|NCT00310375|18323436|P3|Primary Reporting Phase|Adverse Event|0
5320081|NCT00310375|18323437|P2|Primary Reporting Phase|Adverse Event|22
5320082|NCT00310375|18323438|P1|Primary Reporting Phase|Adverse Event|28
5320083|NCT00310037|18323583|P2|Overall Study|Non-protocol treatment|0
5320084|NCT00310037|18323584|P1|Overall Study|Non-protocol treatment|1
5320085|NCT00310037|18323583|P2|Overall Study|Progression|0
5320086|NCT00310037|18323584|P1|Overall Study|Progression|6
5320087|NCT00310037|18323583|P2|Overall Study|Withdrawal by Subject|3
5320088|NCT00310037|18323584|P1|Overall Study|Withdrawal by Subject|4
5320089|NCT00310037|18323583|P2|Overall Study|Adverse Event|14
5320090|NCT00310037|18323584|P1|Overall Study|Adverse Event|7
5320091|NCT00309985|18323598|P2|Overall Study|Chemotherapy discontinued only|0
5320092|NCT00309985|18323599|P1|Overall Study|Chemotherapy discontinued only|1
5320093|NCT00309985|18323598|P2|Overall Study|Non-compliance|0
5320094|NCT00309985|18323599|P1|Overall Study|Non-compliance|1
5320095|NCT00309985|18323598|P2|Overall Study|Complicating disease|0
5320096|NCT00309985|18323599|P1|Overall Study|Complicating disease|1
5320097|NCT00309985|18323598|P2|Overall Study|Never started treatment|0
5320098|NCT00309985|18323599|P1|Overall Study|Never started treatment|7
5320099|NCT00309985|18323598|P2|Overall Study|Physician Decision|0
5320100|NCT00309985|18323599|P1|Overall Study|Physician Decision|3
5320101|NCT00309985|18323598|P2|Overall Study|Withdrawal by Subject|1
5320102|NCT00309985|18323599|P1|Overall Study|Withdrawal by Subject|5
5320103|NCT00309985|18323598|P2|Overall Study|Death|0
5320104|NCT00309985|18323599|P1|Overall Study|Death|2
5320105|NCT00309985|18323598|P2|Overall Study|Adverse Event|0
5320106|NCT00309985|18323599|P1|Overall Study|Adverse Event|30
5320107|NCT00309985|18323598|P2|Overall Study|Disease progression|0
5320108|NCT00309985|18323599|P1|Overall Study|Disease progression|12
5320109|NCT00309959|18323615|P1|Overall Study|Ineligible - no prior chemotherapy|2
5320110|NCT00309946|18323624|P1|Overall Study|Withdrawal by Subject|1
5320111|NCT00309907|18323630|P1|Overall Study|Major infectious event|4
5320112|NCT00309907|18323630|P1|Overall Study|Ineligible|11
5320113|NCT00309907|18323630|P1|Overall Study|Physician Decision|1
5320114|NCT00309907|18323630|P1|Overall Study|Death|4
5320115|NCT00309842|18323639|P1|Overall Study|Lost to Follow-up|1
5320116|NCT00309777|18323657|P4|Overall Study|Death|0
5320117|NCT00309777|18323658|P3|Overall Study|Death|0
5320118|NCT00309777|18323659|P2|Overall Study|Death|1
5320119|NCT00309777|18323660|P1|Overall Study|Death|0
5320120|NCT00309777|18323657|P4|Overall Study|Lost to Follow-up|0
5320121|NCT00309777|18323658|P3|Overall Study|Lost to Follow-up|1
5320122|NCT00309777|18323659|P2|Overall Study|Lost to Follow-up|0
5320123|NCT00309777|18323660|P1|Overall Study|Lost to Follow-up|0
5320124|NCT00309777|18323657|P4|Overall Study|Withdrawal by Subject|2
5320125|NCT00309777|18323658|P3|Overall Study|Withdrawal by Subject|7
5320126|NCT00309777|18323659|P2|Overall Study|Withdrawal by Subject|5
5320127|NCT00309777|18323660|P1|Overall Study|Withdrawal by Subject|6
5320128|NCT00309777|18323657|P4|Overall Study|Protocol Violation|1
5320129|NCT00309777|18323658|P3|Overall Study|Protocol Violation|3
5320130|NCT00309777|18323659|P2|Overall Study|Protocol Violation|1
5320131|NCT00309777|18323660|P1|Overall Study|Protocol Violation|4
5320132|NCT00309777|18323657|P4|Overall Study|Adverse Event|1
5320133|NCT00309777|18323658|P3|Overall Study|Adverse Event|8
5320134|NCT00309777|18323659|P2|Overall Study|Adverse Event|2
5320135|NCT00309777|18323660|P1|Overall Study|Adverse Event|13
5320136|NCT00309608|18323701|P5|Overall Study|Other incl. Lack of efficacy|0
5320137|NCT00309608|18323702|P4|Overall Study|Other incl. Lack of efficacy|4
5320138|NCT00309608|18323703|P3|Overall Study|Other incl. Lack of efficacy|3
5320139|NCT00309608|18323704|P2|Overall Study|Other incl. Lack of efficacy|4
5320140|NCT00309608|18323705|P1|Overall Study|Other incl. Lack of efficacy|10
5320141|NCT00309608|18323701|P5|Overall Study|Withdrawal by Subject|0
5320142|NCT00309608|18323702|P4|Overall Study|Withdrawal by Subject|0
5320143|NCT00309608|18323703|P3|Overall Study|Withdrawal by Subject|2
5320144|NCT00309608|18323704|P2|Overall Study|Withdrawal by Subject|4
5320145|NCT00309608|18323705|P1|Overall Study|Withdrawal by Subject|1
5320146|NCT00309608|18323701|P5|Overall Study|Lost to Follow-up|1
5320147|NCT00309608|18323702|P4|Overall Study|Lost to Follow-up|0
5320148|NCT00309608|18323703|P3|Overall Study|Lost to Follow-up|2
5320149|NCT00309608|18323704|P2|Overall Study|Lost to Follow-up|0
5320150|NCT00309608|18323705|P1|Overall Study|Lost to Follow-up|0
5320151|NCT00309608|18323701|P5|Overall Study|Protocol Violation|0
5320152|NCT00309608|18323702|P4|Overall Study|Protocol Violation|0
5320153|NCT00309608|18323703|P3|Overall Study|Protocol Violation|0
5320154|NCT00309608|18323704|P2|Overall Study|Protocol Violation|0
5320155|NCT00309608|18323705|P1|Overall Study|Protocol Violation|2
5320156|NCT00309608|18323701|P5|Overall Study|Adverse Event|3
5320157|NCT00309608|18323702|P4|Overall Study|Adverse Event|2
5320158|NCT00309608|18323703|P3|Overall Study|Adverse Event|3
5320159|NCT00309608|18323704|P2|Overall Study|Adverse Event|5
5320160|NCT00309608|18323705|P1|Overall Study|Adverse Event|1
5320161|NCT00309452|18323753|P2|Overall Study|Withdrawal by Subject|0
5320162|NCT00309452|18323754|P1|Overall Study|Withdrawal by Subject|3
5320163|NCT00309387|18323782|P2|Overall Study|Lost to Follow-up|86
5320164|NCT00309387|18323783|P1|Overall Study|Lost to Follow-up|70
5320165|NCT00309387|18323782|P2|Overall Study|Death|73
5320166|NCT00309387|18323783|P1|Overall Study|Death|72
5320167|NCT00309244|18323801|P2|Overall Study|Death|1
5320168|NCT00309244|18323802|P1|Overall Study|Death|4
5320169|NCT00309244|18323801|P2|Overall Study|Randomized but not dosed|12
5320170|NCT00309244|18323802|P1|Overall Study|Randomized but not dosed|11
5320171|NCT00309244|18323801|P2|Overall Study|Various|7
5320172|NCT00309244|18323802|P1|Overall Study|Various|7
5320173|NCT00309244|18323801|P2|Overall Study|Withdrawal by Subject|32
5320174|NCT00309244|18323802|P1|Overall Study|Withdrawal by Subject|50
5320175|NCT00309244|18323801|P2|Overall Study|Protocol Violation|3
5320176|NCT00309244|18323802|P1|Overall Study|Protocol Violation|6
5320177|NCT00309244|18323801|P2|Overall Study|Physician Decision|8
5320178|NCT00309244|18323802|P1|Overall Study|Physician Decision|5
5320179|NCT00309244|18323801|P2|Overall Study|Lost to Follow-up|22
5320180|NCT00309244|18323802|P1|Overall Study|Lost to Follow-up|6
5320181|NCT00309244|18323801|P2|Overall Study|Adverse Event|12
5320182|NCT00309244|18323802|P1|Overall Study|Adverse Event|29
5320183|NCT00309166|18323824|P2|Overall Study|Withdrawal by Subject|3
5320184|NCT00309166|18323825|P1|Overall Study|Withdrawal by Subject|4
5320185|NCT00309166|18323824|P2|Overall Study|Adverse event, non-fatal|0
5320186|NCT00309166|18323825|P1|Overall Study|Adverse event, non-fatal|1
5320187|NCT00308997|18323859|P2|Overall Study|Unable to tolerate intervention|0
5320188|NCT00308997|18323860|P1|Overall Study|Unable to tolerate intervention|1
5320189|NCT00308997|18323859|P2|Overall Study|Subject feigned clinical data|1
5320190|NCT00308997|18323860|P1|Overall Study|Subject feigned clinical data|0
5320191|NCT00308737|18323879|P3|Overall Study|Various|8
5320192|NCT00308737|18323880|P2|Overall Study|Various|20
5320193|NCT00308737|18323881|P1|Overall Study|Various|32
5320194|NCT00308737|18323879|P3|Overall Study|Withdrawal by Subject|18
5320195|NCT00308737|18323880|P2|Overall Study|Withdrawal by Subject|166
5320196|NCT00308737|18323881|P1|Overall Study|Withdrawal by Subject|218
5320197|NCT00308737|18323879|P3|Overall Study|Protocol Violation|5
5320198|NCT00308737|18323880|P2|Overall Study|Protocol Violation|9
5320199|NCT00308737|18323881|P1|Overall Study|Protocol Violation|34
5320200|NCT00308737|18323879|P3|Overall Study|Physician Decision|1
5320201|NCT00308737|18323880|P2|Overall Study|Physician Decision|2
5320202|NCT00308737|18323881|P1|Overall Study|Physician Decision|15
5320203|NCT00308737|18323879|P3|Overall Study|Lost to Follow-up|5
5320204|NCT00308737|18323880|P2|Overall Study|Lost to Follow-up|80
5320205|NCT00308737|18323881|P1|Overall Study|Lost to Follow-up|56
5320206|NCT00308737|18323879|P3|Overall Study|Death|0
5320207|NCT00308737|18323880|P2|Overall Study|Death|3
5320208|NCT00308737|18323881|P1|Overall Study|Death|4
5320209|NCT00308737|18323879|P3|Overall Study|Adverse Event|0
5320210|NCT00308737|18323880|P2|Overall Study|Adverse Event|9
5320211|NCT00308737|18323881|P1|Overall Study|Adverse Event|104
5320212|NCT00308711|18323921|P3|Overall Study|Subject incarcerated, data not allowed|1
5320213|NCT00308711|18323922|P2|Overall Study|Subject incarcerated, data not allowed|0
5320214|NCT00308711|18323923|P1|Overall Study|Subject incarcerated, data not allowed|0
5320215|NCT00308711|18323921|P3|Overall Study|Baby not born within 7 days of treatment|2
5320216|NCT00308711|18323922|P2|Overall Study|Baby not born within 7 days of treatment|2
5320217|NCT00308711|18323923|P1|Overall Study|Baby not born within 7 days of treatment|1
5320218|NCT00308711|18323921|P3|Overall Study|Lost to Follow-up|0
5320219|NCT00308711|18323922|P2|Overall Study|Lost to Follow-up|1
5320220|NCT00308711|18323923|P1|Overall Study|Lost to Follow-up|0
5320221|NCT00308711|18323921|P3|Overall Study|Protocol Violation|1
5320222|NCT00308711|18323922|P2|Overall Study|Protocol Violation|1
5320223|NCT00308711|18323923|P1|Overall Study|Protocol Violation|0
5320224|NCT00308711|18323921|P3|Overall Study|Withdrawal by Subject|1
5320225|NCT00308711|18323922|P2|Overall Study|Withdrawal by Subject|0
5320226|NCT00308711|18323923|P1|Overall Study|Withdrawal by Subject|1
5320227|NCT00308620|18323958|P3|Overall Study|Lost to Follow-up|1
5320228|NCT00308620|18323959|P2|Overall Study|Lost to Follow-up|0
5320229|NCT00308620|18323960|P1|Overall Study|Lost to Follow-up|0
5320230|NCT00308620|18323958|P3|Overall Study|Death|0
5320231|NCT00308620|18323959|P2|Overall Study|Death|1
5320232|NCT00308620|18323960|P1|Overall Study|Death|1
5320233|NCT00308581|18323969|P3|Randomized Maintenance Phase|Unknown reason|0
5320234|NCT00308581|18323970|P2|Randomized Maintenance Phase|Unknown reason|0
5320235|NCT00308581|18323971|P1|Randomized Maintenance Phase|Unknown reason|3
5320236|NCT00308581|18323969|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
5320237|NCT00308581|18323970|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
5320238|NCT00308581|18323971|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
5320239|NCT00308581|18323969|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
5320240|NCT00308581|18323970|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
5320241|NCT00308581|18323971|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
5320242|NCT00308581|18323969|P3|Randomized Maintenance Phase|Lost to Follow-up|0
5320243|NCT00308581|18323970|P2|Randomized Maintenance Phase|Lost to Follow-up|2
5320244|NCT00308581|18323971|P1|Randomized Maintenance Phase|Lost to Follow-up|0
5320245|NCT00308581|18323969|P3|Randomized Maintenance Phase|Lack of Efficacy|0
5320246|NCT00308581|18323970|P2|Randomized Maintenance Phase|Lack of Efficacy|21
5320247|NCT00308581|18323971|P1|Randomized Maintenance Phase|Lack of Efficacy|9
5320248|NCT00308581|18323969|P3|Randomized Maintenance Phase|Adverse Event|0
5320249|NCT00308581|18323970|P2|Randomized Maintenance Phase|Adverse Event|17
5320250|NCT00308581|18323971|P1|Randomized Maintenance Phase|Adverse Event|10
5320251|NCT00308581|18323969|P3|Induction Phase|Unknown reason|3
5320252|NCT00308581|18323970|P2|Induction Phase|Unknown reason|0
5320253|NCT00308581|18323971|P1|Induction Phase|Unknown reason|0
5320254|NCT00308581|18323969|P3|Induction Phase|Withdrawal by Subject|5
5320255|NCT00308581|18323970|P2|Induction Phase|Withdrawal by Subject|0
5320256|NCT00308581|18323971|P1|Induction Phase|Withdrawal by Subject|0
5320257|NCT00308581|18323969|P3|Induction Phase|Lack of Efficacy|121
5320258|NCT00308581|18323970|P2|Induction Phase|Lack of Efficacy|0
5320259|NCT00308581|18323971|P1|Induction Phase|Lack of Efficacy|0
5320260|NCT00308581|18323969|P3|Induction Phase|Adverse Event|37
5320261|NCT00308581|18323970|P2|Induction Phase|Adverse Event|0
5320262|NCT00308581|18323971|P1|Induction Phase|Adverse Event|0
5320263|NCT00308555|18324097|P2|Overall Study|Physician Decision|0
5320264|NCT00308555|18324098|P1|Overall Study|Physician Decision|2
5320265|NCT00308555|18324097|P2|Overall Study|Withdrawal by Subject|0
5320266|NCT00308555|18324098|P1|Overall Study|Withdrawal by Subject|1
5320267|NCT00308308|18324115|P2|Overall Study|Other|0
5320268|NCT00308308|18324116|P1|Overall Study|Other|1
5320269|NCT00308308|18324115|P2|Overall Study|Randomized but not dosed|16
5320270|NCT00308308|18324116|P1|Overall Study|Randomized but not dosed|8
5320271|NCT00308308|18324115|P2|Overall Study|Various|5
5320272|NCT00308308|18324116|P1|Overall Study|Various|7
5320273|NCT00308308|18324115|P2|Overall Study|Withdrawal by Subject|19
5320274|NCT00308308|18324116|P1|Overall Study|Withdrawal by Subject|47
5320275|NCT00308308|18324115|P2|Overall Study|Protocol Violation|14
5320276|NCT00308308|18324116|P1|Overall Study|Protocol Violation|3
5320277|NCT00308308|18324115|P2|Overall Study|Physician Decision|7
5320278|NCT00308308|18324116|P1|Overall Study|Physician Decision|15
5320279|NCT00308308|18324115|P2|Overall Study|Lost to Follow-up|5
5320280|NCT00308308|18324116|P1|Overall Study|Lost to Follow-up|5
5320281|NCT00308308|18324115|P2|Overall Study|Adverse Event|2
5320282|NCT00308308|18324116|P1|Overall Study|Adverse Event|17
5320283|NCT00308139|18324195|P2|Overall Study|Other|0
5320284|NCT00308139|18324196|P1|Overall Study|Other|1
5320285|NCT00308139|18324195|P2|Overall Study|Administrative|4
5320286|NCT00308139|18324196|P1|Overall Study|Administrative|1
5320287|NCT00308139|18324195|P2|Overall Study|Loss of Glucose Control|7
5320288|NCT00308139|18324196|P1|Overall Study|Loss of Glucose Control|5
5320289|NCT00308139|18324195|P2|Overall Study|Investigator Decision|10
5320290|NCT00308139|18324196|P1|Overall Study|Investigator Decision|11
5320291|NCT00308139|18324195|P2|Overall Study|Withdrawal of Consent|42
5320292|NCT00308139|18324196|P1|Overall Study|Withdrawal of Consent|40
5320293|NCT00308139|18324195|P2|Overall Study|Protocol Violation|2
5320294|NCT00308139|18324196|P1|Overall Study|Protocol Violation|3
5320295|NCT00308139|18324195|P2|Overall Study|Lost to Follow-up|8
5320296|NCT00308139|18324196|P1|Overall Study|Lost to Follow-up|13
5320297|NCT00308139|18324195|P2|Overall Study|Adverse Event|14
5320298|NCT00308139|18324196|P1|Overall Study|Adverse Event|20
5320299|NCT00308113|18324270|P4|Overall Study|Protocol closure|1
5320300|NCT00308113|18324271|P3|Overall Study|Protocol closure|0
5320301|NCT00308113|18324272|P2|Overall Study|Protocol closure|0
5320302|NCT00308113|18324273|P1|Overall Study|Protocol closure|0
5320303|NCT00308087|18324293|P2|Overall Study|Other|3
5320304|NCT00308087|18324294|P1|Overall Study|Other|4
5320305|NCT00308087|18324293|P2|Overall Study|Withdrawal by Subject|1
5320306|NCT00308087|18324294|P1|Overall Study|Withdrawal by Subject|2
5320307|NCT00308087|18324293|P2|Overall Study|Study Closure|12
5320308|NCT00308087|18324294|P1|Overall Study|Study Closure|11
5320309|NCT00308087|18324293|P2|Overall Study|Progressive Disease|21
5320310|NCT00308087|18324294|P1|Overall Study|Progressive Disease|19
5320311|NCT00308074|18324310|P1|Overall Study|Withdrawal by Subject|1
5320312|NCT00307931|18324327|P1|Overall Study|Adverse Event|1
5320313|NCT00307801|18324344|P2|Overall Study|Pregnancy|1
5320314|NCT00307801|18324345|P1|Overall Study|Pregnancy|0
5320315|NCT00307801|18324344|P2|Overall Study|No reason specified|0
5320316|NCT00307801|18324345|P1|Overall Study|No reason specified|2
5320317|NCT00307801|18324344|P2|Overall Study|Protocol Violation|2
5320318|NCT00307801|18324345|P1|Overall Study|Protocol Violation|3
5320319|NCT00307801|18324344|P2|Overall Study|Frustration with e-diary|0
5320320|NCT00307801|18324345|P1|Overall Study|Frustration with e-diary|1
5320321|NCT00307801|18324344|P2|Overall Study|Lost to Follow-up, moved abroad|1
5320322|NCT00307801|18324345|P1|Overall Study|Lost to Follow-up, moved abroad|1
5320323|NCT00307801|18324344|P2|Overall Study|Lack of Efficacy|2
5320324|NCT00307801|18324345|P1|Overall Study|Lack of Efficacy|0
5320325|NCT00307801|18324344|P2|Overall Study|Wrong Randomization|0
5320326|NCT00307801|18324345|P1|Overall Study|Wrong Randomization|1
5320327|NCT00307801|18324344|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
5320328|NCT00307801|18324345|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
5320329|NCT00307801|18324344|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
5320330|NCT00307801|18324345|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
5320331|NCT00307801|18324344|P2|Overall Study|Non-compliance, not taken all tablets|2
5320332|NCT00307801|18324345|P1|Overall Study|Non-compliance, not taken all tablets|1
5320333|NCT00307801|18324344|P2|Overall Study|Withdrawal by Subject|4
5320334|NCT00307801|18324345|P1|Overall Study|Withdrawal by Subject|9
5320335|NCT00307801|18324344|P2|Overall Study|Adverse Event|4
5320336|NCT00307801|18324345|P1|Overall Study|Adverse Event|12
5320337|NCT00307736|18324457|P4|Overall Study|Withdrawal by Subject|0
5320338|NCT00307736|18324458|P3|Overall Study|Withdrawal by Subject|2
5320339|NCT00307736|18324459|P2|Overall Study|Withdrawal by Subject|0
5320340|NCT00307736|18324460|P1|Overall Study|Withdrawal by Subject|0
5320341|NCT00307736|18324457|P4|Overall Study|Adverse Event|3
5320342|NCT00307736|18324458|P3|Overall Study|Adverse Event|1
5320343|NCT00307736|18324459|P2|Overall Study|Adverse Event|0
5320344|NCT00307736|18324460|P1|Overall Study|Adverse Event|0
5320345|NCT00307684|18324471|P3|Double Blind Phase|Lack of Efficacy|0
5320346|NCT00307684|18324472|P2|Double Blind Phase|Lack of Efficacy|5
5320347|NCT00307684|18324473|P1|Double Blind Phase|Lack of Efficacy|2
5320348|NCT00307684|18324471|P3|Open Label Phase|other|6
5320349|NCT00307684|18324472|P2|Open Label Phase|other|0
5320350|NCT00307684|18324473|P1|Open Label Phase|other|0
5320351|NCT00307684|18324471|P3|Open Label Phase|non compliance|5
5320352|NCT00307684|18324472|P2|Open Label Phase|non compliance|0
5320353|NCT00307684|18324473|P1|Open Label Phase|non compliance|0
5320354|NCT00307684|18324471|P3|Open Label Phase|Lost to Follow-up|11
5320355|NCT00307684|18324472|P2|Open Label Phase|Lost to Follow-up|0
5320356|NCT00307684|18324473|P1|Open Label Phase|Lost to Follow-up|0
5320357|NCT00307684|18324471|P3|Open Label Phase|Withdrawal by Subject|15
5320358|NCT00307684|18324472|P2|Open Label Phase|Withdrawal by Subject|0
5320359|NCT00307684|18324473|P1|Open Label Phase|Withdrawal by Subject|0
5320360|NCT00307684|18324471|P3|Open Label Phase|Adverse Event|16
5320361|NCT00307684|18324472|P2|Open Label Phase|Adverse Event|0
5320362|NCT00307684|18324473|P1|Open Label Phase|Adverse Event|0
5320363|NCT00307684|18324471|P3|Open Label Phase|Lack of Efficacy|3
5320364|NCT00307684|18324472|P2|Open Label Phase|Lack of Efficacy|0
5320365|NCT00307684|18324473|P1|Open Label Phase|Lack of Efficacy|0
5320366|NCT00307489|18324501|P2|Week 48 Through Week 168|Seroconversion|0
5320367|NCT00307489|18324502|P1|Week 48 Through Week 168|Seroconversion|1
5320368|NCT00307489|18324501|P2|Week 48 Through Week 168|Lost to Follow-up|1
5320369|NCT00307489|18324502|P1|Week 48 Through Week 168|Lost to Follow-up|0
5320370|NCT00307489|18324501|P2|Week 48 Through Week 168|Death|1
5320371|NCT00307489|18324502|P1|Week 48 Through Week 168|Death|0
5320372|NCT00307489|18324501|P2|Week 48 Through Week 168|Lack of Efficacy|2
5320373|NCT00307489|18324502|P1|Week 48 Through Week 168|Lack of Efficacy|2
5320374|NCT00307489|18324501|P2|Week 48 Through Week 168|Withdrawal by Subject|2
5320375|NCT00307489|18324502|P1|Week 48 Through Week 168|Withdrawal by Subject|1
5320376|NCT00307489|18324501|P2|Week 48 Through Week 168|Physician Decision|0
5320377|NCT00307489|18324502|P1|Week 48 Through Week 168|Physician Decision|1
5320378|NCT00307489|18324501|P2|Week 48 Through Week 168|Adverse Event|0
5320379|NCT00307489|18324502|P1|Week 48 Through Week 168|Adverse Event|1
5320380|NCT00307489|18324501|P2|Baseline Through Week 48|Withdrawal by Subject|1
5320381|NCT00307489|18324502|P1|Baseline Through Week 48|Withdrawal by Subject|0
5320382|NCT00307489|18324501|P2|Baseline Through Week 48|Physician Decision|0
5320383|NCT00307489|18324502|P1|Baseline Through Week 48|Physician Decision|1
5320384|NCT00307489|18324501|P2|Baseline Through Week 48|Lost to Follow-up|1
5320385|NCT00307489|18324502|P1|Baseline Through Week 48|Lost to Follow-up|0
5320386|NCT00307437|18324547|P7|After Controlled Period|Other|28
5320387|NCT00307437|18324548|P6|After Controlled Period|Other|40
5320388|NCT00307437|18324549|P5|After Controlled Period|Other|9
5320389|NCT00307437|18324550|P4|After Controlled Period|Other|15
5320390|NCT00307437|18324551|P3|After Controlled Period|Other|0
5320391|NCT00307437|18324552|P2|After Controlled Period|Other|0
5320392|NCT00307437|18324553|P1|After Controlled Period|Other|0
5320393|NCT00307437|18324547|P7|After Controlled Period|Lost to Follow-up|18
5320394|NCT00307437|18324548|P6|After Controlled Period|Lost to Follow-up|13
5320395|NCT00307437|18324549|P5|After Controlled Period|Lost to Follow-up|12
5320396|NCT00307437|18324550|P4|After Controlled Period|Lost to Follow-up|7
5320397|NCT00307437|18324551|P3|After Controlled Period|Lost to Follow-up|0
5320398|NCT00307437|18324552|P2|After Controlled Period|Lost to Follow-up|0
5320399|NCT00307437|18324553|P1|After Controlled Period|Lost to Follow-up|0
5320400|NCT00307437|18324547|P7|After Controlled Period|Lack of Efficacy|24
5320401|NCT00307437|18324548|P6|After Controlled Period|Lack of Efficacy|37
5320402|NCT00307437|18324549|P5|After Controlled Period|Lack of Efficacy|17
5320403|NCT00307437|18324550|P4|After Controlled Period|Lack of Efficacy|15
5320404|NCT00307437|18324551|P3|After Controlled Period|Lack of Efficacy|0
5320405|NCT00307437|18324552|P2|After Controlled Period|Lack of Efficacy|0
5320406|NCT00307437|18324553|P1|After Controlled Period|Lack of Efficacy|0
5320407|NCT00307437|18324547|P7|After Controlled Period|Death|3
5320408|NCT00307437|18324548|P6|After Controlled Period|Death|1
5320409|NCT00307437|18324549|P5|After Controlled Period|Death|1
5320410|NCT00307437|18324550|P4|After Controlled Period|Death|3
5320411|NCT00307437|18324551|P3|After Controlled Period|Death|0
5320412|NCT00307437|18324552|P2|After Controlled Period|Death|0
5320413|NCT00307437|18324553|P1|After Controlled Period|Death|0
5320414|NCT00307437|18324547|P7|After Controlled Period|Adverse Event|40
5320415|NCT00307437|18324548|P6|After Controlled Period|Adverse Event|31
5320416|NCT00307437|18324549|P5|After Controlled Period|Adverse Event|16
5320417|NCT00307437|18324550|P4|After Controlled Period|Adverse Event|18
5320418|NCT00307437|18324551|P3|After Controlled Period|Adverse Event|0
5320419|NCT00307437|18324552|P2|After Controlled Period|Adverse Event|0
5320420|NCT00307437|18324553|P1|After Controlled Period|Adverse Event|0
5320421|NCT00307437|18324547|P7|Controlled Period|Other|0
5320422|NCT00307437|18324548|P6|Controlled Period|Other|0
5320423|NCT00307437|18324549|P5|Controlled Period|Other|0
5320424|NCT00307437|18324550|P4|Controlled Period|Other|0
5320425|NCT00307437|18324551|P3|Controlled Period|Other|3
5320426|NCT00307437|18324552|P2|Controlled Period|Other|1
5320427|NCT00307437|18324553|P1|Controlled Period|Other|5
5320428|NCT00307437|18324547|P7|Controlled Period|Lost to Follow-up|0
5320429|NCT00307437|18324548|P6|Controlled Period|Lost to Follow-up|0
5320430|NCT00307437|18324549|P5|Controlled Period|Lost to Follow-up|0
5320431|NCT00307437|18324550|P4|Controlled Period|Lost to Follow-up|0
5320432|NCT00307437|18324551|P3|Controlled Period|Lost to Follow-up|0
5320433|NCT00307437|18324552|P2|Controlled Period|Lost to Follow-up|3
5320434|NCT00307437|18324553|P1|Controlled Period|Lost to Follow-up|2
5320435|NCT00307437|18324547|P7|Controlled Period|Lack of Efficacy|0
5320436|NCT00307437|18324548|P6|Controlled Period|Lack of Efficacy|0
5320437|NCT00307437|18324549|P5|Controlled Period|Lack of Efficacy|0
5320438|NCT00307437|18324550|P4|Controlled Period|Lack of Efficacy|0
5320439|NCT00307437|18324551|P3|Controlled Period|Lack of Efficacy|0
5320440|NCT00307437|18324552|P2|Controlled Period|Lack of Efficacy|0
5320441|NCT00307437|18324553|P1|Controlled Period|Lack of Efficacy|2
5320442|NCT00307437|18324547|P7|Controlled Period|Death|0
5320443|NCT00307437|18324548|P6|Controlled Period|Death|0
5320444|NCT00307437|18324549|P5|Controlled Period|Death|0
5320445|NCT00307437|18324550|P4|Controlled Period|Death|0
5320446|NCT00307437|18324551|P3|Controlled Period|Death|1
5320447|NCT00307437|18324552|P2|Controlled Period|Death|0
5320448|NCT00307437|18324553|P1|Controlled Period|Death|0
5320449|NCT00307437|18324547|P7|Controlled Period|Adverse Event|0
5320450|NCT00307437|18324548|P6|Controlled Period|Adverse Event|0
5320451|NCT00307437|18324549|P5|Controlled Period|Adverse Event|0
5320452|NCT00307437|18324550|P4|Controlled Period|Adverse Event|0
5320453|NCT00307437|18324551|P3|Controlled Period|Adverse Event|5
5320454|NCT00307437|18324552|P2|Controlled Period|Adverse Event|2
5320455|NCT00307437|18324553|P1|Controlled Period|Adverse Event|7
5320456|NCT00307333|18324579|P2|Overall Study|Lost to Follow-up|3
5320457|NCT00307333|18324580|P1|Overall Study|Lost to Follow-up|11
5320458|NCT00307294|18324592|P1|Overall Study|Withdrawal by Subject|1
5320459|NCT00307164|18324601|P2|Overall Study|Lost to Follow-up|1
5320460|NCT00307164|18324602|P1|Overall Study|Lost to Follow-up|6
5320461|NCT00307164|18324601|P2|Overall Study|Not compliant with requirements|4
5320462|NCT00307164|18324602|P1|Overall Study|Not compliant with requirements|4
5320463|NCT00307164|18324601|P2|Overall Study|Withdrawal by Subject|8
5320464|NCT00307164|18324602|P1|Overall Study|Withdrawal by Subject|1
5320465|NCT00307164|18324601|P2|Overall Study|Subject/parent not able to get to clinic|1
5320466|NCT00307164|18324602|P1|Overall Study|Subject/parent not able to get to clinic|2
5320467|NCT00307164|18324601|P2|Overall Study|Severe debilitation, unable to continue|0
5320468|NCT00307164|18324602|P1|Overall Study|Severe debilitation, unable to continue|1
5320469|NCT00307164|18324601|P2|Overall Study|Death|0
5320470|NCT00307164|18324602|P1|Overall Study|Death|1
5320471|NCT00307151|18324642|P4|Overall Study|Clinic unable to contact subject|1
5320472|NCT00307151|18324643|P3|Overall Study|Clinic unable to contact subject|1
5320473|NCT00307151|18324644|P2|Overall Study|Clinic unable to contact subject|3
5320474|NCT00307151|18324645|P1|Overall Study|Clinic unable to contact subject|3
5320475|NCT00307151|18324642|P4|Overall Study|Not willing to adhere to study reqs|2
5320476|NCT00307151|18324643|P3|Overall Study|Not willing to adhere to study reqs|2
5320477|NCT00307151|18324644|P2|Overall Study|Not willing to adhere to study reqs|0
5320478|NCT00307151|18324645|P1|Overall Study|Not willing to adhere to study reqs|2
5320479|NCT00307151|18324642|P4|Overall Study|Withdrew consent|3
5320480|NCT00307151|18324643|P3|Overall Study|Withdrew consent|1
5320481|NCT00307151|18324644|P2|Overall Study|Withdrew consent|1
5320482|NCT00307151|18324645|P1|Overall Study|Withdrew consent|0
5320483|NCT00307151|18324642|P4|Overall Study|Subject unable to get to clinic|2
5320484|NCT00307151|18324643|P3|Overall Study|Subject unable to get to clinic|6
5320485|NCT00307151|18324644|P2|Overall Study|Subject unable to get to clinic|0
5320486|NCT00307151|18324645|P1|Overall Study|Subject unable to get to clinic|1
5320487|NCT00307151|18324642|P4|Overall Study|Severe debilitation, unable to continue|0
5320488|NCT00307151|18324643|P3|Overall Study|Severe debilitation, unable to continue|0
5320489|NCT00307151|18324644|P2|Overall Study|Severe debilitation, unable to continue|0
5320490|NCT00307151|18324645|P1|Overall Study|Severe debilitation, unable to continue|1
5320491|NCT00307151|18324642|P4|Overall Study|Death|3
5320492|NCT00307151|18324643|P3|Overall Study|Death|10
5320493|NCT00307151|18324644|P2|Overall Study|Death|3
5320494|NCT00307151|18324645|P1|Overall Study|Death|4
5320495|NCT00307125|18324689|P3|Pilot Phase|Withdrawal by Subject|1
5320496|NCT00307125|18324690|P2|Pilot Phase|Withdrawal by Subject|1
5320497|NCT00307125|18324691|P1|Pilot Phase|Withdrawal by Subject|0
5320498|NCT00307125|18324689|P3|Pilot Phase|Lost to Follow-up|0
5320499|NCT00307125|18324690|P2|Pilot Phase|Lost to Follow-up|1
5320500|NCT00307125|18324691|P1|Pilot Phase|Lost to Follow-up|0
5320501|NCT00307125|18324689|P3|Screening Phase|Coronary artery bypass|0
5320502|NCT00307125|18324690|P2|Screening Phase|Coronary artery bypass|0
5320503|NCT00307125|18324691|P1|Screening Phase|Coronary artery bypass|1
5320504|NCT00307125|18324689|P3|Screening Phase|AMR and treated with rituximab|0
5320505|NCT00307125|18324690|P2|Screening Phase|AMR and treated with rituximab|0
5320506|NCT00307125|18324691|P1|Screening Phase|AMR and treated with rituximab|1
5320507|NCT00307125|18324689|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
5320508|NCT00307125|18324690|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
5320509|NCT00307125|18324691|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
5320510|NCT00307125|18324689|P3|Screening Phase|Screen Error|0
5320511|NCT00307125|18324690|P2|Screening Phase|Screen Error|0
5320512|NCT00307125|18324691|P1|Screening Phase|Screen Error|1
5320513|NCT00307125|18324689|P3|Screening Phase|Ineligible|0
5320514|NCT00307125|18324690|P2|Screening Phase|Ineligible|0
5320515|NCT00307125|18324691|P1|Screening Phase|Ineligible|1
5320516|NCT00307125|18324689|P3|Screening Phase|PAK|0
5320517|NCT00307125|18324690|P2|Screening Phase|PAK|0
5320518|NCT00307125|18324691|P1|Screening Phase|PAK|1
5320519|NCT00307125|18324689|P3|Screening Phase|Malignancy|0
5320520|NCT00307125|18324690|P2|Screening Phase|Malignancy|0
5320521|NCT00307125|18324691|P1|Screening Phase|Malignancy|1
5320522|NCT00307125|18324689|P3|Screening Phase|Metastatic colon cancer|0
5320523|NCT00307125|18324690|P2|Screening Phase|Metastatic colon cancer|0
5320524|NCT00307125|18324691|P1|Screening Phase|Metastatic colon cancer|1
5320525|NCT00307125|18324689|P3|Screening Phase|Developed acute leukemia|0
5320526|NCT00307125|18324690|P2|Screening Phase|Developed acute leukemia|0
5320527|NCT00307125|18324691|P1|Screening Phase|Developed acute leukemia|1
5320528|NCT00307125|18324689|P3|Screening Phase|Try to get pregnant|0
5320529|NCT00307125|18324690|P2|Screening Phase|Try to get pregnant|0
5320530|NCT00307125|18324691|P1|Screening Phase|Try to get pregnant|1
5320531|NCT00307125|18324689|P3|Screening Phase|Ineligible for pilot|0
5320532|NCT00307125|18324690|P2|Screening Phase|Ineligible for pilot|0
5320533|NCT00307125|18324691|P1|Screening Phase|Ineligible for pilot|4
5320534|NCT00307125|18324689|P3|Screening Phase|Received Pancreas Transplant|0
5320535|NCT00307125|18324690|P2|Screening Phase|Received Pancreas Transplant|0
5320536|NCT00307125|18324691|P1|Screening Phase|Received Pancreas Transplant|8
5320537|NCT00307125|18324689|P3|Screening Phase|Moved or transferred facilities|0
5320538|NCT00307125|18324690|P2|Screening Phase|Moved or transferred facilities|0
5320539|NCT00307125|18324691|P1|Screening Phase|Moved or transferred facilities|34
5320540|NCT00307125|18324689|P3|Screening Phase|Scheduling issues/Non-compliance|0
5320541|NCT00307125|18324690|P2|Screening Phase|Scheduling issues/Non-compliance|0
5320542|NCT00307125|18324691|P1|Screening Phase|Scheduling issues/Non-compliance|55
5320543|NCT00307125|18324689|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
5320544|NCT00307125|18324690|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
5320545|NCT00307125|18324691|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
5320546|NCT00307125|18324689|P3|Screening Phase|Graft Failure|0
5320547|NCT00307125|18324690|P2|Screening Phase|Graft Failure|0
5320548|NCT00307125|18324691|P1|Screening Phase|Graft Failure|8
5320549|NCT00307125|18324689|P3|Screening Phase|Graft Loss|0
5320550|NCT00307125|18324690|P2|Screening Phase|Graft Loss|0
5320551|NCT00307125|18324691|P1|Screening Phase|Graft Loss|3
5320552|NCT00307125|18324689|P3|Screening Phase|Study Terminated|0
5320553|NCT00307125|18324690|P2|Screening Phase|Study Terminated|0
5320554|NCT00307125|18324691|P1|Screening Phase|Study Terminated|17
5320555|NCT00307125|18324689|P3|Screening Phase|Sponsor Decision|0
5320556|NCT00307125|18324690|P2|Screening Phase|Sponsor Decision|0
5320557|NCT00307125|18324691|P1|Screening Phase|Sponsor Decision|4
5320558|NCT00307125|18324689|P3|Screening Phase|Physician Decision|0
5320559|NCT00307125|18324690|P2|Screening Phase|Physician Decision|0
5320560|NCT00307125|18324691|P1|Screening Phase|Physician Decision|26
5320561|NCT00307125|18324689|P3|Screening Phase|Withdrawal by Subject|0
5320562|NCT00307125|18324690|P2|Screening Phase|Withdrawal by Subject|0
5320563|NCT00307125|18324691|P1|Screening Phase|Withdrawal by Subject|77
5320564|NCT00307125|18324689|P3|Screening Phase|Death|0
5320565|NCT00307125|18324690|P2|Screening Phase|Death|0
5320566|NCT00307125|18324691|P1|Screening Phase|Death|10
5320567|NCT00307125|18324689|P3|Screening Phase|Lost to Follow-up|0
5320568|NCT00307125|18324690|P2|Screening Phase|Lost to Follow-up|0
5320569|NCT00307125|18324691|P1|Screening Phase|Lost to Follow-up|87
5320570|NCT00307125|18324689|P3|Screening Phase|Protocol Violation|0
5320571|NCT00307125|18324690|P2|Screening Phase|Protocol Violation|0
5320572|NCT00307125|18324691|P1|Screening Phase|Protocol Violation|27
5320573|NCT00307125|18324689|P3|Screening Phase|Adverse Event|0
5320574|NCT00307125|18324690|P2|Screening Phase|Adverse Event|0
5320575|NCT00307125|18324691|P1|Screening Phase|Adverse Event|1
5320576|NCT00307086|18324713|P1|Overall Study|ineligible|5
5320577|NCT00307047|18324719|P2|Overall Study|All death, all MI, all Revascularization|16
5320578|NCT00307047|18324720|P1|Overall Study|All death, all MI, all Revascularization|27
5320579|NCT00307047|18324719|P2|Overall Study|Lost to follow-up for other reasons|1
5320580|NCT00307047|18324720|P1|Overall Study|Lost to follow-up for other reasons|0
5320581|NCT00307047|18324719|P2|Overall Study|Physician Decision|2
5320582|NCT00307047|18324720|P1|Overall Study|Physician Decision|1
5320583|NCT00307047|18324719|P2|Overall Study|Withdrawal by Subject|6
5320584|NCT00307047|18324720|P1|Overall Study|Withdrawal by Subject|6
5320585|NCT00307047|18324719|P2|Overall Study|Lost to Follow-up|24
5320586|NCT00307047|18324720|P1|Overall Study|Lost to Follow-up|35
5320587|NCT00307034|18324858|P2|Overall Study|Lost to Follow-up|3
5320588|NCT00307034|18324859|P1|Overall Study|Lost to Follow-up|0
5320589|NCT00307034|18324858|P2|Overall Study|Withdrawal by Subject|2
5320590|NCT00307034|18324859|P1|Overall Study|Withdrawal by Subject|1
5320591|NCT00307034|18324858|P2|Overall Study|Adverse Event|2
5320592|NCT00307034|18324859|P1|Overall Study|Adverse Event|1
5320593|NCT00306995|18324904|P7|Study Part II for Subset 2|Serious Adverse Event|0
5320594|NCT00306995|18324905|P6|Study Part II for Subset 2|Serious Adverse Event|0
5320595|NCT00306995|18324906|P5|Study Part II for Subset 2|Serious Adverse Event|0
5320596|NCT00306995|18324907|P4|Study Part II for Subset 2|Serious Adverse Event|0
5320597|NCT00306995|18324908|P3|Study Part II for Subset 2|Serious Adverse Event|0
5320598|NCT00306995|18324909|P2|Study Part II for Subset 2|Serious Adverse Event|1
5320599|NCT00306995|18324910|P1|Study Part II for Subset 2|Serious Adverse Event|0
5320600|NCT00306995|18324904|P7|Study Part I|Withdrawal by Subject|1
5320601|NCT00306995|18324905|P6|Study Part I|Withdrawal by Subject|0
5320602|NCT00306995|18324906|P5|Study Part I|Withdrawal by Subject|0
5320603|NCT00306995|18324907|P4|Study Part I|Withdrawal by Subject|0
5320604|NCT00306995|18324908|P3|Study Part I|Withdrawal by Subject|0
5320605|NCT00306995|18324909|P2|Study Part I|Withdrawal by Subject|0
5320606|NCT00306995|18324910|P1|Study Part I|Withdrawal by Subject|0
5320607|NCT00306891|18325303|P4|Part B|Development of study specific disc crit.|1
5320608|NCT00306891|18325304|P3|Part B|Development of study specific disc crit.|0
5320609|NCT00306891|18325305|P2|Part B|Development of study specific disc crit.|0
5320610|NCT00306891|18325306|P1|Part B|Development of study specific disc crit.|0
5320611|NCT00306891|18325303|P4|Part B|Condition under investigation worsened|8
5320612|NCT00306891|18325304|P3|Part B|Condition under investigation worsened|2
5320613|NCT00306891|18325305|P2|Part B|Condition under investigation worsened|0
5320614|NCT00306891|18325306|P1|Part B|Condition under investigation worsened|0
5320615|NCT00306891|18325303|P4|Part B|Withdrawal by Subject|1
5320616|NCT00306891|18325304|P3|Part B|Withdrawal by Subject|3
5320617|NCT00306891|18325305|P2|Part B|Withdrawal by Subject|0
5320618|NCT00306891|18325306|P1|Part B|Withdrawal by Subject|0
5320619|NCT00306891|18325303|P4|Part B|Adverse Event|5
5320620|NCT00306891|18325304|P3|Part B|Adverse Event|5
5320621|NCT00306891|18325305|P2|Part B|Adverse Event|0
5320622|NCT00306891|18325306|P1|Part B|Adverse Event|0
5320623|NCT00306891|18325303|P4|Part B|Death|2
5320624|NCT00306891|18325304|P3|Part B|Death|1
5320625|NCT00306891|18325305|P2|Part B|Death|0
5320626|NCT00306891|18325306|P1|Part B|Death|0
5320627|NCT00306891|18325303|P4|Part A|QTC interval outwith elig. criteria|0
5320628|NCT00306891|18325304|P3|Part A|QTC interval outwith elig. criteria|0
5320629|NCT00306891|18325305|P2|Part A|QTC interval outwith elig. criteria|0
5320630|NCT00306891|18325306|P1|Part A|QTC interval outwith elig. criteria|1
5320631|NCT00306891|18325303|P4|Part A|Suspicion of second malignancy|0
5320632|NCT00306891|18325304|P3|Part A|Suspicion of second malignancy|0
5320633|NCT00306891|18325305|P2|Part A|Suspicion of second malignancy|1
5320634|NCT00306891|18325306|P1|Part A|Suspicion of second malignancy|0
5320635|NCT00306891|18325303|P4|Part A|Reaccumul. of ascites following drainage|0
5320636|NCT00306891|18325304|P3|Part A|Reaccumul. of ascites following drainage|0
5320637|NCT00306891|18325305|P2|Part A|Reaccumul. of ascites following drainage|1
5320638|NCT00306891|18325306|P1|Part A|Reaccumul. of ascites following drainage|0
5320639|NCT00306891|18325303|P4|Part A|Partial bowel obstruction|0
5320640|NCT00306891|18325304|P3|Part A|Partial bowel obstruction|0
5320641|NCT00306891|18325305|P2|Part A|Partial bowel obstruction|0
5320642|NCT00306891|18325306|P1|Part A|Partial bowel obstruction|1
5320643|NCT00306891|18325303|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
5320644|NCT00306891|18325304|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
5320645|NCT00306891|18325305|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
5320646|NCT00306891|18325306|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
5320647|NCT00306891|18325303|P4|Part A|Condition under investigation worsened|0
5320648|NCT00306891|18325304|P3|Part A|Condition under investigation worsened|0
5320649|NCT00306891|18325305|P2|Part A|Condition under investigation worsened|2
5320650|NCT00306891|18325306|P1|Part A|Condition under investigation worsened|2
5320651|NCT00306891|18325303|P4|Part A|Withdrawal by Subject|0
5320652|NCT00306891|18325304|P3|Part A|Withdrawal by Subject|0
5320653|NCT00306891|18325305|P2|Part A|Withdrawal by Subject|1
5320654|NCT00306891|18325306|P1|Part A|Withdrawal by Subject|1
5320655|NCT00306852|18325329|P2|Overall Study|Lost to Follow-up|24
5320656|NCT00306852|18325330|P1|Overall Study|Lost to Follow-up|15
5320657|NCT00306852|18325329|P2|Overall Study|Death|14
5320658|NCT00306852|18325330|P1|Overall Study|Death|14
5320659|NCT00306787|18325348|P2|Overall Study|Abnormal laboratory value(s)|0
5320660|NCT00306787|18325349|P1|Overall Study|Abnormal laboratory value(s)|1
5320661|NCT00306787|18325348|P2|Overall Study|Administrative problems|0
5320662|NCT00306787|18325349|P1|Overall Study|Administrative problems|4
5320663|NCT00306787|18325348|P2|Overall Study|Lost to Follow-up|6
5320664|NCT00306787|18325349|P1|Overall Study|Lost to Follow-up|9
5320665|NCT00306787|18325348|P2|Overall Study|Withdrawal by Subject|9
5320666|NCT00306787|18325349|P1|Overall Study|Withdrawal by Subject|2
5320667|NCT00306787|18325348|P2|Overall Study|Protocol Violation|10
5320668|NCT00306787|18325349|P1|Overall Study|Protocol Violation|8
5320669|NCT00306787|18325348|P2|Overall Study|Lack of Efficacy|0
5320670|NCT00306787|18325349|P1|Overall Study|Lack of Efficacy|1
5320671|NCT00306787|18325348|P2|Overall Study|Adverse Event|1
5320672|NCT00306787|18325349|P1|Overall Study|Adverse Event|1
5320673|NCT00306787|18325348|P2|Overall Study|Discontinued without taking study drug|215
5320674|NCT00306787|18325349|P1|Overall Study|Discontinued without taking study drug|208
5320675|NCT00306670|18325367|P2|Overall Study|patients recruited; Genentech, the st|2
5320676|NCT00306670|18325368|P1|Overall Study|patients recruited; Genentech, the st|0
5320677|NCT00306592|18325374|P2|Overall Study|48-week Treatment Period Ongoing|20
5320678|NCT00306592|18325375|P1|Overall Study|48-week Treatment Period Ongoing|0
5320679|NCT00306592|18325374|P2|Overall Study|Other|2
5320680|NCT00306592|18325375|P1|Overall Study|Other|1
5320681|NCT00306592|18325374|P2|Overall Study|Other|10
5320682|NCT00306592|18325375|P1|Overall Study|Other|5
5320683|NCT00306592|18325374|P2|Overall Study|Voluntary|6
5320684|NCT00306592|18325375|P1|Overall Study|Voluntary|10
5320685|NCT00306592|18325374|P2|Overall Study|Persistent Antibodies|3
5320686|NCT00306592|18325375|P1|Overall Study|Persistent Antibodies|6
5320687|NCT00306592|18325374|P2|Overall Study|Noncompliance|2
5320688|NCT00306592|18325375|P1|Overall Study|Noncompliance|0
5320689|NCT00306592|18325374|P2|Overall Study|Lost to Follow-up|0
5320690|NCT00306592|18325375|P1|Overall Study|Lost to Follow-up|1
5320691|NCT00306592|18325374|P2|Overall Study|Adverse Event|15
5320692|NCT00306592|18325375|P1|Overall Study|Adverse Event|8
5320693|NCT00306527|18325385|P4|Overall Study|Death|2
5320694|NCT00306527|18325386|P3|Overall Study|Death|1
5320695|NCT00306527|18325387|P2|Overall Study|Death|0
5320696|NCT00306527|18325388|P1|Overall Study|Death|1
5320697|NCT00306527|18325385|P4|Overall Study|Adverse Event|1
5320698|NCT00306527|18325386|P3|Overall Study|Adverse Event|1
5320699|NCT00306527|18325387|P2|Overall Study|Adverse Event|0
5320700|NCT00306527|18325388|P1|Overall Study|Adverse Event|0
5320701|NCT00306527|18325385|P4|Overall Study|Withdrawal by Subject|3
5320702|NCT00306527|18325386|P3|Overall Study|Withdrawal by Subject|0
5320703|NCT00306527|18325387|P2|Overall Study|Withdrawal by Subject|3
5320704|NCT00306527|18325388|P1|Overall Study|Withdrawal by Subject|2
5320705|NCT00306527|18325385|P4|Overall Study|Lost to Follow-up|0
5320706|NCT00306527|18325386|P3|Overall Study|Lost to Follow-up|3
5320707|NCT00306527|18325387|P2|Overall Study|Lost to Follow-up|4
5320708|NCT00306527|18325388|P1|Overall Study|Lost to Follow-up|3
5320709|NCT00306384|18325460|P3|Overall Study|Site closure|0
5320710|NCT00306384|18325461|P2|Overall Study|Site closure|0
5320711|NCT00306384|18325462|P1|Overall Study|Site closure|2
5320712|NCT00306384|18325460|P3|Overall Study|Other|32
5320713|NCT00306384|18325461|P2|Overall Study|Other|70
5320714|NCT00306384|18325462|P1|Overall Study|Other|80
5320715|NCT00306384|18325460|P3|Overall Study|Investigator discretion|21
5320716|NCT00306384|18325461|P2|Overall Study|Investigator discretion|31
5320717|NCT00306384|18325462|P1|Overall Study|Investigator discretion|28
5320718|NCT00306384|18325460|P3|Overall Study|Lack of Efficacy|38
5320719|NCT00306384|18325461|P2|Overall Study|Lack of Efficacy|40
5320720|NCT00306384|18325462|P1|Overall Study|Lack of Efficacy|26
5320721|NCT00306384|18325460|P3|Overall Study|Pregnancy|1
5320722|NCT00306384|18325461|P2|Overall Study|Pregnancy|1
5320723|NCT00306384|18325462|P1|Overall Study|Pregnancy|3
5320724|NCT00306384|18325460|P3|Overall Study|Study termination|1
5320725|NCT00306384|18325461|P2|Overall Study|Study termination|0
5320726|NCT00306384|18325462|P1|Overall Study|Study termination|1
5320727|NCT00306384|18325460|P3|Overall Study|Voluntary withdrawal|91
5320728|NCT00306384|18325461|P2|Overall Study|Voluntary withdrawal|187
5320729|NCT00306384|18325462|P1|Overall Study|Voluntary withdrawal|199
5320730|NCT00306384|18325460|P3|Overall Study|Lost to Follow-up|35
5320731|NCT00306384|18325461|P2|Overall Study|Lost to Follow-up|41
5320732|NCT00306384|18325462|P1|Overall Study|Lost to Follow-up|57
5320733|NCT00306384|18325460|P3|Overall Study|Major protocol deviation|18
5320734|NCT00306384|18325461|P2|Overall Study|Major protocol deviation|51
5320735|NCT00306384|18325462|P1|Overall Study|Major protocol deviation|43
5320736|NCT00306384|18325460|P3|Overall Study|Adverse Event|40
5320737|NCT00306384|18325461|P2|Overall Study|Adverse Event|87
5320738|NCT00306384|18325462|P1|Overall Study|Adverse Event|103
5320739|NCT00306293|18325494|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
5320740|NCT00306293|18325495|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
5320741|NCT00306293|18325494|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
5320742|NCT00306293|18325495|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
5320743|NCT00306293|18325494|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
5320744|NCT00306293|18325495|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
5320745|NCT00306293|18325494|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
5320746|NCT00306293|18325495|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
5320747|NCT00306293|18325494|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
5320748|NCT00306293|18325495|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
5320749|NCT00306293|18325494|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
5320750|NCT00306293|18325495|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
5320751|NCT00306293|18325494|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
5320752|NCT00306293|18325495|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
5320753|NCT00306293|18325494|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
5320754|NCT00306293|18325495|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
5320755|NCT00306189|18325678|P4|Overall Study|Other|0
5320756|NCT00306189|18325679|P3|Overall Study|Other|0
5320757|NCT00306189|18325680|P2|Overall Study|Other|0
5320758|NCT00306189|18325681|P1|Overall Study|Other|1
5320759|NCT00306189|18325678|P4|Overall Study|Ineligibility determined|1
5320760|NCT00306189|18325679|P3|Overall Study|Ineligibility determined|1
5320761|NCT00306189|18325680|P2|Overall Study|Ineligibility determined|1
5320762|NCT00306189|18325681|P1|Overall Study|Ineligibility determined|1
5320763|NCT00306189|18325678|P4|Overall Study|Withdrawal by Subject|1
5320764|NCT00306189|18325679|P3|Overall Study|Withdrawal by Subject|8
5320765|NCT00306189|18325680|P2|Overall Study|Withdrawal by Subject|2
5320766|NCT00306189|18325681|P1|Overall Study|Withdrawal by Subject|4
5320767|NCT00306189|18325678|P4|Overall Study|Adverse Event|2
5320768|NCT00306189|18325679|P3|Overall Study|Adverse Event|2
5320769|NCT00306189|18325680|P2|Overall Study|Adverse Event|3
5320770|NCT00306189|18325681|P1|Overall Study|Adverse Event|3
5320771|NCT00306189|18325678|P4|Overall Study|Physician Decision|1
5320772|NCT00306189|18325679|P3|Overall Study|Physician Decision|0
5320773|NCT00306189|18325680|P2|Overall Study|Physician Decision|0
5320774|NCT00306189|18325681|P1|Overall Study|Physician Decision|0
5320775|NCT00305877|18325708|P2|Overall Study|Transportation issue with daily RT|1
5320776|NCT00305877|18325709|P1|Overall Study|Transportation issue with daily RT|0
5320777|NCT00305877|18325708|P2|Overall Study|Ineligible|1
5320778|NCT00305877|18325709|P1|Overall Study|Ineligible|2
5320779|NCT00305877|18325708|P2|Overall Study|Never start treatment|5
5320780|NCT00305877|18325709|P1|Overall Study|Never start treatment|2
5320781|NCT00305877|18325708|P2|Overall Study|Physician Decision|1
5320782|NCT00305877|18325709|P1|Overall Study|Physician Decision|1
5320783|NCT00305877|18325708|P2|Overall Study|Withdrawal by Subject|2
5320784|NCT00305877|18325709|P1|Overall Study|Withdrawal by Subject|4
5320785|NCT00305877|18325708|P2|Overall Study|Death|1
5320786|NCT00305877|18325709|P1|Overall Study|Death|0
5320787|NCT00305877|18325708|P2|Overall Study|Adverse Event|14
5320788|NCT00305877|18325709|P1|Overall Study|Adverse Event|9
5320789|NCT00305877|18325708|P2|Overall Study|Lack of Efficacy|9
5320790|NCT00305877|18325709|P1|Overall Study|Lack of Efficacy|6
5320791|NCT00305864|18325723|P4|Overall Study|Ineligible / No protocol treatment|13
5320792|NCT00305864|18325724|P3|Overall Study|Ineligible / No protocol treatment|1
5320793|NCT00305864|18325725|P2|Overall Study|Ineligible / No protocol treatment|1
5320794|NCT00305864|18325726|P1|Overall Study|Ineligible / No protocol treatment|0
5320795|NCT00305773|18325739|P2|Overall Study|All other reasons|2
5320796|NCT00305773|18325740|P1|Overall Study|All other reasons|3
5320797|NCT00305773|18325739|P2|Overall Study|Disease Progression|3
5320798|NCT00305773|18325740|P1|Overall Study|Disease Progression|1
5320799|NCT00305773|18325739|P2|Overall Study|Withdrawal by Subject|4
5320800|NCT00305773|18325740|P1|Overall Study|Withdrawal by Subject|1
5320801|NCT00305773|18325739|P2|Overall Study|Physician Decision|1
5320802|NCT00305773|18325740|P1|Overall Study|Physician Decision|1
5320803|NCT00305773|18325739|P2|Overall Study|Alternative Treatment|4
5320804|NCT00305773|18325740|P1|Overall Study|Alternative Treatment|4
5320805|NCT00305773|18325739|P2|Overall Study|Adverse Event|2
5320806|NCT00305773|18325740|P1|Overall Study|Adverse Event|1
5320807|NCT00305773|18325739|P2|Overall Study|Death|2
5320808|NCT00305773|18325740|P1|Overall Study|Death|3
5320809|NCT00305695|18325760|P2|Overall Study|Did not have baseline scan|1
5320810|NCT00305695|18325761|P1|Overall Study|Did not have baseline scan|1
5320811|NCT00305695|18325760|P2|Overall Study|Withdrawal by subject prior to 18 month|26
5320812|NCT00305695|18325761|P1|Overall Study|Withdrawal by subject prior to 18 month|40
5320813|NCT00305604|18325895|P2|Overall Study|Patient moved|0
5320814|NCT00305604|18325896|P1|Overall Study|Patient moved|1
5320815|NCT00305604|18325895|P2|Overall Study|Withdrawal by Subject|21
5320816|NCT00305604|18325896|P1|Overall Study|Withdrawal by Subject|12
5320817|NCT00305604|18325895|P2|Overall Study|Protocol Violation|1
5320818|NCT00305604|18325896|P1|Overall Study|Protocol Violation|2
5320819|NCT00305604|18325895|P2|Overall Study|Lost to Follow-up|4
5320820|NCT00305604|18325896|P1|Overall Study|Lost to Follow-up|0
5320821|NCT00305604|18325895|P2|Overall Study|Lack of Efficacy|18
5320822|NCT00305604|18325896|P1|Overall Study|Lack of Efficacy|11
5320823|NCT00305604|18325895|P2|Overall Study|Adverse Event|3
5320824|NCT00305604|18325896|P1|Overall Study|Adverse Event|6
5320825|NCT00305448|18326040|P3|Overall Study|Tumor Marker Elevation|1
5320826|NCT00305448|18326041|P2|Overall Study|Tumor Marker Elevation|0
5320827|NCT00305448|18326042|P1|Overall Study|Tumor Marker Elevation|0
5320828|NCT00305448|18326040|P3|Overall Study|Subjective Disease Progression|2
5320829|NCT00305448|18326041|P2|Overall Study|Subjective Disease Progression|2
5320830|NCT00305448|18326042|P1|Overall Study|Subjective Disease Progression|1
5320831|NCT00305448|18326040|P3|Overall Study|Disease Progression|28
5320832|NCT00305448|18326041|P2|Overall Study|Disease Progression|31
5320833|NCT00305448|18326042|P1|Overall Study|Disease Progression|27
5320834|NCT00305448|18326040|P3|Overall Study|Adverse Event|1
5320835|NCT00305448|18326041|P2|Overall Study|Adverse Event|0
5320836|NCT00305448|18326042|P1|Overall Study|Adverse Event|1
5320837|NCT00305448|18326040|P3|Overall Study|Withdrawal by Subject|1
5320838|NCT00305448|18326041|P2|Overall Study|Withdrawal by Subject|0
5320839|NCT00305448|18326042|P1|Overall Study|Withdrawal by Subject|2
5320840|NCT00305448|18326040|P3|Overall Study|Protocol Violation|0
5320841|NCT00305448|18326041|P2|Overall Study|Protocol Violation|1
5320842|NCT00305448|18326042|P1|Overall Study|Protocol Violation|0
5320843|NCT00305253|18326064|P2|Overall Study|Withdrawal by Subject|1
5320844|NCT00305253|18326065|P1|Overall Study|Withdrawal by Subject|0
5320845|NCT00305227|18326077|P2|Overall Study|Lost to Follow-up|6
5320846|NCT00305227|18326078|P1|Overall Study|Lost to Follow-up|7
5320847|NCT00305110|18326125|P1|Overall Study|Missing data|29
5320848|NCT00305058|18326198|P2|Overall Study|Missing outcome data|2
5320849|NCT00305058|18326199|P1|Overall Study|Missing outcome data|3
5320850|NCT00305058|18326198|P2|Overall Study|Missing data collection instrument|2
5320851|NCT00305058|18326199|P1|Overall Study|Missing data collection instrument|3
5320852|NCT00305058|18326198|P2|Overall Study|Participant too young|0
5320853|NCT00305058|18326199|P1|Overall Study|Participant too young|1
5320854|NCT00304954|18326215|P4|Overall Study|Adverse Event|0
5320855|NCT00304954|18326216|P3|Overall Study|Adverse Event|0
5320856|NCT00304954|18326217|P2|Overall Study|Adverse Event|0
5320857|NCT00304954|18326218|P1|Overall Study|Adverse Event|1
5320858|NCT00304954|18326215|P4|Overall Study|Withdrawal by Subject|0
5320859|NCT00304954|18326216|P3|Overall Study|Withdrawal by Subject|1
5320860|NCT00304954|18326217|P2|Overall Study|Withdrawal by Subject|0
5320861|NCT00304954|18326218|P1|Overall Study|Withdrawal by Subject|0
5320862|NCT00304915|18326238|P2|Overall Study|Withdrawal by Subject|0
5320863|NCT00304915|18326239|P1|Overall Study|Withdrawal by Subject|3
5320864|NCT00304915|18326238|P2|Overall Study|Death|5
5320865|NCT00304915|18326239|P1|Overall Study|Death|4
5320866|NCT00304915|18326238|P2|Overall Study|Lost to Follow-up|11
5320867|NCT00304915|18326239|P1|Overall Study|Lost to Follow-up|11
5320868|NCT00304356|18326284|P1|Nitazoxanide|Physician Decision|1
5320869|NCT00304356|18326284|P1|Nitazoxanide|Physician Decision|1
5320870|NCT00304356|18326284|P1|Nitazoxanide|Physician Decision|1
5320871|NCT00304356|18326284|P1|Nitazoxanide|number is 0|1
5320872|NCT00304356|18326284|P1|Nitazoxanide|Physician Decision|1
5320873|NCT00304356|18326284|P1|Nitazoxanide|Physician Decision|5
5320874|NCT00304278|18326288|P1|Overall Study|PT had medical condition preventing TX|1
5320875|NCT00304278|18326288|P1|Overall Study|lack of insurance coverage for chemoRT|1
5320876|NCT00304083|18326337|P2|Overall Study|Other|2
5320877|NCT00304083|18326338|P1|Overall Study|Other|5
5320878|NCT00304083|18326337|P2|Overall Study|Disease Progression|1
5320879|NCT00304083|18326338|P1|Overall Study|Disease Progression|5
5320880|NCT00304083|18326337|P2|Overall Study|Physician Decision|3
5320881|NCT00304083|18326338|P1|Overall Study|Physician Decision|8
5320882|NCT00304083|18326337|P2|Overall Study|Withdrawal by Subject|2
5320883|NCT00304083|18326338|P1|Overall Study|Withdrawal by Subject|4
5320884|NCT00304070|18326357|P3|Overall Study|Progressive Disease|4
5320885|NCT00304070|18326358|P2|Overall Study|Progressive Disease|7
5320886|NCT00304070|18326359|P1|Overall Study|Progressive Disease|3
5320887|NCT00304070|18326357|P3|Overall Study|Withdrawal by Subject|1
5320888|NCT00304070|18326358|P2|Overall Study|Withdrawal by Subject|0
5320889|NCT00304070|18326359|P1|Overall Study|Withdrawal by Subject|0
5320890|NCT00304070|18326357|P3|Overall Study|Physician Decision|3
5320891|NCT00304070|18326358|P2|Overall Study|Physician Decision|0
5320892|NCT00304070|18326359|P1|Overall Study|Physician Decision|0
5320893|NCT00304070|18326357|P3|Overall Study|Lost to Follow-up|1
5320894|NCT00304070|18326358|P2|Overall Study|Lost to Follow-up|0
5320895|NCT00304070|18326359|P1|Overall Study|Lost to Follow-up|0
5320896|NCT00304070|18326357|P3|Overall Study|Death|3
5320897|NCT00304070|18326358|P2|Overall Study|Death|0
5320898|NCT00304070|18326359|P1|Overall Study|Death|0
5320899|NCT00304031|18326374|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
5320900|NCT00304031|18326375|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
5320901|NCT00304031|18326376|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
5320902|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
5320903|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
5320904|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
5320905|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
5320906|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
5320907|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
5320908|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
5320909|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
5320910|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
5320911|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
5320912|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
5320913|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
5320914|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Death|0
5320915|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Death|0
5320916|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Death|18
5320917|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
5320918|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
5320919|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
5320920|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
5320921|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
5320922|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
5320923|NCT00304031|18326374|P3|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
5320924|NCT00304031|18326375|P2|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
5320925|NCT00304031|18326376|P1|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
5320926|NCT00303953|18326458|P1|Overall Study|Physician Decision|1
5320927|NCT00303953|18326458|P1|Overall Study|Lack of Efficacy|12
5320928|NCT00303953|18326458|P1|Overall Study|Adverse Event|4
5320929|NCT00303953|18326458|P1|Overall Study|Death|1
5320930|NCT00303953|18326458|P1|Overall Study|Ineligible|1
5320931|NCT00303719|18326494|P2|Overall Study|Lost to Follow-up|7
5320932|NCT00303719|18326495|P1|Overall Study|Lost to Follow-up|0
5320933|NCT00303719|18326494|P2|Overall Study|Not evaluable, prior therapies|30
5320934|NCT00303719|18326495|P1|Overall Study|Not evaluable, prior therapies|0
5320935|NCT00303667|18326511|P2|Overall Study|Death|4
5320936|NCT00303667|18326512|P1|Overall Study|Death|0
5320937|NCT00303628|18326536|P2|Overall Study|Other|9
5320938|NCT00303628|18326537|P1|Overall Study|Other|8
5320939|NCT00303628|18326536|P2|Overall Study|Not start protocol therapy|5
5320940|NCT00303628|18326537|P1|Overall Study|Not start protocol therapy|3
5320941|NCT00303628|18326536|P2|Overall Study|Other complicating disease|1
5320942|NCT00303628|18326537|P1|Overall Study|Other complicating disease|0
5320943|NCT00303628|18326536|P2|Overall Study|Alternative therapy|0
5320944|NCT00303628|18326537|P1|Overall Study|Alternative therapy|2
5320945|NCT00303628|18326536|P2|Overall Study|Withdrawal by Subject|20
5320946|NCT00303628|18326537|P1|Overall Study|Withdrawal by Subject|11
5320947|NCT00303628|18326536|P2|Overall Study|Death|1
5320948|NCT00303628|18326537|P1|Overall Study|Death|0
5320949|NCT00303628|18326536|P2|Overall Study|Adverse Event|36
5320950|NCT00303628|18326537|P1|Overall Study|Adverse Event|26
5320951|NCT00303628|18326536|P2|Overall Study|Disease progression|1
5320952|NCT00303628|18326537|P1|Overall Study|Disease progression|0
5320953|NCT00303602|18326555|P2|Overall Study|Protocol Violation|0
5320954|NCT00303602|18326556|P1|Overall Study|Protocol Violation|1
5320955|NCT00303602|18326555|P2|Overall Study|Noncompliance|2
5320956|NCT00303602|18326556|P1|Overall Study|Noncompliance|2
5320957|NCT00303602|18326555|P2|Overall Study|Physician Decision|1
5320958|NCT00303602|18326556|P1|Overall Study|Physician Decision|2
5320959|NCT00303602|18326555|P2|Overall Study|Protocol entry criteria not met|2
5320960|NCT00303602|18326556|P1|Overall Study|Protocol entry criteria not met|2
5320961|NCT00303602|18326555|P2|Overall Study|Lost to Follow-up|2
5320962|NCT00303602|18326556|P1|Overall Study|Lost to Follow-up|5
5320963|NCT00303602|18326555|P2|Overall Study|Withdrawal by Subject|6
5320964|NCT00303602|18326556|P1|Overall Study|Withdrawal by Subject|5
5320965|NCT00303602|18326555|P2|Overall Study|Adverse Event|2
5320966|NCT00303602|18326556|P1|Overall Study|Adverse Event|2
5320967|NCT00303485|18326602|P2|Overall Study|Withdrawal by Subject|0
5320968|NCT00303485|18326603|P1|Overall Study|Withdrawal by Subject|1
5320969|NCT00303485|18326602|P2|Overall Study|Failure to return|1
5320970|NCT00303485|18326603|P1|Overall Study|Failure to return|0
5320971|NCT00303485|18326602|P2|Overall Study|Adverse Event/Intercurrent Illness|1
5320972|NCT00303485|18326603|P1|Overall Study|Adverse Event/Intercurrent Illness|0
5320973|NCT00303472|18326634|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
5320974|NCT00303472|18326635|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
5320975|NCT00303472|18326636|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
5320976|NCT00303472|18326637|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
5320977|NCT00303472|18326638|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
5320978|NCT00303472|18326639|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
5320979|NCT00303472|18326640|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
5320980|NCT00303472|18326634|P7|Treatment Extension (Optional)|Other|0
5320981|NCT00303472|18326635|P6|Treatment Extension (Optional)|Other|0
5320982|NCT00303472|18326636|P5|Treatment Extension (Optional)|Other|1
5320983|NCT00303472|18326637|P4|Treatment Extension (Optional)|Other|2
5320984|NCT00303472|18326638|P3|Treatment Extension (Optional)|Other|4
5320985|NCT00303472|18326639|P2|Treatment Extension (Optional)|Other|2
5320986|NCT00303472|18326640|P1|Treatment Extension (Optional)|Other|0
5320987|NCT00303472|18326634|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
5320988|NCT00303472|18326635|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
5320989|NCT00303472|18326636|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
5320990|NCT00303472|18326637|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
5320991|NCT00303472|18326638|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
5320992|NCT00303472|18326639|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
5320993|NCT00303472|18326640|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
5320994|NCT00303472|18326634|P7|Treatment Extension (Optional)|Physician Decision|0
5320995|NCT00303472|18326635|P6|Treatment Extension (Optional)|Physician Decision|0
5320996|NCT00303472|18326636|P5|Treatment Extension (Optional)|Physician Decision|2
5320997|NCT00303472|18326637|P4|Treatment Extension (Optional)|Physician Decision|3
5320998|NCT00303472|18326638|P3|Treatment Extension (Optional)|Physician Decision|2
5320999|NCT00303472|18326639|P2|Treatment Extension (Optional)|Physician Decision|4
5321000|NCT00303472|18326640|P1|Treatment Extension (Optional)|Physician Decision|0
5321001|NCT00303472|18326634|P7|Treatment Extension (Optional)|Lost to Follow-up|0
5321002|NCT00303472|18326635|P6|Treatment Extension (Optional)|Lost to Follow-up|0
5321003|NCT00303472|18326636|P5|Treatment Extension (Optional)|Lost to Follow-up|0
5321004|NCT00303472|18326637|P4|Treatment Extension (Optional)|Lost to Follow-up|1
5321005|NCT00303472|18326638|P3|Treatment Extension (Optional)|Lost to Follow-up|0
5321006|NCT00303472|18326639|P2|Treatment Extension (Optional)|Lost to Follow-up|0
5321007|NCT00303472|18326640|P1|Treatment Extension (Optional)|Lost to Follow-up|0
5321008|NCT00303472|18326634|P7|Treatment Extension (Optional)|Death|0
5321009|NCT00303472|18326635|P6|Treatment Extension (Optional)|Death|0
5321010|NCT00303472|18326636|P5|Treatment Extension (Optional)|Death|0
5321011|NCT00303472|18326637|P4|Treatment Extension (Optional)|Death|0
5321012|NCT00303472|18326638|P3|Treatment Extension (Optional)|Death|1
5321013|NCT00303472|18326639|P2|Treatment Extension (Optional)|Death|0
5321014|NCT00303472|18326640|P1|Treatment Extension (Optional)|Death|2
5321015|NCT00303472|18326634|P7|Treatment Extension (Optional)|Adverse Event|0
5321016|NCT00303472|18326635|P6|Treatment Extension (Optional)|Adverse Event|0
5321017|NCT00303472|18326636|P5|Treatment Extension (Optional)|Adverse Event|0
5321018|NCT00303472|18326637|P4|Treatment Extension (Optional)|Adverse Event|0
5321019|NCT00303472|18326638|P3|Treatment Extension (Optional)|Adverse Event|1
5321020|NCT00303472|18326639|P2|Treatment Extension (Optional)|Adverse Event|0
5321021|NCT00303472|18326640|P1|Treatment Extension (Optional)|Adverse Event|1
5321022|NCT00303472|18326634|P7|Treatment Period|Disease Progression (to AML)|0
5321023|NCT00303472|18326635|P6|Treatment Period|Disease Progression (to AML)|0
5321024|NCT00303472|18326636|P5|Treatment Period|Disease Progression (to AML)|1
5321025|NCT00303472|18326637|P4|Treatment Period|Disease Progression (to AML)|0
5321026|NCT00303472|18326638|P3|Treatment Period|Disease Progression (to AML)|0
5321027|NCT00303472|18326639|P2|Treatment Period|Disease Progression (to AML)|0
5321028|NCT00303472|18326640|P1|Treatment Period|Disease Progression (to AML)|0
5321029|NCT00303472|18326634|P7|Treatment Period|Other|1
5321030|NCT00303472|18326635|P6|Treatment Period|Other|0
5321031|NCT00303472|18326636|P5|Treatment Period|Other|1
5321032|NCT00303472|18326637|P4|Treatment Period|Other|0
5321033|NCT00303472|18326638|P3|Treatment Period|Other|0
5321034|NCT00303472|18326639|P2|Treatment Period|Other|0
5321035|NCT00303472|18326640|P1|Treatment Period|Other|0
5321036|NCT00303472|18326634|P7|Treatment Period|Withdrawal by Subject|0
5321037|NCT00303472|18326635|P6|Treatment Period|Withdrawal by Subject|1
5321038|NCT00303472|18326636|P5|Treatment Period|Withdrawal by Subject|0
5321039|NCT00303472|18326637|P4|Treatment Period|Withdrawal by Subject|1
5321040|NCT00303472|18326638|P3|Treatment Period|Withdrawal by Subject|0
5321041|NCT00303472|18326639|P2|Treatment Period|Withdrawal by Subject|0
5321042|NCT00303472|18326640|P1|Treatment Period|Withdrawal by Subject|0
5321043|NCT00303472|18326634|P7|Treatment Period|Death|1
5321044|NCT00303472|18326635|P6|Treatment Period|Death|0
5321045|NCT00303472|18326636|P5|Treatment Period|Death|0
5321046|NCT00303472|18326637|P4|Treatment Period|Death|1
5321047|NCT00303472|18326638|P3|Treatment Period|Death|0
5321048|NCT00303472|18326639|P2|Treatment Period|Death|0
5321049|NCT00303472|18326640|P1|Treatment Period|Death|0
5321050|NCT00303472|18326634|P7|Treatment Period|Adverse Event|0
5321051|NCT00303472|18326635|P6|Treatment Period|Adverse Event|0
5321052|NCT00303472|18326636|P5|Treatment Period|Adverse Event|1
5321053|NCT00303472|18326637|P4|Treatment Period|Adverse Event|0
5321054|NCT00303472|18326638|P3|Treatment Period|Adverse Event|0
5321055|NCT00303472|18326639|P2|Treatment Period|Adverse Event|0
5321056|NCT00303472|18326640|P1|Treatment Period|Adverse Event|0
5321057|NCT00303459|18326700|P2|Overall Study|Lung transplantation|1
5321058|NCT00303459|18326701|P1|Overall Study|Lung transplantation|1
5321059|NCT00303459|18326700|P2|Overall Study|Decision by the investigator|7
5321060|NCT00303459|18326701|P1|Overall Study|Decision by the investigator|5
5321061|NCT00303459|18326700|P2|Overall Study|Administrative reason|7
5321062|NCT00303459|18326701|P1|Overall Study|Administrative reason|7
5321063|NCT00303459|18326700|P2|Overall Study|Lost to Follow-up|4
5321064|NCT00303459|18326701|P1|Overall Study|Lost to Follow-up|5
5321065|NCT00303459|18326700|P2|Overall Study|Withdrawal of consent|26
5321066|NCT00303459|18326701|P1|Overall Study|Withdrawal of consent|32
5321067|NCT00303459|18326700|P2|Overall Study|Death|44
5321068|NCT00303459|18326701|P1|Overall Study|Death|33
5321069|NCT00303446|18326727|P2|Overall Study|Physician Decision|1
5321070|NCT00303446|18326728|P1|Overall Study|Physician Decision|0
5321071|NCT00303446|18326727|P2|Overall Study|Death|1
5321072|NCT00303446|18326728|P1|Overall Study|Death|0
5321073|NCT00303446|18326727|P2|Overall Study|Withdrawal by Subject|2
5321074|NCT00303446|18326728|P1|Overall Study|Withdrawal by Subject|2
5321075|NCT00303329|18326764|P2|Overall Study|Stopped at end of extension 1|0
5321076|NCT00303329|18326765|P1|Overall Study|Stopped at end of extension 1|1
5321077|NCT00303329|18326764|P2|Overall Study|Stopped at end of core|9
5321078|NCT00303329|18326765|P1|Overall Study|Stopped at end of core|3
5321079|NCT00303329|18326764|P2|Overall Study|Death|12
5321080|NCT00303329|18326765|P1|Overall Study|Death|2
5321081|NCT00303329|18326764|P2|Overall Study|Administrative problems|0
5321082|NCT00303329|18326765|P1|Overall Study|Administrative problems|1
5321083|NCT00303329|18326764|P2|Overall Study|Lost to Follow-up|1
5321084|NCT00303329|18326765|P1|Overall Study|Lost to Follow-up|0
5321085|NCT00303329|18326764|P2|Overall Study|Withdrawal by Subject|15
5321086|NCT00303329|18326765|P1|Overall Study|Withdrawal by Subject|9
5321087|NCT00303329|18326764|P2|Overall Study|Protocol Violation|0
5321088|NCT00303329|18326765|P1|Overall Study|Protocol Violation|3
5321089|NCT00303329|18326764|P2|Overall Study|Condition no longer requires study drug|8
5321090|NCT00303329|18326765|P1|Overall Study|Condition no longer requires study drug|0
5321091|NCT00303329|18326764|P2|Overall Study|Unsatisfactory therapeutic effect|2
5321092|NCT00303329|18326765|P1|Overall Study|Unsatisfactory therapeutic effect|9
5321093|NCT00303329|18326764|P2|Overall Study|Abnormal Laboratory Values|1
5321094|NCT00303329|18326765|P1|Overall Study|Abnormal Laboratory Values|0
5321095|NCT00303329|18326764|P2|Overall Study|Adverse Event|14
5321096|NCT00303329|18326765|P1|Overall Study|Adverse Event|7
5321097|NCT00303316|18326779|P2|Overall Study|Withdrawal by Subject|2
5321098|NCT00303316|18326780|P1|Overall Study|Withdrawal by Subject|1
5321099|NCT00303316|18326779|P2|Overall Study|Lost to Follow-up|1
5321100|NCT00303316|18326780|P1|Overall Study|Lost to Follow-up|0
5321101|NCT00303316|18326779|P2|Overall Study|Protocol Violation|0
5321102|NCT00303316|18326780|P1|Overall Study|Protocol Violation|1
5321103|NCT00303186|18326792|P1|Overall Study|Other|52
5321104|NCT00303108|18326826|P3|Overall Study|ineligible|0
5321105|NCT00303108|18326827|P2|Overall Study|ineligible|1
5321106|NCT00303108|18326828|P1|Overall Study|ineligible|2
5321107|NCT00303108|18326826|P3|Overall Study|Failed Entry|1
5321108|NCT00303108|18326827|P2|Overall Study|Failed Entry|0
5321109|NCT00303108|18326828|P1|Overall Study|Failed Entry|1
5321110|NCT00303108|18326826|P3|Overall Study|Patient Request|8
5321111|NCT00303108|18326827|P2|Overall Study|Patient Request|2
5321112|NCT00303108|18326828|P1|Overall Study|Patient Request|4
5321113|NCT00303108|18326826|P3|Overall Study|Adverse Event|7
5321114|NCT00303108|18326827|P2|Overall Study|Adverse Event|6
5321115|NCT00303108|18326828|P1|Overall Study|Adverse Event|5
5321116|NCT00303069|18326848|P4|Overall Study|Recruitment into Army Reserves|0
5321117|NCT00303069|18326849|P3|Overall Study|Recruitment into Army Reserves|1
5321118|NCT00303069|18326850|P2|Overall Study|Recruitment into Army Reserves|0
5321119|NCT00303069|18326851|P1|Overall Study|Recruitment into Army Reserves|0
5321120|NCT00303069|18326848|P4|Overall Study|subject moved|0
5321121|NCT00303069|18326849|P3|Overall Study|subject moved|0
5321122|NCT00303069|18326850|P2|Overall Study|subject moved|0
5321123|NCT00303069|18326851|P1|Overall Study|subject moved|1
5321124|NCT00303069|18326848|P4|Overall Study|Lost to Follow-up|2
5321125|NCT00303069|18326849|P3|Overall Study|Lost to Follow-up|0
5321126|NCT00303069|18326850|P2|Overall Study|Lost to Follow-up|0
5321127|NCT00303069|18326851|P1|Overall Study|Lost to Follow-up|1
5321128|NCT00302952|18326871|P2|Overall Study|Elevated SGOT (AST) lab value|1
5321129|NCT00302952|18326872|P1|Overall Study|Elevated SGOT (AST) lab value|0
5321130|NCT00302952|18326871|P2|Overall Study|Withdrawal by Subject|3
5321131|NCT00302952|18326872|P1|Overall Study|Withdrawal by Subject|2
5321132|NCT00302952|18326871|P2|Overall Study|Physician Decision|1
5321133|NCT00302952|18326872|P1|Overall Study|Physician Decision|1
5321134|NCT00302731|18326922|P4|Overall Study|cancer unrelated to study discovered|0
5321135|NCT00302731|18326923|P3|Overall Study|cancer unrelated to study discovered|1
5321136|NCT00302731|18326924|P2|Overall Study|cancer unrelated to study discovered|0
5321137|NCT00302731|18326925|P1|Overall Study|cancer unrelated to study discovered|1
5321138|NCT00302731|18326922|P4|Overall Study|Protocol Violation|0
5321139|NCT00302731|18326923|P3|Overall Study|Protocol Violation|0
5321140|NCT00302731|18326924|P2|Overall Study|Protocol Violation|0
5321141|NCT00302731|18326925|P1|Overall Study|Protocol Violation|1
5321142|NCT00302731|18326922|P4|Overall Study|Withdrawal by Subject|0
5321143|NCT00302731|18326923|P3|Overall Study|Withdrawal by Subject|0
5321144|NCT00302731|18326924|P2|Overall Study|Withdrawal by Subject|1
5321145|NCT00302731|18326925|P1|Overall Study|Withdrawal by Subject|1
5321146|NCT00302731|18326922|P4|Overall Study|Adverse Event|0
5321147|NCT00302731|18326923|P3|Overall Study|Adverse Event|2
5321148|NCT00302731|18326924|P2|Overall Study|Adverse Event|2
5321149|NCT00302731|18326925|P1|Overall Study|Adverse Event|0
5321150|NCT00302731|18326922|P4|Overall Study|Lost to Follow-up|0
5321151|NCT00302731|18326923|P3|Overall Study|Lost to Follow-up|0
5321152|NCT00302731|18326924|P2|Overall Study|Lost to Follow-up|2
5321153|NCT00302731|18326925|P1|Overall Study|Lost to Follow-up|1
5321154|NCT00302718|18326951|P4|Overall Study|Participant left primary care setting|1
5321155|NCT00302718|18326952|P3|Overall Study|Participant left primary care setting|2
5321156|NCT00302718|18326953|P2|Overall Study|Participant left primary care setting|0
5321157|NCT00302718|18326954|P1|Overall Study|Participant left primary care setting|0
5321158|NCT00302718|18326951|P4|Overall Study|Withdrawal by Subject|0
5321159|NCT00302718|18326952|P3|Overall Study|Withdrawal by Subject|0
5321160|NCT00302718|18326953|P2|Overall Study|Withdrawal by Subject|1
5321161|NCT00302718|18326954|P1|Overall Study|Withdrawal by Subject|0
5321162|NCT00302718|18326951|P4|Overall Study|Participant left the hospital|1
5321163|NCT00302718|18326952|P3|Overall Study|Participant left the hospital|0
5321164|NCT00302718|18326953|P2|Overall Study|Participant left the hospital|0
5321165|NCT00302718|18326954|P1|Overall Study|Participant left the hospital|1
5321166|NCT00302458|18327020|P1|Overall Study|Withdrawal by Subject|1
5321167|NCT00302458|18327020|P1|Overall Study|Ineligible after screening|1
5321168|NCT00302458|18327020|P1|Overall Study|Lost to Follow-up|1
5321169|NCT00302328|18327031|P3|Overall Study|Physician Decision|0
5321170|NCT00302328|18327032|P2|Overall Study|Physician Decision|1
5321171|NCT00302328|18327033|P1|Overall Study|Physician Decision|0
5321172|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5321173|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
5321174|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5321175|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5321176|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5321177|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
5321178|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5321179|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5321180|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5321181|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5321182|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
5321183|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5321184|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5321185|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5321186|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5321187|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Death|1
5321188|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Death|1
5321189|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Death|0
5321190|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Death|0
5321191|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Death|0
5321192|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Disease progression|2
5321193|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Disease progression|1
5321194|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Disease progression|0
5321195|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Disease progression|0
5321196|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Disease progression|0
5321197|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
5321198|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
5321199|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
5321200|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
5321201|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
5321202|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Adverse Event|0
5321203|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Adverse Event|1
5321204|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Adverse Event|0
5321205|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Adverse Event|0
5321206|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Adverse Event|0
5321207|NCT00302211|18327050|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
5321208|NCT00302211|18327051|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
5321209|NCT00302211|18327052|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
5321210|NCT00302211|18327053|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
5321211|NCT00302211|18327054|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
5321212|NCT00302211|18327050|P5|Double Blind Period (New Patients)|Disease progression|0
5321213|NCT00302211|18327051|P4|Double Blind Period (New Patients)|Disease progression|0
5321214|NCT00302211|18327052|P3|Double Blind Period (New Patients)|Disease progression|1
5321215|NCT00302211|18327053|P2|Double Blind Period (New Patients)|Disease progression|1
5321216|NCT00302211|18327054|P1|Double Blind Period (New Patients)|Disease progression|0
5321217|NCT00302211|18327050|P5|Double Blind Period (New Patients)|Investigator's judgement|0
5321218|NCT00302211|18327051|P4|Double Blind Period (New Patients)|Investigator's judgement|0
5321219|NCT00302211|18327052|P3|Double Blind Period (New Patients)|Investigator's judgement|0
5321220|NCT00302211|18327053|P2|Double Blind Period (New Patients)|Investigator's judgement|0
5321221|NCT00302211|18327054|P1|Double Blind Period (New Patients)|Investigator's judgement|1
5321222|NCT00302211|18327050|P5|Double Blind Period (New Patients)|Adverse Event|0
5321223|NCT00302211|18327051|P4|Double Blind Period (New Patients)|Adverse Event|0
5321224|NCT00302211|18327052|P3|Double Blind Period (New Patients)|Adverse Event|3
5321225|NCT00302211|18327053|P2|Double Blind Period (New Patients)|Adverse Event|0
5321226|NCT00302211|18327054|P1|Double Blind Period (New Patients)|Adverse Event|0
5321227|NCT00302211|18327050|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
5321228|NCT00302211|18327051|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
5321229|NCT00302211|18327052|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
5321230|NCT00302211|18327053|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
5321231|NCT00302211|18327054|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
5321232|NCT00302159|18327080|P1|Overall Study|pt started Avastin|1
5321233|NCT00302159|18327080|P1|Overall Study|pt declined before treatment started|1
5321234|NCT00302107|18327102|P2|Overall Study|Adverse Event|0
5321235|NCT00302107|18327103|P1|Overall Study|Adverse Event|1
5321236|NCT00302107|18327102|P2|Overall Study|Withdrawal by Subject|3
5321237|NCT00302107|18327103|P1|Overall Study|Withdrawal by Subject|0
5321238|NCT00302107|18327102|P2|Overall Study|Relocation|1
5321239|NCT00302107|18327103|P1|Overall Study|Relocation|0
5321240|NCT00302107|18327102|P2|Overall Study|Protocol Violation|0
5321241|NCT00302107|18327103|P1|Overall Study|Protocol Violation|1
5321242|NCT00302107|18327102|P2|Overall Study|Lost to Follow-up|5
5321243|NCT00302107|18327103|P1|Overall Study|Lost to Follow-up|6
5321244|NCT00302081|18327112|P3|Overall Study|Other|5
5321245|NCT00302081|18327113|P2|Overall Study|Other|6
5321246|NCT00302081|18327114|P1|Overall Study|Other|13
5321247|NCT00302081|18327112|P3|Overall Study|Death|0
5321248|NCT00302081|18327113|P2|Overall Study|Death|1
5321249|NCT00302081|18327114|P1|Overall Study|Death|2
5321250|NCT00302081|18327112|P3|Overall Study|Lack of Efficacy|5
5321251|NCT00302081|18327113|P2|Overall Study|Lack of Efficacy|0
5321252|NCT00302081|18327114|P1|Overall Study|Lack of Efficacy|1
5321253|NCT00302081|18327112|P3|Overall Study|Protocol Violation|2
5321254|NCT00302081|18327113|P2|Overall Study|Protocol Violation|1
5321255|NCT00302081|18327114|P1|Overall Study|Protocol Violation|5
5321256|NCT00302081|18327112|P3|Overall Study|Withdrawal by Subject|8
5321257|NCT00302081|18327113|P2|Overall Study|Withdrawal by Subject|12
5321258|NCT00302081|18327114|P1|Overall Study|Withdrawal by Subject|8
5321259|NCT00302081|18327112|P3|Overall Study|Lost to Follow-up|28
5321260|NCT00302081|18327113|P2|Overall Study|Lost to Follow-up|18
5321261|NCT00302081|18327114|P1|Overall Study|Lost to Follow-up|21
5321262|NCT00302081|18327112|P3|Overall Study|Adverse Event|4
5321263|NCT00302081|18327113|P2|Overall Study|Adverse Event|5
5321264|NCT00302081|18327114|P1|Overall Study|Adverse Event|6
5321265|NCT00302003|18327171|P1|Overall Study|Protocol Violation|1
5321266|NCT00302003|18327171|P1|Overall Study|Ineligible|9
5321267|NCT00302003|18327171|P1|Overall Study|Withdrawal by Subject|5
5321268|NCT00302003|18327171|P1|Overall Study|Physician Decision|2
5321269|NCT00302003|18327171|P1|Overall Study|Lost to Follow-up|1
5321270|NCT00302003|18327171|P1|Overall Study|Lack of Efficacy|62
5321271|NCT00301964|18327178|P1|Overall Study|Inadequate pathology|1
5321272|NCT00301964|18327178|P1|Overall Study|Wrong primary|1
5321273|NCT00301964|18327178|P1|Overall Study|Second primary|2
5321274|NCT00301834|18327199|P1|Overall Study|Death|1
5321275|NCT00301821|18327208|P1|Overall Study|Cancel|1
5321276|NCT00301821|18327208|P1|Overall Study|Ineligible|25
5321277|NCT00301808|18327215|P1|Overall Study|Lack of Efficacy|4
5321278|NCT00301808|18327215|P1|Overall Study|Death|3
5321279|NCT00301808|18327215|P1|Overall Study|Adverse Event|5
5321280|NCT00301366|18327240|P1|Overall Study|Adverse Event|1
5321281|NCT00301262|18327246|P2|Open Label Phase (OL)|Other|0
5321282|NCT00301262|18327247|P1|Open Label Phase (OL)|Other|2
5321283|NCT00301262|18327246|P2|Open Label Phase (OL)|Lost to Follow-up|2
5321284|NCT00301262|18327247|P1|Open Label Phase (OL)|Lost to Follow-up|1
5321285|NCT00301262|18327246|P2|Open Label Phase (OL)|Adverse Event|0
5321286|NCT00301262|18327247|P1|Open Label Phase (OL)|Adverse Event|1
5321287|NCT00301262|18327246|P2|Double Blind Phase (DB)|Other|4
5321288|NCT00301262|18327247|P1|Double Blind Phase (DB)|Other|1
5321289|NCT00301262|18327246|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
5321290|NCT00301262|18327247|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
5321291|NCT00301262|18327246|P2|Double Blind Phase (DB)|Lost to Follow-up|3
5321292|NCT00301262|18327247|P1|Double Blind Phase (DB)|Lost to Follow-up|3
5321293|NCT00301262|18327246|P2|Double Blind Phase (DB)|Lack of Efficacy|1
5321294|NCT00301262|18327247|P1|Double Blind Phase (DB)|Lack of Efficacy|0
5321295|NCT00301262|18327246|P2|Double Blind Phase (DB)|Adverse Event|0
5321296|NCT00301262|18327247|P1|Double Blind Phase (DB)|Adverse Event|1
5321297|NCT00301080|18327405|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5321298|NCT00301080|18327406|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5321299|NCT00301080|18327407|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5321300|NCT00301080|18327408|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5321301|NCT00301080|18327409|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
5321302|NCT00301067|18327438|P4|Follow up Until Death|Alive at last data cut point|1
5321303|NCT00301067|18327439|P3|Follow up Until Death|Alive at last data cut point|0
5321304|NCT00301067|18327440|P2|Follow up Until Death|Alive at last data cut point|0
5321305|NCT00301067|18327441|P1|Follow up Until Death|Alive at last data cut point|1
5321306|NCT00301067|18327438|P4|Completed 12 Cycles of Treatment|Adverse Event|1
5321307|NCT00301067|18327439|P3|Completed 12 Cycles of Treatment|Adverse Event|0
5321308|NCT00301067|18327440|P2|Completed 12 Cycles of Treatment|Adverse Event|0
5321309|NCT00301067|18327441|P1|Completed 12 Cycles of Treatment|Adverse Event|0
5321310|NCT00301067|18327438|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
5321311|NCT00301067|18327439|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
5321312|NCT00301067|18327440|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
5321313|NCT00301067|18327441|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
5321314|NCT00301067|18327438|P4|Completed 4 Cycles of Treatment|Progressive disease|5
5321315|NCT00301067|18327439|P3|Completed 4 Cycles of Treatment|Progressive disease|2
5321316|NCT00301067|18327440|P2|Completed 4 Cycles of Treatment|Progressive disease|1
5321317|NCT00301067|18327441|P1|Completed 4 Cycles of Treatment|Progressive disease|1
5321318|NCT00301067|18327438|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
5321319|NCT00301067|18327439|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
5321320|NCT00301067|18327440|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
5321321|NCT00301067|18327441|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
5321322|NCT00301067|18327438|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
5321323|NCT00301067|18327439|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
5321324|NCT00301067|18327440|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
5321325|NCT00301067|18327441|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
5321326|NCT00300885|18327466|P2|Follow-up|Withdrawal by Subject|25
5321327|NCT00300885|18327467|P1|Follow-up|Withdrawal by Subject|26
5321328|NCT00300885|18327466|P2|Follow-up|Lost to Follow-up|7
5321329|NCT00300885|18327467|P1|Follow-up|Lost to Follow-up|11
5321330|NCT00300885|18327466|P2|Follow-up|Death|163
5321331|NCT00300885|18327467|P1|Follow-up|Death|141
5321332|NCT00300885|18327466|P2|Treatment|Non-compliant with study medication|4
5321333|NCT00300885|18327467|P1|Treatment|Non-compliant with study medication|3
5321334|NCT00300885|18327466|P2|Treatment|Random code broken (subject died)|1
5321335|NCT00300885|18327467|P1|Treatment|Random code broken (subject died)|0
5321336|NCT00300885|18327466|P2|Treatment|Disease progression|238
5321337|NCT00300885|18327467|P1|Treatment|Disease progression|171
5321338|NCT00300885|18327466|P2|Treatment|Withdrawal by Subject|23
5321339|NCT00300885|18327467|P1|Treatment|Withdrawal by Subject|26
5321340|NCT00300885|18327466|P2|Treatment|Protocol Violation|11
5321341|NCT00300885|18327467|P1|Treatment|Protocol Violation|11
5321342|NCT00300885|18327466|P2|Treatment|Physician Decision|5
5321343|NCT00300885|18327467|P1|Treatment|Physician Decision|4
5321344|NCT00300885|18327466|P2|Treatment|Lost to Follow-up|2
5321345|NCT00300885|18327467|P1|Treatment|Lost to Follow-up|3
5321346|NCT00300885|18327466|P2|Treatment|Lack of Efficacy|1
5321347|NCT00300885|18327467|P1|Treatment|Lack of Efficacy|1
5321348|NCT00300885|18327466|P2|Treatment|Death|7
5321349|NCT00300885|18327467|P1|Treatment|Death|20
5321350|NCT00300885|18327466|P2|Treatment|Adverse Event|82
5321351|NCT00300885|18327467|P1|Treatment|Adverse Event|134
5321352|NCT00300781|18327485|P2|Overall Study|Lost to Follow-up|1
5321353|NCT00300781|18327486|P1|Overall Study|Lost to Follow-up|0
5321354|NCT00300781|18327485|P2|Overall Study|Symptomatic Deterioration|0
5321355|NCT00300781|18327486|P1|Overall Study|Symptomatic Deterioration|1
5321356|NCT00300781|18327485|P2|Overall Study|Not Recorded|1
5321357|NCT00300781|18327486|P1|Overall Study|Not Recorded|0
5321358|NCT00300781|18327485|P2|Overall Study|Physician Decision|0
5321359|NCT00300781|18327486|P1|Overall Study|Physician Decision|1
5321360|NCT00300781|18327485|P2|Overall Study|Withdrawal by Subject|2
5321361|NCT00300781|18327486|P1|Overall Study|Withdrawal by Subject|1
5321362|NCT00300781|18327485|P2|Overall Study|Adverse Event|6
5321363|NCT00300781|18327486|P1|Overall Study|Adverse Event|5
5321364|NCT00300781|18327485|P2|Overall Study|Disease Progression|52
5321365|NCT00300781|18327486|P1|Overall Study|Disease Progression|55
5321366|NCT00300755|18327501|P3|Overall Study|Protocol Violation|1
5321367|NCT00300755|18327502|P2|Overall Study|Protocol Violation|0
5321368|NCT00300755|18327503|P1|Overall Study|Protocol Violation|0
5321369|NCT00300755|18327501|P3|Overall Study|Withdrawal by Subject|0
5321370|NCT00300755|18327502|P2|Overall Study|Withdrawal by Subject|2
5321371|NCT00300755|18327503|P1|Overall Study|Withdrawal by Subject|0
5321372|NCT00300755|18327501|P3|Overall Study|Adverse Event|1
5321373|NCT00300755|18327502|P2|Overall Study|Adverse Event|2
5321374|NCT00300755|18327503|P1|Overall Study|Adverse Event|1
5321375|NCT00300495|18327537|P2|Overall Study|Protocol Violation|1
5321376|NCT00300495|18327538|P1|Overall Study|Protocol Violation|4
5321377|NCT00300365|18327805|P2|Overall Study|Adverse Event|2
5321378|NCT00300365|18327806|P1|Overall Study|Adverse Event|0
5321379|NCT00300365|18327805|P2|Overall Study|Withdrawal by Subject|0
5321380|NCT00300365|18327806|P1|Overall Study|Withdrawal by Subject|1
5321381|NCT00300365|18327805|P2|Overall Study|Physician Decision|0
5321382|NCT00300365|18327806|P1|Overall Study|Physician Decision|2
5321383|NCT00300365|18327805|P2|Overall Study|Lost to Follow-up|0
5321384|NCT00300365|18327806|P1|Overall Study|Lost to Follow-up|1
5321385|NCT00300274|18327815|P3|Overall Study|Re-transplant|1
5321386|NCT00300274|18327816|P2|Overall Study|Re-transplant|0
5321387|NCT00300274|18327817|P1|Overall Study|Re-transplant|0
5321388|NCT00300274|18327815|P3|Overall Study|Death|25
5321389|NCT00300274|18327816|P2|Overall Study|Death|20
5321390|NCT00300274|18327817|P1|Overall Study|Death|31
5321391|NCT00300274|18327815|P3|Overall Study|Lost to Follow-up|5
5321392|NCT00300274|18327816|P2|Overall Study|Lost to Follow-up|4
5321393|NCT00300274|18327817|P1|Overall Study|Lost to Follow-up|3
5321394|NCT00300274|18327815|P3|Overall Study|Withdrawal by Subject|14
5321395|NCT00300274|18327816|P2|Overall Study|Withdrawal by Subject|3
5321396|NCT00300274|18327817|P1|Overall Study|Withdrawal by Subject|12
5321397|NCT00299975|18327887|P3|Overall Study|Physician Decision|1
5321398|NCT00299975|18327888|P2|Overall Study|Physician Decision|0
5321399|NCT00299975|18327889|P1|Overall Study|Physician Decision|0
5321400|NCT00299975|18327887|P3|Overall Study|Withdrawal by Subject|3
5321401|NCT00299975|18327888|P2|Overall Study|Withdrawal by Subject|1
5321402|NCT00299975|18327889|P1|Overall Study|Withdrawal by Subject|0
5321403|NCT00299975|18327887|P3|Overall Study|Lost to Follow-up|0
5321404|NCT00299975|18327888|P2|Overall Study|Lost to Follow-up|0
5321405|NCT00299975|18327889|P1|Overall Study|Lost to Follow-up|1
5321406|NCT00299975|18327887|P3|Overall Study|Lack of Efficacy|1
5321407|NCT00299975|18327888|P2|Overall Study|Lack of Efficacy|0
5321408|NCT00299975|18327889|P1|Overall Study|Lack of Efficacy|1
5321409|NCT00299975|18327887|P3|Overall Study|Pregnancy|1
5321410|NCT00299975|18327888|P2|Overall Study|Pregnancy|0
5321411|NCT00299975|18327889|P1|Overall Study|Pregnancy|0
5321412|NCT00299975|18327887|P3|Overall Study|Adverse Event|2
5321413|NCT00299975|18327888|P2|Overall Study|Adverse Event|0
5321414|NCT00299975|18327889|P1|Overall Study|Adverse Event|1
5321415|NCT00299702|18327946|P2|Overall Study|Admin issues, sponsor decision, etc.|9
5321416|NCT00299702|18327947|P1|Overall Study|Admin issues, sponsor decision, etc.|5
5321417|NCT00299702|18327946|P2|Overall Study|Insufficient Response|3
5321418|NCT00299702|18327947|P1|Overall Study|Insufficient Response|4
5321419|NCT00299702|18327946|P2|Overall Study|Pregnancy|1
5321420|NCT00299702|18327947|P1|Overall Study|Pregnancy|0
5321421|NCT00299702|18327946|P2|Overall Study|Withdrawal by Subject|23
5321422|NCT00299702|18327947|P1|Overall Study|Withdrawal by Subject|25
5321423|NCT00299702|18327946|P2|Overall Study|Lost to Follow-up|10
5321424|NCT00299702|18327947|P1|Overall Study|Lost to Follow-up|18
5321425|NCT00299702|18327946|P2|Overall Study|Adverse Event|4
5321426|NCT00299702|18327947|P1|Overall Study|Adverse Event|0
5321427|NCT00299702|18327946|P2|Overall Study|Death|0
5321428|NCT00299702|18327947|P1|Overall Study|Death|1
5321429|NCT00299546|18327962|P3|Overall Study|Not treated|1
5321430|NCT00299546|18327963|P2|Overall Study|Not treated|1
5321431|NCT00299546|18327964|P1|Overall Study|Not treated|0
5321432|NCT00299546|18327962|P3|Overall Study|Other|19
5321433|NCT00299546|18327963|P2|Overall Study|Other|26
5321434|NCT00299546|18327964|P1|Overall Study|Other|24
5321435|NCT00299546|18327962|P3|Overall Study|Unsatisfactory therapeutic effect|34
5321436|NCT00299546|18327963|P2|Overall Study|Unsatisfactory therapeutic effect|39
5321437|NCT00299546|18327964|P1|Overall Study|Unsatisfactory therapeutic effect|34
5321438|NCT00299546|18327962|P3|Overall Study|Adverse Event|27
5321439|NCT00299546|18327963|P2|Overall Study|Adverse Event|22
5321440|NCT00299546|18327964|P1|Overall Study|Adverse Event|37
5321441|NCT00299546|18327962|P3|Overall Study|Lost to Follow-up|5
5321442|NCT00299546|18327963|P2|Overall Study|Lost to Follow-up|2
5321443|NCT00299546|18327964|P1|Overall Study|Lost to Follow-up|2
5321444|NCT00299546|18327962|P3|Overall Study|Death|0
5321445|NCT00299546|18327963|P2|Overall Study|Death|2
5321446|NCT00299546|18327964|P1|Overall Study|Death|3
5321447|NCT00299494|18327995|P6|Overall Study|Other - site closure|1
5321448|NCT00299494|18327996|P5|Overall Study|Other - site closure|1
5321449|NCT00299494|18327997|P4|Overall Study|Other - site closure|1
5321450|NCT00299494|18327998|P3|Overall Study|Other - site closure|0
5321451|NCT00299494|18327999|P2|Overall Study|Other - site closure|0
5321452|NCT00299494|18328000|P1|Overall Study|Other - site closure|0
5321453|NCT00299494|18327995|P6|Overall Study|Other - Unspecified|1
5321454|NCT00299494|18327996|P5|Overall Study|Other - Unspecified|3
5321455|NCT00299494|18327997|P4|Overall Study|Other - Unspecified|0
5321456|NCT00299494|18327998|P3|Overall Study|Other - Unspecified|0
5321457|NCT00299494|18327999|P2|Overall Study|Other - Unspecified|0
5321458|NCT00299494|18328000|P1|Overall Study|Other - Unspecified|0
5321459|NCT00299494|18327995|P6|Overall Study|Lost to Follow-up|1
5321460|NCT00299494|18327996|P5|Overall Study|Lost to Follow-up|3
5321461|NCT00299494|18327997|P4|Overall Study|Lost to Follow-up|0
5321462|NCT00299494|18327998|P3|Overall Study|Lost to Follow-up|0
5321463|NCT00299494|18327999|P2|Overall Study|Lost to Follow-up|0
5321464|NCT00299494|18328000|P1|Overall Study|Lost to Follow-up|0
5321465|NCT00299494|18327995|P6|Overall Study|Death|19
5321466|NCT00299494|18327996|P5|Overall Study|Death|18
5321467|NCT00299494|18327997|P4|Overall Study|Death|6
5321468|NCT00299494|18327998|P3|Overall Study|Death|4
5321469|NCT00299494|18327999|P2|Overall Study|Death|1
5321470|NCT00299494|18328000|P1|Overall Study|Death|3
5321471|NCT00299494|18327995|P6|Overall Study|Physician Decision|0
5321472|NCT00299494|18327996|P5|Overall Study|Physician Decision|1
5321473|NCT00299494|18327997|P4|Overall Study|Physician Decision|0
5321474|NCT00299494|18327998|P3|Overall Study|Physician Decision|0
5321475|NCT00299494|18327999|P2|Overall Study|Physician Decision|0
5321476|NCT00299494|18328000|P1|Overall Study|Physician Decision|0
5321477|NCT00299494|18327995|P6|Overall Study|Withdrawal by Subject|4
5321478|NCT00299494|18327996|P5|Overall Study|Withdrawal by Subject|1
5321479|NCT00299494|18327997|P4|Overall Study|Withdrawal by Subject|3
5321480|NCT00299494|18327998|P3|Overall Study|Withdrawal by Subject|0
5321481|NCT00299494|18327999|P2|Overall Study|Withdrawal by Subject|0
5321482|NCT00299494|18328000|P1|Overall Study|Withdrawal by Subject|0
5321483|NCT00299156|18328146|P3|Period 2 (Randomized)|Screen Failure|0
5321484|NCT00299156|18328147|P2|Period 2 (Randomized)|Screen Failure|1
5321485|NCT00299156|18328148|P1|Period 2 (Randomized)|Screen Failure|0
5321486|NCT00299130|18328159|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
5321487|NCT00299130|18328160|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
5321488|NCT00299130|18328161|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
5321489|NCT00299130|18328159|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
5321490|NCT00299130|18328160|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
5321491|NCT00299130|18328161|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
5321492|NCT00299130|18328159|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
5321493|NCT00299130|18328160|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
5321494|NCT00299130|18328161|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
5321495|NCT00299130|18328159|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
5321496|NCT00299130|18328160|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
5321497|NCT00299130|18328161|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
5321498|NCT00299130|18328159|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
5321499|NCT00299130|18328160|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
5321500|NCT00299130|18328161|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
5321501|NCT00299130|18328159|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
5321502|NCT00299130|18328160|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
5321503|NCT00299130|18328161|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
5321504|NCT00299130|18328159|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
5321505|NCT00299130|18328160|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
5321506|NCT00299130|18328161|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
5321507|NCT00299130|18328159|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
5321508|NCT00299130|18328160|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
5321509|NCT00299130|18328161|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
5321510|NCT00299130|18328159|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
5321511|NCT00299130|18328160|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
5321512|NCT00299130|18328161|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
5321513|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
5321514|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
5321515|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
5321516|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
5321517|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
5321518|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
5321519|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Failure to Return|6
5321520|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Failure to Return|6
5321521|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Failure to Return|4
5321522|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
5321523|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
5321524|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
5321525|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
5321526|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
5321527|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
5321528|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
5321529|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
5321530|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
5321531|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Death|1
5321532|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Death|3
5321533|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Death|1
5321534|NCT00299130|18328159|P3|Treatment Period (up to 5 Years)|Adverse Event|13
5321535|NCT00299130|18328160|P2|Treatment Period (up to 5 Years)|Adverse Event|8
5321536|NCT00299130|18328161|P1|Treatment Period (up to 5 Years)|Adverse Event|13
5321537|NCT00299104|18328266|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
5321538|NCT00299104|18328267|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
5321539|NCT00299104|18328268|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
5321540|NCT00299104|18328266|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
5321541|NCT00299104|18328267|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
5321542|NCT00299104|18328268|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
5321543|NCT00299104|18328266|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
5321544|NCT00299104|18328267|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
5321545|NCT00299104|18328268|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
5321546|NCT00299104|18328266|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
5321547|NCT00299104|18328267|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
5321548|NCT00299104|18328268|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
5321549|NCT00299104|18328266|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
5321550|NCT00299104|18328267|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
5321551|NCT00299104|18328268|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
5321552|NCT00299104|18328266|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
5321553|NCT00299104|18328267|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
5321554|NCT00299104|18328268|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
5321555|NCT00299104|18328266|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
5321556|NCT00299104|18328267|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
5321557|NCT00299104|18328268|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
5321558|NCT00299104|18328266|P3|Safety Follow-Up (SFU) Period|Death|1
5321559|NCT00299104|18328267|P2|Safety Follow-Up (SFU) Period|Death|2
5321560|NCT00299104|18328268|P1|Safety Follow-Up (SFU) Period|Death|3
5321561|NCT00299104|18328266|P3|Treatment Period|Administrative reasons|137
5321562|NCT00299104|18328267|P2|Treatment Period|Administrative reasons|120
5321563|NCT00299104|18328268|P1|Treatment Period|Administrative reasons|106
5321564|NCT00299104|18328266|P3|Treatment Period|Withdrew consent|9
5321565|NCT00299104|18328267|P2|Treatment Period|Withdrew consent|19
5321566|NCT00299104|18328268|P1|Treatment Period|Withdrew consent|14
5321567|NCT00299104|18328266|P3|Treatment Period|Refused treatment|2
5321568|NCT00299104|18328267|P2|Treatment Period|Refused treatment|2
5321569|NCT00299104|18328268|P1|Treatment Period|Refused treatment|9
5321570|NCT00299104|18328266|P3|Treatment Period|Protocol Violation|0
5321571|NCT00299104|18328267|P2|Treatment Period|Protocol Violation|1
5321572|NCT00299104|18328268|P1|Treatment Period|Protocol Violation|1
5321573|NCT00299104|18328266|P3|Treatment Period|Violation of selection criteria|0
5321574|NCT00299104|18328267|P2|Treatment Period|Violation of selection criteria|2
5321575|NCT00299104|18328268|P1|Treatment Period|Violation of selection criteria|1
5321576|NCT00299104|18328266|P3|Treatment Period|Failure to return|8
5321577|NCT00299104|18328267|P2|Treatment Period|Failure to return|8
5321578|NCT00299104|18328268|P1|Treatment Period|Failure to return|9
5321579|NCT00299104|18328266|P3|Treatment Period|Insufficient therapeutic response|8
5321580|NCT00299104|18328267|P2|Treatment Period|Insufficient therapeutic response|13
5321581|NCT00299104|18328268|P1|Treatment Period|Insufficient therapeutic response|34
5321582|NCT00299104|18328266|P3|Treatment Period|Death|1
5321583|NCT00299104|18328267|P2|Treatment Period|Death|1
5321584|NCT00299104|18328268|P1|Treatment Period|Death|1
5321585|NCT00299104|18328266|P3|Treatment Period|Adverse Event|7
5321586|NCT00299104|18328267|P2|Treatment Period|Adverse Event|9
5321587|NCT00299104|18328268|P1|Treatment Period|Adverse Event|14
5321588|NCT00298896|18328378|P1|Overall Study|Assigned to treatment in error|1
5321589|NCT00298896|18328378|P1|Overall Study|Withdrawal by Subject|2
5321590|NCT00298896|18328378|P1|Overall Study|Disease Progression|41
5321591|NCT00298896|18328378|P1|Overall Study|Intercurrent Illness|1
5321592|NCT00298896|18328378|P1|Overall Study|Physician Decision|2
5321593|NCT00298896|18328378|P1|Overall Study|Death|3
5321594|NCT00298831|18328383|P1|Overall Study|Participants did not receive treatment|27
5321595|NCT00298831|18328383|P1|Overall Study|Withdrawal by Subject|1
5321596|NCT00298831|18328383|P1|Overall Study|Lost to Follow-up|3
5321597|NCT00298831|18328383|P1|Overall Study|Adverse Event|1
5321598|NCT00298766|18328392|P1|Overall Study|Other|4
5321599|NCT00298766|18328392|P1|Overall Study|Subjects overall condition deterioration|4
5321600|NCT00298766|18328392|P1|Overall Study|Deterioration in KPS and organ function|1
5321601|NCT00298766|18328392|P1|Overall Study|Progression of amyloid markers|4
5321602|NCT00298766|18328392|P1|Overall Study|Treatment ongoing|4
5321603|NCT00298766|18328392|P1|Overall Study|Withdrawal by Subject|9
5321604|NCT00298766|18328392|P1|Overall Study|Death|2
5321605|NCT00298766|18328392|P1|Overall Study|Adverse Event|18
5321606|NCT00298740|18328401|P1|Overall Study|Withdrawal by Subject|3
5321607|NCT00298740|18328401|P1|Overall Study|Lack of Efficacy|6
5321608|NCT00298363|18328471|P3|Overall Study|Lack of Efficacy|0
5321609|NCT00298363|18328472|P2|Overall Study|Lack of Efficacy|3
5321610|NCT00298363|18328473|P1|Overall Study|Lack of Efficacy|2
5321611|NCT00298363|18328471|P3|Overall Study|Adverse Event|2
5321612|NCT00298363|18328472|P2|Overall Study|Adverse Event|2
5321613|NCT00298363|18328473|P1|Overall Study|Adverse Event|5
5321614|NCT00298363|18328471|P3|Overall Study|Withdrawal by Subject|3
5321615|NCT00298363|18328472|P2|Overall Study|Withdrawal by Subject|1
5321616|NCT00298363|18328473|P1|Overall Study|Withdrawal by Subject|5
5321617|NCT00298363|18328471|P3|Overall Study|Protocol Violation|0
5321618|NCT00298363|18328472|P2|Overall Study|Protocol Violation|1
5321619|NCT00298363|18328473|P1|Overall Study|Protocol Violation|1
5321620|NCT00298363|18328471|P3|Overall Study|Physician Decision|0
5321621|NCT00298363|18328472|P2|Overall Study|Physician Decision|1
5321622|NCT00298363|18328473|P1|Overall Study|Physician Decision|4
5321623|NCT00298363|18328471|P3|Overall Study|Lost to Follow-up|1
5321624|NCT00298363|18328472|P2|Overall Study|Lost to Follow-up|0
5321625|NCT00298363|18328473|P1|Overall Study|Lost to Follow-up|0
5321626|NCT00298272|18328631|P2|Safety Follow-up Phase|Administrative/Other Reason|1
5321627|NCT00298272|18328632|P1|Safety Follow-up Phase|Administrative/Other Reason|1
5321628|NCT00298272|18328631|P2|Safety Follow-up Phase|Withdrawal by Subject|2
5321629|NCT00298272|18328632|P1|Safety Follow-up Phase|Withdrawal by Subject|2
5321630|NCT00298272|18328631|P2|Safety Follow-up Phase|Failure to Return|1
5321631|NCT00298272|18328632|P1|Safety Follow-up Phase|Failure to Return|1
5321632|NCT00298272|18328631|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
5321633|NCT00298272|18328632|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
5321634|NCT00298272|18328631|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
5321635|NCT00298272|18328632|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
5321636|NCT00298272|18328631|P2|Open Label Retreatment Phase|Protocol Violation|1
5321637|NCT00298272|18328632|P1|Open Label Retreatment Phase|Protocol Violation|2
5321638|NCT00298272|18328631|P2|Open Label Retreatment Phase|Failure to Return|0
5321639|NCT00298272|18328632|P1|Open Label Retreatment Phase|Failure to Return|1
5321640|NCT00298272|18328631|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
5321641|NCT00298272|18328632|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
5321642|NCT00298272|18328631|P2|Open Label Retreatment Phase|Adverse Event|2
5321643|NCT00298272|18328632|P1|Open Label Retreatment Phase|Adverse Event|1
5321644|NCT00298272|18328631|P2|Double-blind Phase|Withdrawal by Subject|0
5321645|NCT00298272|18328632|P1|Double-blind Phase|Withdrawal by Subject|2
5321646|NCT00298272|18328631|P2|Double-blind Phase|Protocol Violation|0
5321647|NCT00298272|18328632|P1|Double-blind Phase|Protocol Violation|2
5321648|NCT00298272|18328631|P2|Double-blind Phase|Failure to Return|0
5321649|NCT00298272|18328632|P1|Double-blind Phase|Failure to Return|2
5321650|NCT00298272|18328631|P2|Double-blind Phase|Adverse Event|0
5321651|NCT00298272|18328632|P1|Double-blind Phase|Adverse Event|2
5321652|NCT00298038|18328696|P2|Overall Study|Severe Gastrointestinal Bleed|0
5321653|NCT00298038|18328697|P1|Overall Study|Severe Gastrointestinal Bleed|1
5321654|NCT00298038|18328696|P2|Overall Study|Cocaine Abuse|0
5321655|NCT00298038|18328697|P1|Overall Study|Cocaine Abuse|1
5321656|NCT00298038|18328696|P2|Overall Study|Noncompliance|0
5321657|NCT00298038|18328697|P1|Overall Study|Noncompliance|1
5321658|NCT00298038|18328696|P2|Overall Study|Breakthrough overt HE episode|69
5321659|NCT00298038|18328697|P1|Overall Study|Breakthrough overt HE episode|28
5321660|NCT00298038|18328696|P2|Overall Study|Adverse Event|7
5321661|NCT00298038|18328697|P1|Overall Study|Adverse Event|8
5321662|NCT00298038|18328696|P2|Overall Study|Withdrawal by Subject|9
5321663|NCT00298038|18328697|P1|Overall Study|Withdrawal by Subject|6
5321664|NCT00298038|18328696|P2|Overall Study|Death|3
5321665|NCT00298038|18328697|P1|Overall Study|Death|6
5321666|NCT00298038|18328696|P2|Overall Study|Protocol Violation|3
5321667|NCT00298038|18328697|P1|Overall Study|Protocol Violation|1
5321668|NCT00298038|18328696|P2|Overall Study|Liver Transplant|1
5321669|NCT00298038|18328697|P1|Overall Study|Liver Transplant|0
5321670|NCT00298038|18328696|P2|Overall Study|Lost to Follow-up|1
5321671|NCT00298038|18328697|P1|Overall Study|Lost to Follow-up|0
5321672|NCT00297830|18328716|P3|12 Month Visit|Withdrawal by Subject|0
5321673|NCT00297830|18328717|P2|12 Month Visit|Withdrawal by Subject|3
5321674|NCT00297830|18328718|P1|12 Month Visit|Withdrawal by Subject|0
5321675|NCT00297830|18328716|P3|12 Month Visit|Adverse Event|0
5321676|NCT00297830|18328717|P2|12 Month Visit|Adverse Event|3
5321677|NCT00297830|18328718|P1|12 Month Visit|Adverse Event|0
5321678|NCT00297830|18328716|P3|12 Month Visit|Lost to Follow-up|0
5321679|NCT00297830|18328717|P2|12 Month Visit|Lost to Follow-up|0
5321680|NCT00297830|18328718|P1|12 Month Visit|Lost to Follow-up|1
5321681|NCT00297830|18328716|P3|6 Month Visit|Adverse Event|0
5321682|NCT00297830|18328717|P2|6 Month Visit|Adverse Event|1
5321683|NCT00297830|18328718|P1|6 Month Visit|Adverse Event|0
5321684|NCT00297830|18328716|P3|6 Month Visit|Withdrawal by Subject|1
5321685|NCT00297830|18328717|P2|6 Month Visit|Withdrawal by Subject|1
5321686|NCT00297830|18328718|P1|6 Month Visit|Withdrawal by Subject|2
5321687|NCT00297830|18328716|P3|6 Month Visit|Death|2
5321688|NCT00297830|18328717|P2|6 Month Visit|Death|0
5321689|NCT00297830|18328718|P1|6 Month Visit|Death|1
5321690|NCT00297778|18328737|P2|Overall Study|Other|1
5321691|NCT00297778|18328738|P1|Overall Study|Other|0
5321692|NCT00297778|18328737|P2|Overall Study|Non-compliant with trial protocol|3
5321693|NCT00297778|18328738|P1|Overall Study|Non-compliant with trial protocol|0
5321694|NCT00297778|18328737|P2|Overall Study|Lack of Efficacy|1
5321695|NCT00297778|18328738|P1|Overall Study|Lack of Efficacy|2
5321696|NCT00297778|18328737|P2|Overall Study|Withdrawal by Subject|5
5321697|NCT00297778|18328738|P1|Overall Study|Withdrawal by Subject|1
5321698|NCT00297778|18328737|P2|Overall Study|Adverse Event|10
5321699|NCT00297778|18328738|P1|Overall Study|Adverse Event|16
5321700|NCT00297648|18328772|P1|Overall Study|Other: Incompliance|1
5321701|NCT00297648|18328772|P1|Overall Study|Withdrawal by Subject|3
5321702|NCT00297648|18328772|P1|Overall Study|Lost to Follow-up|1
5321703|NCT00297648|18328772|P1|Overall Study|Lack of Efficacy|18
5321704|NCT00297648|18328772|P1|Overall Study|Adverse Event|13
5321705|NCT00297492|18328818|P3|6 Month Follow-up|Lost to Follow-up|27
5321706|NCT00297492|18328819|P2|6 Month Follow-up|Lost to Follow-up|49
5321707|NCT00297492|18328820|P1|6 Month Follow-up|Lost to Follow-up|63
5321708|NCT00297492|18328818|P3|Set Quit Date|Lost to Follow-up|5
5321709|NCT00297492|18328819|P2|Set Quit Date|Lost to Follow-up|13
5321710|NCT00297492|18328820|P1|Set Quit Date|Lost to Follow-up|7
5321711|NCT00297479|18328831|P3|Overall Study|Lost to Follow-up|51
5321712|NCT00297479|18328832|P2|Overall Study|Lost to Follow-up|54
5321713|NCT00297479|18328833|P1|Overall Study|Lost to Follow-up|37
5321714|NCT00297427|18328852|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
5321715|NCT00297427|18328853|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
5321716|NCT00297427|18328852|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
5321717|NCT00297427|18328853|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
5321718|NCT00297427|18328852|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
5321719|NCT00297427|18328853|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
5321720|NCT00297427|18328852|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
5321721|NCT00297427|18328853|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
5321722|NCT00297427|18328852|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
5321723|NCT00297427|18328853|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
5321724|NCT00297427|18328852|P2|Phase 1: Initial Intervention|Death|1
5321725|NCT00297427|18328853|P1|Phase 1: Initial Intervention|Death|0
5321726|NCT00297427|18328852|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
5321727|NCT00297427|18328853|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
5321728|NCT00297427|18328852|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
5321729|NCT00297427|18328853|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
5321730|NCT00297258|18328894|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
5321731|NCT00297258|18328894|P1|Overall Study|Switch to Commercial Treatment|1
5321732|NCT00297258|18328894|P1|Overall Study|Surgery Performed on Target Lesion|1
5321733|NCT00297258|18328894|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
5321734|NCT00297258|18328894|P1|Overall Study|Deteriorization of General Condition|1
5321735|NCT00297258|18328894|P1|Overall Study|Intercurrent Death|2
5321736|NCT00297258|18328894|P1|Overall Study|Intercurrent Illness|3
5321737|NCT00297258|18328894|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
5321738|NCT00297258|18328894|P1|Overall Study|Toxicity (or Toxic Death)|10
5321739|NCT00297258|18328894|P1|Overall Study|Disease Progression, Relapse, Death|120
5321740|NCT00297232|18328913|P1|Overall Study|Other|1
5321741|NCT00297232|18328913|P1|Overall Study|No data available after Week 264|161
5321742|NCT00297232|18328913|P1|Overall Study|Did Not Enroll to Week 480|17
5321743|NCT00297232|18328913|P1|Overall Study|Did Not Enroll to Week 264|34
5321744|NCT00297232|18328913|P1|Overall Study|Investigator Withdrew From Program|19
5321745|NCT00297232|18328913|P1|Overall Study|Persistently Positive Antibodies|11
5321746|NCT00297232|18328913|P1|Overall Study|Subject Withdrew Consent|37
5321747|NCT00297232|18328913|P1|Overall Study|Subject Relocated|7
5321748|NCT00297232|18328913|P1|Overall Study|Sponsor Decision|34
5321749|NCT00297232|18328913|P1|Overall Study|Miscellaneous|5
5321750|NCT00297232|18328913|P1|Overall Study|Anti-JCV Antibody Positive|13
5321751|NCT00297232|18328913|P1|Overall Study|Fear of PML|10
5321752|NCT00297232|18328913|P1|Overall Study|Disease Progression|8
5321753|NCT00297232|18328913|P1|Overall Study|Switched to Commercial Tysabri|22
5321754|NCT00297232|18328913|P1|Overall Study|Anti-natalizumab Positive|8
5321755|NCT00297232|18328913|P1|Overall Study|Death|9
5321756|NCT00297232|18328913|P1|Overall Study|Subject was Noncompliant|9
5321757|NCT00297232|18328913|P1|Overall Study|Voluntary Withdrawal|120
5321758|NCT00297232|18328913|P1|Overall Study|Adverse Event|63
5321759|NCT00297232|18328913|P1|Overall Study|Lost to Follow-up|10
5321760|NCT00297232|18328913|P1|Overall Study|Lack of Efficacy|7
5321761|NCT00297167|18328919|P3|Second Double-blind Intervention Period|Protocol Violation|0
5321762|NCT00297167|18328920|P2|Second Double-blind Intervention Period|Protocol Violation|0
5321763|NCT00297167|18328921|P1|Second Double-blind Intervention Period|Protocol Violation|1
5321764|NCT00297167|18328919|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
5321765|NCT00297167|18328920|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
5321766|NCT00297167|18328921|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
5321767|NCT00297037|18328985|P2|Overall Study|Withdrawal by Subject|0
5321768|NCT00297037|18328986|P1|Overall Study|Withdrawal by Subject|2
5321769|NCT00296816|18328998|P1|Overall Study|ineligibility due to radiation treatment|1
5321770|NCT00296816|18328998|P1|Overall Study|Proteinuria|1
5321771|NCT00296816|18328998|P1|Overall Study|Neuropathy/patient preference|1
5321772|NCT00296816|18328998|P1|Overall Study|Urine protein/creatinine ratio delay|1
5321773|NCT00296816|18328998|P1|Overall Study|Noncompliance/decision to discontinue|1
5321774|NCT00296816|18328998|P1|Overall Study|Relocation to Florida|1
5321775|NCT00296816|18328998|P1|Overall Study|Poor performance status|1
5321776|NCT00296816|18328998|P1|Overall Study|Progression based on CA-125 (biomarker)|2
5321777|NCT00296816|18328998|P1|Overall Study|Missing for end of treatment|4
5321778|NCT00296816|18328998|P1|Overall Study|Non-compliance|1
5321779|NCT00296816|18328998|P1|Overall Study|Investigator/Participant request|5
5321780|NCT00296816|18328998|P1|Overall Study|Adverse Event|18
5321781|NCT00296816|18328998|P1|Overall Study|Disease Progression|37
5321782|NCT00296725|18329010|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
5321783|NCT00296725|18329010|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
5321784|NCT00296725|18329010|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
5321785|NCT00296647|18329023|P5|Overall Study|Withdrawal by Subject|19
5321786|NCT00296647|18329024|P4|Overall Study|Withdrawal by Subject|16
5321787|NCT00296647|18329025|P3|Overall Study|Withdrawal by Subject|32
5321788|NCT00296647|18329026|P2|Overall Study|Withdrawal by Subject|27
5321789|NCT00296647|18329027|P1|Overall Study|Withdrawal by Subject|28
5321790|NCT00296647|18329023|P5|Overall Study|Death|1
5321791|NCT00296647|18329024|P4|Overall Study|Death|1
5321792|NCT00296647|18329025|P3|Overall Study|Death|2
5321793|NCT00296647|18329026|P2|Overall Study|Death|1
5321794|NCT00296647|18329027|P1|Overall Study|Death|4
5321795|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Other|2
5321796|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Other|0
5321797|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
5321798|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
5321799|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
5321800|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
5321801|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
5321802|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
5321803|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
5321804|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
5321805|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
5321806|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
5321807|NCT00296517|18329041|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
5321808|NCT00296517|18329042|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
5321809|NCT00296517|18329041|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
5321810|NCT00296517|18329042|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
5321811|NCT00296517|18329041|P2|Dose Level 2 - Week 2|Adverse Event|5
5321812|NCT00296517|18329042|P1|Dose Level 2 - Week 2|Adverse Event|1
5321813|NCT00296504|18329078|P9|Final Analysis|Poor Adherence|1
5321814|NCT00296504|18329079|P8|Final Analysis|Poor Adherence|0
5321815|NCT00296504|18329080|P7|Final Analysis|Poor Adherence|0
5321816|NCT00296504|18329081|P6|Final Analysis|Poor Adherence|0
5321817|NCT00296504|18329082|P5|Final Analysis|Poor Adherence|0
5321818|NCT00296504|18329083|P4|Final Analysis|Poor Adherence|0
5321819|NCT00296504|18329084|P3|Final Analysis|Poor Adherence|0
5321820|NCT00296504|18329085|P2|Final Analysis|Poor Adherence|0
5321821|NCT00296504|18329086|P1|Final Analysis|Poor Adherence|0
5321822|NCT00296504|18329078|P9|Final Analysis|Participant Moved to Another Country|1
5321823|NCT00296504|18329079|P8|Final Analysis|Participant Moved to Another Country|0
5321824|NCT00296504|18329080|P7|Final Analysis|Participant Moved to Another Country|0
5321825|NCT00296504|18329081|P6|Final Analysis|Participant Moved to Another Country|0
5321826|NCT00296504|18329082|P5|Final Analysis|Participant Moved to Another Country|0
5321827|NCT00296504|18329083|P4|Final Analysis|Participant Moved to Another Country|0
5321828|NCT00296504|18329084|P3|Final Analysis|Participant Moved to Another Country|0
5321829|NCT00296504|18329085|P2|Final Analysis|Participant Moved to Another Country|0
5321830|NCT00296504|18329086|P1|Final Analysis|Participant Moved to Another Country|0
5321831|NCT00296504|18329078|P9|Final Analysis|Tuberculosis|1
5321832|NCT00296504|18329079|P8|Final Analysis|Tuberculosis|0
5321833|NCT00296504|18329080|P7|Final Analysis|Tuberculosis|0
5321834|NCT00296504|18329081|P6|Final Analysis|Tuberculosis|0
5321835|NCT00296504|18329082|P5|Final Analysis|Tuberculosis|0
5321836|NCT00296504|18329083|P4|Final Analysis|Tuberculosis|0
5321837|NCT00296504|18329084|P3|Final Analysis|Tuberculosis|0
5321838|NCT00296504|18329085|P2|Final Analysis|Tuberculosis|0
5321839|NCT00296504|18329086|P1|Final Analysis|Tuberculosis|0
5321840|NCT00296504|18329078|P9|Final Analysis|Pregnancy|4
5321841|NCT00296504|18329079|P8|Final Analysis|Pregnancy|0
5321842|NCT00296504|18329080|P7|Final Analysis|Pregnancy|0
5321843|NCT00296504|18329081|P6|Final Analysis|Pregnancy|0
5321844|NCT00296504|18329082|P5|Final Analysis|Pregnancy|0
5321845|NCT00296504|18329083|P4|Final Analysis|Pregnancy|0
5321846|NCT00296504|18329084|P3|Final Analysis|Pregnancy|0
5321847|NCT00296504|18329085|P2|Final Analysis|Pregnancy|0
5321848|NCT00296504|18329086|P1|Final Analysis|Pregnancy|0
5321849|NCT00296504|18329078|P9|Final Analysis|Adverse Event|2
5321850|NCT00296504|18329079|P8|Final Analysis|Adverse Event|0
5321851|NCT00296504|18329080|P7|Final Analysis|Adverse Event|0
5321852|NCT00296504|18329081|P6|Final Analysis|Adverse Event|0
5321853|NCT00296504|18329082|P5|Final Analysis|Adverse Event|0
5321854|NCT00296504|18329083|P4|Final Analysis|Adverse Event|0
5321855|NCT00296504|18329084|P3|Final Analysis|Adverse Event|0
5321856|NCT00296504|18329085|P2|Final Analysis|Adverse Event|0
5321857|NCT00296504|18329086|P1|Final Analysis|Adverse Event|0
5321858|NCT00296504|18329078|P9|Final Analysis|Insufficient Viral Load Response|6
5321859|NCT00296504|18329079|P8|Final Analysis|Insufficient Viral Load Response|0
5321860|NCT00296504|18329080|P7|Final Analysis|Insufficient Viral Load Response|0
5321861|NCT00296504|18329081|P6|Final Analysis|Insufficient Viral Load Response|0
5321862|NCT00296504|18329082|P5|Final Analysis|Insufficient Viral Load Response|0
5321863|NCT00296504|18329083|P4|Final Analysis|Insufficient Viral Load Response|0
5321864|NCT00296504|18329084|P3|Final Analysis|Insufficient Viral Load Response|0
5321865|NCT00296504|18329085|P2|Final Analysis|Insufficient Viral Load Response|0
5321866|NCT00296504|18329086|P1|Final Analysis|Insufficient Viral Load Response|0
5321867|NCT00296504|18329078|P9|Final Analysis|Lost to Follow-up|5
5321868|NCT00296504|18329079|P8|Final Analysis|Lost to Follow-up|0
5321869|NCT00296504|18329080|P7|Final Analysis|Lost to Follow-up|0
5321870|NCT00296504|18329081|P6|Final Analysis|Lost to Follow-up|0
5321871|NCT00296504|18329082|P5|Final Analysis|Lost to Follow-up|0
5321872|NCT00296504|18329083|P4|Final Analysis|Lost to Follow-up|0
5321873|NCT00296504|18329084|P3|Final Analysis|Lost to Follow-up|0
5321874|NCT00296504|18329085|P2|Final Analysis|Lost to Follow-up|0
5321875|NCT00296504|18329086|P1|Final Analysis|Lost to Follow-up|0
5321876|NCT00296504|18329078|P9|Final Analysis|Withdrawal by Subject|1
5321877|NCT00296504|18329079|P8|Final Analysis|Withdrawal by Subject|0
5321878|NCT00296504|18329080|P7|Final Analysis|Withdrawal by Subject|0
5321879|NCT00296504|18329081|P6|Final Analysis|Withdrawal by Subject|0
5321880|NCT00296504|18329082|P5|Final Analysis|Withdrawal by Subject|0
5321881|NCT00296504|18329083|P4|Final Analysis|Withdrawal by Subject|0
5321882|NCT00296504|18329084|P3|Final Analysis|Withdrawal by Subject|0
5321883|NCT00296504|18329085|P2|Final Analysis|Withdrawal by Subject|0
5321884|NCT00296504|18329086|P1|Final Analysis|Withdrawal by Subject|0
5321885|NCT00296504|18329078|P9|Interim Analysis|Ongoing|0
5321886|NCT00296504|18329079|P8|Interim Analysis|Ongoing|1
5321887|NCT00296504|18329080|P7|Interim Analysis|Ongoing|30
5321888|NCT00296504|18329081|P6|Interim Analysis|Ongoing|0
5321889|NCT00296504|18329082|P5|Interim Analysis|Ongoing|0
5321890|NCT00296504|18329083|P4|Interim Analysis|Ongoing|22
5321891|NCT00296504|18329084|P3|Interim Analysis|Ongoing|16
5321892|NCT00296504|18329085|P2|Interim Analysis|Ongoing|12
5321893|NCT00296504|18329086|P1|Interim Analysis|Ongoing|32
5321894|NCT00296504|18329078|P9|Interim Analysis|Participant Needed Interferon|0
5321895|NCT00296504|18329079|P8|Interim Analysis|Participant Needed Interferon|1
5321896|NCT00296504|18329080|P7|Interim Analysis|Participant Needed Interferon|0
5321897|NCT00296504|18329081|P6|Interim Analysis|Participant Needed Interferon|0
5321898|NCT00296504|18329082|P5|Interim Analysis|Participant Needed Interferon|0
5321899|NCT00296504|18329083|P4|Interim Analysis|Participant Needed Interferon|0
5321900|NCT00296504|18329084|P3|Interim Analysis|Participant Needed Interferon|0
5321901|NCT00296504|18329085|P2|Interim Analysis|Participant Needed Interferon|0
5321902|NCT00296504|18329086|P1|Interim Analysis|Participant Needed Interferon|0
5321903|NCT00296504|18329078|P9|Interim Analysis|Study Ended|0
5321904|NCT00296504|18329079|P8|Interim Analysis|Study Ended|0
5321905|NCT00296504|18329080|P7|Interim Analysis|Study Ended|1
5321906|NCT00296504|18329081|P6|Interim Analysis|Study Ended|0
5321907|NCT00296504|18329082|P5|Interim Analysis|Study Ended|0
5321908|NCT00296504|18329083|P4|Interim Analysis|Study Ended|0
5321909|NCT00296504|18329084|P3|Interim Analysis|Study Ended|0
5321910|NCT00296504|18329085|P2|Interim Analysis|Study Ended|0
5321911|NCT00296504|18329086|P1|Interim Analysis|Study Ended|0
5321912|NCT00296504|18329078|P9|Interim Analysis|Participant Stopped HIV Medications|0
5321913|NCT00296504|18329079|P8|Interim Analysis|Participant Stopped HIV Medications|0
5321914|NCT00296504|18329080|P7|Interim Analysis|Participant Stopped HIV Medications|1
5321915|NCT00296504|18329081|P6|Interim Analysis|Participant Stopped HIV Medications|0
5321916|NCT00296504|18329082|P5|Interim Analysis|Participant Stopped HIV Medications|0
5321917|NCT00296504|18329083|P4|Interim Analysis|Participant Stopped HIV Medications|0
5321918|NCT00296504|18329084|P3|Interim Analysis|Participant Stopped HIV Medications|0
5321919|NCT00296504|18329085|P2|Interim Analysis|Participant Stopped HIV Medications|0
5321920|NCT00296504|18329086|P1|Interim Analysis|Participant Stopped HIV Medications|0
5321921|NCT00296504|18329078|P9|Interim Analysis|Physician and Participant Decision|0
5321922|NCT00296504|18329079|P8|Interim Analysis|Physician and Participant Decision|0
5321923|NCT00296504|18329080|P7|Interim Analysis|Physician and Participant Decision|0
5321924|NCT00296504|18329081|P6|Interim Analysis|Physician and Participant Decision|1
5321925|NCT00296504|18329082|P5|Interim Analysis|Physician and Participant Decision|0
5321926|NCT00296504|18329083|P4|Interim Analysis|Physician and Participant Decision|0
5321927|NCT00296504|18329084|P3|Interim Analysis|Physician and Participant Decision|0
5321928|NCT00296504|18329085|P2|Interim Analysis|Physician and Participant Decision|0
5321929|NCT00296504|18329086|P1|Interim Analysis|Physician and Participant Decision|0
5321930|NCT00296504|18329078|P9|Interim Analysis|Participant Stopped|0
5321931|NCT00296504|18329079|P8|Interim Analysis|Participant Stopped|0
5321932|NCT00296504|18329080|P7|Interim Analysis|Participant Stopped|0
5321933|NCT00296504|18329081|P6|Interim Analysis|Participant Stopped|0
5321934|NCT00296504|18329082|P5|Interim Analysis|Participant Stopped|1
5321935|NCT00296504|18329083|P4|Interim Analysis|Participant Stopped|0
5321936|NCT00296504|18329084|P3|Interim Analysis|Participant Stopped|0
5321937|NCT00296504|18329085|P2|Interim Analysis|Participant Stopped|0
5321938|NCT00296504|18329086|P1|Interim Analysis|Participant Stopped|0
5321939|NCT00296504|18329078|P9|Interim Analysis|Inclusion in Other Protocol|0
5321940|NCT00296504|18329079|P8|Interim Analysis|Inclusion in Other Protocol|0
5321941|NCT00296504|18329080|P7|Interim Analysis|Inclusion in Other Protocol|0
5321942|NCT00296504|18329081|P6|Interim Analysis|Inclusion in Other Protocol|0
5321943|NCT00296504|18329082|P5|Interim Analysis|Inclusion in Other Protocol|0
5321944|NCT00296504|18329083|P4|Interim Analysis|Inclusion in Other Protocol|1
5321945|NCT00296504|18329084|P3|Interim Analysis|Inclusion in Other Protocol|0
5321946|NCT00296504|18329085|P2|Interim Analysis|Inclusion in Other Protocol|0
5321947|NCT00296504|18329086|P1|Interim Analysis|Inclusion in Other Protocol|0
5321948|NCT00296504|18329078|P9|Interim Analysis|Missed Schedule Date|0
5321949|NCT00296504|18329079|P8|Interim Analysis|Missed Schedule Date|0
5321950|NCT00296504|18329080|P7|Interim Analysis|Missed Schedule Date|0
5321951|NCT00296504|18329081|P6|Interim Analysis|Missed Schedule Date|0
5321952|NCT00296504|18329082|P5|Interim Analysis|Missed Schedule Date|0
5321953|NCT00296504|18329083|P4|Interim Analysis|Missed Schedule Date|0
5321954|NCT00296504|18329084|P3|Interim Analysis|Missed Schedule Date|0
5321955|NCT00296504|18329085|P2|Interim Analysis|Missed Schedule Date|0
5321956|NCT00296504|18329086|P1|Interim Analysis|Missed Schedule Date|1
5321957|NCT00296504|18329078|P9|Interim Analysis|Lack of Personnel at Site|0
5321958|NCT00296504|18329079|P8|Interim Analysis|Lack of Personnel at Site|0
5321959|NCT00296504|18329080|P7|Interim Analysis|Lack of Personnel at Site|0
5321960|NCT00296504|18329081|P6|Interim Analysis|Lack of Personnel at Site|0
5321961|NCT00296504|18329082|P5|Interim Analysis|Lack of Personnel at Site|0
5321962|NCT00296504|18329083|P4|Interim Analysis|Lack of Personnel at Site|0
5321963|NCT00296504|18329084|P3|Interim Analysis|Lack of Personnel at Site|0
5321964|NCT00296504|18329085|P2|Interim Analysis|Lack of Personnel at Site|0
5321965|NCT00296504|18329086|P1|Interim Analysis|Lack of Personnel at Site|1
5321966|NCT00296504|18329078|P9|Interim Analysis|Site Closing|0
5321967|NCT00296504|18329079|P8|Interim Analysis|Site Closing|0
5321968|NCT00296504|18329080|P7|Interim Analysis|Site Closing|2
5321969|NCT00296504|18329081|P6|Interim Analysis|Site Closing|1
5321970|NCT00296504|18329082|P5|Interim Analysis|Site Closing|0
5321971|NCT00296504|18329083|P4|Interim Analysis|Site Closing|0
5321972|NCT00296504|18329084|P3|Interim Analysis|Site Closing|0
5321973|NCT00296504|18329085|P2|Interim Analysis|Site Closing|0
5321974|NCT00296504|18329086|P1|Interim Analysis|Site Closing|1
5321975|NCT00296504|18329078|P9|Interim Analysis|Non-adherence|0
5321976|NCT00296504|18329079|P8|Interim Analysis|Non-adherence|1
5321977|NCT00296504|18329080|P7|Interim Analysis|Non-adherence|0
5321978|NCT00296504|18329081|P6|Interim Analysis|Non-adherence|0
5321979|NCT00296504|18329082|P5|Interim Analysis|Non-adherence|1
5321980|NCT00296504|18329083|P4|Interim Analysis|Non-adherence|0
5321981|NCT00296504|18329084|P3|Interim Analysis|Non-adherence|0
5321982|NCT00296504|18329085|P2|Interim Analysis|Non-adherence|0
5321983|NCT00296504|18329086|P1|Interim Analysis|Non-adherence|2
5321984|NCT00296504|18329078|P9|Interim Analysis|Principle Investigator Terminated Study|0
5321985|NCT00296504|18329079|P8|Interim Analysis|Principle Investigator Terminated Study|0
5321986|NCT00296504|18329080|P7|Interim Analysis|Principle Investigator Terminated Study|0
5321987|NCT00296504|18329081|P6|Interim Analysis|Principle Investigator Terminated Study|0
5321988|NCT00296504|18329082|P5|Interim Analysis|Principle Investigator Terminated Study|0
5321989|NCT00296504|18329083|P4|Interim Analysis|Principle Investigator Terminated Study|0
5321990|NCT00296504|18329084|P3|Interim Analysis|Principle Investigator Terminated Study|1
5321991|NCT00296504|18329085|P2|Interim Analysis|Principle Investigator Terminated Study|0
5321992|NCT00296504|18329086|P1|Interim Analysis|Principle Investigator Terminated Study|0
5321993|NCT00296504|18329078|P9|Interim Analysis|Principle Investigator Discretion|0
5321994|NCT00296504|18329079|P8|Interim Analysis|Principle Investigator Discretion|0
5321995|NCT00296504|18329080|P7|Interim Analysis|Principle Investigator Discretion|0
5321996|NCT00296504|18329081|P6|Interim Analysis|Principle Investigator Discretion|0
5321997|NCT00296504|18329082|P5|Interim Analysis|Principle Investigator Discretion|0
5321998|NCT00296504|18329083|P4|Interim Analysis|Principle Investigator Discretion|1
5321999|NCT00296504|18329084|P3|Interim Analysis|Principle Investigator Discretion|1
5322000|NCT00296504|18329085|P2|Interim Analysis|Principle Investigator Discretion|0
5322001|NCT00296504|18329086|P1|Interim Analysis|Principle Investigator Discretion|2
5322002|NCT00296504|18329078|P9|Interim Analysis|Physician Decision|0
5322003|NCT00296504|18329079|P8|Interim Analysis|Physician Decision|0
5322004|NCT00296504|18329080|P7|Interim Analysis|Physician Decision|0
5322005|NCT00296504|18329081|P6|Interim Analysis|Physician Decision|0
5322006|NCT00296504|18329082|P5|Interim Analysis|Physician Decision|0
5322007|NCT00296504|18329083|P4|Interim Analysis|Physician Decision|0
5322008|NCT00296504|18329084|P3|Interim Analysis|Physician Decision|1
5322009|NCT00296504|18329085|P2|Interim Analysis|Physician Decision|0
5322010|NCT00296504|18329086|P1|Interim Analysis|Physician Decision|0
5322011|NCT00296504|18329078|P9|Interim Analysis|Resistance to FPV|0
5322012|NCT00296504|18329079|P8|Interim Analysis|Resistance to FPV|0
5322013|NCT00296504|18329080|P7|Interim Analysis|Resistance to FPV|0
5322014|NCT00296504|18329081|P6|Interim Analysis|Resistance to FPV|0
5322015|NCT00296504|18329082|P5|Interim Analysis|Resistance to FPV|0
5322016|NCT00296504|18329083|P4|Interim Analysis|Resistance to FPV|0
5322017|NCT00296504|18329084|P3|Interim Analysis|Resistance to FPV|1
5322018|NCT00296504|18329085|P2|Interim Analysis|Resistance to FPV|0
5322019|NCT00296504|18329086|P1|Interim Analysis|Resistance to FPV|0
5322020|NCT00296504|18329078|P9|Interim Analysis|Participant Was Incarcerated|0
5322021|NCT00296504|18329079|P8|Interim Analysis|Participant Was Incarcerated|0
5322022|NCT00296504|18329080|P7|Interim Analysis|Participant Was Incarcerated|0
5322023|NCT00296504|18329081|P6|Interim Analysis|Participant Was Incarcerated|0
5322024|NCT00296504|18329082|P5|Interim Analysis|Participant Was Incarcerated|0
5322025|NCT00296504|18329083|P4|Interim Analysis|Participant Was Incarcerated|0
5322026|NCT00296504|18329084|P3|Interim Analysis|Participant Was Incarcerated|1
5322027|NCT00296504|18329085|P2|Interim Analysis|Participant Was Incarcerated|0
5322028|NCT00296504|18329086|P1|Interim Analysis|Participant Was Incarcerated|2
5322029|NCT00296504|18329078|P9|Interim Analysis|Participant Moved|0
5322030|NCT00296504|18329079|P8|Interim Analysis|Participant Moved|0
5322031|NCT00296504|18329080|P7|Interim Analysis|Participant Moved|1
5322032|NCT00296504|18329081|P6|Interim Analysis|Participant Moved|1
5322033|NCT00296504|18329082|P5|Interim Analysis|Participant Moved|0
5322034|NCT00296504|18329083|P4|Interim Analysis|Participant Moved|0
5322035|NCT00296504|18329084|P3|Interim Analysis|Participant Moved|1
5322036|NCT00296504|18329085|P2|Interim Analysis|Participant Moved|0
5322037|NCT00296504|18329086|P1|Interim Analysis|Participant Moved|1
5322038|NCT00296504|18329078|P9|Interim Analysis|Participant Had Problems with Alcohol|0
5322039|NCT00296504|18329079|P8|Interim Analysis|Participant Had Problems with Alcohol|0
5322040|NCT00296504|18329080|P7|Interim Analysis|Participant Had Problems with Alcohol|0
5322041|NCT00296504|18329081|P6|Interim Analysis|Participant Had Problems with Alcohol|0
5322042|NCT00296504|18329082|P5|Interim Analysis|Participant Had Problems with Alcohol|0
5322043|NCT00296504|18329083|P4|Interim Analysis|Participant Had Problems with Alcohol|0
5322044|NCT00296504|18329084|P3|Interim Analysis|Participant Had Problems with Alcohol|1
5322045|NCT00296504|18329085|P2|Interim Analysis|Participant Had Problems with Alcohol|0
5322046|NCT00296504|18329086|P1|Interim Analysis|Participant Had Problems with Alcohol|0
5322047|NCT00296504|18329078|P9|Interim Analysis|To Simplify Treatment|0
5322048|NCT00296504|18329079|P8|Interim Analysis|To Simplify Treatment|0
5322049|NCT00296504|18329080|P7|Interim Analysis|To Simplify Treatment|2
5322050|NCT00296504|18329081|P6|Interim Analysis|To Simplify Treatment|0
5322051|NCT00296504|18329082|P5|Interim Analysis|To Simplify Treatment|0
5322052|NCT00296504|18329083|P4|Interim Analysis|To Simplify Treatment|0
5322053|NCT00296504|18329084|P3|Interim Analysis|To Simplify Treatment|1
5322054|NCT00296504|18329085|P2|Interim Analysis|To Simplify Treatment|0
5322055|NCT00296504|18329086|P1|Interim Analysis|To Simplify Treatment|0
5322056|NCT00296504|18329078|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
5322057|NCT00296504|18329079|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
5322058|NCT00296504|18329080|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
5322059|NCT00296504|18329081|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
5322060|NCT00296504|18329082|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
5322061|NCT00296504|18329083|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
5322062|NCT00296504|18329084|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
5322063|NCT00296504|18329085|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
5322064|NCT00296504|18329086|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
5322065|NCT00296504|18329078|P9|Interim Analysis|Participant Non-compliant|0
5322066|NCT00296504|18329079|P8|Interim Analysis|Participant Non-compliant|2
5322067|NCT00296504|18329080|P7|Interim Analysis|Participant Non-compliant|6
5322068|NCT00296504|18329081|P6|Interim Analysis|Participant Non-compliant|3
5322069|NCT00296504|18329082|P5|Interim Analysis|Participant Non-compliant|1
5322070|NCT00296504|18329083|P4|Interim Analysis|Participant Non-compliant|1
5322071|NCT00296504|18329084|P3|Interim Analysis|Participant Non-compliant|2
5322072|NCT00296504|18329085|P2|Interim Analysis|Participant Non-compliant|1
5322073|NCT00296504|18329086|P1|Interim Analysis|Participant Non-compliant|0
5322074|NCT00296504|18329078|P9|Interim Analysis|Death|0
5322075|NCT00296504|18329079|P8|Interim Analysis|Death|0
5322076|NCT00296504|18329080|P7|Interim Analysis|Death|0
5322077|NCT00296504|18329081|P6|Interim Analysis|Death|0
5322078|NCT00296504|18329082|P5|Interim Analysis|Death|0
5322079|NCT00296504|18329083|P4|Interim Analysis|Death|0
5322080|NCT00296504|18329084|P3|Interim Analysis|Death|3
5322081|NCT00296504|18329085|P2|Interim Analysis|Death|0
5322082|NCT00296504|18329086|P1|Interim Analysis|Death|1
5322083|NCT00296504|18329078|P9|Interim Analysis|Pregnancy|0
5322084|NCT00296504|18329079|P8|Interim Analysis|Pregnancy|1
5322085|NCT00296504|18329080|P7|Interim Analysis|Pregnancy|1
5322086|NCT00296504|18329081|P6|Interim Analysis|Pregnancy|1
5322087|NCT00296504|18329082|P5|Interim Analysis|Pregnancy|0
5322088|NCT00296504|18329083|P4|Interim Analysis|Pregnancy|2
5322089|NCT00296504|18329084|P3|Interim Analysis|Pregnancy|4
5322090|NCT00296504|18329085|P2|Interim Analysis|Pregnancy|1
5322091|NCT00296504|18329086|P1|Interim Analysis|Pregnancy|4
5322092|NCT00296504|18329078|P9|Interim Analysis|Switched to Commercially Available Drug|0
5322093|NCT00296504|18329079|P8|Interim Analysis|Switched to Commercially Available Drug|4
5322094|NCT00296504|18329080|P7|Interim Analysis|Switched to Commercially Available Drug|3
5322095|NCT00296504|18329081|P6|Interim Analysis|Switched to Commercially Available Drug|5
5322096|NCT00296504|18329082|P5|Interim Analysis|Switched to Commercially Available Drug|0
5322097|NCT00296504|18329083|P4|Interim Analysis|Switched to Commercially Available Drug|1
5322098|NCT00296504|18329084|P3|Interim Analysis|Switched to Commercially Available Drug|4
5322099|NCT00296504|18329085|P2|Interim Analysis|Switched to Commercially Available Drug|0
5322100|NCT00296504|18329086|P1|Interim Analysis|Switched to Commercially Available Drug|2
5322101|NCT00296504|18329078|P9|Interim Analysis|Insufficient CD4 Response|0
5322102|NCT00296504|18329079|P8|Interim Analysis|Insufficient CD4 Response|0
5322103|NCT00296504|18329080|P7|Interim Analysis|Insufficient CD4 Response|0
5322104|NCT00296504|18329081|P6|Interim Analysis|Insufficient CD4 Response|1
5322105|NCT00296504|18329082|P5|Interim Analysis|Insufficient CD4 Response|1
5322106|NCT00296504|18329083|P4|Interim Analysis|Insufficient CD4 Response|0
5322107|NCT00296504|18329084|P3|Interim Analysis|Insufficient CD4 Response|0
5322108|NCT00296504|18329085|P2|Interim Analysis|Insufficient CD4 Response|0
5322109|NCT00296504|18329086|P1|Interim Analysis|Insufficient CD4 Response|0
5322110|NCT00296504|18329078|P9|Interim Analysis|Protocol Violation|0
5322111|NCT00296504|18329079|P8|Interim Analysis|Protocol Violation|1
5322112|NCT00296504|18329080|P7|Interim Analysis|Protocol Violation|0
5322113|NCT00296504|18329081|P6|Interim Analysis|Protocol Violation|0
5322114|NCT00296504|18329082|P5|Interim Analysis|Protocol Violation|1
5322115|NCT00296504|18329083|P4|Interim Analysis|Protocol Violation|0
5322116|NCT00296504|18329084|P3|Interim Analysis|Protocol Violation|2
5322117|NCT00296504|18329085|P2|Interim Analysis|Protocol Violation|0
5322118|NCT00296504|18329086|P1|Interim Analysis|Protocol Violation|0
5322119|NCT00296504|18329078|P9|Interim Analysis|Adverse Event|0
5322120|NCT00296504|18329079|P8|Interim Analysis|Adverse Event|5
5322121|NCT00296504|18329080|P7|Interim Analysis|Adverse Event|4
5322122|NCT00296504|18329081|P6|Interim Analysis|Adverse Event|3
5322123|NCT00296504|18329082|P5|Interim Analysis|Adverse Event|6
5322124|NCT00296504|18329083|P4|Interim Analysis|Adverse Event|4
5322125|NCT00296504|18329084|P3|Interim Analysis|Adverse Event|13
5322126|NCT00296504|18329085|P2|Interim Analysis|Adverse Event|0
5322127|NCT00296504|18329086|P1|Interim Analysis|Adverse Event|0
5322128|NCT00296504|18329078|P9|Interim Analysis|Insufficient Viral Load Response|0
5322129|NCT00296504|18329079|P8|Interim Analysis|Insufficient Viral Load Response|24
5322130|NCT00296504|18329080|P7|Interim Analysis|Insufficient Viral Load Response|2
5322131|NCT00296504|18329081|P6|Interim Analysis|Insufficient Viral Load Response|9
5322132|NCT00296504|18329082|P5|Interim Analysis|Insufficient Viral Load Response|7
5322133|NCT00296504|18329083|P4|Interim Analysis|Insufficient Viral Load Response|2
5322134|NCT00296504|18329084|P3|Interim Analysis|Insufficient Viral Load Response|12
5322135|NCT00296504|18329085|P2|Interim Analysis|Insufficient Viral Load Response|1
5322136|NCT00296504|18329086|P1|Interim Analysis|Insufficient Viral Load Response|5
5322137|NCT00296504|18329078|P9|Interim Analysis|Clinical Progression|0
5322138|NCT00296504|18329079|P8|Interim Analysis|Clinical Progression|2
5322139|NCT00296504|18329080|P7|Interim Analysis|Clinical Progression|1
5322140|NCT00296504|18329081|P6|Interim Analysis|Clinical Progression|2
5322141|NCT00296504|18329082|P5|Interim Analysis|Clinical Progression|0
5322142|NCT00296504|18329083|P4|Interim Analysis|Clinical Progression|1
5322143|NCT00296504|18329084|P3|Interim Analysis|Clinical Progression|1
5322144|NCT00296504|18329085|P2|Interim Analysis|Clinical Progression|0
5322145|NCT00296504|18329086|P1|Interim Analysis|Clinical Progression|1
5322146|NCT00296504|18329078|P9|Interim Analysis|Lost to Follow-up|0
5322147|NCT00296504|18329079|P8|Interim Analysis|Lost to Follow-up|4
5322148|NCT00296504|18329080|P7|Interim Analysis|Lost to Follow-up|11
5322149|NCT00296504|18329081|P6|Interim Analysis|Lost to Follow-up|4
5322150|NCT00296504|18329082|P5|Interim Analysis|Lost to Follow-up|14
5322151|NCT00296504|18329083|P4|Interim Analysis|Lost to Follow-up|8
5322152|NCT00296504|18329084|P3|Interim Analysis|Lost to Follow-up|26
5322153|NCT00296504|18329085|P2|Interim Analysis|Lost to Follow-up|3
5322154|NCT00296504|18329086|P1|Interim Analysis|Lost to Follow-up|13
5322155|NCT00296504|18329078|P9|Interim Analysis|Withdrawal by Subject|0
5322156|NCT00296504|18329079|P8|Interim Analysis|Withdrawal by Subject|3
5322157|NCT00296504|18329080|P7|Interim Analysis|Withdrawal by Subject|9
5322158|NCT00296504|18329081|P6|Interim Analysis|Withdrawal by Subject|5
5322159|NCT00296504|18329082|P5|Interim Analysis|Withdrawal by Subject|5
5322160|NCT00296504|18329083|P4|Interim Analysis|Withdrawal by Subject|0
5322161|NCT00296504|18329084|P3|Interim Analysis|Withdrawal by Subject|12
5322162|NCT00296504|18329085|P2|Interim Analysis|Withdrawal by Subject|0
5322163|NCT00296504|18329086|P1|Interim Analysis|Withdrawal by Subject|8
5322164|NCT00296491|18329179|P4|Overall Study|Lost to Follow-up|0
5322165|NCT00296491|18329180|P3|Overall Study|Lost to Follow-up|2
5322166|NCT00296491|18329181|P2|Overall Study|Lost to Follow-up|2
5322167|NCT00296491|18329182|P1|Overall Study|Lost to Follow-up|0
5322168|NCT00296491|18329179|P4|Overall Study|Non-Compliance|14
5322169|NCT00296491|18329180|P3|Overall Study|Non-Compliance|10
5322170|NCT00296491|18329181|P2|Overall Study|Non-Compliance|13
5322171|NCT00296491|18329182|P1|Overall Study|Non-Compliance|12
5322172|NCT00296491|18329179|P4|Overall Study|Withdrawal by Subject|2
5322173|NCT00296491|18329180|P3|Overall Study|Withdrawal by Subject|3
5322174|NCT00296491|18329181|P2|Overall Study|Withdrawal by Subject|3
5322175|NCT00296491|18329182|P1|Overall Study|Withdrawal by Subject|7
5322176|NCT00296491|18329179|P4|Overall Study|Withdrawn due to Asthma|4
5322177|NCT00296491|18329180|P3|Overall Study|Withdrawn due to Asthma|0
5322178|NCT00296491|18329181|P2|Overall Study|Withdrawn due to Asthma|0
5322179|NCT00296491|18329182|P1|Overall Study|Withdrawn due to Asthma|0
5322180|NCT00296491|18329179|P4|Overall Study|Adverse Event|4
5322181|NCT00296491|18329180|P3|Overall Study|Adverse Event|1
5322182|NCT00296491|18329181|P2|Overall Study|Adverse Event|3
5322183|NCT00296491|18329182|P1|Overall Study|Adverse Event|1
5322184|NCT00296491|18329179|P4|Overall Study|Protocol Violation|3
5322185|NCT00296491|18329180|P3|Overall Study|Protocol Violation|2
5322186|NCT00296491|18329181|P2|Overall Study|Protocol Violation|6
5322187|NCT00296491|18329182|P1|Overall Study|Protocol Violation|4
5322188|NCT00296491|18329179|P4|Overall Study|Low Pollen Counts|16
5322189|NCT00296491|18329180|P3|Overall Study|Low Pollen Counts|25
5322190|NCT00296491|18329181|P2|Overall Study|Low Pollen Counts|26
5322191|NCT00296491|18329182|P1|Overall Study|Low Pollen Counts|18
5322192|NCT00296400|18329211|P3|Overall Study|Pregnancy|0
5322193|NCT00296400|18329212|P2|Overall Study|Pregnancy|2
5322194|NCT00296400|18329213|P1|Overall Study|Pregnancy|1
5322195|NCT00296400|18329211|P3|Overall Study|Visit 10 was performed earlier|0
5322196|NCT00296400|18329212|P2|Overall Study|Visit 10 was performed earlier|1
5322197|NCT00296400|18329213|P1|Overall Study|Visit 10 was performed earlier|0
5322198|NCT00296400|18329211|P3|Overall Study|Study specific discontinuation criteria|1
5322199|NCT00296400|18329212|P2|Overall Study|Study specific discontinuation criteria|0
5322200|NCT00296400|18329213|P1|Overall Study|Study specific discontinuation criteria|0
5322201|NCT00296400|18329211|P3|Overall Study|Lost to Follow-up|2
5322202|NCT00296400|18329212|P2|Overall Study|Lost to Follow-up|1
5322203|NCT00296400|18329213|P1|Overall Study|Lost to Follow-up|1
5322204|NCT00296400|18329211|P3|Overall Study|Protocol Violation|1
5322205|NCT00296400|18329212|P2|Overall Study|Protocol Violation|1
5322206|NCT00296400|18329213|P1|Overall Study|Protocol Violation|1
5322207|NCT00296400|18329211|P3|Overall Study|Incorrect enrollment|0
5322208|NCT00296400|18329212|P2|Overall Study|Incorrect enrollment|0
5322209|NCT00296400|18329213|P1|Overall Study|Incorrect enrollment|2
5322210|NCT00296400|18329211|P3|Overall Study|Withdrawal by Subject|2
5322211|NCT00296400|18329212|P2|Overall Study|Withdrawal by Subject|6
5322212|NCT00296400|18329213|P1|Overall Study|Withdrawal by Subject|5
5322213|NCT00296400|18329211|P3|Overall Study|Adverse Event|7
5322214|NCT00296400|18329212|P2|Overall Study|Adverse Event|7
5322215|NCT00296400|18329213|P1|Overall Study|Adverse Event|7
5322216|NCT00296374|18329437|P3|Overall Study|Other|1
5322217|NCT00296374|18329438|P2|Overall Study|Other|0
5322218|NCT00296374|18329439|P1|Overall Study|Other|0
5322219|NCT00296374|18329437|P3|Overall Study|Pregnancy|2
5322220|NCT00296374|18329438|P2|Overall Study|Pregnancy|0
5322221|NCT00296374|18329439|P1|Overall Study|Pregnancy|0
5322222|NCT00296374|18329437|P3|Overall Study|Nephrologist introduced ACE|0
5322223|NCT00296374|18329438|P2|Overall Study|Nephrologist introduced ACE|1
5322224|NCT00296374|18329439|P1|Overall Study|Nephrologist introduced ACE|0
5322225|NCT00296374|18329437|P3|Overall Study|Stopped drug before end of study visit|0
5322226|NCT00296374|18329438|P2|Overall Study|Stopped drug before end of study visit|1
5322227|NCT00296374|18329439|P1|Overall Study|Stopped drug before end of study visit|0
5322228|NCT00296374|18329437|P3|Overall Study|Relocated to another state|0
5322229|NCT00296374|18329438|P2|Overall Study|Relocated to another state|0
5322230|NCT00296374|18329439|P1|Overall Study|Relocated to another state|1
5322231|NCT00296374|18329437|P3|Overall Study|Lost to Follow-up|1
5322232|NCT00296374|18329438|P2|Overall Study|Lost to Follow-up|1
5322233|NCT00296374|18329439|P1|Overall Study|Lost to Follow-up|3
5322234|NCT00296374|18329437|P3|Overall Study|Protocol Violation|3
5322235|NCT00296374|18329438|P2|Overall Study|Protocol Violation|2
5322236|NCT00296374|18329439|P1|Overall Study|Protocol Violation|1
5322237|NCT00296374|18329437|P3|Overall Study|Incorrect enrollment|4
5322238|NCT00296374|18329438|P2|Overall Study|Incorrect enrollment|3
5322239|NCT00296374|18329439|P1|Overall Study|Incorrect enrollment|3
5322240|NCT00296374|18329437|P3|Overall Study|Withdrawal by Subject|11
5322241|NCT00296374|18329438|P2|Overall Study|Withdrawal by Subject|5
5322242|NCT00296374|18329439|P1|Overall Study|Withdrawal by Subject|3
5322243|NCT00296374|18329437|P3|Overall Study|Adverse Event|7
5322244|NCT00296374|18329438|P2|Overall Study|Adverse Event|10
5322245|NCT00296374|18329439|P1|Overall Study|Adverse Event|14
5322246|NCT00296335|18329662|P2|Overall Study|Physician Decision|11
5322247|NCT00296335|18329663|P1|Overall Study|Physician Decision|3
5322248|NCT00296335|18329662|P2|Overall Study|Lost to Follow-up|33
5322249|NCT00296335|18329663|P1|Overall Study|Lost to Follow-up|7
5322250|NCT00296335|18329662|P2|Overall Study|Adverse Event|27
5322251|NCT00296335|18329663|P1|Overall Study|Adverse Event|17
5322252|NCT00296335|18329662|P2|Overall Study|Recurrence|51
5322253|NCT00296335|18329663|P1|Overall Study|Recurrence|3
5322254|NCT00296244|18329703|P2|Overall Study|Underwent retransplant|1
5322255|NCT00296244|18329704|P1|Overall Study|Underwent retransplant|0
5322256|NCT00296140|18329768|P2|Overall Study|Discharge to Nursing Home|0
5322257|NCT00296140|18329769|P1|Overall Study|Discharge to Nursing Home|1
5322258|NCT00296140|18329768|P2|Overall Study|Withdrawal by Subject|0
5322259|NCT00296140|18329769|P1|Overall Study|Withdrawal by Subject|1
5322260|NCT00296140|18329768|P2|Overall Study|Lost to Follow-up|0
5322261|NCT00296140|18329769|P1|Overall Study|Lost to Follow-up|1
5322262|NCT00296036|18329781|P6|Overall Study|Protocol Violation|3
5322263|NCT00296036|18329782|P5|Overall Study|Protocol Violation|0
5322264|NCT00296036|18329783|P4|Overall Study|Protocol Violation|0
5322265|NCT00296036|18329784|P3|Overall Study|Protocol Violation|0
5322266|NCT00296036|18329785|P2|Overall Study|Protocol Violation|0
5322267|NCT00296036|18329786|P1|Overall Study|Protocol Violation|0
5322268|NCT00296036|18329781|P6|Overall Study|Withdrawal by Subject|1
5322269|NCT00296036|18329782|P5|Overall Study|Withdrawal by Subject|2
5322270|NCT00296036|18329783|P4|Overall Study|Withdrawal by Subject|1
5322271|NCT00296036|18329784|P3|Overall Study|Withdrawal by Subject|2
5322272|NCT00296036|18329785|P2|Overall Study|Withdrawal by Subject|0
5322273|NCT00296036|18329786|P1|Overall Study|Withdrawal by Subject|1
5322274|NCT00295932|18329823|P11|Overall Study|Not Treated|1
5322275|NCT00295932|18329824|P10|Overall Study|Not Treated|0
5322276|NCT00295932|18329825|P9|Overall Study|Not Treated|0
5322277|NCT00295932|18329826|P8|Overall Study|Not Treated|0
5322278|NCT00295932|18329827|P7|Overall Study|Not Treated|0
5322279|NCT00295932|18329828|P6|Overall Study|Not Treated|0
5322280|NCT00295932|18329829|P5|Overall Study|Not Treated|0
5322281|NCT00295932|18329830|P4|Overall Study|Not Treated|0
5322282|NCT00295932|18329831|P3|Overall Study|Not Treated|0
5322283|NCT00295932|18329832|P2|Overall Study|Not Treated|0
5322284|NCT00295932|18329833|P1|Overall Study|Not Treated|0
5322285|NCT00295880|18329867|P1|Overall Study|Unit randomization did not occur|1
5322286|NCT00295880|18329867|P1|Overall Study|IBMI unit could not be volume reduced|1
5322287|NCT00295854|18329887|P3|Overall Study|Other|1
5322288|NCT00295854|18329888|P2|Overall Study|Other|5
5322289|NCT00295854|18329889|P1|Overall Study|Other|3
5322290|NCT00295854|18329887|P3|Overall Study|required a prohibited medication|0
5322291|NCT00295854|18329888|P2|Overall Study|required a prohibited medication|0
5322292|NCT00295854|18329889|P1|Overall Study|required a prohibited medication|1
5322293|NCT00295854|18329887|P3|Overall Study|did not continue to meet criteria|2
5322294|NCT00295854|18329888|P2|Overall Study|did not continue to meet criteria|1
5322295|NCT00295854|18329889|P1|Overall Study|did not continue to meet criteria|1
5322296|NCT00295854|18329887|P3|Overall Study|Withdrawal by Subject|4
5322297|NCT00295854|18329888|P2|Overall Study|Withdrawal by Subject|7
5322298|NCT00295854|18329889|P1|Overall Study|Withdrawal by Subject|3
5322299|NCT00295854|18329887|P3|Overall Study|Lost to Follow-up|1
5322300|NCT00295854|18329888|P2|Overall Study|Lost to Follow-up|0
5322301|NCT00295854|18329889|P1|Overall Study|Lost to Follow-up|2
5322302|NCT00295854|18329887|P3|Overall Study|Protocol Violation|1
5322303|NCT00295854|18329888|P2|Overall Study|Protocol Violation|1
5322304|NCT00295854|18329889|P1|Overall Study|Protocol Violation|1
5322305|NCT00295854|18329887|P3|Overall Study|Adverse Event|6
5322306|NCT00295854|18329888|P2|Overall Study|Adverse Event|7
5322307|NCT00295854|18329889|P1|Overall Study|Adverse Event|7
5322308|NCT00295750|18329903|P3|Overall Study|Protocol Violation|2
5322309|NCT00295750|18329904|P2|Overall Study|Protocol Violation|4
5322310|NCT00295750|18329905|P1|Overall Study|Protocol Violation|2
5322311|NCT00295750|18329903|P3|Overall Study|Withdrawal by Subject|7
5322312|NCT00295750|18329904|P2|Overall Study|Withdrawal by Subject|4
5322313|NCT00295750|18329905|P1|Overall Study|Withdrawal by Subject|9
5322314|NCT00295750|18329903|P3|Overall Study|Randomized but never received trial drug|3
5322315|NCT00295750|18329904|P2|Overall Study|Randomized but never received trial drug|3
5322316|NCT00295750|18329905|P1|Overall Study|Randomized but never received trial drug|4
5322317|NCT00295750|18329903|P3|Overall Study|Personal reasons|0
5322318|NCT00295750|18329904|P2|Overall Study|Personal reasons|1
5322319|NCT00295750|18329905|P1|Overall Study|Personal reasons|0
5322320|NCT00295750|18329903|P3|Overall Study|Disease progression|0
5322321|NCT00295750|18329904|P2|Overall Study|Disease progression|1
5322322|NCT00295750|18329905|P1|Overall Study|Disease progression|2
5322323|NCT00295750|18329903|P3|Overall Study|Trial drug errors|0
5322324|NCT00295750|18329904|P2|Overall Study|Trial drug errors|1
5322325|NCT00295750|18329905|P1|Overall Study|Trial drug errors|1
5322326|NCT00295750|18329903|P3|Overall Study|Administrative errors|5
5322327|NCT00295750|18329904|P2|Overall Study|Administrative errors|4
5322328|NCT00295750|18329905|P1|Overall Study|Administrative errors|2
5322329|NCT00295750|18329903|P3|Overall Study|Taking prohibited therapy|2
5322330|NCT00295750|18329904|P2|Overall Study|Taking prohibited therapy|3
5322331|NCT00295750|18329905|P1|Overall Study|Taking prohibited therapy|2
5322332|NCT00295750|18329903|P3|Overall Study|Lost to Follow-up|1
5322333|NCT00295750|18329904|P2|Overall Study|Lost to Follow-up|4
5322334|NCT00295750|18329905|P1|Overall Study|Lost to Follow-up|1
5322335|NCT00295750|18329903|P3|Overall Study|Lack of Efficacy|0
5322336|NCT00295750|18329904|P2|Overall Study|Lack of Efficacy|1
5322337|NCT00295750|18329905|P1|Overall Study|Lack of Efficacy|1
5322338|NCT00295750|18329903|P3|Overall Study|Adverse Event|12
5322339|NCT00295750|18329904|P2|Overall Study|Adverse Event|15
5322340|NCT00295750|18329905|P1|Overall Study|Adverse Event|19
5322341|NCT00295633|18329940|P3|Overall Study|Administrative reason by sponsor|1
5322342|NCT00295633|18329941|P2|Overall Study|Administrative reason by sponsor|0
5322343|NCT00295633|18329942|P1|Overall Study|Administrative reason by sponsor|0
5322344|NCT00295633|18329940|P3|Overall Study|Death|0
5322345|NCT00295633|18329941|P2|Overall Study|Death|1
5322346|NCT00295633|18329942|P1|Overall Study|Death|1
5322347|NCT00295633|18329940|P3|Overall Study|Subject No Longer Meets Study Criteria|3
5322348|NCT00295633|18329941|P2|Overall Study|Subject No Longer Meets Study Criteria|3
5322349|NCT00295633|18329942|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5322350|NCT00295633|18329940|P3|Overall Study|Poor/Noncompliance|6
5322351|NCT00295633|18329941|P2|Overall Study|Poor/Noncompliance|2
5322352|NCT00295633|18329942|P1|Overall Study|Poor/Noncompliance|2
5322353|NCT00295633|18329940|P3|Overall Study|Physician Decision|8
5322354|NCT00295633|18329941|P2|Overall Study|Physician Decision|10
5322355|NCT00295633|18329942|P1|Overall Study|Physician Decision|9
5322356|NCT00295633|18329940|P3|Overall Study|Lost to Follow-up|7
5322357|NCT00295633|18329941|P2|Overall Study|Lost to Follow-up|11
5322358|NCT00295633|18329942|P1|Overall Study|Lost to Follow-up|6
5322359|NCT00295633|18329940|P3|Overall Study|Adverse Event|9
5322360|NCT00295633|18329941|P2|Overall Study|Adverse Event|17
5322361|NCT00295633|18329942|P1|Overall Study|Adverse Event|9
5322362|NCT00295633|18329940|P3|Overall Study|Withdrawal of consent by subject|26
5322363|NCT00295633|18329941|P2|Overall Study|Withdrawal of consent by subject|16
5322364|NCT00295633|18329942|P1|Overall Study|Withdrawal of consent by subject|16
5322365|NCT00295633|18329940|P3|Overall Study|Lack of Efficacy|16
5322366|NCT00295633|18329941|P2|Overall Study|Lack of Efficacy|7
5322367|NCT00295633|18329942|P1|Overall Study|Lack of Efficacy|19
5322368|NCT00295620|18329961|P2|Overall Study|Protocol Violation|32
5322369|NCT00295620|18329962|P1|Overall Study|Protocol Violation|30
5322370|NCT00295620|18329961|P2|Overall Study|Discontinuation by sponsor|593
5322371|NCT00295620|18329962|P1|Overall Study|Discontinuation by sponsor|580
5322372|NCT00295620|18329961|P2|Overall Study|Other reasons|9
5322373|NCT00295620|18329962|P1|Overall Study|Other reasons|10
5322374|NCT00295620|18329961|P2|Overall Study|Death|207
5322375|NCT00295620|18329962|P1|Overall Study|Death|206
5322376|NCT00295620|18329961|P2|Overall Study|Withdrawal by Subject|50
5322377|NCT00295620|18329962|P1|Overall Study|Withdrawal by Subject|37
5322378|NCT00295620|18329961|P2|Overall Study|Lost to Follow-up|5
5322379|NCT00295620|18329962|P1|Overall Study|Lost to Follow-up|9
5322380|NCT00295490|18329986|P4|Overall Study|Other|1
5322381|NCT00295490|18329987|P3|Overall Study|Other|0
5322382|NCT00295490|18329988|P2|Overall Study|Other|2
5322383|NCT00295490|18329989|P1|Overall Study|Other|0
5322384|NCT00295490|18329986|P4|Overall Study|Adverse Event|0
5322385|NCT00295490|18329987|P3|Overall Study|Adverse Event|0
5322386|NCT00295490|18329988|P2|Overall Study|Adverse Event|0
5322387|NCT00295490|18329989|P1|Overall Study|Adverse Event|1
5322388|NCT00295490|18329986|P4|Overall Study|Lost to Follow-up|0
5322389|NCT00295490|18329987|P3|Overall Study|Lost to Follow-up|1
5322390|NCT00295490|18329988|P2|Overall Study|Lost to Follow-up|0
5322391|NCT00295490|18329989|P1|Overall Study|Lost to Follow-up|0
5322392|NCT00295490|18329986|P4|Overall Study|Withdrawal by Subject|1
5322393|NCT00295490|18329987|P3|Overall Study|Withdrawal by Subject|0
5322394|NCT00295490|18329988|P2|Overall Study|Withdrawal by Subject|2
5322395|NCT00295490|18329989|P1|Overall Study|Withdrawal by Subject|0
5322396|NCT00295490|18329986|P4|Overall Study|Protocol Violation|3
5322397|NCT00295490|18329987|P3|Overall Study|Protocol Violation|3
5322398|NCT00295490|18329988|P2|Overall Study|Protocol Violation|0
5322399|NCT00295490|18329989|P1|Overall Study|Protocol Violation|0
5322400|NCT00295022|18330039|P3|Overall Study|Withdrawal by Subject|2
5322401|NCT00295022|18330040|P2|Overall Study|Withdrawal by Subject|0
5322402|NCT00295022|18330041|P1|Overall Study|Withdrawal by Subject|0
5322403|NCT00295022|18330039|P3|Overall Study|Lost to Follow-up|1
5322404|NCT00295022|18330040|P2|Overall Study|Lost to Follow-up|0
5322405|NCT00295022|18330041|P1|Overall Study|Lost to Follow-up|0
5322406|NCT00295022|18330039|P3|Overall Study|Adverse Event|2
5322407|NCT00295022|18330040|P2|Overall Study|Adverse Event|1
5322408|NCT00295022|18330041|P1|Overall Study|Adverse Event|1
5322409|NCT00294762|18330157|P2|Overall Study|Did not receive study treatment|3
5322410|NCT00294762|18330158|P1|Overall Study|Did not receive study treatment|3
5322411|NCT00294723|18330177|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
5322412|NCT00294723|18330178|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
5322413|NCT00294723|18330179|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
5322414|NCT00294723|18330177|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
5322415|NCT00294723|18330178|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
5322416|NCT00294723|18330179|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
5322417|NCT00294723|18330177|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
5322418|NCT00294723|18330178|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
5322419|NCT00294723|18330179|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
5322420|NCT00294723|18330177|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
5322421|NCT00294723|18330178|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
5322422|NCT00294723|18330179|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
5322423|NCT00294723|18330177|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
5322424|NCT00294723|18330178|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
5322425|NCT00294723|18330179|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
5322426|NCT00294723|18330177|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
5322427|NCT00294723|18330178|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
5322428|NCT00294723|18330179|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
5322429|NCT00294723|18330177|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
5322430|NCT00294723|18330178|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
5322431|NCT00294723|18330179|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
5322432|NCT00294723|18330177|P3|Open-Label Extension 52 Weeks|Adverse Event|2
5322433|NCT00294723|18330178|P2|Open-Label Extension 52 Weeks|Adverse Event|5
5322434|NCT00294723|18330179|P1|Open-Label Extension 52 Weeks|Adverse Event|5
5322435|NCT00294723|18330177|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
5322436|NCT00294723|18330178|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
5322437|NCT00294723|18330179|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
5322438|NCT00294723|18330177|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
5322439|NCT00294723|18330178|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
5322440|NCT00294723|18330179|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
5322441|NCT00294723|18330177|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
5322442|NCT00294723|18330178|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
5322443|NCT00294723|18330179|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
5322444|NCT00294723|18330177|P3|Double-Blind Period 52 Weeks|Adverse Event|15
5322445|NCT00294723|18330178|P2|Double-Blind Period 52 Weeks|Adverse Event|25
5322446|NCT00294723|18330179|P1|Double-Blind Period 52 Weeks|Adverse Event|18
5322447|NCT00294684|18330240|P2|Overall Study|Lost to Follow-up|8
5322448|NCT00294684|18330241|P1|Overall Study|Lost to Follow-up|5
5322449|NCT00294671|18330281|P2|Overall Study|Death|1
5322450|NCT00294671|18330282|P1|Overall Study|Death|0
5322451|NCT00294671|18330281|P2|Overall Study|Non-compliance|0
5322452|NCT00294671|18330282|P1|Overall Study|Non-compliance|1
5322453|NCT00294671|18330281|P2|Overall Study|Lost to Follow-up|3
5322454|NCT00294671|18330282|P1|Overall Study|Lost to Follow-up|1
5322455|NCT00294671|18330281|P2|Overall Study|Non-drug related AE|2
5322456|NCT00294671|18330282|P1|Overall Study|Non-drug related AE|3
5322457|NCT00294671|18330281|P2|Overall Study|Drug related adverse event (AE)|2
5322458|NCT00294671|18330282|P1|Overall Study|Drug related adverse event (AE)|4
5322459|NCT00294671|18330281|P2|Overall Study|Liver transplant|9
5322460|NCT00294671|18330282|P1|Overall Study|Liver transplant|7
5322461|NCT00294671|18330281|P2|Overall Study|Lack of Efficacy|23
5322462|NCT00294671|18330282|P1|Overall Study|Lack of Efficacy|11
5322463|NCT00294658|18330298|P2|Overall Study|Patient and family were not satisfied|1
5322464|NCT00294658|18330299|P1|Overall Study|Patient and family were not satisfied|0
5322465|NCT00294658|18330298|P2|Overall Study|Found to have invasive thymoma|0
5322466|NCT00294658|18330299|P1|Overall Study|Found to have invasive thymoma|1
5322467|NCT00294658|18330298|P2|Overall Study|Withdrawal by Subject|4
5322468|NCT00294658|18330299|P1|Overall Study|Withdrawal by Subject|0
5322469|NCT00294658|18330298|P2|Overall Study|Pregnancy|1
5322470|NCT00294658|18330299|P1|Overall Study|Pregnancy|0
5322471|NCT00294658|18330298|P2|Overall Study|Physician Decision|2
5322472|NCT00294658|18330299|P1|Overall Study|Physician Decision|1
5322473|NCT00294658|18330298|P2|Overall Study|Lost to Follow-up|0
5322474|NCT00294658|18330299|P1|Overall Study|Lost to Follow-up|4
5322475|NCT00294658|18330298|P2|Overall Study|Death|1
5322476|NCT00294658|18330299|P1|Overall Study|Death|0
5322477|NCT00294645|18330363|P2|Overall Study|Other|10
5322478|NCT00294645|18330364|P1|Overall Study|Other|4
5322479|NCT00294645|18330363|P2|Overall Study|Physician Decision|20
5322480|NCT00294645|18330364|P1|Overall Study|Physician Decision|15
5322481|NCT00294645|18330363|P2|Overall Study|Withdrawal by Subject|34
5322482|NCT00294645|18330364|P1|Overall Study|Withdrawal by Subject|18
5322483|NCT00294645|18330363|P2|Overall Study|Lost to Follow-up|10
5322484|NCT00294645|18330364|P1|Overall Study|Lost to Follow-up|1
5322485|NCT00294645|18330363|P2|Overall Study|Death|18
5322486|NCT00294645|18330364|P1|Overall Study|Death|10
5322487|NCT00294554|18330408|P2|Overall Study|Physician Decision|1
5322488|NCT00294554|18330409|P1|Overall Study|Physician Decision|0
5322489|NCT00294554|18330408|P2|Overall Study|Lack of Efficacy|1
5322490|NCT00294554|18330409|P1|Overall Study|Lack of Efficacy|0
5322491|NCT00294398|18330436|P2|Overall Study|Lost to Follow-up|26
5322492|NCT00294398|18330437|P1|Overall Study|Lost to Follow-up|21
5322493|NCT00294060|18330445|P1|Overall Study|Device explanted/not replaced|23
5322494|NCT00294060|18330445|P1|Overall Study|Medical condition|3
5322495|NCT00294060|18330445|P1|Overall Study|Physician Decision|797
5322496|NCT00294060|18330445|P1|Overall Study|Withdrawal by Subject|11
5322497|NCT00294060|18330445|P1|Overall Study|Lost to Follow-up|55
5322498|NCT00294060|18330445|P1|Overall Study|Other|59
5322499|NCT00294060|18330445|P1|Overall Study|Death|225
5322500|NCT00294047|18330453|P2|Month 84|No consent for Month 84 Follow-up|754
5322501|NCT00294047|18330454|P1|Month 84|No consent for Month 84 Follow-up|731
5322502|NCT00294047|18330453|P2|Month 84|Visit missed|1
5322503|NCT00294047|18330454|P1|Month 84|Visit missed|0
5322504|NCT00294047|18330453|P2|Month 84|Under investigation locally|0
5322505|NCT00294047|18330454|P1|Month 84|Under investigation locally|1
5322506|NCT00294047|18330453|P2|Month 84|Unable to reach study site|0
5322507|NCT00294047|18330454|P1|Month 84|Unable to reach study site|1
5322508|NCT00294047|18330453|P2|Month 84|Transport reimbursement delayed|1
5322509|NCT00294047|18330454|P1|Month 84|Transport reimbursement delayed|0
5322510|NCT00294047|18330453|P2|Month 84|Subject does not want male physician|0
5322511|NCT00294047|18330454|P1|Month 84|Subject does not want male physician|1
5322512|NCT00294047|18330453|P2|Month 84|Personal reason|4
5322513|NCT00294047|18330454|P1|Month 84|Personal reason|2
5322514|NCT00294047|18330453|P2|Month 84|Lack of time|1
5322515|NCT00294047|18330454|P1|Month 84|Lack of time|3
5322516|NCT00294047|18330453|P2|Month 84|Family problems|2
5322517|NCT00294047|18330454|P1|Month 84|Family problems|2
5322518|NCT00294047|18330453|P2|Month 84|Center closed, subject did not transfer|0
5322519|NCT00294047|18330454|P1|Month 84|Center closed, subject did not transfer|1
5322520|NCT00294047|18330453|P2|Month 84|Work related reasons|2
5322521|NCT00294047|18330454|P1|Month 84|Work related reasons|4
5322522|NCT00294047|18330453|P2|Month 84|Absent Cervix|0
5322523|NCT00294047|18330454|P1|Month 84|Absent Cervix|2
5322524|NCT00294047|18330453|P2|Month 84|Lost to Follow-up|190
5322525|NCT00294047|18330454|P1|Month 84|Lost to Follow-up|187
5322526|NCT00294047|18330453|P2|Month 84|Withdrawal by Subject|31
5322527|NCT00294047|18330454|P1|Month 84|Withdrawal by Subject|33
5322528|NCT00294047|18330453|P2|Month 84|Protocol Violation|1
5322529|NCT00294047|18330454|P1|Month 84|Protocol Violation|1
5322530|NCT00294047|18330453|P2|Month 84|Adverse Event|2
5322531|NCT00294047|18330454|P1|Month 84|Adverse Event|4
5322532|NCT00294047|18330453|P2|Month 48|Other|14
5322533|NCT00294047|18330454|P1|Month 48|Other|10
5322534|NCT00294047|18330453|P2|Month 48|Lost to Follow-up|287
5322535|NCT00294047|18330454|P1|Month 48|Lost to Follow-up|272
5322536|NCT00294047|18330453|P2|Month 48|Withdrawal by Subject|115
5322537|NCT00294047|18330454|P1|Month 48|Withdrawal by Subject|111
5322538|NCT00294047|18330453|P2|Month 48|Protocol Violation|4
5322539|NCT00294047|18330454|P1|Month 48|Protocol Violation|4
5322540|NCT00294047|18330453|P2|Month 48|Adverse Event|13
5322541|NCT00294047|18330454|P1|Month 48|Adverse Event|28
5322542|NCT00293813|18330559|P3|Overall Study|Noncompliance|0
5322543|NCT00293813|18330560|P2|Overall Study|Noncompliance|1
5322544|NCT00293813|18330561|P1|Overall Study|Noncompliance|0
5322545|NCT00293813|18330559|P3|Overall Study|Lost to Follow-up|3
5322546|NCT00293813|18330560|P2|Overall Study|Lost to Follow-up|2
5322547|NCT00293813|18330561|P1|Overall Study|Lost to Follow-up|3
5322548|NCT00293813|18330559|P3|Overall Study|Withdrawal by Subject|4
5322549|NCT00293813|18330560|P2|Overall Study|Withdrawal by Subject|4
5322550|NCT00293813|18330561|P1|Overall Study|Withdrawal by Subject|7
5322551|NCT00293813|18330559|P3|Overall Study|Adverse Event|1
5322552|NCT00293813|18330560|P2|Overall Study|Adverse Event|1
5322553|NCT00293813|18330561|P1|Overall Study|Adverse Event|3
5322554|NCT00293813|18330559|P3|Overall Study|Physician Decision|0
5322555|NCT00293813|18330560|P2|Overall Study|Physician Decision|1
5322556|NCT00293813|18330561|P1|Overall Study|Physician Decision|0
5322557|NCT00293722|18330572|P1|Overall Study|Other|427
5322558|NCT00293709|18330586|P1|Overall Study|Other|47
5322559|NCT00293579|18330600|P1|Overall Study|Withdrawal by Subject|1
5322560|NCT00293462|18330619|P3|Overall Study|Physician Decision|0
5322561|NCT00293462|18330620|P2|Overall Study|Physician Decision|1
5322562|NCT00293462|18330621|P1|Overall Study|Physician Decision|0
5322563|NCT00293462|18330619|P3|Overall Study|Low radiation dose in oral cavity|0
5322564|NCT00293462|18330620|P2|Overall Study|Low radiation dose in oral cavity|1
5322565|NCT00293462|18330621|P1|Overall Study|Low radiation dose in oral cavity|0
5322566|NCT00293462|18330619|P3|Overall Study|Possible Tracheostomy leakage|0
5322567|NCT00293462|18330620|P2|Overall Study|Possible Tracheostomy leakage|1
5322568|NCT00293462|18330621|P1|Overall Study|Possible Tracheostomy leakage|0
5322569|NCT00293462|18330619|P3|Overall Study|Ischemic stroke after chemotherapy|1
5322570|NCT00293462|18330620|P2|Overall Study|Ischemic stroke after chemotherapy|0
5322571|NCT00293462|18330621|P1|Overall Study|Ischemic stroke after chemotherapy|0
5322572|NCT00293462|18330619|P3|Overall Study|Blood clot after chemotherapy|1
5322573|NCT00293462|18330620|P2|Overall Study|Blood clot after chemotherapy|0
5322574|NCT00293462|18330621|P1|Overall Study|Blood clot after chemotherapy|0
5322575|NCT00293462|18330619|P3|Overall Study|Went back to his home country|1
5322576|NCT00293462|18330620|P2|Overall Study|Went back to his home country|0
5322577|NCT00293462|18330621|P1|Overall Study|Went back to his home country|0
5322578|NCT00293462|18330619|P3|Overall Study|No Show|1
5322579|NCT00293462|18330620|P2|Overall Study|No Show|0
5322580|NCT00293462|18330621|P1|Overall Study|No Show|0
5322581|NCT00293462|18330619|P3|Overall Study|Refuse Radiation Treatment|0
5322582|NCT00293462|18330620|P2|Overall Study|Refuse Radiation Treatment|0
5322583|NCT00293462|18330621|P1|Overall Study|Refuse Radiation Treatment|1
5322584|NCT00293462|18330619|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
5322585|NCT00293462|18330620|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
5322586|NCT00293462|18330621|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
5322587|NCT00293462|18330619|P3|Overall Study|Change Treatment Regimen (ineligible)|0
5322588|NCT00293462|18330620|P2|Overall Study|Change Treatment Regimen (ineligible)|0
5322589|NCT00293462|18330621|P1|Overall Study|Change Treatment Regimen (ineligible)|1
5322590|NCT00293462|18330619|P3|Overall Study|Lost to Follow-up|0
5322591|NCT00293462|18330620|P2|Overall Study|Lost to Follow-up|1
5322592|NCT00293462|18330621|P1|Overall Study|Lost to Follow-up|0
5322593|NCT00293462|18330619|P3|Overall Study|Death|0
5322594|NCT00293462|18330620|P2|Overall Study|Death|0
5322595|NCT00293462|18330621|P1|Overall Study|Death|1
5322596|NCT00293462|18330619|P3|Overall Study|Withdrawal by Subject|6
5322597|NCT00293462|18330620|P2|Overall Study|Withdrawal by Subject|3
5322598|NCT00293462|18330621|P1|Overall Study|Withdrawal by Subject|4
5322599|NCT00293397|18330640|P1|Overall Study|Death|2
5322600|NCT00293384|18330650|P1|Overall Study|Ineligible|2
5322601|NCT00293384|18330650|P1|Overall Study|Missed dosage/study drug|1
5322602|NCT00293384|18330650|P1|Overall Study|Non-compliance|2
5322603|NCT00293293|18330659|P2|Overall Study|Patient discontinued chemotherapy|1
5322604|NCT00293293|18330660|P1|Overall Study|Patient discontinued chemotherapy|0
5322605|NCT00293293|18330659|P2|Overall Study|"Patient too anxious to complete trial"|0
5322606|NCT00293293|18330660|P1|Overall Study|"Patient too anxious to complete trial"|1
5322607|NCT00293293|18330659|P2|Overall Study|Withdrawal by Subject|1
5322608|NCT00293293|18330660|P1|Overall Study|Withdrawal by Subject|1
5322609|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
5322610|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
5322611|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
5322612|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
5322613|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
5322614|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
5322615|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
5322616|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
5322617|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
5322618|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
5322619|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
5322620|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
5322621|NCT00293267|18330688|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
5322622|NCT00293267|18330689|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
5322623|NCT00293267|18330688|P2|Extension - Open-Label Week 157-240|Other Reason|1
5322624|NCT00293267|18330689|P1|Extension - Open-Label Week 157-240|Other Reason|3
5322625|NCT00293267|18330688|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
5322626|NCT00293267|18330689|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
5322627|NCT00293267|18330688|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
5322628|NCT00293267|18330689|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
5322629|NCT00293267|18330688|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
5322630|NCT00293267|18330689|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
5322631|NCT00293267|18330688|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
5322632|NCT00293267|18330689|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
5322633|NCT00293267|18330688|P2|Extension - Open-Label Week 157-240|Adverse Event|0
5322634|NCT00293267|18330689|P1|Extension - Open-Label Week 157-240|Adverse Event|5
5322635|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
5322636|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
5322637|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Other Reason|0
5322638|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Other Reason|7
5322639|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
5322640|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
5322641|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Death|0
5322642|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Death|3
5322643|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
5322644|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
5322645|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
5322646|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
5322647|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
5322648|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
5322649|NCT00293267|18330688|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
5322650|NCT00293267|18330689|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
5322651|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
5322652|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
5322653|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
5322654|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
5322655|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
5322656|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
5322657|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
5322658|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
5322659|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Death|3
5322660|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Death|3
5322661|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
5322662|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
5322663|NCT00293267|18330688|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
5322664|NCT00293267|18330689|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
5322665|NCT00293254|18330729|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
5322666|NCT00293254|18330730|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
5322667|NCT00293254|18330729|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
5322668|NCT00293254|18330730|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
5322669|NCT00293254|18330729|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
5322670|NCT00293254|18330730|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
5322671|NCT00293254|18330729|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
5322672|NCT00293254|18330730|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
5322673|NCT00293254|18330729|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
5322674|NCT00293254|18330730|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
5322675|NCT00293254|18330729|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
5322676|NCT00293254|18330730|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
5322677|NCT00293254|18330729|P2|Extension - Open-Label Week 157-240|Other Reason|0
5322678|NCT00293254|18330730|P1|Extension - Open-Label Week 157-240|Other Reason|4
5322679|NCT00293254|18330729|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
5322680|NCT00293254|18330730|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
5322681|NCT00293254|18330729|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
5322682|NCT00293254|18330730|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
5322683|NCT00293254|18330729|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
5322684|NCT00293254|18330730|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
5322685|NCT00293254|18330729|P2|Extension - Open-Label Week 157-240|Adverse Event|1
5322686|NCT00293254|18330730|P1|Extension - Open-Label Week 157-240|Adverse Event|2
5322687|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
5322688|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
5322689|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Other Reason|2
5322690|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Other Reason|10
5322691|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
5322692|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
5322693|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
5322694|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
5322695|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
5322696|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
5322697|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
5322698|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
5322699|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Death|1
5322700|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Death|4
5322701|NCT00293254|18330729|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
5322702|NCT00293254|18330730|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
5322703|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
5322704|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
5322705|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
5322706|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
5322707|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
5322708|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
5322709|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
5322710|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
5322711|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
5322712|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
5322713|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Death|2
5322714|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Death|5
5322715|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
5322716|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
5322717|NCT00293254|18330729|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
5322718|NCT00293254|18330730|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
5322719|NCT00293241|18330770|P2|Overall Study|Withdrawal by Subject|8
5322720|NCT00293241|18330771|P1|Overall Study|Withdrawal by Subject|4
5322721|NCT00293241|18330770|P2|Overall Study|Physician Decision|17
5322722|NCT00293241|18330771|P1|Overall Study|Physician Decision|23
5322723|NCT00293241|18330770|P2|Overall Study|Lost to Follow-up|16
5322724|NCT00293241|18330771|P1|Overall Study|Lost to Follow-up|9
5322725|NCT00293215|18330815|P2|Overall Study|Adverse Event|2
5322726|NCT00293215|18330816|P1|Overall Study|Adverse Event|2
5322727|NCT00293215|18330815|P2|Overall Study|Progressive disease|1
5322728|NCT00293215|18330816|P1|Overall Study|Progressive disease|3
5322729|NCT00293059|18330838|P2|Overall Study|missing|5
5322730|NCT00293059|18330839|P1|Overall Study|missing|3
5322731|NCT00293059|18330838|P2|Overall Study|Noncompliant - sanitary pads collection|1
5322732|NCT00293059|18330839|P1|Overall Study|Noncompliant - sanitary pads collection|0
5322733|NCT00293059|18330838|P2|Overall Study|Participant stopped study drug|0
5322734|NCT00293059|18330839|P1|Overall Study|Participant stopped study drug|1
5322735|NCT00293059|18330838|P2|Overall Study|Participant moved out of state|0
5322736|NCT00293059|18330839|P1|Overall Study|Participant moved out of state|1
5322737|NCT00293059|18330838|P2|Overall Study|Withdrawal by Subject|5
5322738|NCT00293059|18330839|P1|Overall Study|Withdrawal by Subject|11
5322739|NCT00293059|18330838|P2|Overall Study|Protocol Violation|0
5322740|NCT00293059|18330839|P1|Overall Study|Protocol Violation|2
5322741|NCT00293059|18330838|P2|Overall Study|Pregnancy|1
5322742|NCT00293059|18330839|P1|Overall Study|Pregnancy|1
5322743|NCT00293059|18330838|P2|Overall Study|Lost to Follow-up|3
5322744|NCT00293059|18330839|P1|Overall Study|Lost to Follow-up|2
5322745|NCT00293059|18330838|P2|Overall Study|Lack of Efficacy|0
5322746|NCT00293059|18330839|P1|Overall Study|Lack of Efficacy|2
5322747|NCT00293059|18330838|P2|Overall Study|Adverse Event|4
5322748|NCT00293059|18330839|P1|Overall Study|Adverse Event|12
5322749|NCT00293033|18330951|P1|Double-blind Treatment Period|Noncompliance|4
5322750|NCT00293033|18330951|P1|Double-blind Treatment Period|Withdrawal by Subject|4
5322751|NCT00293033|18330951|P1|Double-blind Treatment Period|Lack of Efficacy|1
5322752|NCT00293033|18330951|P1|Double-blind Treatment Period|Adverse Event|3
5322753|NCT00293033|18330951|P1|Open-label Titration Period|Noncompliance and other|27
5322754|NCT00293033|18330951|P1|Open-label Titration Period|Withdrawal by Subject|22
5322755|NCT00293033|18330951|P1|Open-label Titration Period|Protocol Violation|2
5322756|NCT00293033|18330951|P1|Open-label Titration Period|Lack of Efficacy|5
5322757|NCT00293033|18330951|P1|Open-label Titration Period|Death|3
5322758|NCT00293033|18330951|P1|Open-label Titration Period|Adverse Event|10
5322759|NCT00293020|18331054|P1|Overall Study|No dose taken|1
5322760|NCT00293020|18331054|P1|Overall Study|Other Reason|22
5322761|NCT00293020|18331054|P1|Overall Study|Physician Decision|21
5322762|NCT00293020|18331054|P1|Overall Study|Protocol Violation|6
5322763|NCT00293020|18331054|P1|Overall Study|Lost to Follow-up|4
5322764|NCT00293020|18331054|P1|Overall Study|Lack of Efficacy|12
5322765|NCT00293020|18331054|P1|Overall Study|Death|32
5322766|NCT00293020|18331054|P1|Overall Study|Adverse Event|30
5322767|NCT00293020|18331054|P1|Overall Study|Withdrawal by Subject|34
5322768|NCT00292981|18331058|P1|Overall Study|Other|3
5322769|NCT00292981|18331058|P1|Overall Study|Withdrawal by Subject|22
5322770|NCT00292981|18331058|P1|Overall Study|Lost to Follow-up|13
5322771|NCT00292981|18331058|P1|Overall Study|Adverse Event|1
5322772|NCT00292942|18331069|P4|Overall Study|Adverse Event|1
5322773|NCT00292942|18331070|P3|Overall Study|Adverse Event|0
5322774|NCT00292942|18331071|P2|Overall Study|Adverse Event|0
5322775|NCT00292942|18331072|P1|Overall Study|Adverse Event|0
5322776|NCT00292942|18331069|P4|Overall Study|Withdrawal by Subject|0
5322777|NCT00292942|18331070|P3|Overall Study|Withdrawal by Subject|1
5322778|NCT00292942|18331071|P2|Overall Study|Withdrawal by Subject|0
5322779|NCT00292942|18331072|P1|Overall Study|Withdrawal by Subject|0
5322780|NCT00292461|18331118|P2|Overall Study|Lost to Follow-up|0
5322781|NCT00292461|18331119|P1|Overall Study|Lost to Follow-up|1
5322782|NCT00292461|18331118|P2|Overall Study|Protocol Violation|3
5322783|NCT00292461|18331119|P1|Overall Study|Protocol Violation|4
5322784|NCT00292461|18331118|P2|Overall Study|Withdrawal by Subject|1
5322785|NCT00292461|18331119|P1|Overall Study|Withdrawal by Subject|0
5322786|NCT00292461|18331118|P2|Overall Study|Lack of Efficacy|0
5322787|NCT00292461|18331119|P1|Overall Study|Lack of Efficacy|1
5322788|NCT00292461|18331118|P2|Overall Study|Adverse Event|2
5322789|NCT00292461|18331119|P1|Overall Study|Adverse Event|4
5322790|NCT00292370|18331134|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
5322791|NCT00292370|18331135|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
5322792|NCT00292370|18331136|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
5322793|NCT00292370|18331134|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
5322794|NCT00292370|18331135|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
5322795|NCT00292370|18331136|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
5322796|NCT00292370|18331134|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
5322797|NCT00292370|18331135|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
5322798|NCT00292370|18331136|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
5322799|NCT00292370|18331134|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
5322800|NCT00292370|18331135|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
5322801|NCT00292370|18331136|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
5322802|NCT00292370|18331134|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
5322803|NCT00292370|18331135|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
5322804|NCT00292370|18331136|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
5322805|NCT00292370|18331134|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
5322806|NCT00292370|18331135|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
5322807|NCT00292370|18331136|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
5322808|NCT00292318|18331161|P2|Overall Study|Study terminated by officials|1
5322809|NCT00292318|18331162|P1|Overall Study|Study terminated by officials|2
5322810|NCT00292227|18331172|P3|Patch Period|Withdrawal by Subject|1
5322811|NCT00292227|18331173|P2|Patch Period|Withdrawal by Subject|0
5322812|NCT00292227|18331174|P1|Patch Period|Withdrawal by Subject|0
5322813|NCT00292227|18331172|P3|Patch Period|Adverse Event|2
5322814|NCT00292227|18331173|P2|Patch Period|Adverse Event|0
5322815|NCT00292227|18331174|P1|Patch Period|Adverse Event|1
5322816|NCT00292188|18331256|P3|Double-Blind|Laboratory Abnormality|1
5322817|NCT00292188|18331257|P2|Double-Blind|Laboratory Abnormality|0
5322818|NCT00292188|18331258|P1|Double-Blind|Laboratory Abnormality|0
5322819|NCT00292188|18331256|P3|Double-Blind|Withdrawal by Subject|3
5322820|NCT00292188|18331257|P2|Double-Blind|Withdrawal by Subject|0
5322821|NCT00292188|18331258|P1|Double-Blind|Withdrawal by Subject|0
5322822|NCT00292188|18331256|P3|Double-Blind|Other|4
5322823|NCT00292188|18331257|P2|Double-Blind|Other|3
5322824|NCT00292188|18331258|P1|Double-Blind|Other|0
5322825|NCT00292188|18331256|P3|Double-Blind|Lost to Follow-up|0
5322826|NCT00292188|18331257|P2|Double-Blind|Lost to Follow-up|1
5322827|NCT00292188|18331258|P1|Double-Blind|Lost to Follow-up|0
5322828|NCT00292188|18331256|P3|Double-Blind|Lack of Efficacy|12
5322829|NCT00292188|18331257|P2|Double-Blind|Lack of Efficacy|2
5322830|NCT00292188|18331258|P1|Double-Blind|Lack of Efficacy|0
5322831|NCT00292188|18331256|P3|Double-Blind|Adverse Event|9
5322832|NCT00292188|18331257|P2|Double-Blind|Adverse Event|25
5322833|NCT00292188|18331258|P1|Double-Blind|Adverse Event|0
5322834|NCT00292188|18331256|P3|Single-Blind|Did not receive treatment|0
5322835|NCT00292188|18331257|P2|Single-Blind|Did not receive treatment|0
5322836|NCT00292188|18331258|P1|Single-Blind|Did not receive treatment|1
5322837|NCT00292188|18331256|P3|Single-Blind|Withdrawal by Subject|0
5322838|NCT00292188|18331257|P2|Single-Blind|Withdrawal by Subject|0
5322839|NCT00292188|18331258|P1|Single-Blind|Withdrawal by Subject|12
5322840|NCT00292188|18331256|P3|Single-Blind|Other|0
5322841|NCT00292188|18331257|P2|Single-Blind|Other|0
5322842|NCT00292188|18331258|P1|Single-Blind|Other|77
5322843|NCT00292188|18331256|P3|Single-Blind|Lost to Follow-up|0
5322844|NCT00292188|18331257|P2|Single-Blind|Lost to Follow-up|0
5322845|NCT00292188|18331258|P1|Single-Blind|Lost to Follow-up|3
5322846|NCT00292188|18331256|P3|Single-Blind|Laboratory Abnormality|0
5322847|NCT00292188|18331257|P2|Single-Blind|Laboratory Abnormality|0
5322848|NCT00292188|18331258|P1|Single-Blind|Laboratory Abnormality|5
5322849|NCT00292188|18331256|P3|Single-Blind|Lack of Efficacy|0
5322850|NCT00292188|18331257|P2|Single-Blind|Lack of Efficacy|0
5322851|NCT00292188|18331258|P1|Single-Blind|Lack of Efficacy|2
5322852|NCT00292188|18331256|P3|Single-Blind|Adverse Event|0
5322853|NCT00292188|18331257|P2|Single-Blind|Adverse Event|0
5322854|NCT00292188|18331258|P1|Single-Blind|Adverse Event|14
5322855|NCT00291668|18331368|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5322856|NCT00291668|18331369|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5322857|NCT00291668|18331370|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5322858|NCT00291668|18331368|P3|Overall Study|AE, non-serious non-fatal|0
5322859|NCT00291668|18331369|P2|Overall Study|AE, non-serious non-fatal|0
5322860|NCT00291668|18331370|P1|Overall Study|AE, non-serious non-fatal|1
5322861|NCT00291668|18331368|P3|Overall Study|SAE, non-fatal|1
5322862|NCT00291668|18331369|P2|Overall Study|SAE, non-fatal|1
5322863|NCT00291668|18331370|P1|Overall Study|SAE, non-fatal|1
5322864|NCT00291668|18331368|P3|Overall Study|Lack of Efficacy|0
5322865|NCT00291668|18331369|P2|Overall Study|Lack of Efficacy|0
5322866|NCT00291668|18331370|P1|Overall Study|Lack of Efficacy|1
5322867|NCT00291642|18331466|P5|Overall Study|Intake of prohibited medication|0
5322868|NCT00291642|18331467|P4|Overall Study|Intake of prohibited medication|0
5322869|NCT00291642|18331468|P3|Overall Study|Intake of prohibited medication|0
5322870|NCT00291642|18331469|P2|Overall Study|Intake of prohibited medication|0
5322871|NCT00291642|18331470|P1|Overall Study|Intake of prohibited medication|1
5322872|NCT00291642|18331466|P5|Overall Study|Patient missed visit|0
5322873|NCT00291642|18331467|P4|Overall Study|Patient missed visit|0
5322874|NCT00291642|18331468|P3|Overall Study|Patient missed visit|1
5322875|NCT00291642|18331469|P2|Overall Study|Patient missed visit|0
5322876|NCT00291642|18331470|P1|Overall Study|Patient missed visit|0
5322877|NCT00291642|18331466|P5|Overall Study|Adverse Event|1
5322878|NCT00291642|18331467|P4|Overall Study|Adverse Event|0
5322879|NCT00291642|18331468|P3|Overall Study|Adverse Event|1
5322880|NCT00291642|18331469|P2|Overall Study|Adverse Event|0
5322881|NCT00291642|18331470|P1|Overall Study|Adverse Event|1
5322882|NCT00291577|18331522|P1|Overall Study|Lack of Efficacy|14
5322883|NCT00291577|18331522|P1|Overall Study|Withdrawal by Subject|2
5322884|NCT00291577|18331522|P1|Overall Study|Other|4
5322885|NCT00291577|18331522|P1|Overall Study|Adverse Event|1
5322886|NCT00291551|18331541|P1|Overall Study|Withdrawal by Subject|6
5322887|NCT00291551|18331541|P1|Overall Study|Death|7
5322888|NCT00291330|18331589|P2|Overall Study|Other|1
5322889|NCT00291330|18331590|P1|Overall Study|Other|3
5322890|NCT00291330|18331589|P2|Overall Study|Withdrawal by Subject|25
5322891|NCT00291330|18331590|P1|Overall Study|Withdrawal by Subject|22
5322892|NCT00291330|18331589|P2|Overall Study|Lost to Follow-up|11
5322893|NCT00291330|18331590|P1|Overall Study|Lost to Follow-up|16
5322894|NCT00291330|18331589|P2|Overall Study|Protocol Violation|20
5322895|NCT00291330|18331590|P1|Overall Study|Protocol Violation|13
5322896|NCT00291330|18331589|P2|Overall Study|Adverse Event|40
5322897|NCT00291330|18331590|P1|Overall Study|Adverse Event|47
5322898|NCT00291187|18331632|P4|Overall Study|Protocol Violation- No Drug Administered|0
5322899|NCT00291187|18331633|P3|Overall Study|Protocol Violation- No Drug Administered|1
5322900|NCT00291187|18331634|P2|Overall Study|Protocol Violation- No Drug Administered|0
5322901|NCT00291187|18331635|P1|Overall Study|Protocol Violation- No Drug Administered|0
5322902|NCT00291018|18331679|P3|Overall Study|Lost to Follow-up|18
5322903|NCT00291018|18331680|P2|Overall Study|Lost to Follow-up|4
5322904|NCT00291018|18331681|P1|Overall Study|Lost to Follow-up|3
5322905|NCT00291018|18331679|P3|Overall Study|Failures|5
5322906|NCT00291018|18331680|P2|Overall Study|Failures|12
5322907|NCT00291018|18331681|P1|Overall Study|Failures|5
5322908|NCT00291018|18331679|P3|Overall Study|Withdrawal by Subject|1
5322909|NCT00291018|18331680|P2|Overall Study|Withdrawal by Subject|8
5322910|NCT00291018|18331681|P1|Overall Study|Withdrawal by Subject|2
5322911|NCT00291018|18331679|P3|Overall Study|Death|4
5322912|NCT00291018|18331680|P2|Overall Study|Death|3
5322913|NCT00291018|18331681|P1|Overall Study|Death|3
5322914|NCT00291018|18331679|P3|Overall Study|Not Consented or Declined PAS|15
5322915|NCT00291018|18331680|P2|Overall Study|Not Consented or Declined PAS|15
5322916|NCT00291018|18331681|P1|Overall Study|Not Consented or Declined PAS|12
5322917|NCT00290888|18331721|P2|Overall Study|Physician Decision|1
5322918|NCT00290888|18331722|P1|Overall Study|Physician Decision|3
5322919|NCT00290771|18331739|P2|Overall Study|Lost to Follow-up|1
5322920|NCT00290771|18331740|P1|Overall Study|Lost to Follow-up|0
5322921|NCT00290771|18331739|P2|Overall Study|Protocol Violation|0
5322922|NCT00290771|18331740|P1|Overall Study|Protocol Violation|2
5322923|NCT00290771|18331739|P2|Overall Study|Administrative problems|1
5322924|NCT00290771|18331740|P1|Overall Study|Administrative problems|2
5322925|NCT00290771|18331739|P2|Overall Study|Withdrawal by Subject|6
5322926|NCT00290771|18331740|P1|Overall Study|Withdrawal by Subject|5
5322927|NCT00290771|18331739|P2|Overall Study|Adverse Event|6
5322928|NCT00290771|18331740|P1|Overall Study|Adverse Event|12
5322929|NCT00290771|18331739|P2|Overall Study|Death|10
5322930|NCT00290771|18331740|P1|Overall Study|Death|11
5322931|NCT00290771|18331739|P2|Overall Study|Disease progression|73
5322932|NCT00290771|18331740|P1|Overall Study|Disease progression|95
5322933|NCT00290758|18331764|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
5322934|NCT00290758|18331765|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
5322935|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
5322936|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
5322937|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
5322938|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
5322939|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
5322940|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
5322941|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
5322942|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
5322943|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
5322944|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
5322945|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
5322946|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
5322947|NCT00290758|18331764|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
5322948|NCT00290758|18331765|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
5322949|NCT00290732|18331787|P5|Overall Study|Inability to instill drug intraductally.|0
5322950|NCT00290732|18331788|P4|Overall Study|Inability to instill drug intraductally.|0
5322951|NCT00290732|18331789|P3|Overall Study|Inability to instill drug intraductally.|1
5322952|NCT00290732|18331790|P2|Overall Study|Inability to instill drug intraductally.|1
5322953|NCT00290732|18331791|P1|Overall Study|Inability to instill drug intraductally.|0
5322954|NCT00290706|18331813|P4|Overall Study|Physician Decision|1
5322955|NCT00290706|18331814|P3|Overall Study|Physician Decision|0
5322956|NCT00290706|18331815|P2|Overall Study|Physician Decision|0
5322957|NCT00290706|18331816|P1|Overall Study|Physician Decision|0
5322958|NCT00290706|18331813|P4|Overall Study|Receive auto transplant or radiation|1
5322959|NCT00290706|18331814|P3|Overall Study|Receive auto transplant or radiation|0
5322960|NCT00290706|18331815|P2|Overall Study|Receive auto transplant or radiation|0
5322961|NCT00290706|18331816|P1|Overall Study|Receive auto transplant or radiation|0
5322962|NCT00290706|18331813|P4|Overall Study|Adverse Event|0
5322963|NCT00290706|18331814|P3|Overall Study|Adverse Event|2
5322964|NCT00290706|18331815|P2|Overall Study|Adverse Event|1
5322965|NCT00290706|18331816|P1|Overall Study|Adverse Event|0
5322966|NCT00290706|18331813|P4|Overall Study|Progressive Disease|10
5322967|NCT00290706|18331814|P3|Overall Study|Progressive Disease|4
5322968|NCT00290706|18331815|P2|Overall Study|Progressive Disease|5
5322969|NCT00290706|18331816|P1|Overall Study|Progressive Disease|3
5322970|NCT00290706|18331813|P4|Overall Study|Withdrawal by Subject|0
5322971|NCT00290706|18331814|P3|Overall Study|Withdrawal by Subject|0
5322972|NCT00290706|18331815|P2|Overall Study|Withdrawal by Subject|0
5322973|NCT00290706|18331816|P1|Overall Study|Withdrawal by Subject|2
5322974|NCT00290693|18331835|P1|Overall Study|Withdrawal by Subject|2
5322975|NCT00290589|18331863|P2|Overall Study|Lost to Follow-up|2
5322976|NCT00290589|18331864|P1|Overall Study|Lost to Follow-up|2
5322977|NCT00290498|18331882|P2|Overall Study|Non-Compliance|0
5322978|NCT00290498|18331883|P1|Overall Study|Non-Compliance|1
5322979|NCT00290498|18331882|P2|Overall Study|Ineligible|0
5322980|NCT00290498|18331883|P1|Overall Study|Ineligible|3
5322981|NCT00290498|18331882|P2|Overall Study|Withdrawal by Subject|0
5322982|NCT00290498|18331883|P1|Overall Study|Withdrawal by Subject|1
5322983|NCT00290498|18331882|P2|Overall Study|Physician Decision|0
5322984|NCT00290498|18331883|P1|Overall Study|Physician Decision|1
5322985|NCT00290498|18331882|P2|Overall Study|Death|0
5322986|NCT00290498|18331883|P1|Overall Study|Death|2
5322987|NCT00290433|18331908|P1|Overall Study|Unrelated Infection/Death|1
5322988|NCT00290433|18331908|P1|Overall Study|Transplant in CR|5
5322989|NCT00290433|18331908|P1|Overall Study|Congestive Heart Failure|1
5322990|NCT00290433|18331908|P1|Overall Study|Non-Compliance|1
5322991|NCT00290433|18331908|P1|Overall Study|Withdrawal by Subject|1
5322992|NCT00290433|18331908|P1|Overall Study|Adverse Event|14
5322993|NCT00290433|18331908|P1|Overall Study|Disease Progression|13
5322994|NCT00290407|18331912|P1|Overall Study|Physician Decision|2
5322995|NCT00290355|18331919|P2|Overall Study|Other|0
5322996|NCT00290355|18331920|P1|Overall Study|Other|2
5322997|NCT00290355|18331919|P2|Overall Study|Lost to Follow-up|1
5322998|NCT00290355|18331920|P1|Overall Study|Lost to Follow-up|3
5322999|NCT00290355|18331919|P2|Overall Study|Migrated / moved from the study area|0
5323000|NCT00290355|18331920|P1|Overall Study|Migrated / moved from the study area|1
5323001|NCT00290355|18331919|P2|Overall Study|Withdrawal by Subject|0
5323002|NCT00290355|18331920|P1|Overall Study|Withdrawal by Subject|2
5323003|NCT00290355|18331919|P2|Overall Study|Protocol Violation|0
5323004|NCT00290355|18331920|P1|Overall Study|Protocol Violation|1
5323005|NCT00290355|18331919|P2|Overall Study|Study product reactogenicity|0
5323006|NCT00290355|18331920|P1|Overall Study|Study product reactogenicity|1
5323007|NCT00290355|18331919|P2|Overall Study|Serious adverse event|4
5323008|NCT00290355|18331920|P1|Overall Study|Serious adverse event|7
5323009|NCT00290342|18331964|P2|Overall Study|Lost to Follow-up|0
5323010|NCT00290342|18331965|P1|Overall Study|Lost to Follow-up|1
5323011|NCT00290342|18331964|P2|Overall Study|Withdrawal by Subject|4
5323012|NCT00290342|18331965|P1|Overall Study|Withdrawal by Subject|6
5323013|NCT00290342|18331964|P2|Overall Study|Other|1
5323014|NCT00290342|18331965|P1|Overall Study|Other|0
5323015|NCT00290290|18332020|P2|Overall Study|Underwent clean surgical procedure|12
5323016|NCT00290290|18332021|P1|Overall Study|Underwent clean surgical procedure|13
5323017|NCT00290290|18332020|P2|Overall Study|Withdrawal by Subject|2
5323018|NCT00290290|18332021|P1|Overall Study|Withdrawal by Subject|2
5323019|NCT00290290|18332020|P2|Overall Study|Death|4
5323020|NCT00290290|18332021|P1|Overall Study|Death|3
5323021|NCT00290251|18332027|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
5323022|NCT00290251|18332028|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
5323023|NCT00290251|18332029|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
5323024|NCT00290251|18332027|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
5323025|NCT00290251|18332028|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
5323026|NCT00290251|18332029|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
5323027|NCT00290251|18332027|P3|Treatment 1 (Months 1 - 3)|headache|0
5323028|NCT00290251|18332028|P2|Treatment 1 (Months 1 - 3)|headache|1
5323029|NCT00290251|18332029|P1|Treatment 1 (Months 1 - 3)|headache|0
5323030|NCT00290251|18332027|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
5323031|NCT00290251|18332028|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
5323032|NCT00290251|18332029|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
5323033|NCT00290238|18332041|P2|Overall Study|Withdrawal by Subject|13
5323034|NCT00290238|18332042|P1|Overall Study|Withdrawal by Subject|15
5323035|NCT00290238|18332041|P2|Overall Study|Lost to Follow-up|1
5323036|NCT00290238|18332042|P1|Overall Study|Lost to Follow-up|0
5323037|NCT00290238|18332041|P2|Overall Study|Study terminated|27
5323038|NCT00290238|18332042|P1|Overall Study|Study terminated|27
5323039|NCT00290186|18332067|P2|Overall Study|Withdrawal by Subject|1
5323040|NCT00290186|18332068|P1|Overall Study|Withdrawal by Subject|0
5323041|NCT00290186|18332067|P2|Overall Study|Study was terminated prior to 3-month te|1
5323042|NCT00290186|18332068|P1|Overall Study|Study was terminated prior to 3-month te|1
5323043|NCT00290186|18332067|P2|Overall Study|Lost to Follow-up|2
5323044|NCT00290186|18332068|P1|Overall Study|Lost to Follow-up|3
5323045|NCT00290186|18332067|P2|Overall Study|Adverse Event|1
5323046|NCT00290186|18332068|P1|Overall Study|Adverse Event|1
5323047|NCT00289991|18332119|P2|Overall Study|Other|14
5323048|NCT00289991|18332120|P1|Overall Study|Other|5
5323049|NCT00289991|18332119|P2|Overall Study|Withdrawal by Subject|12
5323050|NCT00289991|18332120|P1|Overall Study|Withdrawal by Subject|2
5323051|NCT00289991|18332119|P2|Overall Study|Lost to Follow-up|1
5323052|NCT00289991|18332120|P1|Overall Study|Lost to Follow-up|0
5323053|NCT00289991|18332119|P2|Overall Study|Fungal breakthrough infection|1
5323054|NCT00289991|18332120|P1|Overall Study|Fungal breakthrough infection|0
5323055|NCT00289991|18332119|P2|Overall Study|Failure of prophylaxis|1
5323056|NCT00289991|18332120|P1|Overall Study|Failure of prophylaxis|1
5323057|NCT00289991|18332119|P2|Overall Study|Adverse Event|13
5323058|NCT00289991|18332120|P1|Overall Study|Adverse Event|15
5323059|NCT00289991|18332119|P2|Overall Study|Death|38
5323060|NCT00289991|18332120|P1|Overall Study|Death|35
5323061|NCT00289978|18332145|P3|Overall Study|Death|2
5323062|NCT00289978|18332146|P2|Overall Study|Death|0
5323063|NCT00289978|18332147|P1|Overall Study|Death|1
5323064|NCT00289978|18332145|P3|Overall Study|Abnormal test procedure result(s)|1
5323065|NCT00289978|18332146|P2|Overall Study|Abnormal test procedure result(s)|1
5323066|NCT00289978|18332147|P1|Overall Study|Abnormal test procedure result(s)|2
5323067|NCT00289978|18332145|P3|Overall Study|Protocol Violation|4
5323068|NCT00289978|18332146|P2|Overall Study|Protocol Violation|5
5323069|NCT00289978|18332147|P1|Overall Study|Protocol Violation|5
5323070|NCT00289978|18332145|P3|Overall Study|Lost to Follow-up|7
5323071|NCT00289978|18332146|P2|Overall Study|Lost to Follow-up|5
5323072|NCT00289978|18332147|P1|Overall Study|Lost to Follow-up|3
5323073|NCT00289978|18332145|P3|Overall Study|Abnormal laboratory value(s)|1
5323074|NCT00289978|18332146|P2|Overall Study|Abnormal laboratory value(s)|9
5323075|NCT00289978|18332147|P1|Overall Study|Abnormal laboratory value(s)|20
5323076|NCT00289978|18332145|P3|Overall Study|Lack of Efficacy|25
5323077|NCT00289978|18332146|P2|Overall Study|Lack of Efficacy|6
5323078|NCT00289978|18332147|P1|Overall Study|Lack of Efficacy|13
5323079|NCT00289978|18332145|P3|Overall Study|Adverse Event|18
5323080|NCT00289978|18332146|P2|Overall Study|Adverse Event|13
5323081|NCT00289978|18332147|P1|Overall Study|Adverse Event|22
5323082|NCT00289978|18332145|P3|Overall Study|Withdrawal by Subject|28
5323083|NCT00289978|18332146|P2|Overall Study|Withdrawal by Subject|17
5323084|NCT00289978|18332147|P1|Overall Study|Withdrawal by Subject|31
5323085|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5323086|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5323087|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5323088|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
5323089|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5323090|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
5323091|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5323092|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5323093|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5323094|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5323095|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5323096|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5323097|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
5323098|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
5323099|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5323100|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
5323101|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
5323102|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
5323103|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
5323104|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
5323105|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
5323106|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5323107|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5323108|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5323109|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5323110|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323111|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
5323112|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323113|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323114|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323115|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
5323116|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
5323117|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
5323118|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
5323119|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
5323120|NCT00289913|18332166|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323121|NCT00289913|18332167|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323122|NCT00289913|18332168|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323123|NCT00289913|18332169|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
5323124|NCT00289913|18332170|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323125|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
5323126|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5323127|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5323128|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5323129|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5323130|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
5323131|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5323132|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5323133|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5323134|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5323135|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
5323136|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5323137|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5323138|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5323139|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5323140|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
5323141|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5323142|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5323143|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5323144|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5323145|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
5323146|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5323147|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5323148|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5323149|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5323150|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5323151|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5323152|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5323153|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5323154|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
5323155|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
5323156|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
5323157|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
5323158|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
5323159|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
5323160|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
5323161|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
5323162|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
5323163|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
5323164|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
5323165|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5323166|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
5323167|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
5323168|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
5323169|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5323170|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
5323171|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
5323172|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
5323173|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
5323174|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
5323175|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323176|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323177|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
5323178|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5323179|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
5323180|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5323181|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5323182|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5323183|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
5323184|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5323185|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
5323186|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
5323187|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
5323188|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
5323189|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
5323190|NCT00289913|18332166|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323191|NCT00289913|18332167|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323192|NCT00289913|18332168|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
5323193|NCT00289913|18332169|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323194|NCT00289913|18332170|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323195|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
5323196|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
5323197|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
5323198|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
5323199|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
5323200|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5323201|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
5323202|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
5323203|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
5323204|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5323205|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
5323206|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
5323207|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
5323208|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
5323209|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
5323210|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5323211|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5323212|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5323213|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
5323214|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
5323215|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5323216|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
5323217|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5323218|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5323219|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5323220|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
5323221|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5323222|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5323223|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5323224|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5323225|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5323226|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5323313|NCT00289874|18332330|P1|Overall Study|Adverse Event|1
5323227|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5323228|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5323229|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5323230|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
5323231|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
5323232|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
5323233|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
5323234|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
5323235|NCT00289913|18332166|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323236|NCT00289913|18332167|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323237|NCT00289913|18332168|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323238|NCT00289913|18332169|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
5323239|NCT00289913|18332170|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5323240|NCT00289900|18332201|P6|Overall Study|Not treated|0
5323241|NCT00289900|18332202|P5|Overall Study|Not treated|0
5323242|NCT00289900|18332203|P4|Overall Study|Not treated|0
5323243|NCT00289900|18332204|P3|Overall Study|Not treated|0
5323244|NCT00289900|18332205|P2|Overall Study|Not treated|1
5323245|NCT00289900|18332206|P1|Overall Study|Not treated|0
5323246|NCT00289900|18332201|P6|Overall Study|site terminated|0
5323247|NCT00289900|18332202|P5|Overall Study|site terminated|0
5323248|NCT00289900|18332203|P4|Overall Study|site terminated|0
5323249|NCT00289900|18332204|P3|Overall Study|site terminated|1
5323250|NCT00289900|18332205|P2|Overall Study|site terminated|0
5323251|NCT00289900|18332206|P1|Overall Study|site terminated|1
5323252|NCT00289900|18332201|P6|Overall Study|Protocol Violation|4
5323253|NCT00289900|18332202|P5|Overall Study|Protocol Violation|7
5323254|NCT00289900|18332203|P4|Overall Study|Protocol Violation|6
5323255|NCT00289900|18332204|P3|Overall Study|Protocol Violation|2
5323256|NCT00289900|18332205|P2|Overall Study|Protocol Violation|9
5323257|NCT00289900|18332206|P1|Overall Study|Protocol Violation|3
5323258|NCT00289900|18332201|P6|Overall Study|Withdrawal by Subject|11
5323259|NCT00289900|18332202|P5|Overall Study|Withdrawal by Subject|12
5323260|NCT00289900|18332203|P4|Overall Study|Withdrawal by Subject|18
5323261|NCT00289900|18332204|P3|Overall Study|Withdrawal by Subject|8
5323262|NCT00289900|18332205|P2|Overall Study|Withdrawal by Subject|21
5323263|NCT00289900|18332206|P1|Overall Study|Withdrawal by Subject|10
5323264|NCT00289900|18332201|P6|Overall Study|Participant moved|1
5323265|NCT00289900|18332202|P5|Overall Study|Participant moved|1
5323266|NCT00289900|18332203|P4|Overall Study|Participant moved|1
5323267|NCT00289900|18332204|P3|Overall Study|Participant moved|0
5323268|NCT00289900|18332205|P2|Overall Study|Participant moved|0
5323269|NCT00289900|18332206|P1|Overall Study|Participant moved|1
5323270|NCT00289900|18332201|P6|Overall Study|Other|0
5323271|NCT00289900|18332202|P5|Overall Study|Other|1
5323272|NCT00289900|18332203|P4|Overall Study|Other|5
5323273|NCT00289900|18332204|P3|Overall Study|Other|0
5323274|NCT00289900|18332205|P2|Overall Study|Other|0
5323275|NCT00289900|18332206|P1|Overall Study|Other|0
5323276|NCT00289900|18332201|P6|Overall Study|Participant had flushing|4
5323277|NCT00289900|18332202|P5|Overall Study|Participant had flushing|0
5323278|NCT00289900|18332203|P4|Overall Study|Participant had flushing|2
5323279|NCT00289900|18332204|P3|Overall Study|Participant had flushing|1
5323280|NCT00289900|18332205|P2|Overall Study|Participant had flushing|42
5323281|NCT00289900|18332206|P1|Overall Study|Participant had flushing|18
5323282|NCT00289900|18332201|P6|Overall Study|Lost to Follow-up|8
5323283|NCT00289900|18332202|P5|Overall Study|Lost to Follow-up|4
5323284|NCT00289900|18332203|P4|Overall Study|Lost to Follow-up|8
5323285|NCT00289900|18332204|P3|Overall Study|Lost to Follow-up|8
5323286|NCT00289900|18332205|P2|Overall Study|Lost to Follow-up|7
5323287|NCT00289900|18332206|P1|Overall Study|Lost to Follow-up|7
5323288|NCT00289900|18332201|P6|Overall Study|Adverse Event|33
5323289|NCT00289900|18332202|P5|Overall Study|Adverse Event|20
5323290|NCT00289900|18332203|P4|Overall Study|Adverse Event|19
5323291|NCT00289900|18332204|P3|Overall Study|Adverse Event|13
5323292|NCT00289900|18332205|P2|Overall Study|Adverse Event|40
5323293|NCT00289900|18332206|P1|Overall Study|Adverse Event|28
5323294|NCT00289887|18332310|P2|Overall Study|Other|3
5323295|NCT00289887|18332311|P1|Overall Study|Other|7
5323296|NCT00289887|18332310|P2|Overall Study|Withdrawal by Subject|8
5323297|NCT00289887|18332311|P1|Overall Study|Withdrawal by Subject|3
5323298|NCT00289887|18332310|P2|Overall Study|Protocol Violation|1
5323299|NCT00289887|18332311|P1|Overall Study|Protocol Violation|3
5323300|NCT00289887|18332310|P2|Overall Study|Lost to Follow-up|3
5323301|NCT00289887|18332311|P1|Overall Study|Lost to Follow-up|3
5323302|NCT00289887|18332310|P2|Overall Study|Lack of Efficacy|11
5323303|NCT00289887|18332311|P1|Overall Study|Lack of Efficacy|3
5323304|NCT00289887|18332310|P2|Overall Study|Adverse Event|3
5323305|NCT00289887|18332311|P1|Overall Study|Adverse Event|3
5323306|NCT00289874|18332329|P2|Overall Study|Did not meet eligibility|0
5323307|NCT00289874|18332330|P1|Overall Study|Did not meet eligibility|1
5323308|NCT00289874|18332329|P2|Overall Study|Protocol Violation|2
5323309|NCT00289874|18332330|P1|Overall Study|Protocol Violation|3
5323310|NCT00289874|18332329|P2|Overall Study|Lost to Follow-up|1
5323311|NCT00289874|18332330|P1|Overall Study|Lost to Follow-up|1
5323312|NCT00289874|18332329|P2|Overall Study|Adverse Event|5
5323314|NCT00289848|18332340|P2|Overall Study|Open-Label AHA Treatment Requested|1
5323315|NCT00289848|18332341|P1|Overall Study|Open-Label AHA Treatment Requested|0
5323316|NCT00289848|18332340|P2|Overall Study|Patient Moved|2
5323317|NCT00289848|18332341|P1|Overall Study|Patient Moved|6
5323318|NCT00289848|18332340|P2|Overall Study|Withdrawal by Subject|11
5323319|NCT00289848|18332341|P1|Overall Study|Withdrawal by Subject|5
5323320|NCT00289848|18332340|P2|Overall Study|Protocol Violation|2
5323321|NCT00289848|18332341|P1|Overall Study|Protocol Violation|5
5323322|NCT00289848|18332340|P2|Overall Study|Lost to Follow-up|1
5323323|NCT00289848|18332341|P1|Overall Study|Lost to Follow-up|3
5323324|NCT00289848|18332340|P2|Overall Study|Lack of Efficacy|24
5323325|NCT00289848|18332341|P1|Overall Study|Lack of Efficacy|20
5323326|NCT00289848|18332340|P2|Overall Study|Death|0
5323327|NCT00289848|18332341|P1|Overall Study|Death|1
5323328|NCT00289848|18332340|P2|Overall Study|Adverse Event|4
5323329|NCT00289848|18332341|P1|Overall Study|Adverse Event|6
5323330|NCT00289783|18332353|P2|Fourth Dose Phase|Other|10
5323331|NCT00289783|18332354|P1|Fourth Dose Phase|Other|22
5323332|NCT00289783|18332353|P2|Fourth Dose Phase|Migration from the study area|1
5323333|NCT00289783|18332354|P1|Fourth Dose Phase|Migration from the study area|1
5323334|NCT00289783|18332353|P2|Fourth Dose Phase|Lost to Follow-up|12
5323335|NCT00289783|18332354|P1|Fourth Dose Phase|Lost to Follow-up|53
5323336|NCT00289783|18332353|P2|Fourth Dose Phase|Withdrawal by Subject|1
5323337|NCT00289783|18332354|P1|Fourth Dose Phase|Withdrawal by Subject|10
5323338|NCT00289783|18332353|P2|Fourth Dose Phase|Adverse Event|0
5323339|NCT00289783|18332354|P1|Fourth Dose Phase|Adverse Event|1
5323340|NCT00289783|18332353|P2|Primary Phase|Other|12
5323341|NCT00289783|18332354|P1|Primary Phase|Other|32
5323342|NCT00289783|18332353|P2|Primary Phase|Migration from the study area|10
5323343|NCT00289783|18332354|P1|Primary Phase|Migration from the study area|26
5323344|NCT00289783|18332353|P2|Primary Phase|Lost to Follow-up|14
5323345|NCT00289783|18332354|P1|Primary Phase|Lost to Follow-up|60
5323346|NCT00289783|18332353|P2|Primary Phase|Withdrawal by Subject|40
5323347|NCT00289783|18332354|P1|Primary Phase|Withdrawal by Subject|93
5323348|NCT00289783|18332353|P2|Primary Phase|Protocol Violation|6
5323349|NCT00289783|18332354|P1|Primary Phase|Protocol Violation|27
5323350|NCT00289783|18332353|P2|Primary Phase|Adverse Event|1
5323351|NCT00289783|18332354|P1|Primary Phase|Adverse Event|10
5323352|NCT00289770|18332532|P1|Year 15|Withdrawal by Subject|1
5323353|NCT00289731|18332578|P3|Overall Study|Other|0
5323354|NCT00289731|18332579|P2|Overall Study|Other|0
5323355|NCT00289731|18332580|P1|Overall Study|Other|1
5323356|NCT00289731|18332578|P3|Overall Study|Adverse Event|2
5323357|NCT00289731|18332579|P2|Overall Study|Adverse Event|2
5323358|NCT00289731|18332580|P1|Overall Study|Adverse Event|1
5323359|NCT00289536|18332692|P3|Period 3|Lost to Follow-up|1
5323360|NCT00289536|18332693|P2|Period 3|Lost to Follow-up|0
5323361|NCT00289536|18332694|P1|Period 3|Lost to Follow-up|0
5323362|NCT00289458|18332740|P3|Overall Study|Withdrawal by Subject|4
5323363|NCT00289458|18332741|P2|Overall Study|Withdrawal by Subject|2
5323364|NCT00289458|18332742|P1|Overall Study|Withdrawal by Subject|2
5323365|NCT00289458|18332740|P3|Overall Study|Physician Decision|2
5323366|NCT00289458|18332741|P2|Overall Study|Physician Decision|4
5323367|NCT00289458|18332742|P1|Overall Study|Physician Decision|3
5323368|NCT00289458|18332740|P3|Overall Study|Death|0
5323369|NCT00289458|18332741|P2|Overall Study|Death|0
5323370|NCT00289458|18332742|P1|Overall Study|Death|1
5323371|NCT00289289|18332803|P3|Overall Study|Other Exit Reason|12
5323372|NCT00289289|18332804|P2|Overall Study|Other Exit Reason|4
5323373|NCT00289289|18332805|P1|Overall Study|Other Exit Reason|6
5323374|NCT00289289|18332803|P3|Overall Study|Did not meet inclusion/exclusion|6
5323375|NCT00289289|18332804|P2|Overall Study|Did not meet inclusion/exclusion|0
5323376|NCT00289289|18332805|P1|Overall Study|Did not meet inclusion/exclusion|0
5323377|NCT00289289|18332803|P3|Overall Study|Non-study device implanted|3
5323378|NCT00289289|18332804|P2|Overall Study|Non-study device implanted|1
5323379|NCT00289289|18332805|P1|Overall Study|Non-study device implanted|2
5323380|NCT00289289|18332803|P3|Overall Study|Physician Decision|6
5323381|NCT00289289|18332804|P2|Overall Study|Physician Decision|0
5323382|NCT00289289|18332805|P1|Overall Study|Physician Decision|1
5323383|NCT00289289|18332803|P3|Overall Study|No implant attempted|1
5323384|NCT00289289|18332804|P2|Overall Study|No implant attempted|0
5323385|NCT00289289|18332805|P1|Overall Study|No implant attempted|0
5323386|NCT00289289|18332803|P3|Overall Study|Death|5
5323387|NCT00289289|18332804|P2|Overall Study|Death|2
5323388|NCT00289289|18332805|P1|Overall Study|Death|4
5323389|NCT00289289|18332803|P3|Overall Study|Lost to Follow-up|1
5323390|NCT00289289|18332804|P2|Overall Study|Lost to Follow-up|0
5323391|NCT00289289|18332805|P1|Overall Study|Lost to Follow-up|1
5323392|NCT00289289|18332803|P3|Overall Study|Withdrawal by Subject|15
5323393|NCT00289289|18332804|P2|Overall Study|Withdrawal by Subject|3
5323394|NCT00289289|18332805|P1|Overall Study|Withdrawal by Subject|5
5323395|NCT00289276|18332820|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
5323396|NCT00289276|18332821|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
5323397|NCT00289276|18332820|P2|Second Part of FAST Study (Expansion)|Death|2
5323398|NCT00289276|18332821|P1|Second Part of FAST Study (Expansion)|Death|0
5323399|NCT00289198|18332856|P2|Overall Study|Other: Impossible to come on visit|1
5323400|NCT00289198|18332857|P1|Overall Study|Other: Impossible to come on visit|0
5323401|NCT00289198|18332856|P2|Overall Study|Other: Miscalculation of the visit date|22
5323485|NCT00288639|18333109|P1|Overall Study|Lack of Efficacy|4
5323402|NCT00289198|18332857|P1|Overall Study|Other: Miscalculation of the visit date|21
5323403|NCT00289198|18332856|P2|Overall Study|Other: Unable to attend on schedule|1
5323404|NCT00289198|18332857|P1|Overall Study|Other: Unable to attend on schedule|2
5323405|NCT00289198|18332856|P2|Overall Study|Other: Physician's decision|1
5323406|NCT00289198|18332857|P1|Overall Study|Other: Physician's decision|0
5323407|NCT00289198|18332856|P2|Overall Study|Other: Low compliance|1
5323408|NCT00289198|18332857|P1|Overall Study|Other: Low compliance|0
5323409|NCT00289198|18332856|P2|Overall Study|Lack of Efficacy|0
5323410|NCT00289198|18332857|P1|Overall Study|Lack of Efficacy|2
5323411|NCT00289198|18332856|P2|Overall Study|Withdrawal by Subject|1
5323412|NCT00289198|18332857|P1|Overall Study|Withdrawal by Subject|4
5323413|NCT00289198|18332856|P2|Overall Study|Protocol Violation|1
5323414|NCT00289198|18332857|P1|Overall Study|Protocol Violation|2
5323415|NCT00289198|18332856|P2|Overall Study|Adverse Event|2
5323416|NCT00289198|18332857|P1|Overall Study|Adverse Event|0
5323417|NCT00289185|18332907|P2|Overall Study|Death|1
5323418|NCT00289185|18332908|P1|Overall Study|Death|1
5323419|NCT00289185|18332907|P2|Overall Study|Lost to Follow-up|17
5323420|NCT00289185|18332908|P1|Overall Study|Lost to Follow-up|23
5323421|NCT00289185|18332907|P2|Overall Study|Withdrawal by Subject|8
5323422|NCT00289185|18332908|P1|Overall Study|Withdrawal by Subject|4
5323423|NCT00289133|18332955|P2|Overall Study|Lost to Follow-up|115
5323424|NCT00289133|18332956|P1|Overall Study|Lost to Follow-up|92
5323425|NCT00289133|18332955|P2|Overall Study|Revision|6
5323426|NCT00289133|18332956|P1|Overall Study|Revision|8
5323427|NCT00289133|18332955|P2|Overall Study|Physician Decision|45
5323428|NCT00289133|18332956|P1|Overall Study|Physician Decision|41
5323429|NCT00289133|18332955|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
5323430|NCT00289133|18332956|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
5323431|NCT00289133|18332955|P2|Overall Study|Death|10
5323432|NCT00289133|18332956|P1|Overall Study|Death|5
5323433|NCT00289133|18332955|P2|Overall Study|Withdrawal by Subject|10
5323434|NCT00289133|18332956|P1|Overall Study|Withdrawal by Subject|9
5323435|NCT00289133|18332955|P2|Overall Study|Protocol Violation|38
5323436|NCT00289133|18332956|P1|Overall Study|Protocol Violation|32
5323437|NCT00289133|18332955|P2|Overall Study|Non-study device implanted|0
5323438|NCT00289133|18332956|P1|Overall Study|Non-study device implanted|12
5323439|NCT00289016|18333012|P1|Overall Study|Other|1
5323440|NCT00289016|18333012|P1|Overall Study|Adverse Event|1
5323441|NCT00289016|18333012|P1|Overall Study|Withdrawal by Subject|2
5323442|NCT00289016|18333012|P1|Overall Study|Unrelated Medical Condition or Accident|2
5323443|NCT00289016|18333012|P1|Overall Study|Death|2
5323444|NCT00289016|18333012|P1|Overall Study|Disease Progression|29
5323445|NCT00288912|18333024|P3|Overall Study|Withdrawal by Subject|12
5323446|NCT00288912|18333025|P2|Overall Study|Withdrawal by Subject|5
5323447|NCT00288912|18333026|P1|Overall Study|Withdrawal by Subject|4
5323448|NCT00288912|18333024|P3|Overall Study|Lost to Follow-up|9
5323449|NCT00288912|18333025|P2|Overall Study|Lost to Follow-up|6
5323450|NCT00288912|18333026|P1|Overall Study|Lost to Follow-up|9
5323451|NCT00288912|18333024|P3|Overall Study|Developed exclusion criterion|7
5323452|NCT00288912|18333025|P2|Overall Study|Developed exclusion criterion|6
5323453|NCT00288912|18333026|P1|Overall Study|Developed exclusion criterion|4
5323454|NCT00288860|18333066|P2|Overall Study|Lost to Follow-up|71
5323455|NCT00288860|18333067|P1|Overall Study|Lost to Follow-up|74
5323456|NCT00288860|18333066|P2|Overall Study|Withdrawal by Subject|15
5323457|NCT00288860|18333067|P1|Overall Study|Withdrawal by Subject|20
5323458|NCT00288860|18333066|P2|Overall Study|Death|3
5323459|NCT00288860|18333067|P1|Overall Study|Death|4
5323460|NCT00288860|18333066|P2|Overall Study|Did not complete intake|8
5323461|NCT00288860|18333067|P1|Overall Study|Did not complete intake|4
5323462|NCT00288704|18333080|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
5323463|NCT00288704|18333081|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
5323464|NCT00288704|18333082|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
5323465|NCT00288704|18333080|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
5323466|NCT00288704|18333081|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
5323467|NCT00288704|18333082|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
5323468|NCT00288704|18333080|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
5323469|NCT00288704|18333081|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
5323470|NCT00288704|18333082|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
5323471|NCT00288704|18333080|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
5323472|NCT00288704|18333081|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
5323473|NCT00288704|18333082|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
5323474|NCT00288704|18333080|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
5323475|NCT00288704|18333081|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
5323476|NCT00288704|18333082|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
5323477|NCT00288704|18333080|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
5323478|NCT00288704|18333081|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
5323479|NCT00288704|18333082|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
5323480|NCT00288704|18333080|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
5323481|NCT00288704|18333081|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
5323482|NCT00288704|18333082|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
5323483|NCT00288639|18333109|P1|Overall Study|Other|1
5323484|NCT00288639|18333109|P1|Overall Study|Withdrawal by Subject|2
5323486|NCT00288639|18333109|P1|Overall Study|Adverse Event|5
5323487|NCT00288626|18333126|P1|Overall Study|Withdrawal by Subject|4
5323488|NCT00288626|18333126|P1|Overall Study|Death|3
5323489|NCT00288587|18333160|P2|Overall Study|Severe Aortic Stenosis|0
5323490|NCT00288587|18333161|P1|Overall Study|Severe Aortic Stenosis|1
5323491|NCT00288587|18333160|P2|Overall Study|Physician Decision|2
5323492|NCT00288587|18333161|P1|Overall Study|Physician Decision|0
5323493|NCT00288587|18333160|P2|Overall Study|Adverse Event|1
5323494|NCT00288587|18333161|P1|Overall Study|Adverse Event|0
5323495|NCT00288587|18333160|P2|Overall Study|Transplant|3
5323496|NCT00288587|18333161|P1|Overall Study|Transplant|0
5323497|NCT00288587|18333160|P2|Overall Study|Death|4
5323498|NCT00288587|18333161|P1|Overall Study|Death|4
5323499|NCT00288509|18333204|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
5323500|NCT00288509|18333204|P1|Treatment Cycle 4|Physician Decision|4
5323501|NCT00288509|18333204|P1|Treatment Cycle 4|Withdrawal by Subject|3
5323502|NCT00288509|18333204|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
5323503|NCT00288509|18333204|P1|Treatment Cycle 3|Lost to Follow-up|2
5323504|NCT00288509|18333204|P1|Treatment Cycle 3|Withdrawal by Subject|1
5323505|NCT00288509|18333204|P1|Treatment Cycle 3|Lack of Efficacy|1
5323506|NCT00288509|18333204|P1|Treatment Cycle 2|Withdrawal by Subject|2
5323507|NCT00288509|18333204|P1|Treatment Cycle 2|Lack of Efficacy|1
5323508|NCT00288509|18333204|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
5323509|NCT00288509|18333204|P1|Treatment Cycle 1|Lost to Follow-up|2
5323510|NCT00288509|18333204|P1|Treatment Cycle 1|Withdrawal by Subject|1
5323511|NCT00288509|18333204|P1|Treatment Cycle 1|Lack of Efficacy|1
5323512|NCT00288509|18333204|P1|Treatment Cycle 1|Adverse Event|1
5323513|NCT00288080|18333222|P2|Overall Study|Protocol Violation|20
5323514|NCT00288080|18333223|P1|Overall Study|Protocol Violation|25
5323515|NCT00288080|18333222|P2|Overall Study|Withdrawal by Subject|3
5323516|NCT00288080|18333223|P1|Overall Study|Withdrawal by Subject|1
5323517|NCT00288054|18333245|P1|Overall Study|Not protocol specified|2
5323518|NCT00288054|18333245|P1|Overall Study|Withdrawal by Subject|1
5323519|NCT00288054|18333245|P1|Overall Study|Adverse Event|3
5323520|NCT00288054|18333245|P1|Overall Study|Lack of Efficacy|16
5323521|NCT00288054|18333245|P1|Overall Study|Protocol Violation|2
5323522|NCT00288015|18333253|P1|Follow up for Survival x 2 Years|Other|9
5323523|NCT00288015|18333253|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
5323524|NCT00288015|18333253|P1|Follow up for Survival x 2 Years|Death|13
5323525|NCT00288015|18333253|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
5323526|NCT00288015|18333253|P1|First Response Assessment|Physician Decision|2
5323527|NCT00288015|18333253|P1|First Response Assessment|Death|1
5323528|NCT00288015|18333253|P1|First Response Assessment|Withdrawal by Subject|1
5323529|NCT00288015|18333253|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
5323530|NCT00288015|18333253|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
5323531|NCT00287690|18333345|P2|Overall Study|Protocol Violation|26
5323532|NCT00287690|18333346|P1|Overall Study|Protocol Violation|20
5323533|NCT00287586|18333358|P2|Overall Study|Recurrent Melanoma|1
5323534|NCT00287586|18333359|P1|Overall Study|Recurrent Melanoma|0
5323535|NCT00287586|18333358|P2|Overall Study|Itchy Swollen Eyes|1
5323536|NCT00287586|18333359|P1|Overall Study|Itchy Swollen Eyes|0
5323537|NCT00287586|18333358|P2|Overall Study|Bradycardia|1
5323538|NCT00287586|18333359|P1|Overall Study|Bradycardia|0
5323539|NCT00287586|18333358|P2|Overall Study|Mood Swings and Irritability|1
5323540|NCT00287586|18333359|P1|Overall Study|Mood Swings and Irritability|0
5323541|NCT00287586|18333358|P2|Overall Study|Mastodynia and Gynecomastia|1
5323542|NCT00287586|18333359|P1|Overall Study|Mastodynia and Gynecomastia|0
5323543|NCT00287586|18333358|P2|Overall Study|Retroperitoneal Cancer|1
5323544|NCT00287586|18333359|P1|Overall Study|Retroperitoneal Cancer|0
5323545|NCT00287586|18333358|P2|Overall Study|Elevated IPSS Score|1
5323546|NCT00287586|18333359|P1|Overall Study|Elevated IPSS Score|0
5323547|NCT00287586|18333358|P2|Overall Study|Lung Cancer|2
5323548|NCT00287586|18333359|P1|Overall Study|Lung Cancer|0
5323549|NCT00287586|18333358|P2|Overall Study|Major Depression|2
5323550|NCT00287586|18333359|P1|Overall Study|Major Depression|0
5323551|NCT00287586|18333358|P2|Overall Study|Enrolled in Another Study|0
5323552|NCT00287586|18333359|P1|Overall Study|Enrolled in Another Study|1
5323553|NCT00287586|18333358|P2|Overall Study|Nonadherence|1
5323554|NCT00287586|18333359|P1|Overall Study|Nonadherence|1
5323555|NCT00287586|18333358|P2|Overall Study|Inappropriate Behaviour with Staff|0
5323556|NCT00287586|18333359|P1|Overall Study|Inappropriate Behaviour with Staff|1
5323557|NCT00287586|18333358|P2|Overall Study|Shoulder Pain|0
5323558|NCT00287586|18333359|P1|Overall Study|Shoulder Pain|1
5323559|NCT00287586|18333358|P2|Overall Study|Sleep Apnea|0
5323560|NCT00287586|18333359|P1|Overall Study|Sleep Apnea|1
5323561|NCT00287586|18333358|P2|Overall Study|Pancreatic Cancer|3
5323562|NCT00287586|18333359|P1|Overall Study|Pancreatic Cancer|1
5323563|NCT00287586|18333358|P2|Overall Study|Cognitive Impairment|0
5323564|NCT00287586|18333359|P1|Overall Study|Cognitive Impairment|1
5323565|NCT00287586|18333358|P2|Overall Study|Lower Urinary Tract Symptoms|0
5323566|NCT00287586|18333359|P1|Overall Study|Lower Urinary Tract Symptoms|1
5323567|NCT00287586|18333358|P2|Overall Study|Myocardial Infarction|0
5323568|NCT00287586|18333359|P1|Overall Study|Myocardial Infarction|1
5323569|NCT00287586|18333358|P2|Overall Study|Stroke|0
5323570|NCT00287586|18333359|P1|Overall Study|Stroke|2
5323571|NCT00287586|18333358|P2|Overall Study|Elevated Prostate Specific Antigen|0
5323572|NCT00287586|18333359|P1|Overall Study|Elevated Prostate Specific Antigen|2
5323573|NCT00287586|18333358|P2|Overall Study|Rash|0
5323574|NCT00287586|18333359|P1|Overall Study|Rash|3
5323575|NCT00287586|18333358|P2|Overall Study|Elevated Hematocrit|0
5323576|NCT00287586|18333359|P1|Overall Study|Elevated Hematocrit|3
5323577|NCT00287586|18333358|P2|Overall Study|Death|3
5323578|NCT00287586|18333359|P1|Overall Study|Death|2
5323579|NCT00287586|18333358|P2|Overall Study|Lost to Follow-up|4
5323580|NCT00287586|18333359|P1|Overall Study|Lost to Follow-up|5
5323581|NCT00287586|18333358|P2|Overall Study|Withdrew Consent|30
5323582|NCT00287586|18333359|P1|Overall Study|Withdrew Consent|19
5323583|NCT00287469|18333397|P2|Overall Study|Lost to Follow-up|69
5323584|NCT00287469|18333398|P1|Overall Study|Lost to Follow-up|74
5323585|NCT00287469|18333397|P2|Overall Study|moved from area|138
5323586|NCT00287469|18333398|P1|Overall Study|moved from area|144
5323587|NCT00287469|18333397|P2|Overall Study|Adverse Event|1
5323588|NCT00287469|18333398|P1|Overall Study|Adverse Event|1
5323589|NCT00287469|18333397|P2|Overall Study|serious adverse event|6
5323590|NCT00287469|18333398|P1|Overall Study|serious adverse event|1
5323591|NCT00287365|18333408|P1|Overall Study|sample not acquired|13
5323592|NCT00287118|18333434|P1|Overall Study|Other|7
5323593|NCT00287118|18333434|P1|Overall Study|Protocol Violation|2
5323594|NCT00287118|18333434|P1|Overall Study|Lost to Follow-up|1
5323595|NCT00287118|18333434|P1|Overall Study|Lack of Efficacy|11
5323596|NCT00287118|18333434|P1|Overall Study|Death|1
5323597|NCT00287118|18333434|P1|Overall Study|Adverse Event|30
5323598|NCT00287079|18333440|P2|Overall Study|Other|0
5323599|NCT00287079|18333441|P1|Overall Study|Other|3
5323600|NCT00287079|18333440|P2|Overall Study|Protocol Violation|0
5323601|NCT00287079|18333441|P1|Overall Study|Protocol Violation|1
5323602|NCT00287079|18333440|P2|Overall Study|Adverse Event|0
5323603|NCT00287079|18333441|P1|Overall Study|Adverse Event|5
5323604|NCT00287079|18333440|P2|Overall Study|Non-qualifying relapse|0
5323605|NCT00287079|18333441|P1|Overall Study|Non-qualifying relapse|1
5323606|NCT00287079|18333440|P2|Overall Study|Qualifying relapse|1
5323607|NCT00287079|18333441|P1|Overall Study|Qualifying relapse|12
5323608|NCT00286754|18333469|P3|Overall Study|Moved out of state|1
5323609|NCT00286754|18333470|P2|Overall Study|Moved out of state|0
5323610|NCT00286754|18333471|P1|Overall Study|Moved out of state|0
5323611|NCT00286754|18333469|P3|Overall Study|Lost to Follow-up|6
5323612|NCT00286754|18333470|P2|Overall Study|Lost to Follow-up|14
5323613|NCT00286754|18333471|P1|Overall Study|Lost to Follow-up|12
5323614|NCT00286754|18333469|P3|Overall Study|Withdrawal by Subject|0
5323615|NCT00286754|18333470|P2|Overall Study|Withdrawal by Subject|2
5323616|NCT00286754|18333471|P1|Overall Study|Withdrawal by Subject|6
5323617|NCT00286754|18333469|P3|Overall Study|Adverse Event|3
5323618|NCT00286754|18333470|P2|Overall Study|Adverse Event|2
5323619|NCT00286754|18333471|P1|Overall Study|Adverse Event|2
5323620|NCT00286494|18333530|P3|Overall Study|Protocol Violation|2
5323621|NCT00286494|18333531|P2|Overall Study|Protocol Violation|1
5323622|NCT00286494|18333532|P1|Overall Study|Protocol Violation|1
5323623|NCT00286494|18333530|P3|Overall Study|Lost to Follow-up|3
5323624|NCT00286494|18333531|P2|Overall Study|Lost to Follow-up|1
5323625|NCT00286494|18333532|P1|Overall Study|Lost to Follow-up|3
5323626|NCT00286494|18333530|P3|Overall Study|Physician Decision|1
5323627|NCT00286494|18333531|P2|Overall Study|Physician Decision|5
5323628|NCT00286494|18333532|P1|Overall Study|Physician Decision|5
5323629|NCT00286494|18333530|P3|Overall Study|Adverse Event|6
5323630|NCT00286494|18333531|P2|Overall Study|Adverse Event|8
5323631|NCT00286494|18333532|P1|Overall Study|Adverse Event|3
5323632|NCT00286494|18333530|P3|Overall Study|Withdrawal by Subject|9
5323633|NCT00286494|18333531|P2|Overall Study|Withdrawal by Subject|10
5323634|NCT00286494|18333532|P1|Overall Study|Withdrawal by Subject|2
5323635|NCT00286494|18333530|P3|Overall Study|Hyperglycemic rescue|18
5323636|NCT00286494|18333531|P2|Overall Study|Hyperglycemic rescue|19
5323637|NCT00286494|18333532|P1|Overall Study|Hyperglycemic rescue|12
5323638|NCT00286468|18333693|P3|Overall Study|Physician Decision|1
5323639|NCT00286468|18333694|P2|Overall Study|Physician Decision|2
5323640|NCT00286468|18333695|P1|Overall Study|Physician Decision|3
5323641|NCT00286468|18333693|P3|Overall Study|Withdrawal by Subject|11
5323642|NCT00286468|18333694|P2|Overall Study|Withdrawal by Subject|8
5323643|NCT00286468|18333695|P1|Overall Study|Withdrawal by Subject|3
5323644|NCT00286468|18333693|P3|Overall Study|Lost to Follow-up|2
5323645|NCT00286468|18333694|P2|Overall Study|Lost to Follow-up|1
5323646|NCT00286468|18333695|P1|Overall Study|Lost to Follow-up|1
5323647|NCT00286468|18333693|P3|Overall Study|Protocol Violation|1
5323648|NCT00286468|18333694|P2|Overall Study|Protocol Violation|3
5323649|NCT00286468|18333695|P1|Overall Study|Protocol Violation|0
5323650|NCT00286468|18333693|P3|Overall Study|Adverse Event|4
5323651|NCT00286468|18333694|P2|Overall Study|Adverse Event|6
5323652|NCT00286468|18333695|P1|Overall Study|Adverse Event|2
5323653|NCT00286468|18333693|P3|Overall Study|Hyperglycemic Rescue|31
5323654|NCT00286468|18333694|P2|Overall Study|Hyperglycemic Rescue|30
5323655|NCT00286468|18333695|P1|Overall Study|Hyperglycemic Rescue|28
5323656|NCT00286455|18333856|P3|Overall Study|Withdrawal by Subject|7
5323657|NCT00286455|18333857|P2|Overall Study|Withdrawal by Subject|8
5323658|NCT00286455|18333858|P1|Overall Study|Withdrawal by Subject|0
5323659|NCT00286455|18333856|P3|Overall Study|Participant Non-compliance|0
5323660|NCT00286455|18333857|P2|Overall Study|Participant Non-compliance|0
5323661|NCT00286455|18333858|P1|Overall Study|Participant Non-compliance|1
5323662|NCT00286455|18333856|P3|Overall Study|Protocol Violation|0
5323663|NCT00286455|18333857|P2|Overall Study|Protocol Violation|1
5323664|NCT00286455|18333858|P1|Overall Study|Protocol Violation|1
5323665|NCT00286455|18333856|P3|Overall Study|Physician Decision|2
5323666|NCT00286455|18333857|P2|Overall Study|Physician Decision|0
5323667|NCT00286455|18333858|P1|Overall Study|Physician Decision|3
5323668|NCT00286455|18333856|P3|Overall Study|Lost to Follow-up|3
5323669|NCT00286455|18333857|P2|Overall Study|Lost to Follow-up|3
5323670|NCT00286455|18333858|P1|Overall Study|Lost to Follow-up|0
5323671|NCT00286455|18333856|P3|Overall Study|Adverse Event|2
5323672|NCT00286455|18333857|P2|Overall Study|Adverse Event|3
5323673|NCT00286455|18333858|P1|Overall Study|Adverse Event|1
5323674|NCT00286455|18333856|P3|Overall Study|Hyperglycemia rescue|10
5323675|NCT00286455|18333857|P2|Overall Study|Hyperglycemia rescue|13
5323676|NCT00286455|18333858|P1|Overall Study|Hyperglycemia rescue|19
5323677|NCT00286442|18334037|P3|Overall Study|Withdrawal by Subject|2
5323678|NCT00286442|18334038|P2|Overall Study|Withdrawal by Subject|14
5323679|NCT00286442|18334039|P1|Overall Study|Withdrawal by Subject|2
5323680|NCT00286442|18334037|P3|Overall Study|Administrative Error|0
5323681|NCT00286442|18334038|P2|Overall Study|Administrative Error|1
5323682|NCT00286442|18334039|P1|Overall Study|Administrative Error|1
5323683|NCT00286442|18334037|P3|Overall Study|Physician Decision|1
5323684|NCT00286442|18334038|P2|Overall Study|Physician Decision|1
5323685|NCT00286442|18334039|P1|Overall Study|Physician Decision|1
5323686|NCT00286442|18334037|P3|Overall Study|Lost to Follow-up|1
5323687|NCT00286442|18334038|P2|Overall Study|Lost to Follow-up|2
5323688|NCT00286442|18334039|P1|Overall Study|Lost to Follow-up|5
5323689|NCT00286442|18334037|P3|Overall Study|Protocol Violation|2
5323690|NCT00286442|18334038|P2|Overall Study|Protocol Violation|4
5323691|NCT00286442|18334039|P1|Overall Study|Protocol Violation|2
5323692|NCT00286442|18334037|P3|Overall Study|Adverse Event|1
5323693|NCT00286442|18334038|P2|Overall Study|Adverse Event|6
5323694|NCT00286442|18334039|P1|Overall Study|Adverse Event|7
5323695|NCT00286442|18334037|P3|Overall Study|Hyperglycemic Rescue|25
5323696|NCT00286442|18334038|P2|Overall Study|Hyperglycemic Rescue|17
5323697|NCT00286442|18334039|P1|Overall Study|Hyperglycemic Rescue|19
5323698|NCT00286429|18334200|P3|Overall Study|Administrative Decision|0
5323699|NCT00286429|18334201|P2|Overall Study|Administrative Decision|1
5323700|NCT00286429|18334202|P1|Overall Study|Administrative Decision|0
5323701|NCT00286429|18334200|P3|Overall Study|Administrative Error|1
5323702|NCT00286429|18334201|P2|Overall Study|Administrative Error|1
5323703|NCT00286429|18334202|P1|Overall Study|Administrative Error|1
5323704|NCT00286429|18334200|P3|Overall Study|Withdrawal by Subject|6
5323705|NCT00286429|18334201|P2|Overall Study|Withdrawal by Subject|2
5323706|NCT00286429|18334202|P1|Overall Study|Withdrawal by Subject|3
5323707|NCT00286429|18334200|P3|Overall Study|Protocol Violation|4
5323708|NCT00286429|18334201|P2|Overall Study|Protocol Violation|5
5323709|NCT00286429|18334202|P1|Overall Study|Protocol Violation|3
5323710|NCT00286429|18334200|P3|Overall Study|Physician Decision|7
5323711|NCT00286429|18334201|P2|Overall Study|Physician Decision|7
5323712|NCT00286429|18334202|P1|Overall Study|Physician Decision|10
5323713|NCT00286429|18334200|P3|Overall Study|Lost to Follow-up|3
5323714|NCT00286429|18334201|P2|Overall Study|Lost to Follow-up|4
5323715|NCT00286429|18334202|P1|Overall Study|Lost to Follow-up|2
5323716|NCT00286429|18334200|P3|Overall Study|Lack of Efficacy|25
5323717|NCT00286429|18334201|P2|Overall Study|Lack of Efficacy|27
5323718|NCT00286429|18334202|P1|Overall Study|Lack of Efficacy|52
5323719|NCT00286429|18334200|P3|Overall Study|Adverse Event|6
5323720|NCT00286429|18334201|P2|Overall Study|Adverse Event|1
5323721|NCT00286429|18334202|P1|Overall Study|Adverse Event|4
5323722|NCT00286221|18334318|P4|Overall Study|Unrecognized exclusion criteria met|0
5323723|NCT00286221|18334319|P3|Overall Study|Unrecognized exclusion criteria met|0
5323724|NCT00286221|18334320|P2|Overall Study|Unrecognized exclusion criteria met|1
5323725|NCT00286221|18334321|P1|Overall Study|Unrecognized exclusion criteria met|0
5323726|NCT00286221|18334318|P4|Overall Study|Inability to trigger PCA|0
5323727|NCT00286221|18334319|P3|Overall Study|Inability to trigger PCA|0
5323728|NCT00286221|18334320|P2|Overall Study|Inability to trigger PCA|0
5323729|NCT00286221|18334321|P1|Overall Study|Inability to trigger PCA|2
5323730|NCT00286221|18334318|P4|Overall Study|Unanticipated Neurosurgical Complication|2
5323731|NCT00286221|18334319|P3|Overall Study|Unanticipated Neurosurgical Complication|3
5323732|NCT00286221|18334320|P2|Overall Study|Unanticipated Neurosurgical Complication|3
5323733|NCT00286221|18334321|P1|Overall Study|Unanticipated Neurosurgical Complication|6
5323734|NCT00286221|18334318|P4|Overall Study|Protocol Violation|4
5323735|NCT00286221|18334319|P3|Overall Study|Protocol Violation|6
5323736|NCT00286221|18334320|P2|Overall Study|Protocol Violation|1
5323737|NCT00286221|18334321|P1|Overall Study|Protocol Violation|2
5323738|NCT00286156|18334347|P3|Overall Study|AE: pneumonia|0
5323739|NCT00286156|18334348|P2|Overall Study|AE: pneumonia|0
5323740|NCT00286156|18334349|P1|Overall Study|AE: pneumonia|1
5323741|NCT00286156|18334347|P3|Overall Study|AE: nephrotic-range proteinuruia|0
5323742|NCT00286156|18334348|P2|Overall Study|AE: nephrotic-range proteinuruia|0
5323743|NCT00286156|18334349|P1|Overall Study|AE: nephrotic-range proteinuruia|1
5323744|NCT00286156|18334347|P3|Overall Study|AE: pulmonary embolus|0
5323745|NCT00286156|18334348|P2|Overall Study|AE: pulmonary embolus|1
5323746|NCT00286156|18334349|P1|Overall Study|AE: pulmonary embolus|0
5323747|NCT00286156|18334347|P3|Overall Study|Missed 12 month visit|1
5323748|NCT00286156|18334348|P2|Overall Study|Missed 12 month visit|0
5323749|NCT00286156|18334349|P1|Overall Study|Missed 12 month visit|0
5323750|NCT00286091|18334362|P2|Open-label Treatment Phase|Missing End of Study Information|1
5323751|NCT00286091|18334363|P1|Open-label Treatment Phase|Missing End of Study Information|0
5323752|NCT00286091|18334362|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
5323753|NCT00286091|18334363|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
5323754|NCT00286091|18334362|P2|Open-label Treatment Phase|Lost to Follow-up|1
5323755|NCT00286091|18334363|P1|Open-label Treatment Phase|Lost to Follow-up|0
5323756|NCT00286091|18334362|P2|Open-label Treatment Phase|Noncompliance|1
5323757|NCT00286091|18334363|P1|Open-label Treatment Phase|Noncompliance|3
5323758|NCT00286091|18334362|P2|Open-label Treatment Phase|Disease Progression|3
5323759|NCT00286091|18334363|P1|Open-label Treatment Phase|Disease Progression|9
5323760|NCT00286091|18334362|P2|Open-label Treatment Phase|Death|7
5323761|NCT00286091|18334363|P1|Open-label Treatment Phase|Death|10
5323762|NCT00286091|18334362|P2|Open-label Treatment Phase|Withdrawal by Subject|10
5323763|NCT00286091|18334363|P1|Open-label Treatment Phase|Withdrawal by Subject|14
5323764|NCT00286091|18334362|P2|Open-label Treatment Phase|Other|11
5323765|NCT00286091|18334363|P1|Open-label Treatment Phase|Other|11
5323766|NCT00286091|18334362|P2|Open-label Treatment Phase|Adverse Event|16
5323767|NCT00286091|18334363|P1|Open-label Treatment Phase|Adverse Event|5
5323768|NCT00286091|18334362|P2|Open-label Treatment Phase|Physician Decision|21
5323769|NCT00286091|18334363|P1|Open-label Treatment Phase|Physician Decision|24
5323770|NCT00286091|18334362|P2|Double-blind Treatment Phase|Ineligibility Determined|2
5323771|NCT00286091|18334363|P1|Double-blind Treatment Phase|Ineligibility Determined|1
5323772|NCT00286091|18334362|P2|Double-blind Treatment Phase|Protocol Deviation|3
5323773|NCT00286091|18334363|P1|Double-blind Treatment Phase|Protocol Deviation|1
5323774|NCT00286091|18334362|P2|Double-blind Treatment Phase|Lost to Follow-up|4
5323775|NCT00286091|18334363|P1|Double-blind Treatment Phase|Lost to Follow-up|11
5323776|NCT00286091|18334362|P2|Double-blind Treatment Phase|Noncompliance|8
5323777|NCT00286091|18334363|P1|Double-blind Treatment Phase|Noncompliance|8
5323778|NCT00286091|18334362|P2|Double-blind Treatment Phase|Administrative Decision|21
5323779|NCT00286091|18334363|P1|Double-blind Treatment Phase|Administrative Decision|20
5323780|NCT00286091|18334362|P2|Double-blind Treatment Phase|Other|33
5323781|NCT00286091|18334363|P1|Double-blind Treatment Phase|Other|25
5323782|NCT00286091|18334362|P2|Double-blind Treatment Phase|Disease Progression|35
5323783|NCT00286091|18334363|P1|Double-blind Treatment Phase|Disease Progression|22
5323784|NCT00286091|18334362|P2|Double-blind Treatment Phase|Adverse Event|40
5323785|NCT00286091|18334363|P1|Double-blind Treatment Phase|Adverse Event|28
5323786|NCT00286091|18334362|P2|Double-blind Treatment Phase|Death|65
5323787|NCT00286091|18334363|P1|Double-blind Treatment Phase|Death|58
5323788|NCT00286091|18334362|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
5323789|NCT00286091|18334363|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
5323790|NCT00286091|18334362|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
5323791|NCT00286091|18334363|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
5323792|NCT00285857|18334386|P1|Overall Study|Adverse Event|1
5323793|NCT00285857|18334386|P1|Overall Study|Inadequate initial breast cytology|1
5323794|NCT00285857|18334386|P1|Overall Study|Withdrawal by Subject|2
5323795|NCT00285818|18334399|P2|Overall Study|Lost to Follow-up|0
5323796|NCT00285818|18334400|P1|Overall Study|Lost to Follow-up|1
5323797|NCT00285818|18334399|P2|Overall Study|Withdrawal by Subject|2
5323798|NCT00285818|18334400|P1|Overall Study|Withdrawal by Subject|3
5323799|NCT00285649|18334445|P3|Overall Study|Withdrawal by Subject|2
5323800|NCT00285649|18334446|P2|Overall Study|Withdrawal by Subject|2
5323801|NCT00285649|18334447|P1|Overall Study|Withdrawal by Subject|3
5323802|NCT00285649|18334445|P3|Overall Study|Lost to Follow-up|4
5323803|NCT00285649|18334446|P2|Overall Study|Lost to Follow-up|4
5323804|NCT00285649|18334447|P1|Overall Study|Lost to Follow-up|6
5323805|NCT00285584|18334457|P2|Month 6|Lost to Follow-up|1
5323806|NCT00285584|18334458|P1|Month 6|Lost to Follow-up|0
5323807|NCT00285584|18334457|P2|Month 3|Withdrawal by Subject|0
5323808|NCT00285584|18334458|P1|Month 3|Withdrawal by Subject|1
5323809|NCT00285584|18334457|P2|Month 3|Lost to Follow-up|3
5323810|NCT00285584|18334458|P1|Month 3|Lost to Follow-up|3
5323811|NCT00285207|18334490|P2|Overall Study|non-compliance|1
5323812|NCT00285207|18334491|P1|Overall Study|non-compliance|0
5323813|NCT00285207|18334490|P2|Overall Study|Pregnancy|1
5323814|NCT00285207|18334491|P1|Overall Study|Pregnancy|1
5323815|NCT00285207|18334490|P2|Overall Study|Withdrawal by Subject|2
5323816|NCT00285207|18334491|P1|Overall Study|Withdrawal by Subject|5
5323817|NCT00285207|18334490|P2|Overall Study|Lost to Follow-up|2
5323818|NCT00285207|18334491|P1|Overall Study|Lost to Follow-up|3
5323819|NCT00285012|18334499|P2|Received Study Tx|Other|5
5323820|NCT00285012|18334500|P1|Received Study Tx|Other|5
5323821|NCT00285012|18334499|P2|Received Study Tx|Withdrawal by Subject|43
5323822|NCT00285012|18334500|P1|Received Study Tx|Withdrawal by Subject|31
5323823|NCT00285012|18334499|P2|Received Study Tx|Lost to Follow-up|31
5323824|NCT00285012|18334500|P1|Received Study Tx|Lost to Follow-up|29
5323825|NCT00285012|18334499|P2|Received Study Tx|Lack of Efficacy|3
5323826|NCT00285012|18334500|P1|Received Study Tx|Lack of Efficacy|0
5323827|NCT00285012|18334499|P2|Received Study Tx|Adverse Event|11
5323828|NCT00285012|18334500|P1|Received Study Tx|Adverse Event|5
5323829|NCT00285012|18334499|P2|Received Study Tx|Death|1
5323830|NCT00285012|18334500|P1|Received Study Tx|Death|2
5323831|NCT00285012|18334499|P2|Assigned to Study Treatment (Tx)|Other|3
5323832|NCT00285012|18334500|P1|Assigned to Study Treatment (Tx)|Other|2
5323833|NCT00284934|18334526|P2|Overall Study|Other reasons|1
5323834|NCT00284934|18334527|P1|Overall Study|Other reasons|3
5323835|NCT00284934|18334526|P2|Overall Study|Adverse Event|2
5323836|NCT00284934|18334527|P1|Overall Study|Adverse Event|1
5323837|NCT00284856|18334542|P3|Overall Study|Other|4
5323838|NCT00284856|18334543|P2|Overall Study|Other|5
5323839|NCT00284856|18334544|P1|Overall Study|Other|4
5323840|NCT00284856|18334542|P3|Overall Study|Withdrawal by Subject|18
5323841|NCT00284856|18334543|P2|Overall Study|Withdrawal by Subject|16
5323842|NCT00284856|18334544|P1|Overall Study|Withdrawal by Subject|12
5323843|NCT00284856|18334542|P3|Overall Study|Protocol Violation|5
5323844|NCT00284856|18334543|P2|Overall Study|Protocol Violation|4
5323845|NCT00284856|18334544|P1|Overall Study|Protocol Violation|5
5323846|NCT00284856|18334542|P3|Overall Study|Lost to Follow-up|22
5323847|NCT00284856|18334543|P2|Overall Study|Lost to Follow-up|21
5323848|NCT00284856|18334544|P1|Overall Study|Lost to Follow-up|25
5323849|NCT00284856|18334542|P3|Overall Study|Lack of Efficacy|8
5323850|NCT00284856|18334543|P2|Overall Study|Lack of Efficacy|1
5323851|NCT00284856|18334544|P1|Overall Study|Lack of Efficacy|2
5323852|NCT00284856|18334542|P3|Overall Study|Adverse Event|3
5323853|NCT00284856|18334543|P2|Overall Study|Adverse Event|3
5323854|NCT00284856|18334544|P1|Overall Study|Adverse Event|3
5323855|NCT00284141|18334643|P1|Overall Study|Ongoing treatment|2
5323856|NCT00284141|18334643|P1|Overall Study|Did not take study medication|2
5323857|NCT00284141|18334643|P1|Overall Study|Pneumonia|1
5323858|NCT00284141|18334643|P1|Overall Study|General decline|1
5323859|NCT00284141|18334643|P1|Overall Study|Clinical deterioration / death|2
5323860|NCT00284141|18334643|P1|Overall Study|Symptomatic / Clinical Progression|11
5323861|NCT00284141|18334643|P1|Overall Study|Participant's request|9
5323862|NCT00284141|18334643|P1|Overall Study|Adverse Event|19
5323863|NCT00284141|18334643|P1|Overall Study|Disease Progression / Lack of efficacy|51
5323864|NCT00284089|18334666|P4|Extension Phase|Withdrawal by Subject|3
5323865|NCT00284089|18334667|P3|Extension Phase|Withdrawal by Subject|1
5323866|NCT00284089|18334668|P2|Extension Phase|Withdrawal by Subject|0
5323867|NCT00284089|18334669|P1|Extension Phase|Withdrawal by Subject|0
5323868|NCT00284089|18334666|P4|Extension Phase|Protocol Violation|0
5323869|NCT00284089|18334667|P3|Extension Phase|Protocol Violation|1
5323870|NCT00284089|18334668|P2|Extension Phase|Protocol Violation|0
5323871|NCT00284089|18334669|P1|Extension Phase|Protocol Violation|0
5323872|NCT00284089|18334666|P4|Extension Phase|condition no longer requires study drug|7
5323873|NCT00284089|18334667|P3|Extension Phase|condition no longer requires study drug|2
5323874|NCT00284089|18334668|P2|Extension Phase|condition no longer requires study drug|0
5323875|NCT00284089|18334669|P1|Extension Phase|condition no longer requires study drug|2
5323876|NCT00284089|18334666|P4|Extension Phase|Adverse Event|2
5323877|NCT00284089|18334667|P3|Extension Phase|Adverse Event|2
5323878|NCT00284089|18334668|P2|Extension Phase|Adverse Event|0
5323879|NCT00284089|18334669|P1|Extension Phase|Adverse Event|0
5323880|NCT00284089|18334666|P4|Multiple Dose Phase|Death|1
5323881|NCT00284089|18334667|P3|Multiple Dose Phase|Death|1
5323882|NCT00284089|18334668|P2|Multiple Dose Phase|Death|0
5323883|NCT00284089|18334669|P1|Multiple Dose Phase|Death|0
5323884|NCT00284089|18334666|P4|Multiple Dose Phase|Withdrawal by Subject|2
5323885|NCT00284089|18334667|P3|Multiple Dose Phase|Withdrawal by Subject|1
5323886|NCT00284089|18334668|P2|Multiple Dose Phase|Withdrawal by Subject|0
5323887|NCT00284089|18334669|P1|Multiple Dose Phase|Withdrawal by Subject|0
5323888|NCT00284089|18334666|P4|Multiple Dose Phase|Protocol Violation|0
5323889|NCT00284089|18334667|P3|Multiple Dose Phase|Protocol Violation|1
5323890|NCT00284089|18334668|P2|Multiple Dose Phase|Protocol Violation|0
5323891|NCT00284089|18334669|P1|Multiple Dose Phase|Protocol Violation|0
5323892|NCT00284089|18334666|P4|Multiple Dose Phase|Adverse Event|1
5323893|NCT00284089|18334667|P3|Multiple Dose Phase|Adverse Event|1
5323894|NCT00284089|18334668|P2|Multiple Dose Phase|Adverse Event|0
5323895|NCT00284089|18334669|P1|Multiple Dose Phase|Adverse Event|1
5323896|NCT00284050|18334698|P3|Overall Study|Death|0
5323897|NCT00284050|18334699|P2|Overall Study|Death|0
5323898|NCT00284050|18334700|P1|Overall Study|Death|1
5323899|NCT00284050|18334698|P3|Overall Study|Lost to Follow-up|1
5323900|NCT00284050|18334699|P2|Overall Study|Lost to Follow-up|0
5323901|NCT00284050|18334700|P1|Overall Study|Lost to Follow-up|1
5323902|NCT00284050|18334698|P3|Overall Study|Withdrawal by Subject|2
5323903|NCT00284050|18334699|P2|Overall Study|Withdrawal by Subject|2
5323904|NCT00284050|18334700|P1|Overall Study|Withdrawal by Subject|2
5323905|NCT00284050|18334698|P3|Overall Study|Protocol Violation|2
5323906|NCT00284050|18334699|P2|Overall Study|Protocol Violation|1
5323907|NCT00284050|18334700|P1|Overall Study|Protocol Violation|0
5323908|NCT00284050|18334698|P3|Overall Study|Lack of Efficacy|3
5323909|NCT00284050|18334699|P2|Overall Study|Lack of Efficacy|1
5323910|NCT00284050|18334700|P1|Overall Study|Lack of Efficacy|0
5323911|NCT00284050|18334698|P3|Overall Study|Adverse Event|1
5323912|NCT00284050|18334699|P2|Overall Study|Adverse Event|1
5323913|NCT00284050|18334700|P1|Overall Study|Adverse Event|1
5323914|NCT00283959|18334714|P1|Extension Period|Low Compliance|1
5323915|NCT00283868|18334726|P2|Overall Study|Lost to Follow-up|8
5323916|NCT00283868|18334727|P1|Overall Study|Lost to Follow-up|7
5323917|NCT00283842|18334744|P5|Overall Study|Lost to Follow-up|1
5323918|NCT00283842|18334745|P4|Overall Study|Lost to Follow-up|1
5323919|NCT00283842|18334746|P3|Overall Study|Lost to Follow-up|4
5323920|NCT00283842|18334747|P2|Overall Study|Lost to Follow-up|2
5323921|NCT00283842|18334748|P1|Overall Study|Lost to Follow-up|0
5323922|NCT00283842|18334744|P5|Overall Study|Lack of Efficacy|3
5323923|NCT00283842|18334745|P4|Overall Study|Lack of Efficacy|0
5323924|NCT00283842|18334746|P3|Overall Study|Lack of Efficacy|1
5323925|NCT00283842|18334747|P2|Overall Study|Lack of Efficacy|3
5323926|NCT00283842|18334748|P1|Overall Study|Lack of Efficacy|1
5323927|NCT00283842|18334744|P5|Overall Study|Withdrawal by Subject|4
5323928|NCT00283842|18334745|P4|Overall Study|Withdrawal by Subject|5
5323929|NCT00283842|18334746|P3|Overall Study|Withdrawal by Subject|1
5323930|NCT00283842|18334747|P2|Overall Study|Withdrawal by Subject|1
5323931|NCT00283842|18334748|P1|Overall Study|Withdrawal by Subject|2
5323932|NCT00283842|18334744|P5|Overall Study|Protocol deviation|2
5323933|NCT00283842|18334745|P4|Overall Study|Protocol deviation|0
5323934|NCT00283842|18334746|P3|Overall Study|Protocol deviation|0
5323935|NCT00283842|18334747|P2|Overall Study|Protocol deviation|0
5323936|NCT00283842|18334748|P1|Overall Study|Protocol deviation|0
5323937|NCT00283842|18334744|P5|Overall Study|Protocol Violation|0
5323938|NCT00283842|18334745|P4|Overall Study|Protocol Violation|0
5323939|NCT00283842|18334746|P3|Overall Study|Protocol Violation|4
5323940|NCT00283842|18334747|P2|Overall Study|Protocol Violation|5
5323941|NCT00283842|18334748|P1|Overall Study|Protocol Violation|1
5323942|NCT00283842|18334744|P5|Overall Study|Adverse Event|5
5323943|NCT00283842|18334745|P4|Overall Study|Adverse Event|21
5323944|NCT00283842|18334746|P3|Overall Study|Adverse Event|21
5323945|NCT00283842|18334747|P2|Overall Study|Adverse Event|7
5323946|NCT00283842|18334748|P1|Overall Study|Adverse Event|8
5323947|NCT00283803|18334780|P1|Overall Study|Withdrawal by Subject|4
5323948|NCT00283803|18334780|P1|Overall Study|Physician Decision|9
5323949|NCT00283712|18334788|P2|Overall Study|Death|1
5323950|NCT00283712|18334789|P1|Overall Study|Death|0
5323951|NCT00283686|18334827|P4|Overall Study|Less than full participation|12
5323952|NCT00283686|18334828|P3|Overall Study|Less than full participation|6
5323953|NCT00283686|18334829|P2|Overall Study|Less than full participation|9
5323954|NCT00283686|18334830|P1|Overall Study|Less than full participation|7
5323955|NCT00283686|18334827|P4|Overall Study|Lost to Follow-up|20
5323956|NCT00283686|18334828|P3|Overall Study|Lost to Follow-up|26
5323957|NCT00283686|18334829|P2|Overall Study|Lost to Follow-up|31
5323958|NCT00283686|18334830|P1|Overall Study|Lost to Follow-up|21
5323959|NCT00283686|18334827|P4|Overall Study|Death|0
5323960|NCT00283686|18334828|P3|Overall Study|Death|1
5323961|NCT00283686|18334829|P2|Overall Study|Death|1
5323962|NCT00283686|18334830|P1|Overall Study|Death|1
5323963|NCT00283595|18334874|P2|Overall Study|Withdrawal by Subject|2
5323964|NCT00283595|18334875|P1|Overall Study|Withdrawal by Subject|1
5323965|NCT00283439|18334900|P4|Overall Study|Other|0
5323966|NCT00283439|18334901|P3|Overall Study|Other|0
5323967|NCT00283439|18334902|P2|Overall Study|Other|0
5323968|NCT00283439|18334903|P1|Overall Study|Other|1
5323969|NCT00283439|18334900|P4|Overall Study|Treatment discontinued|3
5323970|NCT00283439|18334901|P3|Overall Study|Treatment discontinued|1
5323971|NCT00283439|18334902|P2|Overall Study|Treatment discontinued|2
5323972|NCT00283439|18334903|P1|Overall Study|Treatment discontinued|0
5323973|NCT00283439|18334900|P4|Overall Study|Stem cell transplant|3
5323974|NCT00283439|18334901|P3|Overall Study|Stem cell transplant|4
5323975|NCT00283439|18334902|P2|Overall Study|Stem cell transplant|6
5323976|NCT00283439|18334903|P1|Overall Study|Stem cell transplant|6
5323977|NCT00283439|18334900|P4|Overall Study|Requirement for alternative therapy|2
5323978|NCT00283439|18334901|P3|Overall Study|Requirement for alternative therapy|5
5323979|NCT00283439|18334902|P2|Overall Study|Requirement for alternative therapy|2
5323980|NCT00283439|18334903|P1|Overall Study|Requirement for alternative therapy|1
5323981|NCT00283439|18334900|P4|Overall Study|Disease progression|0
5323982|NCT00283439|18334901|P3|Overall Study|Disease progression|0
5323983|NCT00283439|18334902|P2|Overall Study|Disease progression|1
5323984|NCT00283439|18334903|P1|Overall Study|Disease progression|0
5323985|NCT00283439|18334900|P4|Overall Study|Death|0
5323986|NCT00283439|18334901|P3|Overall Study|Death|1
5323987|NCT00283439|18334902|P2|Overall Study|Death|0
5323988|NCT00283439|18334903|P1|Overall Study|Death|0
5323989|NCT00283439|18334900|P4|Overall Study|Adverse Event|1
5323990|NCT00283439|18334901|P3|Overall Study|Adverse Event|0
5323991|NCT00283439|18334902|P2|Overall Study|Adverse Event|0
5323992|NCT00283439|18334903|P1|Overall Study|Adverse Event|0
5323993|NCT00283400|18334929|P4|Overall Study|Death|0
5323994|NCT00283400|18334930|P3|Overall Study|Death|1
5323995|NCT00283400|18334931|P2|Overall Study|Death|0
5323996|NCT00283400|18334932|P1|Overall Study|Death|1
5323997|NCT00283400|18334929|P4|Overall Study|Withdrawal by Subject|0
5323998|NCT00283400|18334930|P3|Overall Study|Withdrawal by Subject|0
5323999|NCT00283400|18334931|P2|Overall Study|Withdrawal by Subject|1
5324000|NCT00283400|18334932|P1|Overall Study|Withdrawal by Subject|1
5324001|NCT00283387|18334950|P2|First Intervention|Withdrawal by Subject|1
5324002|NCT00283387|18334951|P1|First Intervention|Withdrawal by Subject|0
5324003|NCT00283387|18334950|P2|First Intervention|Subject non-compliant|1
5324004|NCT00283387|18334951|P1|First Intervention|Subject non-compliant|1
5324005|NCT00283296|18334957|P1|Overall Study|in-home trial not completed|5
5324006|NCT00283244|18334988|P3|Overall Study|Clinical deterioration|3
5324007|NCT00283244|18334989|P2|Overall Study|Clinical deterioration|3
5324008|NCT00283244|18334990|P1|Overall Study|Clinical deterioration|1
5324009|NCT00283244|18334988|P3|Overall Study|Medical illness (other complicating dz)|6
5324010|NCT00283244|18334989|P2|Overall Study|Medical illness (other complicating dz)|3
5324011|NCT00283244|18334990|P1|Overall Study|Medical illness (other complicating dz)|4
5324012|NCT00283244|18334988|P3|Overall Study|Physician Decision|1
5324013|NCT00283244|18334989|P2|Overall Study|Physician Decision|0
5324014|NCT00283244|18334990|P1|Overall Study|Physician Decision|0
5324015|NCT00283244|18334988|P3|Overall Study|Withdrawal by Subject|2
5324016|NCT00283244|18334989|P2|Overall Study|Withdrawal by Subject|2
5324017|NCT00283244|18334990|P1|Overall Study|Withdrawal by Subject|1
5324018|NCT00283244|18334988|P3|Overall Study|Lack of Efficacy|26
5324019|NCT00283244|18334989|P2|Overall Study|Lack of Efficacy|32
5324020|NCT00283244|18334990|P1|Overall Study|Lack of Efficacy|8
5324021|NCT00283244|18334988|P3|Overall Study|Death|2
5324022|NCT00283244|18334989|P2|Overall Study|Death|3
5324023|NCT00283244|18334990|P1|Overall Study|Death|4
5324024|NCT00283244|18334988|P3|Overall Study|Adverse Event|11
5324025|NCT00283244|18334989|P2|Overall Study|Adverse Event|8
5324026|NCT00283244|18334990|P1|Overall Study|Adverse Event|0
5324027|NCT00283062|18335026|P4|Overall Study|chemotherapy not completed (cycle 6)|0
5324028|NCT00283062|18335027|P3|Overall Study|chemotherapy not completed (cycle 6)|0
5324029|NCT00283062|18335028|P2|Overall Study|chemotherapy not completed (cycle 6)|0
5324030|NCT00283062|18335029|P1|Overall Study|chemotherapy not completed (cycle 6)|1
5324031|NCT00283062|18335026|P4|Overall Study|Undefined|4
5324032|NCT00283062|18335027|P3|Overall Study|Undefined|1
5324033|NCT00283062|18335028|P2|Overall Study|Undefined|1
5324034|NCT00283062|18335029|P1|Overall Study|Undefined|0
5324035|NCT00283062|18335026|P4|Overall Study|Participant did not wish to continue|0
5324036|NCT00283062|18335027|P3|Overall Study|Participant did not wish to continue|1
5324037|NCT00283062|18335028|P2|Overall Study|Participant did not wish to continue|2
5324038|NCT00283062|18335029|P1|Overall Study|Participant did not wish to continue|3
5324039|NCT00283062|18335026|P4|Overall Study|Progressive disease|0
5324040|NCT00283062|18335027|P3|Overall Study|Progressive disease|1
5324041|NCT00283062|18335028|P2|Overall Study|Progressive disease|0
5324042|NCT00283062|18335029|P1|Overall Study|Progressive disease|0
5324043|NCT00283062|18335026|P4|Overall Study|Lost to Follow-up|0
5324044|NCT00283062|18335027|P3|Overall Study|Lost to Follow-up|1
5324045|NCT00283062|18335028|P2|Overall Study|Lost to Follow-up|0
5324046|NCT00283062|18335029|P1|Overall Study|Lost to Follow-up|1
5324047|NCT00283062|18335026|P4|Overall Study|Adverse Event|0
5324048|NCT00283062|18335027|P3|Overall Study|Adverse Event|1
5324049|NCT00283062|18335028|P2|Overall Study|Adverse Event|0
5324050|NCT00283062|18335029|P1|Overall Study|Adverse Event|2
5324051|NCT00283062|18335026|P4|Overall Study|Did not receive any study medication|45
5324052|NCT00283062|18335027|P3|Overall Study|Did not receive any study medication|36
5324053|NCT00283062|18335028|P2|Overall Study|Did not receive any study medication|4
5324054|NCT00283062|18335029|P1|Overall Study|Did not receive any study medication|5
5324055|NCT00283049|18335062|P3|Overall Study|No longer requires study treatment|1
5324056|NCT00283049|18335063|P2|Overall Study|No longer requires study treatment|0
5324057|NCT00283049|18335064|P1|Overall Study|No longer requires study treatment|0
5324058|NCT00283049|18335062|P3|Overall Study|Discontinuation of Study|20
5324059|NCT00283049|18335063|P2|Overall Study|Discontinuation of Study|16
5324060|NCT00283049|18335064|P1|Overall Study|Discontinuation of Study|18
5324061|NCT00283049|18335062|P3|Overall Study|Withdrawal by Subject|19
5324062|NCT00283049|18335063|P2|Overall Study|Withdrawal by Subject|24
5324063|NCT00283049|18335064|P1|Overall Study|Withdrawal by Subject|26
5324064|NCT00283049|18335062|P3|Overall Study|Lost to Follow-up|5
5324065|NCT00283049|18335063|P2|Overall Study|Lost to Follow-up|2
5324066|NCT00283049|18335064|P1|Overall Study|Lost to Follow-up|4
5324067|NCT00283049|18335062|P3|Overall Study|Lack of Efficacy|1
5324068|NCT00283049|18335063|P2|Overall Study|Lack of Efficacy|1
5324069|NCT00283049|18335064|P1|Overall Study|Lack of Efficacy|0
5324070|NCT00283049|18335062|P3|Overall Study|Death|1
5324071|NCT00283049|18335063|P2|Overall Study|Death|1
5324072|NCT00283049|18335064|P1|Overall Study|Death|1
5324073|NCT00283049|18335062|P3|Overall Study|Protocol Violation|3
5324074|NCT00283049|18335063|P2|Overall Study|Protocol Violation|0
5324075|NCT00283049|18335064|P1|Overall Study|Protocol Violation|3
5324076|NCT00283049|18335062|P3|Overall Study|Adverse Event|4
5324077|NCT00283049|18335063|P2|Overall Study|Adverse Event|1
5324078|NCT00283049|18335064|P1|Overall Study|Adverse Event|6
5324079|NCT00282984|18335092|P2|Overall Study|Protocol Violation|0
5324080|NCT00282984|18335093|P1|Overall Study|Protocol Violation|2
5324081|NCT00282984|18335092|P2|Overall Study|in prison|1
5324082|NCT00282984|18335093|P1|Overall Study|in prison|0
5324083|NCT00282984|18335092|P2|Overall Study|lack of motivation|0
5324084|NCT00282984|18335093|P1|Overall Study|lack of motivation|1
5324085|NCT00282984|18335092|P2|Overall Study|Participant used antipsychosis meds|1
5324086|NCT00282984|18335093|P1|Overall Study|Participant used antipsychosis meds|0
5324087|NCT00282984|18335092|P2|Overall Study|Participant only allowed phone follow-up|1
5324088|NCT00282984|18335093|P1|Overall Study|Participant only allowed phone follow-up|0
5324089|NCT00282984|18335092|P2|Overall Study|Participant stopped study medication|2
5324090|NCT00282984|18335093|P1|Overall Study|Participant stopped study medication|2
5324091|NCT00282984|18335092|P2|Overall Study|Withdrawal by Participant|34
5324092|NCT00282984|18335093|P1|Overall Study|Withdrawal by Participant|22
5324093|NCT00282984|18335092|P2|Overall Study|Lost to Follow-up|10
5324094|NCT00282984|18335093|P1|Overall Study|Lost to Follow-up|14
5324095|NCT00282984|18335092|P2|Overall Study|Lack of Efficacy|2
5324096|NCT00282984|18335093|P1|Overall Study|Lack of Efficacy|0
5324097|NCT00282984|18335092|P2|Overall Study|Adverse Event|5
5324098|NCT00282984|18335093|P1|Overall Study|Adverse Event|8
5324099|NCT00282984|18335092|P2|Overall Study|Death|5
5324100|NCT00282984|18335093|P1|Overall Study|Death|2
5324101|NCT00282919|18335130|P1|Overall Study|Asymptomatic Parasitemia|2
5324102|NCT00282919|18335130|P1|Overall Study|Withdrawal by Subject|1
5324103|NCT00282919|18335130|P1|Overall Study|Lack of Efficacy|4
5324104|NCT00282867|18335145|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
5324105|NCT00282867|18335146|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
5324106|NCT00282867|18335147|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
5324107|NCT00282568|18335249|P1|Extended Treatment Period|Lost to Follow-up|2
5324108|NCT00282568|18335249|P1|Extended Treatment Period|Physician Decision|1
5324109|NCT00282568|18335249|P1|Extended Treatment Period|Non-compliance|4
5324110|NCT00282568|18335249|P1|Extended Treatment Period|Adverse Event|17
5324111|NCT00282568|18335249|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
5324112|NCT00282568|18335249|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
5324113|NCT00282464|18335275|P2|Overall Study|dropped due to missed visits|1
5324114|NCT00282464|18335276|P1|Overall Study|dropped due to missed visits|0
5324115|NCT00282464|18335275|P2|Overall Study|dispensed wrong kit|1
5324116|NCT00282464|18335276|P1|Overall Study|dispensed wrong kit|0
5324117|NCT00282464|18335275|P2|Overall Study|family crisis|1
5324118|NCT00282464|18335276|P1|Overall Study|family crisis|0
5324119|NCT00282464|18335275|P2|Overall Study|patient incarcerated|1
5324120|NCT00282464|18335276|P1|Overall Study|patient incarcerated|0
5324121|NCT00282464|18335275|P2|Overall Study|patient no show|1
5324122|NCT00282464|18335276|P1|Overall Study|patient no show|0
5324123|NCT00282464|18335275|P2|Overall Study|patient non-compliant|0
5324124|NCT00282464|18335276|P1|Overall Study|patient non-compliant|3
5324125|NCT00282464|18335275|P2|Overall Study|Patient moved|0
5324126|NCT00282464|18335276|P1|Overall Study|Patient moved|1
5324127|NCT00282464|18335275|P2|Overall Study|Protocol Violation|7
5324128|NCT00282464|18335276|P1|Overall Study|Protocol Violation|0
5324129|NCT00282464|18335275|P2|Overall Study|laboratory abnormality|2
5324130|NCT00282464|18335276|P1|Overall Study|laboratory abnormality|1
5324131|NCT00282464|18335275|P2|Overall Study|Withdrawal by Subject|10
5324132|NCT00282464|18335276|P1|Overall Study|Withdrawal by Subject|24
5324133|NCT00282464|18335275|P2|Overall Study|Lost to Follow-up|10
5324134|NCT00282464|18335276|P1|Overall Study|Lost to Follow-up|10
5324135|NCT00282464|18335275|P2|Overall Study|Lack of Efficacy|8
5324136|NCT00282464|18335276|P1|Overall Study|Lack of Efficacy|8
5324137|NCT00282464|18335275|P2|Overall Study|Adverse Event|20
5324138|NCT00282464|18335276|P1|Overall Study|Adverse Event|26
5324139|NCT00282438|18335326|P2|Overall Study|Death|1
5324140|NCT00282438|18335327|P1|Overall Study|Death|0
5324141|NCT00282438|18335326|P2|Overall Study|Lack of Efficacy|0
5324142|NCT00282438|18335327|P1|Overall Study|Lack of Efficacy|1
5324143|NCT00282412|18335337|P1|Overall Study|Death|2
5324144|NCT00282347|18335343|P2|B Cell Follow-up Period|Reason Not Specified|0
5324145|NCT00282347|18335344|P1|B Cell Follow-up Period|Reason Not Specified|2
5324146|NCT00282347|18335343|P2|B Cell Follow-up Period|Physician Decision|0
5324147|NCT00282347|18335344|P1|B Cell Follow-up Period|Physician Decision|1
5324148|NCT00282347|18335343|P2|B Cell Follow-up Period|Withdrawal by Subject|0
5324149|NCT00282347|18335344|P1|B Cell Follow-up Period|Withdrawal by Subject|2
5324150|NCT00282347|18335343|P2|Safety Follow-up Period|Protocol Deviation|2
5324151|NCT00282347|18335344|P1|Safety Follow-up Period|Protocol Deviation|0
5324152|NCT00282347|18335343|P2|Safety Follow-up Period|Physician Decision|1
5324153|NCT00282347|18335344|P1|Safety Follow-up Period|Physician Decision|1
5324154|NCT00282347|18335343|P2|Safety Follow-up Period|Withdrawal by Subject|1
5324155|NCT00282347|18335344|P1|Safety Follow-up Period|Withdrawal by Subject|2
5324156|NCT00282347|18335343|P2|Safety Follow-up Period|Lost to Follow-up|2
5324157|NCT00282347|18335344|P1|Safety Follow-up Period|Lost to Follow-up|0
5324158|NCT00282347|18335343|P2|Treatment Period|Physician Decision|1
5324159|NCT00282347|18335344|P1|Treatment Period|Physician Decision|0
5324160|NCT00282347|18335343|P2|Treatment Period|Withdrawal by Subject|3
5324161|NCT00282347|18335344|P1|Treatment Period|Withdrawal by Subject|1
5324162|NCT00282347|18335343|P2|Treatment Period|Lost to Follow-up|5
5324163|NCT00282347|18335344|P1|Treatment Period|Lost to Follow-up|2
5324164|NCT00282347|18335343|P2|Treatment Period|Death|0
5324165|NCT00282347|18335344|P1|Treatment Period|Death|2
5324166|NCT00282334|18335370|P2|Overall Study|Withdrawal by Subject|5
5324167|NCT00282334|18335371|P1|Overall Study|Withdrawal by Subject|8
5324168|NCT00282308|18335379|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
5324169|NCT00282308|18335380|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
5324170|NCT00282308|18335381|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
5324171|NCT00282308|18335379|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
5324172|NCT00282308|18335380|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
5324173|NCT00282308|18335381|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
5324174|NCT00282308|18335379|P3|Safety Follow-up Period|Lost to Follow-up|5
5324175|NCT00282308|18335380|P2|Safety Follow-up Period|Lost to Follow-up|0
5324176|NCT00282308|18335381|P1|Safety Follow-up Period|Lost to Follow-up|0
5324177|NCT00282308|18335379|P3|Safety Follow-up Period|Adverse Event|1
5324178|NCT00282308|18335380|P2|Safety Follow-up Period|Adverse Event|0
5324179|NCT00282308|18335381|P1|Safety Follow-up Period|Adverse Event|0
5324180|NCT00282308|18335379|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
5324181|NCT00282308|18335380|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
5324182|NCT00282308|18335381|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
5324183|NCT00282308|18335379|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
5324184|NCT00282308|18335380|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
5324185|NCT00282308|18335381|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
5324186|NCT00282308|18335379|P3|Optional Extension Re-treatment Period|Adverse Event|4
5324187|NCT00282308|18335380|P2|Optional Extension Re-treatment Period|Adverse Event|0
5324188|NCT00282308|18335381|P1|Optional Extension Re-treatment Period|Adverse Event|0
5324189|NCT00282308|18335379|P3|Treatment Period|Not Treated with Study Drug|0
5324190|NCT00282308|18335380|P2|Treatment Period|Not Treated with Study Drug|0
5324191|NCT00282308|18335381|P1|Treatment Period|Not Treated with Study Drug|1
5324192|NCT00282308|18335379|P3|Treatment Period|Adverse Event|0
5324193|NCT00282308|18335380|P2|Treatment Period|Adverse Event|2
5324194|NCT00282308|18335381|P1|Treatment Period|Adverse Event|0
5324195|NCT00282308|18335379|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
5324196|NCT00282308|18335380|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
5324197|NCT00282308|18335381|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
5324198|NCT00282308|18335379|P3|Treatment Period|Lost to Follow-up|0
5324199|NCT00282308|18335380|P2|Treatment Period|Lost to Follow-up|0
5324200|NCT00282308|18335381|P1|Treatment Period|Lost to Follow-up|1
5324201|NCT00282295|18335411|P3|Overall Study|Other|0
5324202|NCT00282295|18335412|P2|Overall Study|Other|1
5324203|NCT00282295|18335413|P1|Overall Study|Other|0
5324204|NCT00282295|18335411|P3|Overall Study|Lost to Follow-up|2
5324205|NCT00282295|18335412|P2|Overall Study|Lost to Follow-up|7
5324206|NCT00282295|18335413|P1|Overall Study|Lost to Follow-up|1
5324207|NCT00282295|18335411|P3|Overall Study|Withdrawal by Subject|4
5324208|NCT00282295|18335412|P2|Overall Study|Withdrawal by Subject|6
5324209|NCT00282295|18335413|P1|Overall Study|Withdrawal by Subject|2
5324210|NCT00282295|18335411|P3|Overall Study|Protocol Violation|1
5324211|NCT00282295|18335412|P2|Overall Study|Protocol Violation|2
5324212|NCT00282295|18335413|P1|Overall Study|Protocol Violation|0
5324213|NCT00282295|18335411|P3|Overall Study|Serious Adverse Events|1
5324214|NCT00282295|18335412|P2|Overall Study|Serious Adverse Events|0
5324215|NCT00282295|18335413|P1|Overall Study|Serious Adverse Events|0
5324216|NCT00282295|18335411|P3|Overall Study|Adverse Event|0
5324217|NCT00282295|18335412|P2|Overall Study|Adverse Event|1
5324218|NCT00282295|18335413|P1|Overall Study|Adverse Event|0
5324219|NCT00282256|18335468|P1|Extension Treatment Period|Adverse Event|2
5324220|NCT00282256|18335468|P1|Pharmacokinetic Treatment Period|Poor venous access|1
5324221|NCT00282243|18335489|P1|Extension Treatment Period|Physician Decision|1
5324222|NCT00282243|18335489|P1|Extension Treatment Period|Non-compliance|2
5324223|NCT00282243|18335489|P1|Extension Treatment Period|Withdrawal by Subject|4
5324224|NCT00282243|18335489|P1|Extension Treatment Period|Adverse Event|15
5324225|NCT00282243|18335489|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
5324226|NCT00282243|18335489|P1|Pharmacokinetic Treatment Period|Adverse Event|3
5324227|NCT00282152|18335515|P2|Overall Study|Withdrawal by Subject|0
5324228|NCT00282152|18335516|P1|Overall Study|Withdrawal by Subject|1
5324229|NCT00282113|18335537|P3|Overall Study|Removed at parents request|0
5324230|NCT00282113|18335538|P2|Overall Study|Removed at parents request|0
5324231|NCT00282113|18335539|P1|Overall Study|Removed at parents request|1
5324232|NCT00282087|18335553|P1|Overall Study|Death|1
5324233|NCT00282048|18335566|P1|Overall Study|Ongoing|1
5324234|NCT00282048|18335566|P1|Overall Study|Other|8
5324235|NCT00282048|18335566|P1|Overall Study|Withdrawal by Subject|1
5324236|NCT00282048|18335566|P1|Overall Study|Adverse Event|22
5324237|NCT00282048|18335566|P1|Overall Study|Lack of Efficacy|30
5324238|NCT00281957|18335580|P2|Overall Study|Refusal unrelated to adverse events|1
5324239|NCT00281957|18335581|P1|Overall Study|Refusal unrelated to adverse events|0
5324240|NCT00281957|18335580|P2|Overall Study|Did not start treatment|1
5324241|NCT00281957|18335581|P1|Overall Study|Did not start treatment|3
5324242|NCT00281957|18335580|P2|Overall Study|Not eligible|2
5324243|NCT00281957|18335581|P1|Overall Study|Not eligible|1
5324244|NCT00281957|18335580|P2|Overall Study|Not protocol specified|1
5324245|NCT00281957|18335581|P1|Overall Study|Not protocol specified|8
5324246|NCT00281957|18335580|P2|Overall Study|Progression/relapse|35
5324247|NCT00281957|18335581|P1|Overall Study|Progression/relapse|47
5324248|NCT00281957|18335580|P2|Overall Study|Death|0
5324249|NCT00281957|18335581|P1|Overall Study|Death|1
5324250|NCT00281957|18335580|P2|Overall Study|Adverse Event|2
5324251|NCT00281957|18335581|P1|Overall Study|Adverse Event|7
5324252|NCT00281840|18335655|P1|Overall Study|Complicating Disease|1
5324253|NCT00281840|18335655|P1|Overall Study|exceed maximum delay in treatment|1
5324254|NCT00281840|18335655|P1|Overall Study|Disease Progression|2
5324255|NCT00281840|18335655|P1|Overall Study|Withdrawal by Subject|3
5324256|NCT00281840|18335655|P1|Overall Study|Physician Decision|6
5324257|NCT00281840|18335655|P1|Overall Study|Adverse Event|12
5324258|NCT00281697|18335671|P2|Overall Study|Did not receive study drug|2
5324259|NCT00281697|18335672|P1|Overall Study|Did not receive study drug|3
5324260|NCT00281697|18335671|P2|Overall Study|Subject/guardian's decision to withdraw|6
5324261|NCT00281697|18335672|P1|Overall Study|Subject/guardian's decision to withdraw|33
5324262|NCT00281697|18335671|P2|Overall Study|Physician's decision to withdraw|12
5324263|NCT00281697|18335672|P1|Overall Study|Physician's decision to withdraw|15
5324264|NCT00281697|18335671|P2|Overall Study|Other|6
5324265|NCT00281697|18335672|P1|Overall Study|Other|5
5324266|NCT00281697|18335671|P2|Overall Study|Disease progression|149
5324267|NCT00281697|18335672|P1|Overall Study|Disease progression|279
5324268|NCT00281697|18335671|P2|Overall Study|Death|3
5324269|NCT00281697|18335672|P1|Overall Study|Death|8
5324270|NCT00281697|18335671|P2|Overall Study|Adverse Event|15
5324271|NCT00281697|18335672|P1|Overall Study|Adverse Event|54
5324272|NCT00281697|18335671|P2|Overall Study|> 60 days since last dose of study drug|4
5324273|NCT00281697|18335672|P1|Overall Study|> 60 days since last dose of study drug|4
5324274|NCT00281684|18335692|P4|Overall Study|Withdrawal by Subject|0
5324275|NCT00281684|18335693|P3|Overall Study|Withdrawal by Subject|0
5324276|NCT00281684|18335694|P2|Overall Study|Withdrawal by Subject|0
5324277|NCT00281684|18335695|P1|Overall Study|Withdrawal by Subject|1
5324278|NCT00281684|18335692|P4|Overall Study|Lost to Follow-up|0
5324279|NCT00281684|18335693|P3|Overall Study|Lost to Follow-up|1
5324280|NCT00281684|18335694|P2|Overall Study|Lost to Follow-up|0
5324281|NCT00281684|18335695|P1|Overall Study|Lost to Follow-up|0
5324282|NCT00281658|18335782|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
5324283|NCT00281658|18335783|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
5324284|NCT00281658|18335784|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
5324285|NCT00281658|18335782|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
5324286|NCT00281658|18335783|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
5324287|NCT00281658|18335784|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
5324288|NCT00281658|18335782|P3|Open-label Monotherapy Extension Phase|Death|97
5324289|NCT00281658|18335783|P2|Open-label Monotherapy Extension Phase|Death|0
5324290|NCT00281658|18335784|P1|Open-label Monotherapy Extension Phase|Death|0
5324291|NCT00281658|18335782|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
5324292|NCT00281658|18335783|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
5324293|NCT00281658|18335784|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
5324294|NCT00281658|18335782|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
5324295|NCT00281658|18335783|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
5324296|NCT00281658|18335784|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
5324297|NCT00281658|18335782|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
5324298|NCT00281658|18335783|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
5324299|NCT00281658|18335784|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
5324300|NCT00281658|18335782|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
5324301|NCT00281658|18335783|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
5324302|NCT00281658|18335784|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
5324303|NCT00281658|18335782|P3|Double-blind, Randomized Phase|Death|0
5324304|NCT00281658|18335783|P2|Double-blind, Randomized Phase|Death|46
5324305|NCT00281658|18335784|P1|Double-blind, Randomized Phase|Death|120
5324306|NCT00281632|18335801|P1|Overall Study|Ongoing|3
5324307|NCT00281632|18335801|P1|Overall Study|Physician Decision|1
5324308|NCT00281632|18335801|P1|Overall Study|Death|1
5324309|NCT00281632|18335801|P1|Overall Study|Disease Progression|22
5324310|NCT00281632|18335801|P1|Overall Study|Withdrawal by Subject|2
5324311|NCT00281632|18335801|P1|Overall Study|Adverse Event|7
5324312|NCT00281580|18335843|P16|Overall Study|Randomised in error; pregnancy; moving|2
5324313|NCT00281580|18335844|P15|Overall Study|Randomised in error; pregnancy; moving|1
5324314|NCT00281580|18335845|P14|Overall Study|Randomised in error; pregnancy; moving|0
5324315|NCT00281580|18335846|P13|Overall Study|Randomised in error; pregnancy; moving|2
5324316|NCT00281580|18335847|P12|Overall Study|Randomised in error; pregnancy; moving|1
5324317|NCT00281580|18335848|P11|Overall Study|Randomised in error; pregnancy; moving|1
5324318|NCT00281580|18335849|P10|Overall Study|Randomised in error; pregnancy; moving|1
5324319|NCT00281580|18335850|P9|Overall Study|Randomised in error; pregnancy; moving|2
5324320|NCT00281580|18335851|P8|Overall Study|Randomised in error; pregnancy; moving|0
5324321|NCT00281580|18335852|P7|Overall Study|Randomised in error; pregnancy; moving|1
5324322|NCT00281580|18335853|P6|Overall Study|Randomised in error; pregnancy; moving|0
5324323|NCT00281580|18335854|P5|Overall Study|Randomised in error; pregnancy; moving|0
5324324|NCT00281580|18335855|P4|Overall Study|Randomised in error; pregnancy; moving|2
5324325|NCT00281580|18335856|P3|Overall Study|Randomised in error; pregnancy; moving|0
5324326|NCT00281580|18335857|P2|Overall Study|Randomised in error; pregnancy; moving|0
5324327|NCT00281580|18335858|P1|Overall Study|Randomised in error; pregnancy; moving|0
5324328|NCT00281580|18335843|P16|Overall Study|Lost to Follow-up|0
5324329|NCT00281580|18335844|P15|Overall Study|Lost to Follow-up|0
5324330|NCT00281580|18335845|P14|Overall Study|Lost to Follow-up|0
5324331|NCT00281580|18335846|P13|Overall Study|Lost to Follow-up|1
5324332|NCT00281580|18335847|P12|Overall Study|Lost to Follow-up|0
5324333|NCT00281580|18335848|P11|Overall Study|Lost to Follow-up|1
5324334|NCT00281580|18335849|P10|Overall Study|Lost to Follow-up|1
5324335|NCT00281580|18335850|P9|Overall Study|Lost to Follow-up|2
5324336|NCT00281580|18335851|P8|Overall Study|Lost to Follow-up|1
5324337|NCT00281580|18335852|P7|Overall Study|Lost to Follow-up|0
5324338|NCT00281580|18335853|P6|Overall Study|Lost to Follow-up|1
5324339|NCT00281580|18335854|P5|Overall Study|Lost to Follow-up|0
5324340|NCT00281580|18335855|P4|Overall Study|Lost to Follow-up|3
5324341|NCT00281580|18335856|P3|Overall Study|Lost to Follow-up|0
5324342|NCT00281580|18335857|P2|Overall Study|Lost to Follow-up|0
5324343|NCT00281580|18335858|P1|Overall Study|Lost to Follow-up|0
5324344|NCT00281580|18335843|P16|Overall Study|Lack of Efficacy|0
5324345|NCT00281580|18335844|P15|Overall Study|Lack of Efficacy|1
5324346|NCT00281580|18335845|P14|Overall Study|Lack of Efficacy|2
5324347|NCT00281580|18335846|P13|Overall Study|Lack of Efficacy|0
5324348|NCT00281580|18335847|P12|Overall Study|Lack of Efficacy|1
5324349|NCT00281580|18335848|P11|Overall Study|Lack of Efficacy|0
5324350|NCT00281580|18335849|P10|Overall Study|Lack of Efficacy|0
5324351|NCT00281580|18335850|P9|Overall Study|Lack of Efficacy|0
5324352|NCT00281580|18335851|P8|Overall Study|Lack of Efficacy|0
5324353|NCT00281580|18335852|P7|Overall Study|Lack of Efficacy|0
5324354|NCT00281580|18335853|P6|Overall Study|Lack of Efficacy|0
5324355|NCT00281580|18335854|P5|Overall Study|Lack of Efficacy|2
5324356|NCT00281580|18335855|P4|Overall Study|Lack of Efficacy|6
5324357|NCT00281580|18335856|P3|Overall Study|Lack of Efficacy|1
5324358|NCT00281580|18335857|P2|Overall Study|Lack of Efficacy|1
5324359|NCT00281580|18335858|P1|Overall Study|Lack of Efficacy|2
5324360|NCT00281580|18335843|P16|Overall Study|Withdrawal by Subject|5
5324361|NCT00281580|18335844|P15|Overall Study|Withdrawal by Subject|1
5324362|NCT00281580|18335845|P14|Overall Study|Withdrawal by Subject|2
5324363|NCT00281580|18335846|P13|Overall Study|Withdrawal by Subject|2
5324364|NCT00281580|18335847|P12|Overall Study|Withdrawal by Subject|1
5324365|NCT00281580|18335848|P11|Overall Study|Withdrawal by Subject|1
5324366|NCT00281580|18335849|P10|Overall Study|Withdrawal by Subject|4
5324367|NCT00281580|18335850|P9|Overall Study|Withdrawal by Subject|1
5324368|NCT00281580|18335851|P8|Overall Study|Withdrawal by Subject|0
5324369|NCT00281580|18335852|P7|Overall Study|Withdrawal by Subject|2
5324370|NCT00281580|18335853|P6|Overall Study|Withdrawal by Subject|2
5324371|NCT00281580|18335854|P5|Overall Study|Withdrawal by Subject|1
5324372|NCT00281580|18335855|P4|Overall Study|Withdrawal by Subject|1
5324373|NCT00281580|18335856|P3|Overall Study|Withdrawal by Subject|1
5324374|NCT00281580|18335857|P2|Overall Study|Withdrawal by Subject|0
5324375|NCT00281580|18335858|P1|Overall Study|Withdrawal by Subject|3
5324376|NCT00281580|18335843|P16|Overall Study|Protocol Violation|3
5324377|NCT00281580|18335844|P15|Overall Study|Protocol Violation|1
5324378|NCT00281580|18335845|P14|Overall Study|Protocol Violation|1
5324379|NCT00281580|18335846|P13|Overall Study|Protocol Violation|0
5324380|NCT00281580|18335847|P12|Overall Study|Protocol Violation|2
5324381|NCT00281580|18335848|P11|Overall Study|Protocol Violation|1
5324382|NCT00281580|18335849|P10|Overall Study|Protocol Violation|0
5324383|NCT00281580|18335850|P9|Overall Study|Protocol Violation|2
5324384|NCT00281580|18335851|P8|Overall Study|Protocol Violation|0
5324385|NCT00281580|18335852|P7|Overall Study|Protocol Violation|1
5324386|NCT00281580|18335853|P6|Overall Study|Protocol Violation|0
5324387|NCT00281580|18335854|P5|Overall Study|Protocol Violation|0
5324388|NCT00281580|18335855|P4|Overall Study|Protocol Violation|1
5324389|NCT00281580|18335856|P3|Overall Study|Protocol Violation|1
5324390|NCT00281580|18335857|P2|Overall Study|Protocol Violation|0
5324391|NCT00281580|18335858|P1|Overall Study|Protocol Violation|0
5324392|NCT00281580|18335843|P16|Overall Study|Adverse Event|3
5324393|NCT00281580|18335844|P15|Overall Study|Adverse Event|3
5324394|NCT00281580|18335845|P14|Overall Study|Adverse Event|2
5324395|NCT00281580|18335846|P13|Overall Study|Adverse Event|8
5324396|NCT00281580|18335847|P12|Overall Study|Adverse Event|5
5324397|NCT00281580|18335848|P11|Overall Study|Adverse Event|0
5324398|NCT00281580|18335849|P10|Overall Study|Adverse Event|6
5324399|NCT00281580|18335850|P9|Overall Study|Adverse Event|1
5324400|NCT00281580|18335851|P8|Overall Study|Adverse Event|0
5324401|NCT00281580|18335852|P7|Overall Study|Adverse Event|1
5324402|NCT00281580|18335853|P6|Overall Study|Adverse Event|0
5324403|NCT00281580|18335854|P5|Overall Study|Adverse Event|1
5324404|NCT00281580|18335855|P4|Overall Study|Adverse Event|4
5324405|NCT00281580|18335856|P3|Overall Study|Adverse Event|2
5324406|NCT00281580|18335857|P2|Overall Study|Adverse Event|0
5324407|NCT00281580|18335858|P1|Overall Study|Adverse Event|2
5324408|NCT00281528|18336205|P3|Overall Study|Other|5
5324409|NCT00281528|18336206|P2|Overall Study|Other|3
5324410|NCT00281528|18336207|P1|Overall Study|Other|6
5324411|NCT00281528|18336205|P3|Overall Study|Withdrawal by Subject|7
5324412|NCT00281528|18336206|P2|Overall Study|Withdrawal by Subject|5
5324413|NCT00281528|18336207|P1|Overall Study|Withdrawal by Subject|5
5324414|NCT00281528|18336205|P3|Overall Study|Protocol Violation|1
5324415|NCT00281528|18336206|P2|Overall Study|Protocol Violation|0
5324416|NCT00281528|18336207|P1|Overall Study|Protocol Violation|1
5324417|NCT00281528|18336205|P3|Overall Study|Physician Decision|5
5324418|NCT00281528|18336206|P2|Overall Study|Physician Decision|4
5324419|NCT00281528|18336207|P1|Overall Study|Physician Decision|11
5324420|NCT00281528|18336205|P3|Overall Study|Adverse Event-unrelated to treatment|2
5324421|NCT00281528|18336206|P2|Overall Study|Adverse Event-unrelated to treatment|0
5324422|NCT00281528|18336207|P1|Overall Study|Adverse Event-unrelated to treatment|3
5324423|NCT00281528|18336205|P3|Overall Study|Unacceptable Toxicity-related to trt|32
5324424|NCT00281528|18336206|P2|Overall Study|Unacceptable Toxicity-related to trt|24
5324425|NCT00281528|18336207|P1|Overall Study|Unacceptable Toxicity-related to trt|21
5324426|NCT00281528|18336205|P3|Overall Study|Progressive Disease|27
5324427|NCT00281528|18336206|P2|Overall Study|Progressive Disease|18
5324428|NCT00281528|18336207|P1|Overall Study|Progressive Disease|28
5324429|NCT00281320|18336258|P2|Overall Study|Other|1
5324430|NCT00281320|18336259|P1|Overall Study|Other|3
5324431|NCT00281320|18336258|P2|Overall Study|Lost to Follow-up|2
5324432|NCT00281320|18336259|P1|Overall Study|Lost to Follow-up|1
5324433|NCT00281320|18336258|P2|Overall Study|Withdrawal by Subject|6
5324434|NCT00281320|18336259|P1|Overall Study|Withdrawal by Subject|5
5324435|NCT00281320|18336258|P2|Overall Study|Lack of Efficacy|3
5324436|NCT00281320|18336259|P1|Overall Study|Lack of Efficacy|4
5324437|NCT00281320|18336258|P2|Overall Study|Adverse Event|9
5324438|NCT00281320|18336259|P1|Overall Study|Adverse Event|12
5324439|NCT00281099|18336281|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
5324440|NCT00281099|18336282|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
5324441|NCT00281099|18336281|P2|Overall Study|Physician Decision|72
5324442|NCT00281099|18336282|P1|Overall Study|Physician Decision|79
5324443|NCT00281099|18336281|P2|Overall Study|Withdrawal by Subject|70
5324444|NCT00281099|18336282|P1|Overall Study|Withdrawal by Subject|65
5324445|NCT00281099|18336281|P2|Overall Study|Lost to Follow-up|19
5324446|NCT00281099|18336282|P1|Overall Study|Lost to Follow-up|10
5324447|NCT00281099|18336281|P2|Overall Study|Death|57
5324448|NCT00281099|18336282|P1|Overall Study|Death|46
5324449|NCT00280917|18336331|P4|Overall Study|Noncompliance|0
5324450|NCT00280917|18336332|P3|Overall Study|Noncompliance|2
5324451|NCT00280917|18336333|P2|Overall Study|Noncompliance|1
5324452|NCT00280917|18336334|P1|Overall Study|Noncompliance|0
5324453|NCT00280917|18336331|P4|Overall Study|Withdrawal by Subject|1
5324454|NCT00280917|18336332|P3|Overall Study|Withdrawal by Subject|0
5324455|NCT00280917|18336333|P2|Overall Study|Withdrawal by Subject|2
5324456|NCT00280917|18336334|P1|Overall Study|Withdrawal by Subject|0
5324457|NCT00280917|18336331|P4|Overall Study|Change Therapy|0
5324458|NCT00280917|18336332|P3|Overall Study|Change Therapy|0
5324459|NCT00280917|18336333|P2|Overall Study|Change Therapy|2
5324460|NCT00280917|18336334|P1|Overall Study|Change Therapy|1
5324461|NCT00280917|18336331|P4|Overall Study|Adverse Event|1
5324462|NCT00280917|18336332|P3|Overall Study|Adverse Event|4
5324463|NCT00280917|18336333|P2|Overall Study|Adverse Event|1
5324464|NCT00280917|18336334|P1|Overall Study|Adverse Event|1
5324465|NCT00280748|18336357|P1|Overall Study|Extra-cranial disease progression|1
5324466|NCT00280748|18336357|P1|Overall Study|Decline in performance|3
5324467|NCT00280735|18336367|P1|Overall Study|Intercurrent Illness|2
5324468|NCT00280735|18336367|P1|Overall Study|Withdrawal by Subject|8
5324469|NCT00280735|18336367|P1|Overall Study|Lack of Efficacy|3
5324470|NCT00280735|18336367|P1|Overall Study|Adverse Event|5
5324471|NCT00280683|18336379|P2|Overall Study|Adverse Event|1
5324472|NCT00280683|18336380|P1|Overall Study|Adverse Event|1
5324473|NCT00280683|18336379|P2|Overall Study|Withdrawal by Subject|2
5324474|NCT00280683|18336380|P1|Overall Study|Withdrawal by Subject|1
5324475|NCT00280566|18336390|P3|Period 2 Double Blind|miscellaneous|5
5324476|NCT00280566|18336391|P2|Period 2 Double Blind|miscellaneous|10
5324477|NCT00280566|18336392|P1|Period 2 Double Blind|miscellaneous|0
5324478|NCT00280566|18336390|P3|Period 2 Double Blind|Withdrawal by Subject|9
5324479|NCT00280566|18336391|P2|Period 2 Double Blind|Withdrawal by Subject|9
5324480|NCT00280566|18336392|P1|Period 2 Double Blind|Withdrawal by Subject|0
5324481|NCT00280566|18336390|P3|Period 2 Double Blind|Lost to Follow-up|6
5324482|NCT00280566|18336391|P2|Period 2 Double Blind|Lost to Follow-up|3
5324483|NCT00280566|18336392|P1|Period 2 Double Blind|Lost to Follow-up|0
5324484|NCT00280566|18336390|P3|Period 2 Double Blind|Adverse Event|15
5324485|NCT00280566|18336391|P2|Period 2 Double Blind|Adverse Event|11
5324486|NCT00280566|18336392|P1|Period 2 Double Blind|Adverse Event|0
5324487|NCT00280566|18336390|P3|Period 2 Double Blind|Laboratory Abnormality|0
5324488|NCT00280566|18336391|P2|Period 2 Double Blind|Laboratory Abnormality|1
5324489|NCT00280566|18336392|P1|Period 2 Double Blind|Laboratory Abnormality|0
5324490|NCT00280566|18336390|P3|Period 2 Double Blind|Lack of Efficacy|22
5324491|NCT00280566|18336391|P2|Period 2 Double Blind|Lack of Efficacy|9
5324492|NCT00280566|18336392|P1|Period 2 Double Blind|Lack of Efficacy|0
5324493|NCT00280566|18336390|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
5324494|NCT00280566|18336391|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
5324495|NCT00280566|18336392|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
5324496|NCT00280566|18336390|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
5324497|NCT00280566|18336391|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
5324498|NCT00280566|18336392|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
5324499|NCT00280566|18336390|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
5324500|NCT00280566|18336391|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
5324501|NCT00280566|18336392|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
5324502|NCT00280566|18336390|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
5324503|NCT00280566|18336391|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
5324504|NCT00280566|18336392|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
5324505|NCT00280566|18336390|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
5324506|NCT00280566|18336391|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
5324507|NCT00280566|18336392|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
5324508|NCT00280566|18336390|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
5324509|NCT00280566|18336391|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
5324510|NCT00280566|18336392|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
5324511|NCT00280397|18336417|P1|Overall Study|Adverse Event|1
5324512|NCT00280293|18336483|P2|Overall Study|Adverse Event|1
5324513|NCT00280293|18336484|P1|Overall Study|Adverse Event|0
5324514|NCT00280293|18336483|P2|Overall Study|Incarceration/Legal Reasons|1
5324515|NCT00280293|18336484|P1|Overall Study|Incarceration/Legal Reasons|1
5324516|NCT00280293|18336483|P2|Overall Study|Withdrawal by Subject|5
5324517|NCT00280293|18336484|P1|Overall Study|Withdrawal by Subject|3
5324518|NCT00280293|18336483|P2|Overall Study|Lost to Follow-up|12
5324519|NCT00280293|18336484|P1|Overall Study|Lost to Follow-up|14
5324520|NCT00280293|18336483|P2|Overall Study|Physician Decision|4
5324521|NCT00280293|18336484|P1|Overall Study|Physician Decision|5
5324522|NCT00280293|18336483|P2|Overall Study|Protocol Violation|0
5324523|NCT00280293|18336484|P1|Overall Study|Protocol Violation|3
5324524|NCT00280150|18336507|P4|Overall Study|Declining Performance Status|1
5324525|NCT00280150|18336508|P3|Overall Study|Declining Performance Status|0
5324526|NCT00280150|18336509|P2|Overall Study|Declining Performance Status|0
5324527|NCT00280150|18336510|P1|Overall Study|Declining Performance Status|0
5324528|NCT00280150|18336507|P4|Overall Study|Did not get consolidation therapy|0
5324529|NCT00280150|18336508|P3|Overall Study|Did not get consolidation therapy|3
5324530|NCT00280150|18336509|P2|Overall Study|Did not get consolidation therapy|0
5324531|NCT00280150|18336510|P1|Overall Study|Did not get consolidation therapy|3
5324532|NCT00280150|18336507|P4|Overall Study|Withdrawal by Subject|1
5324533|NCT00280150|18336508|P3|Overall Study|Withdrawal by Subject|0
5324534|NCT00280150|18336509|P2|Overall Study|Withdrawal by Subject|0
5324535|NCT00280150|18336510|P1|Overall Study|Withdrawal by Subject|0
5324536|NCT00280150|18336507|P4|Overall Study|Protocol Violation|1
5324537|NCT00280150|18336508|P3|Overall Study|Protocol Violation|0
5324538|NCT00280150|18336509|P2|Overall Study|Protocol Violation|0
5324539|NCT00280150|18336510|P1|Overall Study|Protocol Violation|0
5324540|NCT00280150|18336507|P4|Overall Study|Physician Decision|1
5324541|NCT00280150|18336508|P3|Overall Study|Physician Decision|0
5324542|NCT00280150|18336509|P2|Overall Study|Physician Decision|0
5324543|NCT00280150|18336510|P1|Overall Study|Physician Decision|0
5324544|NCT00280150|18336507|P4|Overall Study|Lack of Efficacy|3
5324545|NCT00280150|18336508|P3|Overall Study|Lack of Efficacy|0
5324546|NCT00280150|18336509|P2|Overall Study|Lack of Efficacy|0
5324547|NCT00280150|18336510|P1|Overall Study|Lack of Efficacy|0
5324548|NCT00280150|18336507|P4|Overall Study|Adverse Event|3
5324549|NCT00280150|18336508|P3|Overall Study|Adverse Event|2
5324550|NCT00280150|18336509|P2|Overall Study|Adverse Event|1
5324551|NCT00280150|18336510|P1|Overall Study|Adverse Event|0
5324552|NCT00280059|18336525|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
5324553|NCT00280059|18336526|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
5324554|NCT00280059|18336525|P2|Efficacy Assessment Phase|Other|8
5324555|NCT00280059|18336526|P1|Efficacy Assessment Phase|Other|7
5324556|NCT00280059|18336525|P2|Efficacy Assessment Phase|Lost to Follow-up|13
5324557|NCT00280059|18336526|P1|Efficacy Assessment Phase|Lost to Follow-up|6
5324558|NCT00280059|18336525|P2|Efficacy Assessment Phase|Lack of Efficacy|3
5324559|NCT00280059|18336526|P1|Efficacy Assessment Phase|Lack of Efficacy|19
5324560|NCT00280059|18336525|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
5324561|NCT00280059|18336526|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
5324562|NCT00280059|18336525|P2|Efficacy Assessment Phase|Adverse Event|31
5324563|NCT00280059|18336526|P1|Efficacy Assessment Phase|Adverse Event|33
5324564|NCT00280059|18336525|P2|Efficacy Assessment Phase|Death|0
5324565|NCT00280059|18336526|P1|Efficacy Assessment Phase|Death|2
5324566|NCT00279916|18336590|P2|Overall Study|Lost to Follow-up|2
5324567|NCT00279916|18336591|P1|Overall Study|Lost to Follow-up|3
5324568|NCT00279916|18336590|P2|Overall Study|Withdrawal by Subject|3
5324569|NCT00279916|18336591|P1|Overall Study|Withdrawal by Subject|4
5324570|NCT00279812|18336617|P6|Overall Study|Adverse Event|1
5324571|NCT00279812|18336618|P5|Overall Study|Adverse Event|2
5324572|NCT00279812|18336619|P4|Overall Study|Adverse Event|0
5324573|NCT00279812|18336620|P3|Overall Study|Adverse Event|1
5324574|NCT00279812|18336621|P2|Overall Study|Adverse Event|1
5324575|NCT00279812|18336622|P1|Overall Study|Adverse Event|0
5324576|NCT00279812|18336617|P6|Overall Study|Withdrawal by Subject|0
5324577|NCT00279812|18336618|P5|Overall Study|Withdrawal by Subject|0
5324578|NCT00279812|18336619|P4|Overall Study|Withdrawal by Subject|0
5324579|NCT00279812|18336620|P3|Overall Study|Withdrawal by Subject|2
5324580|NCT00279812|18336621|P2|Overall Study|Withdrawal by Subject|4
5324581|NCT00279812|18336622|P1|Overall Study|Withdrawal by Subject|0
5324582|NCT00279812|18336617|P6|Overall Study|Protocol Violation|0
5324583|NCT00279812|18336618|P5|Overall Study|Protocol Violation|1
5324584|NCT00279812|18336619|P4|Overall Study|Protocol Violation|0
5324585|NCT00279812|18336620|P3|Overall Study|Protocol Violation|0
5324586|NCT00279812|18336621|P2|Overall Study|Protocol Violation|1
5324587|NCT00279812|18336622|P1|Overall Study|Protocol Violation|1
5324588|NCT00279708|18336650|P2|Overall Study|Adverse Event|1
5324589|NCT00279708|18336651|P1|Overall Study|Adverse Event|1
5324590|NCT00279708|18336650|P2|Overall Study|Withdrawal by Subject|3
5324591|NCT00279708|18336651|P1|Overall Study|Withdrawal by Subject|2
5324592|NCT00279305|18336689|P2|Overall Study|FDA Safety Alert|1
5324593|NCT00279305|18336690|P1|Overall Study|FDA Safety Alert|4
5324594|NCT00279305|18336689|P2|Overall Study|Dificulting establishing IV|0
5324595|NCT00279305|18336690|P1|Overall Study|Dificulting establishing IV|1
5324596|NCT00279305|18336689|P2|Overall Study|Withdrawal by Subject|0
5324597|NCT00279305|18336690|P1|Overall Study|Withdrawal by Subject|2
5324598|NCT00279305|18336689|P2|Overall Study|Pregnancy|0
5324599|NCT00279305|18336690|P1|Overall Study|Pregnancy|1
5324600|NCT00279214|18336698|P2|Overall Study|Physician Decision|2
5324601|NCT00279214|18336699|P1|Overall Study|Physician Decision|3
5324602|NCT00279201|18336729|P6|Intensification Addendum|Death|0
5324603|NCT00279201|18336730|P5|Intensification Addendum|Death|1
5324604|NCT00279201|18336731|P4|Intensification Addendum|Death|0
5324605|NCT00279201|18336732|P3|Intensification Addendum|Death|0
5324606|NCT00279201|18336733|P2|Intensification Addendum|Death|0
5324607|NCT00279201|18336734|P1|Intensification Addendum|Death|0
5324608|NCT00279201|18336729|P6|Intensification Addendum|Lack of Efficacy|0
5324609|NCT00279201|18336730|P5|Intensification Addendum|Lack of Efficacy|1
5324610|NCT00279201|18336731|P4|Intensification Addendum|Lack of Efficacy|1
5324611|NCT00279201|18336732|P3|Intensification Addendum|Lack of Efficacy|0
5324612|NCT00279201|18336733|P2|Intensification Addendum|Lack of Efficacy|0
5324613|NCT00279201|18336734|P1|Intensification Addendum|Lack of Efficacy|0
5324614|NCT00279201|18336729|P6|Intensification Addendum|Entry Criteria Exclusion|0
5324615|NCT00279201|18336730|P5|Intensification Addendum|Entry Criteria Exclusion|0
5324616|NCT00279201|18336731|P4|Intensification Addendum|Entry Criteria Exclusion|0
5324617|NCT00279201|18336732|P3|Intensification Addendum|Entry Criteria Exclusion|1
5324618|NCT00279201|18336733|P2|Intensification Addendum|Entry Criteria Exclusion|0
5324619|NCT00279201|18336734|P1|Intensification Addendum|Entry Criteria Exclusion|0
5324620|NCT00279201|18336729|P6|Intensification Addendum|Sponsor Decision|1
5324621|NCT00279201|18336730|P5|Intensification Addendum|Sponsor Decision|1
5324622|NCT00279201|18336731|P4|Intensification Addendum|Sponsor Decision|0
5324623|NCT00279201|18336732|P3|Intensification Addendum|Sponsor Decision|0
5324624|NCT00279201|18336733|P2|Intensification Addendum|Sponsor Decision|0
5324625|NCT00279201|18336734|P1|Intensification Addendum|Sponsor Decision|0
5324626|NCT00279201|18336729|P6|Intensification Addendum|Physician Decision|2
5324627|NCT00279201|18336730|P5|Intensification Addendum|Physician Decision|3
5324628|NCT00279201|18336731|P4|Intensification Addendum|Physician Decision|1
5324629|NCT00279201|18336732|P3|Intensification Addendum|Physician Decision|4
5324630|NCT00279201|18336733|P2|Intensification Addendum|Physician Decision|0
5324631|NCT00279201|18336734|P1|Intensification Addendum|Physician Decision|0
5324632|NCT00279201|18336729|P6|Intensification Addendum|Adverse Event|3
5324633|NCT00279201|18336730|P5|Intensification Addendum|Adverse Event|1
5324634|NCT00279201|18336731|P4|Intensification Addendum|Adverse Event|4
5324635|NCT00279201|18336732|P3|Intensification Addendum|Adverse Event|0
5324636|NCT00279201|18336733|P2|Intensification Addendum|Adverse Event|0
5324637|NCT00279201|18336734|P1|Intensification Addendum|Adverse Event|0
5324638|NCT00279201|18336729|P6|Intensification Addendum|Protocol Violation|6
5324639|NCT00279201|18336730|P5|Intensification Addendum|Protocol Violation|6
5324640|NCT00279201|18336731|P4|Intensification Addendum|Protocol Violation|2
5324641|NCT00279201|18336732|P3|Intensification Addendum|Protocol Violation|2
5324642|NCT00279201|18336733|P2|Intensification Addendum|Protocol Violation|0
5324643|NCT00279201|18336734|P1|Intensification Addendum|Protocol Violation|0
5324644|NCT00279201|18336729|P6|Intensification Addendum|Lost to Follow-up|7
5324645|NCT00279201|18336730|P5|Intensification Addendum|Lost to Follow-up|7
5324646|NCT00279201|18336731|P4|Intensification Addendum|Lost to Follow-up|6
5324647|NCT00279201|18336732|P3|Intensification Addendum|Lost to Follow-up|4
5324648|NCT00279201|18336733|P2|Intensification Addendum|Lost to Follow-up|0
5324649|NCT00279201|18336734|P1|Intensification Addendum|Lost to Follow-up|0
5324650|NCT00279201|18336729|P6|Intensification Addendum|Withdrawal by Subject|18
5324651|NCT00279201|18336730|P5|Intensification Addendum|Withdrawal by Subject|9
5324652|NCT00279201|18336731|P4|Intensification Addendum|Withdrawal by Subject|14
5324653|NCT00279201|18336732|P3|Intensification Addendum|Withdrawal by Subject|12
5324654|NCT00279201|18336733|P2|Intensification Addendum|Withdrawal by Subject|0
5324655|NCT00279201|18336734|P1|Intensification Addendum|Withdrawal by Subject|0
5324656|NCT00279201|18336729|P6|Maintenance|HbA1c>7.5%|0
5324657|NCT00279201|18336730|P5|Maintenance|HbA1c>7.5%|0
5324658|NCT00279201|18336731|P4|Maintenance|HbA1c>7.5%|0
5324659|NCT00279201|18336732|P3|Maintenance|HbA1c>7.5%|0
5324660|NCT00279201|18336733|P2|Maintenance|HbA1c>7.5%|126
5324661|NCT00279201|18336734|P1|Maintenance|HbA1c>7.5%|123
5324662|NCT00279201|18336729|P6|Maintenance|Sponsor Decision|0
5324663|NCT00279201|18336730|P5|Maintenance|Sponsor Decision|0
5324664|NCT00279201|18336731|P4|Maintenance|Sponsor Decision|0
5324665|NCT00279201|18336732|P3|Maintenance|Sponsor Decision|0
5324666|NCT00279201|18336733|P2|Maintenance|Sponsor Decision|0
5324667|NCT00279201|18336734|P1|Maintenance|Sponsor Decision|4
5324668|NCT00279201|18336729|P6|Maintenance|Physician Decision|0
5324669|NCT00279201|18336730|P5|Maintenance|Physician Decision|0
5324670|NCT00279201|18336731|P4|Maintenance|Physician Decision|0
5324671|NCT00279201|18336732|P3|Maintenance|Physician Decision|0
5324672|NCT00279201|18336733|P2|Maintenance|Physician Decision|9
5324673|NCT00279201|18336734|P1|Maintenance|Physician Decision|9
5324674|NCT00279201|18336729|P6|Maintenance|Withdrawal by Subject|0
5324675|NCT00279201|18336730|P5|Maintenance|Withdrawal by Subject|0
5324676|NCT00279201|18336731|P4|Maintenance|Withdrawal by Subject|0
5324677|NCT00279201|18336732|P3|Maintenance|Withdrawal by Subject|0
5324678|NCT00279201|18336733|P2|Maintenance|Withdrawal by Subject|18
5324679|NCT00279201|18336734|P1|Maintenance|Withdrawal by Subject|18
5324680|NCT00279201|18336729|P6|Maintenance|Protocol Violation|0
5324681|NCT00279201|18336730|P5|Maintenance|Protocol Violation|0
5324682|NCT00279201|18336731|P4|Maintenance|Protocol Violation|0
5324683|NCT00279201|18336732|P3|Maintenance|Protocol Violation|0
5324684|NCT00279201|18336733|P2|Maintenance|Protocol Violation|24
5324685|NCT00279201|18336734|P1|Maintenance|Protocol Violation|16
5324686|NCT00279201|18336729|P6|Maintenance|Entry Criteria Exclusion|0
5324687|NCT00279201|18336730|P5|Maintenance|Entry Criteria Exclusion|0
5324688|NCT00279201|18336731|P4|Maintenance|Entry Criteria Exclusion|0
5324689|NCT00279201|18336732|P3|Maintenance|Entry Criteria Exclusion|0
5324690|NCT00279201|18336733|P2|Maintenance|Entry Criteria Exclusion|4
5324691|NCT00279201|18336734|P1|Maintenance|Entry Criteria Exclusion|1
5324692|NCT00279201|18336729|P6|Maintenance|Lost to Follow-up|0
5324693|NCT00279201|18336730|P5|Maintenance|Lost to Follow-up|0
5324694|NCT00279201|18336731|P4|Maintenance|Lost to Follow-up|0
5324695|NCT00279201|18336732|P3|Maintenance|Lost to Follow-up|0
5324696|NCT00279201|18336733|P2|Maintenance|Lost to Follow-up|13
5324697|NCT00279201|18336734|P1|Maintenance|Lost to Follow-up|17
5324698|NCT00279201|18336729|P6|Maintenance|Death|0
5324699|NCT00279201|18336730|P5|Maintenance|Death|0
5324700|NCT00279201|18336731|P4|Maintenance|Death|0
5324701|NCT00279201|18336732|P3|Maintenance|Death|0
5324702|NCT00279201|18336733|P2|Maintenance|Death|4
5324703|NCT00279201|18336734|P1|Maintenance|Death|4
5324704|NCT00279201|18336729|P6|Maintenance|Adverse Event|0
5324705|NCT00279201|18336730|P5|Maintenance|Adverse Event|0
5324706|NCT00279201|18336731|P4|Maintenance|Adverse Event|0
5324707|NCT00279201|18336732|P3|Maintenance|Adverse Event|0
5324708|NCT00279201|18336733|P2|Maintenance|Adverse Event|4
5324709|NCT00279201|18336734|P1|Maintenance|Adverse Event|4
5324710|NCT00279201|18336729|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5324711|NCT00279201|18336730|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5324712|NCT00279201|18336731|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5324713|NCT00279201|18336732|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5324714|NCT00279201|18336733|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
5324715|NCT00279201|18336734|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
5324716|NCT00279201|18336729|P6|Maintenance|Lack of Efficacy|0
5324717|NCT00279201|18336730|P5|Maintenance|Lack of Efficacy|0
5324718|NCT00279201|18336731|P4|Maintenance|Lack of Efficacy|0
5324719|NCT00279201|18336732|P3|Maintenance|Lack of Efficacy|0
5324720|NCT00279201|18336733|P2|Maintenance|Lack of Efficacy|30
5324721|NCT00279201|18336734|P1|Maintenance|Lack of Efficacy|32
5324722|NCT00279201|18336729|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
5324723|NCT00279201|18336730|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
5324724|NCT00279201|18336731|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
5324725|NCT00279201|18336732|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
5324726|NCT00279201|18336733|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
5324727|NCT00279201|18336734|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
5324728|NCT00279201|18336729|P6|Initiation|Sponsor Decision|0
5324729|NCT00279201|18336730|P5|Initiation|Sponsor Decision|0
5324730|NCT00279201|18336731|P4|Initiation|Sponsor Decision|0
5324731|NCT00279201|18336732|P3|Initiation|Sponsor Decision|0
5324732|NCT00279201|18336733|P2|Initiation|Sponsor Decision|5
5324733|NCT00279201|18336734|P1|Initiation|Sponsor Decision|13
5324734|NCT00279201|18336729|P6|Initiation|Physician Decision|0
5324735|NCT00279201|18336730|P5|Initiation|Physician Decision|0
5324736|NCT00279201|18336731|P4|Initiation|Physician Decision|0
5324737|NCT00279201|18336732|P3|Initiation|Physician Decision|0
5324738|NCT00279201|18336733|P2|Initiation|Physician Decision|18
5324739|NCT00279201|18336734|P1|Initiation|Physician Decision|15
5324740|NCT00279201|18336729|P6|Initiation|Withdrawal by Subject|0
5324741|NCT00279201|18336730|P5|Initiation|Withdrawal by Subject|0
5324742|NCT00279201|18336731|P4|Initiation|Withdrawal by Subject|0
5324743|NCT00279201|18336732|P3|Initiation|Withdrawal by Subject|0
5324744|NCT00279201|18336733|P2|Initiation|Withdrawal by Subject|41
5324745|NCT00279201|18336734|P1|Initiation|Withdrawal by Subject|35
5324746|NCT00279201|18336729|P6|Initiation|Protocol Violation|0
5324747|NCT00279201|18336730|P5|Initiation|Protocol Violation|0
5324748|NCT00279201|18336731|P4|Initiation|Protocol Violation|0
5324749|NCT00279201|18336732|P3|Initiation|Protocol Violation|0
5324750|NCT00279201|18336733|P2|Initiation|Protocol Violation|10
5324751|NCT00279201|18336734|P1|Initiation|Protocol Violation|9
5324752|NCT00279201|18336729|P6|Initiation|Entry Criteria Exclusion|0
5324753|NCT00279201|18336730|P5|Initiation|Entry Criteria Exclusion|0
5324754|NCT00279201|18336731|P4|Initiation|Entry Criteria Exclusion|0
5324755|NCT00279201|18336732|P3|Initiation|Entry Criteria Exclusion|0
5324756|NCT00279201|18336733|P2|Initiation|Entry Criteria Exclusion|9
5324757|NCT00279201|18336734|P1|Initiation|Entry Criteria Exclusion|7
5324758|NCT00279201|18336729|P6|Initiation|Lost to Follow-up|0
5324759|NCT00279201|18336730|P5|Initiation|Lost to Follow-up|0
5324760|NCT00279201|18336731|P4|Initiation|Lost to Follow-up|0
5324761|NCT00279201|18336732|P3|Initiation|Lost to Follow-up|0
5324762|NCT00279201|18336733|P2|Initiation|Lost to Follow-up|41
5324763|NCT00279201|18336734|P1|Initiation|Lost to Follow-up|42
5324764|NCT00279201|18336729|P6|Initiation|Adverse Event|0
5324765|NCT00279201|18336730|P5|Initiation|Adverse Event|0
5324766|NCT00279201|18336731|P4|Initiation|Adverse Event|0
5324767|NCT00279201|18336732|P3|Initiation|Adverse Event|0
5324768|NCT00279201|18336733|P2|Initiation|Adverse Event|15
5324769|NCT00279201|18336734|P1|Initiation|Adverse Event|6
5324770|NCT00279201|18336729|P6|Initiation|Death|0
5324771|NCT00279201|18336730|P5|Initiation|Death|0
5324772|NCT00279201|18336731|P4|Initiation|Death|0
5324773|NCT00279201|18336732|P3|Initiation|Death|0
5324774|NCT00279201|18336733|P2|Initiation|Death|5
5324775|NCT00279201|18336734|P1|Initiation|Death|1
5324776|NCT00278993|18336878|P1|Overall Study|Not Otherwise Specified|4
5324777|NCT00278993|18336878|P1|Overall Study|Physician Decision|9
5324778|NCT00278993|18336878|P1|Overall Study|Progressive Disease|65
5324779|NCT00278993|18336878|P1|Overall Study|Withdrawal by Subject|5
5324780|NCT00278993|18336878|P1|Overall Study|Adverse Event|24
5324781|NCT00278954|18336886|P1|Overall Study|Withdrawal by Subject|1
5324782|NCT00278954|18336886|P1|Overall Study|Lost to Follow-up|1
5324783|NCT00278954|18336886|P1|Overall Study|Adverse Event|3
5324784|NCT00278915|18336894|P1|Overall Study|Lack of Efficacy|1
5324785|NCT00278889|18336930|P3|Overall Study|Death|17
5324786|NCT00278889|18336931|P2|Overall Study|Death|21
5324787|NCT00278889|18336932|P1|Overall Study|Death|24
5324788|NCT00278889|18336930|P3|Overall Study|Lost to Follow-up|0
5324789|NCT00278889|18336931|P2|Overall Study|Lost to Follow-up|1
5324790|NCT00278889|18336932|P1|Overall Study|Lost to Follow-up|1
5324791|NCT00278889|18336930|P3|Overall Study|Withdrawal by Subject|3
5324792|NCT00278889|18336931|P2|Overall Study|Withdrawal by Subject|5
5324793|NCT00278889|18336932|P1|Overall Study|Withdrawal by Subject|0
5324794|NCT00278629|18336980|P1|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
5324795|NCT00278564|18336987|P1|Overall Study|Lack of Efficacy|4
5324796|NCT00278512|18337008|P2|Overall Study|Death|0
5324797|NCT00278512|18337009|P1|Overall Study|Death|1
5324798|NCT00278473|18337017|P2|Overall Study|drop out|3
5324799|NCT00278473|18337018|P1|Overall Study|drop out|4
5324800|NCT00278395|18337034|P1|Overall Study|Nonevaluable|1
5324801|NCT00278395|18337034|P1|Overall Study|Adverse Event|2
5324802|NCT00278200|18337052|P2|Overall Study|Physician Decision|1
5324803|NCT00278200|18337053|P1|Overall Study|Physician Decision|0
5324804|NCT00278200|18337052|P2|Overall Study|Death|3
5324805|NCT00278200|18337053|P1|Overall Study|Death|1
5324806|NCT00278161|18337062|P1|Overall Study|Death|11
5324807|NCT00278148|18337068|P3|Phase II - Expansion Phase|Adverse Event|2
5324808|NCT00278148|18337069|P2|Phase II - Expansion Phase|Adverse Event|0
5324809|NCT00278148|18337070|P1|Phase II - Expansion Phase|Adverse Event|0
5324810|NCT00278148|18337068|P3|Phase II - Expansion Phase|Disease progression|4
5324811|NCT00278148|18337069|P2|Phase II - Expansion Phase|Disease progression|0
5324812|NCT00278148|18337070|P1|Phase II - Expansion Phase|Disease progression|0
5324813|NCT00278109|18337082|P1|Overall Study|social circumstances|1
5324814|NCT00278109|18337082|P1|Overall Study|Adverse Event|3
5324815|NCT00277355|18337128|P2|Overall Study|Physician Decision|0
5324816|NCT00277355|18337129|P1|Overall Study|Physician Decision|1
5324817|NCT00277355|18337128|P2|Overall Study|Death|0
5324818|NCT00277355|18337129|P1|Overall Study|Death|3
5324819|NCT00277355|18337128|P2|Overall Study|Adverse Event|0
5324820|NCT00277355|18337129|P1|Overall Study|Adverse Event|5
5324821|NCT00277355|18337128|P2|Overall Study|Lost to Follow-up|2
5324822|NCT00277355|18337129|P1|Overall Study|Lost to Follow-up|2
5324823|NCT00277355|18337128|P2|Overall Study|Withdrawal by Subject|3
5324824|NCT00277355|18337129|P1|Overall Study|Withdrawal by Subject|3
5324825|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
5324826|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
5324827|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
5324828|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
5324829|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
5324830|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
5324831|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
5324832|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
5324833|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
5324834|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
5324835|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
5324836|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
5324837|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
5324838|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
5324839|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
5324840|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
5324841|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
5324842|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
5324843|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
5324844|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
5324845|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
5324846|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
5324847|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
5324848|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
5324849|NCT00277212|18337137|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
5324850|NCT00277212|18337138|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
5324851|NCT00277212|18337139|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
5324852|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
5324853|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
5324854|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
5324855|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
5324856|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
5324857|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
5324858|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
5324859|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
5324860|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
5324861|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
5324862|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
5324863|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
5324864|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
5324865|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
5324866|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
5324867|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
5324868|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
5324869|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
5324870|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
5324871|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
5324872|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
5324873|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
5324874|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
5324875|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
5324876|NCT00277212|18337137|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
5324877|NCT00277212|18337138|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
5324878|NCT00277212|18337139|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
5324879|NCT00277095|18337177|P1|Overall Study|Physician Decision|1
5324880|NCT00277095|18337177|P1|Overall Study|Missed Follow-up|9
5324881|NCT00277095|18337177|P1|Overall Study|Lost to Follow-up|2
5324882|NCT00277095|18337177|P1|Overall Study|Explanted|7
5324883|NCT00277095|18337177|P1|Overall Study|Death|2
5324884|NCT00276744|18337186|P1|PART A|Reason unknown|98
5324885|NCT00276614|18337190|P1|Overall Study|Progression of disease under study|3
5324886|NCT00276484|18337201|P2|Overall Study|Could not take time off work|1
5324887|NCT00276484|18337202|P1|Overall Study|Could not take time off work|0
5324888|NCT00276484|18337201|P2|Overall Study|Withdrawal by Subject|3
5324889|NCT00276484|18337202|P1|Overall Study|Withdrawal by Subject|4
5324890|NCT00276484|18337201|P2|Overall Study|Protocol Violation|1
5324891|NCT00276484|18337202|P1|Overall Study|Protocol Violation|0
5324892|NCT00276484|18337201|P2|Overall Study|Lost to Follow-up|1
5324893|NCT00276484|18337202|P1|Overall Study|Lost to Follow-up|1
5324894|NCT00276484|18337201|P2|Overall Study|Adverse Event|7
5324895|NCT00276484|18337202|P1|Overall Study|Adverse Event|4
5324896|NCT00276458|18337234|P2|Overall Study|Protocol Violation|3
5324897|NCT00276458|18337235|P1|Overall Study|Protocol Violation|4
5324898|NCT00276458|18337234|P2|Overall Study|Lost to Follow-up|2
5324899|NCT00276458|18337235|P1|Overall Study|Lost to Follow-up|2
5324900|NCT00276458|18337234|P2|Overall Study|Adverse Event|2
5324901|NCT00276458|18337235|P1|Overall Study|Adverse Event|0
5324902|NCT00276419|18337269|P2|First Intervention|Withdrawal by Subject|2
5324903|NCT00276419|18337270|P1|First Intervention|Withdrawal by Subject|0
5324904|NCT00276419|18337269|P2|First Intervention|Adverse Event|0
5324905|NCT00276419|18337270|P1|First Intervention|Adverse Event|1
5324906|NCT00276380|18337313|P2|Overall Study|Abnormal aPPT Levels|1
5324907|NCT00276380|18337314|P1|Overall Study|Abnormal aPPT Levels|0
5324908|NCT00276380|18337313|P2|Overall Study|Death|3
5324909|NCT00276380|18337314|P1|Overall Study|Death|5
5324910|NCT00276380|18337313|P2|Overall Study|Withdrawal by Subject|6
5324911|NCT00276380|18337314|P1|Overall Study|Withdrawal by Subject|3
5324912|NCT00276380|18337313|P2|Overall Study|Lost to Follow-up|1
5324913|NCT00276380|18337314|P1|Overall Study|Lost to Follow-up|1
5324914|NCT00276380|18337313|P2|Overall Study|Adverse Event|3
5324915|NCT00276380|18337314|P1|Overall Study|Adverse Event|5
5324916|NCT00276159|18337369|P1|Overall Study|Did not receive all 24 doses of 852A|6
5324917|NCT00276094|18337379|P3|Overall Study|Other-Study medication lost|1
5324918|NCT00276094|18337380|P2|Overall Study|Other-Study medication lost|0
5324919|NCT00276094|18337381|P1|Overall Study|Other-Study medication lost|0
5324920|NCT00276094|18337379|P3|Overall Study|Other-Relocation|0
5324921|NCT00276094|18337380|P2|Overall Study|Other-Relocation|1
5324922|NCT00276094|18337381|P1|Overall Study|Other-Relocation|0
5324923|NCT00276094|18337379|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
5324924|NCT00276094|18337380|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
5324925|NCT00276094|18337381|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
5324926|NCT00276094|18337379|P3|Overall Study|Other-Refused follow-up visit|0
5324927|NCT00276094|18337380|P2|Overall Study|Other-Refused follow-up visit|0
5324928|NCT00276094|18337381|P1|Overall Study|Other-Refused follow-up visit|1
5324929|NCT00276094|18337379|P3|Overall Study|Other-Lack of efficacy|0
5324930|NCT00276094|18337380|P2|Overall Study|Other-Lack of efficacy|0
5324931|NCT00276094|18337381|P1|Overall Study|Other-Lack of efficacy|1
5324932|NCT00276094|18337379|P3|Overall Study|Other-Scheduled gastroplasty|0
5324933|NCT00276094|18337380|P2|Overall Study|Other-Scheduled gastroplasty|0
5324934|NCT00276094|18337381|P1|Overall Study|Other-Scheduled gastroplasty|1
5324935|NCT00276094|18337379|P3|Overall Study|Other-Subject moved out of country|0
5324936|NCT00276094|18337380|P2|Overall Study|Other-Subject moved out of country|0
5324937|NCT00276094|18337381|P1|Overall Study|Other-Subject moved out of country|1
5324938|NCT00276094|18337379|P3|Overall Study|Lost to Follow-up|4
5324939|NCT00276094|18337380|P2|Overall Study|Lost to Follow-up|6
5324940|NCT00276094|18337381|P1|Overall Study|Lost to Follow-up|8
5324941|NCT00276094|18337379|P3|Overall Study|Protocol Violation|10
5324942|NCT00276094|18337380|P2|Overall Study|Protocol Violation|7
5324943|NCT00276094|18337381|P1|Overall Study|Protocol Violation|16
5324944|NCT00276094|18337379|P3|Overall Study|Withdrawal by Subject|12
5324945|NCT00276094|18337380|P2|Overall Study|Withdrawal by Subject|14
5324946|NCT00276094|18337381|P1|Overall Study|Withdrawal by Subject|14
5324947|NCT00276094|18337379|P3|Overall Study|Adverse Event|11
5324948|NCT00276094|18337380|P2|Overall Study|Adverse Event|13
5324949|NCT00276094|18337381|P1|Overall Study|Adverse Event|15
5324950|NCT00276016|18337434|P6|Intervention 1|Withdrawal by Subject|0
5324951|NCT00276016|18337435|P5|Intervention 1|Withdrawal by Subject|0
5324952|NCT00276016|18337436|P4|Intervention 1|Withdrawal by Subject|0
5324953|NCT00276016|18337437|P3|Intervention 1|Withdrawal by Subject|0
5324954|NCT00276016|18337438|P2|Intervention 1|Withdrawal by Subject|1
5324955|NCT00276016|18337439|P1|Intervention 1|Withdrawal by Subject|0
5324956|NCT00275821|18337485|P3|Overall Study|Protocol Violation|0
5324957|NCT00275821|18337486|P2|Overall Study|Protocol Violation|1
5324958|NCT00275821|18337487|P1|Overall Study|Protocol Violation|5
5324959|NCT00275821|18337485|P3|Overall Study|Lack of Efficacy|0
5324960|NCT00275821|18337486|P2|Overall Study|Lack of Efficacy|1
5324961|NCT00275821|18337487|P1|Overall Study|Lack of Efficacy|2
5324962|NCT00275821|18337485|P3|Overall Study|Death|1
5324963|NCT00275821|18337486|P2|Overall Study|Death|2
5324964|NCT00275821|18337487|P1|Overall Study|Death|0
5324965|NCT00275821|18337485|P3|Overall Study|Lost to Follow-up|1
5324966|NCT00275821|18337486|P2|Overall Study|Lost to Follow-up|1
5324967|NCT00275821|18337487|P1|Overall Study|Lost to Follow-up|0
5324968|NCT00275821|18337485|P3|Overall Study|Withdrawal by Subject|1
5324969|NCT00275821|18337486|P2|Overall Study|Withdrawal by Subject|2
5324970|NCT00275821|18337487|P1|Overall Study|Withdrawal by Subject|0
5324971|NCT00275821|18337485|P3|Overall Study|Administrative problems|4
5324972|NCT00275821|18337486|P2|Overall Study|Administrative problems|4
5324973|NCT00275821|18337487|P1|Overall Study|Administrative problems|3
5324974|NCT00275821|18337485|P3|Overall Study|Adverse Event|5
5324975|NCT00275821|18337486|P2|Overall Study|Adverse Event|12
5324976|NCT00275821|18337487|P1|Overall Study|Adverse Event|4
5324977|NCT00275561|18337506|P2|Overall Study|Family Issues|2
5324978|NCT00275561|18337507|P1|Overall Study|Family Issues|0
5324979|NCT00275561|18337506|P2|Overall Study|Scheduling|2
5324980|NCT00275561|18337507|P1|Overall Study|Scheduling|1
5324981|NCT00275561|18337506|P2|Overall Study|Travel|1
5324982|NCT00275561|18337507|P1|Overall Study|Travel|1
5324983|NCT00275561|18337506|P2|Overall Study|Withdrawal by Subject|1
5324984|NCT00275561|18337507|P1|Overall Study|Withdrawal by Subject|0
5324985|NCT00275509|18337519|P2|Overall Study|graft thrombosis, post-operative day #8|1
5324986|NCT00275509|18337520|P1|Overall Study|graft thrombosis, post-operative day #8|0
5324987|NCT00275340|18337543|P2|Overall Study|Lost to Follow-up|4
5324988|NCT00275340|18337544|P1|Overall Study|Lost to Follow-up|2
5324989|NCT00275301|18337548|P1|Overall Study|Adverse Event|5
5324990|NCT00275262|18337567|P2|Overall Study|Started Chemotherapy|0
5324991|NCT00275262|18337568|P1|Overall Study|Started Chemotherapy|1
5324992|NCT00275262|18337567|P2|Overall Study|Death|0
5324993|NCT00275262|18337568|P1|Overall Study|Death|1
5324994|NCT00275262|18337567|P2|Overall Study|Protocol Violation|2
5324995|NCT00275262|18337568|P1|Overall Study|Protocol Violation|0
5324996|NCT00275262|18337567|P2|Overall Study|Lost to Follow-up|2
5324997|NCT00275262|18337568|P1|Overall Study|Lost to Follow-up|0
5324998|NCT00275262|18337567|P2|Overall Study|Disease progression|5
5324999|NCT00275262|18337568|P1|Overall Study|Disease progression|2
5325000|NCT00275262|18337567|P2|Overall Study|Adverse Event|0
5325001|NCT00275262|18337568|P1|Overall Study|Adverse Event|2
5325002|NCT00275028|18337582|P1|Overall Study|Physician Decision|2
5325003|NCT00275028|18337582|P1|Overall Study|Progressive Disease|30
5325004|NCT00275028|18337582|P1|Overall Study|Adverse Event|9
5325005|NCT00275028|18337582|P1|Overall Study|Withdrawal by Subject|5
5325006|NCT00275028|18337582|P1|Overall Study|Withdrew consent before treatment began|1
5325007|NCT00275002|18337589|P2|Overall Study|Adverse Event|1
5325008|NCT00275002|18337590|P1|Overall Study|Adverse Event|0
5325009|NCT00275002|18337589|P2|Overall Study|Disease progression|15
5325010|NCT00275002|18337590|P1|Overall Study|Disease progression|21
5325011|NCT00275002|18337589|P2|Overall Study|Death|0
5325012|NCT00275002|18337590|P1|Overall Study|Death|1
5325013|NCT00274937|18337598|P1|Overall Study|Progressive Disease|4
5325014|NCT00274937|18337598|P1|Overall Study|Withdrawal by Subject|6
5325015|NCT00274937|18337598|P1|Overall Study|Physician Decision|10
5325016|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
5325017|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
5325018|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
5325019|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
5325020|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
5325021|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
5325022|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
5325023|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
5325024|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
5325025|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
5325026|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
5325027|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
5325028|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
5325029|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
5325030|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
5325031|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
5325032|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
5325033|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
5325034|NCT00274924|18337610|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
5325035|NCT00274924|18337611|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
5325036|NCT00274924|18337612|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
5325037|NCT00274924|18337610|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
5325038|NCT00274924|18337611|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
5325039|NCT00274924|18337612|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
5325040|NCT00274924|18337610|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
5325041|NCT00274924|18337611|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
5325042|NCT00274924|18337612|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
5325043|NCT00274924|18337610|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
5325044|NCT00274924|18337611|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
5325045|NCT00274924|18337612|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
5325046|NCT00274924|18337610|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
5325047|NCT00274924|18337611|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
5325048|NCT00274924|18337612|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
5325049|NCT00274924|18337610|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
5325050|NCT00274924|18337611|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
5325051|NCT00274924|18337612|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
5325052|NCT00274924|18337610|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
5325053|NCT00274924|18337611|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
5325054|NCT00274924|18337612|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
5325055|NCT00274846|18337621|P1|Overall Study|Did not receive adequate NK cells|1
5325056|NCT00274742|18337650|P6|Overall Study|Other|0
5325057|NCT00274742|18337651|P5|Overall Study|Other|2
5325058|NCT00274742|18337652|P4|Overall Study|Other|0
5325059|NCT00274742|18337653|P3|Overall Study|Other|0
5325060|NCT00274742|18337654|P2|Overall Study|Other|3
5325061|NCT00274742|18337655|P1|Overall Study|Other|0
5325062|NCT00274742|18337650|P6|Overall Study|Disease Progression|0
5325063|NCT00274742|18337651|P5|Overall Study|Disease Progression|1
5325064|NCT00274742|18337652|P4|Overall Study|Disease Progression|0
5325065|NCT00274742|18337653|P3|Overall Study|Disease Progression|1
5325066|NCT00274742|18337654|P2|Overall Study|Disease Progression|1
5325067|NCT00274742|18337655|P1|Overall Study|Disease Progression|0
5325068|NCT00274742|18337650|P6|Overall Study|End of Study|0
5325069|NCT00274742|18337651|P5|Overall Study|End of Study|0
5325070|NCT00274742|18337652|P4|Overall Study|End of Study|1
5325071|NCT00274742|18337653|P3|Overall Study|End of Study|0
5325072|NCT00274742|18337654|P2|Overall Study|End of Study|0
5325073|NCT00274742|18337655|P1|Overall Study|End of Study|0
5325074|NCT00274742|18337650|P6|Overall Study|Lost to Follow-up|0
5325075|NCT00274742|18337651|P5|Overall Study|Lost to Follow-up|1
5325076|NCT00274742|18337652|P4|Overall Study|Lost to Follow-up|0
5325077|NCT00274742|18337653|P3|Overall Study|Lost to Follow-up|0
5325078|NCT00274742|18337654|P2|Overall Study|Lost to Follow-up|0
5325079|NCT00274742|18337655|P1|Overall Study|Lost to Follow-up|0
5325080|NCT00274742|18337650|P6|Overall Study|Adverse Event|3
5325081|NCT00274742|18337651|P5|Overall Study|Adverse Event|12
5325082|NCT00274742|18337652|P4|Overall Study|Adverse Event|4
5325083|NCT00274742|18337653|P3|Overall Study|Adverse Event|1
5325084|NCT00274742|18337654|P2|Overall Study|Adverse Event|4
5325085|NCT00274742|18337655|P1|Overall Study|Adverse Event|0
5325086|NCT00274716|18337693|P6|Phase B|Lost to Follow-up|0
5325087|NCT00274716|18337694|P5|Phase B|Lost to Follow-up|0
5325088|NCT00274716|18337695|P4|Phase B|Lost to Follow-up|0
5325089|NCT00274716|18337696|P3|Phase B|Lost to Follow-up|0
5325090|NCT00274716|18337697|P2|Phase B|Lost to Follow-up|1
5325091|NCT00274716|18337698|P1|Phase B|Lost to Follow-up|0
5325092|NCT00274716|18337693|P6|Phase B|Other non-reported reason|0
5325093|NCT00274716|18337694|P5|Phase B|Other non-reported reason|0
5325094|NCT00274716|18337695|P4|Phase B|Other non-reported reason|1
5325095|NCT00274716|18337696|P3|Phase B|Other non-reported reason|1
5325096|NCT00274716|18337697|P2|Phase B|Other non-reported reason|0
5325097|NCT00274716|18337698|P1|Phase B|Other non-reported reason|0
5325098|NCT00274716|18337693|P6|Phase B|Participant moved|0
5325099|NCT00274716|18337694|P5|Phase B|Participant moved|0
5325100|NCT00274716|18337695|P4|Phase B|Participant moved|0
5325101|NCT00274716|18337696|P3|Phase B|Participant moved|0
5325102|NCT00274716|18337697|P2|Phase B|Participant moved|0
5325103|NCT00274716|18337698|P1|Phase B|Participant moved|1
5325104|NCT00274716|18337693|P6|Phase B|Withdrawal by Subject|0
5325105|NCT00274716|18337694|P5|Phase B|Withdrawal by Subject|0
5325106|NCT00274716|18337695|P4|Phase B|Withdrawal by Subject|0
5325107|NCT00274716|18337696|P3|Phase B|Withdrawal by Subject|0
5325108|NCT00274716|18337697|P2|Phase B|Withdrawal by Subject|1
5325109|NCT00274716|18337698|P1|Phase B|Withdrawal by Subject|0
5325110|NCT00274716|18337693|P6|Phase B|Protocol Violation|0
5325111|NCT00274716|18337694|P5|Phase B|Protocol Violation|0
5325112|NCT00274716|18337695|P4|Phase B|Protocol Violation|0
5325113|NCT00274716|18337696|P3|Phase B|Protocol Violation|0
5325114|NCT00274716|18337697|P2|Phase B|Protocol Violation|2
5325115|NCT00274716|18337698|P1|Phase B|Protocol Violation|0
5325116|NCT00274716|18337693|P6|Phase B|Adverse Event|1
5325117|NCT00274716|18337694|P5|Phase B|Adverse Event|0
5325118|NCT00274716|18337695|P4|Phase B|Adverse Event|0
5325119|NCT00274716|18337696|P3|Phase B|Adverse Event|2
5325120|NCT00274716|18337697|P2|Phase B|Adverse Event|0
5325121|NCT00274716|18337698|P1|Phase B|Adverse Event|0
5325122|NCT00274716|18337693|P6|Phase A|Completed but did not enter Phase B|1
5325123|NCT00274716|18337694|P5|Phase A|Completed but did not enter Phase B|1
5325124|NCT00274716|18337695|P4|Phase A|Completed but did not enter Phase B|2
5325125|NCT00274716|18337696|P3|Phase A|Completed but did not enter Phase B|2
5325126|NCT00274716|18337697|P2|Phase A|Completed but did not enter Phase B|2
5325127|NCT00274716|18337698|P1|Phase A|Completed but did not enter Phase B|1
5325128|NCT00274716|18337693|P6|Phase A|Adverse Event|0
5325129|NCT00274716|18337694|P5|Phase A|Adverse Event|2
5325130|NCT00274716|18337695|P4|Phase A|Adverse Event|0
5325131|NCT00274716|18337696|P3|Phase A|Adverse Event|3
5325132|NCT00274716|18337697|P2|Phase A|Adverse Event|3
5325133|NCT00274716|18337698|P1|Phase A|Adverse Event|2
5325134|NCT00274716|18337693|P6|Phase A|Withdrawal by Subject|1
5325135|NCT00274716|18337694|P5|Phase A|Withdrawal by Subject|0
5325136|NCT00274716|18337695|P4|Phase A|Withdrawal by Subject|3
5325137|NCT00274716|18337696|P3|Phase A|Withdrawal by Subject|1
5325138|NCT00274716|18337697|P2|Phase A|Withdrawal by Subject|2
5325139|NCT00274716|18337698|P1|Phase A|Withdrawal by Subject|2
5325140|NCT00274716|18337693|P6|Phase A|Met criteria for discontinuation|0
5325141|NCT00274716|18337694|P5|Phase A|Met criteria for discontinuation|0
5325142|NCT00274716|18337695|P4|Phase A|Met criteria for discontinuation|0
5325143|NCT00274716|18337696|P3|Phase A|Met criteria for discontinuation|0
5325144|NCT00274716|18337697|P2|Phase A|Met criteria for discontinuation|1
5325145|NCT00274716|18337698|P1|Phase A|Met criteria for discontinuation|1
5325146|NCT00274716|18337693|P6|Phase A|Protocol Violation|0
5325147|NCT00274716|18337694|P5|Phase A|Protocol Violation|0
5325148|NCT00274716|18337695|P4|Phase A|Protocol Violation|1
5325149|NCT00274716|18337696|P3|Phase A|Protocol Violation|0
5325150|NCT00274716|18337697|P2|Phase A|Protocol Violation|0
5325151|NCT00274716|18337698|P1|Phase A|Protocol Violation|1
5325152|NCT00274716|18337693|P6|Phase A|Site Terminated|0
5325153|NCT00274716|18337694|P5|Phase A|Site Terminated|0
5325154|NCT00274716|18337695|P4|Phase A|Site Terminated|1
5325155|NCT00274716|18337696|P3|Phase A|Site Terminated|0
5325156|NCT00274716|18337697|P2|Phase A|Site Terminated|0
5325157|NCT00274716|18337698|P1|Phase A|Site Terminated|0
5325158|NCT00274716|18337693|P6|Phase A|Participant moved|1
5325159|NCT00274716|18337694|P5|Phase A|Participant moved|0
5325160|NCT00274716|18337695|P4|Phase A|Participant moved|0
5325161|NCT00274716|18337696|P3|Phase A|Participant moved|1
5325162|NCT00274716|18337697|P2|Phase A|Participant moved|0
5325163|NCT00274716|18337698|P1|Phase A|Participant moved|0
5325164|NCT00274716|18337693|P6|Phase A|Other non-reported reason|1
5325165|NCT00274716|18337694|P5|Phase A|Other non-reported reason|0
5325166|NCT00274716|18337695|P4|Phase A|Other non-reported reason|2
5325167|NCT00274716|18337696|P3|Phase A|Other non-reported reason|1
5325168|NCT00274716|18337697|P2|Phase A|Other non-reported reason|2
5325169|NCT00274716|18337698|P1|Phase A|Other non-reported reason|4
5325170|NCT00274651|18337760|P2|Overall Study|Physician Decision|7
5325171|NCT00274651|18337761|P1|Overall Study|Physician Decision|8
5325172|NCT00274651|18337760|P2|Overall Study|Withdrawal by Subject|1
5325173|NCT00274651|18337761|P1|Overall Study|Withdrawal by Subject|0
5325174|NCT00274651|18337760|P2|Overall Study|Death|3
5325175|NCT00274651|18337761|P1|Overall Study|Death|1
5325176|NCT00274651|18337760|P2|Overall Study|Lack of Efficacy|6
5325177|NCT00274651|18337761|P1|Overall Study|Lack of Efficacy|13
5325178|NCT00274651|18337760|P2|Overall Study|Adverse Event|3
5325179|NCT00274651|18337761|P1|Overall Study|Adverse Event|6
5325180|NCT00274625|18337776|P2|Overall Study|Excluded from analysis|8
5325181|NCT00274625|18337777|P1|Overall Study|Excluded from analysis|14
5325182|NCT00274625|18337776|P2|Overall Study|Lost to Follow-up|54
5325183|NCT00274625|18337777|P1|Overall Study|Lost to Follow-up|46
5325184|NCT00274469|18337785|P2|Overall Study|Did not consent to OS follow-up|19
5325185|NCT00274469|18337786|P1|Overall Study|Did not consent to OS follow-up|16
5325186|NCT00274469|18337785|P2|Overall Study|Death|74
5325187|NCT00274469|18337786|P1|Overall Study|Death|63
5325188|NCT00274456|18337806|P4|Overall Study|Withdrawal by Subject|13
5325189|NCT00274456|18337807|P3|Overall Study|Withdrawal by Subject|9
5325190|NCT00274456|18337808|P2|Overall Study|Withdrawal by Subject|13
5325191|NCT00274456|18337809|P1|Overall Study|Withdrawal by Subject|18
5325192|NCT00274456|18337806|P4|Overall Study|Lost to Follow-up|0
5325193|NCT00274456|18337807|P3|Overall Study|Lost to Follow-up|1
5325194|NCT00274456|18337808|P2|Overall Study|Lost to Follow-up|0
5325195|NCT00274456|18337809|P1|Overall Study|Lost to Follow-up|0
5325196|NCT00274456|18337806|P4|Overall Study|Physician Decision|13
5325197|NCT00274456|18337807|P3|Overall Study|Physician Decision|6
5325198|NCT00274456|18337808|P2|Overall Study|Physician Decision|5
5325199|NCT00274456|18337809|P1|Overall Study|Physician Decision|7
5325200|NCT00274456|18337806|P4|Overall Study|Adverse Event|2
5325201|NCT00274456|18337807|P3|Overall Study|Adverse Event|2
5325202|NCT00274456|18337808|P2|Overall Study|Adverse Event|1
5325203|NCT00274456|18337809|P1|Overall Study|Adverse Event|0
5325204|NCT00274456|18337806|P4|Overall Study|Unacceptable toxicity|16
5325205|NCT00274456|18337807|P3|Overall Study|Unacceptable toxicity|12
5325206|NCT00274456|18337808|P2|Overall Study|Unacceptable toxicity|5
5325207|NCT00274456|18337809|P1|Overall Study|Unacceptable toxicity|10
5325208|NCT00274456|18337806|P4|Overall Study|Still on treatment|1
5325209|NCT00274456|18337807|P3|Overall Study|Still on treatment|5
5325210|NCT00274456|18337808|P2|Overall Study|Still on treatment|3
5325211|NCT00274456|18337809|P1|Overall Study|Still on treatment|2
5325212|NCT00274287|18337851|P1|Overall Study|subject non-compliance|1
5325213|NCT00274287|18337851|P1|Overall Study|Withdrawal by Subject|1
5325214|NCT00274261|18337861|P2|Overall Study|Lost to Follow-up|75
5325215|NCT00274261|18337862|P1|Overall Study|Lost to Follow-up|106
5325216|NCT00274261|18337861|P2|Overall Study|Protocol Violation|42
5325217|NCT00274261|18337862|P1|Overall Study|Protocol Violation|71
5325218|NCT00274261|18337861|P2|Overall Study|Withdrawal by Subject|126
5325219|NCT00274261|18337862|P1|Overall Study|Withdrawal by Subject|179
5325220|NCT00274261|18337861|P2|Overall Study|Pregnancy|83
5325221|NCT00274261|18337862|P1|Overall Study|Pregnancy|114
5325222|NCT00274261|18337861|P2|Overall Study|Adverse Event|11
5325223|NCT00274261|18337862|P1|Overall Study|Adverse Event|19
5325224|NCT00273858|18337901|P1|Overall Study|Adverse Event|81
5325225|NCT00273858|18337901|P1|Overall Study|Withdrawal by Subject|21
5325226|NCT00273858|18337901|P1|Overall Study|Lost to Follow-up|101
5325227|NCT00273858|18337901|P1|Overall Study|Not completed 24 month observation time|334
5325228|NCT00273182|18337969|P1|Overall Study|Site exit, system change, 36 m FU missed|36
5325229|NCT00273182|18337969|P1|Overall Study|Device/System Explant|154
5325230|NCT00273182|18337969|P1|Overall Study|Withdrawal by Subject|257
5325231|NCT00273182|18337969|P1|Overall Study|Lost to Follow-up|88
5325232|NCT00273182|18337969|P1|Overall Study|Death|450
5325233|NCT00273052|18337979|P2|Overall Study|Worsening serum lipid levels|2
5325234|NCT00273052|18337980|P1|Overall Study|Worsening serum lipid levels|0
5325235|NCT00273052|18337979|P2|Overall Study|Other|0
5325236|NCT00273052|18337980|P1|Overall Study|Other|2
5325237|NCT00273052|18337979|P2|Overall Study|Non-Compliance|1
5325238|NCT00273052|18337980|P1|Overall Study|Non-Compliance|3
5325239|NCT00273052|18337979|P2|Overall Study|Lack of Efficacy|4
5325240|NCT00273052|18337980|P1|Overall Study|Lack of Efficacy|6
5325241|NCT00273052|18337979|P2|Overall Study|Lost to Follow-up|25
5325242|NCT00273052|18337980|P1|Overall Study|Lost to Follow-up|7
5325243|NCT00273052|18337979|P2|Overall Study|Protocol Violation|18
5325244|NCT00273052|18337980|P1|Overall Study|Protocol Violation|14
5325245|NCT00273052|18337979|P2|Overall Study|Adverse Event|19
5325246|NCT00273052|18337980|P1|Overall Study|Adverse Event|21
5325247|NCT00273052|18337979|P2|Overall Study|Withdrawal by Subject|19
5325248|NCT00273052|18337980|P1|Overall Study|Withdrawal by Subject|16
5325249|NCT00272987|18338015|P3|Overall Study|Ongoing|15
5325250|NCT00272987|18338016|P2|Overall Study|Ongoing|14
5325251|NCT00272987|18338017|P1|Overall Study|Ongoing|20
5325252|NCT00272987|18338015|P3|Overall Study|Missed >3 Visits|1
5325253|NCT00272987|18338016|P2|Overall Study|Missed >3 Visits|0
5325254|NCT00272987|18338017|P1|Overall Study|Missed >3 Visits|0
5325255|NCT00272987|18338015|P3|Overall Study|Withdrawal by Subject|3
5325256|NCT00272987|18338016|P2|Overall Study|Withdrawal by Subject|0
5325257|NCT00272987|18338017|P1|Overall Study|Withdrawal by Subject|0
5325258|NCT00272987|18338015|P3|Overall Study|Adverse Event|0
5325259|NCT00272987|18338016|P2|Overall Study|Adverse Event|0
5325260|NCT00272987|18338017|P1|Overall Study|Adverse Event|1
5325261|NCT00272961|18338081|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
5325262|NCT00272961|18338082|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
5325263|NCT00272961|18338083|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
5325264|NCT00272961|18338084|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
5325265|NCT00272961|18338085|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
5325266|NCT00272961|18338081|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
5325267|NCT00272961|18338082|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
5325268|NCT00272961|18338083|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
5325269|NCT00272961|18338084|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
5325270|NCT00272961|18338085|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
5325271|NCT00272961|18338081|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
5325272|NCT00272961|18338082|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
5325273|NCT00272961|18338083|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
5325274|NCT00272961|18338084|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
5325275|NCT00272961|18338085|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
5325276|NCT00272961|18338081|P5|Placebo Run-in Phase: Up to Week 2|Other|0
5325277|NCT00272961|18338082|P4|Placebo Run-in Phase: Up to Week 2|Other|0
5325278|NCT00272961|18338083|P3|Placebo Run-in Phase: Up to Week 2|Other|0
5325279|NCT00272961|18338084|P2|Placebo Run-in Phase: Up to Week 2|Other|0
5325280|NCT00272961|18338085|P1|Placebo Run-in Phase: Up to Week 2|Other|2
5325281|NCT00272961|18338081|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5325282|NCT00272961|18338082|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5325283|NCT00272961|18338083|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5325284|NCT00272961|18338084|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5325285|NCT00272961|18338085|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
5325286|NCT00272961|18338081|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5325287|NCT00272961|18338082|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5325288|NCT00272961|18338083|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5325289|NCT00272961|18338084|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5325290|NCT00272961|18338085|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
5325291|NCT00272961|18338081|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5325292|NCT00272961|18338082|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5325293|NCT00272961|18338083|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5325294|NCT00272961|18338084|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5325295|NCT00272961|18338085|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
5325296|NCT00272961|18338081|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5325297|NCT00272961|18338082|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5325298|NCT00272961|18338083|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5325299|NCT00272961|18338084|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5325300|NCT00272961|18338085|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
5325301|NCT00272844|18338142|P1|Overall Study|Withdrawal by Subject|5
5325302|NCT00272792|18338150|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
5325303|NCT00272792|18338151|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
5325304|NCT00272792|18338150|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
5325305|NCT00272792|18338151|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
5325306|NCT00272792|18338150|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
5325307|NCT00272792|18338151|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
5325308|NCT00272792|18338150|P2|Part 1: Responsiveness|Lost to Follow-up|0
5325309|NCT00272792|18338151|P1|Part 1: Responsiveness|Lost to Follow-up|1
5325310|NCT00272779|18338161|P2|Baseline Through Week 96|Continuing on treatment|38
5325311|NCT00272779|18338162|P1|Baseline Through Week 96|Continuing on treatment|61
5325312|NCT00272779|18338161|P2|Baseline Through Week 96|Never treated|3
5325313|NCT00272779|18338162|P1|Baseline Through Week 96|Never treated|2
5325314|NCT00272779|18338161|P2|Baseline Through Week 96|Pregnancy at Week 96|0
5325315|NCT00272779|18338162|P1|Baseline Through Week 96|Pregnancy at Week 96|1
5325316|NCT00272779|18338161|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
5325317|NCT00272779|18338162|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
5325318|NCT00272779|18338161|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
5325319|NCT00272779|18338162|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
5325320|NCT00272779|18338161|P2|Baseline Through Week 96|Changed address before Week 96|1
5325321|NCT00272779|18338162|P1|Baseline Through Week 96|Changed address before Week 96|0
5325322|NCT00272779|18338161|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
5325323|NCT00272779|18338162|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
5325324|NCT00272779|18338161|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
5325325|NCT00272779|18338162|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
5325326|NCT00272779|18338161|P2|Baseline Through Week 96|Pregnancy before Week 96|7
5325327|NCT00272779|18338162|P1|Baseline Through Week 96|Pregnancy before Week 96|5
5325328|NCT00272779|18338161|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
5325329|NCT00272779|18338162|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
5325330|NCT00272779|18338161|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
5325331|NCT00272779|18338162|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
5325332|NCT00272779|18338161|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
5325333|NCT00272779|18338162|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
5325334|NCT00272779|18338161|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
5325335|NCT00272779|18338162|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
5325336|NCT00272779|18338161|P2|Baseline Through Week 96|Death before Week 96|5
5325337|NCT00272779|18338162|P1|Baseline Through Week 96|Death before Week 96|6
5325338|NCT00272779|18338161|P2|Baseline Through Week 96|Adverse event before Week 96|22
5325339|NCT00272779|18338162|P1|Baseline Through Week 96|Adverse event before Week 96|13
5325340|NCT00272779|18338161|P2|Baseline Through Week 48|Never treated|3
5325341|NCT00272779|18338162|P1|Baseline Through Week 48|Never treated|2
5325342|NCT00272779|18338161|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
5325343|NCT00272779|18338162|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
5325344|NCT00272779|18338161|P2|Baseline Through Week 48|Continuing treatment|368
5325345|NCT00272779|18338162|P1|Baseline Through Week 48|Continuing treatment|385
5325346|NCT00272779|18338161|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
5325347|NCT00272779|18338162|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
5325348|NCT00272779|18338161|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
5325349|NCT00272779|18338162|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
5325350|NCT00272779|18338161|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
5325351|NCT00272779|18338162|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
5325352|NCT00272779|18338161|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
5325353|NCT00272779|18338162|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
5325354|NCT00272779|18338161|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
5325355|NCT00272779|18338162|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
5325356|NCT00272779|18338161|P2|Baseline Through Week 48|Death on/after Week 48|1
5325357|NCT00272779|18338162|P1|Baseline Through Week 48|Death on/after Week 48|1
5325358|NCT00272779|18338161|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
5325359|NCT00272779|18338162|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
5325360|NCT00272779|18338161|P2|Baseline Through Week 48|Chose different site before wk 48|1
5325361|NCT00272779|18338162|P1|Baseline Through Week 48|Chose different site before wk 48|0
5325362|NCT00272779|18338161|P2|Baseline Through Week 48|Participant's decision before wk 48|1
5325363|NCT00272779|18338162|P1|Baseline Through Week 48|Participant's decision before wk 48|0
5325364|NCT00272779|18338161|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
5325453|NCT00271024|18338665|P4|Overall Study|Unknown/Unspecified|4
5325365|NCT00272779|18338162|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
5325366|NCT00272779|18338161|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
5325367|NCT00272779|18338162|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
5325368|NCT00272779|18338161|P2|Baseline Through Week 48|Pregnancy before Week 48|2
5325369|NCT00272779|18338162|P1|Baseline Through Week 48|Pregnancy before Week 48|2
5325370|NCT00272779|18338161|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
5325371|NCT00272779|18338162|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
5325372|NCT00272779|18338161|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
5325373|NCT00272779|18338162|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
5325374|NCT00272779|18338161|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
5325375|NCT00272779|18338162|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
5325376|NCT00272779|18338161|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
5325377|NCT00272779|18338162|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
5325378|NCT00272779|18338161|P2|Baseline Through Week 48|Death before Week 48|4
5325379|NCT00272779|18338162|P1|Baseline Through Week 48|Death before Week 48|4
5325380|NCT00272779|18338161|P2|Baseline Through Week 48|Adverse event before Week 48|14
5325381|NCT00272779|18338162|P1|Baseline Through Week 48|Adverse event before Week 48|10
5325382|NCT00272038|18338422|P1|Overall Study|withdrew before they received 2 cycles|7
5325383|NCT00271947|18338428|P1|Overall Study|Lost to Follow-up|1
5325384|NCT00271856|18338434|P2|Overall Study|Lost to Follow-up|11
5325385|NCT00271856|18338435|P1|Overall Study|Lost to Follow-up|10
5325386|NCT00271856|18338434|P2|Overall Study|Withdrawal by Subject|7
5325387|NCT00271856|18338435|P1|Overall Study|Withdrawal by Subject|1
5325388|NCT00271817|18338454|P3|Part 2|LDL < 50 mg/dL|4
5325389|NCT00271817|18338455|P2|Part 2|LDL < 50 mg/dL|3
5325390|NCT00271817|18338456|P1|Part 2|LDL < 50 mg/dL|0
5325391|NCT00271817|18338454|P3|Part 2|Withdrawal by Subject|13
5325392|NCT00271817|18338455|P2|Part 2|Withdrawal by Subject|2
5325393|NCT00271817|18338456|P1|Part 2|Withdrawal by Subject|0
5325394|NCT00271817|18338454|P3|Part 2|Patient Moved|5
5325395|NCT00271817|18338455|P2|Part 2|Patient Moved|0
5325396|NCT00271817|18338456|P1|Part 2|Patient Moved|0
5325397|NCT00271817|18338454|P3|Part 2|Protocol Violation|5
5325398|NCT00271817|18338455|P2|Part 2|Protocol Violation|3
5325399|NCT00271817|18338456|P1|Part 2|Protocol Violation|0
5325400|NCT00271817|18338454|P3|Part 2|Lost to Follow-up|18
5325401|NCT00271817|18338455|P2|Part 2|Lost to Follow-up|6
5325402|NCT00271817|18338456|P1|Part 2|Lost to Follow-up|0
5325403|NCT00271817|18338454|P3|Part 2|Lack of Efficacy|6
5325404|NCT00271817|18338455|P2|Part 2|Lack of Efficacy|1
5325405|NCT00271817|18338456|P1|Part 2|Lack of Efficacy|0
5325406|NCT00271817|18338454|P3|Part 2|Adverse Event|33
5325407|NCT00271817|18338455|P2|Part 2|Adverse Event|17
5325408|NCT00271817|18338456|P1|Part 2|Adverse Event|0
5325409|NCT00271817|18338454|P3|Part 1|LDL < 50 mg/dL|48
5325410|NCT00271817|18338455|P2|Part 1|LDL < 50 mg/dL|4
5325411|NCT00271817|18338456|P1|Part 1|LDL < 50 mg/dL|1
5325412|NCT00271817|18338454|P3|Part 1|Withdrawal by Subject|45
5325413|NCT00271817|18338455|P2|Part 1|Withdrawal by Subject|17
5325414|NCT00271817|18338456|P1|Part 1|Withdrawal by Subject|23
5325415|NCT00271817|18338454|P3|Part 1|Patient Moved|5
5325416|NCT00271817|18338455|P2|Part 1|Patient Moved|1
5325417|NCT00271817|18338456|P1|Part 1|Patient Moved|3
5325418|NCT00271817|18338454|P3|Part 1|Protocol Violation|7
5325419|NCT00271817|18338455|P2|Part 1|Protocol Violation|4
5325420|NCT00271817|18338456|P1|Part 1|Protocol Violation|5
5325421|NCT00271817|18338454|P3|Part 1|Lost to Follow-up|24
5325422|NCT00271817|18338455|P2|Part 1|Lost to Follow-up|8
5325423|NCT00271817|18338456|P1|Part 1|Lost to Follow-up|6
5325424|NCT00271817|18338454|P3|Part 1|Adverse Event|156
5325425|NCT00271817|18338455|P2|Part 1|Adverse Event|25
5325426|NCT00271817|18338456|P1|Part 1|Adverse Event|68
5325427|NCT00271609|18338498|P2|Overall Study|Withdrawal by Subject|0
5325428|NCT00271609|18338499|P1|Overall Study|Withdrawal by Subject|2
5325429|NCT00271609|18338498|P2|Overall Study|Adverse Event|3
5325430|NCT00271609|18338499|P1|Overall Study|Adverse Event|11
5325431|NCT00271596|18338509|P2|Overall Study|Withdrawal by Subject|1
5325432|NCT00271596|18338510|P1|Overall Study|Withdrawal by Subject|0
5325433|NCT00271596|18338509|P2|Overall Study|Protocol Violation|0
5325434|NCT00271596|18338510|P1|Overall Study|Protocol Violation|1
5325435|NCT00271544|18338545|P1|Overall Study|Implant not attempted|4
5325436|NCT00271544|18338545|P1|Overall Study|Model 4196 lead not attempted|9
5325437|NCT00271544|18338545|P1|Overall Study|Subjects did not receive a 4196 lead|7
5325438|NCT00271505|18338566|P1|Overall Study|Death|1
5325439|NCT00271505|18338566|P1|Overall Study|Adverse Event|1
5325440|NCT00271505|18338566|P1|Overall Study|Screen Failure|3
5325441|NCT00271024|18338665|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
5325442|NCT00271024|18338666|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
5325443|NCT00271024|18338667|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
5325444|NCT00271024|18338668|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
5325445|NCT00271024|18338665|P4|Overall Study|Unpleasant Reaction To Tablet|2
5325446|NCT00271024|18338666|P3|Overall Study|Unpleasant Reaction To Tablet|4
5325447|NCT00271024|18338667|P2|Overall Study|Unpleasant Reaction To Tablet|3
5325448|NCT00271024|18338668|P1|Overall Study|Unpleasant Reaction To Tablet|1
5325449|NCT00271024|18338665|P4|Overall Study|Protocol Violation|11
5325450|NCT00271024|18338666|P3|Overall Study|Protocol Violation|5
5325451|NCT00271024|18338667|P2|Overall Study|Protocol Violation|6
5325452|NCT00271024|18338668|P1|Overall Study|Protocol Violation|1
5325454|NCT00271024|18338666|P3|Overall Study|Unknown/Unspecified|8
5325455|NCT00271024|18338667|P2|Overall Study|Unknown/Unspecified|11
5325456|NCT00271024|18338668|P1|Overall Study|Unknown/Unspecified|11
5325457|NCT00271024|18338665|P4|Overall Study|Lost Interest|3
5325458|NCT00271024|18338666|P3|Overall Study|Lost Interest|2
5325459|NCT00271024|18338667|P2|Overall Study|Lost Interest|4
5325460|NCT00271024|18338668|P1|Overall Study|Lost Interest|3
5325461|NCT00270998|18338718|P3|12 Month Follow-up|Received/desired alternate treatment|1
5325462|NCT00270998|18338719|P2|12 Month Follow-up|Received/desired alternate treatment|4
5325463|NCT00270998|18338720|P1|12 Month Follow-up|Received/desired alternate treatment|1
5325464|NCT00270998|18338718|P3|12 Month Follow-up|Personal/family health|1
5325465|NCT00270998|18338719|P2|12 Month Follow-up|Personal/family health|5
5325466|NCT00270998|18338720|P1|12 Month Follow-up|Personal/family health|0
5325467|NCT00270998|18338718|P3|12 Month Follow-up|Pessary did not fit|0
5325468|NCT00270998|18338719|P2|12 Month Follow-up|Pessary did not fit|0
5325469|NCT00270998|18338720|P1|12 Month Follow-up|Pessary did not fit|1
5325470|NCT00270998|18338718|P3|12 Month Follow-up|Withdrawal by Subject|16
5325471|NCT00270998|18338719|P2|12 Month Follow-up|Withdrawal by Subject|12
5325472|NCT00270998|18338720|P1|12 Month Follow-up|Withdrawal by Subject|7
5325473|NCT00270998|18338718|P3|12 Month Follow-up|Lack of Efficacy|3
5325474|NCT00270998|18338719|P2|12 Month Follow-up|Lack of Efficacy|4
5325475|NCT00270998|18338720|P1|12 Month Follow-up|Lack of Efficacy|5
5325476|NCT00270998|18338718|P3|3 Month Follow-up|Received/desired alternate treatment|2
5325477|NCT00270998|18338719|P2|3 Month Follow-up|Received/desired alternate treatment|5
5325478|NCT00270998|18338720|P1|3 Month Follow-up|Received/desired alternate treatment|13
5325479|NCT00270998|18338718|P3|3 Month Follow-up|Personal/family health|0
5325480|NCT00270998|18338719|P2|3 Month Follow-up|Personal/family health|1
5325481|NCT00270998|18338720|P1|3 Month Follow-up|Personal/family health|1
5325482|NCT00270998|18338718|P3|3 Month Follow-up|Pessary did not fit|0
5325483|NCT00270998|18338719|P2|3 Month Follow-up|Pessary did not fit|0
5325484|NCT00270998|18338720|P1|3 Month Follow-up|Pessary did not fit|12
5325485|NCT00270998|18338718|P3|3 Month Follow-up|Withdrawal by Subject|15
5325486|NCT00270998|18338719|P2|3 Month Follow-up|Withdrawal by Subject|14
5325487|NCT00270998|18338720|P1|3 Month Follow-up|Withdrawal by Subject|11
5325488|NCT00270998|18338718|P3|3 Month Follow-up|Lack of Efficacy|1
5325489|NCT00270998|18338719|P2|3 Month Follow-up|Lack of Efficacy|2
5325490|NCT00270998|18338720|P1|3 Month Follow-up|Lack of Efficacy|1
5325491|NCT00270998|18338718|P3|3 Month Follow-up|Adverse Event|0
5325492|NCT00270998|18338719|P2|3 Month Follow-up|Adverse Event|0
5325493|NCT00270998|18338720|P1|3 Month Follow-up|Adverse Event|1
5325494|NCT00270894|18338749|P1|Overall Study|Withdrawal by Subject|1
5325495|NCT00270894|18338749|P1|Overall Study|Adverse Event|1
5325496|NCT00270855|18338761|P2|Overall Study|Withdrawal by Subject|8
5325497|NCT00270855|18338762|P1|Overall Study|Withdrawal by Subject|8
5325498|NCT00270257|18338898|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
5325499|NCT00270257|18338899|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
5325500|NCT00270231|18338917|P2|Second Intervention|Lost to Follow-up|1
5325501|NCT00270231|18338918|P1|Second Intervention|Lost to Follow-up|0
5325502|NCT00270231|18338917|P2|Washout Period|Lost to Follow-up|0
5325503|NCT00270231|18338918|P1|Washout Period|Lost to Follow-up|1
5325504|NCT00270231|18338917|P2|First Intervention|Lost to Follow-up|1
5325505|NCT00270231|18338918|P1|First Intervention|Lost to Follow-up|1
5325506|NCT00270205|18338928|P4|Overall Study|Lost to Follow-up|1
5325507|NCT00270205|18338929|P3|Overall Study|Lost to Follow-up|0
5325508|NCT00270205|18338930|P2|Overall Study|Lost to Follow-up|0
5325509|NCT00270205|18338931|P1|Overall Study|Lost to Follow-up|1
5325510|NCT00269919|18339049|P1|Overall Study|Started but not treated|1
5325511|NCT00269919|18339049|P1|Overall Study|Other|26
5325512|NCT00269633|18339068|P2|Overall Study|Withdrawal by Subject|0
5325513|NCT00269633|18339069|P1|Overall Study|Withdrawal by Subject|1
5325514|NCT00269477|18339079|P4|Overall Study|Missed post-vaccination blood draw|0
5325515|NCT00269477|18339080|P3|Overall Study|Missed post-vaccination blood draw|0
5325516|NCT00269477|18339081|P2|Overall Study|Missed post-vaccination blood draw|1
5325517|NCT00269477|18339082|P1|Overall Study|Missed post-vaccination blood draw|0
5325518|NCT00269477|18339079|P4|Overall Study|Protocol Violation|0
5325519|NCT00269477|18339080|P3|Overall Study|Protocol Violation|1
5325520|NCT00269477|18339081|P2|Overall Study|Protocol Violation|5
5325521|NCT00269477|18339082|P1|Overall Study|Protocol Violation|5
5325522|NCT00269399|18339098|P2|Overall Study|Development of exclusion criteria|1
5325523|NCT00269399|18339099|P1|Overall Study|Development of exclusion criteria|0
5325524|NCT00269399|18339098|P2|Overall Study|Other|4
5325525|NCT00269399|18339099|P1|Overall Study|Other|0
5325526|NCT00269399|18339098|P2|Overall Study|Negative Lab Result for C. difficile|3
5325527|NCT00269399|18339099|P1|Overall Study|Negative Lab Result for C. difficile|2
5325528|NCT00269399|18339098|P2|Overall Study|Withdrawal by Subject|5
5325529|NCT00269399|18339099|P1|Overall Study|Withdrawal by Subject|2
5325530|NCT00269399|18339098|P2|Overall Study|Adverse Event|4
5325531|NCT00269399|18339099|P1|Overall Study|Adverse Event|10
5325532|NCT00269399|18339098|P2|Overall Study|Lack of Efficacy|10
5325533|NCT00269399|18339099|P1|Overall Study|Lack of Efficacy|27
5325534|NCT00269152|18339109|P2|Overall Study|Protocol Violation|1
5325535|NCT00269152|18339110|P1|Overall Study|Protocol Violation|0
5325536|NCT00269152|18339109|P2|Overall Study|Physician Decision|3
5325537|NCT00269152|18339110|P1|Overall Study|Physician Decision|2
5325538|NCT00269152|18339109|P2|Overall Study|Withdrawal by Subject|3
5325539|NCT00269152|18339110|P1|Overall Study|Withdrawal by Subject|7
5325540|NCT00269152|18339109|P2|Overall Study|Adverse Event|3
5325541|NCT00269152|18339110|P1|Overall Study|Adverse Event|9
5325542|NCT00269113|18339126|P2|Overall Study|Other|2
5325543|NCT00269113|18339127|P1|Overall Study|Other|0
5325544|NCT00269113|18339126|P2|Overall Study|Protocol Violation|5
5325545|NCT00269113|18339127|P1|Overall Study|Protocol Violation|15
5325546|NCT00269113|18339126|P2|Overall Study|Lost to Follow-up|1
5325547|NCT00269113|18339127|P1|Overall Study|Lost to Follow-up|2
5325548|NCT00269113|18339126|P2|Overall Study|Death|2
5325549|NCT00269113|18339127|P1|Overall Study|Death|6
5325550|NCT00269113|18339126|P2|Overall Study|Withdrawal by Subject|2
5325551|NCT00269113|18339127|P1|Overall Study|Withdrawal by Subject|0
5325552|NCT00269113|18339126|P2|Overall Study|Early Improvement|0
5325553|NCT00269113|18339127|P1|Overall Study|Early Improvement|2
5325554|NCT00269113|18339126|P2|Overall Study|Lack of Efficacy|18
5325555|NCT00269113|18339127|P1|Overall Study|Lack of Efficacy|35
5325556|NCT00269113|18339126|P2|Overall Study|Adverse Event|7
5325557|NCT00269113|18339127|P1|Overall Study|Adverse Event|14
5325558|NCT00269087|18339145|P1|Overall Study|Exacerbation of COPD|13
5325559|NCT00269087|18339145|P1|Overall Study|Withdrawal by Subject|1
5325560|NCT00269087|18339145|P1|Overall Study|Adverse Event|20
5325561|NCT00268996|18339175|P2|Overall Study|Other|1
5325562|NCT00268996|18339176|P1|Overall Study|Other|1
5325563|NCT00268996|18339175|P2|Overall Study|Non-compliance|0
5325564|NCT00268996|18339176|P1|Overall Study|Non-compliance|1
5325565|NCT00268996|18339175|P2|Overall Study|Withdrawal by Subject|11
5325566|NCT00268996|18339176|P1|Overall Study|Withdrawal by Subject|5
5325567|NCT00268996|18339175|P2|Overall Study|Lost to Follow-up|1
5325568|NCT00268996|18339176|P1|Overall Study|Lost to Follow-up|3
5325569|NCT00268996|18339175|P2|Overall Study|Adverse Event|7
5325570|NCT00268996|18339176|P1|Overall Study|Adverse Event|11
5325571|NCT00268983|18339220|P2|Overall Study|Death|0
5325572|NCT00268983|18339221|P1|Overall Study|Death|3
5325573|NCT00268905|18339264|P3|Overall Study|Clinical Progression|1
5325574|NCT00268905|18339265|P2|Overall Study|Clinical Progression|4
5325575|NCT00268905|18339266|P1|Overall Study|Clinical Progression|9
5325576|NCT00268905|18339264|P3|Overall Study|Physician Decision|1
5325577|NCT00268905|18339265|P2|Overall Study|Physician Decision|0
5325578|NCT00268905|18339266|P1|Overall Study|Physician Decision|3
5325579|NCT00268905|18339264|P3|Overall Study|Progressive Disease|3
5325580|NCT00268905|18339265|P2|Overall Study|Progressive Disease|4
5325581|NCT00268905|18339266|P1|Overall Study|Progressive Disease|28
5325582|NCT00268905|18339264|P3|Overall Study|Withdrawal by Subject|3
5325583|NCT00268905|18339265|P2|Overall Study|Withdrawal by Subject|0
5325584|NCT00268905|18339266|P1|Overall Study|Withdrawal by Subject|0
5325585|NCT00268905|18339264|P3|Overall Study|Lost to Follow-up|0
5325586|NCT00268905|18339265|P2|Overall Study|Lost to Follow-up|1
5325587|NCT00268905|18339266|P1|Overall Study|Lost to Follow-up|0
5325588|NCT00268905|18339264|P3|Overall Study|Adverse Event|4
5325589|NCT00268905|18339265|P2|Overall Study|Adverse Event|0
5325590|NCT00268905|18339266|P1|Overall Study|Adverse Event|3
5325591|NCT00268892|18339283|P3|Overall Study|Trial Site Closed|2
5325592|NCT00268892|18339284|P2|Overall Study|Trial Site Closed|2
5325593|NCT00268892|18339285|P1|Overall Study|Trial Site Closed|4
5325594|NCT00268892|18339283|P3|Overall Study|Disease Progression|0
5325595|NCT00268892|18339284|P2|Overall Study|Disease Progression|1
5325596|NCT00268892|18339285|P1|Overall Study|Disease Progression|1
5325597|NCT00268892|18339283|P3|Overall Study|Protocol Violation|0
5325598|NCT00268892|18339284|P2|Overall Study|Protocol Violation|1
5325599|NCT00268892|18339285|P1|Overall Study|Protocol Violation|0
5325600|NCT00268892|18339283|P3|Overall Study|Lost to Follow-up|4
5325601|NCT00268892|18339284|P2|Overall Study|Lost to Follow-up|2
5325602|NCT00268892|18339285|P1|Overall Study|Lost to Follow-up|5
5325603|NCT00268892|18339283|P3|Overall Study|Physician Decision|0
5325604|NCT00268892|18339284|P2|Overall Study|Physician Decision|1
5325605|NCT00268892|18339285|P1|Overall Study|Physician Decision|0
5325606|NCT00268892|18339283|P3|Overall Study|Withdrawal by Subject|13
5325607|NCT00268892|18339284|P2|Overall Study|Withdrawal by Subject|15
5325608|NCT00268892|18339285|P1|Overall Study|Withdrawal by Subject|14
5325609|NCT00268892|18339283|P3|Overall Study|Lack of Efficacy|0
5325610|NCT00268892|18339284|P2|Overall Study|Lack of Efficacy|3
5325611|NCT00268892|18339285|P1|Overall Study|Lack of Efficacy|1
5325612|NCT00268892|18339283|P3|Overall Study|Adverse Event|20
5325613|NCT00268892|18339284|P2|Overall Study|Adverse Event|17
5325614|NCT00268892|18339285|P1|Overall Study|Adverse Event|14
5325615|NCT00268463|18339304|P2|Overall Study|study terminated due to low accrual|12
5325616|NCT00268463|18339305|P1|Overall Study|study terminated due to low accrual|10
5325617|NCT00268437|18339321|P1|Overall Study|Ineligible|1
5325618|NCT00268346|18339328|P2|Overall Study|Withdrawal by Subject|1
5325619|NCT00268346|18339329|P1|Overall Study|Withdrawal by Subject|0
5325620|NCT00268346|18339328|P2|Overall Study|Death|1
5325621|NCT00268346|18339329|P1|Overall Study|Death|0
5325622|NCT00268346|18339328|P2|Overall Study|Adverse Event|1
5325623|NCT00268346|18339329|P1|Overall Study|Adverse Event|0
5325624|NCT00268242|18339335|P1|Overall Study|Death|1
5325625|NCT00268203|18339344|P1|Overall Study|Completed 2 Years of Follow-up|62
5325626|NCT00268203|18339344|P1|Overall Study|Reason Not Specified|34
5325627|NCT00268203|18339344|P1|Overall Study|Death|84
5325628|NCT00268203|18339344|P1|Overall Study|Progressive Disease|359
5325629|NCT00268203|18339344|P1|Overall Study|Received Other NHL Therapy|7
5325630|NCT00268203|18339344|P1|Overall Study|Withdrawal by Subject|9
5325631|NCT00268203|18339344|P1|Overall Study|Lost to Follow-up|92
5325632|NCT00267969|18339358|P7|After Controlled Period|Other|25
5325633|NCT00267969|18339359|P6|After Controlled Period|Other|22
5325634|NCT00267969|18339360|P5|After Controlled Period|Other|11
5325635|NCT00267969|18339361|P4|After Controlled Period|Other|13
5325636|NCT00267969|18339362|P3|After Controlled Period|Other|0
5325637|NCT00267969|18339363|P2|After Controlled Period|Other|0
5325638|NCT00267969|18339364|P1|After Controlled Period|Other|0
5325639|NCT00267969|18339358|P7|After Controlled Period|Lost to Follow-up|10
5325640|NCT00267969|18339359|P6|After Controlled Period|Lost to Follow-up|9
5325641|NCT00267969|18339360|P5|After Controlled Period|Lost to Follow-up|8
5325642|NCT00267969|18339361|P4|After Controlled Period|Lost to Follow-up|5
5325643|NCT00267969|18339362|P3|After Controlled Period|Lost to Follow-up|0
5325644|NCT00267969|18339363|P2|After Controlled Period|Lost to Follow-up|0
5325645|NCT00267969|18339364|P1|After Controlled Period|Lost to Follow-up|0
5325646|NCT00267969|18339358|P7|After Controlled Period|Lack of Efficacy|15
5325647|NCT00267969|18339359|P6|After Controlled Period|Lack of Efficacy|28
5325648|NCT00267969|18339360|P5|After Controlled Period|Lack of Efficacy|6
5325649|NCT00267969|18339361|P4|After Controlled Period|Lack of Efficacy|10
5325650|NCT00267969|18339362|P3|After Controlled Period|Lack of Efficacy|0
5325651|NCT00267969|18339363|P2|After Controlled Period|Lack of Efficacy|0
5325652|NCT00267969|18339364|P1|After Controlled Period|Lack of Efficacy|0
5325653|NCT00267969|18339358|P7|After Controlled Period|Death|1
5325654|NCT00267969|18339359|P6|After Controlled Period|Death|0
5325655|NCT00267969|18339360|P5|After Controlled Period|Death|2
5325656|NCT00267969|18339361|P4|After Controlled Period|Death|1
5325657|NCT00267969|18339362|P3|After Controlled Period|Death|0
5325658|NCT00267969|18339363|P2|After Controlled Period|Death|0
5325659|NCT00267969|18339364|P1|After Controlled Period|Death|0
5325660|NCT00267969|18339358|P7|After Controlled Period|Adverse Event|21
5325661|NCT00267969|18339359|P6|After Controlled Period|Adverse Event|23
5325662|NCT00267969|18339360|P5|After Controlled Period|Adverse Event|8
5325663|NCT00267969|18339361|P4|After Controlled Period|Adverse Event|7
5325664|NCT00267969|18339362|P3|After Controlled Period|Adverse Event|0
5325665|NCT00267969|18339363|P2|After Controlled Period|Adverse Event|0
5325666|NCT00267969|18339364|P1|After Controlled Period|Adverse Event|0
5325667|NCT00267969|18339358|P7|Controlled Period|Other|0
5325668|NCT00267969|18339359|P6|Controlled Period|Other|0
5325669|NCT00267969|18339360|P5|Controlled Period|Other|0
5325670|NCT00267969|18339361|P4|Controlled Period|Other|0
5325671|NCT00267969|18339362|P3|Controlled Period|Other|6
5325672|NCT00267969|18339363|P2|Controlled Period|Other|1
5325673|NCT00267969|18339364|P1|Controlled Period|Other|2
5325674|NCT00267969|18339358|P7|Controlled Period|Randomized but not treated|0
5325675|NCT00267969|18339359|P6|Controlled Period|Randomized but not treated|0
5325676|NCT00267969|18339360|P5|Controlled Period|Randomized but not treated|0
5325677|NCT00267969|18339361|P4|Controlled Period|Randomized but not treated|0
5325678|NCT00267969|18339362|P3|Controlled Period|Randomized but not treated|1
5325679|NCT00267969|18339363|P2|Controlled Period|Randomized but not treated|0
5325680|NCT00267969|18339364|P1|Controlled Period|Randomized but not treated|0
5325681|NCT00267969|18339358|P7|Controlled Period|Lost to Follow-up|0
5325682|NCT00267969|18339359|P6|Controlled Period|Lost to Follow-up|0
5325683|NCT00267969|18339360|P5|Controlled Period|Lost to Follow-up|0
5325684|NCT00267969|18339361|P4|Controlled Period|Lost to Follow-up|0
5325685|NCT00267969|18339362|P3|Controlled Period|Lost to Follow-up|1
5325686|NCT00267969|18339363|P2|Controlled Period|Lost to Follow-up|0
5325687|NCT00267969|18339364|P1|Controlled Period|Lost to Follow-up|1
5325688|NCT00267969|18339358|P7|Controlled Period|Lack of Efficacy|0
5325689|NCT00267969|18339359|P6|Controlled Period|Lack of Efficacy|0
5325690|NCT00267969|18339360|P5|Controlled Period|Lack of Efficacy|0
5325691|NCT00267969|18339361|P4|Controlled Period|Lack of Efficacy|0
5325692|NCT00267969|18339362|P3|Controlled Period|Lack of Efficacy|1
5325693|NCT00267969|18339363|P2|Controlled Period|Lack of Efficacy|0
5325694|NCT00267969|18339364|P1|Controlled Period|Lack of Efficacy|3
5325695|NCT00267969|18339358|P7|Controlled Period|Adverse Event|0
5325696|NCT00267969|18339359|P6|Controlled Period|Adverse Event|0
5325697|NCT00267969|18339360|P5|Controlled Period|Adverse Event|0
5325698|NCT00267969|18339361|P4|Controlled Period|Adverse Event|0
5325699|NCT00267969|18339362|P3|Controlled Period|Adverse Event|2
5325700|NCT00267969|18339363|P2|Controlled Period|Adverse Event|0
5325701|NCT00267969|18339364|P1|Controlled Period|Adverse Event|6
5325702|NCT00267956|18339390|P4|After Controlled Period|Withdrew consent|0
5325703|NCT00267956|18339391|P3|After Controlled Period|Withdrew consent|1
5325704|NCT00267956|18339392|P2|After Controlled Period|Withdrew consent|0
5325705|NCT00267956|18339393|P1|After Controlled Period|Withdrew consent|0
5325706|NCT00267956|18339390|P4|After Controlled Period|Lost to Follow-up|0
5325707|NCT00267956|18339391|P3|After Controlled Period|Lost to Follow-up|1
5325708|NCT00267956|18339392|P2|After Controlled Period|Lost to Follow-up|0
5325709|NCT00267956|18339393|P1|After Controlled Period|Lost to Follow-up|0
5325710|NCT00267956|18339390|P4|After Controlled Period|Lack of Efficacy|1
5325711|NCT00267956|18339391|P3|After Controlled Period|Lack of Efficacy|1
5325712|NCT00267956|18339392|P2|After Controlled Period|Lack of Efficacy|0
5325713|NCT00267956|18339393|P1|After Controlled Period|Lack of Efficacy|0
5325714|NCT00267956|18339390|P4|After Controlled Period|Adverse Event|1
5325715|NCT00267956|18339391|P3|After Controlled Period|Adverse Event|2
5325716|NCT00267956|18339392|P2|After Controlled Period|Adverse Event|0
5325717|NCT00267956|18339393|P1|After Controlled Period|Adverse Event|0
5325718|NCT00267956|18339390|P4|Controlled Period|Withdrew consent|0
5325719|NCT00267956|18339391|P3|Controlled Period|Withdrew consent|0
5325720|NCT00267956|18339392|P2|Controlled Period|Withdrew consent|1
5325721|NCT00267956|18339393|P1|Controlled Period|Withdrew consent|3
5325722|NCT00267956|18339390|P4|Controlled Period|Lost to Follow-up|0
5325723|NCT00267956|18339391|P3|Controlled Period|Lost to Follow-up|0
5325724|NCT00267956|18339392|P2|Controlled Period|Lost to Follow-up|0
5325725|NCT00267956|18339393|P1|Controlled Period|Lost to Follow-up|2
5325726|NCT00267956|18339390|P4|Controlled Period|Lack of Efficacy|0
5325727|NCT00267956|18339391|P3|Controlled Period|Lack of Efficacy|0
5325728|NCT00267956|18339392|P2|Controlled Period|Lack of Efficacy|2
5325729|NCT00267956|18339393|P1|Controlled Period|Lack of Efficacy|4
5325730|NCT00267956|18339390|P4|Controlled Period|Adverse Event|0
5325731|NCT00267956|18339391|P3|Controlled Period|Adverse Event|0
5325732|NCT00267956|18339392|P2|Controlled Period|Adverse Event|1
5325733|NCT00267956|18339393|P1|Controlled Period|Adverse Event|4
5325734|NCT00267865|18339411|P1|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
5325735|NCT00267865|18339411|P1|Induction Treatment|Died before completing.|2
5325736|NCT00267748|18339434|P3|Randomized Period|randomized but not treated|3
5325737|NCT00267748|18339435|P2|Randomized Period|randomized but not treated|0
5325738|NCT00267748|18339436|P1|Randomized Period|randomized but not treated|0
5325739|NCT00267748|18339434|P3|Randomized Period|Other|6
5325740|NCT00267748|18339435|P2|Randomized Period|Other|9
5325741|NCT00267748|18339436|P1|Randomized Period|Other|0
5325742|NCT00267748|18339434|P3|Randomized Period|Withdrawal by Subject|2
5325743|NCT00267748|18339435|P2|Randomized Period|Withdrawal by Subject|9
5325744|NCT00267748|18339436|P1|Randomized Period|Withdrawal by Subject|0
5325745|NCT00267748|18339434|P3|Randomized Period|Objective progression or relapse|86
5325746|NCT00267748|18339435|P2|Randomized Period|Objective progression or relapse|77
5325747|NCT00267748|18339436|P1|Randomized Period|Objective progression or relapse|0
5325748|NCT00267748|18339434|P3|Randomized Period|Lost to Follow-up|0
5325749|NCT00267748|18339435|P2|Randomized Period|Lost to Follow-up|1
5325750|NCT00267748|18339436|P1|Randomized Period|Lost to Follow-up|0
5325751|NCT00267748|18339434|P3|Randomized Period|Global deterioration of health status|7
5325752|NCT00267748|18339435|P2|Randomized Period|Global deterioration of health status|6
5325753|NCT00267748|18339436|P1|Randomized Period|Global deterioration of health status|0
5325754|NCT00267748|18339434|P3|Randomized Period|Adverse Event|25
5325755|NCT00267748|18339435|P2|Randomized Period|Adverse Event|23
5325756|NCT00267748|18339436|P1|Randomized Period|Adverse Event|0
5325757|NCT00267748|18339434|P3|Randomized Period|Death|3
5325758|NCT00267748|18339435|P2|Randomized Period|Death|2
5325759|NCT00267748|18339436|P1|Randomized Period|Death|0
5325760|NCT00267748|18339434|P3|Non-randomized Period|Other|0
5325761|NCT00267748|18339435|P2|Non-randomized Period|Other|0
5325762|NCT00267748|18339436|P1|Non-randomized Period|Other|3
5325763|NCT00267748|18339434|P3|Non-randomized Period|Participant not willing to participate|0
5325764|NCT00267748|18339435|P2|Non-randomized Period|Participant not willing to participate|0
5325765|NCT00267748|18339436|P1|Non-randomized Period|Participant not willing to participate|1
5325766|NCT00267748|18339434|P3|Non-randomized Period|Death|0
5325767|NCT00267748|18339435|P2|Non-randomized Period|Death|0
5325768|NCT00267748|18339436|P1|Non-randomized Period|Death|1
5325769|NCT00267748|18339434|P3|Non-randomized Period|Adverse Event|0
5325770|NCT00267748|18339435|P2|Non-randomized Period|Adverse Event|0
5325771|NCT00267748|18339436|P1|Non-randomized Period|Adverse Event|8
5325772|NCT00267748|18339434|P3|Non-randomized Period|Progressive disease|0
5325773|NCT00267748|18339435|P2|Non-randomized Period|Progressive disease|0
5325774|NCT00267748|18339436|P1|Non-randomized Period|Progressive disease|10
5325775|NCT00267488|18339493|P1|Overall Study|Other (Disease Progression)|1
5325776|NCT00267488|18339493|P1|Overall Study|Protocol Violation|1
5325777|NCT00267488|18339493|P1|Overall Study|Sponsor Terminated Study|9
5325778|NCT00267202|18339517|P2|Overall Study|Lost to Follow-up|0
5325779|NCT00267202|18339518|P1|Overall Study|Lost to Follow-up|3
5325780|NCT00267202|18339517|P2|Overall Study|Administrative problems|1
5325781|NCT00267202|18339518|P1|Overall Study|Administrative problems|2
5325782|NCT00267202|18339517|P2|Overall Study|Protocol Violation|3
5325783|NCT00267202|18339518|P1|Overall Study|Protocol Violation|2
5325784|NCT00267202|18339517|P2|Overall Study|Adverse Event|7
5325785|NCT00267202|18339518|P1|Overall Study|Adverse Event|13
5325786|NCT00267202|18339517|P2|Overall Study|Withdrawal by Subject|15
5325787|NCT00267202|18339518|P1|Overall Study|Withdrawal by Subject|12
5325788|NCT00267202|18339517|P2|Overall Study|Unsatisfactory therapeutic effect|8
5325789|NCT00267202|18339518|P1|Overall Study|Unsatisfactory therapeutic effect|21
5325790|NCT00267189|18339539|P2|Overall Study|Missing|0
5325791|NCT00267189|18339540|P1|Overall Study|Missing|3
5325792|NCT00267189|18339539|P2|Overall Study|Death|0
5325793|NCT00267189|18339540|P1|Overall Study|Death|1
5325794|NCT00267189|18339539|P2|Overall Study|Patient withdrew consent|1
5325795|NCT00267189|18339540|P1|Overall Study|Patient withdrew consent|1
5325796|NCT00267150|18339550|P1|Overall Study|Adverse Event|1
5325797|NCT00267098|18339574|P8|Overall Study|Sponsor withdrew subject|0
5325798|NCT00267098|18339575|P7|Overall Study|Sponsor withdrew subject|0
5325799|NCT00267098|18339576|P6|Overall Study|Sponsor withdrew subject|0
5325800|NCT00267098|18339577|P5|Overall Study|Sponsor withdrew subject|0
5325801|NCT00267098|18339578|P4|Overall Study|Sponsor withdrew subject|1
5325802|NCT00267098|18339579|P3|Overall Study|Sponsor withdrew subject|0
5325803|NCT00267098|18339580|P2|Overall Study|Sponsor withdrew subject|0
5325804|NCT00267098|18339581|P1|Overall Study|Sponsor withdrew subject|0
5325805|NCT00267098|18339574|P8|Overall Study|Subject listed for heart transplant|0
5325806|NCT00267098|18339575|P7|Overall Study|Subject listed for heart transplant|1
5325807|NCT00267098|18339576|P6|Overall Study|Subject listed for heart transplant|0
5325808|NCT00267098|18339577|P5|Overall Study|Subject listed for heart transplant|0
5325809|NCT00267098|18339578|P4|Overall Study|Subject listed for heart transplant|0
5325810|NCT00267098|18339579|P3|Overall Study|Subject listed for heart transplant|0
5325811|NCT00267098|18339580|P2|Overall Study|Subject listed for heart transplant|0
5325812|NCT00267098|18339581|P1|Overall Study|Subject listed for heart transplant|0
5325813|NCT00267098|18339574|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
5325814|NCT00267098|18339575|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
5325815|NCT00267098|18339576|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
5325816|NCT00267098|18339577|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
5325817|NCT00267098|18339578|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
5325818|NCT00267098|18339579|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
5325819|NCT00267098|18339580|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
5325820|NCT00267098|18339581|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
5325821|NCT00267098|18339574|P8|Overall Study|Explanted Medtronic device|0
5325822|NCT00267098|18339575|P7|Overall Study|Explanted Medtronic device|0
5325823|NCT00267098|18339576|P6|Overall Study|Explanted Medtronic device|0
5325824|NCT00267098|18339577|P5|Overall Study|Explanted Medtronic device|0
5325825|NCT00267098|18339578|P4|Overall Study|Explanted Medtronic device|1
5325826|NCT00267098|18339579|P3|Overall Study|Explanted Medtronic device|0
5325827|NCT00267098|18339580|P2|Overall Study|Explanted Medtronic device|0
5325828|NCT00267098|18339581|P1|Overall Study|Explanted Medtronic device|0
5325829|NCT00267098|18339574|P8|Overall Study|Site closure|0
5325830|NCT00267098|18339575|P7|Overall Study|Site closure|1
5325831|NCT00267098|18339576|P6|Overall Study|Site closure|1
5325832|NCT00267098|18339577|P5|Overall Study|Site closure|0
5325833|NCT00267098|18339578|P4|Overall Study|Site closure|1
5325834|NCT00267098|18339579|P3|Overall Study|Site closure|0
5325835|NCT00267098|18339580|P2|Overall Study|Site closure|0
5325836|NCT00267098|18339581|P1|Overall Study|Site closure|0
5325837|NCT00267098|18339574|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325838|NCT00267098|18339575|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325839|NCT00267098|18339576|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325840|NCT00267098|18339577|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325841|NCT00267098|18339578|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325842|NCT00267098|18339579|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325843|NCT00267098|18339580|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
5325844|NCT00267098|18339581|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5325845|NCT00267098|18339574|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5325846|NCT00267098|18339575|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5325847|NCT00267098|18339576|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5325848|NCT00267098|18339577|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
5325849|NCT00267098|18339578|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5325850|NCT00267098|18339579|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5325851|NCT00267098|18339580|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5325852|NCT00267098|18339581|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
5325853|NCT00267098|18339574|P8|Overall Study|Physician Decision|0
5325854|NCT00267098|18339575|P7|Overall Study|Physician Decision|3
5325855|NCT00267098|18339576|P6|Overall Study|Physician Decision|4
5325856|NCT00267098|18339577|P5|Overall Study|Physician Decision|5
5325857|NCT00267098|18339578|P4|Overall Study|Physician Decision|11
5325858|NCT00267098|18339579|P3|Overall Study|Physician Decision|7
5325859|NCT00267098|18339580|P2|Overall Study|Physician Decision|0
5325860|NCT00267098|18339581|P1|Overall Study|Physician Decision|5
5325861|NCT00267098|18339574|P8|Overall Study|Withdrawal by Subject|5
5325862|NCT00267098|18339575|P7|Overall Study|Withdrawal by Subject|12
5325863|NCT00267098|18339576|P6|Overall Study|Withdrawal by Subject|9
5325864|NCT00267098|18339577|P5|Overall Study|Withdrawal by Subject|12
5325865|NCT00267098|18339578|P4|Overall Study|Withdrawal by Subject|21
5325866|NCT00267098|18339579|P3|Overall Study|Withdrawal by Subject|24
5325867|NCT00267098|18339580|P2|Overall Study|Withdrawal by Subject|0
5325868|NCT00267098|18339581|P1|Overall Study|Withdrawal by Subject|8
5325869|NCT00267098|18339574|P8|Overall Study|Lost to Follow-up|1
5325870|NCT00267098|18339575|P7|Overall Study|Lost to Follow-up|1
5325871|NCT00267098|18339576|P6|Overall Study|Lost to Follow-up|3
5325872|NCT00267098|18339577|P5|Overall Study|Lost to Follow-up|2
5325873|NCT00267098|18339578|P4|Overall Study|Lost to Follow-up|5
5325874|NCT00267098|18339579|P3|Overall Study|Lost to Follow-up|6
5325875|NCT00267098|18339580|P2|Overall Study|Lost to Follow-up|0
5325876|NCT00267098|18339581|P1|Overall Study|Lost to Follow-up|0
5325877|NCT00267098|18339574|P8|Overall Study|Death|9
5325878|NCT00267098|18339575|P7|Overall Study|Death|28
5325879|NCT00267098|18339576|P6|Overall Study|Death|23
5325880|NCT00267098|18339577|P5|Overall Study|Death|14
5325881|NCT00267098|18339578|P4|Overall Study|Death|66
5325882|NCT00267098|18339579|P3|Overall Study|Death|57
5325883|NCT00267098|18339580|P2|Overall Study|Death|0
5325884|NCT00267098|18339581|P1|Overall Study|Death|0
5325885|NCT00267046|18339724|P2|Overall Study|Radiation|1
5325886|NCT00267046|18339725|P1|Overall Study|Radiation|0
5325887|NCT00267046|18339724|P2|Overall Study|Withdrawal by Subject|0
5325888|NCT00267046|18339725|P1|Overall Study|Withdrawal by Subject|1
5325889|NCT00267046|18339724|P2|Overall Study|Surgery|1
5325890|NCT00267046|18339725|P1|Overall Study|Surgery|3
5325891|NCT00267046|18339724|P2|Overall Study|Open-label palifermin|7
5325892|NCT00267046|18339725|P1|Overall Study|Open-label palifermin|2
5325893|NCT00267046|18339724|P2|Overall Study|Chemotoxicity|0
5325894|NCT00267046|18339725|P1|Overall Study|Chemotoxicity|2
5325895|NCT00267046|18339724|P2|Overall Study|Disease progression|2
5325896|NCT00267046|18339725|P1|Overall Study|Disease progression|4
5325897|NCT00267020|18339735|P2|Overall Study|Other|2
5325898|NCT00267020|18339736|P1|Overall Study|Other|1
5325899|NCT00267020|18339735|P2|Overall Study|Sponsor Request|0
5325900|NCT00267020|18339736|P1|Overall Study|Sponsor Request|1
5325901|NCT00267020|18339735|P2|Overall Study|Unrelated Complication|1
5325902|NCT00267020|18339736|P1|Overall Study|Unrelated Complication|1
5325903|NCT00267020|18339735|P2|Overall Study|Disease Progression|25
5325904|NCT00267020|18339736|P1|Overall Study|Disease Progression|39
5325905|NCT00267020|18339735|P2|Overall Study|Physician Decision|2
5325906|NCT00267020|18339736|P1|Overall Study|Physician Decision|3
5325907|NCT00267020|18339735|P2|Overall Study|Withdrawal by Subject|7
5325908|NCT00267020|18339736|P1|Overall Study|Withdrawal by Subject|17
5325909|NCT00267020|18339735|P2|Overall Study|Death|1
5325910|NCT00267020|18339736|P1|Overall Study|Death|2
5325911|NCT00267020|18339735|P2|Overall Study|Adverse Event|5
5325912|NCT00267020|18339736|P1|Overall Study|Adverse Event|22
5325913|NCT00267007|18339758|P2|Overall Study|Adverse Event|0
5325914|NCT00267007|18339759|P1|Overall Study|Adverse Event|1
5325915|NCT00267007|18339758|P2|Overall Study|Non-compliance|1
5325916|NCT00267007|18339759|P1|Overall Study|Non-compliance|0
5325917|NCT00267007|18339758|P2|Overall Study|Lost to Follow-up|0
5325918|NCT00267007|18339759|P1|Overall Study|Lost to Follow-up|1
5325919|NCT00267007|18339758|P2|Overall Study|Withdrawal by Subject|0
5325920|NCT00267007|18339759|P1|Overall Study|Withdrawal by Subject|6
5325921|NCT00266877|18339770|P3|Overall Study|Concomitant Radiotherapy|0
5325922|NCT00266877|18339771|P2|Overall Study|Concomitant Radiotherapy|1
5325923|NCT00266877|18339772|P1|Overall Study|Concomitant Radiotherapy|0
5325924|NCT00266877|18339770|P3|Overall Study|Hospitalization|0
5325925|NCT00266877|18339771|P2|Overall Study|Hospitalization|0
5325926|NCT00266877|18339772|P1|Overall Study|Hospitalization|1
5325927|NCT00266877|18339770|P3|Overall Study|Symptomatic Deterioration|1
5325928|NCT00266877|18339771|P2|Overall Study|Symptomatic Deterioration|3
5325929|NCT00266877|18339772|P1|Overall Study|Symptomatic Deterioration|6
5325930|NCT00266877|18339770|P3|Overall Study|Disease Progression|23
5325931|NCT00266877|18339771|P2|Overall Study|Disease Progression|37
5325932|NCT00266877|18339772|P1|Overall Study|Disease Progression|72
5325933|NCT00266877|18339770|P3|Overall Study|Withdrawal by Subject|1
5325934|NCT00266877|18339771|P2|Overall Study|Withdrawal by Subject|1
5325935|NCT00266877|18339772|P1|Overall Study|Withdrawal by Subject|3
5325936|NCT00266877|18339770|P3|Overall Study|Physician Decision|1
5325937|NCT00266877|18339771|P2|Overall Study|Physician Decision|1
5325938|NCT00266877|18339772|P1|Overall Study|Physician Decision|2
5325939|NCT00266877|18339770|P3|Overall Study|Adverse Event|1
5325940|NCT00266877|18339771|P2|Overall Study|Adverse Event|4
5325941|NCT00266877|18339772|P1|Overall Study|Adverse Event|6
5325942|NCT00266877|18339770|P3|Overall Study|Death|1
5325943|NCT00266877|18339771|P2|Overall Study|Death|1
5325944|NCT00266877|18339772|P1|Overall Study|Death|1
5325945|NCT00266864|18339791|P2|Overall Study|Withdrawal by Subject|1
5325946|NCT00266864|18339792|P1|Overall Study|Withdrawal by Subject|1
5325947|NCT00266864|18339791|P2|Overall Study|Lost to Follow-up|1
5325948|NCT00266864|18339792|P1|Overall Study|Lost to Follow-up|4
5325949|NCT00266825|18339823|P2|Completed Follow-Up|Withdrawal by Subject|5
5325950|NCT00266825|18339824|P1|Completed Follow-Up|Withdrawal by Subject|11
5325951|NCT00266825|18339823|P2|Completed Follow-Up|Lost to Follow-up|19
5325952|NCT00266825|18339824|P1|Completed Follow-Up|Lost to Follow-up|14
5325953|NCT00266812|18339850|P2|Overall Study|Discontinued before starting study drug|0
5325954|NCT00266812|18339851|P1|Overall Study|Discontinued before starting study drug|4
5325955|NCT00266812|18339850|P2|Overall Study|Withdrawal by Subject|2
5325956|NCT00266812|18339851|P1|Overall Study|Withdrawal by Subject|0
5325957|NCT00266812|18339850|P2|Overall Study|Protocol Violation|1
5325958|NCT00266812|18339851|P1|Overall Study|Protocol Violation|0
5325959|NCT00266812|18339850|P2|Overall Study|Adverse Event|1
5325960|NCT00266812|18339851|P1|Overall Study|Adverse Event|3
5325961|NCT00266812|18339850|P2|Overall Study|Death|4
5325962|NCT00266812|18339851|P1|Overall Study|Death|5
5325963|NCT00266812|18339850|P2|Overall Study|Disease Progression|3
5325964|NCT00266812|18339851|P1|Overall Study|Disease Progression|9
5325965|NCT00266708|18339876|P2|Overall Study|Asthma|2
5325966|NCT00266708|18339877|P1|Overall Study|Asthma|0
5325967|NCT00266708|18339876|P2|Overall Study|Refused biopsy|6
5325968|NCT00266708|18339877|P1|Overall Study|Refused biopsy|3
5325969|NCT00266708|18339876|P2|Overall Study|No renal function|1
5325970|NCT00266708|18339877|P1|Overall Study|No renal function|1
5325971|NCT00266695|18339917|P1|Overall Study|Withdrawal by Subject|15
5325972|NCT00266695|18339917|P1|Overall Study|Lost to Follow-up|3
5325973|NCT00266695|18339917|P1|Overall Study|Physician Decision|1
5325974|NCT00266695|18339917|P1|Overall Study|Death|9
5325975|NCT00266695|18339917|P1|Overall Study|Adverse Event|1
5325976|NCT00266656|18339929|P2|Overall Study|Parent/Caregiver Decision|2
5325977|NCT00266656|18339930|P1|Overall Study|Parent/Caregiver Decision|1
5325978|NCT00266656|18339929|P2|Overall Study|Did Not Reach Final Height|8
5325979|NCT00266656|18339930|P1|Overall Study|Did Not Reach Final Height|4
5325980|NCT00266656|18339929|P2|Overall Study|Withdrawal by Subject|2
5325981|NCT00266656|18339930|P1|Overall Study|Withdrawal by Subject|4
5325982|NCT00266656|18339929|P2|Overall Study|Lost to Follow-up|1
5325983|NCT00266656|18339930|P1|Overall Study|Lost to Follow-up|4
5325984|NCT00266656|18339929|P2|Overall Study|Death|0
5325985|NCT00266656|18339930|P1|Overall Study|Death|1
5325986|NCT00266630|18339954|P2|Overall Study|Other|11
5325987|NCT00266630|18339955|P1|Overall Study|Other|19
5325988|NCT00266630|18339954|P2|Overall Study|Lost to Follow-up|0
5325989|NCT00266630|18339955|P1|Overall Study|Lost to Follow-up|1
5325990|NCT00266630|18339954|P2|Overall Study|Withdrawal by Subject|2
5325991|NCT00266630|18339955|P1|Overall Study|Withdrawal by Subject|10
5325992|NCT00266630|18339954|P2|Overall Study|Physician Decision|2
5325993|NCT00266630|18339955|P1|Overall Study|Physician Decision|1
5325994|NCT00266630|18339954|P2|Overall Study|Protocol Violation|3
5325995|NCT00266630|18339955|P1|Overall Study|Protocol Violation|1
5325996|NCT00266630|18339954|P2|Overall Study|Entry Criteria not met|0
5325997|NCT00266630|18339955|P1|Overall Study|Entry Criteria not met|1
5325998|NCT00266630|18339954|P2|Overall Study|Lack of Efficacy|4
5325999|NCT00266630|18339955|P1|Overall Study|Lack of Efficacy|1
5326000|NCT00266630|18339954|P2|Overall Study|Adverse Event|6
5326001|NCT00266630|18339955|P1|Overall Study|Adverse Event|8
5326002|NCT00266409|18339997|P4|Overall Study|Other|0
5326003|NCT00266409|18339998|P3|Overall Study|Other|2
5326004|NCT00266409|18339999|P2|Overall Study|Other|4
5326005|NCT00266409|18340000|P1|Overall Study|Other|7
5326006|NCT00266409|18339997|P4|Overall Study|Protocol Violation|2
5326007|NCT00266409|18339998|P3|Overall Study|Protocol Violation|4
5326008|NCT00266409|18339999|P2|Overall Study|Protocol Violation|3
5326009|NCT00266409|18340000|P1|Overall Study|Protocol Violation|5
5326010|NCT00266409|18339997|P4|Overall Study|Withdrawal by Subject|9
5326011|NCT00266409|18339998|P3|Overall Study|Withdrawal by Subject|3
5326012|NCT00266409|18339999|P2|Overall Study|Withdrawal by Subject|10
5326013|NCT00266409|18340000|P1|Overall Study|Withdrawal by Subject|6
5326014|NCT00266409|18339997|P4|Overall Study|Lost to Follow-up|8
5326015|NCT00266409|18339998|P3|Overall Study|Lost to Follow-up|6
5326016|NCT00266409|18339999|P2|Overall Study|Lost to Follow-up|21
5326017|NCT00266409|18340000|P1|Overall Study|Lost to Follow-up|18
5326018|NCT00266409|18339997|P4|Overall Study|Adverse Event|1
5326019|NCT00266409|18339998|P3|Overall Study|Adverse Event|1
5326020|NCT00266409|18339999|P2|Overall Study|Adverse Event|2
5326021|NCT00266409|18340000|P1|Overall Study|Adverse Event|7
5326022|NCT00266409|18339997|P4|Overall Study|Lack of Efficacy|2
5326023|NCT00266409|18339998|P3|Overall Study|Lack of Efficacy|1
5326024|NCT00266409|18339999|P2|Overall Study|Lack of Efficacy|6
5326025|NCT00266409|18340000|P1|Overall Study|Lack of Efficacy|2
5326026|NCT00266227|18340289|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
5326027|NCT00266227|18340290|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
5326028|NCT00266227|18340291|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
5326029|NCT00266227|18340289|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
5326030|NCT00266227|18340290|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
5326031|NCT00266227|18340291|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
5326032|NCT00266227|18340289|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
5326033|NCT00266227|18340290|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
5326034|NCT00266227|18340291|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
5326035|NCT00266227|18340289|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
5326036|NCT00266227|18340290|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
5326037|NCT00266227|18340291|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
5326038|NCT00266227|18340289|P3|Retreatment: Week 48 to Week 72|Death|0
5326039|NCT00266227|18340290|P2|Retreatment: Week 48 to Week 72|Death|1
5326040|NCT00266227|18340291|P1|Retreatment: Week 48 to Week 72|Death|1
5326041|NCT00266227|18340289|P3|Retreatment: Up to Week 48|Pregnancy|0
5326042|NCT00266227|18340290|P2|Retreatment: Up to Week 48|Pregnancy|0
5326043|NCT00266227|18340291|P1|Retreatment: Up to Week 48|Pregnancy|1
5326044|NCT00266227|18340289|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
5326045|NCT00266227|18340290|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
5326046|NCT00266227|18340291|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
5326047|NCT00266227|18340289|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
5326048|NCT00266227|18340290|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
5326049|NCT00266227|18340291|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
5326050|NCT00266227|18340289|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
5326051|NCT00266227|18340290|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
5326052|NCT00266227|18340291|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
5326053|NCT00266227|18340289|P3|Retreatment: Up to Week 48|Adverse Event|0
5326054|NCT00266227|18340290|P2|Retreatment: Up to Week 48|Adverse Event|7
5326055|NCT00266227|18340291|P1|Retreatment: Up to Week 48|Adverse Event|7
5326056|NCT00266227|18340289|P3|Retreatment: Up to Week 48|Death|0
5326057|NCT00266227|18340290|P2|Retreatment: Up to Week 48|Death|0
5326058|NCT00266227|18340291|P1|Retreatment: Up to Week 48|Death|1
5326059|NCT00266227|18340289|P3|Initial Treatment|Pregnancy|1
5326060|NCT00266227|18340290|P2|Initial Treatment|Pregnancy|0
5326061|NCT00266227|18340291|P1|Initial Treatment|Pregnancy|0
5326062|NCT00266227|18340289|P3|Initial Treatment|Physician decision to withdraw|12
5326063|NCT00266227|18340290|P2|Initial Treatment|Physician decision to withdraw|0
5326064|NCT00266227|18340291|P1|Initial Treatment|Physician decision to withdraw|0
5326065|NCT00266227|18340289|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
5326066|NCT00266227|18340290|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
5326067|NCT00266227|18340291|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
5326068|NCT00266227|18340289|P3|Initial Treatment|Lost to Follow-up|6
5326069|NCT00266227|18340290|P2|Initial Treatment|Lost to Follow-up|0
5326070|NCT00266227|18340291|P1|Initial Treatment|Lost to Follow-up|0
5326071|NCT00266227|18340289|P3|Initial Treatment|Adverse Event|13
5326072|NCT00266227|18340290|P2|Initial Treatment|Adverse Event|0
5326073|NCT00266227|18340291|P1|Initial Treatment|Adverse Event|0
5326074|NCT00266032|18340345|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
5326075|NCT00266032|18340346|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
5326076|NCT00266032|18340347|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
5326077|NCT00266032|18340345|P3|Open-label Safety Extension|Withdrawal by Subject|12
5326078|NCT00266032|18340346|P2|Open-label Safety Extension|Withdrawal by Subject|3
5326079|NCT00266032|18340347|P1|Open-label Safety Extension|Withdrawal by Subject|19
5326080|NCT00266032|18340345|P3|Open-label Safety Extension|Protocol Violation|2
5326081|NCT00266032|18340346|P2|Open-label Safety Extension|Protocol Violation|3
5326082|NCT00266032|18340347|P1|Open-label Safety Extension|Protocol Violation|1
5326083|NCT00266032|18340345|P3|Open-label Safety Extension|Pregnancy|2
5326084|NCT00266032|18340346|P2|Open-label Safety Extension|Pregnancy|1
5326085|NCT00266032|18340347|P1|Open-label Safety Extension|Pregnancy|4
5326086|NCT00266032|18340345|P3|Open-label Safety Extension|Lost to Follow-up|4
5326087|NCT00266032|18340346|P2|Open-label Safety Extension|Lost to Follow-up|5
5326088|NCT00266032|18340347|P1|Open-label Safety Extension|Lost to Follow-up|2
5326089|NCT00266032|18340345|P3|Open-label Safety Extension|Adverse Event|4
5326090|NCT00266032|18340346|P2|Open-label Safety Extension|Adverse Event|0
5326091|NCT00266032|18340347|P1|Open-label Safety Extension|Adverse Event|5
5326092|NCT00266032|18340345|P3|Treatment|patient moved/wish for pregnancy/no need|8
5326093|NCT00266032|18340346|P2|Treatment|patient moved/wish for pregnancy/no need|5
5326094|NCT00266032|18340347|P1|Treatment|patient moved/wish for pregnancy/no need|13
5326095|NCT00266032|18340345|P3|Treatment|Withdrawal by Subject|12
5326096|NCT00266032|18340346|P2|Treatment|Withdrawal by Subject|13
5326097|NCT00266032|18340347|P1|Treatment|Withdrawal by Subject|28
5326098|NCT00266032|18340345|P3|Treatment|Protocol Violation|13
5326099|NCT00266032|18340346|P2|Treatment|Protocol Violation|14
5326100|NCT00266032|18340347|P1|Treatment|Protocol Violation|6
5326101|NCT00266032|18340345|P3|Treatment|Pregnancy|2
5326102|NCT00266032|18340346|P2|Treatment|Pregnancy|2
5326103|NCT00266032|18340347|P1|Treatment|Pregnancy|3
5326104|NCT00266032|18340345|P3|Treatment|Lost to Follow-up|2
5326105|NCT00266032|18340346|P2|Treatment|Lost to Follow-up|4
5326106|NCT00266032|18340347|P1|Treatment|Lost to Follow-up|19
5326107|NCT00266032|18340345|P3|Treatment|Adverse Event|10
5326108|NCT00266032|18340346|P2|Treatment|Adverse Event|26
5326109|NCT00266032|18340347|P1|Treatment|Adverse Event|42
5326110|NCT00265941|18340382|P2|Overall Study|Lost to Follow-up|1
5326111|NCT00265941|18340383|P1|Overall Study|Lost to Follow-up|1
5326112|NCT00265941|18340382|P2|Overall Study|Protocol Violation|25
5326113|NCT00265941|18340383|P1|Overall Study|Protocol Violation|22
5326114|NCT00265889|18340415|P1|Overall Study|Insurance denied the request|3
5326115|NCT00265889|18340415|P1|Overall Study|Protocol Violation|1
5326116|NCT00265889|18340415|P1|Overall Study|Physician Decision|1
5326117|NCT00265785|18340442|P1|Overall Study|Did not receive protocol treatment|2
5326118|NCT00265785|18340442|P1|Overall Study|Ineligible|1
5326119|NCT00265785|18340442|P1|Overall Study|Not protocol specified|2
5326120|NCT00265785|18340442|P1|Overall Study|Progression/Relapse|15
5326121|NCT00265785|18340442|P1|Overall Study|Withdrawal by Subject|3
5326122|NCT00265785|18340442|P1|Overall Study|Adverse Event|4
5326123|NCT00265759|18340455|P4|Overall Study|Discontinued due to intolerability|1
5326124|NCT00265759|18340456|P3|Overall Study|Discontinued due to intolerability|0
5326125|NCT00265759|18340457|P2|Overall Study|Discontinued due to intolerability|0
5326126|NCT00265759|18340458|P1|Overall Study|Discontinued due to intolerability|0
5326127|NCT00265759|18340455|P4|Overall Study|Bilateral disease|2
5326128|NCT00265759|18340456|P3|Overall Study|Bilateral disease|0
5326129|NCT00265759|18340457|P2|Overall Study|Bilateral disease|0
5326130|NCT00265759|18340458|P1|Overall Study|Bilateral disease|0
5326131|NCT00265759|18340455|P4|Overall Study|Ineligible|1
5326132|NCT00265759|18340456|P3|Overall Study|Ineligible|0
5326133|NCT00265759|18340457|P2|Overall Study|Ineligible|0
5326134|NCT00265759|18340458|P1|Overall Study|Ineligible|0
5326135|NCT00265759|18340455|P4|Overall Study|Cancel|3
5326136|NCT00265759|18340456|P3|Overall Study|Cancel|0
5326137|NCT00265759|18340457|P2|Overall Study|Cancel|0
5326138|NCT00265759|18340458|P1|Overall Study|Cancel|0
5326139|NCT00265759|18340455|P4|Overall Study|Withdrawal by Subject|2
5326140|NCT00265759|18340456|P3|Overall Study|Withdrawal by Subject|2
5326141|NCT00265759|18340457|P2|Overall Study|Withdrawal by Subject|1
5326142|NCT00265759|18340458|P1|Overall Study|Withdrawal by Subject|0
5326143|NCT00265564|18340508|P2|Overall Study|met exclusion criteria|2
5326144|NCT00265564|18340509|P1|Overall Study|met exclusion criteria|5
5326145|NCT00265564|18340508|P2|Overall Study|Lost to Follow-up|7
5326146|NCT00265564|18340509|P1|Overall Study|Lost to Follow-up|5
5326147|NCT00265395|18340559|P2|Overall Study|Administrative|1
5326148|NCT00265395|18340560|P1|Overall Study|Administrative|0
5326149|NCT00265395|18340559|P2|Overall Study|Lack of Efficacy|1
5326150|NCT00265395|18340560|P1|Overall Study|Lack of Efficacy|0
5326151|NCT00265395|18340559|P2|Overall Study|Protocol Violation|2
5326152|NCT00265395|18340560|P1|Overall Study|Protocol Violation|2
5326153|NCT00265395|18340559|P2|Overall Study|Withdrawal by Subject|6
5326154|NCT00265395|18340560|P1|Overall Study|Withdrawal by Subject|1
5326155|NCT00265395|18340559|P2|Overall Study|Lost to Follow-up|1
5326156|NCT00265395|18340560|P1|Overall Study|Lost to Follow-up|2
5326157|NCT00265395|18340559|P2|Overall Study|Adverse Event|6
5326158|NCT00265395|18340560|P1|Overall Study|Adverse Event|3
5326159|NCT00265382|18340565|P1|Overall Study|Death|1
5326160|NCT00265382|18340565|P1|Overall Study|Study terminated by sponsor|94
5326161|NCT00265382|18340565|P1|Overall Study|Withdrawal by Subject|13
5326162|NCT00265382|18340565|P1|Overall Study|Miscellaneous|6
5326163|NCT00265382|18340565|P1|Overall Study|Lack of Efficacy|6
5326164|NCT00265382|18340565|P1|Overall Study|Lost to Follow-up|3
5326165|NCT00265382|18340565|P1|Overall Study|Laboratory Abnormality|1
5326166|NCT00265382|18340565|P1|Overall Study|Adverse Event|21
5326167|NCT00265343|18340585|P2|Overall Study|Other|3
5326168|NCT00265343|18340586|P1|Overall Study|Other|8
5326169|NCT00265343|18340585|P2|Overall Study|Withdrawal by Subject|9
5326170|NCT00265343|18340586|P1|Overall Study|Withdrawal by Subject|3
5326171|NCT00265343|18340585|P2|Overall Study|Adverse Event|7
5326172|NCT00265343|18340586|P1|Overall Study|Adverse Event|10
5326173|NCT00265330|18340594|P1|Overall Study|Protocol Violation|1
5326174|NCT00265330|18340594|P1|Overall Study|Withdrew Consent|1
5326175|NCT00265330|18340594|P1|Overall Study|Principal Investigators Request|1
5326176|NCT00265330|18340594|P1|Overall Study|Site Closed by Sponsor|1
5326177|NCT00265330|18340594|P1|Overall Study|Discharged from Unit for Long Term Care|1
5326178|NCT00265330|18340594|P1|Overall Study|Began Taking Formulary Geodon|1
5326179|NCT00265330|18340594|P1|Overall Study|Family Scheduling Conflicts|1
5326180|NCT00265330|18340594|P1|Overall Study|Lack of Efficacy|4
5326181|NCT00265330|18340594|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
5326182|NCT00265330|18340594|P1|Overall Study|Withdrawal by Subject|34
5326183|NCT00265330|18340594|P1|Overall Study|Lost to Follow-up|8
5326184|NCT00265330|18340594|P1|Overall Study|Adverse Event|41
5326185|NCT00265317|18340620|P4|Phase 2|Other|1
5326186|NCT00265317|18340621|P3|Phase 2|Other|1
5326187|NCT00265317|18340622|P2|Phase 2|Other|0
5326188|NCT00265317|18340623|P1|Phase 2|Other|0
5326189|NCT00265317|18340620|P4|Phase 2|Study terminated by sponsor|0
5326190|NCT00265317|18340621|P3|Phase 2|Study terminated by sponsor|1
5326191|NCT00265317|18340622|P2|Phase 2|Study terminated by sponsor|0
5326192|NCT00265317|18340623|P1|Phase 2|Study terminated by sponsor|0
5326193|NCT00265317|18340620|P4|Phase 2|Withdrawal/other than adverse event|1
5326194|NCT00265317|18340621|P3|Phase 2|Withdrawal/other than adverse event|2
5326195|NCT00265317|18340622|P2|Phase 2|Withdrawal/other than adverse event|0
5326196|NCT00265317|18340623|P1|Phase 2|Withdrawal/other than adverse event|0
5326197|NCT00265317|18340620|P4|Phase 2|Lost to Follow-up|1
5326198|NCT00265317|18340621|P3|Phase 2|Lost to Follow-up|0
5326199|NCT00265317|18340622|P2|Phase 2|Lost to Follow-up|0
5326200|NCT00265317|18340623|P1|Phase 2|Lost to Follow-up|0
5326201|NCT00265317|18340620|P4|Phase 2|Protocol Violation|4
5326202|NCT00265317|18340621|P3|Phase 2|Protocol Violation|1
5326203|NCT00265317|18340622|P2|Phase 2|Protocol Violation|0
5326204|NCT00265317|18340623|P1|Phase 2|Protocol Violation|0
5326205|NCT00265317|18340620|P4|Phase 2|Death|15
5326206|NCT00265317|18340621|P3|Phase 2|Death|12
5326207|NCT00265317|18340622|P2|Phase 2|Death|0
5326208|NCT00265317|18340623|P1|Phase 2|Death|0
5326209|NCT00265317|18340620|P4|Phase 2|Adverse Event|5
5326210|NCT00265317|18340621|P3|Phase 2|Adverse Event|7
5326211|NCT00265317|18340622|P2|Phase 2|Adverse Event|0
5326212|NCT00265317|18340623|P1|Phase 2|Adverse Event|0
5326213|NCT00265317|18340620|P4|Phase 2|Global deterioration of health status|0
5326214|NCT00265317|18340621|P3|Phase 2|Global deterioration of health status|3
5326215|NCT00265317|18340622|P2|Phase 2|Global deterioration of health status|0
5326216|NCT00265317|18340623|P1|Phase 2|Global deterioration of health status|0
5326217|NCT00265317|18340620|P4|Phase 2|Objective progression or relapse|38
5326218|NCT00265317|18340621|P3|Phase 2|Objective progression or relapse|37
5326219|NCT00265317|18340622|P2|Phase 2|Objective progression or relapse|0
5326220|NCT00265317|18340623|P1|Phase 2|Objective progression or relapse|0
5326221|NCT00265317|18340620|P4|Lead-In|Withdrawal/other than adverse event|0
5326222|NCT00265317|18340621|P3|Lead-In|Withdrawal/other than adverse event|0
5326223|NCT00265317|18340622|P2|Lead-In|Withdrawal/other than adverse event|0
5326224|NCT00265317|18340623|P1|Lead-In|Withdrawal/other than adverse event|1
5326225|NCT00265317|18340620|P4|Lead-In|Death|0
5326226|NCT00265317|18340621|P3|Lead-In|Death|0
5326227|NCT00265317|18340622|P2|Lead-In|Death|5
5326228|NCT00265317|18340623|P1|Lead-In|Death|3
5326229|NCT00265317|18340620|P4|Lead-In|Adverse Event|0
5326230|NCT00265317|18340621|P3|Lead-In|Adverse Event|0
5326231|NCT00265317|18340622|P2|Lead-In|Adverse Event|1
5326232|NCT00265317|18340623|P1|Lead-In|Adverse Event|2
5326233|NCT00265317|18340620|P4|Lead-In|Objective progression or relapse|0
5326234|NCT00265317|18340621|P3|Lead-In|Objective progression or relapse|0
5326235|NCT00265317|18340622|P2|Lead-In|Objective progression or relapse|11
5326236|NCT00265317|18340623|P1|Lead-In|Objective progression or relapse|6
5326237|NCT00265239|18340738|P2|Overall Study|Adverse Event|1
5326238|NCT00265239|18340739|P1|Overall Study|Adverse Event|2
5326239|NCT00265148|18340757|P2|Overall Study|Subject chose to change of the dose|0
5326240|NCT00265148|18340758|P1|Overall Study|Subject chose to change of the dose|1
5326241|NCT00265148|18340757|P2|Overall Study|Increasing frailty|1
5326242|NCT00265148|18340758|P1|Overall Study|Increasing frailty|0
5326243|NCT00265148|18340757|P2|Overall Study|Physician Decision|0
5326244|NCT00265148|18340758|P1|Overall Study|Physician Decision|1
5326245|NCT00265148|18340757|P2|Overall Study|Withdrawal by Subject|1
5326246|NCT00265148|18340758|P1|Overall Study|Withdrawal by Subject|2
5326247|NCT00265148|18340757|P2|Overall Study|Lost to Follow-up|1
5326248|NCT00265148|18340758|P1|Overall Study|Lost to Follow-up|0
5326249|NCT00265148|18340757|P2|Overall Study|Protocol Violation|2
5326250|NCT00265148|18340758|P1|Overall Study|Protocol Violation|3
5326251|NCT00265148|18340757|P2|Overall Study|Lack of Efficacy|2
5326252|NCT00265148|18340758|P1|Overall Study|Lack of Efficacy|0
5326253|NCT00265148|18340757|P2|Overall Study|Adverse Event|2
5326254|NCT00265148|18340758|P1|Overall Study|Adverse Event|2
5326255|NCT00265122|18340822|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
5326256|NCT00265122|18340823|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
5326257|NCT00265122|18340824|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
5326258|NCT00265122|18340825|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
5326259|NCT00265122|18340826|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
5326260|NCT00265122|18340827|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
5326261|NCT00265122|18340822|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
5326262|NCT00265122|18340823|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
5326263|NCT00265122|18340824|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
5326264|NCT00265122|18340825|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
5326265|NCT00265122|18340826|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
5326266|NCT00265122|18340827|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
5326267|NCT00265122|18340822|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
5326268|NCT00265122|18340823|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
5326269|NCT00265122|18340824|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
5326270|NCT00265122|18340825|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
5326271|NCT00265122|18340826|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
5326272|NCT00265122|18340827|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
5326273|NCT00265122|18340822|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
5326274|NCT00265122|18340823|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
5326275|NCT00265122|18340824|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
5326276|NCT00265122|18340825|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
5326277|NCT00265122|18340826|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
5326278|NCT00265122|18340827|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
5326279|NCT00265122|18340822|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5326280|NCT00265122|18340823|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5326281|NCT00265122|18340824|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
5326282|NCT00265122|18340825|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5326283|NCT00265122|18340826|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5326284|NCT00265122|18340827|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
5326285|NCT00265122|18340822|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
5326286|NCT00265122|18340823|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
5326287|NCT00265122|18340824|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
5326288|NCT00265122|18340825|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
5326289|NCT00265122|18340826|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
5326290|NCT00265122|18340827|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
5326291|NCT00265109|18340849|P1|Overall Study|Adverse Event|1
5326292|NCT00265109|18340849|P1|Overall Study|Withdrawal by Subject|5
5326293|NCT00265096|18340868|P3|Overall Study|Other|10
5326294|NCT00265096|18340869|P2|Overall Study|Other|19
5326295|NCT00265096|18340870|P1|Overall Study|Other|11
5326296|NCT00265096|18340868|P3|Overall Study|Unsatisfactory therapeutic effect|6
5326297|NCT00265096|18340869|P2|Overall Study|Unsatisfactory therapeutic effect|8
5326298|NCT00265096|18340870|P1|Overall Study|Unsatisfactory therapeutic effect|9
5326299|NCT00265096|18340868|P3|Overall Study|Death|2
5326300|NCT00265096|18340869|P2|Overall Study|Death|1
5326301|NCT00265096|18340870|P1|Overall Study|Death|0
5326302|NCT00265096|18340868|P3|Overall Study|Lost to Follow-up|3
5326303|NCT00265096|18340869|P2|Overall Study|Lost to Follow-up|5
5326304|NCT00265096|18340870|P1|Overall Study|Lost to Follow-up|2
5326305|NCT00265096|18340868|P3|Overall Study|Adverse Event|18
5326306|NCT00265096|18340869|P2|Overall Study|Adverse Event|18
5326307|NCT00265096|18340870|P1|Overall Study|Adverse Event|14
5326308|NCT00265083|18340902|P3|Overall Study|Other|9
5326309|NCT00265083|18340903|P2|Overall Study|Other|12
5326310|NCT00265083|18340904|P1|Overall Study|Other|1
5326311|NCT00265083|18340902|P3|Overall Study|Unsatisfactory therapeutic effect|14
5326312|NCT00265083|18340903|P2|Overall Study|Unsatisfactory therapeutic effect|13
5326313|NCT00265083|18340904|P1|Overall Study|Unsatisfactory therapeutic effect|8
5326314|NCT00265083|18340902|P3|Overall Study|Lost to Follow-up|4
5326315|NCT00265083|18340903|P2|Overall Study|Lost to Follow-up|4
5326316|NCT00265083|18340904|P1|Overall Study|Lost to Follow-up|3
5326317|NCT00265083|18340902|P3|Overall Study|Adverse Event|15
5326318|NCT00265083|18340903|P2|Overall Study|Adverse Event|13
5326319|NCT00265083|18340904|P1|Overall Study|Adverse Event|5
5326320|NCT00264875|18340925|P1|Overall Study|Withdrawal by Subject|7
5326321|NCT00264875|18340925|P1|Overall Study|Protocol Violation|11
5326322|NCT00264875|18340925|P1|Overall Study|Lost to Follow-up|6
5326323|NCT00264875|18340925|P1|Overall Study|Adverse Event|6
5326324|NCT00264849|18340931|P2|Overall Study|Administrative Problems|0
5326325|NCT00264849|18340932|P1|Overall Study|Administrative Problems|2
5326326|NCT00264849|18340931|P2|Overall Study|Death|1
5326327|NCT00264849|18340932|P1|Overall Study|Death|0
5326328|NCT00264849|18340931|P2|Overall Study|Lost to Follow-up|2
5326329|NCT00264849|18340932|P1|Overall Study|Lost to Follow-up|0
5326330|NCT00264849|18340931|P2|Overall Study|Lack of Efficacy|6
5326331|NCT00264849|18340932|P1|Overall Study|Lack of Efficacy|1
5326332|NCT00264849|18340931|P2|Overall Study|Protocol Violation|3
5326333|NCT00264849|18340932|P1|Overall Study|Protocol Violation|5
5326334|NCT00264849|18340931|P2|Overall Study|Withdrawal by Subject|11
5326335|NCT00264849|18340932|P1|Overall Study|Withdrawal by Subject|7
5326336|NCT00264849|18340931|P2|Overall Study|Adverse Event|2
5326337|NCT00264849|18340932|P1|Overall Study|Adverse Event|7
5326338|NCT00264810|18340966|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
5326339|NCT00264810|18340967|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
5326340|NCT00264810|18340966|P2|Open Label Evaluation Period|Death|2
5326341|NCT00264810|18340967|P1|Open Label Evaluation Period|Death|3
5326342|NCT00264810|18340966|P2|Open Label Evaluation Period|Explant due to infection|1
5326343|NCT00264810|18340967|P1|Open Label Evaluation Period|Explant due to infection|1
5326344|NCT00264810|18340966|P2|Blinded Evaluation Period|Explant due to infection|1
5326345|NCT00264810|18340967|P1|Blinded Evaluation Period|Explant due to infection|1
5326346|NCT00264810|18340966|P2|Stimulation Optimization Period|Death|1
5326347|NCT00264810|18340967|P1|Stimulation Optimization Period|Death|0
5326348|NCT00264810|18340966|P2|Stimulation Optimization Period|Withdrawal by Subject|0
5326349|NCT00264810|18340967|P1|Stimulation Optimization Period|Withdrawal by Subject|1
5326350|NCT00264810|18340966|P2|Baseline|Other|1
5326351|NCT00264810|18340967|P1|Baseline|Other|0
5326352|NCT00264810|18340966|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
5326353|NCT00264810|18340967|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
5326354|NCT00264810|18340966|P2|Baseline|Insufficient Seizure Frequency|2
5326355|NCT00264810|18340967|P1|Baseline|Insufficient Seizure Frequency|2
5326356|NCT00264810|18340966|P2|Baseline|Subject Compliance Failure|3
5326357|NCT00264810|18340967|P1|Baseline|Subject Compliance Failure|3
5326358|NCT00264810|18340966|P2|Baseline|Physician Decision|8
5326359|NCT00264810|18340967|P1|Baseline|Physician Decision|7
5326360|NCT00264810|18340966|P2|Baseline|Withdrawal by Subject|10
5326361|NCT00264810|18340967|P1|Baseline|Withdrawal by Subject|10
5326362|NCT00264797|18340977|P2|Overall Study|Other|4
5326363|NCT00264797|18340978|P1|Overall Study|Other|3
5326364|NCT00264797|18340977|P2|Overall Study|Feels treatment not necessary, not worki|1
5326365|NCT00264797|18340978|P1|Overall Study|Feels treatment not necessary, not worki|0
5326366|NCT00264797|18340977|P2|Overall Study|Pressure/advice from Outsiders|1
5326367|NCT00264797|18340978|P1|Overall Study|Pressure/advice from Outsiders|1
5326368|NCT00264797|18340977|P2|Overall Study|Incarceration|5
5326369|NCT00264797|18340978|P1|Overall Study|Incarceration|4
5326370|NCT00264797|18340977|P2|Overall Study|Practical Problems|3
5326371|NCT00264797|18340978|P1|Overall Study|Practical Problems|2
5326372|NCT00264797|18340977|P2|Overall Study|Moved from area|1
5326373|NCT00264797|18340978|P1|Overall Study|Moved from area|3
5326374|NCT00264797|18340977|P2|Overall Study|Lost to Follow-up|17
5326375|NCT00264797|18340978|P1|Overall Study|Lost to Follow-up|9
5326376|NCT00264797|18340977|P2|Overall Study|Withdrawal by Subject|11
5326377|NCT00264797|18340978|P1|Overall Study|Withdrawal by Subject|11
5326378|NCT00264576|18341000|P2|Overall Study|Lost to Follow-up|1
5326379|NCT00264576|18341001|P1|Overall Study|Lost to Follow-up|1
5326380|NCT00264550|18341025|P4|Overall Study|Other|9
5326381|NCT00264550|18341026|P3|Overall Study|Other|3
5326382|NCT00264550|18341027|P2|Overall Study|Other|7
5326383|NCT00264550|18341028|P1|Overall Study|Other|13
5326384|NCT00264550|18341025|P4|Overall Study|Discontinued oral study agent|0
5326385|NCT00264550|18341026|P3|Overall Study|Discontinued oral study agent|0
5326386|NCT00264550|18341027|P2|Overall Study|Discontinued oral study agent|1
5326387|NCT00264550|18341028|P1|Overall Study|Discontinued oral study agent|0
5326388|NCT00264550|18341025|P4|Overall Study|Unsatisfactory therapeutic effect|6
5326389|NCT00264550|18341026|P3|Overall Study|Unsatisfactory therapeutic effect|4
5326390|NCT00264550|18341027|P2|Overall Study|Unsatisfactory therapeutic effect|11
5326391|NCT00264550|18341028|P1|Overall Study|Unsatisfactory therapeutic effect|4
5326392|NCT00264550|18341025|P4|Overall Study|Adverse Event|14
5326393|NCT00264550|18341026|P3|Overall Study|Adverse Event|9
5326394|NCT00264550|18341027|P2|Overall Study|Adverse Event|18
5326395|NCT00264550|18341028|P1|Overall Study|Adverse Event|23
5326396|NCT00264550|18341025|P4|Overall Study|Lost to Follow-up|1
5326397|NCT00264550|18341026|P3|Overall Study|Lost to Follow-up|1
5326398|NCT00264550|18341027|P2|Overall Study|Lost to Follow-up|1
5326399|NCT00264550|18341028|P1|Overall Study|Lost to Follow-up|3
5326400|NCT00264550|18341025|P4|Overall Study|Death|0
5326401|NCT00264550|18341026|P3|Overall Study|Death|0
5326402|NCT00264550|18341027|P2|Overall Study|Death|3
5326403|NCT00264550|18341028|P1|Overall Study|Death|0
5326404|NCT00264537|18341067|P4|Overall Study|Not treated|0
5326405|NCT00264537|18341068|P3|Overall Study|Not treated|1
5326406|NCT00264537|18341069|P2|Overall Study|Not treated|2
5326407|NCT00264537|18341070|P1|Overall Study|Not treated|0
5326408|NCT00264537|18341067|P4|Overall Study|Other|11
5326409|NCT00264537|18341068|P3|Overall Study|Other|10
5326410|NCT00264537|18341069|P2|Overall Study|Other|11
5326411|NCT00264537|18341070|P1|Overall Study|Other|21
5326412|NCT00264537|18341067|P4|Overall Study|Unsatisfactory therapeutic effect|7
5326413|NCT00264537|18341068|P3|Overall Study|Unsatisfactory therapeutic effect|5
5326414|NCT00264537|18341069|P2|Overall Study|Unsatisfactory therapeutic effect|6
5326415|NCT00264537|18341070|P1|Overall Study|Unsatisfactory therapeutic effect|5
5326416|NCT00264537|18341067|P4|Overall Study|Adverse Event|34
5326417|NCT00264537|18341068|P3|Overall Study|Adverse Event|24
5326418|NCT00264537|18341069|P2|Overall Study|Adverse Event|32
5326419|NCT00264537|18341070|P1|Overall Study|Adverse Event|21
5326420|NCT00264537|18341067|P4|Overall Study|Lost to Follow-up|6
5326421|NCT00264537|18341068|P3|Overall Study|Lost to Follow-up|7
5326422|NCT00264537|18341069|P2|Overall Study|Lost to Follow-up|4
5326423|NCT00264537|18341070|P1|Overall Study|Lost to Follow-up|3
5326424|NCT00264537|18341067|P4|Overall Study|Death|2
5326425|NCT00264537|18341068|P3|Overall Study|Death|3
5326426|NCT00264537|18341069|P2|Overall Study|Death|3
5326427|NCT00264537|18341070|P1|Overall Study|Death|0
5326428|NCT00264498|18341102|P2|Crossover Treatment|Withdrawal by Subject|0
5326429|NCT00264498|18341103|P1|Crossover Treatment|Withdrawal by Subject|1
5326430|NCT00264498|18341102|P2|Crossover Treatment|Study closure|1
5326431|NCT00264498|18341103|P1|Crossover Treatment|Study closure|0
5326432|NCT00264498|18341102|P2|Crossover Treatment|Objective disease progression|5
5326433|NCT00264498|18341103|P1|Crossover Treatment|Objective disease progression|4
5326434|NCT00264498|18341102|P2|Crossover Treatment|Death|3
5326435|NCT00264498|18341103|P1|Crossover Treatment|Death|1
5326436|NCT00264498|18341102|P2|Randomized Treatment|Protocol Violation|0
5326437|NCT00264498|18341103|P1|Randomized Treatment|Protocol Violation|1
5326438|NCT00264498|18341102|P2|Randomized Treatment|Study Closure|0
5326439|NCT00264498|18341103|P1|Randomized Treatment|Study Closure|1
5326440|NCT00264498|18341102|P2|Randomized Treatment|Incorrectly randomized|0
5326441|NCT00264498|18341103|P1|Randomized Treatment|Incorrectly randomized|1
5326442|NCT00264498|18341102|P2|Randomized Treatment|Physician Decision|0
5326443|NCT00264498|18341103|P1|Randomized Treatment|Physician Decision|1
5326444|NCT00264498|18341102|P2|Randomized Treatment|Objective disease Progression|14
5326445|NCT00264498|18341103|P1|Randomized Treatment|Objective disease Progression|13
5326446|NCT00264498|18341102|P2|Randomized Treatment|Withdrawal by Subject|1
5326447|NCT00264498|18341103|P1|Randomized Treatment|Withdrawal by Subject|0
5326448|NCT00264498|18341102|P2|Randomized Treatment|Death|3
5326449|NCT00264498|18341103|P1|Randomized Treatment|Death|0
5326450|NCT00264303|18341126|P2|Overall Study|Various reasons listed in study report|7
5326451|NCT00264303|18341127|P1|Overall Study|Various reasons listed in study report|6
5326452|NCT00264303|18341126|P2|Overall Study|Withdrawal by Subject|3
5326453|NCT00264303|18341127|P1|Overall Study|Withdrawal by Subject|2
5326454|NCT00264303|18341126|P2|Overall Study|Lost to Follow-up|3
5326455|NCT00264303|18341127|P1|Overall Study|Lost to Follow-up|3
5326456|NCT00264303|18341126|P2|Overall Study|Lack of Efficacy|13
5326457|NCT00264303|18341127|P1|Overall Study|Lack of Efficacy|10
5326458|NCT00264303|18341126|P2|Overall Study|Adverse Event|3
5326459|NCT00264303|18341127|P1|Overall Study|Adverse Event|4
5326460|NCT00264290|18341145|P2|Intervention (8 Weeks)|Adverse Event|0
5326461|NCT00264290|18341146|P1|Intervention (8 Weeks)|Adverse Event|1
5326462|NCT00264238|18341162|P1|Overall Study|Protocol Violation|1
5326463|NCT00264147|18341174|P6|Treatment II Period|Pre-scheduled total hip replacement|1
5326464|NCT00264147|18341175|P5|Treatment II Period|Pre-scheduled total hip replacement|0
5326465|NCT00264147|18341176|P4|Treatment II Period|Pre-scheduled total hip replacement|0
5326466|NCT00264147|18341177|P3|Treatment II Period|Pre-scheduled total hip replacement|0
5326467|NCT00264147|18341178|P2|Treatment II Period|Pre-scheduled total hip replacement|0
5326468|NCT00264147|18341179|P1|Treatment II Period|Pre-scheduled total hip replacement|0
5326469|NCT00264147|18341174|P6|Treatment II Period|Withdrawal by Subject|2
5326470|NCT00264147|18341175|P5|Treatment II Period|Withdrawal by Subject|3
5326471|NCT00264147|18341176|P4|Treatment II Period|Withdrawal by Subject|0
5326472|NCT00264147|18341177|P3|Treatment II Period|Withdrawal by Subject|0
5326473|NCT00264147|18341178|P2|Treatment II Period|Withdrawal by Subject|0
5326474|NCT00264147|18341179|P1|Treatment II Period|Withdrawal by Subject|0
5326475|NCT00264147|18341174|P6|Treatment II Period|Lost to Follow-up|1
5326476|NCT00264147|18341175|P5|Treatment II Period|Lost to Follow-up|1
5326477|NCT00264147|18341176|P4|Treatment II Period|Lost to Follow-up|0
5326478|NCT00264147|18341177|P3|Treatment II Period|Lost to Follow-up|0
5326479|NCT00264147|18341178|P2|Treatment II Period|Lost to Follow-up|0
5326480|NCT00264147|18341179|P1|Treatment II Period|Lost to Follow-up|0
5326481|NCT00264147|18341174|P6|Treatment II Period|Lack of Efficacy|19
5326482|NCT00264147|18341175|P5|Treatment II Period|Lack of Efficacy|20
5326483|NCT00264147|18341176|P4|Treatment II Period|Lack of Efficacy|0
5326484|NCT00264147|18341177|P3|Treatment II Period|Lack of Efficacy|0
5326485|NCT00264147|18341178|P2|Treatment II Period|Lack of Efficacy|0
5326486|NCT00264147|18341179|P1|Treatment II Period|Lack of Efficacy|0
5326487|NCT00264147|18341174|P6|Treatment II Period|Laboratory Adverse Event|1
5326488|NCT00264147|18341175|P5|Treatment II Period|Laboratory Adverse Event|0
5326489|NCT00264147|18341176|P4|Treatment II Period|Laboratory Adverse Event|0
5326490|NCT00264147|18341177|P3|Treatment II Period|Laboratory Adverse Event|0
5326491|NCT00264147|18341178|P2|Treatment II Period|Laboratory Adverse Event|0
5326492|NCT00264147|18341179|P1|Treatment II Period|Laboratory Adverse Event|0
5326493|NCT00264147|18341174|P6|Treatment II Period|Adverse Event|9
5326494|NCT00264147|18341175|P5|Treatment II Period|Adverse Event|9
5326495|NCT00264147|18341176|P4|Treatment II Period|Adverse Event|0
5326496|NCT00264147|18341177|P3|Treatment II Period|Adverse Event|0
5326497|NCT00264147|18341178|P2|Treatment II Period|Adverse Event|0
5326498|NCT00264147|18341179|P1|Treatment II Period|Adverse Event|0
5326499|NCT00264147|18341174|P6|Treatment I Period|Reassigned to Treatment II Period|0
5326500|NCT00264147|18341175|P5|Treatment I Period|Reassigned to Treatment II Period|45
5326501|NCT00264147|18341176|P4|Treatment I Period|Reassigned to Treatment II Period|63
5326502|NCT00264147|18341177|P3|Treatment I Period|Reassigned to Treatment II Period|65
5326503|NCT00264147|18341178|P2|Treatment I Period|Reassigned to Treatment II Period|72
5326504|NCT00264147|18341179|P1|Treatment I Period|Reassigned to Treatment II Period|84
5326505|NCT00264147|18341174|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
5326506|NCT00264147|18341175|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
5326507|NCT00264147|18341176|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
5326508|NCT00264147|18341177|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
5326509|NCT00264147|18341178|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
5326510|NCT00264147|18341179|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
5326511|NCT00264147|18341174|P6|Treatment I Period|Patient out of town for an extended time|0
5326512|NCT00264147|18341175|P5|Treatment I Period|Patient out of town for an extended time|0
5326513|NCT00264147|18341176|P4|Treatment I Period|Patient out of town for an extended time|0
5326514|NCT00264147|18341177|P3|Treatment I Period|Patient out of town for an extended time|0
5326515|NCT00264147|18341178|P2|Treatment I Period|Patient out of town for an extended time|1
5326516|NCT00264147|18341179|P1|Treatment I Period|Patient out of town for an extended time|0
5326517|NCT00264147|18341174|P6|Treatment I Period|Withdrawal by Subject|0
5326518|NCT00264147|18341175|P5|Treatment I Period|Withdrawal by Subject|2
5326519|NCT00264147|18341176|P4|Treatment I Period|Withdrawal by Subject|2
5326520|NCT00264147|18341177|P3|Treatment I Period|Withdrawal by Subject|0
5326521|NCT00264147|18341178|P2|Treatment I Period|Withdrawal by Subject|0
5326522|NCT00264147|18341179|P1|Treatment I Period|Withdrawal by Subject|2
5326523|NCT00264147|18341174|P6|Treatment I Period|Protocol Violation|0
5326524|NCT00264147|18341175|P5|Treatment I Period|Protocol Violation|0
5326525|NCT00264147|18341176|P4|Treatment I Period|Protocol Violation|0
5326526|NCT00264147|18341177|P3|Treatment I Period|Protocol Violation|0
5326527|NCT00264147|18341178|P2|Treatment I Period|Protocol Violation|2
5326528|NCT00264147|18341179|P1|Treatment I Period|Protocol Violation|2
5326529|NCT00264147|18341174|P6|Treatment I Period|Lost to Follow-up|0
5326530|NCT00264147|18341175|P5|Treatment I Period|Lost to Follow-up|1
5326531|NCT00264147|18341176|P4|Treatment I Period|Lost to Follow-up|1
5326532|NCT00264147|18341177|P3|Treatment I Period|Lost to Follow-up|0
5326533|NCT00264147|18341178|P2|Treatment I Period|Lost to Follow-up|0
5326534|NCT00264147|18341179|P1|Treatment I Period|Lost to Follow-up|1
5326535|NCT00264147|18341174|P6|Treatment I Period|Lack of Efficacy|0
5326536|NCT00264147|18341175|P5|Treatment I Period|Lack of Efficacy|1
5326537|NCT00264147|18341176|P4|Treatment I Period|Lack of Efficacy|0
5326538|NCT00264147|18341177|P3|Treatment I Period|Lack of Efficacy|8
5326539|NCT00264147|18341178|P2|Treatment I Period|Lack of Efficacy|2
5326540|NCT00264147|18341179|P1|Treatment I Period|Lack of Efficacy|6
5326541|NCT00264147|18341174|P6|Treatment I Period|Laboratory Adverse Event|0
5326542|NCT00264147|18341175|P5|Treatment I Period|Laboratory Adverse Event|0
5326543|NCT00264147|18341176|P4|Treatment I Period|Laboratory Adverse Event|1
5326544|NCT00264147|18341177|P3|Treatment I Period|Laboratory Adverse Event|0
5326545|NCT00264147|18341178|P2|Treatment I Period|Laboratory Adverse Event|0
5326546|NCT00264147|18341179|P1|Treatment I Period|Laboratory Adverse Event|0
5326547|NCT00264147|18341174|P6|Treatment I Period|Adverse Event|0
5326548|NCT00264147|18341175|P5|Treatment I Period|Adverse Event|7
5326549|NCT00264147|18341176|P4|Treatment I Period|Adverse Event|5
5326550|NCT00264147|18341177|P3|Treatment I Period|Adverse Event|3
5326551|NCT00264147|18341178|P2|Treatment I Period|Adverse Event|6
5326552|NCT00264147|18341179|P1|Treatment I Period|Adverse Event|3
5326553|NCT00264004|18341222|P4|Overall Study|Not treated|2
5326554|NCT00264004|18341223|P3|Overall Study|Not treated|2
5326555|NCT00264004|18341224|P2|Overall Study|Not treated|0
5326556|NCT00264004|18341225|P1|Overall Study|Not treated|3
5326557|NCT00264004|18341222|P4|Overall Study|Cond. under inv. worsened|4
5326558|NCT00264004|18341223|P3|Overall Study|Cond. under inv. worsened|3
5326559|NCT00264004|18341224|P2|Overall Study|Cond. under inv. worsened|5
5326560|NCT00264004|18341225|P1|Overall Study|Cond. under inv. worsened|9
5326561|NCT00264004|18341222|P4|Overall Study|Development study specific disc. crit.|0
5326562|NCT00264004|18341223|P3|Overall Study|Development study specific disc. crit.|1
5326563|NCT00264004|18341224|P2|Overall Study|Development study specific disc. crit.|0
5326564|NCT00264004|18341225|P1|Overall Study|Development study specific disc. crit.|1
5326565|NCT00264004|18341222|P4|Overall Study|Other|3
5326566|NCT00264004|18341223|P3|Overall Study|Other|0
5326567|NCT00264004|18341224|P2|Overall Study|Other|2
5326568|NCT00264004|18341225|P1|Overall Study|Other|2
5326569|NCT00264004|18341222|P4|Overall Study|Withdrawal by Subject|2
5326570|NCT00264004|18341223|P3|Overall Study|Withdrawal by Subject|2
5326571|NCT00264004|18341224|P2|Overall Study|Withdrawal by Subject|1
5326572|NCT00264004|18341225|P1|Overall Study|Withdrawal by Subject|0
5326573|NCT00264004|18341222|P4|Overall Study|Adverse Event|4
5326574|NCT00264004|18341223|P3|Overall Study|Adverse Event|6
5326575|NCT00264004|18341224|P2|Overall Study|Adverse Event|3
5326576|NCT00264004|18341225|P1|Overall Study|Adverse Event|2
5326577|NCT00263887|18341253|P2|Overall Study|Lack of Efficacy|1
5326578|NCT00263887|18341254|P1|Overall Study|Lack of Efficacy|0
5326579|NCT00263887|18341253|P2|Overall Study|Disease progression|1
5326580|NCT00263887|18341254|P1|Overall Study|Disease progression|0
5326581|NCT00263887|18341253|P2|Overall Study|Adverse Event|2
5326582|NCT00263887|18341254|P1|Overall Study|Adverse Event|0
5326583|NCT00263887|18341253|P2|Overall Study|Too ill to attend visit|0
5326584|NCT00263887|18341254|P1|Overall Study|Too ill to attend visit|1
5326585|NCT00263887|18341253|P2|Overall Study|Lung transplantation|2
5326586|NCT00263887|18341254|P1|Overall Study|Lung transplantation|1
5326587|NCT00263887|18341253|P2|Overall Study|Withdrawal by Subject|1
5326588|NCT00263887|18341254|P1|Overall Study|Withdrawal by Subject|1
5326589|NCT00263757|18341262|P2|Overall Study|Adverse Event|3
5326590|NCT00263757|18341263|P1|Overall Study|Adverse Event|3
5326591|NCT00263757|18341262|P2|Overall Study|Screen failure|1
5326592|NCT00263757|18341263|P1|Overall Study|Screen failure|0
5326593|NCT00263757|18341262|P2|Overall Study|Withdrawal by Subject|4
5326594|NCT00263757|18341263|P1|Overall Study|Withdrawal by Subject|5
5326595|NCT00263666|18341275|P2|Overall Study|Withdrawal by Subject|1
5326596|NCT00263666|18341276|P1|Overall Study|Withdrawal by Subject|0
5326597|NCT00263666|18341275|P2|Overall Study|Lost to Follow-up|2
5326598|NCT00263666|18341276|P1|Overall Study|Lost to Follow-up|1
5326599|NCT00263666|18341275|P2|Overall Study|Adverse Event|8
5326600|NCT00263666|18341276|P1|Overall Study|Adverse Event|6
5326601|NCT00263588|18341329|P2|Overall Study|Sponsor terminated study|1
5326602|NCT00263588|18341330|P1|Overall Study|Sponsor terminated study|0
5326603|NCT00263588|18341329|P2|Overall Study|Investigator decision|15
5326604|NCT00263588|18341330|P1|Overall Study|Investigator decision|7
5326605|NCT00263588|18341329|P2|Overall Study|Protocol Violation|1
5326606|NCT00263588|18341330|P1|Overall Study|Protocol Violation|0
5326607|NCT00263588|18341329|P2|Overall Study|Withdrawal by Subject|4
5326608|NCT00263588|18341330|P1|Overall Study|Withdrawal by Subject|3
5326609|NCT00263588|18341329|P2|Overall Study|Lost to Follow-up|10
5326610|NCT00263588|18341330|P1|Overall Study|Lost to Follow-up|7
5326611|NCT00263588|18341329|P2|Overall Study|disease progression, coma, 1 unknown|11
5326612|NCT00263588|18341330|P1|Overall Study|disease progression, coma, 1 unknown|10
5326613|NCT00263588|18341329|P2|Overall Study|Death|90
5326614|NCT00263588|18341330|P1|Overall Study|Death|54
5326615|NCT00263575|18341353|P1|Maintence Period|Other|7
5326616|NCT00263575|18341353|P1|Maintence Period|Sponsor Decision|24
5326617|NCT00263575|18341353|P1|Maintence Period|Lost to Follow-up|1
5326618|NCT00263575|18341353|P1|Maintence Period|Physician Decision|6
5326619|NCT00263575|18341353|P1|Maintence Period|Lack of Efficacy|4
5326620|NCT00263575|18341353|P1|Maintence Period|Protocol Violation|4
5326621|NCT00263575|18341353|P1|Maintence Period|Withdrawal by Subject|8
5326622|NCT00263575|18341353|P1|Maintence Period|Adverse Event|23
5326623|NCT00263575|18341353|P1|Titration Period|Lack of Efficacy|6
5326624|NCT00263575|18341353|P1|Titration Period|Other|2
5326625|NCT00263575|18341353|P1|Titration Period|Sponsor Decision|2
5326626|NCT00263575|18341353|P1|Titration Period|Protocol Violation|9
5326627|NCT00263575|18341353|P1|Titration Period|Withdrawal by Subject|10
5326628|NCT00263575|18341353|P1|Titration Period|Adverse Event|14
5326629|NCT00263562|18341361|P2|Overall Study|Protocol Violation|0
5326630|NCT00263562|18341362|P1|Overall Study|Protocol Violation|3
5326631|NCT00263328|18341379|P3|Overall Study|Adverse Event|4
5326632|NCT00263328|18341380|P2|Overall Study|Adverse Event|1
5326633|NCT00263328|18341381|P1|Overall Study|Adverse Event|1
5326634|NCT00263328|18341379|P3|Overall Study|Other|1
5326635|NCT00263328|18341380|P2|Overall Study|Other|0
5326636|NCT00263328|18341381|P1|Overall Study|Other|3
5326637|NCT00263328|18341379|P3|Overall Study|Withdrawal by Subject|1
5326638|NCT00263328|18341380|P2|Overall Study|Withdrawal by Subject|0
5326639|NCT00263328|18341381|P1|Overall Study|Withdrawal by Subject|3
5326640|NCT00263328|18341379|P3|Overall Study|Lost to Follow-up|0
5326641|NCT00263328|18341380|P2|Overall Study|Lost to Follow-up|1
5326642|NCT00263328|18341381|P1|Overall Study|Lost to Follow-up|1
5326643|NCT00263328|18341379|P3|Overall Study|Death|1
5326644|NCT00263328|18341380|P2|Overall Study|Death|0
5326645|NCT00263328|18341381|P1|Overall Study|Death|0
5326646|NCT00263211|18341539|P2|Overall Study|Disease Progression|1
5326647|NCT00263211|18341540|P1|Overall Study|Disease Progression|0
5326648|NCT00263211|18341539|P2|Overall Study|Protocol Violation|0
5326649|NCT00263211|18341540|P1|Overall Study|Protocol Violation|1
5326650|NCT00263211|18341539|P2|Overall Study|Withdrawal by Subject|0
5326651|NCT00263211|18341540|P1|Overall Study|Withdrawal by Subject|3
5326652|NCT00263211|18341539|P2|Overall Study|Death|0
5326653|NCT00263211|18341540|P1|Overall Study|Death|1
5326654|NCT00262951|18341591|P1|Overall Study|Off treatment for other disease|1
5326655|NCT00262951|18341591|P1|Overall Study|Alternative treatment|3
5326656|NCT00262951|18341591|P1|Overall Study|Withdrawal by Subject|1
5326657|NCT00262951|18341591|P1|Overall Study|Death|1
5326658|NCT00262951|18341591|P1|Overall Study|Adverse Event|7
5326659|NCT00262951|18341591|P1|Overall Study|Progressive disease/relapse|3
5326660|NCT00262925|18341596|P1|Overall Study|Other|1
5326661|NCT00262925|18341596|P1|Overall Study|alternative therapy|1
5326662|NCT00262925|18341596|P1|Overall Study|Death|2
5326663|NCT00262925|18341596|P1|Overall Study|Adverse Event|4
5326664|NCT00262925|18341596|P1|Overall Study|Lack of Efficacy|3
5326665|NCT00262873|18341602|P1|Overall Study|Withdrawal by Subject|5
5326666|NCT00262873|18341602|P1|Overall Study|Adverse Event|3
5326667|NCT00262860|18341613|P1|Overall Study|Adverse Event|2
5326668|NCT00262847|18341622|P3|Overall Study|Did not receive study treatment|4
5326669|NCT00262847|18341623|P2|Overall Study|Did not receive study treatment|1
5326670|NCT00262847|18341624|P1|Overall Study|Did not receive study treatment|4
5326671|NCT00262847|18341622|P3|Overall Study|Other Reasons|27
5326672|NCT00262847|18341623|P2|Overall Study|Other Reasons|88
5326673|NCT00262847|18341624|P1|Overall Study|Other Reasons|79
5326674|NCT00262847|18341622|P3|Overall Study|Concomitant disease|4
5326675|NCT00262847|18341623|P2|Overall Study|Concomitant disease|2
5326676|NCT00262847|18341624|P1|Overall Study|Concomitant disease|3
5326677|NCT00262847|18341622|P3|Overall Study|Death|11
5326678|NCT00262847|18341623|P2|Overall Study|Death|8
5326679|NCT00262847|18341624|P1|Overall Study|Death|8
5326680|NCT00262847|18341622|P3|Overall Study|Adverse Event|108
5326681|NCT00262847|18341623|P2|Overall Study|Adverse Event|88
5326682|NCT00262847|18341624|P1|Overall Study|Adverse Event|74
5326683|NCT00262847|18341622|P3|Overall Study|Patient Refusal|47
5326684|NCT00262847|18341623|P2|Overall Study|Patient Refusal|52
5326685|NCT00262847|18341624|P1|Overall Study|Patient Refusal|41
5326686|NCT00262847|18341622|P3|Overall Study|Disease Progression|195
5326687|NCT00262847|18341623|P2|Overall Study|Disease Progression|274
5326688|NCT00262847|18341624|P1|Overall Study|Disease Progression|309
5326689|NCT00262834|18341643|P2|Overall Study|Surgery delayed/tissue not collected|4
5326690|NCT00262834|18341644|P1|Overall Study|Surgery delayed/tissue not collected|1
5326691|NCT00262821|18341657|P2|Overall Study|Inevaluable - inadequate data|4
5326692|NCT00262821|18341658|P1|Overall Study|Inevaluable - inadequate data|0
5326693|NCT00262821|18341657|P2|Overall Study|Ineligible - required test not done|4
5326694|NCT00262821|18341658|P1|Overall Study|Ineligible - required test not done|1
5326695|NCT00262821|18341657|P2|Overall Study|Ineligible - elevated creatinine|2
5326696|NCT00262821|18341658|P1|Overall Study|Ineligible - elevated creatinine|0
5326697|NCT00262821|18341657|P2|Overall Study|Ineligible - inadequate pathology|3
5326698|NCT00262821|18341658|P1|Overall Study|Ineligible - inadequate pathology|1
5326699|NCT00262821|18341657|P2|Overall Study|Ineligible - wrong primary|1
5326700|NCT00262821|18341658|P1|Overall Study|Ineligible - wrong primary|0
5326701|NCT00262821|18341657|P2|Overall Study|Ineligible - wrong cell type|2
5326702|NCT00262821|18341658|P1|Overall Study|Ineligible - wrong cell type|2
5326703|NCT00262821|18341657|P2|Overall Study|Ineligible - wrong stage|3
5326704|NCT00262821|18341658|P1|Overall Study|Ineligible - wrong stage|0
5326705|NCT00262743|18341670|P2|Overall Study|Disease progression|3
5326706|NCT00262743|18341671|P1|Overall Study|Disease progression|0
5326707|NCT00262743|18341670|P2|Overall Study|Adverse Event|9
5326708|NCT00262743|18341671|P1|Overall Study|Adverse Event|0
5326709|NCT00262600|18341706|P3|Overall Study|Other|62
5326710|NCT00262600|18341707|P2|Overall Study|Other|59
5326711|NCT00262600|18341708|P1|Overall Study|Other|58
5326712|NCT00262600|18341706|P3|Overall Study|Not Treated|24
5326713|NCT00262600|18341707|P2|Overall Study|Not Treated|17
5326714|NCT00262600|18341708|P1|Overall Study|Not Treated|32
5326715|NCT00262600|18341706|P3|Overall Study|Withdrawal by Subject|139
5326716|NCT00262600|18341707|P2|Overall Study|Withdrawal by Subject|145
5326717|NCT00262600|18341708|P1|Overall Study|Withdrawal by Subject|128
5326718|NCT00262600|18341706|P3|Overall Study|Lost to Follow-up|41
5326719|NCT00262600|18341707|P2|Overall Study|Lost to Follow-up|31
5326720|NCT00262600|18341708|P1|Overall Study|Lost to Follow-up|17
5326721|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
5326722|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
5326723|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
5326724|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
5326725|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Virologic failure|0
5326726|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Virologic failure|8
5326727|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Virologic failure|0
5326728|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Virologic failure|5
5326729|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Death|0
5326730|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Death|2
5326731|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Death|0
5326732|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Death|2
5326733|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Noncompliance|0
5326734|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Noncompliance|11
5326735|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Noncompliance|0
5326736|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Noncompliance|6
5326737|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
5326738|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
5326739|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
5326740|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
5326741|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
5326742|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
5326743|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
5326909|NCT00262028|18341929|P4|Overall Study|Withdrawal by Subject|5
5326744|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
5326745|NCT00262522|18341735|P4|Study Start Through 96 Weeks|Adverse Event|0
5326746|NCT00262522|18341736|P3|Study Start Through 96 Weeks|Adverse Event|16
5326747|NCT00262522|18341737|P2|Study Start Through 96 Weeks|Adverse Event|0
5326748|NCT00262522|18341738|P1|Study Start Through 96 Weeks|Adverse Event|20
5326749|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
5326750|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
5326751|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
5326752|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
5326753|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Virologic failure|0
5326754|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Virologic failure|4
5326755|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Virologic failure|0
5326756|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Virologic failure|2
5326757|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Death|0
5326758|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Death|1
5326759|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Death|0
5326760|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Death|2
5326761|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Noncompliance|0
5326762|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Noncompliance|8
5326763|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Noncompliance|0
5326764|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Noncompliance|3
5326765|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
5326766|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
5326767|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
5326768|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
5326769|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
5326770|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
5326771|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
5326772|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
5326773|NCT00262522|18341735|P4|Study Start Through 48 Weeks|Adverse Event|0
5326774|NCT00262522|18341736|P3|Study Start Through 48 Weeks|Adverse Event|10
5326775|NCT00262522|18341737|P2|Study Start Through 48 Weeks|Adverse Event|0
5326776|NCT00262522|18341738|P1|Study Start Through 48 Weeks|Adverse Event|16
5326777|NCT00262522|18341735|P4|Study Start Through 8 Weeks|Death|0
5326778|NCT00262522|18341736|P3|Study Start Through 8 Weeks|Death|0
5326779|NCT00262522|18341737|P2|Study Start Through 8 Weeks|Death|0
5326780|NCT00262522|18341738|P1|Study Start Through 8 Weeks|Death|1
5326781|NCT00262522|18341735|P4|Study Start Through 8 Weeks|Noncompliance|2
5326782|NCT00262522|18341736|P3|Study Start Through 8 Weeks|Noncompliance|2
5326783|NCT00262522|18341737|P2|Study Start Through 8 Weeks|Noncompliance|0
5326784|NCT00262522|18341738|P1|Study Start Through 8 Weeks|Noncompliance|0
5326785|NCT00262522|18341735|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
5326786|NCT00262522|18341736|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
5326787|NCT00262522|18341737|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
5326788|NCT00262522|18341738|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
5326789|NCT00262522|18341735|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
5326790|NCT00262522|18341736|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
5326791|NCT00262522|18341737|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
5326792|NCT00262522|18341738|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
5326793|NCT00262522|18341735|P4|Study Start Through 8 Weeks|Adverse Event|1
5326794|NCT00262522|18341736|P3|Study Start Through 8 Weeks|Adverse Event|3
5326795|NCT00262522|18341737|P2|Study Start Through 8 Weeks|Adverse Event|2
5326796|NCT00262522|18341738|P1|Study Start Through 8 Weeks|Adverse Event|1
5326797|NCT00262314|18341767|P1|Overall Study|Administrative withdrawal|30
5326798|NCT00262314|18341767|P1|Overall Study|Lost to Follow-up|70
5326799|NCT00262314|18341767|P1|Overall Study|Other|95
5326800|NCT00262314|18341767|P1|Overall Study|Patient's decision|92
5326801|NCT00262314|18341767|P1|Overall Study|Death|12
5326802|NCT00262314|18341767|P1|Overall Study|Changing physicians|38
5326803|NCT00262301|18341785|P3|Double-blind Phase|"worsening of HAE symptoms"|0
5326804|NCT00262301|18341786|P2|Double-blind Phase|"worsening of HAE symptoms"|1
5326805|NCT00262301|18341787|P1|Double-blind Phase|"worsening of HAE symptoms"|0
5326806|NCT00262301|18341785|P3|Double-blind Phase|Lost to Follow-up|0
5326807|NCT00262301|18341786|P2|Double-blind Phase|Lost to Follow-up|0
5326808|NCT00262301|18341787|P1|Double-blind Phase|Lost to Follow-up|1
5326809|NCT00262223|18341800|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
5326810|NCT00262223|18341801|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
5326811|NCT00262223|18341800|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
5326812|NCT00262223|18341801|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
5326813|NCT00262223|18341800|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
5326814|NCT00262223|18341801|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
5326815|NCT00262223|18341800|P2|Treatment Phase|Adverse Event|2
5326816|NCT00262223|18341801|P1|Treatment Phase|Adverse Event|1
5326817|NCT00262223|18341800|P2|Treatment Phase|Withdrawal by Subject|6
5326818|NCT00262223|18341801|P1|Treatment Phase|Withdrawal by Subject|3
5326819|NCT00262119|18341812|P3|Overall Study|Death|16
5326820|NCT00262119|18341813|P2|Overall Study|Death|19
5326821|NCT00262119|18341814|P1|Overall Study|Death|20
5326822|NCT00262119|18341812|P3|Overall Study|Lost to Follow-up|42
5326823|NCT00262119|18341813|P2|Overall Study|Lost to Follow-up|51
5326824|NCT00262119|18341814|P1|Overall Study|Lost to Follow-up|38
5326825|NCT00262080|18341834|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
5326826|NCT00262080|18341835|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
5326827|NCT00262080|18341836|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
5326828|NCT00262080|18341834|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
5326829|NCT00262080|18341835|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
5326830|NCT00262080|18341836|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
5326831|NCT00262080|18341834|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
5326832|NCT00262080|18341835|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
5326833|NCT00262080|18341836|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
5326834|NCT00262080|18341834|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
5326835|NCT00262080|18341835|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
5326836|NCT00262080|18341836|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
5326837|NCT00262080|18341834|P3|Repeat Dose Treatment Period|Adverse Event|0
5326838|NCT00262080|18341835|P2|Repeat Dose Treatment Period|Adverse Event|0
5326839|NCT00262080|18341836|P1|Repeat Dose Treatment Period|Adverse Event|1
5326840|NCT00262080|18341834|P3|Double Blind Treatment Period|Lost to Follow-up|0
5326841|NCT00262080|18341835|P2|Double Blind Treatment Period|Lost to Follow-up|0
5326842|NCT00262080|18341836|P1|Double Blind Treatment Period|Lost to Follow-up|1
5326843|NCT00262067|18341856|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
5326844|NCT00262067|18341857|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
5326845|NCT00262067|18341858|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
5326846|NCT00262067|18341859|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
5326847|NCT00262067|18341856|P4|Overall Study|Sponsor's Decision to Terminate Study|0
5326848|NCT00262067|18341857|P3|Overall Study|Sponsor's Decision to Terminate Study|0
5326849|NCT00262067|18341858|P2|Overall Study|Sponsor's Decision to Terminate Study|0
5326850|NCT00262067|18341859|P1|Overall Study|Sponsor's Decision to Terminate Study|1
5326851|NCT00262067|18341856|P4|Overall Study|Lost to Follow-up|5
5326852|NCT00262067|18341857|P3|Overall Study|Lost to Follow-up|7
5326853|NCT00262067|18341858|P2|Overall Study|Lost to Follow-up|4
5326854|NCT00262067|18341859|P1|Overall Study|Lost to Follow-up|5
5326855|NCT00262067|18341856|P4|Overall Study|Death|99
5326856|NCT00262067|18341857|P3|Overall Study|Death|186
5326857|NCT00262067|18341858|P2|Overall Study|Death|89
5326858|NCT00262067|18341859|P1|Overall Study|Death|190
5326859|NCT00262041|18341893|P3|Overall Study|Unable to classify|0
5326860|NCT00262041|18341894|P2|Overall Study|Unable to classify|0
5326861|NCT00262041|18341895|P1|Overall Study|Unable to classify|1
5326862|NCT00262041|18341893|P3|Overall Study|Lost to Follow-up|5
5326863|NCT00262041|18341894|P2|Overall Study|Lost to Follow-up|1
5326864|NCT00262041|18341895|P1|Overall Study|Lost to Follow-up|1
5326865|NCT00262041|18341893|P3|Overall Study|Withdrawal by Subject|1
5326866|NCT00262041|18341894|P2|Overall Study|Withdrawal by Subject|3
5326867|NCT00262041|18341895|P1|Overall Study|Withdrawal by Subject|0
5326868|NCT00262028|18341924|P9|Overall Study|Unable to classify|1
5326869|NCT00262028|18341925|P8|Overall Study|Unable to classify|0
5326870|NCT00262028|18341926|P7|Overall Study|Unable to classify|0
5326871|NCT00262028|18341927|P6|Overall Study|Unable to classify|0
5326872|NCT00262028|18341928|P5|Overall Study|Unable to classify|0
5326873|NCT00262028|18341929|P4|Overall Study|Unable to classify|0
5326874|NCT00262028|18341930|P3|Overall Study|Unable to classify|0
5326875|NCT00262028|18341931|P2|Overall Study|Unable to classify|3
5326876|NCT00262028|18341932|P1|Overall Study|Unable to classify|0
5326877|NCT00262028|18341924|P9|Overall Study|Protocol Violation|0
5326878|NCT00262028|18341925|P8|Overall Study|Protocol Violation|0
5326879|NCT00262028|18341926|P7|Overall Study|Protocol Violation|0
5326880|NCT00262028|18341927|P6|Overall Study|Protocol Violation|0
5326881|NCT00262028|18341928|P5|Overall Study|Protocol Violation|0
5326882|NCT00262028|18341929|P4|Overall Study|Protocol Violation|1
5326883|NCT00262028|18341930|P3|Overall Study|Protocol Violation|0
5326884|NCT00262028|18341931|P2|Overall Study|Protocol Violation|0
5326885|NCT00262028|18341932|P1|Overall Study|Protocol Violation|0
5326886|NCT00262028|18341924|P9|Overall Study|Administrative Reason|10
5326887|NCT00262028|18341925|P8|Overall Study|Administrative Reason|6
5326888|NCT00262028|18341926|P7|Overall Study|Administrative Reason|4
5326889|NCT00262028|18341927|P6|Overall Study|Administrative Reason|7
5326890|NCT00262028|18341928|P5|Overall Study|Administrative Reason|6
5326891|NCT00262028|18341929|P4|Overall Study|Administrative Reason|12
5326892|NCT00262028|18341930|P3|Overall Study|Administrative Reason|9
5326893|NCT00262028|18341931|P2|Overall Study|Administrative Reason|14
5326894|NCT00262028|18341932|P1|Overall Study|Administrative Reason|11
5326895|NCT00262028|18341924|P9|Overall Study|Lost to Follow-up|6
5326896|NCT00262028|18341925|P8|Overall Study|Lost to Follow-up|5
5326897|NCT00262028|18341926|P7|Overall Study|Lost to Follow-up|3
5326898|NCT00262028|18341927|P6|Overall Study|Lost to Follow-up|3
5326899|NCT00262028|18341928|P5|Overall Study|Lost to Follow-up|4
5326900|NCT00262028|18341929|P4|Overall Study|Lost to Follow-up|5
5326901|NCT00262028|18341930|P3|Overall Study|Lost to Follow-up|5
5326902|NCT00262028|18341931|P2|Overall Study|Lost to Follow-up|7
5326903|NCT00262028|18341932|P1|Overall Study|Lost to Follow-up|7
5326904|NCT00262028|18341924|P9|Overall Study|Withdrawal by Subject|2
5326905|NCT00262028|18341925|P8|Overall Study|Withdrawal by Subject|7
5326906|NCT00262028|18341926|P7|Overall Study|Withdrawal by Subject|5
5326907|NCT00262028|18341927|P6|Overall Study|Withdrawal by Subject|3
5326908|NCT00262028|18341928|P5|Overall Study|Withdrawal by Subject|2
5326910|NCT00262028|18341930|P3|Overall Study|Withdrawal by Subject|6
5326911|NCT00262028|18341931|P2|Overall Study|Withdrawal by Subject|3
5326912|NCT00262028|18341932|P1|Overall Study|Withdrawal by Subject|6
5326913|NCT00262002|18341994|P7|Overall Study|Unable to classify|2
5326914|NCT00262002|18341995|P6|Overall Study|Unable to classify|0
5326915|NCT00262002|18341996|P5|Overall Study|Unable to classify|0
5326916|NCT00262002|18341997|P4|Overall Study|Unable to classify|0
5326917|NCT00262002|18341998|P3|Overall Study|Unable to classify|0
5326918|NCT00262002|18341999|P2|Overall Study|Unable to classify|0
5326919|NCT00262002|18342000|P1|Overall Study|Unable to classify|0
5326920|NCT00262002|18341994|P7|Overall Study|Protocol Violation|2
5326921|NCT00262002|18341995|P6|Overall Study|Protocol Violation|3
5326922|NCT00262002|18341996|P5|Overall Study|Protocol Violation|5
5326923|NCT00262002|18341997|P4|Overall Study|Protocol Violation|2
5326924|NCT00262002|18341998|P3|Overall Study|Protocol Violation|0
5326925|NCT00262002|18341999|P2|Overall Study|Protocol Violation|2
5326926|NCT00262002|18342000|P1|Overall Study|Protocol Violation|3
5326927|NCT00262002|18341994|P7|Overall Study|Inapropriate enrollment|0
5326928|NCT00262002|18341995|P6|Overall Study|Inapropriate enrollment|0
5326929|NCT00262002|18341996|P5|Overall Study|Inapropriate enrollment|0
5326930|NCT00262002|18341997|P4|Overall Study|Inapropriate enrollment|0
5326931|NCT00262002|18341998|P3|Overall Study|Inapropriate enrollment|0
5326932|NCT00262002|18341999|P2|Overall Study|Inapropriate enrollment|1
5326933|NCT00262002|18342000|P1|Overall Study|Inapropriate enrollment|0
5326934|NCT00262002|18341994|P7|Overall Study|Lost to Follow-up|0
5326935|NCT00262002|18341995|P6|Overall Study|Lost to Follow-up|1
5326936|NCT00262002|18341996|P5|Overall Study|Lost to Follow-up|0
5326937|NCT00262002|18341997|P4|Overall Study|Lost to Follow-up|2
5326938|NCT00262002|18341998|P3|Overall Study|Lost to Follow-up|0
5326939|NCT00262002|18341999|P2|Overall Study|Lost to Follow-up|0
5326940|NCT00262002|18342000|P1|Overall Study|Lost to Follow-up|2
5326941|NCT00262002|18341994|P7|Overall Study|Withdrawal by Subject|2
5326942|NCT00262002|18341995|P6|Overall Study|Withdrawal by Subject|2
5326943|NCT00262002|18341996|P5|Overall Study|Withdrawal by Subject|2
5326944|NCT00262002|18341997|P4|Overall Study|Withdrawal by Subject|1
5326945|NCT00262002|18341998|P3|Overall Study|Withdrawal by Subject|0
5326946|NCT00262002|18341999|P2|Overall Study|Withdrawal by Subject|2
5326947|NCT00262002|18342000|P1|Overall Study|Withdrawal by Subject|4
5326948|NCT00262002|18341994|P7|Overall Study|Adverse Event|0
5326949|NCT00262002|18341995|P6|Overall Study|Adverse Event|1
5326950|NCT00262002|18341996|P5|Overall Study|Adverse Event|0
5326951|NCT00262002|18341997|P4|Overall Study|Adverse Event|0
5326952|NCT00262002|18341998|P3|Overall Study|Adverse Event|0
5326953|NCT00262002|18341999|P2|Overall Study|Adverse Event|1
5326954|NCT00262002|18342000|P1|Overall Study|Adverse Event|2
5326955|NCT00261950|18342093|P1|Overall Study|Protocol specified Criteria|11
5326956|NCT00261950|18342093|P1|Overall Study|Physician Decision|1
5326957|NCT00261950|18342093|P1|Overall Study|Other|1
5326958|NCT00261950|18342093|P1|Overall Study|Withdrawal by Subject|5
5326959|NCT00261950|18342093|P1|Overall Study|Death|6
5326960|NCT00261950|18342093|P1|Overall Study|Lost to Follow-up|2
5326961|NCT00261846|18342118|P12|Period 2: Part 2 (Efficacy)|Extension study|1
5326962|NCT00261846|18342119|P11|Period 2: Part 2 (Efficacy)|Extension study|1
5326963|NCT00261846|18342120|P10|Period 2: Part 2 (Efficacy)|Extension study|9
5326964|NCT00261846|18342121|P9|Period 2: Part 2 (Efficacy)|Extension study|5
5326965|NCT00261846|18342122|P8|Period 2: Part 2 (Efficacy)|Extension study|9
5326966|NCT00261846|18342123|P7|Period 2: Part 2 (Efficacy)|Extension study|4
5326967|NCT00261846|18342124|P6|Period 2: Part 2 (Efficacy)|Extension study|0
5326968|NCT00261846|18342125|P5|Period 2: Part 2 (Efficacy)|Extension study|27
5326969|NCT00261846|18342126|P4|Period 2: Part 2 (Efficacy)|Extension study|61
5326970|NCT00261846|18342127|P3|Period 2: Part 2 (Efficacy)|Extension study|0
5326971|NCT00261846|18342128|P2|Period 2: Part 2 (Efficacy)|Extension study|0
5326972|NCT00261846|18342129|P1|Period 2: Part 2 (Efficacy)|Extension study|0
5326973|NCT00261846|18342118|P12|Period 2: Part 2 (Efficacy)|Death|22
5326974|NCT00261846|18342119|P11|Period 2: Part 2 (Efficacy)|Death|44
5326975|NCT00261846|18342120|P10|Period 2: Part 2 (Efficacy)|Death|30
5326976|NCT00261846|18342121|P9|Period 2: Part 2 (Efficacy)|Death|3
5326977|NCT00261846|18342122|P8|Period 2: Part 2 (Efficacy)|Death|12
5326978|NCT00261846|18342123|P7|Period 2: Part 2 (Efficacy)|Death|10
5326979|NCT00261846|18342124|P6|Period 2: Part 2 (Efficacy)|Death|1
5326980|NCT00261846|18342125|P5|Period 2: Part 2 (Efficacy)|Death|7
5326981|NCT00261846|18342126|P4|Period 2: Part 2 (Efficacy)|Death|37
5326982|NCT00261846|18342127|P3|Period 2: Part 2 (Efficacy)|Death|0
5326983|NCT00261846|18342128|P2|Period 2: Part 2 (Efficacy)|Death|0
5326984|NCT00261846|18342129|P1|Period 2: Part 2 (Efficacy)|Death|0
5326985|NCT00261846|18342118|P12|Period 2: Part 2 (Efficacy)|Other|0
5326986|NCT00261846|18342119|P11|Period 2: Part 2 (Efficacy)|Other|0
5326987|NCT00261846|18342120|P10|Period 2: Part 2 (Efficacy)|Other|4
5326988|NCT00261846|18342121|P9|Period 2: Part 2 (Efficacy)|Other|4
5326989|NCT00261846|18342122|P8|Period 2: Part 2 (Efficacy)|Other|5
5326990|NCT00261846|18342123|P7|Period 2: Part 2 (Efficacy)|Other|1
5326991|NCT00261846|18342124|P6|Period 2: Part 2 (Efficacy)|Other|0
5326992|NCT00261846|18342125|P5|Period 2: Part 2 (Efficacy)|Other|4
5326993|NCT00261846|18342126|P4|Period 2: Part 2 (Efficacy)|Other|15
5326994|NCT00261846|18342127|P3|Period 2: Part 2 (Efficacy)|Other|0
5326995|NCT00261846|18342128|P2|Period 2: Part 2 (Efficacy)|Other|0
5326996|NCT00261846|18342129|P1|Period 2: Part 2 (Efficacy)|Other|0
5326997|NCT00261846|18342118|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5326998|NCT00261846|18342119|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5326999|NCT00261846|18342120|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5327000|NCT00261846|18342121|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
5327001|NCT00261846|18342122|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5327002|NCT00261846|18342123|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5327003|NCT00261846|18342124|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5327004|NCT00261846|18342125|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5327005|NCT00261846|18342126|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
5327006|NCT00261846|18342127|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5327007|NCT00261846|18342128|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5327008|NCT00261846|18342129|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5327009|NCT00261846|18342118|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5327010|NCT00261846|18342119|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5327011|NCT00261846|18342120|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
5327012|NCT00261846|18342121|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5327013|NCT00261846|18342122|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
5327014|NCT00261846|18342123|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
5327015|NCT00261846|18342124|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
5327016|NCT00261846|18342125|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
5327017|NCT00261846|18342126|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
5327018|NCT00261846|18342127|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5327019|NCT00261846|18342128|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5327020|NCT00261846|18342129|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5327021|NCT00261846|18342118|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327022|NCT00261846|18342119|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327023|NCT00261846|18342120|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327024|NCT00261846|18342121|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
5327025|NCT00261846|18342122|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327026|NCT00261846|18342123|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327027|NCT00261846|18342124|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327028|NCT00261846|18342125|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327029|NCT00261846|18342126|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
5327030|NCT00261846|18342127|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327031|NCT00261846|18342128|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327032|NCT00261846|18342129|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5327033|NCT00261846|18342118|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327034|NCT00261846|18342119|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327035|NCT00261846|18342120|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327036|NCT00261846|18342121|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327037|NCT00261846|18342122|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327038|NCT00261846|18342123|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327039|NCT00261846|18342124|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327040|NCT00261846|18342125|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327041|NCT00261846|18342126|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5327042|NCT00261846|18342127|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
5327043|NCT00261846|18342128|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
5327044|NCT00261846|18342129|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
5327045|NCT00261833|18342388|P2|Overall Study|Not interested in being participant|1
5327046|NCT00261833|18342389|P1|Overall Study|Not interested in being participant|0
5327047|NCT00261833|18342388|P2|Overall Study|Missing reason|0
5327048|NCT00261833|18342389|P1|Overall Study|Missing reason|1
5327049|NCT00261833|18342388|P2|Overall Study|Lung transplantation|1
5327050|NCT00261833|18342389|P1|Overall Study|Lung transplantation|1
5327051|NCT00261833|18342388|P2|Overall Study|Suspicion of pulmonary cancer|1
5327052|NCT00261833|18342389|P1|Overall Study|Suspicion of pulmonary cancer|0
5327053|NCT00261833|18342388|P2|Overall Study|Protocol Violation|1
5327054|NCT00261833|18342389|P1|Overall Study|Protocol Violation|0
5327055|NCT00261833|18342388|P2|Overall Study|Withdrawal by Subject|7
5327056|NCT00261833|18342389|P1|Overall Study|Withdrawal by Subject|5
5327057|NCT00261833|18342388|P2|Overall Study|Adverse Event|4
5327058|NCT00261833|18342389|P1|Overall Study|Adverse Event|1
5327059|NCT00261833|18342388|P2|Overall Study|Death|3
5327060|NCT00261833|18342389|P1|Overall Study|Death|1
5327061|NCT00261716|18342423|P2|Overall Study|Lost to Follow-up|2
5327062|NCT00261716|18342424|P1|Overall Study|Lost to Follow-up|0
5327063|NCT00261716|18342423|P2|Overall Study|Withdrawal by Subject|8
5327064|NCT00261716|18342424|P1|Overall Study|Withdrawal by Subject|6
5327065|NCT00261495|18342444|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5327066|NCT00261495|18342445|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
5327067|NCT00261495|18342444|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
5327068|NCT00261495|18342445|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
5327069|NCT00261495|18342444|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5327070|NCT00261495|18342445|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5327071|NCT00261495|18342444|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
5327226|NCT00260065|18342988|P1|Overall Study|Death|13
5327072|NCT00261495|18342445|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5327073|NCT00261495|18342444|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5327074|NCT00261495|18342445|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
5327075|NCT00261495|18342444|P2|Extension Phase (Weeks 24 to 52)|Other|2
5327076|NCT00261495|18342445|P1|Extension Phase (Weeks 24 to 52)|Other|4
5327077|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
5327078|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
5327079|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
5327080|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
5327081|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
5327082|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
5327083|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
5327084|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
5327085|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
5327086|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
5327087|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
5327088|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
5327089|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
5327090|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
5327091|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
5327092|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
5327093|NCT00261495|18342444|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
5327094|NCT00261495|18342445|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
5327095|NCT00261495|18342444|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
5327096|NCT00261495|18342445|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
5327097|NCT00261495|18342444|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
5327098|NCT00261495|18342445|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
5327099|NCT00261495|18342444|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
5327100|NCT00261495|18342445|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
5327101|NCT00261495|18342444|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
5327102|NCT00261495|18342445|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
5327103|NCT00261495|18342444|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
5327104|NCT00261495|18342445|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
5327105|NCT00261495|18342444|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
5327106|NCT00261495|18342445|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
5327107|NCT00261443|18342609|P3|4: Extension Phase|Lost to Follow-up|0
5327108|NCT00261443|18342610|P2|4: Extension Phase|Lost to Follow-up|1
5327109|NCT00261443|18342611|P1|4: Extension Phase|Lost to Follow-up|0
5327110|NCT00261443|18342609|P3|4: Extension Phase|Withdrawal by Subject|2
5327111|NCT00261443|18342610|P2|4: Extension Phase|Withdrawal by Subject|1
5327112|NCT00261443|18342611|P1|4: Extension Phase|Withdrawal by Subject|0
5327113|NCT00261443|18342609|P3|4: Extension Phase|Adverse Event|0
5327114|NCT00261443|18342610|P2|4: Extension Phase|Adverse Event|1
5327115|NCT00261443|18342611|P1|4: Extension Phase|Adverse Event|0
5327116|NCT00261443|18342609|P3|3: Assessment of Relapse|Other Reasons|3
5327117|NCT00261443|18342610|P2|3: Assessment of Relapse|Other Reasons|4
5327118|NCT00261443|18342611|P1|3: Assessment of Relapse|Other Reasons|0
5327119|NCT00261443|18342609|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
5327120|NCT00261443|18342610|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
5327121|NCT00261443|18342611|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
5327122|NCT00261443|18342609|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
5327123|NCT00261443|18342610|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
5327124|NCT00261443|18342611|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
5327125|NCT00261443|18342609|P3|3: Assessment of Relapse|Pregnancy|1
5327126|NCT00261443|18342610|P2|3: Assessment of Relapse|Pregnancy|2
5327127|NCT00261443|18342611|P1|3: Assessment of Relapse|Pregnancy|0
5327128|NCT00261443|18342609|P3|3: Assessment of Relapse|Poor/Noncompliance|3
5327129|NCT00261443|18342610|P2|3: Assessment of Relapse|Poor/Noncompliance|5
5327130|NCT00261443|18342611|P1|3: Assessment of Relapse|Poor/Noncompliance|0
5327131|NCT00261443|18342609|P3|3: Assessment of Relapse|Lost to Follow-up|6
5327132|NCT00261443|18342610|P2|3: Assessment of Relapse|Lost to Follow-up|7
5327133|NCT00261443|18342611|P1|3: Assessment of Relapse|Lost to Follow-up|0
5327134|NCT00261443|18342609|P3|3: Assessment of Relapse|Death|1
5327135|NCT00261443|18342610|P2|3: Assessment of Relapse|Death|0
5327136|NCT00261443|18342611|P1|3: Assessment of Relapse|Death|0
5327137|NCT00261443|18342609|P3|3: Assessment of Relapse|Withdrawal by Subject|15
5327138|NCT00261443|18342610|P2|3: Assessment of Relapse|Withdrawal by Subject|14
5327139|NCT00261443|18342611|P1|3: Assessment of Relapse|Withdrawal by Subject|0
5327140|NCT00261443|18342609|P3|3: Assessment of Relapse|Adverse Event|19
5327141|NCT00261443|18342610|P2|3: Assessment of Relapse|Adverse Event|15
5327142|NCT00261443|18342611|P1|3: Assessment of Relapse|Adverse Event|0
5327143|NCT00261443|18342609|P3|3: Assessment of Relapse|Lack of Efficacy|14
5327144|NCT00261443|18342610|P2|3: Assessment of Relapse|Lack of Efficacy|31
5327145|NCT00261443|18342611|P1|3: Assessment of Relapse|Lack of Efficacy|0
5327146|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Other Reasons|0
5327147|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Other Reasons|0
5327148|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Other Reasons|13
5327149|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
5327150|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
5327151|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
5327152|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
5327153|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
5327154|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
5327155|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Pregnancy|0
5327156|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Pregnancy|0
5327157|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Pregnancy|1
5327158|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
5327159|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
5327160|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
5327161|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
5327162|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
5327163|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
5327164|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
5327165|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
5327166|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
5327167|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Adverse Event|0
5327168|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Adverse Event|0
5327169|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Adverse Event|93
5327170|NCT00261443|18342609|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
5327171|NCT00261443|18342610|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
5327172|NCT00261443|18342611|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
5327173|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
5327174|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
5327175|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
5327176|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
5327177|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
5327178|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
5327179|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
5327180|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
5327181|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
5327182|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
5327183|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
5327184|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
5327185|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
5327186|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
5327187|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
5327188|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
5327189|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
5327190|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
5327191|NCT00261443|18342609|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
5327192|NCT00261443|18342610|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
5327193|NCT00261443|18342611|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
5327194|NCT00260832|18342896|P2|Overall Study|Protocol Violation|1
5327195|NCT00260832|18342897|P1|Overall Study|Protocol Violation|3
5327196|NCT00260832|18342896|P2|Overall Study|Other|7
5327197|NCT00260832|18342897|P1|Overall Study|Other|10
5327198|NCT00260832|18342896|P2|Overall Study|Death|62
5327199|NCT00260832|18342897|P1|Overall Study|Death|43
5327200|NCT00260832|18342896|P2|Overall Study|Physician Decision|9
5327201|NCT00260832|18342897|P1|Overall Study|Physician Decision|15
5327202|NCT00260832|18342896|P2|Overall Study|Withdrawal by Subject|17
5327203|NCT00260832|18342897|P1|Overall Study|Withdrawal by Subject|15
5327204|NCT00260832|18342896|P2|Overall Study|Progression|96
5327205|NCT00260832|18342897|P1|Overall Study|Progression|116
5327206|NCT00260832|18342896|P2|Overall Study|Adverse Event|19
5327207|NCT00260832|18342897|P1|Overall Study|Adverse Event|26
5327208|NCT00260533|18342926|P2|Overall Study|Other|3
5327209|NCT00260533|18342927|P1|Overall Study|Other|3
5327210|NCT00260429|18342935|P2|Overall Study|scheduled hand surgery|0
5327211|NCT00260429|18342936|P1|Overall Study|scheduled hand surgery|1
5327212|NCT00260429|18342935|P2|Overall Study|failure to follow appointments|0
5327213|NCT00260429|18342936|P1|Overall Study|failure to follow appointments|1
5327214|NCT00260208|18342944|P2|Overall Study|Missing|16
5327215|NCT00260208|18342945|P1|Overall Study|Missing|18
5327216|NCT00260208|18342944|P2|Overall Study|Death|10
5327217|NCT00260208|18342945|P1|Overall Study|Death|12
5327218|NCT00260208|18342944|P2|Overall Study|Lost to Follow-up|1
5327219|NCT00260208|18342945|P1|Overall Study|Lost to Follow-up|6
5327220|NCT00260208|18342944|P2|Overall Study|Subject withdrew consent|7
5327221|NCT00260208|18342945|P1|Overall Study|Subject withdrew consent|11
5327222|NCT00260065|18342988|P1|Overall Study|Medication Noncompliance|1
5327223|NCT00260065|18342988|P1|Overall Study|Not otherwise specified|8
5327224|NCT00260065|18342988|P1|Overall Study|Physician Decision|19
5327225|NCT00260065|18342988|P1|Overall Study|Withdrawal by Subject|13
5327227|NCT00260065|18342988|P1|Overall Study|Adverse Event|17
5327228|NCT00260065|18342988|P1|Overall Study|Progressive Disease|22
5327229|NCT00259857|18342995|P2|24 Months Treatment|Lost to Follow-up|3
5327230|NCT00259857|18342996|P1|24 Months Treatment|Lost to Follow-up|0
5327231|NCT00259857|18342995|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
5327232|NCT00259857|18342996|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
5327233|NCT00259740|18343014|P2|Overall Study|Requirement for alternative therapy|4
5327234|NCT00259740|18343015|P1|Overall Study|Requirement for alternative therapy|0
5327235|NCT00259740|18343014|P2|Overall Study|Other|0
5327236|NCT00259740|18343015|P1|Overall Study|Other|3
5327237|NCT00259740|18343014|P2|Overall Study|Ongoing|3
5327238|NCT00259740|18343015|P1|Overall Study|Ongoing|17
5327239|NCT00259740|18343014|P2|Overall Study|Disease progression|36
5327240|NCT00259740|18343015|P1|Overall Study|Disease progression|19
5327241|NCT00259740|18343014|P2|Overall Study|Death|1
5327242|NCT00259740|18343015|P1|Overall Study|Death|1
5327243|NCT00259740|18343014|P2|Overall Study|Withdrawal by Subject|6
5327244|NCT00259740|18343015|P1|Overall Study|Withdrawal by Subject|2
5327245|NCT00259740|18343014|P2|Overall Study|Adverse Event|2
5327246|NCT00259740|18343015|P1|Overall Study|Adverse Event|0
5327247|NCT00259740|18343014|P2|Overall Study|Physician Decision|1
5327248|NCT00259740|18343015|P1|Overall Study|Physician Decision|1
5327249|NCT00259649|18343025|P1|Overall Study|irregular menses|3
5327250|NCT00259649|18343025|P1|Overall Study|Lost to Follow-up|7
5327251|NCT00259610|18343033|P4|Overall Study|Serious Adverse Event|2
5327252|NCT00259610|18343034|P3|Overall Study|Serious Adverse Event|2
5327253|NCT00259610|18343035|P2|Overall Study|Serious Adverse Event|2
5327254|NCT00259610|18343036|P1|Overall Study|Serious Adverse Event|8
5327255|NCT00259610|18343033|P4|Overall Study|Adverse Event|2
5327256|NCT00259610|18343034|P3|Overall Study|Adverse Event|5
5327257|NCT00259610|18343035|P2|Overall Study|Adverse Event|4
5327258|NCT00259610|18343036|P1|Overall Study|Adverse Event|3
5327259|NCT00259610|18343033|P4|Overall Study|non medical reason|3
5327260|NCT00259610|18343034|P3|Overall Study|non medical reason|10
5327261|NCT00259610|18343035|P2|Overall Study|non medical reason|2
5327262|NCT00259610|18343036|P1|Overall Study|non medical reason|6
5327263|NCT00259610|18343033|P4|Overall Study|Death|0
5327264|NCT00259610|18343034|P3|Overall Study|Death|2
5327265|NCT00259610|18343035|P2|Overall Study|Death|1
5327266|NCT00259610|18343036|P1|Overall Study|Death|1
5327267|NCT00259610|18343033|P4|Overall Study|Physician Decision|2
5327268|NCT00259610|18343034|P3|Overall Study|Physician Decision|7
5327269|NCT00259610|18343035|P2|Overall Study|Physician Decision|4
5327270|NCT00259610|18343036|P1|Overall Study|Physician Decision|6
5327271|NCT00259610|18343033|P4|Overall Study|Lost to Follow-up|15
5327272|NCT00259610|18343034|P3|Overall Study|Lost to Follow-up|18
5327273|NCT00259610|18343035|P2|Overall Study|Lost to Follow-up|8
5327274|NCT00259610|18343036|P1|Overall Study|Lost to Follow-up|19
5327275|NCT00259610|18343033|P4|Overall Study|Withdrawal by Subject|19
5327276|NCT00259610|18343034|P3|Overall Study|Withdrawal by Subject|29
5327277|NCT00259610|18343035|P2|Overall Study|Withdrawal by Subject|25
5327278|NCT00259610|18343036|P1|Overall Study|Withdrawal by Subject|33
5327279|NCT00259298|18343050|P1|Overall Study|Physician Decision|2
5327280|NCT00259298|18343050|P1|Overall Study|Withdrawal by Subject|1
5327281|NCT00259272|18343068|P4|Overall Study|Lost to Follow-up|1
5327282|NCT00259272|18343069|P3|Overall Study|Lost to Follow-up|0
5327283|NCT00259272|18343070|P2|Overall Study|Lost to Follow-up|0
5327284|NCT00259272|18343071|P1|Overall Study|Lost to Follow-up|1
5327285|NCT00259272|18343068|P4|Overall Study|Withdrawal by Subject|7
5327286|NCT00259272|18343069|P3|Overall Study|Withdrawal by Subject|2
5327287|NCT00259272|18343070|P2|Overall Study|Withdrawal by Subject|2
5327288|NCT00259272|18343071|P1|Overall Study|Withdrawal by Subject|4
5327289|NCT00259272|18343068|P4|Overall Study|Sponsor Decision|0
5327290|NCT00259272|18343069|P3|Overall Study|Sponsor Decision|0
5327291|NCT00259272|18343070|P2|Overall Study|Sponsor Decision|1
5327292|NCT00259272|18343071|P1|Overall Study|Sponsor Decision|0
5327293|NCT00259272|18343068|P4|Overall Study|Protocol Violation|1
5327294|NCT00259272|18343069|P3|Overall Study|Protocol Violation|0
5327295|NCT00259272|18343070|P2|Overall Study|Protocol Violation|0
5327296|NCT00259272|18343071|P1|Overall Study|Protocol Violation|2
5327297|NCT00259272|18343068|P4|Overall Study|Physician Decision|3
5327298|NCT00259272|18343069|P3|Overall Study|Physician Decision|1
5327299|NCT00259272|18343070|P2|Overall Study|Physician Decision|2
5327300|NCT00259272|18343071|P1|Overall Study|Physician Decision|1
5327301|NCT00259272|18343068|P4|Overall Study|Lack of Efficacy|6
5327302|NCT00259272|18343069|P3|Overall Study|Lack of Efficacy|2
5327303|NCT00259272|18343070|P2|Overall Study|Lack of Efficacy|1
5327304|NCT00259272|18343071|P1|Overall Study|Lack of Efficacy|5
5327305|NCT00259272|18343068|P4|Overall Study|Adverse Event|3
5327306|NCT00259272|18343069|P3|Overall Study|Adverse Event|0
5327307|NCT00259272|18343070|P2|Overall Study|Adverse Event|1
5327308|NCT00259272|18343071|P1|Overall Study|Adverse Event|2
5327309|NCT00259012|18343167|P2|Overall Study|Protocol Violation|1
5327310|NCT00259012|18343168|P1|Overall Study|Protocol Violation|1
5327311|NCT00259012|18343167|P2|Overall Study|Lost to Follow-up|1
5327312|NCT00259012|18343168|P1|Overall Study|Lost to Follow-up|0
5327313|NCT00259012|18343167|P2|Overall Study|Physician Decision|1
5327314|NCT00259012|18343168|P1|Overall Study|Physician Decision|0
5327315|NCT00259012|18343167|P2|Overall Study|Withdrawal by Subject|0
5327316|NCT00259012|18343168|P1|Overall Study|Withdrawal by Subject|1
5327317|NCT00259012|18343167|P2|Overall Study|Adverse Event|1
5327318|NCT00259012|18343168|P1|Overall Study|Adverse Event|0
5327319|NCT00258960|18343200|P1|Overall Study|Mistake|2
5327320|NCT00258960|18343200|P1|Overall Study|Withdrawal by Subject|1
5327321|NCT00258960|18343200|P1|Overall Study|Physician Decision|1
5327322|NCT00258960|18343200|P1|Overall Study|Adverse Event|4
5327323|NCT00258960|18343200|P1|Overall Study|Disease Progression|7
5327324|NCT00258960|18343200|P1|Overall Study|Death|2
5327325|NCT00258895|18343216|P2|Overall Study|Withdrawal by Subject|0
5327326|NCT00258895|18343217|P1|Overall Study|Withdrawal by Subject|1
5327327|NCT00258895|18343216|P2|Overall Study|Protocol Violation|2
5327328|NCT00258895|18343217|P1|Overall Study|Protocol Violation|6
5327329|NCT00258895|18343216|P2|Overall Study|Lost to Follow-up|1
5327330|NCT00258895|18343217|P1|Overall Study|Lost to Follow-up|3
5327331|NCT00258856|18343253|P4|Overall Study|Non-compliance|1
5327332|NCT00258856|18343254|P3|Overall Study|Non-compliance|0
5327333|NCT00258856|18343255|P2|Overall Study|Non-compliance|0
5327334|NCT00258856|18343256|P1|Overall Study|Non-compliance|2
5327335|NCT00258856|18343253|P4|Overall Study|Lost to Follow-up|0
5327336|NCT00258856|18343254|P3|Overall Study|Lost to Follow-up|2
5327337|NCT00258856|18343255|P2|Overall Study|Lost to Follow-up|0
5327338|NCT00258856|18343256|P1|Overall Study|Lost to Follow-up|1
5327339|NCT00258674|18343297|P3|Overall Study|Death|34
5327340|NCT00258674|18343298|P2|Overall Study|Death|53
5327341|NCT00258674|18343299|P1|Overall Study|Death|32
5327342|NCT00258440|18343358|P3|Overall Study|Withdrawal by Subject|1
5327343|NCT00258440|18343359|P2|Overall Study|Withdrawal by Subject|0
5327344|NCT00258440|18343360|P1|Overall Study|Withdrawal by Subject|0
5327345|NCT00258154|18343398|P2|Overall Study|Patient Moved|1
5327346|NCT00258154|18343399|P1|Overall Study|Patient Moved|3
5327347|NCT00258154|18343398|P2|Overall Study|Withdrawal by Subject|4
5327348|NCT00258154|18343399|P1|Overall Study|Withdrawal by Subject|3
5327349|NCT00258154|18343398|P2|Overall Study|Protocol Violation|1
5327350|NCT00258154|18343399|P1|Overall Study|Protocol Violation|2
5327351|NCT00258154|18343398|P2|Overall Study|Lost to Follow-up|1
5327352|NCT00258154|18343399|P1|Overall Study|Lost to Follow-up|0
5327353|NCT00258154|18343398|P2|Overall Study|Adverse Event|0
5327354|NCT00258154|18343399|P1|Overall Study|Adverse Event|1
5327355|NCT00257920|18343494|P2|Period: Second Intervention|Other|1
5327356|NCT00257920|18343495|P1|Period: Second Intervention|Other|2
5327357|NCT00257920|18343494|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
5327358|NCT00257920|18343495|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
5327359|NCT00257725|18343518|P1|Overall Study|Adverse Event|3
5327360|NCT00257660|18343557|P2|Overall Study|No longer wanted to do blood draws|0
5327361|NCT00257660|18343558|P1|Overall Study|No longer wanted to do blood draws|1
5327362|NCT00257660|18343557|P2|Overall Study|PI & Subject Schedule Conflicts|0
5327363|NCT00257660|18343558|P1|Overall Study|PI & Subject Schedule Conflicts|1
5327364|NCT00257660|18343557|P2|Overall Study|Lost to Follow-up|0
5327365|NCT00257660|18343558|P1|Overall Study|Lost to Follow-up|1
5327366|NCT00257660|18343557|P2|Overall Study|Withdrawal by Subject|0
5327367|NCT00257660|18343558|P1|Overall Study|Withdrawal by Subject|2
5327368|NCT00257660|18343557|P2|Overall Study|Lack of Efficacy|23
5327369|NCT00257660|18343558|P1|Overall Study|Lack of Efficacy|5
5327370|NCT00257608|18343588|P3|Post Chemotherapy Phase|Not treated|7
5327371|NCT00257608|18343589|P2|Post Chemotherapy Phase|Not treated|4
5327372|NCT00257608|18343590|P1|Post Chemotherapy Phase|Not treated|0
5327373|NCT00257608|18343588|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
5327374|NCT00257608|18343589|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
5327375|NCT00257608|18343590|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
5327376|NCT00257608|18343588|P3|Post Chemotherapy Phase|Physician Decision|11
5327377|NCT00257608|18343589|P2|Post Chemotherapy Phase|Physician Decision|8
5327378|NCT00257608|18343590|P1|Post Chemotherapy Phase|Physician Decision|0
5327379|NCT00257608|18343588|P3|Post Chemotherapy Phase|Lost to Follow-up|1
5327380|NCT00257608|18343589|P2|Post Chemotherapy Phase|Lost to Follow-up|0
5327381|NCT00257608|18343590|P1|Post Chemotherapy Phase|Lost to Follow-up|0
5327382|NCT00257608|18343588|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
5327383|NCT00257608|18343589|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
5327384|NCT00257608|18343590|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
5327385|NCT00257608|18343588|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
5327386|NCT00257608|18343589|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
5327387|NCT00257608|18343590|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
5327388|NCT00257608|18343588|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
5327389|NCT00257608|18343589|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
5327390|NCT00257608|18343590|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
5327391|NCT00257608|18343588|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
5327392|NCT00257608|18343589|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
5327393|NCT00257608|18343590|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
5327394|NCT00257608|18343588|P3|Post Chemotherapy Phase|Disease progression|168
5327395|NCT00257608|18343589|P2|Post Chemotherapy Phase|Disease progression|204
5327396|NCT00257608|18343590|P1|Post Chemotherapy Phase|Disease progression|0
5327397|NCT00257608|18343588|P3|Post Chemotherapy Phase|Adverse Event|38
5327398|NCT00257608|18343589|P2|Post Chemotherapy Phase|Adverse Event|34
5327399|NCT00257608|18343590|P1|Post Chemotherapy Phase|Adverse Event|0
5327400|NCT00257608|18343588|P3|Chemotherapy Phase|Physician Decision|0
5327401|NCT00257608|18343589|P2|Chemotherapy Phase|Physician Decision|0
5327402|NCT00257608|18343590|P1|Chemotherapy Phase|Physician Decision|28
5327403|NCT00257608|18343588|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
5327404|NCT00257608|18343589|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
5327405|NCT00257608|18343590|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
5327406|NCT00257608|18343588|P3|Chemotherapy Phase|Patient's decision to discontinue|0
5327407|NCT00257608|18343589|P2|Chemotherapy Phase|Patient's decision to discontinue|0
5327408|NCT00257608|18343590|P1|Chemotherapy Phase|Patient's decision to discontinue|35
5327409|NCT00257608|18343588|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
5327410|NCT00257608|18343589|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
5327411|NCT00257608|18343590|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
5327412|NCT00257608|18343588|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
5327413|NCT00257608|18343589|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
5327414|NCT00257608|18343590|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
5327415|NCT00257608|18343588|P3|Chemotherapy Phase|Disease progression|0
5327416|NCT00257608|18343589|P2|Chemotherapy Phase|Disease progression|0
5327417|NCT00257608|18343590|P1|Chemotherapy Phase|Disease progression|139
5327418|NCT00257608|18343588|P3|Chemotherapy Phase|Adverse Event|0
5327419|NCT00257608|18343589|P2|Chemotherapy Phase|Adverse Event|0
5327420|NCT00257608|18343590|P1|Chemotherapy Phase|Adverse Event|138
5327421|NCT00257556|18343616|P2|Overall Study|other reason|6
5327422|NCT00257556|18343617|P1|Overall Study|other reason|4
5327423|NCT00257556|18343616|P2|Overall Study|Did not meet hCG criterion|0
5327424|NCT00257556|18343617|P1|Overall Study|Did not meet hCG criterion|3
5327425|NCT00257556|18343616|P2|Overall Study|Physician Decision|0
5327426|NCT00257556|18343617|P1|Overall Study|Physician Decision|6
5327427|NCT00257556|18343616|P2|Overall Study|Adverse Event|4
5327428|NCT00257556|18343617|P1|Overall Study|Adverse Event|1
5327429|NCT00257192|18343661|P2|Overall Study|Miscellaneous|4
5327430|NCT00257192|18343662|P1|Overall Study|Miscellaneous|0
5327431|NCT00257192|18343661|P2|Overall Study|Study terminated by sponsor|0
5327432|NCT00257192|18343662|P1|Overall Study|Study terminated by sponsor|1
5327433|NCT00257192|18343661|P2|Overall Study|Randomized but not treated|1
5327434|NCT00257192|18343662|P1|Overall Study|Randomized but not treated|0
5327435|NCT00257192|18343661|P2|Overall Study|Withdrawal by Subject|2
5327436|NCT00257192|18343662|P1|Overall Study|Withdrawal by Subject|14
5327437|NCT00257192|18343661|P2|Overall Study|Insufficient clinical response|18
5327438|NCT00257192|18343662|P1|Overall Study|Insufficient clinical response|18
5327439|NCT00257192|18343661|P2|Overall Study|Lost to Follow-up|3
5327440|NCT00257192|18343662|P1|Overall Study|Lost to Follow-up|3
5327441|NCT00257192|18343661|P2|Overall Study|Laboratory abnormality|1
5327442|NCT00257192|18343662|P1|Overall Study|Laboratory abnormality|1
5327443|NCT00257192|18343661|P2|Overall Study|Adverse Event|10
5327444|NCT00257192|18343662|P1|Overall Study|Adverse Event|21
5327445|NCT00257166|18343706|P2|Overall Study|Randomized, but not treated|0
5327446|NCT00257166|18343707|P1|Overall Study|Randomized, but not treated|1
5327447|NCT00257166|18343706|P2|Overall Study|Other|21
5327448|NCT00257166|18343707|P1|Overall Study|Other|16
5327449|NCT00257166|18343706|P2|Overall Study|Withdrawal by Subject|2
5327450|NCT00257166|18343707|P1|Overall Study|Withdrawal by Subject|9
5327451|NCT00257166|18343706|P2|Overall Study|Lost to Follow-up|1
5327452|NCT00257166|18343707|P1|Overall Study|Lost to Follow-up|8
5327453|NCT00257166|18343706|P2|Overall Study|Laboratory abnormality|0
5327454|NCT00257166|18343707|P1|Overall Study|Laboratory abnormality|1
5327455|NCT00257166|18343706|P2|Overall Study|Adverse Event|13
5327456|NCT00257166|18343707|P1|Overall Study|Adverse Event|18
5327457|NCT00257010|18343719|P1|Overall Study|no headache reported|9
5327458|NCT00257010|18343719|P1|Overall Study|various|11
5327459|NCT00257010|18343719|P1|Overall Study|Adverse Event|10
5327460|NCT00257010|18343719|P1|Overall Study|Withdrawal by Subject|34
5327461|NCT00257010|18343719|P1|Overall Study|Lost to Follow-up|53
5327462|NCT00257010|18343719|P1|Overall Study|Lack of Efficacy|11
5327463|NCT00256997|18343730|P2|Overall Study|Investigator Withdrew Participant|1
5327464|NCT00256997|18343731|P1|Overall Study|Investigator Withdrew Participant|2
5327465|NCT00256997|18343730|P2|Overall Study|Participant Non-compliant|6
5327466|NCT00256997|18343731|P1|Overall Study|Participant Non-compliant|3
5327467|NCT00256997|18343730|P2|Overall Study|End of Study (As Per Sponsor)|24
5327468|NCT00256997|18343731|P1|Overall Study|End of Study (As Per Sponsor)|12
5327469|NCT00256997|18343730|P2|Overall Study|Other|8
5327470|NCT00256997|18343731|P1|Overall Study|Other|5
5327471|NCT00256997|18343730|P2|Overall Study|Started but not treated|0
5327472|NCT00256997|18343731|P1|Overall Study|Started but not treated|2
5327473|NCT00256997|18343730|P2|Overall Study|Withdrawal by Subject|3
5327474|NCT00256997|18343731|P1|Overall Study|Withdrawal by Subject|13
5327475|NCT00256997|18343730|P2|Overall Study|Lost to Follow-up|5
5327476|NCT00256997|18343731|P1|Overall Study|Lost to Follow-up|3
5327477|NCT00256997|18343730|P2|Overall Study|Adverse Event|0
5327478|NCT00256997|18343731|P1|Overall Study|Adverse Event|4
5327479|NCT00256997|18343730|P2|Overall Study|Death|0
5327480|NCT00256997|18343731|P1|Overall Study|Death|2
5327481|NCT00256997|18343730|P2|Overall Study|Lack of Efficacy|4
5327482|NCT00256997|18343731|P1|Overall Study|Lack of Efficacy|1
5327483|NCT00256997|18343730|P2|Overall Study|Protocol Violation|4
5327484|NCT00256997|18343731|P1|Overall Study|Protocol Violation|1
5327485|NCT00256867|18343773|P8|Overall Study|Withdrawal by participant|0
5327486|NCT00256867|18343774|P7|Overall Study|Withdrawal by participant|0
5327487|NCT00256867|18343775|P6|Overall Study|Withdrawal by participant|1
5327488|NCT00256867|18343776|P5|Overall Study|Withdrawal by participant|0
5327489|NCT00256867|18343777|P4|Overall Study|Withdrawal by participant|0
5327490|NCT00256867|18343778|P3|Overall Study|Withdrawal by participant|0
5327491|NCT00256867|18343779|P2|Overall Study|Withdrawal by participant|0
5327492|NCT00256867|18343780|P1|Overall Study|Withdrawal by participant|0
5327493|NCT00256867|18343773|P8|Overall Study|Participant out of assessment window|0
5327494|NCT00256867|18343774|P7|Overall Study|Participant out of assessment window|0
5327495|NCT00256867|18343775|P6|Overall Study|Participant out of assessment window|0
5327496|NCT00256867|18343776|P5|Overall Study|Participant out of assessment window|0
5327497|NCT00256867|18343777|P4|Overall Study|Participant out of assessment window|0
5327498|NCT00256867|18343778|P3|Overall Study|Participant out of assessment window|1
5327499|NCT00256867|18343779|P2|Overall Study|Participant out of assessment window|0
5327500|NCT00256867|18343780|P1|Overall Study|Participant out of assessment window|0
5327501|NCT00256867|18343773|P8|Overall Study|Participant travelled Overseas|0
5327502|NCT00256867|18343774|P7|Overall Study|Participant travelled Overseas|0
5327503|NCT00256867|18343775|P6|Overall Study|Participant travelled Overseas|0
5327504|NCT00256867|18343776|P5|Overall Study|Participant travelled Overseas|0
5327505|NCT00256867|18343777|P4|Overall Study|Participant travelled Overseas|0
5327506|NCT00256867|18343778|P3|Overall Study|Participant travelled Overseas|0
5327507|NCT00256867|18343779|P2|Overall Study|Participant travelled Overseas|1
5327508|NCT00256867|18343780|P1|Overall Study|Participant travelled Overseas|0
5327509|NCT00256867|18343773|P8|Overall Study|Non-compliance with study medication|1
5327510|NCT00256867|18343774|P7|Overall Study|Non-compliance with study medication|0
5327511|NCT00256867|18343775|P6|Overall Study|Non-compliance with study medication|0
5327512|NCT00256867|18343776|P5|Overall Study|Non-compliance with study medication|0
5327513|NCT00256867|18343777|P4|Overall Study|Non-compliance with study medication|0
5327514|NCT00256867|18343778|P3|Overall Study|Non-compliance with study medication|0
5327515|NCT00256867|18343779|P2|Overall Study|Non-compliance with study medication|0
5327516|NCT00256867|18343780|P1|Overall Study|Non-compliance with study medication|0
5327517|NCT00256867|18343773|P8|Overall Study|Investigator's Decision|0
5327518|NCT00256867|18343774|P7|Overall Study|Investigator's Decision|0
5327519|NCT00256867|18343775|P6|Overall Study|Investigator's Decision|0
5327520|NCT00256867|18343776|P5|Overall Study|Investigator's Decision|1
5327521|NCT00256867|18343777|P4|Overall Study|Investigator's Decision|0
5327522|NCT00256867|18343778|P3|Overall Study|Investigator's Decision|0
5327523|NCT00256867|18343779|P2|Overall Study|Investigator's Decision|0
5327524|NCT00256867|18343780|P1|Overall Study|Investigator's Decision|0
5327525|NCT00256867|18343773|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
5327526|NCT00256867|18343774|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
5327527|NCT00256867|18343775|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
5327528|NCT00256867|18343776|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
5327529|NCT00256867|18343777|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
5327530|NCT00256867|18343778|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
5327531|NCT00256867|18343779|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
5327532|NCT00256867|18343780|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
5327533|NCT00256867|18343773|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327534|NCT00256867|18343774|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327535|NCT00256867|18343775|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327536|NCT00256867|18343776|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327537|NCT00256867|18343777|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327538|NCT00256867|18343778|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327539|NCT00256867|18343779|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
5327540|NCT00256867|18343780|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
5327541|NCT00256867|18343773|P8|Overall Study|Withdrawal by Subject|2
5327542|NCT00256867|18343774|P7|Overall Study|Withdrawal by Subject|3
5327543|NCT00256867|18343775|P6|Overall Study|Withdrawal by Subject|2
5327544|NCT00256867|18343776|P5|Overall Study|Withdrawal by Subject|2
5327545|NCT00256867|18343777|P4|Overall Study|Withdrawal by Subject|1
5327546|NCT00256867|18343778|P3|Overall Study|Withdrawal by Subject|1
5327547|NCT00256867|18343779|P2|Overall Study|Withdrawal by Subject|0
5327548|NCT00256867|18343780|P1|Overall Study|Withdrawal by Subject|0
5327549|NCT00256867|18343773|P8|Overall Study|Protocol Violation|1
5327550|NCT00256867|18343774|P7|Overall Study|Protocol Violation|0
5327551|NCT00256867|18343775|P6|Overall Study|Protocol Violation|1
5327552|NCT00256867|18343776|P5|Overall Study|Protocol Violation|0
5327553|NCT00256867|18343777|P4|Overall Study|Protocol Violation|1
5327554|NCT00256867|18343778|P3|Overall Study|Protocol Violation|0
5327555|NCT00256867|18343779|P2|Overall Study|Protocol Violation|0
5327556|NCT00256867|18343780|P1|Overall Study|Protocol Violation|0
5327557|NCT00256867|18343773|P8|Overall Study|Lost to Follow-up|2
5327558|NCT00256867|18343774|P7|Overall Study|Lost to Follow-up|1
5327559|NCT00256867|18343775|P6|Overall Study|Lost to Follow-up|0
5327560|NCT00256867|18343776|P5|Overall Study|Lost to Follow-up|2
5327561|NCT00256867|18343777|P4|Overall Study|Lost to Follow-up|3
5327562|NCT00256867|18343778|P3|Overall Study|Lost to Follow-up|2
5327563|NCT00256867|18343779|P2|Overall Study|Lost to Follow-up|2
5327564|NCT00256867|18343780|P1|Overall Study|Lost to Follow-up|2
5327565|NCT00256867|18343773|P8|Overall Study|Adverse Event|4
5327566|NCT00256867|18343774|P7|Overall Study|Adverse Event|1
5327567|NCT00256867|18343775|P6|Overall Study|Adverse Event|2
5327568|NCT00256867|18343776|P5|Overall Study|Adverse Event|2
5327569|NCT00256867|18343777|P4|Overall Study|Adverse Event|1
5327570|NCT00256867|18343778|P3|Overall Study|Adverse Event|1
5327571|NCT00256867|18343779|P2|Overall Study|Adverse Event|1
5327572|NCT00256867|18343780|P1|Overall Study|Adverse Event|0
5327573|NCT00256854|18343870|P6|Overall Study|Not compliant with the study drug|0
5327574|NCT00256854|18343871|P5|Overall Study|Not compliant with the study drug|1
5327575|NCT00256854|18343872|P4|Overall Study|Not compliant with the study drug|0
5327576|NCT00256854|18343873|P3|Overall Study|Not compliant with the study drug|0
5327577|NCT00256854|18343874|P2|Overall Study|Not compliant with the study drug|0
5327578|NCT00256854|18343875|P1|Overall Study|Not compliant with the study drug|0
5327579|NCT00256854|18343870|P6|Overall Study|Adverse Event|1
5327580|NCT00256854|18343871|P5|Overall Study|Adverse Event|0
5327581|NCT00256854|18343872|P4|Overall Study|Adverse Event|2
5327582|NCT00256854|18343873|P3|Overall Study|Adverse Event|2
5327583|NCT00256854|18343874|P2|Overall Study|Adverse Event|0
5327584|NCT00256854|18343875|P1|Overall Study|Adverse Event|0
5327585|NCT00256854|18343870|P6|Overall Study|Protocol Violation|0
5327586|NCT00256854|18343871|P5|Overall Study|Protocol Violation|0
5327587|NCT00256854|18343872|P4|Overall Study|Protocol Violation|1
5327588|NCT00256854|18343873|P3|Overall Study|Protocol Violation|1
5327589|NCT00256854|18343874|P2|Overall Study|Protocol Violation|1
5327590|NCT00256854|18343875|P1|Overall Study|Protocol Violation|0
5327591|NCT00256854|18343870|P6|Overall Study|Lack of Efficacy|0
5327592|NCT00256854|18343871|P5|Overall Study|Lack of Efficacy|0
5327593|NCT00256854|18343872|P4|Overall Study|Lack of Efficacy|0
5327594|NCT00256854|18343873|P3|Overall Study|Lack of Efficacy|0
5327595|NCT00256854|18343874|P2|Overall Study|Lack of Efficacy|0
5327596|NCT00256854|18343875|P1|Overall Study|Lack of Efficacy|1
5327597|NCT00256854|18343870|P6|Overall Study|Withdrawal by Subject|0
5327598|NCT00256854|18343871|P5|Overall Study|Withdrawal by Subject|0
5327599|NCT00256854|18343872|P4|Overall Study|Withdrawal by Subject|0
5327600|NCT00256854|18343873|P3|Overall Study|Withdrawal by Subject|0
5327601|NCT00256854|18343874|P2|Overall Study|Withdrawal by Subject|3
5327602|NCT00256854|18343875|P1|Overall Study|Withdrawal by Subject|2
5327603|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Other|5
5327604|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Other|4
5327605|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Other|5
5327606|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
5327607|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
5327608|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
5327609|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
5327610|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
5327611|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
5327612|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
5327613|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
5327614|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
5327615|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
5327616|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
5327617|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
5327618|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Death|4
5327619|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Death|4
5327620|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Death|9
5327621|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
5327622|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
5327623|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
5327624|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
5327625|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
5327626|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
5327627|NCT00256750|18343934|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
5327628|NCT00256750|18343935|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
5327629|NCT00256750|18343936|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
5327630|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Other|1
5327631|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Other|1
5327632|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Other|0
5327633|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
5327634|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
5327635|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
5327636|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
5327637|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
5327638|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
5327639|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
5327640|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
5327641|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
5327642|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Death|1
5327643|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Death|2
5327644|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Death|0
5327645|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
5327646|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
5327647|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
5327648|NCT00256750|18343934|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
5327649|NCT00256750|18343935|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
5327650|NCT00256750|18343936|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
5327651|NCT00256750|18343934|P3|Post-Transplant Treated (24 Months)|Other|1
5327652|NCT00256750|18343935|P2|Post-Transplant Treated (24 Months)|Other|0
5327653|NCT00256750|18343936|P1|Post-Transplant Treated (24 Months)|Other|2
5327654|NCT00256750|18343934|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
5327655|NCT00256750|18343935|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
5327656|NCT00256750|18343936|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
5327657|NCT00256750|18343934|P3|Post-Transplant Treated (24 Months)|Death|0
5327658|NCT00256750|18343935|P2|Post-Transplant Treated (24 Months)|Death|0
5327659|NCT00256750|18343936|P1|Post-Transplant Treated (24 Months)|Death|3
5327660|NCT00256750|18343934|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
5327661|NCT00256750|18343935|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
5327662|NCT00256750|18343936|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
5327663|NCT00256750|18343934|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
5327664|NCT00256750|18343935|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
5327665|NCT00256750|18343936|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
5327666|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
5327667|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
5327668|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
5327669|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
5327670|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
5327671|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
5327672|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Other|2
5327673|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Other|4
5327674|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Other|5
5327675|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
5327676|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
5327677|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
5327678|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
5327679|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
5327680|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
5327681|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Death|4
5327682|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Death|2
5327683|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Death|3
5327684|NCT00256750|18343934|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
5327685|NCT00256750|18343935|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
5327686|NCT00256750|18343936|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
5327687|NCT00256750|18343934|P3|Transplanted Pre-Treatment|Death|0
5327688|NCT00256750|18343935|P2|Transplanted Pre-Treatment|Death|0
5327689|NCT00256750|18343936|P1|Transplanted Pre-Treatment|Death|1
5327690|NCT00256750|18343934|P3|Transplanted Pre-Treatment|Other|0
5327691|NCT00256750|18343935|P2|Transplanted Pre-Treatment|Other|0
5327692|NCT00256750|18343936|P1|Transplanted Pre-Treatment|Other|2
5327693|NCT00256750|18343934|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
5327694|NCT00256750|18343935|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
5327695|NCT00256750|18343936|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
5327696|NCT00256724|18344072|P2|Overall Study|Protocol Violation|3
5327697|NCT00256724|18344073|P1|Overall Study|Protocol Violation|3
5327698|NCT00256724|18344072|P2|Overall Study|Physician Decision|5
5327699|NCT00256724|18344073|P1|Overall Study|Physician Decision|2
5327700|NCT00256698|18344083|P2|Overall Study|Prematurely Discontinued|0
5327701|NCT00256698|18344084|P1|Overall Study|Prematurely Discontinued|1
5327702|NCT00256698|18344083|P2|Overall Study|withdrawn due to osteoporosis|0
5327703|NCT00256698|18344084|P1|Overall Study|withdrawn due to osteoporosis|1
5327704|NCT00256698|18344083|P2|Overall Study|still ongoing at data cut-off|46
5327705|NCT00256698|18344084|P1|Overall Study|still ongoing at data cut-off|41
5327706|NCT00256698|18344083|P2|Overall Study|disease progression|105
5327707|NCT00256698|18344084|P1|Overall Study|disease progression|97
5327708|NCT00256698|18344083|P2|Overall Study|Lost to Follow-up|3
5327709|NCT00256698|18344084|P1|Overall Study|Lost to Follow-up|1
5327710|NCT00256698|18344083|P2|Overall Study|Protocol Violation|5
5327711|NCT00256698|18344084|P1|Overall Study|Protocol Violation|6
5327712|NCT00256698|18344083|P2|Overall Study|Adverse Event|6
5327713|NCT00256698|18344084|P1|Overall Study|Adverse Event|13
5327714|NCT00256698|18344083|P2|Overall Study|Withdrawal by Subject|7
5327715|NCT00256698|18344084|P1|Overall Study|Withdrawal by Subject|7
5327716|NCT00256308|18344131|P1|Overall Study|Death|2
5327717|NCT00256295|18344139|P1|Overall Study|Death|1
5327718|NCT00256295|18344139|P1|Overall Study|Withdrawal by Subject|3
5327719|NCT00256282|18344145|P1|Overall Study|Physician Decision|1
5327720|NCT00256282|18344145|P1|Overall Study|Adverse Event|3
5327721|NCT00256282|18344145|P1|Overall Study|Disease progression, relapse during acti|12
5327722|NCT00256243|18344150|P1|Overall Study|Not treated|1
5327723|NCT00256243|18344150|P1|Overall Study|Death|7
5327724|NCT00256243|18344150|P1|Overall Study|Lost to Follow-up|2
5327725|NCT00256204|18344159|P4|Overall Study|Need for additional prohibited treatment|25
5327726|NCT00256204|18344160|P3|Overall Study|Need for additional prohibited treatment|27
5327727|NCT00256204|18344161|P2|Overall Study|Need for additional prohibited treatment|28
5327728|NCT00256204|18344162|P1|Overall Study|Need for additional prohibited treatment|38
5327729|NCT00256204|18344159|P4|Overall Study|Withdrawal by Subject|5
5327730|NCT00256204|18344160|P3|Overall Study|Withdrawal by Subject|7
5327731|NCT00256204|18344161|P2|Overall Study|Withdrawal by Subject|6
5327732|NCT00256204|18344162|P1|Overall Study|Withdrawal by Subject|17
5327733|NCT00256204|18344159|P4|Overall Study|Physician Decision|2
5327734|NCT00256204|18344160|P3|Overall Study|Physician Decision|1
5327735|NCT00256204|18344161|P2|Overall Study|Physician Decision|0
5327736|NCT00256204|18344162|P1|Overall Study|Physician Decision|0
5327737|NCT00256204|18344159|P4|Overall Study|Protocol Violation|1
5327738|NCT00256204|18344160|P3|Overall Study|Protocol Violation|2
5327739|NCT00256204|18344161|P2|Overall Study|Protocol Violation|0
5327740|NCT00256204|18344162|P1|Overall Study|Protocol Violation|1
5327741|NCT00256204|18344159|P4|Overall Study|Lost to Follow-up|2
5327742|NCT00256204|18344160|P3|Overall Study|Lost to Follow-up|1
5327743|NCT00256204|18344161|P2|Overall Study|Lost to Follow-up|1
5327744|NCT00256204|18344162|P1|Overall Study|Lost to Follow-up|1
5327745|NCT00256204|18344159|P4|Overall Study|Death|0
5327746|NCT00256204|18344160|P3|Overall Study|Death|0
5327747|NCT00256204|18344161|P2|Overall Study|Death|1
5327748|NCT00256204|18344162|P1|Overall Study|Death|0
5327749|NCT00256204|18344159|P4|Overall Study|Adverse Event|14
5327750|NCT00256204|18344160|P3|Overall Study|Adverse Event|16
5327751|NCT00256204|18344161|P2|Overall Study|Adverse Event|14
5327752|NCT00256204|18344162|P1|Overall Study|Adverse Event|10
5327753|NCT00256126|18344177|P2|Overall Study|Other|2
5327754|NCT00256126|18344178|P1|Overall Study|Other|1
5327755|NCT00256126|18344177|P2|Overall Study|Adverse Event|0
5327756|NCT00256126|18344178|P1|Overall Study|Adverse Event|1
5327757|NCT00255944|18344217|P2|Overall Study|Lost to Follow-up|834
5327758|NCT00255944|18344218|P1|Overall Study|Lost to Follow-up|797
5327759|NCT00255840|18344226|P2|Overall Study|Discontinued intervention|56
5327760|NCT00255840|18344227|P1|Overall Study|Discontinued intervention|53
5327761|NCT00255840|18344226|P2|Overall Study|Lost to Follow-up|14
5327762|NCT00255840|18344227|P1|Overall Study|Lost to Follow-up|10
5327763|NCT00255723|18344240|P2|Overall Study|Response Data Not Available|0
5327764|NCT00255723|18344241|P1|Overall Study|Response Data Not Available|1
5327765|NCT00255723|18344240|P2|Overall Study|Death|1
5327766|NCT00255723|18344241|P1|Overall Study|Death|0
5327767|NCT00255723|18344240|P2|Overall Study|Adverse Event|1
5327768|NCT00255723|18344241|P1|Overall Study|Adverse Event|1
5327769|NCT00255346|18344257|P5|Overall Study|Adverse Event|0
5327770|NCT00255346|18344258|P4|Overall Study|Adverse Event|0
5327771|NCT00255346|18344259|P3|Overall Study|Adverse Event|0
5327772|NCT00255346|18344260|P2|Overall Study|Adverse Event|0
5327773|NCT00255346|18344261|P1|Overall Study|Adverse Event|1
5327774|NCT00255190|18344276|P2|Overall Study|Various|23
5327775|NCT00255190|18344277|P1|Overall Study|Various|4
5327776|NCT00255190|18344276|P2|Overall Study|Erosive esophagitis not healed|20
5327777|NCT00255190|18344277|P1|Overall Study|Erosive esophagitis not healed|0
5327778|NCT00255190|18344276|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5327779|NCT00255190|18344277|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5327780|NCT00255190|18344276|P2|Overall Study|Withdrew Consent|48
5327781|NCT00255190|18344277|P1|Overall Study|Withdrew Consent|17
5327782|NCT00255190|18344276|P2|Overall Study|Lost to Follow-up|27
5327783|NCT00255190|18344277|P1|Overall Study|Lost to Follow-up|10
5327784|NCT00255190|18344276|P2|Overall Study|Protocol Violation|2
5327785|NCT00255190|18344277|P1|Overall Study|Protocol Violation|2
5327786|NCT00255190|18344276|P2|Overall Study|Adverse Event|36
5327787|NCT00255190|18344277|P1|Overall Study|Adverse Event|17
5327788|NCT00255164|18344361|P3|Overall Study|Therapeutic Failure|3
5327789|NCT00255164|18344362|P2|Overall Study|Therapeutic Failure|2
5327790|NCT00255164|18344363|P1|Overall Study|Therapeutic Failure|11
5327791|NCT00255164|18344361|P3|Overall Study|Esophageal Stricture|1
5327792|NCT00255164|18344362|P2|Overall Study|Esophageal Stricture|0
5327793|NCT00255164|18344363|P1|Overall Study|Esophageal Stricture|0
5327794|NCT00255164|18344361|P3|Overall Study|Possible Barrett's Esophagus|8
5327795|NCT00255164|18344362|P2|Overall Study|Possible Barrett's Esophagus|3
5327796|NCT00255164|18344363|P1|Overall Study|Possible Barrett's Esophagus|1
5327797|NCT00255164|18344361|P3|Overall Study|Relapse of Erosive Esophagitis|12
5327798|NCT00255164|18344362|P2|Overall Study|Relapse of Erosive Esophagitis|16
5327799|NCT00255164|18344363|P1|Overall Study|Relapse of Erosive Esophagitis|78
5327800|NCT00255164|18344361|P3|Overall Study|Subject Request/Subject Unavailable|2
5327801|NCT00255164|18344362|P2|Overall Study|Subject Request/Subject Unavailable|1
5327802|NCT00255164|18344363|P1|Overall Study|Subject Request/Subject Unavailable|1
5327803|NCT00255164|18344361|P3|Overall Study|Noncompliance|2
5327804|NCT00255164|18344362|P2|Overall Study|Noncompliance|1
5327805|NCT00255164|18344363|P1|Overall Study|Noncompliance|0
5327806|NCT00255164|18344361|P3|Overall Study|Withdrawal by Subject|8
5327807|NCT00255164|18344362|P2|Overall Study|Withdrawal by Subject|17
5327808|NCT00255164|18344363|P1|Overall Study|Withdrawal by Subject|18
5327809|NCT00255164|18344361|P3|Overall Study|Lost to Follow-up|4
5327810|NCT00255164|18344362|P2|Overall Study|Lost to Follow-up|3
5327811|NCT00255164|18344363|P1|Overall Study|Lost to Follow-up|4
5327812|NCT00255164|18344361|P3|Overall Study|Adverse Event|9
5327813|NCT00255164|18344362|P2|Overall Study|Adverse Event|6
5327814|NCT00255164|18344363|P1|Overall Study|Adverse Event|10
5327815|NCT00255151|18344389|P3|Overall Study|Therapeutic Failure|3
5327816|NCT00255151|18344390|P2|Overall Study|Therapeutic Failure|2
5327817|NCT00255151|18344391|P1|Overall Study|Therapeutic Failure|11
5327818|NCT00255151|18344389|P3|Overall Study|Esophageal Stricture|1
5327819|NCT00255151|18344390|P2|Overall Study|Esophageal Stricture|0
5327820|NCT00255151|18344391|P1|Overall Study|Esophageal Stricture|0
5327821|NCT00255151|18344389|P3|Overall Study|Possible Barrett's Esophagus|8
5327822|NCT00255151|18344390|P2|Overall Study|Possible Barrett's Esophagus|3
5327823|NCT00255151|18344391|P1|Overall Study|Possible Barrett's Esophagus|1
5327824|NCT00255151|18344389|P3|Overall Study|Relapse of Erosive Esophagitis|12
5327825|NCT00255151|18344390|P2|Overall Study|Relapse of Erosive Esophagitis|16
5327826|NCT00255151|18344391|P1|Overall Study|Relapse of Erosive Esophagitis|78
5327827|NCT00255151|18344389|P3|Overall Study|Subject Request/Subject Unavailable|2
5327828|NCT00255151|18344390|P2|Overall Study|Subject Request/Subject Unavailable|1
5327829|NCT00255151|18344391|P1|Overall Study|Subject Request/Subject Unavailable|1
5327830|NCT00255151|18344389|P3|Overall Study|Noncompliance|2
5327831|NCT00255151|18344390|P2|Overall Study|Noncompliance|1
5327832|NCT00255151|18344391|P1|Overall Study|Noncompliance|0
5327833|NCT00255151|18344389|P3|Overall Study|Withdrawal by Subject|8
5327834|NCT00255151|18344390|P2|Overall Study|Withdrawal by Subject|17
5327835|NCT00255151|18344391|P1|Overall Study|Withdrawal by Subject|18
5327836|NCT00255151|18344389|P3|Overall Study|Lost to Follow-up|4
5327837|NCT00255151|18344390|P2|Overall Study|Lost to Follow-up|3
5327838|NCT00255151|18344391|P1|Overall Study|Lost to Follow-up|4
5327839|NCT00255151|18344389|P3|Overall Study|Adverse Event|9
5327840|NCT00255151|18344390|P2|Overall Study|Adverse Event|6
5327841|NCT00255151|18344391|P1|Overall Study|Adverse Event|10
5327842|NCT00255086|18344429|P2|Overall Study|Protocol Violation|1
5327843|NCT00255086|18344430|P1|Overall Study|Protocol Violation|1
5327844|NCT00255086|18344429|P2|Overall Study|Adverse Event|1
5327845|NCT00255086|18344430|P1|Overall Study|Adverse Event|1
5327846|NCT00255047|18344442|P4|Overall Study|Withdrawal by Subject|18
5327847|NCT00255047|18344443|P3|Overall Study|Withdrawal by Subject|25
5327848|NCT00255047|18344444|P2|Overall Study|Withdrawal by Subject|23
5327849|NCT00255047|18344445|P1|Overall Study|Withdrawal by Subject|24
5327850|NCT00255047|18344442|P4|Overall Study|Lost to Follow-up|6
5327851|NCT00255047|18344443|P3|Overall Study|Lost to Follow-up|5
5327852|NCT00255047|18344444|P2|Overall Study|Lost to Follow-up|8
5327853|NCT00255047|18344445|P1|Overall Study|Lost to Follow-up|9
5327854|NCT00255047|18344442|P4|Overall Study|Protocol Violation|20
5327855|NCT00255047|18344443|P3|Overall Study|Protocol Violation|16
5327856|NCT00255047|18344444|P2|Overall Study|Protocol Violation|13
5327857|NCT00255047|18344445|P1|Overall Study|Protocol Violation|13
5327858|NCT00255047|18344442|P4|Overall Study|Adverse Event|1
5327859|NCT00255047|18344443|P3|Overall Study|Adverse Event|2
5327860|NCT00255047|18344444|P2|Overall Study|Adverse Event|3
5327861|NCT00255047|18344445|P1|Overall Study|Adverse Event|0
5327862|NCT00255047|18344442|P4|Overall Study|Serious Adverse Events|1
5327863|NCT00255047|18344443|P3|Overall Study|Serious Adverse Events|2
5327864|NCT00255047|18344444|P2|Overall Study|Serious Adverse Events|1
5327865|NCT00255047|18344445|P1|Overall Study|Serious Adverse Events|2
5327866|NCT00255034|18344469|P2|Overall Study|Withdrawal by Subject|38
5327867|NCT00255034|18344470|P1|Overall Study|Withdrawal by Subject|15
5327868|NCT00255008|18344480|P4|Overall Study|Other|2
5327869|NCT00255008|18344481|P3|Overall Study|Other|3
5327870|NCT00255008|18344482|P2|Overall Study|Other|0
5327871|NCT00255008|18344483|P1|Overall Study|Other|7
5327872|NCT00255008|18344480|P4|Overall Study|Adverse lab experience|0
5327873|NCT00255008|18344481|P3|Overall Study|Adverse lab experience|0
5327874|NCT00255008|18344482|P2|Overall Study|Adverse lab experience|0
5327875|NCT00255008|18344483|P1|Overall Study|Adverse lab experience|1
5327876|NCT00255008|18344480|P4|Overall Study|Sponsor request|17
5327877|NCT00255008|18344481|P3|Overall Study|Sponsor request|8
5327878|NCT00255008|18344482|P2|Overall Study|Sponsor request|3
5327879|NCT00255008|18344483|P1|Overall Study|Sponsor request|18
5327880|NCT00255008|18344480|P4|Overall Study|Withdrew consent|0
5327881|NCT00255008|18344481|P3|Overall Study|Withdrew consent|2
5327882|NCT00255008|18344482|P2|Overall Study|Withdrew consent|0
5327883|NCT00255008|18344483|P1|Overall Study|Withdrew consent|0
5327884|NCT00255008|18344480|P4|Overall Study|Did not meet viral reduction criteria|1
5327885|NCT00255008|18344481|P3|Overall Study|Did not meet viral reduction criteria|0
5327886|NCT00255008|18344482|P2|Overall Study|Did not meet viral reduction criteria|5
5327887|NCT00255008|18344483|P1|Overall Study|Did not meet viral reduction criteria|4
5327888|NCT00255008|18344480|P4|Overall Study|Lost to Follow-up|2
5327889|NCT00255008|18344481|P3|Overall Study|Lost to Follow-up|1
5327890|NCT00255008|18344482|P2|Overall Study|Lost to Follow-up|0
5327891|NCT00255008|18344483|P1|Overall Study|Lost to Follow-up|1
5327892|NCT00255008|18344480|P4|Overall Study|Adverse Event|0
5327893|NCT00255008|18344481|P3|Overall Study|Adverse Event|2
5327894|NCT00255008|18344482|P2|Overall Study|Adverse Event|1
5327895|NCT00255008|18344483|P1|Overall Study|Adverse Event|1
5327896|NCT00254982|18344519|P2|Overall Study|Abnormal liver function tests|1
5327897|NCT00254982|18344520|P1|Overall Study|Abnormal liver function tests|2
5327898|NCT00254982|18344519|P2|Overall Study|Opportunistic infection|0
5327899|NCT00254982|18344520|P1|Overall Study|Opportunistic infection|1
5327900|NCT00254982|18344519|P2|Overall Study|Malignancy|2
5327901|NCT00254982|18344520|P1|Overall Study|Malignancy|0
5327902|NCT00254982|18344519|P2|Overall Study|Diagnosis of Tuberculosis|1
5327903|NCT00254982|18344520|P1|Overall Study|Diagnosis of Tuberculosis|1
5327904|NCT00254982|18344519|P2|Overall Study|Protocol deviation|1
5327905|NCT00254982|18344520|P1|Overall Study|Protocol deviation|1
5327906|NCT00254982|18344519|P2|Overall Study|Inclusion/exclusion criteria violation|2
5327907|NCT00254982|18344520|P1|Overall Study|Inclusion/exclusion criteria violation|0
5327908|NCT00254982|18344519|P2|Overall Study|Withdrawal by Subject|1
5327909|NCT00254982|18344520|P1|Overall Study|Withdrawal by Subject|1
5327910|NCT00254982|18344519|P2|Overall Study|Adverse Event|16
5327911|NCT00254982|18344520|P1|Overall Study|Adverse Event|18
5327912|NCT00254982|18344519|P2|Overall Study|Lost to Follow-up|3
5327913|NCT00254982|18344520|P1|Overall Study|Lost to Follow-up|5
5327914|NCT00254982|18344519|P2|Overall Study|Lack of Efficacy|3
5327915|NCT00254982|18344520|P1|Overall Study|Lack of Efficacy|5
5327916|NCT00254982|18344519|P2|Overall Study|Other|1
5327917|NCT00254982|18344520|P1|Overall Study|Other|2
5327918|NCT00254566|18344532|P2|Overall Study|Lost to Follow-up|2
5327919|NCT00254566|18344533|P1|Overall Study|Lost to Follow-up|7
5327920|NCT00254566|18344532|P2|Overall Study|Withdrawal by Subject|6
5327921|NCT00254566|18344533|P1|Overall Study|Withdrawal by Subject|5
5327922|NCT00254566|18344532|P2|Overall Study|Other|5
5327923|NCT00254566|18344533|P1|Overall Study|Other|1
5327924|NCT00254566|18344532|P2|Overall Study|Lack of Efficacy|9
5327925|NCT00254566|18344533|P1|Overall Study|Lack of Efficacy|12
5327926|NCT00254566|18344532|P2|Overall Study|Adverse Event|4
5327927|NCT00254566|18344533|P1|Overall Study|Adverse Event|5
5327928|NCT00254566|18344532|P2|Overall Study|Death|0
5327929|NCT00254566|18344533|P1|Overall Study|Death|1
5327930|NCT00254540|18344557|P2|Overall Study|Laboratory Test Abnormality|1
5327931|NCT00254540|18344558|P1|Overall Study|Laboratory Test Abnormality|0
5327932|NCT00254540|18344557|P2|Overall Study|Death|1
5327933|NCT00254540|18344558|P1|Overall Study|Death|0
5327934|NCT00254540|18344557|P2|Overall Study|Lack of Efficacy|13
5327935|NCT00254540|18344558|P1|Overall Study|Lack of Efficacy|13
5327936|NCT00254540|18344557|P2|Overall Study|Adverse Event|7
5327937|NCT00254540|18344558|P1|Overall Study|Adverse Event|6
5327938|NCT00254501|18344587|P2|Overall Study|Lost to Follow-up|1
5327939|NCT00254501|18344588|P1|Overall Study|Lost to Follow-up|1
5327940|NCT00254397|18344633|P4|Overall Study|Adverse Event|1
5327941|NCT00254397|18344634|P3|Overall Study|Adverse Event|3
5327942|NCT00254397|18344635|P2|Overall Study|Adverse Event|0
5327943|NCT00254397|18344636|P1|Overall Study|Adverse Event|2
5327944|NCT00254397|18344633|P4|Overall Study|Non-Compliant|1
5327945|NCT00254397|18344634|P3|Overall Study|Non-Compliant|0
5327946|NCT00254397|18344635|P2|Overall Study|Non-Compliant|0
5327947|NCT00254397|18344636|P1|Overall Study|Non-Compliant|0
5327948|NCT00254397|18344633|P4|Overall Study|Disease Progression|23
5327949|NCT00254397|18344634|P3|Overall Study|Disease Progression|16
5327950|NCT00254397|18344635|P2|Overall Study|Disease Progression|1
5327951|NCT00254397|18344636|P1|Overall Study|Disease Progression|4
5327952|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Other|1
5327953|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Other|0
5327954|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Other|0
5327955|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Other|0
5327956|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Other|0
5327957|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Other|0
5327958|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Other|0
5327959|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
5327960|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5327961|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5327962|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5327963|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5327964|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5327965|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5327966|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
5327967|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5327968|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5327969|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5327970|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5327971|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5327972|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5327973|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
5327974|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5327975|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5327976|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5327977|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5327978|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5327979|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5327980|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
5327981|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5327982|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5327983|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5327984|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5327985|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5327986|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5327987|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Adverse Event|1
5327988|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Adverse Event|0
5327989|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Adverse Event|0
5327990|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Adverse Event|0
5327991|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Adverse Event|0
5327992|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Adverse Event|0
5327993|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Adverse Event|0
5327994|NCT00254293|18344660|P7|LTE Open Label Fixed Dosing|Death|3
5327995|NCT00254293|18344661|P6|LTE Open Label Fixed Dosing|Death|0
5327996|NCT00254293|18344662|P5|LTE Open Label Fixed Dosing|Death|0
5327997|NCT00254293|18344663|P4|LTE Open Label Fixed Dosing|Death|0
5327998|NCT00254293|18344664|P3|LTE Open Label Fixed Dosing|Death|0
5327999|NCT00254293|18344665|P2|LTE Open Label Fixed Dosing|Death|0
5328000|NCT00254293|18344666|P1|LTE Open Label Fixed Dosing|Death|0
5328001|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Other|0
5328002|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Other|0
5328003|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Other|0
5328004|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Other|0
5328005|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Other|2
5328006|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Other|0
5328007|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Other|0
5328008|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5328009|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5328010|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5328011|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5328012|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
5328013|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5328014|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5328015|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5328016|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5328017|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5328018|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5328019|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
5328020|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5328021|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5328022|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5328023|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5328024|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5328025|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5328026|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
5328027|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5328028|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5328029|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5328030|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5328031|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
5328032|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5328033|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
5328034|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5328035|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
5328036|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
5328037|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
5328038|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
5328039|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
5328040|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
5328041|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
5328042|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
5328043|NCT00254293|18344660|P7|LTE Open Label Variable SC Dosing|Death|0
5328044|NCT00254293|18344661|P6|LTE Open Label Variable SC Dosing|Death|0
5328045|NCT00254293|18344662|P5|LTE Open Label Variable SC Dosing|Death|0
5328046|NCT00254293|18344663|P4|LTE Open Label Variable SC Dosing|Death|0
5328047|NCT00254293|18344664|P3|LTE Open Label Variable SC Dosing|Death|1
5328048|NCT00254293|18344665|P2|LTE Open Label Variable SC Dosing|Death|0
5328049|NCT00254293|18344666|P1|LTE Open Label Variable SC Dosing|Death|0
5328050|NCT00254293|18344660|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5328051|NCT00254293|18344661|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5328052|NCT00254293|18344662|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5328053|NCT00254293|18344663|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5328054|NCT00254293|18344664|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
5328055|NCT00254293|18344665|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5328056|NCT00254293|18344666|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5328057|NCT00254293|18344660|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5328058|NCT00254293|18344661|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5328059|NCT00254293|18344662|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5328060|NCT00254293|18344663|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5328061|NCT00254293|18344664|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
5328062|NCT00254293|18344665|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5328152|NCT00252499|18345075|P1|Overall Study|Lost to Follow-up|1
5328063|NCT00254293|18344666|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5328064|NCT00254293|18344660|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5328065|NCT00254293|18344661|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5328066|NCT00254293|18344662|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5328067|NCT00254293|18344663|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
5328068|NCT00254293|18344664|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5328069|NCT00254293|18344665|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
5328070|NCT00254293|18344666|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5328071|NCT00254163|18344749|P2|Overall Study|Other|8
5328072|NCT00254163|18344750|P1|Overall Study|Other|8
5328073|NCT00254163|18344749|P2|Overall Study|Death|1
5328074|NCT00254163|18344750|P1|Overall Study|Death|0
5328075|NCT00254163|18344749|P2|Overall Study|Progressive disease|1
5328076|NCT00254163|18344750|P1|Overall Study|Progressive disease|0
5328077|NCT00254163|18344749|P2|Overall Study|Failed entry|3
5328078|NCT00254163|18344750|P1|Overall Study|Failed entry|1
5328079|NCT00254163|18344749|P2|Overall Study|Investigator request|3
5328080|NCT00254163|18344750|P1|Overall Study|Investigator request|1
5328081|NCT00254163|18344749|P2|Overall Study|Patient request/withdrew consent|4
5328082|NCT00254163|18344750|P1|Overall Study|Patient request/withdrew consent|6
5328083|NCT00254163|18344749|P2|Overall Study|Adverse Event|26
5328084|NCT00254163|18344750|P1|Overall Study|Adverse Event|29
5328085|NCT00253747|18344801|P2|Overall Study|Administrative Discharge (1), Other (2)|2
5328086|NCT00253747|18344802|P1|Overall Study|Administrative Discharge (1), Other (2)|1
5328087|NCT00253747|18344801|P2|Overall Study|Withdrawal by Subject|11
5328088|NCT00253747|18344802|P1|Overall Study|Withdrawal by Subject|10
5328089|NCT00253747|18344801|P2|Overall Study|Lost to Follow-up|14
5328090|NCT00253747|18344802|P1|Overall Study|Lost to Follow-up|13
5328091|NCT00253643|18344855|P4|Overall Study|Non-Compliance|2
5328092|NCT00253643|18344856|P3|Overall Study|Non-Compliance|0
5328093|NCT00253643|18344857|P2|Overall Study|Non-Compliance|0
5328094|NCT00253643|18344858|P1|Overall Study|Non-Compliance|0
5328095|NCT00253643|18344855|P4|Overall Study|Withdrawal by Subject|1
5328096|NCT00253643|18344856|P3|Overall Study|Withdrawal by Subject|1
5328097|NCT00253643|18344857|P2|Overall Study|Withdrawal by Subject|0
5328098|NCT00253643|18344858|P1|Overall Study|Withdrawal by Subject|0
5328099|NCT00253630|18344872|P1|Overall Study|ineligible|2
5328100|NCT00253448|18344888|P1|Overall Study|Withdrawal by Subject|1
5328101|NCT00253370|18344907|P1|Overall Study|Abdominal pain due to disease|1
5328102|NCT00253370|18344907|P1|Overall Study|Protocol Violation|1
5328103|NCT00253370|18344907|P1|Overall Study|Physician Decision|1
5328104|NCT00253370|18344907|P1|Overall Study|Non-protocol therapy|1
5328105|NCT00253370|18344907|P1|Overall Study|Withdrawal by Subject|6
5328106|NCT00253370|18344907|P1|Overall Study|Death|2
5328107|NCT00253370|18344907|P1|Overall Study|Disease progression|13
5328108|NCT00253370|18344907|P1|Overall Study|Adverse Event|18
5328109|NCT00252733|18344953|P2|Overall Study|Multiple Reasons|14
5328110|NCT00252733|18344954|P1|Overall Study|Multiple Reasons|14
5328111|NCT00252733|18344953|P2|Overall Study|Lost to Follow-up|6
5328112|NCT00252733|18344954|P1|Overall Study|Lost to Follow-up|12
5328113|NCT00252733|18344953|P2|Overall Study|Death|5
5328114|NCT00252733|18344954|P1|Overall Study|Death|7
5328115|NCT00252733|18344953|P2|Overall Study|Withdrawal by Subject|67
5328116|NCT00252733|18344954|P1|Overall Study|Withdrawal by Subject|73
5328117|NCT00252720|18344964|P2|Overall Study|Mainly patients lost to follow-up|18
5328118|NCT00252720|18344965|P1|Overall Study|Mainly patients lost to follow-up|7
5328119|NCT00252720|18344964|P2|Overall Study|Moving|42
5328120|NCT00252720|18344965|P1|Overall Study|Moving|23
5328121|NCT00252720|18344964|P2|Overall Study|Death|8
5328122|NCT00252720|18344965|P1|Overall Study|Death|7
5328123|NCT00252720|18344964|P2|Overall Study|Withdrawal by Subject|97
5328124|NCT00252720|18344965|P1|Overall Study|Withdrawal by Subject|95
5328125|NCT00252694|18344979|P2|Overall Study|Patient Moving|16
5328126|NCT00252694|18344980|P1|Overall Study|Patient Moving|17
5328127|NCT00252694|18344979|P2|Overall Study|Mostly Lost to Follow Up|13
5328128|NCT00252694|18344980|P1|Overall Study|Mostly Lost to Follow Up|8
5328129|NCT00252694|18344979|P2|Overall Study|Death|34
5328130|NCT00252694|18344980|P1|Overall Study|Death|36
5328131|NCT00252694|18344979|P2|Overall Study|Withdrawal by Subject|91
5328132|NCT00252694|18344980|P1|Overall Study|Withdrawal by Subject|83
5328133|NCT00252577|18345026|P1|Overall Study|Lost to Follow-up|20
5328134|NCT00252564|18345032|P2|Overall Study|Withdrawal by Subject|2
5328135|NCT00252564|18345033|P1|Overall Study|Withdrawal by Subject|0
5328136|NCT00252564|18345032|P2|Overall Study|Patient Request|5
5328137|NCT00252564|18345033|P1|Overall Study|Patient Request|4
5328138|NCT00252564|18345032|P2|Overall Study|Lost to Follow-up|0
5328139|NCT00252564|18345033|P1|Overall Study|Lost to Follow-up|1
5328140|NCT00252564|18345032|P2|Overall Study|Physician Decision|0
5328141|NCT00252564|18345033|P1|Overall Study|Physician Decision|1
5328142|NCT00252564|18345032|P2|Overall Study|Death|3
5328143|NCT00252564|18345033|P1|Overall Study|Death|0
5328144|NCT00252564|18345032|P2|Overall Study|Disease Progression|20
5328145|NCT00252564|18345033|P1|Overall Study|Disease Progression|14
5328146|NCT00252564|18345032|P2|Overall Study|Unrelated Complication|1
5328147|NCT00252564|18345033|P1|Overall Study|Unrelated Complication|2
5328148|NCT00252564|18345032|P2|Overall Study|Adverse Event|13
5328149|NCT00252564|18345033|P1|Overall Study|Adverse Event|17
5328150|NCT00252499|18345073|P3|Overall Study|Lost to Follow-up|0
5328151|NCT00252499|18345074|P2|Overall Study|Lost to Follow-up|0
5328153|NCT00252239|18345107|P4|Overall Study|Lost to Follow-up|0
5328154|NCT00252239|18345108|P3|Overall Study|Lost to Follow-up|2
5328155|NCT00252239|18345109|P2|Overall Study|Lost to Follow-up|0
5328156|NCT00252239|18345110|P1|Overall Study|Lost to Follow-up|0
5328157|NCT00252239|18345107|P4|Overall Study|Withdrawal by Subject|1
5328158|NCT00252239|18345108|P3|Overall Study|Withdrawal by Subject|0
5328159|NCT00252239|18345109|P2|Overall Study|Withdrawal by Subject|0
5328160|NCT00252239|18345110|P1|Overall Study|Withdrawal by Subject|1
5328161|NCT00252187|18345122|P2|Overall Study|Withdrawal by Subject|0
5328162|NCT00252187|18345123|P1|Overall Study|Withdrawal by Subject|1
5328163|NCT00252187|18345122|P2|Overall Study|Adverse Event|1
5328164|NCT00252187|18345123|P1|Overall Study|Adverse Event|3
5328165|NCT00252174|18345146|P3|Overall Study|Withdrawal by Subject|0
5328166|NCT00252174|18345147|P2|Overall Study|Withdrawal by Subject|1
5328167|NCT00252174|18345148|P1|Overall Study|Withdrawal by Subject|0
5328168|NCT00252057|18345188|P2|Overall Study|Participant previously enrolled|1
5328169|NCT00252057|18345189|P1|Overall Study|Participant previously enrolled|0
5328170|NCT00252057|18345188|P2|Overall Study|Death|2
5328171|NCT00252057|18345189|P1|Overall Study|Death|1
5328172|NCT00252057|18345188|P2|Overall Study|Withdrawal by Subject|5
5328173|NCT00252057|18345189|P1|Overall Study|Withdrawal by Subject|2
5328174|NCT00251979|18345197|P2|Overall Study|Death|5
5328175|NCT00251979|18345198|P1|Overall Study|Death|3
5328176|NCT00251979|18345197|P2|Overall Study|Lost to Follow-up|6
5328177|NCT00251979|18345198|P1|Overall Study|Lost to Follow-up|8
5328178|NCT00251979|18345197|P2|Overall Study|Withdrawal by Subject|7
5328179|NCT00251979|18345198|P1|Overall Study|Withdrawal by Subject|13
5328180|NCT00251979|18345197|P2|Overall Study|Adverse Event|17
5328181|NCT00251979|18345198|P1|Overall Study|Adverse Event|11
5328182|NCT00251979|18345197|P2|Overall Study|Protocol Violation|5
5328183|NCT00251979|18345198|P1|Overall Study|Protocol Violation|3
5328184|NCT00251927|18345230|P2|Overall Study|Study procedure non-compliance|6
5328185|NCT00251927|18345231|P1|Overall Study|Study procedure non-compliance|5
5328186|NCT00251927|18345230|P2|Overall Study|Study-specific discont. achieved|2
5328187|NCT00251927|18345231|P1|Overall Study|Study-specific discont. achieved|13
5328188|NCT00251927|18345230|P2|Overall Study|Withdrawal by Subject|25
5328189|NCT00251927|18345231|P1|Overall Study|Withdrawal by Subject|40
5328190|NCT00251927|18345230|P2|Overall Study|Pregnancy|0
5328191|NCT00251927|18345231|P1|Overall Study|Pregnancy|2
5328192|NCT00251927|18345230|P2|Overall Study|Protocol Violation|2
5328193|NCT00251927|18345231|P1|Overall Study|Protocol Violation|1
5328194|NCT00251927|18345230|P2|Overall Study|Lost to Follow-up|8
5328195|NCT00251927|18345231|P1|Overall Study|Lost to Follow-up|22
5328196|NCT00251927|18345230|P2|Overall Study|Lack of Efficacy|16
5328197|NCT00251927|18345231|P1|Overall Study|Lack of Efficacy|22
5328198|NCT00251927|18345230|P2|Overall Study|Adverse Event|15
5328199|NCT00251927|18345231|P1|Overall Study|Adverse Event|3
5328200|NCT00251758|18345283|P3|Overall Study|Per Investigator Request|0
5328201|NCT00251758|18345284|P2|Overall Study|Per Investigator Request|0
5328202|NCT00251758|18345285|P1|Overall Study|Per Investigator Request|1
5328203|NCT00251758|18345283|P3|Overall Study|Per Subject Request|1
5328204|NCT00251758|18345284|P2|Overall Study|Per Subject Request|0
5328205|NCT00251758|18345285|P1|Overall Study|Per Subject Request|0
5328206|NCT00251758|18345283|P3|Overall Study|Pregnancy|0
5328207|NCT00251758|18345284|P2|Overall Study|Pregnancy|1
5328208|NCT00251758|18345285|P1|Overall Study|Pregnancy|0
5328209|NCT00251758|18345283|P3|Overall Study|Noncompliant|2
5328210|NCT00251758|18345284|P2|Overall Study|Noncompliant|2
5328211|NCT00251758|18345285|P1|Overall Study|Noncompliant|0
5328212|NCT00251758|18345283|P3|Overall Study|Lack of Efficacy|0
5328213|NCT00251758|18345284|P2|Overall Study|Lack of Efficacy|0
5328214|NCT00251758|18345285|P1|Overall Study|Lack of Efficacy|3
5328215|NCT00251758|18345283|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
5328216|NCT00251758|18345284|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
5328217|NCT00251758|18345285|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5328218|NCT00251758|18345283|P3|Overall Study|Withdrawal by Subject|3
5328219|NCT00251758|18345284|P2|Overall Study|Withdrawal by Subject|7
5328220|NCT00251758|18345285|P1|Overall Study|Withdrawal by Subject|13
5328221|NCT00251758|18345283|P3|Overall Study|Lost to Follow-up|5
5328222|NCT00251758|18345284|P2|Overall Study|Lost to Follow-up|2
5328223|NCT00251758|18345285|P1|Overall Study|Lost to Follow-up|4
5328224|NCT00251758|18345283|P3|Overall Study|Adverse Event|11
5328225|NCT00251758|18345284|P2|Overall Study|Adverse Event|9
5328226|NCT00251758|18345285|P1|Overall Study|Adverse Event|7
5328227|NCT00251745|18345305|P3|Overall Study|Per Investigator Request|0
5328228|NCT00251745|18345306|P2|Overall Study|Per Investigator Request|0
5328229|NCT00251745|18345307|P1|Overall Study|Per Investigator Request|1
5328230|NCT00251745|18345305|P3|Overall Study|Per Subject Request|1
5328231|NCT00251745|18345306|P2|Overall Study|Per Subject Request|0
5328232|NCT00251745|18345307|P1|Overall Study|Per Subject Request|0
5328233|NCT00251745|18345305|P3|Overall Study|Pregnancy|0
5328234|NCT00251745|18345306|P2|Overall Study|Pregnancy|1
5328235|NCT00251745|18345307|P1|Overall Study|Pregnancy|0
5328236|NCT00251745|18345305|P3|Overall Study|Noncompliant|2
5328237|NCT00251745|18345306|P2|Overall Study|Noncompliant|2
5328238|NCT00251745|18345307|P1|Overall Study|Noncompliant|0
5328239|NCT00251745|18345305|P3|Overall Study|Lack of Efficacy|0
5328240|NCT00251745|18345306|P2|Overall Study|Lack of Efficacy|0
5328241|NCT00251745|18345307|P1|Overall Study|Lack of Efficacy|3
5328242|NCT00251745|18345305|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
5328243|NCT00251745|18345306|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
5328244|NCT00251745|18345307|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5328245|NCT00251745|18345305|P3|Overall Study|Withdrawal by Subject|3
5328246|NCT00251745|18345306|P2|Overall Study|Withdrawal by Subject|7
5328247|NCT00251745|18345307|P1|Overall Study|Withdrawal by Subject|13
5328248|NCT00251745|18345305|P3|Overall Study|Lost to Follow-up|5
5328249|NCT00251745|18345306|P2|Overall Study|Lost to Follow-up|2
5328250|NCT00251745|18345307|P1|Overall Study|Lost to Follow-up|4
5328251|NCT00251745|18345305|P3|Overall Study|Adverse Event|11
5328252|NCT00251745|18345306|P2|Overall Study|Adverse Event|9
5328253|NCT00251745|18345307|P1|Overall Study|Adverse Event|7
5328254|NCT00251719|18345327|P3|Overall Study|Barrett's esophagus|0
5328255|NCT00251719|18345328|P2|Overall Study|Barrett's esophagus|2
5328256|NCT00251719|18345329|P1|Overall Study|Barrett's esophagus|2
5328257|NCT00251719|18345327|P3|Overall Study|Noncompliance|1
5328258|NCT00251719|18345328|P2|Overall Study|Noncompliance|3
5328259|NCT00251719|18345329|P1|Overall Study|Noncompliance|2
5328260|NCT00251719|18345327|P3|Overall Study|Investigator decision|0
5328261|NCT00251719|18345328|P2|Overall Study|Investigator decision|1
5328262|NCT00251719|18345329|P1|Overall Study|Investigator decision|1
5328263|NCT00251719|18345327|P3|Overall Study|Inclusion/exclusion criteria not met|2
5328264|NCT00251719|18345328|P2|Overall Study|Inclusion/exclusion criteria not met|6
5328265|NCT00251719|18345329|P1|Overall Study|Inclusion/exclusion criteria not met|12
5328266|NCT00251719|18345327|P3|Overall Study|Lack of Efficacy|0
5328267|NCT00251719|18345328|P2|Overall Study|Lack of Efficacy|1
5328268|NCT00251719|18345329|P1|Overall Study|Lack of Efficacy|2
5328269|NCT00251719|18345327|P3|Overall Study|Withdrawal by Subject|11
5328270|NCT00251719|18345328|P2|Overall Study|Withdrawal by Subject|12
5328271|NCT00251719|18345329|P1|Overall Study|Withdrawal by Subject|14
5328272|NCT00251719|18345327|P3|Overall Study|Lost to Follow-up|8
5328273|NCT00251719|18345328|P2|Overall Study|Lost to Follow-up|11
5328274|NCT00251719|18345329|P1|Overall Study|Lost to Follow-up|5
5328275|NCT00251719|18345327|P3|Overall Study|Protocol Violation|1
5328276|NCT00251719|18345328|P2|Overall Study|Protocol Violation|1
5328277|NCT00251719|18345329|P1|Overall Study|Protocol Violation|1
5328278|NCT00251719|18345327|P3|Overall Study|Adverse Event|7
5328279|NCT00251719|18345328|P2|Overall Study|Adverse Event|8
5328280|NCT00251719|18345329|P1|Overall Study|Adverse Event|14
5328281|NCT00251693|18345355|P3|Overall Study|Abnormal laboratory findings|1
5328282|NCT00251693|18345356|P2|Overall Study|Abnormal laboratory findings|0
5328283|NCT00251693|18345357|P1|Overall Study|Abnormal laboratory findings|0
5328284|NCT00251693|18345355|P3|Overall Study|Subject request/subject unavailable|0
5328285|NCT00251693|18345356|P2|Overall Study|Subject request/subject unavailable|2
5328286|NCT00251693|18345357|P1|Overall Study|Subject request/subject unavailable|1
5328287|NCT00251693|18345355|P3|Overall Study|Possible Barrett's esophagus|2
5328288|NCT00251693|18345356|P2|Overall Study|Possible Barrett's esophagus|5
5328289|NCT00251693|18345357|P1|Overall Study|Possible Barrett's esophagus|3
5328290|NCT00251693|18345355|P3|Overall Study|Noncompliant|2
5328291|NCT00251693|18345356|P2|Overall Study|Noncompliant|0
5328292|NCT00251693|18345357|P1|Overall Study|Noncompliant|0
5328293|NCT00251693|18345355|P3|Overall Study|Inclusion/exclusion criteria not met|8
5328294|NCT00251693|18345356|P2|Overall Study|Inclusion/exclusion criteria not met|3
5328295|NCT00251693|18345357|P1|Overall Study|Inclusion/exclusion criteria not met|5
5328296|NCT00251693|18345355|P3|Overall Study|Lack of Efficacy|0
5328297|NCT00251693|18345356|P2|Overall Study|Lack of Efficacy|1
5328298|NCT00251693|18345357|P1|Overall Study|Lack of Efficacy|0
5328299|NCT00251693|18345355|P3|Overall Study|Withdrawal by Subject|14
5328300|NCT00251693|18345356|P2|Overall Study|Withdrawal by Subject|17
5328301|NCT00251693|18345357|P1|Overall Study|Withdrawal by Subject|11
5328302|NCT00251693|18345355|P3|Overall Study|Lost to Follow-up|8
5328303|NCT00251693|18345356|P2|Overall Study|Lost to Follow-up|7
5328304|NCT00251693|18345357|P1|Overall Study|Lost to Follow-up|12
5328305|NCT00251693|18345355|P3|Overall Study|Protocol Violation|2
5328306|NCT00251693|18345356|P2|Overall Study|Protocol Violation|0
5328307|NCT00251693|18345357|P1|Overall Study|Protocol Violation|2
5328308|NCT00251693|18345355|P3|Overall Study|Adverse Event|9
5328309|NCT00251693|18345356|P2|Overall Study|Adverse Event|9
5328310|NCT00251693|18345357|P1|Overall Study|Adverse Event|17
5328311|NCT00251641|18345382|P2|Overall Study|Switched Treatment|63
5328312|NCT00251641|18345383|P1|Overall Study|Switched Treatment|9
5328313|NCT00251641|18345382|P2|Overall Study|Did not Meet protocol Eligibility|1
5328314|NCT00251641|18345383|P1|Overall Study|Did not Meet protocol Eligibility|2
5328315|NCT00251641|18345382|P2|Overall Study|Protocol Violation|2
5328316|NCT00251641|18345383|P1|Overall Study|Protocol Violation|10
5328317|NCT00251641|18345382|P2|Overall Study|Withdrawal by Subject|8
5328318|NCT00251641|18345383|P1|Overall Study|Withdrawal by Subject|6
5328319|NCT00251641|18345382|P2|Overall Study|Lost to Follow-up|3
5328320|NCT00251641|18345383|P1|Overall Study|Lost to Follow-up|3
5328321|NCT00251641|18345382|P2|Overall Study|Progression of Disease|2
5328322|NCT00251641|18345383|P1|Overall Study|Progression of Disease|0
5328323|NCT00251641|18345382|P2|Overall Study|Lack of Efficacy|1
5328324|NCT00251641|18345383|P1|Overall Study|Lack of Efficacy|2
5328325|NCT00251641|18345382|P2|Overall Study|Adverse Event|8
5328326|NCT00251641|18345383|P1|Overall Study|Adverse Event|80
5328327|NCT00251589|18345401|P4|Overall Study|Discontinued due to progressive disease|1
5328328|NCT00251589|18345402|P3|Overall Study|Discontinued due to progressive disease|0
5328329|NCT00251589|18345403|P2|Overall Study|Discontinued due to progressive disease|1
5328330|NCT00251589|18345404|P1|Overall Study|Discontinued due to progressive disease|9
5328331|NCT00251589|18345401|P4|Overall Study|Withdrawal by Subject|0
5328332|NCT00251589|18345402|P3|Overall Study|Withdrawal by Subject|0
5328333|NCT00251589|18345403|P2|Overall Study|Withdrawal by Subject|1
5328334|NCT00251589|18345404|P1|Overall Study|Withdrawal by Subject|1
5328335|NCT00251589|18345401|P4|Overall Study|Adverse Event|1
5328336|NCT00251589|18345402|P3|Overall Study|Adverse Event|2
5328337|NCT00251589|18345403|P2|Overall Study|Adverse Event|1
5328338|NCT00251589|18345404|P1|Overall Study|Adverse Event|5
5328339|NCT00251316|18345441|P2|Overall Study|Physician Decision|3
5328340|NCT00251316|18345442|P1|Overall Study|Physician Decision|2
5328341|NCT00251004|18345481|P3|Overall Study|Graft Loss|8
5328342|NCT00251004|18345482|P2|Overall Study|Graft Loss|13
5328343|NCT00251004|18345483|P1|Overall Study|Graft Loss|12
5328344|NCT00251004|18345481|P3|Overall Study|Lost to Follow-up|1
5328345|NCT00251004|18345482|P2|Overall Study|Lost to Follow-up|2
5328346|NCT00251004|18345483|P1|Overall Study|Lost to Follow-up|1
5328347|NCT00251004|18345481|P3|Overall Study|Death|8
5328348|NCT00251004|18345482|P2|Overall Study|Death|10
5328349|NCT00251004|18345483|P1|Overall Study|Death|9
5328350|NCT00251004|18345481|P3|Overall Study|Withdrawal by Subject|14
5328351|NCT00251004|18345482|P2|Overall Study|Withdrawal by Subject|16
5328352|NCT00251004|18345483|P1|Overall Study|Withdrawal by Subject|23
5328353|NCT00250835|18345507|P1|Overall Study|Withdrawal by Subject|1
5328354|NCT00250718|18345516|P1|Overall Study|Withdrawal by Subject|1
5328355|NCT00250718|18345516|P1|Overall Study|Adverse Event|1
5328356|NCT00250718|18345516|P1|Overall Study|Death|1
5328357|NCT00250705|18345521|P1|Overall Study|Lack of Efficacy|2
5328358|NCT00250679|18345532|P3|Overall Study|various single events: hip surgery,diary|1
5328359|NCT00250679|18345533|P2|Overall Study|various single events: hip surgery,diary|1
5328360|NCT00250679|18345534|P1|Overall Study|various single events: hip surgery,diary|3
5328361|NCT00250679|18345532|P3|Overall Study|Non-compliance|0
5328362|NCT00250679|18345533|P2|Overall Study|Non-compliance|1
5328363|NCT00250679|18345534|P1|Overall Study|Non-compliance|1
5328364|NCT00250679|18345532|P3|Overall Study|Moved|0
5328365|NCT00250679|18345533|P2|Overall Study|Moved|1
5328366|NCT00250679|18345534|P1|Overall Study|Moved|1
5328367|NCT00250679|18345532|P3|Overall Study|Technical Holter issues|2
5328368|NCT00250679|18345533|P2|Overall Study|Technical Holter issues|0
5328369|NCT00250679|18345534|P1|Overall Study|Technical Holter issues|1
5328370|NCT00250679|18345532|P3|Overall Study|Lack of Efficacy|3
5328371|NCT00250679|18345533|P2|Overall Study|Lack of Efficacy|1
5328372|NCT00250679|18345534|P1|Overall Study|Lack of Efficacy|0
5328373|NCT00250679|18345532|P3|Overall Study|Does Not Meet Entry Criteria|2
5328374|NCT00250679|18345533|P2|Overall Study|Does Not Meet Entry Criteria|4
5328375|NCT00250679|18345534|P1|Overall Study|Does Not Meet Entry Criteria|1
5328376|NCT00250679|18345532|P3|Overall Study|Lost to Follow-up|2
5328377|NCT00250679|18345533|P2|Overall Study|Lost to Follow-up|4
5328378|NCT00250679|18345534|P1|Overall Study|Lost to Follow-up|3
5328379|NCT00250679|18345532|P3|Overall Study|Withdrawal by Subject|15
5328380|NCT00250679|18345533|P2|Overall Study|Withdrawal by Subject|18
5328381|NCT00250679|18345534|P1|Overall Study|Withdrawal by Subject|15
5328382|NCT00250679|18345532|P3|Overall Study|Protocol Violation|3
5328383|NCT00250679|18345533|P2|Overall Study|Protocol Violation|4
5328384|NCT00250679|18345534|P1|Overall Study|Protocol Violation|2
5328385|NCT00250679|18345532|P3|Overall Study|Adverse Event|16
5328386|NCT00250679|18345533|P2|Overall Study|Adverse Event|15
5328387|NCT00250679|18345534|P1|Overall Study|Adverse Event|12
5328388|NCT00250588|18345635|P3|Overall Study|Lost to Follow-up|13
5328389|NCT00250588|18345636|P2|Overall Study|Lost to Follow-up|13
5328390|NCT00250588|18345637|P1|Overall Study|Lost to Follow-up|6
5328391|NCT00250588|18345635|P3|Overall Study|Withdrawal by Subject|0
5328392|NCT00250588|18345636|P2|Overall Study|Withdrawal by Subject|6
5328393|NCT00250588|18345637|P1|Overall Study|Withdrawal by Subject|3
5328394|NCT00250458|18345685|P2|Overall Study|Other|0
5328395|NCT00250458|18345686|P1|Overall Study|Other|1
5328396|NCT00250458|18345685|P2|Overall Study|Qualifying migraine but did not treat|3
5328397|NCT00250458|18345686|P1|Overall Study|Qualifying migraine but did not treat|3
5328398|NCT00250458|18345685|P2|Overall Study|Lack of Migraine Attack|9
5328399|NCT00250458|18345686|P1|Overall Study|Lack of Migraine Attack|20
5328400|NCT00250458|18345685|P2|Overall Study|Withdrawal by Subject|2
5328401|NCT00250458|18345686|P1|Overall Study|Withdrawal by Subject|4
5328402|NCT00250458|18345685|P2|Overall Study|Protocol Violation|1
5328403|NCT00250458|18345686|P1|Overall Study|Protocol Violation|0
5328404|NCT00250458|18345685|P2|Overall Study|Lost to Follow-up|2
5328405|NCT00250458|18345686|P1|Overall Study|Lost to Follow-up|4
5328406|NCT00250432|18345696|P2|Overall Study|Pt was considered untreatable|1
5328407|NCT00250432|18345697|P1|Overall Study|Pt was considered untreatable|0
5328408|NCT00250432|18345696|P2|Overall Study|Pt died out of posttherapy report period|5
5328409|NCT00250432|18345697|P1|Overall Study|Pt died out of posttherapy report period|6
5328410|NCT00250432|18345696|P2|Overall Study|Withdrawal by Subject|2
5328411|NCT00250432|18345697|P1|Overall Study|Withdrawal by Subject|6
5328412|NCT00250432|18345696|P2|Overall Study|Protocol Violation|3
5328413|NCT00250432|18345697|P1|Overall Study|Protocol Violation|0
5328414|NCT00250432|18345696|P2|Overall Study|Patient Moved|1
5328415|NCT00250432|18345697|P1|Overall Study|Patient Moved|0
5328416|NCT00250432|18345696|P2|Overall Study|Lost to Follow-up|5
5328417|NCT00250432|18345697|P1|Overall Study|Lost to Follow-up|6
5328418|NCT00250432|18345696|P2|Overall Study|Lack of Efficacy|1
5328419|NCT00250432|18345697|P1|Overall Study|Lack of Efficacy|2
5328420|NCT00250432|18345696|P2|Overall Study|Adverse Event|29
5328421|NCT00250432|18345697|P1|Overall Study|Adverse Event|25
5328422|NCT00250276|18345709|P4|Overall Study|Lost to Follow-up|8
5328423|NCT00250276|18345710|P3|Overall Study|Lost to Follow-up|13
5328424|NCT00250276|18345711|P2|Overall Study|Lost to Follow-up|18
5328425|NCT00250276|18345712|P1|Overall Study|Lost to Follow-up|11
5328426|NCT00250276|18345709|P4|Overall Study|Migrated/moved from study area|7
5328427|NCT00250276|18345710|P3|Overall Study|Migrated/moved from study area|2
5328428|NCT00250276|18345711|P2|Overall Study|Migrated/moved from study area|0
5328429|NCT00250276|18345712|P1|Overall Study|Migrated/moved from study area|3
5328430|NCT00250276|18345709|P4|Overall Study|Withdrawal by Subject|2
5328431|NCT00250276|18345710|P3|Overall Study|Withdrawal by Subject|3
5328432|NCT00250276|18345711|P2|Overall Study|Withdrawal by Subject|2
5328433|NCT00250276|18345712|P1|Overall Study|Withdrawal by Subject|1
5328434|NCT00250276|18345709|P4|Overall Study|Protocol Violation|0
5328435|NCT00250276|18345710|P3|Overall Study|Protocol Violation|0
5328436|NCT00250276|18345711|P2|Overall Study|Protocol Violation|1
5328437|NCT00250276|18345712|P1|Overall Study|Protocol Violation|0
5328438|NCT00250276|18345709|P4|Overall Study|Non-serious Adverse Event|2
5328439|NCT00250276|18345710|P3|Overall Study|Non-serious Adverse Event|0
5328440|NCT00250276|18345711|P2|Overall Study|Non-serious Adverse Event|0
5328441|NCT00250276|18345712|P1|Overall Study|Non-serious Adverse Event|2
5328442|NCT00250276|18345709|P4|Overall Study|Serious Adverse Event|0
5328443|NCT00250276|18345710|P3|Overall Study|Serious Adverse Event|1
5328444|NCT00250276|18345711|P2|Overall Study|Serious Adverse Event|0
5328445|NCT00250276|18345712|P1|Overall Study|Serious Adverse Event|0
5328446|NCT00249873|18345792|P2|Overall Study|Thromboembolic/outcome event|122
5328447|NCT00249873|18345793|P1|Overall Study|Thromboembolic/outcome event|82
5328448|NCT00249873|18345792|P2|Overall Study|Event related to cardiac condition|21
5328449|NCT00249873|18345793|P1|Overall Study|Event related to cardiac condition|12
5328450|NCT00249873|18345792|P2|Overall Study|Surgery/ procedure|9
5328451|NCT00249873|18345793|P1|Overall Study|Surgery/ procedure|9
5328452|NCT00249873|18345792|P2|Overall Study|Study drug intolerance|0
5328453|NCT00249873|18345793|P1|Overall Study|Study drug intolerance|5
5328454|NCT00249873|18345792|P2|Overall Study|Oral anticoagulant required|157
5328455|NCT00249873|18345793|P1|Overall Study|Oral anticoagulant required|159
5328456|NCT00249873|18345792|P2|Overall Study|Angiotensin II receptor blocker required|0
5328457|NCT00249873|18345793|P1|Overall Study|Angiotensin II receptor blocker required|1
5328458|NCT00249873|18345792|P2|Overall Study|Open label clopidogrel required|42
5328459|NCT00249873|18345793|P1|Overall Study|Open label clopidogrel required|31
5328460|NCT00249873|18345792|P2|Overall Study|Physician withdrew consent|60
5328461|NCT00249873|18345793|P1|Overall Study|Physician withdrew consent|59
5328462|NCT00249873|18345792|P2|Overall Study|Patient not wish to continue after May08|4
5328463|NCT00249873|18345793|P1|Overall Study|Patient not wish to continue after May08|3
5328464|NCT00249873|18345792|P2|Overall Study|Other contraindicated medication|0
5328465|NCT00249873|18345793|P1|Overall Study|Other contraindicated medication|1
5328466|NCT00249873|18345792|P2|Overall Study|Other non serious Adverse Event|108
5328467|NCT00249873|18345793|P1|Overall Study|Other non serious Adverse Event|112
5328468|NCT00249873|18345792|P2|Overall Study|Non-compliance|46
5328469|NCT00249873|18345793|P1|Overall Study|Non-compliance|41
5328470|NCT00249873|18345792|P2|Overall Study|Minor bleeding|37
5328471|NCT00249873|18345793|P1|Overall Study|Minor bleeding|99
5328472|NCT00249873|18345792|P2|Overall Study|Lost to Follow-up|7
5328473|NCT00249873|18345793|P1|Overall Study|Lost to Follow-up|4
5328474|NCT00249873|18345792|P2|Overall Study|Withdrawal by Subject|466
5328475|NCT00249873|18345793|P1|Overall Study|Withdrawal by Subject|504
5328476|NCT00249873|18345792|P2|Overall Study|Contraindication to oral anticoagulant|8
5328477|NCT00249873|18345793|P1|Overall Study|Contraindication to oral anticoagulant|4
5328478|NCT00249873|18345792|P2|Overall Study|Qualifying condition not present|23
5328479|NCT00249873|18345793|P1|Overall Study|Qualifying condition not present|20
5328480|NCT00249873|18345792|P2|Overall Study|Other Serious Adverse Event|97
5328481|NCT00249873|18345793|P1|Overall Study|Other Serious Adverse Event|86
5328482|NCT00249873|18345792|P2|Overall Study|Serious haemorrhagic Adverse Event|30
5328483|NCT00249873|18345793|P1|Overall Study|Serious haemorrhagic Adverse Event|74
5328484|NCT00249873|18345792|P2|Overall Study|Severe allergic reaction|1
5328485|NCT00249873|18345793|P1|Overall Study|Severe allergic reaction|8
5328486|NCT00249873|18345792|P2|Overall Study|Significant thrombocytopenia|8
5328487|NCT00249873|18345793|P1|Overall Study|Significant thrombocytopenia|9
5328488|NCT00249873|18345792|P2|Overall Study|Not treated|8
5328489|NCT00249873|18345793|P1|Overall Study|Not treated|7
5328490|NCT00249834|18345813|P8|Overall Study|Protocol Violation|0
5328491|NCT00249834|18345814|P7|Overall Study|Protocol Violation|0
5328492|NCT00249834|18345815|P6|Overall Study|Protocol Violation|2
5328493|NCT00249834|18345816|P5|Overall Study|Protocol Violation|5
5328494|NCT00249834|18345817|P4|Overall Study|Protocol Violation|8
5328495|NCT00249834|18345818|P3|Overall Study|Protocol Violation|14
5328496|NCT00249834|18345819|P2|Overall Study|Protocol Violation|19
5328497|NCT00249834|18345820|P1|Overall Study|Protocol Violation|0
5328498|NCT00249834|18345813|P8|Overall Study|Failure of down-regulation|0
5328499|NCT00249834|18345814|P7|Overall Study|Failure of down-regulation|1
5328500|NCT00249834|18345815|P6|Overall Study|Failure of down-regulation|0
5328501|NCT00249834|18345816|P5|Overall Study|Failure of down-regulation|0
5328502|NCT00249834|18345817|P4|Overall Study|Failure of down-regulation|0
5328503|NCT00249834|18345818|P3|Overall Study|Failure of down-regulation|0
5328504|NCT00249834|18345819|P2|Overall Study|Failure of down-regulation|0
5328505|NCT00249834|18345820|P1|Overall Study|Failure of down-regulation|0
5328506|NCT00249834|18345813|P8|Overall Study|Ovarian stimulation failed|0
5328507|NCT00249834|18345814|P7|Overall Study|Ovarian stimulation failed|0
5328508|NCT00249834|18345815|P6|Overall Study|Ovarian stimulation failed|0
5328509|NCT00249834|18345816|P5|Overall Study|Ovarian stimulation failed|0
5328510|NCT00249834|18345817|P4|Overall Study|Ovarian stimulation failed|0
5328511|NCT00249834|18345818|P3|Overall Study|Ovarian stimulation failed|0
5328512|NCT00249834|18345819|P2|Overall Study|Ovarian stimulation failed|0
5328513|NCT00249834|18345820|P1|Overall Study|Ovarian stimulation failed|1
5328514|NCT00249821|18345869|P2|Overall Study|Technical problem|1
5328515|NCT00249821|18345870|P1|Overall Study|Technical problem|0
5328516|NCT00249808|18345890|P1|Overall Study|Did Not Provide Post-Baseline Data|11
5328517|NCT00249808|18345890|P1|Overall Study|Lack of Efficacy|52
5328518|NCT00249808|18345890|P1|Overall Study|Adverse Event|81
5328519|NCT00249808|18345890|P1|Overall Study|Lost to Follow-up|8
5328520|NCT00249808|18345890|P1|Overall Study|Protocol Violation|3
5328521|NCT00249808|18345890|P1|Overall Study|Other|27
5328522|NCT00249795|18345898|P2|Overall Study|Missing|1
5328523|NCT00249795|18345899|P1|Overall Study|Missing|0
5328524|NCT00249795|18345898|P2|Overall Study|Lost to Follow-up|2
5328525|NCT00249795|18345899|P1|Overall Study|Lost to Follow-up|0
5328526|NCT00249795|18345898|P2|Overall Study|Site not agree to continue after May08|1
5328527|NCT00249795|18345899|P1|Overall Study|Site not agree to continue after May08|1
5328528|NCT00249795|18345898|P2|Overall Study|Patient not wish to continue after May08|6
5328529|NCT00249795|18345899|P1|Overall Study|Patient not wish to continue after May08|4
5328530|NCT00249795|18345898|P2|Overall Study|Event related to cardiac condition|16
5328531|NCT00249795|18345899|P1|Overall Study|Event related to cardiac condition|17
5328532|NCT00249795|18345898|P2|Overall Study|Other contraindicated medication|1
5328533|NCT00249795|18345899|P1|Overall Study|Other contraindicated medication|1
5328534|NCT00249795|18345898|P2|Overall Study|Hypotension (non-symptomatic)|5
5328535|NCT00249795|18345899|P1|Overall Study|Hypotension (non-symptomatic)|5
5328536|NCT00249795|18345898|P2|Overall Study|Lightheadedness / dizziness|11
5328537|NCT00249795|18345899|P1|Overall Study|Lightheadedness / dizziness|15
5328538|NCT00249795|18345898|P2|Overall Study|Angiotensin II receptor blocker required|58
5328539|NCT00249795|18345899|P1|Overall Study|Angiotensin II receptor blocker required|35
5328540|NCT00249795|18345898|P2|Overall Study|Surgery / procedure|5
5328541|NCT00249795|18345899|P1|Overall Study|Surgery / procedure|4
5328542|NCT00249795|18345898|P2|Overall Study|Physician withdrew consent|63
5328543|NCT00249795|18345899|P1|Overall Study|Physician withdrew consent|71
5328544|NCT00249795|18345898|P2|Overall Study|Other adverse events (non-serious)|159
5328545|NCT00249795|18345899|P1|Overall Study|Other adverse events (non-serious)|188
5328546|NCT00249795|18345898|P2|Overall Study|Study drug intolerance|3
5328547|NCT00249795|18345899|P1|Overall Study|Study drug intolerance|3
5328548|NCT00249795|18345898|P2|Overall Study|Non-compliance|69
5328549|NCT00249795|18345899|P1|Overall Study|Non-compliance|71
5328550|NCT00249795|18345898|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
5328551|NCT00249795|18345899|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
5328552|NCT00249795|18345898|P2|Overall Study|Oral anticoagulant required|0
5328553|NCT00249795|18345899|P1|Overall Study|Oral anticoagulant required|2
5328554|NCT00249795|18345898|P2|Overall Study|Thromboembolic / outcome event|45
5328555|NCT00249795|18345899|P1|Overall Study|Thromboembolic / outcome event|39
5328556|NCT00249795|18345898|P2|Overall Study|Withdrawal by Subject|742
5328557|NCT00249795|18345899|P1|Overall Study|Withdrawal by Subject|678
5328558|NCT00249795|18345898|P2|Overall Study|Qualifying condition not present|29
5328559|NCT00249795|18345899|P1|Overall Study|Qualifying condition not present|26
5328560|NCT00249795|18345898|P2|Overall Study|Other Serious Adverse Event|93
5328561|NCT00249795|18345899|P1|Overall Study|Other Serious Adverse Event|84
5328562|NCT00249795|18345898|P2|Overall Study|Symptomatic hypotension|64
5328563|NCT00249795|18345899|P1|Overall Study|Symptomatic hypotension|127
5328564|NCT00249795|18345898|P2|Overall Study|Not treated|14
5328565|NCT00249795|18345899|P1|Overall Study|Not treated|16
5328566|NCT00249769|18345920|P3|Overall Study|Lost to Follow-up|3
5328567|NCT00249769|18345921|P2|Overall Study|Lost to Follow-up|0
5328568|NCT00249769|18345922|P1|Overall Study|Lost to Follow-up|0
5328569|NCT00249769|18345920|P3|Overall Study|Physician Decision|2
5328570|NCT00249769|18345921|P2|Overall Study|Physician Decision|0
5328571|NCT00249769|18345922|P1|Overall Study|Physician Decision|0
5328572|NCT00249769|18345920|P3|Overall Study|Adverse Event|1
5328573|NCT00249769|18345921|P2|Overall Study|Adverse Event|0
5328574|NCT00249769|18345922|P1|Overall Study|Adverse Event|0
5328575|NCT00249769|18345920|P3|Overall Study|Miscellaneous|2
5328576|NCT00249769|18345921|P2|Overall Study|Miscellaneous|2
5328577|NCT00249769|18345922|P1|Overall Study|Miscellaneous|0
5328578|NCT00249769|18345920|P3|Overall Study|Migration from Study Area|14
5328579|NCT00249769|18345921|P2|Overall Study|Migration from Study Area|3
5328580|NCT00249769|18345922|P1|Overall Study|Migration from Study Area|1
5328581|NCT00249769|18345920|P3|Overall Study|Withdrawal by Subject|6
5328582|NCT00249769|18345921|P2|Overall Study|Withdrawal by Subject|10
5328583|NCT00249769|18345922|P1|Overall Study|Withdrawal by Subject|1
5328584|NCT00249613|18345950|P2|12 Month Follow-up|Lost to Follow-up|8
5328585|NCT00249613|18345951|P1|12 Month Follow-up|Lost to Follow-up|10
5328586|NCT00249613|18345950|P2|12 Month Follow-up|Withdrawal by Subject|6
5328587|NCT00249613|18345951|P1|12 Month Follow-up|Withdrawal by Subject|6
5328588|NCT00249613|18345950|P2|12 Month Follow-up|Death|1
5328589|NCT00249613|18345951|P1|12 Month Follow-up|Death|1
5328590|NCT00249444|18345992|P2|Overall Study|life event|1
5328591|NCT00249444|18345993|P1|Overall Study|life event|0
5328592|NCT00249444|18345992|P2|Overall Study|Adverse Event|1
5328593|NCT00249444|18345993|P1|Overall Study|Adverse Event|1
5328594|NCT00249444|18345992|P2|Overall Study|non-compliant|11
5328595|NCT00249444|18345993|P1|Overall Study|non-compliant|9
5328596|NCT00249444|18345992|P2|Overall Study|Lost to Follow-up|2
5328597|NCT00249444|18345993|P1|Overall Study|Lost to Follow-up|2
5328598|NCT00249288|18346018|P2|Overall Study|Withdrawal by Subject|2
5328599|NCT00249288|18346019|P1|Overall Study|Withdrawal by Subject|2
5328600|NCT00249288|18346018|P2|Overall Study|Lost to Follow-up|3
5328601|NCT00249288|18346019|P1|Overall Study|Lost to Follow-up|3
5328602|NCT00249002|18346111|P1|Overall Study|Other|2
5328603|NCT00249002|18346111|P1|Overall Study|Study cancellation|3
5328604|NCT00249002|18346111|P1|Overall Study|Adverse Event|2
5328605|NCT00248833|18346130|P3|Overall Study|Other|0
5328606|NCT00248833|18346131|P2|Overall Study|Other|1
5328607|NCT00248833|18346132|P1|Overall Study|Other|0
5328608|NCT00248833|18346130|P3|Overall Study|Lost to Follow-up|1
5328609|NCT00248833|18346131|P2|Overall Study|Lost to Follow-up|1
5328610|NCT00248833|18346132|P1|Overall Study|Lost to Follow-up|1
5328611|NCT00248833|18346130|P3|Overall Study|Withdrawal by Subject|1
5328612|NCT00248833|18346131|P2|Overall Study|Withdrawal by Subject|1
5328613|NCT00248833|18346132|P1|Overall Study|Withdrawal by Subject|0
5328614|NCT00248833|18346130|P3|Overall Study|Adverse Event|0
5328615|NCT00248833|18346131|P2|Overall Study|Adverse Event|0
5328616|NCT00248833|18346132|P1|Overall Study|Adverse Event|2
5328617|NCT00248794|18346168|P3|Overall Study|Lost to Follow-up|3
5328618|NCT00248794|18346169|P2|Overall Study|Lost to Follow-up|8
5328619|NCT00248794|18346170|P1|Overall Study|Lost to Follow-up|6
5328620|NCT00248651|18346220|P3|Overall Study|Withdrawal by Subject|32
5328621|NCT00248651|18346221|P2|Overall Study|Withdrawal by Subject|40
5328622|NCT00248651|18346222|P1|Overall Study|Withdrawal by Subject|28
5328623|NCT00248625|18346258|P2|Overall Study|Withdrawal by Subject|2
5328624|NCT00248625|18346259|P1|Overall Study|Withdrawal by Subject|0
5328625|NCT00248495|18346351|P1|Overall Study|Withdrawal by Subject|1
5328626|NCT00248287|18346362|P2|Overall Study|Other|2
5328627|NCT00248287|18346363|P1|Overall Study|Other|3
5328628|NCT00248287|18346362|P2|Overall Study|Patient Request|3
5328629|NCT00248287|18346363|P1|Overall Study|Patient Request|5
5328630|NCT00248287|18346362|P2|Overall Study|Investigator Request|3
5328631|NCT00248287|18346363|P1|Overall Study|Investigator Request|4
5328632|NCT00248287|18346362|P2|Overall Study|Lost to Follow-up|1
5328633|NCT00248287|18346363|P1|Overall Study|Lost to Follow-up|0
5328634|NCT00248287|18346362|P2|Overall Study|Death|0
5328635|NCT00248287|18346363|P1|Overall Study|Death|1
5328636|NCT00248287|18346362|P2|Overall Study|Adverse Event|10
5328637|NCT00248287|18346363|P1|Overall Study|Adverse Event|11
5328638|NCT00248170|18346377|P2|Overall Study|Protocol deviation|19
5328639|NCT00248170|18346378|P1|Overall Study|Protocol deviation|17
5328640|NCT00248170|18346377|P2|Overall Study|Abnormal laboratory values|0
5328641|NCT00248170|18346378|P1|Overall Study|Abnormal laboratory values|4
5328642|NCT00248170|18346377|P2|Overall Study|Abnormal test procedure(s) result|61
5328643|NCT00248170|18346378|P1|Overall Study|Abnormal test procedure(s) result|49
5328644|NCT00248170|18346377|P2|Overall Study|Administrative problems|25
5328645|NCT00248170|18346378|P1|Overall Study|Administrative problems|22
5328646|NCT00248170|18346377|P2|Overall Study|Adverse Event|296
5328647|NCT00248170|18346378|P1|Overall Study|Adverse Event|311
5328648|NCT00248170|18346377|P2|Overall Study|Death|47
5328649|NCT00248170|18346378|P1|Overall Study|Death|28
5328650|NCT00248170|18346377|P2|Overall Study|Disease progression|216
5328651|NCT00248170|18346378|P1|Overall Study|Disease progression|196
5328652|NCT00248170|18346377|P2|Overall Study|Lost to Follow-up|35
5328653|NCT00248170|18346378|P1|Overall Study|Lost to Follow-up|28
5328654|NCT00248170|18346377|P2|Overall Study|Protocol Violation|30
5328655|NCT00248170|18346378|P1|Overall Study|Protocol Violation|35
5328656|NCT00248170|18346377|P2|Overall Study|Withdrawal by Subject|79
5328657|NCT00248170|18346378|P1|Overall Study|Withdrawal by Subject|71
5328658|NCT00248040|18346401|P3|Overall Study|Death|1
5328659|NCT00248040|18346402|P2|Overall Study|Death|0
5328660|NCT00248040|18346403|P1|Overall Study|Death|0
5328661|NCT00248040|18346401|P3|Overall Study|transplant cancelled post treat start|0
5328662|NCT00248040|18346402|P2|Overall Study|transplant cancelled post treat start|0
5328663|NCT00248040|18346403|P1|Overall Study|transplant cancelled post treat start|1
5328664|NCT00248040|18346401|P3|Overall Study|transplantectomy|3
5328665|NCT00248040|18346402|P2|Overall Study|transplantectomy|1
5328666|NCT00248040|18346403|P1|Overall Study|transplantectomy|2
5328667|NCT00247962|18346452|P2|Overall Study|Lack of Efficacy|2
5328668|NCT00247962|18346453|P1|Overall Study|Lack of Efficacy|4
5328669|NCT00247962|18346452|P2|Overall Study|Withdrawal by Subject|2
5328670|NCT00247962|18346453|P1|Overall Study|Withdrawal by Subject|3
5328671|NCT00247962|18346452|P2|Overall Study|Protocol Violation|1
5328672|NCT00247962|18346453|P1|Overall Study|Protocol Violation|1
5328673|NCT00247962|18346452|P2|Overall Study|Physician Decision|1
5328674|NCT00247962|18346453|P1|Overall Study|Physician Decision|0
5328675|NCT00247962|18346452|P2|Overall Study|Lost to Follow-up|1
5328676|NCT00247962|18346453|P1|Overall Study|Lost to Follow-up|3
5328677|NCT00247962|18346452|P2|Overall Study|Adverse Event|12
5328678|NCT00247962|18346453|P1|Overall Study|Adverse Event|15
5328679|NCT00247676|18346480|P1|Overall Study|Withdrawal by Subject|2
5328680|NCT00247676|18346480|P1|Overall Study|Other|3
5328681|NCT00247676|18346480|P1|Overall Study|Lack of Efficacy|15
5328682|NCT00247676|18346480|P1|Overall Study|Adverse Event|11
5328683|NCT00247676|18346480|P1|Overall Study|Death|5
5328684|NCT00247611|18346525|P2|Baselined|Completed baseline only|8
5328685|NCT00247611|18346526|P1|Baselined|Completed baseline only|9
5328686|NCT00247611|18346525|P2|Baselined|Completed baseline, never placed on ARVs|5
5328687|NCT00247611|18346526|P1|Baselined|Completed baseline, never placed on ARVs|8
5328688|NCT00247416|18346544|P2|Overall Study|3 patients were found to be ineligible|2
5328689|NCT00247416|18346545|P1|Overall Study|3 patients were found to be ineligible|1
5328690|NCT00247273|18346586|P2|Overall Study|Did not take any study drug|0
5328691|NCT00247273|18346587|P1|Overall Study|Did not take any study drug|2
5328692|NCT00247273|18346586|P2|Overall Study|Withdrawal by Subject|47
5328693|NCT00247273|18346587|P1|Overall Study|Withdrawal by Subject|46
5328694|NCT00247273|18346586|P2|Overall Study|Lost to Follow-up|7
5328695|NCT00247273|18346587|P1|Overall Study|Lost to Follow-up|7
5328696|NCT00247273|18346586|P2|Overall Study|Physician Decision|3
5328697|NCT00247273|18346587|P1|Overall Study|Physician Decision|6
5328698|NCT00247273|18346586|P2|Overall Study|Adverse Event|80
5328699|NCT00247273|18346587|P1|Overall Study|Adverse Event|85
5328700|NCT00246805|18346633|P2|Phase 1|Lost to Follow-up|0
5328701|NCT00246805|18346634|P1|Phase 1|Lost to Follow-up|1
5328702|NCT00246753|18346640|P1|Overall Study|Unacceptable toxicity|2
5328703|NCT00246753|18346640|P1|Overall Study|Adverse Event|2
5328704|NCT00246753|18346640|P1|Overall Study|Physician Decision|2
5328705|NCT00246753|18346640|P1|Overall Study|Withdrawal by Subject|2
5328706|NCT00246740|18346648|P2|Initial Enrollment|Other|2
5328707|NCT00246740|18346649|P1|Initial Enrollment|Other|1
5328708|NCT00246740|18346648|P2|Initial Enrollment|Surgery schedule change|4
5328709|NCT00246740|18346649|P1|Initial Enrollment|Surgery schedule change|4
5328710|NCT00246740|18346648|P2|Initial Enrollment|Additional surgery scheduled|2
5328711|NCT00246740|18346649|P1|Initial Enrollment|Additional surgery scheduled|0
5328712|NCT00246740|18346648|P2|Initial Enrollment|Death|0
5328713|NCT00246740|18346649|P1|Initial Enrollment|Death|1
5328714|NCT00246571|18346673|P2|Overall Study|Crossover participants|74
5328715|NCT00246571|18346674|P1|Overall Study|Crossover participants|0
5328716|NCT00246571|18346673|P2|Overall Study|Laboratory abnormalities|0
5328717|NCT00246571|18346674|P1|Overall Study|Laboratory abnormalities|1
5328718|NCT00246571|18346673|P2|Overall Study|Did not meet entrance criteria|1
5328719|NCT00246571|18346674|P1|Overall Study|Did not meet entrance criteria|2
5328720|NCT00246571|18346673|P2|Overall Study|Sponsor|1
5328721|NCT00246571|18346674|P1|Overall Study|Sponsor|0
5328722|NCT00246571|18346673|P2|Overall Study|Death|3
5328723|NCT00246571|18346674|P1|Overall Study|Death|17
5328724|NCT00246571|18346673|P2|Overall Study|Lack of Efficacy|21
5328725|NCT00246571|18346674|P1|Overall Study|Lack of Efficacy|84
5328726|NCT00246571|18346673|P2|Overall Study|Withdrawal by Subject|3
5328727|NCT00246571|18346674|P1|Overall Study|Withdrawal by Subject|2
5328728|NCT00246571|18346673|P2|Overall Study|Protocol Violation|1
5328729|NCT00246571|18346674|P1|Overall Study|Protocol Violation|0
5328730|NCT00246571|18346673|P2|Overall Study|Adverse Event|0
5328731|NCT00246571|18346674|P1|Overall Study|Adverse Event|7
5328732|NCT00246376|18346739|P5|Overall Study|Lost to Follow-up|13
5328733|NCT00246376|18346740|P4|Overall Study|Lost to Follow-up|16
5328734|NCT00246376|18346741|P3|Overall Study|Lost to Follow-up|11
5328735|NCT00246376|18346742|P2|Overall Study|Lost to Follow-up|11
5328736|NCT00246376|18346743|P1|Overall Study|Lost to Follow-up|2
5328737|NCT00246376|18346739|P5|Overall Study|Adverse Event|1
5328738|NCT00246376|18346740|P4|Overall Study|Adverse Event|3
5328739|NCT00246376|18346741|P3|Overall Study|Adverse Event|1
5328740|NCT00246376|18346742|P2|Overall Study|Adverse Event|3
5328741|NCT00246376|18346743|P1|Overall Study|Adverse Event|2
5328742|NCT00246376|18346739|P5|Overall Study|Dropped/withdrew during dietary run-in|3
5328743|NCT00246376|18346740|P4|Overall Study|Dropped/withdrew during dietary run-in|7
5328744|NCT00246376|18346741|P3|Overall Study|Dropped/withdrew during dietary run-in|4
5328745|NCT00246376|18346742|P2|Overall Study|Dropped/withdrew during dietary run-in|5
5328746|NCT00246376|18346743|P1|Overall Study|Dropped/withdrew during dietary run-in|11
5328747|NCT00246337|18346794|P9|Overall Study|Reported as completing trial in error|0
5328748|NCT00246337|18346795|P8|Overall Study|Reported as completing trial in error|1
5328749|NCT00246337|18346796|P7|Overall Study|Reported as completing trial in error|0
5328750|NCT00246337|18346797|P6|Overall Study|Reported as completing trial in error|0
5328751|NCT00246337|18346798|P5|Overall Study|Reported as completing trial in error|0
5328752|NCT00246337|18346799|P4|Overall Study|Reported as completing trial in error|0
5328753|NCT00246337|18346800|P3|Overall Study|Reported as completing trial in error|0
5328754|NCT00246337|18346801|P2|Overall Study|Reported as completing trial in error|0
5328755|NCT00246337|18346802|P1|Overall Study|Reported as completing trial in error|0
5328756|NCT00246337|18346794|P9|Overall Study|Protocol Violator|0
5328757|NCT00246337|18346795|P8|Overall Study|Protocol Violator|0
5328758|NCT00246337|18346796|P7|Overall Study|Protocol Violator|0
5328759|NCT00246337|18346797|P6|Overall Study|Protocol Violator|0
5328760|NCT00246337|18346798|P5|Overall Study|Protocol Violator|0
5328761|NCT00246337|18346799|P4|Overall Study|Protocol Violator|0
5328762|NCT00246337|18346800|P3|Overall Study|Protocol Violator|0
5328763|NCT00246337|18346801|P2|Overall Study|Protocol Violator|0
5328764|NCT00246337|18346802|P1|Overall Study|Protocol Violator|1
5328765|NCT00246337|18346794|P9|Overall Study|Overwhelmed|0
5328766|NCT00246337|18346795|P8|Overall Study|Overwhelmed|0
5328767|NCT00246337|18346796|P7|Overall Study|Overwhelmed|0
5328768|NCT00246337|18346797|P6|Overall Study|Overwhelmed|1
5328769|NCT00246337|18346798|P5|Overall Study|Overwhelmed|0
5328770|NCT00246337|18346799|P4|Overall Study|Overwhelmed|0
5328771|NCT00246337|18346800|P3|Overall Study|Overwhelmed|0
5328772|NCT00246337|18346801|P2|Overall Study|Overwhelmed|0
5328773|NCT00246337|18346802|P1|Overall Study|Overwhelmed|0
5328774|NCT00246337|18346794|P9|Overall Study|Abnormal baseline lab values|4
5328775|NCT00246337|18346795|P8|Overall Study|Abnormal baseline lab values|0
5328776|NCT00246337|18346796|P7|Overall Study|Abnormal baseline lab values|2
5328777|NCT00246337|18346797|P6|Overall Study|Abnormal baseline lab values|2
5328778|NCT00246337|18346798|P5|Overall Study|Abnormal baseline lab values|0
5328779|NCT00246337|18346799|P4|Overall Study|Abnormal baseline lab values|0
5328780|NCT00246337|18346800|P3|Overall Study|Abnormal baseline lab values|2
5328781|NCT00246337|18346801|P2|Overall Study|Abnormal baseline lab values|0
5328782|NCT00246337|18346802|P1|Overall Study|Abnormal baseline lab values|7
5328783|NCT00246337|18346794|P9|Overall Study|Site Terminated|2
5328784|NCT00246337|18346795|P8|Overall Study|Site Terminated|6
5328785|NCT00246337|18346796|P7|Overall Study|Site Terminated|1
5328786|NCT00246337|18346797|P6|Overall Study|Site Terminated|7
5328787|NCT00246337|18346798|P5|Overall Study|Site Terminated|0
5328788|NCT00246337|18346799|P4|Overall Study|Site Terminated|0
5328789|NCT00246337|18346800|P3|Overall Study|Site Terminated|0
5328790|NCT00246337|18346801|P2|Overall Study|Site Terminated|0
5328791|NCT00246337|18346802|P1|Overall Study|Site Terminated|10
5328792|NCT00246337|18346794|P9|Overall Study|Lack of Qualifying Event|5
5328793|NCT00246337|18346795|P8|Overall Study|Lack of Qualifying Event|2
5328794|NCT00246337|18346796|P7|Overall Study|Lack of Qualifying Event|3
5328795|NCT00246337|18346797|P6|Overall Study|Lack of Qualifying Event|3
5328796|NCT00246337|18346798|P5|Overall Study|Lack of Qualifying Event|1
5328797|NCT00246337|18346799|P4|Overall Study|Lack of Qualifying Event|1
5328798|NCT00246337|18346800|P3|Overall Study|Lack of Qualifying Event|1
5328799|NCT00246337|18346801|P2|Overall Study|Lack of Qualifying Event|2
5328800|NCT00246337|18346802|P1|Overall Study|Lack of Qualifying Event|8
5328801|NCT00246337|18346794|P9|Overall Study|Withdrawal by Subject|0
5328802|NCT00246337|18346795|P8|Overall Study|Withdrawal by Subject|1
5328803|NCT00246337|18346796|P7|Overall Study|Withdrawal by Subject|1
5328804|NCT00246337|18346797|P6|Overall Study|Withdrawal by Subject|0
5328805|NCT00246337|18346798|P5|Overall Study|Withdrawal by Subject|0
5328806|NCT00246337|18346799|P4|Overall Study|Withdrawal by Subject|0
5328807|NCT00246337|18346800|P3|Overall Study|Withdrawal by Subject|0
5328808|NCT00246337|18346801|P2|Overall Study|Withdrawal by Subject|0
5328809|NCT00246337|18346802|P1|Overall Study|Withdrawal by Subject|2
5328810|NCT00246337|18346794|P9|Overall Study|Protocol Violation|0
5328811|NCT00246337|18346795|P8|Overall Study|Protocol Violation|1
5328812|NCT00246337|18346796|P7|Overall Study|Protocol Violation|1
5328813|NCT00246337|18346797|P6|Overall Study|Protocol Violation|0
5328814|NCT00246337|18346798|P5|Overall Study|Protocol Violation|1
5328815|NCT00246337|18346799|P4|Overall Study|Protocol Violation|0
5328816|NCT00246337|18346800|P3|Overall Study|Protocol Violation|0
5328817|NCT00246337|18346801|P2|Overall Study|Protocol Violation|0
5328818|NCT00246337|18346802|P1|Overall Study|Protocol Violation|1
5328819|NCT00246337|18346794|P9|Overall Study|Lost to Follow-up|0
5328820|NCT00246337|18346795|P8|Overall Study|Lost to Follow-up|2
5328821|NCT00246337|18346796|P7|Overall Study|Lost to Follow-up|1
5328822|NCT00246337|18346797|P6|Overall Study|Lost to Follow-up|2
5328823|NCT00246337|18346798|P5|Overall Study|Lost to Follow-up|2
5328824|NCT00246337|18346799|P4|Overall Study|Lost to Follow-up|0
5328825|NCT00246337|18346800|P3|Overall Study|Lost to Follow-up|0
5328826|NCT00246337|18346801|P2|Overall Study|Lost to Follow-up|0
5328827|NCT00246337|18346802|P1|Overall Study|Lost to Follow-up|3
5328828|NCT00246324|18346849|P1|Overall Study|Withdrawal by Subject|1
5328829|NCT00246259|18346856|P2|Overall Study|randomly assigned, not eligible for ITT|6
5328830|NCT00246259|18346857|P1|Overall Study|randomly assigned, not eligible for ITT|2
5328831|NCT00246259|18346856|P2|Overall Study|Withdrawal by Subject|1
5328832|NCT00246259|18346857|P1|Overall Study|Withdrawal by Subject|5
5328833|NCT00246259|18346856|P2|Overall Study|Lost to Follow-up|4
5328834|NCT00246259|18346857|P1|Overall Study|Lost to Follow-up|3
5328835|NCT00246259|18346856|P2|Overall Study|Adverse Event|0
5328836|NCT00246259|18346857|P1|Overall Study|Adverse Event|5
5328837|NCT00246259|18346856|P2|Overall Study|Investigator withdrew participant|0
5328838|NCT00246259|18346857|P1|Overall Study|Investigator withdrew participant|2
5328839|NCT00246259|18346856|P2|Overall Study|Lack of Efficacy|2
5328840|NCT00246259|18346857|P1|Overall Study|Lack of Efficacy|2
5328841|NCT00246259|18346856|P2|Overall Study|Participant non-compliant|9
5328842|NCT00246259|18346857|P1|Overall Study|Participant non-compliant|4
5328843|NCT00246259|18346856|P2|Overall Study|Not stable by Week 18|1
5328844|NCT00246259|18346857|P1|Overall Study|Not stable by Week 18|2
5328845|NCT00246259|18346856|P2|Overall Study|Other|3
5328846|NCT00246259|18346857|P1|Overall Study|Other|3
5328847|NCT00246090|18346891|P1|Overall Study|Not Otherwise Specified|10
5328848|NCT00246090|18346891|P1|Overall Study|Physician Decision|11
5328849|NCT00246090|18346891|P1|Overall Study|Clinical Progression|30
5328850|NCT00246090|18346891|P1|Overall Study|Progressive Disease|212
5328851|NCT00246090|18346891|P1|Overall Study|Withdrawal by Subject|7
5328852|NCT00246090|18346891|P1|Overall Study|Adverse Event|25
5328853|NCT00246025|18346900|P4|Overall Study|unsuitable medical history was found|1
5328854|NCT00246025|18346901|P3|Overall Study|unsuitable medical history was found|0
5328855|NCT00246025|18346902|P2|Overall Study|unsuitable medical history was found|0
5328856|NCT00246025|18346903|P1|Overall Study|unsuitable medical history was found|0
5328857|NCT00246025|18346900|P4|Overall Study|Withdrawal by Subject|2
5328858|NCT00246025|18346901|P3|Overall Study|Withdrawal by Subject|1
5328859|NCT00246025|18346902|P2|Overall Study|Withdrawal by Subject|0
5328860|NCT00246025|18346903|P1|Overall Study|Withdrawal by Subject|3
5328861|NCT00246025|18346900|P4|Overall Study|Adverse Event|10
5328862|NCT00246025|18346901|P3|Overall Study|Adverse Event|9
5328863|NCT00246025|18346902|P2|Overall Study|Adverse Event|9
5328864|NCT00246025|18346903|P1|Overall Study|Adverse Event|7
5328865|NCT00246012|18346962|P9|Overall Study|Randomly assigned but not treated|0
5328866|NCT00246012|18346963|P8|Overall Study|Randomly assigned but not treated|0
5328867|NCT00246012|18346964|P7|Overall Study|Randomly assigned but not treated|1
5328868|NCT00246012|18346965|P6|Overall Study|Randomly assigned but not treated|1
5328869|NCT00246012|18346966|P5|Overall Study|Randomly assigned but not treated|0
5328870|NCT00246012|18346967|P4|Overall Study|Randomly assigned but not treated|0
5328871|NCT00246012|18346968|P3|Overall Study|Randomly assigned but not treated|0
5328872|NCT00246012|18346969|P2|Overall Study|Randomly assigned but not treated|0
5328873|NCT00246012|18346970|P1|Overall Study|Randomly assigned but not treated|0
5328874|NCT00246012|18346962|P9|Overall Study|Other|0
5328875|NCT00246012|18346963|P8|Overall Study|Other|1
5328876|NCT00246012|18346964|P7|Overall Study|Other|0
5328877|NCT00246012|18346965|P6|Overall Study|Other|0
5328878|NCT00246012|18346966|P5|Overall Study|Other|0
5328879|NCT00246012|18346967|P4|Overall Study|Other|0
5328880|NCT00246012|18346968|P3|Overall Study|Other|0
5328881|NCT00246012|18346969|P2|Overall Study|Other|0
5328882|NCT00246012|18346970|P1|Overall Study|Other|0
5328883|NCT00246012|18346962|P9|Overall Study|Disease progression|26
5328884|NCT00246012|18346963|P8|Overall Study|Disease progression|27
5328885|NCT00246012|18346964|P7|Overall Study|Disease progression|30
5328886|NCT00246012|18346965|P6|Overall Study|Disease progression|25
5328887|NCT00246012|18346966|P5|Overall Study|Disease progression|3
5328888|NCT00246012|18346967|P4|Overall Study|Disease progression|3
5328889|NCT00246012|18346968|P3|Overall Study|Disease progression|2
5328890|NCT00246012|18346969|P2|Overall Study|Disease progression|1
5328891|NCT00246012|18346970|P1|Overall Study|Disease progression|3
5328892|NCT00246012|18346962|P9|Overall Study|Withdrawal by Subject|0
5328893|NCT00246012|18346963|P8|Overall Study|Withdrawal by Subject|0
5328894|NCT00246012|18346964|P7|Overall Study|Withdrawal by Subject|0
5328895|NCT00246012|18346965|P6|Overall Study|Withdrawal by Subject|1
5328896|NCT00246012|18346966|P5|Overall Study|Withdrawal by Subject|0
5328897|NCT00246012|18346967|P4|Overall Study|Withdrawal by Subject|0
5328898|NCT00246012|18346968|P3|Overall Study|Withdrawal by Subject|0
5328899|NCT00246012|18346969|P2|Overall Study|Withdrawal by Subject|0
5328900|NCT00246012|18346970|P1|Overall Study|Withdrawal by Subject|0
5328901|NCT00246012|18346962|P9|Overall Study|Adverse Event|2
5328902|NCT00246012|18346963|P8|Overall Study|Adverse Event|0
5328903|NCT00246012|18346964|P7|Overall Study|Adverse Event|0
5328904|NCT00246012|18346965|P6|Overall Study|Adverse Event|1
5328905|NCT00246012|18346966|P5|Overall Study|Adverse Event|0
5328906|NCT00246012|18346967|P4|Overall Study|Adverse Event|0
5328907|NCT00246012|18346968|P3|Overall Study|Adverse Event|0
5328908|NCT00246012|18346969|P2|Overall Study|Adverse Event|0
5328909|NCT00246012|18346970|P1|Overall Study|Adverse Event|0
5328910|NCT00245960|18347065|P2|Overall Study|Lack of Efficacy|6
5328911|NCT00245960|18347066|P1|Overall Study|Lack of Efficacy|4
5328912|NCT00245960|18347065|P2|Overall Study|Withdrawal by Subject|7
5328913|NCT00245960|18347066|P1|Overall Study|Withdrawal by Subject|5
5328914|NCT00245960|18347065|P2|Overall Study|Protocol Violation|3
5328915|NCT00245960|18347066|P1|Overall Study|Protocol Violation|4
5328916|NCT00245960|18347065|P2|Overall Study|Lost to Follow-up|2
5328917|NCT00245960|18347066|P1|Overall Study|Lost to Follow-up|2
5328918|NCT00245960|18347065|P2|Overall Study|Adverse Event|10
5328919|NCT00245960|18347066|P1|Overall Study|Adverse Event|14
5328920|NCT00245856|18347074|P2|Period Two|Withdrawal by Subject|1
5328921|NCT00245856|18347075|P1|Period Two|Withdrawal by Subject|0
5328922|NCT00245765|18347085|P3|Overall Study|Other|4
5328923|NCT00245765|18347086|P2|Overall Study|Other|4
5328924|NCT00245765|18347087|P1|Overall Study|Other|13
5328925|NCT00245765|18347085|P3|Overall Study|Other reason|1
5328926|NCT00245765|18347086|P2|Overall Study|Other reason|0
5328927|NCT00245765|18347087|P1|Overall Study|Other reason|2
5328928|NCT00245765|18347085|P3|Overall Study|Withdrawal by Subject|3
5328929|NCT00245765|18347086|P2|Overall Study|Withdrawal by Subject|0
5328930|NCT00245765|18347087|P1|Overall Study|Withdrawal by Subject|1
5328931|NCT00245765|18347085|P3|Overall Study|Lost to Follow-up|0
5328932|NCT00245765|18347086|P2|Overall Study|Lost to Follow-up|2
5328933|NCT00245765|18347087|P1|Overall Study|Lost to Follow-up|1
5328934|NCT00245765|18347085|P3|Overall Study|Lack of Efficacy|0
5328935|NCT00245765|18347086|P2|Overall Study|Lack of Efficacy|7
5328936|NCT00245765|18347087|P1|Overall Study|Lack of Efficacy|14
5328937|NCT00245765|18347085|P3|Overall Study|Adverse Event|0
5328938|NCT00245765|18347086|P2|Overall Study|Adverse Event|1
5328939|NCT00245765|18347087|P1|Overall Study|Adverse Event|1
5328940|NCT00245583|18347136|P2|Overall Study|Withdrawal by Subject|3
5328941|NCT00245583|18347137|P1|Overall Study|Withdrawal by Subject|2
5328942|NCT00245583|18347136|P2|Overall Study|Lack of Efficacy|0
5328943|NCT00245583|18347137|P1|Overall Study|Lack of Efficacy|1
5328944|NCT00245583|18347136|P2|Overall Study|Adverse Event|1
5328945|NCT00245583|18347137|P1|Overall Study|Adverse Event|2
5328946|NCT00245583|18347136|P2|Overall Study|Lost to Follow-up|5
5328947|NCT00245583|18347137|P1|Overall Study|Lost to Follow-up|1
5328948|NCT00245570|18347157|P6|Washout Between Periods III and IV|Adverse Event|0
5328949|NCT00245570|18347158|P5|Washout Between Periods III and IV|Adverse Event|0
5328950|NCT00245570|18347159|P4|Washout Between Periods III and IV|Adverse Event|0
5328951|NCT00245570|18347160|P3|Washout Between Periods III and IV|Adverse Event|0
5328952|NCT00245570|18347161|P2|Washout Between Periods III and IV|Adverse Event|1
5328953|NCT00245570|18347162|P1|Washout Between Periods III and IV|Adverse Event|0
5328954|NCT00245466|18347296|P3|Overall Study|Administrative reasons|0
5328955|NCT00245466|18347297|P2|Overall Study|Administrative reasons|1
5328956|NCT00245466|18347298|P1|Overall Study|Administrative reasons|0
5328957|NCT00245466|18347296|P3|Overall Study|Death|0
5328958|NCT00245466|18347297|P2|Overall Study|Death|2
5328959|NCT00245466|18347298|P1|Overall Study|Death|0
5328960|NCT00245466|18347296|P3|Overall Study|Protocol Violation|2
5328961|NCT00245466|18347297|P2|Overall Study|Protocol Violation|2
5328962|NCT00245466|18347298|P1|Overall Study|Protocol Violation|1
5328963|NCT00245466|18347296|P3|Overall Study|Disease progression|1
5328964|NCT00245466|18347297|P2|Overall Study|Disease progression|3
5328965|NCT00245466|18347298|P1|Overall Study|Disease progression|0
5328966|NCT00245466|18347296|P3|Overall Study|Lost to Follow-up|0
5328967|NCT00245466|18347297|P2|Overall Study|Lost to Follow-up|0
5328968|NCT00245466|18347298|P1|Overall Study|Lost to Follow-up|3
5328969|NCT00245466|18347296|P3|Overall Study|Withdrawal by Subject|1
5328970|NCT00245466|18347297|P2|Overall Study|Withdrawal by Subject|2
5328971|NCT00245466|18347298|P1|Overall Study|Withdrawal by Subject|2
5328972|NCT00245466|18347296|P3|Overall Study|Insufficient PSA and testosterone suppr|3
5328973|NCT00245466|18347297|P2|Overall Study|Insufficient PSA and testosterone suppr|0
5328974|NCT00245466|18347298|P1|Overall Study|Insufficient PSA and testosterone suppr|0
5328975|NCT00245466|18347296|P3|Overall Study|Insufficient testosterone suppr|21
5328976|NCT00245466|18347297|P2|Overall Study|Insufficient testosterone suppr|12
5328977|NCT00245466|18347298|P1|Overall Study|Insufficient testosterone suppr|12
5328978|NCT00245466|18347296|P3|Overall Study|Low prostate specific antigen suppr|5
5328979|NCT00245466|18347297|P2|Overall Study|Low prostate specific antigen suppr|14
5328980|NCT00245466|18347298|P1|Overall Study|Low prostate specific antigen suppr|16
5328981|NCT00245466|18347296|P3|Overall Study|Adverse Event|4
5328982|NCT00245466|18347297|P2|Overall Study|Adverse Event|8
5328983|NCT00245466|18347298|P1|Overall Study|Adverse Event|2
5328984|NCT00245102|18347341|P6|Overall Study|Clinical progression|0
5328985|NCT00245102|18347342|P5|Overall Study|Clinical progression|0
5328986|NCT00245102|18347343|P4|Overall Study|Clinical progression|0
5328987|NCT00245102|18347344|P3|Overall Study|Clinical progression|0
5328988|NCT00245102|18347345|P2|Overall Study|Clinical progression|0
5328989|NCT00245102|18347346|P1|Overall Study|Clinical progression|1
5328990|NCT00245102|18347341|P6|Overall Study|Participant needed surgery|0
5328991|NCT00245102|18347342|P5|Overall Study|Participant needed surgery|0
5328992|NCT00245102|18347343|P4|Overall Study|Participant needed surgery|0
5328993|NCT00245102|18347344|P3|Overall Study|Participant needed surgery|1
5328994|NCT00245102|18347345|P2|Overall Study|Participant needed surgery|0
5328995|NCT00245102|18347346|P1|Overall Study|Participant needed surgery|0
5328996|NCT00245102|18347341|P6|Overall Study|Decline in performance|2
5328997|NCT00245102|18347342|P5|Overall Study|Decline in performance|0
5328998|NCT00245102|18347343|P4|Overall Study|Decline in performance|1
5328999|NCT00245102|18347344|P3|Overall Study|Decline in performance|0
5329000|NCT00245102|18347345|P2|Overall Study|Decline in performance|2
5329001|NCT00245102|18347346|P1|Overall Study|Decline in performance|0
5329002|NCT00245102|18347341|P6|Overall Study|Adverse Event|2
5329003|NCT00245102|18347342|P5|Overall Study|Adverse Event|0
5329004|NCT00245102|18347343|P4|Overall Study|Adverse Event|1
5329005|NCT00245102|18347344|P3|Overall Study|Adverse Event|5
5329006|NCT00245102|18347345|P2|Overall Study|Adverse Event|2
5329007|NCT00245102|18347346|P1|Overall Study|Adverse Event|4
5329008|NCT00245102|18347341|P6|Overall Study|Death|0
5329009|NCT00245102|18347342|P5|Overall Study|Death|0
5329010|NCT00245102|18347343|P4|Overall Study|Death|1
5329011|NCT00245102|18347344|P3|Overall Study|Death|0
5329012|NCT00245102|18347345|P2|Overall Study|Death|0
5329013|NCT00245102|18347346|P1|Overall Study|Death|0
5329014|NCT00245102|18347341|P6|Overall Study|Protocol Violation|0
5329015|NCT00245102|18347342|P5|Overall Study|Protocol Violation|0
5329016|NCT00245102|18347343|P4|Overall Study|Protocol Violation|0
5329017|NCT00245102|18347344|P3|Overall Study|Protocol Violation|0
5329018|NCT00245102|18347345|P2|Overall Study|Protocol Violation|0
5329019|NCT00245102|18347346|P1|Overall Study|Protocol Violation|1
5329020|NCT00245102|18347341|P6|Overall Study|Not Treated|0
5329021|NCT00245102|18347342|P5|Overall Study|Not Treated|0
5329022|NCT00245102|18347343|P4|Overall Study|Not Treated|0
5329023|NCT00245102|18347344|P3|Overall Study|Not Treated|1
5329024|NCT00245102|18347345|P2|Overall Study|Not Treated|0
5329025|NCT00245102|18347346|P1|Overall Study|Not Treated|1
5329026|NCT00245063|18347362|P2|Overall Study|Death|0
5329027|NCT00245063|18347363|P1|Overall Study|Death|1
5329028|NCT00245063|18347362|P2|Overall Study|Adverse Event|5
5329029|NCT00245063|18347363|P1|Overall Study|Adverse Event|6
5329030|NCT00245050|18347371|P2|Overall Study|Adverse Event|2
5329031|NCT00245050|18347372|P1|Overall Study|Adverse Event|3
5329032|NCT00245037|18347380|P1|Overall Study|Death|17
5329033|NCT00245011|18347390|P1|Overall Study|Lack of Efficacy|1
5329034|NCT00244933|18347407|P1|Overall Study|Not response evaluable|2
5329035|NCT00244881|18347411|P1|Overall Study|Withdrawal by Subject|3
5329036|NCT00244855|18347419|P2|Overall Study|Withdrawal by Subject|1
5329037|NCT00244855|18347420|P1|Overall Study|Withdrawal by Subject|0
5329038|NCT00244764|18347428|P1|Overall Study|Developed Secondary Malignancy|1
5329039|NCT00244764|18347428|P1|Overall Study|Sponsor Terminated Study|2
5329040|NCT00244764|18347428|P1|Overall Study|Primary Investigator Discretion|2
5329041|NCT00244764|18347428|P1|Overall Study|Participant was Hospitalized until Death|1
5329042|NCT00244764|18347428|P1|Overall Study|Declining Performance Status|1
5329043|NCT00244764|18347428|P1|Overall Study|Off Study Medication for >21 Days|1
5329044|NCT00244764|18347428|P1|Overall Study|Death|1
5329045|NCT00244764|18347428|P1|Overall Study|Protocol Violation|2
5329046|NCT00244764|18347428|P1|Overall Study|Disease Progression|13
5329047|NCT00244764|18347428|P1|Overall Study|Withdrawal by Subject|12
5329048|NCT00244764|18347428|P1|Overall Study|Lost to Follow-up|23
5329049|NCT00244764|18347428|P1|Overall Study|Adverse Event|37
5329050|NCT00244751|18347438|P3|Overall Study|Participant randomized by mistake|1
5329051|NCT00244751|18347439|P2|Overall Study|Participant randomized by mistake|0
5329052|NCT00244751|18347440|P1|Overall Study|Participant randomized by mistake|0
5329053|NCT00244751|18347438|P3|Overall Study|Safety reasons|0
5329054|NCT00244751|18347439|P2|Overall Study|Safety reasons|1
5329055|NCT00244751|18347440|P1|Overall Study|Safety reasons|0
5329056|NCT00244751|18347438|P3|Overall Study|Lack of compliance with protocol|0
5329057|NCT00244751|18347439|P2|Overall Study|Lack of compliance with protocol|1
5329058|NCT00244751|18347440|P1|Overall Study|Lack of compliance with protocol|0
5329059|NCT00244751|18347438|P3|Overall Study|Elevated liver enzymes|0
5329060|NCT00244751|18347439|P2|Overall Study|Elevated liver enzymes|0
5329061|NCT00244751|18347440|P1|Overall Study|Elevated liver enzymes|1
5329062|NCT00244751|18347438|P3|Overall Study|Withdrawal by Subject|3
5329063|NCT00244751|18347439|P2|Overall Study|Withdrawal by Subject|5
5329064|NCT00244751|18347440|P1|Overall Study|Withdrawal by Subject|7
5329065|NCT00244751|18347438|P3|Overall Study|Protocol Violation|1
5329066|NCT00244751|18347439|P2|Overall Study|Protocol Violation|0
5329067|NCT00244751|18347440|P1|Overall Study|Protocol Violation|1
5329068|NCT00244751|18347438|P3|Overall Study|Lost to Follow-up|0
5329069|NCT00244751|18347439|P2|Overall Study|Lost to Follow-up|1
5329070|NCT00244751|18347440|P1|Overall Study|Lost to Follow-up|0
5329071|NCT00244751|18347438|P3|Overall Study|Adverse Event|5
5329072|NCT00244751|18347439|P2|Overall Study|Adverse Event|7
5329073|NCT00244751|18347440|P1|Overall Study|Adverse Event|7
5329074|NCT00244725|18347541|P4|Overall Study|Failed to follow-up|1
5329075|NCT00244725|18347542|P3|Overall Study|Failed to follow-up|1
5329076|NCT00244725|18347543|P2|Overall Study|Failed to follow-up|0
5329077|NCT00244725|18347544|P1|Overall Study|Failed to follow-up|0
5329078|NCT00244725|18347541|P4|Overall Study|Vomit|0
5329079|NCT00244725|18347542|P3|Overall Study|Vomit|1
5329080|NCT00244725|18347543|P2|Overall Study|Vomit|0
5329081|NCT00244725|18347544|P1|Overall Study|Vomit|0
5329082|NCT00244725|18347541|P4|Overall Study|Administrative reason|0
5329083|NCT00244725|18347542|P3|Overall Study|Administrative reason|1
5329084|NCT00244725|18347543|P2|Overall Study|Administrative reason|0
5329085|NCT00244725|18347544|P1|Overall Study|Administrative reason|0
5329086|NCT00244725|18347541|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
5329087|NCT00244725|18347542|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
5329088|NCT00244725|18347543|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
5329089|NCT00244725|18347544|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
5329090|NCT00244725|18347541|P4|Overall Study|Received prohibited medication|1
5329091|NCT00244725|18347542|P3|Overall Study|Received prohibited medication|0
5329092|NCT00244725|18347543|P2|Overall Study|Received prohibited medication|1
5329093|NCT00244725|18347544|P1|Overall Study|Received prohibited medication|0
5329094|NCT00244725|18347541|P4|Overall Study|Headache|0
5329095|NCT00244725|18347542|P3|Overall Study|Headache|0
5329096|NCT00244725|18347543|P2|Overall Study|Headache|1
5329097|NCT00244725|18347544|P1|Overall Study|Headache|0
5329098|NCT00244725|18347541|P4|Overall Study|Rehab Refused to allow participantion|0
5329099|NCT00244725|18347542|P3|Overall Study|Rehab Refused to allow participantion|0
5329100|NCT00244725|18347543|P2|Overall Study|Rehab Refused to allow participantion|1
5329101|NCT00244725|18347544|P1|Overall Study|Rehab Refused to allow participantion|0
5329102|NCT00244725|18347541|P4|Overall Study|Mediciation Error|0
5329103|NCT00244725|18347542|P3|Overall Study|Mediciation Error|0
5329104|NCT00244725|18347543|P2|Overall Study|Mediciation Error|1
5329105|NCT00244725|18347544|P1|Overall Study|Mediciation Error|0
5329106|NCT00244725|18347541|P4|Overall Study|Sponsor withdrew the participant|1
5329107|NCT00244725|18347542|P3|Overall Study|Sponsor withdrew the participant|0
5329108|NCT00244725|18347543|P2|Overall Study|Sponsor withdrew the participant|0
5329109|NCT00244725|18347544|P1|Overall Study|Sponsor withdrew the participant|1
5329110|NCT00244725|18347541|P4|Overall Study|Liver function test abnormality|1
5329111|NCT00244725|18347542|P3|Overall Study|Liver function test abnormality|0
5329112|NCT00244725|18347543|P2|Overall Study|Liver function test abnormality|0
5329113|NCT00244725|18347544|P1|Overall Study|Liver function test abnormality|2
5329114|NCT00244725|18347541|P4|Overall Study|Withdrwal by participant|1
5329115|NCT00244725|18347542|P3|Overall Study|Withdrwal by participant|0
5329116|NCT00244725|18347543|P2|Overall Study|Withdrwal by participant|0
5329117|NCT00244725|18347544|P1|Overall Study|Withdrwal by participant|1
5329118|NCT00244725|18347541|P4|Overall Study|Adverse Events|4
5329119|NCT00244725|18347542|P3|Overall Study|Adverse Events|4
5329120|NCT00244725|18347543|P2|Overall Study|Adverse Events|1
5329121|NCT00244725|18347544|P1|Overall Study|Adverse Events|3
5329122|NCT00244725|18347541|P4|Overall Study|Physician Decision|2
5329123|NCT00244725|18347542|P3|Overall Study|Physician Decision|1
5329124|NCT00244725|18347543|P2|Overall Study|Physician Decision|0
5329125|NCT00244725|18347544|P1|Overall Study|Physician Decision|3
5329126|NCT00244725|18347541|P4|Overall Study|Not meet treatment eligibility criteria|0
5329127|NCT00244725|18347542|P3|Overall Study|Not meet treatment eligibility criteria|0
5329128|NCT00244725|18347543|P2|Overall Study|Not meet treatment eligibility criteria|2
5329129|NCT00244725|18347544|P1|Overall Study|Not meet treatment eligibility criteria|1
5329130|NCT00244725|18347541|P4|Overall Study|Withdrawal by Subject|8
5329131|NCT00244725|18347542|P3|Overall Study|Withdrawal by Subject|7
5329132|NCT00244725|18347543|P2|Overall Study|Withdrawal by Subject|7
5329133|NCT00244725|18347544|P1|Overall Study|Withdrawal by Subject|9
5329134|NCT00244725|18347541|P4|Overall Study|Lost to Follow-up|2
5329135|NCT00244725|18347542|P3|Overall Study|Lost to Follow-up|9
5329136|NCT00244725|18347543|P2|Overall Study|Lost to Follow-up|4
5329137|NCT00244725|18347544|P1|Overall Study|Lost to Follow-up|3
5329138|NCT00244712|18347600|P2|Overall Study|Protocol Violation, disease progression|11
5329139|NCT00244712|18347601|P1|Overall Study|Protocol Violation, disease progression|13
5329140|NCT00244712|18347600|P2|Overall Study|Withdrawal by Subject|23
5329141|NCT00244712|18347601|P1|Overall Study|Withdrawal by Subject|13
5329142|NCT00244712|18347600|P2|Overall Study|Lost to Follow-up|52
5329143|NCT00244712|18347601|P1|Overall Study|Lost to Follow-up|45
5329144|NCT00244712|18347600|P2|Overall Study|Lack of Compliance|11
5329145|NCT00244712|18347601|P1|Overall Study|Lack of Compliance|10
5329146|NCT00244712|18347600|P2|Overall Study|Protocol-Defined Virologic Failure|6
5329147|NCT00244712|18347601|P1|Overall Study|Protocol-Defined Virologic Failure|8
5329148|NCT00244712|18347600|P2|Overall Study|Adverse Event|21
5329149|NCT00244712|18347601|P1|Overall Study|Adverse Event|20
5329150|NCT00244621|18347636|P3|Open-label Treatment Period|Moved abroad|1
5329151|NCT00244621|18347637|P2|Open-label Treatment Period|Moved abroad|0
5329152|NCT00244621|18347638|P1|Open-label Treatment Period|Moved abroad|0
5329153|NCT00244621|18347636|P3|Open-label Treatment Period|Adverse Event|1
5329154|NCT00244621|18347637|P2|Open-label Treatment Period|Adverse Event|0
5329155|NCT00244621|18347638|P1|Open-label Treatment Period|Adverse Event|0
5329156|NCT00244621|18347636|P3|Open-label Treatment Period|Withdrawal by Subject|0
5329157|NCT00244621|18347637|P2|Open-label Treatment Period|Withdrawal by Subject|0
5329158|NCT00244621|18347638|P1|Open-label Treatment Period|Withdrawal by Subject|1
5329159|NCT00244621|18347636|P3|Open-label Treatment Period|Lost to Follow-up|0
5329160|NCT00244621|18347637|P2|Open-label Treatment Period|Lost to Follow-up|1
5329161|NCT00244621|18347638|P1|Open-label Treatment Period|Lost to Follow-up|0
5329162|NCT00244621|18347636|P3|Double-blind Treatment Period|Multiple Reasons|1
5329163|NCT00244621|18347637|P2|Double-blind Treatment Period|Multiple Reasons|1
5329164|NCT00244621|18347638|P1|Double-blind Treatment Period|Multiple Reasons|2
5329165|NCT00244621|18347636|P3|Double-blind Treatment Period|Lack of Efficacy|0
5329166|NCT00244621|18347637|P2|Double-blind Treatment Period|Lack of Efficacy|1
5329167|NCT00244621|18347638|P1|Double-blind Treatment Period|Lack of Efficacy|0
5329168|NCT00244621|18347636|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5329169|NCT00244621|18347637|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5329170|NCT00244621|18347638|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5329171|NCT00244621|18347636|P3|Double-blind Treatment Period|Lost to Follow-up|1
5329172|NCT00244621|18347637|P2|Double-blind Treatment Period|Lost to Follow-up|0
5329173|NCT00244621|18347638|P1|Double-blind Treatment Period|Lost to Follow-up|0
5329174|NCT00244374|18347655|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5329175|NCT00244374|18347656|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5329176|NCT00244374|18347657|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5329177|NCT00244374|18347658|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5329178|NCT00244374|18347659|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
5329179|NCT00244374|18347655|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5329180|NCT00244374|18347656|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5329181|NCT00244374|18347657|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5329182|NCT00244374|18347658|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5329183|NCT00244374|18347659|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
5329184|NCT00244374|18347655|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5329185|NCT00244374|18347656|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5329186|NCT00244374|18347657|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5329187|NCT00244374|18347658|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5329188|NCT00244374|18347659|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
5329189|NCT00244374|18347655|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5329190|NCT00244374|18347656|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5329191|NCT00244374|18347657|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5329192|NCT00244374|18347658|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5329193|NCT00244374|18347659|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
5329194|NCT00244374|18347655|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5329195|NCT00244374|18347656|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5329196|NCT00244374|18347657|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5329197|NCT00244374|18347658|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5329198|NCT00244374|18347659|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
5329199|NCT00244374|18347655|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5329200|NCT00244374|18347656|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5329201|NCT00244374|18347657|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5329202|NCT00244374|18347658|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5329203|NCT00244374|18347659|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
5329204|NCT00244374|18347655|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5329205|NCT00244374|18347656|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5329206|NCT00244374|18347657|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5329207|NCT00244374|18347658|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5329208|NCT00244374|18347659|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
5329209|NCT00244374|18347655|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5329210|NCT00244374|18347656|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5329211|NCT00244374|18347657|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5329212|NCT00244374|18347658|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5329213|NCT00244374|18347659|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
5329214|NCT00244374|18347655|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5329215|NCT00244374|18347656|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5329216|NCT00244374|18347657|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5329217|NCT00244374|18347658|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5329218|NCT00244374|18347659|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
5329219|NCT00243932|18347715|P3|Stage 1: Dose Selection|Lost to Follow-up|0
5329220|NCT00243932|18347716|P2|Stage 1: Dose Selection|Lost to Follow-up|0
5329221|NCT00243932|18347717|P1|Stage 1: Dose Selection|Lost to Follow-up|2
5329222|NCT00243919|18347728|P3|Overall Study|Physician Decision|0
5329223|NCT00243919|18347729|P2|Overall Study|Physician Decision|1
5329224|NCT00243919|18347730|P1|Overall Study|Physician Decision|1
5329225|NCT00243919|18347728|P3|Overall Study|Administrative Error|0
5329226|NCT00243919|18347729|P2|Overall Study|Administrative Error|0
5329227|NCT00243919|18347730|P1|Overall Study|Administrative Error|1
5329228|NCT00243919|18347728|P3|Overall Study|Lost to Follow-up|3
5329229|NCT00243919|18347729|P2|Overall Study|Lost to Follow-up|7
5329230|NCT00243919|18347730|P1|Overall Study|Lost to Follow-up|6
5329231|NCT00243919|18347728|P3|Overall Study|Withdrawal by Subject|2
5329232|NCT00243919|18347729|P2|Overall Study|Withdrawal by Subject|6
5329233|NCT00243919|18347730|P1|Overall Study|Withdrawal by Subject|6
5329234|NCT00243919|18347728|P3|Overall Study|Death|6
5329235|NCT00243919|18347729|P2|Overall Study|Death|4
5329236|NCT00243919|18347730|P1|Overall Study|Death|3
5329237|NCT00243841|18347774|P6|Overall Study|Physician Decision|2
5329238|NCT00243841|18347775|P5|Overall Study|Physician Decision|0
5329239|NCT00243841|18347776|P4|Overall Study|Physician Decision|0
5329240|NCT00243841|18347777|P3|Overall Study|Physician Decision|1
5329241|NCT00243841|18347778|P2|Overall Study|Physician Decision|0
5329242|NCT00243841|18347779|P1|Overall Study|Physician Decision|0
5329243|NCT00243659|18347801|P2|Overall Study|Protocol Violation|2
5329244|NCT00243659|18347802|P1|Overall Study|Protocol Violation|1
5329245|NCT00243659|18347801|P2|Overall Study|Withdrawal by Subject|1
5329246|NCT00243659|18347802|P1|Overall Study|Withdrawal by Subject|1
5329247|NCT00243503|18347810|P1|Overall Study|Other|1
5329248|NCT00243503|18347810|P1|Overall Study|Death|1
5329249|NCT00243503|18347810|P1|Overall Study|Lack of Efficacy|44
5329250|NCT00243503|18347810|P1|Overall Study|Withdrawal by Subject|1
5329251|NCT00243503|18347810|P1|Overall Study|Adverse Event|11
5329252|NCT00243412|18347827|P2|Overall Study|Other|1
5329253|NCT00243412|18347828|P1|Overall Study|Other|1
5329254|NCT00243412|18347827|P2|Overall Study|Withdrawal by Subject|5
5329255|NCT00243412|18347828|P1|Overall Study|Withdrawal by Subject|4
5329256|NCT00243412|18347827|P2|Overall Study|Physician Decision|1
5329257|NCT00243412|18347828|P1|Overall Study|Physician Decision|1
5329258|NCT00243412|18347827|P2|Overall Study|Lost to Follow-up|1
5329259|NCT00243412|18347828|P1|Overall Study|Lost to Follow-up|0
5329260|NCT00243412|18347827|P2|Overall Study|Adverse Event|2
5329261|NCT00243412|18347828|P1|Overall Study|Adverse Event|4
5329262|NCT00243412|18347827|P2|Overall Study|Death|1
5329263|NCT00243412|18347828|P1|Overall Study|Death|0
5329264|NCT00243386|18347854|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
5329265|NCT00243386|18347855|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
5329266|NCT00243386|18347856|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
5329267|NCT00243386|18347854|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
5329268|NCT00243386|18347855|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
5329269|NCT00243386|18347856|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
5329270|NCT00243386|18347854|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
5329271|NCT00243386|18347855|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
5329272|NCT00243386|18347856|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
5329273|NCT00243386|18347854|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
5329274|NCT00243386|18347855|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
5329275|NCT00243386|18347856|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
5329276|NCT00243386|18347854|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
5329277|NCT00243386|18347855|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
5329278|NCT00243386|18347856|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
5329279|NCT00243386|18347854|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
5329280|NCT00243386|18347855|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
5329281|NCT00243386|18347856|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
5329282|NCT00243386|18347854|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
5329283|NCT00243386|18347855|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
5329284|NCT00243386|18347856|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
5329285|NCT00243386|18347854|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
5329286|NCT00243386|18347855|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
5329287|NCT00243386|18347856|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
5329288|NCT00243347|18347921|P1|Overall Study|Condition worsened|7
5329289|NCT00243347|18347921|P1|Overall Study|Withdrawal by Subject|5
5329290|NCT00243347|18347921|P1|Overall Study|Death|1
5329291|NCT00243347|18347921|P1|Overall Study|Adverse Event|2
5329292|NCT00243347|18347921|P1|Overall Study|Lack of Efficacy|4
5329293|NCT00243269|18347930|P4|Overall Study|Lost to Follow-up|3
5329294|NCT00243269|18347931|P3|Overall Study|Lost to Follow-up|1
5329295|NCT00243269|18347932|P2|Overall Study|Lost to Follow-up|0
5329296|NCT00243269|18347933|P1|Overall Study|Lost to Follow-up|1
5329297|NCT00243269|18347930|P4|Overall Study|Protocol Violation|1
5329298|NCT00243269|18347931|P3|Overall Study|Protocol Violation|0
5329299|NCT00243269|18347932|P2|Overall Study|Protocol Violation|1
5329300|NCT00243269|18347933|P1|Overall Study|Protocol Violation|2
5329301|NCT00243074|18347968|P1|Overall Study|Did not receive any treatment|1
5329302|NCT00243074|18347968|P1|Overall Study|not protocol specified|1
5329303|NCT00243074|18347968|P1|Overall Study|Death|2
5329304|NCT00243074|18347968|P1|Overall Study|Lack of Efficacy|36
5329305|NCT00243074|18347968|P1|Overall Study|Withdrawal by Subject|2
5329306|NCT00243074|18347968|P1|Overall Study|Adverse Event|6
5329307|NCT00243074|18347968|P1|Overall Study|Ineligible|6
5329308|NCT00243022|18347994|P2|Overall Study|Difficult Travel Distance|1
5329309|NCT00243022|18347995|P1|Overall Study|Difficult Travel Distance|0
5329310|NCT00243022|18347994|P2|Overall Study|Death|0
5329311|NCT00243022|18347995|P1|Overall Study|Death|1
5329312|NCT00243022|18347994|P2|Overall Study|Withdrawal by Subject|0
5329313|NCT00243022|18347995|P1|Overall Study|Withdrawal by Subject|1
5329314|NCT00242710|18348019|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
5329315|NCT00242710|18348020|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
5329316|NCT00242710|18348021|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
5329317|NCT00242710|18348022|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
5329318|NCT00242710|18348019|P4|Study Extension (up to Year 2)|Protocol Violation|1
5329319|NCT00242710|18348020|P3|Study Extension (up to Year 2)|Protocol Violation|0
5329320|NCT00242710|18348021|P2|Study Extension (up to Year 2)|Protocol Violation|2
5329321|NCT00242710|18348022|P1|Study Extension (up to Year 2)|Protocol Violation|0
5329322|NCT00242710|18348019|P4|Study Extension (up to Year 2)|Other|3
5329323|NCT00242710|18348020|P3|Study Extension (up to Year 2)|Other|4
5329324|NCT00242710|18348021|P2|Study Extension (up to Year 2)|Other|5
5329325|NCT00242710|18348022|P1|Study Extension (up to Year 2)|Other|3
5329326|NCT00242710|18348019|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
5329327|NCT00242710|18348020|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
5329328|NCT00242710|18348021|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
5329329|NCT00242710|18348022|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
5329330|NCT00242710|18348019|P4|Study Extension (up to Year 2)|Death|1
5329331|NCT00242710|18348020|P3|Study Extension (up to Year 2)|Death|0
5329332|NCT00242710|18348021|P2|Study Extension (up to Year 2)|Death|0
5329333|NCT00242710|18348022|P1|Study Extension (up to Year 2)|Death|0
5329334|NCT00242710|18348019|P4|Study Extension (up to Year 2)|Adverse Event|4
5329335|NCT00242710|18348020|P3|Study Extension (up to Year 2)|Adverse Event|2
5329336|NCT00242710|18348021|P2|Study Extension (up to Year 2)|Adverse Event|9
5329337|NCT00242710|18348022|P1|Study Extension (up to Year 2)|Adverse Event|7
5329338|NCT00242710|18348019|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
5329339|NCT00242710|18348020|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
5329340|NCT00242710|18348021|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
5329341|NCT00242710|18348022|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
5329342|NCT00242710|18348019|P4|Period Between Core Study and Extension|Protocol Violation|1
5329343|NCT00242710|18348020|P3|Period Between Core Study and Extension|Protocol Violation|2
5329344|NCT00242710|18348021|P2|Period Between Core Study and Extension|Protocol Violation|0
5329345|NCT00242710|18348022|P1|Period Between Core Study and Extension|Protocol Violation|0
5329346|NCT00242710|18348019|P4|Period Between Core Study and Extension|Extension not Available|7
5329347|NCT00242710|18348020|P3|Period Between Core Study and Extension|Extension not Available|8
5329348|NCT00242710|18348021|P2|Period Between Core Study and Extension|Extension not Available|21
5329349|NCT00242710|18348022|P1|Period Between Core Study and Extension|Extension not Available|17
5329350|NCT00242710|18348019|P4|Period Between Core Study and Extension|Other|11
5329351|NCT00242710|18348020|P3|Period Between Core Study and Extension|Other|9
5329352|NCT00242710|18348021|P2|Period Between Core Study and Extension|Other|24
5329353|NCT00242710|18348022|P1|Period Between Core Study and Extension|Other|24
5329354|NCT00242710|18348019|P4|Period Between Core Study and Extension|Physician Decision|0
5329355|NCT00242710|18348020|P3|Period Between Core Study and Extension|Physician Decision|0
5329356|NCT00242710|18348021|P2|Period Between Core Study and Extension|Physician Decision|1
5329357|NCT00242710|18348022|P1|Period Between Core Study and Extension|Physician Decision|1
5329358|NCT00242710|18348019|P4|Period Between Core Study and Extension|Adverse Event|2
5329359|NCT00242710|18348020|P3|Period Between Core Study and Extension|Adverse Event|5
5329360|NCT00242710|18348021|P2|Period Between Core Study and Extension|Adverse Event|3
5329361|NCT00242710|18348022|P1|Period Between Core Study and Extension|Adverse Event|2
5329362|NCT00242710|18348019|P4|Core Study (up to Year 1)|Randomized but not Treated|2
5329363|NCT00242710|18348020|P3|Core Study (up to Year 1)|Randomized but not Treated|4
5329364|NCT00242710|18348021|P2|Core Study (up to Year 1)|Randomized but not Treated|4
5329365|NCT00242710|18348022|P1|Core Study (up to Year 1)|Randomized but not Treated|12
5329366|NCT00242710|18348019|P4|Core Study (up to Year 1)|Lack of Efficacy|0
5329367|NCT00242710|18348020|P3|Core Study (up to Year 1)|Lack of Efficacy|0
5329368|NCT00242710|18348021|P2|Core Study (up to Year 1)|Lack of Efficacy|0
5329369|NCT00242710|18348022|P1|Core Study (up to Year 1)|Lack of Efficacy|1
5329370|NCT00242710|18348019|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
5329371|NCT00242710|18348020|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
5329372|NCT00242710|18348021|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
5329373|NCT00242710|18348022|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
5329374|NCT00242710|18348019|P4|Core Study (up to Year 1)|Protocol Violation|3
5329375|NCT00242710|18348020|P3|Core Study (up to Year 1)|Protocol Violation|1
5329376|NCT00242710|18348021|P2|Core Study (up to Year 1)|Protocol Violation|9
5329377|NCT00242710|18348022|P1|Core Study (up to Year 1)|Protocol Violation|2
5329378|NCT00242710|18348019|P4|Core Study (up to Year 1)|Other|2
5329379|NCT00242710|18348020|P3|Core Study (up to Year 1)|Other|0
5329380|NCT00242710|18348021|P2|Core Study (up to Year 1)|Other|1
5329381|NCT00242710|18348022|P1|Core Study (up to Year 1)|Other|6
5329382|NCT00242710|18348019|P4|Core Study (up to Year 1)|Lost to Follow-up|3
5329383|NCT00242710|18348020|P3|Core Study (up to Year 1)|Lost to Follow-up|7
5329384|NCT00242710|18348021|P2|Core Study (up to Year 1)|Lost to Follow-up|8
5329385|NCT00242710|18348022|P1|Core Study (up to Year 1)|Lost to Follow-up|8
5329386|NCT00242710|18348019|P4|Core Study (up to Year 1)|Physician Decision|1
5329387|NCT00242710|18348020|P3|Core Study (up to Year 1)|Physician Decision|0
5329388|NCT00242710|18348021|P2|Core Study (up to Year 1)|Physician Decision|1
5329389|NCT00242710|18348022|P1|Core Study (up to Year 1)|Physician Decision|0
5329390|NCT00242710|18348019|P4|Core Study (up to Year 1)|Death|0
5329391|NCT00242710|18348020|P3|Core Study (up to Year 1)|Death|1
5329392|NCT00242710|18348021|P2|Core Study (up to Year 1)|Death|0
5329393|NCT00242710|18348022|P1|Core Study (up to Year 1)|Death|0
5329394|NCT00242710|18348019|P4|Core Study (up to Year 1)|Adverse Event|14
5329395|NCT00242710|18348020|P3|Core Study (up to Year 1)|Adverse Event|23
5329396|NCT00242710|18348021|P2|Core Study (up to Year 1)|Adverse Event|25
5329397|NCT00242710|18348022|P1|Core Study (up to Year 1)|Adverse Event|30
5329398|NCT00242658|18348079|P2|Overall Study|Lost to Follow-up|19
5329399|NCT00242658|18348080|P1|Overall Study|Lost to Follow-up|22
5329400|NCT00242580|18348111|P3|Overall Study|Death|1
5329401|NCT00242580|18348112|P2|Overall Study|Death|2
5329402|NCT00242580|18348113|P1|Overall Study|Death|1
5329403|NCT00242580|18348111|P3|Overall Study|Lost to Follow-up|0
5329404|NCT00242580|18348112|P2|Overall Study|Lost to Follow-up|3
5329405|NCT00242580|18348113|P1|Overall Study|Lost to Follow-up|0
5329406|NCT00242580|18348111|P3|Overall Study|Subject withdrew consent|5
5329407|NCT00242580|18348112|P2|Overall Study|Subject withdrew consent|2
5329408|NCT00242580|18348113|P1|Overall Study|Subject withdrew consent|2
5329409|NCT00242580|18348111|P3|Overall Study|Protocol Violation|1
5329410|NCT00242580|18348112|P2|Overall Study|Protocol Violation|0
5329411|NCT00242580|18348113|P1|Overall Study|Protocol Violation|0
5329412|NCT00242580|18348111|P3|Overall Study|Unsatisfactory therapeutic effect|5
5329413|NCT00242580|18348112|P2|Overall Study|Unsatisfactory therapeutic effect|5
5329414|NCT00242580|18348113|P1|Overall Study|Unsatisfactory therapeutic effect|4
5329415|NCT00242580|18348111|P3|Overall Study|Adverse Event|2
5329416|NCT00242580|18348112|P2|Overall Study|Adverse Event|0
5329417|NCT00242580|18348113|P1|Overall Study|Adverse Event|3
5329418|NCT00242567|18348138|P2|Overall Study|Other|9
5329419|NCT00242567|18348139|P1|Overall Study|Other|14
5329420|NCT00242567|18348138|P2|Overall Study|Use of an inhibitor of bone resorption|2
5329421|NCT00242567|18348139|P1|Overall Study|Use of an inhibitor of bone resorption|0
5329422|NCT00242567|18348138|P2|Overall Study|Protocol Violation|12
5329423|NCT00242567|18348139|P1|Overall Study|Protocol Violation|12
5329424|NCT00242567|18348138|P2|Overall Study|Withdrawal by Subject|28
5329425|NCT00242567|18348139|P1|Overall Study|Withdrawal by Subject|33
5329426|NCT00242567|18348138|P2|Overall Study|Lost to Follow-up|19
5329427|NCT00242567|18348139|P1|Overall Study|Lost to Follow-up|9
5329428|NCT00242567|18348138|P2|Overall Study|Lack of Efficacy|2
5329429|NCT00242567|18348139|P1|Overall Study|Lack of Efficacy|2
5329430|NCT00242567|18348138|P2|Overall Study|Symptomatic deterioration|3
5329431|NCT00242567|18348139|P1|Overall Study|Symptomatic deterioration|9
5329432|NCT00242567|18348138|P2|Overall Study|Disease Progression|22
5329433|NCT00242567|18348139|P1|Overall Study|Disease Progression|17
5329434|NCT00242567|18348138|P2|Overall Study|Adverse Event|43
5329435|NCT00242567|18348139|P1|Overall Study|Adverse Event|70
5329436|NCT00242216|18348186|P2|Overall Study|no medicaiton dispensed|1
5329437|NCT00242216|18348187|P1|Overall Study|no medicaiton dispensed|1
5329438|NCT00242216|18348186|P2|Overall Study|Lack of Efficacy|2
5329439|NCT00242216|18348187|P1|Overall Study|Lack of Efficacy|1
5329440|NCT00242216|18348186|P2|Overall Study|Death|2
5329441|NCT00242216|18348187|P1|Overall Study|Death|4
5329442|NCT00242216|18348186|P2|Overall Study|Lost to Follow-up|17
5329443|NCT00242216|18348187|P1|Overall Study|Lost to Follow-up|12
5329444|NCT00241839|18348225|P2|Overall Study|Adverse Event|1
5329445|NCT00241839|18348226|P1|Overall Study|Adverse Event|1
5329446|NCT00241839|18348225|P2|Overall Study|Withdrawal by Subject|17
5329447|NCT00241839|18348226|P1|Overall Study|Withdrawal by Subject|18
5329448|NCT00241644|18348242|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
5329449|NCT00241644|18348243|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
5329450|NCT00241644|18348244|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
5329451|NCT00241644|18348245|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
5329452|NCT00241644|18348242|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
5329453|NCT00241644|18348243|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
5329454|NCT00241644|18348244|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
5329455|NCT00241644|18348245|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
5329456|NCT00241644|18348242|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
5329457|NCT00241644|18348243|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
5329458|NCT00241644|18348244|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
5329459|NCT00241644|18348245|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
5329460|NCT00241644|18348242|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
5329461|NCT00241644|18348243|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
5329462|NCT00241644|18348244|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
5329463|NCT00241644|18348245|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
5329464|NCT00241644|18348242|P4|Second Efficacy Period (Year 2)|Adverse Event|20
5329465|NCT00241644|18348243|P3|Second Efficacy Period (Year 2)|Adverse Event|12
5329466|NCT00241644|18348244|P2|Second Efficacy Period (Year 2)|Adverse Event|9
5329467|NCT00241644|18348245|P1|Second Efficacy Period (Year 2)|Adverse Event|11
5329468|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
5329469|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
5329470|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
5329471|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
5329472|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
5329473|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
5329474|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
5329475|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
5329476|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
5329477|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
5329478|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
5329479|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
5329480|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Non-compliance|3
5329481|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Non-compliance|2
5329482|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Non-compliance|1
5329483|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Non-compliance|2
5329484|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
5329485|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
5329486|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
5329487|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
5329488|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
5329489|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
5329490|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
5329491|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
5329492|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Protocol Violation|8
5329493|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Protocol Violation|4
5329494|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Protocol Violation|5
5329495|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Protocol Violation|3
5329496|NCT00241644|18348242|P4|First Efficacy Period (Year 1)|Adverse Event|91
5329497|NCT00241644|18348243|P3|First Efficacy Period (Year 1)|Adverse Event|45
5329498|NCT00241644|18348244|P2|First Efficacy Period (Year 1)|Adverse Event|45
5329499|NCT00241644|18348245|P1|First Efficacy Period (Year 1)|Adverse Event|46
5329500|NCT00241631|18348329|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
5329501|NCT00241631|18348330|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
5329502|NCT00241631|18348329|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
5329503|NCT00241631|18348330|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
5329504|NCT00241631|18348329|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
5329505|NCT00241631|18348330|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
5329506|NCT00241631|18348329|P2|Phase 1 (4 Weeks)|sore throat|0
5329507|NCT00241631|18348330|P1|Phase 1 (4 Weeks)|sore throat|1
5329508|NCT00241631|18348329|P2|Run in (2 Weeks)|Physician Decision|3
5329509|NCT00241631|18348330|P1|Run in (2 Weeks)|Physician Decision|3
5329510|NCT00241358|18348343|P3|Overall Study|Determined to be not ineligible|1
5329511|NCT00241358|18348344|P2|Overall Study|Determined to be not ineligible|1
5329512|NCT00241358|18348345|P1|Overall Study|Determined to be not ineligible|0
5329513|NCT00241280|18348378|P2|Overall Study|Excessive Dryness|1
5329514|NCT00241280|18348379|P1|Overall Study|Excessive Dryness|0
5329515|NCT00241280|18348378|P2|Overall Study|Coating on Lens|0
5329516|NCT00241280|18348379|P1|Overall Study|Coating on Lens|1
5329517|NCT00241280|18348378|P2|Overall Study|History of Ocular Surgery|1
5329518|NCT00241280|18348379|P1|Overall Study|History of Ocular Surgery|0
5329519|NCT00241280|18348378|P2|Overall Study|Scheduling Conflict|2
5329520|NCT00241280|18348379|P1|Overall Study|Scheduling Conflict|0
5329521|NCT00241280|18348378|P2|Overall Study|Unacceptable Fit|1
5329522|NCT00241280|18348379|P1|Overall Study|Unacceptable Fit|0
5329523|NCT00241280|18348378|P2|Overall Study|Dispensed incorrect test article|2
5329524|NCT00241280|18348379|P1|Overall Study|Dispensed incorrect test article|1
5329525|NCT00241280|18348378|P2|Overall Study|Subject Ineligible/Dispensed|6
5329526|NCT00241280|18348379|P1|Overall Study|Subject Ineligible/Dispensed|9
5329527|NCT00241280|18348378|P2|Overall Study|Diabetic|0
5329528|NCT00241280|18348379|P1|Overall Study|Diabetic|1
5329529|NCT00241280|18348378|P2|Overall Study|Unsatisfactory Visual Response|1
5329530|NCT00241280|18348379|P1|Overall Study|Unsatisfactory Visual Response|1
5329531|NCT00241280|18348378|P2|Overall Study|Unsatisfactory Physiological Response|1
5329532|NCT00241280|18348379|P1|Overall Study|Unsatisfactory Physiological Response|1
5329533|NCT00241280|18348378|P2|Overall Study|Relocation|4
5329534|NCT00241280|18348379|P1|Overall Study|Relocation|4
5329535|NCT00241280|18348378|P2|Overall Study|Protocol Violation|10
5329536|NCT00241280|18348379|P1|Overall Study|Protocol Violation|4
5329537|NCT00241280|18348378|P2|Overall Study|Withdrawal by Subject|4
5329538|NCT00241280|18348379|P1|Overall Study|Withdrawal by Subject|7
5329539|NCT00241280|18348378|P2|Overall Study|Lost to Follow-up|8
5329540|NCT00241280|18348379|P1|Overall Study|Lost to Follow-up|5
5329541|NCT00241280|18348378|P2|Overall Study|Pregnancy|5
5329542|NCT00241280|18348379|P1|Overall Study|Pregnancy|1
5329543|NCT00241280|18348378|P2|Overall Study|Discomfort|16
5329544|NCT00241280|18348379|P1|Overall Study|Discomfort|11
5329545|NCT00241280|18348378|P2|Overall Study|Adverse Event|6
5329546|NCT00241280|18348379|P1|Overall Study|Adverse Event|2
5329547|NCT00240994|18348394|P1|Overall Study|Graft failure|1
5329548|NCT00240994|18348394|P1|Overall Study|Protocol Violation|1
5329549|NCT00240994|18348394|P1|Overall Study|Lost to Follow-up|1
5329550|NCT00240331|18348529|P2|Overall Study|Option selected by investigator|2
5329551|NCT00240331|18348530|P1|Overall Study|Option selected by investigator|1
5329552|NCT00240331|18348529|P2|Overall Study|Withdrawal by Subject|132
5329553|NCT00240331|18348530|P1|Overall Study|Withdrawal by Subject|125
5329554|NCT00240110|18348573|P2|Overall Study|Lost to Follow-up|7
5329555|NCT00240110|18348574|P1|Overall Study|Lost to Follow-up|6
5329556|NCT00240097|18348582|P1|Part II|did not continue from Part I|23
5329557|NCT00240097|18348582|P1|Part I|unevaluable|1
5329558|NCT00240097|18348582|P1|Part I|histology|1
5329559|NCT00240097|18348582|P1|Part I|Death|1
5329560|NCT00240097|18348582|P1|Part I|Adverse Event|1
5329561|NCT00240071|18348592|P1|Overall Study|Withdrawal by Subject|3
5329562|NCT00239928|18348597|P1|Overall Study|Withdrawal by Subject|2
5329563|NCT00239928|18348597|P1|Overall Study|Not need to continue study|3
5329564|NCT00239928|18348597|P1|Overall Study|Adverse Event|4
5329565|NCT00239928|18348597|P1|Overall Study|Lack of Efficacy|1
5329566|NCT00239837|18348609|P2|Overall Study|Lost to Follow-up|7
5329567|NCT00239837|18348610|P1|Overall Study|Lost to Follow-up|3
5329568|NCT00239720|18348637|P2|Overall Study|Lost to Follow-up|1
5329569|NCT00239720|18348638|P1|Overall Study|Lost to Follow-up|0
5329570|NCT00239720|18348637|P2|Overall Study|Adverse Event|0
5329571|NCT00239720|18348638|P1|Overall Study|Adverse Event|1
5329572|NCT00239681|18348646|P2|Overall Study|No information chacked on CaseReportForm|84
5329573|NCT00239681|18348647|P1|Overall Study|No information chacked on CaseReportForm|90
5329574|NCT00239681|18348646|P2|Overall Study|Physician Decision|17
5329575|NCT00239681|18348647|P1|Overall Study|Physician Decision|13
5329576|NCT00239681|18348646|P2|Overall Study|Protocol Violation|4
5329577|NCT00239681|18348647|P1|Overall Study|Protocol Violation|4
5329578|NCT00239681|18348646|P2|Overall Study|Lost to Follow-up|22
5329579|NCT00239681|18348647|P1|Overall Study|Lost to Follow-up|28
5329580|NCT00239681|18348646|P2|Overall Study|Withdrawal by Subject|489
5329581|NCT00239681|18348647|P1|Overall Study|Withdrawal by Subject|458
5329582|NCT00239681|18348646|P2|Overall Study|Adverse Event|99
5329583|NCT00239681|18348647|P1|Overall Study|Adverse Event|100
5329584|NCT00239590|18348700|P2|Completed Study Protocol|Withdrawal by Subject|1
5329585|NCT00239590|18348701|P1|Completed Study Protocol|Withdrawal by Subject|0
5329586|NCT00239590|18348700|P2|Completed Study Protocol|Adverse Event|1
5329587|NCT00239590|18348701|P1|Completed Study Protocol|Adverse Event|1
5329588|NCT00239590|18348700|P2|Randomized|Withdrawal by Subject|1
5329589|NCT00239590|18348701|P1|Randomized|Withdrawal by Subject|0
5329590|NCT00239590|18348700|P2|Randomized|Lost to Follow-up|1
5329591|NCT00239590|18348701|P1|Randomized|Lost to Follow-up|0
5329592|NCT00239577|18348713|P4|Primary Phase|Other|0
5329593|NCT00239577|18348714|P3|Primary Phase|Other|2
5329594|NCT00239577|18348715|P2|Primary Phase|Other|3
5329595|NCT00239577|18348716|P1|Primary Phase|Other|5
5329596|NCT00239577|18348713|P4|Primary Phase|Adverse Event|0
5329597|NCT00239577|18348714|P3|Primary Phase|Adverse Event|1
5329598|NCT00239577|18348715|P2|Primary Phase|Adverse Event|0
5329599|NCT00239577|18348716|P1|Primary Phase|Adverse Event|0
5329600|NCT00239356|18348820|P2|Overall Study|Drug available on market|2
5329601|NCT00239356|18348821|P1|Overall Study|Drug available on market|11
5329602|NCT00239356|18348820|P2|Overall Study|Administrative reason|1
5329603|NCT00239356|18348821|P1|Overall Study|Administrative reason|0
5329604|NCT00239356|18348820|P2|Overall Study|Pregnancy|0
5329605|NCT00239356|18348821|P1|Overall Study|Pregnancy|1
5329606|NCT00239356|18348820|P2|Overall Study|poor/non-compliance|0
5329607|NCT00239356|18348821|P1|Overall Study|poor/non-compliance|2
5329608|NCT00239356|18348820|P2|Overall Study|Lost to Follow-up|0
5329609|NCT00239356|18348821|P1|Overall Study|Lost to Follow-up|3
5329610|NCT00239356|18348820|P2|Overall Study|Withdrawal by Subject|6
5329611|NCT00239356|18348821|P1|Overall Study|Withdrawal by Subject|15
5329612|NCT00239356|18348820|P2|Overall Study|Adverse Event|0
5329613|NCT00239356|18348821|P1|Overall Study|Adverse Event|6
5329614|NCT00239356|18348820|P2|Overall Study|Lack of Efficacy|0
5329615|NCT00239356|18348821|P1|Overall Study|Lack of Efficacy|1
5329616|NCT00239226|18348843|P4|Overall Study|Lost to Follow-up|0
5329617|NCT00239226|18348844|P3|Overall Study|Lost to Follow-up|1
5329618|NCT00239226|18348845|P2|Overall Study|Lost to Follow-up|0
5329619|NCT00239226|18348846|P1|Overall Study|Lost to Follow-up|1
5329620|NCT00239226|18348843|P4|Overall Study|permAF during stabilization period|3
5329621|NCT00239226|18348844|P3|Overall Study|permAF during stabilization period|0
5329622|NCT00239226|18348845|P2|Overall Study|permAF during stabilization period|0
5329623|NCT00239226|18348846|P1|Overall Study|permAF during stabilization period|0
5329624|NCT00239005|18348858|P2|Overall Study|Lost to Follow-up|1
5329625|NCT00239005|18348859|P1|Overall Study|Lost to Follow-up|0
5329626|NCT00239005|18348858|P2|Overall Study|Subj. cond. no longer needs study drug|1
5329627|NCT00239005|18348859|P1|Overall Study|Subj. cond. no longer needs study drug|0
5329628|NCT00239005|18348858|P2|Overall Study|Protocol Violation|0
5329629|NCT00239005|18348859|P1|Overall Study|Protocol Violation|1
5329630|NCT00239005|18348858|P2|Overall Study|Unsatisfactory Therapeutic effect|0
5329631|NCT00239005|18348859|P1|Overall Study|Unsatisfactory Therapeutic effect|2
5329632|NCT00239005|18348858|P2|Overall Study|Withdrawal by Subject|4
5329633|NCT00239005|18348859|P1|Overall Study|Withdrawal by Subject|3
5329634|NCT00239005|18348858|P2|Overall Study|Adverse Event|6
5329635|NCT00239005|18348859|P1|Overall Study|Adverse Event|6
5329636|NCT00238433|18348875|P1|Overall Study|Death|1
5329637|NCT00238433|18348875|P1|Overall Study|Lost to Follow-up|1
5329638|NCT00238433|18348875|P1|Overall Study|Screen failure|1
5329639|NCT00238420|18348882|P2|Overall Study|Protocol Violation|1
5329640|NCT00238420|18348883|P1|Overall Study|Protocol Violation|1
5329641|NCT00238303|18348900|P3|Overall Study|Adverse Event|3
5329642|NCT00238303|18348901|P2|Overall Study|Adverse Event|1
5329643|NCT00238303|18348902|P1|Overall Study|Adverse Event|0
5329644|NCT00238303|18348900|P3|Overall Study|Poor tolerance of study treatment|1
5329645|NCT00238303|18348901|P2|Overall Study|Poor tolerance of study treatment|0
5329646|NCT00238303|18348902|P1|Overall Study|Poor tolerance of study treatment|1
5329647|NCT00238303|18348900|P3|Overall Study|Other Medical Problems|2
5329648|NCT00238303|18348901|P2|Overall Study|Other Medical Problems|0
5329649|NCT00238303|18348902|P1|Overall Study|Other Medical Problems|2
5329650|NCT00238303|18348900|P3|Overall Study|Death|1
5329651|NCT00238303|18348901|P2|Overall Study|Death|0
5329652|NCT00238303|18348902|P1|Overall Study|Death|1
5329653|NCT00238303|18348900|P3|Overall Study|Withdrawal by Subject|2
5329654|NCT00238303|18348901|P2|Overall Study|Withdrawal by Subject|1
5329655|NCT00238303|18348902|P1|Overall Study|Withdrawal by Subject|11
5329656|NCT00238264|18348919|P1|Overall Study|Ineligible|7
5329657|NCT00238264|18348919|P1|Overall Study|Withdrawal by Subject|4
5329658|NCT00238264|18348919|P1|Overall Study|Lost to Follow-up|18
5329659|NCT00238264|18348919|P1|Overall Study|Death|7
5329660|NCT00238238|18348932|P3|Overall Study|Withdrawal by Subject|0
5329661|NCT00238238|18348933|P2|Overall Study|Withdrawal by Subject|3
5329662|NCT00238238|18348934|P1|Overall Study|Withdrawal by Subject|0
5329663|NCT00238121|18348947|P2|Overall Study|Adverse Event|1
5329664|NCT00238121|18348948|P1|Overall Study|Adverse Event|2
5329665|NCT00238121|18348947|P2|Overall Study|Withdrawal by Subject|1
5329666|NCT00238121|18348948|P1|Overall Study|Withdrawal by Subject|1
5329667|NCT00237809|18348974|P4|Overall Study|Lost to Follow-up|9
5329668|NCT00237809|18348975|P3|Overall Study|Lost to Follow-up|9
5329669|NCT00237809|18348976|P2|Overall Study|Lost to Follow-up|10
5329670|NCT00237809|18348977|P1|Overall Study|Lost to Follow-up|11
5329671|NCT00237796|18349013|P2|Overall Study|Baseline and one other ILSS required|5
5329672|NCT00237796|18349014|P1|Overall Study|Baseline and one other ILSS required|10
5329673|NCT00237744|18349048|P3|Overall Study|Withdrawal by Subject|0
5329674|NCT00237744|18349049|P2|Overall Study|Withdrawal by Subject|1
5329675|NCT00237744|18349050|P1|Overall Study|Withdrawal by Subject|3
5329676|NCT00237692|18349076|P4|Overall Study|Withdrawal by Subject|4
5329677|NCT00237692|18349077|P3|Overall Study|Withdrawal by Subject|10
5329678|NCT00237692|18349078|P2|Overall Study|Withdrawal by Subject|6
5329679|NCT00237692|18349079|P1|Overall Study|Withdrawal by Subject|4
5329680|NCT00237692|18349076|P4|Overall Study|Excluded - did not meet criteria|9
5329681|NCT00237692|18349077|P3|Overall Study|Excluded - did not meet criteria|5
5329682|NCT00237692|18349078|P2|Overall Study|Excluded - did not meet criteria|3
5329683|NCT00237692|18349079|P1|Overall Study|Excluded - did not meet criteria|4
5329684|NCT00237692|18349076|P4|Overall Study|Death|3
5329685|NCT00237692|18349077|P3|Overall Study|Death|2
5329686|NCT00237692|18349078|P2|Overall Study|Death|2
5329687|NCT00237692|18349079|P1|Overall Study|Death|1
5329688|NCT00237692|18349076|P4|Overall Study|Lost to Follow-up|3
5329689|NCT00237692|18349077|P3|Overall Study|Lost to Follow-up|5
5329690|NCT00237692|18349078|P2|Overall Study|Lost to Follow-up|3
5329691|NCT00237692|18349079|P1|Overall Study|Lost to Follow-up|9
5329692|NCT00237458|18349119|P1|Overall Study|Withdrawal by Subject|1
5329693|NCT00237458|18349119|P1|Overall Study|Adverse Event|1
5329694|NCT00237458|18349119|P1|Overall Study|Lack of Efficacy|1
5329695|NCT00237185|18349137|P2|Extension|Death|1
5329696|NCT00237185|18349138|P1|Extension|Death|1
5329697|NCT00237185|18349137|P2|Extension|Administrative problems|0
5329698|NCT00237185|18349138|P1|Extension|Administrative problems|1
5329699|NCT00237185|18349137|P2|Extension|Lost to Follow-up|0
5329700|NCT00237185|18349138|P1|Extension|Lost to Follow-up|1
5329701|NCT00237185|18349137|P2|Extension|Withdrawal by Subject|2
5329702|NCT00237185|18349138|P1|Extension|Withdrawal by Subject|3
5329703|NCT00237185|18349137|P2|Extension|Condition no longer required study drug|1
5329704|NCT00237185|18349138|P1|Extension|Condition no longer required study drug|0
5329705|NCT00237185|18349137|P2|Extension|Lack of Efficacy|14
5329706|NCT00237185|18349138|P1|Extension|Lack of Efficacy|9
5329707|NCT00237185|18349137|P2|Extension|Abnormal laboratory value|1
5329708|NCT00237185|18349138|P1|Extension|Abnormal laboratory value|0
5329709|NCT00237185|18349137|P2|Extension|Adverse Event|0
5329710|NCT00237185|18349138|P1|Extension|Adverse Event|1
5329711|NCT00237185|18349137|P2|Core|Determined ineligible post randomization|0
5329712|NCT00237185|18349138|P1|Core|Determined ineligible post randomization|1
5329713|NCT00237185|18349137|P2|Core|Death|0
5329714|NCT00237185|18349138|P1|Core|Death|4
5329715|NCT00237185|18349137|P2|Core|Administrative problems|1
5329716|NCT00237185|18349138|P1|Core|Administrative problems|0
5329717|NCT00237185|18349137|P2|Core|Withdrawal by Subject|4
5329718|NCT00237185|18349138|P1|Core|Withdrawal by Subject|4
5329719|NCT00237185|18349137|P2|Core|Protocol Violation|1
5329720|NCT00237185|18349138|P1|Core|Protocol Violation|1
5329721|NCT00237185|18349137|P2|Core|Lack of Efficacy|23
5329722|NCT00237185|18349138|P1|Core|Lack of Efficacy|30
5329723|NCT00237185|18349137|P2|Core|Abnormal test procedure results|0
5329724|NCT00237185|18349138|P1|Core|Abnormal test procedure results|1
5329725|NCT00237185|18349137|P2|Core|Abnormal laboratory value|4
5329726|NCT00237185|18349138|P1|Core|Abnormal laboratory value|0
5329727|NCT00237185|18349137|P2|Core|Adverse Event|4
5329728|NCT00237185|18349138|P1|Core|Adverse Event|3
5329729|NCT00237042|18349169|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
5329730|NCT00237042|18349170|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
5329731|NCT00237042|18349171|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
5329732|NCT00237042|18349169|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
5329733|NCT00237042|18349170|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
5329734|NCT00237042|18349171|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
5329735|NCT00237042|18349169|P3|Treatment|Completed no treatment|21
5329736|NCT00237042|18349170|P2|Treatment|Completed no treatment|5
5329737|NCT00237042|18349171|P1|Treatment|Completed no treatment|5
5329738|NCT00237042|18349169|P3|Treatment|Moved out of state|1
5329739|NCT00237042|18349170|P2|Treatment|Moved out of state|1
5329740|NCT00237042|18349171|P1|Treatment|Moved out of state|1
5329741|NCT00237042|18349169|P3|Treatment|Became ineligible post-randomization|16
5329742|NCT00237042|18349170|P2|Treatment|Became ineligible post-randomization|1
5329743|NCT00237042|18349171|P1|Treatment|Became ineligible post-randomization|0
5329744|NCT00236899|18349245|P4|Overall Study|Lack of Efficacy|23
5329745|NCT00236899|18349246|P3|Overall Study|Lack of Efficacy|25
5329746|NCT00236899|18349247|P2|Overall Study|Lack of Efficacy|18
5329747|NCT00236899|18349248|P1|Overall Study|Lack of Efficacy|18
5329748|NCT00236899|18349245|P4|Overall Study|Satisfactory Response|1
5329749|NCT00236899|18349246|P3|Overall Study|Satisfactory Response|0
5329750|NCT00236899|18349247|P2|Overall Study|Satisfactory Response|0
5329751|NCT00236899|18349248|P1|Overall Study|Satisfactory Response|2
5329752|NCT00236899|18349245|P4|Overall Study|Physician Decision|6
5329753|NCT00236899|18349246|P3|Overall Study|Physician Decision|7
5329754|NCT00236899|18349247|P2|Overall Study|Physician Decision|8
5329755|NCT00236899|18349248|P1|Overall Study|Physician Decision|7
5329756|NCT00236899|18349245|P4|Overall Study|Withdrawal by Subject|2
5329757|NCT00236899|18349246|P3|Overall Study|Withdrawal by Subject|5
5329758|NCT00236899|18349247|P2|Overall Study|Withdrawal by Subject|4
5329759|NCT00236899|18349248|P1|Overall Study|Withdrawal by Subject|6
5329760|NCT00236899|18349245|P4|Overall Study|Protocol Violation|0
5329761|NCT00236899|18349246|P3|Overall Study|Protocol Violation|0
5329762|NCT00236899|18349247|P2|Overall Study|Protocol Violation|0
5329763|NCT00236899|18349248|P1|Overall Study|Protocol Violation|1
5329764|NCT00236899|18349245|P4|Overall Study|Entry Criteria Exclusion|0
5329765|NCT00236899|18349246|P3|Overall Study|Entry Criteria Exclusion|1
5329766|NCT00236899|18349247|P2|Overall Study|Entry Criteria Exclusion|1
5329767|NCT00236899|18349248|P1|Overall Study|Entry Criteria Exclusion|0
5329768|NCT00236899|18349245|P4|Overall Study|Lost to Follow-up|0
5329769|NCT00236899|18349246|P3|Overall Study|Lost to Follow-up|0
5329770|NCT00236899|18349247|P2|Overall Study|Lost to Follow-up|1
5329771|NCT00236899|18349248|P1|Overall Study|Lost to Follow-up|0
5329772|NCT00236899|18349245|P4|Overall Study|Death (Study Drug Toxicity)|0
5329773|NCT00236899|18349246|P3|Overall Study|Death (Study Drug Toxicity)|0
5329774|NCT00236899|18349247|P2|Overall Study|Death (Study Drug Toxicity)|0
5329775|NCT00236899|18349248|P1|Overall Study|Death (Study Drug Toxicity)|1
5329776|NCT00236899|18349245|P4|Overall Study|Death (Not Study Related)|0
5329777|NCT00236899|18349246|P3|Overall Study|Death (Not Study Related)|0
5329778|NCT00236899|18349247|P2|Overall Study|Death (Not Study Related)|0
5329779|NCT00236899|18349248|P1|Overall Study|Death (Not Study Related)|2
5329780|NCT00236899|18349245|P4|Overall Study|Death (Study Disease)|0
5329781|NCT00236899|18349246|P3|Overall Study|Death (Study Disease)|0
5329782|NCT00236899|18349247|P2|Overall Study|Death (Study Disease)|4
5329783|NCT00236899|18349248|P1|Overall Study|Death (Study Disease)|1
5329784|NCT00236899|18349245|P4|Overall Study|Adverse Event (Not Study Related)|7
5329785|NCT00236899|18349246|P3|Overall Study|Adverse Event (Not Study Related)|4
5329786|NCT00236899|18349247|P2|Overall Study|Adverse Event (Not Study Related)|3
5329787|NCT00236899|18349248|P1|Overall Study|Adverse Event (Not Study Related)|3
5329788|NCT00236899|18349245|P4|Overall Study|Adverse Event (Study Related)|1
5329789|NCT00236899|18349246|P3|Overall Study|Adverse Event (Study Related)|2
5329790|NCT00236899|18349247|P2|Overall Study|Adverse Event (Study Related)|1
5329791|NCT00236899|18349248|P1|Overall Study|Adverse Event (Study Related)|1
5329792|NCT00236197|18349280|P2|Overall Study|Other|2
5329793|NCT00236197|18349281|P1|Overall Study|Other|0
5329794|NCT00236197|18349280|P2|Overall Study|Medication non-compliance|2
5329795|NCT00236197|18349281|P1|Overall Study|Medication non-compliance|1
5329796|NCT00236197|18349280|P2|Overall Study|Protocol Violation|3
5329797|NCT00236197|18349281|P1|Overall Study|Protocol Violation|0
5329798|NCT00236197|18349280|P2|Overall Study|Lost to Follow-up|5
5329799|NCT00236197|18349281|P1|Overall Study|Lost to Follow-up|1
5329800|NCT00236197|18349280|P2|Overall Study|Withdrawal by Subject|2
5329801|NCT00236197|18349281|P1|Overall Study|Withdrawal by Subject|3
5329802|NCT00236184|18349289|P2|Overall Study|other|2
5329803|NCT00236184|18349290|P1|Overall Study|other|1
5329804|NCT00236184|18349289|P2|Overall Study|non-compliance with study drug|1
5329805|NCT00236184|18349290|P1|Overall Study|non-compliance with study drug|2
5329806|NCT00236184|18349289|P2|Overall Study|Protocol Violation|0
5329807|NCT00236184|18349290|P1|Overall Study|Protocol Violation|3
5329808|NCT00236184|18349289|P2|Overall Study|Withdrawal by Subject|0
5329809|NCT00236184|18349290|P1|Overall Study|Withdrawal by Subject|3
5329810|NCT00236184|18349289|P2|Overall Study|Physician Decision|1
5329811|NCT00236184|18349290|P1|Overall Study|Physician Decision|1
5329812|NCT00236184|18349289|P2|Overall Study|Lost to Follow-up|4
5329813|NCT00236184|18349290|P1|Overall Study|Lost to Follow-up|3
5329814|NCT00236184|18349289|P2|Overall Study|Lack of Efficacy|1
5329815|NCT00236184|18349290|P1|Overall Study|Lack of Efficacy|0
5329816|NCT00236184|18349289|P2|Overall Study|Adverse Event|2
5329817|NCT00236184|18349290|P1|Overall Study|Adverse Event|5
5329818|NCT00236080|18349301|P5|Overall Study|Miscellaneous|0
5329819|NCT00236080|18349302|P4|Overall Study|Miscellaneous|0
5329820|NCT00236080|18349303|P3|Overall Study|Miscellaneous|1
5329821|NCT00236080|18349304|P2|Overall Study|Miscellaneous|0
5329822|NCT00236080|18349305|P1|Overall Study|Miscellaneous|0
5329823|NCT00236080|18349301|P5|Overall Study|Withdrawal by Subject|0
5329824|NCT00236080|18349302|P4|Overall Study|Withdrawal by Subject|0
5329825|NCT00236080|18349303|P3|Overall Study|Withdrawal by Subject|0
5329826|NCT00236080|18349304|P2|Overall Study|Withdrawal by Subject|0
5329827|NCT00236080|18349305|P1|Overall Study|Withdrawal by Subject|1
5329828|NCT00236080|18349301|P5|Overall Study|Physician Decision|1
5329829|NCT00236080|18349302|P4|Overall Study|Physician Decision|1
5329830|NCT00236080|18349303|P3|Overall Study|Physician Decision|1
5329831|NCT00236080|18349304|P2|Overall Study|Physician Decision|0
5329832|NCT00236080|18349305|P1|Overall Study|Physician Decision|1
5329833|NCT00236080|18349301|P5|Overall Study|Lost to Follow-up|0
5329834|NCT00236080|18349302|P4|Overall Study|Lost to Follow-up|0
5329835|NCT00236080|18349303|P3|Overall Study|Lost to Follow-up|0
5329836|NCT00236080|18349304|P2|Overall Study|Lost to Follow-up|1
5329837|NCT00236080|18349305|P1|Overall Study|Lost to Follow-up|0
5329838|NCT00236080|18349301|P5|Overall Study|Adverse Event|0
5329839|NCT00236080|18349302|P4|Overall Study|Adverse Event|1
5329840|NCT00236080|18349303|P3|Overall Study|Adverse Event|3
5329841|NCT00236080|18349304|P2|Overall Study|Adverse Event|0
5329842|NCT00236080|18349305|P1|Overall Study|Adverse Event|0
5329843|NCT00235989|18349326|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
5329844|NCT00235989|18349327|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
5329845|NCT00235989|18349328|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
5329846|NCT00235989|18349329|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
5329847|NCT00235989|18349330|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
5329848|NCT00235989|18349331|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
5329849|NCT00235989|18349326|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
5329850|NCT00235989|18349327|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
5329851|NCT00235989|18349328|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
5329852|NCT00235989|18349329|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
5329853|NCT00235989|18349330|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
5329854|NCT00235989|18349331|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
5329855|NCT00235989|18349326|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
5329856|NCT00235989|18349327|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
5329857|NCT00235989|18349328|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
5329858|NCT00235989|18349329|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
5329859|NCT00235989|18349330|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
5329860|NCT00235989|18349331|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
5329861|NCT00235989|18349326|P6|Extension Treatment Period (ET)|Adverse Event|0
5329862|NCT00235989|18349327|P5|Extension Treatment Period (ET)|Adverse Event|0
5329863|NCT00235989|18349328|P4|Extension Treatment Period (ET)|Adverse Event|0
5329864|NCT00235989|18349329|P3|Extension Treatment Period (ET)|Adverse Event|2
5329865|NCT00235989|18349330|P2|Extension Treatment Period (ET)|Adverse Event|0
5329866|NCT00235989|18349331|P1|Extension Treatment Period (ET)|Adverse Event|3
5329867|NCT00235989|18349326|P6|Core Treatment Period (CT)|Lost to Follow-up|2
5329868|NCT00235989|18349327|P5|Core Treatment Period (CT)|Lost to Follow-up|0
5329869|NCT00235989|18349328|P4|Core Treatment Period (CT)|Lost to Follow-up|0
5329870|NCT00235989|18349329|P3|Core Treatment Period (CT)|Lost to Follow-up|0
5329871|NCT00235989|18349330|P2|Core Treatment Period (CT)|Lost to Follow-up|0
5329872|NCT00235989|18349331|P1|Core Treatment Period (CT)|Lost to Follow-up|0
5329873|NCT00235872|18349345|P1|Overall Study|Administrative reason|61
5329874|NCT00235872|18349345|P1|Overall Study|Withdrawal by Subject|50
5329875|NCT00235872|18349345|P1|Overall Study|Lost to Follow-up|1
5329876|NCT00235872|18349345|P1|Overall Study|Death|1
5329877|NCT00235872|18349345|P1|Overall Study|Adverse Event|34
5329878|NCT00235755|18349376|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
5329879|NCT00235755|18349377|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
5329880|NCT00235755|18349378|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
5329881|NCT00235755|18349376|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
5329882|NCT00235755|18349377|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
5329883|NCT00235755|18349378|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
5329884|NCT00235755|18349376|P3|12-Week Maintenance Phase|Protocol Violation|2
5329885|NCT00235755|18349377|P2|12-Week Maintenance Phase|Protocol Violation|4
5329886|NCT00235755|18349378|P1|12-Week Maintenance Phase|Protocol Violation|0
5329887|NCT00235755|18349376|P3|12-Week Maintenance Phase|Lack of Efficacy|0
5329888|NCT00235755|18349377|P2|12-Week Maintenance Phase|Lack of Efficacy|0
5329889|NCT00235755|18349378|P1|12-Week Maintenance Phase|Lack of Efficacy|5
5329890|NCT00235755|18349376|P3|12-Week Maintenance Phase|Lost to Follow-up|0
5329891|NCT00235755|18349377|P2|12-Week Maintenance Phase|Lost to Follow-up|3
5329892|NCT00235755|18349378|P1|12-Week Maintenance Phase|Lost to Follow-up|2
5329893|NCT00235755|18349376|P3|12-Week Maintenance Phase|Adverse Event|26
5329894|NCT00235755|18349377|P2|12-Week Maintenance Phase|Adverse Event|12
5329895|NCT00235755|18349378|P1|12-Week Maintenance Phase|Adverse Event|8
5329896|NCT00235755|18349376|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
5329897|NCT00235755|18349377|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
5329898|NCT00235755|18349378|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
5329899|NCT00235755|18349376|P3|4-Week Titration Phase|Randomization Occurred in Error|0
5329900|NCT00235755|18349377|P2|4-Week Titration Phase|Randomization Occurred in Error|0
5329901|NCT00235755|18349378|P1|4-Week Titration Phase|Randomization Occurred in Error|1
5329902|NCT00235755|18349376|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
5329903|NCT00235755|18349377|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
5329904|NCT00235755|18349378|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
5329905|NCT00235755|18349376|P3|4-Week Titration Phase|Withdrawal by Subject|3
5329906|NCT00235755|18349377|P2|4-Week Titration Phase|Withdrawal by Subject|2
5329907|NCT00235755|18349378|P1|4-Week Titration Phase|Withdrawal by Subject|1
5329908|NCT00235755|18349376|P3|4-Week Titration Phase|Protocol Violation|1
5329909|NCT00235755|18349377|P2|4-Week Titration Phase|Protocol Violation|2
5329910|NCT00235755|18349378|P1|4-Week Titration Phase|Protocol Violation|2
5329911|NCT00235755|18349376|P3|4-Week Titration Phase|Lost to Follow-up|1
5329912|NCT00235755|18349377|P2|4-Week Titration Phase|Lost to Follow-up|1
5329913|NCT00235755|18349378|P1|4-Week Titration Phase|Lost to Follow-up|0
5329914|NCT00235755|18349376|P3|4-Week Titration Phase|Adverse Event|20
5329915|NCT00235755|18349377|P2|4-Week Titration Phase|Adverse Event|14
5329916|NCT00235755|18349378|P1|4-Week Titration Phase|Adverse Event|6
5329917|NCT00235716|18349456|P4|Overall Study|Physician Decision|3
5329918|NCT00235716|18349457|P3|Overall Study|Physician Decision|1
5329919|NCT00235716|18349458|P2|Overall Study|Physician Decision|1
5329920|NCT00235716|18349459|P1|Overall Study|Physician Decision|0
5329921|NCT00235716|18349456|P4|Overall Study|Adverse Event|0
5329922|NCT00235716|18349457|P3|Overall Study|Adverse Event|1
5329923|NCT00235716|18349458|P2|Overall Study|Adverse Event|1
5329924|NCT00235716|18349459|P1|Overall Study|Adverse Event|1
5329925|NCT00235716|18349456|P4|Overall Study|Lost to Follow-up|10
5329926|NCT00235716|18349457|P3|Overall Study|Lost to Follow-up|14
5329927|NCT00235716|18349458|P2|Overall Study|Lost to Follow-up|7
5329928|NCT00235716|18349459|P1|Overall Study|Lost to Follow-up|12
5329929|NCT00235716|18349456|P4|Overall Study|Withdrawal by Subject|18
5329930|NCT00235716|18349457|P3|Overall Study|Withdrawal by Subject|17
5329931|NCT00235716|18349458|P2|Overall Study|Withdrawal by Subject|19
5329932|NCT00235716|18349459|P1|Overall Study|Withdrawal by Subject|23
5329933|NCT00235716|18349456|P4|Overall Study|Death|31
5329934|NCT00235716|18349457|P3|Overall Study|Death|32
5329935|NCT00235716|18349458|P2|Overall Study|Death|39
5329936|NCT00235716|18349459|P1|Overall Study|Death|26
5329937|NCT00235495|18349510|P2|Overall Study|Visit/assessmen outside window/missing|10
5329938|NCT00235495|18349511|P1|Overall Study|Visit/assessmen outside window/missing|0
5329939|NCT00235495|18349510|P2|Overall Study|Lost to Follow-up|13
5329940|NCT00235495|18349511|P1|Overall Study|Lost to Follow-up|11
5329941|NCT00235495|18349510|P2|Overall Study|Withdrawal by Subject|3
5329942|NCT00235495|18349511|P1|Overall Study|Withdrawal by Subject|5
5329943|NCT00235495|18349510|P2|Overall Study|Death|42
5329944|NCT00235495|18349511|P1|Overall Study|Death|52
5329945|NCT00235443|18349584|P6|Overall Study|Other reasons for premature termination|6
5329946|NCT00235443|18349585|P5|Overall Study|Other reasons for premature termination|3
5329947|NCT00235443|18349586|P4|Overall Study|Other reasons for premature termination|7
5329948|NCT00235443|18349587|P3|Overall Study|Other reasons for premature termination|6
5329949|NCT00235443|18349588|P2|Overall Study|Other reasons for premature termination|6
5329950|NCT00235443|18349589|P1|Overall Study|Other reasons for premature termination|1
5329951|NCT00235443|18349584|P6|Overall Study|Unsatisfactory compliance|0
5329952|NCT00235443|18349585|P5|Overall Study|Unsatisfactory compliance|1
5329953|NCT00235443|18349586|P4|Overall Study|Unsatisfactory compliance|4
5329954|NCT00235443|18349587|P3|Overall Study|Unsatisfactory compliance|3
5329955|NCT00235443|18349588|P2|Overall Study|Unsatisfactory compliance|2
5329956|NCT00235443|18349589|P1|Overall Study|Unsatisfactory compliance|0
5329957|NCT00235443|18349584|P6|Overall Study|Lost to Follow-up|3
5329958|NCT00235443|18349585|P5|Overall Study|Lost to Follow-up|4
5329959|NCT00235443|18349586|P4|Overall Study|Lost to Follow-up|6
5329960|NCT00235443|18349587|P3|Overall Study|Lost to Follow-up|6
5329961|NCT00235443|18349588|P2|Overall Study|Lost to Follow-up|8
5329962|NCT00235443|18349589|P1|Overall Study|Lost to Follow-up|0
5329963|NCT00235443|18349584|P6|Overall Study|Withdrawal by Subject|12
5329964|NCT00235443|18349585|P5|Overall Study|Withdrawal by Subject|10
5329965|NCT00235443|18349586|P4|Overall Study|Withdrawal by Subject|24
5329966|NCT00235443|18349587|P3|Overall Study|Withdrawal by Subject|25
5329967|NCT00235443|18349588|P2|Overall Study|Withdrawal by Subject|9
5329968|NCT00235443|18349589|P1|Overall Study|Withdrawal by Subject|3
5329969|NCT00235443|18349584|P6|Overall Study|Lack of Efficacy|9
5329970|NCT00235443|18349585|P5|Overall Study|Lack of Efficacy|2
5329971|NCT00235443|18349586|P4|Overall Study|Lack of Efficacy|12
5329972|NCT00235443|18349587|P3|Overall Study|Lack of Efficacy|5
5329973|NCT00235443|18349588|P2|Overall Study|Lack of Efficacy|1
5329974|NCT00235443|18349589|P1|Overall Study|Lack of Efficacy|0
5329975|NCT00235443|18349584|P6|Overall Study|Adverse Event|15
5329976|NCT00235443|18349585|P5|Overall Study|Adverse Event|10
5329977|NCT00235443|18349586|P4|Overall Study|Adverse Event|44
5329978|NCT00235443|18349587|P3|Overall Study|Adverse Event|17
5329979|NCT00235443|18349588|P2|Overall Study|Adverse Event|12
5329980|NCT00235443|18349589|P1|Overall Study|Adverse Event|4
5329981|NCT00235391|18349730|P6|Overall Study|Death|0
5329982|NCT00235391|18349731|P5|Overall Study|Death|0
5329983|NCT00235391|18349732|P4|Overall Study|Death|4
5329984|NCT00235391|18349733|P3|Overall Study|Death|1
5329985|NCT00235391|18349734|P2|Overall Study|Death|0
5329986|NCT00235391|18349735|P1|Overall Study|Death|0
5329987|NCT00235391|18349730|P6|Overall Study|Administrative problems|0
5329988|NCT00235391|18349731|P5|Overall Study|Administrative problems|0
5329989|NCT00235391|18349732|P4|Overall Study|Administrative problems|1
5329990|NCT00235391|18349733|P3|Overall Study|Administrative problems|0
5329991|NCT00235391|18349734|P2|Overall Study|Administrative problems|0
5329992|NCT00235391|18349735|P1|Overall Study|Administrative problems|0
5329993|NCT00235391|18349730|P6|Overall Study|Lost to Follow-up|0
5329994|NCT00235391|18349731|P5|Overall Study|Lost to Follow-up|0
5329995|NCT00235391|18349732|P4|Overall Study|Lost to Follow-up|16
5329996|NCT00235391|18349733|P3|Overall Study|Lost to Follow-up|3
5329997|NCT00235391|18349734|P2|Overall Study|Lost to Follow-up|3
5329998|NCT00235391|18349735|P1|Overall Study|Lost to Follow-up|0
5329999|NCT00235391|18349730|P6|Overall Study|Withdrawal by Subject|0
5330000|NCT00235391|18349731|P5|Overall Study|Withdrawal by Subject|5
5330001|NCT00235391|18349732|P4|Overall Study|Withdrawal by Subject|61
5330002|NCT00235391|18349733|P3|Overall Study|Withdrawal by Subject|3
5330003|NCT00235391|18349734|P2|Overall Study|Withdrawal by Subject|3
5330004|NCT00235391|18349735|P1|Overall Study|Withdrawal by Subject|2
5330005|NCT00235391|18349730|P6|Overall Study|Protocol deviation|0
5330006|NCT00235391|18349731|P5|Overall Study|Protocol deviation|0
5330007|NCT00235391|18349732|P4|Overall Study|Protocol deviation|11
5330008|NCT00235391|18349733|P3|Overall Study|Protocol deviation|1
5330009|NCT00235391|18349734|P2|Overall Study|Protocol deviation|0
5330010|NCT00235391|18349735|P1|Overall Study|Protocol deviation|0
5330011|NCT00235391|18349730|P6|Overall Study|Condition no longer requires treatment|0
5330012|NCT00235391|18349731|P5|Overall Study|Condition no longer requires treatment|1
5330013|NCT00235391|18349732|P4|Overall Study|Condition no longer requires treatment|11
5330014|NCT00235391|18349733|P3|Overall Study|Condition no longer requires treatment|0
5330015|NCT00235391|18349734|P2|Overall Study|Condition no longer requires treatment|0
5330016|NCT00235391|18349735|P1|Overall Study|Condition no longer requires treatment|3
5330017|NCT00235391|18349730|P6|Overall Study|Unsatisfactory therapeutic effect|0
5330018|NCT00235391|18349731|P5|Overall Study|Unsatisfactory therapeutic effect|0
5330019|NCT00235391|18349732|P4|Overall Study|Unsatisfactory therapeutic effect|17
5330020|NCT00235391|18349733|P3|Overall Study|Unsatisfactory therapeutic effect|2
5330021|NCT00235391|18349734|P2|Overall Study|Unsatisfactory therapeutic effect|2
5330022|NCT00235391|18349735|P1|Overall Study|Unsatisfactory therapeutic effect|0
5330023|NCT00235391|18349730|P6|Overall Study|Abnormal laboratory value(s)|2
5330024|NCT00235391|18349731|P5|Overall Study|Abnormal laboratory value(s)|1
5330025|NCT00235391|18349732|P4|Overall Study|Abnormal laboratory value(s)|27
5330026|NCT00235391|18349733|P3|Overall Study|Abnormal laboratory value(s)|4
5330027|NCT00235391|18349734|P2|Overall Study|Abnormal laboratory value(s)|5
5330028|NCT00235391|18349735|P1|Overall Study|Abnormal laboratory value(s)|3
5330029|NCT00235391|18349730|P6|Overall Study|Adverse Event|2
5330030|NCT00235391|18349731|P5|Overall Study|Adverse Event|5
5330031|NCT00235391|18349732|P4|Overall Study|Adverse Event|72
5330032|NCT00235391|18349733|P3|Overall Study|Adverse Event|10
5330033|NCT00235391|18349734|P2|Overall Study|Adverse Event|5
5330034|NCT00235391|18349735|P1|Overall Study|Adverse Event|4
5330035|NCT00235326|18349752|P2|Overall Study|Lost to Follow-up|1400
5330036|NCT00235326|18349753|P1|Overall Study|Lost to Follow-up|746
5330037|NCT00234533|18349793|P1|Overall Study|Enrolled but not treated|3
5330038|NCT00234533|18349793|P1|Overall Study|Adverse Event|2
5330039|NCT00234533|18349793|P1|Overall Study|Withdrawal by Subject|6
5330040|NCT00234494|18349812|P1|Overall Study|Protocol Violation|2
5330041|NCT00234104|18349858|P4|Overall Study|Physician Decision|2
5330042|NCT00234104|18349859|P3|Overall Study|Physician Decision|2
5330043|NCT00234104|18349860|P2|Overall Study|Physician Decision|1
5330044|NCT00234104|18349861|P1|Overall Study|Physician Decision|0
5330045|NCT00234104|18349858|P4|Overall Study|Protocol Violation|1
5330046|NCT00234104|18349859|P3|Overall Study|Protocol Violation|0
5330047|NCT00234104|18349860|P2|Overall Study|Protocol Violation|0
5330048|NCT00234104|18349861|P1|Overall Study|Protocol Violation|0
5330049|NCT00234104|18349858|P4|Overall Study|Adverse Event|5
5330050|NCT00234104|18349859|P3|Overall Study|Adverse Event|3
5330051|NCT00234104|18349860|P2|Overall Study|Adverse Event|0
5330052|NCT00234104|18349861|P1|Overall Study|Adverse Event|4
5330053|NCT00234065|18349902|P2|Overall Study|Not Classified|112
5330054|NCT00234065|18349903|P1|Overall Study|Not Classified|111
5330055|NCT00234065|18349902|P2|Overall Study|Physician Decision|22
5330056|NCT00234065|18349903|P1|Overall Study|Physician Decision|23
5330057|NCT00234065|18349902|P2|Overall Study|Withdrawal by Subject|56
5330058|NCT00234065|18349903|P1|Overall Study|Withdrawal by Subject|73
5330059|NCT00234065|18349902|P2|Overall Study|Adverse Event|166
5330060|NCT00234065|18349903|P1|Overall Study|Adverse Event|268
5330061|NCT00234052|18349919|P1|Follow-up for 5 Years|Other|7
5330062|NCT00234052|18349919|P1|Follow-up for 5 Years|Lost to Follow-up|1
5330063|NCT00234052|18349919|P1|Follow-up for 5 Years|Death|41
5330064|NCT00234052|18349919|P1|Treatment|Progressive Disease|11
5330065|NCT00234052|18349919|P1|Treatment|Death|2
5330066|NCT00234052|18349919|P1|Treatment|Adverse Event|5
5330067|NCT00234052|18349919|P1|Treatment|Withdrawal by Subject|3
5330068|NCT00234039|18349929|P1|Overall Study|No Protocol Treatment Received|2
5330069|NCT00234039|18349929|P1|Overall Study|Ineligible|9
5330070|NCT00234039|18349929|P1|Overall Study|Other - Not Protocol Specified|3
5330071|NCT00234039|18349929|P1|Overall Study|Progression/relapse|34
5330072|NCT00234039|18349929|P1|Overall Study|Adverse Event|2
5330073|NCT00233987|18349936|P1|Overall Study|Ineligible|4
5330074|NCT00233987|18349936|P1|Overall Study|Eligible but No Treatment Received|2
5330075|NCT00233987|18349936|P1|Overall Study|Other - Not Protocol Specified|5
5330076|NCT00233987|18349936|P1|Overall Study|Reason Under Review|1
5330077|NCT00233987|18349936|P1|Overall Study|Lack of Efficacy|2
5330078|NCT00233987|18349936|P1|Overall Study|Withdrawal by Subject|1
5330079|NCT00233948|18349945|P6|Overall Study|Adverse Event|0
5330080|NCT00233948|18349946|P5|Overall Study|Adverse Event|0
5330081|NCT00233948|18349947|P4|Overall Study|Adverse Event|0
5330082|NCT00233948|18349948|P3|Overall Study|Adverse Event|0
5330083|NCT00233948|18349949|P2|Overall Study|Adverse Event|0
5330084|NCT00233948|18349950|P1|Overall Study|Adverse Event|1
5330085|NCT00233480|18349976|P2|Overall Study|Underwent status II heart transplant|1
5330086|NCT00233480|18349977|P1|Overall Study|Underwent status II heart transplant|0
5330087|NCT00233454|18349993|P1|Overall Study|Death|6
5330088|NCT00233402|18350001|P2|Overall Study|Lost to follow up etc|21
5330089|NCT00233402|18350002|P1|Overall Study|Lost to follow up etc|3
5330090|NCT00233402|18350001|P2|Overall Study|No Ta/T1|94
5330091|NCT00233402|18350002|P1|Overall Study|No Ta/T1|89
5330092|NCT00233402|18350001|P2|Overall Study|No pathology data|9
5330093|NCT00233402|18350002|P1|Overall Study|No pathology data|12
5330094|NCT00233324|18350017|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
5330095|NCT00233324|18350018|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
5330096|NCT00233324|18350019|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
5330097|NCT00233324|18350020|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
5330098|NCT00233324|18350017|P4|Follow up at 18-22 Months Corrected Age|Death|4
5330099|NCT00233324|18350018|P3|Follow up at 18-22 Months Corrected Age|Death|5
5330100|NCT00233324|18350019|P2|Follow up at 18-22 Months Corrected Age|Death|7
5330101|NCT00233324|18350020|P1|Follow up at 18-22 Months Corrected Age|Death|5
5330102|NCT00233324|18350017|P4|Main Study|Death|47
5330103|NCT00233324|18350018|P3|Main Study|Death|62
5330104|NCT00233324|18350019|P2|Main Study|Death|60
5330105|NCT00233324|18350020|P1|Main Study|Death|68
5330106|NCT00233064|18350142|P2|Overall Study|Moved to Dom. Republic|0
5330107|NCT00233064|18350143|P1|Overall Study|Moved to Dom. Republic|1
5330108|NCT00233064|18350142|P2|Overall Study|Protocol Violation|0
5330109|NCT00233064|18350143|P1|Overall Study|Protocol Violation|1
5330110|NCT00233064|18350142|P2|Overall Study|Relocation|1
5330111|NCT00233064|18350143|P1|Overall Study|Relocation|0
5330112|NCT00233064|18350142|P2|Overall Study|Death|1
5330113|NCT00233064|18350143|P1|Overall Study|Death|0
5330114|NCT00233064|18350142|P2|Overall Study|Withdrawal by Subject|3
5330115|NCT00233064|18350143|P1|Overall Study|Withdrawal by Subject|5
5330116|NCT00233064|18350142|P2|Overall Study|Lost to Follow-up|7
5330117|NCT00233064|18350143|P1|Overall Study|Lost to Follow-up|7
5330118|NCT00232596|18350169|P2|12-Week Maintenance Phase|Other|3
5330119|NCT00232596|18350170|P1|12-Week Maintenance Phase|Other|1
5330120|NCT00232596|18350169|P2|12-Week Maintenance Phase|Protocol Violation|1
5330121|NCT00232596|18350170|P1|12-Week Maintenance Phase|Protocol Violation|3
5330122|NCT00232596|18350169|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
5330123|NCT00232596|18350170|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
5330124|NCT00232596|18350169|P2|12-Week Maintenance Phase|Adverse Event|22
5330125|NCT00232596|18350170|P1|12-Week Maintenance Phase|Adverse Event|7
5330126|NCT00232596|18350169|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
5330127|NCT00232596|18350170|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
5330128|NCT00232596|18350169|P2|6-Week Titration Phase|Other|3
5330129|NCT00232596|18350170|P1|6-Week Titration Phase|Other|3
5330130|NCT00232596|18350169|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
5330131|NCT00232596|18350170|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
5330132|NCT00232596|18350169|P2|6-Week Titration Phase|Protocol Violation|3
5330133|NCT00232596|18350170|P1|6-Week Titration Phase|Protocol Violation|1
5330134|NCT00232596|18350169|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
5330135|NCT00232596|18350170|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
5330136|NCT00232596|18350169|P2|6-Week Titration Phase|Failed to Return|1
5330137|NCT00232596|18350170|P1|6-Week Titration Phase|Failed to Return|2
5330138|NCT00232596|18350169|P2|6-Week Titration Phase|Adverse Event|19
5330139|NCT00232596|18350170|P1|6-Week Titration Phase|Adverse Event|6
5330140|NCT00232557|18350261|P2|Overall Study|Lost to Follow-up|5
5330141|NCT00232557|18350262|P1|Overall Study|Lost to Follow-up|3
5330142|NCT00232544|18350272|P2|Overall Study|Lost to Follow-up|15
5330143|NCT00232544|18350273|P1|Overall Study|Lost to Follow-up|20
5330144|NCT00232180|18350304|P3|Open Label Phase|Randomized but not treated|1
5330145|NCT00232180|18350305|P2|Open Label Phase|Randomized but not treated|0
5330146|NCT00232180|18350306|P1|Open Label Phase|Randomized but not treated|0
5330147|NCT00232180|18350304|P3|Open Label Phase|Laboratory abnormality|10
5330148|NCT00232180|18350305|P2|Open Label Phase|Laboratory abnormality|0
5330149|NCT00232180|18350306|P1|Open Label Phase|Laboratory abnormality|0
5330150|NCT00232180|18350304|P3|Open Label Phase|Adverse Event|25
5330151|NCT00232180|18350305|P2|Open Label Phase|Adverse Event|0
5330152|NCT00232180|18350306|P1|Open Label Phase|Adverse Event|0
5330153|NCT00232180|18350304|P3|Open Label Phase|Other|16
5330154|NCT00232180|18350305|P2|Open Label Phase|Other|0
5330155|NCT00232180|18350306|P1|Open Label Phase|Other|0
5330156|NCT00232180|18350304|P3|Open Label Phase|Withdrawal by Subject|37
5330157|NCT00232180|18350305|P2|Open Label Phase|Withdrawal by Subject|0
5330158|NCT00232180|18350306|P1|Open Label Phase|Withdrawal by Subject|0
5330159|NCT00232180|18350304|P3|Open Label Phase|Study terminated by sponsor|3
5330160|NCT00232180|18350305|P2|Open Label Phase|Study terminated by sponsor|0
5330161|NCT00232180|18350306|P1|Open Label Phase|Study terminated by sponsor|0
5330162|NCT00232180|18350304|P3|Open Label Phase|Protocol Violation|3
5330163|NCT00232180|18350305|P2|Open Label Phase|Protocol Violation|0
5330164|NCT00232180|18350306|P1|Open Label Phase|Protocol Violation|0
5330165|NCT00232180|18350304|P3|Open Label Phase|Lost to Follow-up|5
5330166|NCT00232180|18350305|P2|Open Label Phase|Lost to Follow-up|0
5330167|NCT00232180|18350306|P1|Open Label Phase|Lost to Follow-up|0
5330168|NCT00232180|18350304|P3|Open Label Phase|Death|48
5330169|NCT00232180|18350305|P2|Open Label Phase|Death|0
5330170|NCT00232180|18350306|P1|Open Label Phase|Death|0
5330171|NCT00232180|18350304|P3|Double-blind (DB) Phase|Laboratory abnormality|0
5330172|NCT00232180|18350305|P2|Double-blind (DB) Phase|Laboratory abnormality|7
5330173|NCT00232180|18350306|P1|Double-blind (DB) Phase|Laboratory abnormality|6
5330174|NCT00232180|18350304|P3|Double-blind (DB) Phase|Randomized but not treated|0
5330175|NCT00232180|18350305|P2|Double-blind (DB) Phase|Randomized but not treated|4
5330176|NCT00232180|18350306|P1|Double-blind (DB) Phase|Randomized but not treated|3
5330177|NCT00232180|18350304|P3|Double-blind (DB) Phase|Other|0
5330178|NCT00232180|18350305|P2|Double-blind (DB) Phase|Other|75
5330179|NCT00232180|18350306|P1|Double-blind (DB) Phase|Other|70
5330180|NCT00232180|18350304|P3|Double-blind (DB) Phase|Adverse Event|0
5330181|NCT00232180|18350305|P2|Double-blind (DB) Phase|Adverse Event|100
5330182|NCT00232180|18350306|P1|Double-blind (DB) Phase|Adverse Event|83
5330183|NCT00232180|18350304|P3|Double-blind (DB) Phase|Protocol Violation|0
5330184|NCT00232180|18350305|P2|Double-blind (DB) Phase|Protocol Violation|21
5330185|NCT00232180|18350306|P1|Double-blind (DB) Phase|Protocol Violation|28
5330186|NCT00232180|18350304|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
5330187|NCT00232180|18350305|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
5330188|NCT00232180|18350306|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
5330189|NCT00232180|18350304|P3|Double-blind (DB) Phase|Lost to Follow-up|0
5330190|NCT00232180|18350305|P2|Double-blind (DB) Phase|Lost to Follow-up|28
5330191|NCT00232180|18350306|P1|Double-blind (DB) Phase|Lost to Follow-up|34
5330192|NCT00232180|18350304|P3|Double-blind (DB) Phase|Death|0
5330193|NCT00232180|18350305|P2|Double-blind (DB) Phase|Death|222
5330194|NCT00232180|18350306|P1|Double-blind (DB) Phase|Death|186
5330195|NCT00232141|18350351|P2|Overall Study|Withdrawal by Subject|3
5330196|NCT00232141|18350352|P1|Overall Study|Withdrawal by Subject|5
5330197|NCT00232141|18350351|P2|Overall Study|Other|10
5330198|NCT00232141|18350352|P1|Overall Study|Other|8
5330199|NCT00232141|18350351|P2|Overall Study|Lost to Follow-up|6
5330200|NCT00232141|18350352|P1|Overall Study|Lost to Follow-up|9
5330201|NCT00232141|18350351|P2|Overall Study|Lack of Efficacy|3
5330202|NCT00232141|18350352|P1|Overall Study|Lack of Efficacy|0
5330203|NCT00232141|18350351|P2|Overall Study|Adverse Event|4
5330204|NCT00232141|18350352|P1|Overall Study|Adverse Event|9
5330205|NCT00231894|18350422|P2|Overall Study|Withdrawal by Subject|1
5330206|NCT00231894|18350423|P1|Overall Study|Withdrawal by Subject|1
5330207|NCT00231842|18350449|P1|Overall Study|Did not complete the last 3 cycle|8
5330208|NCT00231842|18350449|P1|Overall Study|Withdrawal by Subject|3
5330209|NCT00231816|18350456|P2|Overall Study|Other|1
5330210|NCT00231816|18350457|P1|Overall Study|Other|2
5330211|NCT00231816|18350456|P2|Overall Study|Withdrawal by Subject|3
5330212|NCT00231816|18350457|P1|Overall Study|Withdrawal by Subject|3
5330213|NCT00231816|18350456|P2|Overall Study|Protocol Violation|3
5330214|NCT00231816|18350457|P1|Overall Study|Protocol Violation|2
5330215|NCT00231816|18350456|P2|Overall Study|Lost to Follow-up|5
5330216|NCT00231816|18350457|P1|Overall Study|Lost to Follow-up|8
5330217|NCT00231816|18350456|P2|Overall Study|Adverse Event|0
5330218|NCT00231816|18350457|P1|Overall Study|Adverse Event|1
5330219|NCT00231777|18350472|P2|Overall Study|Other|2
5330220|NCT00231777|18350473|P1|Overall Study|Other|3
5330221|NCT00231777|18350472|P2|Overall Study|Lost to Follow-up|0
5330222|NCT00231777|18350473|P1|Overall Study|Lost to Follow-up|3
5330223|NCT00231478|18350487|P2|Overall Study|Administrative|2
5330224|NCT00231478|18350488|P1|Overall Study|Administrative|3
5330225|NCT00231478|18350487|P2|Overall Study|Adverse Event|1
5330226|NCT00231478|18350488|P1|Overall Study|Adverse Event|0
5330227|NCT00231478|18350487|P2|Overall Study|Withdrawal by Subject|0
5330228|NCT00231478|18350488|P1|Overall Study|Withdrawal by Subject|1
5330229|NCT00231478|18350487|P2|Overall Study|Refused Treatment|1
5330230|NCT00231478|18350488|P1|Overall Study|Refused Treatment|1
5330231|NCT00231478|18350487|P2|Overall Study|Protocol Violation|2
5330232|NCT00231478|18350488|P1|Overall Study|Protocol Violation|3
5330233|NCT00231465|18350500|P1|Overall Study|Did not have follow up CT scans|1
5330234|NCT00231465|18350500|P1|Overall Study|Completed only one cycle|1
5330235|NCT00231413|18350513|P7|Overall Study|Pregnancy|0
5330236|NCT00231413|18350514|P6|Overall Study|Pregnancy|0
5330237|NCT00231413|18350515|P5|Overall Study|Pregnancy|0
5330238|NCT00231413|18350516|P4|Overall Study|Pregnancy|0
5330239|NCT00231413|18350517|P3|Overall Study|Pregnancy|0
5330240|NCT00231413|18350518|P2|Overall Study|Pregnancy|0
5330241|NCT00231413|18350519|P1|Overall Study|Pregnancy|1
5330242|NCT00231413|18350513|P7|Overall Study|Lost to Follow-up|0
5330243|NCT00231413|18350514|P6|Overall Study|Lost to Follow-up|4
5330244|NCT00231413|18350515|P5|Overall Study|Lost to Follow-up|1
5330245|NCT00231413|18350516|P4|Overall Study|Lost to Follow-up|1
5330246|NCT00231413|18350517|P3|Overall Study|Lost to Follow-up|1
5330247|NCT00231413|18350518|P2|Overall Study|Lost to Follow-up|4
5330248|NCT00231413|18350519|P1|Overall Study|Lost to Follow-up|4
5330249|NCT00231413|18350513|P7|Overall Study|Migrated/moved from study area|0
5330250|NCT00231413|18350514|P6|Overall Study|Migrated/moved from study area|1
5330251|NCT00231413|18350515|P5|Overall Study|Migrated/moved from study area|0
5330252|NCT00231413|18350516|P4|Overall Study|Migrated/moved from study area|0
5330253|NCT00231413|18350517|P3|Overall Study|Migrated/moved from study area|1
5330254|NCT00231413|18350518|P2|Overall Study|Migrated/moved from study area|0
5330255|NCT00231413|18350519|P1|Overall Study|Migrated/moved from study area|0
5330256|NCT00231413|18350513|P7|Overall Study|Withdrawal by Subject|3
5330257|NCT00231413|18350514|P6|Overall Study|Withdrawal by Subject|0
5330258|NCT00231413|18350515|P5|Overall Study|Withdrawal by Subject|2
5330259|NCT00231413|18350516|P4|Overall Study|Withdrawal by Subject|2
5330260|NCT00231413|18350517|P3|Overall Study|Withdrawal by Subject|4
5330261|NCT00231413|18350518|P2|Overall Study|Withdrawal by Subject|1
5330262|NCT00231413|18350519|P1|Overall Study|Withdrawal by Subject|3
5330263|NCT00231413|18350513|P7|Overall Study|Non-serious AE|1
5330264|NCT00231413|18350514|P6|Overall Study|Non-serious AE|0
5330265|NCT00231413|18350515|P5|Overall Study|Non-serious AE|0
5330266|NCT00231413|18350516|P4|Overall Study|Non-serious AE|0
5330267|NCT00231413|18350517|P3|Overall Study|Non-serious AE|1
5330268|NCT00231413|18350518|P2|Overall Study|Non-serious AE|0
5330269|NCT00231413|18350519|P1|Overall Study|Non-serious AE|0
5330270|NCT00231179|18350689|P2|Overall Study|Withdrawal by Subject|3
5330271|NCT00231179|18350690|P1|Overall Study|Withdrawal by Subject|3
5330272|NCT00231179|18350689|P2|Overall Study|Lost to Follow-up|21
5330273|NCT00231179|18350690|P1|Overall Study|Lost to Follow-up|21
5330274|NCT00231114|18350717|P2|Post-Treatment Period|Withdrawal by Subject|0
5330275|NCT00231114|18350718|P1|Post-Treatment Period|Withdrawal by Subject|1
5330276|NCT00231114|18350717|P2|Post-Treatment Period|Physician Decision|0
5330277|NCT00231114|18350718|P1|Post-Treatment Period|Physician Decision|1
5330278|NCT00231114|18350717|P2|Post-Treatment Period|Lost to Follow-up|1
5330279|NCT00231114|18350718|P1|Post-Treatment Period|Lost to Follow-up|6
5330280|NCT00231114|18350717|P2|Treatment Period|Death: Motor Vehicle Accident|0
5330281|NCT00231114|18350718|P1|Treatment Period|Death: Motor Vehicle Accident|1
5330282|NCT00231114|18350717|P2|Randomized|Withdrawal by Subject|3
5330283|NCT00231114|18350718|P1|Randomized|Withdrawal by Subject|6
5330284|NCT00231062|18350754|P1|Overall Study|Physician Decision|6
5330285|NCT00230971|18350762|P2|Baseline Participants|Reintervention|0
5330286|NCT00230971|18350763|P1|Baseline Participants|Reintervention|1
5330287|NCT00230971|18350762|P2|Baseline Participants|Failure to return|1
5330288|NCT00230971|18350763|P1|Baseline Participants|Failure to return|1
5330289|NCT00230971|18350762|P2|Baseline Participants|No bacteria observed|0
5330290|NCT00230971|18350763|P1|Baseline Participants|No bacteria observed|1
5330291|NCT00230971|18350762|P2|Baseline Participants|Adverse Event|0
5330292|NCT00230971|18350763|P1|Baseline Participants|Adverse Event|1
5330293|NCT00230971|18350762|P2|Baseline Participants|Withdrawal by Subject|1
5330294|NCT00230971|18350763|P1|Baseline Participants|Withdrawal by Subject|7
5330295|NCT00230971|18350762|P2|Baseline Participants|Death|5
5330296|NCT00230971|18350763|P1|Baseline Participants|Death|6
5330297|NCT00230971|18350762|P2|Baseline Participants|Lost to Follow-up|12
5330298|NCT00230971|18350763|P1|Baseline Participants|Lost to Follow-up|5
5330299|NCT00230971|18350762|P2|Randomization|No study drug administered|3
5330300|NCT00230971|18350763|P1|Randomization|No study drug administered|3
5330301|NCT00230282|18350801|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
5330302|NCT00230282|18350801|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
5330303|NCT00230282|18350801|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
5330304|NCT00230282|18350801|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
5330305|NCT00230178|18350809|P3|Overall Study|Various other reasons|4
5330306|NCT00230178|18350810|P2|Overall Study|Various other reasons|2
5330307|NCT00230178|18350811|P1|Overall Study|Various other reasons|3
5330308|NCT00230178|18350809|P3|Overall Study|Withdrawal by Subject|1
5330309|NCT00230178|18350810|P2|Overall Study|Withdrawal by Subject|0
5330310|NCT00230178|18350811|P1|Overall Study|Withdrawal by Subject|0
5330311|NCT00230178|18350809|P3|Overall Study|Adverse Event|2
5330312|NCT00230178|18350810|P2|Overall Study|Adverse Event|5
5330313|NCT00230178|18350811|P1|Overall Study|Adverse Event|1
5330314|NCT00230048|18350863|P2|Overall Study|Lost to Follow-up|18
5330315|NCT00230048|18350864|P1|Overall Study|Lost to Follow-up|13
5330316|NCT00229931|18350922|P2|Overall Study|Lost to Follow-up|2
5330317|NCT00229931|18350923|P1|Overall Study|Lost to Follow-up|3
5330318|NCT00229931|18350922|P2|Overall Study|Death|0
5330319|NCT00229931|18350923|P1|Overall Study|Death|1
5330320|NCT00229723|18350938|P7|Maintenance Phase|Other|1
5330321|NCT00229723|18350939|P6|Maintenance Phase|Other|3
5330322|NCT00229723|18350940|P5|Maintenance Phase|Other|3
5330323|NCT00229723|18350941|P4|Maintenance Phase|Other|2
5330324|NCT00229723|18350942|P3|Maintenance Phase|Other|1
5330325|NCT00229723|18350943|P2|Maintenance Phase|Other|4
5330326|NCT00229723|18350944|P1|Maintenance Phase|Other|5
5330327|NCT00229723|18350938|P7|Maintenance Phase|Severe non-compliance|0
5330328|NCT00229723|18350939|P6|Maintenance Phase|Severe non-compliance|0
5330329|NCT00229723|18350940|P5|Maintenance Phase|Severe non-compliance|1
5330330|NCT00229723|18350941|P4|Maintenance Phase|Severe non-compliance|0
5330331|NCT00229723|18350942|P3|Maintenance Phase|Severe non-compliance|0
5330332|NCT00229723|18350943|P2|Maintenance Phase|Severe non-compliance|1
5330333|NCT00229723|18350944|P1|Maintenance Phase|Severe non-compliance|3
5330334|NCT00229723|18350938|P7|Maintenance Phase|Informed consent withdrawn|0
5330335|NCT00229723|18350939|P6|Maintenance Phase|Informed consent withdrawn|1
5330336|NCT00229723|18350940|P5|Maintenance Phase|Informed consent withdrawn|1
5330337|NCT00229723|18350941|P4|Maintenance Phase|Informed consent withdrawn|1
5330338|NCT00229723|18350942|P3|Maintenance Phase|Informed consent withdrawn|0
5330339|NCT00229723|18350943|P2|Maintenance Phase|Informed consent withdrawn|0
5330340|NCT00229723|18350944|P1|Maintenance Phase|Informed consent withdrawn|1
5330341|NCT00229723|18350938|P7|Maintenance Phase|Lost to Follow-up|1
5330342|NCT00229723|18350939|P6|Maintenance Phase|Lost to Follow-up|0
5330343|NCT00229723|18350940|P5|Maintenance Phase|Lost to Follow-up|0
5330344|NCT00229723|18350941|P4|Maintenance Phase|Lost to Follow-up|2
5330345|NCT00229723|18350942|P3|Maintenance Phase|Lost to Follow-up|2
5330346|NCT00229723|18350943|P2|Maintenance Phase|Lost to Follow-up|1
5330347|NCT00229723|18350944|P1|Maintenance Phase|Lost to Follow-up|0
5330348|NCT00229723|18350938|P7|Maintenance Phase|Clinical progression|1
5330349|NCT00229723|18350939|P6|Maintenance Phase|Clinical progression|1
5330350|NCT00229723|18350940|P5|Maintenance Phase|Clinical progression|1
5330351|NCT00229723|18350941|P4|Maintenance Phase|Clinical progression|2
5330352|NCT00229723|18350942|P3|Maintenance Phase|Clinical progression|2
5330353|NCT00229723|18350943|P2|Maintenance Phase|Clinical progression|1
5330354|NCT00229723|18350944|P1|Maintenance Phase|Clinical progression|4
5330355|NCT00229723|18350938|P7|Maintenance Phase|Objective disease progression|5
5330356|NCT00229723|18350939|P6|Maintenance Phase|Objective disease progression|9
5330357|NCT00229723|18350940|P5|Maintenance Phase|Objective disease progression|2
5330358|NCT00229723|18350941|P4|Maintenance Phase|Objective disease progression|6
5330445|NCT00228917|18351068|P3|Overall Study|Migrated/moved from study area|0
5330359|NCT00229723|18350942|P3|Maintenance Phase|Objective disease progression|3
5330360|NCT00229723|18350943|P2|Maintenance Phase|Objective disease progression|5
5330361|NCT00229723|18350944|P1|Maintenance Phase|Objective disease progression|5
5330362|NCT00229723|18350938|P7|Maintenance Phase|Adverse Event|2
5330363|NCT00229723|18350939|P6|Maintenance Phase|Adverse Event|5
5330364|NCT00229723|18350940|P5|Maintenance Phase|Adverse Event|7
5330365|NCT00229723|18350941|P4|Maintenance Phase|Adverse Event|4
5330366|NCT00229723|18350942|P3|Maintenance Phase|Adverse Event|1
5330367|NCT00229723|18350943|P2|Maintenance Phase|Adverse Event|2
5330368|NCT00229723|18350944|P1|Maintenance Phase|Adverse Event|7
5330369|NCT00229723|18350938|P7|Concomitant Phase|Other|0
5330370|NCT00229723|18350939|P6|Concomitant Phase|Other|2
5330371|NCT00229723|18350940|P5|Concomitant Phase|Other|0
5330372|NCT00229723|18350941|P4|Concomitant Phase|Other|1
5330373|NCT00229723|18350942|P3|Concomitant Phase|Other|1
5330374|NCT00229723|18350943|P2|Concomitant Phase|Other|0
5330375|NCT00229723|18350944|P1|Concomitant Phase|Other|3
5330376|NCT00229723|18350938|P7|Concomitant Phase|Severe non-compliance|0
5330377|NCT00229723|18350939|P6|Concomitant Phase|Severe non-compliance|0
5330378|NCT00229723|18350940|P5|Concomitant Phase|Severe non-compliance|1
5330379|NCT00229723|18350941|P4|Concomitant Phase|Severe non-compliance|0
5330380|NCT00229723|18350942|P3|Concomitant Phase|Severe non-compliance|0
5330381|NCT00229723|18350943|P2|Concomitant Phase|Severe non-compliance|1
5330382|NCT00229723|18350944|P1|Concomitant Phase|Severe non-compliance|0
5330383|NCT00229723|18350938|P7|Concomitant Phase|Informed consent withdrawn|0
5330384|NCT00229723|18350939|P6|Concomitant Phase|Informed consent withdrawn|0
5330385|NCT00229723|18350940|P5|Concomitant Phase|Informed consent withdrawn|0
5330386|NCT00229723|18350941|P4|Concomitant Phase|Informed consent withdrawn|2
5330387|NCT00229723|18350942|P3|Concomitant Phase|Informed consent withdrawn|0
5330388|NCT00229723|18350943|P2|Concomitant Phase|Informed consent withdrawn|2
5330389|NCT00229723|18350944|P1|Concomitant Phase|Informed consent withdrawn|3
5330390|NCT00229723|18350938|P7|Concomitant Phase|Lost to Follow-up|0
5330391|NCT00229723|18350939|P6|Concomitant Phase|Lost to Follow-up|0
5330392|NCT00229723|18350940|P5|Concomitant Phase|Lost to Follow-up|1
5330393|NCT00229723|18350941|P4|Concomitant Phase|Lost to Follow-up|0
5330394|NCT00229723|18350942|P3|Concomitant Phase|Lost to Follow-up|0
5330395|NCT00229723|18350943|P2|Concomitant Phase|Lost to Follow-up|0
5330396|NCT00229723|18350944|P1|Concomitant Phase|Lost to Follow-up|0
5330397|NCT00229723|18350938|P7|Concomitant Phase|Clinical progression|1
5330398|NCT00229723|18350939|P6|Concomitant Phase|Clinical progression|0
5330399|NCT00229723|18350940|P5|Concomitant Phase|Clinical progression|0
5330400|NCT00229723|18350941|P4|Concomitant Phase|Clinical progression|0
5330401|NCT00229723|18350942|P3|Concomitant Phase|Clinical progression|0
5330402|NCT00229723|18350943|P2|Concomitant Phase|Clinical progression|0
5330403|NCT00229723|18350944|P1|Concomitant Phase|Clinical progression|0
5330404|NCT00229723|18350938|P7|Concomitant Phase|Objective disease progression|0
5330405|NCT00229723|18350939|P6|Concomitant Phase|Objective disease progression|0
5330406|NCT00229723|18350940|P5|Concomitant Phase|Objective disease progression|0
5330407|NCT00229723|18350941|P4|Concomitant Phase|Objective disease progression|0
5330408|NCT00229723|18350942|P3|Concomitant Phase|Objective disease progression|0
5330409|NCT00229723|18350943|P2|Concomitant Phase|Objective disease progression|0
5330410|NCT00229723|18350944|P1|Concomitant Phase|Objective disease progression|0
5330411|NCT00229723|18350938|P7|Concomitant Phase|Adverse Event|2
5330412|NCT00229723|18350939|P6|Concomitant Phase|Adverse Event|1
5330413|NCT00229723|18350940|P5|Concomitant Phase|Adverse Event|0
5330414|NCT00229723|18350941|P4|Concomitant Phase|Adverse Event|2
5330415|NCT00229723|18350942|P3|Concomitant Phase|Adverse Event|5
5330416|NCT00229723|18350943|P2|Concomitant Phase|Adverse Event|2
5330417|NCT00229723|18350944|P1|Concomitant Phase|Adverse Event|4
5330418|NCT00229658|18350997|P2|Overall Study|Withdrawal of consent|39
5330419|NCT00229658|18350998|P1|Overall Study|Withdrawal of consent|46
5330420|NCT00229658|18350997|P2|Overall Study|Serious Adverse Event|2
5330421|NCT00229658|18350998|P1|Overall Study|Serious Adverse Event|2
5330422|NCT00229658|18350997|P2|Overall Study|Lost to Follow-up|55
5330423|NCT00229658|18350998|P1|Overall Study|Lost to Follow-up|82
5330424|NCT00229658|18350997|P2|Overall Study|Other|60
5330425|NCT00229658|18350998|P1|Overall Study|Other|80
5330426|NCT00229658|18350997|P2|Overall Study|Investigator decision|10
5330427|NCT00229658|18350998|P1|Overall Study|Investigator decision|13
5330428|NCT00229658|18350997|P2|Overall Study|Administrative|1
5330429|NCT00229658|18350998|P1|Overall Study|Administrative|2
5330430|NCT00229203|18351034|P2|Overall Study|Withdrawal by Subject|4
5330431|NCT00229203|18351035|P1|Overall Study|Withdrawal by Subject|1
5330432|NCT00229203|18351034|P2|Overall Study|Other|3
5330433|NCT00229203|18351035|P1|Overall Study|Other|3
5330434|NCT00229203|18351034|P2|Overall Study|Death|2
5330435|NCT00229203|18351035|P1|Overall Study|Death|4
5330436|NCT00229203|18351034|P2|Overall Study|Toxicity|1
5330437|NCT00229203|18351035|P1|Overall Study|Toxicity|6
5330438|NCT00229203|18351034|P2|Overall Study|Progressive disease|9
5330439|NCT00229203|18351035|P1|Overall Study|Progressive disease|18
5330440|NCT00228917|18351063|P8|Overall Study|Migrated/moved from study area|0
5330441|NCT00228917|18351064|P7|Overall Study|Migrated/moved from study area|0
5330442|NCT00228917|18351065|P6|Overall Study|Migrated/moved from study area|2
5330443|NCT00228917|18351066|P5|Overall Study|Migrated/moved from study area|0
5330444|NCT00228917|18351067|P4|Overall Study|Migrated/moved from study area|0
5330446|NCT00228917|18351069|P2|Overall Study|Migrated/moved from study area|0
5330447|NCT00228917|18351070|P1|Overall Study|Migrated/moved from study area|0
5330448|NCT00228813|18351116|P1|Overall Study|Death|4
5330449|NCT00228566|18351122|P1|Overall Study|Miscellaneous|1
5330450|NCT00228566|18351122|P1|Overall Study|Withdrawal by Subject|4
5330451|NCT00228566|18351122|P1|Overall Study|Physician Decision|5
5330452|NCT00228566|18351122|P1|Overall Study|Lost to Follow-up|16
5330453|NCT00228566|18351122|P1|Overall Study|Lack of Efficacy|14
5330454|NCT00228566|18351122|P1|Overall Study|Adverse Event|31
5330455|NCT00228553|18351126|P1|Overall Study|Miscellaneous|46
5330456|NCT00228553|18351126|P1|Overall Study|Pregnancy|2
5330457|NCT00228553|18351126|P1|Overall Study|Withdrawal by Subject|115
5330458|NCT00228553|18351126|P1|Overall Study|Protocol Violation|6
5330459|NCT00228553|18351126|P1|Overall Study|Physician Decision|48
5330460|NCT00228553|18351126|P1|Overall Study|Lost to Follow-up|67
5330461|NCT00228553|18351126|P1|Overall Study|Lack of Efficacy|34
5330462|NCT00228553|18351126|P1|Overall Study|Adverse Event|112
5330463|NCT00228384|18351132|P2|Overall Study|Physician Decision|1
5330464|NCT00228384|18351133|P1|Overall Study|Physician Decision|0
5330465|NCT00228384|18351132|P2|Overall Study|Withdrawal by Subject|10
5330466|NCT00228384|18351133|P1|Overall Study|Withdrawal by Subject|9
5330467|NCT00228384|18351132|P2|Overall Study|Surgical Intervention (bypass)|5
5330468|NCT00228384|18351133|P1|Overall Study|Surgical Intervention (bypass)|5
5330469|NCT00228384|18351132|P2|Overall Study|Lost to Follow-up|10
5330470|NCT00228384|18351133|P1|Overall Study|Lost to Follow-up|6
5330471|NCT00228384|18351132|P2|Overall Study|Death|3
5330472|NCT00228384|18351133|P1|Overall Study|Death|9
5330473|NCT00227903|18351184|P2|Overall Study|Miscarriage|0
5330474|NCT00227903|18351185|P1|Overall Study|Miscarriage|1
5330475|NCT00227903|18351184|P2|Overall Study|Lost to Follow-up|3
5330476|NCT00227903|18351185|P1|Overall Study|Lost to Follow-up|1
5330477|NCT00227903|18351184|P2|Overall Study|Subject moved out of area|2
5330478|NCT00227903|18351185|P1|Overall Study|Subject moved out of area|1
5330479|NCT00227903|18351184|P2|Overall Study|Withdrawal by Subject|5
5330480|NCT00227903|18351185|P1|Overall Study|Withdrawal by Subject|2
5330481|NCT00227877|18351249|P4|12-months Follow-up|Lost to Follow-up|26
5330482|NCT00227877|18351250|P3|12-months Follow-up|Lost to Follow-up|30
5330483|NCT00227877|18351251|P2|12-months Follow-up|Lost to Follow-up|189
5330484|NCT00227877|18351252|P1|12-months Follow-up|Lost to Follow-up|232
5330485|NCT00227877|18351249|P4|12-months Follow-up|Completed late|0
5330486|NCT00227877|18351250|P3|12-months Follow-up|Completed late|1
5330487|NCT00227877|18351251|P2|12-months Follow-up|Completed late|74
5330488|NCT00227877|18351252|P1|12-months Follow-up|Completed late|78
5330489|NCT00227877|18351249|P4|3-months Follow-up|Lost to Follow-up|13
5330490|NCT00227877|18351250|P3|3-months Follow-up|Lost to Follow-up|18
5330491|NCT00227877|18351251|P2|3-months Follow-up|Lost to Follow-up|139
5330492|NCT00227877|18351252|P1|3-months Follow-up|Lost to Follow-up|178
5330493|NCT00227877|18351249|P4|3-months Follow-up|Completed late|8
5330494|NCT00227877|18351250|P3|3-months Follow-up|Completed late|34
5330495|NCT00227877|18351251|P2|3-months Follow-up|Completed late|128
5330496|NCT00227877|18351252|P1|3-months Follow-up|Completed late|135
5330497|NCT00227877|18351249|P4|Post-visit Checklist|Lost to Follow-up|0
5330498|NCT00227877|18351250|P3|Post-visit Checklist|Lost to Follow-up|1
5330499|NCT00227877|18351251|P2|Post-visit Checklist|Lost to Follow-up|13
5330500|NCT00227877|18351252|P1|Post-visit Checklist|Lost to Follow-up|24
5330501|NCT00227877|18351249|P4|Pre-visit Assessment|Technical difficulties|0
5330502|NCT00227877|18351250|P3|Pre-visit Assessment|Technical difficulties|0
5330503|NCT00227877|18351251|P2|Pre-visit Assessment|Technical difficulties|3
5330504|NCT00227877|18351252|P1|Pre-visit Assessment|Technical difficulties|7
5330505|NCT00227721|18351288|P1|Overall Study|On study, but never treated.|1
5330506|NCT00227591|18351310|P1|Overall Study|Withdrawal by Subject|1
5330507|NCT00227539|18351314|P1|Overall Study|Protocol Violation|1
5330508|NCT00227370|18351322|P2|Overall Study|Other reasons|1
5330509|NCT00227370|18351323|P1|Overall Study|Other reasons|2
5330510|NCT00227370|18351322|P2|Overall Study|Physician Decision|6
5330511|NCT00227370|18351323|P1|Overall Study|Physician Decision|9
5330512|NCT00227370|18351322|P2|Overall Study|Adverse Event|11
5330513|NCT00227370|18351323|P1|Overall Study|Adverse Event|6
5330514|NCT00227370|18351322|P2|Overall Study|Death|4
5330515|NCT00227370|18351323|P1|Overall Study|Death|3
5330516|NCT00227370|18351322|P2|Overall Study|Withdrawal by Subject|2
5330517|NCT00227370|18351323|P1|Overall Study|Withdrawal by Subject|1
5330518|NCT00227344|18351343|P2|Overall Study|study terminated early|5
5330519|NCT00227344|18351344|P1|Overall Study|study terminated early|12
5330520|NCT00227305|18351364|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
5330521|NCT00227305|18351364|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
5330522|NCT00227305|18351364|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
5330523|NCT00227305|18351364|P1|Overall Study|Physician Decision|3
5330524|NCT00227305|18351364|P1|Overall Study|Lack of Efficacy|7
5330525|NCT00227305|18351364|P1|Overall Study|MOVED OUT OF AREA|3
5330526|NCT00227305|18351364|P1|Overall Study|Study specific discontinuation|13
5330527|NCT00227305|18351364|P1|Overall Study|Lost to Follow-up|33
5330528|NCT00227305|18351364|P1|Overall Study|Withdrawal by Subject|42
5330529|NCT00227305|18351364|P1|Overall Study|Adverse Event|40
5330530|NCT00227266|18351381|P3|Overall Study|Excessive weight gain|2
5330531|NCT00227266|18351382|P2|Overall Study|Excessive weight gain|0
5330532|NCT00227266|18351383|P1|Overall Study|Excessive weight gain|0
5330533|NCT00227266|18351381|P3|Overall Study|Protocol Violation|1
5330534|NCT00227266|18351382|P2|Overall Study|Protocol Violation|0
5330535|NCT00227266|18351383|P1|Overall Study|Protocol Violation|1
5330536|NCT00227266|18351381|P3|Overall Study|Withdrawal by Subject|1
5330537|NCT00227266|18351382|P2|Overall Study|Withdrawal by Subject|0
5330538|NCT00227266|18351383|P1|Overall Study|Withdrawal by Subject|0
5330539|NCT00226941|18351413|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
5330540|NCT00226941|18351414|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
5330541|NCT00226941|18351415|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
5330542|NCT00226941|18351416|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
5330543|NCT00226941|18351413|P4|Overall Study|Withdrawal by subject - toxicity|1
5330544|NCT00226941|18351414|P3|Overall Study|Withdrawal by subject - toxicity|0
5330545|NCT00226941|18351415|P2|Overall Study|Withdrawal by subject - toxicity|0
5330546|NCT00226941|18351416|P1|Overall Study|Withdrawal by subject - toxicity|0
5330547|NCT00226811|18351450|P1|Overall Study|Withdrawal by Subject|2
5330548|NCT00226811|18351450|P1|Overall Study|Lack of Efficacy|55
5330549|NCT00226811|18351450|P1|Overall Study|Adverse Event|11
5330550|NCT00226811|18351450|P1|Overall Study|Death|8
5330551|NCT00226655|18351460|P1|Overall Study|Clinical deterioration|10
5330552|NCT00226655|18351460|P1|Overall Study|Physician Decision|6
5330553|NCT00226655|18351460|P1|Overall Study|Adverse Event|35
5330554|NCT00226655|18351460|P1|Overall Study|Withdrawal by Subject|15
5330555|NCT00226655|18351460|P1|Overall Study|Death|13
5330556|NCT00226499|18351482|P3|Overall Study|Others|356
5330557|NCT00226499|18351483|P2|Overall Study|Others|1066
5330558|NCT00226499|18351484|P1|Overall Study|Others|1064
5330559|NCT00226499|18351482|P3|Overall Study|Adverse Event|3
5330560|NCT00226499|18351483|P2|Overall Study|Adverse Event|6
5330561|NCT00226499|18351484|P1|Overall Study|Adverse Event|10
5330562|NCT00225758|18351619|P1|Overall Study|Adverse Event|4
5330563|NCT00225277|18351651|P2|Overall Study|Other|9
5330564|NCT00225277|18351652|P1|Overall Study|Other|7
5330565|NCT00225277|18351651|P2|Overall Study|Withdrawal by Subject|34
5330566|NCT00225277|18351652|P1|Overall Study|Withdrawal by Subject|40
5330567|NCT00225277|18351651|P2|Overall Study|Protocol Violation|3
5330568|NCT00225277|18351652|P1|Overall Study|Protocol Violation|6
5330569|NCT00225277|18351651|P2|Overall Study|Physician Decision|8
5330570|NCT00225277|18351652|P1|Overall Study|Physician Decision|6
5330571|NCT00225277|18351651|P2|Overall Study|Lost to Follow-up|6
5330572|NCT00225277|18351652|P1|Overall Study|Lost to Follow-up|4
5330573|NCT00225277|18351651|P2|Overall Study|Lack of Efficacy|1
5330574|NCT00225277|18351652|P1|Overall Study|Lack of Efficacy|4
5330575|NCT00225277|18351651|P2|Overall Study|Adverse Event|34
5330576|NCT00225277|18351652|P1|Overall Study|Adverse Event|30
5330577|NCT00225251|18351670|P2|Overall Study|Withdrawal by Subject|1
5330578|NCT00225251|18351671|P1|Overall Study|Withdrawal by Subject|1
5330579|NCT00225212|18351685|P1|Overall Study|Intercurrent illness|1
5330580|NCT00225212|18351685|P1|Overall Study|Adverse Event|2
5330581|NCT00225212|18351685|P1|Overall Study|Death|1
5330582|NCT00225212|18351685|P1|Overall Study|Disease progression|2
5330583|NCT00225147|18351694|P4|Open-label Phase|Withdrawal by Subject|6
5330584|NCT00225147|18351695|P3|Open-label Phase|Withdrawal by Subject|0
5330585|NCT00225147|18351696|P2|Open-label Phase|Withdrawal by Subject|0
5330586|NCT00225147|18351697|P1|Open-label Phase|Withdrawal by Subject|0
5330587|NCT00225147|18351694|P4|Open-label Phase|Lost to Follow-up|4
5330588|NCT00225147|18351695|P3|Open-label Phase|Lost to Follow-up|0
5330589|NCT00225147|18351696|P2|Open-label Phase|Lost to Follow-up|0
5330590|NCT00225147|18351697|P1|Open-label Phase|Lost to Follow-up|0
5330591|NCT00224874|18351744|P4|Overall Study|Withdrawal by Subject|0
5330592|NCT00224874|18351745|P3|Overall Study|Withdrawal by Subject|1
5330593|NCT00224874|18351746|P2|Overall Study|Withdrawal by Subject|0
5330594|NCT00224874|18351747|P1|Overall Study|Withdrawal by Subject|0
5330595|NCT00224770|18351792|P3|Overall Study|Lost to Follow-up|0
5330596|NCT00224770|18351793|P2|Overall Study|Lost to Follow-up|2
5330597|NCT00224770|18351794|P1|Overall Study|Lost to Follow-up|4
5330598|NCT00224484|18351829|P3|Overall Study|Reason not specified|2
5330599|NCT00224484|18351830|P2|Overall Study|Reason not specified|4
5330600|NCT00224484|18351831|P1|Overall Study|Reason not specified|5
5330601|NCT00224484|18351829|P3|Overall Study|Lost to Follow-up|36
5330602|NCT00224484|18351830|P2|Overall Study|Lost to Follow-up|28
5330603|NCT00224484|18351831|P1|Overall Study|Lost to Follow-up|66
5330604|NCT00224484|18351829|P3|Overall Study|Migrated/moved from study area|5
5330605|NCT00224484|18351830|P2|Overall Study|Migrated/moved from study area|5
5330606|NCT00224484|18351831|P1|Overall Study|Migrated/moved from study area|18
5330607|NCT00224484|18351829|P3|Overall Study|Withdrawal by Subject|16
5330608|NCT00224484|18351830|P2|Overall Study|Withdrawal by Subject|18
5330609|NCT00224484|18351831|P1|Overall Study|Withdrawal by Subject|49
5330610|NCT00224484|18351829|P3|Overall Study|Protocol Violation|0
5330611|NCT00224484|18351830|P2|Overall Study|Protocol Violation|2
5330612|NCT00224484|18351831|P1|Overall Study|Protocol Violation|2
5330613|NCT00224484|18351829|P3|Overall Study|Non-Serious Adverse Event|3
5330614|NCT00224484|18351830|P2|Overall Study|Non-Serious Adverse Event|7
5330615|NCT00224484|18351831|P1|Overall Study|Non-Serious Adverse Event|5
5330616|NCT00224484|18351829|P3|Overall Study|Serious Adverse Event|0
5330617|NCT00224484|18351830|P2|Overall Study|Serious Adverse Event|1
5330618|NCT00224484|18351831|P1|Overall Study|Serious Adverse Event|1
5330619|NCT00224133|18351895|P1|Overall Study|Other|14
5330620|NCT00224133|18351895|P1|Overall Study|Physician Decision|1
5330621|NCT00224133|18351895|P1|Overall Study|Lost to Follow-up|21
5330622|NCT00224133|18351895|P1|Overall Study|Lack of Efficacy|58
5330623|NCT00224133|18351895|P1|Overall Study|Withdrawal by Subject|33
5330624|NCT00224133|18351895|P1|Overall Study|Protocol Violation|6
5330625|NCT00224133|18351895|P1|Overall Study|Adverse Event|93
5330626|NCT00224120|18351901|P2|Overall Study|Other|5
5330627|NCT00224120|18351902|P1|Overall Study|Other|4
5330628|NCT00224120|18351901|P2|Overall Study|Lost to Follow-up|3
5330629|NCT00224120|18351902|P1|Overall Study|Lost to Follow-up|2
5330630|NCT00224120|18351901|P2|Overall Study|Lack of Efficacy|2
5330631|NCT00224120|18351902|P1|Overall Study|Lack of Efficacy|0
5330632|NCT00224120|18351901|P2|Overall Study|Withdrawal by Subject|10
5330633|NCT00224120|18351902|P1|Overall Study|Withdrawal by Subject|5
5330634|NCT00224120|18351901|P2|Overall Study|Protocol Violation|0
5330635|NCT00224120|18351902|P1|Overall Study|Protocol Violation|1
5330636|NCT00224120|18351901|P2|Overall Study|Adverse Event|4
5330637|NCT00224120|18351902|P1|Overall Study|Adverse Event|10
5330638|NCT00224107|18351912|P2|Overall Study|Other|1
5330639|NCT00224107|18351913|P1|Overall Study|Other|1
5330640|NCT00224107|18351912|P2|Overall Study|Physician Decision|0
5330641|NCT00224107|18351913|P1|Overall Study|Physician Decision|1
5330642|NCT00224107|18351912|P2|Overall Study|Lost to Follow-up|0
5330643|NCT00224107|18351913|P1|Overall Study|Lost to Follow-up|4
5330644|NCT00224107|18351912|P2|Overall Study|Lack of Efficacy|0
5330645|NCT00224107|18351913|P1|Overall Study|Lack of Efficacy|2
5330646|NCT00224107|18351912|P2|Overall Study|Withdrawal by Subject|4
5330647|NCT00224107|18351913|P1|Overall Study|Withdrawal by Subject|1
5330648|NCT00224107|18351912|P2|Overall Study|Protocol Violation|3
5330649|NCT00224107|18351913|P1|Overall Study|Protocol Violation|2
5330650|NCT00224107|18351912|P2|Overall Study|Adverse Event|6
5330651|NCT00224107|18351913|P1|Overall Study|Adverse Event|20
5330652|NCT00224055|18351923|P2|Overall Study|Other|0
5330653|NCT00224055|18351924|P1|Overall Study|Other|1
5330654|NCT00224055|18351923|P2|Overall Study|Withdrawal by Subject|2
5330655|NCT00224055|18351924|P1|Overall Study|Withdrawal by Subject|0
5330656|NCT00224055|18351923|P2|Overall Study|Inclusion Violation|6
5330657|NCT00224055|18351924|P1|Overall Study|Inclusion Violation|3
5330658|NCT00224055|18351923|P2|Overall Study|Protocol Violation|1
5330659|NCT00224055|18351924|P1|Overall Study|Protocol Violation|1
5330660|NCT00224055|18351923|P2|Overall Study|Lost to Follow-up|2
5330661|NCT00224055|18351924|P1|Overall Study|Lost to Follow-up|1
5330662|NCT00224055|18351923|P2|Overall Study|Adverse Event|3
5330663|NCT00224055|18351924|P1|Overall Study|Adverse Event|9
5330664|NCT00224042|18351934|P2|Overall Study|Other|0
5330665|NCT00224042|18351935|P1|Overall Study|Other|2
5330666|NCT00224042|18351934|P2|Overall Study|Did not meet lab incusion criteria|3
5330667|NCT00224042|18351935|P1|Overall Study|Did not meet lab incusion criteria|2
5330668|NCT00224042|18351934|P2|Overall Study|Physician Decision|1
5330669|NCT00224042|18351935|P1|Overall Study|Physician Decision|0
5330670|NCT00224042|18351934|P2|Overall Study|Protocol Violation|1
5330671|NCT00224042|18351935|P1|Overall Study|Protocol Violation|0
5330672|NCT00224042|18351934|P2|Overall Study|Adverse Event|1
5330673|NCT00224042|18351935|P1|Overall Study|Adverse Event|2
5330674|NCT00224029|18351947|P1|Overall Study|Other|1
5330675|NCT00224029|18351947|P1|Overall Study|Withdrawal by Subject|4
5330676|NCT00224029|18351947|P1|Overall Study|Lost to Follow-up|1
5330677|NCT00224016|18351953|P2|Maintenance Period|Lost to Follow-up|1
5330678|NCT00224016|18351954|P1|Maintenance Period|Lost to Follow-up|0
5330679|NCT00224016|18351953|P2|Maintenance Period|Withdrawal by Subject|0
5330680|NCT00224016|18351954|P1|Maintenance Period|Withdrawal by Subject|2
5330681|NCT00224016|18351953|P2|Titration Period|Lost to Follow-up|0
5330682|NCT00224016|18351954|P1|Titration Period|Lost to Follow-up|1
5330683|NCT00224016|18351953|P2|Titration Period|Withdrawal by Subject|1
5330684|NCT00224016|18351954|P1|Titration Period|Withdrawal by Subject|0
5330685|NCT00224003|18351962|P1|Overall Study|unk|3
5330686|NCT00224003|18351962|P1|Overall Study|Withdrawal by Subject|1
5330687|NCT00224003|18351962|P1|Overall Study|Protocol Violation|2
5330688|NCT00224003|18351962|P1|Overall Study|Adverse Event|1
5330689|NCT00223990|18351968|P2|Overall Study|Lost to Follow-up|0
5330690|NCT00223990|18351969|P1|Overall Study|Lost to Follow-up|1
5330691|NCT00223990|18351968|P2|Overall Study|Withdrawal by Subject|8
5330692|NCT00223990|18351969|P1|Overall Study|Withdrawal by Subject|4
5330693|NCT00223990|18351968|P2|Overall Study|Moved from area|1
5330694|NCT00223990|18351969|P1|Overall Study|Moved from area|2
5330695|NCT00223977|18351994|P3|Overall Study|Other|0
5330696|NCT00223977|18351995|P2|Overall Study|Other|0
5330697|NCT00223977|18351996|P1|Overall Study|Other|1
5330698|NCT00223977|18351994|P3|Overall Study|Withdrawal by Subject|2
5330699|NCT00223977|18351995|P2|Overall Study|Withdrawal by Subject|1
5330700|NCT00223977|18351996|P1|Overall Study|Withdrawal by Subject|1
5330701|NCT00223977|18351994|P3|Overall Study|Protocol Violation|1
5330702|NCT00223977|18351995|P2|Overall Study|Protocol Violation|0
5330703|NCT00223977|18351996|P1|Overall Study|Protocol Violation|0
5330704|NCT00223977|18351994|P3|Overall Study|Adverse Event|0
5330705|NCT00223977|18351995|P2|Overall Study|Adverse Event|10
5330706|NCT00223977|18351996|P1|Overall Study|Adverse Event|7
5330707|NCT00223808|18352030|P3|Overall Study|<5 hrs therapy before discharge|5
5330708|NCT00223808|18352031|P2|Overall Study|<5 hrs therapy before discharge|5
5330709|NCT00223808|18352032|P1|Overall Study|<5 hrs therapy before discharge|3
5330710|NCT00223795|18352049|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
5330711|NCT00223795|18352050|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
5330712|NCT00223795|18352049|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
5330713|NCT00223795|18352050|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
5330714|NCT00223496|18352128|P1|Overall Study|Physician Decision|2
5330715|NCT00223496|18352128|P1|Overall Study|Withdrawal by Subject|1
5330716|NCT00223496|18352128|P1|Overall Study|Lack of Efficacy|6
5330717|NCT00223496|18352128|P1|Overall Study|Lost to Follow-up|4
5330718|NCT00223496|18352128|P1|Overall Study|screen failure|9
5330719|NCT00223080|18352158|P2|Overall Study|Adverse Event|1
5330720|NCT00223080|18352159|P1|Overall Study|Adverse Event|0
5330721|NCT00223080|18352158|P2|Overall Study|Reason not provided|140
5330722|NCT00223080|18352159|P1|Overall Study|Reason not provided|141
5330723|NCT00223080|18352158|P2|Overall Study|Other|11
5330724|NCT00223080|18352159|P1|Overall Study|Other|14
5330725|NCT00223080|18352158|P2|Overall Study|Death|74
5330726|NCT00223080|18352159|P1|Overall Study|Death|85
5330727|NCT00223080|18352158|P2|Overall Study|Lost to Follow-up|284
5330728|NCT00223080|18352159|P1|Overall Study|Lost to Follow-up|259
5330729|NCT00223080|18352158|P2|Overall Study|Moved from study area|47
5330730|NCT00223080|18352159|P1|Overall Study|Moved from study area|37
5330731|NCT00223080|18352158|P2|Overall Study|Non-compliant|7
5330732|NCT00223080|18352159|P1|Overall Study|Non-compliant|7
5330733|NCT00223080|18352158|P2|Overall Study|Required contraindicated med|1
5330734|NCT00223080|18352159|P1|Overall Study|Required contraindicated med|0
5330735|NCT00223080|18352158|P2|Overall Study|Withdrawal by Subject|232
5330736|NCT00223080|18352159|P1|Overall Study|Withdrawal by Subject|253
5330737|NCT00222729|18352177|P1|Overall Study|Adverse Event|3
5330738|NCT00222105|18352195|P1|Overall Study|Death|2
5330739|NCT00222105|18352195|P1|Overall Study|Treatment delays|2
5330740|NCT00222105|18352195|P1|Overall Study|Adverse Event|8
5330741|NCT00222105|18352195|P1|Overall Study|Withdrawal by Subject|1
5330742|NCT00222105|18352195|P1|Overall Study|Removed due to wrong diagnosis|1
5330743|NCT00221403|18352203|P3|Overall Study|Adverse Event|0
5330744|NCT00221403|18352204|P2|Overall Study|Adverse Event|1
5330745|NCT00221403|18352205|P1|Overall Study|Adverse Event|0
5330746|NCT00221403|18352203|P3|Overall Study|Lack of Efficacy|0
5330747|NCT00221403|18352204|P2|Overall Study|Lack of Efficacy|1
5330748|NCT00221403|18352205|P1|Overall Study|Lack of Efficacy|0
5330749|NCT00221403|18352203|P3|Overall Study|Withdrawal by Subject|0
5330750|NCT00221403|18352204|P2|Overall Study|Withdrawal by Subject|3
5330751|NCT00221403|18352205|P1|Overall Study|Withdrawal by Subject|0
5330752|NCT00221403|18352203|P3|Overall Study|Physician Decision|0
5330753|NCT00221403|18352204|P2|Overall Study|Physician Decision|0
5330754|NCT00221403|18352205|P1|Overall Study|Physician Decision|1
5330755|NCT00221403|18352203|P3|Overall Study|Protocol Violation|0
5330756|NCT00221403|18352204|P2|Overall Study|Protocol Violation|0
5330757|NCT00221403|18352205|P1|Overall Study|Protocol Violation|1
5330758|NCT00221195|18352248|P2|Therapy 2 (Months 10-15)|Adverse Event|0
5330759|NCT00221195|18352249|P1|Therapy 2 (Months 10-15)|Adverse Event|1
5330760|NCT00221195|18352248|P2|Therapy 2 (Months 10-15)|Death|0
5330761|NCT00221195|18352249|P1|Therapy 2 (Months 10-15)|Death|1
5330762|NCT00221195|18352248|P2|Washout Period (Months 7-9)|Death|1
5330763|NCT00221195|18352249|P1|Washout Period (Months 7-9)|Death|0
5330764|NCT00221195|18352248|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
5330765|NCT00221195|18352249|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
5330766|NCT00221195|18352248|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
5330767|NCT00221195|18352249|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
5330768|NCT00221104|18352271|P2|Overall Study|Others|47
5330769|NCT00221104|18352272|P1|Overall Study|Others|37
5330770|NCT00221104|18352271|P2|Overall Study|Withdrawal by Subject|29
5330771|NCT00221104|18352272|P1|Overall Study|Withdrawal by Subject|42
5330772|NCT00221104|18352271|P2|Overall Study|Protocol Violation|0
5330773|NCT00221104|18352272|P1|Overall Study|Protocol Violation|2
5330774|NCT00221104|18352271|P2|Overall Study|Physician Decision|0
5330775|NCT00221104|18352272|P1|Overall Study|Physician Decision|1
5330776|NCT00221104|18352271|P2|Overall Study|Adverse Event|0
5330777|NCT00221104|18352272|P1|Overall Study|Adverse Event|1
5330778|NCT00220805|18352305|P2|Overall Study|Develop. of choroidal neovascularization|8
5330779|NCT00220805|18352306|P1|Overall Study|Develop. of choroidal neovascularization|3
5330780|NCT00220805|18352305|P2|Overall Study|Lack of Efficacy|0
5330781|NCT00220805|18352306|P1|Overall Study|Lack of Efficacy|1
5330782|NCT00220805|18352305|P2|Overall Study|Withdrawal by Subject|0
5330783|NCT00220805|18352306|P1|Overall Study|Withdrawal by Subject|3
5330784|NCT00220805|18352305|P2|Overall Study|Adverse Event|3
5330785|NCT00220805|18352306|P1|Overall Study|Adverse Event|1
5330786|NCT00220779|18352327|P3|Overall Study|Lack of Efficacy|1
5330787|NCT00220779|18352328|P2|Overall Study|Lack of Efficacy|0
5330788|NCT00220779|18352329|P1|Overall Study|Lack of Efficacy|3
5330789|NCT00220779|18352327|P3|Overall Study|Pregnancy|2
5330790|NCT00220779|18352328|P2|Overall Study|Pregnancy|0
5330791|NCT00220779|18352329|P1|Overall Study|Pregnancy|0
5330792|NCT00220779|18352327|P3|Overall Study|Too time consuming|0
5330793|NCT00220779|18352328|P2|Overall Study|Too time consuming|0
5330794|NCT00220779|18352329|P1|Overall Study|Too time consuming|1
5330795|NCT00220779|18352327|P3|Overall Study|Non-compliance|0
5330796|NCT00220779|18352328|P2|Overall Study|Non-compliance|0
5330797|NCT00220779|18352329|P1|Overall Study|Non-compliance|1
5330798|NCT00220779|18352327|P3|Overall Study|Withdrawal by Subject|1
5330799|NCT00220779|18352328|P2|Overall Study|Withdrawal by Subject|4
5330800|NCT00220779|18352329|P1|Overall Study|Withdrawal by Subject|1
5330801|NCT00220779|18352327|P3|Overall Study|Adverse Event|0
5330802|NCT00220779|18352328|P2|Overall Study|Adverse Event|0
5330803|NCT00220779|18352329|P1|Overall Study|Adverse Event|1
5330804|NCT00220740|18352339|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
5330805|NCT00220740|18352340|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
5330806|NCT00220740|18352339|P2|Efficacy Period|Protocol Violation|0
5330807|NCT00220740|18352340|P1|Efficacy Period|Protocol Violation|1
5330808|NCT00220740|18352339|P2|Efficacy Period|Withdrawal by Subject|0
5330809|NCT00220740|18352340|P1|Efficacy Period|Withdrawal by Subject|1
5330810|NCT00220740|18352339|P2|Efficacy Period|Adverse Event|1
5330811|NCT00220740|18352340|P1|Efficacy Period|Adverse Event|1
5330812|NCT00220740|18352339|P2|Efficacy Period|Entered rescue treatment with placebo|0
5330813|NCT00220740|18352340|P1|Efficacy Period|Entered rescue treatment with placebo|23
5330814|NCT00220727|18352354|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
5330815|NCT00220727|18352355|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
5330816|NCT00220701|18352371|P2|Overall Study|Lost to Follow-up|4
5330817|NCT00220701|18352372|P1|Overall Study|Lost to Follow-up|5
5330818|NCT00220636|18352388|P1|Overall Study|Withdrawal by Subject|4
5330819|NCT00219557|18352398|P3|Phase 2|Treatment not received|3
5330820|NCT00219557|18352399|P2|Phase 2|Treatment not received|1
5330821|NCT00219557|18352400|P1|Phase 2|Treatment not received|0
5330822|NCT00219557|18352398|P3|Phase 2|Withdrawal by Subject|5
5330823|NCT00219557|18352399|P2|Phase 2|Withdrawal by Subject|9
5330824|NCT00219557|18352400|P1|Phase 2|Withdrawal by Subject|0
5330825|NCT00219557|18352398|P3|Phase 2|Other|6
5330826|NCT00219557|18352399|P2|Phase 2|Other|8
5330827|NCT00219557|18352400|P1|Phase 2|Other|0
5330828|NCT00219557|18352398|P3|Phase 2|Death|2
5330829|NCT00219557|18352399|P2|Phase 2|Death|8
5330830|NCT00219557|18352400|P1|Phase 2|Death|0
5330831|NCT00219557|18352398|P3|Phase 2|Adverse Event|2
5330832|NCT00219557|18352399|P2|Phase 2|Adverse Event|22
5330833|NCT00219557|18352400|P1|Phase 2|Adverse Event|0
5330834|NCT00219557|18352398|P3|Phase 2|Lack of Efficacy|15
5330835|NCT00219557|18352399|P2|Phase 2|Lack of Efficacy|21
5330836|NCT00219557|18352400|P1|Phase 2|Lack of Efficacy|0
5330837|NCT00219557|18352398|P3|Phase 1|Started chemotherapy at other institute|0
5330838|NCT00219557|18352399|P2|Phase 1|Started chemotherapy at other institute|0
5330839|NCT00219557|18352400|P1|Phase 1|Started chemotherapy at other institute|1
5330840|NCT00219557|18352398|P3|Phase 1|Withdrawal by Subject|0
5330841|NCT00219557|18352399|P2|Phase 1|Withdrawal by Subject|0
5330842|NCT00219557|18352400|P1|Phase 1|Withdrawal by Subject|1
5330843|NCT00219557|18352398|P3|Phase 1|Adverse Event|0
5330844|NCT00219557|18352399|P2|Phase 1|Adverse Event|0
5330845|NCT00219557|18352400|P1|Phase 1|Adverse Event|2
5330846|NCT00219557|18352398|P3|Phase 1|Lack of Efficacy|0
5330847|NCT00219557|18352399|P2|Phase 1|Lack of Efficacy|0
5330848|NCT00219557|18352400|P1|Phase 1|Lack of Efficacy|3
5330849|NCT00219544|18352428|P2|Single Blind Treatment Period|Withdrawal by Subject|0
5330850|NCT00219544|18352429|P1|Single Blind Treatment Period|Withdrawal by Subject|1
5330851|NCT00219544|18352428|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
5330852|NCT00219544|18352429|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
5330853|NCT00219544|18352428|P2|Single Blind Treatment Period|Lost to Follow-up|0
5330854|NCT00219544|18352429|P1|Single Blind Treatment Period|Lost to Follow-up|2
5330855|NCT00219544|18352428|P2|Single Blind Treatment Period|Protocol Violation|0
5330856|NCT00219544|18352429|P1|Single Blind Treatment Period|Protocol Violation|4
5330857|NCT00219544|18352428|P2|Single Blind Treatment Period|Adverse Event|0
5330858|NCT00219544|18352429|P1|Single Blind Treatment Period|Adverse Event|9
5330859|NCT00219544|18352428|P2|Single Blind Treatment Period|Lack of Efficacy|0
5330860|NCT00219544|18352429|P1|Single Blind Treatment Period|Lack of Efficacy|5
5330861|NCT00219349|18352467|P1|Escitalopram Phase|Withdrawal by Subject|3
5330862|NCT00219349|18352467|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
5330863|NCT00219349|18352467|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
5330864|NCT00219349|18352467|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
5330865|NCT00219284|18352480|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
5330866|NCT00219284|18352481|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
5330867|NCT00219284|18352480|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
5330868|NCT00219284|18352481|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
5330869|NCT00219284|18352480|P2|Extension Phase - 8 Weeks|Adverse Event|3
5330870|NCT00219284|18352481|P1|Extension Phase - 8 Weeks|Adverse Event|2
5330871|NCT00219284|18352480|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
5330872|NCT00219284|18352481|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
5330873|NCT00219284|18352480|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
5330874|NCT00219284|18352481|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
5330875|NCT00219284|18352480|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
5330876|NCT00219284|18352481|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
5330877|NCT00219284|18352480|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
5330878|NCT00219284|18352481|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
5330879|NCT00219284|18352480|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
5330880|NCT00219284|18352481|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
5330881|NCT00219284|18352480|P2|Treatment Phase - 16 Weeks|Adverse Event|24
5330882|NCT00219284|18352481|P1|Treatment Phase - 16 Weeks|Adverse Event|26
5330883|NCT00219141|18352506|P3|Overall Study|Condition no longer requires study drug|0
5331062|NCT00215683|18353158|P1|Overall Study|Intermittent therapy required|0
5330884|NCT00219141|18352507|P2|Overall Study|Condition no longer requires study drug|0
5330885|NCT00219141|18352508|P1|Overall Study|Condition no longer requires study drug|1
5330886|NCT00219141|18352506|P3|Overall Study|Withdrawal by Subject|5
5330887|NCT00219141|18352507|P2|Overall Study|Withdrawal by Subject|3
5330888|NCT00219141|18352508|P1|Overall Study|Withdrawal by Subject|1
5330889|NCT00219141|18352506|P3|Overall Study|Protocol Violation|1
5330890|NCT00219141|18352507|P2|Overall Study|Protocol Violation|1
5330891|NCT00219141|18352508|P1|Overall Study|Protocol Violation|3
5330892|NCT00219141|18352506|P3|Overall Study|Lost to Follow-up|1
5330893|NCT00219141|18352507|P2|Overall Study|Lost to Follow-up|4
5330894|NCT00219141|18352508|P1|Overall Study|Lost to Follow-up|2
5330895|NCT00219141|18352506|P3|Overall Study|Administrative problems|0
5330896|NCT00219141|18352507|P2|Overall Study|Administrative problems|1
5330897|NCT00219141|18352508|P1|Overall Study|Administrative problems|0
5330898|NCT00219141|18352506|P3|Overall Study|Lack of Efficacy|0
5330899|NCT00219141|18352507|P2|Overall Study|Lack of Efficacy|2
5330900|NCT00219141|18352508|P1|Overall Study|Lack of Efficacy|3
5330901|NCT00219141|18352506|P3|Overall Study|Adverse Event|5
5330902|NCT00219141|18352507|P2|Overall Study|Adverse Event|10
5330903|NCT00219141|18352508|P1|Overall Study|Adverse Event|4
5330904|NCT00218634|18352554|P2|Overall Study|Lost to Follow-up|15
5330905|NCT00218634|18352555|P1|Overall Study|Lost to Follow-up|8
5330906|NCT00218543|18352575|P1|Overall Study|Adverse Event|2
5330907|NCT00218543|18352575|P1|Overall Study|Physician Decision|3
5330908|NCT00218543|18352575|P1|Overall Study|Withdrawal by Subject|1
5330909|NCT00218543|18352575|P1|Overall Study|relocated|1
5330910|NCT00218543|18352575|P1|Overall Study|Lost to Follow-up|8
5330911|NCT00218296|18352753|P2|Overall Study|Randomized but did not enter treatment|67
5330912|NCT00218296|18352754|P1|Overall Study|Randomized but did not enter treatment|66
5330913|NCT00218296|18352753|P2|Overall Study|Withdrawal by Subject|47
5330914|NCT00218296|18352754|P1|Overall Study|Withdrawal by Subject|36
5330915|NCT00218296|18352753|P2|Overall Study|Lost to Follow-up|7
5330916|NCT00218296|18352754|P1|Overall Study|Lost to Follow-up|9
5330917|NCT00218257|18352770|P2|Period Between Visit 1 and 2|Lost to Follow-up|3
5330918|NCT00218257|18352771|P1|Period Between Visit 1 and 2|Lost to Follow-up|4
5330919|NCT00217971|18352872|P2|Overall Study|non compliant|0
5330920|NCT00217971|18352873|P1|Overall Study|non compliant|1
5330921|NCT00217971|18352872|P2|Overall Study|Withdrawal by Subject|12
5330922|NCT00217971|18352873|P1|Overall Study|Withdrawal by Subject|7
5330923|NCT00217971|18352872|P2|Overall Study|Physician Decision|1
5330924|NCT00217971|18352873|P1|Overall Study|Physician Decision|0
5330925|NCT00217971|18352872|P2|Overall Study|Lost to Follow-up|19
5330926|NCT00217971|18352873|P1|Overall Study|Lost to Follow-up|15
5330927|NCT00217971|18352872|P2|Overall Study|Adverse Event|1
5330928|NCT00217971|18352873|P1|Overall Study|Adverse Event|1
5330929|NCT00217672|18352888|P2|Follow-up|Lost to Follow-up|0
5330930|NCT00217672|18352889|P1|Follow-up|Lost to Follow-up|1
5330931|NCT00217672|18352888|P2|Follow-up|Withdrawal by Subject|0
5330932|NCT00217672|18352889|P1|Follow-up|Withdrawal by Subject|4
5330933|NCT00217672|18352888|P2|Treatment|secondary malignancy|0
5330934|NCT00217672|18352889|P1|Treatment|secondary malignancy|1
5330935|NCT00217672|18352888|P2|Treatment|Death|0
5330936|NCT00217672|18352889|P1|Treatment|Death|2
5330937|NCT00217672|18352888|P2|Treatment|insurance issues|1
5330938|NCT00217672|18352889|P1|Treatment|insurance issues|1
5330939|NCT00217672|18352888|P2|Treatment|Physician Decision|0
5330940|NCT00217672|18352889|P1|Treatment|Physician Decision|6
5330941|NCT00217672|18352888|P2|Treatment|reqd treatment not permitted by protocol|0
5330942|NCT00217672|18352889|P1|Treatment|reqd treatment not permitted by protocol|6
5330943|NCT00217672|18352888|P2|Treatment|Adverse Event|2
5330944|NCT00217672|18352889|P1|Treatment|Adverse Event|18
5330945|NCT00217672|18352888|P2|Treatment|disease progression|4
5330946|NCT00217672|18352889|P1|Treatment|disease progression|33
5330947|NCT00217672|18352888|P2|Allocation|Ineligible|0
5330948|NCT00217672|18352889|P1|Allocation|Ineligible|2
5330949|NCT00217620|18352895|P1|Overall Study|Never received treatment|1
5330950|NCT00217620|18352895|P1|Overall Study|Ineligible|13
5330951|NCT00217620|18352895|P1|Overall Study|Not Protocol Specified|4
5330952|NCT00217620|18352895|P1|Overall Study|Progression|31
5330953|NCT00217620|18352895|P1|Overall Study|Adverse Event|2
5330954|NCT00217581|18352910|P1|Overall Study|Withdrawal by Subject|1
5330955|NCT00217464|18352939|P1|Overall Study|Other|2
5330956|NCT00217464|18352939|P1|Overall Study|Progression|15
5330957|NCT00217425|18352955|P1|Overall Study|Other|4
5330958|NCT00217425|18352955|P1|Overall Study|Other complicating disease|1
5330959|NCT00217425|18352955|P1|Overall Study|Withdrawal by Subject|4
5330960|NCT00217425|18352955|P1|Overall Study|Adverse Event|8
5330961|NCT00217425|18352955|P1|Overall Study|Lack of Efficacy|13
5330962|NCT00217425|18352955|P1|Overall Study|Patient ineligible|5
5330963|NCT00217425|18352955|P1|Overall Study|Never started treatment|2
5330964|NCT00217087|18352969|P2|Overall Study|completed less than 12 months return|18
5330965|NCT00217087|18352970|P1|Overall Study|completed less than 12 months return|10
5330966|NCT00217087|18352969|P2|Overall Study|decided to have esophagectomy|2
5330967|NCT00217087|18352970|P1|Overall Study|decided to have esophagectomy|1
5330968|NCT00217022|18352984|P2|Overall Study|Withdrawal by Subject|1
5330969|NCT00217022|18352985|P1|Overall Study|Withdrawal by Subject|1
5330970|NCT00216736|18352995|P2|Overall Study|Lost to Follow-up|1
5330971|NCT00216736|18352996|P1|Overall Study|Lost to Follow-up|1
5330972|NCT00216671|18353010|P2|Overall Study|Insufficient Response Adverse Event|1
5330973|NCT00216671|18353011|P1|Overall Study|Insufficient Response Adverse Event|2
5330974|NCT00216671|18353010|P2|Overall Study|Ineligible, no efficacy data|2
5330975|NCT00216671|18353011|P1|Overall Study|Ineligible, no efficacy data|2
5330976|NCT00216671|18353010|P2|Overall Study|Patient Moved|1
5330977|NCT00216671|18353011|P1|Overall Study|Patient Moved|0
5330978|NCT00216671|18353010|P2|Overall Study|Investigator Illness|1
5330979|NCT00216671|18353011|P1|Overall Study|Investigator Illness|0
5330980|NCT00216671|18353010|P2|Overall Study|Relapse|0
5330981|NCT00216671|18353011|P1|Overall Study|Relapse|1
5330982|NCT00216671|18353010|P2|Overall Study|Protocol Violation|5
5330983|NCT00216671|18353011|P1|Overall Study|Protocol Violation|3
5330984|NCT00216671|18353010|P2|Overall Study|Physician Decision|1
5330985|NCT00216671|18353011|P1|Overall Study|Physician Decision|1
5330986|NCT00216671|18353010|P2|Overall Study|Ineligible|2
5330987|NCT00216671|18353011|P1|Overall Study|Ineligible|0
5330988|NCT00216671|18353010|P2|Overall Study|Non compliant|2
5330989|NCT00216671|18353011|P1|Overall Study|Non compliant|2
5330990|NCT00216671|18353010|P2|Overall Study|Lost to Follow-up|5
5330991|NCT00216671|18353011|P1|Overall Study|Lost to Follow-up|3
5330992|NCT00216671|18353010|P2|Overall Study|Insufficient Response|4
5330993|NCT00216671|18353011|P1|Overall Study|Insufficient Response|9
5330994|NCT00216671|18353010|P2|Overall Study|No Need to Continue Medication|1
5330995|NCT00216671|18353011|P1|Overall Study|No Need to Continue Medication|1
5330996|NCT00216671|18353010|P2|Overall Study|Refused Injections|13
5330997|NCT00216671|18353011|P1|Overall Study|Refused Injections|3
5330998|NCT00216671|18353010|P2|Overall Study|Withdrawal by Subject|2
5330999|NCT00216671|18353011|P1|Overall Study|Withdrawal by Subject|4
5331000|NCT00216671|18353010|P2|Overall Study|Pregnancy|1
5331001|NCT00216671|18353011|P1|Overall Study|Pregnancy|0
5331002|NCT00216671|18353010|P2|Overall Study|Adverse Event|9
5331003|NCT00216671|18353011|P1|Overall Study|Adverse Event|4
5331004|NCT00216476|18353029|P3|Overall Study|Patient Moved|0
5331005|NCT00216476|18353030|P2|Overall Study|Patient Moved|2
5331006|NCT00216476|18353031|P1|Overall Study|Patient Moved|2
5331007|NCT00216476|18353029|P3|Overall Study|Protocol Deviation|0
5331008|NCT00216476|18353030|P2|Overall Study|Protocol Deviation|1
5331009|NCT00216476|18353031|P1|Overall Study|Protocol Deviation|5
5331010|NCT00216476|18353029|P3|Overall Study|Administrative Reasons|0
5331011|NCT00216476|18353030|P2|Overall Study|Administrative Reasons|1
5331012|NCT00216476|18353031|P1|Overall Study|Administrative Reasons|1
5331013|NCT00216476|18353029|P3|Overall Study|Higher dose/Extra Medication Required|2
5331014|NCT00216476|18353030|P2|Overall Study|Higher dose/Extra Medication Required|0
5331015|NCT00216476|18353031|P1|Overall Study|Higher dose/Extra Medication Required|2
5331016|NCT00216476|18353029|P3|Overall Study|Non-compliance|1
5331017|NCT00216476|18353030|P2|Overall Study|Non-compliance|4
5331018|NCT00216476|18353031|P1|Overall Study|Non-compliance|0
5331019|NCT00216476|18353029|P3|Overall Study|No Further Need for Treatment|1
5331020|NCT00216476|18353030|P2|Overall Study|No Further Need for Treatment|4
5331021|NCT00216476|18353031|P1|Overall Study|No Further Need for Treatment|3
5331022|NCT00216476|18353029|P3|Overall Study|Refuses Injection|0
5331023|NCT00216476|18353030|P2|Overall Study|Refuses Injection|0
5331024|NCT00216476|18353031|P1|Overall Study|Refuses Injection|11
5331025|NCT00216476|18353029|P3|Overall Study|Other|1
5331026|NCT00216476|18353030|P2|Overall Study|Other|0
5331027|NCT00216476|18353031|P1|Overall Study|Other|0
5331028|NCT00216476|18353029|P3|Overall Study|Pregnancy|1
5331029|NCT00216476|18353030|P2|Overall Study|Pregnancy|1
5331030|NCT00216476|18353031|P1|Overall Study|Pregnancy|0
5331031|NCT00216476|18353029|P3|Overall Study|Death|0
5331032|NCT00216476|18353030|P2|Overall Study|Death|0
5331033|NCT00216476|18353031|P1|Overall Study|Death|2
5331034|NCT00216476|18353029|P3|Overall Study|Lack of Efficacy|0
5331035|NCT00216476|18353030|P2|Overall Study|Lack of Efficacy|3
5331036|NCT00216476|18353031|P1|Overall Study|Lack of Efficacy|4
5331037|NCT00216476|18353029|P3|Overall Study|Adverse Event|1
5331038|NCT00216476|18353030|P2|Overall Study|Adverse Event|10
5331039|NCT00216476|18353031|P1|Overall Study|Adverse Event|6
5331040|NCT00216476|18353029|P3|Overall Study|Lost to Follow-up|1
5331041|NCT00216476|18353030|P2|Overall Study|Lost to Follow-up|9
5331042|NCT00216476|18353031|P1|Overall Study|Lost to Follow-up|10
5331043|NCT00216476|18353029|P3|Overall Study|Withdrawal by Subject|9
5331044|NCT00216476|18353030|P2|Overall Study|Withdrawal by Subject|72
5331045|NCT00216476|18353031|P1|Overall Study|Withdrawal by Subject|59
5331046|NCT00216203|18353068|P1|Overall Study|Withdrawal by Subject|2
5331047|NCT00216086|18353098|P1|Overall Study|Social Reasons|2
5331048|NCT00216086|18353098|P1|Overall Study|Diagnosis of Metastatic Disease|1
5331049|NCT00216086|18353098|P1|Overall Study|Protocol Violation|1
5331050|NCT00215943|18353130|P2|Overall Study|Other complications|1
5331051|NCT00215943|18353131|P1|Overall Study|Other complications|3
5331052|NCT00215943|18353130|P2|Overall Study|Other disease|1
5331053|NCT00215943|18353131|P1|Overall Study|Other disease|0
5331054|NCT00215943|18353130|P2|Overall Study|Adverse Event|6
5331055|NCT00215943|18353131|P1|Overall Study|Adverse Event|3
5331056|NCT00215943|18353130|P2|Overall Study|Alternate therapy|1
5331057|NCT00215943|18353131|P1|Overall Study|Alternate therapy|0
5331058|NCT00215943|18353130|P2|Overall Study|Disease Progression|5
5331059|NCT00215943|18353131|P1|Overall Study|Disease Progression|3
5331060|NCT00215683|18353156|P3|Overall Study|Intermittent therapy required|0
5331061|NCT00215683|18353157|P2|Overall Study|Intermittent therapy required|1
5331063|NCT00215683|18353156|P3|Overall Study|No study drug available|0
5331064|NCT00215683|18353157|P2|Overall Study|No study drug available|1
5331065|NCT00215683|18353158|P1|Overall Study|No study drug available|0
5331066|NCT00215683|18353156|P3|Overall Study|Difficult to attend visits|0
5331067|NCT00215683|18353157|P2|Overall Study|Difficult to attend visits|1
5331068|NCT00215683|18353158|P1|Overall Study|Difficult to attend visits|0
5331069|NCT00215683|18353156|P3|Overall Study|Physician Decision|1
5331070|NCT00215683|18353157|P2|Overall Study|Physician Decision|0
5331071|NCT00215683|18353158|P1|Overall Study|Physician Decision|0
5331072|NCT00215683|18353156|P3|Overall Study|Withdrawal by Subject|13
5331073|NCT00215683|18353157|P2|Overall Study|Withdrawal by Subject|4
5331074|NCT00215683|18353158|P1|Overall Study|Withdrawal by Subject|9
5331075|NCT00215683|18353156|P3|Overall Study|Lost to Follow-up|1
5331076|NCT00215683|18353157|P2|Overall Study|Lost to Follow-up|2
5331077|NCT00215683|18353158|P1|Overall Study|Lost to Follow-up|0
5331078|NCT00215683|18353156|P3|Overall Study|Lack of Efficacy|2
5331079|NCT00215683|18353157|P2|Overall Study|Lack of Efficacy|1
5331080|NCT00215683|18353158|P1|Overall Study|Lack of Efficacy|5
5331081|NCT00215683|18353156|P3|Overall Study|Adverse Event|15
5331082|NCT00215683|18353157|P2|Overall Study|Adverse Event|16
5331083|NCT00215683|18353158|P1|Overall Study|Adverse Event|15
5331084|NCT00215657|18353177|P8|Overall Study|Other|1
5331085|NCT00215657|18353178|P7|Overall Study|Other|6
5331086|NCT00215657|18353179|P6|Overall Study|Other|4
5331087|NCT00215657|18353180|P5|Overall Study|Other|5
5331088|NCT00215657|18353181|P4|Overall Study|Other|3
5331089|NCT00215657|18353182|P3|Overall Study|Other|2
5331090|NCT00215657|18353183|P2|Overall Study|Other|1
5331091|NCT00215657|18353184|P1|Overall Study|Other|3
5331092|NCT00215657|18353177|P8|Overall Study|Insufficient testosterone response|7
5331093|NCT00215657|18353178|P7|Overall Study|Insufficient testosterone response|4
5331094|NCT00215657|18353179|P6|Overall Study|Insufficient testosterone response|12
5331095|NCT00215657|18353180|P5|Overall Study|Insufficient testosterone response|8
5331096|NCT00215657|18353181|P4|Overall Study|Insufficient testosterone response|12
5331097|NCT00215657|18353182|P3|Overall Study|Insufficient testosterone response|1
5331098|NCT00215657|18353183|P2|Overall Study|Insufficient testosterone response|4
5331099|NCT00215657|18353184|P1|Overall Study|Insufficient testosterone response|5
5331100|NCT00215657|18353177|P8|Overall Study|Insuff prostate specific antigen resp|2
5331101|NCT00215657|18353178|P7|Overall Study|Insuff prostate specific antigen resp|3
5331102|NCT00215657|18353179|P6|Overall Study|Insuff prostate specific antigen resp|2
5331103|NCT00215657|18353180|P5|Overall Study|Insuff prostate specific antigen resp|1
5331104|NCT00215657|18353181|P4|Overall Study|Insuff prostate specific antigen resp|2
5331105|NCT00215657|18353182|P3|Overall Study|Insuff prostate specific antigen resp|2
5331106|NCT00215657|18353183|P2|Overall Study|Insuff prostate specific antigen resp|2
5331107|NCT00215657|18353184|P1|Overall Study|Insuff prostate specific antigen resp|3
5331108|NCT00215657|18353177|P8|Overall Study|Withdrawal by Subject|3
5331109|NCT00215657|18353178|P7|Overall Study|Withdrawal by Subject|10
5331110|NCT00215657|18353179|P6|Overall Study|Withdrawal by Subject|1
5331111|NCT00215657|18353180|P5|Overall Study|Withdrawal by Subject|6
5331112|NCT00215657|18353181|P4|Overall Study|Withdrawal by Subject|1
5331113|NCT00215657|18353182|P3|Overall Study|Withdrawal by Subject|3
5331114|NCT00215657|18353183|P2|Overall Study|Withdrawal by Subject|3
5331115|NCT00215657|18353184|P1|Overall Study|Withdrawal by Subject|6
5331116|NCT00215657|18353177|P8|Overall Study|Adverse Event|3
5331117|NCT00215657|18353178|P7|Overall Study|Adverse Event|0
5331118|NCT00215657|18353179|P6|Overall Study|Adverse Event|1
5331119|NCT00215657|18353180|P5|Overall Study|Adverse Event|3
5331120|NCT00215657|18353181|P4|Overall Study|Adverse Event|0
5331121|NCT00215657|18353182|P3|Overall Study|Adverse Event|3
5331122|NCT00215657|18353183|P2|Overall Study|Adverse Event|1
5331123|NCT00215657|18353184|P1|Overall Study|Adverse Event|5
5331124|NCT00215644|18353212|P2|Overall Study|Randomized but Not Treated|0
5331125|NCT00215644|18353213|P1|Overall Study|Randomized but Not Treated|1
5331126|NCT00215644|18353212|P2|Overall Study|Other|15
5331127|NCT00215644|18353213|P1|Overall Study|Other|3
5331128|NCT00215644|18353212|P2|Overall Study|Withdrawal by Subject|0
5331129|NCT00215644|18353213|P1|Overall Study|Withdrawal by Subject|1
5331130|NCT00215644|18353212|P2|Overall Study|Death|2
5331131|NCT00215644|18353213|P1|Overall Study|Death|1
5331132|NCT00215644|18353212|P2|Overall Study|Adverse Event|9
5331133|NCT00215644|18353213|P1|Overall Study|Adverse Event|2
5331134|NCT00215644|18353212|P2|Overall Study|Disease Progression|10
5331135|NCT00215644|18353213|P1|Overall Study|Disease Progression|28
5331136|NCT00215553|18353240|P7|Overall Study|Adverse Event|0
5331137|NCT00215553|18353241|P6|Overall Study|Adverse Event|6
5331138|NCT00215553|18353242|P5|Overall Study|Adverse Event|2
5331139|NCT00215553|18353243|P4|Overall Study|Adverse Event|1
5331140|NCT00215553|18353244|P3|Overall Study|Adverse Event|2
5331141|NCT00215553|18353245|P2|Overall Study|Adverse Event|1
5331142|NCT00215553|18353246|P1|Overall Study|Adverse Event|0
5331143|NCT00215540|18353279|P3|Overall Study|Withdrew from study medication|0
5331144|NCT00215540|18353280|P2|Overall Study|Withdrew from study medication|0
5331145|NCT00215540|18353281|P1|Overall Study|Withdrew from study medication|1
5331146|NCT00215150|18353316|P1|Randomization Phase Placebo|Withdrawal by Subject|1
5331147|NCT00215150|18353316|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
5331148|NCT00215150|18353316|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
5331149|NCT00215150|18353316|P1|Open Label Phase|Did not meet randomization criteria|9
5331235|NCT00213148|18353604|P2|Cycle 2 (1 Month)|Other|1
5331150|NCT00215150|18353316|P1|Open Label Phase|Did not complete a post base visit|13
5331151|NCT00215150|18353316|P1|Open Label Phase|Withdrawal by Subject|1
5331152|NCT00215150|18353316|P1|Open Label Phase|Lost to Follow-up|7
5331153|NCT00215137|18353324|P3|Randomization Period|Withdrawal by Subject|0
5331154|NCT00215137|18353325|P2|Randomization Period|Withdrawal by Subject|1
5331155|NCT00215137|18353326|P1|Randomization Period|Withdrawal by Subject|0
5331156|NCT00215137|18353324|P3|Randomization Period|Lost to Follow-up|0
5331157|NCT00215137|18353325|P2|Randomization Period|Lost to Follow-up|1
5331158|NCT00215137|18353326|P1|Randomization Period|Lost to Follow-up|0
5331159|NCT00215137|18353324|P3|Open Label Escitalopram|Lack of Efficacy|0
5331160|NCT00215137|18353325|P2|Open Label Escitalopram|Lack of Efficacy|0
5331161|NCT00215137|18353326|P1|Open Label Escitalopram|Lack of Efficacy|1
5331162|NCT00214500|18353424|P1|Extension Period|Withdrawal by Subject|2
5331163|NCT00214500|18353424|P1|Treatment Period|Adverse Event|1
5331164|NCT00214461|18353445|P4|Overall Study|Withdrawal by Subject|0
5331165|NCT00214461|18353446|P3|Overall Study|Withdrawal by Subject|1
5331166|NCT00214461|18353447|P2|Overall Study|Withdrawal by Subject|0
5331167|NCT00214461|18353448|P1|Overall Study|Withdrawal by Subject|0
5331168|NCT00214461|18353445|P4|Overall Study|Adverse Event|1
5331169|NCT00214461|18353446|P3|Overall Study|Adverse Event|1
5331170|NCT00214461|18353447|P2|Overall Study|Adverse Event|0
5331171|NCT00214461|18353448|P1|Overall Study|Adverse Event|0
5331172|NCT00214422|18353465|P3|Overall Study|Unable to make a radiation treatment|1
5331173|NCT00214422|18353466|P2|Overall Study|Unable to make a radiation treatment|0
5331174|NCT00214422|18353467|P1|Overall Study|Unable to make a radiation treatment|0
5331175|NCT00214422|18353465|P3|Overall Study|Disease progression on study|0
5331176|NCT00214422|18353466|P2|Overall Study|Disease progression on study|0
5331177|NCT00214422|18353467|P1|Overall Study|Disease progression on study|1
5331178|NCT00214422|18353465|P3|Overall Study|Pt taken off study|0
5331179|NCT00214422|18353466|P2|Overall Study|Pt taken off study|1
5331180|NCT00214422|18353467|P1|Overall Study|Pt taken off study|1
5331181|NCT00214422|18353465|P3|Overall Study|Developed esophageal ca|0
5331182|NCT00214422|18353466|P2|Overall Study|Developed esophageal ca|0
5331183|NCT00214422|18353467|P1|Overall Study|Developed esophageal ca|1
5331184|NCT00214422|18353465|P3|Overall Study|Physician Decision|0
5331185|NCT00214422|18353466|P2|Overall Study|Physician Decision|0
5331186|NCT00214422|18353467|P1|Overall Study|Physician Decision|2
5331187|NCT00214383|18353490|P2|Overall Study|Lost to Follow-up|26
5331188|NCT00214383|18353491|P1|Overall Study|Lost to Follow-up|16
5331189|NCT00214201|18353503|P2|Overall Study|Death|2
5331190|NCT00214201|18353504|P1|Overall Study|Death|0
5331191|NCT00214201|18353503|P2|Overall Study|Withdrawal by Subject|0
5331192|NCT00214201|18353504|P1|Overall Study|Withdrawal by Subject|2
5331193|NCT00214136|18353519|P1|Overall Study|Death|5
5331194|NCT00214019|18353564|P1|Overall Study|Screen Failed prior to randomization|17
5331195|NCT00214019|18353564|P1|Overall Study|Withdrawal by Subject|2
5331196|NCT00214019|18353564|P1|Overall Study|Lost to Follow-up|11
5331197|NCT00213980|18353573|P2|Overall Study|Failed to obtain all 3 DXAs|3
5331198|NCT00213980|18353574|P1|Overall Study|Failed to obtain all 3 DXAs|1
5331199|NCT00213980|18353573|P2|Overall Study|Developed ovarian cancer|0
5331200|NCT00213980|18353574|P1|Overall Study|Developed ovarian cancer|1
5331201|NCT00213980|18353573|P2|Overall Study|Disease progression|2
5331202|NCT00213980|18353574|P1|Overall Study|Disease progression|0
5331203|NCT00213980|18353573|P2|Overall Study|Adverse Event|1
5331204|NCT00213980|18353574|P1|Overall Study|Adverse Event|1
5331205|NCT00213980|18353573|P2|Overall Study|Withdrawal by Subject|1
5331206|NCT00213980|18353574|P1|Overall Study|Withdrawal by Subject|3
5331207|NCT00213148|18353601|P5|Cycle 3 (1 Month)|Other|0
5331208|NCT00213148|18353602|P4|Cycle 3 (1 Month)|Other|1
5331209|NCT00213148|18353603|P3|Cycle 3 (1 Month)|Other|1
5331210|NCT00213148|18353604|P2|Cycle 3 (1 Month)|Other|0
5331211|NCT00213148|18353605|P1|Cycle 3 (1 Month)|Other|0
5331212|NCT00213148|18353601|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
5331213|NCT00213148|18353602|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
5331214|NCT00213148|18353603|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
5331215|NCT00213148|18353604|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
5331216|NCT00213148|18353605|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
5331217|NCT00213148|18353601|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
5331218|NCT00213148|18353602|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
5331219|NCT00213148|18353603|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
5331220|NCT00213148|18353604|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
5331221|NCT00213148|18353605|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
5331222|NCT00213148|18353601|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5331223|NCT00213148|18353602|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5331224|NCT00213148|18353603|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5331225|NCT00213148|18353604|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5331226|NCT00213148|18353605|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
5331227|NCT00213148|18353601|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5331228|NCT00213148|18353602|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5331229|NCT00213148|18353603|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5331230|NCT00213148|18353604|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
5331231|NCT00213148|18353605|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5331232|NCT00213148|18353601|P5|Cycle 2 (1 Month)|Other|7
5331233|NCT00213148|18353602|P4|Cycle 2 (1 Month)|Other|8
5331234|NCT00213148|18353603|P3|Cycle 2 (1 Month)|Other|2
5331236|NCT00213148|18353605|P1|Cycle 2 (1 Month)|Other|2
5331237|NCT00213148|18353601|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
5331238|NCT00213148|18353602|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
5331239|NCT00213148|18353603|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
5331240|NCT00213148|18353604|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
5331241|NCT00213148|18353605|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
5331242|NCT00213148|18353601|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
5331243|NCT00213148|18353602|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
5331244|NCT00213148|18353603|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
5331245|NCT00213148|18353604|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
5331246|NCT00213148|18353605|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
5331247|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
5331248|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
5331249|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
5331250|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
5331251|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
5331252|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
5331253|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5331254|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5331255|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5331256|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5331257|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5331258|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
5331259|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5331260|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5331261|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5331262|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Other|7
5331263|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Other|2
5331264|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Other|2
5331265|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Other|0
5331266|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Other|3
5331267|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Protocol Violation|0
5331268|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Protocol Violation|0
5331269|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Protocol Violation|1
5331270|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Protocol Violation|0
5331271|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Protocol Violation|1
5331272|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
5331273|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
5331274|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
5331275|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
5331276|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
5331277|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Adverse Event|0
5331278|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Adverse Event|0
5331279|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Adverse Event|1
5331280|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Adverse Event|0
5331281|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Adverse Event|0
5331282|NCT00213148|18353601|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
5331283|NCT00213148|18353602|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
5331284|NCT00213148|18353603|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
5331285|NCT00213148|18353604|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
5331286|NCT00213148|18353605|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
5331287|NCT00213135|18353632|P3|Overall Study|Other|15
5331288|NCT00213135|18353633|P2|Overall Study|Other|12
5331289|NCT00213135|18353634|P1|Overall Study|Other|21
5331290|NCT00213135|18353632|P3|Overall Study|Disease progression|21
5331291|NCT00213135|18353633|P2|Overall Study|Disease progression|5
5331292|NCT00213135|18353634|P1|Overall Study|Disease progression|4
5331293|NCT00213135|18353632|P3|Overall Study|Death|2
5331294|NCT00213135|18353633|P2|Overall Study|Death|1
5331295|NCT00213135|18353634|P1|Overall Study|Death|1
5331296|NCT00213135|18353632|P3|Overall Study|Protocol Violation|10
5331297|NCT00213135|18353633|P2|Overall Study|Protocol Violation|4
5331298|NCT00213135|18353634|P1|Overall Study|Protocol Violation|4
5331299|NCT00213135|18353632|P3|Overall Study|Lost to Follow-up|4
5331300|NCT00213135|18353633|P2|Overall Study|Lost to Follow-up|8
5331301|NCT00213135|18353634|P1|Overall Study|Lost to Follow-up|11
5331302|NCT00213135|18353632|P3|Overall Study|Adverse Event|5
5331303|NCT00213135|18353633|P2|Overall Study|Adverse Event|5
5331304|NCT00213135|18353634|P1|Overall Study|Adverse Event|9
5331305|NCT00212758|18353677|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
5331306|NCT00212758|18353678|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
5331307|NCT00212758|18353677|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
5331308|NCT00212758|18353678|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
5331309|NCT00212355|18353694|P1|Overall Study|A change of address|1
5331310|NCT00212355|18353694|P1|Overall Study|Withdrawal by Subject|1
5331311|NCT00212355|18353694|P1|Overall Study|Adverse Event|1
5331312|NCT00212134|18353715|P2|Phase 3 (Age 10 Years)|On Going|21
5331313|NCT00212134|18353716|P1|Phase 3 (Age 10 Years)|On Going|21
5331314|NCT00211887|18353737|P3|Overall Study|Side effects|5
5331315|NCT00211887|18353738|P2|Overall Study|Side effects|13
5331316|NCT00211887|18353739|P1|Overall Study|Side effects|19
5331317|NCT00211887|18353737|P3|Overall Study|Other medical reason|7
5331318|NCT00211887|18353738|P2|Overall Study|Other medical reason|11
5331319|NCT00211887|18353739|P1|Overall Study|Other medical reason|15
5331320|NCT00211887|18353737|P3|Overall Study|Non-medical reason|8
5331321|NCT00211887|18353738|P2|Overall Study|Non-medical reason|14
5331322|NCT00211887|18353739|P1|Overall Study|Non-medical reason|31
5331323|NCT00211887|18353737|P3|Overall Study|Lost to Follow-up|9
5331324|NCT00211887|18353738|P2|Overall Study|Lost to Follow-up|13
5331325|NCT00211887|18353739|P1|Overall Study|Lost to Follow-up|28
5331326|NCT00211887|18353737|P3|Overall Study|Death|1
5331327|NCT00211887|18353738|P2|Overall Study|Death|1
5331328|NCT00211887|18353739|P1|Overall Study|Death|1
5331329|NCT00211887|18353737|P3|Overall Study|Adverse Event|6
5331330|NCT00211887|18353738|P2|Overall Study|Adverse Event|4
5331331|NCT00211887|18353739|P1|Overall Study|Adverse Event|8
5331332|NCT00211809|18353756|P1|Overall Study|side effects|2
5331333|NCT00211809|18353756|P1|Overall Study|Pregnancy|1
5331334|NCT00211809|18353756|P1|Overall Study|Lost to Follow-up|2
5331335|NCT00211809|18353756|P1|Overall Study|Lack of Efficacy|1
5331336|NCT00211757|18353772|P2|Overall Study|Lack of Efficacy|1
5331337|NCT00211757|18353773|P1|Overall Study|Lack of Efficacy|0
5331338|NCT00211757|18353772|P2|Overall Study|Withdrawal by Subject|1
5331339|NCT00211757|18353773|P1|Overall Study|Withdrawal by Subject|1
5331340|NCT00211536|18353794|P2|Overall Study|Adverse Event|0
5331341|NCT00211536|18353795|P1|Overall Study|Adverse Event|2
5331342|NCT00211536|18353794|P2|Overall Study|Physician Decision|5
5331343|NCT00211536|18353795|P1|Overall Study|Physician Decision|0
5331344|NCT00211536|18353794|P2|Overall Study|Withdrawal by Subject|2
5331345|NCT00211536|18353795|P1|Overall Study|Withdrawal by Subject|2
5331346|NCT00211510|18353811|P2|Overall Study|Withdrawal by Subject|1
5331347|NCT00211510|18353812|P1|Overall Study|Withdrawal by Subject|3
5331348|NCT00211510|18353811|P2|Overall Study|Physician Decision|1
5331349|NCT00211510|18353812|P1|Overall Study|Physician Decision|3
5331350|NCT00211237|18353830|P3|12 Months|unrelated medical problem|1
5331351|NCT00211237|18353831|P2|12 Months|unrelated medical problem|0
5331352|NCT00211237|18353832|P1|12 Months|unrelated medical problem|0
5331353|NCT00211237|18353830|P3|12 Months|Withdrew|1
5331354|NCT00211237|18353831|P2|12 Months|Withdrew|0
5331355|NCT00211237|18353832|P1|12 Months|Withdrew|0
5331356|NCT00211237|18353830|P3|12 Months|Lost to Follow-up|1
5331357|NCT00211237|18353831|P2|12 Months|Lost to Follow-up|0
5331358|NCT00211237|18353832|P1|12 Months|Lost to Follow-up|1
5331359|NCT00211237|18353830|P3|12 Months|Death|3
5331360|NCT00211237|18353831|P2|12 Months|Death|2
5331361|NCT00211237|18353832|P1|12 Months|Death|8
5331362|NCT00211237|18353830|P3|6 Months|Could not comply with protocol|0
5331363|NCT00211237|18353831|P2|6 Months|Could not comply with protocol|2
5331364|NCT00211237|18353832|P1|6 Months|Could not comply with protocol|0
5331365|NCT00211237|18353830|P3|6 Months|Lost to Follow-up|0
5331366|NCT00211237|18353831|P2|6 Months|Lost to Follow-up|0
5331367|NCT00211237|18353832|P1|6 Months|Lost to Follow-up|2
5331368|NCT00211237|18353830|P3|6 Months|Death|3
5331369|NCT00211237|18353831|P2|6 Months|Death|0
5331370|NCT00211237|18353832|P1|6 Months|Death|6
5331371|NCT00211237|18353830|P3|3 Months|Non-medical problem|1
5331372|NCT00211237|18353831|P2|3 Months|Non-medical problem|0
5331373|NCT00211237|18353832|P1|3 Months|Non-medical problem|0
5331374|NCT00211237|18353830|P3|3 Months|Withdrew|0
5331375|NCT00211237|18353831|P2|3 Months|Withdrew|1
5331376|NCT00211237|18353832|P1|3 Months|Withdrew|0
5331377|NCT00211237|18353830|P3|3 Months|Could not comply with protocol|0
5331378|NCT00211237|18353831|P2|3 Months|Could not comply with protocol|0
5331379|NCT00211237|18353832|P1|3 Months|Could not comply with protocol|1
5331380|NCT00211237|18353830|P3|3 Months|Death|0
5331381|NCT00211237|18353831|P2|3 Months|Death|3
5331382|NCT00211237|18353832|P1|3 Months|Death|7
5331383|NCT00211237|18353830|P3|1 Month|Non-medical problem|0
5331384|NCT00211237|18353831|P2|1 Month|Non-medical problem|2
5331385|NCT00211237|18353832|P1|1 Month|Non-medical problem|0
5331386|NCT00211237|18353830|P3|1 Month|Additional surgery needed|0
5331387|NCT00211237|18353831|P2|1 Month|Additional surgery needed|0
5331388|NCT00211237|18353832|P1|1 Month|Additional surgery needed|1
5331389|NCT00211237|18353830|P3|1 Month|Withdrew|0
5331390|NCT00211237|18353831|P2|1 Month|Withdrew|4
5331391|NCT00211237|18353832|P1|1 Month|Withdrew|0
5331392|NCT00211237|18353830|P3|1 Month|Lost to Follow-up|0
5331393|NCT00211237|18353831|P2|1 Month|Lost to Follow-up|2
5331394|NCT00211237|18353832|P1|1 Month|Lost to Follow-up|0
5331395|NCT00211237|18353830|P3|1 Month|Death|0
5331396|NCT00211237|18353831|P2|1 Month|Death|1
5331397|NCT00211237|18353832|P1|1 Month|Death|2
5331398|NCT00211237|18353830|P3|Baseline|Refused random assignment|0
5331399|NCT00211237|18353831|P2|Baseline|Refused random assignment|0
5331400|NCT00211237|18353832|P1|Baseline|Refused random assignment|1
5331401|NCT00211237|18353830|P3|Baseline|Withdrew|0
5331402|NCT00211237|18353831|P2|Baseline|Withdrew|3
5331403|NCT00211237|18353832|P1|Baseline|Withdrew|1
5331404|NCT00211185|18353922|P1|Overall Study|Physician Decision|5
5331405|NCT00211185|18353922|P1|Overall Study|Withdrawal by Subject|6
5331406|NCT00211185|18353922|P1|Overall Study|Disease progression|7
5331407|NCT00211185|18353922|P1|Overall Study|Death|2
5331408|NCT00211172|18353936|P2|Overall Study|Died or lost health plan eligibility|32
5331409|NCT00211172|18353937|P1|Overall Study|Died or lost health plan eligibility|39
5331410|NCT00211081|18353943|P1|Overall Study|Withdrawal by Subject|2
5331411|NCT00210639|18353955|P2|Overall Study|Other|12
5331412|NCT00210639|18353956|P1|Overall Study|Other|18
5331413|NCT00210639|18353955|P2|Overall Study|Withdrawal by Subject|1
5331414|NCT00210639|18353956|P1|Overall Study|Withdrawal by Subject|8
5331415|NCT00210639|18353955|P2|Overall Study|Lost to Follow-up|29
5331416|NCT00210639|18353956|P1|Overall Study|Lost to Follow-up|37
5331417|NCT00210626|18353964|P2|Overall Study|Other|5
5331418|NCT00210626|18353965|P1|Overall Study|Other|4
5331419|NCT00210626|18353964|P2|Overall Study|Sponser Request|0
5331420|NCT00210626|18353965|P1|Overall Study|Sponser Request|1
5331421|NCT00210626|18353964|P2|Overall Study|Physician Decision|2
5331422|NCT00210626|18353965|P1|Overall Study|Physician Decision|0
5331423|NCT00210626|18353964|P2|Overall Study|Withdrawal by Subject|20
5331424|NCT00210626|18353965|P1|Overall Study|Withdrawal by Subject|29
5331425|NCT00210626|18353964|P2|Overall Study|Death|0
5331426|NCT00210626|18353965|P1|Overall Study|Death|1
5331427|NCT00210626|18353964|P2|Overall Study|Lost to Follow-up|11
5331428|NCT00210626|18353965|P1|Overall Study|Lost to Follow-up|11
5331429|NCT00210626|18353964|P2|Overall Study|Protocol Violation|5
5331430|NCT00210626|18353965|P1|Overall Study|Protocol Violation|1
5331431|NCT00210626|18353964|P2|Overall Study|Adverse Event|2
5331432|NCT00210626|18353965|P1|Overall Study|Adverse Event|1
5331433|NCT00210470|18353973|P1|Overall Study|Subject did not continue to surgery|1
5331434|NCT00209560|18354004|P2|Overall Study|Lack of Efficacy|0
5331435|NCT00209560|18354005|P1|Overall Study|Lack of Efficacy|1
5331436|NCT00209339|18354024|P1|At 5 Years Follow-up|Death|1
5331437|NCT00209339|18354024|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
5331438|NCT00209339|18354024|P1|At 5 Years Follow-up|Withdrawal by Subject|2
5331439|NCT00209339|18354024|P1|At 4 Years Follow-up|Death|1
5331440|NCT00209339|18354024|P1|At 4 Years Follow-up|Withdrawal by Subject|4
5331441|NCT00209339|18354024|P1|At 3 Years Follow-up|Withdrawal by Subject|1
5331442|NCT00209339|18354024|P1|At 24 Months Follow-up|Death|1
5331443|NCT00209339|18354024|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
5331444|NCT00209339|18354024|P1|At 24 Months Follow-up|Withdrawal by Subject|4
5331445|NCT00209339|18354024|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
5331446|NCT00209339|18354024|P1|At 12 Months Follow-up|Death|1
5331447|NCT00209339|18354024|P1|At 12 Months Follow-up|Withdrawal by Subject|8
5331448|NCT00209274|18354108|P2|Overall Study|Randomized not treated (RNT)|15
5331449|NCT00209274|18354109|P1|Overall Study|Randomized not treated (RNT)|6
5331450|NCT00209274|18354108|P2|Overall Study|Withdrawal by Subject|15
5331451|NCT00209274|18354109|P1|Overall Study|Withdrawal by Subject|30
5331452|NCT00209274|18354108|P2|Overall Study|Death|15
5331453|NCT00209274|18354109|P1|Overall Study|Death|32
5331454|NCT00209274|18354108|P2|Overall Study|Missed visit|2
5331455|NCT00209274|18354109|P1|Overall Study|Missed visit|3
5331456|NCT00209170|18354429|P2|Overall Study|Lack of Efficacy|1
5331457|NCT00209170|18354430|P1|Overall Study|Lack of Efficacy|0
5331458|NCT00209170|18354429|P2|Overall Study|Withdrawal by Subject|1
5331459|NCT00209170|18354430|P1|Overall Study|Withdrawal by Subject|2
5331460|NCT00209170|18354429|P2|Overall Study|Adverse Event|1
5331461|NCT00209170|18354430|P1|Overall Study|Adverse Event|0
5331462|NCT00209131|18354438|P2|Overall Study|Lack of personnel due to turnovers.|11
5331463|NCT00209131|18354439|P1|Overall Study|Lack of personnel due to turnovers.|15
5331464|NCT00209092|18354449|P2|Overall Study|Withdrawal by Subject|0
5331465|NCT00209092|18354450|P1|Overall Study|Withdrawal by Subject|1
5331466|NCT00209092|18354449|P2|Overall Study|Adverse Event|1
5331467|NCT00209092|18354450|P1|Overall Study|Adverse Event|0
5331468|NCT00209092|18354449|P2|Overall Study|Progression of disease|1
5331469|NCT00209092|18354450|P1|Overall Study|Progression of disease|7
5331470|NCT00209027|18354460|P2|Overall Study|study terminated|0
5331471|NCT00209027|18354461|P1|Overall Study|study terminated|10
5331472|NCT00208767|18354485|P2|Overall Study|Lost to Follow-up|3
5331473|NCT00208767|18354486|P1|Overall Study|Lost to Follow-up|3
5331474|NCT00208767|18354485|P2|Overall Study|Death|0
5331475|NCT00208767|18354486|P1|Overall Study|Death|1
5331476|NCT00208767|18354485|P2|Overall Study|Withdrawal by Subject|3
5331477|NCT00208767|18354486|P1|Overall Study|Withdrawal by Subject|14
5331478|NCT00208767|18354485|P2|Overall Study|Adverse Event|1
5331479|NCT00208767|18354486|P1|Overall Study|Adverse Event|9
5331480|NCT00208325|18354514|P4|Overall Study|Mis-Randomized|0
5331481|NCT00208325|18354515|P3|Overall Study|Mis-Randomized|0
5331482|NCT00208325|18354516|P2|Overall Study|Mis-Randomized|20
5331483|NCT00208325|18354517|P1|Overall Study|Mis-Randomized|17
5331484|NCT00208325|18354514|P4|Overall Study|Other|0
5331485|NCT00208325|18354515|P3|Overall Study|Other|1
5331486|NCT00208325|18354516|P2|Overall Study|Other|1
5331487|NCT00208325|18354517|P1|Overall Study|Other|2
5331488|NCT00208325|18354514|P4|Overall Study|Does not wish to Continue in Study|2
5331489|NCT00208325|18354515|P3|Overall Study|Does not wish to Continue in Study|3
5331490|NCT00208325|18354516|P2|Overall Study|Does not wish to Continue in Study|8
5331491|NCT00208325|18354517|P1|Overall Study|Does not wish to Continue in Study|5
5331492|NCT00208325|18354514|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
5331493|NCT00208325|18354515|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
5331494|NCT00208325|18354516|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
5331495|NCT00208325|18354517|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
5331496|NCT00208325|18354514|P4|Overall Study|Lost to Follow-up|0
5331497|NCT00208325|18354515|P3|Overall Study|Lost to Follow-up|2
5331498|NCT00208325|18354516|P2|Overall Study|Lost to Follow-up|0
5331499|NCT00208325|18354517|P1|Overall Study|Lost to Follow-up|1
5331500|NCT00208325|18354514|P4|Overall Study|Revision|4
5331501|NCT00208325|18354515|P3|Overall Study|Revision|0
5331502|NCT00208325|18354516|P2|Overall Study|Revision|1
5331503|NCT00208325|18354517|P1|Overall Study|Revision|4
5331504|NCT00208325|18354514|P4|Overall Study|Withdrawal by Subject|0
5331505|NCT00208325|18354515|P3|Overall Study|Withdrawal by Subject|0
5331506|NCT00208325|18354516|P2|Overall Study|Withdrawal by Subject|1
5331507|NCT00208325|18354517|P1|Overall Study|Withdrawal by Subject|0
5331508|NCT00208325|18354514|P4|Overall Study|Death|5
5331509|NCT00208325|18354515|P3|Overall Study|Death|7
5331510|NCT00208325|18354516|P2|Overall Study|Death|19
5331511|NCT00208325|18354517|P1|Overall Study|Death|18
5331512|NCT00207740|18354654|P4|Overall Study|Other|5
5331513|NCT00207740|18354655|P3|Overall Study|Other|7
5331514|NCT00207740|18354656|P2|Overall Study|Other|10
5331515|NCT00207740|18354657|P1|Overall Study|Other|2
5331516|NCT00207740|18354654|P4|Overall Study|Sponsor Directive|21
5331517|NCT00207740|18354655|P3|Overall Study|Sponsor Directive|16
5331518|NCT00207740|18354656|P2|Overall Study|Sponsor Directive|15
5331519|NCT00207740|18354657|P1|Overall Study|Sponsor Directive|22
5331520|NCT00207740|18354654|P4|Overall Study|Death|1
5331521|NCT00207740|18354655|P3|Overall Study|Death|0
5331522|NCT00207740|18354656|P2|Overall Study|Death|0
5331523|NCT00207740|18354657|P1|Overall Study|Death|0
5331524|NCT00207740|18354654|P4|Overall Study|Lost to Follow-up|1
5331525|NCT00207740|18354655|P3|Overall Study|Lost to Follow-up|1
5331526|NCT00207740|18354656|P2|Overall Study|Lost to Follow-up|2
5331527|NCT00207740|18354657|P1|Overall Study|Lost to Follow-up|0
5331528|NCT00207740|18354654|P4|Overall Study|Unsatisfactory therapeutic effect|4
5331529|NCT00207740|18354655|P3|Overall Study|Unsatisfactory therapeutic effect|2
5331530|NCT00207740|18354656|P2|Overall Study|Unsatisfactory therapeutic effect|0
5331531|NCT00207740|18354657|P1|Overall Study|Unsatisfactory therapeutic effect|1
5331532|NCT00207740|18354654|P4|Overall Study|Adverse Event|11
5331533|NCT00207740|18354655|P3|Overall Study|Adverse Event|14
5331534|NCT00207740|18354656|P2|Overall Study|Adverse Event|14
5331535|NCT00207740|18354657|P1|Overall Study|Adverse Event|4
5331536|NCT00207727|18354703|P5|Overall Study|Other|33
5331537|NCT00207727|18354704|P4|Overall Study|Other|37
5331538|NCT00207727|18354705|P3|Overall Study|Other|41
5331539|NCT00207727|18354706|P2|Overall Study|Other|41
5331540|NCT00207727|18354707|P1|Overall Study|Other|38
5331541|NCT00207727|18354703|P5|Overall Study|Lost to Follow-up|0
5331542|NCT00207727|18354704|P4|Overall Study|Lost to Follow-up|0
5331543|NCT00207727|18354705|P3|Overall Study|Lost to Follow-up|0
5331544|NCT00207727|18354706|P2|Overall Study|Lost to Follow-up|1
5331545|NCT00207727|18354707|P1|Overall Study|Lost to Follow-up|0
5331546|NCT00207727|18354703|P5|Overall Study|Withdrawal by Subject|1
5331547|NCT00207727|18354704|P4|Overall Study|Withdrawal by Subject|0
5331548|NCT00207727|18354705|P3|Overall Study|Withdrawal by Subject|0
5331549|NCT00207727|18354706|P2|Overall Study|Withdrawal by Subject|0
5331550|NCT00207727|18354707|P1|Overall Study|Withdrawal by Subject|0
5331551|NCT00207714|18354734|P5|Overall Study|Other|0
5331552|NCT00207714|18354735|P4|Overall Study|Other|1
5331553|NCT00207714|18354736|P3|Overall Study|Other|5
5331554|NCT00207714|18354737|P2|Overall Study|Other|2
5331555|NCT00207714|18354738|P1|Overall Study|Other|3
5331556|NCT00207714|18354734|P5|Overall Study|Unsatisfactory therapeutic effect|4
5331557|NCT00207714|18354735|P4|Overall Study|Unsatisfactory therapeutic effect|4
5331558|NCT00207714|18354736|P3|Overall Study|Unsatisfactory therapeutic effect|1
5331559|NCT00207714|18354737|P2|Overall Study|Unsatisfactory therapeutic effect|3
5331560|NCT00207714|18354738|P1|Overall Study|Unsatisfactory therapeutic effect|5
5331561|NCT00207714|18354734|P5|Overall Study|Adverse Event|1
5331562|NCT00207714|18354735|P4|Overall Study|Adverse Event|3
5331563|NCT00207714|18354736|P3|Overall Study|Adverse Event|4
5331564|NCT00207714|18354737|P2|Overall Study|Adverse Event|2
5331565|NCT00207714|18354738|P1|Overall Study|Adverse Event|6
5331566|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
5331567|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
5331568|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
5331569|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
5331570|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Death|1
5331571|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Death|0
5331572|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Death|0
5331573|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Death|0
5331574|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
5331575|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
5331576|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
5331577|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
5331578|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
5331579|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
5331580|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
5331581|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
5331582|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
5331583|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
5331584|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
5331585|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
5331586|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
5331587|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
5331588|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
5331589|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
5331590|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
5331591|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
5331592|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
5331679|NCT00206375|18354869|P1|Overall Study|Lost to Follow-up|1
5331593|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
5331594|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
5331595|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
5331596|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
5331597|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
5331598|NCT00207142|18354760|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
5331599|NCT00207142|18354761|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
5331600|NCT00207142|18354762|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
5331601|NCT00207142|18354763|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
5331602|NCT00207142|18354760|P4|Induction Phase|Missing lab data|0
5331603|NCT00207142|18354761|P3|Induction Phase|Missing lab data|0
5331604|NCT00207142|18354762|P2|Induction Phase|Missing lab data|0
5331605|NCT00207142|18354763|P1|Induction Phase|Missing lab data|1
5331606|NCT00207142|18354760|P4|Induction Phase|Incarceration|0
5331607|NCT00207142|18354761|P3|Induction Phase|Incarceration|0
5331608|NCT00207142|18354762|P2|Induction Phase|Incarceration|0
5331609|NCT00207142|18354763|P1|Induction Phase|Incarceration|1
5331610|NCT00207142|18354760|P4|Induction Phase|Withdrawal by Subject|0
5331611|NCT00207142|18354761|P3|Induction Phase|Withdrawal by Subject|0
5331612|NCT00207142|18354762|P2|Induction Phase|Withdrawal by Subject|0
5331613|NCT00207142|18354763|P1|Induction Phase|Withdrawal by Subject|4
5331614|NCT00207142|18354760|P4|Induction Phase|Subject no longer meets study criteria|0
5331615|NCT00207142|18354761|P3|Induction Phase|Subject no longer meets study criteria|0
5331616|NCT00207142|18354762|P2|Induction Phase|Subject no longer meets study criteria|0
5331617|NCT00207142|18354763|P1|Induction Phase|Subject no longer meets study criteria|3
5331618|NCT00207142|18354760|P4|Induction Phase|Pregnancy|0
5331619|NCT00207142|18354761|P3|Induction Phase|Pregnancy|0
5331620|NCT00207142|18354762|P2|Induction Phase|Pregnancy|0
5331621|NCT00207142|18354763|P1|Induction Phase|Pregnancy|1
5331622|NCT00207142|18354760|P4|Induction Phase|Poor/noncompliance|0
5331623|NCT00207142|18354761|P3|Induction Phase|Poor/noncompliance|0
5331624|NCT00207142|18354762|P2|Induction Phase|Poor/noncompliance|0
5331625|NCT00207142|18354763|P1|Induction Phase|Poor/noncompliance|2
5331626|NCT00207142|18354760|P4|Induction Phase|Physician Decision|0
5331627|NCT00207142|18354761|P3|Induction Phase|Physician Decision|0
5331628|NCT00207142|18354762|P2|Induction Phase|Physician Decision|0
5331629|NCT00207142|18354763|P1|Induction Phase|Physician Decision|2
5331630|NCT00207142|18354760|P4|Induction Phase|Lost to Follow-up|0
5331631|NCT00207142|18354761|P3|Induction Phase|Lost to Follow-up|0
5331632|NCT00207142|18354762|P2|Induction Phase|Lost to Follow-up|0
5331633|NCT00207142|18354763|P1|Induction Phase|Lost to Follow-up|5
5331634|NCT00207142|18354760|P4|Induction Phase|Lack of Efficacy|0
5331635|NCT00207142|18354761|P3|Induction Phase|Lack of Efficacy|0
5331636|NCT00207142|18354762|P2|Induction Phase|Lack of Efficacy|0
5331637|NCT00207142|18354763|P1|Induction Phase|Lack of Efficacy|1
5331638|NCT00207142|18354760|P4|Induction Phase|Death|0
5331639|NCT00207142|18354761|P3|Induction Phase|Death|0
5331640|NCT00207142|18354762|P2|Induction Phase|Death|0
5331641|NCT00207142|18354763|P1|Induction Phase|Death|1
5331642|NCT00207142|18354760|P4|Induction Phase|Adverse Event|0
5331643|NCT00207142|18354761|P3|Induction Phase|Adverse Event|0
5331644|NCT00207142|18354762|P2|Induction Phase|Adverse Event|0
5331645|NCT00207142|18354763|P1|Induction Phase|Adverse Event|9
5331646|NCT00207090|18354800|P1|Overall Study|Physician Decision|1
5331647|NCT00207090|18354800|P1|Overall Study|Disease progression/relapse|2
5331648|NCT00207090|18354800|P1|Overall Study|Chest wall mass larger|1
5331649|NCT00207090|18354800|P1|Overall Study|Study drug toxicity|3
5331650|NCT00206726|18354829|P1|Overall Study|Withdrawal by Subject|8
5331651|NCT00206726|18354829|P1|Overall Study|Protocol Violation|1
5331652|NCT00206726|18354829|P1|Overall Study|Death|4
5331653|NCT00206726|18354829|P1|Overall Study|Adverse Event|17
5331654|NCT00206726|18354829|P1|Overall Study|Bone marrow transplant|1
5331655|NCT00206726|18354829|P1|Overall Study|Placed on new protocol|1
5331656|NCT00206726|18354829|P1|Overall Study|Progressive disease or relapsed disease|18
5331657|NCT00206726|18354829|P1|Overall Study|Delayed recovery of blood counts|1
5331658|NCT00206518|18354840|P2|Overall Study|Protocol Violation|1
5331659|NCT00206518|18354841|P1|Overall Study|Protocol Violation|1
5331660|NCT00206518|18354840|P2|Overall Study|Physician Decision|0
5331661|NCT00206518|18354841|P1|Overall Study|Physician Decision|1
5331662|NCT00206518|18354840|P2|Overall Study|Adverse Event|1
5331663|NCT00206518|18354841|P1|Overall Study|Adverse Event|2
5331664|NCT00206518|18354840|P2|Overall Study|Lack of Efficacy|4
5331665|NCT00206518|18354841|P1|Overall Study|Lack of Efficacy|6
5331666|NCT00206440|18354853|P2|Overall Study|Adverse Event|2
5331667|NCT00206440|18354854|P1|Overall Study|Adverse Event|4
5331668|NCT00206440|18354853|P2|Overall Study|Protocol Violation|2
5331669|NCT00206440|18354854|P1|Overall Study|Protocol Violation|1
5331670|NCT00206427|18354860|P1|Overall Study|Adverse Event|2
5331671|NCT00206375|18354867|P3|Overall Study|Study terminated due to lack of funds|1
5331672|NCT00206375|18354868|P2|Overall Study|Study terminated due to lack of funds|1
5331673|NCT00206375|18354869|P1|Overall Study|Study terminated due to lack of funds|0
5331674|NCT00206375|18354867|P3|Overall Study|Withdrawal by Subject|3
5331675|NCT00206375|18354868|P2|Overall Study|Withdrawal by Subject|1
5331676|NCT00206375|18354869|P1|Overall Study|Withdrawal by Subject|2
5331677|NCT00206375|18354867|P3|Overall Study|Lost to Follow-up|0
5331678|NCT00206375|18354868|P2|Overall Study|Lost to Follow-up|0
5331680|NCT00206323|18354889|P2|Overall Study|Lost to Follow-up|1
5331681|NCT00206323|18354890|P1|Overall Study|Lost to Follow-up|1
5331682|NCT00206323|18354889|P2|Overall Study|Adverse Event|1
5331683|NCT00206323|18354890|P1|Overall Study|Adverse Event|1
5331684|NCT00206323|18354889|P2|Overall Study|Lack of Efficacy|1
5331685|NCT00206323|18354890|P1|Overall Study|Lack of Efficacy|4
5331686|NCT00206102|18354898|P2|Overall Study|None of those categories|36
5331687|NCT00206102|18354899|P1|Overall Study|None of those categories|42
5331688|NCT00206102|18354898|P2|Overall Study|Study-specific discontinuation criteria|17
5331689|NCT00206102|18354899|P1|Overall Study|Study-specific discontinuation criteria|18
5331690|NCT00206102|18354898|P2|Overall Study|Withdrawal by Subject|101
5331691|NCT00206102|18354899|P1|Overall Study|Withdrawal by Subject|118
5331692|NCT00206102|18354898|P2|Overall Study|Lost to Follow-up|66
5331693|NCT00206102|18354899|P1|Overall Study|Lost to Follow-up|95
5331694|NCT00206102|18354898|P2|Overall Study|Lack of therapeutic response|11
5331695|NCT00206102|18354899|P1|Overall Study|Lack of therapeutic response|16
5331696|NCT00206102|18354898|P2|Overall Study|Protocol Violation|2
5331697|NCT00206102|18354899|P1|Overall Study|Protocol Violation|0
5331698|NCT00206102|18354898|P2|Overall Study|Adverse Event|82
5331699|NCT00206102|18354899|P1|Overall Study|Adverse Event|119
5331700|NCT00206076|18354935|P2|Overall Study|Withdrawal by Subject|1
5331701|NCT00206076|18354936|P1|Overall Study|Withdrawal by Subject|1
5331702|NCT00206076|18354935|P2|Overall Study|Physician Decision|0
5331703|NCT00206076|18354936|P1|Overall Study|Physician Decision|2
5331704|NCT00205881|18354946|P1|Overall Study|Withdrawal by Subject|16
5331705|NCT00205855|18354951|P1|Overall Study|Withdrawal by Subject|5
5331706|NCT00205855|18354951|P1|Overall Study|Only received temporary implants|16
5331707|NCT00205803|18354957|P2|Toddler Dose|Lost to Follow-up|3
5331708|NCT00205803|18354958|P1|Toddler Dose|Lost to Follow-up|2
5331709|NCT00205803|18354957|P2|After Infant Series|Other|4
5331710|NCT00205803|18354958|P1|After Infant Series|Other|10
5331711|NCT00205803|18354957|P2|After Infant Series|Withdrawal by Subject|4
5331712|NCT00205803|18354958|P1|After Infant Series|Withdrawal by Subject|1
5331713|NCT00205803|18354957|P2|After Infant Series|Physician Decision|2
5331714|NCT00205803|18354958|P1|After Infant Series|Physician Decision|3
5331715|NCT00205803|18354957|P2|After Infant Series|Lost to Follow-up|1
5331716|NCT00205803|18354958|P1|After Infant Series|Lost to Follow-up|2
5331717|NCT00205803|18354957|P2|After Infant Series|Protocol Violation|1
5331718|NCT00205803|18354958|P1|After Infant Series|Protocol Violation|1
5331719|NCT00205803|18354957|P2|After Infant Series|Adverse Event|1
5331720|NCT00205803|18354958|P1|After Infant Series|Adverse Event|1
5331721|NCT00205803|18354957|P2|Infant Series|Sponsor request|0
5331722|NCT00205803|18354958|P1|Infant Series|Sponsor request|1
5331723|NCT00205803|18354957|P2|Infant Series|Non-compliant|0
5331724|NCT00205803|18354958|P1|Infant Series|Non-compliant|1
5331725|NCT00205803|18354957|P2|Infant Series|Lost Kaiser coverage|1
5331726|NCT00205803|18354958|P1|Infant Series|Lost Kaiser coverage|0
5331727|NCT00205803|18354957|P2|Infant Series|Protocol Violation|0
5331728|NCT00205803|18354958|P1|Infant Series|Protocol Violation|1
5331729|NCT00205803|18354957|P2|Infant Series|Physician Decision|1
5331730|NCT00205803|18354958|P1|Infant Series|Physician Decision|3
5331731|NCT00205803|18354957|P2|Infant Series|Withdrawal by Subject|5
5331732|NCT00205803|18354958|P1|Infant Series|Withdrawal by Subject|2
5331733|NCT00205803|18354957|P2|Infant Series|Lost to Follow-up|4
5331734|NCT00205803|18354958|P1|Infant Series|Lost to Follow-up|10
5331735|NCT00205777|18355014|P6|Study Extension II|Enrolled but not treated|131
5331736|NCT00205777|18355015|P5|Study Extension II|Enrolled but not treated|0
5331737|NCT00205777|18355016|P4|Study Extension II|Enrolled but not treated|71
5331738|NCT00205777|18355017|P3|Study Extension II|Enrolled but not treated|0
5331739|NCT00205777|18355018|P2|Study Extension II|Enrolled but not treated|0
5331740|NCT00205777|18355019|P1|Study Extension II|Enrolled but not treated|0
5331741|NCT00205777|18355014|P6|Study Extension II|Other Event|20
5331742|NCT00205777|18355015|P5|Study Extension II|Other Event|0
5331743|NCT00205777|18355016|P4|Study Extension II|Other Event|12
5331744|NCT00205777|18355017|P3|Study Extension II|Other Event|0
5331745|NCT00205777|18355018|P2|Study Extension II|Other Event|0
5331746|NCT00205777|18355019|P1|Study Extension II|Other Event|0
5331747|NCT00205777|18355014|P6|Study Extension II|Failed to return|26
5331748|NCT00205777|18355015|P5|Study Extension II|Failed to return|0
5331749|NCT00205777|18355016|P4|Study Extension II|Failed to return|14
5331750|NCT00205777|18355017|P3|Study Extension II|Failed to return|0
5331751|NCT00205777|18355018|P2|Study Extension II|Failed to return|0
5331752|NCT00205777|18355019|P1|Study Extension II|Failed to return|0
5331753|NCT00205777|18355014|P6|Study Extension II|Lack of Efficacy|1
5331754|NCT00205777|18355015|P5|Study Extension II|Lack of Efficacy|0
5331755|NCT00205777|18355016|P4|Study Extension II|Lack of Efficacy|0
5331756|NCT00205777|18355017|P3|Study Extension II|Lack of Efficacy|0
5331757|NCT00205777|18355018|P2|Study Extension II|Lack of Efficacy|0
5331758|NCT00205777|18355019|P1|Study Extension II|Lack of Efficacy|0
5331759|NCT00205777|18355014|P6|Study Extension II|Protocol Violation|10
5331760|NCT00205777|18355015|P5|Study Extension II|Protocol Violation|0
5331761|NCT00205777|18355016|P4|Study Extension II|Protocol Violation|1
5331762|NCT00205777|18355017|P3|Study Extension II|Protocol Violation|0
5331763|NCT00205777|18355018|P2|Study Extension II|Protocol Violation|0
5331764|NCT00205777|18355019|P1|Study Extension II|Protocol Violation|0
5331765|NCT00205777|18355014|P6|Study Extension II|Withdrawal by Subject|59
5331766|NCT00205777|18355015|P5|Study Extension II|Withdrawal by Subject|0
5331767|NCT00205777|18355016|P4|Study Extension II|Withdrawal by Subject|35
5331768|NCT00205777|18355017|P3|Study Extension II|Withdrawal by Subject|0
5331769|NCT00205777|18355018|P2|Study Extension II|Withdrawal by Subject|0
5331770|NCT00205777|18355019|P1|Study Extension II|Withdrawal by Subject|0
5331771|NCT00205777|18355014|P6|Study Extension II|Death|5
5331772|NCT00205777|18355015|P5|Study Extension II|Death|0
5331773|NCT00205777|18355016|P4|Study Extension II|Death|2
5331774|NCT00205777|18355017|P3|Study Extension II|Death|0
5331775|NCT00205777|18355018|P2|Study Extension II|Death|0
5331776|NCT00205777|18355019|P1|Study Extension II|Death|0
5331777|NCT00205777|18355014|P6|Study Extension II|Adverse Event|30
5331778|NCT00205777|18355015|P5|Study Extension II|Adverse Event|0
5331779|NCT00205777|18355016|P4|Study Extension II|Adverse Event|14
5331780|NCT00205777|18355017|P3|Study Extension II|Adverse Event|0
5331781|NCT00205777|18355018|P2|Study Extension II|Adverse Event|0
5331782|NCT00205777|18355019|P1|Study Extension II|Adverse Event|0
5331783|NCT00205777|18355014|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
5331784|NCT00205777|18355015|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
5331785|NCT00205777|18355016|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
5331786|NCT00205777|18355017|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
5331787|NCT00205777|18355018|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
5331788|NCT00205777|18355019|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
5331789|NCT00205777|18355014|P6|Study Extension I|Withdrawn as per protocol|0
5331790|NCT00205777|18355015|P5|Study Extension I|Withdrawn as per protocol|0
5331791|NCT00205777|18355016|P4|Study Extension I|Withdrawn as per protocol|0
5331792|NCT00205777|18355017|P3|Study Extension I|Withdrawn as per protocol|1070
5331793|NCT00205777|18355018|P2|Study Extension I|Withdrawn as per protocol|0
5331794|NCT00205777|18355019|P1|Study Extension I|Withdrawn as per protocol|0
5331795|NCT00205777|18355014|P6|Study Extension I|Other Event|0
5331796|NCT00205777|18355015|P5|Study Extension I|Other Event|29
5331797|NCT00205777|18355016|P4|Study Extension I|Other Event|34
5331798|NCT00205777|18355017|P3|Study Extension I|Other Event|0
5331799|NCT00205777|18355018|P2|Study Extension I|Other Event|0
5331800|NCT00205777|18355019|P1|Study Extension I|Other Event|34
5331801|NCT00205777|18355014|P6|Study Extension I|Failed to return|0
5331802|NCT00205777|18355015|P5|Study Extension I|Failed to return|13
5331803|NCT00205777|18355016|P4|Study Extension I|Failed to return|17
5331804|NCT00205777|18355017|P3|Study Extension I|Failed to return|0
5331805|NCT00205777|18355018|P2|Study Extension I|Failed to return|0
5331806|NCT00205777|18355019|P1|Study Extension I|Failed to return|15
5331807|NCT00205777|18355014|P6|Study Extension I|Lack of Efficacy|0
5331808|NCT00205777|18355015|P5|Study Extension I|Lack of Efficacy|2
5331809|NCT00205777|18355016|P4|Study Extension I|Lack of Efficacy|1
5331810|NCT00205777|18355017|P3|Study Extension I|Lack of Efficacy|0
5331811|NCT00205777|18355018|P2|Study Extension I|Lack of Efficacy|0
5331812|NCT00205777|18355019|P1|Study Extension I|Lack of Efficacy|0
5331813|NCT00205777|18355014|P6|Study Extension I|Protocol Violation|0
5331814|NCT00205777|18355015|P5|Study Extension I|Protocol Violation|8
5331815|NCT00205777|18355016|P4|Study Extension I|Protocol Violation|8
5331816|NCT00205777|18355017|P3|Study Extension I|Protocol Violation|0
5331817|NCT00205777|18355018|P2|Study Extension I|Protocol Violation|0
5331818|NCT00205777|18355019|P1|Study Extension I|Protocol Violation|4
5331819|NCT00205777|18355014|P6|Study Extension I|Withdrawal by Subject|0
5331820|NCT00205777|18355015|P5|Study Extension I|Withdrawal by Subject|89
5331821|NCT00205777|18355016|P4|Study Extension I|Withdrawal by Subject|106
5331822|NCT00205777|18355017|P3|Study Extension I|Withdrawal by Subject|0
5331823|NCT00205777|18355018|P2|Study Extension I|Withdrawal by Subject|0
5331824|NCT00205777|18355019|P1|Study Extension I|Withdrawal by Subject|99
5331825|NCT00205777|18355014|P6|Study Extension I|Death|0
5331826|NCT00205777|18355015|P5|Study Extension I|Death|2
5331827|NCT00205777|18355016|P4|Study Extension I|Death|1
5331828|NCT00205777|18355017|P3|Study Extension I|Death|0
5331829|NCT00205777|18355018|P2|Study Extension I|Death|0
5331830|NCT00205777|18355019|P1|Study Extension I|Death|5
5331831|NCT00205777|18355014|P6|Study Extension I|Adverse Event|0
5331832|NCT00205777|18355015|P5|Study Extension I|Adverse Event|58
5331833|NCT00205777|18355016|P4|Study Extension I|Adverse Event|61
5331834|NCT00205777|18355017|P3|Study Extension I|Adverse Event|0
5331835|NCT00205777|18355018|P2|Study Extension I|Adverse Event|0
5331836|NCT00205777|18355019|P1|Study Extension I|Adverse Event|57
5331837|NCT00205777|18355014|P6|Completed Core Study, Entered SE I|Other Event|0
5331838|NCT00205777|18355015|P5|Completed Core Study, Entered SE I|Other Event|0
5331839|NCT00205777|18355016|P4|Completed Core Study, Entered SE I|Other Event|50
5331840|NCT00205777|18355017|P3|Completed Core Study, Entered SE I|Other Event|47
5331841|NCT00205777|18355018|P2|Completed Core Study, Entered SE I|Other Event|46
5331842|NCT00205777|18355019|P1|Completed Core Study, Entered SE I|Other Event|52
5331843|NCT00205777|18355014|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
5331844|NCT00205777|18355015|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
5331845|NCT00205777|18355016|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
5331846|NCT00205777|18355017|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
5331847|NCT00205777|18355018|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
5331848|NCT00205777|18355019|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
5331849|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
5331850|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
5331851|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
5331852|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
5331853|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
5331854|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
5331855|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
5331856|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
5331857|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
5331858|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
5331859|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
5331860|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
5331861|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Protocol Violation|0
5331862|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Protocol Violation|0
5331863|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Protocol Violation|42
5331864|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Protocol Violation|50
5331865|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Protocol Violation|55
5331866|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Protocol Violation|53
5331867|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
5331868|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
5331869|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
5331870|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
5331871|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
5331872|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
5331873|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Other Event|0
5331874|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Other Event|0
5331875|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Other Event|58
5331876|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Other Event|41
5331877|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Other Event|52
5331878|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Other Event|49
5331879|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Failed to return|0
5331880|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Failed to return|0
5331881|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Failed to return|27
5331882|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Failed to return|27
5331883|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Failed to return|25
5331884|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Failed to return|40
5331885|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Death|0
5331886|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Death|0
5331887|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Death|7
5331888|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Death|14
5331889|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Death|7
5331890|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Death|9
5331891|NCT00205777|18355014|P6|Core Study (Up to 3 Years)|Adverse Event|0
5331892|NCT00205777|18355015|P5|Core Study (Up to 3 Years)|Adverse Event|0
5331893|NCT00205777|18355016|P4|Core Study (Up to 3 Years)|Adverse Event|232
5331894|NCT00205777|18355017|P3|Core Study (Up to 3 Years)|Adverse Event|252
5331895|NCT00205777|18355018|P2|Core Study (Up to 3 Years)|Adverse Event|267
5331896|NCT00205777|18355019|P1|Core Study (Up to 3 Years)|Adverse Event|260
5331897|NCT00205712|18355228|P2|Overall Study|Lost to Follow-up|1
5331898|NCT00205712|18355229|P1|Overall Study|Lost to Follow-up|0
5331899|NCT00205699|18355242|P3|Overall Study|Lack of Efficacy|0
5331900|NCT00205699|18355243|P2|Overall Study|Lack of Efficacy|1
5331901|NCT00205699|18355244|P1|Overall Study|Lack of Efficacy|0
5331902|NCT00205699|18355242|P3|Overall Study|Withdrawal by Subject|1
5331903|NCT00205699|18355243|P2|Overall Study|Withdrawal by Subject|2
5331904|NCT00205699|18355244|P1|Overall Study|Withdrawal by Subject|1
5331905|NCT00205699|18355242|P3|Overall Study|Adverse Event|0
5331906|NCT00205699|18355243|P2|Overall Study|Adverse Event|0
5331907|NCT00205699|18355244|P1|Overall Study|Adverse Event|1
5331908|NCT00205699|18355242|P3|Overall Study|Lost to Follow-up|5
5331909|NCT00205699|18355243|P2|Overall Study|Lost to Follow-up|3
5331910|NCT00205699|18355244|P1|Overall Study|Lost to Follow-up|1
5331911|NCT00205179|18355324|P2|Overall Study|Adverse Event|1
5331912|NCT00205179|18355325|P1|Overall Study|Adverse Event|1
5331913|NCT00205179|18355324|P2|Overall Study|Physician Decision|1
5331914|NCT00205179|18355325|P1|Overall Study|Physician Decision|1
5331915|NCT00205179|18355324|P2|Overall Study|Death|2
5331916|NCT00205179|18355325|P1|Overall Study|Death|0
5331917|NCT00203996|18355443|P10|Overall Study|Scheduling issue|0
5331918|NCT00203996|18355444|P9|Overall Study|Scheduling issue|0
5331919|NCT00203996|18355445|P8|Overall Study|Scheduling issue|2
5331920|NCT00203996|18355446|P7|Overall Study|Scheduling issue|0
5331921|NCT00203996|18355447|P6|Overall Study|Scheduling issue|0
5331922|NCT00203996|18355448|P5|Overall Study|Scheduling issue|0
5331923|NCT00203996|18355449|P4|Overall Study|Scheduling issue|0
5331924|NCT00203996|18355450|P3|Overall Study|Scheduling issue|0
5331925|NCT00203996|18355451|P2|Overall Study|Scheduling issue|0
5331926|NCT00203996|18355452|P1|Overall Study|Scheduling issue|0
5331927|NCT00203996|18355443|P10|Overall Study|CPAP machine malfunction|0
5331928|NCT00203996|18355444|P9|Overall Study|CPAP machine malfunction|0
5331929|NCT00203996|18355445|P8|Overall Study|CPAP machine malfunction|0
5331930|NCT00203996|18355446|P7|Overall Study|CPAP machine malfunction|0
5331931|NCT00203996|18355447|P6|Overall Study|CPAP machine malfunction|0
5331932|NCT00203996|18355448|P5|Overall Study|CPAP machine malfunction|0
5331933|NCT00203996|18355449|P4|Overall Study|CPAP machine malfunction|1
5331934|NCT00203996|18355450|P3|Overall Study|CPAP machine malfunction|0
5331935|NCT00203996|18355451|P2|Overall Study|CPAP machine malfunction|0
5331936|NCT00203996|18355452|P1|Overall Study|CPAP machine malfunction|0
5331937|NCT00203996|18355443|P10|Overall Study|Physician Decision|1
5331938|NCT00203996|18355444|P9|Overall Study|Physician Decision|0
5331939|NCT00203996|18355445|P8|Overall Study|Physician Decision|0
5331940|NCT00203996|18355446|P7|Overall Study|Physician Decision|0
5331941|NCT00203996|18355447|P6|Overall Study|Physician Decision|0
5331942|NCT00203996|18355448|P5|Overall Study|Physician Decision|0
5331943|NCT00203996|18355449|P4|Overall Study|Physician Decision|2
5331944|NCT00203996|18355450|P3|Overall Study|Physician Decision|0
5331945|NCT00203996|18355451|P2|Overall Study|Physician Decision|0
5331946|NCT00203996|18355452|P1|Overall Study|Physician Decision|0
5331947|NCT00203996|18355443|P10|Overall Study|Protocol Violation|0
5331948|NCT00203996|18355444|P9|Overall Study|Protocol Violation|0
5331949|NCT00203996|18355445|P8|Overall Study|Protocol Violation|0
5331950|NCT00203996|18355446|P7|Overall Study|Protocol Violation|0
5331951|NCT00203996|18355447|P6|Overall Study|Protocol Violation|0
5331952|NCT00203996|18355448|P5|Overall Study|Protocol Violation|1
5331953|NCT00203996|18355449|P4|Overall Study|Protocol Violation|6
5331954|NCT00203996|18355450|P3|Overall Study|Protocol Violation|0
5331955|NCT00203996|18355451|P2|Overall Study|Protocol Violation|0
5331956|NCT00203996|18355452|P1|Overall Study|Protocol Violation|0
5331957|NCT00203996|18355443|P10|Overall Study|Lost to Follow-up|0
5331958|NCT00203996|18355444|P9|Overall Study|Lost to Follow-up|0
5331959|NCT00203996|18355445|P8|Overall Study|Lost to Follow-up|0
5331960|NCT00203996|18355446|P7|Overall Study|Lost to Follow-up|0
5331961|NCT00203996|18355447|P6|Overall Study|Lost to Follow-up|0
5331962|NCT00203996|18355448|P5|Overall Study|Lost to Follow-up|0
5331963|NCT00203996|18355449|P4|Overall Study|Lost to Follow-up|1
5331964|NCT00203996|18355450|P3|Overall Study|Lost to Follow-up|0
5331965|NCT00203996|18355451|P2|Overall Study|Lost to Follow-up|0
5331966|NCT00203996|18355452|P1|Overall Study|Lost to Follow-up|0
5331967|NCT00203892|18355519|P3|Overall Study|Death|0
5331968|NCT00203892|18355520|P2|Overall Study|Death|0
5331969|NCT00203892|18355521|P1|Overall Study|Death|1
5331970|NCT00203892|18355519|P3|Overall Study|Physician Decision|0
5331971|NCT00203892|18355520|P2|Overall Study|Physician Decision|2
5331972|NCT00203892|18355521|P1|Overall Study|Physician Decision|1
5331973|NCT00203502|18355532|P1|Overall Study|Death|1
5331974|NCT00203476|18355543|P3|Overall Study|Withdrawal by Subject|0
5331975|NCT00203476|18355544|P2|Overall Study|Withdrawal by Subject|1
5331976|NCT00203476|18355545|P1|Overall Study|Withdrawal by Subject|0
5331977|NCT00203476|18355543|P3|Overall Study|Lost to Follow-up|0
5331978|NCT00203476|18355544|P2|Overall Study|Lost to Follow-up|0
5331979|NCT00203476|18355545|P1|Overall Study|Lost to Follow-up|1
5331980|NCT00203424|18355562|P1|Follow-up Period|Lost to Follow-up|1
5331981|NCT00203424|18355562|P1|Follow-up Period|progressive disease|4
5331982|NCT00203424|18355562|P1|Follow-up Period|Withdrawal by Subject|1
5331983|NCT00203424|18355562|P1|Treatment Period|progressive disease|2
5331984|NCT00203424|18355562|P1|Treatment Period|Adverse Event|5
5331985|NCT00203424|18355562|P1|Treatment Period|Withdrawal by Subject|4
5331986|NCT00203411|18355569|P1|Follow-up|Progressive Disease|4
5331987|NCT00203307|18355578|P2|First Intervention|Adverse Event|0
5331988|NCT00203307|18355579|P1|First Intervention|Adverse Event|2
5331989|NCT00203294|18355587|P2|Overall Study|Withdrawal by Subject|13
5331990|NCT00203294|18355588|P1|Overall Study|Withdrawal by Subject|8
5331991|NCT00203268|18355594|P1|Early Treatment|Withdrawal by Subject|1
5331992|NCT00203268|18355594|P1|Early Treatment|Lost to Follow-up|1
5331993|NCT00203268|18355594|P1|Early Treatment|only treated one headache|2
5331994|NCT00203242|18355600|P1|Overall Study|Lost to Follow-up|1
5331995|NCT00203047|18355652|P2|Overall Study|Other|5
5331996|NCT00203047|18355653|P1|Overall Study|Other|5
5331997|NCT00203047|18355652|P2|Overall Study|Pregnancy|0
5331998|NCT00203047|18355653|P1|Overall Study|Pregnancy|3
5331999|NCT00203047|18355652|P2|Overall Study|Death|2
5332000|NCT00203047|18355653|P1|Overall Study|Death|1
5332001|NCT00203047|18355652|P2|Overall Study|Adverse Event|18
5332002|NCT00203047|18355653|P1|Overall Study|Adverse Event|8
5332003|NCT00203047|18355652|P2|Overall Study|Lost to Follow-up|5
5332004|NCT00203047|18355653|P1|Overall Study|Lost to Follow-up|11
5332005|NCT00203047|18355652|P2|Overall Study|Protocol Violation|0
5332006|NCT00203047|18355653|P1|Overall Study|Protocol Violation|1
5332007|NCT00203047|18355652|P2|Overall Study|Non-compliance|8
5332008|NCT00203047|18355653|P1|Overall Study|Non-compliance|4
5332009|NCT00203047|18355652|P2|Overall Study|Physician Decision|7
5332010|NCT00203047|18355653|P1|Overall Study|Physician Decision|8
5332011|NCT00203047|18355652|P2|Overall Study|Teva requested participant withdrawal|1
5332012|NCT00203047|18355653|P1|Overall Study|Teva requested participant withdrawal|1
5332013|NCT00203047|18355652|P2|Overall Study|Withdrawal by Subject|47
5332014|NCT00203047|18355653|P1|Overall Study|Withdrawal by Subject|13
5332015|NCT00203047|18355652|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
5332016|NCT00203047|18355653|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
5332017|NCT00203047|18355652|P2|Overall Study|Ongoing: in database - January 29, 2009|109
5332018|NCT00203047|18355653|P1|Overall Study|Ongoing: in database - January 29, 2009|131
5332019|NCT00203021|18355667|P2|Overall Study|Other than specified|16
5332020|NCT00203021|18355668|P1|Overall Study|Other than specified|11
5332021|NCT00203021|18355667|P2|Overall Study|Lost to Follow-up|7
5332022|NCT00203021|18355668|P1|Overall Study|Lost to Follow-up|9
5332023|NCT00203021|18355667|P2|Overall Study|Withdrawal by Subject|48
5332024|NCT00203021|18355668|P1|Overall Study|Withdrawal by Subject|45
5332025|NCT00203021|18355667|P2|Overall Study|Adverse Event|5
5332026|NCT00203021|18355668|P1|Overall Study|Adverse Event|10
5332027|NCT00203021|18355667|P2|Overall Study|Death|1
5332028|NCT00203021|18355668|P1|Overall Study|Death|4
5332029|NCT00202878|18355678|P2|Overall Study|Withdrawal by Subject|808
5332030|NCT00202878|18355679|P1|Overall Study|Withdrawal by Subject|795
5332031|NCT00202878|18355678|P2|Overall Study|Site Closure|36
5332032|NCT00202878|18355679|P1|Overall Study|Site Closure|39
5332033|NCT00202878|18355678|P2|Overall Study|Lost to Follow-up|49
5332034|NCT00202878|18355679|P1|Overall Study|Lost to Follow-up|44
5332035|NCT00202878|18355678|P2|Overall Study|Only Vital Status Known|356
5332036|NCT00202878|18355679|P1|Overall Study|Only Vital Status Known|357
5332037|NCT00202878|18355678|P2|Overall Study|Death|968
5332038|NCT00202878|18355679|P1|Overall Study|Death|964
5332039|NCT00202839|18355693|P2|Overall Study|Lost to Follow-up|2
5332040|NCT00202839|18355694|P1|Overall Study|Lost to Follow-up|3
5332041|NCT00202839|18355693|P2|Overall Study|Protocol Violation|1
5332042|NCT00202839|18355694|P1|Overall Study|Protocol Violation|2
5332043|NCT00202839|18355693|P2|Overall Study|Withdrawal by Subject|2
5332044|NCT00202839|18355694|P1|Overall Study|Withdrawal by Subject|6
5332045|NCT00202839|18355693|P2|Overall Study|Physician Decision|0
5332046|NCT00202839|18355694|P1|Overall Study|Physician Decision|12
5332047|NCT00202839|18355693|P2|Overall Study|Adverse Event|5
5332048|NCT00202839|18355694|P1|Overall Study|Adverse Event|1
5332049|NCT00202644|18355709|P2|Overall Study|Other|1
5332050|NCT00202644|18355710|P1|Overall Study|Other|9
5332051|NCT00202644|18355709|P2|Overall Study|Lost to Follow-up|1
5332052|NCT00202644|18355710|P1|Overall Study|Lost to Follow-up|0
5332053|NCT00202644|18355709|P2|Overall Study|Lack of Efficacy|6
5332054|NCT00202644|18355710|P1|Overall Study|Lack of Efficacy|6
5332055|NCT00202644|18355709|P2|Overall Study|Withdrawal by Subject|6
5332056|NCT00202644|18355710|P1|Overall Study|Withdrawal by Subject|8
5332057|NCT00202644|18355709|P2|Overall Study|Adverse Event|13
5332058|NCT00202644|18355710|P1|Overall Study|Adverse Event|12
5332059|NCT00201851|18355771|P3|Overall Study|Ineligible post enrollment|1
5332060|NCT00201851|18355772|P2|Overall Study|Ineligible post enrollment|1
5332061|NCT00201851|18355773|P1|Overall Study|Ineligible post enrollment|6
5332062|NCT00201851|18355771|P3|Overall Study|Lost to Follow-up|0
5332063|NCT00201851|18355772|P2|Overall Study|Lost to Follow-up|1
5332064|NCT00201851|18355773|P1|Overall Study|Lost to Follow-up|2
5332065|NCT00201643|18355845|P2|Overall Study|Withdrawal by Subject|4
5332066|NCT00201643|18355846|P1|Overall Study|Withdrawal by Subject|5
5332067|NCT00201201|18355910|P2|Overall Study|Withdrawal by Subject|5
5332068|NCT00201201|18355911|P1|Overall Study|Withdrawal by Subject|5
5332069|NCT00201201|18355910|P2|Overall Study|Death|2
5332070|NCT00201201|18355911|P1|Overall Study|Death|0
5332071|NCT00201006|18355949|P3|Overall Study|Adverse Event|1
5332072|NCT00201006|18355950|P2|Overall Study|Adverse Event|0
5332073|NCT00201006|18355951|P1|Overall Study|Adverse Event|1
5332074|NCT00201006|18355949|P3|Overall Study|Withdrawal by Subject|3
5332075|NCT00201006|18355950|P2|Overall Study|Withdrawal by Subject|2
5332076|NCT00201006|18355951|P1|Overall Study|Withdrawal by Subject|7
5332077|NCT00200967|18355961|P2|Run-out Period|Lost to Follow-up|0
5332078|NCT00200967|18355962|P1|Run-out Period|Lost to Follow-up|1
5332079|NCT00200967|18355961|P2|Second Treatment Period|Withdrawal by Subject|2
5332080|NCT00200967|18355962|P1|Second Treatment Period|Withdrawal by Subject|1
5332081|NCT00200967|18355961|P2|Wash-out Period|Lost to Follow-up|1
5332082|NCT00200967|18355962|P1|Wash-out Period|Lost to Follow-up|0
5332083|NCT00200967|18355961|P2|First Treatment Period|Pregnancy|0
5332084|NCT00200967|18355962|P1|First Treatment Period|Pregnancy|1
5332085|NCT00200967|18355961|P2|First Treatment Period|Withdrawal by Subject|1
5332086|NCT00200967|18355962|P1|First Treatment Period|Withdrawal by Subject|5
5332087|NCT00200850|18356012|P3|Overall Study|Adverse Event|2
5332088|NCT00200850|18356013|P2|Overall Study|Adverse Event|1
5332089|NCT00200850|18356014|P1|Overall Study|Adverse Event|1
5332090|NCT00200850|18356012|P3|Overall Study|optic neuritis|1
5332091|NCT00200850|18356013|P2|Overall Study|optic neuritis|0
5332092|NCT00200850|18356014|P1|Overall Study|optic neuritis|0
5332093|NCT00200850|18356012|P3|Overall Study|Poor adherence|1
5332094|NCT00200850|18356013|P2|Overall Study|Poor adherence|0
5332095|NCT00200850|18356014|P1|Overall Study|Poor adherence|0
5332096|NCT00200850|18356012|P3|Overall Study|Pregnancy|1
5332097|NCT00200850|18356013|P2|Overall Study|Pregnancy|0
5332098|NCT00200850|18356014|P1|Overall Study|Pregnancy|0
5332099|NCT00200850|18356012|P3|Overall Study|too busy|0
5332100|NCT00200850|18356013|P2|Overall Study|too busy|0
5332101|NCT00200850|18356014|P1|Overall Study|too busy|1
5332102|NCT00200850|18356012|P3|Overall Study|relocation|1
5332103|NCT00200850|18356013|P2|Overall Study|relocation|0
5332104|NCT00200850|18356014|P1|Overall Study|relocation|1
5332105|NCT00200356|18356035|P2|Overall Study|Nontreatment|0
5332106|NCT00200356|18356036|P1|Overall Study|Nontreatment|1
5332107|NCT00200356|18356035|P2|Overall Study|Protocol Violation|4
5332108|NCT00200356|18356036|P1|Overall Study|Protocol Violation|4
5332109|NCT00200356|18356035|P2|Overall Study|Lack of Efficacy|3
5332110|NCT00200356|18356036|P1|Overall Study|Lack of Efficacy|3
5332111|NCT00200057|18356103|P1|Overall Study|Death|1
5332112|NCT00200057|18356103|P1|Overall Study|Infection|1
5332113|NCT00200057|18356103|P1|Overall Study|Change in medical condition|1
5332114|NCT00200057|18356103|P1|Overall Study|Withdrawal by Subject|1
5332115|NCT00200057|18356103|P1|Overall Study|Exited due to terminal illness of PI|2
5332116|NCT00200057|18356103|P1|Overall Study|Lack of Efficacy|3
5332117|NCT00199875|18356127|P5|Overall Study|Withdrawal by Subject|1
5332118|NCT00199875|18356128|P4|Overall Study|Withdrawal by Subject|0
5332119|NCT00199875|18356129|P3|Overall Study|Withdrawal by Subject|0
5332120|NCT00199875|18356130|P2|Overall Study|Withdrawal by Subject|0
5332121|NCT00199875|18356131|P1|Overall Study|Withdrawal by Subject|0
5332122|NCT00199381|18356153|P1|Overall Study|Study termination by Sponsor|323
5332123|NCT00199381|18356153|P1|Overall Study|Not including due to early termination|37
5332124|NCT00199381|18356153|P1|Overall Study|Lack of Efficacy|27
5332125|NCT00199381|18356153|P1|Overall Study|Protocol Violation|6
5332126|NCT00199381|18356153|P1|Overall Study|Adverse Event|73
5332127|NCT00199381|18356153|P1|Overall Study|Withdrawal by Subject|38
5332128|NCT00198822|18356160|P3|Overall Study|Lost to Follow-up|21
5332129|NCT00198822|18356161|P2|Overall Study|Lost to Follow-up|20
5332130|NCT00198822|18356162|P1|Overall Study|Lost to Follow-up|14
5332131|NCT00198133|18356181|P2|Overall Study|Physician Decision|0
5332132|NCT00198133|18356182|P1|Overall Study|Physician Decision|1
5332133|NCT00198133|18356181|P2|Overall Study|Withdrawal by Subject|0
5332134|NCT00198133|18356182|P1|Overall Study|Withdrawal by Subject|1
5332135|NCT00198133|18356181|P2|Overall Study|Adverse Event|3
5332136|NCT00198133|18356182|P1|Overall Study|Adverse Event|1
5332137|NCT00198133|18356181|P2|Overall Study|Disease progression|5
5332138|NCT00198133|18356182|P1|Overall Study|Disease progression|2
5332139|NCT00198107|18356194|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
5332140|NCT00198107|18356195|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
5332141|NCT00198107|18356196|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
5332142|NCT00198107|18356194|P3|Double-Blind Period|Withdrawal by Subject|0
5332143|NCT00198107|18356195|P2|Double-Blind Period|Withdrawal by Subject|1
5332144|NCT00198107|18356196|P1|Double-Blind Period|Withdrawal by Subject|0
5332145|NCT00198107|18356194|P3|Double-Blind Period|Physician Decision|0
5332146|NCT00198107|18356195|P2|Double-Blind Period|Physician Decision|0
5332147|NCT00198107|18356196|P1|Double-Blind Period|Physician Decision|1
5332148|NCT00198107|18356194|P3|Double-Blind Period|Lost to Follow-up|0
5332149|NCT00198107|18356195|P2|Double-Blind Period|Lost to Follow-up|1
5332150|NCT00198107|18356196|P1|Double-Blind Period|Lost to Follow-up|2
5332151|NCT00198107|18356194|P3|Double-Blind Period|Lack of Efficacy|0
5332152|NCT00198107|18356195|P2|Double-Blind Period|Lack of Efficacy|0
5332153|NCT00198107|18356196|P1|Double-Blind Period|Lack of Efficacy|2
5332154|NCT00198107|18356194|P3|Double-Blind Period|Adverse Event|0
5332155|NCT00198107|18356195|P2|Double-Blind Period|Adverse Event|1
5332156|NCT00198107|18356196|P1|Double-Blind Period|Adverse Event|1
5332157|NCT00198029|18356264|P1|Overall Study|Withdrawal by Subject|4
5332158|NCT00197496|18356271|P2|Follow-up|Lost to Follow-up|1
5332159|NCT00197496|18356272|P1|Follow-up|Lost to Follow-up|2
5332160|NCT00197496|18356271|P2|Baseline to Discharge|Protocol Violation|1
5332161|NCT00197496|18356272|P1|Baseline to Discharge|Protocol Violation|0
5332162|NCT00197496|18356271|P2|Baseline to Discharge|Physician Decision|1
5332163|NCT00197496|18356272|P1|Baseline to Discharge|Physician Decision|0
5332164|NCT00197496|18356271|P2|Baseline to Discharge|MRSA|0
5332165|NCT00197496|18356272|P1|Baseline to Discharge|MRSA|1
5332166|NCT00197496|18356271|P2|Baseline to Discharge|not interested|0
5332167|NCT00197496|18356272|P1|Baseline to Discharge|not interested|1
5332168|NCT00197236|18356320|P3|Overall Study|Returned out of specified time window|1
5332169|NCT00197236|18356321|P2|Overall Study|Returned out of specified time window|0
5332170|NCT00197236|18356322|P1|Overall Study|Returned out of specified time window|0
5332171|NCT00197236|18356320|P3|Overall Study|Study drug/medication expiration|3
5332172|NCT00197236|18356321|P2|Overall Study|Study drug/medication expiration|0
5332173|NCT00197236|18356322|P1|Overall Study|Study drug/medication expiration|1
5332174|NCT00197236|18356320|P3|Overall Study|Withdrawal by Subject|11
5332175|NCT00197236|18356321|P2|Overall Study|Withdrawal by Subject|3
5332176|NCT00197236|18356322|P1|Overall Study|Withdrawal by Subject|7
5332177|NCT00197236|18356320|P3|Overall Study|Protocol Violation|1
5332178|NCT00197236|18356321|P2|Overall Study|Protocol Violation|0
5332179|NCT00197236|18356322|P1|Overall Study|Protocol Violation|0
5332180|NCT00197236|18356320|P3|Overall Study|Lost to Follow-up|6
5332181|NCT00197236|18356321|P2|Overall Study|Lost to Follow-up|14
5332182|NCT00197236|18356322|P1|Overall Study|Lost to Follow-up|5
5332183|NCT00197236|18356320|P3|Overall Study|Adverse Event|1
5332184|NCT00197236|18356321|P2|Overall Study|Adverse Event|0
5332185|NCT00197236|18356322|P1|Overall Study|Adverse Event|1
5332186|NCT00197145|18356396|P2|Period 2 : Open Label Phase|Other|0
5332187|NCT00197145|18356397|P1|Period 2 : Open Label Phase|Other|1
5332188|NCT00197145|18356396|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
5332189|NCT00197145|18356397|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
5332190|NCT00197145|18356396|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
5332191|NCT00197145|18356397|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
5332192|NCT00197145|18356396|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
5332193|NCT00197145|18356397|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
5332194|NCT00197145|18356396|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
5332195|NCT00197145|18356397|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
5332196|NCT00197145|18356396|P2|Period 1: Randomized Treatment Phase|Other|2
5332197|NCT00197145|18356397|P1|Period 1: Randomized Treatment Phase|Other|2
5332198|NCT00197145|18356396|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
5332199|NCT00197145|18356397|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
5332200|NCT00197145|18356396|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
5332201|NCT00197145|18356397|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
5332202|NCT00197106|18356468|P3|Overall Treatment Period|Withdrawal by Subject|2
5332203|NCT00197106|18356469|P2|Overall Treatment Period|Withdrawal by Subject|0
5332204|NCT00197106|18356470|P1|Overall Treatment Period|Withdrawal by Subject|0
5332205|NCT00197106|18356468|P3|Overall Treatment Period|Protocol Violation|2
5332206|NCT00197106|18356469|P2|Overall Treatment Period|Protocol Violation|0
5332207|NCT00197106|18356470|P1|Overall Treatment Period|Protocol Violation|0
5332208|NCT00197106|18356468|P3|Overall Treatment Period|Lost to Follow-up|2
5332209|NCT00197106|18356469|P2|Overall Treatment Period|Lost to Follow-up|0
5332210|NCT00197106|18356470|P1|Overall Treatment Period|Lost to Follow-up|0
5332211|NCT00197106|18356468|P3|Overall Treatment Period|Lack of Efficacy|0
5332212|NCT00197106|18356469|P2|Overall Treatment Period|Lack of Efficacy|1
5332213|NCT00197106|18356470|P1|Overall Treatment Period|Lack of Efficacy|0
5332214|NCT00197106|18356468|P3|4-Week Run-In Period|Did not meet entry criteria|0
5332215|NCT00197106|18356469|P2|4-Week Run-In Period|Did not meet entry criteria|0
5332216|NCT00197106|18356470|P1|4-Week Run-In Period|Did not meet entry criteria|99
5332217|NCT00197028|18356506|P2|Overall Study|Other|6
5332218|NCT00197028|18356507|P1|Overall Study|Other|3
5332219|NCT00197028|18356506|P2|Overall Study|Lost to Follow-up|0
5332220|NCT00197028|18356507|P1|Overall Study|Lost to Follow-up|1
5332221|NCT00197028|18356506|P2|Overall Study|Withdrawal by Subject|12
5332222|NCT00197028|18356507|P1|Overall Study|Withdrawal by Subject|8
5332223|NCT00197028|18356506|P2|Overall Study|Protocol Violation|1
5332224|NCT00197028|18356507|P1|Overall Study|Protocol Violation|2
5332225|NCT00197028|18356506|P2|Overall Study|Adverse Event|2
5332226|NCT00197028|18356507|P1|Overall Study|Adverse Event|2
5332227|NCT00197015|18356550|P3|Overall Study|Other|2
5332228|NCT00197015|18356551|P2|Overall Study|Other|3
5332229|NCT00197015|18356552|P1|Overall Study|Other|2
5332230|NCT00197015|18356550|P3|Overall Study|Lost to Follow-up|37
5332231|NCT00197015|18356551|P2|Overall Study|Lost to Follow-up|46
5332232|NCT00197015|18356552|P1|Overall Study|Lost to Follow-up|28
5332233|NCT00197015|18356550|P3|Overall Study|Withdrawal by Subject|34
5332234|NCT00197015|18356551|P2|Overall Study|Withdrawal by Subject|37
5332235|NCT00197015|18356552|P1|Overall Study|Withdrawal by Subject|17
5332236|NCT00197015|18356550|P3|Overall Study|Protocol Violation|3
5332237|NCT00197015|18356551|P2|Overall Study|Protocol Violation|3
5332238|NCT00197015|18356552|P1|Overall Study|Protocol Violation|0
5332239|NCT00197015|18356550|P3|Overall Study|Adverse Event|1
5332240|NCT00197015|18356551|P2|Overall Study|Adverse Event|0
5332241|NCT00197015|18356552|P1|Overall Study|Adverse Event|3
5332242|NCT00197002|18356611|P3|Overall Study|Others|1
5332243|NCT00197002|18356612|P2|Overall Study|Others|1
5332244|NCT00197002|18356613|P1|Overall Study|Others|3
5332245|NCT00197002|18356611|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
5332246|NCT00197002|18356612|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
5332247|NCT00197002|18356613|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
5332248|NCT00197002|18356611|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
5332249|NCT00197002|18356612|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
5332250|NCT00197002|18356613|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
5332251|NCT00197002|18356611|P3|Overall Study|Migrated/moved from study area|1
5332252|NCT00197002|18356612|P2|Overall Study|Migrated/moved from study area|5
5332253|NCT00197002|18356613|P1|Overall Study|Migrated/moved from study area|3
5332254|NCT00197002|18356611|P3|Overall Study|Withdrawal by Subject|7
5332255|NCT00197002|18356612|P2|Overall Study|Withdrawal by Subject|5
5332256|NCT00197002|18356613|P1|Overall Study|Withdrawal by Subject|9
5332257|NCT00197002|18356611|P3|Overall Study|Protocol Violation|2
5332258|NCT00197002|18356612|P2|Overall Study|Protocol Violation|0
5332259|NCT00197002|18356613|P1|Overall Study|Protocol Violation|1
5332260|NCT00197002|18356611|P3|Overall Study|Adverse Event|0
5332261|NCT00197002|18356612|P2|Overall Study|Adverse Event|1
5332262|NCT00197002|18356613|P1|Overall Study|Adverse Event|0
5332263|NCT00196976|18356664|P14|Booster Study|Lost to Follow-up|0
5332264|NCT00196976|18356665|P13|Booster Study|Lost to Follow-up|0
5332265|NCT00196976|18356666|P12|Booster Study|Lost to Follow-up|2
5332266|NCT00196976|18356667|P11|Booster Study|Lost to Follow-up|1
5332267|NCT00196976|18356668|P10|Booster Study|Lost to Follow-up|0
5332268|NCT00196976|18356669|P9|Booster Study|Lost to Follow-up|0
5332269|NCT00196976|18356670|P8|Booster Study|Lost to Follow-up|0
5332270|NCT00196976|18356671|P7|Booster Study|Lost to Follow-up|0
5332271|NCT00196976|18356672|P6|Booster Study|Lost to Follow-up|0
5332272|NCT00196976|18356673|P5|Booster Study|Lost to Follow-up|0
5332273|NCT00196976|18356674|P4|Booster Study|Lost to Follow-up|0
5332274|NCT00196976|18356675|P3|Booster Study|Lost to Follow-up|0
5332275|NCT00196976|18356676|P2|Booster Study|Lost to Follow-up|0
5332276|NCT00196976|18356677|P1|Booster Study|Lost to Follow-up|0
5332277|NCT00196976|18356664|P14|Booster Study|Withdrawal by Subject|0
5332278|NCT00196976|18356665|P13|Booster Study|Withdrawal by Subject|0
5332279|NCT00196976|18356666|P12|Booster Study|Withdrawal by Subject|0
5332280|NCT00196976|18356667|P11|Booster Study|Withdrawal by Subject|1
5332281|NCT00196976|18356668|P10|Booster Study|Withdrawal by Subject|0
5332282|NCT00196976|18356669|P9|Booster Study|Withdrawal by Subject|0
5332283|NCT00196976|18356670|P8|Booster Study|Withdrawal by Subject|0
5332284|NCT00196976|18356671|P7|Booster Study|Withdrawal by Subject|0
5332285|NCT00196976|18356672|P6|Booster Study|Withdrawal by Subject|0
5332286|NCT00196976|18356673|P5|Booster Study|Withdrawal by Subject|0
5332287|NCT00196976|18356674|P4|Booster Study|Withdrawal by Subject|0
5332288|NCT00196976|18356675|P3|Booster Study|Withdrawal by Subject|0
5332289|NCT00196976|18356676|P2|Booster Study|Withdrawal by Subject|0
5332290|NCT00196976|18356677|P1|Booster Study|Withdrawal by Subject|0
5332291|NCT00196976|18356664|P14|Primary Study|Other|0
5332292|NCT00196976|18356665|P13|Primary Study|Other|0
5332293|NCT00196976|18356666|P12|Primary Study|Other|0
5332294|NCT00196976|18356667|P11|Primary Study|Other|0
5332295|NCT00196976|18356668|P10|Primary Study|Other|0
5332296|NCT00196976|18356669|P9|Primary Study|Other|0
5332297|NCT00196976|18356670|P8|Primary Study|Other|0
5332298|NCT00196976|18356671|P7|Primary Study|Other|0
5332299|NCT00196976|18356672|P6|Primary Study|Other|0
5332300|NCT00196976|18356673|P5|Primary Study|Other|0
5332301|NCT00196976|18356674|P4|Primary Study|Other|0
5332302|NCT00196976|18356675|P3|Primary Study|Other|2
5332303|NCT00196976|18356676|P2|Primary Study|Other|0
5332304|NCT00196976|18356677|P1|Primary Study|Other|0
5332305|NCT00196976|18356664|P14|Primary Study|Lost to Follow-up|0
5332306|NCT00196976|18356665|P13|Primary Study|Lost to Follow-up|0
5332307|NCT00196976|18356666|P12|Primary Study|Lost to Follow-up|0
5332308|NCT00196976|18356667|P11|Primary Study|Lost to Follow-up|0
5332309|NCT00196976|18356668|P10|Primary Study|Lost to Follow-up|0
5332310|NCT00196976|18356669|P9|Primary Study|Lost to Follow-up|0
5332311|NCT00196976|18356670|P8|Primary Study|Lost to Follow-up|2
5332312|NCT00196976|18356671|P7|Primary Study|Lost to Follow-up|0
5332313|NCT00196976|18356672|P6|Primary Study|Lost to Follow-up|1
5332314|NCT00196976|18356673|P5|Primary Study|Lost to Follow-up|1
5332315|NCT00196976|18356674|P4|Primary Study|Lost to Follow-up|0
5332316|NCT00196976|18356675|P3|Primary Study|Lost to Follow-up|0
5332317|NCT00196976|18356676|P2|Primary Study|Lost to Follow-up|0
5332318|NCT00196976|18356677|P1|Primary Study|Lost to Follow-up|0
5332319|NCT00196976|18356664|P14|Primary Study|Withdrawal by Subject|0
5332320|NCT00196976|18356665|P13|Primary Study|Withdrawal by Subject|0
5332321|NCT00196976|18356666|P12|Primary Study|Withdrawal by Subject|0
5332322|NCT00196976|18356667|P11|Primary Study|Withdrawal by Subject|0
5332323|NCT00196976|18356668|P10|Primary Study|Withdrawal by Subject|1
5332324|NCT00196976|18356669|P9|Primary Study|Withdrawal by Subject|0
5332325|NCT00196976|18356670|P8|Primary Study|Withdrawal by Subject|0
5332326|NCT00196976|18356671|P7|Primary Study|Withdrawal by Subject|0
5332327|NCT00196976|18356672|P6|Primary Study|Withdrawal by Subject|1
5332328|NCT00196976|18356673|P5|Primary Study|Withdrawal by Subject|2
5332329|NCT00196976|18356674|P4|Primary Study|Withdrawal by Subject|1
5332330|NCT00196976|18356675|P3|Primary Study|Withdrawal by Subject|1
5332331|NCT00196976|18356676|P2|Primary Study|Withdrawal by Subject|0
5332332|NCT00196976|18356677|P1|Primary Study|Withdrawal by Subject|1
5332333|NCT00196976|18356664|P14|Primary Study|Protocol Violation|0
5332334|NCT00196976|18356665|P13|Primary Study|Protocol Violation|0
5332335|NCT00196976|18356666|P12|Primary Study|Protocol Violation|0
5332336|NCT00196976|18356667|P11|Primary Study|Protocol Violation|0
5332337|NCT00196976|18356668|P10|Primary Study|Protocol Violation|0
5332338|NCT00196976|18356669|P9|Primary Study|Protocol Violation|0
5332339|NCT00196976|18356670|P8|Primary Study|Protocol Violation|0
5332340|NCT00196976|18356671|P7|Primary Study|Protocol Violation|0
5332341|NCT00196976|18356672|P6|Primary Study|Protocol Violation|0
5332342|NCT00196976|18356673|P5|Primary Study|Protocol Violation|0
5332343|NCT00196976|18356674|P4|Primary Study|Protocol Violation|0
5332344|NCT00196976|18356675|P3|Primary Study|Protocol Violation|1
5332345|NCT00196976|18356676|P2|Primary Study|Protocol Violation|1
5332346|NCT00196976|18356677|P1|Primary Study|Protocol Violation|0
5332347|NCT00196976|18356664|P14|Primary Study|Migrated from study area|0
5332348|NCT00196976|18356665|P13|Primary Study|Migrated from study area|0
5332349|NCT00196976|18356666|P12|Primary Study|Migrated from study area|0
5332350|NCT00196976|18356667|P11|Primary Study|Migrated from study area|0
5332351|NCT00196976|18356668|P10|Primary Study|Migrated from study area|0
5332352|NCT00196976|18356669|P9|Primary Study|Migrated from study area|0
5332353|NCT00196976|18356670|P8|Primary Study|Migrated from study area|1
5332354|NCT00196976|18356671|P7|Primary Study|Migrated from study area|0
5332355|NCT00196976|18356672|P6|Primary Study|Migrated from study area|0
5332356|NCT00196976|18356673|P5|Primary Study|Migrated from study area|0
5332357|NCT00196976|18356674|P4|Primary Study|Migrated from study area|0
5332358|NCT00196976|18356675|P3|Primary Study|Migrated from study area|0
5332359|NCT00196976|18356676|P2|Primary Study|Migrated from study area|0
5332360|NCT00196976|18356677|P1|Primary Study|Migrated from study area|0
5332361|NCT00196937|18356873|P3|Overall Study|Other|1
5332362|NCT00196937|18356874|P2|Overall Study|Other|1
5332363|NCT00196937|18356875|P1|Overall Study|Other|3
5332364|NCT00196937|18356873|P3|Overall Study|Lost to Follow-up|3
5332365|NCT00196937|18356874|P2|Overall Study|Lost to Follow-up|3
5332366|NCT00196937|18356875|P1|Overall Study|Lost to Follow-up|4
5332367|NCT00196937|18356873|P3|Overall Study|Withdrawal by Subject|2
5332368|NCT00196937|18356874|P2|Overall Study|Withdrawal by Subject|0
5332369|NCT00196937|18356875|P1|Overall Study|Withdrawal by Subject|0
5332370|NCT00196937|18356873|P3|Overall Study|Non-serious adverse event|1
5332371|NCT00196937|18356874|P2|Overall Study|Non-serious adverse event|1
5332372|NCT00196937|18356875|P1|Overall Study|Non-serious adverse event|1
5332373|NCT00196937|18356873|P3|Overall Study|Serious Adverse Event|0
5332374|NCT00196937|18356874|P2|Overall Study|Serious Adverse Event|0
5332375|NCT00196937|18356875|P1|Overall Study|Serious Adverse Event|1
5332376|NCT00196326|18356929|P1|Overall Study|Other|22
5332377|NCT00196326|18356929|P1|Overall Study|Lost to Follow-up|304
5332378|NCT00196326|18356929|P1|Overall Study|Pregnancy|34
5332379|NCT00196326|18356929|P1|Overall Study|Adverse Event|253
5332380|NCT00196326|18356929|P1|Overall Study|Withdrawal by Subject|225
5332381|NCT00196326|18356929|P1|Overall Study|Physician Decision|3
5332382|NCT00196326|18356929|P1|Overall Study|Non-compliance with the protocol|81
5332383|NCT00196326|18356929|P1|Overall Study|Did not meet protocol requirements|64
5332384|NCT00196313|18356937|P2|Overall Study|Lost to Follow-up|2
5332385|NCT00196313|18356938|P1|Overall Study|Lost to Follow-up|2
5332386|NCT00196313|18356937|P2|Overall Study|Subject Pregnant|1
5332387|NCT00196313|18356938|P1|Overall Study|Subject Pregnant|1
5332388|NCT00196313|18356937|P2|Overall Study|Adverse Event|1
5332389|NCT00196313|18356938|P1|Overall Study|Adverse Event|3
5332390|NCT00196313|18356937|P2|Overall Study|Withdrawal by Subject|1
5332391|NCT00196313|18356938|P1|Overall Study|Withdrawal by Subject|3
5332392|NCT00196313|18356937|P2|Overall Study|Protocol Violation|3
5332393|NCT00196313|18356938|P1|Overall Study|Protocol Violation|2
5332394|NCT00196196|18356952|P1|Overall Study|Did not have required condition (hydroce|5
5332395|NCT00196196|18356952|P1|Overall Study|Withdrawal by Subject|2
5332396|NCT00196105|18356960|P3|Overall Study|Lost to Follow-up|7
5332397|NCT00196105|18356961|P2|Overall Study|Lost to Follow-up|5
5332398|NCT00196105|18356962|P1|Overall Study|Lost to Follow-up|4
5332399|NCT00195819|18356982|P2|Open-label|Withdrawal by Subject|5
5332400|NCT00195819|18356983|P1|Open-label|Withdrawal by Subject|0
5332401|NCT00195819|18356982|P2|Open-label|Moved|1
5332402|NCT00195819|18356983|P1|Open-label|Moved|0
5332403|NCT00195819|18356982|P2|Open-label|Protocol Violation|2
5332404|NCT00195819|18356983|P1|Open-label|Protocol Violation|0
5332405|NCT00195819|18356982|P2|Open-label|Pregnancy|1
5332406|NCT00195819|18356983|P1|Open-label|Pregnancy|0
5332407|NCT00195819|18356982|P2|Open-label|Lack of Efficacy|2
5332408|NCT00195819|18356983|P1|Open-label|Lack of Efficacy|0
5332409|NCT00195819|18356982|P2|Open-label|Adverse Event|9
5332410|NCT00195819|18356983|P1|Open-label|Adverse Event|0
5332411|NCT00195819|18356982|P2|Double-Blind|Moved|0
5332412|NCT00195819|18356983|P1|Double-Blind|Moved|1
5332413|NCT00195819|18356982|P2|Double-Blind|Withdrawal by Subject|0
5332414|NCT00195819|18356983|P1|Double-Blind|Withdrawal by Subject|1
5332415|NCT00195715|18357033|P1|Overall Study|Sponsor discretion - trial ended early|1
5332416|NCT00195715|18357033|P1|Overall Study|Sponsor discontinued trial|1
5332417|NCT00195715|18357033|P1|Overall Study|Colonic stricture|1
5332418|NCT00195715|18357033|P1|Overall Study|Ineligible|1
5332419|NCT00195715|18357033|P1|Overall Study|Increased infection rate|1
5332420|NCT00195715|18357033|P1|Overall Study|Planned surgery|2
5332421|NCT00195715|18357033|P1|Overall Study|Use of prohibited medication|2
5332422|NCT00195715|18357033|P1|Overall Study|Subject wants to get pregnant|4
5332423|NCT00195715|18357033|P1|Overall Study|Investigator's decision|2
5332424|NCT00195715|18357033|P1|Overall Study|Administrative reasons|2
5332425|NCT00195715|18357033|P1|Overall Study|Sponsor stopped study|1
5332426|NCT00195715|18357033|P1|Overall Study|Loss of response/no improvement|3
5332427|NCT00195715|18357033|P1|Overall Study|Subject choice|3
5332428|NCT00195715|18357033|P1|Overall Study|Subject started commercial Humira|5
5332429|NCT00195715|18357033|P1|Overall Study|Subject non-compliance|6
5332430|NCT00195715|18357033|P1|Overall Study|Subject moved/relocated|7
5332431|NCT00195715|18357033|P1|Overall Study|Investigative site closure|8
5332432|NCT00195715|18357033|P1|Overall Study|Pregnancy|14
5332433|NCT00195715|18357033|P1|Overall Study|Lack of Efficacy|93
5332434|NCT00195715|18357033|P1|Overall Study|Protocol Violation|13
5332435|NCT00195715|18357033|P1|Overall Study|Lost to Follow-up|27
5332436|NCT00195715|18357033|P1|Overall Study|Withdrawal by Subject|58
5332437|NCT00195715|18357033|P1|Overall Study|Adverse Event|122
5332438|NCT00195676|18357133|P1|Period R - Retreatment 16 Weeks|Other reasons|6
5332439|NCT00195676|18357133|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
5332440|NCT00195676|18357133|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
5332441|NCT00195676|18357133|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
5332442|NCT00195676|18357133|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
5332443|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
5332444|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
5332445|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
5332446|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
5332447|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
5332448|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
5332449|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Death|2
5332450|NCT00195676|18357133|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
5332451|NCT00195676|18357133|P1|Period O - Open-label Treatment|Other reasons|68
5332452|NCT00195676|18357133|P1|Period O - Open-label Treatment|Administrative reasons|2
5332453|NCT00195676|18357133|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
5332454|NCT00195676|18357133|P1|Period O - Open-label Treatment|Protocol Violation|12
5332455|NCT00195676|18357133|P1|Period O - Open-label Treatment|Lost to Follow-up|91
5332456|NCT00195676|18357133|P1|Period O - Open-label Treatment|Lack of Efficacy|198
5332457|NCT00195676|18357133|P1|Period O - Open-label Treatment|Death|6
5332458|NCT00195676|18357133|P1|Period O - Open-label Treatment|Adverse Event|82
5332459|NCT00195663|18357147|P3|Open-Label Extension Period|Administrative reasons|13
5332460|NCT00195663|18357148|P2|Open-Label Extension Period|Administrative reasons|11
5332461|NCT00195663|18357149|P1|Open-Label Extension Period|Administrative reasons|11
5332462|NCT00195663|18357147|P3|Open-Label Extension Period|Lack of Efficacy|12
5332463|NCT00195663|18357148|P2|Open-Label Extension Period|Lack of Efficacy|6
5332464|NCT00195663|18357149|P1|Open-Label Extension Period|Lack of Efficacy|14
5332465|NCT00195663|18357147|P3|Open-Label Extension Period|Withdrawal by Subject|22
5332466|NCT00195663|18357148|P2|Open-Label Extension Period|Withdrawal by Subject|15
5332467|NCT00195663|18357149|P1|Open-Label Extension Period|Withdrawal by Subject|16
5332468|NCT00195663|18357147|P3|Open-Label Extension Period|Death|2
5332469|NCT00195663|18357148|P2|Open-Label Extension Period|Death|2
5332470|NCT00195663|18357149|P1|Open-Label Extension Period|Death|2
5332471|NCT00195663|18357147|P3|Open-Label Extension Period|Protocol Violation|4
5332472|NCT00195663|18357148|P2|Open-Label Extension Period|Protocol Violation|4
5332473|NCT00195663|18357149|P1|Open-Label Extension Period|Protocol Violation|3
5332474|NCT00195663|18357147|P3|Open-Label Extension Period|Recovery|2
5332475|NCT00195663|18357148|P2|Open-Label Extension Period|Recovery|2
5332476|NCT00195663|18357149|P1|Open-Label Extension Period|Recovery|0
5332477|NCT00195663|18357147|P3|Open-Label Extension Period|Lost to Follow-up|6
5332478|NCT00195663|18357148|P2|Open-Label Extension Period|Lost to Follow-up|2
5332479|NCT00195663|18357149|P1|Open-Label Extension Period|Lost to Follow-up|9
5332480|NCT00195663|18357147|P3|Open-Label Extension Period|Adverse Event|36
5332481|NCT00195663|18357148|P2|Open-Label Extension Period|Adverse Event|32
5332482|NCT00195663|18357149|P1|Open-Label Extension Period|Adverse Event|21
5332483|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Administrative reasons|9
5332484|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Administrative reasons|2
5332485|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Administrative reasons|3
5332486|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Recovery|1
5332487|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Recovery|0
5332488|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Recovery|1
5332489|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
5332490|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
5332491|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
5332492|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Protocol Violation|4
5332493|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Protocol Violation|6
5332494|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Protocol Violation|6
5332495|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
5332496|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
5332497|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
5332498|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
5332499|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
5332500|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
5332501|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
5332502|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
5332503|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
5332504|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Death|0
5332505|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Death|2
5332506|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Death|0
5332507|NCT00195663|18357147|P3|2-year Double-blind Treatment Period|Adverse Event|32
5332508|NCT00195663|18357148|P2|2-year Double-blind Treatment Period|Adverse Event|27
5332509|NCT00195663|18357149|P1|2-year Double-blind Treatment Period|Adverse Event|21
5332510|NCT00195650|18357243|P1|Overall Study|Administrative reasons|83
5332511|NCT00195650|18357243|P1|Overall Study|Protocol Violation|15
5332512|NCT00195650|18357243|P1|Overall Study|Death|23
5332513|NCT00195650|18357243|P1|Overall Study|Lost to Follow-up|44
5332514|NCT00195650|18357243|P1|Overall Study|Withdrawal by Subject|67
5332515|NCT00195650|18357243|P1|Overall Study|Lack of Efficacy|99
5332516|NCT00195650|18357243|P1|Overall Study|Adverse Event|194
5332517|NCT00195507|18357268|P2|Overall Study|Protocol Deviation|3
5332518|NCT00195507|18357269|P1|Overall Study|Protocol Deviation|6
5332519|NCT00195507|18357268|P2|Overall Study|Withdrawal by Subject|23
5332520|NCT00195507|18357269|P1|Overall Study|Withdrawal by Subject|16
5332521|NCT00195507|18357268|P2|Overall Study|Lack of Efficacy|67
5332522|NCT00195507|18357269|P1|Overall Study|Lack of Efficacy|40
5332523|NCT00195507|18357268|P2|Overall Study|Protocol Violation|4
5332524|NCT00195507|18357269|P1|Overall Study|Protocol Violation|5
5332525|NCT00195507|18357268|P2|Overall Study|Lost to Follow-up|2
5332526|NCT00195507|18357269|P1|Overall Study|Lost to Follow-up|3
5332527|NCT00195507|18357268|P2|Overall Study|Physician Decision|2
5332528|NCT00195507|18357269|P1|Overall Study|Physician Decision|1
5332529|NCT00195507|18357268|P2|Overall Study|Failed to Return|3
5332530|NCT00195507|18357269|P1|Overall Study|Failed to Return|4
5332531|NCT00195507|18357268|P2|Overall Study|Death|1
5332532|NCT00195507|18357269|P1|Overall Study|Death|0
5332533|NCT00195507|18357268|P2|Overall Study|Adverse Event|13
5332534|NCT00195507|18357269|P1|Overall Study|Adverse Event|24
5332535|NCT00195494|18357283|P6|Year 2|System toxicity|0
5332536|NCT00195494|18357284|P5|Year 2|System toxicity|0
5332537|NCT00195494|18357285|P4|Year 2|System toxicity|1
5332538|NCT00195494|18357286|P3|Year 2|System toxicity|0
5332539|NCT00195494|18357287|P2|Year 2|System toxicity|0
5332540|NCT00195494|18357288|P1|Year 2|System toxicity|0
5332541|NCT00195494|18357283|P6|Year 2|Withdrawal by Subject|0
5332542|NCT00195494|18357284|P5|Year 2|Withdrawal by Subject|0
5332543|NCT00195494|18357285|P4|Year 2|Withdrawal by Subject|3
5332544|NCT00195494|18357286|P3|Year 2|Withdrawal by Subject|4
5332545|NCT00195494|18357287|P2|Year 2|Withdrawal by Subject|5
5332546|NCT00195494|18357288|P1|Year 2|Withdrawal by Subject|1
5332547|NCT00195494|18357283|P6|Year 2|Physician Decision|0
5332548|NCT00195494|18357284|P5|Year 2|Physician Decision|0
5332549|NCT00195494|18357285|P4|Year 2|Physician Decision|0
5332550|NCT00195494|18357286|P3|Year 2|Physician Decision|0
5332551|NCT00195494|18357287|P2|Year 2|Physician Decision|1
5332552|NCT00195494|18357288|P1|Year 2|Physician Decision|1
5332553|NCT00195494|18357283|P6|Year 2|Protocol deviation|0
5332554|NCT00195494|18357284|P5|Year 2|Protocol deviation|0
5332555|NCT00195494|18357285|P4|Year 2|Protocol deviation|0
5332556|NCT00195494|18357286|P3|Year 2|Protocol deviation|0
5332557|NCT00195494|18357287|P2|Year 2|Protocol deviation|1
5332558|NCT00195494|18357288|P1|Year 2|Protocol deviation|0
5332559|NCT00195494|18357283|P6|Year 2|Missed >4 consecutive doses|0
5332560|NCT00195494|18357284|P5|Year 2|Missed >4 consecutive doses|0
5332561|NCT00195494|18357285|P4|Year 2|Missed >4 consecutive doses|0
5332562|NCT00195494|18357286|P3|Year 2|Missed >4 consecutive doses|1
5332563|NCT00195494|18357287|P2|Year 2|Missed >4 consecutive doses|1
5332564|NCT00195494|18357288|P1|Year 2|Missed >4 consecutive doses|1
5332565|NCT00195494|18357283|P6|Year 2|Lost to Follow-up|0
5332566|NCT00195494|18357284|P5|Year 2|Lost to Follow-up|0
5332567|NCT00195494|18357285|P4|Year 2|Lost to Follow-up|1
5332568|NCT00195494|18357286|P3|Year 2|Lost to Follow-up|1
5332569|NCT00195494|18357287|P2|Year 2|Lost to Follow-up|0
5332570|NCT00195494|18357288|P1|Year 2|Lost to Follow-up|0
5332571|NCT00195494|18357283|P6|Year 2|Compliance|0
5332572|NCT00195494|18357284|P5|Year 2|Compliance|0
5332573|NCT00195494|18357285|P4|Year 2|Compliance|2
5332574|NCT00195494|18357286|P3|Year 2|Compliance|0
5332575|NCT00195494|18357287|P2|Year 2|Compliance|0
5332576|NCT00195494|18357288|P1|Year 2|Compliance|1
5332577|NCT00195494|18357283|P6|Year 2|Lack of Efficacy|0
5332578|NCT00195494|18357284|P5|Year 2|Lack of Efficacy|0
5332579|NCT00195494|18357285|P4|Year 2|Lack of Efficacy|7
5332580|NCT00195494|18357286|P3|Year 2|Lack of Efficacy|7
5332581|NCT00195494|18357287|P2|Year 2|Lack of Efficacy|1
5332582|NCT00195494|18357288|P1|Year 2|Lack of Efficacy|0
5332583|NCT00195494|18357283|P6|Year 2|Adverse Event|0
5332584|NCT00195494|18357284|P5|Year 2|Adverse Event|0
5332585|NCT00195494|18357285|P4|Year 2|Adverse Event|9
5332586|NCT00195494|18357286|P3|Year 2|Adverse Event|5
5332587|NCT00195494|18357287|P2|Year 2|Adverse Event|7
5332588|NCT00195494|18357288|P1|Year 2|Adverse Event|3
5332589|NCT00195494|18357283|P6|Year 1|Protocol Violation|1
5332590|NCT00195494|18357284|P5|Year 1|Protocol Violation|1
5332591|NCT00195494|18357285|P4|Year 1|Protocol Violation|0
5332592|NCT00195494|18357286|P3|Year 1|Protocol Violation|0
5332593|NCT00195494|18357287|P2|Year 1|Protocol Violation|0
5332594|NCT00195494|18357288|P1|Year 1|Protocol Violation|0
5332595|NCT00195494|18357283|P6|Year 1|Withdrawal by Subject|9
5332596|NCT00195494|18357284|P5|Year 1|Withdrawal by Subject|8
5332597|NCT00195494|18357285|P4|Year 1|Withdrawal by Subject|0
5332598|NCT00195494|18357286|P3|Year 1|Withdrawal by Subject|0
5332599|NCT00195494|18357287|P2|Year 1|Withdrawal by Subject|0
5332600|NCT00195494|18357288|P1|Year 1|Withdrawal by Subject|0
5332601|NCT00195494|18357283|P6|Year 1|Physician Decision|0
5332602|NCT00195494|18357284|P5|Year 1|Physician Decision|1
5332603|NCT00195494|18357285|P4|Year 1|Physician Decision|0
5332604|NCT00195494|18357286|P3|Year 1|Physician Decision|0
5332605|NCT00195494|18357287|P2|Year 1|Physician Decision|0
5332606|NCT00195494|18357288|P1|Year 1|Physician Decision|0
5332607|NCT00195494|18357283|P6|Year 1|Protocol deviation|3
5332608|NCT00195494|18357284|P5|Year 1|Protocol deviation|2
5332609|NCT00195494|18357285|P4|Year 1|Protocol deviation|0
5332610|NCT00195494|18357286|P3|Year 1|Protocol deviation|0
5332611|NCT00195494|18357287|P2|Year 1|Protocol deviation|0
5332612|NCT00195494|18357288|P1|Year 1|Protocol deviation|0
5332613|NCT00195494|18357283|P6|Year 1|Missed >4 consecutive doses|2
5332614|NCT00195494|18357284|P5|Year 1|Missed >4 consecutive doses|3
5332615|NCT00195494|18357285|P4|Year 1|Missed >4 consecutive doses|0
5332616|NCT00195494|18357286|P3|Year 1|Missed >4 consecutive doses|0
5332617|NCT00195494|18357287|P2|Year 1|Missed >4 consecutive doses|0
5332618|NCT00195494|18357288|P1|Year 1|Missed >4 consecutive doses|0
5332619|NCT00195494|18357283|P6|Year 1|Lost to Follow-up|0
5332620|NCT00195494|18357284|P5|Year 1|Lost to Follow-up|1
5332621|NCT00195494|18357285|P4|Year 1|Lost to Follow-up|0
5332622|NCT00195494|18357286|P3|Year 1|Lost to Follow-up|0
5332623|NCT00195494|18357287|P2|Year 1|Lost to Follow-up|0
5332624|NCT00195494|18357288|P1|Year 1|Lost to Follow-up|0
5332625|NCT00195494|18357283|P6|Year 1|Compliance|1
5332626|NCT00195494|18357284|P5|Year 1|Compliance|5
5332627|NCT00195494|18357285|P4|Year 1|Compliance|0
5332628|NCT00195494|18357286|P3|Year 1|Compliance|0
5332629|NCT00195494|18357287|P2|Year 1|Compliance|0
5332630|NCT00195494|18357288|P1|Year 1|Compliance|0
5332631|NCT00195494|18357283|P6|Year 1|Lack of Efficacy|9
5332632|NCT00195494|18357284|P5|Year 1|Lack of Efficacy|24
5332633|NCT00195494|18357285|P4|Year 1|Lack of Efficacy|0
5332634|NCT00195494|18357286|P3|Year 1|Lack of Efficacy|0
5332635|NCT00195494|18357287|P2|Year 1|Lack of Efficacy|0
5332636|NCT00195494|18357288|P1|Year 1|Lack of Efficacy|0
5332637|NCT00195494|18357283|P6|Year 1|System Toxicity|1
5332638|NCT00195494|18357284|P5|Year 1|System Toxicity|0
5332639|NCT00195494|18357285|P4|Year 1|System Toxicity|0
5332640|NCT00195494|18357286|P3|Year 1|System Toxicity|0
5332641|NCT00195494|18357287|P2|Year 1|System Toxicity|0
5332642|NCT00195494|18357288|P1|Year 1|System Toxicity|0
5332643|NCT00195494|18357283|P6|Year 1|Adverse Event|27
5332644|NCT00195494|18357284|P5|Year 1|Adverse Event|34
5332645|NCT00195494|18357285|P4|Year 1|Adverse Event|0
5332646|NCT00195494|18357286|P3|Year 1|Adverse Event|0
5332647|NCT00195494|18357287|P2|Year 1|Adverse Event|0
5332648|NCT00195494|18357288|P1|Year 1|Adverse Event|0
5332649|NCT00195442|18357306|P1|Overall Study|Other|14
5332650|NCT00195442|18357306|P1|Overall Study|Poor cooperation|2
5332651|NCT00195442|18357306|P1|Overall Study|No reason specified|4
5332652|NCT00195442|18357306|P1|Overall Study|Death|7
5332653|NCT00195442|18357306|P1|Overall Study|Intermittent product shortage|21
5332654|NCT00195442|18357306|P1|Overall Study|Switch to other Factor VIII preparation|23
5332655|NCT00195442|18357306|P1|Overall Study|Lost to Follow-up|27
5332656|NCT00195442|18357306|P1|Overall Study|Less than expected therapeutic effect|38
5332657|NCT00195429|18357325|P2|Overall Study|Lost to Follow-up|0
5332658|NCT00195429|18357326|P1|Overall Study|Lost to Follow-up|1
5332659|NCT00195429|18357325|P2|Overall Study|Lack of Efficacy|1
5332660|NCT00195429|18357326|P1|Overall Study|Lack of Efficacy|2
5332661|NCT00195429|18357325|P2|Overall Study|Adverse Event|4
5332662|NCT00195429|18357326|P1|Overall Study|Adverse Event|2
5332663|NCT00195351|18357342|P2|Overall Study|Lack of Efficacy|1
5332664|NCT00195351|18357343|P1|Overall Study|Lack of Efficacy|0
5332665|NCT00195351|18357342|P2|Overall Study|Death|1
5332666|NCT00195351|18357343|P1|Overall Study|Death|3
5332667|NCT00195351|18357342|P2|Overall Study|Protocol Deviation|2
5332668|NCT00195351|18357343|P1|Overall Study|Protocol Deviation|3
5332669|NCT00195351|18357342|P2|Overall Study|Withdrawal by Subject|3
5332670|NCT00195351|18357343|P1|Overall Study|Withdrawal by Subject|6
5332671|NCT00195351|18357342|P2|Overall Study|Lost to Follow-up|9
5332672|NCT00195351|18357343|P1|Overall Study|Lost to Follow-up|9
5332673|NCT00195338|18357353|P1|Overall Study|Early closure of the site|4
5332674|NCT00195338|18357353|P1|Overall Study|Lack of Efficacy|1
5332675|NCT00195338|18357353|P1|Overall Study|Adverse Event|5
5332676|NCT00195338|18357353|P1|Overall Study|Lost to Follow-up|2
5332677|NCT00195273|18357363|P2|Overall Study|Procedural complications|3
5332678|NCT00195273|18357364|P1|Overall Study|Procedural complications|9
5332679|NCT00195273|18357363|P2|Overall Study|Lack of Efficacy|1
5332680|NCT00195273|18357364|P1|Overall Study|Lack of Efficacy|3
5332681|NCT00195273|18357363|P2|Overall Study|Protocol deviation|1
5332682|NCT00195273|18357364|P1|Overall Study|Protocol deviation|0
5332683|NCT00195273|18357363|P2|Overall Study|Adverse Event|9
5332684|NCT00195273|18357364|P1|Overall Study|Adverse Event|9
5332685|NCT00195260|18357378|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
5332686|NCT00195260|18357379|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
5332687|NCT00195260|18357380|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
5332688|NCT00195260|18357381|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332689|NCT00195260|18357382|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332690|NCT00195260|18357383|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332691|NCT00195260|18357384|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332692|NCT00195260|18357385|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332693|NCT00195260|18357386|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332694|NCT00195260|18357387|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332695|NCT00195260|18357388|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5332696|NCT00195260|18357378|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
5332697|NCT00195260|18357379|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
5332698|NCT00195260|18357380|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
5332699|NCT00195260|18357381|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332700|NCT00195260|18357382|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332701|NCT00195260|18357383|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332702|NCT00195260|18357384|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332703|NCT00195260|18357385|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332704|NCT00195260|18357386|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332705|NCT00195260|18357387|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332706|NCT00195260|18357388|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5332707|NCT00195260|18357378|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
5332708|NCT00195260|18357379|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
5332709|NCT00195260|18357380|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
5332710|NCT00195260|18357381|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332711|NCT00195260|18357382|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332712|NCT00195260|18357383|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332713|NCT00195260|18357384|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332714|NCT00195260|18357385|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332715|NCT00195260|18357386|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332716|NCT00195260|18357387|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332717|NCT00195260|18357388|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5332718|NCT00195260|18357378|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
5332719|NCT00195260|18357379|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
5332720|NCT00195260|18357380|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
5332721|NCT00195260|18357381|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332722|NCT00195260|18357382|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332723|NCT00195260|18357383|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332724|NCT00195260|18357384|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332725|NCT00195260|18357385|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332726|NCT00195260|18357386|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332727|NCT00195260|18357387|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332728|NCT00195260|18357388|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5332729|NCT00195260|18357378|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332730|NCT00195260|18357379|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332731|NCT00195260|18357380|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332732|NCT00195260|18357381|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332733|NCT00195260|18357382|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332734|NCT00195260|18357383|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
5332735|NCT00195260|18357384|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332736|NCT00195260|18357385|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
5332737|NCT00195260|18357386|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
5332738|NCT00195260|18357387|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
5332739|NCT00195260|18357388|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
5332740|NCT00195260|18357378|P11|Part 1: Dose Escalation|Disease Progression|0
5332741|NCT00195260|18357379|P10|Part 1: Dose Escalation|Disease Progression|0
5332742|NCT00195260|18357380|P9|Part 1: Dose Escalation|Disease Progression|0
5332743|NCT00195260|18357381|P8|Part 1: Dose Escalation|Disease Progression|4
5332744|NCT00195260|18357382|P7|Part 1: Dose Escalation|Disease Progression|7
5332745|NCT00195260|18357383|P6|Part 1: Dose Escalation|Disease Progression|6
5332746|NCT00195260|18357384|P5|Part 1: Dose Escalation|Disease Progression|4
5332747|NCT00195260|18357385|P4|Part 1: Dose Escalation|Disease Progression|6
5332748|NCT00195260|18357386|P3|Part 1: Dose Escalation|Disease Progression|5
5332749|NCT00195260|18357387|P2|Part 1: Dose Escalation|Disease Progression|2
5332750|NCT00195260|18357388|P1|Part 1: Dose Escalation|Disease Progression|3
5332751|NCT00195260|18357378|P11|Part 1: Dose Escalation|Death|0
5332752|NCT00195260|18357379|P10|Part 1: Dose Escalation|Death|0
5332753|NCT00195260|18357380|P9|Part 1: Dose Escalation|Death|0
5332754|NCT00195260|18357381|P8|Part 1: Dose Escalation|Death|1
5332755|NCT00195260|18357382|P7|Part 1: Dose Escalation|Death|0
5332756|NCT00195260|18357383|P6|Part 1: Dose Escalation|Death|0
5332757|NCT00195260|18357384|P5|Part 1: Dose Escalation|Death|0
5332758|NCT00195260|18357385|P4|Part 1: Dose Escalation|Death|0
5332759|NCT00195260|18357386|P3|Part 1: Dose Escalation|Death|0
5332760|NCT00195260|18357387|P2|Part 1: Dose Escalation|Death|0
5332761|NCT00195260|18357388|P1|Part 1: Dose Escalation|Death|0
5332762|NCT00195260|18357378|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
5332763|NCT00195260|18357379|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
5332764|NCT00195260|18357380|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
5332765|NCT00195260|18357381|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
5332766|NCT00195260|18357382|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
5332767|NCT00195260|18357383|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
5332768|NCT00195260|18357384|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
5332769|NCT00195260|18357385|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
5332770|NCT00195260|18357386|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
5332771|NCT00195260|18357387|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
5332772|NCT00195260|18357388|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
5332773|NCT00195260|18357378|P11|Part 1: Dose Escalation|Adverse Event|0
5332774|NCT00195260|18357379|P10|Part 1: Dose Escalation|Adverse Event|0
5332775|NCT00195260|18357380|P9|Part 1: Dose Escalation|Adverse Event|0
5332776|NCT00195260|18357381|P8|Part 1: Dose Escalation|Adverse Event|0
5332777|NCT00195260|18357382|P7|Part 1: Dose Escalation|Adverse Event|3
5332778|NCT00195260|18357383|P6|Part 1: Dose Escalation|Adverse Event|0
5332779|NCT00195260|18357384|P5|Part 1: Dose Escalation|Adverse Event|1
5332780|NCT00195260|18357385|P4|Part 1: Dose Escalation|Adverse Event|1
5332781|NCT00195260|18357386|P3|Part 1: Dose Escalation|Adverse Event|0
5332782|NCT00195260|18357387|P2|Part 1: Dose Escalation|Adverse Event|1
5332783|NCT00195260|18357388|P1|Part 1: Dose Escalation|Adverse Event|0
5332784|NCT00194987|18357556|P2|Overall Study|Withdrawal by Subject|3
5332785|NCT00194987|18357557|P1|Overall Study|Withdrawal by Subject|0
5332786|NCT00194792|18357590|P1|Overall Study|Withdrawal by Subject|1
5332787|NCT00194675|18357614|P2|Overall Study|Death|0
5332788|NCT00194675|18357615|P1|Overall Study|Death|1
5332789|NCT00194675|18357614|P2|Overall Study|Protocol Violation|0
5332790|NCT00194675|18357615|P1|Overall Study|Protocol Violation|1
5332791|NCT00194675|18357614|P2|Overall Study|"withdrew due to edgy feeling"|0
5332792|NCT00194675|18357615|P1|Overall Study|"withdrew due to edgy feeling"|1
5332793|NCT00194675|18357614|P2|Overall Study|lack of interest|1
5332794|NCT00194675|18357615|P1|Overall Study|lack of interest|1
5332795|NCT00194675|18357614|P2|Overall Study|Lost to Follow-up|1
5332796|NCT00194675|18357615|P1|Overall Study|Lost to Follow-up|1
5332797|NCT00194077|18357690|P2|Overall Study|Withdrawal by Subject|1
5332798|NCT00194077|18357691|P1|Overall Study|Withdrawal by Subject|1
5332799|NCT00194077|18357690|P2|Overall Study|Study nonadherence|0
5332800|NCT00194077|18357691|P1|Overall Study|Study nonadherence|1
5332801|NCT00194077|18357690|P2|Overall Study|Lack of Efficacy|29
5332802|NCT00194077|18357691|P1|Overall Study|Lack of Efficacy|22
5332803|NCT00194025|18357697|P1|Overall Study|non-adherence with study medication|4
5332804|NCT00194025|18357697|P1|Overall Study|Adverse Event|1
5332805|NCT00194012|18357712|P2|Open Label Extension (OLE)|Lack of Efficacy|0
5332806|NCT00194012|18357713|P1|Open Label Extension (OLE)|Lack of Efficacy|1
5332807|NCT00194012|18357712|P2|Open Label Extension (OLE)|Lost to Follow-up|5
5332808|NCT00194012|18357713|P1|Open Label Extension (OLE)|Lost to Follow-up|3
5332809|NCT00194012|18357712|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
5332810|NCT00194012|18357713|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
5332811|NCT00194012|18357712|P2|Open Label Extension (OLE)|Weight Gain|0
5332812|NCT00194012|18357713|P1|Open Label Extension (OLE)|Weight Gain|1
5332813|NCT00194012|18357712|P2|Randomized Phase|Oral/nasal twitching|1
5332814|NCT00194012|18357713|P1|Randomized Phase|Oral/nasal twitching|0
5332815|NCT00194012|18357712|P2|Randomized Phase|Emesis and enuresis|1
5332816|NCT00194012|18357713|P1|Randomized Phase|Emesis and enuresis|0
5332817|NCT00194012|18357712|P2|Randomized Phase|Participant reported having a rash|0
5332818|NCT00194012|18357713|P1|Randomized Phase|Participant reported having a rash|1
5332819|NCT00194012|18357712|P2|Randomized Phase|Adverse Event|1
5332820|NCT00194012|18357713|P1|Randomized Phase|Adverse Event|2
5332821|NCT00194012|18357712|P2|Randomized Phase|Withdrawal by Subject|3
5332822|NCT00194012|18357713|P1|Randomized Phase|Withdrawal by Subject|3
5332823|NCT00194012|18357712|P2|Randomized Phase|Study nonadherence|1
5332824|NCT00194012|18357713|P1|Randomized Phase|Study nonadherence|2
5332825|NCT00194012|18357712|P2|Randomized Phase|Lack of Efficacy|18
5332826|NCT00194012|18357713|P1|Randomized Phase|Lack of Efficacy|8
5332827|NCT00193609|18357749|P1|Overall Study|Adverse Event|2
5332828|NCT00193609|18357749|P1|Overall Study|Lack of Efficacy|2
5332829|NCT00193479|18357776|P1|Induction Chemotherapy|Disease Progression|1
5332830|NCT00193479|18357776|P1|Induction Chemotherapy|Adverse Event|2
5332831|NCT00193206|18357817|P1|Postoperative Therapy|Protocol Violation|1
5332832|NCT00193206|18357817|P1|Postoperative Therapy|Lack of Efficacy|1
5332833|NCT00193206|18357817|P1|Postoperative Therapy|Intercurrent Illness|2
5332834|NCT00193206|18357817|P1|Postoperative Therapy|Physician Decision|3
5332835|NCT00193206|18357817|P1|Postoperative Therapy|Withdrawal by Subject|7
5332836|NCT00193206|18357817|P1|Preoperative Therapy|False Positive Pregnancy Test|1
5332837|NCT00193206|18357817|P1|Preoperative Therapy|Withdrawal by Subject|2
5332838|NCT00193206|18357817|P1|Preoperative Therapy|Adverse Event|2
5332839|NCT00193206|18357817|P1|Preoperative Therapy|Lack of Efficacy|2
5332840|NCT00193180|18357821|P1|Overall Study|Protocol Violation|1
5332841|NCT00193180|18357821|P1|Overall Study|Adverse Event|8
5332842|NCT00193180|18357821|P1|Overall Study|Lack of Efficacy|1
5332843|NCT00193063|18357836|P1|Overall Study|Adverse Event|1
5332844|NCT00193063|18357836|P1|Overall Study|Lack of Efficacy|3
5332845|NCT00193050|18357842|P1|Adjuvant|Lack of Efficacy|2
5332846|NCT00193050|18357842|P1|Adjuvant|Intercurrent Hospitalization|3
5332847|NCT00193050|18357842|P1|Adjuvant|Physician Decision|5
5332848|NCT00193050|18357842|P1|Neoadjuvant Treatment|Adverse Event|2
5332849|NCT00193050|18357842|P1|Neoadjuvant Treatment|Physician Decision|2
5332850|NCT00193050|18357842|P1|Neoadjuvant Treatment|Intercurrent Illness|3
5332851|NCT00193050|18357842|P1|Neoadjuvant Treatment|Lack of Efficacy|2
5332852|NCT00192647|18357859|P2|Overall Study|Other/Administrative|3
5332853|NCT00192647|18357860|P1|Overall Study|Other/Administrative|5
5332854|NCT00192647|18357859|P2|Overall Study|Failure to Return|13
5332855|NCT00192647|18357860|P1|Overall Study|Failure to Return|11
5332856|NCT00192647|18357859|P2|Overall Study|Refused Treatment/Did not Cooperate|8
5332857|NCT00192647|18357860|P1|Overall Study|Refused Treatment/Did not Cooperate|10
5332858|NCT00192647|18357859|P2|Overall Study|Protocol Violation|1
5332859|NCT00192647|18357860|P1|Overall Study|Protocol Violation|3
5332860|NCT00192647|18357859|P2|Overall Study|Entry Criteria Violation|6
5332861|NCT00192647|18357860|P1|Overall Study|Entry Criteria Violation|6
5332862|NCT00192647|18357859|P2|Overall Study|Insufficient Therapeutic Response|83
5332863|NCT00192647|18357860|P1|Overall Study|Insufficient Therapeutic Response|53
5332864|NCT00192647|18357859|P2|Overall Study|Laboratory Test Abnormality|2
5332865|NCT00192647|18357860|P1|Overall Study|Laboratory Test Abnormality|4
5332866|NCT00192647|18357859|P2|Overall Study|Adverse Event|29
5332867|NCT00192647|18357860|P1|Overall Study|Adverse Event|35
5332868|NCT00192647|18357859|P2|Overall Study|Death|1
5332869|NCT00192647|18357860|P1|Overall Study|Death|1
5332870|NCT00192296|18357880|P4|Overall Study|Withdrawal by Subject|0
5332871|NCT00192296|18357881|P3|Overall Study|Withdrawal by Subject|0
5332872|NCT00192296|18357882|P2|Overall Study|Withdrawal by Subject|1
5332873|NCT00192296|18357883|P1|Overall Study|Withdrawal by Subject|0
5332874|NCT00192114|18357937|P1|Overall Study|Death|1
5332875|NCT00192114|18357937|P1|Overall Study|Clinical Progression|2
5332876|NCT00192114|18357937|P1|Overall Study|Adverse Event|2
5332877|NCT00192114|18357937|P1|Overall Study|Objective Tumor Progression|19
5332878|NCT00192075|18357954|P2|Overall Study|Other|2
5332879|NCT00192075|18357955|P1|Overall Study|Other|5
5332880|NCT00192075|18357954|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
5332881|NCT00192075|18357955|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
5332882|NCT00192075|18357954|P2|Overall Study|Patient Non-Compliance|1
5332883|NCT00192075|18357955|P1|Overall Study|Patient Non-Compliance|0
5332884|NCT00192075|18357954|P2|Overall Study|Withdrawal by Subject|5
5332885|NCT00192075|18357955|P1|Overall Study|Withdrawal by Subject|5
5332886|NCT00192075|18357954|P2|Overall Study|Physician Decision|0
5332887|NCT00192075|18357955|P1|Overall Study|Physician Decision|3
5332888|NCT00192075|18357954|P2|Overall Study|Lack of Efficacy|0
5332889|NCT00192075|18357955|P1|Overall Study|Lack of Efficacy|0
5332890|NCT00192075|18357954|P2|Overall Study|Death|1
5332891|NCT00192075|18357955|P1|Overall Study|Death|0
5332892|NCT00192075|18357954|P2|Overall Study|Adverse Event|3
5332893|NCT00192075|18357955|P1|Overall Study|Adverse Event|1
5332894|NCT00192075|18357954|P2|Overall Study|Disease Progression|6
5332895|NCT00192075|18357955|P1|Overall Study|Disease Progression|23
5332896|NCT00192036|18357980|P1|Overall Study|Unknown or Not Specified|5
5332897|NCT00192036|18357980|P1|Overall Study|Death|1
5332898|NCT00192036|18357980|P1|Overall Study|Clinical Disease Progression|1
5332899|NCT00192036|18357980|P1|Overall Study|Objective Tumor Progression|4
5332900|NCT00192036|18357980|P1|Overall Study|Patient/Physician Perception|1
5332901|NCT00192036|18357980|P1|Overall Study|Adverse Event|6
5332902|NCT00192036|18357980|P1|Overall Study|Protocol Violation|3
5332903|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Physician Decision|0
5332904|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Physician Decision|9
5332905|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
5332906|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
5332907|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Protocol Violation|0
5332908|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Protocol Violation|1
5332909|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
5332910|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
5332911|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
5332912|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
5332913|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
5332914|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
5332915|NCT00192023|18357990|P2|Period IV - Optional Open-Label|Adverse Event|0
5332916|NCT00192023|18357991|P1|Period IV - Optional Open-Label|Adverse Event|6
5332917|NCT00192023|18357990|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
5332918|NCT00192023|18357991|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
5332919|NCT00192023|18357990|P2|Period III - Double-Blind|Physician Decision|0
5332920|NCT00192023|18357991|P1|Period III - Double-Blind|Physician Decision|2
5332921|NCT00192023|18357990|P2|Period III - Double-Blind|Adverse Event|0
5332922|NCT00192023|18357991|P1|Period III - Double-Blind|Adverse Event|3
5332923|NCT00191984|18358013|P1|Overall Study|Physician Decision|4
5332924|NCT00191984|18358013|P1|Overall Study|Withdrawal by Subject|7
5332925|NCT00191984|18358013|P1|Overall Study|Entry Criteria Exclusion|1
5332926|NCT00191984|18358013|P1|Overall Study|Death|2
5332927|NCT00191984|18358013|P1|Overall Study|Adverse Event|4
5332928|NCT00191984|18358013|P1|Overall Study|Disease Progression|21
5332929|NCT00191945|18358023|P2|Double-Blind Acute Treatment|Physician Decision|2
5332930|NCT00191945|18358024|P1|Double-Blind Acute Treatment|Physician Decision|0
5332931|NCT00191945|18358023|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
5332932|NCT00191945|18358024|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
5332933|NCT00191945|18358023|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
5332934|NCT00191945|18358024|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
5332935|NCT00191945|18358023|P2|Double-Blind Acute Treatment|Parent's Decision|0
5332936|NCT00191945|18358024|P1|Double-Blind Acute Treatment|Parent's Decision|3
5332937|NCT00191906|18358060|P4|Study Period III|Lack of Efficacy|0
5332938|NCT00191906|18358061|P3|Study Period III|Lack of Efficacy|0
5332939|NCT00191906|18358062|P2|Study Period III|Lack of Efficacy|3
5332940|NCT00191906|18358063|P1|Study Period III|Lack of Efficacy|3
5332941|NCT00191906|18358060|P4|Study Period III|Parent/Caregiver Decision|0
5332942|NCT00191906|18358061|P3|Study Period III|Parent/Caregiver Decision|0
5332943|NCT00191906|18358062|P2|Study Period III|Parent/Caregiver Decision|0
5332944|NCT00191906|18358063|P1|Study Period III|Parent/Caregiver Decision|1
5332945|NCT00191906|18358060|P4|Study Period III|Lost to Follow-up|0
5332946|NCT00191906|18358061|P3|Study Period III|Lost to Follow-up|0
5332947|NCT00191906|18358062|P2|Study Period III|Lost to Follow-up|1
5332948|NCT00191906|18358063|P1|Study Period III|Lost to Follow-up|0
5332949|NCT00191906|18358060|P4|Study Period III|Adverse Event|0
5332950|NCT00191906|18358061|P3|Study Period III|Adverse Event|0
5332951|NCT00191906|18358062|P2|Study Period III|Adverse Event|0
5332952|NCT00191906|18358063|P1|Study Period III|Adverse Event|1
5332953|NCT00191906|18358060|P4|Study Period II|Entry Criteria Exclusion|0
5332954|NCT00191906|18358061|P3|Study Period II|Entry Criteria Exclusion|1
5332955|NCT00191906|18358062|P2|Study Period II|Entry Criteria Exclusion|0
5332956|NCT00191906|18358063|P1|Study Period II|Entry Criteria Exclusion|0
5332957|NCT00191906|18358060|P4|Study Period II|Parent/Caregiver Decision|0
5332958|NCT00191906|18358061|P3|Study Period II|Parent/Caregiver Decision|0
5332959|NCT00191906|18358062|P2|Study Period II|Parent/Caregiver Decision|1
5332960|NCT00191906|18358063|P1|Study Period II|Parent/Caregiver Decision|0
5332961|NCT00191906|18358060|P4|Study Period II|Withdrawal by Subject|0
5332962|NCT00191906|18358061|P3|Study Period II|Withdrawal by Subject|0
5332963|NCT00191906|18358062|P2|Study Period II|Withdrawal by Subject|3
5332964|NCT00191906|18358063|P1|Study Period II|Withdrawal by Subject|0
5332965|NCT00191906|18358060|P4|Study Period II|Adverse Event|0
5332966|NCT00191906|18358061|P3|Study Period II|Adverse Event|0
5332967|NCT00191906|18358062|P2|Study Period II|Adverse Event|1
5332968|NCT00191906|18358063|P1|Study Period II|Adverse Event|0
5332969|NCT00191854|18358106|P3|Overall Study|Screen Failure|1
5332970|NCT00191854|18358107|P2|Overall Study|Screen Failure|0
5332971|NCT00191854|18358108|P1|Overall Study|Screen Failure|0
5332972|NCT00191854|18358106|P3|Overall Study|Sponsor Decision|1
5332973|NCT00191854|18358107|P2|Overall Study|Sponsor Decision|0
5332974|NCT00191854|18358108|P1|Overall Study|Sponsor Decision|0
5332975|NCT00191854|18358106|P3|Overall Study|Withdrawal by Subject|3
5332976|NCT00191854|18358107|P2|Overall Study|Withdrawal by Subject|2
5332977|NCT00191854|18358108|P1|Overall Study|Withdrawal by Subject|4
5332978|NCT00191854|18358106|P3|Overall Study|Lost to Follow-up|5
5332979|NCT00191854|18358107|P2|Overall Study|Lost to Follow-up|5
5332980|NCT00191854|18358108|P1|Overall Study|Lost to Follow-up|7
5332981|NCT00191854|18358106|P3|Overall Study|Death|29
5332982|NCT00191854|18358107|P2|Overall Study|Death|23
5332983|NCT00191854|18358108|P1|Overall Study|Death|26
5332984|NCT00191815|18358128|P1|Overall Study|Withdrawal by Subject|7
5332985|NCT00191815|18358128|P1|Overall Study|Physician Decision|2
5332986|NCT00191815|18358128|P1|Overall Study|Protocol Violation|3
5332987|NCT00191815|18358128|P1|Overall Study|Death|2
5332988|NCT00191815|18358128|P1|Overall Study|Disease progression or relapse|24
5332989|NCT00191815|18358128|P1|Overall Study|Adverse Event|2
5332990|NCT00191789|18358140|P1|Overall Study|Death - Not Study-Drug Related|1
5332991|NCT00191789|18358140|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
5332992|NCT00191789|18358140|P1|Overall Study|Death - Possibly Study Drug Related|4
5332993|NCT00191789|18358140|P1|Overall Study|Withdrawal by Subject|4
5332994|NCT00191789|18358140|P1|Overall Study|Patient/Physician: Satisfactory Response|4
5332995|NCT00191789|18358140|P1|Overall Study|Patient: Satisfactory Response|5
5332996|NCT00191789|18358140|P1|Overall Study|Adverse Event|5
5332997|NCT00191724|18358157|P5|Overall Study|Withdrawal by Subject|0
5332998|NCT00191724|18358158|P4|Overall Study|Withdrawal by Subject|1
5332999|NCT00191724|18358159|P3|Overall Study|Withdrawal by Subject|0
5333000|NCT00191724|18358160|P2|Overall Study|Withdrawal by Subject|0
5333001|NCT00191724|18358161|P1|Overall Study|Withdrawal by Subject|0
5333002|NCT00191724|18358157|P5|Overall Study|Lost to Follow-up|3
5333003|NCT00191724|18358158|P4|Overall Study|Lost to Follow-up|2
5333004|NCT00191724|18358159|P3|Overall Study|Lost to Follow-up|0
5333005|NCT00191724|18358160|P2|Overall Study|Lost to Follow-up|1
5333006|NCT00191724|18358161|P1|Overall Study|Lost to Follow-up|1
5333007|NCT00191724|18358157|P5|Overall Study|Adverse Event|0
5333008|NCT00191724|18358158|P4|Overall Study|Adverse Event|0
5333009|NCT00191724|18358159|P3|Overall Study|Adverse Event|1
5333010|NCT00191724|18358160|P2|Overall Study|Adverse Event|0
5333011|NCT00191724|18358161|P1|Overall Study|Adverse Event|0
5333012|NCT00191646|18358190|P2|Overall Study|Missing Data|11
5333013|NCT00191646|18358191|P1|Overall Study|Missing Data|18
5333014|NCT00191646|18358190|P2|Overall Study|Other|34
5333015|NCT00191646|18358191|P1|Overall Study|Other|33
5333016|NCT00191646|18358190|P2|Overall Study|Death|8
5333017|NCT00191646|18358191|P1|Overall Study|Death|6
5333018|NCT00191646|18358190|P2|Overall Study|Protocol Violation|7
5333019|NCT00191646|18358191|P1|Overall Study|Protocol Violation|5
5333020|NCT00191646|18358190|P2|Overall Study|Withdrawal by Subject|39
5333021|NCT00191646|18358191|P1|Overall Study|Withdrawal by Subject|58
5333022|NCT00191646|18358190|P2|Overall Study|Physician Decision|11
5333023|NCT00191646|18358191|P1|Overall Study|Physician Decision|20
5333024|NCT00191646|18358190|P2|Overall Study|Disease Progression|6
5333025|NCT00191646|18358191|P1|Overall Study|Disease Progression|5
5333026|NCT00191646|18358190|P2|Overall Study|Toxicity|37
5333027|NCT00191646|18358191|P1|Overall Study|Toxicity|26
5333028|NCT00191477|18358211|P2|Overall Study|Discontinued Prior to Instillation|14
5333029|NCT00191477|18358212|P1|Overall Study|Discontinued Prior to Instillation|13
5333030|NCT00191477|18358211|P2|Overall Study|Pathological Specimen Lost|0
5333031|NCT00191477|18358212|P1|Overall Study|Pathological Specimen Lost|1
5333032|NCT00191477|18358211|P2|Overall Study|Not Eligible|38
5333033|NCT00191477|18358212|P1|Overall Study|Not Eligible|41
5333034|NCT00191477|18358211|P2|Overall Study|Other|0
5333035|NCT00191477|18358212|P1|Overall Study|Other|2
5333036|NCT00191477|18358211|P2|Overall Study|Withdrawal by Subject|0
5333037|NCT00191477|18358212|P1|Overall Study|Withdrawal by Subject|2
5333038|NCT00191477|18358211|P2|Overall Study|Treatment Change|0
5333039|NCT00191477|18358212|P1|Overall Study|Treatment Change|2
5333040|NCT00191477|18358211|P2|Overall Study|Protocol Violation|1
5333041|NCT00191477|18358212|P1|Overall Study|Protocol Violation|1
5333042|NCT00191477|18358211|P2|Overall Study|Lost to Follow-up|21
5333043|NCT00191477|18358212|P1|Overall Study|Lost to Follow-up|23
5333044|NCT00191477|18358211|P2|Overall Study|Death, Other Cause|6
5333045|NCT00191477|18358212|P1|Overall Study|Death, Other Cause|3
5333046|NCT00191477|18358211|P2|Overall Study|Death, Study Disease|1
5333047|NCT00191477|18358212|P1|Overall Study|Death, Study Disease|1
5333048|NCT00191477|18358211|P2|Overall Study|Tumor Recurrence|48
5333049|NCT00191477|18358212|P1|Overall Study|Tumor Recurrence|49
5333050|NCT00191451|18358231|P3|Overall Study|Reason Not Specified|3
5333051|NCT00191451|18358232|P2|Overall Study|Reason Not Specified|1
5333052|NCT00191451|18358233|P1|Overall Study|Reason Not Specified|2
5333053|NCT00191451|18358231|P3|Overall Study|Ineligible|0
5333054|NCT00191451|18358232|P2|Overall Study|Ineligible|1
5333055|NCT00191451|18358233|P1|Overall Study|Ineligible|0
5333056|NCT00191451|18358231|P3|Overall Study|Sponsor Decision|0
5333057|NCT00191451|18358232|P2|Overall Study|Sponsor Decision|0
5333058|NCT00191451|18358233|P1|Overall Study|Sponsor Decision|1
5333059|NCT00191451|18358231|P3|Overall Study|Physician Decision|6
5333060|NCT00191451|18358232|P2|Overall Study|Physician Decision|9
5333061|NCT00191451|18358233|P1|Overall Study|Physician Decision|2
5333062|NCT00191451|18358231|P3|Overall Study|Withdrawal by Subject|5
5333063|NCT00191451|18358232|P2|Overall Study|Withdrawal by Subject|3
5333064|NCT00191451|18358233|P1|Overall Study|Withdrawal by Subject|2
5333065|NCT00191386|18358253|P1|Overall Study|Lack of Efficacy|15
5333066|NCT00191386|18358253|P1|Overall Study|Physician Decision|11
5333067|NCT00191386|18358253|P1|Overall Study|Withdrawal by Subject|96
5333068|NCT00191386|18358253|P1|Overall Study|Protocol Violation|18
5333069|NCT00191386|18358253|P1|Overall Study|Entry Criteria Exclusion|3
5333070|NCT00191386|18358253|P1|Overall Study|Lost to Follow-up|1
5333071|NCT00191386|18358253|P1|Overall Study|Adverse Event|16
5333072|NCT00191334|18358260|P1|Overall Study|Withdrawal by Subject|4
5333073|NCT00191334|18358260|P1|Overall Study|Physician Decision|1
5333074|NCT00191334|18358260|P1|Overall Study|Disease Progression or Relapse|8
5333075|NCT00191334|18358260|P1|Overall Study|Adverse Event|4
5333076|NCT00191308|18358268|P1|Overall Study|Adverse Event|1
5333077|NCT00191282|18358278|P2|Overall Study|Lost to Follow-up|31
5333078|NCT00191282|18358279|P1|Overall Study|Lost to Follow-up|24
5333079|NCT00191282|18358278|P2|Overall Study|Sponsor's decision|2
5333080|NCT00191282|18358279|P1|Overall Study|Sponsor's decision|2
5333081|NCT00191282|18358278|P2|Overall Study|Severity of outcome|5
5333082|NCT00191282|18358279|P1|Overall Study|Severity of outcome|2
5333083|NCT00191282|18358278|P2|Overall Study|Protocol Violation|12
5333084|NCT00191282|18358279|P1|Overall Study|Protocol Violation|9
5333085|NCT00191282|18358278|P2|Overall Study|Protocol entry criteria not met|9
5333086|NCT00191282|18358279|P1|Overall Study|Protocol entry criteria not met|14
5333087|NCT00191282|18358278|P2|Overall Study|Physician Decision|15
5333088|NCT00191282|18358279|P1|Overall Study|Physician Decision|18
5333089|NCT00191282|18358278|P2|Overall Study|Withdrawal by Subject|44
5333090|NCT00191282|18358279|P1|Overall Study|Withdrawal by Subject|59
5333091|NCT00191282|18358278|P2|Overall Study|Patient moved|14
5333092|NCT00191282|18358279|P1|Overall Study|Patient moved|11
5333093|NCT00191282|18358278|P2|Overall Study|Noncompliance|17
5333094|NCT00191282|18358279|P1|Overall Study|Noncompliance|14
5333095|NCT00191282|18358278|P2|Overall Study|Lack of Efficacy|6
5333096|NCT00191282|18358279|P1|Overall Study|Lack of Efficacy|11
5333097|NCT00191282|18358278|P2|Overall Study|Death|51
5333098|NCT00191282|18358279|P1|Overall Study|Death|51
5333099|NCT00191282|18358278|P2|Overall Study|Adverse Event|6
5333100|NCT00191282|18358279|P1|Overall Study|Adverse Event|5
5333101|NCT00191269|18358339|P2|Overall Study|Physician Decision|3
5333102|NCT00191269|18358340|P1|Overall Study|Physician Decision|0
5333103|NCT00191269|18358339|P2|Overall Study|Pathologic Aggrevation|1
5333104|NCT00191269|18358340|P1|Overall Study|Pathologic Aggrevation|0
5333105|NCT00191269|18358339|P2|Overall Study|Withdrawal by Subject|1
5333106|NCT00191269|18358340|P1|Overall Study|Withdrawal by Subject|0
5333107|NCT00191269|18358339|P2|Overall Study|Lack of Efficacy|5
5333108|NCT00191269|18358340|P1|Overall Study|Lack of Efficacy|1
5333109|NCT00191269|18358339|P2|Overall Study|Progression of Disease|42
5333110|NCT00191269|18358340|P1|Overall Study|Progression of Disease|4
5333111|NCT00191269|18358339|P2|Overall Study|Adverse Event|4
5333112|NCT00191269|18358340|P1|Overall Study|Adverse Event|1
5333113|NCT00191269|18358339|P2|Overall Study|Protocol Violation|2
5333114|NCT00191269|18358340|P1|Overall Study|Protocol Violation|0
5333115|NCT00191191|18358356|P2|Overall Study|Good Clinical Practice Violation|1
5333116|NCT00191191|18358357|P1|Overall Study|Good Clinical Practice Violation|0
5333117|NCT00191191|18358356|P2|Overall Study|Physician Decision|2
5333118|NCT00191191|18358357|P1|Overall Study|Physician Decision|3
5333119|NCT00191191|18358356|P2|Overall Study|Lost to Follow-up|0
5333120|NCT00191191|18358357|P1|Overall Study|Lost to Follow-up|1
5333121|NCT00191191|18358356|P2|Overall Study|Family/Caregiver Decision|7
5333122|NCT00191191|18358357|P1|Overall Study|Family/Caregiver Decision|5
5333123|NCT00191191|18358356|P2|Overall Study|Toxicity After Dose Reduction|8
5333124|NCT00191191|18358357|P1|Overall Study|Toxicity After Dose Reduction|7
5333125|NCT00191191|18358356|P2|Overall Study|Progressive Disease|72
5333126|NCT00191191|18358357|P1|Overall Study|Progressive Disease|84
5333127|NCT00191191|18358356|P2|Overall Study|Adverse Event|21
5333128|NCT00191191|18358357|P1|Overall Study|Adverse Event|11
5333129|NCT00191191|18358356|P2|Overall Study|Treated with Another Systemic Agent|1
5333130|NCT00191191|18358357|P1|Overall Study|Treated with Another Systemic Agent|1
5333131|NCT00191191|18358356|P2|Overall Study|Entry Criteria Exclusion|0
5333132|NCT00191191|18358357|P1|Overall Study|Entry Criteria Exclusion|2
5333133|NCT00191165|18358373|P2|Overall Study|Participant Moved Away|1
5333134|NCT00191165|18358374|P1|Overall Study|Participant Moved Away|0
5333135|NCT00191165|18358373|P2|Overall Study|Protocol Violation|1
5333136|NCT00191165|18358374|P1|Overall Study|Protocol Violation|0
5333137|NCT00191165|18358373|P2|Overall Study|Adverse Event|0
5333138|NCT00191165|18358374|P1|Overall Study|Adverse Event|2
5333139|NCT00191152|18358386|P2|Crossover Treatment|Other|3
5333140|NCT00191152|18358387|P1|Crossover Treatment|Other|4
5333141|NCT00191152|18358386|P2|Crossover Treatment|Lost to Follow-up|1
5333142|NCT00191152|18358387|P1|Crossover Treatment|Lost to Follow-up|2
5333143|NCT00191152|18358386|P2|Crossover Treatment|Withdrawal by Subject|9
5333144|NCT00191152|18358387|P1|Crossover Treatment|Withdrawal by Subject|6
5333145|NCT00191152|18358386|P2|Crossover Treatment|Physician Decision|7
5333146|NCT00191152|18358387|P1|Crossover Treatment|Physician Decision|7
5333147|NCT00191152|18358386|P2|Crossover Treatment|Adverse Event|8
5333148|NCT00191152|18358387|P1|Crossover Treatment|Adverse Event|8
5333149|NCT00191152|18358386|P2|Initial Treatment|Other|21
5333150|NCT00191152|18358387|P1|Initial Treatment|Other|18
5333151|NCT00191152|18358386|P2|Initial Treatment|Lost to Follow-up|6
5333152|NCT00191152|18358387|P1|Initial Treatment|Lost to Follow-up|0
5333153|NCT00191152|18358386|P2|Initial Treatment|Withdrawal by Subject|28
5333154|NCT00191152|18358387|P1|Initial Treatment|Withdrawal by Subject|40
5333155|NCT00191152|18358386|P2|Initial Treatment|Physician Decision|31
5333156|NCT00191152|18358387|P1|Initial Treatment|Physician Decision|40
5333157|NCT00191152|18358386|P2|Initial Treatment|Adverse Event|67
5333158|NCT00191152|18358387|P1|Initial Treatment|Adverse Event|43
5333159|NCT00191139|18358419|P2|Overall Study|Other|2
5333160|NCT00191139|18358420|P1|Overall Study|Other|1
5333161|NCT00191139|18358419|P2|Overall Study|Disease Progression|1
5333162|NCT00191139|18358420|P1|Overall Study|Disease Progression|0
5333163|NCT00191139|18358419|P2|Overall Study|Withdrawal by Subject|3
5333164|NCT00191139|18358420|P1|Overall Study|Withdrawal by Subject|0
5333165|NCT00191139|18358419|P2|Overall Study|Death|0
5333166|NCT00191139|18358420|P1|Overall Study|Death|2
5333167|NCT00191139|18358419|P2|Overall Study|Adverse Event|6
5333168|NCT00191139|18358420|P1|Overall Study|Adverse Event|2
5333169|NCT00191113|18358436|P2|Core Study|Death|0
5333170|NCT00191113|18358437|P1|Core Study|Death|1
5333171|NCT00191113|18358436|P2|Core Study|Lack of Efficacy|2
5333172|NCT00191113|18358437|P1|Core Study|Lack of Efficacy|0
5333173|NCT00191113|18358436|P2|Core Study|Adverse Event|2
5333174|NCT00191113|18358437|P1|Core Study|Adverse Event|0
5333175|NCT00191113|18358436|P2|Core Study|Lost to Follow-up|0
5333176|NCT00191113|18358437|P1|Core Study|Lost to Follow-up|3
5333177|NCT00191113|18358436|P2|Core Study|Protocol Violation|2
5333178|NCT00191113|18358437|P1|Core Study|Protocol Violation|6
5333179|NCT00191113|18358436|P2|Core Study|Withdrawal by Subject|9
5333180|NCT00191113|18358437|P1|Core Study|Withdrawal by Subject|25
5333181|NCT00191100|18358479|P2|Overall Study|Reason Not Specified|1
5333182|NCT00191100|18358480|P1|Overall Study|Reason Not Specified|0
5333183|NCT00191100|18358479|P2|Overall Study|Death from Other Cause|0
5333184|NCT00191100|18358480|P1|Overall Study|Death from Other Cause|1
5333185|NCT00191100|18358479|P2|Overall Study|Protocol Violation|1
5333186|NCT00191100|18358480|P1|Overall Study|Protocol Violation|1
5333187|NCT00191100|18358479|P2|Overall Study|Death from Study Drug Toxicity|0
5333188|NCT00191100|18358480|P1|Overall Study|Death from Study Drug Toxicity|2
5333189|NCT00191100|18358479|P2|Overall Study|Physician Decision|1
5333190|NCT00191100|18358480|P1|Overall Study|Physician Decision|3
5333191|NCT00191100|18358479|P2|Overall Study|Lack of Efficacy, Stable Disease|0
5333192|NCT00191100|18358480|P1|Overall Study|Lack of Efficacy, Stable Disease|1
5333193|NCT00191100|18358479|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
5333194|NCT00191100|18358480|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
5333195|NCT00191100|18358479|P2|Overall Study|Clinical Relapse|1
5333196|NCT00191100|18358480|P1|Overall Study|Clinical Relapse|2
5333197|NCT00191100|18358479|P2|Overall Study|Protocol Entry Criteria Not Met|1
5333198|NCT00191100|18358480|P1|Overall Study|Protocol Entry Criteria Not Met|2
5333199|NCT00191100|18358479|P2|Overall Study|Withdrawal by Subject|3
5333200|NCT00191100|18358480|P1|Overall Study|Withdrawal by Subject|9
5333201|NCT00191100|18358479|P2|Overall Study|Patient Moved|1
5333202|NCT00191100|18358480|P1|Overall Study|Patient Moved|0
5333203|NCT00191100|18358479|P2|Overall Study|Lost to Follow-up|0
5333204|NCT00191100|18358480|P1|Overall Study|Lost to Follow-up|2
5333205|NCT00191100|18358479|P2|Overall Study|Adverse Event|1
5333206|NCT00191100|18358480|P1|Overall Study|Adverse Event|18
5333207|NCT00190983|18358496|P1|Overall Study|Inevaluable (never treated)|2
5333208|NCT00190775|18358505|P2|Overall Study|Exclusion Criteria Met|3
5333209|NCT00190775|18358506|P1|Overall Study|Exclusion Criteria Met|1
5333210|NCT00190775|18358505|P2|Overall Study|Protocol Violation|1
5333211|NCT00190775|18358506|P1|Overall Study|Protocol Violation|0
5333212|NCT00190775|18358505|P2|Overall Study|Noncompliance|5
5333213|NCT00190775|18358506|P1|Overall Study|Noncompliance|3
5333214|NCT00190775|18358505|P2|Overall Study|Physician Decision|0
5333215|NCT00190775|18358506|P1|Overall Study|Physician Decision|3
5333216|NCT00190775|18358505|P2|Overall Study|Sponsor Decision|0
5333217|NCT00190775|18358506|P1|Overall Study|Sponsor Decision|1
5333218|NCT00190775|18358505|P2|Overall Study|Withdrawal by Subject|13
5333219|NCT00190775|18358506|P1|Overall Study|Withdrawal by Subject|24
5333220|NCT00190775|18358505|P2|Overall Study|Participant Moved|1
5333221|NCT00190775|18358506|P1|Overall Study|Participant Moved|0
5333222|NCT00190775|18358505|P2|Overall Study|Lost to Follow-up|23
5333223|NCT00190775|18358506|P1|Overall Study|Lost to Follow-up|31
5333224|NCT00190775|18358505|P2|Overall Study|Lack of Efficacy|32
5333225|NCT00190775|18358506|P1|Overall Study|Lack of Efficacy|28
5333226|NCT00190775|18358505|P2|Overall Study|Satisfactory Response|0
5333227|NCT00190775|18358506|P1|Overall Study|Satisfactory Response|1
5333228|NCT00190775|18358505|P2|Overall Study|Adverse Event|22
5333229|NCT00190775|18358506|P1|Overall Study|Adverse Event|57
5333230|NCT00190749|18358577|P2|Overall Study|Sponsor Decision|0
5333231|NCT00190749|18358578|P1|Overall Study|Sponsor Decision|1
5333232|NCT00190749|18358577|P2|Overall Study|Reason Not Specified|2
5333233|NCT00190749|18358578|P1|Overall Study|Reason Not Specified|0
5333234|NCT00190749|18358577|P2|Overall Study|Lack of Efficacy|3
5333235|NCT00190749|18358578|P1|Overall Study|Lack of Efficacy|2
5333236|NCT00190749|18358577|P2|Overall Study|Adverse Event|5
5333237|NCT00190749|18358578|P1|Overall Study|Adverse Event|0
5333238|NCT00190749|18358577|P2|Overall Study|Protocol Violation|4
5333239|NCT00190749|18358578|P1|Overall Study|Protocol Violation|5
5333240|NCT00190749|18358577|P2|Overall Study|Withdrawal by Subject|6
5333241|NCT00190749|18358578|P1|Overall Study|Withdrawal by Subject|10
5333242|NCT00190749|18358577|P2|Overall Study|Lost to Follow-up|11
5333243|NCT00190749|18358578|P1|Overall Study|Lost to Follow-up|8
5333244|NCT00190684|18358642|P1|Overall Study|Study Period V Completed|1
5333245|NCT00190684|18358642|P1|Overall Study|Study Period III Completed|103
5333246|NCT00190684|18358642|P1|Overall Study|Protocol Violation|123
5333247|NCT00190684|18358642|P1|Overall Study|Physician Decision|84
5333248|NCT00190684|18358642|P1|Overall Study|Sponsor's decision|17
5333249|NCT00190684|18358642|P1|Overall Study|Clinical relapse|67
5333250|NCT00190684|18358642|P1|Overall Study|Patient Decision|432
5333251|NCT00190684|18358642|P1|Overall Study|Patient moved|60
5333252|NCT00190684|18358642|P1|Overall Study|Lost to Follow-up|232
5333253|NCT00190684|18358642|P1|Overall Study|Lack of efficacy|204
5333254|NCT00190684|18358642|P1|Overall Study|Satisfactory response|80
5333255|NCT00190684|18358642|P1|Overall Study|Adverse Event|86
5333256|NCT00190671|18358663|P2|Overall Study|Withdrawal by Subject|2
5333257|NCT00190671|18358664|P1|Overall Study|Withdrawal by Subject|0
5333258|NCT00190671|18358663|P2|Overall Study|Protocol Violation|1
5333259|NCT00190671|18358664|P1|Overall Study|Protocol Violation|0
5333260|NCT00190671|18358663|P2|Overall Study|Death from Other Causes|2
5333261|NCT00190671|18358664|P1|Overall Study|Death from Other Causes|0
5333262|NCT00190671|18358663|P2|Overall Study|Death from Study-Drug Toxicity|2
5333263|NCT00190671|18358664|P1|Overall Study|Death from Study-Drug Toxicity|0
5333264|NCT00190671|18358663|P2|Overall Study|Clinical Relapse|1
5333265|NCT00190671|18358664|P1|Overall Study|Clinical Relapse|0
5333266|NCT00190671|18358663|P2|Overall Study|Adverse Event|2
5333267|NCT00190671|18358664|P1|Overall Study|Adverse Event|3
5333268|NCT00190671|18358663|P2|Overall Study|Death from Study Disease|1
5333269|NCT00190671|18358664|P1|Overall Study|Death from Study Disease|1
5333270|NCT00190671|18358663|P2|Overall Study|Lack of Efficacy|24
5333271|NCT00190671|18358664|P1|Overall Study|Lack of Efficacy|19
5333272|NCT00190671|18358663|P2|Overall Study|Satisfactory Response|7
5333273|NCT00190671|18358664|P1|Overall Study|Satisfactory Response|4
5333274|NCT00189540|18358684|P2|Overall Study|Death|1
5333275|NCT00189540|18358685|P1|Overall Study|Death|4
5333276|NCT00189540|18358684|P2|Overall Study|Withdrawal by Subject|0
5333277|NCT00189540|18358685|P1|Overall Study|Withdrawal by Subject|3
5333278|NCT00189488|18358703|P2|Overall Study|Other|0
5333279|NCT00189488|18358704|P1|Overall Study|Other|1
5333280|NCT00189488|18358703|P2|Overall Study|Death|8
5333281|NCT00189488|18358704|P1|Overall Study|Death|5
5333282|NCT00189488|18358703|P2|Overall Study|Administrative Decision|2
5333283|NCT00189488|18358704|P1|Overall Study|Administrative Decision|0
5333284|NCT00189488|18358703|P2|Overall Study|Disease progression|4
5333285|NCT00189488|18358704|P1|Overall Study|Disease progression|2
5333286|NCT00189488|18358703|P2|Overall Study|Withdrawal by Subject|6
5333287|NCT00189488|18358704|P1|Overall Study|Withdrawal by Subject|2
5333288|NCT00189488|18358703|P2|Overall Study|Adverse Event|1
5333289|NCT00189488|18358704|P1|Overall Study|Adverse Event|2
5333290|NCT00189488|18358703|P2|Overall Study|Protocol deviation|1
5333291|NCT00189488|18358704|P1|Overall Study|Protocol deviation|2
5333292|NCT00189488|18358703|P2|Overall Study|Ineligibility determined|0
5333293|NCT00189488|18358704|P1|Overall Study|Ineligibility determined|1
5333294|NCT00189462|18358735|P2|Overall Study|Lost to Follow-up|20
5333295|NCT00189462|18358736|P1|Overall Study|Lost to Follow-up|18
5333296|NCT00189462|18358735|P2|Overall Study|Lack of Efficacy|1
5333297|NCT00189462|18358736|P1|Overall Study|Lack of Efficacy|5
5333298|NCT00189423|18358753|P2|Overall Study|Lost to Follow-up|10
5333299|NCT00189423|18358754|P1|Overall Study|Lost to Follow-up|10
5333300|NCT00189423|18358753|P2|Overall Study|Withdrawal by Subject|9
5333301|NCT00189423|18358754|P1|Overall Study|Withdrawal by Subject|9
5333302|NCT00189423|18358753|P2|Overall Study|Death|747
5333303|NCT00189423|18358754|P1|Overall Study|Death|746
5333304|NCT00189306|18358776|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
5333305|NCT00189306|18358776|P1|Long-Term Follow-up|Lost to Follow-up|9
5333306|NCT00189306|18358776|P1|Long-Term Follow-up|Intercurrent disease|2
5333307|NCT00189306|18358776|P1|Long-Term Follow-up|Withdrawal by Subject|1
5333308|NCT00189306|18358776|P1|Long-Term Follow-up|Death|4
5333309|NCT00189306|18358776|P1|Long-Term Follow-up|Adverse Event|2
5333310|NCT00189306|18358776|P1|Posttreatment Period|Local skin reaction/sign|1
5333311|NCT00189306|18358776|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
5333312|NCT00189306|18358776|P1|Posttreatment Period|Protocol Violation|1
5333313|NCT00189306|18358776|P1|Posttreatment Period|Target lesion excised|1
5333314|NCT00189306|18358776|P1|Posttreatment Period|Noncompliance|1
5333315|NCT00189306|18358776|P1|Posttreatment Period|Withdrawal by Subject|2
5333316|NCT00189306|18358776|P1|Posttreatment Period|Death|1
5333317|NCT00189306|18358776|P1|Treatment Period|Protocol Violation|1
5333318|NCT00189306|18358776|P1|Treatment Period|Adverse Event|2
5333319|NCT00189306|18358776|P1|Treatment Period|Withdrawal by Subject|2
5333320|NCT00189202|18358785|P1|Overall Study|Physician Decision|5
5333321|NCT00187889|18358826|P2|Overall Study|Withdrawal by Subject|4
5333322|NCT00187889|18358827|P1|Overall Study|Withdrawal by Subject|6
5333323|NCT00187486|18358869|P1|Overall Study|Protocol Violation|1
5333324|NCT00187135|18358949|P6|Visit Three|Study Discontinued|6
5333325|NCT00187135|18358950|P5|Visit Three|Study Discontinued|7
5333326|NCT00187135|18358951|P4|Visit Three|Study Discontinued|7
5333327|NCT00187135|18358952|P3|Visit Three|Study Discontinued|7
5333328|NCT00187135|18358953|P2|Visit Three|Study Discontinued|6
5333329|NCT00187135|18358954|P1|Visit Three|Study Discontinued|7
5333330|NCT00187135|18358949|P6|Visit Three|Withdrawal by Subject|0
5333331|NCT00187135|18358950|P5|Visit Three|Withdrawal by Subject|0
5333332|NCT00187135|18358951|P4|Visit Three|Withdrawal by Subject|2
5333333|NCT00187135|18358952|P3|Visit Three|Withdrawal by Subject|1
5333334|NCT00187135|18358953|P2|Visit Three|Withdrawal by Subject|1
5333335|NCT00187135|18358954|P1|Visit Three|Withdrawal by Subject|0
5333336|NCT00187135|18358949|P6|Visit Three|Death|0
5333337|NCT00187135|18358950|P5|Visit Three|Death|1
5333338|NCT00187135|18358951|P4|Visit Three|Death|0
5333339|NCT00187135|18358952|P3|Visit Three|Death|1
5333340|NCT00187135|18358953|P2|Visit Three|Death|0
5333341|NCT00187135|18358954|P1|Visit Three|Death|0
5333342|NCT00187135|18358949|P6|Visit Two|Study Discontinued|6
5333343|NCT00187135|18358950|P5|Visit Two|Study Discontinued|5
5333344|NCT00187135|18358951|P4|Visit Two|Study Discontinued|7
5333345|NCT00187135|18358952|P3|Visit Two|Study Discontinued|1
5333346|NCT00187135|18358953|P2|Visit Two|Study Discontinued|2
5333347|NCT00187135|18358954|P1|Visit Two|Study Discontinued|3
5333348|NCT00187135|18358949|P6|Visit Two|Withdrawal by Subject|1
5333349|NCT00187135|18358950|P5|Visit Two|Withdrawal by Subject|1
5333350|NCT00187135|18358951|P4|Visit Two|Withdrawal by Subject|0
5333351|NCT00187135|18358952|P3|Visit Two|Withdrawal by Subject|1
5333352|NCT00187135|18358953|P2|Visit Two|Withdrawal by Subject|1
5333353|NCT00187135|18358954|P1|Visit Two|Withdrawal by Subject|1
5333354|NCT00187135|18358949|P6|Visit Two|Physician Decision|0
5333355|NCT00187135|18358950|P5|Visit Two|Physician Decision|0
5333356|NCT00187135|18358951|P4|Visit Two|Physician Decision|0
5333357|NCT00187135|18358952|P3|Visit Two|Physician Decision|0
5333358|NCT00187135|18358953|P2|Visit Two|Physician Decision|0
5333359|NCT00187135|18358954|P1|Visit Two|Physician Decision|1
5333360|NCT00187135|18358949|P6|Visit Two|Death|1
5333361|NCT00187135|18358950|P5|Visit Two|Death|0
5333362|NCT00187135|18358951|P4|Visit Two|Death|1
5333363|NCT00187135|18358952|P3|Visit Two|Death|0
5333364|NCT00187135|18358953|P2|Visit Two|Death|0
5333365|NCT00187135|18358954|P1|Visit Two|Death|0
5333366|NCT00187135|18358949|P6|Visit One|Physician Decision|1
5333367|NCT00187135|18358950|P5|Visit One|Physician Decision|0
5333368|NCT00187135|18358951|P4|Visit One|Physician Decision|0
5333369|NCT00187135|18358952|P3|Visit One|Physician Decision|0
5333370|NCT00187135|18358953|P2|Visit One|Physician Decision|1
5333371|NCT00187135|18358954|P1|Visit One|Physician Decision|3
5333372|NCT00187135|18358949|P6|Visit One|Withdrawal by Subject|1
5333373|NCT00187135|18358950|P5|Visit One|Withdrawal by Subject|0
5333374|NCT00187135|18358951|P4|Visit One|Withdrawal by Subject|0
5333375|NCT00187135|18358952|P3|Visit One|Withdrawal by Subject|0
5333376|NCT00187135|18358953|P2|Visit One|Withdrawal by Subject|0
5333377|NCT00187135|18358954|P1|Visit One|Withdrawal by Subject|1
5333378|NCT00187096|18358977|P3|Overall Study|unacceptable toxicity|1
5333379|NCT00187096|18358978|P2|Overall Study|unacceptable toxicity|0
5333380|NCT00187096|18358979|P1|Overall Study|unacceptable toxicity|0
5333381|NCT00186901|18359017|P3|Overall Study|Bone Mineral Density > 0|149
5333382|NCT00186901|18359018|P2|Overall Study|Bone Mineral Density > 0|0
5333383|NCT00186901|18359019|P1|Overall Study|Bone Mineral Density > 0|0
5333384|NCT00186901|18359017|P3|Overall Study|Limited adherence to study requirements|0
5333385|NCT00186901|18359018|P2|Overall Study|Limited adherence to study requirements|23
5333386|NCT00186901|18359019|P1|Overall Study|Limited adherence to study requirements|20
5333387|NCT00186901|18359017|P3|Overall Study|Open label|0
5333388|NCT00186901|18359018|P2|Overall Study|Open label|2
5333389|NCT00186901|18359019|P1|Overall Study|Open label|3
5333390|NCT00186901|18359017|P3|Overall Study|Withdrawal by Subject|0
5333391|NCT00186901|18359018|P2|Overall Study|Withdrawal by Subject|5
5333392|NCT00186901|18359019|P1|Overall Study|Withdrawal by Subject|4
5333393|NCT00186901|18359017|P3|Overall Study|ALL relapse or second malignancy|0
5333394|NCT00186901|18359018|P2|Overall Study|ALL relapse or second malignancy|2
5333395|NCT00186901|18359019|P1|Overall Study|ALL relapse or second malignancy|1
5333396|NCT00186901|18359017|P3|Overall Study|Bone Mineral Density dropped > 5%|0
5333397|NCT00186901|18359018|P2|Overall Study|Bone Mineral Density dropped > 5%|7
5333398|NCT00186901|18359019|P1|Overall Study|Bone Mineral Density dropped > 5%|9
5333399|NCT00186901|18359017|P3|Overall Study|Lost to Follow-up|0
5333400|NCT00186901|18359018|P2|Overall Study|Lost to Follow-up|3
5333401|NCT00186901|18359019|P1|Overall Study|Lost to Follow-up|6
5333402|NCT00186901|18359017|P3|Overall Study|Pregnancy|0
5333403|NCT00186901|18359018|P2|Overall Study|Pregnancy|3
5333404|NCT00186901|18359019|P1|Overall Study|Pregnancy|6
5333405|NCT00186888|18359059|P3|Overall Study|Relapse or progression of disease|0
5333406|NCT00186888|18359060|P2|Overall Study|Relapse or progression of disease|2
5333407|NCT00186888|18359061|P1|Overall Study|Relapse or progression of disease|4
5333408|NCT00186888|18359059|P3|Overall Study|Toxicity|0
5333409|NCT00186888|18359060|P2|Overall Study|Toxicity|1
5333410|NCT00186888|18359061|P1|Overall Study|Toxicity|0
5333411|NCT00186628|18359153|P1|Overall Study|Withdrawal by subject (before treatment)|1
5333412|NCT00186628|18359153|P1|Overall Study|Death|2
5333413|NCT00186537|18359164|P3|Overall Study|ALT > 1.5 x ULN|0
5333414|NCT00186537|18359165|P2|Overall Study|ALT > 1.5 x ULN|0
5333415|NCT00186537|18359166|P1|Overall Study|ALT > 1.5 x ULN|3
5333416|NCT00186537|18359164|P3|Overall Study|Withdrawal by Subject|3
5333417|NCT00186537|18359165|P2|Overall Study|Withdrawal by Subject|0
5333418|NCT00186537|18359166|P1|Overall Study|Withdrawal by Subject|4
5333419|NCT00186485|18359189|P1|Overall Study|Lost to Follow-up|3
5333420|NCT00186186|18359201|P1|Overall Study|Not reported as to reason|2
5333421|NCT00186186|18359201|P1|Overall Study|Withdrawal by Subject|3
5333422|NCT00186186|18359201|P1|Overall Study|Lack of Efficacy|3
5333423|NCT00186121|18359206|P1|Overall Study|Not eligible (no treatment)|1
5333424|NCT00186121|18359206|P1|Overall Study|Underwent oophorectomy (no treatment)|1
5333425|NCT00186121|18359206|P1|Overall Study|Subject withdrawal (no treatment)|1
5333426|NCT00186043|18359240|P2|Overall Study|Protocol Violation|1
5333427|NCT00186043|18359241|P1|Overall Study|Protocol Violation|2
5333428|NCT00186043|18359240|P2|Overall Study|Adverse Event|3
5333429|NCT00186043|18359241|P1|Overall Study|Adverse Event|7
5333430|NCT00186043|18359240|P2|Overall Study|Withdrawal by Subject|0
5333431|NCT00186043|18359241|P1|Overall Study|Withdrawal by Subject|1
5333432|NCT00186043|18359240|P2|Overall Study|Lost to Follow-up|6
5333433|NCT00186043|18359241|P1|Overall Study|Lost to Follow-up|4
5333434|NCT00186043|18359240|P2|Overall Study|Lack of Efficacy|3
5333435|NCT00186043|18359241|P1|Overall Study|Lack of Efficacy|1
5333436|NCT00185965|18359268|P2|Overall Study|Adverse Event|1
5333437|NCT00185965|18359269|P1|Overall Study|Adverse Event|0
5333438|NCT00185731|18359294|P1|Overall Study|Not Eligible|1
5333439|NCT00185731|18359294|P1|Overall Study|Withdrawal by Subject|1
5333440|NCT00185640|18359311|P1|Overall Study|Death|138
5333441|NCT00185640|18359311|P1|Overall Study|Withdrawal by Subject|3
5333442|NCT00185640|18359311|P1|Overall Study|Not Eligible|4
5333443|NCT00185614|18359320|P1|Inter-treatment Period|Lack of allogenic donor|1
5333444|NCT00185614|18359320|P1|Inter-treatment Period|Relapse|2
5333445|NCT00185614|18359320|P1|Inter-treatment Period|Physician Decision|1
5333446|NCT00185588|18359332|P4|Overall Study|Physician Decision|0
5333447|NCT00185588|18359333|P3|Overall Study|Physician Decision|1
5333448|NCT00185588|18359334|P2|Overall Study|Physician Decision|0
5333449|NCT00185588|18359335|P1|Overall Study|Physician Decision|0
5333450|NCT00185588|18359332|P4|Overall Study|Withdrawal by Subject|0
5333451|NCT00185588|18359333|P3|Overall Study|Withdrawal by Subject|0
5333452|NCT00185588|18359334|P2|Overall Study|Withdrawal by Subject|1
5333453|NCT00185588|18359335|P1|Overall Study|Withdrawal by Subject|0
5333454|NCT00185588|18359332|P4|Overall Study|Lost to Follow-up|2
5333455|NCT00185588|18359333|P3|Overall Study|Lost to Follow-up|1
5333456|NCT00185588|18359334|P2|Overall Study|Lost to Follow-up|0
5333457|NCT00185588|18359335|P1|Overall Study|Lost to Follow-up|0
5333458|NCT00185588|18359332|P4|Overall Study|Adverse Event|2
5333459|NCT00185588|18359333|P3|Overall Study|Adverse Event|4
5333460|NCT00185588|18359334|P2|Overall Study|Adverse Event|1
5333461|NCT00185588|18359335|P1|Overall Study|Adverse Event|3
5333462|NCT00185458|18359349|P1|HRT Phase|Withdrawal by Subject|3
5333463|NCT00185458|18359349|P1|HRT Phase|Protocol Violation|2
5333464|NCT00185458|18359349|P1|HRT Phase|Lost to Follow-up|4
5333465|NCT00185458|18359349|P1|HRT Phase|Adverse Event|18
5333466|NCT00185458|18359349|P1|Contraception Phase|Withdrawal by Subject|7
5333467|NCT00185458|18359349|P1|Contraception Phase|Physician Decision|2
5333468|NCT00185458|18359349|P1|Contraception Phase|Protocol Violation|2
5333469|NCT00185458|18359349|P1|Contraception Phase|Lost to Follow-up|10
5333470|NCT00185458|18359349|P1|Contraception Phase|Adverse Event|37
5333471|NCT00185380|18359412|P3|Overall Study|personal reason|1
5333472|NCT00185380|18359413|P2|Overall Study|personal reason|1
5333473|NCT00185380|18359414|P1|Overall Study|personal reason|6
5333474|NCT00185380|18359412|P3|Overall Study|Could not attend visits|4
5333475|NCT00185380|18359413|P2|Overall Study|Could not attend visits|0
5333476|NCT00185380|18359414|P1|Overall Study|Could not attend visits|2
5333477|NCT00185380|18359412|P3|Overall Study|No need for contraception|3
5333478|NCT00185380|18359413|P2|Overall Study|No need for contraception|3
5333479|NCT00185380|18359414|P1|Overall Study|No need for contraception|3
5333480|NCT00185380|18359412|P3|Overall Study|Planned pregnancy|12
5333481|NCT00185380|18359413|P2|Overall Study|Planned pregnancy|12
5333482|NCT00185380|18359414|P1|Overall Study|Planned pregnancy|9
5333483|NCT00185380|18359412|P3|Overall Study|Failed insertion|2
5333484|NCT00185380|18359413|P2|Overall Study|Failed insertion|1
5333485|NCT00185380|18359414|P1|Overall Study|Failed insertion|1
5333486|NCT00185380|18359412|P3|Overall Study|Withdrawal by Subject|0
5333487|NCT00185380|18359413|P2|Overall Study|Withdrawal by Subject|2
5333488|NCT00185380|18359414|P1|Overall Study|Withdrawal by Subject|1
5333489|NCT00185380|18359412|P3|Overall Study|Protocol Violation|1
5333490|NCT00185380|18359413|P2|Overall Study|Protocol Violation|2
5333491|NCT00185380|18359414|P1|Overall Study|Protocol Violation|2
5333492|NCT00185380|18359412|P3|Overall Study|Pregnancy|0
5333493|NCT00185380|18359413|P2|Overall Study|Pregnancy|4
5333494|NCT00185380|18359414|P1|Overall Study|Pregnancy|1
5333495|NCT00185380|18359412|P3|Overall Study|Lost to Follow-up|3
5333496|NCT00185380|18359413|P2|Overall Study|Lost to Follow-up|4
5333497|NCT00185380|18359414|P1|Overall Study|Lost to Follow-up|0
5333498|NCT00185380|18359412|P3|Overall Study|Adverse Event|48
5333499|NCT00185380|18359413|P2|Overall Study|Adverse Event|43
5333500|NCT00185380|18359414|P1|Overall Study|Adverse Event|41
5333501|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
5333502|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
5333503|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
5333504|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
5333505|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
5333506|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
5333507|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
5333508|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
5333509|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
5333510|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
5333511|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
5333512|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
5333513|NCT00185211|18359442|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
5333514|NCT00185211|18359443|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
5333515|NCT00185211|18359442|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
5333516|NCT00185211|18359443|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
5333517|NCT00185211|18359442|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
5333518|NCT00185211|18359443|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
5333519|NCT00185211|18359442|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
5333520|NCT00185211|18359443|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
5333521|NCT00185211|18359442|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
5333522|NCT00185211|18359443|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
5333523|NCT00185211|18359442|P2|Placebo-controlled Study (92012)|Adverse Event|0
5333524|NCT00185211|18359443|P1|Placebo-controlled Study (92012)|Adverse Event|8
5333525|NCT00184600|18359516|P3|Overall Study|Unclassified|3
5333526|NCT00184600|18359517|P2|Overall Study|Unclassified|5
5333527|NCT00184600|18359518|P1|Overall Study|Unclassified|4
5333528|NCT00184600|18359516|P3|Overall Study|Withdrawal by Subject|12
5333529|NCT00184600|18359517|P2|Overall Study|Withdrawal by Subject|28
5333530|NCT00184600|18359518|P1|Overall Study|Withdrawal by Subject|20
5333531|NCT00184600|18359516|P3|Overall Study|Protocol Violation|3
5333532|NCT00184600|18359517|P2|Overall Study|Protocol Violation|2
5333533|NCT00184600|18359518|P1|Overall Study|Protocol Violation|2
5333534|NCT00184600|18359516|P3|Overall Study|Lost to Follow-up|1
5333535|NCT00184600|18359517|P2|Overall Study|Lost to Follow-up|6
5333536|NCT00184600|18359518|P1|Overall Study|Lost to Follow-up|4
5333537|NCT00184600|18359516|P3|Overall Study|Lack of Efficacy|3
5333538|NCT00184600|18359517|P2|Overall Study|Lack of Efficacy|1
5333539|NCT00184600|18359518|P1|Overall Study|Lack of Efficacy|3
5333540|NCT00184600|18359516|P3|Overall Study|Death|7
5333541|NCT00184600|18359517|P2|Overall Study|Death|9
5333542|NCT00184600|18359518|P1|Overall Study|Death|3
5333543|NCT00184600|18359516|P3|Overall Study|Adverse Event|5
5333544|NCT00184600|18359517|P2|Overall Study|Adverse Event|0
5333545|NCT00184600|18359518|P1|Overall Study|Adverse Event|9
5333546|NCT00184093|18359609|P1|Overall Study|Withdrawal by Subject|2
5333547|NCT00184093|18359609|P1|Overall Study|Physician Decision|1
5333548|NCT00184093|18359609|P1|Overall Study|Lost to Follow-up|3
5333549|NCT00184093|18359609|P1|Overall Study|Adverse Event|3
5333550|NCT00184054|18359614|P1|Overall Study|Adverse Event|1
5333551|NCT00184028|18359619|P1|Overall Study|Non-compliance|2
5333552|NCT00184028|18359619|P1|Overall Study|Withdrawal by Subject|1
5333553|NCT00184028|18359619|P1|Overall Study|Adverse Event|2
5333554|NCT00184028|18359619|P1|Overall Study|Lack of Efficacy|4
5333555|NCT00184028|18359619|P1|Overall Study|Death|1
5333556|NCT00184002|18359624|P1|Overall Study|Withdrawal by Subject|4
5333557|NCT00184002|18359624|P1|Overall Study|Physician Decision|1
5333558|NCT00184002|18359624|P1|Overall Study|Death|3
5333559|NCT00184002|18359624|P1|Overall Study|Adverse Event|9
5333560|NCT00183872|18359650|P1|Overall Study|Drug delayed more than 28 days|2
5333561|NCT00183872|18359650|P1|Overall Study|Withdrawal by Subject|2
5333562|NCT00183872|18359650|P1|Overall Study|Adverse Event|9
5333563|NCT00183872|18359650|P1|Overall Study|Death|3
5333564|NCT00183625|18359679|P4|Overall Study|Withdrawal by Subject|14
5333565|NCT00183625|18359680|P3|Overall Study|Withdrawal by Subject|19
5333566|NCT00183625|18359681|P2|Overall Study|Withdrawal by Subject|18
5333567|NCT00183625|18359682|P1|Overall Study|Withdrawal by Subject|18
5333568|NCT00183430|18359779|P2|Overall Study|Withdrawal by Subject|0
5333569|NCT00183430|18359780|P1|Overall Study|Withdrawal by Subject|1
5333570|NCT00183430|18359779|P2|Overall Study|did not meet inclusion criteria|0
5333571|NCT00183430|18359780|P1|Overall Study|did not meet inclusion criteria|1
5333572|NCT00183430|18359779|P2|Overall Study|Lost to Follow-up|0
5333573|NCT00183430|18359780|P1|Overall Study|Lost to Follow-up|3
5333574|NCT00183430|18359779|P2|Overall Study|Adverse Event|0
5333575|NCT00183430|18359780|P1|Overall Study|Adverse Event|1
5333576|NCT00183391|18359792|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
5333577|NCT00183391|18359793|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
5333578|NCT00183391|18359792|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
5333579|NCT00183391|18359793|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
5333580|NCT00183274|18359866|P6|Phase 3: Double-Blind|Relapsed|2
5333581|NCT00183274|18359867|P5|Phase 3: Double-Blind|Relapsed|11
5333582|NCT00183274|18359868|P4|Phase 3: Double-Blind|Relapsed|1
5333583|NCT00183274|18359869|P3|Phase 3: Double-Blind|Relapsed|0
5333584|NCT00183274|18359870|P2|Phase 3: Double-Blind|Relapsed|0
5333585|NCT00183274|18359871|P1|Phase 3: Double-Blind|Relapsed|0
5333586|NCT00183274|18359866|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
5333587|NCT00183274|18359867|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
5333588|NCT00183274|18359868|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
5333589|NCT00183274|18359869|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
5333590|NCT00183274|18359870|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
5333591|NCT00183274|18359871|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
5333592|NCT00183274|18359866|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
5333593|NCT00183274|18359867|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
5333594|NCT00183274|18359868|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
5333595|NCT00183274|18359869|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
5333596|NCT00183274|18359870|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
5333597|NCT00183274|18359871|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
5333598|NCT00183274|18359866|P6|Phase 2: Double-Blind|Relapsed|0
5333599|NCT00183274|18359867|P5|Phase 2: Double-Blind|Relapsed|0
5333600|NCT00183274|18359868|P4|Phase 2: Double-Blind|Relapsed|0
5333601|NCT00183274|18359869|P3|Phase 2: Double-Blind|Relapsed|29
5333602|NCT00183274|18359870|P2|Phase 2: Double-Blind|Relapsed|8
5333603|NCT00183274|18359871|P1|Phase 2: Double-Blind|Relapsed|0
5333604|NCT00183274|18359866|P6|Phase 1: Open-Label|Other|0
5333605|NCT00183274|18359867|P5|Phase 1: Open-Label|Other|0
5333606|NCT00183274|18359868|P4|Phase 1: Open-Label|Other|0
5333607|NCT00183274|18359869|P3|Phase 1: Open-Label|Other|0
5333608|NCT00183274|18359870|P2|Phase 1: Open-Label|Other|0
5333609|NCT00183274|18359871|P1|Phase 1: Open-Label|Other|9
5333610|NCT00183274|18359866|P6|Phase 1: Open-Label|Lost to Follow-up|0
5333611|NCT00183274|18359867|P5|Phase 1: Open-Label|Lost to Follow-up|0
5333612|NCT00183274|18359868|P4|Phase 1: Open-Label|Lost to Follow-up|0
5333613|NCT00183274|18359869|P3|Phase 1: Open-Label|Lost to Follow-up|0
5333614|NCT00183274|18359870|P2|Phase 1: Open-Label|Lost to Follow-up|0
5333615|NCT00183274|18359871|P1|Phase 1: Open-Label|Lost to Follow-up|33
5333616|NCT00183274|18359866|P6|Phase 1: Open-Label|Withdrawal by Subject|0
5333617|NCT00183274|18359867|P5|Phase 1: Open-Label|Withdrawal by Subject|0
5333618|NCT00183274|18359868|P4|Phase 1: Open-Label|Withdrawal by Subject|0
5333619|NCT00183274|18359869|P3|Phase 1: Open-Label|Withdrawal by Subject|0
5333620|NCT00183274|18359870|P2|Phase 1: Open-Label|Withdrawal by Subject|0
5333621|NCT00183274|18359871|P1|Phase 1: Open-Label|Withdrawal by Subject|13
5333622|NCT00183274|18359866|P6|Phase 1: Open-Label|Protocol Violation|0
5333623|NCT00183274|18359867|P5|Phase 1: Open-Label|Protocol Violation|0
5333624|NCT00183274|18359868|P4|Phase 1: Open-Label|Protocol Violation|0
5333625|NCT00183274|18359869|P3|Phase 1: Open-Label|Protocol Violation|0
5333626|NCT00183274|18359870|P2|Phase 1: Open-Label|Protocol Violation|0
5333627|NCT00183274|18359871|P1|Phase 1: Open-Label|Protocol Violation|11
5333628|NCT00183274|18359866|P6|Phase 1: Open-Label|Lack of Efficacy|0
5333629|NCT00183274|18359867|P5|Phase 1: Open-Label|Lack of Efficacy|0
5333630|NCT00183274|18359868|P4|Phase 1: Open-Label|Lack of Efficacy|0
5333631|NCT00183274|18359869|P3|Phase 1: Open-Label|Lack of Efficacy|0
5333632|NCT00183274|18359870|P2|Phase 1: Open-Label|Lack of Efficacy|0
5333633|NCT00183274|18359871|P1|Phase 1: Open-Label|Lack of Efficacy|13
5333634|NCT00183274|18359866|P6|Phase 1: Open-Label|Adverse Event|0
5333635|NCT00183274|18359867|P5|Phase 1: Open-Label|Adverse Event|0
5333636|NCT00183274|18359868|P4|Phase 1: Open-Label|Adverse Event|0
5333637|NCT00183274|18359869|P3|Phase 1: Open-Label|Adverse Event|0
5333638|NCT00183274|18359870|P2|Phase 1: Open-Label|Adverse Event|0
5333639|NCT00183274|18359871|P1|Phase 1: Open-Label|Adverse Event|31
5333640|NCT00183248|18359888|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
5333641|NCT00183248|18359889|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
5333642|NCT00183248|18359888|P2|Overall Study|Lost to Follow-up|1
5333643|NCT00183248|18359889|P1|Overall Study|Lost to Follow-up|0
5333644|NCT00183196|18359910|P3|Overall Study|Required more intensive care|2
5333645|NCT00183196|18359911|P2|Overall Study|Required more intensive care|1
5333646|NCT00183196|18359912|P1|Overall Study|Required more intensive care|0
5333647|NCT00183196|18359910|P3|Overall Study|Legal event|1
5333648|NCT00183196|18359911|P2|Overall Study|Legal event|1
5333649|NCT00183196|18359912|P1|Overall Study|Legal event|1
5333650|NCT00183196|18359910|P3|Overall Study|Adverse Event|2
5333651|NCT00183196|18359911|P2|Overall Study|Adverse Event|2
5333652|NCT00183196|18359912|P1|Overall Study|Adverse Event|1
5333653|NCT00183196|18359910|P3|Overall Study|Withdrawal by Subject|13
5333654|NCT00183196|18359911|P2|Overall Study|Withdrawal by Subject|11
5333655|NCT00183196|18359912|P1|Overall Study|Withdrawal by Subject|18
5333656|NCT00182689|18359995|P2|Overall Study|Never received treatment|0
5333657|NCT00182689|18359996|P1|Overall Study|Never received treatment|1
5333658|NCT00182689|18359995|P2|Overall Study|Ineligible|4
5333659|NCT00182689|18359996|P1|Overall Study|Ineligible|1
5333660|NCT00182689|18359995|P2|Overall Study|not protocol specified|3
5333661|NCT00182689|18359996|P1|Overall Study|not protocol specified|0
5333662|NCT00182689|18359995|P2|Overall Study|Death|0
5333663|NCT00182689|18359996|P1|Overall Study|Death|1
5333664|NCT00182689|18359995|P2|Overall Study|Progression|29
5333665|NCT00182689|18359996|P1|Overall Study|Progression|27
5333666|NCT00182689|18359995|P2|Overall Study|Withdrawal by Subject|2
5333667|NCT00182689|18359996|P1|Overall Study|Withdrawal by Subject|2
5333668|NCT00182689|18359995|P2|Overall Study|Adverse Event|11
5333669|NCT00182689|18359996|P1|Overall Study|Adverse Event|8
5333670|NCT00182637|18360006|P1|Overall Study|Disease Progression|1
5333671|NCT00182637|18360006|P1|Overall Study|Adverse Event|2
5333672|NCT00182325|18360014|P2|Overall Study|Did not complete survey|43
5333673|NCT00182325|18360015|P1|Overall Study|Did not complete survey|22
5333674|NCT00182325|18360014|P2|Overall Study|Miscarriage|3
5333675|NCT00182325|18360015|P1|Overall Study|Miscarriage|5
5333676|NCT00182325|18360014|P2|Overall Study|Lost to Follow-up|7
5333677|NCT00182325|18360015|P1|Overall Study|Lost to Follow-up|7
5333678|NCT00182091|18360043|P4|Overall Study|Withdrawal by Subject|0
5333679|NCT00182091|18360044|P3|Overall Study|Withdrawal by Subject|0
5333680|NCT00182091|18360045|P2|Overall Study|Withdrawal by Subject|0
5333681|NCT00182091|18360046|P1|Overall Study|Withdrawal by Subject|1
5333682|NCT00182078|18360062|P2|Overall Study|Withdrawal by Subject|0
5333683|NCT00182078|18360063|P1|Overall Study|Withdrawal by Subject|1
5333684|NCT00181883|18360091|P1|Overall Study|Lost to Follow-up|1
5333685|NCT00181883|18360091|P1|Overall Study|Withdrawal by Subject|4
5333686|NCT00181883|18360091|P1|Overall Study|Treatment Limiting AEs|3
5333687|NCT00181883|18360091|P1|Overall Study|Lack of Efficacy|2
5333688|NCT00181844|18360095|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
5333689|NCT00181844|18360095|P1|Exposed to Study Medication|Withdrawal by Subject|1
5333690|NCT00181844|18360095|P1|Exposed to Study Medication|Non-compliance|2
5333691|NCT00181844|18360095|P1|Exposed to Study Medication|Lack of Efficacy|2
5333692|NCT00181844|18360095|P1|Exposed to Study Medication|Adverse Event|10
5333693|NCT00181844|18360095|P1|Signed Consent|Did not meet entrance criteria|7
5333694|NCT00181844|18360095|P1|Signed Consent|Withdrawal by Subject|5
5333695|NCT00181766|18360099|P1|Overall Study|non-compliance|2
5333696|NCT00181766|18360099|P1|Overall Study|Adverse Event|4
5333697|NCT00181766|18360099|P1|Overall Study|Lost to Follow-up|6
5333698|NCT00181155|18360173|P2|Overall Study|Withdrawal by Subject|0
5333699|NCT00181155|18360174|P1|Overall Study|Withdrawal by Subject|1
5333700|NCT00181155|18360173|P2|Overall Study|Physician Decision|0
5333701|NCT00181155|18360174|P1|Overall Study|Physician Decision|1
5333702|NCT00180713|18360184|P2|Overall Study|Adverse Event|3
5333703|NCT00180713|18360185|P1|Overall Study|Adverse Event|3
5333704|NCT00180713|18360184|P2|Overall Study|Withdrawal by Subject|0
5333705|NCT00180713|18360185|P1|Overall Study|Withdrawal by Subject|2
5333706|NCT00180479|18360249|P2|Overall Study|Informed consent not signed|1
5333707|NCT00180479|18360250|P1|Overall Study|Informed consent not signed|0
5333708|NCT00180479|18360249|P2|Overall Study|Withdrawal by Subject|3
5333709|NCT00180479|18360250|P1|Overall Study|Withdrawal by Subject|3
5333710|NCT00180479|18360249|P2|Overall Study|Lost to Follow-up|7
5333711|NCT00180479|18360250|P1|Overall Study|Lost to Follow-up|9
5333712|NCT00180479|18360249|P2|Overall Study|Death|2
5333713|NCT00180479|18360250|P1|Overall Study|Death|4
5333714|NCT00179959|18360375|P2|Overall Study|Withdrawal by Subject|2
5333715|NCT00179959|18360376|P1|Overall Study|Withdrawal by Subject|3
5333716|NCT00179959|18360375|P2|Overall Study|Lost to Follow-up|1
5333717|NCT00179959|18360376|P1|Overall Study|Lost to Follow-up|3
5333718|NCT00179673|18360382|P1|Overall Study|Other Observations and options|14
5333719|NCT00179673|18360382|P1|Overall Study|Death|4
5333720|NCT00179673|18360382|P1|Overall Study|Withdrawal by Subject|3
5333721|NCT00179673|18360382|P1|Overall Study|Lack of Efficacy|15
5333722|NCT00179673|18360382|P1|Overall Study|Adverse Event|7
5333723|NCT00179660|18360390|P1|Overall Study|Other - Unspecified|9
5333724|NCT00179660|18360390|P1|Overall Study|Death|3
5333725|NCT00179660|18360390|P1|Overall Study|Lost to Follow-up|1
5333726|NCT00179660|18360390|P1|Overall Study|Withdrawal by Subject|2
5333727|NCT00179660|18360390|P1|Overall Study|Lack of therapeutic effect|28
5333728|NCT00179660|18360390|P1|Overall Study|Adverse Event|7
5333729|NCT00179647|18360399|P1|Overall Study|Other|960
5333730|NCT00179647|18360399|P1|Overall Study|Death|94
5333731|NCT00179647|18360399|P1|Overall Study|Lost to Follow-up|4
5333732|NCT00179647|18360399|P1|Overall Study|Withdrawal by Subject|83
5333733|NCT00179647|18360399|P1|Overall Study|Lack of Efficacy|478
5333734|NCT00179647|18360399|P1|Overall Study|Adverse Event|294
5333735|NCT00179621|18360406|P4|Open-Label Period|Other|2
5333736|NCT00179621|18360407|P3|Open-Label Period|Other|1
5333737|NCT00179621|18360408|P2|Open-Label Period|Other|1
5333738|NCT00179621|18360409|P1|Open-Label Period|Other|0
5333739|NCT00179621|18360406|P4|Open-Label Period|Death|2
5333740|NCT00179621|18360407|P3|Open-Label Period|Death|1
5333741|NCT00179621|18360408|P2|Open-Label Period|Death|0
5333742|NCT00179621|18360409|P1|Open-Label Period|Death|0
5333743|NCT00179621|18360406|P4|Open-Label Period|Withdrawal by Subject|2
5333744|NCT00179621|18360407|P3|Open-Label Period|Withdrawal by Subject|2
5333745|NCT00179621|18360408|P2|Open-Label Period|Withdrawal by Subject|2
5333746|NCT00179621|18360409|P1|Open-Label Period|Withdrawal by Subject|0
5333747|NCT00179621|18360406|P4|Open-Label Period|Adverse Event|6
5333748|NCT00179621|18360407|P3|Open-Label Period|Adverse Event|5
5333749|NCT00179621|18360408|P2|Open-Label Period|Adverse Event|6
5333750|NCT00179621|18360409|P1|Open-Label Period|Adverse Event|0
5333751|NCT00179621|18360406|P4|Open-Label Period|Lack of Therapeutic Effect|31
5333752|NCT00179621|18360407|P3|Open-Label Period|Lack of Therapeutic Effect|19
5333753|NCT00179621|18360408|P2|Open-Label Period|Lack of Therapeutic Effect|19
5333754|NCT00179621|18360409|P1|Open-Label Period|Lack of Therapeutic Effect|0
5333755|NCT00179621|18360406|P4|Double-Blind Period|Other|0
5333756|NCT00179621|18360407|P3|Double-Blind Period|Other|2
5333757|NCT00179621|18360408|P2|Double-Blind Period|Other|2
5333758|NCT00179621|18360409|P1|Double-Blind Period|Other|0
5333759|NCT00179621|18360406|P4|Double-Blind Period|Protocol Violation|0
5333760|NCT00179621|18360407|P3|Double-Blind Period|Protocol Violation|0
5333761|NCT00179621|18360408|P2|Double-Blind Period|Protocol Violation|0
5333762|NCT00179621|18360409|P1|Double-Blind Period|Protocol Violation|1
5333763|NCT00179621|18360406|P4|Double-Blind Period|Death|0
5333764|NCT00179621|18360407|P3|Double-Blind Period|Death|2
5333765|NCT00179621|18360408|P2|Double-Blind Period|Death|1
5333766|NCT00179621|18360409|P1|Double-Blind Period|Death|0
5333767|NCT00179621|18360406|P4|Double-Blind Period|Withdrawal by Subject|0
5333768|NCT00179621|18360407|P3|Double-Blind Period|Withdrawal by Subject|3
5333769|NCT00179621|18360408|P2|Double-Blind Period|Withdrawal by Subject|1
5333770|NCT00179621|18360409|P1|Double-Blind Period|Withdrawal by Subject|2
5333771|NCT00179621|18360406|P4|Double-Blind Period|Adverse Event|0
5333772|NCT00179621|18360407|P3|Double-Blind Period|Adverse Event|4
5333773|NCT00179621|18360408|P2|Double-Blind Period|Adverse Event|7
5333774|NCT00179621|18360409|P1|Double-Blind Period|Adverse Event|2
5333775|NCT00179621|18360406|P4|Double-Blind Period|Lack of Therapeutic Effect|0
5333776|NCT00179621|18360407|P3|Double-Blind Period|Lack of Therapeutic Effect|19
5333777|NCT00179621|18360408|P2|Double-Blind Period|Lack of Therapeutic Effect|35
5333778|NCT00179621|18360409|P1|Double-Blind Period|Lack of Therapeutic Effect|59
5333779|NCT00179517|18360462|P2|Overall Study|Withdrawal by Subject|1
5333780|NCT00179517|18360463|P1|Overall Study|Withdrawal by Subject|2
5333781|NCT00179413|18360501|P2|Overall Study|Withdrawal by Subject|95
5333782|NCT00179413|18360502|P1|Overall Study|Withdrawal by Subject|87
5333783|NCT00179413|18360501|P2|Overall Study|Adverse Event|20
5333784|NCT00179413|18360502|P1|Overall Study|Adverse Event|38
5333785|NCT00179309|18360514|P2|Treatment|Allergy|0
5333786|NCT00179309|18360515|P1|Treatment|Allergy|1
5333787|NCT00179309|18360514|P2|Treatment|Withdrawal by Subject|2
5333788|NCT00179309|18360515|P1|Treatment|Withdrawal by Subject|1
5333789|NCT00179309|18360514|P2|Treatment|Toxicity|3
5333790|NCT00179309|18360515|P1|Treatment|Toxicity|2
5333791|NCT00179010|18360538|P2|Overall Study|Failure to place arterial line|1
5333792|NCT00179010|18360539|P1|Overall Study|Failure to place arterial line|0
5333793|NCT00179010|18360538|P2|Overall Study|Muscle probe defective|1
5333794|NCT00179010|18360539|P1|Overall Study|Muscle probe defective|1
5333795|NCT00178685|18360578|P3|Overall Study|Withdrawal by Subject|7
5333796|NCT00178685|18360579|P2|Overall Study|Withdrawal by Subject|14
5333797|NCT00178685|18360580|P1|Overall Study|Withdrawal by Subject|8
5333798|NCT00178685|18360578|P3|Overall Study|Lost to Follow-up|183
5333799|NCT00178685|18360579|P2|Overall Study|Lost to Follow-up|187
5333800|NCT00178685|18360580|P1|Overall Study|Lost to Follow-up|100
5333801|NCT00178685|18360578|P3|Overall Study|Death|6
5333802|NCT00178685|18360579|P2|Overall Study|Death|3
5333803|NCT00178685|18360580|P1|Overall Study|Death|3
5333804|NCT00178633|18360591|P1|Overall Study|Lost to Follow-up|6
5333805|NCT00178464|18360621|P1|Overall Study|Physician Decision|1
5333806|NCT00178464|18360621|P1|Overall Study|Withdrawal by Subject|1
5333807|NCT00178399|18360626|P1|Overall Study|Lost to Follow-up|1
5333808|NCT00178399|18360626|P1|Overall Study|Withdrawal by Subject|8
5333809|NCT00178399|18360626|P1|Overall Study|Physician Decision|4
5333810|NCT00178256|18360633|P4|Overall Study|Cancer progression|1
5333811|NCT00178256|18360634|P3|Overall Study|Cancer progression|0
5333812|NCT00178256|18360635|P2|Overall Study|Cancer progression|0
5333813|NCT00178256|18360636|P1|Overall Study|Cancer progression|2
5333814|NCT00178256|18360633|P4|Overall Study|Death|1
5333815|NCT00178256|18360634|P3|Overall Study|Death|0
5333816|NCT00178256|18360635|P2|Overall Study|Death|1
5333817|NCT00178256|18360636|P1|Overall Study|Death|0
5333818|NCT00178256|18360633|P4|Overall Study|Adverse Event|0
5333819|NCT00178256|18360634|P3|Overall Study|Adverse Event|0
5333820|NCT00178256|18360635|P2|Overall Study|Adverse Event|0
5333821|NCT00178256|18360636|P1|Overall Study|Adverse Event|2
5333822|NCT00178126|18360675|P2|Overall Study|did not receive intervention|6
5333823|NCT00178126|18360676|P1|Overall Study|did not receive intervention|4
5333824|NCT00178126|18360675|P2|Overall Study|Lost to Follow-up|21
5333825|NCT00178126|18360676|P1|Overall Study|Lost to Follow-up|21
5333826|NCT00177671|18360718|P2|Overall Study|Physician Decision|8
5333827|NCT00177671|18360719|P1|Overall Study|Physician Decision|12
5333828|NCT00177671|18360718|P2|Overall Study|Adverse Event|0
5333829|NCT00177671|18360719|P1|Overall Study|Adverse Event|6
5333830|NCT00177671|18360718|P2|Overall Study|medical complications|0
5333831|NCT00177671|18360719|P1|Overall Study|medical complications|2
5333832|NCT00177671|18360718|P2|Overall Study|Withdrawal by Subject|6
5333833|NCT00177671|18360719|P1|Overall Study|Withdrawal by Subject|5
5333834|NCT00177307|18360731|P1|Overall Study|Withdrawal by Subject|1
5333835|NCT00177294|18360740|P2|Overall Study|Withdrawal by Subject|5
5333836|NCT00177294|18360741|P1|Overall Study|Withdrawal by Subject|7
5333837|NCT00177216|18360755|P3|Overall Study|Withdrawal by Subject|1
5333838|NCT00177216|18360756|P2|Overall Study|Withdrawal by Subject|3
5333839|NCT00177216|18360757|P1|Overall Study|Withdrawal by Subject|6
5333840|NCT00177164|18360773|P2|Overall Study|Pregnancy|1
5333841|NCT00177164|18360774|P1|Overall Study|Pregnancy|0
5333842|NCT00177164|18360773|P2|Overall Study|Lack of Efficacy|1
5333843|NCT00177164|18360774|P1|Overall Study|Lack of Efficacy|2
5333844|NCT00177164|18360773|P2|Overall Study|discharge from hospital|0
5333845|NCT00177164|18360774|P1|Overall Study|discharge from hospital|1
5333846|NCT00177164|18360773|P2|Overall Study|Adverse Event|0
5333847|NCT00177164|18360774|P1|Overall Study|Adverse Event|1
5333848|NCT00177164|18360773|P2|Overall Study|increase in alcohol and drug use|2
5333849|NCT00177164|18360774|P1|Overall Study|increase in alcohol and drug use|1
5333850|NCT00177164|18360773|P2|Overall Study|Lost to Follow-up|5
5333851|NCT00177164|18360774|P1|Overall Study|Lost to Follow-up|4
5333852|NCT00177164|18360773|P2|Overall Study|Protocol Violation|7
5333853|NCT00177164|18360774|P1|Overall Study|Protocol Violation|0
5333854|NCT00176644|18360947|P1|Overall Study|Withdrawal by Subject|1
5333855|NCT00176605|18360960|P1|Overall Study|Withdrawal by Subject|2
5333856|NCT00176488|18360971|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
5333857|NCT00176462|18360979|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
5333858|NCT00176462|18360980|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
5333859|NCT00176462|18360979|P2|Intensive Continuation (8X8-week Cycles)|Death|0
5333860|NCT00176462|18360980|P1|Intensive Continuation (8X8-week Cycles)|Death|1
5333861|NCT00176462|18360979|P2|Consolidation (12 Weeks)|Not documented|1
5333862|NCT00176462|18360980|P1|Consolidation (12 Weeks)|Not documented|0
5333863|NCT00176462|18360979|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
5333864|NCT00176462|18360980|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
5333865|NCT00176462|18360979|P2|Consolidation (12 Weeks)|Adverse Event|1
5333866|NCT00176462|18360980|P1|Consolidation (12 Weeks)|Adverse Event|0
5333867|NCT00176462|18360979|P2|Consolidation (12 Weeks)|Patient moved to another state|1
5333868|NCT00176462|18360980|P1|Consolidation (12 Weeks)|Patient moved to another state|0
5333869|NCT00176462|18360979|P2|Induction (4 Weeks)|Lack of Efficacy|1
5333870|NCT00176462|18360980|P1|Induction (4 Weeks)|Lack of Efficacy|0
5333871|NCT00176462|18360979|P2|Induction (4 Weeks)|Death|2
5333872|NCT00176462|18360980|P1|Induction (4 Weeks)|Death|1
5333873|NCT00176462|18360979|P2|Induction (4 Weeks)|Withdrawal by Subject|2
5333874|NCT00176462|18360980|P1|Induction (4 Weeks)|Withdrawal by Subject|0
5333875|NCT00176254|18361000|P1|Overall Study|Lost to Follow-up|1
5333876|NCT00175916|18361028|P1|Overall Study|Patient went to prison|1
5333877|NCT00175916|18361028|P1|Overall Study|Site was closed|9
5333878|NCT00175916|18361028|P1|Overall Study|Loss of job and economic burden|1
5333879|NCT00175916|18361028|P1|Overall Study|Moved overseas|1
5333880|NCT00175916|18361028|P1|Overall Study|Treating physiciant's choice|1
5333881|NCT00175916|18361028|P1|Overall Study|Patient's request|2
5333882|NCT00175916|18361028|P1|Overall Study|Pregnancy|1
5333883|NCT00175916|18361028|P1|Overall Study|Administrative reason|1
5333884|NCT00175916|18361028|P1|Overall Study|Seizure - free|4
5333885|NCT00175916|18361028|P1|Overall Study|Withdrawal by Subject|1
5333886|NCT00175916|18361028|P1|Overall Study|Suicidal behaviour|1
5333887|NCT00175916|18361028|P1|Overall Study|Vigabatrin intake|1
5333888|NCT00175916|18361028|P1|Overall Study|Sponsor decision|17
5333889|NCT00175916|18361028|P1|Overall Study|Patient cannot record seizures|1
5333890|NCT00175916|18361028|P1|Overall Study|Lack of compliance|8
5333891|NCT00175916|18361028|P1|Overall Study|Subject Choice|98
5333892|NCT00175916|18361028|P1|Overall Study|Lost to Follow-up|17
5333893|NCT00175916|18361028|P1|Overall Study|Lack of Efficacy|354
5333894|NCT00175916|18361028|P1|Overall Study|Adverse Event|81
5333895|NCT00175916|18361028|P1|Overall Study|Death|19
5333896|NCT00175877|18361037|P1|Overall Study|Withdrawal by subject & Other|1
5333897|NCT00175877|18361037|P1|Overall Study|AE & Other|1
5333898|NCT00175877|18361037|P1|Overall Study|Other Reason|20
5333899|NCT00175877|18361037|P1|Overall Study|Protocol Violation|15
5333900|NCT00175877|18361037|P1|Overall Study|Lack of Efficacy|26
5333901|NCT00175877|18361037|P1|Overall Study|Lost to Follow-up|9
5333902|NCT00175877|18361037|P1|Overall Study|Withdrawal by Subject|141
5333903|NCT00175877|18361037|P1|Overall Study|Adverse Event|136
5333904|NCT00175825|18361072|P4|Overall Study|Withdrawal by Subject|0
5333905|NCT00175825|18361073|P3|Overall Study|Withdrawal by Subject|0
5333906|NCT00175825|18361074|P2|Overall Study|Withdrawal by Subject|0
5333907|NCT00175825|18361075|P1|Overall Study|Withdrawal by Subject|1
5333908|NCT00175825|18361072|P4|Overall Study|Lost to Follow-up|0
5333909|NCT00175825|18361073|P3|Overall Study|Lost to Follow-up|0
5333910|NCT00175825|18361074|P2|Overall Study|Lost to Follow-up|2
5333911|NCT00175825|18361075|P1|Overall Study|Lost to Follow-up|1
5333912|NCT00175825|18361072|P4|Overall Study|Adverse Event|1
5333913|NCT00175825|18361073|P3|Overall Study|Adverse Event|1
5333914|NCT00175825|18361074|P2|Overall Study|Adverse Event|2
5333915|NCT00175825|18361075|P1|Overall Study|Adverse Event|3
5333916|NCT00175019|18361128|P3|Overall Study|Reason Not Specified|11
5333917|NCT00175019|18361129|P2|Overall Study|Reason Not Specified|34
5333918|NCT00175019|18361130|P1|Overall Study|Reason Not Specified|40
5333919|NCT00175019|18361128|P3|Overall Study|Gout Flare|0
5333920|NCT00175019|18361129|P2|Overall Study|Gout Flare|3
5333921|NCT00175019|18361130|P1|Overall Study|Gout Flare|2
5333922|NCT00175019|18361128|P3|Overall Study|Therapeutic Failure|22
5333923|NCT00175019|18361129|P2|Overall Study|Therapeutic Failure|38
5333924|NCT00175019|18361130|P1|Overall Study|Therapeutic Failure|10
5333925|NCT00175019|18361128|P3|Overall Study|Personal Reason(s)|8
5333926|NCT00175019|18361129|P2|Overall Study|Personal Reason(s)|31
5333927|NCT00175019|18361130|P1|Overall Study|Personal Reason(s)|39
5333928|NCT00175019|18361128|P3|Overall Study|Did not continue under Amendment 4|2
5333929|NCT00175019|18361129|P2|Overall Study|Did not continue under Amendment 4|1
5333930|NCT00175019|18361130|P1|Overall Study|Did not continue under Amendment 4|1
5333931|NCT00175019|18361128|P3|Overall Study|Lost to Follow-up|9
5333932|NCT00175019|18361129|P2|Overall Study|Lost to Follow-up|39
5333933|NCT00175019|18361130|P1|Overall Study|Lost to Follow-up|42
5333934|NCT00175019|18361128|P3|Overall Study|Protocol Violation|3
5333935|NCT00175019|18361129|P2|Overall Study|Protocol Violation|3
5333936|NCT00175019|18361130|P1|Overall Study|Protocol Violation|6
5333937|NCT00175019|18361128|P3|Overall Study|Adverse Event|2
5333938|NCT00175019|18361129|P2|Overall Study|Adverse Event|22
5333939|NCT00175019|18361130|P1|Overall Study|Adverse Event|54
5333940|NCT00174967|18361183|P4|Overall Study|Other|0
5333941|NCT00174967|18361184|P3|Overall Study|Other|0
5333942|NCT00174967|18361185|P2|Overall Study|Other|1
5333943|NCT00174967|18361186|P1|Overall Study|Other|0
5333944|NCT00174967|18361183|P4|Overall Study|Gout Flare|1
5333945|NCT00174967|18361184|P3|Overall Study|Gout Flare|0
5333946|NCT00174967|18361185|P2|Overall Study|Gout Flare|0
5333947|NCT00174967|18361186|P1|Overall Study|Gout Flare|0
5333948|NCT00174967|18361183|P4|Overall Study|Adverse Event|1
5333949|NCT00174967|18361184|P3|Overall Study|Adverse Event|2
5333950|NCT00174967|18361185|P2|Overall Study|Adverse Event|2
5333951|NCT00174967|18361186|P1|Overall Study|Adverse Event|1
5333952|NCT00174954|18361232|P1|Overall Study|Physician Decision|1
5333953|NCT00174954|18361232|P1|Overall Study|No tophi found in MRI|1
5333954|NCT00174954|18361232|P1|Overall Study|Adverse Event|2
5333955|NCT00174941|18361240|P4|Overall Study|Reason Not Specified|9
5333956|NCT00174941|18361241|P3|Overall Study|Reason Not Specified|2
5333957|NCT00174941|18361242|P2|Overall Study|Reason Not Specified|6
5333958|NCT00174941|18361243|P1|Overall Study|Reason Not Specified|1
5333959|NCT00174941|18361240|P4|Overall Study|Gout Flare|8
5333960|NCT00174941|18361241|P3|Overall Study|Gout Flare|4
5333961|NCT00174941|18361242|P2|Overall Study|Gout Flare|4
5333962|NCT00174941|18361243|P1|Overall Study|Gout Flare|0
5333963|NCT00174941|18361240|P4|Overall Study|Personal Reason(s)|22
5333964|NCT00174941|18361241|P3|Overall Study|Personal Reason(s)|8
5333965|NCT00174941|18361242|P2|Overall Study|Personal Reason(s)|14
5333966|NCT00174941|18361243|P1|Overall Study|Personal Reason(s)|0
5333967|NCT00174941|18361240|P4|Overall Study|Lost to Follow-up|5
5333968|NCT00174941|18361241|P3|Overall Study|Lost to Follow-up|2
5333969|NCT00174941|18361242|P2|Overall Study|Lost to Follow-up|3
5333970|NCT00174941|18361243|P1|Overall Study|Lost to Follow-up|0
5333971|NCT00174941|18361240|P4|Overall Study|Protocol Violation|1
5333972|NCT00174941|18361241|P3|Overall Study|Protocol Violation|0
5333973|NCT00174941|18361242|P2|Overall Study|Protocol Violation|1
5333974|NCT00174941|18361243|P1|Overall Study|Protocol Violation|0
5333975|NCT00174941|18361240|P4|Overall Study|Adverse Event|13
5333976|NCT00174941|18361241|P3|Overall Study|Adverse Event|2
5333977|NCT00174941|18361242|P2|Overall Study|Adverse Event|10
5333978|NCT00174941|18361243|P1|Overall Study|Adverse Event|1
5333979|NCT00174915|18361318|P5|Overall Study|Therapeutic Failure|3
5333980|NCT00174915|18361319|P4|Overall Study|Therapeutic Failure|1
5333981|NCT00174915|18361320|P3|Overall Study|Therapeutic Failure|2
5333982|NCT00174915|18361321|P2|Overall Study|Therapeutic Failure|3
5333983|NCT00174915|18361322|P1|Overall Study|Therapeutic Failure|6
5333984|NCT00174915|18361318|P5|Overall Study|Protocol Violation|3
5333985|NCT00174915|18361319|P4|Overall Study|Protocol Violation|6
5333986|NCT00174915|18361320|P3|Overall Study|Protocol Violation|3
5333987|NCT00174915|18361321|P2|Overall Study|Protocol Violation|3
5333988|NCT00174915|18361322|P1|Overall Study|Protocol Violation|6
5333989|NCT00174915|18361318|P5|Overall Study|Gout Flare|0
5333990|NCT00174915|18361319|P4|Overall Study|Gout Flare|1
5333991|NCT00174915|18361320|P3|Overall Study|Gout Flare|8
5333992|NCT00174915|18361321|P2|Overall Study|Gout Flare|6
5333993|NCT00174915|18361322|P1|Overall Study|Gout Flare|13
5333994|NCT00174915|18361318|P5|Overall Study|Other|3
5333995|NCT00174915|18361319|P4|Overall Study|Other|5
5333996|NCT00174915|18361320|P3|Overall Study|Other|6
5333997|NCT00174915|18361321|P2|Overall Study|Other|8
5333998|NCT00174915|18361322|P1|Overall Study|Other|15
5333999|NCT00174915|18361318|P5|Overall Study|Personal Reason(s)|9
5334000|NCT00174915|18361319|P4|Overall Study|Personal Reason(s)|9
5334001|NCT00174915|18361320|P3|Overall Study|Personal Reason(s)|9
5334002|NCT00174915|18361321|P2|Overall Study|Personal Reason(s)|16
5334003|NCT00174915|18361322|P1|Overall Study|Personal Reason(s)|16
5334004|NCT00174915|18361318|P5|Overall Study|Adverse Event|5
5334005|NCT00174915|18361319|P4|Overall Study|Adverse Event|18
5334006|NCT00174915|18361320|P3|Overall Study|Adverse Event|11
5334007|NCT00174915|18361321|P2|Overall Study|Adverse Event|16
5334008|NCT00174915|18361322|P1|Overall Study|Adverse Event|18
5334009|NCT00174915|18361318|P5|Overall Study|Lost to Follow-up|10
5334010|NCT00174915|18361319|P4|Overall Study|Lost to Follow-up|17
5334011|NCT00174915|18361320|P3|Overall Study|Lost to Follow-up|9
5334012|NCT00174915|18361321|P2|Overall Study|Lost to Follow-up|17
5334013|NCT00174915|18361322|P1|Overall Study|Lost to Follow-up|19
5334014|NCT00174785|18361381|P2|Overall Study|Not pre-specified/Not coded|70
5334015|NCT00174785|18361382|P1|Overall Study|Not pre-specified/Not coded|56
5334016|NCT00174785|18361381|P2|Overall Study|Family request|8
5334017|NCT00174785|18361382|P1|Overall Study|Family request|6
5334018|NCT00174785|18361381|P2|Overall Study|Other prohibited medication|3
5334019|NCT00174785|18361382|P1|Overall Study|Other prohibited medication|5
5334020|NCT00174785|18361381|P2|Overall Study|Prohibited antiarrhythmic medication|88
5334021|NCT00174785|18361382|P1|Overall Study|Prohibited antiarrhythmic medication|39
5334022|NCT00174785|18361381|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
5334023|NCT00174785|18361382|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
5334024|NCT00174785|18361381|P2|Overall Study|Withdrawal by Subject|175
5334025|NCT00174785|18361382|P1|Overall Study|Withdrawal by Subject|173
5334026|NCT00174785|18361381|P2|Overall Study|Protocol Violation|14
5334027|NCT00174785|18361382|P1|Overall Study|Protocol Violation|14
5334028|NCT00174785|18361381|P2|Overall Study|Adverse Event|191
5334029|NCT00174785|18361382|P1|Overall Study|Adverse Event|293
5334030|NCT00174460|18361398|P2|Overall Study|Withdrawal by Subject|1
5334031|NCT00174460|18361399|P1|Overall Study|Withdrawal by Subject|0
5334032|NCT00174447|18361445|P1|Overall Study|Administrative reason/Other|2
5334033|NCT00174447|18361445|P1|Overall Study|Lack of Efficacy|1
5334034|NCT00174447|18361445|P1|Overall Study|Protocol Violation|1
5334035|NCT00174447|18361445|P1|Overall Study|Withdrawal by Subject|15
5334036|NCT00174447|18361445|P1|Overall Study|Adverse Event|19
5334037|NCT00174382|18361454|P1|Overall Study|Lost to Follow-up|1
5334038|NCT00174382|18361454|P1|Overall Study|Subject felt pill not effective enough|1
5334039|NCT00174382|18361454|P1|Overall Study|Arrived early for last visit in error|1
5334040|NCT00174382|18361454|P1|Overall Study|Protocol Violation|3
5334041|NCT00174382|18361454|P1|Overall Study|Withdrawal by Subject|6
5334042|NCT00174382|18361454|P1|Overall Study|Adverse Event|19
5334043|NCT00174382|18361454|P1|Overall Study|Death|2
5334044|NCT00174291|18361473|P2|Overall Study|Withdrawal by Subject|3
5334045|NCT00174291|18361474|P1|Overall Study|Withdrawal by Subject|3
5334046|NCT00174291|18361473|P2|Overall Study|Study terminated by sponsor|0
5334047|NCT00174291|18361474|P1|Overall Study|Study terminated by sponsor|1
5334048|NCT00174291|18361473|P2|Overall Study|Protocol Violation|2
5334049|NCT00174291|18361474|P1|Overall Study|Protocol Violation|0
5334050|NCT00174291|18361473|P2|Overall Study|Lost to Follow-up|1
5334051|NCT00174291|18361474|P1|Overall Study|Lost to Follow-up|1
5334052|NCT00174265|18361504|P2|Overall Study|Other (Not specified)|10
5334053|NCT00174265|18361505|P1|Overall Study|Other (Not specified)|16
5334054|NCT00174265|18361504|P2|Overall Study|Lost to Follow-up|0
5334055|NCT00174265|18361505|P1|Overall Study|Lost to Follow-up|1
5334056|NCT00174265|18361504|P2|Overall Study|Withdrawal by Subject|5
5334057|NCT00174265|18361505|P1|Overall Study|Withdrawal by Subject|3
5334058|NCT00174265|18361504|P2|Overall Study|Lack of Efficacy|2
5334059|NCT00174265|18361505|P1|Overall Study|Lack of Efficacy|2
5334060|NCT00174265|18361504|P2|Overall Study|Adverse Event|4
5334061|NCT00174265|18361505|P1|Overall Study|Adverse Event|7
5334062|NCT00174252|18361513|P1|Overall Study|Protocol Violation|2
5334063|NCT00174187|18361548|P3|Period 2 (After 3 Years)|Other|5
5334064|NCT00174187|18361549|P2|Period 2 (After 3 Years)|Other|0
5334065|NCT00174187|18361550|P1|Period 2 (After 3 Years)|Other|0
5334066|NCT00174187|18361548|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
5334067|NCT00174187|18361549|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
5334068|NCT00174187|18361550|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
5334069|NCT00174187|18361548|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
5334070|NCT00174187|18361549|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
5334071|NCT00174187|18361550|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
5334072|NCT00174187|18361548|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
5334073|NCT00174187|18361549|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
5334074|NCT00174187|18361550|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
5334075|NCT00174187|18361548|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
5334076|NCT00174187|18361549|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
5334077|NCT00174187|18361550|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
5334078|NCT00174187|18361548|P3|Period 1 (up to 3 Years)|Other|0
5334079|NCT00174187|18361549|P2|Period 1 (up to 3 Years)|Other|1
5334080|NCT00174187|18361550|P1|Period 1 (up to 3 Years)|Other|0
5334081|NCT00174187|18361548|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
5334082|NCT00174187|18361549|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
5334083|NCT00174187|18361550|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
5334084|NCT00174187|18361548|P3|Period 1 (up to 3 Years)|Non compliance|0
5334085|NCT00174187|18361549|P2|Period 1 (up to 3 Years)|Non compliance|1
5334086|NCT00174187|18361550|P1|Period 1 (up to 3 Years)|Non compliance|0
5334087|NCT00174187|18361548|P3|Period 1 (up to 3 Years)|Serious adverse event|0
5334088|NCT00174187|18361549|P2|Period 1 (up to 3 Years)|Serious adverse event|1
5334089|NCT00174187|18361550|P1|Period 1 (up to 3 Years)|Serious adverse event|0
5334090|NCT00172185|18361615|P4|Overall Study|Withdrawal by Subject|0
5334091|NCT00172185|18361616|P3|Overall Study|Withdrawal by Subject|1
5334092|NCT00172185|18361617|P2|Overall Study|Withdrawal by Subject|0
5334093|NCT00172185|18361618|P1|Overall Study|Withdrawal by Subject|0
5334094|NCT00172185|18361615|P4|Overall Study|SPONSOR Decision|0
5334095|NCT00172185|18361616|P3|Overall Study|SPONSOR Decision|0
5334096|NCT00172185|18361617|P2|Overall Study|SPONSOR Decision|1
5334097|NCT00172185|18361618|P1|Overall Study|SPONSOR Decision|0
5334098|NCT00172185|18361615|P4|Overall Study|Physician Decision|0
5334099|NCT00172185|18361616|P3|Overall Study|Physician Decision|1
5334100|NCT00172185|18361617|P2|Overall Study|Physician Decision|0
5334101|NCT00172185|18361618|P1|Overall Study|Physician Decision|0
5334102|NCT00172185|18361615|P4|Overall Study|Adverse Event|4
5334103|NCT00172185|18361616|P3|Overall Study|Adverse Event|3
5334104|NCT00172185|18361617|P2|Overall Study|Adverse Event|1
5334105|NCT00172185|18361618|P1|Overall Study|Adverse Event|0
5334106|NCT00172042|18361634|P2|Overall Study|Death|42
5334107|NCT00172042|18361635|P1|Overall Study|Death|42
5334108|NCT00172042|18361634|P2|Overall Study|Administrative problems|10
5334109|NCT00172042|18361635|P1|Overall Study|Administrative problems|13
5334110|NCT00172042|18361634|P2|Overall Study|Lost to Follow-up|5
5334111|NCT00172042|18361635|P1|Overall Study|Lost to Follow-up|3
5334112|NCT00172042|18361634|P2|Overall Study|Withdrawal by Subject|25
5334113|NCT00172042|18361635|P1|Overall Study|Withdrawal by Subject|37
5334114|NCT00172042|18361634|P2|Overall Study|Protocol Violation|7
5334115|NCT00172042|18361635|P1|Overall Study|Protocol Violation|8
5334116|NCT00172042|18361634|P2|Overall Study|Patient no longer requires study drug|8
5334117|NCT00172042|18361635|P1|Overall Study|Patient no longer requires study drug|10
5334118|NCT00172042|18361634|P2|Overall Study|Unsatisfactory therapeutic effect|11
5334119|NCT00172042|18361635|P1|Overall Study|Unsatisfactory therapeutic effect|13
5334120|NCT00172042|18361634|P2|Overall Study|Abnormal test procedure(s)|3
5334121|NCT00172042|18361635|P1|Overall Study|Abnormal test procedure(s)|0
5334122|NCT00172042|18361634|P2|Overall Study|Abnormal laboratory value(s)|1
5334123|NCT00172042|18361635|P1|Overall Study|Abnormal laboratory value(s)|5
5334124|NCT00172042|18361634|P2|Overall Study|Adverse Event|13
5334125|NCT00172042|18361635|P1|Overall Study|Adverse Event|27
5334126|NCT00171925|18361657|P2|Overall Study|Death|2
5334127|NCT00171925|18361658|P1|Overall Study|Death|1
5334128|NCT00171925|18361657|P2|Overall Study|Administrative problems|11
5334129|NCT00171925|18361658|P1|Overall Study|Administrative problems|10
5334130|NCT00171925|18361657|P2|Overall Study|Lost to Follow-up|2
5334131|NCT00171925|18361658|P1|Overall Study|Lost to Follow-up|2
5334132|NCT00171925|18361657|P2|Overall Study|Withdrawal by Subject|9
5334133|NCT00171925|18361658|P1|Overall Study|Withdrawal by Subject|6
5334134|NCT00171925|18361657|P2|Overall Study|Protocol Violation|1
5334135|NCT00171925|18361658|P1|Overall Study|Protocol Violation|1
5334136|NCT00171925|18361657|P2|Overall Study|Adverse Event|6
5334137|NCT00171925|18361658|P1|Overall Study|Adverse Event|10
5334138|NCT00171873|18361670|P2|Overall Study|Switched to Octreotide|1
5334139|NCT00171873|18361671|P1|Overall Study|Switched to Octreotide|0
5334140|NCT00171873|18361670|P2|Overall Study|Adverse Event|0
5334141|NCT00171873|18361671|P1|Overall Study|Adverse Event|5
5334142|NCT00171873|18361670|P2|Overall Study|Withdrawal by Subject|2
5334143|NCT00171873|18361671|P1|Overall Study|Withdrawal by Subject|4
5334144|NCT00171834|18361684|P7|Overall Study|Treatment Duration Completed|0
5334145|NCT00171834|18361685|P6|Overall Study|Treatment Duration Completed|1
5334146|NCT00171834|18361686|P5|Overall Study|Treatment Duration Completed|2
5334147|NCT00171834|18361687|P4|Overall Study|Treatment Duration Completed|0
5334148|NCT00171834|18361688|P3|Overall Study|Treatment Duration Completed|1
5334149|NCT00171834|18361689|P2|Overall Study|Treatment Duration Completed|0
5334150|NCT00171834|18361690|P1|Overall Study|Treatment Duration Completed|0
5334151|NCT00171834|18361684|P7|Overall Study|Disease Progression|3
5334152|NCT00171834|18361685|P6|Overall Study|Disease Progression|18
5334153|NCT00171834|18361686|P5|Overall Study|Disease Progression|2
5334154|NCT00171834|18361687|P4|Overall Study|Disease Progression|9
5334155|NCT00171834|18361688|P3|Overall Study|Disease Progression|8
5334156|NCT00171834|18361689|P2|Overall Study|Disease Progression|8
5334157|NCT00171834|18361690|P1|Overall Study|Disease Progression|4
5334158|NCT00171834|18361684|P7|Overall Study|Death from study indication|0
5334159|NCT00171834|18361685|P6|Overall Study|Death from study indication|0
5334160|NCT00171834|18361686|P5|Overall Study|Death from study indication|1
5334161|NCT00171834|18361687|P4|Overall Study|Death from study indication|0
5334162|NCT00171834|18361688|P3|Overall Study|Death from study indication|0
5334163|NCT00171834|18361689|P2|Overall Study|Death from study indication|1
5334164|NCT00171834|18361690|P1|Overall Study|Death from study indication|0
5334165|NCT00171834|18361684|P7|Overall Study|Withdrawal by Subject|0
5334166|NCT00171834|18361685|P6|Overall Study|Withdrawal by Subject|1
5334167|NCT00171834|18361686|P5|Overall Study|Withdrawal by Subject|1
5334168|NCT00171834|18361687|P4|Overall Study|Withdrawal by Subject|1
5334169|NCT00171834|18361688|P3|Overall Study|Withdrawal by Subject|0
5334170|NCT00171834|18361689|P2|Overall Study|Withdrawal by Subject|2
5334171|NCT00171834|18361690|P1|Overall Study|Withdrawal by Subject|0
5334172|NCT00171834|18361684|P7|Overall Study|Adverse Event|1
5334173|NCT00171834|18361685|P6|Overall Study|Adverse Event|15
5334174|NCT00171834|18361686|P5|Overall Study|Adverse Event|2
5334175|NCT00171834|18361687|P4|Overall Study|Adverse Event|2
5334176|NCT00171834|18361688|P3|Overall Study|Adverse Event|3
5334177|NCT00171834|18361689|P2|Overall Study|Adverse Event|1
5334178|NCT00171834|18361690|P1|Overall Study|Adverse Event|2
5334179|NCT00171704|18361730|P2|Overall Study|Protocol Violation|1
5334180|NCT00171704|18361731|P1|Overall Study|Protocol Violation|0
5334181|NCT00171704|18361730|P2|Overall Study|Withdrawal by Subject|3
5334182|NCT00171704|18361731|P1|Overall Study|Withdrawal by Subject|1
5334183|NCT00171704|18361730|P2|Overall Study|Death|2
5334184|NCT00171704|18361731|P1|Overall Study|Death|2
5334185|NCT00171704|18361730|P2|Overall Study|Administrative Problems|1
5334186|NCT00171704|18361731|P1|Overall Study|Administrative Problems|2
5334187|NCT00171704|18361730|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
5334188|NCT00171704|18361731|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
5334189|NCT00171704|18361730|P2|Overall Study|Disease Progression|9
5334190|NCT00171704|18361731|P1|Overall Study|Disease Progression|14
5334191|NCT00171704|18361730|P2|Overall Study|Adverse Event|33
5334192|NCT00171704|18361731|P1|Overall Study|Adverse Event|24
5334193|NCT00171340|18361753|P2|Overall Study|Death|6
5334194|NCT00171340|18361754|P1|Overall Study|Death|6
5334195|NCT00171340|18361753|P2|Overall Study|Administrative Problems|2
5334196|NCT00171340|18361754|P1|Overall Study|Administrative Problems|5
5334197|NCT00171340|18361753|P2|Overall Study|No Longer Required Study Drug|1
5334198|NCT00171340|18361754|P1|Overall Study|No Longer Required Study Drug|1
5334199|NCT00171340|18361753|P2|Overall Study|Abnormal Test Procedure Results|11
5334200|NCT00171340|18361754|P1|Overall Study|Abnormal Test Procedure Results|6
5334201|NCT00171340|18361753|P2|Overall Study|Abnormal Laboratory Results|0
5334202|NCT00171340|18361754|P1|Overall Study|Abnormal Laboratory Results|2
5334203|NCT00171340|18361753|P2|Overall Study|Lost to Follow-up|5
5334204|NCT00171340|18361754|P1|Overall Study|Lost to Follow-up|0
5334205|NCT00171340|18361753|P2|Overall Study|Withdrawal by Subject|19
5334206|NCT00171340|18361754|P1|Overall Study|Withdrawal by Subject|22
5334207|NCT00171340|18361753|P2|Overall Study|Protocol Violation|8
5334208|NCT00171340|18361754|P1|Overall Study|Protocol Violation|7
5334209|NCT00171340|18361753|P2|Overall Study|Lack of Efficacy|41
5334210|NCT00171340|18361754|P1|Overall Study|Lack of Efficacy|29
5334211|NCT00171340|18361753|P2|Overall Study|Adverse Event|42
5334212|NCT00171340|18361754|P1|Overall Study|Adverse Event|46
5334213|NCT00171314|18361770|P2|Overall Study|Death|1
5334214|NCT00171314|18361771|P1|Overall Study|Death|2
5334215|NCT00171314|18361770|P2|Overall Study|Lost to Follow-up|3
5334216|NCT00171314|18361771|P1|Overall Study|Lost to Follow-up|1
5334217|NCT00171314|18361770|P2|Overall Study|Administrative Problems|3
5334218|NCT00171314|18361771|P1|Overall Study|Administrative Problems|4
5334219|NCT00171314|18361770|P2|Overall Study|Protocol Violation|7
5334220|NCT00171314|18361771|P1|Overall Study|Protocol Violation|3
5334221|NCT00171314|18361770|P2|Overall Study|Abnormal Test Procedure Results|3
5334222|NCT00171314|18361771|P1|Overall Study|Abnormal Test Procedure Results|9
5334223|NCT00171314|18361770|P2|Overall Study|Withdrawal by Subject|6
5334224|NCT00171314|18361771|P1|Overall Study|Withdrawal by Subject|9
5334225|NCT00171314|18361770|P2|Overall Study|Lack of Efficacy|14
5334226|NCT00171314|18361771|P1|Overall Study|Lack of Efficacy|19
5334227|NCT00171314|18361770|P2|Overall Study|Adverse Event|41
5334228|NCT00171314|18361771|P1|Overall Study|Adverse Event|44
5334229|NCT00171301|18361787|P2|Overall Study|Withdrawal by Subject|1
5334230|NCT00171301|18361788|P1|Overall Study|Withdrawal by Subject|0
5334231|NCT00171301|18361787|P2|Overall Study|Protocol Violation|2
5334232|NCT00171301|18361788|P1|Overall Study|Protocol Violation|0
5334233|NCT00171301|18361787|P2|Overall Study|Lost to Follow-up|2
5334234|NCT00171301|18361788|P1|Overall Study|Lost to Follow-up|6
5334235|NCT00171301|18361787|P2|Overall Study|Adverse Event|2
5334236|NCT00171301|18361788|P1|Overall Study|Adverse Event|1
5334237|NCT00171301|18361787|P2|Overall Study|Death|2
5334238|NCT00171301|18361788|P1|Overall Study|Death|1
5334239|NCT00171210|18361801|P2|Overall Study|Stopped at end of extension 1|1
5334240|NCT00171210|18361802|P1|Overall Study|Stopped at end of extension 1|0
5334241|NCT00171210|18361801|P2|Overall Study|Stopped at end of core|32
5334242|NCT00171210|18361802|P1|Overall Study|Stopped at end of core|0
5334243|NCT00171210|18361801|P2|Overall Study|Death|3
5334244|NCT00171210|18361802|P1|Overall Study|Death|2
5334245|NCT00171210|18361801|P2|Overall Study|Administrative problems|1
5334246|NCT00171210|18361802|P1|Overall Study|Administrative problems|1
5334247|NCT00171210|18361801|P2|Overall Study|Lost to Follow-up|0
5334248|NCT00171210|18361802|P1|Overall Study|Lost to Follow-up|1
5334249|NCT00171210|18361801|P2|Overall Study|Withdrawal by Subject|30
5334250|NCT00171210|18361802|P1|Overall Study|Withdrawal by Subject|32
5334251|NCT00171210|18361801|P2|Overall Study|Protocol Violation|2
5334252|NCT00171210|18361802|P1|Overall Study|Protocol Violation|0
5334253|NCT00171210|18361801|P2|Overall Study|Unsatisfactory therapeutic effect|15
5334254|NCT00171210|18361802|P1|Overall Study|Unsatisfactory therapeutic effect|11
5334255|NCT00171210|18361801|P2|Overall Study|Abnormal test procedure result(s)|1
5334256|NCT00171210|18361802|P1|Overall Study|Abnormal test procedure result(s)|0
5334257|NCT00171210|18361801|P2|Overall Study|Abnormal laboratory value(s)|3
5334258|NCT00171210|18361802|P1|Overall Study|Abnormal laboratory value(s)|6
5334259|NCT00171210|18361801|P2|Overall Study|Adverse Event|27
5334260|NCT00171210|18361802|P1|Overall Study|Adverse Event|16
5334261|NCT00171054|18361832|P2|Overall Study|Condition no longer required study drug|1
5334262|NCT00171054|18361833|P1|Overall Study|Condition no longer required study drug|0
5334263|NCT00171054|18361832|P2|Overall Study|Adverse Event|8
5334264|NCT00171054|18361833|P1|Overall Study|Adverse Event|8
5334265|NCT00171054|18361832|P2|Overall Study|Lost to Follow-up|1
5334266|NCT00171054|18361833|P1|Overall Study|Lost to Follow-up|0
5334267|NCT00171054|18361832|P2|Overall Study|Patient withdrew consent|0
5334268|NCT00171054|18361833|P1|Overall Study|Patient withdrew consent|1
5334269|NCT00171054|18361832|P2|Overall Study|Protocol Violation|2
5334270|NCT00171054|18361833|P1|Overall Study|Protocol Violation|1
5334271|NCT00170950|18361865|P2|Overall Study|Termination Data Not Recorded|22
5334272|NCT00170950|18361866|P1|Overall Study|Termination Data Not Recorded|17
5334273|NCT00170950|18361865|P2|Overall Study|Missing|1
5334274|NCT00170950|18361866|P1|Overall Study|Missing|2
5334275|NCT00170950|18361865|P2|Overall Study|Lost to Follow-up|115
5334276|NCT00170950|18361866|P1|Overall Study|Lost to Follow-up|134
5334277|NCT00170950|18361865|P2|Overall Study|Withdrawal by Subject|498
5334278|NCT00170950|18361866|P1|Overall Study|Withdrawal by Subject|496
5334279|NCT00170950|18361865|P2|Overall Study|Death|274
5334280|NCT00170950|18361866|P1|Overall Study|Death|236
5334281|NCT00170846|18361879|P3|Overall Study|Reason Missing|0
5334282|NCT00170846|18361880|P2|Overall Study|Reason Missing|1
5334283|NCT00170846|18361881|P1|Overall Study|Reason Missing|0
5334284|NCT00170846|18361879|P3|Overall Study|Death|3
5334285|NCT00170846|18361880|P2|Overall Study|Death|3
5334286|NCT00170846|18361881|P1|Overall Study|Death|0
5334287|NCT00170846|18361879|P3|Overall Study|Lost to Follow-up|2
5334288|NCT00170846|18361880|P2|Overall Study|Lost to Follow-up|3
5334289|NCT00170846|18361881|P1|Overall Study|Lost to Follow-up|6
5334290|NCT00170846|18361879|P3|Overall Study|Subject withdrew Informed Consent|8
5334291|NCT00170846|18361880|P2|Overall Study|Subject withdrew Informed Consent|12
5334292|NCT00170846|18361881|P1|Overall Study|Subject withdrew Informed Consent|5
5334293|NCT00169442|18361913|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
5334294|NCT00169442|18361914|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
5334295|NCT00169442|18361915|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
5334296|NCT00169442|18361916|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
5334297|NCT00169442|18361917|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
5334298|NCT00169442|18361918|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
5334299|NCT00169442|18361913|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
5334300|NCT00169442|18361914|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
5334301|NCT00169442|18361915|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
5334302|NCT00169442|18361916|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
5334303|NCT00169442|18361917|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
5334304|NCT00169442|18361918|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
5334305|NCT00169442|18361913|P6|Overall Study|Migrated/moved from study area|2
5334306|NCT00169442|18361914|P5|Overall Study|Migrated/moved from study area|0
5334307|NCT00169442|18361915|P4|Overall Study|Migrated/moved from study area|0
5334308|NCT00169442|18361916|P3|Overall Study|Migrated/moved from study area|0
5334309|NCT00169442|18361917|P2|Overall Study|Migrated/moved from study area|0
5334310|NCT00169442|18361918|P1|Overall Study|Migrated/moved from study area|0
5334311|NCT00169442|18361913|P6|Overall Study|Withdrawal by Subject|0
5334312|NCT00169442|18361914|P5|Overall Study|Withdrawal by Subject|0
5334313|NCT00169442|18361915|P4|Overall Study|Withdrawal by Subject|0
5334314|NCT00169442|18361916|P3|Overall Study|Withdrawal by Subject|1
5334315|NCT00169442|18361917|P2|Overall Study|Withdrawal by Subject|0
5334316|NCT00169442|18361918|P1|Overall Study|Withdrawal by Subject|0
5334317|NCT00169104|18362027|P2|Overall Study|Physician Decision|1
5334318|NCT00169104|18362028|P1|Overall Study|Physician Decision|0
5334319|NCT00169104|18362027|P2|Overall Study|Protocol Violation|1
5334320|NCT00169104|18362028|P1|Overall Study|Protocol Violation|0
5334321|NCT00169104|18362027|P2|Overall Study|Withdrawal by Subject|0
5334322|NCT00169104|18362028|P1|Overall Study|Withdrawal by Subject|2
5334323|NCT00168844|18362042|P3|Overall Study|Other|9
5334324|NCT00168844|18362043|P2|Overall Study|Other|7
5334325|NCT00168844|18362044|P1|Overall Study|Other|6
5334326|NCT00168844|18362042|P3|Overall Study|Protocol Violation|4
5334327|NCT00168844|18362043|P2|Overall Study|Protocol Violation|2
5334328|NCT00168844|18362044|P1|Overall Study|Protocol Violation|2
5334329|NCT00168844|18362042|P3|Overall Study|Withdrawal by Subject|19
5334330|NCT00168844|18362043|P2|Overall Study|Withdrawal by Subject|9
5334331|NCT00168844|18362044|P1|Overall Study|Withdrawal by Subject|12
5334332|NCT00168844|18362042|P3|Overall Study|Lost to Follow-up|11
5334333|NCT00168844|18362043|P2|Overall Study|Lost to Follow-up|5
5334334|NCT00168844|18362044|P1|Overall Study|Lost to Follow-up|4
5334335|NCT00168844|18362042|P3|Overall Study|Adverse Event|48
5334336|NCT00168844|18362043|P2|Overall Study|Adverse Event|32
5334337|NCT00168844|18362044|P1|Overall Study|Adverse Event|31
5334338|NCT00168831|18362226|P3|Overall Study|Other|6
5334339|NCT00168831|18362227|P2|Overall Study|Other|3
5334340|NCT00168831|18362228|P1|Overall Study|Other|6
5334341|NCT00168831|18362226|P3|Overall Study|Protocol Violation|11
5334342|NCT00168831|18362227|P2|Overall Study|Protocol Violation|11
5334343|NCT00168831|18362228|P1|Overall Study|Protocol Violation|6
5334344|NCT00168831|18362226|P3|Overall Study|Withdrawal by Subject|19
5334345|NCT00168831|18362227|P2|Overall Study|Withdrawal by Subject|14
5334346|NCT00168831|18362228|P1|Overall Study|Withdrawal by Subject|7
5334347|NCT00168831|18362226|P3|Overall Study|Lost to Follow-up|4
5334348|NCT00168831|18362227|P2|Overall Study|Lost to Follow-up|6
5334349|NCT00168831|18362228|P1|Overall Study|Lost to Follow-up|5
5334350|NCT00168831|18362226|P3|Overall Study|Adverse Event|74
5334351|NCT00168831|18362227|P2|Overall Study|Adverse Event|47
5334352|NCT00168831|18362228|P1|Overall Study|Adverse Event|36
5334353|NCT00168818|18362410|P3|Treatment|Other|31
5334354|NCT00168818|18362411|P2|Treatment|Other|29
5334355|NCT00168818|18362412|P1|Treatment|Other|23
5334356|NCT00168818|18362410|P3|Treatment|Withdrawal by Subject|22
5334357|NCT00168818|18362411|P2|Treatment|Withdrawal by Subject|20
5334358|NCT00168818|18362412|P1|Treatment|Withdrawal by Subject|25
5334359|NCT00168818|18362410|P3|Treatment|Lost to Follow-up|1
5334360|NCT00168818|18362411|P2|Treatment|Lost to Follow-up|2
5334361|NCT00168818|18362412|P1|Treatment|Lost to Follow-up|0
5334362|NCT00168818|18362410|P3|Treatment|Protocol Violation|11
5334363|NCT00168818|18362411|P2|Treatment|Protocol Violation|11
5334364|NCT00168818|18362412|P1|Treatment|Protocol Violation|8
5334365|NCT00168818|18362410|P3|Treatment|Adverse Event|68
5334366|NCT00168818|18362411|P2|Treatment|Adverse Event|89
5334367|NCT00168818|18362412|P1|Treatment|Adverse Event|77
5334368|NCT00168818|18362410|P3|Overall Study|Other|30
5334369|NCT00168818|18362411|P2|Overall Study|Other|24
5334370|NCT00168818|18362412|P1|Overall Study|Other|22
5334371|NCT00168818|18362410|P3|Overall Study|Withdrawal by Subject|37
5334372|NCT00168818|18362411|P2|Overall Study|Withdrawal by Subject|41
5334373|NCT00168818|18362412|P1|Overall Study|Withdrawal by Subject|43
5334374|NCT00168818|18362410|P3|Overall Study|Lost to Follow-up|15
5334375|NCT00168818|18362411|P2|Overall Study|Lost to Follow-up|4
5334376|NCT00168818|18362412|P1|Overall Study|Lost to Follow-up|13
5334377|NCT00168818|18362410|P3|Overall Study|Protocol Violation|11
5334378|NCT00168818|18362411|P2|Overall Study|Protocol Violation|11
5334379|NCT00168818|18362412|P1|Overall Study|Protocol Violation|16
5334380|NCT00168818|18362410|P3|Overall Study|Adverse Event|31
5334381|NCT00168818|18362411|P2|Overall Study|Adverse Event|29
5334382|NCT00168818|18362412|P1|Overall Study|Adverse Event|23
5334383|NCT00168805|18362456|P3|Treatment|Other|17
5334384|NCT00168805|18362457|P2|Treatment|Other|18
5334385|NCT00168805|18362458|P1|Treatment|Other|18
5334386|NCT00168805|18362456|P3|Treatment|Withdrawal by Subject|8
5334387|NCT00168805|18362457|P2|Treatment|Withdrawal by Subject|7
5334388|NCT00168805|18362458|P1|Treatment|Withdrawal by Subject|3
5334389|NCT00168805|18362456|P3|Treatment|Protocol Violation|5
5334390|NCT00168805|18362457|P2|Treatment|Protocol Violation|5
5334391|NCT00168805|18362458|P1|Treatment|Protocol Violation|3
5334392|NCT00168805|18362456|P3|Treatment|Adverse Event|32
5334393|NCT00168805|18362457|P2|Treatment|Adverse Event|26
5334394|NCT00168805|18362458|P1|Treatment|Adverse Event|25
5334395|NCT00168805|18362456|P3|Overall Study|Other|22
5334396|NCT00168805|18362457|P2|Overall Study|Other|21
5334397|NCT00168805|18362458|P1|Overall Study|Other|24
5334398|NCT00168805|18362456|P3|Overall Study|Withdrawal by Subject|21
5334399|NCT00168805|18362457|P2|Overall Study|Withdrawal by Subject|18
5334400|NCT00168805|18362458|P1|Overall Study|Withdrawal by Subject|16
5334401|NCT00168805|18362456|P3|Overall Study|Lost to Follow-up|11
5334402|NCT00168805|18362457|P2|Overall Study|Lost to Follow-up|17
5334403|NCT00168805|18362458|P1|Overall Study|Lost to Follow-up|12
5334404|NCT00168805|18362456|P3|Overall Study|Protocol Violation|8
5334405|NCT00168805|18362457|P2|Overall Study|Protocol Violation|11
5334406|NCT00168805|18362458|P1|Overall Study|Protocol Violation|12
5334407|NCT00168805|18362456|P3|Overall Study|Adverse Event|16
5334408|NCT00168805|18362457|P2|Overall Study|Adverse Event|11
5334409|NCT00168805|18362458|P1|Overall Study|Adverse Event|7
5334410|NCT00168103|18362694|P4|Overall Study|Lost to Follow-up|0
5334411|NCT00168103|18362695|P3|Overall Study|Lost to Follow-up|0
5334412|NCT00168103|18362696|P2|Overall Study|Lost to Follow-up|3
5334413|NCT00168103|18362697|P1|Overall Study|Lost to Follow-up|1
5334414|NCT00168103|18362694|P4|Overall Study|Withdrawal by Subject|0
5334415|NCT00168103|18362695|P3|Overall Study|Withdrawal by Subject|1
5334416|NCT00168103|18362696|P2|Overall Study|Withdrawal by Subject|2
5334417|NCT00168103|18362697|P1|Overall Study|Withdrawal by Subject|1
5334418|NCT00168064|18362719|P2|Overall Study|Various|3
5334419|NCT00168064|18362720|P1|Overall Study|Various|4
5334420|NCT00168064|18362719|P2|Overall Study|Subject's Best interest|2
5334421|NCT00168064|18362720|P1|Overall Study|Subject's Best interest|2
5334422|NCT00168064|18362719|P2|Overall Study|Concurrent Illness|3
5334423|NCT00168064|18362720|P1|Overall Study|Concurrent Illness|4
5334424|NCT00168064|18362719|P2|Overall Study|Non-compliance|3
5334425|NCT00168064|18362720|P1|Overall Study|Non-compliance|2
5334426|NCT00168064|18362719|P2|Overall Study|Lost to Follow-up|3
5334427|NCT00168064|18362720|P1|Overall Study|Lost to Follow-up|4
5334428|NCT00168064|18362719|P2|Overall Study|Lack of Efficacy|4
5334429|NCT00168064|18362720|P1|Overall Study|Lack of Efficacy|4
5334430|NCT00168064|18362719|P2|Overall Study|Withdrawal by Subject|4
5334431|NCT00168064|18362720|P1|Overall Study|Withdrawal by Subject|3
5334432|NCT00168064|18362719|P2|Overall Study|Adverse Event|22
5334433|NCT00168064|18362720|P1|Overall Study|Adverse Event|26
5334434|NCT00168038|18362728|P1|Overall Study|Therapy failure|1
5334435|NCT00168038|18362728|P1|Overall Study|Adverse Event|1
5334436|NCT00167778|18362751|P1|Overall Study|Withdrawal by Subject|1
5334437|NCT00167414|18362830|P1|Overall Study|Death|10
5334438|NCT00167310|18362855|P2|Overall Study|Withdrawal by Subject|7
5334439|NCT00167310|18362856|P1|Overall Study|Withdrawal by Subject|3
5334440|NCT00167310|18362855|P2|Overall Study|Protocol Violation|3
5334441|NCT00167310|18362856|P1|Overall Study|Protocol Violation|5
5334442|NCT00167245|18362866|P2|Overall Study|Drowsy|0
5334443|NCT00167245|18362867|P1|Overall Study|Drowsy|1
5334444|NCT00167245|18362866|P2|Overall Study|Incarcerated|2
5334445|NCT00167245|18362867|P1|Overall Study|Incarcerated|3
5334446|NCT00167245|18362866|P2|Overall Study|Withdrawal by Subject|8
5334447|NCT00167245|18362867|P1|Overall Study|Withdrawal by Subject|5
5334448|NCT00167245|18362866|P2|Overall Study|Lost to Follow-up|31
5334449|NCT00167245|18362867|P1|Overall Study|Lost to Follow-up|20
5334450|NCT00166712|18362921|P2|Overall Study|Physician Decision|2
5334451|NCT00166712|18362922|P1|Overall Study|Physician Decision|0
5334452|NCT00166712|18362921|P2|Overall Study|Withdrawal by Subject|2
5334453|NCT00166712|18362922|P1|Overall Study|Withdrawal by Subject|1
5334454|NCT00166712|18362921|P2|Overall Study|Adverse Event|0
5334455|NCT00166712|18362922|P1|Overall Study|Adverse Event|1
5334456|NCT00166712|18362921|P2|Overall Study|Death|1
5334457|NCT00166712|18362922|P1|Overall Study|Death|0
5334458|NCT00166517|18362939|P2|Overall Study|Withdrawal by Subject|1
5334459|NCT00166517|18362940|P1|Overall Study|Withdrawal by Subject|0
5334460|NCT00166517|18362939|P2|Overall Study|Protocol Violation|1
5334461|NCT00166517|18362940|P1|Overall Study|Protocol Violation|4
5334462|NCT00166517|18362939|P2|Overall Study|Lost to Follow-up|0
5334463|NCT00166517|18362940|P1|Overall Study|Lost to Follow-up|1
5334464|NCT00166504|18362950|P2|Overall Study|Withdrawal by Subject|0
5334465|NCT00166504|18362951|P1|Overall Study|Withdrawal by Subject|1
5334466|NCT00166504|18362950|P2|Overall Study|Lost to Follow-up|1
5334467|NCT00166504|18362951|P1|Overall Study|Lost to Follow-up|1
5334468|NCT00166504|18362950|P2|Overall Study|Adverse Event|3
5334469|NCT00166504|18362951|P1|Overall Study|Adverse Event|3
5334470|NCT00166439|18362957|P1|Overall Study|Ineligible|5
5334471|NCT00166296|18362974|P2|Overall Study|Lost to Follow-up|2
5334472|NCT00166296|18362975|P1|Overall Study|Lost to Follow-up|4
5334473|NCT00166296|18362974|P2|Overall Study|Adverse Event|4
5334474|NCT00166296|18362975|P1|Overall Study|Adverse Event|2
5334475|NCT00166296|18362974|P2|Overall Study|Withdrawal by Subject|3
5334476|NCT00166296|18362975|P1|Overall Study|Withdrawal by Subject|1
5334477|NCT00166114|18363027|P2|Overall Study|Adverse Event|1
5334478|NCT00166114|18363028|P1|Overall Study|Adverse Event|2
5334479|NCT00166114|18363027|P2|Overall Study|Withdrawal by Subject|4
5334480|NCT00166114|18363028|P1|Overall Study|Withdrawal by Subject|10
5334481|NCT00166114|18363027|P2|Overall Study|Protocol Violation|1
5334482|NCT00166114|18363028|P1|Overall Study|Protocol Violation|2
5334483|NCT00165984|18363045|P1|Overall Study|Death|15
5334484|NCT00165841|18363063|P2|Overall Study|Medication Noncompliance|1
5334485|NCT00165841|18363064|P1|Overall Study|Medication Noncompliance|1
5334486|NCT00165841|18363063|P2|Overall Study|Other|5
5334487|NCT00165841|18363064|P1|Overall Study|Other|3
5334488|NCT00165841|18363063|P2|Overall Study|Protocol Violation|8
5334489|NCT00165841|18363064|P1|Overall Study|Protocol Violation|6
5334490|NCT00165841|18363063|P2|Overall Study|Physician Decision|0
5334491|NCT00165841|18363064|P1|Overall Study|Physician Decision|1
5334492|NCT00165841|18363063|P2|Overall Study|Withdrawal by Subject|8
5334493|NCT00165841|18363064|P1|Overall Study|Withdrawal by Subject|7
5334494|NCT00165841|18363063|P2|Overall Study|Lost to Follow-up|4
5334495|NCT00165841|18363064|P1|Overall Study|Lost to Follow-up|4
5334496|NCT00165841|18363063|P2|Overall Study|Lack of Efficacy|33
5334497|NCT00165841|18363064|P1|Overall Study|Lack of Efficacy|6
5334498|NCT00165841|18363063|P2|Overall Study|Adverse Event|3
5334499|NCT00165841|18363064|P1|Overall Study|Adverse Event|2
5334500|NCT00165789|18363074|P4|Overall Study|Withdrawal by Subject|2
5334501|NCT00165789|18363075|P3|Overall Study|Withdrawal by Subject|1
5334502|NCT00165789|18363076|P2|Overall Study|Withdrawal by Subject|1
5334503|NCT00165789|18363077|P1|Overall Study|Withdrawal by Subject|0
5334504|NCT00165789|18363074|P4|Overall Study|Adverse Event|12
5334505|NCT00165789|18363075|P3|Overall Study|Adverse Event|0
5334506|NCT00165789|18363076|P2|Overall Study|Adverse Event|3
5334507|NCT00165789|18363077|P1|Overall Study|Adverse Event|0
5334508|NCT00165776|18363131|P4|Overall Study|Worsening of Cervical Dystonia|1
5334509|NCT00165776|18363132|P3|Overall Study|Worsening of Cervical Dystonia|0
5334510|NCT00165776|18363133|P2|Overall Study|Worsening of Cervical Dystonia|0
5334511|NCT00165776|18363134|P1|Overall Study|Worsening of Cervical Dystonia|0
5334512|NCT00165776|18363131|P4|Overall Study|Withdrawal by Subject|0
5334513|NCT00165776|18363132|P3|Overall Study|Withdrawal by Subject|2
5334514|NCT00165776|18363133|P2|Overall Study|Withdrawal by Subject|1
5334515|NCT00165776|18363134|P1|Overall Study|Withdrawal by Subject|4
5334516|NCT00165776|18363131|P4|Overall Study|Lack of Efficacy|1
5334517|NCT00165776|18363132|P3|Overall Study|Lack of Efficacy|0
5334518|NCT00165776|18363133|P2|Overall Study|Lack of Efficacy|0
5334519|NCT00165776|18363134|P1|Overall Study|Lack of Efficacy|0
5334520|NCT00165698|18363170|P2|Overall Study|Not Taken/Lost the medicine|2
5334521|NCT00165698|18363171|P1|Overall Study|Not Taken/Lost the medicine|1
5334522|NCT00165698|18363170|P2|Overall Study|Protocol Violation|0
5334523|NCT00165698|18363171|P1|Overall Study|Protocol Violation|1
5334524|NCT00165698|18363170|P2|Overall Study|Withdrawal by Subject|1
5334525|NCT00165698|18363171|P1|Overall Study|Withdrawal by Subject|2
5334526|NCT00165698|18363170|P2|Overall Study|Lost to Follow-up|2
5334527|NCT00165698|18363171|P1|Overall Study|Lost to Follow-up|2
5334528|NCT00165698|18363170|P2|Overall Study|Adverse Event|10
5334529|NCT00165698|18363171|P1|Overall Study|Adverse Event|2
5334530|NCT00165672|18363197|P2|Overall Study|Adverse Event|1
5334531|NCT00165672|18363198|P1|Overall Study|Adverse Event|0
5334532|NCT00165646|18363207|P3|Overall Study|Protocol Violation|0
5334533|NCT00165646|18363208|P2|Overall Study|Protocol Violation|0
5334534|NCT00165646|18363209|P1|Overall Study|Protocol Violation|1
5334535|NCT00165646|18363207|P3|Overall Study|Physician Decision|2
5334536|NCT00165646|18363208|P2|Overall Study|Physician Decision|0
5334537|NCT00165646|18363209|P1|Overall Study|Physician Decision|2
5334538|NCT00165646|18363207|P3|Overall Study|Withdrawal by Subject|1
5334539|NCT00165646|18363208|P2|Overall Study|Withdrawal by Subject|2
5334540|NCT00165646|18363209|P1|Overall Study|Withdrawal by Subject|0
5334541|NCT00165646|18363207|P3|Overall Study|Lack of Efficacy|0
5334542|NCT00165646|18363208|P2|Overall Study|Lack of Efficacy|2
5334543|NCT00165646|18363209|P1|Overall Study|Lack of Efficacy|1
5334544|NCT00165646|18363207|P3|Overall Study|Adverse Event|1
5334545|NCT00165646|18363208|P2|Overall Study|Adverse Event|1
5334546|NCT00165646|18363209|P1|Overall Study|Adverse Event|1
5334547|NCT00165503|18363217|P1|Overall Study|Unresectable|3
5334548|NCT00165503|18363217|P1|Overall Study|Lost to Follow-up|12
5334549|NCT00165503|18363217|P1|Overall Study|Death|1
5334550|NCT00163657|18363224|P3|Overall Study|Other reason|3
5334551|NCT00163657|18363225|P2|Overall Study|Other reason|1
5334552|NCT00163657|18363226|P1|Overall Study|Other reason|0
5334553|NCT00163657|18363224|P3|Overall Study|Lost to Follow-up|10
5334554|NCT00163657|18363225|P2|Overall Study|Lost to Follow-up|3
5334555|NCT00163657|18363226|P1|Overall Study|Lost to Follow-up|1
5334556|NCT00163657|18363224|P3|Overall Study|Non Compliance|0
5334557|NCT00163657|18363225|P2|Overall Study|Non Compliance|0
5334558|NCT00163657|18363226|P1|Overall Study|Non Compliance|1
5334559|NCT00163657|18363224|P3|Overall Study|Physician Decision|1
5334560|NCT00163657|18363225|P2|Overall Study|Physician Decision|1
5334561|NCT00163657|18363226|P1|Overall Study|Physician Decision|0
5334562|NCT00163657|18363224|P3|Overall Study|Withdrawal by Subject|2
5334563|NCT00163657|18363225|P2|Overall Study|Withdrawal by Subject|3
5334564|NCT00163657|18363226|P1|Overall Study|Withdrawal by Subject|2
5334565|NCT00163657|18363224|P3|Overall Study|graft loss|2
5334566|NCT00163657|18363225|P2|Overall Study|graft loss|1
5334567|NCT00163657|18363226|P1|Overall Study|graft loss|4
5334568|NCT00163657|18363224|P3|Overall Study|Death|19
5334569|NCT00163657|18363225|P2|Overall Study|Death|14
5334570|NCT00163657|18363226|P1|Overall Study|Death|12
5334571|NCT00163215|18363316|P1|Overall Study|Other|7
5334572|NCT00163215|18363316|P1|Overall Study|Withdrawal by Subject|5
5334573|NCT00163215|18363316|P1|Overall Study|Lack of Efficacy|3
5334574|NCT00163189|18363336|P1|Overall Study|Did not meet continuation criterion|16
5334575|NCT00163189|18363336|P1|Overall Study|Withdrawal by Subject|11
5334576|NCT00163189|18363336|P1|Overall Study|Study terminated by sponsor|11
5334577|NCT00163189|18363336|P1|Overall Study|Lack of Efficacy|7
5334578|NCT00163189|18363336|P1|Overall Study|Adverse Event|6
5334579|NCT00163189|18363336|P1|Overall Study|Death|3
5334580|NCT00163189|18363336|P1|Overall Study|Protocol Violation|2
5334581|NCT00163189|18363336|P1|Overall Study|Lost to Follow-up|1
5334582|NCT00163189|18363336|P1|Overall Study|Other|6
5334583|NCT00163020|18363360|P2|Overall Study|Lost to Follow-up|2
5334584|NCT00163020|18363361|P1|Overall Study|Lost to Follow-up|0
5334585|NCT00162981|18363401|P2|Overall Study|Physician Decision|0
5334586|NCT00162981|18363402|P1|Overall Study|Physician Decision|1
5334587|NCT00162981|18363401|P2|Overall Study|Withdrawal by Subject|1
5334588|NCT00162981|18363402|P1|Overall Study|Withdrawal by Subject|1
5334589|NCT00162981|18363401|P2|Overall Study|Adverse Event|5
5334590|NCT00162981|18363402|P1|Overall Study|Adverse Event|2
5334591|NCT00162942|18363418|P2|Overall Study|2 or more consecutive treatments missed|0
5334592|NCT00162942|18363419|P1|Overall Study|2 or more consecutive treatments missed|1
5334593|NCT00162942|18363418|P2|Overall Study|Flare During Active Treatment|3
5334594|NCT00162942|18363419|P1|Overall Study|Flare During Active Treatment|7
5334595|NCT00162942|18363418|P2|Overall Study|Lack of Efficacy|0
5334596|NCT00162942|18363419|P1|Overall Study|Lack of Efficacy|1
5334597|NCT00162942|18363418|P2|Overall Study|Alternate Therapy|2
5334598|NCT00162942|18363419|P1|Overall Study|Alternate Therapy|6
5334599|NCT00162942|18363418|P2|Overall Study|Enter Open-Label Study|35
5334600|NCT00162942|18363419|P1|Overall Study|Enter Open-Label Study|76
5334601|NCT00162942|18363418|P2|Overall Study|Physician Decision|0
5334602|NCT00162942|18363419|P1|Overall Study|Physician Decision|1
5334603|NCT00162942|18363418|P2|Overall Study|Withdrawal by Subject|6
5334604|NCT00162942|18363419|P1|Overall Study|Withdrawal by Subject|3
5334605|NCT00162942|18363418|P2|Overall Study|Death|0
5334606|NCT00162942|18363419|P1|Overall Study|Death|1
5334607|NCT00162942|18363418|P2|Overall Study|Adverse Event|6
5334608|NCT00162942|18363419|P1|Overall Study|Adverse Event|10
5334609|NCT00162773|18363467|P1|Overall Study|P.I, Left institution. Study terminated|22
5334610|NCT00162370|18363471|P1|Efficacy Population|Lost to Follow-up|51
5334611|NCT00162266|18363479|P4|Open-Label Period|Other Reasons|15
5334612|NCT00162266|18363480|P3|Open-Label Period|Other Reasons|0
5334613|NCT00162266|18363481|P2|Open-Label Period|Other Reasons|0
5334614|NCT00162266|18363482|P1|Open-Label Period|Other Reasons|0
5334615|NCT00162266|18363479|P4|Open-Label Period|Administrative Reason By Sponsor|9
5334616|NCT00162266|18363480|P3|Open-Label Period|Administrative Reason By Sponsor|0
5334617|NCT00162266|18363481|P2|Open-Label Period|Administrative Reason By Sponsor|0
5334618|NCT00162266|18363482|P1|Open-Label Period|Administrative Reason By Sponsor|0
5334619|NCT00162266|18363479|P4|Open-Label Period|Withdrawal by Subject|31
5334620|NCT00162266|18363480|P3|Open-Label Period|Withdrawal by Subject|0
5334621|NCT00162266|18363481|P2|Open-Label Period|Withdrawal by Subject|0
5334622|NCT00162266|18363482|P1|Open-Label Period|Withdrawal by Subject|0
5334623|NCT00162266|18363479|P4|Open-Label Period|Lost to Follow-up|3
5334624|NCT00162266|18363480|P3|Open-Label Period|Lost to Follow-up|0
5334625|NCT00162266|18363481|P2|Open-Label Period|Lost to Follow-up|0
5334626|NCT00162266|18363482|P1|Open-Label Period|Lost to Follow-up|0
5334627|NCT00162266|18363479|P4|Open-Label Period|Lack of Efficacy|26
5334628|NCT00162266|18363480|P3|Open-Label Period|Lack of Efficacy|0
5334629|NCT00162266|18363481|P2|Open-Label Period|Lack of Efficacy|0
5334630|NCT00162266|18363482|P1|Open-Label Period|Lack of Efficacy|0
5334631|NCT00162266|18363479|P4|Open-Label Period|Adverse Event|46
5334632|NCT00162266|18363480|P3|Open-Label Period|Adverse Event|0
5334633|NCT00162266|18363481|P2|Open-Label Period|Adverse Event|0
5334634|NCT00162266|18363482|P1|Open-Label Period|Adverse Event|0
5334635|NCT00162266|18363479|P4|Open-Label Period|Death|7
5334636|NCT00162266|18363480|P3|Open-Label Period|Death|0
5334637|NCT00162266|18363481|P2|Open-Label Period|Death|0
5334638|NCT00162266|18363482|P1|Open-Label Period|Death|0
5334639|NCT00162266|18363479|P4|Double-Blind Period|Withdrawal by Subject|0
5334640|NCT00162266|18363480|P3|Double-Blind Period|Withdrawal by Subject|6
5334641|NCT00162266|18363481|P2|Double-Blind Period|Withdrawal by Subject|2
5334642|NCT00162266|18363482|P1|Double-Blind Period|Withdrawal by Subject|5
5334643|NCT00162266|18363479|P4|Double-Blind Period|Lack of Efficacy|0
5334644|NCT00162266|18363480|P3|Double-Blind Period|Lack of Efficacy|30
5334645|NCT00162266|18363481|P2|Double-Blind Period|Lack of Efficacy|17
5334646|NCT00162266|18363482|P1|Double-Blind Period|Lack of Efficacy|13
5334647|NCT00162266|18363479|P4|Double-Blind Period|Other Reason|0
5334648|NCT00162266|18363480|P3|Double-Blind Period|Other Reason|1
5334649|NCT00162266|18363481|P2|Double-Blind Period|Other Reason|0
5334650|NCT00162266|18363482|P1|Double-Blind Period|Other Reason|1
5334651|NCT00162266|18363479|P4|Double-Blind Period|Lost to Follow-up|0
5334652|NCT00162266|18363480|P3|Double-Blind Period|Lost to Follow-up|0
5334653|NCT00162266|18363481|P2|Double-Blind Period|Lost to Follow-up|2
5334654|NCT00162266|18363482|P1|Double-Blind Period|Lost to Follow-up|1
5334655|NCT00162266|18363479|P4|Double-Blind Period|Death|0
5334656|NCT00162266|18363480|P3|Double-Blind Period|Death|0
5334657|NCT00162266|18363481|P2|Double-Blind Period|Death|1
5334658|NCT00162266|18363482|P1|Double-Blind Period|Death|0
5334659|NCT00162266|18363479|P4|Double-Blind Period|Adverse Event|0
5334660|NCT00162266|18363480|P3|Double-Blind Period|Adverse Event|11
5334661|NCT00162266|18363481|P2|Double-Blind Period|Adverse Event|9
5334662|NCT00162266|18363482|P1|Double-Blind Period|Adverse Event|5
5334663|NCT00162136|18363683|P1|Overall Study|Withdrawal by Subject|1
5334664|NCT00162136|18363683|P1|Overall Study|Study Drug Toxicity|4
5334665|NCT00162136|18363683|P1|Overall Study|Investigator Request|5
5334666|NCT00162136|18363683|P1|Overall Study|Disease Progression/Relapse|23
5334667|NCT00162136|18363683|P1|Overall Study|Death|1
5334668|NCT00162136|18363683|P1|Overall Study|Adverse Event|1
5334669|NCT00162123|18363715|P8|Overall Study|Follow-up only (not treated or assessed)|57
5334670|NCT00162123|18363716|P7|Overall Study|Follow-up only (not treated or assessed)|0
5334671|NCT00162123|18363717|P6|Overall Study|Follow-up only (not treated or assessed)|0
5334672|NCT00162123|18363718|P5|Overall Study|Follow-up only (not treated or assessed)|0
5334673|NCT00162123|18363719|P4|Overall Study|Follow-up only (not treated or assessed)|0
5334674|NCT00162123|18363720|P3|Overall Study|Follow-up only (not treated or assessed)|0
5334675|NCT00162123|18363721|P2|Overall Study|Follow-up only (not treated or assessed)|0
5334676|NCT00162123|18363722|P1|Overall Study|Follow-up only (not treated or assessed)|0
5334677|NCT00162123|18363715|P8|Overall Study|Tumor assessment only (not treated)|1
5334678|NCT00162123|18363716|P7|Overall Study|Tumor assessment only (not treated)|0
5334679|NCT00162123|18363717|P6|Overall Study|Tumor assessment only (not treated)|0
5334680|NCT00162123|18363718|P5|Overall Study|Tumor assessment only (not treated)|0
5334681|NCT00162123|18363719|P4|Overall Study|Tumor assessment only (not treated)|0
5334682|NCT00162123|18363720|P3|Overall Study|Tumor assessment only (not treated)|0
5334683|NCT00162123|18363721|P2|Overall Study|Tumor assessment only (not treated)|0
5334684|NCT00162123|18363722|P1|Overall Study|Tumor assessment only (not treated)|0
5334685|NCT00162123|18363715|P8|Overall Study|Physician Decision|0
5334686|NCT00162123|18363716|P7|Overall Study|Physician Decision|1
5334687|NCT00162123|18363717|P6|Overall Study|Physician Decision|1
5334688|NCT00162123|18363718|P5|Overall Study|Physician Decision|0
5334689|NCT00162123|18363719|P4|Overall Study|Physician Decision|0
5334690|NCT00162123|18363720|P3|Overall Study|Physician Decision|0
5334691|NCT00162123|18363721|P2|Overall Study|Physician Decision|2
5334692|NCT00162123|18363722|P1|Overall Study|Physician Decision|1
5334693|NCT00162123|18363715|P8|Overall Study|Not specified (after start of treatment)|0
5334694|NCT00162123|18363716|P7|Overall Study|Not specified (after start of treatment)|0
5334695|NCT00162123|18363717|P6|Overall Study|Not specified (after start of treatment)|0
5334696|NCT00162123|18363718|P5|Overall Study|Not specified (after start of treatment)|3
5334697|NCT00162123|18363719|P4|Overall Study|Not specified (after start of treatment)|0
5334698|NCT00162123|18363720|P3|Overall Study|Not specified (after start of treatment)|0
5334699|NCT00162123|18363721|P2|Overall Study|Not specified (after start of treatment)|0
5334700|NCT00162123|18363722|P1|Overall Study|Not specified (after start of treatment)|0
5334701|NCT00162123|18363715|P8|Overall Study|Not specified (before treatment)|0
5334702|NCT00162123|18363716|P7|Overall Study|Not specified (before treatment)|0
5334703|NCT00162123|18363717|P6|Overall Study|Not specified (before treatment)|1
5334704|NCT00162123|18363718|P5|Overall Study|Not specified (before treatment)|12
5334705|NCT00162123|18363719|P4|Overall Study|Not specified (before treatment)|0
5334706|NCT00162123|18363720|P3|Overall Study|Not specified (before treatment)|0
5334707|NCT00162123|18363721|P2|Overall Study|Not specified (before treatment)|0
5334708|NCT00162123|18363722|P1|Overall Study|Not specified (before treatment)|2
5334709|NCT00162123|18363715|P8|Overall Study|Adverse Event|0
5334710|NCT00162123|18363716|P7|Overall Study|Adverse Event|0
5334711|NCT00162123|18363717|P6|Overall Study|Adverse Event|0
5334712|NCT00162123|18363718|P5|Overall Study|Adverse Event|1
5334713|NCT00162123|18363719|P4|Overall Study|Adverse Event|2
5334714|NCT00162123|18363720|P3|Overall Study|Adverse Event|0
5334715|NCT00162123|18363721|P2|Overall Study|Adverse Event|2
5334716|NCT00162123|18363722|P1|Overall Study|Adverse Event|1
5334717|NCT00162123|18363715|P8|Overall Study|Deterioration without progression|0
5334718|NCT00162123|18363716|P7|Overall Study|Deterioration without progression|0
5334719|NCT00162123|18363717|P6|Overall Study|Deterioration without progression|0
5334720|NCT00162123|18363718|P5|Overall Study|Deterioration without progression|1
5334721|NCT00162123|18363719|P4|Overall Study|Deterioration without progression|0
5334722|NCT00162123|18363720|P3|Overall Study|Deterioration without progression|3
5334723|NCT00162123|18363721|P2|Overall Study|Deterioration without progression|2
5334724|NCT00162123|18363722|P1|Overall Study|Deterioration without progression|2
5334725|NCT00162123|18363715|P8|Overall Study|Withdrawal by Subject|0
5334726|NCT00162123|18363716|P7|Overall Study|Withdrawal by Subject|1
5334727|NCT00162123|18363717|P6|Overall Study|Withdrawal by Subject|2
5334728|NCT00162123|18363718|P5|Overall Study|Withdrawal by Subject|1
5334729|NCT00162123|18363719|P4|Overall Study|Withdrawal by Subject|1
5334730|NCT00162123|18363720|P3|Overall Study|Withdrawal by Subject|2
5334731|NCT00162123|18363721|P2|Overall Study|Withdrawal by Subject|0
5334732|NCT00162123|18363722|P1|Overall Study|Withdrawal by Subject|2
5334733|NCT00162123|18363715|P8|Overall Study|Death|0
5334734|NCT00162123|18363716|P7|Overall Study|Death|0
5334735|NCT00162123|18363717|P6|Overall Study|Death|1
5334736|NCT00162123|18363718|P5|Overall Study|Death|1
5334737|NCT00162123|18363719|P4|Overall Study|Death|1
5334738|NCT00162123|18363720|P3|Overall Study|Death|1
5334739|NCT00162123|18363721|P2|Overall Study|Death|3
5334740|NCT00162123|18363722|P1|Overall Study|Death|3
5334741|NCT00162123|18363715|P8|Overall Study|Study drug toxicity|0
5334742|NCT00162123|18363716|P7|Overall Study|Study drug toxicity|1
5334743|NCT00162123|18363717|P6|Overall Study|Study drug toxicity|1
5334744|NCT00162123|18363718|P5|Overall Study|Study drug toxicity|4
5334745|NCT00162123|18363719|P4|Overall Study|Study drug toxicity|0
5334746|NCT00162123|18363720|P3|Overall Study|Study drug toxicity|5
5334747|NCT00162123|18363721|P2|Overall Study|Study drug toxicity|1
5334748|NCT00162123|18363722|P1|Overall Study|Study drug toxicity|6
5334749|NCT00162123|18363715|P8|Overall Study|Disease progression|0
5334750|NCT00162123|18363716|P7|Overall Study|Disease progression|1
5334751|NCT00162123|18363717|P6|Overall Study|Disease progression|3
5334752|NCT00162123|18363718|P5|Overall Study|Disease progression|8
5334753|NCT00162123|18363719|P4|Overall Study|Disease progression|4
5334754|NCT00162123|18363720|P3|Overall Study|Disease progression|10
5334755|NCT00162123|18363721|P2|Overall Study|Disease progression|19
5334756|NCT00162123|18363722|P1|Overall Study|Disease progression|27
5334757|NCT00162097|18363755|P4|Overall Study|Participant no longer met study criteria|1
5334758|NCT00162097|18363756|P3|Overall Study|Participant no longer met study criteria|0
5334759|NCT00162097|18363757|P2|Overall Study|Participant no longer met study criteria|0
5334760|NCT00162097|18363758|P1|Overall Study|Participant no longer met study criteria|0
5334761|NCT00162032|18363820|P2|Overall Study|Reason not specified|0
5334762|NCT00162032|18363821|P1|Overall Study|Reason not specified|1
5334763|NCT00162032|18363820|P2|Overall Study|Lost to Follow-up|2
5334764|NCT00162032|18363821|P1|Overall Study|Lost to Follow-up|4
5334765|NCT00161616|18363842|P2|Overall Study|Protocol deviation|0
5334766|NCT00161616|18363843|P1|Overall Study|Protocol deviation|1
5334767|NCT00161616|18363842|P2|Overall Study|Lost to Follow-up|13
5334768|NCT00161616|18363843|P1|Overall Study|Lost to Follow-up|17
5334769|NCT00161616|18363842|P2|Overall Study|Death|1
5334770|NCT00161616|18363843|P1|Overall Study|Death|1
5334771|NCT00161616|18363842|P2|Overall Study|Physician Decision|0
5334772|NCT00161616|18363843|P1|Overall Study|Physician Decision|1
5334773|NCT00161616|18363842|P2|Overall Study|Withdrawal by Subject|5
5334774|NCT00161616|18363843|P1|Overall Study|Withdrawal by Subject|6
5334775|NCT00161213|18363875|P1|Overall Study|Evaluable for toxicity but not response|1
5334776|NCT00161213|18363875|P1|Overall Study|Withdrawal by Subject|1
5334777|NCT00160706|18363882|P1|Overall Study|Other Reason|11
5334778|NCT00160706|18363882|P1|Overall Study|Lack of Efficacy and Other|1
5334779|NCT00160706|18363882|P1|Overall Study|Lack of Efficacy|42
5334780|NCT00160706|18363882|P1|Overall Study|Lost to Follow-up and Other|1
5334781|NCT00160706|18363882|P1|Overall Study|Lost to Follow-up|4
5334782|NCT00160706|18363882|P1|Overall Study|Physician Decision and Other|3
5334783|NCT00160706|18363882|P1|Overall Study|Physician Decision|10
5334784|NCT00160706|18363882|P1|Overall Study|Withdrawal by Subject and Other|12
5334785|NCT00160706|18363882|P1|Overall Study|Withdrawal by Subject|41
5334786|NCT00160706|18363882|P1|Overall Study|Protocol Violation|3
5334787|NCT00160706|18363882|P1|Overall Study|Adverse Event and Other Reason|105
5334788|NCT00160706|18363882|P1|Overall Study|Adverse Event|53
5334789|NCT00160693|18363894|P1|Overall Study|Study terminated by sponsor|15
5334790|NCT00160693|18363894|P1|Overall Study|Withdrawal by Subject|54
5334791|NCT00160693|18363894|P1|Overall Study|Lost to Follow-up|15
5334792|NCT00160693|18363894|P1|Overall Study|Protocol Violation|24
5334793|NCT00160693|18363894|P1|Overall Study|Lack of Efficacy|30
5334794|NCT00160693|18363894|P1|Overall Study|Adverse Event|97
5334795|NCT00160680|18363913|P2|Overall Study|Withdrawal by Subject|9
5334796|NCT00160680|18363914|P1|Overall Study|Withdrawal by Subject|4
5334797|NCT00160680|18363913|P2|Overall Study|Lost to Follow-up|2
5334798|NCT00160680|18363914|P1|Overall Study|Lost to Follow-up|3
5334799|NCT00160680|18363913|P2|Overall Study|Lack of Efficacy|1
5334800|NCT00160680|18363914|P1|Overall Study|Lack of Efficacy|2
5334801|NCT00160680|18363913|P2|Overall Study|Adverse Event|1
5334802|NCT00160680|18363914|P1|Overall Study|Adverse Event|0
5334803|NCT00160667|18363949|P3|Overall Study|Patient decision|1
5334804|NCT00160667|18363950|P2|Overall Study|Patient decision|0
5334805|NCT00160667|18363951|P1|Overall Study|Patient decision|0
5334806|NCT00160667|18363949|P3|Overall Study|Protocol Violation|0
5334807|NCT00160667|18363950|P2|Overall Study|Protocol Violation|1
5334808|NCT00160667|18363951|P1|Overall Study|Protocol Violation|0
5334809|NCT00160667|18363949|P3|Overall Study|Lack of Efficacy|0
5334810|NCT00160667|18363950|P2|Overall Study|Lack of Efficacy|1
5334811|NCT00160667|18363951|P1|Overall Study|Lack of Efficacy|0
5334812|NCT00160667|18363949|P3|Overall Study|Withdrawal by Subject|1
5334813|NCT00160667|18363950|P2|Overall Study|Withdrawal by Subject|0
5334814|NCT00160667|18363951|P1|Overall Study|Withdrawal by Subject|2
5334815|NCT00160667|18363949|P3|Overall Study|Adverse Event|4
5334816|NCT00160667|18363950|P2|Overall Study|Adverse Event|1
5334817|NCT00160667|18363951|P1|Overall Study|Adverse Event|3
5334818|NCT00160654|18363998|P1|Overall Study|Met exclusion criteria|1
5334819|NCT00160654|18363998|P1|Overall Study|Poor compliance, dilantin toxicity|1
5334820|NCT00160654|18363998|P1|Overall Study|Patient decision|1
5334821|NCT00160654|18363998|P1|Overall Study|Patient met exclusion criteria|1
5334822|NCT00160654|18363998|P1|Overall Study|Sponsor decision|1
5334823|NCT00160654|18363998|P1|Overall Study|Psychological trauma|1
5334824|NCT00160654|18363998|P1|Overall Study|Intake of expired drug|7
5334825|NCT00160654|18363998|P1|Overall Study|Lost to Follow-up|2
5334826|NCT00160654|18363998|P1|Overall Study|Lack of Efficacy|4
5334827|NCT00160654|18363998|P1|Overall Study|Adverse Event|14
5334828|NCT00160641|18364008|P1|Overall Study|Other|9
5334829|NCT00160641|18364008|P1|Overall Study|Protocol Violation|3
5334830|NCT00160641|18364008|P1|Overall Study|Lack of Efficacy|12
5334831|NCT00160641|18364008|P1|Overall Study|Lost to Follow-up|8
5334832|NCT00160641|18364008|P1|Overall Study|Withdrawal by Subject|87
5334833|NCT00160641|18364008|P1|Overall Study|Adverse Event|102
5334834|NCT00160615|18364041|P2|Overall Study|Poor compliance|1
5334835|NCT00160615|18364042|P1|Overall Study|Poor compliance|0
5334836|NCT00160615|18364041|P2|Overall Study|Non-compliance was suspected|1
5334837|NCT00160615|18364042|P1|Overall Study|Non-compliance was suspected|0
5334838|NCT00160615|18364041|P2|Overall Study|Switch to surgical treatment|2
5334839|NCT00160615|18364042|P1|Overall Study|Switch to surgical treatment|0
5334840|NCT00160615|18364041|P2|Overall Study|AE agents had to be discontinued (exam.)|1
5334841|NCT00160615|18364042|P1|Overall Study|AE agents had to be discontinued (exam.)|0
5334842|NCT00160615|18364041|P2|Overall Study|Investigator decision|1
5334843|NCT00160615|18364042|P1|Overall Study|Investigator decision|1
5334844|NCT00160615|18364041|P2|Overall Study|Patient decision|2
5334845|NCT00160615|18364042|P1|Overall Study|Patient decision|1
5334846|NCT00160615|18364041|P2|Overall Study|Lack of Efficacy|23
5334847|NCT00160615|18364042|P1|Overall Study|Lack of Efficacy|11
5334848|NCT00160615|18364041|P2|Overall Study|Withdrawal by Subject|2
5334849|NCT00160615|18364042|P1|Overall Study|Withdrawal by Subject|0
5334850|NCT00160615|18364041|P2|Overall Study|Adverse Event|12
5334851|NCT00160615|18364042|P1|Overall Study|Adverse Event|5
5334852|NCT00160563|18364065|P3|Overall Study|Missing reason|0
5334853|NCT00160563|18364066|P2|Overall Study|Missing reason|1
5334854|NCT00160563|18364067|P1|Overall Study|Missing reason|0
5334855|NCT00160563|18364065|P3|Overall Study|Other (listed in the study report)|81
5334856|NCT00160563|18364066|P2|Overall Study|Other (listed in the study report)|40
5334857|NCT00160563|18364067|P1|Overall Study|Other (listed in the study report)|48
5334858|NCT00160563|18364065|P3|Overall Study|Withdrawal by Subject|3
5334859|NCT00160563|18364066|P2|Overall Study|Withdrawal by Subject|2
5334860|NCT00160563|18364067|P1|Overall Study|Withdrawal by Subject|1
5334861|NCT00160563|18364065|P3|Overall Study|Protocol Violation|3
5334862|NCT00160563|18364066|P2|Overall Study|Protocol Violation|0
5334863|NCT00160563|18364067|P1|Overall Study|Protocol Violation|0
5334864|NCT00160563|18364065|P3|Overall Study|Lost to Follow-up|2
5334865|NCT00160563|18364066|P2|Overall Study|Lost to Follow-up|1
5334866|NCT00160563|18364067|P1|Overall Study|Lost to Follow-up|1
5334867|NCT00160563|18364065|P3|Overall Study|Adverse Event|1
5334868|NCT00160563|18364066|P2|Overall Study|Adverse Event|1
5334869|NCT00160563|18364067|P1|Overall Study|Adverse Event|1
5334870|NCT00160524|18364079|P1|Overall Study|Other|20
5334871|NCT00160524|18364079|P1|Overall Study|Lack of Efficacy and Other|1
5334872|NCT00160524|18364079|P1|Overall Study|Lack of Efficacy|21
5334873|NCT00160524|18364079|P1|Overall Study|Lost to Follow-up and Other|1
5334874|NCT00160524|18364079|P1|Overall Study|Lost to Follow-up|13
5334875|NCT00160524|18364079|P1|Overall Study|Physician Decision and Other|6
5334876|NCT00160524|18364079|P1|Overall Study|Physician Decision|27
5334877|NCT00160524|18364079|P1|Overall Study|Withdrawal by Subject and Other|17
5334878|NCT00160524|18364079|P1|Overall Study|Withdrawal by Subject|141
5334879|NCT00160524|18364079|P1|Overall Study|Protocol Violation and Other|2
5334880|NCT00160524|18364079|P1|Overall Study|Protocol Violation|16
5334881|NCT00160524|18364079|P1|Overall Study|Adverse Event and Other|94
5334882|NCT00160524|18364079|P1|Overall Study|Adverse Event|119
5334883|NCT00160251|18364096|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
5334884|NCT00160251|18364097|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334885|NCT00160251|18364098|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334886|NCT00160251|18364099|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334887|NCT00160251|18364100|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334888|NCT00160251|18364101|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334889|NCT00160251|18364102|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334890|NCT00160251|18364103|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5334891|NCT00160251|18364096|P8|Post-amendment 2|Lack of Efficacy|24
5334892|NCT00160251|18364097|P7|Post-amendment 2|Lack of Efficacy|0
5334893|NCT00160251|18364098|P6|Post-amendment 2|Lack of Efficacy|0
5334894|NCT00160251|18364099|P5|Post-amendment 2|Lack of Efficacy|0
5334895|NCT00160251|18364100|P4|Post-amendment 2|Lack of Efficacy|0
5334896|NCT00160251|18364101|P3|Post-amendment 2|Lack of Efficacy|0
5334897|NCT00160251|18364102|P2|Post-amendment 2|Lack of Efficacy|0
5334898|NCT00160251|18364103|P1|Post-amendment 2|Lack of Efficacy|0
5334899|NCT00160251|18364096|P8|Post-amendment 2|Adverse Event|20
5334900|NCT00160251|18364097|P7|Post-amendment 2|Adverse Event|0
5334901|NCT00160251|18364098|P6|Post-amendment 2|Adverse Event|0
5334902|NCT00160251|18364099|P5|Post-amendment 2|Adverse Event|0
5334903|NCT00160251|18364100|P4|Post-amendment 2|Adverse Event|0
5334904|NCT00160251|18364101|P3|Post-amendment 2|Adverse Event|0
5334905|NCT00160251|18364102|P2|Post-amendment 2|Adverse Event|0
5334906|NCT00160251|18364103|P1|Post-amendment 2|Adverse Event|0
5334907|NCT00160251|18364096|P8|Prior to Amendment 2|Completed Treatment Phase|0
5334908|NCT00160251|18364097|P7|Prior to Amendment 2|Completed Treatment Phase|0
5334909|NCT00160251|18364098|P6|Prior to Amendment 2|Completed Treatment Phase|23
5334910|NCT00160251|18364099|P5|Prior to Amendment 2|Completed Treatment Phase|0
5334911|NCT00160251|18364100|P4|Prior to Amendment 2|Completed Treatment Phase|0
5334912|NCT00160251|18364101|P3|Prior to Amendment 2|Completed Treatment Phase|0
5334913|NCT00160251|18364102|P2|Prior to Amendment 2|Completed Treatment Phase|0
5334914|NCT00160251|18364103|P1|Prior to Amendment 2|Completed Treatment Phase|3
5334915|NCT00160251|18364096|P8|Prior to Amendment 2|Noncompliance with protocol|0
5334916|NCT00160251|18364097|P7|Prior to Amendment 2|Noncompliance with protocol|0
5334917|NCT00160251|18364098|P6|Prior to Amendment 2|Noncompliance with protocol|0
5334918|NCT00160251|18364099|P5|Prior to Amendment 2|Noncompliance with protocol|0
5334919|NCT00160251|18364100|P4|Prior to Amendment 2|Noncompliance with protocol|0
5334920|NCT00160251|18364101|P3|Prior to Amendment 2|Noncompliance with protocol|0
5334921|NCT00160251|18364102|P2|Prior to Amendment 2|Noncompliance with protocol|0
5334922|NCT00160251|18364103|P1|Prior to Amendment 2|Noncompliance with protocol|1
5334923|NCT00160251|18364096|P8|Prior to Amendment 2|Withdrawal by Subject|0
5334924|NCT00160251|18364097|P7|Prior to Amendment 2|Withdrawal by Subject|3
5334925|NCT00160251|18364098|P6|Prior to Amendment 2|Withdrawal by Subject|3
5334926|NCT00160251|18364099|P5|Prior to Amendment 2|Withdrawal by Subject|2
5334927|NCT00160251|18364100|P4|Prior to Amendment 2|Withdrawal by Subject|4
5334928|NCT00160251|18364101|P3|Prior to Amendment 2|Withdrawal by Subject|3
5334929|NCT00160251|18364102|P2|Prior to Amendment 2|Withdrawal by Subject|1
5334930|NCT00160251|18364103|P1|Prior to Amendment 2|Withdrawal by Subject|3
5334931|NCT00160251|18364096|P8|Prior to Amendment 2|Lost to Follow-up|0
5334932|NCT00160251|18364097|P7|Prior to Amendment 2|Lost to Follow-up|0
5334933|NCT00160251|18364098|P6|Prior to Amendment 2|Lost to Follow-up|1
5334934|NCT00160251|18364099|P5|Prior to Amendment 2|Lost to Follow-up|1
5334935|NCT00160251|18364100|P4|Prior to Amendment 2|Lost to Follow-up|0
5334936|NCT00160251|18364101|P3|Prior to Amendment 2|Lost to Follow-up|1
5334937|NCT00160251|18364102|P2|Prior to Amendment 2|Lost to Follow-up|0
5334938|NCT00160251|18364103|P1|Prior to Amendment 2|Lost to Follow-up|0
5334939|NCT00160251|18364096|P8|Prior to Amendment 2|Lack of Efficacy|0
5334940|NCT00160251|18364097|P7|Prior to Amendment 2|Lack of Efficacy|0
5334941|NCT00160251|18364098|P6|Prior to Amendment 2|Lack of Efficacy|55
5334942|NCT00160251|18364099|P5|Prior to Amendment 2|Lack of Efficacy|24
5334943|NCT00160251|18364100|P4|Prior to Amendment 2|Lack of Efficacy|35
5334944|NCT00160251|18364101|P3|Prior to Amendment 2|Lack of Efficacy|37
5334945|NCT00160251|18364102|P2|Prior to Amendment 2|Lack of Efficacy|4
5334946|NCT00160251|18364103|P1|Prior to Amendment 2|Lack of Efficacy|0
5334947|NCT00160251|18364096|P8|Prior to Amendment 2|Adverse Event|0
5334948|NCT00160251|18364097|P7|Prior to Amendment 2|Adverse Event|1
5334949|NCT00160251|18364098|P6|Prior to Amendment 2|Adverse Event|1
5334950|NCT00160251|18364099|P5|Prior to Amendment 2|Adverse Event|1
5334951|NCT00160251|18364100|P4|Prior to Amendment 2|Adverse Event|1
5334952|NCT00160251|18364101|P3|Prior to Amendment 2|Adverse Event|3
5334953|NCT00160251|18364102|P2|Prior to Amendment 2|Adverse Event|1
5334954|NCT00160251|18364103|P1|Prior to Amendment 2|Adverse Event|2
5334955|NCT00160199|18364179|P2|Overall Study|Protocol Violation|8
5334956|NCT00160199|18364180|P1|Overall Study|Protocol Violation|8
5334957|NCT00160199|18364179|P2|Overall Study|Administrative|1
5334958|NCT00160199|18364180|P1|Overall Study|Administrative|0
5334959|NCT00160199|18364179|P2|Overall Study|Withdrawal by Subject|6
5334960|NCT00160199|18364180|P1|Overall Study|Withdrawal by Subject|4
5334961|NCT00160199|18364179|P2|Overall Study|Lost to Follow-up|7
5334962|NCT00160199|18364180|P1|Overall Study|Lost to Follow-up|7
5334963|NCT00160199|18364179|P2|Overall Study|Lack of Efficacy|1
5334964|NCT00160199|18364180|P1|Overall Study|Lack of Efficacy|0
5334965|NCT00160199|18364179|P2|Overall Study|Adverse Event|14
5334966|NCT00160199|18364180|P1|Overall Study|Adverse Event|5
5334967|NCT00159913|18364237|P4|Overall Study|Protocol Violation|0
5334968|NCT00159913|18364238|P3|Overall Study|Protocol Violation|1
5334969|NCT00159913|18364239|P2|Overall Study|Protocol Violation|0
5334970|NCT00159913|18364240|P1|Overall Study|Protocol Violation|1
5334971|NCT00159913|18364237|P4|Overall Study|Lost to Follow-up|1
5334972|NCT00159913|18364238|P3|Overall Study|Lost to Follow-up|0
5334973|NCT00159913|18364239|P2|Overall Study|Lost to Follow-up|0
5334974|NCT00159913|18364240|P1|Overall Study|Lost to Follow-up|0
5334975|NCT00159913|18364237|P4|Overall Study|Withdrawal by Subject|1
5334976|NCT00159913|18364238|P3|Overall Study|Withdrawal by Subject|0
5334977|NCT00159913|18364239|P2|Overall Study|Withdrawal by Subject|0
5334978|NCT00159913|18364240|P1|Overall Study|Withdrawal by Subject|0
5334979|NCT00159913|18364237|P4|Overall Study|Adverse Event|0
5334980|NCT00159913|18364238|P3|Overall Study|Adverse Event|1
5334981|NCT00159913|18364239|P2|Overall Study|Adverse Event|0
5334982|NCT00159913|18364240|P1|Overall Study|Adverse Event|1
5334983|NCT00159874|18364314|P7|Overall Study|Pregnancy|0
5334984|NCT00159874|18364315|P6|Overall Study|Pregnancy|0
5334985|NCT00159874|18364316|P5|Overall Study|Pregnancy|0
5334986|NCT00159874|18364317|P4|Overall Study|Pregnancy|0
5334987|NCT00159874|18364318|P3|Overall Study|Pregnancy|0
5334988|NCT00159874|18364319|P2|Overall Study|Pregnancy|1
5334989|NCT00159874|18364320|P1|Overall Study|Pregnancy|1
5334990|NCT00159874|18364314|P7|Overall Study|Withdrawal by Subject|1
5334991|NCT00159874|18364315|P6|Overall Study|Withdrawal by Subject|2
5334992|NCT00159874|18364316|P5|Overall Study|Withdrawal by Subject|3
5334993|NCT00159874|18364317|P4|Overall Study|Withdrawal by Subject|4
5334994|NCT00159874|18364318|P3|Overall Study|Withdrawal by Subject|8
5334995|NCT00159874|18364319|P2|Overall Study|Withdrawal by Subject|6
5334996|NCT00159874|18364320|P1|Overall Study|Withdrawal by Subject|2
5334997|NCT00159874|18364314|P7|Overall Study|Death|0
5334998|NCT00159874|18364315|P6|Overall Study|Death|2
5334999|NCT00159874|18364316|P5|Overall Study|Death|1
5335000|NCT00159874|18364317|P4|Overall Study|Death|0
5335001|NCT00159874|18364318|P3|Overall Study|Death|15
5335002|NCT00159874|18364319|P2|Overall Study|Death|8
5335003|NCT00159874|18364320|P1|Overall Study|Death|3
5335004|NCT00159874|18364314|P7|Overall Study|Protocol Violation|0
5335005|NCT00159874|18364315|P6|Overall Study|Protocol Violation|0
5335006|NCT00159874|18364316|P5|Overall Study|Protocol Violation|0
5335007|NCT00159874|18364317|P4|Overall Study|Protocol Violation|0
5335008|NCT00159874|18364318|P3|Overall Study|Protocol Violation|2
5335009|NCT00159874|18364319|P2|Overall Study|Protocol Violation|5
5335010|NCT00159874|18364320|P1|Overall Study|Protocol Violation|0
5335011|NCT00159874|18364314|P7|Overall Study|Other|3
5335012|NCT00159874|18364315|P6|Overall Study|Other|1
5335013|NCT00159874|18364316|P5|Overall Study|Other|2
5335014|NCT00159874|18364317|P4|Overall Study|Other|0
5335015|NCT00159874|18364318|P3|Overall Study|Other|8
5335016|NCT00159874|18364319|P2|Overall Study|Other|8
5335017|NCT00159874|18364320|P1|Overall Study|Other|8
5335018|NCT00159874|18364314|P7|Overall Study|Lost to Follow-up|1
5335019|NCT00159874|18364315|P6|Overall Study|Lost to Follow-up|2
5335020|NCT00159874|18364316|P5|Overall Study|Lost to Follow-up|1
5335021|NCT00159874|18364317|P4|Overall Study|Lost to Follow-up|0
5335022|NCT00159874|18364318|P3|Overall Study|Lost to Follow-up|3
5335023|NCT00159874|18364319|P2|Overall Study|Lost to Follow-up|0
5335024|NCT00159874|18364320|P1|Overall Study|Lost to Follow-up|1
5335025|NCT00159874|18364314|P7|Overall Study|Lack of Efficacy|0
5335026|NCT00159874|18364315|P6|Overall Study|Lack of Efficacy|3
5335027|NCT00159874|18364316|P5|Overall Study|Lack of Efficacy|0
5335028|NCT00159874|18364317|P4|Overall Study|Lack of Efficacy|1
5335029|NCT00159874|18364318|P3|Overall Study|Lack of Efficacy|1
5335030|NCT00159874|18364319|P2|Overall Study|Lack of Efficacy|0
5335031|NCT00159874|18364320|P1|Overall Study|Lack of Efficacy|2
5335032|NCT00159874|18364314|P7|Overall Study|Does Not Meet Entrance Criteria|0
5335033|NCT00159874|18364315|P6|Overall Study|Does Not Meet Entrance Criteria|0
5335034|NCT00159874|18364316|P5|Overall Study|Does Not Meet Entrance Criteria|0
5335035|NCT00159874|18364317|P4|Overall Study|Does Not Meet Entrance Criteria|0
5335036|NCT00159874|18364318|P3|Overall Study|Does Not Meet Entrance Criteria|1
5335037|NCT00159874|18364319|P2|Overall Study|Does Not Meet Entrance Criteria|0
5335038|NCT00159874|18364320|P1|Overall Study|Does Not Meet Entrance Criteria|1
5335039|NCT00159874|18364314|P7|Overall Study|Adverse Event|0
5335040|NCT00159874|18364315|P6|Overall Study|Adverse Event|2
5335041|NCT00159874|18364316|P5|Overall Study|Adverse Event|1
5335042|NCT00159874|18364317|P4|Overall Study|Adverse Event|1
5335043|NCT00159874|18364318|P3|Overall Study|Adverse Event|5
5335044|NCT00159874|18364319|P2|Overall Study|Adverse Event|2
5335045|NCT00159874|18364320|P1|Overall Study|Adverse Event|2
5335046|NCT00159861|18364490|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
5335047|NCT00159861|18364491|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
5335048|NCT00159861|18364490|P2|Extension Study - up to 3 Years|Reason Unspecified|19
5335049|NCT00159861|18364491|P1|Extension Study - up to 3 Years|Reason Unspecified|12
5335050|NCT00159861|18364490|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
5335051|NCT00159861|18364491|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
5335052|NCT00159861|18364490|P2|Extension Study - up to 3 Years|Adverse Event|14
5335053|NCT00159861|18364491|P1|Extension Study - up to 3 Years|Adverse Event|14
5335054|NCT00159861|18364490|P2|Extension Study - up to 3 Years|Death|28
5335055|NCT00159861|18364491|P1|Extension Study - up to 3 Years|Death|24
5335056|NCT00159861|18364490|P2|Core Study - 16 Weeks|Randomized but not Treated|0
5335057|NCT00159861|18364491|P1|Core Study - 16 Weeks|Randomized but not Treated|2
5335058|NCT00159861|18364490|P2|Core Study - 16 Weeks|Subject Defaulted|0
5335059|NCT00159861|18364491|P1|Core Study - 16 Weeks|Subject Defaulted|1
5335060|NCT00159861|18364490|P2|Core Study - 16 Weeks|Reason Unspecified|3
5335061|NCT00159861|18364491|P1|Core Study - 16 Weeks|Reason Unspecified|5
5335062|NCT00159861|18364490|P2|Core Study - 16 Weeks|Lack of Efficacy|3
5335063|NCT00159861|18364491|P1|Core Study - 16 Weeks|Lack of Efficacy|2
5335064|NCT00159861|18364490|P2|Core Study - 16 Weeks|Adverse Event|6
5335065|NCT00159861|18364491|P1|Core Study - 16 Weeks|Adverse Event|12
5335066|NCT00159861|18364490|P2|Core Study - 16 Weeks|Death|0
5335067|NCT00159861|18364491|P1|Core Study - 16 Weeks|Death|3
5335068|NCT00159822|18364512|P1|Post-treatment Follow-up Period|Reason unspecified|1
5335069|NCT00159822|18364512|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
5335070|NCT00159822|18364512|P1|Post-treatment Follow-up Period|Death|1
5335071|NCT00159822|18364512|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
5335072|NCT00159822|18364512|P1|Voriconazole Treatment Period|Lost to Follow-up|2
5335073|NCT00159822|18364512|P1|Voriconazole Treatment Period|Protocol Violation|2
5335074|NCT00159822|18364512|P1|Voriconazole Treatment Period|Death|4
5335075|NCT00159822|18364512|P1|Voriconazole Treatment Period|Adverse Event|9
5335076|NCT00159822|18364512|P1|Voriconazole Treatment Period|Lack of Efficacy|3
5335077|NCT00159783|18364530|P3|Overall Study|Other|4
5335078|NCT00159783|18364531|P2|Overall Study|Other|2
5335079|NCT00159783|18364532|P1|Overall Study|Other|0
5335080|NCT00159783|18364530|P3|Overall Study|Lost to Follow-up|11
5335081|NCT00159783|18364531|P2|Overall Study|Lost to Follow-up|5
5335082|NCT00159783|18364532|P1|Overall Study|Lost to Follow-up|6
5335083|NCT00159783|18364530|P3|Overall Study|Withdrawal by Subject|12
5335084|NCT00159783|18364531|P2|Overall Study|Withdrawal by Subject|11
5335085|NCT00159783|18364532|P1|Overall Study|Withdrawal by Subject|7
5335086|NCT00159783|18364530|P3|Overall Study|Lack of Efficacy|3
5335087|NCT00159783|18364531|P2|Overall Study|Lack of Efficacy|2
5335088|NCT00159783|18364532|P1|Overall Study|Lack of Efficacy|1
5335089|NCT00159783|18364530|P3|Overall Study|Adverse Event|9
5335090|NCT00159783|18364531|P2|Overall Study|Adverse Event|7
5335091|NCT00159783|18364532|P1|Overall Study|Adverse Event|5
5335092|NCT00159432|18364562|P1|Overall Study|Lack of Efficacy|8
5335093|NCT00159432|18364562|P1|Overall Study|Death|1
5335094|NCT00159432|18364562|P1|Overall Study|Adverse Event|1
5335095|NCT00158860|18364636|P2|Overall Study|Closed per sponsor|1
5335096|NCT00158860|18364637|P1|Overall Study|Closed per sponsor|0
5335097|NCT00158860|18364636|P2|Overall Study|Lost to Follow up but returned per GSK|1
5335098|NCT00158860|18364637|P1|Overall Study|Lost to Follow up but returned per GSK|0
5335099|NCT00158860|18364636|P2|Overall Study|SPONSOR REQUEST|1
5335100|NCT00158860|18364637|P1|Overall Study|SPONSOR REQUEST|0
5335101|NCT00158860|18364636|P2|Overall Study|SPONSOR STOPPED STUDY|2
5335102|NCT00158860|18364637|P1|Overall Study|SPONSOR STOPPED STUDY|2
5335103|NCT00158860|18364636|P2|Overall Study|Pregnancy|3
5335104|NCT00158860|18364637|P1|Overall Study|Pregnancy|3
5335105|NCT00158860|18364636|P2|Overall Study|MOVING OUT OF STATE|0
5335106|NCT00158860|18364637|P1|Overall Study|MOVING OUT OF STATE|1
5335107|NCT00158860|18364636|P2|Overall Study|Withdrawal by Subject|17
5335108|NCT00158860|18364637|P1|Overall Study|Withdrawal by Subject|7
5335109|NCT00158860|18364636|P2|Overall Study|Protocol Violation|23
5335110|NCT00158860|18364637|P1|Overall Study|Protocol Violation|8
5335111|NCT00158860|18364636|P2|Overall Study|Lost to Follow-up|17
5335112|NCT00158860|18364637|P1|Overall Study|Lost to Follow-up|11
5335113|NCT00158860|18364636|P2|Overall Study|Adverse Event|6
5335114|NCT00158860|18364637|P1|Overall Study|Adverse Event|3
5335115|NCT00158756|18364656|P5|Overall Study|Serious adverse event|0
5335116|NCT00158756|18364657|P4|Overall Study|Serious adverse event|0
5335117|NCT00158756|18364658|P3|Overall Study|Serious adverse event|1
5335118|NCT00158756|18364659|P2|Overall Study|Serious adverse event|0
5335119|NCT00158756|18364660|P1|Overall Study|Serious adverse event|0
5335120|NCT00158756|18364656|P5|Overall Study|Adverse Event|0
5335121|NCT00158756|18364657|P4|Overall Study|Adverse Event|0
5335122|NCT00158756|18364658|P3|Overall Study|Adverse Event|1
5335123|NCT00158756|18364659|P2|Overall Study|Adverse Event|0
5335124|NCT00158756|18364660|P1|Overall Study|Adverse Event|0
5335125|NCT00158756|18364656|P5|Overall Study|Withdrawal by Subject|3
5335126|NCT00158756|18364657|P4|Overall Study|Withdrawal by Subject|1
5335127|NCT00158756|18364658|P3|Overall Study|Withdrawal by Subject|6
5335128|NCT00158756|18364659|P2|Overall Study|Withdrawal by Subject|0
5335129|NCT00158756|18364660|P1|Overall Study|Withdrawal by Subject|5
5335130|NCT00158600|18364766|P2|Overall Study|Withdrawal by Subject|2
5335131|NCT00158600|18364767|P1|Overall Study|Withdrawal by Subject|2
5335132|NCT00158600|18364766|P2|Overall Study|Death|0
5335133|NCT00158600|18364767|P1|Overall Study|Death|1
5335134|NCT00158600|18364766|P2|Overall Study|Adverse Event|1
5335135|NCT00158600|18364767|P1|Overall Study|Adverse Event|2
5335136|NCT00158600|18364766|P2|Overall Study|unable to commit time to study|1
5335137|NCT00158600|18364767|P1|Overall Study|unable to commit time to study|0
5335138|NCT00158262|18364792|P2|Overall Study|Lost to Follow-up|1
5335139|NCT00158262|18364793|P1|Overall Study|Lost to Follow-up|1
5335140|NCT00158184|18364854|P2|Overall Study|Adverse Event|1
5335141|NCT00158184|18364855|P1|Overall Study|Adverse Event|1
5335142|NCT00158184|18364854|P2|Overall Study|failed for follow unit/study rules|0
5335143|NCT00158184|18364855|P1|Overall Study|failed for follow unit/study rules|2
5335144|NCT00158184|18364854|P2|Overall Study|personal issues|1
5335145|NCT00158184|18364855|P1|Overall Study|personal issues|3
5335146|NCT00158054|18364865|P2|Overall Study|Unavailable for follow up|3
5335147|NCT00158054|18364866|P1|Overall Study|Unavailable for follow up|7
5335148|NCT00158054|18364865|P2|Overall Study|Refused to continue|0
5335149|NCT00158054|18364866|P1|Overall Study|Refused to continue|3
5335150|NCT00157950|18364880|P2|Overall Study|Death|0
5335151|NCT00157950|18364881|P1|Overall Study|Death|1
5335152|NCT00157820|18364898|P3|2nd 8 Months|Premature cross-over|9
5335153|NCT00157820|18364899|P2|2nd 8 Months|Premature cross-over|7
5335154|NCT00157820|18364900|P1|2nd 8 Months|Premature cross-over|1
5335155|NCT00157820|18364898|P3|2nd 8 Months|Lost to Follow-up|2
5335156|NCT00157820|18364899|P2|2nd 8 Months|Lost to Follow-up|5
5335157|NCT00157820|18364900|P1|2nd 8 Months|Lost to Follow-up|1
5335158|NCT00157820|18364898|P3|2nd 8 Months|Death|3
5335159|NCT00157820|18364899|P2|2nd 8 Months|Death|1
5335160|NCT00157820|18364900|P1|2nd 8 Months|Death|3
5335161|NCT00157820|18364898|P3|1st 8 Month|Premature cross-over|2
5335162|NCT00157820|18364899|P2|1st 8 Month|Premature cross-over|2
5335163|NCT00157820|18364900|P1|1st 8 Month|Premature cross-over|0
5335164|NCT00157820|18364898|P3|1st 8 Month|Lost to Follow-up|1
5335165|NCT00157820|18364899|P2|1st 8 Month|Lost to Follow-up|2
5335166|NCT00157820|18364900|P1|1st 8 Month|Lost to Follow-up|1
5335167|NCT00157820|18364898|P3|1st 8 Month|Death|3
5335168|NCT00157820|18364899|P2|1st 8 Month|Death|8
5335169|NCT00157820|18364900|P1|1st 8 Month|Death|7
5335170|NCT00157820|18364898|P3|Randomized|Protocol Violation|2
5335171|NCT00157820|18364899|P2|Randomized|Protocol Violation|1
5335172|NCT00157820|18364900|P1|Randomized|Protocol Violation|2
5335173|NCT00157820|18364898|P3|Randomized|Withdrawal by Subject|3
5335174|NCT00157820|18364899|P2|Randomized|Withdrawal by Subject|2
5335175|NCT00157820|18364900|P1|Randomized|Withdrawal by Subject|1
5335176|NCT00157820|18364898|P3|Randomized|Physician Decision|3
5335177|NCT00157820|18364899|P2|Randomized|Physician Decision|2
5335178|NCT00157820|18364900|P1|Randomized|Physician Decision|4
5335179|NCT00157755|18364913|P6|Overall Study|Study completion|2
5335180|NCT00157755|18364914|P5|Overall Study|Study completion|1
5335181|NCT00157755|18364915|P4|Overall Study|Study completion|0
5335182|NCT00157755|18364916|P3|Overall Study|Study completion|0
5335183|NCT00157755|18364917|P2|Overall Study|Study completion|0
5335184|NCT00157755|18364918|P1|Overall Study|Study completion|0
5335185|NCT00157755|18364913|P6|Overall Study|Subject non-compliance|1
5335186|NCT00157755|18364914|P5|Overall Study|Subject non-compliance|0
5335187|NCT00157755|18364915|P4|Overall Study|Subject non-compliance|0
5335188|NCT00157755|18364916|P3|Overall Study|Subject non-compliance|0
5335189|NCT00157755|18364917|P2|Overall Study|Subject non-compliance|0
5335190|NCT00157755|18364918|P1|Overall Study|Subject non-compliance|0
5335191|NCT00157755|18364913|P6|Overall Study|Study site closure|0
5335192|NCT00157755|18364914|P5|Overall Study|Study site closure|0
5335193|NCT00157755|18364915|P4|Overall Study|Study site closure|0
5335194|NCT00157755|18364916|P3|Overall Study|Study site closure|0
5335195|NCT00157755|18364917|P2|Overall Study|Study site closure|1
5335196|NCT00157755|18364918|P1|Overall Study|Study site closure|0
5335197|NCT00157755|18364913|P6|Overall Study|Medical reason|0
5335198|NCT00157755|18364914|P5|Overall Study|Medical reason|0
5335199|NCT00157755|18364915|P4|Overall Study|Medical reason|1
5335200|NCT00157755|18364916|P3|Overall Study|Medical reason|1
5335201|NCT00157755|18364917|P2|Overall Study|Medical reason|0
5335202|NCT00157755|18364918|P1|Overall Study|Medical reason|0
5335203|NCT00157755|18364913|P6|Overall Study|Explant due to infection|0
5335204|NCT00157755|18364914|P5|Overall Study|Explant due to infection|0
5335205|NCT00157755|18364915|P4|Overall Study|Explant due to infection|0
5335206|NCT00157755|18364916|P3|Overall Study|Explant due to infection|1
5335207|NCT00157755|18364917|P2|Overall Study|Explant due to infection|0
5335208|NCT00157755|18364918|P1|Overall Study|Explant due to infection|0
5335209|NCT00157755|18364913|P6|Overall Study|Withdrawal by Subject|2
5335210|NCT00157755|18364914|P5|Overall Study|Withdrawal by Subject|1
5335211|NCT00157755|18364915|P4|Overall Study|Withdrawal by Subject|1
5335212|NCT00157755|18364916|P3|Overall Study|Withdrawal by Subject|1
5335213|NCT00157755|18364917|P2|Overall Study|Withdrawal by Subject|0
5335214|NCT00157755|18364918|P1|Overall Study|Withdrawal by Subject|0
5335215|NCT00157755|18364913|P6|Overall Study|Lost to Follow-up|0
5335216|NCT00157755|18364914|P5|Overall Study|Lost to Follow-up|0
5335217|NCT00157755|18364915|P4|Overall Study|Lost to Follow-up|0
5335218|NCT00157755|18364916|P3|Overall Study|Lost to Follow-up|1
5335219|NCT00157755|18364917|P2|Overall Study|Lost to Follow-up|0
5335220|NCT00157755|18364918|P1|Overall Study|Lost to Follow-up|0
5335221|NCT00157755|18364913|P6|Overall Study|Death|0
5335222|NCT00157755|18364914|P5|Overall Study|Death|0
5335223|NCT00157755|18364915|P4|Overall Study|Death|2
5335224|NCT00157755|18364916|P3|Overall Study|Death|3
5335225|NCT00157755|18364917|P2|Overall Study|Death|3
5335226|NCT00157755|18364918|P1|Overall Study|Death|2
5335227|NCT00157248|18364954|P4|Overall Study|site closures, subject moving|9
5335228|NCT00157248|18364955|P3|Overall Study|site closures, subject moving|3
5335229|NCT00157248|18364956|P2|Overall Study|site closures, subject moving|7
5335230|NCT00157248|18364957|P1|Overall Study|site closures, subject moving|7
5335231|NCT00157248|18364954|P4|Overall Study|Withdrawal by Subject|3
5335232|NCT00157248|18364955|P3|Overall Study|Withdrawal by Subject|3
5335233|NCT00157248|18364956|P2|Overall Study|Withdrawal by Subject|4
5335234|NCT00157248|18364957|P1|Overall Study|Withdrawal by Subject|1
5335235|NCT00157248|18364954|P4|Overall Study|Lost to Follow-up|0
5335236|NCT00157248|18364955|P3|Overall Study|Lost to Follow-up|0
5335237|NCT00157248|18364956|P2|Overall Study|Lost to Follow-up|1
5335238|NCT00157248|18364957|P1|Overall Study|Lost to Follow-up|0
5335239|NCT00157248|18364954|P4|Overall Study|Protocol Violation|2
5335240|NCT00157248|18364955|P3|Overall Study|Protocol Violation|2
5335241|NCT00157248|18364956|P2|Overall Study|Protocol Violation|0
5335242|NCT00157248|18364957|P1|Overall Study|Protocol Violation|4
5335243|NCT00157248|18364954|P4|Overall Study|Adverse Event|33
5335244|NCT00157248|18364955|P3|Overall Study|Adverse Event|13
5335245|NCT00157248|18364956|P2|Overall Study|Adverse Event|25
5335246|NCT00157248|18364957|P1|Overall Study|Adverse Event|36
5335247|NCT00157209|18365063|P2|Overall Study|Ongoing at data cut-off|0
5335248|NCT00157209|18365064|P1|Overall Study|Ongoing at data cut-off|10
5335249|NCT00157196|18365078|P1|Overall Study|Ongoing at data cut-off|9
5335250|NCT00157157|18365084|P1|Overall Study|Inclusion not met- baseline FVIII value|1
5335251|NCT00157157|18365084|P1|Overall Study|Met exclusion criteria|1
5335252|NCT00157157|18365084|P1|Overall Study|Enrolled in another study|1
5335253|NCT00157157|18365084|P1|Overall Study|Lost to Follow-up|1
5335254|NCT00157157|18365084|P1|Overall Study|Physician Decision|1
5335255|NCT00157157|18365084|P1|Overall Study|Withdrawal by Subject|6
5335256|NCT00157014|18365111|P4|Overall Study|Withdrawal by Subject|0
5335257|NCT00157014|18365112|P3|Overall Study|Withdrawal by Subject|0
5335258|NCT00157014|18365113|P2|Overall Study|Withdrawal by Subject|0
5335259|NCT00157014|18365114|P1|Overall Study|Withdrawal by Subject|1
5335260|NCT00157014|18365111|P4|Overall Study|Patient would not receive transplant|0
5335261|NCT00157014|18365112|P3|Overall Study|Patient would not receive transplant|0
5335262|NCT00157014|18365113|P2|Overall Study|Patient would not receive transplant|1
5335263|NCT00157014|18365114|P1|Overall Study|Patient would not receive transplant|0
5335264|NCT00157014|18365111|P4|Overall Study|Patient unable to return in nursing home|0
5335265|NCT00157014|18365112|P3|Overall Study|Patient unable to return in nursing home|0
5335266|NCT00157014|18365113|P2|Overall Study|Patient unable to return in nursing home|0
5335267|NCT00157014|18365114|P1|Overall Study|Patient unable to return in nursing home|1
5335268|NCT00157014|18365111|P4|Overall Study|Patient withdrawn by investigator|0
5335269|NCT00157014|18365112|P3|Overall Study|Patient withdrawn by investigator|0
5335270|NCT00157014|18365113|P2|Overall Study|Patient withdrawn by investigator|0
5335271|NCT00157014|18365114|P1|Overall Study|Patient withdrawn by investigator|1
5335272|NCT00157014|18365111|P4|Overall Study|Medications withdrawn on family request|0
5335273|NCT00157014|18365112|P3|Overall Study|Medications withdrawn on family request|0
5335274|NCT00157014|18365113|P2|Overall Study|Medications withdrawn on family request|1
5335275|NCT00157014|18365114|P1|Overall Study|Medications withdrawn on family request|0
5335276|NCT00157014|18365111|P4|Overall Study|Physician Decision|0
5335277|NCT00157014|18365112|P3|Overall Study|Physician Decision|0
5335278|NCT00157014|18365113|P2|Overall Study|Physician Decision|1
5335279|NCT00157014|18365114|P1|Overall Study|Physician Decision|0
5335280|NCT00157014|18365111|P4|Overall Study|Death|1
5335281|NCT00157014|18365112|P3|Overall Study|Death|1
5335282|NCT00157014|18365113|P2|Overall Study|Death|2
5335283|NCT00157014|18365114|P1|Overall Study|Death|4
5335284|NCT00156819|18365230|P3|Overall Study|Lost to Follow-up|3
5335285|NCT00156819|18365231|P2|Overall Study|Lost to Follow-up|1
5335286|NCT00156819|18365232|P1|Overall Study|Lost to Follow-up|1
5335287|NCT00156533|18365249|P4|Overall Study|Failed Screening|1
5335288|NCT00156533|18365250|P3|Overall Study|Failed Screening|1
5335289|NCT00156533|18365251|P2|Overall Study|Failed Screening|0
5335290|NCT00156533|18365252|P1|Overall Study|Failed Screening|1
5335291|NCT00156533|18365249|P4|Overall Study|Withdrawal by Subject|1
5335292|NCT00156533|18365250|P3|Overall Study|Withdrawal by Subject|0
5335293|NCT00156533|18365251|P2|Overall Study|Withdrawal by Subject|0
5335294|NCT00156533|18365252|P1|Overall Study|Withdrawal by Subject|1
5335295|NCT00156533|18365249|P4|Overall Study|Withdrawn - Medication Expiration|0
5335296|NCT00156533|18365250|P3|Overall Study|Withdrawn - Medication Expiration|1
5335297|NCT00156533|18365251|P2|Overall Study|Withdrawn - Medication Expiration|2
5335298|NCT00156533|18365252|P1|Overall Study|Withdrawn - Medication Expiration|0
5335299|NCT00156065|18365286|P3|Overall Study|Other|3
5335300|NCT00156065|18365287|P2|Overall Study|Other|9
5335301|NCT00156065|18365288|P1|Overall Study|Other|2
5335302|NCT00156065|18365286|P3|Overall Study|Lost to Follow-up|1
5335303|NCT00156065|18365287|P2|Overall Study|Lost to Follow-up|7
5335304|NCT00156065|18365288|P1|Overall Study|Lost to Follow-up|5
5335305|NCT00156065|18365286|P3|Overall Study|Withdrawal by Subject|16
5335306|NCT00156065|18365287|P2|Overall Study|Withdrawal by Subject|26
5335307|NCT00156065|18365288|P1|Overall Study|Withdrawal by Subject|13
5335308|NCT00156065|18365286|P3|Overall Study|Lack of Efficacy|3
5335309|NCT00156065|18365287|P2|Overall Study|Lack of Efficacy|9
5335310|NCT00156065|18365288|P1|Overall Study|Lack of Efficacy|2
5335311|NCT00156065|18365286|P3|Overall Study|Adverse Event|4
5335312|NCT00156065|18365287|P2|Overall Study|Adverse Event|11
5335313|NCT00156065|18365288|P1|Overall Study|Adverse Event|8
5335314|NCT00156065|18365286|P3|Overall Study|Enrolled But Never Received Treatment|0
5335315|NCT00156065|18365287|P2|Overall Study|Enrolled But Never Received Treatment|1
5335316|NCT00156065|18365288|P1|Overall Study|Enrolled But Never Received Treatment|1
5335317|NCT00154375|18365322|P2|Overall Study|Suspected progression of disease|30
5335318|NCT00154375|18365323|P1|Overall Study|Suspected progression of disease|44
5335319|NCT00154375|18365322|P2|Overall Study|Protocol Violation|1
5335320|NCT00154375|18365323|P1|Overall Study|Protocol Violation|0
5335321|NCT00154375|18365322|P2|Overall Study|Abnormal laboratory value(s)|2
5335322|NCT00154375|18365323|P1|Overall Study|Abnormal laboratory value(s)|0
5335323|NCT00154375|18365322|P2|Overall Study|Lost to Follow-up|1
5335324|NCT00154375|18365323|P1|Overall Study|Lost to Follow-up|2
5335325|NCT00154375|18365322|P2|Overall Study|Study drug no longer required|3
5335326|NCT00154375|18365323|P1|Overall Study|Study drug no longer required|5
5335327|NCT00154375|18365322|P2|Overall Study|Death|13
5335328|NCT00154375|18365323|P1|Overall Study|Death|5
5335329|NCT00154375|18365322|P2|Overall Study|Withdrawal by Subject|10
5335330|NCT00154375|18365323|P1|Overall Study|Withdrawal by Subject|14
5335331|NCT00154375|18365322|P2|Overall Study|Adverse Event|20
5335332|NCT00154375|18365323|P1|Overall Study|Adverse Event|18
5335333|NCT00154375|18365322|P2|Overall Study|Unsatisfactory therapeutic effect|26
5335334|NCT00154375|18365323|P1|Overall Study|Unsatisfactory therapeutic effect|25
5335335|NCT00154310|18365334|P2|Overall Study|Death|1
5335336|NCT00154310|18365335|P1|Overall Study|Death|0
5335337|NCT00154310|18365334|P2|Overall Study|Administrative problems|1
5335338|NCT00154310|18365335|P1|Overall Study|Administrative problems|0
5335339|NCT00154310|18365334|P2|Overall Study|Lost to Follow-up|8
5335340|NCT00154310|18365335|P1|Overall Study|Lost to Follow-up|0
5335341|NCT00154310|18365334|P2|Overall Study|Withdrawal by Subject|3
5335342|NCT00154310|18365335|P1|Overall Study|Withdrawal by Subject|9
5335343|NCT00154310|18365334|P2|Overall Study|Protocol Violation|2
5335344|NCT00154310|18365335|P1|Overall Study|Protocol Violation|4
5335345|NCT00154310|18365334|P2|Overall Study|Lack of Efficacy|4
5335346|NCT00154310|18365335|P1|Overall Study|Lack of Efficacy|5
5335347|NCT00154310|18365334|P2|Overall Study|Adverse Event|9
5335348|NCT00154310|18365335|P1|Overall Study|Adverse Event|19
5335349|NCT00154297|18365351|P2|Overall Study|Lost to Follow-up|0
5335350|NCT00154297|18365352|P1|Overall Study|Lost to Follow-up|3
5335351|NCT00154297|18365351|P2|Overall Study|Withdrawal by Subject|5
5335352|NCT00154297|18365352|P1|Overall Study|Withdrawal by Subject|0
5335353|NCT00154297|18365351|P2|Overall Study|Death|2
5335354|NCT00154297|18365352|P1|Overall Study|Death|5
5335355|NCT00154284|18365370|P2|Overall Study|Protocol Violation|1
5335356|NCT00154284|18365371|P1|Overall Study|Protocol Violation|0
5335357|NCT00154284|18365370|P2|Overall Study|Lack of Efficacy|2
5335358|NCT00154284|18365371|P1|Overall Study|Lack of Efficacy|1
5335359|NCT00154284|18365370|P2|Overall Study|Abnormal laboratory value(s)|1
5335360|NCT00154284|18365371|P1|Overall Study|Abnormal laboratory value(s)|0
5335361|NCT00154284|18365370|P2|Overall Study|Adverse Event|9
5335362|NCT00154284|18365371|P1|Overall Study|Adverse Event|6
5335363|NCT00154102|18365385|P2|Overall Study|investigational study phase ongoing|2
5335364|NCT00154102|18365386|P1|Overall Study|investigational study phase ongoing|7
5335365|NCT00154063|18365422|P2|Overall Study|Other|3
5335366|NCT00154063|18365423|P1|Overall Study|Other|3
5335367|NCT00154063|18365422|P2|Overall Study|Withdrawal by Subject|9
5335368|NCT00154063|18365423|P1|Overall Study|Withdrawal by Subject|4
5335369|NCT00154063|18365422|P2|Overall Study|Investigator or Sponsor Request|1
5335370|NCT00154063|18365423|P1|Overall Study|Investigator or Sponsor Request|0
5335371|NCT00154063|18365422|P2|Overall Study|Protocol Violation|1
5335372|NCT00154063|18365423|P1|Overall Study|Protocol Violation|1
5335373|NCT00154063|18365422|P2|Overall Study|Adverse Event|8
5335374|NCT00154063|18365423|P1|Overall Study|Adverse Event|4
5335375|NCT00153920|18365485|P1|Overall Study|Progressive Disease before Trt|1
5335376|NCT00153920|18365485|P1|Overall Study|Withdrawal of Consent before Trt|1
5335377|NCT00153920|18365485|P1|Overall Study|Non-Protocol Therapy|1
5335378|NCT00153920|18365485|P1|Overall Study|Withdrawal by Subject|1
5335379|NCT00153920|18365485|P1|Overall Study|Death|2
5335380|NCT00153920|18365485|P1|Overall Study|Lack of Response|3
5335381|NCT00153920|18365485|P1|Overall Study|Physician Decision|3
5335382|NCT00153920|18365485|P1|Overall Study|Progressive Disease|9
5335383|NCT00153920|18365485|P1|Overall Study|Adverse Event|9
5335384|NCT00153816|18365511|P6|Overall Study|Follow-up exam done, histology missing|2
5335385|NCT00153816|18365512|P5|Overall Study|Follow-up exam done, histology missing|1
5335386|NCT00153816|18365513|P4|Overall Study|Follow-up exam done, histology missing|3
5335387|NCT00153816|18365514|P3|Overall Study|Follow-up exam done, histology missing|3
5335388|NCT00153816|18365515|P2|Overall Study|Follow-up exam done, histology missing|3
5335389|NCT00153816|18365516|P1|Overall Study|Follow-up exam done, histology missing|2
5335390|NCT00153816|18365511|P6|Overall Study|Follow-up exam not done|9
5335391|NCT00153816|18365512|P5|Overall Study|Follow-up exam not done|8
5335392|NCT00153816|18365513|P4|Overall Study|Follow-up exam not done|10
5335393|NCT00153816|18365514|P3|Overall Study|Follow-up exam not done|11
5335394|NCT00153816|18365515|P2|Overall Study|Follow-up exam not done|7
5335395|NCT00153816|18365516|P1|Overall Study|Follow-up exam not done|8
5335396|NCT00153816|18365511|P6|Overall Study|Withdrawal by Subject|5
5335397|NCT00153816|18365512|P5|Overall Study|Withdrawal by Subject|1
5335398|NCT00153816|18365513|P4|Overall Study|Withdrawal by Subject|4
5335399|NCT00153816|18365514|P3|Overall Study|Withdrawal by Subject|9
5335400|NCT00153816|18365515|P2|Overall Study|Withdrawal by Subject|9
5335401|NCT00153816|18365516|P1|Overall Study|Withdrawal by Subject|9
5335402|NCT00153816|18365511|P6|Overall Study|Lost to Follow-up|9
5335403|NCT00153816|18365512|P5|Overall Study|Lost to Follow-up|7
5335404|NCT00153816|18365513|P4|Overall Study|Lost to Follow-up|8
5335405|NCT00153816|18365514|P3|Overall Study|Lost to Follow-up|5
5335406|NCT00153816|18365515|P2|Overall Study|Lost to Follow-up|8
5335407|NCT00153816|18365516|P1|Overall Study|Lost to Follow-up|7
5335408|NCT00153816|18365511|P6|Overall Study|Death|2
5335409|NCT00153816|18365512|P5|Overall Study|Death|0
5335410|NCT00153816|18365513|P4|Overall Study|Death|6
5335411|NCT00153816|18365514|P3|Overall Study|Death|4
5335412|NCT00153816|18365515|P2|Overall Study|Death|5
5335413|NCT00153816|18365516|P1|Overall Study|Death|6
5335414|NCT00153179|18365557|P4|Study Visit Day 2|Withdrawal by Subject|2
5335415|NCT00153179|18365558|P3|Study Visit Day 2|Withdrawal by Subject|2
5335416|NCT00153179|18365559|P2|Study Visit Day 2|Withdrawal by Subject|0
5335417|NCT00153179|18365560|P1|Study Visit Day 2|Withdrawal by Subject|1
5335418|NCT00153101|18365592|P5|Overall Study|Withdrawal by Subject|5
5335419|NCT00153101|18365593|P4|Overall Study|Withdrawal by Subject|3
5335420|NCT00153101|18365594|P3|Overall Study|Withdrawal by Subject|3
5335421|NCT00153101|18365595|P2|Overall Study|Withdrawal by Subject|4
5335422|NCT00153101|18365596|P1|Overall Study|Withdrawal by Subject|3
5335423|NCT00153101|18365592|P5|Overall Study|Lost to Follow-up|5
5335424|NCT00153101|18365593|P4|Overall Study|Lost to Follow-up|5
5335425|NCT00153101|18365594|P3|Overall Study|Lost to Follow-up|12
5335426|NCT00153101|18365595|P2|Overall Study|Lost to Follow-up|14
5335427|NCT00153101|18365596|P1|Overall Study|Lost to Follow-up|14
5335428|NCT00153062|18365704|P4|Overall Study|Other|0
5335429|NCT00153062|18365705|P3|Overall Study|Other|1
5335430|NCT00153062|18365706|P2|Overall Study|Other|0
5335431|NCT00153062|18365707|P1|Overall Study|Other|0
5335432|NCT00153062|18365704|P4|Overall Study|No disposition data available|1
5335433|NCT00153062|18365705|P3|Overall Study|No disposition data available|1
5335434|NCT00153062|18365706|P2|Overall Study|No disposition data available|1
5335435|NCT00153062|18365707|P1|Overall Study|No disposition data available|1
5335436|NCT00153062|18365704|P4|Overall Study|Protocol Violation|1
5335437|NCT00153062|18365705|P3|Overall Study|Protocol Violation|1
5335438|NCT00153062|18365706|P2|Overall Study|Protocol Violation|2
5335439|NCT00153062|18365707|P1|Overall Study|Protocol Violation|0
5335440|NCT00153062|18365704|P4|Overall Study|Adverse Event|0
5335441|NCT00153062|18365705|P3|Overall Study|Adverse Event|1
5335442|NCT00153062|18365706|P2|Overall Study|Adverse Event|1
5335443|NCT00153062|18365707|P1|Overall Study|Adverse Event|0
5335444|NCT00153062|18365704|P4|Overall Study|Lost to Follow-up|16
5335445|NCT00153062|18365705|P3|Overall Study|Lost to Follow-up|15
5335446|NCT00153062|18365706|P2|Overall Study|Lost to Follow-up|20
5335447|NCT00153062|18365707|P1|Overall Study|Lost to Follow-up|12
5335448|NCT00153062|18365704|P4|Overall Study|Withdrawal by Subject|28
5335449|NCT00153062|18365705|P3|Overall Study|Withdrawal by Subject|27
5335450|NCT00153062|18365706|P2|Overall Study|Withdrawal by Subject|30
5335451|NCT00153062|18365707|P1|Overall Study|Withdrawal by Subject|14
5335452|NCT00153062|18365704|P4|Overall Study|Death|365
5335453|NCT00153062|18365705|P3|Overall Study|Death|369
5335454|NCT00153062|18365706|P2|Overall Study|Death|352
5335455|NCT00153062|18365707|P1|Overall Study|Death|360
5335456|NCT00152971|18365726|P3|Treatment|Other|10
5335457|NCT00152971|18365727|P2|Treatment|Other|11
5335458|NCT00152971|18365728|P1|Treatment|Other|9
5335459|NCT00152971|18365726|P3|Treatment|Withdrawal by Subject|5
5335460|NCT00152971|18365727|P2|Treatment|Withdrawal by Subject|4
5335461|NCT00152971|18365728|P1|Treatment|Withdrawal by Subject|4
5335462|NCT00152971|18365726|P3|Treatment|Lost to Follow-up|1
5335463|NCT00152971|18365727|P2|Treatment|Lost to Follow-up|2
5335464|NCT00152971|18365728|P1|Treatment|Lost to Follow-up|1
5335465|NCT00152971|18365726|P3|Treatment|Protocol Violation|10
5335466|NCT00152971|18365727|P2|Treatment|Protocol Violation|6
5335467|NCT00152971|18365728|P1|Treatment|Protocol Violation|8
5335468|NCT00152971|18365726|P3|Treatment|Adverse Event|54
5335469|NCT00152971|18365727|P2|Treatment|Adverse Event|40
5335470|NCT00152971|18365728|P1|Treatment|Adverse Event|49
5335471|NCT00152971|18365726|P3|Overall Study|Other|5
5335472|NCT00152971|18365727|P2|Overall Study|Other|5
5335473|NCT00152971|18365728|P1|Overall Study|Other|3
5335474|NCT00152971|18365726|P3|Overall Study|Withdrawal by Subject|14
5335475|NCT00152971|18365727|P2|Overall Study|Withdrawal by Subject|8
5335476|NCT00152971|18365728|P1|Overall Study|Withdrawal by Subject|9
5335477|NCT00152971|18365726|P3|Overall Study|Lost to Follow-up|13
5335478|NCT00152971|18365727|P2|Overall Study|Lost to Follow-up|14
5335479|NCT00152971|18365728|P1|Overall Study|Lost to Follow-up|17
5335480|NCT00152971|18365726|P3|Overall Study|Protocol Violation|8
5335481|NCT00152971|18365727|P2|Overall Study|Protocol Violation|11
5335482|NCT00152971|18365728|P1|Overall Study|Protocol Violation|10
5335483|NCT00152971|18365726|P3|Overall Study|Adverse Event|9
5335484|NCT00152971|18365727|P2|Overall Study|Adverse Event|10
5335485|NCT00152971|18365728|P1|Overall Study|Adverse Event|12
5335486|NCT00152763|18365764|P4|Overall Study|Lost to Follow-up|13
5335487|NCT00152763|18365765|P3|Overall Study|Lost to Follow-up|2
5335488|NCT00152763|18365766|P2|Overall Study|Lost to Follow-up|4
5335489|NCT00152763|18365767|P1|Overall Study|Lost to Follow-up|6
5335490|NCT00152763|18365764|P4|Overall Study|Death|1
5335491|NCT00152763|18365765|P3|Overall Study|Death|2
5335492|NCT00152763|18365766|P2|Overall Study|Death|1
5335493|NCT00152763|18365767|P1|Overall Study|Death|4
5335494|NCT00152516|18365883|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
5335495|NCT00152516|18365883|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
5335496|NCT00152516|18365883|P1|Overall Study|Other: Moved Out Of State|1
5335497|NCT00152516|18365883|P1|Overall Study|Other: Primary Care Physician's Decision|1
5335498|NCT00152516|18365883|P1|Overall Study|Other: Non-Compliance|2
5335499|NCT00152516|18365883|P1|Overall Study|Other: Parents Withdrew Consent|2
5335500|NCT00152516|18365883|P1|Overall Study|Other: Given Commercial Drug in Error|2
5335501|NCT00152516|18365883|P1|Overall Study|Other: Mother Refused To Cooperate|1
5335502|NCT00152516|18365883|P1|Overall Study|Protocol Violation|3
5335503|NCT00152516|18365883|P1|Overall Study|Withdrawal by Subject|8
5335504|NCT00152516|18365883|P1|Overall Study|Lost to Follow-up|5
5335505|NCT00152516|18365883|P1|Overall Study|Lack and Loss of Efficacy|30
5335506|NCT00152516|18365883|P1|Overall Study|Adverse Event|18
5335507|NCT00152464|18365909|P2|Overall Study|Patient relocated|0
5335508|NCT00152464|18365910|P1|Overall Study|Patient relocated|1
5335509|NCT00152464|18365909|P2|Overall Study|Eczema poorly controlled|0
5335510|NCT00152464|18365910|P1|Overall Study|Eczema poorly controlled|1
5335511|NCT00152464|18365909|P2|Overall Study|Lack of Efficacy|0
5335512|NCT00152464|18365910|P1|Overall Study|Lack of Efficacy|1
5335513|NCT00152464|18365909|P2|Overall Study|Investigator decision|0
5335514|NCT00152464|18365910|P1|Overall Study|Investigator decision|1
5335515|NCT00152464|18365909|P2|Overall Study|Parent decision|1
5335516|NCT00152464|18365910|P1|Overall Study|Parent decision|1
5335517|NCT00152464|18365909|P2|Overall Study|Eczema deterioration|1
5335518|NCT00152464|18365910|P1|Overall Study|Eczema deterioration|0
5335519|NCT00152464|18365909|P2|Overall Study|Atopic dermatitis poorly controlled|1
5335520|NCT00152464|18365910|P1|Overall Study|Atopic dermatitis poorly controlled|0
5335521|NCT00152464|18365909|P2|Overall Study|Withdrawal by Subject|22
5335522|NCT00152464|18365910|P1|Overall Study|Withdrawal by Subject|21
5335523|NCT00152464|18365909|P2|Overall Study|Protocol Violation|1
5335524|NCT00152464|18365910|P1|Overall Study|Protocol Violation|3
5335525|NCT00152464|18365909|P2|Overall Study|Lost to Follow-up|4
5335526|NCT00152464|18365910|P1|Overall Study|Lost to Follow-up|8
5335527|NCT00152464|18365909|P2|Overall Study|Adverse Event|6
5335528|NCT00152464|18365910|P1|Overall Study|Adverse Event|3
5335529|NCT00152009|18365938|P4|Overall Study|Sponsor's decision|3
5335530|NCT00152009|18365939|P3|Overall Study|Sponsor's decision|1
5335531|NCT00152009|18365940|P2|Overall Study|Sponsor's decision|3
5335532|NCT00152009|18365941|P1|Overall Study|Sponsor's decision|3
5335533|NCT00152009|18365938|P4|Overall Study|ECG abnormalities|1
5335534|NCT00152009|18365939|P3|Overall Study|ECG abnormalities|2
5335535|NCT00152009|18365940|P2|Overall Study|ECG abnormalities|2
5335536|NCT00152009|18365941|P1|Overall Study|ECG abnormalities|2
5335537|NCT00152009|18365938|P4|Overall Study|Lack of Efficacy|15
5335538|NCT00152009|18365939|P3|Overall Study|Lack of Efficacy|7
5335539|NCT00152009|18365940|P2|Overall Study|Lack of Efficacy|6
5335540|NCT00152009|18365941|P1|Overall Study|Lack of Efficacy|8
5335541|NCT00152009|18365938|P4|Overall Study|Lost to Follow-up|3
5335542|NCT00152009|18365939|P3|Overall Study|Lost to Follow-up|3
5335543|NCT00152009|18365940|P2|Overall Study|Lost to Follow-up|4
5335544|NCT00152009|18365941|P1|Overall Study|Lost to Follow-up|2
5335545|NCT00152009|18365938|P4|Overall Study|Withdrawal by Subject|9
5335546|NCT00152009|18365939|P3|Overall Study|Withdrawal by Subject|4
5335547|NCT00152009|18365940|P2|Overall Study|Withdrawal by Subject|3
5335548|NCT00152009|18365941|P1|Overall Study|Withdrawal by Subject|2
5335549|NCT00152009|18365938|P4|Overall Study|Protocol Violation|1
5335550|NCT00152009|18365939|P3|Overall Study|Protocol Violation|0
5335551|NCT00152009|18365940|P2|Overall Study|Protocol Violation|0
5335552|NCT00152009|18365941|P1|Overall Study|Protocol Violation|3
5335553|NCT00152009|18365938|P4|Overall Study|Adverse Event|1
5335554|NCT00152009|18365939|P3|Overall Study|Adverse Event|20
5335555|NCT00152009|18365940|P2|Overall Study|Adverse Event|13
5335556|NCT00152009|18365941|P1|Overall Study|Adverse Event|9
5335557|NCT00151996|18365973|P2|Overall Study|Sponsor's decision|2
5335558|NCT00151996|18365974|P1|Overall Study|Sponsor's decision|0
5335559|NCT00151996|18365973|P2|Overall Study|Protocol Violation|2
5335560|NCT00151996|18365974|P1|Overall Study|Protocol Violation|1
5335561|NCT00151996|18365973|P2|Overall Study|Withdrawal by Subject|1
5335562|NCT00151996|18365974|P1|Overall Study|Withdrawal by Subject|1
5335563|NCT00151996|18365973|P2|Overall Study|Adverse Event|2
5335564|NCT00151996|18365974|P1|Overall Study|Adverse Event|3
5335565|NCT00151892|18365990|P2|Overall Study|Lack of study medication at center|1
5335566|NCT00151892|18365991|P1|Overall Study|Lack of study medication at center|0
5335567|NCT00151892|18365990|P2|Overall Study|Used prohibited corticosteroids|0
5335568|NCT00151892|18365991|P1|Overall Study|Used prohibited corticosteroids|1
5335569|NCT00151892|18365990|P2|Overall Study|Did not return for a visit|0
5335570|NCT00151892|18365991|P1|Overall Study|Did not return for a visit|1
5335571|NCT00151892|18365990|P2|Overall Study|Pregnancy|1
5335572|NCT00151892|18365991|P1|Overall Study|Pregnancy|0
5335573|NCT00151892|18365990|P2|Overall Study|Non-compliance|1
5335574|NCT00151892|18365991|P1|Overall Study|Non-compliance|0
5335575|NCT00151892|18365990|P2|Overall Study|Protocol Violation|3
5335576|NCT00151892|18365991|P1|Overall Study|Protocol Violation|3
5335577|NCT00151892|18365990|P2|Overall Study|Adverse Event|3
5335578|NCT00151892|18365991|P1|Overall Study|Adverse Event|6
5335579|NCT00151892|18365990|P2|Overall Study|Lost to Follow-up|10
5335580|NCT00151892|18365991|P1|Overall Study|Lost to Follow-up|5
5335581|NCT00151892|18365990|P2|Overall Study|Patient request|7
5335582|NCT00151892|18365991|P1|Overall Study|Patient request|10
5335583|NCT00151892|18365990|P2|Overall Study|Lack of Efficacy|57
5335584|NCT00151892|18365991|P1|Overall Study|Lack of Efficacy|50
5335585|NCT00151775|18366036|P12|Period 4: Open Label|Protocol Violation|0
5335586|NCT00151775|18366037|P11|Period 4: Open Label|Protocol Violation|0
5335587|NCT00151775|18366038|P10|Period 4: Open Label|Protocol Violation|0
5335588|NCT00151775|18366039|P9|Period 4: Open Label|Protocol Violation|0
5335589|NCT00151775|18366040|P8|Period 4: Open Label|Protocol Violation|0
5335590|NCT00151775|18366041|P7|Period 4: Open Label|Protocol Violation|0
5335591|NCT00151775|18366042|P6|Period 4: Open Label|Protocol Violation|0
5335592|NCT00151775|18366043|P5|Period 4: Open Label|Protocol Violation|1
5335593|NCT00151775|18366044|P4|Period 4: Open Label|Protocol Violation|0
5335594|NCT00151775|18366045|P3|Period 4: Open Label|Protocol Violation|0
5335595|NCT00151775|18366046|P2|Period 4: Open Label|Protocol Violation|0
5335596|NCT00151775|18366047|P1|Period 4: Open Label|Protocol Violation|0
5335597|NCT00151775|18366036|P12|Period 4: Open Label|Physician Decision|0
5335598|NCT00151775|18366037|P11|Period 4: Open Label|Physician Decision|0
5335599|NCT00151775|18366038|P10|Period 4: Open Label|Physician Decision|2
5335600|NCT00151775|18366039|P9|Period 4: Open Label|Physician Decision|0
5335601|NCT00151775|18366040|P8|Period 4: Open Label|Physician Decision|0
5335602|NCT00151775|18366041|P7|Period 4: Open Label|Physician Decision|0
5335603|NCT00151775|18366042|P6|Period 4: Open Label|Physician Decision|0
5335604|NCT00151775|18366043|P5|Period 4: Open Label|Physician Decision|0
5335605|NCT00151775|18366044|P4|Period 4: Open Label|Physician Decision|0
5335606|NCT00151775|18366045|P3|Period 4: Open Label|Physician Decision|0
5335607|NCT00151775|18366046|P2|Period 4: Open Label|Physician Decision|0
5335608|NCT00151775|18366047|P1|Period 4: Open Label|Physician Decision|0
5335609|NCT00151775|18366036|P12|Period 4: Open Label|Other|0
5335610|NCT00151775|18366037|P11|Period 4: Open Label|Other|0
5335611|NCT00151775|18366038|P10|Period 4: Open Label|Other|3
5335612|NCT00151775|18366039|P9|Period 4: Open Label|Other|0
5335613|NCT00151775|18366040|P8|Period 4: Open Label|Other|0
5335614|NCT00151775|18366041|P7|Period 4: Open Label|Other|0
5335615|NCT00151775|18366042|P6|Period 4: Open Label|Other|0
5335616|NCT00151775|18366043|P5|Period 4: Open Label|Other|1
5335617|NCT00151775|18366044|P4|Period 4: Open Label|Other|0
5335618|NCT00151775|18366045|P3|Period 4: Open Label|Other|0
5335619|NCT00151775|18366046|P2|Period 4: Open Label|Other|0
5335620|NCT00151775|18366047|P1|Period 4: Open Label|Other|0
5335621|NCT00151775|18366036|P12|Period 4: Open Label|Non-compliance with protocol|0
5335622|NCT00151775|18366037|P11|Period 4: Open Label|Non-compliance with protocol|0
5335623|NCT00151775|18366038|P10|Period 4: Open Label|Non-compliance with protocol|4
5335624|NCT00151775|18366039|P9|Period 4: Open Label|Non-compliance with protocol|0
5335625|NCT00151775|18366040|P8|Period 4: Open Label|Non-compliance with protocol|0
5335626|NCT00151775|18366041|P7|Period 4: Open Label|Non-compliance with protocol|0
5335627|NCT00151775|18366042|P6|Period 4: Open Label|Non-compliance with protocol|0
5335628|NCT00151775|18366043|P5|Period 4: Open Label|Non-compliance with protocol|4
5335629|NCT00151775|18366044|P4|Period 4: Open Label|Non-compliance with protocol|0
5335630|NCT00151775|18366045|P3|Period 4: Open Label|Non-compliance with protocol|0
5335631|NCT00151775|18366046|P2|Period 4: Open Label|Non-compliance with protocol|0
5335632|NCT00151775|18366047|P1|Period 4: Open Label|Non-compliance with protocol|0
5335633|NCT00151775|18366036|P12|Period 4: Open Label|Lost to Follow-up|0
5335634|NCT00151775|18366037|P11|Period 4: Open Label|Lost to Follow-up|0
5335635|NCT00151775|18366038|P10|Period 4: Open Label|Lost to Follow-up|7
5335636|NCT00151775|18366039|P9|Period 4: Open Label|Lost to Follow-up|0
5335637|NCT00151775|18366040|P8|Period 4: Open Label|Lost to Follow-up|0
5335638|NCT00151775|18366041|P7|Period 4: Open Label|Lost to Follow-up|0
5335639|NCT00151775|18366042|P6|Period 4: Open Label|Lost to Follow-up|0
5335640|NCT00151775|18366043|P5|Period 4: Open Label|Lost to Follow-up|17
5335641|NCT00151775|18366044|P4|Period 4: Open Label|Lost to Follow-up|0
5335642|NCT00151775|18366045|P3|Period 4: Open Label|Lost to Follow-up|0
5335643|NCT00151775|18366046|P2|Period 4: Open Label|Lost to Follow-up|0
5335644|NCT00151775|18366047|P1|Period 4: Open Label|Lost to Follow-up|0
5335645|NCT00151775|18366036|P12|Period 4: Open Label|Adverse Event|0
5335646|NCT00151775|18366037|P11|Period 4: Open Label|Adverse Event|0
5335647|NCT00151775|18366038|P10|Period 4: Open Label|Adverse Event|2
5335648|NCT00151775|18366039|P9|Period 4: Open Label|Adverse Event|0
5335649|NCT00151775|18366040|P8|Period 4: Open Label|Adverse Event|0
5335650|NCT00151775|18366041|P7|Period 4: Open Label|Adverse Event|0
5335651|NCT00151775|18366042|P6|Period 4: Open Label|Adverse Event|0
5335652|NCT00151775|18366043|P5|Period 4: Open Label|Adverse Event|1
5335653|NCT00151775|18366044|P4|Period 4: Open Label|Adverse Event|0
5335654|NCT00151775|18366045|P3|Period 4: Open Label|Adverse Event|0
5335655|NCT00151775|18366046|P2|Period 4: Open Label|Adverse Event|0
5335656|NCT00151775|18366047|P1|Period 4: Open Label|Adverse Event|0
5335657|NCT00151775|18366036|P12|Period 4: Open Label|Withdrawal by Subject|0
5335658|NCT00151775|18366037|P11|Period 4: Open Label|Withdrawal by Subject|0
5335659|NCT00151775|18366038|P10|Period 4: Open Label|Withdrawal by Subject|2
5335660|NCT00151775|18366039|P9|Period 4: Open Label|Withdrawal by Subject|0
5335661|NCT00151775|18366040|P8|Period 4: Open Label|Withdrawal by Subject|0
5335662|NCT00151775|18366041|P7|Period 4: Open Label|Withdrawal by Subject|0
5335663|NCT00151775|18366042|P6|Period 4: Open Label|Withdrawal by Subject|0
5335664|NCT00151775|18366043|P5|Period 4: Open Label|Withdrawal by Subject|5
5335665|NCT00151775|18366044|P4|Period 4: Open Label|Withdrawal by Subject|0
5335666|NCT00151775|18366045|P3|Period 4: Open Label|Withdrawal by Subject|0
5335667|NCT00151775|18366046|P2|Period 4: Open Label|Withdrawal by Subject|0
5335668|NCT00151775|18366047|P1|Period 4: Open Label|Withdrawal by Subject|0
5335669|NCT00151775|18366036|P12|Period 4: Open Label|Increased blood pressure|0
5335670|NCT00151775|18366037|P11|Period 4: Open Label|Increased blood pressure|0
5335671|NCT00151775|18366038|P10|Period 4: Open Label|Increased blood pressure|1
5335672|NCT00151775|18366039|P9|Period 4: Open Label|Increased blood pressure|0
5335673|NCT00151775|18366040|P8|Period 4: Open Label|Increased blood pressure|0
5335674|NCT00151775|18366041|P7|Period 4: Open Label|Increased blood pressure|0
5335675|NCT00151775|18366042|P6|Period 4: Open Label|Increased blood pressure|0
5335676|NCT00151775|18366043|P5|Period 4: Open Label|Increased blood pressure|1
5335677|NCT00151775|18366044|P4|Period 4: Open Label|Increased blood pressure|0
5335678|NCT00151775|18366045|P3|Period 4: Open Label|Increased blood pressure|0
5335679|NCT00151775|18366046|P2|Period 4: Open Label|Increased blood pressure|0
5335680|NCT00151775|18366047|P1|Period 4: Open Label|Increased blood pressure|0
5335681|NCT00151775|18366036|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
5335682|NCT00151775|18366037|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335683|NCT00151775|18366038|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335684|NCT00151775|18366039|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335685|NCT00151775|18366040|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335686|NCT00151775|18366041|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335687|NCT00151775|18366042|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335688|NCT00151775|18366043|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335689|NCT00151775|18366044|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335690|NCT00151775|18366045|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335691|NCT00151775|18366046|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335692|NCT00151775|18366047|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5335693|NCT00151775|18366036|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335694|NCT00151775|18366037|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335695|NCT00151775|18366038|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335696|NCT00151775|18366039|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335697|NCT00151775|18366040|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335698|NCT00151775|18366041|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335699|NCT00151775|18366042|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335700|NCT00151775|18366043|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335701|NCT00151775|18366044|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335702|NCT00151775|18366045|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
5335703|NCT00151775|18366046|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335704|NCT00151775|18366047|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5335705|NCT00151775|18366036|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335706|NCT00151775|18366037|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335707|NCT00151775|18366038|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335708|NCT00151775|18366039|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335709|NCT00151775|18366040|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335710|NCT00151775|18366041|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335711|NCT00151775|18366042|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335712|NCT00151775|18366043|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335713|NCT00151775|18366044|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335714|NCT00151775|18366045|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
5335715|NCT00151775|18366046|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335716|NCT00151775|18366047|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
5335717|NCT00151775|18366036|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335718|NCT00151775|18366037|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335719|NCT00151775|18366038|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335720|NCT00151775|18366039|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335721|NCT00151775|18366040|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335722|NCT00151775|18366041|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
5335723|NCT00151775|18366042|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335724|NCT00151775|18366043|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335725|NCT00151775|18366044|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335726|NCT00151775|18366045|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335727|NCT00151775|18366046|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335728|NCT00151775|18366047|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5335729|NCT00151775|18366036|P12|Period 3: Double-blind, Withdrawal|Other|0
5335730|NCT00151775|18366037|P11|Period 3: Double-blind, Withdrawal|Other|0
5335731|NCT00151775|18366038|P10|Period 3: Double-blind, Withdrawal|Other|0
5335732|NCT00151775|18366039|P9|Period 3: Double-blind, Withdrawal|Other|0
5335733|NCT00151775|18366040|P8|Period 3: Double-blind, Withdrawal|Other|1
5335734|NCT00151775|18366041|P7|Period 3: Double-blind, Withdrawal|Other|0
5335735|NCT00151775|18366042|P6|Period 3: Double-blind, Withdrawal|Other|0
5335736|NCT00151775|18366043|P5|Period 3: Double-blind, Withdrawal|Other|0
5335737|NCT00151775|18366044|P4|Period 3: Double-blind, Withdrawal|Other|0
5335738|NCT00151775|18366045|P3|Period 3: Double-blind, Withdrawal|Other|1
5335739|NCT00151775|18366046|P2|Period 3: Double-blind, Withdrawal|Other|0
5335740|NCT00151775|18366047|P1|Period 3: Double-blind, Withdrawal|Other|0
5335741|NCT00151775|18366036|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335742|NCT00151775|18366037|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335743|NCT00151775|18366038|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335744|NCT00151775|18366039|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335745|NCT00151775|18366040|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335746|NCT00151775|18366041|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335747|NCT00151775|18366042|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
5335748|NCT00151775|18366043|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335749|NCT00151775|18366044|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335750|NCT00151775|18366045|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335751|NCT00151775|18366046|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335752|NCT00151775|18366047|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5335753|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335754|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335755|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335756|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335757|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335758|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
5335759|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335760|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335761|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335762|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335763|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335764|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5335765|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335766|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335767|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335768|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335769|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335770|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335771|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
5335772|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335773|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335774|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335775|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335776|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
5335777|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
5335778|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
5335779|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
5335780|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
5335781|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
5335782|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
5335783|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
5335784|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
5335785|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
5335786|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
5335787|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
5335788|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
5335789|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|Other|0
5335790|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|Other|0
5335791|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|Other|0
5335792|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|Other|0
5335793|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|Other|0
5335794|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|Other|1
5335795|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|Other|0
5335796|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|Other|0
5335797|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|Other|0
5335798|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|Other|0
5335799|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|Other|0
5335800|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|Other|0
5335801|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335802|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335803|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335804|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335805|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335806|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335807|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335808|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335809|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335810|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335811|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
5335812|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5335813|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335814|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
5335815|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335816|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335817|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335818|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
5335819|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335820|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335821|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335822|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335823|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5335824|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
5335825|NCT00151775|18366036|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335826|NCT00151775|18366037|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335827|NCT00151775|18366038|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335828|NCT00151775|18366039|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335829|NCT00151775|18366040|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335830|NCT00151775|18366041|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335831|NCT00151775|18366042|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335832|NCT00151775|18366043|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335833|NCT00151775|18366044|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335834|NCT00151775|18366045|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
5335835|NCT00151775|18366046|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
5335836|NCT00151775|18366047|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
5335837|NCT00151476|18366091|P2|FAP Analyzed Subjects|Other study participation|1
5335838|NCT00151476|18366092|P1|FAP Analyzed Subjects|Other study participation|0
5335839|NCT00151476|18366091|P2|FAP Analyzed Subjects|Lost to Follow-up|2
5335840|NCT00151476|18366092|P1|FAP Analyzed Subjects|Lost to Follow-up|0
5335841|NCT00151476|18366091|P2|FAP Identified Subjects|Protocol Violation|1
5335842|NCT00151476|18366092|P1|FAP Identified Subjects|Protocol Violation|0
5335843|NCT00151411|18366149|P2|Overall Study|Pregnancy|4
5335844|NCT00151411|18366150|P1|Overall Study|Pregnancy|0
5335845|NCT00151411|18366149|P2|Overall Study|Adverse Event|0
5335846|NCT00151411|18366150|P1|Overall Study|Adverse Event|6
5335847|NCT00151411|18366149|P2|Overall Study|Withdrawal by Subject|20
5335848|NCT00151411|18366150|P1|Overall Study|Withdrawal by Subject|12
5335849|NCT00151411|18366149|P2|Overall Study|Lost to Follow-up|19
5335850|NCT00151411|18366150|P1|Overall Study|Lost to Follow-up|15
5335851|NCT00151372|18366162|P2|Overall Study|Withdrawal by Subject|7
5335852|NCT00151372|18366163|P1|Overall Study|Withdrawal by Subject|7
5335853|NCT00151372|18366162|P2|Overall Study|Too sick medically to continue|6
5335854|NCT00151372|18366163|P1|Overall Study|Too sick medically to continue|5
5335855|NCT00151372|18366162|P2|Overall Study|Lost to Follow-up|5
5335856|NCT00151372|18366163|P1|Overall Study|Lost to Follow-up|5
5335857|NCT00151372|18366162|P2|Overall Study|Death|11
5335858|NCT00151372|18366163|P1|Overall Study|Death|12
5335859|NCT00151281|18366178|P1|Overall Study|Not evaluable|3
5335860|NCT00150969|18366187|P2|24-48 Month Extension|Other Reason|91
5335861|NCT00150969|18366188|P1|24-48 Month Extension|Other Reason|81
5335862|NCT00150969|18366187|P2|24-48 Month Extension|Adverse Event|3
5335863|NCT00150969|18366188|P1|24-48 Month Extension|Adverse Event|1
5335864|NCT00150969|18366187|P2|24-48 Month Extension|Lack of Efficacy|1
5335865|NCT00150969|18366188|P1|24-48 Month Extension|Lack of Efficacy|0
5335866|NCT00150969|18366187|P2|24-48 Month Extension|Withdrawal by Subject|5
5335867|NCT00150969|18366188|P1|24-48 Month Extension|Withdrawal by Subject|6
5335868|NCT00150969|18366187|P2|24 Month Main Study|Withdrawal by Subject|4
5335869|NCT00150969|18366188|P1|24 Month Main Study|Withdrawal by Subject|7
5335870|NCT00150969|18366187|P2|24 Month Main Study|Protocol Violation|2
5335871|NCT00150969|18366188|P1|24 Month Main Study|Protocol Violation|4
5335872|NCT00150969|18366187|P2|24 Month Main Study|Lost to Follow-up|2
5335873|NCT00150969|18366188|P1|24 Month Main Study|Lost to Follow-up|3
5335874|NCT00150969|18366187|P2|24 Month Main Study|Lack of Efficacy|8
5335875|NCT00150969|18366188|P1|24 Month Main Study|Lack of Efficacy|1
5335876|NCT00150969|18366187|P2|24 Month Main Study|Death|1
5335877|NCT00150969|18366188|P1|24 Month Main Study|Death|1
5335878|NCT00150969|18366187|P2|24 Month Main Study|Adverse Event|4
5335879|NCT00150969|18366188|P1|24 Month Main Study|Adverse Event|3
5335880|NCT00150813|18366220|P1|Overall Study|Switch to commercially available LEV|2
5335881|NCT00150813|18366220|P1|Overall Study|Planned pregancy|1
5335882|NCT00150813|18366220|P1|Overall Study|Remission|3
5335883|NCT00150813|18366220|P1|Overall Study|Withdrawal by Subject|5
5335884|NCT00150813|18366220|P1|Overall Study|Lost to Follow-up|5
5335885|NCT00150813|18366220|P1|Overall Study|Lack of Efficacy|1
5335886|NCT00150813|18366220|P1|Overall Study|Adverse Event|1
5335887|NCT00150800|18366224|P1|Overall Study|PI discontinuation request|1
5335888|NCT00150800|18366224|P1|Overall Study|Pregnancy planned|1
5335889|NCT00150800|18366224|P1|Overall Study|Surgical intervention|4
5335890|NCT00150800|18366224|P1|Overall Study|Patient insurance|1
5335891|NCT00150800|18366224|P1|Overall Study|PI leaving site|2
5335892|NCT00150800|18366224|P1|Overall Study|PI retiring|2
5335893|NCT00150800|18366224|P1|Overall Study|Moved from area/country|8
5335894|NCT00150800|18366224|P1|Overall Study|Generalized Epilepsy|1
5335895|NCT00150800|18366224|P1|Overall Study|Sponsor's request|2
5335896|NCT00150800|18366224|P1|Overall Study|Visit refusal|3
5335897|NCT00150800|18366224|P1|Overall Study|BRV monotherapy|1
5335898|NCT00150800|18366224|P1|Overall Study|Neurosurgery|2
5335899|NCT00150800|18366224|P1|Overall Study|Distance too long for patient|1
5335900|NCT00150800|18366224|P1|Overall Study|Nobody to accompany patient|1
5335901|NCT00150800|18366224|P1|Overall Study|Protocol non-adherence|2
5335902|NCT00150800|18366224|P1|Overall Study|Site closure|24
5335903|NCT00150800|18366224|P1|Overall Study|IP misshandling|1
5335904|NCT00150800|18366224|P1|Overall Study|No compliance|18
5335905|NCT00150800|18366224|P1|Overall Study|Subject's choice|90
5335906|NCT00150800|18366224|P1|Overall Study|Lost to Follow-up|58
5335907|NCT00150800|18366224|P1|Overall Study|Lack of Efficacy|166
5335908|NCT00150800|18366224|P1|Overall Study|Death|18
5335909|NCT00150800|18366224|P1|Overall Study|Adverse Event|89
5335910|NCT00150618|18366238|P5|Overall Study|Sponsor's decision|0
5335911|NCT00150618|18366239|P4|Overall Study|Sponsor's decision|1
5335912|NCT00150618|18366240|P3|Overall Study|Sponsor's decision|0
5335913|NCT00150618|18366241|P2|Overall Study|Sponsor's decision|0
5335914|NCT00150618|18366242|P1|Overall Study|Sponsor's decision|0
5335915|NCT00150618|18366238|P5|Overall Study|Abnormal ECG|0
5335916|NCT00150618|18366239|P4|Overall Study|Abnormal ECG|0
5335917|NCT00150618|18366240|P3|Overall Study|Abnormal ECG|0
5335918|NCT00150618|18366241|P2|Overall Study|Abnormal ECG|0
5335919|NCT00150618|18366242|P1|Overall Study|Abnormal ECG|1
5335920|NCT00150618|18366238|P5|Overall Study|Lack of compliance|1
5335921|NCT00150618|18366239|P4|Overall Study|Lack of compliance|0
5335922|NCT00150618|18366240|P3|Overall Study|Lack of compliance|1
5335923|NCT00150618|18366241|P2|Overall Study|Lack of compliance|1
5335924|NCT00150618|18366242|P1|Overall Study|Lack of compliance|2
5335925|NCT00150618|18366238|P5|Overall Study|Physician Decision|1
5335926|NCT00150618|18366239|P4|Overall Study|Physician Decision|0
5335927|NCT00150618|18366240|P3|Overall Study|Physician Decision|0
5335928|NCT00150618|18366241|P2|Overall Study|Physician Decision|2
5335929|NCT00150618|18366242|P1|Overall Study|Physician Decision|0
5335930|NCT00150618|18366238|P5|Overall Study|No study meds|2
5335931|NCT00150618|18366239|P4|Overall Study|No study meds|0
5335932|NCT00150618|18366240|P3|Overall Study|No study meds|0
5335933|NCT00150618|18366241|P2|Overall Study|No study meds|0
5335934|NCT00150618|18366242|P1|Overall Study|No study meds|0
5335935|NCT00150618|18366238|P5|Overall Study|Lack of Efficacy|6
5335936|NCT00150618|18366239|P4|Overall Study|Lack of Efficacy|4
5335937|NCT00150618|18366240|P3|Overall Study|Lack of Efficacy|7
5335938|NCT00150618|18366241|P2|Overall Study|Lack of Efficacy|4
5335939|NCT00150618|18366242|P1|Overall Study|Lack of Efficacy|1
5335940|NCT00150618|18366238|P5|Overall Study|Protocol Violation|1
5335941|NCT00150618|18366239|P4|Overall Study|Protocol Violation|0
5335942|NCT00150618|18366240|P3|Overall Study|Protocol Violation|0
5335943|NCT00150618|18366241|P2|Overall Study|Protocol Violation|0
5335944|NCT00150618|18366242|P1|Overall Study|Protocol Violation|1
5335945|NCT00150618|18366238|P5|Overall Study|Lost to Follow-up|4
5335946|NCT00150618|18366239|P4|Overall Study|Lost to Follow-up|8
5335947|NCT00150618|18366240|P3|Overall Study|Lost to Follow-up|5
5335948|NCT00150618|18366241|P2|Overall Study|Lost to Follow-up|1
5335949|NCT00150618|18366242|P1|Overall Study|Lost to Follow-up|4
5335950|NCT00150618|18366238|P5|Overall Study|Withdrawal by Subject|5
5335951|NCT00150618|18366239|P4|Overall Study|Withdrawal by Subject|4
5335952|NCT00150618|18366240|P3|Overall Study|Withdrawal by Subject|8
5335953|NCT00150618|18366241|P2|Overall Study|Withdrawal by Subject|8
5335954|NCT00150618|18366242|P1|Overall Study|Withdrawal by Subject|6
5335955|NCT00150618|18366238|P5|Overall Study|Adverse Event|5
5335956|NCT00150618|18366239|P4|Overall Study|Adverse Event|9
5335957|NCT00150618|18366240|P3|Overall Study|Adverse Event|6
5335958|NCT00150618|18366241|P2|Overall Study|Adverse Event|2
5335959|NCT00150618|18366242|P1|Overall Study|Adverse Event|2
5335960|NCT00150592|18366276|P2|Overall Study|Non-compliance|0
5335961|NCT00150592|18366277|P1|Overall Study|Non-compliance|1
5335962|NCT00150592|18366276|P2|Overall Study|Withdrawal by Subject|2
5335963|NCT00150592|18366277|P1|Overall Study|Withdrawal by Subject|1
5335964|NCT00150592|18366276|P2|Overall Study|Protocol Violation|0
5335965|NCT00150592|18366277|P1|Overall Study|Protocol Violation|1
5335966|NCT00150592|18366276|P2|Overall Study|Adverse Event|1
5335967|NCT00150592|18366277|P1|Overall Study|Adverse Event|4
5335968|NCT00150462|18366308|P11|Overall Study|Other|1
5335969|NCT00150462|18366309|P10|Overall Study|Other|1
5335970|NCT00150462|18366310|P9|Overall Study|Other|0
5335971|NCT00150462|18366311|P8|Overall Study|Other|0
5335972|NCT00150462|18366312|P7|Overall Study|Other|0
5335973|NCT00150462|18366313|P6|Overall Study|Other|0
5335974|NCT00150462|18366314|P5|Overall Study|Other|0
5335975|NCT00150462|18366315|P4|Overall Study|Other|0
5335976|NCT00150462|18366316|P3|Overall Study|Other|0
5335977|NCT00150462|18366317|P2|Overall Study|Other|0
5335978|NCT00150462|18366318|P1|Overall Study|Other|0
5335979|NCT00150462|18366308|P11|Overall Study|Physician Decision|0
5335980|NCT00150462|18366309|P10|Overall Study|Physician Decision|0
5335981|NCT00150462|18366310|P9|Overall Study|Physician Decision|0
5335982|NCT00150462|18366311|P8|Overall Study|Physician Decision|0
5335983|NCT00150462|18366312|P7|Overall Study|Physician Decision|0
5335984|NCT00150462|18366313|P6|Overall Study|Physician Decision|0
5335985|NCT00150462|18366314|P5|Overall Study|Physician Decision|0
5335986|NCT00150462|18366315|P4|Overall Study|Physician Decision|1
5335987|NCT00150462|18366316|P3|Overall Study|Physician Decision|1
5335988|NCT00150462|18366317|P2|Overall Study|Physician Decision|0
5335989|NCT00150462|18366318|P1|Overall Study|Physician Decision|0
5335990|NCT00150462|18366308|P11|Overall Study|Adverse Event|0
5335991|NCT00150462|18366309|P10|Overall Study|Adverse Event|1
5335992|NCT00150462|18366310|P9|Overall Study|Adverse Event|0
5335993|NCT00150462|18366311|P8|Overall Study|Adverse Event|2
5335994|NCT00150462|18366312|P7|Overall Study|Adverse Event|0
5335995|NCT00150462|18366313|P6|Overall Study|Adverse Event|0
5335996|NCT00150462|18366314|P5|Overall Study|Adverse Event|0
5335997|NCT00150462|18366315|P4|Overall Study|Adverse Event|1
5335998|NCT00150462|18366316|P3|Overall Study|Adverse Event|0
5335999|NCT00150462|18366317|P2|Overall Study|Adverse Event|0
5336000|NCT00150462|18366318|P1|Overall Study|Adverse Event|0
5336001|NCT00150462|18366308|P11|Overall Study|Death|0
5336002|NCT00150462|18366309|P10|Overall Study|Death|0
5336003|NCT00150462|18366310|P9|Overall Study|Death|1
5336004|NCT00150462|18366311|P8|Overall Study|Death|0
5336005|NCT00150462|18366312|P7|Overall Study|Death|0
5336006|NCT00150462|18366313|P6|Overall Study|Death|0
5336007|NCT00150462|18366314|P5|Overall Study|Death|0
5336008|NCT00150462|18366315|P4|Overall Study|Death|0
5336009|NCT00150462|18366316|P3|Overall Study|Death|0
5336010|NCT00150462|18366317|P2|Overall Study|Death|1
5336011|NCT00150462|18366318|P1|Overall Study|Death|0
5336012|NCT00150462|18366308|P11|Overall Study|Withdrawal by Subject|0
5336013|NCT00150462|18366309|P10|Overall Study|Withdrawal by Subject|1
5336014|NCT00150462|18366310|P9|Overall Study|Withdrawal by Subject|0
5336015|NCT00150462|18366311|P8|Overall Study|Withdrawal by Subject|1
5336016|NCT00150462|18366312|P7|Overall Study|Withdrawal by Subject|0
5336017|NCT00150462|18366313|P6|Overall Study|Withdrawal by Subject|2
5336018|NCT00150462|18366314|P5|Overall Study|Withdrawal by Subject|1
5336019|NCT00150462|18366315|P4|Overall Study|Withdrawal by Subject|0
5336020|NCT00150462|18366316|P3|Overall Study|Withdrawal by Subject|1
5336021|NCT00150462|18366317|P2|Overall Study|Withdrawal by Subject|1
5336022|NCT00150462|18366318|P1|Overall Study|Withdrawal by Subject|0
5336023|NCT00150462|18366308|P11|Overall Study|Disease Progression or Relapse|2
5336024|NCT00150462|18366309|P10|Overall Study|Disease Progression or Relapse|3
5336025|NCT00150462|18366310|P9|Overall Study|Disease Progression or Relapse|5
5336026|NCT00150462|18366311|P8|Overall Study|Disease Progression or Relapse|5
5336027|NCT00150462|18366312|P7|Overall Study|Disease Progression or Relapse|3
5336028|NCT00150462|18366313|P6|Overall Study|Disease Progression or Relapse|2
5336029|NCT00150462|18366314|P5|Overall Study|Disease Progression or Relapse|2
5336030|NCT00150462|18366315|P4|Overall Study|Disease Progression or Relapse|1
5336031|NCT00150462|18366316|P3|Overall Study|Disease Progression or Relapse|2
5336032|NCT00150462|18366317|P2|Overall Study|Disease Progression or Relapse|1
5336033|NCT00150462|18366318|P1|Overall Study|Disease Progression or Relapse|3
5336034|NCT00150345|18366428|P2|Overall Study|Other|14
5336035|NCT00150345|18366429|P1|Overall Study|Other|12
5336036|NCT00150345|18366428|P2|Overall Study|Laboratory abnormality|2
5336037|NCT00150345|18366429|P1|Overall Study|Laboratory abnormality|1
5336038|NCT00150345|18366428|P2|Overall Study|Withdrawal by Subject|4
5336039|NCT00150345|18366429|P1|Overall Study|Withdrawal by Subject|3
5336040|NCT00150345|18366428|P2|Overall Study|Lack of Efficacy|4
5336041|NCT00150345|18366429|P1|Overall Study|Lack of Efficacy|5
5336042|NCT00150345|18366428|P2|Overall Study|Adverse Event|6
5336043|NCT00150345|18366429|P1|Overall Study|Adverse Event|8
5336044|NCT00150345|18366428|P2|Overall Study|Death|2
5336045|NCT00150345|18366429|P1|Overall Study|Death|5
5336046|NCT00150176|18366493|P2|Overall Study|OTHER|13
5336047|NCT00150176|18366494|P1|Overall Study|OTHER|11
5336048|NCT00150176|18366493|P2|Overall Study|Lost to Follow-up|3
5336049|NCT00150176|18366494|P1|Overall Study|Lost to Follow-up|3
5336050|NCT00150176|18366493|P2|Overall Study|Withdrawal by Subject|12
5336051|NCT00150176|18366494|P1|Overall Study|Withdrawal by Subject|19
5336052|NCT00150176|18366493|P2|Overall Study|Relapse/Impending relapse, non-AE|39
5336053|NCT00150176|18366494|P1|Overall Study|Relapse/Impending relapse, non-AE|10
5336054|NCT00150176|18366493|P2|Overall Study|Adverse Event|53
5336055|NCT00150176|18366494|P1|Overall Study|Adverse Event|16
5336056|NCT00149994|18366505|P2|Overall Study|Protocol Violation|1
5336057|NCT00149994|18366506|P1|Overall Study|Protocol Violation|0
5336058|NCT00149994|18366505|P2|Overall Study|Administrative problems:|0
5336059|NCT00149994|18366506|P1|Overall Study|Administrative problems:|1
5336060|NCT00149890|18366514|P2|Overall Study|Graft Loss|1
5336061|NCT00149890|18366515|P1|Overall Study|Graft Loss|2
5336062|NCT00149890|18366514|P2|Overall Study|Lost to Follow-up|0
5336063|NCT00149890|18366515|P1|Overall Study|Lost to Follow-up|1
5336064|NCT00149890|18366514|P2|Overall Study|Protocol Violation|0
5336065|NCT00149890|18366515|P1|Overall Study|Protocol Violation|1
5336066|NCT00149890|18366514|P2|Overall Study|Lack of Efficacy|9
5336067|NCT00149890|18366515|P1|Overall Study|Lack of Efficacy|8
5336068|NCT00149890|18366514|P2|Overall Study|Adverse Event|8
5336069|NCT00149890|18366515|P1|Overall Study|Adverse Event|1
5336070|NCT00149825|18366550|P2|Overall Study|Other|0
5336071|NCT00149825|18366551|P1|Overall Study|Other|1
5336072|NCT00149825|18366550|P2|Overall Study|Not liking insomnia therapy|0
5336073|NCT00149825|18366551|P1|Overall Study|Not liking insomnia therapy|1
5336074|NCT00149825|18366550|P2|Overall Study|Time commitments|1
5336075|NCT00149825|18366551|P1|Overall Study|Time commitments|2
5336076|NCT00149825|18366550|P2|Overall Study|Intolerance to medication side effects|2
5336077|NCT00149825|18366551|P1|Overall Study|Intolerance to medication side effects|1
5336078|NCT00149747|18366579|P2|Overall Study|Withdrawal by Subject|3
5336079|NCT00149747|18366580|P1|Overall Study|Withdrawal by Subject|3
5336080|NCT00149747|18366579|P2|Overall Study|Death|0
5336081|NCT00149747|18366580|P1|Overall Study|Death|1
5336082|NCT00149630|18366626|P2|Overall Study|Adverse Event|0
5336083|NCT00149630|18366627|P1|Overall Study|Adverse Event|2
5336084|NCT00149630|18366626|P2|Overall Study|Treatment Programs|5
5336085|NCT00149630|18366627|P1|Overall Study|Treatment Programs|4
5336086|NCT00149630|18366626|P2|Overall Study|Incarceration|0
5336087|NCT00149630|18366627|P1|Overall Study|Incarceration|2
5336088|NCT00149396|18366637|P1|Overall Study|other treatment|5
5336089|NCT00149396|18366637|P1|Overall Study|Subject noncompliance|2
5336090|NCT00149396|18366637|P1|Overall Study|Withdrawal by Subject|1
5336091|NCT00149396|18366637|P1|Overall Study|Death|15
5336092|NCT00149214|18366707|P2|Overall Study|Progressive Disease|3
5336093|NCT00149214|18366708|P1|Overall Study|Progressive Disease|7
5336094|NCT00149214|18366707|P2|Overall Study|Sponsor Decision|1
5336095|NCT00149214|18366708|P1|Overall Study|Sponsor Decision|0
5336096|NCT00149214|18366707|P2|Overall Study|Physician Decision|3
5336097|NCT00149214|18366708|P1|Overall Study|Physician Decision|3
5336098|NCT00149214|18366707|P2|Overall Study|Withdrawal by Subject|1
5336099|NCT00149214|18366708|P1|Overall Study|Withdrawal by Subject|4
5336100|NCT00149214|18366707|P2|Overall Study|Adverse Event|9
5336101|NCT00149214|18366708|P1|Overall Study|Adverse Event|12
5336102|NCT00148941|18366735|P4|Overall Study|Other|2
5336103|NCT00148941|18366736|P3|Overall Study|Other|1
5336104|NCT00148941|18366737|P2|Overall Study|Other|0
5336105|NCT00148941|18366738|P1|Overall Study|Other|0
5336106|NCT00148941|18366735|P4|Overall Study|Withdrawal by Subject|0
5336107|NCT00148941|18366736|P3|Overall Study|Withdrawal by Subject|1
5336108|NCT00148941|18366737|P2|Overall Study|Withdrawal by Subject|0
5336109|NCT00148941|18366738|P1|Overall Study|Withdrawal by Subject|1
5336110|NCT00148941|18366735|P4|Overall Study|Lost to Follow-up|22
5336111|NCT00148941|18366736|P3|Overall Study|Lost to Follow-up|18
5336112|NCT00148941|18366737|P2|Overall Study|Lost to Follow-up|24
5336113|NCT00148941|18366738|P1|Overall Study|Lost to Follow-up|17
5336114|NCT00148759|18366853|P2|Overall Study|Lost to Follow-up|0
5336115|NCT00148759|18366854|P1|Overall Study|Lost to Follow-up|1
5336116|NCT00148759|18366853|P2|Overall Study|Withdrawal by Subject|1
5336117|NCT00148759|18366854|P1|Overall Study|Withdrawal by Subject|1
5336118|NCT00148343|18366882|P2|Overall Study|Physician Decision|4
5336119|NCT00148343|18366883|P1|Overall Study|Physician Decision|3
5336120|NCT00148343|18366882|P2|Overall Study|Withdrawal by Subject|7
5336121|NCT00148343|18366883|P1|Overall Study|Withdrawal by Subject|12
5336122|NCT00148317|18366897|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
5336123|NCT00148317|18366897|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
5336124|NCT00148317|18366897|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
5336125|NCT00148122|18366904|P1|Overall Study|Withdrawal by Subject|2
5336126|NCT00148109|18366912|P2|Overall Study|Withdrawal by Subject|0
5336127|NCT00148109|18366913|P1|Overall Study|Withdrawal by Subject|2
5336128|NCT00148109|18366912|P2|Overall Study|Adverse Event|2
5336129|NCT00148109|18366913|P1|Overall Study|Adverse Event|0
5336130|NCT00148109|18366912|P2|Overall Study|Lack of Efficacy|18
5336131|NCT00148109|18366913|P1|Overall Study|Lack of Efficacy|10
5336132|NCT00147823|18366929|P2|Overall Study|Did not receive vitoss due to infection|2
5336133|NCT00147823|18366930|P1|Overall Study|Did not receive vitoss due to infection|6
5336134|NCT00147823|18366929|P2|Overall Study|Withdrawal by Subject|1
5336135|NCT00147823|18366930|P1|Overall Study|Withdrawal by Subject|0
5336136|NCT00147823|18366929|P2|Overall Study|Physician Decision|0
5336137|NCT00147823|18366930|P1|Overall Study|Physician Decision|1
5336138|NCT00147823|18366929|P2|Overall Study|Lost to Follow-up|12
5336139|NCT00147823|18366930|P1|Overall Study|Lost to Follow-up|6
5336140|NCT00147745|18366961|P3|Overall Study|Withdrawal by Subject|0
5336141|NCT00147745|18366962|P2|Overall Study|Withdrawal by Subject|0
5336142|NCT00147745|18366963|P1|Overall Study|Withdrawal by Subject|1
5336143|NCT00147537|18366985|P11|Phase 2|Randomized but not treated|1
5336144|NCT00147537|18366986|P10|Phase 2|Randomized but not treated|1
5336145|NCT00147537|18366987|P9|Phase 2|Randomized but not treated|0
5336146|NCT00147537|18366988|P8|Phase 2|Randomized but not treated|0
5336147|NCT00147537|18366989|P7|Phase 2|Randomized but not treated|0
5336148|NCT00147537|18366990|P6|Phase 2|Randomized but not treated|0
5336149|NCT00147537|18366991|P5|Phase 2|Randomized but not treated|0
5336150|NCT00147537|18366992|P4|Phase 2|Randomized but not treated|0
5336151|NCT00147537|18366993|P3|Phase 2|Randomized but not treated|0
5336152|NCT00147537|18366994|P2|Phase 2|Randomized but not treated|0
5336153|NCT00147537|18366995|P1|Phase 2|Randomized but not treated|0
5336154|NCT00147537|18366985|P11|Phase 2|Withdrawal by Subject|4
5336155|NCT00147537|18366986|P10|Phase 2|Withdrawal by Subject|16
5336156|NCT00147537|18366987|P9|Phase 2|Withdrawal by Subject|0
5336157|NCT00147537|18366988|P8|Phase 2|Withdrawal by Subject|0
5336158|NCT00147537|18366989|P7|Phase 2|Withdrawal by Subject|0
5336159|NCT00147537|18366990|P6|Phase 2|Withdrawal by Subject|0
5336160|NCT00147537|18366991|P5|Phase 2|Withdrawal by Subject|0
5336161|NCT00147537|18366992|P4|Phase 2|Withdrawal by Subject|0
5336162|NCT00147537|18366993|P3|Phase 2|Withdrawal by Subject|0
5336163|NCT00147537|18366994|P2|Phase 2|Withdrawal by Subject|0
5336164|NCT00147537|18366995|P1|Phase 2|Withdrawal by Subject|0
5336165|NCT00147537|18366985|P11|Phase 2|Other|12
5336166|NCT00147537|18366986|P10|Phase 2|Other|47
5336167|NCT00147537|18366987|P9|Phase 2|Other|0
5336168|NCT00147537|18366988|P8|Phase 2|Other|0
5336169|NCT00147537|18366989|P7|Phase 2|Other|0
5336170|NCT00147537|18366990|P6|Phase 2|Other|0
5336171|NCT00147537|18366991|P5|Phase 2|Other|0
5336172|NCT00147537|18366992|P4|Phase 2|Other|0
5336173|NCT00147537|18366993|P3|Phase 2|Other|0
5336174|NCT00147537|18366994|P2|Phase 2|Other|0
5336175|NCT00147537|18366995|P1|Phase 2|Other|0
5336176|NCT00147537|18366985|P11|Phase 2|Lost to Follow-up|4
5336177|NCT00147537|18366986|P10|Phase 2|Lost to Follow-up|12
5336178|NCT00147537|18366987|P9|Phase 2|Lost to Follow-up|0
5336179|NCT00147537|18366988|P8|Phase 2|Lost to Follow-up|0
5336180|NCT00147537|18366989|P7|Phase 2|Lost to Follow-up|0
5336181|NCT00147537|18366990|P6|Phase 2|Lost to Follow-up|0
5336182|NCT00147537|18366991|P5|Phase 2|Lost to Follow-up|0
5336183|NCT00147537|18366992|P4|Phase 2|Lost to Follow-up|0
5336184|NCT00147537|18366993|P3|Phase 2|Lost to Follow-up|0
5336185|NCT00147537|18366994|P2|Phase 2|Lost to Follow-up|0
5336186|NCT00147537|18366995|P1|Phase 2|Lost to Follow-up|0
5336187|NCT00147537|18366985|P11|Phase 2|Death|31
5336188|NCT00147537|18366986|P10|Phase 2|Death|85
5336189|NCT00147537|18366987|P9|Phase 2|Death|0
5336190|NCT00147537|18366988|P8|Phase 2|Death|0
5336191|NCT00147537|18366989|P7|Phase 2|Death|0
5336192|NCT00147537|18366990|P6|Phase 2|Death|0
5336193|NCT00147537|18366991|P5|Phase 2|Death|0
5336194|NCT00147537|18366992|P4|Phase 2|Death|0
5336195|NCT00147537|18366993|P3|Phase 2|Death|0
5336196|NCT00147537|18366994|P2|Phase 2|Death|0
5336197|NCT00147537|18366995|P1|Phase 2|Death|0
5336198|NCT00147537|18366985|P11|Phase 1b|Randomized but not treated|0
5336199|NCT00147537|18366986|P10|Phase 1b|Randomized but not treated|0
5336200|NCT00147537|18366987|P9|Phase 1b|Randomized but not treated|1
5336201|NCT00147537|18366988|P8|Phase 1b|Randomized but not treated|0
5336202|NCT00147537|18366989|P7|Phase 1b|Randomized but not treated|1
5336203|NCT00147537|18366990|P6|Phase 1b|Randomized but not treated|0
5336204|NCT00147537|18366991|P5|Phase 1b|Randomized but not treated|0
5336205|NCT00147537|18366992|P4|Phase 1b|Randomized but not treated|0
5336206|NCT00147537|18366993|P3|Phase 1b|Randomized but not treated|0
5336207|NCT00147537|18366994|P2|Phase 1b|Randomized but not treated|0
5336208|NCT00147537|18366995|P1|Phase 1b|Randomized but not treated|0
5336209|NCT00147537|18366985|P11|Phase 1b|Withdrawal by Subject|0
5336210|NCT00147537|18366986|P10|Phase 1b|Withdrawal by Subject|0
5336211|NCT00147537|18366987|P9|Phase 1b|Withdrawal by Subject|2
5336212|NCT00147537|18366988|P8|Phase 1b|Withdrawal by Subject|0
5336213|NCT00147537|18366989|P7|Phase 1b|Withdrawal by Subject|0
5336214|NCT00147537|18366990|P6|Phase 1b|Withdrawal by Subject|0
5336215|NCT00147537|18366991|P5|Phase 1b|Withdrawal by Subject|0
5336216|NCT00147537|18366992|P4|Phase 1b|Withdrawal by Subject|0
5336217|NCT00147537|18366993|P3|Phase 1b|Withdrawal by Subject|0
5336218|NCT00147537|18366994|P2|Phase 1b|Withdrawal by Subject|0
5336219|NCT00147537|18366995|P1|Phase 1b|Withdrawal by Subject|0
5336220|NCT00147537|18366985|P11|Phase 1b|Other|0
5336221|NCT00147537|18366986|P10|Phase 1b|Other|0
5336222|NCT00147537|18366987|P9|Phase 1b|Other|4
5336223|NCT00147537|18366988|P8|Phase 1b|Other|4
5336224|NCT00147537|18366989|P7|Phase 1b|Other|14
5336225|NCT00147537|18366990|P6|Phase 1b|Other|1
5336226|NCT00147537|18366991|P5|Phase 1b|Other|1
5336227|NCT00147537|18366992|P4|Phase 1b|Other|1
5336228|NCT00147537|18366993|P3|Phase 1b|Other|2
5336229|NCT00147537|18366994|P2|Phase 1b|Other|0
5336230|NCT00147537|18366995|P1|Phase 1b|Other|0
5336231|NCT00147537|18366985|P11|Phase 1b|Lost to Follow-up|0
5336232|NCT00147537|18366986|P10|Phase 1b|Lost to Follow-up|0
5336233|NCT00147537|18366987|P9|Phase 1b|Lost to Follow-up|1
5336234|NCT00147537|18366988|P8|Phase 1b|Lost to Follow-up|0
5336235|NCT00147537|18366989|P7|Phase 1b|Lost to Follow-up|2
5336236|NCT00147537|18366990|P6|Phase 1b|Lost to Follow-up|0
5336237|NCT00147537|18366991|P5|Phase 1b|Lost to Follow-up|0
5336238|NCT00147537|18366992|P4|Phase 1b|Lost to Follow-up|0
5336239|NCT00147537|18366993|P3|Phase 1b|Lost to Follow-up|0
5336240|NCT00147537|18366994|P2|Phase 1b|Lost to Follow-up|1
5336241|NCT00147537|18366995|P1|Phase 1b|Lost to Follow-up|2
5336242|NCT00147537|18366985|P11|Phase 1b|Death|0
5336243|NCT00147537|18366986|P10|Phase 1b|Death|0
5336244|NCT00147537|18366987|P9|Phase 1b|Death|9
5336245|NCT00147537|18366988|P8|Phase 1b|Death|3
5336246|NCT00147537|18366989|P7|Phase 1b|Death|1
5336247|NCT00147537|18366990|P6|Phase 1b|Death|2
5336248|NCT00147537|18366991|P5|Phase 1b|Death|2
5336249|NCT00147537|18366992|P4|Phase 1b|Death|1
5336250|NCT00147537|18366993|P3|Phase 1b|Death|2
5336251|NCT00147537|18366994|P2|Phase 1b|Death|1
5336252|NCT00147537|18366995|P1|Phase 1b|Death|0
5336253|NCT00147498|18367178|P4|Overall Study|Other|3
5336254|NCT00147498|18367179|P3|Overall Study|Other|3
5336255|NCT00147498|18367180|P2|Overall Study|Other|1
5336256|NCT00147498|18367181|P1|Overall Study|Other|1
5336257|NCT00147498|18367178|P4|Overall Study|Participant defaulted|3
5336258|NCT00147498|18367179|P3|Overall Study|Participant defaulted|4
5336259|NCT00147498|18367180|P2|Overall Study|Participant defaulted|1
5336260|NCT00147498|18367181|P1|Overall Study|Participant defaulted|0
5336261|NCT00147498|18367178|P4|Overall Study|Laboratory abnormality|0
5336262|NCT00147498|18367179|P3|Overall Study|Laboratory abnormality|2
5336263|NCT00147498|18367180|P2|Overall Study|Laboratory abnormality|0
5336264|NCT00147498|18367181|P1|Overall Study|Laboratory abnormality|0
5336265|NCT00147498|18367178|P4|Overall Study|Lack of Efficacy|8
5336266|NCT00147498|18367179|P3|Overall Study|Lack of Efficacy|1
5336267|NCT00147498|18367180|P2|Overall Study|Lack of Efficacy|1
5336268|NCT00147498|18367181|P1|Overall Study|Lack of Efficacy|1
5336269|NCT00147498|18367178|P4|Overall Study|Adverse Event|3
5336270|NCT00147498|18367179|P3|Overall Study|Adverse Event|7
5336271|NCT00147498|18367180|P2|Overall Study|Adverse Event|6
5336272|NCT00147498|18367181|P1|Overall Study|Adverse Event|1
5336273|NCT00147238|18367305|P1|Overall Study|Inevaluable|8
5336274|NCT00147225|18367315|P6|Overall Study|Chemotherapy Changed|1
5336275|NCT00147225|18367316|P5|Overall Study|Chemotherapy Changed|0
5336276|NCT00147225|18367317|P4|Overall Study|Chemotherapy Changed|0
5336277|NCT00147225|18367318|P3|Overall Study|Chemotherapy Changed|0
5336278|NCT00147225|18367319|P2|Overall Study|Chemotherapy Changed|0
5336279|NCT00147225|18367320|P1|Overall Study|Chemotherapy Changed|0
5336280|NCT00147225|18367315|P6|Overall Study|Screen Failure|0
5336281|NCT00147225|18367316|P5|Overall Study|Screen Failure|1
5336282|NCT00147225|18367317|P4|Overall Study|Screen Failure|0
5336283|NCT00147225|18367318|P3|Overall Study|Screen Failure|0
5336284|NCT00147225|18367319|P2|Overall Study|Screen Failure|0
5336285|NCT00147225|18367320|P1|Overall Study|Screen Failure|0
5336286|NCT00147225|18367315|P6|Overall Study|Adverse Event|0
5336287|NCT00147225|18367316|P5|Overall Study|Adverse Event|0
5336288|NCT00147225|18367317|P4|Overall Study|Adverse Event|1
5336289|NCT00147225|18367318|P3|Overall Study|Adverse Event|1
5336290|NCT00147225|18367319|P2|Overall Study|Adverse Event|0
5336291|NCT00147225|18367320|P1|Overall Study|Adverse Event|0
5336292|NCT00147225|18367315|P6|Overall Study|Withdrawal by Subject|1
5336293|NCT00147225|18367316|P5|Overall Study|Withdrawal by Subject|0
5336294|NCT00147225|18367317|P4|Overall Study|Withdrawal by Subject|0
5336295|NCT00147225|18367318|P3|Overall Study|Withdrawal by Subject|1
5336296|NCT00147225|18367319|P2|Overall Study|Withdrawal by Subject|0
5336297|NCT00147225|18367320|P1|Overall Study|Withdrawal by Subject|1
5336298|NCT00146848|18367495|P3|Post-randomization|Withdrawn|27
5336299|NCT00146848|18367496|P2|Post-randomization|Withdrawn|32
5336300|NCT00146848|18367497|P1|Post-randomization|Withdrawn|26
5336301|NCT00146848|18367495|P3|Post-randomization|Lost to Follow-up|12
5336302|NCT00146848|18367496|P2|Post-randomization|Lost to Follow-up|15
5336303|NCT00146848|18367497|P1|Post-randomization|Lost to Follow-up|12
5336304|NCT00146848|18367495|P3|Pre-randomization|Withdrawal by Subject|0
5336305|NCT00146848|18367496|P2|Pre-randomization|Withdrawal by Subject|0
5336306|NCT00146848|18367497|P1|Pre-randomization|Withdrawal by Subject|40
5336307|NCT00146848|18367495|P3|Pre-randomization|Protocol Violation|0
5336308|NCT00146848|18367496|P2|Pre-randomization|Protocol Violation|0
5336309|NCT00146848|18367497|P1|Pre-randomization|Protocol Violation|172
5336310|NCT00146848|18367495|P3|Pre-randomization|Physician Decision|0
5336311|NCT00146848|18367496|P2|Pre-randomization|Physician Decision|0
5336312|NCT00146848|18367497|P1|Pre-randomization|Physician Decision|8
5336313|NCT00146848|18367495|P3|Pre-randomization|Lost to Follow-up|0
5336314|NCT00146848|18367496|P2|Pre-randomization|Lost to Follow-up|0
5336315|NCT00146848|18367497|P1|Pre-randomization|Lost to Follow-up|70
5336316|NCT00146848|18367495|P3|Pre-randomization|Death|0
5336317|NCT00146848|18367496|P2|Pre-randomization|Death|0
5336318|NCT00146848|18367497|P1|Pre-randomization|Death|19
5336319|NCT00146770|18367513|P2|Overall Study|Withdrawal by Subject|0
5336320|NCT00146770|18367514|P1|Overall Study|Withdrawal by Subject|2
5336321|NCT00146770|18367513|P2|Overall Study|Pregnancy|0
5336322|NCT00146770|18367514|P1|Overall Study|Pregnancy|1
5336323|NCT00146770|18367513|P2|Overall Study|Adverse Event|0
5336324|NCT00146770|18367514|P1|Overall Study|Adverse Event|2
5336325|NCT00146757|18367532|P2|Overall Study|Adverse Event|0
5336326|NCT00146757|18367533|P1|Overall Study|Adverse Event|1
5336327|NCT00146757|18367532|P2|Overall Study|Death|0
5336328|NCT00146757|18367533|P1|Overall Study|Death|1
5336329|NCT00146640|18367552|P2|Overall Study|Non-Medical Reasons|4
5336330|NCT00146640|18367553|P1|Overall Study|Non-Medical Reasons|8
5336331|NCT00146640|18367552|P2|Overall Study|Medical Reasons|0
5336332|NCT00146640|18367553|P1|Overall Study|Medical Reasons|3
5336333|NCT00146640|18367552|P2|Overall Study|Adverse Event|10
5336334|NCT00146640|18367553|P1|Overall Study|Adverse Event|12
5336335|NCT00146328|18367576|P3|Overall Study|Interaction with other medication|1
5336336|NCT00146328|18367577|P2|Overall Study|Interaction with other medication|0
5336337|NCT00146328|18367578|P1|Overall Study|Interaction with other medication|2
5336338|NCT00146328|18367576|P3|Overall Study|Moved|0
5336339|NCT00146328|18367577|P2|Overall Study|Moved|0
5336340|NCT00146328|18367578|P1|Overall Study|Moved|2
5336341|NCT00146328|18367576|P3|Overall Study|Death|1
5336342|NCT00146328|18367577|P2|Overall Study|Death|1
5336343|NCT00146328|18367578|P1|Overall Study|Death|0
5336344|NCT00146328|18367576|P3|Overall Study|Enroll into other trial|2
5336345|NCT00146328|18367577|P2|Overall Study|Enroll into other trial|4
5336346|NCT00146328|18367578|P1|Overall Study|Enroll into other trial|2
5336347|NCT00146328|18367576|P3|Overall Study|Patient decision to end|6
5336348|NCT00146328|18367577|P2|Overall Study|Patient decision to end|1
5336349|NCT00146328|18367578|P1|Overall Study|Patient decision to end|0
5336350|NCT00146328|18367576|P3|Overall Study|Trial ended/site closed|19
5336351|NCT00146328|18367577|P2|Overall Study|Trial ended/site closed|2
5336352|NCT00146328|18367578|P1|Overall Study|Trial ended/site closed|8
5336353|NCT00146328|18367576|P3|Overall Study|Virologic Failure/lack of efficacy|142
5336354|NCT00146328|18367577|P2|Overall Study|Virologic Failure/lack of efficacy|72
5336355|NCT00146328|18367578|P1|Overall Study|Virologic Failure/lack of efficacy|54
5336356|NCT00146328|18367576|P3|Overall Study|Withdrawal by Subject|22
5336357|NCT00146328|18367577|P2|Overall Study|Withdrawal by Subject|16
5336358|NCT00146328|18367578|P1|Overall Study|Withdrawal by Subject|16
5336359|NCT00146328|18367576|P3|Overall Study|Lost to Follow-up|7
5336360|NCT00146328|18367577|P2|Overall Study|Lost to Follow-up|4
5336361|NCT00146328|18367578|P1|Overall Study|Lost to Follow-up|7
5336362|NCT00146328|18367576|P3|Overall Study|Protocol Violation|12
5336363|NCT00146328|18367577|P2|Overall Study|Protocol Violation|6
5336364|NCT00146328|18367578|P1|Overall Study|Protocol Violation|11
5336365|NCT00146328|18367576|P3|Overall Study|Adverse Event|79
5336366|NCT00146328|18367577|P2|Overall Study|Adverse Event|48
5336367|NCT00146328|18367578|P1|Overall Study|Adverse Event|39
5336368|NCT00146172|18367669|P8|Overall Study|Symptomatic Deterioration|2
5336369|NCT00146172|18367670|P7|Overall Study|Symptomatic Deterioration|0
5336370|NCT00146172|18367671|P6|Overall Study|Symptomatic Deterioration|2
5336371|NCT00146172|18367672|P5|Overall Study|Symptomatic Deterioration|1
5336372|NCT00146172|18367673|P4|Overall Study|Symptomatic Deterioration|0
5336373|NCT00146172|18367674|P3|Overall Study|Symptomatic Deterioration|1
5336374|NCT00146172|18367675|P2|Overall Study|Symptomatic Deterioration|0
5336375|NCT00146172|18367676|P1|Overall Study|Symptomatic Deterioration|1
5336376|NCT00146172|18367669|P8|Overall Study|Withdrawal by Subject|4
5336377|NCT00146172|18367670|P7|Overall Study|Withdrawal by Subject|1
5336378|NCT00146172|18367671|P6|Overall Study|Withdrawal by Subject|1
5336379|NCT00146172|18367672|P5|Overall Study|Withdrawal by Subject|0
5336380|NCT00146172|18367673|P4|Overall Study|Withdrawal by Subject|0
5336381|NCT00146172|18367674|P3|Overall Study|Withdrawal by Subject|0
5336382|NCT00146172|18367675|P2|Overall Study|Withdrawal by Subject|0
5336383|NCT00146172|18367676|P1|Overall Study|Withdrawal by Subject|0
5336384|NCT00146172|18367669|P8|Overall Study|Physician Decision|1
5336385|NCT00146172|18367670|P7|Overall Study|Physician Decision|0
5336386|NCT00146172|18367671|P6|Overall Study|Physician Decision|0
5336387|NCT00146172|18367672|P5|Overall Study|Physician Decision|0
5336388|NCT00146172|18367673|P4|Overall Study|Physician Decision|0
5336389|NCT00146172|18367674|P3|Overall Study|Physician Decision|0
5336390|NCT00146172|18367675|P2|Overall Study|Physician Decision|0
5336391|NCT00146172|18367676|P1|Overall Study|Physician Decision|0
5336392|NCT00146172|18367669|P8|Overall Study|Death|0
5336393|NCT00146172|18367670|P7|Overall Study|Death|1
5336394|NCT00146172|18367671|P6|Overall Study|Death|0
5336395|NCT00146172|18367672|P5|Overall Study|Death|0
5336396|NCT00146172|18367673|P4|Overall Study|Death|0
5336397|NCT00146172|18367674|P3|Overall Study|Death|0
5336398|NCT00146172|18367675|P2|Overall Study|Death|0
5336399|NCT00146172|18367676|P1|Overall Study|Death|0
5336400|NCT00146172|18367669|P8|Overall Study|Disease Progression|22
5336401|NCT00146172|18367670|P7|Overall Study|Disease Progression|1
5336402|NCT00146172|18367671|P6|Overall Study|Disease Progression|2
5336403|NCT00146172|18367672|P5|Overall Study|Disease Progression|2
5336404|NCT00146172|18367673|P4|Overall Study|Disease Progression|5
5336405|NCT00146172|18367674|P3|Overall Study|Disease Progression|2
5336406|NCT00146172|18367675|P2|Overall Study|Disease Progression|4
5336407|NCT00146172|18367676|P1|Overall Study|Disease Progression|2
5336408|NCT00146172|18367669|P8|Overall Study|Lost to Follow-up|1
5336409|NCT00146172|18367670|P7|Overall Study|Lost to Follow-up|0
5336410|NCT00146172|18367671|P6|Overall Study|Lost to Follow-up|0
5336411|NCT00146172|18367672|P5|Overall Study|Lost to Follow-up|0
5336412|NCT00146172|18367673|P4|Overall Study|Lost to Follow-up|0
5336413|NCT00146172|18367674|P3|Overall Study|Lost to Follow-up|0
5336414|NCT00146172|18367675|P2|Overall Study|Lost to Follow-up|0
5336415|NCT00146172|18367676|P1|Overall Study|Lost to Follow-up|0
5336416|NCT00146172|18367669|P8|Overall Study|Adverse Event|10
5336417|NCT00146172|18367670|P7|Overall Study|Adverse Event|3
5336418|NCT00146172|18367671|P6|Overall Study|Adverse Event|2
5336419|NCT00146172|18367672|P5|Overall Study|Adverse Event|0
5336420|NCT00146172|18367673|P4|Overall Study|Adverse Event|1
5336421|NCT00146172|18367674|P3|Overall Study|Adverse Event|1
5336422|NCT00146172|18367675|P2|Overall Study|Adverse Event|0
5336423|NCT00146172|18367676|P1|Overall Study|Adverse Event|0
5336424|NCT00145977|18367711|P2|Overall Study|Withdrawal by Subject|0
5336425|NCT00145977|18367712|P1|Overall Study|Withdrawal by Subject|1
5336426|NCT00145977|18367711|P2|Overall Study|Lost to Follow-up|0
5336427|NCT00145977|18367712|P1|Overall Study|Lost to Follow-up|1
5336428|NCT00145977|18367711|P2|Overall Study|Lack of Efficacy|4
5336429|NCT00145977|18367712|P1|Overall Study|Lack of Efficacy|0
5336430|NCT00145795|18367738|P2|Overall Study|Adverse Event|0
5336431|NCT00145795|18367739|P1|Overall Study|Adverse Event|1
5336432|NCT00145626|18367774|P1|Overall Study|Withdrawal by Subject|1
5336433|NCT00145626|18367774|P1|Overall Study|Death|1
5336434|NCT00145626|18367774|P1|Overall Study|Turned 2 years old before treatment|1
5336435|NCT00145626|18367774|P1|Overall Study|Did not have NK infusions|2
5336436|NCT00145600|18367820|P4|Overall Study|Withdrawal by Subject|1
5336437|NCT00145600|18367821|P3|Overall Study|Withdrawal by Subject|0
5336438|NCT00145600|18367822|P2|Overall Study|Withdrawal by Subject|2
5336439|NCT00145600|18367823|P1|Overall Study|Withdrawal by Subject|1
5336440|NCT00145600|18367820|P4|Overall Study|Noncompliance|0
5336441|NCT00145600|18367821|P3|Overall Study|Noncompliance|0
5336442|NCT00145600|18367822|P2|Overall Study|Noncompliance|0
5336443|NCT00145600|18367823|P1|Overall Study|Noncompliance|1
5336444|NCT00145600|18367820|P4|Overall Study|Lost to Follow-up|4
5336445|NCT00145600|18367821|P3|Overall Study|Lost to Follow-up|2
5336446|NCT00145600|18367822|P2|Overall Study|Lost to Follow-up|6
5336447|NCT00145600|18367823|P1|Overall Study|Lost to Follow-up|2
5336448|NCT00145600|18367820|P4|Overall Study|Ineligible|5
5336449|NCT00145600|18367821|P3|Overall Study|Ineligible|1
5336450|NCT00145600|18367822|P2|Overall Study|Ineligible|0
5336451|NCT00145600|18367823|P1|Overall Study|Ineligible|3
5336452|NCT00145600|18367820|P4|Overall Study|Death|6
5336453|NCT00145600|18367821|P3|Overall Study|Death|2
5336454|NCT00145600|18367822|P2|Overall Study|Death|2
5336455|NCT00145600|18367823|P1|Overall Study|Death|1
5336456|NCT00145574|18367947|P3|Open Label Long-term Extension|required restricted medicine|1
5336457|NCT00145574|18367948|P2|Open Label Long-term Extension|required restricted medicine|0
5336458|NCT00145574|18367949|P1|Open Label Long-term Extension|required restricted medicine|0
5336459|NCT00145574|18367947|P3|Open Label Long-term Extension|Withdrawal by Subject|4
5336460|NCT00145574|18367948|P2|Open Label Long-term Extension|Withdrawal by Subject|0
5336461|NCT00145574|18367949|P1|Open Label Long-term Extension|Withdrawal by Subject|0
5336462|NCT00145574|18367947|P3|Open Label Long-term Extension|Lost to Follow-up|1
5336463|NCT00145574|18367948|P2|Open Label Long-term Extension|Lost to Follow-up|0
5336464|NCT00145574|18367949|P1|Open Label Long-term Extension|Lost to Follow-up|0
5336465|NCT00145574|18367947|P3|Open Label Long-term Extension|Adverse Event|5
5336466|NCT00145574|18367948|P2|Open Label Long-term Extension|Adverse Event|0
5336467|NCT00145574|18367949|P1|Open Label Long-term Extension|Adverse Event|0
5336468|NCT00145574|18367947|P3|Double Blind|required restricted medicine|0
5336469|NCT00145574|18367948|P2|Double Blind|required restricted medicine|1
5336470|NCT00145574|18367949|P1|Double Blind|required restricted medicine|0
5336471|NCT00145574|18367947|P3|Double Blind|Withdrawal by Subject|1
5336472|NCT00145574|18367948|P2|Double Blind|Withdrawal by Subject|1
5336473|NCT00145574|18367949|P1|Double Blind|Withdrawal by Subject|1
5336474|NCT00145574|18367947|P3|Double Blind|Adverse Event|1
5336475|NCT00145574|18367948|P2|Double Blind|Adverse Event|3
5336476|NCT00145574|18367949|P1|Double Blind|Adverse Event|0
5336477|NCT00145509|18368006|P2|Overall Study|Reason not provided|1
5336478|NCT00145509|18368007|P1|Overall Study|Reason not provided|2
5336479|NCT00145509|18368006|P2|Overall Study|Withdrew Consent|7
5336480|NCT00145509|18368007|P1|Overall Study|Withdrew Consent|2
5336481|NCT00145509|18368006|P2|Overall Study|Lost to Follow-up|9
5336482|NCT00145509|18368007|P1|Overall Study|Lost to Follow-up|5
5336483|NCT00145509|18368006|P2|Overall Study|Lack of Efficacy|1
5336484|NCT00145509|18368007|P1|Overall Study|Lack of Efficacy|3
5336485|NCT00145509|18368006|P2|Overall Study|Adverse Event|3
5336486|NCT00145509|18368007|P1|Overall Study|Adverse Event|10
5336487|NCT00145496|18368021|P2|Overall Study|Other|13
5336488|NCT00145496|18368022|P1|Overall Study|Other|25
5336489|NCT00145496|18368021|P2|Overall Study|Lost to Follow-up|5
5336490|NCT00145496|18368022|P1|Overall Study|Lost to Follow-up|12
5336491|NCT00145496|18368021|P2|Overall Study|Withdrawal by Subject|26
5336492|NCT00145496|18368022|P1|Overall Study|Withdrawal by Subject|32
5336493|NCT00145496|18368021|P2|Overall Study|Lack of Efficacy|7
5336494|NCT00145496|18368022|P1|Overall Study|Lack of Efficacy|12
5336495|NCT00145496|18368021|P2|Overall Study|Adverse Event|30
5336496|NCT00145496|18368022|P1|Overall Study|Adverse Event|42
5336497|NCT00145470|18368034|P2|Overall Study|Reason Not Reported|9
5336498|NCT00145470|18368035|P1|Overall Study|Reason Not Reported|9
5336499|NCT00145470|18368034|P2|Overall Study|Lost to Follow-up|17
5336500|NCT00145470|18368035|P1|Overall Study|Lost to Follow-up|21
5336501|NCT00145470|18368034|P2|Overall Study|Withdrawal by Subject|34
5336502|NCT00145470|18368035|P1|Overall Study|Withdrawal by Subject|36
5336503|NCT00145470|18368034|P2|Overall Study|Lack of Efficacy|13
5336504|NCT00145470|18368035|P1|Overall Study|Lack of Efficacy|27
5336505|NCT00145470|18368034|P2|Overall Study|Adverse Event|25
5336506|NCT00145470|18368035|P1|Overall Study|Adverse Event|19
5336507|NCT00145327|18368105|P3|Overall Study|Missing - not stated|1
5336508|NCT00145327|18368106|P2|Overall Study|Missing - not stated|0
5336509|NCT00145327|18368107|P1|Overall Study|Missing - not stated|1
5336510|NCT00145327|18368105|P3|Overall Study|Abnormal laboratory value(s)|2
5336511|NCT00145327|18368106|P2|Overall Study|Abnormal laboratory value(s)|0
5336512|NCT00145327|18368107|P1|Overall Study|Abnormal laboratory value(s)|1
5336513|NCT00145327|18368105|P3|Overall Study|Protocol Violation|2
5336514|NCT00145327|18368106|P2|Overall Study|Protocol Violation|0
5336515|NCT00145327|18368107|P1|Overall Study|Protocol Violation|2
5336516|NCT00145327|18368105|P3|Overall Study|Administrative problems|13
5336517|NCT00145327|18368106|P2|Overall Study|Administrative problems|9
5336518|NCT00145327|18368107|P1|Overall Study|Administrative problems|12
5336519|NCT00145327|18368105|P3|Overall Study|Lost to Follow-up|14
5336520|NCT00145327|18368106|P2|Overall Study|Lost to Follow-up|14
5336521|NCT00145327|18368107|P1|Overall Study|Lost to Follow-up|9
5336522|NCT00145327|18368105|P3|Overall Study|Adverse Event|22
5336523|NCT00145327|18368106|P2|Overall Study|Adverse Event|11
5336524|NCT00145327|18368107|P1|Overall Study|Adverse Event|14
5336525|NCT00145327|18368105|P3|Overall Study|Death|30
5336526|NCT00145327|18368106|P2|Overall Study|Death|18
5336527|NCT00145327|18368107|P1|Overall Study|Death|26
5336528|NCT00145327|18368105|P3|Overall Study|Withdrawal by Subject|164
5336529|NCT00145327|18368106|P2|Overall Study|Withdrawal by Subject|72
5336530|NCT00145327|18368107|P1|Overall Study|Withdrawal by Subject|77
5336531|NCT00145119|18368206|P1|Overall Study|Death|45
5336532|NCT00144781|18368224|P4|Overall Study|Non-compliant|0
5336533|NCT00144781|18368225|P3|Overall Study|Non-compliant|0
5336534|NCT00144781|18368226|P2|Overall Study|Non-compliant|1
5336535|NCT00144781|18368227|P1|Overall Study|Non-compliant|0
5336536|NCT00144781|18368224|P4|Overall Study|Adverse Event|0
5336537|NCT00144781|18368225|P3|Overall Study|Adverse Event|0
5336538|NCT00144781|18368226|P2|Overall Study|Adverse Event|1
5336539|NCT00144781|18368227|P1|Overall Study|Adverse Event|0
5336540|NCT00144339|18368256|P2|Overall Study|Other|60
5336541|NCT00144339|18368257|P1|Overall Study|Other|58
5336542|NCT00144339|18368256|P2|Overall Study|Lost to Follow-up|64
5336543|NCT00144339|18368257|P1|Overall Study|Lost to Follow-up|76
5336544|NCT00144339|18368256|P2|Overall Study|Withdrawal by Subject|300
5336545|NCT00144339|18368257|P1|Overall Study|Withdrawal by Subject|403
5336546|NCT00144339|18368256|P2|Overall Study|Protocol Violation|48
5336547|NCT00144339|18368257|P1|Overall Study|Protocol Violation|75
5336548|NCT00144339|18368256|P2|Overall Study|Adverse Event|627
5336549|NCT00144339|18368257|P1|Overall Study|Adverse Event|746
5336550|NCT00144300|18368465|P2|Overall Study|Other reason (not specified)|3
5336551|NCT00144300|18368466|P1|Overall Study|Other reason (not specified)|1
5336552|NCT00144300|18368465|P2|Overall Study|Withdrawal by Subject|6
5336553|NCT00144300|18368466|P1|Overall Study|Withdrawal by Subject|6
5336554|NCT00144300|18368465|P2|Overall Study|Lost to Follow-up|0
5336555|NCT00144300|18368466|P1|Overall Study|Lost to Follow-up|3
5336556|NCT00144300|18368465|P2|Overall Study|Protocol Violation|3
5336557|NCT00144300|18368466|P1|Overall Study|Protocol Violation|1
5336558|NCT00144300|18368465|P2|Overall Study|Adverse Event|16
5336559|NCT00144300|18368466|P1|Overall Study|Adverse Event|18
5336560|NCT00144170|18368514|P2|Overall Study|Other reason not defined above|316
5336561|NCT00144170|18368515|P1|Overall Study|Other reason not defined above|211
5336562|NCT00144170|18368514|P2|Overall Study|Withdrawal by Subject|13
5336563|NCT00144170|18368515|P1|Overall Study|Withdrawal by Subject|29
5336564|NCT00144170|18368514|P2|Overall Study|Lost to Follow-up|10
5336565|NCT00144170|18368515|P1|Overall Study|Lost to Follow-up|5
5336566|NCT00144170|18368514|P2|Overall Study|Protocol Violation|16
5336567|NCT00144170|18368515|P1|Overall Study|Protocol Violation|23
5336568|NCT00144170|18368514|P2|Overall Study|Adverse Event|41
5336569|NCT00144170|18368515|P1|Overall Study|Adverse Event|84
5336570|NCT00144027|18368705|P2|Overall Study|did not complete baseline assessment|6
5336571|NCT00144027|18368706|P1|Overall Study|did not complete baseline assessment|0
5336572|NCT00144027|18368705|P2|Overall Study|Withdrawal by Subject|2
5336573|NCT00144027|18368706|P1|Overall Study|Withdrawal by Subject|2
5336574|NCT00144027|18368705|P2|Overall Study|Lost to Follow-up|3
5336575|NCT00144027|18368706|P1|Overall Study|Lost to Follow-up|1
5336576|NCT00143598|18368736|P2|Overall Study|Death|36
5336577|NCT00143598|18368737|P1|Overall Study|Death|36
5336578|NCT00143598|18368736|P2|Overall Study|Withdrawal by Subject|37
5336579|NCT00143598|18368737|P1|Overall Study|Withdrawal by Subject|33
5336580|NCT00143598|18368736|P2|Overall Study|Lost to Follow-up|21
5336581|NCT00143598|18368737|P1|Overall Study|Lost to Follow-up|23
5336582|NCT00143507|18368751|P2|Overall Study|Withdrawn by sponsor's decision|3
5336583|NCT00143507|18368752|P1|Overall Study|Withdrawn by sponsor's decision|0
5336584|NCT00143507|18368751|P2|Overall Study|Lost to Follow-up|0
5336585|NCT00143507|18368752|P1|Overall Study|Lost to Follow-up|1
5336586|NCT00143507|18368751|P2|Overall Study|Withdrawal by Subject|102
5336587|NCT00143507|18368752|P1|Overall Study|Withdrawal by Subject|114
5336588|NCT00143507|18368751|P2|Overall Study|Death|547
5336589|NCT00143507|18368752|P1|Overall Study|Death|572
5336590|NCT00143455|18368786|P4|Cohort 2|Randomized But Not Treated|1
5336591|NCT00143455|18368787|P3|Cohort 2|Randomized But Not Treated|1
5336592|NCT00143455|18368788|P2|Cohort 2|Randomized But Not Treated|0
5336593|NCT00143455|18368789|P1|Cohort 2|Randomized But Not Treated|0
5336594|NCT00143455|18368786|P4|Cohort 2|Other|6
5336595|NCT00143455|18368787|P3|Cohort 2|Other|7
5336596|NCT00143455|18368788|P2|Cohort 2|Other|0
5336597|NCT00143455|18368789|P1|Cohort 2|Other|0
5336598|NCT00143455|18368786|P4|Cohort 2|Withdrawal by Subject|12
5336599|NCT00143455|18368787|P3|Cohort 2|Withdrawal by Subject|13
5336600|NCT00143455|18368788|P2|Cohort 2|Withdrawal by Subject|0
5336601|NCT00143455|18368789|P1|Cohort 2|Withdrawal by Subject|0
5336602|NCT00143455|18368786|P4|Cohort 2|Progressive Disease|27
5336603|NCT00143455|18368787|P3|Cohort 2|Progressive Disease|20
5336604|NCT00143455|18368788|P2|Cohort 2|Progressive Disease|0
5336605|NCT00143455|18368789|P1|Cohort 2|Progressive Disease|0
5336606|NCT00143455|18368786|P4|Cohort 2|Death|12
5336607|NCT00143455|18368787|P3|Cohort 2|Death|20
5336608|NCT00143455|18368788|P2|Cohort 2|Death|0
5336609|NCT00143455|18368789|P1|Cohort 2|Death|0
5336610|NCT00143455|18368786|P4|Cohort 2|Lost to Follow-up|4
5336611|NCT00143455|18368787|P3|Cohort 2|Lost to Follow-up|1
5336612|NCT00143455|18368788|P2|Cohort 2|Lost to Follow-up|0
5336613|NCT00143455|18368789|P1|Cohort 2|Lost to Follow-up|0
5336614|NCT00143455|18368786|P4|Cohort 2|Protocol Violation|1
5336615|NCT00143455|18368787|P3|Cohort 2|Protocol Violation|1
5336616|NCT00143455|18368788|P2|Cohort 2|Protocol Violation|0
5336617|NCT00143455|18368789|P1|Cohort 2|Protocol Violation|0
5336618|NCT00143455|18368786|P4|Cohort 2|No Longer Required Study Treatment|0
5336619|NCT00143455|18368787|P3|Cohort 2|No Longer Required Study Treatment|1
5336620|NCT00143455|18368788|P2|Cohort 2|No Longer Required Study Treatment|0
5336621|NCT00143455|18368789|P1|Cohort 2|No Longer Required Study Treatment|0
5336622|NCT00143455|18368786|P4|Cohort 2|Adverse Event|30
5336623|NCT00143455|18368787|P3|Cohort 2|Adverse Event|42
5336624|NCT00143455|18368788|P2|Cohort 2|Adverse Event|0
5336625|NCT00143455|18368789|P1|Cohort 2|Adverse Event|0
5336626|NCT00143455|18368786|P4|Cohort 1|Randomized But Not Treated|0
5336627|NCT00143455|18368787|P3|Cohort 1|Randomized But Not Treated|0
5336628|NCT00143455|18368788|P2|Cohort 1|Randomized But Not Treated|1
5336629|NCT00143455|18368789|P1|Cohort 1|Randomized But Not Treated|0
5336630|NCT00143455|18368786|P4|Cohort 1|Withdrawal by Subject|0
5336631|NCT00143455|18368787|P3|Cohort 1|Withdrawal by Subject|0
5336632|NCT00143455|18368788|P2|Cohort 1|Withdrawal by Subject|4
5336633|NCT00143455|18368789|P1|Cohort 1|Withdrawal by Subject|1
5336634|NCT00143455|18368786|P4|Cohort 1|Progressive Disease|0
5336635|NCT00143455|18368787|P3|Cohort 1|Progressive Disease|0
5336636|NCT00143455|18368788|P2|Cohort 1|Progressive Disease|6
5336637|NCT00143455|18368789|P1|Cohort 1|Progressive Disease|0
5336638|NCT00143455|18368786|P4|Cohort 1|Death|0
5336639|NCT00143455|18368787|P3|Cohort 1|Death|0
5336640|NCT00143455|18368788|P2|Cohort 1|Death|2
5336641|NCT00143455|18368789|P1|Cohort 1|Death|5
5336642|NCT00143455|18368786|P4|Cohort 1|Adverse Event|0
5336643|NCT00143455|18368787|P3|Cohort 1|Adverse Event|0
5336644|NCT00143455|18368788|P2|Cohort 1|Adverse Event|4
5336645|NCT00143455|18368789|P1|Cohort 1|Adverse Event|8
5336646|NCT00143403|18368823|P2|Overall Study|Randomized Not Treated|8
5336647|NCT00143403|18368824|P1|Overall Study|Randomized Not Treated|7
5336648|NCT00143403|18368823|P2|Overall Study|specified by site|9
5336649|NCT00143403|18368824|P1|Overall Study|specified by site|4
5336650|NCT00143403|18368823|P2|Overall Study|Protocol Violation|2
5336651|NCT00143403|18368824|P1|Overall Study|Protocol Violation|2
5336652|NCT00143403|18368823|P2|Overall Study|Relapse|7
5336653|NCT00143403|18368824|P1|Overall Study|Relapse|15
5336654|NCT00143403|18368823|P2|Overall Study|Withdrawal by Subject|12
5336655|NCT00143403|18368824|P1|Overall Study|Withdrawal by Subject|3
5336656|NCT00143403|18368823|P2|Overall Study|Death|0
5336657|NCT00143403|18368824|P1|Overall Study|Death|1
5336658|NCT00143403|18368823|P2|Overall Study|Adverse Event|8
5336659|NCT00143403|18368824|P1|Overall Study|Adverse Event|3
5336660|NCT00143390|18368834|P2|Overall Study|Other|2
5336661|NCT00143390|18368835|P1|Overall Study|Other|1
5336662|NCT00143390|18368834|P2|Overall Study|Adverse Event|8
5336663|NCT00143390|18368835|P1|Overall Study|Adverse Event|9
5336664|NCT00143390|18368834|P2|Overall Study|Study termination|15
5336665|NCT00143390|18368835|P1|Overall Study|Study termination|10
5336666|NCT00143390|18368834|P2|Overall Study|Protocol Violation|0
5336667|NCT00143390|18368835|P1|Overall Study|Protocol Violation|2
5336668|NCT00143390|18368834|P2|Overall Study|Progressive disease|115
5336669|NCT00143390|18368835|P1|Overall Study|Progressive disease|119
5336670|NCT00143390|18368834|P2|Overall Study|Withdrawal by Subject|4
5336671|NCT00143390|18368835|P1|Overall Study|Withdrawal by Subject|4
5336672|NCT00143390|18368834|P2|Overall Study|Not meeting entry criteria|5
5336673|NCT00143390|18368835|P1|Overall Study|Not meeting entry criteria|2
5336674|NCT00143390|18368834|P2|Overall Study|Death|0
5336675|NCT00143390|18368835|P1|Overall Study|Death|2
5336676|NCT00143312|18368851|P1|Overall Study|Withdrawal by Subject|1
5336677|NCT00143312|18368851|P1|Overall Study|Other|1
5336678|NCT00143312|18368851|P1|Overall Study|Lost to Follow-up|1
5336679|NCT00143312|18368851|P1|Overall Study|Adverse Event|2
5336680|NCT00143312|18368851|P1|Overall Study|Death|11
5336681|NCT00143247|18368861|P1|Overall Study|Other|12
5336682|NCT00143247|18368861|P1|Overall Study|following inaccurate lab adverse event|1
5336683|NCT00143247|18368861|P1|Overall Study|Lost to Follow-up|12
5336684|NCT00143247|18368861|P1|Overall Study|Protocol Violation|15
5336685|NCT00143247|18368861|P1|Overall Study|Study terminated by sponsor|31
5336686|NCT00143247|18368861|P1|Overall Study|Withdrawal by Subject|55
5336687|NCT00143247|18368861|P1|Overall Study|Lack of Efficacy|3
5336688|NCT00143247|18368861|P1|Overall Study|Adverse Event|19
5336689|NCT00143247|18368861|P1|Overall Study|Death|8
5336690|NCT00142935|18368878|P3|Overall Study|Death|1
5336691|NCT00142935|18368879|P2|Overall Study|Death|2
5336692|NCT00142935|18368880|P1|Overall Study|Death|0
5336693|NCT00142935|18368878|P3|Overall Study|Lost to Follow-up|5
5336694|NCT00142935|18368879|P2|Overall Study|Lost to Follow-up|5
5336695|NCT00142935|18368880|P1|Overall Study|Lost to Follow-up|2
5336696|NCT00142935|18368878|P3|Overall Study|Other reason|1
5336697|NCT00142935|18368879|P2|Overall Study|Other reason|1
5336698|NCT00142935|18368880|P1|Overall Study|Other reason|1
5336699|NCT00142909|18368905|P2|Medications Begin|Withdrawal by Subject|0
5336700|NCT00142909|18368906|P1|Medications Begin|Withdrawal by Subject|2
5336701|NCT00142909|18368905|P2|Medications Begin|Withdrawal by Subject|3
5336702|NCT00142909|18368906|P1|Medications Begin|Withdrawal by Subject|5
5336703|NCT00142909|18368905|P2|Medications Begin|Protocol Violation|0
5336704|NCT00142909|18368906|P1|Medications Begin|Protocol Violation|2
5336705|NCT00142909|18368905|P2|Randomization|Various Reasons|10
5336706|NCT00142909|18368906|P1|Randomization|Various Reasons|7
5336707|NCT00142792|18368946|P3|Overall Study|No category|1
5336708|NCT00142792|18368947|P2|Overall Study|No category|2
5336709|NCT00142792|18368948|P1|Overall Study|No category|1
5336710|NCT00142792|18368946|P3|Overall Study|Lost to Follow-up|7
5336711|NCT00142792|18368947|P2|Overall Study|Lost to Follow-up|11
5336712|NCT00142792|18368948|P1|Overall Study|Lost to Follow-up|8
5336713|NCT00142792|18368946|P3|Overall Study|Withdrawal by Subject|3
5336714|NCT00142792|18368947|P2|Overall Study|Withdrawal by Subject|2
5336715|NCT00142792|18368948|P1|Overall Study|Withdrawal by Subject|3
5336716|NCT00142792|18368946|P3|Overall Study|Death|1
5336717|NCT00142792|18368947|P2|Overall Study|Death|0
5336718|NCT00142792|18368948|P1|Overall Study|Death|0
5336719|NCT00142519|18368970|P2|Overall Study|Withdrawal by Subject|7
5336720|NCT00142519|18368971|P1|Overall Study|Withdrawal by Subject|10
5336721|NCT00142519|18368970|P2|Overall Study|Protocol Violation|0
5336722|NCT00142519|18368971|P1|Overall Study|Protocol Violation|1
5336723|NCT00142519|18368970|P2|Overall Study|Not Treated|9
5336724|NCT00142519|18368971|P1|Overall Study|Not Treated|7
5336725|NCT00142415|18369000|P6|Overall Study|Physician Decision|2
5336726|NCT00142415|18369001|P5|Overall Study|Physician Decision|1
5336727|NCT00142415|18369002|P4|Overall Study|Physician Decision|0
5336728|NCT00142415|18369003|P3|Overall Study|Physician Decision|0
5336729|NCT00142415|18369004|P2|Overall Study|Physician Decision|0
5336730|NCT00142415|18369005|P1|Overall Study|Physician Decision|0
5336731|NCT00142298|18369043|P10|Overall Study|Treatment Failure|0
5336732|NCT00142298|18369044|P9|Overall Study|Treatment Failure|0
5336733|NCT00142298|18369045|P8|Overall Study|Treatment Failure|0
5336734|NCT00142298|18369046|P7|Overall Study|Treatment Failure|2
5336735|NCT00142298|18369047|P6|Overall Study|Treatment Failure|2
5336736|NCT00142298|18369048|P5|Overall Study|Treatment Failure|0
5336737|NCT00142298|18369049|P4|Overall Study|Treatment Failure|0
5336738|NCT00142298|18369050|P3|Overall Study|Treatment Failure|0
5336739|NCT00142298|18369051|P2|Overall Study|Treatment Failure|0
5336740|NCT00142298|18369052|P1|Overall Study|Treatment Failure|0
5336741|NCT00142298|18369043|P10|Overall Study|Lost to Follow-up|0
5336742|NCT00142298|18369044|P9|Overall Study|Lost to Follow-up|0
5336743|NCT00142298|18369045|P8|Overall Study|Lost to Follow-up|0
5336744|NCT00142298|18369046|P7|Overall Study|Lost to Follow-up|2
5336745|NCT00142298|18369047|P6|Overall Study|Lost to Follow-up|0
5336746|NCT00142298|18369048|P5|Overall Study|Lost to Follow-up|0
5336747|NCT00142298|18369049|P4|Overall Study|Lost to Follow-up|0
5336748|NCT00142298|18369050|P3|Overall Study|Lost to Follow-up|0
5336749|NCT00142298|18369051|P2|Overall Study|Lost to Follow-up|0
5336750|NCT00142298|18369052|P1|Overall Study|Lost to Follow-up|0
5336751|NCT00142298|18369043|P10|Overall Study|Other- not specified|0
5336752|NCT00142298|18369044|P9|Overall Study|Other- not specified|0
5336753|NCT00142298|18369045|P8|Overall Study|Other- not specified|0
5336754|NCT00142298|18369046|P7|Overall Study|Other- not specified|0
5336755|NCT00142298|18369047|P6|Overall Study|Other- not specified|0
5336756|NCT00142298|18369048|P5|Overall Study|Other- not specified|0
5336757|NCT00142298|18369049|P4|Overall Study|Other- not specified|1
5336758|NCT00142298|18369050|P3|Overall Study|Other- not specified|0
5336759|NCT00142298|18369051|P2|Overall Study|Other- not specified|3
5336760|NCT00142298|18369052|P1|Overall Study|Other- not specified|0
5336761|NCT00142298|18369043|P10|Overall Study|Virologic breakthrough|0
5336762|NCT00142298|18369044|P9|Overall Study|Virologic breakthrough|0
5336763|NCT00142298|18369045|P8|Overall Study|Virologic breakthrough|0
5336764|NCT00142298|18369046|P7|Overall Study|Virologic breakthrough|3
5336765|NCT00142298|18369047|P6|Overall Study|Virologic breakthrough|3
5336766|NCT00142298|18369048|P5|Overall Study|Virologic breakthrough|2
5336767|NCT00142298|18369049|P4|Overall Study|Virologic breakthrough|7
5336768|NCT00142298|18369050|P3|Overall Study|Virologic breakthrough|9
5336769|NCT00142298|18369051|P2|Overall Study|Virologic breakthrough|23
5336770|NCT00142298|18369052|P1|Overall Study|Virologic breakthrough|19
5336771|NCT00142298|18369043|P10|Overall Study|Pregnancy|0
5336772|NCT00142298|18369044|P9|Overall Study|Pregnancy|1
5336773|NCT00142298|18369045|P8|Overall Study|Pregnancy|0
5336774|NCT00142298|18369046|P7|Overall Study|Pregnancy|0
5336775|NCT00142298|18369047|P6|Overall Study|Pregnancy|0
5336776|NCT00142298|18369048|P5|Overall Study|Pregnancy|0
5336777|NCT00142298|18369049|P4|Overall Study|Pregnancy|3
5336778|NCT00142298|18369050|P3|Overall Study|Pregnancy|2
5336779|NCT00142298|18369051|P2|Overall Study|Pregnancy|4
5336780|NCT00142298|18369052|P1|Overall Study|Pregnancy|4
5336781|NCT00142298|18369043|P10|Overall Study|Patient, Investigator,or Sponsor request|0
5336782|NCT00142298|18369044|P9|Overall Study|Patient, Investigator,or Sponsor request|1
5336783|NCT00142298|18369045|P8|Overall Study|Patient, Investigator,or Sponsor request|4
5336784|NCT00142298|18369046|P7|Overall Study|Patient, Investigator,or Sponsor request|1
5336785|NCT00142298|18369047|P6|Overall Study|Patient, Investigator,or Sponsor request|3
5336786|NCT00142298|18369048|P5|Overall Study|Patient, Investigator,or Sponsor request|4
5336787|NCT00142298|18369049|P4|Overall Study|Patient, Investigator,or Sponsor request|51
5336788|NCT00142298|18369050|P3|Overall Study|Patient, Investigator,or Sponsor request|11
5336789|NCT00142298|18369051|P2|Overall Study|Patient, Investigator,or Sponsor request|60
5336790|NCT00142298|18369052|P1|Overall Study|Patient, Investigator,or Sponsor request|66
5336791|NCT00142298|18369043|P10|Overall Study|Non-compliance|0
5336792|NCT00142298|18369044|P9|Overall Study|Non-compliance|3
5336793|NCT00142298|18369045|P8|Overall Study|Non-compliance|3
5336794|NCT00142298|18369046|P7|Overall Study|Non-compliance|0
5336795|NCT00142298|18369047|P6|Overall Study|Non-compliance|0
5336796|NCT00142298|18369048|P5|Overall Study|Non-compliance|1
5336797|NCT00142298|18369049|P4|Overall Study|Non-compliance|6
5336798|NCT00142298|18369050|P3|Overall Study|Non-compliance|0
5336799|NCT00142298|18369051|P2|Overall Study|Non-compliance|13
5336800|NCT00142298|18369052|P1|Overall Study|Non-compliance|15
5336801|NCT00142298|18369043|P10|Overall Study|Lack of Efficacy|0
5336802|NCT00142298|18369044|P9|Overall Study|Lack of Efficacy|0
5336803|NCT00142298|18369045|P8|Overall Study|Lack of Efficacy|1
5336804|NCT00142298|18369046|P7|Overall Study|Lack of Efficacy|0
5336805|NCT00142298|18369047|P6|Overall Study|Lack of Efficacy|0
5336806|NCT00142298|18369048|P5|Overall Study|Lack of Efficacy|1
5336807|NCT00142298|18369049|P4|Overall Study|Lack of Efficacy|12
5336808|NCT00142298|18369050|P3|Overall Study|Lack of Efficacy|9
5336809|NCT00142298|18369051|P2|Overall Study|Lack of Efficacy|62
5336810|NCT00142298|18369052|P1|Overall Study|Lack of Efficacy|44
5336811|NCT00142298|18369043|P10|Overall Study|Death|0
5336812|NCT00142298|18369044|P9|Overall Study|Death|0
5336813|NCT00142298|18369045|P8|Overall Study|Death|0
5336814|NCT00142298|18369046|P7|Overall Study|Death|0
5336815|NCT00142298|18369047|P6|Overall Study|Death|6
5336816|NCT00142298|18369048|P5|Overall Study|Death|0
5336817|NCT00142298|18369049|P4|Overall Study|Death|0
5336818|NCT00142298|18369050|P3|Overall Study|Death|1
5336819|NCT00142298|18369051|P2|Overall Study|Death|1
5336820|NCT00142298|18369052|P1|Overall Study|Death|1
5336821|NCT00142298|18369043|P10|Overall Study|Clinical disease progression|0
5336822|NCT00142298|18369044|P9|Overall Study|Clinical disease progression|0
5336823|NCT00142298|18369045|P8|Overall Study|Clinical disease progression|0
5336824|NCT00142298|18369046|P7|Overall Study|Clinical disease progression|0
5336825|NCT00142298|18369047|P6|Overall Study|Clinical disease progression|0
5336826|NCT00142298|18369048|P5|Overall Study|Clinical disease progression|0
5336827|NCT00142298|18369049|P4|Overall Study|Clinical disease progression|0
5336828|NCT00142298|18369050|P3|Overall Study|Clinical disease progression|0
5336829|NCT00142298|18369051|P2|Overall Study|Clinical disease progression|0
5336830|NCT00142298|18369052|P1|Overall Study|Clinical disease progression|1
5336831|NCT00142298|18369043|P10|Overall Study|Adverse Event|0
5336832|NCT00142298|18369044|P9|Overall Study|Adverse Event|0
5336833|NCT00142298|18369045|P8|Overall Study|Adverse Event|0
5336834|NCT00142298|18369046|P7|Overall Study|Adverse Event|0
5336835|NCT00142298|18369047|P6|Overall Study|Adverse Event|2
5336836|NCT00142298|18369048|P5|Overall Study|Adverse Event|2
5336837|NCT00142298|18369049|P4|Overall Study|Adverse Event|5
5336838|NCT00142298|18369050|P3|Overall Study|Adverse Event|1
5336839|NCT00142298|18369051|P2|Overall Study|Adverse Event|10
5336840|NCT00142298|18369052|P1|Overall Study|Adverse Event|10
5336841|NCT00141921|18369086|P1|Overall Study|Other|8
5336842|NCT00141921|18369086|P1|Overall Study|Ineligibility Determined|2
5336843|NCT00141921|18369086|P1|Overall Study|Pregnancy|4
5336844|NCT00141921|18369086|P1|Overall Study|Administrative Decision|2
5336845|NCT00141921|18369086|P1|Overall Study|Adverse Event|5
5336846|NCT00141921|18369086|P1|Overall Study|Protocol Deviation|7
5336847|NCT00141921|18369086|P1|Overall Study|Disease Progression|7
5336848|NCT00141921|18369086|P1|Overall Study|Noncompliance|17
5336849|NCT00141921|18369086|P1|Overall Study|Lost to Follow-up|19
5336850|NCT00141921|18369086|P1|Overall Study|Withdrawal by Subject|42
5336851|NCT00141921|18369086|P1|Overall Study|Remain on Study|28
5336852|NCT00141817|18369112|P4|Overall Study|Parent request|0
5336853|NCT00141817|18369113|P3|Overall Study|Parent request|0
5336854|NCT00141817|18369114|P2|Overall Study|Parent request|0
5336855|NCT00141817|18369115|P1|Overall Study|Parent request|1
5336856|NCT00141817|18369112|P4|Overall Study|Protocol Violation|0
5336857|NCT00141817|18369113|P3|Overall Study|Protocol Violation|1
5336858|NCT00141817|18369114|P2|Overall Study|Protocol Violation|0
5336859|NCT00141817|18369115|P1|Overall Study|Protocol Violation|0
5336860|NCT00141778|18369156|P3|Started Study Medication|Chest Discomfort|1
5336861|NCT00141778|18369157|P2|Started Study Medication|Chest Discomfort|0
5336862|NCT00141778|18369158|P1|Started Study Medication|Chest Discomfort|0
5336863|NCT00141778|18369156|P3|Started Study Medication|Difficulty Swallowing|0
5336864|NCT00141778|18369157|P2|Started Study Medication|Difficulty Swallowing|1
5336865|NCT00141778|18369158|P1|Started Study Medication|Difficulty Swallowing|0
5336866|NCT00141778|18369156|P3|Started Study Medication|Withdrawal by Subject|0
5336867|NCT00141778|18369157|P2|Started Study Medication|Withdrawal by Subject|2
5336868|NCT00141778|18369158|P1|Started Study Medication|Withdrawal by Subject|0
5336869|NCT00141778|18369156|P3|Started Study Medication|Met safety criteria for discontinuation|3
5336870|NCT00141778|18369157|P2|Started Study Medication|Met safety criteria for discontinuation|4
5336871|NCT00141778|18369158|P1|Started Study Medication|Met safety criteria for discontinuation|2
5336872|NCT00141778|18369156|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
5336873|NCT00141778|18369157|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
5336874|NCT00141778|18369158|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
5336875|NCT00141726|18369211|P1|Overall Study|Completed <50% Scheduled Dosing|3
5336876|NCT00141518|18369219|P3|Overall Study|Lack of Efficacy|0
5336877|NCT00141518|18369220|P2|Overall Study|Lack of Efficacy|0
5336878|NCT00141518|18369221|P1|Overall Study|Lack of Efficacy|5
5336879|NCT00141518|18369219|P3|Overall Study|Protocol Violation|2
5336880|NCT00141518|18369220|P2|Overall Study|Protocol Violation|1
5336881|NCT00141518|18369221|P1|Overall Study|Protocol Violation|1
5336882|NCT00141518|18369219|P3|Overall Study|Withdrawal by Subject|2
5336883|NCT00141518|18369220|P2|Overall Study|Withdrawal by Subject|0
5336884|NCT00141518|18369221|P1|Overall Study|Withdrawal by Subject|2
5336885|NCT00141518|18369219|P3|Overall Study|Adverse Event|2
5336886|NCT00141518|18369220|P2|Overall Study|Adverse Event|5
5336887|NCT00141518|18369221|P1|Overall Study|Adverse Event|7
5336888|NCT00141518|18369219|P3|Overall Study|Withdrew Consent Prior to Treatment|0
5336889|NCT00141518|18369220|P2|Overall Study|Withdrew Consent Prior to Treatment|0
5336890|NCT00141518|18369221|P1|Overall Study|Withdrew Consent Prior to Treatment|1
5336891|NCT00141453|18369410|P2|Overall Study|Protocol Violation|5
5336892|NCT00141453|18369411|P1|Overall Study|Protocol Violation|6
5336893|NCT00141297|18369425|P10|Overall Study|Transitioned|0
5336894|NCT00141297|18369426|P9|Overall Study|Transitioned|0
5336895|NCT00141297|18369427|P8|Overall Study|Transitioned|0
5336896|NCT00141297|18369428|P7|Overall Study|Transitioned|0
5336897|NCT00141297|18369429|P6|Overall Study|Transitioned|0
5336898|NCT00141297|18369430|P5|Overall Study|Transitioned|1
5336899|NCT00141297|18369431|P4|Overall Study|Transitioned|0
5336900|NCT00141297|18369432|P3|Overall Study|Transitioned|0
5336901|NCT00141297|18369433|P2|Overall Study|Transitioned|0
5336902|NCT00141297|18369434|P1|Overall Study|Transitioned|0
5336903|NCT00141297|18369425|P10|Overall Study|Progressive Disease|6
5336904|NCT00141297|18369426|P9|Overall Study|Progressive Disease|15
5336905|NCT00141297|18369427|P8|Overall Study|Progressive Disease|3
5336906|NCT00141297|18369428|P7|Overall Study|Progressive Disease|3
5336907|NCT00141297|18369429|P6|Overall Study|Progressive Disease|2
5336908|NCT00141297|18369430|P5|Overall Study|Progressive Disease|15
5336909|NCT00141297|18369431|P4|Overall Study|Progressive Disease|2
5336910|NCT00141297|18369432|P3|Overall Study|Progressive Disease|6
5336911|NCT00141297|18369433|P2|Overall Study|Progressive Disease|3
5336912|NCT00141297|18369434|P1|Overall Study|Progressive Disease|2
5336913|NCT00141297|18369425|P10|Overall Study|Other|0
5336914|NCT00141297|18369426|P9|Overall Study|Other|2
5336915|NCT00141297|18369427|P8|Overall Study|Other|0
5336916|NCT00141297|18369428|P7|Overall Study|Other|0
5336917|NCT00141297|18369429|P6|Overall Study|Other|0
5336918|NCT00141297|18369430|P5|Overall Study|Other|5
5336919|NCT00141297|18369431|P4|Overall Study|Other|1
5336920|NCT00141297|18369432|P3|Overall Study|Other|0
5336921|NCT00141297|18369433|P2|Overall Study|Other|0
5336922|NCT00141297|18369434|P1|Overall Study|Other|0
5336923|NCT00141297|18369425|P10|Overall Study|Withdrawal by Subject|0
5336924|NCT00141297|18369426|P9|Overall Study|Withdrawal by Subject|1
5336925|NCT00141297|18369427|P8|Overall Study|Withdrawal by Subject|0
5336926|NCT00141297|18369428|P7|Overall Study|Withdrawal by Subject|0
5336927|NCT00141297|18369429|P6|Overall Study|Withdrawal by Subject|0
5336928|NCT00141297|18369430|P5|Overall Study|Withdrawal by Subject|0
5336929|NCT00141297|18369431|P4|Overall Study|Withdrawal by Subject|0
5336930|NCT00141297|18369432|P3|Overall Study|Withdrawal by Subject|0
5336931|NCT00141297|18369433|P2|Overall Study|Withdrawal by Subject|0
5336932|NCT00141297|18369434|P1|Overall Study|Withdrawal by Subject|0
5336933|NCT00141297|18369425|P10|Overall Study|Death|0
5336934|NCT00141297|18369426|P9|Overall Study|Death|1
5336935|NCT00141297|18369427|P8|Overall Study|Death|0
5336936|NCT00141297|18369428|P7|Overall Study|Death|0
5336937|NCT00141297|18369429|P6|Overall Study|Death|0
5336938|NCT00141297|18369430|P5|Overall Study|Death|0
5336939|NCT00141297|18369431|P4|Overall Study|Death|0
5336940|NCT00141297|18369432|P3|Overall Study|Death|0
5336941|NCT00141297|18369433|P2|Overall Study|Death|0
5336942|NCT00141297|18369434|P1|Overall Study|Death|1
5336943|NCT00141297|18369425|P10|Overall Study|Adverse Event|0
5336944|NCT00141297|18369426|P9|Overall Study|Adverse Event|1
5336945|NCT00141297|18369427|P8|Overall Study|Adverse Event|1
5336946|NCT00141297|18369428|P7|Overall Study|Adverse Event|0
5336947|NCT00141297|18369429|P6|Overall Study|Adverse Event|1
5336948|NCT00141297|18369430|P5|Overall Study|Adverse Event|1
5336949|NCT00141297|18369431|P4|Overall Study|Adverse Event|0
5336950|NCT00141297|18369432|P3|Overall Study|Adverse Event|1
5336951|NCT00141297|18369433|P2|Overall Study|Adverse Event|0
5336952|NCT00141297|18369434|P1|Overall Study|Adverse Event|0
5336953|NCT00141271|18369712|P3|Overall Study|Other|5
5336954|NCT00141271|18369713|P2|Overall Study|Other|12
5336955|NCT00141271|18369714|P1|Overall Study|Other|11
5336956|NCT00141271|18369712|P3|Overall Study|Withdrawal by Subject|10
5336957|NCT00141271|18369713|P2|Overall Study|Withdrawal by Subject|9
5336958|NCT00141271|18369714|P1|Overall Study|Withdrawal by Subject|14
5336959|NCT00141271|18369712|P3|Overall Study|Lost to Follow-up|21
5336960|NCT00141271|18369713|P2|Overall Study|Lost to Follow-up|15
5336961|NCT00141271|18369714|P1|Overall Study|Lost to Follow-up|15
5336962|NCT00141271|18369712|P3|Overall Study|Lack of Efficacy|3
5336963|NCT00141271|18369713|P2|Overall Study|Lack of Efficacy|7
5336964|NCT00141271|18369714|P1|Overall Study|Lack of Efficacy|7
5336965|NCT00141271|18369712|P3|Overall Study|Laboratory Abnormality|1
5336966|NCT00141271|18369713|P2|Overall Study|Laboratory Abnormality|1
5336967|NCT00141271|18369714|P1|Overall Study|Laboratory Abnormality|2
5336968|NCT00141271|18369712|P3|Overall Study|Adverse Event|17
5336969|NCT00141271|18369713|P2|Overall Study|Adverse Event|19
5336970|NCT00141271|18369714|P1|Overall Study|Adverse Event|31
5336971|NCT00141219|18369835|P2|Overall Study|Withdrawal by Subject|2
5336972|NCT00141219|18369836|P1|Overall Study|Withdrawal by Subject|6
5336973|NCT00141219|18369835|P2|Overall Study|Lack of Efficacy|4
5336974|NCT00141219|18369836|P1|Overall Study|Lack of Efficacy|5
5336975|NCT00141219|18369835|P2|Overall Study|Adverse Event|6
5336976|NCT00141219|18369836|P1|Overall Study|Adverse Event|8
5336977|NCT00141219|18369835|P2|Overall Study|Protocol violations|4
5336978|NCT00141219|18369836|P1|Overall Study|Protocol violations|5
5336979|NCT00141102|18369893|P2|Overall Study|Death|2
5336980|NCT00141102|18369894|P1|Overall Study|Death|2
5336981|NCT00141102|18369893|P2|Overall Study|Randomized But Did Not Receive Treatment|9
5336982|NCT00141102|18369894|P1|Overall Study|Randomized But Did Not Receive Treatment|15
5336983|NCT00141102|18369893|P2|Overall Study|Withdrawal by Subject|142
5336984|NCT00141102|18369894|P1|Overall Study|Withdrawal by Subject|112
5336985|NCT00141102|18369893|P2|Overall Study|Other|76
5336986|NCT00141102|18369894|P1|Overall Study|Other|87
5336987|NCT00141102|18369893|P2|Overall Study|Lost to Follow-up|32
5336988|NCT00141102|18369894|P1|Overall Study|Lost to Follow-up|29
5336989|NCT00141102|18369893|P2|Overall Study|Lack of Efficacy|26
5336990|NCT00141102|18369894|P1|Overall Study|Lack of Efficacy|21
5336991|NCT00141102|18369893|P2|Overall Study|Laboratory Abnormality|33
5336992|NCT00141102|18369894|P1|Overall Study|Laboratory Abnormality|9
5336993|NCT00141102|18369893|P2|Overall Study|Adverse Event|305
5336994|NCT00141102|18369894|P1|Overall Study|Adverse Event|233
5336995|NCT00141037|18369934|P2|Overall Study|Graft Failure|4
5336996|NCT00141037|18369935|P1|Overall Study|Graft Failure|3
5336997|NCT00141037|18369934|P2|Overall Study|Moved from area|7
5336998|NCT00141037|18369935|P1|Overall Study|Moved from area|1
5336999|NCT00141037|18369934|P2|Overall Study|Other|1
5337000|NCT00141037|18369935|P1|Overall Study|Other|0
5337001|NCT00141037|18369934|P2|Overall Study|Withdrawal by Subject|1
5337002|NCT00141037|18369935|P1|Overall Study|Withdrawal by Subject|2
5337003|NCT00141037|18369934|P2|Overall Study|Protocol Violation|2
5337004|NCT00141037|18369935|P1|Overall Study|Protocol Violation|0
5337005|NCT00141037|18369934|P2|Overall Study|Lost to Follow-up|1
5337006|NCT00141037|18369935|P1|Overall Study|Lost to Follow-up|3
5337007|NCT00141037|18369934|P2|Overall Study|Physician Decision|2
5337008|NCT00141037|18369935|P1|Overall Study|Physician Decision|1
5337009|NCT00140426|18369970|P2|Overall Study|Withdrawal by Subject|3
5337010|NCT00140426|18369971|P1|Overall Study|Withdrawal by Subject|0
5337011|NCT00140413|18370004|P2|Overall Study|Withdrawal by Subject|0
5337012|NCT00140413|18370005|P1|Overall Study|Withdrawal by Subject|2
5337013|NCT00140413|18370004|P2|Overall Study|Lost to Follow-up|0
5337014|NCT00140413|18370005|P1|Overall Study|Lost to Follow-up|1
5337015|NCT00140140|18370136|P3|Overall Study|Physician Decision|0
5337016|NCT00140140|18370137|P2|Overall Study|Physician Decision|1
5337017|NCT00140140|18370138|P1|Overall Study|Physician Decision|1
5337018|NCT00140140|18370136|P3|Overall Study|Unacceptable toxicity|2
5337019|NCT00140140|18370137|P2|Overall Study|Unacceptable toxicity|1
5337020|NCT00140140|18370138|P1|Overall Study|Unacceptable toxicity|1
5337021|NCT00139776|18370188|P4|Period III|Withdrawal by Subject|21
5337022|NCT00139776|18370189|P3|Period III|Withdrawal by Subject|16
5337023|NCT00139776|18370190|P2|Period III|Withdrawal by Subject|0
5337024|NCT00139776|18370191|P1|Period III|Withdrawal by Subject|0
5337025|NCT00139776|18370188|P4|Period III|Lost to Follow-up|4
5337026|NCT00139776|18370189|P3|Period III|Lost to Follow-up|5
5337027|NCT00139776|18370190|P2|Period III|Lost to Follow-up|0
5337028|NCT00139776|18370191|P1|Period III|Lost to Follow-up|0
5337029|NCT00139776|18370188|P4|Period III|Lack of Efficacy|24
5337030|NCT00139776|18370189|P3|Period III|Lack of Efficacy|10
5337031|NCT00139776|18370190|P2|Period III|Lack of Efficacy|0
5337032|NCT00139776|18370191|P1|Period III|Lack of Efficacy|0
5337033|NCT00139776|18370188|P4|Period III|Other|34
5337034|NCT00139776|18370189|P3|Period III|Other|23
5337035|NCT00139776|18370190|P2|Period III|Other|0
5337036|NCT00139776|18370191|P1|Period III|Other|0
5337037|NCT00139776|18370188|P4|Period III|Adverse Event|23
5337038|NCT00139776|18370189|P3|Period III|Adverse Event|22
5337039|NCT00139776|18370190|P2|Period III|Adverse Event|0
5337040|NCT00139776|18370191|P1|Period III|Adverse Event|0
5337041|NCT00139776|18370188|P4|Period II|Not Randomized into Period III|0
5337042|NCT00139776|18370189|P3|Period II|Not Randomized into Period III|0
5337043|NCT00139776|18370190|P2|Period II|Not Randomized into Period III|322
5337044|NCT00139776|18370191|P1|Period II|Not Randomized into Period III|0
5337045|NCT00139776|18370188|P4|Period I|Did not enter Period II|0
5337046|NCT00139776|18370189|P3|Period I|Did not enter Period II|0
5337047|NCT00139776|18370190|P2|Period I|Did not enter Period II|0
5337048|NCT00139776|18370191|P1|Period I|Did not enter Period II|575
5337049|NCT00139737|18370226|P1|Overall Study|Screened, Not Treated|13
5337050|NCT00139737|18370226|P1|Overall Study|Did Not Meet Entrance Criteria|1
5337051|NCT00139737|18370226|P1|Overall Study|Withdrew During Screening Phase|8
5337052|NCT00139737|18370226|P1|Overall Study|Protocol Violation|18
5337053|NCT00139737|18370226|P1|Overall Study|Laboratory Abnormality|2
5337054|NCT00139737|18370226|P1|Overall Study|Death|3
5337055|NCT00139737|18370226|P1|Overall Study|Lost to Follow-up|8
5337056|NCT00139737|18370226|P1|Overall Study|Lack of Efficacy|40
5337057|NCT00139737|18370226|P1|Overall Study|Adverse Event|58
5337058|NCT00139737|18370226|P1|Overall Study|Withdrawal by Subject|190
5337059|NCT00139659|18370232|P2|Overall Study|Withdrawal by Subject|10
5337060|NCT00139659|18370233|P1|Overall Study|Withdrawal by Subject|14
5337061|NCT00139659|18370232|P2|Overall Study|Reason not Specified|3
5337062|NCT00139659|18370233|P1|Overall Study|Reason not Specified|6
5337063|NCT00139659|18370232|P2|Overall Study|Lost to Follow-up|3
5337064|NCT00139659|18370233|P1|Overall Study|Lost to Follow-up|7
5337065|NCT00139659|18370232|P2|Overall Study|Lack of Efficacy|1
5337066|NCT00139659|18370233|P1|Overall Study|Lack of Efficacy|1
5337067|NCT00139659|18370232|P2|Overall Study|Adverse Event|1
5337068|NCT00139659|18370233|P1|Overall Study|Adverse Event|12
5337069|NCT00139477|18370311|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
5337070|NCT00139477|18370312|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
5337071|NCT00139477|18370311|P2|Second Intervention -6Months to 12Months|Relocation|0
5337072|NCT00139477|18370312|P1|Second Intervention -6Months to 12Months|Relocation|1
5337073|NCT00139477|18370311|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
5337074|NCT00139477|18370312|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
5337075|NCT00139477|18370311|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
5337076|NCT00139477|18370312|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
5337077|NCT00139477|18370311|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
5337078|NCT00139477|18370312|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
5337079|NCT00139477|18370311|P2|First Intervention -Baseline to 6Months|Relocation|2
5337080|NCT00139477|18370312|P1|First Intervention -Baseline to 6Months|Relocation|1
5337081|NCT00139477|18370311|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
5337082|NCT00139477|18370312|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
5337083|NCT00138671|18370347|P2|Overall Study|Other|3
5337084|NCT00138671|18370348|P1|Overall Study|Other|3
5337085|NCT00138671|18370347|P2|Overall Study|Withdrawal by Subject|5
5337086|NCT00138671|18370348|P1|Overall Study|Withdrawal by Subject|3
5337087|NCT00138671|18370347|P2|Overall Study|Lost to Follow-up|2
5337088|NCT00138671|18370348|P1|Overall Study|Lost to Follow-up|1
5337089|NCT00138671|18370347|P2|Overall Study|Adverse Event|3
5337090|NCT00138671|18370348|P1|Overall Study|Adverse Event|6
5337091|NCT00138671|18370347|P2|Overall Study|Death|3
5337092|NCT00138671|18370348|P1|Overall Study|Death|0
5337093|NCT00138658|18370398|P1|Overall Study|Withdrawal by Subject|5
5337094|NCT00138658|18370398|P1|Overall Study|Physician Decision|11
5337095|NCT00138658|18370398|P1|Overall Study|Disease Progression|21
5337096|NCT00138658|18370398|P1|Overall Study|Death|1
5337097|NCT00138658|18370398|P1|Overall Study|Adverse Event|23
5337098|NCT00138424|18370421|P4|Overall Study|Physician Decision|0
5337099|NCT00138424|18370422|P3|Overall Study|Physician Decision|0
5337100|NCT00138424|18370423|P2|Overall Study|Physician Decision|1
5337101|NCT00138424|18370424|P1|Overall Study|Physician Decision|0
5337102|NCT00138151|18370507|P1|Overall Study|Physician Decision|1
5337103|NCT00138151|18370507|P1|Overall Study|Withdrawal by Subject|3
5337104|NCT00138073|18370522|P1|Overall Study|lack of resources|55
5337105|NCT00137839|18370561|P1|Overall Study|Prolonged Treatment Delay|1
5337106|NCT00137839|18370561|P1|Overall Study|Not Start Treatment|1
5337107|NCT00137839|18370561|P1|Overall Study|Disease Progression|60
5337108|NCT00137839|18370561|P1|Overall Study|Death|8
5337109|NCT00137839|18370561|P1|Overall Study|Physician Decision|7
5337110|NCT00137839|18370561|P1|Overall Study|Adverse Event|7
5337111|NCT00137631|18370574|P2|Overall Study|Lost to Follow-up|41
5337112|NCT00137631|18370575|P1|Overall Study|Lost to Follow-up|37
5337113|NCT00137449|18370591|P2|Overall Study|Withdrawal by Subject|1
5337114|NCT00137449|18370592|P1|Overall Study|Withdrawal by Subject|1
5337115|NCT00137449|18370591|P2|Overall Study|Adverse Event|1
5337116|NCT00137449|18370592|P1|Overall Study|Adverse Event|3
5337117|NCT00137449|18370591|P2|Overall Study|Death|3
5337118|NCT00137449|18370592|P1|Overall Study|Death|4
5337119|NCT00137449|18370591|P2|Overall Study|Disease Progression|13
5337120|NCT00137449|18370592|P1|Overall Study|Disease Progression|8
5337121|NCT00137436|18370629|P1|Overall Study|Other|5
5337122|NCT00137436|18370629|P1|Overall Study|Withdrawal by Subject|6
5337123|NCT00137436|18370629|P1|Overall Study|Lack of Efficacy|17
5337124|NCT00137436|18370629|P1|Overall Study|Death|2
5337125|NCT00137436|18370629|P1|Overall Study|Adverse Event|13
5337126|NCT00137423|18370648|P2|Overall Study|Death|1
5337127|NCT00137423|18370649|P1|Overall Study|Death|0
5337128|NCT00137423|18370648|P2|Overall Study|Lack of Efficacy|33
5337129|NCT00137423|18370649|P1|Overall Study|Lack of Efficacy|31
5337130|NCT00137423|18370648|P2|Overall Study|consent withdrawn|1
5337131|NCT00137423|18370649|P1|Overall Study|consent withdrawn|1
5337132|NCT00137423|18370648|P2|Overall Study|Adverse Event|9
5337133|NCT00137423|18370649|P1|Overall Study|Adverse Event|7
5337134|NCT00137267|18370686|P2|Overall Study|Lost to Follow-up|21
5337135|NCT00137267|18370687|P1|Overall Study|Lost to Follow-up|15
5337136|NCT00137111|18370699|P4|Total Therapy|Non Compliance|0
5337137|NCT00137111|18370700|P3|Total Therapy|Non Compliance|0
5337138|NCT00137111|18370701|P2|Total Therapy|Non Compliance|0
5337139|NCT00137111|18370702|P1|Total Therapy|Non Compliance|5
5337140|NCT00137111|18370699|P4|Total Therapy|Death|0
5337141|NCT00137111|18370700|P3|Total Therapy|Death|0
5337142|NCT00137111|18370701|P2|Total Therapy|Death|0
5337143|NCT00137111|18370702|P1|Total Therapy|Death|35
5337144|NCT00137046|18370716|P2|Overall Study|Withdrew prior to study treatment|1
5337145|NCT00137046|18370717|P1|Overall Study|Withdrew prior to study treatment|1
5337146|NCT00137046|18370716|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
5337147|NCT00137046|18370717|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
5337148|NCT00137046|18370716|P2|Overall Study|Withdrawal by Subject|42
5337149|NCT00137046|18370717|P1|Overall Study|Withdrawal by Subject|33
5337150|NCT00137046|18370716|P2|Overall Study|Other|19
5337151|NCT00137046|18370717|P1|Overall Study|Other|23
5337152|NCT00137046|18370716|P2|Overall Study|Lost to Follow-up|24
5337153|NCT00137046|18370717|P1|Overall Study|Lost to Follow-up|8
5337154|NCT00137046|18370716|P2|Overall Study|Lack of Efficacy|1
5337155|NCT00137046|18370717|P1|Overall Study|Lack of Efficacy|13
5337156|NCT00137046|18370716|P2|Overall Study|Laboratory Abnormality|0
5337157|NCT00137046|18370717|P1|Overall Study|Laboratory Abnormality|2
5337158|NCT00137046|18370716|P2|Overall Study|Adverse Event|5
5337159|NCT00137046|18370717|P1|Overall Study|Adverse Event|16
5337160|NCT00137046|18370716|P2|Overall Study|Death|1
5337161|NCT00137046|18370717|P1|Overall Study|Death|2
5337162|NCT00136955|18370765|P1|Overall Study|Incl. prog. disease, protocol violation|12
5337163|NCT00136955|18370765|P1|Overall Study|Withdrawal by Subject|2
5337164|NCT00136955|18370765|P1|Overall Study|Lost to Follow-up|1
5337165|NCT00136955|18370765|P1|Overall Study|Adverse Event|8
5337166|NCT00136916|18370774|P2|Overall Study|Discontinued in follow up period|0
5337167|NCT00136916|18370775|P1|Overall Study|Discontinued in follow up period|3
5337168|NCT00136916|18370774|P2|Overall Study|Other|24
5337169|NCT00136916|18370775|P1|Overall Study|Other|22
5337170|NCT00136916|18370774|P2|Overall Study|Withdrawal by Subject|46
5337171|NCT00136916|18370775|P1|Overall Study|Withdrawal by Subject|44
5337172|NCT00136916|18370774|P2|Overall Study|Lost to Follow-up|14
5337173|NCT00136916|18370775|P1|Overall Study|Lost to Follow-up|12
5337174|NCT00136916|18370774|P2|Overall Study|Lack of Efficacy|3
5337175|NCT00136916|18370775|P1|Overall Study|Lack of Efficacy|13
5337176|NCT00136916|18370774|P2|Overall Study|Laboratory abnormality|1
5337177|NCT00136916|18370775|P1|Overall Study|Laboratory abnormality|0
5337178|NCT00136916|18370774|P2|Overall Study|Adverse Event|8
5337179|NCT00136916|18370775|P1|Overall Study|Adverse Event|27
5337180|NCT00136916|18370774|P2|Overall Study|Death|3
5337181|NCT00136916|18370775|P1|Overall Study|Death|1
5337182|NCT00136916|18370774|P2|Overall Study|Never received study treatment|5
5337183|NCT00136916|18370775|P1|Overall Study|Never received study treatment|3
5337184|NCT00136604|18370882|P5|Overall Study|Migrated/moved from study area|0
5337185|NCT00136604|18370883|P4|Overall Study|Migrated/moved from study area|0
5337186|NCT00136604|18370884|P3|Overall Study|Migrated/moved from study area|0
5337187|NCT00136604|18370885|P2|Overall Study|Migrated/moved from study area|1
5337188|NCT00136604|18370886|P1|Overall Study|Migrated/moved from study area|0
5337189|NCT00136604|18370882|P5|Overall Study|Lost to Follow-up|1
5337190|NCT00136604|18370883|P4|Overall Study|Lost to Follow-up|0
5337191|NCT00136604|18370884|P3|Overall Study|Lost to Follow-up|0
5337192|NCT00136604|18370885|P2|Overall Study|Lost to Follow-up|0
5337193|NCT00136604|18370886|P1|Overall Study|Lost to Follow-up|1
5337194|NCT00136357|18370994|P2|Overall Study|Withdrawal by Subject|2
5337195|NCT00136357|18370995|P1|Overall Study|Withdrawal by Subject|3
5337196|NCT00136318|18371003|P2|Overall Study|Withdrawal by Subject|2
5337197|NCT00136318|18371004|P1|Overall Study|Withdrawal by Subject|2
5337198|NCT00136318|18371003|P2|Overall Study|Adverse Event|5
5337199|NCT00136318|18371004|P1|Overall Study|Adverse Event|5
5337200|NCT00136084|18371031|P2|Overall Study|Withdrawal by Subject|1
5337201|NCT00136084|18371032|P1|Overall Study|Withdrawal by Subject|5
5337202|NCT00136084|18371031|P2|Overall Study|No Response|2
5337203|NCT00136084|18371032|P1|Overall Study|No Response|1
5337204|NCT00136084|18371031|P2|Overall Study|Lost to Follow-up|0
5337205|NCT00136084|18371032|P1|Overall Study|Lost to Follow-up|2
5337206|NCT00136084|18371031|P2|Overall Study|Relapse|23
5337207|NCT00136084|18371032|P1|Overall Study|Relapse|20
5337208|NCT00136084|18371031|P2|Overall Study|Unacceptable toxicity|11
5337209|NCT00136084|18371032|P1|Overall Study|Unacceptable toxicity|8
5337210|NCT00136084|18371031|P2|Overall Study|Death|5
5337211|NCT00136084|18371032|P1|Overall Study|Death|12
5337212|NCT00135707|18371068|P2|Overall Study|Institutional review board request|0
5337213|NCT00135707|18371069|P1|Overall Study|Institutional review board request|1
5337214|NCT00135707|18371068|P2|Overall Study|Withdrawal by Subject|1
5337215|NCT00135707|18371069|P1|Overall Study|Withdrawal by Subject|0
5337216|NCT00135707|18371068|P2|Overall Study|Lost to Follow-up|89
5337217|NCT00135707|18371069|P1|Overall Study|Lost to Follow-up|94
5337218|NCT00135694|18371152|P3|Overall Study|Ineligible for Random assignment|0
5337219|NCT00135694|18371153|P2|Overall Study|Ineligible for Random assignment|0
5337220|NCT00135694|18371154|P1|Overall Study|Ineligible for Random assignment|42
5337221|NCT00135694|18371152|P3|Overall Study|Hepatitis C related reasons|0
5337222|NCT00135694|18371153|P2|Overall Study|Hepatitis C related reasons|1
5337223|NCT00135694|18371154|P1|Overall Study|Hepatitis C related reasons|39
5337224|NCT00135694|18371152|P3|Overall Study|Protocol Violation|0
5337225|NCT00135694|18371153|P2|Overall Study|Protocol Violation|1
5337226|NCT00135694|18371154|P1|Overall Study|Protocol Violation|19
5337227|NCT00135694|18371152|P3|Overall Study|Withdrawal by Subject|4
5337228|NCT00135694|18371153|P2|Overall Study|Withdrawal by Subject|7
5337229|NCT00135694|18371154|P1|Overall Study|Withdrawal by Subject|41
5337230|NCT00135694|18371152|P3|Overall Study|Lost to Follow-up|1
5337231|NCT00135694|18371153|P2|Overall Study|Lost to Follow-up|7
5337232|NCT00135694|18371154|P1|Overall Study|Lost to Follow-up|8
5337233|NCT00135694|18371152|P3|Overall Study|Death|2
5337234|NCT00135694|18371153|P2|Overall Study|Death|1
5337235|NCT00135694|18371154|P1|Overall Study|Death|14
5337236|NCT00135694|18371152|P3|Overall Study|Adverse Event|0
5337237|NCT00135694|18371153|P2|Overall Study|Adverse Event|4
5337238|NCT00135694|18371154|P1|Overall Study|Adverse Event|17
5337239|NCT00135512|18371172|P1|Overall Study|Other|42
5337240|NCT00135512|18371172|P1|Overall Study|Lack of Efficacy|25
5337241|NCT00135512|18371172|P1|Overall Study|Adverse Event|56
5337242|NCT00135356|18371184|P2|Overall Study|Withdrawal by Subject|4
5337243|NCT00135356|18371185|P1|Overall Study|Withdrawal by Subject|2
5337244|NCT00135356|18371184|P2|Overall Study|No longer meets study criteria|0
5337245|NCT00135356|18371185|P1|Overall Study|No longer meets study criteria|2
5337246|NCT00135356|18371184|P2|Overall Study|Poor/noncompliance|1
5337247|NCT00135356|18371185|P1|Overall Study|Poor/noncompliance|1
5337248|NCT00135356|18371184|P2|Overall Study|Change in antiviral regimen|1
5337249|NCT00135356|18371185|P1|Overall Study|Change in antiviral regimen|0
5337250|NCT00135356|18371184|P2|Overall Study|Surgery for abdominal fat|0
5337251|NCT00135356|18371185|P1|Overall Study|Surgery for abdominal fat|1
5337252|NCT00135356|18371184|P2|Overall Study|Lost to Follow-up|1
5337253|NCT00135356|18371185|P1|Overall Study|Lost to Follow-up|3
5337254|NCT00135356|18371184|P2|Overall Study|Lack of Efficacy|0
5337255|NCT00135356|18371185|P1|Overall Study|Lack of Efficacy|2
5337256|NCT00135356|18371184|P2|Overall Study|Adverse Event|2
5337257|NCT00135356|18371185|P1|Overall Study|Adverse Event|6
5337258|NCT00135330|18371228|P3|Overall Study|Sponsor Decision|0
5337259|NCT00135330|18371229|P2|Overall Study|Sponsor Decision|1
5337260|NCT00135330|18371230|P1|Overall Study|Sponsor Decision|0
5337261|NCT00135330|18371228|P3|Overall Study|Patient Decision|4
5337262|NCT00135330|18371229|P2|Overall Study|Patient Decision|1
5337263|NCT00135330|18371230|P1|Overall Study|Patient Decision|5
5337264|NCT00135330|18371228|P3|Overall Study|Protocol Violation|3
5337265|NCT00135330|18371229|P2|Overall Study|Protocol Violation|3
5337266|NCT00135330|18371230|P1|Overall Study|Protocol Violation|4
5337267|NCT00135330|18371228|P3|Overall Study|Physician Decision|0
5337268|NCT00135330|18371229|P2|Overall Study|Physician Decision|1
5337269|NCT00135330|18371230|P1|Overall Study|Physician Decision|1
5337270|NCT00135330|18371228|P3|Overall Study|Lost to Follow-up|3
5337271|NCT00135330|18371229|P2|Overall Study|Lost to Follow-up|2
5337272|NCT00135330|18371230|P1|Overall Study|Lost to Follow-up|0
5337273|NCT00135330|18371228|P3|Overall Study|Adverse Event|1
5337274|NCT00135330|18371229|P2|Overall Study|Adverse Event|5
5337275|NCT00135330|18371230|P1|Overall Study|Adverse Event|2
5337276|NCT00134901|18371428|P2|Overall Study|discontinued intervention|10
5337277|NCT00134901|18371429|P1|Overall Study|discontinued intervention|12
5337278|NCT00134901|18371428|P2|Overall Study|Lost to Follow-up|5
5337279|NCT00134901|18371429|P1|Overall Study|Lost to Follow-up|5
5337280|NCT00134784|18371441|P4|Overall Study|Withdrawal by Subject|1
5337281|NCT00134784|18371442|P3|Overall Study|Withdrawal by Subject|2
5337282|NCT00134784|18371443|P2|Overall Study|Withdrawal by Subject|2
5337283|NCT00134784|18371444|P1|Overall Study|Withdrawal by Subject|2
5337284|NCT00134719|18371454|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
5337285|NCT00134719|18371455|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
5337286|NCT00134719|18371456|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
5337287|NCT00134719|18371454|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
5337288|NCT00134719|18371455|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
5337289|NCT00134719|18371456|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
5337290|NCT00134719|18371454|P3|Primary Vaccination Phase|Lost to Follow-up|3
5337291|NCT00134719|18371455|P2|Primary Vaccination Phase|Lost to Follow-up|3
5337292|NCT00134719|18371456|P1|Primary Vaccination Phase|Lost to Follow-up|7
5337293|NCT00134719|18371454|P3|Primary Vaccination Phase|Withdrawal by Subject|2
5337294|NCT00134719|18371455|P2|Primary Vaccination Phase|Withdrawal by Subject|3
5337295|NCT00134719|18371456|P1|Primary Vaccination Phase|Withdrawal by Subject|2
5337296|NCT00134719|18371454|P3|Primary Vaccination Phase|Protocol Violation|0
5337297|NCT00134719|18371455|P2|Primary Vaccination Phase|Protocol Violation|0
5337298|NCT00134719|18371456|P1|Primary Vaccination Phase|Protocol Violation|1
5337299|NCT00134719|18371454|P3|Primary Vaccination Phase|Adverse Event|0
5337300|NCT00134719|18371455|P2|Primary Vaccination Phase|Adverse Event|0
5337301|NCT00134719|18371456|P1|Primary Vaccination Phase|Adverse Event|4
5337302|NCT00134563|18371587|P3|Overall Study|Reason other than above|5
5337303|NCT00134563|18371588|P2|Overall Study|Reason other than above|2
5337304|NCT00134563|18371589|P1|Overall Study|Reason other than above|0
5337305|NCT00134563|18371587|P3|Overall Study|did not wish to continue|26
5337306|NCT00134563|18371588|P2|Overall Study|did not wish to continue|32
5337307|NCT00134563|18371589|P1|Overall Study|did not wish to continue|33
5337308|NCT00134563|18371587|P3|Overall Study|progressive disease|2
5337309|NCT00134563|18371588|P2|Overall Study|progressive disease|4
5337310|NCT00134563|18371589|P1|Overall Study|progressive disease|11
5337311|NCT00134563|18371587|P3|Overall Study|Lost to Follow-up|2
5337312|NCT00134563|18371588|P2|Overall Study|Lost to Follow-up|0
5337313|NCT00134563|18371589|P1|Overall Study|Lost to Follow-up|4
5337314|NCT00134563|18371587|P3|Overall Study|Protocol Violation|5
5337315|NCT00134563|18371588|P2|Overall Study|Protocol Violation|2
5337316|NCT00134563|18371589|P1|Overall Study|Protocol Violation|3
5337317|NCT00134563|18371587|P3|Overall Study|Lack of Efficacy|17
5337318|NCT00134563|18371588|P2|Overall Study|Lack of Efficacy|14
5337319|NCT00134563|18371589|P1|Overall Study|Lack of Efficacy|24
5337320|NCT00134563|18371587|P3|Overall Study|Adverse Event|38
5337321|NCT00134563|18371588|P2|Overall Study|Adverse Event|37
5337322|NCT00134563|18371589|P1|Overall Study|Adverse Event|29
5337323|NCT00134563|18371587|P3|Overall Study|Not treated due to protocol violation|1
5337324|NCT00134563|18371588|P2|Overall Study|Not treated due to protocol violation|1
5337325|NCT00134563|18371589|P1|Overall Study|Not treated due to protocol violation|0
5337326|NCT00134082|18371650|P1|Overall Study|Death|1
5337327|NCT00134082|18371650|P1|Overall Study|Adverse Event|2
5337328|NCT00134056|18371659|P2|Eligible for Protocol Assigned Treatment|Other|56
5337329|NCT00134056|18371660|P1|Eligible for Protocol Assigned Treatment|Other|55
5337330|NCT00134056|18371659|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
5337331|NCT00134056|18371660|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
5337332|NCT00134056|18371659|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
5337333|NCT00134056|18371660|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
5337334|NCT00134056|18371659|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
5337335|NCT00134056|18371660|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
5337336|NCT00134056|18371659|P2|Randomization|Not eligible for assigned treatment|20
5337337|NCT00134056|18371660|P1|Randomization|Not eligible for assigned treatment|22
5337338|NCT00133991|18371704|P1|Overall Study|Death|4
5337339|NCT00133952|18371743|P2|Overall Study|Sponsor Decision|1
5337340|NCT00133952|18371744|P1|Overall Study|Sponsor Decision|0
5337341|NCT00133952|18371743|P2|Overall Study|Physician Decision|3
5337342|NCT00133952|18371744|P1|Overall Study|Physician Decision|4
5337343|NCT00133952|18371743|P2|Overall Study|Withdrawal by Subject|4
5337344|NCT00133952|18371744|P1|Overall Study|Withdrawal by Subject|20
5337345|NCT00133952|18371743|P2|Overall Study|Protocol Violation|1
5337346|NCT00133952|18371744|P1|Overall Study|Protocol Violation|1
5337347|NCT00133952|18371743|P2|Overall Study|Protocol Entry Criteria Exclusion|1
5337348|NCT00133952|18371744|P1|Overall Study|Protocol Entry Criteria Exclusion|4
5337349|NCT00133952|18371743|P2|Overall Study|Lost to Follow-up|14
5337350|NCT00133952|18371744|P1|Overall Study|Lost to Follow-up|9
5337351|NCT00133952|18371743|P2|Overall Study|Death|2
5337352|NCT00133952|18371744|P1|Overall Study|Death|3
5337353|NCT00133952|18371743|P2|Overall Study|Adverse Event|2
5337354|NCT00133952|18371744|P1|Overall Study|Adverse Event|1
5337355|NCT00133705|18371775|P2|Overall Study|Withdrawal by Subject|3
5337356|NCT00133705|18371776|P1|Overall Study|Withdrawal by Subject|2
5337357|NCT00132873|18371911|P1|Overall Study|Planned Pregnancy|1
5337358|NCT00132873|18371911|P1|Overall Study|Withdrawal by Subject|3
5337359|NCT00132873|18371911|P1|Overall Study|Lack of Efficacy|1
5337360|NCT00132873|18371911|P1|Overall Study|Lost to Follow-up|1
5337361|NCT00132873|18371911|P1|Overall Study|Adverse Event|3
5337362|NCT00132808|18371919|P3|Stratum II|Withdrawal by Subject|6
5337363|NCT00132808|18371920|P2|Stratum II|Withdrawal by Subject|9
5337364|NCT00132808|18371921|P1|Stratum II|Withdrawal by Subject|4
5337365|NCT00132808|18371919|P3|Stratum II|Protocol Violation|1
5337366|NCT00132808|18371920|P2|Stratum II|Protocol Violation|2
5337367|NCT00132808|18371921|P1|Stratum II|Protocol Violation|0
5337368|NCT00132808|18371919|P3|Stratum II|Lost to Follow-up|1
5337369|NCT00132808|18371920|P2|Stratum II|Lost to Follow-up|2
5337370|NCT00132808|18371921|P1|Stratum II|Lost to Follow-up|2
5337371|NCT00132808|18371919|P3|Stratum II|Death|0
5337372|NCT00132808|18371920|P2|Stratum II|Death|0
5337373|NCT00132808|18371921|P1|Stratum II|Death|1
5337374|NCT00132808|18371919|P3|Stratum II|Adverse Event|1
5337375|NCT00132808|18371920|P2|Stratum II|Adverse Event|2
5337376|NCT00132808|18371921|P1|Stratum II|Adverse Event|1
5337377|NCT00132808|18371919|P3|Stratum I|Abnormal test procedure result (s)|1
5337378|NCT00132808|18371920|P2|Stratum I|Abnormal test procedure result (s)|0
5337379|NCT00132808|18371921|P1|Stratum I|Abnormal test procedure result (s)|0
5337380|NCT00132808|18371919|P3|Stratum I|Withdrawal by Subject|3
5337381|NCT00132808|18371920|P2|Stratum I|Withdrawal by Subject|7
5337382|NCT00132808|18371921|P1|Stratum I|Withdrawal by Subject|4
5337383|NCT00132808|18371919|P3|Stratum I|Lost to Follow-up|1
5337384|NCT00132808|18371920|P2|Stratum I|Lost to Follow-up|4
5337385|NCT00132808|18371921|P1|Stratum I|Lost to Follow-up|3
5337386|NCT00132808|18371919|P3|Stratum I|Adverse Event|0
5337387|NCT00132808|18371920|P2|Stratum I|Adverse Event|1
5337388|NCT00132808|18371921|P1|Stratum I|Adverse Event|2
5337389|NCT00132769|18371946|P2|Overall Study|Protocol Violation|1
5337390|NCT00132769|18371947|P1|Overall Study|Protocol Violation|1
5337391|NCT00132769|18371946|P2|Overall Study|Adverse Event|1
5337392|NCT00132769|18371947|P1|Overall Study|Adverse Event|2
5337393|NCT00132769|18371946|P2|Overall Study|Lack of Efficacy|6
5337394|NCT00132769|18371947|P1|Overall Study|Lack of Efficacy|7
5337395|NCT00132769|18371946|P2|Overall Study|Withdrawal by Subject|3
5337396|NCT00132769|18371947|P1|Overall Study|Withdrawal by Subject|1
5337397|NCT00132730|18371973|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
5337398|NCT00132730|18371974|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
5337399|NCT00132730|18371975|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
5337400|NCT00132730|18371976|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
5337401|NCT00132730|18371977|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
5337402|NCT00132730|18371978|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
5337403|NCT00132730|18371973|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
5337404|NCT00132730|18371974|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
5337405|NCT00132730|18371975|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
5337406|NCT00132730|18371976|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
5337407|NCT00132730|18371977|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
5337408|NCT00132730|18371978|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
5337409|NCT00132730|18371973|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5337410|NCT00132730|18371974|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
5337411|NCT00132730|18371975|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5337412|NCT00132730|18371976|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5337413|NCT00132730|18371977|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5337414|NCT00132730|18371978|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5337415|NCT00132730|18371973|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5337416|NCT00132730|18371974|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
5337417|NCT00132730|18371975|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5337418|NCT00132730|18371976|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5337419|NCT00132730|18371977|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5337420|NCT00132730|18371978|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5337421|NCT00132730|18371973|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
5337422|NCT00132730|18371974|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
5337423|NCT00132730|18371975|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
5337424|NCT00132730|18371976|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
5337425|NCT00132730|18371977|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
5337426|NCT00132730|18371978|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
5337427|NCT00132730|18371973|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
5337428|NCT00132730|18371974|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
5337429|NCT00132730|18371975|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
5337430|NCT00132730|18371976|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
5337431|NCT00132730|18371977|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
5337432|NCT00132730|18371978|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
5337433|NCT00132730|18371973|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5337434|NCT00132730|18371974|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5337435|NCT00132730|18371975|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
5337436|NCT00132730|18371976|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5337437|NCT00132730|18371977|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5337438|NCT00132730|18371978|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5337439|NCT00132730|18371973|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5337440|NCT00132730|18371974|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5337441|NCT00132730|18371975|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
5337442|NCT00132730|18371976|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
5337443|NCT00132730|18371977|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5337444|NCT00132730|18371978|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5337445|NCT00132730|18371973|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
5337446|NCT00132730|18371974|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
5337447|NCT00132730|18371975|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
5337448|NCT00132730|18371976|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
5337449|NCT00132730|18371977|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
5337450|NCT00132730|18371978|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
5337451|NCT00132730|18371973|P6|Period II - 12-week Treatment (Base)|Other reasons|0
5337452|NCT00132730|18371974|P5|Period II - 12-week Treatment (Base)|Other reasons|0
5337453|NCT00132730|18371975|P4|Period II - 12-week Treatment (Base)|Other reasons|13
5337454|NCT00132730|18371976|P3|Period II - 12-week Treatment (Base)|Other reasons|9
5337455|NCT00132730|18371977|P2|Period II - 12-week Treatment (Base)|Other reasons|10
5337456|NCT00132730|18371978|P1|Period II - 12-week Treatment (Base)|Other reasons|11
5337457|NCT00132730|18371973|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5337458|NCT00132730|18371974|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5337459|NCT00132730|18371975|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5337460|NCT00132730|18371976|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5337461|NCT00132730|18371977|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
5337462|NCT00132730|18371978|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
5337463|NCT00132730|18371973|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
5337464|NCT00132730|18371974|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
5337465|NCT00132730|18371975|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
5337466|NCT00132730|18371976|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
5337467|NCT00132730|18371977|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
5337468|NCT00132730|18371978|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
5337469|NCT00132691|18372022|P2|Overall Study|Death|0
5337470|NCT00132691|18372023|P1|Overall Study|Death|2
5337471|NCT00132691|18372022|P2|Overall Study|Missed 2-year visit|4
5337472|NCT00132691|18372023|P1|Overall Study|Missed 2-year visit|4
5337473|NCT00132691|18372022|P2|Overall Study|Lost to Follow-up|8
5337474|NCT00132691|18372023|P1|Overall Study|Lost to Follow-up|5
5337475|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
5337476|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
5337477|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
5337478|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
5337479|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
5337480|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
5337481|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
5337482|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
5337483|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
5337484|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
5337485|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
5337486|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
5337487|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
5337488|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
5337489|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
5337490|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
5337491|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
5337492|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
5337493|NCT00132678|18372063|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
5337494|NCT00132678|18372064|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
5337495|NCT00132678|18372065|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
5337496|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Pregnancy|0
5337497|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Pregnancy|0
5337498|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Pregnancy|2
5337499|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Physician Decision|0
5337500|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Physician Decision|0
5337501|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Physician Decision|1
5337502|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
5337503|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
5337504|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
5337505|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
5337506|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
5337507|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
5337508|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
5337509|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
5337510|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
5337511|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
5337512|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
5337513|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
5337514|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Non responder|0
5337515|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Non responder|0
5337516|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Non responder|107
5337517|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Adverse Event|0
5337518|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Adverse Event|0
5337519|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Adverse Event|12
5337520|NCT00132678|18372063|P3|Period III (Open-Label Stabilization)|Death|0
5337521|NCT00132678|18372064|P2|Period III (Open-Label Stabilization)|Death|0
5337522|NCT00132678|18372065|P1|Period III (Open-Label Stabilization)|Death|2
5337523|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
5337524|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
5337525|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
5337526|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
5337527|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
5337528|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
5337529|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
5337530|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
5337531|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
5337532|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
5337533|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
5337534|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
5337535|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
5337536|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
5337537|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
5337538|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
5337539|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
5337540|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
5337541|NCT00132678|18372063|P3|Period II (Open-Label Oral Risperidone)|Death|1
5337542|NCT00132678|18372064|P2|Period II (Open-Label Oral Risperidone)|Death|0
5337543|NCT00132678|18372065|P1|Period II (Open-Label Oral Risperidone)|Death|0
5337544|NCT00132496|18372079|P2|Overall Study|Physician Decision|0
5337545|NCT00132496|18372080|P1|Overall Study|Physician Decision|1
5337546|NCT00132496|18372079|P2|Overall Study|Withdrawal by Subject|2
5337547|NCT00132496|18372080|P1|Overall Study|Withdrawal by Subject|1
5337548|NCT00132314|18372088|P2|Overall Study|Refused intervention at baseline|7
5337549|NCT00132314|18372089|P1|Overall Study|Refused intervention at baseline|2
5337550|NCT00132314|18372088|P2|Overall Study|Lacked SSN|3
5337551|NCT00132314|18372089|P1|Overall Study|Lacked SSN|1
5337552|NCT00132314|18372088|P2|Overall Study|Lost to Follow-up|62
5337553|NCT00132314|18372089|P1|Overall Study|Lost to Follow-up|70
5337554|NCT00132301|18372099|P2|Overall Study|Excluded by Data Monitoring Committee|0
5337555|NCT00132301|18372100|P1|Overall Study|Excluded by Data Monitoring Committee|1
5337556|NCT00132301|18372099|P2|Overall Study|Other|1
5337557|NCT00132301|18372100|P1|Overall Study|Other|1
5337558|NCT00132301|18372099|P2|Overall Study|Lost to Follow-up|3
5337559|NCT00132301|18372100|P1|Overall Study|Lost to Follow-up|5
5337560|NCT00132301|18372099|P2|Overall Study|Physician Decision|1
5337561|NCT00132301|18372100|P1|Overall Study|Physician Decision|1
5337562|NCT00132301|18372099|P2|Overall Study|Withdrawal by Subject|2
5337563|NCT00132301|18372100|P1|Overall Study|Withdrawal by Subject|5
5337564|NCT00132301|18372099|P2|Overall Study|Death|6
5337565|NCT00132301|18372100|P1|Overall Study|Death|7
5337566|NCT00132132|18372108|P2|Overall Study|Lost to Follow-up|2
5337567|NCT00132132|18372109|P1|Overall Study|Lost to Follow-up|7
5337568|NCT00132041|18372117|P1|18 Months Post Ablation|ExtraHepatic tumor|1
5337569|NCT00132041|18372117|P1|18 Months Post Ablation|Non-Protocol Treatment|3
5337570|NCT00132041|18372117|P1|18 Months Post Ablation|Transplant|1
5337571|NCT00132041|18372117|P1|18 Months Post Ablation|Withdrawal by Subject|1
5337572|NCT00132041|18372117|P1|15 Months Post Ablation|Non-Protocol Treatment|1
5337573|NCT00132041|18372117|P1|15 Months Post Ablation|Transplant|5
5337574|NCT00132041|18372117|P1|15 Months Post Ablation|Death|1
5337575|NCT00132041|18372117|P1|15 Months Post Ablation|Withdrawal by Subject|1
5337576|NCT00132041|18372117|P1|12 Months Post Ablation|non-protocol Treatment|1
5337577|NCT00132041|18372117|P1|12 Months Post Ablation|Transplant|1
5337578|NCT00132041|18372117|P1|12 Months Post Ablation|Death|1
5337579|NCT00132041|18372117|P1|12 Months Post Ablation|Withdrawal by Subject|1
5337580|NCT00132041|18372117|P1|9 Months Post Ablation|Transplant|1
5337581|NCT00132041|18372117|P1|9 Months Post Ablation|Death|1
5337582|NCT00132041|18372117|P1|6 Months Post Ablation|Transplant|6
5337583|NCT00132041|18372117|P1|6 Months Post Ablation|Death|2
5337584|NCT00132041|18372117|P1|6 Months Post Ablation|Withdrawal by Subject|2
5337585|NCT00132041|18372117|P1|3 Months Post Ablation|Non-Protocol Treatment|2
5337586|NCT00132041|18372117|P1|3 Months Post Ablation|Transplant|1
5337587|NCT00132041|18372117|P1|Baseline|Ineligible|6
5337588|NCT00132028|18372132|P1|Overall Study|Physician Decision|3
5337589|NCT00132028|18372132|P1|Overall Study|not eligible|2
5337590|NCT00132028|18372132|P1|Overall Study|Withdrawal by Subject|2
5337591|NCT00132028|18372132|P1|Overall Study|Lack of Efficacy|11
5337592|NCT00132028|18372132|P1|Overall Study|Death|2
5337593|NCT00132028|18372132|P1|Overall Study|Adverse Event|7
5337594|NCT00131937|18372144|P1|Overall Study|Alternative therapy|1
5337595|NCT00131937|18372144|P1|Overall Study|Disease Progression|7
5337596|NCT00131937|18372144|P1|Overall Study|Physician Decision|1
5337597|NCT00131937|18372144|P1|Overall Study|Withdrawal by Subject|2
5337598|NCT00131937|18372144|P1|Overall Study|Adverse Event|3
5337599|NCT00131911|18372152|P2|Overall Study|Withdrawal by Subject|0
5337600|NCT00131911|18372153|P1|Overall Study|Withdrawal by Subject|1
5337601|NCT00131664|18372223|P6|Second Period (Additional Drug Added)|Administrative reasons|0
5337602|NCT00131664|18372224|P5|Second Period (Additional Drug Added)|Administrative reasons|1
5337603|NCT00131664|18372225|P4|Second Period (Additional Drug Added)|Administrative reasons|0
5337604|NCT00131664|18372226|P3|Second Period (Additional Drug Added)|Administrative reasons|0
5337605|NCT00131664|18372227|P2|Second Period (Additional Drug Added)|Administrative reasons|2
5337606|NCT00131664|18372228|P1|Second Period (Additional Drug Added)|Administrative reasons|4
5337607|NCT00131664|18372223|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5337608|NCT00131664|18372224|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5337609|NCT00131664|18372225|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
5337610|NCT00131664|18372226|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5337611|NCT00131664|18372227|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5337612|NCT00131664|18372228|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5337613|NCT00131664|18372223|P6|Second Period (Additional Drug Added)|Adverse Event|1
5337614|NCT00131664|18372224|P5|Second Period (Additional Drug Added)|Adverse Event|0
5337615|NCT00131664|18372225|P4|Second Period (Additional Drug Added)|Adverse Event|0
5337616|NCT00131664|18372226|P3|Second Period (Additional Drug Added)|Adverse Event|0
5337617|NCT00131664|18372227|P2|Second Period (Additional Drug Added)|Adverse Event|1
5337618|NCT00131664|18372228|P1|Second Period (Additional Drug Added)|Adverse Event|0
5337619|NCT00131664|18372223|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5337620|NCT00131664|18372224|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5337621|NCT00131664|18372225|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5337622|NCT00131664|18372226|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5337623|NCT00131664|18372227|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5337624|NCT00131664|18372228|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
5337625|NCT00131664|18372223|P6|Second Period (Additional Drug Added)|Protocol Violation|0
5337626|NCT00131664|18372224|P5|Second Period (Additional Drug Added)|Protocol Violation|0
5337627|NCT00131664|18372225|P4|Second Period (Additional Drug Added)|Protocol Violation|0
5337628|NCT00131664|18372226|P3|Second Period (Additional Drug Added)|Protocol Violation|1
5337629|NCT00131664|18372227|P2|Second Period (Additional Drug Added)|Protocol Violation|1
5337630|NCT00131664|18372228|P1|Second Period (Additional Drug Added)|Protocol Violation|0
5337631|NCT00131664|18372223|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
5337632|NCT00131664|18372224|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
5337633|NCT00131664|18372225|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
5337634|NCT00131664|18372226|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
5337635|NCT00131664|18372227|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
5337636|NCT00131664|18372228|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
5337637|NCT00131664|18372223|P6|First Period (First 6 Months)|Administrative reasons|0
5337638|NCT00131664|18372224|P5|First Period (First 6 Months)|Administrative reasons|0
5337639|NCT00131664|18372225|P4|First Period (First 6 Months)|Administrative reasons|0
5337640|NCT00131664|18372226|P3|First Period (First 6 Months)|Administrative reasons|5
5337641|NCT00131664|18372227|P2|First Period (First 6 Months)|Administrative reasons|0
5337642|NCT00131664|18372228|P1|First Period (First 6 Months)|Administrative reasons|2
5337643|NCT00131664|18372223|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5337644|NCT00131664|18372224|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5337645|NCT00131664|18372225|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5337646|NCT00131664|18372226|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5337647|NCT00131664|18372227|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
5337648|NCT00131664|18372228|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
5337649|NCT00131664|18372223|P6|First Period (First 6 Months)|Adverse Event|0
5337650|NCT00131664|18372224|P5|First Period (First 6 Months)|Adverse Event|0
5337651|NCT00131664|18372225|P4|First Period (First 6 Months)|Adverse Event|0
5337652|NCT00131664|18372226|P3|First Period (First 6 Months)|Adverse Event|5
5337653|NCT00131664|18372227|P2|First Period (First 6 Months)|Adverse Event|4
5337654|NCT00131664|18372228|P1|First Period (First 6 Months)|Adverse Event|9
5337655|NCT00131664|18372223|P6|First Period (First 6 Months)|Withdrawal by Subject|0
5337656|NCT00131664|18372224|P5|First Period (First 6 Months)|Withdrawal by Subject|0
5337657|NCT00131664|18372225|P4|First Period (First 6 Months)|Withdrawal by Subject|0
5337658|NCT00131664|18372226|P3|First Period (First 6 Months)|Withdrawal by Subject|2
5337659|NCT00131664|18372227|P2|First Period (First 6 Months)|Withdrawal by Subject|6
5337660|NCT00131664|18372228|P1|First Period (First 6 Months)|Withdrawal by Subject|4
5337661|NCT00131664|18372223|P6|First Period (First 6 Months)|Protocol Violation|0
5337662|NCT00131664|18372224|P5|First Period (First 6 Months)|Protocol Violation|0
5337663|NCT00131664|18372225|P4|First Period (First 6 Months)|Protocol Violation|0
5337664|NCT00131664|18372226|P3|First Period (First 6 Months)|Protocol Violation|1
5337665|NCT00131664|18372227|P2|First Period (First 6 Months)|Protocol Violation|2
5337666|NCT00131664|18372228|P1|First Period (First 6 Months)|Protocol Violation|2
5337667|NCT00131664|18372223|P6|First Period (First 6 Months)|Death|0
5337668|NCT00131664|18372224|P5|First Period (First 6 Months)|Death|0
5337669|NCT00131664|18372225|P4|First Period (First 6 Months)|Death|0
5337670|NCT00131664|18372226|P3|First Period (First 6 Months)|Death|0
5337671|NCT00131664|18372227|P2|First Period (First 6 Months)|Death|1
5337672|NCT00131664|18372228|P1|First Period (First 6 Months)|Death|0
5337673|NCT00131664|18372223|P6|First Period (First 6 Months)|Lost to Follow-up|0
5337674|NCT00131664|18372224|P5|First Period (First 6 Months)|Lost to Follow-up|0
5337675|NCT00131664|18372225|P4|First Period (First 6 Months)|Lost to Follow-up|0
5337676|NCT00131664|18372226|P3|First Period (First 6 Months)|Lost to Follow-up|3
5337677|NCT00131664|18372227|P2|First Period (First 6 Months)|Lost to Follow-up|3
5337678|NCT00131664|18372228|P1|First Period (First 6 Months)|Lost to Follow-up|7
5337679|NCT00131508|18372300|P2|Overall Study|Withdrawal by Subject|2
5337680|NCT00131508|18372301|P1|Overall Study|Withdrawal by Subject|1
5337681|NCT00131508|18372300|P2|Overall Study|Non-Compliance|4
5337682|NCT00131508|18372301|P1|Overall Study|Non-Compliance|2
5337683|NCT00131508|18372300|P2|Overall Study|Disease progression|2
5337684|NCT00131508|18372301|P1|Overall Study|Disease progression|0
5337685|NCT00131469|18372325|P2|Overall Study|scan not analyzable|6
5337686|NCT00131469|18372326|P1|Overall Study|scan not analyzable|3
5337687|NCT00131469|18372325|P2|Overall Study|Lost to Follow-up|1
5337688|NCT00131469|18372326|P1|Overall Study|Lost to Follow-up|0
5337689|NCT00131469|18372325|P2|Overall Study|Death|1
5337690|NCT00131469|18372326|P1|Overall Study|Death|0
5337691|NCT00131469|18372325|P2|Overall Study|Protocol Violation|1
5337692|NCT00131469|18372326|P1|Overall Study|Protocol Violation|3
5337693|NCT00131469|18372325|P2|Overall Study|Withdrawal by Subject|4
5337694|NCT00131469|18372326|P1|Overall Study|Withdrawal by Subject|3
5337695|NCT00131365|18372372|P1|Overall Study|Alternative treatment|3
5337696|NCT00131365|18372372|P1|Overall Study|Withdrawal by Subject|1
5337697|NCT00131352|18372379|P2|Repeat Treatment Period|Other|0
5337698|NCT00131352|18372380|P1|Repeat Treatment Period|Other|1
5337699|NCT00131352|18372379|P2|Repeat Treatment Period|Adverse Event|0
5337700|NCT00131352|18372380|P1|Repeat Treatment Period|Adverse Event|1
5337701|NCT00131352|18372379|P2|Initial Treatment Period|Other|2
5337702|NCT00131352|18372380|P1|Initial Treatment Period|Other|0
5337703|NCT00131352|18372379|P2|Initial Treatment Period|Lack of Efficacy|4
5337704|NCT00131352|18372380|P1|Initial Treatment Period|Lack of Efficacy|6
5337705|NCT00131352|18372379|P2|Initial Treatment Period|Withdrawal by Subject|1
5337706|NCT00131352|18372380|P1|Initial Treatment Period|Withdrawal by Subject|1
5337707|NCT00131352|18372379|P2|Initial Treatment Period|Non-compliant|2
5337708|NCT00131352|18372380|P1|Initial Treatment Period|Non-compliant|1
5337709|NCT00131352|18372379|P2|Initial Treatment Period|Adverse Event|3
5337710|NCT00131352|18372380|P1|Initial Treatment Period|Adverse Event|1
5337711|NCT00131248|18372402|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
5337712|NCT00131248|18372403|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
5337713|NCT00130832|18372430|P2|Overall Study|Other|3
5337714|NCT00130832|18372431|P1|Overall Study|Other|0
5337715|NCT00130832|18372430|P2|Overall Study|Moved|2
5337716|NCT00130832|18372431|P1|Overall Study|Moved|2
5337717|NCT00130832|18372430|P2|Overall Study|Withdrawal by Subject|1
5337718|NCT00130832|18372431|P1|Overall Study|Withdrawal by Subject|6
5337719|NCT00130832|18372430|P2|Overall Study|Protocol Violation|8
5337720|NCT00130832|18372431|P1|Overall Study|Protocol Violation|6
5337721|NCT00130832|18372430|P2|Overall Study|Lost to Follow-up|2
5337722|NCT00130832|18372431|P1|Overall Study|Lost to Follow-up|1
5337723|NCT00130832|18372430|P2|Overall Study|Adverse Event|1
5337724|NCT00130832|18372431|P1|Overall Study|Adverse Event|1
5337725|NCT00130793|18372443|P2|Overall Study|Withdrew consent|0
5337726|NCT00130793|18372444|P1|Overall Study|Withdrew consent|2
5337727|NCT00130793|18372443|P2|Overall Study|Lost to Follow-up|4
5337728|NCT00130793|18372444|P1|Overall Study|Lost to Follow-up|1
5337729|NCT00130728|18372465|P2|Overall Study|Withdrawal by Subject|2
5337730|NCT00130728|18372466|P1|Overall Study|Withdrawal by Subject|0
5337731|NCT00130728|18372465|P2|Overall Study|Lost to Follow-up|0
5337732|NCT00130728|18372466|P1|Overall Study|Lost to Follow-up|4
5337733|NCT00130728|18372465|P2|Overall Study|Death|211
5337734|NCT00130728|18372466|P1|Overall Study|Death|207
5337735|NCT00130689|18372478|P1|Overall Study|Ineligible|6
5337736|NCT00130689|18372478|P1|Overall Study|Withdrawal by Subject|3
5337737|NCT00130689|18372478|P1|Overall Study|Clinical Deterioration|4
5337738|NCT00130689|18372478|P1|Overall Study|Death|1
5337739|NCT00130689|18372478|P1|Overall Study|Progressive Disease|29
5337740|NCT00130637|18372482|P1|Overall Study|Withdrawal by Subject|1
5337741|NCT00130637|18372482|P1|Overall Study|Adverse Event|2
5337742|NCT00130533|18372489|P2|Overall Study|Other|5
5337743|NCT00130533|18372490|P1|Overall Study|Other|12
5337744|NCT00130533|18372489|P2|Overall Study|Second Primary Malignancy|1
5337745|NCT00130533|18372490|P1|Overall Study|Second Primary Malignancy|0
5337746|NCT00130533|18372489|P2|Overall Study|Sponsor´s decision|0
5337747|NCT00130533|18372490|P1|Overall Study|Sponsor´s decision|2
5337748|NCT00130533|18372489|P2|Overall Study|Lost to Follow-up|1
5337749|NCT00130533|18372490|P1|Overall Study|Lost to Follow-up|1
5337750|NCT00130533|18372489|P2|Overall Study|Protocol Violation|1
5337751|NCT00130533|18372490|P1|Overall Study|Protocol Violation|5
5337752|NCT00130533|18372489|P2|Overall Study|Death|2
5337753|NCT00130533|18372490|P1|Overall Study|Death|4
5337754|NCT00130533|18372489|P2|Overall Study|Interruption of treatment > 3 weeks|0
5337755|NCT00130533|18372490|P1|Overall Study|Interruption of treatment > 3 weeks|11
5337756|NCT00130533|18372489|P2|Overall Study|Disease relapse|13
5337757|NCT00130533|18372490|P1|Overall Study|Disease relapse|9
5337758|NCT00130533|18372489|P2|Overall Study|Adverse Event|1
5337759|NCT00130533|18372490|P1|Overall Study|Adverse Event|34
5337760|NCT00130533|18372489|P2|Overall Study|Withdrawal by Subject|6
5337761|NCT00130533|18372490|P1|Overall Study|Withdrawal by Subject|33
5337762|NCT00130520|18372502|P1|Overall Study|Did not meet re-treatment criteria|1
5337763|NCT00130520|18372502|P1|Overall Study|Protocol non-compliance|1
5337764|NCT00130520|18372502|P1|Overall Study|Disease Progression|23
5337765|NCT00130520|18372502|P1|Overall Study|Withdrawal by Subject|1
5337766|NCT00130520|18372502|P1|Overall Study|Physician Decision|1
5337767|NCT00130520|18372502|P1|Overall Study|Death|1
5337768|NCT00130520|18372502|P1|Overall Study|Adverse Event|11
5337769|NCT00130286|18372512|P4|Overall Study|Missing lab specimens|0
5337770|NCT00130286|18372513|P3|Overall Study|Missing lab specimens|0
5337771|NCT00130286|18372514|P2|Overall Study|Missing lab specimens|2
5337772|NCT00130286|18372515|P1|Overall Study|Missing lab specimens|0
5337773|NCT00130286|18372512|P4|Overall Study|Adverse Event|0
5337774|NCT00130286|18372513|P3|Overall Study|Adverse Event|2
5337775|NCT00130286|18372514|P2|Overall Study|Adverse Event|0
5337776|NCT00130286|18372515|P1|Overall Study|Adverse Event|0
5337777|NCT00130286|18372512|P4|Overall Study|Withdrawal by Subject|2
5337778|NCT00130286|18372513|P3|Overall Study|Withdrawal by Subject|2
5337779|NCT00130286|18372514|P2|Overall Study|Withdrawal by Subject|1
5337780|NCT00130286|18372515|P1|Overall Study|Withdrawal by Subject|0
5337781|NCT00130247|18372535|P2|Overall Study|Not compliant with DOT|2
5337782|NCT00130247|18372536|P1|Overall Study|Not compliant with DOT|0
5337783|NCT00130247|18372535|P2|Overall Study|Post-randomization exclusion|2
5337784|NCT00130247|18372536|P1|Overall Study|Post-randomization exclusion|1
5337785|NCT00130247|18372535|P2|Overall Study|Pregnancy|0
5337786|NCT00130247|18372536|P1|Overall Study|Pregnancy|1
5337787|NCT00130208|18372554|P2|Washout Period (8 Weeks)|Other|1
5337788|NCT00130208|18372555|P1|Washout Period (8 Weeks)|Other|1
5337789|NCT00130208|18372554|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
5337790|NCT00130208|18372555|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
5337791|NCT00130208|18372554|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
5337792|NCT00130208|18372555|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
5337793|NCT00130208|18372554|P2|Washout Period (8 Weeks)|Adverse Event|6
5337794|NCT00130208|18372555|P1|Washout Period (8 Weeks)|Adverse Event|3
5337795|NCT00130208|18372554|P2|Maintenance Period (26 Weeks)|Other|1
5337796|NCT00130208|18372555|P1|Maintenance Period (26 Weeks)|Other|1
5337797|NCT00130208|18372554|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
5337798|NCT00130208|18372555|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
5337799|NCT00130208|18372554|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
5337800|NCT00130208|18372555|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
5337801|NCT00130208|18372554|P2|Maintenance Period (26 Weeks)|Physician Decision|2
5337802|NCT00130208|18372555|P1|Maintenance Period (26 Weeks)|Physician Decision|0
5337803|NCT00130208|18372554|P2|Maintenance Period (26 Weeks)|Adverse Event|12
5337804|NCT00130208|18372555|P1|Maintenance Period (26 Weeks)|Adverse Event|10
5337805|NCT00130039|18372591|P2|Overall Study|clinical events without follow up MRI|4
5337806|NCT00130039|18372592|P1|Overall Study|clinical events without follow up MRI|5
5337807|NCT00130039|18372591|P2|Overall Study|Physician Decision|0
5337808|NCT00130039|18372592|P1|Overall Study|Physician Decision|3
5337809|NCT00130039|18372591|P2|Overall Study|Adverse Event|2
5337810|NCT00130039|18372592|P1|Overall Study|Adverse Event|4
5337811|NCT00130039|18372591|P2|Overall Study|Lost to Follow-up|1
5337812|NCT00130039|18372592|P1|Overall Study|Lost to Follow-up|3
5337813|NCT00130039|18372591|P2|Overall Study|Withdrawal by Subject|11
5337814|NCT00130039|18372592|P1|Overall Study|Withdrawal by Subject|15
5337815|NCT00129987|18372610|P2|1 Year|Withdrawal by Subject|21
5337816|NCT00129987|18372611|P1|1 Year|Withdrawal by Subject|32
5337817|NCT00129987|18372610|P2|1st Educational Session|Withdrawal by Subject|109
5337818|NCT00129987|18372611|P1|1st Educational Session|Withdrawal by Subject|141
5337819|NCT00129974|18372623|P1|Overall Study|Other|1
5337820|NCT00129961|18372630|P2|Overall Study|Missing Record|1
5337821|NCT00129961|18372631|P1|Overall Study|Missing Record|0
5337822|NCT00129961|18372630|P2|Overall Study|Withdrawal by Subject|1
5337823|NCT00129961|18372631|P1|Overall Study|Withdrawal by Subject|2
5337824|NCT00129961|18372630|P2|Overall Study|Physician Decision|0
5337825|NCT00129961|18372631|P1|Overall Study|Physician Decision|1
5337826|NCT00129961|18372630|P2|Overall Study|Withdrawal by Sponsor|20
5337827|NCT00129961|18372631|P1|Overall Study|Withdrawal by Sponsor|14
5337828|NCT00129961|18372630|P2|Overall Study|Death|1
5337829|NCT00129961|18372631|P1|Overall Study|Death|1
5337830|NCT00129961|18372630|P2|Overall Study|Adverse Event|0
5337831|NCT00129961|18372631|P1|Overall Study|Adverse Event|1
5337832|NCT00129935|18372667|P2|Overall Study|Incorrect study treatment|0
5337833|NCT00129935|18372668|P1|Overall Study|Incorrect study treatment|1
5337834|NCT00129935|18372667|P2|Overall Study|Crossed to the other arm|1
5337835|NCT00129935|18372668|P1|Overall Study|Crossed to the other arm|2
5337836|NCT00129935|18372667|P2|Overall Study|Other|2
5337837|NCT00129935|18372668|P1|Overall Study|Other|3
5337838|NCT00129935|18372667|P2|Overall Study|Second primary|1
5337839|NCT00129935|18372668|P1|Overall Study|Second primary|0
5337840|NCT00129935|18372667|P2|Overall Study|Recurrence|3
5337841|NCT00129935|18372668|P1|Overall Study|Recurrence|1
5337842|NCT00129935|18372667|P2|Overall Study|Physician Decision|4
5337843|NCT00129935|18372668|P1|Overall Study|Physician Decision|3
5337844|NCT00129935|18372667|P2|Overall Study|Protocol Violation|4
5337845|NCT00129935|18372668|P1|Overall Study|Protocol Violation|0
5337846|NCT00129935|18372667|P2|Overall Study|Withdrawal by Subject|20
5337847|NCT00129935|18372668|P1|Overall Study|Withdrawal by Subject|7
5337848|NCT00129935|18372667|P2|Overall Study|Death|1
5337849|NCT00129935|18372668|P1|Overall Study|Death|1
5337850|NCT00129935|18372667|P2|Overall Study|Adverse Event|56
5337851|NCT00129935|18372668|P1|Overall Study|Adverse Event|18
5337852|NCT00129766|18372686|P2|Overall Study|Lost to Follow-up|21
5337853|NCT00129766|18372687|P1|Overall Study|Lost to Follow-up|26
5337854|NCT00129766|18372686|P2|Overall Study|Withdrawal of consent|30
5337855|NCT00129766|18372687|P1|Overall Study|Withdrawal of consent|31
5337856|NCT00129766|18372686|P2|Overall Study|Death|8
5337857|NCT00129766|18372687|P1|Overall Study|Death|3
5337858|NCT00129701|18372736|P1|Overall Study|Withdrawal by Subject|33
5337859|NCT00129649|18372745|P2|Overall Study|Withdrawal by Subject|65
5337860|NCT00129649|18372746|P1|Overall Study|Withdrawal by Subject|76
5337861|NCT00129623|18372754|P2|Overall Study|Uncertainty to return|1
5337862|NCT00129623|18372755|P1|Overall Study|Uncertainty to return|0
5337863|NCT00129623|18372754|P2|Overall Study|Relocated job out of state|0
5337864|NCT00129623|18372755|P1|Overall Study|Relocated job out of state|1
5337865|NCT00129623|18372754|P2|Overall Study|Failure to Return|1
5337866|NCT00129623|18372755|P1|Overall Study|Failure to Return|1
5337867|NCT00129623|18372754|P2|Overall Study|Refused Treatment|3
5337868|NCT00129623|18372755|P1|Overall Study|Refused Treatment|5
5337869|NCT00129623|18372754|P2|Overall Study|Adverse Event|7
5337870|NCT00129623|18372755|P1|Overall Study|Adverse Event|3
5337871|NCT00129545|18372780|P3|Overall Study|Device not implanted|0
5337872|NCT00129545|18372781|P2|Overall Study|Device not implanted|61
5337873|NCT00129545|18372782|P1|Overall Study|Device not implanted|16
5337874|NCT00129545|18372780|P3|Overall Study|Physician Decision|10
5337875|NCT00129545|18372781|P2|Overall Study|Physician Decision|3
5337876|NCT00129545|18372782|P1|Overall Study|Physician Decision|0
5337877|NCT00129545|18372780|P3|Overall Study|Lost to Follow-up|13
5337878|NCT00129545|18372781|P2|Overall Study|Lost to Follow-up|22
5337879|NCT00129545|18372782|P1|Overall Study|Lost to Follow-up|2
5337880|NCT00129545|18372780|P3|Overall Study|Withdrawal by Subject|44
5337881|NCT00129545|18372781|P2|Overall Study|Withdrawal by Subject|18
5337882|NCT00129545|18372782|P1|Overall Study|Withdrawal by Subject|3
5337883|NCT00129545|18372780|P3|Overall Study|Death|44
5337884|NCT00129545|18372781|P2|Overall Study|Death|60
5337885|NCT00129545|18372782|P1|Overall Study|Death|5
5337886|NCT00129467|18372811|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
5337887|NCT00129467|18372812|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
5337888|NCT00129467|18372811|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
5337889|NCT00129467|18372812|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
5337890|NCT00129467|18372811|P2|Received Intervention|Dizzyness, fatigue|1
5337891|NCT00129467|18372812|P1|Received Intervention|Dizzyness, fatigue|0
5337892|NCT00129467|18372811|P2|Received Intervention|Intolerance to citalopram|1
5337893|NCT00129467|18372812|P1|Received Intervention|Intolerance to citalopram|0
5337894|NCT00129467|18372811|P2|Received Intervention|Nausea|0
5337895|NCT00129467|18372812|P1|Received Intervention|Nausea|1
5337896|NCT00129467|18372811|P2|Received Intervention|Withdrawal by Subject|0
5337897|NCT00129467|18372812|P1|Received Intervention|Withdrawal by Subject|1
5337898|NCT00129467|18372811|P2|Received Intervention|Delirium|0
5337899|NCT00129467|18372812|P1|Received Intervention|Delirium|2
5337900|NCT00129467|18372811|P2|Received Intervention|Cardiac SAE (hypertension)|1
5337901|NCT00129467|18372812|P1|Received Intervention|Cardiac SAE (hypertension)|1
5337902|NCT00129467|18372811|P2|Received Intervention|Death|1
5337903|NCT00129467|18372812|P1|Received Intervention|Death|1
5337904|NCT00129402|18372843|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
5337905|NCT00129402|18372844|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5337906|NCT00129402|18372845|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5337907|NCT00129402|18372846|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5337908|NCT00129402|18372847|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5337909|NCT00129402|18372848|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5337910|NCT00129402|18372849|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5337911|NCT00129402|18372843|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
5337912|NCT00129402|18372844|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5337913|NCT00129402|18372845|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5337914|NCT00129402|18372846|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5337915|NCT00129402|18372847|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5337916|NCT00129402|18372848|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5337917|NCT00129402|18372849|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5337918|NCT00129402|18372843|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
5337919|NCT00129402|18372844|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5337920|NCT00129402|18372845|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5337921|NCT00129402|18372846|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5337922|NCT00129402|18372847|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5337923|NCT00129402|18372848|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5337924|NCT00129402|18372849|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5337925|NCT00129402|18372843|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
5337926|NCT00129402|18372844|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5337927|NCT00129402|18372845|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5337928|NCT00129402|18372846|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5337929|NCT00129402|18372847|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5337930|NCT00129402|18372848|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5337931|NCT00129402|18372849|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5337932|NCT00129402|18372843|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5337933|NCT00129402|18372844|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
5337934|NCT00129402|18372845|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5337935|NCT00129402|18372846|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5337936|NCT00129402|18372847|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
5337937|NCT00129402|18372848|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5337938|NCT00129402|18372849|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5337939|NCT00129402|18372843|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5337940|NCT00129402|18372844|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
5337941|NCT00129402|18372845|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5337942|NCT00129402|18372846|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5337943|NCT00129402|18372847|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
5337944|NCT00129402|18372848|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5337945|NCT00129402|18372849|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5337946|NCT00129402|18372843|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5337947|NCT00129402|18372844|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5337948|NCT00129402|18372845|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5337949|NCT00129402|18372846|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5337950|NCT00129402|18372847|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
5337951|NCT00129402|18372848|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5337952|NCT00129402|18372849|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5337953|NCT00129402|18372843|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5337954|NCT00129402|18372844|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
5337955|NCT00129402|18372845|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5337956|NCT00129402|18372846|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5337957|NCT00129402|18372847|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
5337958|NCT00129402|18372848|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5337959|NCT00129402|18372849|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5337960|NCT00129402|18372843|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5337961|NCT00129402|18372844|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5337962|NCT00129402|18372845|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5337963|NCT00129402|18372846|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5337964|NCT00129402|18372847|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
5337965|NCT00129402|18372848|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5337966|NCT00129402|18372849|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5337967|NCT00129402|18372843|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5337968|NCT00129402|18372844|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5337969|NCT00129402|18372845|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
5337970|NCT00129402|18372846|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5337971|NCT00129402|18372847|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
5337972|NCT00129402|18372848|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5337973|NCT00129402|18372849|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5337974|NCT00129402|18372843|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5337975|NCT00129402|18372844|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5337976|NCT00129402|18372845|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5337977|NCT00129402|18372846|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
5337978|NCT00129402|18372847|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5337979|NCT00129402|18372848|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5337980|NCT00129402|18372849|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5337981|NCT00129402|18372843|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5337982|NCT00129402|18372844|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
5337983|NCT00129402|18372845|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5337984|NCT00129402|18372846|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5337985|NCT00129402|18372847|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5337986|NCT00129402|18372848|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5337987|NCT00129402|18372849|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5337988|NCT00129402|18372843|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5337989|NCT00129402|18372844|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
5337990|NCT00129402|18372845|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5337991|NCT00129402|18372846|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5337992|NCT00129402|18372847|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
5337993|NCT00129402|18372848|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
5337994|NCT00129402|18372849|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5337995|NCT00129389|18372868|P2|Overall Study|Crossed to the other arm|16
5337996|NCT00129389|18372869|P1|Overall Study|Crossed to the other arm|1
5337997|NCT00129389|18372868|P2|Overall Study|Not eligible|2
5337998|NCT00129389|18372869|P1|Overall Study|Not eligible|1
5337999|NCT00129389|18372868|P2|Overall Study|Relapse|0
5338000|NCT00129389|18372869|P1|Overall Study|Relapse|1
5338001|NCT00129389|18372868|P2|Overall Study|Withdrawal by Subject|23
5338002|NCT00129389|18372869|P1|Overall Study|Withdrawal by Subject|9
5338003|NCT00129389|18372868|P2|Overall Study|Protocol Violation|6
5338004|NCT00129389|18372869|P1|Overall Study|Protocol Violation|0
5338005|NCT00129389|18372868|P2|Overall Study|Physician Decision|4
5338006|NCT00129389|18372869|P1|Overall Study|Physician Decision|0
5338007|NCT00129389|18372868|P2|Overall Study|Lost to Follow-up|1
5338008|NCT00129389|18372869|P1|Overall Study|Lost to Follow-up|2
5338009|NCT00129389|18372868|P2|Overall Study|Death|1
5338010|NCT00129389|18372869|P1|Overall Study|Death|0
5338011|NCT00129389|18372868|P2|Overall Study|Adverse Event|87
5338012|NCT00129389|18372869|P1|Overall Study|Adverse Event|19
5338013|NCT00129376|18372877|P1|Overall Study|Lack of Efficacy|1
5338014|NCT00129376|18372877|P1|Overall Study|Adverse Event|1
5338015|NCT00129311|18372887|P2|Overall Study|Withdrawal by Subject|19
5338016|NCT00129311|18372888|P1|Overall Study|Withdrawal by Subject|12
5338017|NCT00129272|18372917|P2|Overall Study|Withdrawal by Subject|11
5338018|NCT00129272|18372918|P1|Overall Study|Withdrawal by Subject|5
5338019|NCT00129272|18372917|P2|Overall Study|Lost to Follow-up|11
5338020|NCT00129272|18372918|P1|Overall Study|Lost to Follow-up|12
5338021|NCT00129259|18372928|P2|Overall Study|Only available minimal phone assessments|1
5338022|NCT00129259|18372929|P1|Overall Study|Only available minimal phone assessments|0
5338023|NCT00129259|18372928|P2|Overall Study|Withdrawal by Subject|1
5338024|NCT00129259|18372929|P1|Overall Study|Withdrawal by Subject|2
5338025|NCT00129259|18372928|P2|Overall Study|Lost to Follow-up|1
5338026|NCT00129259|18372929|P1|Overall Study|Lost to Follow-up|1
5338027|NCT00129220|18372957|P3|Study Period III|Reason Not Specified|2
5338028|NCT00129220|18372958|P2|Study Period III|Reason Not Specified|0
5338029|NCT00129220|18372959|P1|Study Period III|Reason Not Specified|9
5338030|NCT00129220|18372957|P3|Study Period III|Sponsor Decision|0
5338031|NCT00129220|18372958|P2|Study Period III|Sponsor Decision|0
5338032|NCT00129220|18372959|P1|Study Period III|Sponsor Decision|1
5338033|NCT00129220|18372957|P3|Study Period III|Withdrawal by Subject|3
5338034|NCT00129220|18372958|P2|Study Period III|Withdrawal by Subject|0
5338035|NCT00129220|18372959|P1|Study Period III|Withdrawal by Subject|1
5338036|NCT00129220|18372957|P3|Study Period III|Protocol Violation|2
5338037|NCT00129220|18372958|P2|Study Period III|Protocol Violation|1
5338038|NCT00129220|18372959|P1|Study Period III|Protocol Violation|1
5338039|NCT00129220|18372957|P3|Study Period III|Adverse Event|3
5338040|NCT00129220|18372958|P2|Study Period III|Adverse Event|0
5338041|NCT00129220|18372959|P1|Study Period III|Adverse Event|1
5338042|NCT00129220|18372957|P3|Study Period II|Reason Not Specified|5
5338043|NCT00129220|18372958|P2|Study Period II|Reason Not Specified|0
5338044|NCT00129220|18372959|P1|Study Period II|Reason Not Specified|2
5338045|NCT00129220|18372957|P3|Study Period II|Withdrawal by Subject|4
5338046|NCT00129220|18372958|P2|Study Period II|Withdrawal by Subject|3
5338047|NCT00129220|18372959|P1|Study Period II|Withdrawal by Subject|1
5338048|NCT00129220|18372957|P3|Study Period II|Physician Decision|0
5338049|NCT00129220|18372958|P2|Study Period II|Physician Decision|1
5338050|NCT00129220|18372959|P1|Study Period II|Physician Decision|0
5338051|NCT00129220|18372957|P3|Study Period II|Protocol Violation|1
5338052|NCT00129220|18372958|P2|Study Period II|Protocol Violation|2
5338053|NCT00129220|18372959|P1|Study Period II|Protocol Violation|4
5338054|NCT00129220|18372957|P3|Study Period II|Entry Criteria Not Met|2
5338055|NCT00129220|18372958|P2|Study Period II|Entry Criteria Not Met|0
5338056|NCT00129220|18372959|P1|Study Period II|Entry Criteria Not Met|2
5338057|NCT00129220|18372957|P3|Study Period II|Lack of Efficacy|28
5338058|NCT00129220|18372958|P2|Study Period II|Lack of Efficacy|1
5338059|NCT00129220|18372959|P1|Study Period II|Lack of Efficacy|15
5338060|NCT00129220|18372957|P3|Study Period II|Adverse Event|7
5338061|NCT00129220|18372958|P2|Study Period II|Adverse Event|5
5338062|NCT00129220|18372959|P1|Study Period II|Adverse Event|9
5338063|NCT00129129|18372999|P5|Fourth Dose Phase|Protocol Violation|0
5338064|NCT00129129|18373000|P4|Fourth Dose Phase|Protocol Violation|1
5338065|NCT00129129|18373001|P3|Fourth Dose Phase|Protocol Violation|0
5338066|NCT00129129|18373002|P2|Fourth Dose Phase|Protocol Violation|0
5338067|NCT00129129|18373003|P1|Fourth Dose Phase|Protocol Violation|0
5338068|NCT00129129|18372999|P5|Fourth Dose Phase|Other|1
5338069|NCT00129129|18373000|P4|Fourth Dose Phase|Other|1
5338070|NCT00129129|18373001|P3|Fourth Dose Phase|Other|0
5338071|NCT00129129|18373002|P2|Fourth Dose Phase|Other|0
5338072|NCT00129129|18373003|P1|Fourth Dose Phase|Other|0
5338073|NCT00129129|18372999|P5|Fourth Dose Phase|Migration from study area|2
5338074|NCT00129129|18373000|P4|Fourth Dose Phase|Migration from study area|0
5338075|NCT00129129|18373001|P3|Fourth Dose Phase|Migration from study area|0
5338076|NCT00129129|18373002|P2|Fourth Dose Phase|Migration from study area|0
5338077|NCT00129129|18373003|P1|Fourth Dose Phase|Migration from study area|0
5338078|NCT00129129|18372999|P5|Fourth Dose Phase|Withdrawal by Subject|1
5338079|NCT00129129|18373000|P4|Fourth Dose Phase|Withdrawal by Subject|0
5338080|NCT00129129|18373001|P3|Fourth Dose Phase|Withdrawal by Subject|0
5338081|NCT00129129|18373002|P2|Fourth Dose Phase|Withdrawal by Subject|0
5338082|NCT00129129|18373003|P1|Fourth Dose Phase|Withdrawal by Subject|0
5338083|NCT00129129|18372999|P5|Fourth Dose Phase|Lost to Follow-up|2
5338084|NCT00129129|18373000|P4|Fourth Dose Phase|Lost to Follow-up|2
5338085|NCT00129129|18373001|P3|Fourth Dose Phase|Lost to Follow-up|0
5338086|NCT00129129|18373002|P2|Fourth Dose Phase|Lost to Follow-up|0
5338087|NCT00129129|18373003|P1|Fourth Dose Phase|Lost to Follow-up|4
5338088|NCT00129129|18372999|P5|Primary Phase|Other|0
5338089|NCT00129129|18373000|P4|Primary Phase|Other|0
5338090|NCT00129129|18373001|P3|Primary Phase|Other|0
5338091|NCT00129129|18373002|P2|Primary Phase|Other|5
5338092|NCT00129129|18373003|P1|Primary Phase|Other|2
5338093|NCT00129129|18372999|P5|Primary Phase|Lost to Follow-up|0
5338094|NCT00129129|18373000|P4|Primary Phase|Lost to Follow-up|0
5338095|NCT00129129|18373001|P3|Primary Phase|Lost to Follow-up|0
5338096|NCT00129129|18373002|P2|Primary Phase|Lost to Follow-up|6
5338097|NCT00129129|18373003|P1|Primary Phase|Lost to Follow-up|8
5338098|NCT00129129|18372999|P5|Primary Phase|Migration from study area|0
5338099|NCT00129129|18373000|P4|Primary Phase|Migration from study area|0
5338100|NCT00129129|18373001|P3|Primary Phase|Migration from study area|0
5338101|NCT00129129|18373002|P2|Primary Phase|Migration from study area|3
5338102|NCT00129129|18373003|P1|Primary Phase|Migration from study area|1
5338103|NCT00129129|18372999|P5|Primary Phase|Withdrawal by Subject|0
5338104|NCT00129129|18373000|P4|Primary Phase|Withdrawal by Subject|0
5338105|NCT00129129|18373001|P3|Primary Phase|Withdrawal by Subject|0
5338106|NCT00129129|18373002|P2|Primary Phase|Withdrawal by Subject|10
5338107|NCT00129129|18373003|P1|Primary Phase|Withdrawal by Subject|12
5338108|NCT00129129|18372999|P5|Primary Phase|Adverse Event|0
5338109|NCT00129129|18373000|P4|Primary Phase|Adverse Event|0
5338110|NCT00129129|18373001|P3|Primary Phase|Adverse Event|0
5338111|NCT00129129|18373002|P2|Primary Phase|Adverse Event|1
5338112|NCT00129129|18373003|P1|Primary Phase|Adverse Event|2
5338113|NCT00129116|18373210|P5|Booster Phase|Lost to Follow-up|1
5338114|NCT00129116|18373211|P4|Booster Phase|Lost to Follow-up|0
5338115|NCT00129116|18373212|P3|Booster Phase|Lost to Follow-up|0
5338116|NCT00129116|18373213|P2|Booster Phase|Lost to Follow-up|0
5338117|NCT00129116|18373214|P1|Booster Phase|Lost to Follow-up|2
5338118|NCT00129116|18373210|P5|Primary Phase|Other|0
5338119|NCT00129116|18373211|P4|Primary Phase|Other|0
5338120|NCT00129116|18373212|P3|Primary Phase|Other|1
5338121|NCT00129116|18373213|P2|Primary Phase|Other|0
5338122|NCT00129116|18373214|P1|Primary Phase|Other|0
5338123|NCT00129116|18373210|P5|Primary Phase|Withdrawal by Subject|0
5338124|NCT00129116|18373211|P4|Primary Phase|Withdrawal by Subject|0
5338125|NCT00129116|18373212|P3|Primary Phase|Withdrawal by Subject|0
5338126|NCT00129116|18373213|P2|Primary Phase|Withdrawal by Subject|1
5338127|NCT00129116|18373214|P1|Primary Phase|Withdrawal by Subject|0
5338128|NCT00129116|18373210|P5|Primary Phase|Adverse Event|0
5338129|NCT00129116|18373211|P4|Primary Phase|Adverse Event|0
5338130|NCT00129116|18373212|P3|Primary Phase|Adverse Event|0
5338131|NCT00129116|18373213|P2|Primary Phase|Adverse Event|1
5338132|NCT00129116|18373214|P1|Primary Phase|Adverse Event|1
5338133|NCT00129116|18373210|P5|Primary Phase|Protocol Violation|0
5338134|NCT00129116|18373211|P4|Primary Phase|Protocol Violation|0
5338135|NCT00129116|18373212|P3|Primary Phase|Protocol Violation|0
5338136|NCT00129116|18373213|P2|Primary Phase|Protocol Violation|1
5338137|NCT00129116|18373214|P1|Primary Phase|Protocol Violation|0
5338138|NCT00129116|18373210|P5|Primary Phase|Lost to Follow-up|1
5338139|NCT00129116|18373211|P4|Primary Phase|Lost to Follow-up|1
5338140|NCT00129116|18373212|P3|Primary Phase|Lost to Follow-up|0
5338141|NCT00129116|18373213|P2|Primary Phase|Lost to Follow-up|1
5338142|NCT00129116|18373214|P1|Primary Phase|Lost to Follow-up|1
5338143|NCT00128830|18373498|P1|Overall Study|Other|9
5338144|NCT00128830|18373498|P1|Overall Study|Discontinued or ineligible for study|2
5338145|NCT00128830|18373498|P1|Overall Study|Non-compliant|4
5338146|NCT00128830|18373498|P1|Overall Study|Reached a virologic endpoint|29
5338147|NCT00128830|18373498|P1|Overall Study|Lost to Follow-up|4
5338148|NCT00128830|18373498|P1|Overall Study|Withdrawal by Subject|14
5338149|NCT00128830|18373498|P1|Overall Study|Adverse Event|10
5338150|NCT00128661|18373540|P2|Overall Study|Other|8
5338151|NCT00128661|18373541|P1|Overall Study|Other|7
5338152|NCT00128661|18373540|P2|Overall Study|Withdrawal by Subject|232
5338153|NCT00128661|18373541|P1|Overall Study|Withdrawal by Subject|243
5338154|NCT00128661|18373540|P2|Overall Study|Lost to Follow-up|7
5338155|NCT00128661|18373541|P1|Overall Study|Lost to Follow-up|10
5338156|NCT00128661|18373540|P2|Overall Study|Adverse Event|11
5338157|NCT00128661|18373541|P1|Overall Study|Adverse Event|14
5338158|NCT00128492|18373587|P2|Overall Study|Pregnancy|1
5338159|NCT00128492|18373588|P1|Overall Study|Pregnancy|0
5338160|NCT00128492|18373587|P2|Overall Study|Withdrawal by Subject|5
5338161|NCT00128492|18373588|P1|Overall Study|Withdrawal by Subject|3
5338162|NCT00128492|18373587|P2|Overall Study|Personal or administrative|22
5338163|NCT00128492|18373588|P1|Overall Study|Personal or administrative|10
5338164|NCT00128492|18373587|P2|Overall Study|Noncompliance|5
5338165|NCT00128492|18373588|P1|Overall Study|Noncompliance|0
5338166|NCT00128492|18373587|P2|Overall Study|Lost to Follow-up|5
5338167|NCT00128492|18373588|P1|Overall Study|Lost to Follow-up|1
5338168|NCT00128492|18373587|P2|Overall Study|Death|0
5338169|NCT00128492|18373588|P1|Overall Study|Death|1
5338170|NCT00128492|18373587|P2|Overall Study|AE related to study|4
5338171|NCT00128492|18373588|P1|Overall Study|AE related to study|1
5338172|NCT00128492|18373587|P2|Overall Study|Study drug intolerance (AE)|8
5338173|NCT00128492|18373588|P1|Overall Study|Study drug intolerance (AE)|2
5338174|NCT00128492|18373587|P2|Overall Study|AE unrelated to study|9
5338175|NCT00128492|18373588|P1|Overall Study|AE unrelated to study|2
5338176|NCT00128206|18373745|P2|Overall Study|Adverse Event|2
5338177|NCT00128206|18373746|P1|Overall Study|Adverse Event|0
5338178|NCT00128206|18373745|P2|Overall Study|Lost to Follow-up|118
5338179|NCT00128206|18373746|P1|Overall Study|Lost to Follow-up|137
5338180|NCT00128102|18374042|P2|Overall Study|Protocol Violation|2
5338181|NCT00128102|18374043|P1|Overall Study|Protocol Violation|2
5338182|NCT00128102|18374042|P2|Overall Study|Withdrawal by Subject|11
5338183|NCT00128102|18374043|P1|Overall Study|Withdrawal by Subject|19
5338184|NCT00128102|18374042|P2|Overall Study|Physician Decision|3
5338185|NCT00128102|18374043|P1|Overall Study|Physician Decision|3
5338186|NCT00128102|18374042|P2|Overall Study|Death|13
5338187|NCT00128102|18374043|P1|Overall Study|Death|12
5338188|NCT00128102|18374042|P2|Overall Study|Adverse Event|11
5338189|NCT00128102|18374043|P1|Overall Study|Adverse Event|34
5338190|NCT00128102|18374042|P2|Overall Study|Progressive Disease|285
5338191|NCT00128102|18374043|P1|Overall Study|Progressive Disease|255
5338192|NCT00128102|18374042|P2|Overall Study|Other|1
5338193|NCT00128102|18374043|P1|Overall Study|Other|0
5338194|NCT00128102|18374042|P2|Overall Study|Site Discontinued|6
5338195|NCT00128102|18374043|P1|Overall Study|Site Discontinued|3
5338196|NCT00127933|18374069|P2|Overall Study|Randomized but not dosed|0
5338197|NCT00127933|18374070|P1|Overall Study|Randomized but not dosed|1
5338198|NCT00127855|18374091|P5|Primary Vaccination Course|Other|1
5338199|NCT00127855|18374092|P4|Primary Vaccination Course|Other|0
5338200|NCT00127855|18374093|P3|Primary Vaccination Course|Other|0
5338201|NCT00127855|18374094|P2|Primary Vaccination Course|Other|0
5338202|NCT00127855|18374095|P1|Primary Vaccination Course|Other|0
5338203|NCT00127855|18374091|P5|Primary Vaccination Course|Lost to Follow-up|2
5338204|NCT00127855|18374092|P4|Primary Vaccination Course|Lost to Follow-up|0
5338205|NCT00127855|18374093|P3|Primary Vaccination Course|Lost to Follow-up|1
5338206|NCT00127855|18374094|P2|Primary Vaccination Course|Lost to Follow-up|1
5338207|NCT00127855|18374095|P1|Primary Vaccination Course|Lost to Follow-up|1
5338208|NCT00127855|18374091|P5|Primary Vaccination Course|Withdrawal by Subject|1
5338209|NCT00127855|18374092|P4|Primary Vaccination Course|Withdrawal by Subject|0
5338210|NCT00127855|18374093|P3|Primary Vaccination Course|Withdrawal by Subject|0
5338211|NCT00127855|18374094|P2|Primary Vaccination Course|Withdrawal by Subject|0
5338212|NCT00127855|18374095|P1|Primary Vaccination Course|Withdrawal by Subject|1
5338213|NCT00127855|18374091|P5|Primary Vaccination Course|Adverse Event|0
5338214|NCT00127855|18374092|P4|Primary Vaccination Course|Adverse Event|0
5338215|NCT00127855|18374093|P3|Primary Vaccination Course|Adverse Event|1
5338216|NCT00127855|18374094|P2|Primary Vaccination Course|Adverse Event|0
5338217|NCT00127855|18374095|P1|Primary Vaccination Course|Adverse Event|0
5338218|NCT00127842|18374277|P1|Overall Study|Other|5
5338219|NCT00127842|18374277|P1|Overall Study|Protocol Violation|1
5338220|NCT00127842|18374277|P1|Overall Study|Noncompliance|2
5338221|NCT00127842|18374277|P1|Overall Study|Lack of Efficacy|12
5338222|NCT00127842|18374277|P1|Overall Study|Lost to Follow-up|1
5338223|NCT00127842|18374277|P1|Overall Study|Withdrawal by Subject|3
5338224|NCT00127842|18374277|P1|Overall Study|Adverse Event|15
5338225|NCT00127803|18374295|P4|Overall Study|Lost to Follow-up|1
5338226|NCT00127803|18374296|P3|Overall Study|Lost to Follow-up|0
5338227|NCT00127803|18374297|P2|Overall Study|Lost to Follow-up|0
5338228|NCT00127803|18374298|P1|Overall Study|Lost to Follow-up|0
5338229|NCT00127803|18374295|P4|Overall Study|Withdrawal by Subject|0
5338230|NCT00127803|18374296|P3|Overall Study|Withdrawal by Subject|0
5338231|NCT00127803|18374297|P2|Overall Study|Withdrawal by Subject|0
5338232|NCT00127803|18374298|P1|Overall Study|Withdrawal by Subject|1
5338233|NCT00127803|18374295|P4|Overall Study|Adverse Event|0
5338234|NCT00127803|18374296|P3|Overall Study|Adverse Event|0
5338235|NCT00127803|18374297|P2|Overall Study|Adverse Event|0
5338236|NCT00127803|18374298|P1|Overall Study|Adverse Event|2
5338237|NCT00127712|18374347|P2|Overall Study|Lack of GI access to continue|0
5338238|NCT00127712|18374348|P1|Overall Study|Lack of GI access to continue|2
5338239|NCT00127712|18374347|P2|Overall Study|Adverse Event|0
5338240|NCT00127712|18374348|P1|Overall Study|Adverse Event|3
5338241|NCT00127660|18374364|P4|Overall Study|Protocol Violation|0
5338242|NCT00127660|18374365|P3|Overall Study|Protocol Violation|5
5338243|NCT00127660|18374366|P2|Overall Study|Protocol Violation|3
5338244|NCT00127660|18374367|P1|Overall Study|Protocol Violation|3
5338245|NCT00127608|18374377|P1|Overall Study|VZV DNA negative|1
5338246|NCT00127413|18374421|P4|Overall Study|Lost to Follow-up|2
5338247|NCT00127413|18374422|P3|Overall Study|Lost to Follow-up|8
5338248|NCT00127413|18374423|P2|Overall Study|Lost to Follow-up|4
5338249|NCT00127413|18374424|P1|Overall Study|Lost to Follow-up|6
5338250|NCT00127205|18374465|P3|Overall Study|Progression|84
5338251|NCT00127205|18374466|P2|Overall Study|Progression|130
5338252|NCT00127205|18374467|P1|Overall Study|Progression|127
5338253|NCT00127205|18374465|P3|Overall Study|Under Review|6
5338254|NCT00127205|18374466|P2|Overall Study|Under Review|21
5338255|NCT00127205|18374467|P1|Overall Study|Under Review|13
5338256|NCT00127205|18374465|P3|Overall Study|Other-non protocol specified|77
5338257|NCT00127205|18374466|P2|Overall Study|Other-non protocol specified|129
5338258|NCT00127205|18374467|P1|Overall Study|Other-non protocol specified|141
5338259|NCT00127205|18374465|P3|Overall Study|Withdrawal by Subject|172
5338260|NCT00127205|18374466|P2|Overall Study|Withdrawal by Subject|308
5338261|NCT00127205|18374467|P1|Overall Study|Withdrawal by Subject|318
5338262|NCT00127205|18374465|P3|Overall Study|Death|6
5338263|NCT00127205|18374466|P2|Overall Study|Death|6
5338264|NCT00127205|18374467|P1|Overall Study|Death|8
5338265|NCT00127205|18374465|P3|Overall Study|Adverse Event|272
5338266|NCT00127205|18374466|P2|Overall Study|Adverse Event|386
5338267|NCT00127205|18374467|P1|Overall Study|Adverse Event|228
5338268|NCT00127192|18374489|P5|Overall Study|Adverse event in pre-treatment period|0
5338269|NCT00127192|18374490|P4|Overall Study|Adverse event in pre-treatment period|0
5338270|NCT00127192|18374491|P3|Overall Study|Adverse event in pre-treatment period|0
5338271|NCT00127192|18374492|P2|Overall Study|Adverse event in pre-treatment period|0
5338272|NCT00127192|18374493|P1|Overall Study|Adverse event in pre-treatment period|1
5338273|NCT00127192|18374489|P5|Overall Study|Withdrawal by Subject|3
5338274|NCT00127192|18374490|P4|Overall Study|Withdrawal by Subject|0
5338275|NCT00127192|18374491|P3|Overall Study|Withdrawal by Subject|1
5338276|NCT00127192|18374492|P2|Overall Study|Withdrawal by Subject|0
5338277|NCT00127192|18374493|P1|Overall Study|Withdrawal by Subject|0
5338278|NCT00127192|18374489|P5|Overall Study|Lack of Efficacy|2
5338279|NCT00127192|18374490|P4|Overall Study|Lack of Efficacy|0
5338280|NCT00127192|18374491|P3|Overall Study|Lack of Efficacy|0
5338281|NCT00127192|18374492|P2|Overall Study|Lack of Efficacy|0
5338282|NCT00127192|18374493|P1|Overall Study|Lack of Efficacy|2
5338283|NCT00127192|18374489|P5|Overall Study|Adverse Event|0
5338284|NCT00127192|18374490|P4|Overall Study|Adverse Event|1
5338285|NCT00127192|18374491|P3|Overall Study|Adverse Event|1
5338286|NCT00127192|18374492|P2|Overall Study|Adverse Event|1
5338287|NCT00127192|18374493|P1|Overall Study|Adverse Event|0
5338288|NCT00127166|18374517|P2|Period II|Patient did not perform Visit 6 exercise|0
5338289|NCT00127166|18374518|P1|Period II|Patient did not perform Visit 6 exercise|1
5338290|NCT00127166|18374517|P2|Period II|Withdrawal by Subject|0
5338291|NCT00127166|18374518|P1|Period II|Withdrawal by Subject|2
5338292|NCT00127166|18374517|P2|Washout Period|Patient did not meet inclusion criteria|1
5338293|NCT00127166|18374518|P1|Washout Period|Patient did not meet inclusion criteria|0
5338294|NCT00127166|18374517|P2|Period I|Patient did not meet inclusion criteria|0
5338295|NCT00127166|18374518|P1|Period I|Patient did not meet inclusion criteria|1
5338296|NCT00127166|18374517|P2|Period I|Withdrawal by Subject|0
5338297|NCT00127166|18374518|P1|Period I|Withdrawal by Subject|2
5338298|NCT00127166|18374517|P2|Period I|Protocol Violation|2
5338299|NCT00127166|18374518|P1|Period I|Protocol Violation|0
5338300|NCT00127101|18374538|P6|Continuation Phase|Withdrawal by Subject|1
5338301|NCT00127101|18374539|P5|Continuation Phase|Withdrawal by Subject|2
5338302|NCT00127101|18374540|P4|Continuation Phase|Withdrawal by Subject|0
5338303|NCT00127101|18374541|P3|Continuation Phase|Withdrawal by Subject|1
5338304|NCT00127101|18374542|P2|Continuation Phase|Withdrawal by Subject|0
5338305|NCT00127101|18374543|P1|Continuation Phase|Withdrawal by Subject|0
5338306|NCT00127101|18374538|P6|Continuation Phase|Lack of Efficacy|1
5338307|NCT00127101|18374539|P5|Continuation Phase|Lack of Efficacy|0
5338308|NCT00127101|18374540|P4|Continuation Phase|Lack of Efficacy|0
5338309|NCT00127101|18374541|P3|Continuation Phase|Lack of Efficacy|0
5338310|NCT00127101|18374542|P2|Continuation Phase|Lack of Efficacy|0
5338311|NCT00127101|18374543|P1|Continuation Phase|Lack of Efficacy|0
5338312|NCT00127101|18374538|P6|Continuation Phase|Adverse Event|1
5338313|NCT00127101|18374539|P5|Continuation Phase|Adverse Event|1
5338314|NCT00127101|18374540|P4|Continuation Phase|Adverse Event|0
5338315|NCT00127101|18374541|P3|Continuation Phase|Adverse Event|0
5338316|NCT00127101|18374542|P2|Continuation Phase|Adverse Event|0
5338317|NCT00127101|18374543|P1|Continuation Phase|Adverse Event|0
5338318|NCT00127101|18374538|P6|Base Protocol|Withdrawal by Subject|1
5338319|NCT00127101|18374539|P5|Base Protocol|Withdrawal by Subject|0
5338320|NCT00127101|18374540|P4|Base Protocol|Withdrawal by Subject|0
5338321|NCT00127101|18374541|P3|Base Protocol|Withdrawal by Subject|1
5338322|NCT00127101|18374542|P2|Base Protocol|Withdrawal by Subject|2
5338323|NCT00127101|18374543|P1|Base Protocol|Withdrawal by Subject|1
5338324|NCT00127101|18374538|P6|Base Protocol|Lack of Efficacy|0
5338325|NCT00127101|18374539|P5|Base Protocol|Lack of Efficacy|2
5338326|NCT00127101|18374540|P4|Base Protocol|Lack of Efficacy|0
5338327|NCT00127101|18374541|P3|Base Protocol|Lack of Efficacy|0
5338328|NCT00127101|18374542|P2|Base Protocol|Lack of Efficacy|0
5338329|NCT00127101|18374543|P1|Base Protocol|Lack of Efficacy|1
5338330|NCT00127101|18374538|P6|Base Protocol|Adverse Event|0
5338331|NCT00127101|18374539|P5|Base Protocol|Adverse Event|0
5338332|NCT00127101|18374540|P4|Base Protocol|Adverse Event|0
5338333|NCT00127101|18374541|P3|Base Protocol|Adverse Event|1
5338334|NCT00127101|18374542|P2|Base Protocol|Adverse Event|2
5338335|NCT00127101|18374543|P1|Base Protocol|Adverse Event|0
5338336|NCT00127036|18374578|P2|Overall Study|Screen Failure|0
5338337|NCT00127036|18374579|P1|Overall Study|Screen Failure|2
5338338|NCT00127036|18374578|P2|Overall Study|Insufficient Data for Analysis|11
5338339|NCT00127036|18374579|P1|Overall Study|Insufficient Data for Analysis|6
5338340|NCT00126776|18374591|P2|Overall Study|follow up complete on all patients|0
5338341|NCT00126776|18374592|P1|Overall Study|follow up complete on all patients|0
5338342|NCT00126659|18374641|P3|Overall Study|Adverse Event|2
5338343|NCT00126659|18374642|P2|Overall Study|Adverse Event|0
5338344|NCT00126659|18374643|P1|Overall Study|Adverse Event|0
5338345|NCT00126594|18374651|P2|Overall Study|Disease Progression|24
5338346|NCT00126594|18374652|P1|Overall Study|Disease Progression|29
5338347|NCT00126594|18374651|P2|Overall Study|Non-compliance|1
5338348|NCT00126594|18374652|P1|Overall Study|Non-compliance|0
5338349|NCT00126594|18374651|P2|Overall Study|Adverse Event|5
5338350|NCT00126594|18374652|P1|Overall Study|Adverse Event|7
5338351|NCT00126594|18374651|P2|Overall Study|Physician Decision|3
5338352|NCT00126594|18374652|P1|Overall Study|Physician Decision|1
5338353|NCT00126594|18374651|P2|Overall Study|Withdrawal by Subject|4
5338354|NCT00126594|18374652|P1|Overall Study|Withdrawal by Subject|0
5338355|NCT00126594|18374651|P2|Overall Study|Ineligible|0
5338356|NCT00126594|18374652|P1|Overall Study|Ineligible|2
5338357|NCT00126581|18374669|P2|Overall Study|Other illness/MD discretion|4
5338358|NCT00126581|18374670|P1|Overall Study|Other illness/MD discretion|3
5338359|NCT00126581|18374669|P2|Overall Study|Alternative therapy|3
5338360|NCT00126581|18374670|P1|Overall Study|Alternative therapy|3
5338361|NCT00126581|18374669|P2|Overall Study|Withdrawal by Subject|4
5338362|NCT00126581|18374670|P1|Overall Study|Withdrawal by Subject|1
5338363|NCT00126581|18374669|P2|Overall Study|Death|2
5338364|NCT00126581|18374670|P1|Overall Study|Death|3
5338365|NCT00126581|18374669|P2|Overall Study|Adverse Event|7
5338366|NCT00126581|18374670|P1|Overall Study|Adverse Event|3
5338367|NCT00126568|18374690|P1|Overall Study|Death|2
5338368|NCT00126555|18374697|P1|Overall Study|Progressive Disease|3
5338369|NCT00126555|18374697|P1|Overall Study|Adverse Event|2
5338370|NCT00126555|18374697|P1|Overall Study|Withdrawal by Subject|1
5338371|NCT00126503|18374719|P2|Overall Study|Physician Decision|1
5338372|NCT00126503|18374720|P1|Overall Study|Physician Decision|2
5338373|NCT00126503|18374719|P2|Overall Study|non-compliant|0
5338374|NCT00126503|18374720|P1|Overall Study|non-compliant|1
5338375|NCT00126503|18374719|P2|Overall Study|Adverse Event|3
5338376|NCT00126503|18374720|P1|Overall Study|Adverse Event|13
5338377|NCT00126503|18374719|P2|Overall Study|Death|0
5338378|NCT00126503|18374720|P1|Overall Study|Death|3
5338379|NCT00126503|18374719|P2|Overall Study|other complicating disease|1
5338380|NCT00126503|18374720|P1|Overall Study|other complicating disease|4
5338381|NCT00126503|18374719|P2|Overall Study|alternative therapy|1
5338382|NCT00126503|18374720|P1|Overall Study|alternative therapy|1
5338383|NCT00126503|18374719|P2|Overall Study|Withdrawal by Subject|1
5338384|NCT00126503|18374720|P1|Overall Study|Withdrawal by Subject|0
5338385|NCT00126503|18374719|P2|Overall Study|disease progression|14
5338386|NCT00126503|18374720|P1|Overall Study|disease progression|23
5338387|NCT00126490|18374732|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
5338388|NCT00126438|18374742|P2|Overall Study|Withdrawal by Subject|2
5338389|NCT00126438|18374743|P1|Overall Study|Withdrawal by Subject|3
5338390|NCT00126438|18374742|P2|Overall Study|Protocol Violation|8
5338391|NCT00126438|18374743|P1|Overall Study|Protocol Violation|8
5338392|NCT00126438|18374742|P2|Overall Study|Lost to Follow-up|0
5338393|NCT00126438|18374743|P1|Overall Study|Lost to Follow-up|22
5338394|NCT00126438|18374742|P2|Overall Study|Withdrawal due to adverse event|0
5338395|NCT00126438|18374743|P1|Overall Study|Withdrawal due to adverse event|1
5338396|NCT00126425|18374751|P2|Overall Study|Other|0
5338397|NCT00126425|18374752|P1|Overall Study|Other|5
5338398|NCT00126425|18374751|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
5338399|NCT00126425|18374752|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
5338400|NCT00126425|18374751|P2|Overall Study|Adverse Event|0
5338401|NCT00126425|18374752|P1|Overall Study|Adverse Event|1
5338402|NCT00126425|18374751|P2|Overall Study|Protocol Violation|6
5338403|NCT00126425|18374752|P1|Overall Study|Protocol Violation|9
5338404|NCT00126425|18374751|P2|Overall Study|Lost to Follow-up|4
5338405|NCT00126425|18374752|P1|Overall Study|Lost to Follow-up|8
5338406|NCT00126425|18374751|P2|Overall Study|Withdrawal by Subject|1
5338407|NCT00126425|18374752|P1|Overall Study|Withdrawal by Subject|17
5338408|NCT00126191|18374760|P2|Overall Study|Death|1
5338409|NCT00126191|18374761|P1|Overall Study|Death|0
5338410|NCT00126191|18374760|P2|Overall Study|Physician Decision|1
5338411|NCT00126191|18374761|P1|Overall Study|Physician Decision|0
5338412|NCT00126126|18374771|P2|Overall Study|Lost to Follow-up|2
5338413|NCT00126126|18374772|P1|Overall Study|Lost to Follow-up|0
5338414|NCT00125853|18374811|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
5338415|NCT00125853|18374812|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
5338416|NCT00125359|18374926|P1|Overall Study|Physician Decision|14
5338417|NCT00125359|18374926|P1|Overall Study|Adverse Event|5
5338418|NCT00125359|18374926|P1|Overall Study|Death|4
5338419|NCT00125268|18374935|P2|Overall Study|Withdrawal by Subject|1
5338420|NCT00125268|18374936|P1|Overall Study|Withdrawal by Subject|1
5338421|NCT00125242|18374948|P2|Overall Study|did not qualify|2
5338422|NCT00125242|18374949|P1|Overall Study|did not qualify|7
5338423|NCT00125190|18374954|P1|Overall Study|Lost to Follow-up|4
5338424|NCT00125190|18374954|P1|Overall Study|Other|1
5338425|NCT00125190|18374954|P1|Overall Study|Adverse Event|1
5338426|NCT00125190|18374954|P1|Overall Study|Non-compliance|2
5338427|NCT00125190|18374954|P1|Overall Study|Subject/Parent Decision|7
5338428|NCT00125164|18374970|P4|Overall Study|Withdrawal by Subject|1
5338429|NCT00125164|18374971|P3|Overall Study|Withdrawal by Subject|1
5338430|NCT00125164|18374972|P2|Overall Study|Withdrawal by Subject|0
5338431|NCT00125164|18374973|P1|Overall Study|Withdrawal by Subject|2
5338432|NCT00125164|18374970|P4|Overall Study|Lost to Follow-up|1
5338433|NCT00125164|18374971|P3|Overall Study|Lost to Follow-up|1
5338434|NCT00125164|18374972|P2|Overall Study|Lost to Follow-up|0
5338435|NCT00125164|18374973|P1|Overall Study|Lost to Follow-up|0
5338436|NCT00125164|18374970|P4|Overall Study|Adverse Event|4
5338437|NCT00125164|18374971|P3|Overall Study|Adverse Event|2
5338438|NCT00125164|18374972|P2|Overall Study|Adverse Event|0
5338439|NCT00125164|18374973|P1|Overall Study|Adverse Event|0
5338440|NCT00125138|18375027|P4|Overall Study|Sponsor decision-pt moved to assist care|1
5338441|NCT00125138|18375028|P3|Overall Study|Sponsor decision-pt moved to assist care|0
5338442|NCT00125138|18375029|P2|Overall Study|Sponsor decision-pt moved to assist care|0
5338443|NCT00125138|18375030|P1|Overall Study|Sponsor decision-pt moved to assist care|0
5338444|NCT00125138|18375027|P4|Overall Study|Lack of Efficacy|1
5338445|NCT00125138|18375028|P3|Overall Study|Lack of Efficacy|0
5338446|NCT00125138|18375029|P2|Overall Study|Lack of Efficacy|0
5338447|NCT00125138|18375030|P1|Overall Study|Lack of Efficacy|0
5338448|NCT00125138|18375027|P4|Overall Study|Withdrawal by Subject|1
5338449|NCT00125138|18375028|P3|Overall Study|Withdrawal by Subject|1
5338450|NCT00125138|18375029|P2|Overall Study|Withdrawal by Subject|3
5338451|NCT00125138|18375030|P1|Overall Study|Withdrawal by Subject|2
5338452|NCT00125138|18375027|P4|Overall Study|Adverse Event|2
5338453|NCT00125138|18375028|P3|Overall Study|Adverse Event|3
5338454|NCT00125138|18375029|P2|Overall Study|Adverse Event|0
5338455|NCT00125138|18375030|P1|Overall Study|Adverse Event|1
5338456|NCT00124982|18375079|P3|Long-term Period|Neurologist Recommendation|1
5338457|NCT00124982|18375080|P2|Long-term Period|Neurologist Recommendation|0
5338458|NCT00124982|18375081|P1|Long-term Period|Neurologist Recommendation|0
5338459|NCT00124982|18375079|P3|Long-term Period|Administrative Reason by Sponsor|1
5338460|NCT00124982|18375080|P2|Long-term Period|Administrative Reason by Sponsor|0
5338461|NCT00124982|18375081|P1|Long-term Period|Administrative Reason by Sponsor|0
5338462|NCT00124982|18375079|P3|Long-term Period|Poor/Non-compliance|2
5338463|NCT00124982|18375080|P2|Long-term Period|Poor/Non-compliance|0
5338464|NCT00124982|18375081|P1|Long-term Period|Poor/Non-compliance|0
5338465|NCT00124982|18375079|P3|Long-term Period|Pregnancy|1
5338466|NCT00124982|18375080|P2|Long-term Period|Pregnancy|0
5338467|NCT00124982|18375081|P1|Long-term Period|Pregnancy|0
5338468|NCT00124982|18375079|P3|Long-term Period|Withdrawal by Subject|16
5338469|NCT00124982|18375080|P2|Long-term Period|Withdrawal by Subject|0
5338470|NCT00124982|18375081|P1|Long-term Period|Withdrawal by Subject|0
5338471|NCT00124982|18375079|P3|Long-term Period|Lost to Follow-up|4
5338472|NCT00124982|18375080|P2|Long-term Period|Lost to Follow-up|0
5338473|NCT00124982|18375081|P1|Long-term Period|Lost to Follow-up|0
5338474|NCT00124982|18375079|P3|Long-term Period|Lack of Efficacy|46
5338475|NCT00124982|18375080|P2|Long-term Period|Lack of Efficacy|0
5338476|NCT00124982|18375081|P1|Long-term Period|Lack of Efficacy|0
5338477|NCT00124982|18375079|P3|Long-term Period|Adverse Event|17
5338478|NCT00124982|18375080|P2|Long-term Period|Adverse Event|0
5338479|NCT00124982|18375081|P1|Long-term Period|Adverse Event|0
5338480|NCT00124982|18375079|P3|Long-term Period|Death|1
5338481|NCT00124982|18375080|P2|Long-term Period|Death|0
5338482|NCT00124982|18375081|P1|Long-term Period|Death|0
5338483|NCT00124982|18375079|P3|Short-term Period|Participant Had Lymphopenia|0
5338484|NCT00124982|18375080|P2|Short-term Period|Participant Had Lymphopenia|0
5338485|NCT00124982|18375081|P1|Short-term Period|Participant Had Lymphopenia|1
5338486|NCT00124982|18375079|P3|Short-term Period|Investigator Decision-No Specific AE|0
5338487|NCT00124982|18375080|P2|Short-term Period|Investigator Decision-No Specific AE|0
5338488|NCT00124982|18375081|P1|Short-term Period|Investigator Decision-No Specific AE|1
5338489|NCT00124982|18375079|P3|Short-term Period|Participant Chose Own Doctor|0
5338490|NCT00124982|18375080|P2|Short-term Period|Participant Chose Own Doctor|1
5338491|NCT00124982|18375081|P1|Short-term Period|Participant Chose Own Doctor|0
5338492|NCT00124982|18375079|P3|Short-term Period|Participant Decision|0
5338493|NCT00124982|18375080|P2|Short-term Period|Participant Decision|0
5338494|NCT00124982|18375081|P1|Short-term Period|Participant Decision|1
5338495|NCT00124982|18375079|P3|Short-term Period|No Longer Meets Study Criteria|0
5338496|NCT00124982|18375080|P2|Short-term Period|No Longer Meets Study Criteria|2
5338497|NCT00124982|18375081|P1|Short-term Period|No Longer Meets Study Criteria|1
5338498|NCT00124982|18375079|P3|Short-term Period|Poor/Non-compliance|0
5338499|NCT00124982|18375080|P2|Short-term Period|Poor/Non-compliance|1
5338500|NCT00124982|18375081|P1|Short-term Period|Poor/Non-compliance|3
5338501|NCT00124982|18375079|P3|Short-term Period|Withdrawal of Consent|0
5338502|NCT00124982|18375080|P2|Short-term Period|Withdrawal of Consent|9
5338503|NCT00124982|18375081|P1|Short-term Period|Withdrawal of Consent|7
5338504|NCT00124982|18375079|P3|Short-term Period|Lost to Follow-up|0
5338505|NCT00124982|18375080|P2|Short-term Period|Lost to Follow-up|5
5338506|NCT00124982|18375081|P1|Short-term Period|Lost to Follow-up|8
5338507|NCT00124982|18375079|P3|Short-term Period|Lack of Efficacy|0
5338508|NCT00124982|18375080|P2|Short-term Period|Lack of Efficacy|73
5338509|NCT00124982|18375081|P1|Short-term Period|Lack of Efficacy|32
5338510|NCT00124982|18375079|P3|Short-term Period|Adverse Event|0
5338511|NCT00124982|18375080|P2|Short-term Period|Adverse Event|22
5338512|NCT00124982|18375081|P1|Short-term Period|Adverse Event|17
5338513|NCT00124982|18375079|P3|Short-term Period|Death|0
5338514|NCT00124982|18375080|P2|Short-term Period|Death|1
5338515|NCT00124982|18375081|P1|Short-term Period|Death|1
5338516|NCT00124943|18375163|P4|Phase II|Withdrawal by Subject|2
5338517|NCT00124943|18375164|P3|Phase II|Withdrawal by Subject|0
5338518|NCT00124943|18375165|P2|Phase II|Withdrawal by Subject|0
5338519|NCT00124943|18375166|P1|Phase II|Withdrawal by Subject|0
5338520|NCT00124943|18375163|P4|Phase II|Lost to Follow-up|1
5338521|NCT00124943|18375164|P3|Phase II|Lost to Follow-up|0
5338522|NCT00124943|18375165|P2|Phase II|Lost to Follow-up|0
5338523|NCT00124943|18375166|P1|Phase II|Lost to Follow-up|0
5338524|NCT00124943|18375163|P4|Phase II|Protocol Violation|1
5338525|NCT00124943|18375164|P3|Phase II|Protocol Violation|0
5338526|NCT00124943|18375165|P2|Phase II|Protocol Violation|0
5338527|NCT00124943|18375166|P1|Phase II|Protocol Violation|0
5338528|NCT00124943|18375163|P4|Phase II|Adverse Event|1
5338529|NCT00124943|18375164|P3|Phase II|Adverse Event|0
5338530|NCT00124943|18375165|P2|Phase II|Adverse Event|2
5338531|NCT00124943|18375166|P1|Phase II|Adverse Event|0
5338532|NCT00124917|18375204|P1|Overall Study|Physician Decision|3
5338533|NCT00124748|18375214|P2|Overall Study|Death|3
5338534|NCT00124748|18375215|P1|Overall Study|Death|1
5338535|NCT00124748|18375214|P2|Overall Study|Administrative Problem(Study Terminated)|174
5338536|NCT00124748|18375215|P1|Overall Study|Administrative Problem(Study Terminated)|101
5338537|NCT00124748|18375214|P2|Overall Study|Lost to Follow-up|7
5338538|NCT00124748|18375215|P1|Overall Study|Lost to Follow-up|2
5338539|NCT00124748|18375214|P2|Overall Study|Withdrawal by Subject|15
5338540|NCT00124748|18375215|P1|Overall Study|Withdrawal by Subject|5
5338541|NCT00124748|18375214|P2|Overall Study|Protocol Violation|1
5338542|NCT00124748|18375215|P1|Overall Study|Protocol Violation|3
5338543|NCT00124748|18375214|P2|Overall Study|No longer requires study drug|1
5338544|NCT00124748|18375215|P1|Overall Study|No longer requires study drug|1
5338545|NCT00124748|18375214|P2|Overall Study|Lack of Efficacy|41
5338546|NCT00124748|18375215|P1|Overall Study|Lack of Efficacy|20
5338547|NCT00124748|18375214|P2|Overall Study|Abnormal Procedure|1
5338548|NCT00124748|18375215|P1|Overall Study|Abnormal Procedure|0
5338549|NCT00124748|18375214|P2|Overall Study|Abnormal laboratory Value|2
5338550|NCT00124748|18375215|P1|Overall Study|Abnormal laboratory Value|2
5338551|NCT00124748|18375214|P2|Overall Study|Adverse Event|39
5338552|NCT00124748|18375215|P1|Overall Study|Adverse Event|8
5338553|NCT00124709|18375322|P2|Overall Study|Lost to Follow-up|120
5338554|NCT00124709|18375323|P1|Overall Study|Lost to Follow-up|114
5338555|NCT00124709|18375322|P2|Overall Study|Withdrawal by Subject|136
5338556|NCT00124709|18375323|P1|Overall Study|Withdrawal by Subject|127
5338557|NCT00124709|18375322|P2|Overall Study|Protocol Violation|5
5338558|NCT00124709|18375323|P1|Overall Study|Protocol Violation|3
5338559|NCT00124709|18375322|P2|Overall Study|Lack of Efficacy|10
5338560|NCT00124709|18375323|P1|Overall Study|Lack of Efficacy|5
5338561|NCT00124709|18375322|P2|Overall Study|Adverse Event|0
5338562|NCT00124709|18375323|P1|Overall Study|Adverse Event|3
5338563|NCT00124709|18375322|P2|Overall Study|Randomized but did not take medication|1
5338564|NCT00124709|18375323|P1|Overall Study|Randomized but did not take medication|3
5338565|NCT00124657|18375340|P3|Overall Study|Intercurrent illness|0
5338566|NCT00124657|18375341|P2|Overall Study|Intercurrent illness|0
5338567|NCT00124657|18375342|P1|Overall Study|Intercurrent illness|1
5338568|NCT00124657|18375340|P3|Overall Study|Progressive disease|27
5338569|NCT00124657|18375341|P2|Overall Study|Progressive disease|5
5338570|NCT00124657|18375342|P1|Overall Study|Progressive disease|14
5338571|NCT00124657|18375340|P3|Overall Study|Non-compliance|4
5338572|NCT00124657|18375341|P2|Overall Study|Non-compliance|0
5338573|NCT00124657|18375342|P1|Overall Study|Non-compliance|1
5338574|NCT00124657|18375340|P3|Overall Study|Toxicity|1
5338575|NCT00124657|18375341|P2|Overall Study|Toxicity|0
5338576|NCT00124657|18375342|P1|Overall Study|Toxicity|0
5338577|NCT00124618|18375377|P1|Overall Study|Ineligible|1
5338578|NCT00124462|18375392|P2|Overall Study|Device fitting, n=2, other hlth issues|1
5338579|NCT00124462|18375393|P1|Overall Study|Device fitting, n=2, other hlth issues|1
5338580|NCT00124462|18375392|P2|Overall Study|Withdrawal by Subject|5
5338581|NCT00124462|18375393|P1|Overall Study|Withdrawal by Subject|4
5338582|NCT00124462|18375392|P2|Overall Study|Physician Decision|4
5338583|NCT00124462|18375393|P1|Overall Study|Physician Decision|3
5338584|NCT00124462|18375392|P2|Overall Study|Lost to Follow-up|3
5338585|NCT00124462|18375393|P1|Overall Study|Lost to Follow-up|3
5338586|NCT00124449|18375403|P2|18-Month Untreated Observation Period|Relocated|0
5338587|NCT00124449|18375404|P1|18-Month Untreated Observation Period|Relocated|1
5338588|NCT00124449|18375403|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
5338589|NCT00124449|18375404|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
5338590|NCT00124449|18375403|P2|18-Month Untreated Observation Period|Pregnancy|0
5338591|NCT00124449|18375404|P1|18-Month Untreated Observation Period|Pregnancy|1
5338592|NCT00124449|18375403|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
5338593|NCT00124449|18375404|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
5338594|NCT00124449|18375403|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
5338595|NCT00124449|18375404|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
5338596|NCT00124449|18375403|P2|18-Month Untreated Observation Period|Adverse Event|1
5338597|NCT00124449|18375404|P1|18-Month Untreated Observation Period|Adverse Event|0
5338598|NCT00124449|18375403|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
5338599|NCT00124449|18375404|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
5338600|NCT00124449|18375403|P2|6-month Double-Blind Treatment Period|Sponsor request|1
5338601|NCT00124449|18375404|P1|6-month Double-Blind Treatment Period|Sponsor request|0
5338602|NCT00124449|18375403|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
5338603|NCT00124449|18375404|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
5338604|NCT00124449|18375403|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
5338605|NCT00124449|18375404|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
5338606|NCT00124449|18375403|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
5338607|NCT00124449|18375404|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
5338608|NCT00124449|18375403|P2|6-month Double-Blind Treatment Period|Adverse Event|0
5338609|NCT00124449|18375404|P1|6-month Double-Blind Treatment Period|Adverse Event|1
5338610|NCT00124072|18375458|P4|Overall Study|Death|480
5338611|NCT00124072|18375459|P3|Overall Study|Death|471
5338612|NCT00124072|18375460|P2|Overall Study|Death|484
5338613|NCT00124072|18375461|P1|Overall Study|Death|499
5338614|NCT00124072|18375458|P4|Overall Study|Lost to Follow-up for Morbidity|18
5338615|NCT00124072|18375459|P3|Overall Study|Lost to Follow-up for Morbidity|19
5338616|NCT00124072|18375460|P2|Overall Study|Lost to Follow-up for Morbidity|25
5338617|NCT00124072|18375461|P1|Overall Study|Lost to Follow-up for Morbidity|15
5338618|NCT00124072|18375458|P4|Overall Study|Lost to Follow-up for Mortality|2
5338619|NCT00124072|18375459|P3|Overall Study|Lost to Follow-up for Mortality|2
5338620|NCT00124072|18375460|P2|Overall Study|Lost to Follow-up for Mortality|3
5338621|NCT00124072|18375461|P1|Overall Study|Lost to Follow-up for Mortality|0
5338622|NCT00124020|18375473|P2|Overall Study|Transfer to another hospital|0
5338623|NCT00124020|18375474|P1|Overall Study|Transfer to another hospital|2
5338624|NCT00124020|18375473|P2|Overall Study|Other|1
5338625|NCT00124020|18375474|P1|Overall Study|Other|1
5338626|NCT00124020|18375473|P2|Overall Study|Lost to Follow-up|8
5338627|NCT00124020|18375474|P1|Overall Study|Lost to Follow-up|5
5338628|NCT00124020|18375473|P2|Overall Study|Withdrawal by Subject|11
5338629|NCT00124020|18375474|P1|Overall Study|Withdrawal by Subject|13
5338630|NCT00124020|18375473|P2|Overall Study|Death|71
5338631|NCT00124020|18375474|P1|Overall Study|Death|67
5338632|NCT00123955|18375482|P2|Overall Study|Death|1
5338633|NCT00123955|18375483|P1|Overall Study|Death|0
5338634|NCT00123955|18375482|P2|Overall Study|Withdrawal by Subject|3
5338635|NCT00123955|18375483|P1|Overall Study|Withdrawal by Subject|4
5338636|NCT00123955|18375482|P2|Overall Study|Adverse Event|0
5338637|NCT00123955|18375483|P1|Overall Study|Adverse Event|1
5338638|NCT00123734|18375495|P1|Overall Study|Withdrawal by Subject|1
5338639|NCT00123734|18375495|P1|Overall Study|Dropout|1
5338640|NCT00123734|18375495|P1|Overall Study|Lost to Follow-up|3
5338641|NCT00123734|18375495|P1|Overall Study|Death|3
5338642|NCT00123487|18375580|P2|Treated With Study Drug|Unknown (case report form lost)|1
5338643|NCT00123487|18375581|P1|Treated With Study Drug|Unknown (case report form lost)|0
5338644|NCT00123487|18375580|P2|Treated With Study Drug|Withdrawal by Subject|13
5338645|NCT00123487|18375581|P1|Treated With Study Drug|Withdrawal by Subject|11
5338646|NCT00123487|18375580|P2|Treated With Study Drug|Study Drug Toxicity|80
5338647|NCT00123487|18375581|P1|Treated With Study Drug|Study Drug Toxicity|62
5338648|NCT00123487|18375580|P2|Treated With Study Drug|Other|58
5338649|NCT00123487|18375581|P1|Treated With Study Drug|Other|59
5338650|NCT00123487|18375580|P2|Treated With Study Drug|Physician Decision|9
5338651|NCT00123487|18375581|P1|Treated With Study Drug|Physician Decision|8
5338652|NCT00123487|18375580|P2|Treated With Study Drug|Disease Progression|122
5338653|NCT00123487|18375581|P1|Treated With Study Drug|Disease Progression|141
5338654|NCT00123487|18375580|P2|Treated With Study Drug|Adverse Event|22
5338655|NCT00123487|18375581|P1|Treated With Study Drug|Adverse Event|23
5338656|NCT00123487|18375580|P2|Randomized|SAE prior to starting treatment|0
5338657|NCT00123487|18375581|P1|Randomized|SAE prior to starting treatment|1
5338658|NCT00123487|18375580|P2|Randomized|Death prior to starting treatment|1
5338659|NCT00123487|18375581|P1|Randomized|Death prior to starting treatment|0
5338660|NCT00123474|18375625|P4|As Treated at Study Closure|Withdrawal by Subject|16
5338661|NCT00123474|18375626|P3|As Treated at Study Closure|Withdrawal by Subject|18
5338662|NCT00123474|18375627|P2|As Treated at Study Closure|Withdrawal by Subject|19
5338663|NCT00123474|18375628|P1|As Treated at Study Closure|Withdrawal by Subject|14
5338664|NCT00123474|18375625|P4|As Treated at Study Closure|Study Drug Toxicity|51
5338665|NCT00123474|18375626|P3|As Treated at Study Closure|Study Drug Toxicity|45
5338666|NCT00123474|18375627|P2|As Treated at Study Closure|Study Drug Toxicity|45
5338667|NCT00123474|18375628|P1|As Treated at Study Closure|Study Drug Toxicity|39
5338668|NCT00123474|18375625|P4|As Treated at Study Closure|non-specified|60
5338669|NCT00123474|18375626|P3|As Treated at Study Closure|non-specified|57
5338670|NCT00123474|18375627|P2|As Treated at Study Closure|non-specified|47
5338671|NCT00123474|18375628|P1|As Treated at Study Closure|non-specified|54
5338672|NCT00123474|18375625|P4|As Treated at Study Closure|Investigator Request|5
5338673|NCT00123474|18375626|P3|As Treated at Study Closure|Investigator Request|7
5338674|NCT00123474|18375627|P2|As Treated at Study Closure|Investigator Request|6
5338675|NCT00123474|18375628|P1|As Treated at Study Closure|Investigator Request|12
5338676|NCT00123474|18375625|P4|As Treated at Study Closure|Disease Progression|27
5338677|NCT00123474|18375626|P3|As Treated at Study Closure|Disease Progression|29
5338678|NCT00123474|18375627|P2|As Treated at Study Closure|Disease Progression|42
5338679|NCT00123474|18375628|P1|As Treated at Study Closure|Disease Progression|35
5338680|NCT00123474|18375625|P4|As Treated at Study Closure|Adverse Event|8
5338681|NCT00123474|18375626|P3|As Treated at Study Closure|Adverse Event|10
5338682|NCT00123474|18375627|P2|As Treated at Study Closure|Adverse Event|4
5338683|NCT00123474|18375628|P1|As Treated at Study Closure|Adverse Event|10
5338684|NCT00123474|18375625|P4|As Treated at Study Closure|not reported when site closed|0
5338685|NCT00123474|18375626|P3|As Treated at Study Closure|not reported when site closed|1
5338686|NCT00123474|18375627|P2|As Treated at Study Closure|not reported when site closed|0
5338687|NCT00123474|18375628|P1|As Treated at Study Closure|not reported when site closed|1
5338688|NCT00123474|18375625|P4|Randomized to Treatment|Randomized, never treated|1
5338689|NCT00123474|18375626|P3|Randomized to Treatment|Randomized, never treated|2
5338690|NCT00123474|18375627|P2|Randomized to Treatment|Randomized, never treated|4
5338691|NCT00123474|18375628|P1|Randomized to Treatment|Randomized, never treated|1
5338692|NCT00123422|18375722|P3|Overall Study|Lost to Follow-up|2
5338693|NCT00123422|18375723|P2|Overall Study|Lost to Follow-up|2
5338694|NCT00123422|18375724|P1|Overall Study|Lost to Follow-up|1
5338695|NCT00123422|18375722|P3|Overall Study|Withdrawal by Subject|2
5338696|NCT00123422|18375723|P2|Overall Study|Withdrawal by Subject|2
5338697|NCT00123422|18375724|P1|Overall Study|Withdrawal by Subject|1
5338698|NCT00123422|18375722|P3|Overall Study|Physician Decision|6
5338699|NCT00123422|18375723|P2|Overall Study|Physician Decision|2
5338700|NCT00123422|18375724|P1|Overall Study|Physician Decision|2
5338701|NCT00122980|18375812|P2|Overall Study|Study termination|35
5338702|NCT00122980|18375813|P1|Overall Study|Study termination|27
5338703|NCT00122980|18375812|P2|Overall Study|Adjudicated stroke (study endpoint)|0
5338704|NCT00122980|18375813|P1|Overall Study|Adjudicated stroke (study endpoint)|7
5338705|NCT00122980|18375812|P2|Overall Study|Withdrawal by Subject|3
5338706|NCT00122980|18375813|P1|Overall Study|Withdrawal by Subject|2
5338707|NCT00122980|18375812|P2|Overall Study|Protocol Violation|1
5338708|NCT00122980|18375813|P1|Overall Study|Protocol Violation|5
5338709|NCT00122980|18375812|P2|Overall Study|Physician Decision|0
5338710|NCT00122980|18375813|P1|Overall Study|Physician Decision|2
5338711|NCT00122980|18375812|P2|Overall Study|Death|1
5338712|NCT00122980|18375813|P1|Overall Study|Death|0
5338713|NCT00122954|18375837|P2|Overall Study|Protocol Violation|1
5338714|NCT00122954|18375838|P1|Overall Study|Protocol Violation|0
5338715|NCT00122954|18375837|P2|Overall Study|Withdrawal by Subject|2
5338716|NCT00122954|18375838|P1|Overall Study|Withdrawal by Subject|2
5338717|NCT00122681|18375848|P2|Overall Study|Personal reasons|147
5338718|NCT00122681|18375849|P1|Overall Study|Personal reasons|150
5338719|NCT00122681|18375848|P2|Overall Study|Withdrawal by Subject|251
5338720|NCT00122681|18375849|P1|Overall Study|Withdrawal by Subject|257
5338721|NCT00122681|18375848|P2|Overall Study|Protocol Violation|10
5338722|NCT00122681|18375849|P1|Overall Study|Protocol Violation|7
5338723|NCT00122681|18375848|P2|Overall Study|Lost to Follow-up|1097
5338724|NCT00122681|18375849|P1|Overall Study|Lost to Follow-up|1080
5338725|NCT00122681|18375848|P2|Overall Study|Adverse Event|16
5338726|NCT00122681|18375849|P1|Overall Study|Adverse Event|20
5338727|NCT00122460|18375923|P2|Overall Study|investigational study phase ongoing|1
5338728|NCT00122460|18375924|P1|Overall Study|investigational study phase ongoing|7
5338729|NCT00122382|18375973|P3|Open-Label Study|Withdrawal of Consent|4
5338730|NCT00122382|18375974|P2|Open-Label Study|Withdrawal of Consent|0
5338731|NCT00122382|18375975|P1|Open-Label Study|Withdrawal of Consent|0
5338732|NCT00122382|18375973|P3|Open-Label Study|Poor/Non-Compliance|1
5338733|NCT00122382|18375974|P2|Open-Label Study|Poor/Non-Compliance|0
5338734|NCT00122382|18375975|P1|Open-Label Study|Poor/Non-Compliance|0
5338735|NCT00122382|18375973|P3|Open-Label Study|Pregnancy|2
5338736|NCT00122382|18375974|P2|Open-Label Study|Pregnancy|0
5338737|NCT00122382|18375975|P1|Open-Label Study|Pregnancy|0
5338738|NCT00122382|18375973|P3|Open-Label Study|Lost to Follow-up|3
5338739|NCT00122382|18375974|P2|Open-Label Study|Lost to Follow-up|0
5338740|NCT00122382|18375975|P1|Open-Label Study|Lost to Follow-up|0
5338741|NCT00122382|18375973|P3|Open-Label Study|Lack of Efficacy|3
5338742|NCT00122382|18375974|P2|Open-Label Study|Lack of Efficacy|0
5338743|NCT00122382|18375975|P1|Open-Label Study|Lack of Efficacy|0
5338744|NCT00122382|18375973|P3|Open-Label Study|Death|2
5338745|NCT00122382|18375974|P2|Open-Label Study|Death|0
5338746|NCT00122382|18375975|P1|Open-Label Study|Death|0
5338747|NCT00122382|18375973|P3|Open-Label Study|Adverse Event|11
5338748|NCT00122382|18375974|P2|Open-Label Study|Adverse Event|0
5338749|NCT00122382|18375975|P1|Open-Label Study|Adverse Event|0
5338750|NCT00122382|18375973|P3|Double-Blind Study|Randomized but not treated|0
5338751|NCT00122382|18375974|P2|Double-Blind Study|Randomized but not treated|2
5338752|NCT00122382|18375975|P1|Double-Blind Study|Randomized but not treated|0
5338753|NCT00122382|18375973|P3|Double-Blind Study|Methotrexate Discontinued|0
5338754|NCT00122382|18375974|P2|Double-Blind Study|Methotrexate Discontinued|1
5338755|NCT00122382|18375975|P1|Double-Blind Study|Methotrexate Discontinued|0
5338756|NCT00122382|18375973|P3|Double-Blind Study|Protocol Violation|0
5338757|NCT00122382|18375974|P2|Double-Blind Study|Protocol Violation|0
5338758|NCT00122382|18375975|P1|Double-Blind Study|Protocol Violation|1
5338759|NCT00122382|18375973|P3|Double-Blind Study|Withdrawal of Consent|0
5338760|NCT00122382|18375974|P2|Double-Blind Study|Withdrawal of Consent|3
5338761|NCT00122382|18375975|P1|Double-Blind Study|Withdrawal of Consent|7
5338762|NCT00122382|18375973|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
5338763|NCT00122382|18375974|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
5338764|NCT00122382|18375975|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
5338765|NCT00122382|18375973|P3|Double-Blind Study|Pregnancy|0
5338766|NCT00122382|18375974|P2|Double-Blind Study|Pregnancy|0
5338767|NCT00122382|18375975|P1|Double-Blind Study|Pregnancy|2
5338768|NCT00122382|18375973|P3|Double-Blind Study|Lost to Follow-up|0
5338769|NCT00122382|18375974|P2|Double-Blind Study|Lost to Follow-up|1
5338770|NCT00122382|18375975|P1|Double-Blind Study|Lost to Follow-up|2
5338771|NCT00122382|18375973|P3|Double-Blind Study|Lack of Efficacy|0
5338772|NCT00122382|18375974|P2|Double-Blind Study|Lack of Efficacy|8
5338773|NCT00122382|18375975|P1|Double-Blind Study|Lack of Efficacy|0
5338774|NCT00122382|18375973|P3|Double-Blind Study|Death|0
5338775|NCT00122382|18375974|P2|Double-Blind Study|Death|2
5338776|NCT00122382|18375975|P1|Double-Blind Study|Death|2
5338777|NCT00122382|18375973|P3|Double-Blind Study|Adverse Event|0
5338778|NCT00122382|18375974|P2|Double-Blind Study|Adverse Event|11
5338779|NCT00122382|18375975|P1|Double-Blind Study|Adverse Event|9
5338780|NCT00122317|18376119|P1|Overall Study|Withdrawal by Subject|1
5338781|NCT00122317|18376119|P1|Overall Study|patient non-compliance|1
5338782|NCT00122317|18376119|P1|Overall Study|Physician Decision|2
5338783|NCT00122317|18376119|P1|Overall Study|Adverse Event|4
5338784|NCT00122317|18376119|P1|Overall Study|Death|3
5338785|NCT00122278|18376128|P2|Overall Study|Lost to Follow-up|0
5338786|NCT00122278|18376129|P1|Overall Study|Lost to Follow-up|2
5338787|NCT00122187|18376139|P2|Overall Study|Withdrew because of resource limitations|2
5338788|NCT00122187|18376140|P1|Overall Study|Withdrew because of resource limitations|2
5338789|NCT00122135|18376154|P2|Overall Study|Withdrawal by Subject|0
5338790|NCT00122135|18376155|P1|Overall Study|Withdrawal by Subject|3
5338791|NCT00122109|18376163|P2|Overall Study|Did not meet criteria|7
5338792|NCT00122109|18376164|P1|Overall Study|Did not meet criteria|6
5338793|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Death|2
5338794|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Death|0
5338795|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Death|0
5338796|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Death|1
5338797|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
5338798|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
5338799|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
5338800|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
5338801|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
5338802|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
5338803|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
5338804|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
5338805|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
5338806|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
5338807|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
5338808|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
5338809|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
5338810|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
5338811|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
5338812|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
5338813|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
5338814|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
5338815|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
5338816|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
5338817|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
5338818|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
5338819|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
5338820|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
5338821|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
5338822|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
5338823|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
5338824|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
5338825|NCT00121667|18376430|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
5338826|NCT00121667|18376431|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
5338827|NCT00121667|18376432|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
5338828|NCT00121667|18376433|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
5338829|NCT00121667|18376430|P4|Short Term (ST) Period|Pregnancy|1
5338830|NCT00121667|18376431|P3|Short Term (ST) Period|Pregnancy|0
5338831|NCT00121667|18376432|P2|Short Term (ST) Period|Pregnancy|0
5338832|NCT00121667|18376433|P1|Short Term (ST) Period|Pregnancy|0
5338833|NCT00121667|18376430|P4|Short Term (ST) Period|Death|1
5338834|NCT00121667|18376431|P3|Short Term (ST) Period|Death|0
5338835|NCT00121667|18376432|P2|Short Term (ST) Period|Death|0
5338836|NCT00121667|18376433|P1|Short Term (ST) Period|Death|0
5338837|NCT00121667|18376430|P4|Short Term (ST) Period|Other Reason|0
5338838|NCT00121667|18376431|P3|Short Term (ST) Period|Other Reason|0
5338839|NCT00121667|18376432|P2|Short Term (ST) Period|Other Reason|0
5338840|NCT00121667|18376433|P1|Short Term (ST) Period|Other Reason|3
5338841|NCT00121667|18376430|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
5338842|NCT00121667|18376431|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
5338843|NCT00121667|18376432|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
5338844|NCT00121667|18376433|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
5338845|NCT00121667|18376430|P4|Short Term (ST) Period|Poor / Non-compliance|2
5338846|NCT00121667|18376431|P3|Short Term (ST) Period|Poor / Non-compliance|1
5338847|NCT00121667|18376432|P2|Short Term (ST) Period|Poor / Non-compliance|1
5338848|NCT00121667|18376433|P1|Short Term (ST) Period|Poor / Non-compliance|0
5338849|NCT00121667|18376430|P4|Short Term (ST) Period|Lost to Follow-up|3
5338850|NCT00121667|18376431|P3|Short Term (ST) Period|Lost to Follow-up|4
5338851|NCT00121667|18376432|P2|Short Term (ST) Period|Lost to Follow-up|4
5338852|NCT00121667|18376433|P1|Short Term (ST) Period|Lost to Follow-up|3
5338853|NCT00121667|18376430|P4|Short Term (ST) Period|Adverse Event|3
5338854|NCT00121667|18376431|P3|Short Term (ST) Period|Adverse Event|5
5338855|NCT00121667|18376432|P2|Short Term (ST) Period|Adverse Event|6
5338856|NCT00121667|18376433|P1|Short Term (ST) Period|Adverse Event|5
5338857|NCT00121667|18376430|P4|Short Term (ST) Period|Subject Withdrew Consent|11
5338858|NCT00121667|18376431|P3|Short Term (ST) Period|Subject Withdrew Consent|4
5338859|NCT00121667|18376432|P2|Short Term (ST) Period|Subject Withdrew Consent|13
5338860|NCT00121667|18376433|P1|Short Term (ST) Period|Subject Withdrew Consent|8
5338861|NCT00121667|18376430|P4|Short Term (ST) Period|Lack of Efficacy|44
5338862|NCT00121667|18376431|P3|Short Term (ST) Period|Lack of Efficacy|27
5338863|NCT00121667|18376432|P2|Short Term (ST) Period|Lack of Efficacy|22
5338864|NCT00121667|18376433|P1|Short Term (ST) Period|Lack of Efficacy|25
5338865|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Other Reason|1
5338866|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Other Reason|0
5338867|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Other Reason|2
5338868|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Other Reason|3
5338869|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Other Reason|5
5338870|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Missing|0
5338871|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Missing|0
5338872|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Missing|1
5338873|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Missing|0
5338874|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Missing|0
5338875|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Death|0
5338876|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Death|1
5338877|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Death|0
5338878|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Death|0
5338879|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Death|0
5338880|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
5338881|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
5338882|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
5338883|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
5338884|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
5338885|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Pregnancy|0
5338886|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Pregnancy|1
5338887|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Pregnancy|0
5338888|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Pregnancy|1
5338889|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Pregnancy|0
5338890|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
5338891|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
5338892|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
5338893|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
5338894|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
5338895|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
5338896|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
5338897|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
5338898|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
5338899|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
5338900|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
5338901|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
5338902|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
5338903|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
5338904|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
5338905|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Adverse Event|5
5338906|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Adverse Event|5
5338907|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Adverse Event|10
5338908|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Adverse Event|10
5338909|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Adverse Event|9
5338910|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
5338911|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
5338912|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
5338991|NCT00120874|18376769|P2|Overall Study|Death|1
5338913|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
5338914|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
5338915|NCT00121641|18376531|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
5338916|NCT00121641|18376532|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
5338917|NCT00121641|18376533|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
5338918|NCT00121641|18376534|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
5338919|NCT00121641|18376535|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
5338920|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Other Reason|0
5338921|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Other Reason|0
5338922|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Other Reason|0
5338923|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Other Reason|0
5338924|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Other Reason|1
5338925|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
5338926|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
5338927|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
5338928|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
5338929|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
5338930|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
5338931|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
5338932|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
5338933|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
5338934|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
5338935|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
5338936|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
5338937|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
5338938|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
5338939|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
5338940|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Adverse Event|2
5338941|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Adverse Event|0
5338942|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Adverse Event|4
5338943|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Adverse Event|3
5338944|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Adverse Event|3
5338945|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
5338946|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
5338947|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
5338948|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
5338949|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
5338950|NCT00121641|18376531|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
5338951|NCT00121641|18376532|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
5338952|NCT00121641|18376533|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
5338953|NCT00121641|18376534|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
5338954|NCT00121641|18376535|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
5338955|NCT00121485|18376648|P2|Overall Study|Crossover|2
5338956|NCT00121485|18376649|P1|Overall Study|Crossover|0
5338957|NCT00121485|18376648|P2|Overall Study|Not implanted|5
5338958|NCT00121485|18376649|P1|Overall Study|Not implanted|1
5338959|NCT00121238|18376694|P1|Overall Study|Protocol Violation|2
5338960|NCT00121238|18376694|P1|Overall Study|disease progression before intervention|1
5338961|NCT00121199|18376710|P1|Overall Study|Ineligible|9
5338962|NCT00121199|18376710|P1|Overall Study|Other - Not Protocol Specified|3
5338963|NCT00121199|18376710|P1|Overall Study|Death|3
5338964|NCT00121199|18376710|P1|Overall Study|Progression/Relapse|1
5338965|NCT00121199|18376710|P1|Overall Study|Refusal Unrelated to Adverse Event|1
5338966|NCT00121199|18376710|P1|Overall Study|Adverse Event|11
5338967|NCT00121134|18376754|P4|Overall Study|Patient Personal Reasons|0
5338968|NCT00121134|18376755|P3|Overall Study|Patient Personal Reasons|0
5338969|NCT00121134|18376756|P2|Overall Study|Patient Personal Reasons|1
5338970|NCT00121134|18376757|P1|Overall Study|Patient Personal Reasons|0
5338971|NCT00121134|18376754|P4|Overall Study|Intercurrent Illness|1
5338972|NCT00121134|18376755|P3|Overall Study|Intercurrent Illness|0
5338973|NCT00121134|18376756|P2|Overall Study|Intercurrent Illness|0
5338974|NCT00121134|18376757|P1|Overall Study|Intercurrent Illness|0
5338975|NCT00121134|18376754|P4|Overall Study|Treatment Delay|0
5338976|NCT00121134|18376755|P3|Overall Study|Treatment Delay|0
5338977|NCT00121134|18376756|P2|Overall Study|Treatment Delay|0
5338978|NCT00121134|18376757|P1|Overall Study|Treatment Delay|1
5338979|NCT00121134|18376754|P4|Overall Study|Physician Decision|1
5338980|NCT00121134|18376755|P3|Overall Study|Physician Decision|4
5338981|NCT00121134|18376756|P2|Overall Study|Physician Decision|4
5338982|NCT00121134|18376757|P1|Overall Study|Physician Decision|6
5338983|NCT00121134|18376754|P4|Overall Study|Toxicity|5
5338984|NCT00121134|18376755|P3|Overall Study|Toxicity|13
5338985|NCT00121134|18376756|P2|Overall Study|Toxicity|7
5338986|NCT00121134|18376757|P1|Overall Study|Toxicity|4
5338987|NCT00121134|18376754|P4|Overall Study|Progression of Disease|2
5338988|NCT00121134|18376755|P3|Overall Study|Progression of Disease|4
5338989|NCT00121134|18376756|P2|Overall Study|Progression of Disease|3
5338990|NCT00121134|18376757|P1|Overall Study|Progression of Disease|5
5338992|NCT00120874|18376770|P1|Overall Study|Death|0
5338993|NCT00120627|18376808|P2|Overall Study|Withdrawal by Subject|5
5338994|NCT00120627|18376809|P1|Overall Study|Withdrawal by Subject|5
5338995|NCT00120406|18376860|P2|Overall Study|patient moved but has not withdrawn|1
5338996|NCT00120406|18376861|P1|Overall Study|patient moved but has not withdrawn|0
5338997|NCT00120406|18376860|P2|Overall Study|received non-study stent|2
5338998|NCT00120406|18376861|P1|Overall Study|received non-study stent|0
5338999|NCT00120406|18376860|P2|Overall Study|Lost to Follow-up|2
5339000|NCT00120406|18376861|P1|Overall Study|Lost to Follow-up|5
5339001|NCT00120406|18376860|P2|Overall Study|Withdrawal by Subject|7
5339002|NCT00120406|18376861|P1|Overall Study|Withdrawal by Subject|5
5339003|NCT00120406|18376860|P2|Overall Study|Death|4
5339004|NCT00120406|18376861|P1|Overall Study|Death|9
5339005|NCT00120289|18376871|P2|Overall Study|Withdrawal by Subject|13
5339006|NCT00120289|18376872|P1|Overall Study|Withdrawal by Subject|14
5339007|NCT00120289|18376871|P2|Overall Study|Lost to Follow-up|14
5339008|NCT00120289|18376872|P1|Overall Study|Lost to Follow-up|11
5339009|NCT00120289|18376871|P2|Overall Study|Death|82
5339010|NCT00120289|18376872|P1|Overall Study|Death|96
5339011|NCT00120250|18376884|P2|Overall Study|Protocol Violation|1
5339012|NCT00120250|18376885|P1|Overall Study|Protocol Violation|0
5339013|NCT00120250|18376884|P2|Overall Study|Lost to Follow-up|1
5339014|NCT00120250|18376885|P1|Overall Study|Lost to Follow-up|1
5339015|NCT00120042|18376901|P3|Overall Study|all completed protocl|0
5339016|NCT00120042|18376902|P2|Overall Study|all completed protocl|0
5339017|NCT00120042|18376903|P1|Overall Study|all completed protocl|0
5339018|NCT00119678|18376926|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
5339019|NCT00119678|18376927|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
5339020|NCT00119678|18376926|P2|Open-label Treatment Period|Pregnancy|0
5339021|NCT00119678|18376927|P1|Open-label Treatment Period|Pregnancy|1
5339022|NCT00119678|18376926|P2|Open-label Treatment Period|Participants not meeting study criteria|0
5339023|NCT00119678|18376927|P1|Open-label Treatment Period|Participants not meeting study criteria|2
5339024|NCT00119678|18376926|P2|Open-label Treatment Period|Participant withdrew consent|0
5339025|NCT00119678|18376927|P1|Open-label Treatment Period|Participant withdrew consent|4
5339026|NCT00119678|18376926|P2|Open-label Treatment Period|Lost to Follow-up|0
5339027|NCT00119678|18376927|P1|Open-label Treatment Period|Lost to Follow-up|3
5339028|NCT00119678|18376926|P2|Open-label Treatment Period|Lack of Efficacy|0
5339029|NCT00119678|18376927|P1|Open-label Treatment Period|Lack of Efficacy|9
5339030|NCT00119678|18376926|P2|Open-label Treatment Period|Adverse Event|0
5339031|NCT00119678|18376927|P1|Open-label Treatment Period|Adverse Event|3
5339032|NCT00119678|18376926|P2|Open-label Treatment Period|Death|0
5339033|NCT00119678|18376927|P1|Open-label Treatment Period|Death|1
5339034|NCT00119678|18376926|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
5339035|NCT00119678|18376927|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
5339036|NCT00119678|18376926|P2|Double-blind Treatment Period|Not treated|2
5339037|NCT00119678|18376927|P1|Double-blind Treatment Period|Not treated|1
5339038|NCT00119678|18376926|P2|Double-blind Treatment Period|Pregnancy|2
5339039|NCT00119678|18376927|P1|Double-blind Treatment Period|Pregnancy|0
5339040|NCT00119678|18376926|P2|Double-blind Treatment Period|Poor/Non-compliance|0
5339041|NCT00119678|18376927|P1|Double-blind Treatment Period|Poor/Non-compliance|3
5339042|NCT00119678|18376926|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
5339043|NCT00119678|18376927|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
5339044|NCT00119678|18376926|P2|Double-blind Treatment Period|Participant withdrew consent|4
5339045|NCT00119678|18376927|P1|Double-blind Treatment Period|Participant withdrew consent|4
5339046|NCT00119678|18376926|P2|Double-blind Treatment Period|Lost to Follow-up|2
5339047|NCT00119678|18376927|P1|Double-blind Treatment Period|Lost to Follow-up|1
5339048|NCT00119678|18376926|P2|Double-blind Treatment Period|Lack of Efficacy|12
5339049|NCT00119678|18376927|P1|Double-blind Treatment Period|Lack of Efficacy|21
5339050|NCT00119678|18376926|P2|Double-blind Treatment Period|Adverse Event|1
5339051|NCT00119678|18376927|P1|Double-blind Treatment Period|Adverse Event|7
5339052|NCT00119678|18376926|P2|Double-blind Treatment Period|Death|0
5339053|NCT00119678|18376927|P1|Double-blind Treatment Period|Death|1
5339054|NCT00119405|18376973|P1|Overall Study|Withdrawal by Subject|1
5339055|NCT00119379|18376987|P2|Overall Study|Adverse Event|1
5339056|NCT00119379|18376988|P1|Overall Study|Adverse Event|4
5339057|NCT00119262|18377006|P2|Overall Study|others|5
5339058|NCT00119262|18377007|P1|Overall Study|others|0
5339059|NCT00119262|18377006|P2|Overall Study|ineligble|2
5339060|NCT00119262|18377007|P1|Overall Study|ineligble|1
5339061|NCT00119262|18377006|P2|Overall Study|other disease|2
5339062|NCT00119262|18377007|P1|Overall Study|other disease|0
5339063|NCT00119262|18377006|P2|Overall Study|Adverse Event|35
5339064|NCT00119262|18377007|P1|Overall Study|Adverse Event|33
5339065|NCT00119262|18377006|P2|Overall Study|Withdrawal by Subject|11
5339066|NCT00119262|18377007|P1|Overall Study|Withdrawal by Subject|12
5339067|NCT00119262|18377006|P2|Overall Study|Lack of Efficacy|3
5339068|NCT00119262|18377007|P1|Overall Study|Lack of Efficacy|0
5339069|NCT00119015|18377044|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
5339070|NCT00119015|18377045|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
5339071|NCT00119015|18377046|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
5339072|NCT00118911|18377062|P2|Overall Study|Withdrawal by Subject|5
5339073|NCT00118911|18377063|P1|Overall Study|Withdrawal by Subject|2
5339074|NCT00118898|18377075|P4|Overall Study|Not able to get to clinic|40
5339075|NCT00118898|18377076|P3|Overall Study|Not able to get to clinic|31
5339076|NCT00118898|18377077|P2|Overall Study|Not able to get to clinic|43
5339077|NCT00118898|18377078|P1|Overall Study|Not able to get to clinic|34
5339078|NCT00118898|18377075|P4|Overall Study|Not compliant with requirements|11
5339079|NCT00118898|18377076|P3|Overall Study|Not compliant with requirements|11
5339080|NCT00118898|18377077|P2|Overall Study|Not compliant with requirements|13
5339081|NCT00118898|18377078|P1|Overall Study|Not compliant with requirements|11
5339082|NCT00118898|18377075|P4|Overall Study|Severe debilitation|4
5339083|NCT00118898|18377076|P3|Overall Study|Severe debilitation|6
5339084|NCT00118898|18377077|P2|Overall Study|Severe debilitation|4
5339085|NCT00118898|18377078|P1|Overall Study|Severe debilitation|1
5339086|NCT00118898|18377075|P4|Overall Study|Site Closure|37
5339087|NCT00118898|18377076|P3|Overall Study|Site Closure|28
5339088|NCT00118898|18377077|P2|Overall Study|Site Closure|31
5339089|NCT00118898|18377078|P1|Overall Study|Site Closure|33
5339090|NCT00118898|18377075|P4|Overall Study|Withdrawal by Subject|8
5339091|NCT00118898|18377076|P3|Overall Study|Withdrawal by Subject|8
5339092|NCT00118898|18377077|P2|Overall Study|Withdrawal by Subject|5
5339093|NCT00118898|18377078|P1|Overall Study|Withdrawal by Subject|10
5339094|NCT00118898|18377075|P4|Overall Study|Lost to Follow-up|33
5339095|NCT00118898|18377076|P3|Overall Study|Lost to Follow-up|33
5339096|NCT00118898|18377077|P2|Overall Study|Lost to Follow-up|34
5339097|NCT00118898|18377078|P1|Overall Study|Lost to Follow-up|26
5339098|NCT00118898|18377075|P4|Overall Study|Death|8
5339099|NCT00118898|18377076|P3|Overall Study|Death|6
5339100|NCT00118898|18377077|P2|Overall Study|Death|11
5339101|NCT00118898|18377078|P1|Overall Study|Death|6
5339102|NCT00118716|18377204|P2|Overall Study|Investigator discretion|1
5339103|NCT00118716|18377205|P1|Overall Study|Investigator discretion|0
5339104|NCT00118716|18377204|P2|Overall Study|Expired drug use|2
5339105|NCT00118716|18377205|P1|Overall Study|Expired drug use|1
5339106|NCT00118716|18377204|P2|Overall Study|misrandomized|1
5339107|NCT00118716|18377205|P1|Overall Study|misrandomized|1
5339108|NCT00118716|18377204|P2|Overall Study|Non-compliance|3
5339109|NCT00118716|18377205|P1|Overall Study|Non-compliance|1
5339110|NCT00118716|18377204|P2|Overall Study|Discontinued by sponsor|1
5339111|NCT00118716|18377205|P1|Overall Study|Discontinued by sponsor|1
5339112|NCT00118716|18377204|P2|Overall Study|Exacerbation|2
5339113|NCT00118716|18377205|P1|Overall Study|Exacerbation|2
5339114|NCT00118716|18377204|P2|Overall Study|Withdrawal by Subject|1
5339115|NCT00118716|18377205|P1|Overall Study|Withdrawal by Subject|0
5339116|NCT00118716|18377204|P2|Overall Study|Protocol Violation|4
5339117|NCT00118716|18377205|P1|Overall Study|Protocol Violation|5
5339118|NCT00118716|18377204|P2|Overall Study|Adverse Event|7
5339119|NCT00118716|18377205|P1|Overall Study|Adverse Event|2
5339120|NCT00118703|18377225|P2|Overall Study|Lost to Follow-up|2
5339121|NCT00118703|18377226|P1|Overall Study|Lost to Follow-up|1
5339122|NCT00118703|18377225|P2|Overall Study|Withdrawal by Subject|5
5339123|NCT00118703|18377226|P1|Overall Study|Withdrawal by Subject|2
5339124|NCT00118703|18377225|P2|Overall Study|Participant took two different treatment|1
5339125|NCT00118703|18377226|P1|Overall Study|Participant took two different treatment|0
5339126|NCT00118703|18377225|P2|Overall Study|Adverse Event|1
5339127|NCT00118703|18377226|P1|Overall Study|Adverse Event|1
5339128|NCT00118703|18377225|P2|Overall Study|Protocol Violation|0
5339129|NCT00118703|18377226|P1|Overall Study|Protocol Violation|1
5339130|NCT00118482|18377323|P2|Overall Study|Withdrawal by Subject|22
5339131|NCT00118482|18377324|P1|Overall Study|Withdrawal by Subject|23
5339132|NCT00118482|18377323|P2|Overall Study|Lost to Follow-up|7
5339133|NCT00118482|18377324|P1|Overall Study|Lost to Follow-up|7
5339134|NCT00118430|18377339|P3|Overall Study|Lost to Follow-up|28
5339135|NCT00118430|18377340|P2|Overall Study|Lost to Follow-up|22
5339136|NCT00118430|18377341|P1|Overall Study|Lost to Follow-up|15
5339137|NCT00118430|18377339|P3|Overall Study|Withdrawal by Subject|0
5339138|NCT00118430|18377340|P2|Overall Study|Withdrawal by Subject|2
5339139|NCT00118430|18377341|P1|Overall Study|Withdrawal by Subject|6
5339140|NCT00118417|18377356|P2|Phase II (Weeks 6 to 12)|Remission|2
5339141|NCT00118417|18377357|P1|Phase II (Weeks 6 to 12)|Remission|1
5339142|NCT00118417|18377356|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
5339143|NCT00118417|18377357|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
5339144|NCT00118417|18377356|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
5339145|NCT00118417|18377357|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
5339146|NCT00118417|18377356|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
5339147|NCT00118417|18377357|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
5339148|NCT00118417|18377356|P2|Phase I (Weeks 0 to 6)|Remission|0
5339149|NCT00118417|18377357|P1|Phase I (Weeks 0 to 6)|Remission|8
5339150|NCT00118287|18377501|P1|Overall Study|Muscle pain|1
5339151|NCT00118287|18377501|P1|Overall Study|Intracranial haemorrhage|1
5339152|NCT00118157|18377534|P1|Overall Study|Withdrawal by Subject|2
5339153|NCT00118157|18377534|P1|Overall Study|Death|8
5339154|NCT00118157|18377534|P1|Overall Study|Adverse Event|2
5339155|NCT00118092|18377552|P1|Overall Study|Protocol Violation|1
5339156|NCT00118092|18377552|P1|Overall Study|Withdrawal by Subject|1
5339157|NCT00118040|18377570|P3|Overall Study|Other|1
5339158|NCT00118040|18377571|P2|Overall Study|Other|0
5339159|NCT00118040|18377572|P1|Overall Study|Other|0
5339160|NCT00118040|18377570|P3|Overall Study|Non-Compliant Participant|2
5339161|NCT00118040|18377571|P2|Overall Study|Non-Compliant Participant|1
5339162|NCT00118040|18377572|P1|Overall Study|Non-Compliant Participant|1
5339163|NCT00118040|18377570|P3|Overall Study|Medical Contraindication|1
5339164|NCT00118040|18377571|P2|Overall Study|Medical Contraindication|0
5339165|NCT00118040|18377572|P1|Overall Study|Medical Contraindication|0
5339166|NCT00118040|18377570|P3|Overall Study|Withdrawal by Subject|2
5339167|NCT00118040|18377571|P2|Overall Study|Withdrawal by Subject|0
5339168|NCT00118040|18377572|P1|Overall Study|Withdrawal by Subject|0
5339169|NCT00118040|18377570|P3|Overall Study|Adverse Event|0
5339170|NCT00118040|18377571|P2|Overall Study|Adverse Event|1
5339171|NCT00118040|18377572|P1|Overall Study|Adverse Event|0
5339172|NCT00117988|18377633|P1|Overall Study|Adverse Event|1
5339173|NCT00117988|18377633|P1|Overall Study|Death|3
5339174|NCT00117949|18377656|P4|Overall Study|Hepatic abnormalities|1
5339175|NCT00117949|18377657|P3|Overall Study|Hepatic abnormalities|0
5339176|NCT00117949|18377658|P2|Overall Study|Hepatic abnormalities|1
5339177|NCT00117949|18377659|P1|Overall Study|Hepatic abnormalities|0
5339178|NCT00117949|18377656|P4|Overall Study|PSA reduction <=50%|4
5339179|NCT00117949|18377657|P3|Overall Study|PSA reduction <=50%|2
5339180|NCT00117949|18377658|P2|Overall Study|PSA reduction <=50%|2
5339181|NCT00117949|18377659|P1|Overall Study|PSA reduction <=50%|0
5339182|NCT00117949|18377656|P4|Overall Study|PSA increase >=10ng/mL|0
5339183|NCT00117949|18377657|P3|Overall Study|PSA increase >=10ng/mL|1
5339184|NCT00117949|18377658|P2|Overall Study|PSA increase >=10ng/mL|1
5339185|NCT00117949|18377659|P1|Overall Study|PSA increase >=10ng/mL|0
5339186|NCT00117949|18377656|P4|Overall Study|Prostate-specific antigen increase >=25%|2
5339187|NCT00117949|18377657|P3|Overall Study|Prostate-specific antigen increase >=25%|1
5339188|NCT00117949|18377658|P2|Overall Study|Prostate-specific antigen increase >=25%|1
5339189|NCT00117949|18377659|P1|Overall Study|Prostate-specific antigen increase >=25%|0
5339190|NCT00117949|18377656|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
5339191|NCT00117949|18377657|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
5339192|NCT00117949|18377658|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
5339193|NCT00117949|18377659|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
5339194|NCT00117949|18377656|P4|Overall Study|Testosterone >1.0 ng/mL|15
5339195|NCT00117949|18377657|P3|Overall Study|Testosterone >1.0 ng/mL|17
5339196|NCT00117949|18377658|P2|Overall Study|Testosterone >1.0 ng/mL|18
5339197|NCT00117949|18377659|P1|Overall Study|Testosterone >1.0 ng/mL|10
5339198|NCT00117845|18377693|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
5339199|NCT00117793|18377711|P1|Overall Study|Withdrawal by Subject|12
5339200|NCT00117676|18377734|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
5339201|NCT00117676|18377735|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
5339202|NCT00117676|18377734|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
5339203|NCT00117676|18377735|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
5339204|NCT00117676|18377734|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
5339205|NCT00117676|18377735|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
5339206|NCT00117676|18377734|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
5339207|NCT00117676|18377735|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
5339208|NCT00117676|18377734|P2|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
5339209|NCT00117676|18377735|P1|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
5339210|NCT00117676|18377734|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
5339211|NCT00117676|18377735|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
5339212|NCT00117676|18377734|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
5339213|NCT00117676|18377735|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
5339214|NCT00117676|18377734|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
5339215|NCT00117676|18377735|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
5339216|NCT00117676|18377734|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
5339217|NCT00117676|18377735|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
5339218|NCT00117676|18377734|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
5339219|NCT00117676|18377735|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
5339220|NCT00117676|18377734|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
5339221|NCT00117676|18377735|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
5339222|NCT00117676|18377734|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
5339223|NCT00117676|18377735|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
5339224|NCT00117676|18377734|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
5339225|NCT00117676|18377735|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
5339226|NCT00117676|18377734|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
5339227|NCT00117676|18377735|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
5339228|NCT00117676|18377734|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
5339229|NCT00117676|18377735|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
5339230|NCT00117676|18377734|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
5339231|NCT00117676|18377735|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
5339232|NCT00117676|18377734|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
5339233|NCT00117676|18377735|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
5339234|NCT00117676|18377734|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
5339235|NCT00117676|18377735|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
5339236|NCT00117676|18377734|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
5339237|NCT00117676|18377735|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
5339238|NCT00117676|18377734|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
5339239|NCT00117676|18377735|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
5339240|NCT00117676|18377734|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
5339241|NCT00117676|18377735|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
5339242|NCT00117676|18377734|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
5339243|NCT00117676|18377735|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
5339244|NCT00117676|18377734|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
5339245|NCT00117676|18377735|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
5339246|NCT00117676|18377734|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
5339247|NCT00117676|18377735|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
5339248|NCT00117676|18377734|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
5339249|NCT00117676|18377735|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
5339250|NCT00117676|18377734|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
5339251|NCT00117676|18377735|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
5339252|NCT00117676|18377734|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
5339253|NCT00117676|18377735|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
5339254|NCT00117676|18377734|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
5339255|NCT00117676|18377735|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
5339256|NCT00117676|18377734|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
5339257|NCT00117676|18377735|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
5339258|NCT00117676|18377734|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
5339259|NCT00117676|18377735|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
5339260|NCT00117676|18377734|P2|Double-blind Period Through Week 48|Withdrew Consent|1
5339261|NCT00117676|18377735|P1|Double-blind Period Through Week 48|Withdrew Consent|0
5339262|NCT00117676|18377734|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
5339263|NCT00117676|18377735|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
5339264|NCT00117676|18377734|P2|Double-blind Period Through Week 48|Protocol Violation|1
5339265|NCT00117676|18377735|P1|Double-blind Period Through Week 48|Protocol Violation|0
5339266|NCT00117676|18377734|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
5339267|NCT00117676|18377735|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
5339268|NCT00117676|18377734|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
5339269|NCT00117676|18377735|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
5339270|NCT00117637|18377824|P2|Second Intervention (Period 2)|reason not reported|0
5339271|NCT00117637|18377825|P1|Second Intervention (Period 2)|reason not reported|1
5339272|NCT00117637|18377824|P2|Second Intervention (Period 2)|non compliant with study medication|1
5339273|NCT00117637|18377825|P1|Second Intervention (Period 2)|non compliant with study medication|1
5339274|NCT00117637|18377824|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
5339275|NCT00117637|18377825|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
5339276|NCT00117637|18377824|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
5339277|NCT00117637|18377825|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
5339278|NCT00117637|18377824|P2|Second Intervention (Period 2)|Protocol Violation|0
5339279|NCT00117637|18377825|P1|Second Intervention (Period 2)|Protocol Violation|1
5339280|NCT00117637|18377824|P2|Second Intervention (Period 2)|Lost to Follow-up|0
5339281|NCT00117637|18377825|P1|Second Intervention (Period 2)|Lost to Follow-up|1
5339282|NCT00117637|18377824|P2|Second Intervention (Period 2)|Adverse Event|9
5339283|NCT00117637|18377825|P1|Second Intervention (Period 2)|Adverse Event|0
5339284|NCT00117637|18377824|P2|First Intervention (Period 1)|reason not reported|1
5339285|NCT00117637|18377825|P1|First Intervention (Period 1)|reason not reported|0
5339286|NCT00117637|18377824|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
5339287|NCT00117637|18377825|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
5339288|NCT00117637|18377824|P2|First Intervention (Period 1)|protocol driven decision point|0
5339289|NCT00117637|18377825|P1|First Intervention (Period 1)|protocol driven decision point|1
5339290|NCT00117637|18377824|P2|First Intervention (Period 1)|study terminated by the sponsor|1
5339291|NCT00117637|18377825|P1|First Intervention (Period 1)|study terminated by the sponsor|3
5339292|NCT00117637|18377824|P2|First Intervention (Period 1)|Withdrawal by Subject|4
5339293|NCT00117637|18377825|P1|First Intervention (Period 1)|Withdrawal by Subject|2
5339294|NCT00117637|18377824|P2|First Intervention (Period 1)|Protocol Violation|0
5339295|NCT00117637|18377825|P1|First Intervention (Period 1)|Protocol Violation|1
5339296|NCT00117637|18377824|P2|First Intervention (Period 1)|Lost to Follow-up|2
5339297|NCT00117637|18377825|P1|First Intervention (Period 1)|Lost to Follow-up|0
5339298|NCT00117637|18377824|P2|First Intervention (Period 1)|Adverse Event|16
5339299|NCT00117637|18377825|P1|First Intervention (Period 1)|Adverse Event|11
5339300|NCT00117598|18377900|P5|After Treament Cross Over|Other|2
5339301|NCT00117598|18377901|P4|After Treament Cross Over|Other|1
5339302|NCT00117598|18377902|P3|After Treament Cross Over|Other|0
5339303|NCT00117598|18377903|P2|After Treament Cross Over|Other|0
5339304|NCT00117598|18377904|P1|After Treament Cross Over|Other|0
5339305|NCT00117598|18377900|P5|After Treament Cross Over|Withdrawal by Subject|0
5339306|NCT00117598|18377901|P4|After Treament Cross Over|Withdrawal by Subject|1
5339307|NCT00117598|18377902|P3|After Treament Cross Over|Withdrawal by Subject|0
5339308|NCT00117598|18377903|P2|After Treament Cross Over|Withdrawal by Subject|0
5339309|NCT00117598|18377904|P1|After Treament Cross Over|Withdrawal by Subject|0
5339310|NCT00117598|18377900|P5|After Treament Cross Over|Death|2
5339311|NCT00117598|18377901|P4|After Treament Cross Over|Death|1
5339312|NCT00117598|18377902|P3|After Treament Cross Over|Death|0
5339313|NCT00117598|18377903|P2|After Treament Cross Over|Death|0
5339314|NCT00117598|18377904|P1|After Treament Cross Over|Death|0
5339315|NCT00117598|18377900|P5|Prior to Treatment Cross Over|Other|0
5339316|NCT00117598|18377901|P4|Prior to Treatment Cross Over|Other|0
5339317|NCT00117598|18377902|P3|Prior to Treatment Cross Over|Other|9
5339318|NCT00117598|18377903|P2|Prior to Treatment Cross Over|Other|9
5339319|NCT00117598|18377904|P1|Prior to Treatment Cross Over|Other|15
5339320|NCT00117598|18377900|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
5339321|NCT00117598|18377901|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
5339322|NCT00117598|18377902|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
5339323|NCT00117598|18377903|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
5339324|NCT00117598|18377904|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
5339325|NCT00117598|18377900|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
5339326|NCT00117598|18377901|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
5339327|NCT00117598|18377902|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
5339328|NCT00117598|18377903|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
5339329|NCT00117598|18377904|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
5339330|NCT00117598|18377900|P5|Prior to Treatment Cross Over|Death|0
5339331|NCT00117598|18377901|P4|Prior to Treatment Cross Over|Death|0
5339332|NCT00117598|18377902|P3|Prior to Treatment Cross Over|Death|37
5339333|NCT00117598|18377903|P2|Prior to Treatment Cross Over|Death|41
5339334|NCT00117598|18377904|P1|Prior to Treatment Cross Over|Death|40
5339335|NCT00117572|18377938|P2|Overall Study|Protocol Violation|0
5339336|NCT00117572|18377939|P1|Overall Study|Protocol Violation|1
5339337|NCT00117572|18377938|P2|Overall Study|Withdrawal by Subject|3
5339338|NCT00117572|18377939|P1|Overall Study|Withdrawal by Subject|3
5339339|NCT00117572|18377938|P2|Overall Study|Site withdrew before starting treatment|3
5339340|NCT00117572|18377939|P1|Overall Study|Site withdrew before starting treatment|2
5339341|NCT00117338|18377980|P2|Overall Study|Lack of Efficacy|1
5339342|NCT00117338|18377981|P1|Overall Study|Lack of Efficacy|0
5339343|NCT00117338|18377980|P2|Overall Study|Did not meet Inclusion Criteria|0
5339344|NCT00117338|18377981|P1|Overall Study|Did not meet Inclusion Criteria|1
5339345|NCT00117338|18377980|P2|Overall Study|Withdrawal by Subject|0
5339346|NCT00117338|18377981|P1|Overall Study|Withdrawal by Subject|1
5339347|NCT00117338|18377980|P2|Overall Study|Protocol Violation|2
5339348|NCT00117338|18377981|P1|Overall Study|Protocol Violation|3
5339349|NCT00117338|18377980|P2|Overall Study|Adverse Event|1
5339350|NCT00117338|18377981|P1|Overall Study|Adverse Event|0
5339351|NCT00117325|18378001|P2|Overall Study|Admisnitrative|0
5339352|NCT00117325|18378002|P1|Overall Study|Admisnitrative|1
5339353|NCT00117325|18378001|P2|Overall Study|Early termination|1
5339354|NCT00117325|18378002|P1|Overall Study|Early termination|1
5339355|NCT00117325|18378001|P2|Overall Study|Use of prohibited medicine|2
5339356|NCT00117325|18378002|P1|Overall Study|Use of prohibited medicine|1
5339357|NCT00117325|18378001|P2|Overall Study|Lack of Efficacy|0
5339358|NCT00117325|18378002|P1|Overall Study|Lack of Efficacy|1
5339359|NCT00117325|18378001|P2|Overall Study|Withdrawal by Subject|2
5339360|NCT00117325|18378002|P1|Overall Study|Withdrawal by Subject|3
5339361|NCT00117325|18378001|P2|Overall Study|Protocol Violation|3
5339362|NCT00117325|18378002|P1|Overall Study|Protocol Violation|2
5339363|NCT00117325|18378001|P2|Overall Study|Lost to Follow-up|1
5339364|NCT00117325|18378002|P1|Overall Study|Lost to Follow-up|1
5339365|NCT00117325|18378001|P2|Overall Study|Adverse Event|3
5339366|NCT00117325|18378002|P1|Overall Study|Adverse Event|3
5339367|NCT00117312|18378034|P4|Overall Study|Withdrawal by Subject|0
5339368|NCT00117312|18378035|P3|Overall Study|Withdrawal by Subject|0
5339369|NCT00117312|18378036|P2|Overall Study|Withdrawal by Subject|2
5339370|NCT00117312|18378037|P1|Overall Study|Withdrawal by Subject|0
5339371|NCT00117312|18378034|P4|Overall Study|Hepatic abnormality|1
5339372|NCT00117312|18378035|P3|Overall Study|Hepatic abnormality|0
5339373|NCT00117312|18378036|P2|Overall Study|Hepatic abnormality|1
5339374|NCT00117312|18378037|P1|Overall Study|Hepatic abnormality|0
5339375|NCT00117312|18378034|P4|Overall Study|PSA increase >= 10ng/mL|0
5339376|NCT00117312|18378035|P3|Overall Study|PSA increase >= 10ng/mL|1
5339377|NCT00117312|18378036|P2|Overall Study|PSA increase >= 10ng/mL|1
5339378|NCT00117312|18378037|P1|Overall Study|PSA increase >= 10ng/mL|0
5339379|NCT00117312|18378034|P4|Overall Study|PSA decrease <=50%|4
5339380|NCT00117312|18378035|P3|Overall Study|PSA decrease <=50%|2
5339381|NCT00117312|18378036|P2|Overall Study|PSA decrease <=50%|2
5339382|NCT00117312|18378037|P1|Overall Study|PSA decrease <=50%|0
5339383|NCT00117312|18378034|P4|Overall Study|Protocol Violation|0
5339384|NCT00117312|18378035|P3|Overall Study|Protocol Violation|3
5339385|NCT00117312|18378036|P2|Overall Study|Protocol Violation|1
5339386|NCT00117312|18378037|P1|Overall Study|Protocol Violation|0
5339387|NCT00117312|18378034|P4|Overall Study|Adverse Event|0
5339388|NCT00117312|18378035|P3|Overall Study|Adverse Event|0
5339389|NCT00117312|18378036|P2|Overall Study|Adverse Event|2
5339390|NCT00117312|18378037|P1|Overall Study|Adverse Event|0
5339391|NCT00117312|18378034|P4|Overall Study|Patient choice|1
5339392|NCT00117312|18378035|P3|Overall Study|Patient choice|2
5339393|NCT00117312|18378036|P2|Overall Study|Patient choice|0
5339394|NCT00117312|18378037|P1|Overall Study|Patient choice|0
5339395|NCT00117312|18378034|P4|Overall Study|Other|1
5339396|NCT00117312|18378035|P3|Overall Study|Other|3
5339397|NCT00117312|18378036|P2|Overall Study|Other|1
5339398|NCT00117312|18378037|P1|Overall Study|Other|0
5339399|NCT00117312|18378034|P4|Overall Study|Prostate-specific antigen increase >=25%|3
5339400|NCT00117312|18378035|P3|Overall Study|Prostate-specific antigen increase >=25%|5
5339401|NCT00117312|18378036|P2|Overall Study|Prostate-specific antigen increase >=25%|1
5339402|NCT00117312|18378037|P1|Overall Study|Prostate-specific antigen increase >=25%|0
5339403|NCT00117312|18378034|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
5339404|NCT00117312|18378035|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
5339405|NCT00117312|18378036|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
5339406|NCT00117312|18378037|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
5339407|NCT00117312|18378034|P4|Overall Study|Testosterone >1.0 ng/mL|9
5339408|NCT00117312|18378035|P3|Overall Study|Testosterone >1.0 ng/mL|5
5339409|NCT00117312|18378036|P2|Overall Study|Testosterone >1.0 ng/mL|9
5339410|NCT00117312|18378037|P1|Overall Study|Testosterone >1.0 ng/mL|9
5339411|NCT00117286|18378053|P2|Overall Study|Research site closing|2
5339412|NCT00117286|18378054|P1|Overall Study|Research site closing|0
5339413|NCT00117286|18378053|P2|Overall Study|Lack of Efficacy|1
5339414|NCT00117286|18378054|P1|Overall Study|Lack of Efficacy|2
5339415|NCT00117286|18378053|P2|Overall Study|Physician Decision|7
5339416|NCT00117286|18378054|P1|Overall Study|Physician Decision|3
5339417|NCT00117286|18378053|P2|Overall Study|Withdrawal by Subject|2
5339418|NCT00117286|18378054|P1|Overall Study|Withdrawal by Subject|6
5339419|NCT00117286|18378053|P2|Overall Study|Protocol Violation|3
5339420|NCT00117286|18378054|P1|Overall Study|Protocol Violation|3
5339421|NCT00117286|18378053|P2|Overall Study|Lost to Follow-up|0
5339422|NCT00117286|18378054|P1|Overall Study|Lost to Follow-up|2
5339423|NCT00117286|18378053|P2|Overall Study|Adverse Event|6
5339424|NCT00117286|18378054|P1|Overall Study|Adverse Event|12
5339425|NCT00117156|18378062|P1|Overall Study|Trt for Pre-Exist Second Primary|1
5339426|NCT00117156|18378062|P1|Overall Study|Physician Decision|1
5339427|NCT00117156|18378062|P1|Overall Study|Adverse Event|9
5339428|NCT00116844|18378130|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
5339429|NCT00116844|18378131|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
5339430|NCT00116844|18378130|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
5339431|NCT00116844|18378131|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
5339432|NCT00116844|18378130|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
5339433|NCT00116844|18378131|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
5339434|NCT00116844|18378130|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
5339435|NCT00116844|18378131|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
5339436|NCT00116844|18378130|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
5339437|NCT00116844|18378131|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
5339438|NCT00116844|18378130|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
5339439|NCT00116844|18378131|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
5339440|NCT00116844|18378130|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
5339441|NCT00116844|18378131|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
5339442|NCT00116844|18378130|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
5339443|NCT00116844|18378131|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
5339444|NCT00116844|18378130|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
5339445|NCT00116844|18378131|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
5339446|NCT00116831|18378149|P2|Overall Study|Missing data for participant|0
5339447|NCT00116831|18378150|P1|Overall Study|Missing data for participant|1
5339448|NCT00116831|18378149|P2|Overall Study|Insufficient therapeutic effect|1
5339449|NCT00116831|18378150|P1|Overall Study|Insufficient therapeutic effect|0
5339450|NCT00116831|18378149|P2|Overall Study|Withdrawal by Subject|32
5339451|NCT00116831|18378150|P1|Overall Study|Withdrawal by Subject|32
5339452|NCT00116831|18378149|P2|Overall Study|Withdrawn investigational product|0
5339453|NCT00116831|18378150|P1|Overall Study|Withdrawn investigational product|1
5339454|NCT00116831|18378149|P2|Overall Study|Low haemoglobin on screening|0
5339455|NCT00116831|18378150|P1|Overall Study|Low haemoglobin on screening|1
5339456|NCT00116831|18378149|P2|Overall Study|Hypoglycaemic events|0
5339457|NCT00116831|18378150|P1|Overall Study|Hypoglycaemic events|1
5339458|NCT00116831|18378149|P2|Overall Study|Protocol Violation|6
5339459|NCT00116831|18378150|P1|Overall Study|Protocol Violation|3
5339460|NCT00116831|18378149|P2|Overall Study|Lost to Follow-up|6
5339461|NCT00116831|18378150|P1|Overall Study|Lost to Follow-up|8
5339462|NCT00116831|18378149|P2|Overall Study|Baseline IVUS determined unevaluable|11
5339463|NCT00116831|18378150|P1|Overall Study|Baseline IVUS determined unevaluable|12
5339464|NCT00116831|18378149|P2|Overall Study|Adverse Event|16
5339465|NCT00116831|18378150|P1|Overall Study|Adverse Event|14
5339466|NCT00116805|18378228|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
5339467|NCT00116805|18378229|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
5339468|NCT00116805|18378228|P2|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
5339469|NCT00116805|18378229|P1|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
5339470|NCT00116805|18378228|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
5339471|NCT00116805|18378229|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
5339472|NCT00116805|18378228|P2|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
5339473|NCT00116805|18378229|P1|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
5339474|NCT00116805|18378228|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
5339475|NCT00116805|18378229|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
5339476|NCT00116805|18378228|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
5339477|NCT00116805|18378229|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
5339478|NCT00116805|18378228|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
5339479|NCT00116805|18378229|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
5339480|NCT00116805|18378228|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
5339481|NCT00116805|18378229|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
5339482|NCT00116805|18378228|P2|Open-label Period Weeks 337 - 384|Completed Study|0
5339483|NCT00116805|18378229|P1|Open-label Period Weeks 337 - 384|Completed Study|1
5339484|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
5339485|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
5339486|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
5339487|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
5339488|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
5339489|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
5339490|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
5339491|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
5339492|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
5339493|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
5339494|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
5339495|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
5339496|NCT00116805|18378228|P2|Open-label Period Weeks 289 - 336|Completed Study|1
5339497|NCT00116805|18378229|P1|Open-label Period Weeks 289 - 336|Completed Study|0
5339498|NCT00116805|18378228|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
5339499|NCT00116805|18378229|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
5339500|NCT00116805|18378228|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
5339501|NCT00116805|18378229|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
5339502|NCT00116805|18378228|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
5339503|NCT00116805|18378229|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
5339504|NCT00116805|18378228|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
5339505|NCT00116805|18378229|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
5339506|NCT00116805|18378228|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
5339507|NCT00116805|18378229|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
5339508|NCT00116805|18378228|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
5339509|NCT00116805|18378229|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
5339510|NCT00116805|18378228|P2|Open-label Period Weeks 193 - 240|Completed Study|1
5339511|NCT00116805|18378229|P1|Open-label Period Weeks 193 - 240|Completed Study|0
5339512|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
5339513|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
5339514|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
5339515|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
5339516|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
5339517|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
5339518|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
5339519|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
5339520|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
5339521|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
5339522|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
5339523|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
5339524|NCT00116805|18378228|P2|Open-label Period Weeks 145 - 192|Completed Study|1
5339525|NCT00116805|18378229|P1|Open-label Period Weeks 145 - 192|Completed Study|1
5339526|NCT00116805|18378228|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
5339527|NCT00116805|18378229|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
5339528|NCT00116805|18378228|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
5339529|NCT00116805|18378229|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
5339530|NCT00116805|18378228|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
5339531|NCT00116805|18378229|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
5339532|NCT00116805|18378228|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
5339533|NCT00116805|18378229|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
5339534|NCT00116805|18378228|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
5339535|NCT00116805|18378229|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
5339536|NCT00116805|18378228|P2|Open-label Period Weeks 97 - 144|Completed Study|0
5339537|NCT00116805|18378229|P1|Open-label Period Weeks 97 - 144|Completed Study|1
5339538|NCT00116805|18378228|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
5339539|NCT00116805|18378229|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
5339540|NCT00116805|18378228|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
5339541|NCT00116805|18378229|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
5339542|NCT00116805|18378228|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
5339543|NCT00116805|18378229|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
5339544|NCT00116805|18378228|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
5339545|NCT00116805|18378229|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
5339546|NCT00116805|18378228|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
5339547|NCT00116805|18378229|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
5339548|NCT00116805|18378228|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
5339549|NCT00116805|18378229|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
5339550|NCT00116805|18378228|P2|Double-blind Period Through Week 48|Withdrew Consent|2
5339551|NCT00116805|18378229|P1|Double-blind Period Through Week 48|Withdrew Consent|4
5339552|NCT00116805|18378228|P2|Double-blind Period Through Week 48|Protocol Violation|1
5339553|NCT00116805|18378229|P1|Double-blind Period Through Week 48|Protocol Violation|1
5339554|NCT00116805|18378228|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
5339555|NCT00116805|18378229|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
5339556|NCT00116779|18378322|P2|Overall Study|Elevated PSA levels|2
5339557|NCT00116779|18378323|P1|Overall Study|Elevated PSA levels|2
5339558|NCT00116779|18378322|P2|Overall Study|Physician Decision|1
5339559|NCT00116779|18378323|P1|Overall Study|Physician Decision|3
5339560|NCT00116779|18378322|P2|Overall Study|Inadequate testosterone suppression|9
5339561|NCT00116779|18378323|P1|Overall Study|Inadequate testosterone suppression|7
5339562|NCT00116779|18378322|P2|Overall Study|Withdrawal by Subject|1
5339563|NCT00116779|18378323|P1|Overall Study|Withdrawal by Subject|4
5339564|NCT00116779|18378322|P2|Overall Study|Protocol Violation|4
5339565|NCT00116779|18378323|P1|Overall Study|Protocol Violation|1
5339566|NCT00116779|18378322|P2|Overall Study|Adverse Event|2
5339567|NCT00116779|18378323|P1|Overall Study|Adverse Event|4
5339568|NCT00116753|18378356|P3|Overall Study|Dosing Error|0
5339569|NCT00116753|18378357|P2|Overall Study|Dosing Error|1
5339570|NCT00116753|18378358|P1|Overall Study|Dosing Error|0
5339571|NCT00116753|18378356|P3|Overall Study|Progressive Parkinson's Disease|0
5339572|NCT00116753|18378357|P2|Overall Study|Progressive Parkinson's Disease|0
5339573|NCT00116753|18378358|P1|Overall Study|Progressive Parkinson's Disease|1
5339574|NCT00116753|18378356|P3|Overall Study|Abnormal Echocardiogram|1
5339575|NCT00116753|18378357|P2|Overall Study|Abnormal Echocardiogram|0
5339576|NCT00116753|18378358|P1|Overall Study|Abnormal Echocardiogram|0
5339577|NCT00116753|18378356|P3|Overall Study|Disease Progression|3
5339578|NCT00116753|18378357|P2|Overall Study|Disease Progression|4
5339579|NCT00116753|18378358|P1|Overall Study|Disease Progression|3
5339580|NCT00116753|18378356|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
5339581|NCT00116753|18378357|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
5339582|NCT00116753|18378358|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
5339583|NCT00116753|18378356|P3|Overall Study|Protocol Violation|1
5339584|NCT00116753|18378357|P2|Overall Study|Protocol Violation|0
5339585|NCT00116753|18378358|P1|Overall Study|Protocol Violation|0
5339586|NCT00116753|18378356|P3|Overall Study|Lost to Follow-up|1
5339587|NCT00116753|18378357|P2|Overall Study|Lost to Follow-up|2
5339588|NCT00116753|18378358|P1|Overall Study|Lost to Follow-up|0
5339589|NCT00116753|18378356|P3|Overall Study|Withdrawal by Subject|8
5339590|NCT00116753|18378357|P2|Overall Study|Withdrawal by Subject|12
5339591|NCT00116753|18378358|P1|Overall Study|Withdrawal by Subject|11
5339592|NCT00116753|18378356|P3|Overall Study|Adverse Event|7
5339593|NCT00116753|18378357|P2|Overall Study|Adverse Event|10
5339594|NCT00116753|18378358|P1|Overall Study|Adverse Event|16
5339595|NCT00116688|18378380|P2|Overall Study|Other|0
5339596|NCT00116688|18378381|P1|Overall Study|Other|11
5339597|NCT00116688|18378380|P2|Overall Study|Pregnancy|0
5339598|NCT00116688|18378381|P1|Overall Study|Pregnancy|1
5339599|NCT00116688|18378380|P2|Overall Study|Protocol-specified criteria|0
5339600|NCT00116688|18378381|P1|Overall Study|Protocol-specified criteria|3
5339601|NCT00116688|18378380|P2|Overall Study|Death|0
5339602|NCT00116688|18378381|P1|Overall Study|Death|15
5339603|NCT00116688|18378380|P2|Overall Study|Lost to Follow-up|0
5339604|NCT00116688|18378381|P1|Overall Study|Lost to Follow-up|3
5339605|NCT00116688|18378380|P2|Overall Study|Physician Decision|0
5339606|NCT00116688|18378381|P1|Overall Study|Physician Decision|7
5339607|NCT00116688|18378380|P2|Overall Study|Requirement for alternative therapy|1
5339608|NCT00116688|18378381|P1|Overall Study|Requirement for alternative therapy|11
5339609|NCT00116688|18378380|P2|Overall Study|Withdrawal by Subject|2
5339610|NCT00116688|18378381|P1|Overall Study|Withdrawal by Subject|26
5339611|NCT00116688|18378380|P2|Overall Study|Adverse Event|0
5339612|NCT00116688|18378381|P1|Overall Study|Adverse Event|11
5339613|NCT00116688|18378380|P2|Overall Study|Noncompliance|1
5339614|NCT00116688|18378381|P1|Overall Study|Noncompliance|3
5339615|NCT00116688|18378380|P2|Overall Study|Protocol deviation|0
5339616|NCT00116688|18378381|P1|Overall Study|Protocol deviation|1
5339617|NCT00116649|18378396|P1|Overall Study|Protocol Specified|7
5339618|NCT00116649|18378396|P1|Overall Study|Various Reasons|18
5339619|NCT00116649|18378396|P1|Overall Study|Local Skin Reaction|9
5339620|NCT00116649|18378396|P1|Overall Study|Withdrawal by Subject|68
5339621|NCT00116649|18378396|P1|Overall Study|Lost to Follow-up|32
5339622|NCT00116649|18378396|P1|Overall Study|Lack of Efficacy|1
5339623|NCT00116649|18378396|P1|Overall Study|Adverse Event|20
5339624|NCT00116584|18378403|P2|Overall Study|Protocol Violation|1
5339625|NCT00116584|18378404|P1|Overall Study|Protocol Violation|1
5339626|NCT00116584|18378403|P2|Overall Study|Withdrawal by Subject|0
5339627|NCT00116584|18378404|P1|Overall Study|Withdrawal by Subject|1
5339628|NCT00116558|18378417|P3|Overall Study|disease progression|18
5339629|NCT00116558|18378418|P2|Overall Study|disease progression|7
5339630|NCT00116558|18378419|P1|Overall Study|disease progression|3
5339631|NCT00116558|18378417|P3|Overall Study|Withdrawal by Subject|12
5339632|NCT00116558|18378418|P2|Overall Study|Withdrawal by Subject|3
5339633|NCT00116558|18378419|P1|Overall Study|Withdrawal by Subject|17
5339634|NCT00116558|18378417|P3|Overall Study|Death|3
5339635|NCT00116558|18378418|P2|Overall Study|Death|5
5339636|NCT00116558|18378419|P1|Overall Study|Death|11
5339637|NCT00116428|18378430|P2|Overall Study|Did not meet inclusion criteria|0
5339638|NCT00116428|18378431|P1|Overall Study|Did not meet inclusion criteria|1
5339639|NCT00116428|18378430|P2|Overall Study|Withdrawal by Subject|5
5339640|NCT00116428|18378431|P1|Overall Study|Withdrawal by Subject|2
5339641|NCT00116272|18378460|P2|Overall Study|Lost to Follow-up|6
5339642|NCT00116272|18378461|P1|Overall Study|Lost to Follow-up|11
5339643|NCT00116168|18378530|P4|Overall Study|Lost to Follow-up|0
5339644|NCT00116168|18378531|P3|Overall Study|Lost to Follow-up|0
5339645|NCT00116168|18378532|P2|Overall Study|Lost to Follow-up|5
5339646|NCT00116168|18378533|P1|Overall Study|Lost to Follow-up|6
5339647|NCT00115934|18378597|P2|Overall Study|Did not receive intervention|2
5339648|NCT00115934|18378598|P1|Overall Study|Did not receive intervention|3
5339649|NCT00115934|18378597|P2|Overall Study|Lost to Follow-up|0
5339650|NCT00115934|18378598|P1|Overall Study|Lost to Follow-up|1
5339651|NCT00115804|18378647|P1|Overall Study|Adverse Event|2
5339652|NCT00115778|18378658|P2|Overall Study|Withdrawal by Subject|1
5339653|NCT00115778|18378659|P1|Overall Study|Withdrawal by Subject|0
5339654|NCT00115765|18378679|P4|Overall Study|Other|2
5339655|NCT00115765|18378680|P3|Overall Study|Other|9
5339656|NCT00115765|18378681|P2|Overall Study|Other|12
5339657|NCT00115765|18378682|P1|Overall Study|Other|6
5339658|NCT00115765|18378679|P4|Overall Study|Lost to Follow-up|1
5339659|NCT00115765|18378680|P3|Overall Study|Lost to Follow-up|18
5339660|NCT00115765|18378681|P2|Overall Study|Lost to Follow-up|20
5339661|NCT00115765|18378682|P1|Overall Study|Lost to Follow-up|3
5339662|NCT00115765|18378679|P4|Overall Study|Physician Decision|13
5339663|NCT00115765|18378680|P3|Overall Study|Physician Decision|18
5339664|NCT00115765|18378681|P2|Overall Study|Physician Decision|15
5339665|NCT00115765|18378682|P1|Overall Study|Physician Decision|4
5339666|NCT00115765|18378679|P4|Overall Study|Withdrawal by Subject|15
5339667|NCT00115765|18378680|P3|Overall Study|Withdrawal by Subject|76
5339668|NCT00115765|18378681|P2|Overall Study|Withdrawal by Subject|53
5339669|NCT00115765|18378682|P1|Overall Study|Withdrawal by Subject|22
5339670|NCT00115739|18378720|P1|Overall Study|Lost to Follow-up|3
5339671|NCT00115349|18378729|P2|Overall Study|Study closed due to low enrollment.|9
5339672|NCT00115349|18378730|P1|Overall Study|Study closed due to low enrollment.|11
5339673|NCT00115336|18378738|P2|Overall Study|Hospital discharge before study drug|1
5339674|NCT00115336|18378739|P1|Overall Study|Hospital discharge before study drug|0
5339675|NCT00115063|18378776|P2|Overall Study|Death|0
5339676|NCT00115063|18378777|P1|Overall Study|Death|1
5339677|NCT00115063|18378776|P2|Overall Study|Lost to Follow-up|104
5339678|NCT00115063|18378777|P1|Overall Study|Lost to Follow-up|98
5339679|NCT00115037|18378795|P6|Phase2|Lost to Follow-up|10
5339680|NCT00115037|18378796|P5|Phase2|Lost to Follow-up|4
5339681|NCT00115037|18378797|P4|Phase2|Lost to Follow-up|14
5339682|NCT00115037|18378798|P3|Phase2|Lost to Follow-up|12
5339683|NCT00115037|18378799|P2|Phase2|Lost to Follow-up|0
5339684|NCT00115037|18378800|P1|Phase2|Lost to Follow-up|0
5339685|NCT00115037|18378795|P6|Phase2|Withdrawal by Subject|1
5339686|NCT00115037|18378796|P5|Phase2|Withdrawal by Subject|2
5339687|NCT00115037|18378797|P4|Phase2|Withdrawal by Subject|1
5339688|NCT00115037|18378798|P3|Phase2|Withdrawal by Subject|2
5339689|NCT00115037|18378799|P2|Phase2|Withdrawal by Subject|0
5339690|NCT00115037|18378800|P1|Phase2|Withdrawal by Subject|0
5339691|NCT00115037|18378795|P6|Phase2|Death|1
5339692|NCT00115037|18378796|P5|Phase2|Death|0
5339693|NCT00115037|18378797|P4|Phase2|Death|0
5339694|NCT00115037|18378798|P3|Phase2|Death|1
5339695|NCT00115037|18378799|P2|Phase2|Death|0
5339696|NCT00115037|18378800|P1|Phase2|Death|0
5339697|NCT00115037|18378795|P6|Phase1|Withdrawal by Subject|0
5339698|NCT00115037|18378796|P5|Phase1|Withdrawal by Subject|0
5339699|NCT00115037|18378797|P4|Phase1|Withdrawal by Subject|0
5339700|NCT00115037|18378798|P3|Phase1|Withdrawal by Subject|0
5339701|NCT00115037|18378799|P2|Phase1|Withdrawal by Subject|4
5339702|NCT00115037|18378800|P1|Phase1|Withdrawal by Subject|9
5339703|NCT00115037|18378795|P6|Phase1|Lost to Follow-up|0
5339704|NCT00115037|18378796|P5|Phase1|Lost to Follow-up|0
5339705|NCT00115037|18378797|P4|Phase1|Lost to Follow-up|0
5339706|NCT00115037|18378798|P3|Phase1|Lost to Follow-up|0
5339707|NCT00115037|18378799|P2|Phase1|Lost to Follow-up|23
5339708|NCT00115037|18378800|P1|Phase1|Lost to Follow-up|16
5339709|NCT00114972|18378816|P2|Overall Study|Lost to Follow-up|5
5339710|NCT00114972|18378817|P1|Overall Study|Lost to Follow-up|8
5339711|NCT00114972|18378816|P2|Overall Study|Withdrawal by Subject|7
5339712|NCT00114972|18378817|P1|Overall Study|Withdrawal by Subject|40
5339713|NCT00114959|18378837|P1|Overall Study|Death|1
5339714|NCT00114959|18378837|P1|Overall Study|Physician Decision|1
5339715|NCT00114959|18378837|P1|Overall Study|Lack of Efficacy|6
5339716|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Other|2
5339717|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Other|0
5339718|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Other|2
5339719|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
5339720|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
5339721|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
5339722|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
5339723|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
5339724|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
5339725|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
5339726|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
5339727|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
5339728|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Adverse Event|7
5339729|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Adverse Event|14
5339730|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Adverse Event|15
5339731|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
5339732|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
5339733|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
5339734|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
5339735|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
5339736|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
5339737|NCT00114777|18378847|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
5339738|NCT00114777|18378848|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
5339739|NCT00114777|18378849|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
5339740|NCT00114777|18378847|P3|Long-Term Extension to Month 84|Death|7
5339741|NCT00114777|18378848|P2|Long-Term Extension to Month 84|Death|13
5339742|NCT00114777|18378849|P1|Long-Term Extension to Month 84|Death|8
5339743|NCT00114777|18378847|P3|Randomization to Month 36|Other|12
5339744|NCT00114777|18378848|P2|Randomization to Month 36|Other|3
5339745|NCT00114777|18378849|P1|Randomization to Month 36|Other|9
5339746|NCT00114777|18378847|P3|Randomization to Month 36|Withdrawal by Subject|5
5339747|NCT00114777|18378848|P2|Randomization to Month 36|Withdrawal by Subject|4
5339748|NCT00114777|18378849|P1|Randomization to Month 36|Withdrawal by Subject|3
5339749|NCT00114777|18378847|P3|Randomization to Month 36|Adverse Event|44
5339750|NCT00114777|18378848|P2|Randomization to Month 36|Adverse Event|35
5339751|NCT00114777|18378849|P1|Randomization to Month 36|Adverse Event|34
5339752|NCT00114777|18378847|P3|Randomization to Month 36|Poor or Non-Compliance|1
5339753|NCT00114777|18378848|P2|Randomization to Month 36|Poor or Non-Compliance|0
5339754|NCT00114777|18378849|P1|Randomization to Month 36|Poor or Non-Compliance|0
5339755|NCT00114777|18378847|P3|Randomization to Month 36|Lack of Efficacy|17
5339756|NCT00114777|18378848|P2|Randomization to Month 36|Lack of Efficacy|15
5339757|NCT00114777|18378849|P1|Randomization to Month 36|Lack of Efficacy|19
5339758|NCT00114777|18378847|P3|Randomization to Month 36|No Longer Met Study Criteria|2
5339759|NCT00114777|18378848|P2|Randomization to Month 36|No Longer Met Study Criteria|0
5339760|NCT00114777|18378849|P1|Randomization to Month 36|No Longer Met Study Criteria|0
5339761|NCT00114777|18378847|P3|Randomization to Month 36|Death|3
5339762|NCT00114777|18378848|P2|Randomization to Month 36|Death|4
5339763|NCT00114777|18378849|P1|Randomization to Month 36|Death|10
5339764|NCT00114738|18378923|P3|Screening for Randomization|Other|0
5339765|NCT00114738|18378924|P2|Screening for Randomization|Other|0
5339766|NCT00114738|18378925|P1|Screening for Randomization|Other|1
5339767|NCT00114738|18378923|P3|Screening for Randomization|CNS Hemorrhage|0
5339768|NCT00114738|18378924|P2|Screening for Randomization|CNS Hemorrhage|0
5339769|NCT00114738|18378925|P1|Screening for Randomization|CNS Hemorrhage|1
5339770|NCT00114738|18378923|P3|Screening for Randomization|Progressive disease|0
5339771|NCT00114738|18378924|P2|Screening for Randomization|Progressive disease|0
5339772|NCT00114738|18378925|P1|Screening for Randomization|Progressive disease|2
5339773|NCT00114738|18378923|P3|Screening for Randomization|Neuropathy|0
5339774|NCT00114738|18378924|P2|Screening for Randomization|Neuropathy|0
5339775|NCT00114738|18378925|P1|Screening for Randomization|Neuropathy|17
5339776|NCT00114738|18378923|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
5339777|NCT00114738|18378924|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
5339778|NCT00114738|18378925|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
5339779|NCT00114738|18378923|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
5339780|NCT00114738|18378924|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
5339781|NCT00114738|18378925|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
5339782|NCT00114634|18378938|P1|Overall Study|failure to return forms|3
5339783|NCT00114530|18378954|P2|Overall Study|Ineligible|0
5339784|NCT00114530|18378955|P1|Overall Study|Ineligible|1
5339785|NCT00114530|18378954|P2|Overall Study|Subject decision after endpoint failure|1
5339786|NCT00114530|18378955|P1|Overall Study|Subject decision after endpoint failure|0
5339787|NCT00114530|18378954|P2|Overall Study|Breast Cancer|0
5339788|NCT00114530|18378955|P1|Overall Study|Breast Cancer|1
5339789|NCT00114530|18378954|P2|Overall Study|Withdrawal by Subject|6
5339790|NCT00114530|18378955|P1|Overall Study|Withdrawal by Subject|2
5339791|NCT00114530|18378954|P2|Overall Study|Physician Decision|1
5339792|NCT00114530|18378955|P1|Overall Study|Physician Decision|1
5339793|NCT00114530|18378954|P2|Overall Study|Lost to Follow-up|1
5339794|NCT00114530|18378955|P1|Overall Study|Lost to Follow-up|1
5339795|NCT00114530|18378954|P2|Overall Study|Death|11
5339796|NCT00114530|18378955|P1|Overall Study|Death|3
5339797|NCT00114244|18379092|P2|Overall Study|Withdrawal by Subject|2
5339798|NCT00114244|18379093|P1|Overall Study|Withdrawal by Subject|0
5339799|NCT00114244|18379092|P2|Overall Study|Adverse Event|5
5339800|NCT00114244|18379093|P1|Overall Study|Adverse Event|2
5339801|NCT00114231|18379105|P2|Overall Study|Biopsy done after registration|0
5339802|NCT00114231|18379106|P1|Overall Study|Biopsy done after registration|1
5339803|NCT00114231|18379105|P2|Overall Study|No Absolute Neutrophil Count|0
5339804|NCT00114231|18379106|P1|Overall Study|No Absolute Neutrophil Count|2
5339805|NCT00114231|18379105|P2|Overall Study|Tumor fixed on digital exam|1
5339806|NCT00114231|18379106|P1|Overall Study|Tumor fixed on digital exam|0
5339807|NCT00114231|18379105|P2|Overall Study|Tumor size > 4cm|0
5339808|NCT00114231|18379106|P1|Overall Study|Tumor size > 4cm|1
5339809|NCT00114231|18379105|P2|Overall Study|Low creatinine clearance|1
5339810|NCT00114231|18379106|P1|Overall Study|Low creatinine clearance|0
5339811|NCT00114231|18379105|P2|Overall Study|No adenocarcinoma|0
5339812|NCT00114231|18379106|P1|Overall Study|No adenocarcinoma|1
5339813|NCT00114231|18379105|P2|Overall Study|Suspected metastatic disease|0
5339814|NCT00114231|18379106|P1|Overall Study|Suspected metastatic disease|1
5339815|NCT00114231|18379105|P2|Overall Study|QARC requirement not met|0
5339816|NCT00114231|18379106|P1|Overall Study|QARC requirement not met|1
5339817|NCT00114231|18379105|P2|Overall Study|No consent|0
5339818|NCT00114231|18379106|P1|Overall Study|No consent|2
5339819|NCT00114218|18379115|P1|Overall Study|Never Treated|1
5339820|NCT00114218|18379115|P1|Overall Study|Wrong Primary|1
5339821|NCT00114218|18379115|P1|Overall Study|Wrong Cell Type|2
5339822|NCT00114166|18379122|P2|Overall Study|Wrong primary|1
5339823|NCT00114166|18379123|P1|Overall Study|Wrong primary|0
5339824|NCT00114140|18379133|P1|Overall Study|Protocol Violation|7
5339825|NCT00114127|18379147|P2|Overall Study|Withdrawal by Subject|3
5339826|NCT00114127|18379148|P1|Overall Study|Withdrawal by Subject|1
5339827|NCT00114127|18379147|P2|Overall Study|Lost to Follow-up|0
5339828|NCT00114127|18379148|P1|Overall Study|Lost to Follow-up|1
5339829|NCT00114127|18379147|P2|Overall Study|Adverse Event|1
5339830|NCT00114127|18379148|P1|Overall Study|Adverse Event|2
5339831|NCT00113919|18379220|P1|Overall Study|Death|6
5339832|NCT00113919|18379220|P1|Overall Study|Physician Decision|8
5339833|NCT00113841|18379288|P2|Overall Study|Non-compliant|0
5339834|NCT00113841|18379289|P1|Overall Study|Non-compliant|1
5339835|NCT00113841|18379288|P2|Overall Study|Disease progression|2
5339836|NCT00113841|18379289|P1|Overall Study|Disease progression|0
5339837|NCT00113763|18379297|P2|Overall Study|Ongoing|0
5339838|NCT00113763|18379298|P1|Overall Study|Ongoing|1
5339839|NCT00113763|18379297|P2|Overall Study|Non-compliance|0
5339840|NCT00113763|18379298|P1|Overall Study|Non-compliance|1
5339841|NCT00113763|18379297|P2|Overall Study|Other|6
5339842|NCT00113763|18379298|P1|Overall Study|Other|27
5339843|NCT00113763|18379297|P2|Overall Study|Withdrawal by Subject|4
5339844|NCT00113763|18379298|P1|Overall Study|Withdrawal by Subject|1
5339845|NCT00113763|18379297|P2|Overall Study|Lost to Follow-up|0
5339846|NCT00113763|18379298|P1|Overall Study|Lost to Follow-up|10
5339847|NCT00113763|18379297|P2|Overall Study|Disease Progression|14
5339848|NCT00113763|18379298|P1|Overall Study|Disease Progression|28
5339849|NCT00113763|18379297|P2|Overall Study|Adverse Event|2
5339850|NCT00113763|18379298|P1|Overall Study|Adverse Event|5
5339851|NCT00113607|18379324|P2|Overall Study|Other|32
5339852|NCT00113607|18379325|P1|Overall Study|Other|43
5339853|NCT00113607|18379324|P2|Overall Study|Complete Response (Confirmed)|24
5339854|NCT00113607|18379325|P1|Overall Study|Complete Response (Confirmed)|14
5339855|NCT00113607|18379324|P2|Overall Study|Disease Progression|142
5339856|NCT00113607|18379325|P1|Overall Study|Disease Progression|180
5339857|NCT00113607|18379324|P2|Overall Study|Lost to Follow-up|2
5339858|NCT00113607|18379325|P1|Overall Study|Lost to Follow-up|0
5339859|NCT00113607|18379324|P2|Overall Study|Withdrawal by Subject|58
5339860|NCT00113607|18379325|P1|Overall Study|Withdrawal by Subject|50
5339861|NCT00113607|18379324|P2|Overall Study|Death|8
5339862|NCT00113607|18379325|P1|Overall Study|Death|8
5339863|NCT00113607|18379324|P2|Overall Study|Adverse Event|71
5339864|NCT00113607|18379325|P1|Overall Study|Adverse Event|40
5339865|NCT00113568|18379339|P1|Overall Study|Other|112
5339866|NCT00113568|18379339|P1|Overall Study|Withdrawal by Subject|117
5339867|NCT00113568|18379339|P1|Overall Study|Protocol Violation|32
5339868|NCT00113568|18379339|P1|Overall Study|Lost to Follow-up|156
5339869|NCT00113568|18379339|P1|Overall Study|Lack of Efficacy|30
5339870|NCT00113568|18379339|P1|Overall Study|Death|1
5339871|NCT00113568|18379339|P1|Overall Study|Adverse Event|97
5339872|NCT00113555|18379351|P1|Overall Study|Lost to Follow-up|8
5339873|NCT00113555|18379351|P1|Overall Study|Missed Followup|4
5339874|NCT00113555|18379351|P1|Overall Study|Death|1
5339875|NCT00113555|18379351|P1|Overall Study|Permanently Explanted|7
5339876|NCT00113555|18379351|P1|Overall Study|Baseline Failure|59
5339877|NCT00113529|18379361|P1|Overall Study|Withdrawal by Subject|4
5339878|NCT00113529|18379361|P1|Overall Study|Decision of sponsor|6
5339879|NCT00113529|18379361|P1|Overall Study|Lack of Efficacy|20
5339880|NCT00113529|18379361|P1|Overall Study|Adverse Event|4
5339881|NCT00113516|18379394|P2|Part 2|Ongoing|1
5339882|NCT00113516|18379395|P1|Part 2|Ongoing|0
5339883|NCT00113516|18379394|P2|Part 2|Laboratory Abnormality|1
5339884|NCT00113516|18379395|P1|Part 2|Laboratory Abnormality|0
5339885|NCT00113516|18379394|P2|Part 2|Other|3
5339886|NCT00113516|18379395|P1|Part 2|Other|0
5339887|NCT00113516|18379394|P2|Part 2|Withdrawal by Subject|3
5339888|NCT00113516|18379395|P1|Part 2|Withdrawal by Subject|0
5339889|NCT00113516|18379394|P2|Part 2|Lack of Efficacy|37
5339890|NCT00113516|18379395|P1|Part 2|Lack of Efficacy|0
5339891|NCT00113516|18379394|P2|Part 2|Death|5
5339892|NCT00113516|18379395|P1|Part 2|Death|0
5339893|NCT00113516|18379394|P2|Part 2|Adverse Event|16
5339894|NCT00113516|18379395|P1|Part 2|Adverse Event|0
5339895|NCT00113516|18379394|P2|Part 1|Missing|0
5339896|NCT00113516|18379395|P1|Part 1|Missing|65
5339897|NCT00113516|18379394|P2|Part 1|Ongoing|0
5339898|NCT00113516|18379395|P1|Part 1|Ongoing|1
5339899|NCT00113516|18379394|P2|Part 1|Laboratory Abnormality|0
5339900|NCT00113516|18379395|P1|Part 1|Laboratory Abnormality|1
5339901|NCT00113516|18379394|P2|Part 1|Did Not Meet Entrance Criteria|0
5339902|NCT00113516|18379395|P1|Part 1|Did Not Meet Entrance Criteria|1
5339903|NCT00113516|18379394|P2|Part 1|Lack of Efficacy|0
5339904|NCT00113516|18379395|P1|Part 1|Lack of Efficacy|2
5339905|NCT00113516|18379394|P2|Part 1|Withdrawal by Subject|0
5339906|NCT00113516|18379395|P1|Part 1|Withdrawal by Subject|2
5339907|NCT00113516|18379394|P2|Part 1|Other|0
5339908|NCT00113516|18379395|P1|Part 1|Other|3
5339909|NCT00113516|18379394|P2|Part 1|Death|0
5339910|NCT00113516|18379395|P1|Part 1|Death|3
5339911|NCT00113516|18379394|P2|Part 1|Adverse Event|0
5339912|NCT00113516|18379395|P1|Part 1|Adverse Event|6
5339913|NCT00113490|18379438|P2|Overall Study|Lost to Follow-up|0
5339914|NCT00113490|18379439|P1|Overall Study|Lost to Follow-up|1
5339915|NCT00113490|18379438|P2|Overall Study|Withdrawal by Subject|3
5339916|NCT00113490|18379439|P1|Overall Study|Withdrawal by Subject|1
5339917|NCT00113399|18379472|P2|Overall Study|Other|1
5339918|NCT00113399|18379473|P1|Overall Study|Other|0
5339919|NCT00113399|18379472|P2|Overall Study|Complete Response|1
5339920|NCT00113399|18379473|P1|Overall Study|Complete Response|0
5339921|NCT00113399|18379472|P2|Overall Study|Withdrawal by Subject|2
5339922|NCT00113399|18379473|P1|Overall Study|Withdrawal by Subject|1
5339923|NCT00113399|18379472|P2|Overall Study|Death|1
5339924|NCT00113399|18379473|P1|Overall Study|Death|1
5339925|NCT00113386|18379481|P2|Overall Study|Unknown - Lost to Follow-Up|1
5339926|NCT00113386|18379482|P1|Overall Study|Unknown - Lost to Follow-Up|2
5339927|NCT00113386|18379481|P2|Overall Study|Ineligible|2
5339928|NCT00113386|18379482|P1|Overall Study|Ineligible|1
5339929|NCT00113386|18379481|P2|Overall Study|Toxicity|0
5339930|NCT00113386|18379482|P1|Overall Study|Toxicity|3
5339931|NCT00113386|18379481|P2|Overall Study|Physician Decision|1
5339932|NCT00113386|18379482|P1|Overall Study|Physician Decision|0
5339933|NCT00113386|18379481|P2|Overall Study|Withdrawal by Subject|0
5339934|NCT00113386|18379482|P1|Overall Study|Withdrawal by Subject|1
5339935|NCT00113373|18379488|P1|Overall Study|Never Treated|1
5339936|NCT00113373|18379488|P1|Overall Study|Ineligible: second primary|1
5339937|NCT00113373|18379488|P1|Overall Study|Ineligible: wrong primary|1
5339938|NCT00113360|18379503|P1|Overall Study|Did not meet eligibility criteria|3
5339939|NCT00113360|18379503|P1|Overall Study|Subject required surgery|1
5339940|NCT00113360|18379503|P1|Overall Study|Adverse Event|3
5339941|NCT00113295|18379517|P2|Overall Study|Unrelated Medical Illness|0
5339942|NCT00113295|18379518|P1|Overall Study|Unrelated Medical Illness|1
5339943|NCT00113295|18379517|P2|Overall Study|Adverse Event|1
5339944|NCT00113295|18379518|P1|Overall Study|Adverse Event|4
5339945|NCT00113269|18379537|P4|Overall Study|Unable to return for follow up|0
5339946|NCT00113269|18379538|P3|Overall Study|Unable to return for follow up|0
5339947|NCT00113269|18379539|P2|Overall Study|Unable to return for follow up|1
5339948|NCT00113269|18379540|P1|Overall Study|Unable to return for follow up|2
5339949|NCT00113269|18379537|P4|Overall Study|Did not meet eligibility criteria|1
5339950|NCT00113269|18379538|P3|Overall Study|Did not meet eligibility criteria|0
5339951|NCT00113269|18379539|P2|Overall Study|Did not meet eligibility criteria|0
5339952|NCT00113269|18379540|P1|Overall Study|Did not meet eligibility criteria|1
5339953|NCT00113269|18379537|P4|Overall Study|Withdrew consent, Prednisone initiated|1
5339954|NCT00113269|18379538|P3|Overall Study|Withdrew consent, Prednisone initiated|0
5339955|NCT00113269|18379539|P2|Overall Study|Withdrew consent, Prednisone initiated|0
5339956|NCT00113269|18379540|P1|Overall Study|Withdrew consent, Prednisone initiated|0
5339957|NCT00113269|18379537|P4|Overall Study|Received pancreas transplant|2
5339958|NCT00113269|18379538|P3|Overall Study|Received pancreas transplant|0
5339959|NCT00113269|18379539|P2|Overall Study|Received pancreas transplant|0
5339960|NCT00113269|18379540|P1|Overall Study|Received pancreas transplant|0
5339961|NCT00113269|18379537|P4|Overall Study|Moved|3
5339962|NCT00113269|18379538|P3|Overall Study|Moved|0
5339963|NCT00113269|18379539|P2|Overall Study|Moved|1
5339964|NCT00113269|18379540|P1|Overall Study|Moved|0
5339965|NCT00113269|18379537|P4|Overall Study|Discontinued due to rejection|0
5339966|NCT00113269|18379538|P3|Overall Study|Discontinued due to rejection|1
5339967|NCT00113269|18379539|P2|Overall Study|Discontinued due to rejection|0
5339968|NCT00113269|18379540|P1|Overall Study|Discontinued due to rejection|0
5339969|NCT00113269|18379537|P4|Overall Study|Sponsor elected to discontinue patient|1
5339970|NCT00113269|18379538|P3|Overall Study|Sponsor elected to discontinue patient|0
5339971|NCT00113269|18379539|P2|Overall Study|Sponsor elected to discontinue patient|0
5339972|NCT00113269|18379540|P1|Overall Study|Sponsor elected to discontinue patient|1
5339973|NCT00113269|18379537|P4|Overall Study|Lost to Follow-up|3
5339974|NCT00113269|18379538|P3|Overall Study|Lost to Follow-up|6
5339975|NCT00113269|18379539|P2|Overall Study|Lost to Follow-up|3
5339976|NCT00113269|18379540|P1|Overall Study|Lost to Follow-up|2
5339977|NCT00113269|18379537|P4|Overall Study|Protocol Violation|2
5339978|NCT00113269|18379538|P3|Overall Study|Protocol Violation|4
5339979|NCT00113269|18379539|P2|Overall Study|Protocol Violation|0
5339980|NCT00113269|18379540|P1|Overall Study|Protocol Violation|1
5339981|NCT00113269|18379537|P4|Overall Study|Graft loss|9
5339982|NCT00113269|18379538|P3|Overall Study|Graft loss|4
5339983|NCT00113269|18379539|P2|Overall Study|Graft loss|6
5339984|NCT00113269|18379540|P1|Overall Study|Graft loss|6
5339985|NCT00113269|18379537|P4|Overall Study|Withdrawal by Subject|2
5339986|NCT00113269|18379538|P3|Overall Study|Withdrawal by Subject|4
5339987|NCT00113269|18379539|P2|Overall Study|Withdrawal by Subject|3
5339988|NCT00113269|18379540|P1|Overall Study|Withdrawal by Subject|4
5339989|NCT00113269|18379537|P4|Overall Study|Adverse Event|7
5339990|NCT00113269|18379538|P3|Overall Study|Adverse Event|11
5339991|NCT00113269|18379539|P2|Overall Study|Adverse Event|7
5339992|NCT00113269|18379540|P1|Overall Study|Adverse Event|2
5339993|NCT00113269|18379537|P4|Overall Study|Did not meet eligibility - pre-treatment|2
5339994|NCT00113269|18379538|P3|Overall Study|Did not meet eligibility - pre-treatment|0
5339995|NCT00113269|18379539|P2|Overall Study|Did not meet eligibility - pre-treatment|0
5339996|NCT00113269|18379540|P1|Overall Study|Did not meet eligibility - pre-treatment|0
5339997|NCT00113269|18379537|P4|Overall Study|Death in operating room|1
5339998|NCT00113269|18379538|P3|Overall Study|Death in operating room|0
5339999|NCT00113269|18379539|P2|Overall Study|Death in operating room|0
5340000|NCT00113269|18379540|P1|Overall Study|Death in operating room|0
5340001|NCT00113269|18379537|P4|Overall Study|Early graft loss, technical|0
5340002|NCT00113269|18379538|P3|Overall Study|Early graft loss, technical|2
5340003|NCT00113269|18379539|P2|Overall Study|Early graft loss, technical|0
5340004|NCT00113269|18379540|P1|Overall Study|Early graft loss, technical|0
5340005|NCT00113269|18379537|P4|Overall Study|Not transplanted, recipient issues|4
5340006|NCT00113269|18379538|P3|Overall Study|Not transplanted, recipient issues|7
5340007|NCT00113269|18379539|P2|Overall Study|Not transplanted, recipient issues|1
5340008|NCT00113269|18379540|P1|Overall Study|Not transplanted, recipient issues|2
5340009|NCT00113269|18379537|P4|Overall Study|Not transplanted, donor issues|2
5340010|NCT00113269|18379538|P3|Overall Study|Not transplanted, donor issues|2
5340011|NCT00113269|18379539|P2|Overall Study|Not transplanted, donor issues|0
5340012|NCT00113269|18379540|P1|Overall Study|Not transplanted, donor issues|4
5340013|NCT00113087|18379600|P2|Overall Study|Family or MD withdrew subject|5
5340014|NCT00113087|18379601|P1|Overall Study|Family or MD withdrew subject|10
5340015|NCT00113087|18379600|P2|Overall Study|Death or Transplant|16
5340016|NCT00113087|18379601|P1|Overall Study|Death or Transplant|14
5340017|NCT00112957|18379672|P1|Overall Study|Physician Decision|1
5340018|NCT00112957|18379672|P1|Overall Study|Progressive disease|18
5340019|NCT00112905|18379712|P1|Overall Study|performance status was deteiorating|1
5340020|NCT00112905|18379712|P1|Overall Study|Alternative treatment|1
5340021|NCT00112905|18379712|P1|Overall Study|Ineligibility|5
5340022|NCT00112905|18379712|P1|Overall Study|Death|1
5340023|NCT00112905|18379712|P1|Overall Study|Adverse Event|4
5340024|NCT00112866|18379721|P2|Overall Study|did not start treatment post-op|2
5340025|NCT00112866|18379722|P1|Overall Study|did not start treatment post-op|1
5340026|NCT00112866|18379721|P2|Overall Study|Protocol Violation|0
5340027|NCT00112866|18379722|P1|Overall Study|Protocol Violation|1
5340028|NCT00112840|18379744|P3|Overall Study|Protocol Violation|5
5340029|NCT00112840|18379745|P2|Overall Study|Protocol Violation|0
5340030|NCT00112840|18379746|P1|Overall Study|Protocol Violation|0
5340031|NCT00112840|18379744|P3|Overall Study|Withdrawal by Subject|1
5340032|NCT00112840|18379745|P2|Overall Study|Withdrawal by Subject|0
5340033|NCT00112840|18379746|P1|Overall Study|Withdrawal by Subject|1
5340034|NCT00112840|18379744|P3|Overall Study|Physician Decision|0
5340035|NCT00112840|18379745|P2|Overall Study|Physician Decision|0
5340036|NCT00112840|18379746|P1|Overall Study|Physician Decision|1
5340037|NCT00112736|18379765|P2|Overall Study|1 pt never had had RX due rapid decline|0
5340038|NCT00112736|18379766|P1|Overall Study|1 pt never had had RX due rapid decline|1
5340039|NCT00112489|18379823|P1|Overall Study|Ineligible|7
5340040|NCT00112489|18379823|P1|Overall Study|Patient never treated|2
5340041|NCT00112489|18379823|P1|Overall Study|Other, Not Specified|9
5340042|NCT00112489|18379823|P1|Overall Study|Death|2
5340043|NCT00112489|18379823|P1|Overall Study|Adverse Event|12
5340044|NCT00112489|18379823|P1|Overall Study|Refused further treatment|8
5340045|NCT00112463|18379833|P1|Overall Study|Never started treatment|2
5340046|NCT00112463|18379833|P1|Overall Study|Withdrawal by Subject|2
5340047|NCT00112463|18379833|P1|Overall Study|Toxicity|3
5340048|NCT00112463|18379833|P1|Overall Study|Second Primary|1
5340049|NCT00112463|18379833|P1|Overall Study|Progression|30
5340050|NCT00112463|18379833|P1|Overall Study|Physician Decision|1
5340051|NCT00112437|18379845|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
5340052|NCT00112437|18379846|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340053|NCT00112437|18379847|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
5340054|NCT00112437|18379848|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
5340055|NCT00112437|18379849|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340056|NCT00112437|18379850|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340057|NCT00112437|18379851|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340058|NCT00112437|18379852|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340059|NCT00112437|18379853|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340060|NCT00112437|18379854|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340061|NCT00112437|18379855|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340062|NCT00112437|18379856|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340063|NCT00112437|18379857|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340064|NCT00112437|18379858|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340065|NCT00112437|18379859|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340066|NCT00112437|18379860|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340067|NCT00112437|18379861|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340068|NCT00112437|18379862|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340888|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|Adverse Event|0
5340069|NCT00112437|18379863|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340070|NCT00112437|18379864|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340071|NCT00112437|18379865|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340072|NCT00112437|18379866|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340073|NCT00112437|18379867|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340074|NCT00112437|18379868|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340075|NCT00112437|18379869|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340076|NCT00112437|18379870|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5340077|NCT00112437|18379845|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
5340078|NCT00112437|18379846|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
5340079|NCT00112437|18379847|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
5340080|NCT00112437|18379848|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
5340081|NCT00112437|18379849|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
5340082|NCT00112437|18379850|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
5340083|NCT00112437|18379851|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
5340084|NCT00112437|18379852|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
5340085|NCT00112437|18379853|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
5340086|NCT00112437|18379854|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
5340087|NCT00112437|18379855|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
5340088|NCT00112437|18379856|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
5340089|NCT00112437|18379857|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
5340090|NCT00112437|18379858|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
5340091|NCT00112437|18379859|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
5340092|NCT00112437|18379860|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
5340093|NCT00112437|18379861|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
5340094|NCT00112437|18379862|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
5340095|NCT00112437|18379863|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
5340096|NCT00112437|18379864|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
5340097|NCT00112437|18379865|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
5340098|NCT00112437|18379866|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
5340099|NCT00112437|18379867|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
5340100|NCT00112437|18379868|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
5340101|NCT00112437|18379869|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
5340102|NCT00112437|18379870|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
5340103|NCT00112437|18379845|P26|Years 6-10 (60-Month Extension)|Other|0
5340104|NCT00112437|18379846|P25|Years 6-10 (60-Month Extension)|Other|1
5340105|NCT00112437|18379847|P24|Years 6-10 (60-Month Extension)|Other|0
5340106|NCT00112437|18379848|P23|Years 6-10 (60-Month Extension)|Other|0
5340107|NCT00112437|18379849|P22|Years 6-10 (60-Month Extension)|Other|0
5340108|NCT00112437|18379850|P21|Years 6-10 (60-Month Extension)|Other|0
5340109|NCT00112437|18379851|P20|Years 6-10 (60-Month Extension)|Other|0
5340110|NCT00112437|18379852|P19|Years 6-10 (60-Month Extension)|Other|0
5340111|NCT00112437|18379853|P18|Years 6-10 (60-Month Extension)|Other|0
5340112|NCT00112437|18379854|P17|Years 6-10 (60-Month Extension)|Other|0
5340113|NCT00112437|18379855|P16|Years 6-10 (60-Month Extension)|Other|0
5340114|NCT00112437|18379856|P15|Years 6-10 (60-Month Extension)|Other|0
5340115|NCT00112437|18379857|P14|Years 6-10 (60-Month Extension)|Other|0
5340116|NCT00112437|18379858|P13|Years 6-10 (60-Month Extension)|Other|0
5340117|NCT00112437|18379859|P12|Years 6-10 (60-Month Extension)|Other|0
5340118|NCT00112437|18379860|P11|Years 6-10 (60-Month Extension)|Other|0
5340119|NCT00112437|18379861|P10|Years 6-10 (60-Month Extension)|Other|0
5340120|NCT00112437|18379862|P9|Years 6-10 (60-Month Extension)|Other|0
5340121|NCT00112437|18379863|P8|Years 6-10 (60-Month Extension)|Other|0
5340122|NCT00112437|18379864|P7|Years 6-10 (60-Month Extension)|Other|0
5340123|NCT00112437|18379865|P6|Years 6-10 (60-Month Extension)|Other|0
5340124|NCT00112437|18379866|P5|Years 6-10 (60-Month Extension)|Other|0
5340125|NCT00112437|18379867|P4|Years 6-10 (60-Month Extension)|Other|0
5340126|NCT00112437|18379868|P3|Years 6-10 (60-Month Extension)|Other|0
5340127|NCT00112437|18379869|P2|Years 6-10 (60-Month Extension)|Other|0
5340128|NCT00112437|18379870|P1|Years 6-10 (60-Month Extension)|Other|0
5340129|NCT00112437|18379845|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
5340130|NCT00112437|18379846|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340131|NCT00112437|18379847|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340132|NCT00112437|18379848|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340133|NCT00112437|18379849|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340134|NCT00112437|18379850|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340135|NCT00112437|18379851|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340136|NCT00112437|18379852|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340137|NCT00112437|18379853|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340138|NCT00112437|18379854|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340139|NCT00112437|18379855|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340140|NCT00112437|18379856|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340141|NCT00112437|18379857|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340142|NCT00112437|18379858|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340143|NCT00112437|18379859|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340144|NCT00112437|18379860|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340889|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|Adverse Event|0
5340145|NCT00112437|18379861|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340146|NCT00112437|18379862|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340147|NCT00112437|18379863|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340148|NCT00112437|18379864|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340149|NCT00112437|18379865|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340150|NCT00112437|18379866|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340151|NCT00112437|18379867|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340152|NCT00112437|18379868|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340153|NCT00112437|18379869|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340154|NCT00112437|18379870|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5340155|NCT00112437|18379845|P26|Years 6-10 (60-Month Extension)|Death|0
5340156|NCT00112437|18379846|P25|Years 6-10 (60-Month Extension)|Death|0
5340157|NCT00112437|18379847|P24|Years 6-10 (60-Month Extension)|Death|2
5340158|NCT00112437|18379848|P23|Years 6-10 (60-Month Extension)|Death|0
5340159|NCT00112437|18379849|P22|Years 6-10 (60-Month Extension)|Death|0
5340160|NCT00112437|18379850|P21|Years 6-10 (60-Month Extension)|Death|0
5340161|NCT00112437|18379851|P20|Years 6-10 (60-Month Extension)|Death|0
5340162|NCT00112437|18379852|P19|Years 6-10 (60-Month Extension)|Death|0
5340163|NCT00112437|18379853|P18|Years 6-10 (60-Month Extension)|Death|0
5340164|NCT00112437|18379854|P17|Years 6-10 (60-Month Extension)|Death|0
5340165|NCT00112437|18379855|P16|Years 6-10 (60-Month Extension)|Death|0
5340166|NCT00112437|18379856|P15|Years 6-10 (60-Month Extension)|Death|0
5340167|NCT00112437|18379857|P14|Years 6-10 (60-Month Extension)|Death|0
5340168|NCT00112437|18379858|P13|Years 6-10 (60-Month Extension)|Death|0
5340169|NCT00112437|18379859|P12|Years 6-10 (60-Month Extension)|Death|0
5340170|NCT00112437|18379860|P11|Years 6-10 (60-Month Extension)|Death|0
5340171|NCT00112437|18379861|P10|Years 6-10 (60-Month Extension)|Death|0
5340172|NCT00112437|18379862|P9|Years 6-10 (60-Month Extension)|Death|0
5340173|NCT00112437|18379863|P8|Years 6-10 (60-Month Extension)|Death|0
5340174|NCT00112437|18379864|P7|Years 6-10 (60-Month Extension)|Death|0
5340175|NCT00112437|18379865|P6|Years 6-10 (60-Month Extension)|Death|0
5340176|NCT00112437|18379866|P5|Years 6-10 (60-Month Extension)|Death|0
5340177|NCT00112437|18379867|P4|Years 6-10 (60-Month Extension)|Death|0
5340178|NCT00112437|18379868|P3|Years 6-10 (60-Month Extension)|Death|0
5340179|NCT00112437|18379869|P2|Years 6-10 (60-Month Extension)|Death|0
5340180|NCT00112437|18379870|P1|Years 6-10 (60-Month Extension)|Death|0
5340181|NCT00112437|18379845|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
5340182|NCT00112437|18379846|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
5340183|NCT00112437|18379847|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
5340184|NCT00112437|18379848|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
5340185|NCT00112437|18379849|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
5340186|NCT00112437|18379850|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
5340187|NCT00112437|18379851|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
5340188|NCT00112437|18379852|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
5340189|NCT00112437|18379853|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
5340190|NCT00112437|18379854|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
5340191|NCT00112437|18379855|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
5340192|NCT00112437|18379856|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
5340193|NCT00112437|18379857|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
5340194|NCT00112437|18379858|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
5340195|NCT00112437|18379859|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
5340196|NCT00112437|18379860|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
5340197|NCT00112437|18379861|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
5340198|NCT00112437|18379862|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
5340199|NCT00112437|18379863|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
5340200|NCT00112437|18379864|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
5340201|NCT00112437|18379865|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
5340202|NCT00112437|18379866|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
5340203|NCT00112437|18379867|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
5340204|NCT00112437|18379868|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
5340205|NCT00112437|18379869|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
5340206|NCT00112437|18379870|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
5340207|NCT00112437|18379845|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340208|NCT00112437|18379846|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340209|NCT00112437|18379847|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340210|NCT00112437|18379848|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340211|NCT00112437|18379849|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
5340212|NCT00112437|18379850|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
5340213|NCT00112437|18379851|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340214|NCT00112437|18379852|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340215|NCT00112437|18379853|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340216|NCT00112437|18379854|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340217|NCT00112437|18379855|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340218|NCT00112437|18379856|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340219|NCT00112437|18379857|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340220|NCT00112437|18379858|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340221|NCT00112437|18379859|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340222|NCT00112437|18379860|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340223|NCT00112437|18379861|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340224|NCT00112437|18379862|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340225|NCT00112437|18379863|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340226|NCT00112437|18379864|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340227|NCT00112437|18379865|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340228|NCT00112437|18379866|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340229|NCT00112437|18379867|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340230|NCT00112437|18379868|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340231|NCT00112437|18379869|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340232|NCT00112437|18379870|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5340233|NCT00112437|18379845|P26|Years 4-5 (24-Month Extension)|Participant moved|0
5340234|NCT00112437|18379846|P25|Years 4-5 (24-Month Extension)|Participant moved|0
5340235|NCT00112437|18379847|P24|Years 4-5 (24-Month Extension)|Participant moved|0
5340236|NCT00112437|18379848|P23|Years 4-5 (24-Month Extension)|Participant moved|0
5340237|NCT00112437|18379849|P22|Years 4-5 (24-Month Extension)|Participant moved|1
5340238|NCT00112437|18379850|P21|Years 4-5 (24-Month Extension)|Participant moved|0
5340239|NCT00112437|18379851|P20|Years 4-5 (24-Month Extension)|Participant moved|0
5340240|NCT00112437|18379852|P19|Years 4-5 (24-Month Extension)|Participant moved|0
5340241|NCT00112437|18379853|P18|Years 4-5 (24-Month Extension)|Participant moved|0
5340242|NCT00112437|18379854|P17|Years 4-5 (24-Month Extension)|Participant moved|0
5340243|NCT00112437|18379855|P16|Years 4-5 (24-Month Extension)|Participant moved|0
5340244|NCT00112437|18379856|P15|Years 4-5 (24-Month Extension)|Participant moved|0
5340245|NCT00112437|18379857|P14|Years 4-5 (24-Month Extension)|Participant moved|0
5340246|NCT00112437|18379858|P13|Years 4-5 (24-Month Extension)|Participant moved|0
5340247|NCT00112437|18379859|P12|Years 4-5 (24-Month Extension)|Participant moved|0
5340248|NCT00112437|18379860|P11|Years 4-5 (24-Month Extension)|Participant moved|0
5340249|NCT00112437|18379861|P10|Years 4-5 (24-Month Extension)|Participant moved|0
5340250|NCT00112437|18379862|P9|Years 4-5 (24-Month Extension)|Participant moved|0
5340251|NCT00112437|18379863|P8|Years 4-5 (24-Month Extension)|Participant moved|0
5340252|NCT00112437|18379864|P7|Years 4-5 (24-Month Extension)|Participant moved|0
5340253|NCT00112437|18379865|P6|Years 4-5 (24-Month Extension)|Participant moved|0
5340254|NCT00112437|18379866|P5|Years 4-5 (24-Month Extension)|Participant moved|0
5340255|NCT00112437|18379867|P4|Years 4-5 (24-Month Extension)|Participant moved|0
5340256|NCT00112437|18379868|P3|Years 4-5 (24-Month Extension)|Participant moved|0
5340257|NCT00112437|18379869|P2|Years 4-5 (24-Month Extension)|Participant moved|0
5340258|NCT00112437|18379870|P1|Years 4-5 (24-Month Extension)|Participant moved|0
5340259|NCT00112437|18379845|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
5340260|NCT00112437|18379846|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
5340261|NCT00112437|18379847|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
5340262|NCT00112437|18379848|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
5340263|NCT00112437|18379849|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
5340264|NCT00112437|18379850|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
5340265|NCT00112437|18379851|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
5340266|NCT00112437|18379852|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
5340267|NCT00112437|18379853|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
5340268|NCT00112437|18379854|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
5340269|NCT00112437|18379855|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
5340270|NCT00112437|18379856|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
5340271|NCT00112437|18379857|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
5340272|NCT00112437|18379858|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
5340273|NCT00112437|18379859|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
5340274|NCT00112437|18379860|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
5340275|NCT00112437|18379861|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
5340276|NCT00112437|18379862|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
5340277|NCT00112437|18379863|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
5340278|NCT00112437|18379864|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
5340279|NCT00112437|18379865|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
5340280|NCT00112437|18379866|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
5340281|NCT00112437|18379867|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
5340282|NCT00112437|18379868|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
5340283|NCT00112437|18379869|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
5340284|NCT00112437|18379870|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
5340285|NCT00112437|18379845|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340286|NCT00112437|18379846|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340287|NCT00112437|18379847|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340288|NCT00112437|18379848|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340289|NCT00112437|18379849|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340290|NCT00112437|18379850|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
5340291|NCT00112437|18379851|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340292|NCT00112437|18379852|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340293|NCT00112437|18379853|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340294|NCT00112437|18379854|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340295|NCT00112437|18379855|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340296|NCT00112437|18379856|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340297|NCT00112437|18379857|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340298|NCT00112437|18379858|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340299|NCT00112437|18379859|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340300|NCT00112437|18379860|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340301|NCT00112437|18379861|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340302|NCT00112437|18379862|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340303|NCT00112437|18379863|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340304|NCT00112437|18379864|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340305|NCT00112437|18379865|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340306|NCT00112437|18379866|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340307|NCT00112437|18379867|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340308|NCT00112437|18379868|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340309|NCT00112437|18379869|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340310|NCT00112437|18379870|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5340311|NCT00112437|18379845|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340312|NCT00112437|18379846|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340313|NCT00112437|18379847|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340314|NCT00112437|18379848|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340315|NCT00112437|18379849|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
5340316|NCT00112437|18379850|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
5340317|NCT00112437|18379851|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340318|NCT00112437|18379852|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340319|NCT00112437|18379853|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340320|NCT00112437|18379854|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340321|NCT00112437|18379855|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340322|NCT00112437|18379856|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340323|NCT00112437|18379857|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340324|NCT00112437|18379858|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340325|NCT00112437|18379859|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340326|NCT00112437|18379860|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340327|NCT00112437|18379861|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340328|NCT00112437|18379862|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340329|NCT00112437|18379863|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340330|NCT00112437|18379864|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340331|NCT00112437|18379865|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340332|NCT00112437|18379866|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340333|NCT00112437|18379867|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340334|NCT00112437|18379868|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340335|NCT00112437|18379869|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340336|NCT00112437|18379870|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5340337|NCT00112437|18379845|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340338|NCT00112437|18379846|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340339|NCT00112437|18379847|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340340|NCT00112437|18379848|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340341|NCT00112437|18379849|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340342|NCT00112437|18379850|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340343|NCT00112437|18379851|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340344|NCT00112437|18379852|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340345|NCT00112437|18379853|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340346|NCT00112437|18379854|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340347|NCT00112437|18379855|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340348|NCT00112437|18379856|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340349|NCT00112437|18379857|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340350|NCT00112437|18379858|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340351|NCT00112437|18379859|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
5340352|NCT00112437|18379860|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
5340353|NCT00112437|18379861|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340354|NCT00112437|18379862|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340355|NCT00112437|18379863|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340356|NCT00112437|18379864|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340357|NCT00112437|18379865|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340358|NCT00112437|18379866|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340359|NCT00112437|18379867|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340360|NCT00112437|18379868|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340361|NCT00112437|18379869|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340362|NCT00112437|18379870|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5340363|NCT00112437|18379845|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340364|NCT00112437|18379846|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340365|NCT00112437|18379847|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340366|NCT00112437|18379848|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340367|NCT00112437|18379849|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340368|NCT00112437|18379850|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340369|NCT00112437|18379851|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340370|NCT00112437|18379852|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340371|NCT00112437|18379853|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340372|NCT00112437|18379854|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340373|NCT00112437|18379855|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340374|NCT00112437|18379856|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
5340375|NCT00112437|18379857|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340376|NCT00112437|18379858|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340377|NCT00112437|18379859|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
5340378|NCT00112437|18379860|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340379|NCT00112437|18379861|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340380|NCT00112437|18379862|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340381|NCT00112437|18379863|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340382|NCT00112437|18379864|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340383|NCT00112437|18379865|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340384|NCT00112437|18379866|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340385|NCT00112437|18379867|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340386|NCT00112437|18379868|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340387|NCT00112437|18379869|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340388|NCT00112437|18379870|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5340389|NCT00112437|18379845|P26|Year 3 (12-Month Extension)|Protocol Violation|0
5340390|NCT00112437|18379846|P25|Year 3 (12-Month Extension)|Protocol Violation|0
5340391|NCT00112437|18379847|P24|Year 3 (12-Month Extension)|Protocol Violation|0
5340392|NCT00112437|18379848|P23|Year 3 (12-Month Extension)|Protocol Violation|0
5340393|NCT00112437|18379849|P22|Year 3 (12-Month Extension)|Protocol Violation|0
5340394|NCT00112437|18379850|P21|Year 3 (12-Month Extension)|Protocol Violation|0
5340395|NCT00112437|18379851|P20|Year 3 (12-Month Extension)|Protocol Violation|0
5340396|NCT00112437|18379852|P19|Year 3 (12-Month Extension)|Protocol Violation|0
5340397|NCT00112437|18379853|P18|Year 3 (12-Month Extension)|Protocol Violation|0
5340398|NCT00112437|18379854|P17|Year 3 (12-Month Extension)|Protocol Violation|0
5340399|NCT00112437|18379855|P16|Year 3 (12-Month Extension)|Protocol Violation|1
5340400|NCT00112437|18379856|P15|Year 3 (12-Month Extension)|Protocol Violation|0
5340401|NCT00112437|18379857|P14|Year 3 (12-Month Extension)|Protocol Violation|0
5340402|NCT00112437|18379858|P13|Year 3 (12-Month Extension)|Protocol Violation|0
5340403|NCT00112437|18379859|P12|Year 3 (12-Month Extension)|Protocol Violation|0
5340404|NCT00112437|18379860|P11|Year 3 (12-Month Extension)|Protocol Violation|0
5340405|NCT00112437|18379861|P10|Year 3 (12-Month Extension)|Protocol Violation|0
5340406|NCT00112437|18379862|P9|Year 3 (12-Month Extension)|Protocol Violation|0
5340407|NCT00112437|18379863|P8|Year 3 (12-Month Extension)|Protocol Violation|0
5340408|NCT00112437|18379864|P7|Year 3 (12-Month Extension)|Protocol Violation|0
5340409|NCT00112437|18379865|P6|Year 3 (12-Month Extension)|Protocol Violation|0
5340410|NCT00112437|18379866|P5|Year 3 (12-Month Extension)|Protocol Violation|0
5340411|NCT00112437|18379867|P4|Year 3 (12-Month Extension)|Protocol Violation|0
5340412|NCT00112437|18379868|P3|Year 3 (12-Month Extension)|Protocol Violation|0
5340413|NCT00112437|18379869|P2|Year 3 (12-Month Extension)|Protocol Violation|0
5340414|NCT00112437|18379870|P1|Year 3 (12-Month Extension)|Protocol Violation|0
5340415|NCT00112437|18379845|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340416|NCT00112437|18379846|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340417|NCT00112437|18379847|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340418|NCT00112437|18379848|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340419|NCT00112437|18379849|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340420|NCT00112437|18379850|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340421|NCT00112437|18379851|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340422|NCT00112437|18379852|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340423|NCT00112437|18379853|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340424|NCT00112437|18379854|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340425|NCT00112437|18379855|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
5340426|NCT00112437|18379856|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340427|NCT00112437|18379857|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340428|NCT00112437|18379858|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340429|NCT00112437|18379859|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340430|NCT00112437|18379860|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340431|NCT00112437|18379861|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340432|NCT00112437|18379862|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340433|NCT00112437|18379863|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340434|NCT00112437|18379864|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340435|NCT00112437|18379865|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340436|NCT00112437|18379866|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340437|NCT00112437|18379867|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340438|NCT00112437|18379868|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340439|NCT00112437|18379869|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340440|NCT00112437|18379870|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
5340441|NCT00112437|18379845|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340442|NCT00112437|18379846|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340443|NCT00112437|18379847|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340444|NCT00112437|18379848|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340445|NCT00112437|18379849|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340446|NCT00112437|18379850|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340447|NCT00112437|18379851|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340448|NCT00112437|18379852|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
5340449|NCT00112437|18379853|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340450|NCT00112437|18379854|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340451|NCT00112437|18379855|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
5340452|NCT00112437|18379856|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340453|NCT00112437|18379857|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
5340454|NCT00112437|18379858|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340455|NCT00112437|18379859|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
5340456|NCT00112437|18379860|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340457|NCT00112437|18379861|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340458|NCT00112437|18379862|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340459|NCT00112437|18379863|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340460|NCT00112437|18379864|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340461|NCT00112437|18379865|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340462|NCT00112437|18379866|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340463|NCT00112437|18379867|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340464|NCT00112437|18379868|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340465|NCT00112437|18379869|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340466|NCT00112437|18379870|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
5340467|NCT00112437|18379845|P26|Year 3 (12-Month Extension)|Adverse Event|0
5340468|NCT00112437|18379846|P25|Year 3 (12-Month Extension)|Adverse Event|0
5340469|NCT00112437|18379847|P24|Year 3 (12-Month Extension)|Adverse Event|0
5340470|NCT00112437|18379848|P23|Year 3 (12-Month Extension)|Adverse Event|0
5340471|NCT00112437|18379849|P22|Year 3 (12-Month Extension)|Adverse Event|0
5340472|NCT00112437|18379850|P21|Year 3 (12-Month Extension)|Adverse Event|0
5340473|NCT00112437|18379851|P20|Year 3 (12-Month Extension)|Adverse Event|1
5340474|NCT00112437|18379852|P19|Year 3 (12-Month Extension)|Adverse Event|0
5340475|NCT00112437|18379853|P18|Year 3 (12-Month Extension)|Adverse Event|1
5340476|NCT00112437|18379854|P17|Year 3 (12-Month Extension)|Adverse Event|3
5340477|NCT00112437|18379855|P16|Year 3 (12-Month Extension)|Adverse Event|1
5340478|NCT00112437|18379856|P15|Year 3 (12-Month Extension)|Adverse Event|0
5340479|NCT00112437|18379857|P14|Year 3 (12-Month Extension)|Adverse Event|0
5340480|NCT00112437|18379858|P13|Year 3 (12-Month Extension)|Adverse Event|0
5340481|NCT00112437|18379859|P12|Year 3 (12-Month Extension)|Adverse Event|0
5340482|NCT00112437|18379860|P11|Year 3 (12-Month Extension)|Adverse Event|1
5340483|NCT00112437|18379861|P10|Year 3 (12-Month Extension)|Adverse Event|0
5340484|NCT00112437|18379862|P9|Year 3 (12-Month Extension)|Adverse Event|0
5340485|NCT00112437|18379863|P8|Year 3 (12-Month Extension)|Adverse Event|0
5340486|NCT00112437|18379864|P7|Year 3 (12-Month Extension)|Adverse Event|0
5340487|NCT00112437|18379865|P6|Year 3 (12-Month Extension)|Adverse Event|0
5340488|NCT00112437|18379866|P5|Year 3 (12-Month Extension)|Adverse Event|0
5340489|NCT00112437|18379867|P4|Year 3 (12-Month Extension)|Adverse Event|0
5340490|NCT00112437|18379868|P3|Year 3 (12-Month Extension)|Adverse Event|0
5340491|NCT00112437|18379869|P2|Year 3 (12-Month Extension)|Adverse Event|0
5340492|NCT00112437|18379870|P1|Year 3 (12-Month Extension)|Adverse Event|0
5340493|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Moved|0
5340494|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Moved|0
5340495|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Moved|0
5340496|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Moved|0
5340497|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Moved|0
5340498|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Moved|0
5340499|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Moved|0
5340500|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Moved|0
5340501|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Moved|0
5340502|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Moved|0
5340503|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Moved|0
5340504|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Moved|0
5340505|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Moved|0
5340506|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Moved|0
5340507|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Moved|0
5340508|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Moved|0
5340509|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Moved|1
5340510|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Moved|0
5340511|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Moved|0
5340512|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Moved|0
5340513|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Moved|0
5340514|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Moved|0
5340515|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Moved|0
5340516|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Moved|0
5340517|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Moved|0
5340518|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Moved|0
5340519|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|patient was out of windows|0
5340890|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|Adverse Event|0
5340520|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|patient was out of windows|0
5340521|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|patient was out of windows|0
5340522|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|patient was out of windows|0
5340523|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|patient was out of windows|0
5340524|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|patient was out of windows|0
5340525|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|patient was out of windows|0
5340526|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|patient was out of windows|0
5340527|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|patient was out of windows|0
5340528|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|patient was out of windows|0
5340529|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|patient was out of windows|0
5340530|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|patient was out of windows|0
5340531|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|patient was out of windows|0
5340532|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|patient was out of windows|0
5340533|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|patient was out of windows|0
5340534|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|patient was out of windows|0
5340535|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|patient was out of windows|1
5340536|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|patient was out of windows|0
5340537|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|patient was out of windows|0
5340538|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|patient was out of windows|0
5340539|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|patient was out of windows|0
5340540|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|patient was out of windows|0
5340541|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|patient was out of windows|0
5340542|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|patient was out of windows|0
5340543|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|patient was out of windows|0
5340544|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|patient was out of windows|0
5340545|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340546|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340547|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340548|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340549|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340550|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340551|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340552|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340553|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340554|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340555|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340556|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340557|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340558|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340559|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340560|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340561|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
5340562|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340563|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340564|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340565|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340566|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340567|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340568|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340569|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340570|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5340571|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340572|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340573|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340574|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340575|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340576|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340577|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340578|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340579|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340580|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340581|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340582|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340583|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340584|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340585|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340586|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340587|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
5340588|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
5340891|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|Adverse Event|0
5340589|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
5340590|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
5340591|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
5340592|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340593|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340594|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340595|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340596|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5340597|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Protocol Violation|0
5340598|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Protocol Violation|0
5340599|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Protocol Violation|0
5340600|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Protocol Violation|0
5340601|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Protocol Violation|0
5340602|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Protocol Violation|0
5340603|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Protocol Violation|0
5340604|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Protocol Violation|0
5340605|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Protocol Violation|0
5340606|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Protocol Violation|0
5340607|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Protocol Violation|0
5340608|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Protocol Violation|0
5340609|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Protocol Violation|0
5340610|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Protocol Violation|0
5340611|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Protocol Violation|0
5340612|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Protocol Violation|0
5340613|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Protocol Violation|0
5340614|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Protocol Violation|1
5340615|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Protocol Violation|0
5340616|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Protocol Violation|0
5340617|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Protocol Violation|0
5340618|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Protocol Violation|0
5340619|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Protocol Violation|0
5340620|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Protocol Violation|0
5340621|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Protocol Violation|0
5340622|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Protocol Violation|0
5340623|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340624|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340625|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340626|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340627|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340628|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340629|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340630|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340631|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340632|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340633|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340634|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340635|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340636|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340637|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340638|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340639|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340640|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
5340641|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340642|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340643|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340644|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340645|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340646|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340647|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340648|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
5340649|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340650|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340651|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340652|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340653|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340654|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340655|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340656|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340657|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340658|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340659|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340660|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340661|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340662|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340663|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340664|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340665|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
5340666|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340667|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340668|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
5340669|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
5340670|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340671|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340672|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340673|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340674|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
5340675|NCT00112437|18379845|P26|Year 2 (12-Month Extension)|Adverse Event|0
5340676|NCT00112437|18379846|P25|Year 2 (12-Month Extension)|Adverse Event|0
5340677|NCT00112437|18379847|P24|Year 2 (12-Month Extension)|Adverse Event|0
5340678|NCT00112437|18379848|P23|Year 2 (12-Month Extension)|Adverse Event|0
5340679|NCT00112437|18379849|P22|Year 2 (12-Month Extension)|Adverse Event|0
5340680|NCT00112437|18379850|P21|Year 2 (12-Month Extension)|Adverse Event|0
5340681|NCT00112437|18379851|P20|Year 2 (12-Month Extension)|Adverse Event|0
5340682|NCT00112437|18379852|P19|Year 2 (12-Month Extension)|Adverse Event|0
5340683|NCT00112437|18379853|P18|Year 2 (12-Month Extension)|Adverse Event|0
5340684|NCT00112437|18379854|P17|Year 2 (12-Month Extension)|Adverse Event|0
5340685|NCT00112437|18379855|P16|Year 2 (12-Month Extension)|Adverse Event|0
5340686|NCT00112437|18379856|P15|Year 2 (12-Month Extension)|Adverse Event|0
5340687|NCT00112437|18379857|P14|Year 2 (12-Month Extension)|Adverse Event|0
5340688|NCT00112437|18379858|P13|Year 2 (12-Month Extension)|Adverse Event|0
5340689|NCT00112437|18379859|P12|Year 2 (12-Month Extension)|Adverse Event|0
5340690|NCT00112437|18379860|P11|Year 2 (12-Month Extension)|Adverse Event|0
5340691|NCT00112437|18379861|P10|Year 2 (12-Month Extension)|Adverse Event|7
5340692|NCT00112437|18379862|P9|Year 2 (12-Month Extension)|Adverse Event|1
5340693|NCT00112437|18379863|P8|Year 2 (12-Month Extension)|Adverse Event|6
5340694|NCT00112437|18379864|P7|Year 2 (12-Month Extension)|Adverse Event|2
5340695|NCT00112437|18379865|P6|Year 2 (12-Month Extension)|Adverse Event|1
5340696|NCT00112437|18379866|P5|Year 2 (12-Month Extension)|Adverse Event|0
5340697|NCT00112437|18379867|P4|Year 2 (12-Month Extension)|Adverse Event|0
5340698|NCT00112437|18379868|P3|Year 2 (12-Month Extension)|Adverse Event|0
5340699|NCT00112437|18379869|P2|Year 2 (12-Month Extension)|Adverse Event|0
5340700|NCT00112437|18379870|P1|Year 2 (12-Month Extension)|Adverse Event|0
5340701|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340702|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340703|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340704|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340705|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340706|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340707|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340708|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340709|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340710|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340711|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340712|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340713|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340714|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340715|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340716|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340717|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340718|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340719|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340720|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340721|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340722|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
5340723|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340724|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340725|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340726|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5340727|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340728|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340729|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340730|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340731|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340732|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340733|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340734|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340735|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340736|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340892|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|Adverse Event|0
5340737|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340738|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340739|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340740|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340741|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340742|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340743|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340744|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340745|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340746|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340747|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340748|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340749|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
5340750|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340751|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340752|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5340753|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|moved|0
5340754|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|moved|0
5340755|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|moved|0
5340756|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|moved|0
5340757|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|moved|0
5340758|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|moved|0
5340759|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|moved|0
5340760|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|moved|0
5340761|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|moved|0
5340762|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|moved|0
5340763|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|moved|0
5340764|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|moved|0
5340765|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|moved|0
5340766|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|moved|0
5340767|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|moved|0
5340768|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|moved|0
5340769|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|moved|0
5340770|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|moved|0
5340771|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|moved|0
5340772|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|moved|0
5340773|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|moved|0
5340774|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|moved|0
5340775|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|moved|0
5340776|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|moved|1
5340777|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|moved|1
5340778|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|moved|0
5340779|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340780|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340781|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340782|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340783|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340784|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340785|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340786|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340787|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340788|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340789|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340790|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340791|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340792|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340793|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340794|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340795|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340796|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340797|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340798|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340799|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5340800|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
5340801|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
5340802|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
5340803|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
5340804|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
5340805|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
5340806|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
5340807|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
5340808|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
5340809|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
5340810|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
5340811|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
5340893|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|Adverse Event|0
5340812|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
5340813|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
5340814|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
5340815|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
5340816|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
5340817|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
5340818|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
5340819|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
5340820|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
5340821|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
5340822|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
5340823|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
5340824|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
5340825|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
5340826|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
5340827|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
5340828|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
5340829|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
5340830|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
5340831|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340832|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340833|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340834|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340835|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340836|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340837|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340838|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340839|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340840|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340841|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340842|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340843|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340844|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340845|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340846|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340847|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340848|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340849|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340850|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340851|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340852|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340853|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340854|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340855|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
5340856|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5340857|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340858|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340859|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340860|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340861|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340862|NCT00112437|18379850|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340863|NCT00112437|18379851|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340864|NCT00112437|18379852|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340865|NCT00112437|18379853|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340866|NCT00112437|18379854|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340867|NCT00112437|18379855|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340868|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340869|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340870|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340871|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340872|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340873|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340874|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340875|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340876|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340877|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340878|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340879|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340880|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340881|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
5340882|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5340883|NCT00112437|18379845|P26|Year 1 (12-Month Base Study)|Adverse Event|0
5340884|NCT00112437|18379846|P25|Year 1 (12-Month Base Study)|Adverse Event|0
5340885|NCT00112437|18379847|P24|Year 1 (12-Month Base Study)|Adverse Event|0
5340886|NCT00112437|18379848|P23|Year 1 (12-Month Base Study)|Adverse Event|0
5340887|NCT00112437|18379849|P22|Year 1 (12-Month Base Study)|Adverse Event|0
5340894|NCT00112437|18379856|P15|Year 1 (12-Month Base Study)|Adverse Event|0
5340895|NCT00112437|18379857|P14|Year 1 (12-Month Base Study)|Adverse Event|0
5340896|NCT00112437|18379858|P13|Year 1 (12-Month Base Study)|Adverse Event|0
5340897|NCT00112437|18379859|P12|Year 1 (12-Month Base Study)|Adverse Event|0
5340898|NCT00112437|18379860|P11|Year 1 (12-Month Base Study)|Adverse Event|0
5340899|NCT00112437|18379861|P10|Year 1 (12-Month Base Study)|Adverse Event|0
5340900|NCT00112437|18379862|P9|Year 1 (12-Month Base Study)|Adverse Event|0
5340901|NCT00112437|18379863|P8|Year 1 (12-Month Base Study)|Adverse Event|0
5340902|NCT00112437|18379864|P7|Year 1 (12-Month Base Study)|Adverse Event|0
5340903|NCT00112437|18379865|P6|Year 1 (12-Month Base Study)|Adverse Event|0
5340904|NCT00112437|18379866|P5|Year 1 (12-Month Base Study)|Adverse Event|3
5340905|NCT00112437|18379867|P4|Year 1 (12-Month Base Study)|Adverse Event|4
5340906|NCT00112437|18379868|P3|Year 1 (12-Month Base Study)|Adverse Event|6
5340907|NCT00112437|18379869|P2|Year 1 (12-Month Base Study)|Adverse Event|10
5340908|NCT00112437|18379870|P1|Year 1 (12-Month Base Study)|Adverse Event|9
5340909|NCT00112385|18380150|P2|Overall Study|Withdrawal by Subject|1
5340910|NCT00112385|18380151|P1|Overall Study|Withdrawal by Subject|0
5340911|NCT00112385|18380150|P2|Overall Study|Lost to Follow-up|0
5340912|NCT00112385|18380151|P1|Overall Study|Lost to Follow-up|1
5340913|NCT00112359|18380241|P2|Overall Study|Other|0
5340914|NCT00112359|18380242|P1|Overall Study|Other|3
5340915|NCT00112359|18380241|P2|Overall Study|Personal/administrative|1
5340916|NCT00112359|18380242|P1|Overall Study|Personal/administrative|1
5340917|NCT00112359|18380241|P2|Overall Study|Lost to Follow-up|1
5340918|NCT00112359|18380242|P1|Overall Study|Lost to Follow-up|0
5340919|NCT00112359|18380241|P2|Overall Study|Related adverse event|3
5340920|NCT00112359|18380242|P1|Overall Study|Related adverse event|5
5340921|NCT00112359|18380241|P2|Overall Study|Trial drug intolerance (adverse event)|0
5340922|NCT00112359|18380242|P1|Overall Study|Trial drug intolerance (adverse event)|2
5340923|NCT00112359|18380241|P2|Overall Study|Unrelated adverse event|8
5340924|NCT00112359|18380242|P1|Overall Study|Unrelated adverse event|16
5340925|NCT00112294|18380268|P2|Overall Study|Still on study|0
5340926|NCT00112294|18380269|P1|Overall Study|Still on study|5
5340927|NCT00112047|18380577|P2|Atripla Phase|Other|1
5340928|NCT00112047|18380578|P1|Atripla Phase|Other|3
5340929|NCT00112047|18380577|P2|Atripla Phase|Non-compliance|0
5340930|NCT00112047|18380578|P1|Atripla Phase|Non-compliance|1
5340931|NCT00112047|18380577|P2|Atripla Phase|Sub-optimal virological response|1
5340932|NCT00112047|18380578|P1|Atripla Phase|Sub-optimal virological response|0
5340933|NCT00112047|18380577|P2|Atripla Phase|Withdrew consent|7
5340934|NCT00112047|18380578|P1|Atripla Phase|Withdrew consent|7
5340935|NCT00112047|18380577|P2|Atripla Phase|Death|2
5340936|NCT00112047|18380578|P1|Atripla Phase|Death|0
5340937|NCT00112047|18380577|P2|Atripla Phase|Pregnancy|1
5340938|NCT00112047|18380578|P1|Atripla Phase|Pregnancy|0
5340939|NCT00112047|18380577|P2|Atripla Phase|Lost to Follow-up|7
5340940|NCT00112047|18380578|P1|Atripla Phase|Lost to Follow-up|5
5340941|NCT00112047|18380577|P2|Atripla Phase|Adverse Event|1
5340942|NCT00112047|18380578|P1|Atripla Phase|Adverse Event|2
5340943|NCT00112047|18380577|P2|Randomized Phase|High Hepatitis B DNA|1
5340944|NCT00112047|18380578|P1|Randomized Phase|High Hepatitis B DNA|0
5340945|NCT00112047|18380577|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
5340946|NCT00112047|18380578|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
5340947|NCT00112047|18380577|P2|Randomized Phase|Moved out of State|1
5340948|NCT00112047|18380578|P1|Randomized Phase|Moved out of State|0
5340949|NCT00112047|18380577|P2|Randomized Phase|Incarceration|2
5340950|NCT00112047|18380578|P1|Randomized Phase|Incarceration|3
5340951|NCT00112047|18380577|P2|Randomized Phase|Inability to swallow pills|1
5340952|NCT00112047|18380578|P1|Randomized Phase|Inability to swallow pills|0
5340953|NCT00112047|18380577|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
5340954|NCT00112047|18380578|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
5340955|NCT00112047|18380577|P2|Randomized Phase|Death|3
5340956|NCT00112047|18380578|P1|Randomized Phase|Death|1
5340957|NCT00112047|18380577|P2|Randomized Phase|Pregnancy|1
5340958|NCT00112047|18380578|P1|Randomized Phase|Pregnancy|3
5340959|NCT00112047|18380577|P2|Randomized Phase|Protocol Violation|0
5340960|NCT00112047|18380578|P1|Randomized Phase|Protocol Violation|2
5340961|NCT00112047|18380577|P2|Randomized Phase|Noncompliance|4
5340962|NCT00112047|18380578|P1|Randomized Phase|Noncompliance|8
5340963|NCT00112047|18380577|P2|Randomized Phase|Sub-optimal virological response|13
5340964|NCT00112047|18380578|P1|Randomized Phase|Sub-optimal virological response|3
5340965|NCT00112047|18380577|P2|Randomized Phase|Withrawal of consent|18
5340966|NCT00112047|18380578|P1|Randomized Phase|Withrawal of consent|10
5340967|NCT00112047|18380577|P2|Randomized Phase|Adverse Event|10
5340968|NCT00112047|18380578|P1|Randomized Phase|Adverse Event|10
5340969|NCT00112047|18380577|P2|Randomized Phase|Lost to Follow-up|33
5340970|NCT00112047|18380578|P1|Randomized Phase|Lost to Follow-up|26
5340971|NCT00111917|18380678|P2|Overall Study|Withdrawal by Subject|1
5340972|NCT00111917|18380679|P1|Overall Study|Withdrawal by Subject|1
5340973|NCT00111839|18380694|P3|Overall Study|Randomized but Not Treated|2
5340974|NCT00111839|18380695|P2|Overall Study|Randomized but Not Treated|0
5340975|NCT00111839|18380696|P1|Overall Study|Randomized but Not Treated|0
5340976|NCT00111839|18380694|P3|Overall Study|Other|3
5340977|NCT00111839|18380695|P2|Overall Study|Other|3
5340978|NCT00111839|18380696|P1|Overall Study|Other|6
5340979|NCT00111839|18380694|P3|Overall Study|Logistical Constraint|0
5340980|NCT00111839|18380695|P2|Overall Study|Logistical Constraint|0
5340981|NCT00111839|18380696|P1|Overall Study|Logistical Constraint|1
5340982|NCT00111839|18380694|P3|Overall Study|Lost to Follow-up|0
5340983|NCT00111839|18380695|P2|Overall Study|Lost to Follow-up|0
5340984|NCT00111839|18380696|P1|Overall Study|Lost to Follow-up|1
5340985|NCT00111839|18380694|P3|Overall Study|Withdrawal by Subject|2
5340986|NCT00111839|18380695|P2|Overall Study|Withdrawal by Subject|2
5340987|NCT00111839|18380696|P1|Overall Study|Withdrawal by Subject|2
5340988|NCT00111839|18380694|P3|Overall Study|Death|6
5340989|NCT00111839|18380695|P2|Overall Study|Death|1
5340990|NCT00111839|18380696|P1|Overall Study|Death|1
5340991|NCT00111839|18380694|P3|Overall Study|Protocol Violation|2
5340992|NCT00111839|18380695|P2|Overall Study|Protocol Violation|4
5340993|NCT00111839|18380696|P1|Overall Study|Protocol Violation|2
5340994|NCT00111839|18380694|P3|Overall Study|Adverse Event|1
5340995|NCT00111839|18380695|P2|Overall Study|Adverse Event|3
5340996|NCT00111839|18380696|P1|Overall Study|Adverse Event|5
5340997|NCT00111839|18380694|P3|Overall Study|Disease Progression|33
5340998|NCT00111839|18380695|P2|Overall Study|Disease Progression|33
5340999|NCT00111839|18380696|P1|Overall Study|Disease Progression|30
5341000|NCT00111813|18380716|P6|Overall Study|Other|0
5341001|NCT00111813|18380717|P5|Overall Study|Other|0
5341002|NCT00111813|18380718|P4|Overall Study|Other|0
5341003|NCT00111813|18380719|P3|Overall Study|Other|1
5341004|NCT00111813|18380720|P2|Overall Study|Other|0
5341005|NCT00111813|18380721|P1|Overall Study|Other|0
5341006|NCT00111813|18380716|P6|Overall Study|Lack of Efficacy|1
5341007|NCT00111813|18380717|P5|Overall Study|Lack of Efficacy|0
5341008|NCT00111813|18380718|P4|Overall Study|Lack of Efficacy|0
5341009|NCT00111813|18380719|P3|Overall Study|Lack of Efficacy|0
5341010|NCT00111813|18380720|P2|Overall Study|Lack of Efficacy|0
5341011|NCT00111813|18380721|P1|Overall Study|Lack of Efficacy|0
5341012|NCT00111813|18380716|P6|Overall Study|Progressive disease|3
5341013|NCT00111813|18380717|P5|Overall Study|Progressive disease|4
5341014|NCT00111813|18380718|P4|Overall Study|Progressive disease|3
5341015|NCT00111813|18380719|P3|Overall Study|Progressive disease|5
5341016|NCT00111813|18380720|P2|Overall Study|Progressive disease|1
5341017|NCT00111813|18380721|P1|Overall Study|Progressive disease|2
5341018|NCT00111813|18380716|P6|Overall Study|Adverse Event|2
5341019|NCT00111813|18380717|P5|Overall Study|Adverse Event|2
5341020|NCT00111813|18380718|P4|Overall Study|Adverse Event|2
5341021|NCT00111813|18380719|P3|Overall Study|Adverse Event|4
5341022|NCT00111813|18380720|P2|Overall Study|Adverse Event|2
5341023|NCT00111813|18380721|P1|Overall Study|Adverse Event|1
5341024|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5341025|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5341026|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5341027|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
5341028|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5341029|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5341030|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5341031|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5341032|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5341033|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
5341034|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5341035|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5341036|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5341037|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5341038|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5341039|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5341040|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
5341041|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5341042|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5341043|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5341044|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5341045|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
5341046|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5341047|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5341048|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5341049|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
5341050|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5341051|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5341052|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
5341053|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5341054|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
5341055|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
5341056|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
5341057|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
5341058|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
5341059|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
5341060|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5341061|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5341062|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5341063|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
5341064|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
5341065|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5341066|NCT00111800|18380760|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
5341067|NCT00111800|18380761|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
5341068|NCT00111800|18380762|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
5341069|NCT00111800|18380763|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
5341070|NCT00111800|18380764|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
5341071|NCT00111800|18380765|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
5341072|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
5341073|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5341074|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5341075|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5341076|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5341077|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5341078|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5341079|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
5341080|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5341081|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5341082|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5341083|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5341084|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5341085|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
5341086|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5341087|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5341088|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5341089|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5341090|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5341091|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5341092|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
5341093|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5341094|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5341095|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5341096|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5341097|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5341098|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
5341099|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5341100|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5341101|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5341102|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5341103|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5341104|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5341105|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5341106|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
5341107|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5341108|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5341109|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5341110|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5341111|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5341112|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
5341113|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5341114|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5341115|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5341116|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5341117|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5341118|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
5341119|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5341120|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5341121|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5341122|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5341123|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5341124|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
5341125|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5341126|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5341127|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5341128|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5341129|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5341130|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5341131|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
5341132|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5341133|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5341134|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5341135|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5341136|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
5341137|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
5341138|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
5341139|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
5341140|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
5341141|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
5341142|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
5341143|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
5341144|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5341145|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
5341146|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5341147|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5341148|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5341149|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
5341150|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5341151|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5341152|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
5341153|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5341154|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5341155|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
5341156|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
5341157|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
5341158|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
5341159|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
5341160|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
5341161|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
5341162|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
5341163|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
5341164|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
5341165|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
5341166|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
5341167|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
5341168|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
5341169|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
5341170|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
5341171|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
5341172|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
5341173|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
5341174|NCT00111800|18380760|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
5341175|NCT00111800|18380761|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
5341176|NCT00111800|18380762|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
5341177|NCT00111800|18380763|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
5341178|NCT00111800|18380764|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
5341179|NCT00111800|18380765|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
5341180|NCT00111761|18380935|P2|Part 2|Other|0
5341181|NCT00111761|18380936|P1|Part 2|Other|1
5341182|NCT00111761|18380935|P2|Part 2|Protocol-specified criteria|0
5341183|NCT00111761|18380936|P1|Part 2|Protocol-specified criteria|1
5341184|NCT00111761|18380935|P2|Part 2|Disease progression|0
5341185|NCT00111761|18380936|P1|Part 2|Disease progression|3
5341186|NCT00111761|18380935|P2|Part 2|Death|0
5341187|NCT00111761|18380936|P1|Part 2|Death|1
5341188|NCT00111761|18380935|P2|Part 2|Physician Decision|0
5341189|NCT00111761|18380936|P1|Part 2|Physician Decision|1
5341190|NCT00111761|18380935|P2|Part 2|Adverse Event|0
5341191|NCT00111761|18380936|P1|Part 2|Adverse Event|1
5341192|NCT00111761|18380935|P2|Part 1|Withdrawal by Subject|1
5341193|NCT00111761|18380936|P1|Part 1|Withdrawal by Subject|0
5341194|NCT00111761|18380935|P2|Part 1|Other|1
5341195|NCT00111761|18380936|P1|Part 1|Other|0
5341196|NCT00111761|18380935|P2|Part 1|Death|2
5341197|NCT00111761|18380936|P1|Part 1|Death|0
5341198|NCT00111761|18380935|P2|Part 1|Physician Decision|1
5341199|NCT00111761|18380936|P1|Part 1|Physician Decision|0
5341200|NCT00111475|18380973|P10|Overall Study|Lost to Follow-up|0
5341201|NCT00111475|18380974|P9|Overall Study|Lost to Follow-up|0
5341202|NCT00111475|18380975|P8|Overall Study|Lost to Follow-up|0
5341203|NCT00111475|18380976|P7|Overall Study|Lost to Follow-up|0
5341204|NCT00111475|18380977|P6|Overall Study|Lost to Follow-up|1
5341205|NCT00111475|18380978|P5|Overall Study|Lost to Follow-up|0
5341206|NCT00111475|18380979|P4|Overall Study|Lost to Follow-up|0
5341207|NCT00111475|18380980|P3|Overall Study|Lost to Follow-up|0
5341208|NCT00111475|18380981|P2|Overall Study|Lost to Follow-up|0
5341209|NCT00111475|18380982|P1|Overall Study|Lost to Follow-up|0
5341210|NCT00111241|18381100|P2|Overall Study|Adverse Event|0
5341211|NCT00111241|18381101|P1|Overall Study|Adverse Event|1
5341212|NCT00111241|18381100|P2|Overall Study|Protocol Violation|8
5341213|NCT00111241|18381101|P1|Overall Study|Protocol Violation|9
5341214|NCT00111241|18381100|P2|Overall Study|Withdrawal by Subject|0
5341215|NCT00111241|18381101|P1|Overall Study|Withdrawal by Subject|4
5341216|NCT00111241|18381100|P2|Overall Study|Lost to Follow-up|0
5341217|NCT00111241|18381101|P1|Overall Study|Lost to Follow-up|1
5341218|NCT00111228|18381112|P3|Overall Study|Withdrawal by Subject|0
5341219|NCT00111228|18381113|P2|Overall Study|Withdrawal by Subject|1
5341220|NCT00111228|18381114|P1|Overall Study|Withdrawal by Subject|5
5341221|NCT00111007|18381127|P2|Long Term Follow-up|Missing|3
5341222|NCT00111007|18381128|P1|Long Term Follow-up|Missing|10
5341223|NCT00111007|18381127|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
5341224|NCT00111007|18381128|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
5341225|NCT00111007|18381127|P2|Long Term Follow-up|Withdrawal by Subject|1
5341226|NCT00111007|18381128|P1|Long Term Follow-up|Withdrawal by Subject|0
5341227|NCT00111007|18381127|P2|Long Term Follow-up|Lost to Follow-up|1
5341228|NCT00111007|18381128|P1|Long Term Follow-up|Lost to Follow-up|1
5341229|NCT00111007|18381127|P2|Long Term Follow-up|Death|39
5341230|NCT00111007|18381128|P1|Long Term Follow-up|Death|34
5341231|NCT00111007|18381127|P2|Active Follow-up|Disease progression/recurrence/relapse|2
5341232|NCT00111007|18381128|P1|Active Follow-up|Disease progression/recurrence/relapse|3
5341233|NCT00111007|18381127|P2|Active Follow-up|Death|0
5341234|NCT00111007|18381128|P1|Active Follow-up|Death|2
5341235|NCT00111007|18381127|P2|Active Follow-up|Adverse Event|0
5341236|NCT00111007|18381128|P1|Active Follow-up|Adverse Event|1
5341237|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Primary reason with other category|1
5341238|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Primary reason with other category|0
5341239|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
5341240|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
5341241|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
5341242|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
5341243|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Relapse|0
5341244|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Relapse|1
5341245|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
5341246|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
5341247|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
5341248|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
5341249|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Protocol Violation|1
5341250|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Protocol Violation|0
5341251|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Death|2
5341252|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Death|5
5341253|NCT00111007|18381127|P2|Double-blind (DB) Treatment|Adverse Event|4
5341254|NCT00111007|18381128|P1|Double-blind (DB) Treatment|Adverse Event|12
5341255|NCT00110994|18381144|P2|Long Term Follow-up|Death|17
5341256|NCT00110994|18381145|P1|Long Term Follow-up|Death|19
5341257|NCT00110994|18381144|P2|Active Follow-up|Other reasons|2
5341258|NCT00110994|18381145|P1|Active Follow-up|Other reasons|0
5341259|NCT00110994|18381144|P2|Active Follow-up|Disease progression/recurrence/replace|0
5341260|NCT00110994|18381145|P1|Active Follow-up|Disease progression/recurrence/replace|1
5341261|NCT00110994|18381144|P2|Double-blind (DB) Treatment|other reasons|3
5341262|NCT00110994|18381145|P1|Double-blind (DB) Treatment|other reasons|2
5341263|NCT00110994|18381144|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
5341264|NCT00110994|18381145|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
5341265|NCT00110994|18381144|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
5341266|NCT00110994|18381145|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
5341267|NCT00110994|18381144|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
5341268|NCT00110994|18381145|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
5341269|NCT00110994|18381144|P2|Double-blind (DB) Treatment|Death|0
5341270|NCT00110994|18381145|P1|Double-blind (DB) Treatment|Death|1
5341271|NCT00110994|18381144|P2|Double-blind (DB) Treatment|Adverse Event|0
5341272|NCT00110994|18381145|P1|Double-blind (DB) Treatment|Adverse Event|3
5341273|NCT00110890|18381171|P2|Overall Study|Did not enter follow-up phase|4
5341274|NCT00110890|18381172|P1|Overall Study|Did not enter follow-up phase|10
5341275|NCT00110890|18381171|P2|Overall Study|Parathyroidectomy|1
5341276|NCT00110890|18381172|P1|Overall Study|Parathyroidectomy|0
5341277|NCT00110890|18381171|P2|Overall Study|Disease progression|1
5341278|NCT00110890|18381172|P1|Overall Study|Disease progression|0
5341279|NCT00110890|18381171|P2|Overall Study|Requirement for alternative therapy|1
5341280|NCT00110890|18381172|P1|Overall Study|Requirement for alternative therapy|0
5341281|NCT00110890|18381171|P2|Overall Study|Ineligibility determined|0
5341282|NCT00110890|18381172|P1|Overall Study|Ineligibility determined|3
5341283|NCT00110890|18381171|P2|Overall Study|Other|23
5341284|NCT00110890|18381172|P1|Overall Study|Other|34
5341285|NCT00110890|18381171|P2|Overall Study|Invest. Product Commercially Available|110
5341286|NCT00110890|18381172|P1|Overall Study|Invest. Product Commercially Available|217
5341287|NCT00110890|18381171|P2|Overall Study|Kidney Transplant|12
5341288|NCT00110890|18381172|P1|Overall Study|Kidney Transplant|16
5341289|NCT00110890|18381171|P2|Overall Study|Noncompliance|0
5341290|NCT00110890|18381172|P1|Overall Study|Noncompliance|10
5341291|NCT00110890|18381171|P2|Overall Study|Protocol Deviation|0
5341292|NCT00110890|18381172|P1|Overall Study|Protocol Deviation|1
5341293|NCT00110890|18381171|P2|Overall Study|Withdrawal by Subject|5
5341294|NCT00110890|18381172|P1|Overall Study|Withdrawal by Subject|17
5341295|NCT00110890|18381171|P2|Overall Study|Physician Decision|5
5341296|NCT00110890|18381172|P1|Overall Study|Physician Decision|4
5341297|NCT00110890|18381171|P2|Overall Study|Lost to Follow-up|1
5341298|NCT00110890|18381172|P1|Overall Study|Lost to Follow-up|3
5341299|NCT00110890|18381171|P2|Overall Study|Death|9
5341300|NCT00110890|18381172|P1|Overall Study|Death|16
5341301|NCT00110890|18381171|P2|Overall Study|Adverse Event|7
5341302|NCT00110890|18381172|P1|Overall Study|Adverse Event|30
5341303|NCT00110812|18381189|P3|Extended Follow-up|Lost to Follow-up|1
5341304|NCT00110812|18381190|P2|Extended Follow-up|Lost to Follow-up|3
5341305|NCT00110812|18381191|P1|Extended Follow-up|Lost to Follow-up|1
5341306|NCT00110812|18381189|P3|Extended Follow-up|Withdrawal by Subject|0
5341307|NCT00110812|18381190|P2|Extended Follow-up|Withdrawal by Subject|1
5341308|NCT00110812|18381191|P1|Extended Follow-up|Withdrawal by Subject|0
5341309|NCT00110812|18381189|P3|Extended Follow-up|Death|3
5341310|NCT00110812|18381190|P2|Extended Follow-up|Death|0
5341311|NCT00110812|18381191|P1|Extended Follow-up|Death|1
5341312|NCT00110812|18381189|P3|Main Study|Lost to Follow-up|10
5341313|NCT00110812|18381190|P2|Main Study|Lost to Follow-up|11
5341314|NCT00110812|18381191|P1|Main Study|Lost to Follow-up|8
5341315|NCT00110812|18381189|P3|Main Study|Withdrawal by Subject|1
5341316|NCT00110812|18381190|P2|Main Study|Withdrawal by Subject|0
5341317|NCT00110812|18381191|P1|Main Study|Withdrawal by Subject|0
5341318|NCT00110812|18381189|P3|Main Study|Death|2
5341319|NCT00110812|18381190|P2|Main Study|Death|0
5341320|NCT00110812|18381191|P1|Main Study|Death|0
5341321|NCT00110617|18381236|P2|Overall Study|Did not receive study drug|12
5341322|NCT00110617|18381237|P1|Overall Study|Did not receive study drug|0
5341323|NCT00110617|18381236|P2|Overall Study|Death|1
5341324|NCT00110617|18381237|P1|Overall Study|Death|1
5341325|NCT00110617|18381236|P2|Overall Study|Administrative problems|5
5341326|NCT00110617|18381237|P1|Overall Study|Administrative problems|6
5341327|NCT00110617|18381236|P2|Overall Study|Lost to Follow-up|1
5341328|NCT00110617|18381237|P1|Overall Study|Lost to Follow-up|9
5341329|NCT00110617|18381236|P2|Overall Study|Withdrawal by Subject|4
5341330|NCT00110617|18381237|P1|Overall Study|Withdrawal by Subject|10
5341331|NCT00110617|18381236|P2|Overall Study|Protocol Violation|0
5341332|NCT00110617|18381237|P1|Overall Study|Protocol Violation|5
5341333|NCT00110617|18381236|P2|Overall Study|Patient no longer requires study drug|0
5341334|NCT00110617|18381237|P1|Overall Study|Patient no longer requires study drug|1
5341335|NCT00110617|18381236|P2|Overall Study|Lack of Efficacy|0
5341336|NCT00110617|18381237|P1|Overall Study|Lack of Efficacy|1
5341337|NCT00110617|18381236|P2|Overall Study|Abnormal Laboratory Value|2
5341338|NCT00110617|18381237|P1|Overall Study|Abnormal Laboratory Value|4
5341339|NCT00110617|18381236|P2|Overall Study|Adverse Event|4
5341340|NCT00110617|18381237|P1|Overall Study|Adverse Event|2
5341341|NCT00110396|18381354|P1|Overall Study|Patient is to be administered copaxone|1
5341342|NCT00110396|18381354|P1|Overall Study|The patient has refused to visit site|1
5341343|NCT00110396|18381354|P1|Overall Study|The patient has refused|2
5341344|NCT00110396|18381354|P1|Overall Study|Patient refused to come back|1
5341345|NCT00110396|18381354|P1|Overall Study|Protocol Violation|2
5341346|NCT00110396|18381354|P1|Overall Study|Pregnancy (Protocol violation)|2
5341347|NCT00110396|18381354|P1|Overall Study|Pregnancy|1
5341348|NCT00110396|18381354|P1|Overall Study|Participation in MS vaccine study|1
5341349|NCT00110396|18381354|P1|Overall Study|Patient's decision|1
5341350|NCT00110396|18381354|P1|Overall Study|Patient will|1
5341351|NCT00110396|18381354|P1|Overall Study|Patient refused to participate|1
5341352|NCT00110396|18381354|P1|Overall Study|Patient refused to continue|1
5341353|NCT00110396|18381354|P1|Overall Study|Patient non-compliance|1
5341354|NCT00110396|18381354|P1|Overall Study|Decided not to continue treatment|1
5341355|NCT00110396|18381354|P1|Overall Study|Lack of Efficacy|1
5341356|NCT00110396|18381354|P1|Overall Study|Initiated mitoxantrone therapy|1
5341357|NCT00110396|18381354|P1|Overall Study|Administration of plasmapheresis|1
5341358|NCT00110396|18381354|P1|Overall Study|Lost to Follow-up|1
5341359|NCT00110396|18381354|P1|Overall Study|Adverse Event|15
5341360|NCT00110357|18381362|P2|Overall Study|Withdrawal by Subject|1
5341361|NCT00110357|18381363|P1|Overall Study|Withdrawal by Subject|3
5341362|NCT00110357|18381362|P2|Overall Study|Study Drug Toxicity|3
5341363|NCT00110357|18381363|P1|Overall Study|Study Drug Toxicity|1
5341364|NCT00110357|18381362|P2|Overall Study|Study Closure|0
5341365|NCT00110357|18381363|P1|Overall Study|Study Closure|1
5341366|NCT00110357|18381362|P2|Overall Study|Disease progression/relapse|15
5341367|NCT00110357|18381363|P1|Overall Study|Disease progression/relapse|20
5341368|NCT00110357|18381362|P2|Overall Study|Deterioration without progression|0
5341369|NCT00110357|18381363|P1|Overall Study|Deterioration without progression|2
5341370|NCT00110305|18381451|P2|Overall Study|Other|2
5341371|NCT00110305|18381452|P1|Overall Study|Other|8
5341372|NCT00110305|18381451|P2|Overall Study|Lost to Follow-up|3
5341373|NCT00110305|18381452|P1|Overall Study|Lost to Follow-up|20
5341374|NCT00110305|18381451|P2|Overall Study|Withdrawal by Subject|7
5341375|NCT00110305|18381452|P1|Overall Study|Withdrawal by Subject|7
5341376|NCT00110305|18381451|P2|Overall Study|Protocol Violation|1
5341377|NCT00110305|18381452|P1|Overall Study|Protocol Violation|0
5341378|NCT00110305|18381451|P2|Overall Study|Subject Reached A Virologic Endpoint|3
5341379|NCT00110305|18381452|P1|Overall Study|Subject Reached A Virologic Endpoint|21
5341380|NCT00110305|18381451|P2|Overall Study|Subject Ineligible To Continue The Trial|1
5341381|NCT00110305|18381452|P1|Overall Study|Subject Ineligible To Continue The Trial|2
5341382|NCT00110305|18381451|P2|Overall Study|Subject Non-Compliant|2
5341383|NCT00110305|18381452|P1|Overall Study|Subject Non-Compliant|9
5341384|NCT00110305|18381451|P2|Overall Study|Sponsors Decision|0
5341385|NCT00110305|18381452|P1|Overall Study|Sponsors Decision|1
5341386|NCT00110305|18381451|P2|Overall Study|Adverse Event|13
5341387|NCT00110305|18381452|P1|Overall Study|Adverse Event|46
5341388|NCT00110214|18381505|P2|Overall Study|Other (not specified)|75
5341389|NCT00110214|18381506|P1|Overall Study|Other (not specified)|61
5341390|NCT00110214|18381505|P2|Overall Study|Refused further treatment|65
5341391|NCT00110214|18381506|P1|Overall Study|Refused further treatment|52
5341392|NCT00110214|18381505|P2|Overall Study|Adverse Event|192
5341393|NCT00110214|18381506|P1|Overall Study|Adverse Event|115
5341394|NCT00110214|18381505|P2|Overall Study|Disease progression or death|151
5341395|NCT00110214|18381506|P1|Overall Study|Disease progression or death|260
5341396|NCT00110214|18381505|P2|Overall Study|Never started treatment|20
5341397|NCT00110214|18381506|P1|Overall Study|Never started treatment|21
5341398|NCT00110149|18381518|P1|Overall Study|Physician Decision|3
5341399|NCT00110084|18381532|P1|Overall Study|Other|2
5341400|NCT00110084|18381532|P1|Overall Study|Intercurrent Illness|1
5341401|NCT00110084|18381532|P1|Overall Study|Alternate Therapy|5
5341402|NCT00110084|18381532|P1|Overall Study|Patient Refusal|10
5341403|NCT00110084|18381532|P1|Overall Study|Death|1
5341404|NCT00110084|18381532|P1|Overall Study|Adverse Event|9
5341405|NCT00110019|18381541|P2|Overall Study|other reasons|30
5341406|NCT00110019|18381542|P1|Overall Study|other reasons|22
5341407|NCT00110019|18381541|P2|Overall Study|Not start protocol therapy|16
5341408|NCT00110019|18381542|P1|Overall Study|Not start protocol therapy|17
5341409|NCT00110019|18381541|P2|Overall Study|symptom deterioration|16
5341410|NCT00110019|18381542|P1|Overall Study|symptom deterioration|13
5341411|NCT00110019|18381541|P2|Overall Study|complicating disease|1
5341412|NCT00110019|18381542|P1|Overall Study|complicating disease|1
5341413|NCT00110019|18381541|P2|Overall Study|alternative therapy|1
5341414|NCT00110019|18381542|P1|Overall Study|alternative therapy|5
5341415|NCT00110019|18381541|P2|Overall Study|Withdrawal by Subject|9
5341416|NCT00110019|18381542|P1|Overall Study|Withdrawal by Subject|21
5341417|NCT00110019|18381541|P2|Overall Study|Death|15
5341418|NCT00110019|18381542|P1|Overall Study|Death|13
5341419|NCT00110019|18381541|P2|Overall Study|Adverse Event|40
5341420|NCT00110019|18381542|P1|Overall Study|Adverse Event|61
5341421|NCT00110019|18381541|P2|Overall Study|Lack of Efficacy|285
5341422|NCT00110019|18381542|P1|Overall Study|Lack of Efficacy|253
5341423|NCT00109967|18381554|P2|Overall Study|Death|2
5341424|NCT00109967|18381555|P1|Overall Study|Death|0
5341425|NCT00109967|18381554|P2|Overall Study|Physician Decision|3
5341426|NCT00109967|18381555|P1|Overall Study|Physician Decision|1
5341427|NCT00109967|18381554|P2|Overall Study|Withdrawal by Subject|0
5341428|NCT00109967|18381555|P1|Overall Study|Withdrawal by Subject|5
5341429|NCT00109967|18381554|P2|Overall Study|Adverse Event|1
5341430|NCT00109967|18381555|P1|Overall Study|Adverse Event|12
5341431|NCT00109967|18381554|P2|Overall Study|Cancel Prior to Treatment|0
5341432|NCT00109967|18381555|P1|Overall Study|Cancel Prior to Treatment|2
5341433|NCT00109928|18381569|P1|Overall Study|not eligible|1
5341434|NCT00109928|18381569|P1|Overall Study|not protocol specified|2
5341435|NCT00109928|18381569|P1|Overall Study|Death|2
5341436|NCT00109928|18381569|P1|Overall Study|Progression|6
5341437|NCT00109928|18381569|P1|Overall Study|Adverse Event|2
5341438|NCT00109850|18381586|P1|Overall Study|Ineligible|1
5341439|NCT00109850|18381586|P1|Overall Study|Death|2
5341440|NCT00109850|18381586|P1|Overall Study|Adverse Event|1
5341441|NCT00109837|18381593|P1|Overall Study|Ineligible|1
5341442|NCT00109837|18381593|P1|Overall Study|Not treated|1
5341443|NCT00109837|18381593|P1|Overall Study|BCR/ABL+ or Ph+|17
5341444|NCT00109837|18381593|P1|Overall Study|Death|1
5341445|NCT00109837|18381593|P1|Overall Study|Refusal unrelated to adverse effects|1
5341446|NCT00109837|18381593|P1|Overall Study|Adverse Event|2
5341447|NCT00109772|18381603|P2|Open-label Extension|Other|10
5341448|NCT00109772|18381604|P1|Open-label Extension|Other|4
5341449|NCT00109772|18381603|P2|Open-label Extension|Protocol Violation|2
5341450|NCT00109772|18381604|P1|Open-label Extension|Protocol Violation|2
5341451|NCT00109772|18381603|P2|Open-label Extension|Death|1
5341452|NCT00109772|18381604|P1|Open-label Extension|Death|0
5341453|NCT00109772|18381603|P2|Open-label Extension|Lost to Follow-up|0
5341454|NCT00109772|18381604|P1|Open-label Extension|Lost to Follow-up|1
5341455|NCT00109772|18381603|P2|Open-label Extension|Withdrawal by Subject|6
5341456|NCT00109772|18381604|P1|Open-label Extension|Withdrawal by Subject|9
5341457|NCT00109772|18381603|P2|Open-label Extension|Lack of Efficacy|11
5341458|NCT00109772|18381604|P1|Open-label Extension|Lack of Efficacy|19
5341459|NCT00109772|18381603|P2|Open-label Extension|Adverse Event|19
5341460|NCT00109772|18381604|P1|Open-label Extension|Adverse Event|10
5341461|NCT00109772|18381603|P2|Double-blind Treatment|Withdrew prior to treatment|1
5341462|NCT00109772|18381604|P1|Double-blind Treatment|Withdrew prior to treatment|3
5341463|NCT00109772|18381603|P2|Double-blind Treatment|Other|4
5341464|NCT00109772|18381604|P1|Double-blind Treatment|Other|0
5341465|NCT00109772|18381603|P2|Double-blind Treatment|Protocol Violation|1
5341466|NCT00109772|18381604|P1|Double-blind Treatment|Protocol Violation|0
5341467|NCT00109772|18381603|P2|Double-blind Treatment|Lost to Follow-up|3
5341468|NCT00109772|18381604|P1|Double-blind Treatment|Lost to Follow-up|2
5341469|NCT00109772|18381603|P2|Double-blind Treatment|Withdrawal by Subject|1
5341470|NCT00109772|18381604|P1|Double-blind Treatment|Withdrawal by Subject|2
5341471|NCT00109772|18381603|P2|Double-blind Treatment|Lack of Efficacy|0
5341472|NCT00109772|18381604|P1|Double-blind Treatment|Lack of Efficacy|1
5341473|NCT00109772|18381603|P2|Double-blind Treatment|Adverse Event|5
5341474|NCT00109772|18381604|P1|Double-blind Treatment|Adverse Event|14
5341475|NCT00109733|18381644|P2|Overall Study|Could not commit time for study|1
5341476|NCT00109733|18381645|P1|Overall Study|Could not commit time for study|1
5341477|NCT00109733|18381644|P2|Overall Study|Non-compliant|1
5341478|NCT00109733|18381645|P1|Overall Study|Non-compliant|0
5341479|NCT00109733|18381644|P2|Overall Study|Stopped taking study drug|1
5341480|NCT00109733|18381645|P1|Overall Study|Stopped taking study drug|1
5341481|NCT00109733|18381644|P2|Overall Study|Protocol Violation|1
5341482|NCT00109733|18381645|P1|Overall Study|Protocol Violation|0
5341483|NCT00109590|18381662|P3|Overall Study|Never Started Treatment|3
5341484|NCT00109590|18381663|P2|Overall Study|Never Started Treatment|2
5341485|NCT00109590|18381664|P1|Overall Study|Never Started Treatment|1
5341486|NCT00109590|18381662|P3|Overall Study|Lost to Follow-up|1
5341487|NCT00109590|18381663|P2|Overall Study|Lost to Follow-up|0
5341488|NCT00109590|18381664|P1|Overall Study|Lost to Follow-up|1
5341489|NCT00109577|18381706|P2|Overall Study|Withdrawal by Subject|3
5341490|NCT00109577|18381707|P1|Overall Study|Withdrawal by Subject|3
5341491|NCT00109343|18381740|P3|Overall Study|Other|1
5341492|NCT00109343|18381741|P2|Overall Study|Other|2
5341493|NCT00109343|18381742|P1|Overall Study|Other|5
5341494|NCT00109343|18381740|P3|Overall Study|Subject Moved|1
5341495|NCT00109343|18381741|P2|Overall Study|Subject Moved|2
5341496|NCT00109343|18381742|P1|Overall Study|Subject Moved|6
5341497|NCT00109343|18381740|P3|Overall Study|Withdrawal by Subject|10
5341498|NCT00109343|18381741|P2|Overall Study|Withdrawal by Subject|11
5341499|NCT00109343|18381742|P1|Overall Study|Withdrawal by Subject|15
5341500|NCT00109343|18381740|P3|Overall Study|Protocol Violation|2
5341501|NCT00109343|18381741|P2|Overall Study|Protocol Violation|2
5341502|NCT00109343|18381742|P1|Overall Study|Protocol Violation|1
5341503|NCT00109343|18381740|P3|Overall Study|Lost to Follow-up|14
5341504|NCT00109343|18381741|P2|Overall Study|Lost to Follow-up|20
5341505|NCT00109343|18381742|P1|Overall Study|Lost to Follow-up|35
5341506|NCT00109343|18381740|P3|Overall Study|Lack of Efficacy|0
5341507|NCT00109343|18381741|P2|Overall Study|Lack of Efficacy|0
5341508|NCT00109343|18381742|P1|Overall Study|Lack of Efficacy|1
5341509|NCT00109343|18381740|P3|Overall Study|Adverse Event|2
5341510|NCT00109343|18381741|P2|Overall Study|Adverse Event|0
5341511|NCT00109343|18381742|P1|Overall Study|Adverse Event|1
5341512|NCT00109031|18381787|P4|Overall Study|Protocol Violation|0
5341513|NCT00109031|18381788|P3|Overall Study|Protocol Violation|1
5341514|NCT00109031|18381789|P2|Overall Study|Protocol Violation|0
5341515|NCT00109031|18381790|P1|Overall Study|Protocol Violation|0
5341516|NCT00109031|18381787|P4|Overall Study|Physician Decision|0
5341517|NCT00109031|18381788|P3|Overall Study|Physician Decision|0
5341518|NCT00109031|18381789|P2|Overall Study|Physician Decision|1
5341519|NCT00109031|18381790|P1|Overall Study|Physician Decision|0
5341520|NCT00109031|18381787|P4|Overall Study|Withdrawal by Subject|0
5341521|NCT00109031|18381788|P3|Overall Study|Withdrawal by Subject|0
5341522|NCT00109031|18381789|P2|Overall Study|Withdrawal by Subject|1
5341523|NCT00109031|18381790|P1|Overall Study|Withdrawal by Subject|0
5341524|NCT00109031|18381787|P4|Overall Study|Adverse Event|0
5341525|NCT00109031|18381788|P3|Overall Study|Adverse Event|1
5341526|NCT00109031|18381789|P2|Overall Study|Adverse Event|0
5341527|NCT00109031|18381790|P1|Overall Study|Adverse Event|0
5341528|NCT00108953|18381841|P2|Follow-up|Study terminated by sponsor|6
5341529|NCT00108953|18381842|P1|Follow-up|Study terminated by sponsor|10
5341530|NCT00108953|18381841|P2|Follow-up|Lost to Follow-up|1
5341531|NCT00108953|18381842|P1|Follow-up|Lost to Follow-up|1
5341532|NCT00108953|18381841|P2|Follow-up|Death|26
5341533|NCT00108953|18381842|P1|Follow-up|Death|18
5341534|NCT00108862|18381864|P2|Overall Study|Lost to Follow-up|19
5341535|NCT00108862|18381865|P1|Overall Study|Lost to Follow-up|27
5341536|NCT00108862|18381864|P2|Overall Study|Withdrawal by Subject|6
5341537|NCT00108862|18381865|P1|Overall Study|Withdrawal by Subject|10
5341538|NCT00108862|18381864|P2|Overall Study|Death|37
5341539|NCT00108862|18381865|P1|Overall Study|Death|31
5341540|NCT00108732|18381893|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
5341541|NCT00108732|18381893|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
5341542|NCT00108732|18381893|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
5341543|NCT00108732|18381893|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
5341544|NCT00108732|18381893|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
5341545|NCT00108732|18381893|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
5341546|NCT00108732|18381893|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
5341547|NCT00108628|18381902|P2|Overall Study|Death|0
5341548|NCT00108628|18381903|P1|Overall Study|Death|1
5341549|NCT00108628|18381902|P2|Overall Study|Lack of Efficacy|1
5341550|NCT00108628|18381903|P1|Overall Study|Lack of Efficacy|2
5341551|NCT00108628|18381902|P2|Overall Study|Withdrawal by Subject|9
5341552|NCT00108628|18381903|P1|Overall Study|Withdrawal by Subject|17
5341553|NCT00108485|18381953|P2|Overall Study|Lost to Follow-up|2
5341554|NCT00108485|18381954|P1|Overall Study|Lost to Follow-up|0
5341555|NCT00108485|18381953|P2|Overall Study|Withdrawal by Subject|0
5341556|NCT00108485|18381954|P1|Overall Study|Withdrawal by Subject|3
5341557|NCT00108433|18381962|P2|Overall Study|Other|14
5341558|NCT00108433|18381963|P1|Overall Study|Other|14
5341559|NCT00108433|18381962|P2|Overall Study|Adverse Event|1
5341560|NCT00108433|18381963|P1|Overall Study|Adverse Event|3
5341561|NCT00108433|18381962|P2|Overall Study|Death|0
5341562|NCT00108433|18381963|P1|Overall Study|Death|3
5341563|NCT00108433|18381962|P2|Overall Study|Lack of Efficacy|2
5341564|NCT00108433|18381963|P1|Overall Study|Lack of Efficacy|1
5341565|NCT00108355|18381979|P2|Overall Study|Loculated ascites, limiting paracentesis|1
5341566|NCT00108355|18381980|P1|Overall Study|Loculated ascites, limiting paracentesis|1
5341567|NCT00108355|18381979|P2|Overall Study|Peritonitis at index paracentesis|1
5341568|NCT00108355|18381980|P1|Overall Study|Peritonitis at index paracentesis|1
5341569|NCT00108160|18382029|P2|Overall Study|Protocol Violation|5
5341570|NCT00108160|18382030|P1|Overall Study|Protocol Violation|9
5341571|NCT00108160|18382029|P2|Overall Study|Withdrawal by Subject|2
5341572|NCT00108160|18382030|P1|Overall Study|Withdrawal by Subject|4
5341573|NCT00108160|18382029|P2|Overall Study|Death|2
5341574|NCT00108160|18382030|P1|Overall Study|Death|1
5341575|NCT00108160|18382029|P2|Overall Study|Lost to Follow-up|12
5341576|NCT00108160|18382030|P1|Overall Study|Lost to Follow-up|25
5341577|NCT00108082|18382043|P3|Overall Study|Blood Pressure Not Controlled|0
5341578|NCT00108082|18382044|P2|Overall Study|Blood Pressure Not Controlled|0
5341579|NCT00108082|18382045|P1|Overall Study|Blood Pressure Not Controlled|1
5341580|NCT00108082|18382043|P3|Overall Study|Investigator Not at Site|0
5341581|NCT00108082|18382044|P2|Overall Study|Investigator Not at Site|0
5341582|NCT00108082|18382045|P1|Overall Study|Investigator Not at Site|1
5341583|NCT00108082|18382043|P3|Overall Study|Subject Left Site Location|0
5341584|NCT00108082|18382044|P2|Overall Study|Subject Left Site Location|0
5341585|NCT00108082|18382045|P1|Overall Study|Subject Left Site Location|1
5341586|NCT00108082|18382043|P3|Overall Study|Study Medication Not Tapered|0
5341587|NCT00108082|18382044|P2|Overall Study|Study Medication Not Tapered|1
5341588|NCT00108082|18382045|P1|Overall Study|Study Medication Not Tapered|0
5341589|NCT00108082|18382043|P3|Overall Study|Protocol Amendment|0
5341590|NCT00108082|18382044|P2|Overall Study|Protocol Amendment|1
5341591|NCT00108082|18382045|P1|Overall Study|Protocol Amendment|0
5341592|NCT00108082|18382043|P3|Overall Study|Site Closed Study|0
5341593|NCT00108082|18382044|P2|Overall Study|Site Closed Study|2
5341594|NCT00108082|18382045|P1|Overall Study|Site Closed Study|0
5341595|NCT00108082|18382043|P3|Overall Study|Stopped Study Medication|1
5341596|NCT00108082|18382044|P2|Overall Study|Stopped Study Medication|0
5341597|NCT00108082|18382045|P1|Overall Study|Stopped Study Medication|0
5341598|NCT00108082|18382043|P3|Overall Study|Non-compliance|2
5341599|NCT00108082|18382044|P2|Overall Study|Non-compliance|0
5341600|NCT00108082|18382045|P1|Overall Study|Non-compliance|1
5341601|NCT00108082|18382043|P3|Overall Study|Incorrectly Randomized|2
5341602|NCT00108082|18382044|P2|Overall Study|Incorrectly Randomized|0
5341603|NCT00108082|18382045|P1|Overall Study|Incorrectly Randomized|0
5341604|NCT00108082|18382043|P3|Overall Study|Woman of Child-bearing Potential|2
5341605|NCT00108082|18382044|P2|Overall Study|Woman of Child-bearing Potential|0
5341606|NCT00108082|18382045|P1|Overall Study|Woman of Child-bearing Potential|2
5341607|NCT00108082|18382043|P3|Overall Study|Amendment 4: > Month 12|5
5341608|NCT00108082|18382044|P2|Overall Study|Amendment 4: > Month 12|7
5341609|NCT00108082|18382045|P1|Overall Study|Amendment 4: > Month 12|5
5341610|NCT00108082|18382043|P3|Overall Study|Lack of Efficacy|2
5341611|NCT00108082|18382044|P2|Overall Study|Lack of Efficacy|1
5341612|NCT00108082|18382045|P1|Overall Study|Lack of Efficacy|3
5341613|NCT00108082|18382043|P3|Overall Study|Protocol Violation|0
5341614|NCT00108082|18382044|P2|Overall Study|Protocol Violation|2
5341615|NCT00108082|18382045|P1|Overall Study|Protocol Violation|1
5341616|NCT00108082|18382043|P3|Overall Study|Consent Withdrawn|5
5341617|NCT00108082|18382044|P2|Overall Study|Consent Withdrawn|3
5341618|NCT00108082|18382045|P1|Overall Study|Consent Withdrawn|3
5341619|NCT00108082|18382043|P3|Overall Study|Lost to Follow-up|7
5341620|NCT00108082|18382044|P2|Overall Study|Lost to Follow-up|3
5341621|NCT00108082|18382045|P1|Overall Study|Lost to Follow-up|6
5341622|NCT00108082|18382043|P3|Overall Study|Adverse Event|17
5341623|NCT00108082|18382044|P2|Overall Study|Adverse Event|12
5341624|NCT00108082|18382045|P1|Overall Study|Adverse Event|14
5341625|NCT00108069|18382094|P2|Overall Study|Progessive disease|11
5341626|NCT00108069|18382095|P1|Overall Study|Progessive disease|27
5341627|NCT00108069|18382094|P2|Overall Study|Death|0
5341628|NCT00108069|18382095|P1|Overall Study|Death|1
5341629|NCT00108069|18382094|P2|Overall Study|Withdrawal by Subject|0
5341630|NCT00108069|18382095|P1|Overall Study|Withdrawal by Subject|1
5341631|NCT00108069|18382094|P2|Overall Study|Adverse Event|1
5341632|NCT00108069|18382095|P1|Overall Study|Adverse Event|1
5341633|NCT00108069|18382094|P2|Overall Study|Never rec'd study drug|1
5341634|NCT00108069|18382095|P1|Overall Study|Never rec'd study drug|0
5341635|NCT00107991|18382109|P1|18-Week Post Treatment Assessment|Adverse Event|2
5341636|NCT00107991|18382109|P1|12 Week Treatment Period|Incarcerated|1
5341637|NCT00107991|18382109|P1|12 Week Treatment Period|Protocol Violation|1
5341638|NCT00107991|18382109|P1|12 Week Treatment Period|Adverse Event|1
5341639|NCT00107991|18382109|P1|12 Week Treatment Period|Lack of Efficacy|2
5341640|NCT00107991|18382109|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
5341641|NCT00107991|18382109|P1|Eligibility Assessment|chronic uncontrolled asthma|1
5341642|NCT00107991|18382109|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
5341643|NCT00107991|18382109|P1|Eligibility Assessment|Abnormal labs|2
5341644|NCT00107991|18382109|P1|Eligibility Assessment|Positive purified protein derivative|4
5341645|NCT00107991|18382109|P1|Eligibility Assessment|Unwilling to participate|7
5341646|NCT00107991|18382109|P1|Eligibility Assessment|Disease not severe enough|7
5341647|NCT00107978|18382119|P2|Overall Study|Other|4
5341648|NCT00107978|18382120|P1|Overall Study|Other|5
5341649|NCT00107978|18382119|P2|Overall Study|Protocol Violation|1
5341650|NCT00107978|18382120|P1|Overall Study|Protocol Violation|0
5341651|NCT00107978|18382119|P2|Overall Study|Withdrawal by Subject|9
5341652|NCT00107978|18382120|P1|Overall Study|Withdrawal by Subject|4
5341653|NCT00107978|18382119|P2|Overall Study|Lost to Follow-up|28
5341654|NCT00107978|18382120|P1|Overall Study|Lost to Follow-up|20
5341655|NCT00107978|18382119|P2|Overall Study|Death|3
5341656|NCT00107978|18382120|P1|Overall Study|Death|3
5341657|NCT00107978|18382119|P2|Overall Study|Adverse Event|5
5341658|NCT00107978|18382120|P1|Overall Study|Adverse Event|1
5341659|NCT00107952|18382128|P2|Overall Study|Never received study treatment|6
5341660|NCT00107952|18382129|P1|Overall Study|Never received study treatment|9
5341661|NCT00107952|18382128|P2|Overall Study|Other|5
5341662|NCT00107952|18382129|P1|Overall Study|Other|2
5341663|NCT00107952|18382128|P2|Overall Study|Withdrawal by Subject|6
5341664|NCT00107952|18382129|P1|Overall Study|Withdrawal by Subject|9
5341665|NCT00107952|18382128|P2|Overall Study|Lost to Follow-up|3
5341666|NCT00107952|18382129|P1|Overall Study|Lost to Follow-up|0
5341667|NCT00107952|18382128|P2|Overall Study|Death|61
5341668|NCT00107952|18382129|P1|Overall Study|Death|75
5341669|NCT00107900|18382141|P6|Overall Study|Administrative Reasons|0
5341670|NCT00107900|18382142|P5|Overall Study|Administrative Reasons|2
5341671|NCT00107900|18382143|P4|Overall Study|Administrative Reasons|2
5341672|NCT00107900|18382144|P3|Overall Study|Administrative Reasons|2
5341673|NCT00107900|18382145|P2|Overall Study|Administrative Reasons|0
5341674|NCT00107900|18382146|P1|Overall Study|Administrative Reasons|1
5341675|NCT00107900|18382141|P6|Overall Study|Withdrawal by Subject|1
5341676|NCT00107900|18382142|P5|Overall Study|Withdrawal by Subject|1
5341677|NCT00107900|18382143|P4|Overall Study|Withdrawal by Subject|0
5341678|NCT00107900|18382144|P3|Overall Study|Withdrawal by Subject|5
5341679|NCT00107900|18382145|P2|Overall Study|Withdrawal by Subject|0
5341680|NCT00107900|18382146|P1|Overall Study|Withdrawal by Subject|1
5341681|NCT00107900|18382141|P6|Overall Study|Protocol Violation|0
5341682|NCT00107900|18382142|P5|Overall Study|Protocol Violation|7
5341683|NCT00107900|18382143|P4|Overall Study|Protocol Violation|5
5341684|NCT00107900|18382144|P3|Overall Study|Protocol Violation|5
5341685|NCT00107900|18382145|P2|Overall Study|Protocol Violation|0
5341686|NCT00107900|18382146|P1|Overall Study|Protocol Violation|1
5341687|NCT00107900|18382141|P6|Overall Study|Lost to Follow-up|5
5341688|NCT00107900|18382142|P5|Overall Study|Lost to Follow-up|5
5341689|NCT00107900|18382143|P4|Overall Study|Lost to Follow-up|2
5341690|NCT00107900|18382144|P3|Overall Study|Lost to Follow-up|3
5341691|NCT00107900|18382145|P2|Overall Study|Lost to Follow-up|1
5341692|NCT00107900|18382146|P1|Overall Study|Lost to Follow-up|4
5341693|NCT00107900|18382141|P6|Overall Study|Death|0
5341694|NCT00107900|18382142|P5|Overall Study|Death|1
5341695|NCT00107900|18382143|P4|Overall Study|Death|0
5341696|NCT00107900|18382144|P3|Overall Study|Death|0
5341697|NCT00107900|18382145|P2|Overall Study|Death|0
5341698|NCT00107900|18382146|P1|Overall Study|Death|0
5341699|NCT00107900|18382141|P6|Overall Study|Adverse Event|3
5341700|NCT00107900|18382142|P5|Overall Study|Adverse Event|5
5341701|NCT00107900|18382143|P4|Overall Study|Adverse Event|3
5341702|NCT00107900|18382144|P3|Overall Study|Adverse Event|10
5341703|NCT00107900|18382145|P2|Overall Study|Adverse Event|2
5341704|NCT00107900|18382146|P1|Overall Study|Adverse Event|3
5341705|NCT00107783|18382180|P2|Overall Study|Second hip replacement|1
5341706|NCT00107783|18382181|P1|Overall Study|Second hip replacement|1
5341707|NCT00107783|18382180|P2|Overall Study|Withdrawal by Subject|0
5341708|NCT00107783|18382181|P1|Overall Study|Withdrawal by Subject|2
5341709|NCT00107783|18382180|P2|Overall Study|Death|1
5341710|NCT00107783|18382181|P1|Overall Study|Death|0
5341711|NCT00107783|18382180|P2|Overall Study|Adverse Event|2
5341712|NCT00107783|18382181|P1|Overall Study|Adverse Event|0
5341713|NCT00107653|18382216|P2|Overall Study|Administrative Reasons|3
5341714|NCT00107653|18382217|P1|Overall Study|Administrative Reasons|3
5341715|NCT00107653|18382216|P2|Overall Study|Lost to Follow-up|5
5341716|NCT00107653|18382217|P1|Overall Study|Lost to Follow-up|13
5341717|NCT00107653|18382216|P2|Overall Study|Withdrawal by Subject|13
5341718|NCT00107653|18382217|P1|Overall Study|Withdrawal by Subject|12
5341719|NCT00107653|18382216|P2|Overall Study|Protocol Violation|0
5341720|NCT00107653|18382217|P1|Overall Study|Protocol Violation|1
5341721|NCT00107653|18382216|P2|Overall Study|Violation of Selection Criteria at Entry|1
5341722|NCT00107653|18382217|P1|Overall Study|Violation of Selection Criteria at Entry|1
5341723|NCT00107653|18382216|P2|Overall Study|Insufficient Therapeutic Response|11
5341724|NCT00107653|18382217|P1|Overall Study|Insufficient Therapeutic Response|25
5341725|NCT00107653|18382216|P2|Overall Study|Adverse Event|43
5341726|NCT00107653|18382217|P1|Overall Study|Adverse Event|24
5341727|NCT00107614|18382263|P1|Overall Study|Death|2
5341728|NCT00107614|18382263|P1|Overall Study|Physician Decision|10
5341729|NCT00107380|18382294|P1|Overall Study|Ineligible|2
5341730|NCT00107380|18382294|P1|Overall Study|Other - not protocol specified|7
5341731|NCT00107380|18382294|P1|Overall Study|Death|3
5341732|NCT00107380|18382294|P1|Overall Study|Progression/relapse|4
5341733|NCT00107380|18382294|P1|Overall Study|Refusal Unrelated to Adverse Event|7
5341734|NCT00107380|18382294|P1|Overall Study|Adverse Event|7
5341735|NCT00107315|18382300|P1|Overall Study|Withdrawal by Subject|2
5341736|NCT00107315|18382300|P1|Overall Study|Adverse Event|4
5341737|NCT00107315|18382300|P1|Overall Study|Disease Progression|9
5341738|NCT00107276|18382307|P1|Overall Study|Ineligible|16
5341739|NCT00107276|18382307|P1|Overall Study|Death|1
5341740|NCT00107276|18382307|P1|Overall Study|Patient refusal|1
5341741|NCT00107276|18382307|P1|Overall Study|M.D. decision|2
5341742|NCT00107276|18382307|P1|Overall Study|Adverse Event|6
5341743|NCT00107276|18382307|P1|Overall Study|Progression|46
5341744|NCT00107198|18382313|P1|Overall Study|Ineligible|5
5341745|NCT00107198|18382313|P1|Overall Study|Withdrawal by Subject|6
5341746|NCT00107198|18382313|P1|Overall Study|Protocol Violation|1
5341747|NCT00107198|18382313|P1|Overall Study|Lost to Follow-up|12
5341748|NCT00107198|18382313|P1|Overall Study|Lack of Efficacy|28
5341749|NCT00107172|18382323|P2|Overall Study|Other Reason|3
5341750|NCT00107172|18382324|P1|Overall Study|Other Reason|4
5341751|NCT00107172|18382323|P2|Overall Study|Death|2
5341752|NCT00107172|18382324|P1|Overall Study|Death|0
5341753|NCT00107172|18382323|P2|Overall Study|Withdrawal by Subject|0
5341754|NCT00107172|18382324|P1|Overall Study|Withdrawal by Subject|1
5341755|NCT00107120|18382354|P2|Overall Study|death of parent|1
5341756|NCT00107120|18382355|P1|Overall Study|death of parent|0
5341757|NCT00107120|18382354|P2|Overall Study|moving away from site|1
5341758|NCT00107120|18382355|P1|Overall Study|moving away from site|1
5341759|NCT00107120|18382354|P2|Overall Study|Pregnancy|1
5341760|NCT00107120|18382355|P1|Overall Study|Pregnancy|0
5341761|NCT00107120|18382354|P2|Overall Study|Lost to Follow-up|6
5341762|NCT00107120|18382355|P1|Overall Study|Lost to Follow-up|8
5341763|NCT00107120|18382354|P2|Overall Study|Withdrawal by Subject|9
5341764|NCT00107120|18382355|P1|Overall Study|Withdrawal by Subject|8
5341765|NCT00107120|18382354|P2|Overall Study|Protocol Violation|0
5341766|NCT00107120|18382355|P1|Overall Study|Protocol Violation|3
5341767|NCT00107120|18382354|P2|Overall Study|Lack of Efficacy|5
5341768|NCT00107120|18382355|P1|Overall Study|Lack of Efficacy|5
5341769|NCT00107120|18382354|P2|Overall Study|Adverse Event|1
5341770|NCT00107120|18382355|P1|Overall Study|Adverse Event|4
5341771|NCT00107042|18382367|P2|Overall Study|Disallowed medications|2
5341772|NCT00107042|18382368|P1|Overall Study|Disallowed medications|0
5341773|NCT00107042|18382367|P2|Overall Study|vaccinated outside window|1
5341774|NCT00107042|18382368|P1|Overall Study|vaccinated outside window|1
5341775|NCT00107042|18382367|P2|Overall Study|Inadvertent enrollment|1
5341776|NCT00107042|18382368|P1|Overall Study|Inadvertent enrollment|0
5341777|NCT00107042|18382367|P2|Overall Study|Pregnancy|1
5341778|NCT00107042|18382368|P1|Overall Study|Pregnancy|1
5341779|NCT00107042|18382367|P2|Overall Study|Moved out of area|3
5341780|NCT00107042|18382368|P1|Overall Study|Moved out of area|5
5341781|NCT00107042|18382367|P2|Overall Study|Withdrawal by Subject|1
5341782|NCT00107042|18382368|P1|Overall Study|Withdrawal by Subject|6
5341783|NCT00107042|18382367|P2|Overall Study|Lost to Follow-up|7
5341784|NCT00107042|18382368|P1|Overall Study|Lost to Follow-up|9
5341785|NCT00106964|18382434|P3|Overall Study|Required disallowed medication|0
5341786|NCT00106964|18382435|P2|Overall Study|Required disallowed medication|1
5341787|NCT00106964|18382436|P1|Overall Study|Required disallowed medication|0
5341788|NCT00106964|18382434|P3|Overall Study|Did not meet eligibility criteria|2
5341789|NCT00106964|18382435|P2|Overall Study|Did not meet eligibility criteria|2
5341790|NCT00106964|18382436|P1|Overall Study|Did not meet eligibility criteria|0
5341791|NCT00106964|18382434|P3|Overall Study|Failure to adhere|0
5341792|NCT00106964|18382435|P2|Overall Study|Failure to adhere|0
5341793|NCT00106964|18382436|P1|Overall Study|Failure to adhere|2
5341794|NCT00106964|18382434|P3|Overall Study|Site Funding Terminated|1
5341795|NCT00106964|18382435|P2|Overall Study|Site Funding Terminated|1
5341796|NCT00106964|18382436|P1|Overall Study|Site Funding Terminated|0
5341797|NCT00106964|18382434|P3|Overall Study|Incarceration|0
5341798|NCT00106964|18382435|P2|Overall Study|Incarceration|1
5341799|NCT00106964|18382436|P1|Overall Study|Incarceration|0
5341800|NCT00106964|18382434|P3|Overall Study|Death|0
5341801|NCT00106964|18382435|P2|Overall Study|Death|1
5341802|NCT00106964|18382436|P1|Overall Study|Death|1
5341803|NCT00106964|18382434|P3|Overall Study|Pregnancy|2
5341804|NCT00106964|18382435|P2|Overall Study|Pregnancy|3
5341805|NCT00106964|18382436|P1|Overall Study|Pregnancy|2
5341806|NCT00106964|18382434|P3|Overall Study|Lost to Follow-up|2
5341807|NCT00106964|18382435|P2|Overall Study|Lost to Follow-up|6
5341808|NCT00106964|18382436|P1|Overall Study|Lost to Follow-up|8
5341809|NCT00106704|18382531|P2|Overall Study|Laboratory test|1
5341810|NCT00106704|18382532|P1|Overall Study|Laboratory test|1
5341811|NCT00106704|18382531|P2|Overall Study|Unable to re-enter US|0
5341812|NCT00106704|18382532|P1|Overall Study|Unable to re-enter US|1
5341813|NCT00106704|18382531|P2|Overall Study|Patient Received Glycemic Medication|41
5341814|NCT00106704|18382532|P1|Overall Study|Patient Received Glycemic Medication|22
5341815|NCT00106704|18382531|P2|Overall Study|Planned major surgery|0
5341816|NCT00106704|18382532|P1|Overall Study|Planned major surgery|1
5341817|NCT00106704|18382531|P2|Overall Study|Site terminated|1
5341818|NCT00106704|18382532|P1|Overall Study|Site terminated|0
5341819|NCT00106704|18382531|P2|Overall Study|Patient moved|0
5341820|NCT00106704|18382532|P1|Overall Study|Patient moved|1
5341821|NCT00106704|18382531|P2|Overall Study|Withdrawal by Subject|21
5341822|NCT00106704|18382532|P1|Overall Study|Withdrawal by Subject|14
5341823|NCT00106704|18382531|P2|Overall Study|Protocol Violation|7
5341824|NCT00106704|18382532|P1|Overall Study|Protocol Violation|4
5341825|NCT00106704|18382531|P2|Overall Study|Pregnancy|0
5341826|NCT00106704|18382532|P1|Overall Study|Pregnancy|1
5341827|NCT00106704|18382531|P2|Overall Study|Lost to Follow-up|3
5341828|NCT00106704|18382532|P1|Overall Study|Lost to Follow-up|7
5341829|NCT00106704|18382531|P2|Overall Study|Lack of Efficacy|69
5341830|NCT00106704|18382532|P1|Overall Study|Lack of Efficacy|67
5341831|NCT00106704|18382531|P2|Overall Study|Death|1
5341832|NCT00106704|18382532|P1|Overall Study|Death|2
5341833|NCT00106704|18382531|P2|Overall Study|Adverse Event|7
5341834|NCT00106704|18382532|P1|Overall Study|Adverse Event|10
5341835|NCT00106639|18382543|P3|Overall Study|Participant defaulted|1
5341836|NCT00106639|18382544|P2|Overall Study|Participant defaulted|1
5341837|NCT00106639|18382545|P1|Overall Study|Participant defaulted|0
5341838|NCT00106639|18382543|P3|Overall Study|Withdrawal by Subject|0
5341839|NCT00106639|18382544|P2|Overall Study|Withdrawal by Subject|1
5341840|NCT00106639|18382545|P1|Overall Study|Withdrawal by Subject|0
5341841|NCT00106639|18382543|P3|Overall Study|Protocol Violation|0
5341842|NCT00106639|18382544|P2|Overall Study|Protocol Violation|1
5341843|NCT00106639|18382545|P1|Overall Study|Protocol Violation|0
5341844|NCT00106639|18382543|P3|Overall Study|Adverse Event|1
5341845|NCT00106639|18382544|P2|Overall Study|Adverse Event|4
5341846|NCT00106639|18382545|P1|Overall Study|Adverse Event|3
5341847|NCT00106626|18382672|P4|Overall Study|> 14 day delay in therapy start|0
5341848|NCT00106626|18382673|P3|Overall Study|> 14 day delay in therapy start|0
5341849|NCT00106626|18382674|P2|Overall Study|> 14 day delay in therapy start|1
5341850|NCT00106626|18382675|P1|Overall Study|> 14 day delay in therapy start|0
5341851|NCT00106626|18382672|P4|Overall Study|Received radiation on new therapy|0
5341852|NCT00106626|18382673|P3|Overall Study|Received radiation on new therapy|0
5341853|NCT00106626|18382674|P2|Overall Study|Received radiation on new therapy|0
5341854|NCT00106626|18382675|P1|Overall Study|Received radiation on new therapy|1
5341855|NCT00106626|18382672|P4|Overall Study|Progressive Disease|10
5341856|NCT00106626|18382673|P3|Overall Study|Progressive Disease|9
5341857|NCT00106626|18382674|P2|Overall Study|Progressive Disease|1
5341858|NCT00106626|18382675|P1|Overall Study|Progressive Disease|4
5341859|NCT00106626|18382672|P4|Overall Study|Adverse Event|3
5341860|NCT00106626|18382673|P3|Overall Study|Adverse Event|3
5341861|NCT00106626|18382674|P2|Overall Study|Adverse Event|4
5341862|NCT00106626|18382675|P1|Overall Study|Adverse Event|5
5341863|NCT00106353|18383020|P7|Part 2|Physician Decision|0
5341864|NCT00106353|18383021|P6|Part 2|Physician Decision|1
5341865|NCT00106353|18383022|P5|Part 2|Physician Decision|0
5341866|NCT00106353|18383023|P4|Part 2|Physician Decision|0
5341867|NCT00106353|18383024|P3|Part 2|Physician Decision|0
5341868|NCT00106353|18383025|P2|Part 2|Physician Decision|0
5341869|NCT00106353|18383026|P1|Part 2|Physician Decision|0
5341870|NCT00106353|18383020|P7|Part 2|Withdrawal by Subject|0
5341871|NCT00106353|18383021|P6|Part 2|Withdrawal by Subject|0
5341872|NCT00106353|18383022|P5|Part 2|Withdrawal by Subject|1
5341873|NCT00106353|18383023|P4|Part 2|Withdrawal by Subject|0
5341874|NCT00106353|18383024|P3|Part 2|Withdrawal by Subject|0
5341875|NCT00106353|18383025|P2|Part 2|Withdrawal by Subject|0
5341876|NCT00106353|18383026|P1|Part 2|Withdrawal by Subject|0
5341877|NCT00106353|18383020|P7|Part 2|Other|1
5341878|NCT00106353|18383021|P6|Part 2|Other|1
5341879|NCT00106353|18383022|P5|Part 2|Other|1
5341880|NCT00106353|18383023|P4|Part 2|Other|0
5341881|NCT00106353|18383024|P3|Part 2|Other|0
5341882|NCT00106353|18383025|P2|Part 2|Other|0
5341883|NCT00106353|18383026|P1|Part 2|Other|0
5341884|NCT00106353|18383020|P7|Part 2|Adverse Event|1
5341885|NCT00106353|18383021|P6|Part 2|Adverse Event|2
5341886|NCT00106353|18383022|P5|Part 2|Adverse Event|0
5341887|NCT00106353|18383023|P4|Part 2|Adverse Event|0
5341888|NCT00106353|18383024|P3|Part 2|Adverse Event|0
5341889|NCT00106353|18383025|P2|Part 2|Adverse Event|0
5341890|NCT00106353|18383026|P1|Part 2|Adverse Event|0
5341891|NCT00106353|18383020|P7|Part 2|Symptomatic deterioration|0
5341892|NCT00106353|18383021|P6|Part 2|Symptomatic deterioration|0
5341893|NCT00106353|18383022|P5|Part 2|Symptomatic deterioration|3
5341894|NCT00106353|18383023|P4|Part 2|Symptomatic deterioration|0
5341895|NCT00106353|18383024|P3|Part 2|Symptomatic deterioration|0
5341896|NCT00106353|18383025|P2|Part 2|Symptomatic deterioration|0
5341897|NCT00106353|18383026|P1|Part 2|Symptomatic deterioration|0
5341898|NCT00106353|18383020|P7|Part 2|Death|1
5341899|NCT00106353|18383021|P6|Part 2|Death|0
5341900|NCT00106353|18383022|P5|Part 2|Death|3
5341901|NCT00106353|18383023|P4|Part 2|Death|0
5341902|NCT00106353|18383024|P3|Part 2|Death|0
5341903|NCT00106353|18383025|P2|Part 2|Death|0
5341904|NCT00106353|18383026|P1|Part 2|Death|0
5341905|NCT00106353|18383020|P7|Part 2|Disease progression|13
5341906|NCT00106353|18383021|P6|Part 2|Disease progression|14
5341907|NCT00106353|18383022|P5|Part 2|Disease progression|8
5341908|NCT00106353|18383023|P4|Part 2|Disease progression|0
5341909|NCT00106353|18383024|P3|Part 2|Disease progression|0
5341910|NCT00106353|18383025|P2|Part 2|Disease progression|0
5341911|NCT00106353|18383026|P1|Part 2|Disease progression|0
5341912|NCT00106353|18383020|P7|Part 1|Adverse Event|0
5341913|NCT00106353|18383021|P6|Part 1|Adverse Event|0
5341914|NCT00106353|18383022|P5|Part 1|Adverse Event|0
5341915|NCT00106353|18383023|P4|Part 1|Adverse Event|1
5341916|NCT00106353|18383024|P3|Part 1|Adverse Event|0
5341917|NCT00106353|18383025|P2|Part 1|Adverse Event|0
5341918|NCT00106353|18383026|P1|Part 1|Adverse Event|0
5341919|NCT00106353|18383020|P7|Part 1|Entered follow-up phase|0
5341920|NCT00106353|18383021|P6|Part 1|Entered follow-up phase|0
5341921|NCT00106353|18383022|P5|Part 1|Entered follow-up phase|0
5341922|NCT00106353|18383023|P4|Part 1|Entered follow-up phase|1
5341923|NCT00106353|18383024|P3|Part 1|Entered follow-up phase|0
5341924|NCT00106353|18383025|P2|Part 1|Entered follow-up phase|1
5341925|NCT00106353|18383026|P1|Part 1|Entered follow-up phase|1
5341926|NCT00106353|18383020|P7|Part 1|Symptomatic deterioration|0
5341927|NCT00106353|18383021|P6|Part 1|Symptomatic deterioration|0
5341928|NCT00106353|18383022|P5|Part 1|Symptomatic deterioration|0
5341929|NCT00106353|18383023|P4|Part 1|Symptomatic deterioration|0
5341930|NCT00106353|18383024|P3|Part 1|Symptomatic deterioration|1
5341931|NCT00106353|18383025|P2|Part 1|Symptomatic deterioration|0
5341932|NCT00106353|18383026|P1|Part 1|Symptomatic deterioration|0
5341933|NCT00106353|18383020|P7|Part 1|Withdrawal by Subject|0
5341934|NCT00106353|18383021|P6|Part 1|Withdrawal by Subject|0
5341935|NCT00106353|18383022|P5|Part 1|Withdrawal by Subject|0
5341936|NCT00106353|18383023|P4|Part 1|Withdrawal by Subject|2
5341937|NCT00106353|18383024|P3|Part 1|Withdrawal by Subject|1
5341938|NCT00106353|18383025|P2|Part 1|Withdrawal by Subject|0
5341939|NCT00106353|18383026|P1|Part 1|Withdrawal by Subject|0
5341940|NCT00106353|18383020|P7|Part 1|Disease progression|0
5341941|NCT00106353|18383021|P6|Part 1|Disease progression|0
5341942|NCT00106353|18383022|P5|Part 1|Disease progression|0
5341943|NCT00106353|18383023|P4|Part 1|Disease progression|3
5341944|NCT00106353|18383024|P3|Part 1|Disease progression|1
5341945|NCT00106353|18383025|P2|Part 1|Disease progression|4
5341946|NCT00106353|18383026|P1|Part 1|Disease progression|3
5341947|NCT00106249|18383153|P2|Overall Study|Lost to Follow-up|2
5341948|NCT00106249|18383154|P1|Overall Study|Lost to Follow-up|3
5341949|NCT00106184|18383166|P2|Overall Study|Withdrawal by Subject|2
5341950|NCT00106184|18383167|P1|Overall Study|Withdrawal by Subject|3
5341951|NCT00106080|18383209|P2|Overall Study|Withdrew/Loss to follow-up|27
5341952|NCT00106080|18383210|P1|Overall Study|Withdrew/Loss to follow-up|43
5341953|NCT00106028|18383220|P2|Overall Study|Lost to Follow-up|1
5341954|NCT00106028|18383221|P1|Overall Study|Lost to Follow-up|0
5341955|NCT00106028|18383220|P2|Overall Study|Withdrawal by Subject|8
5341956|NCT00106028|18383221|P1|Overall Study|Withdrawal by Subject|2
5341957|NCT00106028|18383220|P2|Overall Study|Protocol Violation|1
5341958|NCT00106028|18383221|P1|Overall Study|Protocol Violation|1
5341959|NCT00106028|18383220|P2|Overall Study|Adverse Event|2
5341960|NCT00106028|18383221|P1|Overall Study|Adverse Event|3
5341961|NCT00106002|18383315|P1|Overall Study|Ineligible after Registration|1
5341962|NCT00106002|18383315|P1|Overall Study|Did not take any study drug|1
5341963|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
5341964|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
5341965|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
5341966|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
5341967|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Death|0
5341968|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Death|0
5341969|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
5341970|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
5341971|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
5341972|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
5341973|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
5341974|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
5341975|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
5341976|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
5341977|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
5341978|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
5341979|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
5341980|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
5341981|NCT00105989|18383323|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
5341982|NCT00105989|18383324|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
5341983|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
5341984|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
5341985|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
5341986|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
5341987|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Death|0
5341988|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Death|0
5341989|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
5341990|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
5341991|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
5341992|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
5341993|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
5341994|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
5341995|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
5341996|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
5341997|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
5341998|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
5341999|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
5342000|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
5342001|NCT00105989|18383323|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
5342002|NCT00105989|18383324|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
5342003|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
5342004|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
5342005|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
5342006|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
5342007|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Death|0
5342008|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Death|1
5342009|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Physician Decision|0
5342010|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Physician Decision|0
5342011|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
5342012|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
5342013|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
5342014|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
5342015|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
5342016|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
5342017|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
5342018|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
5342019|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
5342020|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
5342021|NCT00105989|18383323|P2|Acute - Open Label: Week 0-10|Adverse Event|0
5342022|NCT00105989|18383324|P1|Acute - Open Label: Week 0-10|Adverse Event|33
5342023|NCT00105586|18383440|P2|Overall Study|Physician Decision|13
5342024|NCT00105586|18383441|P1|Overall Study|Physician Decision|13
5342025|NCT00105586|18383440|P2|Overall Study|Adverse Event|3
5342026|NCT00105586|18383441|P1|Overall Study|Adverse Event|4
5342027|NCT00105560|18383449|P1|Overall Study|Lost to Follow-up|1
5342028|NCT00105534|18383471|P2|Overall Study|Other Reason|2
5342029|NCT00105534|18383472|P1|Overall Study|Other Reason|0
5342030|NCT00105534|18383471|P2|Overall Study|Treatment unmasked|0
5342031|NCT00105534|18383472|P1|Overall Study|Treatment unmasked|1
5342032|NCT00105534|18383471|P2|Overall Study|Lack of Efficacy|15
5342033|NCT00105534|18383472|P1|Overall Study|Lack of Efficacy|7
5342034|NCT00105534|18383471|P2|Overall Study|Lost to Follow-up|1
5342035|NCT00105534|18383472|P1|Overall Study|Lost to Follow-up|5
5342036|NCT00105534|18383471|P2|Overall Study|Withdrawal by Subject|6
5342037|NCT00105534|18383472|P1|Overall Study|Withdrawal by Subject|6
5342038|NCT00105534|18383471|P2|Overall Study|Protocol Violation|4
5342039|NCT00105534|18383472|P1|Overall Study|Protocol Violation|1
5342040|NCT00105534|18383471|P2|Overall Study|Adverse Event|5
5342041|NCT00105534|18383472|P1|Overall Study|Adverse Event|2
5342042|NCT00105521|18383484|P4|Overall Study|Lost to Follow-up|0
5342043|NCT00105521|18383485|P3|Overall Study|Lost to Follow-up|0
5342044|NCT00105521|18383486|P2|Overall Study|Lost to Follow-up|1
5342045|NCT00105521|18383487|P1|Overall Study|Lost to Follow-up|0
5342046|NCT00105521|18383484|P4|Overall Study|Protocol Violation|4
5342047|NCT00105521|18383485|P3|Overall Study|Protocol Violation|4
5342048|NCT00105521|18383486|P2|Overall Study|Protocol Violation|5
5342049|NCT00105521|18383487|P1|Overall Study|Protocol Violation|3
5342050|NCT00105521|18383484|P4|Overall Study|Lack of Efficacy|1
5342051|NCT00105521|18383485|P3|Overall Study|Lack of Efficacy|0
5342052|NCT00105521|18383486|P2|Overall Study|Lack of Efficacy|0
5342053|NCT00105521|18383487|P1|Overall Study|Lack of Efficacy|0
5342054|NCT00105521|18383484|P4|Overall Study|Withdrawal by Subject|4
5342055|NCT00105521|18383485|P3|Overall Study|Withdrawal by Subject|1
5342056|NCT00105521|18383486|P2|Overall Study|Withdrawal by Subject|0
5342057|NCT00105521|18383487|P1|Overall Study|Withdrawal by Subject|1
5342058|NCT00105521|18383484|P4|Overall Study|Adverse Event|8
5342059|NCT00105521|18383485|P3|Overall Study|Adverse Event|10
5342060|NCT00105521|18383486|P2|Overall Study|Adverse Event|4
5342061|NCT00105521|18383487|P1|Overall Study|Adverse Event|10
5342062|NCT00105521|18383484|P4|Overall Study|Other|0
5342063|NCT00105521|18383485|P3|Overall Study|Other|2
5342064|NCT00105521|18383486|P2|Overall Study|Other|1
5342065|NCT00105521|18383487|P1|Overall Study|Other|1
5342066|NCT00105508|18383511|P2|Overall Study|Other|9
5342067|NCT00105508|18383512|P1|Overall Study|Other|8
5342068|NCT00105508|18383511|P2|Overall Study|Protocol Violation|2
5342069|NCT00105508|18383512|P1|Overall Study|Protocol Violation|1
5342070|NCT00105508|18383511|P2|Overall Study|Lost to Follow-up|0
5342071|NCT00105508|18383512|P1|Overall Study|Lost to Follow-up|3
5342072|NCT00105508|18383511|P2|Overall Study|Withdrawal by Subject|6
5342073|NCT00105508|18383512|P1|Overall Study|Withdrawal by Subject|10
5342074|NCT00105508|18383511|P2|Overall Study|Insufficient Efficacy|0
5342075|NCT00105508|18383512|P1|Overall Study|Insufficient Efficacy|1
5342076|NCT00105508|18383511|P2|Overall Study|Adverse Event|19
5342077|NCT00105508|18383512|P1|Overall Study|Adverse Event|16
5342078|NCT00105508|18383511|P2|Overall Study|Prephase Dropout|0
5342079|NCT00105508|18383512|P1|Overall Study|Prephase Dropout|1
5342080|NCT00105482|18383526|P2|Overall Study|Withdrawn by PI|1
5342081|NCT00105482|18383527|P1|Overall Study|Withdrawn by PI|1
5342082|NCT00105482|18383526|P2|Overall Study|Scheduling Conflict|3
5342083|NCT00105482|18383527|P1|Overall Study|Scheduling Conflict|2
5342084|NCT00105482|18383526|P2|Overall Study|Lost Interest|32
5342085|NCT00105482|18383527|P1|Overall Study|Lost Interest|29
5342086|NCT00105482|18383526|P2|Overall Study|Withdrawal by Subject|1
5342087|NCT00105482|18383527|P1|Overall Study|Withdrawal by Subject|0
5342088|NCT00105482|18383526|P2|Overall Study|Lost to Follow-up|17
5342089|NCT00105482|18383527|P1|Overall Study|Lost to Follow-up|26
5342090|NCT00105482|18383526|P2|Overall Study|Adverse Event|1
5342091|NCT00105482|18383527|P1|Overall Study|Adverse Event|1
5342092|NCT00105469|18383543|P2|Overall Study|Other Reason|0
5342093|NCT00105469|18383544|P1|Overall Study|Other Reason|4
5342094|NCT00105469|18383543|P2|Overall Study|Lack of Efficacy|0
5342095|NCT00105469|18383544|P1|Overall Study|Lack of Efficacy|2
5342096|NCT00105469|18383543|P2|Overall Study|Lost to Follow-up|0
5342097|NCT00105469|18383544|P1|Overall Study|Lost to Follow-up|1
5342098|NCT00105469|18383543|P2|Overall Study|Withdrawal by Subject|3
5342099|NCT00105469|18383544|P1|Overall Study|Withdrawal by Subject|2
5342100|NCT00105469|18383543|P2|Overall Study|Protocol Violation|0
5342101|NCT00105469|18383544|P1|Overall Study|Protocol Violation|4
5342102|NCT00105469|18383543|P2|Overall Study|Adverse Event|8
5342103|NCT00105469|18383544|P1|Overall Study|Adverse Event|9
5342104|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
5342105|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
5342106|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
5342107|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
5342108|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
5342109|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
5342110|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
5342111|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
5342112|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
5342113|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
5342114|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
5342115|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
5342116|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
5342117|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
5342118|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
5342119|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
5342120|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
5342121|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
5342122|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
5342123|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
5342124|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
5342125|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
5342126|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
5342127|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
5342128|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
5342129|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
5342130|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
5342131|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
5342132|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
5342133|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
5342134|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
5342135|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
5342136|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
5342137|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
5342138|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
5342139|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
5342140|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
5342141|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
5342142|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
5342143|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
5342144|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
5342145|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
5342146|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
5342147|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
5342148|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
5342149|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
5342150|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
5342151|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
5342152|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
5342153|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
5342154|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
5342155|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
5342156|NCT00105443|18383554|P4|Follow-up and/or Open Label Nexavar|Death|4
5342157|NCT00105443|18383555|P3|Follow-up and/or Open Label Nexavar|Death|219
5342158|NCT00105443|18383556|P2|Follow-up and/or Open Label Nexavar|Death|7
5342159|NCT00105443|18383557|P1|Follow-up and/or Open Label Nexavar|Death|180
5342160|NCT00105443|18383554|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
5342161|NCT00105443|18383555|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
5342162|NCT00105443|18383556|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
5342163|NCT00105443|18383557|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
5342164|NCT00105443|18383554|P4|Double-Blind Treatment|Physician Decision|0
5342165|NCT00105443|18383555|P3|Double-Blind Treatment|Physician Decision|2
5342166|NCT00105443|18383556|P2|Double-Blind Treatment|Physician Decision|0
5342167|NCT00105443|18383557|P1|Double-Blind Treatment|Physician Decision|1
5342168|NCT00105443|18383554|P4|Double-Blind Treatment|Withdrawal by Subject|0
5342169|NCT00105443|18383555|P3|Double-Blind Treatment|Withdrawal by Subject|7
5342170|NCT00105443|18383556|P2|Double-Blind Treatment|Withdrawal by Subject|0
5342171|NCT00105443|18383557|P1|Double-Blind Treatment|Withdrawal by Subject|8
5342172|NCT00105443|18383554|P4|Double-Blind Treatment|Lost to Follow-up|0
5342173|NCT00105443|18383555|P3|Double-Blind Treatment|Lost to Follow-up|1
5342174|NCT00105443|18383556|P2|Double-Blind Treatment|Lost to Follow-up|0
5342175|NCT00105443|18383557|P1|Double-Blind Treatment|Lost to Follow-up|0
5342176|NCT00105443|18383554|P4|Double-Blind Treatment|Adverse Event|0
5342177|NCT00105443|18383555|P3|Double-Blind Treatment|Adverse Event|0
5342178|NCT00105443|18383556|P2|Double-Blind Treatment|Adverse Event|0
5342179|NCT00105443|18383557|P1|Double-Blind Treatment|Adverse Event|1
5342180|NCT00105235|18383584|P1|Overall Study|Withdrawal by Subject|2
5342181|NCT00105235|18383584|P1|Overall Study|Physician Decision|1
5342182|NCT00105235|18383584|P1|Overall Study|Death|4
5342183|NCT00105196|18383597|P2|Overall Study|Subject became unblinded|1
5342184|NCT00105196|18383598|P1|Overall Study|Subject became unblinded|0
5342185|NCT00105196|18383597|P2|Overall Study|marijuana use|1
5342186|NCT00105196|18383598|P1|Overall Study|marijuana use|0
5342187|NCT00105196|18383597|P2|Overall Study|pending surgery|1
5342188|NCT00105196|18383598|P1|Overall Study|pending surgery|0
5342189|NCT00105196|18383597|P2|Overall Study|Protocol Violation|2
5342190|NCT00105196|18383598|P1|Overall Study|Protocol Violation|5
5342191|NCT00105196|18383597|P2|Overall Study|Poor/noncompliance|4
5342192|NCT00105196|18383598|P1|Overall Study|Poor/noncompliance|3
5342193|NCT00105196|18383597|P2|Overall Study|Lost to Follow-up|2
5342194|NCT00105196|18383598|P1|Overall Study|Lost to Follow-up|3
5342195|NCT00105196|18383597|P2|Overall Study|Withdrawal by Subject|6
5342196|NCT00105196|18383598|P1|Overall Study|Withdrawal by Subject|6
5342197|NCT00105196|18383597|P2|Overall Study|Adverse Event|3
5342198|NCT00105196|18383598|P1|Overall Study|Adverse Event|11
5342199|NCT00105196|18383597|P2|Overall Study|Lack of Efficacy|3
5342200|NCT00105196|18383598|P1|Overall Study|Lack of Efficacy|2
5342201|NCT00105183|18383621|P3|Overall Study|Other reason|0
5342202|NCT00105183|18383622|P2|Overall Study|Other reason|2
5342203|NCT00105183|18383623|P1|Overall Study|Other reason|1
5342204|NCT00105183|18383621|P3|Overall Study|Lost to Follow-up|1
5342205|NCT00105183|18383622|P2|Overall Study|Lost to Follow-up|1
5342206|NCT00105183|18383623|P1|Overall Study|Lost to Follow-up|0
5342207|NCT00105183|18383621|P3|Overall Study|Physician Decision|3
5342208|NCT00105183|18383622|P2|Overall Study|Physician Decision|2
5342209|NCT00105183|18383623|P1|Overall Study|Physician Decision|1
5342210|NCT00105183|18383621|P3|Overall Study|Withdrawal by Subject|4
5342211|NCT00105183|18383622|P2|Overall Study|Withdrawal by Subject|1
5342212|NCT00105183|18383623|P1|Overall Study|Withdrawal by Subject|1
5342213|NCT00105183|18383621|P3|Overall Study|Death|15
5342214|NCT00105183|18383622|P2|Overall Study|Death|13
5342215|NCT00105183|18383623|P1|Overall Study|Death|19
5342216|NCT00105157|18383659|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
5342217|NCT00105157|18383660|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
5342218|NCT00105157|18383661|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
5342219|NCT00105157|18383662|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
5342220|NCT00105157|18383659|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
5342221|NCT00105157|18383660|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
5342222|NCT00105157|18383661|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
5342223|NCT00105157|18383662|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
5342224|NCT00105157|18383659|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
5342225|NCT00105157|18383660|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
5342226|NCT00105157|18383661|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
5342227|NCT00105157|18383662|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
5342228|NCT00105157|18383659|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
5342229|NCT00105157|18383660|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
5342230|NCT00105157|18383661|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
5342231|NCT00105157|18383662|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
5342232|NCT00105157|18383659|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
5342233|NCT00105157|18383660|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
5342234|NCT00105157|18383661|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
5342235|NCT00105157|18383662|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
5342236|NCT00105157|18383659|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
5342237|NCT00105157|18383660|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
5342238|NCT00105157|18383661|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
5342239|NCT00105157|18383662|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
5342240|NCT00105157|18383659|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
5342241|NCT00105157|18383660|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
5342242|NCT00105157|18383661|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
5342243|NCT00105157|18383662|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
5342244|NCT00105157|18383659|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
5342245|NCT00105157|18383660|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
5342246|NCT00105157|18383661|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
5342247|NCT00105157|18383662|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
5342248|NCT00105157|18383659|P4|Open-Label Continuation of DB|Lost to Follow-up|0
5342249|NCT00105157|18383660|P3|Open-Label Continuation of DB|Lost to Follow-up|1
5342250|NCT00105157|18383661|P2|Open-Label Continuation of DB|Lost to Follow-up|1
5342251|NCT00105157|18383662|P1|Open-Label Continuation of DB|Lost to Follow-up|1
5342252|NCT00105157|18383659|P4|Open-Label Continuation of DB|Lack of Efficacy|1
5342253|NCT00105157|18383660|P3|Open-Label Continuation of DB|Lack of Efficacy|3
5342254|NCT00105157|18383661|P2|Open-Label Continuation of DB|Lack of Efficacy|4
5342255|NCT00105157|18383662|P1|Open-Label Continuation of DB|Lack of Efficacy|1
5342256|NCT00105157|18383659|P4|Open-Label Continuation of DB|Adverse Event|0
5342257|NCT00105157|18383660|P3|Open-Label Continuation of DB|Adverse Event|0
5342258|NCT00105157|18383661|P2|Open-Label Continuation of DB|Adverse Event|1
5342259|NCT00105157|18383662|P1|Open-Label Continuation of DB|Adverse Event|3
5342260|NCT00105157|18383659|P4|Double-Blind (DB)|Lack of Efficacy|38
5342261|NCT00105157|18383660|P3|Double-Blind (DB)|Lack of Efficacy|11
5342262|NCT00105157|18383661|P2|Double-Blind (DB)|Lack of Efficacy|14
5342263|NCT00105157|18383662|P1|Double-Blind (DB)|Lack of Efficacy|11
5342264|NCT00105157|18383659|P4|Double-Blind (DB)|Adverse Event|1
5342265|NCT00105157|18383660|P3|Double-Blind (DB)|Adverse Event|1
5342266|NCT00105157|18383661|P2|Double-Blind (DB)|Adverse Event|0
5342267|NCT00105157|18383662|P1|Double-Blind (DB)|Adverse Event|2
5342268|NCT00105157|18383659|P4|Double-Blind (DB)|Never Treated|0
5342269|NCT00105157|18383660|P3|Double-Blind (DB)|Never Treated|0
5342270|NCT00105157|18383661|P2|Double-Blind (DB)|Never Treated|0
5342271|NCT00105157|18383662|P1|Double-Blind (DB)|Never Treated|1
5342272|NCT00105079|18383856|P2|Overall Study|Other|1
5342273|NCT00105079|18383857|P1|Overall Study|Other|3
5342274|NCT00105079|18383856|P2|Overall Study|Protocol Violation|0
5342275|NCT00105079|18383857|P1|Overall Study|Protocol Violation|1
5342276|NCT00105079|18383856|P2|Overall Study|Violation of selection criteria at entry|2
5342277|NCT00105079|18383857|P1|Overall Study|Violation of selection criteria at entry|0
5342278|NCT00105079|18383856|P2|Overall Study|Refused treatment|4
5342279|NCT00105079|18383857|P1|Overall Study|Refused treatment|6
5342280|NCT00105079|18383856|P2|Overall Study|Lack of Efficacy|3
5342281|NCT00105079|18383857|P1|Overall Study|Lack of Efficacy|9
5342282|NCT00105079|18383856|P2|Overall Study|Lost to Follow-up|12
5342283|NCT00105079|18383857|P1|Overall Study|Lost to Follow-up|12
5342284|NCT00105079|18383856|P2|Overall Study|Death|1
5342285|NCT00105079|18383857|P1|Overall Study|Death|3
5342286|NCT00105079|18383856|P2|Overall Study|Adverse Event|12
5342287|NCT00105079|18383857|P1|Overall Study|Adverse Event|5
5342288|NCT00105066|18383875|P2|Overall Study|Adverse Event|5
5342289|NCT00105066|18383876|P1|Overall Study|Adverse Event|2
5342290|NCT00104884|18383954|P1|Overall Study|Disease progression|4
5342291|NCT00104871|18383958|P1|Overall Study|Not evaluable|1
5342292|NCT00104728|18383979|P1|Overall Study|screen failures|19
5342293|NCT00104650|18383987|P3|Follow-up Period|Other|0
5342294|NCT00104650|18383988|P2|Follow-up Period|Other|1
5342295|NCT00104650|18383989|P1|Follow-up Period|Other|0
5342296|NCT00104650|18383987|P3|Follow-up Period|Lost to Follow-up|2
5342297|NCT00104650|18383988|P2|Follow-up Period|Lost to Follow-up|1
5342298|NCT00104650|18383989|P1|Follow-up Period|Lost to Follow-up|0
5342299|NCT00104650|18383987|P3|Follow-up Period|Disease progression|0
5342300|NCT00104650|18383988|P2|Follow-up Period|Disease progression|1
5342301|NCT00104650|18383989|P1|Follow-up Period|Disease progression|3
5342302|NCT00104650|18383987|P3|Follow-up Period|Death|4
5342303|NCT00104650|18383988|P2|Follow-up Period|Death|6
5342304|NCT00104650|18383989|P1|Follow-up Period|Death|6
5342305|NCT00104650|18383987|P3|Follow-up Period|Withdrawal by Subject|3
5342306|NCT00104650|18383988|P2|Follow-up Period|Withdrawal by Subject|3
5342307|NCT00104650|18383989|P1|Follow-up Period|Withdrawal by Subject|0
5342308|NCT00104650|18383987|P3|Follow-up Period|Adverse Event|1
5342309|NCT00104650|18383988|P2|Follow-up Period|Adverse Event|0
5342310|NCT00104650|18383989|P1|Follow-up Period|Adverse Event|1
5342311|NCT00104650|18383987|P3|Follow-up Period|Physician Decision|0
5342312|NCT00104650|18383988|P2|Follow-up Period|Physician Decision|1
5342313|NCT00104650|18383989|P1|Follow-up Period|Physician Decision|1
5342314|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Protocol deviation|0
5342315|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Protocol deviation|1
5342316|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Protocol deviation|0
5342317|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Other|0
5342318|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Other|0
5342319|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Other|1
5342320|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
5342321|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
5342322|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
5342323|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Disease progression|2
5342324|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Disease progression|3
5342325|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Disease progression|2
5342326|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Death|6
5342327|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Death|5
5342328|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Death|7
5342329|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
5342330|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
5342331|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
5342332|NCT00104650|18383987|P3|Treatment Period (25 Weeks)|Physician Decision|1
5342333|NCT00104650|18383988|P2|Treatment Period (25 Weeks)|Physician Decision|0
5342334|NCT00104650|18383989|P1|Treatment Period (25 Weeks)|Physician Decision|0
5342335|NCT00104637|18384021|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
5342336|NCT00104637|18384022|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
5342337|NCT00104572|18384051|P3|Overall Study|Withdrawal by Subject|0
5342338|NCT00104572|18384052|P2|Overall Study|Withdrawal by Subject|3
5342339|NCT00104572|18384053|P1|Overall Study|Withdrawal by Subject|3
5342340|NCT00104520|18384072|P2|Overall Study|Other|5
5342341|NCT00104520|18384073|P1|Overall Study|Other|1
5342342|NCT00104520|18384072|P2|Overall Study|Personal/administrative|1
5342343|NCT00104520|18384073|P1|Overall Study|Personal/administrative|1
5342344|NCT00104520|18384072|P2|Overall Study|Noncompliance|2
5342345|NCT00104520|18384073|P1|Overall Study|Noncompliance|0
5342346|NCT00104520|18384072|P2|Overall Study|Lost to Follow-up|0
5342347|NCT00104520|18384073|P1|Overall Study|Lost to Follow-up|1
5342348|NCT00104520|18384072|P2|Overall Study|Related adverse event|15
5342349|NCT00104520|18384073|P1|Overall Study|Related adverse event|13
5342350|NCT00104520|18384072|P2|Overall Study|Study drug intolerance|1
5342351|NCT00104520|18384073|P1|Overall Study|Study drug intolerance|0
5342352|NCT00104520|18384072|P2|Overall Study|Unrelated adverse event|47
5342353|NCT00104520|18384073|P1|Overall Study|Unrelated adverse event|34
5342354|NCT00104416|18384093|P5|Continuation Phase|Non-compliance|1
5342355|NCT00104416|18384094|P4|Continuation Phase|Non-compliance|0
5342356|NCT00104416|18384095|P3|Continuation Phase|Non-compliance|0
5342357|NCT00104416|18384096|P2|Continuation Phase|Non-compliance|0
5342358|NCT00104416|18384097|P1|Continuation Phase|Non-compliance|0
5342359|NCT00104416|18384093|P5|Continuation Phase|Pregnancy|0
5342360|NCT00104416|18384094|P4|Continuation Phase|Pregnancy|1
5342361|NCT00104416|18384095|P3|Continuation Phase|Pregnancy|1
5342362|NCT00104416|18384096|P2|Continuation Phase|Pregnancy|0
5342363|NCT00104416|18384097|P1|Continuation Phase|Pregnancy|0
5342364|NCT00104416|18384093|P5|Continuation Phase|Withdrawal by Subject|1
5342365|NCT00104416|18384094|P4|Continuation Phase|Withdrawal by Subject|1
5342366|NCT00104416|18384095|P3|Continuation Phase|Withdrawal by Subject|2
5342367|NCT00104416|18384096|P2|Continuation Phase|Withdrawal by Subject|0
5342368|NCT00104416|18384097|P1|Continuation Phase|Withdrawal by Subject|0
5342369|NCT00104416|18384093|P5|Continuation Phase|Lost to Follow-up|1
5342370|NCT00104416|18384094|P4|Continuation Phase|Lost to Follow-up|0
5342371|NCT00104416|18384095|P3|Continuation Phase|Lost to Follow-up|1
5342372|NCT00104416|18384096|P2|Continuation Phase|Lost to Follow-up|0
5342373|NCT00104416|18384097|P1|Continuation Phase|Lost to Follow-up|0
5342374|NCT00104416|18384093|P5|Continuation Phase|Adverse Event|2
5342375|NCT00104416|18384094|P4|Continuation Phase|Adverse Event|0
5342376|NCT00104416|18384095|P3|Continuation Phase|Adverse Event|2
5342377|NCT00104416|18384096|P2|Continuation Phase|Adverse Event|0
5342378|NCT00104416|18384097|P1|Continuation Phase|Adverse Event|0
5342379|NCT00104416|18384093|P5|Double-Blind Phase|Participant Did Not Take Drug|0
5342380|NCT00104416|18384094|P4|Double-Blind Phase|Participant Did Not Take Drug|0
5342381|NCT00104416|18384095|P3|Double-Blind Phase|Participant Did Not Take Drug|0
5342382|NCT00104416|18384096|P2|Double-Blind Phase|Participant Did Not Take Drug|4
5342383|NCT00104416|18384097|P1|Double-Blind Phase|Participant Did Not Take Drug|3
5342384|NCT00104416|18384093|P5|Double-Blind Phase|Pregnancy|0
5342385|NCT00104416|18384094|P4|Double-Blind Phase|Pregnancy|0
5342386|NCT00104416|18384095|P3|Double-Blind Phase|Pregnancy|0
5342387|NCT00104416|18384096|P2|Double-Blind Phase|Pregnancy|0
5342388|NCT00104416|18384097|P1|Double-Blind Phase|Pregnancy|1
5342389|NCT00104416|18384093|P5|Double-Blind Phase|Withdrawal by Subject|0
5342390|NCT00104416|18384094|P4|Double-Blind Phase|Withdrawal by Subject|0
5342391|NCT00104416|18384095|P3|Double-Blind Phase|Withdrawal by Subject|0
5342392|NCT00104416|18384096|P2|Double-Blind Phase|Withdrawal by Subject|3
5342393|NCT00104416|18384097|P1|Double-Blind Phase|Withdrawal by Subject|2
5342394|NCT00104416|18384093|P5|Double-Blind Phase|Protocol Violation|0
5342395|NCT00104416|18384094|P4|Double-Blind Phase|Protocol Violation|0
5342396|NCT00104416|18384095|P3|Double-Blind Phase|Protocol Violation|0
5342397|NCT00104416|18384096|P2|Double-Blind Phase|Protocol Violation|1
5342398|NCT00104416|18384097|P1|Double-Blind Phase|Protocol Violation|0
5342399|NCT00104416|18384093|P5|Double-Blind Phase|Lost to Follow-up|0
5342400|NCT00104416|18384094|P4|Double-Blind Phase|Lost to Follow-up|0
5342401|NCT00104416|18384095|P3|Double-Blind Phase|Lost to Follow-up|0
5342402|NCT00104416|18384096|P2|Double-Blind Phase|Lost to Follow-up|1
5342403|NCT00104416|18384097|P1|Double-Blind Phase|Lost to Follow-up|0
5342404|NCT00104416|18384093|P5|Double-Blind Phase|Adverse Event|0
5342405|NCT00104416|18384094|P4|Double-Blind Phase|Adverse Event|0
5342406|NCT00104416|18384095|P3|Double-Blind Phase|Adverse Event|0
5342407|NCT00104416|18384096|P2|Double-Blind Phase|Adverse Event|1
5342408|NCT00104416|18384097|P1|Double-Blind Phase|Adverse Event|2
5342409|NCT00104299|18384142|P2|Overall Study|To have renal transplant|0
5342410|NCT00104299|18384143|P1|Overall Study|To have renal transplant|1
5342411|NCT00104299|18384142|P2|Overall Study|Physician Decision|1
5342412|NCT00104299|18384143|P1|Overall Study|Physician Decision|1
5342413|NCT00104299|18384142|P2|Overall Study|Withdrawal by Subject|6
5342414|NCT00104299|18384143|P1|Overall Study|Withdrawal by Subject|2
5342415|NCT00104299|18384142|P2|Overall Study|Death|2
5342416|NCT00104299|18384143|P1|Overall Study|Death|2
5342417|NCT00104299|18384142|P2|Overall Study|Adverse Event|1
5342418|NCT00104299|18384143|P1|Overall Study|Adverse Event|3
5342419|NCT00104247|18384165|P2|Overall Study|Noncompliant with dosing|1
5342420|NCT00104247|18384166|P1|Overall Study|Noncompliant with dosing|0
5342421|NCT00104247|18384165|P2|Overall Study|Withdrawal by Subject|0
5342422|NCT00104247|18384166|P1|Overall Study|Withdrawal by Subject|1
5342423|NCT00104104|18384185|P2|Overall Study|Death|6
5342424|NCT00104104|18384186|P1|Overall Study|Death|9
5342425|NCT00104104|18384185|P2|Overall Study|Administrative problems|13
5342426|NCT00104104|18384186|P1|Overall Study|Administrative problems|12
5342427|NCT00104104|18384185|P2|Overall Study|Lost to Follow-up|7
5342428|NCT00104104|18384186|P1|Overall Study|Lost to Follow-up|3
5342429|NCT00104104|18384185|P2|Overall Study|Withdrawal by Subject|15
5342430|NCT00104104|18384186|P1|Overall Study|Withdrawal by Subject|11
5342431|NCT00104104|18384185|P2|Overall Study|Protocol Violation|2
5342432|NCT00104104|18384186|P1|Overall Study|Protocol Violation|5
5342433|NCT00104104|18384185|P2|Overall Study|Condition no longer requires study drug|4
5342434|NCT00104104|18384186|P1|Overall Study|Condition no longer requires study drug|7
5342435|NCT00104104|18384185|P2|Overall Study|Lack of Efficacy|3
5342436|NCT00104104|18384186|P1|Overall Study|Lack of Efficacy|0
5342437|NCT00104104|18384185|P2|Overall Study|Abnormal laboratory value(s)|14
5342438|NCT00104104|18384186|P1|Overall Study|Abnormal laboratory value(s)|20
5342439|NCT00104104|18384185|P2|Overall Study|Adverse Event|8
5342440|NCT00104104|18384186|P1|Overall Study|Adverse Event|8
5342441|NCT00104052|18384200|P1|Overall Study|Discontinuation unrelated to treatment|2
5342442|NCT00104052|18384200|P1|Overall Study|Lack of Efficacy|26
5342443|NCT00104052|18384200|P1|Overall Study|Adverse Event|1
5342444|NCT00103857|18384211|P7|50-Week Extension Study|reason unspecified|0
5342445|NCT00103857|18384212|P6|50-Week Extension Study|reason unspecified|0
5342446|NCT00103857|18384213|P5|50-Week Extension Study|reason unspecified|1
5342447|NCT00103857|18384214|P4|50-Week Extension Study|reason unspecified|0
5342448|NCT00103857|18384215|P3|50-Week Extension Study|reason unspecified|0
5342449|NCT00103857|18384216|P2|50-Week Extension Study|reason unspecified|0
5342450|NCT00103857|18384217|P1|50-Week Extension Study|reason unspecified|0
5342451|NCT00103857|18384211|P7|50-Week Extension Study|patient scheduled for elective surgery|0
5342452|NCT00103857|18384212|P6|50-Week Extension Study|patient scheduled for elective surgery|0
5342453|NCT00103857|18384213|P5|50-Week Extension Study|patient scheduled for elective surgery|0
5342454|NCT00103857|18384214|P4|50-Week Extension Study|patient scheduled for elective surgery|0
5342455|NCT00103857|18384215|P3|50-Week Extension Study|patient scheduled for elective surgery|1
5342456|NCT00103857|18384216|P2|50-Week Extension Study|patient scheduled for elective surgery|0
5342457|NCT00103857|18384217|P1|50-Week Extension Study|patient scheduled for elective surgery|0
5342458|NCT00103857|18384211|P7|50-Week Extension Study|patient moved|0
5342459|NCT00103857|18384212|P6|50-Week Extension Study|patient moved|0
5342460|NCT00103857|18384213|P5|50-Week Extension Study|patient moved|0
5342461|NCT00103857|18384214|P4|50-Week Extension Study|patient moved|2
5342462|NCT00103857|18384215|P3|50-Week Extension Study|patient moved|1
5342463|NCT00103857|18384216|P2|50-Week Extension Study|patient moved|0
5342464|NCT00103857|18384217|P1|50-Week Extension Study|patient moved|0
5342465|NCT00103857|18384211|P7|50-Week Extension Study|non-compliance with study procedures|0
5342466|NCT00103857|18384212|P6|50-Week Extension Study|non-compliance with study procedures|0
5342467|NCT00103857|18384213|P5|50-Week Extension Study|non-compliance with study procedures|1
5342468|NCT00103857|18384214|P4|50-Week Extension Study|non-compliance with study procedures|1
5342469|NCT00103857|18384215|P3|50-Week Extension Study|non-compliance with study procedures|0
5342470|NCT00103857|18384216|P2|50-Week Extension Study|non-compliance with study procedures|0
5342471|NCT00103857|18384217|P1|50-Week Extension Study|non-compliance with study procedures|1
5342472|NCT00103857|18384211|P7|50-Week Extension Study|protocol discontinuation criteria|0
5342473|NCT00103857|18384212|P6|50-Week Extension Study|protocol discontinuation criteria|3
5342474|NCT00103857|18384213|P5|50-Week Extension Study|protocol discontinuation criteria|3
5342475|NCT00103857|18384214|P4|50-Week Extension Study|protocol discontinuation criteria|2
5342476|NCT00103857|18384215|P3|50-Week Extension Study|protocol discontinuation criteria|3
5342477|NCT00103857|18384216|P2|50-Week Extension Study|protocol discontinuation criteria|2
5342478|NCT00103857|18384217|P1|50-Week Extension Study|protocol discontinuation criteria|2
5342479|NCT00103857|18384211|P7|50-Week Extension Study|Withdrawal by Subject|0
5342480|NCT00103857|18384212|P6|50-Week Extension Study|Withdrawal by Subject|3
5342481|NCT00103857|18384213|P5|50-Week Extension Study|Withdrawal by Subject|3
5342482|NCT00103857|18384214|P4|50-Week Extension Study|Withdrawal by Subject|8
5342483|NCT00103857|18384215|P3|50-Week Extension Study|Withdrawal by Subject|2
5342484|NCT00103857|18384216|P2|50-Week Extension Study|Withdrawal by Subject|5
5342485|NCT00103857|18384217|P1|50-Week Extension Study|Withdrawal by Subject|2
5342486|NCT00103857|18384211|P7|50-Week Extension Study|Protocol Violation|0
5342487|NCT00103857|18384212|P6|50-Week Extension Study|Protocol Violation|1
5342488|NCT00103857|18384213|P5|50-Week Extension Study|Protocol Violation|0
5342489|NCT00103857|18384214|P4|50-Week Extension Study|Protocol Violation|2
5342490|NCT00103857|18384215|P3|50-Week Extension Study|Protocol Violation|1
5342491|NCT00103857|18384216|P2|50-Week Extension Study|Protocol Violation|1
5342492|NCT00103857|18384217|P1|50-Week Extension Study|Protocol Violation|1
5342493|NCT00103857|18384211|P7|50-Week Extension Study|Pregnancy|0
5342494|NCT00103857|18384212|P6|50-Week Extension Study|Pregnancy|0
5342495|NCT00103857|18384213|P5|50-Week Extension Study|Pregnancy|1
5342496|NCT00103857|18384214|P4|50-Week Extension Study|Pregnancy|0
5342497|NCT00103857|18384215|P3|50-Week Extension Study|Pregnancy|1
5342498|NCT00103857|18384216|P2|50-Week Extension Study|Pregnancy|0
5342499|NCT00103857|18384217|P1|50-Week Extension Study|Pregnancy|0
5342500|NCT00103857|18384211|P7|50-Week Extension Study|Physician Decision|0
5342501|NCT00103857|18384212|P6|50-Week Extension Study|Physician Decision|0
5342502|NCT00103857|18384213|P5|50-Week Extension Study|Physician Decision|0
5342503|NCT00103857|18384214|P4|50-Week Extension Study|Physician Decision|0
5342504|NCT00103857|18384215|P3|50-Week Extension Study|Physician Decision|1
5342505|NCT00103857|18384216|P2|50-Week Extension Study|Physician Decision|1
5342506|NCT00103857|18384217|P1|50-Week Extension Study|Physician Decision|0
5342507|NCT00103857|18384211|P7|50-Week Extension Study|Lost to Follow-up|0
5342508|NCT00103857|18384212|P6|50-Week Extension Study|Lost to Follow-up|3
5342509|NCT00103857|18384213|P5|50-Week Extension Study|Lost to Follow-up|3
5342510|NCT00103857|18384214|P4|50-Week Extension Study|Lost to Follow-up|4
5342511|NCT00103857|18384215|P3|50-Week Extension Study|Lost to Follow-up|1
5342512|NCT00103857|18384216|P2|50-Week Extension Study|Lost to Follow-up|0
5342513|NCT00103857|18384217|P1|50-Week Extension Study|Lost to Follow-up|4
5342514|NCT00103857|18384211|P7|50-Week Extension Study|Lack of Efficacy|0
5342515|NCT00103857|18384212|P6|50-Week Extension Study|Lack of Efficacy|8
5342516|NCT00103857|18384213|P5|50-Week Extension Study|Lack of Efficacy|8
5342517|NCT00103857|18384214|P4|50-Week Extension Study|Lack of Efficacy|16
5342518|NCT00103857|18384215|P3|50-Week Extension Study|Lack of Efficacy|13
5342519|NCT00103857|18384216|P2|50-Week Extension Study|Lack of Efficacy|15
5342520|NCT00103857|18384217|P1|50-Week Extension Study|Lack of Efficacy|26
5342521|NCT00103857|18384211|P7|50-Week Extension Study|Death|0
5342522|NCT00103857|18384212|P6|50-Week Extension Study|Death|1
5342523|NCT00103857|18384213|P5|50-Week Extension Study|Death|0
5342524|NCT00103857|18384214|P4|50-Week Extension Study|Death|1
5342525|NCT00103857|18384215|P3|50-Week Extension Study|Death|0
5342526|NCT00103857|18384216|P2|50-Week Extension Study|Death|0
5342527|NCT00103857|18384217|P1|50-Week Extension Study|Death|0
5342528|NCT00103857|18384211|P7|50-Week Extension Study|Adverse Event|0
5342529|NCT00103857|18384212|P6|50-Week Extension Study|Adverse Event|1
5342530|NCT00103857|18384213|P5|50-Week Extension Study|Adverse Event|1
5342531|NCT00103857|18384214|P4|50-Week Extension Study|Adverse Event|0
5342532|NCT00103857|18384215|P3|50-Week Extension Study|Adverse Event|2
5342533|NCT00103857|18384216|P2|50-Week Extension Study|Adverse Event|3
5342534|NCT00103857|18384217|P1|50-Week Extension Study|Adverse Event|2
5342535|NCT00103857|18384211|P7|54-Week Base Study|patient intolerance to rescue therapy|0
5342536|NCT00103857|18384212|P6|54-Week Base Study|patient intolerance to rescue therapy|0
5342537|NCT00103857|18384213|P5|54-Week Base Study|patient intolerance to rescue therapy|0
5342538|NCT00103857|18384214|P4|54-Week Base Study|patient intolerance to rescue therapy|0
5342539|NCT00103857|18384215|P3|54-Week Base Study|patient intolerance to rescue therapy|0
5342540|NCT00103857|18384216|P2|54-Week Base Study|patient intolerance to rescue therapy|0
5342541|NCT00103857|18384217|P1|54-Week Base Study|patient intolerance to rescue therapy|1
5342542|NCT00103857|18384211|P7|54-Week Base Study|site error|0
5342543|NCT00103857|18384212|P6|54-Week Base Study|site error|1
5342544|NCT00103857|18384213|P5|54-Week Base Study|site error|0
5342545|NCT00103857|18384214|P4|54-Week Base Study|site error|0
5342546|NCT00103857|18384215|P3|54-Week Base Study|site error|0
5342547|NCT00103857|18384216|P2|54-Week Base Study|site error|0
5342548|NCT00103857|18384217|P1|54-Week Base Study|site error|0
5342549|NCT00103857|18384211|P7|54-Week Base Study|laboratory reporting error|0
5342550|NCT00103857|18384212|P6|54-Week Base Study|laboratory reporting error|0
5342551|NCT00103857|18384213|P5|54-Week Base Study|laboratory reporting error|1
5342552|NCT00103857|18384214|P4|54-Week Base Study|laboratory reporting error|0
5342553|NCT00103857|18384215|P3|54-Week Base Study|laboratory reporting error|0
5342554|NCT00103857|18384216|P2|54-Week Base Study|laboratory reporting error|0
5342555|NCT00103857|18384217|P1|54-Week Base Study|laboratory reporting error|0
5342556|NCT00103857|18384211|P7|54-Week Base Study|patient incarcerated|0
5342557|NCT00103857|18384212|P6|54-Week Base Study|patient incarcerated|1
5342558|NCT00103857|18384213|P5|54-Week Base Study|patient incarcerated|1
5342559|NCT00103857|18384214|P4|54-Week Base Study|patient incarcerated|0
5342560|NCT00103857|18384215|P3|54-Week Base Study|patient incarcerated|0
5342561|NCT00103857|18384216|P2|54-Week Base Study|patient incarcerated|0
5342562|NCT00103857|18384217|P1|54-Week Base Study|patient incarcerated|0
5342563|NCT00103857|18384211|P7|54-Week Base Study|non-compliance with study procedures|0
5342564|NCT00103857|18384212|P6|54-Week Base Study|non-compliance with study procedures|2
5342565|NCT00103857|18384213|P5|54-Week Base Study|non-compliance with study procedures|0
5342566|NCT00103857|18384214|P4|54-Week Base Study|non-compliance with study procedures|0
5342567|NCT00103857|18384215|P3|54-Week Base Study|non-compliance with study procedures|0
5342568|NCT00103857|18384216|P2|54-Week Base Study|non-compliance with study procedures|2
5342569|NCT00103857|18384217|P1|54-Week Base Study|non-compliance with study procedures|1
5342570|NCT00103857|18384211|P7|54-Week Base Study|patient moved|0
5342571|NCT00103857|18384212|P6|54-Week Base Study|patient moved|1
5342572|NCT00103857|18384213|P5|54-Week Base Study|patient moved|3
5342573|NCT00103857|18384214|P4|54-Week Base Study|patient moved|2
5342574|NCT00103857|18384215|P3|54-Week Base Study|patient moved|1
5342575|NCT00103857|18384216|P2|54-Week Base Study|patient moved|1
5342576|NCT00103857|18384217|P1|54-Week Base Study|patient moved|0
5342577|NCT00103857|18384211|P7|54-Week Base Study|protocol discontinuation criteria|5
5342578|NCT00103857|18384212|P6|54-Week Base Study|protocol discontinuation criteria|3
5342579|NCT00103857|18384213|P5|54-Week Base Study|protocol discontinuation criteria|5
5342580|NCT00103857|18384214|P4|54-Week Base Study|protocol discontinuation criteria|6
5342581|NCT00103857|18384215|P3|54-Week Base Study|protocol discontinuation criteria|2
5342582|NCT00103857|18384216|P2|54-Week Base Study|protocol discontinuation criteria|5
5342583|NCT00103857|18384217|P1|54-Week Base Study|protocol discontinuation criteria|2
5342584|NCT00103857|18384211|P7|54-Week Base Study|Withdrawal by Subject|4
5342585|NCT00103857|18384212|P6|54-Week Base Study|Withdrawal by Subject|15
5342586|NCT00103857|18384213|P5|54-Week Base Study|Withdrawal by Subject|10
5342587|NCT00103857|18384214|P4|54-Week Base Study|Withdrawal by Subject|15
5342588|NCT00103857|18384215|P3|54-Week Base Study|Withdrawal by Subject|16
5342589|NCT00103857|18384216|P2|54-Week Base Study|Withdrawal by Subject|16
5342590|NCT00103857|18384217|P1|54-Week Base Study|Withdrawal by Subject|17
5342591|NCT00103857|18384211|P7|54-Week Base Study|Protocol Violation|3
5342592|NCT00103857|18384212|P6|54-Week Base Study|Protocol Violation|3
5342593|NCT00103857|18384213|P5|54-Week Base Study|Protocol Violation|0
5342594|NCT00103857|18384214|P4|54-Week Base Study|Protocol Violation|4
5342595|NCT00103857|18384215|P3|54-Week Base Study|Protocol Violation|2
5342596|NCT00103857|18384216|P2|54-Week Base Study|Protocol Violation|4
5342597|NCT00103857|18384217|P1|54-Week Base Study|Protocol Violation|6
5342598|NCT00103857|18384211|P7|54-Week Base Study|Pregnancy|1
5342599|NCT00103857|18384212|P6|54-Week Base Study|Pregnancy|0
5342600|NCT00103857|18384213|P5|54-Week Base Study|Pregnancy|1
5342601|NCT00103857|18384214|P4|54-Week Base Study|Pregnancy|0
5342602|NCT00103857|18384215|P3|54-Week Base Study|Pregnancy|0
5342603|NCT00103857|18384216|P2|54-Week Base Study|Pregnancy|0
5342604|NCT00103857|18384217|P1|54-Week Base Study|Pregnancy|1
5342605|NCT00103857|18384211|P7|54-Week Base Study|Physician Decision|0
5342606|NCT00103857|18384212|P6|54-Week Base Study|Physician Decision|0
5342607|NCT00103857|18384213|P5|54-Week Base Study|Physician Decision|1
5342608|NCT00103857|18384214|P4|54-Week Base Study|Physician Decision|0
5342609|NCT00103857|18384215|P3|54-Week Base Study|Physician Decision|0
5342610|NCT00103857|18384216|P2|54-Week Base Study|Physician Decision|1
5342611|NCT00103857|18384217|P1|54-Week Base Study|Physician Decision|1
5342612|NCT00103857|18384211|P7|54-Week Base Study|Lost to Follow-up|3
5342613|NCT00103857|18384212|P6|54-Week Base Study|Lost to Follow-up|9
5342614|NCT00103857|18384213|P5|54-Week Base Study|Lost to Follow-up|10
5342615|NCT00103857|18384214|P4|54-Week Base Study|Lost to Follow-up|5
5342616|NCT00103857|18384215|P3|54-Week Base Study|Lost to Follow-up|7
5342617|NCT00103857|18384216|P2|54-Week Base Study|Lost to Follow-up|4
5342618|NCT00103857|18384217|P1|54-Week Base Study|Lost to Follow-up|5
5342619|NCT00103857|18384211|P7|54-Week Base Study|Lack of Efficacy|19
5342620|NCT00103857|18384212|P6|54-Week Base Study|Lack of Efficacy|14
5342621|NCT00103857|18384213|P5|54-Week Base Study|Lack of Efficacy|3
5342622|NCT00103857|18384214|P4|54-Week Base Study|Lack of Efficacy|4
5342623|NCT00103857|18384215|P3|54-Week Base Study|Lack of Efficacy|8
5342624|NCT00103857|18384216|P2|54-Week Base Study|Lack of Efficacy|14
5342625|NCT00103857|18384217|P1|54-Week Base Study|Lack of Efficacy|11
5342626|NCT00103857|18384211|P7|54-Week Base Study|Death|0
5342627|NCT00103857|18384212|P6|54-Week Base Study|Death|1
5342628|NCT00103857|18384213|P5|54-Week Base Study|Death|1
5342629|NCT00103857|18384214|P4|54-Week Base Study|Death|0
5342630|NCT00103857|18384215|P3|54-Week Base Study|Death|0
5342631|NCT00103857|18384216|P2|54-Week Base Study|Death|0
5342632|NCT00103857|18384217|P1|54-Week Base Study|Death|0
5342633|NCT00103857|18384211|P7|54-Week Base Study|Adverse Event|3
5342634|NCT00103857|18384212|P6|54-Week Base Study|Adverse Event|11
5342635|NCT00103857|18384213|P5|54-Week Base Study|Adverse Event|5
5342636|NCT00103857|18384214|P4|54-Week Base Study|Adverse Event|6
5342637|NCT00103857|18384215|P3|54-Week Base Study|Adverse Event|11
5342638|NCT00103857|18384216|P2|54-Week Base Study|Adverse Event|9
5342639|NCT00103857|18384217|P1|54-Week Base Study|Adverse Event|12
5342640|NCT00103740|18384316|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
5342641|NCT00103740|18384317|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
5342642|NCT00103740|18384316|P2|Period 2 - Extended Observation Period|Death|2
5342643|NCT00103740|18384317|P1|Period 2 - Extended Observation Period|Death|6
5342644|NCT00103740|18384316|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
5342645|NCT00103740|18384317|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
5342646|NCT00103740|18384316|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
5342647|NCT00103740|18384317|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
5342648|NCT00103740|18384316|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
5342649|NCT00103740|18384317|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
5342650|NCT00103740|18384316|P2|Period 1 - Core|Patient withdrew consent|2
5342651|NCT00103740|18384317|P1|Period 1 - Core|Patient withdrew consent|3
5342652|NCT00103740|18384316|P2|Period 1 - Core|Protocol Violation|2
5342653|NCT00103740|18384317|P1|Period 1 - Core|Protocol Violation|3
5342654|NCT00103740|18384316|P2|Period 1 - Core|Adverse Event|0
5342655|NCT00103740|18384317|P1|Period 1 - Core|Adverse Event|1
5342656|NCT00103662|18384345|P2|Overall Study|Intercurrent illness|0
5342657|NCT00103662|18384346|P1|Overall Study|Intercurrent illness|1
5342658|NCT00103662|18384345|P2|Overall Study|Failed mobilization|4
5342659|NCT00103662|18384346|P1|Overall Study|Failed mobilization|0
5342660|NCT00103662|18384345|P2|Overall Study|Other|9
5342661|NCT00103662|18384346|P1|Overall Study|Other|6
5342662|NCT00103662|18384345|P2|Overall Study|Lost to Follow-up|1
5342663|NCT00103662|18384346|P1|Overall Study|Lost to Follow-up|0
5342664|NCT00103662|18384345|P2|Overall Study|Elective Withdrawal|5
5342665|NCT00103662|18384346|P1|Overall Study|Elective Withdrawal|5
5342666|NCT00103662|18384345|P2|Overall Study|Death|7
5342667|NCT00103662|18384346|P1|Overall Study|Death|7
5342668|NCT00103662|18384345|P2|Overall Study|Entered Rescue Procedure|7
5342669|NCT00103662|18384346|P1|Overall Study|Entered Rescue Procedure|0
5342670|NCT00103610|18384372|P2|Overall Study|Noncompliance|1
5342671|NCT00103610|18384373|P1|Overall Study|Noncompliance|0
5342672|NCT00103610|18384372|P2|Overall Study|Failed mobilization|5
5342673|NCT00103610|18384373|P1|Overall Study|Failed mobilization|1
5342674|NCT00103610|18384372|P2|Overall Study|Other|7
5342675|NCT00103610|18384373|P1|Overall Study|Other|2
5342676|NCT00103610|18384372|P2|Overall Study|Adverse Event|2
5342677|NCT00103610|18384373|P1|Overall Study|Adverse Event|2
5342678|NCT00103610|18384372|P2|Overall Study|Lost to Follow-up|1
5342679|NCT00103610|18384373|P1|Overall Study|Lost to Follow-up|3
5342680|NCT00103610|18384372|P2|Overall Study|Elective Withdrawal|0
5342681|NCT00103610|18384373|P1|Overall Study|Elective Withdrawal|4
5342682|NCT00103610|18384372|P2|Overall Study|Death|12
5342683|NCT00103610|18384373|P1|Overall Study|Death|16
5342684|NCT00103610|18384372|P2|Overall Study|Entered Rescue Procedure|52
5342685|NCT00103610|18384373|P1|Overall Study|Entered Rescue Procedure|10
5342686|NCT00103506|18384397|P2|Overall Study|Withdrawal by Subject|21
5342687|NCT00103506|18384398|P1|Overall Study|Withdrawal by Subject|18
5342688|NCT00103506|18384397|P2|Overall Study|Lost to Follow-up|13
5342689|NCT00103506|18384398|P1|Overall Study|Lost to Follow-up|13
5342690|NCT00103506|18384397|P2|Overall Study|Death|253
5342691|NCT00103506|18384398|P1|Overall Study|Death|257
5342692|NCT00103506|18384397|P2|Overall Study|Study closed by sponsor|37
5342693|NCT00103506|18384398|P1|Overall Study|Study closed by sponsor|34
5342694|NCT00103402|18384410|P2|Overall Study|Personal constraints/Other|0
5342695|NCT00103402|18384411|P1|Overall Study|Personal constraints/Other|5
5342696|NCT00103402|18384410|P2|Overall Study|Dissatisfied/No longer interested|6
5342697|NCT00103402|18384411|P1|Overall Study|Dissatisfied/No longer interested|6
5342698|NCT00103402|18384410|P2|Overall Study|Lost to Follow-up|7
5342699|NCT00103402|18384411|P1|Overall Study|Lost to Follow-up|8
5342700|NCT00103402|18384410|P2|Overall Study|Adverse Event|4
5342701|NCT00103402|18384411|P1|Overall Study|Adverse Event|3
5342702|NCT00103311|18384452|P2|Overall Study|Adverse Event|0
5342703|NCT00103311|18384453|P1|Overall Study|Adverse Event|1
5342704|NCT00103311|18384452|P2|Overall Study|Withdrawal by Subject|1
5342705|NCT00103311|18384453|P1|Overall Study|Withdrawal by Subject|2
5342706|NCT00103311|18384452|P2|Overall Study|Lost to Follow-up|0
5342707|NCT00103311|18384453|P1|Overall Study|Lost to Follow-up|1
5342708|NCT00103285|18384463|P8|Response Assignment|Other|53
5342709|NCT00103285|18384464|P7|Response Assignment|Other|11
5342710|NCT00103285|18384465|P6|Response Assignment|Other|17
5342711|NCT00103285|18384466|P5|Response Assignment|Other|37
5342712|NCT00103285|18384467|P4|Response Assignment|Other|38
5342713|NCT00103285|18384468|P3|Response Assignment|Other|48
5342714|NCT00103285|18384469|P2|Response Assignment|Other|30
5342715|NCT00103285|18384470|P1|Response Assignment|Other|0
5342716|NCT00103285|18384463|P8|Response Assignment|Refusal|10
5342717|NCT00103285|18384464|P7|Response Assignment|Refusal|30
5342718|NCT00103285|18384465|P6|Response Assignment|Refusal|15
5342719|NCT00103285|18384466|P5|Response Assignment|Refusal|25
5342720|NCT00103285|18384467|P4|Response Assignment|Refusal|3
5342721|NCT00103285|18384468|P3|Response Assignment|Refusal|5
5342722|NCT00103285|18384469|P2|Response Assignment|Refusal|53
5342723|NCT00103285|18384470|P1|Response Assignment|Refusal|0
5342724|NCT00103285|18384463|P8|Response Assignment|Ineligible|5
5342725|NCT00103285|18384464|P7|Response Assignment|Ineligible|1
5342726|NCT00103285|18384465|P6|Response Assignment|Ineligible|3
5342727|NCT00103285|18384466|P5|Response Assignment|Ineligible|0
5342728|NCT00103285|18384467|P4|Response Assignment|Ineligible|2
5342729|NCT00103285|18384468|P3|Response Assignment|Ineligible|6
5342730|NCT00103285|18384469|P2|Response Assignment|Ineligible|8
5342731|NCT00103285|18384470|P1|Response Assignment|Ineligible|0
5342732|NCT00103285|18384463|P8|Response Assignment|Withdrawal by Subject|2
5342733|NCT00103285|18384464|P7|Response Assignment|Withdrawal by Subject|0
5342734|NCT00103285|18384465|P6|Response Assignment|Withdrawal by Subject|2
5342735|NCT00103285|18384466|P5|Response Assignment|Withdrawal by Subject|2
5342736|NCT00103285|18384467|P4|Response Assignment|Withdrawal by Subject|1
5342737|NCT00103285|18384468|P3|Response Assignment|Withdrawal by Subject|1
5342738|NCT00103285|18384469|P2|Response Assignment|Withdrawal by Subject|4
5342739|NCT00103285|18384470|P1|Response Assignment|Withdrawal by Subject|0
5342740|NCT00103285|18384463|P8|Response Assignment|Protocol Violation|0
5342741|NCT00103285|18384464|P7|Response Assignment|Protocol Violation|0
5342742|NCT00103285|18384465|P6|Response Assignment|Protocol Violation|0
5342743|NCT00103285|18384466|P5|Response Assignment|Protocol Violation|0
5342744|NCT00103285|18384467|P4|Response Assignment|Protocol Violation|0
5342745|NCT00103285|18384468|P3|Response Assignment|Protocol Violation|0
5342746|NCT00103285|18384469|P2|Response Assignment|Protocol Violation|2
5342747|NCT00103285|18384470|P1|Response Assignment|Protocol Violation|0
5342748|NCT00103285|18384463|P8|Response Assignment|Physician Decision|35
5342749|NCT00103285|18384464|P7|Response Assignment|Physician Decision|4
5342750|NCT00103285|18384465|P6|Response Assignment|Physician Decision|7
5342751|NCT00103285|18384466|P5|Response Assignment|Physician Decision|13
5342752|NCT00103285|18384467|P4|Response Assignment|Physician Decision|9
5342753|NCT00103285|18384468|P3|Response Assignment|Physician Decision|14
5342754|NCT00103285|18384469|P2|Response Assignment|Physician Decision|13
5342755|NCT00103285|18384470|P1|Response Assignment|Physician Decision|0
5342756|NCT00103285|18384463|P8|Response Assignment|Lost to Follow-up|5
5342757|NCT00103285|18384464|P7|Response Assignment|Lost to Follow-up|2
5342758|NCT00103285|18384465|P6|Response Assignment|Lost to Follow-up|2
5342759|NCT00103285|18384466|P5|Response Assignment|Lost to Follow-up|1
5342760|NCT00103285|18384467|P4|Response Assignment|Lost to Follow-up|5
5342761|NCT00103285|18384468|P3|Response Assignment|Lost to Follow-up|5
5342762|NCT00103285|18384469|P2|Response Assignment|Lost to Follow-up|9
5342763|NCT00103285|18384470|P1|Response Assignment|Lost to Follow-up|0
5342764|NCT00103285|18384463|P8|Response Assignment|Death|8
5342765|NCT00103285|18384464|P7|Response Assignment|Death|0
5342766|NCT00103285|18384465|P6|Response Assignment|Death|1
5342767|NCT00103285|18384466|P5|Response Assignment|Death|3
5342768|NCT00103285|18384467|P4|Response Assignment|Death|2
5342769|NCT00103285|18384468|P3|Response Assignment|Death|2
5342770|NCT00103285|18384469|P2|Response Assignment|Death|5
5342771|NCT00103285|18384470|P1|Response Assignment|Death|0
5342772|NCT00103285|18384463|P8|Response Assignment|Adverse Event|2
5342773|NCT00103285|18384464|P7|Response Assignment|Adverse Event|1
5342774|NCT00103285|18384465|P6|Response Assignment|Adverse Event|1
5342775|NCT00103285|18384466|P5|Response Assignment|Adverse Event|3
5342776|NCT00103285|18384467|P4|Response Assignment|Adverse Event|2
5342777|NCT00103285|18384468|P3|Response Assignment|Adverse Event|3
5342778|NCT00103285|18384469|P2|Response Assignment|Adverse Event|8
5342779|NCT00103285|18384470|P1|Response Assignment|Adverse Event|0
5342780|NCT00103285|18384463|P8|Induction|Other|0
5342781|NCT00103285|18384464|P7|Induction|Other|0
5342782|NCT00103285|18384465|P6|Induction|Other|0
5342783|NCT00103285|18384466|P5|Induction|Other|0
5342784|NCT00103285|18384467|P4|Induction|Other|0
5342785|NCT00103285|18384468|P3|Induction|Other|0
5342786|NCT00103285|18384469|P2|Induction|Other|0
5342787|NCT00103285|18384470|P1|Induction|Other|258
5342788|NCT00103285|18384463|P8|Induction|Refusal|0
5342789|NCT00103285|18384464|P7|Induction|Refusal|0
5342790|NCT00103285|18384465|P6|Induction|Refusal|0
5342791|NCT00103285|18384466|P5|Induction|Refusal|0
5342792|NCT00103285|18384467|P4|Induction|Refusal|0
5342793|NCT00103285|18384468|P3|Induction|Refusal|0
5342794|NCT00103285|18384469|P2|Induction|Refusal|0
5342795|NCT00103285|18384470|P1|Induction|Refusal|906
5342796|NCT00103285|18384463|P8|Induction|Ineligible|0
5342797|NCT00103285|18384464|P7|Induction|Ineligible|0
5342798|NCT00103285|18384465|P6|Induction|Ineligible|0
5342799|NCT00103285|18384466|P5|Induction|Ineligible|0
5342800|NCT00103285|18384467|P4|Induction|Ineligible|0
5342801|NCT00103285|18384468|P3|Induction|Ineligible|0
5342802|NCT00103285|18384469|P2|Induction|Ineligible|0
5342803|NCT00103285|18384470|P1|Induction|Ineligible|43
5342804|NCT00103285|18384463|P8|Induction|Withdrawal by Subject|0
5342805|NCT00103285|18384464|P7|Induction|Withdrawal by Subject|0
5342806|NCT00103285|18384465|P6|Induction|Withdrawal by Subject|0
5342807|NCT00103285|18384466|P5|Induction|Withdrawal by Subject|0
5342808|NCT00103285|18384467|P4|Induction|Withdrawal by Subject|0
5342809|NCT00103285|18384468|P3|Induction|Withdrawal by Subject|0
5342810|NCT00103285|18384469|P2|Induction|Withdrawal by Subject|0
5342811|NCT00103285|18384470|P1|Induction|Withdrawal by Subject|1
5342812|NCT00103285|18384463|P8|Induction|Physician Decision|0
5342813|NCT00103285|18384464|P7|Induction|Physician Decision|0
5342814|NCT00103285|18384465|P6|Induction|Physician Decision|0
5342815|NCT00103285|18384466|P5|Induction|Physician Decision|0
5342816|NCT00103285|18384467|P4|Induction|Physician Decision|0
5342817|NCT00103285|18384468|P3|Induction|Physician Decision|0
5342818|NCT00103285|18384469|P2|Induction|Physician Decision|0
5342819|NCT00103285|18384470|P1|Induction|Physician Decision|103
5342820|NCT00103285|18384463|P8|Induction|Death|0
5342821|NCT00103285|18384464|P7|Induction|Death|0
5342822|NCT00103285|18384465|P6|Induction|Death|0
5342823|NCT00103285|18384466|P5|Induction|Death|0
5342824|NCT00103285|18384467|P4|Induction|Death|0
5342825|NCT00103285|18384468|P3|Induction|Death|0
5342826|NCT00103285|18384469|P2|Induction|Death|0
5342827|NCT00103285|18384470|P1|Induction|Death|24
5342828|NCT00103285|18384463|P8|Induction|Adverse Event|0
5342829|NCT00103285|18384464|P7|Induction|Adverse Event|0
5342830|NCT00103285|18384465|P6|Induction|Adverse Event|0
5342831|NCT00103285|18384466|P5|Induction|Adverse Event|0
5342832|NCT00103285|18384467|P4|Induction|Adverse Event|0
5342833|NCT00103285|18384468|P3|Induction|Adverse Event|0
5342834|NCT00103285|18384469|P2|Induction|Adverse Event|0
5342835|NCT00103285|18384470|P1|Induction|Adverse Event|14
5342836|NCT00103259|18384499|P2|Overall Study|ineligible/no protocol therapy|6
5342837|NCT00103259|18384500|P1|Overall Study|ineligible/no protocol therapy|4
5342838|NCT00103259|18384499|P2|Overall Study|other (reasons were not specified)|1
5342839|NCT00103259|18384500|P1|Overall Study|other (reasons were not specified)|2
5342840|NCT00103259|18384499|P2|Overall Study|alternative therapy|0
5342841|NCT00103259|18384500|P1|Overall Study|alternative therapy|1
5342842|NCT00103259|18384499|P2|Overall Study|Withdrawal by Subject|3
5342843|NCT00103259|18384500|P1|Overall Study|Withdrawal by Subject|2
5342844|NCT00103259|18384499|P2|Overall Study|Death|2
5342845|NCT00103259|18384500|P1|Overall Study|Death|3
5342846|NCT00103207|18384512|P1|Overall Study|Diagnosis of BAC not confirmed|27
5342847|NCT00103207|18384512|P1|Overall Study|Ineligible|4
5342848|NCT00103207|18384512|P1|Overall Study|Other complicating disease|1
5342849|NCT00103207|18384512|P1|Overall Study|Withdrawal by Subject|2
5342850|NCT00103207|18384512|P1|Overall Study|Death|1
5342851|NCT00103207|18384512|P1|Overall Study|Adverse Event|3
5342852|NCT00103142|18384531|P2|Overall Study|Progression of disease|1
5342853|NCT00103142|18384532|P1|Overall Study|Progression of disease|2
5342854|NCT00103142|18384531|P2|Overall Study|Adverse Event|0
5342855|NCT00103142|18384532|P1|Overall Study|Adverse Event|1
5342856|NCT00103012|18384548|P3|Overall Study|Subject non-compliant with medications|1
5342857|NCT00103012|18384549|P2|Overall Study|Subject non-compliant with medications|0
5342858|NCT00103012|18384550|P1|Overall Study|Subject non-compliant with medications|0
5342859|NCT00103012|18384548|P3|Overall Study|Adverse Event|1
5342860|NCT00103012|18384549|P2|Overall Study|Adverse Event|0
5342861|NCT00103012|18384550|P1|Overall Study|Adverse Event|0
5342862|NCT00103012|18384548|P3|Overall Study|Pregnancy|0
5342863|NCT00103012|18384549|P2|Overall Study|Pregnancy|0
5342864|NCT00103012|18384550|P1|Overall Study|Pregnancy|1
5342865|NCT00103012|18384548|P3|Overall Study|Withdrawal by Subject|2
5342866|NCT00103012|18384549|P2|Overall Study|Withdrawal by Subject|1
5342867|NCT00103012|18384550|P1|Overall Study|Withdrawal by Subject|2
5342868|NCT00102960|18384561|P3|Overall Study|Withdrawal by Subject|1
5342869|NCT00102960|18384562|P2|Overall Study|Withdrawal by Subject|0
5342870|NCT00102960|18384563|P1|Overall Study|Withdrawal by Subject|1
5342871|NCT00102960|18384561|P3|Overall Study|Lost to Follow-up|16
5342872|NCT00102960|18384562|P2|Overall Study|Lost to Follow-up|12
5342873|NCT00102960|18384563|P1|Overall Study|Lost to Follow-up|6
5342874|NCT00102960|18384561|P3|Overall Study|Death|11
5342875|NCT00102960|18384562|P2|Overall Study|Death|11
5342876|NCT00102960|18384563|P1|Overall Study|Death|23
5342877|NCT00102804|18384612|P2|Overall Study|Alive, Receiving Treatment|2
5342878|NCT00102804|18384613|P1|Overall Study|Alive, Receiving Treatment|7
5342879|NCT00102804|18384612|P2|Overall Study|Sponsor Decision|0
5342880|NCT00102804|18384613|P1|Overall Study|Sponsor Decision|1
5342881|NCT00102804|18384612|P2|Overall Study|Satisfactory Response|0
5342882|NCT00102804|18384613|P1|Overall Study|Satisfactory Response|2
5342883|NCT00102804|18384612|P2|Overall Study|Protocol Violation|1
5342884|NCT00102804|18384613|P1|Overall Study|Protocol Violation|2
5342885|NCT00102804|18384612|P2|Overall Study|Lost to Follow-up|1
5342886|NCT00102804|18384613|P1|Overall Study|Lost to Follow-up|4
5342887|NCT00102804|18384612|P2|Overall Study|Enrollment Criteria Not Met|0
5342888|NCT00102804|18384613|P1|Overall Study|Enrollment Criteria Not Met|6
5342889|NCT00102804|18384612|P2|Overall Study|Death|6
5342890|NCT00102804|18384613|P1|Overall Study|Death|5
5342891|NCT00102804|18384612|P2|Overall Study|Physician Decision|6
5342892|NCT00102804|18384613|P1|Overall Study|Physician Decision|24
5342893|NCT00102804|18384612|P2|Overall Study|Adverse Event|3
5342894|NCT00102804|18384613|P1|Overall Study|Adverse Event|37
5342895|NCT00102804|18384612|P2|Overall Study|Withdrawal by Subject|7
5342896|NCT00102804|18384613|P1|Overall Study|Withdrawal by Subject|46
5342897|NCT00102804|18384612|P2|Overall Study|Progressive Disease (PD)|196
5342898|NCT00102804|18384613|P1|Overall Study|Progressive Disease (PD)|307
5342899|NCT00102687|18384634|P5|Maintenance Period|Physician Decision|4
5342900|NCT00102687|18384635|P4|Maintenance Period|Physician Decision|0
5342901|NCT00102687|18384636|P3|Maintenance Period|Physician Decision|3
5342902|NCT00102687|18384637|P2|Maintenance Period|Physician Decision|2
5342903|NCT00102687|18384638|P1|Maintenance Period|Physician Decision|1
5342904|NCT00102687|18384634|P5|Maintenance Period|Death|1
5342905|NCT00102687|18384635|P4|Maintenance Period|Death|1
5342906|NCT00102687|18384636|P3|Maintenance Period|Death|0
5342907|NCT00102687|18384637|P2|Maintenance Period|Death|0
5342908|NCT00102687|18384638|P1|Maintenance Period|Death|0
5342909|NCT00102687|18384634|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
5342910|NCT00102687|18384635|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
5342911|NCT00102687|18384636|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
5342912|NCT00102687|18384637|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
5342913|NCT00102687|18384638|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
5342914|NCT00102687|18384634|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
5342915|NCT00102687|18384635|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
5342916|NCT00102687|18384636|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
5342917|NCT00102687|18384637|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
5342918|NCT00102687|18384638|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
5342919|NCT00102687|18384634|P5|Maintenance Period|Adverse Event|3
5342920|NCT00102687|18384635|P4|Maintenance Period|Adverse Event|1
5342921|NCT00102687|18384636|P3|Maintenance Period|Adverse Event|0
5342922|NCT00102687|18384637|P2|Maintenance Period|Adverse Event|0
5342923|NCT00102687|18384638|P1|Maintenance Period|Adverse Event|1
5342924|NCT00102687|18384634|P5|Maintenance Period|Withdrawal by Subject|1
5342925|NCT00102687|18384635|P4|Maintenance Period|Withdrawal by Subject|3
5342926|NCT00102687|18384636|P3|Maintenance Period|Withdrawal by Subject|2
5342927|NCT00102687|18384637|P2|Maintenance Period|Withdrawal by Subject|0
5342928|NCT00102687|18384638|P1|Maintenance Period|Withdrawal by Subject|4
5342929|NCT00102687|18384634|P5|Initial Period|Death|0
5342930|NCT00102687|18384635|P4|Initial Period|Death|0
5342931|NCT00102687|18384636|P3|Initial Period|Death|1
5342932|NCT00102687|18384637|P2|Initial Period|Death|1
5342933|NCT00102687|18384638|P1|Initial Period|Death|1
5342934|NCT00102687|18384634|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
5342935|NCT00102687|18384635|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
5342936|NCT00102687|18384636|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
5342937|NCT00102687|18384637|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
5342938|NCT00102687|18384638|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
5342939|NCT00102687|18384634|P5|Initial Period|Sponsor's decision|0
5342940|NCT00102687|18384635|P4|Initial Period|Sponsor's decision|0
5342941|NCT00102687|18384636|P3|Initial Period|Sponsor's decision|1
5342942|NCT00102687|18384637|P2|Initial Period|Sponsor's decision|1
5342943|NCT00102687|18384638|P1|Initial Period|Sponsor's decision|0
5342944|NCT00102687|18384634|P5|Initial Period|Physician Decision|0
5342945|NCT00102687|18384635|P4|Initial Period|Physician Decision|0
5342946|NCT00102687|18384636|P3|Initial Period|Physician Decision|6
5342947|NCT00102687|18384637|P2|Initial Period|Physician Decision|9
5342948|NCT00102687|18384638|P1|Initial Period|Physician Decision|2
5342949|NCT00102687|18384634|P5|Initial Period|Protocol Violation|0
5342950|NCT00102687|18384635|P4|Initial Period|Protocol Violation|0
5342951|NCT00102687|18384636|P3|Initial Period|Protocol Violation|2
5342952|NCT00102687|18384637|P2|Initial Period|Protocol Violation|0
5342953|NCT00102687|18384638|P1|Initial Period|Protocol Violation|0
5342954|NCT00102687|18384634|P5|Initial Period|Transformation to AML (blast > 30%)|0
5342955|NCT00102687|18384635|P4|Initial Period|Transformation to AML (blast > 30%)|0
5342956|NCT00102687|18384636|P3|Initial Period|Transformation to AML (blast > 30%)|0
5342957|NCT00102687|18384637|P2|Initial Period|Transformation to AML (blast > 30%)|3
5342958|NCT00102687|18384638|P1|Initial Period|Transformation to AML (blast > 30%)|1
5342959|NCT00102687|18384634|P5|Initial Period|Adverse Event|0
5342960|NCT00102687|18384635|P4|Initial Period|Adverse Event|0
5342961|NCT00102687|18384636|P3|Initial Period|Adverse Event|9
5342962|NCT00102687|18384637|P2|Initial Period|Adverse Event|7
5342963|NCT00102687|18384638|P1|Initial Period|Adverse Event|4
5342964|NCT00102687|18384634|P5|Initial Period|Withdrawal by Subject|0
5342965|NCT00102687|18384635|P4|Initial Period|Withdrawal by Subject|0
5342966|NCT00102687|18384636|P3|Initial Period|Withdrawal by Subject|5
5342967|NCT00102687|18384637|P2|Initial Period|Withdrawal by Subject|3
5342968|NCT00102687|18384638|P1|Initial Period|Withdrawal by Subject|6
5342969|NCT00102596|18384702|P2|Part A|Adverse Event|0
5342970|NCT00102596|18384703|P1|Part A|Adverse Event|1
5342971|NCT00102596|18384702|P2|Part A|Screen failures|0
5342972|NCT00102596|18384703|P1|Part A|Screen failures|6
5342973|NCT00102531|18384714|P2|Overall Study|Physician Decision|1
5342974|NCT00102531|18384715|P1|Overall Study|Physician Decision|0
5342975|NCT00102531|18384714|P2|Overall Study|Disease Progression|9
5342976|NCT00102531|18384715|P1|Overall Study|Disease Progression|5
5342977|NCT00102531|18384714|P2|Overall Study|Adverse Event|1
5342978|NCT00102531|18384715|P1|Overall Study|Adverse Event|0
5342979|NCT00102440|18384730|P3|Overall Study|Protocol Violation|1
5342980|NCT00102440|18384731|P2|Overall Study|Protocol Violation|2
5342981|NCT00102440|18384732|P1|Overall Study|Protocol Violation|7
5342982|NCT00102440|18384730|P3|Overall Study|Other|14
5342983|NCT00102440|18384731|P2|Overall Study|Other|14
5342984|NCT00102440|18384732|P1|Overall Study|Other|11
5342985|NCT00102440|18384730|P3|Overall Study|Personal Reason(s)|13
5342986|NCT00102440|18384731|P2|Overall Study|Personal Reason(s)|13
5342987|NCT00102440|18384732|P1|Overall Study|Personal Reason(s)|19
5342988|NCT00102440|18384730|P3|Overall Study|Gout Flare|9
5342989|NCT00102440|18384731|P2|Overall Study|Gout Flare|28
5342990|NCT00102440|18384732|P1|Overall Study|Gout Flare|10
5342991|NCT00102440|18384730|P3|Overall Study|Adverse Event|8
5342992|NCT00102440|18384731|P2|Overall Study|Adverse Event|23
5342993|NCT00102440|18384732|P1|Overall Study|Adverse Event|16
5342994|NCT00102440|18384730|P3|Overall Study|Lost to Follow-up|21
5342995|NCT00102440|18384731|P2|Overall Study|Lost to Follow-up|18
5342996|NCT00102440|18384732|P1|Overall Study|Lost to Follow-up|25
5342997|NCT00102063|18384782|P3|Overall Study|Protocol Violation|1
5342998|NCT00102063|18384783|P2|Overall Study|Protocol Violation|1
5342999|NCT00102063|18384784|P1|Overall Study|Protocol Violation|0
5343000|NCT00102063|18384782|P3|Overall Study|Lost to Follow-up|1
5343001|NCT00102063|18384783|P2|Overall Study|Lost to Follow-up|0
5343002|NCT00102063|18384784|P1|Overall Study|Lost to Follow-up|0
5343003|NCT00102063|18384782|P3|Overall Study|Withdrawal by Subject|5
5343004|NCT00102063|18384783|P2|Overall Study|Withdrawal by Subject|12
5343005|NCT00102063|18384784|P1|Overall Study|Withdrawal by Subject|4
5343006|NCT00102063|18384782|P3|Overall Study|Adverse Event|2
5343007|NCT00102063|18384783|P2|Overall Study|Adverse Event|4
5343008|NCT00102063|18384784|P1|Overall Study|Adverse Event|7
5343009|NCT00102063|18384782|P3|Overall Study|Lack of Efficacy|1
5343010|NCT00102063|18384783|P2|Overall Study|Lack of Efficacy|1
5343011|NCT00102063|18384784|P1|Overall Study|Lack of Efficacy|5
5343012|NCT00101907|18384842|P6|Overall Study|Withdrawal by Subject|0
5343013|NCT00101907|18384843|P5|Overall Study|Withdrawal by Subject|1
5343014|NCT00101907|18384844|P4|Overall Study|Withdrawal by Subject|0
5343015|NCT00101907|18384845|P3|Overall Study|Withdrawal by Subject|1
5343016|NCT00101907|18384846|P2|Overall Study|Withdrawal by Subject|0
5343017|NCT00101907|18384847|P1|Overall Study|Withdrawal by Subject|1
5343018|NCT00101907|18384842|P6|Overall Study|Physician Decision|0
5343019|NCT00101907|18384843|P5|Overall Study|Physician Decision|1
5343020|NCT00101907|18384844|P4|Overall Study|Physician Decision|1
5343021|NCT00101907|18384845|P3|Overall Study|Physician Decision|0
5343022|NCT00101907|18384846|P2|Overall Study|Physician Decision|0
5343023|NCT00101907|18384847|P1|Overall Study|Physician Decision|0
5343024|NCT00101907|18384842|P6|Overall Study|Death|0
5343025|NCT00101907|18384843|P5|Overall Study|Death|3
5343026|NCT00101907|18384844|P4|Overall Study|Death|0
5343027|NCT00101907|18384845|P3|Overall Study|Death|0
5343028|NCT00101907|18384846|P2|Overall Study|Death|1
5343029|NCT00101907|18384847|P1|Overall Study|Death|0
5343030|NCT00101907|18384842|P6|Overall Study|Adverse Event|0
5343031|NCT00101907|18384843|P5|Overall Study|Adverse Event|0
5343032|NCT00101907|18384844|P4|Overall Study|Adverse Event|0
5343033|NCT00101907|18384845|P3|Overall Study|Adverse Event|0
5343034|NCT00101907|18384846|P2|Overall Study|Adverse Event|0
5343035|NCT00101907|18384847|P1|Overall Study|Adverse Event|1
5343036|NCT00101868|18384889|P2|Overall Study|Lost to Follow-up|13
5343037|NCT00101868|18384890|P1|Overall Study|Lost to Follow-up|8
5343038|NCT00101868|18384889|P2|Overall Study|Protocol Violation|0
5343039|NCT00101868|18384890|P1|Overall Study|Protocol Violation|3
5343040|NCT00101868|18384889|P2|Overall Study|Withdrawal by Subject|9
5343041|NCT00101868|18384890|P1|Overall Study|Withdrawal by Subject|8
5343042|NCT00101868|18384889|P2|Overall Study|Death|10
5343043|NCT00101868|18384890|P1|Overall Study|Death|10
5343044|NCT00101686|18384960|P10|Overall Study|Withdrawal by Subject|9
5343045|NCT00101686|18384961|P9|Overall Study|Withdrawal by Subject|8
5343046|NCT00101686|18384962|P8|Overall Study|Withdrawal by Subject|7
5343047|NCT00101686|18384963|P7|Overall Study|Withdrawal by Subject|7
5343048|NCT00101686|18384964|P6|Overall Study|Withdrawal by Subject|7
5343049|NCT00101686|18384965|P5|Overall Study|Withdrawal by Subject|8
5343050|NCT00101686|18384966|P4|Overall Study|Withdrawal by Subject|8
5343051|NCT00101686|18384967|P3|Overall Study|Withdrawal by Subject|6
5343052|NCT00101686|18384968|P2|Overall Study|Withdrawal by Subject|8
5343053|NCT00101686|18384969|P1|Overall Study|Withdrawal by Subject|9
5343054|NCT00101686|18384960|P10|Overall Study|Other|3
5343055|NCT00101686|18384961|P9|Overall Study|Other|3
5343056|NCT00101686|18384962|P8|Overall Study|Other|5
5343057|NCT00101686|18384963|P7|Overall Study|Other|1
5343058|NCT00101686|18384964|P6|Overall Study|Other|12
5343059|NCT00101686|18384965|P5|Overall Study|Other|2
5343060|NCT00101686|18384966|P4|Overall Study|Other|6
5343061|NCT00101686|18384967|P3|Overall Study|Other|1
5343062|NCT00101686|18384968|P2|Overall Study|Other|4
5343063|NCT00101686|18384969|P1|Overall Study|Other|1
5343064|NCT00101686|18384960|P10|Overall Study|Physician Decision|1
5343065|NCT00101686|18384961|P9|Overall Study|Physician Decision|1
5343066|NCT00101686|18384962|P8|Overall Study|Physician Decision|5
5343067|NCT00101686|18384963|P7|Overall Study|Physician Decision|5
5343068|NCT00101686|18384964|P6|Overall Study|Physician Decision|9
5343069|NCT00101686|18384965|P5|Overall Study|Physician Decision|8
5343070|NCT00101686|18384966|P4|Overall Study|Physician Decision|7
5343071|NCT00101686|18384967|P3|Overall Study|Physician Decision|6
5343072|NCT00101686|18384968|P2|Overall Study|Physician Decision|13
5343073|NCT00101686|18384969|P1|Overall Study|Physician Decision|10
5343074|NCT00101686|18384960|P10|Overall Study|intercurrent non-cancer related illness|1
5343075|NCT00101686|18384961|P9|Overall Study|intercurrent non-cancer related illness|1
5343076|NCT00101686|18384962|P8|Overall Study|intercurrent non-cancer related illness|0
5343077|NCT00101686|18384963|P7|Overall Study|intercurrent non-cancer related illness|1
5343078|NCT00101686|18384964|P6|Overall Study|intercurrent non-cancer related illness|3
5343079|NCT00101686|18384965|P5|Overall Study|intercurrent non-cancer related illness|1
5343080|NCT00101686|18384966|P4|Overall Study|intercurrent non-cancer related illness|0
5343081|NCT00101686|18384967|P3|Overall Study|intercurrent non-cancer related illness|2
5343082|NCT00101686|18384968|P2|Overall Study|intercurrent non-cancer related illness|0
5343083|NCT00101686|18384969|P1|Overall Study|intercurrent non-cancer related illness|0
5343084|NCT00101686|18384960|P10|Overall Study|Randomized but did not receive treament|1
5343085|NCT00101686|18384961|P9|Overall Study|Randomized but did not receive treament|0
5343086|NCT00101686|18384962|P8|Overall Study|Randomized but did not receive treament|1
5343087|NCT00101686|18384963|P7|Overall Study|Randomized but did not receive treament|0
5343088|NCT00101686|18384964|P6|Overall Study|Randomized but did not receive treament|2
5343089|NCT00101686|18384965|P5|Overall Study|Randomized but did not receive treament|2
5343090|NCT00101686|18384966|P4|Overall Study|Randomized but did not receive treament|2
5343091|NCT00101686|18384967|P3|Overall Study|Randomized but did not receive treament|2
5343092|NCT00101686|18384968|P2|Overall Study|Randomized but did not receive treament|6
5343093|NCT00101686|18384969|P1|Overall Study|Randomized but did not receive treament|1
5343094|NCT00101686|18384960|P10|Overall Study|unacceptable toxicity|4
5343095|NCT00101686|18384961|P9|Overall Study|unacceptable toxicity|1
5343096|NCT00101686|18384962|P8|Overall Study|unacceptable toxicity|2
5343097|NCT00101686|18384963|P7|Overall Study|unacceptable toxicity|4
5343098|NCT00101686|18384964|P6|Overall Study|unacceptable toxicity|10
5343099|NCT00101686|18384965|P5|Overall Study|unacceptable toxicity|16
5343100|NCT00101686|18384966|P4|Overall Study|unacceptable toxicity|6
5343101|NCT00101686|18384967|P3|Overall Study|unacceptable toxicity|10
5343102|NCT00101686|18384968|P2|Overall Study|unacceptable toxicity|9
5343103|NCT00101686|18384969|P1|Overall Study|unacceptable toxicity|3
5343104|NCT00101686|18384960|P10|Overall Study|>3 week delay treatment due toxicity|0
5343105|NCT00101686|18384961|P9|Overall Study|>3 week delay treatment due toxicity|3
5343106|NCT00101686|18384962|P8|Overall Study|>3 week delay treatment due toxicity|1
5343107|NCT00101686|18384963|P7|Overall Study|>3 week delay treatment due toxicity|2
5343108|NCT00101686|18384964|P6|Overall Study|>3 week delay treatment due toxicity|3
5343109|NCT00101686|18384965|P5|Overall Study|>3 week delay treatment due toxicity|7
5343110|NCT00101686|18384966|P4|Overall Study|>3 week delay treatment due toxicity|2
5343111|NCT00101686|18384967|P3|Overall Study|>3 week delay treatment due toxicity|1
5343112|NCT00101686|18384968|P2|Overall Study|>3 week delay treatment due toxicity|2
5343113|NCT00101686|18384969|P1|Overall Study|>3 week delay treatment due toxicity|6
5343114|NCT00101686|18384960|P10|Overall Study|initiation other anti-cancer treatment|3
5343115|NCT00101686|18384961|P9|Overall Study|initiation other anti-cancer treatment|3
5343116|NCT00101686|18384962|P8|Overall Study|initiation other anti-cancer treatment|2
5343117|NCT00101686|18384963|P7|Overall Study|initiation other anti-cancer treatment|2
5343118|NCT00101686|18384964|P6|Overall Study|initiation other anti-cancer treatment|1
5343119|NCT00101686|18384965|P5|Overall Study|initiation other anti-cancer treatment|1
5343120|NCT00101686|18384966|P4|Overall Study|initiation other anti-cancer treatment|3
5343121|NCT00101686|18384967|P3|Overall Study|initiation other anti-cancer treatment|4
5343122|NCT00101686|18384968|P2|Overall Study|initiation other anti-cancer treatment|3
5343123|NCT00101686|18384969|P1|Overall Study|initiation other anti-cancer treatment|4
5343124|NCT00101686|18384960|P10|Overall Study|Progressive Disease|8
5343125|NCT00101686|18384961|P9|Overall Study|Progressive Disease|10
5343126|NCT00101686|18384962|P8|Overall Study|Progressive Disease|7
5343127|NCT00101686|18384963|P7|Overall Study|Progressive Disease|5
5343128|NCT00101686|18384964|P6|Overall Study|Progressive Disease|25
5343129|NCT00101686|18384965|P5|Overall Study|Progressive Disease|28
5343130|NCT00101686|18384966|P4|Overall Study|Progressive Disease|38
5343131|NCT00101686|18384967|P3|Overall Study|Progressive Disease|37
5343132|NCT00101686|18384968|P2|Overall Study|Progressive Disease|28
5343133|NCT00101686|18384969|P1|Overall Study|Progressive Disease|37
5343134|NCT00101582|18385086|P2|Overall Study|Other|1
5343135|NCT00101582|18385087|P1|Overall Study|Other|0
5343136|NCT00101582|18385086|P2|Overall Study|Death|5
5343137|NCT00101582|18385087|P1|Overall Study|Death|3
5343138|NCT00101582|18385086|P2|Overall Study|Physician Decision|0
5343139|NCT00101582|18385087|P1|Overall Study|Physician Decision|1
5343140|NCT00101582|18385086|P2|Overall Study|Withdrawal by Subject|4
5343141|NCT00101582|18385087|P1|Overall Study|Withdrawal by Subject|6
5343142|NCT00101582|18385086|P2|Overall Study|Adverse Event|4
5343143|NCT00101582|18385087|P1|Overall Study|Adverse Event|1
5343144|NCT00101582|18385086|P2|Overall Study|Ineligibility determined|1
5343145|NCT00101582|18385087|P1|Overall Study|Ineligibility determined|0
5343146|NCT00101452|18385110|P3|Overall Study|Other|12
5343147|NCT00101452|18385111|P2|Overall Study|Other|16
5343148|NCT00101452|18385112|P1|Overall Study|Other|15
5343149|NCT00101452|18385110|P3|Overall Study|Protocol Violation|3
5343150|NCT00101452|18385111|P2|Overall Study|Protocol Violation|1
5343151|NCT00101452|18385112|P1|Overall Study|Protocol Violation|2
5343152|NCT00101452|18385110|P3|Overall Study|Physician Decision|2
5343153|NCT00101452|18385111|P2|Overall Study|Physician Decision|3
5343154|NCT00101452|18385112|P1|Overall Study|Physician Decision|0
5343155|NCT00101452|18385110|P3|Overall Study|Baseline Fail|2
5343156|NCT00101452|18385111|P2|Overall Study|Baseline Fail|1
5343157|NCT00101452|18385112|P1|Overall Study|Baseline Fail|2
5343158|NCT00101452|18385110|P3|Overall Study|Withdrawal by Subject|9
5343159|NCT00101452|18385111|P2|Overall Study|Withdrawal by Subject|14
5343160|NCT00101452|18385112|P1|Overall Study|Withdrawal by Subject|10
5343161|NCT00101452|18385110|P3|Overall Study|Lost to Follow-up|14
5343162|NCT00101452|18385111|P2|Overall Study|Lost to Follow-up|8
5343163|NCT00101452|18385112|P1|Overall Study|Lost to Follow-up|13
5343164|NCT00101452|18385110|P3|Overall Study|Adverse Event|1
5343165|NCT00101452|18385111|P2|Overall Study|Adverse Event|0
5343166|NCT00101452|18385112|P1|Overall Study|Adverse Event|2
5343167|NCT00101439|18385126|P2|Period 2|Withdrawal by Subject|2
5343168|NCT00101439|18385127|P1|Period 2|Withdrawal by Subject|0
5343169|NCT00101400|18385143|P1|Survival Follow-Up|Alive|7
5343170|NCT00101283|18385163|P2|Overall Study|Prostate Cancer Recurrence|1
5343171|NCT00101283|18385164|P1|Overall Study|Prostate Cancer Recurrence|0
5343172|NCT00101283|18385163|P2|Overall Study|Insurance Refusal|1
5343173|NCT00101283|18385164|P1|Overall Study|Insurance Refusal|0
5343174|NCT00101283|18385163|P2|Overall Study|Withdrawal by Subject|1
5343175|NCT00101283|18385164|P1|Overall Study|Withdrawal by Subject|0
5343176|NCT00101192|18385174|P1|Overall Study|Inevaluable|1
5343177|NCT00101192|18385174|P1|Overall Study|Ineligible|6
5343178|NCT00101166|18385178|P1|Overall Study|progressive disease|10
5343179|NCT00101101|18385186|P1|Overall Study|never received vaccine|20
5343180|NCT00101010|18385207|P1|Overall Study|Physician Decision|1
5343181|NCT00100932|18385214|P2|Overall Study|Other|2
5343182|NCT00100932|18385215|P1|Overall Study|Other|5
5343183|NCT00100932|18385214|P2|Overall Study|Physician Decision|5
5343184|NCT00100932|18385215|P1|Overall Study|Physician Decision|7
5343185|NCT00100932|18385214|P2|Overall Study|Progressive Disease|18
5343186|NCT00100932|18385215|P1|Overall Study|Progressive Disease|44
5343187|NCT00100932|18385214|P2|Overall Study|Withdrawal by Subject|0
5343188|NCT00100932|18385215|P1|Overall Study|Withdrawal by Subject|6
5343189|NCT00100932|18385214|P2|Overall Study|Adverse Event|2
5343190|NCT00100932|18385215|P1|Overall Study|Adverse Event|11
5343191|NCT00100828|18385230|P1|Overall Study|Physician Decision|6
5343192|NCT00100815|18385234|P1|Overall Study|Other|3
5343193|NCT00100815|18385234|P1|Overall Study|Death|4
5343194|NCT00100815|18385234|P1|Overall Study|Adverse Event|18
5343195|NCT00100815|18385234|P1|Overall Study|Progression|24
5343196|NCT00100802|18385242|P1|Overall Study|Ineligible|12
5343197|NCT00100802|18385242|P1|Overall Study|Withdrawal by Subject|5
5343198|NCT00100802|18385242|P1|Overall Study|Protocol Violation|1
5343199|NCT00100802|18385242|P1|Overall Study|Physician Decision|5
5343200|NCT00100802|18385242|P1|Overall Study|Lack of Efficacy|47
5343201|NCT00100802|18385242|P1|Overall Study|Death|1
5343202|NCT00100802|18385242|P1|Overall Study|Adverse Event|9
5343203|NCT00100789|18385247|P1|Overall Study|Never received treatment|1
5343204|NCT00100789|18385247|P1|Overall Study|Ineligible|3
5343205|NCT00100789|18385247|P1|Overall Study|Not protocol specified|5
5343206|NCT00100789|18385247|P1|Overall Study|Death|2
5343207|NCT00100789|18385247|P1|Overall Study|Progression/relapse|42
5343208|NCT00100789|18385247|P1|Overall Study|Withdrawal by Subject|1
5343209|NCT00100789|18385247|P1|Overall Study|Adverse Event|10
5343210|NCT00100178|18385324|P3|Overall Study|Physician Decision|3
5343211|NCT00100178|18385325|P2|Overall Study|Physician Decision|1
5343212|NCT00100178|18385326|P1|Overall Study|Physician Decision|6
5343213|NCT00100178|18385324|P3|Overall Study|Withdrawal by Subject|1
5343214|NCT00100178|18385325|P2|Overall Study|Withdrawal by Subject|1
5343215|NCT00100178|18385326|P1|Overall Study|Withdrawal by Subject|1
5343216|NCT00100178|18385324|P3|Overall Study|Adverse Event|1
5343217|NCT00100178|18385325|P2|Overall Study|Adverse Event|2
5343218|NCT00100178|18385326|P1|Overall Study|Adverse Event|2
5343219|NCT00100178|18385324|P3|Overall Study|Lost to Follow-up|5
5343220|NCT00100178|18385325|P2|Overall Study|Lost to Follow-up|6
5343221|NCT00100178|18385326|P1|Overall Study|Lost to Follow-up|0
5343222|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5343223|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5343224|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
5343225|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5343226|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5343227|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5343228|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
5343229|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
5343230|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
5343231|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
5343232|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
5343233|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
5343234|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
5343235|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
5343236|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
5343237|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
5343238|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
5343239|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
5343240|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
5343241|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
5343242|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
5343243|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
5343244|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
5343245|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
5343246|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
5343247|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
5343248|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
5343249|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
5343250|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
5343251|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
5343252|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
5343253|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
5343254|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
5343255|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
5343256|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
5343257|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
5343258|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
5343259|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
5343260|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
5343261|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
5343262|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
5343263|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
5343264|NCT00100048|18385355|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
5343265|NCT00100048|18385356|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
5343266|NCT00100048|18385357|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
5343267|NCT00100048|18385358|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
5343268|NCT00100048|18385359|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
5343269|NCT00100048|18385360|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
5343270|NCT00099983|18385469|P2|Overall Study|Other issue|0
5343271|NCT00099983|18385470|P1|Overall Study|Other issue|1
5343272|NCT00099983|18385469|P2|Overall Study|Intolerant of burden of visits|1
5343273|NCT00099983|18385470|P1|Overall Study|Intolerant of burden of visits|0
5343274|NCT00099983|18385469|P2|Overall Study|Incarcerated|1
5343275|NCT00099983|18385470|P1|Overall Study|Incarcerated|0
5343276|NCT00099983|18385469|P2|Overall Study|Other psychiatric problem|0
5343277|NCT00099983|18385470|P1|Overall Study|Other psychiatric problem|1
5343278|NCT00099983|18385469|P2|Overall Study|Moved|0
5343279|NCT00099983|18385470|P1|Overall Study|Moved|1
5343280|NCT00099983|18385469|P2|Overall Study|Unable to return for appointments|1
5343281|NCT00099983|18385470|P1|Overall Study|Unable to return for appointments|1
5343282|NCT00099983|18385469|P2|Overall Study|Lack of Efficacy|1
5343283|NCT00099983|18385470|P1|Overall Study|Lack of Efficacy|0
5343284|NCT00099983|18385469|P2|Overall Study|Adverse Event|1
5343285|NCT00099983|18385470|P1|Overall Study|Adverse Event|1
5343286|NCT00099983|18385469|P2|Overall Study|Withdrawal by Subject|2
5343287|NCT00099983|18385470|P1|Overall Study|Withdrawal by Subject|3
5343288|NCT00099983|18385469|P2|Overall Study|Missing Source Documents|15
5343289|NCT00099983|18385470|P1|Overall Study|Missing Source Documents|14
5343290|NCT00099983|18385469|P2|Overall Study|Lost to Follow-up|3
5343291|NCT00099983|18385470|P1|Overall Study|Lost to Follow-up|2
5343292|NCT00099632|18385482|P6|Overall Study|Protocol Violation|1
5343293|NCT00099632|18385483|P5|Overall Study|Protocol Violation|0
5343294|NCT00099632|18385484|P4|Overall Study|Protocol Violation|0
5343295|NCT00099632|18385485|P3|Overall Study|Protocol Violation|0
5343296|NCT00099632|18385486|P2|Overall Study|Protocol Violation|0
5343297|NCT00099632|18385487|P1|Overall Study|Protocol Violation|0
5343298|NCT00099632|18385482|P6|Overall Study|Withdrawal by Subject|1
5343299|NCT00099632|18385483|P5|Overall Study|Withdrawal by Subject|0
5343300|NCT00099632|18385484|P4|Overall Study|Withdrawal by Subject|0
5343301|NCT00099632|18385485|P3|Overall Study|Withdrawal by Subject|0
5343302|NCT00099632|18385486|P2|Overall Study|Withdrawal by Subject|1
5343303|NCT00099632|18385487|P1|Overall Study|Withdrawal by Subject|0
5343304|NCT00099632|18385482|P6|Overall Study|Lost to Follow-up|0
5343305|NCT00099632|18385483|P5|Overall Study|Lost to Follow-up|1
5343306|NCT00099632|18385484|P4|Overall Study|Lost to Follow-up|1
5343307|NCT00099632|18385485|P3|Overall Study|Lost to Follow-up|3
5343308|NCT00099632|18385486|P2|Overall Study|Lost to Follow-up|0
5343309|NCT00099632|18385487|P1|Overall Study|Lost to Follow-up|1
5343310|NCT00099437|18385527|P2|Overall Study|Ongoing in FU but not on treatment|45
5343311|NCT00099437|18385528|P1|Overall Study|Ongoing in FU but not on treatment|37
5343312|NCT00099437|18385527|P2|Overall Study|Withdrawal by Subject|10
5343313|NCT00099437|18385528|P1|Overall Study|Withdrawal by Subject|6
5343314|NCT00099437|18385527|P2|Overall Study|Death|261
5343315|NCT00099437|18385528|P1|Overall Study|Death|293
5343316|NCT00099437|18385527|P2|Overall Study|Lost to Follow-up|33
5343317|NCT00099437|18385528|P1|Overall Study|Lost to Follow-up|30
5343318|NCT00099359|18385551|P3|Overall Study|moved out of area|4
5343319|NCT00099359|18385552|P2|Overall Study|moved out of area|7
5343320|NCT00099359|18385553|P1|Overall Study|moved out of area|9
5343321|NCT00099359|18385551|P3|Overall Study|Lost to Follow-up|24
5343322|NCT00099359|18385552|P2|Overall Study|Lost to Follow-up|24
5343323|NCT00099359|18385553|P1|Overall Study|Lost to Follow-up|15
5343324|NCT00099359|18385551|P3|Overall Study|Withdrawal by Subject|23
5343325|NCT00099359|18385552|P2|Overall Study|Withdrawal by Subject|19
5343326|NCT00099359|18385553|P1|Overall Study|Withdrawal by Subject|19
5343327|NCT00099359|18385551|P3|Overall Study|Death|17
5343328|NCT00099359|18385552|P2|Overall Study|Death|15
5343329|NCT00099359|18385553|P1|Overall Study|Death|11
5343330|NCT00099268|18385576|P2|Overall Study|Death|1
5343331|NCT00099268|18385577|P1|Overall Study|Death|3
5343332|NCT00099268|18385576|P2|Overall Study|Administrative problems|4
5343333|NCT00099268|18385577|P1|Overall Study|Administrative problems|4
5343334|NCT00099268|18385576|P2|Overall Study|Lack of Efficacy|18
5343335|NCT00099268|18385577|P1|Overall Study|Lack of Efficacy|5
5343336|NCT00099268|18385576|P2|Overall Study|Lost to Follow-up|4
5343337|NCT00099268|18385577|P1|Overall Study|Lost to Follow-up|6
5343338|NCT00099268|18385576|P2|Overall Study|Protocol Violation|8
5343339|NCT00099268|18385577|P1|Overall Study|Protocol Violation|9
5343340|NCT00099268|18385576|P2|Overall Study|Adverse Event|19
5343341|NCT00099268|18385577|P1|Overall Study|Adverse Event|19
5343342|NCT00099268|18385576|P2|Overall Study|Withdrawal by Subject|28
5343343|NCT00099268|18385577|P1|Overall Study|Withdrawal by Subject|46
5343344|NCT00098865|18385617|P1|Overall Study|Alternative Therapy|1
5343345|NCT00098865|18385617|P1|Overall Study|Adverse Event|2
5343346|NCT00098865|18385617|P1|Overall Study|Progressive Disease|6
5343347|NCT00098839|18385625|P2|Overall Study|Ineligible|0
5343348|NCT00098839|18385626|P1|Overall Study|Ineligible|2
5343349|NCT00098839|18385625|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
5343350|NCT00098839|18385626|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
5343351|NCT00098839|18385625|P2|Overall Study|Relapse|3
5343352|NCT00098839|18385626|P1|Overall Study|Relapse|6
5343353|NCT00098839|18385625|P2|Overall Study|Refusal of further protocol therapy|1
5343354|NCT00098839|18385626|P1|Overall Study|Refusal of further protocol therapy|3
5343355|NCT00098839|18385625|P2|Overall Study|Withdrawal by Subject|0
5343356|NCT00098839|18385626|P1|Overall Study|Withdrawal by Subject|1
5343357|NCT00098839|18385625|P2|Overall Study|Physician Decision|14
5343358|NCT00098839|18385626|P1|Overall Study|Physician Decision|4
5343359|NCT00098839|18385625|P2|Overall Study|Death|2
5343360|NCT00098839|18385626|P1|Overall Study|Death|1
5343361|NCT00098839|18385625|P2|Overall Study|Adverse Event|2
5343362|NCT00098839|18385626|P1|Overall Study|Adverse Event|5
5343363|NCT00098813|18385637|P1|Overall Study|Reversal of RAI resistance|1
5343364|NCT00098813|18385637|P1|Overall Study|Other complicating disease|1
5343365|NCT00098813|18385637|P1|Overall Study|Progression of Disease|1
5343366|NCT00098813|18385637|P1|Overall Study|Withdrawal by Subject|7
5343367|NCT00098813|18385637|P1|Overall Study|Protocol Violation|1
5343368|NCT00098813|18385637|P1|Overall Study|Death|8
5343369|NCT00098787|18385644|P3|Overall Study|Other|9
5343370|NCT00098787|18385645|P2|Overall Study|Other|6
5343371|NCT00098787|18385646|P1|Overall Study|Other|7
5343372|NCT00098787|18385644|P3|Overall Study|Alternative therapy|13
5343373|NCT00098787|18385645|P2|Overall Study|Alternative therapy|13
5343374|NCT00098787|18385646|P1|Overall Study|Alternative therapy|8
5343375|NCT00098787|18385644|P3|Overall Study|Withdrawal by Subject|6
5343376|NCT00098787|18385645|P2|Overall Study|Withdrawal by Subject|12
5343377|NCT00098787|18385646|P1|Overall Study|Withdrawal by Subject|4
5343378|NCT00098787|18385644|P3|Overall Study|Death|0
5343379|NCT00098787|18385645|P2|Overall Study|Death|1
5343380|NCT00098787|18385646|P1|Overall Study|Death|6
5343381|NCT00098787|18385644|P3|Overall Study|Adverse Event|8
5343382|NCT00098787|18385645|P2|Overall Study|Adverse Event|17
5343383|NCT00098787|18385646|P1|Overall Study|Adverse Event|8
5343384|NCT00098787|18385644|P3|Overall Study|Disease progression|23
5343385|NCT00098787|18385645|P2|Overall Study|Disease progression|17
5343386|NCT00098787|18385646|P1|Overall Study|Disease progression|28
5343387|NCT00098787|18385644|P3|Overall Study|Ineligible|3
5343388|NCT00098787|18385645|P2|Overall Study|Ineligible|7
5343389|NCT00098787|18385646|P1|Overall Study|Ineligible|9
5343390|NCT00098787|18385644|P3|Overall Study|Never started treatment|1
5343391|NCT00098787|18385645|P2|Overall Study|Never started treatment|2
5343392|NCT00098787|18385646|P1|Overall Study|Never started treatment|3
5343393|NCT00098774|18385660|P1|Overall Study|Physician Decision|2
5343394|NCT00098774|18385660|P1|Overall Study|Failed (to respond) during induction|4
5343395|NCT00098774|18385660|P1|Overall Study|Withdrawal by Subject|1
5343396|NCT00098774|18385660|P1|Overall Study|Disease Progression|9
5343397|NCT00098774|18385660|P1|Overall Study|Adverse Event|2
5343398|NCT00098748|18385670|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
5343399|NCT00098748|18385671|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
5343400|NCT00098748|18385672|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
5343401|NCT00098748|18385670|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
5343402|NCT00098748|18385671|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
5343403|NCT00098748|18385672|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
5343404|NCT00098748|18385670|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
5343405|NCT00098748|18385671|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
5343406|NCT00098748|18385672|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
5343407|NCT00098748|18385670|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
5343408|NCT00098748|18385671|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
5343409|NCT00098748|18385672|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
5343410|NCT00098748|18385670|P3|Continued on Open-Label Treatment|Adverse Event|0
5343411|NCT00098748|18385671|P2|Continued on Open-Label Treatment|Adverse Event|1
5343412|NCT00098748|18385672|P1|Continued on Open-Label Treatment|Adverse Event|0
5343413|NCT00098748|18385670|P3|Received Study Treatment|Subject defaulted|4
5343414|NCT00098748|18385671|P2|Received Study Treatment|Subject defaulted|4
5343415|NCT00098748|18385672|P1|Received Study Treatment|Subject defaulted|3
5343416|NCT00098748|18385670|P3|Received Study Treatment|Other|6
5343417|NCT00098748|18385671|P2|Received Study Treatment|Other|2
5343418|NCT00098748|18385672|P1|Received Study Treatment|Other|2
5343419|NCT00098748|18385670|P3|Received Study Treatment|Lack of Efficacy|27
5343420|NCT00098748|18385671|P2|Received Study Treatment|Lack of Efficacy|27
5343421|NCT00098748|18385672|P1|Received Study Treatment|Lack of Efficacy|40
5343422|NCT00098748|18385670|P3|Received Study Treatment|Adverse Event|5
5343423|NCT00098748|18385671|P2|Received Study Treatment|Adverse Event|2
5343424|NCT00098748|18385672|P1|Received Study Treatment|Adverse Event|1
5343425|NCT00098748|18385670|P3|Received Study Treatment|Death|2
5343426|NCT00098748|18385671|P2|Received Study Treatment|Death|1
5343427|NCT00098748|18385672|P1|Received Study Treatment|Death|2
5343428|NCT00098748|18385670|P3|Assigned to Study Treatment|Randomized, but not treated|2
5343429|NCT00098748|18385671|P2|Assigned to Study Treatment|Randomized, but not treated|2
5343430|NCT00098748|18385672|P1|Assigned to Study Treatment|Randomized, but not treated|0
5343431|NCT00098722|18385728|P7|Observation Phase|Other|10
5343432|NCT00098722|18385729|P6|Observation Phase|Other|21
5343433|NCT00098722|18385730|P5|Observation Phase|Other|0
5343434|NCT00098722|18385731|P4|Observation Phase|Other|0
5343435|NCT00098722|18385732|P3|Observation Phase|Other|0
5343436|NCT00098722|18385733|P2|Observation Phase|Other|0
5343437|NCT00098722|18385734|P1|Observation Phase|Other|0
5343438|NCT00098722|18385728|P7|Observation Phase|Participant defaulted|4
5343439|NCT00098722|18385729|P6|Observation Phase|Participant defaulted|17
5343440|NCT00098722|18385730|P5|Observation Phase|Participant defaulted|0
5343441|NCT00098722|18385731|P4|Observation Phase|Participant defaulted|0
5343442|NCT00098722|18385732|P3|Observation Phase|Participant defaulted|0
5343443|NCT00098722|18385733|P2|Observation Phase|Participant defaulted|0
5343444|NCT00098722|18385734|P1|Observation Phase|Participant defaulted|0
5343445|NCT00098722|18385728|P7|Observation Phase|Lack of Efficacy|0
5343446|NCT00098722|18385729|P6|Observation Phase|Lack of Efficacy|2
5343447|NCT00098722|18385730|P5|Observation Phase|Lack of Efficacy|0
5343448|NCT00098722|18385731|P4|Observation Phase|Lack of Efficacy|0
5343449|NCT00098722|18385732|P3|Observation Phase|Lack of Efficacy|0
5343450|NCT00098722|18385733|P2|Observation Phase|Lack of Efficacy|0
5343451|NCT00098722|18385734|P1|Observation Phase|Lack of Efficacy|0
5343452|NCT00098722|18385728|P7|Observation Phase|Death|3
5343453|NCT00098722|18385729|P6|Observation Phase|Death|5
5343454|NCT00098722|18385730|P5|Observation Phase|Death|0
5343455|NCT00098722|18385731|P4|Observation Phase|Death|0
5343456|NCT00098722|18385732|P3|Observation Phase|Death|0
5343457|NCT00098722|18385733|P2|Observation Phase|Death|0
5343458|NCT00098722|18385734|P1|Observation Phase|Death|0
5343459|NCT00098722|18385728|P7|Open Label Phase|Other|0
5343460|NCT00098722|18385729|P6|Open Label Phase|Other|0
5343461|NCT00098722|18385730|P5|Open Label Phase|Other|0
5343462|NCT00098722|18385731|P4|Open Label Phase|Other|18
5343463|NCT00098722|18385732|P3|Open Label Phase|Other|0
5343464|NCT00098722|18385733|P2|Open Label Phase|Other|0
5343465|NCT00098722|18385734|P1|Open Label Phase|Other|0
5343466|NCT00098722|18385728|P7|Open Label Phase|Ongoing at cut-off date|0
5343467|NCT00098722|18385729|P6|Open Label Phase|Ongoing at cut-off date|0
5343468|NCT00098722|18385730|P5|Open Label Phase|Ongoing at cut-off date|50
5343469|NCT00098722|18385731|P4|Open Label Phase|Ongoing at cut-off date|220
5343470|NCT00098722|18385732|P3|Open Label Phase|Ongoing at cut-off date|0
5343471|NCT00098722|18385733|P2|Open Label Phase|Ongoing at cut-off date|0
5343472|NCT00098722|18385734|P1|Open Label Phase|Ongoing at cut-off date|0
5343473|NCT00098722|18385728|P7|Open Label Phase|Participant defaulted|0
5343474|NCT00098722|18385729|P6|Open Label Phase|Participant defaulted|0
5343475|NCT00098722|18385730|P5|Open Label Phase|Participant defaulted|0
5343476|NCT00098722|18385731|P4|Open Label Phase|Participant defaulted|18
5343477|NCT00098722|18385732|P3|Open Label Phase|Participant defaulted|0
5343478|NCT00098722|18385733|P2|Open Label Phase|Participant defaulted|0
5343479|NCT00098722|18385734|P1|Open Label Phase|Participant defaulted|0
5343480|NCT00098722|18385728|P7|Open Label Phase|Pregnancy|0
5343481|NCT00098722|18385729|P6|Open Label Phase|Pregnancy|0
5343482|NCT00098722|18385730|P5|Open Label Phase|Pregnancy|0
5343483|NCT00098722|18385731|P4|Open Label Phase|Pregnancy|1
5343484|NCT00098722|18385732|P3|Open Label Phase|Pregnancy|0
5343485|NCT00098722|18385733|P2|Open Label Phase|Pregnancy|0
5343486|NCT00098722|18385734|P1|Open Label Phase|Pregnancy|0
5343487|NCT00098722|18385728|P7|Open Label Phase|Lack of Efficacy|0
5343488|NCT00098722|18385729|P6|Open Label Phase|Lack of Efficacy|0
5343489|NCT00098722|18385730|P5|Open Label Phase|Lack of Efficacy|0
5343490|NCT00098722|18385731|P4|Open Label Phase|Lack of Efficacy|8
5343491|NCT00098722|18385732|P3|Open Label Phase|Lack of Efficacy|0
5343492|NCT00098722|18385733|P2|Open Label Phase|Lack of Efficacy|0
5343493|NCT00098722|18385734|P1|Open Label Phase|Lack of Efficacy|0
5343494|NCT00098722|18385728|P7|Open Label Phase|Death|0
5343495|NCT00098722|18385729|P6|Open Label Phase|Death|0
5343496|NCT00098722|18385730|P5|Open Label Phase|Death|0
5343497|NCT00098722|18385731|P4|Open Label Phase|Death|2
5343498|NCT00098722|18385732|P3|Open Label Phase|Death|0
5343499|NCT00098722|18385733|P2|Open Label Phase|Death|0
5343500|NCT00098722|18385734|P1|Open Label Phase|Death|0
5343501|NCT00098722|18385728|P7|Open Label Phase|Adverse Event|0
5343502|NCT00098722|18385729|P6|Open Label Phase|Adverse Event|0
5343503|NCT00098722|18385730|P5|Open Label Phase|Adverse Event|0
5343504|NCT00098722|18385731|P4|Open Label Phase|Adverse Event|5
5343505|NCT00098722|18385732|P3|Open Label Phase|Adverse Event|0
5343506|NCT00098722|18385733|P2|Open Label Phase|Adverse Event|0
5343507|NCT00098722|18385734|P1|Open Label Phase|Adverse Event|0
5343508|NCT00098722|18385728|P7|Double Blind Phase|Other|0
5343509|NCT00098722|18385729|P6|Double Blind Phase|Other|0
5343510|NCT00098722|18385730|P5|Double Blind Phase|Other|0
5343511|NCT00098722|18385731|P4|Double Blind Phase|Other|0
5343512|NCT00098722|18385732|P3|Double Blind Phase|Other|7
5343513|NCT00098722|18385733|P2|Double Blind Phase|Other|8
5343514|NCT00098722|18385734|P1|Double Blind Phase|Other|7
5343515|NCT00098722|18385728|P7|Double Blind Phase|Ongoing at cut-off date|0
5343516|NCT00098722|18385729|P6|Double Blind Phase|Ongoing at cut-off date|0
5343517|NCT00098722|18385730|P5|Double Blind Phase|Ongoing at cut-off date|0
5343518|NCT00098722|18385731|P4|Double Blind Phase|Ongoing at cut-off date|0
5343519|NCT00098722|18385732|P3|Double Blind Phase|Ongoing at cut-off date|57
5343520|NCT00098722|18385733|P2|Double Blind Phase|Ongoing at cut-off date|137
5343521|NCT00098722|18385734|P1|Double Blind Phase|Ongoing at cut-off date|128
5343522|NCT00098722|18385728|P7|Double Blind Phase|Randomized, not treated|0
5343523|NCT00098722|18385729|P6|Double Blind Phase|Randomized, not treated|0
5343524|NCT00098722|18385730|P5|Double Blind Phase|Randomized, not treated|0
5343525|NCT00098722|18385731|P4|Double Blind Phase|Randomized, not treated|0
5343526|NCT00098722|18385732|P3|Double Blind Phase|Randomized, not treated|3
5343527|NCT00098722|18385733|P2|Double Blind Phase|Randomized, not treated|3
5343528|NCT00098722|18385734|P1|Double Blind Phase|Randomized, not treated|4
5343529|NCT00098722|18385728|P7|Double Blind Phase|Pregnancy|0
5343530|NCT00098722|18385729|P6|Double Blind Phase|Pregnancy|0
5343531|NCT00098722|18385730|P5|Double Blind Phase|Pregnancy|0
5343532|NCT00098722|18385731|P4|Double Blind Phase|Pregnancy|0
5343533|NCT00098722|18385732|P3|Double Blind Phase|Pregnancy|0
5343534|NCT00098722|18385733|P2|Double Blind Phase|Pregnancy|0
5343535|NCT00098722|18385734|P1|Double Blind Phase|Pregnancy|1
5343536|NCT00098722|18385728|P7|Double Blind Phase|Participant defaulted|0
5343537|NCT00098722|18385729|P6|Double Blind Phase|Participant defaulted|0
5343538|NCT00098722|18385730|P5|Double Blind Phase|Participant defaulted|0
5343539|NCT00098722|18385731|P4|Double Blind Phase|Participant defaulted|0
5343540|NCT00098722|18385732|P3|Double Blind Phase|Participant defaulted|9
5343541|NCT00098722|18385733|P2|Double Blind Phase|Participant defaulted|11
5343542|NCT00098722|18385734|P1|Double Blind Phase|Participant defaulted|16
5343543|NCT00098722|18385728|P7|Double Blind Phase|Lack of Efficacy|0
5343544|NCT00098722|18385729|P6|Double Blind Phase|Lack of Efficacy|0
5343545|NCT00098722|18385730|P5|Double Blind Phase|Lack of Efficacy|0
5343546|NCT00098722|18385731|P4|Double Blind Phase|Lack of Efficacy|0
5343547|NCT00098722|18385732|P3|Double Blind Phase|Lack of Efficacy|15
5343548|NCT00098722|18385733|P2|Double Blind Phase|Lack of Efficacy|23
5343549|NCT00098722|18385734|P1|Double Blind Phase|Lack of Efficacy|21
5343550|NCT00098722|18385728|P7|Double Blind Phase|Death|0
5343551|NCT00098722|18385729|P6|Double Blind Phase|Death|0
5343552|NCT00098722|18385730|P5|Double Blind Phase|Death|0
5343553|NCT00098722|18385731|P4|Double Blind Phase|Death|0
5343554|NCT00098722|18385732|P3|Double Blind Phase|Death|0
5343555|NCT00098722|18385733|P2|Double Blind Phase|Death|5
5343556|NCT00098722|18385734|P1|Double Blind Phase|Death|2
5343557|NCT00098722|18385728|P7|Double Blind Phase|Adverse Event|0
5343558|NCT00098722|18385729|P6|Double Blind Phase|Adverse Event|0
5343559|NCT00098722|18385730|P5|Double Blind Phase|Adverse Event|0
5343560|NCT00098722|18385731|P4|Double Blind Phase|Adverse Event|0
5343561|NCT00098722|18385732|P3|Double Blind Phase|Adverse Event|3
5343562|NCT00098722|18385733|P2|Double Blind Phase|Adverse Event|7
5343563|NCT00098722|18385734|P1|Double Blind Phase|Adverse Event|7
5343564|NCT00098475|18385808|P4|Step 2|Never started treatment|0
5343565|NCT00098475|18385809|P3|Step 2|Never started treatment|0
5343566|NCT00098475|18385810|P2|Step 2|Never started treatment|1
5343567|NCT00098475|18385811|P1|Step 2|Never started treatment|1
5343568|NCT00098475|18385808|P4|Step 2|Alternative therapy|0
5343569|NCT00098475|18385809|P3|Step 2|Alternative therapy|0
5343570|NCT00098475|18385810|P2|Step 2|Alternative therapy|2
5343571|NCT00098475|18385811|P1|Step 2|Alternative therapy|1
5343572|NCT00098475|18385808|P4|Step 2|Physician Decision|0
5343573|NCT00098475|18385809|P3|Step 2|Physician Decision|0
5343574|NCT00098475|18385810|P2|Step 2|Physician Decision|1
5343575|NCT00098475|18385811|P1|Step 2|Physician Decision|0
5343576|NCT00098475|18385808|P4|Step 2|Withdrawal by Subject|0
5343577|NCT00098475|18385809|P3|Step 2|Withdrawal by Subject|0
5343578|NCT00098475|18385810|P2|Step 2|Withdrawal by Subject|2
5343579|NCT00098475|18385811|P1|Step 2|Withdrawal by Subject|0
5343580|NCT00098475|18385808|P4|Step 2|Adverse Event|0
5343581|NCT00098475|18385809|P3|Step 2|Adverse Event|0
5343582|NCT00098475|18385810|P2|Step 2|Adverse Event|0
5343583|NCT00098475|18385811|P1|Step 2|Adverse Event|2
5343584|NCT00098475|18385808|P4|Step 2|Disease progression|0
5343585|NCT00098475|18385809|P3|Step 2|Disease progression|0
5343586|NCT00098475|18385810|P2|Step 2|Disease progression|4
5343587|NCT00098475|18385811|P1|Step 2|Disease progression|1
5343588|NCT00098475|18385808|P4|Step 1|Not documented|0
5343589|NCT00098475|18385809|P3|Step 1|Not documented|0
5343590|NCT00098475|18385810|P2|Step 1|Not documented|1
5343591|NCT00098475|18385811|P1|Step 1|Not documented|0
5343592|NCT00098475|18385808|P4|Step 1|Patient fell with fracture|0
5343593|NCT00098475|18385809|P3|Step 1|Patient fell with fracture|0
5343594|NCT00098475|18385810|P2|Step 1|Patient fell with fracture|0
5343595|NCT00098475|18385811|P1|Step 1|Patient fell with fracture|1
5343596|NCT00098475|18385808|P4|Step 1|Misinterpretation of lab data|0
5343597|NCT00098475|18385809|P3|Step 1|Misinterpretation of lab data|0
5343598|NCT00098475|18385810|P2|Step 1|Misinterpretation of lab data|1
5343599|NCT00098475|18385811|P1|Step 1|Misinterpretation of lab data|0
5343600|NCT00098475|18385808|P4|Step 1|Criteria to continue treatment not met|0
5343601|NCT00098475|18385809|P3|Step 1|Criteria to continue treatment not met|0
5343602|NCT00098475|18385810|P2|Step 1|Criteria to continue treatment not met|1
5343603|NCT00098475|18385811|P1|Step 1|Criteria to continue treatment not met|0
5343604|NCT00098475|18385808|P4|Step 1|Referred to other physicians|0
5343605|NCT00098475|18385809|P3|Step 1|Referred to other physicians|0
5343606|NCT00098475|18385810|P2|Step 1|Referred to other physicians|1
5343607|NCT00098475|18385811|P1|Step 1|Referred to other physicians|0
5343608|NCT00098475|18385808|P4|Step 1|Rising paraprotein|0
5343609|NCT00098475|18385809|P3|Step 1|Rising paraprotein|0
5343610|NCT00098475|18385810|P2|Step 1|Rising paraprotein|1
5343611|NCT00098475|18385811|P1|Step 1|Rising paraprotein|0
5343612|NCT00098475|18385808|P4|Step 1|Insurance issue|0
5343613|NCT00098475|18385809|P3|Step 1|Insurance issue|0
5343614|NCT00098475|18385810|P2|Step 1|Insurance issue|1
5343615|NCT00098475|18385811|P1|Step 1|Insurance issue|0
5343616|NCT00098475|18385808|P4|Step 1|Declining performance status|0
5343617|NCT00098475|18385809|P3|Step 1|Declining performance status|0
5343618|NCT00098475|18385810|P2|Step 1|Declining performance status|1
5343619|NCT00098475|18385811|P1|Step 1|Declining performance status|0
5343620|NCT00098475|18385808|P4|Step 1|Off treatment for > specified timeframe|0
5343621|NCT00098475|18385809|P3|Step 1|Off treatment for > specified timeframe|0
5343622|NCT00098475|18385810|P2|Step 1|Off treatment for > specified timeframe|1
5343623|NCT00098475|18385811|P1|Step 1|Off treatment for > specified timeframe|1
5343624|NCT00098475|18385808|P4|Step 1|Incorrect disease assessment|0
5343625|NCT00098475|18385809|P3|Step 1|Incorrect disease assessment|0
5343626|NCT00098475|18385810|P2|Step 1|Incorrect disease assessment|0
5343627|NCT00098475|18385811|P1|Step 1|Incorrect disease assessment|2
5343628|NCT00098475|18385808|P4|Step 1|Both patient and physician's decision|0
5343629|NCT00098475|18385809|P3|Step 1|Both patient and physician's decision|0
5343630|NCT00098475|18385810|P2|Step 1|Both patient and physician's decision|1
5343631|NCT00098475|18385811|P1|Step 1|Both patient and physician's decision|2
5343632|NCT00098475|18385808|P4|Step 1|Cannot comply due to other tx|0
5343633|NCT00098475|18385809|P3|Step 1|Cannot comply due to other tx|0
5343634|NCT00098475|18385810|P2|Step 1|Cannot comply due to other tx|1
5343635|NCT00098475|18385811|P1|Step 1|Cannot comply due to other tx|0
5343636|NCT00098475|18385808|P4|Step 1|Complications|0
5343637|NCT00098475|18385809|P3|Step 1|Complications|0
5343638|NCT00098475|18385810|P2|Step 1|Complications|0
5343639|NCT00098475|18385811|P1|Step 1|Complications|1
5343640|NCT00098475|18385808|P4|Step 1|Knee surgery|0
5343641|NCT00098475|18385809|P3|Step 1|Knee surgery|0
5343642|NCT00098475|18385810|P2|Step 1|Knee surgery|0
5343643|NCT00098475|18385811|P1|Step 1|Knee surgery|1
5343644|NCT00098475|18385808|P4|Step 1|Still on treatment as of this analysis|0
5343645|NCT00098475|18385809|P3|Step 1|Still on treatment as of this analysis|0
5343646|NCT00098475|18385810|P2|Step 1|Still on treatment as of this analysis|27
5343647|NCT00098475|18385811|P1|Step 1|Still on treatment as of this analysis|14
5343648|NCT00098475|18385808|P4|Step 1|Never started treatment|0
5343649|NCT00098475|18385809|P3|Step 1|Never started treatment|0
5343650|NCT00098475|18385810|P2|Step 1|Never started treatment|2
5343651|NCT00098475|18385811|P1|Step 1|Never started treatment|0
5343652|NCT00098475|18385808|P4|Step 1|Other disease|0
5343653|NCT00098475|18385809|P3|Step 1|Other disease|1
5343654|NCT00098475|18385810|P2|Step 1|Other disease|1
5343655|NCT00098475|18385811|P1|Step 1|Other disease|2
5343656|NCT00098475|18385808|P4|Step 1|Alternative therapy|0
5343657|NCT00098475|18385809|P3|Step 1|Alternative therapy|1
5343658|NCT00098475|18385810|P2|Step 1|Alternative therapy|43
5343659|NCT00098475|18385811|P1|Step 1|Alternative therapy|31
5343660|NCT00098475|18385808|P4|Step 1|Physician Decision|0
5343661|NCT00098475|18385809|P3|Step 1|Physician Decision|0
5343662|NCT00098475|18385810|P2|Step 1|Physician Decision|2
5343663|NCT00098475|18385811|P1|Step 1|Physician Decision|5
5343664|NCT00098475|18385808|P4|Step 1|Withdrawal by Subject|0
5343665|NCT00098475|18385809|P3|Step 1|Withdrawal by Subject|0
5343666|NCT00098475|18385810|P2|Step 1|Withdrawal by Subject|11
5343667|NCT00098475|18385811|P1|Step 1|Withdrawal by Subject|14
5343668|NCT00098475|18385808|P4|Step 1|Death|1
5343669|NCT00098475|18385809|P3|Step 1|Death|0
5343670|NCT00098475|18385810|P2|Step 1|Death|5
5343671|NCT00098475|18385811|P1|Step 1|Death|8
5343672|NCT00098475|18385808|P4|Step 1|Adverse Event|1
5343673|NCT00098475|18385809|P3|Step 1|Adverse Event|0
5343674|NCT00098475|18385810|P2|Step 1|Adverse Event|37
5343675|NCT00098475|18385811|P1|Step 1|Adverse Event|56
5343676|NCT00098475|18385808|P4|Step 1|Progressive disease|1
5343677|NCT00098475|18385809|P3|Step 1|Progressive disease|2
5343678|NCT00098475|18385810|P2|Step 1|Progressive disease|35
5343679|NCT00098475|18385811|P1|Step 1|Progressive disease|33
5343680|NCT00098345|18385848|P1|Overall Study|progression|4
5343681|NCT00098345|18385848|P1|Overall Study|Withdrawal by Subject|2
5343682|NCT00098345|18385848|P1|Overall Study|Adverse Event|7
5343683|NCT00098306|18385861|P7|Observational Phase|Un-specified|4
5343684|NCT00098306|18385862|P6|Observational Phase|Un-specified|7
5343685|NCT00098306|18385863|P5|Observational Phase|Un-specified|0
5343686|NCT00098306|18385864|P4|Observational Phase|Un-specified|0
5343687|NCT00098306|18385865|P3|Observational Phase|Un-specified|0
5343688|NCT00098306|18385866|P2|Observational Phase|Un-specified|0
5343689|NCT00098306|18385867|P1|Observational Phase|Un-specified|0
5343690|NCT00098306|18385861|P7|Observational Phase|Participant defaulted|18
5343691|NCT00098306|18385862|P6|Observational Phase|Participant defaulted|34
5343692|NCT00098306|18385863|P5|Observational Phase|Participant defaulted|0
5343693|NCT00098306|18385864|P4|Observational Phase|Participant defaulted|0
5343694|NCT00098306|18385865|P3|Observational Phase|Participant defaulted|0
5343695|NCT00098306|18385866|P2|Observational Phase|Participant defaulted|0
5343696|NCT00098306|18385867|P1|Observational Phase|Participant defaulted|0
5343697|NCT00098306|18385861|P7|Observational Phase|Death|4
5343698|NCT00098306|18385862|P6|Observational Phase|Death|5
5343699|NCT00098306|18385863|P5|Observational Phase|Death|0
5343700|NCT00098306|18385864|P4|Observational Phase|Death|0
5343701|NCT00098306|18385865|P3|Observational Phase|Death|0
5343702|NCT00098306|18385866|P2|Observational Phase|Death|0
5343703|NCT00098306|18385867|P1|Observational Phase|Death|0
5343704|NCT00098306|18385861|P7|Open Label|Ongoing at cut-off date|0
5343705|NCT00098306|18385862|P6|Open Label|Ongoing at cut-off date|0
5343706|NCT00098306|18385863|P5|Open Label|Ongoing at cut-off date|62
5343707|NCT00098306|18385864|P4|Open Label|Ongoing at cut-off date|269
5343708|NCT00098306|18385865|P3|Open Label|Ongoing at cut-off date|0
5343709|NCT00098306|18385866|P2|Open Label|Ongoing at cut-off date|0
5343710|NCT00098306|18385867|P1|Open Label|Ongoing at cut-off date|0
5343711|NCT00098306|18385861|P7|Open Label|Un-specified|0
5343712|NCT00098306|18385862|P6|Open Label|Un-specified|0
5343713|NCT00098306|18385863|P5|Open Label|Un-specified|0
5343714|NCT00098306|18385864|P4|Open Label|Un-specified|15
5343715|NCT00098306|18385865|P3|Open Label|Un-specified|0
5343716|NCT00098306|18385866|P2|Open Label|Un-specified|0
5343717|NCT00098306|18385867|P1|Open Label|Un-specified|0
5343718|NCT00098306|18385861|P7|Open Label|Participant defaulted|0
5343719|NCT00098306|18385862|P6|Open Label|Participant defaulted|0
5343720|NCT00098306|18385863|P5|Open Label|Participant defaulted|0
5343721|NCT00098306|18385864|P4|Open Label|Participant defaulted|24
5343722|NCT00098306|18385865|P3|Open Label|Participant defaulted|0
5343723|NCT00098306|18385866|P2|Open Label|Participant defaulted|0
5343724|NCT00098306|18385867|P1|Open Label|Participant defaulted|0
5343725|NCT00098306|18385861|P7|Open Label|Death|0
5343726|NCT00098306|18385862|P6|Open Label|Death|0
5343727|NCT00098306|18385863|P5|Open Label|Death|0
5343728|NCT00098306|18385864|P4|Open Label|Death|4
5343729|NCT00098306|18385865|P3|Open Label|Death|0
5343730|NCT00098306|18385866|P2|Open Label|Death|0
5343731|NCT00098306|18385867|P1|Open Label|Death|0
5343732|NCT00098306|18385861|P7|Open Label|Adverse Event|0
5343733|NCT00098306|18385862|P6|Open Label|Adverse Event|0
5343734|NCT00098306|18385863|P5|Open Label|Adverse Event|0
5343735|NCT00098306|18385864|P4|Open Label|Adverse Event|2
5343736|NCT00098306|18385865|P3|Open Label|Adverse Event|0
5343737|NCT00098306|18385866|P2|Open Label|Adverse Event|0
5343738|NCT00098306|18385867|P1|Open Label|Adverse Event|0
5343739|NCT00098306|18385861|P7|Open Label|Lack of Efficacy|0
5343740|NCT00098306|18385862|P6|Open Label|Lack of Efficacy|0
5343741|NCT00098306|18385863|P5|Open Label|Lack of Efficacy|0
5343742|NCT00098306|18385864|P4|Open Label|Lack of Efficacy|13
5343743|NCT00098306|18385865|P3|Open Label|Lack of Efficacy|0
5343744|NCT00098306|18385866|P2|Open Label|Lack of Efficacy|0
5343745|NCT00098306|18385867|P1|Open Label|Lack of Efficacy|0
5343746|NCT00098306|18385861|P7|Double Blind|Un-specified|0
5343747|NCT00098306|18385862|P6|Double Blind|Un-specified|0
5343748|NCT00098306|18385863|P5|Double Blind|Un-specified|0
5343749|NCT00098306|18385864|P4|Double Blind|Un-specified|0
5343750|NCT00098306|18385865|P3|Double Blind|Un-specified|11
5343751|NCT00098306|18385866|P2|Double Blind|Un-specified|3
5343752|NCT00098306|18385867|P1|Double Blind|Un-specified|7
5343753|NCT00098306|18385861|P7|Double Blind|Participant defaulted|0
5343754|NCT00098306|18385862|P6|Double Blind|Participant defaulted|0
5343755|NCT00098306|18385863|P5|Double Blind|Participant defaulted|0
5343756|NCT00098306|18385864|P4|Double Blind|Participant defaulted|0
5343757|NCT00098306|18385865|P3|Double Blind|Participant defaulted|11
5343758|NCT00098306|18385866|P2|Double Blind|Participant defaulted|18
5343759|NCT00098306|18385867|P1|Double Blind|Participant defaulted|19
5343760|NCT00098306|18385861|P7|Double Blind|Death|0
5343761|NCT00098306|18385862|P6|Double Blind|Death|0
5343762|NCT00098306|18385863|P5|Double Blind|Death|0
5343763|NCT00098306|18385864|P4|Double Blind|Death|0
5343764|NCT00098306|18385865|P3|Double Blind|Death|1
5343765|NCT00098306|18385866|P2|Double Blind|Death|4
5343766|NCT00098306|18385867|P1|Double Blind|Death|1
5343767|NCT00098306|18385861|P7|Double Blind|Lack of Efficacy|0
5343768|NCT00098306|18385862|P6|Double Blind|Lack of Efficacy|0
5343769|NCT00098306|18385863|P5|Double Blind|Lack of Efficacy|0
5343770|NCT00098306|18385864|P4|Double Blind|Lack of Efficacy|0
5343771|NCT00098306|18385865|P3|Double Blind|Lack of Efficacy|17
5343772|NCT00098306|18385866|P2|Double Blind|Lack of Efficacy|34
5343773|NCT00098306|18385867|P1|Double Blind|Lack of Efficacy|43
5343774|NCT00098306|18385861|P7|Double Blind|Adverse Event|0
5343775|NCT00098306|18385862|P6|Double Blind|Adverse Event|0
5343776|NCT00098306|18385863|P5|Double Blind|Adverse Event|0
5343777|NCT00098306|18385864|P4|Double Blind|Adverse Event|0
5343778|NCT00098306|18385865|P3|Double Blind|Adverse Event|6
5343779|NCT00098306|18385866|P2|Double Blind|Adverse Event|10
5343780|NCT00098306|18385867|P1|Double Blind|Adverse Event|11
5343781|NCT00098306|18385861|P7|Double Blind|Ongoing at cut-off date|0
5343782|NCT00098306|18385862|P6|Double Blind|Ongoing at cut-off date|0
5343783|NCT00098306|18385863|P5|Double Blind|Ongoing at cut-off date|0
5343784|NCT00098306|18385864|P4|Double Blind|Ongoing at cut-off date|0
5343785|NCT00098306|18385865|P3|Double Blind|Ongoing at cut-off date|72
5343786|NCT00098306|18385866|P2|Double Blind|Ongoing at cut-off date|166
5343787|NCT00098306|18385867|P1|Double Blind|Ongoing at cut-off date|151
5343788|NCT00098306|18385861|P7|Double Blind|Randomized, not treated|0
5343789|NCT00098306|18385862|P6|Double Blind|Randomized, not treated|0
5343790|NCT00098306|18385863|P5|Double Blind|Randomized, not treated|0
5343791|NCT00098306|18385864|P4|Double Blind|Randomized, not treated|0
5343792|NCT00098306|18385865|P3|Double Blind|Randomized, not treated|2
5343793|NCT00098306|18385866|P2|Double Blind|Randomized, not treated|5
5343794|NCT00098306|18385867|P1|Double Blind|Randomized, not treated|9
5343795|NCT00098293|18385933|P5|Supplemental Phase (SP)|Other|22
5343796|NCT00098293|18385934|P4|Supplemental Phase (SP)|Other|0
5343797|NCT00098293|18385935|P3|Supplemental Phase (SP)|Other|0
5343798|NCT00098293|18385936|P2|Supplemental Phase (SP)|Other|0
5343799|NCT00098293|18385937|P1|Supplemental Phase (SP)|Other|0
5343800|NCT00098293|18385933|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
5343801|NCT00098293|18385934|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
5343802|NCT00098293|18385935|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
5343803|NCT00098293|18385936|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
5343804|NCT00098293|18385937|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
5343805|NCT00098293|18385933|P5|Supplemental Phase (SP)|Lost to Follow-up|2
5343806|NCT00098293|18385934|P4|Supplemental Phase (SP)|Lost to Follow-up|0
5343807|NCT00098293|18385935|P3|Supplemental Phase (SP)|Lost to Follow-up|0
5343808|NCT00098293|18385936|P2|Supplemental Phase (SP)|Lost to Follow-up|0
5343809|NCT00098293|18385937|P1|Supplemental Phase (SP)|Lost to Follow-up|0
5343810|NCT00098293|18385933|P5|Supplemental Phase (SP)|Death|1
5343811|NCT00098293|18385934|P4|Supplemental Phase (SP)|Death|0
5343812|NCT00098293|18385935|P3|Supplemental Phase (SP)|Death|0
5343813|NCT00098293|18385936|P2|Supplemental Phase (SP)|Death|0
5343814|NCT00098293|18385937|P1|Supplemental Phase (SP)|Death|0
5343815|NCT00098293|18385933|P5|Open-label (OL) Phase|Death|0
5343816|NCT00098293|18385934|P4|Open-label (OL) Phase|Death|0
5343817|NCT00098293|18385935|P3|Open-label (OL) Phase|Death|3
5343818|NCT00098293|18385936|P2|Open-label (OL) Phase|Death|2
5343819|NCT00098293|18385937|P1|Open-label (OL) Phase|Death|0
5343820|NCT00098293|18385933|P5|Open-label (OL) Phase|Participant Defaulted|0
5343821|NCT00098293|18385934|P4|Open-label (OL) Phase|Participant Defaulted|20
5343822|NCT00098293|18385935|P3|Open-label (OL) Phase|Participant Defaulted|16
5343823|NCT00098293|18385936|P2|Open-label (OL) Phase|Participant Defaulted|6
5343824|NCT00098293|18385937|P1|Open-label (OL) Phase|Participant Defaulted|0
5343825|NCT00098293|18385933|P5|Open-label (OL) Phase|Protocol Violation|0
5343826|NCT00098293|18385934|P4|Open-label (OL) Phase|Protocol Violation|16
5343827|NCT00098293|18385935|P3|Open-label (OL) Phase|Protocol Violation|13
5343828|NCT00098293|18385936|P2|Open-label (OL) Phase|Protocol Violation|6
5343829|NCT00098293|18385937|P1|Open-label (OL) Phase|Protocol Violation|0
5343830|NCT00098293|18385933|P5|Open-label (OL) Phase|Pregnancy|0
5343831|NCT00098293|18385934|P4|Open-label (OL) Phase|Pregnancy|3
5343832|NCT00098293|18385935|P3|Open-label (OL) Phase|Pregnancy|0
5343833|NCT00098293|18385936|P2|Open-label (OL) Phase|Pregnancy|1
5343834|NCT00098293|18385937|P1|Open-label (OL) Phase|Pregnancy|0
5343835|NCT00098293|18385933|P5|Open-label (OL) Phase|Lack of Efficacy|0
5343836|NCT00098293|18385934|P4|Open-label (OL) Phase|Lack of Efficacy|20
5343837|NCT00098293|18385935|P3|Open-label (OL) Phase|Lack of Efficacy|2
5343838|NCT00098293|18385936|P2|Open-label (OL) Phase|Lack of Efficacy|7
5343839|NCT00098293|18385937|P1|Open-label (OL) Phase|Lack of Efficacy|0
5343840|NCT00098293|18385933|P5|Open-label (OL) Phase|Adverse Event|0
5343841|NCT00098293|18385934|P4|Open-label (OL) Phase|Adverse Event|6
5343842|NCT00098293|18385935|P3|Open-label (OL) Phase|Adverse Event|7
5343843|NCT00098293|18385936|P2|Open-label (OL) Phase|Adverse Event|3
5343844|NCT00098293|18385937|P1|Open-label (OL) Phase|Adverse Event|0
5343845|NCT00098293|18385933|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5343846|NCT00098293|18385934|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5343847|NCT00098293|18385935|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
5343848|NCT00098293|18385936|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5343849|NCT00098293|18385937|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5343850|NCT00098293|18385933|P5|Double-blind (DB) Phase|Terminated by sponsor|0
5343851|NCT00098293|18385934|P4|Double-blind (DB) Phase|Terminated by sponsor|0
5343852|NCT00098293|18385935|P3|Double-blind (DB) Phase|Terminated by sponsor|0
5343853|NCT00098293|18385936|P2|Double-blind (DB) Phase|Terminated by sponsor|0
5343854|NCT00098293|18385937|P1|Double-blind (DB) Phase|Terminated by sponsor|135
5343855|NCT00098293|18385933|P5|Double-blind (DB) Phase|Protocol Violation|0
5343856|NCT00098293|18385934|P4|Double-blind (DB) Phase|Protocol Violation|0
5343857|NCT00098293|18385935|P3|Double-blind (DB) Phase|Protocol Violation|22
5343858|NCT00098293|18385936|P2|Double-blind (DB) Phase|Protocol Violation|18
5343859|NCT00098293|18385937|P1|Double-blind (DB) Phase|Protocol Violation|2
5343860|NCT00098293|18385933|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
5343861|NCT00098293|18385934|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
5343862|NCT00098293|18385935|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
5343863|NCT00098293|18385936|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
5343864|NCT00098293|18385937|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
5343865|NCT00098293|18385933|P5|Double-blind (DB) Phase|Death|0
5343866|NCT00098293|18385934|P4|Double-blind (DB) Phase|Death|0
5343867|NCT00098293|18385935|P3|Double-blind (DB) Phase|Death|2
5343868|NCT00098293|18385936|P2|Double-blind (DB) Phase|Death|2
5343869|NCT00098293|18385937|P1|Double-blind (DB) Phase|Death|1
5343870|NCT00098293|18385933|P5|Double-blind (DB) Phase|Lack of Efficacy|0
5343871|NCT00098293|18385934|P4|Double-blind (DB) Phase|Lack of Efficacy|0
5343872|NCT00098293|18385935|P3|Double-blind (DB) Phase|Lack of Efficacy|30
5343873|NCT00098293|18385936|P2|Double-blind (DB) Phase|Lack of Efficacy|64
5343874|NCT00098293|18385937|P1|Double-blind (DB) Phase|Lack of Efficacy|11
5343875|NCT00098293|18385933|P5|Double-blind (DB) Phase|Participant Defaulted|0
5343876|NCT00098293|18385934|P4|Double-blind (DB) Phase|Participant Defaulted|0
5343877|NCT00098293|18385935|P3|Double-blind (DB) Phase|Participant Defaulted|36
5343878|NCT00098293|18385936|P2|Double-blind (DB) Phase|Participant Defaulted|40
5343879|NCT00098293|18385937|P1|Double-blind (DB) Phase|Participant Defaulted|11
5343880|NCT00098293|18385933|P5|Double-blind (DB) Phase|Pregnancy|0
5343881|NCT00098293|18385934|P4|Double-blind (DB) Phase|Pregnancy|0
5343882|NCT00098293|18385935|P3|Double-blind (DB) Phase|Pregnancy|9
5343883|NCT00098293|18385936|P2|Double-blind (DB) Phase|Pregnancy|7
5343884|NCT00098293|18385937|P1|Double-blind (DB) Phase|Pregnancy|0
5343885|NCT00098293|18385933|P5|Double-blind (DB) Phase|Adverse Event|0
5343886|NCT00098293|18385934|P4|Double-blind (DB) Phase|Adverse Event|0
5343887|NCT00098293|18385935|P3|Double-blind (DB) Phase|Adverse Event|60
5343888|NCT00098293|18385936|P2|Double-blind (DB) Phase|Adverse Event|27
5343889|NCT00098293|18385937|P1|Double-blind (DB) Phase|Adverse Event|14
5343890|NCT00098254|18385990|P1|Overall Study|Death|1
5343891|NCT00098254|18385990|P1|Overall Study|Adverse Event|2
5343892|NCT00098020|18386056|P1|Overall Study|Low epidermal growth factor receptor|1
5343893|NCT00098020|18386056|P1|Overall Study|Low urine PCR|1
5343894|NCT00098020|18386056|P1|Overall Study|elevated liver enzymes|1
5343895|NCT00098020|18386056|P1|Overall Study|Lost to Follow-up|1
5343896|NCT00098020|18386056|P1|Overall Study|Adverse Event|2
5343897|NCT00097981|18386063|P2|Overall Study|Other|13
5343898|NCT00097981|18386064|P1|Overall Study|Other|19
5343899|NCT00097981|18386063|P2|Overall Study|Transplant planned|27
5343900|NCT00097981|18386064|P1|Overall Study|Transplant planned|28
5343901|NCT00097981|18386063|P2|Overall Study|Disease Progression|2
5343902|NCT00097981|18386064|P1|Overall Study|Disease Progression|8
5343903|NCT00097981|18386063|P2|Overall Study|Physician Decision|1
5343904|NCT00097981|18386064|P1|Overall Study|Physician Decision|7
5343905|NCT00097981|18386063|P2|Overall Study|Death|4
5343906|NCT00097981|18386064|P1|Overall Study|Death|2
5343907|NCT00097981|18386063|P2|Overall Study|Protocol Violation|1
5343908|NCT00097981|18386064|P1|Overall Study|Protocol Violation|1
5343909|NCT00097981|18386063|P2|Overall Study|Withdrawal by Subject|8
5343910|NCT00097981|18386064|P1|Overall Study|Withdrawal by Subject|10
5343911|NCT00097981|18386063|P2|Overall Study|Adverse Event|44
5343912|NCT00097981|18386064|P1|Overall Study|Adverse Event|31
5343913|NCT00097786|18386086|P4|Overall Study|lost to follow-up for all-cause death|310
5343914|NCT00097786|18386087|P3|Overall Study|lost to follow-up for all-cause death|313
5343915|NCT00097786|18386088|P2|Overall Study|lost to follow-up for all-cause death|292
5343916|NCT00097786|18386089|P1|Overall Study|lost to follow-up for all-cause death|296
5343917|NCT00097773|18386111|P4|Overall Study|Other|0
5343918|NCT00097773|18386112|P3|Overall Study|Other|2
5343919|NCT00097773|18386113|P2|Overall Study|Other|0
5343920|NCT00097773|18386114|P1|Overall Study|Other|1
5343921|NCT00097773|18386111|P4|Overall Study|Adverse Event|0
5343922|NCT00097773|18386112|P3|Overall Study|Adverse Event|0
5343923|NCT00097773|18386113|P2|Overall Study|Adverse Event|1
5343924|NCT00097773|18386114|P1|Overall Study|Adverse Event|0
5343925|NCT00097773|18386111|P4|Overall Study|Withdrawal by Subject|1
5343926|NCT00097773|18386112|P3|Overall Study|Withdrawal by Subject|3
5343927|NCT00097773|18386113|P2|Overall Study|Withdrawal by Subject|3
5343928|NCT00097773|18386114|P1|Overall Study|Withdrawal by Subject|3
5343929|NCT00097773|18386111|P4|Overall Study|Physician Decision|1
5343930|NCT00097773|18386112|P3|Overall Study|Physician Decision|3
5343931|NCT00097773|18386113|P2|Overall Study|Physician Decision|2
5343932|NCT00097773|18386114|P1|Overall Study|Physician Decision|2
5343933|NCT00097773|18386111|P4|Overall Study|Lost to Follow-up|1
5343934|NCT00097773|18386112|P3|Overall Study|Lost to Follow-up|0
5343935|NCT00097773|18386113|P2|Overall Study|Lost to Follow-up|2
5343936|NCT00097773|18386114|P1|Overall Study|Lost to Follow-up|2
5343937|NCT00097721|18386134|P2|Overall Study|Reason not given|1
5343938|NCT00097721|18386135|P1|Overall Study|Reason not given|1
5343939|NCT00097721|18386134|P2|Overall Study|Physician Decision|3
5343940|NCT00097721|18386135|P1|Overall Study|Physician Decision|1
5343941|NCT00097721|18386134|P2|Overall Study|Progressive Disease|27
5343942|NCT00097721|18386135|P1|Overall Study|Progressive Disease|55
5343943|NCT00097721|18386134|P2|Overall Study|Withdrawal by Subject|1
5343944|NCT00097721|18386135|P1|Overall Study|Withdrawal by Subject|6
5343945|NCT00097721|18386134|P2|Overall Study|Adverse Event|1
5343946|NCT00097721|18386135|P1|Overall Study|Adverse Event|8
5343947|NCT00097591|18386194|P2|Overall Study|Other|3
5343948|NCT00097591|18386195|P1|Overall Study|Other|0
5343949|NCT00097591|18386194|P2|Overall Study|Lost to follow up|10
5343950|NCT00097591|18386195|P1|Overall Study|Lost to follow up|6
5343951|NCT00097591|18386194|P2|Overall Study|Unable to attend termination visit|51
5343952|NCT00097591|18386195|P1|Overall Study|Unable to attend termination visit|53
5343953|NCT00097591|18386194|P2|Overall Study|Less than 6 months on study drug|7
5343954|NCT00097591|18386195|P1|Overall Study|Less than 6 months on study drug|9
5343955|NCT00097591|18386194|P2|Overall Study|Withdrawal of consent|323
5343956|NCT00097591|18386195|P1|Overall Study|Withdrawal of consent|342
5343957|NCT00097539|18386218|P7|Overall Study|Reason not Specified|2
5343958|NCT00097539|18386219|P6|Overall Study|Reason not Specified|40
5343959|NCT00097539|18386220|P5|Overall Study|Reason not Specified|11
5343960|NCT00097539|18386221|P4|Overall Study|Reason not Specified|21
5343961|NCT00097539|18386222|P3|Overall Study|Reason not Specified|53
5343962|NCT00097539|18386223|P2|Overall Study|Reason not Specified|49
5343963|NCT00097539|18386224|P1|Overall Study|Reason not Specified|111
5343964|NCT00097539|18386218|P7|Overall Study|Reasons Other Than Above|34
5343965|NCT00097539|18386219|P6|Overall Study|Reasons Other Than Above|1244
5343966|NCT00097539|18386220|P5|Overall Study|Reasons Other Than Above|361
5343967|NCT00097539|18386221|P4|Overall Study|Reasons Other Than Above|692
5343968|NCT00097539|18386222|P3|Overall Study|Reasons Other Than Above|1757
5343969|NCT00097539|18386223|P2|Overall Study|Reasons Other Than Above|1382
5343970|NCT00097539|18386224|P1|Overall Study|Reasons Other Than Above|3602
5343971|NCT00097539|18386218|P7|Overall Study|Death|0
5343972|NCT00097539|18386219|P6|Overall Study|Death|3
5343973|NCT00097539|18386220|P5|Overall Study|Death|1
5343974|NCT00097539|18386221|P4|Overall Study|Death|0
5343975|NCT00097539|18386222|P3|Overall Study|Death|0
5343976|NCT00097539|18386223|P2|Overall Study|Death|7
5343977|NCT00097539|18386224|P1|Overall Study|Death|2
5343978|NCT00097539|18386218|P7|Overall Study|Adverse Event|1
5343979|NCT00097539|18386219|P6|Overall Study|Adverse Event|59
5343980|NCT00097539|18386220|P5|Overall Study|Adverse Event|30
5343981|NCT00097539|18386221|P4|Overall Study|Adverse Event|27
5343982|NCT00097539|18386222|P3|Overall Study|Adverse Event|37
5343983|NCT00097539|18386223|P2|Overall Study|Adverse Event|133
5343984|NCT00097539|18386224|P1|Overall Study|Adverse Event|78
5343985|NCT00097539|18386218|P7|Overall Study|Lack of Efficacy|5
5343986|NCT00097539|18386219|P6|Overall Study|Lack of Efficacy|228
5343987|NCT00097539|18386220|P5|Overall Study|Lack of Efficacy|45
5343988|NCT00097539|18386221|P4|Overall Study|Lack of Efficacy|105
5343989|NCT00097539|18386222|P3|Overall Study|Lack of Efficacy|202
5343990|NCT00097539|18386223|P2|Overall Study|Lack of Efficacy|122
5343991|NCT00097539|18386224|P1|Overall Study|Lack of Efficacy|249
5343992|NCT00097539|18386218|P7|Overall Study|Participant Non-compliant|18
5343993|NCT00097539|18386219|P6|Overall Study|Participant Non-compliant|543
5343994|NCT00097539|18386220|P5|Overall Study|Participant Non-compliant|136
5343995|NCT00097539|18386221|P4|Overall Study|Participant Non-compliant|353
5343996|NCT00097539|18386222|P3|Overall Study|Participant Non-compliant|1067
5343997|NCT00097539|18386223|P2|Overall Study|Participant Non-compliant|567
5343998|NCT00097539|18386224|P1|Overall Study|Participant Non-compliant|2140
5343999|NCT00097539|18386218|P7|Overall Study|Withdrawal by Subject|3
5344000|NCT00097539|18386219|P6|Overall Study|Withdrawal by Subject|229
5344001|NCT00097539|18386220|P5|Overall Study|Withdrawal by Subject|68
5344002|NCT00097539|18386221|P4|Overall Study|Withdrawal by Subject|217
5344003|NCT00097539|18386222|P3|Overall Study|Withdrawal by Subject|346
5344004|NCT00097539|18386223|P2|Overall Study|Withdrawal by Subject|323
5344005|NCT00097539|18386224|P1|Overall Study|Withdrawal by Subject|925
5344006|NCT00097539|18386218|P7|Overall Study|Status Unknown (Or no final evaluation)|108
5344007|NCT00097539|18386219|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
5344008|NCT00097539|18386220|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
5344009|NCT00097539|18386221|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
5344010|NCT00097539|18386222|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
5344011|NCT00097539|18386223|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
5344012|NCT00097539|18386224|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
5344013|NCT00097500|18386270|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
5344014|NCT00097500|18386271|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
5344015|NCT00097500|18386270|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
5344016|NCT00097500|18386271|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
5344017|NCT00097500|18386270|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
5344018|NCT00097500|18386271|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
5344019|NCT00097500|18386270|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
5344020|NCT00097500|18386271|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
5344021|NCT00097500|18386270|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
5344022|NCT00097500|18386271|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
5344023|NCT00097500|18386270|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
5344024|NCT00097500|18386271|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
5344025|NCT00097500|18386270|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
5344026|NCT00097500|18386271|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
5344027|NCT00097370|18386302|P1|Stage 3|Lost to Follow-up|1
5344028|NCT00097370|18386302|P1|Stage 3|Sponsor Terminated Study|52
5344029|NCT00097370|18386302|P1|Stage 3|Lack of Efficacy|1
5344030|NCT00097370|18386302|P1|Stage 3|Withdrawal by Subject|3
5344031|NCT00097370|18386302|P1|Stage 3|Adverse Event|2
5344032|NCT00097370|18386302|P1|Stage 2|Lost to Follow-up|1
5344033|NCT00097370|18386302|P1|Stage 2|Sponsor Terminated Study|2
5344034|NCT00097370|18386302|P1|Stage 2|Pregnancy|1
5344035|NCT00097370|18386302|P1|Stage 2|Lack of Efficacy|3
5344036|NCT00097370|18386302|P1|Stage 2|Withdrawal by Subject|1
5344037|NCT00097370|18386302|P1|Stage 2|Adverse Event|5
5344038|NCT00097370|18386302|P1|Stage 1|Lack of Efficacy|2
5344039|NCT00097370|18386302|P1|Stage 1|Withdrawal by Subject|1
5344040|NCT00097370|18386302|P1|Stage 1|Adverse Event|3
5344041|NCT00096993|18386336|P2|Overall Study|Other unspecified|1
5344042|NCT00096993|18386337|P1|Overall Study|Other unspecified|1
5344043|NCT00096993|18386336|P2|Overall Study|Non-compliance|1
5344044|NCT00096993|18386337|P1|Overall Study|Non-compliance|0
5344045|NCT00096993|18386336|P2|Overall Study|Physician Decision|1
5344046|NCT00096993|18386337|P1|Overall Study|Physician Decision|2
5344047|NCT00096993|18386336|P2|Overall Study|Subject's decision|1
5344048|NCT00096993|18386337|P1|Overall Study|Subject's decision|3
5344049|NCT00096993|18386336|P2|Overall Study|Adverse Event|8
5344050|NCT00096993|18386337|P1|Overall Study|Adverse Event|2
5344051|NCT00096993|18386336|P2|Overall Study|Disease progression|53
5344052|NCT00096993|18386337|P1|Overall Study|Disease progression|56
5344053|NCT00096993|18386336|P2|Overall Study|Death|0
5344054|NCT00096993|18386337|P1|Overall Study|Death|1
5344055|NCT00096954|18386353|P2|Overall Study|Lost to Follow-up|5
5344056|NCT00096954|18386354|P1|Overall Study|Lost to Follow-up|8
5344057|NCT00096954|18386353|P2|Overall Study|Non-compliance|3
5344058|NCT00096954|18386354|P1|Overall Study|Non-compliance|0
5344059|NCT00096954|18386353|P2|Overall Study|Initiation of immunotherapy|0
5344060|NCT00096954|18386354|P1|Overall Study|Initiation of immunotherapy|1
5344061|NCT00096954|18386353|P2|Overall Study|Pregnancy|1
5344062|NCT00096954|18386354|P1|Overall Study|Pregnancy|1
5344063|NCT00096954|18386353|P2|Overall Study|Sponsors Decision|1
5344064|NCT00096954|18386354|P1|Overall Study|Sponsors Decision|1
5344065|NCT00096954|18386353|P2|Overall Study|Physician Decision|1
5344066|NCT00096954|18386354|P1|Overall Study|Physician Decision|1
5344067|NCT00096954|18386353|P2|Overall Study|Withdrawal by Subject|8
5344068|NCT00096954|18386354|P1|Overall Study|Withdrawal by Subject|9
5344069|NCT00096954|18386353|P2|Overall Study|Adverse Event|1
5344070|NCT00096954|18386354|P1|Overall Study|Adverse Event|3
5344071|NCT00096941|18386366|P1|Overall Study|disease progression|3
5344072|NCT00096785|18386373|P2|Overall Study|Relocated|0
5344073|NCT00096785|18386374|P1|Overall Study|Relocated|1
5344074|NCT00096785|18386373|P2|Overall Study|Withdrawal by Subject|1
5344075|NCT00096785|18386374|P1|Overall Study|Withdrawal by Subject|0
5344076|NCT00096785|18386373|P2|Overall Study|Lost to Follow-up|0
5344077|NCT00096785|18386374|P1|Overall Study|Lost to Follow-up|1
5344078|NCT00096538|18386403|P1|Overall Study|Withdrawal by Subject|1
5344079|NCT00096486|18386411|P4|Overall Study|Not Treated|1
5344080|NCT00096486|18386412|P3|Overall Study|Not Treated|1
5344081|NCT00096486|18386413|P2|Overall Study|Not Treated|0
5344082|NCT00096486|18386414|P1|Overall Study|Not Treated|0
5344083|NCT00096486|18386411|P4|Overall Study|Withdrawal by Subject|1
5344084|NCT00096486|18386412|P3|Overall Study|Withdrawal by Subject|1
5344085|NCT00096486|18386413|P2|Overall Study|Withdrawal by Subject|0
5344086|NCT00096486|18386414|P1|Overall Study|Withdrawal by Subject|0
5344087|NCT00096447|18386433|P1|Overall Study|Never treated|1
5344088|NCT00096382|18386449|P2|Overall Study|Death during treatment|0
5344089|NCT00096382|18386450|P1|Overall Study|Death during treatment|1
5344090|NCT00096382|18386449|P2|Overall Study|Not treated|0
5344091|NCT00096382|18386450|P1|Overall Study|Not treated|1
5344092|NCT00096356|18386460|P2|Overall Study|multiple reasons|18
5344093|NCT00096356|18386461|P1|Overall Study|multiple reasons|10
5344094|NCT00096356|18386460|P2|Overall Study|Lack of Efficacy|0
5344095|NCT00096356|18386461|P1|Overall Study|Lack of Efficacy|1
5344096|NCT00096356|18386460|P2|Overall Study|Withdrawal by Subject|23
5344097|NCT00096356|18386461|P1|Overall Study|Withdrawal by Subject|17
5344098|NCT00096356|18386460|P2|Overall Study|Physician Decision|3
5344099|NCT00096356|18386461|P1|Overall Study|Physician Decision|5
5344100|NCT00096356|18386460|P2|Overall Study|Adverse Event|9
5344101|NCT00096356|18386461|P1|Overall Study|Adverse Event|11
5344102|NCT00096278|18386473|P2|Overall Study|Patient not at risk for primary endpoint|2
5344103|NCT00096278|18386474|P1|Overall Study|Patient not at risk for primary endpoint|3
5344104|NCT00096278|18386473|P2|Overall Study|No follow-up data|18
5344105|NCT00096278|18386474|P1|Overall Study|No follow-up data|15
5344106|NCT00096265|18386493|P3|Overall Study|Ineligible|0
5344107|NCT00096265|18386494|P2|Overall Study|Ineligible|0
5344108|NCT00096265|18386495|P1|Overall Study|Ineligible|1
5344109|NCT00096226|18386521|P1|Overall Study|Protocol treatment not started|1
5344110|NCT00096226|18386521|P1|Overall Study|Ineligible|2
5344111|NCT00096200|18386535|P3|Overall Study|Ineligible pathology|0
5344112|NCT00096200|18386536|P2|Overall Study|Ineligible pathology|1
5344113|NCT00096200|18386537|P1|Overall Study|Ineligible pathology|0
5344114|NCT00096200|18386535|P3|Overall Study|Withdrawal by Subject|0
5344115|NCT00096200|18386536|P2|Overall Study|Withdrawal by Subject|2
5344116|NCT00096200|18386537|P1|Overall Study|Withdrawal by Subject|1
5344117|NCT00096200|18386535|P3|Overall Study|Adverse Event|0
5344118|NCT00096200|18386536|P2|Overall Study|Adverse Event|4
5344119|NCT00096200|18386537|P1|Overall Study|Adverse Event|0
5344120|NCT00096174|18386551|P1|Overall Study|other reason|8
5344121|NCT00096174|18386551|P1|Overall Study|Ineligible|6
5344122|NCT00096174|18386551|P1|Overall Study|Not started protocol therapy|3
5344123|NCT00096174|18386551|P1|Overall Study|Withdrawal by Subject|15
5344124|NCT00096174|18386551|P1|Overall Study|Death|6
5344125|NCT00096174|18386551|P1|Overall Study|Adverse Event|15
5344126|NCT00096174|18386551|P1|Overall Study|Lack of Efficacy|9
5344127|NCT00096135|18386596|P2|Overall Study|Ineligible|0
5344128|NCT00096135|18386597|P1|Overall Study|Ineligible|2
5344129|NCT00096135|18386596|P2|Overall Study|Other, specify|3
5344130|NCT00096135|18386597|P1|Overall Study|Other, specify|15
5344131|NCT00096135|18386596|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
5344132|NCT00096135|18386597|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
5344133|NCT00096135|18386596|P2|Overall Study|Refusal of further protocol therapy|1
5344134|NCT00096135|18386597|P1|Overall Study|Refusal of further protocol therapy|4
5344135|NCT00096135|18386596|P2|Overall Study|Physician Decision|4
5344136|NCT00096135|18386597|P1|Overall Study|Physician Decision|20
5344137|NCT00096044|18386613|P1|Overall Study|Disease Progression|4
5344138|NCT00096044|18386613|P1|Overall Study|Adverse Event|21
5344139|NCT00096044|18386613|P1|Overall Study|Withdrawal by Subject|9
5344140|NCT00096031|18386622|P1|Overall Study|Not protocol specified|5
5344141|NCT00096031|18386622|P1|Overall Study|Ineligible|8
5344142|NCT00096031|18386622|P1|Overall Study|Withdrawal by Subject|1
5344143|NCT00096031|18386622|P1|Overall Study|Death|4
5344144|NCT00096031|18386622|P1|Overall Study|Lack of Efficacy|42
5344145|NCT00096031|18386622|P1|Overall Study|Adverse Event|3
5344146|NCT00096018|18386630|P2|Overall Study|Miscellaneous|1
5344147|NCT00096018|18386631|P1|Overall Study|Miscellaneous|2
5344148|NCT00096018|18386630|P2|Overall Study|Withdrawal by Subject|2
5344149|NCT00096018|18386631|P1|Overall Study|Withdrawal by Subject|0
5344150|NCT00096018|18386630|P2|Overall Study|Death|1
5344151|NCT00096018|18386631|P1|Overall Study|Death|0
5344152|NCT00096018|18386630|P2|Overall Study|Adverse Event|5
5344153|NCT00096018|18386631|P1|Overall Study|Adverse Event|0
5344154|NCT00096018|18386630|P2|Overall Study|Miscellaneous (not treated)|2
5344155|NCT00096018|18386631|P1|Overall Study|Miscellaneous (not treated)|0
5344156|NCT00096018|18386630|P2|Overall Study|Became Ineligible (not treated)|3
5344157|NCT00096018|18386631|P1|Overall Study|Became Ineligible (not treated)|0
5344158|NCT00095979|18386639|P1|Overall Study|Ineligible: Second primary cancer site|2
5344159|NCT00095940|18386657|P9|Lapatinib Continuation/Phase II|Adverse Event|0
5344160|NCT00095940|18386658|P8|Lapatinib Continuation/Phase II|Adverse Event|1
5344161|NCT00095940|18386659|P7|Lapatinib Continuation/Phase II|Adverse Event|0
5344162|NCT00095940|18386660|P6|Lapatinib Continuation/Phase II|Adverse Event|0
5344163|NCT00095940|18386661|P5|Lapatinib Continuation/Phase II|Adverse Event|0
5344164|NCT00095940|18386662|P4|Lapatinib Continuation/Phase II|Adverse Event|0
5344165|NCT00095940|18386663|P3|Lapatinib Continuation/Phase II|Adverse Event|0
5344166|NCT00095940|18386664|P2|Lapatinib Continuation/Phase II|Adverse Event|0
5344167|NCT00095940|18386665|P1|Lapatinib Continuation/Phase II|Adverse Event|0
5344168|NCT00095940|18386657|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5344169|NCT00095940|18386658|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5344170|NCT00095940|18386659|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5344171|NCT00095940|18386660|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5344172|NCT00095940|18386661|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5344173|NCT00095940|18386662|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5344174|NCT00095940|18386663|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5344175|NCT00095940|18386664|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5344176|NCT00095940|18386665|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5344177|NCT00095940|18386657|P9|Lapatinib Continuation/Phase II|Disease Progression|12
5344178|NCT00095940|18386658|P8|Lapatinib Continuation/Phase II|Disease Progression|1
5344179|NCT00095940|18386659|P7|Lapatinib Continuation/Phase II|Disease Progression|2
5344180|NCT00095940|18386660|P6|Lapatinib Continuation/Phase II|Disease Progression|13
5344181|NCT00095940|18386661|P5|Lapatinib Continuation/Phase II|Disease Progression|0
5344182|NCT00095940|18386662|P4|Lapatinib Continuation/Phase II|Disease Progression|0
5344183|NCT00095940|18386663|P3|Lapatinib Continuation/Phase II|Disease Progression|15
5344184|NCT00095940|18386664|P2|Lapatinib Continuation/Phase II|Disease Progression|1
5344185|NCT00095940|18386665|P1|Lapatinib Continuation/Phase II|Disease Progression|1
5344186|NCT00095836|18386698|P1|Overall Study|Death|2
5344187|NCT00095836|18386698|P1|Overall Study|Adverse Event|1
5344188|NCT00095836|18386698|P1|Overall Study|Lost to Follow-up|1
5344189|NCT00095628|18386728|P1|Overall Study|Disease progression prior to treatment|1
5344190|NCT00095576|18386739|P2|Overall Study|Subject moved|36
5344191|NCT00095576|18386740|P1|Overall Study|Subject moved|30
5344192|NCT00095576|18386739|P2|Overall Study|Site terminated|67
5344193|NCT00095576|18386740|P1|Overall Study|Site terminated|75
5344194|NCT00095576|18386739|P2|Overall Study|Option to switch to a rollover study|1099
5344195|NCT00095576|18386740|P1|Overall Study|Option to switch to a rollover study|1097
5344196|NCT00095576|18386739|P2|Overall Study|Withdrawal by Subject|47
5344197|NCT00095576|18386740|P1|Overall Study|Withdrawal by Subject|34
5344198|NCT00095576|18386739|P2|Overall Study|Protocol Violation|0
5344199|NCT00095576|18386740|P1|Overall Study|Protocol Violation|1
5344200|NCT00095576|18386739|P2|Overall Study|Lost to Follow-up|229
5344201|NCT00095576|18386740|P1|Overall Study|Lost to Follow-up|233
5344202|NCT00095576|18386739|P2|Overall Study|Adverse Event|3
5344203|NCT00095576|18386740|P1|Overall Study|Adverse Event|5
5344204|NCT00095498|18386764|P3|Overall Study|Requirement for alternative therapy|2
5344205|NCT00095498|18386765|P2|Overall Study|Requirement for alternative therapy|0
5344206|NCT00095498|18386766|P1|Overall Study|Requirement for alternative therapy|1
5344207|NCT00095498|18386764|P3|Overall Study|Protocol Violation|1
5344208|NCT00095498|18386765|P2|Overall Study|Protocol Violation|0
5344209|NCT00095498|18386766|P1|Overall Study|Protocol Violation|0
5344210|NCT00095498|18386764|P3|Overall Study|Other|6
5344211|NCT00095498|18386765|P2|Overall Study|Other|7
5344212|NCT00095498|18386766|P1|Overall Study|Other|6
5344213|NCT00095498|18386764|P3|Overall Study|Noncompliance|1
5344214|NCT00095498|18386765|P2|Overall Study|Noncompliance|0
5344215|NCT00095498|18386766|P1|Overall Study|Noncompliance|1
5344216|NCT00095498|18386764|P3|Overall Study|Lost to Follow-up|2
5344217|NCT00095498|18386765|P2|Overall Study|Lost to Follow-up|1
5344218|NCT00095498|18386766|P1|Overall Study|Lost to Follow-up|1
5344219|NCT00095498|18386764|P3|Overall Study|Ineligibility determined|2
5344220|NCT00095498|18386765|P2|Overall Study|Ineligibility determined|0
5344221|NCT00095498|18386766|P1|Overall Study|Ineligibility determined|3
5344222|NCT00095498|18386764|P3|Overall Study|Disease progression|1
5344223|NCT00095498|18386765|P2|Overall Study|Disease progression|1
5344224|NCT00095498|18386766|P1|Overall Study|Disease progression|0
5344225|NCT00095498|18386764|P3|Overall Study|Withdrawal by Subject|15
5344226|NCT00095498|18386765|P2|Overall Study|Withdrawal by Subject|16
5344227|NCT00095498|18386766|P1|Overall Study|Withdrawal by Subject|15
5344228|NCT00095498|18386764|P3|Overall Study|Adverse Event|1
5344229|NCT00095498|18386765|P2|Overall Study|Adverse Event|0
5344230|NCT00095498|18386766|P1|Overall Study|Adverse Event|1
5344231|NCT00095498|18386764|P3|Overall Study|Physician Decision|8
5344232|NCT00095498|18386765|P2|Overall Study|Physician Decision|10
5344233|NCT00095498|18386766|P1|Overall Study|Physician Decision|9
5344234|NCT00095303|18387193|P2|Follow Up Study|Lost to Follow-up|58
5344235|NCT00095303|18387194|P1|Follow Up Study|Lost to Follow-up|59
5344236|NCT00095303|18387193|P2|Main Study|Lost to Follow-up|87
5344237|NCT00095303|18387194|P1|Main Study|Lost to Follow-up|91
5344238|NCT00095238|18387262|P2|Overall Study|Other Reasons|88
5344239|NCT00095238|18387263|P1|Overall Study|Other Reasons|87
5344240|NCT00095238|18387262|P2|Overall Study|Missing|0
5344241|NCT00095238|18387263|P1|Overall Study|Missing|1
5344242|NCT00095238|18387262|P2|Overall Study|Study terminated by sponsor|1
5344243|NCT00095238|18387263|P1|Overall Study|Study terminated by sponsor|0
5344244|NCT00095238|18387262|P2|Overall Study|No longer met study criteria|5
5344245|NCT00095238|18387263|P1|Overall Study|No longer met study criteria|4
5344246|NCT00095238|18387262|P2|Overall Study|Noncompliance|45
5344247|NCT00095238|18387263|P1|Overall Study|Noncompliance|44
5344248|NCT00095238|18387262|P2|Overall Study|Lost to Follow-up|24
5344249|NCT00095238|18387263|P1|Overall Study|Lost to Follow-up|19
5344250|NCT00095238|18387262|P2|Overall Study|Death|170
5344251|NCT00095238|18387263|P1|Overall Study|Death|154
5344252|NCT00095238|18387262|P2|Overall Study|Subject Withdrew Consent|223
5344253|NCT00095238|18387263|P1|Overall Study|Subject Withdrew Consent|208
5344254|NCT00095238|18387262|P2|Overall Study|Adverse Event|287
5344255|NCT00095238|18387263|P1|Overall Study|Adverse Event|331
5344256|NCT00095238|18387262|P2|Overall Study|Lack of Efficacy|9
5344257|NCT00095238|18387263|P1|Overall Study|Lack of Efficacy|9
5344258|NCT00095212|18387325|P2|Overall Study|Withdrawal by Subject|3
5344259|NCT00095212|18387326|P1|Overall Study|Withdrawal by Subject|1
5344260|NCT00095199|18387356|P4|Overall Study|Data inadvertently lost by site|0
5344261|NCT00095199|18387357|P3|Overall Study|Data inadvertently lost by site|0
5344262|NCT00095199|18387358|P2|Overall Study|Data inadvertently lost by site|0
5344263|NCT00095199|18387359|P1|Overall Study|Data inadvertently lost by site|1
5344264|NCT00095199|18387356|P4|Overall Study|Primary tumor removed in other surgery|0
5344265|NCT00095199|18387357|P3|Overall Study|Primary tumor removed in other surgery|0
5344266|NCT00095199|18387358|P2|Overall Study|Primary tumor removed in other surgery|1
5344267|NCT00095199|18387359|P1|Overall Study|Primary tumor removed in other surgery|0
5344268|NCT00095199|18387356|P4|Overall Study|Started radiotherapy regimen|0
5344269|NCT00095199|18387357|P3|Overall Study|Started radiotherapy regimen|0
5344270|NCT00095199|18387358|P2|Overall Study|Started radiotherapy regimen|1
5344271|NCT00095199|18387359|P1|Overall Study|Started radiotherapy regimen|0
5344272|NCT00095199|18387356|P4|Overall Study|Started Palliative Radiotherapy|0
5344273|NCT00095199|18387357|P3|Overall Study|Started Palliative Radiotherapy|0
5344274|NCT00095199|18387358|P2|Overall Study|Started Palliative Radiotherapy|0
5344275|NCT00095199|18387359|P1|Overall Study|Started Palliative Radiotherapy|1
5344276|NCT00095199|18387356|P4|Overall Study|Not eligible|1
5344277|NCT00095199|18387357|P3|Overall Study|Not eligible|0
5344278|NCT00095199|18387358|P2|Overall Study|Not eligible|7
5344279|NCT00095199|18387359|P1|Overall Study|Not eligible|1
5344280|NCT00095199|18387356|P4|Overall Study|Physician Decision|1
5344281|NCT00095199|18387357|P3|Overall Study|Physician Decision|1
5344282|NCT00095199|18387358|P2|Overall Study|Physician Decision|6
5344283|NCT00095199|18387359|P1|Overall Study|Physician Decision|5
5344284|NCT00095199|18387356|P4|Overall Study|Surgery needed could not start in 7 days|0
5344285|NCT00095199|18387357|P3|Overall Study|Surgery needed could not start in 7 days|1
5344286|NCT00095199|18387358|P2|Overall Study|Surgery needed could not start in 7 days|0
5344287|NCT00095199|18387359|P1|Overall Study|Surgery needed could not start in 7 days|0
5344288|NCT00095199|18387356|P4|Overall Study|Liver function test results elevated|1
5344289|NCT00095199|18387357|P3|Overall Study|Liver function test results elevated|1
5344290|NCT00095199|18387358|P2|Overall Study|Liver function test results elevated|0
5344291|NCT00095199|18387359|P1|Overall Study|Liver function test results elevated|0
5344292|NCT00095199|18387356|P4|Overall Study|Protocol Violation|0
5344293|NCT00095199|18387357|P3|Overall Study|Protocol Violation|2
5344294|NCT00095199|18387358|P2|Overall Study|Protocol Violation|4
5344295|NCT00095199|18387359|P1|Overall Study|Protocol Violation|4
5344296|NCT00095199|18387356|P4|Overall Study|Withdrawal by Subject|22
5344297|NCT00095199|18387357|P3|Overall Study|Withdrawal by Subject|13
5344298|NCT00095199|18387358|P2|Overall Study|Withdrawal by Subject|16
5344299|NCT00095199|18387359|P1|Overall Study|Withdrawal by Subject|21
5344300|NCT00095199|18387356|P4|Overall Study|Death|9
5344301|NCT00095199|18387357|P3|Overall Study|Death|11
5344302|NCT00095199|18387358|P2|Overall Study|Death|6
5344303|NCT00095199|18387359|P1|Overall Study|Death|10
5344304|NCT00095199|18387356|P4|Overall Study|Progressive disease|98
5344305|NCT00095199|18387357|P3|Overall Study|Progressive disease|105
5344306|NCT00095199|18387358|P2|Overall Study|Progressive disease|179
5344307|NCT00095199|18387359|P1|Overall Study|Progressive disease|213
5344308|NCT00095199|18387356|P4|Overall Study|Adverse Event|11
5344309|NCT00095199|18387357|P3|Overall Study|Adverse Event|26
5344310|NCT00095199|18387358|P2|Overall Study|Adverse Event|22
5344311|NCT00095199|18387359|P1|Overall Study|Adverse Event|40
5344312|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Other|8
5344313|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Other|6
5344314|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Other|4
5344315|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Other|0
5344316|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Other|0
5344317|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Other|0
5344318|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
5344319|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
5344320|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
5344321|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
5344322|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
5344323|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
5344324|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
5344325|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
5344326|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5344327|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5344328|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5344329|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5344330|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
5344331|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
5344332|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5344333|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5344334|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5344335|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5344336|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5344337|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
5344338|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
5344339|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5344340|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5344341|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5344342|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
5344343|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
5344344|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
5344345|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
5344346|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
5344347|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
5344348|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
5344349|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
5344350|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
5344351|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
5344352|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
5344353|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
5344354|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
5344355|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
5344356|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
5344357|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
5344358|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
5344359|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
5344360|NCT00095173|18387397|P6|Open-Label Extension Phase (Period C)|Death|1
5344361|NCT00095173|18387398|P5|Open-Label Extension Phase (Period C)|Death|0
5344362|NCT00095173|18387399|P4|Open-Label Extension Phase (Period C)|Death|0
5344363|NCT00095173|18387400|P3|Open-Label Extension Phase (Period C)|Death|0
5344364|NCT00095173|18387401|P2|Open-Label Extension Phase (Period C)|Death|0
5344365|NCT00095173|18387402|P1|Open-Label Extension Phase (Period C)|Death|0
5344366|NCT00095173|18387397|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5344367|NCT00095173|18387398|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5344368|NCT00095173|18387399|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5344369|NCT00095173|18387400|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5344370|NCT00095173|18387401|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
5344371|NCT00095173|18387402|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5344372|NCT00095173|18387397|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
5344373|NCT00095173|18387398|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
5344374|NCT00095173|18387399|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
5344375|NCT00095173|18387400|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
5344376|NCT00095173|18387401|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
5344377|NCT00095173|18387402|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
5344378|NCT00095173|18387397|P6|Open-Label Lead-In Phase (Period A)|Other|0
5344379|NCT00095173|18387398|P5|Open-Label Lead-In Phase (Period A)|Other|0
5344380|NCT00095173|18387399|P4|Open-Label Lead-In Phase (Period A)|Other|0
5344381|NCT00095173|18387400|P3|Open-Label Lead-In Phase (Period A)|Other|0
5344382|NCT00095173|18387401|P2|Open-Label Lead-In Phase (Period A)|Other|0
5344383|NCT00095173|18387402|P1|Open-Label Lead-In Phase (Period A)|Other|1
5344384|NCT00095173|18387397|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5344385|NCT00095173|18387398|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5344386|NCT00095173|18387399|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5344387|NCT00095173|18387400|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5344388|NCT00095173|18387401|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5344389|NCT00095173|18387402|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
5344390|NCT00095173|18387397|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5344391|NCT00095173|18387398|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5344392|NCT00095173|18387399|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5344393|NCT00095173|18387400|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5344394|NCT00095173|18387401|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5344395|NCT00095173|18387402|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
5344396|NCT00095173|18387397|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5344397|NCT00095173|18387398|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5344398|NCT00095173|18387399|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5344399|NCT00095173|18387400|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5344400|NCT00095173|18387401|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5344401|NCT00095173|18387402|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
5344402|NCT00095147|18387440|P5|Long-term Extension Period|Leaving country|1
5344403|NCT00095147|18387441|P4|Long-term Extension Period|Leaving country|0
5344404|NCT00095147|18387442|P3|Long-term Extension Period|Leaving country|0
5344405|NCT00095147|18387443|P2|Long-term Extension Period|Leaving country|0
5344406|NCT00095147|18387444|P1|Long-term Extension Period|Leaving country|0
5344407|NCT00095147|18387440|P5|Long-term Extension Period|Participant chose to use Revellex|1
5344408|NCT00095147|18387441|P4|Long-term Extension Period|Participant chose to use Revellex|0
5344409|NCT00095147|18387442|P3|Long-term Extension Period|Participant chose to use Revellex|0
5344410|NCT00095147|18387443|P2|Long-term Extension Period|Participant chose to use Revellex|0
5344411|NCT00095147|18387444|P1|Long-term Extension Period|Participant chose to use Revellex|0
5344412|NCT00095147|18387440|P5|Long-term Extension Period|No longer meets study criteria|1
5344413|NCT00095147|18387441|P4|Long-term Extension Period|No longer meets study criteria|0
5344414|NCT00095147|18387442|P3|Long-term Extension Period|No longer meets study criteria|0
5344415|NCT00095147|18387443|P2|Long-term Extension Period|No longer meets study criteria|0
5344416|NCT00095147|18387444|P1|Long-term Extension Period|No longer meets study criteria|0
5344417|NCT00095147|18387440|P5|Long-term Extension Period|Pregnancy|1
5344418|NCT00095147|18387441|P4|Long-term Extension Period|Pregnancy|0
5344419|NCT00095147|18387442|P3|Long-term Extension Period|Pregnancy|0
5344420|NCT00095147|18387443|P2|Long-term Extension Period|Pregnancy|0
5344421|NCT00095147|18387444|P1|Long-term Extension Period|Pregnancy|0
5344422|NCT00095147|18387440|P5|Long-term Extension Period|Withdrawal of consent|12
5344423|NCT00095147|18387441|P4|Long-term Extension Period|Withdrawal of consent|0
5344424|NCT00095147|18387442|P3|Long-term Extension Period|Withdrawal of consent|0
5344425|NCT00095147|18387443|P2|Long-term Extension Period|Withdrawal of consent|0
5344426|NCT00095147|18387444|P1|Long-term Extension Period|Withdrawal of consent|0
5344427|NCT00095147|18387440|P5|Long-term Extension Period|Lost to Follow-up|6
5344428|NCT00095147|18387441|P4|Long-term Extension Period|Lost to Follow-up|0
5344429|NCT00095147|18387442|P3|Long-term Extension Period|Lost to Follow-up|0
5344430|NCT00095147|18387443|P2|Long-term Extension Period|Lost to Follow-up|0
5344431|NCT00095147|18387444|P1|Long-term Extension Period|Lost to Follow-up|0
5344432|NCT00095147|18387440|P5|Long-term Extension Period|Lack of Efficacy|9
5344433|NCT00095147|18387441|P4|Long-term Extension Period|Lack of Efficacy|0
5344434|NCT00095147|18387442|P3|Long-term Extension Period|Lack of Efficacy|0
5344435|NCT00095147|18387443|P2|Long-term Extension Period|Lack of Efficacy|0
5344436|NCT00095147|18387444|P1|Long-term Extension Period|Lack of Efficacy|0
5344437|NCT00095147|18387440|P5|Long-term Extension Period|Adverse Event|11
5344438|NCT00095147|18387441|P4|Long-term Extension Period|Adverse Event|0
5344439|NCT00095147|18387442|P3|Long-term Extension Period|Adverse Event|0
5344440|NCT00095147|18387443|P2|Long-term Extension Period|Adverse Event|0
5344441|NCT00095147|18387444|P1|Long-term Extension Period|Adverse Event|0
5344442|NCT00095147|18387440|P5|Long-term Extension Period|Death|3
5344443|NCT00095147|18387441|P4|Long-term Extension Period|Death|0
5344444|NCT00095147|18387442|P3|Long-term Extension Period|Death|0
5344445|NCT00095147|18387443|P2|Long-term Extension Period|Death|0
5344446|NCT00095147|18387444|P1|Long-term Extension Period|Death|0
5344447|NCT00095147|18387440|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
5344448|NCT00095147|18387441|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
5344449|NCT00095147|18387442|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
5344450|NCT00095147|18387443|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
5344451|NCT00095147|18387444|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
5344452|NCT00095147|18387440|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
5344453|NCT00095147|18387441|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
5344454|NCT00095147|18387442|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
5344455|NCT00095147|18387443|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
5344456|NCT00095147|18387444|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
5344457|NCT00095147|18387440|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
5344458|NCT00095147|18387441|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
5344459|NCT00095147|18387442|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
5344460|NCT00095147|18387443|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
5344461|NCT00095147|18387444|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
5344462|NCT00095147|18387440|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
5344463|NCT00095147|18387441|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
5344464|NCT00095147|18387442|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
5344465|NCT00095147|18387443|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
5344466|NCT00095147|18387444|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
5344467|NCT00095147|18387440|P5|Double-blind Period 2 (Days 198-365)|Death|0
5344468|NCT00095147|18387441|P4|Double-blind Period 2 (Days 198-365)|Death|1
5344469|NCT00095147|18387442|P3|Double-blind Period 2 (Days 198-365)|Death|0
5344470|NCT00095147|18387443|P2|Double-blind Period 2 (Days 198-365)|Death|1
5344471|NCT00095147|18387444|P1|Double-blind Period 2 (Days 198-365)|Death|0
5344472|NCT00095147|18387440|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
5344473|NCT00095147|18387441|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
5344474|NCT00095147|18387442|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
5344475|NCT00095147|18387443|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
5344476|NCT00095147|18387444|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
5344477|NCT00095147|18387440|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
5344478|NCT00095147|18387441|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
5344479|NCT00095147|18387442|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
5344480|NCT00095147|18387443|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
5344481|NCT00095147|18387444|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
5344482|NCT00095147|18387440|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
5344483|NCT00095147|18387441|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
5344484|NCT00095147|18387442|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
5344485|NCT00095147|18387443|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
5344486|NCT00095147|18387444|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
5344487|NCT00095147|18387440|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
5344488|NCT00095147|18387441|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
5344489|NCT00095147|18387442|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
5344490|NCT00095147|18387443|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
5344491|NCT00095147|18387444|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
5344492|NCT00095147|18387440|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
5344493|NCT00095147|18387441|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
5344494|NCT00095147|18387442|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
5344495|NCT00095147|18387443|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
5344496|NCT00095147|18387444|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
5344497|NCT00095147|18387440|P5|Double-blind Period 1 (Days 1-197)|Death|0
5344498|NCT00095147|18387441|P4|Double-blind Period 1 (Days 1-197)|Death|0
5344499|NCT00095147|18387442|P3|Double-blind Period 1 (Days 1-197)|Death|0
5344500|NCT00095147|18387443|P2|Double-blind Period 1 (Days 1-197)|Death|0
5344501|NCT00095147|18387444|P1|Double-blind Period 1 (Days 1-197)|Death|1
5344502|NCT00095121|18387639|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
5344503|NCT00095121|18387640|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
5344504|NCT00095121|18387639|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
5344505|NCT00095121|18387640|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
5344506|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Protocol Violation|1
5344507|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Protocol Violation|0
5344508|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
5344509|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
5344510|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Death|1
5344511|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Death|3
5344512|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Patient Moved|0
5344513|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Patient Moved|1
5344514|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
5344515|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
5344516|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
5344517|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
5344518|NCT00095056|18387686|P2|Phase B (Weeks 12-54)|Adverse Event|2
5344519|NCT00095056|18387687|P1|Phase B (Weeks 12-54)|Adverse Event|2
5344520|NCT00095056|18387686|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
5344521|NCT00095056|18387687|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
5344522|NCT00095056|18387686|P2|Phase A (Weeks 0-12)|Death|0
5344523|NCT00095056|18387687|P1|Phase A (Weeks 0-12)|Death|1
5344524|NCT00095056|18387686|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
5344525|NCT00095056|18387687|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
5344526|NCT00095056|18387686|P2|Phase A (Weeks 0-12)|Adverse Event|1
5344527|NCT00095056|18387687|P1|Phase A (Weeks 0-12)|Adverse Event|1
5344528|NCT00094861|18387816|P2|Overall Study|Other|0
5344529|NCT00094861|18387817|P1|Overall Study|Other|3
5344530|NCT00094861|18387816|P2|Overall Study|Death|2
5344531|NCT00094861|18387817|P1|Overall Study|Death|4
5344532|NCT00094861|18387816|P2|Overall Study|Lost to Follow-up|1
5344533|NCT00094861|18387817|P1|Overall Study|Lost to Follow-up|0
5344534|NCT00094861|18387816|P2|Overall Study|Physician Decision|1
5344535|NCT00094861|18387817|P1|Overall Study|Physician Decision|1
5344536|NCT00094861|18387816|P2|Overall Study|Withdrawal by Subject|3
5344537|NCT00094861|18387817|P1|Overall Study|Withdrawal by Subject|5
5344538|NCT00094861|18387816|P2|Overall Study|Adverse Event|2
5344539|NCT00094861|18387817|P1|Overall Study|Adverse Event|5
5344540|NCT00094835|18387844|P7|Overall Study|Other|0
5344541|NCT00094835|18387845|P6|Overall Study|Other|0
5344542|NCT00094835|18387846|P5|Overall Study|Other|0
5344543|NCT00094835|18387847|P4|Overall Study|Other|1
5344544|NCT00094835|18387848|P3|Overall Study|Other|1
5344545|NCT00094835|18387849|P2|Overall Study|Other|1
5344546|NCT00094835|18387850|P1|Overall Study|Other|1
5344547|NCT00094835|18387844|P7|Overall Study|Non-compliance|1
5344548|NCT00094835|18387845|P6|Overall Study|Non-compliance|2
5344549|NCT00094835|18387846|P5|Overall Study|Non-compliance|2
5344550|NCT00094835|18387847|P4|Overall Study|Non-compliance|0
5344551|NCT00094835|18387848|P3|Overall Study|Non-compliance|2
5344552|NCT00094835|18387849|P2|Overall Study|Non-compliance|2
5344553|NCT00094835|18387850|P1|Overall Study|Non-compliance|1
5344554|NCT00094835|18387844|P7|Overall Study|Death|0
5344555|NCT00094835|18387845|P6|Overall Study|Death|0
5344556|NCT00094835|18387846|P5|Overall Study|Death|1
5344557|NCT00094835|18387847|P4|Overall Study|Death|0
5344558|NCT00094835|18387848|P3|Overall Study|Death|0
5344559|NCT00094835|18387849|P2|Overall Study|Death|0
5344560|NCT00094835|18387850|P1|Overall Study|Death|1
5344561|NCT00094835|18387844|P7|Overall Study|Lost to Follow-up|0
5344562|NCT00094835|18387845|P6|Overall Study|Lost to Follow-up|0
5344563|NCT00094835|18387846|P5|Overall Study|Lost to Follow-up|1
5344564|NCT00094835|18387847|P4|Overall Study|Lost to Follow-up|0
5344565|NCT00094835|18387848|P3|Overall Study|Lost to Follow-up|0
5344566|NCT00094835|18387849|P2|Overall Study|Lost to Follow-up|0
5344567|NCT00094835|18387850|P1|Overall Study|Lost to Follow-up|0
5344568|NCT00094835|18387844|P7|Overall Study|Withdrawal by Subject|1
5344569|NCT00094835|18387845|P6|Overall Study|Withdrawal by Subject|0
5344570|NCT00094835|18387846|P5|Overall Study|Withdrawal by Subject|0
5344571|NCT00094835|18387847|P4|Overall Study|Withdrawal by Subject|0
5344572|NCT00094835|18387848|P3|Overall Study|Withdrawal by Subject|0
5344573|NCT00094835|18387849|P2|Overall Study|Withdrawal by Subject|0
5344574|NCT00094835|18387850|P1|Overall Study|Withdrawal by Subject|0
5344575|NCT00094835|18387844|P7|Overall Study|Physician Decision|0
5344576|NCT00094835|18387845|P6|Overall Study|Physician Decision|1
5344577|NCT00094835|18387846|P5|Overall Study|Physician Decision|0
5344578|NCT00094835|18387847|P4|Overall Study|Physician Decision|0
5344579|NCT00094835|18387848|P3|Overall Study|Physician Decision|0
5344580|NCT00094835|18387849|P2|Overall Study|Physician Decision|0
5344581|NCT00094835|18387850|P1|Overall Study|Physician Decision|1
5344582|NCT00094809|18387928|P2|Overall Study|Other|1
5344583|NCT00094809|18387929|P1|Overall Study|Other|1
5344584|NCT00094809|18387928|P2|Overall Study|Study drug not received|8
5344585|NCT00094809|18387929|P1|Overall Study|Study drug not received|2
5344586|NCT00094809|18387928|P2|Overall Study|Informed consent signed after treatment|0
5344587|NCT00094809|18387929|P1|Overall Study|Informed consent signed after treatment|1
5344588|NCT00094809|18387928|P2|Overall Study|Other|4
5344589|NCT00094809|18387929|P1|Overall Study|Other|2
5344590|NCT00094809|18387928|P2|Overall Study|Protocol-specified criteria|1
5344591|NCT00094809|18387929|P1|Overall Study|Protocol-specified criteria|1
5344592|NCT00094809|18387928|P2|Overall Study|Death|25
5344593|NCT00094809|18387929|P1|Overall Study|Death|19
5344594|NCT00094809|18387928|P2|Overall Study|Lost to Follow-up|6
5344595|NCT00094809|18387929|P1|Overall Study|Lost to Follow-up|6
5344596|NCT00094809|18387928|P2|Overall Study|Physician Decision|5
5344597|NCT00094809|18387929|P1|Overall Study|Physician Decision|3
5344598|NCT00094809|18387928|P2|Overall Study|Disease progression|3
5344599|NCT00094809|18387929|P1|Overall Study|Disease progression|3
5344600|NCT00094809|18387928|P2|Overall Study|Withdrawal by Subject|9
5344601|NCT00094809|18387929|P1|Overall Study|Withdrawal by Subject|8
5344602|NCT00094809|18387928|P2|Overall Study|Adverse Event|1
5344603|NCT00094809|18387929|P1|Overall Study|Adverse Event|3
5344604|NCT00094809|18387928|P2|Overall Study|Noncompliance|0
5344605|NCT00094809|18387929|P1|Overall Study|Noncompliance|1
5344606|NCT00094809|18387928|P2|Overall Study|Protocol deviation|2
5344607|NCT00094809|18387929|P1|Overall Study|Protocol deviation|2
5344608|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Other|23
5344609|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Other|15
5344610|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
5344611|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
5344612|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
5344613|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
5344614|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
5344615|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
5344616|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
5344617|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
5344618|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
5344619|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
5344620|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
5344621|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
5344622|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
5344623|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
5344624|NCT00094770|18387955|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
5344625|NCT00094770|18387956|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
5344626|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Other|11
5344627|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Other|10
5344628|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
5344629|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
5344630|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
5344631|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
5344632|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
5344633|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
5344634|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
5344635|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
5344636|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
5344637|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
5344638|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
5344639|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
5344640|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
5344641|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
5344642|NCT00094770|18387955|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
5344643|NCT00094770|18387956|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
5344644|NCT00094757|18387987|P3|Overall Study|Protocol specified discontinuation|0
5344645|NCT00094757|18387988|P2|Overall Study|Protocol specified discontinuation|3
5344646|NCT00094757|18387989|P1|Overall Study|Protocol specified discontinuation|1
5344647|NCT00094757|18387987|P3|Overall Study|Other|1
5344648|NCT00094757|18387988|P2|Overall Study|Other|3
5344649|NCT00094757|18387989|P1|Overall Study|Other|3
5344650|NCT00094757|18387987|P3|Overall Study|Withdrawal by Subject|5
5344651|NCT00094757|18387988|P2|Overall Study|Withdrawal by Subject|21
5344652|NCT00094757|18387989|P1|Overall Study|Withdrawal by Subject|14
5344653|NCT00094757|18387987|P3|Overall Study|Protocol Violation|3
5344654|NCT00094757|18387988|P2|Overall Study|Protocol Violation|5
5344655|NCT00094757|18387989|P1|Overall Study|Protocol Violation|8
5344656|NCT00094757|18387987|P3|Overall Study|Patient Moved|1
5344657|NCT00094757|18387988|P2|Overall Study|Patient Moved|1
5344658|NCT00094757|18387989|P1|Overall Study|Patient Moved|2
5344659|NCT00094757|18387987|P3|Overall Study|Lost to Follow-up|6
5344660|NCT00094757|18387988|P2|Overall Study|Lost to Follow-up|5
5344661|NCT00094757|18387989|P1|Overall Study|Lost to Follow-up|3
5344662|NCT00094757|18387987|P3|Overall Study|Lack of Efficacy|8
5344663|NCT00094757|18387988|P2|Overall Study|Lack of Efficacy|15
5344664|NCT00094757|18387989|P1|Overall Study|Lack of Efficacy|11
5344665|NCT00094757|18387987|P3|Overall Study|Adverse Event|6
5344666|NCT00094757|18387988|P2|Overall Study|Adverse Event|9
5344667|NCT00094757|18387989|P1|Overall Study|Adverse Event|11
5344668|NCT00094653|18388009|P3|Overall Study|Protocol Violation|1
5344669|NCT00094653|18388010|P2|Overall Study|Protocol Violation|0
5344670|NCT00094653|18388011|P1|Overall Study|Protocol Violation|0
5344671|NCT00094653|18388009|P3|Overall Study|Lost to Follow-up|1
5344672|NCT00094653|18388010|P2|Overall Study|Lost to Follow-up|2
5344673|NCT00094653|18388011|P1|Overall Study|Lost to Follow-up|3
5344674|NCT00094653|18388009|P3|Overall Study|Other|2
5344675|NCT00094653|18388010|P2|Overall Study|Other|2
5344676|NCT00094653|18388011|P1|Overall Study|Other|2
5344677|NCT00094653|18388009|P3|Overall Study|Subject Withdrew Consent|3
5344678|NCT00094653|18388010|P2|Overall Study|Subject Withdrew Consent|2
5344679|NCT00094653|18388011|P1|Overall Study|Subject Withdrew Consent|10
5344680|NCT00094653|18388009|P3|Overall Study|Death|119
5344681|NCT00094653|18388010|P2|Overall Study|Death|100
5344682|NCT00094653|18388011|P1|Overall Study|Death|306
5344683|NCT00094575|18388074|P2|Overall Study|Death|146
5344684|NCT00094575|18388075|P1|Overall Study|Death|146
5344685|NCT00094536|18388095|P1|Treatment and Follow-up|Unable to attend visits|1
5344686|NCT00094536|18388095|P1|Treatment and Follow-up|Subject non-compliance|9
5344687|NCT00094536|18388095|P1|Treatment and Follow-up|Withdrawal by Subject|1
5344688|NCT00094536|18388095|P1|Treatment and Follow-up|Lost to Follow-up|7
5344689|NCT00094536|18388095|P1|Treatment and Follow-up|Lack of Efficacy|9
5344690|NCT00094536|18388095|P1|Treatment and Follow-up|Adverse Event|4
5344691|NCT00094536|18388095|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
5344692|NCT00094458|18388119|P6|OLE: Open-Label Extension|Patient decision|0
5344693|NCT00094458|18388120|P5|OLE: Open-Label Extension|Patient decision|1
5344694|NCT00094458|18388121|P4|OLE: Open-Label Extension|Patient decision|0
5344695|NCT00094458|18388122|P3|OLE: Open-Label Extension|Patient decision|0
5344696|NCT00094458|18388123|P2|OLE: Open-Label Extension|Patient decision|0
5344697|NCT00094458|18388124|P1|OLE: Open-Label Extension|Patient decision|0
5344698|NCT00094458|18388119|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5344699|NCT00094458|18388120|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
5344700|NCT00094458|18388121|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
5344701|NCT00094458|18388122|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5344702|NCT00094458|18388123|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5344703|NCT00094458|18388124|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5344704|NCT00094458|18388119|P6|OLE: Open-Label Extension|Adverse Event|4
5344705|NCT00094458|18388120|P5|OLE: Open-Label Extension|Adverse Event|3
5344706|NCT00094458|18388121|P4|OLE: Open-Label Extension|Adverse Event|0
5344707|NCT00094458|18388122|P3|OLE: Open-Label Extension|Adverse Event|0
5344708|NCT00094458|18388123|P2|OLE: Open-Label Extension|Adverse Event|0
5344709|NCT00094458|18388124|P1|OLE: Open-Label Extension|Adverse Event|0
5344710|NCT00094458|18388119|P6|Study Extension: Week 30 Through Week 50|Other|0
5344711|NCT00094458|18388120|P5|Study Extension: Week 30 Through Week 50|Other|0
5344712|NCT00094458|18388121|P4|Study Extension: Week 30 Through Week 50|Other|0
5344713|NCT00094458|18388122|P3|Study Extension: Week 30 Through Week 50|Other|3
5344714|NCT00094458|18388123|P2|Study Extension: Week 30 Through Week 50|Other|2
5344715|NCT00094458|18388124|P1|Study Extension: Week 30 Through Week 50|Other|1
5344716|NCT00094458|18388119|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
5344717|NCT00094458|18388120|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
5344718|NCT00094458|18388121|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
5344719|NCT00094458|18388122|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
5344720|NCT00094458|18388123|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
5344721|NCT00094458|18388124|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
5344722|NCT00094458|18388119|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5344723|NCT00094458|18388120|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5344724|NCT00094458|18388121|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5344725|NCT00094458|18388122|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
5344726|NCT00094458|18388123|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5344727|NCT00094458|18388124|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
5344728|NCT00094458|18388119|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
5344729|NCT00094458|18388120|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
5344730|NCT00094458|18388121|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
5344731|NCT00094458|18388122|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
5344732|NCT00094458|18388123|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
5344733|NCT00094458|18388124|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
5344734|NCT00094458|18388119|P6|Main Study: Through Week 30|Other|0
5344735|NCT00094458|18388120|P5|Main Study: Through Week 30|Other|0
5344736|NCT00094458|18388121|P4|Main Study: Through Week 30|Other|0
5344737|NCT00094458|18388122|P3|Main Study: Through Week 30|Other|9
5344738|NCT00094458|18388123|P2|Main Study: Through Week 30|Other|16
5344739|NCT00094458|18388124|P1|Main Study: Through Week 30|Other|19
5344740|NCT00094458|18388119|P6|Main Study: Through Week 30|Death|0
5344741|NCT00094458|18388120|P5|Main Study: Through Week 30|Death|0
5344742|NCT00094458|18388121|P4|Main Study: Through Week 30|Death|0
5344743|NCT00094458|18388122|P3|Main Study: Through Week 30|Death|0
5344744|NCT00094458|18388123|P2|Main Study: Through Week 30|Death|0
5344745|NCT00094458|18388124|P1|Main Study: Through Week 30|Death|1
5344746|NCT00094458|18388119|P6|Main Study: Through Week 30|Adverse Event|0
5344747|NCT00094458|18388120|P5|Main Study: Through Week 30|Adverse Event|0
5344748|NCT00094458|18388121|P4|Main Study: Through Week 30|Adverse Event|0
5344749|NCT00094458|18388122|P3|Main Study: Through Week 30|Adverse Event|28
5344750|NCT00094458|18388123|P2|Main Study: Through Week 30|Adverse Event|20
5344751|NCT00094458|18388124|P1|Main Study: Through Week 30|Adverse Event|38
5344752|NCT00094458|18388119|P6|Main Study: Through Week 30|Withdrawal by Subject|0
5344753|NCT00094458|18388120|P5|Main Study: Through Week 30|Withdrawal by Subject|0
5344754|NCT00094458|18388121|P4|Main Study: Through Week 30|Withdrawal by Subject|0
5344755|NCT00094458|18388122|P3|Main Study: Through Week 30|Withdrawal by Subject|7
5344756|NCT00094458|18388123|P2|Main Study: Through Week 30|Withdrawal by Subject|9
5344757|NCT00094458|18388124|P1|Main Study: Through Week 30|Withdrawal by Subject|18
5344758|NCT00094458|18388119|P6|Main Study: Through Week 30|Lost to Follow-up|0
5344759|NCT00094458|18388120|P5|Main Study: Through Week 30|Lost to Follow-up|0
5344760|NCT00094458|18388121|P4|Main Study: Through Week 30|Lost to Follow-up|0
5344761|NCT00094458|18388122|P3|Main Study: Through Week 30|Lost to Follow-up|2
5344762|NCT00094458|18388123|P2|Main Study: Through Week 30|Lost to Follow-up|5
5344763|NCT00094458|18388124|P1|Main Study: Through Week 30|Lost to Follow-up|5
5344764|NCT00094458|18388119|P6|Main Study: Through Week 30|Eligibility criteria not met|0
5344765|NCT00094458|18388120|P5|Main Study: Through Week 30|Eligibility criteria not met|0
5344766|NCT00094458|18388121|P4|Main Study: Through Week 30|Eligibility criteria not met|0
5344767|NCT00094458|18388122|P3|Main Study: Through Week 30|Eligibility criteria not met|2
5344768|NCT00094458|18388123|P2|Main Study: Through Week 30|Eligibility criteria not met|8
5344769|NCT00094458|18388124|P1|Main Study: Through Week 30|Eligibility criteria not met|3
5344770|NCT00094445|18388162|P1|Overall Study|Progressive Disease|2
5344771|NCT00094445|18388162|P1|Overall Study|Lost to Follow-up|1
5344772|NCT00094445|18388162|P1|Overall Study|Withdrawal by Subject|3
5344773|NCT00094328|18388166|P1|Overall Study|Lost to Follow-up|1
5344774|NCT00094302|18388180|P2|Overall Study|Death|246
5344775|NCT00094302|18388181|P1|Overall Study|Death|266
5344776|NCT00094302|18388180|P2|Overall Study|Withdrawal by Subject|111
5344777|NCT00094302|18388181|P1|Overall Study|Withdrawal by Subject|103
5344778|NCT00094302|18388180|P2|Overall Study|Physician Decision|8
5344779|NCT00094302|18388181|P1|Overall Study|Physician Decision|5
5344780|NCT00094302|18388180|P2|Overall Study|Lost to Follow-up|41
5344781|NCT00094302|18388181|P1|Overall Study|Lost to Follow-up|43
5344782|NCT00094172|18388270|P2|Overall Study|Started other MS therapy due to disease|0
5344783|NCT00094172|18388271|P1|Overall Study|Started other MS therapy due to disease|1
5344784|NCT00094172|18388270|P2|Overall Study|Primary endpoint met.|0
5344785|NCT00094172|18388271|P1|Overall Study|Primary endpoint met.|1
5344786|NCT00094172|18388270|P2|Overall Study|Withdrawal by Subject|5
5344787|NCT00094172|18388271|P1|Overall Study|Withdrawal by Subject|10
5344788|NCT00094172|18388270|P2|Overall Study|Protocol Violation|1
5344789|NCT00094172|18388271|P1|Overall Study|Protocol Violation|0
5344790|NCT00094172|18388270|P2|Overall Study|Lost to Follow-up|0
5344791|NCT00094172|18388271|P1|Overall Study|Lost to Follow-up|2
5344792|NCT00094172|18388270|P2|Overall Study|Adverse Event|1
5344793|NCT00094172|18388271|P1|Overall Study|Adverse Event|0
5344794|NCT00094107|18388281|P1|Overall Study|Withdrawal due to Disease Progression|1
5344795|NCT00094107|18388281|P1|Overall Study|Adverse Event|3
5344796|NCT00094107|18388281|P1|Overall Study|Death|5
5344797|NCT00094107|18388281|P1|Overall Study|Lack of Efficacy|23
5344798|NCT00094094|18388290|P1|Overall Study|Adverse Event|7
5344799|NCT00094094|18388290|P1|Overall Study|Lack of Efficacy|23
5344800|NCT00094094|18388290|P1|Overall Study|Death|2
5344801|NCT00094055|18388299|P1|Overall Study|Withdrawal by Subject|9
5344802|NCT00094055|18388299|P1|Overall Study|roll-over to another study|14
5344803|NCT00094055|18388299|P1|Overall Study|clinical progression|1
5344804|NCT00094055|18388299|P1|Overall Study|progressive disease|2
5344805|NCT00094055|18388299|P1|Overall Study|Lost to Follow-up|2
5344806|NCT00094055|18388299|P1|Overall Study|Lack of Efficacy|17
5344807|NCT00094055|18388299|P1|Overall Study|Death|4
5344808|NCT00094055|18388299|P1|Overall Study|Adverse Event|11
5344809|NCT00093808|18388356|P1|Overall Study|Protocol Violation|1
5344810|NCT00093808|18388356|P1|Overall Study|Cancel participation before receiving tx|1
5344811|NCT00093795|18388366|P3|Overall Study|No follow up data|17
5344812|NCT00093795|18388367|P2|Overall Study|No follow up data|16
5344813|NCT00093795|18388368|P1|Overall Study|No follow up data|20
5344814|NCT00093496|18388413|P2|Overall Study|Protocol Violation|3
5344815|NCT00093496|18388414|P1|Overall Study|Protocol Violation|1
5344816|NCT00093470|18388427|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
5344817|NCT00093470|18388428|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
5344818|NCT00093470|18388427|P2|Overall Study|Never started treatment|0
5344819|NCT00093470|18388428|P1|Overall Study|Never started treatment|1
5344820|NCT00093470|18388427|P2|Overall Study|Physician Decision|0
5344821|NCT00093470|18388428|P1|Overall Study|Physician Decision|2
5344822|NCT00093470|18388427|P2|Overall Study|Other complicating disease|0
5344823|NCT00093470|18388428|P1|Overall Study|Other complicating disease|3
5344824|NCT00093470|18388427|P2|Overall Study|Alternative therapy|0
5344825|NCT00093470|18388428|P1|Overall Study|Alternative therapy|2
5344826|NCT00093470|18388427|P2|Overall Study|Withdrawal by Subject|0
5344827|NCT00093470|18388428|P1|Overall Study|Withdrawal by Subject|8
5344828|NCT00093470|18388427|P2|Overall Study|Death|0
5344829|NCT00093470|18388428|P1|Overall Study|Death|2
5344830|NCT00093470|18388427|P2|Overall Study|Adverse Event|0
5344831|NCT00093470|18388428|P1|Overall Study|Adverse Event|15
5344832|NCT00093470|18388427|P2|Overall Study|Disease progression|0
5344833|NCT00093470|18388428|P1|Overall Study|Disease progression|39
5344834|NCT00093145|18388442|P1|Overall Study|Other|1
5344835|NCT00093145|18388442|P1|Overall Study|Withdrawal by Subject|9
5344836|NCT00093145|18388442|P1|Overall Study|Physician Decision|5
5344837|NCT00093145|18388442|P1|Overall Study|Unacceptable Toxicity Only|2
5344838|NCT00093015|18388484|P2|Overall Study|Death|385
5344839|NCT00093015|18388485|P1|Overall Study|Death|375
5344840|NCT00093015|18388484|P2|Overall Study|Lost to Follow-up|108
5344841|NCT00093015|18388485|P1|Overall Study|Lost to Follow-up|96
5344842|NCT00093015|18388484|P2|Overall Study|Withdrawal by Subject|171
5344843|NCT00093015|18388485|P1|Overall Study|Withdrawal by Subject|194
5344844|NCT00092677|18388513|P2|Overall Study|Adminstrative|9
5344845|NCT00092677|18388514|P1|Overall Study|Adminstrative|5
5344846|NCT00092677|18388513|P2|Overall Study|Lost to Follow-up|2
5344847|NCT00092677|18388514|P1|Overall Study|Lost to Follow-up|0
5344848|NCT00092547|18388558|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
5344849|NCT00092547|18388559|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
5344850|NCT00092547|18388560|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
5344851|NCT00092547|18388558|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
5344852|NCT00092547|18388559|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
5344853|NCT00092547|18388560|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
5344854|NCT00092547|18388558|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
5344855|NCT00092547|18388559|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
5344856|NCT00092547|18388560|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
5344857|NCT00092547|18388558|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
5344858|NCT00092547|18388559|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
5344859|NCT00092547|18388560|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
5344860|NCT00092547|18388558|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
5344861|NCT00092547|18388559|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
5344862|NCT00092547|18388560|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
5344863|NCT00092547|18388558|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
5344864|NCT00092547|18388559|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
5344865|NCT00092547|18388560|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
5344866|NCT00092547|18388558|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
5344867|NCT00092547|18388559|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
5344868|NCT00092547|18388560|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
5344869|NCT00092547|18388558|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
5344870|NCT00092547|18388559|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
5344871|NCT00092547|18388560|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
5344872|NCT00092547|18388558|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
5344873|NCT00092547|18388559|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
5344874|NCT00092547|18388560|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
5344875|NCT00092547|18388558|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
5344876|NCT00092547|18388559|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
5344877|NCT00092547|18388560|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
5344878|NCT00092547|18388558|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
5344879|NCT00092547|18388559|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
5344880|NCT00092547|18388560|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
5344881|NCT00092547|18388558|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
5344882|NCT00092547|18388559|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
5344883|NCT00092547|18388560|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
5344884|NCT00092547|18388558|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
5344885|NCT00092547|18388559|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
5344886|NCT00092547|18388560|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
5344887|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
5344888|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
5344889|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
5344890|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
5344891|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
5344892|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
5344893|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
5344894|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
5344895|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
5344896|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
5344897|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
5344898|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
5344899|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
5344900|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
5344901|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
5344902|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
5344903|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
5344904|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
5344905|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
5344906|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
5344907|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
5344908|NCT00092547|18388558|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
5344909|NCT00092547|18388559|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
5344910|NCT00092547|18388560|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
5344911|NCT00092534|18388604|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5344912|NCT00092534|18388605|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
5344913|NCT00092534|18388606|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5344914|NCT00092534|18388607|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5344915|NCT00092534|18388608|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5344916|NCT00092534|18388604|P5|Base Study EXT|Protocol Violation|0
5344917|NCT00092534|18388605|P4|Base Study EXT|Protocol Violation|0
5344918|NCT00092534|18388606|P3|Base Study EXT|Protocol Violation|15
5344919|NCT00092534|18388607|P2|Base Study EXT|Protocol Violation|0
5344920|NCT00092534|18388608|P1|Base Study EXT|Protocol Violation|0
5344921|NCT00092534|18388604|P5|Base Study EXT|Study ended|0
5344922|NCT00092534|18388605|P4|Base Study EXT|Study ended|0
5344923|NCT00092534|18388606|P3|Base Study EXT|Study ended|29
5344924|NCT00092534|18388607|P2|Base Study EXT|Study ended|0
5344925|NCT00092534|18388608|P1|Base Study EXT|Study ended|0
5344926|NCT00092534|18388604|P5|Base Study EXT|Site closed|0
5344927|NCT00092534|18388605|P4|Base Study EXT|Site closed|0
5344928|NCT00092534|18388606|P3|Base Study EXT|Site closed|21
5344929|NCT00092534|18388607|P2|Base Study EXT|Site closed|0
5344930|NCT00092534|18388608|P1|Base Study EXT|Site closed|0
5344931|NCT00092534|18388604|P5|Base Study EXT|Travel|0
5344932|NCT00092534|18388605|P4|Base Study EXT|Travel|0
5344933|NCT00092534|18388606|P3|Base Study EXT|Travel|2
5344934|NCT00092534|18388607|P2|Base Study EXT|Travel|0
5344935|NCT00092534|18388608|P1|Base Study EXT|Travel|0
5344936|NCT00092534|18388604|P5|Base Study EXT|Participant moved|0
5344937|NCT00092534|18388605|P4|Base Study EXT|Participant moved|0
5344938|NCT00092534|18388606|P3|Base Study EXT|Participant moved|6
5344939|NCT00092534|18388607|P2|Base Study EXT|Participant moved|0
5344940|NCT00092534|18388608|P1|Base Study EXT|Participant moved|0
5344941|NCT00092534|18388604|P5|Base Study EXT|Withdrawal by Subject|0
5344942|NCT00092534|18388605|P4|Base Study EXT|Withdrawal by Subject|0
5344943|NCT00092534|18388606|P3|Base Study EXT|Withdrawal by Subject|18
5344944|NCT00092534|18388607|P2|Base Study EXT|Withdrawal by Subject|0
5344945|NCT00092534|18388608|P1|Base Study EXT|Withdrawal by Subject|0
5344946|NCT00092534|18388604|P5|Base Study EXT|Pregnancy|0
5344947|NCT00092534|18388605|P4|Base Study EXT|Pregnancy|0
5344948|NCT00092534|18388606|P3|Base Study EXT|Pregnancy|12
5344949|NCT00092534|18388607|P2|Base Study EXT|Pregnancy|0
5344950|NCT00092534|18388608|P1|Base Study EXT|Pregnancy|0
5344951|NCT00092534|18388604|P5|Base Study EXT|Physician Decision|0
5344952|NCT00092534|18388605|P4|Base Study EXT|Physician Decision|0
5344953|NCT00092534|18388606|P3|Base Study EXT|Physician Decision|1
5344954|NCT00092534|18388607|P2|Base Study EXT|Physician Decision|0
5344955|NCT00092534|18388608|P1|Base Study EXT|Physician Decision|0
5344956|NCT00092534|18388604|P5|Base Study EXT|Lost to Follow-up|0
5344957|NCT00092534|18388605|P4|Base Study EXT|Lost to Follow-up|0
5344958|NCT00092534|18388606|P3|Base Study EXT|Lost to Follow-up|41
5344959|NCT00092534|18388607|P2|Base Study EXT|Lost to Follow-up|0
5344960|NCT00092534|18388608|P1|Base Study EXT|Lost to Follow-up|0
5344961|NCT00092534|18388604|P5|Base Study Follow-Up Period|Subjects in extension|0
5344962|NCT00092534|18388605|P4|Base Study Follow-Up Period|Subjects in extension|0
5344963|NCT00092534|18388606|P3|Base Study Follow-Up Period|Subjects in extension|0
5344964|NCT00092534|18388607|P2|Base Study Follow-Up Period|Subjects in extension|371
5344965|NCT00092534|18388608|P1|Base Study Follow-Up Period|Subjects in extension|15
5344966|NCT00092534|18388604|P5|Base Study Follow-Up Period|Subjects continuing|0
5344967|NCT00092534|18388605|P4|Base Study Follow-Up Period|Subjects continuing|0
5344968|NCT00092534|18388606|P3|Base Study Follow-Up Period|Subjects continuing|0
5344969|NCT00092534|18388607|P2|Base Study Follow-Up Period|Subjects continuing|31
5344970|NCT00092534|18388608|P1|Base Study Follow-Up Period|Subjects continuing|27
5344971|NCT00092534|18388604|P5|Base Study Follow-Up Period|Site Closed|0
5344972|NCT00092534|18388605|P4|Base Study Follow-Up Period|Site Closed|0
5344973|NCT00092534|18388606|P3|Base Study Follow-Up Period|Site Closed|0
5344974|NCT00092534|18388607|P2|Base Study Follow-Up Period|Site Closed|2
5344975|NCT00092534|18388608|P1|Base Study Follow-Up Period|Site Closed|0
5344976|NCT00092534|18388604|P5|Base Study Follow-Up Period|Travel|0
5344977|NCT00092534|18388605|P4|Base Study Follow-Up Period|Travel|0
5344978|NCT00092534|18388606|P3|Base Study Follow-Up Period|Travel|0
5344979|NCT00092534|18388607|P2|Base Study Follow-Up Period|Travel|7
5344980|NCT00092534|18388608|P1|Base Study Follow-Up Period|Travel|10
5344981|NCT00092534|18388604|P5|Base Study Follow-Up Period|Moved|0
5344982|NCT00092534|18388605|P4|Base Study Follow-Up Period|Moved|0
5344983|NCT00092534|18388606|P3|Base Study Follow-Up Period|Moved|0
5344984|NCT00092534|18388607|P2|Base Study Follow-Up Period|Moved|58
5344985|NCT00092534|18388608|P1|Base Study Follow-Up Period|Moved|62
5344986|NCT00092534|18388604|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
5344987|NCT00092534|18388605|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
5344988|NCT00092534|18388606|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
5344989|NCT00092534|18388607|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
5344990|NCT00092534|18388608|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
5344991|NCT00092534|18388604|P5|Base Study Follow-Up Period|Protocol Violation|0
5344992|NCT00092534|18388605|P4|Base Study Follow-Up Period|Protocol Violation|0
5344993|NCT00092534|18388606|P3|Base Study Follow-Up Period|Protocol Violation|0
5344994|NCT00092534|18388607|P2|Base Study Follow-Up Period|Protocol Violation|2
5344995|NCT00092534|18388608|P1|Base Study Follow-Up Period|Protocol Violation|1
5344996|NCT00092534|18388604|P5|Base Study Follow-Up Period|Pregnancy|0
5344997|NCT00092534|18388605|P4|Base Study Follow-Up Period|Pregnancy|0
5344998|NCT00092534|18388606|P3|Base Study Follow-Up Period|Pregnancy|0
5344999|NCT00092534|18388607|P2|Base Study Follow-Up Period|Pregnancy|10
5345000|NCT00092534|18388608|P1|Base Study Follow-Up Period|Pregnancy|6
5345001|NCT00092534|18388604|P5|Base Study Follow-Up Period|Lost to Follow-up|0
5345002|NCT00092534|18388605|P4|Base Study Follow-Up Period|Lost to Follow-up|0
5345003|NCT00092534|18388606|P3|Base Study Follow-Up Period|Lost to Follow-up|0
5345004|NCT00092534|18388607|P2|Base Study Follow-Up Period|Lost to Follow-up|146
5345005|NCT00092534|18388608|P1|Base Study Follow-Up Period|Lost to Follow-up|120
5345006|NCT00092534|18388604|P5|Base Study Follow-Up Period|Death|0
5345007|NCT00092534|18388605|P4|Base Study Follow-Up Period|Death|0
5345008|NCT00092534|18388606|P3|Base Study Follow-Up Period|Death|0
5345009|NCT00092534|18388607|P2|Base Study Follow-Up Period|Death|1
5345010|NCT00092534|18388608|P1|Base Study Follow-Up Period|Death|2
5345011|NCT00092534|18388604|P5|Base Study Follow-Up Period|Adverse Event|0
5345012|NCT00092534|18388605|P4|Base Study Follow-Up Period|Adverse Event|0
5345013|NCT00092534|18388606|P3|Base Study Follow-Up Period|Adverse Event|0
5345014|NCT00092534|18388607|P2|Base Study Follow-Up Period|Adverse Event|4
5345015|NCT00092534|18388608|P1|Base Study Follow-Up Period|Adverse Event|2
5345016|NCT00092534|18388604|P5|Base Study Vaccination Period|Site Closed|0
5345017|NCT00092534|18388605|P4|Base Study Vaccination Period|Site Closed|0
5345018|NCT00092534|18388606|P3|Base Study Vaccination Period|Site Closed|0
5345019|NCT00092534|18388607|P2|Base Study Vaccination Period|Site Closed|1
5345020|NCT00092534|18388608|P1|Base Study Vaccination Period|Site Closed|0
5345021|NCT00092534|18388604|P5|Base Study Vaccination Period|Travel|0
5345022|NCT00092534|18388605|P4|Base Study Vaccination Period|Travel|0
5345023|NCT00092534|18388606|P3|Base Study Vaccination Period|Travel|0
5345024|NCT00092534|18388607|P2|Base Study Vaccination Period|Travel|0
5345025|NCT00092534|18388608|P1|Base Study Vaccination Period|Travel|1
5345026|NCT00092534|18388604|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
5345027|NCT00092534|18388605|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
5345028|NCT00092534|18388606|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
5345029|NCT00092534|18388607|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
5345030|NCT00092534|18388608|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
5345031|NCT00092534|18388604|P5|Base Study Vaccination Period|Moved|0
5345032|NCT00092534|18388605|P4|Base Study Vaccination Period|Moved|0
5345033|NCT00092534|18388606|P3|Base Study Vaccination Period|Moved|0
5345034|NCT00092534|18388607|P2|Base Study Vaccination Period|Moved|12
5345035|NCT00092534|18388608|P1|Base Study Vaccination Period|Moved|14
5345036|NCT00092534|18388604|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5345037|NCT00092534|18388605|P4|Base Study Vaccination Period|Withdrawal by Subject|0
5345038|NCT00092534|18388606|P3|Base Study Vaccination Period|Withdrawal by Subject|0
5345039|NCT00092534|18388607|P2|Base Study Vaccination Period|Withdrawal by Subject|58
5345040|NCT00092534|18388608|P1|Base Study Vaccination Period|Withdrawal by Subject|85
5345041|NCT00092534|18388604|P5|Base Study Vaccination Period|Protocol Violation|0
5345042|NCT00092534|18388605|P4|Base Study Vaccination Period|Protocol Violation|0
5345043|NCT00092534|18388606|P3|Base Study Vaccination Period|Protocol Violation|0
5345044|NCT00092534|18388607|P2|Base Study Vaccination Period|Protocol Violation|1
5345045|NCT00092534|18388608|P1|Base Study Vaccination Period|Protocol Violation|2
5345046|NCT00092534|18388604|P5|Base Study Vaccination Period|Pregnancy|0
5345047|NCT00092534|18388605|P4|Base Study Vaccination Period|Pregnancy|0
5345048|NCT00092534|18388606|P3|Base Study Vaccination Period|Pregnancy|0
5345049|NCT00092534|18388607|P2|Base Study Vaccination Period|Pregnancy|7
5345050|NCT00092534|18388608|P1|Base Study Vaccination Period|Pregnancy|9
5345051|NCT00092534|18388604|P5|Base Study Vaccination Period|Physician Decision|0
5345052|NCT00092534|18388605|P4|Base Study Vaccination Period|Physician Decision|0
5345053|NCT00092534|18388606|P3|Base Study Vaccination Period|Physician Decision|0
5345054|NCT00092534|18388607|P2|Base Study Vaccination Period|Physician Decision|0
5345055|NCT00092534|18388608|P1|Base Study Vaccination Period|Physician Decision|1
5345056|NCT00092534|18388604|P5|Base Study Vaccination Period|Lost to Follow-up|0
5345057|NCT00092534|18388605|P4|Base Study Vaccination Period|Lost to Follow-up|0
5345058|NCT00092534|18388606|P3|Base Study Vaccination Period|Lost to Follow-up|0
5345059|NCT00092534|18388607|P2|Base Study Vaccination Period|Lost to Follow-up|37
5345060|NCT00092534|18388608|P1|Base Study Vaccination Period|Lost to Follow-up|41
5345061|NCT00092534|18388604|P5|Base Study Vaccination Period|Death|0
5345062|NCT00092534|18388605|P4|Base Study Vaccination Period|Death|0
5345063|NCT00092534|18388606|P3|Base Study Vaccination Period|Death|0
5345064|NCT00092534|18388607|P2|Base Study Vaccination Period|Death|4
5345065|NCT00092534|18388608|P1|Base Study Vaccination Period|Death|5
5345066|NCT00092534|18388604|P5|Base Study Vaccination Period|Adverse Event|0
5345067|NCT00092534|18388605|P4|Base Study Vaccination Period|Adverse Event|0
5345068|NCT00092534|18388606|P3|Base Study Vaccination Period|Adverse Event|0
5345069|NCT00092534|18388607|P2|Base Study Vaccination Period|Adverse Event|1
5345070|NCT00092534|18388608|P1|Base Study Vaccination Period|Adverse Event|3
5345071|NCT00092534|18388604|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
5345072|NCT00092534|18388605|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
5345073|NCT00092534|18388606|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
5345074|NCT00092534|18388607|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
5345075|NCT00092534|18388608|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
5345076|NCT00092521|18388639|P4|Extension Study (Group 4)|Unable/unwilling to return|25
5345077|NCT00092521|18388640|P3|Extension Study (Group 4)|Unable/unwilling to return|0
5345078|NCT00092521|18388641|P2|Extension Study (Group 4)|Unable/unwilling to return|0
5345079|NCT00092521|18388642|P1|Extension Study (Group 4)|Unable/unwilling to return|0
5345080|NCT00092521|18388639|P4|Extension Study (Group 4)|Site Terminated|4
5345081|NCT00092521|18388640|P3|Extension Study (Group 4)|Site Terminated|0
5345082|NCT00092521|18388641|P2|Extension Study (Group 4)|Site Terminated|0
5345083|NCT00092521|18388642|P1|Extension Study (Group 4)|Site Terminated|0
5345084|NCT00092521|18388639|P4|Extension Study (Group 4)|Moved|16
5345085|NCT00092521|18388640|P3|Extension Study (Group 4)|Moved|0
5345086|NCT00092521|18388641|P2|Extension Study (Group 4)|Moved|0
5345087|NCT00092521|18388642|P1|Extension Study (Group 4)|Moved|0
5345088|NCT00092521|18388639|P4|Extension Study (Group 4)|Withdrawal by Subject|46
5345089|NCT00092521|18388640|P3|Extension Study (Group 4)|Withdrawal by Subject|0
5345090|NCT00092521|18388641|P2|Extension Study (Group 4)|Withdrawal by Subject|0
5345091|NCT00092521|18388642|P1|Extension Study (Group 4)|Withdrawal by Subject|0
5345092|NCT00092521|18388639|P4|Extension Study (Group 4)|Protocol Violation|2
5345093|NCT00092521|18388640|P3|Extension Study (Group 4)|Protocol Violation|0
5345094|NCT00092521|18388641|P2|Extension Study (Group 4)|Protocol Violation|0
5345095|NCT00092521|18388642|P1|Extension Study (Group 4)|Protocol Violation|0
5345096|NCT00092521|18388639|P4|Extension Study (Group 4)|Pregnancy|4
5345097|NCT00092521|18388640|P3|Extension Study (Group 4)|Pregnancy|0
5345098|NCT00092521|18388641|P2|Extension Study (Group 4)|Pregnancy|0
5345099|NCT00092521|18388642|P1|Extension Study (Group 4)|Pregnancy|0
5345100|NCT00092521|18388639|P4|Extension Study (Group 4)|Lost to Follow-up|87
5345101|NCT00092521|18388640|P3|Extension Study (Group 4)|Lost to Follow-up|0
5345102|NCT00092521|18388641|P2|Extension Study (Group 4)|Lost to Follow-up|0
5345103|NCT00092521|18388642|P1|Extension Study (Group 4)|Lost to Follow-up|0
5345104|NCT00092521|18388639|P4|Extension Study (Group 4)|Adverse Event|2
5345105|NCT00092521|18388640|P3|Extension Study (Group 4)|Adverse Event|0
5345106|NCT00092521|18388641|P2|Extension Study (Group 4)|Adverse Event|0
5345107|NCT00092521|18388642|P1|Extension Study (Group 4)|Adverse Event|0
5345108|NCT00092521|18388639|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
5345109|NCT00092521|18388640|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
5345110|NCT00092521|18388641|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
5345111|NCT00092521|18388642|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
5345112|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Visits Compressed|0
5345113|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Visits Compressed|5
5345114|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Visits Compressed|0
5345115|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Visits Compressed|5
5345116|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Travel|0
5345117|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Travel|0
5345118|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Travel|0
5345119|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Travel|2
5345120|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Site Terminated|0
5345121|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Site Terminated|3
5345122|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Site Terminated|0
5345123|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Site Terminated|3
5345124|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Moved|0
5345125|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Moved|28
5345126|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Moved|2
5345127|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Moved|32
5345128|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
5345129|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
5345130|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
5345131|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
5345132|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Protocol Violation|0
5345133|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Protocol Violation|5
5345134|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Protocol Violation|1
5345135|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Protocol Violation|1
5345136|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
5345137|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
5345138|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
5345139|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
5345140|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Death|0
5345141|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Death|1
5345142|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Death|0
5345143|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Death|2
5345144|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Adverse Event|0
5345145|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Adverse Event|0
5345146|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Adverse Event|0
5345147|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Adverse Event|1
5345148|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Subjects in Extension|0
5345149|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Subjects in Extension|412
5345150|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Subjects in Extension|109
5345151|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Subjects in Extension|13
5345152|NCT00092521|18388639|P4|Follow-Up (After Month 7)|Subjects Continuing|0
5345153|NCT00092521|18388640|P3|Follow-Up (After Month 7)|Subjects Continuing|35
5345154|NCT00092521|18388641|P2|Follow-Up (After Month 7)|Subjects Continuing|4
5345155|NCT00092521|18388642|P1|Follow-Up (After Month 7)|Subjects Continuing|34
5345156|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
5345157|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
5345158|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
5345159|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
5345160|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
5345161|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
5345162|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
5345163|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
5345164|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Moved|0
5345165|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Moved|18
5345166|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Moved|1
5345167|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Moved|14
5345168|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
5345169|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
5345170|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
5345171|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
5345172|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
5345173|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
5345174|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
5345175|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
5345176|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
5345177|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
5345178|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
5345179|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
5345180|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Death|0
5345181|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Death|1
5345182|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Death|0
5345183|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Death|0
5345184|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
5345185|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
5345186|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
5345187|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
5345188|NCT00092521|18388639|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
5345189|NCT00092521|18388640|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
5345190|NCT00092521|18388641|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
5345191|NCT00092521|18388642|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
5345192|NCT00092495|18388656|P5|Base Study Follow-up Period|Withdrawal by Subject|0
5345193|NCT00092495|18388657|P4|Base Study Follow-up Period|Withdrawal by Subject|0
5345194|NCT00092495|18388658|P3|Base Study Follow-up Period|Withdrawal by Subject|0
5345195|NCT00092495|18388659|P2|Base Study Follow-up Period|Withdrawal by Subject|0
5345196|NCT00092495|18388660|P1|Base Study Follow-up Period|Withdrawal by Subject|2
5345197|NCT00092495|18388656|P5|Base Study Follow-up Period|Lost to Follow-up|0
5345198|NCT00092495|18388657|P4|Base Study Follow-up Period|Lost to Follow-up|12
5345199|NCT00092495|18388658|P3|Base Study Follow-up Period|Lost to Follow-up|3
5345200|NCT00092495|18388659|P2|Base Study Follow-up Period|Lost to Follow-up|3
5345201|NCT00092495|18388660|P1|Base Study Follow-up Period|Lost to Follow-up|1
5345202|NCT00092495|18388656|P5|Base Study Follow-up Period|Extended|0
5345203|NCT00092495|18388657|P4|Base Study Follow-up Period|Extended|2
5345204|NCT00092495|18388658|P3|Base Study Follow-up Period|Extended|1
5345205|NCT00092495|18388659|P2|Base Study Follow-up Period|Extended|0
5345206|NCT00092495|18388660|P1|Base Study Follow-up Period|Extended|0
5345207|NCT00092495|18388656|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5345208|NCT00092495|18388657|P4|Base Study Vaccination Period|Withdrawal by Subject|25
5345209|NCT00092495|18388658|P3|Base Study Vaccination Period|Withdrawal by Subject|14
5345210|NCT00092495|18388659|P2|Base Study Vaccination Period|Withdrawal by Subject|10
5345211|NCT00092495|18388660|P1|Base Study Vaccination Period|Withdrawal by Subject|9
5345212|NCT00092495|18388656|P5|Base Study Vaccination Period|Protocol Violation|0
5345213|NCT00092495|18388657|P4|Base Study Vaccination Period|Protocol Violation|0
5345214|NCT00092495|18388658|P3|Base Study Vaccination Period|Protocol Violation|0
5345215|NCT00092495|18388659|P2|Base Study Vaccination Period|Protocol Violation|0
5345216|NCT00092495|18388660|P1|Base Study Vaccination Period|Protocol Violation|1
5345217|NCT00092495|18388656|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
5345218|NCT00092495|18388657|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
5345219|NCT00092495|18388658|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
5345220|NCT00092495|18388659|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
5345221|NCT00092495|18388660|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
5345222|NCT00092495|18388656|P5|Base Study Vaccination Period|Pregnancy|0
5345223|NCT00092495|18388657|P4|Base Study Vaccination Period|Pregnancy|0
5345224|NCT00092495|18388658|P3|Base Study Vaccination Period|Pregnancy|0
5345225|NCT00092495|18388659|P2|Base Study Vaccination Period|Pregnancy|0
5345226|NCT00092495|18388660|P1|Base Study Vaccination Period|Pregnancy|2
5345227|NCT00092495|18388656|P5|Base Study Vaccination Period|Other|0
5345228|NCT00092495|18388657|P4|Base Study Vaccination Period|Other|2
5345229|NCT00092495|18388658|P3|Base Study Vaccination Period|Other|0
5345230|NCT00092495|18388659|P2|Base Study Vaccination Period|Other|1
5345231|NCT00092495|18388660|P1|Base Study Vaccination Period|Other|1
5345232|NCT00092495|18388656|P5|Base Study Vaccination Period|Moved|0
5345233|NCT00092495|18388657|P4|Base Study Vaccination Period|Moved|2
5345234|NCT00092495|18388658|P3|Base Study Vaccination Period|Moved|2
5345235|NCT00092495|18388659|P2|Base Study Vaccination Period|Moved|1
5345236|NCT00092495|18388660|P1|Base Study Vaccination Period|Moved|3
5345237|NCT00092495|18388656|P5|Base Study Vaccination Period|Lost to Follow-up|0
5345238|NCT00092495|18388657|P4|Base Study Vaccination Period|Lost to Follow-up|36
5345239|NCT00092495|18388658|P3|Base Study Vaccination Period|Lost to Follow-up|11
5345240|NCT00092495|18388659|P2|Base Study Vaccination Period|Lost to Follow-up|6
5345241|NCT00092495|18388660|P1|Base Study Vaccination Period|Lost to Follow-up|16
5345242|NCT00092495|18388656|P5|Base Study Vaccination Period|Adverse Event|0
5345243|NCT00092495|18388657|P4|Base Study Vaccination Period|Adverse Event|3
5345244|NCT00092495|18388658|P3|Base Study Vaccination Period|Adverse Event|0
5345245|NCT00092495|18388659|P2|Base Study Vaccination Period|Adverse Event|0
5345246|NCT00092495|18388660|P1|Base Study Vaccination Period|Adverse Event|1
5345247|NCT00092495|18388656|P5|Base Study Vaccination Period|*Pregnancy|0
5345248|NCT00092495|18388657|P4|Base Study Vaccination Period|*Pregnancy|7
5345249|NCT00092495|18388658|P3|Base Study Vaccination Period|*Pregnancy|5
5345250|NCT00092495|18388659|P2|Base Study Vaccination Period|*Pregnancy|2
5345251|NCT00092495|18388660|P1|Base Study Vaccination Period|*Pregnancy|0
5345252|NCT00092495|18388656|P5|Base Study Vaccination Period|*Other reasons|0
5345253|NCT00092495|18388657|P4|Base Study Vaccination Period|*Other reasons|1
5345254|NCT00092495|18388658|P3|Base Study Vaccination Period|*Other reasons|0
5345255|NCT00092495|18388659|P2|Base Study Vaccination Period|*Other reasons|0
5345256|NCT00092495|18388660|P1|Base Study Vaccination Period|*Other reasons|1
5345257|NCT00092495|18388656|P5|Base Study Vaccination Period|*Clinical AE|0
5345258|NCT00092495|18388657|P4|Base Study Vaccination Period|*Clinical AE|2
5345259|NCT00092495|18388658|P3|Base Study Vaccination Period|*Clinical AE|1
5345260|NCT00092495|18388659|P2|Base Study Vaccination Period|*Clinical AE|0
5345261|NCT00092495|18388660|P1|Base Study Vaccination Period|*Clinical AE|1
5345262|NCT00092495|18388656|P5|Base Study Vaccination Period|Extended|0
5345263|NCT00092495|18388657|P4|Base Study Vaccination Period|Extended|1
5345264|NCT00092495|18388658|P3|Base Study Vaccination Period|Extended|0
5345265|NCT00092495|18388659|P2|Base Study Vaccination Period|Extended|0
5345266|NCT00092495|18388660|P1|Base Study Vaccination Period|Extended|0
5345267|NCT00092495|18388656|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
5345268|NCT00092495|18388657|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
5345269|NCT00092495|18388658|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
5345270|NCT00092495|18388659|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
5345271|NCT00092495|18388660|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
5345272|NCT00092456|18388726|P4|Overall Study|Other|0
5345273|NCT00092456|18388727|P3|Overall Study|Other|3
5345274|NCT00092456|18388728|P2|Overall Study|Other|2
5345275|NCT00092456|18388729|P1|Overall Study|Other|4
5345276|NCT00092456|18388726|P4|Overall Study|Moved|1
5345277|NCT00092456|18388727|P3|Overall Study|Moved|0
5345278|NCT00092456|18388728|P2|Overall Study|Moved|1
5345279|NCT00092456|18388729|P1|Overall Study|Moved|1
5345280|NCT00092456|18388726|P4|Overall Study|Withdrawal by Subject|6
5345281|NCT00092456|18388727|P3|Overall Study|Withdrawal by Subject|16
5345282|NCT00092456|18388728|P2|Overall Study|Withdrawal by Subject|5
5345283|NCT00092456|18388729|P1|Overall Study|Withdrawal by Subject|13
5345284|NCT00092456|18388726|P4|Overall Study|Protocol Violation|6
5345285|NCT00092456|18388727|P3|Overall Study|Protocol Violation|8
5345286|NCT00092456|18388728|P2|Overall Study|Protocol Violation|7
5345287|NCT00092456|18388729|P1|Overall Study|Protocol Violation|5
5345288|NCT00092456|18388726|P4|Overall Study|Lost to Follow-up|2
5345289|NCT00092456|18388727|P3|Overall Study|Lost to Follow-up|1
5345290|NCT00092456|18388728|P2|Overall Study|Lost to Follow-up|2
5345291|NCT00092456|18388729|P1|Overall Study|Lost to Follow-up|2
5345292|NCT00092456|18388726|P4|Overall Study|Adverse Event|1
5345293|NCT00092456|18388727|P3|Overall Study|Adverse Event|1
5345294|NCT00092456|18388728|P2|Overall Study|Adverse Event|0
5345295|NCT00092456|18388729|P1|Overall Study|Adverse Event|0
5345296|NCT00092443|18388777|P2|Overall Study|Other|13
5345297|NCT00092443|18388778|P1|Overall Study|Other|17
5345298|NCT00092443|18388777|P2|Overall Study|Moved|5
5345299|NCT00092443|18388778|P1|Overall Study|Moved|5
5345300|NCT00092443|18388777|P2|Overall Study|Withdrawal by Subject|11
5345301|NCT00092443|18388778|P1|Overall Study|Withdrawal by Subject|9
5345302|NCT00092443|18388777|P2|Overall Study|Protocol Violation|9
5345303|NCT00092443|18388778|P1|Overall Study|Protocol Violation|11
5345304|NCT00092443|18388777|P2|Overall Study|Lost to Follow-up|3
5345305|NCT00092443|18388778|P1|Overall Study|Lost to Follow-up|7
5345306|NCT00092443|18388777|P2|Overall Study|Adverse Event|13
5345307|NCT00092443|18388778|P1|Overall Study|Adverse Event|9
5345308|NCT00092417|18388796|P2|Overall Study|Other|0
5345309|NCT00092417|18388797|P1|Overall Study|Other|1
5345310|NCT00092417|18388796|P2|Overall Study|Withdrawal by Subject|1
5345311|NCT00092417|18388797|P1|Overall Study|Withdrawal by Subject|2
5345312|NCT00092417|18388796|P2|Overall Study|Lost to Follow-up|0
5345313|NCT00092417|18388797|P1|Overall Study|Lost to Follow-up|2
5345314|NCT00092131|18388811|P2|Treatment Period II|Adverse Event|1
5345315|NCT00092131|18388812|P1|Treatment Period II|Adverse Event|0
5345316|NCT00092131|18388811|P2|Treatment Period I|Adverse Event|0
5345317|NCT00092131|18388812|P1|Treatment Period I|Adverse Event|1
5345318|NCT00092118|18388842|P2|Overall Study|Other|5
5345319|NCT00092118|18388843|P1|Overall Study|Other|6
5345320|NCT00092118|18388842|P2|Overall Study|Withdrawal by Subject|10
5345321|NCT00092118|18388843|P1|Overall Study|Withdrawal by Subject|4
5345322|NCT00092118|18388842|P2|Overall Study|Protocol Violation|25
5345323|NCT00092118|18388843|P1|Overall Study|Protocol Violation|23
5345324|NCT00092118|18388842|P2|Overall Study|Lost to Follow-up|3
5345325|NCT00092118|18388843|P1|Overall Study|Lost to Follow-up|4
5345326|NCT00092118|18388842|P2|Overall Study|Lack of Efficacy|14
5345327|NCT00092118|18388843|P1|Overall Study|Lack of Efficacy|12
5345328|NCT00092118|18388842|P2|Overall Study|Adverse Event|32
5345329|NCT00092118|18388843|P1|Overall Study|Adverse Event|35
5345330|NCT00091949|18388877|P2|Overall Study|Lost to Follow-up|41
5345331|NCT00091949|18388878|P1|Overall Study|Lost to Follow-up|58
5345332|NCT00091949|18388877|P2|Overall Study|Withdrawal by Subject|110
5345333|NCT00091949|18388878|P1|Overall Study|Withdrawal by Subject|117
5345334|NCT00091832|18388902|P6|Overall Study|Protocol Violation|1
5345335|NCT00091832|18388903|P5|Overall Study|Protocol Violation|0
5345336|NCT00091832|18388904|P4|Overall Study|Protocol Violation|0
5345337|NCT00091832|18388905|P3|Overall Study|Protocol Violation|1
5345338|NCT00091832|18388906|P2|Overall Study|Protocol Violation|0
5345339|NCT00091832|18388907|P1|Overall Study|Protocol Violation|0
5345340|NCT00091832|18388902|P6|Overall Study|Other|0
5345341|NCT00091832|18388903|P5|Overall Study|Other|0
5345342|NCT00091832|18388904|P4|Overall Study|Other|0
5345343|NCT00091832|18388905|P3|Overall Study|Other|2
5345344|NCT00091832|18388906|P2|Overall Study|Other|1
5345345|NCT00091832|18388907|P1|Overall Study|Other|0
5345346|NCT00091832|18388902|P6|Overall Study|Noncompliance|0
5345347|NCT00091832|18388903|P5|Overall Study|Noncompliance|0
5345348|NCT00091832|18388904|P4|Overall Study|Noncompliance|0
5345349|NCT00091832|18388905|P3|Overall Study|Noncompliance|0
5345350|NCT00091832|18388906|P2|Overall Study|Noncompliance|1
5345351|NCT00091832|18388907|P1|Overall Study|Noncompliance|0
5345352|NCT00091832|18388902|P6|Overall Study|Lost to Follow-up|1
5345353|NCT00091832|18388903|P5|Overall Study|Lost to Follow-up|2
5345354|NCT00091832|18388904|P4|Overall Study|Lost to Follow-up|3
5345355|NCT00091832|18388905|P3|Overall Study|Lost to Follow-up|3
5345356|NCT00091832|18388906|P2|Overall Study|Lost to Follow-up|0
5345357|NCT00091832|18388907|P1|Overall Study|Lost to Follow-up|1
5345358|NCT00091832|18388902|P6|Overall Study|Ineligibility Determined|0
5345359|NCT00091832|18388903|P5|Overall Study|Ineligibility Determined|1
5345360|NCT00091832|18388904|P4|Overall Study|Ineligibility Determined|0
5345361|NCT00091832|18388905|P3|Overall Study|Ineligibility Determined|1
5345362|NCT00091832|18388906|P2|Overall Study|Ineligibility Determined|0
5345363|NCT00091832|18388907|P1|Overall Study|Ineligibility Determined|0
5345364|NCT00091832|18388902|P6|Overall Study|Disease Progression|2
5345365|NCT00091832|18388903|P5|Overall Study|Disease Progression|1
5345366|NCT00091832|18388904|P4|Overall Study|Disease Progression|1
5345367|NCT00091832|18388905|P3|Overall Study|Disease Progression|0
5345368|NCT00091832|18388906|P2|Overall Study|Disease Progression|0
5345369|NCT00091832|18388907|P1|Overall Study|Disease Progression|2
5345370|NCT00091832|18388902|P6|Overall Study|Death|6
5345371|NCT00091832|18388903|P5|Overall Study|Death|5
5345372|NCT00091832|18388904|P4|Overall Study|Death|8
5345373|NCT00091832|18388905|P3|Overall Study|Death|5
5345374|NCT00091832|18388906|P2|Overall Study|Death|4
5345375|NCT00091832|18388907|P1|Overall Study|Death|6
5345376|NCT00091832|18388902|P6|Overall Study|Withdrawal by Subject|1
5345377|NCT00091832|18388903|P5|Overall Study|Withdrawal by Subject|3
5345378|NCT00091832|18388904|P4|Overall Study|Withdrawal by Subject|1
5345379|NCT00091832|18388905|P3|Overall Study|Withdrawal by Subject|0
5345380|NCT00091832|18388906|P2|Overall Study|Withdrawal by Subject|5
5345381|NCT00091832|18388907|P1|Overall Study|Withdrawal by Subject|4
5345382|NCT00091832|18388902|P6|Overall Study|Adverse Event|0
5345383|NCT00091832|18388903|P5|Overall Study|Adverse Event|3
5345384|NCT00091832|18388904|P4|Overall Study|Adverse Event|1
5345385|NCT00091832|18388905|P3|Overall Study|Adverse Event|0
5345386|NCT00091832|18388906|P2|Overall Study|Adverse Event|0
5345387|NCT00091832|18388907|P1|Overall Study|Adverse Event|0
5345388|NCT00091832|18388902|P6|Overall Study|Physician Decision|0
5345389|NCT00091832|18388903|P5|Overall Study|Physician Decision|0
5345390|NCT00091832|18388904|P4|Overall Study|Physician Decision|0
5345391|NCT00091832|18388905|P3|Overall Study|Physician Decision|0
5345392|NCT00091832|18388906|P2|Overall Study|Physician Decision|0
5345393|NCT00091832|18388907|P1|Overall Study|Physician Decision|1
5345394|NCT00091819|18389025|P2|Overall Study|Never received study treatment|4
5345395|NCT00091819|18389026|P1|Overall Study|Never received study treatment|3
5345396|NCT00091819|18389025|P2|Overall Study|Other|3
5345397|NCT00091819|18389026|P1|Overall Study|Other|2
5345398|NCT00091819|18389025|P2|Overall Study|Protocol Violation|2
5345399|NCT00091819|18389026|P1|Overall Study|Protocol Violation|1
5345400|NCT00091819|18389025|P2|Overall Study|Withdrawal by Subject|8
5345401|NCT00091819|18389026|P1|Overall Study|Withdrawal by Subject|5
5345402|NCT00091819|18389025|P2|Overall Study|Lost to Follow-up|23
5345403|NCT00091819|18389026|P1|Overall Study|Lost to Follow-up|26
5345404|NCT00091819|18389025|P2|Overall Study|Death|5
5345405|NCT00091819|18389026|P1|Overall Study|Death|4
5345406|NCT00091819|18389025|P2|Overall Study|Adverse Event|1
5345407|NCT00091819|18389026|P1|Overall Study|Adverse Event|1
5345408|NCT00091793|18389034|P2|Overall Study|Other|0
5345409|NCT00091793|18389035|P1|Overall Study|Other|2
5345410|NCT00091793|18389034|P2|Overall Study|Noncompliance|0
5345411|NCT00091793|18389035|P1|Overall Study|Noncompliance|2
5345412|NCT00091793|18389034|P2|Overall Study|Lost to Follow-up|5
5345413|NCT00091793|18389035|P1|Overall Study|Lost to Follow-up|7
5345414|NCT00091793|18389034|P2|Overall Study|Ineligibility determined|0
5345415|NCT00091793|18389035|P1|Overall Study|Ineligibility determined|2
5345416|NCT00091793|18389034|P2|Overall Study|Withdrawal by Subject|15
5345417|NCT00091793|18389035|P1|Overall Study|Withdrawal by Subject|10
5345418|NCT00091793|18389034|P2|Overall Study|Adverse Event|2
5345419|NCT00091793|18389035|P1|Overall Study|Adverse Event|1
5345420|NCT00091572|18389059|P2|Overall Study|Toxicity (Related AE)|9
5345421|NCT00091572|18389060|P1|Overall Study|Toxicity (Related AE)|53
5345422|NCT00091572|18389059|P2|Overall Study|Major Protocol Violation|0
5345423|NCT00091572|18389060|P1|Overall Study|Major Protocol Violation|2
5345424|NCT00091572|18389059|P2|Overall Study|Ongoing (still on treatment)|12
5345425|NCT00091572|18389060|P1|Overall Study|Ongoing (still on treatment)|8
5345426|NCT00091572|18389059|P2|Overall Study|Other Reason|13
5345427|NCT00091572|18389060|P1|Overall Study|Other Reason|6
5345428|NCT00091572|18389059|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
5345429|NCT00091572|18389060|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
5345430|NCT00091572|18389059|P2|Overall Study|Death not due to malignancy/toxicity|3
5345431|NCT00091572|18389060|P1|Overall Study|Death not due to malignancy/toxicity|1
5345432|NCT00091572|18389059|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
5345433|NCT00091572|18389060|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
5345434|NCT00091572|18389059|P2|Overall Study|Lost to Follow-up|1
5345435|NCT00091572|18389060|P1|Overall Study|Lost to Follow-up|1
5345436|NCT00091442|18389091|P2|Overall Study|Other|6
5345437|NCT00091442|18389092|P1|Overall Study|Other|2
5345438|NCT00091442|18389091|P2|Overall Study|Lost to Follow-up|3
5345439|NCT00091442|18389092|P1|Overall Study|Lost to Follow-up|1
5345440|NCT00091442|18389091|P2|Overall Study|Death|7
5345441|NCT00091442|18389092|P1|Overall Study|Death|9
5345442|NCT00091442|18389091|P2|Overall Study|2cycles therapy beyond Complete response|16
5345443|NCT00091442|18389092|P1|Overall Study|2cycles therapy beyond Complete response|9
5345444|NCT00091442|18389091|P2|Overall Study|Adverse Event|48
5345445|NCT00091442|18389092|P1|Overall Study|Adverse Event|29
5345446|NCT00091442|18389091|P2|Overall Study|Withdrawal by Subject|46
5345447|NCT00091442|18389092|P1|Overall Study|Withdrawal by Subject|38
5345448|NCT00091442|18389091|P2|Overall Study|Physician Decision|58
5345449|NCT00091442|18389092|P1|Overall Study|Physician Decision|61
5345450|NCT00091442|18389091|P2|Overall Study|Progressive Disease|189
5345451|NCT00091442|18389092|P1|Overall Study|Progressive Disease|220
5345452|NCT00091390|18389102|P1|Overall Study|No protocol treatment|3
5345453|NCT00091390|18389102|P1|Overall Study|Protocol Violation|1
5345454|NCT00091169|18389127|P2|Overall Study|Not start protocol therapy|17
5345455|NCT00091169|18389128|P1|Overall Study|Not start protocol therapy|26
5345456|NCT00091169|18389127|P2|Overall Study|Other|4
5345457|NCT00091169|18389128|P1|Overall Study|Other|3
5345458|NCT00091169|18389127|P2|Overall Study|Withdrawal by Subject|13
5345459|NCT00091169|18389128|P1|Overall Study|Withdrawal by Subject|10
5345460|NCT00091169|18389127|P2|Overall Study|Death|1
5345461|NCT00091169|18389128|P1|Overall Study|Death|4
5345462|NCT00091169|18389127|P2|Overall Study|Adverse Event|17
5345463|NCT00091169|18389128|P1|Overall Study|Adverse Event|11
5345464|NCT00091169|18389127|P2|Overall Study|Disease progression|1
5345465|NCT00091169|18389128|P1|Overall Study|Disease progression|3
5345466|NCT00091026|18389146|P2|Overall Study|Unknown-never received treatment|1
5345467|NCT00091026|18389147|P1|Overall Study|Unknown-never received treatment|0
5345468|NCT00091026|18389146|P2|Overall Study|Patient withdrew and never received trea|2
5345469|NCT00091026|18389147|P1|Overall Study|Patient withdrew and never received trea|0
5345470|NCT00091026|18389146|P2|Overall Study|Patient deemed non eligible-never receiv|0
5345471|NCT00091026|18389147|P1|Overall Study|Patient deemed non eligible-never receiv|1
5345472|NCT00090987|18389157|P1|Overall Study|Incarcerated|1
5345473|NCT00090987|18389157|P1|Overall Study|Non-compliance|4
5345474|NCT00090987|18389157|P1|Overall Study|alternative therapy|1
5345475|NCT00090987|18389157|P1|Overall Study|Withdrawal by Subject|3
5345476|NCT00090987|18389157|P1|Overall Study|Lack of Efficacy|7
5345477|NCT00090987|18389157|P1|Overall Study|Adverse Event|5
5345478|NCT00090857|18389170|P2|Overall Study|Adverse Event|2
5345479|NCT00090857|18389171|P1|Overall Study|Adverse Event|2
5345480|NCT00090857|18389170|P2|Overall Study|Withdrawal by Subject|0
5345481|NCT00090857|18389171|P1|Overall Study|Withdrawal by Subject|2
5345482|NCT00090857|18389170|P2|Overall Study|Lost to Follow-up|1
5345483|NCT00090857|18389171|P1|Overall Study|Lost to Follow-up|0
5345484|NCT00090779|18389210|P2|Step 3|Off extended study due to study closure|3
5345485|NCT00090779|18389211|P1|Step 3|Off extended study due to study closure|4
5345486|NCT00090779|18389210|P2|Step 3|Initiation of ART and off extended study|2
5345487|NCT00090779|18389211|P1|Step 3|Initiation of ART and off extended study|3
5345488|NCT00090779|18389210|P2|Step 2|Non-compliance to study requirements|1
5345489|NCT00090779|18389211|P1|Step 2|Non-compliance to study requirements|0
5345490|NCT00090779|18389210|P2|Step 2|Subject relocated|1
5345491|NCT00090779|18389211|P1|Step 2|Subject relocated|0
5345492|NCT00090779|18389210|P2|Step 2|Off study per study closure|16
5345493|NCT00090779|18389211|P1|Step 2|Off study per study closure|6
5345494|NCT00090779|18389210|P2|Step 1|Subject relocated|8
5345495|NCT00090779|18389211|P1|Step 1|Subject relocated|2
5345496|NCT00090779|18389210|P2|Step 1|Non-compliance to study requirements|1
5345497|NCT00090779|18389211|P1|Step 1|Non-compliance to study requirements|0
5345498|NCT00090779|18389210|P2|Step 1|Pregnancy|0
5345499|NCT00090779|18389211|P1|Step 1|Pregnancy|1
5345500|NCT00090779|18389210|P2|Step 1|Physician Decision|0
5345501|NCT00090779|18389211|P1|Step 1|Physician Decision|1
5345502|NCT00090779|18389210|P2|Step 1|Death|2
5345503|NCT00090779|18389211|P1|Step 1|Death|0
5345504|NCT00090779|18389210|P2|Step 1|Lost to Follow-up|2
5345505|NCT00090779|18389211|P1|Step 1|Lost to Follow-up|3
5345506|NCT00090779|18389210|P2|Step 1|Withdrawal by Subject|2
5345507|NCT00090779|18389211|P1|Step 1|Withdrawal by Subject|4
5345508|NCT00090766|18389235|P3|Overall Study|Lost to Follow-up|2
5345509|NCT00090766|18389236|P2|Overall Study|Lost to Follow-up|0
5345510|NCT00090766|18389237|P1|Overall Study|Lost to Follow-up|2
5345511|NCT00090766|18389235|P3|Overall Study|Admin|0
5345512|NCT00090766|18389236|P2|Overall Study|Admin|2
5345513|NCT00090766|18389237|P1|Overall Study|Admin|0
5345514|NCT00090766|18389235|P3|Overall Study|Death|0
5345515|NCT00090766|18389236|P2|Overall Study|Death|0
5345516|NCT00090766|18389237|P1|Overall Study|Death|1
5345517|NCT00090766|18389235|P3|Overall Study|Nephrectomy Planned|1
5345518|NCT00090766|18389236|P2|Overall Study|Nephrectomy Planned|0
5345519|NCT00090766|18389237|P1|Overall Study|Nephrectomy Planned|0
5345520|NCT00090753|18389279|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
5345521|NCT00090753|18389280|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
5345522|NCT00090753|18389279|P2|Extended Treatment Period|Mircera Commercialization|93
5345523|NCT00090753|18389280|P1|Extended Treatment Period|Mircera Commercialization|188
5345524|NCT00090753|18389279|P2|Extended Treatment Period|Renal Transplant|12
5345525|NCT00090753|18389280|P1|Extended Treatment Period|Renal Transplant|15
5345526|NCT00090753|18389279|P2|Extended Treatment Period|Lost to Follow-up|1
5345527|NCT00090753|18389280|P1|Extended Treatment Period|Lost to Follow-up|3
5345528|NCT00090753|18389279|P2|Extended Treatment Period|Refused Treatment|12
5345529|NCT00090753|18389280|P1|Extended Treatment Period|Refused Treatment|18
5345530|NCT00090753|18389279|P2|Extended Treatment Period|Lack of Efficacy|0
5345531|NCT00090753|18389280|P1|Extended Treatment Period|Lack of Efficacy|1
5345532|NCT00090753|18389279|P2|Extended Treatment Period|Death|30
5345533|NCT00090753|18389280|P1|Extended Treatment Period|Death|58
5345534|NCT00090753|18389279|P2|Extended Treatment Period|Adverse Event|0
5345535|NCT00090753|18389280|P1|Extended Treatment Period|Adverse Event|11
5345536|NCT00090753|18389279|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
5345537|NCT00090753|18389280|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
5345538|NCT00090753|18389279|P2|First Treatment Period|Mircera Commercialization|0
5345539|NCT00090753|18389280|P1|First Treatment Period|Mircera Commercialization|1
5345540|NCT00090753|18389279|P2|First Treatment Period|Renal Transplant|50
5345541|NCT00090753|18389280|P1|First Treatment Period|Renal Transplant|70
5345542|NCT00090753|18389279|P2|First Treatment Period|Lost to Follow-up|4
5345543|NCT00090753|18389280|P1|First Treatment Period|Lost to Follow-up|4
5345544|NCT00090753|18389279|P2|First Treatment Period|Refused Treatment|25
5345545|NCT00090753|18389280|P1|First Treatment Period|Refused Treatment|32
5345546|NCT00090753|18389279|P2|First Treatment Period|Lack of Efficacy|1
5345547|NCT00090753|18389280|P1|First Treatment Period|Lack of Efficacy|2
5345548|NCT00090753|18389279|P2|First Treatment Period|Death|62
5345549|NCT00090753|18389280|P1|First Treatment Period|Death|88
5345550|NCT00090753|18389279|P2|First Treatment Period|Adverse Event|8
5345551|NCT00090753|18389280|P1|First Treatment Period|Adverse Event|20
5345552|NCT00090610|18389290|P2|Overall Study|Withdrawal by Subject|1
5345553|NCT00090610|18389291|P1|Overall Study|Withdrawal by Subject|1
5345554|NCT00090584|18389307|P2|Baseline to 8 Months|Lost to Follow-up|41
5345555|NCT00090584|18389308|P1|Baseline to 8 Months|Lost to Follow-up|44
5345556|NCT00090584|18389307|P2|Baseline to 10 Weeks|Lost to Follow-up|12
5345557|NCT00090584|18389308|P1|Baseline to 10 Weeks|Lost to Follow-up|15
5345558|NCT00090519|18389340|P2|Overall Study|Sponsor Decision|1
5345559|NCT00090519|18389341|P1|Overall Study|Sponsor Decision|3
5345560|NCT00090519|18389340|P2|Overall Study|Physician Decision|3
5345561|NCT00090519|18389341|P1|Overall Study|Physician Decision|2
5345562|NCT00090519|18389340|P2|Overall Study|Withdrawal by Subject|29
5345563|NCT00090519|18389341|P1|Overall Study|Withdrawal by Subject|28
5345564|NCT00090519|18389340|P2|Overall Study|Lost to Follow-up|29
5345565|NCT00090519|18389341|P1|Overall Study|Lost to Follow-up|26
5345566|NCT00090519|18389340|P2|Overall Study|Death|9
5345567|NCT00090519|18389341|P1|Overall Study|Death|9
5345568|NCT00090519|18389340|P2|Overall Study|Adverse Event|4
5345569|NCT00090519|18389341|P1|Overall Study|Adverse Event|5
5345570|NCT00090493|18389365|P1|Overall Study|Physician Decision|2
5345571|NCT00090363|18389372|P3|Overall Study|Continuing on study off treatment|16
5345572|NCT00090363|18389373|P2|Overall Study|Continuing on study off treatment|13
5345573|NCT00090363|18389374|P1|Overall Study|Continuing on study off treatment|14
5345574|NCT00090363|18389372|P3|Overall Study|Reasons not specified|1
5345575|NCT00090363|18389373|P2|Overall Study|Reasons not specified|1
5345576|NCT00090363|18389374|P1|Overall Study|Reasons not specified|2
5345577|NCT00090363|18389372|P3|Overall Study|Consent expired|9
5345578|NCT00090363|18389373|P2|Overall Study|Consent expired|10
5345579|NCT00090363|18389374|P1|Overall Study|Consent expired|7
5345580|NCT00090363|18389372|P3|Overall Study|Eligibility criteria not fulfilled|1
5345581|NCT00090363|18389373|P2|Overall Study|Eligibility criteria not fulfilled|0
5345582|NCT00090363|18389374|P1|Overall Study|Eligibility criteria not fulfilled|0
5345583|NCT00090363|18389372|P3|Overall Study|Study-specific discontinuation criteria|62
5345584|NCT00090363|18389373|P2|Overall Study|Study-specific discontinuation criteria|74
5345585|NCT00090363|18389374|P1|Overall Study|Study-specific discontinuation criteria|75
5345586|NCT00090363|18389372|P3|Overall Study|Withdrawal by Subject|6
5345587|NCT00090363|18389373|P2|Overall Study|Withdrawal by Subject|7
5345588|NCT00090363|18389374|P1|Overall Study|Withdrawal by Subject|7
5345589|NCT00090363|18389372|P3|Overall Study|Lost to Follow-up|1
5345590|NCT00090363|18389373|P2|Overall Study|Lost to Follow-up|2
5345591|NCT00090363|18389374|P1|Overall Study|Lost to Follow-up|1
5345592|NCT00090545|18389396|P2|Overall Study|Adverse Event|2
5345593|NCT00090545|18389397|P1|Overall Study|Adverse Event|0
5345594|NCT00090545|18389396|P2|Overall Study|Death|1
5345595|NCT00090545|18389397|P1|Overall Study|Death|0
5345596|NCT00090545|18389396|P2|Overall Study|Refused further treatment|4
5345597|NCT00090545|18389397|P1|Overall Study|Refused further treatment|1
5345598|NCT00090545|18389396|P2|Overall Study|Disease progression on study|17
5345599|NCT00090545|18389397|P1|Overall Study|Disease progression on study|21
5345600|NCT00090285|18389417|P6|Long-term Follow-up (EXT2)|Physician Decision|5
5345601|NCT00090285|18389418|P5|Long-term Follow-up (EXT2)|Physician Decision|6
5345602|NCT00090285|18389419|P4|Long-term Follow-up (EXT2)|Physician Decision|0
5345603|NCT00090285|18389420|P3|Long-term Follow-up (EXT2)|Physician Decision|0
5345604|NCT00090285|18389421|P2|Long-term Follow-up (EXT2)|Physician Decision|0
5345605|NCT00090285|18389422|P1|Long-term Follow-up (EXT2)|Physician Decision|0
5345606|NCT00090285|18389417|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
5345607|NCT00090285|18389418|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
5345608|NCT00090285|18389419|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345609|NCT00090285|18389420|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345610|NCT00090285|18389421|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345611|NCT00090285|18389422|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345612|NCT00090285|18389417|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
5345613|NCT00090285|18389418|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
5345614|NCT00090285|18389419|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345615|NCT00090285|18389420|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345616|NCT00090285|18389421|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345617|NCT00090285|18389422|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345618|NCT00090285|18389417|P6|Long-term Follow-up (EXT2)|Adverse Event|2
5345619|NCT00090285|18389418|P5|Long-term Follow-up (EXT2)|Adverse Event|5
5345620|NCT00090285|18389419|P4|Long-term Follow-up (EXT2)|Adverse Event|0
5345621|NCT00090285|18389420|P3|Long-term Follow-up (EXT2)|Adverse Event|0
5345622|NCT00090285|18389421|P2|Long-term Follow-up (EXT2)|Adverse Event|0
5345623|NCT00090285|18389422|P1|Long-term Follow-up (EXT2)|Adverse Event|0
5345624|NCT00090285|18389417|P6|Extension 1|Moved|0
5345625|NCT00090285|18389418|P5|Extension 1|Moved|0
5345626|NCT00090285|18389419|P4|Extension 1|Moved|0
5345627|NCT00090285|18389420|P3|Extension 1|Moved|3
5345628|NCT00090285|18389421|P2|Extension 1|Moved|0
5345629|NCT00090285|18389422|P1|Extension 1|Moved|0
5345630|NCT00090285|18389417|P6|Extension 1|Other|0
5345631|NCT00090285|18389418|P5|Extension 1|Other|0
5345632|NCT00090285|18389419|P4|Extension 1|Other|0
5345633|NCT00090285|18389420|P3|Extension 1|Other|4
5345634|NCT00090285|18389421|P2|Extension 1|Other|0
5345635|NCT00090285|18389422|P1|Extension 1|Other|0
5345636|NCT00090285|18389417|P6|Extension 1|Withdrawal by Subject|0
5345637|NCT00090285|18389418|P5|Extension 1|Withdrawal by Subject|0
5345638|NCT00090285|18389419|P4|Extension 1|Withdrawal by Subject|1
5345639|NCT00090285|18389420|P3|Extension 1|Withdrawal by Subject|13
5345640|NCT00090285|18389421|P2|Extension 1|Withdrawal by Subject|0
5345641|NCT00090285|18389422|P1|Extension 1|Withdrawal by Subject|0
5345642|NCT00090285|18389417|P6|Extension 1|Lost to Follow-up|0
5345643|NCT00090285|18389418|P5|Extension 1|Lost to Follow-up|0
5345644|NCT00090285|18389419|P4|Extension 1|Lost to Follow-up|0
5345645|NCT00090285|18389420|P3|Extension 1|Lost to Follow-up|35
5345646|NCT00090285|18389421|P2|Extension 1|Lost to Follow-up|0
5345647|NCT00090285|18389422|P1|Extension 1|Lost to Follow-up|0
5345648|NCT00090285|18389417|P6|Extension 1|Adverse Event|0
5345649|NCT00090285|18389418|P5|Extension 1|Adverse Event|0
5345650|NCT00090285|18389419|P4|Extension 1|Adverse Event|0
5345651|NCT00090285|18389420|P3|Extension 1|Adverse Event|2
5345652|NCT00090285|18389421|P2|Extension 1|Adverse Event|0
5345653|NCT00090285|18389422|P1|Extension 1|Adverse Event|0
5345654|NCT00090285|18389417|P6|Base Study Follow-up Period|Subject Incarcerated|0
5345655|NCT00090285|18389418|P5|Base Study Follow-up Period|Subject Incarcerated|0
5345656|NCT00090285|18389419|P4|Base Study Follow-up Period|Subject Incarcerated|0
5345657|NCT00090285|18389420|P3|Base Study Follow-up Period|Subject Incarcerated|0
5345658|NCT00090285|18389421|P2|Base Study Follow-up Period|Subject Incarcerated|2
5345659|NCT00090285|18389422|P1|Base Study Follow-up Period|Subject Incarcerated|0
5345660|NCT00090285|18389417|P6|Base Study Follow-up Period|Uncooperative|0
5345661|NCT00090285|18389418|P5|Base Study Follow-up Period|Uncooperative|0
5345662|NCT00090285|18389419|P4|Base Study Follow-up Period|Uncooperative|0
5345663|NCT00090285|18389420|P3|Base Study Follow-up Period|Uncooperative|0
5345664|NCT00090285|18389421|P2|Base Study Follow-up Period|Uncooperative|4
5345665|NCT00090285|18389422|P1|Base Study Follow-up Period|Uncooperative|3
5345666|NCT00090285|18389417|P6|Base Study Follow-up Period|Protocol Violation|0
5345667|NCT00090285|18389418|P5|Base Study Follow-up Period|Protocol Violation|0
5345668|NCT00090285|18389419|P4|Base Study Follow-up Period|Protocol Violation|0
5345669|NCT00090285|18389420|P3|Base Study Follow-up Period|Protocol Violation|0
5345670|NCT00090285|18389421|P2|Base Study Follow-up Period|Protocol Violation|0
5345671|NCT00090285|18389422|P1|Base Study Follow-up Period|Protocol Violation|1
5345672|NCT00090285|18389417|P6|Base Study Follow-up Period|Other|0
5345673|NCT00090285|18389418|P5|Base Study Follow-up Period|Other|0
5345674|NCT00090285|18389419|P4|Base Study Follow-up Period|Other|0
5345675|NCT00090285|18389420|P3|Base Study Follow-up Period|Other|0
5345676|NCT00090285|18389421|P2|Base Study Follow-up Period|Other|0
5345677|NCT00090285|18389422|P1|Base Study Follow-up Period|Other|2
5345678|NCT00090285|18389417|P6|Base Study Follow-up Period|Moved|0
5345679|NCT00090285|18389418|P5|Base Study Follow-up Period|Moved|0
5345680|NCT00090285|18389419|P4|Base Study Follow-up Period|Moved|0
5345681|NCT00090285|18389420|P3|Base Study Follow-up Period|Moved|0
5345682|NCT00090285|18389421|P2|Base Study Follow-up Period|Moved|36
5345683|NCT00090285|18389422|P1|Base Study Follow-up Period|Moved|41
5345684|NCT00090285|18389417|P6|Base Study Follow-up Period|Withdrawal by Subject|0
5345685|NCT00090285|18389418|P5|Base Study Follow-up Period|Withdrawal by Subject|0
5345686|NCT00090285|18389419|P4|Base Study Follow-up Period|Withdrawal by Subject|0
5345687|NCT00090285|18389420|P3|Base Study Follow-up Period|Withdrawal by Subject|0
5345688|NCT00090285|18389421|P2|Base Study Follow-up Period|Withdrawal by Subject|64
5345689|NCT00090285|18389422|P1|Base Study Follow-up Period|Withdrawal by Subject|53
5345690|NCT00090285|18389417|P6|Base Study Follow-up Period|Lost to Follow-up|0
5345691|NCT00090285|18389418|P5|Base Study Follow-up Period|Lost to Follow-up|0
5345692|NCT00090285|18389419|P4|Base Study Follow-up Period|Lost to Follow-up|0
5345693|NCT00090285|18389420|P3|Base Study Follow-up Period|Lost to Follow-up|0
5345694|NCT00090285|18389421|P2|Base Study Follow-up Period|Lost to Follow-up|226
5345695|NCT00090285|18389422|P1|Base Study Follow-up Period|Lost to Follow-up|232
5345696|NCT00090285|18389417|P6|Base Study Follow-up Period|Adverse Event|0
5345697|NCT00090285|18389418|P5|Base Study Follow-up Period|Adverse Event|0
5345698|NCT00090285|18389419|P4|Base Study Follow-up Period|Adverse Event|0
5345699|NCT00090285|18389420|P3|Base Study Follow-up Period|Adverse Event|0
5345700|NCT00090285|18389421|P2|Base Study Follow-up Period|Adverse Event|10
5345701|NCT00090285|18389422|P1|Base Study Follow-up Period|Adverse Event|3
5345702|NCT00090285|18389417|P6|Base Study Vaccination Period|HIV positive|0
5345703|NCT00090285|18389418|P5|Base Study Vaccination Period|HIV positive|0
5345704|NCT00090285|18389419|P4|Base Study Vaccination Period|HIV positive|0
5345705|NCT00090285|18389420|P3|Base Study Vaccination Period|HIV positive|0
5345706|NCT00090285|18389421|P2|Base Study Vaccination Period|HIV positive|1
5345707|NCT00090285|18389422|P1|Base Study Vaccination Period|HIV positive|1
5345708|NCT00090285|18389417|P6|Base Study Vaccination Period|Subject Incarcerated|0
5345709|NCT00090285|18389418|P5|Base Study Vaccination Period|Subject Incarcerated|0
5345710|NCT00090285|18389419|P4|Base Study Vaccination Period|Subject Incarcerated|0
5345711|NCT00090285|18389420|P3|Base Study Vaccination Period|Subject Incarcerated|0
5345712|NCT00090285|18389421|P2|Base Study Vaccination Period|Subject Incarcerated|2
5345713|NCT00090285|18389422|P1|Base Study Vaccination Period|Subject Incarcerated|2
5345714|NCT00090285|18389417|P6|Base Study Vaccination Period|Other|0
5345715|NCT00090285|18389418|P5|Base Study Vaccination Period|Other|0
5345716|NCT00090285|18389419|P4|Base Study Vaccination Period|Other|0
5345717|NCT00090285|18389420|P3|Base Study Vaccination Period|Other|0
5345718|NCT00090285|18389421|P2|Base Study Vaccination Period|Other|2
5345719|NCT00090285|18389422|P1|Base Study Vaccination Period|Other|2
5345720|NCT00090285|18389417|P6|Base Study Vaccination Period|Site Terminated|0
5345721|NCT00090285|18389418|P5|Base Study Vaccination Period|Site Terminated|0
5345722|NCT00090285|18389419|P4|Base Study Vaccination Period|Site Terminated|0
5345723|NCT00090285|18389420|P3|Base Study Vaccination Period|Site Terminated|0
5345724|NCT00090285|18389421|P2|Base Study Vaccination Period|Site Terminated|0
5345725|NCT00090285|18389422|P1|Base Study Vaccination Period|Site Terminated|1
5345726|NCT00090285|18389417|P6|Base Study Vaccination Period|Moved|0
5345727|NCT00090285|18389418|P5|Base Study Vaccination Period|Moved|0
5345728|NCT00090285|18389419|P4|Base Study Vaccination Period|Moved|0
5345729|NCT00090285|18389420|P3|Base Study Vaccination Period|Moved|0
5345730|NCT00090285|18389421|P2|Base Study Vaccination Period|Moved|21
5345731|NCT00090285|18389422|P1|Base Study Vaccination Period|Moved|20
5345732|NCT00090285|18389417|P6|Base Study Vaccination Period|Uncooperative|0
5345733|NCT00090285|18389418|P5|Base Study Vaccination Period|Uncooperative|0
5345734|NCT00090285|18389419|P4|Base Study Vaccination Period|Uncooperative|0
5345735|NCT00090285|18389420|P3|Base Study Vaccination Period|Uncooperative|0
5345736|NCT00090285|18389421|P2|Base Study Vaccination Period|Uncooperative|2
5345737|NCT00090285|18389422|P1|Base Study Vaccination Period|Uncooperative|2
5345738|NCT00090285|18389417|P6|Base Study Vaccination Period|Withdrawal by Subject|0
5345739|NCT00090285|18389418|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5345740|NCT00090285|18389419|P4|Base Study Vaccination Period|Withdrawal by Subject|0
5345741|NCT00090285|18389420|P3|Base Study Vaccination Period|Withdrawal by Subject|0
5345742|NCT00090285|18389421|P2|Base Study Vaccination Period|Withdrawal by Subject|69
5345743|NCT00090285|18389422|P1|Base Study Vaccination Period|Withdrawal by Subject|64
5345744|NCT00090285|18389417|P6|Base Study Vaccination Period|Protocol Violation|0
5345745|NCT00090285|18389418|P5|Base Study Vaccination Period|Protocol Violation|0
5345746|NCT00090285|18389419|P4|Base Study Vaccination Period|Protocol Violation|0
5345747|NCT00090285|18389420|P3|Base Study Vaccination Period|Protocol Violation|0
5345748|NCT00090285|18389421|P2|Base Study Vaccination Period|Protocol Violation|3
5345749|NCT00090285|18389422|P1|Base Study Vaccination Period|Protocol Violation|2
5345750|NCT00090285|18389417|P6|Base Study Vaccination Period|Lost to Follow-up|0
5345751|NCT00090285|18389418|P5|Base Study Vaccination Period|Lost to Follow-up|0
5345752|NCT00090285|18389419|P4|Base Study Vaccination Period|Lost to Follow-up|0
5345753|NCT00090285|18389420|P3|Base Study Vaccination Period|Lost to Follow-up|0
5345754|NCT00090285|18389421|P2|Base Study Vaccination Period|Lost to Follow-up|112
5345755|NCT00090285|18389422|P1|Base Study Vaccination Period|Lost to Follow-up|111
5345756|NCT00090285|18389417|P6|Base Study Vaccination Period|Adverse Event|0
5345757|NCT00090285|18389418|P5|Base Study Vaccination Period|Adverse Event|0
5345758|NCT00090285|18389419|P4|Base Study Vaccination Period|Adverse Event|0
5345759|NCT00090285|18389420|P3|Base Study Vaccination Period|Adverse Event|0
5345760|NCT00090285|18389421|P2|Base Study Vaccination Period|Adverse Event|4
5345761|NCT00090285|18389422|P1|Base Study Vaccination Period|Adverse Event|2
5345762|NCT00090285|18389417|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
5345763|NCT00090285|18389418|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
5345764|NCT00090285|18389419|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
5345765|NCT00090285|18389420|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
5345766|NCT00090285|18389421|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
5345767|NCT00090285|18389422|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
5345768|NCT00090259|18389459|P2|Overall Study|Investigator site closed|7
5345769|NCT00090259|18389460|P1|Overall Study|Investigator site closed|11
5345770|NCT00090259|18389459|P2|Overall Study|Withdrawal by Subject|15
5345771|NCT00090259|18389460|P1|Overall Study|Withdrawal by Subject|21
5345772|NCT00090259|18389459|P2|Overall Study|Lost to Follow-up|26
5345773|NCT00090259|18389460|P1|Overall Study|Lost to Follow-up|30
5345774|NCT00090233|18389476|P2|Overall Study|Data not available at data cut-off point|1563
5345775|NCT00090233|18389477|P1|Overall Study|Data not available at data cut-off point|1552
5345776|NCT00090233|18389476|P2|Overall Study|Other|1160
5345777|NCT00090233|18389477|P1|Overall Study|Other|1211
5345778|NCT00090233|18389476|P2|Overall Study|Moved|189
5345779|NCT00090233|18389477|P1|Overall Study|Moved|203
5345780|NCT00090233|18389476|P2|Overall Study|Withdrawal by Subject|211
5345781|NCT00090233|18389477|P1|Overall Study|Withdrawal by Subject|182
5345782|NCT00090233|18389476|P2|Overall Study|Protocol Violation|1022
5345783|NCT00090233|18389477|P1|Overall Study|Protocol Violation|960
5345784|NCT00090233|18389476|P2|Overall Study|Lost to Follow-up|95
5345785|NCT00090233|18389477|P1|Overall Study|Lost to Follow-up|68
5345786|NCT00090233|18389476|P2|Overall Study|Adverse Event|198
5345787|NCT00090233|18389477|P1|Overall Study|Adverse Event|214
5345788|NCT00090233|18389476|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
5345789|NCT00090233|18389477|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
5345790|NCT00090220|18389501|P6|Long-term Follow-up (EXT2)|Other|0
5345791|NCT00090220|18389502|P5|Long-term Follow-up (EXT2)|Other|1
5345792|NCT00090220|18389503|P4|Long-term Follow-up (EXT2)|Other|0
5345793|NCT00090220|18389504|P3|Long-term Follow-up (EXT2)|Other|0
5345794|NCT00090220|18389505|P2|Long-term Follow-up (EXT2)|Other|0
5345795|NCT00090220|18389506|P1|Long-term Follow-up (EXT2)|Other|0
5345796|NCT00090220|18389501|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
5345797|NCT00090220|18389502|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
5345798|NCT00090220|18389503|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345799|NCT00090220|18389504|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345800|NCT00090220|18389505|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345801|NCT00090220|18389506|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5345802|NCT00090220|18389501|P6|Long-term Follow-up (EXT2)|Death|1
5345803|NCT00090220|18389502|P5|Long-term Follow-up (EXT2)|Death|1
5345804|NCT00090220|18389503|P4|Long-term Follow-up (EXT2)|Death|0
5345805|NCT00090220|18389504|P3|Long-term Follow-up (EXT2)|Death|0
5345806|NCT00090220|18389505|P2|Long-term Follow-up (EXT2)|Death|0
5345807|NCT00090220|18389506|P1|Long-term Follow-up (EXT2)|Death|0
5345808|NCT00090220|18389501|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
5345809|NCT00090220|18389502|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
5345810|NCT00090220|18389503|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345811|NCT00090220|18389504|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345812|NCT00090220|18389505|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345813|NCT00090220|18389506|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5345814|NCT00090220|18389501|P6|Extension 1 (EXT1)|Other reason|0
5345815|NCT00090220|18389502|P5|Extension 1 (EXT1)|Other reason|0
5345816|NCT00090220|18389503|P4|Extension 1 (EXT1)|Other reason|0
5345817|NCT00090220|18389504|P3|Extension 1 (EXT1)|Other reason|2
5345818|NCT00090220|18389505|P2|Extension 1 (EXT1)|Other reason|0
5345819|NCT00090220|18389506|P1|Extension 1 (EXT1)|Other reason|0
5345820|NCT00090220|18389501|P6|Extension 1 (EXT1)|Protocol Violation|0
5345821|NCT00090220|18389502|P5|Extension 1 (EXT1)|Protocol Violation|0
5345822|NCT00090220|18389503|P4|Extension 1 (EXT1)|Protocol Violation|1
5345823|NCT00090220|18389504|P3|Extension 1 (EXT1)|Protocol Violation|0
5345824|NCT00090220|18389505|P2|Extension 1 (EXT1)|Protocol Violation|0
5345825|NCT00090220|18389506|P1|Extension 1 (EXT1)|Protocol Violation|0
5345826|NCT00090220|18389501|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
5345827|NCT00090220|18389502|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
5345828|NCT00090220|18389503|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
5345829|NCT00090220|18389504|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
5345830|NCT00090220|18389505|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
5345831|NCT00090220|18389506|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
5345832|NCT00090220|18389501|P6|Extension 1 (EXT1)|Moved|0
5345833|NCT00090220|18389502|P5|Extension 1 (EXT1)|Moved|0
5345834|NCT00090220|18389503|P4|Extension 1 (EXT1)|Moved|1
5345835|NCT00090220|18389504|P3|Extension 1 (EXT1)|Moved|2
5345836|NCT00090220|18389505|P2|Extension 1 (EXT1)|Moved|0
5345837|NCT00090220|18389506|P1|Extension 1 (EXT1)|Moved|0
5345838|NCT00090220|18389501|P6|Extension 1 (EXT1)|Lost to Follow-up|0
5345839|NCT00090220|18389502|P5|Extension 1 (EXT1)|Lost to Follow-up|0
5345840|NCT00090220|18389503|P4|Extension 1 (EXT1)|Lost to Follow-up|0
5345841|NCT00090220|18389504|P3|Extension 1 (EXT1)|Lost to Follow-up|22
5345842|NCT00090220|18389505|P2|Extension 1 (EXT1)|Lost to Follow-up|0
5345843|NCT00090220|18389506|P1|Extension 1 (EXT1)|Lost to Follow-up|0
5345844|NCT00090220|18389501|P6|Extension 1 (EXT1)|Adverse Event|0
5345845|NCT00090220|18389502|P5|Extension 1 (EXT1)|Adverse Event|0
5345846|NCT00090220|18389503|P4|Extension 1 (EXT1)|Adverse Event|0
5345847|NCT00090220|18389504|P3|Extension 1 (EXT1)|Adverse Event|4
5345848|NCT00090220|18389505|P2|Extension 1 (EXT1)|Adverse Event|0
5345849|NCT00090220|18389506|P1|Extension 1 (EXT1)|Adverse Event|0
5345850|NCT00090220|18389501|P6|Base Study Follow-up Period|Other|0
5345851|NCT00090220|18389502|P5|Base Study Follow-up Period|Other|0
5345852|NCT00090220|18389503|P4|Base Study Follow-up Period|Other|0
5345853|NCT00090220|18389504|P3|Base Study Follow-up Period|Other|0
5345854|NCT00090220|18389505|P2|Base Study Follow-up Period|Other|21
5345855|NCT00090220|18389506|P1|Base Study Follow-up Period|Other|19
5345856|NCT00090220|18389501|P6|Base Study Follow-up Period|Patient Moved|0
5345857|NCT00090220|18389502|P5|Base Study Follow-up Period|Patient Moved|0
5345858|NCT00090220|18389503|P4|Base Study Follow-up Period|Patient Moved|0
5345859|NCT00090220|18389504|P3|Base Study Follow-up Period|Patient Moved|0
5345860|NCT00090220|18389505|P2|Base Study Follow-up Period|Patient Moved|28
5345861|NCT00090220|18389506|P1|Base Study Follow-up Period|Patient Moved|20
5345862|NCT00090220|18389501|P6|Base Study Follow-up Period|Withdrawal by Subject|0
5345863|NCT00090220|18389502|P5|Base Study Follow-up Period|Withdrawal by Subject|0
5345864|NCT00090220|18389503|P4|Base Study Follow-up Period|Withdrawal by Subject|0
5345865|NCT00090220|18389504|P3|Base Study Follow-up Period|Withdrawal by Subject|0
5345866|NCT00090220|18389505|P2|Base Study Follow-up Period|Withdrawal by Subject|36
5345867|NCT00090220|18389506|P1|Base Study Follow-up Period|Withdrawal by Subject|27
5345868|NCT00090220|18389501|P6|Base Study Follow-up Period|Lost to Follow-up|0
5345869|NCT00090220|18389502|P5|Base Study Follow-up Period|Lost to Follow-up|0
5345870|NCT00090220|18389503|P4|Base Study Follow-up Period|Lost to Follow-up|0
5345871|NCT00090220|18389504|P3|Base Study Follow-up Period|Lost to Follow-up|0
5345872|NCT00090220|18389505|P2|Base Study Follow-up Period|Lost to Follow-up|78
5345873|NCT00090220|18389506|P1|Base Study Follow-up Period|Lost to Follow-up|88
5345874|NCT00090220|18389501|P6|Base Study Follow-up Period|Adverse Event|0
5345875|NCT00090220|18389502|P5|Base Study Follow-up Period|Adverse Event|0
5345876|NCT00090220|18389503|P4|Base Study Follow-up Period|Adverse Event|0
5345877|NCT00090220|18389504|P3|Base Study Follow-up Period|Adverse Event|0
5345878|NCT00090220|18389505|P2|Base Study Follow-up Period|Adverse Event|1
5345879|NCT00090220|18389506|P1|Base Study Follow-up Period|Adverse Event|6
5345880|NCT00090220|18389501|P6|Base Study Vaccination Period|Other|0
5345881|NCT00090220|18389502|P5|Base Study Vaccination Period|Other|0
5345882|NCT00090220|18389503|P4|Base Study Vaccination Period|Other|0
5345883|NCT00090220|18389504|P3|Base Study Vaccination Period|Other|0
5345884|NCT00090220|18389505|P2|Base Study Vaccination Period|Other|4
5345885|NCT00090220|18389506|P1|Base Study Vaccination Period|Other|4
5345886|NCT00090220|18389501|P6|Base Study Vaccination Period|Patient Moved|0
5345887|NCT00090220|18389502|P5|Base Study Vaccination Period|Patient Moved|0
5345888|NCT00090220|18389503|P4|Base Study Vaccination Period|Patient Moved|0
5345889|NCT00090220|18389504|P3|Base Study Vaccination Period|Patient Moved|0
5345890|NCT00090220|18389505|P2|Base Study Vaccination Period|Patient Moved|2
5345891|NCT00090220|18389506|P1|Base Study Vaccination Period|Patient Moved|6
5345892|NCT00090220|18389501|P6|Base Study Vaccination Period|Withdrawal by Subject|0
5345893|NCT00090220|18389502|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5345894|NCT00090220|18389503|P4|Base Study Vaccination Period|Withdrawal by Subject|0
5345895|NCT00090220|18389504|P3|Base Study Vaccination Period|Withdrawal by Subject|0
5345896|NCT00090220|18389505|P2|Base Study Vaccination Period|Withdrawal by Subject|27
5345897|NCT00090220|18389506|P1|Base Study Vaccination Period|Withdrawal by Subject|23
5345898|NCT00090220|18389501|P6|Base Study Vaccination Period|Lost to Follow-up|0
5345899|NCT00090220|18389502|P5|Base Study Vaccination Period|Lost to Follow-up|0
5345900|NCT00090220|18389503|P4|Base Study Vaccination Period|Lost to Follow-up|0
5345901|NCT00090220|18389504|P3|Base Study Vaccination Period|Lost to Follow-up|0
5345902|NCT00090220|18389505|P2|Base Study Vaccination Period|Lost to Follow-up|28
5345903|NCT00090220|18389506|P1|Base Study Vaccination Period|Lost to Follow-up|24
5345904|NCT00090220|18389501|P6|Base Study Vaccination Period|Adverse Event|0
5345905|NCT00090220|18389502|P5|Base Study Vaccination Period|Adverse Event|0
5345906|NCT00090220|18389503|P4|Base Study Vaccination Period|Adverse Event|0
5345907|NCT00090220|18389504|P3|Base Study Vaccination Period|Adverse Event|0
5345908|NCT00090220|18389505|P2|Base Study Vaccination Period|Adverse Event|1
5345909|NCT00090220|18389506|P1|Base Study Vaccination Period|Adverse Event|6
5345910|NCT00090220|18389501|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
5345911|NCT00090220|18389502|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
5345912|NCT00090220|18389503|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
5345913|NCT00090220|18389504|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
5345914|NCT00090220|18389505|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
5345915|NCT00090220|18389506|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
5345916|NCT00090402|18389601|P3|Overall Study|stopped taking study medication|1
5345917|NCT00090402|18389602|P2|Overall Study|stopped taking study medication|0
5345918|NCT00090402|18389603|P1|Overall Study|stopped taking study medication|1
5345919|NCT00090402|18389601|P3|Overall Study|subject moved|0
5345920|NCT00090402|18389602|P2|Overall Study|subject moved|1
5345921|NCT00090402|18389603|P1|Overall Study|subject moved|0
5345922|NCT00090402|18389601|P3|Overall Study|Death|0
5345923|NCT00090402|18389602|P2|Overall Study|Death|1
5345924|NCT00090402|18389603|P1|Overall Study|Death|1
5345925|NCT00090142|18389617|P2|Treatment Period II|Other|0
5345926|NCT00090142|18389618|P1|Treatment Period II|Other|1
5345927|NCT00090142|18389617|P2|Treatment Period I|Other|1
5345928|NCT00090142|18389618|P1|Treatment Period I|Other|0
5345929|NCT00090142|18389617|P2|Treatment Period I|Withdrawal by Subject|0
5345930|NCT00090142|18389618|P1|Treatment Period I|Withdrawal by Subject|2
5345931|NCT00090142|18389617|P2|Treatment Period I|Protocol Violation|0
5345932|NCT00090142|18389618|P1|Treatment Period I|Protocol Violation|2
5345933|NCT00090142|18389617|P2|Treatment Period I|Lost to Follow-up|2
5345934|NCT00090142|18389618|P1|Treatment Period I|Lost to Follow-up|1
5345935|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Other|0
5345936|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Other|1
5345937|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Other|0
5345938|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Jailed|0
5345939|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Jailed|1
5345940|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Jailed|0
5345941|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
5345942|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
5345943|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
5345944|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Depression|0
5345945|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Depression|1
5345946|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Depression|0
5345947|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
5345948|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
5345949|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
5345950|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
5345951|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
5345952|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
5345953|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Back Pain|0
5345954|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Back Pain|1
5345955|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Back Pain|0
5345956|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
5345957|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
5345958|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
5345959|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
5345960|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
5345961|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
5345962|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
5345963|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
5345964|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
5345965|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Gyneomastia|0
5345966|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Gyneomastia|0
5345967|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Gyneomastia|1
5345968|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Death|1
5345969|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Death|0
5345970|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Death|1
5345971|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
5345972|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
5345973|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
5345974|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Enrollment Error|2
5345975|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Enrollment Error|0
5345976|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Enrollment Error|1
5345977|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Loss of Libido|0
5345978|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Loss of Libido|0
5345979|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Loss of Libido|1
5345980|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
5345981|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
5345982|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
5345983|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
5345984|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
5345985|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
5345986|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
5345987|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
5345988|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
5345989|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
5345990|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
5345991|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
5345992|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Participant relocated|1
5345993|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Participant relocated|3
5345994|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Participant relocated|2
5345995|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
5345996|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
5345997|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
5345998|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Loss of Contact|2
5345999|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Loss of Contact|0
5346000|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Loss of Contact|4
5346001|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
5346002|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
5346003|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
5346004|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
5346005|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
5346006|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
5346007|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Protocol Violation|17
5346008|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Protocol Violation|18
5346009|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Protocol Violation|18
5346010|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
5346011|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
5346012|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
5346013|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
5346014|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
5346015|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
5346016|NCT00090103|18389649|P3|16-Week Safety Follow-up Period|Adverse Event|44
5346017|NCT00090103|18389650|P2|16-Week Safety Follow-up Period|Adverse Event|39
5346018|NCT00090103|18389651|P1|16-Week Safety Follow-up Period|Adverse Event|34
5346019|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
5346020|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
5346021|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
5346022|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
5346023|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
5346024|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
5346025|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
5346026|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
5346027|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
5346028|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
5346029|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
5346030|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
5346031|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
5346032|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
5346033|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
5346034|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
5346035|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
5346036|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
5346037|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
5346038|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
5346039|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
5346040|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
5346041|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
5346042|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
5346043|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
5346044|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
5346045|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
5346046|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
5346047|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
5346048|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
5346049|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
5346050|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
5346051|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
5346052|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
5346053|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
5346054|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
5346055|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
5346056|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
5346057|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
5346058|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
5346059|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
5346060|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
5346061|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
5346062|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
5346063|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
5346064|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
5346065|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
5346066|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
5346067|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
5346068|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
5346069|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
5346070|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
5346071|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
5346072|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
5346073|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
5346074|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
5346075|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
5346076|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
5346077|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
5346078|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
5346079|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
5346080|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
5346081|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
5346082|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
5346083|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
5346084|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
5346161|NCT00089986|18389841|P3|Overall Study|Lost to Follow-up|1
5346085|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
5346086|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
5346087|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
5346088|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
5346089|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
5346090|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
5346091|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
5346092|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
5346093|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
5346094|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
5346095|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
5346096|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
5346097|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
5346098|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
5346099|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
5346100|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
5346101|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
5346102|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
5346103|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
5346104|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
5346105|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
5346106|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
5346107|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
5346108|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
5346109|NCT00090103|18389649|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
5346110|NCT00090103|18389650|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
5346111|NCT00090103|18389651|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
5346112|NCT00089999|18389817|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
5346113|NCT00089999|18389818|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
5346114|NCT00089999|18389817|P2|Overall Study|Patient Underwent Surgery|0
5346115|NCT00089999|18389818|P1|Overall Study|Patient Underwent Surgery|2
5346116|NCT00089999|18389817|P2|Overall Study|Physician Decision|2
5346117|NCT00089999|18389818|P1|Overall Study|Physician Decision|2
5346118|NCT00089999|18389817|P2|Overall Study|Clinical Progression|2
5346119|NCT00089999|18389818|P1|Overall Study|Clinical Progression|1
5346120|NCT00089999|18389817|P2|Overall Study|Poor General Condition|0
5346121|NCT00089999|18389818|P1|Overall Study|Poor General Condition|1
5346122|NCT00089999|18389817|P2|Overall Study|Death|3
5346123|NCT00089999|18389818|P1|Overall Study|Death|3
5346124|NCT00089999|18389817|P2|Overall Study|Symptomatic Progression of Cancer|5
5346125|NCT00089999|18389818|P1|Overall Study|Symptomatic Progression of Cancer|2
5346126|NCT00089999|18389817|P2|Overall Study|Radiological Progression of Cancer|44
5346127|NCT00089999|18389818|P1|Overall Study|Radiological Progression of Cancer|52
5346128|NCT00089999|18389817|P2|Overall Study|Lost to Follow-up|1
5346129|NCT00089999|18389818|P1|Overall Study|Lost to Follow-up|2
5346130|NCT00089999|18389817|P2|Overall Study|Withdrawal by Subject|4
5346131|NCT00089999|18389818|P1|Overall Study|Withdrawal by Subject|0
5346132|NCT00089999|18389817|P2|Overall Study|Adverse Event|7
5346133|NCT00089999|18389818|P1|Overall Study|Adverse Event|4
5346134|NCT00089986|18389841|P3|Overall Study|Withdrawal by Subject|2
5346135|NCT00089986|18389842|P2|Overall Study|Withdrawal by Subject|6
5346136|NCT00089986|18389843|P1|Overall Study|Withdrawal by Subject|3
5346137|NCT00089986|18389841|P3|Overall Study|Do not resuscitate (DNR)|1
5346138|NCT00089986|18389842|P2|Overall Study|Do not resuscitate (DNR)|0
5346139|NCT00089986|18389843|P1|Overall Study|Do not resuscitate (DNR)|0
5346140|NCT00089986|18389841|P3|Overall Study|Family decision|0
5346141|NCT00089986|18389842|P2|Overall Study|Family decision|1
5346142|NCT00089986|18389843|P1|Overall Study|Family decision|0
5346143|NCT00089986|18389841|P3|Overall Study|Enrollment in another study|0
5346144|NCT00089986|18389842|P2|Overall Study|Enrollment in another study|1
5346145|NCT00089986|18389843|P1|Overall Study|Enrollment in another study|0
5346146|NCT00089986|18389841|P3|Overall Study|Investigator decision to withdrew|0
5346147|NCT00089986|18389842|P2|Overall Study|Investigator decision to withdrew|1
5346148|NCT00089986|18389843|P1|Overall Study|Investigator decision to withdrew|0
5346149|NCT00089986|18389841|P3|Overall Study|Hemohlobin stopping rule|0
5346150|NCT00089986|18389842|P2|Overall Study|Hemohlobin stopping rule|1
5346151|NCT00089986|18389843|P1|Overall Study|Hemohlobin stopping rule|0
5346152|NCT00089986|18389841|P3|Overall Study|Subject withdrew but agreed follow up|0
5346153|NCT00089986|18389842|P2|Overall Study|Subject withdrew but agreed follow up|2
5346154|NCT00089986|18389843|P1|Overall Study|Subject withdrew but agreed follow up|1
5346155|NCT00089986|18389841|P3|Overall Study|Patient transferred to another hospital|0
5346156|NCT00089986|18389842|P2|Overall Study|Patient transferred to another hospital|1
5346157|NCT00089986|18389843|P1|Overall Study|Patient transferred to another hospital|2
5346158|NCT00089986|18389841|P3|Overall Study|Protocol Violation|0
5346159|NCT00089986|18389842|P2|Overall Study|Protocol Violation|1
5346160|NCT00089986|18389843|P1|Overall Study|Protocol Violation|0
5346162|NCT00089986|18389842|P2|Overall Study|Lost to Follow-up|1
5346163|NCT00089986|18389843|P1|Overall Study|Lost to Follow-up|3
5346164|NCT00089986|18389841|P3|Overall Study|Adverse Event|6
5346165|NCT00089986|18389842|P2|Overall Study|Adverse Event|9
5346166|NCT00089986|18389843|P1|Overall Study|Adverse Event|6
5346167|NCT00089973|18389860|P1|Overall Study|Death|1
5346168|NCT00089973|18389860|P1|Overall Study|Disease progression|45
5346169|NCT00089973|18389860|P1|Overall Study|Withdrawal by Subject|1
5346170|NCT00089973|18389860|P1|Overall Study|Adverse Event|3
5346171|NCT00089895|18389875|P2|Overall Study|Missing|2
5346172|NCT00089895|18389876|P1|Overall Study|Missing|4
5346173|NCT00089895|18389875|P2|Overall Study|Not otherwise specified|8
5346174|NCT00089895|18389876|P1|Overall Study|Not otherwise specified|4
5346175|NCT00089895|18389875|P2|Overall Study|Exclusion criteria met|6
5346176|NCT00089895|18389876|P1|Overall Study|Exclusion criteria met|6
5346177|NCT00089895|18389875|P2|Overall Study|Physician Decision|7
5346178|NCT00089895|18389876|P1|Overall Study|Physician Decision|3
5346179|NCT00089895|18389875|P2|Overall Study|Bleeding|2
5346180|NCT00089895|18389876|P1|Overall Study|Bleeding|0
5346181|NCT00089895|18389875|P2|Overall Study|Surgery|1
5346182|NCT00089895|18389876|P1|Overall Study|Surgery|0
5346183|NCT00089895|18389875|P2|Overall Study|Technical reason|2
5346184|NCT00089895|18389876|P1|Overall Study|Technical reason|7
5346185|NCT00089895|18389875|P2|Overall Study|Consent Withdrawn|14
5346186|NCT00089895|18389876|P1|Overall Study|Consent Withdrawn|11
5346187|NCT00089843|18389888|P4|Overall Study|Physician Decision|1
5346188|NCT00089843|18389889|P3|Overall Study|Physician Decision|0
5346189|NCT00089843|18389890|P2|Overall Study|Physician Decision|0
5346190|NCT00089843|18389891|P1|Overall Study|Physician Decision|1
5346191|NCT00089843|18389888|P4|Overall Study|Withdrawal by Subject|6
5346192|NCT00089843|18389889|P3|Overall Study|Withdrawal by Subject|5
5346193|NCT00089843|18389890|P2|Overall Study|Withdrawal by Subject|4
5346194|NCT00089843|18389891|P1|Overall Study|Withdrawal by Subject|1
5346195|NCT00089791|18389903|P2|Overall Study|Requirement for alternative therapy|4
5346196|NCT00089791|18389904|P1|Overall Study|Requirement for alternative therapy|7
5346197|NCT00089791|18389903|P2|Overall Study|Protocol deviation|10
5346198|NCT00089791|18389904|P1|Overall Study|Protocol deviation|12
5346199|NCT00089791|18389903|P2|Overall Study|Other|32
5346200|NCT00089791|18389904|P1|Overall Study|Other|20
5346201|NCT00089791|18389903|P2|Overall Study|Noncompliance|13
5346202|NCT00089791|18389904|P1|Overall Study|Noncompliance|17
5346203|NCT00089791|18389903|P2|Overall Study|Lost to Follow-up|57
5346204|NCT00089791|18389904|P1|Overall Study|Lost to Follow-up|57
5346205|NCT00089791|18389903|P2|Overall Study|Ineligibility determined|9
5346206|NCT00089791|18389904|P1|Overall Study|Ineligibility determined|12
5346207|NCT00089791|18389903|P2|Overall Study|Disease progression|3
5346208|NCT00089791|18389904|P1|Overall Study|Disease progression|7
5346209|NCT00089791|18389903|P2|Overall Study|Death|62
5346210|NCT00089791|18389904|P1|Overall Study|Death|78
5346211|NCT00089791|18389903|P2|Overall Study|Withdrawal by Subject|344
5346212|NCT00089791|18389904|P1|Overall Study|Withdrawal by Subject|403
5346213|NCT00089791|18389903|P2|Overall Study|Adverse Event|93
5346214|NCT00089791|18389904|P1|Overall Study|Adverse Event|81
5346215|NCT00089791|18389903|P2|Overall Study|Physician Decision|3
5346216|NCT00089791|18389904|P1|Overall Study|Physician Decision|6
5346217|NCT00089778|18389938|P3|Overall Study|Protocol Violation|1
5346218|NCT00089778|18389939|P2|Overall Study|Protocol Violation|0
5346219|NCT00089778|18389940|P1|Overall Study|Protocol Violation|0
5346220|NCT00089674|18389953|P2|Overall Study|Requirement for alternative therapy|4
5346221|NCT00089674|18389954|P1|Overall Study|Requirement for alternative therapy|14
5346222|NCT00089674|18389953|P2|Overall Study|Other|9
5346223|NCT00089674|18389954|P1|Overall Study|Other|5
5346224|NCT00089674|18389953|P2|Overall Study|Noncompliance|3
5346225|NCT00089674|18389954|P1|Overall Study|Noncompliance|7
5346226|NCT00089674|18389953|P2|Overall Study|Lost to Follow-up|17
5346227|NCT00089674|18389954|P1|Overall Study|Lost to Follow-up|21
5346228|NCT00089674|18389953|P2|Overall Study|Ineligibility determined|10
5346229|NCT00089674|18389954|P1|Overall Study|Ineligibility determined|8
5346230|NCT00089674|18389953|P2|Overall Study|Disease progression|23
5346231|NCT00089674|18389954|P1|Overall Study|Disease progression|21
5346232|NCT00089674|18389953|P2|Overall Study|Death|43
5346233|NCT00089674|18389954|P1|Overall Study|Death|43
5346234|NCT00089674|18389953|P2|Overall Study|Withdrawal by Subject|127
5346235|NCT00089674|18389954|P1|Overall Study|Withdrawal by Subject|143
5346236|NCT00089674|18389953|P2|Overall Study|Adverse Event|29
5346237|NCT00089674|18389954|P1|Overall Study|Adverse Event|23
5346238|NCT00089674|18389953|P2|Overall Study|Physician Decision|2
5346239|NCT00089674|18389954|P1|Overall Study|Physician Decision|4
5346240|NCT00089661|18389980|P2|Overall Study|Other|1
5346241|NCT00089661|18389981|P1|Overall Study|Other|2
5346242|NCT00089661|18389980|P2|Overall Study|Noncompliance|4
5346243|NCT00089661|18389981|P1|Overall Study|Noncompliance|2
5346244|NCT00089661|18389980|P2|Overall Study|Ineligibility determined|4
5346245|NCT00089661|18389981|P1|Overall Study|Ineligibility determined|4
5346246|NCT00089661|18389980|P2|Overall Study|Disease progression|3
5346247|NCT00089661|18389981|P1|Overall Study|Disease progression|1
5346248|NCT00089661|18389980|P2|Overall Study|Withdrawal by Subject|9
5346249|NCT00089661|18389981|P1|Overall Study|Withdrawal by Subject|11
5346250|NCT00089661|18389980|P2|Overall Study|Lost to Follow-up|3
5346251|NCT00089661|18389981|P1|Overall Study|Lost to Follow-up|0
5346252|NCT00089661|18389980|P2|Overall Study|Death|0
5346253|NCT00089661|18389981|P1|Overall Study|Death|1
5346254|NCT00089661|18389980|P2|Overall Study|Adverse Event|2
5346255|NCT00089661|18389981|P1|Overall Study|Adverse Event|0
5346256|NCT00089648|18389997|P1|Overall Study|Lack of Efficacy|33
5346257|NCT00089648|18389997|P1|Overall Study|Withdrawal by Subject|1
5346258|NCT00089648|18389997|P1|Overall Study|Adverse Event|7
5346259|NCT00089635|18390013|P1|Overall Study|Other|2
5346260|NCT00089635|18390013|P1|Overall Study|Ineligibility determined|1
5346261|NCT00089635|18390013|P1|Overall Study|Withdrawal by Subject|6
5346262|NCT00089635|18390013|P1|Overall Study|Lost to Follow-up|3
5346263|NCT00089635|18390013|P1|Overall Study|Disease Progression|12
5346264|NCT00089635|18390013|P1|Overall Study|Death|17
5346265|NCT00089635|18390013|P1|Overall Study|Adverse Event|2
5346266|NCT00089583|18390027|P2|Overall Study|Participant Incarcerated|1
5346267|NCT00089583|18390028|P1|Overall Study|Participant Incarcerated|0
5346268|NCT00089583|18390027|P2|Overall Study|Necessity to Use Prohibited Drug|0
5346269|NCT00089583|18390028|P1|Overall Study|Necessity to Use Prohibited Drug|1
5346270|NCT00089583|18390027|P2|Overall Study|Start of Disallowed Medication|1
5346271|NCT00089583|18390028|P1|Overall Study|Start of Disallowed Medication|0
5346272|NCT00089583|18390027|P2|Overall Study|Principal Investigator Decision|10
5346273|NCT00089583|18390028|P1|Overall Study|Principal Investigator Decision|0
5346274|NCT00089583|18390027|P2|Overall Study|Protocol Violation|3
5346275|NCT00089583|18390028|P1|Overall Study|Protocol Violation|0
5346276|NCT00089583|18390027|P2|Overall Study|Reason Not Provided|1
5346277|NCT00089583|18390028|P1|Overall Study|Reason Not Provided|0
5346278|NCT00089583|18390027|P2|Overall Study|Participant Management Criteria Met|1
5346279|NCT00089583|18390028|P1|Overall Study|Participant Management Criteria Met|0
5346280|NCT00089583|18390027|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
5346281|NCT00089583|18390028|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
5346282|NCT00089583|18390027|P2|Overall Study|Non-Compliance|4
5346283|NCT00089583|18390028|P1|Overall Study|Non-Compliance|0
5346284|NCT00089583|18390027|P2|Overall Study|Participant Refused Study Medication|2
5346285|NCT00089583|18390028|P1|Overall Study|Participant Refused Study Medication|0
5346286|NCT00089583|18390027|P2|Overall Study|Participant (Par) Didn't Take Medication|0
5346287|NCT00089583|18390028|P1|Overall Study|Participant (Par) Didn't Take Medication|1
5346288|NCT00089583|18390027|P2|Overall Study|Withdrawal by Subject|4
5346289|NCT00089583|18390028|P1|Overall Study|Withdrawal by Subject|0
5346290|NCT00089583|18390027|P2|Overall Study|Insufficient Viral Load Response|5
5346291|NCT00089583|18390028|P1|Overall Study|Insufficient Viral Load Response|5
5346292|NCT00089583|18390027|P2|Overall Study|Adverse Event|3
5346293|NCT00089583|18390028|P1|Overall Study|Adverse Event|0
5346294|NCT00089609|18390122|P2|Overall Study|Withdrawal by Subject|1
5346295|NCT00089609|18390123|P1|Overall Study|Withdrawal by Subject|3
5346296|NCT00089544|18390142|P2|Overall Study|Ineligible|0
5346297|NCT00089544|18390143|P1|Overall Study|Ineligible|1
5346298|NCT00089505|18390157|P4|Overall Study|Protocol Violation|0
5346299|NCT00089505|18390158|P3|Overall Study|Protocol Violation|1
5346300|NCT00089505|18390159|P2|Overall Study|Protocol Violation|0
5346301|NCT00089505|18390160|P1|Overall Study|Protocol Violation|0
5346302|NCT00089505|18390157|P4|Overall Study|Physician Decision|0
5346303|NCT00089505|18390158|P3|Overall Study|Physician Decision|0
5346304|NCT00089505|18390159|P2|Overall Study|Physician Decision|0
5346305|NCT00089505|18390160|P1|Overall Study|Physician Decision|1
5346306|NCT00089505|18390157|P4|Overall Study|Lost to Follow-up|7
5346307|NCT00089505|18390158|P3|Overall Study|Lost to Follow-up|9
5346308|NCT00089505|18390159|P2|Overall Study|Lost to Follow-up|1
5346309|NCT00089505|18390160|P1|Overall Study|Lost to Follow-up|1
5346310|NCT00089505|18390157|P4|Overall Study|Withdrawal by Subject|6
5346311|NCT00089505|18390158|P3|Overall Study|Withdrawal by Subject|6
5346312|NCT00089505|18390159|P2|Overall Study|Withdrawal by Subject|0
5346313|NCT00089505|18390160|P1|Overall Study|Withdrawal by Subject|3
5346314|NCT00089505|18390157|P4|Overall Study|Death|8
5346315|NCT00089505|18390158|P3|Overall Study|Death|5
5346316|NCT00089505|18390159|P2|Overall Study|Death|1
5346317|NCT00089505|18390160|P1|Overall Study|Death|4
5346318|NCT00089479|18390204|P2|Overall Study|Lost to Follow-up|107
5346319|NCT00089479|18390205|P1|Overall Study|Lost to Follow-up|137
5346320|NCT00089479|18390204|P2|Overall Study|Withdrawal by Subject|107
5346321|NCT00089479|18390205|P1|Overall Study|Withdrawal by Subject|86
5346322|NCT00089479|18390204|P2|Overall Study|Death|75
5346323|NCT00089479|18390205|P1|Overall Study|Death|108
5346324|NCT00089297|18390248|P1|Overall Study|Non-compliance|1
5346325|NCT00089297|18390248|P1|Overall Study|IRB approval not ready|1
5346326|NCT00089297|18390248|P1|Overall Study|Secondary malignancy|1
5346327|NCT00089297|18390248|P1|Overall Study|Ineligible|11
5346328|NCT00089297|18390248|P1|Overall Study|Disease progression|2
5346329|NCT00089297|18390248|P1|Overall Study|Withdrawal by Subject|12
5346330|NCT00089297|18390248|P1|Overall Study|Death|1
5346331|NCT00089297|18390248|P1|Overall Study|Adverse Event|9
5346332|NCT00089284|18390260|P7|Overall Study|Adverse event before starting treatment|1
5346333|NCT00089284|18390261|P6|Overall Study|Adverse event before starting treatment|0
5346334|NCT00089284|18390262|P5|Overall Study|Adverse event before starting treatment|0
5346335|NCT00089284|18390263|P4|Overall Study|Adverse event before starting treatment|0
5346336|NCT00089284|18390264|P3|Overall Study|Adverse event before starting treatment|0
5346337|NCT00089284|18390265|P2|Overall Study|Adverse event before starting treatment|0
5346338|NCT00089284|18390266|P1|Overall Study|Adverse event before starting treatment|0
5346339|NCT00089141|18390303|P2|Overall Study|Termination of trial|24
5346340|NCT00089141|18390304|P1|Overall Study|Termination of trial|18
5346341|NCT00089076|18390340|P1|Overall Study|Progression|7
5346342|NCT00089076|18390340|P1|Overall Study|Withdrawal by Subject|2
5346343|NCT00089076|18390340|P1|Overall Study|Alternate Therapy|1
5346344|NCT00088907|18390397|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
5346345|NCT00088907|18390398|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
5346346|NCT00088907|18390397|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
5346347|NCT00088907|18390398|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
5346348|NCT00088907|18390397|P2|Single Gefitinib Treatment (Step 2)|Death|0
5346349|NCT00088907|18390398|P1|Single Gefitinib Treatment (Step 2)|Death|1
5346350|NCT00088907|18390397|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
5346351|NCT00088907|18390398|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
5346352|NCT00088907|18390397|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
5346353|NCT00088907|18390398|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
5346354|NCT00088907|18390397|P2|Randomized Study (Step 1)|unknown/not specify|13
5346355|NCT00088907|18390398|P1|Randomized Study (Step 1)|unknown/not specify|24
5346356|NCT00088907|18390397|P2|Randomized Study (Step 1)|complicating disease|1
5346357|NCT00088907|18390398|P1|Randomized Study (Step 1)|complicating disease|3
5346358|NCT00088907|18390397|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
5346359|NCT00088907|18390398|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
5346360|NCT00088907|18390397|P2|Randomized Study (Step 1)|Death|12
5346361|NCT00088907|18390398|P1|Randomized Study (Step 1)|Death|11
5346362|NCT00088907|18390397|P2|Randomized Study (Step 1)|Adverse Event|19
5346363|NCT00088907|18390398|P1|Randomized Study (Step 1)|Adverse Event|14
5346364|NCT00088907|18390397|P2|Randomized Study (Step 1)|Lack of Efficacy|62
5346365|NCT00088907|18390398|P1|Randomized Study (Step 1)|Lack of Efficacy|55
5346366|NCT00088881|18390409|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
5346367|NCT00088881|18390409|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
5346368|NCT00088881|18390409|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
5346369|NCT00088881|18390409|P1|Step 1 - R-CHOP|Physician Decision|1
5346370|NCT00088881|18390409|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
5346371|NCT00088881|18390409|P1|Step 1 - R-CHOP|Adverse Event|1
5346372|NCT00088881|18390409|P1|Step 1 - R-CHOP|Patient ineligible|9
5346373|NCT00088829|18390418|P1|Overall Study|PI left institution and study was close|22
5346374|NCT00088595|18390460|P1|Overall Study|New Cancer Therapy|2
5346375|NCT00088595|18390460|P1|Overall Study|Ongoing (After Core)|7
5346376|NCT00088595|18390460|P1|Overall Study|Withdrawal by Subject|8
5346377|NCT00088595|18390460|P1|Overall Study|Adverse Event|11
5346378|NCT00088530|18390478|P2|Overall Study|Patient never treated|0
5346379|NCT00088530|18390479|P1|Overall Study|Patient never treated|1
5346380|NCT00088530|18390478|P2|Overall Study|Sponsor decision|1
5346381|NCT00088530|18390479|P1|Overall Study|Sponsor decision|0
5346382|NCT00088530|18390478|P2|Overall Study|Physician Decision|0
5346383|NCT00088530|18390479|P1|Overall Study|Physician Decision|2
5346384|NCT00088530|18390478|P2|Overall Study|Lost to Follow-up|0
5346385|NCT00088530|18390479|P1|Overall Study|Lost to Follow-up|2
5346386|NCT00088530|18390478|P2|Overall Study|Withdrawal by Subject|5
5346387|NCT00088530|18390479|P1|Overall Study|Withdrawal by Subject|2
5346388|NCT00088530|18390478|P2|Overall Study|Adverse Event|9
5346389|NCT00088530|18390479|P1|Overall Study|Adverse Event|15
5346390|NCT00088530|18390478|P2|Overall Study|Progressive/Relapsed Disease|39
5346391|NCT00088530|18390479|P1|Overall Study|Progressive/Relapsed Disease|28
5346392|NCT00088465|18390491|P1|Overall Study|Death|11
5346393|NCT00088465|18390491|P1|Overall Study|Protocol Violation|17
5346394|NCT00088465|18390491|P1|Overall Study|Lack of Efficacy|27
5346395|NCT00088465|18390491|P1|Overall Study|Sponsor Decision|37
5346396|NCT00088465|18390491|P1|Overall Study|Physician Decision|45
5346397|NCT00088465|18390491|P1|Overall Study|Lost to Follow-up|57
5346398|NCT00088465|18390491|P1|Overall Study|Adverse Event|77
5346399|NCT00088465|18390491|P1|Overall Study|Withdrawal by Subject|290
5346400|NCT00088452|18390517|P3|Overall Study|Did not receive intervention|1
5346401|NCT00088452|18390518|P2|Overall Study|Did not receive intervention|0
5346402|NCT00088452|18390519|P1|Overall Study|Did not receive intervention|1
5346403|NCT00088413|18390537|P4|Overall Study|Patient unevaluable due to adverse event|0
5346404|NCT00088413|18390538|P3|Overall Study|Patient unevaluable due to adverse event|1
5346405|NCT00088413|18390539|P2|Overall Study|Patient unevaluable due to adverse event|0
5346406|NCT00088413|18390540|P1|Overall Study|Patient unevaluable due to adverse event|0
5346407|NCT00088413|18390537|P4|Overall Study|Other|0
5346408|NCT00088413|18390538|P3|Overall Study|Other|0
5346409|NCT00088413|18390539|P2|Overall Study|Other|1
5346410|NCT00088413|18390540|P1|Overall Study|Other|0
5346411|NCT00088413|18390537|P4|Overall Study|Progressive disease|14
5346412|NCT00088413|18390538|P3|Overall Study|Progressive disease|8
5346413|NCT00088413|18390539|P2|Overall Study|Progressive disease|11
5346414|NCT00088413|18390540|P1|Overall Study|Progressive disease|9
5346415|NCT00088413|18390537|P4|Overall Study|Death|0
5346416|NCT00088413|18390538|P3|Overall Study|Death|0
5346417|NCT00088413|18390539|P2|Overall Study|Death|1
5346418|NCT00088413|18390540|P1|Overall Study|Death|0
5346419|NCT00088413|18390537|P4|Overall Study|Off study due to missing a vaccine dose|0
5346420|NCT00088413|18390538|P3|Overall Study|Off study due to missing a vaccine dose|0
5346421|NCT00088413|18390539|P2|Overall Study|Off study due to missing a vaccine dose|0
5346422|NCT00088413|18390540|P1|Overall Study|Off study due to missing a vaccine dose|1
5346423|NCT00088413|18390537|P4|Overall Study|Refused trmt Off-study per pt wishes|0
5346424|NCT00088413|18390538|P3|Overall Study|Refused trmt Off-study per pt wishes|1
5346425|NCT00088413|18390539|P2|Overall Study|Refused trmt Off-study per pt wishes|1
5346426|NCT00088413|18390540|P1|Overall Study|Refused trmt Off-study per pt wishes|0
5346427|NCT00088413|18390537|P4|Overall Study|Adverse Events/Side Effects|0
5346428|NCT00088413|18390538|P3|Overall Study|Adverse Events/Side Effects|1
5346429|NCT00088413|18390539|P2|Overall Study|Adverse Events/Side Effects|1
5346430|NCT00088413|18390540|P1|Overall Study|Adverse Events/Side Effects|0
5346431|NCT00088413|18390537|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
5346432|NCT00088413|18390538|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
5346433|NCT00088413|18390539|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
5346434|NCT00088413|18390540|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
5346435|NCT00088374|18390554|P1|Overall Study|patient received <1 cycle only of 17AAG|1
5346436|NCT00088374|18390554|P1|Overall Study|patient did not receive any 17AAG|1
5346437|NCT00088205|18390572|P1|Overall Study|Death Due to Study Disease|4
5346438|NCT00088205|18390572|P1|Overall Study|Physician Decision|1
5346439|NCT00088205|18390572|P1|Overall Study|Progressive Disease|51
5346440|NCT00088205|18390572|P1|Overall Study|Adverse Event|4
5346441|NCT00088166|18390589|P2|Overall Study|Withdrawal by Subject|5
5346442|NCT00088166|18390590|P1|Overall Study|Withdrawal by Subject|5
5346443|NCT00088166|18390589|P2|Overall Study|Patient deterioration|39
5346444|NCT00088166|18390590|P1|Overall Study|Patient deterioration|29
5346445|NCT00088166|18390589|P2|Overall Study|Protocol Violation|5
5346446|NCT00088166|18390590|P1|Overall Study|Protocol Violation|1
5346447|NCT00088166|18390589|P2|Overall Study|Physician Decision|1
5346448|NCT00088166|18390590|P1|Overall Study|Physician Decision|4
5346449|NCT00088166|18390589|P2|Overall Study|Lost to Follow-up|1
5346450|NCT00088166|18390590|P1|Overall Study|Lost to Follow-up|0
5346451|NCT00088166|18390589|P2|Overall Study|Death|1
5346452|NCT00088166|18390590|P1|Overall Study|Death|3
5346453|NCT00088166|18390589|P2|Overall Study|Adverse Event|9
5346454|NCT00088166|18390590|P1|Overall Study|Adverse Event|11
5346455|NCT00088153|18390614|P2|Overall Study|Lost to Follow-up|12
5346456|NCT00088153|18390615|P1|Overall Study|Lost to Follow-up|11
5346457|NCT00088153|18390614|P2|Overall Study|Withdrawal by Subject|10
5346458|NCT00088153|18390615|P1|Overall Study|Withdrawal by Subject|10
5346459|NCT00088153|18390614|P2|Overall Study|Physician Decision|3
5346460|NCT00088153|18390615|P1|Overall Study|Physician Decision|3
5346461|NCT00087698|18390625|P1|Overall Study|Protocol Violation|1
5346462|NCT00087698|18390625|P1|Overall Study|Death from Study Drug Toxicity|2
5346463|NCT00087698|18390625|P1|Overall Study|Death from Study Disease|2
5346464|NCT00087698|18390625|P1|Overall Study|Clinical Relapse|1
5346465|NCT00087698|18390625|P1|Overall Study|Protocol Entry Criteria Not Met|2
5346466|NCT00087698|18390625|P1|Overall Study|Lack of Efficacy, Physician Perception|3
5346467|NCT00087698|18390625|P1|Overall Study|Withdrawal by Subject|4
5346468|NCT00087698|18390625|P1|Overall Study|Adverse Event|4
5346469|NCT00087698|18390625|P1|Overall Study|Death from Other Causes|3
5346470|NCT00087698|18390625|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
5346471|NCT00087685|18390634|P1|Overall Study|Withdrawal by Subject|3
5346472|NCT00087685|18390634|P1|Overall Study|Progressive Disease|5
5346473|NCT00087685|18390634|P1|Overall Study|Non-Compliance|1
5346474|NCT00087685|18390634|P1|Overall Study|Adverse Event|5
5346475|NCT00087646|18390647|P4|Overall Study|Violation of Selection Criteria at Entry|1
5346476|NCT00087646|18390648|P3|Overall Study|Violation of Selection Criteria at Entry|0
5346477|NCT00087646|18390649|P2|Overall Study|Violation of Selection Criteria at Entry|0
5346478|NCT00087646|18390650|P1|Overall Study|Violation of Selection Criteria at Entry|1
5346479|NCT00087646|18390647|P4|Overall Study|Other Protocol Violation|0
5346480|NCT00087646|18390648|P3|Overall Study|Other Protocol Violation|0
5346481|NCT00087646|18390649|P2|Overall Study|Other Protocol Violation|1
5346482|NCT00087646|18390650|P1|Overall Study|Other Protocol Violation|3
5346483|NCT00087646|18390647|P4|Overall Study|Administrative/Other|2
5346484|NCT00087646|18390648|P3|Overall Study|Administrative/Other|1
5346485|NCT00087646|18390649|P2|Overall Study|Administrative/Other|1
5346486|NCT00087646|18390650|P1|Overall Study|Administrative/Other|6
5346487|NCT00087646|18390647|P4|Overall Study|Failure to Return|3
5346488|NCT00087646|18390648|P3|Overall Study|Failure to Return|2
5346489|NCT00087646|18390649|P2|Overall Study|Failure to Return|2
5346490|NCT00087646|18390650|P1|Overall Study|Failure to Return|5
5346491|NCT00087646|18390647|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
5346492|NCT00087646|18390648|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
5346493|NCT00087646|18390649|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
5346494|NCT00087646|18390650|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
5346495|NCT00087646|18390647|P4|Overall Study|Insufficient therapeutic response|51
5346496|NCT00087646|18390648|P3|Overall Study|Insufficient therapeutic response|38
5346497|NCT00087646|18390649|P2|Overall Study|Insufficient therapeutic response|24
5346498|NCT00087646|18390650|P1|Overall Study|Insufficient therapeutic response|64
5346499|NCT00087646|18390647|P4|Overall Study|Withdrawal by Subject|2
5346500|NCT00087646|18390648|P3|Overall Study|Withdrawal by Subject|2
5346501|NCT00087646|18390649|P2|Overall Study|Withdrawal by Subject|1
5346502|NCT00087646|18390650|P1|Overall Study|Withdrawal by Subject|6
5346503|NCT00087646|18390647|P4|Overall Study|Death|0
5346504|NCT00087646|18390648|P3|Overall Study|Death|0
5346505|NCT00087646|18390649|P2|Overall Study|Death|1
5346506|NCT00087646|18390650|P1|Overall Study|Death|0
5346507|NCT00087646|18390647|P4|Overall Study|Adverse Event|20
5346508|NCT00087646|18390648|P3|Overall Study|Adverse Event|18
5346509|NCT00087646|18390649|P2|Overall Study|Adverse Event|6
5346510|NCT00087646|18390650|P1|Overall Study|Adverse Event|37
5346511|NCT00087607|18390689|P2|Overall Study|Violation of Selection Criteria at Entry|1
5346512|NCT00087607|18390690|P1|Overall Study|Violation of Selection Criteria at Entry|0
5346513|NCT00087607|18390689|P2|Overall Study|Other Protocol Violation|2
5346514|NCT00087607|18390690|P1|Overall Study|Other Protocol Violation|5
5346515|NCT00087607|18390689|P2|Overall Study|Refused Treatment|7
5346516|NCT00087607|18390690|P1|Overall Study|Refused Treatment|5
5346517|NCT00087607|18390689|P2|Overall Study|Administrative|12
5346518|NCT00087607|18390690|P1|Overall Study|Administrative|12
5346519|NCT00087607|18390689|P2|Overall Study|Withdrew Consent|16
5346520|NCT00087607|18390690|P1|Overall Study|Withdrew Consent|12
5346521|NCT00087607|18390689|P2|Overall Study|Failure to return|17
5346522|NCT00087607|18390690|P1|Overall Study|Failure to return|21
5346523|NCT00087607|18390689|P2|Overall Study|Insufficient Therapeutic Response|42
5346524|NCT00087607|18390690|P1|Overall Study|Insufficient Therapeutic Response|53
5346525|NCT00087607|18390689|P2|Overall Study|Death|1
5346526|NCT00087607|18390690|P1|Overall Study|Death|0
5346527|NCT00087607|18390689|P2|Overall Study|Adverse Event|24
5346528|NCT00087607|18390690|P1|Overall Study|Adverse Event|14
5346529|NCT00087594|18390730|P2|Overall Study|Lack of Efficacy|5
5346530|NCT00087594|18390731|P1|Overall Study|Lack of Efficacy|2
5346531|NCT00087594|18390730|P2|Overall Study|Withdrawal by Subject|2
5346532|NCT00087594|18390731|P1|Overall Study|Withdrawal by Subject|4
5346533|NCT00087594|18390730|P2|Overall Study|Lost to Follow-up|2
5346534|NCT00087594|18390731|P1|Overall Study|Lost to Follow-up|0
5346535|NCT00087594|18390730|P2|Overall Study|Adverse Event|3
5346536|NCT00087594|18390731|P1|Overall Study|Adverse Event|2
5346537|NCT00087568|18390765|P2|Overall Study|Lack of Efficacy|1
5346538|NCT00087568|18390766|P1|Overall Study|Lack of Efficacy|24
5346539|NCT00087568|18390765|P2|Overall Study|Lost to Follow-up|0
5346540|NCT00087568|18390766|P1|Overall Study|Lost to Follow-up|1
5346541|NCT00087568|18390765|P2|Overall Study|Withdrawal by Subject|1
5346542|NCT00087568|18390766|P1|Overall Study|Withdrawal by Subject|1
5346543|NCT00087568|18390765|P2|Overall Study|Adverse Event|0
5346544|NCT00087568|18390766|P1|Overall Study|Adverse Event|4
5346545|NCT00087555|18390793|P3|Overall Study|Patient wanted to go back on Med|0
5346546|NCT00087555|18390794|P2|Overall Study|Patient wanted to go back on Med|0
5346547|NCT00087555|18390795|P1|Overall Study|Patient wanted to go back on Med|1
5346548|NCT00087555|18390793|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
5346549|NCT00087555|18390794|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
5346550|NCT00087555|18390795|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
5346551|NCT00087555|18390793|P3|Overall Study|Non Compliance|1
5346552|NCT00087555|18390794|P2|Overall Study|Non Compliance|0
5346553|NCT00087555|18390795|P1|Overall Study|Non Compliance|0
5346554|NCT00087555|18390793|P3|Overall Study|Lack of Efficacy|1
5346555|NCT00087555|18390794|P2|Overall Study|Lack of Efficacy|0
5346556|NCT00087555|18390795|P1|Overall Study|Lack of Efficacy|2
5346557|NCT00087555|18390793|P3|Overall Study|Withdrawal by Subject|1
5346558|NCT00087555|18390794|P2|Overall Study|Withdrawal by Subject|2
5346559|NCT00087555|18390795|P1|Overall Study|Withdrawal by Subject|3
5346560|NCT00087555|18390793|P3|Overall Study|Pregnancy|1
5346561|NCT00087555|18390794|P2|Overall Study|Pregnancy|1
5346562|NCT00087555|18390795|P1|Overall Study|Pregnancy|0
5346563|NCT00087555|18390793|P3|Overall Study|Screen Failure|0
5346564|NCT00087555|18390794|P2|Overall Study|Screen Failure|1
5346565|NCT00087555|18390795|P1|Overall Study|Screen Failure|1
5346566|NCT00087555|18390793|P3|Overall Study|Protocol Violation|2
5346567|NCT00087555|18390794|P2|Overall Study|Protocol Violation|0
5346568|NCT00087555|18390795|P1|Overall Study|Protocol Violation|0
5346569|NCT00087555|18390793|P3|Overall Study|Non - Compliance|0
5346570|NCT00087555|18390794|P2|Overall Study|Non - Compliance|0
5346571|NCT00087555|18390795|P1|Overall Study|Non - Compliance|1
5346572|NCT00087555|18390793|P3|Overall Study|Lost to Follow-up|1
5346573|NCT00087555|18390794|P2|Overall Study|Lost to Follow-up|1
5346574|NCT00087555|18390795|P1|Overall Study|Lost to Follow-up|0
5346575|NCT00087555|18390793|P3|Overall Study|Adverse Event|14
5346576|NCT00087555|18390794|P2|Overall Study|Adverse Event|6
5346577|NCT00087555|18390795|P1|Overall Study|Adverse Event|3
5346578|NCT00087529|18390805|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
5346579|NCT00087529|18390806|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
5346580|NCT00087529|18390805|P2|Overall Study|Disease Progression|4
5346581|NCT00087529|18390806|P1|Overall Study|Disease Progression|5
5346582|NCT00087529|18390805|P2|Overall Study|Participant Noncompliance|1
5346583|NCT00087529|18390806|P1|Overall Study|Participant Noncompliance|0
5346584|NCT00087529|18390805|P2|Overall Study|Initiation of Excluded Therapy|1
5346585|NCT00087529|18390806|P1|Overall Study|Initiation of Excluded Therapy|0
5346586|NCT00087529|18390805|P2|Overall Study|Physician Decision|8
5346587|NCT00087529|18390806|P1|Overall Study|Physician Decision|4
5346588|NCT00087529|18390805|P2|Overall Study|Participant Decision|37
5346589|NCT00087529|18390806|P1|Overall Study|Participant Decision|14
5346590|NCT00087529|18390805|P2|Overall Study|Lost to Follow-up|3
5346591|NCT00087529|18390806|P1|Overall Study|Lost to Follow-up|2
5346592|NCT00087529|18390805|P2|Overall Study|Pregnancy|1
5346593|NCT00087529|18390806|P1|Overall Study|Pregnancy|0
5346594|NCT00087529|18390805|P2|Overall Study|Adverse Event|8
5346595|NCT00087529|18390806|P1|Overall Study|Adverse Event|0
5346596|NCT00087529|18390805|P2|Overall Study|Death|0
5346597|NCT00087529|18390806|P1|Overall Study|Death|1
5346598|NCT00087516|18390821|P4|Overall Study|Other|0
5346599|NCT00087516|18390822|P3|Overall Study|Other|1
5346600|NCT00087516|18390823|P2|Overall Study|Other|0
5346601|NCT00087516|18390824|P1|Overall Study|Other|0
5346602|NCT00087516|18390821|P4|Overall Study|Recommendation of Primary Care Physician|1
5346603|NCT00087516|18390822|P3|Overall Study|Recommendation of Primary Care Physician|0
5346604|NCT00087516|18390823|P2|Overall Study|Recommendation of Primary Care Physician|0
5346605|NCT00087516|18390824|P1|Overall Study|Recommendation of Primary Care Physician|0
5346606|NCT00087516|18390821|P4|Overall Study|Patient was non-compliant|0
5346607|NCT00087516|18390822|P3|Overall Study|Patient was non-compliant|0
5346608|NCT00087516|18390823|P2|Overall Study|Patient was non-compliant|1
5346609|NCT00087516|18390824|P1|Overall Study|Patient was non-compliant|3
5346610|NCT00087516|18390821|P4|Overall Study|Patient moved|0
5346611|NCT00087516|18390822|P3|Overall Study|Patient moved|1
5346612|NCT00087516|18390823|P2|Overall Study|Patient moved|2
5346613|NCT00087516|18390824|P1|Overall Study|Patient moved|3
5346614|NCT00087516|18390821|P4|Overall Study|Protocol specified discontinuation|26
5346615|NCT00087516|18390822|P3|Overall Study|Protocol specified discontinuation|33
5346616|NCT00087516|18390823|P2|Overall Study|Protocol specified discontinuation|33
5346617|NCT00087516|18390824|P1|Overall Study|Protocol specified discontinuation|35
5346618|NCT00087516|18390821|P4|Overall Study|Site terminated|0
5346619|NCT00087516|18390822|P3|Overall Study|Site terminated|1
5346620|NCT00087516|18390823|P2|Overall Study|Site terminated|2
5346621|NCT00087516|18390824|P1|Overall Study|Site terminated|0
5346622|NCT00087516|18390821|P4|Overall Study|Withdrawal by Subject|12
5346623|NCT00087516|18390822|P3|Overall Study|Withdrawal by Subject|11
5346624|NCT00087516|18390823|P2|Overall Study|Withdrawal by Subject|27
5346625|NCT00087516|18390824|P1|Overall Study|Withdrawal by Subject|16
5346626|NCT00087516|18390821|P4|Overall Study|Protocol Violation|6
5346627|NCT00087516|18390822|P3|Overall Study|Protocol Violation|3
5346628|NCT00087516|18390823|P2|Overall Study|Protocol Violation|8
5346629|NCT00087516|18390824|P1|Overall Study|Protocol Violation|4
5346630|NCT00087516|18390821|P4|Overall Study|Lost to Follow-up|5
5346631|NCT00087516|18390822|P3|Overall Study|Lost to Follow-up|5
5346632|NCT00087516|18390823|P2|Overall Study|Lost to Follow-up|6
5346633|NCT00087516|18390824|P1|Overall Study|Lost to Follow-up|8
5346634|NCT00087516|18390821|P4|Overall Study|Lack of Efficacy|29
5346635|NCT00087516|18390822|P3|Overall Study|Lack of Efficacy|39
5346636|NCT00087516|18390823|P2|Overall Study|Lack of Efficacy|80
5346637|NCT00087516|18390824|P1|Overall Study|Lack of Efficacy|82
5346638|NCT00087516|18390821|P4|Overall Study|Adverse Event|6
5346639|NCT00087516|18390822|P3|Overall Study|Adverse Event|3
5346640|NCT00087516|18390823|P2|Overall Study|Adverse Event|10
5346641|NCT00087516|18390824|P1|Overall Study|Adverse Event|10
5346642|NCT00087490|18390853|P2|Overall Study|Randomized but not treated|18
5346643|NCT00087490|18390854|P1|Overall Study|Randomized but not treated|7
5346644|NCT00087490|18390853|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
5346645|NCT00087490|18390854|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
5346646|NCT00087490|18390853|P2|Overall Study|Protocol Violation or (/) Unspecified|201
5346647|NCT00087490|18390854|P1|Overall Study|Protocol Violation or (/) Unspecified|214
5346648|NCT00087490|18390853|P2|Overall Study|Lack of Efficacy|2
5346649|NCT00087490|18390854|P1|Overall Study|Lack of Efficacy|0
5346650|NCT00087490|18390853|P2|Overall Study|Adverse Event|8
5346651|NCT00087490|18390854|P1|Overall Study|Adverse Event|3
5346652|NCT00087490|18390853|P2|Overall Study|Death|4
5346653|NCT00087490|18390854|P1|Overall Study|Death|6
5346654|NCT00087438|18390888|P1|Overall Study|Ineligible / No protocol treatment|4
5346655|NCT00087152|18390898|P1|Overall Study|Ineligible|6
5346656|NCT00087139|18390907|P3|Overall Study|Extradural disease|1
5346657|NCT00087139|18390908|P2|Overall Study|Extradural disease|0
5346658|NCT00087139|18390909|P1|Overall Study|Extradural disease|0
5346659|NCT00087139|18390907|P3|Overall Study|Response achieved|0
5346660|NCT00087139|18390908|P2|Overall Study|Response achieved|1
5346661|NCT00087139|18390909|P1|Overall Study|Response achieved|0
5346662|NCT00087139|18390907|P3|Overall Study|Use of coumadin|0
5346663|NCT00087139|18390908|P2|Overall Study|Use of coumadin|0
5346664|NCT00087139|18390909|P1|Overall Study|Use of coumadin|1
5346665|NCT00087139|18390907|P3|Overall Study|Symptomatic deterioration|3
5346666|NCT00087139|18390908|P2|Overall Study|Symptomatic deterioration|1
5346667|NCT00087139|18390909|P1|Overall Study|Symptomatic deterioration|1
5346668|NCT00087139|18390907|P3|Overall Study|Ineligible|4
5346669|NCT00087139|18390908|P2|Overall Study|Ineligible|7
5346670|NCT00087139|18390909|P1|Overall Study|Ineligible|4
5346671|NCT00087139|18390907|P3|Overall Study|Disease progression|12
5346672|NCT00087139|18390908|P2|Overall Study|Disease progression|19
5346673|NCT00087139|18390909|P1|Overall Study|Disease progression|9
5346674|NCT00087139|18390907|P3|Overall Study|Physician Decision|1
5346675|NCT00087139|18390908|P2|Overall Study|Physician Decision|1
5346676|NCT00087139|18390909|P1|Overall Study|Physician Decision|1
5346677|NCT00087139|18390907|P3|Overall Study|Withdrawal by Subject|2
5346678|NCT00087139|18390908|P2|Overall Study|Withdrawal by Subject|2
5346679|NCT00087139|18390909|P1|Overall Study|Withdrawal by Subject|3
5346680|NCT00087139|18390907|P3|Overall Study|Death|0
5346681|NCT00087139|18390908|P2|Overall Study|Death|1
5346682|NCT00087139|18390909|P1|Overall Study|Death|2
5346683|NCT00087139|18390907|P3|Overall Study|Adverse Event|13
5346684|NCT00087139|18390908|P2|Overall Study|Adverse Event|17
5346685|NCT00087139|18390909|P1|Overall Study|Adverse Event|18
5346686|NCT00087126|18390924|P1|Overall Study|Never treated|1
5346687|NCT00087126|18390924|P1|Overall Study|Ineligible - second primary|1
5346688|NCT00086996|18390949|P1|Overall Study|not eligible|5
5346689|NCT00086996|18390949|P1|Overall Study|Other|6
5346690|NCT00086996|18390949|P1|Overall Study|Withdrawal by Subject|13
5346691|NCT00086996|18390949|P1|Overall Study|progression/relapse|7
5346692|NCT00086996|18390949|P1|Overall Study|Death|4
5346693|NCT00086996|18390949|P1|Overall Study|Adverse Event|29
5346694|NCT00086684|18390971|P3|Overall Study|Other|3
5346695|NCT00086684|18390972|P2|Overall Study|Other|2
5346696|NCT00086684|18390973|P1|Overall Study|Other|4
5346697|NCT00086684|18390971|P3|Overall Study|WITHDRAWAL OF CONSENT|5
5346698|NCT00086684|18390972|P2|Overall Study|WITHDRAWAL OF CONSENT|7
5346699|NCT00086684|18390973|P1|Overall Study|WITHDRAWAL OF CONSENT|5
5346700|NCT00086684|18390971|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
5346701|NCT00086684|18390972|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
5346702|NCT00086684|18390973|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
5346703|NCT00086684|18390971|P3|Overall Study|NONCOMPLIANCE|6
5346704|NCT00086684|18390972|P2|Overall Study|NONCOMPLIANCE|7
5346705|NCT00086684|18390973|P1|Overall Study|NONCOMPLIANCE|5
5346706|NCT00086684|18390971|P3|Overall Study|Withdrawal by Subject|10
5346707|NCT00086684|18390972|P2|Overall Study|Withdrawal by Subject|4
5346708|NCT00086684|18390973|P1|Overall Study|Withdrawal by Subject|0
5346709|NCT00086684|18390971|P3|Overall Study|Protocol Violation|0
5346710|NCT00086684|18390972|P2|Overall Study|Protocol Violation|3
5346711|NCT00086684|18390973|P1|Overall Study|Protocol Violation|8
5346712|NCT00086684|18390971|P3|Overall Study|Lost to Follow-up|10
5346713|NCT00086684|18390972|P2|Overall Study|Lost to Follow-up|8
5346714|NCT00086684|18390973|P1|Overall Study|Lost to Follow-up|15
5346715|NCT00086684|18390971|P3|Overall Study|Lack of Efficacy|5
5346716|NCT00086684|18390972|P2|Overall Study|Lack of Efficacy|6
5346717|NCT00086684|18390973|P1|Overall Study|Lack of Efficacy|6
5346718|NCT00086684|18390971|P3|Overall Study|Adverse Event|14
5346719|NCT00086684|18390972|P2|Overall Study|Adverse Event|17
5346720|NCT00086684|18390973|P1|Overall Study|Adverse Event|12
5346721|NCT00086619|18390986|P2|Overall Study|Protocol Violation|1
5346722|NCT00086619|18390987|P1|Overall Study|Protocol Violation|1
5346723|NCT00086619|18390986|P2|Overall Study|Adverse Event|10
5346724|NCT00086619|18390987|P1|Overall Study|Adverse Event|8
5346725|NCT00086619|18390986|P2|Overall Study|Withdrawal by Subject|6
5346726|NCT00086619|18390987|P1|Overall Study|Withdrawal by Subject|6
5346727|NCT00086580|18390997|P2|Observation Period|Other|7
5346728|NCT00086580|18390998|P1|Observation Period|Other|8
5346729|NCT00086580|18390997|P2|Observation Period|Death|55
5346730|NCT00086580|18390998|P1|Observation Period|Death|33
5346731|NCT00086580|18390997|P2|Observation Period|Withdrawal by Subject|2
5346732|NCT00086580|18390998|P1|Observation Period|Withdrawal by Subject|4
5346733|NCT00086580|18390997|P2|Observation Period|Unable to comply with protocol|1
5346734|NCT00086580|18390998|P1|Observation Period|Unable to comply with protocol|1
5346735|NCT00086580|18390997|P2|Follow-up Period|Other|6
5346736|NCT00086580|18390998|P1|Follow-up Period|Other|7
5346737|NCT00086580|18390997|P2|Follow-up Period|Death|7
5346738|NCT00086580|18390998|P1|Follow-up Period|Death|13
5346739|NCT00086580|18390997|P2|Follow-up Period|AE - not related|0
5346740|NCT00086580|18390998|P1|Follow-up Period|AE - not related|1
5346741|NCT00086580|18390997|P2|Follow-up Period|Physician Decision|1
5346742|NCT00086580|18390998|P1|Follow-up Period|Physician Decision|0
5346743|NCT00086580|18390997|P2|Follow-up Period|Withdrawal by Subject|6
5346744|NCT00086580|18390998|P1|Follow-up Period|Withdrawal by Subject|6
5346745|NCT00086580|18390997|P2|Follow-up Period|Unable to comply with protocol|0
5346746|NCT00086580|18390998|P1|Follow-up Period|Unable to comply with protocol|5
5346747|NCT00086580|18390997|P2|Follow-up Period|Disease progression|99
5346748|NCT00086580|18390998|P1|Follow-up Period|Disease progression|72
5346749|NCT00086580|18390997|P2|Treatment Period|Other|3
5346750|NCT00086580|18390998|P1|Treatment Period|Other|5
5346751|NCT00086580|18390997|P2|Treatment Period|Death|7
5346752|NCT00086580|18390998|P1|Treatment Period|Death|5
5346753|NCT00086580|18390997|P2|Treatment Period|Anemia or thrombocytopenia|4
5346754|NCT00086580|18390998|P1|Treatment Period|Anemia or thrombocytopenia|1
5346755|NCT00086580|18390997|P2|Treatment Period|Toxicity - treatment related|15
5346756|NCT00086580|18390998|P1|Treatment Period|Toxicity - treatment related|15
5346757|NCT00086580|18390997|P2|Treatment Period|AE - not treatment related|7
5346758|NCT00086580|18390998|P1|Treatment Period|AE - not treatment related|7
5346759|NCT00086580|18390997|P2|Treatment Period|Physician Decision|7
5346760|NCT00086580|18390998|P1|Treatment Period|Physician Decision|13
5346761|NCT00086580|18390997|P2|Treatment Period|Withdrawal by Subject|8
5346762|NCT00086580|18390998|P1|Treatment Period|Withdrawal by Subject|7
5346763|NCT00086580|18390997|P2|Treatment Period|Unable to comply with protocol|1
5346764|NCT00086580|18390998|P1|Treatment Period|Unable to comply with protocol|3
5346765|NCT00086580|18390997|P2|Treatment Period|Disease progression|8
5346766|NCT00086580|18390998|P1|Treatment Period|Disease progression|9
5346767|NCT00086411|18391046|P4|Overall Study|Lost to Follow-up|12
5346768|NCT00086411|18391047|P3|Overall Study|Lost to Follow-up|13
5346769|NCT00086411|18391048|P2|Overall Study|Lost to Follow-up|11
5346770|NCT00086411|18391049|P1|Overall Study|Lost to Follow-up|11
5346771|NCT00086385|18391067|P4|Overall Study|Death|1
5346772|NCT00086385|18391068|P3|Overall Study|Death|1
5346773|NCT00086385|18391069|P2|Overall Study|Death|2
5346774|NCT00086385|18391070|P1|Overall Study|Death|2
5346775|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Discontinued in error|0
5346776|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Discontinued in error|1
5346777|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
5346778|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
5346779|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
5346780|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
5346781|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Patient Died|1
5346782|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Patient Died|3
5346783|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
5346784|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
5346785|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
5346786|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
5346787|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Patient Moved|2
5346788|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Patient Moved|2
5346789|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
5346790|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
5346791|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Protocol Violation|0
5346792|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Protocol Violation|1
5346793|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Physician Decision|0
5346794|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Physician Decision|3
5346795|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
5346796|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
5346797|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
5346798|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
5346799|NCT00086515|18391082|P2|Phase B (Weeks 24-104)|Adverse Event|10
5346800|NCT00086515|18391083|P1|Phase B (Weeks 24-104)|Adverse Event|16
5346801|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
5346802|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
5346803|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Poor compliance|0
5346804|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Poor compliance|1
5346805|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
5346806|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
5346807|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
5346808|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
5346809|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Protocol Violation|1
5346810|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Protocol Violation|0
5346811|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
5346812|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
5346813|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
5346814|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
5346815|NCT00086515|18391082|P2|Phase A to Phase B Transition Period|Adverse Event|1
5346816|NCT00086515|18391083|P1|Phase A to Phase B Transition Period|Adverse Event|2
5346817|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
5346818|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
5346819|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
5346820|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
5346821|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Poor compliance|0
5346822|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Poor compliance|1
5346823|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
5346824|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
5346825|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Patient Moved|3
5346826|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Patient Moved|2
5346827|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
5346828|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
5346829|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Protocol Violation|1
5346830|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Protocol Violation|3
5346831|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
5346832|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
5346833|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
5346834|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
5346835|NCT00086515|18391082|P2|Phase A (Weeks 0-24)|Adverse Event|9
5346836|NCT00086515|18391083|P1|Phase A (Weeks 0-24)|Adverse Event|17
5346837|NCT00086502|18391095|P2|Overall Study|Patient Accidentally Unblinded|0
5346838|NCT00086502|18391096|P1|Overall Study|Patient Accidentally Unblinded|1
5346839|NCT00086502|18391095|P2|Overall Study|Protocol Discontinuation Criteria|3
5346840|NCT00086502|18391096|P1|Overall Study|Protocol Discontinuation Criteria|1
5346841|NCT00086502|18391095|P2|Overall Study|Patient Moved|1
5346842|NCT00086502|18391096|P1|Overall Study|Patient Moved|1
5346843|NCT00086502|18391095|P2|Overall Study|Withdrawal by Subject|6
5346844|NCT00086502|18391096|P1|Overall Study|Withdrawal by Subject|5
5346845|NCT00086502|18391095|P2|Overall Study|Protocol Violation|3
5346846|NCT00086502|18391096|P1|Overall Study|Protocol Violation|3
5346847|NCT00086502|18391095|P2|Overall Study|Pregnancy|1
5346848|NCT00086502|18391096|P1|Overall Study|Pregnancy|0
5346849|NCT00086502|18391095|P2|Overall Study|Physician Decision|1
5346850|NCT00086502|18391096|P1|Overall Study|Physician Decision|1
5346851|NCT00086502|18391095|P2|Overall Study|Lost to Follow-up|1
5346852|NCT00086502|18391096|P1|Overall Study|Lost to Follow-up|3
5346853|NCT00086502|18391095|P2|Overall Study|Lack of Efficacy|2
5346854|NCT00086502|18391096|P1|Overall Study|Lack of Efficacy|0
5346855|NCT00086502|18391095|P2|Overall Study|Adverse Event|2
5346856|NCT00086502|18391096|P1|Overall Study|Adverse Event|11
5346857|NCT00086346|18391121|P2|Patients Dosed With Test Article|Lack of Efficacy|0
5346858|NCT00086346|18391122|P1|Patients Dosed With Test Article|Lack of Efficacy|11
5346859|NCT00086346|18391121|P2|Patients Dosed With Test Article|Protocol Violation|3
5346860|NCT00086346|18391122|P1|Patients Dosed With Test Article|Protocol Violation|11
5346861|NCT00086346|18391121|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
5346862|NCT00086346|18391122|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
5346863|NCT00086346|18391121|P2|Patients Dosed With Test Article|Nonmedical event|3
5346864|NCT00086346|18391122|P1|Patients Dosed With Test Article|Nonmedical event|7
5346865|NCT00086346|18391121|P2|Patients Dosed With Test Article|Lost to Follow-up|3
5346866|NCT00086346|18391122|P1|Patients Dosed With Test Article|Lost to Follow-up|1
5346867|NCT00086346|18391121|P2|Patients Dosed With Test Article|Adverse Event|11
5346868|NCT00086346|18391122|P1|Patients Dosed With Test Article|Adverse Event|94
5346869|NCT00086346|18391121|P2|Randomization|Did not receive test article|4
5346870|NCT00086346|18391122|P1|Randomization|Did not receive test article|4
5346871|NCT00086281|18391149|P15|Phase 2|Adverse Event|0
5346872|NCT00086281|18391150|P14|Phase 2|Adverse Event|1
5346873|NCT00086281|18391151|P13|Phase 2|Adverse Event|1
5346874|NCT00086281|18391152|P12|Phase 2|Adverse Event|0
5346875|NCT00086281|18391153|P11|Phase 2|Adverse Event|0
5346876|NCT00086281|18391154|P10|Phase 2|Adverse Event|0
5346877|NCT00086281|18391155|P9|Phase 2|Adverse Event|0
5346878|NCT00086281|18391156|P8|Phase 2|Adverse Event|0
5346879|NCT00086281|18391157|P7|Phase 2|Adverse Event|0
5346880|NCT00086281|18391158|P6|Phase 2|Adverse Event|0
5346881|NCT00086281|18391159|P5|Phase 2|Adverse Event|0
5346882|NCT00086281|18391160|P4|Phase 2|Adverse Event|0
5346883|NCT00086281|18391161|P3|Phase 2|Adverse Event|0
5346884|NCT00086281|18391162|P2|Phase 2|Adverse Event|0
5346885|NCT00086281|18391163|P1|Phase 2|Adverse Event|0
5346886|NCT00086281|18391149|P15|Phase 1|Serious Adverse Event|1
5346887|NCT00086281|18391150|P14|Phase 1|Serious Adverse Event|0
5346888|NCT00086281|18391151|P13|Phase 1|Serious Adverse Event|0
5346889|NCT00086281|18391152|P12|Phase 1|Serious Adverse Event|0
5346890|NCT00086281|18391153|P11|Phase 1|Serious Adverse Event|0
5346891|NCT00086281|18391154|P10|Phase 1|Serious Adverse Event|0
5346892|NCT00086281|18391155|P9|Phase 1|Serious Adverse Event|0
5346893|NCT00086281|18391156|P8|Phase 1|Serious Adverse Event|0
5346894|NCT00086281|18391157|P7|Phase 1|Serious Adverse Event|0
5346895|NCT00086281|18391158|P6|Phase 1|Serious Adverse Event|0
5346896|NCT00086281|18391159|P5|Phase 1|Serious Adverse Event|0
5346897|NCT00086281|18391160|P4|Phase 1|Serious Adverse Event|0
5346898|NCT00086281|18391161|P3|Phase 1|Serious Adverse Event|0
5346899|NCT00086281|18391162|P2|Phase 1|Serious Adverse Event|0
5346900|NCT00086281|18391163|P1|Phase 1|Serious Adverse Event|0
5346901|NCT00086281|18391149|P15|Phase 1|Protocol Violation|0
5346902|NCT00086281|18391150|P14|Phase 1|Protocol Violation|0
5346903|NCT00086281|18391151|P13|Phase 1|Protocol Violation|0
5346904|NCT00086281|18391152|P12|Phase 1|Protocol Violation|0
5346905|NCT00086281|18391153|P11|Phase 1|Protocol Violation|1
5346906|NCT00086281|18391154|P10|Phase 1|Protocol Violation|0
5346907|NCT00086281|18391155|P9|Phase 1|Protocol Violation|0
5346908|NCT00086281|18391156|P8|Phase 1|Protocol Violation|0
5346909|NCT00086281|18391157|P7|Phase 1|Protocol Violation|0
5346910|NCT00086281|18391158|P6|Phase 1|Protocol Violation|0
5346911|NCT00086281|18391159|P5|Phase 1|Protocol Violation|0
5346912|NCT00086281|18391160|P4|Phase 1|Protocol Violation|0
5346913|NCT00086281|18391161|P3|Phase 1|Protocol Violation|0
5346914|NCT00086281|18391162|P2|Phase 1|Protocol Violation|0
5346915|NCT00086281|18391163|P1|Phase 1|Protocol Violation|0
5346916|NCT00086281|18391149|P15|Phase 1|Adverse Event|2
5346917|NCT00086281|18391150|P14|Phase 1|Adverse Event|1
5346918|NCT00086281|18391151|P13|Phase 1|Adverse Event|1
5346919|NCT00086281|18391152|P12|Phase 1|Adverse Event|1
5346920|NCT00086281|18391153|P11|Phase 1|Adverse Event|2
5346921|NCT00086281|18391154|P10|Phase 1|Adverse Event|1
5346922|NCT00086281|18391155|P9|Phase 1|Adverse Event|0
5346923|NCT00086281|18391156|P8|Phase 1|Adverse Event|0
5346924|NCT00086281|18391157|P7|Phase 1|Adverse Event|0
5346925|NCT00086281|18391158|P6|Phase 1|Adverse Event|0
5346926|NCT00086281|18391159|P5|Phase 1|Adverse Event|0
5346927|NCT00086281|18391160|P4|Phase 1|Adverse Event|0
5346928|NCT00086281|18391161|P3|Phase 1|Adverse Event|0
5346929|NCT00086281|18391162|P2|Phase 1|Adverse Event|0
5346930|NCT00086281|18391163|P1|Phase 1|Adverse Event|0
5346931|NCT00086307|18391176|P3|Overall Study|Withdrawal by Subject|2
5346932|NCT00086307|18391177|P2|Overall Study|Withdrawal by Subject|0
5346933|NCT00086307|18391178|P1|Overall Study|Withdrawal by Subject|0
5346934|NCT00086307|18391176|P3|Overall Study|Fatigue and difficulty falling asleep|1
5346935|NCT00086307|18391177|P2|Overall Study|Fatigue and difficulty falling asleep|0
5346936|NCT00086307|18391178|P1|Overall Study|Fatigue and difficulty falling asleep|0
5346937|NCT00086307|18391176|P3|Overall Study|Suicidal ideation|1
5346938|NCT00086307|18391177|P2|Overall Study|Suicidal ideation|0
5346939|NCT00086307|18391178|P1|Overall Study|Suicidal ideation|0
5346940|NCT00086307|18391176|P3|Overall Study|Constipation and sleepiness|1
5346941|NCT00086307|18391177|P2|Overall Study|Constipation and sleepiness|0
5346942|NCT00086307|18391178|P1|Overall Study|Constipation and sleepiness|0
5346943|NCT00086307|18391176|P3|Overall Study|Nausea and headaches|1
5346944|NCT00086307|18391177|P2|Overall Study|Nausea and headaches|0
5346945|NCT00086307|18391178|P1|Overall Study|Nausea and headaches|0
5346946|NCT00086307|18391176|P3|Overall Study|Shortness of breath and muscle spasms|0
5346947|NCT00086307|18391177|P2|Overall Study|Shortness of breath and muscle spasms|0
5346948|NCT00086307|18391178|P1|Overall Study|Shortness of breath and muscle spasms|1
5346949|NCT00086307|18391176|P3|Overall Study|Lack of Efficacy|2
5346950|NCT00086307|18391177|P2|Overall Study|Lack of Efficacy|1
5346951|NCT00086307|18391178|P1|Overall Study|Lack of Efficacy|1
5346952|NCT00086190|18391189|P3|Overall Study|Worsening depression|2
5346953|NCT00086190|18391190|P2|Overall Study|Worsening depression|0
5346954|NCT00086190|18391191|P1|Overall Study|Worsening depression|0
5346955|NCT00086190|18391189|P3|Overall Study|Moved|0
5346956|NCT00086190|18391190|P2|Overall Study|Moved|0
5346957|NCT00086190|18391191|P1|Overall Study|Moved|1
5346958|NCT00086190|18391189|P3|Overall Study|Protocol Violation|0
5346959|NCT00086190|18391190|P2|Overall Study|Protocol Violation|0
5346960|NCT00086190|18391191|P1|Overall Study|Protocol Violation|1
5346961|NCT00086190|18391189|P3|Overall Study|Withdrawal by Subject|2
5346962|NCT00086190|18391190|P2|Overall Study|Withdrawal by Subject|2
5346963|NCT00086190|18391191|P1|Overall Study|Withdrawal by Subject|0
5346964|NCT00086190|18391189|P3|Overall Study|Adverse Event|2
5346965|NCT00086190|18391190|P2|Overall Study|Adverse Event|2
5346966|NCT00086190|18391191|P1|Overall Study|Adverse Event|6
5346967|NCT00086047|18391260|P2|Overall Study|Physician Decision|1
5346968|NCT00086047|18391261|P1|Overall Study|Physician Decision|0
5346969|NCT00086047|18391260|P2|Overall Study|Lost to Follow-up|6
5346970|NCT00086047|18391261|P1|Overall Study|Lost to Follow-up|7
5346971|NCT00085917|18391269|P2|Overall Study|Adverse Event|3
5346972|NCT00085917|18391270|P1|Overall Study|Adverse Event|4
5346973|NCT00085735|18391299|P6|Overall Study|Pt transferred to inst w/out study open|0
5346974|NCT00085735|18391300|P5|Overall Study|Pt transferred to inst w/out study open|0
5346975|NCT00085735|18391301|P4|Overall Study|Pt transferred to inst w/out study open|0
5346976|NCT00085735|18391302|P3|Overall Study|Pt transferred to inst w/out study open|0
5346977|NCT00085735|18391303|P2|Overall Study|Pt transferred to inst w/out study open|0
5346978|NCT00085735|18391304|P1|Overall Study|Pt transferred to inst w/out study open|1
5346979|NCT00085735|18391299|P6|Overall Study|Reason not documented|0
5346980|NCT00085735|18391300|P5|Overall Study|Reason not documented|1
5346981|NCT00085735|18391301|P4|Overall Study|Reason not documented|0
5346982|NCT00085735|18391302|P3|Overall Study|Reason not documented|1
5346983|NCT00085735|18391303|P2|Overall Study|Reason not documented|0
5346984|NCT00085735|18391304|P1|Overall Study|Reason not documented|1
5346985|NCT00085735|18391299|P6|Overall Study|Excess residual disease|4
5346986|NCT00085735|18391300|P5|Overall Study|Excess residual disease|1
5346987|NCT00085735|18391301|P4|Overall Study|Excess residual disease|1
5346988|NCT00085735|18391302|P3|Overall Study|Excess residual disease|1
5346989|NCT00085735|18391303|P2|Overall Study|Excess residual disease|2
5346990|NCT00085735|18391304|P1|Overall Study|Excess residual disease|2
5346991|NCT00085735|18391299|P6|Overall Study|Patient ineligible|8
5346992|NCT00085735|18391300|P5|Overall Study|Patient ineligible|17
5346993|NCT00085735|18391301|P4|Overall Study|Patient ineligible|7
5346994|NCT00085735|18391302|P3|Overall Study|Patient ineligible|3
5346995|NCT00085735|18391303|P2|Overall Study|Patient ineligible|0
5346996|NCT00085735|18391304|P1|Overall Study|Patient ineligible|1
5346997|NCT00085735|18391299|P6|Overall Study|Withdrawal by Subject|8
5346998|NCT00085735|18391300|P5|Overall Study|Withdrawal by Subject|7
5346999|NCT00085735|18391301|P4|Overall Study|Withdrawal by Subject|5
5347000|NCT00085735|18391302|P3|Overall Study|Withdrawal by Subject|4
5347001|NCT00085735|18391303|P2|Overall Study|Withdrawal by Subject|0
5347002|NCT00085735|18391304|P1|Overall Study|Withdrawal by Subject|1
5347003|NCT00085735|18391299|P6|Overall Study|Protocol Violation|0
5347004|NCT00085735|18391300|P5|Overall Study|Protocol Violation|0
5347005|NCT00085735|18391301|P4|Overall Study|Protocol Violation|0
5347006|NCT00085735|18391302|P3|Overall Study|Protocol Violation|0
5347007|NCT00085735|18391303|P2|Overall Study|Protocol Violation|0
5347008|NCT00085735|18391304|P1|Overall Study|Protocol Violation|1
5347009|NCT00085735|18391299|P6|Overall Study|Physician Decision|8
5347010|NCT00085735|18391300|P5|Overall Study|Physician Decision|11
5347011|NCT00085735|18391301|P4|Overall Study|Physician Decision|3
5347012|NCT00085735|18391302|P3|Overall Study|Physician Decision|2
5347013|NCT00085735|18391303|P2|Overall Study|Physician Decision|3
5347014|NCT00085735|18391304|P1|Overall Study|Physician Decision|2
5347015|NCT00085735|18391299|P6|Overall Study|Lost to Follow-up|0
5347016|NCT00085735|18391300|P5|Overall Study|Lost to Follow-up|1
5347017|NCT00085735|18391301|P4|Overall Study|Lost to Follow-up|0
5347018|NCT00085735|18391302|P3|Overall Study|Lost to Follow-up|0
5347019|NCT00085735|18391303|P2|Overall Study|Lost to Follow-up|1
5347020|NCT00085735|18391304|P1|Overall Study|Lost to Follow-up|0
5347021|NCT00085735|18391299|P6|Overall Study|Lack of Efficacy|3
5347022|NCT00085735|18391300|P5|Overall Study|Lack of Efficacy|4
5347023|NCT00085735|18391301|P4|Overall Study|Lack of Efficacy|3
5347024|NCT00085735|18391302|P3|Overall Study|Lack of Efficacy|6
5347025|NCT00085735|18391303|P2|Overall Study|Lack of Efficacy|4
5347026|NCT00085735|18391304|P1|Overall Study|Lack of Efficacy|2
5347027|NCT00085735|18391299|P6|Overall Study|Adverse Event|0
5347028|NCT00085735|18391300|P5|Overall Study|Adverse Event|0
5347029|NCT00085735|18391301|P4|Overall Study|Adverse Event|0
5347030|NCT00085735|18391302|P3|Overall Study|Adverse Event|0
5347031|NCT00085735|18391303|P2|Overall Study|Adverse Event|0
5347032|NCT00085735|18391304|P1|Overall Study|Adverse Event|1
5347033|NCT00085709|18391359|P2|Overall Study|Withdrawal by Subject|1
5347034|NCT00085709|18391360|P1|Overall Study|Withdrawal by Subject|2
5347035|NCT00085709|18391359|P2|Overall Study|Not eligible|19
5347036|NCT00085709|18391360|P1|Overall Study|Not eligible|19
5347037|NCT00085709|18391359|P2|Overall Study|Not protocol specified|22
5347038|NCT00085709|18391360|P1|Overall Study|Not protocol specified|12
5347039|NCT00085709|18391359|P2|Overall Study|Progression|4
5347040|NCT00085709|18391360|P1|Overall Study|Progression|3
5347041|NCT00085709|18391359|P2|Overall Study|Refusal unrelated to adverse events|2
5347042|NCT00085709|18391360|P1|Overall Study|Refusal unrelated to adverse events|1
5347043|NCT00085709|18391359|P2|Overall Study|Death|2
5347044|NCT00085709|18391360|P1|Overall Study|Death|8
5347045|NCT00085709|18391359|P2|Overall Study|Adverse Event|0
5347046|NCT00085709|18391360|P1|Overall Study|Adverse Event|8
5347047|NCT00085644|18391376|P3|Open-Label Period|Personal reason|4
5347048|NCT00085644|18391377|P2|Open-Label Period|Personal reason|0
5347049|NCT00085644|18391378|P1|Open-Label Period|Personal reason|0
5347050|NCT00085644|18391376|P3|Open-Label Period|Protocol Violation|4
5347051|NCT00085644|18391377|P2|Open-Label Period|Protocol Violation|0
5347052|NCT00085644|18391378|P1|Open-Label Period|Protocol Violation|0
5347053|NCT00085644|18391376|P3|Open-Label Period|Contemplating pregnancy|3
5347054|NCT00085644|18391377|P2|Open-Label Period|Contemplating pregnancy|0
5347055|NCT00085644|18391378|P1|Open-Label Period|Contemplating pregnancy|0
5347056|NCT00085644|18391376|P3|Open-Label Period|Pregnancy|3
5347057|NCT00085644|18391377|P2|Open-Label Period|Pregnancy|0
5347058|NCT00085644|18391378|P1|Open-Label Period|Pregnancy|0
5347059|NCT00085644|18391376|P3|Open-Label Period|Lack of Efficacy|15
5347060|NCT00085644|18391377|P2|Open-Label Period|Lack of Efficacy|0
5347061|NCT00085644|18391378|P1|Open-Label Period|Lack of Efficacy|0
5347062|NCT00085644|18391376|P3|Open-Label Period|Lost to Follow-up|13
5347063|NCT00085644|18391377|P2|Open-Label Period|Lost to Follow-up|0
5347064|NCT00085644|18391378|P1|Open-Label Period|Lost to Follow-up|0
5347065|NCT00085644|18391376|P3|Open-Label Period|Withdrawal by Subject|29
5347066|NCT00085644|18391377|P2|Open-Label Period|Withdrawal by Subject|0
5347067|NCT00085644|18391378|P1|Open-Label Period|Withdrawal by Subject|0
5347068|NCT00085644|18391376|P3|Open-Label Period|Adverse Event|38
5347069|NCT00085644|18391377|P2|Open-Label Period|Adverse Event|0
5347070|NCT00085644|18391378|P1|Open-Label Period|Adverse Event|0
5347071|NCT00085644|18391376|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
5347072|NCT00085644|18391377|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
5347073|NCT00085644|18391378|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
5347074|NCT00085644|18391376|P3|Double-Blind Period|Contemplating pregnancy|0
5347075|NCT00085644|18391377|P2|Double-Blind Period|Contemplating pregnancy|0
5347076|NCT00085644|18391378|P1|Double-Blind Period|Contemplating pregnancy|1
5347077|NCT00085644|18391376|P3|Double-Blind Period|Lack/loss of efficacy|0
5347078|NCT00085644|18391377|P2|Double-Blind Period|Lack/loss of efficacy|2
5347079|NCT00085644|18391378|P1|Double-Blind Period|Lack/loss of efficacy|2
5347080|NCT00085644|18391376|P3|Double-Blind Period|Lost to Follow-up|0
5347081|NCT00085644|18391377|P2|Double-Blind Period|Lost to Follow-up|1
5347082|NCT00085644|18391378|P1|Double-Blind Period|Lost to Follow-up|2
5347083|NCT00085644|18391376|P3|Double-Blind Period|Withdrawal by Subject|0
5347084|NCT00085644|18391377|P2|Double-Blind Period|Withdrawal by Subject|0
5347085|NCT00085644|18391378|P1|Double-Blind Period|Withdrawal by Subject|3
5347086|NCT00085644|18391376|P3|Double-Blind Period|Adverse Event|0
5347087|NCT00085644|18391377|P2|Double-Blind Period|Adverse Event|2
5347088|NCT00085644|18391378|P1|Double-Blind Period|Adverse Event|5
5347089|NCT00085631|18391419|P3|Overall Study|Missing Data|7
5347090|NCT00085631|18391420|P2|Overall Study|Missing Data|11
5347091|NCT00085631|18391421|P1|Overall Study|Missing Data|4
5347092|NCT00085566|18391431|P3|Overall Study|Clinical progression|1
5347093|NCT00085566|18391432|P2|Overall Study|Clinical progression|0
5347094|NCT00085566|18391433|P1|Overall Study|Clinical progression|0
5347095|NCT00085566|18391431|P3|Overall Study|Patient Not treated|3
5347096|NCT00085566|18391432|P2|Overall Study|Patient Not treated|0
5347097|NCT00085566|18391433|P1|Overall Study|Patient Not treated|0
5347098|NCT00085566|18391431|P3|Overall Study|Adverse Event|10
5347099|NCT00085566|18391432|P2|Overall Study|Adverse Event|0
5347100|NCT00085566|18391433|P1|Overall Study|Adverse Event|0
5347101|NCT00085540|18391443|P2|Overall Study|Protocol Violation|1
5347102|NCT00085540|18391444|P1|Overall Study|Protocol Violation|0
5347103|NCT00085540|18391443|P2|Overall Study|Withdrawal by Subject|1
5347104|NCT00085540|18391444|P1|Overall Study|Withdrawal by Subject|0
5347105|NCT00085423|18391456|P1|Overall Study|screen failure|1
5347106|NCT00085423|18391456|P1|Overall Study|Withdrawal by Subject|1
5347107|NCT00085202|18391507|P2|Overall Study|Progressive disease|11
5347108|NCT00085202|18391508|P1|Overall Study|Progressive disease|1
5347109|NCT00085202|18391507|P2|Overall Study|Physician Decision|1
5347110|NCT00085202|18391508|P1|Overall Study|Physician Decision|4
5347111|NCT00085202|18391507|P2|Overall Study|Withdrawal by Subject|1
5347112|NCT00085202|18391508|P1|Overall Study|Withdrawal by Subject|2
5347113|NCT00085202|18391507|P2|Overall Study|Non-specified|5
5347114|NCT00085202|18391508|P1|Overall Study|Non-specified|3
5347115|NCT00085202|18391507|P2|Overall Study|Excessive toxicity|5
5347116|NCT00085202|18391508|P1|Overall Study|Excessive toxicity|6
5347117|NCT00085202|18391507|P2|Overall Study|Bone involvement confirmed by bone scan|1
5347118|NCT00085202|18391508|P1|Overall Study|Bone involvement confirmed by bone scan|0
5347119|NCT00085202|18391507|P2|Overall Study|Still on therapy|0
5347120|NCT00085202|18391508|P1|Overall Study|Still on therapy|2
5347121|NCT00085098|18391529|P2|Overall Study|Ineligible|1
5347122|NCT00085098|18391530|P1|Overall Study|Ineligible|1
5347123|NCT00085098|18391529|P2|Overall Study|Withdrawal by Subject|1
5347124|NCT00085098|18391530|P1|Overall Study|Withdrawal by Subject|0
5347125|NCT00084929|18391540|P1|Overall Study|Missing Reference Standard (Colonoscopy)|42
5347126|NCT00084929|18391540|P1|Overall Study|Missing/incomplete CTC exam|9
5347127|NCT00084929|18391540|P1|Overall Study|Withdrawal by Subject|10
5347128|NCT00084929|18391540|P1|Overall Study|Ineligible - Medical history|6
5347129|NCT00084929|18391540|P1|Overall Study|ineligible - Pre-scheduled procedure not|1
5347130|NCT00084929|18391540|P1|Overall Study|ineligible - medical contraindication|1
5347131|NCT00084864|18391562|P4|Overall Study|Adverse Event|0
5347132|NCT00084864|18391563|P3|Overall Study|Adverse Event|0
5347133|NCT00084864|18391564|P2|Overall Study|Adverse Event|0
5347134|NCT00084864|18391565|P1|Overall Study|Adverse Event|1
5347135|NCT00084838|18391591|P1|Overall Study|Ineligible|4
5347136|NCT00084838|18391591|P1|Overall Study|Pt Non-Compliance|1
5347137|NCT00084838|18391591|P1|Overall Study|Progressive Disease|4
5347138|NCT00084838|18391591|P1|Overall Study|Withdrawal by Subject|1
5347139|NCT00084838|18391591|P1|Overall Study|Adverse Event|2
5347140|NCT00084838|18391591|P1|Overall Study|Death|1
5347141|NCT00084747|18391613|P1|Overall Study|Withdrawal by Subject|2
5347142|NCT00084747|18391613|P1|Overall Study|Death|3
5347143|NCT00084747|18391613|P1|Overall Study|Relapsed|8
5347144|NCT00084682|18391618|P1|Overall Study|Withdrawal by Subject|1
5347145|NCT00084617|18391622|P1|Overall Study|Protocol Violation|1
5347146|NCT00084617|18391622|P1|Overall Study|Lack of Efficacy|1
5347147|NCT00084617|18391622|P1|Overall Study|Withdrawal by Subject|7
5347148|NCT00084487|18391628|P1|Overall Study|Death|1
5347149|NCT00084318|18391672|P2|Overall Study|No protocol treatment|0
5347150|NCT00084318|18391673|P1|Overall Study|No protocol treatment|2
5347151|NCT00084318|18391672|P2|Overall Study|Protocol Violation|11
5347152|NCT00084318|18391673|P1|Overall Study|Protocol Violation|15
5347153|NCT00084318|18391672|P2|Overall Study|Withdrawal by Subject|2
5347154|NCT00084318|18391673|P1|Overall Study|Withdrawal by Subject|5
5347155|NCT00084266|18391693|P2|Overall Study|Randomized not treated|20
5347156|NCT00084266|18391694|P1|Overall Study|Randomized not treated|21
5347157|NCT00084266|18391693|P2|Overall Study|Other|344
5347158|NCT00084266|18391694|P1|Overall Study|Other|360
5347159|NCT00084266|18391693|P2|Overall Study|Participant not willing to participate|8
5347160|NCT00084266|18391694|P1|Overall Study|Participant not willing to participate|3
5347161|NCT00084266|18391693|P2|Overall Study|Lost to Follow-up|3
5347162|NCT00084266|18391694|P1|Overall Study|Lost to Follow-up|5
5347163|NCT00084266|18391693|P2|Overall Study|Lack of Efficacy|4
5347164|NCT00084266|18391694|P1|Overall Study|Lack of Efficacy|2
5347165|NCT00084266|18391693|P2|Overall Study|Adverse Event|5
5347166|NCT00084266|18391694|P1|Overall Study|Adverse Event|8
5347167|NCT00084266|18391693|P2|Overall Study|Death|39
5347168|NCT00084266|18391694|P1|Overall Study|Death|42
5347169|NCT00084136|18391752|P3|NRTI Comparison|Not reason above|0
5347170|NCT00084136|18391753|P2|NRTI Comparison|Not reason above|0
5347171|NCT00084136|18391754|P1|NRTI Comparison|Not reason above|1
5347172|NCT00084136|18391752|P3|NRTI Comparison|Clinic site closed|14
5347173|NCT00084136|18391753|P2|NRTI Comparison|Clinic site closed|0
5347174|NCT00084136|18391754|P1|NRTI Comparison|Clinic site closed|12
5347175|NCT00084136|18391752|P3|NRTI Comparison|Withdrawal by Subject|38
5347176|NCT00084136|18391753|P2|NRTI Comparison|Withdrawal by Subject|0
5347177|NCT00084136|18391754|P1|NRTI Comparison|Withdrawal by Subject|54
5347178|NCT00084136|18391752|P3|NRTI Comparison|Lost to Follow-up|12
5347179|NCT00084136|18391753|P2|NRTI Comparison|Lost to Follow-up|0
5347180|NCT00084136|18391754|P1|NRTI Comparison|Lost to Follow-up|14
5347181|NCT00084136|18391752|P3|NRTI Comparison|Death|18
5347182|NCT00084136|18391753|P2|NRTI Comparison|Death|0
5347183|NCT00084136|18391754|P1|NRTI Comparison|Death|20
5347184|NCT00084136|18391752|P3|PI Comparison|Clinic site closed|0
5347185|NCT00084136|18391753|P2|PI Comparison|Clinic site closed|0
5347186|NCT00084136|18391754|P1|PI Comparison|Clinic site closed|1
5347187|NCT00084136|18391752|P3|PI Comparison|Withdrawal by Subject|0
5347188|NCT00084136|18391753|P2|PI Comparison|Withdrawal by Subject|30
5347189|NCT00084136|18391754|P1|PI Comparison|Withdrawal by Subject|33
5347190|NCT00084136|18391752|P3|PI Comparison|Lost to Follow-up|0
5347191|NCT00084136|18391753|P2|PI Comparison|Lost to Follow-up|8
5347192|NCT00084136|18391754|P1|PI Comparison|Lost to Follow-up|11
5347193|NCT00084136|18391752|P3|PI Comparison|Death|0
5347194|NCT00084136|18391753|P2|PI Comparison|Death|9
5347195|NCT00084136|18391754|P1|PI Comparison|Death|10
5347196|NCT00084084|18391813|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
5347197|NCT00084084|18391813|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
5347198|NCT00083915|18391823|P2|Overall Study|Insurance issues|1
5347199|NCT00083915|18391824|P1|Overall Study|Insurance issues|1
5347200|NCT00083915|18391823|P2|Overall Study|No response|1
5347201|NCT00083915|18391824|P1|Overall Study|No response|3
5347202|NCT00083915|18391823|P2|Overall Study|Failure to collect|0
5347203|NCT00083915|18391824|P1|Overall Study|Failure to collect|3
5347204|NCT00083915|18391823|P2|Overall Study|disease progression|23
5347205|NCT00083915|18391824|P1|Overall Study|disease progression|18
5347206|NCT00083915|18391823|P2|Overall Study|Withdrawal by Subject|3
5347207|NCT00083915|18391824|P1|Overall Study|Withdrawal by Subject|8
5347208|NCT00083915|18391823|P2|Overall Study|Physician Decision|6
5347209|NCT00083915|18391824|P1|Overall Study|Physician Decision|11
5347210|NCT00083915|18391823|P2|Overall Study|Death|3
5347211|NCT00083915|18391824|P1|Overall Study|Death|6
5347212|NCT00083889|18391832|P2|Overall Study|Crossover to SU011248|25
5347213|NCT00083889|18391833|P1|Overall Study|Crossover to SU011248|0
5347214|NCT00083889|18391832|P2|Overall Study|Completed on marketed sunitinub|0
5347215|NCT00083889|18391833|P1|Overall Study|Completed on marketed sunitinub|3
5347216|NCT00083889|18391832|P2|Overall Study|Randomized: did not take study drug|15
5347217|NCT00083889|18391833|P1|Overall Study|Randomized: did not take study drug|0
5347218|NCT00083889|18391832|P2|Overall Study|Decision of sponsor|4
5347219|NCT00083889|18391833|P1|Overall Study|Decision of sponsor|32
5347220|NCT00083889|18391832|P2|Overall Study|Lack of Efficacy|219
5347221|NCT00083889|18391833|P1|Overall Study|Lack of Efficacy|240
5347222|NCT00083889|18391832|P2|Overall Study|Withdrawal by Subject|24
5347223|NCT00083889|18391833|P1|Overall Study|Withdrawal by Subject|22
5347224|NCT00083889|18391832|P2|Overall Study|Protocol Violation|2
5347225|NCT00083889|18391833|P1|Overall Study|Protocol Violation|2
5347226|NCT00083889|18391832|P2|Overall Study|Adverse Event|86
5347227|NCT00083889|18391833|P1|Overall Study|Adverse Event|76
5347228|NCT00083759|18391891|P2|Overall Study|Other|13
5347229|NCT00083759|18391892|P1|Overall Study|Other|14
5347230|NCT00083759|18391891|P2|Overall Study|Sponsor's Discretion|29
5347231|NCT00083759|18391892|P1|Overall Study|Sponsor's Discretion|28
5347232|NCT00083759|18391891|P2|Overall Study|Non-Compliance|0
5347233|NCT00083759|18391892|P1|Overall Study|Non-Compliance|1
5347234|NCT00083759|18391891|P2|Overall Study|Subject Withdrew Consent|2
5347235|NCT00083759|18391892|P1|Overall Study|Subject Withdrew Consent|2
5347236|NCT00083759|18391891|P2|Overall Study|Inadequate Therapeutic Response|35
5347237|NCT00083759|18391892|P1|Overall Study|Inadequate Therapeutic Response|32
5347238|NCT00083759|18391891|P2|Overall Study|Death|1
5347239|NCT00083759|18391892|P1|Overall Study|Death|1
5347240|NCT00083759|18391891|P2|Overall Study|Lost to Follow-up|0
5347241|NCT00083759|18391892|P1|Overall Study|Lost to Follow-up|1
5347242|NCT00083759|18391891|P2|Overall Study|Adverse Event|3
5347243|NCT00083759|18391892|P1|Overall Study|Adverse Event|5
5347244|NCT00083616|18391910|P1|Overall Study|Other|6
5347245|NCT00083616|18391910|P1|Overall Study|Non-compliance|1
5347246|NCT00083616|18391910|P1|Overall Study|Ineligibility determined|2
5347247|NCT00083616|18391910|P1|Overall Study|Withdrawal by Subject|3
5347248|NCT00083616|18391910|P1|Overall Study|Physician Decision|2
5347249|NCT00083616|18391910|P1|Overall Study|Lost to Follow-up|1
5347250|NCT00083616|18391910|P1|Overall Study|Disease Progression|16
5347251|NCT00082888|18391938|P3|Overall Study|Ineligible|0
5347252|NCT00082888|18391939|P2|Overall Study|Ineligible|0
5347253|NCT00082888|18391940|P1|Overall Study|Ineligible|1
5347254|NCT00082810|18391960|P1|Overall Study|Withdrawal by Subject|4
5347255|NCT00082810|18391960|P1|Overall Study|Progressive disease|24
5347256|NCT00082810|18391960|P1|Overall Study|Adverse Event|3
5347257|NCT00082758|18391971|P3|Overall Study|Protocol Violation|0
5347258|NCT00082758|18391972|P2|Overall Study|Protocol Violation|1
5347259|NCT00082758|18391973|P1|Overall Study|Protocol Violation|0
5347260|NCT00082758|18391971|P3|Overall Study|Withdrawal by Subject|0
5347261|NCT00082758|18391972|P2|Overall Study|Withdrawal by Subject|0
5347262|NCT00082758|18391973|P1|Overall Study|Withdrawal by Subject|3
5347263|NCT00082758|18391971|P3|Overall Study|Physician Decision|0
5347264|NCT00082758|18391972|P2|Overall Study|Physician Decision|1
5347265|NCT00082758|18391973|P1|Overall Study|Physician Decision|0
5347266|NCT00082758|18391971|P3|Overall Study|Lack of Efficacy|0
5347267|NCT00082758|18391972|P2|Overall Study|Lack of Efficacy|13
5347268|NCT00082758|18391973|P1|Overall Study|Lack of Efficacy|12
5347269|NCT00082758|18391971|P3|Overall Study|Adverse Event|0
5347270|NCT00082758|18391972|P2|Overall Study|Adverse Event|2
5347271|NCT00082758|18391973|P1|Overall Study|Adverse Event|0
5347272|NCT00083226|18391993|P1|Overall Study|ineligible or not receiving treatment|4
5347273|NCT00083226|18391993|P1|Overall Study|Other|2
5347274|NCT00083226|18391993|P1|Overall Study|Withdrawal by Subject|4
5347275|NCT00083226|18391993|P1|Overall Study|Death|4
5347276|NCT00083226|18391993|P1|Overall Study|Adverse Event|9
5347277|NCT00083226|18391993|P1|Overall Study|Lack of Efficacy|19
5347278|NCT00082628|18392037|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
5347279|NCT00082628|18392038|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
5347280|NCT00082628|18392039|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
5347281|NCT00082628|18392040|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
5347282|NCT00082628|18392041|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
5347283|NCT00082628|18392037|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5347284|NCT00082628|18392038|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
5347285|NCT00082628|18392039|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5347286|NCT00082628|18392040|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5347287|NCT00082628|18392041|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5347288|NCT00082628|18392037|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
5347289|NCT00082628|18392038|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5347290|NCT00082628|18392039|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5347291|NCT00082628|18392040|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5347292|NCT00082628|18392041|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5347293|NCT00082628|18392037|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
5347294|NCT00082628|18392038|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
5347295|NCT00082628|18392039|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
5347296|NCT00082628|18392040|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
5347297|NCT00082628|18392041|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
5347298|NCT00082628|18392037|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
5347299|NCT00082628|18392038|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
5347300|NCT00082628|18392039|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
5347301|NCT00082628|18392040|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
5347302|NCT00082628|18392041|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
5347303|NCT00082628|18392037|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
5347304|NCT00082628|18392038|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
5347305|NCT00082628|18392039|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
5347306|NCT00082628|18392040|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
5347307|NCT00082628|18392041|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
5347308|NCT00082628|18392037|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5347309|NCT00082628|18392038|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5347310|NCT00082628|18392039|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5347311|NCT00082628|18392040|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
5347312|NCT00082628|18392041|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5347313|NCT00082433|18392061|P2|Overall Study|Impending surgery|1
5347314|NCT00082433|18392062|P1|Overall Study|Impending surgery|0
5347315|NCT00082433|18392061|P2|Overall Study|New primary cancer|0
5347316|NCT00082433|18392062|P1|Overall Study|New primary cancer|1
5347317|NCT00082433|18392061|P2|Overall Study|Noncompliance|1
5347318|NCT00082433|18392062|P1|Overall Study|Noncompliance|2
5347319|NCT00082433|18392061|P2|Overall Study|Ineligible|1
5347320|NCT00082433|18392062|P1|Overall Study|Ineligible|2
5347321|NCT00082433|18392061|P2|Overall Study|Not Treated|11
5347322|NCT00082433|18392062|P1|Overall Study|Not Treated|12
5347323|NCT00082433|18392061|P2|Overall Study|Still On Treatment|1
5347324|NCT00082433|18392062|P1|Overall Study|Still On Treatment|2
5347325|NCT00082433|18392061|P2|Overall Study|Withdrawal by Subject|30
5347326|NCT00082433|18392062|P1|Overall Study|Withdrawal by Subject|55
5347327|NCT00082433|18392061|P2|Overall Study|Study Drug Toxicity|66
5347328|NCT00082433|18392062|P1|Overall Study|Study Drug Toxicity|179
5347329|NCT00082433|18392061|P2|Overall Study|Lost to Follow-up|2
5347330|NCT00082433|18392062|P1|Overall Study|Lost to Follow-up|1
5347331|NCT00082433|18392061|P2|Overall Study|Physician Decision|61
5347332|NCT00082433|18392062|P1|Overall Study|Physician Decision|50
5347333|NCT00082433|18392061|P2|Overall Study|Disease Progression/Relapse|388
5347334|NCT00082433|18392062|P1|Overall Study|Disease Progression/Relapse|270
5347335|NCT00082433|18392061|P2|Overall Study|Death|18
5347336|NCT00082433|18392062|P1|Overall Study|Death|8
5347337|NCT00082433|18392061|P2|Overall Study|Adverse Event|17
5347338|NCT00082433|18392062|P1|Overall Study|Adverse Event|12
5347339|NCT00082381|18392082|P2|Overall Study|Loss of Glucose Control|0
5347340|NCT00082381|18392083|P1|Overall Study|Loss of Glucose Control|4
5347341|NCT00082381|18392082|P2|Overall Study|Protocol Violation|11
5347342|NCT00082381|18392083|P1|Overall Study|Protocol Violation|10
5347343|NCT00082381|18392082|P2|Overall Study|Physician Decision|2
5347344|NCT00082381|18392083|P1|Overall Study|Physician Decision|1
5347345|NCT00082381|18392082|P2|Overall Study|Patient Decision|4
5347346|NCT00082381|18392083|P1|Overall Study|Patient Decision|8
5347347|NCT00082381|18392082|P2|Overall Study|Lost to Follow-up|7
5347348|NCT00082381|18392083|P1|Overall Study|Lost to Follow-up|5
5347349|NCT00082381|18392082|P2|Overall Study|Adverse Event|2
5347350|NCT00082381|18392083|P1|Overall Study|Adverse Event|27
5347351|NCT00082407|18392103|P2|Overall Study|Lost to Follow-up|3
5347352|NCT00082407|18392104|P1|Overall Study|Lost to Follow-up|0
5347353|NCT00082407|18392103|P2|Overall Study|Death|1
5347354|NCT00082407|18392104|P1|Overall Study|Death|2
5347355|NCT00082407|18392103|P2|Overall Study|Loss of Glucose Control|2
5347356|NCT00082407|18392104|P1|Overall Study|Loss of Glucose Control|2
5347357|NCT00082407|18392103|P2|Overall Study|Physician Decision|3
5347358|NCT00082407|18392104|P1|Overall Study|Physician Decision|5
5347359|NCT00082407|18392103|P2|Overall Study|Patient Decision|6
5347360|NCT00082407|18392104|P1|Overall Study|Patient Decision|13
5347361|NCT00082407|18392103|P2|Overall Study|Protocol Violation|12
5347362|NCT00082407|18392104|P1|Overall Study|Protocol Violation|14
5347363|NCT00082407|18392103|P2|Overall Study|Adverse Event|0
5347364|NCT00082407|18392104|P1|Overall Study|Adverse Event|20
5347365|NCT00082368|18392122|P1|Overall Study|Not treated-pt had poor IV access|1
5347366|NCT00082355|18392127|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
5347367|NCT00082355|18392127|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
5347368|NCT00082355|18392127|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
5347369|NCT00082173|18392161|P2|Overall Study|Culture negative or resistant at baselin|6
5347370|NCT00082173|18392162|P1|Overall Study|Culture negative or resistant at baselin|5
5347371|NCT00082173|18392161|P2|Overall Study|Adverse Event|0
5347372|NCT00082173|18392162|P1|Overall Study|Adverse Event|1
5347373|NCT00082173|18392161|P2|Overall Study|Lost to Follow-up|0
5347374|NCT00082173|18392162|P1|Overall Study|Lost to Follow-up|1
5347375|NCT00082173|18392161|P2|Overall Study|Withdrawal by Subject|5
5347376|NCT00082173|18392162|P1|Overall Study|Withdrawal by Subject|3
5347377|NCT00081770|18392207|P3|Overall Study|Other|8
5347378|NCT00081770|18392208|P2|Overall Study|Other|7
5347379|NCT00081770|18392209|P1|Overall Study|Other|2
5347380|NCT00081770|18392207|P3|Overall Study|Administrative|1
5347381|NCT00081770|18392208|P2|Overall Study|Administrative|0
5347382|NCT00081770|18392209|P1|Overall Study|Administrative|1
5347383|NCT00081770|18392207|P3|Overall Study|Did not meet protocol eligibility|3
5347384|NCT00081770|18392208|P2|Overall Study|Did not meet protocol eligibility|0
5347385|NCT00081770|18392209|P1|Overall Study|Did not meet protocol eligibility|2
5347386|NCT00081770|18392207|P3|Overall Study|Withdrawal by Subject|42
5347387|NCT00081770|18392208|P2|Overall Study|Withdrawal by Subject|40
5347388|NCT00081770|18392209|P1|Overall Study|Withdrawal by Subject|45
5347389|NCT00081770|18392207|P3|Overall Study|Protocol Violation|10
5347390|NCT00081770|18392208|P2|Overall Study|Protocol Violation|10
5347391|NCT00081770|18392209|P1|Overall Study|Protocol Violation|15
5347392|NCT00081770|18392207|P3|Overall Study|Lost to Follow-up|45
5347393|NCT00081770|18392208|P2|Overall Study|Lost to Follow-up|34
5347394|NCT00081770|18392209|P1|Overall Study|Lost to Follow-up|45
5347395|NCT00081770|18392207|P3|Overall Study|Lack of Efficacy|211
5347396|NCT00081770|18392208|P2|Overall Study|Lack of Efficacy|357
5347397|NCT00081770|18392209|P1|Overall Study|Lack of Efficacy|262
5347398|NCT00081770|18392207|P3|Overall Study|Adverse Event|136
5347399|NCT00081770|18392208|P2|Overall Study|Adverse Event|98
5347400|NCT00081770|18392209|P1|Overall Study|Adverse Event|130
5347401|NCT00081731|18392228|P2|Overall Study|scientific integrity issue|8
5347402|NCT00081731|18392229|P1|Overall Study|scientific integrity issue|8
5347403|NCT00081653|18392249|P2|Overall Study|Loss of bone mass|2
5347404|NCT00081653|18392250|P1|Overall Study|Loss of bone mass|0
5347405|NCT00081653|18392249|P2|Overall Study|Participant leaving country|0
5347406|NCT00081653|18392250|P1|Overall Study|Participant leaving country|1
5347407|NCT00081653|18392249|P2|Overall Study|Bone loss|0
5347408|NCT00081653|18392250|P1|Overall Study|Bone loss|2
5347409|NCT00081653|18392249|P2|Overall Study|Low bone mineral density|0
5347410|NCT00081653|18392250|P1|Overall Study|Low bone mineral density|1
5347411|NCT00081653|18392249|P2|Overall Study|Refused Treatment|14
5347412|NCT00081653|18392250|P1|Overall Study|Refused Treatment|18
5347413|NCT00081653|18392249|P2|Overall Study|Lost to Follow-up|4
5347414|NCT00081653|18392250|P1|Overall Study|Lost to Follow-up|2
5347415|NCT00081653|18392249|P2|Overall Study|Adverse Event|17
5347416|NCT00081653|18392250|P1|Overall Study|Adverse Event|23
5347417|NCT00081497|18392268|P2|Overall Study|Non-compliance|1
5347418|NCT00081497|18392269|P1|Overall Study|Non-compliance|0
5347419|NCT00081497|18392268|P2|Overall Study|Withdrawal by Subject|0
5347420|NCT00081497|18392269|P1|Overall Study|Withdrawal by Subject|1
5347421|NCT00081497|18392268|P2|Overall Study|Death|1
5347422|NCT00081497|18392269|P1|Overall Study|Death|0
5347423|NCT00081497|18392268|P2|Overall Study|Adverse Event|0
5347424|NCT00081497|18392269|P1|Overall Study|Adverse Event|2
5347425|NCT00081458|18392287|P3|Overall Study|Randomized but not dosed|1
5347426|NCT00081458|18392288|P2|Overall Study|Randomized but not dosed|0
5347427|NCT00081458|18392289|P1|Overall Study|Randomized but not dosed|0
5347428|NCT00081458|18392287|P3|Overall Study|Withdrawal by Subject|1
5347429|NCT00081458|18392288|P2|Overall Study|Withdrawal by Subject|3
5347430|NCT00081458|18392289|P1|Overall Study|Withdrawal by Subject|0
5347431|NCT00081458|18392287|P3|Overall Study|Adverse Event|2
5347432|NCT00081458|18392288|P2|Overall Study|Adverse Event|5
5347433|NCT00081458|18392289|P1|Overall Study|Adverse Event|1
5347434|NCT00081289|18392345|P2|Overall Study|Ineligible / no protocol treatment|4
5347435|NCT00081289|18392346|P1|Overall Study|Ineligible / no protocol treatment|3
5347436|NCT00081289|18392345|P2|Overall Study|Accrued prior to chemotherapy amendment|17
5347437|NCT00081289|18392346|P1|Overall Study|Accrued prior to chemotherapy amendment|18
5347438|NCT00081263|18392390|P2|Overall Study|Inadequate data|10
5347439|NCT00081263|18392391|P1|Overall Study|Inadequate data|5
5347440|NCT00081263|18392390|P2|Overall Study|Never treated|5
5347441|NCT00081263|18392391|P1|Overall Study|Never treated|4
5347442|NCT00081263|18392390|P2|Overall Study|Inadequate pathology|1
5347443|NCT00081263|18392391|P1|Overall Study|Inadequate pathology|0
5347444|NCT00081263|18392390|P2|Overall Study|improper pre-protocol therapy|1
5347445|NCT00081263|18392391|P1|Overall Study|improper pre-protocol therapy|0
5347446|NCT00081263|18392390|P2|Overall Study|wrong cell type|5
5347447|NCT00081263|18392391|P1|Overall Study|wrong cell type|7
5347448|NCT00081263|18392390|P2|Overall Study|clerical error|0
5347449|NCT00081263|18392391|P1|Overall Study|clerical error|1
5347450|NCT00081159|18392401|P2|Overall Study|Lost to Follow-up|1
5347451|NCT00081159|18392402|P1|Overall Study|Lost to Follow-up|2
5347452|NCT00081159|18392401|P2|Overall Study|Myelosuppression prior to treatment|1
5347453|NCT00081159|18392402|P1|Overall Study|Myelosuppression prior to treatment|0
5347454|NCT00081159|18392401|P2|Overall Study|Withdrawal by Subject|3
5347455|NCT00081159|18392402|P1|Overall Study|Withdrawal by Subject|0
5347456|NCT00080938|18392412|P1|Overall Study|Ineligible|4
5347457|NCT00080938|18392412|P1|Overall Study|Not started protocol therapy|1
5347458|NCT00080938|18392412|P1|Overall Study|other disease|1
5347459|NCT00080938|18392412|P1|Overall Study|Lack of Efficacy|7
5347460|NCT00080938|18392412|P1|Overall Study|Death|2
5347461|NCT00080938|18392412|P1|Overall Study|Withdrawal by Subject|6
5347462|NCT00080938|18392412|P1|Overall Study|Adverse Event|3
5347463|NCT00080899|18392428|P1|Overall Study|Adverse Event|1
5347464|NCT00080483|18392440|P2|Overall Study|Physician Decision|1
5347465|NCT00080483|18392441|P1|Overall Study|Physician Decision|1
5347466|NCT00080483|18392440|P2|Overall Study|Lost to Follow-up|1
5347467|NCT00080483|18392441|P1|Overall Study|Lost to Follow-up|1
5347468|NCT00002525|18392449|P2|Overall Study|Never start protocol therapy|0
5347469|NCT00002525|18392450|P1|Overall Study|Never start protocol therapy|8
5347470|NCT00002525|18392449|P2|Overall Study|Other|0
5347471|NCT00002525|18392450|P1|Overall Study|Other|26
5347472|NCT00002525|18392449|P2|Overall Study|Error|0
5347473|NCT00002525|18392450|P1|Overall Study|Error|6
5347474|NCT00002525|18392449|P2|Overall Study|Duke's A, B1, D disease|0
5347475|NCT00002525|18392450|P1|Overall Study|Duke's A, B1, D disease|92
5347476|NCT00002525|18392449|P2|Overall Study|Other complicating disease|0
5347477|NCT00002525|18392450|P1|Overall Study|Other complicating disease|1
5347478|NCT00002525|18392449|P2|Overall Study|Start non-protocol therapy|0
5347479|NCT00002525|18392450|P1|Overall Study|Start non-protocol therapy|1
5347480|NCT00002525|18392449|P2|Overall Study|Withdrawal by Subject|0
5347481|NCT00002525|18392450|P1|Overall Study|Withdrawal by Subject|11
5347482|NCT00002525|18392449|P2|Overall Study|Death|0
5347483|NCT00002525|18392450|P1|Overall Study|Death|5
5347484|NCT00002525|18392449|P2|Overall Study|Adverse Event|0
5347485|NCT00002525|18392450|P1|Overall Study|Adverse Event|36
5347486|NCT00080301|18392477|P2|Overall Study|Still on Treatment as of CSR date|1
5347487|NCT00080301|18392478|P1|Overall Study|Still on Treatment as of CSR date|0
5347488|NCT00080301|18392477|P2|Overall Study|Randomized but Never Treated|10
5347489|NCT00080301|18392478|P1|Overall Study|Randomized but Never Treated|5
5347490|NCT00080288|18392498|P2|Overall Study|Miscellaneous|11
5347491|NCT00080288|18392499|P1|Overall Study|Miscellaneous|11
5347492|NCT00080288|18392498|P2|Overall Study|Withdrawal by Subject|16
5347493|NCT00080288|18392499|P1|Overall Study|Withdrawal by Subject|3
5347494|NCT00080288|18392498|P2|Overall Study|Physician Decision|2
5347495|NCT00080288|18392499|P1|Overall Study|Physician Decision|6
5347496|NCT00080288|18392498|P2|Overall Study|Lost to Follow-up|5
5347497|NCT00080288|18392499|P1|Overall Study|Lost to Follow-up|3
5347498|NCT00080288|18392498|P2|Overall Study|Adverse Event|4
5347499|NCT00080288|18392499|P1|Overall Study|Adverse Event|7
5347500|NCT00080223|18392507|P1|Overall Study|Physician Decision|1
5347501|NCT00080223|18392507|P1|Overall Study|Participant unwilling to continue|2
5347502|NCT00080223|18392507|P1|Overall Study|Non-compliance With Study Treatment|7
5347503|NCT00080223|18392507|P1|Overall Study|Lung Transplantation|9
5347504|NCT00080223|18392507|P1|Overall Study|Withdrawal by Subject|13
5347505|NCT00080223|18392507|P1|Overall Study|Death|21
5347506|NCT00080223|18392507|P1|Overall Study|Adverse Event|23
5347507|NCT00002540|18392517|P2|Overall Study|Refused Screen (Prostate Screening)|2433
5347508|NCT00002540|18392518|P1|Overall Study|Refused Screen (Prostate Screening)|0
5347509|NCT00002540|18392517|P2|Overall Study|Refused ASU (Control)|0
5347510|NCT00002540|18392518|P1|Overall Study|Refused ASU (Control)|597
5347511|NCT00002540|18392517|P2|Overall Study|Died Before ASU (Control)|0
5347512|NCT00002540|18392518|P1|Overall Study|Died Before ASU (Control)|202
5347513|NCT00002540|18392517|P2|Overall Study|Died Before Randomization|6
5347514|NCT00002540|18392518|P1|Overall Study|Died Before Randomization|2
5347515|NCT00002540|18392517|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
5347516|NCT00002540|18392518|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
5347517|NCT00080119|18392548|P4|Overall Study|Lost to Follow-up|14
5347518|NCT00080119|18392549|P3|Overall Study|Lost to Follow-up|19
5347519|NCT00080119|18392550|P2|Overall Study|Lost to Follow-up|19
5347520|NCT00080119|18392551|P1|Overall Study|Lost to Follow-up|16
5347521|NCT00080119|18392548|P4|Overall Study|Unwilling to adhere to study requirement|1
5347522|NCT00080119|18392549|P3|Overall Study|Unwilling to adhere to study requirement|5
5347523|NCT00080119|18392550|P2|Overall Study|Unwilling to adhere to study requirement|2
5347524|NCT00080119|18392551|P1|Overall Study|Unwilling to adhere to study requirement|3
5347525|NCT00080119|18392548|P4|Overall Study|Consent withdrawn|6
5347526|NCT00080119|18392549|P3|Overall Study|Consent withdrawn|4
5347527|NCT00080119|18392550|P2|Overall Study|Consent withdrawn|17
5347528|NCT00080119|18392551|P1|Overall Study|Consent withdrawn|13
5347529|NCT00080119|18392548|P4|Overall Study|Unable to get to clinic|1
5347530|NCT00080119|18392549|P3|Overall Study|Unable to get to clinic|7
5347531|NCT00080119|18392550|P2|Overall Study|Unable to get to clinic|24
5347532|NCT00080119|18392551|P1|Overall Study|Unable to get to clinic|24
5347533|NCT00080119|18392548|P4|Overall Study|Discontinued because of study closure|141
5347534|NCT00080119|18392549|P3|Overall Study|Discontinued because of study closure|130
5347535|NCT00080119|18392550|P2|Overall Study|Discontinued because of study closure|0
5347536|NCT00080119|18392551|P1|Overall Study|Discontinued because of study closure|0
5347537|NCT00079937|18392585|P2|Overall Study|Administrative problems|11
5347538|NCT00079937|18392586|P1|Overall Study|Administrative problems|22
5347539|NCT00079937|18392585|P2|Overall Study|Lost to Follow-up|5
5347540|NCT00079937|18392586|P1|Overall Study|Lost to Follow-up|12
5347541|NCT00079937|18392585|P2|Overall Study|Withdrawal by Subject|7
5347542|NCT00079937|18392586|P1|Overall Study|Withdrawal by Subject|21
5347543|NCT00079937|18392585|P2|Overall Study|Protocol Violation|6
5347544|NCT00079937|18392586|P1|Overall Study|Protocol Violation|8
5347545|NCT00079937|18392585|P2|Overall Study|Subject no longer requires study drug|0
5347546|NCT00079937|18392586|P1|Overall Study|Subject no longer requires study drug|3
5347547|NCT00079937|18392585|P2|Overall Study|Unsatisfactory therapeutic effect|2
5347548|NCT00079937|18392586|P1|Overall Study|Unsatisfactory therapeutic effect|1
5347549|NCT00079937|18392585|P2|Overall Study|Adverse Event|1
5347550|NCT00079937|18392586|P1|Overall Study|Adverse Event|2
5347551|NCT00009737|18392604|P2|Overall Study|Administrative/Other Reasons|1
5347552|NCT00009737|18392605|P1|Overall Study|Administrative/Other Reasons|7
5347553|NCT00009737|18392604|P2|Overall Study|Lost to Follow-up|1
5347554|NCT00009737|18392605|P1|Overall Study|Lost to Follow-up|1
5347555|NCT00009737|18392604|P2|Overall Study|Refused Treatment|16
5347556|NCT00009737|18392605|P1|Overall Study|Refused Treatment|15
5347557|NCT00009737|18392604|P2|Overall Study|Other Protocol Violation|0
5347558|NCT00009737|18392605|P1|Overall Study|Other Protocol Violation|1
5347559|NCT00009737|18392604|P2|Overall Study|Violation of Selection Criteria at Entry|9
5347560|NCT00009737|18392605|P1|Overall Study|Violation of Selection Criteria at Entry|13
5347561|NCT00009737|18392604|P2|Overall Study|Lack of Efficacy|15
5347562|NCT00009737|18392605|P1|Overall Study|Lack of Efficacy|17
5347563|NCT00009737|18392604|P2|Overall Study|Death|6
5347564|NCT00009737|18392605|P1|Overall Study|Death|4
5347565|NCT00009737|18392604|P2|Overall Study|Adverse Event|75
5347566|NCT00009737|18392605|P1|Overall Study|Adverse Event|112
5347567|NCT00079781|18392624|P3|Follow-up Period|Death|1
5347568|NCT00079781|18392625|P2|Follow-up Period|Death|0
5347569|NCT00079781|18392626|P1|Follow-up Period|Death|0
5347570|NCT00079781|18392624|P3|Follow-up Period|Lost to Follow-up|0
5347571|NCT00079781|18392625|P2|Follow-up Period|Lost to Follow-up|0
5347572|NCT00079781|18392626|P1|Follow-up Period|Lost to Follow-up|1
5347573|NCT00079781|18392624|P3|Follow-up Period|Withdrawal by Subject|1
5347574|NCT00079781|18392625|P2|Follow-up Period|Withdrawal by Subject|0
5347575|NCT00079781|18392626|P1|Follow-up Period|Withdrawal by Subject|3
5347576|NCT00079781|18392624|P3|Pre-implant Period|Did not meet I/E criteria|1
5347577|NCT00079781|18392625|P2|Pre-implant Period|Did not meet I/E criteria|1
5347578|NCT00079781|18392626|P1|Pre-implant Period|Did not meet I/E criteria|1
5347579|NCT00079781|18392624|P3|Pre-implant Period|Withdrawal by Subject|0
5347580|NCT00079781|18392625|P2|Pre-implant Period|Withdrawal by Subject|0
5347581|NCT00079781|18392626|P1|Pre-implant Period|Withdrawal by Subject|2
5347582|NCT00079677|18392635|P2|Overall Study|Miscellaneous|0
5347583|NCT00079677|18392636|P1|Overall Study|Miscellaneous|2
5347584|NCT00079677|18392635|P2|Overall Study|Withdrawal by Subject|3
5347585|NCT00079677|18392636|P1|Overall Study|Withdrawal by Subject|5
5347586|NCT00079677|18392635|P2|Overall Study|Protocol Violation|3
5347587|NCT00079677|18392636|P1|Overall Study|Protocol Violation|2
5347588|NCT00079677|18392635|P2|Overall Study|Physician Decision|0
5347589|NCT00079677|18392636|P1|Overall Study|Physician Decision|3
5347590|NCT00079677|18392635|P2|Overall Study|Lost to Follow-up|2
5347591|NCT00079677|18392636|P1|Overall Study|Lost to Follow-up|2
5347592|NCT00079677|18392635|P2|Overall Study|Lack of Efficacy|0
5347593|NCT00079677|18392636|P1|Overall Study|Lack of Efficacy|1
5347594|NCT00079677|18392635|P2|Overall Study|Adverse Event|6
5347595|NCT00079677|18392636|P1|Overall Study|Adverse Event|5
5347596|NCT00079417|18392652|P1|Overall Study|Ineligible|7
5347597|NCT00079417|18392652|P1|Overall Study|Physician Decision|2
5347598|NCT00079391|18392660|P1|Overall Study|Withdrawal by Subject|1
5347599|NCT00079339|18392672|P3|Overall Study|Disease progression|2
5347600|NCT00079339|18392673|P2|Overall Study|Disease progression|28
5347601|NCT00079339|18392674|P1|Overall Study|Disease progression|3
5347602|NCT00079339|18392672|P3|Overall Study|Withdrawal by Subject|1
5347603|NCT00079339|18392673|P2|Overall Study|Withdrawal by Subject|4
5347604|NCT00079339|18392674|P1|Overall Study|Withdrawal by Subject|0
5347605|NCT00079339|18392672|P3|Overall Study|Non-compliance|1
5347606|NCT00079339|18392673|P2|Overall Study|Non-compliance|0
5347607|NCT00079339|18392674|P1|Overall Study|Non-compliance|0
5347608|NCT00079339|18392672|P3|Overall Study|Death|0
5347609|NCT00079339|18392673|P2|Overall Study|Death|0
5347610|NCT00079339|18392674|P1|Overall Study|Death|1
5347611|NCT00079339|18392672|P3|Overall Study|Adverse Event|2
5347612|NCT00079339|18392673|P2|Overall Study|Adverse Event|7
5347613|NCT00079339|18392674|P1|Overall Study|Adverse Event|1
5347614|NCT00079274|18392705|P7|Overall Study|Other|0
5347615|NCT00079274|18392706|P6|Overall Study|Other|2
5347616|NCT00079274|18392707|P5|Overall Study|Other|1
5347617|NCT00079274|18392708|P4|Overall Study|Other|55
5347618|NCT00079274|18392709|P3|Overall Study|Other|5
5347619|NCT00079274|18392710|P2|Overall Study|Other|7
5347620|NCT00079274|18392711|P1|Overall Study|Other|43
5347621|NCT00079274|18392705|P7|Overall Study|Cytogenetic resistance|0
5347622|NCT00079274|18392706|P6|Overall Study|Cytogenetic resistance|0
5347623|NCT00079274|18392707|P5|Overall Study|Cytogenetic resistance|0
5347624|NCT00079274|18392708|P4|Overall Study|Cytogenetic resistance|2
5347625|NCT00079274|18392709|P3|Overall Study|Cytogenetic resistance|0
5347626|NCT00079274|18392710|P2|Overall Study|Cytogenetic resistance|0
5347627|NCT00079274|18392711|P1|Overall Study|Cytogenetic resistance|0
5347628|NCT00079274|18392705|P7|Overall Study|Death|0
5347629|NCT00079274|18392706|P6|Overall Study|Death|0
5347630|NCT00079274|18392707|P5|Overall Study|Death|0
5347631|NCT00079274|18392708|P4|Overall Study|Death|15
5347632|NCT00079274|18392709|P3|Overall Study|Death|1
5347633|NCT00079274|18392710|P2|Overall Study|Death|0
5347634|NCT00079274|18392711|P1|Overall Study|Death|4
5347635|NCT00079274|18392705|P7|Overall Study|Other Medical Problems|0
5347636|NCT00079274|18392706|P6|Overall Study|Other Medical Problems|0
5347637|NCT00079274|18392707|P5|Overall Study|Other Medical Problems|0
5347638|NCT00079274|18392708|P4|Overall Study|Other Medical Problems|7
5347639|NCT00079274|18392709|P3|Overall Study|Other Medical Problems|0
5347640|NCT00079274|18392710|P2|Overall Study|Other Medical Problems|1
5347641|NCT00079274|18392711|P1|Overall Study|Other Medical Problems|6
5347642|NCT00079274|18392705|P7|Overall Study|Alternate Treatment|0
5347643|NCT00079274|18392706|P6|Overall Study|Alternate Treatment|0
5347644|NCT00079274|18392707|P5|Overall Study|Alternate Treatment|0
5347645|NCT00079274|18392708|P4|Overall Study|Alternate Treatment|3
5347646|NCT00079274|18392709|P3|Overall Study|Alternate Treatment|0
5347647|NCT00079274|18392710|P2|Overall Study|Alternate Treatment|1
5347648|NCT00079274|18392711|P1|Overall Study|Alternate Treatment|6
5347649|NCT00079274|18392705|P7|Overall Study|Recurrence|0
5347650|NCT00079274|18392706|P6|Overall Study|Recurrence|2
5347651|NCT00079274|18392707|P5|Overall Study|Recurrence|0
5347652|NCT00079274|18392708|P4|Overall Study|Recurrence|15
5347653|NCT00079274|18392709|P3|Overall Study|Recurrence|1
5347654|NCT00079274|18392710|P2|Overall Study|Recurrence|0
5347655|NCT00079274|18392711|P1|Overall Study|Recurrence|21
5347656|NCT00079274|18392705|P7|Overall Study|Adverse Event|0
5347657|NCT00079274|18392706|P6|Overall Study|Adverse Event|8
5347658|NCT00079274|18392707|P5|Overall Study|Adverse Event|7
5347659|NCT00079274|18392708|P4|Overall Study|Adverse Event|184
5347660|NCT00079274|18392709|P3|Overall Study|Adverse Event|8
5347661|NCT00079274|18392710|P2|Overall Study|Adverse Event|8
5347662|NCT00079274|18392711|P1|Overall Study|Adverse Event|130
5347663|NCT00079274|18392705|P7|Overall Study|Withdrawal by Subject|0
5347664|NCT00079274|18392706|P6|Overall Study|Withdrawal by Subject|8
5347665|NCT00079274|18392707|P5|Overall Study|Withdrawal by Subject|7
5347666|NCT00079274|18392708|P4|Overall Study|Withdrawal by Subject|163
5347667|NCT00079274|18392709|P3|Overall Study|Withdrawal by Subject|12
5347668|NCT00079274|18392710|P2|Overall Study|Withdrawal by Subject|10
5347669|NCT00079274|18392711|P1|Overall Study|Withdrawal by Subject|111
5347670|NCT00079183|18392732|P1|Overall Study|Specimen collection non-compliance|1
5347671|NCT00079183|18392732|P1|Overall Study|Study medication non-compliance|2
5347672|NCT00079183|18392732|P1|Overall Study|Withdrawal by Subject|4
5347673|NCT00079040|18392747|P1|Overall Study|Ineligible|1
5347674|NCT00079040|18392747|P1|Overall Study|Withdrew before treatment|1
5347675|NCT00078949|18392770|P4|Overall Study|No treated|3
5347676|NCT00078949|18392771|P3|Overall Study|No treated|3
5347677|NCT00078949|18392772|P2|Overall Study|No treated|5
5347678|NCT00078949|18392773|P1|Overall Study|No treated|4
5347679|NCT00078819|18392802|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
5347680|NCT00078819|18392803|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
5347681|NCT00078819|18392804|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
5347682|NCT00078819|18392805|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
5347683|NCT00078819|18392802|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
5347684|NCT00078819|18392803|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
5347685|NCT00078819|18392804|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
5347686|NCT00078819|18392805|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
5347687|NCT00078819|18392802|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
5347688|NCT00078819|18392803|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
5347689|NCT00078819|18392804|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
5347690|NCT00078819|18392805|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
5347691|NCT00078819|18392802|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
5347692|NCT00078819|18392803|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
5347693|NCT00078819|18392804|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
5347694|NCT00078819|18392805|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
5347695|NCT00078819|18392802|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
5347696|NCT00078819|18392803|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
5347697|NCT00078819|18392804|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
5347698|NCT00078819|18392805|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
5347699|NCT00078819|18392802|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
5347700|NCT00078819|18392803|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
5347701|NCT00078819|18392804|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
5347702|NCT00078819|18392805|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
5347703|NCT00078819|18392802|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
5347704|NCT00078819|18392803|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
5347705|NCT00078819|18392804|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
5347706|NCT00078819|18392805|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
5347707|NCT00078819|18392802|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
5347708|NCT00078819|18392803|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
5347709|NCT00078819|18392804|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
5347710|NCT00078819|18392805|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
5347711|NCT00078806|18392830|P4|Part 2|Adverse Event|0
5347712|NCT00078806|18392831|P3|Part 2|Adverse Event|0
5347713|NCT00078806|18392832|P2|Part 2|Adverse Event|1
5347714|NCT00078806|18392833|P1|Part 2|Adverse Event|0
5347715|NCT00078806|18392830|P4|Part 1B|Lack of Efficacy|0
5347716|NCT00078806|18392831|P3|Part 1B|Lack of Efficacy|0
5347717|NCT00078806|18392832|P2|Part 1B|Lack of Efficacy|0
5347718|NCT00078806|18392833|P1|Part 1B|Lack of Efficacy|7
5347719|NCT00078806|18392830|P4|Part 1B|Adverse Event|0
5347720|NCT00078806|18392831|P3|Part 1B|Adverse Event|0
5347721|NCT00078806|18392832|P2|Part 1B|Adverse Event|0
5347722|NCT00078806|18392833|P1|Part 1B|Adverse Event|1
5347723|NCT00078806|18392830|P4|Part 1A|Other|0
5347724|NCT00078806|18392831|P3|Part 1A|Other|0
5347725|NCT00078806|18392832|P2|Part 1A|Other|0
5347726|NCT00078806|18392833|P1|Part 1A|Other|1
5347727|NCT00078806|18392830|P4|Part 1A|Lack of Efficacy|0
5347728|NCT00078806|18392831|P3|Part 1A|Lack of Efficacy|0
5347729|NCT00078806|18392832|P2|Part 1A|Lack of Efficacy|0
5347730|NCT00078806|18392833|P1|Part 1A|Lack of Efficacy|7
5347731|NCT00078806|18392830|P4|Part 1A|Adverse Event|0
5347732|NCT00078806|18392831|P3|Part 1A|Adverse Event|0
5347733|NCT00078806|18392832|P2|Part 1A|Adverse Event|0
5347734|NCT00078806|18392833|P1|Part 1A|Adverse Event|2
5347735|NCT00078767|18392869|P2|Overall Study|Withdrawal by Subject|1
5347736|NCT00078767|18392870|P1|Overall Study|Withdrawal by Subject|1
5347737|NCT00005947|18392917|P2|Overall Study|Site Closure|0
5347738|NCT00005947|18392918|P1|Overall Study|Site Closure|1
5347739|NCT00005947|18392917|P2|Overall Study|Patient Refused to Continue|1
5347740|NCT00005947|18392918|P1|Overall Study|Patient Refused to Continue|2
5347741|NCT00005947|18392917|P2|Overall Study|Death|40
5347742|NCT00005947|18392918|P1|Overall Study|Death|54
5347743|NCT00002597|18392954|P2|Overall Study|Withdrawal by Subject|6
5347744|NCT00002597|18392955|P1|Overall Study|Withdrawal by Subject|7
5347745|NCT00002597|18392954|P2|Overall Study|Protocol Violation|17
5347746|NCT00002597|18392955|P1|Overall Study|Protocol Violation|19
5347747|NCT00078377|18392980|P3|Overall Study|Miscellaneous|1
5347748|NCT00078377|18392981|P2|Overall Study|Miscellaneous|6
5347749|NCT00078377|18392982|P1|Overall Study|Miscellaneous|2
5347750|NCT00078377|18392980|P3|Overall Study|Withdrawal by Subject|4
5347751|NCT00078377|18392981|P2|Overall Study|Withdrawal by Subject|4
5347752|NCT00078377|18392982|P1|Overall Study|Withdrawal by Subject|3
5347753|NCT00078377|18392980|P3|Overall Study|Physician Decision|0
5347754|NCT00078377|18392981|P2|Overall Study|Physician Decision|0
5347755|NCT00078377|18392982|P1|Overall Study|Physician Decision|2
5347756|NCT00078377|18392980|P3|Overall Study|Lost to Follow-up|1
5347757|NCT00078377|18392981|P2|Overall Study|Lost to Follow-up|1
5347758|NCT00078377|18392982|P1|Overall Study|Lost to Follow-up|0
5347759|NCT00078377|18392980|P3|Overall Study|Lack of Efficacy|2
5347760|NCT00078377|18392981|P2|Overall Study|Lack of Efficacy|0
5347761|NCT00078377|18392982|P1|Overall Study|Lack of Efficacy|2
5347762|NCT00078377|18392980|P3|Overall Study|Adverse Event|1
5347763|NCT00078377|18392981|P2|Overall Study|Adverse Event|5
5347764|NCT00078377|18392982|P1|Overall Study|Adverse Event|2
5347765|NCT00078338|18392997|P2|Overall Study|Subjects randomized, but not treated|3
5347766|NCT00078338|18392998|P1|Overall Study|Subjects randomized, but not treated|3
5347767|NCT00078338|18392997|P2|Overall Study|Other|16
5347768|NCT00078338|18392998|P1|Overall Study|Other|28
5347769|NCT00078338|18392997|P2|Overall Study|Disease Progression|7
5347770|NCT00078338|18392998|P1|Overall Study|Disease Progression|4
5347771|NCT00078338|18392997|P2|Overall Study|Protocol Violation|2
5347772|NCT00078338|18392998|P1|Overall Study|Protocol Violation|2
5347773|NCT00078338|18392997|P2|Overall Study|Lost to Follow-up|2
5347774|NCT00078338|18392998|P1|Overall Study|Lost to Follow-up|17
5347775|NCT00078338|18392997|P2|Overall Study|Adverse Event|24
5347776|NCT00078338|18392998|P1|Overall Study|Adverse Event|31
5347777|NCT00078325|18393091|P3|Overall Study|Miscellaneous|1
5347778|NCT00078325|18393092|P2|Overall Study|Miscellaneous|1
5347779|NCT00078325|18393093|P1|Overall Study|Miscellaneous|1
5347780|NCT00078325|18393091|P3|Overall Study|Physician Decision|1
5347781|NCT00078325|18393092|P2|Overall Study|Physician Decision|0
5347782|NCT00078325|18393093|P1|Overall Study|Physician Decision|2
5347783|NCT00078325|18393091|P3|Overall Study|Lost to Follow-up|1
5347784|NCT00078325|18393092|P2|Overall Study|Lost to Follow-up|1
5347785|NCT00078325|18393093|P1|Overall Study|Lost to Follow-up|0
5347786|NCT00078325|18393091|P3|Overall Study|Withdrawal by Subject|3
5347787|NCT00078325|18393092|P2|Overall Study|Withdrawal by Subject|5
5347788|NCT00078325|18393093|P1|Overall Study|Withdrawal by Subject|1
5347789|NCT00078325|18393091|P3|Overall Study|Protocol Violation|0
5347790|NCT00078325|18393092|P2|Overall Study|Protocol Violation|2
5347791|NCT00078325|18393093|P1|Overall Study|Protocol Violation|2
5347792|NCT00078325|18393091|P3|Overall Study|Adverse Event|5
5347793|NCT00078325|18393092|P2|Overall Study|Adverse Event|10
5347794|NCT00078325|18393093|P1|Overall Study|Adverse Event|15
5347795|NCT00078312|18393104|P1|Overall Study|Miscellaneous|33
5347796|NCT00078312|18393104|P1|Overall Study|Withdrawal by Subject|33
5347797|NCT00078312|18393104|P1|Overall Study|Protocol Violation|3
5347798|NCT00078312|18393104|P1|Overall Study|Physician Decision|9
5347799|NCT00078312|18393104|P1|Overall Study|Lost to Follow-up|41
5347800|NCT00078312|18393104|P1|Overall Study|Lack of Efficacy|15
5347801|NCT00078312|18393104|P1|Overall Study|Adverse Event|43
5347802|NCT00077974|18393119|P1|Overall Study|Decision of Sponsor|2
5347803|NCT00077974|18393119|P1|Overall Study|Lack of Efficacy|76
5347804|NCT00077974|18393119|P1|Overall Study|Withdrawal by Subject|3
5347805|NCT00077974|18393119|P1|Overall Study|Protocol Violation|1
5347806|NCT00077974|18393119|P1|Overall Study|Adverse Event|22
5347807|NCT00077857|18393136|P2|Overall Study|Other|13
5347808|NCT00077857|18393137|P1|Overall Study|Other|15
5347809|NCT00077857|18393136|P2|Overall Study|Failure to return|5
5347810|NCT00077857|18393137|P1|Overall Study|Failure to return|5
5347811|NCT00077857|18393136|P2|Overall Study|Refused treatment|21
5347812|NCT00077857|18393137|P1|Overall Study|Refused treatment|29
5347813|NCT00077857|18393136|P2|Overall Study|Other protocol violation|1
5347814|NCT00077857|18393137|P1|Overall Study|Other protocol violation|0
5347815|NCT00077857|18393136|P2|Overall Study|Violation of selection criteria at entry|1
5347816|NCT00077857|18393137|P1|Overall Study|Violation of selection criteria at entry|3
5347817|NCT00077857|18393136|P2|Overall Study|Insufficient therapeutic response|128
5347818|NCT00077857|18393137|P1|Overall Study|Insufficient therapeutic response|112
5347819|NCT00077857|18393136|P2|Overall Study|Death|3
5347820|NCT00077857|18393137|P1|Overall Study|Death|7
5347821|NCT00077857|18393136|P2|Overall Study|Adverse Event|32
5347822|NCT00077857|18393137|P1|Overall Study|Adverse Event|30
5347823|NCT00077766|18393157|P2|Overall Study|Participants Vacation|1
5347824|NCT00077766|18393158|P1|Overall Study|Participants Vacation|2
5347825|NCT00077766|18393157|P2|Overall Study|Stop Dialysis|1
5347826|NCT00077766|18393158|P1|Overall Study|Stop Dialysis|0
5347827|NCT00077766|18393157|P2|Overall Study|Started Nocturnal Dialysis|1
5347828|NCT00077766|18393158|P1|Overall Study|Started Nocturnal Dialysis|0
5347829|NCT00077766|18393157|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
5347830|NCT00077766|18393158|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
5347831|NCT00077766|18393157|P2|Overall Study|Dialysis|1
5347832|NCT00077766|18393158|P1|Overall Study|Dialysis|0
5347833|NCT00077766|18393157|P2|Overall Study|Dialysis Discontinued|0
5347834|NCT00077766|18393158|P1|Overall Study|Dialysis Discontinued|1
5347835|NCT00077766|18393157|P2|Overall Study|Participant's decision|0
5347836|NCT00077766|18393158|P1|Overall Study|Participant's decision|1
5347837|NCT00077766|18393157|P2|Overall Study|Investigators Discretion|0
5347838|NCT00077766|18393158|P1|Overall Study|Investigators Discretion|1
5347839|NCT00077766|18393157|P2|Overall Study|Transplantation|1
5347840|NCT00077766|18393158|P1|Overall Study|Transplantation|5
5347841|NCT00077766|18393157|P2|Overall Study|Kidney Transplantation|5
5347842|NCT00077766|18393158|P1|Overall Study|Kidney Transplantation|9
5347843|NCT00077766|18393157|P2|Overall Study|Protocol Violation|0
5347844|NCT00077766|18393158|P1|Overall Study|Protocol Violation|1
5347845|NCT00077766|18393157|P2|Overall Study|Lost to Follow-up|0
5347846|NCT00077766|18393158|P1|Overall Study|Lost to Follow-up|2
5347847|NCT00077766|18393157|P2|Overall Study|Death|10
5347848|NCT00077766|18393158|P1|Overall Study|Death|12
5347849|NCT00077766|18393157|P2|Overall Study|Withdrawal by Subject|3
5347850|NCT00077766|18393158|P1|Overall Study|Withdrawal by Subject|4
5347851|NCT00077766|18393157|P2|Overall Study|Adverse Event|1
5347852|NCT00077766|18393158|P1|Overall Study|Adverse Event|1
5347853|NCT00077675|18393183|P2|Overall Study|Never received study treatment|3
5347854|NCT00077675|18393184|P1|Overall Study|Never received study treatment|3
5347855|NCT00077675|18393183|P2|Overall Study|Other|1
5347856|NCT00077675|18393184|P1|Overall Study|Other|0
5347857|NCT00077675|18393183|P2|Overall Study|Withdrawal by Subject|0
5347858|NCT00077675|18393184|P1|Overall Study|Withdrawal by Subject|1
5347859|NCT00077675|18393183|P2|Overall Study|Lost to Follow-up|3
5347860|NCT00077675|18393184|P1|Overall Study|Lost to Follow-up|6
5347861|NCT00077675|18393183|P2|Overall Study|Adverse Event|2
5347862|NCT00077675|18393184|P1|Overall Study|Adverse Event|1
5347863|NCT00077649|18393194|P4|Overall Study|Randomized but never dosed|0
5347864|NCT00077649|18393195|P3|Overall Study|Randomized but never dosed|0
5347865|NCT00077649|18393196|P2|Overall Study|Randomized but never dosed|0
5347866|NCT00077649|18393197|P1|Overall Study|Randomized but never dosed|1
5347867|NCT00077649|18393194|P4|Overall Study|Abnormality of Laboratory Test|2
5347868|NCT00077649|18393195|P3|Overall Study|Abnormality of Laboratory Test|1
5347869|NCT00077649|18393196|P2|Overall Study|Abnormality of Laboratory Test|2
5347870|NCT00077649|18393197|P1|Overall Study|Abnormality of Laboratory Test|1
5347871|NCT00077649|18393194|P4|Overall Study|Lost to Follow-up|2
5347872|NCT00077649|18393195|P3|Overall Study|Lost to Follow-up|3
5347873|NCT00077649|18393196|P2|Overall Study|Lost to Follow-up|2
5347874|NCT00077649|18393197|P1|Overall Study|Lost to Follow-up|2
5347875|NCT00077649|18393194|P4|Overall Study|Withdrawal by Subject|2
5347876|NCT00077649|18393195|P3|Overall Study|Withdrawal by Subject|1
5347877|NCT00077649|18393196|P2|Overall Study|Withdrawal by Subject|1
5347878|NCT00077649|18393197|P1|Overall Study|Withdrawal by Subject|0
5347879|NCT00077649|18393194|P4|Overall Study|Lack of Efficacy|2
5347880|NCT00077649|18393195|P3|Overall Study|Lack of Efficacy|3
5347881|NCT00077649|18393196|P2|Overall Study|Lack of Efficacy|3
5347882|NCT00077649|18393197|P1|Overall Study|Lack of Efficacy|5
5347883|NCT00077649|18393194|P4|Overall Study|Adverse Event|9
5347884|NCT00077649|18393195|P3|Overall Study|Adverse Event|7
5347885|NCT00077649|18393196|P2|Overall Study|Adverse Event|1
5347886|NCT00077649|18393197|P1|Overall Study|Adverse Event|5
5347887|NCT00077636|18393245|P2|Overall Study|Abnormality Of Laboratory Test|2
5347888|NCT00077636|18393246|P1|Overall Study|Abnormality Of Laboratory Test|3
5347889|NCT00077636|18393245|P2|Overall Study|Lost to Follow-up|18
5347890|NCT00077636|18393246|P1|Overall Study|Lost to Follow-up|10
5347891|NCT00077636|18393245|P2|Overall Study|Protocol Violation|2
5347892|NCT00077636|18393246|P1|Overall Study|Protocol Violation|0
5347893|NCT00077636|18393245|P2|Overall Study|Adverse Event|34
5347894|NCT00077636|18393246|P1|Overall Study|Adverse Event|17
5347895|NCT00077636|18393245|P2|Overall Study|Withdrawal by Subject|2
5347896|NCT00077636|18393246|P1|Overall Study|Withdrawal by Subject|2
5347897|NCT00077636|18393245|P2|Overall Study|Admin|3
5347898|NCT00077636|18393246|P1|Overall Study|Admin|3
5347899|NCT00077636|18393245|P2|Overall Study|Refused Treatment|31
5347900|NCT00077636|18393246|P1|Overall Study|Refused Treatment|9
5347901|NCT00077623|18393267|P3|Overall Study|Failure to return|0
5347902|NCT00077623|18393268|P2|Overall Study|Failure to return|0
5347903|NCT00077623|18393269|P1|Overall Study|Failure to return|1
5347904|NCT00077623|18393267|P3|Overall Study|Death|11
5347905|NCT00077623|18393268|P2|Overall Study|Death|18
5347906|NCT00077623|18393269|P1|Overall Study|Death|12
5347907|NCT00077623|18393267|P3|Overall Study|Insufficient therapeutic response|0
5347908|NCT00077623|18393268|P2|Overall Study|Insufficient therapeutic response|0
5347909|NCT00077623|18393269|P1|Overall Study|Insufficient therapeutic response|2
5347910|NCT00077623|18393267|P3|Overall Study|Other-Non safety reason|19
5347911|NCT00077623|18393268|P2|Overall Study|Other-Non safety reason|15
5347912|NCT00077623|18393269|P1|Overall Study|Other-Non safety reason|18
5347913|NCT00077623|18393267|P3|Overall Study|Withdrawal by Subject|1
5347914|NCT00077623|18393268|P2|Overall Study|Withdrawal by Subject|10
5347915|NCT00077623|18393269|P1|Overall Study|Withdrawal by Subject|2
5347916|NCT00077623|18393267|P3|Overall Study|Adverse Event|1
5347917|NCT00077623|18393268|P2|Overall Study|Adverse Event|0
5347918|NCT00077623|18393269|P1|Overall Study|Adverse Event|1
5347919|NCT00077610|18393304|P3|Overall Study|Sponsors decision to withdraw|1
5347920|NCT00077610|18393305|P2|Overall Study|Sponsors decision to withdraw|0
5347921|NCT00077610|18393306|P1|Overall Study|Sponsors decision to withdraw|0
5347922|NCT00077610|18393304|P3|Overall Study|Financial issues|0
5347923|NCT00077610|18393305|P2|Overall Study|Financial issues|1
5347924|NCT00077610|18393306|P1|Overall Study|Financial issues|0
5347925|NCT00077610|18393304|P3|Overall Study|Relocation|5
5347926|NCT00077610|18393305|P2|Overall Study|Relocation|8
5347927|NCT00077610|18393306|P1|Overall Study|Relocation|0
5347928|NCT00077610|18393304|P3|Overall Study|Change in dialysis modality|0
5347929|NCT00077610|18393305|P2|Overall Study|Change in dialysis modality|0
5347930|NCT00077610|18393306|P1|Overall Study|Change in dialysis modality|1
5347931|NCT00077610|18393304|P3|Overall Study|Transfer to other center for surgery|0
5347932|NCT00077610|18393305|P2|Overall Study|Transfer to other center for surgery|0
5347933|NCT00077610|18393306|P1|Overall Study|Transfer to other center for surgery|1
5347934|NCT00077610|18393304|P3|Overall Study|Transfer to satellite unit|0
5347935|NCT00077610|18393305|P2|Overall Study|Transfer to satellite unit|0
5347936|NCT00077610|18393306|P1|Overall Study|Transfer to satellite unit|1
5347937|NCT00077610|18393304|P3|Overall Study|Transferred to nursing home|1
5347938|NCT00077610|18393305|P2|Overall Study|Transferred to nursing home|0
5347939|NCT00077610|18393306|P1|Overall Study|Transferred to nursing home|0
5347940|NCT00077610|18393304|P3|Overall Study|Transferred to other unit|1
5347941|NCT00077610|18393305|P2|Overall Study|Transferred to other unit|0
5347942|NCT00077610|18393306|P1|Overall Study|Transferred to other unit|0
5347943|NCT00077610|18393304|P3|Overall Study|Given Epogen in hospital|0
5347944|NCT00077610|18393305|P2|Overall Study|Given Epogen in hospital|0
5347945|NCT00077610|18393306|P1|Overall Study|Given Epogen in hospital|1
5347946|NCT00077610|18393304|P3|Overall Study|Worsening of health condition|0
5347947|NCT00077610|18393305|P2|Overall Study|Worsening of health condition|1
5347948|NCT00077610|18393306|P1|Overall Study|Worsening of health condition|1
5347949|NCT00077610|18393304|P3|Overall Study|Principal Investigator's decision|1
5347950|NCT00077610|18393305|P2|Overall Study|Principal Investigator's decision|0
5347951|NCT00077610|18393306|P1|Overall Study|Principal Investigator's decision|1
5347952|NCT00077610|18393304|P3|Overall Study|Multiple blood transfusions|1
5347953|NCT00077610|18393305|P2|Overall Study|Multiple blood transfusions|0
5347954|NCT00077610|18393306|P1|Overall Study|Multiple blood transfusions|0
5347955|NCT00077610|18393304|P3|Overall Study|Insufficient Therapeutic Response|0
5347956|NCT00077610|18393305|P2|Overall Study|Insufficient Therapeutic Response|0
5347957|NCT00077610|18393306|P1|Overall Study|Insufficient Therapeutic Response|1
5347958|NCT00077610|18393304|P3|Overall Study|Withdrew from dialysis care|3
5347959|NCT00077610|18393305|P2|Overall Study|Withdrew from dialysis care|0
5347960|NCT00077610|18393306|P1|Overall Study|Withdrew from dialysis care|5
5347961|NCT00077610|18393304|P3|Overall Study|Renal transplant|11
5347962|NCT00077610|18393305|P2|Overall Study|Renal transplant|15
5347963|NCT00077610|18393306|P1|Overall Study|Renal transplant|12
5347964|NCT00077610|18393304|P3|Overall Study|Death|13
5347965|NCT00077610|18393305|P2|Overall Study|Death|13
5347966|NCT00077610|18393306|P1|Overall Study|Death|17
5347967|NCT00077610|18393304|P3|Overall Study|Withdrawal by Subject|6
5347968|NCT00077610|18393305|P2|Overall Study|Withdrawal by Subject|10
5347969|NCT00077610|18393306|P1|Overall Study|Withdrawal by Subject|4
5347970|NCT00077610|18393304|P3|Overall Study|Lost to Follow-up|2
5347971|NCT00077610|18393305|P2|Overall Study|Lost to Follow-up|1
5347972|NCT00077610|18393306|P1|Overall Study|Lost to Follow-up|0
5347973|NCT00077610|18393304|P3|Overall Study|Adverse Event|1
5347974|NCT00077610|18393305|P2|Overall Study|Adverse Event|7
5347975|NCT00077610|18393306|P1|Overall Study|Adverse Event|9
5347976|NCT00077376|18393335|P1|Overall Study|Insurance ran out|1
5347977|NCT00077376|18393335|P1|Overall Study|Surgery|1
5347978|NCT00077376|18393335|P1|Overall Study|Symptomatic deterioration|1
5347979|NCT00077376|18393335|P1|Overall Study|Still on treatment|1
5347980|NCT00077376|18393335|P1|Overall Study|Complicating disease|1
5347981|NCT00077376|18393335|P1|Overall Study|Alternative therapy|5
5347982|NCT00077376|18393335|P1|Overall Study|Physician Decision|1
5347983|NCT00077376|18393335|P1|Overall Study|Death|1
5347984|NCT00077376|18393335|P1|Overall Study|Withdrawal by Subject|2
5347985|NCT00077376|18393335|P1|Overall Study|Adverse Event|8
5347986|NCT00077207|18393346|P1|Overall Study|Ineligible|1
5347987|NCT00077207|18393346|P1|Overall Study|Withdrawal by Subject|6
5347988|NCT00077207|18393346|P1|Overall Study|Physician Decision|6
5347989|NCT00077207|18393346|P1|Overall Study|Lack of Efficacy|12
5347990|NCT00077207|18393346|P1|Overall Study|Adverse Event|5
5347991|NCT00077064|18393358|P2|Overall Study|Patient refusal|2
5347992|NCT00077064|18393359|P1|Overall Study|Patient refusal|0
5347993|NCT00077064|18393358|P2|Overall Study|Adverse Event|4
5347994|NCT00077064|18393359|P1|Overall Study|Adverse Event|0
5347995|NCT00076999|18393375|P5|Overall Study|Other reason (not specified)|13
5347996|NCT00076999|18393376|P4|Overall Study|Other reason (not specified)|1
5347997|NCT00076999|18393377|P3|Overall Study|Other reason (not specified)|4
5347998|NCT00076999|18393378|P2|Overall Study|Other reason (not specified)|8
5347999|NCT00076999|18393379|P1|Overall Study|Other reason (not specified)|8
5348000|NCT00076999|18393375|P5|Overall Study|Withdrawal by Subject|1
5348001|NCT00076999|18393376|P4|Overall Study|Withdrawal by Subject|0
5348002|NCT00076999|18393377|P3|Overall Study|Withdrawal by Subject|3
5348003|NCT00076999|18393378|P2|Overall Study|Withdrawal by Subject|4
5348004|NCT00076999|18393379|P1|Overall Study|Withdrawal by Subject|0
5348005|NCT00076999|18393375|P5|Overall Study|Lost to Follow-up|0
5348006|NCT00076999|18393376|P4|Overall Study|Lost to Follow-up|0
5348007|NCT00076999|18393377|P3|Overall Study|Lost to Follow-up|0
5348008|NCT00076999|18393378|P2|Overall Study|Lost to Follow-up|1
5348009|NCT00076999|18393379|P1|Overall Study|Lost to Follow-up|2
5348010|NCT00076999|18393375|P5|Overall Study|Protocol Violation|9
5348011|NCT00076999|18393376|P4|Overall Study|Protocol Violation|0
5348012|NCT00076999|18393377|P3|Overall Study|Protocol Violation|4
5348013|NCT00076999|18393378|P2|Overall Study|Protocol Violation|3
5348014|NCT00076999|18393379|P1|Overall Study|Protocol Violation|0
5348015|NCT00076999|18393375|P5|Overall Study|Adverse Event|2
5348016|NCT00076999|18393376|P4|Overall Study|Adverse Event|0
5348017|NCT00076999|18393377|P3|Overall Study|Adverse Event|6
5348018|NCT00076999|18393378|P2|Overall Study|Adverse Event|8
5348019|NCT00076999|18393379|P1|Overall Study|Adverse Event|2
5348020|NCT00003222|18393498|P2|Overall Study|Physician Decision|1
5348021|NCT00003222|18393499|P1|Overall Study|Physician Decision|0
5348022|NCT00076804|18393511|P2|Overall Study|Early study Closure|32
5348023|NCT00076804|18393512|P1|Overall Study|Early study Closure|32
5348024|NCT00076804|18393511|P2|Overall Study|Withdrawal by Subject|8
5348025|NCT00076804|18393512|P1|Overall Study|Withdrawal by Subject|10
5348026|NCT00076804|18393511|P2|Overall Study|Lost to Follow-up|9
5348027|NCT00076804|18393512|P1|Overall Study|Lost to Follow-up|9
5348028|NCT00076804|18393511|P2|Overall Study|Death|20
5348029|NCT00076804|18393512|P1|Overall Study|Death|9
5348030|NCT00076752|18393524|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
5348031|NCT00076752|18393524|P1|Overall Study|Death|2
5348032|NCT00076570|18393570|P2|Overall Study|Drug intolerance|8
5348033|NCT00076570|18393571|P1|Overall Study|Drug intolerance|8
5348034|NCT00003298|18393579|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
5348035|NCT00003298|18393579|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
5348036|NCT00003298|18393579|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
5348037|NCT00003298|18393579|P1|Step 2 (Adjuvant Therapy)|Death|1
5348038|NCT00003298|18393579|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
5348039|NCT00003298|18393579|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
5348040|NCT00003298|18393579|P1|Re-register to Step 2 After Surgery|Reason unknown|1
5348041|NCT00003298|18393579|P1|Re-register to Step 2 After Surgery|Other complications|2
5348042|NCT00003298|18393579|P1|Re-register to Step 2 After Surgery|Positive margins|5
5348043|NCT00003298|18393579|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
5348044|NCT00003298|18393579|P1|Surgery|Unevaluable and off study|2
5348045|NCT00003298|18393579|P1|Surgery|Progression before surgery|2
5348046|NCT00003298|18393579|P1|Surgery|Unresectable at surgery|3
5348047|NCT00003298|18393579|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
5348048|NCT00003298|18393579|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
5348049|NCT00076336|18393589|P2|Overall Study|Treatment failure|5
5348050|NCT00076336|18393590|P1|Overall Study|Treatment failure|4
5348051|NCT00076336|18393589|P2|Overall Study|Virologic Breakthrough|16
5348052|NCT00076336|18393590|P1|Overall Study|Virologic Breakthrough|14
5348053|NCT00076336|18393589|P2|Overall Study|Liver Transplantation|3
5348054|NCT00076336|18393590|P1|Overall Study|Liver Transplantation|3
5348055|NCT00076336|18393589|P2|Overall Study|Patient, Investigator, Sponsor request|6
5348056|NCT00076336|18393590|P1|Overall Study|Patient, Investigator, Sponsor request|8
5348057|NCT00076336|18393589|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
5348058|NCT00076336|18393590|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
5348059|NCT00076336|18393589|P2|Overall Study|Non-Compliance|0
5348060|NCT00076336|18393590|P1|Overall Study|Non-Compliance|2
5348061|NCT00076336|18393589|P2|Overall Study|Lost to Follow-up|4
5348062|NCT00076336|18393590|P1|Overall Study|Lost to Follow-up|4
5348063|NCT00076336|18393589|P2|Overall Study|Adverse Event|4
5348064|NCT00076336|18393590|P1|Overall Study|Adverse Event|4
5348065|NCT00076336|18393589|P2|Overall Study|Death|17
5348066|NCT00076336|18393590|P1|Overall Study|Death|13
5348067|NCT00076102|18393643|P1|Overall Study|refusal of further therapy|2
5348068|NCT00076102|18393643|P1|Overall Study|plexiform neurofibroma surgery|1
5348069|NCT00076102|18393643|P1|Overall Study|Progression in pre-existing brain tumor|1
5348070|NCT00076102|18393643|P1|Overall Study|Clinical progression|1
5348071|NCT00076024|18393671|P4|Phase 2, Open-label|Other|2
5348072|NCT00076024|18393672|P3|Phase 2, Open-label|Other|0
5348073|NCT00076024|18393673|P2|Phase 2, Open-label|Other|0
5348074|NCT00076024|18393674|P1|Phase 2, Open-label|Other|0
5348075|NCT00076024|18393671|P4|Phase 2, Open-label|Withdrawal by Subject|1
5348076|NCT00076024|18393672|P3|Phase 2, Open-label|Withdrawal by Subject|0
5348077|NCT00076024|18393673|P2|Phase 2, Open-label|Withdrawal by Subject|0
5348078|NCT00076024|18393674|P1|Phase 2, Open-label|Withdrawal by Subject|0
5348079|NCT00076024|18393671|P4|Phase 2, Open-label|Lack of Efficacy|11
5348080|NCT00076024|18393672|P3|Phase 2, Open-label|Lack of Efficacy|0
5348081|NCT00076024|18393673|P2|Phase 2, Open-label|Lack of Efficacy|0
5348082|NCT00076024|18393674|P1|Phase 2, Open-label|Lack of Efficacy|0
5348083|NCT00076024|18393671|P4|Phase 2, Open-label|Adverse Event|2
5348084|NCT00076024|18393672|P3|Phase 2, Open-label|Adverse Event|0
5348085|NCT00076024|18393673|P2|Phase 2, Open-label|Adverse Event|0
5348086|NCT00076024|18393674|P1|Phase 2, Open-label|Adverse Event|0
5348087|NCT00076024|18393671|P4|Phase 2, Double-blind|Randomized but not treated|0
5348088|NCT00076024|18393672|P3|Phase 2, Double-blind|Randomized but not treated|0
5348089|NCT00076024|18393673|P2|Phase 2, Double-blind|Randomized but not treated|1
5348090|NCT00076024|18393674|P1|Phase 2, Double-blind|Randomized but not treated|0
5348091|NCT00076024|18393671|P4|Phase 2, Double-blind|Un-specified|0
5348092|NCT00076024|18393672|P3|Phase 2, Double-blind|Un-specified|6
5348093|NCT00076024|18393673|P2|Phase 2, Double-blind|Un-specified|14
5348094|NCT00076024|18393674|P1|Phase 2, Double-blind|Un-specified|0
5348095|NCT00076024|18393671|P4|Phase 2, Double-blind|Adverse Event|0
5348096|NCT00076024|18393672|P3|Phase 2, Double-blind|Adverse Event|6
5348097|NCT00076024|18393673|P2|Phase 2, Double-blind|Adverse Event|25
5348098|NCT00076024|18393674|P1|Phase 2, Double-blind|Adverse Event|0
5348099|NCT00076024|18393671|P4|Phase 2, Double-blind|Withdrawal by Subject|0
5348100|NCT00076024|18393672|P3|Phase 2, Double-blind|Withdrawal by Subject|4
5348101|NCT00076024|18393673|P2|Phase 2, Double-blind|Withdrawal by Subject|13
5348102|NCT00076024|18393674|P1|Phase 2, Double-blind|Withdrawal by Subject|0
5348103|NCT00076024|18393671|P4|Phase 2, Double-blind|Lack of Efficacy|0
5348104|NCT00076024|18393672|P3|Phase 2, Double-blind|Lack of Efficacy|40
5348105|NCT00076024|18393673|P2|Phase 2, Double-blind|Lack of Efficacy|59
5348106|NCT00076024|18393674|P1|Phase 2, Double-blind|Lack of Efficacy|0
5348107|NCT00076024|18393671|P4|Phase 1, Lead-in|Clinical progression|0
5348108|NCT00076024|18393672|P3|Phase 1, Lead-in|Clinical progression|0
5348109|NCT00076024|18393673|P2|Phase 1, Lead-in|Clinical progression|0
5348110|NCT00076024|18393674|P1|Phase 1, Lead-in|Clinical progression|1
5348111|NCT00076024|18393671|P4|Phase 1, Lead-in|Adverse Event|0
5348112|NCT00076024|18393672|P3|Phase 1, Lead-in|Adverse Event|0
5348113|NCT00076024|18393673|P2|Phase 1, Lead-in|Adverse Event|0
5348114|NCT00076024|18393674|P1|Phase 1, Lead-in|Adverse Event|1
5348115|NCT00076024|18393671|P4|Phase 1, Lead-in|Lack of Efficacy|0
5348116|NCT00076024|18393672|P3|Phase 1, Lead-in|Lack of Efficacy|0
5348117|NCT00076024|18393673|P2|Phase 1, Lead-in|Lack of Efficacy|0
5348118|NCT00076024|18393674|P1|Phase 1, Lead-in|Lack of Efficacy|4
5348119|NCT00076011|18393688|P1|Overall Study|Ongoing|1
5348120|NCT00076011|18393688|P1|Overall Study|Other|11
5348121|NCT00076011|18393688|P1|Overall Study|Study terminated by sponsor|3
5348122|NCT00076011|18393688|P1|Overall Study|Withdrawal by Subject|1
5348123|NCT00076011|18393688|P1|Overall Study|Lack of Efficacy|25
5348124|NCT00076011|18393688|P1|Overall Study|Adverse Event|10
5348125|NCT00076011|18393688|P1|Overall Study|Death|1
5348126|NCT00075946|18393700|P5|Overall Study|Other|0
5348127|NCT00075946|18393701|P4|Overall Study|Other|2
5348128|NCT00075946|18393702|P3|Overall Study|Other|0
5348129|NCT00075946|18393703|P2|Overall Study|Other|13
5348130|NCT00075946|18393704|P1|Overall Study|Other|5
5348131|NCT00075946|18393700|P5|Overall Study|Time to progression less than 6 months|0
5348132|NCT00075946|18393701|P4|Overall Study|Time to progression less than 6 months|3
5348133|NCT00075946|18393702|P3|Overall Study|Time to progression less than 6 months|8
5348134|NCT00075946|18393703|P2|Overall Study|Time to progression less than 6 months|30
5348135|NCT00075946|18393704|P1|Overall Study|Time to progression less than 6 months|15
5348136|NCT00075946|18393700|P5|Overall Study|No response to retreatment|0
5348137|NCT00075946|18393701|P4|Overall Study|No response to retreatment|0
5348138|NCT00075946|18393702|P3|Overall Study|No response to retreatment|2
5348139|NCT00075946|18393703|P2|Overall Study|No response to retreatment|0
5348140|NCT00075946|18393704|P1|Overall Study|No response to retreatment|23
5348141|NCT00075946|18393700|P5|Overall Study|Other complicating disease|0
5348142|NCT00075946|18393701|P4|Overall Study|Other complicating disease|4
5348143|NCT00075946|18393702|P3|Overall Study|Other complicating disease|1
5348144|NCT00075946|18393703|P2|Overall Study|Other complicating disease|13
5348145|NCT00075946|18393704|P1|Overall Study|Other complicating disease|7
5348146|NCT00075946|18393700|P5|Overall Study|Alternative therapy|0
5348147|NCT00075946|18393701|P4|Overall Study|Alternative therapy|0
5348148|NCT00075946|18393702|P3|Overall Study|Alternative therapy|5
5348149|NCT00075946|18393703|P2|Overall Study|Alternative therapy|2
5348150|NCT00075946|18393704|P1|Overall Study|Alternative therapy|16
5348151|NCT00075946|18393700|P5|Overall Study|Withdrawal by Subject|0
5348152|NCT00075946|18393701|P4|Overall Study|Withdrawal by Subject|9
5348153|NCT00075946|18393702|P3|Overall Study|Withdrawal by Subject|4
5348154|NCT00075946|18393703|P2|Overall Study|Withdrawal by Subject|58
5348155|NCT00075946|18393704|P1|Overall Study|Withdrawal by Subject|23
5348156|NCT00075946|18393700|P5|Overall Study|Death|0
5348157|NCT00075946|18393701|P4|Overall Study|Death|0
5348158|NCT00075946|18393702|P3|Overall Study|Death|0
5348159|NCT00075946|18393703|P2|Overall Study|Death|1
5348160|NCT00075946|18393704|P1|Overall Study|Death|0
5348161|NCT00075946|18393700|P5|Overall Study|Adverse Event|0
5348162|NCT00075946|18393701|P4|Overall Study|Adverse Event|2
5348163|NCT00075946|18393702|P3|Overall Study|Adverse Event|0
5348164|NCT00075946|18393703|P2|Overall Study|Adverse Event|10
5348165|NCT00075946|18393704|P1|Overall Study|Adverse Event|2
5348166|NCT00075946|18393700|P5|Overall Study|Still on treatment at time of analysis|0
5348167|NCT00075946|18393701|P4|Overall Study|Still on treatment at time of analysis|9
5348168|NCT00075946|18393702|P3|Overall Study|Still on treatment at time of analysis|3
5348169|NCT00075946|18393703|P2|Overall Study|Still on treatment at time of analysis|19
5348170|NCT00075946|18393704|P1|Overall Study|Still on treatment at time of analysis|52
5348171|NCT00075946|18393700|P5|Overall Study|Incorrectly randomized (no response)|0
5348172|NCT00075946|18393701|P4|Overall Study|Incorrectly randomized (no response)|1
5348173|NCT00075946|18393702|P3|Overall Study|Incorrectly randomized (no response)|5
5348174|NCT00075946|18393703|P2|Overall Study|Incorrectly randomized (no response)|5
5348175|NCT00075946|18393704|P1|Overall Study|Incorrectly randomized (no response)|5
5348176|NCT00075946|18393700|P5|Overall Study|Did not achieve response after induction|182
5348177|NCT00075946|18393701|P4|Overall Study|Did not achieve response after induction|0
5348178|NCT00075946|18393702|P3|Overall Study|Did not achieve response after induction|0
5348179|NCT00075946|18393703|P2|Overall Study|Did not achieve response after induction|0
5348180|NCT00075946|18393704|P1|Overall Study|Did not achieve response after induction|0
5348181|NCT00075946|18393700|P5|Overall Study|Path ineligible: undetermined histology|6
5348182|NCT00075946|18393701|P4|Overall Study|Path ineligible: undetermined histology|0
5348183|NCT00075946|18393702|P3|Overall Study|Path ineligible: undetermined histology|0
5348184|NCT00075946|18393703|P2|Overall Study|Path ineligible: undetermined histology|0
5348185|NCT00075946|18393704|P1|Overall Study|Path ineligible: undetermined histology|0
5348186|NCT00075881|18393719|P1|Overall Study|never start protocol therapy|1
5348187|NCT00075881|18393719|P1|Overall Study|Ineligible|1
5348188|NCT00075881|18393719|P1|Overall Study|missing data|2
5348189|NCT00075881|18393719|P1|Overall Study|other|4
5348190|NCT00075881|18393719|P1|Overall Study|other complicating disease|3
5348191|NCT00075881|18393719|P1|Overall Study|Protocol Violation|4
5348192|NCT00075881|18393719|P1|Overall Study|Withdrawal by Subject|2
5348193|NCT00075881|18393719|P1|Overall Study|Death|1
5348194|NCT00075881|18393719|P1|Overall Study|Adverse Event|7
5348195|NCT00075881|18393719|P1|Overall Study|Lack of Efficacy|18
5348196|NCT00075816|18393763|P2|Overall Study|Did not undergo transplantation|11
5348197|NCT00075816|18393764|P1|Overall Study|Did not undergo transplantation|14
5348198|NCT00075764|18393833|P2|Overall Study|Under review|1
5348199|NCT00075764|18393834|P1|Overall Study|Under review|0
5348200|NCT00075764|18393833|P2|Overall Study|Not protocol specified|19
5348201|NCT00075764|18393834|P1|Overall Study|Not protocol specified|27
5348202|NCT00075764|18393833|P2|Overall Study|Delinquent|2
5348203|NCT00075764|18393834|P1|Overall Study|Delinquent|4
5348204|NCT00075764|18393833|P2|Overall Study|Still on treatment|15
5348205|NCT00075764|18393834|P1|Overall Study|Still on treatment|8
5348206|NCT00075764|18393833|P2|Overall Study|Progression|274
5348207|NCT00075764|18393834|P1|Overall Study|Progression|269
5348208|NCT00075764|18393833|P2|Overall Study|Withdrawal by Subject|18
5348209|NCT00075764|18393834|P1|Overall Study|Withdrawal by Subject|28
5348210|NCT00075764|18393833|P2|Overall Study|Death|8
5348211|NCT00075764|18393834|P1|Overall Study|Death|4
5348212|NCT00075764|18393833|P2|Overall Study|Adverse Event|12
5348213|NCT00075764|18393834|P1|Overall Study|Adverse Event|5
5348214|NCT00075725|18393858|P12|Overall Study|Pt incarcerated|0
5348215|NCT00075725|18393859|P11|Overall Study|Pt incarcerated|0
5348216|NCT00075725|18393860|P10|Overall Study|Pt incarcerated|0
5348217|NCT00075725|18393861|P9|Overall Study|Pt incarcerated|0
5348218|NCT00075725|18393862|P8|Overall Study|Pt incarcerated|1
5348219|NCT00075725|18393863|P7|Overall Study|Pt incarcerated|0
5348220|NCT00075725|18393864|P6|Overall Study|Pt incarcerated|0
5348221|NCT00075725|18393865|P5|Overall Study|Pt incarcerated|0
5348222|NCT00075725|18393866|P4|Overall Study|Pt incarcerated|0
5348223|NCT00075725|18393867|P3|Overall Study|Pt incarcerated|0
5348224|NCT00075725|18393868|P2|Overall Study|Pt incarcerated|0
5348225|NCT00075725|18393869|P1|Overall Study|Pt incarcerated|0
5348226|NCT00075725|18393858|P12|Overall Study|Pt care terminated due to pt behavior|0
5348227|NCT00075725|18393859|P11|Overall Study|Pt care terminated due to pt behavior|0
5348228|NCT00075725|18393860|P10|Overall Study|Pt care terminated due to pt behavior|0
5348229|NCT00075725|18393861|P9|Overall Study|Pt care terminated due to pt behavior|0
5348230|NCT00075725|18393862|P8|Overall Study|Pt care terminated due to pt behavior|1
5348231|NCT00075725|18393863|P7|Overall Study|Pt care terminated due to pt behavior|0
5348232|NCT00075725|18393864|P6|Overall Study|Pt care terminated due to pt behavior|0
5348233|NCT00075725|18393865|P5|Overall Study|Pt care terminated due to pt behavior|0
5348234|NCT00075725|18393866|P4|Overall Study|Pt care terminated due to pt behavior|0
5348235|NCT00075725|18393867|P3|Overall Study|Pt care terminated due to pt behavior|0
5348575|NCT00075582|18393967|P1|Overall Study|Ineligible for study|36
5348236|NCT00075725|18393868|P2|Overall Study|Pt care terminated due to pt behavior|0
5348237|NCT00075725|18393869|P1|Overall Study|Pt care terminated due to pt behavior|0
5348238|NCT00075725|18393858|P12|Overall Study|Other complications|0
5348239|NCT00075725|18393859|P11|Overall Study|Other complications|0
5348240|NCT00075725|18393860|P10|Overall Study|Other complications|0
5348241|NCT00075725|18393861|P9|Overall Study|Other complications|0
5348242|NCT00075725|18393862|P8|Overall Study|Other complications|0
5348243|NCT00075725|18393863|P7|Overall Study|Other complications|0
5348244|NCT00075725|18393864|P6|Overall Study|Other complications|1
5348245|NCT00075725|18393865|P5|Overall Study|Other complications|0
5348246|NCT00075725|18393866|P4|Overall Study|Other complications|0
5348247|NCT00075725|18393867|P3|Overall Study|Other complications|0
5348248|NCT00075725|18393868|P2|Overall Study|Other complications|0
5348249|NCT00075725|18393869|P1|Overall Study|Other complications|0
5348250|NCT00075725|18393858|P12|Overall Study|Study Closure|0
5348251|NCT00075725|18393859|P11|Overall Study|Study Closure|0
5348252|NCT00075725|18393860|P10|Overall Study|Study Closure|0
5348253|NCT00075725|18393861|P9|Overall Study|Study Closure|0
5348254|NCT00075725|18393862|P8|Overall Study|Study Closure|1
5348255|NCT00075725|18393863|P7|Overall Study|Study Closure|0
5348256|NCT00075725|18393864|P6|Overall Study|Study Closure|3
5348257|NCT00075725|18393865|P5|Overall Study|Study Closure|1
5348258|NCT00075725|18393866|P4|Overall Study|Study Closure|0
5348259|NCT00075725|18393867|P3|Overall Study|Study Closure|0
5348260|NCT00075725|18393868|P2|Overall Study|Study Closure|0
5348261|NCT00075725|18393869|P1|Overall Study|Study Closure|1
5348262|NCT00075725|18393858|P12|Overall Study|Institution Terminated|0
5348263|NCT00075725|18393859|P11|Overall Study|Institution Terminated|0
5348264|NCT00075725|18393860|P10|Overall Study|Institution Terminated|0
5348265|NCT00075725|18393861|P9|Overall Study|Institution Terminated|0
5348266|NCT00075725|18393862|P8|Overall Study|Institution Terminated|3
5348267|NCT00075725|18393863|P7|Overall Study|Institution Terminated|0
5348268|NCT00075725|18393864|P6|Overall Study|Institution Terminated|0
5348269|NCT00075725|18393865|P5|Overall Study|Institution Terminated|1
5348270|NCT00075725|18393866|P4|Overall Study|Institution Terminated|0
5348271|NCT00075725|18393867|P3|Overall Study|Institution Terminated|0
5348272|NCT00075725|18393868|P2|Overall Study|Institution Terminated|0
5348273|NCT00075725|18393869|P1|Overall Study|Institution Terminated|0
5348274|NCT00075725|18393858|P12|Overall Study|Pt relocated|0
5348275|NCT00075725|18393859|P11|Overall Study|Pt relocated|0
5348276|NCT00075725|18393860|P10|Overall Study|Pt relocated|0
5348277|NCT00075725|18393861|P9|Overall Study|Pt relocated|1
5348278|NCT00075725|18393862|P8|Overall Study|Pt relocated|2
5348279|NCT00075725|18393863|P7|Overall Study|Pt relocated|1
5348280|NCT00075725|18393864|P6|Overall Study|Pt relocated|1
5348281|NCT00075725|18393865|P5|Overall Study|Pt relocated|0
5348282|NCT00075725|18393866|P4|Overall Study|Pt relocated|2
5348283|NCT00075725|18393867|P3|Overall Study|Pt relocated|0
5348284|NCT00075725|18393868|P2|Overall Study|Pt relocated|0
5348285|NCT00075725|18393869|P1|Overall Study|Pt relocated|0
5348286|NCT00075725|18393858|P12|Overall Study|Pt received additional steroids|0
5348287|NCT00075725|18393859|P11|Overall Study|Pt received additional steroids|0
5348288|NCT00075725|18393860|P10|Overall Study|Pt received additional steroids|0
5348289|NCT00075725|18393861|P9|Overall Study|Pt received additional steroids|0
5348290|NCT00075725|18393862|P8|Overall Study|Pt received additional steroids|0
5348291|NCT00075725|18393863|P7|Overall Study|Pt received additional steroids|0
5348292|NCT00075725|18393864|P6|Overall Study|Pt received additional steroids|0
5348293|NCT00075725|18393865|P5|Overall Study|Pt received additional steroids|0
5348294|NCT00075725|18393866|P4|Overall Study|Pt received additional steroids|1
5348295|NCT00075725|18393867|P3|Overall Study|Pt received additional steroids|0
5348296|NCT00075725|18393868|P2|Overall Study|Pt received additional steroids|0
5348297|NCT00075725|18393869|P1|Overall Study|Pt received additional steroids|0
5348298|NCT00075725|18393858|P12|Overall Study|Pt went to transplant|0
5348299|NCT00075725|18393859|P11|Overall Study|Pt went to transplant|0
5348300|NCT00075725|18393860|P10|Overall Study|Pt went to transplant|0
5348301|NCT00075725|18393861|P9|Overall Study|Pt went to transplant|0
5348302|NCT00075725|18393862|P8|Overall Study|Pt went to transplant|0
5348303|NCT00075725|18393863|P7|Overall Study|Pt went to transplant|0
5348304|NCT00075725|18393864|P6|Overall Study|Pt went to transplant|1
5348305|NCT00075725|18393865|P5|Overall Study|Pt went to transplant|0
5348306|NCT00075725|18393866|P4|Overall Study|Pt went to transplant|1
5348307|NCT00075725|18393867|P3|Overall Study|Pt went to transplant|0
5348308|NCT00075725|18393868|P2|Overall Study|Pt went to transplant|0
5348309|NCT00075725|18393869|P1|Overall Study|Pt went to transplant|0
5348310|NCT00075725|18393858|P12|Overall Study|specimen(s) not submitted|0
5348311|NCT00075725|18393859|P11|Overall Study|specimen(s) not submitted|0
5348312|NCT00075725|18393860|P10|Overall Study|specimen(s) not submitted|0
5348313|NCT00075725|18393861|P9|Overall Study|specimen(s) not submitted|0
5348314|NCT00075725|18393862|P8|Overall Study|specimen(s) not submitted|0
5348315|NCT00075725|18393863|P7|Overall Study|specimen(s) not submitted|0
5348316|NCT00075725|18393864|P6|Overall Study|specimen(s) not submitted|0
5348317|NCT00075725|18393865|P5|Overall Study|specimen(s) not submitted|0
5348318|NCT00075725|18393866|P4|Overall Study|specimen(s) not submitted|0
5348319|NCT00075725|18393867|P3|Overall Study|specimen(s) not submitted|2
5348320|NCT00075725|18393868|P2|Overall Study|specimen(s) not submitted|0
5348321|NCT00075725|18393869|P1|Overall Study|specimen(s) not submitted|0
5348576|NCT00075582|18393966|P2|Overall Study|Withdrawal by Subject|2
5348322|NCT00075725|18393858|P12|Overall Study|Unsuccessful institutional transfer|0
5348323|NCT00075725|18393859|P11|Overall Study|Unsuccessful institutional transfer|0
5348324|NCT00075725|18393860|P10|Overall Study|Unsuccessful institutional transfer|1
5348325|NCT00075725|18393861|P9|Overall Study|Unsuccessful institutional transfer|0
5348326|NCT00075725|18393862|P8|Overall Study|Unsuccessful institutional transfer|0
5348327|NCT00075725|18393863|P7|Overall Study|Unsuccessful institutional transfer|0
5348328|NCT00075725|18393864|P6|Overall Study|Unsuccessful institutional transfer|0
5348329|NCT00075725|18393865|P5|Overall Study|Unsuccessful institutional transfer|0
5348330|NCT00075725|18393866|P4|Overall Study|Unsuccessful institutional transfer|0
5348331|NCT00075725|18393867|P3|Overall Study|Unsuccessful institutional transfer|2
5348332|NCT00075725|18393868|P2|Overall Study|Unsuccessful institutional transfer|0
5348333|NCT00075725|18393869|P1|Overall Study|Unsuccessful institutional transfer|0
5348334|NCT00075725|18393858|P12|Overall Study|Clinic chart lost unable to recreate|0
5348335|NCT00075725|18393859|P11|Overall Study|Clinic chart lost unable to recreate|0
5348336|NCT00075725|18393860|P10|Overall Study|Clinic chart lost unable to recreate|0
5348337|NCT00075725|18393861|P9|Overall Study|Clinic chart lost unable to recreate|0
5348338|NCT00075725|18393862|P8|Overall Study|Clinic chart lost unable to recreate|0
5348339|NCT00075725|18393863|P7|Overall Study|Clinic chart lost unable to recreate|0
5348340|NCT00075725|18393864|P6|Overall Study|Clinic chart lost unable to recreate|0
5348341|NCT00075725|18393865|P5|Overall Study|Clinic chart lost unable to recreate|0
5348342|NCT00075725|18393866|P4|Overall Study|Clinic chart lost unable to recreate|0
5348343|NCT00075725|18393867|P3|Overall Study|Clinic chart lost unable to recreate|1
5348344|NCT00075725|18393868|P2|Overall Study|Clinic chart lost unable to recreate|0
5348345|NCT00075725|18393869|P1|Overall Study|Clinic chart lost unable to recreate|0
5348346|NCT00075725|18393858|P12|Overall Study|Pt trying to find a BM donor|0
5348347|NCT00075725|18393859|P11|Overall Study|Pt trying to find a BM donor|0
5348348|NCT00075725|18393860|P10|Overall Study|Pt trying to find a BM donor|0
5348349|NCT00075725|18393861|P9|Overall Study|Pt trying to find a BM donor|0
5348350|NCT00075725|18393862|P8|Overall Study|Pt trying to find a BM donor|0
5348351|NCT00075725|18393863|P7|Overall Study|Pt trying to find a BM donor|0
5348352|NCT00075725|18393864|P6|Overall Study|Pt trying to find a BM donor|0
5348353|NCT00075725|18393865|P5|Overall Study|Pt trying to find a BM donor|0
5348354|NCT00075725|18393866|P4|Overall Study|Pt trying to find a BM donor|0
5348355|NCT00075725|18393867|P3|Overall Study|Pt trying to find a BM donor|0
5348356|NCT00075725|18393868|P2|Overall Study|Pt trying to find a BM donor|1
5348357|NCT00075725|18393869|P1|Overall Study|Pt trying to find a BM donor|0
5348358|NCT00075725|18393858|P12|Overall Study|Other|3
5348359|NCT00075725|18393859|P11|Overall Study|Other|0
5348360|NCT00075725|18393860|P10|Overall Study|Other|1
5348361|NCT00075725|18393861|P9|Overall Study|Other|2
5348362|NCT00075725|18393862|P8|Overall Study|Other|9
5348363|NCT00075725|18393863|P7|Overall Study|Other|2
5348364|NCT00075725|18393864|P6|Overall Study|Other|4
5348365|NCT00075725|18393865|P5|Overall Study|Other|1
5348366|NCT00075725|18393866|P4|Overall Study|Other|1
5348367|NCT00075725|18393867|P3|Overall Study|Other|1
5348368|NCT00075725|18393868|P2|Overall Study|Other|2
5348369|NCT00075725|18393869|P1|Overall Study|Other|4
5348370|NCT00075725|18393858|P12|Overall Study|Inevaluable|0
5348371|NCT00075725|18393859|P11|Overall Study|Inevaluable|1
5348372|NCT00075725|18393860|P10|Overall Study|Inevaluable|0
5348373|NCT00075725|18393861|P9|Overall Study|Inevaluable|2
5348374|NCT00075725|18393862|P8|Overall Study|Inevaluable|11
5348375|NCT00075725|18393863|P7|Overall Study|Inevaluable|1
5348376|NCT00075725|18393864|P6|Overall Study|Inevaluable|9
5348377|NCT00075725|18393865|P5|Overall Study|Inevaluable|2
5348378|NCT00075725|18393866|P4|Overall Study|Inevaluable|2
5348379|NCT00075725|18393867|P3|Overall Study|Inevaluable|4
5348380|NCT00075725|18393868|P2|Overall Study|Inevaluable|1
5348381|NCT00075725|18393869|P1|Overall Study|Inevaluable|1
5348382|NCT00075725|18393858|P12|Overall Study|Pt has very high risk ALL characteristic|3
5348383|NCT00075725|18393859|P11|Overall Study|Pt has very high risk ALL characteristic|0
5348384|NCT00075725|18393860|P10|Overall Study|Pt has very high risk ALL characteristic|1
5348385|NCT00075725|18393861|P9|Overall Study|Pt has very high risk ALL characteristic|29
5348386|NCT00075725|18393862|P8|Overall Study|Pt has very high risk ALL characteristic|74
5348387|NCT00075725|18393863|P7|Overall Study|Pt has very high risk ALL characteristic|23
5348388|NCT00075725|18393864|P6|Overall Study|Pt has very high risk ALL characteristic|75
5348389|NCT00075725|18393865|P5|Overall Study|Pt has very high risk ALL characteristic|11
5348390|NCT00075725|18393866|P4|Overall Study|Pt has very high risk ALL characteristic|18
5348391|NCT00075725|18393867|P3|Overall Study|Pt has very high risk ALL characteristic|26
5348392|NCT00075725|18393868|P2|Overall Study|Pt has very high risk ALL characteristic|11
5348393|NCT00075725|18393869|P1|Overall Study|Pt has very high risk ALL characteristic|15
5348394|NCT00075725|18393858|P12|Overall Study|MRD positive after extended ind|0
5348395|NCT00075725|18393859|P11|Overall Study|MRD positive after extended ind|0
5348396|NCT00075725|18393860|P10|Overall Study|MRD positive after extended ind|0
5348397|NCT00075725|18393861|P9|Overall Study|MRD positive after extended ind|0
5348398|NCT00075725|18393862|P8|Overall Study|MRD positive after extended ind|1
5348399|NCT00075725|18393863|P7|Overall Study|MRD positive after extended ind|0
5348400|NCT00075725|18393864|P6|Overall Study|MRD positive after extended ind|2
5348401|NCT00075725|18393865|P5|Overall Study|MRD positive after extended ind|1
5348402|NCT00075725|18393866|P4|Overall Study|MRD positive after extended ind|0
5348403|NCT00075725|18393867|P3|Overall Study|MRD positive after extended ind|1
5348404|NCT00075725|18393868|P2|Overall Study|MRD positive after extended ind|1
5348405|NCT00075725|18393869|P1|Overall Study|MRD positive after extended ind|0
5348406|NCT00075725|18393858|P12|Overall Study|Insurance issues|0
5348407|NCT00075725|18393859|P11|Overall Study|Insurance issues|0
5348408|NCT00075725|18393860|P10|Overall Study|Insurance issues|0
5348409|NCT00075725|18393861|P9|Overall Study|Insurance issues|0
5348410|NCT00075725|18393862|P8|Overall Study|Insurance issues|1
5348411|NCT00075725|18393863|P7|Overall Study|Insurance issues|0
5348412|NCT00075725|18393864|P6|Overall Study|Insurance issues|1
5348413|NCT00075725|18393865|P5|Overall Study|Insurance issues|1
5348414|NCT00075725|18393866|P4|Overall Study|Insurance issues|1
5348415|NCT00075725|18393867|P3|Overall Study|Insurance issues|0
5348416|NCT00075725|18393868|P2|Overall Study|Insurance issues|1
5348417|NCT00075725|18393869|P1|Overall Study|Insurance issues|0
5348418|NCT00075725|18393858|P12|Overall Study|Pt age out of range for treatment|0
5348419|NCT00075725|18393859|P11|Overall Study|Pt age out of range for treatment|0
5348420|NCT00075725|18393860|P10|Overall Study|Pt age out of range for treatment|0
5348421|NCT00075725|18393861|P9|Overall Study|Pt age out of range for treatment|0
5348422|NCT00075725|18393862|P8|Overall Study|Pt age out of range for treatment|1
5348423|NCT00075725|18393863|P7|Overall Study|Pt age out of range for treatment|0
5348424|NCT00075725|18393864|P6|Overall Study|Pt age out of range for treatment|1
5348425|NCT00075725|18393865|P5|Overall Study|Pt age out of range for treatment|0
5348426|NCT00075725|18393866|P4|Overall Study|Pt age out of range for treatment|0
5348427|NCT00075725|18393867|P3|Overall Study|Pt age out of range for treatment|0
5348428|NCT00075725|18393868|P2|Overall Study|Pt age out of range for treatment|1
5348429|NCT00075725|18393869|P1|Overall Study|Pt age out of range for treatment|0
5348430|NCT00075725|18393858|P12|Overall Study|Pt non compliant with therapy|0
5348431|NCT00075725|18393859|P11|Overall Study|Pt non compliant with therapy|0
5348432|NCT00075725|18393860|P10|Overall Study|Pt non compliant with therapy|0
5348433|NCT00075725|18393861|P9|Overall Study|Pt non compliant with therapy|3
5348434|NCT00075725|18393862|P8|Overall Study|Pt non compliant with therapy|5
5348435|NCT00075725|18393863|P7|Overall Study|Pt non compliant with therapy|2
5348436|NCT00075725|18393864|P6|Overall Study|Pt non compliant with therapy|14
5348437|NCT00075725|18393865|P5|Overall Study|Pt non compliant with therapy|2
5348438|NCT00075725|18393866|P4|Overall Study|Pt non compliant with therapy|0
5348439|NCT00075725|18393867|P3|Overall Study|Pt non compliant with therapy|1
5348440|NCT00075725|18393868|P2|Overall Study|Pt non compliant with therapy|1
5348441|NCT00075725|18393869|P1|Overall Study|Pt non compliant with therapy|2
5348442|NCT00075725|18393858|P12|Overall Study|Pt/Guardian refused RT therapy|0
5348443|NCT00075725|18393859|P11|Overall Study|Pt/Guardian refused RT therapy|0
5348444|NCT00075725|18393860|P10|Overall Study|Pt/Guardian refused RT therapy|0
5348445|NCT00075725|18393861|P9|Overall Study|Pt/Guardian refused RT therapy|0
5348446|NCT00075725|18393862|P8|Overall Study|Pt/Guardian refused RT therapy|0
5348447|NCT00075725|18393863|P7|Overall Study|Pt/Guardian refused RT therapy|0
5348448|NCT00075725|18393864|P6|Overall Study|Pt/Guardian refused RT therapy|0
5348449|NCT00075725|18393865|P5|Overall Study|Pt/Guardian refused RT therapy|1
5348450|NCT00075725|18393866|P4|Overall Study|Pt/Guardian refused RT therapy|2
5348451|NCT00075725|18393867|P3|Overall Study|Pt/Guardian refused RT therapy|1
5348452|NCT00075725|18393868|P2|Overall Study|Pt/Guardian refused RT therapy|0
5348453|NCT00075725|18393869|P1|Overall Study|Pt/Guardian refused RT therapy|1
5348454|NCT00075725|18393858|P12|Overall Study|Ineligible or wrong diagnosis|4
5348455|NCT00075725|18393859|P11|Overall Study|Ineligible or wrong diagnosis|2
5348456|NCT00075725|18393860|P10|Overall Study|Ineligible or wrong diagnosis|1
5348457|NCT00075725|18393861|P9|Overall Study|Ineligible or wrong diagnosis|10
5348458|NCT00075725|18393862|P8|Overall Study|Ineligible or wrong diagnosis|9
5348459|NCT00075725|18393863|P7|Overall Study|Ineligible or wrong diagnosis|6
5348460|NCT00075725|18393864|P6|Overall Study|Ineligible or wrong diagnosis|17
5348461|NCT00075725|18393865|P5|Overall Study|Ineligible or wrong diagnosis|3
5348462|NCT00075725|18393866|P4|Overall Study|Ineligible or wrong diagnosis|10
5348463|NCT00075725|18393867|P3|Overall Study|Ineligible or wrong diagnosis|3
5348464|NCT00075725|18393868|P2|Overall Study|Ineligible or wrong diagnosis|3
5348465|NCT00075725|18393869|P1|Overall Study|Ineligible or wrong diagnosis|8
5348466|NCT00075725|18393858|P12|Overall Study|Patient off treatment|0
5348467|NCT00075725|18393859|P11|Overall Study|Patient off treatment|0
5348468|NCT00075725|18393860|P10|Overall Study|Patient off treatment|0
5348469|NCT00075725|18393861|P9|Overall Study|Patient off treatment|1
5348470|NCT00075725|18393862|P8|Overall Study|Patient off treatment|2
5348471|NCT00075725|18393863|P7|Overall Study|Patient off treatment|0
5348472|NCT00075725|18393864|P6|Overall Study|Patient off treatment|0
5348473|NCT00075725|18393865|P5|Overall Study|Patient off treatment|1
5348474|NCT00075725|18393866|P4|Overall Study|Patient off treatment|2
5348475|NCT00075725|18393867|P3|Overall Study|Patient off treatment|1
5348476|NCT00075725|18393868|P2|Overall Study|Patient off treatment|0
5348477|NCT00075725|18393869|P1|Overall Study|Patient off treatment|0
5348478|NCT00075725|18393858|P12|Overall Study|Disease Progression, all other reasons|5
5348479|NCT00075725|18393859|P11|Overall Study|Disease Progression, all other reasons|0
5348480|NCT00075725|18393860|P10|Overall Study|Disease Progression, all other reasons|4
5348481|NCT00075725|18393861|P9|Overall Study|Disease Progression, all other reasons|21
5348482|NCT00075725|18393862|P8|Overall Study|Disease Progression, all other reasons|46
5348483|NCT00075725|18393863|P7|Overall Study|Disease Progression, all other reasons|20
5348484|NCT00075725|18393864|P6|Overall Study|Disease Progression, all other reasons|59
5348485|NCT00075725|18393865|P5|Overall Study|Disease Progression, all other reasons|21
5348486|NCT00075725|18393866|P4|Overall Study|Disease Progression, all other reasons|6
5348487|NCT00075725|18393867|P3|Overall Study|Disease Progression, all other reasons|33
5348488|NCT00075725|18393868|P2|Overall Study|Disease Progression, all other reasons|5
5348489|NCT00075725|18393869|P1|Overall Study|Disease Progression, all other reasons|17
5348490|NCT00075725|18393858|P12|Overall Study|Withdrawal by Subject|0
5348491|NCT00075725|18393859|P11|Overall Study|Withdrawal by Subject|0
5348492|NCT00075725|18393860|P10|Overall Study|Withdrawal by Subject|2
5348493|NCT00075725|18393861|P9|Overall Study|Withdrawal by Subject|10
5348494|NCT00075725|18393862|P8|Overall Study|Withdrawal by Subject|31
5348495|NCT00075725|18393863|P7|Overall Study|Withdrawal by Subject|7
5348496|NCT00075725|18393864|P6|Overall Study|Withdrawal by Subject|27
5348497|NCT00075725|18393865|P5|Overall Study|Withdrawal by Subject|6
5348498|NCT00075725|18393866|P4|Overall Study|Withdrawal by Subject|10
5348499|NCT00075725|18393867|P3|Overall Study|Withdrawal by Subject|6
5348500|NCT00075725|18393868|P2|Overall Study|Withdrawal by Subject|3
5348501|NCT00075725|18393869|P1|Overall Study|Withdrawal by Subject|12
5348502|NCT00075725|18393858|P12|Overall Study|Protocol Violation|1
5348503|NCT00075725|18393859|P11|Overall Study|Protocol Violation|0
5348504|NCT00075725|18393860|P10|Overall Study|Protocol Violation|0
5348505|NCT00075725|18393861|P9|Overall Study|Protocol Violation|3
5348506|NCT00075725|18393862|P8|Overall Study|Protocol Violation|2
5348507|NCT00075725|18393863|P7|Overall Study|Protocol Violation|1
5348508|NCT00075725|18393864|P6|Overall Study|Protocol Violation|2
5348509|NCT00075725|18393865|P5|Overall Study|Protocol Violation|3
5348510|NCT00075725|18393866|P4|Overall Study|Protocol Violation|3
5348511|NCT00075725|18393867|P3|Overall Study|Protocol Violation|0
5348512|NCT00075725|18393868|P2|Overall Study|Protocol Violation|1
5348513|NCT00075725|18393869|P1|Overall Study|Protocol Violation|1
5348514|NCT00075725|18393858|P12|Overall Study|Pregnancy|0
5348515|NCT00075725|18393859|P11|Overall Study|Pregnancy|0
5348516|NCT00075725|18393860|P10|Overall Study|Pregnancy|0
5348517|NCT00075725|18393861|P9|Overall Study|Pregnancy|0
5348518|NCT00075725|18393862|P8|Overall Study|Pregnancy|1
5348519|NCT00075725|18393863|P7|Overall Study|Pregnancy|0
5348520|NCT00075725|18393864|P6|Overall Study|Pregnancy|1
5348521|NCT00075725|18393865|P5|Overall Study|Pregnancy|0
5348522|NCT00075725|18393866|P4|Overall Study|Pregnancy|0
5348523|NCT00075725|18393867|P3|Overall Study|Pregnancy|0
5348524|NCT00075725|18393868|P2|Overall Study|Pregnancy|0
5348525|NCT00075725|18393869|P1|Overall Study|Pregnancy|0
5348526|NCT00075725|18393858|P12|Overall Study|Physician Decision|0
5348527|NCT00075725|18393859|P11|Overall Study|Physician Decision|1
5348528|NCT00075725|18393860|P10|Overall Study|Physician Decision|0
5348529|NCT00075725|18393861|P9|Overall Study|Physician Decision|5
5348530|NCT00075725|18393862|P8|Overall Study|Physician Decision|17
5348531|NCT00075725|18393863|P7|Overall Study|Physician Decision|3
5348532|NCT00075725|18393864|P6|Overall Study|Physician Decision|19
5348533|NCT00075725|18393865|P5|Overall Study|Physician Decision|4
5348534|NCT00075725|18393866|P4|Overall Study|Physician Decision|8
5348535|NCT00075725|18393867|P3|Overall Study|Physician Decision|5
5348536|NCT00075725|18393868|P2|Overall Study|Physician Decision|6
5348537|NCT00075725|18393869|P1|Overall Study|Physician Decision|2
5348538|NCT00075725|18393858|P12|Overall Study|Lost to Follow-up|0
5348539|NCT00075725|18393859|P11|Overall Study|Lost to Follow-up|0
5348540|NCT00075725|18393860|P10|Overall Study|Lost to Follow-up|0
5348541|NCT00075725|18393861|P9|Overall Study|Lost to Follow-up|1
5348542|NCT00075725|18393862|P8|Overall Study|Lost to Follow-up|4
5348543|NCT00075725|18393863|P7|Overall Study|Lost to Follow-up|2
5348544|NCT00075725|18393864|P6|Overall Study|Lost to Follow-up|13
5348545|NCT00075725|18393865|P5|Overall Study|Lost to Follow-up|0
5348546|NCT00075725|18393866|P4|Overall Study|Lost to Follow-up|1
5348547|NCT00075725|18393867|P3|Overall Study|Lost to Follow-up|4
5348548|NCT00075725|18393868|P2|Overall Study|Lost to Follow-up|1
5348549|NCT00075725|18393869|P1|Overall Study|Lost to Follow-up|1
5348550|NCT00075725|18393858|P12|Overall Study|Death|0
5348551|NCT00075725|18393859|P11|Overall Study|Death|3
5348552|NCT00075725|18393860|P10|Overall Study|Death|4
5348553|NCT00075725|18393861|P9|Overall Study|Death|14
5348554|NCT00075725|18393862|P8|Overall Study|Death|22
5348555|NCT00075725|18393863|P7|Overall Study|Death|4
5348556|NCT00075725|18393864|P6|Overall Study|Death|25
5348557|NCT00075725|18393865|P5|Overall Study|Death|3
5348558|NCT00075725|18393866|P4|Overall Study|Death|2
5348559|NCT00075725|18393867|P3|Overall Study|Death|10
5348560|NCT00075725|18393868|P2|Overall Study|Death|5
5348561|NCT00075725|18393869|P1|Overall Study|Death|3
5348562|NCT00075725|18393858|P12|Overall Study|Adverse Event|2
5348563|NCT00075725|18393859|P11|Overall Study|Adverse Event|2
5348564|NCT00075725|18393860|P10|Overall Study|Adverse Event|4
5348565|NCT00075725|18393861|P9|Overall Study|Adverse Event|15
5348566|NCT00075725|18393862|P8|Overall Study|Adverse Event|51
5348567|NCT00075725|18393863|P7|Overall Study|Adverse Event|3
5348568|NCT00075725|18393864|P6|Overall Study|Adverse Event|38
5348569|NCT00075725|18393865|P5|Overall Study|Adverse Event|4
5348570|NCT00075725|18393866|P4|Overall Study|Adverse Event|8
5348571|NCT00075725|18393867|P3|Overall Study|Adverse Event|20
5348572|NCT00075725|18393868|P2|Overall Study|Adverse Event|6
5348573|NCT00075725|18393869|P1|Overall Study|Adverse Event|6
5348574|NCT00075582|18393966|P2|Overall Study|Ineligible for study|16
5348577|NCT00075582|18393967|P1|Overall Study|Withdrawal by Subject|2
5348578|NCT00075582|18393966|P2|Overall Study|Physician Decision|8
5348579|NCT00075582|18393967|P1|Overall Study|Physician Decision|5
5348580|NCT00075582|18393966|P2|Overall Study|Lack of Efficacy|8
5348581|NCT00075582|18393967|P1|Overall Study|Lack of Efficacy|4
5348582|NCT00075582|18393966|P2|Overall Study|Adverse Event|1
5348583|NCT00075582|18393967|P1|Overall Study|Adverse Event|3
5348584|NCT00075504|18393981|P2|Overall Study|Withdrawal by Subject|7
5348585|NCT00075504|18393982|P1|Overall Study|Withdrawal by Subject|9
5348586|NCT00075478|18393994|P2|Overall Study|Physician Decision|1
5348587|NCT00075478|18393995|P1|Overall Study|Physician Decision|0
5348588|NCT00075478|18393994|P2|Overall Study|not eligible|0
5348589|NCT00075478|18393995|P1|Overall Study|not eligible|1
5348590|NCT00075400|18394015|P1|Overall Study|Never treated|2
5348591|NCT00075400|18394015|P1|Overall Study|Ineligible: wrong primary|1
5348592|NCT00075270|18394036|P2|Overall Study|Missing|13
5348593|NCT00075270|18394037|P1|Overall Study|Missing|26
5348594|NCT00075270|18394036|P2|Overall Study|Other/Unknown|5
5348595|NCT00075270|18394037|P1|Overall Study|Other/Unknown|9
5348596|NCT00075270|18394036|P2|Overall Study|Death|215
5348597|NCT00075270|18394037|P1|Overall Study|Death|198
5348598|NCT00075270|18394036|P2|Overall Study|Protocol Violation|2
5348599|NCT00075270|18394037|P1|Overall Study|Protocol Violation|0
5348600|NCT00075270|18394036|P2|Overall Study|Lost to Follow-up|28
5348601|NCT00075270|18394037|P1|Overall Study|Lost to Follow-up|25
5348602|NCT00075270|18394036|P2|Overall Study|Withdrawal by Subject|21
5348603|NCT00075270|18394037|P1|Overall Study|Withdrawal by Subject|28
5348604|NCT00075218|18394083|P3|Open-Label Treatment|enrolled in a separate continuation|9
5348605|NCT00075218|18394084|P2|Open-Label Treatment|enrolled in a separate continuation|0
5348606|NCT00075218|18394085|P1|Open-Label Treatment|enrolled in a separate continuation|0
5348607|NCT00075218|18394083|P3|Open-Label Treatment|Protocol Violation|1
5348608|NCT00075218|18394084|P2|Open-Label Treatment|Protocol Violation|0
5348609|NCT00075218|18394085|P1|Open-Label Treatment|Protocol Violation|0
5348610|NCT00075218|18394083|P3|Open-Label Treatment|Decision of Sponsor|8
5348611|NCT00075218|18394084|P2|Open-Label Treatment|Decision of Sponsor|0
5348612|NCT00075218|18394085|P1|Open-Label Treatment|Decision of Sponsor|0
5348613|NCT00075218|18394083|P3|Open-Label Treatment|Withdrawal by Subject|12
5348614|NCT00075218|18394084|P2|Open-Label Treatment|Withdrawal by Subject|0
5348615|NCT00075218|18394085|P1|Open-Label Treatment|Withdrawal by Subject|0
5348616|NCT00075218|18394083|P3|Open-Label Treatment|Adverse Event|51
5348617|NCT00075218|18394084|P2|Open-Label Treatment|Adverse Event|0
5348618|NCT00075218|18394085|P1|Open-Label Treatment|Adverse Event|0
5348619|NCT00075218|18394083|P3|Open-Label Treatment|Lack of Efficacy|174
5348620|NCT00075218|18394084|P2|Open-Label Treatment|Lack of Efficacy|0
5348621|NCT00075218|18394085|P1|Open-Label Treatment|Lack of Efficacy|0
5348622|NCT00075218|18394083|P3|Double-Blind Treatment|No study medication taken|0
5348623|NCT00075218|18394084|P2|Double-Blind Treatment|No study medication taken|0
5348624|NCT00075218|18394085|P1|Double-Blind Treatment|No study medication taken|2
5348625|NCT00075218|18394083|P3|Double-Blind Treatment|Decision of Sponsor|0
5348626|NCT00075218|18394084|P2|Double-Blind Treatment|Decision of Sponsor|1
5348627|NCT00075218|18394085|P1|Double-Blind Treatment|Decision of Sponsor|0
5348628|NCT00075218|18394083|P3|Double-Blind Treatment|Lack of Efficacy|0
5348629|NCT00075218|18394084|P2|Double-Blind Treatment|Lack of Efficacy|6
5348630|NCT00075218|18394085|P1|Double-Blind Treatment|Lack of Efficacy|58
5348631|NCT00075218|18394083|P3|Double-Blind Treatment|Lost to Follow-up|0
5348632|NCT00075218|18394084|P2|Double-Blind Treatment|Lost to Follow-up|0
5348633|NCT00075218|18394085|P1|Double-Blind Treatment|Lost to Follow-up|1
5348634|NCT00075218|18394083|P3|Double-Blind Treatment|Withdrawal by Subject|0
5348635|NCT00075218|18394084|P2|Double-Blind Treatment|Withdrawal by Subject|4
5348636|NCT00075218|18394085|P1|Double-Blind Treatment|Withdrawal by Subject|7
5348637|NCT00075218|18394083|P3|Double-Blind Treatment|Adverse Event|0
5348638|NCT00075218|18394084|P2|Double-Blind Treatment|Adverse Event|4
5348639|NCT00075218|18394085|P1|Double-Blind Treatment|Adverse Event|23
5348640|NCT00075023|18394134|P2|Pilot Study|Withdrawal by Subject|0
5348641|NCT00075023|18394135|P1|Pilot Study|Withdrawal by Subject|1
5348642|NCT00075023|18394134|P2|Pilot Study|Physician Decision|2
5348643|NCT00075023|18394135|P1|Pilot Study|Physician Decision|1
5348644|NCT00074984|18394144|P2|Overall Study|Patient Withdrawn Per Protocol|3
5348645|NCT00074984|18394145|P1|Overall Study|Patient Withdrawn Per Protocol|0
5348646|NCT00074984|18394144|P2|Overall Study|Withdrawal by Subject|3
5348647|NCT00074984|18394145|P1|Overall Study|Withdrawal by Subject|2
5348648|NCT00074984|18394144|P2|Overall Study|Death|2
5348649|NCT00074984|18394145|P1|Overall Study|Death|1
5348650|NCT00074958|18394160|P1|Overall Study|Adverse Event|1
5348651|NCT00074711|18394201|P2|Overall Study|Participant stopped study drug|6
5348652|NCT00074711|18394202|P1|Overall Study|Participant stopped study drug|4
5348653|NCT00074711|18394201|P2|Overall Study|Lost to Follow-up|8
5348654|NCT00074711|18394202|P1|Overall Study|Lost to Follow-up|10
5348655|NCT00074711|18394201|P2|Overall Study|Withdrawal by Subject|1
5348656|NCT00074711|18394202|P1|Overall Study|Withdrawal by Subject|1
5348657|NCT00074581|18394220|P2|Overall Study|Other|19
5348658|NCT00074581|18394221|P1|Overall Study|Other|14
5348659|NCT00074581|18394220|P2|Overall Study|Ended relationship w. index participant|106
5348660|NCT00074581|18394221|P1|Overall Study|Ended relationship w. index participant|117
5348661|NCT00074581|18394220|P2|Overall Study|Lost to Follow-up|11
5348662|NCT00074581|18394221|P1|Overall Study|Lost to Follow-up|16
5348663|NCT00074581|18394220|P2|Overall Study|Were withdrawn by investigator|2
5348664|NCT00074581|18394221|P1|Overall Study|Were withdrawn by investigator|5
5348665|NCT00074581|18394220|P2|Overall Study|Relocated|9
5348666|NCT00074581|18394221|P1|Overall Study|Relocated|14
5348667|NCT00074581|18394220|P2|Overall Study|Unable to adhere to visit schedule|14
5348668|NCT00074581|18394221|P1|Overall Study|Unable to adhere to visit schedule|13
5348669|NCT00074581|18394220|P2|Overall Study|Withdrawal by Subject|49
5348670|NCT00074581|18394221|P1|Overall Study|Withdrawal by Subject|50
5348671|NCT00074581|18394220|P2|Overall Study|Death|16
5348672|NCT00074581|18394221|P1|Overall Study|Death|15
5348673|NCT00074490|18394234|P6|Overall Study|Progressive malignancy|0
5348674|NCT00074490|18394235|P5|Overall Study|Progressive malignancy|3
5348675|NCT00074490|18394236|P4|Overall Study|Progressive malignancy|0
5348676|NCT00074490|18394237|P3|Overall Study|Progressive malignancy|0
5348677|NCT00074490|18394238|P2|Overall Study|Progressive malignancy|7
5348678|NCT00074490|18394239|P1|Overall Study|Progressive malignancy|0
5348679|NCT00074412|18394273|P2|Overall Study|Lost to Follow-up|58
5348680|NCT00074412|18394274|P1|Overall Study|Lost to Follow-up|52
5348681|NCT00074412|18394273|P2|Overall Study|Death|26
5348682|NCT00074412|18394274|P1|Overall Study|Death|30
5348683|NCT00074282|18394305|P3|Step 2|Ineligible|1
5348684|NCT00074282|18394306|P2|Step 2|Ineligible|0
5348685|NCT00074282|18394307|P1|Step 2|Ineligible|0
5348686|NCT00074282|18394305|P3|Step 2|Physician Decision|1
5348687|NCT00074282|18394306|P2|Step 2|Physician Decision|0
5348688|NCT00074282|18394307|P1|Step 2|Physician Decision|0
5348689|NCT00074282|18394305|P3|Step 2|Withdrawal by Subject|2
5348690|NCT00074282|18394306|P2|Step 2|Withdrawal by Subject|0
5348691|NCT00074282|18394307|P1|Step 2|Withdrawal by Subject|0
5348692|NCT00074282|18394305|P3|Step 2|Death|3
5348693|NCT00074282|18394306|P2|Step 2|Death|0
5348694|NCT00074282|18394307|P1|Step 2|Death|0
5348695|NCT00074282|18394305|P3|Step 2|Disease progression|5
5348696|NCT00074282|18394306|P2|Step 2|Disease progression|0
5348697|NCT00074282|18394307|P1|Step 2|Disease progression|0
5348698|NCT00074282|18394305|P3|Step 2|Adverse Event|12
5348699|NCT00074282|18394306|P2|Step 2|Adverse Event|2
5348700|NCT00074282|18394307|P1|Step 2|Adverse Event|0
5348701|NCT00074282|18394305|P3|Step 1|Never started treatment|0
5348702|NCT00074282|18394306|P2|Step 1|Never started treatment|0
5348703|NCT00074282|18394307|P1|Step 1|Never started treatment|2
5348704|NCT00074282|18394305|P3|Step 1|Ineligible|0
5348705|NCT00074282|18394306|P2|Step 1|Ineligible|0
5348706|NCT00074282|18394307|P1|Step 1|Ineligible|4
5348707|NCT00074282|18394305|P3|Step 1|Physician Decision|0
5348708|NCT00074282|18394306|P2|Step 1|Physician Decision|0
5348709|NCT00074282|18394307|P1|Step 1|Physician Decision|1
5348710|NCT00074282|18394305|P3|Step 1|Other complicating disease|0
5348711|NCT00074282|18394306|P2|Step 1|Other complicating disease|0
5348712|NCT00074282|18394307|P1|Step 1|Other complicating disease|2
5348713|NCT00074282|18394305|P3|Step 1|Alternative therapy|0
5348714|NCT00074282|18394306|P2|Step 1|Alternative therapy|0
5348715|NCT00074282|18394307|P1|Step 1|Alternative therapy|2
5348716|NCT00074282|18394305|P3|Step 1|Disease progression|0
5348717|NCT00074282|18394306|P2|Step 1|Disease progression|0
5348718|NCT00074282|18394307|P1|Step 1|Disease progression|2
5348719|NCT00074282|18394305|P3|Step 1|Withdrawal by Subject|0
5348720|NCT00074282|18394306|P2|Step 1|Withdrawal by Subject|0
5348721|NCT00074282|18394307|P1|Step 1|Withdrawal by Subject|7
5348722|NCT00074282|18394305|P3|Step 1|Death|0
5348723|NCT00074282|18394306|P2|Step 1|Death|0
5348724|NCT00074282|18394307|P1|Step 1|Death|6
5348725|NCT00074282|18394305|P3|Step 1|Adverse Event|0
5348726|NCT00074282|18394306|P2|Step 1|Adverse Event|0
5348727|NCT00074282|18394307|P1|Step 1|Adverse Event|32
5348728|NCT00074152|18394334|P2|Overall Study|Lack of Efficacy|24
5348729|NCT00074152|18394335|P1|Overall Study|Lack of Efficacy|34
5348730|NCT00074152|18394334|P2|Overall Study|Death|9
5348731|NCT00074152|18394335|P1|Overall Study|Death|21
5348732|NCT00073983|18394352|P1|Overall Study|not evaluable|1
5348733|NCT00073918|18394373|P1|Overall Study|Eligibility requirement not met-low CD20|1
5348734|NCT00073918|18394373|P1|Overall Study|Rapid disease progression|2
5348735|NCT00073918|18394373|P1|Overall Study|Eligibility requirement not met - HAMA+|1
5348736|NCT00073749|18394387|P7|Overall Study|Other|0
5348737|NCT00073749|18394388|P6|Overall Study|Other|2
5348738|NCT00073749|18394389|P5|Overall Study|Other|0
5348739|NCT00073749|18394390|P4|Overall Study|Other|0
5348740|NCT00073749|18394391|P3|Overall Study|Other|0
5348741|NCT00073749|18394392|P2|Overall Study|Other|0
5348742|NCT00073749|18394393|P1|Overall Study|Other|0
5348743|NCT00073749|18394387|P7|Overall Study|Lost to Follow-up|2
5348744|NCT00073749|18394388|P6|Overall Study|Lost to Follow-up|0
5348745|NCT00073749|18394389|P5|Overall Study|Lost to Follow-up|0
5348746|NCT00073749|18394390|P4|Overall Study|Lost to Follow-up|0
5348747|NCT00073749|18394391|P3|Overall Study|Lost to Follow-up|0
5348748|NCT00073749|18394392|P2|Overall Study|Lost to Follow-up|0
5348749|NCT00073749|18394393|P1|Overall Study|Lost to Follow-up|0
5348750|NCT00073749|18394387|P7|Overall Study|Discontinuation of Study by Sponsor|4
5348751|NCT00073749|18394388|P6|Overall Study|Discontinuation of Study by Sponsor|0
5348752|NCT00073749|18394389|P5|Overall Study|Discontinuation of Study by Sponsor|0
5348753|NCT00073749|18394390|P4|Overall Study|Discontinuation of Study by Sponsor|0
5348754|NCT00073749|18394391|P3|Overall Study|Discontinuation of Study by Sponsor|0
5348755|NCT00073749|18394392|P2|Overall Study|Discontinuation of Study by Sponsor|0
5348756|NCT00073749|18394393|P1|Overall Study|Discontinuation of Study by Sponsor|0
5348757|NCT00073749|18394387|P7|Overall Study|Withdrawal by Subject|2
5348758|NCT00073749|18394388|P6|Overall Study|Withdrawal by Subject|0
5348759|NCT00073749|18394389|P5|Overall Study|Withdrawal by Subject|1
5348760|NCT00073749|18394390|P4|Overall Study|Withdrawal by Subject|0
5348761|NCT00073749|18394391|P3|Overall Study|Withdrawal by Subject|0
5348762|NCT00073749|18394392|P2|Overall Study|Withdrawal by Subject|1
5348763|NCT00073749|18394393|P1|Overall Study|Withdrawal by Subject|0
5348764|NCT00073749|18394387|P7|Overall Study|Physician Decision|0
5348765|NCT00073749|18394388|P6|Overall Study|Physician Decision|2
5348766|NCT00073749|18394389|P5|Overall Study|Physician Decision|0
5348767|NCT00073749|18394390|P4|Overall Study|Physician Decision|0
5348768|NCT00073749|18394391|P3|Overall Study|Physician Decision|1
5348769|NCT00073749|18394392|P2|Overall Study|Physician Decision|0
5348770|NCT00073749|18394393|P1|Overall Study|Physician Decision|0
5348771|NCT00073749|18394387|P7|Overall Study|Adverse Event|0
5348772|NCT00073749|18394388|P6|Overall Study|Adverse Event|1
5348773|NCT00073749|18394389|P5|Overall Study|Adverse Event|2
5348774|NCT00073749|18394390|P4|Overall Study|Adverse Event|4
5348775|NCT00073749|18394391|P3|Overall Study|Adverse Event|6
5348776|NCT00073749|18394392|P2|Overall Study|Adverse Event|3
5348777|NCT00073749|18394393|P1|Overall Study|Adverse Event|0
5348778|NCT00073749|18394387|P7|Overall Study|Death|29
5348779|NCT00073749|18394388|P6|Overall Study|Death|0
5348780|NCT00073749|18394389|P5|Overall Study|Death|0
5348781|NCT00073749|18394390|P4|Overall Study|Death|0
5348782|NCT00073749|18394391|P3|Overall Study|Death|1
5348783|NCT00073749|18394392|P2|Overall Study|Death|1
5348784|NCT00073749|18394393|P1|Overall Study|Death|0
5348785|NCT00073749|18394387|P7|Overall Study|Disease Progression|3
5348786|NCT00073749|18394388|P6|Overall Study|Disease Progression|1
5348787|NCT00073749|18394389|P5|Overall Study|Disease Progression|3
5348788|NCT00073749|18394390|P4|Overall Study|Disease Progression|2
5348789|NCT00073749|18394391|P3|Overall Study|Disease Progression|3
5348790|NCT00073749|18394392|P2|Overall Study|Disease Progression|0
5348791|NCT00073749|18394393|P1|Overall Study|Disease Progression|2
5348792|NCT00073528|18394424|P2|Overall Study|Ongoing|344
5348793|NCT00073528|18394425|P1|Overall Study|Ongoing|349
5348794|NCT00073528|18394424|P2|Overall Study|Non-compliance|1
5348795|NCT00073528|18394425|P1|Overall Study|Non-compliance|0
5348796|NCT00073528|18394424|P2|Overall Study|Enrolled in Error|1
5348797|NCT00073528|18394425|P1|Overall Study|Enrolled in Error|0
5348798|NCT00073528|18394424|P2|Overall Study|Participant Was Unblinded|1
5348799|NCT00073528|18394425|P1|Overall Study|Participant Was Unblinded|0
5348800|NCT00073528|18394424|P2|Overall Study|Progressive Disease|1
5348801|NCT00073528|18394425|P1|Overall Study|Progressive Disease|0
5348802|NCT00073528|18394424|P2|Overall Study|Randomized in Error; Not Treated|0
5348803|NCT00073528|18394425|P1|Overall Study|Randomized in Error; Not Treated|2
5348804|NCT00073528|18394424|P2|Overall Study|Mastectomy Intervention|0
5348805|NCT00073528|18394425|P1|Overall Study|Mastectomy Intervention|1
5348806|NCT00073528|18394424|P2|Overall Study|Death|238
5348807|NCT00073528|18394425|P1|Overall Study|Death|229
5348808|NCT00073528|18394424|P2|Overall Study|Protocol Violation|5
5348809|NCT00073528|18394425|P1|Overall Study|Protocol Violation|3
5348810|NCT00073528|18394424|P2|Overall Study|Lost to Follow-up|22
5348811|NCT00073528|18394425|P1|Overall Study|Lost to Follow-up|26
5348812|NCT00073528|18394424|P2|Overall Study|Withdrawal by Subject|29
5348813|NCT00073528|18394425|P1|Overall Study|Withdrawal by Subject|34
5348814|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
5348815|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
5348816|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
5348817|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
5348818|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
5348819|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
5348820|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
5348821|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
5348822|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
5348823|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
5348824|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
5348825|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
5348826|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
5348827|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
5348828|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
5348829|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
5348830|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
5348831|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
5348832|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
5348833|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
5348834|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
5348835|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
5348836|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
5348837|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
5348838|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
5348839|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
5348840|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
5348841|NCT00073307|18394514|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
5348842|NCT00073307|18394515|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
5348843|NCT00073307|18394516|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
5348844|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
5348845|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
5348846|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
5348847|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
5348848|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
5348849|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
5348850|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
5348851|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
5348852|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
5348853|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
5348854|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
5348855|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
5348856|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
5348857|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
5348858|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
5348859|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
5348860|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
5348861|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
5348862|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
5348863|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
5348864|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
5348865|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
5348866|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
5348867|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
5348868|NCT00073307|18394514|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
5348869|NCT00073307|18394515|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
5348870|NCT00073307|18394516|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
5348871|NCT00073021|18394547|P2|Overall Study|Lack of Efficacy|5
5348872|NCT00073021|18394548|P1|Overall Study|Lack of Efficacy|11
5348873|NCT00073021|18394547|P2|Overall Study|Physician Decision|1
5348874|NCT00073021|18394548|P1|Overall Study|Physician Decision|3
5348875|NCT00073021|18394547|P2|Overall Study|Withdrawal by Subject|5
5348876|NCT00073021|18394548|P1|Overall Study|Withdrawal by Subject|6
5348877|NCT00073021|18394547|P2|Overall Study|Adverse Event|4
5348878|NCT00073021|18394548|P1|Overall Study|Adverse Event|4
5348879|NCT00073021|18394547|P2|Overall Study|Protocol Violation|1
5348880|NCT00073021|18394548|P1|Overall Study|Protocol Violation|2
5348881|NCT00073008|18394578|P2|Overall Study|"Other selected on Case Report Form"|5
5348882|NCT00073008|18394579|P1|Overall Study|"Other selected on Case Report Form"|7
5348883|NCT00073008|18394578|P2|Overall Study|Death|47
5348884|NCT00073008|18394579|P1|Overall Study|Death|46
5348885|NCT00073008|18394578|P2|Overall Study|Lost to Follow-up|3
5348886|NCT00073008|18394579|P1|Overall Study|Lost to Follow-up|1
5348887|NCT00073008|18394578|P2|Overall Study|Withdrawal by Subject|2
5348888|NCT00073008|18394579|P1|Overall Study|Withdrawal by Subject|2
5348889|NCT00073008|18394578|P2|Overall Study|Missing|6
5348890|NCT00073008|18394579|P1|Overall Study|Missing|6
5348891|NCT00072475|18394618|P1|Overall Study|Patient/Investigator Decision|4
5348892|NCT00072475|18394618|P1|Overall Study|Withdrawal by Subject|46
5348893|NCT00072475|18394618|P1|Overall Study|Death|3
5348894|NCT00072475|18394618|P1|Overall Study|Adverse Event|44
5348895|NCT00072384|18394633|P1|Overall Study|Ineligible|8
5348896|NCT00072384|18394633|P1|Overall Study|Physician Decision|1
5348897|NCT00072293|18394646|P2|Overall Study|Withdrawal by Subject|1
5348898|NCT00072293|18394647|P1|Overall Study|Withdrawal by Subject|0
5348899|NCT00072293|18394646|P2|Overall Study|Lost to Follow-up|1
5348900|NCT00072293|18394647|P1|Overall Study|Lost to Follow-up|1
5348901|NCT00072280|18394659|P2|Follow-up|Early termination of study|2
5348902|NCT00072280|18394660|P1|Follow-up|Early termination of study|2
5348903|NCT00072280|18394659|P2|Treatment|Found ineligible|2
5348904|NCT00072280|18394660|P1|Treatment|Found ineligible|1
5348905|NCT00072189|18394665|P1|Overall Study|Withdrawal by Subject|1
5348906|NCT00072176|18394673|P2|Overall Study|Protocol Violation|1
5348907|NCT00072176|18394674|P1|Overall Study|Protocol Violation|0
5348908|NCT00072176|18394673|P2|Overall Study|Withdrawal by Subject|0
5348909|NCT00072176|18394674|P1|Overall Study|Withdrawal by Subject|1
5348910|NCT00071981|18394686|P4|Overall Study|others (not specified in the study)|0
5348911|NCT00071981|18394687|P3|Overall Study|others (not specified in the study)|2
5348912|NCT00071981|18394688|P2|Overall Study|others (not specified in the study)|2
5348913|NCT00071981|18394689|P1|Overall Study|others (not specified in the study)|0
5348914|NCT00071981|18394686|P4|Overall Study|No protocol therapy|0
5348915|NCT00071981|18394687|P3|Overall Study|No protocol therapy|1
5348916|NCT00071981|18394688|P2|Overall Study|No protocol therapy|5
5348917|NCT00071981|18394689|P1|Overall Study|No protocol therapy|2
5348918|NCT00071981|18394686|P4|Overall Study|Withdrawal by Subject|0
5348919|NCT00071981|18394687|P3|Overall Study|Withdrawal by Subject|0
5348920|NCT00071981|18394688|P2|Overall Study|Withdrawal by Subject|1
5348921|NCT00071981|18394689|P1|Overall Study|Withdrawal by Subject|3
5348922|NCT00071981|18394686|P4|Overall Study|Death|1
5348923|NCT00071981|18394687|P3|Overall Study|Death|1
5348924|NCT00071981|18394688|P2|Overall Study|Death|0
5348925|NCT00071981|18394689|P1|Overall Study|Death|0
5348926|NCT00071981|18394686|P4|Overall Study|Adverse Event|1
5348927|NCT00071981|18394687|P3|Overall Study|Adverse Event|3
5348928|NCT00071981|18394688|P2|Overall Study|Adverse Event|4
5348929|NCT00071981|18394689|P1|Overall Study|Adverse Event|4
5348930|NCT00071981|18394686|P4|Overall Study|Lack of Efficacy|43
5348931|NCT00071981|18394687|P3|Overall Study|Lack of Efficacy|30
5348932|NCT00071981|18394688|P2|Overall Study|Lack of Efficacy|29
5348933|NCT00071981|18394689|P1|Overall Study|Lack of Efficacy|37
5348934|NCT00071812|18394732|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
5348935|NCT00071812|18394733|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
5348936|NCT00071812|18394734|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
5348937|NCT00071812|18394735|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
5348938|NCT00071812|18394732|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
5348939|NCT00071812|18394733|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5348940|NCT00071812|18394734|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5348941|NCT00071812|18394735|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5348942|NCT00071812|18394732|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
5348943|NCT00071812|18394733|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
5348944|NCT00071812|18394734|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
5348945|NCT00071812|18394735|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
5348946|NCT00071812|18394732|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
5348947|NCT00071812|18394733|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
5348948|NCT00071812|18394734|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
5348949|NCT00071812|18394735|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
5348950|NCT00071812|18394732|P4|24-Week Open-Label Extension Period|Adverse Event|7
5348951|NCT00071812|18394733|P3|24-Week Open-Label Extension Period|Adverse Event|0
5348952|NCT00071812|18394734|P2|24-Week Open-Label Extension Period|Adverse Event|0
5348953|NCT00071812|18394735|P1|24-Week Open-Label Extension Period|Adverse Event|0
5348954|NCT00071812|18394732|P4|24-Week Double-Blind Period|Protocol Violation|1
5348955|NCT00071812|18394733|P3|24-Week Double-Blind Period|Protocol Violation|0
5348956|NCT00071812|18394734|P2|24-Week Double-Blind Period|Protocol Violation|0
5348957|NCT00071812|18394735|P1|24-Week Double-Blind Period|Protocol Violation|0
5348958|NCT00071812|18394732|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
5348959|NCT00071812|18394733|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
5348960|NCT00071812|18394734|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
5348961|NCT00071812|18394735|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
5348962|NCT00071812|18394732|P4|24-Week Double-Blind Period|Lost to Follow-up|0
5348963|NCT00071812|18394733|P3|24-Week Double-Blind Period|Lost to Follow-up|1
5348964|NCT00071812|18394734|P2|24-Week Double-Blind Period|Lost to Follow-up|1
5348965|NCT00071812|18394735|P1|24-Week Double-Blind Period|Lost to Follow-up|0
5348966|NCT00071812|18394732|P4|24-Week Double-Blind Period|Lack of Efficacy|1
5348967|NCT00071812|18394733|P3|24-Week Double-Blind Period|Lack of Efficacy|2
5348968|NCT00071812|18394734|P2|24-Week Double-Blind Period|Lack of Efficacy|1
5348969|NCT00071812|18394735|P1|24-Week Double-Blind Period|Lack of Efficacy|3
5348970|NCT00071812|18394732|P4|24-Week Double-Blind Period|Adverse Event|4
5348971|NCT00071812|18394733|P3|24-Week Double-Blind Period|Adverse Event|4
5348972|NCT00071812|18394734|P2|24-Week Double-Blind Period|Adverse Event|3
5348973|NCT00071812|18394735|P1|24-Week Double-Blind Period|Adverse Event|2
5348974|NCT00071799|18394777|P2|Overall Study|Not Documented|2
5348975|NCT00071799|18394778|P1|Overall Study|Not Documented|0
5348976|NCT00071799|18394777|P2|Overall Study|Different Central+Local Pathology Review|1
5348977|NCT00071799|18394778|P1|Overall Study|Different Central+Local Pathology Review|0
5348978|NCT00071799|18394777|P2|Overall Study|Disease Progression|20
5348979|NCT00071799|18394778|P1|Overall Study|Disease Progression|23
5348980|NCT00071799|18394777|P2|Overall Study|Lack of Efficacy|18
5348981|NCT00071799|18394778|P1|Overall Study|Lack of Efficacy|11
5348982|NCT00071799|18394777|P2|Overall Study|Physician Decision|2
5348983|NCT00071799|18394778|P1|Overall Study|Physician Decision|0
5348984|NCT00071799|18394777|P2|Overall Study|Withdrawal by Subject|37
5348985|NCT00071799|18394778|P1|Overall Study|Withdrawal by Subject|15
5348986|NCT00071799|18394777|P2|Overall Study|Lost to Follow-up|1
5348987|NCT00071799|18394778|P1|Overall Study|Lost to Follow-up|1
5348988|NCT00071799|18394777|P2|Overall Study|Protocol Violation|7
5348989|NCT00071799|18394778|P1|Overall Study|Protocol Violation|1
5348990|NCT00071799|18394777|P2|Overall Study|Adverse Event|10
5348991|NCT00071799|18394778|P1|Overall Study|Adverse Event|19
5348992|NCT00071760|18394831|P1|Overall Study|Ongoing|25
5348993|NCT00071760|18394831|P1|Overall Study|Study Team Rec./Resistance|1
5348994|NCT00071760|18394831|P1|Overall Study|Investigator's Recommendation (Rec.)|4
5348995|NCT00071760|18394831|P1|Overall Study|Relocation|1
5348996|NCT00071760|18394831|P1|Overall Study|Unavailability of RTV|8
5348997|NCT00071760|18394831|P1|Overall Study|Pulmonary Tuberculosis|1
5348998|NCT00071760|18394831|P1|Overall Study|Insufficient Viral Load Response|3
5348999|NCT00071760|18394831|P1|Overall Study|Withdrawal by Subject|3
5349000|NCT00071760|18394831|P1|Overall Study|Protocol Violation|1
5349001|NCT00071760|18394831|P1|Overall Study|Lost to Follow-up|4
5349002|NCT00071760|18394831|P1|Overall Study|Adverse Event|3
5349003|NCT00071513|18394911|P2|Follow-up Assessment|Withdrawal by Subject|6
5349004|NCT00071513|18394912|P1|Follow-up Assessment|Withdrawal by Subject|6
5349005|NCT00071513|18394911|P2|Intervention Component|Withdrawal by Subject|3
5349006|NCT00071513|18394912|P1|Intervention Component|Withdrawal by Subject|2
5349007|NCT00071487|18394924|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
5349008|NCT00071487|18394925|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
5349009|NCT00071487|18394926|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
5349010|NCT00071487|18394927|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
5349011|NCT00071487|18394924|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
5349012|NCT00071487|18394925|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
5349013|NCT00071487|18394926|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
5349014|NCT00071487|18394927|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
5349015|NCT00071487|18394924|P4|24-Week Open-Label Extension Period|Pregnancy|1
5349016|NCT00071487|18394925|P3|24-Week Open-Label Extension Period|Pregnancy|0
5349017|NCT00071487|18394926|P2|24-Week Open-Label Extension Period|Pregnancy|0
5349018|NCT00071487|18394927|P1|24-Week Open-Label Extension Period|Pregnancy|0
5349019|NCT00071487|18394924|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
5349020|NCT00071487|18394925|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5349021|NCT00071487|18394926|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5349022|NCT00071487|18394927|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5349023|NCT00071487|18394924|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
5349024|NCT00071487|18394925|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
5349025|NCT00071487|18394926|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
5349026|NCT00071487|18394927|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
5349027|NCT00071487|18394924|P4|24-Week Open-Label Extension Period|Adverse Event|6
5349028|NCT00071487|18394925|P3|24-Week Open-Label Extension Period|Adverse Event|1
5349029|NCT00071487|18394926|P2|24-Week Open-Label Extension Period|Adverse Event|0
5349030|NCT00071487|18394927|P1|24-Week Open-Label Extension Period|Adverse Event|0
5349031|NCT00071487|18394924|P4|52-Week Double-Blind Period|Lack of Compliance|3
5349032|NCT00071487|18394925|P3|52-Week Double-Blind Period|Lack of Compliance|3
5349033|NCT00071487|18394926|P2|52-Week Double-Blind Period|Lack of Compliance|3
5349034|NCT00071487|18394927|P1|52-Week Double-Blind Period|Lack of Compliance|6
5349035|NCT00071487|18394924|P4|52-Week Double-Blind Period|Death|0
5349036|NCT00071487|18394925|P3|52-Week Double-Blind Period|Death|0
5349037|NCT00071487|18394926|P2|52-Week Double-Blind Period|Death|1
5349038|NCT00071487|18394927|P1|52-Week Double-Blind Period|Death|0
5349039|NCT00071487|18394924|P4|52-Week Double-Blind Period|Protocol Violation|0
5349040|NCT00071487|18394925|P3|52-Week Double-Blind Period|Protocol Violation|1
5349041|NCT00071487|18394926|P2|52-Week Double-Blind Period|Protocol Violation|1
5349042|NCT00071487|18394927|P1|52-Week Double-Blind Period|Protocol Violation|0
5349043|NCT00071487|18394924|P4|52-Week Double-Blind Period|Pregnancy|0
5349044|NCT00071487|18394925|P3|52-Week Double-Blind Period|Pregnancy|0
5349045|NCT00071487|18394926|P2|52-Week Double-Blind Period|Pregnancy|1
5349046|NCT00071487|18394927|P1|52-Week Double-Blind Period|Pregnancy|0
5349047|NCT00071487|18394924|P4|52-Week Double-Blind Period|Lost to Follow-up|2
5349048|NCT00071487|18394925|P3|52-Week Double-Blind Period|Lost to Follow-up|2
5349049|NCT00071487|18394926|P2|52-Week Double-Blind Period|Lost to Follow-up|0
5349050|NCT00071487|18394927|P1|52-Week Double-Blind Period|Lost to Follow-up|0
5349051|NCT00071487|18394924|P4|52-Week Double-Blind Period|Physician Decision|0
5349052|NCT00071487|18394925|P3|52-Week Double-Blind Period|Physician Decision|0
5349053|NCT00071487|18394926|P2|52-Week Double-Blind Period|Physician Decision|0
5349054|NCT00071487|18394927|P1|52-Week Double-Blind Period|Physician Decision|1
5349055|NCT00071487|18394924|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
5349056|NCT00071487|18394925|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
5349057|NCT00071487|18394926|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
5349058|NCT00071487|18394927|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
5349059|NCT00071487|18394924|P4|52-Week Double-Blind Period|Lack of Efficacy|1
5349060|NCT00071487|18394925|P3|52-Week Double-Blind Period|Lack of Efficacy|0
5349061|NCT00071487|18394926|P2|52-Week Double-Blind Period|Lack of Efficacy|2
5349062|NCT00071487|18394927|P1|52-Week Double-Blind Period|Lack of Efficacy|1
5349063|NCT00071487|18394924|P4|52-Week Double-Blind Period|Adverse Event|8
5349064|NCT00071487|18394925|P3|52-Week Double-Blind Period|Adverse Event|4
5349065|NCT00071487|18394926|P2|52-Week Double-Blind Period|Adverse Event|8
5349066|NCT00071487|18394927|P1|52-Week Double-Blind Period|Adverse Event|5
5349067|NCT00071396|18394971|P1|Overall Study|Physician Decision|2
5349068|NCT00071396|18394971|P1|Overall Study|Withdrawal by Subject|1
5349069|NCT00071110|18394977|P2|Overall Study|Protocol Violation|4
5349070|NCT00071110|18394978|P1|Overall Study|Protocol Violation|0
5349071|NCT00071032|18394992|P2|Overall Study|Missing Primary Outcome|1
5349072|NCT00071032|18394993|P1|Overall Study|Missing Primary Outcome|0
5349073|NCT00071032|18394992|P2|Overall Study|Withdrawal by Subject|6
5349074|NCT00071032|18394993|P1|Overall Study|Withdrawal by Subject|8
5349075|NCT00071032|18394992|P2|Overall Study|Lost to Follow-up|1
5349076|NCT00071032|18394993|P1|Overall Study|Lost to Follow-up|1
5349077|NCT00071006|18395029|P1|Overall Study|Other|3
5349078|NCT00071006|18395029|P1|Overall Study|Withdrawal by Subject|1
5349079|NCT00071006|18395029|P1|Overall Study|Adverse Event|1
5349080|NCT00071006|18395029|P1|Overall Study|Lack of Efficacy|7
5349081|NCT00070941|18395042|P3|Overall Study|Adverse Event|4
5349082|NCT00070941|18395043|P2|Overall Study|Adverse Event|8
5349083|NCT00070941|18395044|P1|Overall Study|Adverse Event|10
5349084|NCT00071058|18395052|P1|Overall Study|brain tumor-removed from study|1
5349085|NCT00070707|18395059|P2|Overall Study|Unrelated to Study Medication|0
5349086|NCT00070707|18395060|P1|Overall Study|Unrelated to Study Medication|1
5349087|NCT00070707|18395059|P2|Overall Study|Protocol Violation|4
5349088|NCT00070707|18395060|P1|Overall Study|Protocol Violation|8
5349089|NCT00070707|18395059|P2|Overall Study|Lack of Efficacy|1
5349090|NCT00070707|18395060|P1|Overall Study|Lack of Efficacy|4
5349091|NCT00070707|18395059|P2|Overall Study|Adverse Event|2
5349092|NCT00070707|18395060|P1|Overall Study|Adverse Event|1
5349093|NCT00003907|18395108|P2|Overall Study|ineligible or not treated|2
5349094|NCT00003907|18395109|P1|Overall Study|ineligible or not treated|2
5349095|NCT00003907|18395108|P2|Overall Study|Other|3
5349096|NCT00003907|18395109|P1|Overall Study|Other|1
5349097|NCT00003907|18395108|P2|Overall Study|Complicating disease|0
5349098|NCT00003907|18395109|P1|Overall Study|Complicating disease|1
5349099|NCT00003907|18395108|P2|Overall Study|Progressive disease|4
5349100|NCT00003907|18395109|P1|Overall Study|Progressive disease|4
5349101|NCT00003907|18395108|P2|Overall Study|Withdrawal by Subject|3
5349102|NCT00003907|18395109|P1|Overall Study|Withdrawal by Subject|1
5349103|NCT00003907|18395108|P2|Overall Study|Death|0
5349104|NCT00003907|18395109|P1|Overall Study|Death|2
5349105|NCT00003907|18395108|P2|Overall Study|Adverse Event|11
5349106|NCT00003907|18395109|P1|Overall Study|Adverse Event|2
5349107|NCT00070564|18395125|P6|Overall Study|Not reported|0
5349108|NCT00070564|18395126|P5|Overall Study|Not reported|1
5349109|NCT00070564|18395127|P4|Overall Study|Not reported|0
5349110|NCT00070564|18395128|P3|Overall Study|Not reported|0
5349111|NCT00070564|18395129|P2|Overall Study|Not reported|0
5349112|NCT00070564|18395130|P1|Overall Study|Not reported|0
5349113|NCT00070564|18395125|P6|Overall Study|Withdrawal by Subject|8
5349114|NCT00070564|18395126|P5|Overall Study|Withdrawal by Subject|8
5349115|NCT00070564|18395127|P4|Overall Study|Withdrawal by Subject|30
5349116|NCT00070564|18395128|P3|Overall Study|Withdrawal by Subject|23
5349117|NCT00070564|18395129|P2|Overall Study|Withdrawal by Subject|37
5349118|NCT00070564|18395130|P1|Overall Study|Withdrawal by Subject|26
5349119|NCT00070564|18395125|P6|Overall Study|Other, not protocol specified|7
5349120|NCT00070564|18395126|P5|Overall Study|Other, not protocol specified|6
5349121|NCT00070564|18395127|P4|Overall Study|Other, not protocol specified|19
5349122|NCT00070564|18395128|P3|Overall Study|Other, not protocol specified|14
5349123|NCT00070564|18395129|P2|Overall Study|Other, not protocol specified|15
5349124|NCT00070564|18395130|P1|Overall Study|Other, not protocol specified|17
5349125|NCT00070564|18395125|P6|Overall Study|Death|1
5349126|NCT00070564|18395126|P5|Overall Study|Death|0
5349127|NCT00070564|18395127|P4|Overall Study|Death|3
5349128|NCT00070564|18395128|P3|Overall Study|Death|5
5349129|NCT00070564|18395129|P2|Overall Study|Death|1
5349130|NCT00070564|18395130|P1|Overall Study|Death|4
5349131|NCT00070564|18395125|P6|Overall Study|Adverse Event|36
5349132|NCT00070564|18395126|P5|Overall Study|Adverse Event|63
5349133|NCT00070564|18395127|P4|Overall Study|Adverse Event|108
5349134|NCT00070564|18395128|P3|Overall Study|Adverse Event|120
5349135|NCT00070564|18395129|P2|Overall Study|Adverse Event|142
5349136|NCT00070564|18395130|P1|Overall Study|Adverse Event|150
5349137|NCT00070564|18395125|P6|Overall Study|Delinquent|0
5349138|NCT00070564|18395126|P5|Overall Study|Delinquent|0
5349139|NCT00070564|18395127|P4|Overall Study|Delinquent|0
5349140|NCT00070564|18395128|P3|Overall Study|Delinquent|2
5349141|NCT00070564|18395129|P2|Overall Study|Delinquent|4
5349142|NCT00070564|18395130|P1|Overall Study|Delinquent|1
5349143|NCT00070564|18395125|P6|Overall Study|Progression|0
5349144|NCT00070564|18395126|P5|Overall Study|Progression|1
5349145|NCT00070564|18395127|P4|Overall Study|Progression|7
5349146|NCT00070564|18395128|P3|Overall Study|Progression|7
5349147|NCT00070564|18395129|P2|Overall Study|Progression|4
5349148|NCT00070564|18395130|P1|Overall Study|Progression|2
5349149|NCT00070499|18395184|P4|Overall Study|Not eligible|2
5349150|NCT00070499|18395185|P3|Overall Study|Not eligible|3
5349151|NCT00070499|18395186|P2|Overall Study|Not eligible|5
5349152|NCT00070499|18395187|P1|Overall Study|Not eligible|2
5349153|NCT00070499|18395184|P4|Overall Study|Did not start treatment|2
5349154|NCT00070499|18395185|P3|Overall Study|Did not start treatment|0
5349155|NCT00070499|18395186|P2|Overall Study|Did not start treatment|0
5349156|NCT00070499|18395187|P1|Overall Study|Did not start treatment|1
5349157|NCT00070499|18395184|P4|Overall Study|Still on protocol treatment|57
5349158|NCT00070499|18395185|P3|Overall Study|Still on protocol treatment|79
5349159|NCT00070499|18395186|P2|Overall Study|Still on protocol treatment|4
5349160|NCT00070499|18395187|P1|Overall Study|Still on protocol treatment|10
5349161|NCT00070499|18395184|P4|Overall Study|Other - not protocol specified|20
5349162|NCT00070499|18395185|P3|Overall Study|Other - not protocol specified|12
5349163|NCT00070499|18395186|P2|Overall Study|Other - not protocol specified|3
5349164|NCT00070499|18395187|P1|Overall Study|Other - not protocol specified|7
5349165|NCT00070499|18395184|P4|Overall Study|Death|2
5349166|NCT00070499|18395185|P3|Overall Study|Death|1
5349167|NCT00070499|18395186|P2|Overall Study|Death|1
5349168|NCT00070499|18395187|P1|Overall Study|Death|1
5349169|NCT00070499|18395184|P4|Overall Study|Progression/relapse|4
5349170|NCT00070499|18395185|P3|Overall Study|Progression/relapse|1
5349171|NCT00070499|18395186|P2|Overall Study|Progression/relapse|2
5349172|NCT00070499|18395187|P1|Overall Study|Progression/relapse|4
5349173|NCT00070499|18395184|P4|Overall Study|Refusal unrelated to adverse effects|8
5349174|NCT00070499|18395185|P3|Overall Study|Refusal unrelated to adverse effects|5
5349175|NCT00070499|18395186|P2|Overall Study|Refusal unrelated to adverse effects|5
5349176|NCT00070499|18395187|P1|Overall Study|Refusal unrelated to adverse effects|7
5349177|NCT00070499|18395184|P4|Overall Study|Adverse Event|15
5349178|NCT00070499|18395185|P3|Overall Study|Adverse Event|19
5349179|NCT00070499|18395186|P2|Overall Study|Adverse Event|6
5349180|NCT00070499|18395187|P1|Overall Study|Adverse Event|6
5349181|NCT00070317|18395213|P1|Overall Study|Ineligible-Inadequate pathology|6
5349182|NCT00070317|18395213|P1|Overall Study|Ineligible-Improper prior treatment|2
5349183|NCT00070317|18395213|P1|Overall Study|Ineligible required test not done|1
5349184|NCT00070317|18395213|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
5349185|NCT00070317|18395213|P1|Overall Study|Inevaluable (Never Treated)|1
5349186|NCT00070291|18395218|P1|Step 2|Adverse Event|1
5349187|NCT00070291|18395218|P1|Step 1|Adverse Event|1
5349188|NCT00070291|18395218|P1|Step 1|Withdrawal by Subject|1
5349189|NCT00070109|18395234|P5|Overall Study|removed from prot thpy prior to chemo|0
5349190|NCT00070109|18395235|P4|Overall Study|removed from prot thpy prior to chemo|1
5349191|NCT00070109|18395236|P3|Overall Study|removed from prot thpy prior to chemo|0
5349192|NCT00070109|18395237|P2|Overall Study|removed from prot thpy prior to chemo|0
5349193|NCT00070109|18395238|P1|Overall Study|removed from prot thpy prior to chemo|0
5349194|NCT00070109|18395234|P5|Overall Study|Adverse Event|2
5349195|NCT00070109|18395235|P4|Overall Study|Adverse Event|4
5349196|NCT00070109|18395236|P3|Overall Study|Adverse Event|2
5349197|NCT00070109|18395237|P2|Overall Study|Adverse Event|0
5349198|NCT00070109|18395238|P1|Overall Study|Adverse Event|0
5349199|NCT00070109|18395234|P5|Overall Study|Withdrawal by Subject|0
5349200|NCT00070109|18395235|P4|Overall Study|Withdrawal by Subject|0
5349201|NCT00070109|18395236|P3|Overall Study|Withdrawal by Subject|1
5349202|NCT00070109|18395237|P2|Overall Study|Withdrawal by Subject|1
5349203|NCT00070109|18395238|P1|Overall Study|Withdrawal by Subject|0
5349204|NCT00070109|18395234|P5|Overall Study|Physician Decision|0
5349205|NCT00070109|18395235|P4|Overall Study|Physician Decision|0
5349206|NCT00070109|18395236|P3|Overall Study|Physician Decision|0
5349207|NCT00070109|18395237|P2|Overall Study|Physician Decision|0
5349208|NCT00070109|18395238|P1|Overall Study|Physician Decision|1
5349209|NCT00070109|18395234|P5|Overall Study|Lack of Efficacy|5
5349210|NCT00070109|18395235|P4|Overall Study|Lack of Efficacy|15
5349211|NCT00070109|18395236|P3|Overall Study|Lack of Efficacy|5
5349212|NCT00070109|18395237|P2|Overall Study|Lack of Efficacy|4
5349213|NCT00070109|18395238|P1|Overall Study|Lack of Efficacy|6
5349214|NCT00070109|18395234|P5|Overall Study|Death|1
5349215|NCT00070109|18395235|P4|Overall Study|Death|0
5349216|NCT00070109|18395236|P3|Overall Study|Death|0
5349217|NCT00070109|18395237|P2|Overall Study|Death|1
5349218|NCT00070109|18395238|P1|Overall Study|Death|1
5349219|NCT00070018|18395266|P1|Overall Study|Withdrawal by Subject|1
5349220|NCT00070018|18395266|P1|Overall Study|Lack of Efficacy|1
5349221|NCT00070018|18395266|P1|Overall Study|Adverse Event|2
5349222|NCT00069953|18395270|P1|Overall Study|Protocol Violation|2
5349223|NCT00069784|18395276|P2|Overall Study|Other|0
5349224|NCT00069784|18395277|P1|Overall Study|Other|17
5349225|NCT00069784|18395276|P2|Overall Study|Withdrawal by Subject|0
5349226|NCT00069784|18395277|P1|Overall Study|Withdrawal by Subject|1090
5349227|NCT00069784|18395276|P2|Overall Study|Adverse Event|0
5349228|NCT00069784|18395277|P1|Overall Study|Adverse Event|105
5349229|NCT00069823|18395297|P2|Overall Study|Did not have follow-up diary cards|3
5349230|NCT00069823|18395298|P1|Overall Study|Did not have follow-up diary cards|6
5349231|NCT00069641|18395341|P3|Overall Study|Death|1
5349232|NCT00069641|18395342|P2|Overall Study|Death|0
5349233|NCT00069641|18395343|P1|Overall Study|Death|1
5349234|NCT00069576|18395370|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
5349235|NCT00069576|18395371|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
5349236|NCT00069576|18395370|P2|Original Trial|Lost to Follow-up|33
5349237|NCT00069576|18395371|P1|Original Trial|Lost to Follow-up|25
5349238|NCT00069277|18395421|P1|Overall Study|Physician Decision|2
5349239|NCT00069277|18395421|P1|Overall Study|Progressive Disease|15
5349240|NCT00069277|18395421|P1|Overall Study|Withdrawal by Subject|1
5349241|NCT00069277|18395421|P1|Overall Study|Adverse Event|3
5349242|NCT00069264|18395425|P1|Overall Study|Discon Therapy|3
5349243|NCT00069264|18395425|P1|Overall Study|Withdrawal by Subject|3
5349244|NCT00069264|18395425|P1|Overall Study|Progressive Disease|23
5349245|NCT00069264|18395425|P1|Overall Study|Adverse Event|3
5349246|NCT00069238|18395453|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
5349247|NCT00069238|18395454|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
5349248|NCT00069238|18395455|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
5349249|NCT00069238|18395453|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
5349250|NCT00069238|18395454|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
5349251|NCT00069238|18395455|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
5349252|NCT00069238|18395453|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
5349253|NCT00069238|18395454|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
5349254|NCT00069238|18395455|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
5349255|NCT00069121|18395463|P2|Overall Study|Lost to Follow-up|63
5349256|NCT00069121|18395464|P1|Overall Study|Lost to Follow-up|63
5349257|NCT00069121|18395463|P2|Overall Study|Withdrawal by Subject|20
5349258|NCT00069121|18395464|P1|Overall Study|Withdrawal by Subject|18
5349259|NCT00069121|18395463|P2|Overall Study|Death|242
5349260|NCT00069121|18395464|P1|Overall Study|Death|286
5349261|NCT00069108|18395486|P2|Overall Study|Refused treatment|10
5349262|NCT00069108|18395487|P1|Overall Study|Refused treatment|5
5349263|NCT00069108|18395486|P2|Overall Study|Violation criteria|4
5349264|NCT00069108|18395487|P1|Overall Study|Violation criteria|1
5349265|NCT00069108|18395486|P2|Overall Study|Insufficient therapy|144
5349266|NCT00069108|18395487|P1|Overall Study|Insufficient therapy|117
5349267|NCT00069108|18395486|P2|Overall Study|Administration|4
5349268|NCT00069108|18395487|P1|Overall Study|Administration|15
5349269|NCT00069108|18395486|P2|Overall Study|Death|6
5349270|NCT00069108|18395487|P1|Overall Study|Death|6
5349271|NCT00069108|18395486|P2|Overall Study|Adverse Event|42
5349272|NCT00069108|18395487|P1|Overall Study|Adverse Event|64
5349273|NCT00069108|18395486|P2|Overall Study|Withdrawal by Subject|9
5349274|NCT00069108|18395487|P1|Overall Study|Withdrawal by Subject|5
5349275|NCT00069095|18395519|P6|Follow-up Phase|Death|101
5349276|NCT00069095|18395520|P5|Follow-up Phase|Death|92
5349277|NCT00069095|18395521|P4|Follow-up Phase|Death|112
5349278|NCT00069095|18395522|P3|Follow-up Phase|Death|120
5349279|NCT00069095|18395523|P2|Follow-up Phase|Death|206
5349280|NCT00069095|18395524|P1|Follow-up Phase|Death|174
5349281|NCT00069095|18395519|P6|Post-study Treatment Phase|Investigator decision|1
5349282|NCT00069095|18395520|P5|Post-study Treatment Phase|Investigator decision|0
5349283|NCT00069095|18395521|P4|Post-study Treatment Phase|Investigator decision|0
5349284|NCT00069095|18395522|P3|Post-study Treatment Phase|Investigator decision|0
5349285|NCT00069095|18395523|P2|Post-study Treatment Phase|Investigator decision|0
5349286|NCT00069095|18395524|P1|Post-study Treatment Phase|Investigator decision|0
5349287|NCT00069095|18395519|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5349288|NCT00069095|18395520|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
5349289|NCT00069095|18395521|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5349290|NCT00069095|18395522|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5349291|NCT00069095|18395523|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5349292|NCT00069095|18395524|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5349293|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
5349294|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
5349295|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
5349296|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
5349297|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
5349298|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
5349299|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant had progressive disease|0
5349300|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant had progressive disease|1
5349301|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant had progressive disease|0
5349302|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant had progressive disease|0
5349303|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant had progressive disease|0
5349304|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant had progressive disease|0
5349305|NCT00069095|18395519|P6|Post-study Treatment Phase|Death|0
5349306|NCT00069095|18395520|P5|Post-study Treatment Phase|Death|1
5349307|NCT00069095|18395521|P4|Post-study Treatment Phase|Death|0
5349308|NCT00069095|18395522|P3|Post-study Treatment Phase|Death|0
5349309|NCT00069095|18395523|P2|Post-study Treatment Phase|Death|0
5349310|NCT00069095|18395524|P1|Post-study Treatment Phase|Death|0
5349311|NCT00069095|18395519|P6|Post-study Treatment Phase|Surgery|0
5349312|NCT00069095|18395520|P5|Post-study Treatment Phase|Surgery|1
5349313|NCT00069095|18395521|P4|Post-study Treatment Phase|Surgery|1
5349314|NCT00069095|18395522|P3|Post-study Treatment Phase|Surgery|0
5349315|NCT00069095|18395523|P2|Post-study Treatment Phase|Surgery|0
5349316|NCT00069095|18395524|P1|Post-study Treatment Phase|Surgery|0
5349317|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant completed treatment|0
5349318|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant completed treatment|0
5349319|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant completed treatment|1
5349320|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant completed treatment|0
5349321|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant completed treatment|0
5349322|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant completed treatment|0
5349323|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
5349324|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
5349325|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
5349326|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
5349327|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
5349328|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
5349329|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant will start new treatment|0
5349330|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant will start new treatment|0
5349331|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant will start new treatment|0
5349332|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant will start new treatment|1
5349333|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant will start new treatment|0
5349334|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant will start new treatment|0
5349335|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant withdrew consent|0
5349336|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant withdrew consent|0
5349337|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant withdrew consent|0
5349338|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant withdrew consent|1
5349339|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant withdrew consent|0
5349340|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant withdrew consent|0
5349341|NCT00069095|18395519|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
5349342|NCT00069095|18395520|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
5349343|NCT00069095|18395521|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
5349344|NCT00069095|18395522|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
5349345|NCT00069095|18395523|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
5349346|NCT00069095|18395524|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
5349347|NCT00069095|18395519|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
5349348|NCT00069095|18395520|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
5349349|NCT00069095|18395521|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
5349350|NCT00069095|18395522|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
5349351|NCT00069095|18395523|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
5349352|NCT00069095|18395524|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
5349353|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant had complete response|0
5349354|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant had complete response|0
5349355|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant had complete response|0
5349356|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant had complete response|0
5349357|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant had complete response|1
5349358|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant had complete response|1
5349359|NCT00069095|18395519|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
5349360|NCT00069095|18395520|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5349361|NCT00069095|18395521|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5349362|NCT00069095|18395522|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5349363|NCT00069095|18395523|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5349364|NCT00069095|18395524|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
5349365|NCT00069095|18395519|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
5349366|NCT00069095|18395520|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
5349367|NCT00069095|18395521|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
5349368|NCT00069095|18395522|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
5349369|NCT00069095|18395523|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
5349370|NCT00069095|18395524|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
5349371|NCT00069095|18395519|P6|Post-study Treatment Phase|Eligible for surgery|0
5349372|NCT00069095|18395520|P5|Post-study Treatment Phase|Eligible for surgery|0
5349373|NCT00069095|18395521|P4|Post-study Treatment Phase|Eligible for surgery|0
5349374|NCT00069095|18395522|P3|Post-study Treatment Phase|Eligible for surgery|0
5349375|NCT00069095|18395523|P2|Post-study Treatment Phase|Eligible for surgery|0
5349376|NCT00069095|18395524|P1|Post-study Treatment Phase|Eligible for surgery|2
5349377|NCT00069095|18395519|P6|Post-study Treatment Phase|Adverse Event|1
5349378|NCT00069095|18395520|P5|Post-study Treatment Phase|Adverse Event|5
5349379|NCT00069095|18395521|P4|Post-study Treatment Phase|Adverse Event|0
5349380|NCT00069095|18395522|P3|Post-study Treatment Phase|Adverse Event|1
5349381|NCT00069095|18395523|P2|Post-study Treatment Phase|Adverse Event|3
5349382|NCT00069095|18395524|P1|Post-study Treatment Phase|Adverse Event|2
5349383|NCT00069095|18395519|P6|Post-study Treatment Phase|Missing reason|17
5349384|NCT00069095|18395520|P5|Post-study Treatment Phase|Missing reason|18
5349385|NCT00069095|18395521|P4|Post-study Treatment Phase|Missing reason|8
5349386|NCT00069095|18395522|P3|Post-study Treatment Phase|Missing reason|12
5349387|NCT00069095|18395523|P2|Post-study Treatment Phase|Missing reason|3
5349388|NCT00069095|18395524|P1|Post-study Treatment Phase|Missing reason|1
5349389|NCT00069095|18395519|P6|Primary Treatment Phase|Violation criteria|5
5349390|NCT00069095|18395520|P5|Primary Treatment Phase|Violation criteria|1
5349391|NCT00069095|18395521|P4|Primary Treatment Phase|Violation criteria|3
5349392|NCT00069095|18395522|P3|Primary Treatment Phase|Violation criteria|4
5349393|NCT00069095|18395523|P2|Primary Treatment Phase|Violation criteria|2
5349394|NCT00069095|18395524|P1|Primary Treatment Phase|Violation criteria|0
5349395|NCT00069095|18395519|P6|Primary Treatment Phase|Other Violation|1
5349396|NCT00069095|18395520|P5|Primary Treatment Phase|Other Violation|0
5349397|NCT00069095|18395521|P4|Primary Treatment Phase|Other Violation|1
5349398|NCT00069095|18395522|P3|Primary Treatment Phase|Other Violation|1
5349399|NCT00069095|18395523|P2|Primary Treatment Phase|Other Violation|1
5349400|NCT00069095|18395524|P1|Primary Treatment Phase|Other Violation|0
5349401|NCT00069095|18395519|P6|Primary Treatment Phase|Withdrew|9
5349402|NCT00069095|18395520|P5|Primary Treatment Phase|Withdrew|4
5349403|NCT00069095|18395521|P4|Primary Treatment Phase|Withdrew|2
5349404|NCT00069095|18395522|P3|Primary Treatment Phase|Withdrew|8
5349405|NCT00069095|18395523|P2|Primary Treatment Phase|Withdrew|3
5349406|NCT00069095|18395524|P1|Primary Treatment Phase|Withdrew|2
5349407|NCT00069095|18395519|P6|Primary Treatment Phase|Refused treatment|27
5349408|NCT00069095|18395520|P5|Primary Treatment Phase|Refused treatment|24
5349409|NCT00069095|18395521|P4|Primary Treatment Phase|Refused treatment|31
5349410|NCT00069095|18395522|P3|Primary Treatment Phase|Refused treatment|17
5349411|NCT00069095|18395523|P2|Primary Treatment Phase|Refused treatment|26
5349412|NCT00069095|18395524|P1|Primary Treatment Phase|Refused treatment|15
5349413|NCT00069095|18395519|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
5349414|NCT00069095|18395520|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
5349415|NCT00069095|18395521|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
5349416|NCT00069095|18395522|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
5349417|NCT00069095|18395523|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
5349418|NCT00069095|18395524|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
5349419|NCT00069095|18395519|P6|Primary Treatment Phase|Failure to return|2
5349420|NCT00069095|18395520|P5|Primary Treatment Phase|Failure to return|0
5349421|NCT00069095|18395521|P4|Primary Treatment Phase|Failure to return|0
5349422|NCT00069095|18395522|P3|Primary Treatment Phase|Failure to return|0
5349423|NCT00069095|18395523|P2|Primary Treatment Phase|Failure to return|5
5349424|NCT00069095|18395524|P1|Primary Treatment Phase|Failure to return|5
5349425|NCT00069095|18395519|P6|Primary Treatment Phase|Death|8
5349426|NCT00069095|18395520|P5|Primary Treatment Phase|Death|8
5349427|NCT00069095|18395521|P4|Primary Treatment Phase|Death|5
5349428|NCT00069095|18395522|P3|Primary Treatment Phase|Death|2
5349429|NCT00069095|18395523|P2|Primary Treatment Phase|Death|8
5349430|NCT00069095|18395524|P1|Primary Treatment Phase|Death|14
5349431|NCT00069095|18395519|P6|Primary Treatment Phase|Adverse Event|101
5349432|NCT00069095|18395520|P5|Primary Treatment Phase|Adverse Event|109
5349433|NCT00069095|18395521|P4|Primary Treatment Phase|Adverse Event|72
5349434|NCT00069095|18395522|P3|Primary Treatment Phase|Adverse Event|71
5349435|NCT00069095|18395523|P2|Primary Treatment Phase|Adverse Event|92
5349436|NCT00069095|18395524|P1|Primary Treatment Phase|Adverse Event|99
5349437|NCT00069095|18395519|P6|Primary Treatment Phase|Admin/Other|42
5349438|NCT00069095|18395520|P5|Primary Treatment Phase|Admin/Other|48
5349439|NCT00069095|18395521|P4|Primary Treatment Phase|Admin/Other|45
5349440|NCT00069095|18395522|P3|Primary Treatment Phase|Admin/Other|31
5349441|NCT00069095|18395523|P2|Primary Treatment Phase|Admin/Other|38
5349442|NCT00069095|18395524|P1|Primary Treatment Phase|Admin/Other|29
5349443|NCT00069095|18395519|P6|Primary Treatment Phase|Ongoing|4
5349444|NCT00069095|18395520|P5|Primary Treatment Phase|Ongoing|7
5349445|NCT00069095|18395521|P4|Primary Treatment Phase|Ongoing|7
5349446|NCT00069095|18395522|P3|Primary Treatment Phase|Ongoing|5
5349447|NCT00069095|18395523|P2|Primary Treatment Phase|Ongoing|0
5349448|NCT00069095|18395524|P1|Primary Treatment Phase|Ongoing|0
5349449|NCT00068822|18395594|P2|First Randomized Intervention|Lost to Follow-up|2
5349450|NCT00068822|18395595|P1|First Randomized Intervention|Lost to Follow-up|1
5349451|NCT00068692|18395629|P8|Step 2: Randomization|never start protocol therapy|0
5349452|NCT00068692|18395630|P7|Step 2: Randomization|never start protocol therapy|0
5349453|NCT00068692|18395631|P6|Step 2: Randomization|never start protocol therapy|0
5349454|NCT00068692|18395632|P5|Step 2: Randomization|never start protocol therapy|1
5349455|NCT00068692|18395633|P4|Step 2: Randomization|never start protocol therapy|0
5349456|NCT00068692|18395634|P3|Step 2: Randomization|never start protocol therapy|1
5349457|NCT00068692|18395635|P2|Step 2: Randomization|never start protocol therapy|0
5349458|NCT00068692|18395636|P1|Step 2: Randomization|never start protocol therapy|0
5349459|NCT00068692|18395629|P8|Step 2: Randomization|Other|0
5349460|NCT00068692|18395630|P7|Step 2: Randomization|Other|0
5349461|NCT00068692|18395631|P6|Step 2: Randomization|Other|1
5349462|NCT00068692|18395632|P5|Step 2: Randomization|Other|0
5349463|NCT00068692|18395633|P4|Step 2: Randomization|Other|1
5349464|NCT00068692|18395634|P3|Step 2: Randomization|Other|0
5349465|NCT00068692|18395635|P2|Step 2: Randomization|Other|0
5349466|NCT00068692|18395636|P1|Step 2: Randomization|Other|0
5349467|NCT00068692|18395629|P8|Step 2: Randomization|Physician Decision|0
5349468|NCT00068692|18395630|P7|Step 2: Randomization|Physician Decision|0
5349469|NCT00068692|18395631|P6|Step 2: Randomization|Physician Decision|0
5349470|NCT00068692|18395632|P5|Step 2: Randomization|Physician Decision|1
5349471|NCT00068692|18395633|P4|Step 2: Randomization|Physician Decision|1
5349472|NCT00068692|18395634|P3|Step 2: Randomization|Physician Decision|0
5349473|NCT00068692|18395635|P2|Step 2: Randomization|Physician Decision|0
5349474|NCT00068692|18395636|P1|Step 2: Randomization|Physician Decision|0
5349475|NCT00068692|18395629|P8|Step 2: Randomization|alternative therapy|0
5349476|NCT00068692|18395630|P7|Step 2: Randomization|alternative therapy|0
5349477|NCT00068692|18395631|P6|Step 2: Randomization|alternative therapy|0
5349478|NCT00068692|18395632|P5|Step 2: Randomization|alternative therapy|1
5349479|NCT00068692|18395633|P4|Step 2: Randomization|alternative therapy|1
5349480|NCT00068692|18395634|P3|Step 2: Randomization|alternative therapy|0
5349481|NCT00068692|18395635|P2|Step 2: Randomization|alternative therapy|0
5349482|NCT00068692|18395636|P1|Step 2: Randomization|alternative therapy|0
5349483|NCT00068692|18395629|P8|Step 2: Randomization|Withdrawal by Subject|3
5349484|NCT00068692|18395630|P7|Step 2: Randomization|Withdrawal by Subject|0
5349485|NCT00068692|18395631|P6|Step 2: Randomization|Withdrawal by Subject|2
5349486|NCT00068692|18395632|P5|Step 2: Randomization|Withdrawal by Subject|3
5349487|NCT00068692|18395633|P4|Step 2: Randomization|Withdrawal by Subject|6
5349488|NCT00068692|18395634|P3|Step 2: Randomization|Withdrawal by Subject|4
5349489|NCT00068692|18395635|P2|Step 2: Randomization|Withdrawal by Subject|0
5349490|NCT00068692|18395636|P1|Step 2: Randomization|Withdrawal by Subject|0
5349491|NCT00068692|18395629|P8|Step 2: Randomization|Death|1
5349492|NCT00068692|18395630|P7|Step 2: Randomization|Death|0
5349493|NCT00068692|18395631|P6|Step 2: Randomization|Death|0
5349494|NCT00068692|18395632|P5|Step 2: Randomization|Death|1
5349495|NCT00068692|18395633|P4|Step 2: Randomization|Death|0
5349496|NCT00068692|18395634|P3|Step 2: Randomization|Death|0
5349497|NCT00068692|18395635|P2|Step 2: Randomization|Death|0
5349498|NCT00068692|18395636|P1|Step 2: Randomization|Death|0
5349499|NCT00068692|18395629|P8|Step 2: Randomization|Adverse Event|4
5349500|NCT00068692|18395630|P7|Step 2: Randomization|Adverse Event|4
5349501|NCT00068692|18395631|P6|Step 2: Randomization|Adverse Event|3
5349502|NCT00068692|18395632|P5|Step 2: Randomization|Adverse Event|2
5349503|NCT00068692|18395633|P4|Step 2: Randomization|Adverse Event|2
5349504|NCT00068692|18395634|P3|Step 2: Randomization|Adverse Event|4
5349505|NCT00068692|18395635|P2|Step 2: Randomization|Adverse Event|0
5349506|NCT00068692|18395636|P1|Step 2: Randomization|Adverse Event|0
5349507|NCT00068692|18395629|P8|Step 2: Randomization|Disesae progression/replase|0
5349508|NCT00068692|18395630|P7|Step 2: Randomization|Disesae progression/replase|0
5349509|NCT00068692|18395631|P6|Step 2: Randomization|Disesae progression/replase|0
5349510|NCT00068692|18395632|P5|Step 2: Randomization|Disesae progression/replase|0
5349511|NCT00068692|18395633|P4|Step 2: Randomization|Disesae progression/replase|1
5349512|NCT00068692|18395634|P3|Step 2: Randomization|Disesae progression/replase|1
5349513|NCT00068692|18395635|P2|Step 2: Randomization|Disesae progression/replase|0
5349514|NCT00068692|18395636|P1|Step 2: Randomization|Disesae progression/replase|0
5349515|NCT00068692|18395629|P8|Step 1: Registration|Registered but not randomized|0
5349516|NCT00068692|18395630|P7|Step 1: Registration|Registered but not randomized|0
5349517|NCT00068692|18395631|P6|Step 1: Registration|Registered but not randomized|0
5349518|NCT00068692|18395632|P5|Step 1: Registration|Registered but not randomized|0
5349519|NCT00068692|18395633|P4|Step 1: Registration|Registered but not randomized|0
5349520|NCT00068692|18395634|P3|Step 1: Registration|Registered but not randomized|0
5349521|NCT00068692|18395635|P2|Step 1: Registration|Registered but not randomized|1
5349522|NCT00068692|18395636|P1|Step 1: Registration|Registered but not randomized|0
5349523|NCT00068692|18395629|P8|Step 1: Registration|Not start protocol therapy|0
5349524|NCT00068692|18395630|P7|Step 1: Registration|Not start protocol therapy|0
5349525|NCT00068692|18395631|P6|Step 1: Registration|Not start protocol therapy|0
5349526|NCT00068692|18395632|P5|Step 1: Registration|Not start protocol therapy|0
5349527|NCT00068692|18395633|P4|Step 1: Registration|Not start protocol therapy|0
5349528|NCT00068692|18395634|P3|Step 1: Registration|Not start protocol therapy|0
5349529|NCT00068692|18395635|P2|Step 1: Registration|Not start protocol therapy|0
5349530|NCT00068692|18395636|P1|Step 1: Registration|Not start protocol therapy|3
5349531|NCT00068692|18395629|P8|Step 1: Registration|Other|0
5349532|NCT00068692|18395630|P7|Step 1: Registration|Other|0
5349533|NCT00068692|18395631|P6|Step 1: Registration|Other|0
5349534|NCT00068692|18395632|P5|Step 1: Registration|Other|0
5349535|NCT00068692|18395633|P4|Step 1: Registration|Other|0
5349536|NCT00068692|18395634|P3|Step 1: Registration|Other|0
5349537|NCT00068692|18395635|P2|Step 1: Registration|Other|0
5349538|NCT00068692|18395636|P1|Step 1: Registration|Other|2
5349539|NCT00068692|18395629|P8|Step 1: Registration|Not eligible|0
5349540|NCT00068692|18395630|P7|Step 1: Registration|Not eligible|0
5349541|NCT00068692|18395631|P6|Step 1: Registration|Not eligible|0
5349542|NCT00068692|18395632|P5|Step 1: Registration|Not eligible|0
5349543|NCT00068692|18395633|P4|Step 1: Registration|Not eligible|0
5349544|NCT00068692|18395634|P3|Step 1: Registration|Not eligible|0
5349545|NCT00068692|18395635|P2|Step 1: Registration|Not eligible|0
5349546|NCT00068692|18395636|P1|Step 1: Registration|Not eligible|6
5349547|NCT00068692|18395629|P8|Step 1: Registration|Protocol Violation|0
5349548|NCT00068692|18395630|P7|Step 1: Registration|Protocol Violation|0
5349549|NCT00068692|18395631|P6|Step 1: Registration|Protocol Violation|0
5349550|NCT00068692|18395632|P5|Step 1: Registration|Protocol Violation|0
5349551|NCT00068692|18395633|P4|Step 1: Registration|Protocol Violation|0
5349552|NCT00068692|18395634|P3|Step 1: Registration|Protocol Violation|0
5349553|NCT00068692|18395635|P2|Step 1: Registration|Protocol Violation|0
5349554|NCT00068692|18395636|P1|Step 1: Registration|Protocol Violation|1
5349555|NCT00068692|18395629|P8|Step 1: Registration|Complicating disease|0
5349556|NCT00068692|18395630|P7|Step 1: Registration|Complicating disease|0
5349557|NCT00068692|18395631|P6|Step 1: Registration|Complicating disease|0
5349558|NCT00068692|18395632|P5|Step 1: Registration|Complicating disease|0
5349559|NCT00068692|18395633|P4|Step 1: Registration|Complicating disease|0
5349560|NCT00068692|18395634|P3|Step 1: Registration|Complicating disease|0
5349561|NCT00068692|18395635|P2|Step 1: Registration|Complicating disease|0
5349562|NCT00068692|18395636|P1|Step 1: Registration|Complicating disease|2
5349563|NCT00068692|18395629|P8|Step 1: Registration|Alternative therapy|0
5349564|NCT00068692|18395630|P7|Step 1: Registration|Alternative therapy|0
5349565|NCT00068692|18395631|P6|Step 1: Registration|Alternative therapy|0
5349566|NCT00068692|18395632|P5|Step 1: Registration|Alternative therapy|0
5349567|NCT00068692|18395633|P4|Step 1: Registration|Alternative therapy|0
5349568|NCT00068692|18395634|P3|Step 1: Registration|Alternative therapy|0
5349569|NCT00068692|18395635|P2|Step 1: Registration|Alternative therapy|0
5349570|NCT00068692|18395636|P1|Step 1: Registration|Alternative therapy|2
5349571|NCT00068692|18395629|P8|Step 1: Registration|Withdrawal by Subject|0
5349572|NCT00068692|18395630|P7|Step 1: Registration|Withdrawal by Subject|0
5349573|NCT00068692|18395631|P6|Step 1: Registration|Withdrawal by Subject|0
5349574|NCT00068692|18395632|P5|Step 1: Registration|Withdrawal by Subject|0
5349575|NCT00068692|18395633|P4|Step 1: Registration|Withdrawal by Subject|0
5349576|NCT00068692|18395634|P3|Step 1: Registration|Withdrawal by Subject|0
5349577|NCT00068692|18395635|P2|Step 1: Registration|Withdrawal by Subject|0
5349578|NCT00068692|18395636|P1|Step 1: Registration|Withdrawal by Subject|11
5349579|NCT00068692|18395629|P8|Step 1: Registration|Death|0
5349580|NCT00068692|18395630|P7|Step 1: Registration|Death|0
5349581|NCT00068692|18395631|P6|Step 1: Registration|Death|0
5349582|NCT00068692|18395632|P5|Step 1: Registration|Death|0
5349583|NCT00068692|18395633|P4|Step 1: Registration|Death|0
5349584|NCT00068692|18395634|P3|Step 1: Registration|Death|0
5349585|NCT00068692|18395635|P2|Step 1: Registration|Death|0
5349586|NCT00068692|18395636|P1|Step 1: Registration|Death|1
5349587|NCT00068692|18395629|P8|Step 1: Registration|Adverse Event|0
5349588|NCT00068692|18395630|P7|Step 1: Registration|Adverse Event|0
5349589|NCT00068692|18395631|P6|Step 1: Registration|Adverse Event|0
5349590|NCT00068692|18395632|P5|Step 1: Registration|Adverse Event|0
5349591|NCT00068692|18395633|P4|Step 1: Registration|Adverse Event|0
5349592|NCT00068692|18395634|P3|Step 1: Registration|Adverse Event|0
5349593|NCT00068692|18395635|P2|Step 1: Registration|Adverse Event|0
5349594|NCT00068692|18395636|P1|Step 1: Registration|Adverse Event|7
5349595|NCT00068692|18395629|P8|Step 1: Registration|Disese progression/relapse|0
5349596|NCT00068692|18395630|P7|Step 1: Registration|Disese progression/relapse|0
5349597|NCT00068692|18395631|P6|Step 1: Registration|Disese progression/relapse|0
5349598|NCT00068692|18395632|P5|Step 1: Registration|Disese progression/relapse|0
5349599|NCT00068692|18395633|P4|Step 1: Registration|Disese progression/relapse|0
5349600|NCT00068692|18395634|P3|Step 1: Registration|Disese progression/relapse|0
5349601|NCT00068692|18395635|P2|Step 1: Registration|Disese progression/relapse|0
5349602|NCT00068692|18395636|P1|Step 1: Registration|Disese progression/relapse|5
5349603|NCT00068601|18395659|P2|Overall Study|Missing primary outcome data|34
5349604|NCT00068601|18395660|P1|Overall Study|Missing primary outcome data|30
5349605|NCT00068601|18395659|P2|Overall Study|Lost to Follow-up|2
5349606|NCT00068601|18395660|P1|Overall Study|Lost to Follow-up|3
5349607|NCT00068601|18395659|P2|Overall Study|Death|3
5349608|NCT00068601|18395660|P1|Overall Study|Death|11
5349609|NCT00068601|18395659|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
5349610|NCT00068601|18395660|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
5349611|NCT00068601|18395659|P2|Overall Study|Not evaluable: withdrew consent|4
5349612|NCT00068601|18395660|P1|Overall Study|Not evaluable: withdrew consent|5
5349613|NCT00068601|18395659|P2|Overall Study|Ineligible|13
5349614|NCT00068601|18395660|P1|Overall Study|Ineligible|11
5349615|NCT00068588|18395673|P3|Overall Study|Poor KPS|1
5349616|NCT00068588|18395674|P2|Overall Study|Poor KPS|0
5349617|NCT00068588|18395675|P1|Overall Study|Poor KPS|0
5349618|NCT00068588|18395673|P3|Overall Study|Withdrawal by Subject|1
5349619|NCT00068588|18395674|P2|Overall Study|Withdrawal by Subject|0
5349620|NCT00068588|18395675|P1|Overall Study|Withdrawal by Subject|0
5349621|NCT00068588|18395673|P3|Overall Study|Adverse Event|2
5349622|NCT00068588|18395674|P2|Overall Study|Adverse Event|0
5349623|NCT00068588|18395675|P1|Overall Study|Adverse Event|0
5349624|NCT00068445|18395691|P2|Treatment|Other (Specifics not available)|5
5349625|NCT00068445|18395692|P1|Treatment|Other (Specifics not available)|9
5349626|NCT00068445|18395691|P2|Treatment|Adverse Event|1
5349627|NCT00068445|18395692|P1|Treatment|Adverse Event|7
5349628|NCT00068445|18395691|P2|Treatment|Refused Further Treatment|10
5349629|NCT00068445|18395692|P1|Treatment|Refused Further Treatment|13
5349630|NCT00068445|18395691|P2|Randomization|Ineligible|1
5349631|NCT00068445|18395692|P1|Randomization|Ineligible|1
5349632|NCT00068445|18395691|P2|Randomization|Cancel|3
5349633|NCT00068445|18395692|P1|Randomization|Cancel|1
5349634|NCT00068419|18395716|P1|Overall Study|Ineligible|11
5349635|NCT00068419|18395716|P1|Overall Study|Withdrawal by Subject|14
5349636|NCT00068419|18395716|P1|Overall Study|Physician Decision|7
5349637|NCT00068419|18395716|P1|Overall Study|Lost to Follow-up|1
5349638|NCT00068419|18395716|P1|Overall Study|Lack of Efficacy|24
5349639|NCT00068419|18395716|P1|Overall Study|Adverse Event|3
5349640|NCT00068406|18395725|P1|Overall Study|Ineligible-Inadequate Pathology|2
5349641|NCT00068406|18395725|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
5349642|NCT00068393|18395730|P1|Overall Study|Quality of life worsening|1
5349643|NCT00068393|18395730|P1|Overall Study|Alternative treatment|1
5349644|NCT00068393|18395730|P1|Overall Study|Withdrawal by Subject|3
5349645|NCT00068393|18395730|P1|Overall Study|Death|3
5349646|NCT00068393|18395730|P1|Overall Study|Adverse Event|2
5349647|NCT00068380|18395736|P1|Overall Study|Adverse Event|2
5349648|NCT00068380|18395736|P1|Overall Study|Withdrawal by Subject|3
5349649|NCT00068250|18395780|P4|Phase I: Dose Level 2|Protocol Violation|0
5349650|NCT00068250|18395781|P3|Phase I: Dose Level 2|Protocol Violation|0
5349651|NCT00068250|18395782|P2|Phase I: Dose Level 2|Protocol Violation|1
5349652|NCT00068250|18395783|P1|Phase I: Dose Level 2|Protocol Violation|0
5349653|NCT00068237|18395793|P1|Overall Study|No protocol treatment received|2
5349654|NCT00068237|18395793|P1|Overall Study|Ineligible|3
5349655|NCT00068107|18395805|P1|Overall Study|Withdrawal by Subject|1
5349656|NCT00068107|18395805|P1|Overall Study|Death|2
5349657|NCT00068107|18395805|P1|Overall Study|end-stage renal disease|6
5349658|NCT00067990|18395818|P2|Overall Study|Withdrawal by Subject|12
5349659|NCT00067990|18395819|P1|Overall Study|Withdrawal by Subject|4
5349660|NCT00067990|18395818|P2|Overall Study|ESRD, Non IF/TA|3
5349661|NCT00067990|18395819|P1|Overall Study|ESRD, Non IF/TA|1
5349662|NCT00067990|18395818|P2|Overall Study|Death|7
5349663|NCT00067990|18395819|P1|Overall Study|Death|5
5349664|NCT00067470|18395842|P2|Overall Study|Withdrawal by Subject|1
5349665|NCT00067470|18395843|P1|Overall Study|Withdrawal by Subject|0
5349666|NCT00067002|18395864|P2|Overall Study|Graft Failure|6
5349667|NCT00067002|18395865|P1|Overall Study|Graft Failure|5
5349668|NCT00067002|18395864|P2|Overall Study|Delayed|1
5349669|NCT00067002|18395865|P1|Overall Study|Delayed|1
5349670|NCT00067002|18395864|P2|Overall Study|Early Death|2
5349671|NCT00067002|18395865|P1|Overall Study|Early Death|1
5349672|NCT00066807|18395923|P2|Overall Study|Study was terminated early|15
5349673|NCT00066807|18395924|P1|Overall Study|Study was terminated early|14
5349674|NCT00066742|18395949|P1|Consolidation Chemotherapy|Ineligible|2
5349675|NCT00066742|18395949|P1|Consolidation Chemotherapy|not protocol specified|1
5349676|NCT00066742|18395949|P1|Induction Chemoradiotherapy|Ineligible|3
5349677|NCT00066742|18395949|P1|Induction Chemoradiotherapy|not protocol specified|2
5349678|NCT00066742|18395949|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
5349679|NCT00066742|18395949|P1|Induction Chemoradiotherapy|Adverse Event|21
5349680|NCT00066742|18395949|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
5349681|NCT00066703|18395958|P2|Overall Study|Treatment ongoing|311
5349682|NCT00066703|18395959|P1|Overall Study|Treatment ongoing|346
5349683|NCT00066703|18395958|P2|Overall Study|Withdrawal by Subject|63
5349684|NCT00066703|18395959|P1|Overall Study|Withdrawal by Subject|38
5349685|NCT00066703|18395958|P2|Overall Study|Lost to Follow-up|28
5349686|NCT00066703|18395959|P1|Overall Study|Lost to Follow-up|31
5349687|NCT00066703|18395958|P2|Overall Study|Lack of Efficacy|69
5349688|NCT00066703|18395959|P1|Overall Study|Lack of Efficacy|114
5349689|NCT00066703|18395958|P2|Overall Study|Death|0
5349690|NCT00066703|18395959|P1|Overall Study|Death|3
5349691|NCT00066703|18395958|P2|Overall Study|Adverse Event|111
5349692|NCT00066703|18395959|P1|Overall Study|Adverse Event|80
5349693|NCT00066690|18395974|P3|Overall Study|Treatment Ongoing|282
5349694|NCT00066690|18395975|P2|Overall Study|Treatment Ongoing|278
5349695|NCT00066690|18395976|P1|Overall Study|Treatment Ongoing|246
5349696|NCT00066690|18395974|P3|Overall Study|Withdrawal by Subject|49
5349697|NCT00066690|18395975|P2|Overall Study|Withdrawal by Subject|55
5349698|NCT00066690|18395976|P1|Overall Study|Withdrawal by Subject|50
5349699|NCT00066690|18395974|P3|Overall Study|Lost to Follow-up|29
5349700|NCT00066690|18395975|P2|Overall Study|Lost to Follow-up|21
5349701|NCT00066690|18395976|P1|Overall Study|Lost to Follow-up|40
5349702|NCT00066690|18395974|P3|Overall Study|Lack of Efficacy|76
5349703|NCT00066690|18395975|P2|Overall Study|Lack of Efficacy|110
5349704|NCT00066690|18395976|P1|Overall Study|Lack of Efficacy|114
5349705|NCT00066690|18395974|P3|Overall Study|Death|2
5349706|NCT00066690|18395975|P2|Overall Study|Death|0
5349707|NCT00066690|18395976|P1|Overall Study|Death|3
5349708|NCT00066690|18395974|P3|Overall Study|Adverse Event|126
5349709|NCT00066690|18395975|P2|Overall Study|Adverse Event|58
5349710|NCT00066690|18395976|P1|Overall Study|Adverse Event|145
5349711|NCT00066573|18395995|P2|Overall Study|Did not received protocol treatment|28
5349712|NCT00066573|18395996|P1|Overall Study|Did not received protocol treatment|28
5349713|NCT00066469|18396008|P1|Overall Study|ineligible|1
5349714|NCT00066469|18396008|P1|Overall Study|Withdrawal by Subject|1
5349715|NCT00066469|18396008|P1|Overall Study|Physician Decision|1
5349716|NCT00066469|18396008|P1|Overall Study|Lost to Follow-up|1
5349717|NCT00066469|18396008|P1|Overall Study|Lack of Efficacy|9
5349718|NCT00066469|18396008|P1|Overall Study|Death|3
5349719|NCT00066365|18396014|P2|Overall Study|Ineligible|2
5349720|NCT00066365|18396015|P1|Overall Study|Ineligible|4
5349721|NCT00066365|18396014|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
5349722|NCT00066365|18396015|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
5349723|NCT00066365|18396014|P2|Overall Study|Physician Decision|0
5349724|NCT00066365|18396015|P1|Overall Study|Physician Decision|1
5349725|NCT00066365|18396014|P2|Overall Study|Lack of Efficacy|12
5349726|NCT00066365|18396015|P1|Overall Study|Lack of Efficacy|15
5349727|NCT00066365|18396014|P2|Overall Study|Adverse Event|0
5349728|NCT00066365|18396015|P1|Overall Study|Adverse Event|1
5349729|NCT00066222|18396043|P1|Overall Study|No protocol treatment received|1
5349730|NCT00066170|18396056|P4|Overall Study|Other|0
5349731|NCT00066170|18396057|P3|Overall Study|Other|2
5349732|NCT00066170|18396058|P2|Overall Study|Other|5
5349733|NCT00066170|18396059|P1|Overall Study|Other|1
5349734|NCT00066170|18396056|P4|Overall Study|Protocol Violation|0
5349735|NCT00066170|18396057|P3|Overall Study|Protocol Violation|0
5349736|NCT00066170|18396058|P2|Overall Study|Protocol Violation|0
5349737|NCT00066170|18396059|P1|Overall Study|Protocol Violation|3
5349738|NCT00066170|18396056|P4|Overall Study|Non-Compliance with Trial Medicine|1
5349739|NCT00066170|18396057|P3|Overall Study|Non-Compliance with Trial Medicine|0
5349740|NCT00066170|18396058|P2|Overall Study|Non-Compliance with Trial Medicine|0
5349741|NCT00066170|18396059|P1|Overall Study|Non-Compliance with Trial Medicine|1
5349742|NCT00066170|18396056|P4|Overall Study|Lost to Follow-up|0
5349743|NCT00066170|18396057|P3|Overall Study|Lost to Follow-up|0
5349744|NCT00066170|18396058|P2|Overall Study|Lost to Follow-up|1
5349745|NCT00066170|18396059|P1|Overall Study|Lost to Follow-up|0
5349746|NCT00066170|18396056|P4|Overall Study|Serious Adverse Event|1
5349747|NCT00066170|18396057|P3|Overall Study|Serious Adverse Event|1
5349748|NCT00066170|18396058|P2|Overall Study|Serious Adverse Event|0
5349749|NCT00066170|18396059|P1|Overall Study|Serious Adverse Event|0
5349750|NCT00066170|18396056|P4|Overall Study|Adverse Event|7
5349751|NCT00066170|18396057|P3|Overall Study|Adverse Event|1
5349752|NCT00066170|18396058|P2|Overall Study|Adverse Event|4
5349753|NCT00066170|18396059|P1|Overall Study|Adverse Event|2
5349754|NCT00066066|18396072|P6|Overall Study|Lost to Follow-up|5
5349755|NCT00066066|18396073|P5|Overall Study|Lost to Follow-up|3
5349756|NCT00066066|18396074|P4|Overall Study|Lost to Follow-up|4
5349757|NCT00066066|18396075|P3|Overall Study|Lost to Follow-up|7
5349758|NCT00066066|18396076|P2|Overall Study|Lost to Follow-up|4
5349759|NCT00066066|18396077|P1|Overall Study|Lost to Follow-up|6
5349760|NCT00065507|18396155|P2|Overall Study|Subject No Longer Meets Study Criteria|0
5349761|NCT00065507|18396156|P1|Overall Study|Subject No Longer Meets Study Criteria|1
5349762|NCT00065507|18396155|P2|Overall Study|Subject Withdrew Consent|1
5349763|NCT00065507|18396156|P1|Overall Study|Subject Withdrew Consent|2
5349764|NCT00065507|18396155|P2|Overall Study|Lost to Follow-up|0
5349765|NCT00065507|18396156|P1|Overall Study|Lost to Follow-up|3
5349766|NCT00065507|18396155|P2|Overall Study|Poor/Non-compliance|2
5349767|NCT00065507|18396156|P1|Overall Study|Poor/Non-compliance|3
5349768|NCT00065507|18396155|P2|Overall Study|Lack of Efficacy|6
5349769|NCT00065507|18396156|P1|Overall Study|Lack of Efficacy|0
5349770|NCT00065507|18396155|P2|Overall Study|Adverse Event|3
5349771|NCT00065507|18396156|P1|Overall Study|Adverse Event|4
5349772|NCT00065507|18396155|P2|Overall Study|Death|17
5349773|NCT00065507|18396156|P1|Overall Study|Death|16
5349774|NCT00065468|18396221|P3|Overall Study|Other|18
5349775|NCT00065468|18396222|P2|Overall Study|Other|24
5349776|NCT00065468|18396223|P1|Overall Study|Other|14
5349777|NCT00065468|18396221|P3|Overall Study|Disease progression|1
5349778|NCT00065468|18396222|P2|Overall Study|Disease progression|0
5349779|NCT00065468|18396223|P1|Overall Study|Disease progression|0
5349780|NCT00065468|18396221|P3|Overall Study|Discontinuation of study by Sponsor|13
5349781|NCT00065468|18396222|P2|Overall Study|Discontinuation of study by Sponsor|9
5349782|NCT00065468|18396223|P1|Overall Study|Discontinuation of study by Sponsor|13
5349783|NCT00065468|18396221|P3|Overall Study|Lost to Follow-up|2
5349784|NCT00065468|18396222|P2|Overall Study|Lost to Follow-up|3
5349785|NCT00065468|18396223|P1|Overall Study|Lost to Follow-up|5
5349786|NCT00065468|18396221|P3|Overall Study|Withdrawal by Subject|5
5349787|NCT00065468|18396222|P2|Overall Study|Withdrawal by Subject|4
5349788|NCT00065468|18396223|P1|Overall Study|Withdrawal by Subject|3
5349789|NCT00065468|18396221|P3|Overall Study|Death|171
5349790|NCT00065468|18396222|P2|Overall Study|Death|169
5349791|NCT00065468|18396223|P1|Overall Study|Death|172
5349792|NCT00065442|18396254|P2|Overall Study|Withdrawal by Subject|9
5349793|NCT00065442|18396255|P1|Overall Study|Withdrawal by Subject|3
5349794|NCT00065442|18396254|P2|Overall Study|Death|210
5349795|NCT00065442|18396255|P1|Overall Study|Death|121
5349796|NCT00065442|18396254|P2|Overall Study|Lost to Follow-up|1
5349797|NCT00065442|18396255|P1|Overall Study|Lost to Follow-up|1
5349798|NCT00065429|18396270|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5349799|NCT00065429|18396271|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5349800|NCT00065429|18396272|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
5349801|NCT00065429|18396273|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5349802|NCT00065429|18396274|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5349803|NCT00065429|18396275|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5349804|NCT00065429|18396276|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5349805|NCT00065429|18396270|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5349806|NCT00065429|18396271|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5349807|NCT00065429|18396272|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
5349808|NCT00065429|18396273|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5349809|NCT00065429|18396274|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5349810|NCT00065429|18396275|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5349811|NCT00065429|18396276|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5349812|NCT00065429|18396270|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
5349813|NCT00065429|18396271|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
5349814|NCT00065429|18396272|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
5349815|NCT00065429|18396273|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
5349816|NCT00065429|18396274|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
5349817|NCT00065429|18396275|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
5349818|NCT00065429|18396276|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
5349819|NCT00065429|18396270|P7|Phase I - May 2001 - Oct 2002|Death|0
5349820|NCT00065429|18396271|P6|Phase I - May 2001 - Oct 2002|Death|0
5349821|NCT00065429|18396272|P5|Phase I - May 2001 - Oct 2002|Death|1
5349822|NCT00065429|18396273|P4|Phase I - May 2001 - Oct 2002|Death|0
5349823|NCT00065429|18396274|P3|Phase I - May 2001 - Oct 2002|Death|0
5349824|NCT00065429|18396275|P2|Phase I - May 2001 - Oct 2002|Death|0
5349825|NCT00065429|18396276|P1|Phase I - May 2001 - Oct 2002|Death|0
5349826|NCT00065429|18396270|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
5349827|NCT00065429|18396271|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
5349828|NCT00065429|18396272|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
5349829|NCT00065429|18396273|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
5349830|NCT00065429|18396274|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
5349831|NCT00065429|18396275|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
5349832|NCT00065429|18396276|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
5349833|NCT00065429|18396270|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5349834|NCT00065429|18396271|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5349835|NCT00065429|18396272|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5349836|NCT00065429|18396273|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5349837|NCT00065429|18396274|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
5349838|NCT00065429|18396275|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5349839|NCT00065429|18396276|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5349840|NCT00065429|18396270|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5349841|NCT00065429|18396271|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
5349842|NCT00065429|18396272|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5349843|NCT00065429|18396273|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5349844|NCT00065429|18396274|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5349845|NCT00065429|18396275|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5349846|NCT00065429|18396276|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5349847|NCT00065260|18396290|P2|Overall Study|Death|1
5349848|NCT00065260|18396291|P1|Overall Study|Death|0
5349849|NCT00065182|18396299|P2|Overall Study|Decline in Status|1
5349850|NCT00065182|18396300|P1|Overall Study|Decline in Status|0
5349851|NCT00065182|18396299|P2|Overall Study|Death|1
5349852|NCT00065182|18396300|P1|Overall Study|Death|0
5349853|NCT00065182|18396299|P2|Overall Study|No clinical benefit|0
5349854|NCT00065182|18396300|P1|Overall Study|No clinical benefit|1
5349855|NCT00065182|18396299|P2|Overall Study|Withdrawal by Subject|3
5349856|NCT00065182|18396300|P1|Overall Study|Withdrawal by Subject|8
5349857|NCT00065182|18396299|P2|Overall Study|Sponsor Decision|7
5349858|NCT00065182|18396300|P1|Overall Study|Sponsor Decision|11
5349859|NCT00065182|18396299|P2|Overall Study|Serious adverse events (SAE)|0
5349860|NCT00065182|18396300|P1|Overall Study|Serious adverse events (SAE)|1
5349861|NCT00065182|18396299|P2|Overall Study|Protocol Violation|4
5349862|NCT00065182|18396300|P1|Overall Study|Protocol Violation|3
5349863|NCT00065182|18396299|P2|Overall Study|Lost to Follow-up|4
5349864|NCT00065182|18396300|P1|Overall Study|Lost to Follow-up|0
5349865|NCT00065182|18396299|P2|Overall Study|Adverse Event|17
5349866|NCT00065182|18396300|P1|Overall Study|Adverse Event|24
5349867|NCT00065156|18396326|P1|Overall Study|Secondary Malign Disease|1
5349868|NCT00065156|18396326|P1|Overall Study|Loss of Response|1
5349869|NCT00065156|18396326|P1|Overall Study|Non-Compliance|2
5349870|NCT00065156|18396326|P1|Overall Study|Investigator Decision|2
5349871|NCT00065156|18396326|P1|Overall Study|Disease Progression|7
5349872|NCT00065156|18396326|P1|Overall Study|Study Closed by Sponsor|2
5349873|NCT00065156|18396326|P1|Overall Study|Death|11
5349874|NCT00065156|18396326|P1|Overall Study|Lost to Follow-up|1
5349875|NCT00065156|18396326|P1|Overall Study|Withdrawal by Subject|8
5349876|NCT00065156|18396326|P1|Overall Study|Lack of Efficacy|52
5349877|NCT00065156|18396326|P1|Overall Study|Adverse Event|37
5349878|NCT00065065|18396343|P2|Overall Study|Other|2
5349879|NCT00065065|18396344|P1|Overall Study|Other|2
5349880|NCT00065065|18396343|P2|Overall Study|Lack of Efficacy|11
5349881|NCT00065065|18396344|P1|Overall Study|Lack of Efficacy|4
5349882|NCT00065065|18396343|P2|Overall Study|Withdrawal by Subject|5
5349883|NCT00065065|18396344|P1|Overall Study|Withdrawal by Subject|1
5349884|NCT00065065|18396343|P2|Overall Study|Adverse Event|2
5349885|NCT00065065|18396344|P1|Overall Study|Adverse Event|3
5349886|NCT00003895|18396356|P2|Overall Study|Withdrawal by Subject|3
5349887|NCT00003895|18396357|P1|Overall Study|Withdrawal by Subject|0
5349888|NCT00003895|18396356|P2|Overall Study|Patient Vacation|0
5349889|NCT00003895|18396357|P1|Overall Study|Patient Vacation|2
5349890|NCT00003895|18396356|P2|Overall Study|Lack of Efficacy|1
5349891|NCT00003895|18396357|P1|Overall Study|Lack of Efficacy|1
5349892|NCT00003895|18396356|P2|Overall Study|Adverse Event|0
5349893|NCT00003895|18396357|P1|Overall Study|Adverse Event|4
5349894|NCT00064987|18396365|P2|Overall Study|Physician Decision|0
5349895|NCT00064987|18396366|P1|Overall Study|Physician Decision|3
5349896|NCT00064753|18396397|P2|Overall Study|Lost to Follow-up|235
5349897|NCT00064753|18396398|P1|Overall Study|Lost to Follow-up|225
5349898|NCT00064753|18396397|P2|Overall Study|Withdrawal by Subject|171
5349899|NCT00064753|18396398|P1|Overall Study|Withdrawal by Subject|198
5349900|NCT00064753|18396397|P2|Overall Study|Death|242
5349901|NCT00064753|18396398|P1|Overall Study|Death|251
5349902|NCT00003645|18396428|P2|Overall Study|Withdrawal by Subject|3
5349903|NCT00003645|18396429|P1|Overall Study|Withdrawal by Subject|1
5349904|NCT00003645|18396428|P2|Overall Study|Lost to Follow-up|8
5349905|NCT00003645|18396429|P1|Overall Study|Lost to Follow-up|7
5349906|NCT00003645|18396428|P2|Overall Study|Death|1
5349907|NCT00003645|18396429|P1|Overall Study|Death|4
5349908|NCT00064792|18396443|P2|Overall Study|Adverse Event|0
5349909|NCT00064792|18396444|P1|Overall Study|Adverse Event|3
5349910|NCT00064792|18396443|P2|Overall Study|Withdrawal by Subject|0
5349911|NCT00064792|18396444|P1|Overall Study|Withdrawal by Subject|2
5349912|NCT00064701|18396455|P3|Clinical Continuation Phase|Patient opted out|1
5349913|NCT00064701|18396456|P2|Clinical Continuation Phase|Patient opted out|0
5349914|NCT00064701|18396457|P1|Clinical Continuation Phase|Patient opted out|0
5349915|NCT00064701|18396455|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
5349916|NCT00064701|18396456|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
5349917|NCT00064701|18396457|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
5349918|NCT00064701|18396455|P3|Clinical Continuation Phase|Discharged to nursing home|0
5349919|NCT00064701|18396456|P2|Clinical Continuation Phase|Discharged to nursing home|1
5349920|NCT00064701|18396457|P1|Clinical Continuation Phase|Discharged to nursing home|0
5349921|NCT00064701|18396455|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
5349922|NCT00064701|18396456|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
5349923|NCT00064701|18396457|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
5349924|NCT00064701|18396455|P3|Clinical Continuation Phase|Pancreas transplant|0
5349925|NCT00064701|18396456|P2|Clinical Continuation Phase|Pancreas transplant|0
5349926|NCT00064701|18396457|P1|Clinical Continuation Phase|Pancreas transplant|1
5349927|NCT00064701|18396455|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
5349928|NCT00064701|18396456|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
5349929|NCT00064701|18396457|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
5349930|NCT00064701|18396455|P3|Clinical Continuation Phase|Physician Decision|0
5349931|NCT00064701|18396456|P2|Clinical Continuation Phase|Physician Decision|3
5349932|NCT00064701|18396457|P1|Clinical Continuation Phase|Physician Decision|1
5349933|NCT00064701|18396455|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
5349934|NCT00064701|18396456|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
5349935|NCT00064701|18396457|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
5349936|NCT00064701|18396455|P3|Clinical Continuation Phase|Sponsor discontinued study|79
5349937|NCT00064701|18396456|P2|Clinical Continuation Phase|Sponsor discontinued study|129
5349938|NCT00064701|18396457|P1|Clinical Continuation Phase|Sponsor discontinued study|113
5349939|NCT00064701|18396455|P3|Clinical Continuation Phase|Rejection|2
5349940|NCT00064701|18396456|P2|Clinical Continuation Phase|Rejection|2
5349941|NCT00064701|18396457|P1|Clinical Continuation Phase|Rejection|1
5349942|NCT00064701|18396455|P3|Clinical Continuation Phase|Graft Failure|2
5349943|NCT00064701|18396456|P2|Clinical Continuation Phase|Graft Failure|5
5349944|NCT00064701|18396457|P1|Clinical Continuation Phase|Graft Failure|5
5349945|NCT00064701|18396455|P3|Clinical Continuation Phase|Lost to Follow-up|6
5349946|NCT00064701|18396456|P2|Clinical Continuation Phase|Lost to Follow-up|3
5349947|NCT00064701|18396457|P1|Clinical Continuation Phase|Lost to Follow-up|6
5349948|NCT00064701|18396455|P3|Clinical Continuation Phase|Withdrawal by Subject|22
5349949|NCT00064701|18396456|P2|Clinical Continuation Phase|Withdrawal by Subject|3
5349950|NCT00064701|18396457|P1|Clinical Continuation Phase|Withdrawal by Subject|22
5349951|NCT00064701|18396455|P3|Clinical Continuation Phase|Non-compliance|7
5349952|NCT00064701|18396456|P2|Clinical Continuation Phase|Non-compliance|6
5349953|NCT00064701|18396457|P1|Clinical Continuation Phase|Non-compliance|8
5349954|NCT00064701|18396455|P3|Clinical Continuation Phase|Adverse Event|14
5349955|NCT00064701|18396456|P2|Clinical Continuation Phase|Adverse Event|21
5349956|NCT00064701|18396457|P1|Clinical Continuation Phase|Adverse Event|12
5349957|NCT00064701|18396455|P3|One Year Post-transplant|Pancreas transplant|1
5349958|NCT00064701|18396456|P2|One Year Post-transplant|Pancreas transplant|0
5349959|NCT00064701|18396457|P1|One Year Post-transplant|Pancreas transplant|0
5349960|NCT00064701|18396455|P3|One Year Post-transplant|Poor absorption|0
5349961|NCT00064701|18396456|P2|One Year Post-transplant|Poor absorption|1
5349962|NCT00064701|18396457|P1|One Year Post-transplant|Poor absorption|0
5349963|NCT00064701|18396455|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
5349964|NCT00064701|18396456|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
5349965|NCT00064701|18396457|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
5349966|NCT00064701|18396455|P3|One Year Post-transplant|Incorrect study drug dispensed|0
5349967|NCT00064701|18396456|P2|One Year Post-transplant|Incorrect study drug dispensed|1
5349968|NCT00064701|18396457|P1|One Year Post-transplant|Incorrect study drug dispensed|0
5349969|NCT00064701|18396455|P3|One Year Post-transplant|Acute tubular necrosis|0
5349970|NCT00064701|18396456|P2|One Year Post-transplant|Acute tubular necrosis|0
5349971|NCT00064701|18396457|P1|One Year Post-transplant|Acute tubular necrosis|1
5349972|NCT00064701|18396455|P3|One Year Post-transplant|Converted to rapamycin|0
5349973|NCT00064701|18396456|P2|One Year Post-transplant|Converted to rapamycin|0
5349974|NCT00064701|18396457|P1|One Year Post-transplant|Converted to rapamycin|1
5349975|NCT00064701|18396455|P3|One Year Post-transplant|Lost to Follow-up|0
5349976|NCT00064701|18396456|P2|One Year Post-transplant|Lost to Follow-up|0
5349977|NCT00064701|18396457|P1|One Year Post-transplant|Lost to Follow-up|1
5349978|NCT00064701|18396455|P3|One Year Post-transplant|Withdrawal by Subject|1
5349979|NCT00064701|18396456|P2|One Year Post-transplant|Withdrawal by Subject|4
5349980|NCT00064701|18396457|P1|One Year Post-transplant|Withdrawal by Subject|0
5349981|NCT00064701|18396455|P3|One Year Post-transplant|Graft Failure|1
5349982|NCT00064701|18396456|P2|One Year Post-transplant|Graft Failure|2
5349983|NCT00064701|18396457|P1|One Year Post-transplant|Graft Failure|3
5349984|NCT00064701|18396455|P3|One Year Post-transplant|Non-compliance|5
5349985|NCT00064701|18396456|P2|One Year Post-transplant|Non-compliance|2
5349986|NCT00064701|18396457|P1|One Year Post-transplant|Non-compliance|4
5349987|NCT00064701|18396455|P3|One Year Post-transplant|Rejection|16
5349988|NCT00064701|18396456|P2|One Year Post-transplant|Rejection|1
5349989|NCT00064701|18396457|P1|One Year Post-transplant|Rejection|0
5349990|NCT00064701|18396455|P3|One Year Post-transplant|Adverse Event|37
5349991|NCT00064701|18396456|P2|One Year Post-transplant|Adverse Event|19
5349992|NCT00064701|18396457|P1|One Year Post-transplant|Adverse Event|23
5349993|NCT00064701|18396455|P3|One Year Post-transplant|Did not receive study drug|11
5349994|NCT00064701|18396456|P2|One Year Post-transplant|Did not receive study drug|12
5349995|NCT00064701|18396457|P1|One Year Post-transplant|Did not receive study drug|7
5349996|NCT00064662|18396509|P2|Overall Study|Administratively withdrawn|2
5349997|NCT00064662|18396510|P1|Overall Study|Administratively withdrawn|2
5349998|NCT00064662|18396509|P2|Overall Study|Withdrawal by Subject|14
5349999|NCT00064662|18396510|P1|Overall Study|Withdrawal by Subject|14
5350000|NCT00064662|18396509|P2|Overall Study|Lost to Follow-up|44
5350001|NCT00064662|18396510|P1|Overall Study|Lost to Follow-up|57
5350002|NCT00064662|18396509|P2|Overall Study|Death|1
5350003|NCT00064662|18396510|P1|Overall Study|Death|1
5350004|NCT00064350|18396521|P3|Cross-Over|Other|0
5350005|NCT00064350|18396522|P2|Cross-Over|Other|2
5350006|NCT00064350|18396523|P1|Cross-Over|Other|0
5350007|NCT00064350|18396521|P3|Cross-Over|Ineligible or never started treatment|0
5350008|NCT00064350|18396522|P2|Cross-Over|Ineligible or never started treatment|6
5350009|NCT00064350|18396523|P1|Cross-Over|Ineligible or never started treatment|3
5350010|NCT00064350|18396521|P3|Cross-Over|Withdrawal by Subject|0
5350011|NCT00064350|18396522|P2|Cross-Over|Withdrawal by Subject|2
5350012|NCT00064350|18396523|P1|Cross-Over|Withdrawal by Subject|2
5350013|NCT00064350|18396521|P3|Cross-Over|Death|0
5350014|NCT00064350|18396522|P2|Cross-Over|Death|3
5350015|NCT00064350|18396523|P1|Cross-Over|Death|1
5350016|NCT00064350|18396521|P3|Cross-Over|Adverse Event|0
5350017|NCT00064350|18396522|P2|Cross-Over|Adverse Event|1
5350018|NCT00064350|18396523|P1|Cross-Over|Adverse Event|0
5350019|NCT00064350|18396521|P3|Randomization|Other|0
5350020|NCT00064350|18396522|P2|Randomization|Other|0
5350021|NCT00064350|18396523|P1|Randomization|Other|5
5350022|NCT00064350|18396521|P3|Randomization|Ineligible or never started treatment|0
5350023|NCT00064350|18396522|P2|Randomization|Ineligible or never started treatment|15
5350024|NCT00064350|18396523|P1|Randomization|Ineligible or never started treatment|9
5350025|NCT00064350|18396521|P3|Randomization|Withdrawal by Subject|0
5350026|NCT00064350|18396522|P2|Randomization|Withdrawal by Subject|0
5350027|NCT00064350|18396523|P1|Randomization|Withdrawal by Subject|1
5350028|NCT00064350|18396521|P3|Randomization|Death|0
5350029|NCT00064350|18396522|P2|Randomization|Death|0
5350030|NCT00064350|18396523|P1|Randomization|Death|3
5350031|NCT00064350|18396521|P3|Randomization|Adverse Event|0
5350032|NCT00064350|18396522|P2|Randomization|Adverse Event|3
5350033|NCT00064350|18396523|P1|Randomization|Adverse Event|8
5350034|NCT00064350|18396521|P3|Induction Treatment|Other|13
5350035|NCT00064350|18396522|P2|Induction Treatment|Other|0
5350036|NCT00064350|18396523|P1|Induction Treatment|Other|0
5350037|NCT00064350|18396521|P3|Induction Treatment|Ineligible or never started treatment|34
5350038|NCT00064350|18396522|P2|Induction Treatment|Ineligible or never started treatment|6
5350039|NCT00064350|18396523|P1|Induction Treatment|Ineligible or never started treatment|3
5350040|NCT00064350|18396521|P3|Induction Treatment|Withdrawal by Subject|21
5350041|NCT00064350|18396522|P2|Induction Treatment|Withdrawal by Subject|0
5350042|NCT00064350|18396523|P1|Induction Treatment|Withdrawal by Subject|0
5350043|NCT00064350|18396521|P3|Induction Treatment|Death|9
5350044|NCT00064350|18396522|P2|Induction Treatment|Death|0
5350045|NCT00064350|18396523|P1|Induction Treatment|Death|0
5350046|NCT00064350|18396521|P3|Induction Treatment|Adverse Event|49
5350047|NCT00064350|18396522|P2|Induction Treatment|Adverse Event|2
5350048|NCT00064350|18396523|P1|Induction Treatment|Adverse Event|0
5350049|NCT00064350|18396521|P3|Induction Treatment|Disease Progression|110
5350050|NCT00064350|18396522|P2|Induction Treatment|Disease Progression|1
5350051|NCT00064350|18396523|P1|Induction Treatment|Disease Progression|5
5350052|NCT00064337|18396538|P1|Maintenance|Death|1
5350053|NCT00064337|18396538|P1|Maintenance|Not protocol-specified|2
5350054|NCT00064337|18396538|P1|Maintenance|On treatment at time of analysis|2
5350055|NCT00064337|18396538|P1|Maintenance|Progression|2
5350056|NCT00064337|18396538|P1|Maintenance|Adverse Event|3
5350057|NCT00064337|18396538|P1|Transplant|Progression|2
5350058|NCT00064337|18396538|P1|Transplant|Patient Refusal|2
5350059|NCT00064337|18396538|P1|Transplant|Death|3
5350060|NCT00064337|18396538|P1|Transplant|Not protocol-specified|5
5350061|NCT00064337|18396538|P1|Transplant|Adverse Event|9
5350062|NCT00064337|18396538|P1|PBSCC or Induction/PBSCC|Death|2
5350063|NCT00064337|18396538|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
5350064|NCT00064337|18396538|P1|PBSCC or Induction/PBSCC|Progression|3
5350065|NCT00064337|18396538|P1|PBSCC or Induction/PBSCC|Adverse Event|6
5350066|NCT00064337|18396538|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
5350067|NCT00064298|18396547|P2|Overall Study|Disease Progression|1
5350068|NCT00064298|18396548|P1|Overall Study|Disease Progression|2
5350069|NCT00064298|18396547|P2|Overall Study|Death|1
5350070|NCT00064298|18396548|P1|Overall Study|Death|0
5350071|NCT00064298|18396547|P2|Overall Study|Lost to Follow-up|2
5350072|NCT00064298|18396548|P1|Overall Study|Lost to Follow-up|2
5350073|NCT00064298|18396547|P2|Overall Study|Withdrawal by Subject|1
5350074|NCT00064298|18396548|P1|Overall Study|Withdrawal by Subject|2
5350075|NCT00064259|18396556|P4|Overall Study|Adverse Event|1
5350076|NCT00064259|18396557|P3|Overall Study|Adverse Event|0
5350077|NCT00064259|18396558|P2|Overall Study|Adverse Event|0
5350078|NCT00064259|18396559|P1|Overall Study|Adverse Event|1
5350079|NCT00064077|18396567|P4|Overall Study|Other reasons|2
5350080|NCT00064077|18396568|P3|Overall Study|Other reasons|1
5350081|NCT00064077|18396569|P2|Overall Study|Other reasons|2
5350082|NCT00064077|18396570|P1|Overall Study|Other reasons|2
5350083|NCT00064077|18396567|P4|Overall Study|No tumor|0
5350084|NCT00064077|18396568|P3|Overall Study|No tumor|1
5350085|NCT00064077|18396569|P2|Overall Study|No tumor|0
5350086|NCT00064077|18396570|P1|Overall Study|No tumor|0
5350087|NCT00064077|18396567|P4|Overall Study|No surgery|0
5350088|NCT00064077|18396568|P3|Overall Study|No surgery|1
5350089|NCT00064077|18396569|P2|Overall Study|No surgery|0
5350090|NCT00064077|18396570|P1|Overall Study|No surgery|0
5350091|NCT00064077|18396567|P4|Overall Study|Pathology|4
5350092|NCT00064077|18396568|P3|Overall Study|Pathology|3
5350093|NCT00064077|18396569|P2|Overall Study|Pathology|7
5350094|NCT00064077|18396570|P1|Overall Study|Pathology|10
5350095|NCT00064077|18396567|P4|Overall Study|Poor risk|1
5350096|NCT00064077|18396568|P3|Overall Study|Poor risk|1
5350097|NCT00064077|18396569|P2|Overall Study|Poor risk|0
5350098|NCT00064077|18396570|P1|Overall Study|Poor risk|2
5350099|NCT00064077|18396567|P4|Overall Study|Improper prior treatment|0
5350100|NCT00064077|18396568|P3|Overall Study|Improper prior treatment|0
5350101|NCT00064077|18396569|P2|Overall Study|Improper prior treatment|0
5350102|NCT00064077|18396570|P1|Overall Study|Improper prior treatment|1
5350103|NCT00064025|18396614|P1|Overall Study|Inevaluable|3
5350104|NCT00064025|18396614|P1|Overall Study|Ineligible|4
5350105|NCT00063999|18396623|P2|Overall Study|Ineligible|24
5350106|NCT00063999|18396624|P1|Overall Study|Ineligible|44
5350107|NCT00063999|18396623|P2|Overall Study|Withdrawal by Subject|0
5350108|NCT00063999|18396624|P1|Overall Study|Withdrawal by Subject|1
5350109|NCT00063986|18396640|P1|Overall Study|Intra-operatively ineligible|4
5350110|NCT00063986|18396640|P1|Overall Study|Ineligible|1
5350111|NCT00063986|18396640|P1|Overall Study|Withdrawal by Subject|1
5350112|NCT00063934|18396652|P1|Overall Study|Ineligible|1
5350113|NCT00063882|18396661|P2|Overall Study|Withdrawal by Subject|1
5350114|NCT00063882|18396662|P1|Overall Study|Withdrawal by Subject|2
5350115|NCT00063882|18396661|P2|Overall Study|Protocol Violation|3
5350116|NCT00063882|18396662|P1|Overall Study|Protocol Violation|3
5350117|NCT00063258|18396789|P2|Overall Study|Lack of Efficacy|0
5350118|NCT00063258|18396790|P1|Overall Study|Lack of Efficacy|2
5350119|NCT00063258|18396789|P2|Overall Study|Physician Decision|0
5350120|NCT00063258|18396790|P1|Overall Study|Physician Decision|2
5350121|NCT00063154|18396796|P1|Overall Study|Did not receive treatment|8
5350122|NCT00063154|18396796|P1|Overall Study|Reason unspecified|1
5350123|NCT00063154|18396796|P1|Overall Study|Death|3
5350124|NCT00063154|18396796|P1|Overall Study|Physician Decision|10
5350125|NCT00063154|18396796|P1|Overall Study|Adverse Event|2
5350126|NCT00063154|18396796|P1|Overall Study|Disease progression|27
5350127|NCT00062868|18396830|P21|Dose Level 3|Withdrew|0
5350128|NCT00062868|18396831|P20|Dose Level 3|Withdrew|0
5350129|NCT00062868|18396832|P19|Dose Level 3|Withdrew|0
5350130|NCT00062868|18396833|P18|Dose Level 3|Withdrew|0
5350131|NCT00062868|18396834|P17|Dose Level 3|Withdrew|0
5350132|NCT00062868|18396835|P16|Dose Level 3|Withdrew|0
5350133|NCT00062868|18396836|P15|Dose Level 3|Withdrew|0
5350134|NCT00062868|18396837|P14|Dose Level 3|Withdrew|0
5350135|NCT00062868|18396838|P13|Dose Level 3|Withdrew|0
5350136|NCT00062868|18396839|P12|Dose Level 3|Withdrew|0
5350137|NCT00062868|18396840|P11|Dose Level 3|Withdrew|0
5350138|NCT00062868|18396841|P10|Dose Level 3|Withdrew|0
5350139|NCT00062868|18396842|P9|Dose Level 3|Withdrew|0
5350140|NCT00062868|18396843|P8|Dose Level 3|Withdrew|0
5350141|NCT00062868|18396844|P7|Dose Level 3|Withdrew|0
5350142|NCT00062868|18396845|P6|Dose Level 3|Withdrew|0
5350143|NCT00062868|18396846|P5|Dose Level 3|Withdrew|0
5350144|NCT00062868|18396847|P4|Dose Level 3|Withdrew|0
5350145|NCT00062868|18396848|P3|Dose Level 3|Withdrew|2
5350146|NCT00062868|18396849|P2|Dose Level 3|Withdrew|0
5350147|NCT00062868|18396850|P1|Dose Level 3|Withdrew|0
5350148|NCT00062868|18396830|P21|Dose Level 3|Lost to Follow-up|0
5350149|NCT00062868|18396831|P20|Dose Level 3|Lost to Follow-up|0
5350150|NCT00062868|18396832|P19|Dose Level 3|Lost to Follow-up|0
5350151|NCT00062868|18396833|P18|Dose Level 3|Lost to Follow-up|0
5350152|NCT00062868|18396834|P17|Dose Level 3|Lost to Follow-up|0
5350153|NCT00062868|18396835|P16|Dose Level 3|Lost to Follow-up|0
5350154|NCT00062868|18396836|P15|Dose Level 3|Lost to Follow-up|1
5350155|NCT00062868|18396837|P14|Dose Level 3|Lost to Follow-up|0
5350156|NCT00062868|18396838|P13|Dose Level 3|Lost to Follow-up|0
5350157|NCT00062868|18396839|P12|Dose Level 3|Lost to Follow-up|0
5350158|NCT00062868|18396840|P11|Dose Level 3|Lost to Follow-up|0
5350159|NCT00062868|18396841|P10|Dose Level 3|Lost to Follow-up|0
5350160|NCT00062868|18396842|P9|Dose Level 3|Lost to Follow-up|0
5350161|NCT00062868|18396843|P8|Dose Level 3|Lost to Follow-up|0
5350162|NCT00062868|18396844|P7|Dose Level 3|Lost to Follow-up|0
5350163|NCT00062868|18396845|P6|Dose Level 3|Lost to Follow-up|0
5350164|NCT00062868|18396846|P5|Dose Level 3|Lost to Follow-up|0
5350165|NCT00062868|18396847|P4|Dose Level 3|Lost to Follow-up|0
5350166|NCT00062868|18396848|P3|Dose Level 3|Lost to Follow-up|0
5350167|NCT00062868|18396849|P2|Dose Level 3|Lost to Follow-up|0
5350168|NCT00062868|18396850|P1|Dose Level 3|Lost to Follow-up|0
5350169|NCT00062868|18396830|P21|Dose Level 3|Death|0
5350170|NCT00062868|18396831|P20|Dose Level 3|Death|0
5350171|NCT00062868|18396832|P19|Dose Level 3|Death|0
5350172|NCT00062868|18396833|P18|Dose Level 3|Death|1
5350173|NCT00062868|18396834|P17|Dose Level 3|Death|0
5350174|NCT00062868|18396835|P16|Dose Level 3|Death|0
5350175|NCT00062868|18396836|P15|Dose Level 3|Death|0
5350176|NCT00062868|18396837|P14|Dose Level 3|Death|0
5350177|NCT00062868|18396838|P13|Dose Level 3|Death|0
5350178|NCT00062868|18396839|P12|Dose Level 3|Death|1
5350179|NCT00062868|18396840|P11|Dose Level 3|Death|0
5350180|NCT00062868|18396841|P10|Dose Level 3|Death|0
5350181|NCT00062868|18396842|P9|Dose Level 3|Death|0
5350182|NCT00062868|18396843|P8|Dose Level 3|Death|0
5350183|NCT00062868|18396844|P7|Dose Level 3|Death|0
5350184|NCT00062868|18396845|P6|Dose Level 3|Death|0
5350185|NCT00062868|18396846|P5|Dose Level 3|Death|0
5350186|NCT00062868|18396847|P4|Dose Level 3|Death|0
5350187|NCT00062868|18396848|P3|Dose Level 3|Death|0
5350188|NCT00062868|18396849|P2|Dose Level 3|Death|0
5350189|NCT00062868|18396850|P1|Dose Level 3|Death|0
5350190|NCT00062868|18396830|P21|Dose Level 2|Lost to Follow-up|0
5350191|NCT00062868|18396831|P20|Dose Level 2|Lost to Follow-up|0
5350192|NCT00062868|18396832|P19|Dose Level 2|Lost to Follow-up|0
5350193|NCT00062868|18396833|P18|Dose Level 2|Lost to Follow-up|0
5350194|NCT00062868|18396834|P17|Dose Level 2|Lost to Follow-up|1
5350195|NCT00062868|18396835|P16|Dose Level 2|Lost to Follow-up|0
5350196|NCT00062868|18396836|P15|Dose Level 2|Lost to Follow-up|0
5350197|NCT00062868|18396837|P14|Dose Level 2|Lost to Follow-up|1
5350198|NCT00062868|18396838|P13|Dose Level 2|Lost to Follow-up|0
5350199|NCT00062868|18396839|P12|Dose Level 2|Lost to Follow-up|0
5350200|NCT00062868|18396840|P11|Dose Level 2|Lost to Follow-up|0
5350201|NCT00062868|18396841|P10|Dose Level 2|Lost to Follow-up|0
5350202|NCT00062868|18396842|P9|Dose Level 2|Lost to Follow-up|0
5350203|NCT00062868|18396843|P8|Dose Level 2|Lost to Follow-up|0
5350204|NCT00062868|18396844|P7|Dose Level 2|Lost to Follow-up|0
5350205|NCT00062868|18396845|P6|Dose Level 2|Lost to Follow-up|0
5350206|NCT00062868|18396846|P5|Dose Level 2|Lost to Follow-up|0
5350207|NCT00062868|18396847|P4|Dose Level 2|Lost to Follow-up|0
5350208|NCT00062868|18396848|P3|Dose Level 2|Lost to Follow-up|0
5350209|NCT00062868|18396849|P2|Dose Level 2|Lost to Follow-up|0
5350210|NCT00062868|18396850|P1|Dose Level 2|Lost to Follow-up|0
5350211|NCT00062868|18396830|P21|Dose Level 2|Death|0
5350212|NCT00062868|18396831|P20|Dose Level 2|Death|0
5350213|NCT00062868|18396832|P19|Dose Level 2|Death|0
5350214|NCT00062868|18396833|P18|Dose Level 2|Death|0
5350215|NCT00062868|18396834|P17|Dose Level 2|Death|2
5350216|NCT00062868|18396835|P16|Dose Level 2|Death|0
5350217|NCT00062868|18396836|P15|Dose Level 2|Death|0
5350218|NCT00062868|18396837|P14|Dose Level 2|Death|0
5350219|NCT00062868|18396838|P13|Dose Level 2|Death|0
5350220|NCT00062868|18396839|P12|Dose Level 2|Death|0
5350221|NCT00062868|18396840|P11|Dose Level 2|Death|1
5350222|NCT00062868|18396841|P10|Dose Level 2|Death|0
5350223|NCT00062868|18396842|P9|Dose Level 2|Death|0
5350224|NCT00062868|18396843|P8|Dose Level 2|Death|0
5350225|NCT00062868|18396844|P7|Dose Level 2|Death|0
5350226|NCT00062868|18396845|P6|Dose Level 2|Death|0
5350227|NCT00062868|18396846|P5|Dose Level 2|Death|2
5350228|NCT00062868|18396847|P4|Dose Level 2|Death|0
5350229|NCT00062868|18396848|P3|Dose Level 2|Death|0
5350230|NCT00062868|18396849|P2|Dose Level 2|Death|3
5350231|NCT00062868|18396850|P1|Dose Level 2|Death|0
5350232|NCT00062868|18396830|P21|Dose Level 1|Lost to Follow-up|1
5350233|NCT00062868|18396831|P20|Dose Level 1|Lost to Follow-up|0
5350234|NCT00062868|18396832|P19|Dose Level 1|Lost to Follow-up|2
5350235|NCT00062868|18396833|P18|Dose Level 1|Lost to Follow-up|0
5350236|NCT00062868|18396834|P17|Dose Level 1|Lost to Follow-up|0
5350237|NCT00062868|18396835|P16|Dose Level 1|Lost to Follow-up|0
5350238|NCT00062868|18396836|P15|Dose Level 1|Lost to Follow-up|0
5350239|NCT00062868|18396837|P14|Dose Level 1|Lost to Follow-up|0
5350240|NCT00062868|18396838|P13|Dose Level 1|Lost to Follow-up|1
5350241|NCT00062868|18396839|P12|Dose Level 1|Lost to Follow-up|0
5350242|NCT00062868|18396840|P11|Dose Level 1|Lost to Follow-up|0
5350243|NCT00062868|18396841|P10|Dose Level 1|Lost to Follow-up|0
5350244|NCT00062868|18396842|P9|Dose Level 1|Lost to Follow-up|0
5350245|NCT00062868|18396843|P8|Dose Level 1|Lost to Follow-up|0
5350246|NCT00062868|18396844|P7|Dose Level 1|Lost to Follow-up|0
5350247|NCT00062868|18396845|P6|Dose Level 1|Lost to Follow-up|0
5350248|NCT00062868|18396846|P5|Dose Level 1|Lost to Follow-up|0
5350249|NCT00062868|18396847|P4|Dose Level 1|Lost to Follow-up|0
5350250|NCT00062868|18396848|P3|Dose Level 1|Lost to Follow-up|0
5350251|NCT00062868|18396849|P2|Dose Level 1|Lost to Follow-up|0
5350252|NCT00062868|18396850|P1|Dose Level 1|Lost to Follow-up|0
5350253|NCT00062868|18396830|P21|Dose Level 1|Death|1
5350254|NCT00062868|18396831|P20|Dose Level 1|Death|0
5350255|NCT00062868|18396832|P19|Dose Level 1|Death|7
5350256|NCT00062868|18396833|P18|Dose Level 1|Death|0
5350257|NCT00062868|18396834|P17|Dose Level 1|Death|0
5350258|NCT00062868|18396835|P16|Dose Level 1|Death|0
5350259|NCT00062868|18396836|P15|Dose Level 1|Death|0
5350260|NCT00062868|18396837|P14|Dose Level 1|Death|0
5350261|NCT00062868|18396838|P13|Dose Level 1|Death|0
5350262|NCT00062868|18396839|P12|Dose Level 1|Death|0
5350263|NCT00062868|18396840|P11|Dose Level 1|Death|0
5350264|NCT00062868|18396841|P10|Dose Level 1|Death|0
5350265|NCT00062868|18396842|P9|Dose Level 1|Death|0
5350266|NCT00062868|18396843|P8|Dose Level 1|Death|0
5350267|NCT00062868|18396844|P7|Dose Level 1|Death|3
5350268|NCT00062868|18396845|P6|Dose Level 1|Death|0
5350269|NCT00062868|18396846|P5|Dose Level 1|Death|0
5350270|NCT00062868|18396847|P4|Dose Level 1|Death|2
5350271|NCT00062868|18396848|P3|Dose Level 1|Death|0
5350272|NCT00062868|18396849|P2|Dose Level 1|Death|0
5350273|NCT00062868|18396850|P1|Dose Level 1|Death|2
5350274|NCT00062751|18396949|P5|Overall Study|Death|0
5350275|NCT00062751|18396950|P4|Overall Study|Death|0
5350276|NCT00062751|18396951|P3|Overall Study|Death|1
5350277|NCT00062751|18396952|P2|Overall Study|Death|0
5350278|NCT00062751|18396953|P1|Overall Study|Death|1
5350279|NCT00062751|18396949|P5|Overall Study|Symptomatic deterioration|1
5350280|NCT00062751|18396950|P4|Overall Study|Symptomatic deterioration|0
5350281|NCT00062751|18396951|P3|Overall Study|Symptomatic deterioration|0
5350282|NCT00062751|18396952|P2|Overall Study|Symptomatic deterioration|1
5350283|NCT00062751|18396953|P1|Overall Study|Symptomatic deterioration|1
5350284|NCT00062751|18396949|P5|Overall Study|Withdrawal by Subject|0
5350285|NCT00062751|18396950|P4|Overall Study|Withdrawal by Subject|1
5350286|NCT00062751|18396951|P3|Overall Study|Withdrawal by Subject|2
5350287|NCT00062751|18396952|P2|Overall Study|Withdrawal by Subject|2
5350288|NCT00062751|18396953|P1|Overall Study|Withdrawal by Subject|1
5350289|NCT00062751|18396949|P5|Overall Study|Other|1
5350290|NCT00062751|18396950|P4|Overall Study|Other|0
5350291|NCT00062751|18396951|P3|Overall Study|Other|1
5350292|NCT00062751|18396952|P2|Overall Study|Other|3
5350293|NCT00062751|18396953|P1|Overall Study|Other|2
5350294|NCT00062751|18396949|P5|Overall Study|Adverse Event|2
5350295|NCT00062751|18396950|P4|Overall Study|Adverse Event|2
5350296|NCT00062751|18396951|P3|Overall Study|Adverse Event|2
5350297|NCT00062751|18396952|P2|Overall Study|Adverse Event|7
5350298|NCT00062751|18396953|P1|Overall Study|Adverse Event|4
5350299|NCT00062751|18396949|P5|Overall Study|Disease progression|2
5350300|NCT00062751|18396950|P4|Overall Study|Disease progression|2
5350301|NCT00062751|18396951|P3|Overall Study|Disease progression|24
5350302|NCT00062751|18396952|P2|Overall Study|Disease progression|17
5350303|NCT00062751|18396953|P1|Overall Study|Disease progression|24
5350304|NCT00062647|18397039|P2|Overall Study|Never received study treatment|1
5350305|NCT00062647|18397040|P1|Overall Study|Never received study treatment|1
5350306|NCT00062647|18397039|P2|Overall Study|Other|4
5350307|NCT00062647|18397040|P1|Overall Study|Other|4
5350308|NCT00062647|18397039|P2|Overall Study|Failed continuation criteria|2
5350309|NCT00062647|18397040|P1|Overall Study|Failed continuation criteria|4
5350310|NCT00062647|18397039|P2|Overall Study|Lost to Follow-up|2
5350311|NCT00062647|18397040|P1|Overall Study|Lost to Follow-up|1
5350312|NCT00062647|18397039|P2|Overall Study|Protocol Violation|0
5350313|NCT00062647|18397040|P1|Overall Study|Protocol Violation|1
5350314|NCT00062647|18397039|P2|Overall Study|Withdrawal by Subject|1
5350315|NCT00062647|18397040|P1|Overall Study|Withdrawal by Subject|2
5350316|NCT00062647|18397039|P2|Overall Study|Adverse Event|1
5350317|NCT00062647|18397040|P1|Overall Study|Adverse Event|1
5350318|NCT00062647|18397039|P2|Overall Study|Death|2
5350319|NCT00062647|18397040|P1|Overall Study|Death|2
5350320|NCT00062439|18397046|P1|Consolidation Chemotherapy|Adverse Event|2
5350321|NCT00062439|18397046|P1|Surgery|Adverse Event|2
5350322|NCT00062439|18397046|P1|Surgery|Death|1
5350323|NCT00062439|18397046|P1|Surgery|Physician Decision|4
5350324|NCT00062439|18397046|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
5350325|NCT00062439|18397046|P1|Post Chemoradiation Assessment|Physician Decision|1
5350326|NCT00062439|18397046|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
5350327|NCT00062439|18397046|P1|Post Chemoradiation Assessment|Disease progression|2
5350328|NCT00062439|18397046|P1|Post Chemoradiation Assessment|Death|1
5350329|NCT00062439|18397046|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
5350330|NCT00062439|18397046|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
5350331|NCT00062439|18397046|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
5350332|NCT00062439|18397046|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
5350333|NCT00062374|18397058|P1|Overall Study|Not treated|12
5350334|NCT00062166|18397063|P1|Overall Study|Withdrawal by Subject|6
5350335|NCT00062010|18397071|P1|Overall Study|Ineligible|3
5350336|NCT00061945|18397079|P2|Course IV: Alemtuzumab|Early exits|15
5350337|NCT00061945|18397080|P1|Course IV: Alemtuzumab|Early exits|6
5350338|NCT00061945|18397079|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
5350339|NCT00061945|18397080|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
5350340|NCT00061945|18397079|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
5350341|NCT00061945|18397080|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
5350342|NCT00061945|18397079|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
5350343|NCT00061945|18397080|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
5350344|NCT00061932|18397090|P2|Overall Study|Withdrawal by Subject|4
5350345|NCT00061932|18397091|P1|Overall Study|Withdrawal by Subject|13
5350346|NCT00061633|18397104|P2|Overall Study|Never received study treatment|2
5350347|NCT00061633|18397105|P1|Overall Study|Never received study treatment|0
5350348|NCT00061633|18397104|P2|Overall Study|Other|1
5350349|NCT00061633|18397105|P1|Overall Study|Other|1
5350350|NCT00061633|18397104|P2|Overall Study|Lost to Follow-up|4
5350351|NCT00061633|18397105|P1|Overall Study|Lost to Follow-up|1
5350352|NCT00061633|18397104|P2|Overall Study|Withdrawal by Subject|2
5350353|NCT00061633|18397105|P1|Overall Study|Withdrawal by Subject|2
5350354|NCT00061633|18397104|P2|Overall Study|Adverse Event|2
5350355|NCT00061633|18397105|P1|Overall Study|Adverse Event|1
5350356|NCT00061048|18397130|P1|Overall Study|disease progression|20
5350357|NCT00061048|18397130|P1|Overall Study|Adverse Event|2
5350358|NCT00060944|18397140|P2|Overall Study|randomized but not treated|4
5350359|NCT00060944|18397141|P1|Overall Study|randomized but not treated|6
5350360|NCT00060944|18397140|P2|Overall Study|Other|4
5350361|NCT00060944|18397141|P1|Overall Study|Other|2
5350362|NCT00060944|18397140|P2|Overall Study|Treatment Switch|13
5350363|NCT00060944|18397141|P1|Overall Study|Treatment Switch|0
5350364|NCT00060944|18397140|P2|Overall Study|Subject Ineligible To Continue|1
5350365|NCT00060944|18397141|P1|Overall Study|Subject Ineligible To Continue|2
5350366|NCT00060944|18397140|P2|Overall Study|Lost to Follow-up|0
5350367|NCT00060944|18397141|P1|Overall Study|Lost to Follow-up|1
5350368|NCT00060944|18397140|P2|Overall Study|Disease Progression|94
5350369|NCT00060944|18397141|P1|Overall Study|Disease Progression|93
5350370|NCT00060944|18397140|P2|Overall Study|Withdrawal by Subject|5
5350371|NCT00060944|18397141|P1|Overall Study|Withdrawal by Subject|18
5350372|NCT00060944|18397140|P2|Overall Study|Death|3
5350373|NCT00060944|18397141|P1|Overall Study|Death|2
5350374|NCT00060944|18397140|P2|Overall Study|Adverse Event|10
5350375|NCT00060944|18397141|P1|Overall Study|Adverse Event|12
5350376|NCT00060840|18397157|P2|Overall Study|Other|0
5350377|NCT00060840|18397158|P1|Overall Study|Other|1
5350378|NCT00060840|18397157|P2|Overall Study|Physician Decision|0
5350379|NCT00060840|18397158|P1|Overall Study|Physician Decision|1
5350380|NCT00060840|18397157|P2|Overall Study|Subinvestigator unavailable|1
5350381|NCT00060840|18397158|P1|Overall Study|Subinvestigator unavailable|0
5350382|NCT00060840|18397157|P2|Overall Study|Withdrawal by Subject|1
5350383|NCT00060840|18397158|P1|Overall Study|Withdrawal by Subject|0
5350384|NCT00060840|18397157|P2|Overall Study|Death|1
5350385|NCT00060840|18397158|P1|Overall Study|Death|0
5350386|NCT00060840|18397157|P2|Overall Study|Change in surgical plan|6
5350387|NCT00060840|18397158|P1|Overall Study|Change in surgical plan|2
5350388|NCT00059839|18397224|P2|Overall Study|Ineligible|3
5350389|NCT00059839|18397225|P1|Overall Study|Ineligible|1
5350390|NCT00059839|18397224|P2|Overall Study|Withdrawal by Subject|6
5350391|NCT00059839|18397225|P1|Overall Study|Withdrawal by Subject|1
5350392|NCT00059839|18397224|P2|Overall Study|Physician Decision|2
5350393|NCT00059839|18397225|P1|Overall Study|Physician Decision|1
5350394|NCT00059839|18397224|P2|Overall Study|Lost to Follow-up|0
5350395|NCT00059839|18397225|P1|Overall Study|Lost to Follow-up|2
5350396|NCT00059839|18397224|P2|Overall Study|Lack of Efficacy|5
5350397|NCT00059839|18397225|P1|Overall Study|Lack of Efficacy|6
5350398|NCT00059839|18397224|P2|Overall Study|Death|1
5350399|NCT00059839|18397225|P1|Overall Study|Death|1
5350400|NCT00059787|18397231|P1|Overall Study|Other|4
5350401|NCT00059787|18397231|P1|Overall Study|ineligible|1
5350402|NCT00059787|18397231|P1|Overall Study|disease progression|2
5350403|NCT00059787|18397231|P1|Overall Study|Adverse Event|13
5350404|NCT00059332|18397282|P2|Overall Study|Lost to Follow-up|1
5350405|NCT00059332|18397283|P1|Overall Study|Lost to Follow-up|1
5350406|NCT00059332|18397282|P2|Overall Study|Withdrawal by Subject|1
5350407|NCT00059332|18397283|P1|Overall Study|Withdrawal by Subject|2
5350408|NCT00059215|18397309|P4|Overall Study|Physician Decision|1
5350409|NCT00059215|18397310|P3|Overall Study|Physician Decision|1
5350410|NCT00059215|18397311|P2|Overall Study|Physician Decision|2
5350411|NCT00059215|18397312|P1|Overall Study|Physician Decision|1
5350412|NCT00059215|18397309|P4|Overall Study|Protocol entry criteria not met|2
5350413|NCT00059215|18397310|P3|Overall Study|Protocol entry criteria not met|0
5350414|NCT00059215|18397311|P2|Overall Study|Protocol entry criteria not met|1
5350415|NCT00059215|18397312|P1|Overall Study|Protocol entry criteria not met|1
5350416|NCT00059215|18397309|P4|Overall Study|Protocol Violation|0
5350417|NCT00059215|18397310|P3|Overall Study|Protocol Violation|1
5350418|NCT00059215|18397311|P2|Overall Study|Protocol Violation|0
5350419|NCT00059215|18397312|P1|Overall Study|Protocol Violation|1
5350420|NCT00059215|18397309|P4|Overall Study|Withdrawal by Subject|3
5350421|NCT00059215|18397310|P3|Overall Study|Withdrawal by Subject|1
5350422|NCT00059215|18397311|P2|Overall Study|Withdrawal by Subject|4
5350423|NCT00059215|18397312|P1|Overall Study|Withdrawal by Subject|4
5350424|NCT00059215|18397309|P4|Overall Study|Lost to Follow-up|0
5350425|NCT00059215|18397310|P3|Overall Study|Lost to Follow-up|0
5350426|NCT00059215|18397311|P2|Overall Study|Lost to Follow-up|2
5350427|NCT00059215|18397312|P1|Overall Study|Lost to Follow-up|1
5350428|NCT00059215|18397309|P4|Overall Study|Death|0
5350429|NCT00059215|18397310|P3|Overall Study|Death|3
5350430|NCT00059215|18397311|P2|Overall Study|Death|0
5350431|NCT00059215|18397312|P1|Overall Study|Death|0
5350432|NCT00059215|18397309|P4|Overall Study|Adverse Event|9
5350433|NCT00059215|18397310|P3|Overall Study|Adverse Event|9
5350434|NCT00059215|18397311|P2|Overall Study|Adverse Event|5
5350435|NCT00059215|18397312|P1|Overall Study|Adverse Event|5
5350436|NCT00058825|18397349|P1|Overall Study|Death|3
5350437|NCT00058825|18397349|P1|Overall Study|Graft Failure|5
5350438|NCT00058825|18397349|P1|Overall Study|Progressive Disease|5
5350439|NCT00058825|18397349|P1|Overall Study|Relapse|9
5350440|NCT00058552|18397365|P2|Overall Study|Clinical disease progression|4
5350441|NCT00058552|18397366|P1|Overall Study|Clinical disease progression|0
5350442|NCT00058552|18397365|P2|Overall Study|Physician Decision|5
5350443|NCT00058552|18397366|P1|Overall Study|Physician Decision|2
5350444|NCT00058552|18397365|P2|Overall Study|Withdrawal by Subject|5
5350445|NCT00058552|18397366|P1|Overall Study|Withdrawal by Subject|3
5350446|NCT00058552|18397365|P2|Overall Study|Adverse Event|2
5350447|NCT00058552|18397366|P1|Overall Study|Adverse Event|4
5350448|NCT00058552|18397365|P2|Overall Study|Disease progression|44
5350449|NCT00058552|18397366|P1|Overall Study|Disease progression|52
5350450|NCT00058552|18397365|P2|Overall Study|Died prior to receiving treatment|2
5350451|NCT00058552|18397366|P1|Overall Study|Died prior to receiving treatment|4
5350452|NCT00058539|18397384|P1|Overall Study|Death|1
5350453|NCT00058539|18397384|P1|Overall Study|Physician Decision|9
5350454|NCT00058539|18397384|P1|Overall Study|Withdrawal by Subject|5
5350455|NCT00058539|18397384|P1|Overall Study|Adverse Event|3
5350456|NCT00058539|18397384|P1|Overall Study|Disease progression|24
5350457|NCT00058422|18397394|P1|Overall Study|Not treated|2
5350458|NCT00058214|18397425|P1|Overall Study|Adverse Event|1
5350459|NCT00058123|18397447|P1|Overall Study|Received >3 prior treatments|1
5350460|NCT00058123|18397447|P1|Overall Study|Wrong histology|9
5350461|NCT00058058|18397454|P1|Overall Study|Poor positioning, illness,pain|3
5350462|NCT00058058|18397454|P1|Overall Study|technical issues|6
5350463|NCT00058058|18397454|P1|Overall Study|Claustrophobic|5
5350464|NCT00058058|18397454|P1|Overall Study|Ineligible|20
5350465|NCT00058058|18397454|P1|Overall Study|Withdrawal by Subject|4
5350466|NCT00057954|18397479|P1|Overall Study|Disease progression|1
5350467|NCT00057954|18397479|P1|Overall Study|Death|1
5350468|NCT00057941|18397487|P2|Overall Study|Ineligible|5
5350469|NCT00057941|18397488|P1|Overall Study|Ineligible|2
5350470|NCT00057941|18397487|P2|Overall Study|insurance, symptomatic deterioration|3
5350471|NCT00057941|18397488|P1|Overall Study|insurance, symptomatic deterioration|1
5350472|NCT00057941|18397487|P2|Overall Study|still on treatment|1
5350473|NCT00057941|18397488|P1|Overall Study|still on treatment|3
5350474|NCT00057941|18397487|P2|Overall Study|Withdrawal by Subject|1
5350475|NCT00057941|18397488|P1|Overall Study|Withdrawal by Subject|6
5350476|NCT00057941|18397487|P2|Overall Study|Lack of Efficacy|53
5350477|NCT00057941|18397488|P1|Overall Study|Lack of Efficacy|54
5350478|NCT00057941|18397487|P2|Overall Study|Adverse Event|9
5350479|NCT00057941|18397488|P1|Overall Study|Adverse Event|7
5350480|NCT00057941|18397487|P2|Overall Study|Death|2
5350481|NCT00057941|18397488|P1|Overall Study|Death|1
5350482|NCT00057876|18397496|P2|Overall Study|other complicating disease|0
5350483|NCT00057876|18397497|P1|Overall Study|other complicating disease|1
5350484|NCT00057876|18397496|P2|Overall Study|other reason|2
5350485|NCT00057876|18397497|P1|Overall Study|other reason|2
5350486|NCT00057876|18397496|P2|Overall Study|Ineligible|2
5350487|NCT00057876|18397497|P1|Overall Study|Ineligible|1
5350488|NCT00057876|18397496|P2|Overall Study|Lack of Efficacy|8
5350489|NCT00057876|18397497|P1|Overall Study|Lack of Efficacy|10
5350490|NCT00057876|18397496|P2|Overall Study|Withdrawal by Subject|6
5350491|NCT00057876|18397497|P1|Overall Study|Withdrawal by Subject|5
5350492|NCT00057876|18397496|P2|Overall Study|Death|1
5350493|NCT00057876|18397497|P1|Overall Study|Death|2
5350494|NCT00057876|18397496|P2|Overall Study|Adverse Event|8
5350495|NCT00057876|18397497|P1|Overall Study|Adverse Event|8
5350496|NCT00057863|18397507|P1|Overall Study|Withdrawal by Subject|2
5350497|NCT00057863|18397507|P1|Overall Study|Death|1
5350498|NCT00057837|18397516|P2|Overall Study|Never started treatment|1
5350499|NCT00057837|18397517|P1|Overall Study|Never started treatment|1
5350500|NCT00057837|18397516|P2|Overall Study|Ineligible|3
5350501|NCT00057837|18397517|P1|Overall Study|Ineligible|3
5350502|NCT00057837|18397516|P2|Overall Study|Physician Decision|0
5350503|NCT00057837|18397517|P1|Overall Study|Physician Decision|1
5350504|NCT00057837|18397516|P2|Overall Study|Other complicating disease|1
5350505|NCT00057837|18397517|P1|Overall Study|Other complicating disease|2
5350506|NCT00057837|18397516|P2|Overall Study|Alternative therapy|1
5350507|NCT00057837|18397517|P1|Overall Study|Alternative therapy|0
5350508|NCT00057837|18397516|P2|Overall Study|Withdrawal by Subject|3
5350509|NCT00057837|18397517|P1|Overall Study|Withdrawal by Subject|5
5350510|NCT00057837|18397516|P2|Overall Study|Death|4
5350511|NCT00057837|18397517|P1|Overall Study|Death|5
5350512|NCT00057837|18397516|P2|Overall Study|Adverse Event|12
5350513|NCT00057837|18397517|P1|Overall Study|Adverse Event|2
5350514|NCT00057837|18397516|P2|Overall Study|Progression/relapse|14
5350515|NCT00057837|18397517|P1|Overall Study|Progression/relapse|12
5350516|NCT00057811|18397529|P2|Overall Study|Inevaluable|2
5350517|NCT00057811|18397530|P1|Overall Study|Inevaluable|1
5350518|NCT00057811|18397529|P2|Overall Study|Ineligible|2
5350519|NCT00057811|18397530|P1|Overall Study|Ineligible|4
5350520|NCT00057811|18397529|P2|Overall Study|Withdrawal by Subject|4
5350521|NCT00057811|18397530|P1|Overall Study|Withdrawal by Subject|3
5350522|NCT00057811|18397529|P2|Overall Study|Physician Decision|0
5350523|NCT00057811|18397530|P1|Overall Study|Physician Decision|1
5350524|NCT00057811|18397529|P2|Overall Study|Lack of Efficacy|4
5350525|NCT00057811|18397530|P1|Overall Study|Lack of Efficacy|1
5350526|NCT00057746|18397549|P3|Overall Study|Withdrawal by Subject|1
5350527|NCT00057746|18397550|P2|Overall Study|Withdrawal by Subject|0
5350528|NCT00057746|18397551|P1|Overall Study|Withdrawal by Subject|0
5350529|NCT00023673|18397562|P4|Overall Study|Patient withdrew consent|1
5350530|NCT00023673|18397563|P3|Overall Study|Patient withdrew consent|0
5350531|NCT00023673|18397564|P2|Overall Study|Patient withdrew consent|0
5350532|NCT00023673|18397565|P1|Overall Study|Patient withdrew consent|0
5350533|NCT00023673|18397562|P4|Overall Study|Ineligible / no protocol treatment|1
5350534|NCT00023673|18397563|P3|Overall Study|Ineligible / no protocol treatment|0
5350535|NCT00023673|18397564|P2|Overall Study|Ineligible / no protocol treatment|0
5350536|NCT00023673|18397565|P1|Overall Study|Ineligible / no protocol treatment|0
5350537|NCT00057330|18397629|P2|Overall Study|Other|206
5350538|NCT00057330|18397630|P1|Overall Study|Other|260
5350539|NCT00057330|18397629|P2|Overall Study|Physician Decision|0
5350540|NCT00057330|18397630|P1|Overall Study|Physician Decision|1
5350541|NCT00057330|18397629|P2|Overall Study|Lost to Follow-up|617
5350542|NCT00057330|18397630|P1|Overall Study|Lost to Follow-up|745
5350543|NCT00057330|18397629|P2|Overall Study|Withdrawal by Subject|84
5350544|NCT00057330|18397630|P1|Overall Study|Withdrawal by Subject|115
5350545|NCT00057330|18397629|P2|Overall Study|Protocol Violation|1
5350546|NCT00057330|18397630|P1|Overall Study|Protocol Violation|1
5350547|NCT00057330|18397629|P2|Overall Study|Death|0
5350548|NCT00057330|18397630|P1|Overall Study|Death|1
5350549|NCT00057330|18397629|P2|Overall Study|Adverse Event|12
5350550|NCT00057330|18397630|P1|Overall Study|Adverse Event|9
5350551|NCT00056862|18397660|P2|Overall Study|Protocol Violation|0
5350552|NCT00056862|18397661|P1|Overall Study|Protocol Violation|1
5350553|NCT00056407|18397719|P2|Overall Study|Missing|34
5350554|NCT00056407|18397720|P1|Overall Study|Missing|25
5350555|NCT00056407|18397719|P2|Overall Study|"Listed as Other on Case Report Form"|60
5350556|NCT00056407|18397720|P1|Overall Study|"Listed as Other on Case Report Form"|98
5350557|NCT00056407|18397719|P2|Overall Study|Diagnosed with Prostate Cancer|166
5350558|NCT00056407|18397720|P1|Overall Study|Diagnosed with Prostate Cancer|202
5350559|NCT00056407|18397719|P2|Overall Study|Protocol Violation|95
5350560|NCT00056407|18397720|P1|Overall Study|Protocol Violation|104
5350561|NCT00056407|18397719|P2|Overall Study|Lost to Follow-up|113
5350562|NCT00056407|18397720|P1|Overall Study|Lost to Follow-up|123
5350563|NCT00056407|18397719|P2|Overall Study|Withdrawal by Subject|361
5350564|NCT00056407|18397720|P1|Overall Study|Withdrawal by Subject|377
5350565|NCT00056407|18397719|P2|Overall Study|Adverse Event|364
5350566|NCT00056407|18397720|P1|Overall Study|Adverse Event|282
5350567|NCT00056316|18397778|P2|Overall Study|Death/NH placement of pt|1
5350568|NCT00056316|18397779|P1|Overall Study|Death/NH placement of pt|1
5350569|NCT00056316|18397778|P2|Overall Study|Withdrawal by Subject|2
5350570|NCT00056316|18397779|P1|Overall Study|Withdrawal by Subject|2
5350571|NCT00056160|18397793|P2|Final Follow-up|Adverse Event|0
5350572|NCT00056160|18397794|P1|Final Follow-up|Adverse Event|1
5350573|NCT00056160|18397793|P2|Final Follow-up|Transferred into RevAssist Program|0
5350574|NCT00056160|18397794|P1|Final Follow-up|Transferred into RevAssist Program|2
5350575|NCT00056160|18397793|P2|Final Follow-up|Transferred into expanded access study.|0
5350576|NCT00056160|18397794|P1|Final Follow-up|Transferred into expanded access study.|3
5350577|NCT00056160|18397793|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
5350578|NCT00056160|18397794|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
5350579|NCT00056160|18397793|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
5350580|NCT00056160|18397794|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
5350581|NCT00056160|18397793|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
5350582|NCT00056160|18397794|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
5350583|NCT00056160|18397793|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
5350584|NCT00056160|18397794|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
5350585|NCT00056160|18397793|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
5350586|NCT00056160|18397794|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
5350587|NCT00056160|18397793|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
5350588|NCT00056160|18397794|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
5350589|NCT00056160|18397793|P2|Up to Unblinding (07 Jun 2005)|Other|7
5350590|NCT00056160|18397794|P1|Up to Unblinding (07 Jun 2005)|Other|8
5350591|NCT00056160|18397793|P2|Up to Unblinding (07 Jun 2005)|Death|1
5350592|NCT00056160|18397794|P1|Up to Unblinding (07 Jun 2005)|Death|2
5350593|NCT00056160|18397793|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
5350594|NCT00056160|18397794|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
5350595|NCT00056160|18397793|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
5350596|NCT00056160|18397794|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
5350597|NCT00056160|18397793|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
5350598|NCT00056160|18397794|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
5350599|NCT00056160|18397793|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
5350600|NCT00056160|18397794|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
5350601|NCT00055601|18397817|P2|Overall Study|No protocol treatment received|1
5350602|NCT00055601|18397818|P1|Overall Study|No protocol treatment received|1
5350603|NCT00055601|18397817|P2|Overall Study|Protocol Violation|1
5350604|NCT00055601|18397818|P1|Overall Study|Protocol Violation|1
5350605|NCT00055497|18397832|P4|Overall Study|Other|11
5350606|NCT00055497|18397833|P3|Overall Study|Other|0
5350607|NCT00055497|18397834|P2|Overall Study|Other|0
5350608|NCT00055497|18397835|P1|Overall Study|Other|0
5350609|NCT00055497|18397832|P4|Overall Study|Administrative Reasons|1
5350610|NCT00055497|18397833|P3|Overall Study|Administrative Reasons|0
5350611|NCT00055497|18397834|P2|Overall Study|Administrative Reasons|0
5350612|NCT00055497|18397835|P1|Overall Study|Administrative Reasons|0
5350613|NCT00055497|18397832|P4|Overall Study|Lack of Efficacy|27
5350614|NCT00055497|18397833|P3|Overall Study|Lack of Efficacy|0
5350615|NCT00055497|18397834|P2|Overall Study|Lack of Efficacy|0
5350616|NCT00055497|18397835|P1|Overall Study|Lack of Efficacy|1
5350617|NCT00055497|18397832|P4|Overall Study|Protocol Violation|3
5350618|NCT00055497|18397833|P3|Overall Study|Protocol Violation|0
5350619|NCT00055497|18397834|P2|Overall Study|Protocol Violation|0
5350620|NCT00055497|18397835|P1|Overall Study|Protocol Violation|0
5350621|NCT00055497|18397832|P4|Overall Study|Lost to Follow-up|5
5350622|NCT00055497|18397833|P3|Overall Study|Lost to Follow-up|0
5350623|NCT00055497|18397834|P2|Overall Study|Lost to Follow-up|1
5350624|NCT00055497|18397835|P1|Overall Study|Lost to Follow-up|0
5350625|NCT00055497|18397832|P4|Overall Study|Withdrawal by Subject|15
5350626|NCT00055497|18397833|P3|Overall Study|Withdrawal by Subject|1
5350627|NCT00055497|18397834|P2|Overall Study|Withdrawal by Subject|1
5350628|NCT00055497|18397835|P1|Overall Study|Withdrawal by Subject|3
5350629|NCT00055497|18397832|P4|Overall Study|Adverse Event|28
5350630|NCT00055497|18397833|P3|Overall Study|Adverse Event|1
5350631|NCT00055497|18397834|P2|Overall Study|Adverse Event|1
5350632|NCT00055497|18397835|P1|Overall Study|Adverse Event|1
5350633|NCT00055471|18397880|P3|Period 1: Dose Escalation Period|Disease progression|0
5350634|NCT00055471|18397881|P2|Period 1: Dose Escalation Period|Disease progression|1
5350635|NCT00055471|18397882|P1|Period 1: Dose Escalation Period|Disease progression|0
5350636|NCT00055471|18397880|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
5350637|NCT00055471|18397881|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
5350638|NCT00055471|18397882|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
5350639|NCT00055471|18397880|P3|Period 1: Dose Escalation Period|Adverse Event|2
5350640|NCT00055471|18397881|P2|Period 1: Dose Escalation Period|Adverse Event|1
5350641|NCT00055471|18397882|P1|Period 1: Dose Escalation Period|Adverse Event|0
5350642|NCT00054717|18397937|P2|Overall Study|Other reason not defined above|217
5350643|NCT00054717|18397938|P1|Overall Study|Other reason not defined above|117
5350644|NCT00054717|18397937|P2|Overall Study|Withdrawal by Subject|20
5350645|NCT00054717|18397938|P1|Overall Study|Withdrawal by Subject|32
5350646|NCT00054717|18397937|P2|Overall Study|Lost to Follow-up|13
5350647|NCT00054717|18397938|P1|Overall Study|Lost to Follow-up|23
5350648|NCT00054717|18397937|P2|Overall Study|Protocol Violation|19
5350649|NCT00054717|18397938|P1|Overall Study|Protocol Violation|18
5350650|NCT00054717|18397937|P2|Overall Study|Adverse Event|22
5350651|NCT00054717|18397938|P1|Overall Study|Adverse Event|70
5350652|NCT00054717|18397937|P2|Overall Study|Randomized but not treated|8
5350653|NCT00054717|18397938|P1|Overall Study|Randomized but not treated|2
5350654|NCT00054704|18398126|P2|Overall Study|Lost to Follow-up|1
5350655|NCT00054704|18398127|P1|Overall Study|Lost to Follow-up|0
5350656|NCT00054704|18398126|P2|Overall Study|Adverse Event|1
5350657|NCT00054704|18398127|P1|Overall Study|Adverse Event|3
5350658|NCT00054704|18398126|P2|Overall Study|Lack of Efficacy|3
5350659|NCT00054704|18398127|P1|Overall Study|Lack of Efficacy|2
5350660|NCT00054691|18398133|P1|Overall Study|Noncompliant|1
5350661|NCT00054691|18398133|P1|Overall Study|Unmeasurable Disease|2
5350662|NCT00054639|18398147|P1|Overall Study|Physician Decision|1
5350663|NCT00054639|18398147|P1|Overall Study|Lack of Efficacy|1
5350664|NCT00054327|18398180|P6|Overall Study|Engraftment failure|0
5350665|NCT00054327|18398181|P5|Overall Study|Engraftment failure|0
5350666|NCT00054327|18398182|P4|Overall Study|Engraftment failure|0
5350667|NCT00054327|18398183|P3|Overall Study|Engraftment failure|0
5350668|NCT00054327|18398184|P2|Overall Study|Engraftment failure|0
5350669|NCT00054327|18398185|P1|Overall Study|Engraftment failure|1
5350670|NCT00054275|18398223|P1|Overall Study|Physician Decision|1
5350671|NCT00054275|18398223|P1|Overall Study|Progressive disease in cycle 1|1
5350672|NCT00054275|18398223|P1|Overall Study|Adverse Event|5
5350673|NCT00054275|18398223|P1|Overall Study|Withdrawal by Subject|4
5350674|NCT00054132|18398229|P1|Overall Study|Not Treated|1
5350675|NCT00053898|18398256|P2|Overall Study|Follow-up from telephone contact only|1
5350676|NCT00053898|18398257|P1|Overall Study|Follow-up from telephone contact only|5
5350677|NCT00053898|18398256|P2|Overall Study|No follow-up data from any source|12
5350678|NCT00053898|18398257|P1|Overall Study|No follow-up data from any source|9
5350679|NCT00053846|18398283|P2|Overall Study|Pills too large|1
5350680|NCT00053846|18398284|P1|Overall Study|Pills too large|0
5350681|NCT00053846|18398283|P2|Overall Study|Quit due to side effects|3
5350682|NCT00053846|18398284|P1|Overall Study|Quit due to side effects|1
5350683|NCT00053846|18398283|P2|Overall Study|Did not return data|2
5350684|NCT00053846|18398284|P1|Overall Study|Did not return data|1
5350685|NCT00053846|18398283|P2|Overall Study|Became ineligible|1
5350686|NCT00053846|18398284|P1|Overall Study|Became ineligible|3
5350687|NCT00053846|18398283|P2|Overall Study|Expired|0
5350688|NCT00053846|18398284|P1|Overall Study|Expired|5
5350689|NCT00053846|18398283|P2|Overall Study|Became too ill|7
5350690|NCT00053846|18398284|P1|Overall Study|Became too ill|8
5350691|NCT00053846|18398283|P2|Overall Study|Changed mind|13
5350692|NCT00053846|18398284|P1|Overall Study|Changed mind|8
5350693|NCT00053417|18398443|P4|Overall Study|Lost to Follow-up|0
5350694|NCT00053417|18398444|P3|Overall Study|Lost to Follow-up|0
5350695|NCT00053417|18398445|P2|Overall Study|Lost to Follow-up|1
5350696|NCT00053417|18398446|P1|Overall Study|Lost to Follow-up|1
5350697|NCT00053417|18398443|P4|Overall Study|Withdrawal by Subject|0
5350698|NCT00053417|18398444|P3|Overall Study|Withdrawal by Subject|0
5350699|NCT00053417|18398445|P2|Overall Study|Withdrawal by Subject|1
5350700|NCT00053417|18398446|P1|Overall Study|Withdrawal by Subject|0
5350701|NCT00053417|18398443|P4|Overall Study|Non-Compliance|1
5350702|NCT00053417|18398444|P3|Overall Study|Non-Compliance|0
5350703|NCT00053417|18398445|P2|Overall Study|Non-Compliance|0
5350704|NCT00053417|18398446|P1|Overall Study|Non-Compliance|0
5350705|NCT00053417|18398443|P4|Overall Study|Adverse Event|5
5350706|NCT00053417|18398444|P3|Overall Study|Adverse Event|1
5350707|NCT00053417|18398445|P2|Overall Study|Adverse Event|0
5350708|NCT00053417|18398446|P1|Overall Study|Adverse Event|1
5350709|NCT00053365|18398456|P1|Overall Study|Never treated|4
5350710|NCT00053365|18398456|P1|Overall Study|Platinum-sensitive interval >12 months|1
5350711|NCT00053365|18398456|P1|Overall Study|Incorrect cell type|1
5350712|NCT00053352|18398465|P2|Overall Study|Disease at new site|0
5350713|NCT00053352|18398466|P1|Overall Study|Disease at new site|1
5350714|NCT00053352|18398465|P2|Overall Study|Ineligible|8
5350715|NCT00053352|18398466|P1|Overall Study|Ineligible|8
5350716|NCT00053352|18398465|P2|Overall Study|Withdrawal by Subject|0
5350717|NCT00053352|18398466|P1|Overall Study|Withdrawal by Subject|1
5350718|NCT00053352|18398465|P2|Overall Study|Physician Decision|1
5350719|NCT00053352|18398466|P1|Overall Study|Physician Decision|11
5350720|NCT00053352|18398465|P2|Overall Study|Lost to Follow-up|1
5350721|NCT00053352|18398466|P1|Overall Study|Lost to Follow-up|0
5350722|NCT00003830|18398482|P2|Overall Study|Sentinel node positive patients|793
5350723|NCT00003830|18398483|P1|Overall Study|Sentinel node positive patients|829
5350724|NCT00003830|18398482|P2|Overall Study|No follow up data|0
5350725|NCT00003830|18398483|P1|Overall Study|No follow up data|3
5350726|NCT00052962|18398509|P2|Overall Study|Not randomized/not evaluable|0
5350727|NCT00052962|18398510|P1|Overall Study|Not randomized/not evaluable|1
5350728|NCT00052962|18398509|P2|Overall Study|Not evaluable|2
5350729|NCT00052962|18398510|P1|Overall Study|Not evaluable|0
5350730|NCT00052715|18398529|P1|Overall Study|wrong histology|1
5350731|NCT00049673|18398545|P2|Overall Study|No receive treatment/lost to follow-up|3
5350732|NCT00049673|18398546|P1|Overall Study|No receive treatment/lost to follow-up|1
5350733|NCT00049543|18398556|P2|Overall Study|still on treatment|9
5350734|NCT00049543|18398557|P1|Overall Study|still on treatment|2
5350735|NCT00049530|18398567|P1|Overall Study|ineligible|3
5350736|NCT00049530|18398567|P1|Overall Study|symptomatic deterioration|1
5350737|NCT00049530|18398567|P1|Overall Study|Death|1
5350738|NCT00049530|18398567|P1|Overall Study|Adverse Event|2
5350739|NCT00049530|18398567|P1|Overall Study|Lack of Efficacy|25
5350740|NCT00049517|18398576|P6|Conditioning/Transplant|Reasons not reported|5
5350741|NCT00049517|18398577|P5|Conditioning/Transplant|Reasons not reported|5
5350742|NCT00049517|18398578|P4|Conditioning/Transplant|Reasons not reported|15
5350743|NCT00049517|18398579|P3|Conditioning/Transplant|Reasons not reported|18
5350744|NCT00049517|18398580|P2|Conditioning/Transplant|Reasons not reported|31
5350745|NCT00049517|18398581|P1|Conditioning/Transplant|Reasons not reported|25
5350746|NCT00049517|18398576|P6|Conditioning/Transplant|Other complicating disease|1
5350747|NCT00049517|18398577|P5|Conditioning/Transplant|Other complicating disease|0
5350748|NCT00049517|18398578|P4|Conditioning/Transplant|Other complicating disease|4
5350749|NCT00049517|18398579|P3|Conditioning/Transplant|Other complicating disease|0
5350750|NCT00049517|18398580|P2|Conditioning/Transplant|Other complicating disease|0
5350751|NCT00049517|18398581|P1|Conditioning/Transplant|Other complicating disease|2
5350752|NCT00049517|18398576|P6|Conditioning/Transplant|Alternative therapy|0
5350753|NCT00049517|18398577|P5|Conditioning/Transplant|Alternative therapy|1
5350754|NCT00049517|18398578|P4|Conditioning/Transplant|Alternative therapy|1
5350755|NCT00049517|18398579|P3|Conditioning/Transplant|Alternative therapy|2
5350756|NCT00049517|18398580|P2|Conditioning/Transplant|Alternative therapy|4
5350757|NCT00049517|18398581|P1|Conditioning/Transplant|Alternative therapy|4
5350758|NCT00049517|18398576|P6|Conditioning/Transplant|Withdrawal by Subject|0
5350759|NCT00049517|18398577|P5|Conditioning/Transplant|Withdrawal by Subject|0
5350760|NCT00049517|18398578|P4|Conditioning/Transplant|Withdrawal by Subject|7
5350761|NCT00049517|18398579|P3|Conditioning/Transplant|Withdrawal by Subject|4
5350762|NCT00049517|18398580|P2|Conditioning/Transplant|Withdrawal by Subject|8
5350763|NCT00049517|18398581|P1|Conditioning/Transplant|Withdrawal by Subject|4
5350764|NCT00049517|18398576|P6|Conditioning/Transplant|Death|0
5350765|NCT00049517|18398577|P5|Conditioning/Transplant|Death|0
5350766|NCT00049517|18398578|P4|Conditioning/Transplant|Death|2
5350767|NCT00049517|18398579|P3|Conditioning/Transplant|Death|0
5350768|NCT00049517|18398580|P2|Conditioning/Transplant|Death|0
5350769|NCT00049517|18398581|P1|Conditioning/Transplant|Death|1
5350770|NCT00049517|18398576|P6|Conditioning/Transplant|Adverse Event|0
5350771|NCT00049517|18398577|P5|Conditioning/Transplant|Adverse Event|0
5350772|NCT00049517|18398578|P4|Conditioning/Transplant|Adverse Event|8
5350773|NCT00049517|18398579|P3|Conditioning/Transplant|Adverse Event|4
5350774|NCT00049517|18398580|P2|Conditioning/Transplant|Adverse Event|1
5350775|NCT00049517|18398581|P1|Conditioning/Transplant|Adverse Event|2
5350776|NCT00049517|18398576|P6|Conditioning/Transplant|Disease progression|0
5350777|NCT00049517|18398577|P5|Conditioning/Transplant|Disease progression|0
5350778|NCT00049517|18398578|P4|Conditioning/Transplant|Disease progression|6
5350779|NCT00049517|18398579|P3|Conditioning/Transplant|Disease progression|10
5350780|NCT00049517|18398580|P2|Conditioning/Transplant|Disease progression|6
5350781|NCT00049517|18398581|P1|Conditioning/Transplant|Disease progression|14
5350782|NCT00049517|18398576|P6|Induction|Reasons not reported|25
5350783|NCT00049517|18398577|P5|Induction|Reasons not reported|22
5350784|NCT00049517|18398578|P4|Induction|Reasons not reported|0
5350785|NCT00049517|18398579|P3|Induction|Reasons not reported|0
5350786|NCT00049517|18398580|P2|Induction|Reasons not reported|0
5350787|NCT00049517|18398581|P1|Induction|Reasons not reported|0
5350788|NCT00049517|18398576|P6|Induction|Other complicating disease|0
5350789|NCT00049517|18398577|P5|Induction|Other complicating disease|3
5350790|NCT00049517|18398578|P4|Induction|Other complicating disease|0
5350791|NCT00049517|18398579|P3|Induction|Other complicating disease|0
5350792|NCT00049517|18398580|P2|Induction|Other complicating disease|0
5350793|NCT00049517|18398581|P1|Induction|Other complicating disease|0
5350794|NCT00049517|18398576|P6|Induction|Alternative therapy|2
5350795|NCT00049517|18398577|P5|Induction|Alternative therapy|2
5350796|NCT00049517|18398578|P4|Induction|Alternative therapy|0
5350797|NCT00049517|18398579|P3|Induction|Alternative therapy|0
5350798|NCT00049517|18398580|P2|Induction|Alternative therapy|0
5350799|NCT00049517|18398581|P1|Induction|Alternative therapy|0
5350800|NCT00049517|18398576|P6|Induction|Withdrawal by Subject|3
5350801|NCT00049517|18398577|P5|Induction|Withdrawal by Subject|1
5350802|NCT00049517|18398578|P4|Induction|Withdrawal by Subject|0
5350803|NCT00049517|18398579|P3|Induction|Withdrawal by Subject|0
5350804|NCT00049517|18398580|P2|Induction|Withdrawal by Subject|0
5350805|NCT00049517|18398581|P1|Induction|Withdrawal by Subject|0
5350806|NCT00049517|18398576|P6|Induction|Death|6
5350807|NCT00049517|18398577|P5|Induction|Death|9
5350808|NCT00049517|18398578|P4|Induction|Death|0
5350809|NCT00049517|18398579|P3|Induction|Death|0
5350810|NCT00049517|18398580|P2|Induction|Death|0
5350811|NCT00049517|18398581|P1|Induction|Death|0
5350812|NCT00049517|18398576|P6|Induction|Adverse Event|7
5350813|NCT00049517|18398577|P5|Induction|Adverse Event|5
5350814|NCT00049517|18398578|P4|Induction|Adverse Event|0
5350815|NCT00049517|18398579|P3|Induction|Adverse Event|0
5350816|NCT00049517|18398580|P2|Induction|Adverse Event|0
5350817|NCT00049517|18398581|P1|Induction|Adverse Event|0
5350818|NCT00049517|18398576|P6|Induction|Disease progression|11
5350819|NCT00049517|18398577|P5|Induction|Disease progression|18
5350820|NCT00049517|18398578|P4|Induction|Disease progression|0
5350821|NCT00049517|18398579|P3|Induction|Disease progression|0
5350822|NCT00049517|18398580|P2|Induction|Disease progression|0
5350823|NCT00049517|18398581|P1|Induction|Disease progression|0
5350824|NCT00049322|18398599|P2|Overall Study|refused angio|3
5350825|NCT00049322|18398600|P1|Overall Study|refused angio|0
5350826|NCT00049322|18398599|P2|Overall Study|Adverse Event|0
5350827|NCT00049322|18398600|P1|Overall Study|Adverse Event|1
5350828|NCT00049322|18398599|P2|Overall Study|disease burden|3
5350829|NCT00049322|18398600|P1|Overall Study|disease burden|0
5350830|NCT00049257|18398612|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
5350831|NCT00049257|18398612|P1|Carboplatin, Paclitaxel|Death|2
5350832|NCT00049257|18398612|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
5350833|NCT00049257|18398612|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
5350834|NCT00049127|18398624|P5|Overall Study|Withdrawal by Subject|0
5350835|NCT00049127|18398625|P4|Overall Study|Withdrawal by Subject|0
5350836|NCT00049127|18398626|P3|Overall Study|Withdrawal by Subject|1
5350837|NCT00049127|18398627|P2|Overall Study|Withdrawal by Subject|0
5350838|NCT00049127|18398628|P1|Overall Study|Withdrawal by Subject|0
5350839|NCT00048997|18398666|P2|Overall Study|Withdrawal by Subject|1
5350840|NCT00048997|18398667|P1|Overall Study|Withdrawal by Subject|6
5350841|NCT00048997|18398666|P2|Overall Study|Protocol Violation|2
5350842|NCT00048997|18398667|P1|Overall Study|Protocol Violation|7
5350843|NCT00047385|18398690|P2|Overall Study|Eligible for screening but had no screen|492
5350844|NCT00047385|18398691|P1|Overall Study|Eligible for screening but had no screen|260
5350845|NCT00047385|18398690|P2|Overall Study|Lung Cancer diagnosed before screening|3
5350846|NCT00047385|18398691|P1|Overall Study|Lung Cancer diagnosed before screening|5
5350847|NCT00047385|18398690|P2|Overall Study|Death before any screening|5
5350848|NCT00047385|18398691|P1|Overall Study|Death before any screening|2
5350849|NCT00047320|18398709|P1|Overall Study|Ineligible|2
5350850|NCT00047320|18398709|P1|Overall Study|Withdrawal by Subject|9
5350851|NCT00047320|18398709|P1|Overall Study|Physician Decision|8
5350852|NCT00047320|18398709|P1|Overall Study|Lost to Follow-up|1
5350853|NCT00047320|18398709|P1|Overall Study|Lack of Efficacy|8
5350854|NCT00047008|18398724|P2|Overall Study|Ineligible|8
5350855|NCT00047008|18398725|P1|Overall Study|Ineligible|9
5350856|NCT00047008|18398724|P2|Overall Study|Withdrawn consent|3
5350857|NCT00047008|18398725|P1|Overall Study|Withdrawn consent|2
5350858|NCT00046930|18398733|P2|Overall Study|Ineligible|4
5350859|NCT00046930|18398734|P1|Overall Study|Ineligible|12
5350860|NCT00046891|18398749|P2|Overall Study|Adverse Event|5
5350861|NCT00046891|18398750|P1|Overall Study|Adverse Event|5
5350862|NCT00046891|18398749|P2|Overall Study|Withdrawal by Subject|15
5350863|NCT00046891|18398750|P1|Overall Study|Withdrawal by Subject|18
5350864|NCT00046891|18398749|P2|Overall Study|Ineligible|1
5350865|NCT00046891|18398750|P1|Overall Study|Ineligible|1
5350866|NCT00046891|18398749|P2|Overall Study|Cancels|9
5350867|NCT00046891|18398750|P1|Overall Study|Cancels|5
5350868|NCT00046839|18398770|P2|Overall Study|Withdrawal of consent|0
5350869|NCT00046839|18398771|P1|Overall Study|Withdrawal of consent|1
5350870|NCT00046839|18398770|P2|Overall Study|Ineligible / No protocol treatment|2
5350871|NCT00046839|18398771|P1|Overall Study|Ineligible / No protocol treatment|0
5350872|NCT00045734|18398778|P1|Overall Study|Protocol Violation|1
5350873|NCT00045708|18398793|P3|Phase 1|early progressive disease|0
5350874|NCT00045708|18398794|P2|Phase 1|early progressive disease|1
5350875|NCT00045708|18398795|P1|Phase 1|early progressive disease|0
5350876|NCT00045630|18398820|P1|Overall Study|Ineligible|2
5350877|NCT00045630|18398820|P1|Overall Study|Death|1
5350878|NCT00045630|18398820|P1|Overall Study|Progression/relapse|1
5350879|NCT00045630|18398820|P1|Overall Study|Refusal unrelated to adverse event|1
5350880|NCT00045630|18398820|P1|Overall Study|Adverse Event|1
5350881|NCT00045305|18398839|P1|Overall Study|site error|2
5350882|NCT00045305|18398839|P1|Overall Study|Death|3
5350883|NCT00045305|18398839|P1|Overall Study|Adverse Event|3
5350884|NCT00045305|18398839|P1|Overall Study|Lack of Efficacy|6
5350885|NCT00045162|18398850|P2|Overall Study|Other|16
5350886|NCT00045162|18398851|P1|Overall Study|Other|21
5350887|NCT00045162|18398850|P2|Overall Study|Withdrawal by Subject|3
5350888|NCT00045162|18398851|P1|Overall Study|Withdrawal by Subject|5
5350889|NCT00045162|18398850|P2|Overall Study|Death|10
5350890|NCT00045162|18398851|P1|Overall Study|Death|10
5350891|NCT00045162|18398850|P2|Overall Study|Lack of Efficacy|29
5350892|NCT00045162|18398851|P1|Overall Study|Lack of Efficacy|32
5350893|NCT00045162|18398850|P2|Overall Study|Adverse Event|50
5350894|NCT00045162|18398851|P1|Overall Study|Adverse Event|55
5350895|NCT00045162|18398850|P2|Overall Study|Not treated|2
5350896|NCT00045162|18398851|P1|Overall Study|Not treated|7
5350897|NCT00045162|18398850|P2|Overall Study|Ineligible|8
5350898|NCT00045162|18398851|P1|Overall Study|Ineligible|12
5350899|NCT00045110|18398866|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
5350900|NCT00045110|18398867|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
5350901|NCT00045110|18398868|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
5350902|NCT00045110|18398866|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
5350903|NCT00045110|18398867|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
5350904|NCT00045110|18398868|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
5350905|NCT00045110|18398866|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
5350906|NCT00045110|18398867|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
5350907|NCT00045110|18398868|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
5350908|NCT00045032|18398917|P3|Overall Study|Other|105
5350909|NCT00045032|18398918|P2|Overall Study|Other|84
5350910|NCT00045032|18398919|P1|Overall Study|Other|93
5350911|NCT00045032|18398917|P3|Overall Study|Failure to Return|61
5350912|NCT00045032|18398918|P2|Overall Study|Failure to Return|62
5350913|NCT00045032|18398919|P1|Overall Study|Failure to Return|57
5350914|NCT00045032|18398917|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
5350915|NCT00045032|18398918|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
5350916|NCT00045032|18398919|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
5350917|NCT00045032|18398917|P3|Overall Study|Other Protocol Violation|1
5350918|NCT00045032|18398918|P2|Overall Study|Other Protocol Violation|0
5350919|NCT00045032|18398919|P1|Overall Study|Other Protocol Violation|2
5350920|NCT00045032|18398917|P3|Overall Study|Violation of Selection Criteria at Entry|6
5350921|NCT00045032|18398918|P2|Overall Study|Violation of Selection Criteria at Entry|6
5350922|NCT00045032|18398919|P1|Overall Study|Violation of Selection Criteria at Entry|3
5350923|NCT00045032|18398917|P3|Overall Study|Insufficient Therapeutic Response|445
5350924|NCT00045032|18398918|P2|Overall Study|Insufficient Therapeutic Response|437
5350925|NCT00045032|18398919|P1|Overall Study|Insufficient Therapeutic Response|542
5350926|NCT00045032|18398917|P3|Overall Study|Death|17
5350927|NCT00045032|18398918|P2|Overall Study|Death|24
5350928|NCT00045032|18398919|P1|Overall Study|Death|22
5350929|NCT00045032|18398917|P3|Overall Study|Adverse Event/Intercurrent Illness|7
5350930|NCT00045032|18398918|P2|Overall Study|Adverse Event/Intercurrent Illness|2
5350931|NCT00045032|18398919|P1|Overall Study|Adverse Event/Intercurrent Illness|2
5350932|NCT00042991|18399053|P7|Overall Study|Alternative Therapy|0
5350933|NCT00042991|18399054|P6|Overall Study|Alternative Therapy|0
5350934|NCT00042991|18399055|P5|Overall Study|Alternative Therapy|1
5350935|NCT00042991|18399056|P4|Overall Study|Alternative Therapy|0
5350936|NCT00042991|18399057|P3|Overall Study|Alternative Therapy|0
5350937|NCT00042991|18399058|P2|Overall Study|Alternative Therapy|0
5350938|NCT00042991|18399059|P1|Overall Study|Alternative Therapy|0
5350939|NCT00042991|18399053|P7|Overall Study|Disease Progression|2
5350940|NCT00042991|18399054|P6|Overall Study|Disease Progression|4
5350941|NCT00042991|18399055|P5|Overall Study|Disease Progression|1
5350942|NCT00042991|18399056|P4|Overall Study|Disease Progression|2
5350943|NCT00042991|18399057|P3|Overall Study|Disease Progression|2
5350944|NCT00042991|18399058|P2|Overall Study|Disease Progression|29
5350945|NCT00042991|18399059|P1|Overall Study|Disease Progression|5
5350946|NCT00042991|18399053|P7|Overall Study|Withdrawal by Subject|0
5350947|NCT00042991|18399054|P6|Overall Study|Withdrawal by Subject|0
5350948|NCT00042991|18399055|P5|Overall Study|Withdrawal by Subject|1
5350949|NCT00042991|18399056|P4|Overall Study|Withdrawal by Subject|0
5350950|NCT00042991|18399057|P3|Overall Study|Withdrawal by Subject|2
5350951|NCT00042991|18399058|P2|Overall Study|Withdrawal by Subject|7
5350952|NCT00042991|18399059|P1|Overall Study|Withdrawal by Subject|0
5350953|NCT00042991|18399053|P7|Overall Study|Adverse Event|0
5350954|NCT00042991|18399054|P6|Overall Study|Adverse Event|1
5350955|NCT00042991|18399055|P5|Overall Study|Adverse Event|0
5350956|NCT00042991|18399056|P4|Overall Study|Adverse Event|0
5350957|NCT00042991|18399057|P3|Overall Study|Adverse Event|2
5350958|NCT00042991|18399058|P2|Overall Study|Adverse Event|4
5350959|NCT00042991|18399059|P1|Overall Study|Adverse Event|1
5350960|NCT00042939|18399102|P2|Overall Study|Did not start treatment|1
5350961|NCT00042939|18399103|P1|Overall Study|Did not start treatment|2
5350962|NCT00042939|18399102|P2|Overall Study|Treatment break > 4 weeks|1
5350963|NCT00042939|18399103|P1|Overall Study|Treatment break > 4 weeks|0
5350964|NCT00042939|18399102|P2|Overall Study|Still on treatment|0
5350965|NCT00042939|18399103|P1|Overall Study|Still on treatment|1
5350966|NCT00042939|18399102|P2|Overall Study|Patient non-compliance|0
5350967|NCT00042939|18399103|P1|Overall Study|Patient non-compliance|1
5350968|NCT00042939|18399102|P2|Overall Study|Rising ca 19-9|0
5350969|NCT00042939|18399103|P1|Overall Study|Rising ca 19-9|1
5350970|NCT00042939|18399102|P2|Overall Study|QOL diminished|0
5350971|NCT00042939|18399103|P1|Overall Study|QOL diminished|1
5350972|NCT00042939|18399102|P2|Overall Study|Deterioration of health|4
5350973|NCT00042939|18399103|P1|Overall Study|Deterioration of health|3
5350974|NCT00042939|18399102|P2|Overall Study|Ineligible|2
5350975|NCT00042939|18399103|P1|Overall Study|Ineligible|2
5350976|NCT00042939|18399102|P2|Overall Study|Other disease|0
5350977|NCT00042939|18399103|P1|Overall Study|Other disease|1
5350978|NCT00042939|18399102|P2|Overall Study|Withdrawal by Subject|4
5350979|NCT00042939|18399103|P1|Overall Study|Withdrawal by Subject|3
5350980|NCT00042939|18399102|P2|Overall Study|Death|2
5350981|NCT00042939|18399103|P1|Overall Study|Death|3
5350982|NCT00042939|18399102|P2|Overall Study|Adverse Event|7
5350983|NCT00042939|18399103|P1|Overall Study|Adverse Event|6
5350984|NCT00041132|18399117|P1|Overall Study|Physician Decision|2
5350985|NCT00041132|18399117|P1|Overall Study|Withdrawal by Subject|1
5350986|NCT00041132|18399117|P1|Overall Study|Not Eligible|7
5350987|NCT00041132|18399117|P1|Overall Study|Death|1
5350988|NCT00041132|18399117|P1|Overall Study|Adverse Event|19
5350989|NCT00041080|18399152|P2|Overall Study|Ineligible|0
5350990|NCT00041080|18399153|P1|Overall Study|Ineligible|1
5350991|NCT00041080|18399152|P2|Overall Study|Did not start therapy|1
5350992|NCT00041080|18399153|P1|Overall Study|Did not start therapy|1
5350993|NCT00041080|18399152|P2|Overall Study|Concommitant Illness/Other|2
5350994|NCT00041080|18399153|P1|Overall Study|Concommitant Illness/Other|1
5350995|NCT00041080|18399152|P2|Overall Study|Withdrawal by Subject|6
5350996|NCT00041080|18399153|P1|Overall Study|Withdrawal by Subject|6
5350997|NCT00041080|18399152|P2|Overall Study|Adverse Event|1
5350998|NCT00041080|18399153|P1|Overall Study|Adverse Event|21
5350999|NCT00041067|18399159|P1|Overall Study|Ineligible|2
5351000|NCT00041067|18399159|P1|Overall Study|Other reasons|23
5351001|NCT00041067|18399159|P1|Overall Study|Patient refusal|12
5351002|NCT00041067|18399159|P1|Overall Study|Progression|19
5351003|NCT00041067|18399159|P1|Overall Study|Adverse Event|20
5351004|NCT00040742|18399226|P4|Overall Study|Other medical|5
5351005|NCT00040742|18399227|P3|Overall Study|Other medical|5
5351006|NCT00040742|18399228|P2|Overall Study|Other medical|5
5351007|NCT00040742|18399229|P1|Overall Study|Other medical|7
5351008|NCT00040742|18399226|P4|Overall Study|Incomplete Forms|5
5351009|NCT00040742|18399227|P3|Overall Study|Incomplete Forms|4
5351010|NCT00040742|18399228|P2|Overall Study|Incomplete Forms|10
5351011|NCT00040742|18399229|P1|Overall Study|Incomplete Forms|6
5351012|NCT00040742|18399226|P4|Overall Study|Chemotoxicity|2
5351013|NCT00040742|18399227|P3|Overall Study|Chemotoxicity|5
5351014|NCT00040742|18399228|P2|Overall Study|Chemotoxicity|3
5351015|NCT00040742|18399229|P1|Overall Study|Chemotoxicity|4
5351016|NCT00040742|18399226|P4|Overall Study|Withdrawal by Subject|13
5351017|NCT00040742|18399227|P3|Overall Study|Withdrawal by Subject|10
5351018|NCT00040742|18399228|P2|Overall Study|Withdrawal by Subject|15
5351019|NCT00040742|18399229|P1|Overall Study|Withdrawal by Subject|7
5351020|NCT00040742|18399226|P4|Overall Study|Adverse Event|9
5351021|NCT00040742|18399227|P3|Overall Study|Adverse Event|21
5351022|NCT00040742|18399228|P2|Overall Study|Adverse Event|16
5351023|NCT00040742|18399229|P1|Overall Study|Adverse Event|15
5351024|NCT00040742|18399226|P4|Overall Study|Death|0
5351025|NCT00040742|18399227|P3|Overall Study|Death|1
5351026|NCT00040742|18399228|P2|Overall Study|Death|0
5351027|NCT00040742|18399229|P1|Overall Study|Death|0
5351028|NCT00039377|18399243|P4|Initial Registration|Withdrawal by Subject|0
5351029|NCT00039377|18399244|P3|Initial Registration|Withdrawal by Subject|0
5351030|NCT00039377|18399245|P2|Initial Registration|Withdrawal by Subject|0
5351031|NCT00039377|18399246|P1|Initial Registration|Withdrawal by Subject|3
5351032|NCT00039377|18399243|P4|Initial Registration|Received non-protocol therapy|0
5351033|NCT00039377|18399244|P3|Initial Registration|Received non-protocol therapy|0
5351034|NCT00039377|18399245|P2|Initial Registration|Received non-protocol therapy|0
5351035|NCT00039377|18399246|P1|Initial Registration|Received non-protocol therapy|11
5351036|NCT00039377|18399243|P4|Initial Registration|Relapsed|0
5351037|NCT00039377|18399244|P3|Initial Registration|Relapsed|0
5351038|NCT00039377|18399245|P2|Initial Registration|Relapsed|0
5351039|NCT00039377|18399246|P1|Initial Registration|Relapsed|6
5351040|NCT00039377|18399243|P4|Initial Registration|Adverse Event|0
5351041|NCT00039377|18399244|P3|Initial Registration|Adverse Event|0
5351042|NCT00039377|18399245|P2|Initial Registration|Adverse Event|0
5351043|NCT00039377|18399246|P1|Initial Registration|Adverse Event|2
5351044|NCT00039130|18399262|P1|Overall Study|Physician Decision|3
5351045|NCT00039130|18399262|P1|Overall Study|Subsequent treatment|2
5351046|NCT00039130|18399262|P1|Overall Study|Progression|2
5351047|NCT00039130|18399262|P1|Overall Study|Withdrawal by Subject|3
5351048|NCT00039130|18399262|P1|Overall Study|Death|9
5351049|NCT00039130|18399262|P1|Overall Study|Adverse Event|11
5351050|NCT00033657|18399278|P2|Adjuvant Chemotherapy|Other|2
5351051|NCT00033657|18399279|P1|Adjuvant Chemotherapy|Other|0
5351052|NCT00033657|18399278|P2|Adjuvant Chemotherapy|alternative therapy|0
5351053|NCT00033657|18399279|P1|Adjuvant Chemotherapy|alternative therapy|1
5351054|NCT00033657|18399278|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
5351055|NCT00033657|18399279|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
5351056|NCT00033657|18399278|P2|Adjuvant Chemotherapy|Death|1
5351057|NCT00033657|18399279|P1|Adjuvant Chemotherapy|Death|2
5351058|NCT00033657|18399278|P2|Adjuvant Chemotherapy|Adverse Event|10
5351059|NCT00033657|18399279|P1|Adjuvant Chemotherapy|Adverse Event|7
5351060|NCT00033657|18399278|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
5351061|NCT00033657|18399279|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
5351062|NCT00033657|18399278|P2|Surgical Resection|not complete resection|3
5351063|NCT00033657|18399279|P1|Surgical Resection|not complete resection|0
5351064|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
5351065|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
5351066|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|Ineligible|4
5351067|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|Ineligible|8
5351068|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|other complicating disease|1
5351069|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|other complicating disease|0
5351070|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
5351071|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
5351072|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|Death|1
5351073|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|Death|1
5351074|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|Adverse Event|2
5351075|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|Adverse Event|0
5351076|NCT00033657|18399278|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
5351077|NCT00033657|18399279|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
5351078|NCT00033631|18399293|P2|Overall Study|Withdrawal by Subject|4
5351079|NCT00033631|18399294|P1|Overall Study|Withdrawal by Subject|4
5351080|NCT00033631|18399293|P2|Overall Study|Protocol Violation|11
5351081|NCT00033631|18399294|P1|Overall Study|Protocol Violation|14
5351082|NCT00033540|18399312|P1|Overall Study|Never received treatment|2
5351083|NCT00033540|18399312|P1|Overall Study|Ineligible|3
5351084|NCT00033540|18399312|P1|Overall Study|Other|5
5351085|NCT00033540|18399312|P1|Overall Study|Withdrawal by Subject|6
5351086|NCT00033540|18399312|P1|Overall Study|Progression|26
5351087|NCT00033540|18399312|P1|Overall Study|Death|1
5351088|NCT00033540|18399312|P1|Overall Study|Adverse Event|14
5351089|NCT00033514|18399322|P2|Overall Study|Withdrawal by Subject|3
5351090|NCT00033514|18399323|P1|Overall Study|Withdrawal by Subject|0
5351091|NCT00033514|18399322|P2|Overall Study|Lost to Follow-up|1
5351092|NCT00033514|18399323|P1|Overall Study|Lost to Follow-up|1
5351093|NCT00033371|18399333|P2|Overall Study|Disease Progression|1
5351094|NCT00033371|18399334|P1|Overall Study|Disease Progression|0
5351095|NCT00033371|18399333|P2|Overall Study|Withdrawal by Subject|3
5351096|NCT00033371|18399334|P1|Overall Study|Withdrawal by Subject|3
5351097|NCT00033371|18399333|P2|Overall Study|Lost to Follow-up|1
5351098|NCT00033371|18399334|P1|Overall Study|Lost to Follow-up|2
5351099|NCT00033371|18399333|P2|Overall Study|Adverse Event|5
5351100|NCT00033371|18399334|P1|Overall Study|Adverse Event|1
5351101|NCT00033293|18399352|P2|Overall Study|Treatment refused|6
5351102|NCT00033293|18399353|P1|Overall Study|Treatment refused|0
5351103|NCT00033293|18399352|P2|Overall Study|Could not be weaned from steroid therapy|1
5351104|NCT00033293|18399353|P1|Overall Study|Could not be weaned from steroid therapy|1
5351105|NCT00033293|18399352|P2|Overall Study|Withdrawal by Subject|0
5351106|NCT00033293|18399353|P1|Overall Study|Withdrawal by Subject|1
5351107|NCT00033293|18399352|P2|Overall Study|Physician Decision|1
5351108|NCT00033293|18399353|P1|Overall Study|Physician Decision|3
5351109|NCT00033293|18399352|P2|Overall Study|Lost to Follow-up|1
5351110|NCT00033293|18399353|P1|Overall Study|Lost to Follow-up|0
5351111|NCT00033293|18399352|P2|Overall Study|Lack of Efficacy|8
5351112|NCT00033293|18399353|P1|Overall Study|Lack of Efficacy|5
5351113|NCT00033293|18399352|P2|Overall Study|Death|1
5351114|NCT00033293|18399353|P1|Overall Study|Death|0
5351115|NCT00031694|18399371|P1|Overall Study|Withdrawal by Subject|5
5351116|NCT00031694|18399371|P1|Overall Study|Death|2
5351117|NCT00031694|18399371|P1|Overall Study|Adverse Event|12
5351118|NCT00031590|18399375|P1|Overall Study|Withdrawal by parents|2
5351119|NCT00031590|18399375|P1|Overall Study|Adverse Event|1
5351120|NCT00030901|18399382|P3|Randomization|Ineligible|14
5351121|NCT00030901|18399383|P2|Randomization|Ineligible|15
5351122|NCT00030901|18399384|P1|Randomization|Ineligible|0
5351123|NCT00030901|18399382|P3|Randomization|Other|33
5351124|NCT00030901|18399383|P2|Randomization|Other|36
5351125|NCT00030901|18399384|P1|Randomization|Other|0
5351126|NCT00030901|18399382|P3|Randomization|Death|3
5351127|NCT00030901|18399383|P2|Randomization|Death|1
5351128|NCT00030901|18399384|P1|Randomization|Death|0
5351129|NCT00030901|18399382|P3|Randomization|Progression/Relapse|21
5351130|NCT00030901|18399383|P2|Randomization|Progression/Relapse|22
5351131|NCT00030901|18399384|P1|Randomization|Progression/Relapse|0
5351132|NCT00030901|18399382|P3|Randomization|Refusal Unrelated to Adverse Event|10
5351133|NCT00030901|18399383|P2|Randomization|Refusal Unrelated to Adverse Event|16
5351134|NCT00030901|18399384|P1|Randomization|Refusal Unrelated to Adverse Event|0
5351135|NCT00030901|18399382|P3|Randomization|Adverse Event|7
5351136|NCT00030901|18399383|P2|Randomization|Adverse Event|11
5351137|NCT00030901|18399384|P1|Randomization|Adverse Event|0
5351138|NCT00030901|18399382|P3|Initial Registration|Ineligible|0
5351139|NCT00030901|18399383|P2|Initial Registration|Ineligible|0
5351140|NCT00030901|18399384|P1|Initial Registration|Ineligible|167
5351141|NCT00030823|18399392|P1|Overall Study|Withdrawal by Subject|1
5351142|NCT00028769|18399400|P1|Overall Study|Not Analyzable|1
5351143|NCT00028769|18399400|P1|Overall Study|Ineligible|5
5351144|NCT00028769|18399400|P1|Overall Study|Other - Not Protocol Specified|1
5351145|NCT00028769|18399400|P1|Overall Study|Progression or Death|31
5351146|NCT00028769|18399400|P1|Overall Study|Refusal Unrelated to Adverse Events|1
5351147|NCT00028769|18399400|P1|Overall Study|Adverse Event|2
5351148|NCT00028002|18399406|P1|Overall Study|Ineligible|8
5351149|NCT00028002|18399406|P1|Overall Study|Withdrawal by Subject|3
5351150|NCT00027846|18399416|P3|Overall Study|Neuraxis dissemination during/after ther|5
5351151|NCT00027846|18399417|P2|Overall Study|Neuraxis dissemination during/after ther|2
5351152|NCT00027846|18399418|P1|Overall Study|Neuraxis dissemination during/after ther|0
5351153|NCT00027846|18399416|P3|Overall Study|Entry into another COG therapeutic study|2
5351154|NCT00027846|18399417|P2|Overall Study|Entry into another COG therapeutic study|5
5351155|NCT00027846|18399418|P1|Overall Study|Entry into another COG therapeutic study|0
5351156|NCT00027846|18399416|P3|Overall Study|Ineligible for study|14
5351157|NCT00027846|18399417|P2|Overall Study|Ineligible for study|6
5351158|NCT00027846|18399418|P1|Overall Study|Ineligible for study|2
5351159|NCT00027846|18399416|P3|Overall Study|Withdrawal by Subject|7
5351160|NCT00027846|18399417|P2|Overall Study|Withdrawal by Subject|14
5351161|NCT00027846|18399418|P1|Overall Study|Withdrawal by Subject|0
5351162|NCT00027846|18399416|P3|Overall Study|Lost to Follow-up|9
5351163|NCT00027846|18399417|P2|Overall Study|Lost to Follow-up|41
5351164|NCT00027846|18399418|P1|Overall Study|Lost to Follow-up|0
5351165|NCT00027560|18399436|P1|Overall Study|Withdrawal by Subject|1
5351166|NCT00026494|18399449|P4|Overall Study|Clinical progression|0
5351167|NCT00026494|18399450|P3|Overall Study|Clinical progression|3
5351168|NCT00026494|18399451|P2|Overall Study|Clinical progression|0
5351169|NCT00026494|18399452|P1|Overall Study|Clinical progression|0
5351170|NCT00026494|18399449|P4|Overall Study|Patient not treated|0
5351171|NCT00026494|18399450|P3|Overall Study|Patient not treated|2
5351172|NCT00026494|18399451|P2|Overall Study|Patient not treated|0
5351173|NCT00026494|18399452|P1|Overall Study|Patient not treated|0
5351174|NCT00026494|18399449|P4|Overall Study|Patient non-compliance|0
5351175|NCT00026494|18399450|P3|Overall Study|Patient non-compliance|0
5351176|NCT00026494|18399451|P2|Overall Study|Patient non-compliance|0
5351177|NCT00026494|18399452|P1|Overall Study|Patient non-compliance|1
5351178|NCT00026494|18399449|P4|Overall Study|Withdrawal by Subject|0
5351179|NCT00026494|18399450|P3|Overall Study|Withdrawal by Subject|1
5351180|NCT00026494|18399451|P2|Overall Study|Withdrawal by Subject|0
5351181|NCT00026494|18399452|P1|Overall Study|Withdrawal by Subject|1
5351182|NCT00026312|18399464|P2|Overall Study|Refusal by patient/parent/guardian|59
5351183|NCT00026312|18399465|P1|Overall Study|Refusal by patient/parent/guardian|8
5351184|NCT00026312|18399464|P2|Overall Study|Entry onto another COG study|1
5351185|NCT00026312|18399465|P1|Overall Study|Entry onto another COG study|0
5351186|NCT00026312|18399464|P2|Overall Study|Ineligible|5
5351187|NCT00026312|18399465|P1|Overall Study|Ineligible|4
5351188|NCT00026312|18399464|P2|Overall Study|Withdrawal by Subject|6
5351189|NCT00026312|18399465|P1|Overall Study|Withdrawal by Subject|1
5351190|NCT00026312|18399464|P2|Overall Study|Protocol Violation|3
5351191|NCT00026312|18399465|P1|Overall Study|Protocol Violation|0
5351192|NCT00026312|18399464|P2|Overall Study|Physician Decision|37
5351193|NCT00026312|18399465|P1|Overall Study|Physician Decision|1
5351194|NCT00026312|18399464|P2|Overall Study|Lost to Follow-up|5
5351195|NCT00026312|18399465|P1|Overall Study|Lost to Follow-up|0
5351196|NCT00026312|18399464|P2|Overall Study|Lack of Efficacy|114
5351197|NCT00026312|18399465|P1|Overall Study|Lack of Efficacy|19
5351198|NCT00026312|18399464|P2|Overall Study|Death|7
5351199|NCT00026312|18399465|P1|Overall Study|Death|1
5351200|NCT00026312|18399464|P2|Overall Study|Adverse Event|32
5351201|NCT00026312|18399465|P1|Overall Study|Adverse Event|0
5351202|NCT00026208|18399504|P2|Overall Study|Complications of auto accident|0
5351203|NCT00026208|18399505|P1|Overall Study|Complications of auto accident|1
5351204|NCT00025662|18399523|P1|Overall Study|Technical failure of manipulation|1
5351205|NCT00025662|18399523|P1|Overall Study|Withdrawal by Subject|2
5351206|NCT00025506|18399531|P1|Overall Study|Never Treated|2
5351207|NCT00025506|18399531|P1|Overall Study|Ineligible: inadequate pathology|2
5351208|NCT00025506|18399531|P1|Overall Study|Ineligible: wrong cell type|5
5351209|NCT00025506|18399531|P1|Overall Study|Ineligible: clerical error|1
5351210|NCT00025259|18399552|P7|Overall Study|Adverse Event|0
5351211|NCT00025259|18399553|P6|Overall Study|Adverse Event|0
5351212|NCT00025259|18399554|P5|Overall Study|Adverse Event|0
5351213|NCT00025259|18399555|P4|Overall Study|Adverse Event|0
5351214|NCT00025259|18399556|P3|Overall Study|Adverse Event|0
5351215|NCT00025259|18399557|P2|Overall Study|Adverse Event|0
5351216|NCT00025259|18399558|P1|Overall Study|Adverse Event|1
5351217|NCT00025259|18399552|P7|Overall Study|Randomization error|2
5351218|NCT00025259|18399553|P6|Overall Study|Randomization error|7
5351219|NCT00025259|18399554|P5|Overall Study|Randomization error|1
5351220|NCT00025259|18399555|P4|Overall Study|Randomization error|0
5351221|NCT00025259|18399556|P3|Overall Study|Randomization error|0
5351222|NCT00025259|18399557|P2|Overall Study|Randomization error|0
5351223|NCT00025259|18399558|P1|Overall Study|Randomization error|1
5351224|NCT00025259|18399552|P7|Overall Study|Ineligible|1
5351225|NCT00025259|18399553|P6|Overall Study|Ineligible|0
5351226|NCT00025259|18399554|P5|Overall Study|Ineligible|6
5351227|NCT00025259|18399555|P4|Overall Study|Ineligible|0
5351228|NCT00025259|18399556|P3|Overall Study|Ineligible|0
5351229|NCT00025259|18399557|P2|Overall Study|Ineligible|1
5351230|NCT00025259|18399558|P1|Overall Study|Ineligible|14
5351231|NCT00025259|18399552|P7|Overall Study|Withdrawal by Subject|3
5351232|NCT00025259|18399553|P6|Overall Study|Withdrawal by Subject|8
5351233|NCT00025259|18399554|P5|Overall Study|Withdrawal by Subject|11
5351234|NCT00025259|18399555|P4|Overall Study|Withdrawal by Subject|14
5351235|NCT00025259|18399556|P3|Overall Study|Withdrawal by Subject|6
5351236|NCT00025259|18399557|P2|Overall Study|Withdrawal by Subject|27
5351237|NCT00025259|18399558|P1|Overall Study|Withdrawal by Subject|9
5351238|NCT00025259|18399552|P7|Overall Study|Protocol Violation|3
5351239|NCT00025259|18399553|P6|Overall Study|Protocol Violation|1
5351240|NCT00025259|18399554|P5|Overall Study|Protocol Violation|2
5351241|NCT00025259|18399555|P4|Overall Study|Protocol Violation|1
5351242|NCT00025259|18399556|P3|Overall Study|Protocol Violation|2
5351243|NCT00025259|18399557|P2|Overall Study|Protocol Violation|2
5351244|NCT00025259|18399558|P1|Overall Study|Protocol Violation|3
5351245|NCT00025259|18399552|P7|Overall Study|Physician Decision|1
5351246|NCT00025259|18399553|P6|Overall Study|Physician Decision|2
5351247|NCT00025259|18399554|P5|Overall Study|Physician Decision|4
5351248|NCT00025259|18399555|P4|Overall Study|Physician Decision|5
5351249|NCT00025259|18399556|P3|Overall Study|Physician Decision|0
5351250|NCT00025259|18399557|P2|Overall Study|Physician Decision|1
5351251|NCT00025259|18399558|P1|Overall Study|Physician Decision|12
5351252|NCT00025259|18399552|P7|Overall Study|Lost to Follow-up|1
5351253|NCT00025259|18399553|P6|Overall Study|Lost to Follow-up|3
5351254|NCT00025259|18399554|P5|Overall Study|Lost to Follow-up|1
5351255|NCT00025259|18399555|P4|Overall Study|Lost to Follow-up|13
5351256|NCT00025259|18399556|P3|Overall Study|Lost to Follow-up|13
5351257|NCT00025259|18399557|P2|Overall Study|Lost to Follow-up|9
5351258|NCT00025259|18399558|P1|Overall Study|Lost to Follow-up|2
5351259|NCT00025259|18399552|P7|Overall Study|Lack of Efficacy|38
5351260|NCT00025259|18399553|P6|Overall Study|Lack of Efficacy|30
5351261|NCT00025259|18399554|P5|Overall Study|Lack of Efficacy|11
5351262|NCT00025259|18399555|P4|Overall Study|Lack of Efficacy|78
5351263|NCT00025259|18399556|P3|Overall Study|Lack of Efficacy|60
5351264|NCT00025259|18399557|P2|Overall Study|Lack of Efficacy|46
5351265|NCT00025259|18399558|P1|Overall Study|Lack of Efficacy|2
5351266|NCT00025259|18399552|P7|Overall Study|Death|2
5351267|NCT00025259|18399553|P6|Overall Study|Death|1
5351268|NCT00025259|18399554|P5|Overall Study|Death|0
5351269|NCT00025259|18399555|P4|Overall Study|Death|3
5351270|NCT00025259|18399556|P3|Overall Study|Death|0
5351271|NCT00025259|18399557|P2|Overall Study|Death|3
5351272|NCT00025259|18399558|P1|Overall Study|Death|1
5351273|NCT00025233|18399594|P1|Overall Study|Never treated|1
5351274|NCT00025233|18399594|P1|Overall Study|Ineligible: improper prior treatment|1
5351275|NCT00025233|18399594|P1|Overall Study|Ineligible: wrong primary|1
5351276|NCT00025233|18399594|P1|Overall Study|Ineligible: wrong cell type|1
5351277|NCT00025155|18399609|P1|Overall Study|Ineligible: Second primary cancer site|1
5351278|NCT00025155|18399609|P1|Overall Study|Ineligible: Wrong primary cancer site|1
5351279|NCT00024258|18399620|P1|Overall Study|Disease Progression|8
5351280|NCT00024258|18399620|P1|Overall Study|Withdrawal by Subject|1
5351281|NCT00024167|18399627|P2|Overall Study|Death|47
5351282|NCT00024167|18399628|P1|Overall Study|Death|53
5351283|NCT00023764|18399652|P1|Overall Study|delay in obtaining staging images|1
5351284|NCT00023764|18399652|P1|Overall Study|patient received other treatment|1
5351285|NCT00023764|18399652|P1|Overall Study|Progression of disease|6
5351286|NCT00023764|18399652|P1|Overall Study|Withdrawal by Subject|1
5351287|NCT00023764|18399652|P1|Overall Study|Adverse Event|4
5351288|NCT00023764|18399652|P1|Overall Study|Other|1
5351289|NCT00023712|18399659|P2|Overall Study|Never treated|1
5351290|NCT00023712|18399660|P1|Overall Study|Never treated|1
5351291|NCT00023712|18399659|P2|Overall Study|Not platinum sensitive|0
5351292|NCT00023712|18399660|P1|Overall Study|Not platinum sensitive|1
5351293|NCT00022698|18399684|P2|Overall Study|Administrative /other|7
5351294|NCT00022698|18399685|P1|Overall Study|Administrative /other|1
5351295|NCT00022698|18399684|P2|Overall Study|Insufficient therapeutic response|14
5351296|NCT00022698|18399685|P1|Overall Study|Insufficient therapeutic response|2
5351297|NCT00022698|18399684|P2|Overall Study|Refused treatment|2
5351298|NCT00022698|18399685|P1|Overall Study|Refused treatment|0
5351299|NCT00022698|18399684|P2|Overall Study|Failure to return|1
5351300|NCT00022698|18399685|P1|Overall Study|Failure to return|0
5351301|NCT00022698|18399684|P2|Overall Study|Death|2
5351302|NCT00022698|18399685|P1|Overall Study|Death|0
5351303|NCT00022698|18399684|P2|Overall Study|Adverse Event|9
5351304|NCT00022698|18399685|P1|Overall Study|Adverse Event|5
5351305|NCT00022672|18399710|P2|Extension Phase|Other|1
5351306|NCT00022672|18399711|P1|Extension Phase|Other|1
5351307|NCT00022672|18399710|P2|Extension Phase|Refused Treatment|2
5351308|NCT00022672|18399711|P1|Extension Phase|Refused Treatment|0
5351309|NCT00022672|18399710|P2|Extension Phase|Insufficient Therapeutic Response|44
5351310|NCT00022672|18399711|P1|Extension Phase|Insufficient Therapeutic Response|1
5351311|NCT00022672|18399710|P2|Extension Phase|Death|1
5351312|NCT00022672|18399711|P1|Extension Phase|Death|0
5351313|NCT00022672|18399710|P2|Extension Phase|Adverse Event|3
5351314|NCT00022672|18399711|P1|Extension Phase|Adverse Event|1
5351315|NCT00022672|18399710|P2|Main Phase: 24 Months|Other|0
5351316|NCT00022672|18399711|P1|Main Phase: 24 Months|Other|1
5351317|NCT00022672|18399710|P2|Main Phase: 24 Months|Failure to Return|1
5351318|NCT00022672|18399711|P1|Main Phase: 24 Months|Failure to Return|1
5351319|NCT00022672|18399710|P2|Main Phase: 24 Months|Refused Treatment|4
5351320|NCT00022672|18399711|P1|Main Phase: 24 Months|Refused Treatment|3
5351321|NCT00022672|18399710|P2|Main Phase: 24 Months|Other Protocol Violation|0
5351322|NCT00022672|18399711|P1|Main Phase: 24 Months|Other Protocol Violation|1
5351323|NCT00022672|18399710|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
5351324|NCT00022672|18399711|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
5351325|NCT00022672|18399710|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
5351326|NCT00022672|18399711|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
5351327|NCT00022672|18399710|P2|Main Phase: 24 Months|Death|3
5351328|NCT00022672|18399711|P1|Main Phase: 24 Months|Death|0
5351329|NCT00022672|18399710|P2|Main Phase: 24 Months|Adverse Event|0
5351330|NCT00022672|18399711|P1|Main Phase: 24 Months|Adverse Event|6
5351331|NCT00022659|18399744|P1|Overall Study|Never treated|1
5351332|NCT00022659|18399744|P1|Overall Study|Ineligible: wrong primary|1
5351333|NCT00022633|18399757|P2|Overall Study|Ineligible|0
5351334|NCT00022633|18399758|P1|Overall Study|Ineligible|4
5351335|NCT00022633|18399757|P2|Overall Study|Other - not protocol specified|2
5351336|NCT00022633|18399758|P1|Overall Study|Other - not protocol specified|3
5351337|NCT00022633|18399757|P2|Overall Study|Death|0
5351338|NCT00022633|18399758|P1|Overall Study|Death|4
5351339|NCT00022633|18399757|P2|Overall Study|Progression/relapse|2
5351340|NCT00022633|18399758|P1|Overall Study|Progression/relapse|9
5351341|NCT00022633|18399757|P2|Overall Study|Refusal unrelated to adverse event|0
5351342|NCT00022633|18399758|P1|Overall Study|Refusal unrelated to adverse event|1
5351343|NCT00022633|18399757|P2|Overall Study|Adverse Event|1
5351344|NCT00022633|18399758|P1|Overall Study|Adverse Event|11
5351345|NCT00022516|18399771|P2|Overall Study|Incomplete documentation|27
5351346|NCT00022516|18399772|P1|Overall Study|Incomplete documentation|0
5351347|NCT00022516|18399771|P2|Overall Study|Withdrawal by Subject|113
5351348|NCT00022516|18399772|P1|Overall Study|Withdrawal by Subject|2
5351349|NCT00022516|18399771|P2|Overall Study|Protocol Violation|3
5351350|NCT00022516|18399772|P1|Overall Study|Protocol Violation|1
5351351|NCT00022516|18399771|P2|Overall Study|Physician Decision|1
5351352|NCT00022516|18399772|P1|Overall Study|Physician Decision|0
5351353|NCT00022516|18399771|P2|Overall Study|Lack of Efficacy|27
5351354|NCT00022516|18399772|P1|Overall Study|Lack of Efficacy|0
5351355|NCT00022516|18399771|P2|Overall Study|Adverse Event|59
5351356|NCT00022516|18399772|P1|Overall Study|Adverse Event|0
5351357|NCT00021255|18399791|P3|Overall Study|Randomized but not treated|18
5351358|NCT00021255|18399792|P2|Overall Study|Randomized but not treated|2
5351359|NCT00021255|18399793|P1|Overall Study|Randomized but not treated|28
5351360|NCT00021255|18399791|P3|Overall Study|Missing|13
5351361|NCT00021255|18399792|P2|Overall Study|Missing|27
5351362|NCT00021255|18399793|P1|Overall Study|Missing|0
5351363|NCT00021255|18399791|P3|Overall Study|Other than specified above|19
5351364|NCT00021255|18399792|P2|Overall Study|Other than specified above|38
5351365|NCT00021255|18399793|P1|Overall Study|Other than specified above|0
5351366|NCT00021255|18399791|P3|Overall Study|Protocol Violation|0
5351367|NCT00021255|18399792|P2|Overall Study|Protocol Violation|2
5351368|NCT00021255|18399793|P1|Overall Study|Protocol Violation|0
5351369|NCT00021255|18399791|P3|Overall Study|Adverse Event|18
5351370|NCT00021255|18399792|P2|Overall Study|Adverse Event|30
5351371|NCT00021255|18399793|P1|Overall Study|Adverse Event|46
5351372|NCT00021255|18399791|P3|Overall Study|Herceptin toxicity|6
5351373|NCT00021255|18399792|P2|Overall Study|Herceptin toxicity|22
5351374|NCT00021255|18399793|P1|Overall Study|Herceptin toxicity|0
5351375|NCT00021255|18399791|P3|Overall Study|Cardiac toxicity|32
5351376|NCT00021255|18399792|P2|Overall Study|Cardiac toxicity|61
5351377|NCT00021255|18399793|P1|Overall Study|Cardiac toxicity|0
5351378|NCT00021255|18399791|P3|Overall Study|Lost to Follow-up|3
5351379|NCT00021255|18399792|P2|Overall Study|Lost to Follow-up|2
5351380|NCT00021255|18399793|P1|Overall Study|Lost to Follow-up|0
5351381|NCT00021255|18399791|P3|Overall Study|Withdrawal by Subject|26
5351382|NCT00021255|18399792|P2|Overall Study|Withdrawal by Subject|64
5351383|NCT00021255|18399793|P1|Overall Study|Withdrawal by Subject|41
5351384|NCT00021255|18399791|P3|Overall Study|Second primary malignancy|1
5351385|NCT00021255|18399792|P2|Overall Study|Second primary malignancy|4
5351386|NCT00021255|18399793|P1|Overall Study|Second primary malignancy|0
5351387|NCT00021255|18399791|P3|Overall Study|Breast cancer relapse|11
5351388|NCT00021255|18399792|P2|Overall Study|Breast cancer relapse|18
5351389|NCT00021255|18399793|P1|Overall Study|Breast cancer relapse|5
5351390|NCT00021255|18399791|P3|Overall Study|Death|2
5351391|NCT00021255|18399792|P2|Overall Study|Death|0
5351392|NCT00021255|18399793|P1|Overall Study|Death|1
5351393|NCT00021229|18399810|P3|Overall Study|Punctate hemmorrhage post RT|0
5351394|NCT00021229|18399811|P2|Overall Study|Punctate hemmorrhage post RT|0
5351395|NCT00021229|18399812|P1|Overall Study|Punctate hemmorrhage post RT|2
5351396|NCT00021229|18399810|P3|Overall Study|Physician Decision|1
5351397|NCT00021229|18399811|P2|Overall Study|Physician Decision|0
5351398|NCT00021229|18399812|P1|Overall Study|Physician Decision|0
5351399|NCT00021229|18399810|P3|Overall Study|Protocol Violation|0
5351400|NCT00021229|18399811|P2|Overall Study|Protocol Violation|1
5351401|NCT00021229|18399812|P1|Overall Study|Protocol Violation|1
5351402|NCT00021229|18399810|P3|Overall Study|Progressive Disease|12
5351403|NCT00021229|18399811|P2|Overall Study|Progressive Disease|19
5351404|NCT00021229|18399812|P1|Overall Study|Progressive Disease|15
5351405|NCT00021229|18399810|P3|Overall Study|Withdrawal by Subject|1
5351406|NCT00021229|18399811|P2|Overall Study|Withdrawal by Subject|7
5351407|NCT00021229|18399812|P1|Overall Study|Withdrawal by Subject|7
5351408|NCT00021229|18399810|P3|Overall Study|Death|0
5351409|NCT00021229|18399811|P2|Overall Study|Death|1
5351410|NCT00021229|18399812|P1|Overall Study|Death|0
5351411|NCT00021229|18399810|P3|Overall Study|Adverse Event|2
5351412|NCT00021229|18399811|P2|Overall Study|Adverse Event|5
5351413|NCT00021229|18399812|P1|Overall Study|Adverse Event|10
5351414|NCT00019604|18399867|P1|Overall Study|Details for other not available|4
5351415|NCT00019604|18399867|P1|Overall Study|Unable to evaluate|1
5351416|NCT00019604|18399867|P1|Overall Study|Too much disease|1
5351417|NCT00019604|18399867|P1|Overall Study|Pt going to immunotherapy study|1
5351418|NCT00019604|18399867|P1|Overall Study|Started new chemo regimen|1
5351419|NCT00019604|18399867|P1|Overall Study|Resectable disease|1
5351420|NCT00019604|18399867|P1|Overall Study|Non compliant|1
5351421|NCT00019604|18399867|P1|Overall Study|Non compliant on systemic CH|1
5351422|NCT00019604|18399867|P1|Overall Study|Move to a different study|1
5351423|NCT00019604|18399867|P1|Overall Study|Going to have liver transplant|1
5351424|NCT00019604|18399867|P1|Overall Study|Carcinoid tumor, not treatable|1
5351425|NCT00019604|18399867|P1|Overall Study|Refused treatment|1
5351426|NCT00019604|18399867|P1|Overall Study|Progressive disease|23
5351427|NCT00019604|18399867|P1|Overall Study|Death|1
5351428|NCT00016354|18399890|P8|Overall Study|Lack of Efficacy|1
5351429|NCT00016354|18399891|P7|Overall Study|Lack of Efficacy|0
5351430|NCT00016354|18399892|P6|Overall Study|Lack of Efficacy|0
5351431|NCT00016354|18399893|P5|Overall Study|Lack of Efficacy|0
5351432|NCT00016354|18399894|P4|Overall Study|Lack of Efficacy|0
5351433|NCT00016354|18399895|P3|Overall Study|Lack of Efficacy|0
5351434|NCT00016354|18399896|P2|Overall Study|Lack of Efficacy|0
5351435|NCT00016354|18399897|P1|Overall Study|Lack of Efficacy|0
5351436|NCT00014495|18399911|P4|Overall Study|Clinical deterioration|1
5351437|NCT00014495|18399912|P3|Overall Study|Clinical deterioration|0
5351438|NCT00014495|18399913|P2|Overall Study|Clinical deterioration|0
5351439|NCT00014495|18399914|P1|Overall Study|Clinical deterioration|0
5351440|NCT00014495|18399911|P4|Overall Study|Death|0
5351441|NCT00014495|18399912|P3|Overall Study|Death|1
5351442|NCT00014495|18399913|P2|Overall Study|Death|0
5351443|NCT00014495|18399914|P1|Overall Study|Death|0
5351444|NCT00012012|18399980|P2|Overall Study|Withdrawal by Subject|2
5351445|NCT00012012|18399981|P1|Overall Study|Withdrawal by Subject|0
5351446|NCT00012012|18399980|P2|Overall Study|Protocol Violation|1
5351447|NCT00012012|18399981|P1|Overall Study|Protocol Violation|1
5351448|NCT00010257|18400020|P2|Overall Study|Withdrawal by Subject|0
5351449|NCT00010257|18400021|P1|Overall Study|Withdrawal by Subject|1
5351450|NCT00009945|18400031|P2|Overall Study|no follow up data|5
5351451|NCT00009945|18400032|P1|Overall Study|no follow up data|7
5351452|NCT00008385|18400048|P2|Overall Study|Not start protocol therapy|175
5351453|NCT00008385|18400049|P1|Overall Study|Not start protocol therapy|44
5351454|NCT00008385|18400048|P2|Overall Study|Other|212
5351455|NCT00008385|18400049|P1|Overall Study|Other|105
5351456|NCT00008385|18400048|P2|Overall Study|Maximum dose reached|2
5351457|NCT00008385|18400049|P1|Overall Study|Maximum dose reached|0
5351458|NCT00008385|18400048|P2|Overall Study|Other complicating disease|30
5351459|NCT00008385|18400049|P1|Overall Study|Other complicating disease|17
5351460|NCT00008385|18400048|P2|Overall Study|Start non-protocol therapy|1
5351461|NCT00008385|18400049|P1|Overall Study|Start non-protocol therapy|3
5351462|NCT00008385|18400048|P2|Overall Study|Withdrawal by Subject|157
5351463|NCT00008385|18400049|P1|Overall Study|Withdrawal by Subject|67
5351464|NCT00008385|18400048|P2|Overall Study|Death|18
5351465|NCT00008385|18400049|P1|Overall Study|Death|12
5351466|NCT00008385|18400048|P2|Overall Study|Adverse Event|20
5351467|NCT00008385|18400049|P1|Overall Study|Adverse Event|8
5351468|NCT00008385|18400048|P2|Overall Study|Progressive disease|117
5351469|NCT00008385|18400049|P1|Overall Study|Progressive disease|52
5351470|NCT00008385|18400048|P2|Overall Study|Off treatment reasons not reported|70
5351471|NCT00008385|18400049|P1|Overall Study|Off treatment reasons not reported|79
5351472|NCT00008138|18400059|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
5351473|NCT00008138|18400059|P1|Post-Cytoreduction Chemotherapy|Progression|1
5351474|NCT00008138|18400059|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
5351475|NCT00008138|18400059|P1|Interval Debulking|Withdrawal by Subject|2
5351476|NCT00008138|18400059|P1|Neoadjuvant Chemotherapy|not protocol specified|8
5351477|NCT00008138|18400059|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
5351478|NCT00008138|18400059|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
5351479|NCT00008138|18400059|P1|Neoadjuvant Chemotherapy|Adverse Event|3
5351480|NCT00006916|18400065|P1|Overall Study|Complication of device insertion|1
5351481|NCT00006916|18400065|P1|Overall Study|Device not inserted|4
5351482|NCT00006903|18400071|P3|Overall Study|Ineligible|2
5351483|NCT00006903|18400072|P2|Overall Study|Ineligible|1
5351484|NCT00006903|18400073|P1|Overall Study|Ineligible|10
5351485|NCT00006903|18400071|P3|Overall Study|Patient never treated|1
5351486|NCT00006903|18400072|P2|Overall Study|Patient never treated|0
5351487|NCT00006903|18400073|P1|Overall Study|Patient never treated|0
5351488|NCT00006903|18400071|P3|Overall Study|Death|0
5351489|NCT00006903|18400072|P2|Overall Study|Death|1
5351490|NCT00006903|18400073|P1|Overall Study|Death|0
5351491|NCT00006903|18400071|P3|Overall Study|Adverse Event|1
5351492|NCT00006903|18400072|P2|Overall Study|Adverse Event|0
5351493|NCT00006903|18400073|P1|Overall Study|Adverse Event|0
5351494|NCT00006903|18400071|P3|Overall Study|Refused further treatment|1
5351495|NCT00006903|18400072|P2|Overall Study|Refused further treatment|2
5351496|NCT00006903|18400073|P1|Overall Study|Refused further treatment|0
5351497|NCT00006903|18400071|P3|Overall Study|Still receiving treatment|1
5351498|NCT00006903|18400072|P2|Overall Study|Still receiving treatment|0
5351499|NCT00006903|18400073|P1|Overall Study|Still receiving treatment|0
5351500|NCT00006721|18400086|P3|Overall Study|Eligible but no Treatment Received|0
5351501|NCT00006721|18400087|P2|Overall Study|Eligible but no Treatment Received|0
5351502|NCT00006721|18400088|P1|Overall Study|Eligible but no Treatment Received|1
5351503|NCT00006721|18400086|P3|Overall Study|Ineligible|10
5351504|NCT00006721|18400087|P2|Overall Study|Ineligible|12
5351505|NCT00006721|18400088|P1|Overall Study|Ineligible|2
5351506|NCT00006721|18400086|P3|Overall Study|Other - Not Protocol Specified|7
5351507|NCT00006721|18400087|P2|Overall Study|Other - Not Protocol Specified|7
5351508|NCT00006721|18400088|P1|Overall Study|Other - Not Protocol Specified|0
5351509|NCT00006721|18400086|P3|Overall Study|Death|2
5351510|NCT00006721|18400087|P2|Overall Study|Death|1
5351511|NCT00006721|18400088|P1|Overall Study|Death|0
5351512|NCT00006721|18400086|P3|Overall Study|Progression/Relapse|2
5351513|NCT00006721|18400087|P2|Overall Study|Progression/Relapse|1
5351514|NCT00006721|18400088|P1|Overall Study|Progression/Relapse|0
5351515|NCT00006721|18400086|P3|Overall Study|Refusal Unrelated to Adverse Event|8
5351516|NCT00006721|18400087|P2|Overall Study|Refusal Unrelated to Adverse Event|0
5351517|NCT00006721|18400088|P1|Overall Study|Refusal Unrelated to Adverse Event|1
5351518|NCT00006721|18400086|P3|Overall Study|Adverse Event|4
5351519|NCT00006721|18400087|P2|Overall Study|Adverse Event|4
5351520|NCT00006721|18400088|P1|Overall Study|Adverse Event|0
5351521|NCT00006478|18400106|P1|Overall Study|Physician Decision|6
5351522|NCT00006478|18400106|P1|Overall Study|Vaccine could not be produced|1
5351523|NCT00006392|18400117|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
5351524|NCT00006392|18400118|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
5351525|NCT00006392|18400119|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
5351526|NCT00006392|18400120|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
5351527|NCT00006392|18400117|P4|Overall Study|Ineligible|5
5351528|NCT00006392|18400118|P3|Overall Study|Ineligible|5
5351529|NCT00006392|18400119|P2|Overall Study|Ineligible|3
5351530|NCT00006392|18400120|P1|Overall Study|Ineligible|11
5351531|NCT00006389|18400150|P1|Overall Study|Adverse Event|1
5351532|NCT00006237|18400167|P2|Overall Study|Not protocol specified|5
5351533|NCT00006237|18400168|P1|Overall Study|Not protocol specified|14
5351534|NCT00006237|18400167|P2|Overall Study|Withdrawal by Subject|1
5351535|NCT00006237|18400168|P1|Overall Study|Withdrawal by Subject|0
5351536|NCT00006237|18400167|P2|Overall Study|Not eligible|20
5351537|NCT00006237|18400168|P1|Overall Study|Not eligible|9
5351538|NCT00006237|18400167|P2|Overall Study|Progression/relapse|2
5351539|NCT00006237|18400168|P1|Overall Study|Progression/relapse|54
5351540|NCT00006237|18400167|P2|Overall Study|Refusal unrelated to adverse effects|4
5351541|NCT00006237|18400168|P1|Overall Study|Refusal unrelated to adverse effects|8
5351542|NCT00006237|18400167|P2|Overall Study|Death|0
5351543|NCT00006237|18400168|P1|Overall Study|Death|1
5351544|NCT00006237|18400167|P2|Overall Study|Adverse Event|29
5351545|NCT00006237|18400168|P1|Overall Study|Adverse Event|39
5351546|NCT00006011|18400211|P3|Overall Study|Ineligible|9
5351547|NCT00006011|18400212|P2|Overall Study|Ineligible|16
5351548|NCT00006011|18400213|P1|Overall Study|Ineligible|18
5351549|NCT00006011|18400211|P3|Overall Study|Other|5
5351550|NCT00006011|18400212|P2|Overall Study|Other|2
5351551|NCT00006011|18400213|P1|Overall Study|Other|4
5351552|NCT00006011|18400211|P3|Overall Study|Death|2
5351553|NCT00006011|18400212|P2|Overall Study|Death|1
5351554|NCT00006011|18400213|P1|Overall Study|Death|0
5351555|NCT00006011|18400211|P3|Overall Study|Adverse Event|5
5351556|NCT00006011|18400212|P2|Overall Study|Adverse Event|39
5351557|NCT00006011|18400213|P1|Overall Study|Adverse Event|15
5351558|NCT00006011|18400211|P3|Overall Study|Refused further treatment|26
5351559|NCT00006011|18400212|P2|Overall Study|Refused further treatment|13
5351560|NCT00006011|18400213|P1|Overall Study|Refused further treatment|15
5351561|NCT00006011|18400211|P3|Overall Study|Disease progression|26
5351562|NCT00006011|18400212|P2|Overall Study|Disease progression|6
5351563|NCT00006011|18400213|P1|Overall Study|Disease progression|13
5351564|NCT00005957|18400221|P2|Overall Study|Crossover to the other arm|19
5351565|NCT00005957|18400222|P1|Overall Study|Crossover to the other arm|5
5351566|NCT00005957|18400221|P2|Overall Study|No treated|9
5351567|NCT00005957|18400222|P1|Overall Study|No treated|3
5351568|NCT00005879|18400232|P2|Overall Study|Withdrawal by Subject|10
5351569|NCT00005879|18400233|P1|Overall Study|Withdrawal by Subject|8
5351570|NCT00005047|18400256|P4|Overall Study|Lack of Efficacy|0
5351571|NCT00005047|18400257|P3|Overall Study|Lack of Efficacy|0
5351572|NCT00005047|18400258|P2|Overall Study|Lack of Efficacy|0
5351573|NCT00005047|18400259|P1|Overall Study|Lack of Efficacy|1
5351574|NCT00005047|18400256|P4|Overall Study|Lost to Follow-up|0
5351575|NCT00005047|18400257|P3|Overall Study|Lost to Follow-up|0
5351576|NCT00005047|18400258|P2|Overall Study|Lost to Follow-up|0
5351577|NCT00005047|18400259|P1|Overall Study|Lost to Follow-up|1
5351578|NCT00005047|18400256|P4|Overall Study|Adverse Event|0
5351579|NCT00005047|18400257|P3|Overall Study|Adverse Event|0
5351580|NCT00005047|18400258|P2|Overall Study|Adverse Event|0
5351581|NCT00005047|18400259|P1|Overall Study|Adverse Event|5
5351582|NCT00005047|18400256|P4|Overall Study|Withdrawal by Subject|0
5351583|NCT00005047|18400257|P3|Overall Study|Withdrawal by Subject|0
5351584|NCT00005047|18400258|P2|Overall Study|Withdrawal by Subject|0
5351585|NCT00005047|18400259|P1|Overall Study|Withdrawal by Subject|12
5351586|NCT00005044|18400275|P2|Overall Study|No protocol treatment|1
5351587|NCT00005044|18400276|P1|Overall Study|No protocol treatment|0
5351588|NCT00005044|18400275|P2|Overall Study|Withdrawal by Subject|5
5351589|NCT00005044|18400276|P1|Overall Study|Withdrawal by Subject|1
5351590|NCT00005044|18400275|P2|Overall Study|Protocol Violation|46
5351591|NCT00005044|18400276|P1|Overall Study|Protocol Violation|37
5351592|NCT00004888|18400296|P2|Overall Study|Toxic death|0
5351593|NCT00004888|18400297|P1|Overall Study|Toxic death|1
5351594|NCT00004888|18400296|P2|Overall Study|Death without progressive disease|1
5351595|NCT00004888|18400297|P1|Overall Study|Death without progressive disease|0
5351596|NCT00004888|18400296|P2|Overall Study|Progressive Disease|9
5351597|NCT00004888|18400297|P1|Overall Study|Progressive Disease|4
5351598|NCT00004888|18400296|P2|Overall Study|Physician Decision|1
5351599|NCT00004888|18400297|P1|Overall Study|Physician Decision|1
5351600|NCT00004888|18400296|P2|Overall Study|Withdrawal by Subject|3
5351601|NCT00004888|18400297|P1|Overall Study|Withdrawal by Subject|0
5351602|NCT00004888|18400296|P2|Overall Study|Adverse Event|10
5351603|NCT00004888|18400297|P1|Overall Study|Adverse Event|5
5351604|NCT00004859|18400315|P2|Overall Study|Other|21
5351605|NCT00004859|18400316|P1|Overall Study|Other|13
5351606|NCT00004859|18400315|P2|Overall Study|missing data|11
5351607|NCT00004859|18400316|P1|Overall Study|missing data|14
5351608|NCT00004859|18400315|P2|Overall Study|error|1
5351609|NCT00004859|18400316|P1|Overall Study|error|3
5351610|NCT00004859|18400315|P2|Overall Study|other disease|3
5351611|NCT00004859|18400316|P1|Overall Study|other disease|0
5351612|NCT00004859|18400315|P2|Overall Study|Protocol Violation|2
5351613|NCT00004859|18400316|P1|Overall Study|Protocol Violation|2
5351614|NCT00004859|18400315|P2|Overall Study|Withdrawal by Subject|33
5351615|NCT00004859|18400316|P1|Overall Study|Withdrawal by Subject|7
5351616|NCT00004859|18400315|P2|Overall Study|Death|5
5351617|NCT00004859|18400316|P1|Overall Study|Death|5
5351618|NCT00004859|18400315|P2|Overall Study|Adverse Event|93
5351619|NCT00004859|18400316|P1|Overall Study|Adverse Event|31
5351620|NCT00004859|18400315|P2|Overall Study|Lack of Efficacy|113
5351621|NCT00004859|18400316|P1|Overall Study|Lack of Efficacy|43
5351622|NCT00004259|18400330|P4|Overall Study|Withdrawal by Subject|0
5351623|NCT00004259|18400331|P3|Overall Study|Withdrawal by Subject|0
5351624|NCT00004259|18400332|P2|Overall Study|Withdrawal by Subject|2
5351625|NCT00004259|18400333|P1|Overall Study|Withdrawal by Subject|0
5351626|NCT00004259|18400330|P4|Overall Study|Protocol Violation|0
5351627|NCT00004259|18400331|P3|Overall Study|Protocol Violation|0
5351628|NCT00004259|18400332|P2|Overall Study|Protocol Violation|2
5351629|NCT00004259|18400333|P1|Overall Study|Protocol Violation|1
5351630|NCT00004228|18400358|P7|Overall Study|ineligible|5
5351631|NCT00004228|18400359|P6|Overall Study|ineligible|2
5351632|NCT00004228|18400360|P5|Overall Study|ineligible|1
5351633|NCT00004228|18400361|P4|Overall Study|ineligible|1
5351634|NCT00004228|18400362|P3|Overall Study|ineligible|4
5351635|NCT00004228|18400363|P2|Overall Study|ineligible|2
5351636|NCT00004228|18400364|P1|Overall Study|ineligible|4
5351637|NCT00004228|18400358|P7|Overall Study|Other|0
5351638|NCT00004228|18400359|P6|Overall Study|Other|0
5351639|NCT00004228|18400360|P5|Overall Study|Other|0
5351640|NCT00004228|18400361|P4|Overall Study|Other|0
5351641|NCT00004228|18400362|P3|Overall Study|Other|1
5351642|NCT00004228|18400363|P2|Overall Study|Other|0
5351643|NCT00004228|18400364|P1|Overall Study|Other|0
5351644|NCT00004228|18400358|P7|Overall Study|Withdrawal by Subject|2
5351645|NCT00004228|18400359|P6|Overall Study|Withdrawal by Subject|1
5351646|NCT00004228|18400360|P5|Overall Study|Withdrawal by Subject|2
5351647|NCT00004228|18400361|P4|Overall Study|Withdrawal by Subject|0
5351648|NCT00004228|18400362|P3|Overall Study|Withdrawal by Subject|1
5351649|NCT00004228|18400363|P2|Overall Study|Withdrawal by Subject|0
5351650|NCT00004228|18400364|P1|Overall Study|Withdrawal by Subject|3
5351651|NCT00004228|18400358|P7|Overall Study|Protocol Violation|0
5351652|NCT00004228|18400359|P6|Overall Study|Protocol Violation|2
5351653|NCT00004228|18400360|P5|Overall Study|Protocol Violation|1
5351654|NCT00004228|18400361|P4|Overall Study|Protocol Violation|1
5351655|NCT00004228|18400362|P3|Overall Study|Protocol Violation|2
5351656|NCT00004228|18400363|P2|Overall Study|Protocol Violation|5
5351657|NCT00004228|18400364|P1|Overall Study|Protocol Violation|0
5351658|NCT00004228|18400358|P7|Overall Study|Physician Decision|1
5351659|NCT00004228|18400359|P6|Overall Study|Physician Decision|1
5351660|NCT00004228|18400360|P5|Overall Study|Physician Decision|1
5351661|NCT00004228|18400361|P4|Overall Study|Physician Decision|2
5351662|NCT00004228|18400362|P3|Overall Study|Physician Decision|3
5351663|NCT00004228|18400363|P2|Overall Study|Physician Decision|0
5351664|NCT00004228|18400364|P1|Overall Study|Physician Decision|1
5351665|NCT00004228|18400358|P7|Overall Study|Lost to Follow-up|0
5351666|NCT00004228|18400359|P6|Overall Study|Lost to Follow-up|0
5351667|NCT00004228|18400360|P5|Overall Study|Lost to Follow-up|0
5351668|NCT00004228|18400361|P4|Overall Study|Lost to Follow-up|0
5351669|NCT00004228|18400362|P3|Overall Study|Lost to Follow-up|1
5351670|NCT00004228|18400363|P2|Overall Study|Lost to Follow-up|0
5351671|NCT00004228|18400364|P1|Overall Study|Lost to Follow-up|0
5351672|NCT00004228|18400358|P7|Overall Study|Lack of Efficacy|4
5351673|NCT00004228|18400359|P6|Overall Study|Lack of Efficacy|8
5351674|NCT00004228|18400360|P5|Overall Study|Lack of Efficacy|9
5351675|NCT00004228|18400361|P4|Overall Study|Lack of Efficacy|3
5351676|NCT00004228|18400362|P3|Overall Study|Lack of Efficacy|5
5351677|NCT00004228|18400363|P2|Overall Study|Lack of Efficacy|6
5351678|NCT00004228|18400364|P1|Overall Study|Lack of Efficacy|1
5351679|NCT00004228|18400358|P7|Overall Study|Death|0
5351680|NCT00004228|18400359|P6|Overall Study|Death|0
5351681|NCT00004228|18400360|P5|Overall Study|Death|1
5351682|NCT00004228|18400361|P4|Overall Study|Death|0
5351683|NCT00004228|18400362|P3|Overall Study|Death|2
5351684|NCT00004228|18400363|P2|Overall Study|Death|1
5351685|NCT00004228|18400364|P1|Overall Study|Death|0
5351686|NCT00004228|18400358|P7|Overall Study|Adverse Event|0
5351687|NCT00004228|18400359|P6|Overall Study|Adverse Event|0
5351688|NCT00004228|18400360|P5|Overall Study|Adverse Event|1
5351689|NCT00004228|18400361|P4|Overall Study|Adverse Event|0
5351690|NCT00004228|18400362|P3|Overall Study|Adverse Event|0
5351691|NCT00004228|18400363|P2|Overall Study|Adverse Event|1
5351692|NCT00004228|18400364|P1|Overall Study|Adverse Event|0
5351693|NCT00004124|18400398|P2|Overall Study|Received no protocol therapy|20
5351694|NCT00004124|18400399|P1|Overall Study|Received no protocol therapy|12
5351695|NCT00004088|18400424|P1|Overall Study|Physician Decision|1
5351696|NCT00004088|18400424|P1|Overall Study|Protocol Violation|3
5351697|NCT00004088|18400424|P1|Overall Study|Withdrawal by Subject|1
5351698|NCT00004088|18400424|P1|Overall Study|No C2 given due to study on hold by IRB|4
5351699|NCT00003901|18400457|P1|Overall Study|Medical problems|6
5351700|NCT00003901|18400457|P1|Overall Study|Chest X-Ray not done prior registration|1
5351701|NCT00003901|18400457|P1|Overall Study|CT Scan not within protocol requirement|2
5351702|NCT00003901|18400457|P1|Overall Study|Ineligible|6
5351703|NCT00003901|18400457|P1|Overall Study|Withdrawal by Subject|1
5351704|NCT00003901|18400457|P1|Overall Study|Adverse Event|1
5351705|NCT00003896|18400468|P1|Overall Study|ineligible|5
5351706|NCT00003896|18400468|P1|Overall Study|not protocol specified|3
5351707|NCT00003896|18400468|P1|Overall Study|Death|3
5351708|NCT00003896|18400468|P1|Overall Study|Lack of Efficacy|1
5351709|NCT00003896|18400468|P1|Overall Study|Withdrawal by Subject|1
5351710|NCT00003896|18400468|P1|Overall Study|Adverse Event|16
5351711|NCT00003875|18400474|P1|Overall Study|Screen Failed|1
5351712|NCT00003869|18400483|P2|Overall Study|Alternative treatmnt, medical problems|4
5351713|NCT00003869|18400484|P1|Overall Study|Alternative treatmnt, medical problems|5
5351714|NCT00003869|18400483|P2|Overall Study|Death|2
5351715|NCT00003869|18400484|P1|Overall Study|Death|1
5351716|NCT00003869|18400483|P2|Overall Study|Withdrawal by Subject|3
5351717|NCT00003869|18400484|P1|Overall Study|Withdrawal by Subject|21
5351718|NCT00003869|18400483|P2|Overall Study|Adverse Event|3
5351719|NCT00003869|18400484|P1|Overall Study|Adverse Event|14
5351720|NCT00003782|18400510|P3|Overall Study|No follow up data|26
5351721|NCT00003782|18400511|P2|Overall Study|No follow up data|31
5351722|NCT00003782|18400512|P1|Overall Study|No follow up data|30
5351723|NCT00003702|18400522|P2|Overall Study|Inadequate documentation of disease|3
5351724|NCT00003702|18400523|P1|Overall Study|Inadequate documentation of disease|1
5351725|NCT00003702|18400522|P2|Overall Study|WHO score > 6|1
5351726|NCT00003702|18400523|P1|Overall Study|WHO score > 6|2
5351727|NCT00003702|18400522|P2|Overall Study|Did not meet criteria for persistence|5
5351728|NCT00003702|18400523|P1|Overall Study|Did not meet criteria for persistence|8
5351729|NCT00003702|18400522|P2|Overall Study|Ineligible cell types|2
5351730|NCT00003702|18400523|P1|Overall Study|Ineligible cell types|2
5351731|NCT00003659|18400532|P1|Overall Study|Withdrawal by Subject|3
5351732|NCT00003641|18400553|P2|Overall Study|Never started interferon|12
5351733|NCT00003641|18400554|P1|Overall Study|Never started interferon|567
5351734|NCT00003641|18400553|P2|Overall Study|Should not receive interferon therapy|0
5351735|NCT00003641|18400554|P1|Overall Study|Should not receive interferon therapy|2
5351736|NCT00003641|18400553|P2|Overall Study|Unknown/missing|22
5351737|NCT00003641|18400554|P1|Overall Study|Unknown/missing|0
5351738|NCT00003641|18400553|P2|Overall Study|Disease progression|2
5351739|NCT00003641|18400554|P1|Overall Study|Disease progression|0
5351740|NCT00003641|18400553|P2|Overall Study|Adverse Event|38
5351741|NCT00003641|18400554|P1|Overall Study|Adverse Event|0
5351742|NCT00003641|18400553|P2|Overall Study|Withdrawal by Subject|100
5351743|NCT00003641|18400554|P1|Overall Study|Withdrawal by Subject|0
5351744|NCT00003631|18400565|P3|Overall Study|Evaluable for toxicity only|2
5351745|NCT00003631|18400566|P2|Overall Study|Evaluable for toxicity only|0
5351746|NCT00003631|18400567|P1|Overall Study|Evaluable for toxicity only|0
5351747|NCT00003631|18400565|P3|Overall Study|Death|1
5351748|NCT00003631|18400566|P2|Overall Study|Death|0
5351749|NCT00003631|18400567|P1|Overall Study|Death|0
5351750|NCT00003631|18400565|P3|Overall Study|Adverse Event|5
5351751|NCT00003631|18400566|P2|Overall Study|Adverse Event|1
5351752|NCT00003631|18400567|P1|Overall Study|Adverse Event|1
5351753|NCT00003631|18400565|P3|Overall Study|Protocol Violation|0
5351754|NCT00003631|18400566|P2|Overall Study|Protocol Violation|0
5351755|NCT00003631|18400567|P1|Overall Study|Protocol Violation|1
5351756|NCT00003631|18400565|P3|Overall Study|Patient not treated|1
5351757|NCT00003631|18400566|P2|Overall Study|Patient not treated|0
5351758|NCT00003631|18400567|P1|Overall Study|Patient not treated|1
5351759|NCT00003590|18400575|P1|Overall Study|Physician Decision|1
5351760|NCT00003590|18400575|P1|Overall Study|Death|1
5351761|NCT00003590|18400575|P1|Overall Study|Lack of Efficacy|11
5351762|NCT00003590|18400575|P1|Overall Study|Withdrawal by Subject|1
5351763|NCT00003590|18400575|P1|Overall Study|Adverse Event|7
5351764|NCT00003590|18400575|P1|Overall Study|Ineligible Patient|1
5351765|NCT00003537|18400580|P1|Overall Study|Not evalauable|1
5351766|NCT00003535|18400585|P1|Overall Study|Not evaluable|5
5351767|NCT00003499|18400590|P1|Overall Study|Not evaluable|8
5351768|NCT00003483|18400595|P1|Overall Study|Not evaluable|1
5351769|NCT00003479|18400600|P1|Overall Study|Not evaluable|3
5351770|NCT00003477|18400605|P1|Overall Study|Not evalauable|4
5351771|NCT00003476|18400610|P1|Overall Study|Not evaluable|1
5351772|NCT00003475|18400615|P1|Overall Study|Not evaluable|13
5351773|NCT00003474|18400620|P1|Overall Study|Not Evaluable|14
5351774|NCT00003473|18400625|P1|Overall Study|Three patients were not evaluable.|3
5351775|NCT00003472|18400630|P1|Overall Study|Not evaluable|3
5351776|NCT00003471|18400635|P1|Overall Study|Not evaluable|4
5351777|NCT00003470|18400640|P1|Overall Study|Not evaluable|6
5351778|NCT00003458|18400665|P1|Overall Study|Not evaluable|4
5351779|NCT00003457|18400670|P1|Overall Study|Not evaluable|9
5351780|NCT00003456|18400675|P1|Overall Study|Not evaluable|8
5351781|NCT00003389|18400692|P2|Overall Study|Ineligible|27
5351782|NCT00003389|18400693|P1|Overall Study|Ineligible|33
5351783|NCT00003389|18400692|P2|Overall Study|Off-treatment reason missing|21
5351784|NCT00003389|18400693|P1|Overall Study|Off-treatment reason missing|31
5351785|NCT00003389|18400692|P2|Overall Study|Complicating disease|0
5351786|NCT00003389|18400693|P1|Overall Study|Complicating disease|1
5351787|NCT00003389|18400692|P2|Overall Study|Alternative therapy|1
5351788|NCT00003389|18400693|P1|Overall Study|Alternative therapy|2
5351789|NCT00003389|18400692|P2|Overall Study|Withdrawal by Subject|5
5351790|NCT00003389|18400693|P1|Overall Study|Withdrawal by Subject|12
5351791|NCT00003389|18400692|P2|Overall Study|Death|3
5351792|NCT00003389|18400693|P1|Overall Study|Death|0
5351793|NCT00003389|18400692|P2|Overall Study|Adverse Event|2
5351794|NCT00003389|18400693|P1|Overall Study|Adverse Event|13
5351795|NCT00003389|18400692|P2|Overall Study|Disease progression|1
5351796|NCT00003389|18400693|P1|Overall Study|Disease progression|6
5351797|NCT00003377|18400708|P5|Period II|Ureteral stent complications|1
5351798|NCT00003377|18400709|P4|Period II|Ureteral stent complications|0
5351799|NCT00003377|18400710|P3|Period II|Ureteral stent complications|0
5351800|NCT00003377|18400711|P2|Period II|Ureteral stent complications|0
5351801|NCT00003377|18400712|P1|Period II|Ureteral stent complications|0
5351802|NCT00003377|18400708|P5|Period I|Dose Limiting Toxicity(DLT)|0
5351803|NCT00003377|18400709|P4|Period I|Dose Limiting Toxicity(DLT)|1
5351804|NCT00003377|18400710|P3|Period I|Dose Limiting Toxicity(DLT)|1
5351805|NCT00003377|18400711|P2|Period I|Dose Limiting Toxicity(DLT)|0
5351806|NCT00003377|18400712|P1|Period I|Dose Limiting Toxicity(DLT)|0
5351807|NCT00003199|18400726|P1|Overall Study|Screen fail|15
5351808|NCT00003199|18400726|P1|Overall Study|Lack of insurance clearance|2
5351809|NCT00003199|18400726|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
5351810|NCT00003138|18400734|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
5351811|NCT00003138|18400735|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
5351812|NCT00003138|18400734|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
5351813|NCT00003138|18400735|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
5351814|NCT00003138|18400734|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
5351815|NCT00003138|18400735|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
5351816|NCT00003138|18400734|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
5351817|NCT00003138|18400735|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
5351818|NCT00003138|18400734|P2|Step 1|Never started treatment|0
5351819|NCT00003138|18400735|P1|Step 1|Never started treatment|1
5351820|NCT00003138|18400734|P2|Step 1|Reasons off treatment not documented|57
5351821|NCT00003138|18400735|P1|Step 1|Reasons off treatment not documented|60
5351822|NCT00002931|18400752|P1|Overall Study|rapidly progressing disease during|2
5351823|NCT00002874|18400760|P2|Overall Study|Protocol Violation|34
5351824|NCT00002874|18400761|P1|Overall Study|Protocol Violation|44
5351825|NCT00002874|18400760|P2|Overall Study|Withdrawal by Subject|1
5351826|NCT00002874|18400761|P1|Overall Study|Withdrawal by Subject|1
5351827|NCT00002850|18400786|P3|Overall Study|Withdrawal by Subject|0
5351828|NCT00002850|18400787|P2|Overall Study|Withdrawal by Subject|1
5351829|NCT00002850|18400788|P1|Overall Study|Withdrawal by Subject|0
5351830|NCT00002850|18400786|P3|Overall Study|Protocol Violation|1
5351831|NCT00002850|18400787|P2|Overall Study|Protocol Violation|0
5351832|NCT00002850|18400788|P1|Overall Study|Protocol Violation|1
5351833|NCT00002850|18400786|P3|Overall Study|Death|3
5351834|NCT00002850|18400787|P2|Overall Study|Death|1
5351835|NCT00002850|18400788|P1|Overall Study|Death|4
5351836|NCT00002842|18400796|P1|Overall Study|ineligible for surgical resection|27
5351837|NCT00002766|18400802|P2|Overall Study|Protocol Violation|0
5351838|NCT00002766|18400803|P1|Overall Study|Protocol Violation|1
5351839|NCT00002766|18400802|P2|Overall Study|Adverse Event|1
5351840|NCT00002766|18400803|P1|Overall Study|Adverse Event|1
5351841|NCT00002766|18400802|P2|Overall Study|Patient Not Treated|2
5351842|NCT00002766|18400803|P1|Overall Study|Patient Not Treated|1
5351843|NCT00002766|18400802|P2|Overall Study|Withdrawal by Subject|1
5351844|NCT00002766|18400803|P1|Overall Study|Withdrawal by Subject|0
5351845|NCT00002651|18400811|P3|Consolidation and Randomization|not eligible|112
5351846|NCT00002651|18400812|P2|Consolidation and Randomization|not eligible|102
5351847|NCT00002651|18400813|P1|Consolidation and Randomization|not eligible|0
5351848|NCT00002651|18400811|P3|Consolidation and Randomization|Other|313
5351849|NCT00002651|18400812|P2|Consolidation and Randomization|Other|314
5351850|NCT00002651|18400813|P1|Consolidation and Randomization|Other|0
5351851|NCT00002651|18400811|P3|Consolidation and Randomization|Death|48
5351852|NCT00002651|18400812|P2|Consolidation and Randomization|Death|38
5351853|NCT00002651|18400813|P1|Consolidation and Randomization|Death|0
5351854|NCT00002651|18400811|P3|Consolidation and Randomization|Progression/relapse|298
5351855|NCT00002651|18400812|P2|Consolidation and Randomization|Progression/relapse|295
5351856|NCT00002651|18400813|P1|Consolidation and Randomization|Progression/relapse|0
5351857|NCT00002651|18400811|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
5351858|NCT00002651|18400812|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
5351859|NCT00002651|18400813|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
5351860|NCT00002651|18400811|P3|Consolidation and Randomization|Adverse Event|14
5351861|NCT00002651|18400812|P2|Consolidation and Randomization|Adverse Event|36
5351862|NCT00002651|18400813|P1|Consolidation and Randomization|Adverse Event|0
5351863|NCT00002651|18400811|P3|Induction|not eligible|0
5351864|NCT00002651|18400812|P2|Induction|not eligible|0
5351865|NCT00002651|18400813|P1|Induction|not eligible|90
5351866|NCT00002651|18400811|P3|Induction|Other|0
5351867|NCT00002651|18400812|P2|Induction|Other|0
5351868|NCT00002651|18400813|P1|Induction|Other|823
5351869|NCT00002651|18400811|P3|Induction|Death|0
5351870|NCT00002651|18400812|P2|Induction|Death|0
5351871|NCT00002651|18400813|P1|Induction|Death|62
5351872|NCT00002651|18400811|P3|Induction|Progression/relapse|0
5351873|NCT00002651|18400812|P2|Induction|Progression/relapse|0
5351874|NCT00002651|18400813|P1|Induction|Progression/relapse|274
5351875|NCT00002651|18400811|P3|Induction|Refusal unrelated to adverse event|0
5351876|NCT00002651|18400812|P2|Induction|Refusal unrelated to adverse event|0
5351877|NCT00002651|18400813|P1|Induction|Refusal unrelated to adverse event|50
5351878|NCT00002651|18400811|P3|Induction|Adverse Event|0
5351879|NCT00002651|18400812|P2|Induction|Adverse Event|0
5351880|NCT00002651|18400813|P1|Induction|Adverse Event|44
5351881|NCT00002558|18400831|P2|Overall Study|Withdrawal by Subject|1
5351882|NCT00002558|18400832|P1|Overall Study|Withdrawal by Subject|0
5351883|NCT00051636|18400857|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
5351884|NCT00051636|18400858|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
5351885|NCT00051636|18400857|P2|Period 2- Extended Observation Period|Death|5
5351886|NCT00051636|18400858|P1|Period 2- Extended Observation Period|Death|4
5351887|NCT00051636|18400857|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
5351888|NCT00051636|18400858|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
5351889|NCT00051636|18400857|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
5351890|NCT00051636|18400858|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
5351891|NCT00051636|18400857|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
5351892|NCT00051636|18400858|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
5351893|NCT00051636|18400857|P2|Period 1 - Core|Lost to Follow-up|2
5351894|NCT00051636|18400858|P1|Period 1 - Core|Lost to Follow-up|0
5351895|NCT00051636|18400857|P2|Period 1 - Core|Withdrawal by Subject|2
5351896|NCT00051636|18400858|P1|Period 1 - Core|Withdrawal by Subject|1
5351897|NCT00051636|18400857|P2|Period 1 - Core|Protocol Violation|0
5351898|NCT00051636|18400858|P1|Period 1 - Core|Protocol Violation|1
5351899|NCT00051636|18400857|P2|Period 1 - Core|Adverse Event|2
5351900|NCT00051636|18400858|P1|Period 1 - Core|Adverse Event|2
5351901|NCT00051558|18400886|P2|Overall Study|Physician Decision|0
5351902|NCT00051558|18400887|P1|Overall Study|Physician Decision|5
5351903|NCT00051558|18400886|P2|Overall Study|Significant Lab Value|0
5351904|NCT00051558|18400887|P1|Overall Study|Significant Lab Value|2
5351905|NCT00051558|18400886|P2|Overall Study|Other|1
5351906|NCT00051558|18400887|P1|Overall Study|Other|2
5351907|NCT00051558|18400886|P2|Overall Study|Sponsor Decision|1
5351908|NCT00051558|18400887|P1|Overall Study|Sponsor Decision|6
5351909|NCT00051558|18400886|P2|Overall Study|Protocol Entry Criteria Unmet|2
5351910|NCT00051558|18400887|P1|Overall Study|Protocol Entry Criteria Unmet|1
5351911|NCT00051558|18400886|P2|Overall Study|Protocol Violation|4
5351912|NCT00051558|18400887|P1|Overall Study|Protocol Violation|3
5351913|NCT00051558|18400886|P2|Overall Study|Lost to Follow-up|13
5351914|NCT00051558|18400887|P1|Overall Study|Lost to Follow-up|4
5351915|NCT00051558|18400886|P2|Overall Study|Death|15
5351916|NCT00051558|18400887|P1|Overall Study|Death|9
5351917|NCT00051558|18400886|P2|Overall Study|Withdrawal by Subject|42
5351918|NCT00051558|18400887|P1|Overall Study|Withdrawal by Subject|29
5351919|NCT00051558|18400886|P2|Overall Study|Adverse Event|18
5351920|NCT00051558|18400887|P1|Overall Study|Adverse Event|30
5351921|NCT00051363|18400923|P2|Overall Study|Excluded Pre-Randomization|5
5351922|NCT00051363|18400924|P1|Overall Study|Excluded Pre-Randomization|2
5351923|NCT00051363|18400923|P2|Overall Study|Death|2
5351924|NCT00051363|18400924|P1|Overall Study|Death|2
5351925|NCT00051363|18400923|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
5351926|NCT00051363|18400924|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
5351927|NCT00051363|18400923|P2|Overall Study|Dropped Post-Rand for Any Reason|126
5351928|NCT00051363|18400924|P1|Overall Study|Dropped Post-Rand for Any Reason|102
5351929|NCT00051025|18400964|P2|Overall Study|Death|1
5351930|NCT00051025|18400965|P1|Overall Study|Death|0
5351931|NCT00051025|18400964|P2|Overall Study|Withdrawal by Subject|1
5351932|NCT00051025|18400965|P1|Overall Study|Withdrawal by Subject|0
5351933|NCT00051025|18400964|P2|Overall Study|Adverse Event|1
5351934|NCT00051025|18400965|P1|Overall Study|Adverse Event|1
5351935|NCT00051025|18400964|P2|Overall Study|Progressive Disease|1
5351936|NCT00051025|18400965|P1|Overall Study|Progressive Disease|1
5351937|NCT00050960|18400979|P2|Overall Study|Death|15
5351938|NCT00050960|18400980|P1|Overall Study|Death|13
5351939|NCT00050960|18400979|P2|Overall Study|Non-compliance|1
5351940|NCT00050960|18400980|P1|Overall Study|Non-compliance|3
5351941|NCT00050960|18400979|P2|Overall Study|Administrative|46
5351942|NCT00050960|18400980|P1|Overall Study|Administrative|31
5351943|NCT00050960|18400979|P2|Overall Study|Withdrawal by Subject|18
5351944|NCT00050960|18400980|P1|Overall Study|Withdrawal by Subject|23
5351945|NCT00050960|18400979|P2|Overall Study|Lost to Follow-up|1
5351946|NCT00050960|18400980|P1|Overall Study|Lost to Follow-up|0
5351947|NCT00050960|18400979|P2|Overall Study|Adverse Event|61
5351948|NCT00050960|18400980|P1|Overall Study|Adverse Event|62
5351949|NCT00050960|18400979|P2|Overall Study|Complete Response|2
5351950|NCT00050960|18400980|P1|Overall Study|Complete Response|0
5351951|NCT00050960|18400979|P2|Overall Study|Partial Response|19
5351952|NCT00050960|18400980|P1|Overall Study|Partial Response|14
5351953|NCT00050960|18400979|P2|Overall Study|Stable Disease|48
5351954|NCT00050960|18400980|P1|Overall Study|Stable Disease|19
5351955|NCT00050960|18400979|P2|Overall Study|Progressive Disease|93
5351956|NCT00050960|18400980|P1|Overall Study|Progressive Disease|137
5351957|NCT00050778|18400989|P3|Overall Study|Familial and personal reasons|0
5351958|NCT00050778|18400990|P2|Overall Study|Familial and personal reasons|0
5351959|NCT00050778|18400991|P1|Overall Study|Familial and personal reasons|1
5351960|NCT00050778|18400989|P3|Overall Study|Randomized but not treated|2
5351961|NCT00050778|18400990|P2|Overall Study|Randomized but not treated|5
5351962|NCT00050778|18400991|P1|Overall Study|Randomized but not treated|4
5351963|NCT00050778|18400989|P3|Overall Study|Withdrawal by Subject|4
5351964|NCT00050778|18400990|P2|Overall Study|Withdrawal by Subject|8
5351965|NCT00050778|18400991|P1|Overall Study|Withdrawal by Subject|6
5351966|NCT00050778|18400989|P3|Overall Study|Protocol Violation|1
5351967|NCT00050778|18400990|P2|Overall Study|Protocol Violation|0
5351968|NCT00050778|18400991|P1|Overall Study|Protocol Violation|2
5351969|NCT00050778|18400989|P3|Overall Study|Physician Decision|2
5351970|NCT00050778|18400990|P2|Overall Study|Physician Decision|0
5351971|NCT00050778|18400991|P1|Overall Study|Physician Decision|3
5351972|NCT00050778|18400989|P3|Overall Study|Lost to Follow-up|4
5351973|NCT00050778|18400990|P2|Overall Study|Lost to Follow-up|2
5351974|NCT00050778|18400991|P1|Overall Study|Lost to Follow-up|0
5351975|NCT00050778|18400989|P3|Overall Study|Lack of Efficacy|2
5351976|NCT00050778|18400990|P2|Overall Study|Lack of Efficacy|2
5351977|NCT00050778|18400991|P1|Overall Study|Lack of Efficacy|16
5351978|NCT00050778|18400989|P3|Overall Study|Death|1
5351979|NCT00050778|18400990|P2|Overall Study|Death|1
5351980|NCT00050778|18400991|P1|Overall Study|Death|0
5351981|NCT00050778|18400989|P3|Overall Study|Adverse Event|2
5351982|NCT00050778|18400990|P2|Overall Study|Adverse Event|3
5351983|NCT00050778|18400991|P1|Overall Study|Adverse Event|13
5351984|NCT00050622|18401017|P1|Overall Study|Adverse Event|1
5351985|NCT00050167|18401055|P2|Overall Study|not eligible not invasive|1
5351986|NCT00050167|18401056|P1|Overall Study|not eligible not invasive|1
5351987|NCT00050011|18401089|P2|Overall Study|Unknown - Reason is missing|2
5351988|NCT00050011|18401090|P1|Overall Study|Unknown - Reason is missing|0
5351989|NCT00050011|18401089|P2|Overall Study|Death|4
5351990|NCT00050011|18401090|P1|Overall Study|Death|7
5351991|NCT00050011|18401089|P2|Overall Study|Administrative problems|6
5351992|NCT00050011|18401090|P1|Overall Study|Administrative problems|10
5351993|NCT00050011|18401089|P2|Overall Study|Lost to Follow-up|9
5351994|NCT00050011|18401090|P1|Overall Study|Lost to Follow-up|7
5351995|NCT00050011|18401089|P2|Overall Study|Withdrawal by Subject|26
5351996|NCT00050011|18401090|P1|Overall Study|Withdrawal by Subject|34
5351997|NCT00050011|18401089|P2|Overall Study|Protocol Violation|10
5351998|NCT00050011|18401090|P1|Overall Study|Protocol Violation|4
5351999|NCT00050011|18401089|P2|Overall Study|Participant condition no longer required|0
5352000|NCT00050011|18401090|P1|Overall Study|Participant condition no longer required|1
5352001|NCT00050011|18401089|P2|Overall Study|Lack of Efficacy|21
5352002|NCT00050011|18401090|P1|Overall Study|Lack of Efficacy|16
5352003|NCT00050011|18401089|P2|Overall Study|Abnormal test procedure results|1
5352004|NCT00050011|18401090|P1|Overall Study|Abnormal test procedure results|0
5352005|NCT00050011|18401089|P2|Overall Study|Abnormal laboratory value(s)|1
5352006|NCT00050011|18401090|P1|Overall Study|Abnormal laboratory value(s)|1
5352007|NCT00050011|18401089|P2|Overall Study|Adverse Event|46
5352008|NCT00050011|18401090|P1|Overall Study|Adverse Event|41
5352009|NCT00049842|18401112|P2|Follow-up Phase|Other|4
5352010|NCT00049842|18401113|P1|Follow-up Phase|Other|1
5352011|NCT00049842|18401112|P2|Follow-up Phase|Adverse Event|1
5352012|NCT00049842|18401113|P1|Follow-up Phase|Adverse Event|6
5352013|NCT00049842|18401112|P2|Treatment Phase|Did not meet protocol eligibility|1
5352014|NCT00049842|18401113|P1|Treatment Phase|Did not meet protocol eligibility|0
5352015|NCT00049842|18401112|P2|Treatment Phase|Administrative|3
5352016|NCT00049842|18401113|P1|Treatment Phase|Administrative|0
5352017|NCT00049842|18401112|P2|Treatment Phase|Lost to Follow-up|8
5352018|NCT00049842|18401113|P1|Treatment Phase|Lost to Follow-up|4
5352019|NCT00049842|18401112|P2|Treatment Phase|Non-compliance with protocol|8
5352020|NCT00049842|18401113|P1|Treatment Phase|Non-compliance with protocol|7
5352021|NCT00049842|18401112|P2|Treatment Phase|Withdrawal by Subject|46
5352022|NCT00049842|18401113|P1|Treatment Phase|Withdrawal by Subject|35
5352023|NCT00049842|18401112|P2|Treatment Phase|Adverse Event|12
5352024|NCT00049842|18401113|P1|Treatment Phase|Adverse Event|47
5352025|NCT00048932|18401131|P3|Open Label Period (OL)|Participant Surgery|1
5352026|NCT00048932|18401132|P2|Open Label Period (OL)|Participant Surgery|0
5352027|NCT00048932|18401133|P1|Open Label Period (OL)|Participant Surgery|0
5352028|NCT00048932|18401131|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
5352029|NCT00048932|18401132|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
5352030|NCT00048932|18401133|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
5352031|NCT00048932|18401131|P3|Open Label Period (OL)|Site Staff Issues|2
5352032|NCT00048932|18401132|P2|Open Label Period (OL)|Site Staff Issues|0
5352033|NCT00048932|18401133|P1|Open Label Period (OL)|Site Staff Issues|0
5352034|NCT00048932|18401131|P3|Open Label Period (OL)|Investigator Decision|4
5352035|NCT00048932|18401132|P2|Open Label Period (OL)|Investigator Decision|0
5352036|NCT00048932|18401133|P1|Open Label Period (OL)|Investigator Decision|0
5352037|NCT00048932|18401131|P3|Open Label Period (OL)|Medication Lost Efficacy|1
5352038|NCT00048932|18401132|P2|Open Label Period (OL)|Medication Lost Efficacy|0
5352039|NCT00048932|18401133|P1|Open Label Period (OL)|Medication Lost Efficacy|0
5352040|NCT00048932|18401131|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
5352041|NCT00048932|18401132|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
5352042|NCT00048932|18401133|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
5352043|NCT00048932|18401131|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
5352044|NCT00048932|18401132|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
5352045|NCT00048932|18401133|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
5352046|NCT00048932|18401131|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
5352047|NCT00048932|18401132|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
5352048|NCT00048932|18401133|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
5352049|NCT00048932|18401131|P3|Open Label Period (OL)|Patient Decision|4
5352050|NCT00048932|18401132|P2|Open Label Period (OL)|Patient Decision|0
5352051|NCT00048932|18401133|P1|Open Label Period (OL)|Patient Decision|0
5352052|NCT00048932|18401131|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
5352053|NCT00048932|18401132|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
5352054|NCT00048932|18401133|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
5352055|NCT00048932|18401131|P3|Open Label Period (OL)|Trial Terminated|1
5352056|NCT00048932|18401132|P2|Open Label Period (OL)|Trial Terminated|0
5352057|NCT00048932|18401133|P1|Open Label Period (OL)|Trial Terminated|0
5352058|NCT00048932|18401131|P3|Open Label Period (OL)|Site Closure|3
5352059|NCT00048932|18401132|P2|Open Label Period (OL)|Site Closure|0
5352060|NCT00048932|18401133|P1|Open Label Period (OL)|Site Closure|0
5352061|NCT00048932|18401131|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
5352062|NCT00048932|18401132|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
5352063|NCT00048932|18401133|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
5352064|NCT00048932|18401131|P3|Open Label Period (OL)|Participant Relocated|6
5352065|NCT00048932|18401132|P2|Open Label Period (OL)|Participant Relocated|0
5352066|NCT00048932|18401133|P1|Open Label Period (OL)|Participant Relocated|0
5352067|NCT00048932|18401131|P3|Open Label Period (OL)|Participant Transportation Issues|1
5352068|NCT00048932|18401132|P2|Open Label Period (OL)|Participant Transportation Issues|0
5352069|NCT00048932|18401133|P1|Open Label Period (OL)|Participant Transportation Issues|0
5352070|NCT00048932|18401131|P3|Open Label Period (OL)|Investigator Retiring|2
5352071|NCT00048932|18401132|P2|Open Label Period (OL)|Investigator Retiring|0
5352072|NCT00048932|18401133|P1|Open Label Period (OL)|Investigator Retiring|0
5352073|NCT00048932|18401131|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
5352074|NCT00048932|18401132|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
5352075|NCT00048932|18401133|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
5352076|NCT00048932|18401131|P3|Open Label Period (OL)|Pregnancy|6
5352077|NCT00048932|18401132|P2|Open Label Period (OL)|Pregnancy|0
5352078|NCT00048932|18401133|P1|Open Label Period (OL)|Pregnancy|0
5352079|NCT00048932|18401131|P3|Open Label Period (OL)|Poor/Non-Compliance|13
5352080|NCT00048932|18401132|P2|Open Label Period (OL)|Poor/Non-Compliance|0
5352081|NCT00048932|18401133|P1|Open Label Period (OL)|Poor/Non-Compliance|0
5352082|NCT00048932|18401131|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
5352083|NCT00048932|18401132|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
5352084|NCT00048932|18401133|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
5352085|NCT00048932|18401131|P3|Open Label Period (OL)|Withdrawal by Subject|117
5352086|NCT00048932|18401132|P2|Open Label Period (OL)|Withdrawal by Subject|0
5352087|NCT00048932|18401133|P1|Open Label Period (OL)|Withdrawal by Subject|0
5352088|NCT00048932|18401131|P3|Open Label Period (OL)|Lost to Follow-up|27
5352089|NCT00048932|18401132|P2|Open Label Period (OL)|Lost to Follow-up|0
5352090|NCT00048932|18401133|P1|Open Label Period (OL)|Lost to Follow-up|0
5352091|NCT00048932|18401131|P3|Open Label Period (OL)|Lack of Efficacy|81
5352092|NCT00048932|18401132|P2|Open Label Period (OL)|Lack of Efficacy|0
5352093|NCT00048932|18401133|P1|Open Label Period (OL)|Lack of Efficacy|0
5352094|NCT00048932|18401131|P3|Open Label Period (OL)|Adverse Event|103
5352095|NCT00048932|18401132|P2|Open Label Period (OL)|Adverse Event|0
5352096|NCT00048932|18401133|P1|Open Label Period (OL)|Adverse Event|0
5352097|NCT00048932|18401131|P3|Open Label Period (OL)|Death|25
5352098|NCT00048932|18401132|P2|Open Label Period (OL)|Death|0
5352099|NCT00048932|18401133|P1|Open Label Period (OL)|Death|0
5352100|NCT00048932|18401131|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
5352101|NCT00048932|18401132|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
5352102|NCT00048932|18401133|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
5352103|NCT00048932|18401131|P3|Double Blind Period (DB)|Withdrawal by Subject|0
5352104|NCT00048932|18401132|P2|Double Blind Period (DB)|Withdrawal by Subject|10
5352105|NCT00048932|18401133|P1|Double Blind Period (DB)|Withdrawal by Subject|24
5352106|NCT00048932|18401131|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
5352107|NCT00048932|18401132|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
5352108|NCT00048932|18401133|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
5352109|NCT00048932|18401131|P3|Double Blind Period (DB)|Pregnancy|0
5352110|NCT00048932|18401132|P2|Double Blind Period (DB)|Pregnancy|0
5352111|NCT00048932|18401133|P1|Double Blind Period (DB)|Pregnancy|1
5352112|NCT00048932|18401131|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
5352113|NCT00048932|18401132|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
5352114|NCT00048932|18401133|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
5352115|NCT00048932|18401131|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
5352116|NCT00048932|18401132|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
5352117|NCT00048932|18401133|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
5352118|NCT00048932|18401131|P3|Double Blind Period (DB)|Relocation|0
5352119|NCT00048932|18401132|P2|Double Blind Period (DB)|Relocation|0
5352120|NCT00048932|18401133|P1|Double Blind Period (DB)|Relocation|1
5352121|NCT00048932|18401131|P3|Double Blind Period (DB)|Lost to Follow-up|0
5352122|NCT00048932|18401132|P2|Double Blind Period (DB)|Lost to Follow-up|4
5352123|NCT00048932|18401133|P1|Double Blind Period (DB)|Lost to Follow-up|3
5352124|NCT00048932|18401131|P3|Double Blind Period (DB)|Lack of Efficacy|0
5352125|NCT00048932|18401132|P2|Double Blind Period (DB)|Lack of Efficacy|44
5352126|NCT00048932|18401133|P1|Double Blind Period (DB)|Lack of Efficacy|26
5352127|NCT00048932|18401131|P3|Double Blind Period (DB)|Death|0
5352128|NCT00048932|18401132|P2|Double Blind Period (DB)|Death|3
5352129|NCT00048932|18401133|P1|Double Blind Period (DB)|Death|5
5352130|NCT00048932|18401131|P3|Double Blind Period (DB)|Adverse Event|0
5352131|NCT00048932|18401132|P2|Double Blind Period (DB)|Adverse Event|19
5352132|NCT00048932|18401133|P1|Double Blind Period (DB)|Adverse Event|51
5352133|NCT00048932|18401131|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
5352134|NCT00048932|18401132|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
5352135|NCT00048932|18401133|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
5352136|NCT00048581|18401175|P3|Open-Label Period|Study Ended By Sponsor|1
5352137|NCT00048581|18401176|P2|Open-Label Period|Study Ended By Sponsor|0
5352138|NCT00048581|18401177|P1|Open-Label Period|Study Ended By Sponsor|0
5352139|NCT00048581|18401175|P3|Open-Label Period|Primary Investigator Retired|2
5352140|NCT00048581|18401176|P2|Open-Label Period|Primary Investigator Retired|0
5352141|NCT00048581|18401177|P1|Open-Label Period|Primary Investigator Retired|0
5352142|NCT00048581|18401175|P3|Open-Label Period|Problem With Transportation To Site|1
5352143|NCT00048581|18401176|P2|Open-Label Period|Problem With Transportation To Site|0
5352144|NCT00048581|18401177|P1|Open-Label Period|Problem With Transportation To Site|0
5352145|NCT00048581|18401175|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
5352146|NCT00048581|18401176|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
5352147|NCT00048581|18401177|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
5352148|NCT00048581|18401175|P3|Open-Label Period|Study Site Closure|2
5352149|NCT00048581|18401176|P2|Open-Label Period|Study Site Closure|0
5352150|NCT00048581|18401177|P1|Open-Label Period|Study Site Closure|0
5352151|NCT00048581|18401175|P3|Open-Label Period|Pregnancy|7
5352152|NCT00048581|18401176|P2|Open-Label Period|Pregnancy|0
5352153|NCT00048581|18401177|P1|Open-Label Period|Pregnancy|0
5352154|NCT00048581|18401175|P3|Open-Label Period|Poor/Non-compliance|5
5352155|NCT00048581|18401176|P2|Open-Label Period|Poor/Non-compliance|0
5352156|NCT00048581|18401177|P1|Open-Label Period|Poor/Non-compliance|0
5352157|NCT00048581|18401175|P3|Open-Label Period|No Longer Meets Study Criteria|2
5352158|NCT00048581|18401176|P2|Open-Label Period|No Longer Meets Study Criteria|0
5352159|NCT00048581|18401177|P1|Open-Label Period|No Longer Meets Study Criteria|0
5352160|NCT00048581|18401175|P3|Open-Label Period|Withdrawal by Subject|20
5352161|NCT00048581|18401176|P2|Open-Label Period|Withdrawal by Subject|0
5352162|NCT00048581|18401177|P1|Open-Label Period|Withdrawal by Subject|0
5352163|NCT00048581|18401175|P3|Open-Label Period|Lost to Follow-up|14
5352164|NCT00048581|18401176|P2|Open-Label Period|Lost to Follow-up|0
5352165|NCT00048581|18401177|P1|Open-Label Period|Lost to Follow-up|0
5352166|NCT00048581|18401175|P3|Open-Label Period|Lack of Efficacy|69
5352167|NCT00048581|18401176|P2|Open-Label Period|Lack of Efficacy|0
5352168|NCT00048581|18401177|P1|Open-Label Period|Lack of Efficacy|0
5352169|NCT00048581|18401175|P3|Open-Label Period|Adverse Event|37
5352170|NCT00048581|18401176|P2|Open-Label Period|Adverse Event|0
5352171|NCT00048581|18401177|P1|Open-Label Period|Adverse Event|0
5352172|NCT00048581|18401175|P3|Open-Label Period|Death|4
5352173|NCT00048581|18401176|P2|Open-Label Period|Death|0
5352174|NCT00048581|18401177|P1|Open-Label Period|Death|0
5352175|NCT00048581|18401175|P3|Double-Blind Period|Investigator Decision|0
5352176|NCT00048581|18401176|P2|Double-Blind Period|Investigator Decision|0
5352177|NCT00048581|18401177|P1|Double-Blind Period|Investigator Decision|1
5352178|NCT00048581|18401175|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
5352179|NCT00048581|18401176|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
5352180|NCT00048581|18401177|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
5352181|NCT00048581|18401175|P3|Double-Blind Period|Withdrawal by Subject|0
5352182|NCT00048581|18401176|P2|Double-Blind Period|Withdrawal by Subject|2
5352183|NCT00048581|18401177|P1|Double-Blind Period|Withdrawal by Subject|5
5352184|NCT00048581|18401175|P3|Double-Blind Period|Lost to Follow-up|0
5352185|NCT00048581|18401176|P2|Double-Blind Period|Lost to Follow-up|0
5352186|NCT00048581|18401177|P1|Double-Blind Period|Lost to Follow-up|5
5352187|NCT00048581|18401175|P3|Double-Blind Period|Lack of Efficacy|0
5352188|NCT00048581|18401176|P2|Double-Blind Period|Lack of Efficacy|27
5352189|NCT00048581|18401177|P1|Double-Blind Period|Lack of Efficacy|14
5352190|NCT00048581|18401175|P3|Double-Blind Period|Adverse Event|0
5352191|NCT00048581|18401176|P2|Double-Blind Period|Adverse Event|5
5352192|NCT00048581|18401177|P1|Double-Blind Period|Adverse Event|9
5352193|NCT00048568|18401344|P3|Open-Label Period|Lost to Follow-up|7
5352194|NCT00048568|18401345|P2|Open-Label Period|Lost to Follow-up|0
5352195|NCT00048568|18401346|P1|Open-Label Period|Lost to Follow-up|0
5352196|NCT00048568|18401344|P3|Open-Label Period|Unknown Reasons|25
5352197|NCT00048568|18401345|P2|Open-Label Period|Unknown Reasons|0
5352198|NCT00048568|18401346|P1|Open-Label Period|Unknown Reasons|0
5352199|NCT00048568|18401344|P3|Open-Label Period|Administrative Decision By Sponsor|1
5352200|NCT00048568|18401345|P2|Open-Label Period|Administrative Decision By Sponsor|0
5352201|NCT00048568|18401346|P1|Open-Label Period|Administrative Decision By Sponsor|0
5352202|NCT00048568|18401344|P3|Open-Label Period|No Longer Met Study Criteria|2
5352203|NCT00048568|18401345|P2|Open-Label Period|No Longer Met Study Criteria|0
5352204|NCT00048568|18401346|P1|Open-Label Period|No Longer Met Study Criteria|0
5352205|NCT00048568|18401344|P3|Open-Label Period|Pregnancy|5
5352206|NCT00048568|18401345|P2|Open-Label Period|Pregnancy|0
5352207|NCT00048568|18401346|P1|Open-Label Period|Pregnancy|0
5352208|NCT00048568|18401344|P3|Open-Label Period|Withdrawal by Subject|26
5352209|NCT00048568|18401345|P2|Open-Label Period|Withdrawal by Subject|0
5352210|NCT00048568|18401346|P1|Open-Label Period|Withdrawal by Subject|0
5352211|NCT00048568|18401344|P3|Open-Label Period|Lack of Efficacy|32
5352212|NCT00048568|18401345|P2|Open-Label Period|Lack of Efficacy|0
5352213|NCT00048568|18401346|P1|Open-Label Period|Lack of Efficacy|0
5352214|NCT00048568|18401344|P3|Open-Label Period|Adverse Event|49
5352215|NCT00048568|18401345|P2|Open-Label Period|Adverse Event|0
5352216|NCT00048568|18401346|P1|Open-Label Period|Adverse Event|0
5352217|NCT00048568|18401344|P3|Open-Label Period|Death|13
5352218|NCT00048568|18401345|P2|Open-Label Period|Death|0
5352219|NCT00048568|18401346|P1|Open-Label Period|Death|0
5352220|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
5352221|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
5352222|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
5352223|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
5352224|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
5352225|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
5352226|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
5352227|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
5352228|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
5352229|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
5352230|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
5352231|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
5352232|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
5352233|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
5352234|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
5352235|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
5352236|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
5352237|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
5352238|NCT00048568|18401344|P3|Double-Blind Period Days 170 to 365|Death|0
5352239|NCT00048568|18401345|P2|Double-Blind Period Days 170 to 365|Death|1
5352240|NCT00048568|18401346|P1|Double-Blind Period Days 170 to 365|Death|1
5352241|NCT00048568|18401344|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
5352242|NCT00048568|18401345|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
5352243|NCT00048568|18401346|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
5352244|NCT00048568|18401344|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
5352245|NCT00048568|18401345|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
5352246|NCT00048568|18401346|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
5352247|NCT00048568|18401344|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
5352248|NCT00048568|18401345|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
5352249|NCT00048568|18401346|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
5352250|NCT00048568|18401344|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
5352251|NCT00048568|18401345|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
5352252|NCT00048568|18401346|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
5352253|NCT00048568|18401344|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
5352254|NCT00048568|18401345|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
5352255|NCT00048568|18401346|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
5352256|NCT00048724|18401651|P2|Overall Study|Administrative|1
5352257|NCT00048724|18401652|P1|Overall Study|Administrative|1
5352258|NCT00048724|18401651|P2|Overall Study|Did Not Meet Protocol Eligibility|2
5352259|NCT00048724|18401652|P1|Overall Study|Did Not Meet Protocol Eligibility|2
5352260|NCT00048724|18401651|P2|Overall Study|Noncompliance With Protocol|12
5352261|NCT00048724|18401652|P1|Overall Study|Noncompliance With Protocol|4
5352262|NCT00048724|18401651|P2|Overall Study|Protocol-defined Clinical Event|32
5352263|NCT00048724|18401652|P1|Overall Study|Protocol-defined Clinical Event|17
5352264|NCT00048724|18401651|P2|Overall Study|Lost to Follow-up|5
5352265|NCT00048724|18401652|P1|Overall Study|Lost to Follow-up|5
5352266|NCT00048724|18401651|P2|Overall Study|Withdrawal by Subject|54
5352267|NCT00048724|18401652|P1|Overall Study|Withdrawal by Subject|34
5352268|NCT00048724|18401651|P2|Overall Study|Adverse Event|12
5352269|NCT00048724|18401652|P1|Overall Study|Adverse Event|53
5352270|NCT00048542|18401664|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
5352271|NCT00048542|18401665|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
5352272|NCT00048542|18401666|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5352273|NCT00048542|18401667|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5352274|NCT00048542|18401668|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5352275|NCT00048542|18401669|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5352276|NCT00048542|18401670|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5352277|NCT00048542|18401671|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5352278|NCT00048542|18401664|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
5352279|NCT00048542|18401665|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
5352280|NCT00048542|18401666|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5352281|NCT00048542|18401667|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5352282|NCT00048542|18401668|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5352283|NCT00048542|18401669|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5352284|NCT00048542|18401670|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5352285|NCT00048542|18401671|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5352286|NCT00048542|18401664|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
5352287|NCT00048542|18401665|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
5352288|NCT00048542|18401666|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5352289|NCT00048542|18401667|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5352290|NCT00048542|18401668|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5352291|NCT00048542|18401669|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5352292|NCT00048542|18401670|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5352293|NCT00048542|18401671|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5352294|NCT00048542|18401664|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
5352295|NCT00048542|18401665|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
5352296|NCT00048542|18401666|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5352297|NCT00048542|18401667|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5352298|NCT00048542|18401668|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5352299|NCT00048542|18401669|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5352300|NCT00048542|18401670|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5352301|NCT00048542|18401671|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5352302|NCT00048542|18401664|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
5352303|NCT00048542|18401665|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
5352304|NCT00048542|18401666|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5352305|NCT00048542|18401667|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5352306|NCT00048542|18401668|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5352307|NCT00048542|18401669|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5352308|NCT00048542|18401670|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5352309|NCT00048542|18401671|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5352310|NCT00048542|18401664|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
5352311|NCT00048542|18401665|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
5352312|NCT00048542|18401666|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5352313|NCT00048542|18401667|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5352314|NCT00048542|18401668|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5352315|NCT00048542|18401669|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5352316|NCT00048542|18401670|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5352317|NCT00048542|18401671|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5352318|NCT00048542|18401664|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
5352319|NCT00048542|18401665|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
5352320|NCT00048542|18401666|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
5352321|NCT00048542|18401667|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
5352322|NCT00048542|18401668|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
5352323|NCT00048542|18401669|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
5352324|NCT00048542|18401670|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
5352325|NCT00048542|18401671|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
5352326|NCT00048542|18401664|P8|Open-Label Extension BSA Phase|Adverse Event|0
5352327|NCT00048542|18401665|P7|Open-Label Extension BSA Phase|Adverse Event|0
5352328|NCT00048542|18401666|P6|Open-Label Extension BSA Phase|Adverse Event|1
5352329|NCT00048542|18401667|P5|Open-Label Extension BSA Phase|Adverse Event|1
5352330|NCT00048542|18401668|P4|Open-Label Extension BSA Phase|Adverse Event|0
5352331|NCT00048542|18401669|P3|Open-Label Extension BSA Phase|Adverse Event|0
5352332|NCT00048542|18401670|P2|Open-Label Extension BSA Phase|Adverse Event|0
5352333|NCT00048542|18401671|P1|Open-Label Extension BSA Phase|Adverse Event|0
5352334|NCT00048542|18401664|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
5352335|NCT00048542|18401665|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
5352336|NCT00048542|18401666|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
5352337|NCT00048542|18401667|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
5352338|NCT00048542|18401668|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
5352339|NCT00048542|18401669|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
5352340|NCT00048542|18401670|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
5352341|NCT00048542|18401671|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
5352342|NCT00048542|18401664|P8|Open-Label Extension BSA Phase|Protocol Violation|0
5352343|NCT00048542|18401665|P7|Open-Label Extension BSA Phase|Protocol Violation|0
5352344|NCT00048542|18401666|P6|Open-Label Extension BSA Phase|Protocol Violation|1
5352345|NCT00048542|18401667|P5|Open-Label Extension BSA Phase|Protocol Violation|0
5352346|NCT00048542|18401668|P4|Open-Label Extension BSA Phase|Protocol Violation|0
5352347|NCT00048542|18401669|P3|Open-Label Extension BSA Phase|Protocol Violation|0
5352348|NCT00048542|18401670|P2|Open-Label Extension BSA Phase|Protocol Violation|0
5352349|NCT00048542|18401671|P1|Open-Label Extension BSA Phase|Protocol Violation|0
5352350|NCT00048542|18401664|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5352351|NCT00048542|18401665|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5352352|NCT00048542|18401666|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
5352353|NCT00048542|18401667|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
5352354|NCT00048542|18401668|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5352355|NCT00048542|18401669|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5352356|NCT00048542|18401670|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5352357|NCT00048542|18401671|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5352358|NCT00048542|18401664|P8|Double-Blind Phase|Randomized in error|0
5352359|NCT00048542|18401665|P7|Double-Blind Phase|Randomized in error|0
5352360|NCT00048542|18401666|P6|Double-Blind Phase|Randomized in error|0
5352361|NCT00048542|18401667|P5|Double-Blind Phase|Randomized in error|0
5352362|NCT00048542|18401668|P4|Double-Blind Phase|Randomized in error|0
5352363|NCT00048542|18401669|P3|Double-Blind Phase|Randomized in error|0
5352364|NCT00048542|18401670|P2|Double-Blind Phase|Randomized in error|0
5352365|NCT00048542|18401671|P1|Double-Blind Phase|Randomized in error|1
5352366|NCT00048542|18401664|P8|Double-Blind Phase|Sponsor request or decision|0
5352367|NCT00048542|18401665|P7|Double-Blind Phase|Sponsor request or decision|0
5352368|NCT00048542|18401666|P6|Double-Blind Phase|Sponsor request or decision|0
5352369|NCT00048542|18401667|P5|Double-Blind Phase|Sponsor request or decision|0
5352370|NCT00048542|18401668|P4|Double-Blind Phase|Sponsor request or decision|0
5352371|NCT00048542|18401669|P3|Double-Blind Phase|Sponsor request or decision|0
5352372|NCT00048542|18401670|P2|Double-Blind Phase|Sponsor request or decision|0
5352373|NCT00048542|18401671|P1|Double-Blind Phase|Sponsor request or decision|2
5352374|NCT00048542|18401664|P8|Double-Blind Phase|Protocol Violation|0
5352375|NCT00048542|18401665|P7|Double-Blind Phase|Protocol Violation|0
5352376|NCT00048542|18401666|P6|Double-Blind Phase|Protocol Violation|0
5352377|NCT00048542|18401667|P5|Double-Blind Phase|Protocol Violation|0
5352378|NCT00048542|18401668|P4|Double-Blind Phase|Protocol Violation|0
5352379|NCT00048542|18401669|P3|Double-Blind Phase|Protocol Violation|1
5352380|NCT00048542|18401670|P2|Double-Blind Phase|Protocol Violation|0
5352381|NCT00048542|18401671|P1|Double-Blind Phase|Protocol Violation|0
5352382|NCT00048542|18401664|P8|Double-Blind Phase|Withdrawal by Subject|0
5352383|NCT00048542|18401665|P7|Double-Blind Phase|Withdrawal by Subject|0
5352384|NCT00048542|18401666|P6|Double-Blind Phase|Withdrawal by Subject|0
5352385|NCT00048542|18401667|P5|Double-Blind Phase|Withdrawal by Subject|0
5352386|NCT00048542|18401668|P4|Double-Blind Phase|Withdrawal by Subject|0
5352387|NCT00048542|18401669|P3|Double-Blind Phase|Withdrawal by Subject|0
5352388|NCT00048542|18401670|P2|Double-Blind Phase|Withdrawal by Subject|1
5352389|NCT00048542|18401671|P1|Double-Blind Phase|Withdrawal by Subject|0
5352390|NCT00048347|18401737|P1|Overall Study|Screen failure|2
5352391|NCT00048165|18401743|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
5352392|NCT00048165|18401744|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
5352393|NCT00048165|18401743|P2|Completed 12 Months Study|Death|1
5352394|NCT00048165|18401744|P1|Completed 12 Months Study|Death|2
5352395|NCT00048165|18401743|P2|Completed 12 Months Study|Administration/Other|2
5352396|NCT00048165|18401744|P1|Completed 12 Months Study|Administration/Other|0
5352397|NCT00048165|18401743|P2|Completed 6 Months Study|Did not receive study drug|6
5352398|NCT00048165|18401744|P1|Completed 6 Months Study|Did not receive study drug|6
5352399|NCT00048165|18401743|P2|Completed 6 Months Study|Violation criteria|2
5352400|NCT00048165|18401744|P1|Completed 6 Months Study|Violation criteria|0
5352401|NCT00048165|18401743|P2|Completed 6 Months Study|Refused treatment|5
5352402|NCT00048165|18401744|P1|Completed 6 Months Study|Refused treatment|5
5352403|NCT00048165|18401743|P2|Completed 6 Months Study|Other violation|6
5352404|NCT00048165|18401744|P1|Completed 6 Months Study|Other violation|4
5352405|NCT00048165|18401743|P2|Completed 6 Months Study|Insufficient therapy|4
5352406|NCT00048165|18401744|P1|Completed 6 Months Study|Insufficient therapy|1
5352407|NCT00048165|18401743|P2|Completed 6 Months Study|Death|6
5352408|NCT00048165|18401744|P1|Completed 6 Months Study|Death|12
5352409|NCT00048165|18401743|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
5352410|NCT00048165|18401744|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
5352411|NCT00048165|18401743|P2|Completed 6 Months Study|Abnormality of laboratory test|0
5352412|NCT00048165|18401744|P1|Completed 6 Months Study|Abnormality of laboratory test|1
5352413|NCT00048165|18401743|P2|Completed 6 Months Study|Administration/Other|8
5352414|NCT00048165|18401744|P1|Completed 6 Months Study|Administration/Other|8
5352415|NCT00048074|18401779|P3|Overall Study|Social reasons|0
5352416|NCT00048074|18401780|P2|Overall Study|Social reasons|0
5352417|NCT00048074|18401781|P1|Overall Study|Social reasons|1
5352418|NCT00048074|18401779|P3|Overall Study|Out of station|1
5352419|NCT00048074|18401780|P2|Overall Study|Out of station|1
5352420|NCT00048074|18401781|P1|Overall Study|Out of station|0
5352421|NCT00048074|18401779|P3|Overall Study|Poor compliance|0
5352422|NCT00048074|18401780|P2|Overall Study|Poor compliance|1
5352423|NCT00048074|18401781|P1|Overall Study|Poor compliance|0
5352424|NCT00048074|18401779|P3|Overall Study|Husband ill|0
5352425|NCT00048074|18401780|P2|Overall Study|Husband ill|1
5352426|NCT00048074|18401781|P1|Overall Study|Husband ill|0
5352427|NCT00048074|18401779|P3|Overall Study|Study participation was terminated|0
5352428|NCT00048074|18401780|P2|Overall Study|Study participation was terminated|1
5352429|NCT00048074|18401781|P1|Overall Study|Study participation was terminated|0
5352430|NCT00048074|18401779|P3|Overall Study|Protocol Violation|0
5352431|NCT00048074|18401780|P2|Overall Study|Protocol Violation|3
5352432|NCT00048074|18401781|P1|Overall Study|Protocol Violation|1
5352433|NCT00048074|18401779|P3|Overall Study|Withdrawal by Subject|35
5352434|NCT00048074|18401780|P2|Overall Study|Withdrawal by Subject|30
5352435|NCT00048074|18401781|P1|Overall Study|Withdrawal by Subject|28
5352436|NCT00048074|18401779|P3|Overall Study|Lost to Follow-up|6
5352437|NCT00048074|18401780|P2|Overall Study|Lost to Follow-up|6
5352438|NCT00048074|18401781|P1|Overall Study|Lost to Follow-up|2
5352439|NCT00048074|18401779|P3|Overall Study|Death|2
5352440|NCT00048074|18401780|P2|Overall Study|Death|3
5352441|NCT00048074|18401781|P1|Overall Study|Death|3
5352442|NCT00048074|18401779|P3|Overall Study|Adverse Event|53
5352443|NCT00048074|18401780|P2|Overall Study|Adverse Event|41
5352444|NCT00048074|18401781|P1|Overall Study|Adverse Event|46
5352445|NCT00048061|18401838|P4|Overall Study|Early improvement|0
5352446|NCT00048061|18401839|P3|Overall Study|Early improvement|3
5352447|NCT00048061|18401840|P2|Overall Study|Early improvement|5
5352448|NCT00048061|18401841|P1|Overall Study|Early improvement|6
5352449|NCT00048061|18401838|P4|Overall Study|Did not follow-up|5
5352450|NCT00048061|18401839|P3|Overall Study|Did not follow-up|4
5352451|NCT00048061|18401840|P2|Overall Study|Did not follow-up|5
5352452|NCT00048061|18401841|P1|Overall Study|Did not follow-up|5
5352453|NCT00048061|18401838|P4|Overall Study|Withdrawal by Subject|32
5352454|NCT00048061|18401839|P3|Overall Study|Withdrawal by Subject|29
5352455|NCT00048061|18401840|P2|Overall Study|Withdrawal by Subject|29
5352456|NCT00048061|18401841|P1|Overall Study|Withdrawal by Subject|20
5352457|NCT00048061|18401838|P4|Overall Study|Lost to Follow-up|5
5352458|NCT00048061|18401839|P3|Overall Study|Lost to Follow-up|4
5352459|NCT00048061|18401840|P2|Overall Study|Lost to Follow-up|2
5352460|NCT00048061|18401841|P1|Overall Study|Lost to Follow-up|3
5352461|NCT00048061|18401838|P4|Overall Study|Adverse Event|37
5352462|NCT00048061|18401839|P3|Overall Study|Adverse Event|44
5352463|NCT00048061|18401840|P2|Overall Study|Adverse Event|32
5352464|NCT00048061|18401841|P1|Overall Study|Adverse Event|41
5352465|NCT00048048|18401920|P12|Extension Year 2|Early withdrawals|2
5352466|NCT00048048|18401921|P11|Extension Year 2|Early withdrawals|4
5352467|NCT00048048|18401922|P10|Extension Year 2|Early withdrawals|0
5352468|NCT00048048|18401923|P9|Extension Year 2|Early withdrawals|0
5352469|NCT00048048|18401924|P8|Extension Year 2|Early withdrawals|0
5352470|NCT00048048|18401925|P7|Extension Year 2|Early withdrawals|0
5352471|NCT00048048|18401926|P6|Extension Year 2|Early withdrawals|0
5352472|NCT00048048|18401927|P5|Extension Year 2|Early withdrawals|0
5352473|NCT00048048|18401928|P4|Extension Year 2|Early withdrawals|0
5352474|NCT00048048|18401929|P3|Extension Year 2|Early withdrawals|0
5352475|NCT00048048|18401930|P2|Extension Year 2|Early withdrawals|0
5352476|NCT00048048|18401931|P1|Extension Year 2|Early withdrawals|0
5352477|NCT00048048|18401920|P12|Extension Year 1|Early withdrawals|4
5352478|NCT00048048|18401921|P11|Extension Year 1|Early withdrawals|2
5352479|NCT00048048|18401922|P10|Extension Year 1|Early withdrawals|2
5352480|NCT00048048|18401923|P9|Extension Year 1|Early withdrawals|0
5352481|NCT00048048|18401924|P8|Extension Year 1|Early withdrawals|0
5352482|NCT00048048|18401925|P7|Extension Year 1|Early withdrawals|0
5352483|NCT00048048|18401926|P6|Extension Year 1|Early withdrawals|0
5352484|NCT00048048|18401927|P5|Extension Year 1|Early withdrawals|0
5352485|NCT00048048|18401928|P4|Extension Year 1|Early withdrawals|0
5352486|NCT00048048|18401929|P3|Extension Year 1|Early withdrawals|0
5352487|NCT00048048|18401930|P2|Extension Year 1|Early withdrawals|0
5352488|NCT00048048|18401931|P1|Extension Year 1|Early withdrawals|0
5352489|NCT00048048|18401920|P12|Core Treatment|Adverse Event|0
5352490|NCT00048048|18401921|P11|Core Treatment|Adverse Event|0
5352491|NCT00048048|18401922|P10|Core Treatment|Adverse Event|0
5352492|NCT00048048|18401923|P9|Core Treatment|Adverse Event|0
5352493|NCT00048048|18401924|P8|Core Treatment|Adverse Event|1
5352494|NCT00048048|18401925|P7|Core Treatment|Adverse Event|0
5352495|NCT00048048|18401926|P6|Core Treatment|Adverse Event|0
5352496|NCT00048048|18401927|P5|Core Treatment|Adverse Event|0
5352497|NCT00048048|18401928|P4|Core Treatment|Adverse Event|0
5352498|NCT00048048|18401929|P3|Core Treatment|Adverse Event|0
5352499|NCT00048048|18401930|P2|Core Treatment|Adverse Event|0
5352500|NCT00048048|18401931|P1|Core Treatment|Adverse Event|0
5352501|NCT00048048|18401920|P12|Core Treatment|Withdrawal by Subject|0
5352502|NCT00048048|18401921|P11|Core Treatment|Withdrawal by Subject|0
5352503|NCT00048048|18401922|P10|Core Treatment|Withdrawal by Subject|0
5352504|NCT00048048|18401923|P9|Core Treatment|Withdrawal by Subject|0
5352505|NCT00048048|18401924|P8|Core Treatment|Withdrawal by Subject|0
5352506|NCT00048048|18401925|P7|Core Treatment|Withdrawal by Subject|0
5352507|NCT00048048|18401926|P6|Core Treatment|Withdrawal by Subject|0
5352508|NCT00048048|18401927|P5|Core Treatment|Withdrawal by Subject|0
5352509|NCT00048048|18401928|P4|Core Treatment|Withdrawal by Subject|0
5352510|NCT00048048|18401929|P3|Core Treatment|Withdrawal by Subject|1
5352511|NCT00048048|18401930|P2|Core Treatment|Withdrawal by Subject|0
5352512|NCT00048048|18401931|P1|Core Treatment|Withdrawal by Subject|0
5352513|NCT00048035|18401987|P8|Extension Year 2|Early Withdrawals|3
5352514|NCT00048035|18401988|P7|Extension Year 2|Early Withdrawals|3
5352515|NCT00048035|18401989|P6|Extension Year 2|Early Withdrawals|0
5352516|NCT00048035|18401990|P5|Extension Year 2|Early Withdrawals|0
5352517|NCT00048035|18401991|P4|Extension Year 2|Early Withdrawals|0
5352518|NCT00048035|18401992|P3|Extension Year 2|Early Withdrawals|0
5352519|NCT00048035|18401993|P2|Extension Year 2|Early Withdrawals|0
5352520|NCT00048035|18401994|P1|Extension Year 2|Early Withdrawals|0
5352521|NCT00048035|18401987|P8|Extension Year 1|Early Withdrawals|11
5352522|NCT00048035|18401988|P7|Extension Year 1|Early Withdrawals|11
5352523|NCT00048035|18401989|P6|Extension Year 1|Early Withdrawals|0
5352524|NCT00048035|18401990|P5|Extension Year 1|Early Withdrawals|0
5352525|NCT00048035|18401991|P4|Extension Year 1|Early Withdrawals|0
5352526|NCT00048035|18401992|P3|Extension Year 1|Early Withdrawals|0
5352527|NCT00048035|18401993|P2|Extension Year 1|Early Withdrawals|0
5352528|NCT00048035|18401994|P1|Extension Year 1|Early Withdrawals|0
5352529|NCT00048035|18401987|P8|Core Period|Early Withdrawals|0
5352530|NCT00048035|18401988|P7|Core Period|Early Withdrawals|0
5352531|NCT00048035|18401989|P6|Core Period|Early Withdrawals|1
5352532|NCT00048035|18401990|P5|Core Period|Early Withdrawals|1
5352533|NCT00048035|18401991|P4|Core Period|Early Withdrawals|1
5352534|NCT00048035|18401992|P3|Core Period|Early Withdrawals|1
5352535|NCT00048035|18401993|P2|Core Period|Early Withdrawals|2
5352536|NCT00048035|18401994|P1|Core Period|Early Withdrawals|4
5352537|NCT00047879|18402032|P2|Overall Study|Progressive disease|3
5352538|NCT00047879|18402033|P1|Overall Study|Progressive disease|4
5352539|NCT00047463|18402069|P2|Overall Study|Withdrawal by Subject|3
5352540|NCT00047463|18402070|P1|Overall Study|Withdrawal by Subject|0
5352541|NCT00045942|18402187|P9|PKC412A2104E2|Death|0
5352542|NCT00045942|18402188|P8|PKC412A2104E2|Death|0
5352543|NCT00045942|18402189|P7|PKC412A2104E2|Death|2
5352544|NCT00045942|18402190|P6|PKC412A2104E2|Death|1
5352545|NCT00045942|18402191|P5|PKC412A2104E2|Death|0
5352546|NCT00045942|18402192|P4|PKC412A2104E2|Death|0
5352547|NCT00045942|18402193|P3|PKC412A2104E2|Death|0
5352548|NCT00045942|18402194|P2|PKC412A2104E2|Death|0
5352549|NCT00045942|18402195|P1|PKC412A2104E2|Death|0
5352550|NCT00045942|18402187|P9|PKC412A2104E2|Adverse Event|0
5352551|NCT00045942|18402188|P8|PKC412A2104E2|Adverse Event|1
5352552|NCT00045942|18402189|P7|PKC412A2104E2|Adverse Event|3
5352553|NCT00045942|18402190|P6|PKC412A2104E2|Adverse Event|4
5352554|NCT00045942|18402191|P5|PKC412A2104E2|Adverse Event|0
5352555|NCT00045942|18402192|P4|PKC412A2104E2|Adverse Event|0
5352556|NCT00045942|18402193|P3|PKC412A2104E2|Adverse Event|0
5352557|NCT00045942|18402194|P2|PKC412A2104E2|Adverse Event|0
5352558|NCT00045942|18402195|P1|PKC412A2104E2|Adverse Event|0
5352559|NCT00045942|18402187|P9|PKC412A2104E2|Lack of Efficacy|6
5352560|NCT00045942|18402188|P8|PKC412A2104E2|Lack of Efficacy|2
5352561|NCT00045942|18402189|P7|PKC412A2104E2|Lack of Efficacy|2
5352562|NCT00045942|18402190|P6|PKC412A2104E2|Lack of Efficacy|3
5352563|NCT00045942|18402191|P5|PKC412A2104E2|Lack of Efficacy|0
5352564|NCT00045942|18402192|P4|PKC412A2104E2|Lack of Efficacy|0
5352565|NCT00045942|18402193|P3|PKC412A2104E2|Lack of Efficacy|0
5352566|NCT00045942|18402194|P2|PKC412A2104E2|Lack of Efficacy|0
5352567|NCT00045942|18402195|P1|PKC412A2104E2|Lack of Efficacy|0
5352568|NCT00045942|18402187|P9|PKC412A2104E2|Withdrawal by Subject|0
5352569|NCT00045942|18402188|P8|PKC412A2104E2|Withdrawal by Subject|1
5352570|NCT00045942|18402189|P7|PKC412A2104E2|Withdrawal by Subject|0
5352571|NCT00045942|18402190|P6|PKC412A2104E2|Withdrawal by Subject|1
5352572|NCT00045942|18402191|P5|PKC412A2104E2|Withdrawal by Subject|0
5352573|NCT00045942|18402192|P4|PKC412A2104E2|Withdrawal by Subject|0
5352574|NCT00045942|18402193|P3|PKC412A2104E2|Withdrawal by Subject|0
5352575|NCT00045942|18402194|P2|PKC412A2104E2|Withdrawal by Subject|0
5352576|NCT00045942|18402195|P1|PKC412A2104E2|Withdrawal by Subject|0
5352577|NCT00045942|18402187|P9|PKC412A2104E2|Lost to Follow-up|0
5352578|NCT00045942|18402188|P8|PKC412A2104E2|Lost to Follow-up|3
5352579|NCT00045942|18402189|P7|PKC412A2104E2|Lost to Follow-up|0
5352580|NCT00045942|18402190|P6|PKC412A2104E2|Lost to Follow-up|0
5352581|NCT00045942|18402191|P5|PKC412A2104E2|Lost to Follow-up|0
5352582|NCT00045942|18402192|P4|PKC412A2104E2|Lost to Follow-up|0
5352583|NCT00045942|18402193|P3|PKC412A2104E2|Lost to Follow-up|0
5352584|NCT00045942|18402194|P2|PKC412A2104E2|Lost to Follow-up|0
5352585|NCT00045942|18402195|P1|PKC412A2104E2|Lost to Follow-up|0
5352586|NCT00045942|18402187|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352587|NCT00045942|18402188|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352588|NCT00045942|18402189|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352589|NCT00045942|18402190|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352590|NCT00045942|18402191|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352591|NCT00045942|18402192|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
5352592|NCT00045942|18402193|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
5352593|NCT00045942|18402194|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352594|NCT00045942|18402195|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5352595|NCT00045942|18402187|P9|PKC412A2104E1|Death|0
5352596|NCT00045942|18402188|P8|PKC412A2104E1|Death|0
5352597|NCT00045942|18402189|P7|PKC412A2104E1|Death|0
5352598|NCT00045942|18402190|P6|PKC412A2104E1|Death|0
5352599|NCT00045942|18402191|P5|PKC412A2104E1|Death|1
5352600|NCT00045942|18402192|P4|PKC412A2104E1|Death|1
5352601|NCT00045942|18402193|P3|PKC412A2104E1|Death|1
5352602|NCT00045942|18402194|P2|PKC412A2104E1|Death|4
5352603|NCT00045942|18402195|P1|PKC412A2104E1|Death|0
5352604|NCT00045942|18402187|P9|PKC412A2104E1|Adverse Event|0
5352605|NCT00045942|18402188|P8|PKC412A2104E1|Adverse Event|0
5352606|NCT00045942|18402189|P7|PKC412A2104E1|Adverse Event|0
5352607|NCT00045942|18402190|P6|PKC412A2104E1|Adverse Event|0
5352608|NCT00045942|18402191|P5|PKC412A2104E1|Adverse Event|6
5352609|NCT00045942|18402192|P4|PKC412A2104E1|Adverse Event|3
5352610|NCT00045942|18402193|P3|PKC412A2104E1|Adverse Event|1
5352611|NCT00045942|18402194|P2|PKC412A2104E1|Adverse Event|1
5352612|NCT00045942|18402195|P1|PKC412A2104E1|Adverse Event|0
5352613|NCT00045942|18402187|P9|PKC412A2104E1|Abnormal laboratory value|0
5352614|NCT00045942|18402188|P8|PKC412A2104E1|Abnormal laboratory value|0
5352615|NCT00045942|18402189|P7|PKC412A2104E1|Abnormal laboratory value|0
5352616|NCT00045942|18402190|P6|PKC412A2104E1|Abnormal laboratory value|0
5352617|NCT00045942|18402191|P5|PKC412A2104E1|Abnormal laboratory value|0
5352618|NCT00045942|18402192|P4|PKC412A2104E1|Abnormal laboratory value|0
5352619|NCT00045942|18402193|P3|PKC412A2104E1|Abnormal laboratory value|0
5352620|NCT00045942|18402194|P2|PKC412A2104E1|Abnormal laboratory value|1
5352621|NCT00045942|18402195|P1|PKC412A2104E1|Abnormal laboratory value|0
5352622|NCT00045942|18402187|P9|PKC412A2104E1|Lack of Efficacy|0
5352623|NCT00045942|18402188|P8|PKC412A2104E1|Lack of Efficacy|0
5352624|NCT00045942|18402189|P7|PKC412A2104E1|Lack of Efficacy|0
5352625|NCT00045942|18402190|P6|PKC412A2104E1|Lack of Efficacy|0
5352626|NCT00045942|18402191|P5|PKC412A2104E1|Lack of Efficacy|17
5352627|NCT00045942|18402192|P4|PKC412A2104E1|Lack of Efficacy|23
5352628|NCT00045942|18402193|P3|PKC412A2104E1|Lack of Efficacy|11
5352629|NCT00045942|18402194|P2|PKC412A2104E1|Lack of Efficacy|11
5352630|NCT00045942|18402195|P1|PKC412A2104E1|Lack of Efficacy|0
5352631|NCT00045942|18402187|P9|PKC412A2104E1|Condition no longer requires study drug|0
5352632|NCT00045942|18402188|P8|PKC412A2104E1|Condition no longer requires study drug|0
5352633|NCT00045942|18402189|P7|PKC412A2104E1|Condition no longer requires study drug|0
5352634|NCT00045942|18402190|P6|PKC412A2104E1|Condition no longer requires study drug|0
5352635|NCT00045942|18402191|P5|PKC412A2104E1|Condition no longer requires study drug|1
5352636|NCT00045942|18402192|P4|PKC412A2104E1|Condition no longer requires study drug|0
5352637|NCT00045942|18402193|P3|PKC412A2104E1|Condition no longer requires study drug|1
5352638|NCT00045942|18402194|P2|PKC412A2104E1|Condition no longer requires study drug|1
5352639|NCT00045942|18402195|P1|PKC412A2104E1|Condition no longer requires study drug|0
5352640|NCT00045942|18402187|P9|PKC412A2104E1|Withdrawal by Subject|0
5352641|NCT00045942|18402188|P8|PKC412A2104E1|Withdrawal by Subject|0
5352642|NCT00045942|18402189|P7|PKC412A2104E1|Withdrawal by Subject|0
5352643|NCT00045942|18402190|P6|PKC412A2104E1|Withdrawal by Subject|0
5352644|NCT00045942|18402191|P5|PKC412A2104E1|Withdrawal by Subject|2
5352645|NCT00045942|18402192|P4|PKC412A2104E1|Withdrawal by Subject|5
5352646|NCT00045942|18402193|P3|PKC412A2104E1|Withdrawal by Subject|2
5352647|NCT00045942|18402194|P2|PKC412A2104E1|Withdrawal by Subject|0
5352648|NCT00045942|18402195|P1|PKC412A2104E1|Withdrawal by Subject|0
5352649|NCT00045942|18402187|P9|PKC412A2104 (Core)|Death|0
5352650|NCT00045942|18402188|P8|PKC412A2104 (Core)|Death|0
5352651|NCT00045942|18402189|P7|PKC412A2104 (Core)|Death|0
5352652|NCT00045942|18402190|P6|PKC412A2104 (Core)|Death|0
5352653|NCT00045942|18402191|P5|PKC412A2104 (Core)|Death|0
5352654|NCT00045942|18402192|P4|PKC412A2104 (Core)|Death|0
5352655|NCT00045942|18402193|P3|PKC412A2104 (Core)|Death|0
5352656|NCT00045942|18402194|P2|PKC412A2104 (Core)|Death|0
5352657|NCT00045942|18402195|P1|PKC412A2104 (Core)|Death|1
5352658|NCT00045942|18402187|P9|PKC412A2104 (Core)|Lack of Efficacy|0
5352659|NCT00045942|18402188|P8|PKC412A2104 (Core)|Lack of Efficacy|0
5352660|NCT00045942|18402189|P7|PKC412A2104 (Core)|Lack of Efficacy|0
5352661|NCT00045942|18402190|P6|PKC412A2104 (Core)|Lack of Efficacy|0
5352662|NCT00045942|18402191|P5|PKC412A2104 (Core)|Lack of Efficacy|0
5352663|NCT00045942|18402192|P4|PKC412A2104 (Core)|Lack of Efficacy|0
5352664|NCT00045942|18402193|P3|PKC412A2104 (Core)|Lack of Efficacy|0
5352665|NCT00045942|18402194|P2|PKC412A2104 (Core)|Lack of Efficacy|0
5352666|NCT00045942|18402195|P1|PKC412A2104 (Core)|Lack of Efficacy|13
5352667|NCT00045942|18402187|P9|PKC412A2104 (Core)|Adverse Event|0
5352668|NCT00045942|18402188|P8|PKC412A2104 (Core)|Adverse Event|0
5352669|NCT00045942|18402189|P7|PKC412A2104 (Core)|Adverse Event|0
5352670|NCT00045942|18402190|P6|PKC412A2104 (Core)|Adverse Event|0
5352671|NCT00045942|18402191|P5|PKC412A2104 (Core)|Adverse Event|0
5352672|NCT00045942|18402192|P4|PKC412A2104 (Core)|Adverse Event|0
5352673|NCT00045942|18402193|P3|PKC412A2104 (Core)|Adverse Event|0
5352674|NCT00045942|18402194|P2|PKC412A2104 (Core)|Adverse Event|0
5352675|NCT00045942|18402195|P1|PKC412A2104 (Core)|Adverse Event|5
5352676|NCT00045942|18402187|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
5352677|NCT00045942|18402188|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
5352678|NCT00045942|18402189|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
5352679|NCT00045942|18402190|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
5352680|NCT00045942|18402191|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
5352681|NCT00045942|18402192|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
5352682|NCT00045942|18402193|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
5352683|NCT00045942|18402194|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
5352684|NCT00045942|18402195|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
5352685|NCT00044512|18402284|P1|Follow Up|Lost to Follow-up|2
5352686|NCT00044213|18402299|P4|Overall Study|Lost to Follow-up|4
5352687|NCT00044213|18402300|P3|Overall Study|Lost to Follow-up|5
5352688|NCT00044213|18402301|P2|Overall Study|Lost to Follow-up|5
5352689|NCT00044213|18402302|P1|Overall Study|Lost to Follow-up|8
5352690|NCT00044213|18402299|P4|Overall Study|Death|49
5352691|NCT00044213|18402300|P3|Overall Study|Death|42
5352692|NCT00044213|18402301|P2|Overall Study|Death|42
5352693|NCT00044213|18402302|P1|Overall Study|Death|42
5352694|NCT00044213|18402299|P4|Overall Study|Withdrawal by Subject|83
5352695|NCT00044213|18402300|P3|Overall Study|Withdrawal by Subject|91
5352696|NCT00044213|18402301|P2|Overall Study|Withdrawal by Subject|65
5352697|NCT00044213|18402302|P1|Overall Study|Withdrawal by Subject|50
5352698|NCT00044083|18402367|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
5352699|NCT00044083|18402368|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
5352700|NCT00044083|18402367|P2|First Intervention (One Week) Patients|Used illegal drug|0
5352701|NCT00044083|18402368|P1|First Intervention (One Week) Patients|Used illegal drug|1
5352702|NCT00044083|18402367|P2|First Intervention (One Week) Patients|Not follow directions|2
5352703|NCT00044083|18402368|P1|First Intervention (One Week) Patients|Not follow directions|0
5352704|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
5352705|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
5352706|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
5352707|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
5352708|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
5352709|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
5352710|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Pregnancy|0
5352711|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Pregnancy|1
5352712|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
5352713|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
5352714|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Not follow directions|2
5352715|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Not follow directions|2
5352716|NCT00044083|18402367|P2|First Intervention (One Week)- HV's|Adverse Event|0
5352717|NCT00044083|18402368|P1|First Intervention (One Week)- HV's|Adverse Event|1
5352718|NCT00043979|18402406|P3|Period 1|recipient with progressive disease|3
5352719|NCT00043979|18402407|P2|Period 1|recipient with progressive disease|4
5352720|NCT00043979|18402408|P1|Period 1|recipient with progressive disease|7
5352721|NCT00043550|18402429|P3|Overall Study|Withdrawal by Subject|20
5352722|NCT00043550|18402430|P2|Overall Study|Withdrawal by Subject|12
5352723|NCT00043550|18402431|P1|Overall Study|Withdrawal by Subject|22
5352724|NCT00043186|18402448|P9|Overall Study|Other|0
5352725|NCT00043186|18402449|P8|Overall Study|Other|0
5352726|NCT00043186|18402450|P7|Overall Study|Other|0
5352727|NCT00043186|18402451|P6|Overall Study|Other|0
5352728|NCT00043186|18402452|P5|Overall Study|Other|0
5352729|NCT00043186|18402453|P4|Overall Study|Other|1
5352730|NCT00043186|18402454|P3|Overall Study|Other|1
5352731|NCT00043186|18402455|P2|Overall Study|Other|0
5352732|NCT00043186|18402456|P1|Overall Study|Other|0
5352733|NCT00043186|18402448|P9|Overall Study|Noncompliance|0
5352734|NCT00043186|18402449|P8|Overall Study|Noncompliance|0
5352735|NCT00043186|18402450|P7|Overall Study|Noncompliance|0
5352736|NCT00043186|18402451|P6|Overall Study|Noncompliance|0
5352737|NCT00043186|18402452|P5|Overall Study|Noncompliance|0
5352738|NCT00043186|18402453|P4|Overall Study|Noncompliance|1
5352739|NCT00043186|18402454|P3|Overall Study|Noncompliance|1
5352740|NCT00043186|18402455|P2|Overall Study|Noncompliance|0
5352741|NCT00043186|18402456|P1|Overall Study|Noncompliance|0
5352742|NCT00043186|18402448|P9|Overall Study|Lost to Follow-up|2
5352743|NCT00043186|18402449|P8|Overall Study|Lost to Follow-up|1
5352744|NCT00043186|18402450|P7|Overall Study|Lost to Follow-up|1
5352745|NCT00043186|18402451|P6|Overall Study|Lost to Follow-up|1
5352746|NCT00043186|18402452|P5|Overall Study|Lost to Follow-up|1
5352747|NCT00043186|18402453|P4|Overall Study|Lost to Follow-up|1
5352748|NCT00043186|18402454|P3|Overall Study|Lost to Follow-up|1
5352749|NCT00043186|18402455|P2|Overall Study|Lost to Follow-up|5
5352750|NCT00043186|18402456|P1|Overall Study|Lost to Follow-up|3
5352751|NCT00043186|18402448|P9|Overall Study|Ineligibility determined|1
5352752|NCT00043186|18402449|P8|Overall Study|Ineligibility determined|0
5352753|NCT00043186|18402450|P7|Overall Study|Ineligibility determined|0
5352754|NCT00043186|18402451|P6|Overall Study|Ineligibility determined|0
5352755|NCT00043186|18402452|P5|Overall Study|Ineligibility determined|0
5352756|NCT00043186|18402453|P4|Overall Study|Ineligibility determined|0
5352757|NCT00043186|18402454|P3|Overall Study|Ineligibility determined|0
5352758|NCT00043186|18402455|P2|Overall Study|Ineligibility determined|0
5352759|NCT00043186|18402456|P1|Overall Study|Ineligibility determined|0
5352760|NCT00043186|18402448|P9|Overall Study|Disease progression|0
5352761|NCT00043186|18402449|P8|Overall Study|Disease progression|4
5352762|NCT00043186|18402450|P7|Overall Study|Disease progression|0
5352763|NCT00043186|18402451|P6|Overall Study|Disease progression|0
5352764|NCT00043186|18402452|P5|Overall Study|Disease progression|0
5352765|NCT00043186|18402453|P4|Overall Study|Disease progression|3
5352766|NCT00043186|18402454|P3|Overall Study|Disease progression|0
5352767|NCT00043186|18402455|P2|Overall Study|Disease progression|0
5352768|NCT00043186|18402456|P1|Overall Study|Disease progression|1
5352769|NCT00043186|18402448|P9|Overall Study|Death|0
5352770|NCT00043186|18402449|P8|Overall Study|Death|0
5352771|NCT00043186|18402450|P7|Overall Study|Death|2
5352772|NCT00043186|18402451|P6|Overall Study|Death|0
5352773|NCT00043186|18402452|P5|Overall Study|Death|0
5352774|NCT00043186|18402453|P4|Overall Study|Death|0
5352775|NCT00043186|18402454|P3|Overall Study|Death|1
5352776|NCT00043186|18402455|P2|Overall Study|Death|0
5352777|NCT00043186|18402456|P1|Overall Study|Death|0
5352778|NCT00043186|18402448|P9|Overall Study|Withdrawal by Subject|10
5352779|NCT00043186|18402449|P8|Overall Study|Withdrawal by Subject|9
5352780|NCT00043186|18402450|P7|Overall Study|Withdrawal by Subject|12
5352781|NCT00043186|18402451|P6|Overall Study|Withdrawal by Subject|6
5352782|NCT00043186|18402452|P5|Overall Study|Withdrawal by Subject|14
5352783|NCT00043186|18402453|P4|Overall Study|Withdrawal by Subject|13
5352784|NCT00043186|18402454|P3|Overall Study|Withdrawal by Subject|11
5352785|NCT00043186|18402455|P2|Overall Study|Withdrawal by Subject|8
5352786|NCT00043186|18402456|P1|Overall Study|Withdrawal by Subject|11
5352787|NCT00043186|18402448|P9|Overall Study|Adverse Event|3
5352788|NCT00043186|18402449|P8|Overall Study|Adverse Event|1
5352789|NCT00043186|18402450|P7|Overall Study|Adverse Event|2
5352790|NCT00043186|18402451|P6|Overall Study|Adverse Event|1
5352791|NCT00043186|18402452|P5|Overall Study|Adverse Event|2
5352792|NCT00043186|18402453|P4|Overall Study|Adverse Event|3
5352793|NCT00043186|18402454|P3|Overall Study|Adverse Event|2
5352794|NCT00043186|18402455|P2|Overall Study|Adverse Event|2
5352795|NCT00043186|18402456|P1|Overall Study|Adverse Event|2
5352796|NCT00043186|18402448|P9|Overall Study|Physician Decision|1
5352797|NCT00043186|18402449|P8|Overall Study|Physician Decision|1
5352798|NCT00043186|18402450|P7|Overall Study|Physician Decision|0
5352799|NCT00043186|18402451|P6|Overall Study|Physician Decision|0
5352800|NCT00043186|18402452|P5|Overall Study|Physician Decision|1
5352801|NCT00043186|18402453|P4|Overall Study|Physician Decision|0
5352802|NCT00043186|18402454|P3|Overall Study|Physician Decision|3
5352803|NCT00043186|18402455|P2|Overall Study|Physician Decision|0
5352804|NCT00043186|18402456|P1|Overall Study|Physician Decision|0
5352805|NCT00042666|18402782|P1|Overall Study|Other|4
5352806|NCT00042666|18402782|P1|Overall Study|Other|1
5352807|NCT00042666|18402782|P1|Overall Study|Progressive Disease|41
5352808|NCT00042666|18402782|P1|Overall Study|Participant/Physician Perception|1
5352809|NCT00042666|18402782|P1|Overall Study|Protocol Violation|1
5352810|NCT00042666|18402782|P1|Overall Study|Death|4
5352811|NCT00042666|18402782|P1|Overall Study|Adverse Event|2
5352812|NCT00042432|18402794|P2|Overall Study|Other|0
5352813|NCT00042432|18402795|P1|Overall Study|Other|2
5352814|NCT00042432|18402794|P2|Overall Study|Initiation of maintenance dialysis|1
5352815|NCT00042432|18402795|P1|Overall Study|Initiation of maintenance dialysis|1
5352816|NCT00042432|18402794|P2|Overall Study|Ineligibility determined|0
5352817|NCT00042432|18402795|P1|Overall Study|Ineligibility determined|1
5352818|NCT00042432|18402794|P2|Overall Study|Death|2
5352819|NCT00042432|18402795|P1|Overall Study|Death|0
5352820|NCT00042432|18402794|P2|Overall Study|Withdrawal by Subject|3
5352821|NCT00042432|18402795|P1|Overall Study|Withdrawal by Subject|1
5352822|NCT00042432|18402794|P2|Overall Study|Adverse Event|1
5352823|NCT00042432|18402795|P1|Overall Study|Adverse Event|4
5352824|NCT00041756|18402848|P5|Overall Study|Data Monitoring Committee Recommendation|21
5352825|NCT00041756|18402849|P4|Overall Study|Data Monitoring Committee Recommendation|0
5352826|NCT00041756|18402850|P3|Overall Study|Data Monitoring Committee Recommendation|0
5352827|NCT00041756|18402851|P2|Overall Study|Data Monitoring Committee Recommendation|0
5352828|NCT00041756|18402852|P1|Overall Study|Data Monitoring Committee Recommendation|0
5352829|NCT00041756|18402848|P5|Overall Study|Unable to meet protocol criteria|1
5352830|NCT00041756|18402849|P4|Overall Study|Unable to meet protocol criteria|0
5352831|NCT00041756|18402850|P3|Overall Study|Unable to meet protocol criteria|1
5352832|NCT00041756|18402851|P2|Overall Study|Unable to meet protocol criteria|0
5352833|NCT00041756|18402852|P1|Overall Study|Unable to meet protocol criteria|0
5352834|NCT00041756|18402848|P5|Overall Study|Lost to Follow-up|0
5352835|NCT00041756|18402849|P4|Overall Study|Lost to Follow-up|1
5352836|NCT00041756|18402850|P3|Overall Study|Lost to Follow-up|0
5352837|NCT00041756|18402851|P2|Overall Study|Lost to Follow-up|1
5352838|NCT00041756|18402852|P1|Overall Study|Lost to Follow-up|0
5352839|NCT00041756|18402848|P5|Overall Study|Withdrawal by Subject|3
5352840|NCT00041756|18402849|P4|Overall Study|Withdrawal by Subject|2
5352841|NCT00041756|18402850|P3|Overall Study|Withdrawal by Subject|4
5352842|NCT00041756|18402851|P2|Overall Study|Withdrawal by Subject|3
5352843|NCT00041756|18402852|P1|Overall Study|Withdrawal by Subject|3
5352844|NCT00041756|18402848|P5|Overall Study|Protocol Violation|1
5352845|NCT00041756|18402849|P4|Overall Study|Protocol Violation|2
5352846|NCT00041756|18402850|P3|Overall Study|Protocol Violation|2
5352847|NCT00041756|18402851|P2|Overall Study|Protocol Violation|1
5352848|NCT00041756|18402852|P1|Overall Study|Protocol Violation|1
5352849|NCT00041756|18402848|P5|Overall Study|Adverse Event|34
5352850|NCT00041756|18402849|P4|Overall Study|Adverse Event|11
5352851|NCT00041756|18402850|P3|Overall Study|Adverse Event|6
5352852|NCT00041756|18402851|P2|Overall Study|Adverse Event|10
5352853|NCT00041756|18402852|P1|Overall Study|Adverse Event|4
5352854|NCT00041470|18402880|P1|Overall Study|Loss of Funding|38
5352855|NCT00040664|18402885|P4|Overall Study|Non-viability of oral suspension|0
5352856|NCT00040664|18402886|P3|Overall Study|Non-viability of oral suspension|1
5352857|NCT00040664|18402887|P2|Overall Study|Non-viability of oral suspension|0
5352858|NCT00040664|18402888|P1|Overall Study|Non-viability of oral suspension|1
5352859|NCT00040664|18402885|P4|Overall Study|Change of formulation|0
5352860|NCT00040664|18402886|P3|Overall Study|Change of formulation|0
5352861|NCT00040664|18402887|P2|Overall Study|Change of formulation|2
5352862|NCT00040664|18402888|P1|Overall Study|Change of formulation|2
5352863|NCT00040664|18402885|P4|Overall Study|Pharmacokinetic target not achieved|1
5352864|NCT00040664|18402886|P3|Overall Study|Pharmacokinetic target not achieved|0
5352865|NCT00040664|18402887|P2|Overall Study|Pharmacokinetic target not achieved|1
5352866|NCT00040664|18402888|P1|Overall Study|Pharmacokinetic target not achieved|2
5352867|NCT00040664|18402885|P4|Overall Study|Poor taste|0
5352868|NCT00040664|18402886|P3|Overall Study|Poor taste|2
5352869|NCT00040664|18402887|P2|Overall Study|Poor taste|0
5352870|NCT00040664|18402888|P1|Overall Study|Poor taste|2
5352871|NCT00040664|18402885|P4|Overall Study|Medication adherence/compliance problems|5
5352872|NCT00040664|18402886|P3|Overall Study|Medication adherence/compliance problems|1
5352873|NCT00040664|18402887|P2|Overall Study|Medication adherence/compliance problems|2
5352874|NCT00040664|18402888|P1|Overall Study|Medication adherence/compliance problems|8
5352875|NCT00040664|18402885|P4|Overall Study|Pregnancy|3
5352876|NCT00040664|18402886|P3|Overall Study|Pregnancy|0
5352877|NCT00040664|18402887|P2|Overall Study|Pregnancy|0
5352878|NCT00040664|18402888|P1|Overall Study|Pregnancy|3
5352879|NCT00040664|18402885|P4|Overall Study|Withdrawal by Subject|4
5352880|NCT00040664|18402886|P3|Overall Study|Withdrawal by Subject|3
5352881|NCT00040664|18402887|P2|Overall Study|Withdrawal by Subject|0
5352882|NCT00040664|18402888|P1|Overall Study|Withdrawal by Subject|7
5352883|NCT00040664|18402885|P4|Overall Study|Protocol Violation|1
5352884|NCT00040664|18402886|P3|Overall Study|Protocol Violation|0
5352885|NCT00040664|18402887|P2|Overall Study|Protocol Violation|1
5352886|NCT00040664|18402888|P1|Overall Study|Protocol Violation|2
5352887|NCT00040664|18402885|P4|Overall Study|Lost to Follow-up|2
5352888|NCT00040664|18402886|P3|Overall Study|Lost to Follow-up|0
5352889|NCT00040664|18402887|P2|Overall Study|Lost to Follow-up|2
5352890|NCT00040664|18402888|P1|Overall Study|Lost to Follow-up|4
5352891|NCT00040664|18402885|P4|Overall Study|Insufficient CD4 response|0
5352892|NCT00040664|18402886|P3|Overall Study|Insufficient CD4 response|1
5352893|NCT00040664|18402887|P2|Overall Study|Insufficient CD4 response|0
5352894|NCT00040664|18402888|P1|Overall Study|Insufficient CD4 response|1
5352895|NCT00040664|18402885|P4|Overall Study|Lack of Efficacy|4
5352896|NCT00040664|18402886|P3|Overall Study|Lack of Efficacy|3
5352897|NCT00040664|18402887|P2|Overall Study|Lack of Efficacy|2
5352898|NCT00040664|18402888|P1|Overall Study|Lack of Efficacy|9
5352899|NCT00040664|18402885|P4|Overall Study|Adverse Event|7
5352900|NCT00040664|18402886|P3|Overall Study|Adverse Event|2
5352901|NCT00040664|18402887|P2|Overall Study|Adverse Event|3
5352902|NCT00040664|18402888|P1|Overall Study|Adverse Event|12
5352903|NCT00040365|18402954|P1|Overall Study|Lost to Follow-up|3
5352904|NCT00040365|18402954|P1|Overall Study|Progressive disease|7
5352905|NCT00040365|18402954|P1|Overall Study|Death|1
5352906|NCT00039871|18402963|P1|Overall Study|Never entered follow-up|7
5352907|NCT00039871|18402963|P1|Overall Study|Discontinued at Week 12 per protocol|1061
5352908|NCT00039871|18402963|P1|Overall Study|Administrative|1
5352909|NCT00039871|18402963|P1|Overall Study|Did not meet eligibility criteria|11
5352910|NCT00039871|18402963|P1|Overall Study|Withdrawal by Subject|97
5352911|NCT00039871|18402963|P1|Overall Study|Protocol Violation|24
5352912|NCT00039871|18402963|P1|Overall Study|Lost to Follow-up|18
5352913|NCT00039871|18402963|P1|Overall Study|Adverse Event|165
5352914|NCT00039741|18402973|P4|Overall Study|Missed final visit|2
5352915|NCT00039741|18402974|P3|Overall Study|Missed final visit|2
5352916|NCT00039741|18402975|P2|Overall Study|Missed final visit|1
5352917|NCT00039741|18402976|P1|Overall Study|Missed final visit|2
5352918|NCT00039741|18402973|P4|Overall Study|Withdrew consent|1
5352919|NCT00039741|18402974|P3|Overall Study|Withdrew consent|0
5352920|NCT00039741|18402975|P2|Overall Study|Withdrew consent|5
5352921|NCT00039741|18402976|P1|Overall Study|Withdrew consent|0
5352922|NCT00039741|18402973|P4|Overall Study|Non-compliance with protocol|0
5352923|NCT00039741|18402974|P3|Overall Study|Non-compliance with protocol|1
5352924|NCT00039741|18402975|P2|Overall Study|Non-compliance with protocol|0
5352925|NCT00039741|18402976|P1|Overall Study|Non-compliance with protocol|1
5352926|NCT00039741|18402973|P4|Overall Study|Moved|6
5352927|NCT00039741|18402974|P3|Overall Study|Moved|3
5352928|NCT00039741|18402975|P2|Overall Study|Moved|2
5352929|NCT00039741|18402976|P1|Overall Study|Moved|3
5352930|NCT00039741|18402973|P4|Overall Study|Not able to get to clinic|3
5352931|NCT00039741|18402974|P3|Overall Study|Not able to get to clinic|0
5352932|NCT00039741|18402975|P2|Overall Study|Not able to get to clinic|2
5352933|NCT00039741|18402976|P1|Overall Study|Not able to get to clinic|5
5352934|NCT00039741|18402973|P4|Overall Study|Confounding medical condition|0
5352935|NCT00039741|18402974|P3|Overall Study|Confounding medical condition|0
5352936|NCT00039741|18402975|P2|Overall Study|Confounding medical condition|0
5352937|NCT00039741|18402976|P1|Overall Study|Confounding medical condition|1
5352938|NCT00039741|18402973|P4|Overall Study|Lost to Follow-up|2
5352939|NCT00039741|18402974|P3|Overall Study|Lost to Follow-up|5
5352940|NCT00039741|18402975|P2|Overall Study|Lost to Follow-up|1
5352941|NCT00039741|18402976|P1|Overall Study|Lost to Follow-up|3
5352942|NCT00039741|18402973|P4|Overall Study|Death|0
5352943|NCT00039741|18402974|P3|Overall Study|Death|0
5352944|NCT00039741|18402975|P2|Overall Study|Death|1
5352945|NCT00039741|18402976|P1|Overall Study|Death|0
5352946|NCT00038948|18403020|P2|Overall Study|Lack of Efficacy|6
5352947|NCT00038948|18403021|P1|Overall Study|Lack of Efficacy|3
5352948|NCT00038948|18403020|P2|Overall Study|Protocol Violation|7
5352949|NCT00038948|18403021|P1|Overall Study|Protocol Violation|3
5352950|NCT00038948|18403020|P2|Overall Study|Withdrawal by Subject|10
5352951|NCT00038948|18403021|P1|Overall Study|Withdrawal by Subject|23
5352952|NCT00038948|18403020|P2|Overall Study|Nonmedical event|7
5352953|NCT00038948|18403021|P1|Overall Study|Nonmedical event|5
5352954|NCT00038948|18403020|P2|Overall Study|Lost to Follow-up|4
5352955|NCT00038948|18403021|P1|Overall Study|Lost to Follow-up|4
5352956|NCT00038948|18403020|P2|Overall Study|Adverse Event|43
5352957|NCT00038948|18403021|P1|Overall Study|Adverse Event|131
5352958|NCT00038649|18403056|P1|Overall Study|Adverse Event|9
5352959|NCT00038467|18403069|P2|Overall Study|Other|28
5352960|NCT00038467|18403070|P1|Overall Study|Other|26
5352961|NCT00038467|18403069|P2|Overall Study|Randomized, but not treated|35
5352962|NCT00038467|18403070|P1|Overall Study|Randomized, but not treated|31
5352963|NCT00038467|18403069|P2|Overall Study|Recurrence|179
5352964|NCT00038467|18403070|P1|Overall Study|Recurrence|109
5352965|NCT00038467|18403069|P2|Overall Study|Lost to Follow-up|10
5352966|NCT00038467|18403070|P1|Overall Study|Lost to Follow-up|15
5352967|NCT00038467|18403069|P2|Overall Study|Death|16
5352968|NCT00038467|18403070|P1|Overall Study|Death|22
5352969|NCT00038467|18403069|P2|Overall Study|Protocol Violation|22
5352970|NCT00038467|18403070|P1|Overall Study|Protocol Violation|19
5352971|NCT00038467|18403069|P2|Overall Study|Withdrawal by Subject|107
5352972|NCT00038467|18403070|P1|Overall Study|Withdrawal by Subject|150
5352973|NCT00038467|18403069|P2|Overall Study|Adverse Event|145
5352974|NCT00038467|18403070|P1|Overall Study|Adverse Event|170
5352975|NCT00038142|18403132|P2|Overall Study|Unknown Reason|0
5352976|NCT00038142|18403133|P1|Overall Study|Unknown Reason|8
5352977|NCT00038142|18403132|P2|Overall Study|Adverse Event|0
5352978|NCT00038142|18403133|P1|Overall Study|Adverse Event|1
5352979|NCT00038142|18403132|P2|Overall Study|Death|0
5352980|NCT00038142|18403133|P1|Overall Study|Death|1
5352981|NCT00038142|18403132|P2|Overall Study|Progressive Disease|7
5352982|NCT00038142|18403133|P1|Overall Study|Progressive Disease|11
5352983|NCT00038142|18403132|P2|Overall Study|Ineligible|0
5352984|NCT00038142|18403133|P1|Overall Study|Ineligible|1
5352985|NCT00038103|18403141|P2|Overall Study|Randomized/never treated|0
5352986|NCT00038103|18403142|P1|Overall Study|Randomized/never treated|2
5352987|NCT00038103|18403141|P2|Overall Study|Sponsor Decision|1
5352988|NCT00038103|18403142|P1|Overall Study|Sponsor Decision|0
5352989|NCT00038103|18403141|P2|Overall Study|Protocol Violation|2
5352990|NCT00038103|18403142|P1|Overall Study|Protocol Violation|0
5352991|NCT00038103|18403141|P2|Overall Study|Lost to Follow-up|3
5352992|NCT00038103|18403142|P1|Overall Study|Lost to Follow-up|0
5352993|NCT00038103|18403141|P2|Overall Study|Withdrawal by Subject|3
5352994|NCT00038103|18403142|P1|Overall Study|Withdrawal by Subject|0
5352995|NCT00038103|18403141|P2|Overall Study|Lack of Efficacy|41
5352996|NCT00038103|18403142|P1|Overall Study|Lack of Efficacy|48
5352997|NCT00038103|18403141|P2|Overall Study|Adverse Event|6
5352998|NCT00038103|18403142|P1|Overall Study|Adverse Event|5
5352999|NCT00037830|18403165|P3|Overall Study|Unrelated Medical Problem|0
5353000|NCT00037830|18403166|P2|Overall Study|Unrelated Medical Problem|0
5353001|NCT00037830|18403167|P1|Overall Study|Unrelated Medical Problem|2
5353002|NCT00037830|18403165|P3|Overall Study|Protocol Violation|0
5353003|NCT00037830|18403166|P2|Overall Study|Protocol Violation|2
5353004|NCT00037830|18403167|P1|Overall Study|Protocol Violation|2
5353005|NCT00037830|18403165|P3|Overall Study|Withdrawal by Subject|1
5353006|NCT00037830|18403166|P2|Overall Study|Withdrawal by Subject|5
5353007|NCT00037830|18403167|P1|Overall Study|Withdrawal by Subject|4
5353008|NCT00037830|18403165|P3|Overall Study|Adverse Event|0
5353009|NCT00037830|18403166|P2|Overall Study|Adverse Event|0
5353010|NCT00037830|18403167|P1|Overall Study|Adverse Event|2
5353011|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
5353012|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
5353013|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Too early switch|103
5353014|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Too early switch|0
5353015|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
5353016|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
5353017|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Protocol Violation|91
5353018|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Protocol Violation|23
5353019|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
5353020|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
5353021|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Treatment refusal|208
5353022|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Treatment refusal|113
5353023|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Other|288
5353024|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Other|277
5353025|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Adverse Event|782
5353026|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Adverse Event|501
5353027|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
5353028|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
5353029|NCT00036270|18403199|P2|Study Treatment to 5 Year Report|Ongoing|736
5353030|NCT00036270|18403200|P1|Study Treatment to 5 Year Report|Ongoing|1081
5353031|NCT00036270|18403199|P2|Randomized to Study Treatment|Withdrawal by Subject|7
5353032|NCT00036270|18403200|P1|Randomized to Study Treatment|Withdrawal by Subject|6
5353033|NCT00035932|18403219|P3|Overall Study|Lack of Efficacy|28
5353034|NCT00035932|18403220|P2|Overall Study|Lack of Efficacy|33
5353035|NCT00035932|18403221|P1|Overall Study|Lack of Efficacy|33
5353036|NCT00035932|18403219|P3|Overall Study|Study Termination by Sponsor|0
5353037|NCT00035932|18403220|P2|Overall Study|Study Termination by Sponsor|0
5353038|NCT00035932|18403221|P1|Overall Study|Study Termination by Sponsor|1
5353039|NCT00035932|18403219|P3|Overall Study|Withdrawal by Subject|0
5353040|NCT00035932|18403220|P2|Overall Study|Withdrawal by Subject|5
5353041|NCT00035932|18403221|P1|Overall Study|Withdrawal by Subject|1
5353042|NCT00035932|18403219|P3|Overall Study|Protocol Violation While on Study|2
5353043|NCT00035932|18403220|P2|Overall Study|Protocol Violation While on Study|1
5353044|NCT00035932|18403221|P1|Overall Study|Protocol Violation While on Study|0
5353045|NCT00035932|18403219|P3|Overall Study|Noncompliance|6
5353046|NCT00035932|18403220|P2|Overall Study|Noncompliance|7
5353047|NCT00035932|18403221|P1|Overall Study|Noncompliance|6
5353048|NCT00035932|18403219|P3|Overall Study|Lost to Follow-up|3
5353049|NCT00035932|18403220|P2|Overall Study|Lost to Follow-up|4
5353050|NCT00035932|18403221|P1|Overall Study|Lost to Follow-up|4
5353051|NCT00035932|18403219|P3|Overall Study|Disease Progression / Relapse|0
5353052|NCT00035932|18403220|P2|Overall Study|Disease Progression / Relapse|1
5353053|NCT00035932|18403221|P1|Overall Study|Disease Progression / Relapse|1
5353054|NCT00035932|18403219|P3|Overall Study|Death|1
5353055|NCT00035932|18403220|P2|Overall Study|Death|0
5353056|NCT00035932|18403221|P1|Overall Study|Death|0
5353057|NCT00035932|18403219|P3|Overall Study|Adverse Event|9
5353058|NCT00035932|18403220|P2|Overall Study|Adverse Event|9
5353059|NCT00035932|18403221|P1|Overall Study|Adverse Event|10
5353060|NCT00035815|18403347|P2|Overall Study|Withdrawal by Subject|11
5353061|NCT00035815|18403348|P1|Overall Study|Withdrawal by Subject|17
5353062|NCT00035555|18403361|P3|Overall Study|Received cyclosporin in error|1
5353063|NCT00035555|18403362|P2|Overall Study|Received cyclosporin in error|0
5353064|NCT00035555|18403363|P1|Overall Study|Received cyclosporin in error|0
5353065|NCT00035555|18403361|P3|Overall Study|Investigator deemed not a good candidate|1
5353066|NCT00035555|18403362|P2|Overall Study|Investigator deemed not a good candidate|0
5353067|NCT00035555|18403363|P1|Overall Study|Investigator deemed not a good candidate|0
5353068|NCT00035555|18403361|P3|Overall Study|Withdrawal by Subject|2
5353069|NCT00035555|18403362|P2|Overall Study|Withdrawal by Subject|0
5353070|NCT00035555|18403363|P1|Overall Study|Withdrawal by Subject|2
5353071|NCT00035555|18403361|P3|Overall Study|Treatment failure/lack of efficacy|3
5353072|NCT00035555|18403362|P2|Overall Study|Treatment failure/lack of efficacy|5
5353073|NCT00035555|18403363|P1|Overall Study|Treatment failure/lack of efficacy|7
5353074|NCT00035555|18403361|P3|Overall Study|Prohibited medication|0
5353075|NCT00035555|18403362|P2|Overall Study|Prohibited medication|1
5353076|NCT00035555|18403363|P1|Overall Study|Prohibited medication|1
5353077|NCT00035555|18403361|P3|Overall Study|Noncompliance|1
5353078|NCT00035555|18403362|P2|Overall Study|Noncompliance|1
5353079|NCT00035555|18403363|P1|Overall Study|Noncompliance|0
5353080|NCT00035555|18403361|P3|Overall Study|Lost to Follow-up|1
5353081|NCT00035555|18403362|P2|Overall Study|Lost to Follow-up|0
5353082|NCT00035555|18403363|P1|Overall Study|Lost to Follow-up|0
5353083|NCT00035555|18403361|P3|Overall Study|Death|2
5353084|NCT00035555|18403362|P2|Overall Study|Death|0
5353085|NCT00035555|18403363|P1|Overall Study|Death|0
5353086|NCT00035555|18403361|P3|Overall Study|Allograft loss|2
5353087|NCT00035555|18403362|P2|Overall Study|Allograft loss|1
5353088|NCT00035555|18403363|P1|Overall Study|Allograft loss|1
5353089|NCT00035555|18403361|P3|Overall Study|Adverse Event|9
5353090|NCT00035555|18403362|P2|Overall Study|Adverse Event|8
5353091|NCT00035555|18403363|P1|Overall Study|Adverse Event|5
5353092|NCT00032487|18403447|P2|Overall Study|Had other reason|12
5353093|NCT00032487|18403448|P1|Overall Study|Had other reason|12
5353094|NCT00032487|18403447|P2|Overall Study|Lost to Follow-up|58
5353095|NCT00032487|18403448|P1|Overall Study|Lost to Follow-up|57
5353096|NCT00032487|18403447|P2|Overall Study|Adverse Event|7
5353097|NCT00032487|18403448|P1|Overall Study|Adverse Event|3
5353098|NCT00032487|18403447|P2|Overall Study|Withdrawal by Subject|43
5353099|NCT00032487|18403448|P1|Overall Study|Withdrawal by Subject|67
5353100|NCT00031551|18403458|P2|Overall Study|Withdrew due to chemotherapy effects|0
5353101|NCT00031551|18403459|P1|Overall Study|Withdrew due to chemotherapy effects|2
5353102|NCT00031486|18403471|P2|Overall Study|Other|1
5353103|NCT00031486|18403472|P1|Overall Study|Other|1
5353104|NCT00031486|18403471|P2|Overall Study|Did not meet eligibility requirement|1
5353105|NCT00031486|18403472|P1|Overall Study|Did not meet eligibility requirement|2
5353106|NCT00031486|18403471|P2|Overall Study|Non-compliant|4
5353107|NCT00031486|18403472|P1|Overall Study|Non-compliant|0
5353108|NCT00031486|18403471|P2|Overall Study|Death|3
5353109|NCT00031486|18403472|P1|Overall Study|Death|0
5353110|NCT00031486|18403471|P2|Overall Study|Withdrawal by Subject|2
5353111|NCT00031486|18403472|P1|Overall Study|Withdrawal by Subject|3
5353112|NCT00031486|18403471|P2|Overall Study|Lost to Follow-up|1
5353113|NCT00031486|18403472|P1|Overall Study|Lost to Follow-up|0
5353114|NCT00031486|18403471|P2|Overall Study|Adverse Event|0
5353115|NCT00031486|18403472|P1|Overall Study|Adverse Event|1
5353116|NCT00031460|18403498|P2|Overall Study|Confirmed unevaluable|1
5353117|NCT00031460|18403499|P1|Overall Study|Confirmed unevaluable|0
5353118|NCT00031460|18403498|P2|Overall Study|Disruption of blinded drug supply|0
5353119|NCT00031460|18403499|P1|Overall Study|Disruption of blinded drug supply|2
5353120|NCT00031460|18403498|P2|Overall Study|Reactivation of Disease|9
5353121|NCT00031460|18403499|P1|Overall Study|Reactivation of Disease|5
5353122|NCT00031460|18403498|P2|Overall Study|Death|1
5353123|NCT00031460|18403499|P1|Overall Study|Death|0
5353124|NCT00031460|18403498|P2|Overall Study|Non-Compliant|1
5353125|NCT00031460|18403499|P1|Overall Study|Non-Compliant|1
5353126|NCT00031460|18403498|P2|Overall Study|Withdrawal by Subject|1
5353127|NCT00031460|18403499|P1|Overall Study|Withdrawal by Subject|1
5353128|NCT00031460|18403498|P2|Overall Study|Lost to Follow-up|1
5353129|NCT00031460|18403499|P1|Overall Study|Lost to Follow-up|0
5353130|NCT00031447|18403513|P2|Overall Study|Disruption of blinded study drug supply|4
5353131|NCT00031447|18403514|P1|Overall Study|Disruption of blinded study drug supply|7
5353132|NCT00031447|18403513|P2|Overall Study|Re-activation of Disease|1
5353133|NCT00031447|18403514|P1|Overall Study|Re-activation of Disease|2
5353134|NCT00031447|18403513|P2|Overall Study|Non-compliant|1
5353135|NCT00031447|18403514|P1|Overall Study|Non-compliant|1
5353136|NCT00031447|18403513|P2|Overall Study|Lost to Follow-up|1
5353137|NCT00031447|18403514|P1|Overall Study|Lost to Follow-up|0
5353138|NCT00029146|18403589|P2|Overall Study|Lost to Follow-up|1
5353139|NCT00029146|18403590|P1|Overall Study|Lost to Follow-up|2
5353140|NCT00027378|18403641|P2|Overall Study|Physician Decision|3
5353141|NCT00027378|18403642|P1|Overall Study|Physician Decision|0
5353142|NCT00027027|18403655|P5|Overall Study|Withdrawal by Subject|1
5353143|NCT00027027|18403656|P4|Overall Study|Withdrawal by Subject|0
5353144|NCT00027027|18403657|P3|Overall Study|Withdrawal by Subject|0
5353145|NCT00027027|18403658|P2|Overall Study|Withdrawal by Subject|0
5353146|NCT00027027|18403659|P1|Overall Study|Withdrawal by Subject|0
5353147|NCT00027027|18403655|P5|Overall Study|Physician Decision Due To PD|5
5353148|NCT00027027|18403656|P4|Overall Study|Physician Decision Due To PD|3
5353149|NCT00027027|18403657|P3|Overall Study|Physician Decision Due To PD|2
5353150|NCT00027027|18403658|P2|Overall Study|Physician Decision Due To PD|3
5353151|NCT00027027|18403659|P1|Overall Study|Physician Decision Due To PD|2
5353152|NCT00027027|18403655|P5|Overall Study|PD Requiring Surgery|0
5353153|NCT00027027|18403656|P4|Overall Study|PD Requiring Surgery|0
5353154|NCT00027027|18403657|P3|Overall Study|PD Requiring Surgery|1
5353155|NCT00027027|18403658|P2|Overall Study|PD Requiring Surgery|0
5353156|NCT00027027|18403659|P1|Overall Study|PD Requiring Surgery|0
5353157|NCT00027027|18403655|P5|Overall Study|Clinical Symptoms Progression not PD|0
5353158|NCT00027027|18403656|P4|Overall Study|Clinical Symptoms Progression not PD|0
5353159|NCT00027027|18403657|P3|Overall Study|Clinical Symptoms Progression not PD|0
5353160|NCT00027027|18403658|P2|Overall Study|Clinical Symptoms Progression not PD|0
5353161|NCT00027027|18403659|P1|Overall Study|Clinical Symptoms Progression not PD|1
5353162|NCT00027027|18403655|P5|Overall Study|Admitted for Signs of PD|1
5353163|NCT00027027|18403656|P4|Overall Study|Admitted for Signs of PD|0
5353164|NCT00027027|18403657|P3|Overall Study|Admitted for Signs of PD|0
5353165|NCT00027027|18403658|P2|Overall Study|Admitted for Signs of PD|0
5353166|NCT00027027|18403659|P1|Overall Study|Admitted for Signs of PD|0
5353167|NCT00027027|18403655|P5|Overall Study|Adverse Event|1
5353168|NCT00027027|18403656|P4|Overall Study|Adverse Event|0
5353169|NCT00027027|18403657|P3|Overall Study|Adverse Event|1
5353170|NCT00027027|18403658|P2|Overall Study|Adverse Event|0
5353171|NCT00027027|18403659|P1|Overall Study|Adverse Event|0
5353172|NCT00026793|18403704|P1|Overall Study|Off study|2
5353173|NCT00026793|18403704|P1|Overall Study|Physician Decision|2
5353174|NCT00026793|18403704|P1|Overall Study|Death on study due to underlying disease|4
5353175|NCT00025883|18403714|P1|Overall Study|didn't reach 6 months of Metreleptin|10
5353176|NCT00025883|18403714|P1|Overall Study|Adverse Event|1
5353177|NCT00025883|18403714|P1|Overall Study|Death|1
5353178|NCT00025883|18403714|P1|Overall Study|no baseline data|1
5353179|NCT00025883|18403714|P1|Overall Study|had atypical progeriod lipodystrophy|4
5353180|NCT00023595|18403726|P5|10 Year Follow up|Lost to Follow-up|0
5353181|NCT00023595|18403727|P4|10 Year Follow up|Lost to Follow-up|0
5353182|NCT00023595|18403728|P3|10 Year Follow up|Lost to Follow-up|3
5353183|NCT00023595|18403729|P2|10 Year Follow up|Lost to Follow-up|10
5353184|NCT00023595|18403730|P1|10 Year Follow up|Lost to Follow-up|12
5353185|NCT00023595|18403726|P5|5 Year Follow up|Lost to Follow-up|3
5353186|NCT00023595|18403727|P4|5 Year Follow up|Lost to Follow-up|7
5353187|NCT00023595|18403728|P3|5 Year Follow up|Lost to Follow-up|1
5353188|NCT00023595|18403729|P2|5 Year Follow up|Lost to Follow-up|2
5353189|NCT00023595|18403730|P1|5 Year Follow up|Lost to Follow-up|2
5353190|NCT00023452|18403941|P2|Overall Study|Other|69
5353191|NCT00023452|18403942|P1|Overall Study|Other|204
5353192|NCT00023452|18403941|P2|Overall Study|Pregnant|20
5353193|NCT00023452|18403942|P1|Overall Study|Pregnant|53
5353194|NCT00023452|18403941|P2|Overall Study|Refused Treatment (continued follow-up)|224
5353195|NCT00023452|18403942|P1|Overall Study|Refused Treatment (continued follow-up)|225
5353196|NCT00023452|18403941|P2|Overall Study|Physician Decision|21
5353197|NCT00023452|18403942|P1|Overall Study|Physician Decision|49
5353198|NCT00023452|18403941|P2|Overall Study|Lost to Follow-up|60
5353199|NCT00023452|18403942|P1|Overall Study|Lost to Follow-up|293
5353200|NCT00023452|18403941|P2|Overall Study|Adverse Event|196
5353201|NCT00023452|18403942|P1|Overall Study|Adverse Event|139
5353202|NCT00023452|18403941|P2|Overall Study|Withdrawal by Subject|54
5353203|NCT00023452|18403942|P1|Overall Study|Withdrawal by Subject|66
5353204|NCT00023452|18403941|P2|Overall Study|Death|0
5353205|NCT00023452|18403942|P1|Overall Study|Death|2
5353206|NCT00023452|18403941|P2|Overall Study|Out of Window|69
5353207|NCT00023452|18403942|P1|Overall Study|Out of Window|129
5353208|NCT00023452|18403941|P2|Overall Study|Ineligible for Study|159
5353209|NCT00023452|18403942|P1|Overall Study|Ineligible for Study|163
5353210|NCT00023322|18403966|P1|Overall Study|Lost to Follow-up|1
5353211|NCT00022763|18403990|P2|Overall Study|Admin|2
5353212|NCT00022763|18403991|P1|Overall Study|Admin|3
5353213|NCT00022763|18403990|P2|Overall Study|Insufficient Therapy|0
5353214|NCT00022763|18403991|P1|Overall Study|Insufficient Therapy|1
5353215|NCT00022763|18403990|P2|Overall Study|Withdrawal by Subject|7
5353216|NCT00022763|18403991|P1|Overall Study|Withdrawal by Subject|4
5353217|NCT00022763|18403990|P2|Overall Study|Lost to Follow-up|3
5353218|NCT00022763|18403991|P1|Overall Study|Lost to Follow-up|0
5353219|NCT00022763|18403990|P2|Overall Study|Death|1
5353220|NCT00022763|18403991|P1|Overall Study|Death|0
5353221|NCT00022763|18403990|P2|Overall Study|Injection Site Reactions|2
5353222|NCT00022763|18403991|P1|Overall Study|Injection Site Reactions|0
5353223|NCT00022763|18403990|P2|Overall Study|Adverse Event|2
5353224|NCT00022763|18403991|P1|Overall Study|Adverse Event|1
5353225|NCT00014911|18404033|P1|Overall Study|Immunosuppression-related Side Effects|1
5353226|NCT00014911|18404033|P1|Overall Study|Unknown Reasons|2
5353227|NCT00014911|18404033|P1|Overall Study|Withdrawal by Subject|6
5353228|NCT00014911|18404033|P1|Overall Study|Lost to Follow-up|1
5353229|NCT00014911|18404033|P1|Overall Study|Adverse Event|1
5353230|NCT00006604|18404049|P17|Overall Study|Other Reason|0
5353231|NCT00006604|18404050|P16|Overall Study|Other Reason|0
5353232|NCT00006604|18404051|P15|Overall Study|Other Reason|0
5353233|NCT00006604|18404052|P14|Overall Study|Other Reason|0
5353234|NCT00006604|18404053|P13|Overall Study|Other Reason|0
5353235|NCT00006604|18404054|P12|Overall Study|Other Reason|0
5353236|NCT00006604|18404055|P11|Overall Study|Other Reason|0
5353237|NCT00006604|18404056|P10|Overall Study|Other Reason|1
5353238|NCT00006604|18404057|P9|Overall Study|Other Reason|0
5353239|NCT00006604|18404058|P8|Overall Study|Other Reason|0
5353240|NCT00006604|18404059|P7|Overall Study|Other Reason|0
5353241|NCT00006604|18404060|P6|Overall Study|Other Reason|1
5353242|NCT00006604|18404061|P5|Overall Study|Other Reason|0
5353243|NCT00006604|18404062|P4|Overall Study|Other Reason|0
5353244|NCT00006604|18404063|P3|Overall Study|Other Reason|0
5353245|NCT00006604|18404064|P2|Overall Study|Other Reason|0
5353246|NCT00006604|18404065|P1|Overall Study|Other Reason|0
5353247|NCT00006604|18404049|P17|Overall Study|Lost to Follow-up|3
5353248|NCT00006604|18404050|P16|Overall Study|Lost to Follow-up|1
5353249|NCT00006604|18404051|P15|Overall Study|Lost to Follow-up|0
5353250|NCT00006604|18404052|P14|Overall Study|Lost to Follow-up|0
5353251|NCT00006604|18404053|P13|Overall Study|Lost to Follow-up|0
5353252|NCT00006604|18404054|P12|Overall Study|Lost to Follow-up|0
5353253|NCT00006604|18404055|P11|Overall Study|Lost to Follow-up|0
5353254|NCT00006604|18404056|P10|Overall Study|Lost to Follow-up|2
5353255|NCT00006604|18404057|P9|Overall Study|Lost to Follow-up|0
5353256|NCT00006604|18404058|P8|Overall Study|Lost to Follow-up|1
5353257|NCT00006604|18404059|P7|Overall Study|Lost to Follow-up|0
5353258|NCT00006604|18404060|P6|Overall Study|Lost to Follow-up|0
5353259|NCT00006604|18404061|P5|Overall Study|Lost to Follow-up|0
5353260|NCT00006604|18404062|P4|Overall Study|Lost to Follow-up|0
5353261|NCT00006604|18404063|P3|Overall Study|Lost to Follow-up|0
5353262|NCT00006604|18404064|P2|Overall Study|Lost to Follow-up|0
5353263|NCT00006604|18404065|P1|Overall Study|Lost to Follow-up|0
5353264|NCT00006604|18404049|P17|Overall Study|Subj/parent not willing to adhere to req|4
5353265|NCT00006604|18404050|P16|Overall Study|Subj/parent not willing to adhere to req|3
5353266|NCT00006604|18404051|P15|Overall Study|Subj/parent not willing to adhere to req|3
5353267|NCT00006604|18404052|P14|Overall Study|Subj/parent not willing to adhere to req|2
5353268|NCT00006604|18404053|P13|Overall Study|Subj/parent not willing to adhere to req|0
5353269|NCT00006604|18404054|P12|Overall Study|Subj/parent not willing to adhere to req|0
5353270|NCT00006604|18404055|P11|Overall Study|Subj/parent not willing to adhere to req|3
5353271|NCT00006604|18404056|P10|Overall Study|Subj/parent not willing to adhere to req|6
5353272|NCT00006604|18404057|P9|Overall Study|Subj/parent not willing to adhere to req|0
5353273|NCT00006604|18404058|P8|Overall Study|Subj/parent not willing to adhere to req|1
5353274|NCT00006604|18404059|P7|Overall Study|Subj/parent not willing to adhere to req|3
5353275|NCT00006604|18404060|P6|Overall Study|Subj/parent not willing to adhere to req|0
5353276|NCT00006604|18404061|P5|Overall Study|Subj/parent not willing to adhere to req|0
5353277|NCT00006604|18404062|P4|Overall Study|Subj/parent not willing to adhere to req|3
5353278|NCT00006604|18404063|P3|Overall Study|Subj/parent not willing to adhere to req|1
5353279|NCT00006604|18404064|P2|Overall Study|Subj/parent not willing to adhere to req|0
5353280|NCT00006604|18404065|P1|Overall Study|Subj/parent not willing to adhere to req|0
5353281|NCT00006604|18404049|P17|Overall Study|Withdrawal by Subject|1
5353282|NCT00006604|18404050|P16|Overall Study|Withdrawal by Subject|0
5353283|NCT00006604|18404051|P15|Overall Study|Withdrawal by Subject|1
5353284|NCT00006604|18404052|P14|Overall Study|Withdrawal by Subject|2
5353285|NCT00006604|18404053|P13|Overall Study|Withdrawal by Subject|1
5353286|NCT00006604|18404054|P12|Overall Study|Withdrawal by Subject|0
5353287|NCT00006604|18404055|P11|Overall Study|Withdrawal by Subject|2
5353288|NCT00006604|18404056|P10|Overall Study|Withdrawal by Subject|3
5353289|NCT00006604|18404057|P9|Overall Study|Withdrawal by Subject|1
5353290|NCT00006604|18404058|P8|Overall Study|Withdrawal by Subject|0
5353291|NCT00006604|18404059|P7|Overall Study|Withdrawal by Subject|2
5353292|NCT00006604|18404060|P6|Overall Study|Withdrawal by Subject|2
5353293|NCT00006604|18404061|P5|Overall Study|Withdrawal by Subject|1
5353294|NCT00006604|18404062|P4|Overall Study|Withdrawal by Subject|0
5353295|NCT00006604|18404063|P3|Overall Study|Withdrawal by Subject|2
5353296|NCT00006604|18404064|P2|Overall Study|Withdrawal by Subject|0
5353297|NCT00006604|18404065|P1|Overall Study|Withdrawal by Subject|1
5353298|NCT00006604|18404049|P17|Overall Study|Site closing|1
5353299|NCT00006604|18404050|P16|Overall Study|Site closing|0
5353300|NCT00006604|18404051|P15|Overall Study|Site closing|0
5353301|NCT00006604|18404052|P14|Overall Study|Site closing|1
5353302|NCT00006604|18404053|P13|Overall Study|Site closing|1
5353303|NCT00006604|18404054|P12|Overall Study|Site closing|1
5353304|NCT00006604|18404055|P11|Overall Study|Site closing|0
5353305|NCT00006604|18404056|P10|Overall Study|Site closing|0
5353306|NCT00006604|18404057|P9|Overall Study|Site closing|0
5353307|NCT00006604|18404058|P8|Overall Study|Site closing|1
5353308|NCT00006604|18404059|P7|Overall Study|Site closing|0
5353309|NCT00006604|18404060|P6|Overall Study|Site closing|0
5353310|NCT00006604|18404061|P5|Overall Study|Site closing|0
5353311|NCT00006604|18404062|P4|Overall Study|Site closing|1
5353312|NCT00006604|18404063|P3|Overall Study|Site closing|1
5353313|NCT00006604|18404064|P2|Overall Study|Site closing|0
5353314|NCT00006604|18404065|P1|Overall Study|Site closing|0
5353315|NCT00006604|18404049|P17|Overall Study|Subj/Parent not able to get to clinic|0
5353316|NCT00006604|18404050|P16|Overall Study|Subj/Parent not able to get to clinic|0
5353317|NCT00006604|18404051|P15|Overall Study|Subj/Parent not able to get to clinic|3
5353318|NCT00006604|18404052|P14|Overall Study|Subj/Parent not able to get to clinic|1
5353319|NCT00006604|18404053|P13|Overall Study|Subj/Parent not able to get to clinic|1
5353320|NCT00006604|18404054|P12|Overall Study|Subj/Parent not able to get to clinic|1
5353321|NCT00006604|18404055|P11|Overall Study|Subj/Parent not able to get to clinic|2
5353322|NCT00006604|18404056|P10|Overall Study|Subj/Parent not able to get to clinic|1
5353323|NCT00006604|18404057|P9|Overall Study|Subj/Parent not able to get to clinic|0
5353324|NCT00006604|18404058|P8|Overall Study|Subj/Parent not able to get to clinic|0
5353325|NCT00006604|18404059|P7|Overall Study|Subj/Parent not able to get to clinic|1
5353326|NCT00006604|18404060|P6|Overall Study|Subj/Parent not able to get to clinic|0
5353327|NCT00006604|18404061|P5|Overall Study|Subj/Parent not able to get to clinic|1
5353328|NCT00006604|18404062|P4|Overall Study|Subj/Parent not able to get to clinic|1
5353329|NCT00006604|18404063|P3|Overall Study|Subj/Parent not able to get to clinic|0
5353330|NCT00006604|18404064|P2|Overall Study|Subj/Parent not able to get to clinic|0
5353331|NCT00006604|18404065|P1|Overall Study|Subj/Parent not able to get to clinic|0
5353332|NCT00006604|18404049|P17|Overall Study|Severe debilitation, unable to continue|0
5353333|NCT00006604|18404050|P16|Overall Study|Severe debilitation, unable to continue|0
5353334|NCT00006604|18404051|P15|Overall Study|Severe debilitation, unable to continue|2
5353335|NCT00006604|18404052|P14|Overall Study|Severe debilitation, unable to continue|0
5353336|NCT00006604|18404053|P13|Overall Study|Severe debilitation, unable to continue|1
5353337|NCT00006604|18404054|P12|Overall Study|Severe debilitation, unable to continue|2
5353338|NCT00006604|18404055|P11|Overall Study|Severe debilitation, unable to continue|0
5353339|NCT00006604|18404056|P10|Overall Study|Severe debilitation, unable to continue|5
5353340|NCT00006604|18404057|P9|Overall Study|Severe debilitation, unable to continue|0
5353341|NCT00006604|18404058|P8|Overall Study|Severe debilitation, unable to continue|0
5353342|NCT00006604|18404059|P7|Overall Study|Severe debilitation, unable to continue|3
5353343|NCT00006604|18404060|P6|Overall Study|Severe debilitation, unable to continue|0
5353344|NCT00006604|18404061|P5|Overall Study|Severe debilitation, unable to continue|0
5353345|NCT00006604|18404062|P4|Overall Study|Severe debilitation, unable to continue|0
5353346|NCT00006604|18404063|P3|Overall Study|Severe debilitation, unable to continue|0
5353347|NCT00006604|18404064|P2|Overall Study|Severe debilitation, unable to continue|0
5353348|NCT00006604|18404065|P1|Overall Study|Severe debilitation, unable to continue|0
5353349|NCT00006604|18404049|P17|Overall Study|Death|0
5353350|NCT00006604|18404050|P16|Overall Study|Death|0
5353351|NCT00006604|18404051|P15|Overall Study|Death|0
5353352|NCT00006604|18404052|P14|Overall Study|Death|0
5353353|NCT00006604|18404053|P13|Overall Study|Death|0
5353354|NCT00006604|18404054|P12|Overall Study|Death|1
5353355|NCT00006604|18404055|P11|Overall Study|Death|1
5353356|NCT00006604|18404056|P10|Overall Study|Death|1
5353357|NCT00006604|18404057|P9|Overall Study|Death|0
5353358|NCT00006604|18404058|P8|Overall Study|Death|0
5353359|NCT00006604|18404059|P7|Overall Study|Death|0
5353360|NCT00006604|18404060|P6|Overall Study|Death|0
5353361|NCT00006604|18404061|P5|Overall Study|Death|0
5353362|NCT00006604|18404062|P4|Overall Study|Death|0
5353363|NCT00006604|18404063|P3|Overall Study|Death|0
5353364|NCT00006604|18404064|P2|Overall Study|Death|0
5353365|NCT00006604|18404065|P1|Overall Study|Death|0
5353366|NCT00006604|18404049|P17|Overall Study|Randomization entry error-no RX, no FU|0
5353367|NCT00006604|18404050|P16|Overall Study|Randomization entry error-no RX, no FU|0
5353368|NCT00006604|18404051|P15|Overall Study|Randomization entry error-no RX, no FU|0
5353369|NCT00006604|18404052|P14|Overall Study|Randomization entry error-no RX, no FU|0
5353370|NCT00006604|18404053|P13|Overall Study|Randomization entry error-no RX, no FU|0
5353371|NCT00006604|18404054|P12|Overall Study|Randomization entry error-no RX, no FU|1
5353372|NCT00006604|18404055|P11|Overall Study|Randomization entry error-no RX, no FU|0
5353373|NCT00006604|18404056|P10|Overall Study|Randomization entry error-no RX, no FU|0
5353374|NCT00006604|18404057|P9|Overall Study|Randomization entry error-no RX, no FU|0
5353375|NCT00006604|18404058|P8|Overall Study|Randomization entry error-no RX, no FU|0
5353376|NCT00006604|18404059|P7|Overall Study|Randomization entry error-no RX, no FU|0
5353377|NCT00006604|18404060|P6|Overall Study|Randomization entry error-no RX, no FU|0
5353378|NCT00006604|18404061|P5|Overall Study|Randomization entry error-no RX, no FU|0
5353379|NCT00006604|18404062|P4|Overall Study|Randomization entry error-no RX, no FU|0
5353380|NCT00006604|18404063|P3|Overall Study|Randomization entry error-no RX, no FU|0
5353381|NCT00006604|18404064|P2|Overall Study|Randomization entry error-no RX, no FU|0
5353382|NCT00006604|18404065|P1|Overall Study|Randomization entry error-no RX, no FU|0
5353383|NCT00006604|18404049|P17|Overall Study|Met study objective - no further FU|0
5353384|NCT00006604|18404050|P16|Overall Study|Met study objective - no further FU|1
5353385|NCT00006604|18404051|P15|Overall Study|Met study objective - no further FU|1
5353386|NCT00006604|18404052|P14|Overall Study|Met study objective - no further FU|0
5353387|NCT00006604|18404053|P13|Overall Study|Met study objective - no further FU|0
5353388|NCT00006604|18404054|P12|Overall Study|Met study objective - no further FU|0
5353389|NCT00006604|18404055|P11|Overall Study|Met study objective - no further FU|0
5353390|NCT00006604|18404056|P10|Overall Study|Met study objective - no further FU|0
5353391|NCT00006604|18404057|P9|Overall Study|Met study objective - no further FU|0
5353392|NCT00006604|18404058|P8|Overall Study|Met study objective - no further FU|0
5353393|NCT00006604|18404059|P7|Overall Study|Met study objective - no further FU|0
5353394|NCT00006604|18404060|P6|Overall Study|Met study objective - no further FU|0
5353395|NCT00006604|18404061|P5|Overall Study|Met study objective - no further FU|0
5353396|NCT00006604|18404062|P4|Overall Study|Met study objective - no further FU|0
5353397|NCT00006604|18404063|P3|Overall Study|Met study objective - no further FU|0
5353398|NCT00006604|18404064|P2|Overall Study|Met study objective - no further FU|0
5353399|NCT00006604|18404065|P1|Overall Study|Met study objective - no further FU|1
5353400|NCT00004978|18404181|P2|Overall Study|site closure - not in analysis cohort|20
5353401|NCT00004978|18404182|P1|Overall Study|site closure - not in analysis cohort|19
5353402|NCT00004978|18404181|P2|Overall Study|Withdrawal by Subject|26
5353403|NCT00004978|18404182|P1|Overall Study|Withdrawal by Subject|17
5353404|NCT00004978|18404181|P2|Overall Study|Lost to Follow-up|108
5353405|NCT00004978|18404182|P1|Overall Study|Lost to Follow-up|101
5353406|NCT00004978|18404181|P2|Overall Study|Death|116
5353407|NCT00004978|18404182|P1|Overall Study|Death|107
5353408|NCT00021541|18404208|P2|Period 2-crossover|Pts that did not progress|3
5353409|NCT00021541|18404209|P1|Period 2-crossover|Pts that did not progress|2
5353410|NCT00021541|18404208|P2|Period 2-crossover|non-adherence|0
5353411|NCT00021541|18404209|P1|Period 2-crossover|non-adherence|1
5353412|NCT00021541|18404208|P2|Period 2-crossover|Adverse Event|2
5353413|NCT00021541|18404209|P1|Period 2-crossover|Adverse Event|2
5353414|NCT00021541|18404208|P2|Period 2-crossover|Withdrawal by Subject|4
5353415|NCT00021541|18404209|P1|Period 2-crossover|Withdrawal by Subject|3
5353416|NCT00021541|18404208|P2|Period 2-crossover|refused phase B|2
5353417|NCT00021541|18404209|P1|Period 2-crossover|refused phase B|2
5353418|NCT00021541|18404208|P2|Period 1-First Treatment|Ineligible|2
5353419|NCT00021541|18404209|P1|Period 1-First Treatment|Ineligible|0
5353420|NCT00021541|18404208|P2|Period 1-First Treatment|Pts that did not progress|2
5353421|NCT00021541|18404209|P1|Period 1-First Treatment|Pts that did not progress|2
5353422|NCT00021541|18404208|P2|Period 1-First Treatment|Death|0
5353423|NCT00021541|18404209|P1|Period 1-First Treatment|Death|1
5353424|NCT00021541|18404208|P2|Period 1-First Treatment|non-adherence|0
5353425|NCT00021541|18404209|P1|Period 1-First Treatment|non-adherence|3
5353426|NCT00021541|18404208|P2|Period 1-First Treatment|Adverse Event|1
5353427|NCT00021541|18404209|P1|Period 1-First Treatment|Adverse Event|2
5353428|NCT00021541|18404208|P2|Period 1-First Treatment|Withdrawal by Subject|3
5353429|NCT00021541|18404209|P1|Period 1-First Treatment|Withdrawal by Subject|3
5353430|NCT00015457|18404223|P2|Second Intervention|Withdrawal by Subject|0
5353431|NCT00015457|18404224|P1|Second Intervention|Withdrawal by Subject|1
5353432|NCT00015457|18404223|P2|First Intervention|Lack of Efficacy|1
5353433|NCT00015457|18404224|P1|First Intervention|Lack of Efficacy|0
5353434|NCT00015457|18404223|P2|First Intervention|Adverse Event|2
5353435|NCT00015457|18404224|P1|First Intervention|Adverse Event|0
5353436|NCT00013611|18404234|P2|Overall Study|Lost to Follow-up|100
5353437|NCT00013611|18404235|P1|Overall Study|Lost to Follow-up|91
5353438|NCT00010803|18404253|P2|Overall Study|Withdrawal by Subject|98
5353439|NCT00010803|18404254|P1|Overall Study|Withdrawal by Subject|97
5353440|NCT00010374|18404269|P1|Overall Study|False positive phrenic nerve test|1
5353441|NCT00007475|18404287|P4|Overall Study|Adverse Event|0
5353442|NCT00007475|18404288|P3|Overall Study|Adverse Event|0
5353443|NCT00007475|18404289|P2|Overall Study|Adverse Event|0
5353444|NCT00007475|18404290|P1|Overall Study|Adverse Event|3
5353445|NCT00007475|18404287|P4|Overall Study|Withdrawal by Subject|0
5353446|NCT00007475|18404288|P3|Overall Study|Withdrawal by Subject|0
5353447|NCT00007475|18404289|P2|Overall Study|Withdrawal by Subject|0
5353448|NCT00007475|18404290|P1|Overall Study|Withdrawal by Subject|1
5353449|NCT00007345|18404312|P2|Overall Study|Death on study|1
5353450|NCT00007345|18404313|P1|Overall Study|Death on study|1
5353451|NCT00007345|18404312|P2|Overall Study|Intercurrent illness|0
5353452|NCT00007345|18404313|P1|Overall Study|Intercurrent illness|1
5353453|NCT00007345|18404312|P2|Overall Study|Switched to alternative treatment|3
5353454|NCT00007345|18404313|P1|Overall Study|Switched to alternative treatment|0
5353455|NCT00007345|18404312|P2|Overall Study|Refused further treatment|7
5353456|NCT00007345|18404313|P1|Overall Study|Refused further treatment|0
5353457|NCT00007020|18404331|P1|Overall Study|No evidence of treatment|6
5353458|NCT00007020|18404331|P1|Overall Study|Pt cared for by outside physician|4
5353459|NCT00007020|18404331|P1|Overall Study|Pt withdrawn (liver transplant)|4
5353460|NCT00007020|18404331|P1|Overall Study|Pt withdrawn (worsening cholestasis)|1
5353461|NCT00007020|18404331|P1|Overall Study|Lost to Follow-up|13
5353462|NCT00007020|18404331|P1|Overall Study|Death|16
5353463|NCT00006489|18404344|P4|Overall Study|Death|1
5353464|NCT00006489|18404345|P3|Overall Study|Death|0
5353465|NCT00006489|18404346|P2|Overall Study|Death|0
5353466|NCT00006489|18404347|P1|Overall Study|Death|0
5353467|NCT00006489|18404344|P4|Overall Study|Scheduling Conflict|1
5353468|NCT00006489|18404345|P3|Overall Study|Scheduling Conflict|2
5353469|NCT00006489|18404346|P2|Overall Study|Scheduling Conflict|3
5353470|NCT00006489|18404347|P1|Overall Study|Scheduling Conflict|0
5353471|NCT00006489|18404344|P4|Overall Study|Withdrawal by Subject|6
5353472|NCT00006489|18404345|P3|Overall Study|Withdrawal by Subject|9
5353473|NCT00006489|18404346|P2|Overall Study|Withdrawal by Subject|9
5353474|NCT00006489|18404347|P1|Overall Study|Withdrawal by Subject|10
5353475|NCT00006489|18404344|P4|Overall Study|Adverse Event|3
5353476|NCT00006489|18404345|P3|Overall Study|Adverse Event|4
5353477|NCT00006489|18404346|P2|Overall Study|Adverse Event|2
5353478|NCT00006489|18404347|P1|Overall Study|Adverse Event|3
5353479|NCT00006409|18404382|P6|Post-3 Year Intervention|Protocol Violation|62
5353480|NCT00006409|18404383|P5|Post-3 Year Intervention|Protocol Violation|62
5353481|NCT00006409|18404384|P4|Post-3 Year Intervention|Protocol Violation|0
5353482|NCT00006409|18404385|P3|Post-3 Year Intervention|Protocol Violation|0
5353483|NCT00006409|18404386|P2|Post-3 Year Intervention|Protocol Violation|0
5353484|NCT00006409|18404387|P1|Post-3 Year Intervention|Protocol Violation|0
5353485|NCT00006409|18404382|P6|Post-2 Year Intervention|Protocol Violation|0
5353486|NCT00006409|18404383|P5|Post-2 Year Intervention|Protocol Violation|0
5353487|NCT00006409|18404384|P4|Post-2 Year Intervention|Protocol Violation|168
5353488|NCT00006409|18404385|P3|Post-2 Year Intervention|Protocol Violation|251
5353489|NCT00006409|18404386|P2|Post-2 Year Intervention|Protocol Violation|0
5353490|NCT00006409|18404387|P1|Post-2 Year Intervention|Protocol Violation|0
5353491|NCT00006409|18404382|P6|Baseline|Protocol Violation|0
5353492|NCT00006409|18404383|P5|Baseline|Protocol Violation|0
5353493|NCT00006409|18404384|P4|Baseline|Protocol Violation|0
5353494|NCT00006409|18404385|P3|Baseline|Protocol Violation|0
5353495|NCT00006409|18404386|P2|Baseline|Protocol Violation|70
5353496|NCT00006409|18404387|P1|Baseline|Protocol Violation|48
5353497|NCT00006305|18404426|P4|Overall Study|Withdrawal by Subject|14
5353498|NCT00006305|18404427|P3|Overall Study|Withdrawal by Subject|15
5353499|NCT00006305|18404428|P2|Overall Study|Withdrawal by Subject|10
5353500|NCT00006305|18404429|P1|Overall Study|Withdrawal by Subject|17
5353501|NCT00006289|18404445|P2|Second Intervention (5 Weeks)|Protocol Violation|1
5353502|NCT00006289|18404446|P1|Second Intervention (5 Weeks)|Protocol Violation|1
5353503|NCT00006289|18404445|P2|First Intervention (5 Weeks)|Adverse Event|0
5353504|NCT00006289|18404446|P1|First Intervention (5 Weeks)|Adverse Event|1
5353505|NCT00006184|18404464|P2|Overall Study|Death|0
5353506|NCT00006184|18404465|P1|Overall Study|Death|1
5353507|NCT00006164|18404516|P2|Overall Study|Withdrew or lost to follow-up|81
5353508|NCT00006164|18404517|P1|Overall Study|Withdrew or lost to follow-up|70
5353509|NCT00005937|18404560|P1|Overall Study|Lack of Efficacy|5
5353510|NCT00005908|18404564|P2|Overall Study|Withdrawal by Subject|0
5353511|NCT00005908|18404565|P1|Overall Study|Withdrawal by Subject|1
5353512|NCT00005906|18404574|P1|Overall Study|Lack of Efficacy|3
5353513|NCT00004980|18404618|P2|Overall Study|Physician Decision|1
5353514|NCT00004980|18404619|P1|Overall Study|Physician Decision|0
5353515|NCT00004980|18404618|P2|Overall Study|memory difficulties|1
5353516|NCT00004980|18404619|P1|Overall Study|memory difficulties|1
5353517|NCT00004980|18404618|P2|Overall Study|Withdrawal by Subject|0
5353518|NCT00004980|18404619|P1|Overall Study|Withdrawal by Subject|1
5353519|NCT00004732|18404633|P2|Overall Study|Lost to Follow-up|47
5353520|NCT00004732|18404634|P1|Overall Study|Lost to Follow-up|33
5353521|NCT00004732|18404633|P2|Overall Study|Withdrawal by Subject|64
5353522|NCT00004732|18404634|P1|Overall Study|Withdrawal by Subject|36
5353523|NCT00004635|18404644|P2|Period Two|discrepancy in data entry|1
5353524|NCT00004635|18404645|P1|Period Two|discrepancy in data entry|0
5353525|NCT00004635|18404644|P2|Period Two|Lost to Follow-up|0
5353526|NCT00004635|18404645|P1|Period Two|Lost to Follow-up|1
5353527|NCT00004635|18404644|P2|Period Two|secondary malignancy|1
5353528|NCT00004635|18404645|P1|Period Two|secondary malignancy|1
5353529|NCT00004635|18404644|P2|Period Two|travel issues|1
5353530|NCT00004635|18404645|P1|Period Two|travel issues|0
5353531|NCT00004635|18404644|P2|Period Two|health problem|1
5353532|NCT00004635|18404645|P1|Period Two|health problem|1
5353533|NCT00004635|18404644|P2|Period Two|refused|2
5353534|NCT00004635|18404645|P1|Period Two|refused|0
5353535|NCT00004635|18404644|P2|Period Two|Adverse Event|0
5353536|NCT00004635|18404645|P1|Period Two|Adverse Event|1
5353537|NCT00004635|18404644|P2|Period Two|progression|3
5353538|NCT00004635|18404645|P1|Period Two|progression|2
5353539|NCT00004635|18404644|P2|Period One|discrepancy in data entry|1
5353540|NCT00004635|18404645|P1|Period One|discrepancy in data entry|0
5353541|NCT00004635|18404644|P2|Period One|health problem|1
5353542|NCT00004635|18404645|P1|Period One|health problem|0
5353543|NCT00004635|18404644|P2|Period One|progressed|2
5353544|NCT00004635|18404645|P1|Period One|progressed|0
5353545|NCT00004635|18404644|P2|Period One|second malignancy|0
5353546|NCT00004635|18404645|P1|Period One|second malignancy|1
5353547|NCT00004635|18404644|P2|Period One|PSA did not go <5 ng/mL|0
5353548|NCT00004635|18404645|P1|Period One|PSA did not go <5 ng/mL|1
5353549|NCT00004635|18404644|P2|Period One|Protocol Violation|0
5353550|NCT00004635|18404645|P1|Period One|Protocol Violation|1
5353551|NCT00004635|18404644|P2|Period One|Withdrawal by Subject|1
5353552|NCT00004635|18404645|P1|Period One|Withdrawal by Subject|1
5353553|NCT00004635|18404644|P2|Period One|refused|1
5353554|NCT00004635|18404645|P1|Period One|refused|2
5353555|NCT00004563|18404657|P2|Overall Study|Death|3
5353556|NCT00004563|18404658|P1|Overall Study|Death|2
5353557|NCT00004563|18404657|P2|Overall Study|Lack of Efficacy|5
5353558|NCT00004563|18404658|P1|Overall Study|Lack of Efficacy|3
5353559|NCT00004563|18404657|P2|Overall Study|Withdrawal by Subject|16
5353560|NCT00004563|18404658|P1|Overall Study|Withdrawal by Subject|20
5353561|NCT00004562|18404670|P2|Overall Study|Lost to Follow-up|91
5353562|NCT00004562|18404671|P1|Overall Study|Lost to Follow-up|102
5353563|NCT00001962|18404712|P1|Overall Study|Adverse Event|1
5353564|NCT00001962|18404712|P1|Overall Study|Lost to Follow-up|2
5353565|NCT00001962|18404712|P1|Overall Study|Death|1
5353566|NCT00001962|18404712|P1|Overall Study|Lack of Accrual|6
5353567|NCT00001962|18404712|P1|Overall Study|Lack of Efficacy|18
5353568|NCT00001959|18404716|P1|Overall Study|non-compliance|1
5353569|NCT00001959|18404716|P1|Overall Study|disabling sedation|1
5353570|NCT00001959|18404716|P1|Overall Study|newly diagnosed colon cancer|1
5353571|NCT00001941|18404722|P5|Overall Study|not treated- rapidly progressing disease|1
5353572|NCT00001941|18404723|P4|Overall Study|not treated- rapidly progressing disease|0
5353573|NCT00001941|18404724|P3|Overall Study|not treated- rapidly progressing disease|0
5353574|NCT00001941|18404725|P2|Overall Study|not treated- rapidly progressing disease|0
5353575|NCT00001941|18404726|P1|Overall Study|not treated- rapidly progressing disease|0
5353576|NCT00001832|18404758|P15|Treatment Period|Not treated|0
5353577|NCT00001832|18404759|P14|Treatment Period|Not treated|0
5353578|NCT00001832|18404760|P13|Treatment Period|Not treated|0
5353579|NCT00001832|18404761|P12|Treatment Period|Not treated|0
5353580|NCT00001832|18404762|P11|Treatment Period|Not treated|0
5353581|NCT00001832|18404763|P10|Treatment Period|Not treated|0
5353582|NCT00001832|18404764|P9|Treatment Period|Not treated|0
5353583|NCT00001832|18404765|P8|Treatment Period|Not treated|1
5353584|NCT00001832|18404766|P7|Treatment Period|Not treated|0
5353585|NCT00001832|18404767|P6|Treatment Period|Not treated|0
5353586|NCT00001832|18404768|P5|Treatment Period|Not treated|0
5353587|NCT00001832|18404769|P4|Treatment Period|Not treated|0
5353588|NCT00001832|18404770|P3|Treatment Period|Not treated|0
5353589|NCT00001832|18404771|P2|Treatment Period|Not treated|0
5353590|NCT00001832|18404772|P1|Treatment Period|Not treated|0
5353591|NCT00001832|18404758|P15|Treatment Period|Death during treatment|0
5353592|NCT00001832|18404759|P14|Treatment Period|Death during treatment|0
5353593|NCT00001832|18404760|P13|Treatment Period|Death during treatment|0
5353594|NCT00001832|18404761|P12|Treatment Period|Death during treatment|0
5353595|NCT00001832|18404762|P11|Treatment Period|Death during treatment|0
5353596|NCT00001832|18404763|P10|Treatment Period|Death during treatment|0
5353597|NCT00001832|18404764|P9|Treatment Period|Death during treatment|0
5353598|NCT00001832|18404765|P8|Treatment Period|Death during treatment|0
5353599|NCT00001832|18404766|P7|Treatment Period|Death during treatment|0
5353600|NCT00001832|18404767|P6|Treatment Period|Death during treatment|1
5353601|NCT00001832|18404768|P5|Treatment Period|Death during treatment|0
5353602|NCT00001832|18404769|P4|Treatment Period|Death during treatment|0
5353603|NCT00001832|18404770|P3|Treatment Period|Death during treatment|0
5353604|NCT00001832|18404771|P2|Treatment Period|Death during treatment|0
5353605|NCT00001832|18404772|P1|Treatment Period|Death during treatment|0
5353606|NCT00001832|18404758|P15|Apheresis Period|not able to manufacture treatment cells|0
5353607|NCT00001832|18404759|P14|Apheresis Period|not able to manufacture treatment cells|0
5353608|NCT00001832|18404760|P13|Apheresis Period|not able to manufacture treatment cells|0
5353609|NCT00001832|18404761|P12|Apheresis Period|not able to manufacture treatment cells|0
5353610|NCT00001832|18404762|P11|Apheresis Period|not able to manufacture treatment cells|0
5353611|NCT00001832|18404763|P10|Apheresis Period|not able to manufacture treatment cells|0
5353612|NCT00001832|18404764|P9|Apheresis Period|not able to manufacture treatment cells|0
5353613|NCT00001832|18404765|P8|Apheresis Period|not able to manufacture treatment cells|0
5353614|NCT00001832|18404766|P7|Apheresis Period|not able to manufacture treatment cells|0
5353615|NCT00001832|18404767|P6|Apheresis Period|not able to manufacture treatment cells|0
5353616|NCT00001832|18404768|P5|Apheresis Period|not able to manufacture treatment cells|0
5353617|NCT00001832|18404769|P4|Apheresis Period|not able to manufacture treatment cells|0
5353618|NCT00001832|18404770|P3|Apheresis Period|not able to manufacture treatment cells|0
5353619|NCT00001832|18404771|P2|Apheresis Period|not able to manufacture treatment cells|0
5353620|NCT00001832|18404772|P1|Apheresis Period|not able to manufacture treatment cells|60
5353621|NCT00001723|18404818|P2|Overall Study|medication intolerance|2
5353622|NCT00001723|18404819|P1|Overall Study|medication intolerance|1
5353623|NCT00001723|18404818|P2|Overall Study|Lost to Follow-up|2
5353624|NCT00001723|18404819|P1|Overall Study|Lost to Follow-up|2
5353625|NCT00001723|18404818|P2|Overall Study|Lack of family interest|5
5353626|NCT00001723|18404819|P1|Overall Study|Lack of family interest|4
5353627|NCT00001723|18404818|P2|Overall Study|Lack of Efficacy|7
5353628|NCT00001723|18404819|P1|Overall Study|Lack of Efficacy|6
5353629|NCT00001703|18404835|P1|Overall Study|recurrent disease|2
5353630|NCT00001703|18404835|P1|Overall Study|No evidence of disease|1
5353631|NCT00001703|18404835|P1|Overall Study|progressed disease|2
5353632|NCT00001596|18404873|P2|Overall Study|Adverse Event|0
5353633|NCT00001596|18404874|P1|Overall Study|Adverse Event|1
5353634|NCT00001596|18404873|P2|Overall Study|Study Termination|9
5353635|NCT00001596|18404874|P1|Overall Study|Study Termination|12
5353636|NCT00001596|18404873|P2|Overall Study|Withdrawal by Subject|1
5353637|NCT00001596|18404874|P1|Overall Study|Withdrawal by Subject|3
5353638|NCT00001596|18404873|P2|Overall Study|Death|0
5353639|NCT00001596|18404874|P1|Overall Study|Death|1
5353640|NCT00001575|18404905|P1|Overall Study|Withdrawn/deaths|23
5353641|NCT00001575|18404905|P1|Overall Study|Screening failures-Ph I portion|22
5353642|NCT00001566|18404911|P1|Overall Study|unable to complete initial apheresis|1
5353643|NCT00001566|18404911|P1|Overall Study|Lost to Follow-up|1
5353644|NCT00001566|18404911|P1|Overall Study|Death|13
5353645|NCT00001566|18404911|P1|Overall Study|stopped after C3 due to symptomatic PD|1
5353646|NCT00001566|18404911|P1|Overall Study|patients' choice to discontinue protocol|3
5353647|NCT00001262|18404951|P3|Overall Study|Withdrawal by Subject|0
5353648|NCT00001262|18404952|P2|Overall Study|Withdrawal by Subject|3
5353649|NCT00001262|18404953|P1|Overall Study|Withdrawal by Subject|0
5353650|NCT00001262|18404951|P3|Overall Study|Death|0
5353651|NCT00001262|18404952|P2|Overall Study|Death|11
5353652|NCT00001262|18404953|P1|Overall Study|Death|10
5353653|NCT00001213|18404979|P1|Overall Study|Death|18
5353654|NCT00000378|18404990|P2|Overall Study|Lack of Efficacy|14
5353655|NCT00000378|18404991|P1|Overall Study|Lack of Efficacy|16
5353656|NCT00000620|18405008|P8|Overall Study|missed closeout visit|16
5353657|NCT00000620|18405009|P7|Overall Study|missed closeout visit|13
5353658|NCT00000620|18405010|P6|Overall Study|missed closeout visit|28
5353659|NCT00000620|18405011|P5|Overall Study|missed closeout visit|26
5353660|NCT00000620|18405012|P4|Overall Study|missed closeout visit|11
5353661|NCT00000620|18405013|P3|Overall Study|missed closeout visit|16
5353662|NCT00000620|18405014|P2|Overall Study|missed closeout visit|28
5353663|NCT00000620|18405015|P1|Overall Study|missed closeout visit|22
5353664|NCT00000620|18405008|P8|Overall Study|Withdrawal by Subject|21
5353665|NCT00000620|18405009|P7|Overall Study|Withdrawal by Subject|32
5353666|NCT00000620|18405010|P6|Overall Study|Withdrawal by Subject|32
5353667|NCT00000620|18405011|P5|Overall Study|Withdrawal by Subject|30
5353668|NCT00000620|18405012|P4|Overall Study|Withdrawal by Subject|27
5353669|NCT00000620|18405013|P3|Overall Study|Withdrawal by Subject|28
5353670|NCT00000620|18405014|P2|Overall Study|Withdrawal by Subject|27
5353671|NCT00000620|18405015|P1|Overall Study|Withdrawal by Subject|40
5353672|NCT00000620|18405008|P8|Overall Study|Lost to Follow-up|14
5353673|NCT00000620|18405009|P7|Overall Study|Lost to Follow-up|13
5353674|NCT00000620|18405010|P6|Overall Study|Lost to Follow-up|15
5353675|NCT00000620|18405011|P5|Overall Study|Lost to Follow-up|15
5353676|NCT00000620|18405012|P4|Overall Study|Lost to Follow-up|14
5353677|NCT00000620|18405013|P3|Overall Study|Lost to Follow-up|14
5353678|NCT00000620|18405014|P2|Overall Study|Lost to Follow-up|14
5353679|NCT00000620|18405015|P1|Overall Study|Lost to Follow-up|14
5353680|NCT00000620|18405008|P8|Overall Study|Death|95
5353681|NCT00000620|18405009|P7|Overall Study|Death|91
5353682|NCT00000620|18405010|P6|Overall Study|Death|77
5353683|NCT00000620|18405011|P5|Overall Study|Death|64
5353684|NCT00000620|18405012|P4|Overall Study|Death|126
5353685|NCT00000620|18405013|P3|Overall Study|Death|112
5353686|NCT00000620|18405014|P2|Overall Study|Death|67
5353687|NCT00000620|18405015|P1|Overall Study|Death|86
5353688|NCT00004445|18405096|P1|Overall Study|Withdrawal by Subject|1
5353689|NCT00004445|18405096|P1|Overall Study|Physician Decision|2
5353690|NCT00004412|18405109|P3|Randomized Period|Moved to Crossover Period|0
5353691|NCT00004412|18405110|P2|Randomized Period|Moved to Crossover Period|0
5353692|NCT00004412|18405111|P1|Randomized Period|Moved to Crossover Period|3
5353693|NCT00000135|18405152|P2|Overall Study|Death|14
5353694|NCT00000135|18405153|P1|Overall Study|Death|27
